Citrus Sinensis ID: 003052
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 853 | 2.2.26 [Sep-21-2011] | |||||||
| Q54UL8 | 983 | Probable serine/threonine | yes | no | 0.318 | 0.276 | 0.49 | 8e-71 | |
| O94235 | 678 | Serine/threonine-protein | yes | no | 0.361 | 0.454 | 0.407 | 2e-69 | |
| P33981 | 857 | Dual specificity protein | yes | no | 0.339 | 0.338 | 0.432 | 8e-64 | |
| Q4R945 | 856 | Dual specificity protein | N/A | no | 0.339 | 0.338 | 0.435 | 9e-64 | |
| P35761 | 856 | Dual specificity protein | yes | no | 0.315 | 0.314 | 0.437 | 6e-61 | |
| Q8AYG3 | 982 | Dual specificity protein | yes | no | 0.344 | 0.299 | 0.408 | 1e-60 | |
| P54199 | 764 | Serine/threonine-protein | yes | no | 0.344 | 0.384 | 0.377 | 1e-59 | |
| Q8SSH4 | 586 | Probable serine/threonine | yes | no | 0.301 | 0.438 | 0.397 | 6e-50 | |
| Q9Y6R4 | 1608 | Mitogen-activated protein | no | no | 0.376 | 0.199 | 0.287 | 7e-25 | |
| Q03306 | 898 | Serine/threonine-protein | no | no | 0.212 | 0.201 | 0.330 | 2e-24 |
| >sp|Q54UL8|MPS1_DICDI Probable serine/threonine-protein kinase mps1 OS=Dictyostelium discoideum GN=mps1 PE=3 SV=1 | Back alignment and function desciption |
|---|
Score = 269 bits (687), Expect = 8e-71, Method: Compositional matrix adjust.
Identities = 147/300 (49%), Positives = 195/300 (65%), Gaps = 28/300 (9%)
Query: 469 VNGKLYQRLGKIGSGGSSEVHKVISSDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLK 528
VNGK Y R+ IG GGS +V+KV+S D IYALK + L + A EIE L +L+
Sbjct: 709 VNGKPYLRIEFIGKGGSGKVYKVLSGDLKIYALKYVCLSDPNEIEAQ--LNEIEMLKRLR 766
Query: 529 GKNNIIQLIDYEVTEKALLREVLNGSMNNKDGRVKDDGYIYMVLEYGEIDLAHMLSQKWK 588
+ NIIQLIDYEV N + N YI +VLE+GEIDL+ +L Q+ +
Sbjct: 767 KQVNIIQLIDYEV----------NMAKN----------YILLVLEFGEIDLSKLL-QRLQ 805
Query: 589 EMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLLVKGSLKLIDFGIAKA 648
+G+N N++R YWQQ+L+AV+TIHEE+I+H DLKPANF+ V+GSLKLIDFGIAKA
Sbjct: 806 TPNGTNV----NFIRIYWQQMLQAVHTIHEEKIIHGDLKPANFVSVQGSLKLIDFGIAKA 861
Query: 649 IMSD-TTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGR 707
I SD TTNI R+SQ+GT++Y+SPEA + +K GR SDIWSLGCILY+M +G
Sbjct: 862 IQSDDTTNIVRESQIGTINYISPEALIDTSQGGPKQCMKLGRASDIWSLGCILYEMAFGY 921
Query: 708 TPFSEYKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQHPFL 767
PF + +K++ I +P+H+I + PN LL ++K CL + +ER IP LL H FL
Sbjct: 922 PPFKSFSNIISKYQAIINPHHKIEFPVHPNENLLKVLKLCLIRNPHERPTIPTLLNHDFL 981
|
Dictyostelium discoideum (taxid: 44689) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|O94235|MPH1_SCHPO Serine/threonine-protein kinase mph1 OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) GN=mph1 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 264 bits (675), Expect = 2e-69, Method: Compositional matrix adjust.
Identities = 152/373 (40%), Positives = 210/373 (56%), Gaps = 65/373 (17%)
Query: 474 YQRLGKIGSGGSSEVHKVISSDCT-IYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNN 532
+ +LG +G GGSS V+++ S D + +YALK++ D T G+ EI L KL G +
Sbjct: 316 FIKLGVVGKGGSSMVYRIFSPDNSRLYALKEVNFINADQTTIQGYKNEIALLRKLSGNDR 375
Query: 533 IIQLIDYEVTEKALLREVLNGSMNNKDGRVKDDGYIYMVLEYGEIDLAHMLSQKWKEMDG 592
II+L EV + G + MV+E GE DLA++L + K
Sbjct: 376 IIKLYAAEVNDTL--------------------GQLNMVMECGETDLANLLMKNMK---- 411
Query: 593 SNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLLVKGSLKLIDFGIAKAIMSD 652
+ ++ N++R YW+Q+LEAV +H++ IVHSDLKPANFLLV+G+LKLIDFGIAKAI +D
Sbjct: 412 --KPINLNFIRMYWEQMLEAVQVVHDQNIVHSDLKPANFLLVEGNLKLIDFGIAKAIGND 469
Query: 653 TTNIQRDSQVGTLSYMSPEAF--MCNESDENGNIIKCGRPSDIWSLGCILYQMVYGRTPF 710
TTNI RDS +GT++YM+PEA M ++ ++K GRPSD+WSLGCILYQMVYGR PF
Sbjct: 470 TTNIHRDSHIGTINYMAPEALTDMNAHTNSGVKLVKLGRPSDVWSLGCILYQMVYGRAPF 529
Query: 711 SEYKTFWAKFKVITDPNHEITYEPVP------------------NPWLLDLMKKCLAWDR 752
+ K A I + + I + V P L+D+MK+CL D+
Sbjct: 530 AHLKMIQA-IAAIPNEQYHIHFPEVALPANAVQEKEGSLPGVTVGPDLMDVMKRCLERDQ 588
Query: 753 NERWRIPQLLQHPFLVP------PVSTQ--PSSSQDQSYQLLQLLAEASASDHEASTICS 804
+R IP+LL HPFL P P++ + P S + L+L E SA S
Sbjct: 589 RKRLTIPELLVHPFLNPLPSYLTPLAKKPLPVSGHTNNAHPLRLSTEISA---------S 639
Query: 805 QLSQLIRNPVMLA 817
QLS +I V L+
Sbjct: 640 QLSMIIERSVELS 652
|
Involved in the regulation of the onset of mitosis. Involved in a pathway that coordinates cell proliferation and differentiation. Schizosaccharomyces pombe (strain 972 / ATCC 24843) (taxid: 284812) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 2 EC: . EC: 2 |
| >sp|P33981|TTK_HUMAN Dual specificity protein kinase TTK OS=Homo sapiens GN=TTK PE=1 SV=2 | Back alignment and function description |
|---|
Score = 246 bits (627), Expect = 8e-64, Method: Compositional matrix adjust.
Identities = 143/331 (43%), Positives = 196/331 (59%), Gaps = 41/331 (12%)
Query: 469 VNGKLYQRLGKIGSGGSSEVHKVISSDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLK 528
V G++Y L +IGSGGSS+V +V++ IYA+K + L+ D T + EI YLNKL+
Sbjct: 520 VKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQ 579
Query: 529 GKNN-IIQLIDYEVTEKALLREVLNGSMNNKDGRVKDDGYIYMVLEYGEIDLAHMLSQKW 587
++ II+L DYE+T D YIYMV+E G IDL L +K
Sbjct: 580 QHSDKIIRLYDYEIT----------------------DQYIYMVMECGNIDLNSWLKKK- 616
Query: 588 KEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLLVKGSLKLIDFGIAK 647
+++D + YW+ +LEAV+TIH+ IVHSDLKPANFL+V G LKLIDFGIA
Sbjct: 617 -------KSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVDGMLKLIDFGIAN 669
Query: 648 AIMSDTTNIQRDSQVGTLSYMSPEAFM-CNESDENG-NIIKCGRPSDIWSLGCILYQMVY 705
+ DTT++ +DSQVGT++YM PEA + S ENG + K SD+WSLGCILY M Y
Sbjct: 670 QMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTY 729
Query: 706 GRTPFSEYKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQHP 765
G+TPF + +K I DPNHEI + +P L D++K CL D +R IP+LL HP
Sbjct: 730 GKTPFQQIINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHP 789
Query: 766 FLVPPVSTQP------SSSQDQSYQLLQLLA 790
++ + T P ++++ Y L QL+
Sbjct: 790 YV--QIQTHPVNQMAKGTTEEMKYVLGQLVG 818
|
Phosphorylates proteins on serine, threonine, and tyrosine. Probably associated with cell proliferation. Essential for chromosome alignment by enhancing AURKB activity (via direct CDCA8 phosphorylation) at the centromere, and for the mitotic checkpoint. Homo sapiens (taxid: 9606) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 2 EC: . EC: 1 |
| >sp|Q4R945|TTK_MACFA Dual specificity protein kinase TTK OS=Macaca fascicularis GN=TTK PE=2 SV=1 | Back alignment and function description |
|---|
Score = 245 bits (626), Expect = 9e-64, Method: Compositional matrix adjust.
Identities = 144/331 (43%), Positives = 195/331 (58%), Gaps = 41/331 (12%)
Query: 469 VNGKLYQRLGKIGSGGSSEVHKVISSDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLK 528
V G++Y L +IGSGGSS+V +V++ IYA+K + L+ D T + EI YLNKL+
Sbjct: 519 VKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKFVNLEEADNQTLDSYRNEIAYLNKLQ 578
Query: 529 GKNN-IIQLIDYEVTEKALLREVLNGSMNNKDGRVKDDGYIYMVLEYGEIDLAHMLSQKW 587
++ II+L DYE+T D YIYMV+E G IDL L +K
Sbjct: 579 QHSDKIIRLYDYEIT----------------------DQYIYMVMECGNIDLNSWLKKK- 615
Query: 588 KEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLLVKGSLKLIDFGIAK 647
+++D + YW+ +LEAV+TIH+ IVHSDLKPANFL+V G LKLIDFGIA
Sbjct: 616 -------KSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVDGMLKLIDFGIAN 668
Query: 648 AIMSDTTNIQRDSQVGTLSYMSPEAFM-CNESDENG-NIIKCGRPSDIWSLGCILYQMVY 705
+ DTT+I +DSQVGT++YM PEA + S ENG + K SD+WSLGCILY M Y
Sbjct: 669 QMQPDTTSIVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTY 728
Query: 706 GRTPFSEYKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQHP 765
G+TPF +K I DPNHEI + +P L D++K CL D +R IP+LL HP
Sbjct: 729 GKTPFQHIINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHP 788
Query: 766 FLVPPVSTQP------SSSQDQSYQLLQLLA 790
++ + T P ++++ Y L QL+
Sbjct: 789 YV--QIQTHPGNQMAKGTTEEMKYVLGQLVG 817
|
Phosphorylates proteins on serine, threonine, and tyrosine. Probably associated with cell proliferation. Essential for chromosome alignment by enhancing AURKB activity (via direct CDCA8 phosphorylation) at the centromere, and for the mitotic checkpoint. Macaca fascicularis (taxid: 9541) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 2 EC: . EC: 1 |
| >sp|P35761|TTK_MOUSE Dual specificity protein kinase TTK OS=Mus musculus GN=Ttk PE=1 SV=1 | Back alignment and function description |
|---|
Score = 236 bits (602), Expect = 6e-61, Method: Compositional matrix adjust.
Identities = 132/302 (43%), Positives = 181/302 (59%), Gaps = 33/302 (10%)
Query: 469 VNGKLYQRLGKIGSGGSSEVHKVISSDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLK 528
VNG++Y L +IGSGGSS+V +V++ I A+K + L+ D T + EI +LNKL+
Sbjct: 519 VNGRIYSILKQIGSGGSSKVFQVLNEKKQINAIKYVNLEDADSQTIESYRNEIAFLNKLQ 578
Query: 529 GKNN-IIQLIDYEVTEKALLREVLNGSMNNKDGRVKDDGYIYMVLEYGEIDLAHMLSQKW 587
++ II+L DYE+TE+ YIYMV+E G IDL L +K
Sbjct: 579 QHSDKIIRLYDYEITEQ----------------------YIYMVMECGNIDLNSWLKKK- 615
Query: 588 KEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLLVKGSLKLIDFGIAK 647
++++ + YW+ +LEAV+ IH+ IVHSDLKPANF++V G LKLIDFGIA
Sbjct: 616 -------KSINPWERKSYWKNMLEAVHIIHQHGIVHSDLKPANFVIVDGMLKLIDFGIAN 668
Query: 648 AIMSDTTNIQRDSQVGTLSYMSPEAFM-CNESDENGNI-IKCGRPSDIWSLGCILYQMVY 705
+ DTT+I +DSQVGT++YM+PEA + S EN I K SD+WSLGCILY M Y
Sbjct: 669 QMQPDTTSIVKDSQVGTVNYMAPEAIRDMSSSRENSKIRTKVSPRSDVWSLGCILYYMTY 728
Query: 706 GRTPFSEYKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQHP 765
GRTPF +K I +P HEI + + L D++K CL + ER IP+LL HP
Sbjct: 729 GRTPFQHIINQVSKLHAIINPAHEIEFPEISEKDLRDVLKCCLVRNPKERISIPELLTHP 788
Query: 766 FL 767
++
Sbjct: 789 YV 790
|
Essential for chromosome alignment by enhancing AURKB activity (via direct CDCA8 phosphorylation) at the centromere, and for the mitotic checkpoint (By similarity). Phosphorylates proteins on serine, threonine, and tyrosine. Probably associated with cell proliferation. May play some role in the control of cell proliferation or differentiation and could be involved in modulating different levels of signal transduction pathways. Mus musculus (taxid: 10090) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 2 EC: . EC: 1 |
| >sp|Q8AYG3|TTK_DANRE Dual specificity protein kinase Ttk OS=Danio rerio GN=ttk PE=1 SV=2 | Back alignment and function description |
|---|
Score = 235 bits (599), Expect = 1e-60, Method: Compositional matrix adjust.
Identities = 134/328 (40%), Positives = 180/328 (54%), Gaps = 34/328 (10%)
Query: 469 VNGKLYQRLGKIGSGGSSEVHKVISSDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLK 528
+ GK + IG GGSS+V++V +YA+K + L+ D + EIE+LN L+
Sbjct: 648 IKGKQFFIFKMIGRGGSSKVYQVFDHKKHVYAVKYVNLEEADAQAVESYKNEIEHLNHLQ 707
Query: 529 G-KNNIIQLIDYEVTEKALLREVLNGSMNNKDGRVKDDGYIYMVLEYGEIDLAHMLSQKW 587
+ II+L DYE+T YIYM++E G +DL W
Sbjct: 708 QYSDQIIKLYDYEIT----------------------SSYIYMLMECGHLDL-----NTW 740
Query: 588 KEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLLVKGSLKLIDFGIAK 647
+ + LD + YW+ +LEAV+TIH+ IVHSDLKPANFL+V GSLKLIDFGIA
Sbjct: 741 LRNRKTVKPLDR---KAYWRNMLEAVHTIHKHGIVHSDLKPANFLIVDGSLKLIDFGIAN 797
Query: 648 AIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNI-IKCGRPSDIWSLGCILYQMVYG 706
I D T+I +DSQVGTL+YM PEA ++ NG K D+WSLGCILY M YG
Sbjct: 798 QIQPDVTSIMKDSQVGTLNYMPPEAI--KDTSSNGKPGSKISAKGDVWSLGCILYCMTYG 855
Query: 707 RTPFSEYKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQHPF 766
+TPF +K I DP+HEI + +P LLD++KKCL + ER I +LL HP+
Sbjct: 856 KTPFQNITNQISKIHAIIDPSHEIDFPDIPEKDLLDVLKKCLVRNPRERISIAELLDHPY 915
Query: 767 LVPPVSTQPSSSQDQSYQLLQLLAEASA 794
L P ++ S ++L E A
Sbjct: 916 LQLQPQPAPEPAETSSSDFKRILNELVA 943
|
Phosphorylates proteins on serine, threonine, and tyrosine (By similarity). Involved in mitotic cell cycle checkpoint control. Required for fin and heart regeneration. Required to prevent chromosome segregation errors during meiosis. Danio rerio (taxid: 7955) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 2 EC: . EC: 1 |
| >sp|P54199|MPS1_YEAST Serine/threonine-protein kinase MPS1 OS=Saccharomyces cerevisiae (strain ATCC 204508 / S288c) GN=MPS1 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 231 bits (590), Expect = 1e-59, Method: Compositional matrix adjust.
Identities = 129/342 (37%), Positives = 195/342 (57%), Gaps = 48/342 (14%)
Query: 441 SEKQEKAVSSKGASAPRKRNYDPDLFFKVNGKLYQRLGKIGSGGSSEVHKVISSDCTIYA 500
++K E +K AS RN VN Y+++ +G GGSS V+KV S +YA
Sbjct: 412 TKKVEIVEPAKSASLSNNRN-----IITVNDSQYEKIELLGRGGSSRVYKVKGSGNRVYA 466
Query: 501 LKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLREVLNGSMNNKDG 560
LK++ D ++ GF EIE L KLK + +IQL+DYE+
Sbjct: 467 LKRVSFDAFDDSSIDGFKGEIELLEKLKDQKRVIQLLDYEMG------------------ 508
Query: 561 RVKDDGYIYMVLEYGEIDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEER 620
DG +Y+++E G+ DL+ +L+Q+ S LD N++RFY +++L + +H+
Sbjct: 509 ----DGLLYLIMECGDHDLSQILNQR------SGMPLDFNFVRFYTKEMLLCIKVVHDAG 558
Query: 621 IVHSDLKPANFLLVKGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMC----- 675
IVHSDLKPANF+LVKG LK+IDFGIA A+ T NI R++Q+GT +YM+PEA +
Sbjct: 559 IVHSDLKPANFVLVKGILKIIDFGIANAVPEHTVNIYRETQIGTPNYMAPEALVAMNYTQ 618
Query: 676 -NESDENGNIIKCGRPSDIWSLGCILYQMVYGRTPFSEYKTFWAKFKVITDPNHEITY-- 732
+E+ GN K GRPSD+WS GCI+YQM+YG+ P+ ++ + I +P+ +I +
Sbjct: 619 NSENQHEGNKWKVGRPSDMWSCGCIIYQMIYGKPPYGSFQG-QNRLLAIMNPDVKIPFPE 677
Query: 733 -----EPVPNPWLLDLMKKCLAWDRNERWRIPQLLQHPFLVP 769
E +P ++LMK CL + ++RW + ++L FL P
Sbjct: 678 HTSNNEKIPKSA-IELMKACLYRNPDKRWTVDKVLSSTFLQP 718
|
Involved in the regulation of the onset of mitosis. Involved in a pathway that coordinates cell proliferation and differentiation. Implicated in spindle pole body (SPD) duplication. Dual specificity kinase that can phosphorylate serine, threonine and tyrosine residues. Phosphorylates the SPC29 and SPC110 spindle pole body components. Saccharomyces cerevisiae (strain ATCC 204508 / S288c) (taxid: 559292) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 2 EC: . EC: 2 |
| >sp|Q8SSH4|MPS1_ENCCU Probable serine/threonine-protein kinase MPS1 homolog OS=Encephalitozoon cuniculi (strain GB-M1) GN=MPS1 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 199 bits (507), Expect = 6e-50, Method: Compositional matrix adjust.
Identities = 119/299 (39%), Positives = 169/299 (56%), Gaps = 42/299 (14%)
Query: 469 VNGKLYQRLGKIGSGGSSEVHKVISSDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLK 528
+ G+ + L +IG GGSS+V+KV+ +YALK+++L G D + EI L K K
Sbjct: 284 IKGREIEILKQIGKGGSSKVYKVLFGS-NVYALKRVELIG-DEKMLSSYINEINLLYKFK 341
Query: 529 GKNNIIQLIDYEVTEKALLREVLNGSMNNKDGRVKDDGYIYMVLEYGEIDLAHMLSQKWK 588
G + I+++ID+EV E Y++++LEYGE DL+ ++ +
Sbjct: 342 GTSEIVEIIDHEVGED----------------------YLHILLEYGETDLSKIIRKGGL 379
Query: 589 EMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLLVKGSLKLIDFGIAKA 648
M N+++ W+Q+L V +H ERI+H DLKPANFL VKG +KLIDFGI+K
Sbjct: 380 SM---------NFIKDVWEQMLLIVKRVHIERIIHCDLKPANFLFVKGRVKLIDFGISKV 430
Query: 649 IMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGRT 708
I +DTT+I + Q GT++YMSPEA N+S K R SDIWSLGCILY+MV+
Sbjct: 431 IRNDTTSILSEEQCGTVNYMSPEAVTQNKS-------KVARSSDIWSLGCILYEMVHSNP 483
Query: 709 PFSEYKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQHPFL 767
P EY K + + + + E Y N + +MK+CLA D +R I LL H FL
Sbjct: 484 PLHEYPNLIQKIQRLQEYS-EFKYTS-KNKAAVMVMKECLARDPKKRPTIDNLLNHRFL 540
|
Involved in the regulation of the onset of mitosis. Involved in a pathway that coordinates cell proliferation and differentiation. Implicated in spindle pole body (SPD) duplication. Dual specificity kinase that can phosphorylate serine, threonine and tyrosine residues. Encephalitozoon cuniculi (strain GB-M1) (taxid: 284813) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 2 EC: . EC: 2 |
| >sp|Q9Y6R4|M3K4_HUMAN Mitogen-activated protein kinase kinase kinase 4 OS=Homo sapiens GN=MAP3K4 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 116 bits (291), Expect = 7e-25, Method: Compositional matrix adjust.
Identities = 108/376 (28%), Positives = 173/376 (46%), Gaps = 55/376 (14%)
Query: 403 STHKSMEGRQHTGNSPELKSQAPLSKNSSSDMKLEASKSEKQEKAVSSKGASAPRKRNYD 462
ST +S E R S + S+ + ++L K ++ + + G ++YD
Sbjct: 1270 STRRSWELRTLISQSKDTASKLGPIEAIQKSVRLFEEKRYREMRRKNIIGQVCDTPKSYD 1329
Query: 463 PDLFF---KVNGKLYQRLGKIGSGGSSEVHKVISSDC-TIYALKKIKLKGRDYATAYGFC 518
+ KV K +QR KIG G +V+ IS D + A+K+I+ + D+ T
Sbjct: 1330 NVMHVGLRKVTFK-WQRGNKIGEGQYGKVYTCISVDTGELMAMKEIRFQPNDHKTIKETA 1388
Query: 519 QEIEYLNKLKGKNNIIQLIDYEVTEKALLREVLNGSMNNKDGRVKDDGYIYMVLEYGEID 578
E++ +K N L+ Y E L RE + Y+ +EY +
Sbjct: 1389 DELKIFEGIKHPN----LVRYFGVE--LHREEM-----------------YIFMEYCDEG 1425
Query: 579 LAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPAN-FLLVKGS 637
+S+ L E+ +R Y +QI A+N +HE IVH D+K AN FL G
Sbjct: 1426 TLEEVSR---------LGLQEHVIRLYSKQITIAINVLHEHGIVHRDIKGANIFLTSSGL 1476
Query: 638 LKLIDFGIAKAIMSDTTNI--QRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWS 695
+KL DFG + + ++ + + +S +GT +YM+PE + + + GR +DIWS
Sbjct: 1477 IKLGDFGCSVKLKNNAQTMPGEVNSTLGTAAYMAPEVITRAKGEGH------GRAADIWS 1530
Query: 696 LGCILYQMVYGRTPFSEYK-TFWAKFKVITDPNHEITYEPVP---NPWLLDLMKKCLAWD 751
LGC++ +MV G+ P+ EY+ F +KV H+ P+P +P D + CL D
Sbjct: 1531 LGCVVIEMVTGKRPWHEYEHNFQIMYKV--GMGHK---PPIPERLSPEGKDFLSHCLESD 1585
Query: 752 RNERWRIPQLLQHPFL 767
RW QLL H F+
Sbjct: 1586 PKMRWTASQLLDHSFV 1601
|
Component of a protein kinase signal transduction cascade. Activates the CSBP2, P38 and JNK MAPK pathways, but not the ERK pathway. Specifically phosphorylates and activates MAP2K4 and MAP2K6. Homo sapiens (taxid: 9606) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 5 |
| >sp|Q03306|PKH3_YEAST Serine/threonine-protein kinase PKH3 OS=Saccharomyces cerevisiae (strain ATCC 204508 / S288c) GN=PKH3 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 115 bits (287), Expect = 2e-24, Method: Compositional matrix adjust.
Identities = 77/233 (33%), Positives = 118/233 (50%), Gaps = 52/233 (22%)
Query: 564 DDGYIYMVLEY---GEI-DLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEE 619
D+ +Y VL++ GE+ L H + T ++ W R + Q+++A+ IH
Sbjct: 84 DEENLYFVLDFAPGGELLSLLHKMG-----------TFNDIWTRHFTAQLIDALEFIHSH 132
Query: 620 RIVHSDLKPANFLLVK-GSLKLIDFGIAKAI----------MSDTTNIQRDSQ-----VG 663
I+H DLKP N LL + G L + DFG A I + +N +D+Q VG
Sbjct: 133 GIIHRDLKPENVLLDRDGRLMITDFGAAATIDPSLSGDSAKFNSDSNGSKDNQNCASFVG 192
Query: 664 TLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGRTPF---SEYKTFWAKF 720
T Y+SPE + N+ CG SDIW+LGC++YQ V G+ PF +E KTF
Sbjct: 193 TAEYVSPELLLYNQ---------CGYGSDIWALGCMIYQFVQGQPPFRGENELKTFE--- 240
Query: 721 KVIT-----DPNHEITYEPVP-NPWLLDLMKKCLAWDRNERWRIPQLLQHPFL 767
K++ PN+ I P NP +++L++K L + NER + Q+ +HP+
Sbjct: 241 KIVALDYPWGPNNRINNSTSPINPLVINLVQKILVIEVNERISLEQIKRHPYF 293
|
Serine/threonine-protein kinase which may phosphorylate the same targets substrates as PKH1 and PKH2, 2 upstream activators of PKC1. Saccharomyces cerevisiae (strain ATCC 204508 / S288c) (taxid: 559292) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 853 | ||||||
| 224063138 | 818 | predicted protein [Populus trichocarpa] | 0.901 | 0.940 | 0.660 | 0.0 | |
| 255545510 | 832 | dual specificity protein kinase-ttk, put | 0.954 | 0.978 | 0.635 | 0.0 | |
| 359492410 | 845 | PREDICTED: uncharacterized protein LOC10 | 0.958 | 0.968 | 0.623 | 0.0 | |
| 224084848 | 740 | predicted protein [Populus trichocarpa] | 0.856 | 0.987 | 0.614 | 0.0 | |
| 449445244 | 825 | PREDICTED: uncharacterized protein LOC10 | 0.954 | 0.986 | 0.577 | 0.0 | |
| 297839631 | 786 | kinase family protein [Arabidopsis lyrat | 0.910 | 0.988 | 0.574 | 0.0 | |
| 357489005 | 732 | Serine/threonine protein kinase [Medicag | 0.747 | 0.871 | 0.656 | 0.0 | |
| 356552833 | 729 | PREDICTED: uncharacterized protein LOC10 | 0.764 | 0.894 | 0.655 | 0.0 | |
| 356507668 | 711 | PREDICTED: uncharacterized protein LOC10 | 0.735 | 0.881 | 0.646 | 0.0 | |
| 42563293 | 777 | serine/threonine-protein kinase TTK/MPS1 | 0.895 | 0.983 | 0.557 | 0.0 |
| >gi|224063138|ref|XP_002301009.1| predicted protein [Populus trichocarpa] gi|222842735|gb|EEE80282.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 1040 bits (2690), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 535/810 (66%), Positives = 613/810 (75%), Gaps = 41/810 (5%)
Query: 44 FRHVQAAFKRHRPLGSMQSN-SIMPKRSLVPKREASRCLGTSVDINVDTDKSKDMVSLSH 102
RHVQAAFKRHRPLG MQ+N SI P+R+L+P+REASR + ++VD T KS+D+V LS
Sbjct: 43 LRHVQAAFKRHRPLGIMQTNNSIKPRRTLIPQREASRTVASNVDPTTGTKKSQDVVPLS- 101
Query: 103 GHAVKDPISQIKNEAATAVAETQEDASITPPSILGTRTNTFDENFNPFDAQRDHSKLTIG 162
KD I Q KN A + ET EDAS P GT T TFDE+FNPFD QR+ + I
Sbjct: 102 ----KDSILQTKNPVA-VIRETHEDASPFP----GTITKTFDESFNPFDGQREQPESVIA 152
Query: 163 CKENNSLTLAHLEPPHDQGQRKVRFSVGNSTSCQGADDRMATGMENLSSHMGSLALTEME 222
KE+N + L +E +G+RKV+F N + Q EME
Sbjct: 153 TKEDNQVPLTCVESQLFEGKRKVQFLTVNKATSQ-----------------------EME 189
Query: 223 WDASNQVEVSTVVNNNSKLQQVRNTEPDISLRPDGA-SSLAKRTTVVQDQLHQFRNFLGQ 281
WD SNQVEVS V+N+ +K Q +N E D++ R DGA +SLAKR VVQDQLHQ RNFL Q
Sbjct: 190 WDVSNQVEVSNVINDETKQQNFQNMESDVTSRSDGAVTSLAKRAMVVQDQLHQLRNFLNQ 249
Query: 282 PATQFSMVGSSCPTSTYIHSTSAPMLNSTTKCSRSHQEGSTLGAVEPVEDFSRNPEPANR 341
PATQ S+VG SC T+T +HSTSAPMLNSTT CSR H E + AVEP+ D + N +
Sbjct: 250 PATQSSVVGPSCATTTSVHSTSAPMLNSTTYCSRLHTESGSQAAVEPLRDSNANSQHVTP 309
Query: 342 GDMVHLSCSSLKDTKTP-VDQAVRAPQASTSVIDPKPEIKKQEWPKEQQDCVVKEGGIPN 400
++ LS LKDT +D A Q STS I + K+ + PKEQ+ + + I N
Sbjct: 310 RNLEQLSHPLLKDTSAMLIDLRATATQPSTSAI--HSQFKELDLPKEQKGSMPEAHDIAN 367
Query: 401 DPS-THKSMEGRQHTGNSPELKSQAPLSKNSSSDMKLEASKSEKQEKAVSSKGASAPRKR 459
+PS K + R +++SQ P+S+N SS++KLE SK E +EK SSKG S PRKR
Sbjct: 368 NPSLVDKPAKERGPADEGTDVQSQRPMSRNPSSNVKLEPSKPENKEKVASSKGTSVPRKR 427
Query: 460 NYDPDLFFKVNGKLYQRLGKIGSGGSSEVHKVISSDCTIYALKKIKLKGRDYATAYGFCQ 519
+YDPDLFFKVNGKLYQRLGKIGSGGSSEVHKVISSDCTIYALKKIKLKGRDY TAYGFCQ
Sbjct: 428 SYDPDLFFKVNGKLYQRLGKIGSGGSSEVHKVISSDCTIYALKKIKLKGRDYGTAYGFCQ 487
Query: 520 EIEYLNKLKGKNNIIQLIDYEVTEKALLREVLNGSMNNKDGRVKDDGYIYMVLEYGEIDL 579
EI YLNKLKGKNNIIQLIDYEVT+KALL EV++ S++NKDGRVKDDG IYMVLEYGEIDL
Sbjct: 488 EILYLNKLKGKNNIIQLIDYEVTDKALLHEVMSSSISNKDGRVKDDGCIYMVLEYGEIDL 547
Query: 580 AHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLLVKGSLK 639
AHML+QKWKEMD SNQT+DENWLRFYWQQIL+AVNTIHEERIVHSDLKPANFLLVKGSLK
Sbjct: 548 AHMLAQKWKEMDSSNQTIDENWLRFYWQQILQAVNTIHEERIVHSDLKPANFLLVKGSLK 607
Query: 640 LIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCI 699
LIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESD NGN IKCGRPSDIWSLGCI
Sbjct: 608 LIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDANGNTIKCGRPSDIWSLGCI 667
Query: 700 LYQMVYGRTPFSEYKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIP 759
LYQMVYGRTPFSE+KTFWAKFKVITDPNHEITYEPV NPWLLDLMKKCLAWDRNERWRIP
Sbjct: 668 LYQMVYGRTPFSEFKTFWAKFKVITDPNHEITYEPVSNPWLLDLMKKCLAWDRNERWRIP 727
Query: 760 QLLQHPFLVPPVSTQPSSSQDQSYQLLQLLAEASASDHEASTICSQLSQLIRNPVMLAAT 819
QLLQHPFLVPPV TQPS SQ Q +LLQL++E + D EAS +C +L QL+ NP L
Sbjct: 728 QLLQHPFLVPPVPTQPSVSQKQGCKLLQLVSETCSGDQEASVLCRELQQLL-NPGTLTP- 785
Query: 820 QLSTSQDQQCKLLLKLSKLCLELQKRLANL 849
+ STS+DQQCKLL ++SKLC +L++ LA L
Sbjct: 786 ESSTSRDQQCKLLSQMSKLCFQLRECLAKL 815
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255545510|ref|XP_002513815.1| dual specificity protein kinase-ttk, putative [Ricinus communis] gi|223546901|gb|EEF48398.1| dual specificity protein kinase-ttk, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 1027 bits (2656), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 549/864 (63%), Positives = 644/864 (74%), Gaps = 50/864 (5%)
Query: 1 MDREASLPVPPPLSSRFRPTVTSDTTSSSSSSSFTSSSSPPDLFRHVQAAFKRHRPLGSM 60
MDREA+LP ++ RP + + ++SSSSSSF+SSSSPP+ RHVQAAFKRHR LG+M
Sbjct: 1 MDREANLPK----NNIARP-ILNSDSTSSSSSSFSSSSSPPEFLRHVQAAFKRHRALGTM 55
Query: 61 QSNSIMPKRSLVPKREASRCLGTSVDINVDTDKSKDMVS-LSHGHAVKDPISQI---KNE 116
Q+NS+MP+R LVP+R+ S+ S D V K D+++ S + KD S I KN
Sbjct: 56 QTNSLMPRRILVPQRDTSQTSAASSD--VYPKKFHDVINPSSQVQSRKDSSSTIMHTKNP 113
Query: 117 AATAVAETQEDASITPPSILGTR-TNTFDENFNPFDAQRDHSKLTIGCKENNSL--TLAH 173
V ET EDASITPP I T T TF E+FN QRD SK I CKENN + + +H
Sbjct: 114 VIAVVRETPEDASITPPPISATTITKTFGESFN---VQRDQSKSAIECKENNPIPASFSH 170
Query: 174 LEPPHDQGQRKVRFSVGNSTSCQGADDRMATGMENLSSHMGSLALTEMEWDASNQVEVST 233
+E H +RKV+FS+ N+ + Q EMEWDASN VE
Sbjct: 171 VESQHVDSKRKVQFSIANNATSQ-----------------------EMEWDASNPVEALN 207
Query: 234 VVNNNSKLQQVRNTEPDISLRPDGASSL-AKRTTVVQDQLHQFRNFLGQPATQFSMVGSS 292
V+N SK + +N + D+ LR DGA SL AKRT VQDQLHQ RNFL QP TQ S++G+S
Sbjct: 208 VINEESKHRNFQNVDSDVCLRSDGAGSLLAKRTMAVQDQLHQLRNFLSQPVTQSSVIGTS 267
Query: 293 CPTSTYIHSTSAPMLNSTTKCSRSHQEGSTLGAVEP----VEDFSRNPEPANRGDMVHLS 348
C T+T +HSTSAP+LNSTT CS SH EG T AVEP + D + + + A++ +M LS
Sbjct: 268 CATTTSVHSTSAPILNSTTYCSCSHPEGGTHAAVEPAVEPLGDLNASSQHASQKNMEQLS 327
Query: 349 CSSLKDTK-TPVDQAVRAPQASTSVIDPKPEIKKQEWPKEQQDCVVKEGGIPNDPS--TH 405
SL+DT +DQ A Q STSVI+ +IK+ P+E + + K IP +PS
Sbjct: 328 NPSLRDTSGMLIDQTSIAAQPSTSVINA--QIKEHPVPRENEGRLAKGTDIPKNPSYVCE 385
Query: 406 KSMEGRQHTGNSPELKSQAPLSKNSSSDMKLEASKSEKQEKAVSSKGASAPRKRNYDPDL 465
K + R + +++ Q P SKN SD+KLE+SK EKQEK KGAS PRK+NYDPDL
Sbjct: 386 KPTKERVSADDVTDVQPQDPSSKNPPSDVKLESSKPEKQEKVTGGKGASVPRKKNYDPDL 445
Query: 466 FFKVNGKLYQRLGKIGSGGSSEVHKVISSDCTIYALKKIKLKGRDYATAYGFCQEIEYLN 525
FFKVNGKLYQRLGKIGSGGSSEVHKVISSDCTIYALKKIKLKGRDYATAYGFCQEI YLN
Sbjct: 446 FFKVNGKLYQRLGKIGSGGSSEVHKVISSDCTIYALKKIKLKGRDYATAYGFCQEILYLN 505
Query: 526 KLKGKNNIIQLIDYEVTEKALLREVLNGSMNNKDGRVKDDGYIYMVLEYGEIDLAHMLSQ 585
KLKGKNNIIQLIDYEVT+K+LLREV+N SM+NKDGRVKDDGYIYMVLEYGEIDLAHMLSQ
Sbjct: 506 KLKGKNNIIQLIDYEVTDKSLLREVMNESMSNKDGRVKDDGYIYMVLEYGEIDLAHMLSQ 565
Query: 586 KWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLLVKGSLKLIDFGI 645
KWKEMD + QT+DENWLRFYWQQIL+AVNTIHEERIVHSDLKPANFLLVKGSLKLIDFGI
Sbjct: 566 KWKEMDSAYQTIDENWLRFYWQQILQAVNTIHEERIVHSDLKPANFLLVKGSLKLIDFGI 625
Query: 646 AKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVY 705
AKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNE D NGN IKCGRPSDIWSLGCILYQMVY
Sbjct: 626 AKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNECDANGNTIKCGRPSDIWSLGCILYQMVY 685
Query: 706 GRTPFSEYKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQHP 765
GRTPF+EYKTFWAKFKVITDPNHEITYE VPNPWLLDLMKKCLAWDR+ERWRIPQLLQHP
Sbjct: 686 GRTPFAEYKTFWAKFKVITDPNHEITYESVPNPWLLDLMKKCLAWDRSERWRIPQLLQHP 745
Query: 766 FLVPPVSTQPSSSQDQSYQLLQLLAEASASDHEASTICSQLSQLIRNPVMLAATQLSTSQ 825
FLVPP+ TQ S +++ +LLQL+AEA A + EAS + + QL+++P+ +Q TSQ
Sbjct: 746 FLVPPIPTQLSIPKEEDCKLLQLVAEACADNQEASKLWYDIRQLLKDPIASLTSQSLTSQ 805
Query: 826 DQQCKLLLKLSKLCLELQKRLANL 849
+QQCKLL ++S LC +L++ L+ L
Sbjct: 806 NQQCKLLSQMSMLCFQLRECLSKL 829
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359492410|ref|XP_002284392.2| PREDICTED: uncharacterized protein LOC100262634 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 1019 bits (2635), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 544/872 (62%), Positives = 652/872 (74%), Gaps = 54/872 (6%)
Query: 1 MDREASLPVP---------PPLSSRFRPTVTSDTTSSSSSSSFTSSSSPPDLFRHVQAAF 51
MD EA+LP P P L ++ + ++SSSSSSS SSSPPD RHVQAAF
Sbjct: 1 MDGEANLPAPSASANNLSRPILPDSYQNRSITSSSSSSSSSSSFYSSSPPDFLRHVQAAF 60
Query: 52 KRHRPLGSMQSNSIMPKRSLVPKREASRCLGTSVDINVDTDKSKDMV-SLSHGHAVKDPI 110
KRHRPLG+MQSNSIMP+R LVP+RE S+ ++V +D KS+D+ S+ G+ K+ +
Sbjct: 61 KRHRPLGTMQSNSIMPRRILVPRRETSKITASNVVPTIDAKKSQDVRPSMHQGNTGKELV 120
Query: 111 SQIKNEAATAVAETQEDASITPPSILGTRTNTFDENFNPFDAQRDHSKLTIGCKENNSLT 170
+I+N+ + V ET+EDA ITPPSI G+ TN + +D QR K GCK + ++
Sbjct: 121 VEIRNKVS-VVGETEEDAPITPPSISGSITNE-----DLYDVQRVQCKPVAGCKNTDGVS 174
Query: 171 LAHLEPPHD---QGQRKVRFSVGNSTSCQGADDRMATGMENLSSHMGSLALTEMEWDASN 227
+H+E H GQ+KV+F +G + S Q EMEWD SN
Sbjct: 175 FSHVESQHVPVVDGQKKVQFLLGKNASSQ-----------------------EMEWDVSN 211
Query: 228 QVEVSTVVNNNSKLQQVRNTEPDISLRPDGASS--LAKRTTVVQDQLHQFRNFL----GQ 281
QVE T VN++ K +N E D++ R DG S LAK+ + QDQLH+FRNFL
Sbjct: 212 QVEAPTDVNHDLKHGYFQNLESDVTSRSDGGISSLLAKKPVLAQDQLHRFRNFLQSDINH 271
Query: 282 PATQFSMVGSSCPTSTYIHSTSAPMLNSTTKCSRSHQEGSTLGAVEPVEDFSRNPEPANR 341
P TQ S+ GSSC T+ +H+TSAP++NSTT CS SHQ+ S AVE + D + N +P ++
Sbjct: 272 PMTQASVAGSSCATTISVHATSAPVINSTTYCSSSHQDISPHLAVETLGDVNLNSQPISK 331
Query: 342 GDMVHLSCSSLKDTK-TPVDQAVRAPQASTSVIDPKPEIKKQEWPKEQQDCVVKEGGIPN 400
GD++ S K T VD+ A QAS+S ID + ++K+ + EQQD V E IP
Sbjct: 332 GDVMQPSHPPSKSTSGVIVDRTAIAAQASSSSIDTQSKVKEYGF-SEQQDRVPNERDIPK 390
Query: 401 DPS--THKSMEGRQHTGNSPELKSQAPLSKNSSSDMKLEASKSEKQEKAVSSKGASAPRK 458
+PS S +G+ TG+ +L+SQ PLSK+SSSD+KLE SKSEKQEK VS KG+S PRK
Sbjct: 391 NPSPLDDNSTKGKGFTGDVTDLQSQVPLSKSSSSDVKLETSKSEKQEKVVSGKGSSVPRK 450
Query: 459 RNYDPDLFFKVNGKLYQRLGKIGSGGSSEVHKVISSDCTIYALKKIKLKGRDYATAYGFC 518
+NYDPD+F KVNGKLYQRLGKIGSGGSSEVHKVISSDC+IYALKKI+LKGRDYATAYGFC
Sbjct: 451 KNYDPDMFLKVNGKLYQRLGKIGSGGSSEVHKVISSDCSIYALKKIRLKGRDYATAYGFC 510
Query: 519 QEIEYLNKLKGKNNIIQLIDYEVTEKALLREVLNGSMNNKDGRVKDDGYIYMVLEYGEID 578
QEI+YLNKLKGK+NIIQLIDYEVT+K LL+EV+NGSM+NKD RVKDDG IYMVLEYGEID
Sbjct: 511 QEIQYLNKLKGKSNIIQLIDYEVTDKTLLQEVMNGSMSNKDSRVKDDGCIYMVLEYGEID 570
Query: 579 LAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLLVKGSL 638
LA+MLSQKWKEMD S++T+DENWLRFYWQQIL+AVNTIHEERIVHSDLKPANFLLVKGSL
Sbjct: 571 LANMLSQKWKEMDSSDRTIDENWLRFYWQQILQAVNTIHEERIVHSDLKPANFLLVKGSL 630
Query: 639 KLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGC 698
KLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESD NGN IKCGRPSDIWSLGC
Sbjct: 631 KLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDANGNTIKCGRPSDIWSLGC 690
Query: 699 ILYQMVYGRTPFSEYKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRI 758
ILYQMVYGRTPFSE+KTFWAKFKVITD NHEI YEPV NPWLLD+MKKCLAWDRNERWRI
Sbjct: 691 ILYQMVYGRTPFSEFKTFWAKFKVITDRNHEIKYEPVSNPWLLDIMKKCLAWDRNERWRI 750
Query: 759 PQLLQHPFLVPPVST--QPSSSQDQSYQLLQLLAEASASDHEASTICSQLSQLIRNPVML 816
P+LLQHPFLVPPV Q SSSQDQS +LLQL+ EA A+D +A +C QL QL+R+PV +
Sbjct: 751 PELLQHPFLVPPVPVLAQLSSSQDQSCKLLQLITEACANDPKALILCRQLQQLLRDPVTV 810
Query: 817 AATQLSTSQDQQCKLLLKLSKLCLELQKRLAN 848
+Q+ TS+DQQCKLL +SKLC +LQ+ L++
Sbjct: 811 PTSQVLTSRDQQCKLLSYVSKLCCQLQEYLSD 842
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224084848|ref|XP_002307420.1| predicted protein [Populus trichocarpa] gi|222856869|gb|EEE94416.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 978 bits (2528), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 523/851 (61%), Positives = 594/851 (69%), Gaps = 120/851 (14%)
Query: 1 MDREASLPVP--PPLSSRFRPTVTSDTTSSSSSSSFTSSSSPPDLFRHVQAAFKRHRPLG 58
MDREA+L VP PP + RP T ++ ++SS +SSSSPPD RHVQAAFKRHRPLG
Sbjct: 1 MDREANLLVPSAPPQRNLVRPV----TNAADTTSSSSSSSSPPDFLRHVQAAFKRHRPLG 56
Query: 59 SMQ-SNSIMPKRSLVPKREASRCLGTSVDINVDTDKSKDMVSLSHGHAVKDPISQIKNEA 117
MQ SNS P+R+L+PKREASR + ++ T S+D+V LS + K
Sbjct: 57 IMQTSNSTKPRRTLIPKREASRTVASNAGPTTGTKNSQDVVPLSKDSTLP------KKNT 110
Query: 118 ATAVAETQEDASITPPSILGTRTNTFDENFNPFDAQRDHSKLTIGCKENNSLTLAHLEPP 177
T + E+ EDASITPPS GT T TFDE+FNPF+AQR+ K I KENN + L +E
Sbjct: 111 VTVIRESHEDASITPPSFPGTITKTFDESFNPFEAQREQPKSAIDTKENNPMPLTCIE-- 168
Query: 178 HDQGQRKVRFSVGNSTSCQGADDRMATGMENLSSHMGSLALTEMEWDASNQVEVSTVVNN 237
S + EMEWD SNQVEVS V+N+
Sbjct: 169 -------------------------------------SQLVEEMEWDVSNQVEVSNVIND 191
Query: 238 NSKLQQVRNTEPDISLRPDGA-SSLAKRTTVVQDQLHQFRNFLGQPATQFSMVGSSCPTS 296
+K Q N E D++LR DGA SLAKRT V+Q+QLHQ RNFL QPATQ S+VG SC T+
Sbjct: 192 ETKQQ---NMESDLTLRSDGAVPSLAKRTMVIQNQLHQLRNFLSQPATQSSVVGPSCATT 248
Query: 297 TYIHSTSAPMLNSTTKCSRSHQEGSTLGAVEPVEDFSRNPEPANRGDMVHLSCSSLKDTK 356
T +HSTSAPMLNS T CSR E + AVEP+ D + N + G++ LS ++
Sbjct: 249 TSVHSTSAPMLNSMTYCSR---ESGSQAAVEPLRDANANSQSFTPGNLEQLSTEDIE--- 302
Query: 357 TPVDQAVRAPQASTSVIDPKPEIKKQEWPKEQQDCVVKEGGIPNDPSTHKSMEGRQHTGN 416
P D + + +P + K +PS+ +E +H
Sbjct: 303 -PADDG--------AAVQSQPPMSK-------------------NPSSDVKLEPPKH--- 331
Query: 417 SPELKSQAPLSKNSSSDMKLEASKSEKQEKAVSSKGASAPRKRNYDPDLFFKVNGKLYQR 476
EKQEK SSKGAS PRKRN DPDLFFKVNGKLYQR
Sbjct: 332 -------------------------EKQEKVSSSKGASVPRKRNLDPDLFFKVNGKLYQR 366
Query: 477 LGKIGSGGSSEVHKVISSDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQL 536
LGKIGSGGSSEVHKVISSDCTIYALKKIKLKGRDY TAYGFCQEI YLNKLKGKNNIIQL
Sbjct: 367 LGKIGSGGSSEVHKVISSDCTIYALKKIKLKGRDYGTAYGFCQEILYLNKLKGKNNIIQL 426
Query: 537 IDYEVTEKALLREVLNGSMNNKDGRVKDDGYIYMVLEYGEIDLAHMLSQKWKEMDGSNQT 596
IDYEVT+K LL EV++GS+NNKDGRVKDDG IYMVLEYGEIDLAHMLSQKWKEMD SNQT
Sbjct: 427 IDYEVTDKTLLHEVMSGSVNNKDGRVKDDGCIYMVLEYGEIDLAHMLSQKWKEMDSSNQT 486
Query: 597 LDENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLLVKGSLKLIDFGIAKAIMSDTTNI 656
+DENWLRFYWQQIL+AVNTIHEERIVHSDLKPANFLLVKGSLKLIDFGIAKAIMSDTTNI
Sbjct: 487 IDENWLRFYWQQILQAVNTIHEERIVHSDLKPANFLLVKGSLKLIDFGIAKAIMSDTTNI 546
Query: 657 QRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGRTPFSEYKTF 716
QRDSQVGTLSYMSPEAFMCNESD NGN IKCGRPSDIWSLGCILYQMVYGRTPFS YKTF
Sbjct: 547 QRDSQVGTLSYMSPEAFMCNESDANGNTIKCGRPSDIWSLGCILYQMVYGRTPFSAYKTF 606
Query: 717 WAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQHPFLVPPVSTQPS 776
WAKFKVITDPNHEITYEPV NPWLLDLMK+CLAW+RNERWRIPQ LQHPFLVPPV TQ S
Sbjct: 607 WAKFKVITDPNHEITYEPVSNPWLLDLMKRCLAWERNERWRIPQFLQHPFLVPPVPTQQS 666
Query: 777 SSQDQSYQLLQLLAEASASDHEASTICSQLSQLIRNPVMLAATQLSTSQDQQCKLLLKLS 836
SQ+Q +LLQL+AE SD EAS +C +L QL+ NP L + L TS+DQQ KLL ++S
Sbjct: 667 ESQNQGCELLQLVAETCGSDQEASMLCHELQQLL-NPGTLISESL-TSRDQQYKLLSQMS 724
Query: 837 KLCLELQKRLA 847
KLC +L++ LA
Sbjct: 725 KLCFQLRECLA 735
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449445244|ref|XP_004140383.1| PREDICTED: uncharacterized protein LOC101214794 [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 903 bits (2334), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 497/860 (57%), Positives = 587/860 (68%), Gaps = 46/860 (5%)
Query: 1 MDREASLPVPPPLSSRFRPTVTSDTTSSSSSSSFTSSSSPPDLFRHVQAAFKRHRPLGSM 60
MDREA+LP + +TTSS +SSSS P RHVQAAFKRHRPLG
Sbjct: 1 MDREANLPAQFEFDKKLTRQTNPETTSS------SSSSSSPGFLRHVQAAFKRHRPLGVT 54
Query: 61 QSNSIMPKRSLVPKREASRCLGTSVDINVDTDKSKDMVSLSHGHAVKDPISQIKNEAATA 120
QSNSI P+R LVP+R SR + + + + +SLS H VKD I Q K+ T
Sbjct: 55 QSNSIRPRRLLVPQRGVSRNPRSEARLAESDKEPETEISLSQDHVVKDLIEQTKS-TMTI 113
Query: 121 VAETQEDASITPPSILGTRTNTFDENFNPFDAQRDHSKLTIGCKENNSLTLAHLEPPHDQ 180
+ ETQ D SIT PSI G T +FD ++ P D QRD GC+ ++ + +
Sbjct: 114 IGETQ-DESITRPSISGLMTKSFDGSYAP-DIQRDELVRGAGCQSRSTSSALNTGSQQVD 171
Query: 181 GQRKVRFSVGNSTSCQGADDRMATGMENLSSHMGSLALTEMEWDASNQVEVSTVVNNN-S 239
Q+ VRFS+ + Q EM+W A N E S+V+N++ S
Sbjct: 172 VQKMVRFSIKTNKISQ-----------------------EMDWTAGNLGEASSVINHDES 208
Query: 240 KLQQVRNTEPDISLRPDGASSLAKRTTVVQDQLHQFRNFLGQPATQFSMVGSSCPTSTYI 299
K NTE D+ G S +A+RT V+DQL +F +FL QP +Q S G CPT+T +
Sbjct: 209 KHGSFPNTESDMK-SNGGISMMAQRTPAVEDQLKRFEDFLNQPISQPSF-GPPCPTTTSV 266
Query: 300 HSTSAPMLNSTTKCSRSHQEGSTLGAVEPVEDFSRNPEPANRGDMVHLSCSSLKDTKTPV 359
HS+S MLNSTT CS H E + EP+ +F+ N + + ++ S SL+DT V
Sbjct: 267 HSSSVAMLNSTTYCSHLHHESGGKISTEPLSEFNANIQCEAKRSVLPTSGLSLRDTSDEV 326
Query: 360 -----DQAVRAPQASTSVIDPKPEIKKQEWPKEQQDCVVKEGGIPNDPSTH--KSMEGRQ 412
+ A+ AP + + + I + KE ++ + E I H KS EG+
Sbjct: 327 KNGKGNDAIHAPGLTANT---EKVISHYDISKEYREQLGGESDISKHSLQHVDKSYEGKC 383
Query: 413 HTGNSPELKSQAPLSKNSSSDMKLEASKSEKQEKAVSSKGASAPRKRNYDPDLFFKVNGK 472
GN+ + KS+A + K S SD+ L S S+K +K S K AS RKRNYDPD+FFKVNGK
Sbjct: 384 AIGNAIDTKSKAQVPKKSVSDVNLNPSGSDKLDKVASGKSASTNRKRNYDPDMFFKVNGK 443
Query: 473 LYQRLGKIGSGGSSEVHKVISSDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNN 532
LYQRLGKIGSGGSSEVHKVISSDCTIYALKKIKLKGRDYATAYGFCQEI YLNKLKGKNN
Sbjct: 444 LYQRLGKIGSGGSSEVHKVISSDCTIYALKKIKLKGRDYATAYGFCQEIVYLNKLKGKNN 503
Query: 533 IIQLIDYEVTEKALLREVLNGSMNNKDGRVKDDGYIYMVLEYGEIDLAHMLSQKWKEMDG 592
IIQL+DYEVT++ LL+EVLNGS NNKD RVKDDGYIYMVLEYGEIDLAHMLSQKWKE+DG
Sbjct: 504 IIQLVDYEVTDRTLLQEVLNGSTNNKDARVKDDGYIYMVLEYGEIDLAHMLSQKWKEIDG 563
Query: 593 SNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLLVKGSLKLIDFGIAKAIMSD 652
++Q +DENWLRFYWQQIL+AVNTIHEERIVHSDLKPANFLLVKGSLKLIDFGIAKAIMSD
Sbjct: 564 TDQIIDENWLRFYWQQILQAVNTIHEERIVHSDLKPANFLLVKGSLKLIDFGIAKAIMSD 623
Query: 653 TTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGRTPFSE 712
TTNIQRDSQVGTLSYMSPEAFMCNE D NGN IKCGRPSDIWSLGCILYQMVYGRTPFSE
Sbjct: 624 TTNIQRDSQVGTLSYMSPEAFMCNEKDANGNTIKCGRPSDIWSLGCILYQMVYGRTPFSE 683
Query: 713 YKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQHPFLVPPVS 772
YKTFWAKFKVITDPNHEI YEPV N WLLDLMKKCLAWDRNERWRIP+LLQHPFLVPPVS
Sbjct: 684 YKTFWAKFKVITDPNHEIKYEPVSNHWLLDLMKKCLAWDRNERWRIPELLQHPFLVPPVS 743
Query: 773 TQPSSSQDQSYQLLQLLAEASASDHEAST-ICSQLSQLIRNPVMLAATQLSTSQDQQCKL 831
S SQ QS + LQL+ E+ +DHEAS+ + +L QL+ N V + L TS+D QC+L
Sbjct: 744 PHLSLSQGQSSKFLQLIVESCENDHEASSHLLPKLQQLLLNSVQPMTSLLITSKDSQCEL 803
Query: 832 LLKLSKLCLELQKRLANLRE 851
+ SK L K LA ++
Sbjct: 804 FSQTSKDYFLLHKSLATQKD 823
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297839631|ref|XP_002887697.1| kinase family protein [Arabidopsis lyrata subsp. lyrata] gi|297333538|gb|EFH63956.1| kinase family protein [Arabidopsis lyrata subsp. lyrata] | Back alignment and taxonomy information |
|---|
Score = 888 bits (2294), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 491/855 (57%), Positives = 594/855 (69%), Gaps = 78/855 (9%)
Query: 1 MDREASLPVPP--PLSSRFRPTVTSDTTSSSSSSSFTSSSSPPDLFRHVQAAFKRHRPLG 58
MDREA+LPV P P S RP + +TTSSSSSSS P+L RH+QAAFKRHRPL
Sbjct: 1 MDREANLPVQPDKPPKSLVRPILNLETTSSSSSSS-------PELLRHLQAAFKRHRPLS 53
Query: 59 SMQSNSIMPKRSLVPKREASRCLGTSVDINVDTDKSKDMVSLSHGHAVKDPISQIKNEAA 118
MQ+ +I P+RS+ P+R+ASR + + + +S+D+V+LS A N A
Sbjct: 54 KMQTTTIGPRRSVAPQRQASR---NTRLVTAEGQRSQDVVTLSQSLAANTLTQDTSNLAT 110
Query: 119 TAVAETQEDASITPPSILGTRTNTFDENFNPFDAQRDHSKLTIGCKENNSLTLAHLEPPH 178
+ E+ E+ASITPPS+ GT N F +NFNP D Q D K + +N + +
Sbjct: 111 SVAGESIENASITPPSVSGTVNNMFGQNFNPSDRQLDFGKSAVASLGSN----LDIGSQN 166
Query: 179 DQGQRKVRFSVGNSTSCQGADDRMATGMENLSSHMGSLALTEMEWDASNQVEVSTV-VNN 237
+ QRK + +G++ + Q +MEWDA+NQ E S +
Sbjct: 167 ENDQRKFQSLIGSTLTSQ-----------------------DMEWDATNQAEASHLGACI 203
Query: 238 NSKLQQVRNTEPDISLRPDG--ASSLAKRTTVVQDQLHQFRNFLGQPATQFSMVGSSCPT 295
SK Q +++ + +ISL+ + +SSLAK QL +FRNFL QP TQ S VGSSC T
Sbjct: 204 GSKRQNLQSVDSEISLKSEYKVSSSLAKN----HGQLGEFRNFLNQPKTQCSAVGSSCAT 259
Query: 296 STYIHSTSAPMLNSTTKCSRSHQEGSTLGAVEPVEDFSRNPEPANRGDMVHLSCSSLKDT 355
+T IHS+S PMLN+TT SRS+ E D S NP + S KD+
Sbjct: 260 TTLIHSSSGPMLNATTHVSRSYAEA----------DSSANPHAVQSQGNLPSCYPSSKDS 309
Query: 356 K---TPVDQAVRAPQASTSVIDPKPEIKKQEWPKEQQDCVVKEGGIPNDPSTHKSMEGRQ 412
T D A AST+ DP+ +K+++ K+QQ C E P S+H +G+
Sbjct: 310 NILHTNKDAPPSAIPASTN--DPEVRVKERDKSKQQQ-CTT-ELEAPVGSSSHGG-DGQA 364
Query: 413 HTGNSPELKSQAPLSKNSSSDMKLEASKSEKQEKAVSSKGASAPRKRNYDPDLFFKVNGK 472
+ EL L+ SS + KS+KQEK SSKG SAPRKRNYDPDLFFKVNGK
Sbjct: 365 NARLPDEL-----LTSVSS-----QPQKSDKQEKVASSKGPSAPRKRNYDPDLFFKVNGK 414
Query: 473 LYQRLGKIGSGGSSEVHKVISSDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNN 532
LYQRLGKIGSGGSSEVHKVISSDCTIYALKKIKLKGRDYATAYGFCQEI YL KLKGK N
Sbjct: 415 LYQRLGKIGSGGSSEVHKVISSDCTIYALKKIKLKGRDYATAYGFCQEIGYLKKLKGKTN 474
Query: 533 IIQLIDYEVTEKALLREVLNGSMNNKDGRVKDDGYIYMVLEYGEIDLAHMLSQKWKEMDG 592
IIQLIDYEVT+K LL+EVLNG+M+NKDGRVKDDG+IYMVLEYGEIDLAHMLSQKW+E++G
Sbjct: 475 IIQLIDYEVTDKTLLQEVLNGTMSNKDGRVKDDGFIYMVLEYGEIDLAHMLSQKWREIEG 534
Query: 593 SNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLLVKGSLKLIDFGIAKAIMSD 652
S++T+DENWLRFYWQQIL+AVNTIHEERIVHSDLKPANFLLV+G LKLIDFGIAKAI SD
Sbjct: 535 SDRTIDENWLRFYWQQILQAVNTIHEERIVHSDLKPANFLLVRGFLKLIDFGIAKAINSD 594
Query: 653 TTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGRTPFSE 712
TTNIQRDSQVGTLSYMSPEAFMCNESDENGN IKCGRPSDIWSLGCILYQMVYGRTPF++
Sbjct: 595 TTNIQRDSQVGTLSYMSPEAFMCNESDENGNTIKCGRPSDIWSLGCILYQMVYGRTPFAD 654
Query: 713 YKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQHPFLVPPVS 772
YKTFWAKFKVITDPNHEITY + NPWL+DLMKKCLAWDRN+RWRIP+LLQHPFL PP+
Sbjct: 655 YKTFWAKFKVITDPNHEITYNQLSNPWLIDLMKKCLAWDRNQRWRIPELLQHPFLAPPIP 714
Query: 773 TQPSSSQDQSYQLLQLLAEASASDHE-ASTICSQLSQLIRNPVMLAATQLSTSQDQQCKL 831
+P Q + +LL L+AE+ SD + A+++ SQL QL+ NP L S+DQ +L
Sbjct: 715 PEP---QVKIIKLLSLIAESCVSDDDKANSMISQLEQLLTNPAPLPRNDHLDSRDQNQQL 771
Query: 832 LLKLSKLCLELQKRL 846
L ++S+LC++L+ RL
Sbjct: 772 LFRVSELCIQLKDRL 786
|
Source: Arabidopsis lyrata subsp. lyrata Species: Arabidopsis lyrata Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357489005|ref|XP_003614790.1| Serine/threonine protein kinase [Medicago truncatula] gi|355516125|gb|AES97748.1| Serine/threonine protein kinase [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 857 bits (2215), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 434/661 (65%), Positives = 501/661 (75%), Gaps = 23/661 (3%)
Query: 196 QGADDRMATGMENLSSHMGSLALTEMEWDASNQVEVSTVVNNNSKLQQVRNTEPDISLRP 255
+G D +EN+SSH+ SLALTEM+ AS E ST +N + K + + E + SL
Sbjct: 83 EGFSDVKVCELENISSHLSSLALTEMDL-ASGVTEASTRINQDMKYRTSQQAESEKSLIS 141
Query: 256 DGA--SSLAKRTTVVQDQLHQFRNFLGQPATQFSMVGSSCPTSTYIHSTSAPMLNSTTKC 313
G S L +RT + QD +F+NFL QPATQ S+VG SC T+T +HS+SAPMLNS T
Sbjct: 142 KGGKISMLPRRTLISQDHSDKFKNFLSQPATQSSIVGPSCATTTSVHSSSAPMLNSLTGS 201
Query: 314 SRSHQEGSTLGAVEPVEDFSRNPEPANRGDMVHLSCSSLKDTK-TPVDQAVRAPQASTSV 372
S SH A V + N P + H +S+K+T T DQA QA +S+
Sbjct: 202 SHSHPNS----ASNLVANRCGNLNPHQ---ITHGVVNSVKETNITSTDQATTGVQACSSL 254
Query: 373 IDPKPEIKKQEWPKEQQDCVVKEGGIPNDPSTH-----KSMEGRQHTGNSPELKSQAPLS 427
D + K++ KEQQ C +KE I N+ S + K E T PE AP
Sbjct: 255 TDAELTFKERNSCKEQQGCALKETIISNNASCYDDALSKGKESAVATNTQPE----AP-- 308
Query: 428 KNSSSDMKLEASKSEKQEKAVSSKGASAPRKRNYDPDLFFKVNGKLYQRLGKIGSGGSSE 487
SSD+KLE+SK K +KA SSKG S RKR YDPD FFKV+GKLYQRLG+IGSGGSSE
Sbjct: 309 -TVSSDVKLESSKLGKPDKAASSKGPSGSRKRTYDPDYFFKVSGKLYQRLGRIGSGGSSE 367
Query: 488 VHKVISSDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALL 547
VHKVISSDCTIYALKKIKLKGRDYATAYGFCQEIEYLN+LKGK+NIIQLIDYEVT+KALL
Sbjct: 368 VHKVISSDCTIYALKKIKLKGRDYATAYGFCQEIEYLNRLKGKSNIIQLIDYEVTDKALL 427
Query: 548 REVLNGSMNNKDGRVKDDGYIYMVLEYGEIDLAHMLSQKWKEMDGSNQTLDENWLRFYWQ 607
VL+GS NNKDGRVKDDG+IYMVLEYGEIDLAHMLSQKWKE+DG NQT+DENWLRFYWQ
Sbjct: 428 EGVLSGSFNNKDGRVKDDGFIYMVLEYGEIDLAHMLSQKWKELDGCNQTIDENWLRFYWQ 487
Query: 608 QILEAVNTIHEERIVHSDLKPANFLLVKGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSY 667
QIL+AVNTIHEERIVHSDLKPANFLLVKGSLKLIDFGIAKAIMSDTTNIQRDSQVGTL+Y
Sbjct: 488 QILQAVNTIHEERIVHSDLKPANFLLVKGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLNY 547
Query: 668 MSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGRTPFSEYKTFWAKFKVITDPN 727
MSPEAFMCNESD NGNIIKCGRPSDIWSLGCILYQMVYGRTPFS+YKTFWAK KVITDPN
Sbjct: 548 MSPEAFMCNESDANGNIIKCGRPSDIWSLGCILYQMVYGRTPFSDYKTFWAKVKVITDPN 607
Query: 728 HEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQHPFLVPPVSTQPSSSQDQSYQLLQ 787
H+ITYEPV NP L+DLMK+CLAWDRNERWRIPQLLQHPFL PPVS+ PS SQD S++ LQ
Sbjct: 608 HQITYEPVSNPCLVDLMKRCLAWDRNERWRIPQLLQHPFLAPPVSSHPSLSQDHSFKWLQ 667
Query: 788 LLAEASASDHEASTICSQLSQLIRNPVMLAATQLSTSQDQQCKLLLKLSKLCLELQKRLA 847
++AE D EA +CSQL Q++ +P L + S S+D QCKLL ++S++C++L +RL
Sbjct: 668 VIAETCKCDREAVQLCSQLQQVLGDPFSLITSDTSNSRDGQCKLLSRISEVCVQLHERLT 727
Query: 848 N 848
N
Sbjct: 728 N 728
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356552833|ref|XP_003544767.1| PREDICTED: uncharacterized protein LOC100816674 [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 856 bits (2212), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 433/661 (65%), Positives = 505/661 (76%), Gaps = 9/661 (1%)
Query: 192 STSCQGADDRMATGMENLS--SHMGSLALTEME-WDASNQVEVSTVVNNNSKLQQVRNTE 248
S + +G + + +++LS +H LTE+ A Q E S N + K Q + E
Sbjct: 66 SDTGEGCKNESSLQVKSLSVGAHKKVQFLTEINNATAQPQDEASIGFNQHVKHQNTQQAE 125
Query: 249 PDISLRPDGASS--LAKRTTVVQDQLHQFRNFLGQPATQFSMVGSSCPTSTYIHSTSAPM 306
+ SL +G S L KRT V QD L QF+NFL QPATQ S+VG CPT+T +HSTSAPM
Sbjct: 126 SETSLVYEGGKSSPLPKRTIVTQDHLQQFKNFLRQPATQSSVVGLPCPTTTSVHSTSAPM 185
Query: 307 LNSTTKCSRSHQEGSTLGAVEPVEDFSRNPEPANRGDMVHLSCSSLKDT-KTPVDQAVRA 365
LNS T CS S + + A EP + + NP P +GD V +SLKDT + +DQ A
Sbjct: 186 LNSITHCSNSCIDSGSHVAAEPYGNLNVNPHPITQGD-VKSPNNSLKDTNRISIDQVASA 244
Query: 366 PQASTSVIDPKPEIKKQEWPKEQQDCVVKEGGIPNDPSTHKSMEGRQHTGNSPELKSQAP 425
Q S+ID + +K+ + KEQQ C++K+ I S M + S + + P
Sbjct: 245 VQDCNSLIDAELTLKQSDPSKEQQGCMLKDTSISKCTSCRDDMLSKGEV--SAAVTNIQP 302
Query: 426 LSKNSSSDMKLEASKSEKQEKAVSSKGASAPRKRNYDPDLFFKVNGKLYQRLGKIGSGGS 485
SSS++KLE+SK EKQEK SSK +S RKR YDP+LFFKVNGKLYQRLGKIGSGGS
Sbjct: 303 QVPTSSSEVKLESSKLEKQEKNTSSKASSGLRKRAYDPELFFKVNGKLYQRLGKIGSGGS 362
Query: 486 SEVHKVISSDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKA 545
SEVHKVISSDCTIYALK+IKLKGRDYATAYGFCQEIEYLN+LKGKNNIIQLIDYEVT+KA
Sbjct: 363 SEVHKVISSDCTIYALKRIKLKGRDYATAYGFCQEIEYLNRLKGKNNIIQLIDYEVTDKA 422
Query: 546 LLREVLNGSMNNKDGRVKDDGYIYMVLEYGEIDLAHMLSQKWKEMDGSNQTLDENWLRFY 605
L V+NGS +NKDGRVKDDGYIYMVLEYGEIDLAHMLSQKWKE+DGSNQT+DENWLRFY
Sbjct: 423 LFEGVINGSFSNKDGRVKDDGYIYMVLEYGEIDLAHMLSQKWKELDGSNQTIDENWLRFY 482
Query: 606 WQQILEAVNTIHEERIVHSDLKPANFLLVKGSLKLIDFGIAKAIMSDTTNIQRDSQVGTL 665
WQQIL+AVNTIHEERIVHSDLKPANFLLVKGSLKLIDFGIAKAIMSDTTNIQRDSQVGTL
Sbjct: 483 WQQILQAVNTIHEERIVHSDLKPANFLLVKGSLKLIDFGIAKAIMSDTTNIQRDSQVGTL 542
Query: 666 SYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGRTPFSEYKTFWAKFKVITD 725
SYMSPEAFMCNESD +GNIIKCGRPSDIWSLGCILYQMVYGRTPF++YKTFWAKFKVITD
Sbjct: 543 SYMSPEAFMCNESDASGNIIKCGRPSDIWSLGCILYQMVYGRTPFADYKTFWAKFKVITD 602
Query: 726 PNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQHPFLVPPVSTQPSSSQDQSYQL 785
PNHEI Y PV NPWLLDLM++CLAWDRNERWRIPQLLQHPFLVPPV S Q+Q+++L
Sbjct: 603 PNHEIMYAPVSNPWLLDLMRRCLAWDRNERWRIPQLLQHPFLVPPVPCHSSFYQEQTFKL 662
Query: 786 LQLLAEASASDHEASTICSQLSQLIRNPVMLAATQLSTSQDQQCKLLLKLSKLCLELQKR 845
LQL++EA +D E+S +C QL Q++ NP+ + S DQQ KLL ++S+LC+ LQ+R
Sbjct: 663 LQLISEACINDPESSQLCCQLQQVLGNPIKSTSIHSLNSLDQQHKLLSRISELCILLQER 722
Query: 846 L 846
L
Sbjct: 723 L 723
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356507668|ref|XP_003522586.1| PREDICTED: uncharacterized protein LOC100788990 [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 849 bits (2194), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 438/678 (64%), Positives = 507/678 (74%), Gaps = 51/678 (7%)
Query: 181 GQRKVRFSVGNSTSCQGADDRMATGMENLSSHMGSLALTEMEWDASNQVEVSTVVNNNS- 239
Q+KV+FSV ++ + Q D AT +ENLSSHM SL EMEW +Q+E S+ +
Sbjct: 80 AQKKVQFSVRSNAALQ---DGKATELENLSSHMSSLGFAEMEWVEGSQIESSSSSSLGCI 136
Query: 240 KLQQVRNTEPDISLRPD-GASS-LAKRTTVVQDQLHQFRNFLGQPATQFSMVGSSCPTST 297
+L+ V D SL+ + G SS L KR+ V QD L QFR+FL QPATQ S+VG SC T+T
Sbjct: 137 QLENVPQAAFDASLKCESGVSSVLPKRSLVTQDHLQQFRSFLSQPATQSSVVGPSCATTT 196
Query: 298 YIHSTSAPMLNSTTKCSRSHQEGSTLGAVEPVEDFSRNPEPANRGDMVHLSCSSLKDTKT 357
+HSTSAPMLNS T+ S Q+G + A EP+ + + NP ++G
Sbjct: 197 SVHSTSAPMLNSATRYSHLRQDGGSSVAAEPLGEVNANPWLLSKGS-------------- 242
Query: 358 PVDQAVRAPQASTSVIDPKPEIKKQEWPKEQQDCVVKEGGIPNDPSTHKSMEGRQHTGNS 417
KEQQ V+KE G N T + +
Sbjct: 243 -------------------------NRSKEQQGGVLKESG--NSKYTSCDDAKGKEAVDV 275
Query: 418 PELKSQAPL--SKNSSSDMKLEASKSEKQEKAVSSKGASAPRKRNYDPDLFFKVNGKLYQ 475
+++QAPL + SSSDMKL +SK EK+EK SSKGAS RKR YDPDLFFKVNGKLYQ
Sbjct: 276 ATVQTQAPLPTTITSSSDMKLGSSKEEKREKTASSKGASGTRKRTYDPDLFFKVNGKLYQ 335
Query: 476 RLGKIGSGGSSEVHKVISSDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQ 535
RLGKIGSGGSSEVHKVISSDC IYALKKIKLKGRDYATAYGFCQEIEYLN+LKGK+NIIQ
Sbjct: 336 RLGKIGSGGSSEVHKVISSDCRIYALKKIKLKGRDYATAYGFCQEIEYLNRLKGKDNIIQ 395
Query: 536 LIDYEVTEKALLREVLNGSMNNKDGRVKDDGYIYMVLEYGEIDLAHMLSQKWKEMDGSNQ 595
LIDYEVT+KALL EV+ GS +NKDGRVKDDG IYMVLEYGEIDLAHMLSQKWKE+DG+N+
Sbjct: 396 LIDYEVTDKALLEEVMKGSFSNKDGRVKDDGCIYMVLEYGEIDLAHMLSQKWKELDGNNK 455
Query: 596 TLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLLVKGSLKLIDFGIAKAIMSDTTN 655
T+DENWLRFYWQQIL AVNTIHEERIVHSDLKPANFLLVKGSLKLIDFGIAKAIMSDTTN
Sbjct: 456 TIDENWLRFYWQQILLAVNTIHEERIVHSDLKPANFLLVKGSLKLIDFGIAKAIMSDTTN 515
Query: 656 IQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGRTPFSEYKT 715
IQRDSQVGTLSYMSPEAF+CNE+D NGNIIKCGRPSDIWSLGCILYQMVYGRTPFS+YKT
Sbjct: 516 IQRDSQVGTLSYMSPEAFLCNETDANGNIIKCGRPSDIWSLGCILYQMVYGRTPFSDYKT 575
Query: 716 FWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQHPFLVPPVSTQP 775
FWAKFKVITDPNH+ITYEPV NPWLLDLMK+CLAWDRN+RWRIPQLLQHPFLVPPV + P
Sbjct: 576 FWAKFKVITDPNHKITYEPVSNPWLLDLMKRCLAWDRNQRWRIPQLLQHPFLVPPVPSNP 635
Query: 776 SSSQDQSYQLLQLLAEASASDHEASTICSQLSQLIRNPVMLAATQLSTSQDQQCKLLLKL 835
S QD + +LLQL++E D EA+ +CSQL +L+ +P+ L S+DQQ KLL ++
Sbjct: 636 SLPQDHTCKLLQLISETCTYDPEATQLCSQLQRLLSDPLEKTTCSL-YSRDQQLKLLSQM 694
Query: 836 SKLCLELQKRLANLRENK 853
S+LC++L +RL N ENK
Sbjct: 695 SELCIQLHERLTN-TENK 711
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|42563293|ref|NP_565160.3| serine/threonine-protein kinase TTK/MPS1 [Arabidopsis thaliana] gi|28416703|gb|AAO42882.1| At1g77720 [Arabidopsis thaliana] gi|110743245|dbj|BAE99513.1| putative protein kinase [Arabidopsis thaliana] gi|332197892|gb|AEE36013.1| serine/threonine-protein kinase TTK/MPS1 [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 848 bits (2192), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 478/858 (55%), Positives = 584/858 (68%), Gaps = 94/858 (10%)
Query: 1 MDREASLPVPP--PLSSRFRPTVTSDTTSSSSSSSFTSSSSPPDLFRHVQAAFKRHRPLG 58
MDRE +LPV P P S RP + +TTSSSSSSS +S P+L RH+QAAFKRHRPL
Sbjct: 1 MDREDNLPVQPDKPPKSLVRPILNLETTSSSSSSSSSS----PELLRHLQAAFKRHRPLS 56
Query: 59 SMQSNSIMPKRSLVPKREASRCLGTSVDINVDTDKSKDMVSLSHGHAVKDPISQ--IKNE 116
MQ+ SI P+RS+ P+R+ASR + + + +S+D+V+LS A + ++Q N
Sbjct: 57 KMQTTSIGPRRSVAPQRQASR---NTRLVTAEGQRSQDVVTLSQSLAA-NTLTQDTTNNL 112
Query: 117 AATAVAETQEDASITPPSILGTRTNTFDENFNPFDAQRDHSKLTIGCKENNSLTLAHLEP 176
A T+VA E ASIT P T E+FNP D Q D K + E+N
Sbjct: 113 AITSVA--GESASITQP--------TVSEHFNPSDRQMDFGKSAVTSLESNL-------- 154
Query: 177 PHDQGQRKVRFSVGNSTSCQGADDRMATGMENLSSHMGSLALTEMEWDASNQVEVSTV-V 235
QRK + +G S +MEWDA+NQ E S +
Sbjct: 155 ---DVQRKSQSLIGTSQ--------------------------DMEWDATNQAEASHLDA 185
Query: 236 NNNSKLQQVRNTEPDISLRPD--GASSLAKRTTVVQDQLHQFRNFLGQPATQFSMVGSSC 293
SK Q + + + ++SL+ + +SSLAK +Q QL +F NFL QP T+ S VGSS
Sbjct: 186 CIGSKHQNLPSVDSEVSLKSEYKDSSSLAK----IQGQLGEFPNFLNQPRTRCSAVGSSW 241
Query: 294 PTSTYIHSTSAPMLNSTTKCSRSHQEGSTLGAVEPVEDFSRNPEPA-NRGDMVHLSCSSL 352
T+T IHS+SAPMLN+TT SRS+ E D + NP ++G++ SS
Sbjct: 242 ATTTLIHSSSAPMLNATTHVSRSYVEA----------DSNANPHAVQSQGNLPSCCPSSK 291
Query: 353 KDTKTPVDQAVRAPQASTSVIDPKPEIKKQEWPKEQQDCVVKEGGIPNDPSTHKSMEGRQ 412
++ A + S DP+ +K+ + K+QQ E + + S+ G
Sbjct: 292 VSNILHPNKDATASEMPASTNDPEVRVKETDTSKQQQITTGLEAPVGS------SIYGSD 345
Query: 413 HTGNSPELKSQAPLSKNSSSDMKLEASKSEKQEKAVSSKGASAPRKRNYDPDLFFKVNGK 472
N A L + + + + KS+K EK SSKG SAPRKRNYDPDLFFKVNGK
Sbjct: 346 GQAN-------ARLPEELHTSVSSQPQKSDKHEKVASSKGPSAPRKRNYDPDLFFKVNGK 398
Query: 473 LYQRLGKIGSGGSSEVHKVISSDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNN 532
LYQRLGKIGSGGSSEVHKVISSDCTIYALKKIKLKGRDYATAYGFCQEI YL KLKGK N
Sbjct: 399 LYQRLGKIGSGGSSEVHKVISSDCTIYALKKIKLKGRDYATAYGFCQEIGYLKKLKGKTN 458
Query: 533 IIQLIDYEVTEKALLREVLNGSMNNKDGRVKDDGYIYMVLEYGEIDLAHMLSQKWKEMDG 592
IIQLIDYEVT+K LL+EVLNG+M+NKDGRVK+DG+IYMVLEYGEIDLAHMLSQKW+E++G
Sbjct: 459 IIQLIDYEVTDKTLLQEVLNGTMSNKDGRVKEDGFIYMVLEYGEIDLAHMLSQKWREIEG 518
Query: 593 SNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLLVKGSLKLIDFGIAKAIMSD 652
S++T+DENWLRFYWQQIL+AVNTIHEERIVHSDLKPANFLLV+G LKLIDFGIAKAI SD
Sbjct: 519 SDRTIDENWLRFYWQQILQAVNTIHEERIVHSDLKPANFLLVRGFLKLIDFGIAKAINSD 578
Query: 653 TTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGRTPFSE 712
TTNIQRDSQVGTLSYMSPEAFMCNESDENGN IKCGRPSDIWSLGCILYQMVYGRTPF++
Sbjct: 579 TTNIQRDSQVGTLSYMSPEAFMCNESDENGNTIKCGRPSDIWSLGCILYQMVYGRTPFAD 638
Query: 713 YKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQHPFLVPPVS 772
YKTFWAKFKVITDPNHEITY + NPWL+DLMKKCLAWDRN+RWRIP+LLQHPFL PP+
Sbjct: 639 YKTFWAKFKVITDPNHEITYNQLSNPWLIDLMKKCLAWDRNQRWRIPELLQHPFLAPPIP 698
Query: 773 TQPSSSQDQSYQLLQLLAEASASDHE-ASTICSQLSQLIRNPVMLAATQLSTSQDQQCKL 831
+P Q ++ +L L+AE+ SD + A+++ SQL QL+ NP L + S+DQ +L
Sbjct: 699 HEP---QVKTIKLFSLIAESCGSDDDKANSMISQLEQLLSNPAPLPRNDVLDSRDQNQQL 755
Query: 832 LLKLSKLCLELQKRLANL 849
L ++S+LC++LQ RL L
Sbjct: 756 LSRVSELCIQLQDRLQGL 773
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 853 | ||||||
| TAIR|locus:2203196 | 777 | PPK1 "putative protein kinase | 0.550 | 0.604 | 0.674 | 1.2e-190 | |
| DICTYBASE|DDB_G0280995 | 983 | mps1 "TTK family protein kinas | 0.228 | 0.198 | 0.527 | 1.9e-63 | |
| UNIPROTKB|J9NVE1 | 855 | TTK "Uncharacterized protein" | 0.276 | 0.276 | 0.457 | 2e-57 | |
| UNIPROTKB|E2QYE4 | 820 | TTK "Uncharacterized protein" | 0.276 | 0.287 | 0.457 | 7.3e-57 | |
| CGD|CAL0004016 | 690 | MPS1 [Candida albicans (taxid: | 0.225 | 0.278 | 0.432 | 2.5e-52 | |
| SGD|S000002186 | 764 | MPS1 "Dual-specificity kinase" | 0.228 | 0.255 | 0.411 | 4.3e-52 | |
| ASPGD|ASPL0000035269 | 828 | AN2927 [Emericella nidulans (t | 0.233 | 0.240 | 0.437 | 2.2e-49 | |
| POMBASE|SPBC106.01 | 678 | mph1 "dual specificity protein | 0.252 | 0.317 | 0.461 | 2.4e-48 | |
| UNIPROTKB|D4A4S7 | 835 | Ttk "Protein Ttk" [Rattus norv | 0.633 | 0.646 | 0.308 | 1e-45 | |
| UNIPROTKB|P33981 | 857 | TTK "Dual specificity protein | 0.276 | 0.275 | 0.453 | 3.3e-45 |
| TAIR|locus:2203196 PPK1 "putative protein kinase 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1626 (577.4 bits), Expect = 1.2e-190, Sum P(2) = 1.2e-190
Identities = 329/488 (67%), Positives = 368/488 (75%)
Query: 331 DFSRNPEPANRGDMVHLSCSSLKDTKT--PVDQAVRAPQASTSVIDPKPEIKKQEWPKEQ 388
D + NP + C S K + P A A + S DP+ +K+ + K+Q
Sbjct: 269 DSNANPHAVQSQGNLPSCCPSSKVSNILHPNKDAT-ASEMPASTNDPEVRVKETDTSKQQ 327
Query: 389 QDCVVKEGGIPNDPSTHKSMEGRQHTGNSPELKSQAPLSKNSSSDMKLEASKSEKQEKAV 448
Q E P S + S +G Q PE L + SS + KS+K EK
Sbjct: 328 QITTGLEA--PVGSSIYGS-DG-QANARLPE-----ELHTSVSS----QPQKSDKHEKVA 374
Query: 449 SSKGASAPRKRNYDPDLFFKVNGKLYQRLGKIGSGGSSEVHKVISSDCTIYALKKIKLKG 508
SSKG SAPRKRNYDPDLFFKVNGKLYQRLGKIGSGGSSEVHKVISSDCTIYALKKIKLKG
Sbjct: 375 SSKGPSAPRKRNYDPDLFFKVNGKLYQRLGKIGSGGSSEVHKVISSDCTIYALKKIKLKG 434
Query: 509 RDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLREVLNGSMNNKDGRVKDDGYI 568
RDYATAYGFCQEI YL KLKGK NIIQLIDYEVT+K LL+EVLNG+M+NKDGRVK+DG+I
Sbjct: 435 RDYATAYGFCQEIGYLKKLKGKTNIIQLIDYEVTDKTLLQEVLNGTMSNKDGRVKEDGFI 494
Query: 569 YMVLEYGEIDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKP 628
YMVLEYGEIDLAHMLSQKW+E++GS++T+DENWLRFYWQQIL+AVNTIHEERIVHSDLKP
Sbjct: 495 YMVLEYGEIDLAHMLSQKWREIEGSDRTIDENWLRFYWQQILQAVNTIHEERIVHSDLKP 554
Query: 629 ANFLLVKGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCG 688
ANFLLV+G LKLIDFGIAKAI SDTTNIQRDSQVGTLSYMSPEAFMCNESDENGN IKCG
Sbjct: 555 ANFLLVRGFLKLIDFGIAKAINSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNTIKCG 614
Query: 689 RPSDIWSLGCILYQMVYGRTPFSEYKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCL 748
RPSDIWSLGCILYQMVYGRTPF++YKTFWAKFKVITDPNHEITY + NPWL+DLMKKCL
Sbjct: 615 RPSDIWSLGCILYQMVYGRTPFADYKTFWAKFKVITDPNHEITYNQLSNPWLIDLMKKCL 674
Query: 749 AWDRNERWRIPQLLQHPFXXXXXXXXXXXXXXXXXXXXXXXXXXXXXDHEASTICSQLSQ 808
AWDRN+RWRIP+LLQHPF D +A+++ SQL Q
Sbjct: 675 AWDRNQRWRIPELLQHPFLAPPIPHEPQVKTIKLFSLIAESCGSD--DDKANSMISQLEQ 732
Query: 809 LIRNPVML 816
L+ NP L
Sbjct: 733 LLSNPAPL 740
|
|
| DICTYBASE|DDB_G0280995 mps1 "TTK family protein kinase Mps1" [Dictyostelium discoideum (taxid:44689)] | Back alignment and assigned GO terms |
|---|
Score = 531 (192.0 bits), Expect = 1.9e-63, Sum P(3) = 1.9e-63
Identities = 106/201 (52%), Positives = 144/201 (71%)
Query: 567 YIYMVLEYGEIDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDL 626
YI +VLE+GEIDL+ +L Q+ + +G+N N++R YWQQ+L+AV+TIHEE+I+H DL
Sbjct: 785 YILLVLEFGEIDLSKLL-QRLQTPNGTNV----NFIRIYWQQMLQAVHTIHEEKIIHGDL 839
Query: 627 KPANFLLVKGSLKLIDFGIAKAIMSD-TTNIQRDSQVGTLSYMSPEAFMCNESDENGNII 685
KPANF+ V+GSLKLIDFGIAKAI SD TTNI R+SQ+GT++Y+SPEA + +
Sbjct: 840 KPANFVSVQGSLKLIDFGIAKAIQSDDTTNIVRESQIGTINYISPEALIDTSQGGPKQCM 899
Query: 686 KCGRPSDIWSLGCILYQMVYGRTPFSEYKTFWAKFKVITDPNHEITYEPVPNPWLLDLMK 745
K GR SDIWSLGCILY+M +G PF + +K++ I +P+H+I + PN LL ++K
Sbjct: 900 KLGRASDIWSLGCILYEMAFGYPPFKSFSNIISKYQAIINPHHKIEFPVHPNENLLKVLK 959
Query: 746 KCLAWDRNERWRIPQLLQHPF 766
CL + +ER IP LL H F
Sbjct: 960 LCLIRNPHERPTIPTLLNHDF 980
|
|
| UNIPROTKB|J9NVE1 TTK "Uncharacterized protein" [Canis lupus familiaris (taxid:9615)] | Back alignment and assigned GO terms |
|---|
Score = 494 (179.0 bits), Expect = 2.0e-57, Sum P(2) = 2.0e-57
Identities = 114/249 (45%), Positives = 147/249 (59%)
Query: 521 IEYLNKLKGKNNIIQLIDYEVTEKALLREVLNGSMNNKDGRVKDDGYIYMVLEYGEIDLA 580
I+Y+N + N I+ E+ L++ + + D + D YIYMV+E G IDL
Sbjct: 549 IKYVNLEEADNQTIESYRNEIAYLNKLQQHSDKIIRLYDYEITDQ-YIYMVMECGNIDLN 607
Query: 581 HMLSQKWKEMDGSNQTLDENWLR-FYWQQILEAVNTIHEERIVHSDLKPANFLLVKGSLK 639
L +K K ++ W R YW+ +LEAV TIH+ IVHSDLKPANFL+V G LK
Sbjct: 608 SWLKKK-KSINP--------WERKSYWKNMLEAVYTIHQHGIVHSDLKPANFLIVDGMLK 658
Query: 640 LIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFM-CNESDENGNI-IKCGRPSDIWSLG 697
LIDFGIA + DTT+I +DSQVGT++YM PEA + S ENG K SD+WSLG
Sbjct: 659 LIDFGIANQMQPDTTSIVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLG 718
Query: 698 CILYQMVYGRTPFSEYKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWR 757
CILY M YG+TPF +K I DPNHEI + +P L D++K CL D +R
Sbjct: 719 CILYYMTYGKTPFQHIINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLIRDPKQRIS 778
Query: 758 IPQLLQHPF 766
IP LL HP+
Sbjct: 779 IPDLLAHPY 787
|
|
| UNIPROTKB|E2QYE4 TTK "Uncharacterized protein" [Canis lupus familiaris (taxid:9615)] | Back alignment and assigned GO terms |
|---|
Score = 494 (179.0 bits), Expect = 7.3e-57, Sum P(2) = 7.3e-57
Identities = 114/249 (45%), Positives = 147/249 (59%)
Query: 521 IEYLNKLKGKNNIIQLIDYEVTEKALLREVLNGSMNNKDGRVKDDGYIYMVLEYGEIDLA 580
I+Y+N + N I+ E+ L++ + + D + D YIYMV+E G IDL
Sbjct: 530 IKYVNLEEADNQTIESYRNEIAYLNKLQQHSDKIIRLYDYEITDQ-YIYMVMECGNIDLN 588
Query: 581 HMLSQKWKEMDGSNQTLDENWLR-FYWQQILEAVNTIHEERIVHSDLKPANFLLVKGSLK 639
L +K K ++ W R YW+ +LEAV TIH+ IVHSDLKPANFL+V G LK
Sbjct: 589 SWLKKK-KSINP--------WERKSYWKNMLEAVYTIHQHGIVHSDLKPANFLIVDGMLK 639
Query: 640 LIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFM-CNESDENGNI-IKCGRPSDIWSLG 697
LIDFGIA + DTT+I +DSQVGT++YM PEA + S ENG K SD+WSLG
Sbjct: 640 LIDFGIANQMQPDTTSIVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLG 699
Query: 698 CILYQMVYGRTPFSEYKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWR 757
CILY M YG+TPF +K I DPNHEI + +P L D++K CL D +R
Sbjct: 700 CILYYMTYGKTPFQHIINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLIRDPKQRIS 759
Query: 758 IPQLLQHPF 766
IP LL HP+
Sbjct: 760 IPDLLAHPY 768
|
|
| CGD|CAL0004016 MPS1 [Candida albicans (taxid:5476)] | Back alignment and assigned GO terms |
|---|
Score = 436 (158.5 bits), Expect = 2.5e-52, Sum P(3) = 2.5e-52
Identities = 89/206 (43%), Positives = 134/206 (65%)
Query: 568 IYMVLEYGEIDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLK 627
+Y+++E G++DLA +L + K +D LD N+++++ ++ + + +H+ IVHSDLK
Sbjct: 438 LYLIMEKGDLDLAEVLQYRLK-LDAP---LDLNFVKYHTIEMFKCIKDVHDAGIVHSDLK 493
Query: 628 PANFLLVKGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKC 687
PANFL V+G LK+IDFGIA A+ T N+ R++Q+GT +YM+PEA +C + + I K
Sbjct: 494 PANFLFVRGMLKIIDFGIANAVPDHTINVYRENQIGTPNYMAPEA-ICESNYTSARIWKV 552
Query: 688 GRPSDIWSLGCILYQMVYGRTPFSEYKTFWAKFKVITDPNHEITYE-------PVPNPWL 740
G+PSDIWS+GCILYQ +YG+ PF+ Y K IT+P+ +I++ PVP
Sbjct: 553 GKPSDIWSIGCILYQFIYGKAPFAGYSGN-QKLMAITNPHIKISFPSSGIGNTPVPVS-A 610
Query: 741 LDLMKKCLAWDRNERWRIPQLLQHPF 766
++LMK CL D N+RW I Q L F
Sbjct: 611 IELMKNCLHRDPNDRWTIEQCLTCDF 636
|
|
| SGD|S000002186 MPS1 "Dual-specificity kinase" [Saccharomyces cerevisiae (taxid:4932)] | Back alignment and assigned GO terms |
|---|
Score = 429 (156.1 bits), Expect = 4.3e-52, Sum P(3) = 4.3e-52
Identities = 88/214 (41%), Positives = 134/214 (62%)
Query: 565 DGYIYMVLEYGEIDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHS 624
DG +Y+++E G+ DL+ +L+Q+ S LD N++RFY +++L + +H+ IVHS
Sbjct: 509 DGLLYLIMECGDHDLSQILNQR------SGMPLDFNFVRFYTKEMLLCIKVVHDAGIVHS 562
Query: 625 DLKPANFLLVKGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMC---NESDEN 681
DLKPANF+LVKG LK+IDFGIA A+ T NI R++Q+GT +YM+PEA + ++ EN
Sbjct: 563 DLKPANFVLVKGILKIIDFGIANAVPEHTVNIYRETQIGTPNYMAPEALVAMNYTQNSEN 622
Query: 682 ---GNIIKCGRPSDIWSLGCILYQMVYGRTPFSEYKTFWAKFKVITD------PNHEITY 732
GN K GRPSD+WS GCI+YQM+YG+ P+ ++ ++ P H
Sbjct: 623 QHEGNKWKVGRPSDMWSCGCIIYQMIYGKPPYGSFQGQNRLLAIMNPDVKIPFPEHTSNN 682
Query: 733 EPVPNPWLLDLMKKCLAWDRNERWRIPQLLQHPF 766
E +P ++LMK CL + ++RW + ++L F
Sbjct: 683 EKIPKS-AIELMKACLYRNPDKRWTVDKVLSSTF 715
|
|
| ASPGD|ASPL0000035269 AN2927 [Emericella nidulans (taxid:162425)] | Back alignment and assigned GO terms |
|---|
Score = 440 (159.9 bits), Expect = 2.2e-49, Sum P(3) = 2.2e-49
Identities = 95/217 (43%), Positives = 136/217 (62%)
Query: 564 DDGYIYMVLEYGEIDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVH 623
D + +++E GE DL +L+ K ++ + T D N+ RFYW+++LE V +HE +VH
Sbjct: 557 DKRTLSVLMEIGESDLEKVLTYK---LNAEDATFDINFTRFYWKEMLECVQAVHEYNVVH 613
Query: 624 SDLKPANFLLVKGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDEN-- 681
SDLKPANFLLV+G LKLIDFGIA AI +T N+ R+ QVGT +YMSPEA + + +
Sbjct: 614 SDLKPANFLLVQGRLKLIDFGIANAIQDNTVNVHREQQVGTPNYMSPEALVDSNASLGLP 673
Query: 682 ---GNIIKCGRPSDIWSLGCILYQMVYGRTPFSEYKTFWAKFKVITDPNHEITYEP---- 734
G ++K G+PSD+WSLGCILY+MVYG+ PF++ ++ + I +P +I +
Sbjct: 674 ASVGKMMKLGKPSDVWSLGCILYKMVYGQPPFAKIAKYYERIMAIPNPKVKIDFPAFGVG 733
Query: 735 ---VPNPWLLDLMKKCLAWDRNERWRIPQLL--QHPF 766
VP P L+ +K CL D+ R I LL + PF
Sbjct: 734 GIQVP-PGLIRTLKGCLQRDQTLRPTISDLLGQRDPF 769
|
|
| POMBASE|SPBC106.01 mph1 "dual specificity protein kinase Mph1" [Schizosaccharomyces pombe (taxid:4896)] | Back alignment and assigned GO terms |
|---|
Score = 467 (169.5 bits), Expect = 2.4e-48, Sum P(3) = 2.4e-48
Identities = 108/234 (46%), Positives = 146/234 (62%)
Query: 510 DYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLREVLNGSMNNK--DGRVKDD-G 566
D + Y +E+ ++N IQ Y+ E ALLR++ K V D G
Sbjct: 337 DNSRLYAL-KEVNFIN---ADQTTIQ--GYK-NEIALLRKLSGNDRIIKLYAAEVNDTLG 389
Query: 567 YIYMVLEYGEIDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDL 626
+ MV+E GE DLA++L + K+ ++ N++R YW+Q+LEAV +H++ IVHSDL
Sbjct: 390 QLNMVMECGETDLANLLMKNMKK------PINLNFIRMYWEQMLEAVQVVHDQNIVHSDL 443
Query: 627 KPANFLLVKGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFM-CNESDENG-NI 684
KPANFLLV+G+LKLIDFGIAKAI +DTTNI RDS +GT++YM+PEA N +G +
Sbjct: 444 KPANFLLVEGNLKLIDFGIAKAIGNDTTNIHRDSHIGTINYMAPEALTDMNAHTNSGVKL 503
Query: 685 IKCGRPSDIWSLGCILYQMVYGRTPFSEYKTFWAKFKVITDPNHEITYEPVPNP 738
+K GRPSD+WSLGCILYQMVYGR PF+ K A I + + I + V P
Sbjct: 504 VKLGRPSDVWSLGCILYQMVYGRAPFAHLKMIQA-IAAIPNEQYHIHFPEVALP 556
|
|
| UNIPROTKB|D4A4S7 Ttk "Protein Ttk" [Rattus norvegicus (taxid:10116)] | Back alignment and assigned GO terms |
|---|
Score = 505 (182.8 bits), Expect = 1.0e-45, P = 1.0e-45
Identities = 181/586 (30%), Positives = 271/586 (46%)
Query: 204 TGMENLSSHMGSLALTEMEWDASNQVEVSTVVNNNSKLQQVRNTEPDISLR-PDGASSLA 262
T E+ SS +G+L + D Q + ++ + + + ++S R P ++
Sbjct: 206 TAQESFSSSLGNLQSRKSSCDPKVQAAAARILYG----ENMPPKDAEVSHRNPLKQTNKT 261
Query: 263 KRTTVVQDQLHQFRNFLGQPATQFSMVGSSCPTSTYIHSTSAPMLNSTTKCSRSHQEGS- 321
KR+ ++ N L P GS+ P T + + +S S+S S
Sbjct: 262 KRSCPF-GRVPV--NLLNSPDYYVKTDGSAVPQFTKRKISGSEYRDSIMPGSKSSGNDSY 318
Query: 322 TLGAVEPVEDFSRNPEPANRGDMVHLSCSSLKDTKTPVDQAVRAPQASTSVIDPK-PEIK 380
L ++P++ + L S L K+ D ++ + +P+ PE +
Sbjct: 319 ELRGLKPIQAIHLKDSLVSNEKSSELM-SDLVTLKSKTDSSLTKLEEPKVRQEPEIPERR 377
Query: 381 KQEWPKEQQD-CVVKEGGIPNDPSTHKSMEGRQHTGNSPEL--------KSQAPLSKNSS 431
++W ++ C ++ P H + SP L KS +SS
Sbjct: 378 HKQWQSARKPGCGIQNSAA-FAPQWHVPDVTPKADKESPPLSVPKWIDPKSVCETPSSSS 436
Query: 432 SDMKLEASKSEKQEKAVSSKGASAPRKRNYDPDLFFKVNGKLYQRLGKIGSGGSSEVHKV 491
D ++ K+ + S+ + G L L + GSS + +
Sbjct: 437 LDDYMKCFKTSVVKNEFPPACPSSTPYSQLARHQQHQQQG-LSTPLQNLQISGSSSMSEC 495
Query: 492 ISSDCTIYA-LKKIKLKGRDYATAYGFCQEIEYLNKLKGKN---NIIQLIDYEVTEKALL 547
IS + IY+ LK+I G + + E + +N +K N Q ID E A L
Sbjct: 496 ISVNGRIYSILKQIGSGGS--SKVFQVLNEKKQINAIKYVNLEDADSQTIDSYRNEIAYL 553
Query: 548 REVLNGSMNNKDGRVKD----DGYIYMVLEYGEIDLAHMLSQKWKEMDGSNQTLDENWLR 603
++ S +K R+ D D YIYMV+E G IDL L +K K ++ W R
Sbjct: 554 NKLQQHS--DKIIRLYDYEITDRYIYMVMECGNIDLNSWLKKK-KSINP--------WER 602
Query: 604 -FYWQQILEAVNTIHEERIVHSDLKPANFLLVKGSLKLIDFGIAKAIMSDTTNIQRDSQV 662
YW+ +LEAV+TIH+ IVHSDLKPANFL+V G LKLIDFGIA + DTT+I +DSQV
Sbjct: 603 KSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVDGMLKLIDFGIANQMQPDTTSIVKDSQV 662
Query: 663 GTLSYMSPEAFM-CNESDENGNI-IKCGRPSDIWSLGCILYQMVYGRTPFSEYKTFWAKF 720
GT++YM+PEA + S ENG I K SD+WSLGCILY M YG+TPF +K
Sbjct: 663 GTVNYMAPEAIRDMSSSRENGKIKTKISPRSDVWSLGCILYYMTYGKTPFQHIINQVSKL 722
Query: 721 KVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQHPF 766
I DP+HEI + + L D++K CL + ER IP+LL HP+
Sbjct: 723 HAIIDPSHEIEFPEISEKDLRDVLKCCLVRNPKERISIPELLAHPY 768
|
|
| UNIPROTKB|P33981 TTK "Dual specificity protein kinase TTK" [Homo sapiens (taxid:9606)] | Back alignment and assigned GO terms |
|---|
Score = 501 (181.4 bits), Expect = 3.3e-45, P = 3.3e-45
Identities = 113/249 (45%), Positives = 149/249 (59%)
Query: 521 IEYLNKLKGKNNIIQLIDYEVTEKALLREVLNGSMNNKDGRVKDDGYIYMVLEYGEIDLA 580
I+Y+N + N + E+ L++ + + D + D YIYMV+E G IDL
Sbjct: 552 IKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQ-YIYMVMECGNIDLN 610
Query: 581 HMLSQKWKEMDGSNQTLDENWLR-FYWQQILEAVNTIHEERIVHSDLKPANFLLVKGSLK 639
L +K K +D W R YW+ +LEAV+TIH+ IVHSDLKPANFL+V G LK
Sbjct: 611 SWLKKK-KSIDP--------WERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVDGMLK 661
Query: 640 LIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFM-CNESDENGNI-IKCGRPSDIWSLG 697
LIDFGIA + DTT++ +DSQVGT++YM PEA + S ENG K SD+WSLG
Sbjct: 662 LIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLG 721
Query: 698 CILYQMVYGRTPFSEYKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWR 757
CILY M YG+TPF + +K I DPNHEI + +P L D++K CL D +R
Sbjct: 722 CILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRIS 781
Query: 758 IPQLLQHPF 766
IP+LL HP+
Sbjct: 782 IPELLAHPY 790
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | LOW CONFIDENCE prediction! |
| 3rd Layer | 2.7.11 | 0.691 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
| Your Input: |  |
 |
 |
 |
 |
 |
 |
 |
 |
||
 | fgenesh4_pm.C_LG_II000405 | hypothetical protein (818 aa) | |||||||||
(Populus trichocarpa) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 853 | |||
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 3e-72 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 8e-66 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 5e-52 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 1e-50 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 2e-44 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 7e-43 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 4e-42 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 6e-42 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 5e-38 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 1e-37 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 8e-37 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 9e-37 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 9e-37 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 2e-33 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 3e-33 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 5e-33 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 7e-31 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 1e-30 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 1e-29 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 6e-29 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 9e-29 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 2e-28 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 5e-28 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 6e-27 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 2e-26 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 2e-26 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 2e-26 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 5e-26 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 3e-25 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 3e-25 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 3e-25 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 7e-25 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 8e-25 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 1e-24 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 1e-24 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 2e-24 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 2e-24 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 2e-24 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 3e-24 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 3e-24 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 1e-23 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 1e-23 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 2e-23 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 2e-23 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 5e-23 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 5e-23 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 6e-23 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 7e-23 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 2e-22 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 2e-22 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 2e-22 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 3e-22 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 3e-22 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 4e-22 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 8e-22 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 1e-21 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 2e-21 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 2e-21 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 3e-21 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 3e-21 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 4e-21 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 5e-21 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 5e-21 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 6e-21 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 1e-20 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 1e-20 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 1e-20 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 1e-20 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 2e-20 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 4e-20 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 4e-20 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 6e-20 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 7e-20 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 2e-19 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 3e-19 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 3e-19 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 4e-19 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 5e-19 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 5e-19 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 5e-19 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 6e-19 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 6e-19 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 7e-19 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 1e-18 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 1e-18 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 2e-18 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 2e-18 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 2e-18 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 3e-18 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 4e-18 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 6e-18 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 6e-18 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 8e-18 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 9e-18 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 1e-17 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 2e-17 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 2e-17 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 2e-17 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 2e-17 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 3e-17 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 3e-17 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 4e-17 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 4e-17 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 5e-17 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 5e-17 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 6e-17 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 9e-17 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 2e-16 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 3e-16 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 4e-16 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 4e-16 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 4e-16 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 1e-15 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 1e-15 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 2e-15 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 2e-15 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 3e-15 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 3e-15 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 5e-15 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 5e-15 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 6e-15 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 6e-15 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 7e-15 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 9e-15 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 1e-14 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 1e-14 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 1e-14 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 2e-14 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 2e-14 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 2e-14 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 3e-14 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 3e-14 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 3e-14 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 4e-14 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 5e-14 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 5e-14 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 5e-14 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 6e-14 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 6e-14 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 7e-14 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 9e-14 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 1e-13 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 1e-13 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 2e-13 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 2e-13 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 4e-13 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 5e-13 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 6e-13 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 9e-13 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 9e-13 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 1e-12 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 1e-12 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 2e-12 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 4e-12 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 4e-12 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 4e-12 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 4e-12 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 5e-12 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 5e-12 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 6e-12 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 7e-12 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 7e-12 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 7e-12 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 1e-11 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 2e-11 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 2e-11 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 3e-11 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 3e-11 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 3e-11 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 3e-11 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 4e-11 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 5e-11 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 7e-11 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 7e-11 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 8e-11 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 1e-10 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 1e-10 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 2e-10 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 2e-10 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 2e-10 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 4e-10 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 4e-10 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 5e-10 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 6e-10 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 7e-10 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 7e-10 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 2e-09 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 4e-09 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 4e-09 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 4e-09 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 5e-09 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 5e-09 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 5e-09 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 2e-08 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 2e-08 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 3e-08 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 3e-08 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 5e-08 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 6e-08 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 7e-08 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 9e-08 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 9e-08 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 1e-07 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 1e-07 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 1e-07 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 3e-07 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 3e-07 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 3e-07 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 4e-07 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 5e-07 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 5e-07 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 6e-07 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 7e-07 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 9e-07 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 9e-07 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 1e-06 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 1e-06 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 2e-06 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 2e-06 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 3e-06 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 4e-06 | |
| TIGR03724 | 199 | TIGR03724, arch_bud32, Kae1-associated kinase Bud3 | 5e-06 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 7e-06 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 7e-06 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 1e-05 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 1e-05 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 1e-05 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 1e-05 | |
| PRK09605 | 535 | PRK09605, PRK09605, bifunctional UGMP family prote | 2e-05 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 2e-05 | |
| PRK14879 | 211 | PRK14879, PRK14879, serine/threonine protein kinas | 3e-05 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 3e-05 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 4e-05 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 4e-05 | |
| PTZ00284 | 467 | PTZ00284, PTZ00284, protein kinase; Provisional | 5e-05 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 6e-05 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 7e-05 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 7e-05 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 7e-05 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 9e-05 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 1e-04 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 1e-04 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 1e-04 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 1e-04 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 1e-04 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 1e-04 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 2e-04 | |
| COG3642 | 204 | COG3642, COG3642, Mn2+-dependent serine/threonine | 2e-04 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 2e-04 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 2e-04 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 2e-04 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 3e-04 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 3e-04 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 3e-04 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 3e-04 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 4e-04 | |
| PLN03225 | 566 | PLN03225, PLN03225, Serine/threonine-protein kinas | 4e-04 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 4e-04 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 5e-04 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 6e-04 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 7e-04 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 8e-04 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 8e-04 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 8e-04 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 8e-04 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 0.001 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 0.001 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 0.001 | |
| PLN03224 | 507 | PLN03224, PLN03224, probable serine/threonine prot | 0.002 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 0.002 | |
| cd05151 | 170 | cd05151, ChoK, Choline Kinase (ChoK) | 0.002 | |
| PHA02882 | 294 | PHA02882, PHA02882, putative serine/threonine kina | 0.002 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 0.003 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 0.003 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 0.004 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 0.004 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 237 bits (607), Expect = 3e-72
Identities = 94/302 (31%), Positives = 132/302 (43%), Gaps = 56/302 (18%)
Query: 474 YQRLGKIGSGGSSEVHKVIS-SDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNN 532
Y+ L K+G G +V+ + A+K IK K + +EI+ L KLK N
Sbjct: 1 YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIK-KKKIKKDRERILREIKILKKLKHPN- 58
Query: 533 IIQLIDYEVTEKALLREVLNGSMNNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEMD 591
I++L D D+ +Y+V+EY E DL +L
Sbjct: 59 IVRLYDVFE----------------------DEDKLYLVMEYCEGGDLFDLLK------- 89
Query: 592 GSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLLVK-GSLKLIDFGIAKAIM 650
L E+ RFY +QIL A+ +H + IVH DLKP N LL + G +KL DFG+A+ +
Sbjct: 90 -KRGRLSEDEARFYLRQILSALEYLHSKGIVHRDLKPENILLDEDGHVKLADFGLARQLD 148
Query: 651 SDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGRTPF 710
+ VGT YM+PE + G+ DIWSLG ILY+++ G+ PF
Sbjct: 149 PGEK---LTTFVGTPEYMAPEVLLGK---------GYGKAVDIWSLGVILYELLTGKPPF 196
Query: 711 SEYKTFWAKFKVITDPNHEITYEPVPNPW-----LLDLMKKCLAWDRNERWRIPQLLQHP 765
FK I P P W DL++K L D +R + LQHP
Sbjct: 197 PGDDQLLELFKKIGKP----KPPFPPPEWDISPEAKDLIRKLLVKDPEKRLTAEEALQHP 252
Query: 766 FL 767
F
Sbjct: 253 FF 254
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 220 bits (562), Expect = 8e-66
Identities = 86/302 (28%), Positives = 135/302 (44%), Gaps = 50/302 (16%)
Query: 474 YQRLGKIGSGGSSEVHKVI-SSDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNN 532
Y+ L K+GSG V+K I A+K +K + +EI L +L N
Sbjct: 1 YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPN- 59
Query: 533 IIQLIDYEVTEKALLREVLNGSMNNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEMD 591
I++LID +D ++Y+V+EY E DL LS+
Sbjct: 60 IVRLIDA----------------------FEDKDHLYLVMEYCEGGDLFDYLSRG----- 92
Query: 592 GSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLLV-KGSLKLIDFGIAKAIM 650
L E+ + QIL + +H I+H DLKP N LL G +K+ DFG+AK ++
Sbjct: 93 ---GPLSEDEAKKIALQILRGLEYLHSNGIIHRDLKPENILLDENGVVKIADFGLAKKLL 149
Query: 651 SDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGRTPF 710
+++ + VGT YM+PE + G D+WSLG ILY+++ G+ PF
Sbjct: 150 KSSSS--LTTFVGTPWYMAPEVLLGGNGY--------GPKVDVWSLGVILYELLTGKPPF 199
Query: 711 SEYKTFWAKFKVI-----TDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQHP 765
S + + ++I + + DL+KKCL D ++R ++LQHP
Sbjct: 200 SG-ENILDQLQLIRRILGPPLEFDEPKWSSGSEEAKDLIKKCLNKDPSKRPTAEEILQHP 258
Query: 766 FL 767
+
Sbjct: 259 WF 260
|
Length = 260 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 180 bits (459), Expect = 5e-52
Identities = 75/290 (25%), Positives = 112/290 (38%), Gaps = 79/290 (27%)
Query: 480 IGSGGSSEVHKVIS-SDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLID 538
+G GG V+ A+K IK + +EIE L KL N I++L
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEE-LLREIEILKKLNHPN-IVKLYG 58
Query: 539 YEVTEKALLREVLNGSMNNKDGRVKDDGYIYMVLEYGEI-DLAHMLSQKWKEMDGSNQTL 597
+D+ ++Y+V+EY E L +L + L
Sbjct: 59 V----------------------FEDENHLYLVMEYCEGGSLKDLLKEN-------EGKL 89
Query: 598 DENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLL--VKGSLKLIDFGIAKAIMSDTTN 655
E+ + QILE + +H I+H DLKP N LL G +KL DFG++K + +
Sbjct: 90 SEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDNGKVKLADFGLSKLL--TSDK 147
Query: 656 IQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGRTPFSEYKT 715
+ VGT +YM+PE + SDIWSLG ILY++
Sbjct: 148 SLLKTIVGTPAYMAPEVLL--------GKGYYSEKSDIWSLGVILYEL------------ 187
Query: 716 FWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQHP 765
P L DL++K L D +R ++L+H
Sbjct: 188 ----------------------PELKDLIRKMLQKDPEKRPSAKEILEHL 215
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 178 bits (453), Expect = 1e-50
Identities = 87/303 (28%), Positives = 129/303 (42%), Gaps = 53/303 (17%)
Query: 474 YQRLGKIGSGGSSEVHKVISSDC-TIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNN 532
+ R +G G V+ + D + A+K ++L G +EI L+ L+ N
Sbjct: 2 WTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPN- 60
Query: 533 IIQLIDYEVTEKALLREVLNGSMNNKDGRVKDDGYIYMVLEY---GEIDLAHMLSQKWKE 589
I++ E E + + + LEY G L+ +L + K
Sbjct: 61 IVRYYGSERDE--------------------EKNTLNIFLEYVSGG--SLSSLLKKFGK- 97
Query: 590 MDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLLV-KGSLKLIDFGIAKA 648
L E +R Y +QILE + +H IVH D+K AN L+ G +KL DFG AK
Sbjct: 98 -------LPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSDGVVKLADFGCAKR 150
Query: 649 IMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGRT 708
+ T S GT +M+PE E GR +DIWSLGC + +M G+
Sbjct: 151 LGDIETGEGTGSVRGTPYWMAPEVIRGEEY---------GRAADIWSLGCTVIEMATGKP 201
Query: 709 PFSEYK-TFWAKFKVITDPNHEITYEPVPN---PWLLDLMKKCLAWDRNERWRIPQLLQH 764
P+SE A +K+ + +P D ++KCL D +R +LLQH
Sbjct: 202 PWSELGNPMAALYKIGSSGEP----PEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQH 257
Query: 765 PFL 767
PFL
Sbjct: 258 PFL 260
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 160 bits (408), Expect = 2e-44
Identities = 88/307 (28%), Positives = 138/307 (44%), Gaps = 67/307 (21%)
Query: 473 LYQRLGKIGSGGSSEVHKVIS-SDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKN 531
L++ L KIG GG EV+K A+K IKL+ ++ EI+ L K K N
Sbjct: 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKII--NEIQILKKCKHPN 58
Query: 532 NIIQLIDYEVTEKALLREVLNGSMNNKDGRVKDDGYIYMVLEY---GEIDLAHMLSQKWK 588
I++ G +++V+E+ G +
Sbjct: 59 -IVKYY----------------------GSYLKKDELWIVMEFCSGGSLKDL-------- 87
Query: 589 EMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLL-VKGSLKLIDFGIAK 647
+ +NQTL E+ + + +++L+ + +H I+H D+K AN LL G +KLIDFG++
Sbjct: 88 -LKSTNQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSDGEVKLIDFGLS- 145
Query: 648 AIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGR---PSDIWSLGCILYQMV 704
A +SDT R++ VGT +M+PE +I +DIWSLG ++
Sbjct: 146 AQLSDTK--ARNTMVGTPYWMAPE------------VINGKPYDYKADIWSLGITAIELA 191
Query: 705 YGRTPFSEYKTFWAKFKVITDPNHEITYEPVPNPW-----LLDLMKKCLAWDRNERWRIP 759
G+ P+SE A FK+ T+ + NP D +KKCL + +R
Sbjct: 192 EGKPPYSELPPMKALFKIATNGPPGL-----RNPEKWSDEFKDFLKKCLQKNPEKRPTAE 246
Query: 760 QLLQHPF 766
QLL+HPF
Sbjct: 247 QLLKHPF 253
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 156 bits (398), Expect = 7e-43
Identities = 98/321 (30%), Positives = 135/321 (42%), Gaps = 84/321 (26%)
Query: 480 IGSGGSSEVHKVIS-SDCTIYALK---K---IKLKGRDYATAYGFCQEIEYLNKLKGKNN 532
IG G S V YA+K K IK K Y E E L +L G
Sbjct: 9 IGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYV-----KIEKEVLTRLNGHPG 63
Query: 533 IIQLIDYEVTEKALLREVLNGSMNNKDGRVKDDGYIYMVLEYGEI-DLAHMLSQKWKEMD 591
II+L +D+ +Y VLEY +L + +
Sbjct: 64 IIKLY----------------------YTFQDEENLYFVLEYAPNGELLQYIRKY----- 96
Query: 592 GSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLLVK-GSLKLIDFGIAKAIM 650
GS LDE RFY +IL A+ +H + I+H DLKP N LL K +K+ DFG AK +
Sbjct: 97 GS---LDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLD 153
Query: 651 SDTTNIQ------------------RDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSD 692
+++ S VGT Y+SPE + NE G+ SD
Sbjct: 154 PNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPE--LLNEKP-------AGKSSD 204
Query: 693 IWSLGCILYQMVYGRTPF---SEYKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLA 749
+W+LGCI+YQM+ G+ PF +EY TF K++ E ++ P P DL++K L
Sbjct: 205 LWALGCIIYQMLTGKPPFRGSNEYLTFQ---KIL---KLEYSFPPNFPPDAKDLIEKLLV 258
Query: 750 WDRNER----WRIPQLLQHPF 766
D +R +L HPF
Sbjct: 259 LDPQDRLGVNEGYDELKAHPF 279
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 154 bits (391), Expect = 4e-42
Identities = 94/306 (30%), Positives = 142/306 (46%), Gaps = 55/306 (17%)
Query: 474 YQRLGKIGSGGSSEVHKVISSDC-TIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNN 532
+QR KIG G +V+ ++ D + A+K+I+++ D T E++ L LK N
Sbjct: 2 WQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPN- 60
Query: 533 IIQLIDYEVTEKALLREVLNGSMNNKDGRVKDDGYIYMVLEYGEIDLAHMLSQKWKEMDG 592
L+ Y E + RE + M G G + +LE+G I
Sbjct: 61 ---LVKYYGVE--VHREKVYIFMEYCSG-----GTLEELLEHGRI--------------- 95
Query: 593 SNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLLVK-GSLKLIDFGIAKAIMS 651
LDE+ +R Y Q+LE + +H IVH D+KPAN L G +KL DFG A + +
Sbjct: 96 ----LDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKN 151
Query: 652 DTTNIQRDSQ--VGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGRTP 709
+TT + + Q GT +YM+PE + +G R +DIWSLGC++ +M G+ P
Sbjct: 152 NTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHG------RAADIWSLGCVVLEMATGKRP 205
Query: 710 FSEYKTFWA-KFKV-------ITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQL 761
+SE + F V I D +P D + +CL D +R +L
Sbjct: 206 WSELDNEFQIMFHVGAGHKPPIPDSLQL-------SPEGKDFLDRCLESDPKKRPTASEL 258
Query: 762 LQHPFL 767
LQHPF+
Sbjct: 259 LQHPFV 264
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 153 bits (390), Expect = 6e-42
Identities = 89/312 (28%), Positives = 147/312 (47%), Gaps = 73/312 (23%)
Query: 474 YQRLGKIGSGGSSEVHKVIS-SDCTIYALKKIKLKG-----RDYATAYGFCQEIEYLNKL 527
Y+ + +IG G +V+ V SD +Y LK+I L R+ A E++ L KL
Sbjct: 2 YEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDAL-----NEVKILKKL 56
Query: 528 KGKNNIIQLIDYEVTEKALLREVLNGSMNNKDGRVKDDGYIYMVLEYGEI-DLAHMLSQK 586
NII+ + ++ G + +V+EY + DL+ + ++
Sbjct: 57 N-HPNIIKYYE----------------------SFEEKGKLCIVMEYADGGDLSQKIKKQ 93
Query: 587 WKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPAN-FLLVKGSLKLIDFGI 645
KE + E + ++ Q+ A+ +H +I+H D+KP N FL G +KL DFGI
Sbjct: 94 KKE----GKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGI 149
Query: 646 AKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRP----SDIWSLGCILY 701
+K ++S T ++ + + VGT Y+SPE +C +P SDIWSLGC+LY
Sbjct: 150 SK-VLSSTVDLAK-TVVGTPYYLSPE--LCQ-----------NKPYNYKSDIWSLGCVLY 194
Query: 702 QMVYGRTPF---SEYKTFWAKFKVITDPNHEITYEPVPNPW---LLDLMKKCLAWDRNER 755
++ + PF + + K++ Y P+P+ + L +L+ L D ER
Sbjct: 195 ELCTLKHPFEGENLLELAL---KILKG-----QYPPIPSQYSSELRNLVSSLLQKDPEER 246
Query: 756 WRIPQLLQHPFL 767
I Q+LQ PF+
Sbjct: 247 PSIAQILQSPFI 258
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 143 bits (362), Expect = 5e-38
Identities = 85/330 (25%), Positives = 136/330 (41%), Gaps = 84/330 (25%)
Query: 474 YQRLGKIGSGGSSEVHKVISSDC-TIYALKKIKLKGRDY---ATAYGFCQEIEYLNKLKG 529
Y++L K+G G V+K I ALKKI+L + +TA +EI L +LK
Sbjct: 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTA---LREISLLKELK- 56
Query: 530 KNNIIQLIDYEVTEKALLREVLNGSMNNKDGRVKDDGYIYMVLEYGEIDLAHMLSQKWKE 589
NI++L+D TE+ +Y+V EY ++DL L ++
Sbjct: 57 HPNIVKLLDVIHTERK----------------------LYLVFEYCDMDLKKYLDKR--- 91
Query: 590 MDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLL-VKGSLKLIDFGIAKA 648
L N ++ Q+L + H RI+H DLKP N L+ G LKL DFG+A+A
Sbjct: 92 ----PGPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRDGVLKLADFGLARA 147
Query: 649 IMSDTTNIQRDSQ-VGTLSYMSPEAFM-CNESDENGNIIKCGRPS-DIWSLGCILYQMVY 705
++ + V TL Y +PE + + DIWS+GCI +M+
Sbjct: 148 FGI---PLRTYTHEVVTLWYRAPEILLGSKHYS----------TAVDIWSVGCIFAEMIT 194
Query: 706 GR--------------------TP-------FSEYKTFWAKFKVIT-DPNHEITYEPVPN 737
G+ TP ++ + F ++ P +
Sbjct: 195 GKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKPTFPKFPPKDLEKVL--PRLD 252
Query: 738 PWLLDLMKKCLAWDRNERWRIPQLLQHPFL 767
P +DL+ K L ++ +R + L+HP+
Sbjct: 253 PEGIDLLSKMLQYNPAKRISAKEALKHPYF 282
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 145 bits (365), Expect = 1e-37
Identities = 85/324 (26%), Positives = 127/324 (39%), Gaps = 51/324 (15%)
Query: 474 YQRLGKIGSGGSSEVHKVISSDCTIYALKKIKLKGRDYATA-YGFCQEIEYLNKLKGKNN 532
Y+ L K+G G EV+ + ALK + K + F +EI+ L L N
Sbjct: 2 YRILRKLGEGSFGEVYLARDRK--LVALKVLAKKLESKSKEVERFLREIQILASLNHPPN 59
Query: 533 IIQLIDYEVTEKALLREVLNGSMNNKDGRVKDDGYIYMVLEYGEIDLAHMLSQKWKEMDG 592
I++L D+ +D+G +Y+V+EY + + G
Sbjct: 60 IVKLYDF----------------------FQDEGSLYLVMEYVDGGSLE----DLLKKIG 93
Query: 593 SNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLLVK--GSLKLIDFGIAKAIM 650
L E+ F QIL A+ +H + I+H D+KP N LL + +KLIDFG+AK +
Sbjct: 94 RKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLP 153
Query: 651 SDTT----NIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYG 706
+ + VGT YM+PE ++ SDIWSLG LY+++ G
Sbjct: 154 DPGSTSSIPALPSTSVGTPGYMAPEVL------LGLSLAYASSSSDIWSLGITLYELLTG 207
Query: 707 RTPF------SEYKTFWAKFKVITDPNHEITYEP----VPNPWLLDLMKKCLAWDRNERW 756
PF S + P+ P + + DL+KK LA D R
Sbjct: 208 LPPFEGEKNSSATSQTLKIILELPTPSLASPLSPSNPELISKAASDLLKKLLAKDPKNRL 267
Query: 757 RIPQLLQHPFLVPPVSTQPSSSQD 780
L H L + S
Sbjct: 268 SSSSDLSHDLLAHLKLKESDLSDL 291
|
Length = 384 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 139 bits (353), Expect = 8e-37
Identities = 85/327 (25%), Positives = 127/327 (38%), Gaps = 77/327 (23%)
Query: 474 YQRLGKIGSGGSSEVHKVISSDC-TIYALKKIKLKGRDYATAYGFCQ----EIEYLNKLK 528
YQ+LGKIG G V+K I A+KKIKL+ G + EI+ L +L
Sbjct: 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESE----GIPKTALREIKLLKELN 56
Query: 529 GKNNIIQLIDYEVTEKALLREVLNGSMNNKDGRVKDDGYIYMVLEYGEIDLAHMLSQKWK 588
N II+L+D + G +Y+V E+ + DL
Sbjct: 57 HPN-IIKLLDV----------------------FRHKGDLYLVFEFMDTDLYK------- 86
Query: 589 EMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLLVK-GSLKLIDFGIAK 647
+ + L E+ ++ Y Q+L+ + H I+H DLKP N L+ G LKL DFG+A+
Sbjct: 87 LIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTEGVLKLADFGLAR 146
Query: 648 AIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGR 707
+ S V T Y +PE + P DIWS+GCI +++ R
Sbjct: 147 SFGSP--VRPYTHYVVTRWYRAPELLL--------GDKGYSTPVDIWSVGCIFAELLSRR 196
Query: 708 TPF-----------------SEYKTFWAKFKVITDPNHEITYEPVPNPW----------L 740
F + W KF + + P
Sbjct: 197 PLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKFSFPKKAGMPLPKLFPNASPQA 256
Query: 741 LDLMKKCLAWDRNERWRIPQLLQHPFL 767
LDL+ + L +D ++R Q L HP+
Sbjct: 257 LDLLSQMLHYDPHKRITAEQALAHPYF 283
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 138 bits (351), Expect = 9e-37
Identities = 90/315 (28%), Positives = 130/315 (41%), Gaps = 81/315 (25%)
Query: 475 QRLGKIGSGGSSEVHKVI-SSDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNI 533
+R+ +G G S V+KV IYALKKI + G
Sbjct: 4 ERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGD------------------------ 39
Query: 534 IQLIDYEVTEKALLREVLNGSMNNKDGRVK------DDGYIYMVLEYGEIDLAHMLSQKW 587
E K LLRE+ VK +G I +VLEY
Sbjct: 40 ------EEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY------------- 80
Query: 588 KEMDG--------SNQTLDENWLRFYWQQILEAVNTIHEER-IVHSDLKPANFLL-VKGS 637
MDG + E L + +QIL+ ++ +H +R I+H D+KP+N L+ KG
Sbjct: 81 --MDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKGE 138
Query: 638 LKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLG 697
+K+ DFGI+K + + T Q ++ VGT++YMSPE ES +DIWSLG
Sbjct: 139 VKIADFGISKVL--ENTLDQCNTFVGTVTYMSPERIQ-GESY--------SYAADIWSLG 187
Query: 698 CILYQMVYGRTPFS--EYKTFWAKFKVITDPNHEITYEPVPNPW---LLDLMKKCLAWDR 752
L + G+ PF +F+ + I D + D + CL D
Sbjct: 188 LTLLECALGKFPFLPPGQPSFFELMQAICD---GPPPSLPAEEFSPEFRDFISACLQKDP 244
Query: 753 NERWRIPQLLQHPFL 767
+R +LLQHPF+
Sbjct: 245 KKRPSAAELLQHPFI 259
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 138 bits (350), Expect = 9e-37
Identities = 79/309 (25%), Positives = 131/309 (42%), Gaps = 82/309 (26%)
Query: 480 IGSGGSSEVHKV-ISSDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQ--L 536
+G G +V V +YA+K +K K II+
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLK------------------------KKKIIKRKE 36
Query: 537 IDYEVTEKALLREVLNGSMNNKDGRVK------DDGYIYMVLEY---GEIDLAHMLSQKW 587
+++ +TE+ +L + + + VK + +Y+VLEY GE L LS+
Sbjct: 37 VEHTLTERNILSRINHPFI------VKLHYAFQTEEKLYLVLEYAPGGE--LFSHLSK-- 86
Query: 588 KEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLLVK-GSLKLIDFGIA 646
E RFY +I+ A+ +H I++ DLKP N LL G +KL DFG+A
Sbjct: 87 ------EGRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDADGHIKLTDFGLA 140
Query: 647 KAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIK---CGRPSDIWSLGCILYQM 703
K + S+ + ++ GT Y++PE ++ G+ D WSLG +LY+M
Sbjct: 141 KELSSE--GSRTNTFCGTPEYLAPE------------VLLGKGYGKAVDWWSLGVLLYEM 186
Query: 704 VYGRTPF---SEYKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNER---WR 757
+ G+ PF + + K++ DP + + +P DL+ L D +R
Sbjct: 187 LTGKPPFYAEDRKEIY---EKILKDP---LRFPEFLSPEARDLISGLLQKDPTKRLGSGG 240
Query: 758 IPQLLQHPF 766
++ HPF
Sbjct: 241 AEEIKAHPF 249
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 132 bits (333), Expect = 2e-33
Identities = 70/268 (26%), Positives = 109/268 (40%), Gaps = 72/268 (26%)
Query: 564 DDGYIYMVLEY---GEIDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEER 620
D+ ++Y+V+EY G DL ++L +K E RFY +++ A++++H+
Sbjct: 72 DEEHLYLVMEYMPGG--DLMNLLIRK--------DVFPEETARFYIAELVLALDSVHKLG 121
Query: 621 IVHSDLKPANFLL-VKGSLKLIDFGIAKAI---------------MSDTTNIQ------- 657
+H D+KP N L+ G +KL DFG+ K + + N+
Sbjct: 122 FIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHK 181
Query: 658 -----RDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGRTPFSE 712
+S VGT Y++PE D WSLG ILY+M+YG PF
Sbjct: 182 QRRVRANSTVGTPDYIAPEVLRGTPYGLE---------CDWWSLGVILYEMLYGFPPFYS 232
Query: 713 YKTFWAKFKVITDPNHEIT-----YEPVPNPWLLDLMKKCLAWDRNERW-RIPQLLQHPF 766
K+I N + + PV P +DL+ + L D +R ++ HPF
Sbjct: 233 DTLQETYNKII---NWKESLRFPPDPPVS-PEAIDLICRLLC-DPEDRLGSFEEIKSHPF 287
Query: 767 -----------LVPPVSTQPSSSQDQSY 783
PP + SS D S
Sbjct: 288 FKGIDWENLRETKPPFVPELSSPLDTSN 315
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 129 bits (327), Expect = 3e-33
Identities = 90/332 (27%), Positives = 143/332 (43%), Gaps = 85/332 (25%)
Query: 474 YQRLGKIGSGGSSEVHKVIS-SDCTIYALKKIKLK-GRDYATAYGF----CQEIEYLNKL 527
Y+++ +IG G +V+K + + ALKKI+++ ++ GF +EI+ L KL
Sbjct: 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKE-----GFPITAIREIKLLQKL 55
Query: 528 KGKNNIIQLIDYEVTEKALLREVLNGSMNNKDGRVKDDGYIYMVLEYGEIDLAHMLSQKW 587
+ N I++L + VT K GS IYMV EY + DL +L
Sbjct: 56 RHPN-IVRLKEI-VTSKG------KGS-------------IYMVFEYMDHDLTGLLDSP- 93
Query: 588 KEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLLV-KGSLKLIDFGIA 646
E+ ++ Y +Q+LE + +H I+H D+K +N L+ G LKL DFG+A
Sbjct: 94 ------EVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDGVLKLADFGLA 147
Query: 647 KAIMS----DTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQ 702
+ D TN +V TL Y PE + + G D+WS+GCIL +
Sbjct: 148 RPYTKRNSADYTN-----RVITLWYRPPELLLGAT--------RYGPEVDMWSVGCILAE 194
Query: 703 MVYGRTPF---SEYKTFWAKFKVITDPNHEI-------------------------TYEP 734
+ G+ F +E + F++ P E ++
Sbjct: 195 LFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPWFENLKPKKPYKRRLREFFKH 254
Query: 735 VPNPWLLDLMKKCLAWDRNERWRIPQLLQHPF 766
+ +P LDL+ K L D +R Q LQH +
Sbjct: 255 LIDPSALDLLDKLLTLDPKKRISADQALQHEY 286
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 128 bits (323), Expect = 5e-33
Identities = 88/314 (28%), Positives = 132/314 (42%), Gaps = 70/314 (22%)
Query: 474 YQRLGKIGSGGSSEVHKVI-SSDCTIYALKKIKL-----KGRDYATAYGFCQEIEYLNKL 527
Y+ L IG G V KV SD I K+I K + + E+ L +L
Sbjct: 2 YEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVS-----EVNILREL 56
Query: 528 KGKNNIIQLIDYEV-TEKALLREVLNGSMNNKDGRVKDDGYIYMVLEY-GEIDLAHMLSQ 585
K N I++ D + L YI M EY DLA ++ +
Sbjct: 57 KHPN-IVRYYDRIIDRSNQTL-------------------YIVM--EYCEGGDLAQLIQK 94
Query: 586 KWKEMDGSNQTLDENWLRFYWQ---QILEAVNTIH-----EERIVHSDLKPAN-FLLVKG 636
KE + ++E F W+ Q+L A+ H ++H DLKPAN FL
Sbjct: 95 CKKE----RKYIEEE---FIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANN 147
Query: 637 SLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSL 696
++KL DFG+AK + D++ + + VGT YMSPE DE SDIWSL
Sbjct: 148 NVKLGDFGLAKILGHDSSFAK--TYVGTPYYMSPEQLNHMSYDEK---------SDIWSL 196
Query: 697 GCILYQMVYGRTPFSEYKTFWAKFKVITDPNHEITYEPVP---NPWLLDLMKKCLAWDRN 753
GC++Y++ PF+ + E + +P + L +++K L D +
Sbjct: 197 GCLIYELCALSPPFTAR-----NQLQLASKIKEGKFRRIPYRYSSELNEVIKSMLNVDPD 251
Query: 754 ERWRIPQLLQHPFL 767
+R +LLQ P +
Sbjct: 252 KRPSTEELLQLPLI 265
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 121 bits (306), Expect = 7e-31
Identities = 82/306 (26%), Positives = 134/306 (43%), Gaps = 65/306 (21%)
Query: 474 YQRLGKIGSGGSSEVHKVISSDC-TIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNN 532
YQ IG G V+K ++ + A+K+I L+ QEI+ L LK N
Sbjct: 2 YQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLK-HPN 60
Query: 533 IIQLIDYEVTEKALLREVLNGSMNNKDGRVKDDGYIYMVLEYGEIDLAHMLSQKWKEMDG 592
I++ I G ++ +Y++LEY E +G
Sbjct: 61 IVKYI----------------------GSIETSDSLYIILEYAE--------------NG 84
Query: 593 SNQTLDENWLRF-------YWQQILEAVNTIHEERIVHSDLKPANFLLVK-GSLKLIDFG 644
S + + + + F Y Q+L+ + +HE+ ++H D+K AN L K G +KL DFG
Sbjct: 85 SLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKDGVVKLADFG 144
Query: 645 IAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMV 704
+A + + S VGT +M+PE + +G DIWSLGC + +++
Sbjct: 145 VATKLNDVSK--DDASVVGTPYWMAPEVI-----EMSGASTAS----DIWSLGCTVIELL 193
Query: 705 YGRTPFSEYKTFWAKFKVITDPNHEITYEPVPN---PWLLDLMKKCLAWDRNERWRIPQL 761
G P+ + A F+++ D + P+P P L D + +C D N R QL
Sbjct: 194 TGNPPYYDLNPMAALFRIVQDD-----HPPLPEGISPELKDFLMQCFQKDPNLRPTAKQL 248
Query: 762 LQHPFL 767
L+HP++
Sbjct: 249 LKHPWI 254
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 121 bits (305), Expect = 1e-30
Identities = 85/294 (28%), Positives = 125/294 (42%), Gaps = 77/294 (26%)
Query: 498 IYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLREVLNGSMNN 557
IYA+K IK + KN + Q++ TE+ +L + + +
Sbjct: 20 IYAIKVIKKA------------------DMIRKNQVDQVL----TERDILSQAQSPYV-- 55
Query: 558 KDGRVK------DDGYIYMVLEY---GEIDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQ 608
VK +Y+V+EY G DLA +L E GS LDE+ R Y +
Sbjct: 56 ----VKLYYSFQGKKNLYLVMEYLPGG--DLASLL-----ENVGS---LDEDVARIYIAE 101
Query: 609 ILEAVNTIHEERIVHSDLKPANFLLVK-GSLKLIDFGIAKAIMSDTTNIQRDSQ------ 661
I+ A+ +H I+H DLKP N L+ G LKL DFG++K + D +
Sbjct: 102 IVLALEYLHSNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRI 161
Query: 662 VGTLSYMSPEAFMCNESDENGNIIKC---GRPSDIWSLGCILYQMVYGRTPFSEYKTFWA 718
VGT Y++PE +I + D WSLGCILY+ + G PF +T
Sbjct: 162 VGTPDYIAPE------------VILGQGHSKTVDWWSLGCILYEFLVGIPPFHG-ETPEE 208
Query: 719 KFKVITDPNHEITYEPVPN--PWLLDLMKKCLAWDRNER---WRIPQLLQHPFL 767
F+ I N +I + +DL+ K L D +R I ++ HPF
Sbjct: 209 IFQNIL--NGKIEWPEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNHPFF 260
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 118 bits (297), Expect = 1e-29
Identities = 92/299 (30%), Positives = 140/299 (46%), Gaps = 51/299 (17%)
Query: 474 YQRLGKIGSGGSSEVHKVISS-DCTIYALKKIKLKGRDYATAYGFC-QEIEYLNKLKGKN 531
++ KIG G S V+K I D + ALKK+++ A A C +EI+ L +L
Sbjct: 4 FKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD-HP 62
Query: 532 NIIQLIDYEVTEKALLREVLNGSMNNKDGRVKDDGYIYMVLEYGEI-DLAHMLSQKWKEM 590
N+I+ + + ++ + +VLE + DL+ M+ K
Sbjct: 63 NVIKYLASFI----------------------ENNELNIVLELADAGDLSRMI----KHF 96
Query: 591 DGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPAN-FLLVKGSLKLIDFGIAKAI 649
+ + E + Y+ Q+ A+ +H +RI+H D+KPAN F+ G +KL D G+ +
Sbjct: 97 KKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFF 156
Query: 650 MSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGRTP 709
S TT S VGT YMSPE ENG K SDIWSLGC+LY+M ++P
Sbjct: 157 SSKTTAAH--SLVGTPYYMSPERI-----HENGYNFK----SDIWSLGCLLYEMAALQSP 205
Query: 710 FSEYK-TFWAKFKVITDPNHEITYEPVPNPW----LLDLMKKCLAWDRNERWRIPQLLQ 763
F K ++ K I + Y P+P L DL+ +C+ D +R I +LQ
Sbjct: 206 FYGDKMNLYSLCKKIE----KCDYPPLPADHYSEELRDLVSRCINPDPEKRPDISYVLQ 260
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 117 bits (294), Expect = 6e-29
Identities = 98/330 (29%), Positives = 142/330 (43%), Gaps = 83/330 (25%)
Query: 474 YQRLGKIGSGGSSEVHKVIS-SDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNN 532
YQ++ KIG G V+K I ALKKI+L+ D +EI L +L N
Sbjct: 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELN-HPN 59
Query: 533 IIQLIDYEVTEKALLREVLNGSMNNKDGRVKDDGYIYMVLEYGEIDLAHMLSQKWKEMDG 592
I++L+D +E L Y+V E+ ++DL K MD
Sbjct: 60 IVRLLDVVHSENKL----------------------YLVFEFLDLDLK-------KYMDS 90
Query: 593 -SNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLLVK-GSLKLIDFGIAKAI- 649
LD ++ Y Q+L+ + H R++H DLKP N L+ + G+LKL DFG+A+A
Sbjct: 91 SPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREGALKLADFGLARAFG 150
Query: 650 --MSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGR----PSDIWSLGCILYQM 703
+ T+ +V TL Y +PE I+ R P DIWS+GCI +M
Sbjct: 151 VPVRTYTH-----EVVTLWYRAPE------------ILLGSRQYSTPVDIWSIGCIFAEM 193
Query: 704 VYGRTPF---SEYKTFWAKFKVITDPNHE----ITYEP-----------------VPN-- 737
V R F SE + F+ + P+ + +T P VPN
Sbjct: 194 VNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYKPTFPKWARQDLSKVVPNLD 253
Query: 738 PWLLDLMKKCLAWDRNERWRIPQLLQHPFL 767
LDL+ K L +D +R LQHP+
Sbjct: 254 EDGLDLLSKMLVYDPAKRISAKAALQHPYF 283
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 115 bits (290), Expect = 9e-29
Identities = 81/300 (27%), Positives = 134/300 (44%), Gaps = 61/300 (20%)
Query: 480 IGSGGSSEVHKVISSDC-TIYALKKIKLKGRDYATAYGFC----QEIEYLNKLKGKNNII 534
+GSG V++ ++ D +A+K++ L D T QEI L+KL+ NI+
Sbjct: 8 LGSGSFGSVYEGLNLDDGDFFAVKEVSL-ADDGQTGQEAVKQLEQEIALLSKLQ-HPNIV 65
Query: 535 QLIDYEVTEKALLREVLNGSMNNKDGRVKDDGYIYMVLEY---GEIDLAHMLSQKWKEMD 591
Q + G +++ +Y+ LE G + L +K+
Sbjct: 66 QYL----------------------GTEREEDNLYIFLELVPGGSL---AKLLKKY---- 96
Query: 592 GSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLL-VKGSLKLIDFGIAKAIM 650
+ E +R Y +QIL + +H+ VH D+K AN L+ G +KL DFG+AK ++
Sbjct: 97 ---GSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTNGVVKLADFGMAKQVV 153
Query: 651 SDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGRTPF 710
S G+ +M+PE + + G +DIWSLGC + +M G+ P+
Sbjct: 154 ---EFSFAKSFKGSPYWMAPE--VIAQQGGYGL------AADIWSLGCTVLEMATGKPPW 202
Query: 711 SEYKTFWAKFKVITDPNHEITYEPVPN---PWLLDLMKKCLAWDRNERWRIPQLLQHPFL 767
S+ + A FK+ P+P+ D + KCL D + R +LL+HPF+
Sbjct: 203 SQLEGVAAVFKIGRSKEL----PPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLEHPFV 258
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 114 bits (288), Expect = 2e-28
Identities = 86/299 (28%), Positives = 133/299 (44%), Gaps = 49/299 (16%)
Query: 474 YQRLGKIGSGGSSEVHKVI-SSDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNN 532
++ L KIG G V KV+ +D +YA+K+I L + E L KL
Sbjct: 2 FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSY- 60
Query: 533 IIQLIDYEVTEKALLREVLNGSMNNKDGRVKDDGYIYMVLEYGEIDLAHMLSQKWKEMDG 592
II+ + + D G + +V+EY E H L + + G
Sbjct: 61 IIRYYESFL----------------------DKGKLNIVMEYAENGDLHKLLKMQR---G 95
Query: 593 SNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLLVKG-SLKLIDFGIAKAIMS 651
D+ W RF+ Q IL + +H ++I+H D+K N L ++K+ D G+AK ++S
Sbjct: 96 RPLPEDQVW-RFFIQ-ILLGLAHLHSKKILHRDIKSLNLFLDAYDNVKIGDLGVAK-LLS 152
Query: 652 DTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGRTPFS 711
D TN + VGT Y+SPE +C + N SD+W+LG +LY+ G+ PF
Sbjct: 153 DNTNFAN-TIVGTPYYLSPE--LCEDKPYN-------EKSDVWALGVVLYECCTGKHPFD 202
Query: 712 EYKTFWAKFKVITDPNHEITYEPVPNPW---LLDLMKKCLAWDRNERWRIPQLLQHPFL 767
K+I + PV + L L+ +CL D +R QLL++P L
Sbjct: 203 ANNQGALILKIIRG-----VFPPVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRNPSL 256
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 114 bits (287), Expect = 5e-28
Identities = 87/311 (27%), Positives = 131/311 (42%), Gaps = 71/311 (22%)
Query: 472 KLYQRLGKIGSGGSSEVHKVI-SSDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGK 530
+LY+ L KIG G S EV+K + A+KK++L+ ++ EI + K
Sbjct: 19 ELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELII---NEILIMKDCKHP 75
Query: 531 NNIIQLID-YEVTEKALLREVLNGSMNNKDGRVKDDGYIYMVLEYGEIDLAHMLSQKWKE 589
N I+ D Y V +++V+EY
Sbjct: 76 N-IVDYYDSYLV-----------------------GDELWVVMEY--------------- 96
Query: 590 MDGSNQT--LDENWLRFYWQQI-------LEAVNTIHEERIVHSDLKPANFLLVK-GSLK 639
MDG + T + +N++R QI L+ + +H + ++H D+K N LL K GS+K
Sbjct: 97 MDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDGSVK 156
Query: 640 LIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCI 699
L DFG A + + + R+S VGT +M+PE + K DIWSLG +
Sbjct: 157 LADFGFAAQLTKEKSK--RNSVVGTPYWMAPEVIKRKDYGP-----KV----DIWSLGIM 205
Query: 700 LYQMVYGRTPFSEYKTFWAKFKVITDPNHEITYEPVPNPW---LLDLMKKCLAWDRNERW 756
+M G P+ A F + T + P W D + KCL D +R
Sbjct: 206 CIEMAEGEPPYLREPPLRALFLITTKGIPPLKN---PEKWSPEFKDFLNKCLVKDPEKRP 262
Query: 757 RIPQLLQHPFL 767
+LLQHPFL
Sbjct: 263 SAEELLQHPFL 273
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 112 bits (282), Expect = 6e-27
Identities = 76/248 (30%), Positives = 112/248 (45%), Gaps = 58/248 (23%)
Query: 563 KDDGYIYMVLEY---GEIDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEE 619
+DD Y+Y+ +EY G D +L+ + L E+ RFY ++ EAV+ +HE
Sbjct: 71 QDDEYLYLAMEYVPGG--DFRTLLN--------NLGVLSEDHARFYMAEMFEAVDALHEL 120
Query: 620 RIVHSDLKPANFLL-VKGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNES 678
+H DLKP NFL+ G +KL DFG++K I++ +S VG+ YM+PE
Sbjct: 121 GYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT-----YANSVVGSPDYMAPEVL----- 170
Query: 679 DENGNIIKCGRPSDIWSLGCILYQMVYGRTPFS--------EYKTFWAKF---KVITDPN 727
G D WSLGC+LY+ + G PFS E +W + V DP
Sbjct: 171 --RGK--GYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYDDPR 226
Query: 728 HEITYEPVPNPWLLDLMKKCLAWDRNERWR-IPQLLQHPF-----------LVPPVSTQP 775
++ E W DL+ K + D + R+ + + HPF L PP +
Sbjct: 227 FNLSDE----AW--DLITKLIN-DPSRRFGSLEDIKNHPFFKEVDWNELRELKPPFVPEL 279
Query: 776 SSSQDQSY 783
S D Y
Sbjct: 280 ESEIDTGY 287
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 109 bits (275), Expect = 2e-26
Identities = 80/326 (24%), Positives = 133/326 (40%), Gaps = 74/326 (22%)
Query: 474 YQRLGKIGSGGSSEVHK--VISSDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKN 531
Y+ LG+IG G V K + T+ ALKK+ L+ + +EI+ L +
Sbjct: 2 YKILGRIGEGAHGIVFKAKDRETGETV-ALKKVALRRLEGGIPNQALREIKALQACQHPY 60
Query: 532 NIIQLIDYEVTEKALLREVLNGSMNNKDGRVKDDGYIYMVLEYGEIDLAHMLSQKWKEMD 591
+++L+D V +V+EY M S + +
Sbjct: 61 -VVKLLD-----------VFP-----------HGSGFVLVMEY-------MPSDLSEVLR 90
Query: 592 GSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLLV-KGSLKLIDFGIAKAIM 650
+ L E ++ Y + +L+ V +H I+H DLKPAN L+ G LK+ DFG+A+ +
Sbjct: 91 DEERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISADGVLKIADFGLAR-LF 149
Query: 651 SDTTNIQRDSQVGTLSYMSPEA-FMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGRTP 709
S+ QV T Y +PE + + D D+W++GCI +++ G
Sbjct: 150 SEEEPRLYSHQVATRWYRAPELLYGARKYDPG---------VDLWAVGCIFAELLNGSPL 200
Query: 710 FSE----------YKTF-------WAKFKVITDPNHEITYEP-VPNPW----------LL 741
F ++T W + D N +IT+ P P L
Sbjct: 201 FPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDYN-KITFPESKPIPLEEIFPDASPEAL 259
Query: 742 DLMKKCLAWDRNERWRIPQLLQHPFL 767
DL+K L +D ++R + L+HP+
Sbjct: 260 DLLKGLLVYDPSKRLSAAEALRHPYF 285
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 2e-26
Identities = 78/285 (27%), Positives = 113/285 (39%), Gaps = 70/285 (24%)
Query: 480 IGSGGSSEVHKVIS-SDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLID 538
+G GG V V S +ALK +K + + G QE +I
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVK---KRHIVETG-QQE-----------HIFS--- 42
Query: 539 YEVTEKALLREVLNGSMNNKDGRVKDDGYIYMVLEY---GEI-DLAHMLSQKWKEMDGSN 594
EK +L E + + KD YIYM++EY GE+ +
Sbjct: 43 ----EKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGELWTILRDRGL--------- 89
Query: 595 QTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLL-VKGSLKLIDFGIAKAIMS-- 651
DE RFY ++ A +H I++ DLKP N LL G +KL+DFG AK + S
Sbjct: 90 --FDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ 147
Query: 652 DTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKC---GRPSDIWSLGCILYQMVYGRT 708
T GT Y++PE II D WSLG +LY+++ GR
Sbjct: 148 KTWTF-----CGTPEYVAPE------------IILNKGYDFSVDYWSLGILLYELLTGRP 190
Query: 709 PFSE-----YKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCL 748
PF E + + I N ++ + + DL+K+ L
Sbjct: 191 PFGEDDEDPMEI----YNDILKGNGKLEFPNYIDKAAKDLIKQLL 231
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 2e-26
Identities = 71/298 (23%), Positives = 127/298 (42%), Gaps = 46/298 (15%)
Query: 480 IGSGGSSEVHKVISSDC-TIYALKKIKLKG-RDYATAYGFCQEIEYLNKLKGKNNIIQLI 537
IG G +V+K + A+K + + + +E L K NI
Sbjct: 14 IGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIK----EEYNILRKYSNHPNIA--- 66
Query: 538 DYEVTEKALLREVLNGSMNNKDGRVKDDGYIYMVLEYGE----IDLAHMLSQKWKEMDGS 593
+ G+ K+ DD +++V+E DL L
Sbjct: 67 TFY------------GAFIKKNPPGNDD-QLWLVMELCGGGSVTDLVKGL-------RKK 106
Query: 594 NQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLLVK-GSLKLIDFGIAKAIMSD 652
+ L E W+ + ++ L + +HE +++H D+K N LL K +KL+DFG++ D
Sbjct: 107 GKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVSA--QLD 164
Query: 653 TTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGRTPFSE 712
+T +R++ +GT +M+PE C+E + + D+WSLG ++ G+ P +
Sbjct: 165 STLGRRNTFIGTPYWMAPEVIACDEQPDASYDARS----DVWSLGITAIELADGKPPLCD 220
Query: 713 YKTFWAKFKVITDPNHEITYEPVPNPW---LLDLMKKCLAWDRNERWRIPQLLQHPFL 767
A FK+ +P + P W D + +CL + +R + +LL+HPF+
Sbjct: 221 MHPMRALFKIPRNPPPTLKS---PENWSKKFNDFISECLIKNYEQRPFMEELLEHPFI 275
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 5e-26
Identities = 87/304 (28%), Positives = 130/304 (42%), Gaps = 59/304 (19%)
Query: 474 YQRLGKIGSGGSSEVHKVIS-SDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNN 532
++ L K+G G V+KV SD YALK++ L EI L + N
Sbjct: 2 FKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPN- 60
Query: 533 IIQLIDYEVTEKALLREVLNGSMNNKDGRVKDDGYIYMVLEYGEI-DLAHMLSQKWKEMD 591
+I Y+ +A L DG + +V+EY DL+ +S++ +
Sbjct: 61 ---IISYK---EAFL-----------DGNK-----LCIVMEYAPFGDLSKAISKR--KKK 96
Query: 592 GSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLLVKGSL-KLIDFGIAKAIM 650
E W F Q+L + +HE++I+H DLK AN LLV L K+ D GI+K +
Sbjct: 97 RKLIPEQEIWRIFI--QLLRGLQALHEQKILHRDLKSANILLVANDLVKIGDLGISKVLK 154
Query: 651 SDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRP----SDIWSLGCILYQMVYG 706
+ +Q+GT YM+PE + GRP SDIWSLGC+LY+M
Sbjct: 155 KNMAK----TQIGTPHYMAPEVWK-------------GRPYSYKSDIWSLGCLLYEMATF 197
Query: 707 RTPFSEYKTFWAKFKVITDPNHEITYEPVPNPWLLDL---MKKCLAWDRNERWRIPQLLQ 763
PF ++KV Y P+P + DL ++ L R ++L
Sbjct: 198 APPFEARSMQDLRYKVQRG-----KYPPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILA 252
Query: 764 HPFL 767
P +
Sbjct: 253 SPAV 256
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 3e-25
Identities = 86/327 (26%), Positives = 134/327 (40%), Gaps = 74/327 (22%)
Query: 474 YQRLGKIGSGGSSEVHKVISSDCT-IYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNN 532
Y+ LG +G G V K + I A+KK K D +E++ L +L+ +N
Sbjct: 3 YEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHEN- 61
Query: 533 IIQLIDYEVTEKALLREVLNGSMNNKDGRVKDDGYIYMVLEYGEIDLAHMLSQKWKEMDG 592
I+ L + A R+ G +Y+V EY E L +L +
Sbjct: 62 IVNLKE------AFRRK----------------GRLYLVFEYVERTLLELL-------EA 92
Query: 593 SNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLLVK--GSLKLIDFGIAKAIM 650
S L + +R Y Q+L+A+ H I+H D+KP N +LV G LKL DFG A+A +
Sbjct: 93 SPGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPEN-ILVSESGVLKLCDFGFARA-L 150
Query: 651 SDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGRTPF 710
V T Y +PE + + + G+P D+W++GCI+ +++ G F
Sbjct: 151 RARPASPLTDYVATRWYRAPELLVGDTN--------YGKPVDVWAIGCIMAELLDGEPLF 202
Query: 711 ---------------------SEYKTF-----WAKFKVITDPNHEIT----YEPVPNPWL 740
S + F +A +P+ + Y +
Sbjct: 203 PGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAGVAFP-EPSQPESLERRYPGKVSSPA 261
Query: 741 LDLMKKCLAWDRNERWRIPQLLQHPFL 767
LD +K CL D ER +LLQHP+
Sbjct: 262 LDFLKACLRMDPKERLTCDELLQHPYF 288
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 106 bits (267), Expect = 3e-25
Identities = 93/339 (27%), Positives = 136/339 (40%), Gaps = 81/339 (23%)
Query: 474 YQRLGKIGSGGSSEVHKVI-SSDCTIYALKKIKLKGRDYA------TAYGFCQEIEYLNK 526
Y++ K+G G + V+K I A+KKIKL R A TA +EI+ L +
Sbjct: 2 YEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTAL---REIKLLQE 58
Query: 527 LKGKNNIIQLIDYEVTEKALLREVLNGSMNNKDGRVKDDGYIYMVLEYGEIDLAHMLSQK 586
LK NII L+D I +V E+ E DL ++ K
Sbjct: 59 LKHP-NIIGLLDVFGH----------------------KSNINLVFEFMETDLEKVIKDK 95
Query: 587 WKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLLVK-GSLKLIDFGI 645
+ L ++ Y L + +H I+H DLKP N L+ G LKL DFG+
Sbjct: 96 -------SIVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASDGVLKLADFGL 148
Query: 646 AKAIMSDTTNIQRDSQVGTLSYMSPEAFM-CNESDENGNIIKCGRPSDIWSLGCILYQMV 704
A++ S + QV T Y +PE G D+WS+GCI +++
Sbjct: 149 ARSFGSPNRKMT--HQVVTRWYRAPELLFGAR---------HYGVGVDMWSVGCIFAELL 197
Query: 705 YGRTPF----SEYKTFWAKFKVITDPNHE-----------ITYEPVP-NPW--------- 739
R PF S+ F+ + P E + ++P P P
Sbjct: 198 L-RVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLPDYVEFKPFPPTPLKQIFPAASD 256
Query: 740 -LLDLMKKCLAWDRNERWRIPQLLQHP-FLVPPVSTQPS 776
LDL+++ L + N+R Q L+HP F P T PS
Sbjct: 257 DALDLLQRLLTLNPNKRITARQALEHPYFSNDPAPTPPS 295
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 3e-25
Identities = 59/190 (31%), Positives = 93/190 (48%), Gaps = 36/190 (18%)
Query: 530 KNNIIQL--IDYEVTEKALLREVLNGSMNNKDGRVKDDGYIYMVLEY---GEIDLAHMLS 584
K I++L +++ + EK +L+ + + + N G +DD +Y+V+EY GE L L
Sbjct: 36 KAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVMEYVPGGE--LFSHLR 93
Query: 585 QKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLL-VKGSLKLIDF 643
+ + E RFY Q++ A+ +H IV+ DLKP N LL G +K+ DF
Sbjct: 94 K--------SGRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSDGYIKITDF 145
Query: 644 GIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIK---CGRPSDIWSLGCIL 700
G AK + T + GT Y++PE II G+ D W+LG ++
Sbjct: 146 GFAKRVKGRTYTL-----CGTPEYLAPE------------IILSKGYGKAVDWWALGILI 188
Query: 701 YQMVYGRTPF 710
Y+M+ G PF
Sbjct: 189 YEMLAGYPPF 198
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 104 bits (263), Expect = 7e-25
Identities = 83/330 (25%), Positives = 136/330 (41%), Gaps = 83/330 (25%)
Query: 474 YQRLGKIGSGGSSEVHKVISSDC-TIYALKKIKLKGRDYATAYGFC---QEIEYLNKLKG 529
Y+ + ++G G V+ + + + A+KK+K K + + + C +E++ L KL
Sbjct: 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKK---FYS-WEECMNLREVKSLRKLNE 56
Query: 530 KNNIIQLIDYEVTEKALLREVLNGSMNNKDGRVKDDGYIYMVLEYGEIDLAHMLSQKWKE 589
NI++L EV +++ +Y V EY E +L ++ +
Sbjct: 57 HPNIVKL--KEV--------------------FRENDELYFVFEYMEGNLYQLMKDR--- 91
Query: 590 MDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLLVKGS--LKLIDFGIAK 647
+ E+ +R QIL+ + IH+ H DLKP N LLV G +K+ DFG+A+
Sbjct: 92 ---KGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPEN-LLVSGPEVVKIADFGLAR 147
Query: 648 AIMSDTTNIQRD---SQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMV 704
I S R V T Y +PE + + + P DIW+LGCI+ ++
Sbjct: 148 EIRS------RPPYTDYVSTRWYRAPEILL---RSTSYS-----SPVDIWALGCIMAELY 193
Query: 705 YGRTPF---SEYKTFWAKFKVITDPNHEI----------------TYEPVP--------N 737
R F SE + V+ P + + P +
Sbjct: 194 TLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLGFRFPQFAPTSLHQLIPNAS 253
Query: 738 PWLLDLMKKCLAWDRNERWRIPQLLQHPFL 767
P +DL+K L WD +R Q LQHP+
Sbjct: 254 PEAIDLIKDMLRWDPKKRPTASQALQHPYF 283
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 104 bits (260), Expect = 8e-25
Identities = 65/215 (30%), Positives = 103/215 (47%), Gaps = 39/215 (18%)
Query: 564 DDGYIYMVLEYGEI-DLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIV 622
DD + + +EY L + ++ Q +E + +Y QI+ AV+ IH+ I+
Sbjct: 70 DDNTLLIEMEYANGGTLYDKIVRQKG------QLFEEEMVLWYLFQIVSAVSYIHKAGIL 123
Query: 623 HSDLKPANFLLVKGSL-KLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDEN 681
H D+K N L K L KL DFGI+K + S+ + + + VGT YMSPE +C N
Sbjct: 124 HRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAE--TVVGTPYYMSPE--LCQGVKYN 179
Query: 682 GNIIKCGRPSDIWSLGCILYQMVYGRTPFSEYKTFWAKFKVITDPNHEIT------YEPV 735
SDIW+LGC+LY+++ + +TF A T+P + + Y PV
Sbjct: 180 FK-------SDIWALGCVLYELLTLK------RTFDA-----TNPLNLVVKIVQGNYTPV 221
Query: 736 PNPW---LLDLMKKCLAWDRNERWRIPQLLQHPFL 767
+ + L+ L+ L D +R ++L P L
Sbjct: 222 VSVYSSELISLVHSLLQQDPEKRPTADEVLDQPLL 256
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 1e-24
Identities = 89/336 (26%), Positives = 138/336 (41%), Gaps = 78/336 (23%)
Query: 474 YQRLGKIGSGGSSEVHKVISSDC-TIYALKKIKLKG-RDYATAYGF----CQEIEYLNKL 527
Y+ LGK+G G EV+K + ALKKI + +D GF +EI+ L KL
Sbjct: 10 YEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKD-----GFPITALREIKILKKL 64
Query: 528 KGKNNIIQLIDYEVTEKALLREVLNGSMNNKDGRVKDDGYIYMVLEYGEIDLAHMLSQKW 587
K N ++ LID E+ D + G +YMV Y + DL+ +L
Sbjct: 65 KHPN-VVPLIDM-AVERP-------------DKSKRKRGSVYMVTPYMDHDLSGLL---- 105
Query: 588 KEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLL-VKGSLKLIDFGIA 646
+ + L E+ ++ Y Q+LE +N +HE I+H D+K AN L+ +G LK+ DFG+A
Sbjct: 106 ---ENPSVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLA 162
Query: 647 KAIMSDTTNIQRDSQVGTLSYMS---------PEAFMCNESDENGNIIKCGRPSDIWSLG 697
+ N + GT Y + PE + + DIW +G
Sbjct: 163 RPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGER--------RYTTAVDIWGIG 214
Query: 698 CILYQMVYGR--------------------TP----FSEYKTFWAKFKVITDPNHEITYE 733
C+ +M R TP + +++ V + N+ T E
Sbjct: 215 CVFAEMFTRRPILQGKSDIDQLHLIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLE 274
Query: 734 PVPNPWL---LDLMKKCLAWDRNERWRIPQLLQHPF 766
LDL+ K L+ D +R L+HP+
Sbjct: 275 ERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEHPY 310
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 104 bits (260), Expect = 1e-24
Identities = 67/202 (33%), Positives = 99/202 (49%), Gaps = 19/202 (9%)
Query: 595 QTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLL-VKGSLKLIDFGIAKAIMSDT 653
+ L E +R +Q LEA+N +HE +I+H DLK N L + G +KL DFG++ +T
Sbjct: 98 RPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLDGDIKLADFGVSA---KNT 154
Query: 654 TNIQ-RDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGRTPFSE 712
IQ RDS +GT +M+PE MC S + K +D+WSLG L +M P E
Sbjct: 155 RTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYK----ADVWSLGITLIEMAQIEPPHHE 210
Query: 713 YKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQHPFLVPPVS 772
K+ + + D +KKCL + + RW QLLQHPF+
Sbjct: 211 LNPMRVLLKIAKSEPPTLAQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQHPFV----- 265
Query: 773 TQPSSSQDQSYQLLQLLAEASA 794
+ + + + +L+AEA A
Sbjct: 266 -----TVNSNKPIRELIAEAKA 282
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 2e-24
Identities = 88/279 (31%), Positives = 133/279 (47%), Gaps = 39/279 (13%)
Query: 474 YQRLGKIGSGGSSEVHKV--ISSDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKN 531
Y++L KIG G EV K + I ALKK+ ++ +EI+ L LK
Sbjct: 14 YEKLAKIGQGTFGEVFKARHKKTK-QIVALKKVLMENEKEGFPITALREIKILQLLK-HE 71
Query: 532 NIIQLIDYEVTEKALLREVLNGSMNNKDGRVKDDGYIYMVLEYGEIDLAHMLSQKWKEMD 591
N++ LI+ T+ + N+ G Y+V E+ E DLA +LS K +
Sbjct: 72 NVVNLIEICRTKA---------TPYNRY-----KGSFYLVFEFCEHDLAGLLSNKNVKF- 116
Query: 592 GSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLLVK-GSLKLIDFGIAKAIM 650
TL E ++ + +L + IH +I+H D+K AN L+ K G LKL DFG+A+A
Sbjct: 117 ----TLSE--IKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGLARAF- 169
Query: 651 SDTTNIQRD---SQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGR 707
S + N + + ++V TL Y PE + E D G P D+W GCI+ +M + R
Sbjct: 170 SLSKNSKPNRYTNRVVTLWYRPPE-LLLGERDY-------GPPIDMWGAGCIMAEM-WTR 220
Query: 708 TPFSEYKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKK 746
+P + T + +I+ IT E P L+L KK
Sbjct: 221 SPIMQGNTEQHQLTLISQLCGSITPEVWPGVDKLELFKK 259
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 2e-24
Identities = 77/308 (25%), Positives = 126/308 (40%), Gaps = 66/308 (21%)
Query: 472 KLYQRLGKIGSGGSSEVHKVISSDC-TIYALKKIKL-KGRDYATAYGFCQEIEYLNKLKG 529
+L+ L IG G EV+K I + A+K I L + D QEI++L++
Sbjct: 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIED--IQQEIQFLSQC-- 56
Query: 530 KNNIIQLIDYEVTEKALLREVLNGSMNNKDGRVKDDGYIYMVLEYGEIDLAHMLSQKWKE 589
+ Y G +++++EY
Sbjct: 57 --RSPYITKYY-------------------GSFLKGSKLWIIMEY--------------- 80
Query: 590 MDGSN-------QTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLLVK-GSLKLI 641
G + LDE ++ F +++L + +HEE +H D+K AN LL + G +KL
Sbjct: 81 CGGGSCLDLLKPGKLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSEEGDVKLA 140
Query: 642 DFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILY 701
DFG++ ++ T + +R++ VGT +M+PE + DE K DIWSLG
Sbjct: 141 DFGVS-GQLTSTMS-KRNTFVGTPFWMAPEVIKQSGYDE-----KA----DIWSLGITAI 189
Query: 702 QMVYGRTPFSEYKTFWAKFKVITDPNHEI-TYEPVPNPWLL-DLMKKCLAWDRNERWRIP 759
++ G P S+ F + P + + E D + CL D ER
Sbjct: 190 ELAKGEPPLSDLHPMRVLFLI---PKNNPPSLEGNKFSKPFKDFVSLCLNKDPKERPSAK 246
Query: 760 QLLQHPFL 767
+LL+H F+
Sbjct: 247 ELLKHKFI 254
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 2e-24
Identities = 72/299 (24%), Positives = 124/299 (41%), Gaps = 59/299 (19%)
Query: 480 IGSGGSSEVHKVISSDC-TIYALKKIKLKGRDYATAYGFCQEIEYLNKLKG-KNNIIQLI 537
IG G +V V D ++A+K Y+NK K + ++ +
Sbjct: 8 IGKGAFGKVCIVQKRDTKKMFAMK--------------------YMNKQKCVEKGSVRNV 47
Query: 538 DYEVTEKALLREVLNGSMNNKDGRVKDDGYIYMVLEY-GEIDLAHMLSQKWKEMDGSNQT 596
+ E+ +L+E+ + + N +D+ +Y+V++ DL + LSQK K
Sbjct: 48 ---LNERRILQELNHPFLVNLWYSFQDEENMYLVVDLLLGGDLRYHLSQKVK-------- 96
Query: 597 LDENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLL-VKGSLKLIDFGIAKAIMSDTTN 655
E ++F+ +I+ A+ +H + I+H D+KP N LL +G + + DF IA ++ T
Sbjct: 97 FSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQGHVHITDFNIA-TKVTPDTL 155
Query: 656 IQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGRTPF---SE 712
S GT YM+PE D WSLG Y+ + G+ P+ S
Sbjct: 156 T--TSTSGTPGYMAPEVLCRQGY---------SVAVDWWSLGVTAYECLRGKRPYRGHSR 204
Query: 713 YKTFW--AKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERW--RIPQLLQHPFL 767
AK + ++ Y + +D + K L D +R + L HP+
Sbjct: 205 TIRDQIRAKQE-----TADVLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLKNHPYF 258
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 3e-24
Identities = 84/325 (25%), Positives = 141/325 (43%), Gaps = 72/325 (22%)
Query: 474 YQRLGKIGSGGSSEVHK-VISSDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNN 532
Y ++ KIG G V+K I A+KKI+L+ + +EI L +L+ N
Sbjct: 2 YTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQ-HPN 60
Query: 533 IIQLIDYEVTEKALLREVLNGSMNNKDGRVKDDGYIYMVLEYGEIDLAHMLSQKWKEMDG 592
I+ L D L++E ++ +Y++ E+ +DL +K+ +
Sbjct: 61 IVCLQD------VLMQE-------SR---------LYLIFEFLSMDL-----KKYLDSLP 93
Query: 593 SNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLL-VKGSLKLIDFGIAKAI-- 649
Q +D ++ Y QIL+ + H R++H DLKP N L+ KG +KL DFG+A+A
Sbjct: 94 KGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGI 153
Query: 650 -MSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGRT 708
+ T+ +V TL Y +PE + + + P DIWS+G I +M +
Sbjct: 154 PVRVYTH-----EVVTLWYRAPEVLLGSP--------RYSTPVDIWSIGTIFAEMATKKP 200
Query: 709 PF---SEYKTFWAKFKVITDPNHEI--------TYEPVPNPWL---------------LD 742
F SE + F+++ P ++ Y+ W LD
Sbjct: 201 LFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDYKNTFPKWKKGSLRSAVKNLDEDGLD 260
Query: 743 LMKKCLAWDRNERWRIPQLLQHPFL 767
L++K L +D +R + L HP+
Sbjct: 261 LLEKMLIYDPAKRISAKKALNHPYF 285
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 3e-24
Identities = 78/328 (23%), Positives = 128/328 (39%), Gaps = 67/328 (20%)
Query: 472 KLYQRLGKIGSGGSSEVHKVISSDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKN 531
+L + LG+ G +S+ A+KKI A +E++ L +G
Sbjct: 3 ELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHK 62
Query: 532 NIIQLIDYEVTEKALLREVLNGSMNNKDGRVKDDGYIYMVLEYGEIDLAHMLSQKWKEMD 591
NI L D ++ E+ Y+Y E E DL ++
Sbjct: 63 NITCLYDMDIVFPGNFNEL----------------YLYE--ELMEADLHQIIR------- 97
Query: 592 GSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLL-VKGSLKLIDFGIAKAIM 650
S Q L + + + QIL + IH ++H DLKP N L+ LK+ DFG+A+
Sbjct: 98 -SGQPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFS 156
Query: 651 SDTTNIQR--DSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGRT 708
+ V T Y +PE + +S + D+WS+GCIL ++ GR
Sbjct: 157 ENPGENAGFMTEYVATRWYRAPEIMLSFQS--------YTKAIDVWSVGCILAEL-LGRK 207
Query: 709 PFSEYKTFWAK----FKVITDPNHEI-----------------TYEPVPNPWL------- 740
P + K + + +V+ P+ E P +
Sbjct: 208 PVFKGKDYVDQLNQILQVLGTPDEETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPL 267
Query: 741 -LDLMKKCLAWDRNERWRIPQLLQHPFL 767
LDL++K LA+D +R + + L+HP+L
Sbjct: 268 ALDLLEKLLAFDPTKRISVEEALEHPYL 295
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 100 bits (252), Expect = 1e-23
Identities = 61/182 (33%), Positives = 90/182 (49%), Gaps = 18/182 (9%)
Query: 590 MDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLL-VKGSLKLIDFGIAKA 648
M +N+TL E + Q L+ + +H + +H D+K N LL +G KL DFG++
Sbjct: 89 MKITNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEGQAKLADFGVS-G 147
Query: 649 IMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGRT 708
++DT +R++ +GT +M+PE E G K DIWSLG +M G+
Sbjct: 148 QLTDT-MAKRNTVIGTPFWMAPEVIQ-----EIGYNNKA----DIWSLGITAIEMAEGKP 197
Query: 709 PFSEYKTFWAKFKVITDPNHEITYEPVPNPW---LLDLMKKCLAWDRNERWRIPQLLQHP 765
P+S+ A F + P ++ P W D +KKCL D ER QLLQHP
Sbjct: 198 PYSDIHPMRAIFMIPNKPPPTLS---DPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQHP 254
Query: 766 FL 767
F+
Sbjct: 255 FI 256
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 1e-23
Identities = 87/323 (26%), Positives = 137/323 (42%), Gaps = 65/323 (20%)
Query: 474 YQRLGKIGSGGSSEVHKVIS-SDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKN- 531
Y+ L +IG G V+K + ALKK+++ + +EI L +L+
Sbjct: 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEH 60
Query: 532 -NIIQLIDYEVTEKALLREVLNGSMNNKDGRVKDDGYIYMVLEYGEIDLAHMLSQKWKEM 590
NI++L+D RE+ + +V E+ + DLA LS+
Sbjct: 61 PNIVRLLDVCHG-PRTDRELK----------------LTLVFEHVDQDLATYLSKC---- 99
Query: 591 DGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLLVK-GSLKLIDFGIAKAI 649
L ++ +Q+L V+ +H RIVH DLKP N L+ G +K+ DFG+A+ I
Sbjct: 100 --PKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLAR-I 156
Query: 650 MSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGRTP 709
S + S V TL Y +PE + + P D+WS+GCI ++ + R P
Sbjct: 157 YSF--EMALTSVVVTLWYRAPEVLLQSSY---------ATPVDMWSVGCIFAEL-FRRRP 204
Query: 710 ----FSEYKTFWAKFKVITDPNHE----------ITYEP---------VPN--PWLLDLM 744
SE F VI P+ E ++ VP LDL+
Sbjct: 205 LFRGTSEADQLDKIFDVIGLPSEEEWPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLL 264
Query: 745 KKCLAWDRNERWRIPQLLQHPFL 767
KK L ++ ++R + LQHP+
Sbjct: 265 KKMLTFNPHKRISAFEALQHPYF 287
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (252), Expect = 2e-23
Identities = 85/326 (26%), Positives = 143/326 (43%), Gaps = 60/326 (18%)
Query: 474 YQRLGKIGSGGSSEVHKVISSDCTIY-ALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNN 532
++ +G++G G +V+K + ++ A K I+++ F EI+ L++ K N
Sbjct: 7 WEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIE--SEEELEDFMVEIDILSECKHPN- 63
Query: 533 IIQLIDYEVTEKALLREVLNGSMNNKDGRVKDDGYIYMVLEY---GEIDLAHMLSQKWKE 589
I+ L + E L ++++E+ G +D
Sbjct: 64 IVGLYEAYFYENKL----------------------WILIEFCDGGALD---------SI 92
Query: 590 MDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLLVK-GSLKLIDFGIAKA 648
M + L E +R+ +Q+LEA+N +H +++H DLK N LL G +KL DFG++
Sbjct: 93 MLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLDGDVKLADFGVSAK 152
Query: 649 IMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGRT 708
S T +RD+ +GT +M+PE C +N K +DIWSLG L ++
Sbjct: 153 NKS--TLQKRDTFIGTPYWMAPEVVACETFKDNPYDYK----ADIWSLGITLIELAQMEP 206
Query: 709 PFSEYKTFWAKFKVITDPNHEITYEPVPNPW---LLDLMKKCLAWDRNERWRIPQLLQHP 765
P E K++ + P+ W D +K CL D ++R +LL+HP
Sbjct: 207 PHHELNPMRVLLKILKSEPPTLD---QPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKHP 263
Query: 766 FLVPPVSTQPSSSQDQSYQLLQLLAE 791
F+ S Q + + LLAE
Sbjct: 264 FV---------SDQSDNKAIKDLLAE 280
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 2e-23
Identities = 78/296 (26%), Positives = 132/296 (44%), Gaps = 43/296 (14%)
Query: 476 RLGK-IGSGGSSEVHKVISSDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNII 534
R GK +G G V+ D GR+ A +++ + +
Sbjct: 5 RRGKLLGQGAFGRVYLCYDVD-----------TGRELAV-----KQVPFDPDSPETKKEV 48
Query: 535 QLIDYEVTEKALLREVLNGSMNNKDGRVKDDGYIYMVLEYGEIDLAHMLSQKWKEMDGSN 594
++ E+ LL+ + + + G ++DD + + +EY M K+ +
Sbjct: 49 NALECEIQ---LLKNLQHERIVQYYGCLRDDETLSIFMEY-------MPGGSVKDQLKAY 98
Query: 595 QTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLL-VKGSLKLIDFGIAK---AIM 650
L E R Y +QILE V +H IVH D+K AN L G++KL DFG +K I
Sbjct: 99 GALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTIC 158
Query: 651 SDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGRTPF 710
S T ++ S GT +MSPE +G GR +D+WS+GC + +M+ + P+
Sbjct: 159 SSGTGMK--SVTGTPYWMSPEVI-------SGE--GYGRKADVWSVGCTVVEMLTEKPPW 207
Query: 711 SEYKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQHPF 766
+E++ A FK+ T P + V +P + +++ + +R +LL+H F
Sbjct: 208 AEFEAMAAIFKIATQPTNPQLPSHV-SPDARNFLRRTFVENAKKRPSAEELLRHFF 262
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 99.1 bits (247), Expect = 5e-23
Identities = 61/224 (27%), Positives = 103/224 (45%), Gaps = 46/224 (20%)
Query: 554 SMNNKDGRVKDDGYIYMVLEY---GEIDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQIL 610
S +KD Y+Y+V+EY G D A ++ K + G L E+W + Y +++
Sbjct: 65 SFQSKD-------YLYLVMEYLNGG--DCASLI----KTLGG----LPEDWAKQYIAEVV 107
Query: 611 EAVNTIHEERIVHSDLKPANFLL-VKGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMS 669
V +H+ I+H D+KP N L+ G LKL DFG+++ + + VGT Y++
Sbjct: 108 LGVEDLHQRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGL-----ENKKF-VGTPDYLA 161
Query: 670 PEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGRTPFSEY--KTFWAKF--KVITD 725
PE + D+ SD WSLGC++++ ++G PF + + I
Sbjct: 162 PETILGVGDDKM---------SDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINW 212
Query: 726 PNHEITYEPVPNPWLLDLMKKCLAWDRNERWR---IPQLLQHPF 766
P + +P +DL+ + L D +R ++ HPF
Sbjct: 213 PEEVKEFC---SPEAVDLINRLLCMDPAKRLGANGYQEIKSHPF 253
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 99.2 bits (247), Expect = 5e-23
Identities = 60/179 (33%), Positives = 89/179 (49%), Gaps = 20/179 (11%)
Query: 597 LDENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLLV-KGSLKLIDFGIAKAI----MS 651
L E Y +QIL+ V +H +VH D+K N +L+ G +KLIDFG A+ + +
Sbjct: 99 LPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLH 158
Query: 652 DTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGRTPFS 711
T + S GT +M+PE NES GR SDIWS+GC +++M G+ P +
Sbjct: 159 GTHSNMLKSMHGTPYWMAPEVI--NESGY-------GRKSDIWSIGCTVFEMATGKPPLA 209
Query: 712 EYKTFWAKFKVITDPNHEITYEPVPNPW---LLDLMKKCLAWDRNERWRIPQLLQHPFL 767
A F + H +P+ + +D + CL D++ER QLL+H FL
Sbjct: 210 SMDRLAAMFYI---GAHRGLMPRLPDSFSAAAIDFVTSCLTRDQHERPSALQLLRHDFL 265
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 6e-23
Identities = 59/152 (38%), Positives = 80/152 (52%), Gaps = 21/152 (13%)
Query: 563 KDDGYIYMVLEY---GEIDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEE 619
+DD Y+YMV+EY G DL +++S N + E W RFY +++ A++ IH
Sbjct: 113 QDDKYLYMVMEYMPGG--DLVNLMS---------NYDIPEKWARFYTAEVVLALDAIHSM 161
Query: 620 RIVHSDLKPANFLLVK-GSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNES 678
+H D+KP N LL K G LKL DFG M ++ D+ VGT Y+SPE
Sbjct: 162 GFIHRDVKPDNMLLDKSGHLKLADFGTCMK-MDANGMVRCDTAVGTPDYISPEVLKSQGG 220
Query: 679 DENGNIIKCGRPSDIWSLGCILYQMVYGRTPF 710
D GR D WS+G LY+M+ G TPF
Sbjct: 221 DG-----YYGRECDWWSVGVFLYEMLVGDTPF 247
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 7e-23
Identities = 68/239 (28%), Positives = 106/239 (44%), Gaps = 42/239 (17%)
Query: 480 IGSGGSSEVHKVISSDC-TIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLID 538
+G G EV V IYA+K +K F +E + + I QL
Sbjct: 9 VGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQL-Q 67
Query: 539 YEVTEKALLREVLNGSMNNKDGRVKDDGYIYMVLEY---GEIDLAHMLSQKWKEMDGSNQ 595
Y +D +Y+V+EY G DL +L++
Sbjct: 68 YAF---------------------QDKDNLYLVMEYQPGG--DLLSLLNR-------YED 97
Query: 596 TLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLLVK-GSLKLIDFGIAKAIMSDTT 654
DE+ +FY +++ A++++H+ VH D+KP N L+ + G +KL DFG A + ++
Sbjct: 98 QFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKM 157
Query: 655 NIQRDSQVGTLSYMSPEAFMCNESDENGNI-IKCGRPSDIWSLGCILYQMVYGRTPFSE 712
+ VGT Y++PE D G ++C D WSLG I Y+M+YGR+PF E
Sbjct: 158 -VNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVEC----DWWSLGVIAYEMIYGRSPFHE 211
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 98.4 bits (245), Expect = 2e-22
Identities = 91/324 (28%), Positives = 138/324 (42%), Gaps = 72/324 (22%)
Query: 474 YQRLGKIGSGGSSEVHKVIS--SDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKN 531
Y+++ KIG G V+K ++ TI ALKKI+L+ D +EI L +++
Sbjct: 4 YEKVEKIGEGTYGVVYKARDRVTNETI-ALKKIRLEQEDEGVPSTAIREISLLKEMQ-HG 61
Query: 532 NIIQLIDYEVTEKALLREVLNGSMNNKDGRVKDDGYIYMVLEYGEIDLAHMLSQKWKEMD 591
NI++L D +EK L Y+V EY ++DL K MD
Sbjct: 62 NIVRLQDVVHSEKRL----------------------YLVFEYLDLDLK-------KHMD 92
Query: 592 GS-NQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLLVK--GSLKLIDFGIAKA 648
S + + ++ Y QIL + H R++H DLKP N L+ + +LKL DFG+A+A
Sbjct: 93 SSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARA 152
Query: 649 IMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGRT 708
+V TL Y +PE + + P DIWS+GCI +MV +
Sbjct: 153 FGIPVRTFTH--EVVTLWYRAPEILLGSRHYST--------PVDIWSVGCIFAEMVNQKP 202
Query: 709 PF---SEYKTFWAKFKVITDPNHEI-----------------------TYEPVPNPWLLD 742
F SE + F+++ PN E T P P +D
Sbjct: 203 LFPGDSEIDELFKIFRILGTPNEETWPGVTSLPDYKSAFPKWPPKDLATVVPTLEPAGVD 262
Query: 743 LMKKCLAWDRNERWRIPQLLQHPF 766
L+ K L D ++R L+H +
Sbjct: 263 LLSKMLRLDPSKRITARAALEHEY 286
|
Length = 294 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 97.9 bits (244), Expect = 2e-22
Identities = 86/323 (26%), Positives = 143/323 (44%), Gaps = 71/323 (21%)
Query: 474 YQRLGKIGSGGSSEVHKVISSDCT-IYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNN 532
+++L K+G G + V+K + I ALK+I L + T +EI + +LK N
Sbjct: 2 FKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDA-EEGTPSTAIREISLMKELK-HEN 59
Query: 533 IIQLIDYEVTEKALLREVLNGSMNNKDGRVKDDGYIYMVLEYGEIDLAHMLSQKWKEMDG 592
I++L D TE L+ +V EY + DL +K+ + G
Sbjct: 60 IVRLHDVIHTENKLM----------------------LVFEYMDKDL-----KKYMDTHG 92
Query: 593 SNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLLVK-GSLKLIDFGIAKAIMS 651
LD N ++ + Q+L+ + HE R++H DLKP N L+ K G LKL DFG+A+A
Sbjct: 93 VRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRGELKLADFGLARAFGI 152
Query: 652 DTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGRTPF- 710
++V TL Y +P+ + + + + +I DIWS+GCI+ +M+ GR F
Sbjct: 153 PVNTFS--NEVVTLWYRAPDVLLGSRT-YSTSI-------DIWSVGCIMAEMITGRPLFP 202
Query: 711 ----------------SEYKTFWAKFKVITDPNHEITYEPVP-----------NPWLLDL 743
+ ++ W + P ++ T+ P +P +DL
Sbjct: 203 GTNNEDQLLKIFRIMGTPTESTWPGISQL--PEYKPTFPRYPPQDLQQLFPHADPLGIDL 260
Query: 744 MKKCLAWDRNERWRIPQLLQHPF 766
+ + L + R LQHP+
Sbjct: 261 LHRLLQLNPELRISAHDALQHPW 283
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 98.9 bits (247), Expect = 2e-22
Identities = 94/336 (27%), Positives = 142/336 (42%), Gaps = 74/336 (22%)
Query: 467 FKVNGKLYQRLGKIGSGGSSEVHKVI--SSDCTIYALKKIKLKGRDYATAYGFCQEIEYL 524
F V + Y+ + IGSG V I S + A+KKI A +E++ L
Sbjct: 1 FDVGSR-YKPIENIGSGAYGVVCSAIDTRSGKKV-AIKKIPHAFDVPTLAKRTLRELKIL 58
Query: 525 NKLKGKNNIIQLIDYEVTEKALLREVLNGSMNNKDGRVKDDGYIYMVLEYGEIDLAHMLS 584
K +NII + D A ++V Y+V++ E DL H++
Sbjct: 59 RHFK-HDNIIAIRDILRPPGADFKDV------------------YVVMDLMESDLHHIIH 99
Query: 585 QKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLLVKG--SLKLID 642
S+Q L E +R++ Q+L + IH ++H DLKP+N LLV L++ D
Sbjct: 100 --------SDQPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSN-LLVNEDCELRIGD 150
Query: 643 FGIAKAIMSDTTNIQR--DSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCIL 700
FG+A+ + S T + V T Y +PE + E I D+WS+GCI
Sbjct: 151 FGMARGLSSSPTEHKYFMTEYVATRWYRAPELLL--SLPEYTTAI------DMWSVGCIF 202
Query: 701 YQMVYGRTPFSEYKTFWAKFKVITD----PNHEITYE-----------------PVP--- 736
+M+ GR K + + K+I P+ E+ PVP
Sbjct: 203 AEML-GRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRIGSDRVRKYIQNLPRKQPVPWSK 261
Query: 737 -----NPWLLDLMKKCLAWDRNERWRIPQLLQHPFL 767
+P LDL+ + L +D ER + Q LQHPFL
Sbjct: 262 IFPKASPEALDLLSQMLQFDPEERITVEQALQHPFL 297
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 97.6 bits (243), Expect = 3e-22
Identities = 91/328 (27%), Positives = 137/328 (41%), Gaps = 81/328 (24%)
Query: 474 YQRLGKIGSGGSSEVHKVISSDC-TIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNN 532
+Q++ KIG G V+K + + ALKKI+L +EI L +L N
Sbjct: 2 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN- 60
Query: 533 IIQLIDYEVTEKALLREVLNGSMNNKDGRVKDDGYIYMVLEYGEIDLAHMLSQKWKEMDG 592
I++L+D TE L Y+V E+ DL K MD
Sbjct: 61 IVKLLDVIHTENKL----------------------YLVFEFLHQDLK-------KFMDA 91
Query: 593 SNQT-LDENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLL-VKGSLKLIDFGIAKAI- 649
S + + ++ Y Q+L+ + H R++H DLKP N L+ +G++KL DFG+A+A
Sbjct: 92 SPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFG 151
Query: 650 --MSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKC---GRPSDIWSLGCILYQMV 704
+ T+ +V TL Y +PE ++ C DIWSLGCI +MV
Sbjct: 152 VPVRTYTH-----EVVTLWYRAPEI-----------LLGCKYYSTAVDIWSLGCIFAEMV 195
Query: 705 YGRTPF---SEYKTFWAKFKVITDPNHEI--------TYEP-------------VPN--P 738
R F SE + F+ + P+ + Y+P VP
Sbjct: 196 TRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDYKPSFPKWARQDFSKVVPPLDE 255
Query: 739 WLLDLMKKCLAWDRNERWRIPQLLQHPF 766
DL+ + L +D N+R L HPF
Sbjct: 256 DGRDLLSQMLHYDPNKRISAKAALAHPF 283
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 97.6 bits (243), Expect = 3e-22
Identities = 84/322 (26%), Positives = 142/322 (44%), Gaps = 60/322 (18%)
Query: 474 YQRLGKIGSGGSSEVHKVIS-SDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNN 532
Y++L KIG G +V+K + + ALKK +L+ + +EI L L
Sbjct: 3 YEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIY 62
Query: 533 IIQLIDYEVTEKALLREVLNGSMNNKDGRVKDDGYIYMVLEYGEIDLAHMLSQKWKEMDG 592
I++L+D E E K+G+ +Y+V EY + DL + + G
Sbjct: 63 IVRLLDVEHVE-------------EKNGKPS----LYLVFEYLDSDLKKFMDSNGR---G 102
Query: 593 SNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLL--VKGSLKLIDFGIAKAIM 650
+ L ++ + Q+L+ V H+ ++H DLKP N L+ KG LK+ D G+ +A
Sbjct: 103 PGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAF- 161
Query: 651 SDTTNIQRDS-QVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGRTP 709
+ ++ + ++ TL Y +PE + + P DIWS+GCI +M +
Sbjct: 162 --SIPVKSYTHEIVTLWYRAPEVLLGSTHYST--------PVDIWSVGCIFAEMSRKQPL 211
Query: 710 F---SEYKTFWAKFKVITDPNHEI--------------TYEP------VPN--PWLLDLM 744
F SE + FK++ P ++ ++P VP+ P LDL+
Sbjct: 212 FPGDSELQQLLHIFKLLGTPTEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLL 271
Query: 745 KKCLAWDRNERWRIPQLLQHPF 766
+K L +D +R L HP+
Sbjct: 272 QKMLRYDPAKRISAKAALTHPY 293
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 98.0 bits (245), Expect = 4e-22
Identities = 72/300 (24%), Positives = 125/300 (41%), Gaps = 75/300 (25%)
Query: 520 EIEYLNKLKGKNNIIQLIDYEVTEKALLREVLNGSMNNKDGRVKDDGYIYMVLEYGEIDL 579
EI+ L L+ +N II L+D +LR N+ +Y+V E E DL
Sbjct: 49 EIKLLRHLRHEN-IIGLLD-------ILRPPSPEDFND----------VYIVTELMETDL 90
Query: 580 AHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLLVKGS-- 637
++ S Q L ++ ++++ QIL + +H ++H DLKP+N +LV +
Sbjct: 91 HKVIK--------SPQPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSN-ILVNSNCD 141
Query: 638 LKLIDFGIAKAIMSDTTNIQRDSQ-VGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSL 696
LK+ DFG+A+ + D ++ V T Y +PE + + + + DIWS+
Sbjct: 142 LKICDFGLARGVDPDEDEKGFLTEYVVTRWYRAPELLLSSS--------RYTKAIDIWSV 193
Query: 697 GCILYQMVYGRTPFSEYKTFWAKFKVITD----PNHEI-----------------TYEPV 735
GCI +++ R P + + + +I + P+ E
Sbjct: 194 GCIFAELL-TRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFITSEKARNYLKSLPKKPKK 252
Query: 736 P--------NPWLLDLMKKCLAWDRNERWRIPQLLQHPFLVP-------PVSTQPSSSQD 780
P +P +DL++K L +D +R + L HP+L PV+ P
Sbjct: 253 PLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHDPEDEPVAKPPFDFDF 312
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 96.2 bits (240), Expect = 8e-22
Identities = 91/334 (27%), Positives = 139/334 (41%), Gaps = 94/334 (28%)
Query: 474 YQRLGKIGSGGSSEVHKVIS-SDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNN 532
Y+ LGKIG G SEV K S YA+K +K + +EI+ L +L N
Sbjct: 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNN-LREIQALRRLSPHPN 59
Query: 533 IIQLIDYEVTEKALLREVLNGSMNNKDGRVKDDGYIYMVLEYGEIDLAHMLSQKWKEMDG 592
I++LI EVL + K GR+ +V E +++L + + G
Sbjct: 60 ILRLI-----------EVL---FDRKTGRLA------LVFELMDMNLYEL-------IKG 92
Query: 593 SNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLLVKGSLKLIDFGIAKAIMSD 652
+ L E ++ Y Q+L++++ +H I H D+KP N L+ LKL DFG + I S
Sbjct: 93 RKRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKDDILKLADFGSCRGIYSK 152
Query: 653 ---TTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPS---DIWSLGCILYQM--- 703
T I T Y +PE C ++ G DIW++GC+ +++
Sbjct: 153 PPYTEYI------STRWYRAPE---C--------LLTDGYYGPKMDIWAVGCVFFEILSL 195
Query: 704 ------------------VYGRTPFSEYKTFWAKFKVITDPNHEITYE------------ 733
V G TP +E KF+ + + Y
Sbjct: 196 FPLFPGTNELDQIAKIHDVLG-TPDAEVL---KKFR----KSRHMNYNFPSKKGTGLRKL 247
Query: 734 -PVPNPWLLDLMKKCLAWDRNERWRIPQLLQHPF 766
P + LDL+KK LA+D +ER Q L+HP+
Sbjct: 248 LPNASAEGLDLLKKLLAYDPDERITAKQALRHPY 281
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 96.9 bits (242), Expect = 1e-21
Identities = 91/332 (27%), Positives = 141/332 (42%), Gaps = 76/332 (22%)
Query: 474 YQRLGKIGSGGSSEVHKVISSDC-TIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNN 532
Y+ L K+G G V K I + ALKKI R+ A +EI +L +L N
Sbjct: 9 YEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPN 68
Query: 533 IIQLIDYEVTEKALLREVLNGSMNNKDGRVKDDGYIYMVLEYGEIDLAHMLSQKWKEMDG 592
I++L++ KA N+KD IY+V EY E DL H + +
Sbjct: 69 IVKLLN---VIKA---------ENDKD--------IYLVFEYMETDL-HAVIRA------ 101
Query: 593 SNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLL-VKGSLKLIDFGIAKAIMS 651
L++ R+ Q+L+A+ IH ++H DLKP+N LL +KL DFG+A+++
Sbjct: 102 --NILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSE 159
Query: 652 DTTNIQRDSQ---VGTLSYMSPEAFMCNESDENGNIIKCGRPS---DIWSLGCILYQMVY 705
N + V T Y +PE ++ R + D+WS+GCIL +M+
Sbjct: 160 LEENPENPVLTDYVATRWYRAPEI-----------LLGSTRYTKGVDMWSVGCILGEMLL 208
Query: 706 GRTPFSEYKTFWAKFKVIT---DPNHE-------------------------ITYEPVPN 737
G+ F T K+I P+ E P +
Sbjct: 209 GKPLFPGTSTLNQLEKIIEVIGPPSAEDIESIKSPFAATMLDSLPSRPRKPLDELLPKAS 268
Query: 738 PWLLDLMKKCLAWDRNERWRIPQLLQHPFLVP 769
LDL+KK L ++ N+R + L+HP++
Sbjct: 269 DDALDLLKKLLVFNPNKRLTAEEALEHPYVAQ 300
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 95.3 bits (237), Expect = 2e-21
Identities = 83/307 (27%), Positives = 130/307 (42%), Gaps = 61/307 (19%)
Query: 477 LGKIGSGGSSEVHKVISSDC-TIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQ 535
L ++G G V+KV+ A+K+I+L+ D + E++ L+K
Sbjct: 6 LDELGKGNYGSVYKVLHRPTGVTMAMKEIRLE-LDESKFNQIIMELDILHKA----VSPY 60
Query: 536 LIDYEVTEKALLREVLNGSMNNKDGRVKDDGYIYMVLEY---GEIDLAHMLSQKWKEMDG 592
++D+ G +G +YM +EY G +D K G
Sbjct: 61 IVDFY-------------------GAFFIEGAVYMCMEYMDAGSLD---------KLYAG 92
Query: 593 SNQT--LDENWLRFYWQQILEAVNTIHEE-RIVHSDLKPANFLL-VKGSLKLIDFGIAKA 648
T + E+ LR +++ + + EE I+H D+KP N L+ G +KL DFG++
Sbjct: 93 GVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGN 152
Query: 649 IMSD--TTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYG 706
+++ TNI G SYM+PE ++N SD+WSLG + +M G
Sbjct: 153 LVASLAKTNI------GCQSYMAPERIKSGGPNQNPTYTV---QSDVWSLGLSILEMALG 203
Query: 707 RTPF--SEYKTFWAKFKVITD---PNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQL 761
R P+ Y +A+ I D P Y D + KCL N R QL
Sbjct: 204 RYPYPPETYANIFAQLSAIVDGDPPTLPSGYSDDAQ----DFVAKCLNKIPNRRPTYAQL 259
Query: 762 LQHPFLV 768
L+HP+LV
Sbjct: 260 LEHPWLV 266
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 96.2 bits (239), Expect = 2e-21
Identities = 58/152 (38%), Positives = 84/152 (55%), Gaps = 18/152 (11%)
Query: 563 KDDGYIYMVLEY---GEIDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEE 619
+D+ Y+Y+V++Y G DL +LS+ L E+ RFY +++ A+++IH+
Sbjct: 71 QDENYLYLVMDYYVGG--DLLTLLSK-------FEDRLPEDMARFYIAEMVLAIHSIHQL 121
Query: 620 RIVHSDLKPANFLL-VKGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNES 678
VH D+KP N LL + G ++L DFG + D T +Q VGT Y+SPE E
Sbjct: 122 HYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGT-VQSSVAVGTPDYISPEILQAME- 179
Query: 679 DENGNIIKCGRPSDIWSLGCILYQMVYGRTPF 710
D G K G D WSLG +Y+M+YG TPF
Sbjct: 180 DGMG---KYGPECDWWSLGVCMYEMLYGETPF 208
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 94.1 bits (234), Expect = 3e-21
Identities = 68/217 (31%), Positives = 103/217 (47%), Gaps = 29/217 (13%)
Query: 560 GRVKDDGYIYMVLEY---GEIDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTI 616
G ++G+ + +E G L+ +L KW + + QT+ FY +QILE + +
Sbjct: 72 GSDSENGFFKIFMEQVPGGS--LSALLRSKWGPLKDNEQTI-----IFYTKQILEGLKYL 124
Query: 617 HEERIVHSDLKPANFLL--VKGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFM 674
H+ +IVH D+K N L+ G +K+ DFG +K + N ++ GTL YM+PE
Sbjct: 125 HDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAG--INPCTETFTGTLQYMAPEVI- 181
Query: 675 CNESDENGNIIKCGRPSDIWSLGCILYQMVYGRTPFSEYKTFWAK-FKVITDPNHEITYE 733
+ G G P+DIWSLGC + +M G+ PF E A FKV H
Sbjct: 182 --DKGPRGY----GAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKIH----P 231
Query: 734 PVPNPWLLD---LMKKCLAWDRNERWRIPQLLQHPFL 767
+P + + +C D ++R LLQ PFL
Sbjct: 232 EIPESLSAEAKNFILRCFEPDPDKRASAHDLLQDPFL 268
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 96.2 bits (239), Expect = 3e-21
Identities = 57/150 (38%), Positives = 82/150 (54%), Gaps = 17/150 (11%)
Query: 563 KDDGYIYMVLEYGEI-DLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERI 621
+DD Y+YMV+EY DL +++S N + E W +FY +++ A++ IH +
Sbjct: 113 QDDKYLYMVMEYMPGGDLVNLMS---------NYDVPEKWAKFYTAEVVLALDAIHSMGL 163
Query: 622 VHSDLKPANFLLVK-GSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDE 680
+H D+KP N LL K G LKL DFG M +T ++ D+ VGT Y+SPE D
Sbjct: 164 IHRDVKPDNMLLDKHGHLKLADFGTCMK-MDETGMVRCDTAVGTPDYISPEVLKSQGGDG 222
Query: 681 NGNIIKCGRPSDIWSLGCILYQMVYGRTPF 710
GR D WS+G L++M+ G TPF
Sbjct: 223 -----YYGRECDWWSVGVFLFEMLVGDTPF 247
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 94.3 bits (234), Expect = 4e-21
Identities = 95/347 (27%), Positives = 153/347 (44%), Gaps = 71/347 (20%)
Query: 458 KRNYDPDLFFKVNGKLYQRLGKIGSGGSSEVHKVISSDCTIYALKK-IKLKGRDYATAYG 516
+R+ DP ++++ +G++G G +V+K + + A K I+ K + Y
Sbjct: 5 RRDLDP-------NEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDY- 56
Query: 517 FCQEIEYLNKLKGKNNIIQLIDYEVTEKALLREVLNGSMNNKDGRVKDDGYIYMVLEY-- 574
EIE I+ ++ K L G DG +++++E+
Sbjct: 57 -MVEIE----------ILATCNHPYIVKLL-------------GAFYWDGKLWIMIEFCP 92
Query: 575 -GEIDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLL 633
G +D A ML E+D + L E ++ +Q+LEA+ +H +I+H DLK N LL
Sbjct: 93 GGAVD-AIML-----ELD---RGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLL 143
Query: 634 -VKGSLKLIDFGIAKAIMSDTTNIQ-RDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPS 691
+ G +KL DFG++ + +Q RDS +GT +M+PE MC + K +
Sbjct: 144 TLDGDIKLADFGVSA---KNVKTLQRRDSFIGTPYWMAPEVVMCETMKDTPYDYK----A 196
Query: 692 DIWSLGCILYQMVYGRTPFSEYKTFWAKFKVI-TDPNHEITYEPVPNPWLL---DLMKKC 747
DIWSLG L +M P E K+ ++P P+ W + D +K
Sbjct: 197 DIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLSQ----PSKWSMEFRDFLKTA 252
Query: 748 LAWDRNERWRIPQLLQHPFLVPPVSTQPSSSQDQSYQLLQLLAEASA 794
L R QLL+HPF+ S +P L +L+AEA A
Sbjct: 253 LDKHPETRPSAAQLLEHPFVSSVTSNRP---------LRELVAEAKA 290
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 94.8 bits (236), Expect = 5e-21
Identities = 56/152 (36%), Positives = 88/152 (57%), Gaps = 18/152 (11%)
Query: 563 KDDGYIYMVLEY---GEIDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEE 619
+D+ +Y+V++Y G DL +LS K+++ L E+ RFY +++ A++++H+
Sbjct: 71 QDENNLYLVMDYYVGG--DLLTLLS-KFED------RLPEDMARFYLAEMVLAIDSVHQL 121
Query: 620 RIVHSDLKPANFLL-VKGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNES 678
VH D+KP N LL G ++L DFG +++D T +Q + VGT Y+SPE E
Sbjct: 122 GYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGT-VQSNVAVGTPDYISPEILQAME- 179
Query: 679 DENGNIIKCGRPSDIWSLGCILYQMVYGRTPF 710
D G + G D WSLG +Y+M+YG TPF
Sbjct: 180 DGKG---RYGPECDWWSLGVCMYEMLYGETPF 208
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 93.7 bits (233), Expect = 5e-21
Identities = 83/322 (25%), Positives = 129/322 (40%), Gaps = 69/322 (21%)
Query: 474 YQRLGKIGSGGSSEVHKVISSDC-TIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNN 532
Y++L KIG G V K + + I ALK+++L D +EI L +LK KN
Sbjct: 2 YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKN- 60
Query: 533 IIQLIDYEVTEKALLREVLNGSMNNKDGRVKDDGYIYMVLEYGEIDLAHMLSQKWKEMDG 592
I++L D ++K L +V EY + DL K D
Sbjct: 61 IVRLYDVLHSDKKLT----------------------LVFEYCDQDLK-------KYFDS 91
Query: 593 SNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLLVK-GSLKLIDFGIAKAIMS 651
N +D ++ + Q+L+ + H ++H DLKP N L+ K G LKL DFG+A+A
Sbjct: 92 CNGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKNGELKLADFGLARAFGI 151
Query: 652 DTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGRTPFS 711
++V TL Y P+ + +I D+WS GCI ++ P
Sbjct: 152 PVR--CYSAEVVTLWYRPPDVLF-GAKLYSTSI-------DMWSAGCIFAELANAGRPLF 201
Query: 712 EYKTFWAK----FKVITDPNHEI--------TYEPVP---------------NPWLLDLM 744
+ F+++ P E Y+P P N DL+
Sbjct: 202 PGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDYKPYPMYPATTSLVNVVPKLNSTGRDLL 261
Query: 745 KKCLAWDRNERWRIPQLLQHPF 766
+ L + +R + LQHP+
Sbjct: 262 QNLLVCNPVQRISAEEALQHPY 283
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 93.4 bits (232), Expect = 6e-21
Identities = 76/255 (29%), Positives = 126/255 (49%), Gaps = 43/255 (16%)
Query: 528 KGKNNIIQLIDYEVTEKALLREVLNGSMNNKDGRVKDDGYIYMVLEY---GEIDLAHMLS 584
K+ ++D E ALL+E+ + ++ G D ++ + LEY G + A +L+
Sbjct: 41 SSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADHLNIFLEYVPGGSV--AALLN 98
Query: 585 QKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLL-VKGSLKLIDF 643
G+ +E +R + +QIL+ +N +H I+H D+K AN L+ KG +K+ DF
Sbjct: 99 NY-----GA---FEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNKGGIKISDF 150
Query: 644 GIAKA----IMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIK---CGRPSDIWSL 696
GI+K +S TN R S G++ +M+PE ++K R +DIWSL
Sbjct: 151 GISKKLEANSLSTKTNGARPSLQGSVFWMAPE------------VVKQTSYTRKADIWSL 198
Query: 697 GCILYQMVYGRTPFSEYKTFWAKFK----VITDPNHEITYEPVPNPWLLDLMKKCLAWDR 752
GC++ +M+ G+ PF + A FK + I+ E + D ++K D
Sbjct: 199 GCLVVEMLTGKHPFPDCTQLQAIFKIGENASPEIPSNISSEAI------DFLEKTFEIDH 252
Query: 753 NERWRIPQLLQHPFL 767
N+R +LL+HPFL
Sbjct: 253 NKRPTAAELLKHPFL 267
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 94.7 bits (235), Expect = 1e-20
Identities = 57/150 (38%), Positives = 80/150 (53%), Gaps = 17/150 (11%)
Query: 563 KDDGYIYMVLEYGEI-DLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERI 621
+DD Y+YMV+EY DL +++S N + E W RFY +++ A++ IH
Sbjct: 113 QDDRYLYMVMEYMPGGDLVNLMS---------NYDVPEKWARFYTAEVVLALDAIHSMGF 163
Query: 622 VHSDLKPANFLLVK-GSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDE 680
+H D+KP N LL K G LKL DFG + + ++ D+ VGT Y+SPE D
Sbjct: 164 IHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGM-VRCDTAVGTPDYISPEVLKSQGGDG 222
Query: 681 NGNIIKCGRPSDIWSLGCILYQMVYGRTPF 710
GR D WS+G LY+M+ G TPF
Sbjct: 223 -----YYGRECDWWSVGVFLYEMLVGDTPF 247
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 92.4 bits (229), Expect = 1e-20
Identities = 90/292 (30%), Positives = 133/292 (45%), Gaps = 47/292 (16%)
Query: 479 KIGSGGSSEVHKVISS-DCTIYALKKIKLKGRDYATAYGFC-QEIEYLNKLKGKNNIIQL 536
KIG G SEV++ D ALKK+++ A A C +EI+ L +L N+I+
Sbjct: 9 KIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLN-HPNVIKY 67
Query: 537 IDYEVTEKALLREVLNGSMNNKDGRVKDDGYIYMVLEYGEIDLAHMLSQKWKEMDGSNQT 596
+D + +D + +VLE + A LSQ K +
Sbjct: 68 LDSFI----------------------EDNELNIVLELAD---AGDLSQMIKYFKKQKRL 102
Query: 597 LDENWLRFYWQQILEAVNTIHEERIVHSDLKPAN-FLLVKGSLKLIDFGIAKAIMSDTTN 655
+ E + Y+ Q+ AV +H R++H D+KPAN F+ G +KL D G+ + S TT
Sbjct: 103 IPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTA 162
Query: 656 IQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGRTPFSEYKT 715
S VGT YMSPE ENG K SDIWSLGC+LY+M ++PF K
Sbjct: 163 AH--SLVGTPYYMSPERI-----HENGYNFK----SDIWSLGCLLYEMAALQSPFYGDKM 211
Query: 716 FWAKFKVITDPNHEITYEPVP----NPWLLDLMKKCLAWDRNERWRIPQLLQ 763
+ + Y P+P + L +L+ C+ D ++R I + Q
Sbjct: 212 ---NLFSLCQKIEQCDYPPLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQ 260
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 93.1 bits (232), Expect = 1e-20
Identities = 88/332 (26%), Positives = 140/332 (42%), Gaps = 85/332 (25%)
Query: 474 YQRLGKIGSGGSSEVHKV--ISSDCTIYALKKIKL-KGRDYATAYGF----CQEIEYLNK 526
Y++L +I G V++ + I ALKK+K+ K ++ GF +EI L K
Sbjct: 7 YEKLNRIEEGTYGVVYRARDKKTG-EIVALKKLKMEKEKE-----GFPITSLREINILLK 60
Query: 527 LKGKNNIIQLIDYEVTEKALLREVLNGSMNNKDGRVKDDGYIYMVLEYGEIDLAHMLSQK 586
L+ NI+ + +EV+ GS +K IYMV+EY E DL +
Sbjct: 61 LQ-HPNIVTV-----------KEVVVGSNLDK---------IYMVMEYVEHDLKSL---- 95
Query: 587 WKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLLV-KGSLKLIDFGI 645
M+ Q ++ ++ Q+L V +H+ I+H DLK +N LL +G LK+ DFG+
Sbjct: 96 ---METMKQPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGL 152
Query: 646 AKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVY 705
A+ S + V TL Y +PE + + + D+WS+GCI +++
Sbjct: 153 AREYGSPLKPYTQ--LVVTLWYRAPELLLGAK--------EYSTAIDMWSVGCIFAELLT 202
Query: 706 GR--------------------TP-------FSEYKTFWAKFKVITDPNHEITYEPVPNP 738
+ TP FSE AK K T + + P
Sbjct: 203 KKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELPG--AKKKTFTKYPYNQLRKKFPAL 260
Query: 739 WL----LDLMKKCLAWDRNERWRIPQLLQHPF 766
L DL+ + L +D +R L+HP+
Sbjct: 261 SLSDNGFDLLNRLLTYDPAKRISAEDALKHPY 292
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 92.0 bits (229), Expect = 1e-20
Identities = 88/313 (28%), Positives = 130/313 (41%), Gaps = 76/313 (24%)
Query: 476 RLGKIGSGGSSEVHKV-ISSDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNII 534
LG++G+G S V KV I A+K I+L+ N I
Sbjct: 5 YLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEI----------------------NEAI 42
Query: 535 QLIDYEVTEKALLREVLNGSMNNKD-------GRVKDDGYIYMVLEY---GEIDLAHMLS 584
Q K +LRE L+ G ++G I + +EY G +D
Sbjct: 43 Q--------KQILRE-LDILHKCNSPYIVGFYGAFYNNGDISICMEYMDGGSLD------ 87
Query: 585 QKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEER-IVHSDLKPANFLL-VKGSLKLID 642
+ KE+ G + E L +L+ + +HE+ I+H D+KP+N L+ +G +KL D
Sbjct: 88 KILKEVQG---RIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRGQIKLCD 144
Query: 643 FGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQ 702
FG++ + N + VGT SYM+PE N +K SDIWSLG L +
Sbjct: 145 FGVSGQL----VNSLAKTFVGTSSYMAPERI-----QGNDYSVK----SDIWSLGLSLIE 191
Query: 703 MVYGRTPFSEYKTFWAKFKVITDPNHEITYEPVP-------NPWLLDLMKKCLAWDRNER 755
+ GR P+ I + I EP P +P D + CL D ER
Sbjct: 192 LATGRFPYPPENDPP---DGIFELLQYIVNEPPPRLPSGKFSPDFQDFVNLCLIKDPRER 248
Query: 756 WRIPQLLQHPFLV 768
+LL+HPF+
Sbjct: 249 PSYKELLEHPFIK 261
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 92.1 bits (229), Expect = 2e-20
Identities = 65/217 (29%), Positives = 101/217 (46%), Gaps = 31/217 (14%)
Query: 543 EKALLREVLNGSMNNKDGRVKDDGYIYMVLEY---GEIDLAHMLSQKWKEMDGSNQTLDE 599
EK +L+EV + + D ++YM++EY GE + S SN T
Sbjct: 51 EKRVLKEVSHPFIIRLFWTEHDQRFLYMLMEYVPGGE-----LFSYLRNSGRFSNSTG-- 103
Query: 600 NWLRFYWQQILEAVNTIHEERIVHSDLKPANFLLVK-GSLKLIDFGIAKAIMSDTTNIQR 658
FY +I+ A+ +H + IV+ DLKP N LL K G +KL DFG AK + T +
Sbjct: 104 ---LFYASEIVCALEYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRTWTL-- 158
Query: 659 DSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGRTPFSEYKTFWA 718
GT Y++PE G+ + D W+LG ++Y+M+ G PF + F
Sbjct: 159 ---CGTPEYLAPEVI-----QSKGH----NKAVDWWALGILIYEMLVGYPPFFDDNPFGI 206
Query: 719 KFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNER 755
K++ ++ + + + DL+KK L DR R
Sbjct: 207 YEKILA---GKLEFPRHLDLYAKDLIKKLLVVDRTRR 240
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 90.9 bits (225), Expect = 4e-20
Identities = 77/235 (32%), Positives = 110/235 (46%), Gaps = 40/235 (17%)
Query: 479 KIGSGGSSEVHKVISS-DCTIYALKKIKLKGRDYATAYGFC-QEIEYLNKLKGKNNIIQL 536
KIG G SEV++ D ALKK+++ A A C +EI+ L +L N +
Sbjct: 9 KIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPN----V 64
Query: 537 IDYEVTEKALLREVLNGSMNNKDGRVKDDGYIYMVLEYGEIDLAHMLSQKWKEMDGSNQT 596
I Y + +D + +VLE + A LS+ K +
Sbjct: 65 IKYYAS-------------------FIEDNELNIVLELAD---AGDLSRMIKHFKKQKRL 102
Query: 597 LDENWLRFYWQQILEAVNTIHEERIVHSDLKPAN-FLLVKGSLKLIDFGIAKAIMSDTTN 655
+ E + Y+ Q+ A+ +H R++H D+KPAN F+ G +KL D G+ + S TT
Sbjct: 103 IPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTA 162
Query: 656 IQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGRTPF 710
S VGT YMSPE ENG K SDIWSLGC+LY+M ++PF
Sbjct: 163 AH--SLVGTPYYMSPERI-----HENGYNFK----SDIWSLGCLLYEMAALQSPF 206
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 90.6 bits (225), Expect = 4e-20
Identities = 59/177 (33%), Positives = 90/177 (50%), Gaps = 19/177 (10%)
Query: 598 DENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLL-VKGSLKLIDFGIAKAIMSDTTNI 656
+E +RF+ +Q+LE + +H + I+H DLK N L+ G K+ DFGI+K N
Sbjct: 106 EEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDND 165
Query: 657 QRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGRTPFSEYKTF 716
Q S G++ +M+PE S G K DIWSLGC++ +M GR P+S+ +
Sbjct: 166 QNMSMQGSVFWMAPEVI---HSYSQGYSAKV----DIWSLGCVVLEMFAGRRPWSDEEAI 218
Query: 717 WAKFKVITDPNHEITYEPVP-------NPWLLDLMKKCLAWDRNERWRIPQLLQHPF 766
A FK+ + + P+P +P LD + C + + R +LLQHPF
Sbjct: 219 AAMFKLGN----KRSAPPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQHPF 271
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 90.9 bits (226), Expect = 6e-20
Identities = 76/248 (30%), Positives = 118/248 (47%), Gaps = 53/248 (21%)
Query: 471 GKL--YQRLGKIGSGGSSEVHKVISS-DCTIYALKKIKLKGRDYA--TAYGFCQEIEYLN 525
GKL Y++L K+G G + V+K S + ALK+I+L+ + A TA +E L
Sbjct: 2 GKLETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTA---IREASLLK 58
Query: 526 KLKGKNNIIQLIDYEVTEKALLREVLNGSMNNKDGRVKDDGYIYMVLEYGEIDLAHMLSQ 585
LK NI+ L D T+K L +V EY + DL
Sbjct: 59 DLK-HANIVTLHDIIHTKKTLT----------------------LVFEYLDTDLK----- 90
Query: 586 KWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLL-VKGSLKLIDFG 644
+ MD L + +R + Q+L + H+ R++H DLKP N L+ +G LKL DFG
Sbjct: 91 --QYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISERGELKLADFG 148
Query: 645 IAKA--IMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQ 702
+A+A + S T + ++V TL Y P+ + ++ + ++ D+W +GCI Y+
Sbjct: 149 LARAKSVPSKTYS----NEVVTLWYRPPDVLL-GSTEYSTSL-------DMWGVGCIFYE 196
Query: 703 MVYGRTPF 710
M GR F
Sbjct: 197 MATGRPLF 204
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 91.8 bits (228), Expect = 7e-20
Identities = 89/324 (27%), Positives = 137/324 (42%), Gaps = 63/324 (19%)
Query: 475 QRLGKIGSGGSSEVHKVI-SSDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNI 533
+R+ +IGSG V+KVI +YALK I + C+EIE
Sbjct: 77 ERVNRIGSGAGGTVYKVIHRPTGRLYALKVI-YGNHEDTVRRQICREIE----------- 124
Query: 534 IQLIDYEVTEKALLREVLNGSMNNKDGRVKDDGYIYMVLEYGEIDLAHMLSQKWKEMDGS 593
+LR+V + ++ +G I ++LE+ MDG
Sbjct: 125 ------------ILRDVNHPNVVKCHDMFDHNGEIQVLLEF---------------MDGG 157
Query: 594 N----QTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLLVKG-SLKLIDFGIAKA 648
+ DE +L +QIL + +H IVH D+KP+N L+ ++K+ DFG+++
Sbjct: 158 SLEGTHIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSR- 216
Query: 649 IMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGRT 708
I++ T + +S VGT++YMSPE +D N G DIWSLG + + GR
Sbjct: 217 ILAQTMD-PCNSSVGTIAYMSPERI---NTDLNHGAYD-GYAGDIWSLGVSILEFYLGRF 271
Query: 709 PFSEYKTF-WAKFKV---ITDPNHEITYEPVPN--PWLLDLMKKCLAWDRNERWRIPQLL 762
PF + WA ++ P E + CL + +RW QLL
Sbjct: 272 PFGVGRQGDWASLMCAICMSQPP-----EAPATASREFRHFISCCLQREPAKRWSAMQLL 326
Query: 763 QHPFLVPPVSTQPSSSQDQSYQLL 786
QHPF++ +QLL
Sbjct: 327 QHPFILRA-QPGQGQGGPNLHQLL 349
|
Length = 353 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 88.7 bits (220), Expect = 2e-19
Identities = 48/164 (29%), Positives = 72/164 (43%), Gaps = 20/164 (12%)
Query: 597 LDENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLLVK-GSLKLIDFGIAKAIMSDTTN 655
E FY QI+ + +H+ RIV+ DLKP N LL G++++ D G+A +
Sbjct: 92 FPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKI 151
Query: 656 IQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGRTPFSEYKT 715
R GT YM+PE D D ++LGC LY+M+ GR+PF + K
Sbjct: 152 KGR---AGTPGYMAPEVLQGEVYDF---------SVDWFALGCTLYEMIAGRSPFRQRKE 199
Query: 716 FWA----KFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNER 755
K + + + Y +P DL + L D +R
Sbjct: 200 KVEKEELKRRTLEMA---VEYPDKFSPEAKDLCEALLQKDPEKR 240
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 88.9 bits (220), Expect = 3e-19
Identities = 87/323 (26%), Positives = 134/323 (41%), Gaps = 71/323 (21%)
Query: 474 YQRLGKIGSGGSSEVHKVISSDCT-IYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNN 532
++ LG +G G V K + I A+KK K + +E++ L LK + N
Sbjct: 3 FEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLK-QEN 61
Query: 533 IIQLIDYEVTEKALLREVLNGSMNNKDGRVKDDGYIYMVLEYGEIDLAHMLSQKWKEMDG 592
I++L ++A R G +Y+V EY E ++ +L +
Sbjct: 62 IVEL------KEAFRRR----------------GKLYLVFEYVEKNMLELLEEM------ 93
Query: 593 SNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLLVKGS-LKLIDFGIAKAIMS 651
N E +R Y Q+++A++ H+ IVH D+KP N L+ LKL DFG A+ +S
Sbjct: 94 PNGVPPEK-VRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARN-LS 151
Query: 652 DTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCIL----------- 700
+ +N V T Y SPE + G+ D+WS+GCIL
Sbjct: 152 EGSNANYTEYVATRWYRSPELLLGAPY---------GKAVDMWSVGCILGELSDGQPLFP 202
Query: 701 ----------YQMVYGRTPFSEYKTFWA-------KFKVITDPNH-EITYEPVPNPWLLD 742
Q V G P + K F++ +F + P E Y + + LLD
Sbjct: 203 GESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHGLRFPAVNHPQSLERRYLGILSGVLLD 262
Query: 743 LMKKCLAWDRNERWRIPQLLQHP 765
LMK L + +R+ Q L HP
Sbjct: 263 LMKNLLKLNPTDRYLTEQCLNHP 285
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 88.6 bits (220), Expect = 3e-19
Identities = 82/323 (25%), Positives = 130/323 (40%), Gaps = 70/323 (21%)
Query: 474 YQRLGKIGSGGSSEVHKVISSDC-TIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNN 532
Y+ LG +G G V K + I A+KK D +EI L +L+ N
Sbjct: 3 YENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLR-HEN 61
Query: 533 IIQLIDYEVTEKALLREVLNGSMNNKDGRVKDDGYIYMVLEYGEIDLAHMLSQKWKEMDG 592
++ LI EV + +Y+V E+ +D H + +++
Sbjct: 62 LVNLI-----------EVF-----------RRKKRLYLVFEF--VD--HTV---LDDLEK 92
Query: 593 SNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLLVK-GSLKLIDFGIAKAIMS 651
LDE+ +R Y QIL + H I+H D+KP N L+ + G +KL DFG A+ + +
Sbjct: 93 YPNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAA 152
Query: 652 DTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGRTPF- 710
+ D V T Y +PE + + K GR DIW++GC++ +M+ G F
Sbjct: 153 -PGEVYTD-YVATRWYRAPELLVGD--------TKYGRAVDIWAVGCLVTEMLTGEPLFP 202
Query: 711 -------------------SEYKTFWAKFKVITDPNHEITYEPVP--------NPWLLDL 743
++ + K + E P + +LDL
Sbjct: 203 GDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDL 262
Query: 744 MKKCLAWDRNERWRIPQLLQHPF 766
K+CL D ++R QLL H F
Sbjct: 263 AKQCLRIDPDDRPSSSQLLHHEF 285
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 87.7 bits (218), Expect = 4e-19
Identities = 81/313 (25%), Positives = 132/313 (42%), Gaps = 71/313 (22%)
Query: 472 KLYQRLGKIGSGGSSEVHK--VISSDCTIYALKKIKLK-GRDYATAYGFCQEIEYLNKLK 528
+ Y+ + +IGSG +V+K I++ + A+K IKL+ G D+ QEI L + +
Sbjct: 3 EDYELIQRIGSGTYGDVYKARDIATG-ELVAIKVIKLEPGDDFEI---IQQEISMLKECR 58
Query: 529 GKNNIIQLIDYEVTEKALLREVLNGSMNNKDGRVKDDGYIYMVLEY---GEI-DLAHMLS 584
NI+ G +++V+EY G + D+ +
Sbjct: 59 -HPNIVAYF----------------------GSYLRRDKLWIVMEYCGGGSLQDIYQVT- 94
Query: 585 QKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLLVK-GSLKLIDF 643
L E + + ++ L+ + +HE +H D+K AN LL + G +KL DF
Sbjct: 95 ---------RGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTEDGDVKLADF 145
Query: 644 GIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQM 703
G++ + T +R S +GT +M+PE + + G KC DIW+LG ++
Sbjct: 146 GVSAQL--TATIAKRKSFIGTPYWMAPE--VAAVERKGGYDGKC----DIWALGITAIEL 197
Query: 704 VYGRTPFSEYKTFWAKFKVITDPNHEITYEPVPNPWLLD----------LMKKCLAWDRN 753
+ P + A F I+ P P L D +KKCL D
Sbjct: 198 AELQPPMFDLHPMRALFL--------ISKSNFPPPKLKDKEKWSPVFHDFIKKCLTKDPK 249
Query: 754 ERWRIPQLLQHPF 766
+R +LLQHPF
Sbjct: 250 KRPTATKLLQHPF 262
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 87.6 bits (217), Expect = 5e-19
Identities = 50/178 (28%), Positives = 88/178 (49%), Gaps = 25/178 (14%)
Query: 599 ENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLLVKGS---LKLIDFGIAKAIMSDTTN 655
E + Y +Q+L ++ +HE +I+H D+K AN LL+ + L++ DFG A + + T
Sbjct: 102 EAVIINYTEQLLRGLSYLHENQIIHRDVKGAN-LLIDSTGQRLRIADFGAAARLAAKGTG 160
Query: 656 IQ--RDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGRTPFSEY 713
+ +GT+++M+PE E GR D+WS+GC++ +M + P++
Sbjct: 161 AGEFQGQLLGTIAFMAPEVL----RGEQ-----YGRSCDVWSVGCVIIEMATAKPPWNAE 211
Query: 714 KT---FWAKFKVITDPNHEITYEPVP---NPWLLDLMKKCLAWDRNERWRIPQLLQHP 765
K FK+ + T +P +P L D+ +CL +R +LL+HP
Sbjct: 212 KHSNHLALIFKIAS----ATTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLKHP 265
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 87.8 bits (217), Expect = 5e-19
Identities = 49/173 (28%), Positives = 93/173 (53%), Gaps = 8/173 (4%)
Query: 596 TLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLLVKGS-LKLIDFGIAKAIMSDTT 654
TL E W+ + ++IL ++ +H+ +++H D+K N LL + + +KL+DFG++ + D T
Sbjct: 107 TLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQL--DRT 164
Query: 655 NIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGRTPFSEYK 714
+R++ +GT +M+PE C+E+ + K SD+WSLG +M G P +
Sbjct: 165 VGRRNTFIGTPYWMAPEVIACDENPDATYDFK----SDLWSLGITAIEMAEGAPPLCDMH 220
Query: 715 TFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQHPFL 767
A F + +P + + + ++ CL + ++R QL++HPF+
Sbjct: 221 PMRALFLIPRNPAPRLKSKKWSKKF-QSFIESCLVKNHSQRPTTEQLMKHPFI 272
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 87.4 bits (216), Expect = 5e-19
Identities = 61/177 (34%), Positives = 92/177 (51%), Gaps = 23/177 (12%)
Query: 597 LDENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLL-VKGSLKLIDFGIAKAIMS---D 652
L EN R Y +QIL+ V+ +H IVH D+K AN L G++KL DFG +K I +
Sbjct: 103 LTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMS 162
Query: 653 TTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGRTPFSE 712
T I+ S GT +MSPE +G GR +D+WS+ C + +M+ + P++E
Sbjct: 163 GTGIK--SVTGTPYWMSPEVI-------SGE--GYGRKADVWSVACTVVEMLTEKPPWAE 211
Query: 713 YKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIP---QLLQHPF 766
Y+ A FK+ T P + + V + D +K+ ++ R P LL+HPF
Sbjct: 212 YEAMAAIFKIATQPTKPMLPDGVSDA-CRDFLKQIFVEEK----RRPTAEFLLRHPF 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 88.5 bits (220), Expect = 6e-19
Identities = 87/361 (24%), Positives = 138/361 (38%), Gaps = 113/361 (31%)
Query: 473 LYQRLGKIGSGGSSEVHKVIS---SDCTIYALKKIKLKGRDYATAYGF----CQEIEYLN 525
Y+ G IG G V+K D YA+KK K Y G C+EI L
Sbjct: 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYT---GISQSACREIALLR 57
Query: 526 KLKGKNNIIQLIDYEVTEKALLREVLNGSMNNKDGRVKDDGYIYMVLEYGEIDLAHMLSQ 585
+LK +N ++ L EV + + D V Y++ +Y E DL ++
Sbjct: 58 ELKHEN-VVSL-----------VEVF---LEHADKSV------YLLFDYAEHDLWQII-- 94
Query: 586 KWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLLV-----KGSLKL 640
K+ + + ++ QIL V+ +H ++H DLKPAN L++ +G +K+
Sbjct: 95 KFHRQAKRVS-IPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKI 153
Query: 641 IDFGIA-------KAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCG----- 688
D G+A K + D V T+ Y +PE + G
Sbjct: 154 GDLGLARLFNAPLKPLADL------DPVVVTIWYRAPELLL-------------GARHYT 194
Query: 689 RPSDIWSLGCILYQMV------YGR-------TPFS------------------------ 711
+ DIW++GCI +++ GR PF
Sbjct: 195 KAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERIFEVLGTPTEKDWPDIKK 254
Query: 712 --EYKTFWAKFKVITDPNHEIT--YEPV--PNPWLLDLMKKCLAWDRNERWRIPQLLQHP 765
EY T FK T P++ + E P+ DL++K L +D +R + L+HP
Sbjct: 255 MPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEHP 314
Query: 766 F 766
+
Sbjct: 315 Y 315
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 88.6 bits (219), Expect = 6e-19
Identities = 56/152 (36%), Positives = 84/152 (55%), Gaps = 18/152 (11%)
Query: 563 KDDGYIYMVLEY---GEIDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEE 619
+D+ +Y+V++Y G DL +LS+ L E+ RFY +++ A++++H+
Sbjct: 71 QDENNLYLVMDYYVGG--DLLTLLSK-------FEDRLPEDMARFYLAEMVIAIDSVHQL 121
Query: 620 RIVHSDLKPANFLL-VKGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNES 678
VH D+KP N L+ + G ++L DFG +M D T +Q VGT Y+SPE E
Sbjct: 122 HYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGT-VQSSVAVGTPDYISPEILQAME- 179
Query: 679 DENGNIIKCGRPSDIWSLGCILYQMVYGRTPF 710
D G K G D WSLG +Y+M+YG TPF
Sbjct: 180 DGKG---KYGPECDWWSLGVCMYEMLYGETPF 208
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 87.4 bits (217), Expect = 7e-19
Identities = 82/325 (25%), Positives = 135/325 (41%), Gaps = 74/325 (22%)
Query: 474 YQRLGKIGSGGSSEVHKVISSDC-TIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNN 532
Y++L KIG G V K + + I A+KK D +EI L +LK N
Sbjct: 3 YEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLK-HPN 61
Query: 533 IIQLIDYEVTEKALLREVLNGSMNNKDGRVKDDGYIYMVLEYGEIDLAHMLSQKWKEMDG 592
++ LI EV + K +++V EY + + + E++
Sbjct: 62 LVNLI--EVFRR-----------KRK---------LHLVFEYCDHTVLN-------ELEK 92
Query: 593 SNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLLVK-GSLKLIDFGIAKAIMS 651
+ + + E+ ++ Q L+AVN H+ +H D+KP N L+ K G +KL DFG A+ I++
Sbjct: 93 NPRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQGQIKLCDFGFAR-ILT 151
Query: 652 DTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYG----- 706
+ D V T Y +PE + + + G P D+W++GC+ +++ G
Sbjct: 152 GPGDDYTD-YVATRWYRAPELLVGD--------TQYGPPVDVWAIGCVFAELLTGQPLWP 202
Query: 707 ----------------------RTPFSEYKTFWAKFKVITDPNHEITYE---PVPNPWLL 741
+ FS + F K I +P E P + L
Sbjct: 203 GKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFF--KGLSIPEPETREPLESKFPNISSPAL 260
Query: 742 DLMKKCLAWDRNERWRIPQLLQHPF 766
+K CL D ER +LL+HP+
Sbjct: 261 SFLKGCLQMDPTERLSCEELLEHPY 285
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 87.0 bits (215), Expect = 1e-18
Identities = 75/244 (30%), Positives = 110/244 (45%), Gaps = 45/244 (18%)
Query: 471 GKL--YQRLGKIGSGGSSEVHKVISS-DCTIYALKKIKLKGRDYATAYGFCQEIEYLNKL 527
GKL Y +L K+G G + V K S + ALK+I+L+ + A +E+ L L
Sbjct: 2 GKLETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAI-REVSLLKNL 60
Query: 528 KGKNNIIQLIDYEVTEKALLREVLNGSMNNKDGRVKDDGYIYMVLEYGEIDLAHMLSQKW 587
K NI+ L D TE+ L +V EY + DL L
Sbjct: 61 K-HANIVTLHDIIHTERCLT----------------------LVFEYLDSDLKQYLDNCG 97
Query: 588 KEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLL-VKGSLKLIDFGIA 646
M N ++ + Q+L ++ H+ +I+H DLKP N L+ KG LKL DFG+A
Sbjct: 98 NLMSMHN-------VKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKGELKLADFGLA 150
Query: 647 KAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYG 706
+A T ++V TL Y P+ + + + P D+W +GCILY+M G
Sbjct: 151 RAKSVPTKTYS--NEVVTLWYRPPDVLLGS--------TEYSTPIDMWGVGCILYEMATG 200
Query: 707 RTPF 710
R F
Sbjct: 201 RPMF 204
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 87.1 bits (216), Expect = 1e-18
Identities = 86/332 (25%), Positives = 142/332 (42%), Gaps = 76/332 (22%)
Query: 474 YQRLGKIGSGGSSEVHKVISSDC-TIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNN 532
+ +G+IG G +V+K D + ALKK++L +EI+ L +L +N
Sbjct: 9 FDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRN- 67
Query: 533 IIQLIDYEVTEKALLREVLNGSMNNKDGRVKDDGYIYMVLEYGEIDLAHMLSQKWKEMDG 592
I+ L + VT+K +++ K KD G Y+V EY + DL +L
Sbjct: 68 IVNLKEI-VTDK-------QDALDFK----KDKGAFYLVFEYMDHDLMGLLESGL----- 110
Query: 593 SNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLL-VKGSLKLIDFGIAKAIMS 651
E+ ++ + +Q+LE +N H++ +H D+K +N LL KG +KL DFG+A+ S
Sbjct: 111 --VHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNS 168
Query: 652 DT----TNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGR 707
+ TN +V TL Y PE + E + G D+WS GCIL ++ + +
Sbjct: 169 EESRPYTN-----KVITLWYRPPELLLGEE--------RYGPAIDVWSCGCILGEL-FTK 214
Query: 708 TPFSEYKTFWAKFKVITDPNHEITYEPVPNPW---------------------------- 739
P + A+ ++I+ + P P W
Sbjct: 215 KPIFQANQELAQLELIS----RLCGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSF 270
Query: 740 ----LLDLMKKCLAWDRNERWRIPQLLQHPFL 767
LDL+ L D ++R + L P+L
Sbjct: 271 IPTPALDLLDHMLTLDPSKRCTAEEALNSPWL 302
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 86.2 bits (213), Expect = 2e-18
Identities = 52/177 (29%), Positives = 86/177 (48%), Gaps = 13/177 (7%)
Query: 595 QTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLLV-KGSLKLIDFGIAKAIMSDT 653
Q LDE + + L + +H RI+H D+K N LL +G +KL+DFG++ + S
Sbjct: 123 QRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTS-- 180
Query: 654 TNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGRTPFSEY 713
T ++R++ VGT +M+PE C + + +C D+WSLG ++ G P +
Sbjct: 181 TRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARC----DVWSLGITAIELGDGDPPLFDM 236
Query: 714 KTFWAKFKVITDPNHEITYEPVPNPWLLD---LMKKCLAWDRNERWRIPQLLQHPFL 767
FK+ +P + + P W + +CL D R + LL+HPF+
Sbjct: 237 HPVKTLFKIPRNPPPTLLH---PEKWCRSFNHFISQCLIKDFEARPSVTHLLEHPFI 290
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 85.9 bits (213), Expect = 2e-18
Identities = 53/164 (32%), Positives = 92/164 (56%), Gaps = 12/164 (7%)
Query: 609 ILEAVNTIHEE-RIVHSDLKPANFLLVK-GSLKLIDFGIAKAIMSDTTNIQRDSQVGTLS 666
I++A+ +H + ++H D+KP+N L+ + G +KL DFGI+ ++ + + G
Sbjct: 112 IVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDS---VAKTIDAGCKP 168
Query: 667 YMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGRTPFSEYKTFWAKFK-VITD 725
YM+PE + E ++ G +K SD+WSLG + ++ GR P+ +KT + + K V+ +
Sbjct: 169 YMAPER-INPELNQKGYDVK----SDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEE 223
Query: 726 PNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQHPFLVP 769
P+ ++ E +P D + KCL + ER P+LLQHPF
Sbjct: 224 PSPQLPAEKF-SPEFQDFVNKCLKKNYKERPNYPELLQHPFFEL 266
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 85.4 bits (211), Expect = 2e-18
Identities = 79/300 (26%), Positives = 138/300 (46%), Gaps = 50/300 (16%)
Query: 474 YQRLGKIGSGGSSEVHKVI-SSDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNN 532
Y + +G G EV V +D Y +KK+ L+ QE + L++LK N
Sbjct: 2 YCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPN- 60
Query: 533 IIQLIDYEVTEKALLREVLNGSMNNKDGRVKDDGYIYMVLEYGEI-DLAHMLSQKWKEMD 591
++ Y RE G +DG +Y+V+ + E DL H L ++ ++
Sbjct: 61 ---IVAY--------RESWEG----------EDGLLYIVMGFCEGGDLYHKLKEQKGKLL 99
Query: 592 GSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLLVKGS-LKLIDFGIAKAIM 650
NQ ++ ++ QI A+ +HE+ I+H DLK N L + + +K+ D GIA+ +
Sbjct: 100 PENQVVE------WFVQIAMALQYLHEKHILHRDLKTQNVFLTRTNIIKVGDLGIARVL- 152
Query: 651 SDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGRTPF 710
+ + +GT YMSPE F S++ N SD+W+LGC +Y+M + F
Sbjct: 153 -ENQCDMASTLIGTPYYMSPELF----SNKPYNY-----KSDVWALGCCVYEMATLKHAF 202
Query: 711 SEYKTFWAKFKVITDPNHEITYEPVP---NPWLLDLMKKCLAWDRNERWRIPQLLQHPFL 767
+ +++I E P+P +P L +L+ L+ +R + +L+ P++
Sbjct: 203 NAKDMNSLVYRII-----EGKLPPMPKDYSPELGELIATMLSKRPEKRPSVKSILRQPYI 257
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 85.8 bits (212), Expect = 3e-18
Identities = 83/302 (27%), Positives = 124/302 (41%), Gaps = 68/302 (22%)
Query: 474 YQRLGKIGSGGSSEVHKVISS-DCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNN 532
Y L K+G G + V+K IS + + ALK I +K + + +E L LK N
Sbjct: 7 YLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEE-GVPFTAIREASLLKGLK-HAN 64
Query: 533 IIQLIDYEVTEKALLREVLNGSMNNKDGRVKDDGYIYMVLEYGEIDLAHMLSQKWKEMDG 592
I+ L D T++ L V EY DLA + Q +
Sbjct: 65 IVLLHDIIHTKETLT----------------------FVFEYMHTDLAQYMIQHPGGLHP 102
Query: 593 SNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLLVK-GSLKLIDFGIA--KAI 649
N +R + Q+L + IH + I+H DLKP N L+ G LKL DFG+A K+I
Sbjct: 103 YN-------VRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYLGELKLADFGLARAKSI 155
Query: 650 MSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGRTP 709
S T + S+V TL Y P+ + +D + + DIW GCI +M+ G+
Sbjct: 156 PSQTYS----SEVVTLWYRPPDVLL-GATDYSSAL-------DIWGAGCIFIEMLQGQPA 203
Query: 710 FS-------EYKTFWAKFKVITD---------PNHEITYEPVPNPWLLDLMKKCLAWDRN 753
F + + W V T+ PN++ + P L ++ W R
Sbjct: 204 FPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPNYKPEWFLPCKPQQLRVV-----WKRL 258
Query: 754 ER 755
R
Sbjct: 259 SR 260
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 85.9 bits (213), Expect = 4e-18
Identities = 84/335 (25%), Positives = 138/335 (41%), Gaps = 74/335 (22%)
Query: 474 YQRLGKIGSGGSSEVHKVISSDCT-IYALKKIKL-KGRDYATAYGFCQEIEYLNKLKGKN 531
+++L +IG G V++ + I ALKK+++ RD +EI L L+ N
Sbjct: 9 FEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSL-REITLLLNLRHPN 67
Query: 532 NIIQLIDYEVTEKALLREVLNGSMNNKDGRVKDDGYIYMVLEYGEIDLAHMLSQKWKEMD 591
I++L +EV+ G + I++V+EY E DLA +L D
Sbjct: 68 -IVEL-----------KEVVVGKHLDS---------IFLVMEYCEQDLASLL-------D 99
Query: 592 GSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLLV-KGSLKLIDFGIAKAIM 650
E+ ++ Q+L + +HE I+H DLK +N LL KG LK+ DFG+A+
Sbjct: 100 NMPTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYG 159
Query: 651 SDTTNIQRDSQVGTLSYMSPEA-FMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGRTP 709
+V TL Y +PE C D+W++GCIL +++ + P
Sbjct: 160 LPAK--PMTPKVVTLWYRAPELLLGCTTYT---------TAIDMWAVGCILAELLAHK-P 207
Query: 710 FSEYKTFWAKFKVITD----PNHEI--TYEPVPN------------------PWL----L 741
K+ + +I PN I + +P PWL L
Sbjct: 208 LLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGL 267
Query: 742 DLMKKCLAWDRNERWRIPQLLQHPFLV-PPVSTQP 775
L+ L +D +R + L+ + P+ +P
Sbjct: 268 RLLNFLLMYDPKKRATAEEALESSYFKEKPLPCEP 302
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 86.0 bits (213), Expect = 6e-18
Identities = 88/350 (25%), Positives = 145/350 (41%), Gaps = 68/350 (19%)
Query: 471 GKLYQRLGKIGSGGSSEVHKVISSDCTI-YALKKIKLKGRDYATAYGFCQEIEYLNKLKG 529
G Y L +G G + V + SDC A+KKI L D + +EI+ + +L
Sbjct: 4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLT--DPQSVKHALREIKIIRRLD- 60
Query: 530 KNNIIQLIDYEVTEKALLREVLNGSMNNKDGRVKDD-GYIYMVLEYGEIDLAHMLSQKWK 588
+NI+++ YEV + GS +D + +Y+V EY E DLA++L Q
Sbjct: 61 HDNIVKV--YEVLGPS-------GSDLTEDVGSLTELNSVYIVQEYMETDLANVLEQ--- 108
Query: 589 EMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLLVKGS--LKLIDFGIA 646
L E R + Q+L + IH ++H DLKPAN + LK+ DFG+A
Sbjct: 109 ------GPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIGDFGLA 162
Query: 647 KAIMSDTTNIQRDSQ-VGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVY 705
+ + ++ S+ + T Y SP + S N + D+W+ GCI +M+
Sbjct: 163 RIVDPHYSHKGYLSEGLVTKWYRSPRLLL---SPNNYT-----KAIDMWAAGCIFAEMLT 214
Query: 706 GRTPFS---EYKTFWAKFKVI-------------TDPNHEITYEPVP-----------NP 738
G+ F+ E + + + P+ P NP
Sbjct: 215 GKPLFAGAHELEQMQLILESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNP 274
Query: 739 WLLDLMKKCLAWDRNERWRIPQLLQHPFLVP-------PVSTQPSSSQDQ 781
LD +++ L ++ +R + L HP++ PVS P +D+
Sbjct: 275 EALDFLEQILTFNPMDRLTAEEALMHPYMSCYSCPFDEPVSLHPFHIEDE 324
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 85.8 bits (213), Expect = 6e-18
Identities = 96/350 (27%), Positives = 144/350 (41%), Gaps = 88/350 (25%)
Query: 471 GKLYQRLGKIGSGG----SSEVHKVISSDCTIYALKKIKLKGRDYATAYGFCQ----EIE 522
G YQ L IG G S HK A+KKI ++ T FCQ EI+
Sbjct: 4 GPRYQNLSYIGEGAYGMVCSATHKPTG---VKVAIKKIS--PFEHQT---FCQRTLREIK 55
Query: 523 YLNKLKGKNNIIQLIDYEVTEKALLREVLNGSMNNKDGRVKDDGYIYMVLEYGEIDLAHM 582
L + K NII ++D ++R S N+ +Y+V E E DL +
Sbjct: 56 ILRRFK-HENIIGILD-------IIRPPSFESFND----------VYIVQELMETDLYKL 97
Query: 583 LSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLLVKG-SLKLI 641
+ Q L + ++++ QIL + IH ++H DLKP+N LL LK+
Sbjct: 98 IK---------TQHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKIC 148
Query: 642 DFGIAKAIMSDTTNIQRDSQ-VGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCIL 700
DFG+A+ + + ++ V T Y +PE M N I DIWS+GCIL
Sbjct: 149 DFGLARIADPEHDHTGFLTEYVATRWYRAPE-IMLNSKGYTKAI-------DIWSVGCIL 200
Query: 701 YQMVYGRTPF--SEYK-TFWAKFKVITDPNHE----IT-------------YEPVP---- 736
+M+ R F +Y V+ P+ E I VP
Sbjct: 201 AEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCIISLRARNYIKSLPFKPKVPWNKL 260
Query: 737 ----NPWLLDLMKKCLAWDRNERWRIPQLLQHPFLVP-------PVSTQP 775
+P LDL+ K L ++ ++R + + L HP+L PV+ +P
Sbjct: 261 FPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYHDPSDEPVAEEP 310
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 84.8 bits (209), Expect = 8e-18
Identities = 53/172 (30%), Positives = 84/172 (48%), Gaps = 12/172 (6%)
Query: 597 LDENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLL-VKGSLKLIDFGIAKAIMSDTTN 655
+DE + ++ L+A+ +H +++H D+K N LL + GS+KL DFG I + +
Sbjct: 112 MDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQS- 170
Query: 656 IQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGRTPFSEYKT 715
+R + VGT +M+PE G DIWSLG + +MV G P+
Sbjct: 171 -KRSTMVGTPYWMAPEVVTRKAY---------GPKVDIWSLGIMAIEMVEGEPPYLNENP 220
Query: 716 FWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQHPFL 767
A + + T+ E+ +P D + +CL D +R +LLQHPFL
Sbjct: 221 LRALYLIATNGTPELQNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQHPFL 272
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 84.6 bits (209), Expect = 9e-18
Identities = 77/305 (25%), Positives = 125/305 (40%), Gaps = 60/305 (19%)
Query: 472 KLYQRLGKIGSGGSSEVHKVI-SSDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGK 530
K Y R KIG G S V+ I + A+K++ L+ EI + + K
Sbjct: 19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQ--QQPKKELIINEILVMRENKHP 76
Query: 531 NNIIQLIDYEVTEKALLREVLNGSMNNKDGRVKDDGYIYMVLEYGEIDLAHMLSQKWKEM 590
N + L Y V ++ +++V+EY +
Sbjct: 77 NIVNYLDSYLVGDE-----------------------LWVVMEY---------------L 98
Query: 591 DGSNQT-------LDENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLL-VKGSLKLID 642
G + T +DE + ++ L+A+ +H +++H D+K N LL + GS+KL D
Sbjct: 99 AGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTD 158
Query: 643 FGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQ 702
FG I + + +R + VGT +M+PE G DIWSLG + +
Sbjct: 159 FGFCAQITPEQS--KRSTMVGTPYWMAPEVVTRKAY---------GPKVDIWSLGIMAIE 207
Query: 703 MVYGRTPFSEYKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLL 762
MV G P+ A + + T+ E+ + D + +CL D +R +LL
Sbjct: 208 MVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELL 267
Query: 763 QHPFL 767
QHPFL
Sbjct: 268 QHPFL 272
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 83.3 bits (206), Expect = 1e-17
Identities = 83/306 (27%), Positives = 144/306 (47%), Gaps = 63/306 (20%)
Query: 474 YQRLGKIGSGGSSEVHKVIS-SDCTIYALKKIKL-----KGRDYATAYGFCQEIEYLNKL 527
Y ++ KIG G + V S D Y +K+I + K R+ + +E+ L+ +
Sbjct: 2 YVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESR-----KEVAVLSNM 56
Query: 528 KGKNNIIQLIDYEVTEKALLREVLNGSMNNKDGRVKDDGYIYMVLEYGEI-DLAHMLSQK 586
K NI+Q +E +++G +Y+V++Y E DL ++ +
Sbjct: 57 K-HPNIVQY-----------QESF-----------EENGNLYIVMDYCEGGDLYKKINAQ 93
Query: 587 WKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLLVK-GSLKLIDFGI 645
+ +Q LD ++ QI A+ +H+ +I+H D+K N L K G++KL DFGI
Sbjct: 94 RGVLFPEDQILD------WFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGI 147
Query: 646 AKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVY 705
A+ +++ T + R + +GT Y+SPE +C N SDIW+LGC+LY+M
Sbjct: 148 AR-VLNSTVELAR-TCIGTPYYLSPE--ICENRPYNNK-------SDIWALGCVLYEMCT 196
Query: 706 GRTPFSEYKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLA--WDRNERWR--IPQL 761
+ F K+I +Y PV + + DL + ++ + RN R R + +
Sbjct: 197 LKHAFEAGNMKNLVLKIIRG-----SYPPVSSHYSYDL-RNLVSQLFKRNPRDRPSVNSI 250
Query: 762 LQHPFL 767
L+ F+
Sbjct: 251 LEKNFI 256
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 83.6 bits (207), Expect = 2e-17
Identities = 49/173 (28%), Positives = 81/173 (46%), Gaps = 15/173 (8%)
Query: 607 QQILEAVNTIHEERIVHSDLKPANFLLVK-GSLKLIDFGIAKAIMSDTTNIQRDSQVGTL 665
+L+A++ +H + ++H D+K + LL G +KL DFG + + +R S VGT
Sbjct: 122 LAVLKALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVP--RRKSLVGTP 179
Query: 666 SYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGRTPFSEYKTFWAKFKVITD 725
+M+PE + + G DIWSLG ++ +MV G P+ A ++ +
Sbjct: 180 YWMAPEVI---------SRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDN 230
Query: 726 PNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQHPFLV---PPVSTQP 775
++ +P L + + L D +R +LL HPFL PP S P
Sbjct: 231 LPPKLKNLHKVSPRLRSFLDRMLVRDPAQRATAAELLNHPFLAKAGPPSSIVP 283
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 83.5 bits (206), Expect = 2e-17
Identities = 48/172 (27%), Positives = 89/172 (51%), Gaps = 7/172 (4%)
Query: 597 LDENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLLV-KGSLKLIDFGIAKAIMSDTTN 655
++E + + + L + +H + +H D+K N LL +G +KL+DFG++ + S T
Sbjct: 121 MEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTS--TR 178
Query: 656 IQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGRTPFSEYKT 715
++R++ VGT +M+PE C + ++ +C D+WSLG ++ G P ++
Sbjct: 179 LRRNTSVGTPFWMAPEVIACEQQLDSTYDARC----DVWSLGITAIELGDGDPPLADLHP 234
Query: 716 FWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQHPFL 767
A FK+ +P + + + D ++KCL D +R + LLQH F+
Sbjct: 235 MRALFKIPRNPPPTLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVFI 286
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 82.8 bits (204), Expect = 2e-17
Identities = 65/195 (33%), Positives = 99/195 (50%), Gaps = 17/195 (8%)
Query: 577 IDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLL-VK 635
I + HM K+ S L EN R Y +QILE V+ +H IVH D+K AN L
Sbjct: 83 IFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSV 142
Query: 636 GSLKLIDFGIAKAIMS---DTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSD 692
G++KL DFG +K + + T ++ S GT +MSPE S E GR +D
Sbjct: 143 GNVKLGDFGASKRLQTICLSGTGMK--SVTGTPYWMSPEVI----SGEG-----YGRKAD 191
Query: 693 IWSLGCILYQMVYGRTPFSEYKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDR 752
IWS+GC + +M+ + P++E++ A FK+ T P + + P + D +K+ +
Sbjct: 192 IWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPV-LPPHVSDHCRDFLKRIFV-EA 249
Query: 753 NERWRIPQLLQHPFL 767
R +LL+H F+
Sbjct: 250 KLRPSADELLRHTFV 264
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 83.1 bits (205), Expect = 2e-17
Identities = 55/204 (26%), Positives = 103/204 (50%), Gaps = 13/204 (6%)
Query: 565 DGYIYMVLEYGEIDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHS 624
D +++V+E+ L + K L E+W+ + ++IL + +H +++H
Sbjct: 91 DDQLWLVMEFCGAGSVTDLVKNTK-----GNALKEDWIAYICREILRGLAHLHAHKVIHR 145
Query: 625 DLKPANFLLVKGS-LKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGN 683
D+K N LL + + +KL+DFG++ + D T +R++ +GT +M+PE C+E+ +
Sbjct: 146 DIKGQNVLLTENAEVKLVDFGVSAQL--DRTVGRRNTFIGTPYWMAPEVIACDENPDATY 203
Query: 684 IIKCGRPSDIWSLGCILYQMVYGRTPFSEYKTFWAKFKVITDPNHEITYEPVPNPWLLDL 743
+ SDIWSLG +M G P + A F + +P ++ + + +D
Sbjct: 204 DYR----SDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPPPKLKSKKWSKKF-IDF 258
Query: 744 MKKCLAWDRNERWRIPQLLQHPFL 767
++ CL + R QLL+HPF+
Sbjct: 259 IEGCLVKNYLSRPSTEQLLKHPFI 282
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 82.3 bits (203), Expect = 3e-17
Identities = 58/187 (31%), Positives = 89/187 (47%), Gaps = 17/187 (9%)
Query: 583 LSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLLVKGSLKLID 642
L K +E+ + +TL EN + ++ Q+L V+ +H+ RI+H DLK N L LK+ D
Sbjct: 89 LDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKNNLLKIGD 148
Query: 643 FGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQ 702
FG+++ +M + GT YMSPEA D SDIWSLGCILY+
Sbjct: 149 FGVSRLLMGSCD--LATTFTGTPYYMSPEALKHQGYDSK---------SDIWSLGCILYE 197
Query: 703 MVYGRTPFSEYKTFWAKFKVITDPNHEI--TYEPVPNPWLLDLMKKCLAWDRNERWRIPQ 760
M F +++ P + TY N +M+ L D + R +
Sbjct: 198 MCCLAHAFEGQNFLSVVLRIVEGPTPSLPETYSRQLNS----IMQSMLNKDPSLRPSAAE 253
Query: 761 LLQHPFL 767
+L++PF+
Sbjct: 254 ILRNPFI 260
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 82.4 bits (203), Expect = 3e-17
Identities = 63/177 (35%), Positives = 91/177 (51%), Gaps = 23/177 (12%)
Query: 597 LDENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLL-VKGSLKLIDFGIAK---AIMSD 652
L E+ R Y +QILE ++ +H IVH D+K AN L G++KL DFG +K I
Sbjct: 103 LTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMS 162
Query: 653 TTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGRTPFSE 712
T I+ S GT +MSPE S E GR +D+WSLGC + +M+ + P++E
Sbjct: 163 GTGIR--SVTGTPYWMSPEVI----SGEG-----YGRKADVWSLGCTVVEMLTEKPPWAE 211
Query: 713 YKTFWAKFKVITDPNHEITYEPVP---NPWLLDLMKKCLAWDRNERWRIPQLLQHPF 766
Y+ A FK+ T P T +P + D + C+ + R +LL+HPF
Sbjct: 212 YEAMAAIFKIATQP----TNPQLPSHISEHARDFL-GCIFVEARHRPSAEELLRHPF 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 83.2 bits (206), Expect = 4e-17
Identities = 67/245 (27%), Positives = 108/245 (44%), Gaps = 56/245 (22%)
Query: 568 IYMVLEYGEIDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLK 627
+Y+V E + DL ++ S+QTL ++ +++ Q+L + IH ++H DLK
Sbjct: 84 VYIVYELMDTDLHQIIR--------SSQTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLK 135
Query: 628 PANFLL-VKGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIK 686
P+N LL LK+ DFG+A+ + V T Y +PE + E I
Sbjct: 136 PSNLLLNANCDLKICDFGLART--TSEKGDFMTEYVVTRWYRAPELLLN--CSEYTTAI- 190
Query: 687 CGRPSDIWSLGCILYQMVYGRTPFSEYKTFWAKFKVITD----PNHE----ITYE----- 733
D+WS+GCI +++ GR P K + + K+IT+ P+ E I E
Sbjct: 191 -----DVWSVGCIFAELL-GRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRNEKARRY 244
Query: 734 ----------------PVPNPWLLDLMKKCLAWDRNERWRIPQLLQHPFLVP-------P 770
P NP +DL++K L +D ++R + + L HP+L P
Sbjct: 245 IRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLHDPSDEP 304
Query: 771 VSTQP 775
V P
Sbjct: 305 VCQTP 309
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 82.4 bits (203), Expect = 4e-17
Identities = 74/244 (30%), Positives = 114/244 (46%), Gaps = 45/244 (18%)
Query: 471 GKL--YQRLGKIGSGGSSEVHKVISSDC-TIYALKKIKLKGRDYATAYGFCQEIEYLNKL 527
GKL Y +L K+G G + V+K S + ALK+I+L+ + A +E+ L L
Sbjct: 3 GKLETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAI-REVSLLKDL 61
Query: 528 KGKNNIIQLIDYEVTEKALLREVLNGSMNNKDGRVKDDGYIYMVLEYGEIDLAHMLSQKW 587
K NI+ L D TEK+L +V EY + DL L
Sbjct: 62 K-HANIVTLHDIIHTEKSLT----------------------LVFEYLDKDLKQYL---- 94
Query: 588 KEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLL-VKGSLKLIDFGIA 646
D +++ + ++ + Q+L +N H +++H DLKP N L+ +G LKL DFG+A
Sbjct: 95 ---DDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLA 151
Query: 647 KAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYG 706
+A T ++V TL Y P+ + +D + I D+W +GCI Y+M G
Sbjct: 152 RAKSIPTKTYS--NEVVTLWYRPPDILL-GSTDYSTQI-------DMWGVGCIFYEMSTG 201
Query: 707 RTPF 710
R F
Sbjct: 202 RPLF 205
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 82.0 bits (203), Expect = 5e-17
Identities = 51/182 (28%), Positives = 93/182 (51%), Gaps = 22/182 (12%)
Query: 594 NQTLDENWLRFYWQQILEAVNTIHEE-RIVHSDLKPANFLL-VKGSLKLIDFGIAKAIMS 651
+ E L ++A+N + EE +I+H D+KP+N LL G++KL DFGI+ ++
Sbjct: 101 KSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVD 160
Query: 652 DTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGRTPFS 711
+I + G YM+PE + S +G ++ SD+WSLG LY++ G+ P+
Sbjct: 161 ---SIAKTRDAGCRPYMAPERI--DPSARDGYDVR----SDVWSLGITLYEVATGKFPYP 211
Query: 712 EYKTFWAKFKV-------ITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQH 764
++ + + + I + E + +P ++ + CL D ++R + +LL+H
Sbjct: 212 KWNSVFDQLTQVVKGDPPILSNSEEREF----SPSFVNFINLCLIKDESKRPKYKELLEH 267
Query: 765 PF 766
PF
Sbjct: 268 PF 269
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 82.1 bits (202), Expect = 5e-17
Identities = 52/172 (30%), Positives = 84/172 (48%), Gaps = 12/172 (6%)
Query: 597 LDENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLL-VKGSLKLIDFGIAKAIMSDTTN 655
+DE + ++ L+A++ +H +++H D+K N LL + GS+KL DFG I + +
Sbjct: 112 MDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS- 170
Query: 656 IQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGRTPFSEYKT 715
+R + VGT +M+PE G DIWSLG + +MV G P+
Sbjct: 171 -KRSTMVGTPYWMAPEVVTRKAY---------GPKVDIWSLGIMAIEMVEGEPPYLNENP 220
Query: 716 FWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQHPFL 767
A + + T+ E+ + D + +CL D + R +LLQHPFL
Sbjct: 221 LRALYLIATNGTPELQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQHPFL 272
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 82.0 bits (203), Expect = 6e-17
Identities = 43/150 (28%), Positives = 74/150 (49%), Gaps = 10/150 (6%)
Query: 621 IVHSDLKPANFLL-VKGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESD 679
++H D+KP+N LL G++KL DFGI+ ++ + G +YM+PE + +
Sbjct: 136 VIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKA---KTRSAGCAAYMAPERIDPPDPN 192
Query: 680 ENGNIIKCGRPSDIWSLGCILYQMVYGRTPFSEYKT-FWAKFKVITDPNHEITYEPVPNP 738
+I +D+WSLG L ++ G+ P+ KT F K++ + + +P
Sbjct: 193 PKYDI-----RADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEPPSLPPNEGFSP 247
Query: 739 WLLDLMKKCLAWDRNERWRIPQLLQHPFLV 768
+ CL D +R + +LLQHPF+
Sbjct: 248 DFCSFVDLCLTKDHRKRPKYRELLQHPFIR 277
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 81.3 bits (201), Expect = 9e-17
Identities = 74/305 (24%), Positives = 120/305 (39%), Gaps = 53/305 (17%)
Query: 477 LGKIGSGGSSEVHKV-ISSDCTIYALKKIKLKGRDYATAY--GFCQEIEYLNKLKGKNNI 533
L ++G G V K + + I+ALK I D +E+E K I
Sbjct: 6 LSRLGEGAGGSVTKCRLKNTGMIFALKTIT---TDPNPDLQKQILRELEINKSCK-SPYI 61
Query: 534 IQLIDYEVTEKALLREVLNGSMNNKDGRVKDDGYIYMVLEYGEIDLAHMLSQKWKEMDGS 593
++ + E I + +EY E L +K++
Sbjct: 62 VKYYGAFLDES--------------------SSSIGIAMEYCE---GGSLDSIYKKVKKR 98
Query: 594 NQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLLV-KGSLKLIDFGIAKAIMSD 652
+ E L + +L+ ++ +H +I+H D+KP+N LL KG +KL DFG++ +
Sbjct: 99 GGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVS----GE 154
Query: 653 TTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGRTPFSE 712
N + GT YM+PE + +I SD+WSLG L ++ R PF
Sbjct: 155 LVNSLAGTFTGTSFYMAPERI----QGKPYSI-----TSDVWSLGLTLLEVAQNRFPFPP 205
Query: 713 YKTFWAK-----FKVITDPNHEITYEPVPN-PW---LLDLMKKCLAWDRNERWRIPQLLQ 763
++ PN E+ EP W D +K+CL D R +L+
Sbjct: 206 EGEPPLGPIELLSYIVNMPNPELKDEPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLE 265
Query: 764 HPFLV 768
HP++
Sbjct: 266 HPWIK 270
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 79.5 bits (196), Expect = 2e-16
Identities = 62/212 (29%), Positives = 106/212 (50%), Gaps = 37/212 (17%)
Query: 564 DDGYIYMVLEYGEI-DLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIV 622
+D + +V+EY LA + ++ N LDE+ + ++ QIL A++ +H + I+
Sbjct: 70 EDKALMIVMEYAPGGTLAEYIQKR------CNSLLDEDTILHFFVQILLALHHVHTKLIL 123
Query: 623 HSDLKPANFLLVKGS--LKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDE 680
H DLK N LL K +K+ DFGI+K + S + + + VGT Y+SPE +C
Sbjct: 124 HRDLKTQNILLDKHKMVVKIGDFGISKILSSKS---KAYTVVGTPCYISPE--LCE---- 174
Query: 681 NGNIIKCGRP----SDIWSLGCILYQMVYGRTPFSEYKTFWAKFKVITDPNHEITYEPVP 736
G+P SDIW+LGC+LY++ + F K+++ T+ P+
Sbjct: 175 -------GKPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSG-----TFAPIS 222
Query: 737 N---PWLLDLMKKCLAWDRNERWRIPQLLQHP 765
+ P L L+ L D ++R ++ Q++ P
Sbjct: 223 DRYSPDLRQLILSMLNLDPSKRPQLSQIMAQP 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 80.2 bits (198), Expect = 3e-16
Identities = 56/159 (35%), Positives = 83/159 (52%), Gaps = 32/159 (20%)
Query: 567 YIYMVLEYGEI-DLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSD 625
++ MV+EY E D A +L K + L + R Y+ + + A+ +H IVH D
Sbjct: 75 HLCMVMEYVEGGDCATLL----KNIG----ALPVDMARMYFAETVLALEYLHNYGIVHRD 126
Query: 626 LKPANFLLVK-GSLKLIDFGIAK-AIMSDTTN-----IQRDS------QV-GTLSYMSPE 671
LKP N L+ G +KL DFG++K +MS TTN I++D+ QV GT Y++PE
Sbjct: 127 LKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPE 186
Query: 672 AFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGRTPF 710
+ G G+P D W++G ILY+ + G PF
Sbjct: 187 VIL-----RQGY----GKPVDWWAMGIILYEFLVGCVPF 216
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 80.4 bits (199), Expect = 4e-16
Identities = 68/256 (26%), Positives = 113/256 (44%), Gaps = 60/256 (23%)
Query: 568 IYMVLEYGEIDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLK 627
+Y+V DL +++ Q L ++ ++F QIL + IH I+H DLK
Sbjct: 95 VYLVTHLMGADLNNIVKC---------QKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLK 145
Query: 628 PANFLLVKGS-LKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIK 686
P+N + + LK++DFG+A+ + T V T Y +PE M N N +
Sbjct: 146 PSNIAVNEDCELKILDFGLARHTDDEMT-----GYVATRWYRAPE-IMLNWMHYNQTV-- 197
Query: 687 CGRPSDIWSLGCILYQMVYGRTPF--SEYKTFWAKFKVITD----PNHEI---------- 730
DIWS+GCI+ +++ G+T F S++ + K I + P+ E+
Sbjct: 198 -----DIWSVGCIMAELLTGKTLFPGSDHI---DQLKRIMNLVGTPDEELLQKISSESAR 249
Query: 731 TY-EPVP--------------NPWLLDLMKKCLAWDRNERWRIPQLLQHPFLVP---PVS 772
Y + +P NP +DL++K L D ++R + L HP+L P
Sbjct: 250 NYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYLAEYHDPED 309
Query: 773 TQPSSSQDQSYQLLQL 788
+ DQS++ L
Sbjct: 310 EPVAPPYDQSFESRDL 325
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 79.1 bits (195), Expect = 4e-16
Identities = 86/304 (28%), Positives = 126/304 (41%), Gaps = 57/304 (18%)
Query: 474 YQRLGKIGSGGSSEVHKV--ISSDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKN 531
Y L +GSG V+KV ++ + ALK+I + A+G K K
Sbjct: 2 YAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHN----PAFG-----------KDKR 46
Query: 532 NIIQLIDYEVTEKALLREVLNGSMNNKDGRV---KDDGYIYMVLEYGEIDLAHMLSQKWK 588
+ I V+E +++E L + + D YI M L G H S K K
Sbjct: 47 ERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEK 106
Query: 589 EMDGSNQTLDENWLRFYWQQILEAVNTIHEE-RIVHSDLKPANFLL-VKGSLKLIDFGIA 646
T + W F Q++ A+ +H+E RIVH DL P N +L + + DFG+A
Sbjct: 107 ---KQRFTEERIWNIFV--QMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGLA 161
Query: 647 KAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKC---GRPSDIWSLGCILYQM 703
K + S VGT+ Y PE I+K G +D+W+ GCILYQM
Sbjct: 162 K---QKQPESKLTSVVGTILYSCPE------------IVKNEPYGEKADVWAFGCILYQM 206
Query: 704 VYGRTPFSEYKTFWAKFKVITDPNHEITYEPVPNPW----LLDLMKKCLAWDRNERWRIP 759
+ PF K++ E YEP+P + D++ CL D R P
Sbjct: 207 CTLQPPFYSTNMLSLATKIV-----EAVYEPLPEGMYSEDVTDVITSCLTPDAEAR---P 258
Query: 760 QLLQ 763
++Q
Sbjct: 259 DIIQ 262
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.5 bits (199), Expect = 4e-16
Identities = 71/275 (25%), Positives = 110/275 (40%), Gaps = 73/275 (26%)
Query: 563 KDDGYIYMVLEY---GEIDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEE 619
+D+ Y+Y+++EY G D+ +L +K T E RFY + + A+++IH+
Sbjct: 71 QDENYLYLIMEYLPGG--DMMTLLMKK--------DTFTEEETRFYIAETILAIDSIHKL 120
Query: 620 RIVHSDLKPANFLL-VKGSLKLIDFGI-------------------AKAIMSDTTNIQRD 659
+H D+KP N LL KG +KL DFG+ + D +
Sbjct: 121 GYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMS 180
Query: 660 -----------------SQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQ 702
S VGT Y++PE F+ + G +C D WSLG I+Y+
Sbjct: 181 SKRKAETWKRNRRALAYSTVGTPDYIAPEVFL-----QTGYNKEC----DWWSLGVIMYE 231
Query: 703 MVYGRTPFSEYKTFWAKFKVITDPNHEITYEPVP-NPWLLDLMKK--CLAWDRNERWRIP 759
M+ G PF K+I + VP +P DL+K+ C A R +
Sbjct: 232 MLVGYPPFCSDNPQETYRKIINWKETLQFPDEVPLSPEAKDLIKRLCCEAERRLGNNGVN 291
Query: 760 QLLQHPFL-----------VPPVSTQPSSSQDQSY 783
++ HPF P+ + S D S
Sbjct: 292 EIKSHPFFKGVDWEHIRERPAPIIPELKSITDTSN 326
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.9 bits (192), Expect = 1e-15
Identities = 45/122 (36%), Positives = 64/122 (52%), Gaps = 13/122 (10%)
Query: 594 NQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLLV-KGSLKLIDFGIAKAIMSD 652
N DE FY +I + +H ERIV+ DLKP N LL G +++ D G+A I
Sbjct: 96 NPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEG 155
Query: 653 TTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGRTPFSE 712
T R VGT+ YM+PE + NE + D W LGC++Y+M+ G++PF +
Sbjct: 156 ETIRGR---VGTVGYMAPEV-VKNE--------RYTFSPDWWGLGCLIYEMIEGKSPFRQ 203
Query: 713 YK 714
K
Sbjct: 204 RK 205
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 78.7 bits (194), Expect = 1e-15
Identities = 69/244 (28%), Positives = 106/244 (43%), Gaps = 51/244 (20%)
Query: 568 IYMVLEYGEIDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLK 627
IY+V E E DL ++ +N L +F+ Q+L A+ IH + H DLK
Sbjct: 79 IYVVFELMESDLHQVI--------KANDDLTPEHHQFFLYQLLRALKYIHTANVFHRDLK 130
Query: 628 PANFLL-VKGSLKLIDFGIAKAIMSDT-TNIQRDSQVGTLSYMSPEAFMCNESDENGNII 685
P N L LK+ DFG+A+ +DT T I V T Y +PE +C G+
Sbjct: 131 PKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPE--LC------GSFF 182
Query: 686 KCGRPS-DIWSLGCILYQMVYGRTPFSEYKTFWAKFKVITD-----PNHEIT-------- 731
P+ DIWS+GCI +++ G+ P K + +ITD I+
Sbjct: 183 SKYTPAIDIWSIGCIFAEVLTGK-PLFPGKNVVHQLDLITDLLGTPSPETISRVRNEKAR 241
Query: 732 --------YEPVP--------NPWLLDLMKKCLAWDRNERWRIPQLLQHPFL--VPPVST 773
+PVP +P L L+++ LA+D +R + L P+ + V
Sbjct: 242 RYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYFKGLAKVER 301
Query: 774 QPSS 777
+PS+
Sbjct: 302 EPSA 305
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 77.5 bits (191), Expect = 2e-15
Identities = 50/151 (33%), Positives = 79/151 (52%), Gaps = 25/151 (16%)
Query: 565 DGYIYMVLEY---GEIDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERI 621
G +Y++LEY GE+ H+ E +G E+ FY +I A+ +H++ I
Sbjct: 72 GGKLYLILEYLSGGEL-FMHL------EREG---IFMEDTACFYLSEISLALEHLHQQGI 121
Query: 622 VHSDLKPANFLL-VKGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDE 680
++ DLKP N LL +G +KL DFG+ K + + + GT+ YM+PE M
Sbjct: 122 IYRDLKPENILLDAQGHVKLTDFGLCKESIHE--GTVTHTFCGTIEYMAPEILM-----R 174
Query: 681 NGNIIKCGRPSDIWSLGCILYQMVYGRTPFS 711
+G+ G+ D WSLG ++Y M+ G PF+
Sbjct: 175 SGH----GKAVDWWSLGALMYDMLTGAPPFT 201
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 2e-15
Identities = 53/147 (36%), Positives = 78/147 (53%), Gaps = 17/147 (11%)
Query: 565 DGYIYMVLEYGEIDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHS 624
DG++Y+V+EY + L QK K G + E+ + ++ Q+ V IHE+R++H
Sbjct: 70 DGHLYIVMEYCD---GGDLMQKIKLQRG--KLFPEDTILQWFVQMCLGVQHIHEKRVLHR 124
Query: 625 DLKPAN-FLLVKGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGN 683
D+K N FL G +KL DFG A+ + S + VGT Y+ PE + EN
Sbjct: 125 DIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYAC--TYVGTPYYVPPEIW------EN-- 174
Query: 684 IIKCGRPSDIWSLGCILYQMVYGRTPF 710
+ SDIWSLGCILY++ + PF
Sbjct: 175 -MPYNNKSDIWSLGCILYELCTLKHPF 200
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 77.3 bits (190), Expect = 3e-15
Identities = 71/244 (29%), Positives = 110/244 (45%), Gaps = 45/244 (18%)
Query: 471 GKL--YQRLGKIGSGGSSEVHKVISSDC-TIYALKKIKLKGRDYATAYGFCQEIEYLNKL 527
GK+ Y +L K+G G + V K S + ALK+I+L+ + A +E+ L L
Sbjct: 3 GKMETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAI-REVSLLKDL 61
Query: 528 KGKNNIIQLIDYEVTEKALLREVLNGSMNNKDGRVKDDGYIYMVLEYGEIDLAHMLSQKW 587
K NI+ L D T+K+L +V EY + DL
Sbjct: 62 K-HANIVTLHDIVHTDKSLT----------------------LVFEYLDKDLKQY----- 93
Query: 588 KEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLL-VKGSLKLIDFGIA 646
MD + + ++ + QIL + H +++H DLKP N L+ +G LKL DFG+A
Sbjct: 94 --MDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLA 151
Query: 647 KAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYG 706
+A T ++V TL Y P+ + S+ + I D+W +GCI ++M G
Sbjct: 152 RAKSVPTKTYS--NEVVTLWYRPPDVLL-GSSEYSTQI-------DMWGVGCIFFEMASG 201
Query: 707 RTPF 710
R F
Sbjct: 202 RPLF 205
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 77.1 bits (190), Expect = 3e-15
Identities = 62/246 (25%), Positives = 106/246 (43%), Gaps = 64/246 (26%)
Query: 567 YIYMVLEY---GEIDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVH 623
+++ V+EY G DL + + DE RFY +I+ + +H++ I++
Sbjct: 70 HLFFVMEYLNGG--DLMFHIQSSGR--------FDEARARFYAAEIICGLQFLHKKGIIY 119
Query: 624 SDLKPANFLLVK-GSLKLIDFGIAKAIMSDTTNIQRDSQV----GTLSYMSPEAFMCNES 678
DLK N LL K G +K+ DFG+ K N+ + + GT Y++PE +
Sbjct: 120 RDLKLDNVLLDKDGHIKIADFGMCK------ENMNGEGKASTFCGTPDYIAPEILKGQKY 173
Query: 679 DENGNIIKCGRPSDIWSLGCILYQMVYGRTPFS---EYKTFWAKFKVITDPNHEITYEPV 735
+E+ D WS G +LY+M+ G++PF E + F + ++ + P
Sbjct: 174 NES---------VDWWSFGVLLYEMLIGQSPFHGEDEDELFDSIL-------NDRPHFPR 217
Query: 736 PNPWLLDLMKKCLA--WDRNERWRI---PQLLQHPF-------------LVPPVSTQPSS 777
W+ K CL+ ++R+ R+ + QHPF + PP + S
Sbjct: 218 ---WISKEAKDCLSKLFERDPTKRLGVDGDIRQHPFFRGIDWERLEKREIPPPFKPKVKS 274
Query: 778 SQDQSY 783
D S
Sbjct: 275 PSDASN 280
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 76.3 bits (187), Expect = 5e-15
Identities = 50/172 (29%), Positives = 82/172 (47%), Gaps = 12/172 (6%)
Query: 597 LDENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLL-VKGSLKLIDFGIAKAIMSDTTN 655
+DE + ++ L+A+ +H +++H D+K N LL + GS+KL DFG I + +
Sbjct: 113 MDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS- 171
Query: 656 IQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGRTPFSEYKT 715
+R + VGT +M+PE G DIWSLG + +M+ G P+
Sbjct: 172 -KRSTMVGTPYWMAPEVVTRKAY---------GPKVDIWSLGIMAIEMIEGEPPYLNENP 221
Query: 716 FWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQHPFL 767
A + + T+ E+ + D + +CL D +R +LLQH FL
Sbjct: 222 LRALYLIATNGTPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFL 273
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 75.9 bits (187), Expect = 5e-15
Identities = 54/234 (23%), Positives = 98/234 (41%), Gaps = 26/234 (11%)
Query: 546 LLREVLNGSMNNKDGRVK------DDGYIYMVLEY-GEIDLAHMLSQKWKEMDGSNQTLD 598
L +EV S N VK +++V+ Y L ++ + G LD
Sbjct: 46 LRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPR-GG----LD 100
Query: 599 ENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLLVK-GSLKLIDFGIAKAIMSDTTNIQ 657
E + +++L+ + +H +H D+K N LL + GS+K+ DFG++ ++ +
Sbjct: 101 EAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTR 160
Query: 658 --RDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGRTPFSEYKT 715
R + VGT +M+PE +G K +DIWS G ++ G P+S+Y
Sbjct: 161 KVRKTFVGTPCWMAPEVM----EQVHGYDFK----ADIWSFGITAIELATGAAPYSKYPP 212
Query: 716 FWAKFKVITDPNHEITYEPVPNPW---LLDLMKKCLAWDRNERWRIPQLLQHPF 766
+ + + + ++ CL D ++R +LL+H F
Sbjct: 213 MKVLMLTLQNDPPSLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKHKF 266
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 76.4 bits (188), Expect = 6e-15
Identities = 68/236 (28%), Positives = 105/236 (44%), Gaps = 61/236 (25%)
Query: 568 IYMVLEYGEIDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLK 627
IY V E DL +L+ + L++ +++++ QIL + +H +VH DLK
Sbjct: 85 IYFVTELLGTDLHRLLTSR---------PLEKQFIQYFLYQILRGLKYVHSAGVVHRDLK 135
Query: 628 PANFLLVKG-SLKLIDFGIAKAIMSDTTNIQRDSQ----VGTLSYMSPEAFMCNESDENG 682
P+N L+ + LK+ DFG+A+ IQ D Q V T Y +PE + +
Sbjct: 136 PSNILINENCDLKICDFGLAR--------IQ-DPQMTGYVSTRYYRAPEIMLTWQ----- 181
Query: 683 NIIKCGRPSDIWSLGCILYQMVYGRTPFSEYKTFWAKFKVITD----PNHEIT------- 731
K DIWS GCI +M+ G+ P K +F +ITD P ++
Sbjct: 182 ---KYDVEVDIWSAGCIFAEMLEGK-PLFPGKDHVNQFSIITDLLGTPPDDVINTICSEN 237
Query: 732 ----------YEPVP--------NPWLLDLMKKCLAWDRNERWRIPQLLQHPFLVP 769
EPVP +P +DL++K L +D +R + L HP+L P
Sbjct: 238 TLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYLAP 293
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.6 bits (186), Expect = 6e-15
Identities = 68/260 (26%), Positives = 113/260 (43%), Gaps = 65/260 (25%)
Query: 473 LYQRLGKIGSGGSSEVHKVISSDC-TIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKN 531
LYQRL IG G V++ + ALK I L D + +E+ L++L+
Sbjct: 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVS-DIQREVALLSQLRQSQ 60
Query: 532 --NIIQLIDYEVTEKALLREVLNGSMNNKDGRVKDDGYIYMVLEYGEIDLAHMLSQKWKE 589
NI + G +++++EY E
Sbjct: 61 PPNITKYY----------------------GSYLKGPRLWIIMEYAE------------- 85
Query: 590 MDGSNQTL------DENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLLVK-GSLKLID 642
GS +TL E ++ +++L A+ IH+ ++H D+K AN L+ G++KL D
Sbjct: 86 -GGSVRTLMKAGPIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTNTGNVKLCD 144
Query: 643 FGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGR----PSDIWSLGC 698
FG+A + +++ +R + VGT +M+PE +I G+ +DIWSLG
Sbjct: 145 FGVAALLNQNSS--KRSTFVGTPYWMAPE------------VITEGKYYDTKADIWSLGI 190
Query: 699 ILYQMVYGRTPFSEYKTFWA 718
+Y+M G P+S+ F A
Sbjct: 191 TIYEMATGNPPYSDVDAFRA 210
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 75.2 bits (186), Expect = 7e-15
Identities = 64/289 (22%), Positives = 105/289 (36%), Gaps = 58/289 (20%)
Query: 479 KIGSGGSSEVHK-----VISSDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNI 533
K+G G EV+K T A+K +K + F +E + KL N I
Sbjct: 6 KLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEERE-EFLEEASIMKKLSHPN-I 63
Query: 534 IQLIDYEVTEKALLREVLNGSMNNKDGRVKDDGYIYMVLEY---GEIDLAHMLSQKWKEM 590
++L+ G +Y+V EY G DL L +
Sbjct: 64 VRLL----------------------GVCTQGEPLYIVTEYMPGG--DLLDFLRKH---- 95
Query: 591 DGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLLVK-GSLKLIDFGIAKAI 649
+ L L QI + + + + VH DL N L+ + +K+ DFG+++ I
Sbjct: 96 ---GEKLTLKDLLQMALQIAKGMEYLESKNFVHRDLAARNCLVTENLVVKISDFGLSRDI 152
Query: 650 MSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMV-YGRT 708
D +R + +M+PE+ K SD+WS G +L+++ G
Sbjct: 153 YEDDYYRKRGGGKLPIKWMAPESLKDG---------KFTSKSDVWSFGVLLWEIFTLGEQ 203
Query: 709 PFSEYKTFWAKFKVITDPNHEITYEPVPN--PWLLDLMKKCLAWDRNER 755
P+ + P N L +LM +C A+D +R
Sbjct: 204 PYPGMSNEEVLELLEDGYRLPR---P-ENCPDELYELMLQCWAYDPEDR 248
|
Length = 258 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 9e-15
Identities = 62/226 (27%), Positives = 104/226 (46%), Gaps = 35/226 (15%)
Query: 537 IDYEVTEKALLREVLNGSMNNKDGRVKDDGYIYMVLEYGEIDLAHMLSQKWKEMDGSNQT 596
+D+ +E+ +L + + N G KD+ Y+Y+VLE+ ++ ++ N+
Sbjct: 75 VDHVFSERKILNYINHPFCVNLYGSFKDESYLYLVLEF-------VIGGEFFTFLRRNKR 127
Query: 597 LDENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLLVK-GSLKLIDFGIAKAIMSDTTN 655
+ FY QI+ + IV+ DLKP N LL K G +K+ DFG AK + + T
Sbjct: 128 FPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTRTYT 187
Query: 656 IQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGRTPFSEYKT 715
+ GT Y++PE + + G+ +D W+LG +Y+++ G PF +
Sbjct: 188 L-----CGTPEYIAPEILLN---------VGHGKAADWWTLGIFIYEILVGCPPFYANEP 233
Query: 716 FWAKFKVITDPNHEITYEPVPNPWLLD-----LMKKCLAWDRNERW 756
K++ I Y P LD LMKK L+ D +R+
Sbjct: 234 LLIYQKILEG----IIYFPK----FLDNNCKHLMKKLLSHDLTKRY 271
|
Length = 340 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.7 bits (186), Expect = 1e-14
Identities = 65/254 (25%), Positives = 111/254 (43%), Gaps = 52/254 (20%)
Query: 480 IGSGGSSEVHKVISSDCT-IYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQL-- 536
IG G +V +V D IYALK I+ K +I+
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIR------------------------KAHIVSRSE 36
Query: 537 IDYEVTEKALLREVLNGSMNNKDGRVKDDGYIYMVLEY---GEIDLAHMLSQKWKEMDGS 593
+ + + E+ +L +V + + +Y+VL + GE L H L ++ +
Sbjct: 37 VTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGE--LFHHLQREGR----- 89
Query: 594 NQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLL-VKGSLKLIDFGIAKAIMSD 652
D + RFY ++L A+ +H+ +++ DLKP N LL +G + L DFG+ K M D
Sbjct: 90 ---FDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKD 146
Query: 653 TTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGRTPFSE 712
+ ++ GT Y++PE + + K D W+LG +LY+M+ G PF +
Sbjct: 147 DD--KTNTFCGTPEYLAPELLLGH------GYTKA---VDWWTLGVLLYEMLTGLPPFYD 195
Query: 713 YKTFWAKFKVITDP 726
K++ +P
Sbjct: 196 ENVNEMYRKILQEP 209
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 74.5 bits (184), Expect = 1e-14
Identities = 61/291 (20%), Positives = 107/291 (36%), Gaps = 55/291 (18%)
Query: 479 KIGSGGSSEVHK----VISSDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNII 534
K+G G EV+K T A+K +K + F +E + KL N ++
Sbjct: 2 KLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASE-EERKDFLKEARVMKKLGHPN-VV 59
Query: 535 QLIDYEVTEKALLREVLNGSMNNKDGRVKDDGYIYMVLEY---GEIDLAHMLSQKWKEMD 591
+L+ G ++ +Y+VLEY G DL L +
Sbjct: 60 RLL----------------------GVCTEEEPLYLVLEYMEGG--DLLDYLRKSRPVFP 95
Query: 592 GSN-QTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLL-VKGSLKLIDFGIAKAI 649
TL L + QI + + + ++ VH DL N L+ +K+ DFG+++ +
Sbjct: 96 SPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDV 155
Query: 650 MSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMV-YGRT 708
D ++ + +M+PE+ SD+WS G +L+++ G T
Sbjct: 156 YDDDYYRKKTGGKLPIRWMAPESLKDGIFTSK---------SDVWSFGVLLWEIFTLGAT 206
Query: 709 PFSEYKTFWAKFKVITDPNH----EITYEPVPNPWLLDLMKKCLAWDRNER 755
P+ + + E + L +LM C D +R
Sbjct: 207 PYPGLSNEEV-LEYLRKGYRLPKPEYCPDE-----LYELMLSCWQLDPEDR 251
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 75.0 bits (184), Expect = 1e-14
Identities = 44/122 (36%), Positives = 64/122 (52%), Gaps = 13/122 (10%)
Query: 594 NQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLLV-KGSLKLIDFGIAKAIMSD 652
N DE FY ++ + + ERIV+ DLKP N LL +G +++ D G+A I
Sbjct: 96 NPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEG 155
Query: 653 TTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGRTPFSE 712
T R VGT+ YM+PE + NE K D W LGC++Y+M+ G++PF +
Sbjct: 156 ETVRGR---VGTVGYMAPEV-INNE--------KYTFSPDWWGLGCLIYEMIQGQSPFRK 203
Query: 713 YK 714
K
Sbjct: 204 RK 205
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 2e-14
Identities = 62/211 (29%), Positives = 97/211 (45%), Gaps = 36/211 (17%)
Query: 594 NQTLDENWLRFYWQQILEAVNTIHEER-IVHSDLKPANFLLVK-GSLKLIDFGIAKAIMS 651
+ E+ RFY +I+ A++ +H E+ +V+ DLK N +L K G +K+ DFG+ K +
Sbjct: 89 ERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIK 148
Query: 652 DTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGRTPFS 711
D ++ + GT Y++PE N+ GR D W LG ++Y+M+ GR PF
Sbjct: 149 DGATMK--TFCGTPEYLAPEVLEDNDY---------GRAVDWWGLGVVMYEMMCGRLPF- 196
Query: 712 EYKTFWAK-FKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERW-----RIPQLLQHP 765
Y K F++I EI + +P L+ L D +R +++QH
Sbjct: 197 -YNQDHEKLFELIL--MEEIRFPRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQHK 253
Query: 766 F-------------LVPPVSTQPSSSQDQSY 783
F LVPP Q +S D Y
Sbjct: 254 FFAGIVWQDVYEKKLVPPFKPQVTSETDTRY 284
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 2e-14
Identities = 43/122 (35%), Positives = 66/122 (54%), Gaps = 19/122 (15%)
Query: 597 LDENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLLVK-GSLKLIDFGIAKAIMSDTTN 655
+E FY +I + +H+ERIV+ DLKP N LL G +++ D G+A + T
Sbjct: 99 FEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTI 158
Query: 656 IQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPS---DIWSLGCILYQMVYGRTPFSE 712
R VGT+ YM+PE ++K R + D W+LGC+LY+M+ G++PF +
Sbjct: 159 KGR---VGTVGYMAPE------------VVKNERYTFSPDWWALGCLLYEMIAGQSPFQQ 203
Query: 713 YK 714
K
Sbjct: 204 RK 205
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 2e-14
Identities = 52/173 (30%), Positives = 85/173 (49%), Gaps = 14/173 (8%)
Query: 597 LDENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLLV-KGSLKLIDFGIAKAIMSDTTN 655
L+E ++ ++IL+ ++ +H ER +H D+K AN LL +G +KL DFG+A + T
Sbjct: 98 LEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTD--TQ 155
Query: 656 IQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGRTPFSEYKT 715
I+R++ VGT +M+PE + D +DIWSLG ++ G P S+
Sbjct: 156 IKRNTFVGTPFWMAPEVIKQSAYDFK---------ADIWSLGITAIELAKGEPPNSDLHP 206
Query: 716 FWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQHPFLV 768
F + N T E + + ++ CL D R +LL+H F+
Sbjct: 207 MRVLF--LIPKNSPPTLEGQYSKPFKEFVEACLNKDPRFRPTAKELLKHKFIT 257
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 3e-14
Identities = 61/218 (27%), Positives = 96/218 (44%), Gaps = 53/218 (24%)
Query: 595 QTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLLVK-GSLKLIDFGIAKAIMSDT 653
+ E+ RFY +I+ A++ +H +IV+ DLK N +L K G +K+ DFG+ K ++D
Sbjct: 90 RVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDA 149
Query: 654 TNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGRTPFSEY 713
++ + GT Y++PE N+ GR D W LG ++Y+M+ GR PF
Sbjct: 150 ATMK--TFCGTPEYLAPEVLEDNDY---------GRAVDWWGLGVVMYEMMCGRLPF--- 195
Query: 714 KTFWAKFKVITDPNHE-----ITYEPVPNPWLL-----DLMKKCLAWDRNERW-----RI 758
+ +HE I E + P L L+ L D N+R
Sbjct: 196 ----------YNQDHEKLFELILMEDIKFPRTLSADAKSLLSGLLIKDPNKRLGGGPDDA 245
Query: 759 PQLLQHPF-------------LVPPVSTQPSSSQDQSY 783
++++H F LVPP Q +S D Y
Sbjct: 246 KEIMRHSFFTGVNWQDVYDKKLVPPFKPQVTSETDTRY 283
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 74.5 bits (183), Expect = 3e-14
Identities = 53/206 (25%), Positives = 97/206 (47%), Gaps = 39/206 (18%)
Query: 523 YLNKLKGKNNIIQL--IDYEVTEKALLREVLNGSMNNKDGRVKDDGYIYMVLEY---GEI 577
Y K K I+++ + + EK++L E+ + + N +D+ +Y +LE+ GE+
Sbjct: 46 YAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLLEFVVGGEL 105
Query: 578 DLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLL-VKG 636
H+ D + +FY +++ A +H + I++ DLKP N LL KG
Sbjct: 106 -FTHLRKAGRFPNDVA---------KFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKG 155
Query: 637 SLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKC---GRPSDI 693
+K+ DFG AK + T + GT Y++PE +I+ G+ D
Sbjct: 156 HVKVTDFGFAKKVPDRTFTL-----CGTPEYLAPE------------VIQSKGHGKAVDW 198
Query: 694 WSLGCILYQMVYGRTPF---SEYKTF 716
W++G +LY+ + G PF + ++ +
Sbjct: 199 WTMGVLLYEFIAGYPPFFDDTPFRIY 224
|
Length = 329 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 74.4 bits (183), Expect = 3e-14
Identities = 49/149 (32%), Positives = 72/149 (48%), Gaps = 29/149 (19%)
Query: 568 IYMVLEY---GEIDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHS 624
+Y VL+Y GE+ H+ ++ + E RFY +I A+ +H I++
Sbjct: 71 LYFVLDYVNGGEL-FFHLQRER---------SFPEPRARFYAAEIASALGYLHSLNIIYR 120
Query: 625 DLKPANFLL-VKGSLKLIDFGIAKAIM--SDTTNIQRDSQVGTLSYMSPEAFMCNESDEN 681
DLKP N LL +G + L DFG+ K + S TT+ + GT Y++PE D
Sbjct: 121 DLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTS----TFCGTPEYLAPEVLRKQPYD-- 174
Query: 682 GNIIKCGRPSDIWSLGCILYQMVYGRTPF 710
R D W LG +LY+M+YG PF
Sbjct: 175 -------RTVDWWCLGAVLYEMLYGLPPF 196
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 4e-14
Identities = 82/338 (24%), Positives = 144/338 (42%), Gaps = 82/338 (24%)
Query: 472 KLYQRLGKIGSGGSSEVHKVISSDCTI-YALKKIKLKGRDYATAYGFCQEIEYLNKLKGK 530
K YQ+L IGSG V + I A+KK+ ++ A +E+ L + K
Sbjct: 21 KRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHK 80
Query: 531 NNIIQLIDYEVTEKALLREVLNGSMNNKDGRVKDDGYIYMVLEYGEIDLAHMLSQKWKEM 590
N II L++ +K+L ++ +Y+V+E + +L ++ M
Sbjct: 81 N-IISLLNVFTPQKSL----------------EEFQDVYLVMELMDANLCQVI-----HM 118
Query: 591 DGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLLVKG--SLKLIDFGIAKA 648
+ LD + + Q+L + +H I+H DLKP+N ++VK +LK++DFG+A+
Sbjct: 119 E-----LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSN-IVVKSDCTLKILDFGLAR- 171
Query: 649 IMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGRT 708
+ TN V T Y +PE + EN DIWS+GCI+ ++V G
Sbjct: 172 --TACTNFMMTPYVVTRYYRAPEVILGMGYKEN---------VDIWSVGCIMGELVKGSV 220
Query: 709 PF--SEYKTFWAK-FKVITDPN---------------------HEITYEPVPNPWLL--- 741
F +++ W K + + P+ I++E + W+
Sbjct: 221 IFQGTDHIDQWNKVIEQLGTPSAEFMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSE 280
Query: 742 ------------DLMKKCLAWDRNERWRIPQLLQHPFL 767
DL+ K L D ++R + + L+HP++
Sbjct: 281 SERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPYI 318
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 73.2 bits (179), Expect = 5e-14
Identities = 51/173 (29%), Positives = 84/173 (48%), Gaps = 14/173 (8%)
Query: 597 LDENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLLVK-GSLKLIDFGIAKAIMSDTTN 655
DE + ++IL+ ++ +H E+ +H D+K AN LL + G +KL DFG+A + T
Sbjct: 98 FDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTD--TQ 155
Query: 656 IQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGRTPFSEYKT 715
I+R++ VGT +M+PE + D +DIWSLG ++ G P S+
Sbjct: 156 IKRNTFVGTPFWMAPEVIQQSAYDSK---------ADIWSLGITAIELAKGEPPNSDMHP 206
Query: 716 FWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQHPFLV 768
F + + +T E + + CL D + R +LL+H F+V
Sbjct: 207 MRVLFLIPKNNPPTLTGEFSKP--FKEFIDACLNKDPSFRPTAKELLKHKFIV 257
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 73.2 bits (179), Expect = 5e-14
Identities = 54/173 (31%), Positives = 88/173 (50%), Gaps = 14/173 (8%)
Query: 597 LDENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLLVK-GSLKLIDFGIAKAIMSDTTN 655
LDE + ++IL+ ++ +H E+ +H D+K AN LL + G +KL DFG+A + T
Sbjct: 98 LDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTD--TQ 155
Query: 656 IQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGRTPFSEYKT 715
I+R++ VGT +M+PE + D +DIWSLG ++ G P SE
Sbjct: 156 IKRNTFVGTPFWMAPEVIKQSAYDSK---------ADIWSLGITAIELAKGEPPHSELHP 206
Query: 716 FWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQHPFLV 768
F + N+ T E + L + ++ CL + + R +LL+H F+V
Sbjct: 207 MKVLF--LIPKNNPPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFIV 257
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.8 bits (181), Expect = 5e-14
Identities = 42/115 (36%), Positives = 66/115 (57%), Gaps = 15/115 (13%)
Query: 599 ENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLL-VKGSLKLIDFGIAKAIMSD--TTN 655
E+ +FY +++ A+ +H+ IV+ DLKP N LL G + L DFG++KA ++D TTN
Sbjct: 95 EDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTN 154
Query: 656 IQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGRTPF 710
+ GT Y++PE + DE G + D WSLG ++++M G +PF
Sbjct: 155 ----TFCGTTEYLAPEVLL----DEKGY----TKHVDFWSLGVLVFEMCCGWSPF 197
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 6e-14
Identities = 52/177 (29%), Positives = 85/177 (48%), Gaps = 12/177 (6%)
Query: 593 SNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLL-VKGSLKLIDFGIAKAIMS 651
S L+E + + +L+A+ +H + ++H D+K + LL + G +KL DFG I
Sbjct: 110 SQTRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISK 169
Query: 652 DTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGRTPFS 711
D +R S VGT +M+PE + G DIWSLG ++ +MV G P+
Sbjct: 170 DVP--KRKSLVGTPYWMAPEVI---------SRTPYGTEVDIWSLGIMVIEMVDGEPPYF 218
Query: 712 EYKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQHPFLV 768
A ++ P ++ +P L D +++ L + ER +LL HPFL+
Sbjct: 219 SDSPVQAMKRLRDSPPPKLKNAHKISPVLRDFLERMLTREPQERATAQELLDHPFLL 275
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 6e-14
Identities = 41/119 (34%), Positives = 60/119 (50%), Gaps = 13/119 (10%)
Query: 597 LDENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLL-VKGSLKLIDFGIAKAIMSDTTN 655
L+ + Y QI + +H IV+ D+KP N LL +G+ +L D G+A + T
Sbjct: 92 LEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTI 151
Query: 656 IQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGRTPFSEYK 714
QR GT YM+PE E P D +++GC +Y+MV GRTPF ++K
Sbjct: 152 TQR---AGTNGYMAPEILK-EEPYSY--------PVDWFAMGCSIYEMVAGRTPFKDHK 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 7e-14
Identities = 85/351 (24%), Positives = 140/351 (39%), Gaps = 72/351 (20%)
Query: 474 YQRLGKIGSGGSSEVHKVISSDCTI-YALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNN 532
YQ L +GSG V + + A+KK+ + A +E+ L +K N
Sbjct: 19 YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMK-HEN 77
Query: 533 IIQLIDYEVTEKALLREVLNGSMNNKDGRVKDDGYIYMVLEYGEIDLAHMLSQKWKEMDG 592
+I L+D ++L ++ +Y+V DL +++
Sbjct: 78 VIGLLDVFTPARSL----------------EEFNDVYLVTHLMGADLNNIVK-------- 113
Query: 593 SNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLLVKG-SLKLIDFGIAKAIMS 651
Q L ++ ++F QIL + IH I+H DLKP+N + + LK++DFG+A+
Sbjct: 114 -CQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD 172
Query: 652 DTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGRTPF- 710
+ T V T Y +PE M N N + DIWS+GCI+ +++ GRT F
Sbjct: 173 EMT-----GYVATRWYRAPE-IMLNWMHYNQTV-------DIWSVGCIMAELLTGRTLFP 219
Query: 711 --SEYKTFWAKFKVITDPNHE----------------ITYEPV---------PNPWLLDL 743
+++ P E +T P NP +DL
Sbjct: 220 GTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDL 279
Query: 744 MKKCLAWDRNERWRIPQLLQHPFLVP---PVSTQPSSSQDQSYQLLQLLAE 791
++K L D ++R Q L H + P + DQS++ LL +
Sbjct: 280 LEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVADPYDQSFESRDLLID 330
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 72.9 bits (179), Expect = 9e-14
Identities = 60/209 (28%), Positives = 94/209 (44%), Gaps = 35/209 (16%)
Query: 595 QTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLLVK-GSLKLIDFGIAKAIMSDT 653
+ E+ RFY +I+ A+ +H +V+ DLK N +L K G +K+ DFG+ K +SD
Sbjct: 90 RVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDG 149
Query: 654 TNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGRTPFSEY 713
++ + GT Y++PE N+ GR D W LG ++Y+M+ GR PF Y
Sbjct: 150 ATMK--TFCGTPEYLAPEVLEDNDY---------GRAVDWWGLGVVMYEMMCGRLPF--Y 196
Query: 714 KTFWAK-FKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERW-----RIPQLLQHPF- 766
K F++I EI + +P L+ L D +R ++++H F
Sbjct: 197 NQDHEKLFELIL--MEEIRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEHRFF 254
Query: 767 ------------LVPPVSTQPSSSQDQSY 783
L PP Q +S D Y
Sbjct: 255 ASINWQDVVQKKLEPPFKPQVTSETDTRY 283
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 71.9 bits (176), Expect = 1e-13
Identities = 58/208 (27%), Positives = 101/208 (48%), Gaps = 22/208 (10%)
Query: 563 KDDGYIYMVLEYGEI-DLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERI 621
+++G +++V+EY + DL ++++ + +Q L ++ QI + IH+ +I
Sbjct: 69 QENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILS------WFVQISLGLKHIHDRKI 122
Query: 622 VHSDLKPANFLLVKGSL--KLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESD 679
+H D+K N L K + KL DFGIA+ ++D+ + + VGT Y+SPE +C
Sbjct: 123 LHRDIKSQNIFLSKNGMVAKLGDFGIAR-QLNDSMELAY-TCVGTPYYLSPE--ICQNRP 178
Query: 680 ENGNIIKCGRPSDIWSLGCILYQMVYGRTPFSEYKTFWAKFKVITDPNHEITYEPVPNPW 739
N +DIWSLGC+LY++ + PF K+ I+ P +
Sbjct: 179 YNNK-------TDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGYFAPIS--PNFSRD 229
Query: 740 LLDLMKKCLAWDRNERWRIPQLLQHPFL 767
L L+ + +R I +L+ PFL
Sbjct: 230 LRSLISQLFKVSPRDRPSITSILKRPFL 257
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 72.1 bits (177), Expect = 1e-13
Identities = 43/156 (27%), Positives = 80/156 (51%), Gaps = 32/156 (20%)
Query: 565 DGYIYMVLEY---GEIDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERI 621
D ++++L+Y GE+ H L Q+ + E+ +R Y +I+ A++ +H+ I
Sbjct: 77 DTKLHLILDYVNGGEL-FTH-LYQR--------EHFTESEVRVYIAEIVLALDHLHQLGI 126
Query: 622 VHSDLKPANFLLVK-GSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDE 680
++ D+K N LL G + L DFG++K +++ + S GT+ YM+PE
Sbjct: 127 IYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEE-RAYSFCGTIEYMAPE--------- 176
Query: 681 NGNIIKCGRPS-----DIWSLGCILYQMVYGRTPFS 711
+I+ G D WSLG + ++++ G +PF+
Sbjct: 177 ---VIRGGSGGHDKAVDWWSLGVLTFELLTGASPFT 209
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 71.4 bits (175), Expect = 2e-13
Identities = 53/167 (31%), Positives = 76/167 (45%), Gaps = 33/167 (19%)
Query: 618 EERIVHSDLKPANFLL-VKGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCN 676
RI+H D+KP+N L+ +G +KL DFG++ ++ N D+ VGT +YMSPE
Sbjct: 122 VHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELI----NSIADTFVGTSTYMSPER---- 173
Query: 677 ESDENGNIIKCGR---PSDIWSLGCILYQMVYGRTPFS---EYKTFWAKFKVITDPNHEI 730
I+ G+ SD+WSLG + ++ G+ PF+ I D +I
Sbjct: 174 --------IQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQI 225
Query: 731 TYEPVPN-------PWLLDLMKKCLAWDRNERWRIPQLL--QHPFLV 768
EP P L D + CL D ER PQ L PF+
Sbjct: 226 VQEPPPRLPSSDFPEDLRDFVDACLLKDPTER-PTPQQLCAMPPFIQ 271
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 2e-13
Identities = 73/262 (27%), Positives = 113/262 (43%), Gaps = 47/262 (17%)
Query: 474 YQRLGKIGSGGSSEVHKVISS-DCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNN 532
Y++L K+G G + V+K S + + ALK I+L+ + T + +E L LK N
Sbjct: 7 YEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQ-EEEGTPFTAIREASLLKGLK-HAN 64
Query: 533 IIQLIDYEVTEKALLREVLNGSMNNKDGRVKDDGYIYMVLEYGEIDLAHMLSQKWKEMDG 592
I+ L D T++ L +V EY DL MD
Sbjct: 65 IVLLHDIIHTKETLT----------------------LVFEYVHTDLCQY-------MDK 95
Query: 593 SNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLLV-KGSLKLIDFGIAKAIMS 651
L ++ + Q+L ++ IH+ I+H DLKP N L+ G LKL DFG+A+A
Sbjct: 96 HPGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDTGELKLADFGLARA--K 153
Query: 652 DTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGRTPFS 711
+ ++V TL Y P+ + S E + D+W +GCI +M+ G F
Sbjct: 154 SVPSHTYSNEVVTLWYRPPDVLL--GSTEYSTCL------DMWGVGCIFVEMIQGVAAFP 205
Query: 712 EYKTFWAK----FKVITDPNHE 729
K + F V+ PN +
Sbjct: 206 GMKDIQDQLERIFLVLGTPNED 227
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 4e-13
Identities = 39/113 (34%), Positives = 61/113 (53%), Gaps = 12/113 (10%)
Query: 599 ENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLLVK-GSLKLIDFGIAKAIMSDTTNIQ 657
E RFY +I+ A+ +H +V+ D+K N +L K G +K+ DFG+ K +SD ++
Sbjct: 94 EERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMK 153
Query: 658 RDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGRTPF 710
+ GT Y++PE N+ GR D W LG ++Y+M+ GR PF
Sbjct: 154 --TFCGTPEYLAPEVLEDNDY---------GRAVDWWGLGVVMYEMMCGRLPF 195
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 71.1 bits (174), Expect = 5e-13
Identities = 58/230 (25%), Positives = 99/230 (43%), Gaps = 52/230 (22%)
Query: 569 YMVLEYGEIDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKP 628
Y+V+ Y + DL ++ L E+ +++ Q+L + IH I+H DLKP
Sbjct: 96 YLVMPYMQTDLQKIMGHP----------LSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKP 145
Query: 629 ANFLLVKG-SLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKC 687
N + + LK++DFG+A+ ++ T V T Y +PE + N +
Sbjct: 146 GNLAVNEDCELKILDFGLARHADAEMT-----GYVVTRWYRAPEVIL--------NWMHY 192
Query: 688 GRPSDIWSLGCILYQMVYGRTPF--SEYKTFWAK-FKVITDPNHEITYE----------- 733
+ DIWS+GCI+ +M+ G+T F +Y + KV P E +
Sbjct: 193 NQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLEDKAAKSYIK 252
Query: 734 --------------PVPNPWLLDLMKKCLAWDRNERWRIPQLLQHPFLVP 769
P +P +DL++K L D ++R + L+HP+
Sbjct: 253 SLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDS 302
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 6e-13
Identities = 43/139 (30%), Positives = 74/139 (53%), Gaps = 21/139 (15%)
Query: 578 DLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLLVK-G 636
DL + LSQ + E +RFY +I+ + +H +V+ DLKPAN LL + G
Sbjct: 83 DLHYHLSQ--------HGVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHG 134
Query: 637 SLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSL 696
+++ D G+A D + + + VGT YM+PE + ++ +D +SL
Sbjct: 135 HVRISDLGLA----CDFSKKKPHASVGTHGYMAPEVLQKGTAYDSS--------ADWFSL 182
Query: 697 GCILYQMVYGRTPFSEYKT 715
GC+L++++ G +PF ++KT
Sbjct: 183 GCMLFKLLRGHSPFRQHKT 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 69.6 bits (171), Expect = 9e-13
Identities = 65/246 (26%), Positives = 105/246 (42%), Gaps = 75/246 (30%)
Query: 567 YIYMVLEY---GEIDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVH 623
Y+ +V++Y GE+ L Q+ + L E RFY ++L A+ +H IV+
Sbjct: 75 YLCLVMDYCPGGEL---FRLLQRQPG-----KCLSEEVARFYAAEVLLALEYLHLLGIVY 126
Query: 624 SDLKPANFLLVK-GSLKLIDFGIAKA---------------------------IMSDTTN 655
DLKP N LL + G + L DF ++K S+ +
Sbjct: 127 RDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPS 186
Query: 656 IQRDSQVGTLSYMSPEAFMCNESDENGNIIK-CGRPS--DIWSLGCILYQMVYGRTPF-- 710
+ +S VGT Y++PE +I G S D W+LG +LY+M+YG TPF
Sbjct: 187 FRSNSFVGTEEYIAPE------------VISGDGHGSAVDWWTLGILLYEMLYGTTPFKG 234
Query: 711 -SEYKTFWAKFKVITDP-----NHEITYEPVPNPWLLDLMKKCLAWDRNER---WR-IPQ 760
+ +TF ++ + ++ DL++K L D ++R R +
Sbjct: 235 SNRDETF---SNILKKEVTFPGSPPVSSS------ARDLIRKLLVKDPSKRLGSKRGAAE 285
Query: 761 LLQHPF 766
+ QHPF
Sbjct: 286 IKQHPF 291
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 9e-13
Identities = 87/353 (24%), Positives = 143/353 (40%), Gaps = 82/353 (23%)
Query: 472 KLYQRLGK-IGSGGSSEVHKVISS-DCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKG 529
+ Y + G +G G +V K + I A+KK+K+ IE N +
Sbjct: 8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKI--------------IEISNDVTK 53
Query: 530 KNNIIQLIDYEVTEKALLRE--VLN-----GSMNNKDGRVKDDGYIYMVLEYGEIDLAHM 582
QL+ LRE ++N M D V+ D +I +V++ DL +
Sbjct: 54 DR---QLVGMCGIHFTTLRELKIMNEIKHENIMGLVDVYVEGD-FINLVMDIMASDLKKV 109
Query: 583 LSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPAN-FLLVKGSLKLI 641
+ +K + L E+ ++ QIL +N +H+ +H DL PAN F+ KG K+
Sbjct: 110 VDRKIR--------LTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGICKIA 161
Query: 642 DFGIAKAI--------MSDTTNIQRD----SQVGTLSYMSPEAFMCNESDENGNIIKCGR 689
DFG+A+ +S +QR S+V TL Y +PE M E K
Sbjct: 162 DFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAE--------KYHF 213
Query: 690 PSDIWSLGCILYQMVYGRTPF---SEYKTFWAKFKVITDPNH----EITYEPVPNPWL-- 740
D+WS+GCI +++ G+ F +E F+++ PN + P+ +
Sbjct: 214 AVDMWSVGCIFAELLTGKPLFPGENEIDQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPR 273
Query: 741 ----------------LDLMKKCLAWDRNERWRIPQLLQHP-FLVPPVSTQPS 776
+DL++ L + ER + L+H F P+ PS
Sbjct: 274 KPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKHEYFKSDPLPCDPS 326
|
Length = 335 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 69.2 bits (169), Expect = 1e-12
Identities = 63/238 (26%), Positives = 108/238 (45%), Gaps = 43/238 (18%)
Query: 480 IGSGGSSEVHKVISSDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDY 539
+G GG EV C +++ G+ YA C+ +E K K + L +
Sbjct: 8 LGKGGFGEV-------CAC----QVRATGKMYA-----CKRLEKKRIKKRKGESMALNEK 51
Query: 540 EVTEKALLREVLN--GSMNNKDGRVKDDGYIYMVLEYGEIDLAHMLSQKWKEMDGSNQTL 597
++ EK + V+N + KD + ++ G++ K+ + N
Sbjct: 52 QILEKVNSQFVVNLAYAYETKDALC----LVLTIMNGGDL--------KFHIYNMGNPGF 99
Query: 598 DENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLLVK-GSLKLIDFGIAKAIMSDTTNI 656
+E FY +IL + +H E V+ DLKP N LL G +++ D G+A I + +I
Sbjct: 100 EEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYGHIRISDLGLAVKI-PEGESI 158
Query: 657 QRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGRTPFSEYK 714
+ +VGT+ YM+PE + N+ + D W LGC++Y+M+ G++PF K
Sbjct: 159 R--GRVGTVGYMAPEV-LNNQ--------RYTLSPDYWGLGCLIYEMIEGQSPFRGRK 205
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 69.7 bits (171), Expect = 1e-12
Identities = 45/152 (29%), Positives = 74/152 (48%), Gaps = 35/152 (23%)
Query: 568 IYMVLEY---GEIDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHS 624
++ V+EY G++ + H+ DE RFY +I+ + +HE I++
Sbjct: 71 LFFVMEYVNGGDL-MFHIQRSG---------RFDEPRARFYAAEIVLGLQFLHERGIIYR 120
Query: 625 DLKPANFLL-VKGSLKLIDFGIAKAIM--SDTTNIQRDSQVGTLSYMSPEAFMCNESDEN 681
DLK N LL +G +K+ DFG+ K + TT+ + GT Y++PE
Sbjct: 121 DLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTS----TFCGTPDYIAPE---------- 166
Query: 682 GNII---KCGRPSDIWSLGCILYQMVYGRTPF 710
I+ G D W+LG +LY+M+ G++PF
Sbjct: 167 --ILSYQPYGPAVDWWALGVLLYEMLAGQSPF 196
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 68.4 bits (167), Expect = 2e-12
Identities = 57/199 (28%), Positives = 95/199 (47%), Gaps = 32/199 (16%)
Query: 578 DLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLLVK-G 636
DL + LSQ + E +RFY +I+ + +H +V+ DLKPAN LL + G
Sbjct: 83 DLHYHLSQ--------HGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHG 134
Query: 637 SLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSL 696
+++ D G+A D + + + VGT YM+PE + ++ +D +SL
Sbjct: 135 HVRISDLGLA----CDFSKKKPHASVGTHGYMAPEVLQKGVAYDSS--------ADWFSL 182
Query: 697 GCILYQMVYGRTPFSEYKTFWAKFKVITDPNHEITYEPVPN---PWLLDLMKKCLAWDRN 753
GC+L++++ G +PF ++KT K K D +P+ P L L++ L D N
Sbjct: 183 GCMLFKLLRGHSPFRQHKT---KDKHEIDRMTLTMAVELPDSFSPELRSLLEGLLQRDVN 239
Query: 754 ER-----WRIPQLLQHPFL 767
R ++ +HPF
Sbjct: 240 RRLGCLGRGAQEVKEHPFF 258
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 67.2 bits (165), Expect = 4e-12
Identities = 61/285 (21%), Positives = 110/285 (38%), Gaps = 50/285 (17%)
Query: 479 KIGSGGSSEVHK---VISSDCTIY--ALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNI 533
K+G G EV+K D A+K +K + F +E + KL N I
Sbjct: 6 KLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLK-EDASEQQIEEFLREARIMRKLDHPN-I 63
Query: 534 IQLIDYEVTEKALLREVLNGSMNNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEMDG 592
++L+ G ++ + +V+EY DL L +K + +
Sbjct: 64 VKLL----------------------GVCTEEEPLMIVMEYMPGGDLLDYL-RKNRPKEL 100
Query: 593 SNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLLVKG-SLKLIDFGIAKAIMS 651
S L L F Q I + + + +H DL N L+ + +K+ DFG+++ +
Sbjct: 101 SLSDL----LSFALQ-IARGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYD 155
Query: 652 DTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMV-YGRTPF 710
D + ++ + +M+PE+ + SD+WS G +L+++ G P+
Sbjct: 156 DDYYKVKGGKL-PIRWMAPESLKEGKFTSK---------SDVWSFGVLLWEIFTLGEEPY 205
Query: 711 SEYKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNER 755
+ + + P P L LM +C A D +R
Sbjct: 206 PGMSNAEVLEYLKK--GYRLPKPPNCPPELYKLMLQCWAEDPEDR 248
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 4e-12
Identities = 54/179 (30%), Positives = 85/179 (47%), Gaps = 19/179 (10%)
Query: 609 ILEAVNTIHEERIVHSDLKPANFLLV-KGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSY 667
+L+A++ +H + ++H D+K + LL G +KL DFG + + +R S VGT +
Sbjct: 125 VLKALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP--RRKSLVGTPYW 182
Query: 668 MSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGRTPFSEYKTFWAKFKVITD-- 725
M+PE + + G DIWSLG ++ +MV G P+ A K+I D
Sbjct: 183 MAPELI---------SRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKA-MKMIRDNL 232
Query: 726 PNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQHPFLV---PPVSTQPSSSQDQ 781
P V +P L + + L D +R +LL+HPFL PP P Q++
Sbjct: 233 PPKLKNLHKV-SPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAGPPSCIVPLMRQNR 290
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 4e-12
Identities = 56/228 (24%), Positives = 94/228 (41%), Gaps = 51/228 (22%)
Query: 569 YMVLEYGEIDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKP 628
Y+V+ + DL ++ + L E+ ++F Q+L+ + IH I+H DLKP
Sbjct: 96 YLVMPFMGTDLGKLMKH---------EKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKP 146
Query: 629 ANFLLVKG-SLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKC 687
N + + LK++DFG+A+ S+ T V T Y +PE + N +
Sbjct: 147 GNLAVNEDCELKILDFGLARQTDSEMT-----GYVVTRWYRAPEVIL--------NWMHY 193
Query: 688 GRPSDIWSLGCILYQMVYGRTPFS---EYKTFWAKFKVITDPNHEITYE----------- 733
+ DIWS+GCI+ +M+ G+ F KV P+ E +
Sbjct: 194 TQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQSEDAKNYVK 253
Query: 734 --------------PVPNPWLLDLMKKCLAWDRNERWRIPQLLQHPFL 767
P NP +++++K L D R + L HP+
Sbjct: 254 KLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYF 301
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 68.3 bits (167), Expect = 4e-12
Identities = 58/252 (23%), Positives = 95/252 (37%), Gaps = 67/252 (26%)
Query: 563 KDDGYIYMVLEY---GEIDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEE 619
+D +Y V++Y G D+ +L + +E+ RFY ++ A+ ++H+
Sbjct: 71 QDKDNLYFVMDYIPGG--DMMSLLIRL--------GIFEEDLARFYIAELTCAIESVHKM 120
Query: 620 RIVHSDLKPANFLLVK-GSLKLIDFGIAKAI----------------------------- 649
+H D+KP N L+ + G +KL DFG+
Sbjct: 121 GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEI 180
Query: 650 ------------MSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLG 697
S VGT +Y++PE + G C D WS+G
Sbjct: 181 DRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLL-----RTGYTQLC----DWWSVG 231
Query: 698 CILYQMVYGRTPFSEYKTFWAKFKVITDPNH-EITYEPVPNPWLLDLMKK--CLAWDRNE 754
ILY+M+ G+ PF + KVI I + + DL+ + C A DR
Sbjct: 232 VILYEMLVGQPPFLADTPAETQLKVINWETTLHIPSQAKLSREASDLILRLCCGAEDRLG 291
Query: 755 RWRIPQLLQHPF 766
+ ++ HPF
Sbjct: 292 KNGADEIKAHPF 303
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 66.8 bits (164), Expect = 5e-12
Identities = 63/293 (21%), Positives = 113/293 (38%), Gaps = 67/293 (22%)
Query: 479 KIGSGGSSEVHK---VISSDCTIY--ALKKIKLKGRDYATAYG---FCQEIEYLNKLKGK 530
K+G G EV+K A+K +K + A+ F +E + KL
Sbjct: 6 KLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLK----EDASEQQIEEFLREARIMRKLDHP 61
Query: 531 NNIIQLIDYEVTEKALLREVLNGSMNNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKE 589
N +++L+ G ++ +Y+V+EY E DL L + +
Sbjct: 62 N-VVKLL----------------------GVCTEEEPLYIVMEYMEGGDLLSYLRKNRPK 98
Query: 590 MDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLLVKG-SLKLIDFGIAKA 648
+ S L L F Q I + + + +H DL N L+ + +K+ DFG+++
Sbjct: 99 L--SLSDL----LSFALQ-IARGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRD 151
Query: 649 IMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMV-YGR 707
+ D +R ++ + +M+PE+ + SD+WS G +L+++ G
Sbjct: 152 LYDDDYYRKRGGKL-PIRWMAPESLKEGKFTSK---------SDVWSFGVLLWEIFTLGE 201
Query: 708 TPFSEYKTFWAKFKVITD-----PNHEITYEPVPNPWLLDLMKKCLAWDRNER 755
P+ + P + P L DLM +C A D +R
Sbjct: 202 QPYPGMSNEEVLEYLKNGYRLPQPPN-------CPPELYDLMLQCWAEDPEDR 247
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 5e-12
Identities = 43/119 (36%), Positives = 58/119 (48%), Gaps = 16/119 (13%)
Query: 595 QTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLL-VKGSLKLIDFGIAKA--IMS 651
++ E RFY +I A+ +H IV+ DLKP N LL +G + L DFG+ K S
Sbjct: 91 RSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQS 150
Query: 652 DTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGRTPF 710
DTT + GT Y++PE D D W LG +LY+M+YG PF
Sbjct: 151 DTTT----TFCGTPEYLAPEVIRKQPYD---------NTVDWWCLGAVLYEMLYGLPPF 196
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 6e-12
Identities = 64/211 (30%), Positives = 101/211 (47%), Gaps = 25/211 (11%)
Query: 563 KDDGYIYMVLEYGEI-DLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERI 621
K D + +++EYG DL + Q+ KE + E L FY QI+ A++ +H ++
Sbjct: 135 KSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEY--EVGLLFY--QIVLALDEVHSRKM 190
Query: 622 VHSDLKPAN-FLLVKGSLKLIDFGIAKAIMSDTTNIQRDSQ-VGTLSYMSPEAFMCNESD 679
+H DLK AN FL+ G +KL DFG +K SD+ ++ S GT Y++PE +
Sbjct: 191 MHRDLKSANIFLMPTGIIKLGDFGFSKQ-YSDSVSLDVASSFCGTPYYLAPELWERK--- 246
Query: 680 ENGNIIKCGRPSDIWSLGCILYQMVYGRTPFSEYKTFWAKFKVITDPNHEITYEPVPNP- 738
+ + +D+WSLG ILY+++ PF +V+ Y+P P P
Sbjct: 247 ------RYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYG-----KYDPFPCPV 295
Query: 739 --WLLDLMKKCLAWDRNERWRIPQLLQHPFL 767
+ L+ L+ + R QLL FL
Sbjct: 296 SSGMKALLDPLLSKNPALRPTTQQLLHTEFL 326
|
Length = 478 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 67.4 bits (164), Expect = 7e-12
Identities = 77/332 (23%), Positives = 135/332 (40%), Gaps = 83/332 (25%)
Query: 474 YQRLGKIGSGGSSEVHKVISSDCTIY--------ALKKIKLKGRDYATAYGFCQEIEYLN 525
YQ L +GSG V C+ Y A+KK+ + A +E+ L
Sbjct: 17 YQNLTPVGSGAYGSV-------CSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLK 69
Query: 526 KLKGKNNIIQLIDYEVTEKALLREVLNGSMNNKDGRVKDDGYIYMVLEYGEIDLAHMLSQ 585
+K N+I L+D ++ ++ +Y+V DL +++
Sbjct: 70 HMK-HENVIGLLDVFTPATSI----------------ENFNEVYLVTNLMGADLNNIVK- 111
Query: 586 KWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLLVKG-SLKLIDFG 644
Q L + ++F Q+L + IH I+H DLKP+N + + L+++DFG
Sbjct: 112 --------CQKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFG 163
Query: 645 IAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMV 704
+A+ + T V T Y +PE M N N + DIWS+GCI+ +++
Sbjct: 164 LARQADDEMT-----GYVATRWYRAPE-IMLNWMHYNQTV-------DIWSVGCIMAELL 210
Query: 705 YGRT--PFSEYKTFWAK-FKVITDPNHEI--------------TYEPVP----------- 736
G+ P ++Y + +V+ P+ E+ + +P
Sbjct: 211 KGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKISSEHARKYIQSLPHMPQQDLKKIFRGA 270
Query: 737 NPWLLDLMKKCLAWDRNERWRIPQLLQHPFLV 768
NP +DL++K L D ++R + L HP+
Sbjct: 271 NPLAIDLLEKMLVLDSDKRISASEALAHPYFS 302
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 66.9 bits (163), Expect = 7e-12
Identities = 76/323 (23%), Positives = 130/323 (40%), Gaps = 65/323 (20%)
Query: 474 YQRLGKIGSGGSSEVHKVISSDCTIY-ALKKIKLKGRDYATAYGFCQEIEYLNKLKGKN- 531
Y+ + +IG G V+K + ALK ++++ + +E+ L +L+ +
Sbjct: 2 YEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDH 61
Query: 532 -NIIQLIDYEVTEKALLREVLNGSMNNKDGRVKDDGYIYMVLEYGEIDLAHMLSQKWKEM 590
NI++L+D T + D K + +V E+ + DL L +
Sbjct: 62 PNIVRLMDVCATSRT-------------DRETK----VTLVFEHVDQDLRTYLDK----- 99
Query: 591 DGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLLV-KGSLKLIDFGIAKAI 649
L ++ +Q L ++ +H IVH DLKP N L+ G +KL DFG+A+
Sbjct: 100 -VPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLARIY 158
Query: 650 MSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGRTP 709
+ + V TL Y +PE + + P D+WS+GCI +M + R P
Sbjct: 159 ---SCQMALTPVVVTLWYRAPEVLLQSTY---------ATPVDMWSVGCIFAEM-FRRKP 205
Query: 710 F----SEYKTFWAKFKVITDPNHE---------------ITYEPVPN--PWL----LDLM 744
SE F +I P + PV + P + L+
Sbjct: 206 LFCGNSEADQLGKIFDLIGLPPEDDWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLL 265
Query: 745 KKCLAWDRNERWRIPQLLQHPFL 767
+ L ++ ++R + LQHPF
Sbjct: 266 LEMLTFNPHKRISAFRALQHPFF 288
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 7e-12
Identities = 39/111 (35%), Positives = 57/111 (51%), Gaps = 16/111 (14%)
Query: 603 RFYWQQILEAVNTIHEERIVHSDLKPANFLL-VKGSLKLIDFGIAKAIM--SDTTNIQRD 659
RFY ++ A+ +H I++ DLKP N LL +G + L DFG+ K + +TT+
Sbjct: 99 RFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTS---- 154
Query: 660 SQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGRTPF 710
+ GT Y++PE D R D W LG +LY+M+YG PF
Sbjct: 155 TFCGTPEYLAPEVLRKEPYD---------RTVDWWCLGAVLYEMLYGLPPF 196
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 66.8 bits (163), Expect = 1e-11
Identities = 47/149 (31%), Positives = 78/149 (52%), Gaps = 29/149 (19%)
Query: 568 IYMVLEY---GEIDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHS 624
++ V+E+ G++ + HM Q+ L E RFY +I A+N +HE I++
Sbjct: 71 LFFVIEFVSGGDL-MFHMQRQR---------KLPEEHARFYSAEISLALNFLHERGIIYR 120
Query: 625 DLKPANFLL-VKGSLKLIDFGIAKAIM--SDTTNIQRDSQVGTLSYMSPEAFMCNESDEN 681
DLK N LL +G +KL D+G+ K + DTT+ + GT +Y++PE +
Sbjct: 121 DLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTS----TFCGTPNYIAPEILRGEDY--- 173
Query: 682 GNIIKCGRPSDIWSLGCILYQMVYGRTPF 710
G D W+LG ++++M+ GR+PF
Sbjct: 174 ------GFSVDWWALGVLMFEMMAGRSPF 196
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 2e-11
Identities = 49/148 (33%), Positives = 76/148 (51%), Gaps = 27/148 (18%)
Query: 568 IYMVLEY--GEIDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSD 625
+++V+EY G + HM Q+ L E RFY +I A+N +HE I++ D
Sbjct: 71 LFLVIEYVNGGDLMFHMQRQR---------KLPEEHARFYAAEICIALNFLHERGIIYRD 121
Query: 626 LKPANFLL-VKGSLKLIDFGIAKAIM--SDTTNIQRDSQVGTLSYMSPEAFMCNESDENG 682
LK N LL G +KL D+G+ K + DTT+ + GT +Y++PE E
Sbjct: 122 LKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTS----TFCGTPNYIAPEILRGEEY---- 173
Query: 683 NIIKCGRPSDIWSLGCILYQMVYGRTPF 710
G D W+LG ++++M+ GR+PF
Sbjct: 174 -----GFSVDWWALGVLMFEMMAGRSPF 196
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 2e-11
Identities = 42/118 (35%), Positives = 56/118 (47%), Gaps = 20/118 (16%)
Query: 603 RFYWQQILEAVNTIHEERIVHSDLKPANFLL-VKGSLKLIDFGIAKAIMSDTTNIQRDSQ 661
RFY +I A+ +H IV+ DLKP N LL +G + L DFG+ K NI+ +
Sbjct: 99 RFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCK------ENIEHNGT 152
Query: 662 V----GTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGRTPFSEYKT 715
GT Y++PE D R D W LG +LY+M+YG PF T
Sbjct: 153 TSTFCGTPEYLAPEVLHKQPYD---------RTVDWWCLGAVLYEMLYGLPPFYSRNT 201
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 3e-11
Identities = 78/329 (23%), Positives = 126/329 (38%), Gaps = 89/329 (27%)
Query: 474 YQRLGKIGSGGSSEVHKVISSDCT-IYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNN 532
Y + IG GG EV+ C+ ALKKI+ D
Sbjct: 4 YDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIR---ED---------------------- 38
Query: 533 IIQLIDYEVTEKALLREVLNGSMNNKDGRVK-----DDG-YIYMVLEYGE-IDLAHMLSQ 585
L + + +K LRE + G V DG +Y + Y E L +L
Sbjct: 39 ---LSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTMPYIEGYTLKSLLKS 95
Query: 586 KWKE----MDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLLVK-GSLKL 640
W++ + + +T +L + +I + +H + ++H DLKP N LL G + +
Sbjct: 96 VWQKESLSKELAEKTSVGAFLSIF-HKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVI 154
Query: 641 IDFGIAKAIMSDTTNIQRDSQ---------------------VGTLSYMSPEAFMCNESD 679
+D+G A ++ + VGT YM+PE + +
Sbjct: 155 LDWGAAIFK-----KLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPAS 209
Query: 680 ENGNIIKCGRPSDIWSLGCILYQMVYGRTPFSEYKTFWAKFKVITDPNH-----EIT-YE 733
E+ +DI++LG ILYQM+ P+ K + I+ + E+ Y
Sbjct: 210 ES---------TDIYALGVILYQMLTLSFPYRR-----KKGRKISYRDVILSPIEVAPYR 255
Query: 734 PVPNPWLLDLMKKCLAWDRNERWRIPQLL 762
+P P+L + K LA D ER+ Q L
Sbjct: 256 EIP-PFLSQIAMKALAVDPAERYSSVQEL 283
|
Length = 932 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 65.1 bits (159), Expect = 3e-11
Identities = 54/186 (29%), Positives = 76/186 (40%), Gaps = 49/186 (26%)
Query: 618 EERIVHSDLKPANFLL-VKGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCN 676
+ +I+H D+KP+N L+ +G +KL DFG++ ++ N S VGT SYMSPE
Sbjct: 118 KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN----SFVGTRSYMSPERLQGT 173
Query: 677 ESDENGNIIKCGRPSDIWSLGCILYQMVYGRTPF-----SEYKTFW--------AKFKVI 723
SDIWSLG L +M GR P E + + AK
Sbjct: 174 HYTVQ---------SDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHR 224
Query: 724 TDPNHE---------------ITYEPVP-------NPWLLDLMKKCLAWDRNERWRIPQL 761
H I EP P + D + KCL + ER + +L
Sbjct: 225 PVSGHPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKEL 284
Query: 762 LQHPFL 767
+HPF+
Sbjct: 285 TKHPFI 290
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 65.5 bits (159), Expect = 3e-11
Identities = 60/210 (28%), Positives = 94/210 (44%), Gaps = 54/210 (25%)
Query: 563 KDDGYIYMVLEY-GEIDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERI 621
+D +Y+++E+ D+ +L +K TL E +FY + + A+++IH+
Sbjct: 71 QDKLNLYLIMEFLPGGDMMTLLMKK--------DTLTEEETQFYIAETVLAIDSIHQLGF 122
Query: 622 VHSDLKPANFLL-VKGSLKLIDFGIAKAIM----------------SDTT----NIQRD- 659
+H D+KP N LL KG +KL DFG+ + SD T N +R
Sbjct: 123 IHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKA 182
Query: 660 ------------SQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGR 707
S VGT Y++PE FM + G C D WSLG I+Y+M+ G
Sbjct: 183 ETWKRNRRQLAFSTVGTPDYIAPEVFM-----QTGYNKLC----DWWSLGVIMYEMLIGY 233
Query: 708 TPFSEYKTFWAKFKVITDPNHEITYEP-VP 736
PF +T +K + + + + P VP
Sbjct: 234 PPFCS-ETPQETYKKVMNWKETLIFPPEVP 262
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 3e-11
Identities = 65/264 (24%), Positives = 113/264 (42%), Gaps = 43/264 (16%)
Query: 474 YQRLGKIGSGGSSEVHKV--ISSDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKG-- 529
Y+ + +IG G +V K + + ALK+++++ + +E+ L L+
Sbjct: 3 YECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFE 62
Query: 530 KNNIIQLIDYEVTEKALLREVLNGSMNNKDGRVKDDGYIYMVLEYGEIDLAHMLSQKWKE 589
N+++L D V S +++ ++ +V E+ + DL L K E
Sbjct: 63 HPNVVRLFD-----------VCTVSRTDRETKLT------LVFEHVDQDLTTYL-DKVPE 104
Query: 590 MDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLLVK-GSLKLIDFGIAKA 648
+T+ + Q+L ++ +H R+VH DLKP N L+ G +KL DFG+A+
Sbjct: 105 PGVPTETIKDMMF-----QLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARI 159
Query: 649 IMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGRT 708
+ + S V TL Y +PE + + P D+WS+GCI +M +
Sbjct: 160 Y---SFQMALTSVVVTLWYRAPEVLLQSSY---------ATPVDLWSVGCIFAEMFRRKP 207
Query: 709 PF---SEYKTFWAKFKVITDPNHE 729
F S+ VI P E
Sbjct: 208 LFRGSSDVDQLGKILDVIGLPGEE 231
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 65.5 bits (159), Expect = 4e-11
Identities = 84/345 (24%), Positives = 137/345 (39%), Gaps = 96/345 (27%)
Query: 472 KLYQRLGKIGSGGSSEVHKVISSDCTIY--------ALKKIKLKGRDYATAYGFCQEIEY 523
K YQ L IGSG V C Y A+KK+ ++ A +E+
Sbjct: 24 KRYQNLKPIGSGAQGIV-------CAAYDAILERNVAIKKLSRPFQNQTHAKRAYREL-V 75
Query: 524 LNKLKGKNNIIQLIDYEVTEKALLREVLNGSMNNKDGRVKDDGYIYMVLEYGEIDLAHML 583
L K NII L++ +K+L ++ +Y+V+E + +L ++
Sbjct: 76 LMKCVNHKNIIGLLNVFTPQKSL----------------EEFQDVYIVMELMDANLCQVI 119
Query: 584 SQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLLVKG--SLKLI 641
+ LD + + Q+L + +H I+H DLKP+N ++VK +LK++
Sbjct: 120 QME----------LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSN-IVVKSDCTLKIL 168
Query: 642 DFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILY 701
DFG+A+ + T+ V T Y +PE + EN DIWS+GCI+
Sbjct: 169 DFGLAR---TAGTSFMMTPYVVTRYYRAPEVILGMGYKEN---------VDIWSVGCIMG 216
Query: 702 QMVYGRT--PFSEYKTFWAK-----------FKVITDPNHEITYEPVPN----------P 738
+M+ G P +++ W K F P E P P
Sbjct: 217 EMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFP 276
Query: 739 WLL----------------DLMKKCLAWDRNERWRIPQLLQHPFL 767
+L DL+ K L D ++R + + LQHP++
Sbjct: 277 DVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYI 321
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 5e-11
Identities = 75/294 (25%), Positives = 131/294 (44%), Gaps = 53/294 (18%)
Query: 428 KNSSSDMKLEASKSEKQEKAVSS-KGASAPRKRNYDPDLFFKVNGKLYQRLGKIGSGGSS 486
K S ++ K +++E++ ++ G ++ D D+ + K Y+ IG+G
Sbjct: 22 KGGSGKFEMNDKKLDEEERSHNNNAGEDEDEEKMIDNDIN-RSPNKSYKLGNIIGNGSFG 80
Query: 487 EVHKVISSDCT-IYALKKIKLKGRDYATAYGFCQEIEYLNK----LKGKN--NIIQLIDY 539
V++ I D + A+KK+ Q+ +Y N+ +K N NII L DY
Sbjct: 81 VVYEAICIDTSEKVAIKKV-------------LQDPQYKNRELLIMKNLNHINIIFLKDY 127
Query: 540 EVTEKALLREVLNGSMNNKDGRVKDDGYIYMVLEYGEIDLAHMLSQKWKEMDGSNQTLDE 599
TE E + ++ +V+E+ + + + K +N L
Sbjct: 128 YYTECFKKNE--------------KNIFLNVVMEF----IPQTVHKYMKHYARNNHALPL 169
Query: 600 NWLRFYWQQILEAVNTIHEERIVHSDLKPANFLLVKG--SLKLIDFGIAKAIMSDTTNIQ 657
++ Y Q+ A+ IH + I H DLKP N L+ +LKL DFG AK +++ ++
Sbjct: 170 FLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSV- 228
Query: 658 RDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGRTPFS 711
S + + Y +PE M ++ +I D+WSLGCI+ +M+ G FS
Sbjct: 229 --SYICSRFYRAPE-LMLGATNYTTHI-------DLWSLGCIIAEMILGYPIFS 272
|
Length = 440 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 64.9 bits (158), Expect = 7e-11
Identities = 51/197 (25%), Positives = 84/197 (42%), Gaps = 68/197 (34%)
Query: 563 KDDGYIYMVLEY---GEIDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEE 619
+D Y+Y+++E+ G DL ML K+ T E+ RFY + + A+ +H+
Sbjct: 71 QDAQYLYLIMEFLPGG--DLMTMLI-KY-------DTFSEDVTRFYMAECVLAIEAVHKL 120
Query: 620 RIVHSDLKPANFLL-VKGSLKLIDFGIA----------------------------KAIM 650
+H D+KP N L+ G +KL DFG++ ++
Sbjct: 121 GFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVA 180
Query: 651 SDTTNI---QRD--------------SQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDI 693
D+ N+ +D S VGT Y++PE F+ + G +C D
Sbjct: 181 VDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFL-----QQGYGQEC----DW 231
Query: 694 WSLGCILYQMVYGRTPF 710
WSLG I+++ + G PF
Sbjct: 232 WSLGAIMFECLIGWPPF 248
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 7e-11
Identities = 62/242 (25%), Positives = 105/242 (43%), Gaps = 43/242 (17%)
Query: 479 KIGSGGSSEVHKVISSDCTI---YALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQ 535
K+G G V+K D YALK+I+ G + C+EI L +LK N I
Sbjct: 8 KVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG----ISMSACREIALLRELKHPNVI-- 61
Query: 536 LIDYEVTEKALLREVLNGSMNNKDGRVKDDGYIYMVLEYGEIDLAHMLS-QKWKEMDGSN 594
AL + L+ S D ++++ +Y E DL H++ + + +
Sbjct: 62 ---------ALQKVFLSHS----------DRKVWLLFDYAEHDLWHIIKFHRASKANKKP 102
Query: 595 QTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLLV-----KGSLKLIDFGIAKAI 649
L + ++ QIL+ ++ +H ++H DLKPAN L++ +G +K+ D G A+
Sbjct: 103 MQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLF 162
Query: 650 MSDTTNIQR-DSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGRT 708
S + D V T Y +PE + + DIW++GCI +++
Sbjct: 163 NSPLKPLADLDPVVVTFWYRAPELLLGAR--------HYTKAIDIWAIGCIFAELLTSEP 214
Query: 709 PF 710
F
Sbjct: 215 IF 216
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 8e-11
Identities = 54/180 (30%), Positives = 88/180 (48%), Gaps = 28/180 (15%)
Query: 537 IDYEVTEKALLREVLNGS-MNNKDGRVKDDGYIYMVLEY--GEIDLAHMLSQKWKEMDGS 593
ID+ TEK + + N + + + ++ V+EY G + HM Q+
Sbjct: 39 IDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQR------- 91
Query: 594 NQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLL-VKGSLKLIDFGIAKAIM-- 650
L E RFY +I A+N +HE I++ DLK N LL +G +KL D+G+ K +
Sbjct: 92 --KLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP 149
Query: 651 SDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGRTPF 710
DTT+ + GT +Y++PE + G D W+LG ++++M+ GR+PF
Sbjct: 150 GDTTS----TFCGTPNYIAPEILRGEDY---------GFSVDWWALGVLMFEMMAGRSPF 196
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 1e-10
Identities = 37/122 (30%), Positives = 59/122 (48%), Gaps = 12/122 (9%)
Query: 590 MDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLL-VKGSLKLIDFGIAKA 648
+D N E FY QI+ + +H+ RI++ DLKP N LL G++++ D G+A
Sbjct: 87 VDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLAVE 146
Query: 649 IMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGRT 708
+ + + GT +M+PE E D + D ++LG LY+M+ R
Sbjct: 147 LKDGQSKTK--GYAGTPGFMAPELLQGEEYDFS---------VDYFALGVTLYEMIAARG 195
Query: 709 PF 710
PF
Sbjct: 196 PF 197
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 63.2 bits (153), Expect = 1e-10
Identities = 63/244 (25%), Positives = 105/244 (43%), Gaps = 47/244 (19%)
Query: 479 KIGSGGSSEVHKVISSDCTI---YALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQ 535
K+G G V+K D YALK+I+ G + C+EI L +LK N+I
Sbjct: 8 KVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG----ISMSACREIALLRELK-HPNVIS 62
Query: 536 LIDYEVTEKALLREVLNGSMNNKDGRVKDDGYIYMVLEYGEIDLAHMLSQKWKEMDGSNQ 595
L +K L D ++++ +Y E DL H++ K+ +N+
Sbjct: 63 L------QKVFLSHA--------------DRKVWLLFDYAEHDLWHII--KFHRASKANK 100
Query: 596 T---LDENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLLV-----KGSLKLIDFGIAK 647
L ++ QIL+ ++ +H ++H DLKPAN L++ +G +K+ D G A+
Sbjct: 101 KPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFAR 160
Query: 648 AIMSDTTNIQR-DSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYG 706
S + D V T Y +PE + + DIW++GCI +++
Sbjct: 161 LFNSPLKPLADLDPVVVTFWYRAPELLLGAR--------HYTKAIDIWAIGCIFAELLTS 212
Query: 707 RTPF 710
F
Sbjct: 213 EPIF 216
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 63.0 bits (153), Expect = 2e-10
Identities = 53/183 (28%), Positives = 89/183 (48%), Gaps = 24/183 (13%)
Query: 595 QTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLL-VKGSLKLIDFGIAKAIMSDT 653
E+ +RFY +I+ A+ +H+ IV+ D+K N LL +G + L DFG++K +S+
Sbjct: 100 DNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEE 159
Query: 654 TNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGRTPFS-- 711
+ S GT+ YM+PE + G+ G+ D WSLG ++++++ G +PF+
Sbjct: 160 KE-RTYSFCGTIEYMAPEII----RGKGGH----GKAVDWWSLGILIFELLTGASPFTLE 210
Query: 712 -EYKTFWAKFKVI--TDPNHEITYEPVPNPWLLDLMKKCLAWDRNER-----WRIPQLLQ 763
E T + I DP + P DL+ K L D +R ++ +
Sbjct: 211 GERNTQSEVSRRILKCDP----PFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKE 266
Query: 764 HPF 766
HPF
Sbjct: 267 HPF 269
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 63.2 bits (153), Expect = 2e-10
Identities = 69/260 (26%), Positives = 112/260 (43%), Gaps = 59/260 (22%)
Query: 472 KLYQRLGKIGSGGSSEVHKVISSDCTIY--------ALKKIKLKGRDYATAYGFCQEIEY 523
K YQ L IGSG V C Y A+KK+ ++ A +E+
Sbjct: 17 KRYQNLKPIGSGAQGIV-------CAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYREL-V 68
Query: 524 LNKLKGKNNIIQLIDYEVTEKALLREVLNGSMNNKDGRVKDDGYIYMVLEYGEIDLAHML 583
L K NII L++ +K+L ++ +Y+V+E + +L ++
Sbjct: 69 LMKCVNHKNIISLLNVFTPQKSL----------------EEFQDVYLVMELMDANLCQVI 112
Query: 584 SQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLLVKG--SLKLI 641
+ LD + + Q+L + +H I+H DLKP+N ++VK +LK++
Sbjct: 113 QME----------LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSN-IVVKSDCTLKIL 161
Query: 642 DFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILY 701
DFG+A+ + T+ V T Y +PE + EN DIWS+GCI+
Sbjct: 162 DFGLAR---TAGTSFMMTPYVVTRYYRAPEVILGMGYKEN---------VDIWSVGCIMG 209
Query: 702 QMVYGRT--PFSEYKTFWAK 719
+MV + P +Y W K
Sbjct: 210 EMVRHKILFPGRDYIDQWNK 229
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 2e-10
Identities = 54/183 (29%), Positives = 81/183 (44%), Gaps = 52/183 (28%)
Query: 563 KDDGYIYMVLEY-GEIDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERI 621
+D +Y+++E+ D+ +L +K TL E +FY + + A++ IH+
Sbjct: 71 QDKRNLYLIMEFLPGGDMMTLLMKK--------DTLSEEATQFYIAETVLAIDAIHQLGF 122
Query: 622 VHSDLKPANFLL-VKGSLKLIDFGIAKAIM----------------SD----TTNIQRD- 659
+H D+KP N LL KG +KL DFG+ + SD N +R
Sbjct: 123 IHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKA 182
Query: 660 ------------SQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGR 707
S VGT Y++PE FM + G C D WSLG I+Y+M+ G
Sbjct: 183 ETWKKNRRQLAYSTVGTPDYIAPEVFM-----QTGYNKLC----DWWSLGVIMYEMLIGY 233
Query: 708 TPF 710
PF
Sbjct: 234 PPF 236
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 62.5 bits (152), Expect = 4e-10
Identities = 39/120 (32%), Positives = 60/120 (50%), Gaps = 12/120 (10%)
Query: 593 SNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLLVKGS--LKLIDFGIAKAIM 650
S Q L + ++ + QIL + +H I+H D+KP N LLV + LK+ DFG+A+
Sbjct: 96 SPQPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGN-LLVNSNCVLKICDFGLARVEE 154
Query: 651 SDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGRTPF 710
D + +V T Y +PE M S + + DIWS+GCI +++ R F
Sbjct: 155 PDESKHM-TQEVVTQYYRAPEILM--GSRHYTSAV------DIWSVGCIFAELLGRRILF 205
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 61.4 bits (149), Expect = 4e-10
Identities = 41/162 (25%), Positives = 72/162 (44%), Gaps = 32/162 (19%)
Query: 620 RIVHSDLKPANFLL-VKGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNES 678
+I+H D+KP+N L+ +G +KL DFG++ +++ + VGT +YM+PE +
Sbjct: 115 KILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSIAK----TYVGTNAYMAPERISGEQY 170
Query: 679 DENGNIIKCGRPSDIWSLGCILYQMVYGRTPFSEYKTFWAK------FKVITD------P 726
G SD+WSLG ++ GR P+ + + + I D P
Sbjct: 171 ---------GIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVLP 221
Query: 727 NHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQHPFLV 768
+ + + + +C+ ER L+ HPF+V
Sbjct: 222 VGQFS------EKFVHFITQCMRKQPKERPAPENLMDHPFIV 257
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 5e-10
Identities = 41/151 (27%), Positives = 77/151 (50%), Gaps = 22/151 (14%)
Query: 565 DGYIYMVLEY---GEIDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERI 621
D ++++L+Y GE+ H LSQ+ + E ++ Y +I+ A+ +H+ I
Sbjct: 77 DTKLHLILDYINGGEL-FTH-LSQR--------ERFKEQEVQIYSGEIVLALEHLHKLGI 126
Query: 622 VHSDLKPANFLL-VKGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDE 680
++ D+K N LL G + L DFG++K D + S GT+ YM+P+ +
Sbjct: 127 IYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVE-RAYSFCGTIEYMAPDIVRGGDGGH 185
Query: 681 NGNIIKCGRPSDIWSLGCILYQMVYGRTPFS 711
+ + D WS+G ++Y+++ G +PF+
Sbjct: 186 D-------KAVDWWSMGVLMYELLTGASPFT 209
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 61.4 bits (149), Expect = 6e-10
Identities = 63/231 (27%), Positives = 105/231 (45%), Gaps = 55/231 (23%)
Query: 488 VHKVISSDC-TIYA---LKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTE 543
V K+ D +YA LKK LK RD +++ K E
Sbjct: 15 VRKITGPDAGQLYAMKVLKKATLKVRD---------------RVRTKM-----------E 48
Query: 544 KALLREVLNGSMNNKDGRVKDDGYIYMVLEY---GEIDLAHMLSQKWKEMDGSNQTLDEN 600
+ +L EV + + + +G +Y++L++ G DL LS KE+ E
Sbjct: 49 RDILAEVNHPFIVKLHYAFQTEGKLYLILDFLRGG--DLFTRLS---KEV-----MFTEE 98
Query: 601 WLRFYWQQILEAVNTIHEERIVHSDLKPANFLL-VKGSLKLIDFGIAKAIMSDTTNIQRD 659
++FY ++ A++ +H I++ DLKP N LL +G +KL DFG++K +
Sbjct: 99 DVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAY-- 156
Query: 660 SQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGRTPF 710
S GT+ YM+PE + G+ + +D WS G ++++M+ G PF
Sbjct: 157 SFCGTVEYMAPEVV-----NRRGH----TQSADWWSFGVLMFEMLTGSLPF 198
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 61.3 bits (149), Expect = 7e-10
Identities = 44/145 (30%), Positives = 74/145 (51%), Gaps = 25/145 (17%)
Query: 568 IYMVLEYGEIDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLK 627
+Y+V+E + +L ++ +MD LD + + Q+L + +H I+H DLK
Sbjct: 96 VYLVMELMDANLCQVI-----QMD-----LDHERMSYLLYQMLCGIKHLHSAGIIHRDLK 145
Query: 628 PANFLLVKG--SLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNII 685
P+N ++VK +LK++DFG+A+ + T+ V T Y +PE + EN
Sbjct: 146 PSN-IVVKSDCTLKILDFGLAR---TAGTSFMMTPYVVTRYYRAPEVILGMGYKEN---- 197
Query: 686 KCGRPSDIWSLGCILYQMVYGRTPF 710
DIWS+GCI+ +M+ G F
Sbjct: 198 -----VDIWSVGCIMGEMIRGTVLF 217
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 60.9 bits (148), Expect = 7e-10
Identities = 35/112 (31%), Positives = 57/112 (50%), Gaps = 16/112 (14%)
Query: 603 RFYWQQILEAVNTIHEERIVHSDLKPANFLL-VKGSLKLIDFGIAKAIM--SDTTNIQRD 659
FY ++ + +HE +IV+ DLK N LL +G +K+ DFG+ K M D T+
Sbjct: 104 VFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDRTS---- 159
Query: 660 SQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGRTPFS 711
+ GT +++PE ++ R D W LG ++Y+M+ G +PF
Sbjct: 160 TFCGTPEFLAPEVL----TET-----SYTRAVDWWGLGVLIYEMLVGESPFP 202
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 2e-09
Identities = 51/174 (29%), Positives = 81/174 (46%), Gaps = 21/174 (12%)
Query: 609 ILEAVNTIHEERIVHSDLKPANFLLVK-GSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSY 667
+L A++ +H + ++H D+K + LL G +KL DFG + + +R S VGT +
Sbjct: 127 VLRALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVP--KRKSLVGTPYW 184
Query: 668 MSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGRTPFSEYKTFWAKFKVITD-P 726
M+PE + + G DIWSLG ++ +M+ G P+ A ++ + P
Sbjct: 185 MAPEVI---------SRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNLP 235
Query: 727 NHEITYEPVPNPW--LLDLMKKCLAWDRNERWRIPQLLQHPFLV---PPVSTQP 775
V + LDLM L + ++R +LLQHPFL PP P
Sbjct: 236 PRVKDSHKVSSVLRGFLDLM---LVREPSQRATAQELLQHPFLKLAGPPSCIVP 286
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 58.7 bits (142), Expect = 4e-09
Identities = 36/114 (31%), Positives = 56/114 (49%), Gaps = 12/114 (10%)
Query: 598 DENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLL-VKGSLKLIDFGIAKAIMSDTTNI 656
DE RFY ++ A+ +H +++ DLK N LL +G KL DFG+ K + +
Sbjct: 94 DEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGI--LNGV 151
Query: 657 QRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGRTPF 710
+ GT Y++PE E G D W+LG ++Y+M+ G+ PF
Sbjct: 152 TTTTFCGTPDYIAPEILQELEY---------GPSVDWWALGVLMYEMMAGQPPF 196
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 4e-09
Identities = 35/93 (37%), Positives = 49/93 (52%), Gaps = 14/93 (15%)
Query: 618 EERIVHSDLKPANFLL-VKGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCN 676
+ +I+H D+KP+N L+ +G +KL DFG++ ++ N S VGT SYMSPE
Sbjct: 122 KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN----SFVGTRSYMSPERLQGT 177
Query: 677 ESDENGNIIKCGRPSDIWSLGCILYQMVYGRTP 709
SDIWS+G L +M GR P
Sbjct: 178 HYSVQ---------SDIWSMGLSLVEMAIGRYP 201
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 58.8 bits (142), Expect = 4e-09
Identities = 43/137 (31%), Positives = 66/137 (48%), Gaps = 15/137 (10%)
Query: 597 LDENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLL-VKGSLKLIDFGIAKAIMSDTTN 655
DE RFY +I A+ +H++ I++ DLK N LL +G KL DFG+ K + +
Sbjct: 93 FDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFN--G 150
Query: 656 IQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGRTPFSEYKT 715
+ GT Y++PE + G D W++G +LY+M+ G PF E +
Sbjct: 151 KTTSTFCGTPDYIAPEIL---------QEMLYGPSVDWWAMGVLLYEMLCGHAPF-EAEN 200
Query: 716 FWAKFKVITDPNHEITY 732
F+ I N E+ Y
Sbjct: 201 EDDLFEAIL--NDEVVY 215
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 59.8 bits (144), Expect = 5e-09
Identities = 72/270 (26%), Positives = 115/270 (42%), Gaps = 62/270 (22%)
Query: 474 YQRLGKIGSGGSSEVHKVISSDCT-IYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNN 532
Y+ + KIG+G EV V + K I +G E+ + +LK KN
Sbjct: 15 YEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKN- 73
Query: 533 IIQLIDYEVTEKALLREVLNGSMNNKDGRVKDDGYIYMVLEYGEI-DLAHMLSQKWKEMD 591
I++ ID LN K + +Y+++E+ + DL+ + QK +M
Sbjct: 74 IVRYID----------RFLN----------KANQKLYILMEFCDAGDLSRNI-QKCYKMF 112
Query: 592 GSNQTLDENWLRFYWQQILEAVNTIHE-------ERIVHSDLKPANFLLVKGS------- 637
G ++E+ + +Q+L A+ H ER++H DLKP N L G
Sbjct: 113 GK---IEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKIT 169
Query: 638 -----------LKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIK 686
K+ DFG++K I ++ S VGT Y SPE + +
Sbjct: 170 AQANNLNGRPIAKIGDFGLSKNIGIES---MAHSCVGTPYYWSPELLLHETKSYDDK--- 223
Query: 687 CGRPSDIWSLGCILYQMVYGRTPFSEYKTF 716
SD+W+LGCI+Y++ G+TPF + F
Sbjct: 224 ----SDMWALGCIIYELCSGKTPFHKANNF 249
|
Length = 1021 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 59.5 bits (144), Expect = 5e-09
Identities = 44/145 (30%), Positives = 76/145 (52%), Gaps = 15/145 (10%)
Query: 568 IYMVLEYGEIDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLK 627
I +VL+Y A L Q+ K +N+T E+ + Q+L AV+ +H + ++H D+K
Sbjct: 114 IALVLDYAN---AGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIK 170
Query: 628 PANFLLV-KGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAF-MCNESDENGNII 685
AN LL G +KL DFG +K + ++ + GT Y++PE + S
Sbjct: 171 SANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYS------- 223
Query: 686 KCGRPSDIWSLGCILYQMVYGRTPF 710
+ +D++SLG +LY+++ + PF
Sbjct: 224 ---KKADMFSLGVLLYELLTLKRPF 245
|
Length = 496 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 58.4 bits (141), Expect = 5e-09
Identities = 35/108 (32%), Positives = 55/108 (50%), Gaps = 12/108 (11%)
Query: 604 FYWQQILEAVNTIHEERIVHSDLKPANFLL-VKGSLKLIDFGIAKAIMSDTTNIQRDSQV 662
FY +I+ + +H + IV+ DLK N LL G +K+ DFG+ K M + + +
Sbjct: 100 FYAAEIICGLQFLHSKGIVYRDLKLDNILLDTDGHIKIADFGMCKENM--LGDAKTCTFC 157
Query: 663 GTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGRTPF 710
GT Y++PE + K D WS G +LY+M+ G++PF
Sbjct: 158 GTPDYIAPEILLGQ---------KYNTSVDWWSFGVLLYEMLIGQSPF 196
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 2e-08
Identities = 41/157 (26%), Positives = 69/157 (43%), Gaps = 36/157 (22%)
Query: 608 QILEAVNTIHEERIVHSDLKPANFLLVKGSL-KLIDFGIAKAIMSDTTNIQRDSQVGTLS 666
Q+ + + + VH DL N L+ +G L K+ DFG+A+ IM D+ I + S L
Sbjct: 247 QVANGMEFLASKNCVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLK 306
Query: 667 YMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQM-VYGRTPFSEYKTFWAKFKVITD 725
+M+PE+ N SD+WS G +L+++ G TP+ E
Sbjct: 307 WMAPESIFNNLYTT---------LSDVWSFGILLWEIFTLGGTPYPEL------------ 345
Query: 726 PNHEITYEPVPNPW-----------LLDLMKKCLAWD 751
P +E Y + + + ++M+KC W+
Sbjct: 346 PMNEQFYNAIKRGYRMAKPAHASDEIYEIMQKC--WE 380
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 2e-08
Identities = 34/93 (36%), Positives = 49/93 (52%), Gaps = 14/93 (15%)
Query: 618 EERIVHSDLKPANFLL-VKGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCN 676
+ +I+H D+KP+N L+ +G +KL DFG++ ++ N S VGT SYMSPE
Sbjct: 122 KHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN----SFVGTRSYMSPERLQGT 177
Query: 677 ESDENGNIIKCGRPSDIWSLGCILYQMVYGRTP 709
SDIWS+G L ++ GR P
Sbjct: 178 HYSVQ---------SDIWSMGLSLVELAIGRYP 201
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 56.4 bits (136), Expect = 3e-08
Identities = 59/259 (22%), Positives = 113/259 (43%), Gaps = 47/259 (18%)
Query: 517 FCQEIEYLNKLKGK-NNIIQLIDYEVTEKALLREVLNGSMNNKDGRVKDDGYIYM----- 570
+C + LN L+ K ++ I + E AL + +L+ + D + Y+ M
Sbjct: 120 YCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSL---NEYMDMKPGVS 176
Query: 571 --------------VLEYGEIDLAHMLSQKWKEMDGSNQTLD-ENWLRFYWQQILEAVNT 615
Y + D+ + ++ LD E+ L F +Q + + ++
Sbjct: 177 YVVPTKADKRRSVRSGSYIDQDVTSEI------LEEDELALDTEDLLSFSYQ-VAKGMSF 229
Query: 616 IHEERIVHSDLKPANFLLVKGSL-KLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEA-F 673
+ + +H DL N LL G + K+ DFG+A+ I +D+ + + + + +M+PE+ F
Sbjct: 230 LASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNARLPVKWMAPESIF 289
Query: 674 MCNESDENGNIIKCGRPSDIWSLGCILYQMV-YGRTPFSEYKTFWAKFKVITDPNHEITY 732
C + E SD+WS G +L+++ G +P+ +K+I + ++
Sbjct: 290 NCVYTFE----------SDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGYRMLSP 339
Query: 733 EPVPNPWLLDLMKKCLAWD 751
E P + D+MK C WD
Sbjct: 340 ECAP-SEMYDIMKSC--WD 355
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 56.0 bits (135), Expect = 3e-08
Identities = 53/204 (25%), Positives = 93/204 (45%), Gaps = 25/204 (12%)
Query: 566 GYIYMVLEY---GEIDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIV 622
G I ++ EY G DL + L +K + L L + Q+ + + + + +
Sbjct: 112 GPILVITEYCCYG--DLLNFLRRKRESF------LTLEDLLSFSYQVAKGMAFLASKNCI 163
Query: 623 HSDLKPANFLLVKGSL-KLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEA-FMCNESDE 680
H DL N LL G + K+ DFG+A+ IM+D+ + + + + +M+PE+ F C + E
Sbjct: 164 HRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFE 223
Query: 681 NGNIIKCGRPSDIWSLGCILYQMV-YGRTPFSEYKTFWAKFKVITDPNHEITYEPVPNPW 739
SD+WS G +L+++ G P+ +K+I + E P
Sbjct: 224 ----------SDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEGYRMAQPEHAPAE- 272
Query: 740 LLDLMKKCLAWDRNERWRIPQLLQ 763
+ D+MK C D +R Q++Q
Sbjct: 273 IYDIMKTCWDADPLKRPTFKQIVQ 296
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 5e-08
Identities = 71/314 (22%), Positives = 133/314 (42%), Gaps = 59/314 (18%)
Query: 464 DLFFKVN-GKLYQRLGKIGSGGSSEVH---KVISSDCTIYALKKIKLKGRDYATAY-GFC 518
+LF K + KL+ L +IG G V+ V +++ + A+KK+ G+ +
Sbjct: 6 ELFSKDDPEKLFTDLREIGHGSFGAVYFARDVRTNE--VVAIKKMSYSGKQSNEKWQDII 63
Query: 519 QEIEYLNKLKGKNNIIQLIDYEVTEKALLREVLNGSMNNKDGRVKDDGYIYMVLEYGEID 578
+E+ +L +L+ N I+Y+ LRE ++V+EY
Sbjct: 64 KEVRFLQQLRHPN----TIEYK---GCYLREHT----------------AWLVMEYCLGS 100
Query: 579 LAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLLVK-GS 637
+ +L + + L E + L+ + +H +H D+K N LL + G+
Sbjct: 101 ASDIL-------EVHKKPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEPGT 153
Query: 638 LKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMC-NESDENGNIIKCGRPSDIWSL 696
+KL DFG A +++S +S VGT +M+PE + +E +G + D+WSL
Sbjct: 154 VKLADFGSA-SLVSPA-----NSFVGTPYWMAPEVILAMDEGQYDGKV-------DVWSL 200
Query: 697 GCILYQMVYGRTPFSEYKTFWAKFKVITDPNHEITYEPVPNPW---LLDLMKKCLAWDRN 753
G ++ + P A + + + + ++ N W + + CL
Sbjct: 201 GITCIELAERKPPLFNMNAMSALYHIAQNDSPTLS----SNDWSDYFRNFVDSCLQKIPQ 256
Query: 754 ERWRIPQLLQHPFL 767
+R +LL+H F+
Sbjct: 257 DRPSSEELLKHRFV 270
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 54.2 bits (131), Expect = 6e-08
Identities = 62/241 (25%), Positives = 98/241 (40%), Gaps = 57/241 (23%)
Query: 479 KIGSGGSSEVHKVISSDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLID 538
K+G+G EV + T A+K +K G A F QE + + KL+ + ++QL
Sbjct: 13 KLGAGQFGEVWMGTWNGTTKVAVKTLK-PGTMSPEA--FLQEAQIMKKLR-HDKLVQL-- 66
Query: 539 YEVTEKALLREVLNGSMNNKDGRVKDDGYIYMVLEYGEIDLAHM----LSQKWKEMDGSN 594
Y V ++ IY+V EY M L K +G
Sbjct: 67 YAV--------------------CSEEEPIYIVTEY-------MSKGSLLDFLKSGEGKK 99
Query: 595 QTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLLVKGSL-KLIDFGIAKAIMSDT 653
L + L QI E + + +H DL N L+ + + K+ DFG+A+ I D
Sbjct: 100 LRLPQ--LVDMAAQIAEGMAYLESRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDE 157
Query: 654 TNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGR---PSDIWSLGCILYQMV-YGRTP 709
+ ++ + + +PEA GR SD+WS G +L ++V YGR P
Sbjct: 158 YTAREGAKF-PIKWTAPEA------------ANYGRFTIKSDVWSFGILLTEIVTYGRVP 204
Query: 710 F 710
+
Sbjct: 205 Y 205
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 54.8 bits (132), Expect = 7e-08
Identities = 46/153 (30%), Positives = 71/153 (46%), Gaps = 37/153 (24%)
Query: 568 IYMVLEY---GEIDLAHMLSQ--KWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIV 622
+Y V+EY G DL + + Q K+KE FY +I + +H + I+
Sbjct: 76 LYFVMEYVNGG--DLMYHIQQVGKFKEPHAV----------FYAAEIAIGLFFLHSKGII 123
Query: 623 HSDLKPANFLL-VKGSLKLIDFGIAKA-IMSDTTNIQRDSQVGTLSYMSPEAFMCNESDE 680
+ DLK N +L +G +K+ DFG+ K I T + GT Y++PE
Sbjct: 124 YRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTT---RTFCGTPDYIAPE--------- 171
Query: 681 NGNII---KCGRPSDIWSLGCILYQMVYGRTPF 710
II G+ D W+ G +LY+M+ G+ PF
Sbjct: 172 ---IIAYQPYGKSVDWWAFGVLLYEMLAGQPPF 201
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 9e-08
Identities = 43/147 (29%), Positives = 68/147 (46%), Gaps = 25/147 (17%)
Query: 568 IYMVLEY-GEIDLAHMLSQ--KWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHS 624
+Y V+EY DL + + Q K+KE FY +I + +H I++
Sbjct: 76 LYFVMEYVNGGDLMYHIQQVGKFKEPQAV----------FYAAEISVGLFFLHRRGIIYR 125
Query: 625 DLKPANFLL-VKGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGN 683
DLK N +L +G +K+ DFG+ K M D + + GT Y++PE
Sbjct: 126 DLKLDNVMLDSEGHIKIADFGMCKEHMVD--GVTTRTFCGTPDYIAPEIIAYQPY----- 178
Query: 684 IIKCGRPSDIWSLGCILYQMVYGRTPF 710
G+ D W+ G +LY+M+ G+ PF
Sbjct: 179 ----GKSVDWWAYGVLLYEMLAGQPPF 201
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 9e-08
Identities = 79/306 (25%), Positives = 128/306 (41%), Gaps = 62/306 (20%)
Query: 474 YQRLGKIGSGGSSEVHKVIS-SDCTIYALKKIKLK-GRDYATAYGFCQEIEYLNKLKGKN 531
++ + +IGSG +V+K + + + A+K IKL+ G D+A QEI + K N
Sbjct: 11 FELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQ---QEIIMMKDCKHSN 67
Query: 532 NIIQLIDYEVTEKALLREVLNGSMNNKDGRVKDDGYIYMVLEYGEIDLAHMLSQKWKEMD 591
+ Y L R+ L M G D IY V
Sbjct: 68 IVAYFGSY------LRRDKLWICMEFCGGGSLQD--IYHV-------------------- 99
Query: 592 GSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLLV-KGSLKLIDFGIAKAIM 650
L E+ + + ++ L+ + +H + +H D+K AN LL G +KL DFG++ I
Sbjct: 100 --TGPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDNGHVKLADFGVSAQIT 157
Query: 651 SDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGRTPF 710
+ T +R S +GT +M+PE + DIW++G ++ + P
Sbjct: 158 A--TIAKRKSFIGTPYWMAPEVAAVERKGGYNQL------CDIWAVGITAIELAELQPPM 209
Query: 711 SEYKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKC--------LAWDRNERWR--IPQ 760
+ A F ++T N ++P P L D MK +A +N + R +
Sbjct: 210 FDLHPMRALF-LMTKSN----FQP---PKLKDKMKWSNSFHHFVKMALTKNPKKRPTAEK 261
Query: 761 LLQHPF 766
LLQHPF
Sbjct: 262 LLQHPF 267
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 53.8 bits (129), Expect = 1e-07
Identities = 45/189 (23%), Positives = 80/189 (42%), Gaps = 21/189 (11%)
Query: 570 MVLEYGEIDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPA 629
+V+E E+ + QK N+ + E + Q+ + + E VH DL
Sbjct: 72 LVMELAELGPLNKFLQK-------NKHVTEKNITELVHQVSMGMKYLEETNFVHRDLAAR 124
Query: 630 NFLLV-KGSLKLIDFGIAKAIMSDTTNIQRDSQVG-TLSYMSPEAFMCNESDENGNIIKC 687
N LLV + K+ DFG++KA+ +D + + + + +PE N K
Sbjct: 125 NVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECM---------NYYKF 175
Query: 688 GRPSDIWSLGCILYQMV-YGRTPFSEYKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKK 746
SD+WS G ++++ YG+ P+ K + + + + P + DLMK
Sbjct: 176 SSKSDVWSFGVLMWEAFSYGQKPYKGMKG--NEVTQMIESGERMECPQRCPPEMYDLMKL 233
Query: 747 CLAWDRNER 755
C + +ER
Sbjct: 234 CWTYGVDER 242
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 1e-07
Identities = 43/145 (29%), Positives = 70/145 (48%), Gaps = 17/145 (11%)
Query: 568 IYMVLEYGEIDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLK 627
IY++ E+ L K +GS Q L + L + QI E + I + +H DL+
Sbjct: 75 IYIITEFMA---KGSLLDFLKSDEGSKQPLPK--LIDFSAQIAEGMAFIEQRNYIHRDLR 129
Query: 628 PANFLLVKGSL-KLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIK 686
AN L+ + K+ DFG+A+ ++ D R+ + + +PEA + IK
Sbjct: 130 AANILVSASLVCKIADFGLAR-VIEDNEYTAREGAKFPIKWTAPEAI-----NFGSFTIK 183
Query: 687 CGRPSDIWSLGCILYQMV-YGRTPF 710
SD+WS G +L ++V YGR P+
Sbjct: 184 ----SDVWSFGILLMEIVTYGRIPY 204
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 1e-07
Identities = 57/221 (25%), Positives = 88/221 (39%), Gaps = 64/221 (28%)
Query: 599 ENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLL-VKGSLKLIDFGIAKAI-------- 649
E RFY ++ A+ ++H+ +H D+KP N L+ + G +KL DFG+
Sbjct: 100 EVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKY 159
Query: 650 MSDTTNIQRDSQ-------------------------------------VGTLSYMSPEA 672
++I++DS VGT +Y++PE
Sbjct: 160 YQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEV 219
Query: 673 FMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGRTPFSEYKTFWAKFKVITDPNHEITY 732
+ G C D WS+G IL++M+ G+ PF + KVI N E T
Sbjct: 220 LL-----RKGYTQLC----DWWSVGVILFEMLVGQPPFLAPTPTETQLKVI---NWENTL 267
Query: 733 EPVP----NPWLLDLMKK--CLAWDRNERWRIPQLLQHPFL 767
P +P +DL+ K C A +R R + HPF
Sbjct: 268 HIPPQVKLSPEAVDLITKLCCSAEERLGRNGADDIKAHPFF 308
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 53.0 bits (127), Expect = 3e-07
Identities = 34/112 (30%), Positives = 57/112 (50%), Gaps = 20/112 (17%)
Query: 604 FYWQQILEAVNTIHEERIVHSDLKPANFLLVK-GSLKLIDFGIAKAIMSDTTNIQRDSQV 662
FY +I+ + +H + I++ DLK N +L + G +K+ DFG+ K N+ D++
Sbjct: 100 FYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGHIKIADFGMCKE------NVFGDNRA 153
Query: 663 ----GTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGRTPF 710
GT Y++PE +K D WS G +LY+M+ G++PF
Sbjct: 154 STFCGTPDYIAPEILQG---------LKYTFSVDWWSFGVLLYEMLIGQSPF 196
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 3e-07
Identities = 46/165 (27%), Positives = 76/165 (46%), Gaps = 24/165 (14%)
Query: 591 DGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLLVKGSL-KLIDFGIAKAI 649
D ++ L L + Q+ + + + VH DL N LL +G + K+ DFG+A+ I
Sbjct: 228 DDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVLLAQGKIVKICDFGLARDI 287
Query: 650 MSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMV-YGRT 708
M D+ + + S + +M+PE+ N SD+WS G +L+++ G T
Sbjct: 288 MHDSNYVSKGSTFLPVKWMAPESIFDNLYTT---------LSDVWSYGILLWEIFSLGGT 338
Query: 709 PFSEY---KTFWAKFKV---ITDPNHEITYEPVPNPWLLDLMKKC 747
P+ TF+ K K + P+H T E + D+M KC
Sbjct: 339 PYPGMIVDSTFYNKIKSGYRMAKPDHA-TQE------VYDIMVKC 376
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 52.2 bits (126), Expect = 3e-07
Identities = 36/126 (28%), Positives = 60/126 (47%), Gaps = 21/126 (16%)
Query: 593 SNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLLV--KGSLKLIDFGIAKAIM 650
L E ++ +Q++EA+N +H+ I+H+D+K N L K + L D+G+ K I
Sbjct: 102 KEGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIG 161
Query: 651 SDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIK--CGRPSDIWSLGCILYQMVYGRT 708
+ + D GTL Y SPE I D W++G + Y+++ G+
Sbjct: 162 TPSC---YD---GTLDYFSPE-----------KIKGHNYDVSFDWWAVGVLTYELLTGKH 204
Query: 709 PFSEYK 714
PF E +
Sbjct: 205 PFKEDE 210
|
Length = 267 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 4e-07
Identities = 42/147 (28%), Positives = 69/147 (46%), Gaps = 25/147 (17%)
Query: 568 IYMVLEY-GEIDLAHMLSQ--KWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHS 624
+Y V+EY DL + + Q ++KE FY +I + +H + I++
Sbjct: 76 LYFVMEYVNGGDLMYQIQQVGRFKEPHAV----------FYAAEIAIGLFFLHSKGIIYR 125
Query: 625 DLKPANFLL-VKGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGN 683
DLK N +L +G +K+ DFG+ K M D + + GT Y++PE
Sbjct: 126 DLKLDNVMLDSEGHIKIADFGMCKENMWD--GVTTKTFCGTPDYIAPEIIAYQPY----- 178
Query: 684 IIKCGRPSDIWSLGCILYQMVYGRTPF 710
G+ D W+ G +LY+M+ G+ PF
Sbjct: 179 ----GKSVDWWAFGVLLYEMLAGQAPF 201
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 51.7 bits (124), Expect = 5e-07
Identities = 55/249 (22%), Positives = 102/249 (40%), Gaps = 73/249 (29%)
Query: 479 KIGSGGSSEVHKVISSDCTIYALKKIK----LKGRDYATAYGFCQEIEYLNKLKGKNNII 534
K+GSG EV + + + A+K +K LK +D+ E++ L +L+ K+ +I
Sbjct: 13 KLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQK------EVQALKRLRHKH-LI 65
Query: 535 QL-----------IDYEVTEKALLREVLNGSMNNKDGRVKDDGYIYMVLEYGEIDLAHML 583
L I E+ EK L L + +G+V + +A ++
Sbjct: 66 SLFAVCSVGEPVYIITELMEKGSLLAFLR----SPEGQV--------------LPVASLI 107
Query: 584 SQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLLVKGSL-KLID 642
Q+ E + + E+ +H DL N L+ + + K+ D
Sbjct: 108 DMAC--------------------QVAEGMAYLEEQNSIHRDLAARNILVGEDLVCKVAD 147
Query: 643 FGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQ 702
FG+A+ ++ + + D ++ + +PEA + SD+WS G +LY+
Sbjct: 148 FGLAR-LIKEDVYLSSDKKI-PYKWTAPEAA---------SHGTFSTKSDVWSFGILLYE 196
Query: 703 MV-YGRTPF 710
M YG+ P+
Sbjct: 197 MFTYGQVPY 205
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 52.0 bits (124), Expect = 5e-07
Identities = 75/323 (23%), Positives = 137/323 (42%), Gaps = 68/323 (21%)
Query: 462 DPD---LFFKVN-GKLYQRLGKIGSGGSSEV---HKVISSDCTIYALKKIKLKGRDYATA 514
DP+ LFFK + KL+ L +IG G V V +++ + A+KK+ G+
Sbjct: 11 DPEIAELFFKEDPEKLFTDLREIGHGSFGAVYFARDVRTNE--VVAIKKMSYSGKQSNEK 68
Query: 515 Y-GFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLREVLNGSMNNKDGRVKDDGYIYMVLE 573
+ +E+++L ++K N+I +Y+ LRE ++V+E
Sbjct: 69 WQDIIKEVKFLQRIKHPNSI----EYK---GCYLRE----------------HTAWLVME 105
Query: 574 Y---GEIDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPAN 630
Y DL + + +E++ + T L+ + +H ++H D+K N
Sbjct: 106 YCLGSASDLLEVHKKPLQEVEIAAIT----------HGALQGLAYLHSHNMIHRDIKAGN 155
Query: 631 FLLVK-GSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMC-NESDENGNIIKCG 688
LL + G +KL DFG A ++ N S VGT +M+PE + +E +G +
Sbjct: 156 ILLTEPGQVKLADFG--SASIASPAN----SFVGTPYWMAPEVILAMDEGQYDGKV---- 205
Query: 689 RPSDIWSLGCILYQMVYGRTPFSEYKTFWAKFKVITDPNHEITYEPVPNPW---LLDLMK 745
D+WSLG ++ + P A + + + + + N W + +
Sbjct: 206 ---DVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQ----SNEWSDYFRNFVD 258
Query: 746 KCLAWDRNERWRIPQLLQHPFLV 768
CL +R +LL+H F++
Sbjct: 259 SCLQKIPQDRPTSEELLKHMFVL 281
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 6e-07
Identities = 37/106 (34%), Positives = 56/106 (52%), Gaps = 14/106 (13%)
Query: 608 QILEAVNTIHEERIVHSDLKPANFLLVKGSL--KLIDFGIAKAIMSDTTNIQRDSQVGTL 665
QI E + I + +H DL+ AN +LV SL K+ DFG+A+ I D R+ +
Sbjct: 111 QIAEGMAYIERKNYIHRDLRAAN-VLVSESLMCKIADFGLARVI-EDNEYTAREGAKFPI 168
Query: 666 SYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMV-YGRTPF 710
+ +PEA + IK SD+WS G +LY++V YG+ P+
Sbjct: 169 KWTAPEAI-----NFGSFTIK----SDVWSFGILLYEIVTYGKIPY 205
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 7e-07
Identities = 46/171 (26%), Positives = 67/171 (39%), Gaps = 55/171 (32%)
Query: 599 ENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLLVK-GSLKLIDFGIAKAIM------- 650
E+ RFY ++ AV ++H+ +H D+KP N L+ + G +KL DFG+
Sbjct: 100 EDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKY 159
Query: 651 ------------------SDTTNI-----------------QR---DSQVGTLSYMSPEA 672
D N QR S VGT +Y++PE
Sbjct: 160 YQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEV 219
Query: 673 FMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGRTPFSEYKTFWAKFKVI 723
+ G C D WS+G ILY+M+ G+ PF + KVI
Sbjct: 220 LL-----RTGYTQLC----DWWSVGVILYEMLVGQPPFLAQTPLETQMKVI 261
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 9e-07
Identities = 75/323 (23%), Positives = 131/323 (40%), Gaps = 70/323 (21%)
Query: 462 DP---DLFFKVN-GKLYQRLGKIGSGGSSEVH--KVISSDCTIYALKKIKLKGRDYATAY 515
DP +LFFK + KL+ L +IG G V+ + + + + A+KK+ G+ +
Sbjct: 1 DPDVAELFFKDDPEKLFSDLREIGHGSFGAVYFARDVRNS-EVVAIKKMSYSGKQSNEKW 59
Query: 516 -GFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLREVLNGSMNNKDGRVKDDGYIYMVLEY 574
+E+ +L KL+ N I Y LRE ++V+EY
Sbjct: 60 QDIIKEVRFLQKLRHPNTI----QYR---GCYLRE----------------HTAWLVMEY 96
Query: 575 ---GEIDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANF 631
DL + + +E++ + T L+ + +H ++H D+K N
Sbjct: 97 CLGSASDLLEVHKKPLQEVEIAAVT----------HGALQGLAYLHSHNMIHRDVKAGNI 146
Query: 632 LLVK-GSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMC-NESDENGNIIKCGR 689
LL + G +KL DFG A +IM+ + VGT +M+PE + +E +G +
Sbjct: 147 LLSEPGLVKLGDFGSA-SIMAPA-----NXFVGTPYWMAPEVILAMDEGQYDGKV----- 195
Query: 690 PSDIWSLGCILYQMVYGRTPFSEYKTFWAKFKVITDPNHEITYEPV--PNPW---LLDLM 744
D+WSLG ++ + P A + + + + P W + +
Sbjct: 196 --DVWSLGITCIELAERKPPLFNMNAMSALYHIAQNES------PALQSGHWSEYFRNFV 247
Query: 745 KKCLAWDRNERWRIPQLLQHPFL 767
CL +R LL+H F+
Sbjct: 248 DSCLQKIPQDRPTSEVLLKHRFV 270
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 51.3 bits (123), Expect = 9e-07
Identities = 44/212 (20%), Positives = 80/212 (37%), Gaps = 49/212 (23%)
Query: 605 YWQQILEAVNTIHEERIVHSDLKPANFLLVKGSL-KLIDFGIAKAIMSD----TTNIQRD 659
+ QI + ++ + +R +H DL N L+ L K+ DFG+AK + D +
Sbjct: 114 FSSQICKGMDYLGSQRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGE 173
Query: 660 SQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMV-YGRTPFSEYKTFWA 718
S + + +PE + K SD+WS G LY++ YG
Sbjct: 174 SPI---FWYAPECLRTS---------KFSSASDVWSFGVTLYELFTYGDP---------- 211
Query: 719 KFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQHPFLVPPVSTQPSSS 778
+ P + + + + R+ +LL+ +P P S
Sbjct: 212 ------------SQSPPAEFLRMIGIAQ----GQMIVTRLLELLKEGERLPR----PPSC 251
Query: 779 QDQSYQLLQLLAEASASDHEA-STICSQLSQL 809
D+ Y L++L EA D + + + + +L
Sbjct: 252 PDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 50.5 bits (121), Expect = 1e-06
Identities = 45/161 (27%), Positives = 68/161 (42%), Gaps = 46/161 (28%)
Query: 610 LEAVNTIHEERIVHSDLKPANFLLVKGSL-KLIDFGIAKAIMSDTTNIQRDSQVGT---L 665
LEA N IH DL N L+ + ++ K+ DFG+A+ I D ++ G +
Sbjct: 119 LEAQNYIHR------DLAARNVLVGENNICKVADFGLARVIKEDIYE----AREGAKFPI 168
Query: 666 SYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMV-YGRTPFSEYKTFWAKFKVIT 724
+ +PEA + N IK SD+WS G +L ++V YGR P+
Sbjct: 169 KWTAPEAALYNRFS-----IK----SDVWSFGILLTEIVTYGRMPYPGM----------- 208
Query: 725 DPNHEITYE-------PVPN---PWLLDLMKKCLAWDRNER 755
N E+ + P P L D+M C D ++R
Sbjct: 209 -TNAEVLQQVDQGYRMPCPPGCPKELYDIMLDCWKEDPDDR 248
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 50.4 bits (121), Expect = 1e-06
Identities = 36/152 (23%), Positives = 64/152 (42%), Gaps = 16/152 (10%)
Query: 608 QILEAVNTIHEERIVHSDLKPANFLLV-KGSLKLIDFGIAKAIMSDTTNIQRDSQVGT-- 664
Q+ + + + VH DL N LLV + K+ DFG+++A+ + ++ R + G
Sbjct: 103 QVAMGMAYLESKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAG-SDYYRATTAGRWP 161
Query: 665 LSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMV-YGRTPFSEYKTFWAKFKVI 723
L + +PE N K SD+WS G L++ YG P+ E K A+ +
Sbjct: 162 LKWYAPECI---------NYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKG--AEVIAM 210
Query: 724 TDPNHEITYEPVPNPWLLDLMKKCLAWDRNER 755
+ + + +M C + +R
Sbjct: 211 LESGERLPRPEECPQEIYSIMLSCWKYRPEDR 242
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 50.1 bits (120), Expect = 2e-06
Identities = 54/211 (25%), Positives = 82/211 (38%), Gaps = 28/211 (13%)
Query: 560 GRVKDDGYIYMVLEYGEI-DLAHML------SQKWKEMDGSNQTLDENWLRFYWQQILEA 612
G + MV EY E DL L + K D L + L QI
Sbjct: 75 GVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASG 134
Query: 613 VNTIHEERIVHSDLKPANFLLVKGSL--KLIDFGIAKAIMSDTTNIQR--DSQVGTLSYM 668
+ + + VH DL N LV L K+ DFG+++ + TT+ R + + +M
Sbjct: 135 MVYLASQHFVHRDLATRN-CLVGYDLVVKIGDFGMSRDVY--TTDYYRVGGHTMLPIRWM 191
Query: 669 SPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQM-VYGRTPFSEYKTFWAKFKVITDPN 727
PE+ M K SD+WS G +L+++ YG+ P+ + IT
Sbjct: 192 PPESIMYR---------KFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEV-IECITQGR 241
Query: 728 HEITYEPVPNPWLLDLMKKCLAWDRNERWRI 758
P + D+M C W R+ + RI
Sbjct: 242 LLQRPRTCP-SEVYDIMLGC--WKRDPQQRI 269
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 2e-06
Identities = 71/317 (22%), Positives = 127/317 (40%), Gaps = 58/317 (18%)
Query: 462 DP---DLFFKVN-GKLYQRLGKIGSGGSSEVHKVISSDCT-IYALKKIKLKGRDYATAY- 515
DP DLF+K + +++ L +IG G V+ +S + A+KK+ G+ +
Sbjct: 7 DPEIADLFYKDDPEEIFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQ 66
Query: 516 GFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLREVLNGSMNNKDGRVKDDGYIYMVLEYG 575
+E+++L +LK N I +Y+ G + ++V+EY
Sbjct: 67 DIIKEVKFLQQLKHPNTI----EYK-------------------GCYLKEHTAWLVMEY- 102
Query: 576 EIDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLLVK 635
L ++ + L E + L+ + +H ++H D+K N LL +
Sbjct: 103 ------CLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTE 156
Query: 636 -GSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMC-NESDENGNIIKCGRPSDI 693
G +KL DFG A +S VGT +M+PE + +E +G + D+
Sbjct: 157 PGQVKLADFGSASKSSP------ANSFVGTPYWMAPEVILAMDEGQYDGKV-------DV 203
Query: 694 WSLGCILYQMVYGRTPFSEYKTFWAKFKVITDPNHEITYEPVPNPW---LLDLMKKCLAW 750
WSLG ++ + P A + + + + + N W + CL
Sbjct: 204 WSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLQ----SNEWTDSFRGFVDYCLQK 259
Query: 751 DRNERWRIPQLLQHPFL 767
ER +LL+H F+
Sbjct: 260 IPQERPASAELLRHDFV 276
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 49.5 bits (118), Expect = 3e-06
Identities = 46/146 (31%), Positives = 71/146 (48%), Gaps = 19/146 (13%)
Query: 568 IYMVLEYGEIDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLK 627
IY++ EY E L K +G T+ N L QI E + I + +H DL+
Sbjct: 75 IYIITEYME---NGSLVDFLKTPEGIKLTI--NKLIDMAAQIAEGMAFIERKNYIHRDLR 129
Query: 628 PANFLLVKGSL--KLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNII 685
AN +LV +L K+ DFG+A+ ++ D R+ + + +PEA + I
Sbjct: 130 AAN-ILVSETLCCKIADFGLAR-LIEDNEYTAREGAKFPIKWTAPEAI-----NYGTFTI 182
Query: 686 KCGRPSDIWSLGCILYQMV-YGRTPF 710
K SD+WS G +L ++V YGR P+
Sbjct: 183 K----SDVWSFGILLTEIVTYGRIPY 204
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 4e-06
Identities = 59/231 (25%), Positives = 103/231 (44%), Gaps = 52/231 (22%)
Query: 474 YQRLGKIGSGGSSEVHKVIS-SDCTIYALKKIKLK-GRDYATAYGFCQEIEYLNKLKGKN 531
Y+ + ++GSG +V+K + + A+K IKL+ G D++ QEI + + K N
Sbjct: 11 YELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQ---QEIFMVKECKHCN 67
Query: 532 NIIQLIDYEVTEKALLREVLNGSMNNKDGRVKDDGYIYMVLEY---GEI-DLAHMLSQKW 587
+ Y EK +++ +EY G + D+ H+
Sbjct: 68 IVAYFGSYLSREK-----------------------LWICMEYCGGGSLQDIYHVTG--- 101
Query: 588 KEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLLV-KGSLKLIDFGIA 646
L E + + ++ L+ + +H + +H D+K AN LL G +KL DFG+A
Sbjct: 102 --------PLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTDNGDVKLADFGVA 153
Query: 647 KAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLG 697
I + T +R S +GT +M+PE ++NG + DIW++G
Sbjct: 154 AKITA--TIAKRKSFIGTPYWMAPEVAAV---EKNGGY---NQLCDIWAVG 196
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|234331 TIGR03724, arch_bud32, Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Score = 48.0 bits (115), Expect = 5e-06
Identities = 15/37 (40%), Positives = 21/37 (56%)
Query: 611 EAVNTIHEERIVHSDLKPANFLLVKGSLKLIDFGIAK 647
V +H+ IVH DL +N ++ L LIDFG+ K
Sbjct: 101 RLVGKLHKAGIVHGDLTTSNIIVRDDKLYLIDFGLGK 137
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine [Unknown function, General]. Length = 199 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 48.5 bits (116), Expect = 7e-06
Identities = 41/160 (25%), Positives = 73/160 (45%), Gaps = 20/160 (12%)
Query: 608 QILEAVNTIHEERIVHSDLKPANFLLVK-GSLKLIDFGIAKAIMSDTTNIQRDSQVGTL- 665
+I + + + ++ VH DL N ++ + ++K+ DFG+ + I T+ R G L
Sbjct: 127 EIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYE--TDYYRKGGKGLLP 184
Query: 666 -SYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMV-YGRTPFSEYKTFWAKFKVI 723
+M+PE+ +G SD+WS G +L++M P+ + + K +
Sbjct: 185 VRWMAPESLK------DGVFTT---KSDVWSFGVVLWEMATLAEQPY-QGLSNEEVLKFV 234
Query: 724 TDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQ 763
D H E P+ L+LM+ C W N + R P L+
Sbjct: 235 IDGGHLDLPENCPDKL-LELMRMC--WQYNPKMR-PTFLE 270
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 48.4 bits (115), Expect = 7e-06
Identities = 45/204 (22%), Positives = 92/204 (45%), Gaps = 31/204 (15%)
Query: 527 LKGKNNIIQLIDYEVTEKALLREVLNGSMNNKDGRVKDDGYIYMVLEY-------GEIDL 579
LK + +L D ++E LL++V + + G DG + +++EY +
Sbjct: 38 LKENASSSELRDL-LSEFNLLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRE 96
Query: 580 AHMLSQKWKEMDGS-NQTLDEN----------WLRFYWQQILEAVNTIHEERIVHSDLKP 628
+ + + DG+ N + +N + F WQ I + + E ++VH DL
Sbjct: 97 SRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQ-ISRGMQYLAEMKLVHRDLAA 155
Query: 629 ANFLLVKGS-LKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKC 687
N L+ +G +K+ DFG+++ + + + ++R + +M+ E+ +
Sbjct: 156 RNVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQ------ 209
Query: 688 GRPSDIWSLGCILYQMV-YGRTPF 710
SD+WS G +L+++V G P+
Sbjct: 210 ---SDVWSFGVLLWEIVTLGGNPY 230
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 47.8 bits (114), Expect = 1e-05
Identities = 51/204 (25%), Positives = 84/204 (41%), Gaps = 36/204 (17%)
Query: 568 IYMVLE---YGEIDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHS 624
+++V+E GE L L +LD L Y Q+ A+ + +R VH
Sbjct: 81 VWIVMELAPLGE--LRSYLQVN-------KYSLDLASLILYSYQLSTALAYLESKRFVHR 131
Query: 625 DLKPANFLLV-KGSLKLIDFGIAKAIMSDTTNIQRDSQVGTL--SYMSPEAFMCNESDEN 681
D+ N L+ +KL DFG+++ + ++ + G L +M+PE+
Sbjct: 132 DIAARNVLVSSPDCVKLGDFGLSRYLEDESY---YKASKGKLPIKWMAPESI-------- 180
Query: 682 GNIIKCGRPSDIWSLG-CILYQMVYGRTPFSEYKTFWAKFKVITDPNHEITYEPVPN--- 737
N + SD+W G C+ ++ G PF K + P+P
Sbjct: 181 -NFRRFTSASDVWMFGVCMWEILMLGVKPF-----QGVKNNDVIGRIENGERLPMPPNCP 234
Query: 738 PWLLDLMKKCLAWDRNERWRIPQL 761
P L LM KC A+D ++R R +L
Sbjct: 235 PTLYSLMTKCWAYDPSKRPRFTEL 258
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 48.7 bits (116), Expect = 1e-05
Identities = 28/95 (29%), Positives = 48/95 (50%), Gaps = 16/95 (16%)
Query: 567 YIYMVLEY---GEI-DLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIV 622
+Y+V+EY G++ L H+ DE Y ++ A++ +H I+
Sbjct: 78 NVYLVMEYLIGGDVKSLLHIYGY-----------FDEEMAVKYISEVALALDYLHRHGII 126
Query: 623 HSDLKPANFLLV-KGSLKLIDFGIAKAIMSDTTNI 656
H DLKP N L+ +G +KL DFG++K ++ N+
Sbjct: 127 HRDLKPDNMLISNEGHIKLTDFGLSKVTLNRELNM 161
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 1e-05
Identities = 31/113 (27%), Positives = 55/113 (48%), Gaps = 13/113 (11%)
Query: 601 WLRFYWQQILEAVNTIHEERIVHSDLKPANFLLVKGS--LKLIDFGIAKAIMSDTTNIQR 658
+L + QI + +N + E R+VH DL N +LVK +K+ DFG+AK + +D
Sbjct: 110 YLLNWCVQIAKGMNYLEERRLVHRDLAARN-VLVKTPQHVKITDFGLAKLLGADEKEYHA 168
Query: 659 DSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQ-MVYGRTPF 710
+ + +M+ E+ + SD+WS G +++ M +G P+
Sbjct: 169 EGGKVPIKWMALESILHRIYTHQ---------SDVWSYGVTVWELMTFGSKPY 212
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 47.6 bits (113), Expect = 1e-05
Identities = 67/277 (24%), Positives = 117/277 (42%), Gaps = 55/277 (19%)
Query: 498 IYALKKIKLKGRDYATAYGFCQEIEYLNK-LKGKNNIIQLIDYEVTEKALLREVLNGSMN 556
IYA + K D Y + +EI+ + K L + I L +E +++R+V + +
Sbjct: 11 IYA-GILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETA--SMMRQVSHKHIV 67
Query: 557 NKDGRVKDDGYIYMV---LEYGEIDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAV 613
G D MV +E+G +DL M + L W +Q+ A+
Sbjct: 68 LLYGVCVRDVENIMVEEFVEFGPLDLF---------MHRKSDVLTTPWKFKVAKQLASAL 118
Query: 614 NTIHEERIVHSDLKPANFLLVKGSL--------KLIDFGIAKAIMSDTTNIQRDSQVGTL 665
+ + ++ +VH ++ N LL + + KL D GI ++S R V +
Sbjct: 119 SYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPITVLS------RQECVERI 172
Query: 666 SYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVY-GRTPF-----SEYKTFW-A 718
+++PE C E +N +I +D WS G L+++ Y G P +E + F+
Sbjct: 173 PWIAPE---CVEDSKNLSI-----AADKWSFGTTLWEICYNGEIPLKDKTLAEKERFYEG 224
Query: 719 KFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNER 755
+ ++T E L DLM C+ +D N+R
Sbjct: 225 QCMLVTPSCKE----------LADLMTHCMNYDPNQR 251
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|236586 PRK09605, PRK09605, bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Score = 47.6 bits (114), Expect = 2e-05
Identities = 17/37 (45%), Positives = 23/37 (62%)
Query: 611 EAVNTIHEERIVHSDLKPANFLLVKGSLKLIDFGIAK 647
E V +H+ IVH DL +NF++ L LIDFG+ K
Sbjct: 439 EIVAKLHKAGIVHGDLTTSNFIVRDDRLYLIDFGLGK 475
|
Length = 535 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 47.1 bits (112), Expect = 2e-05
Identities = 31/103 (30%), Positives = 45/103 (43%), Gaps = 10/103 (9%)
Query: 609 ILEAVNTIHEERIVHSDLKPAN-FLLVKGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSY 667
+LEA+ +H I+H D+K N FL + L DFG A + + Q GTL
Sbjct: 194 LLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQCYGWSGTLET 253
Query: 668 MSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGRTPF 710
SPE + C + +DIWS G +L++M
Sbjct: 254 NSPELLALDPY--------CAK-TDIWSAGLVLFEMSVKNVTL 287
|
Length = 392 |
| >gnl|CDD|237847 PRK14879, PRK14879, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 45.7 bits (109), Expect = 3e-05
Identities = 15/35 (42%), Positives = 22/35 (62%)
Query: 613 VNTIHEERIVHSDLKPANFLLVKGSLKLIDFGIAK 647
V +H I+H DL +N +L G + LIDFG+A+
Sbjct: 108 VGKLHSAGIIHGDLTTSNMILSGGKIYLIDFGLAE 142
|
Length = 211 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 46.3 bits (110), Expect = 3e-05
Identities = 39/150 (26%), Positives = 67/150 (44%), Gaps = 28/150 (18%)
Query: 568 IYMVLEYGEIDLAH-MLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDL 626
I++V EY +A+ L +E G T WL + EA+ + +H DL
Sbjct: 74 IFIVTEY----MANGCLLNYLRERKGKLGT---EWLLDMCSDVCEAMEYLESNGFIHRDL 126
Query: 627 KPANFLL-VKGSLKLIDFGIAKAIMSDTTNIQRDSQVGT---LSYMSPEAFMCNESDENG 682
N L+ +K+ DFG+A+ ++ D Q S GT + + PE F +
Sbjct: 127 AARNCLVGEDNVVKVSDFGLARYVLDD----QYTSSQGTKFPVKWAPPEVFDYS------ 176
Query: 683 NIIKCGRPSDIWSLGCILYQMVY--GRTPF 710
+ SD+WS G ++++ V+ G+ P+
Sbjct: 177 ---RFSSKSDVWSFGVLMWE-VFSEGKMPY 202
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 46.1 bits (109), Expect = 4e-05
Identities = 76/304 (25%), Positives = 125/304 (41%), Gaps = 68/304 (22%)
Query: 472 KLYQRLGKIGSGGSSEVHKVISSDCTIYALKKIKLKG-RDYATAYGFCQEIEYLNKLKGK 530
KL Q +GK E V+ D Y K+ +K ++ ATA F E + +L+
Sbjct: 9 KLLQTIGK------GEFGDVMLGD---YRGNKVAVKCIKNDATAQAFLAEASVMTQLR-H 58
Query: 531 NNIIQLIDYEVTEKALLREVLNGSMNNKDGRVKDDGYIYMVLEY-GEIDLAHMLSQKWKE 589
+N++QL+ V EK G +Y+V EY + L L + +
Sbjct: 59 SNLVQLLGVIVEEK---------------------GGLYIVTEYMAKGSLVDYLRSRGRS 97
Query: 590 MDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLLVKGSL-KLIDFGIAKA 648
+ G + L + + EA+ + VH DL N L+ + ++ K+ DFG+ K
Sbjct: 98 VLGGDCLLK------FSLDVCEAMEYLEANNFVHRDLAARNVLVSEDNVAKVSDFGLTKE 151
Query: 649 IMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMV-YGR 707
S +D+ + + +PEA K SD+WS G +L+++ +GR
Sbjct: 152 ASS-----TQDTGKLPVKWTAPEALREK---------KFSTKSDVWSFGILLWEIYSFGR 197
Query: 708 TPFSEYKTFWAKFKVITDPNHEITYE-PVPN---PWLLDLMKKCLAWDRNERWRIPQL-- 761
P+ K + P E Y+ P+ P + D+MK+C D R QL
Sbjct: 198 VPYPR-----IPLKDVV-PRVEKGYKMDAPDGCPPVVYDVMKQCWHLDAATRPSFLQLRE 251
Query: 762 -LQH 764
L+H
Sbjct: 252 QLEH 255
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 46.0 bits (109), Expect = 4e-05
Identities = 52/211 (24%), Positives = 90/211 (42%), Gaps = 36/211 (17%)
Query: 568 IYMVLEYGEI-DL-AHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSD 625
+V EY E+ DL +++ ++W + Q L L+ +I V +H+ +HSD
Sbjct: 70 YLLVFEYCELGDLKSYLSQEQWHRRNS--QLLL---LQRMACEIAAGVTHMHKHNFLHSD 124
Query: 626 LKPAN-FLLVKGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNI 684
L N FL ++K+ D+GI + + D + L +++PE + +G +
Sbjct: 125 LALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPELV----GEFHGGL 180
Query: 685 IKC--GRPSDIWSLGCILYQMVYGRTPFSEYKTFWAKFKVITDPNHEITYEPVPNPWLLD 742
I +PS++W+LG T W F+ P ++ V N + D
Sbjct: 181 ITAEQTKPSNVWALGV----------------TLWELFENAAQPYSHLSDREVLNHVIKD 224
Query: 743 ----LMKKCLAWDRNERWRIPQLLQHPFLVP 769
L K L +ERW ++LQ +L P
Sbjct: 225 QQVKLFKPQLELPYSERWY--EVLQFCWLSP 253
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 5e-05
Identities = 53/233 (22%), Positives = 92/233 (39%), Gaps = 70/233 (30%)
Query: 608 QILEAVNTIHEE-RIVHSDLKPANFLLVKGSLKLIDFGIAKAIMSDTTNIQ--------- 657
Q A++ H E ++H+DLKP N L+ + S ++D +A+ D ++
Sbjct: 239 QTGVALDYFHTELHLMHTDLKPENILM-ETSDTVVDPVTNRALPPDPCRVRICDLGGCCD 297
Query: 658 ----RDSQVGTLSYMSPEAFMCNESDENGNIIKCG--RPSDIWSLGCILYQMVYGRTPFS 711
R + V T Y SPE ++ G +D+WS+GCI+Y++ G+ +
Sbjct: 298 ERHSRTAIVSTRHYRSPEV-----------VLGLGWMYSTDMWSMGCIIYELYTGKLLYD 346
Query: 712 EY----------KTF------WA----------------KFKVITDPNH-------EITY 732
+ KT WA + + TDP H
Sbjct: 347 THDNLEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVR 406
Query: 733 EPVPNPWLLDLMKKCLAWDRNERWRIPQLLQHPFLV---PPVSTQPSSSQDQS 782
E + + L DL+ L +DR +R Q+ HP+++ P P+ ++S
Sbjct: 407 EVIRDDLLCDLIYGLLHYDRQKRLNARQMTTHPYVLKYYPECRQHPNYPDNRS 459
|
Length = 467 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 45.5 bits (108), Expect = 6e-05
Identities = 49/214 (22%), Positives = 84/214 (39%), Gaps = 49/214 (22%)
Query: 500 ALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLREVLNGSMNNKD 559
A+K +K D A F E + L+ N ++QL+
Sbjct: 33 AVKCLK---DDSTAAQAFLAEASVMTTLRHPN-LVQLL---------------------- 66
Query: 560 GRVKDDGYIYMVLEY-GEIDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHE 618
G V +Y+V EY + L L + + + Q L + + E + + E
Sbjct: 67 GVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLG------FALDVCEGMEYLEE 120
Query: 619 ERIVHSDLKPANFLLVK-GSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNE 677
+ VH DL N L+ + K+ DFG+AK + +DS + + +PEA +
Sbjct: 121 KNFVHRDLAARNVLVSEDLVAKVSDFGLAKE-----ASQGQDSGKLPVKWTAPEALREKK 175
Query: 678 SDENGNIIKCGRPSDIWSLGCILYQMV-YGRTPF 710
SD+WS G +L+++ +GR P+
Sbjct: 176 FSTK---------SDVWSFGILLWEIYSFGRVPY 200
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 45.1 bits (107), Expect = 7e-05
Identities = 30/108 (27%), Positives = 51/108 (47%), Gaps = 11/108 (10%)
Query: 608 QILEAVNTIHEERIVHSDLKPANFLLVKG-SLKLIDFGIAKAIMSDTTNIQRDSQVGTLS 666
QI + + VH DL N L+ +G ++K+ DFG+++ I S + + +
Sbjct: 132 QIAAGMEYLSSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLLPVR 191
Query: 667 YMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMV-YGRTPFSEY 713
+M PEA + K SDIWS G +L+++ YG P+ +
Sbjct: 192 WMPPEAILYG---------KFTTESDIWSFGVVLWEIFSYGLQPYYGF 230
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 7e-05
Identities = 32/109 (29%), Positives = 53/109 (48%), Gaps = 13/109 (11%)
Query: 608 QILEAVNTIHEERIVHSDLKPANFLLV-KGSLKLIDFGIAKAIMS-DTTNIQRDSQVGTL 665
QI + + +VH DL N L+ K ++K+ D G+ + + + D + +S + +
Sbjct: 132 QIAAGMEFLSSHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGNSLL-PI 190
Query: 666 SYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMV-YGRTPFSEY 713
+MSPEA M K SDIWS G +L+++ YG P+ Y
Sbjct: 191 RWMSPEAIMYG---------KFSIDSDIWSYGVVLWEVFSYGLQPYCGY 230
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 7e-05
Identities = 40/159 (25%), Positives = 71/159 (44%), Gaps = 17/159 (10%)
Query: 608 QILEAVNTIHEERIVHSDLKPANFLLVKGS--LKLIDFGIAKAIMSDTTNIQRDSQVGTL 665
QI + ++ + E R+VH DL N +LVK +K+ DFG+A+ + D T D +
Sbjct: 117 QIAKGMSYLEEVRLVHRDLAARN-VLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPI 175
Query: 666 SYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQ-MVYGRTPFSEYKTFWAK-FKVI 723
+M+ E+ + + SD+WS G +++ M +G P Y A+ +
Sbjct: 176 KWMALESILHR---------RFTHQSDVWSYGVTVWELMTFGAKP---YDGIPAREIPDL 223
Query: 724 TDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLL 762
+ + P+ + +M KC D R R +L+
Sbjct: 224 LEKGERLPQPPICTIDVYMIMVKCWMIDSECRPRFRELV 262
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 44.8 bits (106), Expect = 9e-05
Identities = 38/183 (20%), Positives = 81/183 (44%), Gaps = 21/183 (11%)
Query: 591 DGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLLVKGSL-KLIDFGIAKAI 649
+ + Q ++ L + QI A+ + ++ +H DL N L+ + L K+ DFG+++ +
Sbjct: 95 ECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLM 154
Query: 650 MSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQM-VYGRT 708
DT ++ + + +PE+ N K SD+W+ G +L+++ YG +
Sbjct: 155 TGDTYTAHAGAKF-PIKWTAPESLAYN---------KFSIKSDVWAFGVLLWEIATYGMS 204
Query: 709 PFS--EYKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWR---IPQLLQ 763
P+ + + + + + P + +LM+ C W+ ++R I Q +
Sbjct: 205 PYPGIDLSQVYELL----EKGYRMERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFE 260
Query: 764 HPF 766
F
Sbjct: 261 TMF 263
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 45.6 bits (108), Expect = 1e-04
Identities = 24/74 (32%), Positives = 41/74 (55%), Gaps = 11/74 (14%)
Query: 608 QILEAVNTIHEERIVHSDLKPANFLLVKGSL----KLIDFGIAKAIMSDT-----TNIQR 658
Q+L+A+ H + IVH DLKP N ++ + + K++DFGI ++ + R
Sbjct: 87 QVLDALACAHNQGIVHRDLKPQNIMVSQTGVRPHAKVLDFGIG-TLLPGVRDADVATLTR 145
Query: 659 DSQV-GTLSYMSPE 671
++V GT +Y +PE
Sbjct: 146 TTEVLGTPTYCAPE 159
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 45.5 bits (107), Expect = 1e-04
Identities = 44/148 (29%), Positives = 68/148 (45%), Gaps = 22/148 (14%)
Query: 562 VKDDGYIYMVLEYGEIDL-AHMLSQ--KWKEMDGSNQTLDENWLRFYWQQILEAVNTIHE 618
++ + YM+ + + DL + M + WK+ QT R +Q+L AV IH+
Sbjct: 232 LRSEANTYMITQKYDFDLYSFMYDEAFDWKDRPLLKQT------RAIMKQLLCAVEYIHD 285
Query: 619 ERIVHSDLKPAN-FLLVKGSLKLIDFGIAKAIMSDTTNIQRD-SQVGTLSYMSPEAFMCN 676
++++H D+K N FL G + L DFG A + D VGT++ SPE +
Sbjct: 286 KKLIHRDIKLENIFLNCDGKIVLGDFGTAMPF--EKEREAFDYGWVGTVATNSPEILAGD 343
Query: 677 ESDENGNIIKCGRPSDIWSLGCILYQMV 704
E +DIWS G IL M+
Sbjct: 344 GYCE---------ITDIWSCGLILLDML 362
|
Length = 501 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 44.3 bits (105), Expect = 1e-04
Identities = 44/177 (24%), Positives = 70/177 (39%), Gaps = 29/177 (16%)
Query: 592 GSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLLVKGSL-KLIDFGIAKAIM 650
GS L NW QI + ++ + E+R+VH DL N L+ K+ DFG+AK +
Sbjct: 107 GSQYLL--NWCV----QIAKGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLD 160
Query: 651 SDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQ-MVYGRTP 709
D + + P +M ES + SD+WS G +++ M +G P
Sbjct: 161 VD------EKEYHAEGGKVPIKWMALESILHR---IYTHKSDVWSYGVTVWELMTFGAKP 211
Query: 710 FSEYKTFWAKFKVITDPNHEITYEPVPNPWLLDL-----MKKCLAWDRNERWRIPQL 761
+ I P+ E +P P + + + KC D R +L
Sbjct: 212 YEGIPA-----VEI--PDLLEKGERLPQPPICTIDVYMVLVKCWMIDAESRPTFKEL 261
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 44.8 bits (106), Expect = 1e-04
Identities = 31/115 (26%), Positives = 64/115 (55%), Gaps = 14/115 (12%)
Query: 599 ENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLLVKGSL-KLIDFGIAKAIMSDTTNIQ 657
++ LRF Q + + ++ + + +H D+ N LL G + K+ DFG+A+ IM+D+ +
Sbjct: 212 DDLLRFSSQ-VAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVV 270
Query: 658 RDSQVGTLSYMSPEA-FMCNESDENGNIIKCGRPSDIWSLGCILYQMV-YGRTPF 710
+ + + +M+PE+ F C + + SD+WS G +L+++ G++P+
Sbjct: 271 KGNARLPVKWMAPESIFDCVYTVQ----------SDVWSYGILLWEIFSLGKSPY 315
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 1e-04
Identities = 38/154 (24%), Positives = 68/154 (44%), Gaps = 18/154 (11%)
Query: 607 QQILEAVNTIHEERIVHSDLKPANFLLV-KGSLKLIDFGIAKAIMSDTTNIQ-RDSQVGT 664
Q+ + + + VH DL N LLV + K+ DFG++KA+ +D + + R +
Sbjct: 102 HQVSMGMKYLEGKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWP 161
Query: 665 LSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQ-MVYGRTPFSEYKTFWAKFKVI 723
L + +PE N K SD+WS G +++ YG+ P+ + K +V+
Sbjct: 162 LKWYAPECI---------NFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMK----GPEVM 208
Query: 724 T--DPNHEITYEPVPNPWLLDLMKKCLAWDRNER 755
+ + + P + LMK C + +R
Sbjct: 209 SFIEQGKRLDCPAECPPEMYALMKDCWIYKWEDR 242
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 44.3 bits (105), Expect = 1e-04
Identities = 37/167 (22%), Positives = 73/167 (43%), Gaps = 31/167 (18%)
Query: 608 QILEAVNTIHEERIVHSDLKPANFLLVKGS-LKLIDFGIAKAIMSDTTNIQRDSQVGTLS 666
QI ++ +H+ ++H D+ N ++ + +K+ D +++ + + D++ +
Sbjct: 125 QIACGMSYLHKRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRPVK 184
Query: 667 YMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMV-YGRTPFSEYKTFWAKFKVITD 725
+M+ E+ + E SD+WS G +L++++ G+TP+ E D
Sbjct: 185 WMALESLVNKEYSSA---------SDVWSFGVLLWELMTLGQTPYVE-----------ID 224
Query: 726 PNHEITY--------EPVPNP-WLLDLMKKCLAWDRNERWRIPQLLQ 763
P Y +P+ P L +M C A D ER QL+Q
Sbjct: 225 PFEMAAYLKDGYRLAQPINCPDELFAVMACCWALDPEERPSFSQLVQ 271
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 44.1 bits (104), Expect = 2e-04
Identities = 42/151 (27%), Positives = 67/151 (44%), Gaps = 26/151 (17%)
Query: 622 VHSDLKPANFLLVKGSL--KLIDFGIAKAIMSDTTNIQRDSQVG---TLSYMSPEAFMCN 676
VH DL N +LV +L K+ DFG+++ + DT++ S +G + + +PEA
Sbjct: 128 VHRDLAARN-ILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYR 186
Query: 677 ESDENGNIIKCGRPSDIWSLGCILYQ-MVYGRTPFSEYKTFW--AKFKVITDPNHEITYE 733
K SD+WS G ++++ M YG P+ W + VI +
Sbjct: 187 ---------KFTSASDVWSYGIVMWEVMSYGERPY------WDMSNQDVINAIEQDYRLP 231
Query: 734 PVPN--PWLLDLMKKCLAWDRNERWRIPQLL 762
P + L LM C DRN R + Q++
Sbjct: 232 PPMDCPTALHQLMLDCWQKDRNARPKFGQIV 262
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|226168 COG3642, COG3642, Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Score = 43.0 bits (102), Expect = 2e-04
Identities = 14/37 (37%), Positives = 21/37 (56%)
Query: 611 EAVNTIHEERIVHSDLKPANFLLVKGSLKLIDFGIAK 647
V +H+ IVH DL +N +L G + IDFG+ +
Sbjct: 103 RLVGKLHKAGIVHGDLTTSNIILSGGRIYFIDFGLGE 139
|
Length = 204 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 43.5 bits (103), Expect = 2e-04
Identities = 30/108 (27%), Positives = 43/108 (39%), Gaps = 10/108 (9%)
Query: 605 YWQQILEAVNTIHEERIVHSDLKPANFLLVKGSL-KLIDFGIAKAIMSDTTNIQRDSQVG 663
Y QI + + +R +H DL N LL K+ DFG+ +A+ D V
Sbjct: 102 YAVQIANGMRYLESKRFIHRDLAARNILLASDDKVKIGDFGLMRAL-----PQNEDHYVM 156
Query: 664 TLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQM-VYGRTPF 710
P A+ ES SD+W G L++M YG P+
Sbjct: 157 EEHLKVPFAWCAPESL---RTRTFSHASDVWMFGVTLWEMFTYGEEPW 201
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 2e-04
Identities = 32/107 (29%), Positives = 48/107 (44%), Gaps = 11/107 (10%)
Query: 607 QQILEAVNTIHEERIVHSDLKPAN-FLLVKGSLKLIDFGIAKAIMSDTTNIQRDSQVGTL 665
+ +L A+ +HE RI+H D+K N F+ G + L DFG A D + GT+
Sbjct: 189 RSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFG-AACFPVDINANKYYGWAGTI 247
Query: 666 SYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGRTPFSE 712
+ +PE D G + DIWS G +L++M E
Sbjct: 248 ATNAPELL---ARDPYGPAV------DIWSAGIVLFEMATCHDSLFE 285
|
Length = 391 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 2e-04
Identities = 45/146 (30%), Positives = 67/146 (45%), Gaps = 19/146 (13%)
Query: 568 IYMVLEY-GEIDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDL 626
IY+V E+ G+ L L KE DG L + L QI + + I +H DL
Sbjct: 75 IYIVTEFMGKGSLLDFL----KEGDGKYLKLPQ--LVDMAAQIADGMAYIERMNYIHRDL 128
Query: 627 KPANFLLVKGSL-KLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNII 685
+ AN L+ + K+ DFG+A+ I D R + + +PEA + I
Sbjct: 129 RAANILVGDNLVCKIADFGLARLI-EDNEYTARQGAKFPIKWTAPEAALYGRF-----TI 182
Query: 686 KCGRPSDIWSLGCILYQMVY-GRTPF 710
K SD+WS G +L ++V GR P+
Sbjct: 183 K----SDVWSFGILLTELVTKGRVPY 204
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 3e-04
Identities = 36/156 (23%), Positives = 66/156 (42%), Gaps = 13/156 (8%)
Query: 608 QILEAVNTIHEERIVHSDLKPANFLLVK-GSLKLIDFGIAKAIMSDTTNIQRDSQVGTLS 666
QI + + + E R+VH DL N L+ +K+ DFG+A+ + D D +
Sbjct: 117 QIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIK 176
Query: 667 YMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQ-MVYGRTPFSEYKTFWAKFKVITD 725
+M+ E + K SD+WS G +++ M +G P+ T + + +
Sbjct: 177 WMALECI---------HYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPT--REIPDLLE 225
Query: 726 PNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQL 761
+ P+ + +M KC D + R + +L
Sbjct: 226 KGERLPQPPICTIDVYMVMVKCWMIDADSRPKFKEL 261
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 43.4 bits (102), Expect = 3e-04
Identities = 31/105 (29%), Positives = 50/105 (47%), Gaps = 17/105 (16%)
Query: 605 YWQQILEAVNTIHEERIVHSDLKPANFLL-VKGSLKLIDFGIAKAIMSD----TTNIQRD 659
Y QI + ++ + + VH DL N L+ + +K+ DFG+ KAI +D T D
Sbjct: 114 YAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLD 173
Query: 660 SQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMV 704
S V + +PE + + K SD+WS G LY+++
Sbjct: 174 SPV---FWYAPECLIQS---------KFYIASDVWSFGVTLYELL 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 3e-04
Identities = 32/105 (30%), Positives = 50/105 (47%), Gaps = 12/105 (11%)
Query: 608 QILEAVNTIHEERIVHSDLKPANFLLVKGSL-KLIDFGIAKAIMSDTTNIQRDSQVGTLS 666
Q+ + I +H DL+ AN L+ G + K+ DFG+A+ I D R +
Sbjct: 110 QVAAGMAYIERMNYIHRDLRSANILVGDGLVCKIADFGLARLI-EDNEYTARQGAKFPIK 168
Query: 667 YMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVY-GRTPF 710
+ +PEA + IK SD+WS G +L ++V GR P+
Sbjct: 169 WTAPEAALYGRF-----TIK----SDVWSFGILLTELVTKGRVPY 204
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 42.9 bits (101), Expect = 3e-04
Identities = 37/155 (23%), Positives = 68/155 (43%), Gaps = 26/155 (16%)
Query: 568 IYMVLEYGEID-LAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDL 626
+Y+V E+ E L + L Q+ + L ++ L Q + E + + +H DL
Sbjct: 74 LYIVTEFMENGCLLNYLRQRQGK-------LSKDMLLSMCQDVCEGMEYLERNSFIHRDL 126
Query: 627 KPANFLL-VKGSLKLIDFGIAKAIMSDTTNIQRDSQVGT---LSYMSPEAFMCNESDENG 682
N L+ G +K+ DFG+ + ++ D + S G + + PE F
Sbjct: 127 AARNCLVSSTGVVKVSDFGMTRYVLDD----EYTSSSGAKFPVKWSPPEVF--------- 173
Query: 683 NIIKCGRPSDIWSLGCILYQM-VYGRTPFSEYKTF 716
N K SD+WS G +++++ G+ PF + +
Sbjct: 174 NFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNY 208
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 43.0 bits (101), Expect = 4e-04
Identities = 31/105 (29%), Positives = 48/105 (45%), Gaps = 11/105 (10%)
Query: 602 LRFYWQQILEAVNTIHEERIVHSDLKPANFLLVKGSL-KLIDFGIAKAIMSDTTNIQ-RD 659
L + QQI E + +H + +H DL N LL L K+ DFG+AKA+ + R+
Sbjct: 109 LLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVRE 168
Query: 660 SQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMV 704
+ + + E N K SD+WS G LY+++
Sbjct: 169 DGDSPVFWYAVECLKEN---------KFSYASDVWSFGVTLYELL 204
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Score = 43.6 bits (103), Expect = 4e-04
Identities = 36/125 (28%), Positives = 49/125 (39%), Gaps = 38/125 (30%)
Query: 607 QQILEAVNTIHEERIVHSDLKPANFLL--VKGSLKLIDFGIA------------------ 646
+QIL A++ +H IVH D+KP N + GS K+ID G A
Sbjct: 262 RQILFALDGLHSTGIVHRDVKPQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDP 321
Query: 647 ------KAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCIL 700
+ IMS T + V T +SP + N D DI+S G I
Sbjct: 322 RYAAPEQYIMSTQTPSAPSAPVATA--LSPVLWQLNLPDR----------FDIYSAGLIF 369
Query: 701 YQMVY 705
QM +
Sbjct: 370 LQMAF 374
|
Length = 566 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 42.9 bits (101), Expect = 4e-04
Identities = 29/111 (26%), Positives = 53/111 (47%), Gaps = 14/111 (12%)
Query: 607 QQILEAVNTIHEERIVHSDLKPAN-FLLVKGSLKLIDFGIAKAIMSDTTNIQRDSQVGTL 665
+QILE + +H +RI+H D+K N F+ + + D G A+ + + GT+
Sbjct: 164 KQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFL---GLAGTV 220
Query: 666 SYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMV-YGRTPFSEYKT 715
+PE ++ + +DIWS G +L++M+ Y T F + +
Sbjct: 221 ETNAPEVLARDKYNSK---------ADIWSAGIVLFEMLAYPSTIFEDPPS 262
|
Length = 357 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 5e-04
Identities = 29/108 (26%), Positives = 51/108 (47%), Gaps = 11/108 (10%)
Query: 605 YWQQILEAVNTIHEERIVHSDLKPANFLLV-KGSLKLIDFGIAKAIMSDTTNIQRDSQVG 663
Y Q+ + + + + +H DL N LL +K+ DFG+A+ I D +++
Sbjct: 184 YSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARL 243
Query: 664 TLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMV-YGRTPF 710
L +M+PE D I SD+WS G +L+++ G +P+
Sbjct: 244 PLKWMAPETIF----DRVYTI-----QSDVWSFGVLLWEIFSLGASPY 282
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 6e-04
Identities = 28/108 (25%), Positives = 52/108 (48%), Gaps = 11/108 (10%)
Query: 605 YWQQILEAVNTIHEERIVHSDLKPANFLLVKGSL-KLIDFGIAKAIMSDTTNIQRDSQVG 663
Y Q+ + + + +H DL N LL + ++ K+ DFG+A+ I D +++ S
Sbjct: 179 YSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARL 238
Query: 664 TLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMV-YGRTPF 710
L +M+PE+ SD+WS G +L+++ G +P+
Sbjct: 239 PLKWMAPESIFDKVYTTQ---------SDVWSFGVLLWEIFSLGASPY 277
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 42.0 bits (98), Expect = 7e-04
Identities = 30/108 (27%), Positives = 52/108 (48%), Gaps = 11/108 (10%)
Query: 607 QQILEAVNTIHEERIVHSDLKPANFLLVKGSL-KLIDFGIAKAIMSDTTNIQRDSQVGTL 665
QQI + + + VH DL N L+ + L K+ DFG+++ + S + +
Sbjct: 127 QQIAAGMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPI 186
Query: 666 SYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQM-VYGRTPFSE 712
+M PE+ M K SD+WSLG +L+++ YG+ P+ +
Sbjct: 187 RWMPPESIMYR---------KFTTESDVWSLGVVLWEIFTYGKQPWYQ 225
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 8e-04
Identities = 50/205 (24%), Positives = 83/205 (40%), Gaps = 45/205 (21%)
Query: 517 FCQEIEYLNKLKGKNNIIQLIDYEVTEKALLREVLNGSMNNKDGRVKDDGYIYMVLEYGE 576
F E+E L KL NII L+ G ++ GY+Y+ +EY
Sbjct: 49 FAGELEVLCKLGHHPNIINLL----------------------GACENRGYLYIAIEYAP 86
Query: 577 ID--LAHMLSQKWKEMD-------GSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLK 627
L + + E D G+ TL L + + + + E++ +H DL
Sbjct: 87 YGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLA 146
Query: 628 PANFLLVKG-SLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIK 686
N L+ + + K+ DFG+++ + +G L P +M ES N
Sbjct: 147 ARNVLVGENLASKIADFGLSRG-----EEVYVKKTMGRL----PVRWMAIESL---NYSV 194
Query: 687 CGRPSDIWSLGCILYQMV-YGRTPF 710
SD+WS G +L+++V G TP+
Sbjct: 195 YTTKSDVWSFGVLLWEIVSLGGTPY 219
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 42.0 bits (98), Expect = 8e-04
Identities = 48/205 (23%), Positives = 81/205 (39%), Gaps = 45/205 (21%)
Query: 517 FCQEIEYLNKLKGKNNIIQLIDYEVTEKALLREVLNGSMNNKDGRVKDDGYIYMVLEYGE 576
F E+E L KL NII L+ G + GY+Y+ +EY
Sbjct: 42 FAGELEVLCKLGHHPNIINLL----------------------GACEHRGYLYLAIEYAP 79
Query: 577 ID--LAHMLSQKWKEMD-------GSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLK 627
L + + E D + TL L + + ++ + +++ +H DL
Sbjct: 80 HGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLA 139
Query: 628 PANFLLVKG-SLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIK 686
N L+ + K+ DFG+++ + +G L P +M ES N
Sbjct: 140 ARNILVGENYVAKIADFGLSRG-----QEVYVKKTMGRL----PVRWMAIESL---NYSV 187
Query: 687 CGRPSDIWSLGCILYQMV-YGRTPF 710
SD+WS G +L+++V G TP+
Sbjct: 188 YTTNSDVWSYGVLLWEIVSLGGTPY 212
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 8e-04
Identities = 28/104 (26%), Positives = 51/104 (49%), Gaps = 16/104 (15%)
Query: 609 ILEAVNTIHEERIVHSDLKPANFLLVK-GSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSY 667
+ E + + +++VH DL N L+ + G K+ DFG+A+ ++ D+ + +
Sbjct: 109 VAEGMEYLESKKLVHRDLAARNILVSEDGVAKVSDFGLARV-----GSMGVDNSKLPVKW 163
Query: 668 MSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMV-YGRTPF 710
+PEA K SD+WS G +L+++ YGR P+
Sbjct: 164 TAPEALKHK---------KFSSKSDVWSYGVLLWEVFSYGRAPY 198
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 8e-04
Identities = 29/105 (27%), Positives = 48/105 (45%), Gaps = 11/105 (10%)
Query: 608 QILEAVNTIHEERIVHSDLKPANFLLVKGSL-KLIDFGIAKAIMSDTTNIQRDSQVGTLS 666
QI + + + VH DL N L+ L K+ DFG+++ + S + +
Sbjct: 131 QIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIR 190
Query: 667 YMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQM-VYGRTPF 710
+M PE+ M K SD+WS G IL+++ YG+ P+
Sbjct: 191 WMPPESIMYR---------KFTTESDVWSFGVILWEIFTYGKQPW 226
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 41.6 bits (98), Expect = 0.001
Identities = 48/184 (26%), Positives = 78/184 (42%), Gaps = 34/184 (18%)
Query: 597 LDENWLRFYWQQILE-------AVNTIHEERIVHSDLKPANFLLVKGSL--KLIDFGIAK 647
L EN +F Q++ + + E VH DL N +LV +L K+ DFG+++
Sbjct: 96 LRENDGKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARN-ILVNSNLVCKVSDFGLSR 154
Query: 648 AIMSDTTNIQRDSQVGTLS--YMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQ-MV 704
+ + + ++ G + + +PEA K SD+WS G ++++ M
Sbjct: 155 RL--EDSEATYTTKGGKIPIRWTAPEAI---------AYRKFTSASDVWSFGIVMWEVMS 203
Query: 705 YGRTPFSEYKTFWAKFKVITDPNHEITYE---PVPNPWLL-DLMKKCLAWDRNERWRIPQ 760
YG P+ + + VI E Y P+ P L LM C DRNER Q
Sbjct: 204 YGERPYWD----MSNQDVIKAV--EDGYRLPPPMDCPSALYQLMLDCWQKDRNERPTFSQ 257
Query: 761 LLQH 764
++
Sbjct: 258 IVST 261
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 41.3 bits (97), Expect = 0.001
Identities = 32/110 (29%), Positives = 50/110 (45%), Gaps = 13/110 (11%)
Query: 597 LDENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLLVKGSL-KLIDFGIAKAIMSDTT- 654
LD L Y QI + + + +R VH DL N L+ + K+ DFG+ K + D
Sbjct: 105 LDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEY 164
Query: 655 -NIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQM 703
++ + Y +PE+ ES K SD+WS G +LY++
Sbjct: 165 YKVREPGESPIFWY-APESL--TES-------KFSVASDVWSFGVVLYEL 204
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 41.1 bits (96), Expect = 0.001
Identities = 31/106 (29%), Positives = 53/106 (50%), Gaps = 11/106 (10%)
Query: 608 QILEAVNTIHEERIVHSDLKPANFLLVKGS-LKLIDFGIAKAIMSDTTNIQRDSQVGTLS 666
QI + + + E R+VH +L N LL S +++ DFG+A + D D +
Sbjct: 117 QIAKGMYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVADLLYPD------DKKYFYSE 170
Query: 667 YMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMV-YGRTPFS 711
+ +P +M ES G + SD+WS G +++M+ YG P++
Sbjct: 171 HKTPIKWMALESILFG---RYTHQSDVWSYGVTVWEMMSYGAEPYA 213
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 41.6 bits (97), Expect = 0.002
Identities = 29/84 (34%), Positives = 43/84 (51%), Gaps = 6/84 (7%)
Query: 598 DENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLL-VKGSLKLIDFGIAKAIMSDTTNI 656
D N ++ +Q+L + +H IVH D+KP N L+ V G +K+IDFG A + T I
Sbjct: 307 DINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFG---AAVDMCTGI 363
Query: 657 QRDSQVGTLS--YMSPEAFMCNES 678
+ G L Y PE + +S
Sbjct: 364 NFNPLYGMLDPRYSPPEELVMPQS 387
|
Length = 507 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 40.2 bits (94), Expect = 0.002
Identities = 34/142 (23%), Positives = 63/142 (44%), Gaps = 22/142 (15%)
Query: 568 IYMVLEYGEIDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLK 627
+++VL++ E + W + + E ++ + +++ A++ +H E IV DL
Sbjct: 60 VFLVLQHAE------GGKLWSHI-SKFLNIPEECVKRWAAEMVVALDALHREGIVCRDLN 112
Query: 628 PANFLL-VKGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIK 686
P N LL +G ++L F + D + Y +PE G I +
Sbjct: 113 PNNILLDDRGHIQLTYFSRWSEVED-----SCDGEAVENMYCAPEV---------GGISE 158
Query: 687 CGRPSDIWSLGCILYQMVYGRT 708
D WSLG IL++++ G+T
Sbjct: 159 ETEACDWWSLGAILFELLTGKT 180
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|240172 cd05151, ChoK, Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Score = 39.6 bits (93), Expect = 0.002
Identities = 17/62 (27%), Positives = 30/62 (48%), Gaps = 5/62 (8%)
Query: 587 WKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIV-----HSDLKPANFLLVKGSLKLI 641
+ ++GS ++ ++I + + +H + H+DL P NFLL G L LI
Sbjct: 70 TEFIEGSELLTEDFSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLDDGRLWLI 129
Query: 642 DF 643
D+
Sbjct: 130 DW 131
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate and displays negligible activity towards N-methylated derivatives of Etn. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Length = 170 |
| >gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Score = 40.7 bits (95), Expect = 0.002
Identities = 34/100 (34%), Positives = 49/100 (49%), Gaps = 18/100 (18%)
Query: 609 ILEAVNTIHEERIVHSDLKPANFLLVKGSLK--LIDFGIAKAIMSDTTNI-----QRDSQ 661
+L + IHE I H D+KP N ++V G+ + +ID+GIA + +I Q+D
Sbjct: 135 MLTTLEYIHEHGISHGDIKPEN-IMVDGNNRGYIIDYGIASHFIIHGKHIEYSKEQKDLH 193
Query: 662 VGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLG-CIL 700
GTL Y +A NG R D+ SLG C+L
Sbjct: 194 RGTLYYAGLDA-------HNGA--CVTRRGDLESLGYCML 224
|
Length = 294 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 40.2 bits (94), Expect = 0.003
Identities = 33/130 (25%), Positives = 62/130 (47%), Gaps = 27/130 (20%)
Query: 597 LDENWLRFYWQQILEAVNTIHE-------ERIVHSDLKPANFLL-VKGSLKLIDFGIAKA 648
L E+ RF Q+LE + E ++ +H DL N L+ +G +K+ DFG+++
Sbjct: 90 LREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRY 149
Query: 649 IMSDTTNIQRDSQVGT---LSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVY 705
++ D + S VG+ + + PE + K SD+W+ G ++++ VY
Sbjct: 150 VLDD----EYTSSVGSKFPVRWSPPEVLL---------YSKFSSKSDVWAFGVLMWE-VY 195
Query: 706 --GRTPFSEY 713
G+ P+ +
Sbjct: 196 SLGKMPYERF 205
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 40.0 bits (93), Expect = 0.003
Identities = 40/146 (27%), Positives = 63/146 (43%), Gaps = 19/146 (13%)
Query: 568 IYMVLEY-GEIDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDL 626
IY+V EY + L L + + Q +D QI + + VH DL
Sbjct: 75 IYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVD------MAAQIASGMAYVERMNYVHRDL 128
Query: 627 KPANFLLVKGSL-KLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNII 685
+ AN L+ + + K+ DFG+A+ I D R + + +PEA + I
Sbjct: 129 RAANILVGENLVCKVADFGLARLI-EDNEYTARQGAKFPIKWTAPEAALYGRF-----TI 182
Query: 686 KCGRPSDIWSLGCILYQMVY-GRTPF 710
K SD+WS G +L ++ GR P+
Sbjct: 183 K----SDVWSFGILLTELTTKGRVPY 204
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 39.6 bits (92), Expect = 0.004
Identities = 41/143 (28%), Positives = 66/143 (46%), Gaps = 25/143 (17%)
Query: 622 VHSDLKPANFLLVKG-SLKLIDFGIAKAIMSDTTNIQRDSQVG-----TLSYMSPEAFMC 675
VH DL N L+ +G +K+ DFG+++ I S T+ R VG + +M PE+ +
Sbjct: 144 VHRDLATRNCLVGQGLVVKIGDFGMSRDIYS--TDYYR---VGGRTMLPIRWMPPESILY 198
Query: 676 NESDENGNIIKCGRPSDIWSLGCILYQM-VYGRTPFSEYKTFWAKFKVITDPNHEITYEP 734
K SDIWS G +L+++ YG+ P+ + A + IT E+
Sbjct: 199 R---------KFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEA-IECITQ-GRELERPR 247
Query: 735 VPNPWLLDLMKKCLAWDRNERWR 757
P + +M+ C W R + R
Sbjct: 248 TCPPEVYAIMQGC--WQREPQQR 268
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 40.0 bits (93), Expect = 0.004
Identities = 51/231 (22%), Positives = 94/231 (40%), Gaps = 64/231 (27%)
Query: 500 ALKKIKLKGRDYATA---YGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLREVLNGSMN 556
A+K++K +YA+ F E+E L KL NII L+
Sbjct: 38 AIKRMK----EYASKDDHRDFAGELEVLCKLGHHPNIINLL------------------- 74
Query: 557 NKDGRVKDDGYIYMVLEYG---------------EIDLAHMLSQKWKEMDGSNQTLDENW 601
G + GY+Y+ +EY E D A ++ + TL
Sbjct: 75 ---GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANS------TASTLSSQQ 125
Query: 602 LRFYWQQILEAVNTIHEERIVHSDLKPANFLLVKGSL-KLIDFGIAKAIMSDTTNIQRDS 660
L + + ++ + +++ +H DL N L+ + + K+ DFG+++ +++
Sbjct: 126 LLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRG---QEVYVKKTM 182
Query: 661 QVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMV-YGRTPF 710
+ +M+ E+ N S N SD+WS G +L+++V G TP+
Sbjct: 183 GRLPVRWMAIESL--NYSVYTTN-------SDVWSYGVLLWEIVSLGGTPY 224
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 853 | |||
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 100.0 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 100.0 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 100.0 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 100.0 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 100.0 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.98 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 99.97 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 99.97 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 99.97 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.97 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 99.97 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.97 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.97 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.96 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 99.96 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 99.96 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.95 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.95 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 99.95 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 99.95 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.94 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 99.94 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.94 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.93 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.93 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.92 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.92 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.92 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.89 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.89 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.88 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.88 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.85 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.83 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.82 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.82 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.8 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.8 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.79 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.78 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.78 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.74 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.72 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.72 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.72 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.71 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.65 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.64 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.62 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.61 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.61 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.6 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.53 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.52 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.46 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.3 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.27 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.23 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.19 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.18 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.16 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 98.97 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.91 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 98.89 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.83 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 98.82 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 98.77 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 98.73 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.72 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.55 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.54 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.46 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.34 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.29 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.29 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.11 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.1 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.08 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 97.89 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 97.81 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 97.76 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 97.75 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 97.53 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.49 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 97.47 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 97.45 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 97.35 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.29 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 97.25 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 97.21 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.15 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 97.04 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 96.99 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 96.76 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 96.75 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 96.74 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 96.64 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 96.62 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 96.53 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 96.39 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 96.17 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 95.15 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 95.13 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 95.06 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 95.05 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 94.94 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 94.93 | |
| PLN02236 | 344 | choline kinase | 94.9 | |
| PTZ00384 | 383 | choline kinase; Provisional | 94.88 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 94.8 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 93.94 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 92.72 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 92.3 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 91.41 | |
| PHA03111 | 444 | Ser/Thr kinase; Provisional | 91.26 | |
| PF05445 | 434 | Pox_ser-thr_kin: Poxvirus serine/threonine protein | 91.04 | |
| PTZ00296 | 442 | choline kinase; Provisional | 89.98 | |
| PRK10271 | 188 | thiK thiamine kinase; Provisional | 89.61 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 85.95 | |
| COG0510 | 269 | ycfN Thiamine kinase and related kinases [Coenzyme | 85.16 |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-62 Score=544.85 Aligned_cols=502 Identities=39% Similarity=0.559 Sum_probs=368.7
Q ss_pred hhhccccCccchhhhc-ccccccccccccCCccccccCCcccccch--hhhhhhhhHHhhhhcCCCcccccccCCCCccc
Q 003052 220 EMEWDASNQVEVSTVV-NNNSKLQQVRNTEPDISLRPDGASSLAKR--TTVVQDQLHQFRNFLGQPATQFSMVGSSCPTS 296 (853)
Q Consensus 220 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 296 (853)
.|+|++.|+.++.+-. ....+++|++..+.....+. .|..+ .+--..++..|-||+.+|-+|++..+...||+
T Consensus 107 ~~~~~~~~~~~v~~~~~e~~~r~~Nl~~k~~~sa~~~----~lk~~~s~l~~~gr~~dl~n~c~~~~~~t~n~~~~~at~ 182 (677)
T KOG0596|consen 107 QLLCKALNRSAVPLEMLEITERNLNLQKKQLLSAKKK----VLKASESFLGSLGRLQDLNNFCDSPGPQTTNSRKLYATV 182 (677)
T ss_pred hhHHHHHhhhccchhHHHHHHhhcccccccchhhHHH----HhhhhhhhhhhhhhhhhcccccCCCCCCCCcccccccee
Confidence 6899999999886432 22347888888775433331 22222 12256789999999999999999999999999
Q ss_pred eeeecCCcccccccccccCCcccCCccccccCccccCCCCCCCCCCCccccccCCCCCC--CCCCcccCCCCCCCCCCCC
Q 003052 297 TYIHSTSAPMLNSTTKCSRSHQEGSTLGAVEPVEDFSRNPEPANRGDMVHLSCSSLKDT--KTPVDQAVRAPQASTSVID 374 (853)
Q Consensus 297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~ 374 (853)
+..|..++|+.|.+++-...++.. +++.||.....+..+...|+.+... ..|- ..+.++....+..+
T Consensus 183 ~~P~e~s~~~~~k~r~~n~t~~~~----------~~~~~P~~~~~k~nlp~~~~~~i~~~l~~~g-s~~~~~~~~a~sNd 251 (677)
T KOG0596|consen 183 TLPQEASIGYRNKLRQTNKTYQSC----------DFGRNPVNLLNKPNLPVKTDDSIVPDLRVPG-SKPLGNDSCASSND 251 (677)
T ss_pred cCcchhhcchhhcccccccccccc----------ccCCCccccccCCCCCcccccccchhhcccC-cccccccccccccC
Confidence 999999999999988766664443 7778998887777776677666411 1111 11122333333333
Q ss_pred CCc---ccccCCCCcccccccc---cc--CCCCCCCCCcccccCcCCCCCCCCccccCCCC------CCCCchhhhhhch
Q 003052 375 PKP---EIKKQEWPKEQQDCVV---KE--GGIPNDPSTHKSMEGRQHTGNSPELKSQAPLS------KNSSSDMKLEASK 440 (853)
Q Consensus 375 ~~~---~~~~~~~~~~~~~~~~---~~--~~~~~~ps~~~~~~~~~~~~~sp~~~s~~~~~------~~sss~~~~e~s~ 440 (853)
... ..+++....++-.... .. ..+...+....+. .++.. .|.++.....+ ..++.++- + ..
T Consensus 252 ~~~~n~l~ke~~ts~~~~~~t~~~~~~~~ss~s~s~~~~~~~-~kee~--~~~sq~~s~~S~~~~~~~~s~~d~~-p-~~ 326 (677)
T KOG0596|consen 252 KSVQNSLFKEPLTSDEKSIITDSITAKNKSSSSLSAKIPERK-EKEEP--EPESQNPSASSNFEQVFSVSKQDMT-P-VK 326 (677)
T ss_pred hhhhhhhccCCCcccccccCCcceeeccCcccccCCCccccc-cccCC--CccccCCcccchhhhhhhhhccccc-h-hh
Confidence 322 3566666544421110 00 0000000000000 00000 01110000000 00000000 0 00
Q ss_pred hhhhhhhhccCCCCCCCCcCC---CCCceeEEcCceeeEEEeEeccCceEEEEEEecCCcEEEEEEEecCCCChhhHhhH
Q 003052 441 SEKQEKAVSSKGASAPRKRNY---DPDLFFKVNGKLYQRLGKIGSGGSSEVHKVISSDCTIYALKKIKLKGRDYATAYGF 517 (853)
Q Consensus 441 se~~e~~~ss~~~~~~rk~~~---dp~~~~~v~g~~Y~ilk~LG~G~FG~Vyka~~~~g~~vAVKkik~~~~~~~~~~~~ 517 (853)
....+...+.......+.+.+ ....+++++|+.|+++++||+||.+.||+|...+++.||+|++.....+...+..|
T Consensus 327 ~~r~~Pk~~vs~P~~~~~p~~~~~~~~~~i~Vkg~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy 406 (677)
T KOG0596|consen 327 KDRFEPKCSVSTPQILATPLQASSSANEIIKVKGREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGY 406 (677)
T ss_pred ccCCCCCcccCCCccccCccccCCCcCeeEEECcchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHH
Confidence 001111111111122222222 22578999999999999999999999999999999999999999999999999999
Q ss_pred HHHHHHHHHhcCCCceeEeeehhhhHHHHHHHHhhCCCCCCCCccccCCeEEEEEecchhhHHHHHHHhhhhccCCCCCC
Q 003052 518 CQEIEYLNKLKGKNNIIQLIDYEVTEKALLREVLNGSMNNKDGRVKDDGYIYMVLEYGEIDLAHMLSQKWKEMDGSNQTL 597 (853)
Q Consensus 518 l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~~l~~~~iv~~~g~~~d~~~lyLVmEy~~gdL~~~L~~~~k~~~~~~~~L 597 (853)
++||.+|.+|++|.+||+|+||.++ ++++||||||++.||..+|++++. .+
T Consensus 407 ~nEI~lL~KLkg~~~IIqL~DYEv~----------------------d~~lYmvmE~Gd~DL~kiL~k~~~-------~~ 457 (677)
T KOG0596|consen 407 RNEIALLNKLKGHDKIIQLYDYEVT----------------------DGYLYMVMECGDIDLNKILKKKKS-------ID 457 (677)
T ss_pred HHHHHHHHHhcCCceEEEEeeeecc----------------------CceEEEEeecccccHHHHHHhccC-------CC
Confidence 9999999999999999999999653 678999999999999999998743 23
Q ss_pred CHHHHHHHHHHhhhhhhhcccCceeeCCCCCccEEeecCcEEEEecccchhcccCCccccccccccCccccCchhhccCC
Q 003052 598 DENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLLVKGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNE 677 (853)
Q Consensus 598 sE~~~r~I~~QIl~AL~yLHs~gIIHRDLKPeNILL~~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~ 677 (853)
+.-++++|++||+.|+.++|.+||||.||||.|+|+..|.+||+|||+|..+..+.+++.+.+.+||+.||+||.+....
T Consensus 458 ~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLlVkG~LKLIDFGIA~aI~~DTTsI~kdsQvGT~NYMsPEAl~~~~ 537 (677)
T KOG0596|consen 458 PDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLLVKGRLKLIDFGIANAIQPDTTSIVKDSQVGTVNYMSPEALTDMS 537 (677)
T ss_pred chHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEEEeeeEEeeeechhcccCccccceeeccccCcccccCHHHHhhcc
Confidence 43489999999999999999999999999999999999999999999999999999999999999999999999998876
Q ss_pred CCCCC--ccccCCCccchhhhHHHHHHHHhCCCCCCcchhHHHHHHhhcCCCCcccCCCCCChh-HHHHHHHhcccCCCC
Q 003052 678 SDENG--NIIKCGRPSDIWSLGCILYQMVYGRTPFSEYKTFWAKFKVITDPNHEITYEPVPNPW-LLDLMKKCLAWDRNE 754 (853)
Q Consensus 678 ~~~~~--~~~~ys~ksDIWSLGVILyELLtG~~PF~~~~~~~~~~kii~~~~~~~~~~~~~s~~-l~dLI~kcL~~DP~k 754 (853)
++..+ +..++++++||||||||||+|++|++||..+.+.+..+..+.+++.++.|+...+.+ +.++++.||.+||++
T Consensus 538 s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~~aKl~aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkk 617 (677)
T KOG0596|consen 538 SSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQIAKLHAITDPNHEIEFPDIPENDELIDVMKCCLARDPKK 617 (677)
T ss_pred ccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHHHHHHHhhcCCCccccccCCCCchHHHHHHHHHHhcCccc
Confidence 65333 467789999999999999999999999999999999999999999999999888877 999999999999999
Q ss_pred CCChhHHhcCCCCCCC
Q 003052 755 RWRIPQLLQHPFLVPP 770 (853)
Q Consensus 755 RpTa~EIL~HPwf~~~ 770 (853)
||++.++|+|||+.+.
T Consensus 618 R~si~eLLqhpFl~~~ 633 (677)
T KOG0596|consen 618 RWSIPELLQHPFLQIQ 633 (677)
T ss_pred CCCcHHHhcCcccccc
Confidence 9999999999999873
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-52 Score=449.39 Aligned_cols=259 Identities=30% Similarity=0.397 Sum_probs=217.0
Q ss_pred CceeeEEEeEeccCceEEEEEEe-cCCcEEEEEEEecCCCCh-----hhHhhHHHHHHHHHHhcCCCceeEeeehhhhHH
Q 003052 471 GKLYQRLGKIGSGGSSEVHKVIS-SDCTIYALKKIKLKGRDY-----ATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEK 544 (853)
Q Consensus 471 g~~Y~ilk~LG~G~FG~Vyka~~-~~g~~vAVKkik~~~~~~-----~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~ 544 (853)
.+.|.+.+.||+|+||.|-+|.. ++|+.||||++.+..... .....+.+|++||++|. |||||+++++
T Consensus 171 ~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~-HP~IV~~~d~----- 244 (475)
T KOG0615|consen 171 NDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLS-HPNIVRIKDF----- 244 (475)
T ss_pred cceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcC-CCCEEEEeee-----
Confidence 36699999999999999999987 688999999998754322 22334679999999998 9999999998
Q ss_pred HHHHHHhhCCCCCCCCccccCCeEEEEEecch-hhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceee
Q 003052 545 ALLREVLNGSMNNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVH 623 (853)
Q Consensus 545 ~iL~~l~~~~iv~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIH 623 (853)
|....++||||||++ |+|++.+-.+ +.+.|...+.+++||+.||.|||++||+|
T Consensus 245 -----------------f~~~ds~YmVlE~v~GGeLfd~vv~n--------k~l~ed~~K~~f~Qll~avkYLH~~GI~H 299 (475)
T KOG0615|consen 245 -----------------FEVPDSSYMVLEYVEGGELFDKVVAN--------KYLREDLGKLLFKQLLTAVKYLHSQGIIH 299 (475)
T ss_pred -----------------eecCCceEEEEEEecCccHHHHHHhc--------cccccchhHHHHHHHHHHHHHHHHcCccc
Confidence 566778899999965 6999988765 67999999999999999999999999999
Q ss_pred CCCCCccEEeec----CcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHH
Q 003052 624 SDLKPANFLLVK----GSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCI 699 (853)
Q Consensus 624 RDLKPeNILL~~----g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVI 699 (853)
|||||+||||.. ..+||+|||+|+.... .....++||||.|.|||++...... .|..++|||||||+
T Consensus 300 RDiKPeNILl~~~~e~~llKItDFGlAK~~g~---~sfm~TlCGTpsYvAPEVl~~kg~~------~~~~kVDiWSlGcv 370 (475)
T KOG0615|consen 300 RDIKPENILLSNDAEDCLLKITDFGLAKVSGE---GSFMKTLCGTPSYVAPEVLASKGVE------YYPSKVDIWSLGCV 370 (475)
T ss_pred ccCCcceEEeccCCcceEEEecccchhhcccc---ceehhhhcCCccccChhheecCCee------cccchheeeeccce
Confidence 999999999943 3799999999998753 2345699999999999999877544 46679999999999
Q ss_pred HHHHHhCCCCCCcchhHHHHHHhhcCCCCccc--CCCCCChhHHHHHHHhcccCCCCCCChhHHhcCCCCCC
Q 003052 700 LYQMVYGRTPFSEYKTFWAKFKVITDPNHEIT--YEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQHPFLVP 769 (853)
Q Consensus 700 LyELLtG~~PF~~~~~~~~~~kii~~~~~~~~--~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~HPwf~~ 769 (853)
||-+|+|.+||.+........+.+..+...+. .+...+.++++||.+||.+||++||++.|+|+||||+.
T Consensus 371 LfvcLsG~pPFS~~~~~~sl~eQI~~G~y~f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW~~~ 442 (475)
T KOG0615|consen 371 LFVCLSGYPPFSEEYTDPSLKEQILKGRYAFGPLQWDRISEEALDLINWMLVVDPENRPSADEALNHPWFKD 442 (475)
T ss_pred EEEEeccCCCcccccCCccHHHHHhcCcccccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcChhhhc
Confidence 99999999999875444434444544444332 34567889999999999999999999999999999974
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-50 Score=455.24 Aligned_cols=261 Identities=28% Similarity=0.462 Sum_probs=224.1
Q ss_pred CceeEEcCceeeEEEeEeccCceEEEEEEe-cCCcEEEEEEEecCCC-ChhhHhhHHHHHHHHHHhcCCCceeEeeehhh
Q 003052 464 DLFFKVNGKLYQRLGKIGSGGSSEVHKVIS-SDCTIYALKKIKLKGR-DYATAYGFCQEIEYLNKLKGKNNIIQLIDYEV 541 (853)
Q Consensus 464 ~~~~~v~g~~Y~ilk~LG~G~FG~Vyka~~-~~g~~vAVKkik~~~~-~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~ 541 (853)
+.+.+...++|...+.||+|||+.||++++ .+|..||+|++.+... .......+.+||+|++.|+ |||||+++++
T Consensus 10 ~~i~D~~~~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~-HpnIV~f~~~-- 86 (592)
T KOG0575|consen 10 EVIEDPRSKRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLK-HPNIVQFYHF-- 86 (592)
T ss_pred CeeecCCcceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcC-CCcEEeeeeE--
Confidence 444555557899999999999999999999 7889999999976432 3345567889999999998 9999999987
Q ss_pred hHHHHHHHHhhCCCCCCCCccccCCeEEEEEecch-hhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCc
Q 003052 542 TEKALLREVLNGSMNNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEER 620 (853)
Q Consensus 542 ~e~~iL~~l~~~~iv~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~g 620 (853)
|+|.+++|||+|+|. ++|.++++++ ..++|.++++|++||+.||.|||+++
T Consensus 87 --------------------FEDs~nVYivLELC~~~sL~el~Krr--------k~ltEpEary~l~QIv~GlkYLH~~~ 138 (592)
T KOG0575|consen 87 --------------------FEDSNNVYIVLELCHRGSLMELLKRR--------KPLTEPEARYFLRQIVEGLKYLHSLG 138 (592)
T ss_pred --------------------eecCCceEEEEEecCCccHHHHHHhc--------CCCCcHHHHHHHHHHHHHHHHHHhcC
Confidence 789999999999998 5888887743 68999999999999999999999999
Q ss_pred eeeCCCCCccEEeecC-cEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHH
Q 003052 621 IVHSDLKPANFLLVKG-SLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCI 699 (853)
Q Consensus 621 IIHRDLKPeNILL~~g-~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVI 699 (853)
|||||||..||||++. +|||+|||+|..+..+.. ...+.||||.|+|||++... .+++.+||||+|||
T Consensus 139 IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~E--rk~TlCGTPNYIAPEVl~k~---------gHsfEvDiWSlGcv 207 (592)
T KOG0575|consen 139 IIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDGE--RKKTLCGTPNYIAPEVLNKS---------GHSFEVDIWSLGCV 207 (592)
T ss_pred ceecccchhheeecCcCcEEecccceeeeecCccc--ccceecCCCcccChhHhccC---------CCCCchhhhhhhhH
Confidence 9999999999999776 999999999998875433 33589999999999999754 36899999999999
Q ss_pred HHHHHhCCCCCCcchhHHHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCCChhHHhcCCCCCC
Q 003052 700 LYQMVYGRTPFSEYKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQHPFLVP 769 (853)
Q Consensus 700 LyELLtG~~PF~~~~~~~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~HPwf~~ 769 (853)
||-||+|++||... ...+.+..+.. .....|...+.++++||.+||..||.+|||+++||.|+||+.
T Consensus 208 mYtLL~G~PPFetk-~vkety~~Ik~--~~Y~~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h~Ff~~ 274 (592)
T KOG0575|consen 208 MYTLLVGRPPFETK-TVKETYNKIKL--NEYSMPSHLSAEAKDLIRKLLRPNPSERPSLDEVLDHPFFKS 274 (592)
T ss_pred HHhhhhCCCCcccc-hHHHHHHHHHh--cCcccccccCHHHHHHHHHHhcCCcccCCCHHHHhcCHhhhC
Confidence 99999999999763 44455555543 334556688999999999999999999999999999999953
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-48 Score=420.19 Aligned_cols=256 Identities=30% Similarity=0.433 Sum_probs=215.2
Q ss_pred cCceeeEEEeEeccCceEEEEEEec-CCcEEEEEEEecCCCC-hhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHH
Q 003052 470 NGKLYQRLGKIGSGGSSEVHKVISS-DCTIYALKKIKLKGRD-YATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALL 547 (853)
Q Consensus 470 ~g~~Y~ilk~LG~G~FG~Vyka~~~-~g~~vAVKkik~~~~~-~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL 547 (853)
.-++|++++.||+|+||+||.|+.+ +++.||+|++++.... .........|..||.+++ ||.||.++.
T Consensus 23 ~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~-hPFiv~l~y--------- 92 (357)
T KOG0598|consen 23 GPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIK-HPFIVKLIY--------- 92 (357)
T ss_pred ChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCC-CCcEeeeEE---------
Confidence 3467999999999999999999884 6699999999876442 234556778999999976 888888864
Q ss_pred HHHhhCCCCCCCCccccCCeEEEEEecch-hhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCC
Q 003052 548 REVLNGSMNNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDL 626 (853)
Q Consensus 548 ~~l~~~~iv~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDL 626 (853)
.|++...+|||+||.. |+|+..|++. +.|+|..+++|+.+|+.||.|||++|||||||
T Consensus 93 -------------sFQt~~kLylVld~~~GGeLf~hL~~e--------g~F~E~~arfYlaEi~lAL~~LH~~gIiyRDl 151 (357)
T KOG0598|consen 93 -------------SFQTEEKLYLVLDYLNGGELFYHLQRE--------GRFSEDRARFYLAEIVLALGYLHSKGIIYRDL 151 (357)
T ss_pred -------------ecccCCeEEEEEeccCCccHHHHHHhc--------CCcchhHHHHHHHHHHHHHHHHHhCCeeeccC
Confidence 3889999999999954 5999988764 78999999999999999999999999999999
Q ss_pred CCccEEe-ecCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHh
Q 003052 627 KPANFLL-VKGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVY 705 (853)
Q Consensus 627 KPeNILL-~~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLt 705 (853)
||+|||| .+|+|+|+|||+|+....... ...++|||+.|||||++.+.. |+..+|||||||++||||+
T Consensus 152 KPENILLd~~GHi~LtDFgL~k~~~~~~~--~t~tfcGT~eYmAPEil~~~g---------y~~~vDWWsLGillYeML~ 220 (357)
T KOG0598|consen 152 KPENILLDEQGHIKLTDFGLCKEDLKDGD--ATRTFCGTPEYMAPEILLGKG---------YDKAVDWWSLGILLYEMLT 220 (357)
T ss_pred CHHHeeecCCCcEEEeccccchhcccCCC--ccccccCCccccChHHHhcCC---------CCcccchHhHHHHHHHHhh
Confidence 9999999 579999999999997655433 234799999999999998874 6689999999999999999
Q ss_pred CCCCCCcchhHHHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCC----ChhHHhcCCCCCC
Q 003052 706 GRTPFSEYKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERW----RIPQLLQHPFLVP 769 (853)
Q Consensus 706 G~~PF~~~~~~~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRp----Ta~EIL~HPwf~~ 769 (853)
|.+||.+.+......++.... ...++...+.++++||+++|.+||++|. .+.+|-+||||..
T Consensus 221 G~pPF~~~~~~~~~~~I~~~k--~~~~p~~ls~~ardll~~LL~rdp~~RLg~~~d~~~ik~HpfF~~ 286 (357)
T KOG0598|consen 221 GKPPFYAEDVKKMYDKILKGK--LPLPPGYLSEEARDLLKKLLKRDPRQRLGGPGDAEEIKRHPFFKG 286 (357)
T ss_pred CCCCCcCccHHHHHHHHhcCc--CCCCCccCCHHHHHHHHHHhccCHHHhcCCCCChHHhhcCccccc
Confidence 999998866554444444432 2334445889999999999999999996 6999999999964
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-49 Score=431.74 Aligned_cols=263 Identities=28% Similarity=0.470 Sum_probs=223.3
Q ss_pred cCceeeEEEeEeccCceEEEEEEe-cCCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHH
Q 003052 470 NGKLYQRLGKIGSGGSSEVHKVIS-SDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLR 548 (853)
Q Consensus 470 ~g~~Y~ilk~LG~G~FG~Vyka~~-~~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~ 548 (853)
.-++|.++++||.|+||.||+|+. .++..||||+++.+....+... -+||++.|++|..|||||+|.+++
T Consensus 8 ~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~-nLREvksL~kln~hpniikL~Evi-------- 78 (538)
T KOG0661|consen 8 FMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECM-NLREVKSLRKLNPHPNIIKLKEVI-------- 78 (538)
T ss_pred HHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHH-HHHHHHHHHhcCCCCcchhhHHHh--------
Confidence 346799999999999999999988 5778999999998877665543 469999999999999999998763
Q ss_pred HHhhCCCCCCCCccccCC-eEEEEEecchhhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCC
Q 003052 549 EVLNGSMNNKDGRVKDDG-YIYMVLEYGEIDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLK 627 (853)
Q Consensus 549 ~l~~~~iv~~~g~~~d~~-~lyLVmEy~~gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLK 627 (853)
.+.. .+|+||||++.+|+++++.+ +..|+|..++.|+.||++||+|+|.+|+.|||||
T Consensus 79 --------------~d~~~~L~fVfE~Md~NLYqLmK~R-------~r~fse~~irnim~QilqGL~hiHk~GfFHRDlK 137 (538)
T KOG0661|consen 79 --------------RDNDRILYFVFEFMDCNLYQLMKDR-------NRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLK 137 (538)
T ss_pred --------------hccCceEeeeHHhhhhhHHHHHhhc-------CCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCC
Confidence 3333 89999999999999999875 4689999999999999999999999999999999
Q ss_pred CccEEee-cCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHhC
Q 003052 628 PANFLLV-KGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYG 706 (853)
Q Consensus 628 PeNILL~-~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLtG 706 (853)
|||||+. ...|||+|||+|+.+..... .+.++.|.||+|||++.... .|+.++||||+|||++|+++-
T Consensus 138 PENiLi~~~~~iKiaDFGLARev~SkpP---YTeYVSTRWYRAPEvLLrs~--------~Ys~pvD~wA~GcI~aEl~sL 206 (538)
T KOG0661|consen 138 PENILISGNDVIKIADFGLAREVRSKPP---YTEYVSTRWYRAPEVLLRSG--------YYSSPVDMWAVGCIMAELYSL 206 (538)
T ss_pred hhheEecccceeEecccccccccccCCC---cchhhhcccccchHHhhhcc--------ccCCchHHHHHHHHHHHHHHh
Confidence 9999996 78999999999998865433 35789999999999998654 589999999999999999999
Q ss_pred CCCCCcchhHHHHHHh---hcCCCCcc-------------cC-----------CCCCChhHHHHHHHhcccCCCCCCChh
Q 003052 707 RTPFSEYKTFWAKFKV---ITDPNHEI-------------TY-----------EPVPNPWLLDLMKKCLAWDRNERWRIP 759 (853)
Q Consensus 707 ~~PF~~~~~~~~~~ki---i~~~~~~~-------------~~-----------~~~~s~~l~dLI~kcL~~DP~kRpTa~ 759 (853)
++.|.+.+++.+++++ +..+.... .+ -+..+.++.+||.+||.|||.+||||.
T Consensus 207 rPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~ 286 (538)
T KOG0661|consen 207 RPLFPGASEIDQIYKICEVLGTPDKDSWPEGYNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTAS 286 (538)
T ss_pred cccCCCCcHHHHHHHHHHHhCCCccccchhHHHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHH
Confidence 9999887666555554 44433221 11 133677899999999999999999999
Q ss_pred HHhcCCCCCCCCCC
Q 003052 760 QLLQHPFLVPPVST 773 (853)
Q Consensus 760 EIL~HPwf~~~~~~ 773 (853)
|+|+||||......
T Consensus 287 ~al~~pffq~~~~~ 300 (538)
T KOG0661|consen 287 QALQHPFFQVGRAS 300 (538)
T ss_pred HHhcCccccccccc
Confidence 99999999865543
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-48 Score=406.47 Aligned_cols=257 Identities=28% Similarity=0.498 Sum_probs=216.0
Q ss_pred eeeEEEeEeccCceEEEEEEec-CCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHHHHh
Q 003052 473 LYQRLGKIGSGGSSEVHKVISS-DCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLREVL 551 (853)
Q Consensus 473 ~Y~ilk~LG~G~FG~Vyka~~~-~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~~l~ 551 (853)
.|+.+.++|+|+||+||+|+++ +|++||||++.....+....+..++||++|++|+ |+|+|.|+++|
T Consensus 3 kYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLk-H~NLVnLiEVF----------- 70 (396)
T KOG0593|consen 3 KYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLK-HENLVNLIEVF----------- 70 (396)
T ss_pred HHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcc-cchHHHHHHHH-----------
Confidence 5888999999999999999995 6799999999877777777777899999999998 89999998774
Q ss_pred hCCCCCCCCccccCCeEEEEEecchhhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCCCccE
Q 003052 552 NGSMNNKDGRVKDDGYIYMVLEYGEIDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANF 631 (853)
Q Consensus 552 ~~~iv~~~g~~~d~~~lyLVmEy~~gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLKPeNI 631 (853)
.....+++|+|||+.++.+.+... ...+++..++.|++|++.|+.|||+++||||||||+||
T Consensus 71 -----------rrkrklhLVFE~~dhTvL~eLe~~-------p~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENI 132 (396)
T KOG0593|consen 71 -----------RRKRKLHLVFEYCDHTVLHELERY-------PNGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENI 132 (396)
T ss_pred -----------HhcceeEEEeeecchHHHHHHHhc-------cCCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhhe
Confidence 455678999999999888888764 35689999999999999999999999999999999999
Q ss_pred Ee-ecCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHhCCCCC
Q 003052 632 LL-VKGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGRTPF 710 (853)
Q Consensus 632 LL-~~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLtG~~PF 710 (853)
|| .+|.+||||||+|+.+..+.. ..+.++.|.||+|||++.|.. .|+..+||||+||++.||++|.+.|
T Consensus 133 Lit~~gvvKLCDFGFAR~L~~pgd--~YTDYVATRWYRaPELLvGDt--------qYG~pVDiWAiGCv~aEl~~G~pL~ 202 (396)
T KOG0593|consen 133 LITQNGVVKLCDFGFARTLSAPGD--NYTDYVATRWYRAPELLVGDT--------QYGKPVDIWAIGCVFAELLTGEPLW 202 (396)
T ss_pred EEecCCcEEeccchhhHhhcCCcc--hhhhhhhhhhccChhhhcccC--------cCCCcccchhhhHHHHHHhcCCcCC
Confidence 99 578999999999998875433 345889999999999998753 5899999999999999999999999
Q ss_pred CcchhHHHHHHhhcCCCCc----------------ccCC------------CCCChhHHHHHHHhcccCCCCCCChhHHh
Q 003052 711 SEYKTFWAKFKVITDPNHE----------------ITYE------------PVPNPWLLDLMKKCLAWDRNERWRIPQLL 762 (853)
Q Consensus 711 ~~~~~~~~~~kii~~~~~~----------------~~~~------------~~~s~~l~dLI~kcL~~DP~kRpTa~EIL 762 (853)
.+.....+.+.+...-..- +.++ +..+.-+.||+++||..||.+|++.+|+|
T Consensus 203 PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll 282 (396)
T KOG0593|consen 203 PGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLL 282 (396)
T ss_pred CCcchHHHHHHHHHHHcccCHHHHHHhccCCceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHh
Confidence 8776665554443211000 0011 23344589999999999999999999999
Q ss_pred cCCCCCC
Q 003052 763 QHPFLVP 769 (853)
Q Consensus 763 ~HPwf~~ 769 (853)
.|+||..
T Consensus 283 ~H~yFd~ 289 (396)
T KOG0593|consen 283 HHPYFDG 289 (396)
T ss_pred cChHHHH
Confidence 9999943
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-47 Score=415.01 Aligned_cols=257 Identities=30% Similarity=0.463 Sum_probs=218.3
Q ss_pred ceeeEEEeEeccCceEEEEEEe-cCCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHHHH
Q 003052 472 KLYQRLGKIGSGGSSEVHKVIS-SDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLREV 550 (853)
Q Consensus 472 ~~Y~ilk~LG~G~FG~Vyka~~-~~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~~l 550 (853)
..|.+.++||+|+||+||+|++ .++..||||.|.++.......+.+..||++|+.|+ |+|||+|+|+
T Consensus 10 ~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~-H~nIV~l~d~----------- 77 (429)
T KOG0595|consen 10 GDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELK-HPNIVRLLDC----------- 77 (429)
T ss_pred ccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcC-CcceeeEEEE-----------
Confidence 3488999999999999999998 56789999999888766677777889999999999 9999999987
Q ss_pred hhCCCCCCCCccccCCeEEEEEecch-hhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCCCc
Q 003052 551 LNGSMNNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPA 629 (853)
Q Consensus 551 ~~~~iv~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLKPe 629 (853)
+++++++|||||||. |||.++|..+ +.++|..++.++.||+.||++||+++||||||||+
T Consensus 78 -----------~~~~~~i~lVMEyC~gGDLs~yi~~~--------~~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQ 138 (429)
T KOG0595|consen 78 -----------IEDDDFIYLVMEYCNGGDLSDYIRRR--------GRLPEATARHFMQQLASALQFLHENNIIHRDLKPQ 138 (429)
T ss_pred -----------EecCCeEEEEEEeCCCCCHHHHHHHc--------CCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcc
Confidence 567889999999988 6999999876 68999999999999999999999999999999999
Q ss_pred cEEeec-------CcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHH
Q 003052 630 NFLLVK-------GSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQ 702 (853)
Q Consensus 630 NILL~~-------g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyE 702 (853)
||||+. -.+||+|||+|+.+.... ...+.||+|.|||||+++... |+-|+|+||+|+|+|+
T Consensus 139 NiLLs~~~~~~~~~~LKIADFGfAR~L~~~~---~a~tlcGSplYMAPEV~~~~~---------YdAKADLWSiG~Ilyq 206 (429)
T KOG0595|consen 139 NILLSTTARNDTSPVLKIADFGFARFLQPGS---MAETLCGSPLYMAPEVIMSQQ---------YDAKADLWSIGTILYQ 206 (429)
T ss_pred eEEeccCCCCCCCceEEecccchhhhCCchh---HHHHhhCCccccCHHHHHhcc---------ccchhhHHHHHHHHHH
Confidence 999943 258999999999886432 345899999999999998664 5569999999999999
Q ss_pred HHhCCCCCCcchhHHHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCCChhHHhcCCCCCCCC
Q 003052 703 MVYGRTPFSEYKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQHPFLVPPV 771 (853)
Q Consensus 703 LLtG~~PF~~~~~~~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~HPwf~~~~ 771 (853)
|++|++||......+....+-.........+...+..+.+|+...|..++..|.+..+.+.|+++....
T Consensus 207 ~l~g~~Pf~a~t~~eL~~~~~k~~~~~~~~~~~~s~~~~~Ll~~ll~~~~~~~~~~~~~~~~~~l~~~p 275 (429)
T KOG0595|consen 207 CLTGKPPFDAETPKELLLYIKKGNEIVPVLPAELSNPLRELLISLLQRNPKDRISFEDFFDHPFLAANP 275 (429)
T ss_pred HHhCCCCccccCHHHHHHHHhccccccCchhhhccCchhhhhhHHHhcCccccCchHHhhhhhhcccCc
Confidence 999999998654433333333333333344556677788999999999999999999999999997644
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-47 Score=412.11 Aligned_cols=254 Identities=31% Similarity=0.465 Sum_probs=213.9
Q ss_pred ceeeEEEeEeccCceEEEEEEec-CCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHHHH
Q 003052 472 KLYQRLGKIGSGGSSEVHKVISS-DCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLREV 550 (853)
Q Consensus 472 ~~Y~ilk~LG~G~FG~Vyka~~~-~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~~l 550 (853)
.+.+.++.||+|..|+||+|.++ +++.||+|+|... .+.+..+.+++|+++|+++. +|+||.+++.
T Consensus 79 ~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~-~~~~~~~Qi~rEl~il~~~~-spyIV~~yga----------- 145 (364)
T KOG0581|consen 79 SDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLN-IDPALQKQILRELEILRSCQ-SPYIVGFYGA----------- 145 (364)
T ss_pred HHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeeccc-CCHHHHHHHHHHHHHHhhCC-CCCeeeEeEE-----------
Confidence 45677889999999999999994 7799999999543 45567778999999999995 9999999876
Q ss_pred hhCCCCCCCCccccCC-eEEEEEecch-hhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhccc-CceeeCCCC
Q 003052 551 LNGSMNNKDGRVKDDG-YIYMVLEYGE-IDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHE-ERIVHSDLK 627 (853)
Q Consensus 551 ~~~~iv~~~g~~~d~~-~lyLVmEy~~-gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs-~gIIHRDLK 627 (853)
|..++ .++|+|||++ |+|..++... +.++|.....++.+|++||.|||+ ++|||||||
T Consensus 146 -----------F~~~~~~isI~mEYMDgGSLd~~~k~~--------g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIK 206 (364)
T KOG0581|consen 146 -----------FYSNGEEISICMEYMDGGSLDDILKRV--------GRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIK 206 (364)
T ss_pred -----------EEeCCceEEeehhhcCCCCHHHHHhhc--------CCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCC
Confidence 44555 5999999987 4888877654 679999999999999999999995 899999999
Q ss_pred CccEEe-ecCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHhC
Q 003052 628 PANFLL-VKGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYG 706 (853)
Q Consensus 628 PeNILL-~~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLtG 706 (853)
|.|||+ ..|.|||||||.++.+... ...+++||..|||||.+.+.. |+.++||||||++++||++|
T Consensus 207 PsNlLvNskGeVKicDFGVS~~lvnS----~a~tfvGT~~YMsPERi~g~~---------Ys~~sDIWSLGLsllE~a~G 273 (364)
T KOG0581|consen 207 PSNLLVNSKGEVKICDFGVSGILVNS----IANTFVGTSAYMSPERISGES---------YSVKSDIWSLGLSLLELAIG 273 (364)
T ss_pred HHHeeeccCCCEEeccccccHHhhhh----hcccccccccccChhhhcCCc---------CCcccceecccHHHHHHhhC
Confidence 999999 6899999999999988654 345899999999999998874 67899999999999999999
Q ss_pred CCCCCcc----hhHHHHHHhhcCCCCcccCCC-CCChhHHHHHHHhcccCCCCCCChhHHhcCCCCCCCC
Q 003052 707 RTPFSEY----KTFWAKFKVITDPNHEITYEP-VPNPWLLDLMKKCLAWDRNERWRIPQLLQHPFLVPPV 771 (853)
Q Consensus 707 ~~PF~~~----~~~~~~~kii~~~~~~~~~~~-~~s~~l~dLI~kcL~~DP~kRpTa~EIL~HPwf~~~~ 771 (853)
++||... ....+.+..|.+.. ....+. .+++++++||..||++||.+||++.|+|+|||++...
T Consensus 274 rfP~~~~~~~~~~~~~Ll~~Iv~~p-pP~lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~Hpfi~~~~ 342 (364)
T KOG0581|consen 274 RFPYPPPNPPYLDIFELLCAIVDEP-PPRLPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQHPFIKKFE 342 (364)
T ss_pred CCCCCCcCCCCCCHHHHHHHHhcCC-CCCCCcccCCHHHHHHHHHHhcCCcccCCCHHHHhcCHHHhhcc
Confidence 9999653 23344444444322 223344 5899999999999999999999999999999998654
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-46 Score=419.45 Aligned_cols=255 Identities=31% Similarity=0.439 Sum_probs=215.6
Q ss_pred ceeeEEEeEeccCceEEEEEEe-cCCcEEEEEEEecCCC--C-hhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHH
Q 003052 472 KLYQRLGKIGSGGSSEVHKVIS-SDCTIYALKKIKLKGR--D-YATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALL 547 (853)
Q Consensus 472 ~~Y~ilk~LG~G~FG~Vyka~~-~~g~~vAVKkik~~~~--~-~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL 547 (853)
..|.+.+.||+|+||+|++|.+ .++..||+|++..... . ......+.+|+.+++++.+||||+++++++
T Consensus 17 g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~------- 89 (370)
T KOG0583|consen 17 GKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVF------- 89 (370)
T ss_pred CceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEE-------
Confidence 5699999999999999999987 5779999997766411 1 233445668999999999999999999984
Q ss_pred HHHhhCCCCCCCCccccCCeEEEEEecch-hhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCC
Q 003052 548 REVLNGSMNNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDL 626 (853)
Q Consensus 548 ~~l~~~~iv~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDL 626 (853)
.....+|+||||+. |+|++++..+ +++.|..++.+|+||+.||+|||++||+||||
T Consensus 90 ---------------~t~~~~~ivmEy~~gGdL~~~i~~~--------g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDL 146 (370)
T KOG0583|consen 90 ---------------ATPTKIYIVMEYCSGGDLFDYIVNK--------GRLKEDEARKYFRQLISAVAYCHSRGIVHRDL 146 (370)
T ss_pred ---------------ecCCeEEEEEEecCCccHHHHHHHc--------CCCChHHHHHHHHHHHHHHHHHHhCCEeeCCC
Confidence 44566999999976 4999999864 68999999999999999999999999999999
Q ss_pred CCccEEee-c-CcEEEEecccchhcccCCccccccccccCccccCchhhccCC-CCCCCccccCCCccchhhhHHHHHHH
Q 003052 627 KPANFLLV-K-GSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNE-SDENGNIIKCGRPSDIWSLGCILYQM 703 (853)
Q Consensus 627 KPeNILL~-~-g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~-~~~~~~~~~ys~ksDIWSLGVILyEL 703 (853)
||+|||++ + +++||+|||++.... .......+.|||+.|+|||++.+.. |+ +.++|||||||+||.|
T Consensus 147 K~ENilld~~~~~~Kl~DFG~s~~~~--~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~--------g~~aDvWS~GViLy~m 216 (370)
T KOG0583|consen 147 KPENILLDGNEGNLKLSDFGLSAISP--GEDGLLKTFCGSPAYAAPEVLSGKGTYS--------GKAADVWSLGVILYVL 216 (370)
T ss_pred CHHHEEecCCCCCEEEeccccccccC--CCCCcccCCCCCcccCCHHHhCCCCCcC--------CchhhhhhhHHHHHHH
Confidence 99999995 4 799999999998763 1122446899999999999998875 43 5899999999999999
Q ss_pred HhCCCCCCcchhHHHHHHhhcCCCCcccCCCCC-ChhHHHHHHHhcccCCCCCCChhHHhcCCCCCC
Q 003052 704 VYGRTPFSEYKTFWAKFKVITDPNHEITYEPVP-NPWLLDLMKKCLAWDRNERWRIPQLLQHPFLVP 769 (853)
Q Consensus 704 LtG~~PF~~~~~~~~~~kii~~~~~~~~~~~~~-s~~l~dLI~kcL~~DP~kRpTa~EIL~HPwf~~ 769 (853)
++|+.||.+.+......+ +. ...+.++... ++++++||.+||..||.+|+++.+|+.||||+.
T Consensus 217 l~G~~PF~d~~~~~l~~k-i~--~~~~~~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~~h~w~~~ 280 (370)
T KOG0583|consen 217 LCGRLPFDDSNVPNLYRK-IR--KGEFKIPSYLLSPEARSLIEKMLVPDPSTRITLLEILEHPWFQK 280 (370)
T ss_pred HhCCCCCCCccHHHHHHH-Hh--cCCccCCCCcCCHHHHHHHHHHcCCCcccCCCHHHHhhChhhcc
Confidence 999999988555444444 33 3445666667 999999999999999999999999999999997
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-47 Score=423.11 Aligned_cols=256 Identities=32% Similarity=0.493 Sum_probs=218.6
Q ss_pred ceeeEEEeEeccCceEEEEEEe-cCCcEEEEEEEecCCCC-hhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHHH
Q 003052 472 KLYQRLGKIGSGGSSEVHKVIS-SDCTIYALKKIKLKGRD-YATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLRE 549 (853)
Q Consensus 472 ~~Y~ilk~LG~G~FG~Vyka~~-~~g~~vAVKkik~~~~~-~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~~ 549 (853)
.+|.+.+.||+|+|++||+|+. .+++.||||++.++..- ......+.+|-.+|.+|.+||.|++|+--
T Consensus 73 ~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~T---------- 142 (604)
T KOG0592|consen 73 NDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFT---------- 142 (604)
T ss_pred hhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEE----------
Confidence 4588999999999999999998 56799999999765432 22334567899999999999999999853
Q ss_pred HhhCCCCCCCCccccCCeEEEEEecch-hhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCCC
Q 003052 550 VLNGSMNNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKP 628 (853)
Q Consensus 550 l~~~~iv~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLKP 628 (853)
|+|+..+|+|+||+. |+|.++|++. +.|+|.++|+|+.||+.||+|||++|||||||||
T Consensus 143 ------------FQD~~sLYFvLe~A~nGdll~~i~K~--------Gsfde~caR~YAAeIldAleylH~~GIIHRDlKP 202 (604)
T KOG0592|consen 143 ------------FQDEESLYFVLEYAPNGDLLDLIKKY--------GSFDETCARFYAAEILDALEYLHSNGIIHRDLKP 202 (604)
T ss_pred ------------eecccceEEEEEecCCCcHHHHHHHh--------CcchHHHHHHHHHHHHHHHHHHHhcCceeccCCh
Confidence 889999999999965 7999999876 7899999999999999999999999999999999
Q ss_pred ccEEe-ecCcEEEEecccchhcccCCcc-----------ccccccccCccccCchhhccCCCCCCCccccCCCccchhhh
Q 003052 629 ANFLL-VKGSLKLIDFGIAKAIMSDTTN-----------IQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSL 696 (853)
Q Consensus 629 eNILL-~~g~VKL~DFGlAk~~~~~~~~-----------~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSL 696 (853)
||||| .++++||+|||.|+.+...... ..+.+++||..|.+||+|.... .++.+|||+|
T Consensus 203 ENILLd~dmhikITDFGsAK~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~---------~~~~sDiWAl 273 (604)
T KOG0592|consen 203 ENILLDKDGHIKITDFGSAKILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSP---------AGPSSDLWAL 273 (604)
T ss_pred hheeEcCCCcEEEeeccccccCChhhccccCccCcccccCcccceeeeecccCHHHhcCCC---------CCcccchHHH
Confidence 99999 5789999999999987542211 1125699999999999997764 4679999999
Q ss_pred HHHHHHHHhCCCCCCcchhHHHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCCChhHHhcCCCCCC
Q 003052 697 GCILYQMVYGRTPFSEYKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQHPFLVP 769 (853)
Q Consensus 697 GVILyELLtG~~PF~~~~~~~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~HPwf~~ 769 (853)
|||||+|+.|.+||.+.++.....+++ .....+++..++.++|||+++|..||.+|+|+.||-+||||..
T Consensus 274 GCilyQmlaG~PPFra~NeyliFqkI~---~l~y~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~HpFF~~ 343 (604)
T KOG0592|consen 274 GCILYQMLAGQPPFRAANEYLIFQKIQ---ALDYEFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAHPFFEG 343 (604)
T ss_pred HHHHHHHhcCCCCCccccHHHHHHHHH---HhcccCCCCCCHHHHHHHHHHHccCccccccHHHHhhCccccc
Confidence 999999999999998877654444443 2556778888999999999999999999999999999999953
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-46 Score=393.11 Aligned_cols=250 Identities=27% Similarity=0.463 Sum_probs=214.0
Q ss_pred ceeeEEEeEeccCceEEEEEEec-CCcEEEEEEEecCCC-ChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHHH
Q 003052 472 KLYQRLGKIGSGGSSEVHKVISS-DCTIYALKKIKLKGR-DYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLRE 549 (853)
Q Consensus 472 ~~Y~ilk~LG~G~FG~Vyka~~~-~g~~vAVKkik~~~~-~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~~ 549 (853)
++|++++.||.|+||.|.+++.+ ++..||+|++++..- ...+.+...+|..+|+.+. ||.++++++
T Consensus 44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~-~PFlv~l~~----------- 111 (355)
T KOG0616|consen 44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVS-HPFLVKLYG----------- 111 (355)
T ss_pred hhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhcc-CceeEEEEE-----------
Confidence 56999999999999999999984 678999999976432 2344455677888888887 777777764
Q ss_pred HhhCCCCCCCCccccCCeEEEEEecc-hhhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCCC
Q 003052 550 VLNGSMNNKDGRVKDDGYIYMVLEYG-EIDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKP 628 (853)
Q Consensus 550 l~~~~iv~~~g~~~d~~~lyLVmEy~-~gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLKP 628 (853)
.|.+..++||||||. +|.|+.++++. ++|+|..+++|+.||+.||+|||+++|+||||||
T Consensus 112 -----------t~~d~~~lymvmeyv~GGElFS~Lrk~--------~rF~e~~arFYAAeivlAleylH~~~iiYRDLKP 172 (355)
T KOG0616|consen 112 -----------TFKDNSNLYMVMEYVPGGELFSYLRKS--------GRFSEPHARFYAAEIVLALEYLHSLDIIYRDLKP 172 (355)
T ss_pred -----------eeccCCeEEEEEeccCCccHHHHHHhc--------CCCCchhHHHHHHHHHHHHHHHHhcCeeeccCCh
Confidence 478899999999995 46888888765 6899999999999999999999999999999999
Q ss_pred ccEEe-ecCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHhCC
Q 003052 629 ANFLL-VKGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGR 707 (853)
Q Consensus 629 eNILL-~~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLtG~ 707 (853)
||||| .+|++||+|||+|+.+... ..+.||||.|+|||++...+ |++++|+|||||++|||+.|.
T Consensus 173 ENiLlD~~G~iKitDFGFAK~v~~r-----T~TlCGTPeYLAPEii~sk~---------ynkavDWWalGVLIYEMlaG~ 238 (355)
T KOG0616|consen 173 ENLLLDQNGHIKITDFGFAKRVSGR-----TWTLCGTPEYLAPEIIQSKG---------YNKAVDWWALGVLIYEMLAGY 238 (355)
T ss_pred HHeeeccCCcEEEEeccceEEecCc-----EEEecCCccccChHHhhcCC---------CCcchhHHHHHHHHHHHHcCC
Confidence 99999 5789999999999987543 23889999999999998774 568999999999999999999
Q ss_pred CCCCcchhHHHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCC-----ChhHHhcCCCCCC
Q 003052 708 TPFSEYKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERW-----RIPQLLQHPFLVP 769 (853)
Q Consensus 708 ~PF~~~~~~~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRp-----Ta~EIL~HPwf~~ 769 (853)
+||.+.+++....+++. ....++...++++++||+++|++|-.+|. ...+|..||||..
T Consensus 239 pPF~~~~~~~iY~KI~~---~~v~fP~~fs~~~kdLl~~LL~vD~t~R~gnlknG~~dIk~H~wF~~ 302 (355)
T KOG0616|consen 239 PPFYDDNPIQIYEKILE---GKVKFPSYFSSDAKDLLKKLLQVDLTKRFGNLKNGVEDIKNHPWFKG 302 (355)
T ss_pred CCCcCCChHHHHHHHHh---CcccCCcccCHHHHHHHHHHHhhhhHhhhcCcCCCccccccCccccc
Confidence 99998877655555543 45678888999999999999999999995 5789999999974
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-46 Score=423.64 Aligned_cols=254 Identities=29% Similarity=0.447 Sum_probs=220.6
Q ss_pred eeeEEEeEeccCceEEEEEEe-cCCcEEEEEEEecC-CCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHHHH
Q 003052 473 LYQRLGKIGSGGSSEVHKVIS-SDCTIYALKKIKLK-GRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLREV 550 (853)
Q Consensus 473 ~Y~ilk~LG~G~FG~Vyka~~-~~g~~vAVKkik~~-~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~~l 550 (853)
-|++.+.||.|+-|.|.+|++ .+|+..|||+|.+. .........+.+||-||+.|. ||||++|||+
T Consensus 13 pwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~-HpnVl~LydV----------- 80 (786)
T KOG0588|consen 13 PWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIE-HPNVLRLYDV----------- 80 (786)
T ss_pred ceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhc-CCCeeeeeee-----------
Confidence 389999999999999999998 68999999999876 344556677899999999998 8999999997
Q ss_pred hhCCCCCCCCccccCCeEEEEEecch-hhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCCCc
Q 003052 551 LNGSMNNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPA 629 (853)
Q Consensus 551 ~~~~iv~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLKPe 629 (853)
+++..++|+|+||.. |.|++++-.+ ++|+|..++.+++||+.|+.|||..+|+||||||+
T Consensus 81 -----------we~~~~lylvlEyv~gGELFdylv~k--------G~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpE 141 (786)
T KOG0588|consen 81 -----------WENKQHLYLVLEYVPGGELFDYLVRK--------GPLPEREAAHFFRQILDGVSYCHAFNICHRDLKPE 141 (786)
T ss_pred -----------eccCceEEEEEEecCCchhHHHHHhh--------CCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCch
Confidence 566778999999954 6999999876 88999999999999999999999999999999999
Q ss_pred cEEe-ecCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHhCCC
Q 003052 630 NFLL-VKGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGRT 708 (853)
Q Consensus 630 NILL-~~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLtG~~ 708 (853)
|+|| ..++|||+|||||..-..+ ....+.||+|.|.|||+++|..|+ |.++||||+|||||.||+|++
T Consensus 142 NlLLd~~~nIKIADFGMAsLe~~g---klLeTSCGSPHYA~PEIV~G~pYd--------G~~sDVWSCGVILfALLtG~L 210 (786)
T KOG0588|consen 142 NLLLDVKNNIKIADFGMASLEVPG---KLLETSCGSPHYAAPEIVSGRPYD--------GRPSDVWSCGVILFALLTGKL 210 (786)
T ss_pred hhhhhcccCEeeeccceeecccCC---ccccccCCCcccCCchhhcCCCCC--------CCccccchhHHHHHHHHhCCC
Confidence 9999 4568999999999865432 234588999999999999999876 689999999999999999999
Q ss_pred CCCcchhHHHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCCChhHHhcCCCCCCCC
Q 003052 709 PFSEYKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQHPFLVPPV 771 (853)
Q Consensus 709 PF~~~~~~~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~HPwf~~~~ 771 (853)
||++.+-.....++. ...+..+...++++++||.+||.+||.+|+|.+||++|||+....
T Consensus 211 PFdDdNir~LLlKV~---~G~f~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP~l~g~~ 270 (786)
T KOG0588|consen 211 PFDDDNIRVLLLKVQ---RGVFEMPSNISSEAQDLLRRMLDVDPSTRITTEEILKHPFLSGYT 270 (786)
T ss_pred CCCCccHHHHHHHHH---cCcccCCCcCCHHHHHHHHHHhccCccccccHHHHhhCchhhcCC
Confidence 998754443444443 345566788999999999999999999999999999999997643
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-46 Score=413.69 Aligned_cols=266 Identities=29% Similarity=0.456 Sum_probs=222.6
Q ss_pred eeEEcCceeeEEEeEeccCceEEEEEEe-cCCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHH
Q 003052 466 FFKVNGKLYQRLGKIGSGGSSEVHKVIS-SDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEK 544 (853)
Q Consensus 466 ~~~v~g~~Y~ilk~LG~G~FG~Vyka~~-~~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~ 544 (853)
+.....+.|+.+++||+|.||.||+|++ .+|++||+|++.....+........+||.||++|. ||||++|.+....
T Consensus 111 w~~r~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~-HpNIikL~eivt~-- 187 (560)
T KOG0600|consen 111 WGPRRADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLD-HPNIIKLEEIVTS-- 187 (560)
T ss_pred ccccchHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcC-CCcccceeeEEEe--
Confidence 4445556799999999999999999998 68899999999998877777777889999999998 9999999886322
Q ss_pred HHHHHHhhCCCCCCCCccccCCeEEEEEecchhhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeC
Q 003052 545 ALLREVLNGSMNNKDGRVKDDGYIYMVLEYGEIDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHS 624 (853)
Q Consensus 545 ~iL~~l~~~~iv~~~g~~~d~~~lyLVmEy~~gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHR 624 (853)
...+.+|||+||++.||..++.. ....|++.+++.||+||+.||+|||.+||+||
T Consensus 188 ------------------~~~~siYlVFeYMdhDL~GLl~~-------p~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHR 242 (560)
T KOG0600|consen 188 ------------------KLSGSIYLVFEYMDHDLSGLLSS-------PGVKFTEPQIKCYMKQLLEGLEYCHSRGVLHR 242 (560)
T ss_pred ------------------cCCceEEEEEecccchhhhhhcC-------CCcccChHHHHHHHHHHHHHHHHHhhcCeeec
Confidence 13568999999999999988754 35679999999999999999999999999999
Q ss_pred CCCCccEEe-ecCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHH
Q 003052 625 DLKPANFLL-VKGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQM 703 (853)
Q Consensus 625 DLKPeNILL-~~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyEL 703 (853)
|||..|||| ++|.+||+|||||+.+...... ..+..+-|.||+|||++.|.. .|+.++|+||+||||.||
T Consensus 243 DIK~SNiLidn~G~LKiaDFGLAr~y~~~~~~-~~T~rVvTLWYRpPELLLG~t--------~Yg~aVDlWS~GCIl~El 313 (560)
T KOG0600|consen 243 DIKGSNILIDNNGVLKIADFGLARFYTPSGSA-PYTSRVVTLWYRPPELLLGAT--------SYGTAVDLWSVGCILAEL 313 (560)
T ss_pred cccccceEEcCCCCEEeccccceeeccCCCCc-ccccceEEeeccChHHhcCCc--------ccccceeehhhhHHHHHH
Confidence 999999999 5789999999999987654432 356778999999999999864 589999999999999999
Q ss_pred HhCCCCCCcchhHHH---HHHhhcCCCCcc----cC-------------------CCCCChhHHHHHHHhcccCCCCCCC
Q 003052 704 VYGRTPFSEYKTFWA---KFKVITDPNHEI----TY-------------------EPVPNPWLLDLMKKCLAWDRNERWR 757 (853)
Q Consensus 704 LtG~~PF~~~~~~~~---~~kii~~~~~~~----~~-------------------~~~~s~~l~dLI~kcL~~DP~kRpT 757 (853)
++|++.|.+..+..+ +|+....+.... .+ -...+..+.+|+..||..||.+|.|
T Consensus 314 ~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~t 393 (560)
T KOG0600|consen 314 FLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSKLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGT 393 (560)
T ss_pred HcCCCCcCCccHHHHHHHHHHHhCCCChhccccccCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCcccccc
Confidence 999999987655544 444443332211 00 0233566889999999999999999
Q ss_pred hhHHhcCCCCC
Q 003052 758 IPQLLQHPFLV 768 (853)
Q Consensus 758 a~EIL~HPwf~ 768 (853)
|.++|+|+||.
T Consensus 394 A~~aL~seyF~ 404 (560)
T KOG0600|consen 394 ASSALQSEYFT 404 (560)
T ss_pred HHHHhcCcccc
Confidence 99999999994
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-46 Score=384.19 Aligned_cols=258 Identities=29% Similarity=0.452 Sum_probs=219.4
Q ss_pred ceeeEEEeEeccCceEEEEEEe-cCCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHHHH
Q 003052 472 KLYQRLGKIGSGGSSEVHKVIS-SDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLREV 550 (853)
Q Consensus 472 ~~Y~ilk~LG~G~FG~Vyka~~-~~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~~l 550 (853)
++|..+++||+|.||.||+|++ .+|+.||||+|+............++||++|+.++ |+||+.|+|.
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~-h~nIi~LiD~----------- 69 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELK-HPNIIELIDV----------- 69 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHcc-Ccchhhhhhh-----------
Confidence 4688899999999999999998 68899999999988666555667889999999998 9999999987
Q ss_pred hhCCCCCCCCccccCCeEEEEEecchhhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCCCcc
Q 003052 551 LNGSMNNKDGRVKDDGYIYMVLEYGEIDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPAN 630 (853)
Q Consensus 551 ~~~~iv~~~g~~~d~~~lyLVmEy~~gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLKPeN 630 (853)
|...+.+.||+||++.||...|+.+ ...|+...++.|+.++++||+|||.+.|+||||||+|
T Consensus 70 -----------F~~~~~l~lVfEfm~tdLe~vIkd~-------~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnN 131 (318)
T KOG0659|consen 70 -----------FPHKSNLSLVFEFMPTDLEVVIKDK-------NIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNN 131 (318)
T ss_pred -----------ccCCCceEEEEEeccccHHHHhccc-------ccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccc
Confidence 5566788999999999999998764 5789999999999999999999999999999999999
Q ss_pred EEe-ecCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHhCCCC
Q 003052 631 FLL-VKGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGRTP 709 (853)
Q Consensus 631 ILL-~~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLtG~~P 709 (853)
+|| .+|.+||+|||+|+.+....... ...+-|.||+|||++.|.. .|+..+||||.|||+.||+.|.+-
T Consensus 132 LLis~~g~lKiADFGLAr~f~~p~~~~--~~~V~TRWYRAPELLfGsr--------~Yg~~VDmWavGCI~AELllr~P~ 201 (318)
T KOG0659|consen 132 LLISSDGQLKIADFGLARFFGSPNRIQ--THQVVTRWYRAPELLFGSR--------QYGTGVDMWAVGCIFAELLLRVPF 201 (318)
T ss_pred eEEcCCCcEEeecccchhccCCCCccc--ccceeeeeccChHHhccch--------hcCCcchhhhHHHHHHHHHccCCC
Confidence 999 68899999999999987655433 2348999999999998764 588999999999999999999999
Q ss_pred CCcchhHHH---HHHhhcCCCCccc----------------------CCCCCChhHHHHHHHhcccCCCCCCChhHHhcC
Q 003052 710 FSEYKTFWA---KFKVITDPNHEIT----------------------YEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQH 764 (853)
Q Consensus 710 F~~~~~~~~---~~kii~~~~~~~~----------------------~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~H 764 (853)
|.+..++.+ ++..+..+..... +-+..+.++.|||.+||.+||.+|+++.|+|+|
T Consensus 202 fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~ 281 (318)
T KOG0659|consen 202 FPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKH 281 (318)
T ss_pred CCCCchHHHHHHHHHHcCCCCcccCccccccccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence 977655443 4444444332210 112345668999999999999999999999999
Q ss_pred CCCCC
Q 003052 765 PFLVP 769 (853)
Q Consensus 765 Pwf~~ 769 (853)
+||+.
T Consensus 282 ~yf~~ 286 (318)
T KOG0659|consen 282 PYFKS 286 (318)
T ss_pred hhhhc
Confidence 99985
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-45 Score=410.30 Aligned_cols=258 Identities=29% Similarity=0.490 Sum_probs=208.3
Q ss_pred cCceeeEEEeEeccCceEEEEEEe-cCCcEEEEEEEecCCC-ChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHH
Q 003052 470 NGKLYQRLGKIGSGGSSEVHKVIS-SDCTIYALKKIKLKGR-DYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALL 547 (853)
Q Consensus 470 ~g~~Y~ilk~LG~G~FG~Vyka~~-~~g~~vAVKkik~~~~-~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL 547 (853)
.-++|++++.||+|+||.||+|+. .+|.+||+|++++... .......++.|-.+|.... .+.||+|+-
T Consensus 139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~d-s~~vVKLyY--------- 208 (550)
T KOG0605|consen 139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVD-SPWVVKLYY--------- 208 (550)
T ss_pred CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcC-CCcEEEEEE---------
Confidence 446799999999999999999987 4779999999987543 2344556777888888744 778888864
Q ss_pred HHHhhCCCCCCCCccccCCeEEEEEecc-hhhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCC
Q 003052 548 REVLNGSMNNKDGRVKDDGYIYMVLEYG-EIDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDL 626 (853)
Q Consensus 548 ~~l~~~~iv~~~g~~~d~~~lyLVmEy~-~gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDL 626 (853)
.|++..++||||||. |||+..+|... +.|+|.++++|+.+++.||+.||++|||||||
T Consensus 209 -------------sFQD~~~LYLiMEylPGGD~mTLL~~~--------~~L~e~~arfYiaE~vlAI~~iH~~gyIHRDI 267 (550)
T KOG0605|consen 209 -------------SFQDKEYLYLIMEYLPGGDMMTLLMRK--------DTLTEDWARFYIAETVLAIESIHQLGYIHRDI 267 (550)
T ss_pred -------------EecCCCeeEEEEEecCCccHHHHHHhc--------CcCchHHHHHHHHHHHHHHHHHHHcCcccccC
Confidence 489999999999995 56999888765 78999999999999999999999999999999
Q ss_pred CCccEEe-ecCcEEEEecccchhcccC----------------------Ccc-----c------------------cccc
Q 003052 627 KPANFLL-VKGSLKLIDFGIAKAIMSD----------------------TTN-----I------------------QRDS 660 (853)
Q Consensus 627 KPeNILL-~~g~VKL~DFGlAk~~~~~----------------------~~~-----~------------------~~~t 660 (853)
||+|+|| ..|++||+|||||+.+... ... . ....
T Consensus 268 KPdNlLiD~~GHiKLSDFGLs~gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~S 347 (550)
T KOG0605|consen 268 KPDNLLIDAKGHIKLSDFGLSTGLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYS 347 (550)
T ss_pred ChhheeecCCCCEeeccccccchhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhc
Confidence 9999999 5799999999999643210 000 0 0024
Q ss_pred cccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHhCCCCCCcchhHHHHHHhhcCCC--CcccCCCCCCh
Q 003052 661 QVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGRTPFSEYKTFWAKFKVITDPN--HEITYEPVPNP 738 (853)
Q Consensus 661 ~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLtG~~PF~~~~~~~~~~kii~~~~--~~~~~~~~~s~ 738 (853)
.+|||.|||||++.+.. |+..+||||||||+||||.|.+||....+.....+++ .-. ..+......++
T Consensus 348 tVGTPDYiAPEVll~kg---------Y~~~cDwWSLG~ImyEmLvGyPPF~s~tp~~T~rkI~-nwr~~l~fP~~~~~s~ 417 (550)
T KOG0605|consen 348 TVGTPDYIAPEVLLGKG---------YGKECDWWSLGCIMYEMLVGYPPFCSETPQETYRKIV-NWRETLKFPEEVDLSD 417 (550)
T ss_pred ccCCccccchHHHhcCC---------CCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH-HHhhhccCCCcCcccH
Confidence 68999999999999874 6789999999999999999999998765544333332 222 22333345678
Q ss_pred hHHHHHHHhcccCCCCCCC---hhHHhcCCCCCC
Q 003052 739 WLLDLMKKCLAWDRNERWR---IPQLLQHPFLVP 769 (853)
Q Consensus 739 ~l~dLI~kcL~~DP~kRpT---a~EIL~HPwf~~ 769 (853)
+++|||.+||. ||++|.. ++||-+||||+.
T Consensus 418 eA~DLI~rll~-d~~~RLG~~G~~EIK~HPfF~~ 450 (550)
T KOG0605|consen 418 EAKDLITRLLC-DPENRLGSKGAEEIKKHPFFKG 450 (550)
T ss_pred HHHHHHHHHhc-CHHHhcCcccHHHHhcCCcccc
Confidence 99999999999 9999995 999999999974
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-46 Score=413.50 Aligned_cols=253 Identities=31% Similarity=0.480 Sum_probs=221.3
Q ss_pred eeeEEEeEeccCceEEEEEEec-CCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHHHHh
Q 003052 473 LYQRLGKIGSGGSSEVHKVISS-DCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLREVL 551 (853)
Q Consensus 473 ~Y~ilk~LG~G~FG~Vyka~~~-~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~~l~ 551 (853)
+|.+.+.||+|+||.||||+.+ +.+.||+|.+.+.++.....+.+.+|++|+++|+ |||||.++++
T Consensus 3 ~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lk-Hpniv~m~es------------ 69 (808)
T KOG0597|consen 3 QYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLK-HPNIVEMLES------------ 69 (808)
T ss_pred chhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcC-CcchhhHHHh------------
Confidence 5888899999999999999985 5689999999999998888999999999999999 9999999988
Q ss_pred hCCCCCCCCccccCCeEEEEEecchhhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCCCccE
Q 003052 552 NGSMNNKDGRVKDDGYIYMVLEYGEIDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANF 631 (853)
Q Consensus 552 ~~~iv~~~g~~~d~~~lyLVmEy~~gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLKPeNI 631 (853)
|+...++|+|.||+.|+|..++.+. +.++|+.++.|+.+++.||.|||+++|+|||+||.||
T Consensus 70 ----------fEt~~~~~vVte~a~g~L~~il~~d--------~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqni 131 (808)
T KOG0597|consen 70 ----------FETSAHLWVVTEYAVGDLFTILEQD--------GKLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNI 131 (808)
T ss_pred ----------hcccceEEEEehhhhhhHHHHHHhc--------cCCCHHHHHHHHHHHHHHHHHHHhcCcccccCCccee
Confidence 4567789999999999999999875 7899999999999999999999999999999999999
Q ss_pred Eee-cCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHhCCCCC
Q 003052 632 LLV-KGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGRTPF 710 (853)
Q Consensus 632 LL~-~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLtG~~PF 710 (853)
||. .|.+|+||||+|+...... ...+...|||.|||||++.+.. |+..+|+||||||+|||+.|++||
T Consensus 132 Ll~~~~~~KlcdFg~Ar~m~~~t--~vltsikGtPlYmAPElv~e~p---------yd~~sDlWslGcilYE~~~G~PPF 200 (808)
T KOG0597|consen 132 LLEKGGTLKLCDFGLARAMSTNT--SVLTSIKGTPLYMAPELVEEQP---------YDHTSDLWSLGCILYELYVGQPPF 200 (808)
T ss_pred eecCCCceeechhhhhhhcccCc--eeeeeccCcccccCHHHHcCCC---------ccchhhHHHHHHHHHHHhcCCCCc
Confidence 994 6699999999999875432 2345778999999999998764 568999999999999999999999
Q ss_pred CcchhHHHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCCChhHHhcCCCCCCC
Q 003052 711 SEYKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQHPFLVPP 770 (853)
Q Consensus 711 ~~~~~~~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~HPwf~~~ 770 (853)
....-. +..+.|.. .+..++...+..+.+||..+|.+||.+|+++.+++.|||.+..
T Consensus 201 ~a~si~-~Lv~~I~~--d~v~~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~HpF~k~~ 257 (808)
T KOG0597|consen 201 YARSIT-QLVKSILK--DPVKPPSTASSSFVNFLQGLLIKDPAQRLTWTDLLGHPFWKGK 257 (808)
T ss_pred hHHHHH-HHHHHHhc--CCCCCcccccHHHHHHHHHHhhcChhhcccHHHHhcChHHhhh
Confidence 774444 34444432 3345666889999999999999999999999999999998753
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-45 Score=418.98 Aligned_cols=256 Identities=24% Similarity=0.417 Sum_probs=213.3
Q ss_pred EcCceeeEEEeEeccCceEEEEEEec-CCcEEEEEEEecCCC-ChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHH
Q 003052 469 VNGKLYQRLGKIGSGGSSEVHKVISS-DCTIYALKKIKLKGR-DYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKAL 546 (853)
Q Consensus 469 v~g~~Y~ilk~LG~G~FG~Vyka~~~-~g~~vAVKkik~~~~-~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~i 546 (853)
++-+.|.+++.||+|+||+|+++..+ +++.||||++++... ..........|.+|+.....||.++.|+
T Consensus 365 ~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~--------- 435 (694)
T KOG0694|consen 365 LTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLF--------- 435 (694)
T ss_pred ccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecc---------
Confidence 34467999999999999999999984 668999999987642 2233445667888887777777776665
Q ss_pred HHHHhhCCCCCCCCccccCCeEEEEEecch-hhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCC
Q 003052 547 LREVLNGSMNNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSD 625 (853)
Q Consensus 547 L~~l~~~~iv~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRD 625 (853)
.+|+...++|+||||.. ||+..++ ..+.|+|..+++|+..|+.||+|||++||||||
T Consensus 436 -------------~~fQT~~~l~fvmey~~Ggdm~~~~---------~~~~F~e~rarfyaAev~l~L~fLH~~~IIYRD 493 (694)
T KOG0694|consen 436 -------------SCFQTKEHLFFVMEYVAGGDLMHHI---------HTDVFSEPRARFYAAEVVLGLQFLHENGIIYRD 493 (694)
T ss_pred -------------cccccCCeEEEEEEecCCCcEEEEE---------ecccccHHHHHHHHHHHHHHHHHHHhcCceeee
Confidence 45888999999999955 4643332 236899999999999999999999999999999
Q ss_pred CCCccEEe-ecCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHH
Q 003052 626 LKPANFLL-VKGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMV 704 (853)
Q Consensus 626 LKPeNILL-~~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELL 704 (853)
||.+|||| .+|++||+|||||+..+.... ...++||||.|||||++.+.. |+..+|||||||+|||||
T Consensus 494 lKLdNiLLD~eGh~kiADFGlcKe~m~~g~--~TsTfCGTpey~aPEil~e~~---------Yt~aVDWW~lGVLlyeML 562 (694)
T KOG0694|consen 494 LKLDNLLLDTEGHVKIADFGLCKEGMGQGD--RTSTFCGTPEFLAPEVLTEQS---------YTRAVDWWGLGVLLYEML 562 (694)
T ss_pred cchhheEEcccCcEEecccccccccCCCCC--ccccccCChhhcChhhhccCc---------ccchhhHHHHHHHHHHHH
Confidence 99999999 589999999999998764332 446999999999999998764 678999999999999999
Q ss_pred hCCCCCCcchhHHHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCCC-----hhHHhcCCCCCC
Q 003052 705 YGRTPFSEYKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWR-----IPQLLQHPFLVP 769 (853)
Q Consensus 705 tG~~PF~~~~~~~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpT-----a~EIL~HPwf~~ 769 (853)
.|.+||.+.++ .+.+..|. +.+..|+..++.++.++|+++|.+||++|.. +.+|.+||||..
T Consensus 563 ~Gq~PF~gddE-ee~FdsI~--~d~~~yP~~ls~ea~~il~~ll~k~p~kRLG~~e~d~~~i~~hpFFr~ 629 (694)
T KOG0694|consen 563 VGESPFPGDDE-EEVFDSIV--NDEVRYPRFLSKEAIAIMRRLLRKNPEKRLGSGERDAEDIKKHPFFRS 629 (694)
T ss_pred cCCCCCCCCCH-HHHHHHHh--cCCCCCCCcccHHHHHHHHHHhccCcccccCCCCCCchhhhhCCcccc
Confidence 99999987554 45566555 4566788999999999999999999999996 589999999964
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-45 Score=413.59 Aligned_cols=252 Identities=29% Similarity=0.492 Sum_probs=224.3
Q ss_pred ceeeEEEeEeccCceEEEEEEe-cCCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHHHH
Q 003052 472 KLYQRLGKIGSGGSSEVHKVIS-SDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLREV 550 (853)
Q Consensus 472 ~~Y~ilk~LG~G~FG~Vyka~~-~~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~~l 550 (853)
..|....+||+|+.|.||.+.. .+++.||||++.+..... ..-+++|+.+|+.++ |+|||.+++-|.
T Consensus 273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~--keLilnEi~Vm~~~~-H~NiVnfl~Syl--------- 340 (550)
T KOG0578|consen 273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPK--KELLLNEILVMRDLH-HPNIVNFLDSYL--------- 340 (550)
T ss_pred hhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCc--hhhhHHHHHHHHhcc-chHHHHHHHHhc---------
Confidence 3488888999999999999987 577899999998765432 335789999999998 899999987532
Q ss_pred hhCCCCCCCCccccCCeEEEEEecch-hhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCCCc
Q 003052 551 LNGSMNNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPA 629 (853)
Q Consensus 551 ~~~~iv~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLKPe 629 (853)
..+.+|+||||++ |+|.+.+... .++|.+++.|.++++.||+|||.+||||||||.+
T Consensus 341 -------------v~deLWVVMEym~ggsLTDvVt~~---------~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSD 398 (550)
T KOG0578|consen 341 -------------VGDELWVVMEYMEGGSLTDVVTKT---------RMTEGQIAAICREILQGLKFLHARGIIHRDIKSD 398 (550)
T ss_pred -------------ccceeEEEEeecCCCchhhhhhcc---------cccHHHHHHHHHHHHHHHHHHHhcceeeeccccc
Confidence 2367999999976 4888888653 5999999999999999999999999999999999
Q ss_pred cEEe-ecCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHhCCC
Q 003052 630 NFLL-VKGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGRT 708 (853)
Q Consensus 630 NILL-~~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLtG~~ 708 (853)
|||+ .+|.+||+|||+|..+..... .+.+.+|||+|||||++..+. |++++||||||+|++||+-|++
T Consensus 399 nILL~~~g~vKltDFGFcaqi~~~~~--KR~TmVGTPYWMAPEVvtrk~---------YG~KVDIWSLGIMaIEMveGEP 467 (550)
T KOG0578|consen 399 NILLTMDGSVKLTDFGFCAQISEEQS--KRSTMVGTPYWMAPEVVTRKP---------YGPKVDIWSLGIMAIEMVEGEP 467 (550)
T ss_pred eeEeccCCcEEEeeeeeeeccccccC--ccccccCCCCccchhhhhhcc---------cCccccchhhhhHHHHHhcCCC
Confidence 9999 578999999999998865443 567999999999999998764 6789999999999999999999
Q ss_pred CCCcchhHHHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCCChhHHhcCCCCC
Q 003052 709 PFSEYKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQHPFLV 768 (853)
Q Consensus 709 PF~~~~~~~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~HPwf~ 768 (853)
||-..+++.+++.+...+...+..+..+++.+++||.+||+.|+.+|+++.|||+||||+
T Consensus 468 PYlnE~PlrAlyLIa~ng~P~lk~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~HpFl~ 527 (550)
T KOG0578|consen 468 PYLNENPLRALYLIATNGTPKLKNPEKLSPELKDFLDRCLVVDVEQRASAKELLEHPFLK 527 (550)
T ss_pred CccCCChHHHHHHHhhcCCCCcCCccccCHHHHHHHHHHhhcchhcCCCHHHHhcChhhh
Confidence 999889999999999999999999999999999999999999999999999999999994
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-45 Score=388.91 Aligned_cols=261 Identities=27% Similarity=0.431 Sum_probs=218.2
Q ss_pred ceeeEEEeEeccCceEEEEEEe-cCCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHHHH
Q 003052 472 KLYQRLGKIGSGGSSEVHKVIS-SDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLREV 550 (853)
Q Consensus 472 ~~Y~ilk~LG~G~FG~Vyka~~-~~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~~l 550 (853)
+.|+.+.+|++|+||.||+|++ +++.+||+|+++.........-..++||.+|.+++ |||||.+-++.+.
T Consensus 76 ~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~-H~NIV~vkEVVvG-------- 146 (419)
T KOG0663|consen 76 EEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKAR-HPNIVEVKEVVVG-------- 146 (419)
T ss_pred HHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcC-CCCeeeeEEEEec--------
Confidence 5699999999999999999998 57799999999987766666666789999999998 9999999887432
Q ss_pred hhCCCCCCCCccccCCeEEEEEecchhhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCCCcc
Q 003052 551 LNGSMNNKDGRVKDDGYIYMVLEYGEIDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPAN 630 (853)
Q Consensus 551 ~~~~iv~~~g~~~d~~~lyLVmEy~~gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLKPeN 630 (853)
.+-+.+|||||||+.||..++... ..+|...+++.++.|++.||+|||.+.|+|||||+.|
T Consensus 147 ------------~~~d~iy~VMe~~EhDLksl~d~m-------~q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SN 207 (419)
T KOG0663|consen 147 ------------SNMDKIYIVMEYVEHDLKSLMETM-------KQPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSN 207 (419)
T ss_pred ------------cccceeeeeHHHHHhhHHHHHHhc-------cCCCchHHHHHHHHHHHHHHHHHhhceeEecccchhh
Confidence 223459999999999999888764 3689999999999999999999999999999999999
Q ss_pred EEe-ecCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHhCCCC
Q 003052 631 FLL-VKGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGRTP 709 (853)
Q Consensus 631 ILL-~~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLtG~~P 709 (853)
+|+ ..|.+||+|||+|+.+..+.. ..+..+-|.||+|||++.+.. .|+.++|+||+|||+.||+++++.
T Consensus 208 LLm~~~G~lKiaDFGLAR~ygsp~k--~~T~lVVTLWYRaPELLLG~~--------tyst~iDMWSvGCI~aE~l~~kPl 277 (419)
T KOG0663|consen 208 LLLSHKGILKIADFGLAREYGSPLK--PYTPLVVTLWYRAPELLLGAK--------TYSTAVDMWSVGCIFAELLTQKPL 277 (419)
T ss_pred eeeccCCcEEecccchhhhhcCCcc--cCcceEEEeeecCHHHhcCCc--------ccCcchhhhhHHHHHHHHHhcCCC
Confidence 999 678999999999999876533 345778999999999998864 488999999999999999999999
Q ss_pred CCcchhHHH---HHHhhcCCCCcc-------------------------cCCCC-CChhHHHHHHHhcccCCCCCCChhH
Q 003052 710 FSEYKTFWA---KFKVITDPNHEI-------------------------TYEPV-PNPWLLDLMKKCLAWDRNERWRIPQ 760 (853)
Q Consensus 710 F~~~~~~~~---~~kii~~~~~~~-------------------------~~~~~-~s~~l~dLI~kcL~~DP~kRpTa~E 760 (853)
|.+...+.+ +++.+..+...+ .+... .+....+|+..+|.+||.+|.||.|
T Consensus 278 f~G~sE~dQl~~If~llGtPte~iwpg~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~ 357 (419)
T KOG0663|consen 278 FPGKSEIDQLDKIFKLLGTPSEAIWPGYSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAED 357 (419)
T ss_pred CCCCchHHHHHHHHHHhCCCccccCCCccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHH
Confidence 987655444 444444332211 01111 4567899999999999999999999
Q ss_pred HhcCCCCCCC
Q 003052 761 LLQHPFLVPP 770 (853)
Q Consensus 761 IL~HPwf~~~ 770 (853)
.|+|.||...
T Consensus 358 ~L~h~~F~e~ 367 (419)
T KOG0663|consen 358 GLKHEYFRET 367 (419)
T ss_pred hhcccccccC
Confidence 9999999863
|
|
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-45 Score=391.83 Aligned_cols=267 Identities=28% Similarity=0.454 Sum_probs=219.2
Q ss_pred ceeeEEEeEeccCceEEEEEEe-cCCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHHHH
Q 003052 472 KLYQRLGKIGSGGSSEVHKVIS-SDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLREV 550 (853)
Q Consensus 472 ~~Y~ilk~LG~G~FG~Vyka~~-~~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~~l 550 (853)
..|..++.||+|+||.|..+.+ .++..||||++.......-.+++.++|+++|++++ |+||+.+++.+..
T Consensus 22 ~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~-HeNIi~l~di~~p-------- 92 (359)
T KOG0660|consen 22 RYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLR-HENIIGLLDIFRP-------- 92 (359)
T ss_pred ceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhc-CCCcceEEeeccc--------
Confidence 4566789999999999999998 57799999999877777777888999999999999 9999999998543
Q ss_pred hhCCCCCCCCccccCCeEEEEEecchhhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCCCcc
Q 003052 551 LNGSMNNKDGRVKDDGYIYMVLEYGEIDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPAN 630 (853)
Q Consensus 551 ~~~~iv~~~g~~~d~~~lyLVmEy~~gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLKPeN 630 (853)
.....-+.+|+|+|+++.||...|+.. ..|++.+++++++||+.||+|+|+.||+||||||.|
T Consensus 93 ---------~~~~~f~DvYiV~elMetDL~~iik~~--------~~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsN 155 (359)
T KOG0660|consen 93 ---------PSRDKFNDVYLVFELMETDLHQIIKSQ--------QDLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSN 155 (359)
T ss_pred ---------ccccccceeEEehhHHhhHHHHHHHcC--------ccccHHHHHHHHHHHHHhcchhhcccccccccchhh
Confidence 123445579999999999999999753 569999999999999999999999999999999999
Q ss_pred EEe-ecCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHhCCCC
Q 003052 631 FLL-VKGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGRTP 709 (853)
Q Consensus 631 ILL-~~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLtG~~P 709 (853)
+|+ .++.+||||||+|+...........+.++.|.||+|||++... ..|+..+||||+||||.|||+|++.
T Consensus 156 ll~n~~c~lKI~DFGLAR~~~~~~~~~~mTeYVaTRWYRAPElll~~--------~~Yt~aiDiWSvGCI~AEmL~gkpl 227 (359)
T KOG0660|consen 156 LLLNADCDLKICDFGLARYLDKFFEDGFMTEYVATRWYRAPELLLNS--------SEYTKAIDIWSVGCILAEMLTGKPL 227 (359)
T ss_pred eeeccCCCEEeccccceeeccccCcccchhcceeeeeecCHHHHhcc--------ccccchhhhhhhhHHHHHHHcCCCC
Confidence 999 5679999999999987543223344678999999999999643 2689999999999999999999999
Q ss_pred CCcchhHHHH---HHhhcCCCC----------------------ccc---CCCCCChhHHHHHHHhcccCCCCCCChhHH
Q 003052 710 FSEYKTFWAK---FKVITDPNH----------------------EIT---YEPVPNPWLLDLMKKCLAWDRNERWRIPQL 761 (853)
Q Consensus 710 F~~~~~~~~~---~kii~~~~~----------------------~~~---~~~~~s~~l~dLI~kcL~~DP~kRpTa~EI 761 (853)
|.+.+...++ ...+..+.. ... .-+..++.+.+||.+||..||.+|+|++|+
T Consensus 228 FpG~d~v~Ql~lI~~~lGtP~~e~l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eA 307 (359)
T KOG0660|consen 228 FPGKDYVHQLQLILELLGTPSEEDLQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEA 307 (359)
T ss_pred CCCCchHHHHHHHHHhcCCCCHHHHHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHH
Confidence 9775443222 222111110 000 124678889999999999999999999999
Q ss_pred hcCCCCCCCCC
Q 003052 762 LQHPFLVPPVS 772 (853)
Q Consensus 762 L~HPwf~~~~~ 772 (853)
|.||||.....
T Consensus 308 L~hPYl~~~hd 318 (359)
T KOG0660|consen 308 LAHPYLAPYHD 318 (359)
T ss_pred hcChhhhhhcC
Confidence 99999986543
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-46 Score=387.54 Aligned_cols=250 Identities=34% Similarity=0.458 Sum_probs=212.2
Q ss_pred ceeeEEEeEeccCceEEEEEEe-cCCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHHHH
Q 003052 472 KLYQRLGKIGSGGSSEVHKVIS-SDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLREV 550 (853)
Q Consensus 472 ~~Y~ilk~LG~G~FG~Vyka~~-~~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~~l 550 (853)
..|+++++||+|+||.||++.. .++..+|.|.|.....+....+....||.+|++|+ |||||+++++...
T Consensus 19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~-HpNIVqYy~~~f~-------- 89 (375)
T KOG0591|consen 19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLN-HPNIVQYYAHSFI-------- 89 (375)
T ss_pred HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcC-CchHHHHHHHhhh--------
Confidence 4599999999999999999988 68999999999987778888888999999999999 9999999886432
Q ss_pred hhCCCCCCCCccccCCeEEEEEecch-hhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhccc--Cc--eeeCC
Q 003052 551 LNGSMNNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHE--ER--IVHSD 625 (853)
Q Consensus 551 ~~~~iv~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs--~g--IIHRD 625 (853)
++..-++||||||+ |||..+|+...+ ..+.++|..+|.|+.|++.||.+||+ .. |+|||
T Consensus 90 ------------~~~evlnivmE~c~~GDLsqmIk~~K~----qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRD 153 (375)
T KOG0591|consen 90 ------------EDNEVLNIVMELCDAGDLSQMIKHFKK----QKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRD 153 (375)
T ss_pred ------------ccchhhHHHHHhhcccCHHHHHHHHHh----ccccCchHHHHHHHHHHHHHHHHHhccccccceeecc
Confidence 23334899999987 699998876533 45689999999999999999999999 45 99999
Q ss_pred CCCccEEe-ecCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHH
Q 003052 626 LKPANFLL-VKGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMV 704 (853)
Q Consensus 626 LKPeNILL-~~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELL 704 (853)
|||.||+| ..|.+||+|||+++.+....+ ...+++|||+||+||.+.+.. |++++||||+||++|||+
T Consensus 154 IKPaNIFl~~~gvvKLGDfGL~r~l~s~~t--fA~S~VGTPyYMSPE~i~~~~---------Y~~kSDiWslGCllyEMc 222 (375)
T KOG0591|consen 154 IKPANIFLTANGVVKLGDFGLGRFLSSKTT--FAHSLVGTPYYMSPERIHESG---------YNFKSDIWSLGCLLYEMC 222 (375)
T ss_pred CcchheEEcCCCceeeccchhHhHhcchhH--HHHhhcCCCcccCHHHHhcCC---------CCcchhHHHHHHHHHHHH
Confidence 99999999 578999999999998865443 345889999999999998774 678999999999999999
Q ss_pred hCCCCCCcchhHHHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCh
Q 003052 705 YGRTPFSEYKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRI 758 (853)
Q Consensus 705 tG~~PF~~~~~~~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa 758 (853)
.-++||.+. ++....+.|.............+.++..||..|+.+||+.||+.
T Consensus 223 aL~~PF~g~-n~~~L~~KI~qgd~~~~p~~~YS~~l~~li~~ci~vd~~~RP~t 275 (375)
T KOG0591|consen 223 ALQSPFYGD-NLLSLCKKIEQGDYPPLPDEHYSTDLRELINMCIAVDPEQRPDT 275 (375)
T ss_pred hcCCCcccc-cHHHHHHHHHcCCCCCCcHHHhhhHHHHHHHHHccCCcccCCCc
Confidence 999999986 55555555555443333335668889999999999999999986
|
|
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-45 Score=378.20 Aligned_cols=255 Identities=27% Similarity=0.422 Sum_probs=213.7
Q ss_pred ceeeEEEeEeccCceEEEEEEe-cCCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHHHH
Q 003052 472 KLYQRLGKIGSGGSSEVHKVIS-SDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLREV 550 (853)
Q Consensus 472 ~~Y~ilk~LG~G~FG~Vyka~~-~~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~~l 550 (853)
+.|.+.+.||+|.|+.||++.+ .+|+.||+|+|..+.......+.+.+|+.|.+.|+ ||||++|.+-
T Consensus 11 d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~Lq-HP~IvrL~~t----------- 78 (355)
T KOG0033|consen 11 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQ-HPNIVRLHDS----------- 78 (355)
T ss_pred hhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcC-CCcEeehhhh-----------
Confidence 5688999999999999999987 57889999999776555556667889999999998 9999999764
Q ss_pred hhCCCCCCCCccccCCeEEEEEecchh-hHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCCCc
Q 003052 551 LNGSMNNKDGRVKDDGYIYMVLEYGEI-DLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPA 629 (853)
Q Consensus 551 ~~~~iv~~~g~~~d~~~lyLVmEy~~g-dL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLKPe 629 (853)
+...++.|||+|++.| +|..-|-++ ..++|..+-.+++||+.||.|+|.+||||||+||+
T Consensus 79 -----------i~~~~~~ylvFe~m~G~dl~~eIV~R--------~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~ 139 (355)
T KOG0033|consen 79 -----------IQEESFHYLVFDLVTGGELFEDIVAR--------EFYSEADASHCIQQILEALAYCHSNGIVHRDLKPE 139 (355)
T ss_pred -----------hcccceeEEEEecccchHHHHHHHHH--------HHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChh
Confidence 4567789999999765 888777665 36899999999999999999999999999999999
Q ss_pred cEEeec---C-cEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHh
Q 003052 630 NFLLVK---G-SLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVY 705 (853)
Q Consensus 630 NILL~~---g-~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLt 705 (853)
|+||.. + -+||+|||+|..+.... ....++|||.|||||+++.. .|+..+|||+.|||||.||.
T Consensus 140 nllLASK~~~A~vKL~~FGvAi~l~~g~---~~~G~~GtP~fmaPEvvrkd---------py~kpvDiW~cGViLfiLL~ 207 (355)
T KOG0033|consen 140 NLLLASKAKGAAVKLADFGLAIEVNDGE---AWHGFAGTPGYLSPEVLKKD---------PYSKPVDIWACGVILYILLV 207 (355)
T ss_pred heeeeeccCCCceeecccceEEEeCCcc---ccccccCCCcccCHHHhhcC---------CCCCcchhhhhhHHHHHHHh
Confidence 999932 2 79999999999886322 23478999999999999876 47789999999999999999
Q ss_pred CCCCCCcchhHHHHHHhhcCCCCc--ccCCCCCChhHHHHHHHhcccCCCCCCChhHHhcCCCCCCC
Q 003052 706 GRTPFSEYKTFWAKFKVITDPNHE--ITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQHPFLVPP 770 (853)
Q Consensus 706 G~~PF~~~~~~~~~~kii~~~~~~--~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~HPwf~~~ 770 (853)
|++||.+.... .++..+...... ..+.+..++++++||++||..||.+|+|+.|.|+|||++..
T Consensus 208 G~~PF~~~~~~-rlye~I~~g~yd~~~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~HpWi~~r 273 (355)
T KOG0033|consen 208 GYPPFWDEDQH-RLYEQIKAGAYDYPSPEWDTVTPEAKSLIRRMLTVNPKKRITADEALKHPWICNR 273 (355)
T ss_pred CCCCCCCccHH-HHHHHHhccccCCCCcccCcCCHHHHHHHHHHhccChhhhccHHHHhCCchhcch
Confidence 99999885443 334444333332 33556789999999999999999999999999999999753
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-44 Score=387.11 Aligned_cols=262 Identities=31% Similarity=0.470 Sum_probs=213.2
Q ss_pred ceeeEEEeEeccCceEEEEEEec-CCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHHHH
Q 003052 472 KLYQRLGKIGSGGSSEVHKVISS-DCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLREV 550 (853)
Q Consensus 472 ~~Y~ilk~LG~G~FG~Vyka~~~-~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~~l 550 (853)
..|...+.||+|+||.||++.+. +|..+|||.+...... ....+.+|+.+|.+|+ |||||++++....
T Consensus 17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~--~~~~l~~Ei~iL~~l~-~p~IV~~~G~~~~-------- 85 (313)
T KOG0198|consen 17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSP--TSESLEREIRILSRLN-HPNIVQYYGSSSS-------- 85 (313)
T ss_pred chhhhhccccCccceEEEEEEecCCCcceeeeeeecccch--hHHHHHHHHHHHHhCC-CCCEEeeCCcccc--------
Confidence 34788889999999999999985 5889999999876322 2566889999999999 9999999985321
Q ss_pred hhCCCCCCCCccccCCeEEEEEecch-hhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCCCc
Q 003052 551 LNGSMNNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPA 629 (853)
Q Consensus 551 ~~~~iv~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLKPe 629 (853)
.....++|+|||+. |+|.+++... ++.|+|..++.|.+||++||.|||++|||||||||+
T Consensus 86 ------------~~~~~~~i~mEy~~~GsL~~~~~~~-------g~~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~ 146 (313)
T KOG0198|consen 86 ------------RENDEYNIFMEYAPGGSLSDLIKRY-------GGKLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPA 146 (313)
T ss_pred ------------ccCeeeEeeeeccCCCcHHHHHHHc-------CCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccc
Confidence 11147899999965 6999988764 227999999999999999999999999999999999
Q ss_pred cEEeec--CcEEEEecccchhccc-CCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHhC
Q 003052 630 NFLLVK--GSLKLIDFGIAKAIMS-DTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYG 706 (853)
Q Consensus 630 NILL~~--g~VKL~DFGlAk~~~~-~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLtG 706 (853)
|||+.. +.+||+|||+++.... .........+.||+.|||||++..... -++++|||||||++.||+||
T Consensus 147 NiLl~~~~~~~KlaDFG~a~~~~~~~~~~~~~~~~~Gtp~~maPEvi~~g~~--------~~~~sDiWSlGCtVvEM~Tg 218 (313)
T KOG0198|consen 147 NILLDPSNGDVKLADFGLAKKLESKGTKSDSELSVQGTPNYMAPEVIRNGEV--------ARRESDIWSLGCTVVEMLTG 218 (313)
T ss_pred eEEEeCCCCeEEeccCccccccccccccccccccccCCccccCchhhcCCCc--------CCccchhhhcCCEEEeccCC
Confidence 999954 7999999999987753 111112336789999999999985211 13589999999999999999
Q ss_pred CCCCCc-chhHHHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCCChhHHhcCCCCCCCCC
Q 003052 707 RTPFSE-YKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQHPFLVPPVS 772 (853)
Q Consensus 707 ~~PF~~-~~~~~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~HPwf~~~~~ 772 (853)
..||.+ .......+.+.... ....++...+.++++||.+||.+||++||||.++|+|||+.....
T Consensus 219 ~~PW~~~~~~~~~~~~ig~~~-~~P~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~~~~ 284 (313)
T KOG0198|consen 219 KPPWSEFFEEAEALLLIGRED-SLPEIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFLKQNSI 284 (313)
T ss_pred CCcchhhcchHHHHHHHhccC-CCCCCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChhhhcccc
Confidence 999987 44455556555444 334677788999999999999999999999999999999976543
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-44 Score=391.66 Aligned_cols=265 Identities=28% Similarity=0.466 Sum_probs=209.3
Q ss_pred ceeeEEEeEeccCceEEEEEEe-cCCcEEEEEEEecCCCC------------hhhHhhHHHHHHHHHHhcCCCceeEeee
Q 003052 472 KLYQRLGKIGSGGSSEVHKVIS-SDCTIYALKKIKLKGRD------------YATAYGFCQEIEYLNKLKGKNNIIQLID 538 (853)
Q Consensus 472 ~~Y~ilk~LG~G~FG~Vyka~~-~~g~~vAVKkik~~~~~------------~~~~~~~l~EI~iLkkL~~hpNIV~Lid 538 (853)
..|++++.||+|.||+|-+|++ .+++.||||++.+.... ....+...+||.||++|. |+|||+|++
T Consensus 97 Nqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~-H~nVV~LiE 175 (576)
T KOG0585|consen 97 NQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLH-HPNVVKLIE 175 (576)
T ss_pred hheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcC-CcCeeEEEE
Confidence 4599999999999999999998 57899999999654221 112246789999999998 799999998
Q ss_pred hhhhHHHHHHHHhhCCCCCCCCccccCCeEEEEEecchhhHHHHHHHhhhhccCCCCC-CCHHHHHHHHHHhhhhhhhcc
Q 003052 539 YEVTEKALLREVLNGSMNNKDGRVKDDGYIYMVLEYGEIDLAHMLSQKWKEMDGSNQT-LDENWLRFYWQQILEAVNTIH 617 (853)
Q Consensus 539 ~~~~e~~iL~~l~~~~iv~~~g~~~d~~~lyLVmEy~~gdL~~~L~~~~k~~~~~~~~-LsE~~~r~I~~QIl~AL~yLH 617 (853)
+... .....+|||+|||...-.. | ...... |++.++|+|++.++.||+|||
T Consensus 176 vLDD--------------------P~s~~~YlVley~s~G~v~-----w---~p~d~~els~~~Ar~ylrDvv~GLEYLH 227 (576)
T KOG0585|consen 176 VLDD--------------------PESDKLYLVLEYCSKGEVK-----W---CPPDKPELSEQQARKYLRDVVLGLEYLH 227 (576)
T ss_pred eecC--------------------cccCceEEEEEeccCCccc-----c---CCCCcccccHHHHHHHHHHHHHHHHHHH
Confidence 7322 2345799999998732111 1 113344 999999999999999999999
Q ss_pred cCceeeCCCCCccEEe-ecCcEEEEecccchhcccC---CccccccccccCccccCchhhccCCCCCCCccccCCCccch
Q 003052 618 EERIVHSDLKPANFLL-VKGSLKLIDFGIAKAIMSD---TTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDI 693 (853)
Q Consensus 618 s~gIIHRDLKPeNILL-~~g~VKL~DFGlAk~~~~~---~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDI 693 (853)
.+|||||||||.|+|| ++|+|||+|||.+...... .........+|||.|||||++.+... ....+++.||
T Consensus 228 ~QgiiHRDIKPsNLLl~~~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~-----~~~~g~a~Di 302 (576)
T KOG0585|consen 228 YQGIIHRDIKPSNLLLSSDGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNS-----FSYSGFALDI 302 (576)
T ss_pred hcCeeccccchhheEEcCCCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCC-----ccccchhhhh
Confidence 9999999999999999 6789999999999866221 11122234689999999999987431 2356899999
Q ss_pred hhhHHHHHHHHhCCCCCCcchhHHHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCCChhHHhcCCCCCCCC
Q 003052 694 WSLGCILYQMVYGRTPFSEYKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQHPFLVPPV 771 (853)
Q Consensus 694 WSLGVILyELLtG~~PF~~~~~~~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~HPwf~~~~ 771 (853)
||+||+||.|+.|+.||.+...+....+++. ....+...+.....++|||++||.+||++|+++.+|..|||+....
T Consensus 303 WalGVTLYCllfG~~PF~~~~~~~l~~KIvn-~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~~g 379 (576)
T KOG0585|consen 303 WALGVTLYCLLFGQLPFFDDFELELFDKIVN-DPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTRDG 379 (576)
T ss_pred hhhhhhHHHhhhccCCcccchHHHHHHHHhc-CcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecceeccCC
Confidence 9999999999999999988666555555544 3344444445788999999999999999999999999999997653
|
|
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-43 Score=371.74 Aligned_cols=260 Identities=26% Similarity=0.445 Sum_probs=204.4
Q ss_pred eeeEEEeEeccCceEEEEEEec--CCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhc--CCCceeEeeehhhhHHHHHH
Q 003052 473 LYQRLGKIGSGGSSEVHKVISS--DCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLK--GKNNIIQLIDYEVTEKALLR 548 (853)
Q Consensus 473 ~Y~ilk~LG~G~FG~Vyka~~~--~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~--~hpNIV~Lid~~~~e~~iL~ 548 (853)
+|++++.||+|+||.||+|.+. +++.||+|+++...........+.+|+.+++++. .||||+++++++...
T Consensus 2 ~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~----- 76 (290)
T cd07862 2 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVS----- 76 (290)
T ss_pred CcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecc-----
Confidence 5999999999999999999873 4578999999866544444445778999988885 499999999874211
Q ss_pred HHhhCCCCCCCCccccCCeEEEEEecchhhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCCC
Q 003052 549 EVLNGSMNNKDGRVKDDGYIYMVLEYGEIDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKP 628 (853)
Q Consensus 549 ~l~~~~iv~~~g~~~d~~~lyLVmEy~~gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLKP 628 (853)
.......+|+||||++++|.+++... ....+++..++.++.||+.||.|||++||+||||||
T Consensus 77 ------------~~~~~~~~~lv~e~~~~~l~~~~~~~------~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp 138 (290)
T cd07862 77 ------------RTDRETKLTLVFEHVDQDLTTYLDKV------PEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKP 138 (290)
T ss_pred ------------cCCCCCcEEEEEccCCCCHHHHHHhC------CCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCH
Confidence 12345679999999998998888653 234689999999999999999999999999999999
Q ss_pred ccEEe-ecCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHhCC
Q 003052 629 ANFLL-VKGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGR 707 (853)
Q Consensus 629 eNILL-~~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLtG~ 707 (853)
+|||+ .++.+||+|||+++..... .......||+.|+|||++.+. .++.++|||||||++|||++|+
T Consensus 139 ~Nil~~~~~~~kl~Dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~---------~~~~~~DiwslG~il~el~~g~ 206 (290)
T cd07862 139 QNILVTSSGQIKLADFGLARIYSFQ---MALTSVVVTLWYRAPEVLLQS---------SYATPVDLWSVGCIFAEMFRRK 206 (290)
T ss_pred HHEEEcCCCCEEEccccceEeccCC---cccccccccccccChHHHhCC---------CCCCccchHHHHHHHHHHHcCC
Confidence 99999 5679999999999865432 122356799999999999654 3567999999999999999999
Q ss_pred CCCCcchhHHHHHHhhcC---CCC-c-----------c---------cCCCCCChhHHHHHHHhcccCCCCCCChhHHhc
Q 003052 708 TPFSEYKTFWAKFKVITD---PNH-E-----------I---------TYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQ 763 (853)
Q Consensus 708 ~PF~~~~~~~~~~kii~~---~~~-~-----------~---------~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~ 763 (853)
+||.+.........++.. +.. . + ...+..+..+++||.+||+.||++|||+.++|+
T Consensus 207 ~~f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 286 (290)
T cd07862 207 PLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 286 (290)
T ss_pred CCcCCCCHHHHHHHHHHHhCCCChhhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence 999765443332222210 000 0 0 011345677899999999999999999999999
Q ss_pred CCCC
Q 003052 764 HPFL 767 (853)
Q Consensus 764 HPwf 767 (853)
||||
T Consensus 287 hp~f 290 (290)
T cd07862 287 HPYF 290 (290)
T ss_pred CCCC
Confidence 9998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=378.18 Aligned_cols=266 Identities=27% Similarity=0.399 Sum_probs=205.1
Q ss_pred eeeEEEeEeccCceEEEEEEe-cCCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHHHHh
Q 003052 473 LYQRLGKIGSGGSSEVHKVIS-SDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLREVL 551 (853)
Q Consensus 473 ~Y~ilk~LG~G~FG~Vyka~~-~~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~~l~ 551 (853)
+|++.++||+|+||.||+|.+ .++..||||++............+.+|+++|++++ |+||+++++++...
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~-------- 71 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLR-HPDIVEIKHIMLPP-------- 71 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCC-CCCEeeecceEecc--------
Confidence 489999999999999999998 46789999999754444444556889999999997 99999998864321
Q ss_pred hCCCCCCCCccccCCeEEEEEecchhhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCCCccE
Q 003052 552 NGSMNNKDGRVKDDGYIYMVLEYGEIDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANF 631 (853)
Q Consensus 552 ~~~iv~~~g~~~d~~~lyLVmEy~~gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLKPeNI 631 (853)
...+...+|+||||++++|.+.+... ..+++..++.++.||+.||.|||++||+||||||+||
T Consensus 72 ---------~~~~~~~~~lv~e~~~~~L~~~l~~~--------~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NI 134 (338)
T cd07859 72 ---------SRREFKDIYVVFELMESDLHQVIKAN--------DDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNI 134 (338)
T ss_pred ---------CCCCCceEEEEEecCCCCHHHHHHhc--------ccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHe
Confidence 12233468999999999998887643 4699999999999999999999999999999999999
Q ss_pred Ee-ecCcEEEEecccchhcccCCc-cccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHhCCCC
Q 003052 632 LL-VKGSLKLIDFGIAKAIMSDTT-NIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGRTP 709 (853)
Q Consensus 632 LL-~~g~VKL~DFGlAk~~~~~~~-~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLtG~~P 709 (853)
|+ .++.+||+|||+++....... .......+||+.|+|||++.+.. ..|+.++|||||||++|+|++|++|
T Consensus 135 ll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~-------~~~~~~~DvwSlGvvl~el~tg~~p 207 (338)
T cd07859 135 LANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFF-------SKYTPAIDIWSIGCIFAEVLTGKPL 207 (338)
T ss_pred EECCCCcEEEccCccccccccccCccccccCCCCCCCcCCHHHHhccc-------cccCchhHHHHHHHHHHHHHcCCCC
Confidence 99 567999999999986533221 11223568999999999986421 1467899999999999999999999
Q ss_pred CCcchhHHHH---HHhhcC----------------------CCCcc---cCCCCCChhHHHHHHHhcccCCCCCCChhHH
Q 003052 710 FSEYKTFWAK---FKVITD----------------------PNHEI---TYEPVPNPWLLDLMKKCLAWDRNERWRIPQL 761 (853)
Q Consensus 710 F~~~~~~~~~---~kii~~----------------------~~~~~---~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EI 761 (853)
|.+....... ...... ..... ...+..++.+.+||.+||..||.+||++.|+
T Consensus 208 f~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~ 287 (338)
T cd07859 208 FPGKNVVHQLDLITDLLGTPSPETISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEA 287 (338)
T ss_pred CCCCChHHHHHHHHHHhCCCCHHHHHHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHH
Confidence 9654322110 000000 00000 0112356778999999999999999999999
Q ss_pred hcCCCCCCCC
Q 003052 762 LQHPFLVPPV 771 (853)
Q Consensus 762 L~HPwf~~~~ 771 (853)
|+||||+...
T Consensus 288 l~hp~f~~~~ 297 (338)
T cd07859 288 LADPYFKGLA 297 (338)
T ss_pred hcCchhhhcC
Confidence 9999997643
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=369.80 Aligned_cols=255 Identities=30% Similarity=0.497 Sum_probs=201.8
Q ss_pred eeeEEEeEeccCceEEEEEEec-CCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHHHHh
Q 003052 473 LYQRLGKIGSGGSSEVHKVISS-DCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLREVL 551 (853)
Q Consensus 473 ~Y~ilk~LG~G~FG~Vyka~~~-~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~~l~ 551 (853)
+|++.+.||+|+||.||+|++. +++.||||+++...........+.+|+.++++++ |+||++++++
T Consensus 2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~------------ 68 (287)
T cd07848 2 KFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLK-QENIVELKEA------------ 68 (287)
T ss_pred CceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCC-Cccccchhhh------------
Confidence 5999999999999999999985 6688999999876544445566889999999997 8999998765
Q ss_pred hCCCCCCCCccccCCeEEEEEecchhhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCCCccE
Q 003052 552 NGSMNNKDGRVKDDGYIYMVLEYGEIDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANF 631 (853)
Q Consensus 552 ~~~iv~~~g~~~d~~~lyLVmEy~~gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLKPeNI 631 (853)
+.++..+|+||||+++++...+... ...+++..++.++.||+.||.|||++||+||||||+||
T Consensus 69 ----------~~~~~~~~lv~e~~~~~~l~~~~~~-------~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Ni 131 (287)
T cd07848 69 ----------FRRRGKLYLVFEYVEKNMLELLEEM-------PNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENL 131 (287)
T ss_pred ----------EecCCEEEEEEecCCCCHHHHHHhc-------CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHE
Confidence 4566789999999887666655432 24699999999999999999999999999999999999
Q ss_pred Ee-ecCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHhCCCCC
Q 003052 632 LL-VKGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGRTPF 710 (853)
Q Consensus 632 LL-~~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLtG~~PF 710 (853)
|+ .++.+||+|||+++....... ......+||+.|+|||++.+.. ++.++|||||||++|+|++|++||
T Consensus 132 ll~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~---------~~~~~DiwslGvil~el~~g~~pf 201 (287)
T cd07848 132 LISHNDVLKLCDFGFARNLSEGSN-ANYTEYVATRWYRSPELLLGAP---------YGKAVDMWSVGCILGELSDGQPLF 201 (287)
T ss_pred EEcCCCcEEEeeccCccccccccc-ccccccccccccCCcHHHcCCC---------CCCchhHHhHHHHHHHHHhCCCCC
Confidence 99 567999999999987643221 1223567999999999997643 567999999999999999999999
Q ss_pred CcchhHHHHHHhhc---------------CCC-Ccc-------------cCCCCCChhHHHHHHHhcccCCCCCCChhHH
Q 003052 711 SEYKTFWAKFKVIT---------------DPN-HEI-------------TYEPVPNPWLLDLMKKCLAWDRNERWRIPQL 761 (853)
Q Consensus 711 ~~~~~~~~~~kii~---------------~~~-~~~-------------~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EI 761 (853)
.+.........+.. .+. ... .+....+.++.+||++||++||.+|||+.++
T Consensus 202 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~ 281 (287)
T cd07848 202 PGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQC 281 (287)
T ss_pred CCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHH
Confidence 76433222111100 000 000 0112356779999999999999999999999
Q ss_pred hcCCCC
Q 003052 762 LQHPFL 767 (853)
Q Consensus 762 L~HPwf 767 (853)
|+||||
T Consensus 282 l~hp~f 287 (287)
T cd07848 282 LNHPAF 287 (287)
T ss_pred hcCCCC
Confidence 999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=371.84 Aligned_cols=255 Identities=30% Similarity=0.523 Sum_probs=201.4
Q ss_pred ceeeEEEeEeccCceEEEEEEec-CCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHHHH
Q 003052 472 KLYQRLGKIGSGGSSEVHKVISS-DCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLREV 550 (853)
Q Consensus 472 ~~Y~ilk~LG~G~FG~Vyka~~~-~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~~l 550 (853)
+.|.++++||.|+||.||+|.+. ++..||+|+++..... .....+.+|+.++++++ |+||++++++
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~E~~~l~~l~-h~niv~~~~~----------- 71 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEE-GAPCTAIREVSLLKNLK-HANIVTLHDI----------- 71 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccC-CcchhHHHHHHHHHhCC-CCCEeeEEEE-----------
Confidence 45999999999999999999984 6789999999765322 22335679999999997 8999999987
Q ss_pred hhCCCCCCCCccccCCeEEEEEecchhhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCCCcc
Q 003052 551 LNGSMNNKDGRVKDDGYIYMVLEYGEIDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPAN 630 (853)
Q Consensus 551 ~~~~iv~~~g~~~d~~~lyLVmEy~~gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLKPeN 630 (853)
+.+...+|+||||++++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|
T Consensus 72 -----------~~~~~~~~lv~e~~~~~l~~~l~~~-------~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~N 133 (288)
T cd07871 72 -----------IHTERCLTLVFEYLDSDLKQYLDNC-------GNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQN 133 (288)
T ss_pred -----------EcCCCeEEEEEeCCCcCHHHHHHhc-------CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHH
Confidence 3455689999999998988887543 3468999999999999999999999999999999999
Q ss_pred EEe-ecCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHhCCCC
Q 003052 631 FLL-VKGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGRTP 709 (853)
Q Consensus 631 ILL-~~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLtG~~P 709 (853)
||+ .++.+||+|||+++....... ......|++.|+|||++.+.. .++.++|||||||++|+|++|++|
T Consensus 134 il~~~~~~~kl~DfG~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~--------~~~~~~DiwslG~~l~~l~~g~~p 203 (288)
T cd07871 134 LLINEKGELKLADFGLARAKSVPTK--TYSNEVVTLWYRPPDVLLGST--------EYSTPIDMWGVGCILYEMATGRPM 203 (288)
T ss_pred EEECCCCCEEECcCcceeeccCCCc--cccCceecccccChHHhcCCc--------ccCcHHHHHHHHHHHHHHHhCCCC
Confidence 999 567999999999976533221 223567899999999986532 367899999999999999999999
Q ss_pred CCcchhHHHH---HHhhcCCCC-------------c-----------ccCCCCCChhHHHHHHHhcccCCCCCCChhHHh
Q 003052 710 FSEYKTFWAK---FKVITDPNH-------------E-----------ITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLL 762 (853)
Q Consensus 710 F~~~~~~~~~---~kii~~~~~-------------~-----------~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL 762 (853)
|.+....... ...+..+.. . .......+.++++||.+||.+||.+|||+.|+|
T Consensus 204 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l 283 (288)
T cd07871 204 FPGSTVKEELHLIFRLLGTPTEETWPGITSNEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAAL 283 (288)
T ss_pred CCCCCHHHHHHHHHHHhCCCChHHhhccccchhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHh
Confidence 9764332221 111111000 0 001134577899999999999999999999999
Q ss_pred cCCCC
Q 003052 763 QHPFL 767 (853)
Q Consensus 763 ~HPwf 767 (853)
+||||
T Consensus 284 ~hp~f 288 (288)
T cd07871 284 RHSYF 288 (288)
T ss_pred cCCCC
Confidence 99998
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=374.06 Aligned_cols=258 Identities=29% Similarity=0.461 Sum_probs=202.7
Q ss_pred ceeeEEEeEeccCceEEEEEEec-CCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHHHH
Q 003052 472 KLYQRLGKIGSGGSSEVHKVISS-DCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLREV 550 (853)
Q Consensus 472 ~~Y~ilk~LG~G~FG~Vyka~~~-~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~~l 550 (853)
+.|+++++||+|+||.||+|.+. +++.||||++...... .....+.+|+.+++.+. |+||++++++
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~E~~~l~~l~-h~niv~~~~~----------- 71 (303)
T cd07869 5 DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEE-GTPFTAIREASLLKGLK-HANIVLLHDI----------- 71 (303)
T ss_pred ccceEeeeEEecCCEEEEEEEECCCCCEEEEEEecccccc-ccchhHHHHHHHHhhCC-CCCcCeEEEE-----------
Confidence 56999999999999999999985 6789999999754332 22335678999999997 8999999886
Q ss_pred hhCCCCCCCCccccCCeEEEEEecchhhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCCCcc
Q 003052 551 LNGSMNNKDGRVKDDGYIYMVLEYGEIDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPAN 630 (853)
Q Consensus 551 ~~~~iv~~~g~~~d~~~lyLVmEy~~gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLKPeN 630 (853)
+.++..+|+||||++++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|
T Consensus 72 -----------~~~~~~~~lv~e~~~~~l~~~~~~~-------~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~N 133 (303)
T cd07869 72 -----------IHTKETLTLVFEYVHTDLCQYMDKH-------PGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQN 133 (303)
T ss_pred -----------EecCCeEEEEEECCCcCHHHHHHhC-------CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHH
Confidence 4556789999999999988887643 3568999999999999999999999999999999999
Q ss_pred EEe-ecCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHhCCCC
Q 003052 631 FLL-VKGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGRTP 709 (853)
Q Consensus 631 ILL-~~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLtG~~P 709 (853)
||+ .++.+||+|||+++...... ......+||+.|+|||++.+.. .++.++|||||||++|+|++|..|
T Consensus 134 ill~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~--------~~~~~~DiwslG~il~~l~~g~~p 203 (303)
T cd07869 134 LLISDTGELKLADFGLARAKSVPS--HTYSNEVVTLWYRPPDVLLGST--------EYSTCLDMWGVGCIFVEMIQGVAA 203 (303)
T ss_pred EEECCCCCEEECCCCcceeccCCC--ccCCCCcccCCCCChHHHcCCC--------CCCcHHHHHHHHHHHHHHHhCCCC
Confidence 999 56799999999997543221 1223567899999999986532 356789999999999999999999
Q ss_pred CCcchhHHHHH----HhhcCCCCc---------------cc--C---------CCCCChhHHHHHHHhcccCCCCCCChh
Q 003052 710 FSEYKTFWAKF----KVITDPNHE---------------IT--Y---------EPVPNPWLLDLMKKCLAWDRNERWRIP 759 (853)
Q Consensus 710 F~~~~~~~~~~----kii~~~~~~---------------~~--~---------~~~~s~~l~dLI~kcL~~DP~kRpTa~ 759 (853)
|.+........ .....+... .. . ....+..+.+||.+||++||.+|||+.
T Consensus 204 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~ 283 (303)
T cd07869 204 FPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQ 283 (303)
T ss_pred CCCCccHHHHHHHHHHHhCCCChhhccchhhccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHH
Confidence 97654332221 111111000 00 0 011345689999999999999999999
Q ss_pred HHhcCCCCCCC
Q 003052 760 QLLQHPFLVPP 770 (853)
Q Consensus 760 EIL~HPwf~~~ 770 (853)
|+|+||||...
T Consensus 284 ~~l~h~~f~~~ 294 (303)
T cd07869 284 AALSHEYFSDL 294 (303)
T ss_pred HHhcCcccccC
Confidence 99999999754
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=372.62 Aligned_cols=249 Identities=28% Similarity=0.443 Sum_probs=205.5
Q ss_pred eeeEEEeEeccCceEEEEEEec-CCcEEEEEEEecCCC-ChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHHHH
Q 003052 473 LYQRLGKIGSGGSSEVHKVISS-DCTIYALKKIKLKGR-DYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLREV 550 (853)
Q Consensus 473 ~Y~ilk~LG~G~FG~Vyka~~~-~g~~vAVKkik~~~~-~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~~l 550 (853)
.|++++.||+|+||.||+|.+. +++.||+|++..... .......+.+|+.+|++++ ||||++++++
T Consensus 2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~----------- 69 (291)
T cd05612 2 DLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVS-HPFIIRLFWT----------- 69 (291)
T ss_pred CceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCC-CCcHhhhHhh-----------
Confidence 5899999999999999999985 678999999975432 2234456789999999997 8999998765
Q ss_pred hhCCCCCCCCccccCCeEEEEEecch-hhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCCCc
Q 003052 551 LNGSMNNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPA 629 (853)
Q Consensus 551 ~~~~iv~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLKPe 629 (853)
+.++.++|+||||+. ++|.+++... ..+++..++.++.||+.||+|||++||+||||||+
T Consensus 70 -----------~~~~~~~~lv~e~~~~~~L~~~~~~~--------~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~ 130 (291)
T cd05612 70 -----------EHDQRFLYMLMEYVPGGELFSYLRNS--------GRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPE 130 (291)
T ss_pred -----------hccCCeEEEEEeCCCCCCHHHHHHHc--------CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHH
Confidence 456678999999965 5888888653 56899999999999999999999999999999999
Q ss_pred cEEe-ecCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHhCCC
Q 003052 630 NFLL-VKGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGRT 708 (853)
Q Consensus 630 NILL-~~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLtG~~ 708 (853)
|||+ .+|.+||+|||+++..... ....+||+.|+|||++.+.. ++.++|||||||++|+|++|+.
T Consensus 131 NIli~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~---------~~~~~DiwSlG~il~~l~~g~~ 196 (291)
T cd05612 131 NILLDKEGHIKLTDFGFAKKLRDR-----TWTLCGTPEYLAPEVIQSKG---------HNKAVDWWALGILIYEMLVGYP 196 (291)
T ss_pred HeEECCCCCEEEEecCcchhccCC-----cccccCChhhcCHHHHcCCC---------CCchhhHHHHHHHHHHHHhCCC
Confidence 9999 5679999999999876432 12568999999999997653 5679999999999999999999
Q ss_pred CCCcchhHHHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCCC-----hhHHhcCCCCCC
Q 003052 709 PFSEYKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWR-----IPQLLQHPFLVP 769 (853)
Q Consensus 709 PF~~~~~~~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpT-----a~EIL~HPwf~~ 769 (853)
||.+.........+.. ....++...++.+++||++||..||.+|++ +.++++||||..
T Consensus 197 pf~~~~~~~~~~~i~~---~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~ 259 (291)
T cd05612 197 PFFDDNPFGIYEKILA---GKLEFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNHRWFKS 259 (291)
T ss_pred CCCCCCHHHHHHHHHh---CCcCCCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcCccccC
Confidence 9987554433333322 223455566889999999999999999995 999999999964
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-44 Score=370.29 Aligned_cols=258 Identities=29% Similarity=0.460 Sum_probs=217.6
Q ss_pred eeEEEeEeccCceEEEEEEe-cCCcEEEEEEEecCCC------ChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHH
Q 003052 474 YQRLGKIGSGGSSEVHKVIS-SDCTIYALKKIKLKGR------DYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKAL 546 (853)
Q Consensus 474 Y~ilk~LG~G~FG~Vyka~~-~~g~~vAVKkik~~~~------~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~i 546 (853)
|.-.+.||+|..++|.++.+ .+++.+|+|+|..... -+.....-++|+.||+++.+||+|+++.|+
T Consensus 19 y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~------- 91 (411)
T KOG0599|consen 19 YEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDV------- 91 (411)
T ss_pred cChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeee-------
Confidence 66667899999999999987 5778999999975432 123344556899999999999999999997
Q ss_pred HHHHhhCCCCCCCCccccCCeEEEEEecch-hhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCC
Q 003052 547 LREVLNGSMNNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSD 625 (853)
Q Consensus 547 L~~l~~~~iv~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRD 625 (853)
|+.+.++|+|+|.+. |.|++++... -.++|+..+.||+||+.|++|||.++|||||
T Consensus 92 ---------------yes~sF~FlVFdl~prGELFDyLts~--------VtlSEK~tR~iMrqlfegVeylHa~~IVHRD 148 (411)
T KOG0599|consen 92 ---------------YESDAFVFLVFDLMPRGELFDYLTSK--------VTLSEKETRRIMRQLFEGVEYLHARNIVHRD 148 (411)
T ss_pred ---------------ccCcchhhhhhhhcccchHHHHhhhh--------eeecHHHHHHHHHHHHHHHHHHHHhhhhhcc
Confidence 456778899999976 7999999876 6899999999999999999999999999999
Q ss_pred CCCccEEeec-CcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHH
Q 003052 626 LKPANFLLVK-GSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMV 704 (853)
Q Consensus 626 LKPeNILL~~-g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELL 704 (853)
|||+|||+++ .++||+|||+|+.+..+. .....||||+|.|||.+.+.-++ +...|+..+|+|++|||||-||
T Consensus 149 LKpENILlddn~~i~isDFGFa~~l~~Ge---kLrelCGTPgYLAPEtikC~m~e---~~pGYs~EVD~Wa~GVImyTLL 222 (411)
T KOG0599|consen 149 LKPENILLDDNMNIKISDFGFACQLEPGE---KLRELCGTPGYLAPETIKCSMYE---NHPGYSKEVDEWACGVIMYTLL 222 (411)
T ss_pred cChhheeeccccceEEeccceeeccCCch---hHHHhcCCCcccChhheeeeccc---CCCCccchhhHHHHHHHHHHHH
Confidence 9999999965 499999999999875533 34578999999999999987665 3446899999999999999999
Q ss_pred hCCCCCCcchhHHHHHHhhcCCCCcccCC--CCCChhHHHHHHHhcccCCCCCCChhHHhcCCCCC
Q 003052 705 YGRTPFSEYKTFWAKFKVITDPNHEITYE--PVPNPWLLDLMKKCLAWDRNERWRIPQLLQHPFLV 768 (853)
Q Consensus 705 tG~~PF~~~~~~~~~~kii~~~~~~~~~~--~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~HPwf~ 768 (853)
.|.+||...+++.. .+.+..+...+..+ .+.+...+|||.+||++||.+|+|+.|+|.||||.
T Consensus 223 aGcpPFwHRkQmlM-LR~ImeGkyqF~speWadis~~~KdLIsrlLqVdp~~Ritake~LaHpff~ 287 (411)
T KOG0599|consen 223 AGCPPFWHRKQMLM-LRMIMEGKYQFRSPEWADISATVKDLISRLLQVDPTKRITAKEALAHPFFI 287 (411)
T ss_pred cCCCchhHHHHHHH-HHHHHhcccccCCcchhhccccHHHHHHHHHeeCchhcccHHHHhcChHHH
Confidence 99999998776544 44455555555443 34567799999999999999999999999999994
|
|
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-42 Score=378.85 Aligned_cols=250 Identities=26% Similarity=0.427 Sum_probs=207.5
Q ss_pred ceeeEEEeEeccCceEEEEEEec-CCcEEEEEEEecCCC-ChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHHH
Q 003052 472 KLYQRLGKIGSGGSSEVHKVISS-DCTIYALKKIKLKGR-DYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLRE 549 (853)
Q Consensus 472 ~~Y~ilk~LG~G~FG~Vyka~~~-~g~~vAVKkik~~~~-~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~~ 549 (853)
..|++.+.||+|+||.||+|.+. +++.||||+++.... .......+.+|+.+|++++ |+||++++++
T Consensus 18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~---------- 86 (329)
T PTZ00263 18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELS-HPFIVNMMCS---------- 86 (329)
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCC-CCCCCcEEEE----------
Confidence 45999999999999999999984 678999999975422 2234456889999999997 8999999876
Q ss_pred HhhCCCCCCCCccccCCeEEEEEecch-hhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCCC
Q 003052 550 VLNGSMNNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKP 628 (853)
Q Consensus 550 l~~~~iv~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLKP 628 (853)
+.+++.+|+||||+. ++|.+.+... ..+++..++.++.||+.||.|||++||+||||||
T Consensus 87 ------------~~~~~~~~lv~e~~~~~~L~~~l~~~--------~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp 146 (329)
T PTZ00263 87 ------------FQDENRVYFLLEFVVGGELFTHLRKA--------GRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKP 146 (329)
T ss_pred ------------EEcCCEEEEEEcCCCCChHHHHHHHc--------CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCH
Confidence 456778999999965 5888887653 5689999999999999999999999999999999
Q ss_pred ccEEe-ecCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHhCC
Q 003052 629 ANFLL-VKGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGR 707 (853)
Q Consensus 629 eNILL-~~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLtG~ 707 (853)
+|||| .++.+||+|||+++...... ...+||+.|+|||++.+.. ++.++|||||||++|+|++|+
T Consensus 147 ~NIll~~~~~~kl~Dfg~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~---------~~~~~DiwslG~il~elltg~ 212 (329)
T PTZ00263 147 ENLLLDNKGHVKVTDFGFAKKVPDRT-----FTLCGTPEYLAPEVIQSKG---------HGKAVDWWTMGVLLYEFIAGY 212 (329)
T ss_pred HHEEECCCCCEEEeeccCceEcCCCc-----ceecCChhhcCHHHHcCCC---------CCCcceeechHHHHHHHHcCC
Confidence 99999 56799999999998664321 2568999999999997653 467999999999999999999
Q ss_pred CCCCcchhHHHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCCC-----hhHHhcCCCCCC
Q 003052 708 TPFSEYKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWR-----IPQLLQHPFLVP 769 (853)
Q Consensus 708 ~PF~~~~~~~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpT-----a~EIL~HPwf~~ 769 (853)
.||.+......... +... ...++...+..+++||.+||..||.+|++ +.+++.||||..
T Consensus 213 ~pf~~~~~~~~~~~-i~~~--~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~hp~f~~ 276 (329)
T PTZ00263 213 PPFFDDTPFRIYEK-ILAG--RLKFPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNHPYFHG 276 (329)
T ss_pred CCCCCCCHHHHHHH-HhcC--CcCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCccCC
Confidence 99987555433333 3322 23455667888999999999999999997 799999999975
|
|
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-42 Score=395.70 Aligned_cols=253 Identities=31% Similarity=0.448 Sum_probs=205.5
Q ss_pred ceeeEEEeEeccCceEEEEEEe-cCCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCC-----CceeEeeehhhhHHH
Q 003052 472 KLYQRLGKIGSGGSSEVHKVIS-SDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGK-----NNIIQLIDYEVTEKA 545 (853)
Q Consensus 472 ~~Y~ilk~LG~G~FG~Vyka~~-~~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~h-----pNIV~Lid~~~~e~~ 545 (853)
-+|.+++.||+|+||.|.+|.+ .+++.||||+++.+.. .......||.||.+|+.| -|||+++||
T Consensus 186 ~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~---f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~------ 256 (586)
T KOG0667|consen 186 YRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKR---FLRQAQIEIRILELLNKHDPDDKYNIVRMLDY------ 256 (586)
T ss_pred EEEEEEEEecccccceeEEEEecCCCcEEEEEeeccChH---HHHHHHHHHHHHHHHhccCCCCCeeEEEeeec------
Confidence 3799999999999999999998 5789999999986533 344567899999999833 489999998
Q ss_pred HHHHHhhCCCCCCCCccccCCeEEEEEecchhhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCC
Q 003052 546 LLREVLNGSMNNKDGRVKDDGYIYMVLEYGEIDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSD 625 (853)
Q Consensus 546 iL~~l~~~~iv~~~g~~~d~~~lyLVmEy~~gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRD 625 (853)
|...+++|||+|.++.+|.++|++. ....|+...++.|+.||+.||.+||++||||+|
T Consensus 257 ----------------F~fr~HlciVfELL~~NLYellK~n------~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcD 314 (586)
T KOG0667|consen 257 ----------------FYFRNHLCIVFELLSTNLYELLKNN------KFRGLSLPLVRKFAQQILTALLFLHELGIIHCD 314 (586)
T ss_pred ----------------cccccceeeeehhhhhhHHHHHHhc------CCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecc
Confidence 4566789999999999999999886 446799999999999999999999999999999
Q ss_pred CCCccEEee---cCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHH
Q 003052 626 LKPANFLLV---KGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQ 702 (853)
Q Consensus 626 LKPeNILL~---~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyE 702 (853)
||||||||. ...|||+|||.|..... ...+++.+.+|+|||+|.|.+ |+.++||||||||++|
T Consensus 315 LKPENILL~~~~r~~vKVIDFGSSc~~~q-----~vytYiQSRfYRAPEVILGlp---------Y~~~IDmWSLGCIlAE 380 (586)
T KOG0667|consen 315 LKPENILLKDPKRSRIKVIDFGSSCFESQ-----RVYTYIQSRFYRAPEVILGLP---------YDTAIDMWSLGCILAE 380 (586)
T ss_pred CChhheeeccCCcCceeEEecccccccCC-----cceeeeeccccccchhhccCC---------CCCccceeehhhhHHh
Confidence 999999993 45899999999986532 223789999999999999875 5679999999999999
Q ss_pred HHhCCCCCCcchhHHHHHHhhc---CCC----------------------------------------------CcccCC
Q 003052 703 MVYGRTPFSEYKTFWAKFKVIT---DPN----------------------------------------------HEITYE 733 (853)
Q Consensus 703 LLtG~~PF~~~~~~~~~~kii~---~~~----------------------------------------------~~~~~~ 733 (853)
|++|.+.|.+.+...++..++. .+. .....+
T Consensus 381 L~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~~~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P 460 (586)
T KOG0667|consen 381 LFTGEPLFPGDNEYDQLARIIEVLGLPPPKMLDTAKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGP 460 (586)
T ss_pred HhcCccccCCCCHHHHHHHHHHHhCCCCHHHHHhccccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCC
Confidence 9999999977555433222211 000 000001
Q ss_pred -----------CCCChhHHHHHHHhcccCCCCCCChhHHhcCCCCCC
Q 003052 734 -----------PVPNPWLLDLMKKCLAWDRNERWRIPQLLQHPFLVP 769 (853)
Q Consensus 734 -----------~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~HPwf~~ 769 (853)
......+.|||++||.+||.+|+|+.|+|+||||..
T Consensus 461 ~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R~tp~qal~Hpfl~~ 507 (586)
T KOG0667|consen 461 PGSRSLESGLPKADDKLFIDFLKRCLEWDPAERITPAQALNHPFLTG 507 (586)
T ss_pred CCCcccchhcccccHHHHHHHHHHHhccCchhcCCHHHHhcCccccc
Confidence 011233789999999999999999999999999974
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-42 Score=377.54 Aligned_cols=247 Identities=27% Similarity=0.421 Sum_probs=201.4
Q ss_pred EeEeccCceEEEEEEe-cCCcEEEEEEEecCCC-ChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHHHHhhCCC
Q 003052 478 GKIGSGGSSEVHKVIS-SDCTIYALKKIKLKGR-DYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLREVLNGSM 555 (853)
Q Consensus 478 k~LG~G~FG~Vyka~~-~~g~~vAVKkik~~~~-~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~~l~~~~i 555 (853)
+.||+|+||.||+|.+ .+++.||||+++.... .......+.+|+.+|++++ |+||++++++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-hp~i~~~~~~---------------- 63 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTR-HPFLTALKYS---------------- 63 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCC-CCCCCCEEEE----------------
Confidence 3699999999999988 5778999999986432 2234456789999999997 8999998875
Q ss_pred CCCCCccccCCeEEEEEecch-hhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCCCccEEe-
Q 003052 556 NNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLL- 633 (853)
Q Consensus 556 v~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLKPeNILL- 633 (853)
+.+.+++|+||||+. ++|...+... ..+++..++.++.||+.||+|||++||+||||||+|||+
T Consensus 64 ------~~~~~~~~lv~e~~~~~~L~~~l~~~--------~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~ 129 (323)
T cd05571 64 ------FQTHDRLCFVMEYANGGELFFHLSRE--------RVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLD 129 (323)
T ss_pred ------EEcCCEEEEEEeCCCCCcHHHHHHHc--------CCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEEC
Confidence 566778999999976 5787777543 578999999999999999999999999999999999999
Q ss_pred ecCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHhCCCCCCcc
Q 003052 634 VKGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGRTPFSEY 713 (853)
Q Consensus 634 ~~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLtG~~PF~~~ 713 (853)
.++.+||+|||+|+....... .....+||+.|+|||++.+. .|+.++|||||||++|||++|+.||...
T Consensus 130 ~~~~~kl~DfG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~---------~~~~~~DiwSlG~il~elltg~~Pf~~~ 198 (323)
T cd05571 130 KDGHIKITDFGLCKEGISDGA--TMKTFCGTPEYLAPEVLEDN---------DYGRAVDWWGLGVVMYEMMCGRLPFYNQ 198 (323)
T ss_pred CCCCEEEeeCCCCcccccCCC--cccceecCccccChhhhcCC---------CCCccccCcccchhhhhhhcCCCCCCCC
Confidence 567999999999986432221 22357899999999999765 3568999999999999999999999765
Q ss_pred hhHHHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCC-----ChhHHhcCCCCCC
Q 003052 714 KTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERW-----RIPQLLQHPFLVP 769 (853)
Q Consensus 714 ~~~~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRp-----Ta~EIL~HPwf~~ 769 (853)
+... ....+.. ....++...++++.+||.+||..||.+|| ++.++++||||..
T Consensus 199 ~~~~-~~~~~~~--~~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h~~f~~ 256 (323)
T cd05571 199 DHEK-LFELILM--EEIRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEHRFFAS 256 (323)
T ss_pred CHHH-HHHHHHc--CCCCCCCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHcCCCcCC
Confidence 4432 2233322 22345667889999999999999999999 8999999999975
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-42 Score=385.23 Aligned_cols=256 Identities=30% Similarity=0.416 Sum_probs=216.9
Q ss_pred CceeeEEEeEeccCceEEEEEEec-CCcEEEEEEEecCCCCh-hhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHH
Q 003052 471 GKLYQRLGKIGSGGSSEVHKVISS-DCTIYALKKIKLKGRDY-ATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLR 548 (853)
Q Consensus 471 g~~Y~ilk~LG~G~FG~Vyka~~~-~g~~vAVKkik~~~~~~-~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~ 548 (853)
...|.+.+.||+|.||.||+|+.+ +|+.||+|++.+..... .....+.+|+.+|++|.+|||||.+++.
T Consensus 34 ~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~--------- 104 (382)
T KOG0032|consen 34 KEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDA--------- 104 (382)
T ss_pred cccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEE---------
Confidence 356999999999999999999985 58999999998765432 2345688999999999999999999987
Q ss_pred HHhhCCCCCCCCccccCCeEEEEEecch-hhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCC
Q 003052 549 EVLNGSMNNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLK 627 (853)
Q Consensus 549 ~l~~~~iv~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLK 627 (853)
|++...+|+|||++. |.|++.|... .++|..+..+++||+.|+.|||+.||+|||||
T Consensus 105 -------------~e~~~~~~lvmEL~~GGeLfd~i~~~---------~~sE~da~~~~~~il~av~~lH~~gvvHrDlK 162 (382)
T KOG0032|consen 105 -------------FEDPDSVYLVMELCEGGELFDRIVKK---------HYSERDAAGIIRQILEAVKYLHSLGVVHRDLK 162 (382)
T ss_pred -------------EEcCCeEEEEEEecCCchHHHHHHHc---------cCCHHHHHHHHHHHHHHHHHHHhCCceeccCC
Confidence 567779999999977 5899888754 29999999999999999999999999999999
Q ss_pred CccEEee---c--CcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHH
Q 003052 628 PANFLLV---K--GSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQ 702 (853)
Q Consensus 628 PeNILL~---~--g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyE 702 (853)
|+|||+. + +.+|++|||++..+.. .......|||++|+|||++... .|+..+||||+||++|.
T Consensus 163 pEN~L~~~~~~~~~~ik~~DFGla~~~~~---~~~~~~~~Gtp~y~APEvl~~~---------~y~~~~DiWS~Gvi~yi 230 (382)
T KOG0032|consen 163 PENLLLASKDEGSGRIKLIDFGLAKFIKP---GERLHTIVGTPEYVAPEVLGGR---------PYGDEVDVWSIGVILYI 230 (382)
T ss_pred HHHeeeccccCCCCcEEEeeCCCceEccC---CceEeeecCCccccCchhhcCC---------CCCcccchhHHHHHHHH
Confidence 9999992 2 3799999999998765 2345688999999999999754 47789999999999999
Q ss_pred HHhCCCCCCcchhHHHHHHhhcCCCCcc--cCCCCCChhHHHHHHHhcccCCCCCCChhHHhcCCCCCCC
Q 003052 703 MVYGRTPFSEYKTFWAKFKVITDPNHEI--TYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQHPFLVPP 770 (853)
Q Consensus 703 LLtG~~PF~~~~~~~~~~kii~~~~~~~--~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~HPwf~~~ 770 (853)
|++|.+||.+.........+.. ....+ .+.+..+..+++||++||..||.+|+|+.++|+|||+...
T Consensus 231 LL~G~~PF~~~~~~~~~~~i~~-~~~~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~HpWi~~~ 299 (382)
T KOG0032|consen 231 LLSGVPPFWGETEFEIFLAILR-GDFDFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQHPWIKSI 299 (382)
T ss_pred HhhCCCCCcCCChhHHHHHHHc-CCCCCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcCccccCC
Confidence 9999999988766554444433 33333 3344568889999999999999999999999999999875
|
|
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-42 Score=392.98 Aligned_cols=263 Identities=25% Similarity=0.370 Sum_probs=203.9
Q ss_pred CceeeEEEeEeccCceEEEEEEec-CCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHHH
Q 003052 471 GKLYQRLGKIGSGGSSEVHKVISS-DCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLRE 549 (853)
Q Consensus 471 g~~Y~ilk~LG~G~FG~Vyka~~~-~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~~ 549 (853)
.+.|++.++||+|+||.||+|.+. +++.||||++..... ...+|+.+|++++ |+||+++++++..+.
T Consensus 65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~------~~~~Ei~il~~l~-h~niv~l~~~~~~~~----- 132 (440)
T PTZ00036 65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQ------YKNRELLIMKNLN-HINIIFLKDYYYTEC----- 132 (440)
T ss_pred CCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCcc------hHHHHHHHHHhcC-CCCCcceeeeEeecc-----
Confidence 457999999999999999999984 678999999864322 2347999999997 899999988753321
Q ss_pred HhhCCCCCCCCccccCCeEEEEEecchhhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCCCc
Q 003052 550 VLNGSMNNKDGRVKDDGYIYMVLEYGEIDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPA 629 (853)
Q Consensus 550 l~~~~iv~~~g~~~d~~~lyLVmEy~~gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLKPe 629 (853)
........++|+||||++++|.+++....+ ....+++..++.|+.||+.||.|||++||+||||||+
T Consensus 133 ---------~~~~~~~~~l~lvmE~~~~~l~~~~~~~~~----~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~ 199 (440)
T PTZ00036 133 ---------FKKNEKNIFLNVVMEFIPQTVHKYMKHYAR----NNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQ 199 (440)
T ss_pred ---------cccCCCceEEEEEEecCCccHHHHHHHHhh----cCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHH
Confidence 011233446889999999888877754322 3467999999999999999999999999999999999
Q ss_pred cEEee-c-CcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHhCC
Q 003052 630 NFLLV-K-GSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGR 707 (853)
Q Consensus 630 NILL~-~-g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLtG~ 707 (853)
||||+ + +.+||+|||+|+.+..... ....+||+.|||||++.+.. .|+.++|||||||++|||++|.
T Consensus 200 NILl~~~~~~vkL~DFGla~~~~~~~~---~~~~~~t~~y~aPE~~~~~~--------~~~~~~DiwSlGvil~elltG~ 268 (440)
T PTZ00036 200 NLLIDPNTHTLKLCDFGSAKNLLAGQR---SVSYICSRFYRAPELMLGAT--------NYTTHIDLWSLGCIIAEMILGY 268 (440)
T ss_pred HEEEcCCCCceeeeccccchhccCCCC---cccCCCCcCccCHHHhcCCC--------CCCcHHHHHHHHHHHHHHHhCC
Confidence 99995 3 3699999999987643322 23568999999999986542 3678999999999999999999
Q ss_pred CCCCcchhHHHHHHhh---cCCC-----------Cc------------ccCCCCCChhHHHHHHHhcccCCCCCCChhHH
Q 003052 708 TPFSEYKTFWAKFKVI---TDPN-----------HE------------ITYEPVPNPWLLDLMKKCLAWDRNERWRIPQL 761 (853)
Q Consensus 708 ~PF~~~~~~~~~~kii---~~~~-----------~~------------~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EI 761 (853)
+||.+........+++ ..+. .. ..++...+.++++||.+||.+||.+|||+.|+
T Consensus 269 ~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~ 348 (440)
T PTZ00036 269 PIFSGQSSVDQLVRIIQVLGTPTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEA 348 (440)
T ss_pred CCCCCCChHHHHHHHHHHhCCCCHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHH
Confidence 9997654332222221 1110 00 11233457789999999999999999999999
Q ss_pred hcCCCCCC
Q 003052 762 LQHPFLVP 769 (853)
Q Consensus 762 L~HPwf~~ 769 (853)
|+||||..
T Consensus 349 l~hp~f~~ 356 (440)
T PTZ00036 349 LADPFFDD 356 (440)
T ss_pred hCChhHHh
Confidence 99999964
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-42 Score=377.15 Aligned_cols=268 Identities=23% Similarity=0.400 Sum_probs=224.3
Q ss_pred eEEcCceeeEEEeEeccCceEEEEEEe-cCCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHH
Q 003052 467 FKVNGKLYQRLGKIGSGGSSEVHKVIS-SDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKA 545 (853)
Q Consensus 467 ~~v~g~~Y~ilk~LG~G~FG~Vyka~~-~~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~ 545 (853)
|..+.+.|++...||.|..++||+|+. ..+.+||||++..+..+.. ...+.+|+..|..+. ||||+.++..
T Consensus 21 ~p~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~-ld~l~kE~~~msl~~-HPNIv~~~~s------ 92 (516)
T KOG0582|consen 21 FPLNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNND-LDALRKEVQTMSLID-HPNIVTYHCS------ 92 (516)
T ss_pred CCCCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhh-HHHHHHHHHHhhhcC-CCCcceEEEE------
Confidence 455668899999999999999999987 5779999999998776544 677899999999887 9999998765
Q ss_pred HHHHHhhCCCCCCCCccccCCeEEEEEecch-hhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeC
Q 003052 546 LLREVLNGSMNNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHS 624 (853)
Q Consensus 546 iL~~l~~~~iv~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHR 624 (853)
|..+..+|+||.|+. |++.++++..+. ..|+|..++.|++++++||.|||.+|.|||
T Consensus 93 ----------------Fvv~~~LWvVmpfMa~GS~ldIik~~~~------~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHR 150 (516)
T KOG0582|consen 93 ----------------FVVDSELWVVMPFMAGGSLLDIIKTYYP------DGLEEASIATILREVLKALDYLHQNGHIHR 150 (516)
T ss_pred ----------------EEecceeEEeehhhcCCcHHHHHHHHcc------ccccHHHHHHHHHHHHHHHHHHHhcCceec
Confidence 566778999999965 699999988744 459999999999999999999999999999
Q ss_pred CCCCccEEe-ecCcEEEEecccchhcccCC-ccccc-cccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHH
Q 003052 625 DLKPANFLL-VKGSLKLIDFGIAKAIMSDT-TNIQR-DSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILY 701 (853)
Q Consensus 625 DLKPeNILL-~~g~VKL~DFGlAk~~~~~~-~~~~~-~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILy 701 (853)
|||+.|||| ++|.|||+|||.+..+.... ....+ .+++||++|||||+++.+-. .|+.|+||||||++.+
T Consensus 151 dvKAgnILi~~dG~VkLadFgvsa~l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~-------GYdfKaDIwSfGITA~ 223 (516)
T KOG0582|consen 151 DVKAGNILIDSDGTVKLADFGVSASLFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLH-------GYDFKADIWSFGITAC 223 (516)
T ss_pred ccccccEEEcCCCcEEEcCceeeeeecccCceeeEeeccccCcccccChHHhhhccc-------CccchhhhhhhhHHHH
Confidence 999999999 68999999999887665432 22223 68899999999999865432 5899999999999999
Q ss_pred HHHhCCCCCCcchhHHHHHHhhcCCCCcc-------cCCCCCChhHHHHHHHhcccCCCCCCChhHHhcCCCCCCCC
Q 003052 702 QMVYGRTPFSEYKTFWAKFKVITDPNHEI-------TYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQHPFLVPPV 771 (853)
Q Consensus 702 ELLtG~~PF~~~~~~~~~~kii~~~~~~~-------~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~HPwf~~~~ 771 (853)
||.+|..||..+.++......+....+.. ......+..++++|..||.+||.+|||+.++|+|+||+...
T Consensus 224 ELA~G~aPf~k~pPmkvLl~tLqn~pp~~~t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh~FFk~~k 300 (516)
T KOG0582|consen 224 ELAHGHAPFSKYPPMKVLLLTLQNDPPTLLTSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKHAFFKKAK 300 (516)
T ss_pred HHhcCCCCcccCChHHHHHHHhcCCCCCcccccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhccHHHhhcc
Confidence 99999999999988876666555433311 11233456799999999999999999999999999998643
|
|
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-41 Score=387.44 Aligned_cols=258 Identities=21% Similarity=0.325 Sum_probs=195.3
Q ss_pred EcCceeeEEEeEeccCceEEEEEEec-CCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcC-----CCceeEeeehhhh
Q 003052 469 VNGKLYQRLGKIGSGGSSEVHKVISS-DCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKG-----KNNIIQLIDYEVT 542 (853)
Q Consensus 469 v~g~~Y~ilk~LG~G~FG~Vyka~~~-~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~-----hpNIV~Lid~~~~ 542 (853)
+...+|+++++||+|+||+||+|.+. +++.||||+++.... ....+..|+.+++++.+ +.+|+++++++.
T Consensus 126 ~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~---~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~- 201 (467)
T PTZ00284 126 VSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPK---YTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQ- 201 (467)
T ss_pred cCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecchh---hHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEE-
Confidence 34567999999999999999999984 668899999974321 22345678888888763 345777776632
Q ss_pred HHHHHHHHhhCCCCCCCCccccCCeEEEEEecchhhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhccc-Cce
Q 003052 543 EKALLREVLNGSMNNKDGRVKDDGYIYMVLEYGEIDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHE-ERI 621 (853)
Q Consensus 543 e~~iL~~l~~~~iv~~~g~~~d~~~lyLVmEy~~gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs-~gI 621 (853)
.+..++|+|||+++++|.+++.+. +.+++..++.|+.||+.||.|||+ .||
T Consensus 202 --------------------~~~~~~~iv~~~~g~~l~~~l~~~--------~~l~~~~~~~i~~qi~~aL~yLH~~~gI 253 (467)
T PTZ00284 202 --------------------NETGHMCIVMPKYGPCLLDWIMKH--------GPFSHRHLAQIIFQTGVALDYFHTELHL 253 (467)
T ss_pred --------------------cCCceEEEEEeccCCCHHHHHHHc--------CCCCHHHHHHHHHHHHHHHHHHHhcCCe
Confidence 234578999999998998888653 579999999999999999999997 599
Q ss_pred eeCCCCCccEEeec-C----------------cEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCcc
Q 003052 622 VHSDLKPANFLLVK-G----------------SLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNI 684 (853)
Q Consensus 622 IHRDLKPeNILL~~-g----------------~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~ 684 (853)
|||||||+|||+.. + .+||+|||++..... .....+||+.|||||++.+..
T Consensus 254 iHrDlKP~NILl~~~~~~~~~~~~~~~~~~~~~vkl~DfG~~~~~~~-----~~~~~~gt~~Y~APE~~~~~~------- 321 (467)
T PTZ00284 254 MHTDLKPENILMETSDTVVDPVTNRALPPDPCRVRICDLGGCCDERH-----SRTAIVSTRHYRSPEVVLGLG------- 321 (467)
T ss_pred ecCCCCHHHEEEecCCcccccccccccCCCCceEEECCCCccccCcc-----ccccccCCccccCcHHhhcCC-------
Confidence 99999999999953 2 499999998864321 223678999999999997653
Q ss_pred ccCCCccchhhhHHHHHHHHhCCCCCCcchhHHHHH---HhhcCCC-------------------C--cccC--------
Q 003052 685 IKCGRPSDIWSLGCILYQMVYGRTPFSEYKTFWAKF---KVITDPN-------------------H--EITY-------- 732 (853)
Q Consensus 685 ~~ys~ksDIWSLGVILyELLtG~~PF~~~~~~~~~~---kii~~~~-------------------~--~~~~-------- 732 (853)
|+.++|||||||++|||++|++||.+........ +.+.... . ...+
T Consensus 322 --~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 399 (467)
T PTZ00284 322 --WMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARI 399 (467)
T ss_pred --CCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhh
Confidence 6689999999999999999999997644322111 1110000 0 0000
Q ss_pred -------CCCCChhHHHHHHHhcccCCCCCCChhHHhcCCCCCCCCC
Q 003052 733 -------EPVPNPWLLDLMKKCLAWDRNERWRIPQLLQHPFLVPPVS 772 (853)
Q Consensus 733 -------~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~HPwf~~~~~ 772 (853)
....++.+.+||.+||.+||.+|||+.|+|+||||.....
T Consensus 400 ~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~L~Hp~~~~~~~ 446 (467)
T PTZ00284 400 ARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQMTTHPYVLKYYP 446 (467)
T ss_pred hcccchhhhhchHHHHHHHHHhCCcChhhCCCHHHHhcCccccccCC
Confidence 0012355789999999999999999999999999986543
|
|
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-42 Score=362.59 Aligned_cols=260 Identities=27% Similarity=0.419 Sum_probs=202.1
Q ss_pred eeeEEEeEeccCceEEEEEEec-CCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhc--CCCceeEeeehhhhHHHHHHH
Q 003052 473 LYQRLGKIGSGGSSEVHKVISS-DCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLK--GKNNIIQLIDYEVTEKALLRE 549 (853)
Q Consensus 473 ~Y~ilk~LG~G~FG~Vyka~~~-~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~--~hpNIV~Lid~~~~e~~iL~~ 549 (853)
+|++++.||+|+||.||+|.+. +++.||+|.++...........+.+|+.+++.+. .|+||+++++++...
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~------ 74 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATS------ 74 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccc------
Confidence 4899999999999999999985 6789999999865433333345668888888875 599999999875321
Q ss_pred HhhCCCCCCCCccccCCeEEEEEecchhhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCCCc
Q 003052 550 VLNGSMNNKDGRVKDDGYIYMVLEYGEIDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPA 629 (853)
Q Consensus 550 l~~~~iv~~~g~~~d~~~lyLVmEy~~gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLKPe 629 (853)
.......+++||||+.++|.+++... ....+++..++.++.||+.||.|||++||+||||||+
T Consensus 75 -----------~~~~~~~~~lv~e~~~~~l~~~~~~~------~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~ 137 (288)
T cd07863 75 -----------RTDRETKVTLVFEHVDQDLRTYLDKV------PPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPE 137 (288)
T ss_pred -----------cCCCCceEEEEEcccccCHHHHHHhc------CCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHH
Confidence 12335578999999988888887653 2245899999999999999999999999999999999
Q ss_pred cEEe-ecCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHhCCC
Q 003052 630 NFLL-VKGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGRT 708 (853)
Q Consensus 630 NILL-~~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLtG~~ 708 (853)
|||+ .++.+||+|||+++...... ......||+.|+|||++.+. .++.++|||||||++|+|++|++
T Consensus 138 Nili~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~---------~~~~~~DiwslG~~l~~l~~g~~ 205 (288)
T cd07863 138 NILVTSGGQVKLADFGLARIYSCQM---ALTPVVVTLWYRAPEVLLQS---------TYATPVDMWSVGCIFAEMFRRKP 205 (288)
T ss_pred HEEECCCCCEEECccCccccccCcc---cCCCccccccccCchHhhCC---------CCCCcchhhhHHHHHHHHHhCCc
Confidence 9999 56799999999998664322 12346789999999999654 35679999999999999999999
Q ss_pred CCCcchhHHHHHHh---hcCCCC------------c---------ccCCCCCChhHHHHHHHhcccCCCCCCChhHHhcC
Q 003052 709 PFSEYKTFWAKFKV---ITDPNH------------E---------ITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQH 764 (853)
Q Consensus 709 PF~~~~~~~~~~ki---i~~~~~------------~---------~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~H 764 (853)
||..........++ +..+.. . ....+..+..+.+||.+||++||.+|||+.|+|.|
T Consensus 206 ~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~h 285 (288)
T cd07863 206 LFCGNSEADQLGKIFDLIGLPPEDDWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQH 285 (288)
T ss_pred CcCCCCHHHHHHHHHHHhCCCChhhCcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 99765433222221 110000 0 00112456778999999999999999999999999
Q ss_pred CCC
Q 003052 765 PFL 767 (853)
Q Consensus 765 Pwf 767 (853)
|||
T Consensus 286 p~f 288 (288)
T cd07863 286 PFF 288 (288)
T ss_pred CCC
Confidence 998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-42 Score=377.96 Aligned_cols=255 Identities=26% Similarity=0.430 Sum_probs=222.7
Q ss_pred ceeeEEEeEeccCceEEEEEEe-cCCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHHHH
Q 003052 472 KLYQRLGKIGSGGSSEVHKVIS-SDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLREV 550 (853)
Q Consensus 472 ~~Y~ilk~LG~G~FG~Vyka~~-~~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~~l 550 (853)
..|.+.+.||+|.|++|-+|++ -+|..||||+|.+...+...-..+.+|++.|+.++ |||||+||++
T Consensus 18 GLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQ-HpNiVRLYEV----------- 85 (864)
T KOG4717|consen 18 GLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQ-HPNIVRLYEV----------- 85 (864)
T ss_pred eeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhc-CcCeeeeeeh-----------
Confidence 4699999999999999999988 68999999999988877776677889999999998 9999999987
Q ss_pred hhCCCCCCCCccccCCeEEEEEecchh-hHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCCCc
Q 003052 551 LNGSMNNKDGRVKDDGYIYMVLEYGEI-DLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPA 629 (853)
Q Consensus 551 ~~~~iv~~~g~~~d~~~lyLVmEy~~g-dL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLKPe 629 (853)
......+|||+|++.+ ||+++|.++ ...++|..+++||.||+.|+.|||+.++|||||||+
T Consensus 86 -----------iDTQTKlyLiLELGD~GDl~DyImKH-------e~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPE 147 (864)
T KOG4717|consen 86 -----------IDTQTKLYLILELGDGGDLFDYIMKH-------EEGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPE 147 (864)
T ss_pred -----------hcccceEEEEEEecCCchHHHHHHhh-------hccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcc
Confidence 3456789999999775 999999875 467999999999999999999999999999999999
Q ss_pred cEEe--ecCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHhCC
Q 003052 630 NFLL--VKGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGR 707 (853)
Q Consensus 630 NILL--~~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLtG~ 707 (853)
||.+ .-|-|||.|||++..+... ...++.||+..|-|||++.|..|+. +++||||||||||-|++|+
T Consensus 148 NVVFFEKlGlVKLTDFGFSNkf~PG---~kL~TsCGSLAYSAPEILLGDsYDA--------PAVDiWSLGVILyMLVCGq 216 (864)
T KOG4717|consen 148 NVVFFEKLGLVKLTDFGFSNKFQPG---KKLTTSCGSLAYSAPEILLGDSYDA--------PAVDIWSLGVILYMLVCGQ 216 (864)
T ss_pred eeEEeeecCceEeeeccccccCCCc---chhhcccchhhccCchhhhcCccCC--------cchhhhHHHHHHHHHHhCC
Confidence 9988 4689999999999877543 3456899999999999999998874 7999999999999999999
Q ss_pred CCCCcchhHHHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCCChhHHhcCCCCCCC
Q 003052 708 TPFSEYKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQHPFLVPP 770 (853)
Q Consensus 708 ~PF~~~~~~~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~HPwf~~~ 770 (853)
+||...+.-+..-.++. -....+..++.++++||..||..||.+|.+.++|..|+|+++.
T Consensus 217 ~PFqeANDSETLTmImD---CKYtvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s~~Wlq~~ 276 (864)
T KOG4717|consen 217 PPFQEANDSETLTMIMD---CKYTVPSHVSKECRDLIQSMLVRDPKKRASLEEIVSTSWLQAG 276 (864)
T ss_pred Cccccccchhhhhhhhc---ccccCchhhhHHHHHHHHHHHhcCchhhccHHHHhccccccCC
Confidence 99987666544444432 2334567789999999999999999999999999999999864
|
|
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-42 Score=372.91 Aligned_cols=256 Identities=25% Similarity=0.417 Sum_probs=204.8
Q ss_pred eeeEEEeEeccCceEEEEEEe----cCCcEEEEEEEecCCC--ChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHH
Q 003052 473 LYQRLGKIGSGGSSEVHKVIS----SDCTIYALKKIKLKGR--DYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKAL 546 (853)
Q Consensus 473 ~Y~ilk~LG~G~FG~Vyka~~----~~g~~vAVKkik~~~~--~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~i 546 (853)
.|++++.||+|+||.||+|.. .+++.||+|++..... .......+.+|+.+|+++++|+||++++++
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~------- 73 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYA------- 73 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEE-------
Confidence 388999999999999999986 2578999999975321 223345678899999999989999999876
Q ss_pred HHHHhhCCCCCCCCccccCCeEEEEEecch-hhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCC
Q 003052 547 LREVLNGSMNNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSD 625 (853)
Q Consensus 547 L~~l~~~~iv~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRD 625 (853)
+.+++.+|+||||+. ++|.+++... ..+++..++.++.||+.||.|||++||+|||
T Consensus 74 ---------------~~~~~~~~lv~e~~~~g~L~~~l~~~--------~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrD 130 (332)
T cd05614 74 ---------------FQTEAKLHLILDYVSGGEMFTHLYQR--------DNFSEDEVRFYSGEIILALEHLHKLGIVYRD 130 (332)
T ss_pred ---------------EecCCEEEEEEeCCCCCcHHHHHHHc--------CCCCHHHHHHHHHHHHHHHHHHHHCCcEecC
Confidence 456678999999976 4888877643 5699999999999999999999999999999
Q ss_pred CCCccEEe-ecCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHH
Q 003052 626 LKPANFLL-VKGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMV 704 (853)
Q Consensus 626 LKPeNILL-~~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELL 704 (853)
|||+|||+ .++.+||+|||+++.+...... .....+||+.|||||++.+.. .++.++|||||||++|||+
T Consensus 131 lkp~Nili~~~~~~kl~DfG~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~--------~~~~~~DiwslG~il~ell 201 (332)
T cd05614 131 IKLENILLDSEGHVVLTDFGLSKEFLSEEKE-RTYSFCGTIEYMAPEIIRGKG--------GHGKAVDWWSLGILIFELL 201 (332)
T ss_pred CCHHHeEECCCCCEEEeeCcCCccccccCCC-ccccccCCccccCHHHhcCCC--------CCCCccccccchhhhhhhh
Confidence 99999999 5679999999999865432221 223568999999999997542 2567999999999999999
Q ss_pred hCCCCCCcc---hhHHHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCC-----ChhHHhcCCCCCC
Q 003052 705 YGRTPFSEY---KTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERW-----RIPQLLQHPFLVP 769 (853)
Q Consensus 705 tG~~PF~~~---~~~~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRp-----Ta~EIL~HPwf~~ 769 (853)
+|+.||... .........+.. ....++...++.+.+||.+||..||.+|| ++.++++||||..
T Consensus 202 tg~~pf~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~ 272 (332)
T cd05614 202 TGASPFTLEGERNTQSEVSRRILK--CDPPFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPFFKG 272 (332)
T ss_pred cCCCCCCCCCCCCCHHHHHHHHhc--CCCCCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcCCCcCC
Confidence 999999532 122222222221 22334556788999999999999999999 7889999999975
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-42 Score=364.50 Aligned_cols=253 Identities=26% Similarity=0.391 Sum_probs=203.1
Q ss_pred eeEEEeEeccCceEEEEEEe-cCCcEEEEEEEecCCCC-hhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHHHHh
Q 003052 474 YQRLGKIGSGGSSEVHKVIS-SDCTIYALKKIKLKGRD-YATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLREVL 551 (853)
Q Consensus 474 Y~ilk~LG~G~FG~Vyka~~-~~g~~vAVKkik~~~~~-~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~~l~ 551 (853)
|++.+.||+|+||.||+|.+ .+++.||+|++...... ......+.+|+.+++++. |+||++++++
T Consensus 2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~-~~~iv~~~~~------------ 68 (285)
T cd05631 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVN-SRFVVSLAYA------------ 68 (285)
T ss_pred ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcC-CCcEEEEEEE------------
Confidence 78899999999999999987 57899999999754322 223345789999999997 8899999876
Q ss_pred hCCCCCCCCccccCCeEEEEEecch-hhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCCCcc
Q 003052 552 NGSMNNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPAN 630 (853)
Q Consensus 552 ~~~iv~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLKPeN 630 (853)
+.+++.+|+||||+. ++|...+... ....+++..+..++.||+.||.|||++||+||||||+|
T Consensus 69 ----------~~~~~~~~lv~e~~~~g~L~~~~~~~------~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~N 132 (285)
T cd05631 69 ----------YETKDALCLVLTIMNGGDLKFHIYNM------GNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPEN 132 (285)
T ss_pred ----------EccCCeEEEEEEecCCCcHHHHHHhh------CCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHH
Confidence 455678999999976 5787766543 23468999999999999999999999999999999999
Q ss_pred EEe-ecCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHhCCCC
Q 003052 631 FLL-VKGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGRTP 709 (853)
Q Consensus 631 ILL-~~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLtG~~P 709 (853)
||+ .++.+||+|||++....... .....+||+.|+|||++.+. .|+.++|||||||++|+|++|+.|
T Consensus 133 ill~~~~~~kl~Dfg~~~~~~~~~---~~~~~~g~~~y~aPE~~~~~---------~~~~~~DvwslGvil~el~~g~~p 200 (285)
T cd05631 133 ILLDDRGHIRISDLGLAVQIPEGE---TVRGRVGTVGYMAPEVINNE---------KYTFSPDWWGLGCLIYEMIQGQSP 200 (285)
T ss_pred EEECCCCCEEEeeCCCcEEcCCCC---eecCCCCCCCccCHhhhcCC---------CCCcccCchhHHHHHHHHHhCCCC
Confidence 999 56799999999998653322 12356899999999999765 356799999999999999999999
Q ss_pred CCcchhH---HHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCCC-----hhHHhcCCCCCC
Q 003052 710 FSEYKTF---WAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWR-----IPQLLQHPFLVP 769 (853)
Q Consensus 710 F~~~~~~---~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpT-----a~EIL~HPwf~~ 769 (853)
|...... ......+. .....++...+..+.+||.+||..||.+||+ ++++++||||..
T Consensus 201 f~~~~~~~~~~~~~~~~~--~~~~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h~~~~~ 266 (285)
T cd05631 201 FRKRKERVKREEVDRRVK--EDQEEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQHPIFKN 266 (285)
T ss_pred CCCCCcchhHHHHHHHhh--cccccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcCHhhcC
Confidence 9764321 11222222 2223455667889999999999999999997 899999999975
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=380.03 Aligned_cols=257 Identities=25% Similarity=0.438 Sum_probs=202.7
Q ss_pred eeeEEEeEeccCceEEEEEEe-cCCcEEEEEEEecCCC-ChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHHHH
Q 003052 473 LYQRLGKIGSGGSSEVHKVIS-SDCTIYALKKIKLKGR-DYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLREV 550 (853)
Q Consensus 473 ~Y~ilk~LG~G~FG~Vyka~~-~~g~~vAVKkik~~~~-~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~~l 550 (853)
.|++++.||+|+||+||+|.+ .+++.||||++..... .......+.+|+.+|++++ |+||++++++
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~-h~~iv~l~~~----------- 69 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEAD-NEWVVKLYYS----------- 69 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcC-CCCeeeeEEE-----------
Confidence 488999999999999999988 5678999999976432 3344566889999999997 8999999876
Q ss_pred hhCCCCCCCCccccCCeEEEEEecch-hhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCCCc
Q 003052 551 LNGSMNNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPA 629 (853)
Q Consensus 551 ~~~~iv~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLKPe 629 (853)
+.+..++|+||||+. ++|.+++... ..+++..++.++.||+.||.|||++||+||||||+
T Consensus 70 -----------~~~~~~~~lv~E~~~gg~L~~~l~~~--------~~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~ 130 (381)
T cd05626 70 -----------FQDKDNLYFVMDYIPGGDMMSLLIRM--------EVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPD 130 (381)
T ss_pred -----------EecCCEEEEEEecCCCCcHHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHH
Confidence 456778999999975 5888887653 56899999999999999999999999999999999
Q ss_pred cEEe-ecCcEEEEecccchhcccCCc---------------------------------------------ccccccccc
Q 003052 630 NFLL-VKGSLKLIDFGIAKAIMSDTT---------------------------------------------NIQRDSQVG 663 (853)
Q Consensus 630 NILL-~~g~VKL~DFGlAk~~~~~~~---------------------------------------------~~~~~t~~G 663 (853)
|||| .++.+||+|||+++.+..... .....+.+|
T Consensus 131 Nili~~~~~~kL~DFGl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g 210 (381)
T cd05626 131 NILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVG 210 (381)
T ss_pred HEEECCCCCEEEeeCcCCcccccccccccccccccccccccCcccccccccccccccccchhhccccccccccccccccC
Confidence 9999 567999999999864311000 000124689
Q ss_pred CccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHhCCCCCCcchhHHHHHHhhcC-CCCcccCCCCCChhHHH
Q 003052 664 TLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGRTPFSEYKTFWAKFKVITD-PNHEITYEPVPNPWLLD 742 (853)
Q Consensus 664 Tp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLtG~~PF~~~~~~~~~~kii~~-~~~~~~~~~~~s~~l~d 742 (853)
|+.|+|||++.+. .|+.++|||||||++|||++|+.||..........+++.. ....+......++++++
T Consensus 211 t~~Y~aPE~~~~~---------~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~d 281 (381)
T cd05626 211 TPNYIAPEVLLRK---------GYTQLCDWWSVGVILFEMLVGQPPFLAPTPTETQLKVINWENTLHIPPQVKLSPEAVD 281 (381)
T ss_pred CccccCHHHHcCC---------CCCCccceeehhhHHHHHHhCCCCCcCCCHHHHHHHHHccccccCCCCCCCCCHHHHH
Confidence 9999999999764 3568999999999999999999999775544433333321 12222233356889999
Q ss_pred HHHHhccc--CCCCCCChhHHhcCCCCCC
Q 003052 743 LMKKCLAW--DRNERWRIPQLLQHPFLVP 769 (853)
Q Consensus 743 LI~kcL~~--DP~kRpTa~EIL~HPwf~~ 769 (853)
||.+||.. ++..|+++.++++||||..
T Consensus 282 li~~ll~~~~~~~~R~~~~~~l~hp~f~~ 310 (381)
T cd05626 282 LITKLCCSAEERLGRNGADDIKAHPFFSE 310 (381)
T ss_pred HHHHHccCcccccCCCCHHHHhcCcccCC
Confidence 99996654 5555999999999999975
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-42 Score=371.06 Aligned_cols=269 Identities=30% Similarity=0.469 Sum_probs=216.1
Q ss_pred eeeEEEeEeccCceEEEEEEe-cCCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHHHHh
Q 003052 473 LYQRLGKIGSGGSSEVHKVIS-SDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLREVL 551 (853)
Q Consensus 473 ~Y~ilk~LG~G~FG~Vyka~~-~~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~~l~ 551 (853)
.|..+++||+|+||+||+|+. .+|+.||+|++.....+........+||.+|+.|++.+||++|+|++.++..
T Consensus 12 ~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~------ 85 (323)
T KOG0594|consen 12 DYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNN------ 85 (323)
T ss_pred HHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeeccc------
Confidence 477888899999999999998 5778999999998876544555678999999999944349999998654321
Q ss_pred hCCCCCCCCccccCCeEEEEEecchhhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCCCccE
Q 003052 552 NGSMNNKDGRVKDDGYIYMVLEYGEIDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANF 631 (853)
Q Consensus 552 ~~~iv~~~g~~~d~~~lyLVmEy~~gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLKPeNI 631 (853)
+.....+|+||||...||..++....+ ....++...++.+++||+.||+|||++||+||||||+||
T Consensus 86 ----------~~~~~~l~lvfe~~d~DL~~ymd~~~~----~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNl 151 (323)
T KOG0594|consen 86 ----------HRGIGKLYLVFEFLDRDLKKYMDSLPK----KPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNL 151 (323)
T ss_pred ----------ccccceEEEEEEeecccHHHHHHhccc----cccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceE
Confidence 344568999999999999999876521 114577799999999999999999999999999999999
Q ss_pred Ee-ecCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHhCCCCC
Q 003052 632 LL-VKGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGRTPF 710 (853)
Q Consensus 632 LL-~~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLtG~~PF 710 (853)
|| ..|.+||+|||+|+.+.-+.. ..+..++|.+|+|||++.+.. .|+..+||||+|||++||+++++.|
T Consensus 152 Li~~~G~lKlaDFGlAra~~ip~~--~yt~evvTlWYRaPEvLlGs~--------~Ys~~vDiWs~GcIfaEm~~~~~LF 221 (323)
T KOG0594|consen 152 LISSSGVLKLADFGLARAFSIPMR--TYTPEVVTLWYRAPEVLLGST--------SYSTSVDIWSLGCIFAEMFTRRPLF 221 (323)
T ss_pred EECCCCcEeeeccchHHHhcCCcc--cccccEEEeeccCHHHhcCCC--------cCCCCcchHhHHHHHHHHHhCCCCC
Confidence 99 578999999999997653332 245678999999999998763 4789999999999999999999999
Q ss_pred CcchhHHH---HHHhhcCCCCcc------------cCC------------CCCChhHHHHHHHhcccCCCCCCChhHHhc
Q 003052 711 SEYKTFWA---KFKVITDPNHEI------------TYE------------PVPNPWLLDLMKKCLAWDRNERWRIPQLLQ 763 (853)
Q Consensus 711 ~~~~~~~~---~~kii~~~~~~~------------~~~------------~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~ 763 (853)
.+.....+ +++.+..+.... .++ +..++...+++.+||+++|.+|.++..+|.
T Consensus 222 pG~se~~ql~~If~~lGtP~e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~ 301 (323)
T KOG0594|consen 222 PGDSEIDQLFRIFRLLGTPNEKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALT 301 (323)
T ss_pred CCCcHHHHHHHHHHHcCCCCccCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhc
Confidence 87655544 444444432211 111 122346899999999999999999999999
Q ss_pred CCCCCCCC
Q 003052 764 HPFLVPPV 771 (853)
Q Consensus 764 HPwf~~~~ 771 (853)
||||....
T Consensus 302 h~yf~~~~ 309 (323)
T KOG0594|consen 302 HPYFSELP 309 (323)
T ss_pred Chhhcccc
Confidence 99998653
|
|
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-42 Score=376.90 Aligned_cols=256 Identities=29% Similarity=0.498 Sum_probs=204.9
Q ss_pred eeeEEEeEeccCceEEEEEEec-CCcEEEEEEEecCCC-ChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHHHH
Q 003052 473 LYQRLGKIGSGGSSEVHKVISS-DCTIYALKKIKLKGR-DYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLREV 550 (853)
Q Consensus 473 ~Y~ilk~LG~G~FG~Vyka~~~-~g~~vAVKkik~~~~-~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~~l 550 (853)
.|++++.||+|+||.||+|.+. +++.||||++..... .......+.+|+.+|+.++ |+||++++++
T Consensus 2 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~-h~~iv~~~~~----------- 69 (364)
T cd05599 2 DFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEAD-NPWVVKLYYS----------- 69 (364)
T ss_pred CceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCC-CCCCcceEEE-----------
Confidence 5899999999999999999984 678999999976422 2234456778999999997 9999999876
Q ss_pred hhCCCCCCCCccccCCeEEEEEecch-hhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCCCc
Q 003052 551 LNGSMNNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPA 629 (853)
Q Consensus 551 ~~~~iv~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLKPe 629 (853)
+.++.++|+||||+. ++|.+++... ..+++..++.|+.||+.||.|||++||+||||||+
T Consensus 70 -----------~~~~~~~~lv~E~~~~g~L~~~l~~~--------~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~ 130 (364)
T cd05599 70 -----------FQDENYLYLIMEYLPGGDMMTLLMKK--------DTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPD 130 (364)
T ss_pred -----------EEcCCeEEEEECCCCCcHHHHHHHHc--------CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHH
Confidence 567788999999975 5888887643 56999999999999999999999999999999999
Q ss_pred cEEe-ecCcEEEEecccchhcccCCcc------------------------------------ccccccccCccccCchh
Q 003052 630 NFLL-VKGSLKLIDFGIAKAIMSDTTN------------------------------------IQRDSQVGTLSYMSPEA 672 (853)
Q Consensus 630 NILL-~~g~VKL~DFGlAk~~~~~~~~------------------------------------~~~~t~~GTp~YmAPEv 672 (853)
|||+ .+|.+||+|||+++.+...... ......+||+.|+|||+
T Consensus 131 NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 210 (364)
T cd05599 131 NLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEV 210 (364)
T ss_pred HeEECCCCCEEEeecccceeccccccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHH
Confidence 9999 5679999999999764321100 01123579999999999
Q ss_pred hccCCCCCCCccccCCCccchhhhHHHHHHHHhCCCCCCcchhHHHHHHhhcCCCCcccC--CCCCChhHHHHHHHhccc
Q 003052 673 FMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGRTPFSEYKTFWAKFKVITDPNHEITY--EPVPNPWLLDLMKKCLAW 750 (853)
Q Consensus 673 l~~~~~~~~~~~~~ys~ksDIWSLGVILyELLtG~~PF~~~~~~~~~~kii~~~~~~~~~--~~~~s~~l~dLI~kcL~~ 750 (853)
+.+. .|+.++|||||||++|||++|.+||.+.........++. ......+ ....++.+++||.+||.
T Consensus 211 ~~~~---------~~~~~~DiwSlG~il~el~~G~~Pf~~~~~~~~~~~i~~-~~~~~~~~~~~~~s~~~~~li~~ll~- 279 (364)
T cd05599 211 FLQT---------GYNKECDWWSLGVIMYEMLVGYPPFCSDNPQETYRKIIN-WKETLQFPDEVPLSPEAKDLIKRLCC- 279 (364)
T ss_pred HcCC---------CCCCeeeeecchhHHHHhhcCCCCCCCCCHHHHHHHHHc-CCCccCCCCCCCCCHHHHHHHHHHcc-
Confidence 9754 357899999999999999999999987655433333322 1222222 23467889999999997
Q ss_pred CCCCCCC---hhHHhcCCCCCCC
Q 003052 751 DRNERWR---IPQLLQHPFLVPP 770 (853)
Q Consensus 751 DP~kRpT---a~EIL~HPwf~~~ 770 (853)
+|.+|++ +.++|+||||+..
T Consensus 280 ~p~~R~~~~~~~~ll~h~~~~~~ 302 (364)
T cd05599 280 EAERRLGNNGVNEIKSHPFFKGV 302 (364)
T ss_pred CHhhcCCCCCHHHHhcCCCcCCC
Confidence 9999998 9999999999753
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=374.50 Aligned_cols=259 Identities=28% Similarity=0.442 Sum_probs=211.4
Q ss_pred eeeEEEeEeccCceEEEEEEe-cCCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHHHHh
Q 003052 473 LYQRLGKIGSGGSSEVHKVIS-SDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLREVL 551 (853)
Q Consensus 473 ~Y~ilk~LG~G~FG~Vyka~~-~~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~~l~ 551 (853)
.|.-.+.+|.|+||.||+|.. .+++.+|||++..+.+. . -+|+++|++++ |||||+|+-++....
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~-k-----nrEl~im~~l~-HpNIV~L~~~f~~~~------- 90 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRY-K-----NRELQIMRKLD-HPNIVRLLYFFSSST------- 90 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCc-C-----cHHHHHHHhcC-CcCeeeEEEEEEecC-------
Confidence 488899999999999999987 45689999999766542 1 27999999887 999999998764311
Q ss_pred hCCCCCCCCccccCCeEEEEEecchhhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCCCccE
Q 003052 552 NGSMNNKDGRVKDDGYIYMVLEYGEIDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANF 631 (853)
Q Consensus 552 ~~~iv~~~g~~~d~~~lyLVmEy~~gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLKPeNI 631 (853)
-.+.-++.+||||++.+|.+.++... ..+..++...++.|++||++||.|||+.||+||||||.||
T Consensus 91 ----------~~d~~~lnlVleymP~tL~~~~r~~~----~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNl 156 (364)
T KOG0658|consen 91 ----------ESDEVYLNLVLEYMPETLYRVIRHYT----RANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNL 156 (364)
T ss_pred ----------CCchhHHHHHHHhchHHHHHHHHHHh----hcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheE
Confidence 01244778999999999999887532 2457799999999999999999999999999999999999
Q ss_pred Eee--cCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHhCCCC
Q 003052 632 LLV--KGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGRTP 709 (853)
Q Consensus 632 LL~--~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLtG~~P 709 (853)
|++ .|.+||||||.|+.+..+..+. ++..|.+|+|||++.|.. .|+.++||||+||++.||+-|++.
T Consensus 157 LvD~~tg~LKicDFGSAK~L~~~epni---SYicSRyYRaPELifga~--------~Yt~~IDiWSaGCV~aELl~g~pl 225 (364)
T KOG0658|consen 157 LVDPDTGVLKICDFGSAKVLVKGEPNI---SYICSRYYRAPELIFGAT--------EYTTSIDIWSAGCVMAELLKGQPL 225 (364)
T ss_pred EEcCCCCeEEeccCCcceeeccCCCce---eEEEeccccCHHHHcCcc--------ccCceeEEhhhhHHHHHHhcCCcc
Confidence 994 5899999999999987766553 788999999999998753 589999999999999999999999
Q ss_pred CCcch---hHHHHHHhhcCCCCc----------------c-------cCCCCCChhHHHHHHHhcccCCCCCCChhHHhc
Q 003052 710 FSEYK---TFWAKFKVITDPNHE----------------I-------TYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQ 763 (853)
Q Consensus 710 F~~~~---~~~~~~kii~~~~~~----------------~-------~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~ 763 (853)
|.+.. ++.++.+++..+..+ + .+....++++.+|+.++|.++|.+|.++.|+|.
T Consensus 226 FpG~s~~dQL~eIik~lG~Pt~e~I~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~ 305 (364)
T KOG0658|consen 226 FPGDSSVDQLVEIIKVLGTPTREDIKSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALA 305 (364)
T ss_pred cCCCCHHHHHHHHHHHhCCCCHHHHhhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhc
Confidence 97653 334444444332211 0 123456788999999999999999999999999
Q ss_pred CCCCCCC
Q 003052 764 HPFLVPP 770 (853)
Q Consensus 764 HPwf~~~ 770 (853)
||||...
T Consensus 306 h~fFdel 312 (364)
T KOG0658|consen 306 HPFFDEL 312 (364)
T ss_pred chhhHHh
Confidence 9999653
|
|
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-42 Score=375.68 Aligned_cols=259 Identities=26% Similarity=0.402 Sum_probs=207.2
Q ss_pred ceeeEEEeEeccCceEEEEEEecC-CcEEEEEEEecCCCC-hhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHHH
Q 003052 472 KLYQRLGKIGSGGSSEVHKVISSD-CTIYALKKIKLKGRD-YATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLRE 549 (853)
Q Consensus 472 ~~Y~ilk~LG~G~FG~Vyka~~~~-g~~vAVKkik~~~~~-~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~~ 549 (853)
+.|++++.||.|.-|+||+|...+ +..+|+|++.+.... .....+...|-+||..+. ||-++.|
T Consensus 77 ~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lD-HPFlPTL------------- 142 (459)
T KOG0610|consen 77 RHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLD-HPFLPTL------------- 142 (459)
T ss_pred HHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcC-CCccchh-------------
Confidence 569999999999999999999854 489999999865322 223334445666666655 5555555
Q ss_pred HhhCCCCCCCCccccCCeEEEEEecchh-hHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCCC
Q 003052 550 VLNGSMNNKDGRVKDDGYIYMVLEYGEI-DLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKP 628 (853)
Q Consensus 550 l~~~~iv~~~g~~~d~~~lyLVmEy~~g-dL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLKP 628 (853)
+..|+.+.++|+|||||.| +|..++++. .+..|+|..+++|+.+++.||+|||-.|||+|||||
T Consensus 143 ---------Ya~fet~~~~cl~meyCpGGdL~~LrqkQ------p~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKP 207 (459)
T KOG0610|consen 143 ---------YASFETDKYSCLVMEYCPGGDLHSLRQKQ------PGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKP 207 (459)
T ss_pred ---------hheeeccceeEEEEecCCCccHHHHHhhC------CCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCc
Confidence 4558889999999999875 777666554 678999999999999999999999999999999999
Q ss_pred ccEEe-ecCcEEEEecccchhccc---------------------------------CCc--------------------
Q 003052 629 ANFLL-VKGSLKLIDFGIAKAIMS---------------------------------DTT-------------------- 654 (853)
Q Consensus 629 eNILL-~~g~VKL~DFGlAk~~~~---------------------------------~~~-------------------- 654 (853)
||||| .+|+|.|+||.++..... ...
T Consensus 208 ENILvredGHIMLsDFDLS~~~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep 287 (459)
T KOG0610|consen 208 ENILVREDGHIMLSDFDLSLRCPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEP 287 (459)
T ss_pred ceeEEecCCcEEeeeccccccCCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCC
Confidence 99999 789999999999854211 000
Q ss_pred -cccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHhCCCCCCcchhHHHHHHhhcCCCCcccCC
Q 003052 655 -NIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGRTPFSEYKTFWAKFKVITDPNHEITYE 733 (853)
Q Consensus 655 -~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLtG~~PF~~~~~~~~~~kii~~~~~~~~~~ 733 (853)
......++||-.|+|||++.|.. .+.++|||+|||+|||||+|..||.+.+.......++.. ...+...
T Consensus 288 ~~~RSnSFVGThEYlAPEvI~G~G---------HgsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~-~l~Fp~~ 357 (459)
T KOG0610|consen 288 TGARSNSFVGTHEYLAPEVIRGEG---------HGSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQ-PLKFPEE 357 (459)
T ss_pred CCccccccccccccccceeeecCC---------CCchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcC-CCcCCCC
Confidence 01113578999999999999875 457999999999999999999999988776666666654 3344444
Q ss_pred CCCChhHHHHHHHhcccCCCCCCC----hhHHhcCCCCCC
Q 003052 734 PVPNPWLLDLMKKCLAWDRNERWR----IPQLLQHPFLVP 769 (853)
Q Consensus 734 ~~~s~~l~dLI~kcL~~DP~kRpT----a~EIL~HPwf~~ 769 (853)
+..+..++|||+++|.+||.+|.. +.||-+||||+.
T Consensus 358 ~~vs~~akDLIr~LLvKdP~kRlg~~rGA~eIK~HpFF~g 397 (459)
T KOG0610|consen 358 PEVSSAAKDLIRKLLVKDPSKRLGSKRGAAEIKRHPFFEG 397 (459)
T ss_pred CcchhHHHHHHHHHhccChhhhhccccchHHhhcCccccC
Confidence 466788999999999999999998 999999999975
|
|
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=375.93 Aligned_cols=255 Identities=26% Similarity=0.412 Sum_probs=200.8
Q ss_pred eeeEEEeEeccCceEEEEEEec-CCcEEEEEEEecCCC-ChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHHHH
Q 003052 473 LYQRLGKIGSGGSSEVHKVISS-DCTIYALKKIKLKGR-DYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLREV 550 (853)
Q Consensus 473 ~Y~ilk~LG~G~FG~Vyka~~~-~g~~vAVKkik~~~~-~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~~l 550 (853)
+|++++.||+|+||+||+|.+. +++.||||++..... .......+.+|+.++.+++ |+||+++++.
T Consensus 2 ~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~-~~~iv~~~~~----------- 69 (363)
T cd05628 2 DFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEAD-SLWVVKMFYS----------- 69 (363)
T ss_pred CceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCC-CCCcceEEEE-----------
Confidence 5899999999999999999884 678999999975432 2233456778999999997 8999999876
Q ss_pred hhCCCCCCCCccccCCeEEEEEecch-hhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCCCc
Q 003052 551 LNGSMNNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPA 629 (853)
Q Consensus 551 ~~~~iv~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLKPe 629 (853)
+.+...+|+||||+. ++|.+++... ..+++..++.++.||+.||.|||++||+||||||+
T Consensus 70 -----------~~~~~~~~lv~E~~~gg~L~~~l~~~--------~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~ 130 (363)
T cd05628 70 -----------FQDKLNLYLIMEFLPGGDMMTLLMKK--------DTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPD 130 (363)
T ss_pred -----------EecCCeEEEEEcCCCCCcHHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHH
Confidence 566778999999976 5888888653 57999999999999999999999999999999999
Q ss_pred cEEe-ecCcEEEEecccchhcccCCcc---------------------------------ccccccccCccccCchhhcc
Q 003052 630 NFLL-VKGSLKLIDFGIAKAIMSDTTN---------------------------------IQRDSQVGTLSYMSPEAFMC 675 (853)
Q Consensus 630 NILL-~~g~VKL~DFGlAk~~~~~~~~---------------------------------~~~~t~~GTp~YmAPEvl~~ 675 (853)
|||+ .++.+||+|||+|+.+...... ......+||+.|+|||++.+
T Consensus 131 NILi~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~ 210 (363)
T cd05628 131 NLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQ 210 (363)
T ss_pred HeEECCCCCEEEeeccCcccccccccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcC
Confidence 9999 5679999999999764321100 00124689999999999976
Q ss_pred CCCCCCCccccCCCccchhhhHHHHHHHHhCCCCCCcchhHHHHHHhhcCCCCcccCC--CCCChhHHHHHHHhcccCCC
Q 003052 676 NESDENGNIIKCGRPSDIWSLGCILYQMVYGRTPFSEYKTFWAKFKVITDPNHEITYE--PVPNPWLLDLMKKCLAWDRN 753 (853)
Q Consensus 676 ~~~~~~~~~~~ys~ksDIWSLGVILyELLtG~~PF~~~~~~~~~~kii~~~~~~~~~~--~~~s~~l~dLI~kcL~~DP~ 753 (853)
.. |+.++|||||||++|||++|+.||.+........++.. ......++ ...++.+++||.+|+. +|.
T Consensus 211 ~~---------~~~~~DvwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~-~~~~~~~p~~~~~s~~~~~li~~l~~-~~~ 279 (363)
T cd05628 211 TG---------YNKLCDWWSLGVIMYEMLIGYPPFCSETPQETYKKVMN-WKETLIFPPEVPISEKAKDLILRFCC-EWE 279 (363)
T ss_pred CC---------CCCchhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHc-CcCcccCCCcCCCCHHHHHHHHHHcC-Chh
Confidence 53 56799999999999999999999987554433333322 11222222 2467889999999876 444
Q ss_pred ---CCCChhHHhcCCCCCC
Q 003052 754 ---ERWRIPQLLQHPFLVP 769 (853)
Q Consensus 754 ---kRpTa~EIL~HPwf~~ 769 (853)
.||++.||++||||..
T Consensus 280 ~r~~r~~~~ei~~hp~f~~ 298 (363)
T cd05628 280 HRIGAPGVEEIKTNPFFEG 298 (363)
T ss_pred hcCCCCCHHHHhCCCCCCC
Confidence 4589999999999975
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-41 Score=369.23 Aligned_cols=253 Identities=23% Similarity=0.325 Sum_probs=205.7
Q ss_pred eeeEEEeEeccCceEEEEEEec-CCcEEEEEEEecCCC-ChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHHHH
Q 003052 473 LYQRLGKIGSGGSSEVHKVISS-DCTIYALKKIKLKGR-DYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLREV 550 (853)
Q Consensus 473 ~Y~ilk~LG~G~FG~Vyka~~~-~g~~vAVKkik~~~~-~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~~l 550 (853)
.|++++.||+|+||.||+|.+. +++.||||++..... .......+..|+.++..+.+|++|++++++
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~----------- 69 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSC----------- 69 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEE-----------
Confidence 3889999999999999999985 568899999976422 223445678899999999988888888765
Q ss_pred hhCCCCCCCCccccCCeEEEEEecch-hhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCCCc
Q 003052 551 LNGSMNNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPA 629 (853)
Q Consensus 551 ~~~~iv~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLKPe 629 (853)
+.+.+.+|+||||+. ++|...+... ..+++..++.++.||+.||.|||++||+||||||+
T Consensus 70 -----------~~~~~~~~lv~E~~~~g~L~~~~~~~--------~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~ 130 (324)
T cd05587 70 -----------FQTMDRLYFVMEYVNGGDLMYHIQQV--------GKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLD 130 (324)
T ss_pred -----------EEcCCEEEEEEcCCCCCcHHHHHHHc--------CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHH
Confidence 456678999999975 5888777543 56899999999999999999999999999999999
Q ss_pred cEEe-ecCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHhCCC
Q 003052 630 NFLL-VKGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGRT 708 (853)
Q Consensus 630 NILL-~~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLtG~~ 708 (853)
|||+ .++.+||+|||+++....... .....+||+.|+|||++.+.. |+.++|||||||++|+|++|+.
T Consensus 131 Nill~~~~~~kL~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~---------~~~~~DiwslGvil~elltG~~ 199 (324)
T cd05587 131 NVMLDAEGHIKIADFGMCKENIFGGK--TTRTFCGTPDYIAPEIIAYQP---------YGKSVDWWAFGVLLYEMLAGQP 199 (324)
T ss_pred HeEEcCCCCEEEeecCcceecCCCCC--ceeeecCCccccChhhhcCCC---------CCcccchhhhHHHHHHHHhCCC
Confidence 9999 567999999999875432221 223568999999999997653 5679999999999999999999
Q ss_pred CCCcchhHHHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCh-----hHHhcCCCCCC
Q 003052 709 PFSEYKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRI-----PQLLQHPFLVP 769 (853)
Q Consensus 709 PF~~~~~~~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa-----~EIL~HPwf~~ 769 (853)
||.+......... +.. ....++...+..+.+||.+||.+||.+|++. .++++||||..
T Consensus 200 pf~~~~~~~~~~~-i~~--~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~hp~~~~ 262 (324)
T cd05587 200 PFDGEDEDELFQS-IME--HNVSYPKSLSKEAVSICKGLLTKHPAKRLGCGPTGERDIREHAFFRR 262 (324)
T ss_pred CCCCCCHHHHHHH-HHc--CCCCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCCcCC
Confidence 9976554333322 222 2334566788899999999999999999986 89999999975
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=375.96 Aligned_cols=251 Identities=25% Similarity=0.399 Sum_probs=206.9
Q ss_pred CceeeEEEeEeccCceEEEEEEecC--CcEEEEEEEecCCC-ChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHH
Q 003052 471 GKLYQRLGKIGSGGSSEVHKVISSD--CTIYALKKIKLKGR-DYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALL 547 (853)
Q Consensus 471 g~~Y~ilk~LG~G~FG~Vyka~~~~--g~~vAVKkik~~~~-~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL 547 (853)
-+.|.+++.||+|+||.||+|.+.. +..||+|++..... .......+.+|+.+++.++ ||||++++++
T Consensus 29 ~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~Iv~~~~~-------- 99 (340)
T PTZ00426 29 YEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYIN-HPFCVNLYGS-------- 99 (340)
T ss_pred hhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCC-CCCCcceEEE--------
Confidence 3569999999999999999998643 36899999975422 2234456789999999997 8999999886
Q ss_pred HHHhhCCCCCCCCccccCCeEEEEEecch-hhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCC
Q 003052 548 REVLNGSMNNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDL 626 (853)
Q Consensus 548 ~~l~~~~iv~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDL 626 (853)
+.+.+++|+||||+. ++|.+++... ..+++..++.++.||+.||.|||++||+||||
T Consensus 100 --------------~~~~~~~~lv~Ey~~~g~L~~~i~~~--------~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDL 157 (340)
T PTZ00426 100 --------------FKDESYLYLVLEFVIGGEFFTFLRRN--------KRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDL 157 (340)
T ss_pred --------------EEeCCEEEEEEeCCCCCcHHHHHHHc--------CCCCHHHHHHHHHHHHHHHHHHHHCCeEccCC
Confidence 456778999999975 5888887643 56999999999999999999999999999999
Q ss_pred CCccEEe-ecCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHh
Q 003052 627 KPANFLL-VKGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVY 705 (853)
Q Consensus 627 KPeNILL-~~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLt 705 (853)
||+|||+ .++.+||+|||+++..... ..+.+||+.|||||++.+.. ++.++|||||||++|||++
T Consensus 158 kp~NILl~~~~~ikL~DFG~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~---------~~~~~DiwSlGvil~ell~ 223 (340)
T PTZ00426 158 KPENLLLDKDGFIKMTDFGFAKVVDTR-----TYTLCGTPEYIAPEILLNVG---------HGKAADWWTLGIFIYEILV 223 (340)
T ss_pred CHHHEEECCCCCEEEecCCCCeecCCC-----cceecCChhhcCHHHHhCCC---------CCccccccchhhHHHHHhc
Confidence 9999999 5679999999999865322 23568999999999997643 5679999999999999999
Q ss_pred CCCCCCcchhHHHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCC-----ChhHHhcCCCCCC
Q 003052 706 GRTPFSEYKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERW-----RIPQLLQHPFLVP 769 (853)
Q Consensus 706 G~~PF~~~~~~~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRp-----Ta~EIL~HPwf~~ 769 (853)
|.+||.+.........+.. ....++...++.+++||++||..||.+|+ ++.++++||||..
T Consensus 224 G~~Pf~~~~~~~~~~~i~~---~~~~~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~hp~f~~ 289 (340)
T PTZ00426 224 GCPPFYANEPLLIYQKILE---GIIYFPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEHPWFGN 289 (340)
T ss_pred CCCCCCCCCHHHHHHHHhc---CCCCCCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcCCCcCC
Confidence 9999987655443333332 22345666788999999999999999996 8999999999975
|
|
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=374.99 Aligned_cols=259 Identities=26% Similarity=0.415 Sum_probs=202.9
Q ss_pred ceeeEEEeEeccCceEEEEEEe-cCCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHHHH
Q 003052 472 KLYQRLGKIGSGGSSEVHKVIS-SDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLREV 550 (853)
Q Consensus 472 ~~Y~ilk~LG~G~FG~Vyka~~-~~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~~l 550 (853)
++|++++.||+|+||.||+|.+ .++..||||++............+.+|+.+++.++ |+||+++++++...
T Consensus 21 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~------- 92 (359)
T cd07876 21 KRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVN-HKNIISLLNVFTPQ------- 92 (359)
T ss_pred hceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCC-CCCEeeeeeeeccC-------
Confidence 5699999999999999999998 46789999999866555555667889999999997 89999999875322
Q ss_pred hhCCCCCCCCccccCCeEEEEEecchhhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCCCcc
Q 003052 551 LNGSMNNKDGRVKDDGYIYMVLEYGEIDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPAN 630 (853)
Q Consensus 551 ~~~~iv~~~g~~~d~~~lyLVmEy~~gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLKPeN 630 (853)
..+.....+|+||||++++|...+.. .+++..+..++.||+.||.|||++||+||||||+|
T Consensus 93 ---------~~~~~~~~~~lv~e~~~~~l~~~~~~----------~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~N 153 (359)
T cd07876 93 ---------KSLEEFQDVYLVMELMDANLCQVIHM----------ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSN 153 (359)
T ss_pred ---------CCccccceeEEEEeCCCcCHHHHHhc----------cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHH
Confidence 11234456899999999888776632 48899999999999999999999999999999999
Q ss_pred EEe-ecCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHhCCCC
Q 003052 631 FLL-VKGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGRTP 709 (853)
Q Consensus 631 ILL-~~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLtG~~P 709 (853)
||+ .+|.+||+|||+++...... ......||+.|+|||++.+.. |+.++|||||||++|+|++|+.|
T Consensus 154 Il~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~---------~~~~~DiwSlG~il~el~tg~~p 221 (359)
T cd07876 154 IVVKSDCTLKILDFGLARTACTNF---MMTPYVVTRYYRAPEVILGMG---------YKENVDIWSVGCIMGELVKGSVI 221 (359)
T ss_pred EEECCCCCEEEecCCCccccccCc---cCCCCcccCCCCCchhccCCC---------CCcchhhHHHHHHHHHHHhCCCC
Confidence 999 56799999999997653321 223568999999999997653 56799999999999999999999
Q ss_pred CCcchhHHHHH---HhhcC--------------------CCCc-c---------------cCCCCCChhHHHHHHHhccc
Q 003052 710 FSEYKTFWAKF---KVITD--------------------PNHE-I---------------TYEPVPNPWLLDLMKKCLAW 750 (853)
Q Consensus 710 F~~~~~~~~~~---kii~~--------------------~~~~-~---------------~~~~~~s~~l~dLI~kcL~~ 750 (853)
|.+.+...... +.+.. +... . ......+..+++||.+||..
T Consensus 222 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~ 301 (359)
T cd07876 222 FQGTDHIDQWNKVIEQLGTPSAEFMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVI 301 (359)
T ss_pred CCCCCHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhcc
Confidence 97543321111 00000 0000 0 00112356789999999999
Q ss_pred CCCCCCChhHHhcCCCCCC
Q 003052 751 DRNERWRIPQLLQHPFLVP 769 (853)
Q Consensus 751 DP~kRpTa~EIL~HPwf~~ 769 (853)
||.+|||+.|+|+||||..
T Consensus 302 dP~~R~t~~e~l~hp~~~~ 320 (359)
T cd07876 302 DPDKRISVDEALRHPYITV 320 (359)
T ss_pred CcccCCCHHHHhcCchhhh
Confidence 9999999999999999974
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=372.00 Aligned_cols=256 Identities=29% Similarity=0.481 Sum_probs=206.2
Q ss_pred eeeEEEeEeccCceEEEEEEec-CCcEEEEEEEecCCCC-hhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHHHH
Q 003052 473 LYQRLGKIGSGGSSEVHKVISS-DCTIYALKKIKLKGRD-YATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLREV 550 (853)
Q Consensus 473 ~Y~ilk~LG~G~FG~Vyka~~~-~g~~vAVKkik~~~~~-~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~~l 550 (853)
+|.+++.||+|+||.||+|.+. +++.||||+++..... ......+.+|+.++..+. |+||++++++
T Consensus 2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~-~~~i~~~~~~----------- 69 (350)
T cd05573 2 DFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADAD-SPWIVKLYYS----------- 69 (350)
T ss_pred CceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcC-CCCccchhhh-----------
Confidence 5999999999999999999985 7789999999764321 134456788999999997 8999998765
Q ss_pred hhCCCCCCCCccccCCeEEEEEecch-hhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCCCc
Q 003052 551 LNGSMNNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPA 629 (853)
Q Consensus 551 ~~~~iv~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLKPe 629 (853)
+.+++++|+||||+. ++|.+++... ..+++..++.++.||+.||.|||++||+||||||+
T Consensus 70 -----------~~~~~~~~lv~e~~~~~~L~~~l~~~--------~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~ 130 (350)
T cd05573 70 -----------FQDEEHLYLVMEYMPGGDLMNLLIRK--------DVFPEETARFYIAELVLALDSVHKLGFIHRDIKPD 130 (350)
T ss_pred -----------eecCCeEEEEEcCCCCCCHHHHHHHc--------CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHH
Confidence 566788999999975 5888887653 57999999999999999999999999999999999
Q ss_pred cEEe-ecCcEEEEecccchhcccCC---------------------------ccccccccccCccccCchhhccCCCCCC
Q 003052 630 NFLL-VKGSLKLIDFGIAKAIMSDT---------------------------TNIQRDSQVGTLSYMSPEAFMCNESDEN 681 (853)
Q Consensus 630 NILL-~~g~VKL~DFGlAk~~~~~~---------------------------~~~~~~t~~GTp~YmAPEvl~~~~~~~~ 681 (853)
|||+ .++.+||+|||+++...... ........+||+.|+|||++.+.
T Consensus 131 NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----- 205 (350)
T cd05573 131 NILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGT----- 205 (350)
T ss_pred HeEECCCCCEEeecCCCCccCcccCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCC-----
Confidence 9999 56799999999998664332 00122356799999999999765
Q ss_pred CccccCCCccchhhhHHHHHHHHhCCCCCCcchhHHHHHHhhcC-CCCcccCCCCCChhHHHHHHHhcccCCCCCCC-hh
Q 003052 682 GNIIKCGRPSDIWSLGCILYQMVYGRTPFSEYKTFWAKFKVITD-PNHEITYEPVPNPWLLDLMKKCLAWDRNERWR-IP 759 (853)
Q Consensus 682 ~~~~~ys~ksDIWSLGVILyELLtG~~PF~~~~~~~~~~kii~~-~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpT-a~ 759 (853)
.++.++|||||||++|+|++|+.||..........++... ....+......++++.+||.+||. ||.+|++ +.
T Consensus 206 ----~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~ 280 (350)
T cd05573 206 ----PYGLECDWWSLGVILYEMLYGFPPFYSDTLQETYNKIINWKESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFE 280 (350)
T ss_pred ----CCCCceeeEecchhhhhhccCCCCCCCCCHHHHHHHHhccCCcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHH
Confidence 3568999999999999999999999876544333333221 112222223358899999999997 9999999 99
Q ss_pred HHhcCCCCCC
Q 003052 760 QLLQHPFLVP 769 (853)
Q Consensus 760 EIL~HPwf~~ 769 (853)
++|+||||..
T Consensus 281 ~ll~hp~~~~ 290 (350)
T cd05573 281 EIKSHPFFKG 290 (350)
T ss_pred HHhcCCCcCC
Confidence 9999999975
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-41 Score=377.38 Aligned_cols=256 Identities=26% Similarity=0.436 Sum_probs=203.5
Q ss_pred eeeEEEeEeccCceEEEEEEe-cCCcEEEEEEEecCCC-ChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHHHH
Q 003052 473 LYQRLGKIGSGGSSEVHKVIS-SDCTIYALKKIKLKGR-DYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLREV 550 (853)
Q Consensus 473 ~Y~ilk~LG~G~FG~Vyka~~-~~g~~vAVKkik~~~~-~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~~l 550 (853)
+|.++++||+|+||.||+|.+ .+++.||+|++..... .......+.+|+.+|+++. |+||+++++.
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~-h~~iv~~~~~----------- 69 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEAD-NEWVVRLYYS----------- 69 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCC-CCcCCeEEEE-----------
Confidence 489999999999999999998 4678999999975432 2334456889999999997 8999999876
Q ss_pred hhCCCCCCCCccccCCeEEEEEecch-hhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCCCc
Q 003052 551 LNGSMNNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPA 629 (853)
Q Consensus 551 ~~~~iv~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLKPe 629 (853)
|.++.++|+||||+. ++|.+++... ..+++..++.++.||+.||.|||++||+||||||+
T Consensus 70 -----------~~~~~~~~lv~E~~~gg~L~~~l~~~--------~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~ 130 (382)
T cd05625 70 -----------FQDKDNLYFVMDYIPGGDMMSLLIRM--------GIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPD 130 (382)
T ss_pred -----------EEeCCEEEEEEeCCCCCcHHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHH
Confidence 566778999999976 5888887543 46899999999999999999999999999999999
Q ss_pred cEEe-ecCcEEEEecccchhcccCCc---------------------------------------------ccccccccc
Q 003052 630 NFLL-VKGSLKLIDFGIAKAIMSDTT---------------------------------------------NIQRDSQVG 663 (853)
Q Consensus 630 NILL-~~g~VKL~DFGlAk~~~~~~~---------------------------------------------~~~~~t~~G 663 (853)
|||+ .+|.+||+|||+|+.+..... .......+|
T Consensus 131 NILl~~~g~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g 210 (382)
T cd05625 131 NILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVG 210 (382)
T ss_pred HEEECCCCCEEEeECCCCccccccccccccccccccccccccccccccccccccccccccchhhhhcccccccccccccc
Confidence 9999 568999999999864311000 000124589
Q ss_pred CccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHhCCCCCCcchhHHHHHHhhcC-CCCcccCCCCCChhHHH
Q 003052 664 TLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGRTPFSEYKTFWAKFKVITD-PNHEITYEPVPNPWLLD 742 (853)
Q Consensus 664 Tp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLtG~~PF~~~~~~~~~~kii~~-~~~~~~~~~~~s~~l~d 742 (853)
|+.|+|||++.+.. |+.++|||||||++|||++|++||..........+++.. ...........++++.+
T Consensus 211 t~~Y~aPE~~~~~~---------~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~ 281 (382)
T cd05625 211 TPNYIAPEVLLRTG---------YTQLCDWWSVGVILYEMLVGQPPFLAQTPLETQMKVINWQTSLHIPPQAKLSPEASD 281 (382)
T ss_pred CcccCCHHHhcCCC---------CCCeeeEEechHHHHHHHhCCCCCCCCCHHHHHHHHHccCCCcCCCCcccCCHHHHH
Confidence 99999999997653 567999999999999999999999876555444444321 11222223456889999
Q ss_pred HHHHhcccCCCCCCC---hhHHhcCCCCCC
Q 003052 743 LMKKCLAWDRNERWR---IPQLLQHPFLVP 769 (853)
Q Consensus 743 LI~kcL~~DP~kRpT---a~EIL~HPwf~~ 769 (853)
||.+|+ .||.+|++ +.++++||||..
T Consensus 282 li~~l~-~~p~~R~~~~~~~ei~~hp~f~~ 310 (382)
T cd05625 282 LIIKLC-RGPEDRLGKNGADEIKAHPFFKT 310 (382)
T ss_pred HHHHHc-cCHhHcCCCCCHHHHhcCCCcCC
Confidence 999976 59999997 999999999975
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-41 Score=367.48 Aligned_cols=246 Identities=27% Similarity=0.421 Sum_probs=200.3
Q ss_pred EeccCceEEEEEEec-CCcEEEEEEEecCCC-ChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHHHHhhCCCCC
Q 003052 480 IGSGGSSEVHKVISS-DCTIYALKKIKLKGR-DYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLREVLNGSMNN 557 (853)
Q Consensus 480 LG~G~FG~Vyka~~~-~g~~vAVKkik~~~~-~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~~l~~~~iv~ 557 (853)
||+|+||.||+|.+. +++.||+|+++.... .......+.+|+.+|++++ |+||++++++
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~------------------ 61 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVN-CPFIVPLKFS------------------ 61 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCC-CCcEeceeeE------------------
Confidence 799999999999985 578999999975422 2334456789999999996 8999999875
Q ss_pred CCCccccCCeEEEEEecch-hhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCCCccEEe-ec
Q 003052 558 KDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLL-VK 635 (853)
Q Consensus 558 ~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLKPeNILL-~~ 635 (853)
+.+.+.+|+||||+. ++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||+ .+
T Consensus 62 ----~~~~~~~~lv~e~~~~g~L~~~l~~~--------~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~~ 129 (312)
T cd05585 62 ----FQSPEKLYLVLAFINGGELFHHLQRE--------GRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQ 129 (312)
T ss_pred ----EecCCeEEEEEcCCCCCcHHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEECCC
Confidence 456678999999976 5888887643 568999999999999999999999999999999999999 56
Q ss_pred CcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHhCCCCCCcchh
Q 003052 636 GSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGRTPFSEYKT 715 (853)
Q Consensus 636 g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLtG~~PF~~~~~ 715 (853)
+.+||+|||+++....... .....+||+.|+|||++.+. .|+.++|||||||++|+|++|+.||.+...
T Consensus 130 ~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~---------~~~~~~DvwslGvil~el~tg~~pf~~~~~ 198 (312)
T cd05585 130 GHIALCDFGLCKLNMKDDD--KTNTFCGTPEYLAPELLLGH---------GYTKAVDWWTLGVLLYEMLTGLPPFYDENV 198 (312)
T ss_pred CcEEEEECcccccCccCCC--ccccccCCcccCCHHHHcCC---------CCCCccceechhHHHHHHHhCCCCcCCCCH
Confidence 7999999999986433221 22356899999999999765 356899999999999999999999976544
Q ss_pred HHHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCC---ChhHHhcCCCCCCC
Q 003052 716 FWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERW---RIPQLLQHPFLVPP 770 (853)
Q Consensus 716 ~~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRp---Ta~EIL~HPwf~~~ 770 (853)
......+.. ....++...++.+++||.+||..||.+|| ++.++|+||||...
T Consensus 199 ~~~~~~~~~---~~~~~~~~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~hp~~~~~ 253 (312)
T cd05585 199 NEMYRKILQ---EPLRFPDGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKNHPFFSQL 253 (312)
T ss_pred HHHHHHHHc---CCCCCCCcCCHHHHHHHHHHcCCCHHHcCCCCCHHHHHcCCCcCCC
Confidence 333223322 23345667888999999999999999997 57999999999753
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-41 Score=377.35 Aligned_cols=255 Identities=25% Similarity=0.446 Sum_probs=200.7
Q ss_pred eeeEEEeEeccCceEEEEEEe-cCCcEEEEEEEecCCC-ChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHHHH
Q 003052 473 LYQRLGKIGSGGSSEVHKVIS-SDCTIYALKKIKLKGR-DYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLREV 550 (853)
Q Consensus 473 ~Y~ilk~LG~G~FG~Vyka~~-~~g~~vAVKkik~~~~-~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~~l 550 (853)
.|+++++||+|+||.||+|.+ .+++.||||++..... .......+.+|+++++++. |+||++++++
T Consensus 2 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~-hp~iv~~~~~----------- 69 (377)
T cd05629 2 DFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESD-SPWVVSLYYS----------- 69 (377)
T ss_pred CceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCC-CCCcceEEEE-----------
Confidence 589999999999999999988 5778999999975422 2234456788999999987 8999999886
Q ss_pred hhCCCCCCCCccccCCeEEEEEecch-hhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCCCc
Q 003052 551 LNGSMNNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPA 629 (853)
Q Consensus 551 ~~~~iv~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLKPe 629 (853)
|.++.++|+||||+. ++|.+++... ..+++..++.|+.||+.||+|||++||+||||||+
T Consensus 70 -----------~~~~~~~~lv~E~~~gg~L~~~l~~~--------~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~ 130 (377)
T cd05629 70 -----------FQDAQYLYLIMEFLPGGDLMTMLIKY--------DTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPD 130 (377)
T ss_pred -----------EEcCCeeEEEEeCCCCCcHHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHH
Confidence 566778999999975 6888887643 56899999999999999999999999999999999
Q ss_pred cEEe-ecCcEEEEecccchhcccCCcc---------------------------------------------cccccccc
Q 003052 630 NFLL-VKGSLKLIDFGIAKAIMSDTTN---------------------------------------------IQRDSQVG 663 (853)
Q Consensus 630 NILL-~~g~VKL~DFGlAk~~~~~~~~---------------------------------------------~~~~t~~G 663 (853)
|||+ .++.+||+|||+|+.+...... ......+|
T Consensus 131 NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g 210 (377)
T cd05629 131 NILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVG 210 (377)
T ss_pred HEEECCCCCEEEeecccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCC
Confidence 9999 5679999999999643210000 00013579
Q ss_pred CccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHhCCCCCCcchhHHHHHHhhcCCCCcccCC--CCCChhHH
Q 003052 664 TLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGRTPFSEYKTFWAKFKVITDPNHEITYE--PVPNPWLL 741 (853)
Q Consensus 664 Tp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLtG~~PF~~~~~~~~~~kii~~~~~~~~~~--~~~s~~l~ 741 (853)
|+.|+|||++.+. .|+.++|||||||++|||++|.+||........ +..+......+.++ ...+.+++
T Consensus 211 t~~y~aPE~~~~~---------~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~-~~~i~~~~~~~~~p~~~~~s~~~~ 280 (377)
T cd05629 211 TPDYIAPEIFLQQ---------GYGQECDWWSLGAIMFECLIGWPPFCSENSHET-YRKIINWRETLYFPDDIHLSVEAE 280 (377)
T ss_pred CccccCHHHHccC---------CCCCceeeEecchhhhhhhcCCCCCCCCCHHHH-HHHHHccCCccCCCCCCCCCHHHH
Confidence 9999999999765 367899999999999999999999976544332 22222212222223 24678899
Q ss_pred HHHHHhcccCCCCC---CChhHHhcCCCCCC
Q 003052 742 DLMKKCLAWDRNER---WRIPQLLQHPFLVP 769 (853)
Q Consensus 742 dLI~kcL~~DP~kR---pTa~EIL~HPwf~~ 769 (853)
+||.+||. +|.+| +++.+++.||||..
T Consensus 281 dli~~lL~-~~~~r~~r~~~~~~l~hp~~~~ 310 (377)
T cd05629 281 DLIRRLIT-NAENRLGRGGAHEIKSHPFFRG 310 (377)
T ss_pred HHHHHHhc-CHhhcCCCCCHHHHhcCCCcCC
Confidence 99999998 77765 59999999999974
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-41 Score=370.32 Aligned_cols=252 Identities=29% Similarity=0.463 Sum_probs=204.2
Q ss_pred eeeEEEeEeccCceEEEEEEec-CCcEEEEEEEecCCC-ChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHHHH
Q 003052 473 LYQRLGKIGSGGSSEVHKVISS-DCTIYALKKIKLKGR-DYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLREV 550 (853)
Q Consensus 473 ~Y~ilk~LG~G~FG~Vyka~~~-~g~~vAVKkik~~~~-~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~~l 550 (853)
.|+++++||+|+||.||+|.+. +++.||||+++.... .......+.+|+.++..+. |+||++++++
T Consensus 2 ~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~-h~~iv~~~~~----------- 69 (333)
T cd05600 2 DFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTK-SEWLVKLLYA----------- 69 (333)
T ss_pred CcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCC-CCCCccEEEE-----------
Confidence 5999999999999999999985 578999999976432 2234456789999999998 9999999876
Q ss_pred hhCCCCCCCCccccCCeEEEEEecch-hhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCCCc
Q 003052 551 LNGSMNNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPA 629 (853)
Q Consensus 551 ~~~~iv~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLKPe 629 (853)
+.+..++|+||||+. ++|.+++... ..+++..++.++.||+.||.|||++||+||||||+
T Consensus 70 -----------~~~~~~~~lv~e~~~g~~L~~~l~~~--------~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~ 130 (333)
T cd05600 70 -----------FQDDEYLYLAMEYVPGGDFRTLLNNL--------GVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPE 130 (333)
T ss_pred -----------EEcCCEEEEEEeCCCCCCHHHHHHHc--------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHH
Confidence 566778999999975 5898888643 56899999999999999999999999999999999
Q ss_pred cEEe-ecCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHhCCC
Q 003052 630 NFLL-VKGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGRT 708 (853)
Q Consensus 630 NILL-~~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLtG~~ 708 (853)
|||+ .++.+||+|||+++.... .....+||+.|+|||++.+. .|+.++|||||||++|||++|..
T Consensus 131 Nil~~~~~~~kL~Dfg~a~~~~~-----~~~~~~gt~~y~aPE~~~~~---------~~~~~~DvwslG~il~ell~g~~ 196 (333)
T cd05600 131 NFLIDASGHIKLTDFGLSKGIVT-----YANSVVGSPDYMAPEVLRGK---------GYDFTVDYWSLGCMLYEFLCGFP 196 (333)
T ss_pred HEEECCCCCEEEEeCcCCccccc-----ccCCcccCccccChhHhcCC---------CCCCccceecchHHHhhhhhCCC
Confidence 9999 567999999999986543 22356899999999999765 35689999999999999999999
Q ss_pred CCCcchhHHHHHHhhcCCCCcccC------CCCCChhHHHHHHHhcccCCCCCCChhHHhcCCCCCCC
Q 003052 709 PFSEYKTFWAKFKVITDPNHEITY------EPVPNPWLLDLMKKCLAWDRNERWRIPQLLQHPFLVPP 770 (853)
Q Consensus 709 PF~~~~~~~~~~kii~~~~~~~~~------~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~HPwf~~~ 770 (853)
||...........+ ......... ....+.++.+||.+||..+|.+||++.++++||||...
T Consensus 197 pf~~~~~~~~~~~i-~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h~~~~~~ 263 (333)
T cd05600 197 PFSGSTPNETWENL-KYWKETLQRPVYDDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNHPFFKEV 263 (333)
T ss_pred CCCCCCHHHHHHHH-HhccccccCCCCCccccccCHHHHHHHHHHhhChhhhcCCHHHHHhCcccCCC
Confidence 99764432221111 110111111 12457889999999999999999999999999999753
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-41 Score=372.43 Aligned_cols=259 Identities=27% Similarity=0.415 Sum_probs=203.9
Q ss_pred ceeeEEEeEeccCceEEEEEEe-cCCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHHHH
Q 003052 472 KLYQRLGKIGSGGSSEVHKVIS-SDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLREV 550 (853)
Q Consensus 472 ~~Y~ilk~LG~G~FG~Vyka~~-~~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~~l 550 (853)
++|++.+.||+|+||.||+|.+ ..++.||||++............+.+|+.+++.++ |+||+++++++....
T Consensus 24 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~ii~~~~~~~~~~------ 96 (364)
T cd07875 24 KRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVN-HKNIIGLLNVFTPQK------ 96 (364)
T ss_pred cceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcC-CCCccccceeecccc------
Confidence 5699999999999999999998 46788999999866555555567889999999997 899999988653221
Q ss_pred hhCCCCCCCCccccCCeEEEEEecchhhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCCCcc
Q 003052 551 LNGSMNNKDGRVKDDGYIYMVLEYGEIDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPAN 630 (853)
Q Consensus 551 ~~~~iv~~~g~~~d~~~lyLVmEy~~gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLKPeN 630 (853)
.+.....+|+||||++++|...+.. .+++..++.++.||+.||.|||++||+||||||+|
T Consensus 97 ----------~~~~~~~~~lv~e~~~~~l~~~~~~----------~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~N 156 (364)
T cd07875 97 ----------SLEEFQDVYIVMELMDANLCQVIQM----------ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSN 156 (364)
T ss_pred ----------cccccCeEEEEEeCCCCCHHHHHHh----------cCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHH
Confidence 2344567899999999888877642 47899999999999999999999999999999999
Q ss_pred EEe-ecCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHhCCCC
Q 003052 631 FLL-VKGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGRTP 709 (853)
Q Consensus 631 ILL-~~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLtG~~P 709 (853)
||+ .++.+||+|||+++...... ......||+.|+|||++.+.. ++.++|||||||++|+|++|+.|
T Consensus 157 Ill~~~~~~kL~DfG~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~---------~~~~~DiwSlG~il~ell~g~~p 224 (364)
T cd07875 157 IVVKSDCTLKILDFGLARTAGTSF---MMTPYVVTRYYRAPEVILGMG---------YKENVDIWSVGCIMGEMIKGGVL 224 (364)
T ss_pred EEECCCCcEEEEeCCCccccCCCC---cccCCcccCCcCCHHHHhCCC---------CCchhhHHhHHHHHHHHHhCCCC
Confidence 999 56799999999998653321 223568999999999997653 56799999999999999999999
Q ss_pred CCcchhHHHHHHhhcC---CC------------------Cc------------c------cCCCCCChhHHHHHHHhccc
Q 003052 710 FSEYKTFWAKFKVITD---PN------------------HE------------I------TYEPVPNPWLLDLMKKCLAW 750 (853)
Q Consensus 710 F~~~~~~~~~~kii~~---~~------------------~~------------~------~~~~~~s~~l~dLI~kcL~~ 750 (853)
|.+.+......+++.. +. .. . ......+..+++||.+||..
T Consensus 225 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~ 304 (364)
T cd07875 225 FPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVI 304 (364)
T ss_pred CCCCCHHHHHHHHHHhcCCCCHHHHHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCc
Confidence 9765443222221110 00 00 0 00111245689999999999
Q ss_pred CCCCCCChhHHhcCCCCCC
Q 003052 751 DRNERWRIPQLLQHPFLVP 769 (853)
Q Consensus 751 DP~kRpTa~EIL~HPwf~~ 769 (853)
||.+|||+.++|+||||..
T Consensus 305 dP~~R~t~~e~L~hp~~~~ 323 (364)
T cd07875 305 DASKRISVDEALQHPYINV 323 (364)
T ss_pred CcccCCCHHHHhcCccccc
Confidence 9999999999999999975
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-41 Score=367.87 Aligned_cols=248 Identities=25% Similarity=0.391 Sum_probs=201.6
Q ss_pred EeEeccCceEEEEEEec-CCcEEEEEEEecCCC-ChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHHHHhhCCC
Q 003052 478 GKIGSGGSSEVHKVISS-DCTIYALKKIKLKGR-DYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLREVLNGSM 555 (853)
Q Consensus 478 k~LG~G~FG~Vyka~~~-~g~~vAVKkik~~~~-~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~~l~~~~i 555 (853)
+.||+|+||.||+|.+. +++.||||+++.... .......+..|+.++..+.+|+||++++++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~---------------- 64 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCC---------------- 64 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeE----------------
Confidence 36999999999999984 678999999975421 223345677899999988889999999876
Q ss_pred CCCCCccccCCeEEEEEecch-hhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCCCccEEe-
Q 003052 556 NNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLL- 633 (853)
Q Consensus 556 v~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLKPeNILL- 633 (853)
+.+...+|+||||+. ++|...+... ..+++..++.++.||+.||.|||++||+||||||+|||+
T Consensus 65 ------~~~~~~~~iv~Ey~~~g~L~~~i~~~--------~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~ 130 (320)
T cd05590 65 ------FQTPDRLFFVMEFVNGGDLMFHIQKS--------RRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLD 130 (320)
T ss_pred ------EEcCCEEEEEEcCCCCchHHHHHHHc--------CCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEEC
Confidence 556778999999976 5888777543 569999999999999999999999999999999999999
Q ss_pred ecCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHhCCCCCCcc
Q 003052 634 VKGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGRTPFSEY 713 (853)
Q Consensus 634 ~~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLtG~~PF~~~ 713 (853)
.++.+||+|||+++....... .....+||+.|+|||++.+. .|+.++|||||||++|+|++|+.||...
T Consensus 131 ~~~~~kL~DfG~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~---------~~~~~~DiwslG~il~el~~g~~Pf~~~ 199 (320)
T cd05590 131 HEGHCKLADFGMCKEGIFNGK--TTSTFCGTPDYIAPEILQEM---------LYGPSVDWWAMGVLLYEMLCGHAPFEAE 199 (320)
T ss_pred CCCcEEEeeCCCCeecCcCCC--cccccccCccccCHHHHcCC---------CCCCccchhhhHHHHHHHhhCCCCCCCC
Confidence 567999999999876432221 22356899999999999754 3567999999999999999999999775
Q ss_pred hhHHHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCh------hHHhcCCCCCC
Q 003052 714 KTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRI------PQLLQHPFLVP 769 (853)
Q Consensus 714 ~~~~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa------~EIL~HPwf~~ 769 (853)
..... ...+.. ....++...+.++.+||.+||.+||.+|+++ .++++||||..
T Consensus 200 ~~~~~-~~~i~~--~~~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~~~~h~~f~~ 258 (320)
T cd05590 200 NEDDL-FEAILN--DEVVYPTWLSQDAVDILKAFMTKNPTMRLGSLTLGGEEAILRHPFFKE 258 (320)
T ss_pred CHHHH-HHHHhc--CCCCCCCCCCHHHHHHHHHHcccCHHHCCCCCCCCCHHHHHcCCCcCC
Confidence 54332 333322 2234556678899999999999999999998 99999999965
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-41 Score=365.70 Aligned_cols=253 Identities=23% Similarity=0.326 Sum_probs=205.8
Q ss_pred eeeEEEeEeccCceEEEEEEec-CCcEEEEEEEecCCC-ChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHHHH
Q 003052 473 LYQRLGKIGSGGSSEVHKVISS-DCTIYALKKIKLKGR-DYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLREV 550 (853)
Q Consensus 473 ~Y~ilk~LG~G~FG~Vyka~~~-~g~~vAVKkik~~~~-~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~~l 550 (853)
+|.+++.||+|+||.||+|.+. +++.||||+++.... .......+..|+.++..+.+|++|++++++
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~----------- 69 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSC----------- 69 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEE-----------
Confidence 3889999999999999999985 568999999986432 222334567889999998889999998875
Q ss_pred hhCCCCCCCCccccCCeEEEEEecch-hhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCCCc
Q 003052 551 LNGSMNNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPA 629 (853)
Q Consensus 551 ~~~~iv~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLKPe 629 (853)
+.+.+.+|+||||+. ++|...+... ..+++..++.++.||+.||.|||++||+||||||+
T Consensus 70 -----------~~~~~~~~lv~E~~~~g~L~~~~~~~--------~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~ 130 (323)
T cd05616 70 -----------FQTMDRLYFVMEYVNGGDLMYQIQQV--------GRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLD 130 (323)
T ss_pred -----------EecCCEEEEEEcCCCCCCHHHHHHHc--------CCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHH
Confidence 456678999999975 5888777543 56899999999999999999999999999999999
Q ss_pred cEEe-ecCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHhCCC
Q 003052 630 NFLL-VKGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGRT 708 (853)
Q Consensus 630 NILL-~~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLtG~~ 708 (853)
|||+ .++.+||+|||+++....... .....+||+.|+|||++.+.. |+.++|||||||++|||++|+.
T Consensus 131 Nill~~~~~~kL~DfG~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~---------~~~~~DiwSlGvil~elltg~~ 199 (323)
T cd05616 131 NVMLDSEGHIKIADFGMCKENMWDGV--TTKTFCGTPDYIAPEIIAYQP---------YGKSVDWWAFGVLLYEMLAGQA 199 (323)
T ss_pred HeEECCCCcEEEccCCCceecCCCCC--ccccCCCChhhcCHHHhcCCC---------CCCccchhchhHHHHHHHhCCC
Confidence 9999 567999999999975432221 223578999999999997653 5689999999999999999999
Q ss_pred CCCcchhHHHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCh-----hHHhcCCCCCC
Q 003052 709 PFSEYKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRI-----PQLLQHPFLVP 769 (853)
Q Consensus 709 PF~~~~~~~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa-----~EIL~HPwf~~ 769 (853)
||.+.........+.. ....++...+.++.+||.+||.+||.+|++. .++++||||..
T Consensus 200 Pf~~~~~~~~~~~i~~---~~~~~p~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h~~~~~ 262 (323)
T cd05616 200 PFEGEDEDELFQSIME---HNVAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRY 262 (323)
T ss_pred CCCCCCHHHHHHHHHh---CCCCCCCcCCHHHHHHHHHHcccCHHhcCCCCCCCHHHHhcCCCcCC
Confidence 9987654433333322 2334566788999999999999999999984 89999999974
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-41 Score=374.23 Aligned_cols=260 Identities=30% Similarity=0.488 Sum_probs=207.6
Q ss_pred CceeeEEEeEeccCceEEEEEEec-CCcEEEEEEEecCCC-ChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHH
Q 003052 471 GKLYQRLGKIGSGGSSEVHKVISS-DCTIYALKKIKLKGR-DYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLR 548 (853)
Q Consensus 471 g~~Y~ilk~LG~G~FG~Vyka~~~-~g~~vAVKkik~~~~-~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~ 548 (853)
.+.|+++++||+|+||.||+|.+. +++.||+|++..... .......+.+|+.+++.++ |+||++++++
T Consensus 42 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~-h~~iv~~~~~--------- 111 (370)
T cd05596 42 AEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHAN-SEWIVQLHYA--------- 111 (370)
T ss_pred HHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCC-CCCcceEEEE---------
Confidence 356999999999999999999984 678999999975321 2223345678999999987 8999999876
Q ss_pred HHhhCCCCCCCCccccCCeEEEEEecch-hhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCC
Q 003052 549 EVLNGSMNNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLK 627 (853)
Q Consensus 549 ~l~~~~iv~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLK 627 (853)
+.++.++|+||||+. ++|.+++.. ..+++.+++.++.||+.||.|||++||+|||||
T Consensus 112 -------------~~~~~~~~lv~Ey~~gg~L~~~l~~---------~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLk 169 (370)
T cd05596 112 -------------FQDDKYLYMVMEYMPGGDLVNLMSN---------YDIPEKWARFYTAEVVLALDAIHSMGFIHRDVK 169 (370)
T ss_pred -------------EecCCEEEEEEcCCCCCcHHHHHHh---------cCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCC
Confidence 566778999999975 588887753 358999999999999999999999999999999
Q ss_pred CccEEe-ecCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHhC
Q 003052 628 PANFLL-VKGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYG 706 (853)
Q Consensus 628 PeNILL-~~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLtG 706 (853)
|+|||+ .++.+||+|||+++....... ......+||+.|+|||++.+.... ..++.++|||||||++|||++|
T Consensus 170 p~NILl~~~~~~kL~DfG~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~-----~~~~~~~DiwSlGvilyelltG 243 (370)
T cd05596 170 PDNMLLDKSGHLKLADFGTCMKMDANGM-VRCDTAVGTPDYISPEVLKSQGGD-----GYYGRECDWWSVGVFLYEMLVG 243 (370)
T ss_pred HHHEEEcCCCCEEEEeccceeeccCCCc-ccCCCCCCCcCeECHHHhccCCCC-----CCCCCceeeeehhHHHHHHHhC
Confidence 999999 568999999999986543221 122356899999999999764321 2477899999999999999999
Q ss_pred CCCCCcchhHHHHHHhhcCCCCcccCC--CCCChhHHHHHHHhcccCCCC--CCChhHHhcCCCCCC
Q 003052 707 RTPFSEYKTFWAKFKVITDPNHEITYE--PVPNPWLLDLMKKCLAWDRNE--RWRIPQLLQHPFLVP 769 (853)
Q Consensus 707 ~~PF~~~~~~~~~~kii~~~~~~~~~~--~~~s~~l~dLI~kcL~~DP~k--RpTa~EIL~HPwf~~ 769 (853)
++||.+.........+. .......++ ...+.++++||.+||..+|.+ |+++.++++||||..
T Consensus 244 ~~Pf~~~~~~~~~~~i~-~~~~~~~~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h~~~~~ 309 (370)
T cd05596 244 DTPFYADSLVGTYSKIM-DHKNSLTFPDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSHPFFKN 309 (370)
T ss_pred CCCcCCCCHHHHHHHHH-cCCCcCCCCCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcCcccCC
Confidence 99998755433333332 222223333 356889999999999999998 999999999999975
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-41 Score=376.32 Aligned_cols=256 Identities=25% Similarity=0.428 Sum_probs=202.3
Q ss_pred eeeEEEeEeccCceEEEEEEe-cCCcEEEEEEEecCCC-ChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHHHH
Q 003052 473 LYQRLGKIGSGGSSEVHKVIS-SDCTIYALKKIKLKGR-DYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLREV 550 (853)
Q Consensus 473 ~Y~ilk~LG~G~FG~Vyka~~-~~g~~vAVKkik~~~~-~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~~l 550 (853)
.|+++++||+|+||.||+|.+ .+++.||||++..... .......+.+|+.+|+++. |+||+++++.
T Consensus 2 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~-h~~iv~~~~~----------- 69 (376)
T cd05598 2 MFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEAD-NEWVVKLYYS----------- 69 (376)
T ss_pred CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCC-CCCcceEEEE-----------
Confidence 499999999999999999998 4678999999965321 1223445779999999997 8999999876
Q ss_pred hhCCCCCCCCccccCCeEEEEEecch-hhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCCCc
Q 003052 551 LNGSMNNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPA 629 (853)
Q Consensus 551 ~~~~iv~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLKPe 629 (853)
|.+++++|+||||+. ++|.+++... ..+++..++.++.||+.||+|||++||+||||||+
T Consensus 70 -----------~~~~~~~~lv~E~~~~g~L~~~i~~~--------~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~ 130 (376)
T cd05598 70 -----------FQDKDNLYFVMDYIPGGDMMSLLIRL--------GIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPD 130 (376)
T ss_pred -----------EEcCCEEEEEEeCCCCCcHHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHH
Confidence 566788999999985 5898888653 56899999999999999999999999999999999
Q ss_pred cEEe-ecCcEEEEecccchhcccCC-----------------------------------------ccccccccccCccc
Q 003052 630 NFLL-VKGSLKLIDFGIAKAIMSDT-----------------------------------------TNIQRDSQVGTLSY 667 (853)
Q Consensus 630 NILL-~~g~VKL~DFGlAk~~~~~~-----------------------------------------~~~~~~t~~GTp~Y 667 (853)
|||+ .++.+||+|||+|..+.... ........+||+.|
T Consensus 131 Nill~~~~~ikL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y 210 (376)
T cd05598 131 NILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNY 210 (376)
T ss_pred HEEECCCCCEEEEeCCCCccccccccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccc
Confidence 9999 56799999999985331000 00011245899999
Q ss_pred cCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHhCCCCCCcchhHHHHHHhhcC-CCCcccCCCCCChhHHHHHHH
Q 003052 668 MSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGRTPFSEYKTFWAKFKVITD-PNHEITYEPVPNPWLLDLMKK 746 (853)
Q Consensus 668 mAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLtG~~PF~~~~~~~~~~kii~~-~~~~~~~~~~~s~~l~dLI~k 746 (853)
||||++.+.. ++.++|||||||++|||++|+.||.+.........+... ...........++.+.+||.+
T Consensus 211 ~aPE~~~~~~---------~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ 281 (376)
T cd05598 211 IAPEVLLRTG---------YTQLCDWWSVGVILYEMLVGQPPFLADTPAETQLKVINWETTLHIPSQAKLSREASDLILR 281 (376)
T ss_pred cCHHHHcCCC---------CCcceeeeeccceeeehhhCCCCCCCCCHHHHHHHHhccCccccCCCCCCCCHHHHHHHHH
Confidence 9999997653 567999999999999999999999876554333333221 122222334578889999999
Q ss_pred hcccCCCCCC---ChhHHhcCCCCCC
Q 003052 747 CLAWDRNERW---RIPQLLQHPFLVP 769 (853)
Q Consensus 747 cL~~DP~kRp---Ta~EIL~HPwf~~ 769 (853)
|+ .+|.+|+ ++.++++||||..
T Consensus 282 l~-~~p~~R~~~~t~~ell~h~~~~~ 306 (376)
T cd05598 282 LC-CGAEDRLGKNGADEIKAHPFFKG 306 (376)
T ss_pred Hh-cCHhhcCCCCCHHHHhCCCCcCC
Confidence 76 5999999 9999999999975
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-41 Score=368.49 Aligned_cols=247 Identities=27% Similarity=0.420 Sum_probs=200.3
Q ss_pred EeEeccCceEEEEEEe-cCCcEEEEEEEecCCC-ChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHHHHhhCCC
Q 003052 478 GKIGSGGSSEVHKVIS-SDCTIYALKKIKLKGR-DYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLREVLNGSM 555 (853)
Q Consensus 478 k~LG~G~FG~Vyka~~-~~g~~vAVKkik~~~~-~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~~l~~~~i 555 (853)
+.||+|+||.||+|.+ .+++.||+|++..... .......+.+|+.+|+.+. |+||++++++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~---------------- 63 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTR-HPFLTSLKYS---------------- 63 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCC-CCCCcceEEE----------------
Confidence 3699999999999998 4678999999976432 2234456789999999997 8999998765
Q ss_pred CCCCCccccCCeEEEEEecch-hhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCCCccEEe-
Q 003052 556 NNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLL- 633 (853)
Q Consensus 556 v~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLKPeNILL- 633 (853)
+.++..+|+||||+. ++|...+... ..+++..++.++.||+.||.|||++||+||||||+|||+
T Consensus 64 ------~~~~~~~~lv~Ey~~~g~L~~~l~~~--------~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~ 129 (328)
T cd05593 64 ------FQTKDRLCFVMEYVNGGELFFHLSRE--------RVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLD 129 (328)
T ss_pred ------EEcCCEEEEEEeCCCCCCHHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEEC
Confidence 566778999999976 4777766542 569999999999999999999999999999999999999
Q ss_pred ecCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHhCCCCCCcc
Q 003052 634 VKGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGRTPFSEY 713 (853)
Q Consensus 634 ~~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLtG~~PF~~~ 713 (853)
.++.+||+|||+++....... .....+||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.
T Consensus 130 ~~~~~kL~DfG~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~---------~~~~~~DiwslGvil~elltG~~Pf~~~ 198 (328)
T cd05593 130 KDGHIKITDFGLCKEGITDAA--TMKTFCGTPEYLAPEVLEDN---------DYGRAVDWWGLGVVMYEMMCGRLPFYNQ 198 (328)
T ss_pred CCCcEEEecCcCCccCCCccc--ccccccCCcCccChhhhcCC---------CCCccCCccccchHHHHHhhCCCCCCCC
Confidence 567999999999986432221 22356899999999999754 3568999999999999999999999765
Q ss_pred hhHHHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCC-----ChhHHhcCCCCCC
Q 003052 714 KTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERW-----RIPQLLQHPFLVP 769 (853)
Q Consensus 714 ~~~~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRp-----Ta~EIL~HPwf~~ 769 (853)
.... ....+.. ....++...++++.+||.+||.+||.+|+ ++.++++||||..
T Consensus 199 ~~~~-~~~~~~~--~~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~~~~~ 256 (328)
T cd05593 199 DHEK-LFELILM--EDIKFPRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRHSFFTG 256 (328)
T ss_pred CHHH-HHHHhcc--CCccCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcCCCcCC
Confidence 4332 2222222 23345667889999999999999999997 8999999999965
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-41 Score=371.54 Aligned_cols=260 Identities=27% Similarity=0.394 Sum_probs=203.5
Q ss_pred ceeeEEEeEeccCceEEEEEEe-cCCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHHHH
Q 003052 472 KLYQRLGKIGSGGSSEVHKVIS-SDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLREV 550 (853)
Q Consensus 472 ~~Y~ilk~LG~G~FG~Vyka~~-~~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~~l 550 (853)
++|++++.||+|+||.||+|.+ ..++.||||++............+.+|+.+++.++ |+||+++++++....
T Consensus 17 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~------ 89 (355)
T cd07874 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVN-HKNIISLLNVFTPQK------ 89 (355)
T ss_pred hceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhC-CCchhceeeeeeccc------
Confidence 5699999999999999999988 46788999999876555555667889999999997 899999998753221
Q ss_pred hhCCCCCCCCccccCCeEEEEEecchhhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCCCcc
Q 003052 551 LNGSMNNKDGRVKDDGYIYMVLEYGEIDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPAN 630 (853)
Q Consensus 551 ~~~~iv~~~g~~~d~~~lyLVmEy~~gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLKPeN 630 (853)
.+.....+|+||||++++|.+.+.. .+++..++.++.||+.||.|||++||+||||||+|
T Consensus 90 ----------~~~~~~~~~lv~e~~~~~l~~~~~~----------~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~N 149 (355)
T cd07874 90 ----------SLEEFQDVYLVMELMDANLCQVIQM----------ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSN 149 (355)
T ss_pred ----------cccccceeEEEhhhhcccHHHHHhh----------cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHH
Confidence 1234456899999999888777642 48899999999999999999999999999999999
Q ss_pred EEe-ecCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHhCCCC
Q 003052 631 FLL-VKGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGRTP 709 (853)
Q Consensus 631 ILL-~~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLtG~~P 709 (853)
||+ .++.+||+|||+++...... .....+||+.|+|||++.+.. |+.++|||||||++|+|++|+.|
T Consensus 150 ill~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~---------~~~~~DiwslG~il~el~~g~~p 217 (355)
T cd07874 150 IVVKSDCTLKILDFGLARTAGTSF---MMTPYVVTRYYRAPEVILGMG---------YKENVDIWSVGCIMGEMVRHKIL 217 (355)
T ss_pred EEECCCCCEEEeeCcccccCCCcc---ccCCccccCCccCHHHHcCCC---------CCchhhHHHHHHHHHHHHhCCCC
Confidence 999 56799999999998653321 223568999999999997653 56799999999999999999999
Q ss_pred CCcchhHHHHHHhh---cCC------------------CCc------------------ccCCCCCChhHHHHHHHhccc
Q 003052 710 FSEYKTFWAKFKVI---TDP------------------NHE------------------ITYEPVPNPWLLDLMKKCLAW 750 (853)
Q Consensus 710 F~~~~~~~~~~kii---~~~------------------~~~------------------~~~~~~~s~~l~dLI~kcL~~ 750 (853)
|.+..........+ ..+ ... .......+..+++||.+||..
T Consensus 218 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~ 297 (355)
T cd07874 218 FPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVI 297 (355)
T ss_pred CCCCCHHHHHHHHHHHhCCCCHHHHHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcC
Confidence 97643222111110 000 000 001112345689999999999
Q ss_pred CCCCCCChhHHhcCCCCCCC
Q 003052 751 DRNERWRIPQLLQHPFLVPP 770 (853)
Q Consensus 751 DP~kRpTa~EIL~HPwf~~~ 770 (853)
||.+|||+.|+|+||||...
T Consensus 298 dP~~Rps~~ell~hp~~~~~ 317 (355)
T cd07874 298 DPAKRISVDEALQHPYINVW 317 (355)
T ss_pred CchhcCCHHHHhcCcchhcc
Confidence 99999999999999999754
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-41 Score=367.54 Aligned_cols=247 Identities=26% Similarity=0.414 Sum_probs=199.6
Q ss_pred EeEeccCceEEEEEEe-cCCcEEEEEEEecCCC-ChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHHHHhhCCC
Q 003052 478 GKIGSGGSSEVHKVIS-SDCTIYALKKIKLKGR-DYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLREVLNGSM 555 (853)
Q Consensus 478 k~LG~G~FG~Vyka~~-~~g~~vAVKkik~~~~-~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~~l~~~~i 555 (853)
+.||+|+||.||++.+ .++..||+|+++.... .......+.+|++++++++ ||||++++++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~i~~~~~~---------------- 63 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTR-HPFLTALKYA---------------- 63 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCC-CCCCcceeeE----------------
Confidence 3699999999999998 4678999999976432 2233456778999999997 8999998765
Q ss_pred CCCCCccccCCeEEEEEecch-hhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCCCccEEe-
Q 003052 556 NNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLL- 633 (853)
Q Consensus 556 v~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLKPeNILL- 633 (853)
|....++|+||||++ ++|...+... ..+++..++.++.||+.||.|||++||+||||||+|||+
T Consensus 64 ------~~~~~~~~lv~E~~~~~~L~~~l~~~--------~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~ 129 (323)
T cd05595 64 ------FQTHDRLCFVMEYANGGELFFHLSRE--------RVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLD 129 (323)
T ss_pred ------EecCCEEEEEEeCCCCCcHHHHHHHc--------CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEc
Confidence 456678999999976 5787776543 568999999999999999999999999999999999999
Q ss_pred ecCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHhCCCCCCcc
Q 003052 634 VKGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGRTPFSEY 713 (853)
Q Consensus 634 ~~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLtG~~PF~~~ 713 (853)
.++.+||+|||+++....... .....+||+.|+|||++.+. .++.++|||||||++|+|++|+.||...
T Consensus 130 ~~~~~kL~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~---------~~~~~~DiwSlGvil~ell~g~~Pf~~~ 198 (323)
T cd05595 130 KDGHIKITDFGLCKEGISDGA--TMKTFCGTPEYLAPEVLEDN---------DYGRAVDWWGLGVVMYEMMCGRLPFYNQ 198 (323)
T ss_pred CCCCEEecccHHhccccCCCC--ccccccCCcCcCCcccccCC---------CCCchhchhhhHHHHHHHHhCCCCCCCC
Confidence 567999999999986433221 22356899999999999755 3568999999999999999999999765
Q ss_pred hhHHHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCC-----ChhHHhcCCCCCC
Q 003052 714 KTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERW-----RIPQLLQHPFLVP 769 (853)
Q Consensus 714 ~~~~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRp-----Ta~EIL~HPwf~~ 769 (853)
...... ..+.. ....++...++.+.+||.+||.+||.+|+ ++.++++||||..
T Consensus 199 ~~~~~~-~~~~~--~~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h~~~~~ 256 (323)
T cd05595 199 DHERLF-ELILM--EEIRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLS 256 (323)
T ss_pred CHHHHH-HHHhc--CCCCCCCCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcCCCcCC
Confidence 443222 22221 22345567789999999999999999998 8999999999975
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-41 Score=367.65 Aligned_cols=249 Identities=28% Similarity=0.408 Sum_probs=200.0
Q ss_pred EeEeccCceEEEEEEec-CCcEEEEEEEecCCC-ChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHHHHhhCCC
Q 003052 478 GKIGSGGSSEVHKVISS-DCTIYALKKIKLKGR-DYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLREVLNGSM 555 (853)
Q Consensus 478 k~LG~G~FG~Vyka~~~-~g~~vAVKkik~~~~-~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~~l~~~~i 555 (853)
+.||+|+||.||+|.+. +++.||||+++.... .......+.+|+.+++++.+|+||++++++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~---------------- 64 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSC---------------- 64 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEE----------------
Confidence 36999999999999984 678999999986532 233445678999999999889999999876
Q ss_pred CCCCCccccCCeEEEEEecch-hhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCCCccEEe-
Q 003052 556 NNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLL- 633 (853)
Q Consensus 556 v~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLKPeNILL- 633 (853)
|.+...+|+||||++ ++|..++... ..+++..++.|+.||+.||.|||++||+||||||+|||+
T Consensus 65 ------~~~~~~~~lv~e~~~~g~L~~~~~~~--------~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~ 130 (329)
T cd05588 65 ------FQTESRLFFVIEFVSGGDLMFHMQRQ--------RKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLD 130 (329)
T ss_pred ------EEcCCEEEEEEeCCCCCCHHHHHHHc--------CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEC
Confidence 566778999999976 4887776543 579999999999999999999999999999999999999
Q ss_pred ecCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHhCCCCCCcc
Q 003052 634 VKGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGRTPFSEY 713 (853)
Q Consensus 634 ~~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLtG~~PF~~~ 713 (853)
.++.+||+|||+++....... .....+||+.|+|||++.+.. ++.++|||||||++|+|++|+.||...
T Consensus 131 ~~~~~kL~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~---------~~~~~DiwslG~~l~el~~g~~Pf~~~ 199 (329)
T cd05588 131 AEGHIKLTDYGMCKEGIRPGD--TTSTFCGTPNYIAPEILRGED---------YGFSVDWWALGVLMFEMMAGRSPFDIV 199 (329)
T ss_pred CCCCEEECcCccccccccCCC--ccccccCCccccCHHHHcCCC---------CCCccceechHHHHHHHHHCCCCcccc
Confidence 567999999999975332221 223678999999999997653 567999999999999999999999521
Q ss_pred --------hhHHHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCCC------hhHHhcCCCCCC
Q 003052 714 --------KTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWR------IPQLLQHPFLVP 769 (853)
Q Consensus 714 --------~~~~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpT------a~EIL~HPwf~~ 769 (853)
.........+... ....+...+..+.+||.+||.+||.+|++ +.++++||||..
T Consensus 200 ~~~~~~~~~~~~~~~~~~~~~--~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~hp~~~~ 267 (329)
T cd05588 200 GMSDNPDQNTEDYLFQVILEK--QIRIPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSHPFFRN 267 (329)
T ss_pred cccccccccchHHHHHHHHcC--CCCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcCCCCCC
Confidence 1111122333322 23345667888999999999999999997 789999999964
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-41 Score=366.35 Aligned_cols=248 Identities=23% Similarity=0.346 Sum_probs=201.7
Q ss_pred EeEeccCceEEEEEEec-CCcEEEEEEEecCCC-ChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHHHHhhCCC
Q 003052 478 GKIGSGGSSEVHKVISS-DCTIYALKKIKLKGR-DYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLREVLNGSM 555 (853)
Q Consensus 478 k~LG~G~FG~Vyka~~~-~g~~vAVKkik~~~~-~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~~l~~~~i 555 (853)
+.||+|+||.||+|.+. +++.||||+++.... .......+..|++++..+.+|+||++++++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~---------------- 64 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCC---------------- 64 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeE----------------
Confidence 35999999999999985 568999999976432 223344577899999988889999999876
Q ss_pred CCCCCccccCCeEEEEEecch-hhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCCCccEEe-
Q 003052 556 NNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLL- 633 (853)
Q Consensus 556 v~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLKPeNILL- 633 (853)
+.+.+.+|+||||++ ++|...+... ..+++..++.++.||+.||.|||++||+||||||+|||+
T Consensus 65 ------~~~~~~~~lv~E~~~~~~L~~~l~~~--------~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~ 130 (321)
T cd05591 65 ------FQTKDRLFFVMEYVNGGDLMFQIQRS--------RKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLD 130 (321)
T ss_pred ------EEcCCeEEEEEeCCCCCcHHHHHHHc--------CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEEC
Confidence 456678999999976 5887777543 468999999999999999999999999999999999999
Q ss_pred ecCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHhCCCCCCcc
Q 003052 634 VKGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGRTPFSEY 713 (853)
Q Consensus 634 ~~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLtG~~PF~~~ 713 (853)
.++.+||+|||+|+....... .....+||+.|+|||++.+. .|+.++|||||||++|+|++|+.||...
T Consensus 131 ~~~~~kL~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~---------~~~~~~DvwslG~il~el~tg~~Pf~~~ 199 (321)
T cd05591 131 AEGHCKLADFGMCKEGILNGV--TTTTFCGTPDYIAPEILQEL---------EYGPSVDWWALGVLMYEMMAGQPPFEAD 199 (321)
T ss_pred CCCCEEEeecccceecccCCc--cccccccCccccCHHHHcCC---------CCCCccceechhHHHHHHhcCCCCCCCC
Confidence 567999999999976433222 23356899999999999764 3567999999999999999999999875
Q ss_pred hhHHHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCC-------ChhHHhcCCCCCC
Q 003052 714 KTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERW-------RIPQLLQHPFLVP 769 (853)
Q Consensus 714 ~~~~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRp-------Ta~EIL~HPwf~~ 769 (853)
........+.. ....++...+.++.+||.+||..||.+|+ ++.++++||||..
T Consensus 200 ~~~~~~~~i~~---~~~~~p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~hp~~~~ 259 (321)
T cd05591 200 NEDDLFESILH---DDVLYPVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQHPFFKE 259 (321)
T ss_pred CHHHHHHHHHc---CCCCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcCCccCC
Confidence 54433333322 22345556788999999999999999999 9999999999964
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-42 Score=370.06 Aligned_cols=251 Identities=27% Similarity=0.418 Sum_probs=216.0
Q ss_pred ceeeEEEeEeccCceEEEEEEe-cCCcEEEEEEEecCC-CChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHHH
Q 003052 472 KLYQRLGKIGSGGSSEVHKVIS-SDCTIYALKKIKLKG-RDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLRE 549 (853)
Q Consensus 472 ~~Y~ilk~LG~G~FG~Vyka~~-~~g~~vAVKkik~~~-~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~~ 549 (853)
.+|++.+.||+|.||+|-+|+. ..|+.||||.|++.. .+...+-.+.+||+||..|. ||||++++++
T Consensus 53 HRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLN-HPhII~IyEV---------- 121 (668)
T KOG0611|consen 53 HRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLN-HPHIIQIYEV---------- 121 (668)
T ss_pred hHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcC-CCceeehhhh----------
Confidence 5699999999999999999987 789999999997654 35566777899999999998 9999999876
Q ss_pred HhhCCCCCCCCccccCCeEEEEEecch-hhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCCC
Q 003052 550 VLNGSMNNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKP 628 (853)
Q Consensus 550 l~~~~iv~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLKP 628 (853)
|++.+.+.|||||.. |+|++++.++ +.|+|.+++.||+||+.|+.|||.++++|||||.
T Consensus 122 ------------FENkdKIvivMEYaS~GeLYDYiSer--------~~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKL 181 (668)
T KOG0611|consen 122 ------------FENKDKIVIVMEYASGGELYDYISER--------GSLSEREARHFFRQIVSAVHYCHKNRVVHRDLKL 181 (668)
T ss_pred ------------hcCCceEEEEEEecCCccHHHHHHHh--------ccccHHHHHHHHHHHHHHHHHHhhccceecccch
Confidence 667788999999954 6999999886 7899999999999999999999999999999999
Q ss_pred ccEEee-cCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHhCC
Q 003052 629 ANFLLV-KGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGR 707 (853)
Q Consensus 629 eNILL~-~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLtG~ 707 (853)
+||||+ ++++||+|||++..+.... ...++||+|.|.+||++.|.+|. ++.+|-|||||+||-|+.|.
T Consensus 182 ENILLD~N~NiKIADFGLSNly~~~k---fLqTFCGSPLYASPEIvNG~PY~--------GPEVDsWsLGvLLYtLVyGt 250 (668)
T KOG0611|consen 182 ENILLDQNNNIKIADFGLSNLYADKK---FLQTFCGSPLYASPEIVNGTPYK--------GPEVDSWSLGVLLYTLVYGT 250 (668)
T ss_pred hheeecCCCCeeeeccchhhhhcccc---HHHHhcCCcccCCccccCCCCCC--------CCccchhhHHHHHHHHhhcc
Confidence 999995 6799999999998875432 34699999999999999988764 68999999999999999999
Q ss_pred CCCCcchhHHHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCCChhHHhcCCCCC
Q 003052 708 TPFSEYKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQHPFLV 768 (853)
Q Consensus 708 ~PF~~~~~~~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~HPwf~ 768 (853)
+||++.+-. ...+.|..+. ...+..+..+.-||++||.+||++|.|+.+|-.|=|+.
T Consensus 251 MPFDG~Dhk-~lvrQIs~Ga---YrEP~~PSdA~gLIRwmLmVNP~RRATieDiAsHWWvN 307 (668)
T KOG0611|consen 251 MPFDGRDHK-RLVRQISRGA---YREPETPSDASGLIRWMLMVNPERRATIEDIASHWWVN 307 (668)
T ss_pred cccCCchHH-HHHHHhhccc---ccCCCCCchHHHHHHHHHhcCcccchhHHHHhhhheee
Confidence 999986543 3344443222 23344456689999999999999999999999999975
|
|
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-41 Score=373.88 Aligned_cols=260 Identities=29% Similarity=0.477 Sum_probs=205.5
Q ss_pred CceeeEEEeEeccCceEEEEEEec-CCcEEEEEEEecCCC-ChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHH
Q 003052 471 GKLYQRLGKIGSGGSSEVHKVISS-DCTIYALKKIKLKGR-DYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLR 548 (853)
Q Consensus 471 g~~Y~ilk~LG~G~FG~Vyka~~~-~g~~vAVKkik~~~~-~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~ 548 (853)
.+.|++++.||+|+||.||+|.+. +++.||+|++.+... .......+.+|+.+++.+. ||||++++++
T Consensus 42 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~-hp~iv~~~~~--------- 111 (370)
T cd05621 42 AEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFAN-SPWVVQLFCA--------- 111 (370)
T ss_pred HHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCC-CCCEeeEEEE---------
Confidence 356999999999999999999985 678999999975321 2223345778999998887 8999999876
Q ss_pred HHhhCCCCCCCCccccCCeEEEEEecch-hhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCC
Q 003052 549 EVLNGSMNNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLK 627 (853)
Q Consensus 549 ~l~~~~iv~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLK 627 (853)
+.++.++|+||||+. ++|.+++.. ..+++.+++.++.||+.||+|||++||+|||||
T Consensus 112 -------------~~~~~~~~lv~Ey~~gg~L~~~l~~---------~~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLK 169 (370)
T cd05621 112 -------------FQDDKYLYMVMEYMPGGDLVNLMSN---------YDVPEKWAKFYTAEVVLALDAIHSMGLIHRDVK 169 (370)
T ss_pred -------------EEcCCEEEEEEcCCCCCcHHHHHHh---------cCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCC
Confidence 566778999999975 588888753 358999999999999999999999999999999
Q ss_pred CccEEe-ecCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHhC
Q 003052 628 PANFLL-VKGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYG 706 (853)
Q Consensus 628 PeNILL-~~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLtG 706 (853)
|+|||+ .++.+||+|||+|+.+.... .....+.+||+.|||||++.+...+ ..++.++|||||||++|+|++|
T Consensus 170 p~NILl~~~~~~kL~DFG~a~~~~~~~-~~~~~~~~gt~~Y~aPE~~~~~~~~-----~~~~~~~DiwSlG~ilyell~G 243 (370)
T cd05621 170 PDNMLLDKHGHLKLADFGTCMKMDETG-MVRCDTAVGTPDYISPEVLKSQGGD-----GYYGRECDWWSVGVFLFEMLVG 243 (370)
T ss_pred HHHEEECCCCCEEEEecccceecccCC-ceecccCCCCcccCCHHHHhccCCC-----CCCCcccCEEeehHHHHHHHhC
Confidence 999999 56799999999998764322 1122467899999999999765322 1467899999999999999999
Q ss_pred CCCCCcchhHHHHHHhhcCCCCcccCC--CCCChhHHHHHHHhcccCCCC--CCChhHHhcCCCCCC
Q 003052 707 RTPFSEYKTFWAKFKVITDPNHEITYE--PVPNPWLLDLMKKCLAWDRNE--RWRIPQLLQHPFLVP 769 (853)
Q Consensus 707 ~~PF~~~~~~~~~~kii~~~~~~~~~~--~~~s~~l~dLI~kcL~~DP~k--RpTa~EIL~HPwf~~ 769 (853)
++||...........++ .......++ ...+..+++||.+||..++.+ |+++.|+++||||..
T Consensus 244 ~~Pf~~~~~~~~~~~i~-~~~~~~~~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~hp~~~~ 309 (370)
T cd05621 244 DTPFYADSLVGTYSKIM-DHKNSLNFPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQHPFFKN 309 (370)
T ss_pred CCCCCCCCHHHHHHHHH-hCCcccCCCCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcCcccCC
Confidence 99997755433333333 222222333 346888999999999866554 899999999999975
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=388.93 Aligned_cols=262 Identities=27% Similarity=0.433 Sum_probs=223.8
Q ss_pred ceeeEEEeEeccCceEEEEEEecCCc-EEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHHHH
Q 003052 472 KLYQRLGKIGSGGSSEVHKVISSDCT-IYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLREV 550 (853)
Q Consensus 472 ~~Y~ilk~LG~G~FG~Vyka~~~~g~-~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~~l 550 (853)
+.|.|++.||.|+||+||+|..++.. ..|.|+|..+ ..+.+..++-||+||..+. ||+||+|++.|
T Consensus 32 d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetk--seEELEDylVEIeILa~Cd-HP~ivkLl~ay---------- 98 (1187)
T KOG0579|consen 32 DHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETK--SEEELEDYLVEIEILAECD-HPVIVKLLSAY---------- 98 (1187)
T ss_pred HHHHHHhhhcCccchhhhhhhcccchhhhhhhhhccc--chhHHhhhhhhhhhhhcCC-ChHHHHHHHHH----------
Confidence 55888999999999999999987654 4567777654 3456778999999999998 99999998864
Q ss_pred hhCCCCCCCCccccCCeEEEEEecchhhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCCCcc
Q 003052 551 LNGSMNNKDGRVKDDGYIYMVLEYGEIDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPAN 630 (853)
Q Consensus 551 ~~~~iv~~~g~~~d~~~lyLVmEy~~gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLKPeN 630 (853)
..++.+||++|||+|+-.+.+.-. -+..|.|.+++.+.+|+|.||.|||+++|||||||..|
T Consensus 99 ------------y~enkLwiliEFC~GGAVDaimlE------L~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGN 160 (1187)
T KOG0579|consen 99 ------------YFENKLWILIEFCGGGAVDAIMLE------LGRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGN 160 (1187)
T ss_pred ------------hccCceEEEEeecCCchHhHHHHH------hccccchHHHHHHHHHHHHHHHHHhhcchhhhhccccc
Confidence 335678999999987555544322 35789999999999999999999999999999999999
Q ss_pred EEe-ecCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHhCCCC
Q 003052 631 FLL-VKGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGRTP 709 (853)
Q Consensus 631 ILL-~~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLtG~~P 709 (853)
||+ -+|.|+|+|||.+..... +...+.+++|||+|||||+.++.... ...|.+++||||||++|.||..+.+|
T Consensus 161 iL~TldGdirLADFGVSAKn~~--t~qkRDsFIGTPYWMAPEVvmCET~K----D~PYDykaDiWSlGITLIEMAqiEPP 234 (1187)
T KOG0579|consen 161 ILLTLDGDIRLADFGVSAKNKS--TRQKRDSFIGTPYWMAPEVVMCETFK----DQPYDYKADIWSLGITLIEMAQIEPP 234 (1187)
T ss_pred eEEEecCcEeeecccccccchh--HHhhhccccCCcccccchheeecccc----CCCchhhhhHHhhhhHHHHHhccCCC
Confidence 999 689999999999865432 23456789999999999999987543 24688999999999999999999999
Q ss_pred CCcchhHHHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCCChhHHhcCCCCCCC
Q 003052 710 FSEYKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQHPFLVPP 770 (853)
Q Consensus 710 F~~~~~~~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~HPwf~~~ 770 (853)
-.+.+++.-++++.....+.+..+..++..+.|||++||.+||..||++.+||+||||...
T Consensus 235 HhelnpMRVllKiaKSePPTLlqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~Hpfv~~~ 295 (1187)
T KOG0579|consen 235 HHELNPMRVLLKIAKSEPPTLLQPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKHPFVQNA 295 (1187)
T ss_pred ccccchHHHHHHHhhcCCCcccCcchhhhHHHHHHHHHHhcCCccCCCHHHHhhCcccccC
Confidence 9999999999998887777777888889999999999999999999999999999999753
|
|
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-41 Score=373.35 Aligned_cols=262 Identities=25% Similarity=0.382 Sum_probs=204.3
Q ss_pred eeEEEeEeccCceEEEEEEe-cCCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHHHHhh
Q 003052 474 YQRLGKIGSGGSSEVHKVIS-SDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLREVLN 552 (853)
Q Consensus 474 Y~ilk~LG~G~FG~Vyka~~-~~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~~l~~ 552 (853)
|+++++||+|+||.||+|.+ .+++.||||++.....+......+.+|+.+|+.++ |+||+++++++..+.
T Consensus 2 ~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~-------- 72 (372)
T cd07853 2 VEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFK-HDNVLSALDILQPPH-------- 72 (372)
T ss_pred CcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCC-CCCcCCHhheecCCC--------
Confidence 77889999999999999998 57889999999765444455567889999999997 899999988743210
Q ss_pred CCCCCCCCccccCCeEEEEEecchhhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCCCccEE
Q 003052 553 GSMNNKDGRVKDDGYIYMVLEYGEIDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANFL 632 (853)
Q Consensus 553 ~~iv~~~g~~~d~~~lyLVmEy~~gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLKPeNIL 632 (853)
......+|+||||++++|...+.. ...+++..++.++.||+.||.|||++||+||||||+|||
T Consensus 73 ---------~~~~~~~~lv~e~~~~~l~~~~~~--------~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil 135 (372)
T cd07853 73 ---------IDPFEEIYVVTELMQSDLHKIIVS--------PQPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLL 135 (372)
T ss_pred ---------ccccceEEEEeeccccCHHHHHhc--------CCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEE
Confidence 011236899999998888877643 257999999999999999999999999999999999999
Q ss_pred e-ecCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHhCCCCCC
Q 003052 633 L-VKGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGRTPFS 711 (853)
Q Consensus 633 L-~~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLtG~~PF~ 711 (853)
+ .++.+||+|||+++....... .......+|+.|+|||++.+.. .|+.++|||||||++|||++|+.||.
T Consensus 136 i~~~~~~kL~Dfg~a~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~--------~~~~~~DiwslG~il~el~~g~~pf~ 206 (372)
T cd07853 136 VNSNCVLKICDFGLARVEEPDES-KHMTQEVVTQYYRAPEILMGSR--------HYTSAVDIWSVGCIFAELLGRRILFQ 206 (372)
T ss_pred ECCCCCEEeccccceeecccCcc-ccCCCCCcCCCcCCHHHHcCCC--------CCCcHHHHHhHHHHHHHHHcCCCCCC
Confidence 9 467999999999986533221 1223457899999999987642 35689999999999999999999997
Q ss_pred cchhHHHHHHhh-----------------------cCCCCc------ccCCCCCChhHHHHHHHhcccCCCCCCChhHHh
Q 003052 712 EYKTFWAKFKVI-----------------------TDPNHE------ITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLL 762 (853)
Q Consensus 712 ~~~~~~~~~kii-----------------------~~~~~~------~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL 762 (853)
+.........+. ..+... .......++++.+||.+||.+||.+|||+.|+|
T Consensus 207 ~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l 286 (372)
T cd07853 207 AQSPIQQLDLITDLLGTPSLEAMRSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADAL 286 (372)
T ss_pred CCCHHHHHHHHHHHcCCCCHHHHHHhhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHh
Confidence 654332211110 000000 012234577899999999999999999999999
Q ss_pred cCCCCCCC
Q 003052 763 QHPFLVPP 770 (853)
Q Consensus 763 ~HPwf~~~ 770 (853)
+||||...
T Consensus 287 ~hp~~~~~ 294 (372)
T cd07853 287 AHPYLDEG 294 (372)
T ss_pred cCHhhCCC
Confidence 99999763
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=364.60 Aligned_cols=255 Identities=27% Similarity=0.401 Sum_probs=203.0
Q ss_pred cCceeeEEEeEeccCceEEEEEEec-CCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHH
Q 003052 470 NGKLYQRLGKIGSGGSSEVHKVISS-DCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLR 548 (853)
Q Consensus 470 ~g~~Y~ilk~LG~G~FG~Vyka~~~-~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~ 548 (853)
..++|++++.||+|+||.||++.+. ++..||+|++.... .......+.+|+++|++++ |+||++++++
T Consensus 3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~--------- 71 (331)
T cd06649 3 KDDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEI-KPAIRNQIIRELQVLHECN-SPYIVGFYGA--------- 71 (331)
T ss_pred CcccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeeccc-CHHHHHHHHHHHHHHHHCC-CCCCCeEEEE---------
Confidence 3467999999999999999999985 67889999987643 2334556889999999997 8999999986
Q ss_pred HHhhCCCCCCCCccccCCeEEEEEecch-hhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccC-ceeeCCC
Q 003052 549 EVLNGSMNNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEE-RIVHSDL 626 (853)
Q Consensus 549 ~l~~~~iv~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~-gIIHRDL 626 (853)
+.+++.+|+||||+. ++|.+++... ..+++..+..++.||+.||.|||+. +|+||||
T Consensus 72 -------------~~~~~~~~lv~e~~~~~~L~~~l~~~--------~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dl 130 (331)
T cd06649 72 -------------FYSDGEISICMEHMDGGSLDQVLKEA--------KRIPEEILGKVSIAVLRGLAYLREKHQIMHRDV 130 (331)
T ss_pred -------------EEECCEEEEEeecCCCCcHHHHHHHc--------CCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCC
Confidence 455678999999976 4888887653 4689999999999999999999986 6999999
Q ss_pred CCccEEe-ecCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHh
Q 003052 627 KPANFLL-VKGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVY 705 (853)
Q Consensus 627 KPeNILL-~~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLt 705 (853)
||+|||+ .++.+||+|||+++...... ....+||+.|+|||++.+. .++.++|||||||++|||++
T Consensus 131 kp~Nil~~~~~~~kl~Dfg~~~~~~~~~----~~~~~g~~~y~aPE~~~~~---------~~~~~~DiwslG~il~el~t 197 (331)
T cd06649 131 KPSNILVNSRGEIKLCDFGVSGQLIDSM----ANSFVGTRSYMSPERLQGT---------HYSVQSDIWSMGLSLVELAI 197 (331)
T ss_pred ChhhEEEcCCCcEEEccCcccccccccc----cccCCCCcCcCCHhHhcCC---------CCCchHhHHHHHHHHHHHHh
Confidence 9999999 56799999999998664322 2356899999999999764 35679999999999999999
Q ss_pred CCCCCCcchhHHHHHHhhcC----------------------------------------------CCCcccCCCCCChh
Q 003052 706 GRTPFSEYKTFWAKFKVITD----------------------------------------------PNHEITYEPVPNPW 739 (853)
Q Consensus 706 G~~PF~~~~~~~~~~kii~~----------------------------------------------~~~~~~~~~~~s~~ 739 (853)
|+.||....... ....+.. ...........+++
T Consensus 198 g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 276 (331)
T cd06649 198 GRYPIPPPDAKE-LEAIFGRPVVDGEEGEPHSISPRPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPD 276 (331)
T ss_pred CCCCCCCCCHHH-HHHHhcccccccccCCccccCcccccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHH
Confidence 999996432211 1111100 00000011235678
Q ss_pred HHHHHHHhcccCCCCCCChhHHhcCCCCCCC
Q 003052 740 LLDLMKKCLAWDRNERWRIPQLLQHPFLVPP 770 (853)
Q Consensus 740 l~dLI~kcL~~DP~kRpTa~EIL~HPwf~~~ 770 (853)
+++||.+||.+||++|||+.+||+||||+..
T Consensus 277 l~~li~~~L~~~P~~Rpt~~ell~h~~~~~~ 307 (331)
T cd06649 277 FQEFVNKCLIKNPAERADLKMLMNHTFIKRS 307 (331)
T ss_pred HHHHHHHHccCCcccCCCHHHHhcChHHhhc
Confidence 9999999999999999999999999999754
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-41 Score=377.35 Aligned_cols=251 Identities=22% Similarity=0.246 Sum_probs=196.4
Q ss_pred CceeeEEEeEeccCceEEEEEEe-cCCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHHH
Q 003052 471 GKLYQRLGKIGSGGSSEVHKVIS-SDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLRE 549 (853)
Q Consensus 471 g~~Y~ilk~LG~G~FG~Vyka~~-~~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~~ 549 (853)
...|+++++||+|+||.||+|.+ .+++.||+|+... ..+.+|+++|++|+ ||||++++++
T Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~--------~~~~~E~~il~~l~-HpnIv~~~~~---------- 151 (391)
T PHA03212 91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR--------GGTATEAHILRAIN-HPSIIQLKGT---------- 151 (391)
T ss_pred cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh--------hhhHHHHHHHHhCC-CCCCCCEeEE----------
Confidence 34699999999999999999998 5678899997542 24679999999997 8999999886
Q ss_pred HhhCCCCCCCCccccCCeEEEEEecchhhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCCCc
Q 003052 550 VLNGSMNNKDGRVKDDGYIYMVLEYGEIDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPA 629 (853)
Q Consensus 550 l~~~~iv~~~g~~~d~~~lyLVmEy~~gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLKPe 629 (853)
|..+...|+|||++.++|..++... ..+++..++.|+.||+.||.|||++||+||||||+
T Consensus 152 ------------~~~~~~~~lv~e~~~~~L~~~l~~~--------~~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~ 211 (391)
T PHA03212 152 ------------FTYNKFTCLILPRYKTDLYCYLAAK--------RNIAICDILAIERSVLRAIQYLHENRIIHRDIKAE 211 (391)
T ss_pred ------------EEECCeeEEEEecCCCCHHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChH
Confidence 4556788999999988988887653 46899999999999999999999999999999999
Q ss_pred cEEe-ecCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHhCCC
Q 003052 630 NFLL-VKGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGRT 708 (853)
Q Consensus 630 NILL-~~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLtG~~ 708 (853)
|||+ .++.+||+|||+|+....... ......+||+.|+|||++.+. .|+.++|||||||++|||++|..
T Consensus 212 NIll~~~~~vkL~DFG~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~---------~~~~~~DiwSlGvil~elltg~~ 281 (391)
T PHA03212 212 NIFINHPGDVCLGDFGAACFPVDINA-NKYYGWAGTIATNAPELLARD---------PYGPAVDIWSAGIVLFEMATCHD 281 (391)
T ss_pred hEEEcCCCCEEEEeCCcccccccccc-cccccccCccCCCChhhhcCC---------CCCcHHHHHHHHHHHHHHHHCCC
Confidence 9999 567999999999975432211 122356899999999999764 36789999999999999999998
Q ss_pred CCCcch----------hHHHHHHhhcCCCCc-----------------------cc------CCCCCChhHHHHHHHhcc
Q 003052 709 PFSEYK----------TFWAKFKVITDPNHE-----------------------IT------YEPVPNPWLLDLMKKCLA 749 (853)
Q Consensus 709 PF~~~~----------~~~~~~kii~~~~~~-----------------------~~------~~~~~s~~l~dLI~kcL~ 749 (853)
||.+.. .+..+.......... .. .....+.++.+||.+||.
T Consensus 282 p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~ 361 (391)
T PHA03212 282 SLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLA 361 (391)
T ss_pred CcCCcccccccCchhHHHHHHHHHhcCChhhcCcchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhc
Confidence 874321 111111111000000 00 001234578999999999
Q ss_pred cCCCCCCChhHHhcCCCCCCC
Q 003052 750 WDRNERWRIPQLLQHPFLVPP 770 (853)
Q Consensus 750 ~DP~kRpTa~EIL~HPwf~~~ 770 (853)
+||.+|||+.|+|+||||...
T Consensus 362 ~dP~~Rpta~elL~hp~f~~~ 382 (391)
T PHA03212 362 FDAHHRPSAEALLDFAAFQDI 382 (391)
T ss_pred CChhhCCCHHHHhcChhhccC
Confidence 999999999999999999764
|
|
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-41 Score=364.28 Aligned_cols=251 Identities=22% Similarity=0.376 Sum_probs=200.5
Q ss_pred eeEEEeEeccCceEEEEEEe-cCCcEEEEEEEecCCC-ChhhHhhHHHHHHHHHHhc--CCCceeEeeehhhhHHHHHHH
Q 003052 474 YQRLGKIGSGGSSEVHKVIS-SDCTIYALKKIKLKGR-DYATAYGFCQEIEYLNKLK--GKNNIIQLIDYEVTEKALLRE 549 (853)
Q Consensus 474 Y~ilk~LG~G~FG~Vyka~~-~~g~~vAVKkik~~~~-~~~~~~~~l~EI~iLkkL~--~hpNIV~Lid~~~~e~~iL~~ 549 (853)
|++++.||+|+||.||+|.+ .+++.||||+++.... .......+.+|++++..+. .|+||++++++
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~---------- 70 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFAC---------- 70 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeE----------
Confidence 78899999999999999988 4678999999985431 2233445777877776543 38999999876
Q ss_pred HhhCCCCCCCCccccCCeEEEEEecchh-hHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCCC
Q 003052 550 VLNGSMNNKDGRVKDDGYIYMVLEYGEI-DLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKP 628 (853)
Q Consensus 550 l~~~~iv~~~g~~~d~~~lyLVmEy~~g-dL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLKP 628 (853)
+.+...+|+||||+.+ +|...+.. ..+++..++.++.||+.||.|||++||+||||||
T Consensus 71 ------------~~~~~~~~lv~E~~~~~~L~~~~~~---------~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp 129 (324)
T cd05589 71 ------------FQTEDHVCFVMEYAAGGDLMMHIHT---------DVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKL 129 (324)
T ss_pred ------------EEcCCEEEEEEcCCCCCcHHHHhhc---------CCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCH
Confidence 4567789999999764 77665532 4699999999999999999999999999999999
Q ss_pred ccEEe-ecCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHhCC
Q 003052 629 ANFLL-VKGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGR 707 (853)
Q Consensus 629 eNILL-~~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLtG~ 707 (853)
+|||+ .++.+||+|||+++...... ......+||+.|||||++.+.. ++.++|||||||++|+|++|+
T Consensus 130 ~Nill~~~~~~kL~Dfg~~~~~~~~~--~~~~~~~g~~~y~aPE~~~~~~---------~~~~~DiwslG~il~el~~G~ 198 (324)
T cd05589 130 DNLLLDTEGFVKIADFGLCKEGMGFG--DRTSTFCGTPEFLAPEVLTETS---------YTRAVDWWGLGVLIYEMLVGE 198 (324)
T ss_pred HHeEECCCCcEEeCcccCCccCCCCC--CcccccccCccccCHhHhcCCC---------CCcccchhhHHHHHHHHHhCC
Confidence 99999 56799999999987543222 1234678999999999997643 567999999999999999999
Q ss_pred CCCCcchhHHHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCC-----ChhHHhcCCCCCC
Q 003052 708 TPFSEYKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERW-----RIPQLLQHPFLVP 769 (853)
Q Consensus 708 ~PF~~~~~~~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRp-----Ta~EIL~HPwf~~ 769 (853)
.||.+.........+.. ....++...+..+.+||.+||..||.+|| ++.++++||||..
T Consensus 199 ~pf~~~~~~~~~~~i~~---~~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~~~f~~ 262 (324)
T cd05589 199 SPFPGDDEEEVFDSIVN---DEVRYPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQPFFRD 262 (324)
T ss_pred CCCCCCCHHHHHHHHHh---CCCCCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhCCCcCC
Confidence 99977544333222222 12335566788999999999999999999 7999999999975
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-41 Score=364.36 Aligned_cols=247 Identities=30% Similarity=0.489 Sum_probs=200.0
Q ss_pred EeEeccCceEEEEEEe----cCCcEEEEEEEecCCC--ChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHHHHh
Q 003052 478 GKIGSGGSSEVHKVIS----SDCTIYALKKIKLKGR--DYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLREVL 551 (853)
Q Consensus 478 k~LG~G~FG~Vyka~~----~~g~~vAVKkik~~~~--~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~~l~ 551 (853)
+.||+|+||.||+|.. .+++.||||+++.... .......+.+|+.+|+.++ |+||++++++
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~-hp~iv~~~~~------------ 68 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVK-HPFIVDLIYA------------ 68 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCC-CCchhceeeE------------
Confidence 5799999999999986 3568899999975421 2223345678999999997 8999999876
Q ss_pred hCCCCCCCCccccCCeEEEEEecch-hhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCCCcc
Q 003052 552 NGSMNNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPAN 630 (853)
Q Consensus 552 ~~~iv~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLKPeN 630 (853)
|.+++.+|+||||+. ++|.+.+... ..+.+..++.++.||+.||.|||++||+||||||+|
T Consensus 69 ----------~~~~~~~~lv~e~~~~~~L~~~~~~~--------~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~N 130 (323)
T cd05584 69 ----------FQTGGKLYLILEYLSGGELFMHLERE--------GIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPEN 130 (323)
T ss_pred ----------EecCCeEEEEEeCCCCchHHHHHHHc--------CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHH
Confidence 456678999999976 4888877543 568999999999999999999999999999999999
Q ss_pred EEe-ecCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHhCCCC
Q 003052 631 FLL-VKGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGRTP 709 (853)
Q Consensus 631 ILL-~~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLtG~~P 709 (853)
||+ .++.+||+|||+++....... .....+||+.|+|||++.+.. ++.++|||||||++|||++|+.|
T Consensus 131 il~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~---------~~~~~DiwslG~il~ell~G~~p 199 (323)
T cd05584 131 ILLDAQGHVKLTDFGLCKESIHEGT--VTHTFCGTIEYMAPEILMRSG---------HGKAVDWWSLGALMYDMLTGAPP 199 (323)
T ss_pred eEECCCCCEEEeeCcCCeecccCCC--cccccCCCccccChhhccCCC---------CCCcceecccHHHHHHHhcCCCC
Confidence 999 567999999999975432221 223568999999999997643 46799999999999999999999
Q ss_pred CCcchhHHHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCC-----ChhHHhcCCCCCC
Q 003052 710 FSEYKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERW-----RIPQLLQHPFLVP 769 (853)
Q Consensus 710 F~~~~~~~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRp-----Ta~EIL~HPwf~~ 769 (853)
|...........+.. .....+...++.+.+||.+||.+||.+|| ++.++++||||..
T Consensus 200 f~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h~~~~~ 261 (323)
T cd05584 200 FTAENRKKTIDKILK---GKLNLPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSHPFFRH 261 (323)
T ss_pred CCCCCHHHHHHHHHc---CCCCCCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcCCCcCC
Confidence 987554433333322 22345566788999999999999999999 8999999999975
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-41 Score=360.78 Aligned_cols=257 Identities=28% Similarity=0.461 Sum_probs=192.5
Q ss_pred EeEeccCceEEEEEEec---CCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHHHHhhCC
Q 003052 478 GKIGSGGSSEVHKVISS---DCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLREVLNGS 554 (853)
Q Consensus 478 k~LG~G~FG~Vyka~~~---~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~~l~~~~ 554 (853)
++||+|+||.||+|.+. +++.||+|.+...... ..+.+|+.+|++++ |+||+++++++..
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~~----~~~~~E~~~l~~l~-h~niv~~~~~~~~------------ 69 (317)
T cd07868 7 CKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGIS----MSACREIALLRELK-HPNVISLQKVFLS------------ 69 (317)
T ss_pred cccccCCCeEEEEEEEccCCCCceEEEEEECCCCCc----HHHHHHHHHHHhcC-CCCCcceeeeEec------------
Confidence 57999999999999864 4578999999754322 34678999999997 8999999886421
Q ss_pred CCCCCCccccCCeEEEEEecchhhHHHHHHHhhhhc-cCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCCCccEEe
Q 003052 555 MNNKDGRVKDDGYIYMVLEYGEIDLAHMLSQKWKEM-DGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLL 633 (853)
Q Consensus 555 iv~~~g~~~d~~~lyLVmEy~~gdL~~~L~~~~k~~-~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLKPeNILL 633 (853)
..+..+|+||||++++|.+++....... ......+++..++.++.||+.||.|||++||+||||||+|||+
T Consensus 70 --------~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~ 141 (317)
T cd07868 70 --------HADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILV 141 (317)
T ss_pred --------CCCcEEEEEEeccCCCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEE
Confidence 2345789999999999888876432111 1123468999999999999999999999999999999999999
Q ss_pred e-----cCcEEEEecccchhcccCCcc-ccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHhCC
Q 003052 634 V-----KGSLKLIDFGIAKAIMSDTTN-IQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGR 707 (853)
Q Consensus 634 ~-----~g~VKL~DFGlAk~~~~~~~~-~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLtG~ 707 (853)
. .+.+||+|||+|+.+...... ......+||+.|+|||++.+.. .|+.++|||||||++|+|++|+
T Consensus 142 ~~~~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~--------~~~~~~DiwslG~il~el~~g~ 213 (317)
T cd07868 142 MGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGAR--------HYTKAIDIWAIGCIFAELLTSE 213 (317)
T ss_pred ecCCCCcCcEEEeecCceeccCCCCccccccCCccccccccCCHHHcCCC--------CcCchhhHHHHHHHHHHHHhCC
Confidence 3 358999999999876432211 1223568999999999997642 3678999999999999999999
Q ss_pred CCCCcchh------------HHHHHHhhcCCCCc----------------------c----------cCCCCCChhHHHH
Q 003052 708 TPFSEYKT------------FWAKFKVITDPNHE----------------------I----------TYEPVPNPWLLDL 743 (853)
Q Consensus 708 ~PF~~~~~------------~~~~~kii~~~~~~----------------------~----------~~~~~~s~~l~dL 743 (853)
+||..... ....+.....+... . ......+..+.+|
T Consensus 214 ~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dl 293 (317)
T cd07868 214 PIFHCRQEDIKTSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHL 293 (317)
T ss_pred CCccCCcccccccccccHHHHHHHHHhcCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHH
Confidence 99953211 11111111100000 0 0011234568999
Q ss_pred HHHhcccCCCCCCChhHHhcCCCC
Q 003052 744 MKKCLAWDRNERWRIPQLLQHPFL 767 (853)
Q Consensus 744 I~kcL~~DP~kRpTa~EIL~HPwf 767 (853)
|.+||.+||.+|||++|+|+||||
T Consensus 294 i~~mL~~dP~~R~t~~e~l~hp~f 317 (317)
T cd07868 294 LQKLLTMDPIKRITSEQAMQDPYF 317 (317)
T ss_pred HHHHhccCcccCCCHHHHhcCCCC
Confidence 999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-41 Score=368.86 Aligned_cols=261 Identities=26% Similarity=0.427 Sum_probs=203.7
Q ss_pred ceeeEEEeEeccCceEEEEEEe-cCCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHHHH
Q 003052 472 KLYQRLGKIGSGGSSEVHKVIS-SDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLREV 550 (853)
Q Consensus 472 ~~Y~ilk~LG~G~FG~Vyka~~-~~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~~l 550 (853)
++|++++.||+|+||.||+|.+ .+++.||||++............+.+|+.+|++++ |+||+++++++....
T Consensus 15 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~------ 87 (343)
T cd07878 15 ERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMK-HENVIGLLDVFTPAT------ 87 (343)
T ss_pred hhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcC-CCchhhhhhhhcccc------
Confidence 5699999999999999999998 46789999999765444444556789999999998 899999988753211
Q ss_pred hhCCCCCCCCccccCCeEEEEEecchhhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCCCcc
Q 003052 551 LNGSMNNKDGRVKDDGYIYMVLEYGEIDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPAN 630 (853)
Q Consensus 551 ~~~~iv~~~g~~~d~~~lyLVmEy~~gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLKPeN 630 (853)
.......+|++||+++++|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|
T Consensus 88 ----------~~~~~~~~~~~~~~~~~~l~~~~~~---------~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~N 148 (343)
T cd07878 88 ----------SIENFNEVYLVTNLMGADLNNIVKC---------QKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSN 148 (343)
T ss_pred ----------cccccCcEEEEeecCCCCHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhh
Confidence 1223356899999998888876642 469999999999999999999999999999999999
Q ss_pred EEe-ecCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHhCCCC
Q 003052 631 FLL-VKGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGRTP 709 (853)
Q Consensus 631 ILL-~~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLtG~~P 709 (853)
||+ .++.+||+|||+++..... ....+||+.|+|||++.+.. .++.++|||||||++|+|++|+.|
T Consensus 149 il~~~~~~~kl~Dfg~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~--------~~~~~~DiwslG~il~el~~g~~p 215 (343)
T cd07878 149 VAVNEDCELRILDFGLARQADDE-----MTGYVATRWYRAPEIMLNWM--------HYNQTVDIWSVGCIMAELLKGKAL 215 (343)
T ss_pred EEECCCCCEEEcCCccceecCCC-----cCCccccccccCchHhcCCc--------cCCchhhhHhHHHHHHHHHHCCCC
Confidence 999 5679999999999865432 23568999999999986532 367899999999999999999999
Q ss_pred CCcchhHHHHHHhh---cCCCC-------------------ccc------CCCCCChhHHHHHHHhcccCCCCCCChhHH
Q 003052 710 FSEYKTFWAKFKVI---TDPNH-------------------EIT------YEPVPNPWLLDLMKKCLAWDRNERWRIPQL 761 (853)
Q Consensus 710 F~~~~~~~~~~kii---~~~~~-------------------~~~------~~~~~s~~l~dLI~kcL~~DP~kRpTa~EI 761 (853)
|.+.........+. ..+.. ... .....++.+.+||.+||..||.+|||+.|+
T Consensus 216 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~el 295 (343)
T cd07878 216 FPGNDYIDQLKRIMEVVGTPSPEVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEA 295 (343)
T ss_pred CCCCCHHHHHHHHHHHhCCCCHHHHHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHH
Confidence 97643322111111 00000 000 012345668999999999999999999999
Q ss_pred hcCCCCCCCC
Q 003052 762 LQHPFLVPPV 771 (853)
Q Consensus 762 L~HPwf~~~~ 771 (853)
|+||||....
T Consensus 296 l~hp~~~~~~ 305 (343)
T cd07878 296 LAHPYFSQYH 305 (343)
T ss_pred hcCcchhccC
Confidence 9999998643
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-41 Score=365.74 Aligned_cols=262 Identities=30% Similarity=0.454 Sum_probs=205.9
Q ss_pred eeeEEEeEeccCceEEEEEEe-cCCcEEEEEEEecCCC-ChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHHHH
Q 003052 473 LYQRLGKIGSGGSSEVHKVIS-SDCTIYALKKIKLKGR-DYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLREV 550 (853)
Q Consensus 473 ~Y~ilk~LG~G~FG~Vyka~~-~~g~~vAVKkik~~~~-~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~~l 550 (853)
.|.+.+.||+|+||.||+|.+ .+++.||+|+++.... .......+.+|+.+++.+. |+||++++++
T Consensus 2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~-~~~i~~~~~~----------- 69 (330)
T cd05601 2 DFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISN-SPWIPQLQYA----------- 69 (330)
T ss_pred CceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCC-CCCCcceeeE-----------
Confidence 589999999999999999998 4678999999986533 2234455778999988876 8999998765
Q ss_pred hhCCCCCCCCccccCCeEEEEEecch-hhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCCCc
Q 003052 551 LNGSMNNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPA 629 (853)
Q Consensus 551 ~~~~iv~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLKPe 629 (853)
+.+..++|+||||++ ++|.+++... ...+++..++.++.||+.||.|||++||+||||||+
T Consensus 70 -----------~~~~~~~~lv~e~~~~~~L~~~l~~~-------~~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~ 131 (330)
T cd05601 70 -----------FQDKDNLYLVMEYQPGGDLLSLLNRY-------EDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPE 131 (330)
T ss_pred -----------EecCCeEEEEECCCCCCCHHHHHHHh-------cCCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchH
Confidence 456778999999975 5888887653 246999999999999999999999999999999999
Q ss_pred cEEe-ecCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHhCCC
Q 003052 630 NFLL-VKGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGRT 708 (853)
Q Consensus 630 NILL-~~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLtG~~ 708 (853)
|||+ .+|.+||+|||+|+.+...... .....+||+.|+|||++...... ....++.++|||||||++|+|++|+.
T Consensus 132 NIll~~~~~~kL~Dfg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~---~~~~~~~~~DiwslG~il~el~~g~~ 207 (330)
T cd05601 132 NVLIDRTGHIKLADFGSAARLTANKMV-NSKLPVGTPDYIAPEVLTTMNGD---GKGTYGVECDWWSLGVIAYEMIYGRS 207 (330)
T ss_pred heEECCCCCEEeccCCCCeECCCCCce-eeecccCCccccCHHHhcccccc---ccCCCCCcceeecccceeeeeccCCC
Confidence 9999 5679999999999876432221 22345799999999998753221 01246789999999999999999999
Q ss_pred CCCcchhHHHHHHhhcCC-CCcccCCCCCChhHHHHHHHhcccCCCCCCChhHHhcCCCCCC
Q 003052 709 PFSEYKTFWAKFKVITDP-NHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQHPFLVP 769 (853)
Q Consensus 709 PF~~~~~~~~~~kii~~~-~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~HPwf~~ 769 (853)
||...........+.... ...+......+..+.+||.+||. ||.+||++.++++||||..
T Consensus 208 Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h~~~~~ 268 (330)
T cd05601 208 PFHEGTSAKTYNNIMNFQRFLKFPEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCCHPFFSK 268 (330)
T ss_pred CCCCCCHHHHHHHHHcCCCccCCCCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCCCCcCC
Confidence 997654433333332211 11222233568889999999998 9999999999999999975
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=359.25 Aligned_cols=259 Identities=28% Similarity=0.492 Sum_probs=203.3
Q ss_pred ceeeEEEeEeccCceEEEEEEec-CCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHHHH
Q 003052 472 KLYQRLGKIGSGGSSEVHKVISS-DCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLREV 550 (853)
Q Consensus 472 ~~Y~ilk~LG~G~FG~Vyka~~~-~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~~l 550 (853)
+.|.++++||+|+||.||+|++. +++.||+|+++..... .....+.+|+.++++++ |+||++++++
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~E~~~l~~l~-h~~iv~~~~~----------- 72 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEE-GAPCTAIREVSLLKDLK-HANIVTLHDI----------- 72 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccC-CcchhHHHHHHHHHhCC-CCCcceEEEE-----------
Confidence 45999999999999999999984 6688999999765432 22335678999999997 8999999886
Q ss_pred hhCCCCCCCCccccCCeEEEEEecchhhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCCCcc
Q 003052 551 LNGSMNNKDGRVKDDGYIYMVLEYGEIDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPAN 630 (853)
Q Consensus 551 ~~~~iv~~~g~~~d~~~lyLVmEy~~gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLKPeN 630 (853)
+.+++.+|+||||++++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|
T Consensus 73 -----------~~~~~~~~lv~e~~~~~l~~~~~~~-------~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~N 134 (309)
T cd07872 73 -----------VHTDKSLTLVFEYLDKDLKQYMDDC-------GNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQN 134 (309)
T ss_pred -----------EeeCCeEEEEEeCCCCCHHHHHHhc-------CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHH
Confidence 4556789999999998888877543 3468999999999999999999999999999999999
Q ss_pred EEe-ecCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHhCCCC
Q 003052 631 FLL-VKGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGRTP 709 (853)
Q Consensus 631 ILL-~~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLtG~~P 709 (853)
||+ .++.+||+|||+++....... ......+|+.|+|||++.+.. .++.++|||||||++|+|++|++|
T Consensus 135 ill~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~--------~~~~~~DiwslG~il~el~tg~~p 204 (309)
T cd07872 135 LLINERGELKLADFGLARAKSVPTK--TYSNEVVTLWYRPPDVLLGSS--------EYSTQIDMWGVGCIFFEMASGRPL 204 (309)
T ss_pred EEECCCCCEEECccccceecCCCcc--ccccccccccccCCHHHhCCC--------CCCcHHHHHHHHHHHHHHHhCCCC
Confidence 999 567999999999976533221 223457899999999986532 357899999999999999999999
Q ss_pred CCcchhHH---HHHHhhcCCCC------------------c------ccCCCCCChhHHHHHHHhcccCCCCCCChhHHh
Q 003052 710 FSEYKTFW---AKFKVITDPNH------------------E------ITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLL 762 (853)
Q Consensus 710 F~~~~~~~---~~~kii~~~~~------------------~------~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL 762 (853)
|.+..... ...+.+..+.. . .......++++++||.+||..||.+|||+.|+|
T Consensus 205 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l 284 (309)
T cd07872 205 FPGSTVEDELHLIFRLLGTPTEETWPGISSNDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAM 284 (309)
T ss_pred CCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHh
Confidence 96543221 11111111000 0 011124577899999999999999999999999
Q ss_pred cCCCCCCCC
Q 003052 763 QHPFLVPPV 771 (853)
Q Consensus 763 ~HPwf~~~~ 771 (853)
+||||....
T Consensus 285 ~h~~~~~~~ 293 (309)
T cd07872 285 KHAYFRSLG 293 (309)
T ss_pred cChhhhhcc
Confidence 999998643
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-41 Score=365.62 Aligned_cols=247 Identities=27% Similarity=0.429 Sum_probs=199.1
Q ss_pred EeEeccCceEEEEEEe-cCCcEEEEEEEecCCC-ChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHHHHhhCCC
Q 003052 478 GKIGSGGSSEVHKVIS-SDCTIYALKKIKLKGR-DYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLREVLNGSM 555 (853)
Q Consensus 478 k~LG~G~FG~Vyka~~-~~g~~vAVKkik~~~~-~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~~l~~~~i 555 (853)
+.||+|+||.||+|.+ .+++.||+|+++.... .......+.+|+++++.+. |+||++++++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~-hp~i~~~~~~---------------- 63 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSR-HPFLTALKYS---------------- 63 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCC-CCCCCceEEE----------------
Confidence 3699999999999998 5778999999986432 2233456778999999887 8999998875
Q ss_pred CCCCCccccCCeEEEEEecch-hhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhccc-CceeeCCCCCccEEe
Q 003052 556 NNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHE-ERIVHSDLKPANFLL 633 (853)
Q Consensus 556 v~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs-~gIIHRDLKPeNILL 633 (853)
+.+...+|+||||++ ++|...+... ..+++..++.++.||+.||.|||+ +||+||||||+|||+
T Consensus 64 ------~~~~~~~~lv~E~~~~~~L~~~l~~~--------~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll 129 (325)
T cd05594 64 ------FQTHDRLCFVMEYANGGELFFHLSRE--------RVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLML 129 (325)
T ss_pred ------EEcCCEEEEEEeCCCCCcHHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEE
Confidence 556778999999976 4777766542 569999999999999999999997 799999999999999
Q ss_pred -ecCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHhCCCCCCc
Q 003052 634 -VKGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGRTPFSE 712 (853)
Q Consensus 634 -~~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLtG~~PF~~ 712 (853)
.++.+||+|||+|+....... .....+||+.|+|||++.+. .|+.++|||||||++|+|++|+.||.+
T Consensus 130 ~~~~~~kL~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~---------~~~~~~DiwslG~il~el~tG~~Pf~~ 198 (325)
T cd05594 130 DKDGHIKITDFGLCKEGIKDGA--TMKTFCGTPEYLAPEVLEDN---------DYGRAVDWWGLGVVMYEMMCGRLPFYN 198 (325)
T ss_pred CCCCCEEEecCCCCeecCCCCc--ccccccCCcccCCHHHHccC---------CCCCccccccccceeeeeccCCCCCCC
Confidence 567999999999975432221 22356899999999999765 356899999999999999999999976
Q ss_pred chhHHHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCC-----ChhHHhcCCCCCC
Q 003052 713 YKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERW-----RIPQLLQHPFLVP 769 (853)
Q Consensus 713 ~~~~~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRp-----Ta~EIL~HPwf~~ 769 (853)
.... .....+.. ....++...++++.+||.+||.+||.+|+ ++.++++||||..
T Consensus 199 ~~~~-~~~~~i~~--~~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~~~~~ 257 (325)
T cd05594 199 QDHE-KLFELILM--EEIRFPRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQHKFFAG 257 (325)
T ss_pred CCHH-HHHHHHhc--CCCCCCCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcCCCcCC
Confidence 5443 22233222 23345666789999999999999999997 9999999999975
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-41 Score=369.48 Aligned_cols=255 Identities=27% Similarity=0.445 Sum_probs=202.5
Q ss_pred eeeEEEeEeccCceEEEEEEec-CCcEEEEEEEecCCC-ChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHHHH
Q 003052 473 LYQRLGKIGSGGSSEVHKVISS-DCTIYALKKIKLKGR-DYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLREV 550 (853)
Q Consensus 473 ~Y~ilk~LG~G~FG~Vyka~~~-~g~~vAVKkik~~~~-~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~~l 550 (853)
.|++++.||+|+||.||+|.+. +++.||||++..... .......+.+|+.++..++ |++|++++++
T Consensus 2 ~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~iv~~~~~----------- 69 (360)
T cd05627 2 DFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEAD-GAWVVKMFYS----------- 69 (360)
T ss_pred CceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCC-CCCEeeEEEE-----------
Confidence 5899999999999999999984 678999999975322 2334456788999999997 8999999876
Q ss_pred hhCCCCCCCCccccCCeEEEEEecch-hhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCCCc
Q 003052 551 LNGSMNNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPA 629 (853)
Q Consensus 551 ~~~~iv~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLKPe 629 (853)
+.++.++|+||||+. ++|.+++.+. ..+++..++.|+.||+.||.|||++||+||||||+
T Consensus 70 -----------~~~~~~~~lv~E~~~gg~L~~~l~~~--------~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~ 130 (360)
T cd05627 70 -----------FQDKRNLYLIMEFLPGGDMMTLLMKK--------DTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPD 130 (360)
T ss_pred -----------EEcCCEEEEEEeCCCCccHHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHH
Confidence 566788999999976 5888887653 56999999999999999999999999999999999
Q ss_pred cEEe-ecCcEEEEecccchhcccCCcc---------------------------------ccccccccCccccCchhhcc
Q 003052 630 NFLL-VKGSLKLIDFGIAKAIMSDTTN---------------------------------IQRDSQVGTLSYMSPEAFMC 675 (853)
Q Consensus 630 NILL-~~g~VKL~DFGlAk~~~~~~~~---------------------------------~~~~t~~GTp~YmAPEvl~~ 675 (853)
|||| .+|.+||+|||+|+.+...... ......+||+.|+|||++.+
T Consensus 131 NIli~~~~~vkL~DfG~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~ 210 (360)
T cd05627 131 NLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQ 210 (360)
T ss_pred HEEECCCCCEEEeeccCCcccccccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcC
Confidence 9999 5689999999999754321100 00124589999999999976
Q ss_pred CCCCCCCccccCCCccchhhhHHHHHHHHhCCCCCCcchhHHHHHHhhcCCCCcccCC--CCCChhHHHHHHHhcccCCC
Q 003052 676 NESDENGNIIKCGRPSDIWSLGCILYQMVYGRTPFSEYKTFWAKFKVITDPNHEITYE--PVPNPWLLDLMKKCLAWDRN 753 (853)
Q Consensus 676 ~~~~~~~~~~~ys~ksDIWSLGVILyELLtG~~PF~~~~~~~~~~kii~~~~~~~~~~--~~~s~~l~dLI~kcL~~DP~ 753 (853)
.. |+.++|||||||++|||++|++||.+........++.. ....+.++ ...++++++||.+|+ .||.
T Consensus 211 ~~---------~~~~~DiwSlGvilyel~tG~~Pf~~~~~~~~~~~i~~-~~~~~~~p~~~~~s~~~~~li~~l~-~~p~ 279 (360)
T cd05627 211 TG---------YNKLCDWWSLGVIMYEMLIGYPPFCSETPQETYRKVMN-WKETLVFPPEVPISEKAKDLILRFC-TDSE 279 (360)
T ss_pred CC---------CCCcceeccccceeeecccCCCCCCCCCHHHHHHHHHc-CCCceecCCCCCCCHHHHHHHHHhc-cChh
Confidence 53 56799999999999999999999977555433333322 12222222 236788999999987 4999
Q ss_pred CCC---ChhHHhcCCCCCC
Q 003052 754 ERW---RIPQLLQHPFLVP 769 (853)
Q Consensus 754 kRp---Ta~EIL~HPwf~~ 769 (853)
+|+ ++.++++||||..
T Consensus 280 ~R~~~~~~~ei~~hp~f~~ 298 (360)
T cd05627 280 NRIGSNGVEEIKSHPFFEG 298 (360)
T ss_pred hcCCCCCHHHHhcCCCCCC
Confidence 998 4899999999975
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=362.10 Aligned_cols=248 Identities=24% Similarity=0.345 Sum_probs=199.0
Q ss_pred EeEeccCceEEEEEEec-CCcEEEEEEEecCCC-ChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHHHHhhCCC
Q 003052 478 GKIGSGGSSEVHKVISS-DCTIYALKKIKLKGR-DYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLREVLNGSM 555 (853)
Q Consensus 478 k~LG~G~FG~Vyka~~~-~g~~vAVKkik~~~~-~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~~l~~~~i 555 (853)
+.||+|+||.||+|.+. +++.||||+++.... .......+..|..++..+.+|+||++++++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~---------------- 64 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCT---------------- 64 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeE----------------
Confidence 36999999999999984 568899999986432 223344566788888887789999999876
Q ss_pred CCCCCccccCCeEEEEEecch-hhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCCCccEEe-
Q 003052 556 NNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLL- 633 (853)
Q Consensus 556 v~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLKPeNILL- 633 (853)
+..+.++|+||||++ ++|...+... ..+++..++.|+.||+.||.|||++||+||||||+|||+
T Consensus 65 ------~~~~~~~~lv~e~~~gg~L~~~~~~~--------~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~ 130 (316)
T cd05592 65 ------FQTKEHLFFVMEYLNGGDLMFHIQSS--------GRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLD 130 (316)
T ss_pred ------EEcCCEEEEEEcCCCCCcHHHHHHHc--------CCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEEC
Confidence 456678999999975 5887777543 469999999999999999999999999999999999999
Q ss_pred ecCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHhCCCCCCcc
Q 003052 634 VKGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGRTPFSEY 713 (853)
Q Consensus 634 ~~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLtG~~PF~~~ 713 (853)
.++.+||+|||+|+...... ......+||+.|+|||++.+.. |+.++|||||||++|+|++|+.||.+.
T Consensus 131 ~~~~~kL~Dfg~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~---------~~~~~DvwslG~il~ell~G~~Pf~~~ 199 (316)
T cd05592 131 KDGHIKIADFGMCKENMNGE--GKASTFCGTPDYIAPEILKGQK---------YNESVDWWSFGVLLYEMLIGQSPFHGE 199 (316)
T ss_pred CCCCEEEccCcCCeECCCCC--CccccccCCccccCHHHHcCCC---------CCCcccchhHHHHHHHHHhCCCCCCCC
Confidence 56799999999998653322 1234578999999999997653 567999999999999999999999875
Q ss_pred hhHHHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCh-hHHhcCCCCCC
Q 003052 714 KTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRI-PQLLQHPFLVP 769 (853)
Q Consensus 714 ~~~~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa-~EIL~HPwf~~ 769 (853)
...... ..+.. ....++...+.++.+||.+||..||.+||++ .++++||||..
T Consensus 200 ~~~~~~-~~i~~--~~~~~~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~~h~~~~~ 253 (316)
T cd05592 200 DEDELF-DSILN--DRPHFPRWISKEAKDCLSKLFERDPTKRLGVDGDIRQHPFFRG 253 (316)
T ss_pred CHHHHH-HHHHc--CCCCCCCCCCHHHHHHHHHHccCCHHHcCCChHHHHcCcccCC
Confidence 543322 22222 2233456678889999999999999999986 48999999975
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=362.87 Aligned_cols=248 Identities=23% Similarity=0.315 Sum_probs=199.2
Q ss_pred EeEeccCceEEEEEEec-CCcEEEEEEEecCCC-ChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHHHHhhCCC
Q 003052 478 GKIGSGGSSEVHKVISS-DCTIYALKKIKLKGR-DYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLREVLNGSM 555 (853)
Q Consensus 478 k~LG~G~FG~Vyka~~~-~g~~vAVKkik~~~~-~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~~l~~~~i 555 (853)
+.||+|+||.||+|.+. ++..||+|+++.... .......+..|+.++..+.+|+||++++++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~---------------- 64 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCT---------------- 64 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEE----------------
Confidence 36999999999999985 678999999986432 112334567888999888779999999876
Q ss_pred CCCCCccccCCeEEEEEecch-hhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCCCccEEe-
Q 003052 556 NNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLL- 633 (853)
Q Consensus 556 v~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLKPeNILL- 633 (853)
+.+.+++|+||||+. ++|...+... ..+++.+++.++.||+.||+|||++||+||||||+|||+
T Consensus 65 ------~~~~~~~~lv~E~~~~g~L~~~i~~~--------~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~ 130 (316)
T cd05620 65 ------FQTKEHLFFVMEFLNGGDLMFHIQDK--------GRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLD 130 (316)
T ss_pred ------EEeCCEEEEEECCCCCCcHHHHHHHc--------CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEC
Confidence 566778999999976 5888777543 568999999999999999999999999999999999999
Q ss_pred ecCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHhCCCCCCcc
Q 003052 634 VKGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGRTPFSEY 713 (853)
Q Consensus 634 ~~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLtG~~PF~~~ 713 (853)
.++.+||+|||+++....... .....+||+.|+|||++.+.. |+.++|||||||++|+|++|+.||.+.
T Consensus 131 ~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~---------~~~~~DiwslGvil~el~~g~~Pf~~~ 199 (316)
T cd05620 131 RDGHIKIADFGMCKENVFGDN--RASTFCGTPDYIAPEILQGLK---------YTFSVDWWSFGVLLYEMLIGQSPFHGD 199 (316)
T ss_pred CCCCEEeCccCCCeecccCCC--ceeccCCCcCccCHHHHcCCC---------CCcccchhhhHHHHHHHHhCCCCCCCC
Confidence 567999999999875322111 223678999999999997653 567999999999999999999999765
Q ss_pred hhHHHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCh-hHHhcCCCCCC
Q 003052 714 KTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRI-PQLLQHPFLVP 769 (853)
Q Consensus 714 ~~~~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa-~EIL~HPwf~~ 769 (853)
... .....+... ...++...+.++++||.+||..||.+|+++ .++++||||..
T Consensus 200 ~~~-~~~~~~~~~--~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~~~~~~h~~f~~ 253 (316)
T cd05620 200 DED-ELFESIRVD--TPHYPRWITKESKDILEKLFERDPTRRLGVVGNIRGHPFFKT 253 (316)
T ss_pred CHH-HHHHHHHhC--CCCCCCCCCHHHHHHHHHHccCCHHHcCCChHHHHcCCCcCC
Confidence 443 233333221 233455678899999999999999999998 58999999975
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=370.41 Aligned_cols=258 Identities=24% Similarity=0.325 Sum_probs=211.3
Q ss_pred eEEcCceeeEEEeEeccCceEEEEEEecCCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHH
Q 003052 467 FKVNGKLYQRLGKIGSGGSSEVHKVISSDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKAL 546 (853)
Q Consensus 467 ~~v~g~~Y~ilk~LG~G~FG~Vyka~~~~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~i 546 (853)
+.++.....+.+.||.|+||+||++.+.....||||++.....+......|.+|+.+|.+|+ |||||++++++.
T Consensus 36 ~~i~~~~l~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~-HpNIV~f~G~~~----- 109 (362)
T KOG0192|consen 36 EEIDPDELPIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLR-HPNIVQFYGACT----- 109 (362)
T ss_pred eecChHHhhhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCC-CCCeeeEEEEEc-----
Confidence 44445556677779999999999999977666999999877655555778999999999998 999999998743
Q ss_pred HHHHhhCCCCCCCCccccCC-eEEEEEecch-hhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCc-eee
Q 003052 547 LREVLNGSMNNKDGRVKDDG-YIYMVLEYGE-IDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEER-IVH 623 (853)
Q Consensus 547 L~~l~~~~iv~~~g~~~d~~-~lyLVmEy~~-gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~g-IIH 623 (853)
+.. .++|||||++ |+|.+++... ....++...+..|+.||+.||+|||+++ |||
T Consensus 110 -----------------~~~~~~~iVtEy~~~GsL~~~l~~~------~~~~l~~~~~l~~aldiArGm~YLH~~~~iIH 166 (362)
T KOG0192|consen 110 -----------------SPPGSLCIVTEYMPGGSLSVLLHKK------RKRKLPLKVRLRIALDIARGMEYLHSEGPIIH 166 (362)
T ss_pred -----------------CCCCceEEEEEeCCCCcHHHHHhhc------ccCCCCHHHHHHHHHHHHHHHHHHhcCCCeee
Confidence 333 6899999966 6899988763 2468999999999999999999999999 999
Q ss_pred CCCCCccEEee-cC-cEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHH
Q 003052 624 SDLKPANFLLV-KG-SLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILY 701 (853)
Q Consensus 624 RDLKPeNILL~-~g-~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILy 701 (853)
|||||+|||++ ++ ++||+|||+++...... ...+...||+.|||||++.+. . ..|+.|+|||||||+||
T Consensus 167 rDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~--~~~~~~~GT~~wMAPEv~~~~-~------~~~~~K~DvySFgIvlW 237 (362)
T KOG0192|consen 167 RDLKSDNILVDLKGKTLKIADFGLSREKVISK--TSMTSVAGTYRWMAPEVLRGE-K------SPYTEKSDVYSFGIVLW 237 (362)
T ss_pred cccChhhEEEcCCCCEEEECCCccceeecccc--ccccCCCCCccccChhhhcCC-C------CcCCccchhhhHHHHHH
Confidence 99999999995 44 89999999998765321 223347899999999999854 1 14788999999999999
Q ss_pred HHHhCCCCCCcchhHHHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCCChhHHhc
Q 003052 702 QMVYGRTPFSEYKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQ 763 (853)
Q Consensus 702 ELLtG~~PF~~~~~~~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~ 763 (853)
||+||+.||.+.........+. ........+...++.+..||.+||..||.+||++.+|+.
T Consensus 238 El~t~~~Pf~~~~~~~~~~~v~-~~~~Rp~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~ 298 (362)
T KOG0192|consen 238 ELLTGEIPFEDLAPVQVASAVV-VGGLRPPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVS 298 (362)
T ss_pred HHHHCCCCCCCCCHHHHHHHHH-hcCCCCCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHH
Confidence 9999999999877744444333 334455556668889999999999999999999988874
|
|
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=364.11 Aligned_cols=249 Identities=28% Similarity=0.417 Sum_probs=198.9
Q ss_pred EeEeccCceEEEEEEec-CCcEEEEEEEecCCC-ChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHHHHhhCCC
Q 003052 478 GKIGSGGSSEVHKVISS-DCTIYALKKIKLKGR-DYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLREVLNGSM 555 (853)
Q Consensus 478 k~LG~G~FG~Vyka~~~-~g~~vAVKkik~~~~-~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~~l~~~~i 555 (853)
+.||+|+||.||+|.+. +++.||+|+++.... .......+.+|+.++.++.+|+||++++++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~---------------- 64 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSC---------------- 64 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeE----------------
Confidence 36999999999999984 668999999986532 233445577899999998889999999876
Q ss_pred CCCCCccccCCeEEEEEecch-hhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCCCccEEe-
Q 003052 556 NNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLL- 633 (853)
Q Consensus 556 v~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLKPeNILL- 633 (853)
+.+.+.+|+||||+. ++|...+... ..+++..++.|+.||+.||.|||++||+||||||+|||+
T Consensus 65 ------~~~~~~~~lv~E~~~~~~L~~~~~~~--------~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~ 130 (329)
T cd05618 65 ------FQTESRLFFVIEYVNGGDLMFHMQRQ--------RKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLD 130 (329)
T ss_pred ------EEeCCEEEEEEeCCCCCCHHHHHHHc--------CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEC
Confidence 566778999999976 5777666542 569999999999999999999999999999999999999
Q ss_pred ecCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHhCCCCCCcc
Q 003052 634 VKGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGRTPFSEY 713 (853)
Q Consensus 634 ~~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLtG~~PF~~~ 713 (853)
.++.+||+|||+++....... .....+||+.|+|||++.+.. |+.++|||||||++|+|++|+.||...
T Consensus 131 ~~~~~kL~DfG~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~---------~~~~~DiwslG~il~el~~g~~Pf~~~ 199 (329)
T cd05618 131 SEGHIKLTDYGMCKEGLRPGD--TTSTFCGTPNYIAPEILRGED---------YGFSVDWWALGVLMFEMMAGRSPFDIV 199 (329)
T ss_pred CCCCEEEeeCCccccccCCCC--ccccccCCccccCHHHHcCCC---------CCCccceecccHHHHHHhhCCCCCccC
Confidence 567999999999976432221 223578999999999997653 567999999999999999999999521
Q ss_pred --------hhHHHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCCC------hhHHhcCCCCCC
Q 003052 714 --------KTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWR------IPQLLQHPFLVP 769 (853)
Q Consensus 714 --------~~~~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpT------a~EIL~HPwf~~ 769 (853)
.........+.. ....++...+..+.+||.+||.+||.+|++ +.++++||||..
T Consensus 200 ~~~~~~~~~~~~~~~~~i~~--~~~~~p~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~hp~f~~ 267 (329)
T cd05618 200 GSSDNPDQNTEDYLFQVILE--KQIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRN 267 (329)
T ss_pred CCcCCcccccHHHHHHHHhc--CCCCCCCCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcCCCCCC
Confidence 111122222322 223455667888999999999999999998 579999999965
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-40 Score=361.83 Aligned_cols=257 Identities=30% Similarity=0.499 Sum_probs=199.5
Q ss_pred ceeeEEEeEeccCceEEEEEEec-CCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHHHH
Q 003052 472 KLYQRLGKIGSGGSSEVHKVISS-DCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLREV 550 (853)
Q Consensus 472 ~~Y~ilk~LG~G~FG~Vyka~~~-~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~~l 550 (853)
..|+++++||+|+||.||+|++. +++.||||++.... .......+.+|+++|++++ |+||++++++
T Consensus 74 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~----------- 140 (353)
T PLN00034 74 SELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNH-EDTVRRQICREIEILRDVN-HPNVVKCHDM----------- 140 (353)
T ss_pred HHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCC-cHHHHHHHHHHHHHHHhCC-CCCcceeeeE-----------
Confidence 45788899999999999999984 67899999997543 2344556889999999997 8999999876
Q ss_pred hhCCCCCCCCccccCCeEEEEEecchh-hHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCCCc
Q 003052 551 LNGSMNNKDGRVKDDGYIYMVLEYGEI-DLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPA 629 (853)
Q Consensus 551 ~~~~iv~~~g~~~d~~~lyLVmEy~~g-dL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLKPe 629 (853)
+.+++.+|+||||+.+ +|.. ...+.+..+..++.||+.||.|||++||+||||||+
T Consensus 141 -----------~~~~~~~~lv~e~~~~~~L~~------------~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~ 197 (353)
T PLN00034 141 -----------FDHNGEIQVLLEFMDGGSLEG------------THIADEQFLADVARQILSGIAYLHRRHIVHRDIKPS 197 (353)
T ss_pred -----------eccCCeEEEEEecCCCCcccc------------cccCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHH
Confidence 4556789999999775 4432 134678888999999999999999999999999999
Q ss_pred cEEe-ecCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHhCCC
Q 003052 630 NFLL-VKGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGRT 708 (853)
Q Consensus 630 NILL-~~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLtG~~ 708 (853)
|||+ .++.+||+|||+++.+..... .....+||+.|+|||++...... ...++.++|||||||++|||++|+.
T Consensus 198 NIll~~~~~~kL~DfG~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~----~~~~~~~~DvwslGvil~el~~g~~ 271 (353)
T PLN00034 198 NLLINSAKNVKIADFGVSRILAQTMD--PCNSSVGTIAYMSPERINTDLNH----GAYDGYAGDIWSLGVSILEFYLGRF 271 (353)
T ss_pred HEEEcCCCCEEEcccccceecccccc--cccccccCccccCcccccccccc----CcCCCcchhHHHHHHHHHHHHhCCC
Confidence 9999 467999999999987643221 12356899999999988543211 1134678999999999999999999
Q ss_pred CCCcch--hHHHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCCChhHHhcCCCCCCCC
Q 003052 709 PFSEYK--TFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQHPFLVPPV 771 (853)
Q Consensus 709 PF~~~~--~~~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~HPwf~~~~ 771 (853)
||.... ........+.. ......+...+.++++||.+||..||.+||++.|+|+||||....
T Consensus 272 pf~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~hp~~~~~~ 335 (353)
T PLN00034 272 PFGVGRQGDWASLMCAICM-SQPPEAPATASREFRHFISCCLQREPAKRWSAMQLLQHPFILRAQ 335 (353)
T ss_pred CCCCCCCccHHHHHHHHhc-cCCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcCcccccCC
Confidence 996321 11111111111 122233456778899999999999999999999999999998754
|
|
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-40 Score=361.17 Aligned_cols=252 Identities=23% Similarity=0.336 Sum_probs=204.8
Q ss_pred eeEEEeEeccCceEEEEEEec-CCcEEEEEEEecCCC-ChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHHHHh
Q 003052 474 YQRLGKIGSGGSSEVHKVISS-DCTIYALKKIKLKGR-DYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLREVL 551 (853)
Q Consensus 474 Y~ilk~LG~G~FG~Vyka~~~-~g~~vAVKkik~~~~-~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~~l~ 551 (853)
|.+.+.||+|+||.||+|.+. +++.||+|++..... .......+..|+.++..+.+|++|++++++
T Consensus 2 f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~------------ 69 (323)
T cd05615 2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSC------------ 69 (323)
T ss_pred ceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeE------------
Confidence 778899999999999999984 678999999975422 223345677899999999888888888765
Q ss_pred hCCCCCCCCccccCCeEEEEEecch-hhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCCCcc
Q 003052 552 NGSMNNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPAN 630 (853)
Q Consensus 552 ~~~iv~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLKPeN 630 (853)
+.+.+.+|+||||+. ++|.+++... ..+++..++.|+.||+.||.|||++||+||||||+|
T Consensus 70 ----------~~~~~~~~lv~Ey~~~g~L~~~i~~~--------~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~N 131 (323)
T cd05615 70 ----------FQTVDRLYFVMEYVNGGDLMYHIQQV--------GKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDN 131 (323)
T ss_pred ----------EecCCEEEEEEcCCCCCcHHHHHHHc--------CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHH
Confidence 566778999999976 5888877543 569999999999999999999999999999999999
Q ss_pred EEe-ecCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHhCCCC
Q 003052 631 FLL-VKGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGRTP 709 (853)
Q Consensus 631 ILL-~~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLtG~~P 709 (853)
||+ .++.+||+|||+++....... .....+||+.|+|||++.+.. ++.++|||||||++|+|++|++|
T Consensus 132 ill~~~~~ikL~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~---------~~~~~DiwslGvil~elltG~~p 200 (323)
T cd05615 132 VMLDSEGHIKIADFGMCKEHMVDGV--TTRTFCGTPDYIAPEIIAYQP---------YGKSVDWWAYGVLLYEMLAGQPP 200 (323)
T ss_pred eEECCCCCEEEeccccccccCCCCc--cccCccCCccccCHHHHcCCC---------CCCccchhhhHHHHHHHHhCCCC
Confidence 999 567999999999986433221 223568999999999997653 56799999999999999999999
Q ss_pred CCcchhHHHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCCC-----hhHHhcCCCCCC
Q 003052 710 FSEYKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWR-----IPQLLQHPFLVP 769 (853)
Q Consensus 710 F~~~~~~~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpT-----a~EIL~HPwf~~ 769 (853)
|.+.........+.. ....++...+..+.+|+.+||..||.+|++ ..++++||||..
T Consensus 201 f~~~~~~~~~~~i~~---~~~~~p~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h~~f~~ 262 (323)
T cd05615 201 FDGEDEDELFQSIME---HNVSYPKSLSKEAVSICKGLMTKHPSKRLGCGPEGERDIREHAFFRR 262 (323)
T ss_pred CCCCCHHHHHHHHHh---CCCCCCccCCHHHHHHHHHHcccCHhhCCCCCCCCHHHHhcCcccCC
Confidence 987654433333322 223455667889999999999999999997 479999999975
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=361.80 Aligned_cols=265 Identities=22% Similarity=0.355 Sum_probs=203.1
Q ss_pred eEEcCceeeEEEeEeccCceEEEEEEe------cCCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehh
Q 003052 467 FKVNGKLYQRLGKIGSGGSSEVHKVIS------SDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYE 540 (853)
Q Consensus 467 ~~v~g~~Y~ilk~LG~G~FG~Vyka~~------~~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~ 540 (853)
|.+..++|++.++||+|+||.||+|.+ .++..||||+++... .......+.+|+.+|.++.+|+||+++++++
T Consensus 2 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~ 80 (338)
T cd05102 2 WEFPRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGA-TASEHKALMSELKILIHIGNHLNVVNLLGAC 80 (338)
T ss_pred cccchhHceeeeEeccCCcceEEEEEEeccCCcccchhhheecccccc-chHHHHHHHHHHHHHHHhccCcceeeEEeEe
Confidence 455667899999999999999999974 234679999997543 2334456889999999997799999999863
Q ss_pred hhHHHHHHHHhhCCCCCCCCccccCCeEEEEEecch-hhHHHHHHHhhhhc-----------------------------
Q 003052 541 VTEKALLREVLNGSMNNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEM----------------------------- 590 (853)
Q Consensus 541 ~~e~~iL~~l~~~~iv~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~~----------------------------- 590 (853)
. .....+|+||||+. ++|.+++.......
T Consensus 81 ~---------------------~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 139 (338)
T cd05102 81 T---------------------KPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEA 139 (338)
T ss_pred c---------------------CCCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhcccccccc
Confidence 2 23456899999976 58988886532100
Q ss_pred -------------------------cCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCCCccEEee-cCcEEEEecc
Q 003052 591 -------------------------DGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLLV-KGSLKLIDFG 644 (853)
Q Consensus 591 -------------------------~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLKPeNILL~-~g~VKL~DFG 644 (853)
......+++..+..++.||+.||.|||++||+||||||+|||++ ++.+||+|||
T Consensus 140 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~~~~kl~DfG 219 (338)
T cd05102 140 GQASVLFSRFQPSTSGSTNPPQETDDLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFG 219 (338)
T ss_pred ccCCccccccccccCcccccchhccccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCCCcEEEeecc
Confidence 00124588899999999999999999999999999999999994 6799999999
Q ss_pred cchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHh-CCCCCCcchhHHHHHHhh
Q 003052 645 IAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVY-GRTPFSEYKTFWAKFKVI 723 (853)
Q Consensus 645 lAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLt-G~~PF~~~~~~~~~~kii 723 (853)
+++.+.............+++.|+|||++.+.. |+.++|||||||+||||++ |..||.+..........+
T Consensus 220 ~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~---------~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~ 290 (338)
T cd05102 220 LARDIYKDPDYVRKGSARLPLKWMAPESIFDKV---------YTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRL 290 (338)
T ss_pred cccccccCcchhcccCCCCCccccCcHHhhcCC---------CCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHH
Confidence 998764333222223445678999999997653 5679999999999999997 999997644322222332
Q ss_pred cCCCCcccCCCCCChhHHHHHHHhcccCCCCCCChhHHhc
Q 003052 724 TDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQ 763 (853)
Q Consensus 724 ~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~ 763 (853)
... .....+...++.+.+||.+||..||.+||++.+|++
T Consensus 291 ~~~-~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~el~~ 329 (338)
T cd05102 291 KDG-TRMRAPENATPEIYRIMLACWQGDPKERPTFSALVE 329 (338)
T ss_pred hcC-CCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 222 222334567788999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-42 Score=377.93 Aligned_cols=253 Identities=27% Similarity=0.427 Sum_probs=212.2
Q ss_pred ceeeEEEeEeccCceEEEEEEe-cCCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHHHH
Q 003052 472 KLYQRLGKIGSGGSSEVHKVIS-SDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLREV 550 (853)
Q Consensus 472 ~~Y~ilk~LG~G~FG~Vyka~~-~~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~~l 550 (853)
..|..++.||+|+||.||+|.+ .+++.||+|++...... .....+.+||.+|..++ ++||.++|+
T Consensus 13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~-deIediqqei~~Ls~~~-~~~it~yyg------------ 78 (467)
T KOG0201|consen 13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAE-DEIEDIQQEISVLSQCD-SPNITEYYG------------ 78 (467)
T ss_pred cccccchhccccccceeeeeeeccccceEEEEEechhhcc-hhhHHHHHHHHHHHhcC-cchHHhhhh------------
Confidence 4588889999999999999998 57799999999887554 33456789999999998 577776654
Q ss_pred hhCCCCCCCCccccCCeEEEEEecch-hhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCCCc
Q 003052 551 LNGSMNNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPA 629 (853)
Q Consensus 551 ~~~~iv~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLKPe 629 (853)
+|-.+..++++||||+ |++.+.++. +..+.|..+..++++++.||.|||.++.+|||||+.
T Consensus 79 ----------syl~g~~LwiiMey~~gGsv~~lL~~--------~~~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaa 140 (467)
T KOG0201|consen 79 ----------SYLKGTKLWIIMEYCGGGSVLDLLKS--------GNILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAA 140 (467)
T ss_pred ----------heeecccHHHHHHHhcCcchhhhhcc--------CCCCccceeeeehHHHHHHhhhhhhcceeccccccc
Confidence 3566778999999976 477777653 356699999999999999999999999999999999
Q ss_pred cEEe-ecCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHhCCC
Q 003052 630 NFLL-VKGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGRT 708 (853)
Q Consensus 630 NILL-~~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLtG~~ 708 (853)
|||+ .+|.+||+|||.+..+.... ..+.+++|||+|||||++.+.. |+.++||||||++.|||++|.+
T Consensus 141 nil~s~~g~vkl~DfgVa~ql~~~~--~rr~tfvGTPfwMAPEVI~~~~---------Y~~KADIWSLGITaiEla~GeP 209 (467)
T KOG0201|consen 141 NILLSESGDVKLADFGVAGQLTNTV--KRRKTFVGTPFWMAPEVIKQSG---------YDTKADIWSLGITAIELAKGEP 209 (467)
T ss_pred ceeEeccCcEEEEecceeeeeechh--hccccccccccccchhhhcccc---------ccchhhhhhhhHHHHHHhcCCC
Confidence 9999 56899999999998775433 2347999999999999998654 5679999999999999999999
Q ss_pred CCCcchhHHHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCCChhHHhcCCCCCC
Q 003052 709 PFSEYKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQHPFLVP 769 (853)
Q Consensus 709 PF~~~~~~~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~HPwf~~ 769 (853)
||.+..++...+.+... .+..+...+++.+++||..||.+||+.||+|.++|+|+|++.
T Consensus 210 P~s~~hPmrvlflIpk~--~PP~L~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh~FIk~ 268 (467)
T KOG0201|consen 210 PHSKLHPMRVLFLIPKS--APPRLDGDFSPPFKEFVEACLDKNPEFRPSAKELLKHKFIKR 268 (467)
T ss_pred CCcccCcceEEEeccCC--CCCccccccCHHHHHHHHHHhhcCcccCcCHHHHhhhHHHHh
Confidence 99988776555544432 333445578888999999999999999999999999999987
|
|
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-40 Score=348.46 Aligned_cols=257 Identities=30% Similarity=0.473 Sum_probs=203.5
Q ss_pred eeeEEEeEeccCceEEEEEEec-CCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHHHHh
Q 003052 473 LYQRLGKIGSGGSSEVHKVISS-DCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLREVL 551 (853)
Q Consensus 473 ~Y~ilk~LG~G~FG~Vyka~~~-~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~~l~ 551 (853)
.|++++.||+|+||.||+|.+. ++..||||+++...........+.+|+.+++++. |+||++++++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~------------ 67 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQ-HPNIVCLQDV------------ 67 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcC-CCCEeeeEEE------------
Confidence 3889999999999999999984 6789999999765544444456789999999998 8999999987
Q ss_pred hCCCCCCCCccccCCeEEEEEecchhhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCCCccE
Q 003052 552 NGSMNNKDGRVKDDGYIYMVLEYGEIDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANF 631 (853)
Q Consensus 552 ~~~iv~~~g~~~d~~~lyLVmEy~~gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLKPeNI 631 (853)
+.++..+|+||||++++|.+++... ..+..+++..++.++.||+.||.|||++||+||||||+||
T Consensus 68 ----------~~~~~~~~~v~e~~~~~l~~~~~~~-----~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~ni 132 (285)
T cd07861 68 ----------LMQESRLYLIFEFLSMDLKKYLDSL-----PKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNL 132 (285)
T ss_pred ----------EeeCCeEEEEEecCCCCHHHHHhcC-----CCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHE
Confidence 4456789999999988888777543 1235799999999999999999999999999999999999
Q ss_pred Ee-ecCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHhCCCCC
Q 003052 632 LL-VKGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGRTPF 710 (853)
Q Consensus 632 LL-~~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLtG~~PF 710 (853)
|+ .++.+||+|||++........ ......+++.|+|||++.+.. .++.++|||||||++|+|++|++||
T Consensus 133 l~~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~--------~~~~~~Dv~slG~il~~l~tg~~~~ 202 (285)
T cd07861 133 LIDNKGVIKLADFGLARAFGIPVR--VYTHEVVTLWYRAPEVLLGSP--------RYSTPVDIWSIGTIFAEMATKKPLF 202 (285)
T ss_pred EEcCCCcEEECcccceeecCCCcc--cccCCcccccccChHHhcCCC--------CcCcHHHHHHHHHHHHHHHHCCCCC
Confidence 99 567999999999976533211 123456789999999986542 3567899999999999999999999
Q ss_pred CcchhHHHHHHhhc---CCC-----------------------CcccCCCCCChhHHHHHHHhcccCCCCCCChhHHhcC
Q 003052 711 SEYKTFWAKFKVIT---DPN-----------------------HEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQH 764 (853)
Q Consensus 711 ~~~~~~~~~~kii~---~~~-----------------------~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~H 764 (853)
.+............ ... .........++++.+||.+||..||.+|||+.+|+.|
T Consensus 203 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~ 282 (285)
T cd07861 203 HGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNH 282 (285)
T ss_pred CCCCHHHHHHHHHHHhCCCChhhhhcchhhHHHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcC
Confidence 76543322221110 000 0001123467889999999999999999999999999
Q ss_pred CCC
Q 003052 765 PFL 767 (853)
Q Consensus 765 Pwf 767 (853)
|||
T Consensus 283 ~~~ 285 (285)
T cd07861 283 PYF 285 (285)
T ss_pred CCC
Confidence 997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=362.39 Aligned_cols=247 Identities=24% Similarity=0.420 Sum_probs=201.0
Q ss_pred EeEeccCceEEEEEEe----cCCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHHHHhhC
Q 003052 478 GKIGSGGSSEVHKVIS----SDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLREVLNG 553 (853)
Q Consensus 478 k~LG~G~FG~Vyka~~----~~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~~l~~~ 553 (853)
+.||+|+||.||++.+ .+++.||+|+++...........+.+|+++|++++ |+||++++++
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~-------------- 66 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVN-HPFIVKLHYA-------------- 66 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCC-CCCcccEEEE--------------
Confidence 5799999999999976 35689999999865433334455778999999997 8999999876
Q ss_pred CCCCCCCccccCCeEEEEEecch-hhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCCCccEE
Q 003052 554 SMNNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANFL 632 (853)
Q Consensus 554 ~iv~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLKPeNIL 632 (853)
+.+++.+|+||||+. ++|.+.+... ..+++..++.++.||+.||.|||++||+||||||+|||
T Consensus 67 --------~~~~~~~~lv~e~~~~~~L~~~l~~~--------~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil 130 (318)
T cd05582 67 --------FQTEGKLYLILDFLRGGDLFTRLSKE--------VMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENIL 130 (318)
T ss_pred --------EEcCCEEEEEEcCCCCCcHHHHHHHc--------CCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeE
Confidence 456778999999975 6888877543 56899999999999999999999999999999999999
Q ss_pred e-ecCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHhCCCCCC
Q 003052 633 L-VKGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGRTPFS 711 (853)
Q Consensus 633 L-~~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLtG~~PF~ 711 (853)
+ .++.+||+|||+++....... .....+||+.|+|||++.+.. ++.++|||||||++|+|++|+.||.
T Consensus 131 ~~~~~~~kL~Dfg~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~---------~~~~~DiwslG~il~el~tg~~p~~ 199 (318)
T cd05582 131 LDEEGHIKLTDFGLSKESIDHEK--KAYSFCGTVEYMAPEVVNRRG---------HTQSADWWSFGVLMFEMLTGSLPFQ 199 (318)
T ss_pred ECCCCcEEEeeccCCcccCCCCC--ceecccCChhhcCHHHHcCCC---------CCCccceeccceEeeeeccCCCCCC
Confidence 9 567999999999986543221 223568999999999997643 4679999999999999999999998
Q ss_pred cchhHHHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCCC-----hhHHhcCCCCCC
Q 003052 712 EYKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWR-----IPQLLQHPFLVP 769 (853)
Q Consensus 712 ~~~~~~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpT-----a~EIL~HPwf~~ 769 (853)
..........+.. ....++...++.+.+||.+||..||.+||+ +.+++.||||..
T Consensus 200 ~~~~~~~~~~i~~---~~~~~p~~~~~~~~~li~~~l~~~P~~R~~a~~~~~~~~~~~~~~~~ 259 (318)
T cd05582 200 GKDRKETMTMILK---AKLGMPQFLSPEAQSLLRALFKRNPANRLGAGPDGVEEIKRHPFFST 259 (318)
T ss_pred CCCHHHHHHHHHc---CCCCCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhCCCCcCC
Confidence 7554433333322 223445567889999999999999999999 677999999975
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-40 Score=359.87 Aligned_cols=248 Identities=25% Similarity=0.382 Sum_probs=200.8
Q ss_pred EeEeccCceEEEEEEec-CCcEEEEEEEecCCC-ChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHHHHhhCCC
Q 003052 478 GKIGSGGSSEVHKVISS-DCTIYALKKIKLKGR-DYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLREVLNGSM 555 (853)
Q Consensus 478 k~LG~G~FG~Vyka~~~-~g~~vAVKkik~~~~-~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~~l~~~~i 555 (853)
+.||+|+||.||+|.+. ++..||||+++.... .......+.+|+.++..+.+|+||++++++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~---------------- 64 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSC---------------- 64 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeE----------------
Confidence 36999999999999985 568999999986431 223345577899999999889999999876
Q ss_pred CCCCCccccCCeEEEEEecch-hhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCCCccEEe-
Q 003052 556 NNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLL- 633 (853)
Q Consensus 556 v~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLKPeNILL- 633 (853)
+.+.+.+|+||||+. ++|...+... ..+++..+..++.||+.||.|||++||+||||||+|||+
T Consensus 65 ------~~~~~~~~lv~e~~~~~~L~~~~~~~--------~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~ 130 (318)
T cd05570 65 ------FQTKDRLFFVMEYVNGGDLMFHIQRS--------GRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLD 130 (318)
T ss_pred ------EEcCCEEEEEEcCCCCCCHHHHHHHc--------CCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEEC
Confidence 456678999999975 5887776543 469999999999999999999999999999999999999
Q ss_pred ecCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHhCCCCCCcc
Q 003052 634 VKGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGRTPFSEY 713 (853)
Q Consensus 634 ~~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLtG~~PF~~~ 713 (853)
.++.+||+|||+++....... .....+||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.
T Consensus 131 ~~~~~kl~Dfg~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~---------~~~~~~DiwslGvil~~l~~G~~pf~~~ 199 (318)
T cd05570 131 SEGHIKIADFGMCKEGILGGV--TTSTFCGTPDYIAPEILSYQ---------PYGPAVDWWALGVLLYEMLAGQSPFEGD 199 (318)
T ss_pred CCCcEEecccCCCeecCcCCC--cccceecCccccCHHHhcCC---------CCCcchhhhhHHHHHHHHhhCCCCCCCC
Confidence 567999999999975432221 22356899999999999765 3567999999999999999999999765
Q ss_pred hhHHHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCh-----hHHhcCCCCCC
Q 003052 714 KTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRI-----PQLLQHPFLVP 769 (853)
Q Consensus 714 ~~~~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa-----~EIL~HPwf~~ 769 (853)
.... ....+.. ....++...+..+.+||.+||..||.+||++ .+++.||||..
T Consensus 200 ~~~~-~~~~i~~--~~~~~~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~~~~~~ 257 (318)
T cd05570 200 DEDE-LFQSILE--DEVRYPRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGHPFFRE 257 (318)
T ss_pred CHHH-HHHHHHc--CCCCCCCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcCCCcCC
Confidence 4432 2233322 2234455678899999999999999999999 99999999975
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-40 Score=367.11 Aligned_cols=261 Identities=29% Similarity=0.450 Sum_probs=204.3
Q ss_pred CceeeEEEeEeccCceEEEEEEec-CCcEEEEEEEecCCC-ChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHH
Q 003052 471 GKLYQRLGKIGSGGSSEVHKVISS-DCTIYALKKIKLKGR-DYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLR 548 (853)
Q Consensus 471 g~~Y~ilk~LG~G~FG~Vyka~~~-~g~~vAVKkik~~~~-~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~ 548 (853)
.+.|++.+.||+|+||.||+|.+. +++.||+|++..... .......+.+|+.+++.++ |+||++++++
T Consensus 42 ~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~-hp~iv~~~~~--------- 111 (371)
T cd05622 42 AEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFAN-SPWVVQLFYA--------- 111 (371)
T ss_pred hhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCC-CCCCCeEEEE---------
Confidence 467999999999999999999985 668999999975322 2223345678999998886 8999999876
Q ss_pred HHhhCCCCCCCCccccCCeEEEEEecch-hhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCC
Q 003052 549 EVLNGSMNNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLK 627 (853)
Q Consensus 549 ~l~~~~iv~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLK 627 (853)
+.++.++|+||||++ ++|.+++.. ..+++.+++.++.||+.||.|||++||+|||||
T Consensus 112 -------------~~~~~~~~lv~Ey~~gg~L~~~~~~---------~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLk 169 (371)
T cd05622 112 -------------FQDDRYLYMVMEYMPGGDLVNLMSN---------YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVK 169 (371)
T ss_pred -------------EEcCCEEEEEEcCCCCCcHHHHHHh---------cCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCC
Confidence 456778999999985 588887753 358999999999999999999999999999999
Q ss_pred CccEEe-ecCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHhC
Q 003052 628 PANFLL-VKGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYG 706 (853)
Q Consensus 628 PeNILL-~~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLtG 706 (853)
|+|||+ .++.+||+|||+|+....... ......+||+.|||||++.+.... ..|+.++|||||||++|||++|
T Consensus 170 p~NIll~~~~~ikL~DfG~a~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~-----~~~~~~~DiwSlGvilyell~G 243 (371)
T cd05622 170 PDNMLLDKSGHLKLADFGTCMKMNKEGM-VRCDTAVGTPDYISPEVLKSQGGD-----GYYGRECDWWSVGVFLYEMLVG 243 (371)
T ss_pred HHHEEECCCCCEEEEeCCceeEcCcCCc-ccccCcccCccccCHHHHhccCCC-----ccCCCccceeehhHHHHHHHhC
Confidence 999999 567999999999987643221 122467899999999999764321 1467899999999999999999
Q ss_pred CCCCCcchhHHHHHHhhcCC-CCcccCCCCCChhHHHHHHHhcccCCCC--CCChhHHhcCCCCCC
Q 003052 707 RTPFSEYKTFWAKFKVITDP-NHEITYEPVPNPWLLDLMKKCLAWDRNE--RWRIPQLLQHPFLVP 769 (853)
Q Consensus 707 ~~PF~~~~~~~~~~kii~~~-~~~~~~~~~~s~~l~dLI~kcL~~DP~k--RpTa~EIL~HPwf~~ 769 (853)
++||...........+.... ...+......+..+++||.+||..++.+ |+++.+|++||||..
T Consensus 244 ~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~~~~~ 309 (371)
T cd05622 244 DTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKN 309 (371)
T ss_pred CCCCCCCCHHHHHHHHHcCCCcccCCCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCcccCC
Confidence 99998755433333332211 1222233457889999999999844433 789999999999975
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-40 Score=360.23 Aligned_cols=249 Identities=28% Similarity=0.409 Sum_probs=200.4
Q ss_pred EeEeccCceEEEEEEec-CCcEEEEEEEecCCC-ChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHHHHhhCCC
Q 003052 478 GKIGSGGSSEVHKVISS-DCTIYALKKIKLKGR-DYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLREVLNGSM 555 (853)
Q Consensus 478 k~LG~G~FG~Vyka~~~-~g~~vAVKkik~~~~-~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~~l~~~~i 555 (853)
+.||+|+||.||+|.+. +++.||+|+++.... .......+.+|+.++.++.+|+||++++++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~---------------- 64 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSC---------------- 64 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEE----------------
Confidence 36999999999999984 668999999986532 233455678999999999889999999876
Q ss_pred CCCCCccccCCeEEEEEecch-hhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCCCccEEe-
Q 003052 556 NNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLL- 633 (853)
Q Consensus 556 v~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLKPeNILL- 633 (853)
+.+.+.+|+||||+. ++|...+... ..+++..++.|+.||+.||.|||++||+||||||+|||+
T Consensus 65 ------~~~~~~~~lv~e~~~~~~L~~~~~~~--------~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~ 130 (327)
T cd05617 65 ------FQTTSRLFLVIEYVNGGDLMFHMQRQ--------RKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLD 130 (327)
T ss_pred ------EEeCCEEEEEEeCCCCCcHHHHHHHc--------CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEe
Confidence 566778999999975 5887776543 569999999999999999999999999999999999999
Q ss_pred ecCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHhCCCCCCcc
Q 003052 634 VKGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGRTPFSEY 713 (853)
Q Consensus 634 ~~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLtG~~PF~~~ 713 (853)
.++.+||+|||+++....... .....+||+.|+|||++.+.. |+.++|||||||++|+|++|+.||...
T Consensus 131 ~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~---------~~~~~DiwslGvil~ell~g~~pf~~~ 199 (327)
T cd05617 131 ADGHIKLTDYGMCKEGLGPGD--TTSTFCGTPNYIAPEILRGEE---------YGFSVDWWALGVLMFEMMAGRSPFDII 199 (327)
T ss_pred CCCCEEEeccccceeccCCCC--ceecccCCcccCCHHHHCCCC---------CCchheeehhHHHHHHHHhCCCCCCcc
Confidence 567999999999975432211 223678999999999997653 567999999999999999999999531
Q ss_pred ------hhHHHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCCC------hhHHhcCCCCCC
Q 003052 714 ------KTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWR------IPQLLQHPFLVP 769 (853)
Q Consensus 714 ------~~~~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpT------a~EIL~HPwf~~ 769 (853)
.........+.. .....+...+..+.++|.+||.+||.+|++ +.++++||||..
T Consensus 200 ~~~~~~~~~~~~~~~~~~--~~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h~~f~~ 265 (327)
T cd05617 200 TDNPDMNTEDYLFQVILE--KPIRIPRFLSVKASHVLKGFLNKDPKERLGCQPQTGFSDIKSHTFFRS 265 (327)
T ss_pred CCCcccccHHHHHHHHHh--CCCCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHHcCCCCCC
Confidence 122223333332 223455667888999999999999999998 469999999975
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-40 Score=349.60 Aligned_cols=255 Identities=29% Similarity=0.472 Sum_probs=199.9
Q ss_pred eeeEEEeEeccCceEEEEEEe-cCCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHHHHh
Q 003052 473 LYQRLGKIGSGGSSEVHKVIS-SDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLREVL 551 (853)
Q Consensus 473 ~Y~ilk~LG~G~FG~Vyka~~-~~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~~l~ 551 (853)
+|++.+.||+|+||.||+|++ .++..||+|+++...........+.+|+.++++++ |+||++++++
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~-h~~i~~~~~~------------ 67 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELK-HKNIVRLYDV------------ 67 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcC-CCCeeeHHHH------------
Confidence 488999999999999999998 46789999999865444444456778999999997 8999999876
Q ss_pred hCCCCCCCCccccCCeEEEEEecchhhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCCCccE
Q 003052 552 NGSMNNKDGRVKDDGYIYMVLEYGEIDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANF 631 (853)
Q Consensus 552 ~~~iv~~~g~~~d~~~lyLVmEy~~gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLKPeNI 631 (853)
+.+...+|+||||++++|..++... ...+++..++.++.||+.||.|||++||+||||||+||
T Consensus 68 ----------~~~~~~~~lv~e~~~~~l~~~~~~~-------~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~ni 130 (284)
T cd07839 68 ----------LHSDKKLTLVFEYCDQDLKKYFDSC-------NGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNL 130 (284)
T ss_pred ----------hccCCceEEEEecCCCCHHHHHHhc-------CCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHE
Confidence 3456679999999998888876542 35699999999999999999999999999999999999
Q ss_pred Ee-ecCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHhCCCCC
Q 003052 632 LL-VKGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGRTPF 710 (853)
Q Consensus 632 LL-~~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLtG~~PF 710 (853)
++ .++.+||+|||+++....... ......+++.|+|||++.+.. .++.++|||||||++|+|++|..||
T Consensus 131 l~~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~--------~~~~~~DiwslG~il~~l~tg~~p~ 200 (284)
T cd07839 131 LINKNGELKLADFGLARAFGIPVR--CYSAEVVTLWYRPPDVLFGAK--------LYSTSIDMWSAGCIFAELANAGRPL 200 (284)
T ss_pred EEcCCCcEEECccchhhccCCCCC--CcCCCccccCCcChHHHhCCc--------ccCcHHHHHHHHHHHHHHHhcCCCC
Confidence 99 567999999999986543221 123457899999999986542 3567999999999999999998886
Q ss_pred CcchhHHHHH----HhhcCCC------------C--c---------ccCCCCCChhHHHHHHHhcccCCCCCCChhHHhc
Q 003052 711 SEYKTFWAKF----KVITDPN------------H--E---------ITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQ 763 (853)
Q Consensus 711 ~~~~~~~~~~----kii~~~~------------~--~---------~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~ 763 (853)
.......... +....+. . . ....+..++.+++||.+||..||.+|||+.+++.
T Consensus 201 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~ 280 (284)
T cd07839 201 FPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ 280 (284)
T ss_pred cCCCCHHHHHHHHHHHhCCCChHHhHHhhhcccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence 4322211111 1110000 0 0 0112345778999999999999999999999999
Q ss_pred CCCC
Q 003052 764 HPFL 767 (853)
Q Consensus 764 HPwf 767 (853)
||||
T Consensus 281 h~~f 284 (284)
T cd07839 281 HPYF 284 (284)
T ss_pred CCCC
Confidence 9998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-40 Score=358.93 Aligned_cols=247 Identities=27% Similarity=0.424 Sum_probs=194.8
Q ss_pred EeEeccCceEEEEEEec-CCcEEEEEEEecCCC-ChhhHhhHHHHHHHH-HHhcCCCceeEeeehhhhHHHHHHHHhhCC
Q 003052 478 GKIGSGGSSEVHKVISS-DCTIYALKKIKLKGR-DYATAYGFCQEIEYL-NKLKGKNNIIQLIDYEVTEKALLREVLNGS 554 (853)
Q Consensus 478 k~LG~G~FG~Vyka~~~-~g~~vAVKkik~~~~-~~~~~~~~l~EI~iL-kkL~~hpNIV~Lid~~~~e~~iL~~l~~~~ 554 (853)
+.||+|+||+||+|.+. +++.||||++..... .......+.+|+.++ +.++ |+||++++++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~-hp~iv~~~~~--------------- 64 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVK-HPFLVGLHYS--------------- 64 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCC-CCCCCCeeEE---------------
Confidence 36999999999999984 778999999975432 122334456666654 4454 8999998865
Q ss_pred CCCCCCccccCCeEEEEEecch-hhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCCCccEEe
Q 003052 555 MNNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLL 633 (853)
Q Consensus 555 iv~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLKPeNILL 633 (853)
+.+...+|+||||+. ++|..++... ..+++..++.++.||+.||.|||++||+||||||+|||+
T Consensus 65 -------~~~~~~~~lv~e~~~~g~L~~~l~~~--------~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll 129 (323)
T cd05575 65 -------FQTADKLYFVLDYVNGGELFFHLQRE--------RSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILL 129 (323)
T ss_pred -------EEeCCEEEEEEcCCCCCCHHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEE
Confidence 456778999999976 4887777543 578999999999999999999999999999999999999
Q ss_pred -ecCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHhCCCCCCc
Q 003052 634 -VKGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGRTPFSE 712 (853)
Q Consensus 634 -~~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLtG~~PF~~ 712 (853)
.++.+||+|||+++....... .....+||+.|+|||++.+.. |+.++|||||||++|+|++|..||..
T Consensus 130 ~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~---------~~~~~DvwslG~il~ell~g~~pf~~ 198 (323)
T cd05575 130 DSQGHVVLTDFGLCKEGIEHSK--TTSTFCGTPEYLAPEVLRKQP---------YDRTVDWWCLGAVLYEMLYGLPPFYS 198 (323)
T ss_pred CCCCcEEEeccCCCcccccCCC--ccccccCChhhcChhhhcCCC---------CCccccccccchhhhhhhcCCCCCCC
Confidence 567999999999976432221 223568999999999997653 56799999999999999999999977
Q ss_pred chhHHHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCh----hHHhcCCCCCC
Q 003052 713 YKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRI----PQLLQHPFLVP 769 (853)
Q Consensus 713 ~~~~~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa----~EIL~HPwf~~ 769 (853)
..... .+..+... ....+...+..+.+||.+||+.||.+||++ .++++||||..
T Consensus 199 ~~~~~-~~~~i~~~--~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~il~~~~~~~ 256 (323)
T cd05575 199 RDTAE-MYDNILNK--PLRLKPNISVSARHLLEGLLQKDRTKRLGAKDDFLEIKNHVFFSS 256 (323)
T ss_pred CCHHH-HHHHHHcC--CCCCCCCCCHHHHHHHHHHhhcCHHhCCCCCCCHHHHHcCCCcCC
Confidence 54433 22222221 233455678899999999999999999998 69999999965
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=366.06 Aligned_cols=252 Identities=22% Similarity=0.253 Sum_probs=198.6
Q ss_pred CceeeEEEeEeccCceEEEEEEec---CCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHH
Q 003052 471 GKLYQRLGKIGSGGSSEVHKVISS---DCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALL 547 (853)
Q Consensus 471 g~~Y~ilk~LG~G~FG~Vyka~~~---~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL 547 (853)
...|.+++.||+|+||.||+|... .+..||+|.+.... ...+|+++|++++ |+||++++++
T Consensus 91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~~-------~~~~E~~il~~l~-h~~iv~~~~~-------- 154 (392)
T PHA03207 91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGGK-------TPGREIDILKTIS-HRAIINLIHA-------- 154 (392)
T ss_pred cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEeccccc-------cHHHHHHHHHhcC-CCCccceeee--------
Confidence 457999999999999999999763 34678999886431 2458999999997 8999999876
Q ss_pred HHHhhCCCCCCCCccccCCeEEEEEecchhhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCC
Q 003052 548 REVLNGSMNNKDGRVKDDGYIYMVLEYGEIDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLK 627 (853)
Q Consensus 548 ~~l~~~~iv~~~g~~~d~~~lyLVmEy~~gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLK 627 (853)
+.....+|+||||++++|.+++.. ...+++..++.|+.||+.||.|||++||+|||||
T Consensus 155 --------------~~~~~~~~lv~e~~~~~l~~~l~~--------~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlk 212 (392)
T PHA03207 155 --------------YRWKSTVCMVMPKYKCDLFTYVDR--------SGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVK 212 (392)
T ss_pred --------------EeeCCEEEEEehhcCCCHHHHHHh--------cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCC
Confidence 455678999999999899888743 2579999999999999999999999999999999
Q ss_pred CccEEe-ecCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHhC
Q 003052 628 PANFLL-VKGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYG 706 (853)
Q Consensus 628 PeNILL-~~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLtG 706 (853)
|+|||+ .++.+||+|||+++.+............+||+.|+|||++.+.. |+.++|||||||++|||++|
T Consensus 213 p~Nill~~~~~~~l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---------~~~~~DvwslGvil~el~~g 283 (392)
T PHA03207 213 TENIFLDEPENAVLGDFGAACKLDAHPDTPQCYGWSGTLETNSPELLALDP---------YCAKTDIWSAGLVLFEMSVK 283 (392)
T ss_pred HHHEEEcCCCCEEEccCccccccCcccccccccccccccCccCHhHhcCCC---------CCchhhHHHHHHHHHHHHHC
Confidence 999999 56799999999998765433322333568999999999997653 56799999999999999999
Q ss_pred CCCCCcchh------HHHHHHhhcCCCCc-----------------------ccC-----CCCCChhHHHHHHHhcccCC
Q 003052 707 RTPFSEYKT------FWAKFKVITDPNHE-----------------------ITY-----EPVPNPWLLDLMKKCLAWDR 752 (853)
Q Consensus 707 ~~PF~~~~~------~~~~~kii~~~~~~-----------------------~~~-----~~~~s~~l~dLI~kcL~~DP 752 (853)
+.||.+... +..+.+.+...... ... ....+.++.+||.+||.+||
T Consensus 284 ~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp 363 (392)
T PHA03207 284 NVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQ 363 (392)
T ss_pred CCCCCCCCCCCcHHHHHHHHHHhccCccccCCccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccCh
Confidence 999965321 11111111100000 000 11235678999999999999
Q ss_pred CCCCChhHHhcCCCCCC
Q 003052 753 NERWRIPQLLQHPFLVP 769 (853)
Q Consensus 753 ~kRpTa~EIL~HPwf~~ 769 (853)
.+||++.++|.||||..
T Consensus 364 ~~Rpsa~e~l~~p~f~~ 380 (392)
T PHA03207 364 EFRPSAQDILSLPLFTK 380 (392)
T ss_pred hhCCCHHHHhhCchhhc
Confidence 99999999999999975
|
|
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-40 Score=357.61 Aligned_cols=248 Identities=24% Similarity=0.353 Sum_probs=198.6
Q ss_pred EeEeccCceEEEEEEec-CCcEEEEEEEecCCC-ChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHHHHhhCCC
Q 003052 478 GKIGSGGSSEVHKVISS-DCTIYALKKIKLKGR-DYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLREVLNGSM 555 (853)
Q Consensus 478 k~LG~G~FG~Vyka~~~-~g~~vAVKkik~~~~-~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~~l~~~~i 555 (853)
+.||+|+||.||+|.+. +++.||||+++.... .......+..|+.++..+.+||||++++++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~---------------- 64 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCT---------------- 64 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEE----------------
Confidence 36999999999999985 568999999986422 112334567888898887779999999876
Q ss_pred CCCCCccccCCeEEEEEecch-hhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCCCccEEe-
Q 003052 556 NNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLL- 633 (853)
Q Consensus 556 v~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLKPeNILL- 633 (853)
+.+...+|+||||+. ++|...+... ..+++..+..++.||+.||.|||++||+||||||+|||+
T Consensus 65 ------~~~~~~~~lv~ey~~~g~L~~~l~~~--------~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~ 130 (316)
T cd05619 65 ------FQTKENLFFVMEYLNGGDLMFHIQSC--------HKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLD 130 (316)
T ss_pred ------EEeCCEEEEEEeCCCCCcHHHHHHHc--------CCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEEC
Confidence 456678999999975 5888887643 468999999999999999999999999999999999999
Q ss_pred ecCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHhCCCCCCcc
Q 003052 634 VKGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGRTPFSEY 713 (853)
Q Consensus 634 ~~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLtG~~PF~~~ 713 (853)
.++.+||+|||+++....... .....+||+.|+|||++.+. .|+.++|||||||++|+|++|..||...
T Consensus 131 ~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~---------~~~~~~DvwslG~il~el~~G~~pf~~~ 199 (316)
T cd05619 131 TDGHIKIADFGMCKENMLGDA--KTCTFCGTPDYIAPEILLGQ---------KYNTSVDWWSFGVLLYEMLIGQSPFHGH 199 (316)
T ss_pred CCCCEEEccCCcceECCCCCC--ceeeecCCccccCHHHHcCC---------CCCchhhhhhHHHHHHHHHhCCCCCCCC
Confidence 567999999999975432211 22356899999999999764 3567999999999999999999999765
Q ss_pred hhHHHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCCChh-HHhcCCCCCC
Q 003052 714 KTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIP-QLLQHPFLVP 769 (853)
Q Consensus 714 ~~~~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~-EIL~HPwf~~ 769 (853)
... .....+... ...++...+.++++||.+||..||.+||++. ++++||||..
T Consensus 200 ~~~-~~~~~i~~~--~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~h~~~~~ 253 (316)
T cd05619 200 DEE-ELFQSIRMD--NPCYPRWLTREAKDILVKLFVREPERRLGVKGDIRQHPFFRE 253 (316)
T ss_pred CHH-HHHHHHHhC--CCCCCccCCHHHHHHHHHHhccCHhhcCCChHHHHcCcccCC
Confidence 443 222222221 1234556788899999999999999999996 9999999975
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=378.21 Aligned_cols=272 Identities=25% Similarity=0.331 Sum_probs=214.8
Q ss_pred EEcCceeeEEEeEeccCceEEEEEEe-cCCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHH
Q 003052 468 KVNGKLYQRLGKIGSGGSSEVHKVIS-SDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKAL 546 (853)
Q Consensus 468 ~v~g~~Y~ilk~LG~G~FG~Vyka~~-~~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~i 546 (853)
+..+++|++.+.||+|+||+||+|.+ .+++.||||++............+.+|+.+|..+. |+||+++++.+....
T Consensus 28 ~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~-h~~iv~~~~~~~~~~-- 104 (496)
T PTZ00283 28 KEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCD-FFSIVKCHEDFAKKD-- 104 (496)
T ss_pred cccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCC-CCcEEEeecceeccc--
Confidence 34457899999999999999999987 57899999999877666666667889999999987 889999876532110
Q ss_pred HHHHhhCCCCCCCCccccCCeEEEEEecch-hhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCC
Q 003052 547 LREVLNGSMNNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSD 625 (853)
Q Consensus 547 L~~l~~~~iv~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRD 625 (853)
.........+++||||+. ++|.+++..+.+ ....+++..++.++.||+.||.|||++||+|||
T Consensus 105 ------------~~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~----~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrD 168 (496)
T PTZ00283 105 ------------PRNPENVLMIALVLDYANAGDLRQEIKSRAK----TNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRD 168 (496)
T ss_pred ------------ccCcccceEEEEEEeCCCCCcHHHHHHHhhc----cCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCC
Confidence 000122235789999976 589888865422 345799999999999999999999999999999
Q ss_pred CCCccEEe-ecCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHH
Q 003052 626 LKPANFLL-VKGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMV 704 (853)
Q Consensus 626 LKPeNILL-~~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELL 704 (853)
|||+|||| .++.+||+|||+++.+............+||+.|+|||++.+. .|+.++|||||||++|||+
T Consensus 169 LKP~NILl~~~~~vkL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~---------~~s~k~DVwSlGvilyeLl 239 (496)
T PTZ00283 169 IKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRK---------PYSKKADMFSLGVLLYELL 239 (496)
T ss_pred CCHHHEEEeCCCCEEEEecccCeeccccccccccccccCCcceeCHHHhCCC---------CCCcHHHHHHHHHHHHHHH
Confidence 99999999 5679999999999876433222233467899999999999764 3568999999999999999
Q ss_pred hCCCCCCcchhHHHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCCChhHHhcCCCCCC
Q 003052 705 YGRTPFSEYKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQHPFLVP 769 (853)
Q Consensus 705 tG~~PF~~~~~~~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~HPwf~~ 769 (853)
+|+.||.+..........+.. . ....+...++++.+||.+||..||.+||++.++|+|||++.
T Consensus 240 tG~~Pf~~~~~~~~~~~~~~~-~-~~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~p~~~~ 302 (496)
T PTZ00283 240 TLKRPFDGENMEEVMHKTLAG-R-YDPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNMPICKL 302 (496)
T ss_pred HCCCCCCCCCHHHHHHHHhcC-C-CCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhCHHHHH
Confidence 999999875443333333322 1 12345567889999999999999999999999999999864
|
|
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-40 Score=342.74 Aligned_cols=251 Identities=35% Similarity=0.526 Sum_probs=202.6
Q ss_pred eeEEEeEeccCceEEEEEEec-CCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHHHHhh
Q 003052 474 YQRLGKIGSGGSSEVHKVISS-DCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLREVLN 552 (853)
Q Consensus 474 Y~ilk~LG~G~FG~Vyka~~~-~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~~l~~ 552 (853)
|++++.||+|+||.||++.+. +++.||+|++..............+|+.++++++ |+||++++++
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~-~~~i~~~~~~------------- 66 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLR-HPNIVQILDV------------- 66 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHT-BTTBCHEEEE-------------
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccc-cccccccccc-------------
Confidence 889999999999999999995 5578999999987665555555567999999994 9999999987
Q ss_pred CCCCCCCCccccCCeEEEEEecchh-hHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCCCccE
Q 003052 553 GSMNNKDGRVKDDGYIYMVLEYGEI-DLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANF 631 (853)
Q Consensus 553 ~~iv~~~g~~~d~~~lyLVmEy~~g-dL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLKPeNI 631 (853)
+.+...+|+||||+.+ +|.+++... ..+++..+..++.||+.||.|||++||+||||||+||
T Consensus 67 ---------~~~~~~~~~v~~~~~~~~L~~~l~~~--------~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NI 129 (260)
T PF00069_consen 67 ---------FQDDNYLYIVMEYCPGGSLQDYLQKN--------KPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENI 129 (260)
T ss_dssp ---------EEESSEEEEEEEEETTEBHHHHHHHH--------SSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGE
T ss_pred ---------cccccccccccccccccccccccccc--------ccccccccccccccccccccccccccccccccccccc
Confidence 4457789999999887 899988733 5789999999999999999999999999999999999
Q ss_pred Eee-cCcEEEEecccchhcccCCccccccccccCccccCchhhc-cCCCCCCCccccCCCccchhhhHHHHHHHHhCCCC
Q 003052 632 LLV-KGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFM-CNESDENGNIIKCGRPSDIWSLGCILYQMVYGRTP 709 (853)
Q Consensus 632 LL~-~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~-~~~~~~~~~~~~ys~ksDIWSLGVILyELLtG~~P 709 (853)
|++ ++.++|+|||++..... .........+++.|+|||++. +. .++.++||||||+++|+|++|..|
T Consensus 130 l~~~~~~~~l~Dfg~~~~~~~--~~~~~~~~~~~~~y~aPE~~~~~~---------~~~~~~Di~slG~il~~l~~~~~p 198 (260)
T PF00069_consen 130 LLDENGEVKLIDFGSSVKLSE--NNENFNPFVGTPEYMAPEVLQQGK---------KYTRKSDIWSLGIILYELLTGKLP 198 (260)
T ss_dssp EESTTSEEEESSGTTTEESTS--TTSEBSSSSSSGGGSCHHHHTTTS---------SBSTHHHHHHHHHHHHHHHHSSSS
T ss_pred ccccccccccccccccccccc--cccccccccccccccccccccccc---------cccccccccccccccccccccccc
Confidence 995 77999999999975411 122334678999999999987 32 357899999999999999999999
Q ss_pred CCcc---hhHHHHHHhhcCCCCcccC--CCCCChhHHHHHHHhcccCCCCCCChhHHhcCCCC
Q 003052 710 FSEY---KTFWAKFKVITDPNHEITY--EPVPNPWLLDLMKKCLAWDRNERWRIPQLLQHPFL 767 (853)
Q Consensus 710 F~~~---~~~~~~~kii~~~~~~~~~--~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~HPwf 767 (853)
|... +......+.... ...... ......++.+||.+||..||.+||++.++++||||
T Consensus 199 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~~~~~ 260 (260)
T PF00069_consen 199 FEESNSDDQLEIIEKILKR-PLPSSSQQSREKSEELRDLIKKMLSKDPEQRPSAEELLKHPWF 260 (260)
T ss_dssp STTSSHHHHHHHHHHHHHT-HHHHHTTSHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHTSGGG
T ss_pred cccccchhhhhhhhhcccc-cccccccccchhHHHHHHHHHHHccCChhHCcCHHHHhcCCCC
Confidence 9875 222222222111 111111 11123789999999999999999999999999997
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=356.34 Aligned_cols=261 Identities=29% Similarity=0.454 Sum_probs=201.7
Q ss_pred eeeEEEeEeccCceEEEEEEec-CCcEEEEEEEecCC-CChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHHHH
Q 003052 473 LYQRLGKIGSGGSSEVHKVISS-DCTIYALKKIKLKG-RDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLREV 550 (853)
Q Consensus 473 ~Y~ilk~LG~G~FG~Vyka~~~-~g~~vAVKkik~~~-~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~~l 550 (853)
+|++++.||+|+||.||++.+. +++.||+|++.+.. ........+.+|+.++..++ |+||++++++
T Consensus 2 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~-~~~i~~~~~~----------- 69 (331)
T cd05597 2 DFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGD-RRWITNLHYA----------- 69 (331)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCC-CCCCCceEEE-----------
Confidence 5999999999999999999984 67899999997532 12233445778999998886 8999998875
Q ss_pred hhCCCCCCCCccccCCeEEEEEecc-hhhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCCCc
Q 003052 551 LNGSMNNKDGRVKDDGYIYMVLEYG-EIDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPA 629 (853)
Q Consensus 551 ~~~~iv~~~g~~~d~~~lyLVmEy~-~gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLKPe 629 (853)
+.+++++|+||||+ +++|.+++.+. ...+++..++.++.||+.||+|||++||+||||||+
T Consensus 70 -----------~~~~~~~~lv~e~~~g~~L~~~l~~~-------~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~ 131 (331)
T cd05597 70 -----------FQDENNLYLVMDYYVGGDLLTLLSKF-------EDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPD 131 (331)
T ss_pred -----------EecCCeEEEEEecCCCCcHHHHHHHh-------cCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHH
Confidence 56678899999996 46898888642 246899999999999999999999999999999999
Q ss_pred cEEe-ecCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHhCCC
Q 003052 630 NFLL-VKGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGRT 708 (853)
Q Consensus 630 NILL-~~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLtG~~ 708 (853)
|||+ .++.+||+|||++..+..... ......+||+.|||||++...... ...++.++|||||||++|+|++|+.
T Consensus 132 Nill~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~----~~~~~~~~DiwslG~~l~el~~g~~ 206 (331)
T cd05597 132 NVLLDKNGHIRLADFGSCLRLLADGT-VQSNVAVGTPDYISPEILQAMEDG----KGRYGPECDWWSLGVCMYEMLYGET 206 (331)
T ss_pred HEEECCCCCEEEEECCceeecCCCCC-ccccceeccccccCHHHHhhcccc----ccCCCCcceeehhhhHHHHHhhCCC
Confidence 9999 567999999999976543222 112235799999999999643211 1246789999999999999999999
Q ss_pred CCCcchhHHHHHHhhcCCCCcccC---CCCCChhHHHHHHHhcccCCCC--CCChhHHhcCCCCCC
Q 003052 709 PFSEYKTFWAKFKVITDPNHEITY---EPVPNPWLLDLMKKCLAWDRNE--RWRIPQLLQHPFLVP 769 (853)
Q Consensus 709 PF~~~~~~~~~~kii~~~~~~~~~---~~~~s~~l~dLI~kcL~~DP~k--RpTa~EIL~HPwf~~ 769 (853)
||.+.........+.. ......+ ....+..+++||.+||..++++ |+++.++++||||..
T Consensus 207 Pf~~~~~~~~~~~i~~-~~~~~~~~~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~hp~~~~ 271 (331)
T cd05597 207 PFYAESLVETYGKIMN-HKEHFQFPPDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDHPFFEG 271 (331)
T ss_pred CCCCCCHHHHHHHHHc-CCCcccCCCccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCCCCCC
Confidence 9976544333222222 1111122 2346788999999999765554 789999999999965
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=348.21 Aligned_cols=253 Identities=26% Similarity=0.408 Sum_probs=201.8
Q ss_pred eeEEEeEeccCceEEEEEEe-cCCcEEEEEEEecCCCC-hhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHHHHh
Q 003052 474 YQRLGKIGSGGSSEVHKVIS-SDCTIYALKKIKLKGRD-YATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLREVL 551 (853)
Q Consensus 474 Y~ilk~LG~G~FG~Vyka~~-~~g~~vAVKkik~~~~~-~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~~l~ 551 (853)
|++.++||+|+||.||++.+ .+++.||||++...... ......+.+|+.++++++ |+||++++++
T Consensus 2 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~------------ 68 (285)
T cd05605 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVN-SRFVVSLAYA------------ 68 (285)
T ss_pred ceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcC-CCCEeeeeee------------
Confidence 88999999999999999998 46789999999754322 222345678999999997 8999999875
Q ss_pred hCCCCCCCCccccCCeEEEEEecch-hhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCCCcc
Q 003052 552 NGSMNNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPAN 630 (853)
Q Consensus 552 ~~~iv~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLKPeN 630 (853)
+.++..+|+||||+. ++|...+... ....+++..++.++.||+.||.|||++||+||||||+|
T Consensus 69 ----------~~~~~~~~lv~e~~~~~~L~~~~~~~------~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~N 132 (285)
T cd05605 69 ----------YETKDALCLVLTLMNGGDLKFHIYNM------GNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPEN 132 (285)
T ss_pred ----------ecCCCeEEEEEeccCCCcHHHHHHhc------CcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHH
Confidence 455668999999976 5777666432 23469999999999999999999999999999999999
Q ss_pred EEee-cCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHhCCCC
Q 003052 631 FLLV-KGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGRTP 709 (853)
Q Consensus 631 ILL~-~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLtG~~P 709 (853)
|+++ ++.++|+|||+++...... .....+|++.|+|||++.+. .++.++||||+||++|+|++|+.|
T Consensus 133 il~~~~~~~~l~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~---------~~~~~~Diws~G~~l~el~~g~~p 200 (285)
T cd05605 133 ILLDDYGHIRISDLGLAVEIPEGE---TIRGRVGTVGYMAPEVVKNE---------RYTFSPDWWGLGCLIYEMIEGKSP 200 (285)
T ss_pred EEECCCCCEEEeeCCCceecCCCC---ccccccCCCCccCcHHhcCC---------CCCccccchhHHHHHHHHHHCCCC
Confidence 9994 5799999999998653222 12345899999999999654 356789999999999999999999
Q ss_pred CCcchhHH---HHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCC-----ChhHHhcCCCCCC
Q 003052 710 FSEYKTFW---AKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERW-----RIPQLLQHPFLVP 769 (853)
Q Consensus 710 F~~~~~~~---~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRp-----Ta~EIL~HPwf~~ 769 (853)
|.+..... .....+.. ....++...+..+.+||.+||..||.+|| ++.++++||||..
T Consensus 201 f~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~ 266 (285)
T cd05605 201 FRQRKEKVKREEVERRVKE--DQEEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAHPFFRT 266 (285)
T ss_pred CCCCchhhHHHHHHHHhhh--cccccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcCcCccC
Confidence 97643321 11122221 22234556788899999999999999999 8999999999975
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-40 Score=349.15 Aligned_cols=250 Identities=26% Similarity=0.358 Sum_probs=197.8
Q ss_pred EeccCceEEEEEEec-CCcEEEEEEEecCCCC-hhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHHHHhhCCCCC
Q 003052 480 IGSGGSSEVHKVISS-DCTIYALKKIKLKGRD-YATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLREVLNGSMNN 557 (853)
Q Consensus 480 LG~G~FG~Vyka~~~-~g~~vAVKkik~~~~~-~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~~l~~~~iv~ 557 (853)
||+|+||+||+|.+. +++.||+|++...... ......+..|+.+|++++ |+||++++++
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~-~~~i~~~~~~------------------ 61 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVH-SRFIVSLAYA------------------ 61 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCC-CCcEeeeeEE------------------
Confidence 799999999999884 7789999999754322 223345778999999996 8999999875
Q ss_pred CCCccccCCeEEEEEecch-hhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCCCccEEe-ec
Q 003052 558 KDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLL-VK 635 (853)
Q Consensus 558 ~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLKPeNILL-~~ 635 (853)
+..+..+|+||||+. ++|...+.... .....+++..++.++.||+.||.|||++||+||||||+|||+ .+
T Consensus 62 ----~~~~~~~~lv~e~~~~g~L~~~~~~~~----~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~ 133 (280)
T cd05608 62 ----FQTKTDLCLVMTIMNGGDLRYHIYNVD----EENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDND 133 (280)
T ss_pred ----EcCCCeEEEEEeCCCCCCHHHHHHhcc----ccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCC
Confidence 455678999999976 57877664321 234579999999999999999999999999999999999999 46
Q ss_pred CcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHhCCCCCCcchh
Q 003052 636 GSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGRTPFSEYKT 715 (853)
Q Consensus 636 g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLtG~~PF~~~~~ 715 (853)
+.+||+|||++..+..... ......||+.|+|||++.+.. ++.++|||||||++|+|++|+.||.....
T Consensus 134 ~~~~l~dfg~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~---------~~~~~DvwslG~il~el~~g~~pf~~~~~ 202 (280)
T cd05608 134 GNVRISDLGLAVELKDGQS--KTKGYAGTPGFMAPELLQGEE---------YDFSVDYFALGVTLYEMIAARGPFRARGE 202 (280)
T ss_pred CCEEEeeCccceecCCCCc--cccccCCCcCccCHHHhcCCC---------CCccccHHHHHHHHHHHHhCCCCCCCCCc
Confidence 7999999999986643322 223568999999999997653 56799999999999999999999965322
Q ss_pred H---HHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCC-----ChhHHhcCCCCCC
Q 003052 716 F---WAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERW-----RIPQLLQHPFLVP 769 (853)
Q Consensus 716 ~---~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRp-----Ta~EIL~HPwf~~ 769 (853)
. ......+. .....++...+..+.+|+.+||..||.+|| +++++++||||+.
T Consensus 203 ~~~~~~~~~~~~--~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h~~~~~ 262 (280)
T cd05608 203 KVENKELKQRIL--NDSVTYPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTHPLFRD 262 (280)
T ss_pred chhHHHHHHhhc--ccCCCCcccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcChhhhc
Confidence 1 11112121 122344566788999999999999999999 8899999999975
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-40 Score=360.80 Aligned_cols=248 Identities=27% Similarity=0.411 Sum_probs=194.9
Q ss_pred EeccCceEEEEEEec-CCcEEEEEEEecCCC-ChhhHhhHHHHHHHHHHhc--CCCceeEeeehhhhHHHHHHHHhhCCC
Q 003052 480 IGSGGSSEVHKVISS-DCTIYALKKIKLKGR-DYATAYGFCQEIEYLNKLK--GKNNIIQLIDYEVTEKALLREVLNGSM 555 (853)
Q Consensus 480 LG~G~FG~Vyka~~~-~g~~vAVKkik~~~~-~~~~~~~~l~EI~iLkkL~--~hpNIV~Lid~~~~e~~iL~~l~~~~i 555 (853)
||+|+||.||+|.+. +++.||||++..... .......+..|..++.++. +|+||++++++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~---------------- 64 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFS---------------- 64 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEE----------------
Confidence 799999999999984 678999999975322 2223344567777877665 79999998875
Q ss_pred CCCCCccccCCeEEEEEecch-hhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCCCccEEe-
Q 003052 556 NNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLL- 633 (853)
Q Consensus 556 v~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLKPeNILL- 633 (853)
+.+...+|+||||+. ++|...+... ..+++..++.++.||+.||.|||++||+||||||+|||+
T Consensus 65 ------~~~~~~~~lv~e~~~~g~L~~~l~~~--------~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~ 130 (330)
T cd05586 65 ------FQTDSDLYLVTDYMSGGELFWHLQKE--------GRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLD 130 (330)
T ss_pred ------EecCCeEEEEEcCCCCChHHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEEC
Confidence 556778999999975 5887777543 569999999999999999999999999999999999999
Q ss_pred ecCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHhCCCCCCcc
Q 003052 634 VKGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGRTPFSEY 713 (853)
Q Consensus 634 ~~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLtG~~PF~~~ 713 (853)
.++.+||+|||+++....... .....+||+.|+|||++.+.. .++.++|||||||++|+|++|+.||...
T Consensus 131 ~~~~~kl~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~--------~~~~~~DvwslGvil~elltG~~Pf~~~ 200 (330)
T cd05586 131 ATGHIALCDFGLSKANLTDNK--TTNTFCGTTEYLAPEVLLDEK--------GYTKHVDFWSLGVLVFEMCCGWSPFYAE 200 (330)
T ss_pred CCCCEEEecCCcCcCCCCCCC--CccCccCCccccCHHHHcCCC--------CCCCccceeccccEEEEeccCCCCCCCC
Confidence 567999999999976432221 223678999999999986532 3568999999999999999999999765
Q ss_pred hhHHHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCC----ChhHHhcCCCCCC
Q 003052 714 KTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERW----RIPQLLQHPFLVP 769 (853)
Q Consensus 714 ~~~~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRp----Ta~EIL~HPwf~~ 769 (853)
... ..++.+......+. ....+.++.+||.+||..||.+|| ++.++++||||..
T Consensus 201 ~~~-~~~~~i~~~~~~~~-~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~h~~~~~ 258 (330)
T cd05586 201 DTQ-QMYRNIAFGKVRFP-KNVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKEHPFFAD 258 (330)
T ss_pred CHH-HHHHHHHcCCCCCC-CccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhcCccccC
Confidence 433 22333322222221 224678899999999999999998 7999999999975
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=363.65 Aligned_cols=254 Identities=25% Similarity=0.448 Sum_probs=224.7
Q ss_pred ceeeEEEeEeccCceEEEEEEe-cCCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHHHH
Q 003052 472 KLYQRLGKIGSGGSSEVHKVIS-SDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLREV 550 (853)
Q Consensus 472 ~~Y~ilk~LG~G~FG~Vyka~~-~~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~~l 550 (853)
..|.++++||+|+||.||++++ ..|.++|||++... ..++.+..||.|+.+++ .++||++|+-
T Consensus 33 EVFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~----sDLQEIIKEISIMQQC~-S~yVVKYYGS----------- 96 (502)
T KOG0574|consen 33 EVFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD----TDLQEIIKEISIMQQCK-SKYVVKYYGS----------- 96 (502)
T ss_pred HHHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc----chHHHHHHHHHHHHHcC-Cchhhhhhhh-----------
Confidence 3477888999999999999998 57899999999865 34567889999999998 6788888764
Q ss_pred hhCCCCCCCCccccCCeEEEEEecch-hhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCCCc
Q 003052 551 LNGSMNNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPA 629 (853)
Q Consensus 551 ~~~~iv~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLKPe 629 (853)
+-....+|||||||+ |++.+++..+ +.+|+|.++..+++..+.||+|||...-||||||..
T Consensus 97 -----------YFK~sDLWIVMEYCGAGSiSDI~R~R-------~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAG 158 (502)
T KOG0574|consen 97 -----------YFKHSDLWIVMEYCGAGSISDIMRAR-------RKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAG 158 (502)
T ss_pred -----------hccCCceEeehhhcCCCcHHHHHHHh-------cCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccc
Confidence 334567899999988 6888888654 468999999999999999999999999999999999
Q ss_pred cEEe-ecCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHhCCC
Q 003052 630 NFLL-VKGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGRT 708 (853)
Q Consensus 630 NILL-~~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLtG~~ 708 (853)
|||| .+|+.||+|||.|..+.+ +-..+++.+|||.|||||++..- .|..++||||||++..||..|++
T Consensus 159 NILLNT~G~AKLADFGVAGQLTD--TMAKRNTVIGTPFWMAPEVI~EI---------GY~~~ADIWSLGITaIEMAEG~P 227 (502)
T KOG0574|consen 159 NILLNTDGIAKLADFGVAGQLTD--TMAKRNTVIGTPFWMAPEVIEEI---------GYDTKADIWSLGITAIEMAEGRP 227 (502)
T ss_pred cEEEcccchhhhhhccccchhhh--hHHhhCccccCcccccHHHHHHh---------ccchhhhHhhhcchhhhhhcCCC
Confidence 9999 689999999999987754 23356789999999999999654 46679999999999999999999
Q ss_pred CCCcchhHHHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCCChhHHhcCCCCCCC
Q 003052 709 PFSEYKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQHPFLVPP 770 (853)
Q Consensus 709 PF~~~~~~~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~HPwf~~~ 770 (853)
||.+..++.++|.+-..+...+..+..++.++.|||++||.++|++|-|+-++++|||++..
T Consensus 228 PYsDIHPMRAIFMIPT~PPPTF~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H~FiknA 289 (502)
T KOG0574|consen 228 PYSDIHPMRAIFMIPTKPPPTFKKPEEWSSEFNDFIRSCLIKKPEERKTALRLCEHTFIKNA 289 (502)
T ss_pred CcccccccceeEeccCCCCCCCCChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhhhhhcCC
Confidence 99999999999999898888888888999999999999999999999999999999999864
|
|
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=348.83 Aligned_cols=258 Identities=28% Similarity=0.495 Sum_probs=202.6
Q ss_pred ceeeEEEeEeccCceEEEEEEec-CCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHHHH
Q 003052 472 KLYQRLGKIGSGGSSEVHKVISS-DCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLREV 550 (853)
Q Consensus 472 ~~Y~ilk~LG~G~FG~Vyka~~~-~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~~l 550 (853)
+.|.++++||+|+||.||+|.+. ++..||+|.++..... .....+.+|+.++++++ |+||++++++
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~E~~~l~~l~-h~nI~~~~~~----------- 72 (301)
T cd07873 6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEE-GAPCTAIREVSLLKDLK-HANIVTLHDI----------- 72 (301)
T ss_pred cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEeccccc-CchhHHHHHHHHHHhcC-CCCcceEEEE-----------
Confidence 46999999999999999999884 6788999999765432 22335678999999997 8999999987
Q ss_pred hhCCCCCCCCccccCCeEEEEEecchhhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCCCcc
Q 003052 551 LNGSMNNKDGRVKDDGYIYMVLEYGEIDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPAN 630 (853)
Q Consensus 551 ~~~~iv~~~g~~~d~~~lyLVmEy~~gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLKPeN 630 (853)
+.++..+|+||||++++|..++... ...+++..++.++.||+.||.|||++||+||||||+|
T Consensus 73 -----------~~~~~~~~lv~e~~~~~l~~~l~~~-------~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~N 134 (301)
T cd07873 73 -----------IHTEKSLTLVFEYLDKDLKQYLDDC-------GNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQN 134 (301)
T ss_pred -----------EecCCeEEEEEeccccCHHHHHHhc-------CCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHH
Confidence 4556789999999998888877543 3468999999999999999999999999999999999
Q ss_pred EEe-ecCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHhCCCC
Q 003052 631 FLL-VKGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGRTP 709 (853)
Q Consensus 631 ILL-~~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLtG~~P 709 (853)
||+ .++.+||+|||++........ ......+++.|+|||++.+.. .++.++|||||||++|+|++|++|
T Consensus 135 il~~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~--------~~~~~~Dv~slG~~l~el~tg~~~ 204 (301)
T cd07873 135 LLINERGELKLADFGLARAKSIPTK--TYSNEVVTLWYRPPDILLGST--------DYSTQIDMWGVGCIFYEMSTGRPL 204 (301)
T ss_pred EEECCCCcEEECcCcchhccCCCCC--cccccceeecccCcHHHhCCC--------CCccHHHHHHHHHHHHHHHhCCCC
Confidence 999 567999999999976533221 123456799999999986532 356799999999999999999999
Q ss_pred CCcchhHHHH---HHhhcCCC-------------Cccc-----------CCCCCChhHHHHHHHhcccCCCCCCChhHHh
Q 003052 710 FSEYKTFWAK---FKVITDPN-------------HEIT-----------YEPVPNPWLLDLMKKCLAWDRNERWRIPQLL 762 (853)
Q Consensus 710 F~~~~~~~~~---~kii~~~~-------------~~~~-----------~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL 762 (853)
|......... ...+..+. .... .....++++++||.+||..||.+|||+.|+|
T Consensus 205 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil 284 (301)
T cd07873 205 FPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAM 284 (301)
T ss_pred CCCCCHHHHHHHHHHHcCCCChhhchhhhccccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHh
Confidence 9764332111 11111000 0000 1134577899999999999999999999999
Q ss_pred cCCCCCCC
Q 003052 763 QHPFLVPP 770 (853)
Q Consensus 763 ~HPwf~~~ 770 (853)
+||||...
T Consensus 285 ~h~~f~~~ 292 (301)
T cd07873 285 KHPYFHCL 292 (301)
T ss_pred cCcccccc
Confidence 99999754
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-39 Score=370.59 Aligned_cols=253 Identities=20% Similarity=0.220 Sum_probs=195.3
Q ss_pred cCceeeEEEeEeccCceEEEEEEec-CCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHH
Q 003052 470 NGKLYQRLGKIGSGGSSEVHKVISS-DCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLR 548 (853)
Q Consensus 470 ~g~~Y~ilk~LG~G~FG~Vyka~~~-~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~ 548 (853)
.+..|.+.+.||+|+||.||+|.+. .++.||||.... ..+.+|+++|++|+ |+||++++++
T Consensus 167 ~~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~--------~~~~~E~~iL~~L~-HpnIv~l~~~--------- 228 (461)
T PHA03211 167 AGLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY--------ASSVHEARLLRRLS-HPAVLALLDV--------- 228 (461)
T ss_pred ccCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc--------cCHHHHHHHHHHCC-CCCCCcEEEE---------
Confidence 3556999999999999999999984 568899996432 23568999999997 8999999986
Q ss_pred HHhhCCCCCCCCccccCCeEEEEEecchhhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCCC
Q 003052 549 EVLNGSMNNKDGRVKDDGYIYMVLEYGEIDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKP 628 (853)
Q Consensus 549 ~l~~~~iv~~~g~~~d~~~lyLVmEy~~gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLKP 628 (853)
+..++..|+|||++.++|..++... ...+++..++.|+.||+.||.|||++||+||||||
T Consensus 229 -------------~~~~~~~~lv~e~~~~~L~~~l~~~-------~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP 288 (461)
T PHA03211 229 -------------RVVGGLTCLVLPKYRSDLYTYLGAR-------LRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKT 288 (461)
T ss_pred -------------EEECCEEEEEEEccCCCHHHHHHhc-------CCCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCH
Confidence 3456678999999888888887643 24699999999999999999999999999999999
Q ss_pred ccEEe-ecCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHhCC
Q 003052 629 ANFLL-VKGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGR 707 (853)
Q Consensus 629 eNILL-~~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLtG~ 707 (853)
+|||| .++.+||+|||+++.+............+||+.|||||++.+.. ++.++|||||||+||||++|.
T Consensus 289 ~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~---------~~~~sDvwSlGviL~El~~g~ 359 (461)
T PHA03211 289 ENVLVNGPEDICLGDFGAACFARGSWSTPFHYGIAGTVDTNAPEVLAGDP---------YTPSVDIWSAGLVIFEAAVHT 359 (461)
T ss_pred HHEEECCCCCEEEcccCCceecccccccccccccCCCcCCcCHHHHcCCC---------CCchHHHHHHHHHHHHHHHcC
Confidence 99999 45799999999998664332222223567999999999997653 567999999999999999987
Q ss_pred CCCCcch----------hHHHHHHhhcCCCCcc----------------------cC-------CCCCChhHHHHHHHhc
Q 003052 708 TPFSEYK----------TFWAKFKVITDPNHEI----------------------TY-------EPVPNPWLLDLMKKCL 748 (853)
Q Consensus 708 ~PF~~~~----------~~~~~~kii~~~~~~~----------------------~~-------~~~~s~~l~dLI~kcL 748 (853)
.|+.... .+..++.........+ .+ ....+..+.+||.+||
T Consensus 360 ~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL 439 (461)
T PHA03211 360 ASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRAL 439 (461)
T ss_pred CCcccCCcccccCCcHHHHHHHHHhhccccccCCCCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHc
Confidence 6653211 1111111110000000 00 0123457899999999
Q ss_pred ccCCCCCCChhHHhcCCCCCC
Q 003052 749 AWDRNERWRIPQLLQHPFLVP 769 (853)
Q Consensus 749 ~~DP~kRpTa~EIL~HPwf~~ 769 (853)
.+||.+|||+.|+|+||||..
T Consensus 440 ~~DP~~RPsa~elL~hp~f~~ 460 (461)
T PHA03211 440 TFDGARRPSAAELLRLPLFQS 460 (461)
T ss_pred ccChhhCcCHHHHhhCcccCC
Confidence 999999999999999999964
|
|
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=357.22 Aligned_cols=256 Identities=27% Similarity=0.412 Sum_probs=201.8
Q ss_pred cCceeeEEEeEeccCceEEEEEEec-CCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHH
Q 003052 470 NGKLYQRLGKIGSGGSSEVHKVISS-DCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLR 548 (853)
Q Consensus 470 ~g~~Y~ilk~LG~G~FG~Vyka~~~-~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~ 548 (853)
..+.|++.++||+|+||.||++.+. ++..+|+|++..... ......+.+|+++|++++ |+||++++++
T Consensus 3 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~-~~~~~~~~~E~~~l~~l~-h~~iv~~~~~--------- 71 (333)
T cd06650 3 KDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIK-PAIRNQIIRELQVLHECN-SPYIVGFYGA--------- 71 (333)
T ss_pred chhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccC-HHHHHHHHHHHHHHHHCC-CCcccceeEE---------
Confidence 4567999999999999999999985 678899998876532 334456889999999997 8999999886
Q ss_pred HHhhCCCCCCCCccccCCeEEEEEecch-hhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccC-ceeeCCC
Q 003052 549 EVLNGSMNNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEE-RIVHSDL 626 (853)
Q Consensus 549 ~l~~~~iv~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~-gIIHRDL 626 (853)
|.+++++|+||||+. ++|.+++... ..+++..++.++.||+.||.|||+. +|+||||
T Consensus 72 -------------~~~~~~~~lv~e~~~~~~L~~~l~~~--------~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dl 130 (333)
T cd06650 72 -------------FYSDGEISICMEHMDGGSLDQVLKKA--------GRIPEQILGKVSIAVIKGLTYLREKHKIMHRDV 130 (333)
T ss_pred -------------EEECCEEEEEEecCCCCcHHHHHHHc--------CCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCC
Confidence 456778999999975 5898888643 4689999999999999999999975 7999999
Q ss_pred CCccEEe-ecCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHh
Q 003052 627 KPANFLL-VKGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVY 705 (853)
Q Consensus 627 KPeNILL-~~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLt 705 (853)
||+|||+ .++.+||+|||++..+.... ....+||+.|+|||++.+. .++.++|||||||++|+|++
T Consensus 131 kp~Nili~~~~~~kL~Dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~---------~~~~~~DvwslG~il~~l~~ 197 (333)
T cd06650 131 KPSNILVNSRGEIKLCDFGVSGQLIDSM----ANSFVGTRSYMSPERLQGT---------HYSVQSDIWSMGLSLVEMAI 197 (333)
T ss_pred ChhhEEEcCCCCEEEeeCCcchhhhhhc----cccCCCCccccCHHHhcCC---------CCCcHHHHHHHHHHHHHHHH
Confidence 9999999 46789999999998654322 1246799999999999754 35679999999999999999
Q ss_pred CCCCCCcchhHHH--HHH-----------------------------------------hhcCCCCcccCCCCCChhHHH
Q 003052 706 GRTPFSEYKTFWA--KFK-----------------------------------------VITDPNHEITYEPVPNPWLLD 742 (853)
Q Consensus 706 G~~PF~~~~~~~~--~~k-----------------------------------------ii~~~~~~~~~~~~~s~~l~d 742 (853)
|+.||........ ... .+.............+.++++
T Consensus 198 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 277 (333)
T cd06650 198 GRYPIPPPDAKELELMFGCPVEGDPAESETSPRPRPPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQD 277 (333)
T ss_pred CCCCCCCcchhHHHHHhcCcccCCccccccCcccCCccchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHH
Confidence 9999964322111 000 000000000011234677999
Q ss_pred HHHHhcccCCCCCCChhHHhcCCCCCCC
Q 003052 743 LMKKCLAWDRNERWRIPQLLQHPFLVPP 770 (853)
Q Consensus 743 LI~kcL~~DP~kRpTa~EIL~HPwf~~~ 770 (853)
||.+||++||.+|||+.|++.||||+..
T Consensus 278 li~~~L~~~P~~Rpt~~ell~h~~~~~~ 305 (333)
T cd06650 278 FVNKCLIKNPAERADLKQLMVHAFIKRS 305 (333)
T ss_pred HHHHhccCCcccCcCHHHHhhCHHHhcC
Confidence 9999999999999999999999999754
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-40 Score=357.31 Aligned_cols=248 Identities=26% Similarity=0.387 Sum_probs=194.8
Q ss_pred EeEeccCceEEEEEEe-cCCcEEEEEEEecCCC-ChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHHHHhhCCC
Q 003052 478 GKIGSGGSSEVHKVIS-SDCTIYALKKIKLKGR-DYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLREVLNGSM 555 (853)
Q Consensus 478 k~LG~G~FG~Vyka~~-~~g~~vAVKkik~~~~-~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~~l~~~~i 555 (853)
+.||+|+||.||+|.+ .+++.||+|++..... .......+.+|+.++.+..+|+||++++++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~---------------- 64 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYS---------------- 64 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEE----------------
Confidence 3699999999999998 4778999999975422 223334566676655444458999999876
Q ss_pred CCCCCccccCCeEEEEEecch-hhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCCCccEEe-
Q 003052 556 NNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLL- 633 (853)
Q Consensus 556 v~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLKPeNILL- 633 (853)
+..++.+|+||||+. ++|...+... ..+++..++.++.||+.||.|||++||+||||||+|||+
T Consensus 65 ------~~~~~~~~lv~e~~~~~~L~~~l~~~--------~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~ 130 (325)
T cd05604 65 ------FQTTEKLYFVLDFVNGGELFFHLQRE--------RSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLD 130 (325)
T ss_pred ------EecCCEEEEEEcCCCCCCHHHHHHHc--------CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEEC
Confidence 456778999999976 4777666532 579999999999999999999999999999999999999
Q ss_pred ecCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHhCCCCCCcc
Q 003052 634 VKGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGRTPFSEY 713 (853)
Q Consensus 634 ~~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLtG~~PF~~~ 713 (853)
.+|.+||+|||+++....... .....+||+.|+|||++.+.. |+.++|||||||++|+|++|..||...
T Consensus 131 ~~~~~kL~DfG~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~---------~~~~~DvwslG~il~el~~G~~pf~~~ 199 (325)
T cd05604 131 SQGHVVLTDFGLCKEGIAQSD--TTTTFCGTPEYLAPEVIRKQP---------YDNTVDWWCLGAVLYEMLYGLPPFYCR 199 (325)
T ss_pred CCCCEEEeecCCcccCCCCCC--CcccccCChhhCCHHHHcCCC---------CCCcCccccccceehhhhcCCCCCCCC
Confidence 567999999999975432221 223568999999999997653 567999999999999999999999765
Q ss_pred hhHHHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCh----hHHhcCCCCCC
Q 003052 714 KTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRI----PQLLQHPFLVP 769 (853)
Q Consensus 714 ~~~~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa----~EIL~HPwf~~ 769 (853)
........++. ......+..+..+.++|.+||..||.+||++ .++++||||..
T Consensus 200 ~~~~~~~~~~~---~~~~~~~~~~~~~~~ll~~ll~~~p~~R~~~~~~~~~i~~h~~f~~ 256 (325)
T cd05604 200 DVAEMYDNILH---KPLVLRPGASLTAWSILEELLEKDRQRRLGAKEDFLEIQEHPFFES 256 (325)
T ss_pred CHHHHHHHHHc---CCccCCCCCCHHHHHHHHHHhccCHHhcCCCCCCHHHHhcCCCcCC
Confidence 44333222322 2233445678889999999999999999987 59999999975
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-41 Score=344.39 Aligned_cols=253 Identities=27% Similarity=0.443 Sum_probs=214.2
Q ss_pred ceeeEEEeEeccCceEEEEEEe-cCCcEEEEEEEecCCC-ChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHHH
Q 003052 472 KLYQRLGKIGSGGSSEVHKVIS-SDCTIYALKKIKLKGR-DYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLRE 549 (853)
Q Consensus 472 ~~Y~ilk~LG~G~FG~Vyka~~-~~g~~vAVKkik~~~~-~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~~ 549 (853)
++|.+.+.||+|-||.||.|+. +++-++|+|++.+... .......+.+|++|-..|+ ||||+++++|
T Consensus 22 ~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~-hpnilrlY~~---------- 90 (281)
T KOG0580|consen 22 DDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLR-HPNILRLYGY---------- 90 (281)
T ss_pred hhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccC-CccHHhhhhh----------
Confidence 5689999999999999999987 5678999999976532 2334456789999999998 9999999988
Q ss_pred HhhCCCCCCCCccccCCeEEEEEecc-hhhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCCC
Q 003052 550 VLNGSMNNKDGRVKDDGYIYMVLEYG-EIDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKP 628 (853)
Q Consensus 550 l~~~~iv~~~g~~~d~~~lyLVmEy~-~gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLKP 628 (853)
|.|...+|+++||. .|.|+..+... ....++|..+..|++|++.||.|||.++||||||||
T Consensus 91 ------------fhd~~riyLilEya~~gel~k~L~~~------~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKp 152 (281)
T KOG0580|consen 91 ------------FHDSKRIYLILEYAPRGELYKDLQEG------RMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKP 152 (281)
T ss_pred ------------eeccceeEEEEEecCCchHHHHHHhc------ccccccccchhHHHHHHHHHHHHhccCCcccCCCCH
Confidence 56677899999994 47888888743 346799999999999999999999999999999999
Q ss_pred ccEEe-ecCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHhCC
Q 003052 629 ANFLL-VKGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGR 707 (853)
Q Consensus 629 eNILL-~~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLtG~ 707 (853)
+|+|+ ..|.+||+|||.+-.-. ...+.+.|||..|.+||...+..+ +..+|+|++|++.||+|.|.
T Consensus 153 enlLlg~~~~lkiAdfGwsV~~p----~~kR~tlcgt~dyl~pEmv~~~~h---------d~~Vd~w~lgvl~yeflvg~ 219 (281)
T KOG0580|consen 153 ENLLLGSAGELKIADFGWSVHAP----SNKRKTLCGTLDYLPPEMVEGRGH---------DKFVDLWSLGVLCYEFLVGL 219 (281)
T ss_pred HHhccCCCCCeeccCCCceeecC----CCCceeeecccccCCHhhcCCCCc---------cchhhHHHHHHHHHHHHhcC
Confidence 99999 68899999999986432 335679999999999999987754 46899999999999999999
Q ss_pred CCCCcchhHHHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCCChhHHhcCCCCCC
Q 003052 708 TPFSEYKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQHPFLVP 769 (853)
Q Consensus 708 ~PF~~~~~~~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~HPwf~~ 769 (853)
+||.... ..+.++.+. ...+.++...+..++|||.+||.++|.+|.+..|++.|||+..
T Consensus 220 ppFes~~-~~etYkrI~--k~~~~~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~hpwI~a 278 (281)
T KOG0580|consen 220 PPFESQS-HSETYKRIR--KVDLKFPSTISGGAADLISRLLVKNPIERLALTEVMDHPWIVA 278 (281)
T ss_pred Cchhhhh-hHHHHHHHH--HccccCCcccChhHHHHHHHHhccCccccccHHHHhhhHHHHh
Confidence 9997654 334444444 2445667888999999999999999999999999999999864
|
|
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=355.96 Aligned_cols=247 Identities=27% Similarity=0.401 Sum_probs=194.0
Q ss_pred EeEeccCceEEEEEEec-CCcEEEEEEEecCCCC-hhhHhhHHHHHHH-HHHhcCCCceeEeeehhhhHHHHHHHHhhCC
Q 003052 478 GKIGSGGSSEVHKVISS-DCTIYALKKIKLKGRD-YATAYGFCQEIEY-LNKLKGKNNIIQLIDYEVTEKALLREVLNGS 554 (853)
Q Consensus 478 k~LG~G~FG~Vyka~~~-~g~~vAVKkik~~~~~-~~~~~~~l~EI~i-LkkL~~hpNIV~Lid~~~~e~~iL~~l~~~~ 554 (853)
+.||+|+||.||+|.+. +++.||+|++...... ......+..|... ++.+ .|+||++++++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~-~h~~Iv~~~~~--------------- 64 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNV-KHPFLVGLHFS--------------- 64 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhC-CCCCCCceeEE---------------
Confidence 36999999999999985 6688999999754221 1222344555554 4445 48999998876
Q ss_pred CCCCCCccccCCeEEEEEecchh-hHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCCCccEEe
Q 003052 555 MNNKDGRVKDDGYIYMVLEYGEI-DLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLL 633 (853)
Q Consensus 555 iv~~~g~~~d~~~lyLVmEy~~g-dL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLKPeNILL 633 (853)
+.+.+.+|+||||+.+ +|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||+
T Consensus 65 -------~~~~~~~~lv~e~~~~~~L~~~~~~~--------~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili 129 (325)
T cd05602 65 -------FQTADKLYFVLDYINGGELFYHLQRE--------RCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILL 129 (325)
T ss_pred -------EEcCCeEEEEEeCCCCCcHHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEE
Confidence 4567789999999764 787777543 568899999999999999999999999999999999999
Q ss_pred -ecCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHhCCCCCCc
Q 003052 634 -VKGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGRTPFSE 712 (853)
Q Consensus 634 -~~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLtG~~PF~~ 712 (853)
.++.+||+|||+++....... .....+||+.|+|||++.+.. |+.++|||||||++|+|++|.+||.+
T Consensus 130 ~~~~~~kl~DfG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~---------~~~~~DiwslG~il~el~~g~~pf~~ 198 (325)
T cd05602 130 DSQGHIVLTDFGLCKENIEHNG--TTSTFCGTPEYLAPEVLHKQP---------YDRTVDWWCLGAVLYEMLYGLPPFYS 198 (325)
T ss_pred CCCCCEEEccCCCCcccccCCC--CcccccCCccccCHHHHcCCC---------CCCccccccccHHHHHHhcCCCCCCC
Confidence 567999999999986433221 223678999999999997653 56799999999999999999999987
Q ss_pred chhHHHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCCChh----HHhcCCCCCC
Q 003052 713 YKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIP----QLLQHPFLVP 769 (853)
Q Consensus 713 ~~~~~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~----EIL~HPwf~~ 769 (853)
.........+.. ....+....+..+.+||.+||+.||.+|+++. ++++|+||.+
T Consensus 199 ~~~~~~~~~i~~---~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~i~~~~~~~~ 256 (325)
T cd05602 199 RNTAEMYDNILN---KPLQLKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKNHIFFSP 256 (325)
T ss_pred CCHHHHHHHHHh---CCcCCCCCCCHHHHHHHHHHcccCHHHCCCCCCCHHHHhcCcccCC
Confidence 554433333322 22334556788999999999999999999876 8999999965
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-39 Score=342.14 Aligned_cols=262 Identities=24% Similarity=0.411 Sum_probs=205.2
Q ss_pred eeeEEEeEeccCceEEEEEEec-CCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHHHHh
Q 003052 473 LYQRLGKIGSGGSSEVHKVISS-DCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLREVL 551 (853)
Q Consensus 473 ~Y~ilk~LG~G~FG~Vyka~~~-~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~~l~ 551 (853)
.|++++.||+|+||.||+|.+. +++.||+|+++...... ....+..|+.++.+..+|+||++++++
T Consensus 2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~e~~~~~~~~~~~~iv~~~~~------------ 68 (283)
T cd06617 2 DLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQ-EQKRLLMDLDISMRSVDCPYTVTFYGA------------ 68 (283)
T ss_pred CceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcH-HHHHHHHHHHHHHHHcCCCCeeeeeEE------------
Confidence 5899999999999999999984 68999999998654332 233566788877777779999999987
Q ss_pred hCCCCCCCCccccCCeEEEEEecchhhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccC-ceeeCCCCCcc
Q 003052 552 NGSMNNKDGRVKDDGYIYMVLEYGEIDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEE-RIVHSDLKPAN 630 (853)
Q Consensus 552 ~~~iv~~~g~~~d~~~lyLVmEy~~gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~-gIIHRDLKPeN 630 (853)
+..++.+|+||||++++|.+++..... ....+++..++.++.||+.||.|||++ +|+||||||+|
T Consensus 69 ----------~~~~~~~~lv~e~~~~~l~~~l~~~~~----~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~n 134 (283)
T cd06617 69 ----------LFREGDVWICMEVMDTSLDKFYKKVYD----KGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSN 134 (283)
T ss_pred ----------EecCCcEEEEhhhhcccHHHHHHHhcc----CCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHH
Confidence 345667899999999988888765422 235799999999999999999999998 99999999999
Q ss_pred EEe-ecCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHhCCCC
Q 003052 631 FLL-VKGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGRTP 709 (853)
Q Consensus 631 ILL-~~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLtG~~P 709 (853)
||+ .++.+||+|||++..+.... ......|+..|+|||++.+... ...++.++|+|||||++|+|++|+.|
T Consensus 135 il~~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~-----~~~~~~~~Di~slG~~l~~l~~g~~p 206 (283)
T cd06617 135 VLINRNGQVKLCDFGISGYLVDSV---AKTIDAGCKPYMAPERINPELN-----QKGYDVKSDVWSLGITMIELATGRFP 206 (283)
T ss_pred EEECCCCCEEEeeccccccccccc---ccccccCCccccChhhcCCccc-----ccccCccccchhhHHHHHHHHhCCCC
Confidence 999 56799999999998664321 1223578999999999865322 12467899999999999999999999
Q ss_pred CCcchh-HHHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCCChhHHhcCCCCCCC
Q 003052 710 FSEYKT-FWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQHPFLVPP 770 (853)
Q Consensus 710 F~~~~~-~~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~HPwf~~~ 770 (853)
|..... .......+..... .......+.++.+||.+||..+|.+||++.++++||||...
T Consensus 207 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~ 267 (283)
T cd06617 207 YDSWKTPFQQLKQVVEEPSP-QLPAEKFSPEFQDFVNKCLKKNYKERPNYPELLQHPFFELH 267 (283)
T ss_pred CCccccCHHHHHHHHhcCCC-CCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCchhhhc
Confidence 975332 2222222221111 11223467889999999999999999999999999999864
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=370.91 Aligned_cols=257 Identities=32% Similarity=0.432 Sum_probs=220.7
Q ss_pred ceeeEEEeEeccCceEEEEEEe-cCCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHHHH
Q 003052 472 KLYQRLGKIGSGGSSEVHKVIS-SDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLREV 550 (853)
Q Consensus 472 ~~Y~ilk~LG~G~FG~Vyka~~-~~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~~l 550 (853)
+.|..++.+|+|+||.++.+++ .+.+.|++|+|..............+|+.++.+++ |||||.+.+.++
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~-hP~iv~y~ds~~--------- 73 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLL-HPNIVEYKDSFE--------- 73 (426)
T ss_pred chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhcc-CCCeeeeccchh---------
Confidence 5699999999999999999988 46789999999988777777778899999999987 999999988632
Q ss_pred hhCCCCCCCCccccCCeEEEEEecchh-hHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCCCc
Q 003052 551 LNGSMNNKDGRVKDDGYIYMVLEYGEI-DLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPA 629 (853)
Q Consensus 551 ~~~~iv~~~g~~~d~~~lyLVmEy~~g-dL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLKPe 629 (853)
.++.++||||+||+| +|.+.|.+. .+..|+|+.+..|+.||+.||.|||+++|+|||||+.
T Consensus 74 ------------~~~~~l~Ivm~Y~eGg~l~~~i~~~------k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~ 135 (426)
T KOG0589|consen 74 ------------EDGQLLCIVMEYCEGGDLAQLIKEQ------KGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCA 135 (426)
T ss_pred ------------cCCceEEEEEeecCCCCHHHHHHHH------hhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhh
Confidence 334459999999885 888888776 2467999999999999999999999999999999999
Q ss_pred cEEe-ecCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHhCCC
Q 003052 630 NFLL-VKGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGRT 708 (853)
Q Consensus 630 NILL-~~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLtG~~ 708 (853)
|||+ .++.|||+|||+|+.+..... ...+.+|||+||.||++.+.+ |+.|+|||||||++|||++-++
T Consensus 136 Nifltk~~~VkLgDfGlaK~l~~~~~--~a~tvvGTp~YmcPEil~d~p---------Yn~KSDiWsLGC~~yEm~~lk~ 204 (426)
T KOG0589|consen 136 NIFLTKDKKVKLGDFGLAKILNPEDS--LASTVVGTPYYMCPEILSDIP---------YNEKSDIWSLGCCLYEMCTLKP 204 (426)
T ss_pred hhhccccCceeecchhhhhhcCCchh--hhheecCCCcccCHHHhCCCC---------CCccCcchhhcchHHHHHhccc
Confidence 9999 467889999999999876542 234789999999999998764 6789999999999999999999
Q ss_pred CCCcchhHHHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCCChhHHhcCCCCCC
Q 003052 709 PFSEYKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQHPFLVP 769 (853)
Q Consensus 709 PF~~~~~~~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~HPwf~~ 769 (853)
+|...+......++.... ....+...+.+++.||+.||..+|..||++.++|.+|.+.+
T Consensus 205 aF~a~~m~~Li~ki~~~~--~~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~P~l~~ 263 (426)
T KOG0589|consen 205 AFKASNMSELILKINRGL--YSPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRRPHLLR 263 (426)
T ss_pred ccCccchHHHHHHHhhcc--CCCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhChhhhh
Confidence 998876666666665432 34456678889999999999999999999999999998764
|
|
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=345.64 Aligned_cols=266 Identities=29% Similarity=0.478 Sum_probs=206.0
Q ss_pred eeeEEEeEeccCceEEEEEEec-CCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHHHHh
Q 003052 473 LYQRLGKIGSGGSSEVHKVISS-DCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLREVL 551 (853)
Q Consensus 473 ~Y~ilk~LG~G~FG~Vyka~~~-~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~~l~ 551 (853)
.|++.+.||+|+||.||+|.+. +++.||||+++...........+.+|+.+++++.+|+||+++++++....
T Consensus 2 ~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~------- 74 (295)
T cd07837 2 AYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEE------- 74 (295)
T ss_pred CceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecC-------
Confidence 5899999999999999999984 67899999987654443344567899999999998999999998643211
Q ss_pred hCCCCCCCCccccCCeEEEEEecchhhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCCCccE
Q 003052 552 NGSMNNKDGRVKDDGYIYMVLEYGEIDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANF 631 (853)
Q Consensus 552 ~~~iv~~~g~~~d~~~lyLVmEy~~gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLKPeNI 631 (853)
......+|+||||++++|.+++..... .....+++..++.++.||+.||.|||++||+||||||+||
T Consensus 75 ----------~~~~~~~~lv~e~~~~~l~~~~~~~~~---~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~ni 141 (295)
T cd07837 75 ----------KNGKPSLYLVFEYLDSDLKKFMDSNGR---GPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNL 141 (295)
T ss_pred ----------CCCCceEEEEeeccCcCHHHHHHHhcc---cCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHE
Confidence 112335899999999888888765421 1235689999999999999999999999999999999999
Q ss_pred Eee--cCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHhCCCC
Q 003052 632 LLV--KGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGRTP 709 (853)
Q Consensus 632 LL~--~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLtG~~P 709 (853)
+++ ++.+||+|||+++.+..... ......+++.|+|||++.+.. .++.++|||||||++|+|++|..|
T Consensus 142 l~~~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~--------~~~~~~Di~slG~~l~~l~~g~~~ 211 (295)
T cd07837 142 LVDKQKGLLKIADLGLGRAFSIPVK--SYTHEIVTLWYRAPEVLLGST--------HYSTPVDIWSVGCIFAEMSRKQPL 211 (295)
T ss_pred EEecCCCeEEEeecccceecCCCcc--ccCCcccccCCCChHHhhCCC--------CCCchHHHHHHHHHHHHHHcCCCC
Confidence 995 56899999999986543221 112346789999999986432 356799999999999999999999
Q ss_pred CCcchhHHHHHHhhc---CCCCcc----------------------cCCCCCChhHHHHHHHhcccCCCCCCChhHHhcC
Q 003052 710 FSEYKTFWAKFKVIT---DPNHEI----------------------TYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQH 764 (853)
Q Consensus 710 F~~~~~~~~~~kii~---~~~~~~----------------------~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~H 764 (853)
|.+........++.. .+.... ...+..+..+.+||.+||.+||.+||++.++|.|
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~ 291 (295)
T cd07837 212 FPGDSELQQLLHIFKLLGTPTEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTH 291 (295)
T ss_pred CCCCCHHHHHHHHHHHhCCCChhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 976555443333221 111000 0113467789999999999999999999999999
Q ss_pred CCCC
Q 003052 765 PFLV 768 (853)
Q Consensus 765 Pwf~ 768 (853)
|||+
T Consensus 292 ~~~~ 295 (295)
T cd07837 292 PYFD 295 (295)
T ss_pred CCcC
Confidence 9984
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-41 Score=398.71 Aligned_cols=262 Identities=30% Similarity=0.483 Sum_probs=208.1
Q ss_pred EcCceeeEEEeEeccCceEEEEEEe-cCCcEEEEEEEecCCC-ChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHH
Q 003052 469 VNGKLYQRLGKIGSGGSSEVHKVIS-SDCTIYALKKIKLKGR-DYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKAL 546 (853)
Q Consensus 469 v~g~~Y~ilk~LG~G~FG~Vyka~~-~~g~~vAVKkik~~~~-~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~i 546 (853)
.+.++|.+++.||+|+||.|..++. .++++||+|++.+-.. ....-.-|+.|-.+|-.-.
T Consensus 72 l~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~n------------------ 133 (1317)
T KOG0612|consen 72 LKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGN------------------ 133 (1317)
T ss_pred CCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCC------------------
Confidence 3446799999999999999999998 4679999999975210 0011112445555543322
Q ss_pred HHHHhhCCCCCCCCccccCCeEEEEEec-chhhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCC
Q 003052 547 LREVLNGSMNNKDGRVKDDGYIYMVLEY-GEIDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSD 625 (853)
Q Consensus 547 L~~l~~~~iv~~~g~~~d~~~lyLVmEy-~~gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRD 625 (853)
..-++.++..|+|+.++|+|||| +||||..++... ..++|.++++|+..|+.||.-||+.|+||||
T Consensus 134 -----s~Wiv~LhyAFQD~~~LYlVMdY~pGGDlltLlSk~--------~~~pE~~ArFY~aEiVlAldslH~mgyVHRD 200 (1317)
T KOG0612|consen 134 -----SEWIVQLHYAFQDERYLYLVMDYMPGGDLLTLLSKF--------DRLPEDWARFYTAEIVLALDSLHSMGYVHRD 200 (1317)
T ss_pred -----cHHHHHHHHHhcCccceEEEEecccCchHHHHHhhc--------CCChHHHHHHHHHHHHHHHHHHHhccceecc
Confidence 22245566779999999999999 567999998765 4799999999999999999999999999999
Q ss_pred CCCccEEee-cCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHH
Q 003052 626 LKPANFLLV-KGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMV 704 (853)
Q Consensus 626 LKPeNILL~-~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELL 704 (853)
|||+||||+ .|+|||+|||.|-.+..++ .+.....+|||.|++||++.....+ ...||+.+||||+||++||||
T Consensus 201 iKPDNvLld~~GHikLADFGsClkm~~dG-~V~s~~aVGTPDYISPEvLqs~~~~----~g~yG~ecDwWSlGV~~YEMl 275 (1317)
T KOG0612|consen 201 IKPDNVLLDKSGHIKLADFGSCLKMDADG-TVRSSVAVGTPDYISPEVLQSQGDG----KGEYGRECDWWSLGVFMYEML 275 (1317)
T ss_pred CCcceeEecccCcEeeccchhHHhcCCCC-cEEeccccCCCCccCHHHHHhhcCC----ccccCCccchhhhHHHHHHHH
Confidence 999999995 7999999999998776443 4456678999999999999765432 246999999999999999999
Q ss_pred hCCCCCCcchhHHHHHHhhcCCCCcccCC--CCCChhHHHHHHHhcccCCCCCCC---hhHHhcCCCCC
Q 003052 705 YGRTPFSEYKTFWAKFKVITDPNHEITYE--PVPNPWLLDLMKKCLAWDRNERWR---IPQLLQHPFLV 768 (853)
Q Consensus 705 tG~~PF~~~~~~~~~~kii~~~~~~~~~~--~~~s~~l~dLI~kcL~~DP~kRpT---a~EIL~HPwf~ 768 (853)
+|..||....-...+-++ ......+.+| ..+|.++++||.++|. +|..|.. ++++-.||||.
T Consensus 276 yG~TPFYadslveTY~KI-m~hk~~l~FP~~~~VSeeakdLI~~ll~-~~e~RLgrngiedik~HpFF~ 342 (1317)
T KOG0612|consen 276 YGETPFYADSLVETYGKI-MNHKESLSFPDETDVSEEAKDLIEALLC-DREVRLGRNGIEDIKNHPFFE 342 (1317)
T ss_pred cCCCcchHHHHHHHHHHH-hchhhhcCCCcccccCHHHHHHHHHHhc-ChhhhcccccHHHHHhCcccc
Confidence 999999875544444444 4334455566 5689999999999887 7889998 99999999995
|
|
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-39 Score=347.80 Aligned_cols=257 Identities=28% Similarity=0.465 Sum_probs=192.0
Q ss_pred EeEeccCceEEEEEEec---CCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHHHHhhCC
Q 003052 478 GKIGSGGSSEVHKVISS---DCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLREVLNGS 554 (853)
Q Consensus 478 k~LG~G~FG~Vyka~~~---~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~~l~~~~ 554 (853)
.+||+|+||.||+|... ++..||+|.+..... ...+.+|+.+|++++ |+||+++++++..
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~----~~~~~~E~~~l~~l~-h~niv~~~~~~~~------------ 69 (317)
T cd07867 7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGI----SMSACREIALLRELK-HPNVIALQKVFLS------------ 69 (317)
T ss_pred eEeccCCCeeEEEEEecCCCccceEEEEEecCCCC----cHHHHHHHHHHHhCC-CCCeeeEEEEEec------------
Confidence 57999999999999874 447899999875432 234678999999998 8999999987431
Q ss_pred CCCCCCccccCCeEEEEEecchhhHHHHHHHhhhh-ccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCCCccEEe
Q 003052 555 MNNKDGRVKDDGYIYMVLEYGEIDLAHMLSQKWKE-MDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLL 633 (853)
Q Consensus 555 iv~~~g~~~d~~~lyLVmEy~~gdL~~~L~~~~k~-~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLKPeNILL 633 (853)
..+..+|+||||++++|.+++...... .......+++..++.++.||+.||.|||++||+||||||+|||+
T Consensus 70 --------~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~ 141 (317)
T cd07867 70 --------HSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILV 141 (317)
T ss_pred --------cCCCeEEEEEeeeCCcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEE
Confidence 345678999999999988887643221 11123468999999999999999999999999999999999999
Q ss_pred e-----cCcEEEEecccchhcccCCcc-ccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHhCC
Q 003052 634 V-----KGSLKLIDFGIAKAIMSDTTN-IQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGR 707 (853)
Q Consensus 634 ~-----~g~VKL~DFGlAk~~~~~~~~-~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLtG~ 707 (853)
. .+.+||+|||+|+.+...... ......+||+.|+|||++.+.. .++.++|||||||++|||++|+
T Consensus 142 ~~~~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~--------~~~~~~DiwSlG~il~el~tg~ 213 (317)
T cd07867 142 MGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGAR--------HYTKAIDIWAIGCIFAELLTSE 213 (317)
T ss_pred ccCCCCCCcEEEeeccceeccCCCcccccccCcceecccccCcHHhcCCC--------ccCcHHHHHhHHHHHHHHHhCC
Confidence 2 358999999999876432211 1123567899999999986532 3578999999999999999999
Q ss_pred CCCCcchh------------HHHHHHhhcCCCC----------------------c----------ccCCCCCChhHHHH
Q 003052 708 TPFSEYKT------------FWAKFKVITDPNH----------------------E----------ITYEPVPNPWLLDL 743 (853)
Q Consensus 708 ~PF~~~~~------------~~~~~kii~~~~~----------------------~----------~~~~~~~s~~l~dL 743 (853)
+||..... ....+..+..+.. . .......+..+.+|
T Consensus 214 ~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 293 (317)
T cd07867 214 PIFHCRQEDIKTSNPFHHDQLDRIFSVMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLL 293 (317)
T ss_pred CCcccccccccccccccHHHHHHHHHhcCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHH
Confidence 99953211 0011111000000 0 00011234568899
Q ss_pred HHHhcccCCCCCCChhHHhcCCCC
Q 003052 744 MKKCLAWDRNERWRIPQLLQHPFL 767 (853)
Q Consensus 744 I~kcL~~DP~kRpTa~EIL~HPwf 767 (853)
|.+||..||.+|||+.|+|+||||
T Consensus 294 l~~~l~~dP~~R~t~~e~l~hp~f 317 (317)
T cd07867 294 LQKLLTMDPTKRITSEQALQDPYF 317 (317)
T ss_pred HHHHhccCcccccCHHHHhcCCCC
Confidence 999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=354.13 Aligned_cols=247 Identities=27% Similarity=0.404 Sum_probs=193.8
Q ss_pred EeEeccCceEEEEEEec-CCcEEEEEEEecCCC-ChhhHhhHHHHHHH-HHHhcCCCceeEeeehhhhHHHHHHHHhhCC
Q 003052 478 GKIGSGGSSEVHKVISS-DCTIYALKKIKLKGR-DYATAYGFCQEIEY-LNKLKGKNNIIQLIDYEVTEKALLREVLNGS 554 (853)
Q Consensus 478 k~LG~G~FG~Vyka~~~-~g~~vAVKkik~~~~-~~~~~~~~l~EI~i-LkkL~~hpNIV~Lid~~~~e~~iL~~l~~~~ 554 (853)
+.||+|+||.||+|.+. +++.||+|++..... .......+.+|+.. ++.++ |+||++++++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~-h~~iv~~~~~--------------- 64 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLK-HPFLVGLHYS--------------- 64 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCC-CCCccceeeE---------------
Confidence 36999999999999984 678999999975432 12223445666654 55554 8999998865
Q ss_pred CCCCCCccccCCeEEEEEecch-hhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCCCccEEe
Q 003052 555 MNNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLL 633 (853)
Q Consensus 555 iv~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLKPeNILL 633 (853)
+.+.+.+|+||||++ ++|...+... ..+++..++.++.||+.||.|||++||+||||||+||||
T Consensus 65 -------~~~~~~~~lv~e~~~~~~L~~~l~~~--------~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll 129 (321)
T cd05603 65 -------FQTAEKLYFVLDYVNGGELFFHLQRE--------RCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILL 129 (321)
T ss_pred -------EEcCCEEEEEEcCCCCCCHHHHHHHc--------CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEE
Confidence 556778999999976 4777666542 568999999999999999999999999999999999999
Q ss_pred -ecCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHhCCCCCCc
Q 003052 634 -VKGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGRTPFSE 712 (853)
Q Consensus 634 -~~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLtG~~PF~~ 712 (853)
.+|.+||+|||+++....... .....+||+.|+|||++.+. .|+.++|||||||++|||++|..||..
T Consensus 130 ~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~---------~~~~~~DiwslG~il~el~~g~~pf~~ 198 (321)
T cd05603 130 DSQGHVVLTDFGLCKEGVEPEE--TTSTFCGTPEYLAPEVLRKE---------PYDRTVDWWCLGAVLYEMLYGLPPFYS 198 (321)
T ss_pred CCCCCEEEccCCCCccCCCCCC--ccccccCCcccCCHHHhcCC---------CCCCcCcccccchhhhhhhcCCCCCCC
Confidence 567999999999976432221 22356899999999999754 356799999999999999999999977
Q ss_pred chhHHHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCh----hHHhcCCCCCC
Q 003052 713 YKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRI----PQLLQHPFLVP 769 (853)
Q Consensus 713 ~~~~~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa----~EIL~HPwf~~ 769 (853)
.+... .+..+.. .....+...+..+.++|.+||+.||.+|+++ .++++|+||..
T Consensus 199 ~~~~~-~~~~i~~--~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~~~~~~ 256 (321)
T cd05603 199 RDVSQ-MYDNILH--KPLQLPGGKTVAACDLLVGLLHKDQRRRLGAKADFLEIKNHVFFSP 256 (321)
T ss_pred CCHHH-HHHHHhc--CCCCCCCCCCHHHHHHHHHHccCCHhhcCCCCCCHHHHhCCCCcCC
Confidence 54432 3333322 2234556678889999999999999999976 49999999964
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=367.04 Aligned_cols=261 Identities=22% Similarity=0.275 Sum_probs=211.8
Q ss_pred CCceeEEcCceeeEEEeEeccCceEEEEEEecCCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhh
Q 003052 463 PDLFFKVNGKLYQRLGKIGSGGSSEVHKVISSDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVT 542 (853)
Q Consensus 463 p~~~~~v~g~~Y~ilk~LG~G~FG~Vyka~~~~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~ 542 (853)
....+.+.-....+...||+|.||+||+|.+.. .||||++.......+.++.|.+|+.+|++-+ |.||+-+.+|+.
T Consensus 383 s~~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whG--dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTR-H~NIlLFMG~~~- 458 (678)
T KOG0193|consen 383 SLEEWEIPPEEVLLGERIGSGSFGTVYRGRWHG--DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTR-HENILLFMGACM- 458 (678)
T ss_pred cccccccCHHHhhccceeccccccceeeccccc--ceEEEEEecCCCCHHHHHHHHHHHHHHhhcc-hhhheeeehhhc-
Confidence 345566666778899999999999999998844 3999999999999999999999999999999 889999988743
Q ss_pred HHHHHHHHhhCCCCCCCCccccCCeEEEEEecchh-hHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCce
Q 003052 543 EKALLREVLNGSMNNKDGRVKDDGYIYMVLEYGEI-DLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERI 621 (853)
Q Consensus 543 e~~iL~~l~~~~iv~~~g~~~d~~~lyLVmEy~~g-dL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gI 621 (853)
.+.+ .||.-+|+| +|+.+|... ...|.....+.|++||++|+.|||.++|
T Consensus 459 ---------------------~p~~-AIiTqwCeGsSLY~hlHv~-------etkfdm~~~idIAqQiaqGM~YLHAK~I 509 (678)
T KOG0193|consen 459 ---------------------NPPL-AIITQWCEGSSLYTHLHVQ-------ETKFDMNTTIDIAQQIAQGMDYLHAKNI 509 (678)
T ss_pred ---------------------CCce-eeeehhccCchhhhhccch-------hhhhhHHHHHHHHHHHHHhhhhhhhhhh
Confidence 3334 899999998 888888653 2468899999999999999999999999
Q ss_pred eeCCCCCccEEeec-CcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHH
Q 003052 622 VHSDLKPANFLLVK-GSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCIL 700 (853)
Q Consensus 622 IHRDLKPeNILL~~-g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVIL 700 (853)
||||||..||+|.+ +.|||+|||++..-.............|...|||||+++.... ..|++.+|||||||++
T Consensus 510 IHrDLKSnNIFl~~~~kVkIgDFGLatvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~------nPfS~qSDVYaFGiV~ 583 (678)
T KOG0193|consen 510 IHRDLKSNNIFLHEDLKVKIGDFGLATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDD------NPFSFQSDVYAFGIVW 583 (678)
T ss_pred hhhhccccceEEccCCcEEEecccceeeeeeeccccccCCCccchhhhcHHHHhhccc------CCCCcccchhhhhHHH
Confidence 99999999999954 7999999999975433333334456679999999999986543 3699999999999999
Q ss_pred HHHHhCCCCCCcchhHHHHHHhhcCCC---CcccCCCCCChhHHHHHHHhcccCCCCCCChhHHhc
Q 003052 701 YQMVYGRTPFSEYKTFWAKFKVITDPN---HEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQ 763 (853)
Q Consensus 701 yELLtG~~PF~~~~~~~~~~kii~~~~---~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~ 763 (853)
|||++|.+||.. ....+++-.+..+. .........+.++++|+..||.+++++||.+.+||.
T Consensus 584 YELltg~lPysi-~~~dqIifmVGrG~l~pd~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~ 648 (678)
T KOG0193|consen 584 YELLTGELPYSI-QNRDQIIFMVGRGYLMPDLSKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLS 648 (678)
T ss_pred HHHHhCcCCcCC-CChhheEEEecccccCccchhhhccCHHHHHHHHHHHHhcCcccCccHHHHHH
Confidence 999999999983 33333322222221 112223445668999999999999999999999987
|
|
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-39 Score=352.87 Aligned_cols=261 Identities=29% Similarity=0.456 Sum_probs=202.6
Q ss_pred eeeEEEeEeccCceEEEEEEec-CCcEEEEEEEecCCC-ChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHHHH
Q 003052 473 LYQRLGKIGSGGSSEVHKVISS-DCTIYALKKIKLKGR-DYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLREV 550 (853)
Q Consensus 473 ~Y~ilk~LG~G~FG~Vyka~~~-~g~~vAVKkik~~~~-~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~~l 550 (853)
.|+++++||+|+||.||++... +++.||+|++.+... .......+.+|+.++..+. |++|++++++
T Consensus 2 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~-~~~i~~~~~~----------- 69 (332)
T cd05623 2 DFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGD-NQWITTLHYA----------- 69 (332)
T ss_pred CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCC-CCCEeeEEEE-----------
Confidence 5899999999999999999985 567899999964321 2223345778899988876 8999999875
Q ss_pred hhCCCCCCCCccccCCeEEEEEecch-hhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCCCc
Q 003052 551 LNGSMNNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPA 629 (853)
Q Consensus 551 ~~~~iv~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLKPe 629 (853)
+.+...+|+||||+. ++|.+++.+. ...+++..++.++.||+.||.|||++||+||||||+
T Consensus 70 -----------~~~~~~~~lv~ey~~~g~L~~~l~~~-------~~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~ 131 (332)
T cd05623 70 -----------FQDENNLYLVMDYYVGGDLLTLLSKF-------EDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPD 131 (332)
T ss_pred -----------EecCCEEEEEEeccCCCcHHHHHHHh-------cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHH
Confidence 456778999999965 6898888653 246899999999999999999999999999999999
Q ss_pred cEEe-ecCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHhCCC
Q 003052 630 NFLL-VKGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGRT 708 (853)
Q Consensus 630 NILL-~~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLtG~~ 708 (853)
|||+ .++.+||+|||+++.+..... ......+||+.|+|||++.+.... ...|+.++|||||||++|||++|+.
T Consensus 132 Nili~~~~~~kL~DfG~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~----~~~~~~~~DvwSlGvil~ell~g~~ 206 (332)
T cd05623 132 NILMDMNGHIRLADFGSCLKLMEDGT-VQSSVAVGTPDYISPEILQAMEDG----KGKYGPECDWWSLGVCMYEMLYGET 206 (332)
T ss_pred HEEECCCCCEEEeecchheecccCCc-ceecccccCccccCHHHHhccccC----CCCCCCcCCEEeeHHHHHHHhcCCC
Confidence 9999 567999999999976543222 122346899999999998643211 1146789999999999999999999
Q ss_pred CCCcchhHHHHHHhhcCCCCcccCC---CCCChhHHHHHHHhcccCCCC--CCChhHHhcCCCCCC
Q 003052 709 PFSEYKTFWAKFKVITDPNHEITYE---PVPNPWLLDLMKKCLAWDRNE--RWRIPQLLQHPFLVP 769 (853)
Q Consensus 709 PF~~~~~~~~~~kii~~~~~~~~~~---~~~s~~l~dLI~kcL~~DP~k--RpTa~EIL~HPwf~~ 769 (853)
||..........++... .....++ ...+..+++||.+||..++.+ |+++.++++||||..
T Consensus 207 Pf~~~~~~~~~~~i~~~-~~~~~~p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h~~f~~ 271 (332)
T cd05623 207 PFYAESLVETYGKIMNH-KERFQFPAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQHPFFTG 271 (332)
T ss_pred CCCCCCHHHHHHHHhCC-CccccCCCccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCCCCcCC
Confidence 99875554433333322 2222222 346888999999999765554 789999999999975
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-39 Score=372.48 Aligned_cols=258 Identities=24% Similarity=0.336 Sum_probs=207.6
Q ss_pred ceeeEEEeEeccCceEEEEEEec-C-CcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHHH
Q 003052 472 KLYQRLGKIGSGGSSEVHKVISS-D-CTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLRE 549 (853)
Q Consensus 472 ~~Y~ilk~LG~G~FG~Vyka~~~-~-g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~~ 549 (853)
..|.+.+.||+|+||.||+|... + +..||+|++.... ......+.+|+.+|+.++ |+||++++++
T Consensus 67 ~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~--~~~~~~~~~E~~~l~~l~-Hpniv~~~~~---------- 133 (478)
T PTZ00267 67 HMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLND--ERQAAYARSELHCLAACD-HFGIVKHFDD---------- 133 (478)
T ss_pred eeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCC--HHHHHHHHHHHHHHHhCC-CCCEeEEEEE----------
Confidence 34999999999999999999874 4 5678888775442 334446778999999997 9999999987
Q ss_pred HhhCCCCCCCCccccCCeEEEEEecch-hhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCCC
Q 003052 550 VLNGSMNNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKP 628 (853)
Q Consensus 550 l~~~~iv~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLKP 628 (853)
+..++.+||||||+. ++|.+.+.+... ....+++..++.++.||+.||.|||++||+||||||
T Consensus 134 ------------~~~~~~~~lv~E~~~gg~L~~~l~~~~~----~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp 197 (478)
T PTZ00267 134 ------------FKSDDKLLLIMEYGSGGDLNKQIKQRLK----EHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKS 197 (478)
T ss_pred ------------EEECCEEEEEEECCCCCCHHHHHHHHHh----ccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCH
Confidence 456778999999975 689888765432 235789999999999999999999999999999999
Q ss_pred ccEEe-ecCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHhCC
Q 003052 629 ANFLL-VKGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGR 707 (853)
Q Consensus 629 eNILL-~~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLtG~ 707 (853)
+|||+ .++.+||+|||+|+.+............+||+.|+|||++.+. .++.++|||||||++|+|++|+
T Consensus 198 ~NIll~~~~~~kL~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---------~~~~~~Dv~slG~~l~el~tg~ 268 (478)
T PTZ00267 198 ANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWERK---------RYSKKADMWSLGVILYELLTLH 268 (478)
T ss_pred HhEEECCCCcEEEEeCcCceecCCccccccccccCCCccccCHhHhCCC---------CCCcHHhHHHHHHHHHHHHhCC
Confidence 99999 4679999999999876543222223467899999999999764 3568999999999999999999
Q ss_pred CCCCcchhHHHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCCChhHHhcCCCCCC
Q 003052 708 TPFSEYKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQHPFLVP 769 (853)
Q Consensus 708 ~PF~~~~~~~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~HPwf~~ 769 (853)
.||...........+..... ..++...+..+++||.+||..||.+||++.++|.|+|++.
T Consensus 269 ~Pf~~~~~~~~~~~~~~~~~--~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~~~~~~~ 328 (478)
T PTZ00267 269 RPFKGPSQREIMQQVLYGKY--DPFPCPVSSGMKALLDPLLSKNPALRPTTQQLLHTEFLKY 328 (478)
T ss_pred CCCCCCCHHHHHHHHHhCCC--CCCCccCCHHHHHHHHHHhccChhhCcCHHHHHhCHHHHH
Confidence 99977554333333332211 1234457788999999999999999999999999999853
|
|
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-39 Score=335.52 Aligned_cols=254 Identities=27% Similarity=0.413 Sum_probs=205.9
Q ss_pred eeeEEEeEeccCceEEEEEEe-cCCcEEEEEEEecCCCC---hhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHH
Q 003052 473 LYQRLGKIGSGGSSEVHKVIS-SDCTIYALKKIKLKGRD---YATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLR 548 (853)
Q Consensus 473 ~Y~ilk~LG~G~FG~Vyka~~-~~g~~vAVKkik~~~~~---~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~ 548 (853)
.|.+.+.||+|+||.||+|.+ .++..||+|.+...... ......+.+|++++++++ |+||++++++
T Consensus 3 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~--------- 72 (263)
T cd06625 3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQ-HERIVQYYGC--------- 72 (263)
T ss_pred cccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCC-CCCeeeeEEE---------
Confidence 488899999999999999998 46789999998754332 223456889999999997 8999999887
Q ss_pred HHhhCCCCCCCCccccCCeEEEEEecch-hhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCC
Q 003052 549 EVLNGSMNNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLK 627 (853)
Q Consensus 549 ~l~~~~iv~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLK 627 (853)
+.++..+|+||||+. ++|.+.+... ..+++..++.++.||+.||.|||+.||+|||||
T Consensus 73 -------------~~~~~~~~~v~e~~~~~~l~~~~~~~--------~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~ 131 (263)
T cd06625 73 -------------LRDDETLSIFMEYMPGGSVKDQLKAY--------GALTETVTRKYTRQILEGVEYLHSNMIVHRDIK 131 (263)
T ss_pred -------------EccCCeEEEEEEECCCCcHHHHHHHh--------CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCC
Confidence 345568999999975 5788777643 468999999999999999999999999999999
Q ss_pred CccEEee-cCcEEEEecccchhcccCCccc-cccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHh
Q 003052 628 PANFLLV-KGSLKLIDFGIAKAIMSDTTNI-QRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVY 705 (853)
Q Consensus 628 PeNILL~-~g~VKL~DFGlAk~~~~~~~~~-~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLt 705 (853)
|+||+++ ++.++|+|||+++......... ......|+..|+|||++.+.. ++.++|||||||++|+|++
T Consensus 132 p~nilv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~---------~~~~~Di~slG~il~el~~ 202 (263)
T cd06625 132 GANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGEG---------YGRKADVWSVGCTVVEMLT 202 (263)
T ss_pred HHHEEEcCCCCEEEeecccceeccccccccccccCCCcCccccCcceeccCC---------CCchhhhHHHHHHHHHHHh
Confidence 9999994 5799999999997653321111 112457899999999997653 5679999999999999999
Q ss_pred CCCCCCcchhHHHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCCChhHHhcCCCC
Q 003052 706 GRTPFSEYKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQHPFL 767 (853)
Q Consensus 706 G~~PF~~~~~~~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~HPwf 767 (853)
|+.||.+.+........... ......+...+..+.+||.+||..||.+|||+.++|+||||
T Consensus 203 g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~ 263 (263)
T cd06625 203 EKPPWAEFEAMAAIFKIATQ-PTNPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRHFFV 263 (263)
T ss_pred CCCCccccchHHHHHHHhcc-CCCCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhCCCC
Confidence 99999876555444443332 23344556678899999999999999999999999999997
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-40 Score=347.75 Aligned_cols=265 Identities=29% Similarity=0.512 Sum_probs=213.3
Q ss_pred eeeEEEeEeccCceEEEEEEecC-----CcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHH
Q 003052 473 LYQRLGKIGSGGSSEVHKVISSD-----CTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALL 547 (853)
Q Consensus 473 ~Y~ilk~LG~G~FG~Vyka~~~~-----g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL 547 (853)
.|+++++||+|.||.||+|..++ ++.||||+++............++||.+++.|+ |+||+.|..++..
T Consensus 25 ~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~-h~nvi~Lv~Vfl~----- 98 (438)
T KOG0666|consen 25 EYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELK-HPNVISLVKVFLS----- 98 (438)
T ss_pred HhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhc-CCcchhHHHHHhc-----
Confidence 38999999999999999996532 247999999877555555667899999999998 8999999876432
Q ss_pred HHHhhCCCCCCCCccccCCeEEEEEecchhhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCC
Q 003052 548 REVLNGSMNNKDGRVKDDGYIYMVLEYGEIDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLK 627 (853)
Q Consensus 548 ~~l~~~~iv~~~g~~~d~~~lyLVmEy~~gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLK 627 (853)
.+..+++++||.+.||.++|+-+... ....++...++.|++||+.|+.|||++-|+|||||
T Consensus 99 ----------------~d~~v~l~fdYAEhDL~~II~fHr~~---~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLK 159 (438)
T KOG0666|consen 99 ----------------HDKKVWLLFDYAEHDLWHIIKFHRAS---KAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLK 159 (438)
T ss_pred ----------------cCceEEEEehhhhhhHHHHHHHhccc---hhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCC
Confidence 26789999999999999999766332 23579999999999999999999999999999999
Q ss_pred CccEEe-ec----CcEEEEecccchhcccCCccc-cccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHH
Q 003052 628 PANFLL-VK----GSLKLIDFGIAKAIMSDTTNI-QRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILY 701 (853)
Q Consensus 628 PeNILL-~~----g~VKL~DFGlAk~~~~~~~~~-~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILy 701 (853)
|.|||+ .+ |.|||+|||+|+.+...-... .....+-|.||+|||++.|.. .|++++|||++|||+.
T Consensus 160 PaNIlvmgdgperG~VKIaDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~--------hYT~AiDvWAiGCIfa 231 (438)
T KOG0666|consen 160 PANILVMGDGPERGRVKIADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGAR--------HYTKAIDVWAIGCIFA 231 (438)
T ss_pred cceEEEeccCCccCeeEeecccHHHHhhccccccccCCceEEEEEecChHHhcccc--------cccchhhhHHHHHHHH
Confidence 999999 45 799999999999886543332 334678899999999998764 6899999999999999
Q ss_pred HHHhCCCCCCcc------------hhHHHHHHhhcCCCCccc--------------------C-----------CCCCCh
Q 003052 702 QMVYGRTPFSEY------------KTFWAKFKVITDPNHEIT--------------------Y-----------EPVPNP 738 (853)
Q Consensus 702 ELLtG~~PF~~~------------~~~~~~~kii~~~~~~~~--------------------~-----------~~~~s~ 738 (853)
|||+-.+.|.+. +++..+++++..+..... + ...-++
T Consensus 232 ElLtl~PlF~g~E~k~~~~~Pfq~dQl~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~ 311 (438)
T KOG0666|consen 232 ELLTLEPLFKGREEKIKTKNPFQHDQLDRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDP 311 (438)
T ss_pred HHHccCccccchhhhcccCCCchHHHHHHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCc
Confidence 999999998542 233345555443322110 0 011244
Q ss_pred hHHHHHHHhcccCCCCCCChhHHhcCCCCCCC
Q 003052 739 WLLDLMKKCLAWDRNERWRIPQLLQHPFLVPP 770 (853)
Q Consensus 739 ~l~dLI~kcL~~DP~kRpTa~EIL~HPwf~~~ 770 (853)
...+||.+||++||.+|+|++++|+|+||...
T Consensus 312 ~a~~LL~klL~yDP~kRIta~qAleh~yF~~d 343 (438)
T KOG0666|consen 312 SALDLLQKLLTYDPIKRITAEQALEHPYFTED 343 (438)
T ss_pred hHHHHHHHHhccCchhhccHHHHhcccccccC
Confidence 47899999999999999999999999999754
|
|
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-41 Score=354.89 Aligned_cols=253 Identities=25% Similarity=0.412 Sum_probs=204.7
Q ss_pred ceeeEEEeEeccCceEEEEEEe-cCCcEEEEEEEecCCCC-hhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHHH
Q 003052 472 KLYQRLGKIGSGGSSEVHKVIS-SDCTIYALKKIKLKGRD-YATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLRE 549 (853)
Q Consensus 472 ~~Y~ilk~LG~G~FG~Vyka~~-~~g~~vAVKkik~~~~~-~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~~ 549 (853)
.+|..++.||+|.||+|-+|+. .+++.||+|++++.-.- ......- .+|.+.|+.
T Consensus 168 ~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHT-----------------------lTE~RVL~~ 224 (516)
T KOG0690|consen 168 EDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHT-----------------------LTENRVLQN 224 (516)
T ss_pred chhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhh-----------------------hhHHHHHHh
Confidence 4588899999999999999987 57899999999865321 1111122 344444444
Q ss_pred HhhCCCCCCCCccccCCeEEEEEec-chhhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCCC
Q 003052 550 VLNGSMNNKDGRVKDDGYIYMVLEY-GEIDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKP 628 (853)
Q Consensus 550 l~~~~iv~~~g~~~d~~~lyLVmEy-~~gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLKP 628 (853)
..|+.+..+...|+..+++|+|||| .+|.|+..+... ..|+|..+++|..+|+.||.|||+++||+||||.
T Consensus 225 ~~HPFLt~LKYsFQt~drlCFVMeyanGGeLf~HLsre--------r~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKL 296 (516)
T KOG0690|consen 225 CRHPFLTSLKYSFQTQDRLCFVMEYANGGELFFHLSRE--------RVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKL 296 (516)
T ss_pred ccCcHHHHhhhhhccCceEEEEEEEccCceEeeehhhh--------hcccchhhhhhhHHHHHHhhhhhhCCeeeeechh
Confidence 4455555555679999999999999 456887777653 6899999999999999999999999999999999
Q ss_pred ccEEe-ecCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHhCC
Q 003052 629 ANFLL-VKGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGR 707 (853)
Q Consensus 629 eNILL-~~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLtG~ 707 (853)
+|+|| .+|+|||+|||+|+...... ....++||||.|+|||++..+ .|+.++|||.+||++|||++|+
T Consensus 297 ENLlLDkDGHIKitDFGLCKE~I~~g--~t~kTFCGTPEYLAPEVleDn---------DYgraVDWWG~GVVMYEMmCGR 365 (516)
T KOG0690|consen 297 ENLLLDKDGHIKITDFGLCKEEIKYG--DTTKTFCGTPEYLAPEVLEDN---------DYGRAVDWWGVGVVMYEMMCGR 365 (516)
T ss_pred hhheeccCCceEeeecccchhccccc--ceeccccCChhhcCchhhccc---------cccceeehhhhhHHHHHHHhcc
Confidence 99999 57899999999999765433 244689999999999999765 5789999999999999999999
Q ss_pred CCCCcchhHHHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCC-----ChhHHhcCCCCCC
Q 003052 708 TPFSEYKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERW-----RIPQLLQHPFLVP 769 (853)
Q Consensus 708 ~PF~~~~~~~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRp-----Ta~EIL~HPwf~~ 769 (853)
+||.+.+.. ..+..|. -..+.++...+++++.||..+|.+||.+|. .+.||.+|+||..
T Consensus 366 LPFyn~dh~-kLFeLIl--~ed~kFPr~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~h~FF~~ 429 (516)
T KOG0690|consen 366 LPFYNKDHE-KLFELIL--MEDLKFPRTLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMRHRFFAS 429 (516)
T ss_pred Ccccccchh-HHHHHHH--hhhccCCccCCHHHHHHHHHHhhcChHhhcCCCchhHHHHHhhhhhcc
Confidence 999875443 3344443 245678889999999999999999999998 4899999999953
|
|
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-39 Score=353.27 Aligned_cols=261 Identities=30% Similarity=0.446 Sum_probs=202.9
Q ss_pred eeeEEEeEeccCceEEEEEEec-CCcEEEEEEEecCC-CChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHHHH
Q 003052 473 LYQRLGKIGSGGSSEVHKVISS-DCTIYALKKIKLKG-RDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLREV 550 (853)
Q Consensus 473 ~Y~ilk~LG~G~FG~Vyka~~~-~g~~vAVKkik~~~-~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~~l 550 (853)
+|++++.||+|+||.||++.+. +++.||+|++.... ........+.+|+.++..+. |+||++++++
T Consensus 2 ~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~-~~~i~~l~~~----------- 69 (331)
T cd05624 2 DFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGD-CQWITTLHYA----------- 69 (331)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCC-CCCEeeEEEE-----------
Confidence 5999999999999999999984 66889999997532 22233445778888888886 8999999876
Q ss_pred hhCCCCCCCCccccCCeEEEEEecch-hhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCCCc
Q 003052 551 LNGSMNNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPA 629 (853)
Q Consensus 551 ~~~~iv~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLKPe 629 (853)
+.+++++|+||||+. ++|.+++... ...+++..++.++.||+.||.|||++||+||||||+
T Consensus 70 -----------~~~~~~~~lv~Ey~~gg~L~~~l~~~-------~~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~ 131 (331)
T cd05624 70 -----------FQDENYLYLVMDYYVGGDLLTLLSKF-------EDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPD 131 (331)
T ss_pred -----------EEcCCEEEEEEeCCCCCcHHHHHHHh-------cCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchH
Confidence 566788999999975 6898888653 246899999999999999999999999999999999
Q ss_pred cEEe-ecCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHhCCC
Q 003052 630 NFLL-VKGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGRT 708 (853)
Q Consensus 630 NILL-~~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLtG~~ 708 (853)
|||+ .++.+||+|||+|+.+..... ......+||+.|+|||++.+.... ...++.++|||||||++|+|++|+.
T Consensus 132 Nill~~~~~~kl~DfG~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~----~~~~~~~~DiwSlGvil~ell~g~~ 206 (331)
T cd05624 132 NVLLDMNGHIRLADFGSCLKMNQDGT-VQSSVAVGTPDYISPEILQAMEDG----MGKYGPECDWWSLGVCMYEMLYGET 206 (331)
T ss_pred HEEEcCCCCEEEEeccceeeccCCCc-eeeccccCCcccCCHHHHhccccC----CCCCCCcccEEeeehhhhhhhhCCC
Confidence 9999 567999999999987643322 122346899999999998653211 1146789999999999999999999
Q ss_pred CCCcchhHHHHHHhhcCCCCcccCC---CCCChhHHHHHHHhcccCCCC--CCChhHHhcCCCCCC
Q 003052 709 PFSEYKTFWAKFKVITDPNHEITYE---PVPNPWLLDLMKKCLAWDRNE--RWRIPQLLQHPFLVP 769 (853)
Q Consensus 709 PF~~~~~~~~~~kii~~~~~~~~~~---~~~s~~l~dLI~kcL~~DP~k--RpTa~EIL~HPwf~~ 769 (853)
||..........++. .....+.++ ...+..+++||.+||..++.+ |++++++++||||..
T Consensus 207 Pf~~~~~~~~~~~i~-~~~~~~~~p~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h~~f~~ 271 (331)
T cd05624 207 PFYAESLVETYGKIM-NHEERFQFPSHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKHAFFEG 271 (331)
T ss_pred CccCCCHHHHHHHHH-cCCCcccCCCccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcCCCcCC
Confidence 997654433333332 222222222 235788999999999976655 578999999999975
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-39 Score=338.66 Aligned_cols=264 Identities=24% Similarity=0.459 Sum_probs=207.2
Q ss_pred ceeeEEEeEeccCceEEEEEEe-cCCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHHHH
Q 003052 472 KLYQRLGKIGSGGSSEVHKVIS-SDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLREV 550 (853)
Q Consensus 472 ~~Y~ilk~LG~G~FG~Vyka~~-~~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~~l 550 (853)
..|++.+.||+|+||.||+|.. .+++.||+|++...... ...+.+|+.++.++.+|+||+++++++....
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~---~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~------ 76 (272)
T cd06637 6 GIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDE---EEEIKQEINMLKKYSHHRNIATYYGAFIKKN------ 76 (272)
T ss_pred hhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCcc---HHHHHHHHHHHHHhcCCCCeeeEeeEEeecC------
Confidence 4588889999999999999988 46788999999765432 2357799999999988999999998753210
Q ss_pred hhCCCCCCCCccccCCeEEEEEecch-hhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCCCc
Q 003052 551 LNGSMNNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPA 629 (853)
Q Consensus 551 ~~~~iv~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLKPe 629 (853)
.-.....+|+||||++ ++|.+++... ....+++..++.++.||+.||.|||++||+||||||+
T Consensus 77 ----------~~~~~~~~~iv~e~~~~~~L~~~l~~~------~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~ 140 (272)
T cd06637 77 ----------PPGMDDQLWLVMEFCGAGSVTDLIKNT------KGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQ 140 (272)
T ss_pred ----------CCCCCcEEEEEEEcCCCCcHHHHHHhc------cCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHH
Confidence 0112357899999976 4888887653 2356899999999999999999999999999999999
Q ss_pred cEEe-ecCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHhCCC
Q 003052 630 NFLL-VKGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGRT 708 (853)
Q Consensus 630 NILL-~~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLtG~~ 708 (853)
||++ .++.+||+|||++........ ......|++.|+|||++.+.... ...|+.++|||||||++|+|++|..
T Consensus 141 nili~~~~~~~l~Dfg~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~----~~~~~~~~Dv~slGv~l~el~~g~~ 214 (272)
T cd06637 141 NVLLTENAEVKLVDFGVSAQLDRTVG--RRNTFIGTPYWMAPEVIACDENP----DATYDFKSDLWSLGITAIEMAEGAP 214 (272)
T ss_pred HEEECCCCCEEEccCCCceecccccc--cCCcccccccccCHhHhccccCc----CCCCCchhhHHHHHHHHHHHHhCCC
Confidence 9999 567899999999986533221 23457899999999998643211 1246789999999999999999999
Q ss_pred CCCcchhHHHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCCChhHHhcCCCC
Q 003052 709 PFSEYKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQHPFL 767 (853)
Q Consensus 709 PF~~~~~~~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~HPwf 767 (853)
||................ .........+..+.+||.+||..||.+||++.++++||||
T Consensus 215 p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~~ 272 (272)
T cd06637 215 PLCDMHPMRALFLIPRNP-APRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKHPFI 272 (272)
T ss_pred CccccCHHHHHHHHhcCC-CCCCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhhCCCC
Confidence 997665554444333322 2222334567889999999999999999999999999998
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-39 Score=341.11 Aligned_cols=255 Identities=30% Similarity=0.495 Sum_probs=202.0
Q ss_pred eeEEEeEeccCceEEEEEEec-CCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHHHHhh
Q 003052 474 YQRLGKIGSGGSSEVHKVISS-DCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLREVLN 552 (853)
Q Consensus 474 Y~ilk~LG~G~FG~Vyka~~~-~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~~l~~ 552 (853)
|++++.||.|+||.||+|++. ++..||||++............+.+|++++++++ |+||++++++
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~------------- 67 (284)
T cd07860 2 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN-HPNIVKLLDV------------- 67 (284)
T ss_pred ceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcC-CCCCcchhhh-------------
Confidence 889999999999999999884 6789999999765544444456889999999997 8999999876
Q ss_pred CCCCCCCCccccCCeEEEEEecchhhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCCCccEE
Q 003052 553 GSMNNKDGRVKDDGYIYMVLEYGEIDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANFL 632 (853)
Q Consensus 553 ~~iv~~~g~~~d~~~lyLVmEy~~gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLKPeNIL 632 (853)
+.++..+|+||||+.++|..++... ....+++..++.++.||+.||+|||++||+||||+|+||+
T Consensus 68 ---------~~~~~~~~~v~e~~~~~l~~~~~~~------~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nil 132 (284)
T cd07860 68 ---------IHTENKLYLVFEFLHQDLKKFMDAS------PLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLL 132 (284)
T ss_pred ---------cccCCcEEEEeeccccCHHHHHHhC------CCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEE
Confidence 3456778999999888888777543 2357899999999999999999999999999999999999
Q ss_pred e-ecCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHhCCCCCC
Q 003052 633 L-VKGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGRTPFS 711 (853)
Q Consensus 633 L-~~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLtG~~PF~ 711 (853)
+ .++.+||+|||+++....... ......+++.|+|||++.+.. .++.++|||||||++|+|++|+.||.
T Consensus 133 l~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~--------~~~~~~Dv~slG~il~~l~tg~~p~~ 202 (284)
T cd07860 133 INTEGAIKLADFGLARAFGVPVR--TYTHEVVTLWYRAPEILLGCK--------YYSTAVDIWSLGCIFAEMVTRRALFP 202 (284)
T ss_pred ECCCCCEEEeeccchhhcccCcc--ccccccccccccCCeEEecCC--------CCCcHHHHHHHHHHHHHHHHCCCCCC
Confidence 9 567999999999986543221 122446789999999886542 24678999999999999999999997
Q ss_pred cchhHHHHHHhhc---CCCCc-----------------------ccCCCCCChhHHHHHHHhcccCCCCCCChhHHhcCC
Q 003052 712 EYKTFWAKFKVIT---DPNHE-----------------------ITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQHP 765 (853)
Q Consensus 712 ~~~~~~~~~kii~---~~~~~-----------------------~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~HP 765 (853)
........++.+. .+... .......++.+++||.+||..||.+|||+.++|+||
T Consensus 203 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~ 282 (284)
T cd07860 203 GDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHP 282 (284)
T ss_pred CCCHHHHHHHHHHHhCCCChhhhhhhhHHHHHHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcCC
Confidence 6544332222211 10000 001124567899999999999999999999999999
Q ss_pred CC
Q 003052 766 FL 767 (853)
Q Consensus 766 wf 767 (853)
||
T Consensus 283 ~f 284 (284)
T cd07860 283 FF 284 (284)
T ss_pred CC
Confidence 98
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=380.58 Aligned_cols=276 Identities=29% Similarity=0.420 Sum_probs=222.0
Q ss_pred CCCCcCCCCCceeEEcCceeeEEEeEeccCceEEEEEEecCC-cEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCce
Q 003052 455 APRKRNYDPDLFFKVNGKLYQRLGKIGSGGSSEVHKVISSDC-TIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNI 533 (853)
Q Consensus 455 ~~rk~~~dp~~~~~v~g~~Y~ilk~LG~G~FG~Vyka~~~~g-~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNI 533 (853)
..+...+..+..+.+.+.++++.+.|.+|||+.||+|.+..+ ..||+|++-.. +......+.+||.+|++|++|+||
T Consensus 20 ~~~~~~~~~G~~~~Vg~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~--de~~L~~v~~EI~~MK~L~gh~nI 97 (738)
T KOG1989|consen 20 SPQSENYFVGQTFTVGSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVN--DEEALNAVKREIDIMKLLSGHKNI 97 (738)
T ss_pred CcccccCCCceEEEECCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecC--CHHHHHHHHHHHHHHHHhcCCCce
Confidence 344566777888999999999999999999999999998655 99999999876 566777899999999999999999
Q ss_pred eEeeeh-hhhHHHHHHHHhhCCCCCCCCcccc-CCeEEEEEecch-hhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhh
Q 003052 534 IQLIDY-EVTEKALLREVLNGSMNNKDGRVKD-DGYIYMVLEYGE-IDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQIL 610 (853)
Q Consensus 534 V~Lid~-~~~e~~iL~~l~~~~iv~~~g~~~d-~~~lyLVmEy~~-gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl 610 (853)
|.++|- ..... -.. ...++|.||||. ++|.+++..+.. ..|+|.++.+||.+++
T Consensus 98 V~yidss~~~~~-----------------~~~~~~EvllLmEyC~gg~Lvd~mn~Rlq------~~lte~eVLkIf~dv~ 154 (738)
T KOG1989|consen 98 VSYIDSSAINRS-----------------SNNGVWEVLLLMEYCKGGSLVDFMNTRLQ------TRLTEDEVLKIFYDVC 154 (738)
T ss_pred eeEecccccccc-----------------CCCceeEEEeehhhccCCcHHHHHHHHHh------ccCChHHHHHHHHHHH
Confidence 999993 21110 111 235899999999 699999998743 4599999999999999
Q ss_pred hhhhhcccCc--eeeCCCCCccEEe-ecCcEEEEecccchhcccCCccccc-------cccccCccccCchhhccCCCCC
Q 003052 611 EAVNTIHEER--IVHSDLKPANFLL-VKGSLKLIDFGIAKAIMSDTTNIQR-------DSQVGTLSYMSPEAFMCNESDE 680 (853)
Q Consensus 611 ~AL~yLHs~g--IIHRDLKPeNILL-~~g~VKL~DFGlAk~~~~~~~~~~~-------~t~~GTp~YmAPEvl~~~~~~~ 680 (853)
+|+.+||... |||||||-||||| ++|+.||||||.|............ -...-|+.|+|||.+.-..
T Consensus 155 ~AVa~mH~~~pPiIHRDLKiENvLls~~g~~KLCDFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlys--- 231 (738)
T KOG1989|consen 155 EAVAAMHYLKPPIIHRDLKIENVLLSADGNYKLCDFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYS--- 231 (738)
T ss_pred HHHHHHhcCCCccchhhhhhhheEEcCCCCEEeCcccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhc---
Confidence 9999999997 9999999999999 6789999999999754332211110 0123699999999985432
Q ss_pred CCccccCCCccchhhhHHHHHHHHhCCCCCCcchhHHHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCCChhH
Q 003052 681 NGNIIKCGRPSDIWSLGCILYQMVYGRTPFSEYKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQ 760 (853)
Q Consensus 681 ~~~~~~ys~ksDIWSLGVILyELLtG~~PF~~~~~~~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~E 760 (853)
....+.|+|||+|||+||-|++...||++.-.+ .|......+...+..+..+++||+.||+.||.+||++-|
T Consensus 232 ---g~pI~eKsDIWALGclLYkLCy~t~PFe~sg~l-----aIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Q 303 (738)
T KOG1989|consen 232 ---GLPIGEKSDIWALGCLLYKLCYFTTPFEESGKL-----AILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQ 303 (738)
T ss_pred ---CCCCcchhHHHHHHHHHHHHHHhCCCcCcCcce-----eEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHH
Confidence 124678999999999999999999999774232 233445555555678889999999999999999999999
Q ss_pred HhcCCC
Q 003052 761 LLQHPF 766 (853)
Q Consensus 761 IL~HPw 766 (853)
++.+-+
T Consensus 304 v~~~~~ 309 (738)
T KOG1989|consen 304 VLEEIF 309 (738)
T ss_pred HHHHHH
Confidence 998754
|
|
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=331.39 Aligned_cols=253 Identities=28% Similarity=0.446 Sum_probs=204.5
Q ss_pred eeEEEeEeccCceEEEEEEec-CCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHHHHhh
Q 003052 474 YQRLGKIGSGGSSEVHKVISS-DCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLREVLN 552 (853)
Q Consensus 474 Y~ilk~LG~G~FG~Vyka~~~-~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~~l~~ 552 (853)
|++++.||+|+||.||++.+. +++.||+|++............+.+|++++++++ |+||+++++.+.
T Consensus 2 y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~----------- 69 (257)
T cd08223 2 YCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLK-HPNIVAYRESWE----------- 69 (257)
T ss_pred ceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCC-CCCeeeeeeeec-----------
Confidence 899999999999999999984 5688999999876555555667889999999997 899999876521
Q ss_pred CCCCCCCCccccCCeEEEEEecch-hhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCCCccE
Q 003052 553 GSMNNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANF 631 (853)
Q Consensus 553 ~~iv~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLKPeNI 631 (853)
..+..+|+||||+. ++|.+++... ....+++.+++.++.||+.||.|||++||+||||||+||
T Consensus 70 ----------~~~~~~~lv~e~~~~~~l~~~l~~~------~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~ni 133 (257)
T cd08223 70 ----------GEDGLLYIVMGFCEGGDLYHKLKEQ------KGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNV 133 (257)
T ss_pred ----------CCCCEEEEEecccCCCcHHHHHHHh------cCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhE
Confidence 23457899999976 5888887653 235689999999999999999999999999999999999
Q ss_pred Eee-cCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHhCCCCC
Q 003052 632 LLV-KGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGRTPF 710 (853)
Q Consensus 632 LL~-~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLtG~~PF 710 (853)
+++ ++.++|+|||+++....... ......|++.|+|||++.+.. ++.++|||||||++|+|++|+.||
T Consensus 134 l~~~~~~~~l~df~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~---------~~~~~Dv~slG~il~~l~~g~~~~ 202 (257)
T cd08223 134 FLTRTNIIKVGDLGIARVLENQCD--MASTLIGTPYYMSPELFSNKP---------YNYKSDVWALGCCVYEMATLKHAF 202 (257)
T ss_pred EEecCCcEEEecccceEEecccCC--ccccccCCcCccChhHhcCCC---------CCchhhhHHHHHHHHHHHcCCCCC
Confidence 994 67899999999986643222 223567999999999986543 567899999999999999999999
Q ss_pred CcchhHHHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCCChhHHhcCCCC
Q 003052 711 SEYKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQHPFL 767 (853)
Q Consensus 711 ~~~~~~~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~HPwf 767 (853)
...+............. ...+...++++.+||.+||..||.+||++.++++||||
T Consensus 203 ~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~~~~ 257 (257)
T cd08223 203 NAKDMNSLVYRIIEGKL--PPMPKDYSPELGELIATMLSKRPEKRPSVKSILRQPYI 257 (257)
T ss_pred CCCCHHHHHHHHHhcCC--CCCccccCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 76544333333322211 12345577889999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-39 Score=338.80 Aligned_cols=257 Identities=30% Similarity=0.488 Sum_probs=204.9
Q ss_pred eeeEEEeEeccCceEEEEEEe-cCCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHHHHh
Q 003052 473 LYQRLGKIGSGGSSEVHKVIS-SDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLREVL 551 (853)
Q Consensus 473 ~Y~ilk~LG~G~FG~Vyka~~-~~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~~l~ 551 (853)
+|++.+.||+|+||.||+|.+ .+++.||+|++............+.+|+.++++++ |+||++++++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~-~~~i~~~~~~------------ 67 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQ-HPYVVKLLDV------------ 67 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCC-CCCCcceeeE------------
Confidence 489999999999999999998 46789999999876544455567889999999997 9999999886
Q ss_pred hCCCCCCCCccccCCeEEEEEecchhhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCCCccE
Q 003052 552 NGSMNNKDGRVKDDGYIYMVLEYGEIDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANF 631 (853)
Q Consensus 552 ~~~iv~~~g~~~d~~~lyLVmEy~~gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLKPeNI 631 (853)
+.++..+|+||||++++|.+++... ...+++..++.++.||+.||.|||++||+|+||||+||
T Consensus 68 ----------~~~~~~~~~v~e~~~~~L~~~~~~~-------~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni 130 (286)
T cd07832 68 ----------FPHGSGFVLVMEYMPSDLSEVLRDE-------ERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANL 130 (286)
T ss_pred ----------EecCCeeEEEecccCCCHHHHHHhc-------CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHE
Confidence 4456789999999988998887653 25699999999999999999999999999999999999
Q ss_pred Ee-ecCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHhCCCCC
Q 003052 632 LL-VKGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGRTPF 710 (853)
Q Consensus 632 LL-~~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLtG~~PF 710 (853)
++ .++.++|+|||++........ .......|+..|+|||.+.+.. .++.++|||||||++|+|++|.+||
T Consensus 131 ~~~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~--------~~~~~~Di~slG~~l~~l~tg~~~~ 201 (286)
T cd07832 131 LISADGVLKIADFGLARLFSEEEP-RLYSHQVATRWYRAPELLYGAR--------KYDPGVDLWAVGCIFAELLNGSPLF 201 (286)
T ss_pred EEcCCCcEEEeeeeecccccCCCC-CccccccCcccccCceeeeccc--------cCCchhHHHHHHHHHHHHHcCCcCc
Confidence 99 467999999999987644321 1223567999999999986532 3567999999999999999999988
Q ss_pred CcchhHHHHHHhhc---CCCC-------------cc-----------cCCCCCChhHHHHHHHhcccCCCCCCChhHHhc
Q 003052 711 SEYKTFWAKFKVIT---DPNH-------------EI-----------TYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQ 763 (853)
Q Consensus 711 ~~~~~~~~~~kii~---~~~~-------------~~-----------~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~ 763 (853)
.+.........++. .+.. .. ...+..+..+.+||.+||..||++||++.++|+
T Consensus 202 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~ 281 (286)
T cd07832 202 PGENDIEQLAIVFRTLGTPNEETWPGLTSLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALR 281 (286)
T ss_pred CCCCHHHHHHHHHHHcCCCChHHHhhccCcchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 66443322221111 0000 00 011234678999999999999999999999999
Q ss_pred CCCCC
Q 003052 764 HPFLV 768 (853)
Q Consensus 764 HPwf~ 768 (853)
||||.
T Consensus 282 h~~~~ 286 (286)
T cd07832 282 HPYFT 286 (286)
T ss_pred CcCcC
Confidence 99984
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-39 Score=338.40 Aligned_cols=255 Identities=30% Similarity=0.514 Sum_probs=199.2
Q ss_pred eeEEEeEeccCceEEEEEEe-cCCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHHHHhh
Q 003052 474 YQRLGKIGSGGSSEVHKVIS-SDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLREVLN 552 (853)
Q Consensus 474 Y~ilk~LG~G~FG~Vyka~~-~~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~~l~~ 552 (853)
|+++++||+|+||.||+|.+ .+++.||+|+++........ ....+|+.++.++.+|+||+++++++..
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~-~~~~~e~~~l~~l~~h~~i~~~~~~~~~---------- 69 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQ-VNNLREIQALRRLSPHPNILRLIEVLFD---------- 69 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchh-hhHHHHHHHHhhcCCCCCccceEEEEec----------
Confidence 67899999999999999998 46789999999765433332 2346899999999889999999986321
Q ss_pred CCCCCCCCccccCCeEEEEEecchhhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCCCccEE
Q 003052 553 GSMNNKDGRVKDDGYIYMVLEYGEIDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANFL 632 (853)
Q Consensus 553 ~~iv~~~g~~~d~~~lyLVmEy~~gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLKPeNIL 632 (853)
...+++|+||||++++|.+.+... ...+++..++.++.||+.||.|||++||+||||||+||+
T Consensus 70 ----------~~~~~~~lv~e~~~~~l~~~l~~~-------~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~ 132 (282)
T cd07831 70 ----------RKTGRLALVFELMDMNLYELIKGR-------KRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENIL 132 (282)
T ss_pred ----------CCCCcEEEEEecCCccHHHHHHhc-------cCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEE
Confidence 122678999999988888887653 246899999999999999999999999999999999999
Q ss_pred eecCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHhCCCCCCc
Q 003052 633 LVKGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGRTPFSE 712 (853)
Q Consensus 633 L~~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLtG~~PF~~ 712 (853)
++++.+||+|||+++....... .....+++.|+|||++.... .++.++|||||||++|||++|.+||.+
T Consensus 133 l~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~--------~~~~~~Di~slGv~l~el~~~~~p~~~ 201 (282)
T cd07831 133 IKDDILKLADFGSCRGIYSKPP---YTEYISTRWYRAPECLLTDG--------YYGPKMDIWAVGCVFFEILSLFPLFPG 201 (282)
T ss_pred EcCCCeEEEecccccccccCCC---cCCCCCCcccCChhHhhcCC--------CCCcchhHHHHHHHHHHHHcCCcCCCC
Confidence 9779999999999987643322 12457899999999875432 356799999999999999999999976
Q ss_pred chhHHHHHHh---hcCC------------CCcccC-----------CCCCChhHHHHHHHhcccCCCCCCChhHHhcCCC
Q 003052 713 YKTFWAKFKV---ITDP------------NHEITY-----------EPVPNPWLLDLMKKCLAWDRNERWRIPQLLQHPF 766 (853)
Q Consensus 713 ~~~~~~~~ki---i~~~------------~~~~~~-----------~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~HPw 766 (853)
.+........ ...+ .....+ ....+.++.+||.+||.+||.+||++.++|+|||
T Consensus 202 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~~~ 281 (282)
T cd07831 202 TNELDQIAKIHDVLGTPDAEVLKKFRKSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPY 281 (282)
T ss_pred CCHHHHHHHHHHHcCCCCHHHHHhhcccccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhCCC
Confidence 4432211111 1000 001111 1245688999999999999999999999999999
Q ss_pred C
Q 003052 767 L 767 (853)
Q Consensus 767 f 767 (853)
|
T Consensus 282 ~ 282 (282)
T cd07831 282 F 282 (282)
T ss_pred C
Confidence 7
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-39 Score=334.45 Aligned_cols=267 Identities=23% Similarity=0.438 Sum_probs=211.5
Q ss_pred ceeeEEEeEeccCceEEEEEEec-CCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHHHH
Q 003052 472 KLYQRLGKIGSGGSSEVHKVISS-DCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLREV 550 (853)
Q Consensus 472 ~~Y~ilk~LG~G~FG~Vyka~~~-~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~~l 550 (853)
++|++.+.||+|+||.||+|.+. +++.+++|++..... ....+.+|+.+++++..|+||+++++++....
T Consensus 6 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~---~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~------ 76 (275)
T cd06608 6 GIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED---EEEEIKEEYNILRKYSNHPNIATFYGAFIKKN------ 76 (275)
T ss_pred hheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch---hHHHHHHHHHHHHHhcCCCChheEEEEEEecC------
Confidence 57999999999999999999984 668899999876543 23468899999999988999999999754321
Q ss_pred hhCCCCCCCCccccCCeEEEEEecchh-hHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCCCc
Q 003052 551 LNGSMNNKDGRVKDDGYIYMVLEYGEI-DLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPA 629 (853)
Q Consensus 551 ~~~~iv~~~g~~~d~~~lyLVmEy~~g-dL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLKPe 629 (853)
.......+|+||||+++ +|.+++.... ..+..+++..++.++.||+.||.|||++||+|+||+|+
T Consensus 77 ----------~~~~~~~~~lv~e~~~~~~L~~~~~~~~----~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ 142 (275)
T cd06608 77 ----------PPGNDDQLWLVMELCGGGSVTDLVKGLR----KKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQ 142 (275)
T ss_pred ----------CCCcceEEEEEEEcCCCCcHHHHHHHHh----hcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHH
Confidence 01345678999999774 7777765432 12357899999999999999999999999999999999
Q ss_pred cEEe-ecCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHhCCC
Q 003052 630 NFLL-VKGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGRT 708 (853)
Q Consensus 630 NILL-~~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLtG~~ 708 (853)
||++ .++.+||+|||++....... .......|++.|+|||++...... ...++.++|||||||+||+|++|++
T Consensus 143 ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~----~~~~~~~~Dv~slG~il~~l~~g~~ 216 (275)
T cd06608 143 NILLTKNAEVKLVDFGVSAQLDSTL--GRRNTFIGTPYWMAPEVIACDEQP----DASYDARSDVWSLGITAIELADGKP 216 (275)
T ss_pred HEEEccCCeEEECCCccceecccch--hhhcCccccccccCHhHhcccccc----cCCccccccHHHhHHHHHHHHhCCC
Confidence 9999 56799999999997654322 123356799999999998654322 1246789999999999999999999
Q ss_pred CCCcchhHHHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCCChhHHhcCCCC
Q 003052 709 PFSEYKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQHPFL 767 (853)
Q Consensus 709 PF~~~~~~~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~HPwf 767 (853)
||...........+..........+...+..+++||.+||..||++|||+.++++|||+
T Consensus 217 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~~~~ 275 (275)
T cd06608 217 PLCDMHPMRALFKIPRNPPPTLKSPENWSKKFNDFISECLIKNYEQRPFMEELLEHPFI 275 (275)
T ss_pred CccccchHHHHHHhhccCCCCCCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcCCCC
Confidence 99765555455554443333333334467789999999999999999999999999996
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=329.81 Aligned_cols=252 Identities=31% Similarity=0.469 Sum_probs=207.2
Q ss_pred eeEEEeEeccCceEEEEEEec-CCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHHHHhh
Q 003052 474 YQRLGKIGSGGSSEVHKVISS-DCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLREVLN 552 (853)
Q Consensus 474 Y~ilk~LG~G~FG~Vyka~~~-~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~~l~~ 552 (853)
|.+.+.||+|+||.||+|... ++..|++|.+............+.+|++++++++ |+||++++++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~------------- 67 (256)
T cd08529 2 FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLD-SSYIIRYYES------------- 67 (256)
T ss_pred ceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcC-CCCeehheee-------------
Confidence 788999999999999999984 6789999999876555566677899999999997 8999999876
Q ss_pred CCCCCCCCccccCCeEEEEEecch-hhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCCCccE
Q 003052 553 GSMNNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANF 631 (853)
Q Consensus 553 ~~iv~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLKPeNI 631 (853)
+.+.+.+|+||||+. ++|.+++... ....+++..++.++.||+.||.|||++||+||||||+||
T Consensus 68 ---------~~~~~~~~lv~e~~~~~~L~~~l~~~------~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~ni 132 (256)
T cd08529 68 ---------FLDKGKLNIVMEYAENGDLHKLLKMQ------RGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNL 132 (256)
T ss_pred ---------eccCCEEEEEEEeCCCCcHHHHHHHh------cCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceE
Confidence 445678999999975 5888888653 235789999999999999999999999999999999999
Q ss_pred Eee-cCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHhCCCCC
Q 003052 632 LLV-KGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGRTPF 710 (853)
Q Consensus 632 LL~-~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLtG~~PF 710 (853)
+++ ++.+||+|||+++.+..... .....+|++.|+|||++.+.. ++.++|||||||++|+|++|+.||
T Consensus 133 li~~~~~~~l~df~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~---------~~~~~Di~slG~il~~l~~g~~p~ 201 (256)
T cd08529 133 FLDAYDNVKIGDLGVAKLLSDNTN--FANTIVGTPYYLSPELCEDKP---------YNEKSDVWALGVVLYECCTGKHPF 201 (256)
T ss_pred EEeCCCCEEEcccccceeccCccc--hhhccccCccccCHHHhcCCC---------CCCccchHHHHHHHHHHHhCCCCC
Confidence 995 57999999999987654322 223567999999999997653 457899999999999999999999
Q ss_pred CcchhHHHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCCChhHHhcCCCC
Q 003052 711 SEYKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQHPFL 767 (853)
Q Consensus 711 ~~~~~~~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~HPwf 767 (853)
...........+..... .......+..+.++|.+||+.+|++||++.++++|||+
T Consensus 202 ~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~~~~ 256 (256)
T cd08529 202 DANNQGALILKIIRGVF--PPVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRNPSL 256 (256)
T ss_pred CCCCHHHHHHHHHcCCC--CCCccccCHHHHHHHHHHccCCcccCcCHHHHhhCCCC
Confidence 76654433333333211 12233567889999999999999999999999999996
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-40 Score=344.30 Aligned_cols=255 Identities=26% Similarity=0.342 Sum_probs=209.1
Q ss_pred eeEE-EeEeccCceEEEEEEe-cCCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHHHHh
Q 003052 474 YQRL-GKIGSGGSSEVHKVIS-SDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLREVL 551 (853)
Q Consensus 474 Y~il-k~LG~G~FG~Vyka~~-~~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~~l~ 551 (853)
|.+- ++||-|-.|+|..|.+ .+++.+|+|++... ...++|+++.-...+|+|||.++|++.+
T Consensus 63 Y~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-------~KARrEVeLHw~~s~h~~iV~IidVyeN--------- 126 (400)
T KOG0604|consen 63 YSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS-------PKARREVELHWMASGHPHIVSIIDVYEN--------- 126 (400)
T ss_pred heehhhhhccccCCceEEEEeccchhhhHHHHHhcC-------HHHHhHhhhhhhhcCCCceEEeehhhhh---------
Confidence 4443 3699999999999988 57788999998632 2356999999999999999999998754
Q ss_pred hCCCCCCCCccccCCeEEEEEecch-hhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCCCcc
Q 003052 552 NGSMNNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPAN 630 (853)
Q Consensus 552 ~~~iv~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLKPeN 630 (853)
.|....++.+|||+++ |+|+..|+++ ..+.|+|+++..|++||+.|+.|||+.+|.||||||+|
T Consensus 127 ---------s~~~rkcLLiVmE~meGGeLfsriq~~------g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpEN 191 (400)
T KOG0604|consen 127 ---------SYQGRKCLLIVMECMEGGELFSRIQDR------GDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPEN 191 (400)
T ss_pred ---------hccCceeeEeeeecccchHHHHHHHHc------ccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhh
Confidence 3677889999999976 5999999886 44789999999999999999999999999999999999
Q ss_pred EEee----cCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHhC
Q 003052 631 FLLV----KGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYG 706 (853)
Q Consensus 631 ILL~----~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLtG 706 (853)
+|+. +..+||+|||+|+.-.. .....+.|-||+|.|||++... +|+..+|+||+||++|.||+|
T Consensus 192 LLyt~t~~na~lKLtDfGFAK~t~~---~~~L~TPc~TPyYvaPevlg~e---------KydkscdmwSlgVimYIlLCG 259 (400)
T KOG0604|consen 192 LLYTTTSPNAPLKLTDFGFAKETQE---PGDLMTPCFTPYYVAPEVLGPE---------KYDKSCDMWSLGVIMYILLCG 259 (400)
T ss_pred eeeecCCCCcceEecccccccccCC---CccccCCcccccccCHHHhCch---------hcCCCCCccchhHHHHHhhcC
Confidence 9993 23799999999997543 2344588999999999999665 467899999999999999999
Q ss_pred CCCCCcchhH---HHHHHhhcCCCCcccCC--CCCChhHHHHHHHhcccCCCCCCChhHHhcCCCCCCCC
Q 003052 707 RTPFSEYKTF---WAKFKVITDPNHEITYE--PVPNPWLLDLMKKCLAWDRNERWRIPQLLQHPFLVPPV 771 (853)
Q Consensus 707 ~~PF~~~~~~---~~~~kii~~~~~~~~~~--~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~HPwf~~~~ 771 (853)
.+||...... -.....|..+...+..+ ..++..++|+|+++|..+|.+|.|+.+++.|||+....
T Consensus 260 yPPFYS~hg~aispgMk~rI~~gqy~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpwi~~~~ 329 (400)
T KOG0604|consen 260 YPPFYSNHGLAISPGMKRRIRTGQYEFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPWINQYE 329 (400)
T ss_pred CCcccccCCccCChhHHhHhhccCccCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcCchhcccc
Confidence 9999653221 11223344444444443 34678899999999999999999999999999997643
|
|
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-39 Score=338.86 Aligned_cols=267 Identities=24% Similarity=0.424 Sum_probs=207.3
Q ss_pred CceeeEEEeEeccCceEEEEEEe-cCCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHHH
Q 003052 471 GKLYQRLGKIGSGGSSEVHKVIS-SDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLRE 549 (853)
Q Consensus 471 g~~Y~ilk~LG~G~FG~Vyka~~-~~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~~ 549 (853)
.++|++++.||+|+||.||+|.+ .+++.||+|++...... ...+.+|+.+++++..|+||+++++++...
T Consensus 17 ~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~---~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~------ 87 (286)
T cd06638 17 SDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDI---DEEIEAEYNILKALSDHPNVVKFYGMYYKK------ 87 (286)
T ss_pred ccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccccch---HHHHHHHHHHHHHHhcCCCeeeeeeeeeec------
Confidence 35699999999999999999988 46688999988643221 235778999999997799999999874321
Q ss_pred HhhCCCCCCCCccccCCeEEEEEecch-hhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCCC
Q 003052 550 VLNGSMNNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKP 628 (853)
Q Consensus 550 l~~~~iv~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLKP 628 (853)
...++.++|+||||++ ++|.+++.... .....+++..++.++.||+.||.|||+++|+||||||
T Consensus 88 -----------~~~~~~~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp 152 (286)
T cd06638 88 -----------DVKNGDQLWLVLELCNGGSVTDLVKGFL----KRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKG 152 (286)
T ss_pred -----------ccCCCCeEEEEEeecCCCCHHHHHHHhh----ccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCH
Confidence 1245568999999975 58887765431 1235789999999999999999999999999999999
Q ss_pred ccEEe-ecCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHhCC
Q 003052 629 ANFLL-VKGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGR 707 (853)
Q Consensus 629 eNILL-~~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLtG~ 707 (853)
+||++ .++.+||+|||+++.+..... ......|++.|+|||++...... ...|+.++|||||||++|+|++|+
T Consensus 153 ~nili~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~----~~~~~~~~Dv~slGvi~~el~~g~ 226 (286)
T cd06638 153 NNILLTTEGGVKLVDFGVSAQLTSTRL--RRNTSVGTPFWMAPEVIACEQQL----DSTYDARCDVWSLGITAIELGDGD 226 (286)
T ss_pred HhEEECCCCCEEEccCCceeecccCCC--ccccccCCCcccChhhhchhhhc----cccccchhhhhhHHHHHHHHhcCC
Confidence 99999 467899999999986643221 22355799999999998643211 124678999999999999999999
Q ss_pred CCCCcchhHHHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCCChhHHhcCCCC
Q 003052 708 TPFSEYKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQHPFL 767 (853)
Q Consensus 708 ~PF~~~~~~~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~HPwf 767 (853)
.||.+....................+...+.++.+||.+||..||.+||++.++|+|+||
T Consensus 227 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~~~ 286 (286)
T cd06638 227 PPLADLHPMRALFKIPRNPPPTLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVFI 286 (286)
T ss_pred CCCCCCchhHHHhhccccCCCcccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcccC
Confidence 999876554444333222222222334456789999999999999999999999999997
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=340.56 Aligned_cols=262 Identities=27% Similarity=0.424 Sum_probs=208.0
Q ss_pred ceeeEEEeEeccCceEEEEEEec-CCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHHHH
Q 003052 472 KLYQRLGKIGSGGSSEVHKVISS-DCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLREV 550 (853)
Q Consensus 472 ~~Y~ilk~LG~G~FG~Vyka~~~-~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~~l 550 (853)
+.|+++++||.|+||.||+|.+. ++..||+|.+... .......+.+|+.++++++ |+||++++++
T Consensus 12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~----------- 77 (292)
T cd06644 12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETK--SEEELEDYMVEIEILATCN-HPYIVKLLGA----------- 77 (292)
T ss_pred hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccC--CHHHHHHHHHHHHHHHhCC-CCcEeeeEEE-----------
Confidence 56999999999999999999984 5789999998754 3344566889999999998 8999999886
Q ss_pred hhCCCCCCCCccccCCeEEEEEecchh-hHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCCCc
Q 003052 551 LNGSMNNKDGRVKDDGYIYMVLEYGEI-DLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPA 629 (853)
Q Consensus 551 ~~~~iv~~~g~~~d~~~lyLVmEy~~g-dL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLKPe 629 (853)
+..++.+|+||||+++ +|..++.+. ...+++..++.++.||+.||.|||++||+||||||+
T Consensus 78 -----------~~~~~~~~lv~e~~~~~~l~~~~~~~-------~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~ 139 (292)
T cd06644 78 -----------FYWDGKLWIMIEFCPGGAVDAIMLEL-------DRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAG 139 (292)
T ss_pred -----------EEeCCeEEEEEecCCCCcHHHHHHhh-------cCCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcc
Confidence 3456689999999765 565555432 246899999999999999999999999999999999
Q ss_pred cEEee-cCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHhCCC
Q 003052 630 NFLLV-KGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGRT 708 (853)
Q Consensus 630 NILL~-~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLtG~~ 708 (853)
||+++ ++.+||+|||++....... .......|++.|+|||++.+.... ...++.++|||||||++|+|++|.+
T Consensus 140 Nili~~~~~~kl~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~----~~~~~~~~Dv~slG~il~el~~g~~ 213 (292)
T cd06644 140 NVLLTLDGDIKLADFGVSAKNVKTL--QRRDSFIGTPYWMAPEVVMCETMK----DTPYDYKADIWSLGITLIEMAQIEP 213 (292)
T ss_pred eEEEcCCCCEEEccCccceeccccc--cccceecCCccccCceeecccccc----CCCCCchhhhHhHHHHHHHHhcCCC
Confidence 99994 6799999999987543221 122356789999999998643211 1246789999999999999999999
Q ss_pred CCCcchhHHHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCCChhHHhcCCCCCCCC
Q 003052 709 PFSEYKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQHPFLVPPV 771 (853)
Q Consensus 709 PF~~~~~~~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~HPwf~~~~ 771 (853)
||..........+...........+...+..+.+||.+||..||.+||++.++++||||....
T Consensus 214 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~ 276 (292)
T cd06644 214 PHHELNPMRVLLKIAKSEPPTLSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLEHPFVSSVT 276 (292)
T ss_pred CCccccHHHHHHHHhcCCCccCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHhcCccccccc
Confidence 997765544444443322223333455677899999999999999999999999999997543
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=333.93 Aligned_cols=255 Identities=28% Similarity=0.432 Sum_probs=204.7
Q ss_pred eeeEEEeEeccCceEEEEEEecCCcEEEEEEEecCCCC----hhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHH
Q 003052 473 LYQRLGKIGSGGSSEVHKVISSDCTIYALKKIKLKGRD----YATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLR 548 (853)
Q Consensus 473 ~Y~ilk~LG~G~FG~Vyka~~~~g~~vAVKkik~~~~~----~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~ 548 (853)
+|++.+.||+|+||.||+|...+++.+|+|.++..... ......+.+|+.+|++++ |+||++++++
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~--------- 70 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLK-HVNIVQYLGT--------- 70 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcC-CCCEeeEeeE---------
Confidence 37888999999999999999888899999999765322 223356889999999997 8999999886
Q ss_pred HHhhCCCCCCCCccccCCeEEEEEecch-hhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCC
Q 003052 549 EVLNGSMNNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLK 627 (853)
Q Consensus 549 ~l~~~~iv~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLK 627 (853)
+.+...+|+||||+. ++|.+++.+. ..+++..++.++.||+.||.|||+.||+|+|||
T Consensus 71 -------------~~~~~~~~lv~e~~~~~~L~~~l~~~--------~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~ 129 (265)
T cd06631 71 -------------CLDDNTISIFMEFVPGGSISSILNRF--------GPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIK 129 (265)
T ss_pred -------------eecCCeEEEEEecCCCCcHHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcC
Confidence 455678999999975 4888887543 468999999999999999999999999999999
Q ss_pred CccEEe-ecCcEEEEecccchhcccCCc----cccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHH
Q 003052 628 PANFLL-VKGSLKLIDFGIAKAIMSDTT----NIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQ 702 (853)
Q Consensus 628 PeNILL-~~g~VKL~DFGlAk~~~~~~~----~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyE 702 (853)
|+||++ .++.+||+|||++........ ........|+..|+|||++.+.. ++.++|+|||||++|+
T Consensus 130 p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~---------~~~~~Dv~slG~~~~~ 200 (265)
T cd06631 130 GNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINESG---------YGRKSDIWSIGCTVFE 200 (265)
T ss_pred HHhEEECCCCeEEeccchhhHhhhhccccccccccccccCCCccccChhhhcCCC---------CcchhhHHHHHHHHHH
Confidence 999999 577999999999986532111 11123457899999999986543 5679999999999999
Q ss_pred HHhCCCCCCcchhHHHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCCChhHHhcCCCC
Q 003052 703 MVYGRTPFSEYKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQHPFL 767 (853)
Q Consensus 703 LLtG~~PF~~~~~~~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~HPwf 767 (853)
|++|..||...+.......+..........+...+..+.+||.+||..+|.+||++.++|+||||
T Consensus 201 l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~ 265 (265)
T cd06631 201 MATGKPPLASMDRLAAMFYIGAHRGLMPRLPDSFSAAAIDFVTSCLTRDQHERPSALQLLRHDFL 265 (265)
T ss_pred HHhCCCccccCChHHHHHHhhhccCCCCCCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence 99999999775554433332222112223445678889999999999999999999999999997
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-39 Score=341.92 Aligned_cols=254 Identities=27% Similarity=0.427 Sum_probs=200.1
Q ss_pred eeEEEeEeccCceEEEEEEe-cCCcEEEEEEEecCCCC-hhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHHHHh
Q 003052 474 YQRLGKIGSGGSSEVHKVIS-SDCTIYALKKIKLKGRD-YATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLREVL 551 (853)
Q Consensus 474 Y~ilk~LG~G~FG~Vyka~~-~~g~~vAVKkik~~~~~-~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~~l~ 551 (853)
|++.+.||+|+||.||++.+ .+++.||+|.+...... ......+.+|+.++++++ |++|+.+++.
T Consensus 2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~-~~~i~~~~~~------------ 68 (285)
T cd05630 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVN-SRFVVSLAYA------------ 68 (285)
T ss_pred ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCC-CCCeeeeeEE------------
Confidence 77889999999999999988 46789999999764332 222345678999999997 8899998765
Q ss_pred hCCCCCCCCccccCCeEEEEEecch-hhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCCCcc
Q 003052 552 NGSMNNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPAN 630 (853)
Q Consensus 552 ~~~iv~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLKPeN 630 (853)
+.+...+|+||||+. ++|.+.+... ....+++..+..++.||+.||.|||+.||+||||||+|
T Consensus 69 ----------~~~~~~~~lv~e~~~g~~L~~~l~~~------~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~N 132 (285)
T cd05630 69 ----------YETKDALCLVLTLMNGGDLKFHIYHM------GEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPEN 132 (285)
T ss_pred ----------EecCCEEEEEEEecCCCcHHHHHHHh------cccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHH
Confidence 455678999999975 5888877543 22468999999999999999999999999999999999
Q ss_pred EEee-cCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHhCCCC
Q 003052 631 FLLV-KGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGRTP 709 (853)
Q Consensus 631 ILL~-~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLtG~~P 709 (853)
|+++ ++.++|+|||++........ .....|++.|+|||++.+. .++.++|||||||++|+|++|+.|
T Consensus 133 il~~~~~~~~l~Dfg~~~~~~~~~~---~~~~~g~~~y~aPE~~~~~---------~~~~~~DiwslG~~l~~l~~g~~P 200 (285)
T cd05630 133 ILLDDHGHIRISDLGLAVHVPEGQT---IKGRVGTVGYMAPEVVKNE---------RYTFSPDWWALGCLLYEMIAGQSP 200 (285)
T ss_pred EEECCCCCEEEeeccceeecCCCcc---ccCCCCCccccChHHHcCC---------CCCCccccHHHHHHHHHHHhCCCC
Confidence 9994 57899999999976532221 1245799999999999754 356799999999999999999999
Q ss_pred CCcchhH--HHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCCC-----hhHHhcCCCCCC
Q 003052 710 FSEYKTF--WAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWR-----IPQLLQHPFLVP 769 (853)
Q Consensus 710 F~~~~~~--~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpT-----a~EIL~HPwf~~ 769 (853)
|...... ......... .....+....++++++||.+||+.||.+||+ +.|+++||||..
T Consensus 201 f~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h~~~~~ 266 (285)
T cd05630 201 FQQRKKKIKREEVERLVK-EVQEEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEHPLFKQ 266 (285)
T ss_pred CCCCCccchHHHHHhhhh-hhhhhcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcChhhhc
Confidence 9753221 111111111 1112344567788999999999999999999 899999999975
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=336.71 Aligned_cols=255 Identities=28% Similarity=0.481 Sum_probs=200.1
Q ss_pred eeeEEEeEeccCceEEEEEEec-CCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHHHHh
Q 003052 473 LYQRLGKIGSGGSSEVHKVISS-DCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLREVL 551 (853)
Q Consensus 473 ~Y~ilk~LG~G~FG~Vyka~~~-~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~~l~ 551 (853)
.|++.+.||+|+||.||+|.+. +++.||+|++............+.+|+.+++++. |+||++++++
T Consensus 2 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~-h~~i~~~~~~------------ 68 (286)
T cd07847 2 KYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLK-HPNLVNLIEV------------ 68 (286)
T ss_pred ceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCC-CCCEeeeeeE------------
Confidence 5999999999999999999985 6789999999765433333445789999999998 8999999876
Q ss_pred hCCCCCCCCccccCCeEEEEEecchhhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCCCccE
Q 003052 552 NGSMNNKDGRVKDDGYIYMVLEYGEIDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANF 631 (853)
Q Consensus 552 ~~~iv~~~g~~~d~~~lyLVmEy~~gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLKPeNI 631 (853)
+.+...+|+||||+++.+...+... ...+++..++.++.||+.||.|||++||+||||||+||
T Consensus 69 ----------~~~~~~~~~v~e~~~~~~l~~~~~~-------~~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~ni 131 (286)
T cd07847 69 ----------FRRKRKLHLVFEYCDHTVLNELEKN-------PRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENI 131 (286)
T ss_pred ----------EeeCCEEEEEEeccCccHHHHHHhC-------CCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhE
Confidence 4566789999999887555544321 24689999999999999999999999999999999999
Q ss_pred Ee-ecCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHhCCCCC
Q 003052 632 LL-VKGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGRTPF 710 (853)
Q Consensus 632 LL-~~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLtG~~PF 710 (853)
++ .++.+||+|||++........ ......++..|+|||++.+.. .++.++|||||||++|+|++|++||
T Consensus 132 l~~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~--------~~~~~~Di~slG~i~~~l~~g~~p~ 201 (286)
T cd07847 132 LITKQGQIKLCDFGFARILTGPGD--DYTDYVATRWYRAPELLVGDT--------QYGPPVDVWAIGCVFAELLTGQPLW 201 (286)
T ss_pred EEcCCCcEEECccccceecCCCcc--cccCcccccccCCHHHHhCCC--------CcCchhhhHHHHHHHHHHHhCCCCC
Confidence 99 467999999999987654321 122456889999999986532 3567999999999999999999999
Q ss_pred CcchhHHHHHHhhc---C--------------------CCCcc-----cCCCCCChhHHHHHHHhcccCCCCCCChhHHh
Q 003052 711 SEYKTFWAKFKVIT---D--------------------PNHEI-----TYEPVPNPWLLDLMKKCLAWDRNERWRIPQLL 762 (853)
Q Consensus 711 ~~~~~~~~~~kii~---~--------------------~~~~~-----~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL 762 (853)
.+.........+.. . +.... ......+..+.+||.+||..||.+||++.|++
T Consensus 202 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil 281 (286)
T cd07847 202 PGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELL 281 (286)
T ss_pred CCCChHHHHHHHHHHhCCCChHHhhhcccccccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHh
Confidence 76544322222110 0 00000 00123467799999999999999999999999
Q ss_pred cCCCC
Q 003052 763 QHPFL 767 (853)
Q Consensus 763 ~HPwf 767 (853)
.||||
T Consensus 282 ~~~~f 286 (286)
T cd07847 282 EHPYF 286 (286)
T ss_pred cCCCC
Confidence 99998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=330.29 Aligned_cols=258 Identities=22% Similarity=0.385 Sum_probs=207.1
Q ss_pred eeeEEEeEeccCceEEEEEEec-CCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHHHHh
Q 003052 473 LYQRLGKIGSGGSSEVHKVISS-DCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLREVL 551 (853)
Q Consensus 473 ~Y~ilk~LG~G~FG~Vyka~~~-~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~~l~ 551 (853)
.|++.+.||.|+||.||+|... ++..+|+|++....... ....+.+|+++|+.++ |+||+++++.
T Consensus 2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~e~~~l~~l~-~~~i~~~~~~------------ 67 (267)
T cd06610 2 DYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQT-SVDELRKEVQAMSQCN-HPNVVKYYTS------------ 67 (267)
T ss_pred cceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcch-HHHHHHHHHHHHHhcC-CCCEEEEEEE------------
Confidence 5899999999999999999874 66889999997654433 5567889999999997 8999999875
Q ss_pred hCCCCCCCCccccCCeEEEEEecch-hhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCCCcc
Q 003052 552 NGSMNNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPAN 630 (853)
Q Consensus 552 ~~~iv~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLKPeN 630 (853)
+.++..+|+||||+. ++|.+++.... ....+++..++.++.||+.||.|||++||+||||||+|
T Consensus 68 ----------~~~~~~~~iv~e~~~~~~l~~~~~~~~-----~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~n 132 (267)
T cd06610 68 ----------FVVGDELWLVMPYLSGGSLLDIMKSSY-----PRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGN 132 (267)
T ss_pred ----------EeeCCEEEEEEeccCCCcHHHHHHHhc-----ccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHh
Confidence 455678999999976 48888876531 12468999999999999999999999999999999999
Q ss_pred EEee-cCcEEEEecccchhcccCCccc--cccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHhCC
Q 003052 631 FLLV-KGSLKLIDFGIAKAIMSDTTNI--QRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGR 707 (853)
Q Consensus 631 ILL~-~g~VKL~DFGlAk~~~~~~~~~--~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLtG~ 707 (853)
|+++ ++.+||+|||++..+....... .....+|+..|+|||++.... .++.++|+|||||++|+|++|+
T Consensus 133 i~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~--------~~~~~~Dv~slG~i~~~l~~g~ 204 (267)
T cd06610 133 ILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVH--------GYDFKADIWSFGITAIELATGA 204 (267)
T ss_pred EEEcCCCCEEEcccchHHHhccCccccccccccccCChhhcChHHHcccc--------CcCcccchHhHhHHHHHHHhCC
Confidence 9994 6799999999998776433221 223557999999999986541 3567999999999999999999
Q ss_pred CCCCcchhHHHHHHhhcCCCCcccCC---CCCChhHHHHHHHhcccCCCCCCChhHHhcCCCC
Q 003052 708 TPFSEYKTFWAKFKVITDPNHEITYE---PVPNPWLLDLMKKCLAWDRNERWRIPQLLQHPFL 767 (853)
Q Consensus 708 ~PF~~~~~~~~~~kii~~~~~~~~~~---~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~HPwf 767 (853)
.||..........+............ ...++++.+||.+||.+||.+||++.+|++||||
T Consensus 205 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~p~~ 267 (267)
T cd06610 205 APYSKYPPMKVLMLTLQNDPPSLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKHKFF 267 (267)
T ss_pred CCccccChhhhHHHHhcCCCCCcCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhhCCCC
Confidence 99987655444444443322222222 2456789999999999999999999999999998
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-39 Score=339.09 Aligned_cols=261 Identities=27% Similarity=0.465 Sum_probs=211.2
Q ss_pred ceeeEEEeEeccCceEEEEEEe-cCCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHHHH
Q 003052 472 KLYQRLGKIGSGGSSEVHKVIS-SDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLREV 550 (853)
Q Consensus 472 ~~Y~ilk~LG~G~FG~Vyka~~-~~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~~l 550 (853)
+.|+++++||.|+||.||+|.+ .++..+|+|.+... .......+.+|++++++++ |+||++++++
T Consensus 5 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~--~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~----------- 70 (280)
T cd06611 5 DIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIE--SEEELEDFMVEIDILSECK-HPNIVGLYEA----------- 70 (280)
T ss_pred hHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeC--CHHHHHHHHHHHHHHHhCC-CCceeEEEEE-----------
Confidence 4599999999999999999998 46789999999754 3344567889999999998 9999999987
Q ss_pred hhCCCCCCCCccccCCeEEEEEecchh-hHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCCCc
Q 003052 551 LNGSMNNKDGRVKDDGYIYMVLEYGEI-DLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPA 629 (853)
Q Consensus 551 ~~~~iv~~~g~~~d~~~lyLVmEy~~g-dL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLKPe 629 (853)
+.++..+|+||||+++ +|..++... ...+++..++.++.||+.||.|||++||+||||||+
T Consensus 71 -----------~~~~~~~~lv~e~~~~~~L~~~~~~~-------~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ 132 (280)
T cd06611 71 -----------YFYENKLWILIEFCDGGALDSIMLEL-------ERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAG 132 (280)
T ss_pred -----------EecCCeEEEEeeccCCCcHHHHHHHh-------cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChh
Confidence 3456678999999765 777776543 346999999999999999999999999999999999
Q ss_pred cEEe-ecCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHhCCC
Q 003052 630 NFLL-VKGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGRT 708 (853)
Q Consensus 630 NILL-~~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLtG~~ 708 (853)
||++ .++.++|+|||++........ ......|++.|+|||++...... ...++.++|||||||++|+|++|++
T Consensus 133 nili~~~~~~~l~d~g~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~----~~~~~~~sDi~slG~il~~l~~g~~ 206 (280)
T cd06611 133 NILLTLDGDVKLADFGVSAKNKSTLQ--KRDTFIGTPYWMAPEVVACETFK----DNPYDYKADIWSLGITLIELAQMEP 206 (280)
T ss_pred hEEECCCCCEEEccCccchhhccccc--ccceeecchhhcCHHHHhhcccC----CCCCCccccHHHHHHHHHHHHhCCC
Confidence 9999 567999999999876543221 22356799999999998654321 1246789999999999999999999
Q ss_pred CCCcchhHHHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCCChhHHhcCCCCCCC
Q 003052 709 PFSEYKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQHPFLVPP 770 (853)
Q Consensus 709 PF~~~~~~~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~HPwf~~~ 770 (853)
||.+.................+..+...+.++.+||.+||..||.+||++.++|+||||...
T Consensus 207 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~ 268 (280)
T cd06611 207 PHHELNPMRVLLKILKSEPPTLDQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKHPFVSDQ 268 (280)
T ss_pred CcccCCHHHHHHHHhcCCCCCcCCcccCCHHHHHHHHHHhccChhhCcCHHHHhcChhhccc
Confidence 99876655444444433333334455677889999999999999999999999999999754
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-39 Score=355.27 Aligned_cols=248 Identities=21% Similarity=0.244 Sum_probs=190.0
Q ss_pred ceeeEEEeEeccCceEEEEEEec-CCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHHHH
Q 003052 472 KLYQRLGKIGSGGSSEVHKVISS-DCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLREV 550 (853)
Q Consensus 472 ~~Y~ilk~LG~G~FG~Vyka~~~-~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~~l 550 (853)
..|++++.||+|+||.||+|.+. ++..||+|+.... ....|+.+|++++ |+||++++++
T Consensus 66 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~--------~~~~E~~~l~~l~-h~~iv~~~~~----------- 125 (357)
T PHA03209 66 LGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG--------TTLIEAMLLQNVN-HPSVIRMKDT----------- 125 (357)
T ss_pred cCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc--------ccHHHHHHHHhCC-CCCCcChhhe-----------
Confidence 45999999999999999999985 5578999875432 2347999999997 8999999876
Q ss_pred hhCCCCCCCCccccCCeEEEEEecchhhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCCCcc
Q 003052 551 LNGSMNNKDGRVKDDGYIYMVLEYGEIDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPAN 630 (853)
Q Consensus 551 ~~~~iv~~~g~~~d~~~lyLVmEy~~gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLKPeN 630 (853)
+......|+||||+.++|..++... ...+++..++.|+.||+.||.|||++||+||||||+|
T Consensus 126 -----------~~~~~~~~lv~e~~~~~l~~~l~~~-------~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~N 187 (357)
T PHA03209 126 -----------LVSGAITCMVLPHYSSDLYTYLTKR-------SRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTEN 187 (357)
T ss_pred -----------EEeCCeeEEEEEccCCcHHHHHHhc-------cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHH
Confidence 4556778999999988988887643 3568999999999999999999999999999999999
Q ss_pred EEe-ecCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHhCCCC
Q 003052 631 FLL-VKGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGRTP 709 (853)
Q Consensus 631 ILL-~~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLtG~~P 709 (853)
||+ ..+.+||+|||+++...... ......||+.|+|||++.+. .|+.++|||||||++|||+++..|
T Consensus 188 ill~~~~~~kl~DfG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~---------~~~~~~DiwSlGvvl~ell~~~~~ 255 (357)
T PHA03209 188 IFINDVDQVCIGDLGAAQFPVVAP---AFLGLAGTVETNAPEVLARD---------KYNSKADIWSAGIVLFEMLAYPST 255 (357)
T ss_pred EEECCCCCEEEecCccccccccCc---ccccccccccccCCeecCCC---------CCCchhhHHHHHHHHHHHHHcCCc
Confidence 999 56799999999997543221 12356799999999999765 356899999999999999985444
Q ss_pred -CCcchh------------HHHHHHhhcCCCCccc----------------------------CCCCCChhHHHHHHHhc
Q 003052 710 -FSEYKT------------FWAKFKVITDPNHEIT----------------------------YEPVPNPWLLDLMKKCL 748 (853)
Q Consensus 710 -F~~~~~------------~~~~~kii~~~~~~~~----------------------------~~~~~s~~l~dLI~kcL 748 (853)
|..... +......+......+. .....+..+.+||.+||
T Consensus 256 ~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL 335 (357)
T PHA03209 256 IFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEFPRDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKML 335 (357)
T ss_pred cccCCCCcHHHHHHHHHHHHHHHHHHhccChhhcCCCCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHH
Confidence 432110 0011111100000000 01134556788999999
Q ss_pred ccCCCCCCChhHHhcCCCCCC
Q 003052 749 AWDRNERWRIPQLLQHPFLVP 769 (853)
Q Consensus 749 ~~DP~kRpTa~EIL~HPwf~~ 769 (853)
++||.+|||+.|+|+||||+.
T Consensus 336 ~~dP~~Rpta~e~l~hp~f~~ 356 (357)
T PHA03209 336 TFDAAMRPSAEEILNYPMFAQ 356 (357)
T ss_pred cCCcccCcCHHHHhcCchhcc
Confidence 999999999999999999974
|
|
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=336.99 Aligned_cols=264 Identities=24% Similarity=0.447 Sum_probs=207.0
Q ss_pred ceeeEEEeEeccCceEEEEEEe-cCCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHHHH
Q 003052 472 KLYQRLGKIGSGGSSEVHKVIS-SDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLREV 550 (853)
Q Consensus 472 ~~Y~ilk~LG~G~FG~Vyka~~-~~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~~l 550 (853)
..|++.+.||.|+||.||+|.+ .+++.+|+|++.... .....+..|+.+++++.+|+||+++++++....
T Consensus 16 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~---~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~------ 86 (282)
T cd06636 16 GIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE---DEEEEIKLEINMLKKYSHHRNIATYYGAFIKKS------ 86 (282)
T ss_pred hhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh---HHHHHHHHHHHHHHHhcCCCcEEEEeeehhccc------
Confidence 4588999999999999999998 567899999987543 233457889999999988999999998754210
Q ss_pred hhCCCCCCCCccccCCeEEEEEecchh-hHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCCCc
Q 003052 551 LNGSMNNKDGRVKDDGYIYMVLEYGEI-DLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPA 629 (853)
Q Consensus 551 ~~~~iv~~~g~~~d~~~lyLVmEy~~g-dL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLKPe 629 (853)
......++|++|||+++ +|.+++... ....+++.+++.++.||+.||.|||++||+||||||+
T Consensus 87 ----------~~~~~~~~~iv~e~~~~~~L~~~~~~~------~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~ 150 (282)
T cd06636 87 ----------PPGHDDQLWLVMEFCGAGSVTDLVKNT------KGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQ 150 (282)
T ss_pred ----------ccCCCCEEEEEEEeCCCCcHHHHHHHc------cCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHH
Confidence 11245689999999764 888877653 2346889999999999999999999999999999999
Q ss_pred cEEe-ecCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHhCCC
Q 003052 630 NFLL-VKGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGRT 708 (853)
Q Consensus 630 NILL-~~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLtG~~ 708 (853)
||++ .++.++|+|||++........ .....+|++.|+|||++..... ....++.++|||||||++|+|++|..
T Consensus 151 nili~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~l~~~~~----~~~~~~~~~DvwslG~~l~el~~g~~ 224 (282)
T cd06636 151 NVLLTENAEVKLVDFGVSAQLDRTVG--RRNTFIGTPYWMAPEVIACDEN----PDATYDYRSDIWSLGITAIEMAEGAP 224 (282)
T ss_pred HEEECCCCCEEEeeCcchhhhhcccc--CCCcccccccccCHhhcCcccC----cCcCCCcccchhHHHHHHHHHHhCCC
Confidence 9999 567899999999986543211 2235679999999999864321 11246789999999999999999999
Q ss_pred CCCcchhHHHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCCChhHHhcCCCC
Q 003052 709 PFSEYKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQHPFL 767 (853)
Q Consensus 709 PF~~~~~~~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~HPwf 767 (853)
||.................. .......+.++.+||.+||..||.+||++.|||+||||
T Consensus 225 p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~~~~ 282 (282)
T cd06636 225 PLCDMHPMRALFLIPRNPPP-KLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKHPFI 282 (282)
T ss_pred CccccCHHhhhhhHhhCCCC-CCcccccCHHHHHHHHHHhCCChhhCcCHHHHhcCCCC
Confidence 99776555444433222111 12233567889999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=338.10 Aligned_cols=250 Identities=24% Similarity=0.370 Sum_probs=198.1
Q ss_pred eeeEEEeEeccCceEEEEEEe-cCCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHHHHh
Q 003052 473 LYQRLGKIGSGGSSEVHKVIS-SDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLREVL 551 (853)
Q Consensus 473 ~Y~ilk~LG~G~FG~Vyka~~-~~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~~l~ 551 (853)
.|++++.||+|+||.||+|.+ .+++.||+|++..... ......+.+|+++++++. |+||++++++
T Consensus 2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~E~~~l~~l~-h~~iv~~~~~------------ 67 (279)
T cd06619 2 DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDIT-VELQKQIMSELEILYKCD-SPYIIGFYGA------------ 67 (279)
T ss_pred cchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCC-hHHHHHHHHHHHHHHhCC-CCCeeeEEEE------------
Confidence 478899999999999999998 5778999999976432 334456889999999997 8999999986
Q ss_pred hCCCCCCCCccccCCeEEEEEecchhhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCCCccE
Q 003052 552 NGSMNNKDGRVKDDGYIYMVLEYGEIDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANF 631 (853)
Q Consensus 552 ~~~iv~~~g~~~d~~~lyLVmEy~~gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLKPeNI 631 (853)
+..++.+++||||+++...... ..+++..+..++.||+.||.|||++||+|+||||+||
T Consensus 68 ----------~~~~~~~~lv~e~~~~~~l~~~-----------~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Ni 126 (279)
T cd06619 68 ----------FFVENRISICTEFMDGGSLDVY-----------RKIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNM 126 (279)
T ss_pred ----------EEECCEEEEEEecCCCCChHHh-----------hcCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHE
Confidence 4556788999999775322221 2478999999999999999999999999999999999
Q ss_pred Ee-ecCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHhCCCCC
Q 003052 632 LL-VKGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGRTPF 710 (853)
Q Consensus 632 LL-~~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLtG~~PF 710 (853)
|+ .++.+||+|||++..+.... ....+||..|+|||++.+.. ++.++|+|||||++|+|++|+.||
T Consensus 127 ll~~~~~~~l~dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~---------~~~~~DvwslG~~l~~l~~g~~pf 193 (279)
T cd06619 127 LVNTRGQVKLCDFGVSTQLVNSI----AKTYVGTNAYMAPERISGEQ---------YGIHSDVWSLGISFMELALGRFPY 193 (279)
T ss_pred EECCCCCEEEeeCCcceeccccc----ccCCCCChhhcCceeecCCC---------CCCcchHHHHHHHHHHHHhCCCCc
Confidence 99 56799999999998664322 23568999999999987543 567999999999999999999999
Q ss_pred Ccchh------HHHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCCChhHHhcCCCCCCC
Q 003052 711 SEYKT------FWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQHPFLVPP 770 (853)
Q Consensus 711 ~~~~~------~~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~HPwf~~~ 770 (853)
..... .......+.............++.+++||.+||..||.+||++.++++||||...
T Consensus 194 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~~~~~~~ 259 (279)
T cd06619 194 PQIQKNQGSLMPLQLLQCIVDEDPPVLPVGQFSEKFVHFITQCMRKQPKERPAPENLMDHPFIVQY 259 (279)
T ss_pred hhhcccccccchHHHHHHHhccCCCCCCCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcCcccccc
Confidence 64221 1122222222222222233467789999999999999999999999999999754
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-39 Score=336.27 Aligned_cols=254 Identities=24% Similarity=0.349 Sum_probs=200.4
Q ss_pred ceeeEEEeEeccCceEEEEEEe-cCCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHHHH
Q 003052 472 KLYQRLGKIGSGGSSEVHKVIS-SDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLREV 550 (853)
Q Consensus 472 ~~Y~ilk~LG~G~FG~Vyka~~-~~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~~l 550 (853)
..|++.++||+|+||.||+|.+ .+++.||+|+++.... .....+.+|+.+++.++ |+||++++++
T Consensus 9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~e~~~~~~l~-h~~ii~~~~~----------- 74 (267)
T cd06645 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPG--EDFAVVQQEIIMMKDCK-HSNIVAYFGS----------- 74 (267)
T ss_pred HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCch--hHHHHHHHHHHHHHhCC-CCCeeeEEEE-----------
Confidence 4688999999999999999988 4678999999976532 23345778999999996 8999999876
Q ss_pred hhCCCCCCCCccccCCeEEEEEecch-hhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCCCc
Q 003052 551 LNGSMNNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPA 629 (853)
Q Consensus 551 ~~~~iv~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLKPe 629 (853)
+.+...+|+||||++ ++|.+++... +.+++..++.++.||+.||.|||++||+||||||+
T Consensus 75 -----------~~~~~~~~lv~e~~~~~~L~~~~~~~--------~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~ 135 (267)
T cd06645 75 -----------YLRRDKLWICMEFCGGGSLQDIYHVT--------GPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGA 135 (267)
T ss_pred -----------EEeCCEEEEEEeccCCCcHHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHH
Confidence 455678999999987 4888877543 57999999999999999999999999999999999
Q ss_pred cEEe-ecCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHhCCC
Q 003052 630 NFLL-VKGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGRT 708 (853)
Q Consensus 630 NILL-~~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLtG~~ 708 (853)
||++ .++.+||+|||++........ ......|++.|+|||++..... ..++.++|||||||++|+|++|..
T Consensus 136 nili~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~------~~~~~~~DvwSlG~il~~l~~~~~ 207 (267)
T cd06645 136 NILLTDNGHVKLADFGVSAQITATIA--KRKSFIGTPYWMAPEVAAVERK------GGYNQLCDIWAVGITAIELAELQP 207 (267)
T ss_pred HEEECCCCCEEECcceeeeEccCccc--ccccccCcccccChhhhccccC------CCCCchhhhHHHHHHHHHHhcCCC
Confidence 9999 567999999999976543221 2235689999999999853211 135679999999999999999999
Q ss_pred CCCcchhHHHHHHhhcCCCCc--ccCCCCCChhHHHHHHHhcccCCCCCCChhHHhcCCC
Q 003052 709 PFSEYKTFWAKFKVITDPNHE--ITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQHPF 766 (853)
Q Consensus 709 PF~~~~~~~~~~kii~~~~~~--~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~HPw 766 (853)
||................... .......+..+.+||.+||..||++||++.+|++|||
T Consensus 208 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~~~~ 267 (267)
T cd06645 208 PMFDLHPMRALFLMTKSNFQPPKLKDKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQHPF 267 (267)
T ss_pred CcccccchhhHHhhhccCCCCCcccccCCCCHHHHHHHHHHccCCchhCcCHHHHhcCCC
Confidence 996544433332222111111 1112245678999999999999999999999999999
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=336.93 Aligned_cols=261 Identities=29% Similarity=0.490 Sum_probs=206.9
Q ss_pred ceeeEEEeEeccCceEEEEEEec-CCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHHHH
Q 003052 472 KLYQRLGKIGSGGSSEVHKVISS-DCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLREV 550 (853)
Q Consensus 472 ~~Y~ilk~LG~G~FG~Vyka~~~-~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~~l 550 (853)
+.|+++++||+|+||.||++.+. ++..+|+|.+.... ......+.+|+++++.+. |+||++++++
T Consensus 5 ~~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~e~~~l~~l~-h~~ii~~~~~----------- 70 (282)
T cd06643 5 EFWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKS--EEELEDYMVEIDILASCD-HPNIVKLLDA----------- 70 (282)
T ss_pred HHHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCC--HHHHHHHHHHHHHHHHCC-CCCeeeEEEE-----------
Confidence 34788899999999999999985 56788999886542 344567889999999997 8999999886
Q ss_pred hhCCCCCCCCccccCCeEEEEEecchh-hHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCCCc
Q 003052 551 LNGSMNNKDGRVKDDGYIYMVLEYGEI-DLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPA 629 (853)
Q Consensus 551 ~~~~iv~~~g~~~d~~~lyLVmEy~~g-dL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLKPe 629 (853)
+..+...|+||||+++ +|..++... ...+++..++.++.||+.||.|||+.||+||||||+
T Consensus 71 -----------~~~~~~~~~v~e~~~~~~l~~~~~~~-------~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~ 132 (282)
T cd06643 71 -----------FYYENNLWILIEFCAGGAVDAVMLEL-------ERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAG 132 (282)
T ss_pred -----------EeeCCEEEEEEEecCCCcHHHHHHhc-------CCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcc
Confidence 3445688999999764 666555432 356899999999999999999999999999999999
Q ss_pred cEEe-ecCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHhCCC
Q 003052 630 NFLL-VKGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGRT 708 (853)
Q Consensus 630 NILL-~~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLtG~~ 708 (853)
|||+ .++.+||+|||++........ ......|++.|+|||++...... ...++.++|||||||++|+|++|++
T Consensus 133 nili~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~----~~~~~~~~Dv~slGvil~el~~g~~ 206 (282)
T cd06643 133 NILFTLDGDIKLADFGVSAKNTRTIQ--RRDSFIGTPYWMAPEVVMCETSK----DRPYDYKADVWSLGITLIEMAQIEP 206 (282)
T ss_pred cEEEccCCCEEEcccccccccccccc--ccccccccccccCHhhccccCCC----CCCCCccchhhhHHHHHHHHccCCC
Confidence 9999 567999999999976543211 22356799999999998643221 1246789999999999999999999
Q ss_pred CCCcchhHHHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCCChhHHhcCCCCCCC
Q 003052 709 PFSEYKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQHPFLVPP 770 (853)
Q Consensus 709 PF~~~~~~~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~HPwf~~~ 770 (853)
||......................+...+..+.+||.+||..||.+||++.++++||||...
T Consensus 207 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~ 268 (282)
T cd06643 207 PHHELNPMRVLLKIAKSEPPTLAQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQHPFVTVN 268 (282)
T ss_pred CccccCHHHHHHHHhhcCCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCCCEecc
Confidence 99876655444444333223333445567889999999999999999999999999999754
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-38 Score=335.27 Aligned_cols=267 Identities=24% Similarity=0.407 Sum_probs=208.4
Q ss_pred ceeeEEEeEeccCceEEEEEEe-cCCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHHHH
Q 003052 472 KLYQRLGKIGSGGSSEVHKVIS-SDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLREV 550 (853)
Q Consensus 472 ~~Y~ilk~LG~G~FG~Vyka~~-~~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~~l 550 (853)
..|.+.+.||+|+||.||+|.. .+++.+|+|++..... ....+.+|+.+++++.+|+||+++++++....
T Consensus 22 ~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~---~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~------ 92 (291)
T cd06639 22 DTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISD---VDEEIEAEYNILQSLPNHPNVVKFYGMFYKAD------ 92 (291)
T ss_pred CCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEeccccc---HHHHHHHHHHHHHHhcCCCCeEEEEEEEEecc------
Confidence 5699999999999999999998 4678999999865422 22356789999999977999999998753211
Q ss_pred hhCCCCCCCCccccCCeEEEEEecch-hhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCCCc
Q 003052 551 LNGSMNNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPA 629 (853)
Q Consensus 551 ~~~~iv~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLKPe 629 (853)
......+|+||||++ ++|.+++..... ....+++..++.++.||+.||.|||++||+||||||+
T Consensus 93 -----------~~~~~~~~lv~ey~~~~sL~~~~~~~~~----~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~ 157 (291)
T cd06639 93 -----------KLVGGQLWLVLELCNGGSVTELVKGLLI----CGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGN 157 (291)
T ss_pred -----------ccCCCeeEEEEEECCCCcHHHHHHHhhh----cCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHH
Confidence 112357899999975 588887754311 2356899999999999999999999999999999999
Q ss_pred cEEe-ecCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHhCCC
Q 003052 630 NFLL-VKGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGRT 708 (853)
Q Consensus 630 NILL-~~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLtG~~ 708 (853)
||++ .++.+||+|||++........ ......|+..|+|||++...... ...++.++|||||||++|+|++|++
T Consensus 158 nili~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~----~~~~~~~~Di~slGvi~~el~~g~~ 231 (291)
T cd06639 158 NILLTTEGGVKLVDFGVSAQLTSTRL--RRNTSVGTPFWMAPEVIACEQQY----DYSYDARCDVWSLGITAIELGDGDP 231 (291)
T ss_pred HEEEcCCCCEEEeecccchhcccccc--cccCccCCccccChhhhcCCCCc----ccccCCccchHHHHHHHHHHhhCCC
Confidence 9999 467899999999987543221 12345789999999998654211 1135789999999999999999999
Q ss_pred CCCcchhHHHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCCChhHHhcCCCCC
Q 003052 709 PFSEYKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQHPFLV 768 (853)
Q Consensus 709 PF~~~~~~~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~HPwf~ 768 (853)
||...........+..........+...+..+.+||.+||.+||.+||++.++++||||+
T Consensus 232 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~ 291 (291)
T cd06639 232 PLFDMHPVKTLFKIPRNPPPTLLHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEHPFIK 291 (291)
T ss_pred CCCCCcHHHHHHHHhcCCCCCCCcccccCHHHHHHHHHHhhcChhhCcCHHHHhcCcccC
Confidence 998765544444443333333333445667899999999999999999999999999994
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=342.13 Aligned_cols=261 Identities=28% Similarity=0.418 Sum_probs=203.3
Q ss_pred ceeeEEEeEeccCceEEEEEEe-cCCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHHHH
Q 003052 472 KLYQRLGKIGSGGSSEVHKVIS-SDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLREV 550 (853)
Q Consensus 472 ~~Y~ilk~LG~G~FG~Vyka~~-~~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~~l 550 (853)
+.|++.+.||+|+||.||+|.+ .++..||+|+++...........+.+|+.++++++ |+||+++++++..
T Consensus 7 ~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~-------- 77 (309)
T cd07845 7 TEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLR-HPNIVELKEVVVG-------- 77 (309)
T ss_pred cceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCC-CCCCcceEEEEec--------
Confidence 5699999999999999999998 46789999999865544333345678999999998 8999999987431
Q ss_pred hhCCCCCCCCccccCCeEEEEEecchhhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCCCcc
Q 003052 551 LNGSMNNKDGRVKDDGYIYMVLEYGEIDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPAN 630 (853)
Q Consensus 551 ~~~~iv~~~g~~~d~~~lyLVmEy~~gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLKPeN 630 (853)
...+.+|+||||++++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|
T Consensus 78 ------------~~~~~~~lv~e~~~~~l~~~l~~~-------~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~n 138 (309)
T cd07845 78 ------------KHLDSIFLVMEYCEQDLASLLDNM-------PTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSN 138 (309)
T ss_pred ------------CCCCeEEEEEecCCCCHHHHHHhc-------ccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHH
Confidence 123568999999998888877643 2568999999999999999999999999999999999
Q ss_pred EEe-ecCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHhCCCC
Q 003052 631 FLL-VKGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGRTP 709 (853)
Q Consensus 631 ILL-~~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLtG~~P 709 (853)
|++ .++.+||+|||++........ ......+++.|+|||++.+.. .++.++|||||||++|+|++|++|
T Consensus 139 il~~~~~~~kL~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~--------~~~~~~DvwslG~il~el~~g~~~ 208 (309)
T cd07845 139 LLLTDKGCLKIADFGLARTYGLPAK--PMTPKVVTLWYRAPELLLGCT--------TYTTAIDMWAVGCILAELLAHKPL 208 (309)
T ss_pred EEECCCCCEEECccceeeecCCccC--CCCcccccccccChhhhcCCC--------CcCchHHHHHHHHHHHHHHhCCCC
Confidence 999 567999999999987643321 122345688999999986532 356799999999999999999999
Q ss_pred CCcchhHHHHHHhhc---CCCC-------------cccC-----------CCCCChhHHHHHHHhcccCCCCCCChhHHh
Q 003052 710 FSEYKTFWAKFKVIT---DPNH-------------EITY-----------EPVPNPWLLDLMKKCLAWDRNERWRIPQLL 762 (853)
Q Consensus 710 F~~~~~~~~~~kii~---~~~~-------------~~~~-----------~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL 762 (853)
|.+.........+.. .+.. .... ....++.+.+||.+||.+||++|||+.++|
T Consensus 209 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il 288 (309)
T cd07845 209 LPGKSEIEQLDLIIQLLGTPNESIWPGFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEAL 288 (309)
T ss_pred CCCCCHHHHHHHHHHhcCCCChhhchhhhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHh
Confidence 976544332222111 0000 0000 012467789999999999999999999999
Q ss_pred cCCCCCCC
Q 003052 763 QHPFLVPP 770 (853)
Q Consensus 763 ~HPwf~~~ 770 (853)
.||||...
T Consensus 289 ~h~~f~~~ 296 (309)
T cd07845 289 ESSYFKEK 296 (309)
T ss_pred cChhhccC
Confidence 99999753
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=337.63 Aligned_cols=248 Identities=25% Similarity=0.329 Sum_probs=192.8
Q ss_pred EeccCceEEEEEEe-cCCcEEEEEEEecCCCCh-hhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHHHHhhCCCCC
Q 003052 480 IGSGGSSEVHKVIS-SDCTIYALKKIKLKGRDY-ATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLREVLNGSMNN 557 (853)
Q Consensus 480 LG~G~FG~Vyka~~-~~g~~vAVKkik~~~~~~-~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~~l~~~~iv~ 557 (853)
||+|+||.||++.. .+++.||+|++....... .....+..|++++++++ |+||++++++
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~-hp~i~~~~~~------------------ 61 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVN-SPFIVNLAYA------------------ 61 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcC-CCcEEEEEEE------------------
Confidence 79999999999987 467999999997533221 12234567999999996 8999999876
Q ss_pred CCCccccCCeEEEEEecch-hhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCCCccEEe-ec
Q 003052 558 KDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLL-VK 635 (853)
Q Consensus 558 ~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLKPeNILL-~~ 635 (853)
+.++.++|+||||+. ++|...+... ....+++..+..++.||+.||+|||+.||+||||||+|||+ .+
T Consensus 62 ----~~~~~~~~lv~e~~~g~~L~~~~~~~------~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~ 131 (277)
T cd05607 62 ----FESKTHLCLVMSLMNGGDLKYHIYNV------GERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQ 131 (277)
T ss_pred ----EecCCeEEEEEecCCCCCHHHHHHhc------cccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEcCC
Confidence 456678999999975 5887776543 22458899999999999999999999999999999999999 56
Q ss_pred CcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHhCCCCCCcchh
Q 003052 636 GSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGRTPFSEYKT 715 (853)
Q Consensus 636 g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLtG~~PF~~~~~ 715 (853)
+.+||+|||++....... ......|++.|+|||++.+.. ++.++|||||||++|+|++|+.||.....
T Consensus 132 ~~~~l~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~---------~~~~~DvwslGv~l~el~~g~~p~~~~~~ 199 (277)
T cd05607 132 GNCRLSDLGLAVELKDGK---TITQRAGTNGYMAPEILKEEP---------YSYPVDWFAMGCSIYEMVAGRTPFKDHKE 199 (277)
T ss_pred CCEEEeeceeeeecCCCc---eeeccCCCCCccCHHHHccCC---------CCCchhHHHHHHHHHHHHhCCCCCCCCcc
Confidence 789999999998664322 123457999999999997653 56899999999999999999999965322
Q ss_pred H---HHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCh----hHHhcCCCCCC
Q 003052 716 F---WAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRI----PQLLQHPFLVP 769 (853)
Q Consensus 716 ~---~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa----~EIL~HPwf~~ 769 (853)
. .............. .....+.++++||.+||.+||.+||++ .+++.||||+.
T Consensus 200 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~~~~h~~f~~ 259 (277)
T cd05607 200 KVAKEELKRRTLEDEVKF-EHQNFTEESKDICRLFLAKKPEDRLGSREKNDDPRKHEFFKT 259 (277)
T ss_pred hhhHHHHHHHhhcccccc-ccccCCHHHHHHHHHHhccCHhhCCCCccchhhhhcChhhcC
Confidence 1 12222222111111 123467889999999999999999999 67889999975
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-38 Score=337.16 Aligned_cols=256 Identities=26% Similarity=0.390 Sum_probs=201.6
Q ss_pred eeEEEeEeccCceEEEEEEe-cCCcEEEEEEEecCCCC-hhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHHHHh
Q 003052 474 YQRLGKIGSGGSSEVHKVIS-SDCTIYALKKIKLKGRD-YATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLREVL 551 (853)
Q Consensus 474 Y~ilk~LG~G~FG~Vyka~~-~~g~~vAVKkik~~~~~-~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~~l~ 551 (853)
|+..+.||+|+||+||++.+ .+++.||+|++...... ......+.+|+++|++++ |+||+.++++
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~-~~~i~~~~~~------------ 68 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVN-SQFVVNLAYA------------ 68 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcC-CcCceeEEEE------------
Confidence 77889999999999999988 57789999999764322 222345678999999997 8899988765
Q ss_pred hCCCCCCCCccccCCeEEEEEecch-hhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCCCcc
Q 003052 552 NGSMNNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPAN 630 (853)
Q Consensus 552 ~~~iv~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLKPeN 630 (853)
+.+++.+|+||||+. ++|...+... ....+++..+..++.||+.||.|||++||+||||||+|
T Consensus 69 ----------~~~~~~~~lv~e~~~~~~L~~~~~~~------~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~N 132 (285)
T cd05632 69 ----------YETKDALCLVLTIMNGGDLKFHIYNM------GNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPEN 132 (285)
T ss_pred ----------EecCCEEEEEEEeccCccHHHHHHHh------cCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHH
Confidence 455678999999976 4777766543 23469999999999999999999999999999999999
Q ss_pred EEe-ecCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHhCCCC
Q 003052 631 FLL-VKGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGRTP 709 (853)
Q Consensus 631 ILL-~~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLtG~~P 709 (853)
|++ .++.+||+|||++....... ......|++.|+|||++.+. .++.++|||||||++|+|++|..|
T Consensus 133 ili~~~~~~kl~Dfg~~~~~~~~~---~~~~~~g~~~~~aPE~~~~~---------~~~~~~Di~slG~~l~~l~~g~~P 200 (285)
T cd05632 133 ILLDDYGHIRISDLGLAVKIPEGE---SIRGRVGTVGYMAPEVLNNQ---------RYTLSPDYWGLGCLIYEMIEGQSP 200 (285)
T ss_pred EEECCCCCEEEecCCcceecCCCC---cccCCCCCcCccChHHhcCC---------CCCcccchHHHHHHHHHHHhCCCC
Confidence 999 46789999999997643221 12345799999999999654 356799999999999999999999
Q ss_pred CCcchhHHHHHHhhc-CCCCcccCCCCCChhHHHHHHHhcccCCCCCCC-----hhHHhcCCCCCCC
Q 003052 710 FSEYKTFWAKFKVIT-DPNHEITYEPVPNPWLLDLMKKCLAWDRNERWR-----IPQLLQHPFLVPP 770 (853)
Q Consensus 710 F~~~~~~~~~~kii~-~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpT-----a~EIL~HPwf~~~ 770 (853)
|.+............ .......+....+..+.+|+.+||..||.+||+ +.+++.|+||...
T Consensus 201 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~ 267 (285)
T cd05632 201 FRGRKEKVKREEVDRRVLETEEVYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRHPFFRNM 267 (285)
T ss_pred CCCCCHHHHHHHHHHhhhccccccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcChhhhcC
Confidence 976543222111111 011223345567788999999999999999999 8899999999753
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=385.16 Aligned_cols=261 Identities=28% Similarity=0.416 Sum_probs=209.7
Q ss_pred ceeeEEEeEeccCceEEEEEEec-CCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHHHH
Q 003052 472 KLYQRLGKIGSGGSSEVHKVISS-DCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLREV 550 (853)
Q Consensus 472 ~~Y~ilk~LG~G~FG~Vyka~~~-~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~~l 550 (853)
..|.++++||+|+||.||+|.+. ++..||+|++............+..|+.+|++|. |+||+++++++..
T Consensus 13 ~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~-HPNIVrl~d~f~d-------- 83 (1021)
T PTZ00266 13 NEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELK-HKNIVRYIDRFLN-------- 83 (1021)
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcC-CCCcCeEEEEEEe--------
Confidence 56999999999999999999984 5678999999876555556667899999999998 8999999987432
Q ss_pred hhCCCCCCCCccccCCeEEEEEecch-hhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccC-------cee
Q 003052 551 LNGSMNNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEE-------RIV 622 (853)
Q Consensus 551 ~~~~iv~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~-------gII 622 (853)
.....+||||||+. ++|.++|...+. ....+++..++.|+.||+.||.|||+. +||
T Consensus 84 ------------e~~~~lyIVMEY~~gGSL~~lL~k~~~----~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IV 147 (1021)
T PTZ00266 84 ------------KANQKLYILMEFCDAGDLSRNIQKCYK----MFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVL 147 (1021)
T ss_pred ------------cCCCEEEEEEeCCCCCcHHHHHHHHhh----ccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCce
Confidence 23457899999976 589988876432 235799999999999999999999985 499
Q ss_pred eCCCCCccEEeec------------------CcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCcc
Q 003052 623 HSDLKPANFLLVK------------------GSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNI 684 (853)
Q Consensus 623 HRDLKPeNILL~~------------------g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~ 684 (853)
||||||+||||.. +.+||+|||+++.+.... .....+||+.|+|||++.+...
T Consensus 148 HRDLKPeNILL~s~~~~lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s---~~~s~vGTp~YmAPEvL~ge~~------ 218 (1021)
T PTZ00266 148 HRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGIES---MAHSCVGTPYYWSPELLLHETK------ 218 (1021)
T ss_pred eccCcHHHeEeecCccccccccccccccCCCCceEEccCCccccccccc---cccccCCCccccCHHHHhccCC------
Confidence 9999999999943 248999999998654322 1235689999999999865321
Q ss_pred ccCCCccchhhhHHHHHHHHhCCCCCCcchhHHHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCCChhHHhcC
Q 003052 685 IKCGRPSDIWSLGCILYQMVYGRTPFSEYKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQH 764 (853)
Q Consensus 685 ~~ys~ksDIWSLGVILyELLtG~~PF~~~~~~~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~H 764 (853)
.|+.++||||||||||+|++|..||.....+......+... ..+ .....+.++.+||.+||..+|.+||++.|+|.|
T Consensus 219 -~~s~KSDVWSLG~ILYELLTGk~PF~~~~~~~qli~~lk~~-p~l-pi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h 295 (1021)
T PTZ00266 219 -SYDDKSDMWALGCIIYELCSGKTPFHKANNFSQLISELKRG-PDL-PIKGKSKELNILIKNLLNLSAKERPSALQCLGY 295 (1021)
T ss_pred -CCCchhHHHHHHHHHHHHHHCCCCCCcCCcHHHHHHHHhcC-CCC-CcCCCCHHHHHHHHHHhcCChhHCcCHHHHhcc
Confidence 36789999999999999999999997665554444444322 111 123457889999999999999999999999999
Q ss_pred CCCCC
Q 003052 765 PFLVP 769 (853)
Q Consensus 765 Pwf~~ 769 (853)
|||..
T Consensus 296 ~~ik~ 300 (1021)
T PTZ00266 296 QIIKN 300 (1021)
T ss_pred HHHhh
Confidence 99963
|
|
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=345.86 Aligned_cols=258 Identities=19% Similarity=0.282 Sum_probs=196.7
Q ss_pred EEEeEecc--CceEEEEEEe-cCCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHHHHhh
Q 003052 476 RLGKIGSG--GSSEVHKVIS-SDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLREVLN 552 (853)
Q Consensus 476 ilk~LG~G--~FG~Vyka~~-~~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~~l~~ 552 (853)
++++||+| +||+||++.+ .+++.||+|++............+.+|+.+++.++ ||||++++++
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~-hpniv~~~~~------------- 67 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFN-HPNIVPYRAT------------- 67 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcC-CCCeeeEEEE-------------
Confidence 46789999 7899999988 57799999999876554455556778999999996 8999999887
Q ss_pred CCCCCCCCccccCCeEEEEEecch-hhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCCCccE
Q 003052 553 GSMNNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANF 631 (853)
Q Consensus 553 ~~iv~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLKPeNI 631 (853)
+.+++.+|+||||+. ++|.+++..+ ....+++..++.++.||+.||.|||++||+||||||+||
T Consensus 68 ---------~~~~~~~~lv~e~~~~~~l~~~~~~~------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Ni 132 (327)
T cd08227 68 ---------FIADNELWVVTSFMAYGSAKDLICTH------FMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHI 132 (327)
T ss_pred ---------EEECCEEEEEEeccCCCcHHHHHHhh------ccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhE
Confidence 456678999999976 5888887654 124589999999999999999999999999999999999
Q ss_pred Ee-ecCcEEEEecccchhcccCCccc-----cccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHh
Q 003052 632 LL-VKGSLKLIDFGIAKAIMSDTTNI-----QRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVY 705 (853)
Q Consensus 632 LL-~~g~VKL~DFGlAk~~~~~~~~~-----~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLt 705 (853)
|+ .++.++|+|||.+.......... ......++..|+|||++.+.. ..|+.++|||||||++|||++
T Consensus 133 l~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-------~~~~~~~DiwslG~il~el~~ 205 (327)
T cd08227 133 LISVDGKVYLSGLRSNLSMINHGQRLRVVHDFPKYSVKVLPWLSPEVLQQNL-------QGYDAKSDIYSVGITACELAN 205 (327)
T ss_pred EEecCCcEEEcccchhhccccccccccccccccccccceecccChHHhhccc-------CCCCchhhHHHHHHHHHHHHH
Confidence 99 46799999998765433211110 011235778899999996532 136789999999999999999
Q ss_pred CCCCCCcchhHHHHHHhhcCCCCc-------------------------------------------ccCCCCCChhHHH
Q 003052 706 GRTPFSEYKTFWAKFKVITDPNHE-------------------------------------------ITYEPVPNPWLLD 742 (853)
Q Consensus 706 G~~PF~~~~~~~~~~kii~~~~~~-------------------------------------------~~~~~~~s~~l~d 742 (853)
|+.||.+................. ..+....++.+.+
T Consensus 206 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 285 (327)
T cd08227 206 GHVPFKDMPATQMLLEKLNGTVPCLLDTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHH 285 (327)
T ss_pred CCCCCCCcchhHHHHHHhcCCccccccccchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHH
Confidence 999997543322221111100000 0011234567999
Q ss_pred HHHHhcccCCCCCCChhHHhcCCCCCC
Q 003052 743 LMKKCLAWDRNERWRIPQLLQHPFLVP 769 (853)
Q Consensus 743 LI~kcL~~DP~kRpTa~EIL~HPwf~~ 769 (853)
||.+||++||.+|||+.|+|+||||+.
T Consensus 286 li~~~l~~dP~~Rpt~~ell~~p~f~~ 312 (327)
T cd08227 286 FVEQCLQRNPDARPSASTLLNHSFFKQ 312 (327)
T ss_pred HHHHHHhhCchhcCCHHHHhcChhhhh
Confidence 999999999999999999999999964
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=337.38 Aligned_cols=260 Identities=32% Similarity=0.506 Sum_probs=203.9
Q ss_pred ceeeEEEeEeccCceEEEEEEec-CCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHHHH
Q 003052 472 KLYQRLGKIGSGGSSEVHKVISS-DCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLREV 550 (853)
Q Consensus 472 ~~Y~ilk~LG~G~FG~Vyka~~~-~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~~l 550 (853)
+.|++.+.||+|+||.||+|.+. +++.||+|++............+.+|++++++++ |+||++++++
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~----------- 69 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQ-HGNIVRLQDV----------- 69 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhcc-CCCEeeEEEE-----------
Confidence 35999999999999999999984 6789999999765444344456789999999996 8999999987
Q ss_pred hhCCCCCCCCccccCCeEEEEEecchhhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCCCcc
Q 003052 551 LNGSMNNKDGRVKDDGYIYMVLEYGEIDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPAN 630 (853)
Q Consensus 551 ~~~~iv~~~g~~~d~~~lyLVmEy~~gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLKPeN 630 (853)
+.+..++|+||||++++|...+... ....+++..++.++.||+.||+|||++||+||||||+|
T Consensus 70 -----------~~~~~~~~lv~e~~~~~l~~~~~~~------~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~n 132 (294)
T PLN00009 70 -----------VHSEKRLYLVFEYLDLDLKKHMDSS------PDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQN 132 (294)
T ss_pred -----------EecCCeEEEEEecccccHHHHHHhC------CCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcce
Confidence 4456789999999988888776543 22346889999999999999999999999999999999
Q ss_pred EEee--cCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHhCCC
Q 003052 631 FLLV--KGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGRT 708 (853)
Q Consensus 631 ILL~--~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLtG~~ 708 (853)
|+++ ++.+||+|||++........ ......|++.|+|||++.+.. .++.++|||||||++|+|++|++
T Consensus 133 ill~~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~--------~~~~~~Dv~slG~i~~~l~tg~~ 202 (294)
T PLN00009 133 LLIDRRTNALKLADFGLARAFGIPVR--TFTHEVVTLWYRAPEILLGSR--------HYSTPVDIWSVGCIFAEMVNQKP 202 (294)
T ss_pred EEEECCCCEEEEcccccccccCCCcc--ccccCceeecccCHHHHhCCC--------CCCcHHHHHHHHHHHHHHHhCCC
Confidence 9995 34799999999976533211 123457889999999986532 35679999999999999999999
Q ss_pred CCCcchhHHHHHHhh---cCCCCc-----------------------ccCCCCCChhHHHHHHHhcccCCCCCCChhHHh
Q 003052 709 PFSEYKTFWAKFKVI---TDPNHE-----------------------ITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLL 762 (853)
Q Consensus 709 PF~~~~~~~~~~kii---~~~~~~-----------------------~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL 762 (853)
||..........+.. ..+... ....+..++++.+||.+||..||++||++.+++
T Consensus 203 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l 282 (294)
T PLN00009 203 LFPGDSEIDELFKIFRILGTPNEETWPGVTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAAL 282 (294)
T ss_pred CCCCCCHHHHHHHHHHHhCCCChhhccccccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHh
Confidence 997654433332221 111000 001234577899999999999999999999999
Q ss_pred cCCCCCCC
Q 003052 763 QHPFLVPP 770 (853)
Q Consensus 763 ~HPwf~~~ 770 (853)
+||||...
T Consensus 283 ~~~~~~~~ 290 (294)
T PLN00009 283 EHEYFKDL 290 (294)
T ss_pred cCchHhHH
Confidence 99999753
|
|
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=332.96 Aligned_cols=256 Identities=24% Similarity=0.343 Sum_probs=200.6
Q ss_pred cCceeeEEEeEeccCceEEEEEEe-cCCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHH
Q 003052 470 NGKLYQRLGKIGSGGSSEVHKVIS-SDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLR 548 (853)
Q Consensus 470 ~g~~Y~ilk~LG~G~FG~Vyka~~-~~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~ 548 (853)
..+.|++.++||+|+||.||+|.+ .+++.||+|++...... ....+.+|+.++++++ |+||++++++
T Consensus 7 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~--~~~~~~~e~~~l~~~~-h~~ii~~~~~--------- 74 (267)
T cd06646 7 PQHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGD--DFSLIQQEIFMVKECK-HCNIVAYFGS--------- 74 (267)
T ss_pred chhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccc--hHHHHHHHHHHHHhcC-CCCeeeeeEE---------
Confidence 345699999999999999999998 56788999999754332 2335778999999997 8999999876
Q ss_pred HHhhCCCCCCCCccccCCeEEEEEecch-hhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCC
Q 003052 549 EVLNGSMNNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLK 627 (853)
Q Consensus 549 ~l~~~~iv~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLK 627 (853)
+..+..+|+||||++ ++|.+++... ..+++..+..++.||+.||.|||++||+|||||
T Consensus 75 -------------~~~~~~~~iv~e~~~~~~L~~~~~~~--------~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~ 133 (267)
T cd06646 75 -------------YLSREKLWICMEYCGGGSLQDIYHVT--------GPLSELQIAYVCRETLQGLAYLHSKGKMHRDIK 133 (267)
T ss_pred -------------EEeCCEEEEEEeCCCCCcHHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCC
Confidence 345668899999976 4888777542 468999999999999999999999999999999
Q ss_pred CccEEe-ecCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHhC
Q 003052 628 PANFLL-VKGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYG 706 (853)
Q Consensus 628 PeNILL-~~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLtG 706 (853)
|+||++ .++.+||+|||+++.+..... ......|++.|+|||.+.+.... .++.++|||||||++|||++|
T Consensus 134 p~nill~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~------~~~~~~Dvws~G~il~el~~g 205 (267)
T cd06646 134 GANILLTDNGDVKLADFGVAAKITATIA--KRKSFIGTPYWMAPEVAAVEKNG------GYNQLCDIWAVGITAIELAEL 205 (267)
T ss_pred HHHEEECCCCCEEECcCccceeeccccc--ccCccccCccccCHhHcccccCC------CCcchhhHHHHHHHHHHHHhC
Confidence 999999 467899999999987643221 22356799999999998543211 356799999999999999999
Q ss_pred CCCCCcchhHHHHHHhhcCCC--CcccCCCCCChhHHHHHHHhcccCCCCCCChhHHhcCCC
Q 003052 707 RTPFSEYKTFWAKFKVITDPN--HEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQHPF 766 (853)
Q Consensus 707 ~~PF~~~~~~~~~~kii~~~~--~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~HPw 766 (853)
+.||................. .........+..+.+||.+||..||++||++++||+|+|
T Consensus 206 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l~ 267 (267)
T cd06646 206 QPPMFDLHPMRALFLMSKSNFQPPKLKDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHLF 267 (267)
T ss_pred CCCccccchhhhheeeecCCCCCCCCccccccCHHHHHHHHHHhhCChhhCcCHHHHhcCCC
Confidence 999965544332222211111 111112345778999999999999999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-40 Score=365.45 Aligned_cols=258 Identities=23% Similarity=0.383 Sum_probs=217.5
Q ss_pred ceeeEEEeEeccCceEEEEEEe-cCCcEEEEEEEecCCC-ChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHHH
Q 003052 472 KLYQRLGKIGSGGSSEVHKVIS-SDCTIYALKKIKLKGR-DYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLRE 549 (853)
Q Consensus 472 ~~Y~ilk~LG~G~FG~Vyka~~-~~g~~vAVKkik~~~~-~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~~ 549 (853)
+.|.-++.||.|+||.||.|++ .+..+||||++...+. ..+..+.++.||.+|++|+ |||+|.+.++|.
T Consensus 26 klf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~-HPntieYkgCyL-------- 96 (948)
T KOG0577|consen 26 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLR-HPNTIEYKGCYL-------- 96 (948)
T ss_pred HHHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhcc-CCCcccccceee--------
Confidence 4588889999999999999998 5778999999987665 3456678999999999998 899988876543
Q ss_pred HhhCCCCCCCCccccCCeEEEEEecchhhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCCCc
Q 003052 550 VLNGSMNNKDGRVKDDGYIYMVLEYGEIDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPA 629 (853)
Q Consensus 550 l~~~~iv~~~g~~~d~~~lyLVmEy~~gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLKPe 629 (853)
.+...|+|||||-|+-.+++.-+ ..++-|..+..|..+.+.||.|||+++.||||||..
T Consensus 97 --------------re~TaWLVMEYClGSAsDlleVh-------kKplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAG 155 (948)
T KOG0577|consen 97 --------------REHTAWLVMEYCLGSASDLLEVH-------KKPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAG 155 (948)
T ss_pred --------------ccchHHHHHHHHhccHHHHHHHH-------hccchHHHHHHHHHHHHHHHHHHHHhhHHhhhcccc
Confidence 44567999999988666666543 257999999999999999999999999999999999
Q ss_pred cEEe-ecCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHhCCC
Q 003052 630 NFLL-VKGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGRT 708 (853)
Q Consensus 630 NILL-~~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLtG~~ 708 (853)
|||| ..|.|||+|||.|..... .++++|||+|||||++..-.. ..|+-++||||||+++.||...++
T Consensus 156 NILLse~g~VKLaDFGSAsi~~P------AnsFvGTPywMAPEVILAMDE------GqYdgkvDvWSLGITCIELAERkP 223 (948)
T KOG0577|consen 156 NILLSEPGLVKLADFGSASIMAP------ANSFVGTPYWMAPEVILAMDE------GQYDGKVDVWSLGITCIELAERKP 223 (948)
T ss_pred ceEecCCCeeeeccccchhhcCc------hhcccCCccccchhHheeccc------cccCCccceeeccchhhhhhhcCC
Confidence 9999 568999999999976532 237899999999999964322 257889999999999999999999
Q ss_pred CCCcchhHHHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCCChhHHhcCCCCCCCCC
Q 003052 709 PFSEYKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQHPFLVPPVS 772 (853)
Q Consensus 709 PF~~~~~~~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~HPwf~~~~~ 772 (853)
|+.+.+.+.+.+.+..+..+.+. ...++..++.|+..||.+-|.+|||.+++|.|+|+....+
T Consensus 224 PlFnMNAMSALYHIAQNesPtLq-s~eWS~~F~~Fvd~CLqKipqeRptse~ll~H~fv~R~Rp 286 (948)
T KOG0577|consen 224 PLFNMNAMSALYHIAQNESPTLQ-SNEWSDYFRNFVDSCLQKIPQERPTSEELLKHRFVLRERP 286 (948)
T ss_pred CccCchHHHHHHHHHhcCCCCCC-CchhHHHHHHHHHHHHhhCcccCCcHHHHhhcchhccCCC
Confidence 99998888888877765444333 5567888999999999999999999999999999976543
|
|
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-38 Score=330.23 Aligned_cols=252 Identities=31% Similarity=0.506 Sum_probs=202.9
Q ss_pred eeEEEeEeccCceEEEEEEe-cCCcEEEEEEEecCCCCh-------hhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHH
Q 003052 474 YQRLGKIGSGGSSEVHKVIS-SDCTIYALKKIKLKGRDY-------ATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKA 545 (853)
Q Consensus 474 Y~ilk~LG~G~FG~Vyka~~-~~g~~vAVKkik~~~~~~-------~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~ 545 (853)
|.+...||+|+||.||+|.+ .+++.||+|.+....... .....+.+|+.++++++ |+||++++++
T Consensus 2 ~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~------ 74 (267)
T cd06628 2 WIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQ-HENIVQYLGS------ 74 (267)
T ss_pred ccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcC-CCCeeeEEEE------
Confidence 77888999999999999988 467889999987653321 23356789999999997 8999999987
Q ss_pred HHHHHhhCCCCCCCCccccCCeEEEEEecch-hhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeC
Q 003052 546 LLREVLNGSMNNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHS 624 (853)
Q Consensus 546 iL~~l~~~~iv~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHR 624 (853)
+.+..++|+||||++ ++|.+++... ..+++..++.++.||+.||.|||++||+||
T Consensus 75 ----------------~~~~~~~~lv~e~~~~~~L~~~l~~~--------~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~ 130 (267)
T cd06628 75 ----------------SLDADHLNIFLEYVPGGSVAALLNNY--------GAFEETLVRNFVRQILKGLNYLHNRGIIHR 130 (267)
T ss_pred ----------------EEeCCccEEEEEecCCCCHHHHHHhc--------cCccHHHHHHHHHHHHHHHHHHHhcCcccc
Confidence 345568899999975 4888887643 468999999999999999999999999999
Q ss_pred CCCCccEEe-ecCcEEEEecccchhcccCCc----cccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHH
Q 003052 625 DLKPANFLL-VKGSLKLIDFGIAKAIMSDTT----NIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCI 699 (853)
Q Consensus 625 DLKPeNILL-~~g~VKL~DFGlAk~~~~~~~----~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVI 699 (853)
||||+||++ .++.+||+|||+++....... ........|+..|+|||.+.+.. ++.++|+|||||+
T Consensus 131 di~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~---------~~~~~Dv~slG~i 201 (267)
T cd06628 131 DIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTS---------YTRKADIWSLGCL 201 (267)
T ss_pred cCCHHHEEEcCCCCEEecccCCCcccccccccCCccccccccCCCcCccChhHhccCC---------CCchhhhHHHHHH
Confidence 999999999 567899999999987653211 11122457899999999986543 4678999999999
Q ss_pred HHHHHhCCCCCCcchhHHHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCCChhHHhcCCCC
Q 003052 700 LYQMVYGRTPFSEYKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQHPFL 767 (853)
Q Consensus 700 LyELLtG~~PF~~~~~~~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~HPwf 767 (853)
+|+|++|+.||.+............. .....+...+..+.+||.+||+.||.+||++.++++||||
T Consensus 202 l~~l~~g~~p~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~ 267 (267)
T cd06628 202 VVEMLTGKHPFPDCTQLQAIFKIGEN--ASPEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLKHPFL 267 (267)
T ss_pred HHHHhhCCCCCCCccHHHHHHHHhcc--CCCcCCcccCHHHHHHHHHHccCCchhCcCHHHHhhCCCC
Confidence 99999999999876555444443321 1223345567889999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=336.66 Aligned_cols=263 Identities=24% Similarity=0.443 Sum_probs=202.8
Q ss_pred eeeEEEeEeccCceEEEEEEe-cCCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHHHHh
Q 003052 473 LYQRLGKIGSGGSSEVHKVIS-SDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLREVL 551 (853)
Q Consensus 473 ~Y~ilk~LG~G~FG~Vyka~~-~~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~~l~ 551 (853)
.|...++||+|+||.||++.+ .+++.||+|++...... .....+.+|+.++.++..|+||+++++++
T Consensus 5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~e~~~l~~~~~~~~iv~~~~~~----------- 72 (288)
T cd06616 5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDE-KEQKRLLMDLDVVMRSSDCPYIVKFYGAL----------- 72 (288)
T ss_pred HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccCh-HHHHHHHHHHHHHHHhcCCCCEeeeeeEE-----------
Confidence 466778899999999999998 46789999999765433 34456889999999998899999999863
Q ss_pred hCCCCCCCCccccCCeEEEEEecchhhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccC-ceeeCCCCCcc
Q 003052 552 NGSMNNKDGRVKDDGYIYMVLEYGEIDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEE-RIVHSDLKPAN 630 (853)
Q Consensus 552 ~~~iv~~~g~~~d~~~lyLVmEy~~gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~-gIIHRDLKPeN 630 (853)
.++...|++|||+++++..+....... ....+++..+..++.|++.||+|||+. ||+||||||+|
T Consensus 73 -----------~~~~~~~~~~e~~~~~l~~l~~~~~~~---~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~N 138 (288)
T cd06616 73 -----------FREGDCWICMELMDISLDKFYKYVYEV---LKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSN 138 (288)
T ss_pred -----------ecCCcEEEEEecccCCHHHHHHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHH
Confidence 345678999999877655544321111 235799999999999999999999974 99999999999
Q ss_pred EEee-cCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHhCCCC
Q 003052 631 FLLV-KGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGRTP 709 (853)
Q Consensus 631 ILL~-~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLtG~~P 709 (853)
||++ ++.+||+|||+++.+..... .....|++.|+|||++.+... ..++.++|||||||++|+|++|++|
T Consensus 139 il~~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~------~~~~~~~Di~slG~il~el~~g~~p 209 (288)
T cd06616 139 ILLDRNGNIKLCDFGISGQLVDSIA---KTRDAGCRPYMAPERIDPSAR------DGYDVRSDVWSLGITLYEVATGKFP 209 (288)
T ss_pred EEEccCCcEEEeecchhHHhccCCc---cccccCccCccCHHHhccccc------cCCcchhhhhHHHHHHHHHHhCCCC
Confidence 9994 67899999999987643222 124478999999999875421 1367899999999999999999999
Q ss_pred CCcchhHHHHHHhhcC-CCCcc--cCCCCCChhHHHHHHHhcccCCCCCCChhHHhcCCCCCCC
Q 003052 710 FSEYKTFWAKFKVITD-PNHEI--TYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQHPFLVPP 770 (853)
Q Consensus 710 F~~~~~~~~~~kii~~-~~~~~--~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~HPwf~~~ 770 (853)
|............... ..... ......+..+.+||.+||..||.+||++.+|++||||...
T Consensus 210 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~~~~~~~ 273 (288)
T cd06616 210 YPKWNSVFDQLTQVVKGDPPILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEHPFIKDY 273 (288)
T ss_pred chhcchHHHHHhhhcCCCCCcCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhch
Confidence 9765433332222211 11111 1123467889999999999999999999999999999753
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=350.25 Aligned_cols=259 Identities=26% Similarity=0.428 Sum_probs=202.1
Q ss_pred ceeeEEEeEeccCceEEEEEEe-cCCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHHHH
Q 003052 472 KLYQRLGKIGSGGSSEVHKVIS-SDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLREV 550 (853)
Q Consensus 472 ~~Y~ilk~LG~G~FG~Vyka~~-~~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~~l 550 (853)
++|++++.||+|+||.||+|.+ .+++.||||++............+.+|+.++++++ |+||+++++++...
T Consensus 16 ~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~------- 87 (353)
T cd07850 16 KRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVN-HKNIIGLLNVFTPQ------- 87 (353)
T ss_pred cceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcC-CCCCcceeeeeccC-------
Confidence 5699999999999999999998 47789999999765444455556789999999997 89999999875322
Q ss_pred hhCCCCCCCCccccCCeEEEEEecchhhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCCCcc
Q 003052 551 LNGSMNNKDGRVKDDGYIYMVLEYGEIDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPAN 630 (853)
Q Consensus 551 ~~~~iv~~~g~~~d~~~lyLVmEy~~gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLKPeN 630 (853)
..+.+..++|+||||++++|.+.+.. .+++..+..++.||+.||.|||++||+||||||+|
T Consensus 88 ---------~~~~~~~~~~lv~e~~~~~l~~~~~~----------~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~N 148 (353)
T cd07850 88 ---------KSLEEFQDVYLVMELMDANLCQVIQM----------DLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSN 148 (353)
T ss_pred ---------CCccccCcEEEEEeccCCCHHHHHhh----------cCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHH
Confidence 11334457899999999888887642 28899999999999999999999999999999999
Q ss_pred EEe-ecCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHhCCCC
Q 003052 631 FLL-VKGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGRTP 709 (853)
Q Consensus 631 ILL-~~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLtG~~P 709 (853)
||+ .++.+||+|||+++...... ......|++.|+|||++.+.. ++.++|||||||++|+|++|+.|
T Consensus 149 il~~~~~~~kL~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~---------~~~~~DvwslG~~l~~l~~g~~p 216 (353)
T cd07850 149 IVVKSDCTLKILDFGLARTAGTSF---MMTPYVVTRYYRAPEVILGMG---------YKENVDIWSVGCIMGEMIRGTVL 216 (353)
T ss_pred EEECCCCCEEEccCccceeCCCCC---CCCCCcccccccCHHHHhCCC---------CCCchhhHhHHHHHHHHHHCCCC
Confidence 999 56799999999998654322 123457899999999997653 56899999999999999999999
Q ss_pred CCcchhHHHHHHhh---cCC------------------CC------------cccC-------CCCCChhHHHHHHHhcc
Q 003052 710 FSEYKTFWAKFKVI---TDP------------------NH------------EITY-------EPVPNPWLLDLMKKCLA 749 (853)
Q Consensus 710 F~~~~~~~~~~kii---~~~------------------~~------------~~~~-------~~~~s~~l~dLI~kcL~ 749 (853)
|...+......+++ ..+ .. ...+ ....+..+++||.+||.
T Consensus 217 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~ 296 (353)
T cd07850 217 FPGTDHIDQWNKIIEQLGTPSDEFMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLV 296 (353)
T ss_pred CCCCCHHHHHHHHHHhcCCCCHHHHHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcC
Confidence 96543221111110 000 00 0000 11234568999999999
Q ss_pred cCCCCCCChhHHhcCCCCCC
Q 003052 750 WDRNERWRIPQLLQHPFLVP 769 (853)
Q Consensus 750 ~DP~kRpTa~EIL~HPwf~~ 769 (853)
.||.+|||+.|+|+||||..
T Consensus 297 ~dP~~R~t~~eiL~~~~~~~ 316 (353)
T cd07850 297 IDPEKRISVDDALQHPYINV 316 (353)
T ss_pred CChhhCcCHHHHhcChhHhh
Confidence 99999999999999999864
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=343.68 Aligned_cols=262 Identities=26% Similarity=0.408 Sum_probs=212.5
Q ss_pred ceeeEEE-eEeccCceEEEEEEe-cCCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHHH
Q 003052 472 KLYQRLG-KIGSGGSSEVHKVIS-SDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLRE 549 (853)
Q Consensus 472 ~~Y~ilk-~LG~G~FG~Vyka~~-~~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~~ 549 (853)
+.|++.. .||+|+||.|--|+. .++..||||+|.+. ......++.+|++++...++|+||++|++|
T Consensus 77 d~YkLt~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq--~gHsR~RvfREVe~f~~Cqgh~nilqLief---------- 144 (463)
T KOG0607|consen 77 DMYKLTSELLGEGAYASVQTCVSIQTGKEYAVKIIDKQ--PGHSRSRVFREVETFYQCQGHKNILQLIEF---------- 144 (463)
T ss_pred HHHHhHHHHhcCccceeeeeeeeeccchhhhhhhhhcC--CchHHHHHHHHHHHHHHhcCCccHHHHHHH----------
Confidence 4466554 589999999999987 78899999999876 334556789999999999999999999998
Q ss_pred HhhCCCCCCCCccccCCeEEEEEecch-hhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCCC
Q 003052 550 VLNGSMNNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKP 628 (853)
Q Consensus 550 l~~~~iv~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLKP 628 (853)
|+++..+|||||.+. |.|...|.++ ..|+|.++..++++|+.||.|||.+||.||||||
T Consensus 145 ------------FEdd~~FYLVfEKm~GGplLshI~~~--------~~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKP 204 (463)
T KOG0607|consen 145 ------------FEDDTRFYLVFEKMRGGPLLSHIQKR--------KHFNEREASRVVKDIASALDFLHTKGIAHRDLKP 204 (463)
T ss_pred ------------hcccceEEEEEecccCchHHHHHHHh--------hhccHHHHHHHHHHHHHHHHHHhhcCcccccCCc
Confidence 678889999999954 5888888775 5799999999999999999999999999999999
Q ss_pred ccEEeec-C---cEEEEecccchhcccC-----CccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHH
Q 003052 629 ANFLLVK-G---SLKLIDFGIAKAIMSD-----TTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCI 699 (853)
Q Consensus 629 eNILL~~-g---~VKL~DFGlAk~~~~~-----~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVI 699 (853)
+|||-.. + .||||||.++..+... .......+.||+..|||||+..--. +....|.+++|.||||||
T Consensus 205 ENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv----~qA~~YDKrCDlwSLGvI 280 (463)
T KOG0607|consen 205 ENILCESPNKVSPVKICDFDLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFV----DQATFYDKRCDLWSLGVI 280 (463)
T ss_pred cceeecCCCCcCceeeeccccccccccCCCCCCCCCccccCcccchhhcchhHHhhhc----cccccccccccHHHHHHH
Confidence 9999943 2 6899999988654321 1222345789999999999874321 123478999999999999
Q ss_pred HHHHHhCCCCCCcc----------h----hHHHHHHhhcCCCCcccCCC--CCChhHHHHHHHhcccCCCCCCChhHHhc
Q 003052 700 LYQMVYGRTPFSEY----------K----TFWAKFKVITDPNHEITYEP--VPNPWLLDLMKKCLAWDRNERWRIPQLLQ 763 (853)
Q Consensus 700 LyELLtG~~PF~~~----------~----~~~~~~kii~~~~~~~~~~~--~~s~~l~dLI~kcL~~DP~kRpTa~EIL~ 763 (853)
||.||.|.+||.+. + =....|..|.++..+++-.. ..+.+++|||..+|..|+.+|.++.++++
T Consensus 281 lYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~LFesIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vln 360 (463)
T KOG0607|consen 281 LYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLN 360 (463)
T ss_pred HHHHHhCCCCccCccCCcCCccCCCccHHHHHHHHHHHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence 99999999999531 0 11345666766665554332 45788999999999999999999999999
Q ss_pred CCCCCC
Q 003052 764 HPFLVP 769 (853)
Q Consensus 764 HPwf~~ 769 (853)
|||+..
T Consensus 361 hPw~~~ 366 (463)
T KOG0607|consen 361 HPWVQR 366 (463)
T ss_pred Cccccc
Confidence 999964
|
|
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-38 Score=335.50 Aligned_cols=249 Identities=27% Similarity=0.455 Sum_probs=205.7
Q ss_pred eeeEEEeEeccCceEEEEEEec-CCcEEEEEEEecCCC-ChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHHHH
Q 003052 473 LYQRLGKIGSGGSSEVHKVISS-DCTIYALKKIKLKGR-DYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLREV 550 (853)
Q Consensus 473 ~Y~ilk~LG~G~FG~Vyka~~~-~g~~vAVKkik~~~~-~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~~l 550 (853)
.|++.+.||+|+||.||++.+. +++.||+|++..... .......+.+|+++|+++. |+||++++++
T Consensus 2 ~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~----------- 69 (290)
T cd05580 2 DFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIR-HPFLVNLYGS----------- 69 (290)
T ss_pred ceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCC-CCCccceeeE-----------
Confidence 5899999999999999999984 678999999975432 2234456889999999998 9999999886
Q ss_pred hhCCCCCCCCccccCCeEEEEEecc-hhhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCCCc
Q 003052 551 LNGSMNNKDGRVKDDGYIYMVLEYG-EIDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPA 629 (853)
Q Consensus 551 ~~~~iv~~~g~~~d~~~lyLVmEy~-~gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLKPe 629 (853)
+.+...+|+||||+ +++|.+++... ..+++..+..++.||+.||.|||++||+||||+|.
T Consensus 70 -----------~~~~~~~~~v~e~~~~~~L~~~~~~~--------~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~ 130 (290)
T cd05580 70 -----------FQDDSNLYLVMEYVPGGELFSHLRKS--------GRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPE 130 (290)
T ss_pred -----------EEcCCeEEEEEecCCCCCHHHHHHHc--------CCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHH
Confidence 45667899999998 57888887653 57999999999999999999999999999999999
Q ss_pred cEEe-ecCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHhCCC
Q 003052 630 NFLL-VKGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGRT 708 (853)
Q Consensus 630 NILL-~~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLtG~~ 708 (853)
|||+ .++.+||+|||+++..... ....+|++.|+|||.+.+.. ++.++||||||+++|+|++|..
T Consensus 131 nili~~~~~~kl~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~---------~~~~~Di~slG~il~~l~~g~~ 196 (290)
T cd05580 131 NLLLDSDGYIKITDFGFAKRVKGR-----TYTLCGTPEYLAPEIILSKG---------YGKAVDWWALGILIYEMLAGYP 196 (290)
T ss_pred HEEECCCCCEEEeeCCCccccCCC-----CCCCCCCccccChhhhcCCC---------CCccccHHHHHHHHHHHHhCCC
Confidence 9999 5679999999999876443 23567999999999986542 4578999999999999999999
Q ss_pred CCCcchhHHHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCC-----ChhHHhcCCCCCC
Q 003052 709 PFSEYKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERW-----RIPQLLQHPFLVP 769 (853)
Q Consensus 709 PF~~~~~~~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRp-----Ta~EIL~HPwf~~ 769 (853)
||...........+. . ....++...+..++++|.+||..||.+|+ ++.++++||||..
T Consensus 197 p~~~~~~~~~~~~~~-~--~~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~ 259 (290)
T cd05580 197 PFFDDNPIQIYEKIL-E--GKVRFPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNHPWFAG 259 (290)
T ss_pred CCCCCCHHHHHHHHh-c--CCccCCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHcCccccc
Confidence 997655332222222 2 22344556688999999999999999999 9999999999964
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-38 Score=337.88 Aligned_cols=255 Identities=28% Similarity=0.477 Sum_probs=206.4
Q ss_pred ceeeEEEeEeccCceEEEEEEe-cCCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHHHH
Q 003052 472 KLYQRLGKIGSGGSSEVHKVIS-SDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLREV 550 (853)
Q Consensus 472 ~~Y~ilk~LG~G~FG~Vyka~~-~~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~~l 550 (853)
++|++++.||+|+||.||+|.+ .+++.||+|.+...... ....+.+|+.+++.+. |+||++++++
T Consensus 20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~--~~~~~~~e~~~l~~~~-h~~v~~~~~~----------- 85 (296)
T cd06654 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP--KKELIINEILVMRENK-NPNIVNYLDS----------- 85 (296)
T ss_pred cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcc--hHHHHHHHHHHHHhCC-CCCEeeEEEE-----------
Confidence 5699999999999999999997 46789999999765433 3356789999999986 8999999986
Q ss_pred hhCCCCCCCCccccCCeEEEEEecch-hhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCCCc
Q 003052 551 LNGSMNNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPA 629 (853)
Q Consensus 551 ~~~~iv~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLKPe 629 (853)
+.+..++|+||||+. ++|.+++.. ..+++.++..++.||+.||.|||+.||+||||||+
T Consensus 86 -----------~~~~~~~~lv~e~~~~~~L~~~~~~---------~~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~ 145 (296)
T cd06654 86 -----------YLVGDELWVVMEYLAGGSLTDVVTE---------TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSD 145 (296)
T ss_pred -----------EEeCCEEEEeecccCCCCHHHHHHh---------cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHH
Confidence 345668999999975 588887743 35889999999999999999999999999999999
Q ss_pred cEEe-ecCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHhCCC
Q 003052 630 NFLL-VKGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGRT 708 (853)
Q Consensus 630 NILL-~~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLtG~~ 708 (853)
|||+ .++.+||+|||++........ ......|++.|+|||.+.+. .++.++|||||||++|+|++|+.
T Consensus 146 Nill~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~---------~~~~~~Dv~s~Gvil~~l~~g~~ 214 (296)
T cd06654 146 NILLGMDGSVKLTDFGFCAQITPEQS--KRSTMVGTPYWMAPEVVTRK---------AYGPKVDIWSLGIMAIEMIEGEP 214 (296)
T ss_pred HEEEcCCCCEEECccccchhcccccc--ccCcccCCccccCHHHHcCC---------CCCccchHHHHHHHHHHHHhCCC
Confidence 9999 467899999999886543221 12345799999999998654 24679999999999999999999
Q ss_pred CCCcchhHHHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCCChhHHhcCCCCCCCC
Q 003052 709 PFSEYKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQHPFLVPPV 771 (853)
Q Consensus 709 PF~~~~~~~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~HPwf~~~~ 771 (853)
||......................+...+..+.+||.+||..||.+||++.++++||||....
T Consensus 215 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~~~~~~~~ 277 (296)
T cd06654 215 PYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKIAK 277 (296)
T ss_pred CCCCCCHHHhHHHHhcCCCCCCCCccccCHHHHHHHHHHCcCCcccCcCHHHHhhChhhhccC
Confidence 997655543333333333333334455678899999999999999999999999999997643
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=346.08 Aligned_cols=265 Identities=29% Similarity=0.463 Sum_probs=203.2
Q ss_pred ceeeEEEeEeccCceEEEEEEe-cCCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHHHH
Q 003052 472 KLYQRLGKIGSGGSSEVHKVIS-SDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLREV 550 (853)
Q Consensus 472 ~~Y~ilk~LG~G~FG~Vyka~~-~~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~~l 550 (853)
++|++.++||+|+||.||+|.+ .+++.||||++..... ......+.+|+.++++++ |+||+++++++..
T Consensus 5 ~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~-------- 74 (336)
T cd07849 5 PRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEH-QTFCQRTLREIKILRRFK-HENIIGILDIIRP-------- 74 (336)
T ss_pred cceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEeccccc-chhHHHHHHHHHHHHhCC-CCCcCchhheeec--------
Confidence 5699999999999999999987 4678999999964322 234456788999999998 8999999876422
Q ss_pred hhCCCCCCCCccccCCeEEEEEecchhhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCCCcc
Q 003052 551 LNGSMNNKDGRVKDDGYIYMVLEYGEIDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPAN 630 (853)
Q Consensus 551 ~~~~iv~~~g~~~d~~~lyLVmEy~~gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLKPeN 630 (853)
..+.....+|+||||++++|...+.. ..+++..++.++.||+.||.|||++||+||||||+|
T Consensus 75 ---------~~~~~~~~~~lv~e~~~~~l~~~~~~---------~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~N 136 (336)
T cd07849 75 ---------PSFESFNDVYIVQELMETDLYKLIKT---------QHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSN 136 (336)
T ss_pred ---------ccccccceEEEEehhcccCHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHH
Confidence 11334457899999999888776643 469999999999999999999999999999999999
Q ss_pred EEe-ecCcEEEEecccchhcccCCccc-cccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHhCCC
Q 003052 631 FLL-VKGSLKLIDFGIAKAIMSDTTNI-QRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGRT 708 (853)
Q Consensus 631 ILL-~~g~VKL~DFGlAk~~~~~~~~~-~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLtG~~ 708 (853)
||+ .++.+||+|||+++......... .....+||+.|+|||.+.+.. .++.++|||||||++|+|++|++
T Consensus 137 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--------~~~~~~DvwslGvil~el~~G~~ 208 (336)
T cd07849 137 LLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATRWYRAPEIMLNSK--------GYTKAIDIWSVGCILAEMLSNRP 208 (336)
T ss_pred EEECCCCCEEECcccceeeccccccccCCcCCcCcCCCccChHHhhCCC--------CCCcHHHHHHHHHHHHHHHhCCC
Confidence 999 46799999999998654322111 123467899999999875432 35689999999999999999999
Q ss_pred CCCcchhHHH---HHHhhcCCCC----------------------ccc---CCCCCChhHHHHHHHhcccCCCCCCChhH
Q 003052 709 PFSEYKTFWA---KFKVITDPNH----------------------EIT---YEPVPNPWLLDLMKKCLAWDRNERWRIPQ 760 (853)
Q Consensus 709 PF~~~~~~~~---~~kii~~~~~----------------------~~~---~~~~~s~~l~dLI~kcL~~DP~kRpTa~E 760 (853)
||.+.+.... ....+..+.. ... ..+..+.++.+||.+||..||++|||+.+
T Consensus 209 ~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e 288 (336)
T cd07849 209 LFPGKDYLHQLNLILGVLGTPSQEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEE 288 (336)
T ss_pred CCCCCCHHHHHHHHHHHcCCCCHHHHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHH
Confidence 9965432111 1111110000 000 11234677999999999999999999999
Q ss_pred HhcCCCCCCCCC
Q 003052 761 LLQHPFLVPPVS 772 (853)
Q Consensus 761 IL~HPwf~~~~~ 772 (853)
+++||||.....
T Consensus 289 ~l~hp~~~~~~~ 300 (336)
T cd07849 289 ALAHPYLEQYHD 300 (336)
T ss_pred HhcCccccccCC
Confidence 999999986553
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-38 Score=337.64 Aligned_cols=255 Identities=31% Similarity=0.516 Sum_probs=208.1
Q ss_pred ceeeEEEeEeccCceEEEEEEe-cCCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHHHH
Q 003052 472 KLYQRLGKIGSGGSSEVHKVIS-SDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLREV 550 (853)
Q Consensus 472 ~~Y~ilk~LG~G~FG~Vyka~~-~~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~~l 550 (853)
++|++.+.||.|+||.||+|.+ .+++.||+|.+..... .....+.+|+.+++.++ |+||++++++
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~--~~~~~~~~e~~~l~~l~-h~~iv~~~~~----------- 84 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQ--PKKELIINEILVMKELK-NPNIVNFLDS----------- 84 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccC--chHHHHHHHHHHHHhcC-CCceeeeeee-----------
Confidence 5699999999999999999987 5778999999975433 23456789999999997 8999999886
Q ss_pred hhCCCCCCCCccccCCeEEEEEecch-hhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCCCc
Q 003052 551 LNGSMNNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPA 629 (853)
Q Consensus 551 ~~~~iv~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLKPe 629 (853)
+.+...+|+||||+. ++|..++.. ..+++.++..++.||+.||.|||++||+||||||+
T Consensus 85 -----------~~~~~~~~lv~e~~~~~~L~~~~~~---------~~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~ 144 (296)
T cd06655 85 -----------FLVGDELFVVMEYLAGGSLTDVVTE---------TCMDEAQIAAVCRECLQALEFLHANQVIHRDIKSD 144 (296)
T ss_pred -----------EecCceEEEEEEecCCCcHHHHHHh---------cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHH
Confidence 345668999999975 477776643 35899999999999999999999999999999999
Q ss_pred cEEe-ecCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHhCCC
Q 003052 630 NFLL-VKGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGRT 708 (853)
Q Consensus 630 NILL-~~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLtG~~ 708 (853)
||++ .++.+||+|||++........ ......|++.|+|||.+.+. .++.++|||||||++|+|++|+.
T Consensus 145 Nili~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~---------~~~~~~Dv~slGvil~~lltg~~ 213 (296)
T cd06655 145 NVLLGMDGSVKLTDFGFCAQITPEQS--KRSTMVGTPYWMAPEVVTRK---------AYGPKVDIWSLGIMAIEMVEGEP 213 (296)
T ss_pred HEEECCCCCEEEccCccchhcccccc--cCCCcCCCccccCcchhcCC---------CCCchhhHHHHHHHHHHHHhCCC
Confidence 9999 467999999999986643322 22345799999999998654 25679999999999999999999
Q ss_pred CCCcchhHHHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCCChhHHhcCCCCCCCC
Q 003052 709 PFSEYKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQHPFLVPPV 771 (853)
Q Consensus 709 PF~~~~~~~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~HPwf~~~~ 771 (853)
||...........+..........+...++.+.+||.+||..||.+||++.++++||||....
T Consensus 214 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~~~~~~~~~ 276 (296)
T cd06655 214 PYLNENPLRALYLIATNGTPELQNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQHPFLKLAK 276 (296)
T ss_pred CCCCCCHHHHHHHHHhcCCcccCCcccCCHHHHHHHHHHhhcChhhCCCHHHHhhChHhhhcc
Confidence 998766654444443333333344556788899999999999999999999999999997543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-38 Score=335.08 Aligned_cols=255 Identities=29% Similarity=0.533 Sum_probs=197.7
Q ss_pred ceeeEEEeEeccCceEEEEEEec-CCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHHHH
Q 003052 472 KLYQRLGKIGSGGSSEVHKVISS-DCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLREV 550 (853)
Q Consensus 472 ~~Y~ilk~LG~G~FG~Vyka~~~-~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~~l 550 (853)
+.|++.+.||+|+||.||+|.+. +++.||||.+...... .....+.+|++++++++ |+||++++++
T Consensus 5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~E~~~l~~l~-h~~i~~~~~~----------- 71 (291)
T cd07844 5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEE-GAPFTAIREASLLKDLK-HANIVTLHDI----------- 71 (291)
T ss_pred cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEeccccc-CCchhHHHHHHHHhhCC-CcceeeEEEE-----------
Confidence 46999999999999999999985 6789999999765432 22234678999999997 8999999886
Q ss_pred hhCCCCCCCCccccCCeEEEEEecchhhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCCCcc
Q 003052 551 LNGSMNNKDGRVKDDGYIYMVLEYGEIDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPAN 630 (853)
Q Consensus 551 ~~~~iv~~~g~~~d~~~lyLVmEy~~gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLKPeN 630 (853)
+.++.++|+||||++++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|
T Consensus 72 -----------~~~~~~~~lv~e~~~~~L~~~~~~~-------~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~n 133 (291)
T cd07844 72 -----------IHTKKTLTLVFEYLDTDLKQYMDDC-------GGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQN 133 (291)
T ss_pred -----------EecCCeEEEEEecCCCCHHHHHHhC-------CCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHH
Confidence 4556789999999988888877643 2468999999999999999999999999999999999
Q ss_pred EEe-ecCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHhCCCC
Q 003052 631 FLL-VKGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGRTP 709 (853)
Q Consensus 631 ILL-~~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLtG~~P 709 (853)
||+ .++.+||+|||+++....... ......++..|+|||++.+.. .++.++|||||||++|+|++|+.|
T Consensus 134 il~~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~--------~~~~~~Dv~slG~il~~l~~g~~~ 203 (291)
T cd07844 134 LLISERGELKLADFGLARAKSVPSK--TYSNEVVTLWYRPPDVLLGST--------EYSTSLDMWGVGCIFYEMATGRPL 203 (291)
T ss_pred EEEcCCCCEEECccccccccCCCCc--cccccccccccCCcHHhhcCc--------ccCcHHHHHHHHHHHHHHHhCCCC
Confidence 999 567999999999875432111 112345789999999986532 356789999999999999999999
Q ss_pred CCcchhHHHHH----HhhcCCCCcc------------------------cCCCCCC--hhHHHHHHHhcccCCCCCCChh
Q 003052 710 FSEYKTFWAKF----KVITDPNHEI------------------------TYEPVPN--PWLLDLMKKCLAWDRNERWRIP 759 (853)
Q Consensus 710 F~~~~~~~~~~----kii~~~~~~~------------------------~~~~~~s--~~l~dLI~kcL~~DP~kRpTa~ 759 (853)
|.+........ ..+..+.... ......+ .++.+||.+||..||.+||++.
T Consensus 204 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~ 283 (291)
T cd07844 204 FPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAA 283 (291)
T ss_pred CCCCccHHHHHHHHHHhcCCCChhhhhhhhhccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHH
Confidence 96543221111 1111000000 0001223 6789999999999999999999
Q ss_pred HHhcCCCC
Q 003052 760 QLLQHPFL 767 (853)
Q Consensus 760 EIL~HPwf 767 (853)
++|.||||
T Consensus 284 e~l~~~~f 291 (291)
T cd07844 284 EAMKHPYF 291 (291)
T ss_pred HHhcCCCC
Confidence 99999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-38 Score=333.79 Aligned_cols=255 Identities=31% Similarity=0.469 Sum_probs=197.2
Q ss_pred ceeeEEEeEeccCceEEEEEEe-cCCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHHHH
Q 003052 472 KLYQRLGKIGSGGSSEVHKVIS-SDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLREV 550 (853)
Q Consensus 472 ~~Y~ilk~LG~G~FG~Vyka~~-~~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~~l 550 (853)
..|++++.||+|+||.||+|.+ .++..||+|++...... .....+.+|+.+++.++ |+||++++++
T Consensus 5 ~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~e~~~l~~l~-h~ni~~~~~~----------- 71 (291)
T cd07870 5 TSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEE-GVPFTAIREASLLKGLK-HANIVLLHDI----------- 71 (291)
T ss_pred ceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcC-CCcHHHHHHHHHHHhcC-CCCEeEEEEE-----------
Confidence 4699999999999999999987 46789999999765432 22234678999999997 8999999886
Q ss_pred hhCCCCCCCCccccCCeEEEEEecchhhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCCCcc
Q 003052 551 LNGSMNNKDGRVKDDGYIYMVLEYGEIDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPAN 630 (853)
Q Consensus 551 ~~~~iv~~~g~~~d~~~lyLVmEy~~gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLKPeN 630 (853)
+.++...|+||||++++|...+... ...+++..++.++.||+.||.|||++||+||||||+|
T Consensus 72 -----------~~~~~~~~lv~e~~~~~l~~~~~~~-------~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~N 133 (291)
T cd07870 72 -----------IHTKETLTFVFEYMHTDLAQYMIQH-------PGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQN 133 (291)
T ss_pred -----------EecCCeEEEEEecccCCHHHHHHhC-------CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHH
Confidence 3456689999999988887776542 2457889999999999999999999999999999999
Q ss_pred EEe-ecCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHhCCCC
Q 003052 631 FLL-VKGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGRTP 709 (853)
Q Consensus 631 ILL-~~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLtG~~P 709 (853)
||+ .++.+||+|||+++....... ......+++.|+|||++.+.. .++.++|||||||++|+|++|..|
T Consensus 134 il~~~~~~~~l~Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~--------~~~~~~Dv~slG~~l~~l~~g~~~ 203 (291)
T cd07870 134 LLISYLGELKLADFGLARAKSIPSQ--TYSSEVVTLWYRPPDVLLGAT--------DYSSALDIWGAGCIFIEMLQGQPA 203 (291)
T ss_pred EEEcCCCcEEEeccccccccCCCCC--CCCCccccccccCCceeecCC--------CCCcHHHHHHHHHHHHHHHhCCCC
Confidence 999 567999999999976433221 123456899999999986532 256789999999999999999999
Q ss_pred CCcchhHHHHHHhh----cCCC------------C--c---ccC---------CCCCChhHHHHHHHhcccCCCCCCChh
Q 003052 710 FSEYKTFWAKFKVI----TDPN------------H--E---ITY---------EPVPNPWLLDLMKKCLAWDRNERWRIP 759 (853)
Q Consensus 710 F~~~~~~~~~~kii----~~~~------------~--~---~~~---------~~~~s~~l~dLI~kcL~~DP~kRpTa~ 759 (853)
|............+ ..+. . . ... ....+..+.+||.+||..||.+|||+.
T Consensus 204 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~ 283 (291)
T cd07870 204 FPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQ 283 (291)
T ss_pred CCCchhHHHHHHHHHHHcCCCChhhhhhhhhcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHH
Confidence 97644322211110 0000 0 0 000 011245789999999999999999999
Q ss_pred HHhcCCCC
Q 003052 760 QLLQHPFL 767 (853)
Q Consensus 760 EIL~HPwf 767 (853)
|++.||||
T Consensus 284 ~~l~h~~~ 291 (291)
T cd07870 284 DALLHPYF 291 (291)
T ss_pred HHhcCCCC
Confidence 99999998
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-38 Score=337.03 Aligned_cols=266 Identities=30% Similarity=0.451 Sum_probs=200.9
Q ss_pred ceeeEEEeEeccCceEEEEEEec-CCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHHHH
Q 003052 472 KLYQRLGKIGSGGSSEVHKVISS-DCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLREV 550 (853)
Q Consensus 472 ~~Y~ilk~LG~G~FG~Vyka~~~-~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~~l 550 (853)
+.|++.++||+|+||.||+|.+. +++.||||++............+.+|++++++++ |+||+++++++.....
T Consensus 12 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~----- 85 (310)
T cd07865 12 SKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLK-HENVVNLIEICRTKAT----- 85 (310)
T ss_pred hheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCC-CCCccceEEEEecccc-----
Confidence 46999999999999999999984 6789999999765433333345678999999997 8999999987543210
Q ss_pred hhCCCCCCCCccccCCeEEEEEecchhhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCCCcc
Q 003052 551 LNGSMNNKDGRVKDDGYIYMVLEYGEIDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPAN 630 (853)
Q Consensus 551 ~~~~iv~~~g~~~d~~~lyLVmEy~~gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLKPeN 630 (853)
........+|+||||++++|...+... ...+++..++.++.||+.||.|||++||+|+||||+|
T Consensus 86 ---------~~~~~~~~~~lv~e~~~~~l~~~l~~~-------~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~n 149 (310)
T cd07865 86 ---------PYNRYKGSFYLVFEFCEHDLAGLLSNK-------NVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAAN 149 (310)
T ss_pred ---------cccCCCceEEEEEcCCCcCHHHHHHhc-------ccCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHH
Confidence 012345678999999998888777542 2468999999999999999999999999999999999
Q ss_pred EEee-cCcEEEEecccchhcccCCcc--ccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHhCC
Q 003052 631 FLLV-KGSLKLIDFGIAKAIMSDTTN--IQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGR 707 (853)
Q Consensus 631 ILL~-~g~VKL~DFGlAk~~~~~~~~--~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLtG~ 707 (853)
|+++ ++.+||+|||++..+...... .......++..|+|||++.+.. .++.++|||||||++|+|++|+
T Consensus 150 il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--------~~~~~~Di~slG~~l~el~t~~ 221 (310)
T cd07865 150 ILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGER--------DYGPPIDMWGAGCIMAEMWTRS 221 (310)
T ss_pred EEECCCCcEEECcCCCcccccCCcccCCCCccCcccCccccCcHHhcCCc--------ccCchhhhHHHHHHHHHHHhCC
Confidence 9994 679999999999866432211 1122456889999999986542 2567899999999999999999
Q ss_pred CCCCcchhHHHH--HHhhcCCCCc--------------ccC-------------CCCCChhHHHHHHHhcccCCCCCCCh
Q 003052 708 TPFSEYKTFWAK--FKVITDPNHE--------------ITY-------------EPVPNPWLLDLMKKCLAWDRNERWRI 758 (853)
Q Consensus 708 ~PF~~~~~~~~~--~kii~~~~~~--------------~~~-------------~~~~s~~l~dLI~kcL~~DP~kRpTa 758 (853)
+||......... ...+...... ..+ ....+..+.+||.+||..||.+|||+
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~ 301 (310)
T cd07865 222 PIMQGNTEQHQLTLISQLCGSITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDA 301 (310)
T ss_pred CCCCCCCHHHHHHHHHHHhCCCChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCH
Confidence 999764432111 1111000000 000 11234568899999999999999999
Q ss_pred hHHhcCCCC
Q 003052 759 PQLLQHPFL 767 (853)
Q Consensus 759 ~EIL~HPwf 767 (853)
.++|+||||
T Consensus 302 ~e~l~h~~f 310 (310)
T cd07865 302 DTALNHDFF 310 (310)
T ss_pred HHHhcCCCC
Confidence 999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-38 Score=338.43 Aligned_cols=259 Identities=27% Similarity=0.424 Sum_probs=206.7
Q ss_pred eeeEEEeEeccCceEEEEEEec-CCcEEEEEEEecCCCC-hhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHHHH
Q 003052 473 LYQRLGKIGSGGSSEVHKVISS-DCTIYALKKIKLKGRD-YATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLREV 550 (853)
Q Consensus 473 ~Y~ilk~LG~G~FG~Vyka~~~-~g~~vAVKkik~~~~~-~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~~l 550 (853)
+|++.+.||+|+||.||+|.+. +++.||+|.+...... ......+.+|+++|+++. |+||++++++
T Consensus 2 ~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~----------- 69 (316)
T cd05574 2 HFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLD-HPFLPTLYAS----------- 69 (316)
T ss_pred ceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCC-CCCchhheee-----------
Confidence 5999999999999999999985 5789999999865433 234556889999999998 8999999876
Q ss_pred hhCCCCCCCCccccCCeEEEEEecch-hhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCCCc
Q 003052 551 LNGSMNNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPA 629 (853)
Q Consensus 551 ~~~~iv~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLKPe 629 (853)
+.+...+|+||||+. ++|.+++... ....+++..++.++.||+.||.|||+.||+||||||+
T Consensus 70 -----------~~~~~~~~lv~e~~~~~~L~~~~~~~------~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~ 132 (316)
T cd05574 70 -----------FQTETYLCLVMDYCPGGELFRLLQRQ------PGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPE 132 (316)
T ss_pred -----------eecCCEEEEEEEecCCCCHHHHHHhC------CCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChH
Confidence 455678999999975 4888877643 2357999999999999999999999999999999999
Q ss_pred cEEe-ecCcEEEEecccchhcccCCcc---------------------------ccccccccCccccCchhhccCCCCCC
Q 003052 630 NFLL-VKGSLKLIDFGIAKAIMSDTTN---------------------------IQRDSQVGTLSYMSPEAFMCNESDEN 681 (853)
Q Consensus 630 NILL-~~g~VKL~DFGlAk~~~~~~~~---------------------------~~~~t~~GTp~YmAPEvl~~~~~~~~ 681 (853)
|||+ .++.++|+|||++......... .......||..|+|||++.+..
T Consensus 133 Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~---- 208 (316)
T cd05574 133 NILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDG---- 208 (316)
T ss_pred HeEEcCCCCEEEeecchhhcccccccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCC----
Confidence 9999 5679999999998764321110 0112457899999999997543
Q ss_pred CccccCCCccchhhhHHHHHHHHhCCCCCCcchhHHHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCCC----
Q 003052 682 GNIIKCGRPSDIWSLGCILYQMVYGRTPFSEYKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWR---- 757 (853)
Q Consensus 682 ~~~~~ys~ksDIWSLGVILyELLtG~~PF~~~~~~~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpT---- 757 (853)
++.++|||||||++|+|++|..||.+.........+.. ...........+..+++||.+||..||.+||+
T Consensus 209 -----~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~ 282 (316)
T cd05574 209 -----HGSAVDWWTLGILLYEMLYGTTPFKGSNRDETFSNILK-KEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRG 282 (316)
T ss_pred -----CCchHHHHHHHHHHHHHhhCCCCCCCCchHHHHHHHhc-CCccCCCccccCHHHHHHHHHHccCCHhHCCCchhh
Confidence 46799999999999999999999976554433333332 22222222336888999999999999999999
Q ss_pred hhHHhcCCCCCCC
Q 003052 758 IPQLLQHPFLVPP 770 (853)
Q Consensus 758 a~EIL~HPwf~~~ 770 (853)
+.++|+||||+..
T Consensus 283 ~~~ll~~~~~~~~ 295 (316)
T cd05574 283 AAEIKQHPFFRGV 295 (316)
T ss_pred HHHHHcCchhhcC
Confidence 9999999999753
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=325.33 Aligned_cols=253 Identities=27% Similarity=0.437 Sum_probs=205.4
Q ss_pred eeeEEEeEeccCceEEEEEEe-cCCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHHHHh
Q 003052 473 LYQRLGKIGSGGSSEVHKVIS-SDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLREVL 551 (853)
Q Consensus 473 ~Y~ilk~LG~G~FG~Vyka~~-~~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~~l~ 551 (853)
+|++.++||+|+||.||++.. .+++.||+|.+............+.+|+.++++++ |+||++++++
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~------------ 67 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMK-HPNIVQYQES------------ 67 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCC-CCCeeeeEee------------
Confidence 489999999999999999988 46789999999865544455567889999999998 8999999876
Q ss_pred hCCCCCCCCccccCCeEEEEEecch-hhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCCCcc
Q 003052 552 NGSMNNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPAN 630 (853)
Q Consensus 552 ~~~iv~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLKPeN 630 (853)
+.+.+++|+||||+. ++|.+.+... ....+++..++.++.||+.||.|||++||+|+||+|+|
T Consensus 68 ----------~~~~~~~~lv~e~~~~~~l~~~~~~~------~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~n 131 (256)
T cd08218 68 ----------FEENGNLYIVMDYCEGGDLYKKINAQ------RGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQN 131 (256)
T ss_pred ----------ecCCCeEEEEEecCCCCcHHHHHHhc------cCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHH
Confidence 456678999999975 5888877643 22468999999999999999999999999999999999
Q ss_pred EEee-cCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHhCCCC
Q 003052 631 FLLV-KGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGRTP 709 (853)
Q Consensus 631 ILL~-~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLtG~~P 709 (853)
||++ ++.++|+|||++........ ......|++.|+|||++.+.. ++.++|+|||||++|+|++|+.|
T Consensus 132 il~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~~~~pe~~~~~~---------~~~~~Dv~slG~i~~~l~~g~~~ 200 (256)
T cd08218 132 IFLTKDGTIKLGDFGIARVLNSTVE--LARTCIGTPYYLSPEICENRP---------YNNKSDIWALGCVLYEMCTLKHA 200 (256)
T ss_pred EEEcCCCCEEEeeccceeecCcchh--hhhhccCCccccCHHHhCCCC---------CCCccchhHHHHHHHHHHcCCCC
Confidence 9994 67999999999986543221 122456899999999986543 45789999999999999999999
Q ss_pred CCcchhHHHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCCChhHHhcCCCC
Q 003052 710 FSEYKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQHPFL 767 (853)
Q Consensus 710 F~~~~~~~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~HPwf 767 (853)
|...+.......++.... ...+...+..+.++|.+||..+|.+||++.++|+||||
T Consensus 201 ~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~~~~ 256 (256)
T cd08218 201 FEAGNMKNLVLKIIRGSY--PPVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILEKNFI 256 (256)
T ss_pred ccCCCHHHHHHHHhcCCC--CCCcccCCHHHHHHHHHHhhCChhhCcCHHHHhhCcCC
Confidence 976544433333333221 12344567889999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-38 Score=338.15 Aligned_cols=263 Identities=27% Similarity=0.468 Sum_probs=199.6
Q ss_pred eeeEEEeEeccCceEEEEEEec---CCcEEEEEEEecCC-CChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHH
Q 003052 473 LYQRLGKIGSGGSSEVHKVISS---DCTIYALKKIKLKG-RDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLR 548 (853)
Q Consensus 473 ~Y~ilk~LG~G~FG~Vyka~~~---~g~~vAVKkik~~~-~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~ 548 (853)
.|.+.++||+|+||.||+|.+. ++..||+|.+.... ........+.+|+.++++++ |+||+++++++..
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~------ 73 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELK-HENVVSLVEVFLE------ 73 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcC-CCCccceEEEEeC------
Confidence 3889999999999999999984 46899999998743 11223345778999999997 8999999987421
Q ss_pred HHhhCCCCCCCCccccCCeEEEEEecchhhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCCC
Q 003052 549 EVLNGSMNNKDGRVKDDGYIYMVLEYGEIDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKP 628 (853)
Q Consensus 549 ~l~~~~iv~~~g~~~d~~~lyLVmEy~~gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLKP 628 (853)
.....+|+||||++++|.+.+...... ....+++..++.++.||+.||.|||++||+||||||
T Consensus 74 --------------~~~~~~~lv~e~~~~~l~~~~~~~~~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp 136 (316)
T cd07842 74 --------------HADKSVYLLFDYAEHDLWQIIKFHRQA---KRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKP 136 (316)
T ss_pred --------------CCCceEEEEEeCCCcCHHHHHHhhccC---CCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCH
Confidence 123679999999998888877544221 224789999999999999999999999999999999
Q ss_pred ccEEee-----cCcEEEEecccchhcccCCc-cccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHH
Q 003052 629 ANFLLV-----KGSLKLIDFGIAKAIMSDTT-NIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQ 702 (853)
Q Consensus 629 eNILL~-----~g~VKL~DFGlAk~~~~~~~-~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyE 702 (853)
+|||++ ++.+||+|||+++.+..... .......++++.|+|||++.+.. .++.++|||||||++|+
T Consensus 137 ~Nil~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--------~~~~~~Dv~slG~~l~~ 208 (316)
T cd07842 137 ANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPVVVTIWYRAPELLLGAR--------HYTKAIDIWAIGCIFAE 208 (316)
T ss_pred HHEEEcCCCCccceEEECCCccccccCCCcccccccCCccccccccCHHHHhCCC--------CCCcHHHHHHHHHHHHH
Confidence 999994 57899999999987643222 11223457899999999886532 35679999999999999
Q ss_pred HHhCCCCCCcchhH------------HHHHHhhcC--------------------CCCcccCC-----------CCCChh
Q 003052 703 MVYGRTPFSEYKTF------------WAKFKVITD--------------------PNHEITYE-----------PVPNPW 739 (853)
Q Consensus 703 LLtG~~PF~~~~~~------------~~~~kii~~--------------------~~~~~~~~-----------~~~s~~ 739 (853)
|++|++||.+.... ...+..+.. ......++ ...+..
T Consensus 209 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 288 (316)
T cd07842 209 LLTLEPIFKGREAKIKKSNPFQRDQLERIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQ 288 (316)
T ss_pred HHhcCCCCcCCcccccccchhHHHHHHHHHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHH
Confidence 99999999643211 111111100 00000111 145567
Q ss_pred HHHHHHHhcccCCCCCCChhHHhcCCCC
Q 003052 740 LLDLMKKCLAWDRNERWRIPQLLQHPFL 767 (853)
Q Consensus 740 l~dLI~kcL~~DP~kRpTa~EIL~HPwf 767 (853)
+.++|.+||..||.+|||+.|+++||||
T Consensus 289 ~~~~i~~~l~~~P~~Rps~~eil~~~~f 316 (316)
T cd07842 289 GFDLLRKLLEYDPTKRITAEEALEHPYF 316 (316)
T ss_pred HHHHHHHHhcCCcccCcCHHHHhcCCCC
Confidence 8999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-38 Score=324.34 Aligned_cols=252 Identities=28% Similarity=0.434 Sum_probs=205.3
Q ss_pred eeeEEEeEeccCceEEEEEEe-cCCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHHHHh
Q 003052 473 LYQRLGKIGSGGSSEVHKVIS-SDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLREVL 551 (853)
Q Consensus 473 ~Y~ilk~LG~G~FG~Vyka~~-~~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~~l~ 551 (853)
+|++.+.||+|+||.||+|.+ .++..+|+|.+............+.+|+++|++++ |+||+++++.
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~-~~~i~~~~~~------------ 67 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLS-HPNIIEYYEN------------ 67 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCC-CCchhheeee------------
Confidence 488999999999999999988 46688999999876555555677889999999997 8999998875
Q ss_pred hCCCCCCCCccccCCeEEEEEecch-hhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCCCcc
Q 003052 552 NGSMNNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPAN 630 (853)
Q Consensus 552 ~~~iv~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLKPeN 630 (853)
+..+..+|+||||+. ++|.+++... ....+++..++.++.|++.||.|||++||+||||||+|
T Consensus 68 ----------~~~~~~~~lv~e~~~~~~L~~~~~~~------~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~n 131 (256)
T cd08220 68 ----------FLEDKALMIVMEYAPGGTLAEYIQKR------CNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQN 131 (256)
T ss_pred ----------EecCCEEEEEEecCCCCCHHHHHHHh------cccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHH
Confidence 345678999999975 5888888654 23468999999999999999999999999999999999
Q ss_pred EEeec--CcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHhCCC
Q 003052 631 FLLVK--GSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGRT 708 (853)
Q Consensus 631 ILL~~--g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLtG~~ 708 (853)
|++++ +.+||+|||++........ .....|+..|+|||.+.+. .++.++|||||||++|+|++|+.
T Consensus 132 il~~~~~~~~~l~d~~~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~---------~~~~~~Dv~slG~~l~~l~~~~~ 199 (256)
T cd08220 132 ILLDKHKMVVKIGDFGISKILSSKSK---AYTVVGTPCYISPELCEGK---------PYNQKSDIWALGCVLYELASLKR 199 (256)
T ss_pred EEEcCCCCEEEEccCCCceecCCCcc---ccccccCCcccCchhccCC---------CCCcccchHHHHHHHHHHHhCCC
Confidence 99953 3689999999987643321 2245789999999998654 35678999999999999999999
Q ss_pred CCCcchhHHHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCCChhHHhcCCCC
Q 003052 709 PFSEYKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQHPFL 767 (853)
Q Consensus 709 PF~~~~~~~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~HPwf 767 (853)
||...+.......+.... ....+...+..+.+||.+||..||.+|||+.|+++||||
T Consensus 200 ~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~p~~ 256 (256)
T cd08220 200 AFEAANLPALVLKIMSGT--FAPISDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQPIC 256 (256)
T ss_pred CcccCchHHHHHHHHhcC--CCCCCCCcCHHHHHHHHHHccCChhhCCCHHHHhhCCCC
Confidence 997755443333333221 122344577889999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-38 Score=345.14 Aligned_cols=265 Identities=30% Similarity=0.455 Sum_probs=206.3
Q ss_pred ceeeEEEeEeccCceEEEEEEe-cCCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHHHH
Q 003052 472 KLYQRLGKIGSGGSSEVHKVIS-SDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLREV 550 (853)
Q Consensus 472 ~~Y~ilk~LG~G~FG~Vyka~~-~~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~~l 550 (853)
..|++.+.||+|+||.||+|.+ .++..||+|++............+.+|+.+|++++ |+||+++++++..+
T Consensus 5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~------- 76 (334)
T cd07855 5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFK-HDNIIAIRDILRPP------- 76 (334)
T ss_pred hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcC-CCCccCHHHhcccc-------
Confidence 5699999999999999999998 46789999999866544445567789999999998 99999998764321
Q ss_pred hhCCCCCCCCccccCCeEEEEEecchhhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCCCcc
Q 003052 551 LNGSMNNKDGRVKDDGYIYMVLEYGEIDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPAN 630 (853)
Q Consensus 551 ~~~~iv~~~g~~~d~~~lyLVmEy~~gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLKPeN 630 (853)
......+|+||||++++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|
T Consensus 77 -----------~~~~~~~~lv~e~~~~~l~~~~~~--------~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~N 137 (334)
T cd07855 77 -----------GADFKDVYVVMDLMESDLHHIIHS--------DQPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSN 137 (334)
T ss_pred -----------CCCCceEEEEEehhhhhHHHHhcc--------CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHH
Confidence 134567899999998888877753 2569999999999999999999999999999999999
Q ss_pred EEe-ecCcEEEEecccchhcccCCcc--ccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHhCC
Q 003052 631 FLL-VKGSLKLIDFGIAKAIMSDTTN--IQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGR 707 (853)
Q Consensus 631 ILL-~~g~VKL~DFGlAk~~~~~~~~--~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLtG~ 707 (853)
||+ .++.+||+|||+++........ ......+|+..|+|||++.... .++.++|||||||++|+|++|+
T Consensus 138 il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~--------~~~~~~Di~slG~~l~el~~g~ 209 (334)
T cd07855 138 LLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRAPELLLSLP--------EYTTAIDMWSVGCIFAEMLGRR 209 (334)
T ss_pred EEEcCCCcEEecccccceeecccCcCCCcccccccccccccChHHhcCCc--------ccccccchHHHHHHHHHHHcCC
Confidence 999 5679999999999876432211 1123458999999999986432 3578999999999999999999
Q ss_pred CCCCcchhHHHHHHhh---cCC--------------------C--Cccc---CCCCCChhHHHHHHHhcccCCCCCCChh
Q 003052 708 TPFSEYKTFWAKFKVI---TDP--------------------N--HEIT---YEPVPNPWLLDLMKKCLAWDRNERWRIP 759 (853)
Q Consensus 708 ~PF~~~~~~~~~~kii---~~~--------------------~--~~~~---~~~~~s~~l~dLI~kcL~~DP~kRpTa~ 759 (853)
+||.+.........+. ..+ . .... .....+.++.+||.+||+.||.+||++.
T Consensus 210 ~pf~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~ 289 (334)
T cd07855 210 QLFPGKNYVHQLKLILSVLGSPSEEVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVE 289 (334)
T ss_pred CccCCCChHHHHHHHHHHhCCChhHhhhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHH
Confidence 9996643221111100 000 0 0000 1134578899999999999999999999
Q ss_pred HHhcCCCCCCCC
Q 003052 760 QLLQHPFLVPPV 771 (853)
Q Consensus 760 EIL~HPwf~~~~ 771 (853)
+++.||||....
T Consensus 290 ~~l~~~~~~~~~ 301 (334)
T cd07855 290 QALQHPFLAQYH 301 (334)
T ss_pred HHHhChhhhhcc
Confidence 999999997543
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-38 Score=337.98 Aligned_cols=256 Identities=29% Similarity=0.490 Sum_probs=206.7
Q ss_pred ceeeEEEeEeccCceEEEEEEe-cCCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHHHH
Q 003052 472 KLYQRLGKIGSGGSSEVHKVIS-SDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLREV 550 (853)
Q Consensus 472 ~~Y~ilk~LG~G~FG~Vyka~~-~~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~~l 550 (853)
++|++++.||+|+||.||+|.+ .+++.||+|.+...... ....+.+|+.+++.++ |+||++++++
T Consensus 19 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~e~~~l~~~~-h~~i~~~~~~----------- 84 (297)
T cd06656 19 KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQP--KKELIINEILVMRENK-NPNIVNYLDS----------- 84 (297)
T ss_pred hhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccc--hHHHHHHHHHHHHhCC-CCCEeeEEEE-----------
Confidence 5699999999999999999998 57889999999764432 2345789999999986 8999999986
Q ss_pred hhCCCCCCCCccccCCeEEEEEecch-hhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCCCc
Q 003052 551 LNGSMNNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPA 629 (853)
Q Consensus 551 ~~~~iv~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLKPe 629 (853)
+..+.++|+||||+. ++|.+++.. ..+++..+..++.|++.||.|||+.||+||||||+
T Consensus 85 -----------~~~~~~~~lv~e~~~~~~L~~~~~~---------~~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~ 144 (297)
T cd06656 85 -----------YLVGDELWVVMEYLAGGSLTDVVTE---------TCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSD 144 (297)
T ss_pred -----------EecCCEEEEeecccCCCCHHHHHHh---------CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHH
Confidence 445678999999975 588877743 35899999999999999999999999999999999
Q ss_pred cEEe-ecCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHhCCC
Q 003052 630 NFLL-VKGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGRT 708 (853)
Q Consensus 630 NILL-~~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLtG~~ 708 (853)
|||+ .++.+||+|||++........ ......|++.|+|||.+.+. .++.++|+|||||++|+|++|..
T Consensus 145 Nili~~~~~~~l~Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~---------~~~~~~Di~slGvil~~l~tg~~ 213 (297)
T cd06656 145 NILLGMDGSVKLTDFGFCAQITPEQS--KRSTMVGTPYWMAPEVVTRK---------AYGPKVDIWSLGIMAIEMVEGEP 213 (297)
T ss_pred HEEECCCCCEEECcCccceEccCCcc--CcCcccCCccccCHHHHcCC---------CCCcHHHHHHHHHHHHHHHhCCC
Confidence 9999 467999999999976543221 22356799999999998754 35679999999999999999999
Q ss_pred CCCcchhHHHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCCChhHHhcCCCCCCCCC
Q 003052 709 PFSEYKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQHPFLVPPVS 772 (853)
Q Consensus 709 PF~~~~~~~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~HPwf~~~~~ 772 (853)
||......................+...+..+++||.+||..||.+||++.++++||||.....
T Consensus 214 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~ 277 (297)
T cd06656 214 PYLNENPLRALYLIATNGTPELQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQHPFLKLAKP 277 (297)
T ss_pred CCCCCCcchheeeeccCCCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCchhccccc
Confidence 9976554333333222222233344556788999999999999999999999999999986543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-38 Score=326.85 Aligned_cols=251 Identities=28% Similarity=0.469 Sum_probs=204.4
Q ss_pred ceeeEEEeEeccCceEEEEEEecC-CcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHHHH
Q 003052 472 KLYQRLGKIGSGGSSEVHKVISSD-CTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLREV 550 (853)
Q Consensus 472 ~~Y~ilk~LG~G~FG~Vyka~~~~-g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~~l 550 (853)
+.|++.++||+|+||.||+|.... +..||+|.+..... ...+.+|++++++++ |+||++++++
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~----~~~~~~e~~~~~~l~-~~~i~~~~~~----------- 66 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED----LQEIIKEISILKQCD-SPYIVKYYGS----------- 66 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH----HHHHHHHHHHHHhCC-CCcEeeeeee-----------
Confidence 468999999999999999999854 78999999875422 557889999999995 9999999886
Q ss_pred hhCCCCCCCCccccCCeEEEEEecch-hhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCCCc
Q 003052 551 LNGSMNNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPA 629 (853)
Q Consensus 551 ~~~~iv~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLKPe 629 (853)
+.++.++|++|||++ ++|.+++... ...+++..++.++.||+.||.|||+.||+||||+|+
T Consensus 67 -----------~~~~~~~~l~~e~~~~~~L~~~l~~~-------~~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ 128 (256)
T cd06612 67 -----------YFKNTDLWIVMEYCGAGSVSDIMKIT-------NKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAG 128 (256)
T ss_pred -----------eecCCcEEEEEecCCCCcHHHHHHhC-------ccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcc
Confidence 345577999999976 4888877542 357899999999999999999999999999999999
Q ss_pred cEEe-ecCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHhCCC
Q 003052 630 NFLL-VKGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGRT 708 (853)
Q Consensus 630 NILL-~~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLtG~~ 708 (853)
||++ .++.+||+|||++........ ......|+..|+|||++.+. .++.++|||||||++|+|++|+.
T Consensus 129 ni~~~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~---------~~~~~~Di~s~G~il~~l~~g~~ 197 (256)
T cd06612 129 NILLNEEGQAKLADFGVSGQLTDTMA--KRNTVIGTPFWMAPEVIQEI---------GYNNKADIWSLGITAIEMAEGKP 197 (256)
T ss_pred eEEECCCCcEEEcccccchhcccCcc--ccccccCCccccCHHHHhcC---------CCCchhhHHHHHHHHHHHHhCCC
Confidence 9999 567999999999987654321 22345689999999998665 35679999999999999999999
Q ss_pred CCCcchhHHHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCCChhHHhcCCCC
Q 003052 709 PFSEYKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQHPFL 767 (853)
Q Consensus 709 PF~~~~~~~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~HPwf 767 (853)
||......................+...+..+.+||.+||..||.+||++.++|.||||
T Consensus 198 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~~~~~ 256 (256)
T cd06612 198 PYSDIHPMRAIFMIPNKPPPTLSDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQHPFI 256 (256)
T ss_pred CCCCcchhhhhhhhccCCCCCCCchhhcCHHHHHHHHHHHhcChhhCcCHHHHhcCCCC
Confidence 99875554433333222222233344567789999999999999999999999999997
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-38 Score=333.03 Aligned_cols=255 Identities=33% Similarity=0.547 Sum_probs=201.3
Q ss_pred eeEEEeEeccCceEEEEEEe-cCCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHHHHhh
Q 003052 474 YQRLGKIGSGGSSEVHKVIS-SDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLREVLN 552 (853)
Q Consensus 474 Y~ilk~LG~G~FG~Vyka~~-~~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~~l~~ 552 (853)
|+++++||.|++|.||+|.+ .++..||+|++............+.+|++++++++ |+||++++++
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~-~~~iv~~~~~------------- 66 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELN-HPNIVRLLDV------------- 66 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcC-CCCccCHhhe-------------
Confidence 67788999999999999998 47899999999866544344456789999999998 8999998876
Q ss_pred CCCCCCCCccccCCeEEEEEecchhhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCCCccEE
Q 003052 553 GSMNNKDGRVKDDGYIYMVLEYGEIDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANFL 632 (853)
Q Consensus 553 ~~iv~~~g~~~d~~~lyLVmEy~~gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLKPeNIL 632 (853)
+.++.+.|+||||++++|..++... ....+++..++.++.||+.||.|||++||+||||+|+||+
T Consensus 67 ---------~~~~~~~~iv~e~~~~~l~~~~~~~------~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil 131 (283)
T cd07835 67 ---------VHSENKLYLVFEFLDLDLKKYMDSS------PLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLL 131 (283)
T ss_pred ---------eccCCeEEEEEeccCcCHHHHHhhC------CCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEE
Confidence 3456789999999988888887653 1246899999999999999999999999999999999999
Q ss_pred e-ecCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHhCCCCCC
Q 003052 633 L-VKGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGRTPFS 711 (853)
Q Consensus 633 L-~~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLtG~~PF~ 711 (853)
+ .++.++|+|||+++....... ......+++.|+|||++.+.. .++.++|||||||++|+|++|++||.
T Consensus 132 ~~~~~~~~l~df~~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~--------~~~~~~Di~slG~~l~~l~~g~~pf~ 201 (283)
T cd07835 132 IDREGALKLADFGLARAFGVPVR--TYTHEVVTLWYRAPEILLGSR--------QYSTPVDIWSIGCIFAEMVNRRPLFP 201 (283)
T ss_pred EcCCCcEEEeecccccccCCCcc--ccCccccccCCCCCceeecCc--------ccCcHHHHHHHHHHHHHHHhCCCCCC
Confidence 9 567999999999976532211 112346789999999886532 25678999999999999999999997
Q ss_pred cchhHHHHHHhhcC---CC-----------------------CcccCCCCCChhHHHHHHHhcccCCCCCCChhHHhcCC
Q 003052 712 EYKTFWAKFKVITD---PN-----------------------HEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQHP 765 (853)
Q Consensus 712 ~~~~~~~~~kii~~---~~-----------------------~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~HP 765 (853)
.........++... +. .........+..+.+||.+||+.||.+|||+.+++.||
T Consensus 202 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~ 281 (283)
T cd07835 202 GDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHP 281 (283)
T ss_pred CCCHHHHHHHHHHHhCCCChHHhhhhhhchhhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcCC
Confidence 65443332222110 00 00011234567899999999999999999999999999
Q ss_pred CC
Q 003052 766 FL 767 (853)
Q Consensus 766 wf 767 (853)
||
T Consensus 282 ~~ 283 (283)
T cd07835 282 YF 283 (283)
T ss_pred CC
Confidence 98
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=323.07 Aligned_cols=257 Identities=31% Similarity=0.453 Sum_probs=207.9
Q ss_pred eeeEEEeEeccCceEEEEEEe-cCCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHHHHh
Q 003052 473 LYQRLGKIGSGGSSEVHKVIS-SDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLREVL 551 (853)
Q Consensus 473 ~Y~ilk~LG~G~FG~Vyka~~-~~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~~l~ 551 (853)
.|++++.||.|+||.||+|.+ .++..||+|.+............+.+|++++++++ |+||+++++++..
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~--------- 70 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELK-HPNIVRYYDRIID--------- 70 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcC-CCccceeeeeeec---------
Confidence 388999999999999999987 56789999999876655666677889999999998 8999999886421
Q ss_pred hCCCCCCCCccccCCeEEEEEecch-hhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcc-----cCceeeCC
Q 003052 552 NGSMNNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIH-----EERIVHSD 625 (853)
Q Consensus 552 ~~~iv~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLH-----s~gIIHRD 625 (853)
.....+|++|||+. ++|..++..... ....+++..++.++.||+.||.||| +.+|+|+|
T Consensus 71 -----------~~~~~~~~~~e~~~~~~L~~~l~~~~~----~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~d 135 (265)
T cd08217 71 -----------RSNQTLYIVMEYCEGGDLAQLIQKCKK----ERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRD 135 (265)
T ss_pred -----------CCCCEEEEEehhccCCCHHHHHHHHhh----cccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecC
Confidence 23457899999976 588888865421 3467999999999999999999999 89999999
Q ss_pred CCCccEEee-cCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHH
Q 003052 626 LKPANFLLV-KGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMV 704 (853)
Q Consensus 626 LKPeNILL~-~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELL 704 (853)
|||+||+++ ++.+||+|||++........ ......|++.|+|||.+.+.. ++.++|+|||||++|+|+
T Consensus 136 l~p~nili~~~~~~kl~d~g~~~~~~~~~~--~~~~~~~~~~~~~pE~~~~~~---------~~~~~Dv~slG~il~~l~ 204 (265)
T cd08217 136 LKPANIFLDANNNVKLGDFGLAKILGHDSS--FAKTYVGTPYYMSPEQLNHMS---------YDEKSDIWSLGCLIYELC 204 (265)
T ss_pred CCHHHEEEecCCCEEEecccccccccCCcc--cccccccCCCccChhhhcCCC---------CCchhHHHHHHHHHHHHH
Confidence 999999994 57999999999987654322 123567999999999986543 567899999999999999
Q ss_pred hCCCCCCcchhHHHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCCChhHHhcCCCC
Q 003052 705 YGRTPFSEYKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQHPFL 767 (853)
Q Consensus 705 tG~~PF~~~~~~~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~HPwf 767 (853)
+|+.||..... ......+.... ....+...+..+.+|+.+||..+|.+||++.+||+|||+
T Consensus 205 ~g~~p~~~~~~-~~~~~~~~~~~-~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~~~~ 265 (265)
T cd08217 205 ALSPPFTARNQ-LQLASKIKEGK-FRRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQLPLI 265 (265)
T ss_pred HCCCcccCcCH-HHHHHHHhcCC-CCCCccccCHHHHHHHHHHccCCcccCCCHHHHhhCCCC
Confidence 99999976543 22333333222 223445667889999999999999999999999999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-38 Score=335.63 Aligned_cols=258 Identities=28% Similarity=0.441 Sum_probs=202.6
Q ss_pred ceeeEEEeEeccCceEEEEEEec-CCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHHHH
Q 003052 472 KLYQRLGKIGSGGSSEVHKVISS-DCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLREV 550 (853)
Q Consensus 472 ~~Y~ilk~LG~G~FG~Vyka~~~-~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~~l 550 (853)
+.|++.+.||.|+||.||+|.+. +++.+|+|.++...........+.+|+.++++++ |+||+++++++..
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~-h~ni~~~~~~~~~-------- 75 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQ-HPNIVTVKEVVVG-------- 75 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcC-CCCEEEEEEEEEe--------
Confidence 45899999999999999999985 6789999999866544444445778999999998 9999999987421
Q ss_pred hhCCCCCCCCccccCCeEEEEEecchhhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCCCcc
Q 003052 551 LNGSMNNKDGRVKDDGYIYMVLEYGEIDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPAN 630 (853)
Q Consensus 551 ~~~~iv~~~g~~~d~~~lyLVmEy~~gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLKPeN 630 (853)
.+...+|+||||++++|.+.+... ...+++..++.++.||+.||.|||++||+||||||+|
T Consensus 76 ------------~~~~~~~lv~e~~~~~L~~~~~~~-------~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~n 136 (293)
T cd07843 76 ------------SNLDKIYMVMEYVEHDLKSLMETM-------KQPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSN 136 (293)
T ss_pred ------------cCCCcEEEEehhcCcCHHHHHHhc-------cCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHH
Confidence 122689999999988888887653 2368999999999999999999999999999999999
Q ss_pred EEe-ecCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHhCCCC
Q 003052 631 FLL-VKGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGRTP 709 (853)
Q Consensus 631 ILL-~~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLtG~~P 709 (853)
||+ .++.+||+|||++..+..... ......+++.|+|||.+.+.. .++.++|||||||++|+|++|.+|
T Consensus 137 ili~~~~~~~l~d~g~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~--------~~~~~~Di~slG~~l~~l~~g~~~ 206 (293)
T cd07843 137 LLLNNRGILKICDFGLAREYGSPLK--PYTQLVVTLWYRAPELLLGAK--------EYSTAIDMWSVGCIFAELLTKKPL 206 (293)
T ss_pred EEECCCCcEEEeecCceeeccCCcc--ccccccccccccCchhhcCCc--------cccchhhHHHHHHHHHHHHhCCCC
Confidence 999 467999999999987654321 123456889999999986542 246789999999999999999999
Q ss_pred CCcchhHHHHHHhhc---CC-------------------------CCcccCCCC-CChhHHHHHHHhcccCCCCCCChhH
Q 003052 710 FSEYKTFWAKFKVIT---DP-------------------------NHEITYEPV-PNPWLLDLMKKCLAWDRNERWRIPQ 760 (853)
Q Consensus 710 F~~~~~~~~~~kii~---~~-------------------------~~~~~~~~~-~s~~l~dLI~kcL~~DP~kRpTa~E 760 (853)
|..........++.. .+ .....++.. .++.+.+||.+||..||++|||+.|
T Consensus 207 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~e 286 (293)
T cd07843 207 FPGKSEIDQLNKIFKLLGTPTEKIWPGFSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAED 286 (293)
T ss_pred CCCCChHHHHHHHHHHhCCCchHHHHHhhccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHH
Confidence 976443322211110 00 000111222 4778999999999999999999999
Q ss_pred HhcCCCC
Q 003052 761 LLQHPFL 767 (853)
Q Consensus 761 IL~HPwf 767 (853)
+|.||||
T Consensus 287 ll~~~~f 293 (293)
T cd07843 287 ALKHPYF 293 (293)
T ss_pred HhcCCCC
Confidence 9999998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=325.38 Aligned_cols=255 Identities=28% Similarity=0.430 Sum_probs=203.7
Q ss_pred ceeeEEEeEeccCceEEEEEEec-CCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHHHH
Q 003052 472 KLYQRLGKIGSGGSSEVHKVISS-DCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLREV 550 (853)
Q Consensus 472 ~~Y~ilk~LG~G~FG~Vyka~~~-~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~~l 550 (853)
+.|++.+.||.|+||.||+|.+. +++.+|+|++...... ....+.+|+.++++++ |+||++++++
T Consensus 3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~e~~~l~~~~-h~~i~~~~~~----------- 68 (262)
T cd06613 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGD--DFEIIQQEISMLKECR-HPNIVAYFGS----------- 68 (262)
T ss_pred cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchh--hHHHHHHHHHHHHhCC-CCChhceEEE-----------
Confidence 56999999999999999999984 5688999999865433 4567889999999997 8999999876
Q ss_pred hhCCCCCCCCccccCCeEEEEEecchh-hHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCCCc
Q 003052 551 LNGSMNNKDGRVKDDGYIYMVLEYGEI-DLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPA 629 (853)
Q Consensus 551 ~~~~iv~~~g~~~d~~~lyLVmEy~~g-dL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLKPe 629 (853)
+.+...+|++|||+++ +|.+++... ...+++..++.++.||+.||.|||++||+|+||||+
T Consensus 69 -----------~~~~~~~~l~~e~~~~~~l~~~~~~~-------~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ 130 (262)
T cd06613 69 -----------YLRRDKLWIVMEYCGGGSLQDIYQVT-------RGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGA 130 (262)
T ss_pred -----------EEeCCEEEEEEeCCCCCcHHHHHHhh-------ccCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChh
Confidence 3456789999999775 777766542 246899999999999999999999999999999999
Q ss_pred cEEe-ecCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHhCCC
Q 003052 630 NFLL-VKGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGRT 708 (853)
Q Consensus 630 NILL-~~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLtG~~ 708 (853)
||++ .++.+||+|||++..+..... ......|+..|+|||.+.+... ..++.++|||||||++|+|++|++
T Consensus 131 ni~i~~~~~~~l~d~g~~~~~~~~~~--~~~~~~~~~~y~~Pe~~~~~~~------~~~~~~~Di~slG~~l~~~~tg~~ 202 (262)
T cd06613 131 NILLTEDGDVKLADFGVSAQLTATIA--KRKSFIGTPYWMAPEVAAVERK------GGYDGKCDIWALGITAIELAELQP 202 (262)
T ss_pred hEEECCCCCEEECccccchhhhhhhh--ccccccCCccccCchhhccccc------CCcCchhhhHHHHHHHHHHHhCCC
Confidence 9999 567999999999987643221 2235678999999999865411 135678999999999999999999
Q ss_pred CCCcchhHHHHHHhhcC--CCCcccCCCCCChhHHHHHHHhcccCCCCCCChhHHhcCCC
Q 003052 709 PFSEYKTFWAKFKVITD--PNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQHPF 766 (853)
Q Consensus 709 PF~~~~~~~~~~kii~~--~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~HPw 766 (853)
||.+............. ...........+..+.+||.+||..||.+||++.+++.|+|
T Consensus 203 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~ 262 (262)
T cd06613 203 PMFDLHPMRALFLISKSNFPPPKLKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQHPF 262 (262)
T ss_pred CCCCCCHHHHHHHHHhccCCCccccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhcCCC
Confidence 99876554444333222 11112223345677999999999999999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=337.15 Aligned_cols=251 Identities=29% Similarity=0.435 Sum_probs=198.8
Q ss_pred eeeEEEeEeccCceEEEEEEec-CCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHHHHh
Q 003052 473 LYQRLGKIGSGGSSEVHKVISS-DCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLREVL 551 (853)
Q Consensus 473 ~Y~ilk~LG~G~FG~Vyka~~~-~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~~l~ 551 (853)
.|++.++||+|+||.||++.+. ++..||+|.++.... ......+.+|++++++++ |+||++++++
T Consensus 2 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~-~~~~~~~~~E~~~l~~l~-h~~iv~~~~~------------ 67 (308)
T cd06615 2 DFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIK-PAIRNQIIRELKVLHECN-SPYIVGFYGA------------ 67 (308)
T ss_pred CceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccC-HHHHHHHHHHHHHHHhCC-CCCCCeEEEE------------
Confidence 4899999999999999999884 678899998875432 334456889999999996 8999999876
Q ss_pred hCCCCCCCCccccCCeEEEEEecch-hhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhccc-CceeeCCCCCc
Q 003052 552 NGSMNNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHE-ERIVHSDLKPA 629 (853)
Q Consensus 552 ~~~iv~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs-~gIIHRDLKPe 629 (853)
+.+++++|+||||+. ++|.+++... ..+++..++.++.||+.||.|||+ .+|+||||||+
T Consensus 68 ----------~~~~~~~~lv~ey~~~~~L~~~l~~~--------~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~ 129 (308)
T cd06615 68 ----------FYSDGEISICMEHMDGGSLDQVLKKA--------GRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPS 129 (308)
T ss_pred ----------EeeCCEEEEEeeccCCCcHHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChH
Confidence 456778999999976 5888887653 568999999999999999999997 59999999999
Q ss_pred cEEe-ecCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHhCCC
Q 003052 630 NFLL-VKGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGRT 708 (853)
Q Consensus 630 NILL-~~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLtG~~ 708 (853)
|||+ .++.+||+|||++....... ....+|++.|+|||++.+.. ++.++|||||||++|+|++|+.
T Consensus 130 nil~~~~~~~~l~dfg~~~~~~~~~----~~~~~~~~~~~aPE~~~~~~---------~~~~~DiwslG~~l~~l~~g~~ 196 (308)
T cd06615 130 NILVNSRGEIKLCDFGVSGQLIDSM----ANSFVGTRSYMSPERLQGTH---------YTVQSDIWSLGLSLVEMAIGRY 196 (308)
T ss_pred HEEEecCCcEEEccCCCcccccccc----cccCCCCcCccChhHhcCCC---------CCccchHHHHHHHHHHHHhCCC
Confidence 9999 46789999999997653321 23568999999999986542 5678999999999999999999
Q ss_pred CCCcchhHHHHHHhhcCCC------------------------------------CcccCCCCCChhHHHHHHHhcccCC
Q 003052 709 PFSEYKTFWAKFKVITDPN------------------------------------HEITYEPVPNPWLLDLMKKCLAWDR 752 (853)
Q Consensus 709 PF~~~~~~~~~~kii~~~~------------------------------------~~~~~~~~~s~~l~dLI~kcL~~DP 752 (853)
||...... .....+.... .........+.++++||.+||..||
T Consensus 197 p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P 275 (308)
T cd06615 197 PIPPPDAK-ELEAMFGRPVSEGEAKESHRPVSGHPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNP 275 (308)
T ss_pred CCCCcchh-hHHHhhcCccccccccCCcccccCCCCCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCCh
Confidence 99643321 1111111000 0000011256779999999999999
Q ss_pred CCCCChhHHhcCCCCCC
Q 003052 753 NERWRIPQLLQHPFLVP 769 (853)
Q Consensus 753 ~kRpTa~EIL~HPwf~~ 769 (853)
.+||++.++++||||..
T Consensus 276 ~~Rpt~~~ll~~~~~~~ 292 (308)
T cd06615 276 KERADLKELTKHPFIKR 292 (308)
T ss_pred hhCcCHHHHhcChhhhh
Confidence 99999999999999975
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-38 Score=336.25 Aligned_cols=260 Identities=23% Similarity=0.308 Sum_probs=195.1
Q ss_pred CceeeEEEeEeccCceEEEEEEecC-----------------CcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCce
Q 003052 471 GKLYQRLGKIGSGGSSEVHKVISSD-----------------CTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNI 533 (853)
Q Consensus 471 g~~Y~ilk~LG~G~FG~Vyka~~~~-----------------g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNI 533 (853)
..+|++.++||+|+||.||+|.+.+ +..||+|.+..... ......+.+|+.+|.+++ |+||
T Consensus 4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~-h~ni 81 (304)
T cd05096 4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDAN-KNARNDFLKEVKILSRLK-DPNI 81 (304)
T ss_pred hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCC-HHHHHHHHHHHHHHhhcC-CCCe
Confidence 4579999999999999999997532 24699999875432 334556889999999997 8999
Q ss_pred eEeeehhhhHHHHHHHHhhCCCCCCCCccccCCeEEEEEecch-hhHHHHHHHhhhhc-----------cCCCCCCCHHH
Q 003052 534 IQLIDYEVTEKALLREVLNGSMNNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEM-----------DGSNQTLDENW 601 (853)
Q Consensus 534 V~Lid~~~~e~~iL~~l~~~~iv~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~~-----------~~~~~~LsE~~ 601 (853)
+++++++ .+.+.+|+||||+. ++|.+++....... ......+++..
T Consensus 82 v~~~~~~----------------------~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 139 (304)
T cd05096 82 IRLLGVC----------------------VDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSS 139 (304)
T ss_pred eEEEEEE----------------------ecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHH
Confidence 9999873 44567899999975 58888886532111 11224578899
Q ss_pred HHHHHHHhhhhhhhcccCceeeCCCCCccEEee-cCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCC
Q 003052 602 LRFYWQQILEAVNTIHEERIVHSDLKPANFLLV-KGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDE 680 (853)
Q Consensus 602 ~r~I~~QIl~AL~yLHs~gIIHRDLKPeNILL~-~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~ 680 (853)
+..++.||+.||.|||++||+||||||+|||++ ++.+||+|||+++.+.............++..|||||++.+.
T Consensus 140 ~~~i~~~i~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~---- 215 (304)
T cd05096 140 LLHVALQIASGMKYLSSLNFVHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMG---- 215 (304)
T ss_pred HHHHHHHHHHHHHHHHHCCccccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcC----
Confidence 999999999999999999999999999999994 568999999999865433222222345668899999998654
Q ss_pred CCccccCCCccchhhhHHHHHHHHh--CCCCCCcchhHHHHHH---hhcCC--CCcccCCCCCChhHHHHHHHhcccCCC
Q 003052 681 NGNIIKCGRPSDIWSLGCILYQMVY--GRTPFSEYKTFWAKFK---VITDP--NHEITYEPVPNPWLLDLMKKCLAWDRN 753 (853)
Q Consensus 681 ~~~~~~ys~ksDIWSLGVILyELLt--G~~PF~~~~~~~~~~k---ii~~~--~~~~~~~~~~s~~l~dLI~kcL~~DP~ 753 (853)
.++.++|||||||++|+|++ +..||.+......... ..... ......++..+..+.+||.+||..||.
T Consensus 216 -----~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~ 290 (304)
T cd05096 216 -----KFTTASDVWAFGVTLWEILMLCKEQPYGELTDEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCR 290 (304)
T ss_pred -----CCCchhhhHHHHHHHHHHHHccCCCCCCcCCHHHHHHHHHHHhhhccccccccCCCCCCHHHHHHHHHHccCCch
Confidence 35689999999999999986 6788876433221111 11111 111223345678899999999999999
Q ss_pred CCCChhHHhc
Q 003052 754 ERWRIPQLLQ 763 (853)
Q Consensus 754 kRpTa~EIL~ 763 (853)
+|||+.+|.+
T Consensus 291 ~RPs~~~i~~ 300 (304)
T cd05096 291 ERPSFSDIHA 300 (304)
T ss_pred hCcCHHHHHH
Confidence 9999999953
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=329.90 Aligned_cols=256 Identities=30% Similarity=0.505 Sum_probs=200.6
Q ss_pred eeeEEEeEeccCceEEEEEEec-CCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHHHHh
Q 003052 473 LYQRLGKIGSGGSSEVHKVISS-DCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLREVL 551 (853)
Q Consensus 473 ~Y~ilk~LG~G~FG~Vyka~~~-~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~~l~ 551 (853)
.|+++++||.|+||.||+|++. ++..||||+++..... .....+.+|+.++++++ |+||++++++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~E~~~l~~l~-h~~i~~~~~~------------ 66 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEE-GTPSTAIREISLMKELK-HENIVRLHDV------------ 66 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccc-cchHHHHHHHHHHHhhc-CCCEeeeeee------------
Confidence 3889999999999999999984 6789999999865432 22345678999999996 8999999876
Q ss_pred hCCCCCCCCccccCCeEEEEEecchhhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCCCccE
Q 003052 552 NGSMNNKDGRVKDDGYIYMVLEYGEIDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANF 631 (853)
Q Consensus 552 ~~~iv~~~g~~~d~~~lyLVmEy~~gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLKPeNI 631 (853)
+.+.+.+|+||||++++|.+++.... ....+++..++.++.||+.||.|||+.||+||||||+||
T Consensus 67 ----------~~~~~~~~lv~e~~~~~l~~~~~~~~-----~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni 131 (284)
T cd07836 67 ----------IHTENKLMLVFEYMDKDLKKYMDTHG-----VRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNL 131 (284)
T ss_pred ----------EeeCCcEEEEEecCCccHHHHHHhcC-----CCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHE
Confidence 45567789999999988888876531 124689999999999999999999999999999999999
Q ss_pred Ee-ecCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHhCCCCC
Q 003052 632 LL-VKGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGRTPF 710 (853)
Q Consensus 632 LL-~~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLtG~~PF 710 (853)
++ .++.+||+|||+++....... ......+++.|++||++.+.. .++.++|||||||++|+|++|+.||
T Consensus 132 ~~~~~~~~~l~d~g~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~--------~~~~~~Dv~slG~~l~~l~~g~~~~ 201 (284)
T cd07836 132 LINKRGELKLADFGLARAFGIPVN--TFSNEVVTLWYRAPDVLLGSR--------TYSTSIDIWSVGCIMAEMITGRPLF 201 (284)
T ss_pred EECCCCcEEEeecchhhhhcCCcc--ccccccccccccChHHhcCCC--------CCCcHHHHHHHHHHHHHHHhCCCCC
Confidence 99 567999999999986543221 123456899999999986542 3567999999999999999999999
Q ss_pred CcchhHHHHHHhh---cCCC------------Ccc-----------cCCCCCChhHHHHHHHhcccCCCCCCChhHHhcC
Q 003052 711 SEYKTFWAKFKVI---TDPN------------HEI-----------TYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQH 764 (853)
Q Consensus 711 ~~~~~~~~~~kii---~~~~------------~~~-----------~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~H 764 (853)
.+........+++ ..+. ... ...+..+.++.++|.+||+.||.+||++.++++|
T Consensus 202 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~ 281 (284)
T cd07836 202 PGTNNEDQLLKIFRIMGTPTESTWPGISQLPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQH 281 (284)
T ss_pred CCCCcHHHHHHHHHHhCCCChhhHHHHhcCchhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 7543322111111 0000 000 0112346779999999999999999999999999
Q ss_pred CCC
Q 003052 765 PFL 767 (853)
Q Consensus 765 Pwf 767 (853)
|||
T Consensus 282 ~~f 284 (284)
T cd07836 282 PWF 284 (284)
T ss_pred CCC
Confidence 998
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-38 Score=333.91 Aligned_cols=259 Identities=31% Similarity=0.452 Sum_probs=201.9
Q ss_pred eeeEEEeEeccCceEEEEEEec-CCcEEEEEEEecCCCC---hhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHH
Q 003052 473 LYQRLGKIGSGGSSEVHKVISS-DCTIYALKKIKLKGRD---YATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLR 548 (853)
Q Consensus 473 ~Y~ilk~LG~G~FG~Vyka~~~-~g~~vAVKkik~~~~~---~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~ 548 (853)
+|.+.+.||+|+||.||+|.+. +++.||||+++..... ......+.+|++++++++ |+||++++++
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~-h~~i~~~~~~--------- 70 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELK-HPNIIGLLDV--------- 70 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcC-CCCChhhhhe---------
Confidence 3888999999999999999984 6789999999865433 223345678999999998 8999999876
Q ss_pred HHhhCCCCCCCCccccCCeEEEEEecchhhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCCC
Q 003052 549 EVLNGSMNNKDGRVKDDGYIYMVLEYGEIDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKP 628 (853)
Q Consensus 549 ~l~~~~iv~~~g~~~d~~~lyLVmEy~~gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLKP 628 (853)
+.+..++|+||||++++|.+++... ...+++..++.++.||+.||.|||++||+||||||
T Consensus 71 -------------~~~~~~~~lv~e~~~~~L~~~i~~~-------~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p 130 (298)
T cd07841 71 -------------FGHKSNINLVFEFMETDLEKVIKDK-------SIVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKP 130 (298)
T ss_pred -------------eecCCEEEEEEcccCCCHHHHHhcc-------CCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCh
Confidence 4456789999999988998887643 13699999999999999999999999999999999
Q ss_pred ccEEe-ecCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHhCC
Q 003052 629 ANFLL-VKGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGR 707 (853)
Q Consensus 629 eNILL-~~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLtG~ 707 (853)
+|||+ .++.+||+|||+++....... ......+++.|+|||.+.+.. .++.++|||||||++|+|++|.
T Consensus 131 ~nill~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~--------~~~~~~Dv~slG~il~e~~~g~ 200 (298)
T cd07841 131 NNLLIASDGVLKLADFGLARSFGSPNR--KMTHQVVTRWYRAPELLFGAR--------HYGVGVDMWSVGCIFAELLLRV 200 (298)
T ss_pred hhEEEcCCCCEEEccceeeeeccCCCc--cccccccceeeeCHHHHhCCC--------CCCcHHHHHHHHHHHHHHHcCC
Confidence 99999 567999999999987644322 122446788999999985432 3567999999999999999998
Q ss_pred CCCCcchhHHHHHHhh---cCCCCc----------------------ccCCCCCChhHHHHHHHhcccCCCCCCChhHHh
Q 003052 708 TPFSEYKTFWAKFKVI---TDPNHE----------------------ITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLL 762 (853)
Q Consensus 708 ~PF~~~~~~~~~~kii---~~~~~~----------------------~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL 762 (853)
+||.+........+.. ..+... .......+..+.+||.+||.+||.+||++.++|
T Consensus 201 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l 280 (298)
T cd07841 201 PFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQAL 280 (298)
T ss_pred ccccCCccHHHHHHHHHHcCCCchhhhhhcccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHh
Confidence 8886544322211111 100000 001123356789999999999999999999999
Q ss_pred cCCCCCCCC
Q 003052 763 QHPFLVPPV 771 (853)
Q Consensus 763 ~HPwf~~~~ 771 (853)
+||||....
T Consensus 281 ~~~~~~~~~ 289 (298)
T cd07841 281 EHPYFSNDP 289 (298)
T ss_pred hCccccCCC
Confidence 999998754
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-38 Score=350.66 Aligned_cols=262 Identities=22% Similarity=0.355 Sum_probs=200.9
Q ss_pred EcCceeeEEEeEeccCceEEEEEEec------CCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhh
Q 003052 469 VNGKLYQRLGKIGSGGSSEVHKVISS------DCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVT 542 (853)
Q Consensus 469 v~g~~Y~ilk~LG~G~FG~Vyka~~~------~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~ 542 (853)
+..+.|++.+.||+|+||.||+|++. ++..||||+++..... .....+.+|+.+|+++..|+||++++++
T Consensus 35 ~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~il~~l~~h~nIv~~~~~--- 110 (374)
T cd05106 35 FPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHT-DEREALMSELKILSHLGQHKNIVNLLGA--- 110 (374)
T ss_pred ccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCH-HHHHHHHHHHHHHHhhccCCceeeEeeE---
Confidence 34467999999999999999999852 2357999999765432 3345688999999999779999999986
Q ss_pred HHHHHHHHhhCCCCCCCCccccCCeEEEEEecch-hhHHHHHHHhhhhc-------------------------------
Q 003052 543 EKALLREVLNGSMNNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEM------------------------------- 590 (853)
Q Consensus 543 e~~iL~~l~~~~iv~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~~------------------------------- 590 (853)
+.+...+|+||||+. ++|.+++.......
T Consensus 111 -------------------~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 171 (374)
T cd05106 111 -------------------CTHGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDS 171 (374)
T ss_pred -------------------ecCCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccc
Confidence 445667899999976 58888886532110
Q ss_pred -------------------------------cCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCCCccEEee-cCcE
Q 003052 591 -------------------------------DGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLLV-KGSL 638 (853)
Q Consensus 591 -------------------------------~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLKPeNILL~-~g~V 638 (853)
......+++..++.|+.||+.||.|||++||+||||||+|||++ ++.+
T Consensus 172 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~~~~~ 251 (374)
T cd05106 172 GFSSQGSDTYVEMRPVSSSSSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVA 251 (374)
T ss_pred cccccccccccccCCccccccccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeCCCeE
Confidence 01123588999999999999999999999999999999999995 5689
Q ss_pred EEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHh-CCCCCCcchhHH
Q 003052 639 KLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVY-GRTPFSEYKTFW 717 (853)
Q Consensus 639 KL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLt-G~~PF~~~~~~~ 717 (853)
||+|||+++.+.............+++.|||||++... .|+.++|||||||++|+|++ |+.||.......
T Consensus 252 kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~---------~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~ 322 (374)
T cd05106 252 KICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFDC---------VYTVQSDVWSYGILLWEIFSLGKSPYPGILVNS 322 (374)
T ss_pred EEeeceeeeeccCCcceeeccCCCCccceeCHHHhcCC---------CCCccccHHHHHHHHHHHHhCCCCCCccccccH
Confidence 99999999876443222222234456789999998654 35689999999999999997 999997654333
Q ss_pred HHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCCChhHHhc
Q 003052 718 AKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQ 763 (853)
Q Consensus 718 ~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~ 763 (853)
.....+.. ......+...++++.++|.+||..||.+||++.++++
T Consensus 323 ~~~~~~~~-~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~l~~ 367 (374)
T cd05106 323 KFYKMVKR-GYQMSRPDFAPPEIYSIMKMCWNLEPTERPTFSQISQ 367 (374)
T ss_pred HHHHHHHc-ccCccCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 33333322 2222334456788999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=330.17 Aligned_cols=256 Identities=31% Similarity=0.528 Sum_probs=202.9
Q ss_pred eeeEEEeEeccCceEEEEEEec-CCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHHHHh
Q 003052 473 LYQRLGKIGSGGSSEVHKVISS-DCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLREVL 551 (853)
Q Consensus 473 ~Y~ilk~LG~G~FG~Vyka~~~-~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~~l~ 551 (853)
+|++.++||+|+||.||+|.+. +++.||+|+++...........+.+|+++++++. |+||++++++
T Consensus 2 ~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~------------ 68 (288)
T cd07833 2 KYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLR-HENIVNLKEA------------ 68 (288)
T ss_pred ceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcC-CCCeeehhhe------------
Confidence 5999999999999999999985 5789999999765554455567889999999998 8999999876
Q ss_pred hCCCCCCCCccccCCeEEEEEecchhhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCCCccE
Q 003052 552 NGSMNNKDGRVKDDGYIYMVLEYGEIDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANF 631 (853)
Q Consensus 552 ~~~iv~~~g~~~d~~~lyLVmEy~~gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLKPeNI 631 (853)
+.+++.+|+||||+++++.+.+..+ ...+++..+..++.||+.||.|||++||+||||||+||
T Consensus 69 ----------~~~~~~~~iv~e~~~~~~l~~~~~~-------~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni 131 (288)
T cd07833 69 ----------FRRKGRLYLVFEYVERTLLELLEAS-------PGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENI 131 (288)
T ss_pred ----------EEECCEEEEEEecCCCCHHHHHHhc-------CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHe
Confidence 4456789999999887666554432 24589999999999999999999999999999999999
Q ss_pred Ee-ecCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHhCCCCC
Q 003052 632 LL-VKGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGRTPF 710 (853)
Q Consensus 632 LL-~~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLtG~~PF 710 (853)
++ .++.+||+|||++........ .......|+..|+|||++.+.. .++.++|||||||++|+|++|++||
T Consensus 132 ~~~~~~~~kl~d~g~~~~~~~~~~-~~~~~~~~~~~~~~PE~~~~~~--------~~~~~~Dv~slG~~l~~l~~g~~~~ 202 (288)
T cd07833 132 LVSESGVLKLCDFGFARALRARPA-SPLTDYVATRWYRAPELLVGDT--------NYGKPVDVWAIGCIMAELLDGEPLF 202 (288)
T ss_pred EECCCCCEEEEeeecccccCCCcc-ccccCcccccCCcCCchhcCCC--------CcCchhhHHHHHHHHHHHHhCCCCC
Confidence 99 567999999999987654332 1223567899999999997652 3567999999999999999999999
Q ss_pred CcchhHHHHHHh---hcC------------CCC--------------cccCCCCCChhHHHHHHHhcccCCCCCCChhHH
Q 003052 711 SEYKTFWAKFKV---ITD------------PNH--------------EITYEPVPNPWLLDLMKKCLAWDRNERWRIPQL 761 (853)
Q Consensus 711 ~~~~~~~~~~ki---i~~------------~~~--------------~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EI 761 (853)
.+.......... ... ... ...++...+..+.+||++||..||.+||++.++
T Consensus 203 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~i 282 (288)
T cd07833 203 PGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDEL 282 (288)
T ss_pred CCCCHHHHHHHHHHHhCCCCHHHhhhcccCccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHH
Confidence 754332211111 000 000 001223347789999999999999999999999
Q ss_pred hcCCCC
Q 003052 762 LQHPFL 767 (853)
Q Consensus 762 L~HPwf 767 (853)
++||||
T Consensus 283 l~~~~f 288 (288)
T cd07833 283 LQHPYF 288 (288)
T ss_pred hcCCCC
Confidence 999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-38 Score=331.62 Aligned_cols=255 Identities=31% Similarity=0.502 Sum_probs=198.2
Q ss_pred eeeEEEeEeccCceEEEEEEec-CCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHHHHh
Q 003052 473 LYQRLGKIGSGGSSEVHKVISS-DCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLREVL 551 (853)
Q Consensus 473 ~Y~ilk~LG~G~FG~Vyka~~~-~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~~l~ 551 (853)
.|+++++||+|+||.||+|.+. +++.||+|++............+.+|++++++++ |+||++++++
T Consensus 2 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~------------ 68 (286)
T cd07846 2 KYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLR-HENLVNLIEV------------ 68 (286)
T ss_pred ceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcC-CcchhhHHHh------------
Confidence 5899999999999999999985 5789999998765444344556789999999997 8999998776
Q ss_pred hCCCCCCCCccccCCeEEEEEecchhhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCCCccE
Q 003052 552 NGSMNNKDGRVKDDGYIYMVLEYGEIDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANF 631 (853)
Q Consensus 552 ~~~iv~~~g~~~d~~~lyLVmEy~~gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLKPeNI 631 (853)
+.++..+|+||||+.+.+...+... ...+++..++.++.||+.||.|||+.||+||||+|+||
T Consensus 69 ----------~~~~~~~~lv~e~~~~~~l~~~~~~-------~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni 131 (286)
T cd07846 69 ----------FRRKKRLYLVFEFVDHTVLDDLEKY-------PNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENI 131 (286)
T ss_pred ----------cccCCeEEEEEecCCccHHHHHHhc-------cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHE
Confidence 4566789999999886444333221 24589999999999999999999999999999999999
Q ss_pred Ee-ecCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHhCCCCC
Q 003052 632 LL-VKGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGRTPF 710 (853)
Q Consensus 632 LL-~~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLtG~~PF 710 (853)
++ .++.++|+|||++..+..... ......|+..|+|||++.+.. .++.++|||||||++|+|++|++||
T Consensus 132 ~~~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~--------~~~~~~Dv~slG~~l~el~~g~~~~ 201 (286)
T cd07846 132 LVSQSGVVKLCDFGFARTLAAPGE--VYTDYVATRWYRAPELLVGDT--------KYGRAVDIWAVGCLVTEMLTGEPLF 201 (286)
T ss_pred EECCCCcEEEEeeeeeeeccCCcc--ccCcccceeeccCcHHhcccc--------ccCchHhHHHHHHHHHHHHcCCCCC
Confidence 99 567999999999987543322 223467899999999986532 3567899999999999999999999
Q ss_pred CcchhHHHHHHhhc---C----------C--------CCcc-------cCCCCCChhHHHHHHHhcccCCCCCCChhHHh
Q 003052 711 SEYKTFWAKFKVIT---D----------P--------NHEI-------TYEPVPNPWLLDLMKKCLAWDRNERWRIPQLL 762 (853)
Q Consensus 711 ~~~~~~~~~~kii~---~----------~--------~~~~-------~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL 762 (853)
..........++.. . . .... ...+..+..+.+||.+||..||.+||++.+++
T Consensus 202 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il 281 (286)
T cd07846 202 PGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLL 281 (286)
T ss_pred CCCchHHHHHHHHHHhCCCchhhHHHhccchHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHh
Confidence 65443322111110 0 0 0000 01234567799999999999999999999999
Q ss_pred cCCCC
Q 003052 763 QHPFL 767 (853)
Q Consensus 763 ~HPwf 767 (853)
+||||
T Consensus 282 ~~~~~ 286 (286)
T cd07846 282 HHEFF 286 (286)
T ss_pred cCCCC
Confidence 99998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=326.94 Aligned_cols=256 Identities=28% Similarity=0.420 Sum_probs=202.0
Q ss_pred eeeEEEeEeccCceEEEEEEe-cCCcEEEEEEEecCCC---ChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHH
Q 003052 473 LYQRLGKIGSGGSSEVHKVIS-SDCTIYALKKIKLKGR---DYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLR 548 (853)
Q Consensus 473 ~Y~ilk~LG~G~FG~Vyka~~-~~g~~vAVKkik~~~~---~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~ 548 (853)
.|++.+.||+|+||.||+|.+ .++..||+|++..... .......+.+|+.++++++ |+||+++++++..
T Consensus 3 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~------ 75 (266)
T cd06651 3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQ-HERIVQYYGCLRD------ 75 (266)
T ss_pred CccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcC-CCCeeeEEEEEEc------
Confidence 488889999999999999998 4678999999875432 2234456889999999997 8999999886321
Q ss_pred HHhhCCCCCCCCccccCCeEEEEEecch-hhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCC
Q 003052 549 EVLNGSMNNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLK 627 (853)
Q Consensus 549 ~l~~~~iv~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLK 627 (853)
..+..+|++|||+. ++|.+.+... ..+++..++.++.||+.||.|||++||+|||||
T Consensus 76 --------------~~~~~~~l~~e~~~~~~L~~~l~~~--------~~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~ 133 (266)
T cd06651 76 --------------RAEKTLTIFMEYMPGGSVKDQLKAY--------GALTESVTRKYTRQILEGMSYLHSNMIVHRDIK 133 (266)
T ss_pred --------------CCCCEEEEEEeCCCCCcHHHHHHHc--------CCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCC
Confidence 12457899999976 5888877543 468999999999999999999999999999999
Q ss_pred CccEEe-ecCcEEEEecccchhcccCCc-cccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHh
Q 003052 628 PANFLL-VKGSLKLIDFGIAKAIMSDTT-NIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVY 705 (853)
Q Consensus 628 PeNILL-~~g~VKL~DFGlAk~~~~~~~-~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLt 705 (853)
|+||++ .++.+||+|||+++....... ........|+..|+|||++.+. .++.++|||||||++|+|++
T Consensus 134 p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~---------~~~~~~Dv~slG~i~~el~~ 204 (266)
T cd06651 134 GANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVISGE---------GYGRKADVWSLGCTVVEMLT 204 (266)
T ss_pred HHHEEECCCCCEEEccCCCccccccccccCCccccCCccccccCHHHhCCC---------CCCchhhhHHHHHHHHHHHH
Confidence 999999 456899999999976532111 1111235689999999998654 35679999999999999999
Q ss_pred CCCCCCcchhHHHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCCChhHHhcCCCCC
Q 003052 706 GRTPFSEYKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQHPFLV 768 (853)
Q Consensus 706 G~~PF~~~~~~~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~HPwf~ 768 (853)
|+.||................ ....++...++.+++|| +||..+|.+||++.||++||||.
T Consensus 205 g~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~hp~~~ 265 (266)
T cd06651 205 EKPPWAEYEAMAAIFKIATQP-TNPQLPSHISEHARDFL-GCIFVEARHRPSAEELLRHPFAQ 265 (266)
T ss_pred CCCCccccchHHHHHHHhcCC-CCCCCchhcCHHHHHHH-HHhcCChhhCcCHHHHhcCcccc
Confidence 999998765555444443322 22334455678889999 68889999999999999999996
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=321.92 Aligned_cols=253 Identities=28% Similarity=0.422 Sum_probs=207.4
Q ss_pred eeeEEEeEeccCceEEEEEEe-cCCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHHHHh
Q 003052 473 LYQRLGKIGSGGSSEVHKVIS-SDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLREVL 551 (853)
Q Consensus 473 ~Y~ilk~LG~G~FG~Vyka~~-~~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~~l~ 551 (853)
+|++++.||.|+||.||.+.. .++..+++|.+............+.+|+.++++++ |+||++++++
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~-h~~i~~~~~~------------ 67 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQ-HPNIIAYYNH------------ 67 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCC-CCCeeEEEeE------------
Confidence 489999999999999999987 56788999999876655566667889999999996 8999999987
Q ss_pred hCCCCCCCCccccCCeEEEEEecch-hhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCCCcc
Q 003052 552 NGSMNNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPAN 630 (853)
Q Consensus 552 ~~~iv~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLKPeN 630 (853)
+.+...++++|||+. ++|.+++... ....+++..+..++.|++.||.|||+.||+||||||+|
T Consensus 68 ----------~~~~~~~~~~~e~~~~~~L~~~~~~~------~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~n 131 (256)
T cd08221 68 ----------FMDDNTLLIEMEYANGGTLYDKIVRQ------KGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLN 131 (256)
T ss_pred ----------EecCCeEEEEEEecCCCcHHHHHHhc------cccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHh
Confidence 345678999999976 5888887653 23568999999999999999999999999999999999
Q ss_pred EEe-ecCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHhCCCC
Q 003052 631 FLL-VKGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGRTP 709 (853)
Q Consensus 631 ILL-~~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLtG~~P 709 (853)
|++ .++.+||+|||++........ ......|++.|+|||.+.+.. ++.++|||||||++|+|++|..|
T Consensus 132 i~~~~~~~~kl~d~~~~~~~~~~~~--~~~~~~~~~~y~ape~~~~~~---------~~~~~Dv~slG~i~~~l~~g~~~ 200 (256)
T cd08221 132 IFLTKAGLIKLGDFGISKILGSEYS--MAETVVGTPYYMSPELCQGVK---------YNFKSDIWALGCVLYELLTLKRT 200 (256)
T ss_pred EEEeCCCCEEECcCcceEEcccccc--cccccCCCccccCHhhcCCCC---------CCCcchhHHHHHHHHHHHHCCCC
Confidence 999 467899999999987644332 223567999999999986542 45789999999999999999999
Q ss_pred CCcchhHHHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCCChhHHhcCCCC
Q 003052 710 FSEYKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQHPFL 767 (853)
Q Consensus 710 F~~~~~~~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~HPwf 767 (853)
|...........+.. .... ......+.++.++|.+||..||.+||++.++|+|||+
T Consensus 201 ~~~~~~~~~~~~~~~-~~~~-~~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~~l 256 (256)
T cd08221 201 FDATNPLNLVVKIVQ-GNYT-PVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQPLL 256 (256)
T ss_pred CCCCCHHHHHHHHHc-CCCC-CCccccCHHHHHHHHHHcccCcccCCCHHHHhhCcCC
Confidence 977554433333332 2221 2234567889999999999999999999999999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-38 Score=334.01 Aligned_cols=266 Identities=31% Similarity=0.476 Sum_probs=201.2
Q ss_pred ceeeEEEeEeccCceEEEEEEec-CCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHHHH
Q 003052 472 KLYQRLGKIGSGGSSEVHKVISS-DCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLREV 550 (853)
Q Consensus 472 ~~Y~ilk~LG~G~FG~Vyka~~~-~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~~l 550 (853)
++|++.++||+|+||.||+|.+. +++.+|||++............+.+|++++++++ |+||+++++++.....
T Consensus 8 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~----- 81 (311)
T cd07866 8 RDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLK-HPNVVPLIDMAVERPD----- 81 (311)
T ss_pred ccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcC-CCCccchhhheecccc-----
Confidence 56999999999999999999984 6789999999765443333345679999999997 8999999886432210
Q ss_pred hhCCCCCCCCccccCCeEEEEEecchhhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCCCcc
Q 003052 551 LNGSMNNKDGRVKDDGYIYMVLEYGEIDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPAN 630 (853)
Q Consensus 551 ~~~~iv~~~g~~~d~~~lyLVmEy~~gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLKPeN 630 (853)
........+|+||||++.+|...+... ...+++..++.++.||+.||.|||++||+||||||+|
T Consensus 82 ---------~~~~~~~~~~lv~~~~~~~l~~~~~~~-------~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~n 145 (311)
T cd07866 82 ---------KSKRKRGSVYMVTPYMDHDLSGLLENP-------SVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAAN 145 (311)
T ss_pred ---------cccccCceEEEEEecCCcCHHHHHhcc-------ccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHH
Confidence 112445678999999888877766532 3469999999999999999999999999999999999
Q ss_pred EEe-ecCcEEEEecccchhcccCCcc---------ccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHH
Q 003052 631 FLL-VKGSLKLIDFGIAKAIMSDTTN---------IQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCIL 700 (853)
Q Consensus 631 ILL-~~g~VKL~DFGlAk~~~~~~~~---------~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVIL 700 (853)
||+ .++.+||+|||+++........ .......|++.|+|||++.+.. .++.++|||||||++
T Consensus 146 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--------~~~~~~Dv~slG~il 217 (311)
T cd07866 146 ILIDNQGILKIADFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGER--------RYTTAVDIWGIGCVF 217 (311)
T ss_pred EEECCCCCEEECcCccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCC--------ccCchhHhHHHHHHH
Confidence 999 5679999999999865432211 1112346789999999986532 356789999999999
Q ss_pred HHHHhCCCCCCcchhHHHHHHhh---cCCCC-----------------cccC-------CCCCChhHHHHHHHhcccCCC
Q 003052 701 YQMVYGRTPFSEYKTFWAKFKVI---TDPNH-----------------EITY-------EPVPNPWLLDLMKKCLAWDRN 753 (853)
Q Consensus 701 yELLtG~~PF~~~~~~~~~~kii---~~~~~-----------------~~~~-------~~~~s~~l~dLI~kcL~~DP~ 753 (853)
|+|++|++||.+.........+. ..+.. .... .....+.+.+||.+||..||.
T Consensus 218 ~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~ 297 (311)
T cd07866 218 AEMFTRRPILQGKSDIDQLHLIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPY 297 (311)
T ss_pred HHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcc
Confidence 99999999997644332211111 10000 0000 012345688999999999999
Q ss_pred CCCChhHHhcCCCC
Q 003052 754 ERWRIPQLLQHPFL 767 (853)
Q Consensus 754 kRpTa~EIL~HPwf 767 (853)
+|||+.+++.||||
T Consensus 298 ~R~t~~ell~~~~f 311 (311)
T cd07866 298 KRLTASDALEHPYF 311 (311)
T ss_pred cCcCHHHHhcCCCC
Confidence 99999999999998
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=325.83 Aligned_cols=257 Identities=29% Similarity=0.466 Sum_probs=201.8
Q ss_pred eeeEEEeEeccCceEEEEEEec-CCcEEEEEEEecCCCC--------hhhHhhHHHHHHHHHHhcCCCceeEeeehhhhH
Q 003052 473 LYQRLGKIGSGGSSEVHKVISS-DCTIYALKKIKLKGRD--------YATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTE 543 (853)
Q Consensus 473 ~Y~ilk~LG~G~FG~Vyka~~~-~g~~vAVKkik~~~~~--------~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e 543 (853)
+|.+.+.||.|+||.||+|... +++.+|+|.++..... ......+.+|+.++++++ |+||++++++
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~---- 76 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLD-HLNIVQYLGF---- 76 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcC-CCCcceEEEE----
Confidence 4888999999999999999874 6789999998653221 112345778999999997 8999999876
Q ss_pred HHHHHHHhhCCCCCCCCccccCCeEEEEEecch-hhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCcee
Q 003052 544 KALLREVLNGSMNNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIV 622 (853)
Q Consensus 544 ~~iL~~l~~~~iv~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gII 622 (853)
+.....+|+||||+. ++|.+.+... ..+++..++.++.||+.||.|||++|++
T Consensus 77 ------------------~~~~~~~~lv~e~~~~~~L~~~l~~~--------~~l~~~~~~~~~~qi~~~l~~lH~~~i~ 130 (272)
T cd06629 77 ------------------ETTEEYLSIFLEYVPGGSIGSCLRTY--------GRFEEQLVRFFTEQVLEGLAYLHSKGIL 130 (272)
T ss_pred ------------------eccCCceEEEEecCCCCcHHHHHhhc--------cCCCHHHHHHHHHHHHHHHHHHhhCCee
Confidence 345567899999965 5888877543 5689999999999999999999999999
Q ss_pred eCCCCCccEEe-ecCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHH
Q 003052 623 HSDLKPANFLL-VKGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILY 701 (853)
Q Consensus 623 HRDLKPeNILL-~~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILy 701 (853)
||||||+||++ .++.++|+|||+++...............|+..|+|||.+..... .++.++|+|||||++|
T Consensus 131 H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~-------~~~~~~Dv~slG~~l~ 203 (272)
T cd06629 131 HRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQ-------GYSAKVDIWSLGCVVL 203 (272)
T ss_pred ecCCChhhEEEcCCCeEEEeeccccccccccccccccccccCCccccCHHHhccccC-------CCCccchhHHHHHHHH
Confidence 99999999999 567999999999986543222222234678999999999875431 2568999999999999
Q ss_pred HHHhCCCCCCcchhHHHHHHhhcCCCC---cccCCCCCChhHHHHHHHhcccCCCCCCChhHHhcCCCC
Q 003052 702 QMVYGRTPFSEYKTFWAKFKVITDPNH---EITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQHPFL 767 (853)
Q Consensus 702 ELLtG~~PF~~~~~~~~~~kii~~~~~---~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~HPwf 767 (853)
+|++|..||.........+........ ........+..+.+||.+||..||.+||++.++|+||||
T Consensus 204 ~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~ 272 (272)
T cd06629 204 EMFAGRRPWSDEEAIAAMFKLGNKRSAPPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQHPFI 272 (272)
T ss_pred HHHhCCCCCcCcchHHHHHHhhccccCCcCCccccccCCHHHHHHHHHHhcCChhhCCCHHHHhhCCCC
Confidence 999999999765554444333221111 111223457889999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=341.90 Aligned_cols=263 Identities=26% Similarity=0.424 Sum_probs=203.8
Q ss_pred ceeeEEEeEeccCceEEEEEEe-cCCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHHHH
Q 003052 472 KLYQRLGKIGSGGSSEVHKVIS-SDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLREV 550 (853)
Q Consensus 472 ~~Y~ilk~LG~G~FG~Vyka~~-~~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~~l 550 (853)
.+|++.+.||+|+||.||+|.+ .+++.||||++............+.+|+.+++.++ |+||+++++++....
T Consensus 5 ~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~ni~~~~~~~~~~~------ 77 (337)
T cd07858 5 TKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLD-HENVIAIKDIMPPPH------ 77 (337)
T ss_pred cceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcC-CCCccchHHheeccc------
Confidence 4699999999999999999998 46789999999765444444456789999999997 899999988743211
Q ss_pred hhCCCCCCCCccccCCeEEEEEecchhhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCCCcc
Q 003052 551 LNGSMNNKDGRVKDDGYIYMVLEYGEIDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPAN 630 (853)
Q Consensus 551 ~~~~iv~~~g~~~d~~~lyLVmEy~~gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLKPeN 630 (853)
......+|+||||++++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|
T Consensus 78 -----------~~~~~~~~lv~e~~~~~L~~~~~~~--------~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~N 138 (337)
T cd07858 78 -----------REAFNDVYIVYELMDTDLHQIIRSS--------QTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSN 138 (337)
T ss_pred -----------ccccCcEEEEEeCCCCCHHHHHhcC--------CCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHH
Confidence 1223468999999988888777542 579999999999999999999999999999999999
Q ss_pred EEe-ecCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHhCCCC
Q 003052 631 FLL-VKGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGRTP 709 (853)
Q Consensus 631 ILL-~~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLtG~~P 709 (853)
||+ .++.+||+|||+++...... .......|+..|+|||.+.... .++.++|||||||++|+|++|++|
T Consensus 139 il~~~~~~~kL~Dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~--------~~~~~~DiwslG~il~~l~~g~~p 208 (337)
T cd07858 139 LLLNANCDLKICDFGLARTTSEKG--DFMTEYVVTRWYRAPELLLNCS--------EYTTAIDVWSVGCIFAELLGRKPL 208 (337)
T ss_pred EEEcCCCCEEECcCccccccCCCc--ccccccccccCccChHHHhcCC--------CCCCcccHHHHHHHHHHHHcCCCC
Confidence 999 46799999999998664322 1223567899999999986432 256899999999999999999999
Q ss_pred CCcchhHHH---HHHhhcC------------------------CCCc-ccCCCCCChhHHHHHHHhcccCCCCCCChhHH
Q 003052 710 FSEYKTFWA---KFKVITD------------------------PNHE-ITYEPVPNPWLLDLMKKCLAWDRNERWRIPQL 761 (853)
Q Consensus 710 F~~~~~~~~---~~kii~~------------------------~~~~-~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EI 761 (853)
|.+.+.... ....... .... ....+..++++.+||.+||..||.+||++.++
T Consensus 209 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~el 288 (337)
T cd07858 209 FPGKDYVHQLKLITELLGSPSEEDLGFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEA 288 (337)
T ss_pred CCCCChHHHHHHHHHHhCCCChHHhhhcCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHH
Confidence 965322110 0000000 0000 01123567889999999999999999999999
Q ss_pred hcCCCCCCC
Q 003052 762 LQHPFLVPP 770 (853)
Q Consensus 762 L~HPwf~~~ 770 (853)
|+||||...
T Consensus 289 l~h~~~~~~ 297 (337)
T cd07858 289 LAHPYLASL 297 (337)
T ss_pred HcCcchhhh
Confidence 999999754
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-38 Score=348.78 Aligned_cols=264 Identities=22% Similarity=0.327 Sum_probs=201.4
Q ss_pred EEcCceeeEEEeEeccCceEEEEEEe------cCCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhh
Q 003052 468 KVNGKLYQRLGKIGSGGSSEVHKVIS------SDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEV 541 (853)
Q Consensus 468 ~v~g~~Y~ilk~LG~G~FG~Vyka~~------~~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~ 541 (853)
.+...+|++.++||+|+||.||+|++ .++..||||+++.... ......+.+|+.+|..+..||||++++++
T Consensus 31 ~~~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~-~~~~~~~~~Ei~il~~l~~HpnIv~l~~~-- 107 (375)
T cd05104 31 EFPRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAH-LTEREALMSELKVLSYLGNHINIVNLLGA-- 107 (375)
T ss_pred ccchHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcC-cHHHHHHHHHHHHHHHhcCCcceeeeeee--
Confidence 34445799999999999999999974 2346899999975432 23345688999999999779999999886
Q ss_pred hHHHHHHHHhhCCCCCCCCccccCCeEEEEEecch-hhHHHHHHHhhhhc------------------------------
Q 003052 542 TEKALLREVLNGSMNNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEM------------------------------ 590 (853)
Q Consensus 542 ~e~~iL~~l~~~~iv~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~~------------------------------ 590 (853)
+.+....|+||||+. |+|.+++.......
T Consensus 108 --------------------~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 167 (375)
T cd05104 108 --------------------CTVGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNE 167 (375)
T ss_pred --------------------eccCCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhh
Confidence 455667899999966 58988886532100
Q ss_pred -------------------------------------cCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCCCccEEe
Q 003052 591 -------------------------------------DGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLL 633 (853)
Q Consensus 591 -------------------------------------~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLKPeNILL 633 (853)
......+++..+..++.||+.||.|||++||+||||||+|||+
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill 247 (375)
T cd05104 168 YMDMKPGVSYVVPTKADKRRSVRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILL 247 (375)
T ss_pred hhhcCCCcccccccccccccccccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEE
Confidence 0112358899999999999999999999999999999999999
Q ss_pred e-cCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHh-CCCCCC
Q 003052 634 V-KGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVY-GRTPFS 711 (853)
Q Consensus 634 ~-~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLt-G~~PF~ 711 (853)
+ ++.+||+|||+++.+.............++..|+|||++.+. .++.++|||||||++|||++ |..||.
T Consensus 248 ~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~---------~~~~~sDi~slG~~l~ellt~g~~p~~ 318 (375)
T cd05104 248 THGRITKICDFGLARDIRNDSNYVVKGNARLPVKWMAPESIFNC---------VYTFESDVWSYGILLWEIFSLGSSPYP 318 (375)
T ss_pred ECCCcEEEecCccceeccCcccccccCCCCCCcceeChhHhcCC---------CCCCCCCHHHHHHHHHHHHhcCCCCCC
Confidence 5 458999999999876443222122234456789999999764 35689999999999999997 999997
Q ss_pred cchhHHHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCCChhHHhcC
Q 003052 712 EYKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQH 764 (853)
Q Consensus 712 ~~~~~~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~H 764 (853)
.........+.+.... ....+...+.++.+||.+||..||++||++.+|++.
T Consensus 319 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 370 (375)
T cd05104 319 GMPVDSKFYKMIKEGY-RMLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQL 370 (375)
T ss_pred CCCchHHHHHHHHhCc-cCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHH
Confidence 6543333333333221 222334567789999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=330.61 Aligned_cols=263 Identities=27% Similarity=0.429 Sum_probs=205.4
Q ss_pred eeeEEEeEeccCceEEEEEEec-CCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHHHHh
Q 003052 473 LYQRLGKIGSGGSSEVHKVISS-DCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLREVL 551 (853)
Q Consensus 473 ~Y~ilk~LG~G~FG~Vyka~~~-~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~~l~ 551 (853)
+|++++.||+|+||.||+|.+. ++..||+|.++... .......+.+|+.++++++ |+||++++++
T Consensus 2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~e~~~l~~~~-~~~i~~~~~~------------ 67 (286)
T cd06622 2 EIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLEL-DESKFNQIIMELDILHKAV-SPYIVDFYGA------------ 67 (286)
T ss_pred hhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeeccc-CHHHHHHHHHHHHHHHhcC-CCcHHhhhhh------------
Confidence 5889999999999999999985 77899999997643 2334457889999999996 8999998875
Q ss_pred hCCCCCCCCccccCCeEEEEEecchh-hHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhccc-CceeeCCCCCc
Q 003052 552 NGSMNNKDGRVKDDGYIYMVLEYGEI-DLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHE-ERIVHSDLKPA 629 (853)
Q Consensus 552 ~~~iv~~~g~~~d~~~lyLVmEy~~g-dL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs-~gIIHRDLKPe 629 (853)
+..++++|+||||+.+ +|..++... .....+++..++.++.||+.||.|||+ .||+||||||+
T Consensus 68 ----------~~~~~~~~lv~e~~~~~~l~~~~~~~-----~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~ 132 (286)
T cd06622 68 ----------FFIEGAVYMCMEYMDAGSLDKLYAGG-----VATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPT 132 (286)
T ss_pred ----------eecCCeEEEEEeecCCCCHHHHHHhc-----cccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHH
Confidence 4556789999999875 776666532 012478999999999999999999996 59999999999
Q ss_pred cEEe-ecCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHhCCC
Q 003052 630 NFLL-VKGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGRT 708 (853)
Q Consensus 630 NILL-~~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLtG~~ 708 (853)
||++ .++.+||+|||++..+.... .....|++.|+|||.+.+.... ....++.++|||||||++|+|++|+.
T Consensus 133 nil~~~~~~~~l~dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~---~~~~~~~~~DiwslG~il~~l~~g~~ 205 (286)
T cd06622 133 NVLVNGNGQVKLCDFGVSGNLVASL----AKTNIGCQSYMAPERIKSGGPN---QNPTYTVQSDVWSLGLSILEMALGRY 205 (286)
T ss_pred HEEECCCCCEEEeecCCcccccCCc----cccCCCccCccCcchhcCCCCC---ccCCCCcccchHhHHHHHHHHHhCCC
Confidence 9999 46789999999997654322 2245789999999998654321 11246789999999999999999999
Q ss_pred CCCcchh--HHHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCCChhHHhcCCCCCCCCC
Q 003052 709 PFSEYKT--FWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQHPFLVPPVS 772 (853)
Q Consensus 709 PF~~~~~--~~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~HPwf~~~~~ 772 (853)
||..... .......+.. ......+...+.++.+||.+||..+|.+||++.++++||||.....
T Consensus 206 pf~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~~~~~~~~~ 270 (286)
T cd06622 206 PYPPETYANIFAQLSAIVD-GDPPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEHPWLVKYKN 270 (286)
T ss_pred CCCCcchhhHHHHHHHHhh-cCCCCCCcccCHHHHHHHHHHcccCcccCCCHHHHhcChhhhhccC
Confidence 9964322 1122222222 1222344557889999999999999999999999999999976543
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=360.00 Aligned_cols=250 Identities=31% Similarity=0.489 Sum_probs=207.5
Q ss_pred eEeccCceEEEEEEecCC-cEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHHHHhhCCCCC
Q 003052 479 KIGSGGSSEVHKVISSDC-TIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLREVLNGSMNN 557 (853)
Q Consensus 479 ~LG~G~FG~Vyka~~~~g-~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~~l~~~~iv~ 557 (853)
+||+|.||+||.|++.++ ...|||.|..+.. ...+-+..||.+.++|+ |.|||++++
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekds--r~~QPLhEEIaLH~~Lr-HkNIVrYLG------------------- 639 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDS--REVQPLHEEIALHSTLR-HKNIVRYLG------------------- 639 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccccc--hhhccHHHHHHHHHHHh-hHhHHHHhh-------------------
Confidence 599999999999999765 5689999875533 34456889999999999 889998875
Q ss_pred CCCccccCCeEEEEEec-chhhHHHHHHHhhhhccCCCCCC--CHHHHHHHHHHhhhhhhhcccCceeeCCCCCccEEee
Q 003052 558 KDGRVKDDGYIYMVLEY-GEIDLAHMLSQKWKEMDGSNQTL--DENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLLV 634 (853)
Q Consensus 558 ~~g~~~d~~~lyLVmEy-~~gdL~~~L~~~~k~~~~~~~~L--sE~~~r~I~~QIl~AL~yLHs~gIIHRDLKPeNILL~ 634 (853)
++..++++-|.||- .||+|..++..+|. ++ +|..+.+|.+||++||.|||++.|||||||-+|||++
T Consensus 640 ---s~senGf~kIFMEqVPGGSLSsLLrskWG-------PlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvN 709 (1226)
T KOG4279|consen 640 ---SVSENGFFKIFMEQVPGGSLSSLLRSKWG-------PLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVN 709 (1226)
T ss_pred ---ccCCCCeEEEEeecCCCCcHHHHHHhccC-------CCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEe
Confidence 36778899999998 55799999988864 55 7889999999999999999999999999999999995
Q ss_pred --cCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHhCCCCCCc
Q 003052 635 --KGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGRTPFSE 712 (853)
Q Consensus 635 --~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLtG~~PF~~ 712 (853)
.|.+||+|||.++.+..-. .-..++.||..|||||++..++. .|+.++|||||||++.||.||++||.+
T Consensus 710 TySGvlKISDFGTsKRLAgin--P~TETFTGTLQYMAPEvIDqG~R-------GYG~aADIWS~GCT~vEMATGrPPF~E 780 (1226)
T KOG4279|consen 710 TYSGVLKISDFGTSKRLAGIN--PCTETFTGTLQYMAPEVIDQGPR-------GYGKAADIWSFGCTMVEMATGRPPFVE 780 (1226)
T ss_pred eccceEEecccccchhhccCC--ccccccccchhhhChHhhccCCc-------CCCchhhhhhccceeEeeccCCCCeee
Confidence 6899999999999875432 23358899999999999976543 589999999999999999999999976
Q ss_pred ch-hHHHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCCChhHHhcCCCCCCC
Q 003052 713 YK-TFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQHPFLVPP 770 (853)
Q Consensus 713 ~~-~~~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~HPwf~~~ 770 (853)
.. +..++|++-.- ......+...+.+++.||.+|+..||..||++.++|..||++..
T Consensus 781 lgspqAAMFkVGmy-KvHP~iPeelsaeak~FilrcFepd~~~R~sA~~LL~DpFlq~~ 838 (1226)
T KOG4279|consen 781 LGSPQAAMFKVGMY-KVHPPIPEELSAEAKNFILRCFEPDPCDRPSAKDLLQDPFLQHN 838 (1226)
T ss_pred cCChhHhhhhhcce-ecCCCCcHHHHHHHHHHHHHHcCCCcccCccHHHhccCcccccC
Confidence 43 33445544221 22334556678889999999999999999999999999999765
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-39 Score=356.25 Aligned_cols=239 Identities=25% Similarity=0.392 Sum_probs=200.3
Q ss_pred eEEEeEeccCceEEEEEEecCCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHHHHhhCC
Q 003052 475 QRLGKIGSGGSSEVHKVISSDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLREVLNGS 554 (853)
Q Consensus 475 ~ilk~LG~G~FG~Vyka~~~~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~~l~~~~ 554 (853)
.-++.||.|+-|.||+|+..+ +.||||+++.-. ..+|+.|++|+ |+|||.+.++
T Consensus 127 sELeWlGSGaQGAVF~Grl~n-etVAVKKV~elk---------ETdIKHLRkLk-H~NII~FkGV--------------- 180 (904)
T KOG4721|consen 127 SELEWLGSGAQGAVFLGRLHN-ETVAVKKVRELK---------ETDIKHLRKLK-HPNIITFKGV--------------- 180 (904)
T ss_pred hhhhhhccCcccceeeeeccC-ceehhHHHhhhh---------hhhHHHHHhcc-CcceeeEeee---------------
Confidence 345679999999999998744 569999987321 26899999998 9999999887
Q ss_pred CCCCCCccccCCeEEEEEecch-hhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCCCccEEe
Q 003052 555 MNNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLL 633 (853)
Q Consensus 555 iv~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLKPeNILL 633 (853)
|....++|||||||. |-|..+|+.. .++.......|.++|+.|+.|||.+.|||||||.-||||
T Consensus 181 -------CtqsPcyCIiMEfCa~GqL~~VLka~--------~~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLI 245 (904)
T KOG4721|consen 181 -------CTQSPCYCIIMEFCAQGQLYEVLKAG--------RPITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILI 245 (904)
T ss_pred -------ecCCceeEEeeeccccccHHHHHhcc--------CccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEe
Confidence 456678999999987 6888888753 678999999999999999999999999999999999999
Q ss_pred -ecCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHhCCCCCCc
Q 003052 634 -VKGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGRTPFSE 712 (853)
Q Consensus 634 -~~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLtG~~PF~~ 712 (853)
.++.|||+|||.++...... ..-.++||..|||||+|+..+ ++.|+|||||||+|||||||..||.+
T Consensus 246 s~~d~VKIsDFGTS~e~~~~S---TkMSFaGTVaWMAPEvIrneP---------csEKVDIwSfGVVLWEmLT~EiPYkd 313 (904)
T KOG4721|consen 246 SYDDVVKISDFGTSKELSDKS---TKMSFAGTVAWMAPEVIRNEP---------CSEKVDIWSFGVVLWEMLTGEIPYKD 313 (904)
T ss_pred eccceEEeccccchHhhhhhh---hhhhhhhhHhhhCHHHhhcCC---------cccccceehhHHHHHHHHhcCCCccc
Confidence 57799999999999876543 334799999999999998774 56799999999999999999999988
Q ss_pred chhHHHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCCChhHHhcCCCC
Q 003052 713 YKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQHPFL 767 (853)
Q Consensus 713 ~~~~~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~HPwf 767 (853)
.+....++.+ ......+..+..++.-++=||+.||.-.|..||++.+||.|-=+
T Consensus 314 VdssAIIwGV-GsNsL~LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~HldI 367 (904)
T KOG4721|consen 314 VDSSAIIWGV-GSNSLHLPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDI 367 (904)
T ss_pred cchheeEEec-cCCcccccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHHHhh
Confidence 6654333322 23344556677788889999999999999999999999999543
|
|
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=324.02 Aligned_cols=254 Identities=25% Similarity=0.467 Sum_probs=200.6
Q ss_pred eeEEEeEeccCceEEEEEEe-cCCcEEEEEEEecCCCC----hhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHH
Q 003052 474 YQRLGKIGSGGSSEVHKVIS-SDCTIYALKKIKLKGRD----YATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLR 548 (853)
Q Consensus 474 Y~ilk~LG~G~FG~Vyka~~-~~g~~vAVKkik~~~~~----~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~ 548 (853)
|+..+.||+|+||.||++.+ .+++.||+|++...... ......+.+|+++|++++ |+||++++++
T Consensus 2 ~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~--------- 71 (268)
T cd06630 2 WLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLN-HPHIIRMLGA--------- 71 (268)
T ss_pred ccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcC-CCceehhhce---------
Confidence 77888999999999999987 57789999999754321 224567889999999997 8999999876
Q ss_pred HHhhCCCCCCCCccccCCeEEEEEecch-hhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCC
Q 003052 549 EVLNGSMNNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLK 627 (853)
Q Consensus 549 ~l~~~~iv~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLK 627 (853)
+.+.+.+++||||+. ++|.+++.+. ..+++..++.++.||+.||.|||++||+|||||
T Consensus 72 -------------~~~~~~~~~v~e~~~~~~L~~~l~~~--------~~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~ 130 (268)
T cd06630 72 -------------TCEDSHFNLFVEWMAGGSVSHLLSKY--------GAFKEAVIINYTEQLLRGLSYLHENQIIHRDVK 130 (268)
T ss_pred -------------eccCCeEEEEEeccCCCcHHHHHHHh--------CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCC
Confidence 456678999999966 4888877643 468999999999999999999999999999999
Q ss_pred CccEEee-cC-cEEEEecccchhcccCCcc--ccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHH
Q 003052 628 PANFLLV-KG-SLKLIDFGIAKAIMSDTTN--IQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQM 703 (853)
Q Consensus 628 PeNILL~-~g-~VKL~DFGlAk~~~~~~~~--~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyEL 703 (853)
|+||+++ ++ .+||+|||++......... .......|+..|+|||.+.+.. ++.++|+|||||++|+|
T Consensus 131 ~~nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~---------~~~~~Dv~slG~~l~~l 201 (268)
T cd06630 131 GANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQ---------YGRSCDVWSVGCVIIEM 201 (268)
T ss_pred HHHEEEcCCCCEEEEcccccccccccccccCCccccccccccceeCHhHhccCC---------CCcccchHHHHHHHHHH
Confidence 9999994 44 6999999999876532111 1122457899999999986543 46799999999999999
Q ss_pred HhCCCCCCcchh---HHHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCCChhHHhcCCCCC
Q 003052 704 VYGRTPFSEYKT---FWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQHPFLV 768 (853)
Q Consensus 704 LtG~~PF~~~~~---~~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~HPwf~ 768 (853)
++|..||..... ....... .........+...++.+.++|.+||..||.+||++.++++||||.
T Consensus 202 ~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~~~~~~ 268 (268)
T cd06630 202 ATAKPPWNAEKHSNHLALIFKI-ASATTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLKHPVFR 268 (268)
T ss_pred HhCCCCCCCCCCcchHHHHHHH-hccCCCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhcCcccC
Confidence 999999964321 1111111 111222334456778899999999999999999999999999984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=327.93 Aligned_cols=252 Identities=28% Similarity=0.458 Sum_probs=204.1
Q ss_pred eeeEEEeEeccCceEEEEEEec-CCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHHHHh
Q 003052 473 LYQRLGKIGSGGSSEVHKVISS-DCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLREVL 551 (853)
Q Consensus 473 ~Y~ilk~LG~G~FG~Vyka~~~-~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~~l~ 551 (853)
+|++.+.||.|+||.||+|.+. ++..||+|.+..... ......+.+|+.+++.++ |+||++++++
T Consensus 2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~e~~~l~~l~-h~~i~~~~~~------------ 67 (274)
T cd06609 2 LFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEA-EDEIEDIQQEIQFLSQCR-SPYITKYYGS------------ 67 (274)
T ss_pred hhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeecccc-chHHHHHHHHHHHHHHcC-CCCeeeeeEE------------
Confidence 5888999999999999999984 678999999976532 233456789999999998 8999999876
Q ss_pred hCCCCCCCCccccCCeEEEEEecch-hhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCCCcc
Q 003052 552 NGSMNNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPAN 630 (853)
Q Consensus 552 ~~~iv~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLKPeN 630 (853)
+.++..+|+|+||+. ++|.+++.. ..+++..++.++.||+.||.|||++||+||||+|+|
T Consensus 68 ----------~~~~~~~~~v~e~~~~~~L~~~~~~---------~~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~n 128 (274)
T cd06609 68 ----------FLKGSKLWIIMEYCGGGSCLDLLKP---------GKLDETYIAFILREVLLGLEYLHEEGKIHRDIKAAN 128 (274)
T ss_pred ----------EEECCeEEEEEEeeCCCcHHHHHhh---------cCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHH
Confidence 445678999999976 488877753 278999999999999999999999999999999999
Q ss_pred EEe-ecCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHhCCCC
Q 003052 631 FLL-VKGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGRTP 709 (853)
Q Consensus 631 ILL-~~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLtG~~P 709 (853)
|++ .++.++|+|||+++.+..... ......|++.|+|||.+.+.. ++.++|||||||++|+|++|+.|
T Consensus 129 i~i~~~~~~~l~d~g~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~---------~~~~sDv~slG~il~~l~tg~~p 197 (274)
T cd06609 129 ILLSEEGDVKLADFGVSGQLTSTMS--KRNTFVGTPFWMAPEVIKQSG---------YDEKADIWSLGITAIELAKGEPP 197 (274)
T ss_pred EEECCCCCEEEcccccceeeccccc--ccccccCCccccChhhhccCC---------CCchhhHHHHHHHHHHHHhCCCC
Confidence 999 567999999999987654321 223567899999999997653 56899999999999999999999
Q ss_pred CCcchhHHHHHHhhcCCCCcccCCCC-CChhHHHHHHHhcccCCCCCCChhHHhcCCCCCCC
Q 003052 710 FSEYKTFWAKFKVITDPNHEITYEPV-PNPWLLDLMKKCLAWDRNERWRIPQLLQHPFLVPP 770 (853)
Q Consensus 710 F~~~~~~~~~~kii~~~~~~~~~~~~-~s~~l~dLI~kcL~~DP~kRpTa~EIL~HPwf~~~ 770 (853)
|...........+... ........ .+..+.++|.+||..||.+||++.++++||||...
T Consensus 198 ~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~~~~~~~ 257 (274)
T cd06609 198 LSDLHPMRVLFLIPKN--NPPSLEGNKFSKPFKDFVSLCLNKDPKERPSAKELLKHKFIKKA 257 (274)
T ss_pred cccCchHHHHHHhhhc--CCCCCcccccCHHHHHHHHHHhhCChhhCcCHHHHhhChhhcCC
Confidence 9765543333222221 11122222 67789999999999999999999999999999753
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=340.02 Aligned_cols=271 Identities=26% Similarity=0.427 Sum_probs=205.1
Q ss_pred CceeeEEEeEeccCceEEEEEEe-cCCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHHH
Q 003052 471 GKLYQRLGKIGSGGSSEVHKVIS-SDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLRE 549 (853)
Q Consensus 471 g~~Y~ilk~LG~G~FG~Vyka~~-~~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~~ 549 (853)
+.+|.+.+.||.|+||.||+|.+ .+++.||+|++..... .....+.+|++++++++ |+||+++++++....
T Consensus 4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~--~~~~~~~~Ei~~l~~l~-h~~i~~~~~~~~~~~----- 75 (342)
T cd07854 4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDP--QSVKHALREIKIIRRLD-HDNIVKVYEVLGPSG----- 75 (342)
T ss_pred CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCC--chHHHHHHHHHHHHhcC-CCcchhhHhhhcccc-----
Confidence 46799999999999999999998 4678999999976543 33456789999999996 899999987643221
Q ss_pred HhhCCCCCCCCccccCCeEEEEEecchhhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCCCc
Q 003052 550 VLNGSMNNKDGRVKDDGYIYMVLEYGEIDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPA 629 (853)
Q Consensus 550 l~~~~iv~~~g~~~d~~~lyLVmEy~~gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLKPe 629 (853)
.......+.+.+...+|+||||++++|.+.+.. ..+++..++.++.||+.||.|||++||+||||||+
T Consensus 76 ---~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~---------~~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~ 143 (342)
T cd07854 76 ---SDLTEDVGSLTELNSVYIVQEYMETDLANVLEQ---------GPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPA 143 (342)
T ss_pred ---cccccccccccccceEEEEeecccccHHHHHHc---------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHH
Confidence 111112233556668999999998888776642 36899999999999999999999999999999999
Q ss_pred cEEee--cCcEEEEecccchhcccCCccc-cccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHhC
Q 003052 630 NFLLV--KGSLKLIDFGIAKAIMSDTTNI-QRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYG 706 (853)
Q Consensus 630 NILL~--~g~VKL~DFGlAk~~~~~~~~~-~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLtG 706 (853)
||+++ ++.+||+|||+++......... ......|+..|+|||++.+.. .++.++|||||||++|+|++|
T Consensus 144 Nili~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--------~~~~~~DiwSlGvil~el~~g 215 (342)
T cd07854 144 NVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPN--------NYTKAIDMWAAGCIFAEMLTG 215 (342)
T ss_pred HEEEcCCCceEEECCcccceecCCccccccccccccccccccCHHHHhCcc--------ccCchhhHHHHHHHHHHHHhC
Confidence 99995 3478999999997653221111 112346899999999875432 356799999999999999999
Q ss_pred CCCCCcchhHHHHHHhhcCCC----------------------Cc-----ccCCCCCChhHHHHHHHhcccCCCCCCChh
Q 003052 707 RTPFSEYKTFWAKFKVITDPN----------------------HE-----ITYEPVPNPWLLDLMKKCLAWDRNERWRIP 759 (853)
Q Consensus 707 ~~PF~~~~~~~~~~kii~~~~----------------------~~-----~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~ 759 (853)
+.||............+.... .. .......+.++.+||.+||..||.+|||+.
T Consensus 216 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ 295 (342)
T cd07854 216 KPLFAGAHELEQMQLILESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAE 295 (342)
T ss_pred CCCCCCCCHHHHHHHHHHhcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHH
Confidence 999976544333222211100 00 001234567899999999999999999999
Q ss_pred HHhcCCCCCC
Q 003052 760 QLLQHPFLVP 769 (853)
Q Consensus 760 EIL~HPwf~~ 769 (853)
++|.||||+.
T Consensus 296 ell~h~~~~~ 305 (342)
T cd07854 296 EALMHPYMSC 305 (342)
T ss_pred HHhCCCcccc
Confidence 9999999974
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-37 Score=316.21 Aligned_cols=255 Identities=33% Similarity=0.475 Sum_probs=208.2
Q ss_pred eeeEEEeEeccCceEEEEEEec-CCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHHHHh
Q 003052 473 LYQRLGKIGSGGSSEVHKVISS-DCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLREVL 551 (853)
Q Consensus 473 ~Y~ilk~LG~G~FG~Vyka~~~-~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~~l~ 551 (853)
+|++.+.||+|+||.||+|.+. +++.|++|++............+.+|+.+++++. |+||++++++.
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~----------- 68 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQ-HPNIVRYYGSE----------- 68 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcC-CCCEeeEEEEE-----------
Confidence 3788899999999999999985 6789999999876554455667889999999998 89999998863
Q ss_pred hCCCCCCCCccccC--CeEEEEEecc-hhhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCCC
Q 003052 552 NGSMNNKDGRVKDD--GYIYMVLEYG-EIDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKP 628 (853)
Q Consensus 552 ~~~iv~~~g~~~d~--~~lyLVmEy~-~gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLKP 628 (853)
.+. ..+|+||||+ +++|.+++... ..+++..++.++.|++.||.|||++|++|+||+|
T Consensus 69 -----------~~~~~~~~~lv~e~~~~~~L~~~~~~~--------~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p 129 (260)
T cd06606 69 -----------RDEEKNTLNIFLEYVSGGSLSSLLKKF--------GKLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKG 129 (260)
T ss_pred -----------ecCCCCeEEEEEEecCCCcHHHHHHHc--------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCH
Confidence 233 6889999998 56888887653 3799999999999999999999999999999999
Q ss_pred ccEEee-cCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHhCC
Q 003052 629 ANFLLV-KGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGR 707 (853)
Q Consensus 629 eNILL~-~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLtG~ 707 (853)
+||++. ++.+||+|||++................++..|+|||.+.+.. ++.++|||||||++|+|++|.
T Consensus 130 ~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~---------~~~~~Dv~slG~il~~l~~g~ 200 (260)
T cd06606 130 ANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGEE---------YGRAADIWSLGCTVIEMATGK 200 (260)
T ss_pred HHEEEcCCCCEEEcccccEEecccccccccccCCCCCccccCHhhhcCCC---------CCchhhHHHHHHHHHHHHhCC
Confidence 999995 5799999999998775443211123567899999999986653 467999999999999999999
Q ss_pred CCCCcchhHHHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCCChhHHhcCCCC
Q 003052 708 TPFSEYKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQHPFL 767 (853)
Q Consensus 708 ~PF~~~~~~~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~HPwf 767 (853)
.||............+.........+...+..+.+||.+||..||.+||++.++++||||
T Consensus 201 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~~~~ 260 (260)
T cd06606 201 PPWSELGNPMAALYKIGSSGEPPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQHPFL 260 (260)
T ss_pred CCCCCCCchHHHHHhccccCCCcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhhCCCC
Confidence 999776533222222222223334455668889999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=325.81 Aligned_cols=254 Identities=30% Similarity=0.474 Sum_probs=203.6
Q ss_pred eeeEEEeEeccCceEEEEEEec-CCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHHHHh
Q 003052 473 LYQRLGKIGSGGSSEVHKVISS-DCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLREVL 551 (853)
Q Consensus 473 ~Y~ilk~LG~G~FG~Vyka~~~-~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~~l~ 551 (853)
.|++.+.||.|+||.||+|.+. +++.+|+|.+...... .....+.+|+++++++. |+||++++++
T Consensus 2 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~e~~~l~~~~-~~~i~~~~~~------------ 67 (265)
T cd06605 2 DLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINE-AIQKQILRELDILHKCN-SPYIVGFYGA------------ 67 (265)
T ss_pred cchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccCh-HHHHHHHHHHHHHHHCC-CCchhhhhee------------
Confidence 4788889999999999999985 6789999999765433 44566889999999998 9999998775
Q ss_pred hCCCCCCCCccccCCeEEEEEecch-hhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhccc-CceeeCCCCCc
Q 003052 552 NGSMNNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHE-ERIVHSDLKPA 629 (853)
Q Consensus 552 ~~~iv~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs-~gIIHRDLKPe 629 (853)
+...+.+|+||||++ ++|.+++... ...+++..+..++.||+.||.|||+ .||+||||||+
T Consensus 68 ----------~~~~~~~~lv~e~~~~~~L~~~~~~~-------~~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ 130 (265)
T cd06605 68 ----------FYNNGDISICMEYMDGGSLDKILKEV-------QGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPS 130 (265)
T ss_pred ----------eecCCEEEEEEEecCCCcHHHHHHHc-------cCCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHH
Confidence 345578999999987 6888887653 1578999999999999999999999 99999999999
Q ss_pred cEEee-cCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHhCCC
Q 003052 630 NFLLV-KGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGRT 708 (853)
Q Consensus 630 NILL~-~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLtG~~ 708 (853)
||+++ ++.+||+|||++........ ....|+..|+|||.+.+. .++.++|||||||++|+|++|..
T Consensus 131 ni~~~~~~~~~l~d~g~~~~~~~~~~----~~~~~~~~y~~PE~~~~~---------~~~~~~Dv~slG~~l~~l~~g~~ 197 (265)
T cd06605 131 NILVNSRGQIKLCDFGVSGQLVNSLA----KTFVGTSSYMAPERIQGN---------DYSVKSDIWSLGLSLIELATGRF 197 (265)
T ss_pred HEEECCCCCEEEeecccchhhHHHHh----hcccCChhccCHHHHcCC---------CCCchhhHHHHHHHHHHHHhCCC
Confidence 99994 67899999999976643221 126789999999998665 35679999999999999999999
Q ss_pred CCCcc----hhHHHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCCChhHHhcCCCCCCC
Q 003052 709 PFSEY----KTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQHPFLVPP 770 (853)
Q Consensus 709 PF~~~----~~~~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~HPwf~~~ 770 (853)
||... .........+.............+..+.+||.+||..||.+|||+.+++.||||+..
T Consensus 198 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~~~~ 263 (265)
T cd06605 198 PYPPENDPPDGIFELLQYIVNEPPPRLPSGKFSPDFQDFVNLCLIKDPRERPSYKELLEHPFIKKY 263 (265)
T ss_pred CCCccccccccHHHHHHHHhcCCCCCCChhhcCHHHHHHHHHHcCCCchhCcCHHHHhhCchhhcc
Confidence 99654 222223332222221111112267889999999999999999999999999999754
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-37 Score=321.69 Aligned_cols=256 Identities=27% Similarity=0.391 Sum_probs=201.6
Q ss_pred eeeEEEeEeccCceEEEEEEe-cCCcEEEEEEEecCCC---ChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHH
Q 003052 473 LYQRLGKIGSGGSSEVHKVIS-SDCTIYALKKIKLKGR---DYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLR 548 (853)
Q Consensus 473 ~Y~ilk~LG~G~FG~Vyka~~-~~g~~vAVKkik~~~~---~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~ 548 (853)
.|++.+.||+|+||.||++.+ .++..||||++..... .......+.+|+.+++++. |+||+++++++..
T Consensus 3 ~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~------ 75 (265)
T cd06652 3 NWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLL-HERIVQYYGCLRD------ 75 (265)
T ss_pred cceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcC-CCCeeeEEeEecc------
Confidence 488999999999999999998 4678999999865432 2234557889999999996 8999999886321
Q ss_pred HHhhCCCCCCCCccccCCeEEEEEecch-hhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCC
Q 003052 549 EVLNGSMNNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLK 627 (853)
Q Consensus 549 ~l~~~~iv~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLK 627 (853)
.....+|+||||+. ++|.+++... ..+++..++.++.||+.||.|||++||+|+|||
T Consensus 76 --------------~~~~~~~~v~e~~~~~~L~~~l~~~--------~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~ 133 (265)
T cd06652 76 --------------PMERTLSIFMEHMPGGSIKDQLKSY--------GALTENVTRKYTRQILEGVSYLHSNMIVHRDIK 133 (265)
T ss_pred --------------CCCceEEEEEEecCCCcHHHHHHHc--------CCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCC
Confidence 12356899999975 5888877643 458999999999999999999999999999999
Q ss_pred CccEEe-ecCcEEEEecccchhcccCCcc-ccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHh
Q 003052 628 PANFLL-VKGSLKLIDFGIAKAIMSDTTN-IQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVY 705 (853)
Q Consensus 628 PeNILL-~~g~VKL~DFGlAk~~~~~~~~-~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLt 705 (853)
|+|||+ .++.+||+|||+++........ .......|+..|+|||++.+. .++.++|||||||++|+|++
T Consensus 134 p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~---------~~~~~~Dv~slG~il~el~~ 204 (265)
T cd06652 134 GANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVISGE---------GYGRKADIWSVGCTVVEMLT 204 (265)
T ss_pred HHHEEecCCCCEEECcCccccccccccccccccccCCCCccccChhhhcCC---------CCCcchhHHHHHHHHHHHhh
Confidence 999999 4679999999999865321111 112245799999999998654 24679999999999999999
Q ss_pred CCCCCCcchhHHHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCCChhHHhcCCCCC
Q 003052 706 GRTPFSEYKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQHPFLV 768 (853)
Q Consensus 706 G~~PF~~~~~~~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~HPwf~ 768 (853)
|+.||.+.............+ .....+...+..+.++|.+||. +|.+||++++|++|||+.
T Consensus 205 g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~~~~~ 265 (265)
T cd06652 205 EKPPWAEFEAMAAIFKIATQP-TNPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLRHTFVH 265 (265)
T ss_pred CCCCCCccchHHHHHHHhcCC-CCCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhcCcccC
Confidence 999998765554444433322 2223344567789999999995 999999999999999983
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-37 Score=319.66 Aligned_cols=258 Identities=33% Similarity=0.531 Sum_probs=205.1
Q ss_pred eeeEEEeEeccCceEEEEEEe-cCCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHHHHh
Q 003052 473 LYQRLGKIGSGGSSEVHKVIS-SDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLREVL 551 (853)
Q Consensus 473 ~Y~ilk~LG~G~FG~Vyka~~-~~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~~l~ 551 (853)
+|.+.+.||+|+||.||+|.+ .+++.||+|.++...........+.+|+.++++++ |+||++++++
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~-~~~i~~~~~~------------ 67 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLK-HPNLVKYYGV------------ 67 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCC-CCChhheeee------------
Confidence 488999999999999999987 46789999999876555456677899999999997 8999998875
Q ss_pred hCCCCCCCCccccCCeEEEEEecch-hhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCCCcc
Q 003052 552 NGSMNNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPAN 630 (853)
Q Consensus 552 ~~~iv~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLKPeN 630 (853)
+.+...+++|+||+. ++|.+++... ..+++..++.++.||+.||.|||++||+|+||||+|
T Consensus 68 ----------~~~~~~~~lv~e~~~~~~L~~~~~~~--------~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~n 129 (264)
T cd06626 68 ----------EVHREKVYIFMEYCSGGTLEELLEHG--------RILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPAN 129 (264)
T ss_pred ----------EecCCEEEEEEecCCCCcHHHHHhhc--------CCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHH
Confidence 345668999999976 5888877542 458899999999999999999999999999999999
Q ss_pred EEe-ecCcEEEEecccchhcccCCcccc--ccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHhCC
Q 003052 631 FLL-VKGSLKLIDFGIAKAIMSDTTNIQ--RDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGR 707 (853)
Q Consensus 631 ILL-~~g~VKL~DFGlAk~~~~~~~~~~--~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLtG~ 707 (853)
|++ .++.+||+|||++........... .....+++.|+|||++.+... ..++.++|||||||++|+|++|+
T Consensus 130 il~~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~------~~~~~~~Dv~s~G~il~~l~~g~ 203 (264)
T cd06626 130 IFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKG------KGHGRAADIWSLGCVVLEMATGK 203 (264)
T ss_pred EEECCCCCEEEcccccccccCCCCCcccccccCCcCCcCccChhhccCCCC------CCCCcccchHHHHHHHHHHHhCC
Confidence 999 567899999999987654322111 124578999999999976531 13568999999999999999999
Q ss_pred CCCCcchhHHHHH-HhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCCChhHHhcCCCC
Q 003052 708 TPFSEYKTFWAKF-KVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQHPFL 767 (853)
Q Consensus 708 ~PF~~~~~~~~~~-kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~HPwf 767 (853)
.||......+... .+.......+......++.+.+||.+||..||.+||++.+++.|||+
T Consensus 204 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~~~~~ 264 (264)
T cd06626 204 RPWSELDNEFQIMFHVGAGHKPPIPDSLQLSPEGKDFLDRCLESDPKKRPTASELLQHPFV 264 (264)
T ss_pred CCccCCcchHHHHHHHhcCCCCCCCcccccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence 9997653333222 22222222222223347889999999999999999999999999997
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-39 Score=352.92 Aligned_cols=251 Identities=27% Similarity=0.365 Sum_probs=210.6
Q ss_pred EeEeccCceEEEEEEe-cCCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHHHHhhCCCC
Q 003052 478 GKIGSGGSSEVHKVIS-SDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLREVLNGSMN 556 (853)
Q Consensus 478 k~LG~G~FG~Vyka~~-~~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~~l~~~~iv 556 (853)
+.||+|.||+||-|++ ++|+.||||+|.+-.........+++|+.||+++. ||.||.|--.
T Consensus 570 evLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~-HPGiV~le~M----------------- 631 (888)
T KOG4236|consen 570 EVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLH-HPGIVNLECM----------------- 631 (888)
T ss_pred hhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcC-CCCeeEEEEe-----------------
Confidence 4699999999999998 68899999999876555455567889999999998 8999988654
Q ss_pred CCCCccccCCeEEEEEecchhhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCCCccEEeecC
Q 003052 557 NKDGRVKDDGYIYMVLEYGEIDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLLVKG 636 (853)
Q Consensus 557 ~~~g~~~d~~~lyLVmEy~~gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLKPeNILL~~g 636 (853)
|+....+|+|||.+.||+.++|... ..+.|+|...++++.||+.||.|||.+||+|+||||+||||.+.
T Consensus 632 -----~ET~ervFVVMEKl~GDMLEMILSs------EkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~ 700 (888)
T KOG4236|consen 632 -----FETPERVFVVMEKLHGDMLEMILSS------EKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASA 700 (888)
T ss_pred -----ecCCceEEEEehhhcchHHHHHHHh------hcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccC
Confidence 6777889999999999999998765 34789999999999999999999999999999999999999542
Q ss_pred ----cEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHhCCCCCCc
Q 003052 637 ----SLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGRTPFSE 712 (853)
Q Consensus 637 ----~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLtG~~PF~~ 712 (853)
.+||||||+|+.+.+.. .+.+.+|||.|+|||+++.+. |.+.-|+||.|||+|--|.|..||.+
T Consensus 701 ~~FPQvKlCDFGfARiIgEks---FRrsVVGTPAYLaPEVLrnkG---------yNrSLDMWSVGVIiYVsLSGTFPFNE 768 (888)
T KOG4236|consen 701 SPFPQVKLCDFGFARIIGEKS---FRRSVVGTPAYLAPEVLRNKG---------YNRSLDMWSVGVIIYVSLSGTFPFNE 768 (888)
T ss_pred CCCCceeeccccceeecchhh---hhhhhcCCccccCHHHHhhcc---------ccccccceeeeEEEEEEecccccCCC
Confidence 79999999999886532 455889999999999998775 55789999999999999999999987
Q ss_pred chhHHHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCCChhHHhcCCCCCCC
Q 003052 713 YKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQHPFLVPP 770 (853)
Q Consensus 713 ~~~~~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~HPwf~~~ 770 (853)
.+.+...+...... .+.......++.+.|||..+|++.-.+|.++...|.|||++..
T Consensus 769 dEdIndQIQNAaFM-yPp~PW~eis~~AidlIn~LLqVkm~kRysvdk~lsh~Wlq~y 825 (888)
T KOG4236|consen 769 DEDINDQIQNAAFM-YPPNPWSEISPEAIDLINNLLQVKMRKRYSVDKSLSHPWLQDY 825 (888)
T ss_pred ccchhHHhhccccc-cCCCchhhcCHHHHHHHHHHHHHHHHHhcchHhhccchhhhcc
Confidence 66654443322111 1111223467889999999999999999999999999999754
|
|
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=323.08 Aligned_cols=250 Identities=26% Similarity=0.395 Sum_probs=203.9
Q ss_pred eeeEEEeEeccCceEEEEEEec-CCcEEEEEEEecCCCC-hhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHHHH
Q 003052 473 LYQRLGKIGSGGSSEVHKVISS-DCTIYALKKIKLKGRD-YATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLREV 550 (853)
Q Consensus 473 ~Y~ilk~LG~G~FG~Vyka~~~-~g~~vAVKkik~~~~~-~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~~l 550 (853)
.|++.+.||.|+||.||+|.+. ++..||+|++...... ......+.+|++++++++ |+||++++++
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~----------- 68 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELN-HPFLVNLWYS----------- 68 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCC-CCChHHHHHh-----------
Confidence 3889999999999999999985 6789999999765432 244567889999999997 8999988765
Q ss_pred hhCCCCCCCCccccCCeEEEEEecch-hhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCCCc
Q 003052 551 LNGSMNNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPA 629 (853)
Q Consensus 551 ~~~~iv~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLKPe 629 (853)
+.+...+|+||||+. ++|...+... ..+++..+..++.||+.||.|||++||+|+||||+
T Consensus 69 -----------~~~~~~~~lv~e~~~~~~L~~~l~~~--------~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ 129 (258)
T cd05578 69 -----------FQDEENMYLVVDLLLGGDLRYHLSQK--------VKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPD 129 (258)
T ss_pred -----------hcCCCeEEEEEeCCCCCCHHHHHHhc--------CCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHH
Confidence 456678999999975 5888777543 47899999999999999999999999999999999
Q ss_pred cEEe-ecCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHhCCC
Q 003052 630 NFLL-VKGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGRT 708 (853)
Q Consensus 630 NILL-~~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLtG~~ 708 (853)
||++ .++.++|+|||++....... ......|+..|+|||++.... ++.++|+|||||++|+|++|..
T Consensus 130 nil~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~~y~~PE~~~~~~---------~~~~~Di~slG~~l~~l~~g~~ 197 (258)
T cd05578 130 NILLDEQGHVHITDFNIATKVTPDT---LTTSTSGTPGYMAPEVLCRQG---------YSVAVDWWSLGVTAYECLRGKR 197 (258)
T ss_pred HeEEcCCCCEEEeecccccccCCCc---cccccCCChhhcCHHHHcccC---------CCCcccchhhHHHHHHHHhCCC
Confidence 9999 56799999999998764432 123567899999999987543 5679999999999999999999
Q ss_pred CCCcchh--HHHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCh--hHHhcCCCC
Q 003052 709 PFSEYKT--FWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRI--PQLLQHPFL 767 (853)
Q Consensus 709 PF~~~~~--~~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa--~EIL~HPwf 767 (853)
||..... .......... .....+...+..+.++|.+||..||.+||++ .|+++||||
T Consensus 198 p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~~~~~~ 258 (258)
T cd05578 198 PYRGHSRTIRDQIRAKQET--ADVLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLKNHPYF 258 (258)
T ss_pred CCCCCCccHHHHHHHHhcc--ccccCcccCcHHHHHHHHHHccCChhHcCCccHHHHhcCCCC
Confidence 9976442 2222222221 2334455677889999999999999999999 999999998
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=343.53 Aligned_cols=254 Identities=24% Similarity=0.340 Sum_probs=204.0
Q ss_pred CceeeEEEeEeccCceEEEEEEecC-CcEEEEEEEecCCCC-hhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHH
Q 003052 471 GKLYQRLGKIGSGGSSEVHKVISSD-CTIYALKKIKLKGRD-YATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLR 548 (853)
Q Consensus 471 g~~Y~ilk~LG~G~FG~Vyka~~~~-g~~vAVKkik~~~~~-~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~ 548 (853)
..+|.++..||+|+||+|.++..+. ...||||+++++-.- ....+--+.|-++|......
T Consensus 348 ~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kp------------------ 409 (683)
T KOG0696|consen 348 ATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKP------------------ 409 (683)
T ss_pred ecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCC------------------
Confidence 3458899999999999999998754 478999999864210 00111112233333322222
Q ss_pred HHhhCCCCCCCCccccCCeEEEEEecch-hhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCC
Q 003052 549 EVLNGSMNNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLK 627 (853)
Q Consensus 549 ~l~~~~iv~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLK 627 (853)
+.++.+|.+|+.-+++|+||||+. |||.-.|++. +.+.|..+.+|+.+|+-||-|||++|||+||||
T Consensus 410 ----pFL~qlHScFQTmDRLyFVMEyvnGGDLMyhiQQ~--------GkFKEp~AvFYAaEiaigLFFLh~kgIiYRDLK 477 (683)
T KOG0696|consen 410 ----PFLVQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQV--------GKFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLK 477 (683)
T ss_pred ----chHHHHHHHhhhhhheeeEEEEecCchhhhHHHHh--------cccCCchhhhhhHHHHHHhhhhhcCCeeeeecc
Confidence 335666778899999999999954 6999888876 679999999999999999999999999999999
Q ss_pred CccEEe-ecCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHhC
Q 003052 628 PANFLL-VKGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYG 706 (853)
Q Consensus 628 PeNILL-~~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLtG 706 (853)
.+|||| .+|+|||+|||+|+.-.-+.. ...++||||.|+|||++... .|+..+||||+||+|||||.|
T Consensus 478 LDNvmLd~eGHiKi~DFGmcKEni~~~~--TTkTFCGTPdYiAPEIi~Yq---------PYgksvDWWa~GVLLyEmlaG 546 (683)
T KOG0696|consen 478 LDNVMLDSEGHIKIADFGMCKENIFDGV--TTKTFCGTPDYIAPEIIAYQ---------PYGKSVDWWAFGVLLYEMLAG 546 (683)
T ss_pred ccceEeccCCceEeeecccccccccCCc--ceeeecCCCcccccceEEec---------ccccchhHHHHHHHHHHHHcC
Confidence 999999 689999999999997554332 34589999999999999765 478899999999999999999
Q ss_pred CCCCCcchhHHHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCCC-----hhHHhcCCCCC
Q 003052 707 RTPFSEYKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWR-----IPQLLQHPFLV 768 (853)
Q Consensus 707 ~~PF~~~~~~~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpT-----a~EIL~HPwf~ 768 (853)
++||++.+.. +.+..|.+ ....|+...+.++.++++.+|.+.|.+|.. -.+|-.||||.
T Consensus 547 QpPFdGeDE~-elF~aI~e--hnvsyPKslSkEAv~ickg~ltK~P~kRLGcg~~ge~di~~H~FFR 610 (683)
T KOG0696|consen 547 QPPFDGEDED-ELFQAIME--HNVSYPKSLSKEAVAICKGLLTKHPGKRLGCGPEGERDIREHPFFR 610 (683)
T ss_pred CCCCCCCCHH-HHHHHHHH--ccCcCcccccHHHHHHHHHHhhcCCccccCCCCccccchhhCcchh
Confidence 9999886554 45555553 556788899999999999999999999985 47899999995
|
|
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-38 Score=363.86 Aligned_cols=263 Identities=21% Similarity=0.256 Sum_probs=189.4
Q ss_pred ceeeEEEeEeccCceEEEEEEec--CCcEEEEEEE--------------ecC-CCChhhHhhHHHHHHHHHHhcCCCcee
Q 003052 472 KLYQRLGKIGSGGSSEVHKVISS--DCTIYALKKI--------------KLK-GRDYATAYGFCQEIEYLNKLKGKNNII 534 (853)
Q Consensus 472 ~~Y~ilk~LG~G~FG~Vyka~~~--~g~~vAVKki--------------k~~-~~~~~~~~~~l~EI~iLkkL~~hpNIV 534 (853)
..|+++++||+|+||+||+|..+ ++..+++|.+ .+. .........+.+|+.+|++++ |+||+
T Consensus 148 ~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~-HpnIv 226 (501)
T PHA03210 148 AHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLN-HENIL 226 (501)
T ss_pred hccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCC-CCCcC
Confidence 56999999999999999998753 2222222211 110 111223345789999999997 89999
Q ss_pred EeeehhhhHHHHHHHHhhCCCCCCCCccccCCeEEEEEecchhhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhh
Q 003052 535 QLIDYEVTEKALLREVLNGSMNNKDGRVKDDGYIYMVLEYGEIDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVN 614 (853)
Q Consensus 535 ~Lid~~~~e~~iL~~l~~~~iv~~~g~~~d~~~lyLVmEy~~gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~ 614 (853)
+++++ +.+....|+|||+++++|..++...... .........++.|+.||+.||.
T Consensus 227 ~l~~~----------------------~~~~~~~~lv~e~~~~~l~~~l~~~~~~---~~~~~~~~~~~~i~~ql~~aL~ 281 (501)
T PHA03210 227 KIEEI----------------------LRSEANTYMITQKYDFDLYSFMYDEAFD---WKDRPLLKQTRAIMKQLLCAVE 281 (501)
T ss_pred cEeEE----------------------EEECCeeEEEEeccccCHHHHHhhcccc---ccccccHHHHHHHHHHHHHHHH
Confidence 99887 4566788999999988888877543211 1233456778899999999999
Q ss_pred hcccCceeeCCCCCccEEe-ecCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccch
Q 003052 615 TIHEERIVHSDLKPANFLL-VKGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDI 693 (853)
Q Consensus 615 yLHs~gIIHRDLKPeNILL-~~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDI 693 (853)
|||++|||||||||+|||| .++.+||+|||+++.+...... .....+||+.|+|||++.+.. |+.++||
T Consensus 282 yLH~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~---------~~~~~Di 351 (501)
T PHA03210 282 YIHDKKLIHRDIKLENIFLNCDGKIVLGDFGTAMPFEKEREA-FDYGWVGTVATNSPEILAGDG---------YCEITDI 351 (501)
T ss_pred HHHhCCeecCCCCHHHEEECCCCCEEEEeCCCceecCccccc-ccccccCCcCCCCchhhcCCC---------CCcHHHH
Confidence 9999999999999999999 5679999999999876443221 223568999999999997653 5679999
Q ss_pred hhhHHHHHHHHhCCCC-CCcc--hhHHHHHHhhc---CCCCcc--------------------------cCCCCCChhHH
Q 003052 694 WSLGCILYQMVYGRTP-FSEY--KTFWAKFKVIT---DPNHEI--------------------------TYEPVPNPWLL 741 (853)
Q Consensus 694 WSLGVILyELLtG~~P-F~~~--~~~~~~~kii~---~~~~~~--------------------------~~~~~~s~~l~ 741 (853)
|||||+||||++|..+ |... .......+++. .....+ ......+.++.
T Consensus 352 wSlGvil~ell~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~ 431 (501)
T PHA03210 352 WSCGLILLDMLSHDFCPIGDGGGKPGKQLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFE 431 (501)
T ss_pred HHHHHHHHHHHHCCCCCccCCCCCHHHHHHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHH
Confidence 9999999999998764 4221 11111111111 000000 00112455688
Q ss_pred HHHHHhcccCCCCCCChhHHhcCCCCCCC
Q 003052 742 DLMKKCLAWDRNERWRIPQLLQHPFLVPP 770 (853)
Q Consensus 742 dLI~kcL~~DP~kRpTa~EIL~HPwf~~~ 770 (853)
++|.+||.+||.+|||+.|+|.||||...
T Consensus 432 ~li~kmL~~DP~~Rpsa~elL~hp~f~~~ 460 (501)
T PHA03210 432 YPLVKMLTFDWHLRPGAAELLALPLFSAE 460 (501)
T ss_pred HHHHHHhccCcccCcCHHHHhhChhhhcC
Confidence 89999999999999999999999999753
|
|
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-37 Score=319.62 Aligned_cols=252 Identities=30% Similarity=0.481 Sum_probs=204.0
Q ss_pred eeeEEEeEeccCceEEEEEEec-CCcEEEEEEEecCCCC---hhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHH
Q 003052 473 LYQRLGKIGSGGSSEVHKVISS-DCTIYALKKIKLKGRD---YATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLR 548 (853)
Q Consensus 473 ~Y~ilk~LG~G~FG~Vyka~~~-~g~~vAVKkik~~~~~---~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~ 548 (853)
+|+..+.||+|+||.||+|... ++..|++|.+...... ......+.+|+.++++++ |+||++++++
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~-h~~i~~~~~~--------- 70 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQ-HPNIVQYLGT--------- 70 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcC-CCCchheeee---------
Confidence 3677788999999999999985 7889999999764422 234456889999999996 8999999876
Q ss_pred HHhhCCCCCCCCccccCCeEEEEEecch-hhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCC
Q 003052 549 EVLNGSMNNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLK 627 (853)
Q Consensus 549 ~l~~~~iv~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLK 627 (853)
+.++..+|+||||+. ++|.+++... ..+++..++.++.||+.||.|||++||+|+|||
T Consensus 71 -------------~~~~~~~~lv~e~~~~~~L~~~~~~~--------~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~ 129 (258)
T cd06632 71 -------------EREEDNLYIFLELVPGGSLAKLLKKY--------GSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIK 129 (258)
T ss_pred -------------EecCCeEEEEEEecCCCcHHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCC
Confidence 445678999999976 4888877543 468999999999999999999999999999999
Q ss_pred CccEEe-ecCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHhC
Q 003052 628 PANFLL-VKGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYG 706 (853)
Q Consensus 628 PeNILL-~~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLtG 706 (853)
|+||++ .++.+||+|||++....... ......|++.|+|||.+.... .++.++|+|||||++|+|++|
T Consensus 130 ~~ni~~~~~~~~kl~d~~~~~~~~~~~---~~~~~~~~~~y~~pe~~~~~~--------~~~~~~D~~slG~~l~~l~~g 198 (258)
T cd06632 130 GANILVDTNGVVKLADFGMAKQVVEFS---FAKSFKGSPYWMAPEVIAQQG--------GYGLAADIWSLGCTVLEMATG 198 (258)
T ss_pred HHHEEECCCCCEEEccCccceeccccc---cccccCCCcceeCHHHhcCCC--------CCCchhhhHHHHHHHHHHHhC
Confidence 999999 56799999999998754322 123567999999999986432 256899999999999999999
Q ss_pred CCCCCcchhHHHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCCChhHHhcCCCC
Q 003052 707 RTPFSEYKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQHPFL 767 (853)
Q Consensus 707 ~~PF~~~~~~~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~HPwf 767 (853)
+.||............... ......+...++.+.+||.+||..||.+||++.++|.|||+
T Consensus 199 ~~pf~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~~~~ 258 (258)
T cd06632 199 KPPWSQLEGVAAVFKIGRS-KELPPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLEHPFV 258 (258)
T ss_pred CCCcccCcHHHHHHHHHhc-ccCCCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhcCCCC
Confidence 9999776544444333321 12223445678889999999999999999999999999997
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-38 Score=322.95 Aligned_cols=269 Identities=28% Similarity=0.396 Sum_probs=210.2
Q ss_pred eeEEcCceeeEEEeEeccCceEEEEEEe-cCCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHH
Q 003052 466 FFKVNGKLYQRLGKIGSGGSSEVHKVIS-SDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEK 544 (853)
Q Consensus 466 ~~~v~g~~Y~ilk~LG~G~FG~Vyka~~-~~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~ 544 (853)
...+++++|++.+.||+|||+.||++.. .++..||+|++.... .+.....++|++..++++ ||||++++++...+.
T Consensus 15 tv~In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~--~~~~e~~~rEid~~rkf~-s~~vl~l~dh~l~~~ 91 (302)
T KOG2345|consen 15 TVIINNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHS--QEDIEEALREIDNHRKFN-SPNVLRLVDHQLREE 91 (302)
T ss_pred cEEEcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccc--hHHHHHHHHHHHHHHhhC-CcchHHHHHHHHHhh
Confidence 4578999999999999999999999987 677899999998875 345567889999999999 699999999865432
Q ss_pred HHHHHHhhCCCCCCCCccccCCeEEEEEecch-hhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCc--e
Q 003052 545 ALLREVLNGSMNNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEER--I 621 (853)
Q Consensus 545 ~iL~~l~~~~iv~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~g--I 621 (853)
. ......||++.|.. |+|.+.+..... .+..++|.++..|+.+|++||++||+.. +
T Consensus 92 ~-----------------D~~~~~yll~Pyy~~Gsl~d~i~~~k~----kg~~~sE~~iL~if~gic~gL~~lH~~~~~y 150 (302)
T KOG2345|consen 92 K-----------------DGKHEAYLLLPYYKRGSLLDEIERLKI----KGNFVSEAQILWIFLGICRGLEALHEKEPPY 150 (302)
T ss_pred c-----------------cCceeEEEEeehhccccHHHHHHHHhh----cCCccCHHHHHHHHHHHHHHHHHHhccCCcc
Confidence 1 24457899999954 789998876422 3458999999999999999999999998 9
Q ss_pred eeCCCCCccEEee-cCcEEEEecccchhcccCCccc-------cccccccCccccCchhhccCCCCCCCccccCCCccch
Q 003052 622 VHSDLKPANFLLV-KGSLKLIDFGIAKAIMSDTTNI-------QRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDI 693 (853)
Q Consensus 622 IHRDLKPeNILL~-~g~VKL~DFGlAk~~~~~~~~~-------~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDI 693 (853)
.||||||.|||++ ++.++|.|||.++...-.-.+. .......|..|+|||++...... ..+.++||
T Consensus 151 AH~DiKP~NILls~~~~~vl~D~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~------ti~ertDI 224 (302)
T KOG2345|consen 151 AHRDIKPANILLSDSGLPVLMDLGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHC------TITERTDI 224 (302)
T ss_pred cccCCCcceeEecCCCceEEEeccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCc------ccccccch
Confidence 9999999999995 4899999999987543211110 01133578999999999776543 36789999
Q ss_pred hhhHHHHHHHHhCCCCCCcchhHHH-HHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCCChhHHhcC
Q 003052 694 WSLGCILYQMVYGRTPFSEYKTFWA-KFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQH 764 (853)
Q Consensus 694 WSLGVILyELLtG~~PF~~~~~~~~-~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~H 764 (853)
|||||+||+|++|..||......-. ....+..+...+......+..+.+||+.||++||.+||++.+++.+
T Consensus 225 WSLGCtLYa~mf~~sPfe~~~~~GgSlaLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~ 296 (302)
T KOG2345|consen 225 WSLGCTLYAMMFGESPFERIYQQGGSLALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSK 296 (302)
T ss_pred hhhhHHHHHHHHcCCcchHHhhcCCeEEEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHH
Confidence 9999999999999999953211000 0001122233344445578889999999999999999999999864
|
|
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-37 Score=331.48 Aligned_cols=256 Identities=23% Similarity=0.377 Sum_probs=206.6
Q ss_pred ceeeEEEeEeccCceEEEEEEec-CCcEEEEEEEecCCC-ChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHHH
Q 003052 472 KLYQRLGKIGSGGSSEVHKVISS-DCTIYALKKIKLKGR-DYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLRE 549 (853)
Q Consensus 472 ~~Y~ilk~LG~G~FG~Vyka~~~-~g~~vAVKkik~~~~-~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~~ 549 (853)
+.|.+.++||+|+||.||+|... +++.||+|++..... .......+.+|+++++.++ |+||++++++
T Consensus 15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~-h~niv~~~~~---------- 83 (307)
T cd06607 15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLR-HPNTIEYKGC---------- 83 (307)
T ss_pred hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCC-CCCEEEEEEE----------
Confidence 45899999999999999999884 678999999975433 3344556889999999997 8999999987
Q ss_pred HhhCCCCCCCCccccCCeEEEEEecchhhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCCCc
Q 003052 550 VLNGSMNNKDGRVKDDGYIYMVLEYGEIDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPA 629 (853)
Q Consensus 550 l~~~~iv~~~g~~~d~~~lyLVmEy~~gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLKPe 629 (853)
+.++...|+||||+.++|.+.+... ...+++..+..++.||+.||.|||+.||+||||+|+
T Consensus 84 ------------~~~~~~~~lv~e~~~g~l~~~~~~~-------~~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~ 144 (307)
T cd06607 84 ------------YLREHTAWLVMEYCLGSASDILEVH-------KKPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAG 144 (307)
T ss_pred ------------EEeCCeEEEEHHhhCCCHHHHHHHc-------ccCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcc
Confidence 4456678999999988887776543 246899999999999999999999999999999999
Q ss_pred cEEe-ecCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHhCCC
Q 003052 630 NFLL-VKGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGRT 708 (853)
Q Consensus 630 NILL-~~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLtG~~ 708 (853)
||++ .++.+||+|||++...... ....|++.|+|||++.+... ..++.++|||||||++|+|++|+.
T Consensus 145 nIl~~~~~~~kL~dfg~~~~~~~~------~~~~~~~~y~aPE~~~~~~~------~~~~~~sDv~s~G~il~el~tg~~ 212 (307)
T cd06607 145 NILLTEPGTVKLADFGSASLVSPA------NSFVGTPYWMAPEVILAMDE------GQYDGKVDVWSLGITCIELAERKP 212 (307)
T ss_pred cEEECCCCCEEEeecCcceecCCC------CCccCCccccCceeeeccCC------CCCCcccchHHHHHHHHHHHcCCC
Confidence 9999 5679999999998754321 24578999999998853211 136789999999999999999999
Q ss_pred CCCcchhHHHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCCChhHHhcCCCCCCC
Q 003052 709 PFSEYKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQHPFLVPP 770 (853)
Q Consensus 709 PF~~~~~~~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~HPwf~~~ 770 (853)
||.+.........+....... .....++..+.+||.+||..||.+||++.+|+.||||...
T Consensus 213 p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~ 273 (307)
T cd06607 213 PLFNMNAMSALYHIAQNDSPT-LSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHRFVLRE 273 (307)
T ss_pred CCCCccHHHHHHHHhcCCCCC-CCchhhCHHHHHHHHHHhcCChhhCcCHHHHhcChhhccc
Confidence 998766554444433322211 1223457789999999999999999999999999999764
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-37 Score=330.47 Aligned_cols=257 Identities=26% Similarity=0.351 Sum_probs=200.5
Q ss_pred eeeEEEeEeccCceEEEEEEec-CCcEEEEEEEecCCCC-hhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHHHH
Q 003052 473 LYQRLGKIGSGGSSEVHKVISS-DCTIYALKKIKLKGRD-YATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLREV 550 (853)
Q Consensus 473 ~Y~ilk~LG~G~FG~Vyka~~~-~g~~vAVKkik~~~~~-~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~~l 550 (853)
.|++++.||+|+||.||++.+. +++.||+|.+...... ......+.+|+++++.++ |+||+++++.
T Consensus 2 ~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~-~~~i~~~~~~----------- 69 (305)
T cd05609 2 DFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAE-NPFVVSMFCS----------- 69 (305)
T ss_pred CceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCC-CCCeeeeEEE-----------
Confidence 4899999999999999999984 5688999998765322 233456789999999987 8999999876
Q ss_pred hhCCCCCCCCccccCCeEEEEEecch-hhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCCCc
Q 003052 551 LNGSMNNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPA 629 (853)
Q Consensus 551 ~~~~iv~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLKPe 629 (853)
+..+.++|+||||++ ++|.+++... ..+++..++.++.|++.||.|||++||+||||||+
T Consensus 70 -----------~~~~~~~~lv~e~~~g~~L~~~l~~~--------~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ 130 (305)
T cd05609 70 -----------FETKRHLCMVMEYVEGGDCATLLKNI--------GALPVDMARMYFAETVLALEYLHNYGIVHRDLKPD 130 (305)
T ss_pred -----------EecCCEEEEEEecCCCCcHHHHHHHc--------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchH
Confidence 455678999999976 4888887543 46899999999999999999999999999999999
Q ss_pred cEEe-ecCcEEEEecccchhcccCC-------------ccccccccccCccccCchhhccCCCCCCCccccCCCccchhh
Q 003052 630 NFLL-VKGSLKLIDFGIAKAIMSDT-------------TNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWS 695 (853)
Q Consensus 630 NILL-~~g~VKL~DFGlAk~~~~~~-------------~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWS 695 (853)
||++ ..+.+||+|||+++...... .........|+..|+|||.+.+. .++.++||||
T Consensus 131 NIll~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~---------~~~~~~Di~s 201 (305)
T cd05609 131 NLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQ---------GYGKPVDWWA 201 (305)
T ss_pred HEEECCCCCEEEeeCCCccccCcCccccccccccccchhhccccCCccCccccCchhccCC---------CCCchhhHHH
Confidence 9999 56799999999987421100 00011235688999999998654 3568999999
Q ss_pred hHHHHHHHHhCCCCCCcchhHHHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCCC---hhHHhcCCCCCC
Q 003052 696 LGCILYQMVYGRTPFSEYKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWR---IPQLLQHPFLVP 769 (853)
Q Consensus 696 LGVILyELLtG~~PF~~~~~~~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpT---a~EIL~HPwf~~ 769 (853)
|||++|+|++|..||.+........................+.++.+||.+||..||.+||+ +.++|+||||..
T Consensus 202 lG~vl~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~~~~~ 278 (305)
T cd05609 202 MGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPEGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFLG 278 (305)
T ss_pred HHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCCccccCCHHHHHHHHHHhccChhhccCccCHHHHHhCccccC
Confidence 99999999999999976544322222222111111122356788999999999999999998 799999999965
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-38 Score=355.95 Aligned_cols=255 Identities=26% Similarity=0.384 Sum_probs=216.5
Q ss_pred ceeeEEEeEeccCceEEEEEEe-cCCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHHHH
Q 003052 472 KLYQRLGKIGSGGSSEVHKVIS-SDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLREV 550 (853)
Q Consensus 472 ~~Y~ilk~LG~G~FG~Vyka~~-~~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~~l 550 (853)
..|.++++||+|.|++|.++++ .++..||||.|.+...+......+.+|+++|+.|. |||||+++.+.
T Consensus 56 g~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~-HPnIvkl~~v~---------- 124 (596)
T KOG0586|consen 56 GLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLN-HPNIVKLFSVI---------- 124 (596)
T ss_pred cceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcC-Ccceeeeeeee----------
Confidence 3599999999999999999998 46789999999988888777777899999999998 99999999874
Q ss_pred hhCCCCCCCCccccCCeEEEEEecc-hhhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCCCc
Q 003052 551 LNGSMNNKDGRVKDDGYIYMVLEYG-EIDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPA 629 (853)
Q Consensus 551 ~~~~iv~~~g~~~d~~~lyLVmEy~-~gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLKPe 629 (853)
.....+|+||||+ ++.+++++..+ +.+.+..++.++.|++.|++|||+++|||||||.+
T Consensus 125 ------------~t~~~lylV~eya~~ge~~~yl~~~--------gr~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~e 184 (596)
T KOG0586|consen 125 ------------ETEATLYLVMEYASGGELFDYLVKH--------GRMKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAE 184 (596)
T ss_pred ------------eecceeEEEEEeccCchhHHHHHhc--------ccchhhhhhhhhHHHHHHHHHHhhcceeccccchh
Confidence 3456799999994 57999999875 67888999999999999999999999999999999
Q ss_pred cEEeecC-cEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHhCCC
Q 003052 630 NFLLVKG-SLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGRT 708 (853)
Q Consensus 630 NILL~~g-~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLtG~~ 708 (853)
||||+.. ++||+|||++..+... ....++||++.|.|||++.+..++ ++.+|+||+|++||-|+.|.+
T Consensus 185 NilL~~~mnikIaDfgfS~~~~~~---~~lqt~cgsppyAaPEl~~g~~y~--------gpe~D~Wslgvvly~LV~GsL 253 (596)
T KOG0586|consen 185 NILLDENMNIKIADFGFSTFFDYG---LMLQTFCGSPPYAAPELFNGKKYD--------GPEVDIWSLGVVLYALVEGSL 253 (596)
T ss_pred hcccccccceeeeccccceeeccc---ccccccCCCCCccChHhhcCcccC--------Ccceehhhhhhhheeeeeccc
Confidence 9999766 6999999999988643 234589999999999999988765 689999999999999999999
Q ss_pred CCCcchhHHHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCCChhHHhcCCCCCCCC
Q 003052 709 PFSEYKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQHPFLVPPV 771 (853)
Q Consensus 709 PF~~~~~~~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~HPwf~~~~ 771 (853)
||++..-.....+.+. ..+..+...+-++.++|+++|..+|.+|++++++..|.|+....
T Consensus 254 PFDG~~lk~Lr~rvl~---gk~rIp~~ms~dce~lLrk~lvl~Pskr~~~dqim~~~W~n~~~ 313 (596)
T KOG0586|consen 254 PFDGQNLKELRPRVLR---GKYRIPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKDRWRNDLL 313 (596)
T ss_pred ccCCcccccccchhee---eeecccceeechhHHHHHHhhccCccccCCHHHhhhhcccchhh
Confidence 9987433322222222 22233444677899999999999999999999999999986543
|
|
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-37 Score=325.32 Aligned_cols=255 Identities=27% Similarity=0.469 Sum_probs=203.5
Q ss_pred eeeEEEeEeccCceEEEEEEe-cCCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhc--CCCceeEeeehhhhHHHHHHH
Q 003052 473 LYQRLGKIGSGGSSEVHKVIS-SDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLK--GKNNIIQLIDYEVTEKALLRE 549 (853)
Q Consensus 473 ~Y~ilk~LG~G~FG~Vyka~~-~~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~--~hpNIV~Lid~~~~e~~iL~~ 549 (853)
.|++++.||+|+||.||+|.+ .+++.||+|.+...... .....+.+|+.+++++. .|+||++++++
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~---------- 70 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPD-DDVSDIQREVALLSQLRQSQPPNITKYYGS---------- 70 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCc-hhHHHHHHHHHHHHHhccCCCCCeeeEeee----------
Confidence 478889999999999999997 57789999998764332 33456789999999997 58999999876
Q ss_pred HhhCCCCCCCCccccCCeEEEEEecch-hhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCCC
Q 003052 550 VLNGSMNNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKP 628 (853)
Q Consensus 550 l~~~~iv~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLKP 628 (853)
+.++.++|+||||+. ++|.+++.. ..+++..++.++.||+.||.|||+.||+||||+|
T Consensus 71 ------------~~~~~~~~lv~e~~~~~~L~~~~~~---------~~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p 129 (277)
T cd06917 71 ------------YLKGPRLWIIMEYAEGGSVRTLMKA---------GPIAEKYISVIIREVLVALKYIHKVGVIHRDIKA 129 (277)
T ss_pred ------------eeeCCEEEEEEecCCCCcHHHHHHc---------cCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCH
Confidence 345678999999975 478776643 3689999999999999999999999999999999
Q ss_pred ccEEee-cCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHhCC
Q 003052 629 ANFLLV-KGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGR 707 (853)
Q Consensus 629 eNILL~-~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLtG~ 707 (853)
+||+++ ++.++|+|||++..+..... ......|+..|+|||.+.+.. .++.++|+|||||++|+|++|.
T Consensus 130 ~ni~i~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~--------~~~~~~Dv~slG~~l~~ll~g~ 199 (277)
T cd06917 130 ANILVTNTGNVKLCDFGVAALLNQNSS--KRSTFVGTPYWMAPEVITEGK--------YYDTKADIWSLGITIYEMATGN 199 (277)
T ss_pred HHEEEcCCCCEEEccCCceeecCCCcc--ccccccCCcceeCHHHhccCC--------ccccchhHHHHHHHHHHHHhCC
Confidence 999994 67999999999987654332 223567999999999986432 3567999999999999999999
Q ss_pred CCCCcchhHHHHHHhhcCCCCcccCCC-CCChhHHHHHHHhcccCCCCCCChhHHhcCCCCCCCC
Q 003052 708 TPFSEYKTFWAKFKVITDPNHEITYEP-VPNPWLLDLMKKCLAWDRNERWRIPQLLQHPFLVPPV 771 (853)
Q Consensus 708 ~PF~~~~~~~~~~kii~~~~~~~~~~~-~~s~~l~dLI~kcL~~DP~kRpTa~EIL~HPwf~~~~ 771 (853)
.||.+............. ....... ..+.++.+||.+||..||.+||++.+++.|+||+...
T Consensus 200 ~p~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~il~~~~~~~~~ 262 (277)
T cd06917 200 PPYSDVDAFRAMMLIPKS--KPPRLEDNGYSKLLREFVAACLDEEPKERLSAEELLKSKWIKAHS 262 (277)
T ss_pred CCCCCCChhhhhhccccC--CCCCCCcccCCHHHHHHHHHHcCCCcccCcCHHHHhhChHhhccc
Confidence 999876544333222111 1111222 2677899999999999999999999999999997643
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=342.39 Aligned_cols=265 Identities=20% Similarity=0.334 Sum_probs=202.5
Q ss_pred EEcCceeeEEEeEeccCceEEEEEEec------CCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhh
Q 003052 468 KVNGKLYQRLGKIGSGGSSEVHKVISS------DCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEV 541 (853)
Q Consensus 468 ~v~g~~Y~ilk~LG~G~FG~Vyka~~~------~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~ 541 (853)
.+.+++|++.+.||+|+||.||+|... +++.||+|+++.... ......+.+|+.++.++.+|+||+++++++
T Consensus 3 ~~~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~-~~~~~~~~~E~~~~~~l~~h~niv~~~~~~- 80 (337)
T cd05054 3 EFPRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGAT-ASEYKALMTELKILIHIGHHLNVVNLLGAC- 80 (337)
T ss_pred ccCHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCC-HHHHHHHHHHHHHHHhhccCcchhheeeeE-
Confidence 445678999999999999999999642 347899999975432 233456789999999997799999998864
Q ss_pred hHHHHHHHHhhCCCCCCCCccccCCeEEEEEecch-hhHHHHHHHhhhhc------------------------------
Q 003052 542 TEKALLREVLNGSMNNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEM------------------------------ 590 (853)
Q Consensus 542 ~e~~iL~~l~~~~iv~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~~------------------------------ 590 (853)
+..+..+|++|||+. ++|.+++.......
T Consensus 81 --------------------~~~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 140 (337)
T cd05054 81 --------------------TKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQ 140 (337)
T ss_pred --------------------ecCCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccc
Confidence 234567899999976 58888876432100
Q ss_pred -----------------------cCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCCCccEEee-cCcEEEEecccc
Q 003052 591 -----------------------DGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLLV-KGSLKLIDFGIA 646 (853)
Q Consensus 591 -----------------------~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLKPeNILL~-~g~VKL~DFGlA 646 (853)
......+++..+..++.||+.||.|||++||+||||||+|||++ ++.+||+|||++
T Consensus 141 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~~~vkL~DfG~a 220 (337)
T cd05054 141 SSASSGFIEDKSLSDVEEDEEGDELYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLA 220 (337)
T ss_pred cccccccccCcchhhcccchhhhHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCCCcEEEeccccc
Confidence 00013689999999999999999999999999999999999995 679999999999
Q ss_pred hhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHh-CCCCCCcchhHHHHHHhhcC
Q 003052 647 KAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVY-GRTPFSEYKTFWAKFKVITD 725 (853)
Q Consensus 647 k~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLt-G~~PF~~~~~~~~~~kii~~ 725 (853)
+.+.............++..|+|||++.+.. ++.++|||||||++|||++ |..||.+..........+..
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~---------~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~ 291 (337)
T cd05054 221 RDIYKDPDYVRKGDARLPLKWMAPESIFDKV---------YTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKE 291 (337)
T ss_pred hhcccCcchhhccCCCCCccccCcHHhcCCC---------CCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhc
Confidence 8765433333333456778999999987653 5679999999999999997 99999764322222222221
Q ss_pred CCCcccCCCCCChhHHHHHHHhcccCCCCCCChhHHhcC
Q 003052 726 PNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQH 764 (853)
Q Consensus 726 ~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~H 764 (853)
......+...++++.+++.+||+.+|.+||++.+|++|
T Consensus 292 -~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~ell~~ 329 (337)
T cd05054 292 -GTRMRAPEYATPEIYSIMLDCWHNNPEDRPTFSELVEI 329 (337)
T ss_pred -cCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 12223344567889999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-37 Score=339.29 Aligned_cols=261 Identities=26% Similarity=0.427 Sum_probs=203.4
Q ss_pred CceeeEEEeEeccCceEEEEEEe-cCCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHHH
Q 003052 471 GKLYQRLGKIGSGGSSEVHKVIS-SDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLRE 549 (853)
Q Consensus 471 g~~Y~ilk~LG~G~FG~Vyka~~-~~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~~ 549 (853)
.++|++++.||+|+||.||+|.+ .++..||||++............+.+|+.+|++++ |+||+++++++....
T Consensus 14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~----- 87 (343)
T cd07880 14 PDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMK-HENVIGLLDVFTPDL----- 87 (343)
T ss_pred ccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcC-CCCccceeeeecCCc-----
Confidence 35699999999999999999987 57889999999755444444456789999999997 899999998754321
Q ss_pred HhhCCCCCCCCccccCCeEEEEEecchhhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCCCc
Q 003052 550 VLNGSMNNKDGRVKDDGYIYMVLEYGEIDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPA 629 (853)
Q Consensus 550 l~~~~iv~~~g~~~d~~~lyLVmEy~~gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLKPe 629 (853)
.......+|+||||++++|..++.. ..+++..++.++.||+.||.|||++||+||||||+
T Consensus 88 -----------~~~~~~~~~lv~e~~~~~l~~~~~~---------~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~ 147 (343)
T cd07880 88 -----------SLDRFHDFYLVMPFMGTDLGKLMKH---------EKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPG 147 (343)
T ss_pred -----------cccccceEEEEEecCCCCHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHH
Confidence 0112245799999998888777643 36899999999999999999999999999999999
Q ss_pred cEEe-ecCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHhCCC
Q 003052 630 NFLL-VKGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGRT 708 (853)
Q Consensus 630 NILL-~~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLtG~~ 708 (853)
||++ .++.+||+|||++...... .....+++.|+|||.+.+.. .++.++|+|||||++|+|++|+.
T Consensus 148 Nill~~~~~~kl~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~--------~~~~~~Di~slG~ll~~l~~g~~ 214 (343)
T cd07880 148 NLAVNEDCELKILDFGLARQTDSE-----MTGYVVTRWYRAPEVILNWM--------HYTQTVDIWSVGCIMAEMLTGKP 214 (343)
T ss_pred HEEEcCCCCEEEeecccccccccC-----ccccccCCcccCHHHHhCCC--------CCCcHHHHHHHHHHHHHHHhCCC
Confidence 9999 5679999999999865332 12457899999999986421 35689999999999999999999
Q ss_pred CCCcchhHHHHHHhhcCCC----------------------Cc------ccCCCCCChhHHHHHHHhcccCCCCCCChhH
Q 003052 709 PFSEYKTFWAKFKVITDPN----------------------HE------ITYEPVPNPWLLDLMKKCLAWDRNERWRIPQ 760 (853)
Q Consensus 709 PF~~~~~~~~~~kii~~~~----------------------~~------~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~E 760 (853)
||.+........+++.... .. .......++.+.++|.+||..||.+|||+.+
T Consensus 215 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~ 294 (343)
T cd07880 215 LFKGHDHLDQLMEIMKVTGTPSKEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAE 294 (343)
T ss_pred CCCCCCHHHHHHHHHHhcCCCCHHHHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHH
Confidence 9976443222221111000 00 0112346778999999999999999999999
Q ss_pred HhcCCCCCCC
Q 003052 761 LLQHPFLVPP 770 (853)
Q Consensus 761 IL~HPwf~~~ 770 (853)
++.||||...
T Consensus 295 ~l~~~~~~~~ 304 (343)
T cd07880 295 ALAHPYFEEF 304 (343)
T ss_pred HhcCccHhhh
Confidence 9999999764
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=329.33 Aligned_cols=248 Identities=26% Similarity=0.367 Sum_probs=190.2
Q ss_pred eEeccCceEEEEEEec-CCcEEEEEEEecCCCChh-hHhhHHHHHHHHHHh--cCCCceeEeeehhhhHHHHHHHHhhCC
Q 003052 479 KIGSGGSSEVHKVISS-DCTIYALKKIKLKGRDYA-TAYGFCQEIEYLNKL--KGKNNIIQLIDYEVTEKALLREVLNGS 554 (853)
Q Consensus 479 ~LG~G~FG~Vyka~~~-~g~~vAVKkik~~~~~~~-~~~~~l~EI~iLkkL--~~hpNIV~Lid~~~~e~~iL~~l~~~~ 554 (853)
.||+|+||.||++.+. +++.||+|.+........ ....+.+|..+++.+ .+|+||+.++++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~--------------- 65 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYA--------------- 65 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEE---------------
Confidence 3899999999999984 678999999976533222 222345565555554 358999998876
Q ss_pred CCCCCCccccCCeEEEEEecch-hhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCCCccEEe
Q 003052 555 MNNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLL 633 (853)
Q Consensus 555 iv~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLKPeNILL 633 (853)
+..++.+|+||||+. ++|..++... ..+++..++.++.||+.||.|||++||+||||||+|||+
T Consensus 66 -------~~~~~~~~lv~e~~~~~~L~~~i~~~--------~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~ 130 (279)
T cd05633 66 -------FHTPDKLCFILDLMNGGDLHYHLSQH--------GVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILL 130 (279)
T ss_pred -------EecCCeEEEEEecCCCCCHHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEE
Confidence 445667899999966 5887777543 569999999999999999999999999999999999999
Q ss_pred -ecCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHhCCCCCCc
Q 003052 634 -VKGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGRTPFSE 712 (853)
Q Consensus 634 -~~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLtG~~PF~~ 712 (853)
.++.+||+|||++....... .....||+.|+|||.+.... .++.++|||||||++|+|++|..||..
T Consensus 131 ~~~~~~~l~dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~--------~~~~~~Di~slG~~l~~l~~g~~pf~~ 198 (279)
T cd05633 131 DEHGHVRISDLGLACDFSKKK----PHASVGTHGYMAPEVLQKGT--------AYDSSADWFSLGCMLFKLLRGHSPFRQ 198 (279)
T ss_pred CCCCCEEEccCCcceeccccC----ccCcCCCcCccCHHHhcCCC--------CCCchhhhHHHHHHHHHHHhCCCCcCC
Confidence 56799999999997553321 12457999999999985321 356899999999999999999999964
Q ss_pred chh--HHHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCC-----ChhHHhcCCCCCCC
Q 003052 713 YKT--FWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERW-----RIPQLLQHPFLVPP 770 (853)
Q Consensus 713 ~~~--~~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRp-----Ta~EIL~HPwf~~~ 770 (853)
... ......... ......+...+..+.+||.+||..||.+|+ ++.++++||||+..
T Consensus 199 ~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h~~~~~~ 261 (279)
T cd05633 199 HKTKDKHEIDRMTL--TVNVELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEHVFFKGI 261 (279)
T ss_pred CCCcCHHHHHHHhh--cCCcCCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhCccccCC
Confidence 321 111111111 122334556788999999999999999999 69999999999763
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-37 Score=324.07 Aligned_cols=259 Identities=29% Similarity=0.432 Sum_probs=199.8
Q ss_pred eeEEEeEeccCceEEEEEEec-CCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhc--CCCceeEeeehhhhHHHHHHHH
Q 003052 474 YQRLGKIGSGGSSEVHKVISS-DCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLK--GKNNIIQLIDYEVTEKALLREV 550 (853)
Q Consensus 474 Y~ilk~LG~G~FG~Vyka~~~-~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~--~hpNIV~Lid~~~~e~~iL~~l 550 (853)
|++.+.||+|+||.||+|.+. +++.||+|+++...........+.+|+.+++++. .|+||+++++++....
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~------ 74 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPR------ 74 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeecc------
Confidence 678899999999999999985 5789999999865544444455778999998886 4899999998743211
Q ss_pred hhCCCCCCCCccccCCeEEEEEecchhhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCCCcc
Q 003052 551 LNGSMNNKDGRVKDDGYIYMVLEYGEIDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPAN 630 (853)
Q Consensus 551 ~~~~iv~~~g~~~d~~~lyLVmEy~~gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLKPeN 630 (853)
......+|++|||+.++|.+++... ....+++..++.++.||+.||.|||++||+|+||||+|
T Consensus 75 -----------~~~~~~~~l~~e~~~~~l~~~l~~~------~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~n 137 (287)
T cd07838 75 -----------TDRELKLTLVFEHVDQDLATYLSKC------PKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQN 137 (287)
T ss_pred -----------CCCCceeEEEehhcccCHHHHHHHc------cCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhh
Confidence 1122348999999888888877543 12358999999999999999999999999999999999
Q ss_pred EEe-ecCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHhCCCC
Q 003052 631 FLL-VKGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGRTP 709 (853)
Q Consensus 631 ILL-~~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLtG~~P 709 (853)
|++ .++.+||+|||++..+..... .....++..|+|||++.+.. ++.++|||||||++|+|++|++|
T Consensus 138 ili~~~~~~~l~dfg~~~~~~~~~~---~~~~~~~~~~~~PE~~~~~~---------~~~~~Di~s~G~~l~~l~~~~~~ 205 (287)
T cd07838 138 ILVTSDGQVKIADFGLARIYSFEMA---LTSVVVTLWYRAPEVLLQSS---------YATPVDMWSVGCIFAELFRRRPL 205 (287)
T ss_pred EEEccCCCEEEeccCcceeccCCcc---cccccccccccChHHhccCC---------CCCcchhhhHHHHHHHHHhCCCc
Confidence 999 567999999999987643221 12446889999999997653 46789999999999999999999
Q ss_pred CCcchhHHHHHHhhcCCCC---------------------c---ccCCCCCChhHHHHHHHhcccCCCCCCChhHHhcCC
Q 003052 710 FSEYKTFWAKFKVITDPNH---------------------E---ITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQHP 765 (853)
Q Consensus 710 F~~~~~~~~~~kii~~~~~---------------------~---~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~HP 765 (853)
|.+........+++..... . ....+..+..+.+||.+||..||.+||++.+++.||
T Consensus 206 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~~ 285 (287)
T cd07838 206 FRGTSEADQLDKIFDVIGLPSEEEWPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHP 285 (287)
T ss_pred ccCCChHHHHHHHHHHcCCCChHhcCCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcCc
Confidence 9765443322222110000 0 000112356789999999999999999999999999
Q ss_pred CC
Q 003052 766 FL 767 (853)
Q Consensus 766 wf 767 (853)
||
T Consensus 286 ~~ 287 (287)
T cd07838 286 YF 287 (287)
T ss_pred CC
Confidence 97
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-38 Score=331.90 Aligned_cols=255 Identities=29% Similarity=0.425 Sum_probs=210.0
Q ss_pred CceeeEEEeEeccCceEEEEEEe-cCCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHHH
Q 003052 471 GKLYQRLGKIGSGGSSEVHKVIS-SDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLRE 549 (853)
Q Consensus 471 g~~Y~ilk~LG~G~FG~Vyka~~-~~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~~ 549 (853)
-.+|.+++.||+|+|++|..++. ++.++||+|++++.--+.. .-+||..+|+..++.
T Consensus 249 l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~ndd----------------------edidwvqtek~vfe~ 306 (593)
T KOG0695|consen 249 LQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDD----------------------EDIDWVQTEKHVFEQ 306 (593)
T ss_pred cccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCc----------------------ccchhHHhhHHHHHh
Confidence 35699999999999999999988 5668999999986532211 126777888887776
Q ss_pred Hh-hCCCCCCCCccccCCeEEEEEecc-hhhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCC
Q 003052 550 VL-NGSMNNKDGRVKDDGYIYMVLEYG-EIDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLK 627 (853)
Q Consensus 550 l~-~~~iv~~~g~~~d~~~lyLVmEy~-~gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLK 627 (853)
.. ++.++.++.||+.+..+++|.||. +|+|...+++. ..|+|+.+++|..+|+.||.|||++|||+||||
T Consensus 307 asn~pflvglhscfqtesrlffvieyv~ggdlmfhmqrq--------rklpeeharfys~ei~lal~flh~rgiiyrdlk 378 (593)
T KOG0695|consen 307 ASNNPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQ--------RKLPEEHARFYSAEICLALNFLHERGIIYRDLK 378 (593)
T ss_pred ccCCCeEEehhhhhcccceEEEEEEEecCcceeeehhhh--------hcCcHHHhhhhhHHHHHHHHHHhhcCeeeeecc
Confidence 65 566788999999999999999994 56888777765 569999999999999999999999999999999
Q ss_pred CccEEe-ecCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHhC
Q 003052 628 PANFLL-VKGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYG 706 (853)
Q Consensus 628 PeNILL-~~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLtG 706 (853)
.+|+|| .+|++||.|||+|+....+.. ...++||||.|+|||++++.. |++.+|||+|||+++||+.|
T Consensus 379 ldnvlldaeghikltdygmcke~l~~gd--~tstfcgtpnyiapeilrgee---------ygfsvdwwalgvlmfemmag 447 (593)
T KOG0695|consen 379 LDNVLLDAEGHIKLTDYGMCKEGLGPGD--TTSTFCGTPNYIAPEILRGEE---------YGFSVDWWALGVLMFEMMAG 447 (593)
T ss_pred ccceEEccCCceeecccchhhcCCCCCc--ccccccCCCcccchhhhcccc---------cCceehHHHHHHHHHHHHcC
Confidence 999999 689999999999998655433 345899999999999999874 67999999999999999999
Q ss_pred CCCCC-------cchhHHHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCCC------hhHHhcCCCCC
Q 003052 707 RTPFS-------EYKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWR------IPQLLQHPFLV 768 (853)
Q Consensus 707 ~~PF~-------~~~~~~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpT------a~EIL~HPwf~ 768 (853)
+.||+ +.+...-.+.++.... +..+...+-.+..+++..|++||.+|.. +.++..|+||.
T Consensus 448 rspfdivgm~n~d~ntedylfqvilekq--iriprslsvkas~vlkgflnkdp~erlgc~~~~g~~dik~h~ffr 520 (593)
T KOG0695|consen 448 RSPFDIVGMDNPDMNTEDYLFQVILEKQ--IRIPRSLSVKASHVLKGFLNKDPKERLGCRPQTGFSDIKSHAFFR 520 (593)
T ss_pred CCCcceecCCCcccchhHHHHHHHhhhc--ccccceeehhhHHHHHHhhcCCcHHhcCCCcccchhhhhcchhhh
Confidence 99994 1222233455555433 3345556777889999999999999984 78999999996
|
|
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-37 Score=321.34 Aligned_cols=250 Identities=29% Similarity=0.441 Sum_probs=195.2
Q ss_pred EEeEeccCceEEEEEEec-CCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHHHHhhCCC
Q 003052 477 LGKIGSGGSSEVHKVISS-DCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLREVLNGSM 555 (853)
Q Consensus 477 lk~LG~G~FG~Vyka~~~-~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~~l~~~~i 555 (853)
...||+|+||.||+|.+. ++..||+|.+..... .....+.+|+.++++++ |+||++++++
T Consensus 13 ~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~--~~~~~~~~e~~~l~~l~-h~~iv~~~~~---------------- 73 (268)
T cd06624 13 RVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDS--RYVQPLHEEIALHSYLK-HRNIVQYLGS---------------- 73 (268)
T ss_pred eEEEecCCceEEEEeEecCCCcEEEEEEecCCCH--HHHHHHHHHHHHHHhcC-CCCeeeeeee----------------
Confidence 357999999999999974 567899999875432 34456889999999997 8999999876
Q ss_pred CCCCCccccCCeEEEEEecch-hhHHHHHHHhhhhccCCCCCC--CHHHHHHHHHHhhhhhhhcccCceeeCCCCCccEE
Q 003052 556 NNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEMDGSNQTL--DENWLRFYWQQILEAVNTIHEERIVHSDLKPANFL 632 (853)
Q Consensus 556 v~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~~~~~~~~L--sE~~~r~I~~QIl~AL~yLHs~gIIHRDLKPeNIL 632 (853)
+..++.+|+||||+. ++|.+.+...+ ..+ ++..+..++.||+.||.|||++||+||||||+||+
T Consensus 74 ------~~~~~~~~lv~e~~~~~~L~~~l~~~~-------~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil 140 (268)
T cd06624 74 ------DSENGFFKIFMEQVPGGSLSALLRSKW-------GPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVL 140 (268)
T ss_pred ------eccCCEEEEEEecCCCCCHHHHHHHhc-------ccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEE
Confidence 345678999999975 58888886542 234 88889999999999999999999999999999999
Q ss_pred ee--cCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHhCCCCC
Q 003052 633 LV--KGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGRTPF 710 (853)
Q Consensus 633 L~--~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLtG~~PF 710 (853)
++ .+.+||+|||++........ ......|++.|+|||++.+... .++.++|||||||++|+|++|+.||
T Consensus 141 ~~~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~-------~~~~~~Dv~slGvvl~~l~~g~~p~ 211 (268)
T cd06624 141 VNTYSGVVKISDFGTSKRLAGINP--CTETFTGTLQYMAPEVIDKGPR-------GYGAPADIWSLGCTIVEMATGKPPF 211 (268)
T ss_pred EcCCCCeEEEecchhheecccCCC--ccccCCCCccccChhhhccccc-------cCCchhhhHHHHHHHHHHHhCCCCC
Confidence 95 46899999999976543221 1224568999999999865432 2568999999999999999999999
Q ss_pred CcchhHHHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCCChhHHhcCCCC
Q 003052 711 SEYKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQHPFL 767 (853)
Q Consensus 711 ~~~~~~~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~HPwf 767 (853)
.....................++...++.+.+||.+||..+|.+|||+.+++.||||
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~ 268 (268)
T cd06624 212 IELGEPQAAMFKVGMFKIHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQDPFL 268 (268)
T ss_pred ccccChhhhHhhhhhhccCCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHhCCCC
Confidence 754322111111111111223445677889999999999999999999999999997
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-38 Score=350.92 Aligned_cols=252 Identities=23% Similarity=0.317 Sum_probs=206.4
Q ss_pred eEEcCceeeEEEeEeccCceEEEEEEecCCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHH
Q 003052 467 FKVNGKLYQRLGKIGSGGSSEVHKVISSDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKAL 546 (853)
Q Consensus 467 ~~v~g~~Y~ilk~LG~G~FG~Vyka~~~~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~i 546 (853)
+.+.-..+++++.||+|.||.||.|.+.....||+|.++..... ...|++|+++|++|+ |+|||++++++
T Consensus 201 wei~r~~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~m~---~~~f~~Ea~iMk~L~-H~~lV~l~gV~------ 270 (468)
T KOG0197|consen 201 WEIPREELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGSMS---PEAFLREAQIMKKLR-HEKLVKLYGVC------ 270 (468)
T ss_pred eeecHHHHHHHHHhcCCccceEEEEEEcCCCcccceEEeccccC---hhHHHHHHHHHHhCc-ccCeEEEEEEE------
Confidence 44555668888999999999999999988778999999876433 345889999999999 99999999874
Q ss_pred HHHHhhCCCCCCCCccccCCeEEEEEecch-hhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCC
Q 003052 547 LREVLNGSMNNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSD 625 (853)
Q Consensus 547 L~~l~~~~iv~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRD 625 (853)
..+.-+||||||+. |+|.++|+.. .+..+...+...++.|||+|++||+++++||||
T Consensus 271 ----------------~~~~piyIVtE~m~~GsLl~yLr~~------~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRD 328 (468)
T KOG0197|consen 271 ----------------TKQEPIYIVTEYMPKGSLLDYLRTR------EGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRD 328 (468)
T ss_pred ----------------ecCCceEEEEEecccCcHHHHhhhc------CCCccchHHHHHHHHHHHHHHHHHHhCCccchh
Confidence 33446899999976 7999999763 457799999999999999999999999999999
Q ss_pred CCCccEEee-cCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHH
Q 003052 626 LKPANFLLV-KGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMV 704 (853)
Q Consensus 626 LKPeNILL~-~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELL 704 (853)
|...|||++ +..+||+|||||+.+.+ +.........-...|.|||++... .|+.++|||||||+||||+
T Consensus 329 LAARNiLV~~~~~vKIsDFGLAr~~~d-~~Y~~~~~~kfPIkWtAPEa~~~~---------~FS~kSDVWSFGVlL~E~f 398 (468)
T KOG0197|consen 329 LAARNILVDEDLVVKISDFGLARLIGD-DEYTASEGGKFPIKWTAPEALNYG---------KFSSKSDVWSFGVLLWELF 398 (468)
T ss_pred hhhhheeeccCceEEEcccccccccCC-CceeecCCCCCCceecCHHHHhhC---------CcccccceeehhhhHHHHh
Confidence 999999995 55899999999995433 333223333445689999999755 5789999999999999999
Q ss_pred h-CCCCCCcchhHHHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCCChhHHh
Q 003052 705 Y-GRTPFSEYKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLL 762 (853)
Q Consensus 705 t-G~~PF~~~~~~~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL 762 (853)
| |+.||.+..+...... +. ......-|..+++++.++|..||..+|++|||++.+.
T Consensus 399 T~G~~py~~msn~ev~~~-le-~GyRlp~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~ 455 (468)
T KOG0197|consen 399 TYGRVPYPGMSNEEVLEL-LE-RGYRLPRPEGCPDEVYELMKSCWHEDPEDRPTFETLR 455 (468)
T ss_pred ccCCCCCCCCCHHHHHHH-Hh-ccCcCCCCCCCCHHHHHHHHHHhhCCcccCCCHHHHH
Confidence 6 9999988666543333 32 2456666778999999999999999999999998654
|
|
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-37 Score=336.55 Aligned_cols=263 Identities=27% Similarity=0.402 Sum_probs=201.6
Q ss_pred eeeEEEeEeccCceEEEEEEec-C--CcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHHH
Q 003052 473 LYQRLGKIGSGGSSEVHKVISS-D--CTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLRE 549 (853)
Q Consensus 473 ~Y~ilk~LG~G~FG~Vyka~~~-~--g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~~ 549 (853)
.|++.+.||+|+||.||++.+. + +..||+|++............+.+|+.+++++.+|+||++++++....
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~------ 74 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVF------ 74 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeec------
Confidence 3889999999999999999984 4 678999998754433334556789999999998899999998853210
Q ss_pred HhhCCCCCCCCccccCCeEEEEEecchhhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCCCc
Q 003052 550 VLNGSMNNKDGRVKDDGYIYMVLEYGEIDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPA 629 (853)
Q Consensus 550 l~~~~iv~~~g~~~d~~~lyLVmEy~~gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLKPe 629 (853)
......+|++|||++++|...+... ..+++..++.++.||+.||.|||++||+||||||+
T Consensus 75 ------------~~~~~~~~~~~e~~~~~L~~~l~~~--------~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~ 134 (332)
T cd07857 75 ------------PGNFNELYLYEELMEADLHQIIRSG--------QPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPG 134 (332)
T ss_pred ------------cccCCcEEEEEecccCCHHHHHhcC--------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHH
Confidence 1233568999999988888877532 57999999999999999999999999999999999
Q ss_pred cEEe-ecCcEEEEecccchhcccCCc--cccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHhC
Q 003052 630 NFLL-VKGSLKLIDFGIAKAIMSDTT--NIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYG 706 (853)
Q Consensus 630 NILL-~~g~VKL~DFGlAk~~~~~~~--~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLtG 706 (853)
|||+ .++.+||+|||+++.+..... ........||+.|+|||++.+.. .++.++|||||||++|+|++|
T Consensus 135 Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~--------~~~~~~Di~slGv~l~~l~~g 206 (332)
T cd07857 135 NLLVNADCELKICDFGLARGFSENPGENAGFMTEYVATRWYRAPEIMLSFQ--------SYTKAIDVWSVGCILAELLGR 206 (332)
T ss_pred HeEEcCCCCEEeCcCCCceecccccccccccccCcccCccccCcHHHhCCC--------CCCcHHHHHHHHHHHHHHHhC
Confidence 9999 567999999999986543221 11123467999999999886532 356899999999999999999
Q ss_pred CCCCCcchhHHHHHH---hhcC----------------------CCCcc---cCCCCCChhHHHHHHHhcccCCCCCCCh
Q 003052 707 RTPFSEYKTFWAKFK---VITD----------------------PNHEI---TYEPVPNPWLLDLMKKCLAWDRNERWRI 758 (853)
Q Consensus 707 ~~PF~~~~~~~~~~k---ii~~----------------------~~~~~---~~~~~~s~~l~dLI~kcL~~DP~kRpTa 758 (853)
.+||........... .... ..... ...+..+..+.+||.+||+.||.+|||+
T Consensus 207 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~ 286 (332)
T cd07857 207 KPVFKGKDYVDQLNQILQVLGTPDEETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISV 286 (332)
T ss_pred CcCCCCCCHHHHHHHHHHHhCCCCHHHHHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCH
Confidence 999975432111110 0000 00000 1112346789999999999999999999
Q ss_pred hHHhcCCCCCC
Q 003052 759 PQLLQHPFLVP 769 (853)
Q Consensus 759 ~EIL~HPwf~~ 769 (853)
.+++.||||..
T Consensus 287 ~~ll~~~~~~~ 297 (332)
T cd07857 287 EEALEHPYLAI 297 (332)
T ss_pred HHHhcChhhhh
Confidence 99999999964
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=336.96 Aligned_cols=265 Identities=28% Similarity=0.448 Sum_probs=206.6
Q ss_pred eeeEEEeEeccCceEEEEEEec-CCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHHHHh
Q 003052 473 LYQRLGKIGSGGSSEVHKVISS-DCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLREVL 551 (853)
Q Consensus 473 ~Y~ilk~LG~G~FG~Vyka~~~-~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~~l~ 551 (853)
+|++.+.||.|+||.||+|.+. ++..||||++............+.+|+.+++.++ |+||+++++++....
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~------- 72 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLR-HENIIGLLDILRPPS------- 72 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcC-CcchhhhhhhhcccC-------
Confidence 4889999999999999999985 5789999999876544455567889999999997 999999988743210
Q ss_pred hCCCCCCCCccccCCeEEEEEecchhhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCCCccE
Q 003052 552 NGSMNNKDGRVKDDGYIYMVLEYGEIDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANF 631 (853)
Q Consensus 552 ~~~iv~~~g~~~d~~~lyLVmEy~~gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLKPeNI 631 (853)
......+|+||||++++|...+... ..+++..++.++.||+.||.|||++||+||||||+||
T Consensus 73 ----------~~~~~~~~lv~e~~~~~l~~~l~~~--------~~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~ni 134 (330)
T cd07834 73 ----------PEDFNDVYIVTELMETDLHKVIKSP--------QPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNI 134 (330)
T ss_pred ----------cccccceEEEecchhhhHHHHHhCC--------CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHE
Confidence 0122468999999988888877542 4799999999999999999999999999999999999
Q ss_pred Ee-ecCcEEEEecccchhcccCCcc-ccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHhCCCC
Q 003052 632 LL-VKGSLKLIDFGIAKAIMSDTTN-IQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGRTP 709 (853)
Q Consensus 632 LL-~~g~VKL~DFGlAk~~~~~~~~-~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLtG~~P 709 (853)
|+ .++.++|+|||++......... .......+++.|+|||++.+.. .++.++|||||||++|+|++|++|
T Consensus 135 li~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--------~~~~~sDi~slG~il~~l~~g~~p 206 (330)
T cd07834 135 LVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVVTRWYRAPELLLSSS--------RYTKAIDIWSVGCIFAELLTRKPL 206 (330)
T ss_pred EEcCCCCEEEcccCceEeecccccccccccccccccCcCCceeeeccc--------CCCcchhHHHHHHHHHHHHcCCCC
Confidence 99 4679999999999876543210 1123457899999999997652 357899999999999999999999
Q ss_pred CCcchhHHHHHHhhcC---CCC----------------------c---ccCCCCCChhHHHHHHHhcccCCCCCCChhHH
Q 003052 710 FSEYKTFWAKFKVITD---PNH----------------------E---ITYEPVPNPWLLDLMKKCLAWDRNERWRIPQL 761 (853)
Q Consensus 710 F~~~~~~~~~~kii~~---~~~----------------------~---~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EI 761 (853)
|.+.........+... +.. . .......+.++.+||.+||.+||.+||++.++
T Consensus 207 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~l 286 (330)
T cd07834 207 FPGRDYIDQLNLIVEVLGTPSEEDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEA 286 (330)
T ss_pred cCCCCHHHHHHHHHHhcCCCChhHhhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHH
Confidence 9765433222111110 000 0 00112356789999999999999999999999
Q ss_pred hcCCCCCCCC
Q 003052 762 LQHPFLVPPV 771 (853)
Q Consensus 762 L~HPwf~~~~ 771 (853)
|.||||....
T Consensus 287 l~~~~~~~~~ 296 (330)
T cd07834 287 LAHPYLAQLH 296 (330)
T ss_pred HhCccHHhhc
Confidence 9999997644
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-37 Score=328.20 Aligned_cols=264 Identities=25% Similarity=0.425 Sum_probs=206.1
Q ss_pred EcCceeeEEEeEeccCceEEEEEEec-CCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHH
Q 003052 469 VNGKLYQRLGKIGSGGSSEVHKVISS-DCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALL 547 (853)
Q Consensus 469 v~g~~Y~ilk~LG~G~FG~Vyka~~~-~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL 547 (853)
+..+.|++.+.||+|+||.||+|.+. +++.||||.++..... .....+.+|+.++.++.+|+||++++++
T Consensus 12 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~e~~~~~~~~~~~~i~~~~~~-------- 82 (296)
T cd06618 12 ADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNK-EENKRILMDLDVVLKSHDCPYIVKCYGY-------- 82 (296)
T ss_pred CCcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCCh-HHHHHHHHHHHHHHhccCCCchHhhhee--------
Confidence 34466999999999999999999985 4789999999765433 2344577888888888889999999876
Q ss_pred HHHhhCCCCCCCCccccCCeEEEEEecchhhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhccc-CceeeCCC
Q 003052 548 REVLNGSMNNKDGRVKDDGYIYMVLEYGEIDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHE-ERIVHSDL 626 (853)
Q Consensus 548 ~~l~~~~iv~~~g~~~d~~~lyLVmEy~~gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs-~gIIHRDL 626 (853)
+.++..+|+||||+++.|..++... ...+++..+..++.||+.||.|||+ +||+||||
T Consensus 83 --------------~~~~~~~~~v~e~~~~~l~~l~~~~-------~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl 141 (296)
T cd06618 83 --------------FITDSDVFICMELMSTCLDKLLKRI-------QGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDV 141 (296)
T ss_pred --------------eecCCeEEEEeeccCcCHHHHHHHh-------cCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCC
Confidence 4556789999999887776665442 2478999999999999999999997 59999999
Q ss_pred CCccEEe-ecCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHh
Q 003052 627 KPANFLL-VKGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVY 705 (853)
Q Consensus 627 KPeNILL-~~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLt 705 (853)
+|+||++ .++.+||+|||++..+...... ....|++.|+|||.+.+.... ..++.++|||||||++|+|++
T Consensus 142 ~p~nill~~~~~~kL~dfg~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~-----~~~~~~~Di~slG~il~el~~ 213 (296)
T cd06618 142 KPSNILLDASGNVKLCDFGISGRLVDSKAK---TRSAGCAAYMAPERIDPPDPN-----PKYDIRADVWSLGISLVELAT 213 (296)
T ss_pred cHHHEEEcCCCCEEECccccchhccCCCcc---cCCCCCccccCHhhcCCCCCc-----cccccchhHHHHHHHHHHHHh
Confidence 9999999 5679999999999876432221 234688999999998754311 136789999999999999999
Q ss_pred CCCCCCcchhHHHHH-HhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCCChhHHhcCCCCCCC
Q 003052 706 GRTPFSEYKTFWAKF-KVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQHPFLVPP 770 (853)
Q Consensus 706 G~~PF~~~~~~~~~~-kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~HPwf~~~ 770 (853)
|+.||.......... ..+.............+.++.+||.+||..||.+||++.++++||||...
T Consensus 214 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~ 279 (296)
T cd06618 214 GQFPYKNCKTEFEVLTKILQEEPPSLPPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHPFIRRY 279 (296)
T ss_pred CCCCCCcchhHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcChhhhcc
Confidence 999997643332222 22322222222223467889999999999999999999999999999754
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=328.30 Aligned_cols=256 Identities=23% Similarity=0.376 Sum_probs=201.1
Q ss_pred cCceeeEEEeEeccCceEEEEEEec-CCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHH
Q 003052 470 NGKLYQRLGKIGSGGSSEVHKVISS-DCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLR 548 (853)
Q Consensus 470 ~g~~Y~ilk~LG~G~FG~Vyka~~~-~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~ 548 (853)
+...|+++++||+|+||.||++.+. +++.||+|++..... ......+.+|+++++.++ |+||++++++
T Consensus 3 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~-~~~~~~~~~E~~~l~~l~-h~~i~~~~~~--------- 71 (284)
T cd06620 3 RNEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAK-SSVRKQILRELQIMHECR-SPYIVSFYGA--------- 71 (284)
T ss_pred cHHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCc-chHHHHHHHHHHHHHHcC-CCCcceEeee---------
Confidence 3467999999999999999999984 678899999875432 334557889999999997 8999999886
Q ss_pred HHhhCCCCCCCCccccCCeEEEEEecchh-hHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhccc-CceeeCCC
Q 003052 549 EVLNGSMNNKDGRVKDDGYIYMVLEYGEI-DLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHE-ERIVHSDL 626 (853)
Q Consensus 549 ~l~~~~iv~~~g~~~d~~~lyLVmEy~~g-dL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs-~gIIHRDL 626 (853)
+.+...+|+||||+.+ +|..++... +.+++..++.++.+|+.||.|||+ +||+||||
T Consensus 72 -------------~~~~~~~~lv~e~~~~~~L~~~~~~~--------~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl 130 (284)
T cd06620 72 -------------FLNENNICMCMEFMDCGSLDRIYKKG--------GPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDI 130 (284)
T ss_pred -------------EecCCEEEEEEecCCCCCHHHHHHhc--------cCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCC
Confidence 4455789999999764 777766542 468999999999999999999997 69999999
Q ss_pred CCccEEe-ecCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHh
Q 003052 627 KPANFLL-VKGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVY 705 (853)
Q Consensus 627 KPeNILL-~~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLt 705 (853)
||+||++ .++.++|+|||++....... ....+|+..|+|||++.+. .++.++|||||||++|+|++
T Consensus 131 ~p~nil~~~~~~~~l~d~gl~~~~~~~~----~~~~~~~~~~~aPE~~~~~---------~~~~~~Di~slG~~l~~l~t 197 (284)
T cd06620 131 KPSNILVNSRGQIKLCDFGVSGELINSI----ADTFVGTSTYMSPERIQGG---------KYTVKSDVWSLGISIIELAL 197 (284)
T ss_pred CHHHEEECCCCcEEEccCCcccchhhhc----cCccccCcccCCHHHHccC---------CCCccchHHHHHHHHHHHHh
Confidence 9999999 46789999999987553221 1246899999999998654 35679999999999999999
Q ss_pred CCCCCCcchhH----------HHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCCChhHHhcCCCCCCC
Q 003052 706 GRTPFSEYKTF----------WAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQHPFLVPP 770 (853)
Q Consensus 706 G~~PF~~~~~~----------~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~HPwf~~~ 770 (853)
|+.||...... ......+.............+.++.+||.+||..||.+||++.|+++|+||...
T Consensus 198 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~~ 272 (284)
T cd06620 198 GKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPPRLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQA 272 (284)
T ss_pred CCCCCcccchhhhhhhhhhHHHHHHHHHhhccCCCCCchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCcccccc
Confidence 99999753321 111222211111111112256789999999999999999999999999999754
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-37 Score=329.72 Aligned_cols=245 Identities=19% Similarity=0.220 Sum_probs=195.5
Q ss_pred EeEeccCceEEEEEEecCCcEEEEEEEecCCCCh-hhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHHHHhhCCCC
Q 003052 478 GKIGSGGSSEVHKVISSDCTIYALKKIKLKGRDY-ATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLREVLNGSMN 556 (853)
Q Consensus 478 k~LG~G~FG~Vyka~~~~g~~vAVKkik~~~~~~-~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~~l~~~~iv 556 (853)
..||+|++|.||+|.. +++.||||+++...... .....+.+|+.+|++++ |+||+++++++...
T Consensus 26 ~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~~~g~~~~~------------- 90 (283)
T PHA02988 26 VLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRID-SNNILKIYGFIIDI------------- 90 (283)
T ss_pred eEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcC-CCCEEEEeeeEEec-------------
Confidence 4699999999999988 67889999997654332 23456789999999998 78999999874320
Q ss_pred CCCCccccCCeEEEEEecch-hhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhccc-CceeeCCCCCccEEe-
Q 003052 557 NKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHE-ERIVHSDLKPANFLL- 633 (853)
Q Consensus 557 ~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs-~gIIHRDLKPeNILL- 633 (853)
.....++++||||+. ++|.+++... ..+++.....++.|++.||.|||+ .+++||||||+|||+
T Consensus 91 -----~~~~~~~~lv~Ey~~~g~L~~~l~~~--------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~ 157 (283)
T PHA02988 91 -----VDDLPRLSLILEYCTRGYLREVLDKE--------KDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVT 157 (283)
T ss_pred -----ccCCCceEEEEEeCCCCcHHHHHhhC--------CCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEEC
Confidence 123457899999977 4788887643 468899999999999999999998 499999999999999
Q ss_pred ecCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHhCCCCCCcc
Q 003052 634 VKGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGRTPFSEY 713 (853)
Q Consensus 634 ~~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLtG~~PF~~~ 713 (853)
.++.+||+|||+++...... ...+|++.|+|||++.+.. ..|+.++|||||||++|||++|+.||.+.
T Consensus 158 ~~~~~kl~dfg~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~-------~~~~~k~Di~SlGvil~el~~g~~Pf~~~ 225 (283)
T PHA02988 158 ENYKLKIICHGLEKILSSPP-----FKNVNFMVYFSYKMLNDIF-------SEYTIKDDIYSLGVVLWEIFTGKIPFENL 225 (283)
T ss_pred CCCcEEEcccchHhhhcccc-----ccccCcccccCHHHhhhcc-------ccccchhhhhHHHHHHHHHHHCCCCCCCC
Confidence 46799999999998654321 2457899999999996521 14678999999999999999999999875
Q ss_pred hhHHHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCCChhHHhc
Q 003052 714 KTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQ 763 (853)
Q Consensus 714 ~~~~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~ 763 (853)
... ..+..+.........+...++.+++||.+||+.||.+|||+.++++
T Consensus 226 ~~~-~~~~~i~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~ 274 (283)
T PHA02988 226 TTK-EIYDLIINKNNSLKLPLDCPLEIKCIVEACTSHDSIKRPNIKEILY 274 (283)
T ss_pred CHH-HHHHHHHhcCCCCCCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHH
Confidence 443 3333332233344455567889999999999999999999999985
|
|
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-37 Score=318.08 Aligned_cols=253 Identities=27% Similarity=0.435 Sum_probs=201.7
Q ss_pred eeeEEEeEeccCceEEEEEEec-CCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHHHHh
Q 003052 473 LYQRLGKIGSGGSSEVHKVISS-DCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLREVL 551 (853)
Q Consensus 473 ~Y~ilk~LG~G~FG~Vyka~~~-~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~~l~ 551 (853)
+|.+.+.||+|+||.||+|... ++..+|+|.+............+.+|+.++++++ |+||++++++
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~-h~~i~~~~~~------------ 67 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMK-HPNIVTFFAS------------ 67 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCC-CCChhhhhhe------------
Confidence 4889999999999999999984 6788999999765433344456789999999997 8999998765
Q ss_pred hCCCCCCCCccccCCeEEEEEecch-hhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCCCcc
Q 003052 552 NGSMNNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPAN 630 (853)
Q Consensus 552 ~~~iv~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLKPeN 630 (853)
+.++..+|+|+||+. ++|.+++... ....+++..++.++.||+.||.|||+++|+|+||||+|
T Consensus 68 ----------~~~~~~~~lv~e~~~~~~L~~~~~~~------~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~n 131 (257)
T cd08225 68 ----------FQENGRLFIVMEYCDGGDLMKRINRQ------RGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQN 131 (257)
T ss_pred ----------eccCCeEEEEEecCCCCcHHHHHHhc------cCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHH
Confidence 456678999999975 5888877643 23468999999999999999999999999999999999
Q ss_pred EEeecC--cEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHhCCC
Q 003052 631 FLLVKG--SLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGRT 708 (853)
Q Consensus 631 ILL~~g--~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLtG~~ 708 (853)
|+++++ .+||+|||.+........ ......|++.|+|||++.+. .++.++|+|||||++|+|++|..
T Consensus 132 il~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~~~ape~~~~~---------~~~~~~Dv~slG~il~~l~~g~~ 200 (257)
T cd08225 132 IFLSKNGMVAKLGDFGIARQLNDSME--LAYTCVGTPYYLSPEICQNR---------PYNNKTDIWSLGCVLYELCTLKH 200 (257)
T ss_pred EEEcCCCCeEEecccccchhccCCcc--cccccCCCccccCHHHHcCC---------CCCchhhHHHHHHHHHHHHhCCC
Confidence 999543 579999999987643221 12245689999999998654 25679999999999999999999
Q ss_pred CCCcchhHHHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCCChhHHhcCCCC
Q 003052 709 PFSEYKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQHPFL 767 (853)
Q Consensus 709 PF~~~~~~~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~HPwf 767 (853)
||................ .....+..+.++.++|.+||..+|.+|||+.++++||||
T Consensus 201 p~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~~~~ 257 (257)
T cd08225 201 PFEGNNLHQLVLKICQGY--FAPISPNFSRDLRSLISQLFKVSPRDRPSITSILKRPFL 257 (257)
T ss_pred CCCCccHHHHHHHHhccc--CCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHhhCCCC
Confidence 997654433333322211 112234567789999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-37 Score=321.90 Aligned_cols=253 Identities=33% Similarity=0.526 Sum_probs=205.5
Q ss_pred eeeEEEeEeccCceEEEEEEec-CCcEEEEEEEecCCC-ChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHHHH
Q 003052 473 LYQRLGKIGSGGSSEVHKVISS-DCTIYALKKIKLKGR-DYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLREV 550 (853)
Q Consensus 473 ~Y~ilk~LG~G~FG~Vyka~~~-~g~~vAVKkik~~~~-~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~~l 550 (853)
.|.+.+.||+|+||.||+|... ++..||+|++..... .......+.+|+.+++++..|+||++++++
T Consensus 2 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~----------- 70 (280)
T cd05581 2 DFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYT----------- 70 (280)
T ss_pred CceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHH-----------
Confidence 5899999999999999999984 778999999976322 223345678999999999879999998765
Q ss_pred hhCCCCCCCCccccCCeEEEEEecc-hhhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCCCc
Q 003052 551 LNGSMNNKDGRVKDDGYIYMVLEYG-EIDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPA 629 (853)
Q Consensus 551 ~~~~iv~~~g~~~d~~~lyLVmEy~-~gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLKPe 629 (853)
+.++..+|+||||+ +++|.+++... ..+++..++.++.||+.||.|||++|++|+||||+
T Consensus 71 -----------~~~~~~~~lv~e~~~~~~L~~~l~~~--------~~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ 131 (280)
T cd05581 71 -----------FQDEENLYFVLEYAPNGELLQYIRKY--------GSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPE 131 (280)
T ss_pred -----------hcCCceEEEEEcCCCCCcHHHHHHHc--------CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHH
Confidence 34567899999998 67998888653 47999999999999999999999999999999999
Q ss_pred cEEe-ecCcEEEEecccchhcccCCcc------------------ccccccccCccccCchhhccCCCCCCCccccCCCc
Q 003052 630 NFLL-VKGSLKLIDFGIAKAIMSDTTN------------------IQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRP 690 (853)
Q Consensus 630 NILL-~~g~VKL~DFGlAk~~~~~~~~------------------~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~k 690 (853)
||++ .++.++|+|||++......... .......|+..|+|||++.+.. ++.+
T Consensus 132 ni~i~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~---------~~~~ 202 (280)
T cd05581 132 NILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKP---------AGKS 202 (280)
T ss_pred HeEECCCCCEEecCCccccccCCccccccCCCCCccccccccccccccccccCCccccCHHHhCCCC---------CChh
Confidence 9999 4679999999999866432211 1223457899999999986543 5679
Q ss_pred cchhhhHHHHHHHHhCCCCCCcchhHHHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCh----hHHhcCCC
Q 003052 691 SDIWSLGCILYQMVYGRTPFSEYKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRI----PQLLQHPF 766 (853)
Q Consensus 691 sDIWSLGVILyELLtG~~PF~~~~~~~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa----~EIL~HPw 766 (853)
+|||||||++|+|++|+.||............. .....++...++.+.+||.+||..||.+||++ .++|+|||
T Consensus 203 ~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~~~ 279 (280)
T cd05581 203 SDLWALGCIIYQMLTGKPPFRGSNEYLTFQKIL---KLEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPF 279 (280)
T ss_pred hhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHH---hcCCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcCCC
Confidence 999999999999999999998655433222222 22234455668889999999999999999999 99999999
Q ss_pred C
Q 003052 767 L 767 (853)
Q Consensus 767 f 767 (853)
|
T Consensus 280 ~ 280 (280)
T cd05581 280 F 280 (280)
T ss_pred C
Confidence 8
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=331.87 Aligned_cols=255 Identities=23% Similarity=0.384 Sum_probs=200.3
Q ss_pred eeeEEEeEeccCceEEEEEEe-cCCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHHHHh
Q 003052 473 LYQRLGKIGSGGSSEVHKVIS-SDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLREVL 551 (853)
Q Consensus 473 ~Y~ilk~LG~G~FG~Vyka~~-~~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~~l~ 551 (853)
.|.....||+|+||.||++.+ .++..||||++.... ......+.+|+.+++++. |+||+++++.
T Consensus 23 ~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~-h~~ii~~~~~------------ 87 (292)
T cd06658 23 YLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRK--QQRRELLFNEVVIMRDYH-HENVVDMYNS------------ 87 (292)
T ss_pred HHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecch--HHHHHHHHHHHHHHHhCC-CCcHHHHHHh------------
Confidence 355567799999999999988 467899999987543 234456889999999997 8999988765
Q ss_pred hCCCCCCCCccccCCeEEEEEecchh-hHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCCCcc
Q 003052 552 NGSMNNKDGRVKDDGYIYMVLEYGEI-DLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPAN 630 (853)
Q Consensus 552 ~~~iv~~~g~~~d~~~lyLVmEy~~g-dL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLKPeN 630 (853)
+...+++|+||||+.+ +|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|
T Consensus 88 ----------~~~~~~~~lv~e~~~~~~L~~~~~~---------~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~N 148 (292)
T cd06658 88 ----------YLVGDELWVVMEFLEGGALTDIVTH---------TRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDS 148 (292)
T ss_pred ----------eecCCeEEEEEeCCCCCcHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHH
Confidence 4456789999999865 66665532 358999999999999999999999999999999999
Q ss_pred EEee-cCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHhCCCC
Q 003052 631 FLLV-KGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGRTP 709 (853)
Q Consensus 631 ILL~-~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLtG~~P 709 (853)
|+++ ++.+||+|||++........ ......|++.|+|||.+.+. .++.++|||||||++|||++|+.|
T Consensus 149 ill~~~~~~kL~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~---------~~~~~~Dv~slGvil~el~~g~~p 217 (292)
T cd06658 149 ILLTSDGRIKLSDFGFCAQVSKEVP--KRKSLVGTPYWMAPEVISRL---------PYGTEVDIWSLGIMVIEMIDGEPP 217 (292)
T ss_pred EEEcCCCCEEEccCcchhhcccccc--cCceeecCccccCHHHHccC---------CCCchhhHHHHHHHHHHHHhCCCC
Confidence 9994 67999999999976543222 22346799999999998654 356799999999999999999999
Q ss_pred CCcchhHHHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCCChhHHhcCCCCCCCCC
Q 003052 710 FSEYKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQHPFLVPPVS 772 (853)
Q Consensus 710 F~~~~~~~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~HPwf~~~~~ 772 (853)
|...........+..............+..+.+||.+||..||.+|||+.++++||||.....
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~~~~~~ 280 (292)
T cd06658 218 YFNEPPLQAMRRIRDNLPPRVKDSHKVSSVLRGFLDLMLVREPSQRATAQELLQHPFLKLAGP 280 (292)
T ss_pred CCCCCHHHHHHHHHhcCCCccccccccCHHHHHHHHHHccCChhHCcCHHHHhhChhhhccCC
Confidence 976544333222221111222233356778999999999999999999999999999985543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=338.42 Aligned_cols=262 Identities=32% Similarity=0.473 Sum_probs=204.3
Q ss_pred ceeeEEEeEeccCceEEEEEEec-CCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHHHH
Q 003052 472 KLYQRLGKIGSGGSSEVHKVISS-DCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLREV 550 (853)
Q Consensus 472 ~~Y~ilk~LG~G~FG~Vyka~~~-~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~~l 550 (853)
++|++.+.||+|+||.||+|.+. ++..+|+|++............+.+|+.+++++.+|+||+++++++..
T Consensus 7 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~-------- 78 (337)
T cd07852 7 RKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKA-------- 78 (337)
T ss_pred hHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeecc--------
Confidence 56899999999999999999985 678899999976544444455678999999999669999999986421
Q ss_pred hhCCCCCCCCccccCCeEEEEEecchhhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCCCcc
Q 003052 551 LNGSMNNKDGRVKDDGYIYMVLEYGEIDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPAN 630 (853)
Q Consensus 551 ~~~~iv~~~g~~~d~~~lyLVmEy~~gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLKPeN 630 (853)
.+...+|+||||++++|..++.. ..+++..++.++.||+.||.|||++||+||||||+|
T Consensus 79 ------------~~~~~~~lv~e~~~~~L~~~~~~---------~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~n 137 (337)
T cd07852 79 ------------ENDKDIYLVFEYMETDLHAVIRA---------NILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSN 137 (337)
T ss_pred ------------CCCceEEEEecccccCHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHH
Confidence 23457899999999888877643 268899999999999999999999999999999999
Q ss_pred EEe-ecCcEEEEecccchhcccCCcc---ccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHhC
Q 003052 631 FLL-VKGSLKLIDFGIAKAIMSDTTN---IQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYG 706 (853)
Q Consensus 631 ILL-~~g~VKL~DFGlAk~~~~~~~~---~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLtG 706 (853)
||+ .++.+||+|||+++.+...... .....+.||+.|+|||++.+.. .++.++|||||||++|+|++|
T Consensus 138 ill~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--------~~~~~sDi~slG~~l~el~tg 209 (337)
T cd07852 138 ILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVATRWYRAPEILLGST--------RYTKGVDMWSVGCILGEMLLG 209 (337)
T ss_pred EEEcCCCcEEEeeccchhccccccccccCcchhcccccccccCceeeeccc--------cccccchHHHHHHHHHHHHhC
Confidence 999 5679999999999876443221 1223467999999999886532 356799999999999999999
Q ss_pred CCCCCcchhHHHHHHhhcC--------------------------CC--CcccCCCCCChhHHHHHHHhcccCCCCCCCh
Q 003052 707 RTPFSEYKTFWAKFKVITD--------------------------PN--HEITYEPVPNPWLLDLMKKCLAWDRNERWRI 758 (853)
Q Consensus 707 ~~PF~~~~~~~~~~kii~~--------------------------~~--~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa 758 (853)
++||.+........+.... .. ......+..+.++.+||.+||..||.+||++
T Consensus 210 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~ 289 (337)
T cd07852 210 KPLFPGTSTLNQLEKIIEVIGPPSAEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTA 289 (337)
T ss_pred CCCCCCCChHHHHHHHHHHhCCCCHHHHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCH
Confidence 9999754332221111100 00 0001112357789999999999999999999
Q ss_pred hHHhcCCCCCCC
Q 003052 759 PQLLQHPFLVPP 770 (853)
Q Consensus 759 ~EIL~HPwf~~~ 770 (853)
.++++||||...
T Consensus 290 ~~il~~~~~~~~ 301 (337)
T cd07852 290 EEALEHPYVAQF 301 (337)
T ss_pred HHHhhChhhhhh
Confidence 999999999654
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-37 Score=323.74 Aligned_cols=254 Identities=34% Similarity=0.560 Sum_probs=202.6
Q ss_pred eeEEEeEeccCceEEEEEEec-CCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHHHHhh
Q 003052 474 YQRLGKIGSGGSSEVHKVISS-DCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLREVLN 552 (853)
Q Consensus 474 Y~ilk~LG~G~FG~Vyka~~~-~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~~l~~ 552 (853)
|++.+.||.|++|.||+|.+. +++.+|+|++............+.+|+.+|++++ |+||++++++
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~------------- 66 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELN-HPNIIKLLDV------------- 66 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhc-CCCcchHHHh-------------
Confidence 567889999999999999984 6789999999866554444567889999999998 8999999876
Q ss_pred CCCCCCCCccccCCeEEEEEecchhhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCCCccEE
Q 003052 553 GSMNNKDGRVKDDGYIYMVLEYGEIDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANFL 632 (853)
Q Consensus 553 ~~iv~~~g~~~d~~~lyLVmEy~~gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLKPeNIL 632 (853)
+.++..+|+||||++++|.+.+..+ ...+++..++.++.||+.||.|||++||+|+||||+||+
T Consensus 67 ---------~~~~~~~~~v~e~~~~~l~~~l~~~-------~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nil 130 (283)
T cd05118 67 ---------FRHKGDLYLVFEFMDTDLYKLIKDR-------QRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLL 130 (283)
T ss_pred ---------hccCCCEEEEEeccCCCHHHHHHhh-------cccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEE
Confidence 3445789999999988888887653 257899999999999999999999999999999999999
Q ss_pred ee-cCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHhCCCCCC
Q 003052 633 LV-KGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGRTPFS 711 (853)
Q Consensus 633 L~-~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLtG~~PF~ 711 (853)
++ ++.+||+|||++....... .......++..|+|||.+.+.. .++.++|||||||++|+|++|+.||.
T Consensus 131 i~~~~~~~l~df~~~~~~~~~~--~~~~~~~~~~~~~~PE~~~~~~--------~~~~~~Di~slG~~l~~l~tg~~~~~ 200 (283)
T cd05118 131 INTEGVLKLADFGLARSFGSPV--RPYTHYVVTRWYRAPELLLGDK--------GYSTPVDIWSVGCIFAELLSRRPLFP 200 (283)
T ss_pred ECCCCcEEEeeeeeeEecCCCc--ccccCccCcccccCcHHHhcCC--------CCCchhHHHHHHHHHHHHHhCCCCCC
Confidence 95 5799999999998765432 1223456889999999986541 35689999999999999999999997
Q ss_pred cchhHHHHHHhhcC---CCCc------------------------ccCCCCCChhHHHHHHHhcccCCCCCCChhHHhcC
Q 003052 712 EYKTFWAKFKVITD---PNHE------------------------ITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQH 764 (853)
Q Consensus 712 ~~~~~~~~~kii~~---~~~~------------------------~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~H 764 (853)
..+......++... +... .......+.++.+||.+||.+||.+||++.+++.|
T Consensus 201 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~ 280 (283)
T cd05118 201 GKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAH 280 (283)
T ss_pred CCCHHHHHHHHHHHcCCCchHhcccchhhhhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhC
Confidence 65543332222110 0000 00112356789999999999999999999999999
Q ss_pred CCC
Q 003052 765 PFL 767 (853)
Q Consensus 765 Pwf 767 (853)
|||
T Consensus 281 ~~~ 283 (283)
T cd05118 281 PYF 283 (283)
T ss_pred CCC
Confidence 997
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-37 Score=327.46 Aligned_cols=268 Identities=28% Similarity=0.436 Sum_probs=204.1
Q ss_pred CceeeEEEeEeccCceEEEEEEec-CCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHHH
Q 003052 471 GKLYQRLGKIGSGGSSEVHKVISS-DCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLRE 549 (853)
Q Consensus 471 g~~Y~ilk~LG~G~FG~Vyka~~~-~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~~ 549 (853)
.+.|++.+.||+|+||.||+|.+. +++.||+|+++...........+.+|++++++++ |+||+++++++..+...
T Consensus 6 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~-h~~i~~~~~~~~~~~~~--- 81 (302)
T cd07864 6 VDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLN-HRNIVNLKEIVTDKQDA--- 81 (302)
T ss_pred hhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCC-CCCeeeeeheecCcchh---
Confidence 356999999999999999999985 6789999999865443334446778999999997 89999999875432210
Q ss_pred HhhCCCCCCCCccccCCeEEEEEecchhhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCCCc
Q 003052 550 VLNGSMNNKDGRVKDDGYIYMVLEYGEIDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPA 629 (853)
Q Consensus 550 l~~~~iv~~~g~~~d~~~lyLVmEy~~gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLKPe 629 (853)
...+.+..++|+||||++++|...+... ...+++..++.++.||+.||.|||++||+||||||+
T Consensus 82 ---------~~~~~~~~~~~lv~e~~~~~l~~~l~~~-------~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~ 145 (302)
T cd07864 82 ---------LDFKKDKGAFYLVFEYMDHDLMGLLESG-------LVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCS 145 (302)
T ss_pred ---------hhccccCCcEEEEEcccCccHHHHHhcC-------CCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHH
Confidence 0113445589999999988877776542 246899999999999999999999999999999999
Q ss_pred cEEe-ecCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHhCCC
Q 003052 630 NFLL-VKGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGRT 708 (853)
Q Consensus 630 NILL-~~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLtG~~ 708 (853)
||++ .++.+||+|||++..+...... ......++..|+|||.+.+.. .++.++|||||||++|+|++|++
T Consensus 146 nili~~~~~~kl~dfg~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~--------~~~~~~Di~slG~~~~el~~g~~ 216 (302)
T cd07864 146 NILLNNKGQIKLADFGLARLYNSEESR-PYTNKVITLWYRPPELLLGEE--------RYGPAIDVWSCGCILGELFTKKP 216 (302)
T ss_pred HEEECCCCcEEeCcccccccccCCccc-ccccceeccCccChHHhcCCC--------CCCchhHHHHHHHHHHHHHhCCC
Confidence 9999 4579999999999876443221 112345688999999886432 25678999999999999999999
Q ss_pred CCCcchhHHHHHH---hhcCCCCc-------c-----------------cCCCCCChhHHHHHHHhcccCCCCCCChhHH
Q 003052 709 PFSEYKTFWAKFK---VITDPNHE-------I-----------------TYEPVPNPWLLDLMKKCLAWDRNERWRIPQL 761 (853)
Q Consensus 709 PF~~~~~~~~~~k---ii~~~~~~-------~-----------------~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EI 761 (853)
||...+....... ....+... . ......+..+.+||.+||..||.+||++.++
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~i 296 (302)
T cd07864 217 IFQANQELAQLELISRLCGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEA 296 (302)
T ss_pred CCCCCChHHHHHHHHHHhCCCChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHH
Confidence 9976443322211 11111000 0 0012357789999999999999999999999
Q ss_pred hcCCCC
Q 003052 762 LQHPFL 767 (853)
Q Consensus 762 L~HPwf 767 (853)
+.||||
T Consensus 297 l~~~~~ 302 (302)
T cd07864 297 LNSPWL 302 (302)
T ss_pred hcCCCC
Confidence 999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=317.17 Aligned_cols=253 Identities=32% Similarity=0.512 Sum_probs=207.8
Q ss_pred eeeEEEeEeccCceEEEEEEec-CCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHHHHh
Q 003052 473 LYQRLGKIGSGGSSEVHKVISS-DCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLREVL 551 (853)
Q Consensus 473 ~Y~ilk~LG~G~FG~Vyka~~~-~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~~l~ 551 (853)
.|++.+.||+|+||.||+|.+. +++.||+|++...... .....+.+|+.++.+++ |+||+++++++
T Consensus 2 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~-~~~~~~~~e~~~l~~l~-~~~i~~~~~~~----------- 68 (264)
T cd06623 2 DLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDE-EFRKQLLRELKTLRSCE-SPYVVKCYGAF----------- 68 (264)
T ss_pred cceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcch-HHHHHHHHHHHHHHhcC-CCCeeeEEEEE-----------
Confidence 4889999999999999999985 5889999999866443 44567889999999998 99999998863
Q ss_pred hCCCCCCCCccccCCeEEEEEecch-hhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhccc-CceeeCCCCCc
Q 003052 552 NGSMNNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHE-ERIVHSDLKPA 629 (853)
Q Consensus 552 ~~~iv~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs-~gIIHRDLKPe 629 (853)
.....+|+||||+. ++|.+++... ..+++..+..++.||+.||.|||+ .|++||||+|+
T Consensus 69 -----------~~~~~~~lv~e~~~~~~L~~~l~~~--------~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ 129 (264)
T cd06623 69 -----------YKEGEISIVLEYMDGGSLADLLKKV--------GKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPS 129 (264)
T ss_pred -----------ccCCeEEEEEEecCCCcHHHHHHHc--------CCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHH
Confidence 44578999999987 6888888653 578999999999999999999999 99999999999
Q ss_pred cEEe-ecCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHhCCC
Q 003052 630 NFLL-VKGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGRT 708 (853)
Q Consensus 630 NILL-~~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLtG~~ 708 (853)
||++ .++.++|+|||++......... .....|+..|+|||.+... .++.++|+||||+++|+|++|..
T Consensus 130 ni~~~~~~~~~l~df~~~~~~~~~~~~--~~~~~~~~~y~~pE~~~~~---------~~~~~~Dv~slG~il~~l~tg~~ 198 (264)
T cd06623 130 NLLINSKGEVKIADFGISKVLENTLDQ--CNTFVGTVTYMSPERIQGE---------SYSYAADIWSLGLTLLECALGKF 198 (264)
T ss_pred HEEECCCCCEEEccCccceecccCCCc--ccceeecccccCHhhhCCC---------CCCchhhHHHHHHHHHHHHhCCC
Confidence 9999 5679999999999876443221 1245789999999998654 35679999999999999999999
Q ss_pred CCCcch--hHHHHHHhhcCCCCcccCCCC-CChhHHHHHHHhcccCCCCCCChhHHhcCCCCCC
Q 003052 709 PFSEYK--TFWAKFKVITDPNHEITYEPV-PNPWLLDLMKKCLAWDRNERWRIPQLLQHPFLVP 769 (853)
Q Consensus 709 PF~~~~--~~~~~~kii~~~~~~~~~~~~-~s~~l~dLI~kcL~~DP~kRpTa~EIL~HPwf~~ 769 (853)
||.... ........+..... ...... .+..+.++|.+||..+|.+||++.++++||||+.
T Consensus 199 p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~~~~~~ 261 (264)
T cd06623 199 PFLPPGQPSFFELMQAICDGPP-PSLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQHPFIKK 261 (264)
T ss_pred CCccccccCHHHHHHHHhcCCC-CCCCcccCCHHHHHHHHHHccCChhhCCCHHHHHhCHHHHh
Confidence 997654 44444444332222 223333 6788999999999999999999999999999964
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-37 Score=325.13 Aligned_cols=258 Identities=23% Similarity=0.318 Sum_probs=199.9
Q ss_pred ceeeEEEeEeccCceEEEEEEecC------CcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHH
Q 003052 472 KLYQRLGKIGSGGSSEVHKVISSD------CTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKA 545 (853)
Q Consensus 472 ~~Y~ilk~LG~G~FG~Vyka~~~~------g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~ 545 (853)
.+|++++.||+|+||.||+|.... ...||+|.++... .......+.+|+.++.+++ |+||++++++
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~-~~~~~~~~~~ei~~l~~l~-h~~i~~~~~~------ 76 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENA-EPKVQQEFRQEAELMSDLQ-HPNIVCLLGV------ 76 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCC-CHHHHHHHHHHHHHHHhcC-CcccceEEEE------
Confidence 468999999999999999998632 2579999987543 3344556889999999997 8999999886
Q ss_pred HHHHHhhCCCCCCCCccccCCeEEEEEecch-hhHHHHHHHhhhhcc--------CCCCCCCHHHHHHHHHHhhhhhhhc
Q 003052 546 LLREVLNGSMNNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEMD--------GSNQTLDENWLRFYWQQILEAVNTI 616 (853)
Q Consensus 546 iL~~l~~~~iv~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~~~--------~~~~~LsE~~~r~I~~QIl~AL~yL 616 (853)
+.+...+|++|||+. ++|.+++........ .....+++..++.++.||+.||.||
T Consensus 77 ----------------~~~~~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~l 140 (283)
T cd05048 77 ----------------CTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYL 140 (283)
T ss_pred ----------------EcCCCceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHH
Confidence 345567899999976 588888865421100 0114688999999999999999999
Q ss_pred ccCceeeCCCCCccEEee-cCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhh
Q 003052 617 HEERIVHSDLKPANFLLV-KGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWS 695 (853)
Q Consensus 617 Hs~gIIHRDLKPeNILL~-~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWS 695 (853)
|++||+||||||+|||++ ++.+||+|||+++...............+++.|+|||.+.+.. ++.++||||
T Consensus 141 H~~~i~H~dlkp~Nil~~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~---------~~~~sDv~s 211 (283)
T cd05048 141 SSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGK---------FTTESDIWS 211 (283)
T ss_pred HhCCeeccccccceEEEcCCCcEEECCCcceeeccccccccccCCCcccccccCHHHhccCc---------CchhhhHHH
Confidence 999999999999999994 5689999999998654332222233456789999999986543 567999999
Q ss_pred hHHHHHHHHh-CCCCCCcchhHHHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCCChhHHhcC
Q 003052 696 LGCILYQMVY-GRTPFSEYKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQH 764 (853)
Q Consensus 696 LGVILyELLt-G~~PF~~~~~~~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~H 764 (853)
|||++|||++ |..||.+...... ...+... .....+...+..+.+|+.+||..||.+||++.+|+++
T Consensus 212 lG~il~el~~~g~~p~~~~~~~~~-~~~i~~~-~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~ 279 (283)
T cd05048 212 FGVVLWEIFSYGLQPYYGFSNQEV-IEMIRSR-QLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTR 279 (283)
T ss_pred HHHHHHHHHcCCCCCCCCCCHHHH-HHHHHcC-CcCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 9999999997 9999977544332 2222221 2223445678899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-37 Score=319.54 Aligned_cols=251 Identities=24% Similarity=0.328 Sum_probs=198.7
Q ss_pred EcCceeeEEEeEeccCceEEEEEEecCCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHH
Q 003052 469 VNGKLYQRLGKIGSGGSSEVHKVISSDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLR 548 (853)
Q Consensus 469 v~g~~Y~ilk~LG~G~FG~Vyka~~~~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~ 548 (853)
+..+.|+++++||+|+||.||+|...++..||+|.+..... ....+.+|+.++++++ |+||++++++
T Consensus 3 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~~---~~~~~~~e~~~l~~l~-h~~i~~~~~~--------- 69 (261)
T cd05072 3 IPRESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTM---SVQAFLEEANLMKTLQ-HDKLVRLYAV--------- 69 (261)
T ss_pred CchHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCch---hHHHHHHHHHHHHhCC-CCCeeeEEEE---------
Confidence 45577999999999999999999988888899999875432 2456889999999997 8999999876
Q ss_pred HHhhCCCCCCCCccccCCeEEEEEecch-hhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCC
Q 003052 549 EVLNGSMNNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLK 627 (853)
Q Consensus 549 ~l~~~~iv~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLK 627 (853)
+.+...+|+||||+. ++|.+++... ....+++..++.++.||+.||.|||++||+|||||
T Consensus 70 -------------~~~~~~~~lv~e~~~~~~L~~~l~~~------~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~ 130 (261)
T cd05072 70 -------------VTKEEPIYIITEYMAKGSLLDFLKSD------EGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLR 130 (261)
T ss_pred -------------EcCCCCcEEEEecCCCCcHHHHHHHh------cCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccc
Confidence 345667899999975 6898888653 23568899999999999999999999999999999
Q ss_pred CccEEe-ecCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHh-
Q 003052 628 PANFLL-VKGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVY- 705 (853)
Q Consensus 628 PeNILL-~~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLt- 705 (853)
|+||++ .++.+||+|||++........ .......++..|+|||.+.+. .++.++|||||||++|+|++
T Consensus 131 p~nili~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~---------~~~~~~Di~slG~~l~~l~t~ 200 (261)
T cd05072 131 AANVLVSESLMCKIADFGLARVIEDNEY-TAREGAKFPIKWTAPEAINFG---------SFTIKSDVWSFGILLYEIVTY 200 (261)
T ss_pred hhhEEecCCCcEEECCCccceecCCCce-eccCCCccceecCCHHHhccC---------CCChhhhhhhhHHHHHHHHcc
Confidence 999999 456899999999987643221 112234567789999998654 35678999999999999998
Q ss_pred CCCCCCcchhHHHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCCChhHHhc
Q 003052 706 GRTPFSEYKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQ 763 (853)
Q Consensus 706 G~~PF~~~~~~~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~ 763 (853)
|..||...........+... .........+.++.+||.+||..||++||+++++++
T Consensus 201 g~~p~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 256 (261)
T cd05072 201 GKIPYPGMSNSDVMSALQRG--YRMPRMENCPDELYDIMKTCWKEKAEERPTFDYLQS 256 (261)
T ss_pred CCCCCCCCCHHHHHHHHHcC--CCCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 99999765443322222221 122233456788999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=309.98 Aligned_cols=250 Identities=32% Similarity=0.519 Sum_probs=203.8
Q ss_pred eeeEEEeEeccCceEEEEEEec-CCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHHHHh
Q 003052 473 LYQRLGKIGSGGSSEVHKVISS-DCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLREVL 551 (853)
Q Consensus 473 ~Y~ilk~LG~G~FG~Vyka~~~-~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~~l~ 551 (853)
+|.+.+.||+|+||.||++.+. ++..+++|++..... .....+.+|+.+++++. |+||++++++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~e~~~l~~l~-~~~i~~~~~~------------ 65 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK--EKKEKIINEIQILKKCK-HPNIVKYYGS------------ 65 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch--hHHHHHHHHHHHHHhCC-CCCEeEEEEE------------
Confidence 3788999999999999999985 678999999976543 34557889999999998 9999999886
Q ss_pred hCCCCCCCCccccCCeEEEEEecch-hhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCCCcc
Q 003052 552 NGSMNNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPAN 630 (853)
Q Consensus 552 ~~~iv~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLKPeN 630 (853)
+..+...|+++||++ ++|.+++... ...+++..++.++.||+.||.|||.+|++||||+|+|
T Consensus 66 ----------~~~~~~~~l~~e~~~~~~L~~~~~~~-------~~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~n 128 (253)
T cd05122 66 ----------YLKKDELWIVMEFCSGGSLKDLLKST-------NQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAAN 128 (253)
T ss_pred ----------EecCCeEEEEEecCCCCcHHHHHhhc-------CCCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHH
Confidence 344567899999977 6888877543 1578999999999999999999999999999999999
Q ss_pred EEee-cCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHhCCCC
Q 003052 631 FLLV-KGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGRTP 709 (853)
Q Consensus 631 ILL~-~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLtG~~P 709 (853)
|+++ ++.++|+|||++........ .....|+..|+|||.+.+.. ++.++|+|||||++|+|++|+.|
T Consensus 129 i~i~~~~~~~l~d~~~~~~~~~~~~---~~~~~~~~~~~~PE~~~~~~---------~~~~~Dv~slG~il~~l~~g~~p 196 (253)
T cd05122 129 ILLTSDGEVKLIDFGLSAQLSDTKA---RNTMVGTPYWMAPEVINGKP---------YDYKADIWSLGITAIELAEGKPP 196 (253)
T ss_pred EEEccCCeEEEeecccccccccccc---ccceecCCcccCHHHHcCCC---------CCccccHHHHHHHHHHHHhCCCC
Confidence 9995 67999999999987654321 23567999999999986543 46799999999999999999999
Q ss_pred CCcchhHHHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCCChhHHhcCCC
Q 003052 710 FSEYKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQHPF 766 (853)
Q Consensus 710 F~~~~~~~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~HPw 766 (853)
|..........................+..+.+||.+||..||.+|||+.++|+|||
T Consensus 197 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~~~~ 253 (253)
T cd05122 197 YSELPPMKALFKIATNGPPGLRNPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLKHPF 253 (253)
T ss_pred CCCCchHHHHHHHHhcCCCCcCcccccCHHHHHHHHHHccCChhhCCCHHHHhcCCC
Confidence 987644443333333222222233334788999999999999999999999999999
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-37 Score=338.14 Aligned_cols=261 Identities=27% Similarity=0.427 Sum_probs=202.5
Q ss_pred ceeeEEEeEeccCceEEEEEEe-cCCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHHHH
Q 003052 472 KLYQRLGKIGSGGSSEVHKVIS-SDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLREV 550 (853)
Q Consensus 472 ~~Y~ilk~LG~G~FG~Vyka~~-~~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~~l 550 (853)
++|.+.+.||+|+||.||+|.+ .+++.||+|+++...........+.+|+.++++++ |+||+++++++....
T Consensus 17 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~-h~~iv~~~~~~~~~~------ 89 (345)
T cd07877 17 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMK-HENVIGLLDVFTPAR------ 89 (345)
T ss_pred CceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcC-CCcccceeeeeeecc------
Confidence 5699999999999999999987 57789999999865444444556789999999997 899999988753211
Q ss_pred hhCCCCCCCCccccCCeEEEEEecchhhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCCCcc
Q 003052 551 LNGSMNNKDGRVKDDGYIYMVLEYGEIDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPAN 630 (853)
Q Consensus 551 ~~~~iv~~~g~~~d~~~lyLVmEy~~gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLKPeN 630 (853)
.+.....+|+++++++++|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|
T Consensus 90 ----------~~~~~~~~~lv~~~~~~~L~~~~~~---------~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~N 150 (345)
T cd07877 90 ----------SLEEFNDVYLVTHLMGADLNNIVKC---------QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSN 150 (345)
T ss_pred ----------cccccccEEEEehhcccCHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHH
Confidence 1234456899999998888776643 358999999999999999999999999999999999
Q ss_pred EEe-ecCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHhCCCC
Q 003052 631 FLL-VKGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGRTP 709 (853)
Q Consensus 631 ILL-~~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLtG~~P 709 (853)
|++ .++.+||+|||+++..... .....|++.|+|||++.+.. .++.++|||||||++|+|++|++|
T Consensus 151 Ill~~~~~~kl~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~--------~~~~~~DvwslG~il~el~~g~~p 217 (345)
T cd07877 151 LAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNWM--------HYNQTVDIWSVGCIMAELLTGRTL 217 (345)
T ss_pred EEEcCCCCEEEeccccccccccc-----ccccccCCCccCHHHHhCcc--------CCCchhhHHHHHHHHHHHHhCCCC
Confidence 999 5679999999999764321 22457899999999986422 356799999999999999999999
Q ss_pred CCcchhHHHHHHhhc---C----------------------CCCcccC---CCCCChhHHHHHHHhcccCCCCCCChhHH
Q 003052 710 FSEYKTFWAKFKVIT---D----------------------PNHEITY---EPVPNPWLLDLMKKCLAWDRNERWRIPQL 761 (853)
Q Consensus 710 F~~~~~~~~~~kii~---~----------------------~~~~~~~---~~~~s~~l~dLI~kcL~~DP~kRpTa~EI 761 (853)
|...........+.. . ......+ ....++.+.+||.+||..||.+||++.++
T Consensus 218 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~ 297 (345)
T cd07877 218 FPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQA 297 (345)
T ss_pred CCCCCHHHHHHHHHHHhCCCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHH
Confidence 965433221111100 0 0000000 11346779999999999999999999999
Q ss_pred hcCCCCCCCC
Q 003052 762 LQHPFLVPPV 771 (853)
Q Consensus 762 L~HPwf~~~~ 771 (853)
|.||||....
T Consensus 298 l~h~~f~~~~ 307 (345)
T cd07877 298 LAHAYFAQYH 307 (345)
T ss_pred hcChhhhhcC
Confidence 9999998644
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-37 Score=323.80 Aligned_cols=262 Identities=17% Similarity=0.280 Sum_probs=199.4
Q ss_pred EEcCceeeEEEeEeccCceEEEEEEec------CCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhh
Q 003052 468 KVNGKLYQRLGKIGSGGSSEVHKVISS------DCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEV 541 (853)
Q Consensus 468 ~v~g~~Y~ilk~LG~G~FG~Vyka~~~------~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~ 541 (853)
.+..++|++.++||+|+||.||+|.+. .+..||+|++.... .......+.+|+.+++.++ |+||++++++
T Consensus 2 ~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~-~~~~~~~~~~e~~~l~~l~-~~~iv~~~~~-- 77 (277)
T cd05062 2 EVAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAA-SMRERIEFLNEASVMKEFN-CHHVVRLLGV-- 77 (277)
T ss_pred cccHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccC-CHHHHHHHHHHHHHHHhCC-CCCeeeEEEE--
Confidence 345677999999999999999998753 24679999986432 2234456889999999987 8999999886
Q ss_pred hHHHHHHHHhhCCCCCCCCccccCCeEEEEEecch-hhHHHHHHHhhhhccC--CCCCCCHHHHHHHHHHhhhhhhhccc
Q 003052 542 TEKALLREVLNGSMNNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEMDG--SNQTLDENWLRFYWQQILEAVNTIHE 618 (853)
Q Consensus 542 ~e~~iL~~l~~~~iv~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~~~~--~~~~LsE~~~r~I~~QIl~AL~yLHs 618 (853)
+.+...+|+||||+. ++|.+++......... ....+++..+..++.||+.||.|||+
T Consensus 78 --------------------~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~ 137 (277)
T cd05062 78 --------------------VSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNA 137 (277)
T ss_pred --------------------EcCCCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHH
Confidence 345667899999965 5888888654221111 12356788999999999999999999
Q ss_pred CceeeCCCCCccEEee-cCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhH
Q 003052 619 ERIVHSDLKPANFLLV-KGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLG 697 (853)
Q Consensus 619 ~gIIHRDLKPeNILL~-~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLG 697 (853)
+||+||||||+|||++ ++.+||+|||+++...............+++.|||||++.+. .++.++||||||
T Consensus 138 ~~~vH~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~---------~~~~~~Di~slG 208 (277)
T cd05062 138 NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDG---------VFTTYSDVWSFG 208 (277)
T ss_pred CCcccCCcchheEEEcCCCCEEECCCCCccccCCcceeecCCCCccCHhhcChhHhhcC---------CcCchhHHHHHH
Confidence 9999999999999994 679999999999865432222112234567899999998754 356799999999
Q ss_pred HHHHHHHh-CCCCCCcchhHHHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCCChhHHhcC
Q 003052 698 CILYQMVY-GRTPFSEYKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQH 764 (853)
Q Consensus 698 VILyELLt-G~~PF~~~~~~~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~H 764 (853)
|++|||++ |..||.+.... ...+.+... .....+...+.++.+||.+||+.||.+||++.+++++
T Consensus 209 ~~l~el~~~~~~p~~~~~~~-~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 274 (277)
T cd05062 209 VVLWEIATLAEQPYQGMSNE-QVLRFVMEG-GLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS 274 (277)
T ss_pred HHHHHHHcCCCCCCCCCCHH-HHHHHHHcC-CcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 99999998 79999765443 222222221 1223345567889999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-37 Score=325.22 Aligned_cols=248 Identities=27% Similarity=0.377 Sum_probs=190.8
Q ss_pred eEeccCceEEEEEEe-cCCcEEEEEEEecCCCChhh-HhhHHHHHHHHHHh--cCCCceeEeeehhhhHHHHHHHHhhCC
Q 003052 479 KIGSGGSSEVHKVIS-SDCTIYALKKIKLKGRDYAT-AYGFCQEIEYLNKL--KGKNNIIQLIDYEVTEKALLREVLNGS 554 (853)
Q Consensus 479 ~LG~G~FG~Vyka~~-~~g~~vAVKkik~~~~~~~~-~~~~l~EI~iLkkL--~~hpNIV~Lid~~~~e~~iL~~l~~~~ 554 (853)
.||+|+||.||+|.+ .+++.||+|.+......... ...+..|..+++.+ .+|++|++++++
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~--------------- 65 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYA--------------- 65 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeee---------------
Confidence 389999999999988 46789999999765432211 22244555555444 248899988765
Q ss_pred CCCCCCccccCCeEEEEEecch-hhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCCCccEEe
Q 003052 555 MNNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLL 633 (853)
Q Consensus 555 iv~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLKPeNILL 633 (853)
+.+...+|+||||+. ++|..++... ..+++..++.|+.|++.||.|||+++|+||||||+||++
T Consensus 66 -------~~~~~~~~~v~e~~~g~~L~~~l~~~--------~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili 130 (278)
T cd05606 66 -------FHTPDKLSFILDLMNGGDLHYHLSQH--------GVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILL 130 (278)
T ss_pred -------eecCCEEEEEEecCCCCcHHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEE
Confidence 456678999999975 5777666432 569999999999999999999999999999999999999
Q ss_pred -ecCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHhCCCCCCc
Q 003052 634 -VKGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGRTPFSE 712 (853)
Q Consensus 634 -~~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLtG~~PF~~ 712 (853)
.++.+||+|||+++.+.... ....+|+..|+|||++.+.. .++.++||||+||++|+|++|+.||.+
T Consensus 131 ~~~~~~kl~dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~--------~~~~~~Di~s~G~~l~~l~~g~~p~~~ 198 (278)
T cd05606 131 DEHGHVRISDLGLACDFSKKK----PHASVGTHGYMAPEVLQKGV--------AYDSSADWFSLGCMLFKLLRGHSPFRQ 198 (278)
T ss_pred CCCCCEEEccCcCccccCccC----CcCcCCCcCCcCcHHhcCCC--------CCCcccchHhHHHHHHHHHhCCCCCCC
Confidence 56799999999997654322 22458999999999986432 356789999999999999999999975
Q ss_pred chh--HHHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCC-----ChhHHhcCCCCCCC
Q 003052 713 YKT--FWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERW-----RIPQLLQHPFLVPP 770 (853)
Q Consensus 713 ~~~--~~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRp-----Ta~EIL~HPwf~~~ 770 (853)
... ......... ......+...+..+.++|.+||..||.+|+ ++.++++||||+..
T Consensus 199 ~~~~~~~~~~~~~~--~~~~~~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~~~~~~~ 261 (278)
T cd05606 199 HKTKDKHEIDRMTL--TMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEHPFFRSL 261 (278)
T ss_pred CCccchHHHHHHhh--ccCCCCCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhCccccCC
Confidence 421 111222221 122334555688999999999999999999 99999999999764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=325.10 Aligned_cols=266 Identities=18% Similarity=0.269 Sum_probs=202.3
Q ss_pred EcCceeeEEEeEeccCceEEEEEEec------CCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhh
Q 003052 469 VNGKLYQRLGKIGSGGSSEVHKVISS------DCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVT 542 (853)
Q Consensus 469 v~g~~Y~ilk~LG~G~FG~Vyka~~~------~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~ 542 (853)
+..++|++.++||+|+||.||+|..+ .+..||+|.+..... ......+.+|+.+++++. |+||++++++
T Consensus 3 ~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~-~~~i~~~~~~--- 77 (288)
T cd05061 3 VSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESAS-LRERIEFLNEASVMKGFT-CHHVVRLLGV--- 77 (288)
T ss_pred ccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCC-HHHHHHHHHHHHHHHhCC-CCCeeeEEEE---
Confidence 45578999999999999999999753 235799998875432 333446789999999997 8999999886
Q ss_pred HHHHHHHHhhCCCCCCCCccccCCeEEEEEecch-hhHHHHHHHhhhhcc--CCCCCCCHHHHHHHHHHhhhhhhhcccC
Q 003052 543 EKALLREVLNGSMNNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEMD--GSNQTLDENWLRFYWQQILEAVNTIHEE 619 (853)
Q Consensus 543 e~~iL~~l~~~~iv~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~~~--~~~~~LsE~~~r~I~~QIl~AL~yLHs~ 619 (853)
+.+....|+||||+. ++|.+++........ .....++...++.++.||+.||.|||++
T Consensus 78 -------------------~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~ 138 (288)
T cd05061 78 -------------------VSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAK 138 (288)
T ss_pred -------------------EcCCCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 344567899999975 689998865321111 1124567788999999999999999999
Q ss_pred ceeeCCCCCccEEe-ecCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHH
Q 003052 620 RIVHSDLKPANFLL-VKGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGC 698 (853)
Q Consensus 620 gIIHRDLKPeNILL-~~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGV 698 (853)
||+||||||+|||+ .++.+||+|||+++...............++..|+|||.+.+. .++.++|||||||
T Consensus 139 ~i~H~dikp~nili~~~~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~---------~~~~~~DvwslG~ 209 (288)
T cd05061 139 KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDG---------VFTTSSDMWSFGV 209 (288)
T ss_pred CCcCCCCChheEEEcCCCcEEECcCCccccccccccccccCCCcccccccCHHHhccC---------CCChHhHHHHHHH
Confidence 99999999999999 5679999999999865433222222234567889999998654 3567999999999
Q ss_pred HHHHHHh-CCCCCCcchhHHHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCCChhHHhc------CCCCCC
Q 003052 699 ILYQMVY-GRTPFSEYKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQ------HPFLVP 769 (853)
Q Consensus 699 ILyELLt-G~~PF~~~~~~~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~------HPwf~~ 769 (853)
++|||++ |..||.+..... ..+.+... .....+...++.+.++|.+||..||.+||++.++++ ||||..
T Consensus 210 ~l~el~~~~~~p~~~~~~~~-~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~~~~ 285 (288)
T cd05061 210 VLWEITSLAEQPYQGLSNEQ-VLKFVMDG-GYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPSFPE 285 (288)
T ss_pred HHHHHHhCCCCCCCCCCHHH-HHHHHHcC-CCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcCCCCCC
Confidence 9999998 899997644332 22322221 122234455788999999999999999999999987 899864
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-38 Score=345.90 Aligned_cols=258 Identities=27% Similarity=0.393 Sum_probs=207.4
Q ss_pred EcCceeeEEEeEeccCceEEEEEEe-cCCcEEEEEEEecCCCChh-hHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHH
Q 003052 469 VNGKLYQRLGKIGSGGSSEVHKVIS-SDCTIYALKKIKLKGRDYA-TAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKAL 546 (853)
Q Consensus 469 v~g~~Y~ilk~LG~G~FG~Vyka~~-~~g~~vAVKkik~~~~~~~-~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~i 546 (853)
+..+.|+..++||+||||.||-|.- .+|+.||+|++.++..... .....++|-.||.++. .+.||.+-
T Consensus 182 vt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~-s~FiVsla--------- 251 (591)
T KOG0986|consen 182 VTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVS-SPFIVSLA--------- 251 (591)
T ss_pred ccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhc-cCcEEEEe---------
Confidence 3446688999999999999999976 5789999999965533221 2224568888888887 45666553
Q ss_pred HHHHhhCCCCCCCCccccCCeEEEEEecch-hhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCC
Q 003052 547 LREVLNGSMNNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSD 625 (853)
Q Consensus 547 L~~l~~~~iv~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRD 625 (853)
..|+..+.+|+||..+. |||...|.+. .+..|+|..+++|+.+|+.||++||+.+||+||
T Consensus 252 -------------YAfeTkd~LClVLtlMNGGDLkfHiyn~------g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRD 312 (591)
T KOG0986|consen 252 -------------YAFETKDALCLVLTLMNGGDLKFHIYNH------GNPGFDEQRARFYAAEIICGLEHLHRRRIVYRD 312 (591)
T ss_pred -------------eeecCCCceEEEEEeecCCceeEEeecc------CCCCCchHHHHHHHHHHHhhHHHHHhcceeecc
Confidence 34778889999999965 5888777654 346899999999999999999999999999999
Q ss_pred CCCccEEe-ecCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHH
Q 003052 626 LKPANFLL-VKGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMV 704 (853)
Q Consensus 626 LKPeNILL-~~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELL 704 (853)
|||+|||| +.|+|.|+|+|+|..+...... ...+||.+|||||++... .|+...|||||||+||||+
T Consensus 313 LKPeNILLDd~GhvRISDLGLAvei~~g~~~---~~rvGT~GYMAPEvl~ne---------~Y~~s~Dwf~lGCllYemi 380 (591)
T KOG0986|consen 313 LKPENILLDDHGHVRISDLGLAVEIPEGKPI---RGRVGTVGYMAPEVLQNE---------VYDFSPDWFSLGCLLYEMI 380 (591)
T ss_pred CChhheeeccCCCeEeeccceEEecCCCCcc---ccccCcccccCHHHHcCC---------cccCCccHHHHHhHHHHHH
Confidence 99999999 5689999999999988654432 245999999999999765 3678999999999999999
Q ss_pred hCCCCCCcchhH--H-HHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCC-----ChhHHhcCCCCCC
Q 003052 705 YGRTPFSEYKTF--W-AKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERW-----RIPQLLQHPFLVP 769 (853)
Q Consensus 705 tG~~PF~~~~~~--~-~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRp-----Ta~EIL~HPwf~~ 769 (853)
.|+.||.....- + +.-+.+. .....|+...++++++|.+.+|.+||.+|. .+.++-+||||+.
T Consensus 381 ~G~sPFr~~KeKvk~eEvdrr~~--~~~~ey~~kFS~eakslc~~LL~Kdp~~RLGcrg~ga~evk~HpfFk~ 451 (591)
T KOG0986|consen 381 AGHSPFRQRKEKVKREEVDRRTL--EDPEEYSDKFSEEAKSLCEGLLTKDPEKRLGCRGEGAQEVKEHPFFKD 451 (591)
T ss_pred cccCchhhhhhhhhHHHHHHHHh--cchhhcccccCHHHHHHHHHHHccCHHHhccCCCcCcchhhhCccccc
Confidence 999999654332 1 2222222 344567788999999999999999999998 4779999999974
|
|
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-37 Score=337.43 Aligned_cols=261 Identities=27% Similarity=0.426 Sum_probs=200.7
Q ss_pred ceeeEEEeEeccCceEEEEEEe-cCCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHHHH
Q 003052 472 KLYQRLGKIGSGGSSEVHKVIS-SDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLREV 550 (853)
Q Consensus 472 ~~Y~ilk~LG~G~FG~Vyka~~-~~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~~l 550 (853)
.+|.+.+.||+|+||.||+|++ .++..||||++............+.+|+.+++++. |+||+++++++...
T Consensus 15 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~------- 86 (342)
T cd07879 15 ERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQ-HENVIGLLDVFTSA------- 86 (342)
T ss_pred cceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcC-CCCccchhheeccc-------
Confidence 4699999999999999999998 46789999999765443334456789999999996 89999998874321
Q ss_pred hhCCCCCCCCccccCCeEEEEEecchhhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCCCcc
Q 003052 551 LNGSMNNKDGRVKDDGYIYMVLEYGEIDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPAN 630 (853)
Q Consensus 551 ~~~~iv~~~g~~~d~~~lyLVmEy~~gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLKPeN 630 (853)
..+.....+|+||||+..+|...+ ...+++..++.++.||+.||.|||++||+||||||+|
T Consensus 87 ---------~~~~~~~~~~lv~e~~~~~l~~~~----------~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~N 147 (342)
T cd07879 87 ---------VSGDEFQDFYLVMPYMQTDLQKIM----------GHPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGN 147 (342)
T ss_pred ---------ccCCCCceEEEEecccccCHHHHH----------cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHH
Confidence 112334567999999877665543 1358999999999999999999999999999999999
Q ss_pred EEe-ecCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHhCCCC
Q 003052 631 FLL-VKGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGRTP 709 (853)
Q Consensus 631 ILL-~~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLtG~~P 709 (853)
||+ .++.+||+|||+++..... .....|++.|+|||++.+.. .++.++|||||||++|||++|+.|
T Consensus 148 Ill~~~~~~kL~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~--------~~~~~~Dv~slGvil~el~~g~~p 214 (342)
T cd07879 148 LAVNEDCELKILDFGLARHADAE-----MTGYVVTRWYRAPEVILNWM--------HYNQTVDIWSVGCIMAEMLTGKTL 214 (342)
T ss_pred EEECCCCCEEEeeCCCCcCCCCC-----CCCceeeecccChhhhcCcc--------ccCchHHHHHHHHHHHHHHhCCCC
Confidence 999 5679999999999764321 12457899999999986532 356799999999999999999999
Q ss_pred CCcchhHHHHHHhhcC---CC-------------------C---cc---cCCCCCChhHHHHHHHhcccCCCCCCChhHH
Q 003052 710 FSEYKTFWAKFKVITD---PN-------------------H---EI---TYEPVPNPWLLDLMKKCLAWDRNERWRIPQL 761 (853)
Q Consensus 710 F~~~~~~~~~~kii~~---~~-------------------~---~~---~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EI 761 (853)
|.+.........++.. +. . .. ...+..+..+.+||.+||+.||.+||++.++
T Consensus 215 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~ 294 (342)
T cd07879 215 FKGKDYLDQLTQILKVTGVPGPEFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEA 294 (342)
T ss_pred CCCCCHHHHHHHHHHhcCCCCHHHHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHH
Confidence 9764432222111110 00 0 00 0012356779999999999999999999999
Q ss_pred hcCCCCCCCCC
Q 003052 762 LQHPFLVPPVS 772 (853)
Q Consensus 762 L~HPwf~~~~~ 772 (853)
|.||||.....
T Consensus 295 l~h~~f~~~~~ 305 (342)
T cd07879 295 LEHPYFDSFRD 305 (342)
T ss_pred hcCcchhhccc
Confidence 99999986543
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=319.02 Aligned_cols=251 Identities=25% Similarity=0.335 Sum_probs=198.9
Q ss_pred EcCceeeEEEeEeccCceEEEEEEecCCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHH
Q 003052 469 VNGKLYQRLGKIGSGGSSEVHKVISSDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLR 548 (853)
Q Consensus 469 v~g~~Y~ilk~LG~G~FG~Vyka~~~~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~ 548 (853)
+..+.|++.+.||+|+||.||+|.+.+++.||+|.++..... ...+.+|+.++++++ |+||++++++
T Consensus 3 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~~---~~~~~~e~~~l~~l~-h~~i~~~~~~--------- 69 (261)
T cd05068 3 IDRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTMD---PKDFLAEAQIMKKLR-HPKLIQLYAV--------- 69 (261)
T ss_pred cchhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCccc---HHHHHHHHHHHHHCC-CCCccceeEE---------
Confidence 345679999999999999999999877788999998754332 345889999999998 8999999886
Q ss_pred HHhhCCCCCCCCccccCCeEEEEEecc-hhhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCC
Q 003052 549 EVLNGSMNNKDGRVKDDGYIYMVLEYG-EIDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLK 627 (853)
Q Consensus 549 ~l~~~~iv~~~g~~~d~~~lyLVmEy~-~gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLK 627 (853)
+...+.+|+||||+ +++|.+++... ....+++..+..++.||+.||.|||++||+|||||
T Consensus 70 -------------~~~~~~~~lv~e~~~~~~L~~~~~~~------~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~ 130 (261)
T cd05068 70 -------------CTLEEPIYIVTELMKYGSLLEYLQGG------AGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLA 130 (261)
T ss_pred -------------EecCCCeeeeeecccCCcHHHHHhcc------CCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCC
Confidence 34556789999997 57998888653 23468999999999999999999999999999999
Q ss_pred CccEEe-ecCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHh-
Q 003052 628 PANFLL-VKGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVY- 705 (853)
Q Consensus 628 PeNILL-~~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLt- 705 (853)
|+||++ .++.+||+|||+++........ ......++..|+|||++.+. .++.++|||||||++|+|++
T Consensus 131 p~Nil~~~~~~~~l~dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~---------~~~~~~Di~slG~~l~el~t~ 200 (261)
T cd05068 131 ARNVLVGENNICKVADFGLARVIKEDIYE-AREGAKFPIKWTAPEAALYN---------RFSIKSDVWSFGILLTEIVTY 200 (261)
T ss_pred cceEEEcCCCCEEECCcceEEEccCCccc-ccCCCcCceeccCccccccC---------CCCchhhHHHHHHHHHHHHhc
Confidence 999999 5678999999999876532111 11122234579999988654 35679999999999999999
Q ss_pred CCCCCCcchhHHHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCCChhHHhc
Q 003052 706 GRTPFSEYKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQ 763 (853)
Q Consensus 706 G~~PF~~~~~~~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~ 763 (853)
|+.||.+.........+.. ......+...+..+.+||.+||..||.+||++.++++
T Consensus 201 g~~p~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~ 256 (261)
T cd05068 201 GRMPYPGMTNAEVLQQVDQ--GYRMPCPPGCPKELYDIMLDCWKEDPDDRPTFETLQW 256 (261)
T ss_pred CCCCCCCCCHHHHHHHHHc--CCCCCCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHH
Confidence 9999977554433333222 1223344556788999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=305.62 Aligned_cols=258 Identities=30% Similarity=0.490 Sum_probs=211.3
Q ss_pred eeeEEEeEeccCceEEEEEEec-CCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHHHHh
Q 003052 473 LYQRLGKIGSGGSSEVHKVISS-DCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLREVL 551 (853)
Q Consensus 473 ~Y~ilk~LG~G~FG~Vyka~~~-~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~~l~ 551 (853)
.|...++||+|.||+||+++.. ++.+||+|.+..+..+.......++||-+|+.|+ |.|||+++|+.
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelk-hknivrl~dvl----------- 70 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELK-HKNIVRLHDVL----------- 70 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhh-hcceeehhhhh-----------
Confidence 3667789999999999999984 6689999999998888777778899999999998 88999999874
Q ss_pred hCCCCCCCCccccCCeEEEEEecchhhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCCCccE
Q 003052 552 NGSMNNKDGRVKDDGYIYMVLEYGEIDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANF 631 (853)
Q Consensus 552 ~~~iv~~~g~~~d~~~lyLVmEy~~gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLKPeNI 631 (853)
..+..+.+|+|||.-+|..+... .++.++...++.++.|+++||.|+|+++++||||||.|+
T Consensus 71 -----------hsdkkltlvfe~cdqdlkkyfds-------lng~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnl 132 (292)
T KOG0662|consen 71 -----------HSDKKLTLVFEFCDQDLKKYFDS-------LNGDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNL 132 (292)
T ss_pred -----------ccCceeEEeHHHhhHHHHHHHHh-------cCCcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceE
Confidence 34567899999999888777654 467899999999999999999999999999999999999
Q ss_pred Ee-ecCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHH-hCCCC
Q 003052 632 LL-VKGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMV-YGRTP 709 (853)
Q Consensus 632 LL-~~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELL-tG~~P 709 (853)
|| .+|.+||+|||+|+.+.-+-.. ....+-|.+|++|.++.+.. -|+..+|+||.|||+.|+. .|++.
T Consensus 133 lin~ngelkladfglarafgipvrc--ysaevvtlwyrppdvlfgak--------ly~tsidmwsagcifaelanagrpl 202 (292)
T KOG0662|consen 133 LINRNGELKLADFGLARAFGIPVRC--YSAEVVTLWYRPPDVLFGAK--------LYSTSIDMWSAGCIFAELANAGRPL 202 (292)
T ss_pred EeccCCcEEecccchhhhcCCceEe--eeceeeeeeccCcceeeeee--------hhccchHhhhcchHHHHHhhcCCCC
Confidence 99 5789999999999987543321 23457899999999998753 4788999999999999998 58888
Q ss_pred CCcch---hHHHHHHhhcCCCCcc--------------cCC---------CCCChhHHHHHHHhcccCCCCCCChhHHhc
Q 003052 710 FSEYK---TFWAKFKVITDPNHEI--------------TYE---------PVPNPWLLDLMKKCLAWDRNERWRIPQLLQ 763 (853)
Q Consensus 710 F~~~~---~~~~~~kii~~~~~~~--------------~~~---------~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~ 763 (853)
|.+.+ +...+++.+..+.... .|+ +..+...+||+.++|.-+|.+|+++++.|+
T Consensus 203 fpg~dvddqlkrif~~lg~p~ed~wps~t~lpdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalq 282 (292)
T KOG0662|consen 203 FPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQ 282 (292)
T ss_pred CCCCcHHHHHHHHHHHhCCCccccCCccccCCCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhc
Confidence 87654 3344555544332211 111 222334689999999999999999999999
Q ss_pred CCCCCCC
Q 003052 764 HPFLVPP 770 (853)
Q Consensus 764 HPwf~~~ 770 (853)
||||...
T Consensus 283 hpyf~d~ 289 (292)
T KOG0662|consen 283 HPYFSDF 289 (292)
T ss_pred Ccccccc
Confidence 9999754
|
|
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-37 Score=321.78 Aligned_cols=257 Identities=32% Similarity=0.542 Sum_probs=200.2
Q ss_pred eeEEEeEeccCceEEEEEEec-CCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHHHHhh
Q 003052 474 YQRLGKIGSGGSSEVHKVISS-DCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLREVLN 552 (853)
Q Consensus 474 Y~ilk~LG~G~FG~Vyka~~~-~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~~l~~ 552 (853)
|++.++||.|+||.||+|.+. +++.+|+|++............+.+|+.+++++. |+||+++++++..
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~---------- 69 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLR-HPNIVRLKEIVTS---------- 69 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhcc-CCCeeeheeeEec----------
Confidence 678999999999999999985 5789999999876533344456889999999998 8999999886321
Q ss_pred CCCCCCCCccccCCeEEEEEecchhhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCCCccEE
Q 003052 553 GSMNNKDGRVKDDGYIYMVLEYGEIDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANFL 632 (853)
Q Consensus 553 ~~iv~~~g~~~d~~~lyLVmEy~~gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLKPeNIL 632 (853)
.....+|+||||++++|..++... ...+++..++.++.||+.||+|||++|++|+||||+|||
T Consensus 70 ----------~~~~~~~lv~e~~~~~l~~~~~~~-------~~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil 132 (287)
T cd07840 70 ----------KGKGSIYMVFEYMDHDLTGLLDSP-------EVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNIL 132 (287)
T ss_pred ----------CCCCcEEEEeccccccHHHHHhcc-------CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeE
Confidence 013689999999988888777542 247899999999999999999999999999999999999
Q ss_pred e-ecCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHhCCCCCC
Q 003052 633 L-VKGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGRTPFS 711 (853)
Q Consensus 633 L-~~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLtG~~PF~ 711 (853)
+ .++.+||+|||++........ .......++..|+|||.+.+.. .++.++|||||||++|+|++|+.||.
T Consensus 133 ~~~~~~~~l~d~g~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~--------~~~~~~Dv~slG~~l~el~t~~~p~~ 203 (287)
T cd07840 133 INNDGVLKLADFGLARPYTKRNS-ADYTNRVITLWYRPPELLLGAT--------RYGPEVDMWSVGCILAELFLGKPIFQ 203 (287)
T ss_pred EcCCCCEEEccccceeeccCCCc-ccccccccccccCCceeeEccc--------cCChHHHHHHHHHHHHHHHhCCCCCC
Confidence 9 567999999999987654321 1122446788999999876532 35689999999999999999999997
Q ss_pred cchhHHHHHHhh---cCCCCc-------------------------ccCCCCCChhHHHHHHHhcccCCCCCCChhHHhc
Q 003052 712 EYKTFWAKFKVI---TDPNHE-------------------------ITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQ 763 (853)
Q Consensus 712 ~~~~~~~~~kii---~~~~~~-------------------------~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~ 763 (853)
..........+. ..+... ..+....+..+.++|.+||..||.+||++.+++.
T Consensus 204 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 283 (287)
T cd07840 204 GSTELEQLEKIFELCGSPTDENWPGVSKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQ 283 (287)
T ss_pred CCChHHHHHHHHHHhCCCchhhccccccchhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 654332211111 110000 0011113778999999999999999999999999
Q ss_pred CCCC
Q 003052 764 HPFL 767 (853)
Q Consensus 764 HPwf 767 (853)
||||
T Consensus 284 ~~~~ 287 (287)
T cd07840 284 HEYF 287 (287)
T ss_pred CcCC
Confidence 9997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-37 Score=321.96 Aligned_cols=251 Identities=20% Similarity=0.256 Sum_probs=195.8
Q ss_pred cCceeeEEEeEeccCceEEEEEEec----CCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHH
Q 003052 470 NGKLYQRLGKIGSGGSSEVHKVISS----DCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKA 545 (853)
Q Consensus 470 ~g~~Y~ilk~LG~G~FG~Vyka~~~----~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~ 545 (853)
+...|++.+.||+|+||.||+|... .+..||+|.++.... ......+.+|+.++++++ |+||++++++
T Consensus 3 ~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~-~~~~~~~~~e~~~l~~l~-h~~iv~~~~~------ 74 (266)
T cd05064 3 DNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCS-DKQRRGFLAEALTLGQFD-HSNIVRLEGV------ 74 (266)
T ss_pred chHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCC-HHHHHHHHHHHHHHhcCC-CCCcCeEEEE------
Confidence 4467999999999999999999753 346899999986533 334456889999999996 8999999886
Q ss_pred HHHHHhhCCCCCCCCccccCCeEEEEEecchh-hHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeC
Q 003052 546 LLREVLNGSMNNKDGRVKDDGYIYMVLEYGEI-DLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHS 624 (853)
Q Consensus 546 iL~~l~~~~iv~~~g~~~d~~~lyLVmEy~~g-dL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHR 624 (853)
+..+..+|+||||+++ +|.+++... ...+++..++.++.||+.||+|||++||+||
T Consensus 75 ----------------~~~~~~~~lv~e~~~~~~L~~~l~~~-------~~~l~~~~~~~~~~~i~~al~~lH~~~iiH~ 131 (266)
T cd05064 75 ----------------ITRGNTMMIVTEYMSNGALDSFLRKH-------EGQLVAGQLMGMLPGLASGMKYLSEMGYVHK 131 (266)
T ss_pred ----------------EecCCCcEEEEEeCCCCcHHHHHHhC-------CCCCCHHHHHHHHHHHHHHHHHHHHCCEeec
Confidence 3455678999999764 777777542 2468999999999999999999999999999
Q ss_pred CCCCccEEe-ecCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHH
Q 003052 625 DLKPANFLL-VKGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQM 703 (853)
Q Consensus 625 DLKPeNILL-~~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyEL 703 (853)
||||+|||+ .++.+||+|||.+........ .......++..|+|||++.+. .++.++|||||||++|||
T Consensus 132 dikp~nili~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~---------~~~~~~Di~slG~~l~el 201 (266)
T cd05064 132 GLAAHKVLVNSDLVCKISGFRRLQEDKSEAI-YTTMSGKSPVLWAAPEAIQYH---------HFSSASDVWSFGIVMWEV 201 (266)
T ss_pred cccHhhEEEcCCCcEEECCCcccccccccch-hcccCCCCceeecCHHHHhhC---------CccchhHHHHHHHHHHHH
Confidence 999999999 567899999998765432211 111133456789999998654 356799999999999997
Q ss_pred Hh-CCCCCCcchhHHHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCCChhHHhc
Q 003052 704 VY-GRTPFSEYKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQ 763 (853)
Q Consensus 704 Lt-G~~PF~~~~~~~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~ 763 (853)
++ |..||.+...... .+.+... .....+...+..+.+++.+||..+|.+||++.+|++
T Consensus 202 l~~g~~p~~~~~~~~~-~~~~~~~-~~~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~ 260 (266)
T cd05064 202 MSYGERPYWDMSGQDV-IKAVEDG-FRLPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHS 260 (266)
T ss_pred hcCCCCCcCcCCHHHH-HHHHHCC-CCCCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHH
Confidence 74 9999976544332 2222222 222345567788999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-37 Score=324.04 Aligned_cols=258 Identities=21% Similarity=0.298 Sum_probs=199.7
Q ss_pred CceeeEEEeEeccCceEEEEEEecC------CcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHH
Q 003052 471 GKLYQRLGKIGSGGSSEVHKVISSD------CTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEK 544 (853)
Q Consensus 471 g~~Y~ilk~LG~G~FG~Vyka~~~~------g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~ 544 (853)
...|.+.+.||+|+||.||+|...+ +..||+|+++.... ......+.+|+++|+++. |+||++++++
T Consensus 4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~-~~~i~~~~~~----- 76 (280)
T cd05049 4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETAS-NDARKDFEREAELLTNFQ-HENIVKFYGV----- 76 (280)
T ss_pred hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCC-HHHHHHHHHHHHHHHhcC-CCCchheeeE-----
Confidence 3568899999999999999998632 47899999875433 234467899999999997 8999999886
Q ss_pred HHHHHHhhCCCCCCCCccccCCeEEEEEecch-hhHHHHHHHhhhhc------cCCCCCCCHHHHHHHHHHhhhhhhhcc
Q 003052 545 ALLREVLNGSMNNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEM------DGSNQTLDENWLRFYWQQILEAVNTIH 617 (853)
Q Consensus 545 ~iL~~l~~~~iv~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~~------~~~~~~LsE~~~r~I~~QIl~AL~yLH 617 (853)
+.....+|+||||+. ++|.+++....... ......+++..+..++.||+.||.|||
T Consensus 77 -----------------~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH 139 (280)
T cd05049 77 -----------------CTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLA 139 (280)
T ss_pred -----------------EecCCCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHh
Confidence 344567899999965 58988886542111 122356899999999999999999999
Q ss_pred cCceeeCCCCCccEEe-ecCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhh
Q 003052 618 EERIVHSDLKPANFLL-VKGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSL 696 (853)
Q Consensus 618 s~gIIHRDLKPeNILL-~~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSL 696 (853)
++||+||||||+|||+ .++.+||+|||+++...............+++.|+|||++.+.. ++.++|||||
T Consensus 140 ~~~i~h~dlkp~nili~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~---------~~~~~Di~sl 210 (280)
T cd05049 140 SQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRK---------FTTESDVWSF 210 (280)
T ss_pred hCCeeccccccceEEEcCCCeEEECCcccceecccCcceecCCCCcccceecChhhhccCC---------cchhhhHHHH
Confidence 9999999999999999 56799999999997653322211122445678999999997653 5678999999
Q ss_pred HHHHHHHHh-CCCCCCcchhHHHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCCChhHHhc
Q 003052 697 GCILYQMVY-GRTPFSEYKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQ 763 (853)
Q Consensus 697 GVILyELLt-G~~PF~~~~~~~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~ 763 (853)
||++|+|++ |..||.+....... ..+.... ....+...+..+.+||.+||..||.+||++.|+++
T Consensus 211 G~il~e~~~~g~~p~~~~~~~~~~-~~~~~~~-~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 276 (280)
T cd05049 211 GVVLWEIFTYGKQPWYGLSNEEVI-ECITQGR-LLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHE 276 (280)
T ss_pred HHHHHHHHhcCCCCCCCCCHHHHH-HHHHcCC-cCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 999999998 99999765443322 2222222 22234467788999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=319.16 Aligned_cols=247 Identities=30% Similarity=0.467 Sum_probs=200.7
Q ss_pred EeccCceEEEEEEec-CCcEEEEEEEecCCC-ChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHHHHhhCCCCC
Q 003052 480 IGSGGSSEVHKVISS-DCTIYALKKIKLKGR-DYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLREVLNGSMNN 557 (853)
Q Consensus 480 LG~G~FG~Vyka~~~-~g~~vAVKkik~~~~-~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~~l~~~~iv~ 557 (853)
||.|+||.||+|++. +++.||+|++..... .......+.+|+++++++. |+||++++++
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~------------------ 61 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECN-HPFIVKLYRT------------------ 61 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCC-CCCEeeeeee------------------
Confidence 799999999999984 578999999976433 2234456889999999996 8999999876
Q ss_pred CCCccccCCeEEEEEecch-hhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCCCccEEe-ec
Q 003052 558 KDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLL-VK 635 (853)
Q Consensus 558 ~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLKPeNILL-~~ 635 (853)
+.++..+|+||||.. ++|.+++... ..+++..++.++.||+.||.|||++|++|+||||+||++ .+
T Consensus 62 ----~~~~~~~~lv~e~~~~~~L~~~l~~~--------~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~~~ 129 (262)
T cd05572 62 ----FKDKKYIYMLMEYCLGGELWTILRDR--------GLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSN 129 (262)
T ss_pred ----EEcCCccEEEEecCCCCcHHHHHhhc--------CCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEcCC
Confidence 456678999999965 6898888653 458999999999999999999999999999999999999 56
Q ss_pred CcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHhCCCCCCcch-
Q 003052 636 GSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGRTPFSEYK- 714 (853)
Q Consensus 636 g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLtG~~PF~~~~- 714 (853)
+.++|+|||+++...... ......|++.|+|||.+.... ++.++|+|||||++|+|++|..||....
T Consensus 130 ~~~~l~df~~~~~~~~~~---~~~~~~~~~~~~~PE~~~~~~---------~~~~~Di~slG~il~~l~~g~~p~~~~~~ 197 (262)
T cd05572 130 GYVKLVDFGFAKKLKSGQ---KTWTFCGTPEYVAPEIILNKG---------YDFSVDYWSLGILLYELLTGRPPFGEDDE 197 (262)
T ss_pred CCEEEeeCCcccccCccc---ccccccCCcCccChhHhcCCC---------CCChhhhhhhHHHHHHHHhCCCCcCCCCC
Confidence 799999999998765432 122457899999999986542 5678999999999999999999997654
Q ss_pred -hHHHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCCC-----hhHHhcCCCCCCC
Q 003052 715 -TFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWR-----IPQLLQHPFLVPP 770 (853)
Q Consensus 715 -~~~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpT-----a~EIL~HPwf~~~ 770 (853)
.... ...+........++...+.++.+||.+||..||.+||+ +.|+++||||+..
T Consensus 198 ~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~ 258 (262)
T cd05572 198 DPMEI-YNDILKGNGKLEFPNYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKKHKWFNGF 258 (262)
T ss_pred CHHHH-HHHHhccCCCCCCCcccCHHHHHHHHHHccCChhhCcCCcccCHHHHhcChhhhCC
Confidence 3322 22222223344555556888999999999999999999 9999999999853
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=319.73 Aligned_cols=261 Identities=20% Similarity=0.260 Sum_probs=201.0
Q ss_pred eeEEEeEeccCceEEEEEEec-C---CcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHHH
Q 003052 474 YQRLGKIGSGGSSEVHKVISS-D---CTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLRE 549 (853)
Q Consensus 474 Y~ilk~LG~G~FG~Vyka~~~-~---g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~~ 549 (853)
|++.+.||+|+||.||+|... + +..||+|+++...........+.+|+.+++.++ |+||+++++++...
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~------ 73 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFD-HPNVMKLIGVCFEA------ 73 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCC-CCCeeeEEeeeccC------
Confidence 567889999999999999863 2 367999999876655566667899999999997 89999999864321
Q ss_pred HhhCCCCCCCCccccCCeEEEEEecch-hhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCCC
Q 003052 550 VLNGSMNNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKP 628 (853)
Q Consensus 550 l~~~~iv~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLKP 628 (853)
..+......++||||+. ++|..++..... ......+++..++.++.||+.||.|||++||+||||||
T Consensus 74 ----------~~~~~~~~~~~v~e~~~~~~l~~~l~~~~~--~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp 141 (273)
T cd05035 74 ----------SSLQKIPKPMVILPFMKHGDLHSFLLYSRL--GGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAA 141 (273)
T ss_pred ----------CccccCcccEEEEeccCCCCHHHHHHHhhc--cCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccch
Confidence 11234456899999965 588877754321 11234689999999999999999999999999999999
Q ss_pred ccEEe-ecCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHh-C
Q 003052 629 ANFLL-VKGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVY-G 706 (853)
Q Consensus 629 eNILL-~~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLt-G 706 (853)
+||++ .++.+||+|||+++...............++..|+|||.+.+. .++.++|||||||++|||++ |
T Consensus 142 ~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~---------~~~~~~Dv~SlG~il~el~~~g 212 (273)
T cd05035 142 RNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADR---------VYTSKSDVWAFGVTMWEIATRG 212 (273)
T ss_pred heEEECCCCeEEECCccceeeccccccccccccccCCccccCHhhcccC---------CCCcccchHHHHHHHHHHHhCC
Confidence 99999 4569999999999876543322222233457789999998654 35679999999999999999 9
Q ss_pred CCCCCcchhHHHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCCChhHHhcC
Q 003052 707 RTPFSEYKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQH 764 (853)
Q Consensus 707 ~~PF~~~~~~~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~H 764 (853)
.+||.+...... +..+... .....+...+..+.++|.+||..||.+||++.+++++
T Consensus 213 ~~p~~~~~~~~~-~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~ 268 (273)
T cd05035 213 QTPYPGVENHEI-YDYLRHG-NRLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREV 268 (273)
T ss_pred CCCCCCCCHHHH-HHHHHcC-CCCCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 999977554332 2222222 2333455678889999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-37 Score=328.61 Aligned_cols=253 Identities=26% Similarity=0.432 Sum_probs=200.0
Q ss_pred eeEEEeEeccCceEEEEEEec-CCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHHHHhh
Q 003052 474 YQRLGKIGSGGSSEVHKVISS-DCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLREVLN 552 (853)
Q Consensus 474 Y~ilk~LG~G~FG~Vyka~~~-~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~~l~~ 552 (853)
|....+||+|+||.||++.+. ++..||+|++...... ....+.+|+.+++.+. |+||++++++
T Consensus 23 ~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~--~~~~~~~e~~~l~~l~-hp~i~~~~~~------------- 86 (297)
T cd06659 23 LENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQ--RRELLFNEVVIMRDYQ-HQNVVEMYKS------------- 86 (297)
T ss_pred HHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccc--hHHHHHHHHHHHHhCC-CCchhhhhhh-------------
Confidence 344557999999999999884 6789999999764332 3345789999999997 8999998875
Q ss_pred CCCCCCCCccccCCeEEEEEecchh-hHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCCCccE
Q 003052 553 GSMNNKDGRVKDDGYIYMVLEYGEI-DLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANF 631 (853)
Q Consensus 553 ~~iv~~~g~~~d~~~lyLVmEy~~g-dL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLKPeNI 631 (853)
+..++.+|+||||+.+ +|..++.. ..+++..++.++.||+.||.|||++||+||||||+||
T Consensus 87 ---------~~~~~~~~iv~e~~~~~~L~~~~~~---------~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Ni 148 (297)
T cd06659 87 ---------YLVGEELWVLMEFLQGGALTDIVSQ---------TRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSI 148 (297)
T ss_pred ---------eeeCCeEEEEEecCCCCCHHHHHhh---------cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHe
Confidence 4556789999999764 67665532 3589999999999999999999999999999999999
Q ss_pred Ee-ecCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHhCCCCC
Q 003052 632 LL-VKGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGRTPF 710 (853)
Q Consensus 632 LL-~~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLtG~~PF 710 (853)
|+ .++.+||+|||++..+..... .....+|++.|+|||++.+.. ++.++|||||||++|+|++|+.||
T Consensus 149 ll~~~~~~kL~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~---------~~~~~Dv~slG~il~el~~g~~p~ 217 (297)
T cd06659 149 LLTLDGRVKLSDFGFCAQISKDVP--KRKSLVGTPYWMAPEVISRTP---------YGTEVDIWSLGIMVIEMVDGEPPY 217 (297)
T ss_pred EEccCCcEEEeechhHhhcccccc--cccceecCccccCHHHHccCC---------CCchhhHHHHHHHHHHHHhCCCCC
Confidence 99 467999999999976543221 223567999999999996543 567999999999999999999999
Q ss_pred CcchhHHHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCCChhHHhcCCCCCCCC
Q 003052 711 SEYKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQHPFLVPPV 771 (853)
Q Consensus 711 ~~~~~~~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~HPwf~~~~ 771 (853)
..........................+.++.+||.+||..+|.+||++.++++||||....
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~~~~~~~~ 278 (297)
T cd06659 218 FSDSPVQAMKRLRDSPPPKLKNAHKISPVLRDFLERMLTREPQERATAQELLDHPFLLQTG 278 (297)
T ss_pred CCCCHHHHHHHHhccCCCCccccCCCCHHHHHHHHHHhcCCcccCcCHHHHhhChhhccCC
Confidence 7654443332222222222223345677899999999999999999999999999997653
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-37 Score=335.96 Aligned_cols=263 Identities=27% Similarity=0.442 Sum_probs=204.9
Q ss_pred CceeeEEEeEeccCceEEEEEEec-CCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHHH
Q 003052 471 GKLYQRLGKIGSGGSSEVHKVISS-DCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLRE 549 (853)
Q Consensus 471 g~~Y~ilk~LG~G~FG~Vyka~~~-~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~~ 549 (853)
.+.|.+.+.||+|+||.||+|.+. ++..||||++............+.+|+.+++++. |+||+++.+++....
T Consensus 14 ~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~----- 87 (343)
T cd07851 14 PDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMD-HENVIGLLDVFTPAS----- 87 (343)
T ss_pred cCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhcc-CCCHHHHHHHhhccc-----
Confidence 356999999999999999999984 6689999998765444444556789999999996 899999887643211
Q ss_pred HhhCCCCCCCCccccCCeEEEEEecchhhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCCCc
Q 003052 550 VLNGSMNNKDGRVKDDGYIYMVLEYGEIDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPA 629 (853)
Q Consensus 550 l~~~~iv~~~g~~~d~~~lyLVmEy~~gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLKPe 629 (853)
.......+|+|+||++++|.+++.. ..+++..++.++.||+.||.|||+.||+||||||+
T Consensus 88 -----------~~~~~~~~~lv~e~~~~~L~~~~~~---------~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~ 147 (343)
T cd07851 88 -----------SLEDFQDVYLVTHLMGADLNNIVKC---------QKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPS 147 (343)
T ss_pred -----------cccccccEEEEEecCCCCHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHH
Confidence 0123346899999998888887753 46999999999999999999999999999999999
Q ss_pred cEEe-ecCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHhCCC
Q 003052 630 NFLL-VKGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGRT 708 (853)
Q Consensus 630 NILL-~~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLtG~~ 708 (853)
||++ .++.+||+|||++...... .....++..|+|||++.+.. .++.++|||||||++|+|++|+.
T Consensus 148 Nill~~~~~~kL~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~--------~~~~~~DvwslGv~l~elltg~~ 214 (343)
T cd07851 148 NIAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNWM--------HYNQTVDIWSVGCIMAELLTGKT 214 (343)
T ss_pred HeEECCCCCEEEcccccccccccc-----ccCCcccccccCHHHHhCCC--------CCCchHhHHHHHHHHHHHHhCCC
Confidence 9999 4679999999999865432 23557899999999986432 35689999999999999999999
Q ss_pred CCCcchhHHHHHHhhcC---CCC------------------------cc-cCCCCCChhHHHHHHHhcccCCCCCCChhH
Q 003052 709 PFSEYKTFWAKFKVITD---PNH------------------------EI-TYEPVPNPWLLDLMKKCLAWDRNERWRIPQ 760 (853)
Q Consensus 709 PF~~~~~~~~~~kii~~---~~~------------------------~~-~~~~~~s~~l~dLI~kcL~~DP~kRpTa~E 760 (853)
||.+.........++.. +.. .+ ......+..+.+||.+||..||.+|||+.+
T Consensus 215 pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~e 294 (343)
T cd07851 215 LFPGSDHIDQLKRIMNLVGTPDEELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAE 294 (343)
T ss_pred CCCCCChHHHHHHHHHhcCCCCHHHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHH
Confidence 99765443222211110 000 00 001234778999999999999999999999
Q ss_pred HhcCCCCCCCCC
Q 003052 761 LLQHPFLVPPVS 772 (853)
Q Consensus 761 IL~HPwf~~~~~ 772 (853)
|++||||.....
T Consensus 295 ll~h~~~~~~~~ 306 (343)
T cd07851 295 ALAHPYLAEYHD 306 (343)
T ss_pred HhcCCCccccCC
Confidence 999999986543
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=312.01 Aligned_cols=255 Identities=31% Similarity=0.481 Sum_probs=208.2
Q ss_pred eeeEEEeEeccCceEEEEEEec-CCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHHHHh
Q 003052 473 LYQRLGKIGSGGSSEVHKVISS-DCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLREVL 551 (853)
Q Consensus 473 ~Y~ilk~LG~G~FG~Vyka~~~-~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~~l~ 551 (853)
+|.+.+.||.|+||.||++.+. ++..||+|++............+.+|+++++.++ |+|++++++.
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~~~~~~~~------------ 67 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLN-HPNIIKYYES------------ 67 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcC-CCChhheEEE------------
Confidence 4889999999999999999984 6789999999876665566667889999999998 8999999876
Q ss_pred hCCCCCCCCccccCCeEEEEEecch-hhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCCCcc
Q 003052 552 NGSMNNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPAN 630 (853)
Q Consensus 552 ~~~iv~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLKPeN 630 (853)
+.+...+++||||++ ++|.+.+..... ....+++..+..++.+|+.||.|||++||+|+||+|+|
T Consensus 68 ----------~~~~~~~~lv~e~~~~~~L~~~l~~~~~----~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~n 133 (258)
T cd08215 68 ----------FEEKGKLCIVMEYADGGDLSQKIKKQKK----EGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQN 133 (258)
T ss_pred ----------EecCCEEEEEEEecCCCcHHHHHHHhhc----cCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHH
Confidence 334578999999986 488888866421 23679999999999999999999999999999999999
Q ss_pred EEee-cCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHhCCCC
Q 003052 631 FLLV-KGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGRTP 709 (853)
Q Consensus 631 ILL~-~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLtG~~P 709 (853)
|+++ ++.++|+|||++....... .......|++.|+|||.+.... ++.++|+||+|+++|+|++|..|
T Consensus 134 il~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~y~~pe~~~~~~---------~~~~~Dv~slG~~~~~l~~g~~p 202 (258)
T cd08215 134 IFLTSNGLVKLGDFGISKVLSSTV--DLAKTVVGTPYYLSPELCQNKP---------YNYKSDIWSLGCVLYELCTLKHP 202 (258)
T ss_pred eEEcCCCcEEECCccceeecccCc--ceecceeeeecccChhHhccCC---------CCccccHHHHHHHHHHHHcCCCC
Confidence 9995 5799999999998764432 1223568999999999886543 56789999999999999999999
Q ss_pred CCcchhHHHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCCChhHHhcCCCC
Q 003052 710 FSEYKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQHPFL 767 (853)
Q Consensus 710 F~~~~~~~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~HPwf 767 (853)
|................ ....+...+.++.++|.+||..+|.+||++.++|+||||
T Consensus 203 ~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~~~~ 258 (258)
T cd08215 203 FEGENLLELALKILKGQ--YPPIPSQYSSELRNLVSSLLQKDPEERPSIAQILQSPFI 258 (258)
T ss_pred CCCCcHHHHHHHHhcCC--CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhcCCCC
Confidence 97654433222222221 223344677889999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-39 Score=383.00 Aligned_cols=261 Identities=32% Similarity=0.516 Sum_probs=218.0
Q ss_pred eeeEEEeEeccCceEEEEEEe-cCCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHHHHh
Q 003052 473 LYQRLGKIGSGGSSEVHKVIS-SDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLREVL 551 (853)
Q Consensus 473 ~Y~ilk~LG~G~FG~Vyka~~-~~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~~l~ 551 (853)
+|....+||.|.||.||-|.+ .+|...|+|.|+....+......+.+|.++|..++ |||+|+++++.+..
T Consensus 1236 rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~ln-HpNlV~YyGVEvHR-------- 1306 (1509)
T KOG4645|consen 1236 RWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLN-HPNLVRYYGVEVHR-------- 1306 (1509)
T ss_pred eeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhcc-CccccccCceeecH--------
Confidence 477778899999999999998 57789999999887666666667889999999998 99999999986543
Q ss_pred hCCCCCCCCccccCCeEEEEEecchh-hHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCCCcc
Q 003052 552 NGSMNNKDGRVKDDGYIYMVLEYGEI-DLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPAN 630 (853)
Q Consensus 552 ~~~iv~~~g~~~d~~~lyLVmEy~~g-dL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLKPeN 630 (853)
..+||.||||.+ +|.+.+.. ++..+|...+.|..|++.||.|||++|||||||||+|
T Consensus 1307 --------------ekv~IFMEyC~~GsLa~ll~~--------gri~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aN 1364 (1509)
T KOG4645|consen 1307 --------------EKVYIFMEYCEGGSLASLLEH--------GRIEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPAN 1364 (1509)
T ss_pred --------------HHHHHHHHHhccCcHHHHHHh--------cchhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccc
Confidence 236899999885 77776653 3568899999999999999999999999999999999
Q ss_pred EEe-ecCcEEEEecccchhcccCCcc--ccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHhCC
Q 003052 631 FLL-VKGSLKLIDFGIAKAIMSDTTN--IQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGR 707 (853)
Q Consensus 631 ILL-~~g~VKL~DFGlAk~~~~~~~~--~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLtG~ 707 (853)
||| .+|.+|++|||.|..+...... .......||+.|||||++.+.... ..+.++|||||||+..||+||+
T Consensus 1365 I~Ld~~g~iK~~DFGsa~ki~~~~~~~~~el~~~~GT~~YMAPEvit~t~~k------G~~~A~DiWslGCVVlEM~tGk 1438 (1509)
T KOG4645|consen 1365 ILLDFNGLIKYGDFGSAVKIKNNAQTMPGELQSMMGTPMYMAPEVITGTKGK------GHGGAADIWSLGCVVLEMATGK 1438 (1509)
T ss_pred eeeecCCcEEeecccceeEecCchhcCCHHHHhhcCCchhcCchhhcccccC------CCCcchhhhcccceEEEeecCC
Confidence 999 5789999999999887654321 123467899999999999876533 2467999999999999999999
Q ss_pred CCCCcchhHHHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCCChhHHhcCCCCCCCC
Q 003052 708 TPFSEYKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQHPFLVPPV 771 (853)
Q Consensus 708 ~PF~~~~~~~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~HPwf~~~~ 771 (853)
.||.+.++.|++.-.... .+....|...+++.++||.+||..||++||++.|||+|.|-+...
T Consensus 1439 rPW~~~dne~aIMy~V~~-gh~Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~~f~~~~~ 1501 (1509)
T KOG4645|consen 1439 RPWAELDNEWAIMYHVAA-GHKPQIPERLSSEGRDFLEHCLEQDPKMRWTASQLLEHAFGKSCT 1501 (1509)
T ss_pred CchhhccchhHHHhHHhc-cCCCCCchhhhHhHHHHHHHHHhcCchhhhHHHHHHHhhcccccc
Confidence 999988887776544433 345566777999999999999999999999999999999986543
|
|
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=322.46 Aligned_cols=260 Identities=26% Similarity=0.393 Sum_probs=201.2
Q ss_pred eeeEEEeEeccCceEEEEEEec-CCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHHHHh
Q 003052 473 LYQRLGKIGSGGSSEVHKVISS-DCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLREVL 551 (853)
Q Consensus 473 ~Y~ilk~LG~G~FG~Vyka~~~-~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~~l~ 551 (853)
.|...++||.|+||.||+|.+. +++.||+|.+...... .....+.+|++++++++ |+||+++++++..
T Consensus 2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~-~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~--------- 70 (287)
T cd06621 2 KIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNP-DLQKQILRELEINKSCK-SPYIVKYYGAFLD--------- 70 (287)
T ss_pred ceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCch-HHHHHHHHHHHHHHhCC-CCCeeeeeeEEEc---------
Confidence 5889999999999999999984 6688999998754332 44556889999999997 9999999987432
Q ss_pred hCCCCCCCCccccCCeEEEEEecch-hhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCCCcc
Q 003052 552 NGSMNNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPAN 630 (853)
Q Consensus 552 ~~~iv~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLKPeN 630 (853)
...+.+|+||||++ ++|.+++..... ....+++..+..++.||+.||.|||+.||+|+||+|+|
T Consensus 71 -----------~~~~~~~lv~e~~~~~~L~~~l~~~~~----~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~n 135 (287)
T cd06621 71 -----------ESSSSIGIAMEYCEGGSLDSIYKKVKK----RGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSN 135 (287)
T ss_pred -----------cCCCeEEEEEEecCCCCHHHHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHH
Confidence 23457899999976 488777654321 34568999999999999999999999999999999999
Q ss_pred EEe-ecCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHhCCCC
Q 003052 631 FLL-VKGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGRTP 709 (853)
Q Consensus 631 ILL-~~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLtG~~P 709 (853)
|++ .++.++|+|||++........ ....++..|+|||.+.+.. ++.++|||||||++|+|++|..|
T Consensus 136 il~~~~~~~~l~dfg~~~~~~~~~~----~~~~~~~~y~~pE~~~~~~---------~~~~~Dv~slG~il~~l~~g~~p 202 (287)
T cd06621 136 ILLTRKGQVKLCDFGVSGELVNSLA----GTFTGTSFYMAPERIQGKP---------YSITSDVWSLGLTLLEVAQNRFP 202 (287)
T ss_pred EEEecCCeEEEeecccccccccccc----ccccCCccccCHHHhcCCC---------CCchhhHHHHHHHHHHHHhCCCC
Confidence 999 467899999999876543221 2457889999999986543 56789999999999999999999
Q ss_pred CCcch----hHHHHHHhhcC-CCCcc----cCCCCCChhHHHHHHHhcccCCCCCCChhHHhcCCCCCCCC
Q 003052 710 FSEYK----TFWAKFKVITD-PNHEI----TYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQHPFLVPPV 771 (853)
Q Consensus 710 F~~~~----~~~~~~kii~~-~~~~~----~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~HPwf~~~~ 771 (853)
|.... ........+.. ..... ......++.+.+||.+||..||.+|||+.|++.||||+...
T Consensus 203 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~~~~~~~ 273 (287)
T cd06621 203 FPPEGEPPLGPIELLSYIVNMPNPELKDEPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIKAQM 273 (287)
T ss_pred CCcccCCCCChHHHHHHHhcCCchhhccCCCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHhCccccccc
Confidence 97541 11122222221 11111 00122356799999999999999999999999999996543
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=315.76 Aligned_cols=249 Identities=28% Similarity=0.404 Sum_probs=200.0
Q ss_pred eeeEEEeEeccCceEEEEEEec-CCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHHHHh
Q 003052 473 LYQRLGKIGSGGSSEVHKVISS-DCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLREVL 551 (853)
Q Consensus 473 ~Y~ilk~LG~G~FG~Vyka~~~-~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~~l~ 551 (853)
+|++.++||+|+||.||++.+. ++..||+|.++.... ......+.+|+.++++++ |+||+++++.
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~e~~~l~~l~-h~~i~~~~~~------------ 66 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKS-SSAVEDSRKEAVLLAKMK-HPNIVAFKES------------ 66 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcc-hHHHHHHHHHHHHHHhCC-CCCcceEEEE------------
Confidence 4889999999999999999984 678999999975433 234556789999999997 8999999876
Q ss_pred hCCCCCCCCccccCCeEEEEEecch-hhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCCCcc
Q 003052 552 NGSMNNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPAN 630 (853)
Q Consensus 552 ~~~iv~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLKPeN 630 (853)
+.++.++|+||||+. ++|.+.+... ....+++..++.++.||+.||.|||++||+|+||||+|
T Consensus 67 ----------~~~~~~~~lv~e~~~~~~l~~~~~~~------~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~n 130 (255)
T cd08219 67 ----------FEADGHLYIVMEYCDGGDLMQKIKLQ------RGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKN 130 (255)
T ss_pred ----------EEECCEEEEEEeeCCCCcHHHHHHhc------cCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcce
Confidence 566778999999975 5888877543 23568999999999999999999999999999999999
Q ss_pred EEe-ecCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHhCCCC
Q 003052 631 FLL-VKGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGRTP 709 (853)
Q Consensus 631 ILL-~~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLtG~~P 709 (853)
||+ .++.++|+|||++........ ......|++.|+|||++.+. .++.++|+|||||++|+|++|..|
T Consensus 131 ili~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~---------~~~~~~Dv~slG~i~~~l~~g~~p 199 (255)
T cd08219 131 IFLTQNGKVKLGDFGSARLLTSPGA--YACTYVGTPYYVPPEIWENM---------PYNNKSDIWSLGCILYELCTLKHP 199 (255)
T ss_pred EEECCCCcEEEcccCcceeeccccc--ccccccCCccccCHHHHccC---------CcCchhhhhhhchhheehhhccCC
Confidence 999 467999999999976643221 22356799999999998654 356799999999999999999999
Q ss_pred CCcchhHHHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCCChhHHhcC
Q 003052 710 FSEYKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQH 764 (853)
Q Consensus 710 F~~~~~~~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~H 764 (853)
|.............. .. ....+...+..+.+||.+||..||.+||++.+|+.-
T Consensus 200 ~~~~~~~~~~~~~~~-~~-~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 200 FQANSWKNLILKVCQ-GS-YKPLPSHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred CCCCCHHHHHHHHhc-CC-CCCCCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 976544333333222 11 122344567889999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=342.99 Aligned_cols=264 Identities=23% Similarity=0.323 Sum_probs=202.7
Q ss_pred eEEcCceeeEEEeEeccCceEEEEEEec------CCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehh
Q 003052 467 FKVNGKLYQRLGKIGSGGSSEVHKVISS------DCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYE 540 (853)
Q Consensus 467 ~~v~g~~Y~ilk~LG~G~FG~Vyka~~~------~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~ 540 (853)
+.+..+.|.+.+.||+|+||.||+|++. .+..||||+++.... ......+.+|+++|+++..||||++++++
T Consensus 32 ~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~-~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~- 109 (400)
T cd05105 32 WEFPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTAR-SSEKQALMSELKIMTHLGPHLNIVNLLGA- 109 (400)
T ss_pred eeccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCC-hHHHHHHHHHHHHHHhcCCCCCeeeEEEE-
Confidence 3445567999999999999999999862 124699999975433 33445789999999999889999999987
Q ss_pred hhHHHHHHHHhhCCCCCCCCccccCCeEEEEEecch-hhHHHHHHHhhhhcc----------------------------
Q 003052 541 VTEKALLREVLNGSMNNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEMD---------------------------- 591 (853)
Q Consensus 541 ~~e~~iL~~l~~~~iv~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~~~---------------------------- 591 (853)
+.+...+||||||+. ++|.+++.+......
T Consensus 110 ---------------------~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 168 (400)
T cd05105 110 ---------------------CTKSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVI 168 (400)
T ss_pred ---------------------EccCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhh
Confidence 445667899999976 589888866422110
Q ss_pred ------------------------------------------------------------CCCCCCCHHHHHHHHHHhhh
Q 003052 592 ------------------------------------------------------------GSNQTLDENWLRFYWQQILE 611 (853)
Q Consensus 592 ------------------------------------------------------------~~~~~LsE~~~r~I~~QIl~ 611 (853)
.....+++..+..++.||+.
T Consensus 169 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~ 248 (400)
T cd05105 169 LSFENKGDYMDMKQADTTQYVPMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVAR 248 (400)
T ss_pred hhhcccccccccccccccccchhhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHH
Confidence 01235888999999999999
Q ss_pred hhhhcccCceeeCCCCCccEEee-cCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCc
Q 003052 612 AVNTIHEERIVHSDLKPANFLLV-KGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRP 690 (853)
Q Consensus 612 AL~yLHs~gIIHRDLKPeNILL~-~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~k 690 (853)
||.|||++||+||||||+|||++ ++.+||+|||+++.+.............+++.|+|||++.+.. ++.+
T Consensus 249 aL~~LH~~~ivH~dikp~Nill~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~---------~~~~ 319 (400)
T cd05105 249 GMEFLASKNCVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNL---------YTTL 319 (400)
T ss_pred HHHHHHhCCeeCCCCChHhEEEeCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCC---------CCch
Confidence 99999999999999999999995 5689999999998764433222223456788999999986543 5679
Q ss_pred cchhhhHHHHHHHHh-CCCCCCcchhHHHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCCChhHHhc
Q 003052 691 SDIWSLGCILYQMVY-GRTPFSEYKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQ 763 (853)
Q Consensus 691 sDIWSLGVILyELLt-G~~PF~~~~~~~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~ 763 (853)
+|||||||++|+|++ |..||............+... .....+...+..+.+||.+||..||++||++.+|.+
T Consensus 320 ~DiwSlGvil~ellt~g~~P~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~ 392 (400)
T cd05105 320 SDVWSYGILLWEIFSLGGTPYPGMIVDSTFYNKIKSG-YRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSD 392 (400)
T ss_pred hhHHHHHHHHHHHHHCCCCCCcccchhHHHHHHHhcC-CCCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHH
Confidence 999999999999996 999997643322223333222 223344566788999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=319.16 Aligned_cols=260 Identities=18% Similarity=0.288 Sum_probs=201.8
Q ss_pred EcCceeeEEEeEeccCceEEEEEEecC------CcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhh
Q 003052 469 VNGKLYQRLGKIGSGGSSEVHKVISSD------CTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVT 542 (853)
Q Consensus 469 v~g~~Y~ilk~LG~G~FG~Vyka~~~~------g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~ 542 (853)
+..++|.+.+.||+|+||.||+|.... +..||+|.+.... .......+.+|+.+|+.+. |+||++++++
T Consensus 3 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~-~~~~~~~~~~e~~~l~~~~-~~~i~~~~~~--- 77 (277)
T cd05032 3 LPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENA-SMRERIEFLNEASVMKEFN-CHHVVRLLGV--- 77 (277)
T ss_pred cchHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCcc-CHHHHHHHHHHHHHHHhCC-CCceeEEEEE---
Confidence 445679999999999999999998642 3679999986543 2334456889999999997 8999999987
Q ss_pred HHHHHHHHhhCCCCCCCCccccCCeEEEEEecch-hhHHHHHHHhhhhcc--CCCCCCCHHHHHHHHHHhhhhhhhcccC
Q 003052 543 EKALLREVLNGSMNNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEMD--GSNQTLDENWLRFYWQQILEAVNTIHEE 619 (853)
Q Consensus 543 e~~iL~~l~~~~iv~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~~~--~~~~~LsE~~~r~I~~QIl~AL~yLHs~ 619 (853)
+.+...+|+||||+. ++|.+++........ .....+++..+..++.||+.||.|||++
T Consensus 78 -------------------~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~ 138 (277)
T cd05032 78 -------------------VSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAK 138 (277)
T ss_pred -------------------EcCCCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 344567899999975 689888865422111 1234578999999999999999999999
Q ss_pred ceeeCCCCCccEEe-ecCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHH
Q 003052 620 RIVHSDLKPANFLL-VKGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGC 698 (853)
Q Consensus 620 gIIHRDLKPeNILL-~~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGV 698 (853)
||+||||||+|||+ .++.+||+|||+++.+.............++..|+|||.+.+. .++.++|||||||
T Consensus 139 ~i~H~di~p~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~---------~~~~~~Di~slG~ 209 (277)
T cd05032 139 KFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDG---------VFTTKSDVWSFGV 209 (277)
T ss_pred CccccccChheEEEcCCCCEEECCcccchhhccCcccccCCCCCccccccCHHHHhcC---------CCCcccchHHHHH
Confidence 99999999999999 5679999999999876543322222345678899999998654 3567899999999
Q ss_pred HHHHHHh-CCCCCCcchhHHHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCCChhHHhc
Q 003052 699 ILYQMVY-GRTPFSEYKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQ 763 (853)
Q Consensus 699 ILyELLt-G~~PF~~~~~~~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~ 763 (853)
++|||++ |..||.+.... ...+.+.. ......+...+..+.+||.+||..+|.+|||+.+++.
T Consensus 210 il~el~t~g~~p~~~~~~~-~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~ 273 (277)
T cd05032 210 VLWEMATLAEQPYQGLSNE-EVLKFVID-GGHLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVS 273 (277)
T ss_pred HHHHhhccCCCCCccCCHH-HHHHHHhc-CCCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 9999998 99999764432 22333332 2223345556888999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-37 Score=333.04 Aligned_cols=261 Identities=27% Similarity=0.433 Sum_probs=199.6
Q ss_pred ceee-EEEeEeccCceEEEEEEec-CCcEEEEEEEecCCCChh------------hHhhHHHHHHHHHHhcCCCceeEee
Q 003052 472 KLYQ-RLGKIGSGGSSEVHKVISS-DCTIYALKKIKLKGRDYA------------TAYGFCQEIEYLNKLKGKNNIIQLI 537 (853)
Q Consensus 472 ~~Y~-ilk~LG~G~FG~Vyka~~~-~g~~vAVKkik~~~~~~~------------~~~~~l~EI~iLkkL~~hpNIV~Li 537 (853)
++|. +.+.||.|+||.||+|.+. +++.||||+++....... ....+.+|++++++++ |+||++++
T Consensus 8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~ 86 (335)
T PTZ00024 8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIK-HENIMGLV 86 (335)
T ss_pred cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCC-Ccceeeee
Confidence 3455 4567999999999999984 678999999975432210 1124678999999997 89999999
Q ss_pred ehhhhHHHHHHHHhhCCCCCCCCccccCCeEEEEEecchhhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcc
Q 003052 538 DYEVTEKALLREVLNGSMNNKDGRVKDDGYIYMVLEYGEIDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIH 617 (853)
Q Consensus 538 d~~~~e~~iL~~l~~~~iv~~~g~~~d~~~lyLVmEy~~gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLH 617 (853)
+++ ....++|+||||++++|.+++... ..+++..+..++.||+.||.|||
T Consensus 87 ~~~----------------------~~~~~~~lv~e~~~~~l~~~l~~~--------~~~~~~~~~~~~~ql~~aL~~LH 136 (335)
T PTZ00024 87 DVY----------------------VEGDFINLVMDIMASDLKKVVDRK--------IRLTESQVKCILLQILNGLNVLH 136 (335)
T ss_pred EEE----------------------ecCCcEEEEEeccccCHHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHH
Confidence 873 455688999999999988887543 46899999999999999999999
Q ss_pred cCceeeCCCCCccEEe-ecCcEEEEecccchhcccCC------------ccccccccccCccccCchhhccCCCCCCCcc
Q 003052 618 EERIVHSDLKPANFLL-VKGSLKLIDFGIAKAIMSDT------------TNIQRDSQVGTLSYMSPEAFMCNESDENGNI 684 (853)
Q Consensus 618 s~gIIHRDLKPeNILL-~~g~VKL~DFGlAk~~~~~~------------~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~ 684 (853)
++||+||||||+||++ .++.+||+|||+++...... .........+++.|+|||.+.+..
T Consensus 137 ~~~i~H~dl~~~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~------- 209 (335)
T PTZ00024 137 KWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAE------- 209 (335)
T ss_pred hCCeecccccHHHeEECCCCCEEECCccceeecccccccccccccccccccccccccccccCCCCChhcccCC-------
Confidence 9999999999999999 56799999999997654110 011122346788999999986532
Q ss_pred ccCCCccchhhhHHHHHHHHhCCCCCCcchhHHHHHHh---hcCCCCc----------------------ccCCCCCChh
Q 003052 685 IKCGRPSDIWSLGCILYQMVYGRTPFSEYKTFWAKFKV---ITDPNHE----------------------ITYEPVPNPW 739 (853)
Q Consensus 685 ~~ys~ksDIWSLGVILyELLtG~~PF~~~~~~~~~~ki---i~~~~~~----------------------~~~~~~~s~~ 739 (853)
.++.++|||||||++|+|++|.+||.+.........+ ...+... .......+..
T Consensus 210 -~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 288 (335)
T PTZ00024 210 -KYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDD 288 (335)
T ss_pred -CCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChH
Confidence 3567999999999999999999999765543322211 1111100 0001234677
Q ss_pred HHHHHHHhcccCCCCCCChhHHhcCCCCCCCC
Q 003052 740 LLDLMKKCLAWDRNERWRIPQLLQHPFLVPPV 771 (853)
Q Consensus 740 l~dLI~kcL~~DP~kRpTa~EIL~HPwf~~~~ 771 (853)
+.+||.+||..||.+||+++++|.||||....
T Consensus 289 ~~~li~~~l~~~P~~R~s~~~~l~~~~~~~~~ 320 (335)
T PTZ00024 289 AIDLLQSLLKLNPLERISAKEALKHEYFKSDP 320 (335)
T ss_pred HHHHHHHHcCCCchhccCHHHHhcCcccCCCC
Confidence 89999999999999999999999999998653
|
|
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=323.56 Aligned_cols=264 Identities=21% Similarity=0.349 Sum_probs=203.2
Q ss_pred eEEcCceeeEEEeEeccCceEEEEEEec------CCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehh
Q 003052 467 FKVNGKLYQRLGKIGSGGSSEVHKVISS------DCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYE 540 (853)
Q Consensus 467 ~~v~g~~Y~ilk~LG~G~FG~Vyka~~~------~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~ 540 (853)
+.+...+|++.+.||+|+||.||++... ....+|+|.+..... ......+.+|+.+++++..|+||++++++
T Consensus 7 ~~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~-~~~~~~~~~E~~~l~~l~~h~~i~~~~~~- 84 (293)
T cd05053 7 WELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDAT-EKDLSDLVSEMEMMKMIGKHKNIINLLGV- 84 (293)
T ss_pred cccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCC-HHHHHHHHHHHHHHHhhcCCCCeeeEEEE-
Confidence 4555677999999999999999999863 235799999875433 23445688999999999779999999987
Q ss_pred hhHHHHHHHHhhCCCCCCCCccccCCeEEEEEecch-hhHHHHHHHhhh--------hccCCCCCCCHHHHHHHHHHhhh
Q 003052 541 VTEKALLREVLNGSMNNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWK--------EMDGSNQTLDENWLRFYWQQILE 611 (853)
Q Consensus 541 ~~e~~iL~~l~~~~iv~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k--------~~~~~~~~LsE~~~r~I~~QIl~ 611 (853)
+..++.+|+||||+. ++|..++..+.. ........+++..++.++.||+.
T Consensus 85 ---------------------~~~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~ 143 (293)
T cd05053 85 ---------------------CTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVAR 143 (293)
T ss_pred ---------------------EcCCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHH
Confidence 345567899999965 588888865310 01123467999999999999999
Q ss_pred hhhhcccCceeeCCCCCccEEe-ecCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCc
Q 003052 612 AVNTIHEERIVHSDLKPANFLL-VKGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRP 690 (853)
Q Consensus 612 AL~yLHs~gIIHRDLKPeNILL-~~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~k 690 (853)
||.|||++||+||||||+|||+ .++.+||+|||+++.+.............++..|+|||++.+. .++.+
T Consensus 144 al~~LH~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~---------~~~~~ 214 (293)
T cd05053 144 GMEFLASKKCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDR---------VYTHQ 214 (293)
T ss_pred HHHHHHHCCccccccceeeEEEcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccC---------CcCcc
Confidence 9999999999999999999999 5679999999999876443222112233456789999998654 35679
Q ss_pred cchhhhHHHHHHHHh-CCCCCCcchhHHHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCCChhHHhcC
Q 003052 691 SDIWSLGCILYQMVY-GRTPFSEYKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQH 764 (853)
Q Consensus 691 sDIWSLGVILyELLt-G~~PF~~~~~~~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~H 764 (853)
+|||||||++|+|++ |..||...... ..+..+.. ......+...+..+.+||.+||..||.+|||+.+++++
T Consensus 215 ~Di~slG~il~el~~~g~~p~~~~~~~-~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~ 287 (293)
T cd05053 215 SDVWSFGVLLWEIFTLGGSPYPGIPVE-ELFKLLKE-GYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVED 287 (293)
T ss_pred cceeehhhHHHHHhcCCCCCCCCCCHH-HHHHHHHc-CCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence 999999999999997 99999765433 22333222 12223444567889999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=311.38 Aligned_cols=251 Identities=31% Similarity=0.519 Sum_probs=207.8
Q ss_pred eeeEEEeEeccCceEEEEEEec-CCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHHHHh
Q 003052 473 LYQRLGKIGSGGSSEVHKVISS-DCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLREVL 551 (853)
Q Consensus 473 ~Y~ilk~LG~G~FG~Vyka~~~-~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~~l~ 551 (853)
+|++.+.||+|+||.||++.+. +++.||+|.+............+.+|++++.++. |+||++++++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~------------ 67 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLK-HPNIVKYIGS------------ 67 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCC-CCCccEEEEE------------
Confidence 4888999999999999999884 6688999999876554456667899999999997 8999999876
Q ss_pred hCCCCCCCCccccCCeEEEEEecchh-hHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCCCcc
Q 003052 552 NGSMNNKDGRVKDDGYIYMVLEYGEI-DLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPAN 630 (853)
Q Consensus 552 ~~~iv~~~g~~~d~~~lyLVmEy~~g-dL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLKPeN 630 (853)
+.+...+|+||||+++ +|.+++... ..+++..++.++.|++.||.|||++||+||||||+|
T Consensus 68 ----------~~~~~~~~~v~e~~~~~~L~~~~~~~--------~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~n 129 (254)
T cd06627 68 ----------IETSDSLYIILEYAENGSLRQIIKKF--------GPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAAN 129 (254)
T ss_pred ----------EEeCCEEEEEEecCCCCcHHHHHHhc--------cCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHH
Confidence 3455789999999764 888877543 578999999999999999999999999999999999
Q ss_pred EEee-cCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHhCCCC
Q 003052 631 FLLV-KGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGRTP 709 (853)
Q Consensus 631 ILL~-~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLtG~~P 709 (853)
|+++ ++.++|+|||++......... .....|+..|+|||.+.+.. ++.++|||+||+++|+|++|..|
T Consensus 130 i~i~~~~~~~l~d~~~~~~~~~~~~~--~~~~~~~~~y~~pe~~~~~~---------~~~~~Dv~~lG~~l~~l~~g~~p 198 (254)
T cd06627 130 ILTTKDGVVKLADFGVATKLNDVSKD--DASVVGTPYWMAPEVIEMSG---------ASTASDIWSLGCTVIELLTGNPP 198 (254)
T ss_pred EEECCCCCEEEeccccceecCCCccc--ccccccchhhcCHhhhcCCC---------CCcchhHHHHHHHHHHHHhCCCC
Confidence 9994 579999999999876543321 23567899999999986542 46789999999999999999999
Q ss_pred CCcchhHHHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCCChhHHhcCCCC
Q 003052 710 FSEYKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQHPFL 767 (853)
Q Consensus 710 F~~~~~~~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~HPwf 767 (853)
|............... .....+...+..+.++|.+||..+|++||++.+++.||||
T Consensus 199 ~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~~ 254 (254)
T cd06627 199 YYDLNPMAALFRIVQD--DHPPLPEGISPELKDFLMQCFQKDPNLRPTAKQLLKHPWI 254 (254)
T ss_pred CCCccHHHHHHHHhcc--CCCCCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhcCCCC
Confidence 9876655444444322 2233455677889999999999999999999999999997
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=317.03 Aligned_cols=247 Identities=21% Similarity=0.343 Sum_probs=195.1
Q ss_pred ceeeEEEeEeccCceEEEEEEecCCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHHHHh
Q 003052 472 KLYQRLGKIGSGGSSEVHKVISSDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLREVL 551 (853)
Q Consensus 472 ~~Y~ilk~LG~G~FG~Vyka~~~~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~~l~ 551 (853)
+.|++.+.||+|+||.||++...++..+|+|.+...... ...+.+|+.+|++++ |+||++++++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~~~---~~~~~~e~~~l~~l~-h~~i~~~~~~------------ 67 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGAMS---EEDFIEEAKVMMKLS-HPKLVQLYGV------------ 67 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEeccCceEEEEecccCCcc---HHHHHHHHHHHHHCC-CCCceeEEEE------------
Confidence 458899999999999999999888778999998744322 245789999999997 8999999886
Q ss_pred hCCCCCCCCccccCCeEEEEEecch-hhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCCCcc
Q 003052 552 NGSMNNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPAN 630 (853)
Q Consensus 552 ~~~iv~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLKPeN 630 (853)
+.+...+|+||||+. ++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|
T Consensus 68 ----------~~~~~~~~iv~e~~~~~~L~~~~~~~-------~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~n 130 (256)
T cd05114 68 ----------CTQQKPLYIVTEFMENGCLLNYLRQR-------QGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARN 130 (256)
T ss_pred ----------EccCCCEEEEEEcCCCCcHHHHHHhC-------ccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcce
Confidence 345567899999975 6888877542 2358999999999999999999999999999999999
Q ss_pred EEe-ecCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHh-CCC
Q 003052 631 FLL-VKGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVY-GRT 708 (853)
Q Consensus 631 ILL-~~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLt-G~~ 708 (853)
|++ .++.+||+|||+++....... .......++..|+|||++.+. .++.++|||||||++|+|++ |+.
T Consensus 131 i~i~~~~~~kl~d~g~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~---------~~~~~~Di~s~G~~l~el~~~g~~ 200 (256)
T cd05114 131 CLVSSTGVVKVSDFGMTRYVLDDEY-TSSSGAKFPVKWSPPEVFNFS---------KYSSKSDVWSFGVLMWEVFTEGKM 200 (256)
T ss_pred EEEcCCCeEEECCCCCccccCCCce-eccCCCCCchhhCChhhcccC---------ccchhhhhHHHHHHHHHHHcCCCC
Confidence 999 466899999999986543221 111223456789999998654 35679999999999999999 999
Q ss_pred CCCcchhHHHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCCChhHHhc
Q 003052 709 PFSEYKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQ 763 (853)
Q Consensus 709 PF~~~~~~~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~ 763 (853)
||...........+... .....+...+..+.+||.+||..||.+||++.++++
T Consensus 201 p~~~~~~~~~~~~i~~~--~~~~~~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~ 253 (256)
T cd05114 201 PFEKKSNYEVVEMISRG--FRLYRPKLASMTVYEVMYSCWHEKPEGRPTFAELLR 253 (256)
T ss_pred CCCCCCHHHHHHHHHCC--CCCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 99765543333332221 122234446778999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-37 Score=327.90 Aligned_cols=255 Identities=29% Similarity=0.491 Sum_probs=204.4
Q ss_pred ceeeEEEeEeccCceEEEEEEe-cCCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHHHH
Q 003052 472 KLYQRLGKIGSGGSSEVHKVIS-SDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLREV 550 (853)
Q Consensus 472 ~~Y~ilk~LG~G~FG~Vyka~~-~~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~~l 550 (853)
++|++.+.||+|+||.||++.+ .++..||+|.+..... .....+.+|+.++++++ |+||++++++
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~--~~~~~~~~e~~~l~~l~-hp~i~~~~~~----------- 84 (293)
T cd06647 19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQ--PKKELIINEILVMRENK-HPNIVNYLDS----------- 84 (293)
T ss_pred hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccc--hHHHHHHHHHHHHhhcC-CCCeeehhhe-----------
Confidence 5799999999999999999987 4678899999865432 23456889999999997 8999998875
Q ss_pred hhCCCCCCCCccccCCeEEEEEecch-hhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCCCc
Q 003052 551 LNGSMNNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPA 629 (853)
Q Consensus 551 ~~~~iv~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLKPe 629 (853)
+.....+|+||||+. ++|.+++.+ ..+++..+..++.||+.||.|||++||+||||||+
T Consensus 85 -----------~~~~~~~~lv~e~~~~~~L~~~~~~---------~~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~ 144 (293)
T cd06647 85 -----------YLVGDELWVVMEYLAGGSLTDVVTE---------TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSD 144 (293)
T ss_pred -----------eeeCCcEEEEEecCCCCcHHHHHhh---------cCCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHH
Confidence 445667899999975 588887754 35789999999999999999999999999999999
Q ss_pred cEEe-ecCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHhCCC
Q 003052 630 NFLL-VKGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGRT 708 (853)
Q Consensus 630 NILL-~~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLtG~~ 708 (853)
||++ .++.+||+|||++........ ......|++.|+|||.+.+. .++.++|+|||||++|+|++|+.
T Consensus 145 Nili~~~~~~kL~dfg~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~---------~~~~~~Dv~slG~ll~~ll~g~~ 213 (293)
T cd06647 145 NILLGMDGSVKLTDFGFCAQITPEQS--KRSTMVGTPYWMAPEVVTRK---------AYGPKVDIWSLGIMAIEMVEGEP 213 (293)
T ss_pred HEEEcCCCCEEEccCcceeccccccc--ccccccCChhhcCchhhccC---------CCCchhhHHHHHHHHHHHHhCCC
Confidence 9999 456899999999876543322 22345799999999998654 25679999999999999999999
Q ss_pred CCCcchhHHHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCCChhHHhcCCCCCCCC
Q 003052 709 PFSEYKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQHPFLVPPV 771 (853)
Q Consensus 709 PF~~~~~~~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~HPwf~~~~ 771 (853)
||...+...............+..+...+..+++||.+||..+|.+||++.+++.|+||....
T Consensus 214 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h~~~~~~~ 276 (293)
T cd06647 214 PYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHPFLKIAK 276 (293)
T ss_pred CCCCCChhhheeehhcCCCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCHHHhcCc
Confidence 997655443332222222222333344567899999999999999999999999999997543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=327.15 Aligned_cols=253 Identities=28% Similarity=0.433 Sum_probs=201.3
Q ss_pred ceeeEEEeEeccCceEEEEEEe-cCCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHHHH
Q 003052 472 KLYQRLGKIGSGGSSEVHKVIS-SDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLREV 550 (853)
Q Consensus 472 ~~Y~ilk~LG~G~FG~Vyka~~-~~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~~l 550 (853)
+.|+.++.||+|+||.||+|.+ .++..||+|.+...... .....+.+|+.+++++. |+||++++++
T Consensus 4 ~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~l~~l~-h~~i~~~~~~----------- 70 (277)
T cd06642 4 ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAE-DEIEDIQQEITVLSQCD-SPYITRYYGS----------- 70 (277)
T ss_pred HHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccch-HHHHHHHHHHHHHHcCC-CCccHhhhcc-----------
Confidence 4577788899999999999987 45688999998755432 34457889999999997 8999998876
Q ss_pred hhCCCCCCCCccccCCeEEEEEecch-hhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCCCc
Q 003052 551 LNGSMNNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPA 629 (853)
Q Consensus 551 ~~~~iv~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLKPe 629 (853)
+.++..+|+||||++ ++|.+++.. ..+++..++.++.||+.||.|||++||+|+||+|+
T Consensus 71 -----------~~~~~~~~lv~e~~~~~~L~~~~~~---------~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ 130 (277)
T cd06642 71 -----------YLKGTKLWIIMEYLGGGSALDLLKP---------GPLEETYIATILREILKGLDYLHSERKIHRDIKAA 130 (277)
T ss_pred -----------cccCCceEEEEEccCCCcHHHHhhc---------CCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChh
Confidence 345667899999976 477776632 46899999999999999999999999999999999
Q ss_pred cEEe-ecCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHhCCC
Q 003052 630 NFLL-VKGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGRT 708 (853)
Q Consensus 630 NILL-~~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLtG~~ 708 (853)
||++ .++.++|+|||++..+.... .......|+..|+|||.+.+.. ++.++|+|||||++|+|++|+.
T Consensus 131 ni~i~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~---------~~~~~Dv~slG~il~el~tg~~ 199 (277)
T cd06642 131 NVLLSEQGDVKLADFGVAGQLTDTQ--IKRNTFVGTPFWMAPEVIKQSA---------YDFKADIWSLGITAIELAKGEP 199 (277)
T ss_pred eEEEeCCCCEEEccccccccccCcc--hhhhcccCcccccCHHHhCcCC---------CchhhhHHHHHHHHHHHHhCCC
Confidence 9999 46789999999998764322 1223457899999999986543 5679999999999999999999
Q ss_pred CCCcchhHHHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCCChhHHhcCCCCCCC
Q 003052 709 PFSEYKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQHPFLVPP 770 (853)
Q Consensus 709 PF~~~~~~~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~HPwf~~~ 770 (853)
||.+.........+.. ..........+..+.+||.+||..+|.+||++.++++||||...
T Consensus 200 p~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~ 259 (277)
T cd06642 200 PNSDLHPMRVLFLIPK--NSPPTLEGQYSKPFKEFVEACLNKDPRFRPTAKELLKHKFITRY 259 (277)
T ss_pred CCcccchhhHHhhhhc--CCCCCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHhHHHHHH
Confidence 9976444322222111 11222334567789999999999999999999999999998653
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=316.60 Aligned_cols=255 Identities=32% Similarity=0.434 Sum_probs=199.3
Q ss_pred ceeeEEEeEeccCceEEEEEEe-cCCcEEEEEEEecCC-CChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHHH
Q 003052 472 KLYQRLGKIGSGGSSEVHKVIS-SDCTIYALKKIKLKG-RDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLRE 549 (853)
Q Consensus 472 ~~Y~ilk~LG~G~FG~Vyka~~-~~g~~vAVKkik~~~-~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~~ 549 (853)
..|++.+.||+|+||.||+|++ .+++.||||+++... .+......+.+|+.+++.++ |+||++++++
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~---------- 70 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLN-HPNVIKYLDS---------- 70 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCC-Ccceeeeeee----------
Confidence 3599999999999999999998 477899999987533 23444556889999999997 8999999876
Q ss_pred HhhCCCCCCCCccccCCeEEEEEecch-hhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCCC
Q 003052 550 VLNGSMNNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKP 628 (853)
Q Consensus 550 l~~~~iv~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLKP 628 (853)
+.+.+.+|+||||++ ++|..++.... .....+++..+..++.||+.||.|||++||+||||||
T Consensus 71 ------------~~~~~~~~~v~e~~~~~~L~~~~~~~~----~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~ 134 (267)
T cd08228 71 ------------FIEDNELNIVLELADAGDLSQMIKYFK----KQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKP 134 (267)
T ss_pred ------------EEECCeEEEEEEecCCCcHHHHHHHhh----hccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCH
Confidence 345678899999977 47877775421 1235689999999999999999999999999999999
Q ss_pred ccEEe-ecCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHhCC
Q 003052 629 ANFLL-VKGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGR 707 (853)
Q Consensus 629 eNILL-~~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLtG~ 707 (853)
+|||+ .++.++|+|||++..+..... ......|++.|+|||.+.+.. ++.++|||||||++|+|++|+
T Consensus 135 ~nil~~~~~~~~l~d~g~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~---------~~~~~Di~slG~~l~el~~g~ 203 (267)
T cd08228 135 ANVFITATGVVKLGDLGLGRFFSSKTT--AAHSLVGTPYYMSPERIHENG---------YNFKSDIWSLGCLLYEMAALQ 203 (267)
T ss_pred HHEEEcCCCCEEECccccceeccchhH--HHhcCCCCccccChhhhccCC---------CCchhhHHHHHHHHHHHhcCC
Confidence 99999 467899999999987643221 123467999999999987543 467899999999999999999
Q ss_pred CCCCcch-hHHHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCCChhHHhcC
Q 003052 708 TPFSEYK-TFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQH 764 (853)
Q Consensus 708 ~PF~~~~-~~~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~H 764 (853)
.||.... ........+.............+..+.+||.+||..+|.+||++.++++.
T Consensus 204 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~ 261 (267)
T cd08228 204 SPFYGDKMNLFSLCQKIEQCDYPPLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQI 261 (267)
T ss_pred CCCccccccHHHHHHHHhcCCCCCCChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHH
Confidence 9996432 22223233322222222223456789999999999999999999999964
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-36 Score=321.40 Aligned_cols=254 Identities=25% Similarity=0.410 Sum_probs=202.1
Q ss_pred eeeEEEeEeccCceEEEEEEe-cCCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHHHHh
Q 003052 473 LYQRLGKIGSGGSSEVHKVIS-SDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLREVL 551 (853)
Q Consensus 473 ~Y~ilk~LG~G~FG~Vyka~~-~~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~~l~ 551 (853)
.|...+.||+|+||.||++.+ .++..+|+|++..... .....+.+|+.+++.+. |+||++++++
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~e~~~l~~~~-h~~vv~~~~~------------ 84 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQ--QRRELLFNEVVIMRDYQ-HPNIVEMYSS------------ 84 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccch--hHHHHHHHHHHHHHHcC-CCChheEEEE------------
Confidence 355667899999999999987 4678999999865432 23445789999999997 8999999986
Q ss_pred hCCCCCCCCccccCCeEEEEEecch-hhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCCCcc
Q 003052 552 NGSMNNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPAN 630 (853)
Q Consensus 552 ~~~iv~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLKPeN 630 (853)
+...++.|+|+||+. ++|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|
T Consensus 85 ----------~~~~~~~~~v~e~~~~~~L~~~~~~---------~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~N 145 (285)
T cd06648 85 ----------YLVGDELWVVMEFLEGGALTDIVTH---------TRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDS 145 (285)
T ss_pred ----------EEcCCeEEEEEeccCCCCHHHHHHh---------CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhh
Confidence 344567899999975 588877653 358999999999999999999999999999999999
Q ss_pred EEe-ecCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHhCCCC
Q 003052 631 FLL-VKGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGRTP 709 (853)
Q Consensus 631 ILL-~~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLtG~~P 709 (853)
|++ .++.++|+|||++........ ......|++.|+|||.+.+.. ++.++|||||||++|+|++|+.|
T Consensus 146 il~~~~~~~~l~d~g~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~---------~~~~~Dv~slGv~l~ell~g~~p 214 (285)
T cd06648 146 ILLTSDGRVKLSDFGFCAQVSKEVP--RRKSLVGTPYWMAPEVISRLP---------YGTEVDIWSLGIMVIEMVDGEPP 214 (285)
T ss_pred EEEcCCCcEEEcccccchhhccCCc--ccccccCCccccCHHHhcCCC---------CCCcccHHHHHHHHHHHHhCCCC
Confidence 999 467999999999876543221 223467999999999986643 56799999999999999999999
Q ss_pred CCcchhHHHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCCChhHHhcCCCCCCCC
Q 003052 710 FSEYKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQHPFLVPPV 771 (853)
Q Consensus 710 F~~~~~~~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~HPwf~~~~ 771 (853)
|..........................+..+.+||.+||..||.+||++.++++||||....
T Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~ 276 (285)
T cd06648 215 YFNEPPLQAMKRIRDNLPPKLKNLHKVSPRLRSFLDRMLVRDPAQRATAAELLNHPFLAKAG 276 (285)
T ss_pred CcCCCHHHHHHHHHhcCCCCCcccccCCHHHHHHHHHHcccChhhCcCHHHHccCcccccCC
Confidence 97755543333332222222222334678899999999999999999999999999997654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=319.15 Aligned_cols=260 Identities=18% Similarity=0.249 Sum_probs=196.7
Q ss_pred eEEEeEeccCceEEEEEEecCC-c--EEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHHHHh
Q 003052 475 QRLGKIGSGGSSEVHKVISSDC-T--IYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLREVL 551 (853)
Q Consensus 475 ~ilk~LG~G~FG~Vyka~~~~g-~--~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~~l~ 551 (853)
.+.++||+|+||.||+|.+..+ . .+|+|.++...........+.+|+.++++++ |+||+++++++....
T Consensus 2 ~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~------- 73 (272)
T cd05075 2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFD-HPNVMRLIGVCLQTV------- 73 (272)
T ss_pred ccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCC-CCCcceEEEEEccCC-------
Confidence 4567899999999999987543 2 5899998876555556677899999999996 899999998642210
Q ss_pred hCCCCCCCCccccCCeEEEEEecch-hhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCCCcc
Q 003052 552 NGSMNNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPAN 630 (853)
Q Consensus 552 ~~~iv~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLKPeN 630 (853)
........++||||+. ++|..++.... .......+++..++.++.||+.||.|||++||+||||||+|
T Consensus 74 ---------~~~~~~~~~~v~e~~~~~~l~~~~~~~~--~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~N 142 (272)
T cd05075 74 ---------ESEGYPSPVVILPFMKHGDLHSFLLYSR--LGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARN 142 (272)
T ss_pred ---------cccCCCCcEEEEEeCCCCcHHHHHHHhc--ccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhh
Confidence 0112235799999975 58877764321 11223468999999999999999999999999999999999
Q ss_pred EEee-cCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHh-CCC
Q 003052 631 FLLV-KGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVY-GRT 708 (853)
Q Consensus 631 ILL~-~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLt-G~~ 708 (853)
||++ ++.+||+|||+++.+.............+++.|+|||.+.+. .++.++|||||||++|+|++ |+.
T Consensus 143 il~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~---------~~~~~~Di~slG~il~el~~~g~~ 213 (272)
T cd05075 143 CMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAIESLADR---------VYTTKSDVWSFGVTMWEIATRGQT 213 (272)
T ss_pred eEEcCCCCEEECCCCcccccCcccceecCCcccCCcccCCHHHccCC---------CcChHHHHHHHHHHHHHHHcCCCC
Confidence 9994 678999999999876443221122234567889999998654 35679999999999999999 899
Q ss_pred CCCcchhHHHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCCChhHHhcC
Q 003052 709 PFSEYKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQH 764 (853)
Q Consensus 709 PF~~~~~~~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~H 764 (853)
||...... .....+... .....+...+..+.++|.+||..||.+||++.+|+++
T Consensus 214 p~~~~~~~-~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~ 267 (272)
T cd05075 214 PYPGVENS-EIYDYLRQG-NRLKQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCE 267 (272)
T ss_pred CCCCCCHH-HHHHHHHcC-CCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 99765443 223333322 2223445567789999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-37 Score=363.99 Aligned_cols=279 Identities=27% Similarity=0.391 Sum_probs=205.3
Q ss_pred ceeeEEEeEeccCceEEEEEEec-CCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHH-----
Q 003052 472 KLYQRLGKIGSGGSSEVHKVISS-DCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKA----- 545 (853)
Q Consensus 472 ~~Y~ilk~LG~G~FG~Vyka~~~-~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~----- 545 (853)
.+|+.+..||+||||.||+|+++ ||+.||||+|..+. .......+.+|+++|.+|. |||||+++..++....
T Consensus 479 ~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~-s~~~~skI~rEVk~LArLn-HpNVVRYysAWVEs~~~~~~~ 556 (1351)
T KOG1035|consen 479 NDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKA-SDKLYSKILREVKLLARLN-HPNVVRYYSAWVESTAELTVL 556 (1351)
T ss_pred hhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCch-HHHHHHHHHHHHHHHhhcC-CcceeeeehhhhccCCccccc
Confidence 34788899999999999999985 99999999999887 5566667899999999998 9999999875432110
Q ss_pred -H---HHHHhhCC---------------------------------CC------------------------------CC
Q 003052 546 -L---LREVLNGS---------------------------------MN------------------------------NK 558 (853)
Q Consensus 546 -i---L~~l~~~~---------------------------------iv------------------------------~~ 558 (853)
+ ..+-.+.+ .. ..
T Consensus 557 ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~ 636 (1351)
T KOG1035|consen 557 EIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDS 636 (1351)
T ss_pred cccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccccccc
Confidence 0 00000000 00 00
Q ss_pred C------------------Ccc-------ccCCeEEEEEecchhhHHHHHHHhhhhccCCCCCC--CHHHHHHHHHHhhh
Q 003052 559 D------------------GRV-------KDDGYIYMVLEYGEIDLAHMLSQKWKEMDGSNQTL--DENWLRFYWQQILE 611 (853)
Q Consensus 559 ~------------------g~~-------~d~~~lyLVmEy~~gdL~~~L~~~~k~~~~~~~~L--sE~~~r~I~~QIl~ 611 (853)
. +.+ +...++||-||||+.++...+... ..+ .-..++.+++||+.
T Consensus 637 e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~--------N~~~~~~d~~wrLFreIlE 708 (1351)
T KOG1035|consen 637 EGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRR--------NHFNSQRDEAWRLFREILE 708 (1351)
T ss_pred CCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHh--------cccchhhHHHHHHHHHHHH
Confidence 0 000 112579999999998776666554 223 47788999999999
Q ss_pred hhhhcccCceeeCCCCCccEEe-ecCcEEEEecccchhcc----c------------CCccccccccccCccccCchhhc
Q 003052 612 AVNTIHEERIVHSDLKPANFLL-VKGSLKLIDFGIAKAIM----S------------DTTNIQRDSQVGTLSYMSPEAFM 674 (853)
Q Consensus 612 AL~yLHs~gIIHRDLKPeNILL-~~g~VKL~DFGlAk~~~----~------------~~~~~~~~t~~GTp~YmAPEvl~ 674 (853)
||.|+|+.|||||||||.||+| .++.|||+|||+|+... . .......+..+||..|+|||++.
T Consensus 709 GLaYIH~~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~ 788 (1351)
T KOG1035|consen 709 GLAYIHDQGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLS 788 (1351)
T ss_pred HHHHHHhCceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhc
Confidence 9999999999999999999999 56799999999998621 0 01111235689999999999997
Q ss_pred cCCCCCCCccccCCCccchhhhHHHHHHHHhCCCCCCcchhHHHHHHhhcCCCCccc--CCCCCChhHHHHHHHhcccCC
Q 003052 675 CNESDENGNIIKCGRPSDIWSLGCILYQMVYGRTPFSEYKTFWAKFKVITDPNHEIT--YEPVPNPWLLDLMKKCLAWDR 752 (853)
Q Consensus 675 ~~~~~~~~~~~~ys~ksDIWSLGVILyELLtG~~PF~~~~~~~~~~kii~~~~~~~~--~~~~~s~~l~dLI~kcL~~DP 752 (853)
+... ..|+.|+||||||||||||+ .||............++.+..+.. +....-+.-..+|.+||+.||
T Consensus 789 ~~~~------~~Yn~KiDmYSLGIVlFEM~---yPF~TsMERa~iL~~LR~g~iP~~~~f~~~~~~~e~slI~~Ll~hdP 859 (1351)
T KOG1035|consen 789 DTSS------NKYNSKIDMYSLGIVLFEML---YPFGTSMERASILTNLRKGSIPEPADFFDPEHPEEASLIRWLLSHDP 859 (1351)
T ss_pred cccc------ccccchhhhHHHHHHHHHHh---ccCCchHHHHHHHHhcccCCCCCCcccccccchHHHHHHHHHhcCCC
Confidence 6532 36889999999999999998 457654444445555554444433 111122345789999999999
Q ss_pred CCCCChhHHhcCCCCCC
Q 003052 753 NERWRIPQLLQHPFLVP 769 (853)
Q Consensus 753 ~kRpTa~EIL~HPwf~~ 769 (853)
.+||||.|+|++.||-+
T Consensus 860 ~kRPtA~eLL~s~llpp 876 (1351)
T KOG1035|consen 860 SKRPTATELLNSELLPP 876 (1351)
T ss_pred ccCCCHHHHhhccCCCc
Confidence 99999999999999976
|
|
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=321.19 Aligned_cols=257 Identities=24% Similarity=0.396 Sum_probs=203.1
Q ss_pred eeEEEeEeccCceEEEEEEe----cCCcEEEEEEEecCCC--ChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHH
Q 003052 474 YQRLGKIGSGGSSEVHKVIS----SDCTIYALKKIKLKGR--DYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALL 547 (853)
Q Consensus 474 Y~ilk~LG~G~FG~Vyka~~----~~g~~vAVKkik~~~~--~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL 547 (853)
|++.+.||.|+||.||+|.+ .++..||+|+++.... .......+.+|+++|+++.+|+||+.++++
T Consensus 2 y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~-------- 73 (290)
T cd05613 2 FELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYA-------- 73 (290)
T ss_pred ceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeE--------
Confidence 88999999999999999987 3678999999975322 122334577899999999889999998765
Q ss_pred HHHhhCCCCCCCCccccCCeEEEEEecch-hhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCC
Q 003052 548 REVLNGSMNNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDL 626 (853)
Q Consensus 548 ~~l~~~~iv~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDL 626 (853)
+..+..+|+||||+. ++|.+++... ..+++..+..++.||+.||.|||++||+||||
T Consensus 74 --------------~~~~~~~~lv~e~~~~~~L~~~l~~~--------~~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl 131 (290)
T cd05613 74 --------------FQTDTKLHLILDYINGGELFTHLSQR--------ERFKEQEVQIYSGEIVLALEHLHKLGIIYRDI 131 (290)
T ss_pred --------------eecCCeEEEEEecCCCCcHHHHHHHc--------CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCC
Confidence 456678999999976 4888887643 46899999999999999999999999999999
Q ss_pred CCccEEe-ecCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHh
Q 003052 627 KPANFLL-VKGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVY 705 (853)
Q Consensus 627 KPeNILL-~~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLt 705 (853)
||+|||+ .++.+||+|||+++........ ......|+..|+|||.+.+... .++.++|||||||++|+|++
T Consensus 132 ~p~nil~~~~~~~kl~dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~-------~~~~~~Dv~slG~~l~~ll~ 203 (290)
T cd05613 132 KLENILLDSNGHVVLTDFGLSKEFHEDEVE-RAYSFCGTIEYMAPDIVRGGDG-------GHDKAVDWWSMGVLMYELLT 203 (290)
T ss_pred CHHHeEECCCCCEEEeeCccceeccccccc-ccccccCCcccCChhhccCCCC-------CCCccccHHHHHHHHHHHhc
Confidence 9999999 5679999999999865432211 2235679999999999865321 24678999999999999999
Q ss_pred CCCCCCcch---hHHHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCC-----ChhHHhcCCCCCCC
Q 003052 706 GRTPFSEYK---TFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERW-----RIPQLLQHPFLVPP 770 (853)
Q Consensus 706 G~~PF~~~~---~~~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRp-----Ta~EIL~HPwf~~~ 770 (853)
|..||.... ........+... ...++...++.+.+||.+||..||.+|| ++.+++.||||...
T Consensus 204 g~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~ 274 (290)
T cd05613 204 GASPFTVDGEKNSQAEISRRILKS--EPPYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQKI 274 (290)
T ss_pred CCCCCCcCCccccHHHHHHHhhcc--CCCCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcCcccccC
Confidence 999996321 222222222221 1234555788899999999999999997 89999999999764
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=312.12 Aligned_cols=252 Identities=23% Similarity=0.350 Sum_probs=199.3
Q ss_pred EeEeccCceEEEEEEecC----CcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHHHHhhC
Q 003052 478 GKIGSGGSSEVHKVISSD----CTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLREVLNG 553 (853)
Q Consensus 478 k~LG~G~FG~Vyka~~~~----g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~~l~~~ 553 (853)
+.||+|+||.||+|.+.. +..||+|.+....... ....+.+|++++..+. |+||+++++++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~e~~~l~~~~-~~~i~~~~~~~------------- 65 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEE-ERKDFLKEARVMKKLG-HPNVVRLLGVC------------- 65 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchh-HHHHHHHHHHHHhhcC-CCChheeeeee-------------
Confidence 369999999999998853 6789999998654433 4567889999999998 99999998863
Q ss_pred CCCCCCCccccCCeEEEEEecc-hhhHHHHHHHhhhhc-cCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCCCccE
Q 003052 554 SMNNKDGRVKDDGYIYMVLEYG-EIDLAHMLSQKWKEM-DGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANF 631 (853)
Q Consensus 554 ~iv~~~g~~~d~~~lyLVmEy~-~gdL~~~L~~~~k~~-~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLKPeNI 631 (853)
.+...+|+||||+ +++|.+++....... ......+++..++.++.||+.||.|||++||+||||||+||
T Consensus 66 ---------~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~ni 136 (262)
T cd00192 66 ---------TEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNC 136 (262)
T ss_pred ---------cCCCceEEEEEeccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceE
Confidence 3466799999998 579988886531100 00136799999999999999999999999999999999999
Q ss_pred Eee-cCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHh-CCCC
Q 003052 632 LLV-KGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVY-GRTP 709 (853)
Q Consensus 632 LL~-~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLt-G~~P 709 (853)
+++ ++.+||+|||++................+++.|+|||.+... .++.++|||||||++|+|++ |..|
T Consensus 137 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~---------~~~~~~Di~slG~il~~l~~~g~~p 207 (262)
T cd00192 137 LVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAPESLKDG---------IFTSKSDVWSFGVLLWEIFTLGATP 207 (262)
T ss_pred EECCCCcEEEcccccccccccccccccccCCCcCccccCHHHhccC---------CcchhhccHHHHHHHHHHHhcCCCC
Confidence 995 589999999999876543322223355788999999998754 35689999999999999998 6999
Q ss_pred CCcchhHHHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCCChhHHhcC
Q 003052 710 FSEYKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQH 764 (853)
Q Consensus 710 F~~~~~~~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~H 764 (853)
|......... ..+.. ......+...+.++.++|.+||..||.+||++.+++++
T Consensus 208 ~~~~~~~~~~-~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~ 260 (262)
T cd00192 208 YPGLSNEEVL-EYLRK-GYRLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVER 260 (262)
T ss_pred CCCCCHHHHH-HHHHc-CCCCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 9876443322 22222 22334455668899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=321.19 Aligned_cols=247 Identities=26% Similarity=0.383 Sum_probs=195.7
Q ss_pred EeccCceEEEEEEe-cCCcEEEEEEEecCCCC-hhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHHHHhhCCCCC
Q 003052 480 IGSGGSSEVHKVIS-SDCTIYALKKIKLKGRD-YATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLREVLNGSMNN 557 (853)
Q Consensus 480 LG~G~FG~Vyka~~-~~g~~vAVKkik~~~~~-~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~~l~~~~iv~ 557 (853)
||+|+||+||+|.+ .+++.||+|.+...... ......+.+|+++|++++ |+||++++++
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~------------------ 61 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVS-SRFIVSLAYA------------------ 61 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCC-CCCEeeeeeE------------------
Confidence 69999999999987 46789999999754321 223445678999999997 9999999876
Q ss_pred CCCccccCCeEEEEEecch-hhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCCCccEEe-ec
Q 003052 558 KDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLL-VK 635 (853)
Q Consensus 558 ~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLKPeNILL-~~ 635 (853)
+...+.+|+||||+. ++|.+++... ....+++..++.++.||+.||.|||++||+||||||+||++ .+
T Consensus 62 ----~~~~~~~~lv~e~~~~~~L~~~l~~~------~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~~~ 131 (277)
T cd05577 62 ----FETKDDLCLVMTLMNGGDLKYHIYNV------GEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDH 131 (277)
T ss_pred ----EecCCeEEEEEecCCCCcHHHHHHHc------CcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCC
Confidence 455678999999976 5888877654 12468999999999999999999999999999999999999 56
Q ss_pred CcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHhCCCCCCcchh
Q 003052 636 GSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGRTPFSEYKT 715 (853)
Q Consensus 636 g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLtG~~PF~~~~~ 715 (853)
+.+||+|||++....... ......|+..|+|||++.+.. ++.++|||||||++|+|++|+.||.....
T Consensus 132 ~~~~l~dfg~~~~~~~~~---~~~~~~~~~~y~~PE~~~~~~---------~~~~~Di~slG~il~~l~~g~~p~~~~~~ 199 (277)
T cd05577 132 GNVRISDLGLAVELKGGK---KIKGRAGTPGYMAPEVLQGEV---------YDFSVDWFALGCTLYEMIAGRSPFRQRKE 199 (277)
T ss_pred CCEEEccCcchhhhccCC---ccccccCCCCcCCHHHhcCCC---------CCchhhhHHHHHHHHHHhhCCCCCCCCcc
Confidence 799999999998654321 123457889999999986543 56799999999999999999999965432
Q ss_pred ---HHHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCC-----ChhHHhcCCCCCC
Q 003052 716 ---FWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERW-----RIPQLLQHPFLVP 769 (853)
Q Consensus 716 ---~~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRp-----Ta~EIL~HPwf~~ 769 (853)
......... .....++...++.+.+||.+||..||.+|| ++.++++||||..
T Consensus 200 ~~~~~~~~~~~~--~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~h~~~~~ 259 (277)
T cd05577 200 KVEKEELKRRTL--EMAVEYPDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVREHPLFKD 259 (277)
T ss_pred cccHHHHHhccc--cccccCCccCCHHHHHHHHHHccCChhHccCCCcccHHHHHhChhhhc
Confidence 111111111 122334556788999999999999999999 8888999999964
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=320.10 Aligned_cols=258 Identities=21% Similarity=0.308 Sum_probs=198.8
Q ss_pred ceeeEEEeEeccCceEEEEEEe-----cCCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHH
Q 003052 472 KLYQRLGKIGSGGSSEVHKVIS-----SDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKAL 546 (853)
Q Consensus 472 ~~Y~ilk~LG~G~FG~Vyka~~-----~~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~i 546 (853)
+.|++.+.||+|+||.||+|.. .++..+|+|.++.... ......+.+|+.++++++ |+||++++++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~E~~~l~~l~-h~niv~~~~~------- 75 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINN-PQQWGEFQQEASLMAELH-HPNIVCLLGV------- 75 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCC-HHHHHHHHHHHHHHhhCC-CCCeeeEEEE-------
Confidence 4589999999999999999984 2457899999975433 334456889999999997 8999999986
Q ss_pred HHHHhhCCCCCCCCccccCCeEEEEEecch-hhHHHHHHHhhhh---------ccCCCCCCCHHHHHHHHHHhhhhhhhc
Q 003052 547 LREVLNGSMNNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKE---------MDGSNQTLDENWLRFYWQQILEAVNTI 616 (853)
Q Consensus 547 L~~l~~~~iv~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~---------~~~~~~~LsE~~~r~I~~QIl~AL~yL 616 (853)
+......|+||||+. ++|.+++...... .......+++..+..++.||+.||.||
T Consensus 76 ---------------~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~l 140 (283)
T cd05090 76 ---------------VTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYL 140 (283)
T ss_pred ---------------EecCCceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHH
Confidence 345567899999976 5888887543110 000123588999999999999999999
Q ss_pred ccCceeeCCCCCccEEee-cCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhh
Q 003052 617 HEERIVHSDLKPANFLLV-KGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWS 695 (853)
Q Consensus 617 Hs~gIIHRDLKPeNILL~-~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWS 695 (853)
|++||+||||||+|||++ ++.+||+|||+++...............++..|+|||.+.+. .++.++||||
T Consensus 141 H~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~---------~~~~~~Dv~s 211 (283)
T cd05090 141 SSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYG---------KFSSDSDIWS 211 (283)
T ss_pred HhcCeehhccccceEEEcCCCcEEeccccccccccCCcceecccCCCccceecChHHhccC---------CCCchhhhHH
Confidence 999999999999999994 568999999999876443322223345677889999998654 3567999999
Q ss_pred hHHHHHHHHh-CCCCCCcchhHHHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCCChhHHhcC
Q 003052 696 LGCILYQMVY-GRTPFSEYKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQH 764 (853)
Q Consensus 696 LGVILyELLt-G~~PF~~~~~~~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~H 764 (853)
|||++|||++ |.+||.+....... ..+.. ......+...++.+.+||.+||..||.+||++.+|+++
T Consensus 212 lG~il~el~~~g~~p~~~~~~~~~~-~~~~~-~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~ 279 (283)
T cd05090 212 FGVVLWEIFSFGLQPYYGFSNQEVI-EMVRK-RQLLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTR 279 (283)
T ss_pred HHHHHHHHHcCCCCCCCCCCHHHHH-HHHHc-CCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence 9999999998 99999765443222 22221 12223445667889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=320.31 Aligned_cols=241 Identities=24% Similarity=0.363 Sum_probs=188.3
Q ss_pred eeEEEe--EeccCceEEEEEEe-cCCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHHHH
Q 003052 474 YQRLGK--IGSGGSSEVHKVIS-SDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLREV 550 (853)
Q Consensus 474 Y~ilk~--LG~G~FG~Vyka~~-~~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~~l 550 (853)
|.+.+. ||+|+||.||++.. .++..+|+|.+....... .|+.+...+.+|+||++++++
T Consensus 16 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~-------~e~~~~~~~~~h~~iv~~~~~----------- 77 (267)
T PHA03390 16 CEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA-------IEPMVHQLMKDNPNFIKLYYS----------- 77 (267)
T ss_pred hccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch-------hhHHHHHHhhcCCCEEEEEEE-----------
Confidence 455555 59999999999998 467889999987543211 234444445579999999986
Q ss_pred hhCCCCCCCCccccCCeEEEEEecch-hhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCCCc
Q 003052 551 LNGSMNNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPA 629 (853)
Q Consensus 551 ~~~~iv~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLKPe 629 (853)
|..++.+|+||||+. ++|.+++... ..+++..++.++.||+.||.|||+.||+||||||+
T Consensus 78 -----------~~~~~~~~iv~e~~~~~~L~~~l~~~--------~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~ 138 (267)
T PHA03390 78 -----------VTTLKGHVLIMDYIKDGDLFDLLKKE--------GKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLE 138 (267)
T ss_pred -----------EecCCeeEEEEEcCCCCcHHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHH
Confidence 455668999999975 6999888653 37999999999999999999999999999999999
Q ss_pred cEEee-cC-cEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHhCC
Q 003052 630 NFLLV-KG-SLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGR 707 (853)
Q Consensus 630 NILL~-~g-~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLtG~ 707 (853)
||++. ++ .++|+|||+++..... ....|+..|+|||++.+.. ++.++|||||||++|+|++|+
T Consensus 139 nil~~~~~~~~~l~dfg~~~~~~~~------~~~~~~~~y~aPE~~~~~~---------~~~~~DvwslG~il~~l~~g~ 203 (267)
T PHA03390 139 NVLYDRAKDRIYLCDYGLCKIIGTP------SCYDGTLDYFSPEKIKGHN---------YDVSFDWWAVGVLTYELLTGK 203 (267)
T ss_pred HEEEeCCCCeEEEecCccceecCCC------ccCCCCCcccChhhhcCCC---------CCchhhHHHHHHHHHHHHHCC
Confidence 99994 44 7999999999765322 2457899999999997643 467899999999999999999
Q ss_pred CCCCcchhH---HHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCCC-hhHHhcCCCCC
Q 003052 708 TPFSEYKTF---WAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWR-IPQLLQHPFLV 768 (853)
Q Consensus 708 ~PF~~~~~~---~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpT-a~EIL~HPwf~ 768 (853)
.||...... ........ ..........++.+.+||.+||+.||.+|++ ++++|+||||+
T Consensus 204 ~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~h~~~~ 266 (267)
T PHA03390 204 HPFKEDEDEELDLESLLKRQ--QKKLPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIKHPFLK 266 (267)
T ss_pred CCCCCCCcchhhHHHHHHhh--cccCCcccccCHHHHHHHHHHhccChhhCCchHHHHhcCCccc
Confidence 999643221 11111111 2223344467889999999999999999996 69999999996
|
|
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=322.39 Aligned_cols=259 Identities=21% Similarity=0.304 Sum_probs=198.8
Q ss_pred EcCceeeEEEeEeccCceEEEEEEec------CCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhh
Q 003052 469 VNGKLYQRLGKIGSGGSSEVHKVISS------DCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVT 542 (853)
Q Consensus 469 v~g~~Y~ilk~LG~G~FG~Vyka~~~------~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~ 542 (853)
+++..|.+.+.||+|+||.||++... ++..+|+|.+.... ......+.+|+.+++++. |+||++++++
T Consensus 2 ~~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~e~~~l~~l~-h~~i~~~~~~--- 75 (288)
T cd05093 2 IKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDAS--DNARKDFHREAELLTNLQ-HEHIVKFYGV--- 75 (288)
T ss_pred CchHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcC--HHHHHHHHHHHHHHHhCC-CCCcceEEEE---
Confidence 34567999999999999999999752 33568999886542 234456889999999997 8999999886
Q ss_pred HHHHHHHHhhCCCCCCCCccccCCeEEEEEecch-hhHHHHHHHhhhh-----ccCCCCCCCHHHHHHHHHHhhhhhhhc
Q 003052 543 EKALLREVLNGSMNNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKE-----MDGSNQTLDENWLRFYWQQILEAVNTI 616 (853)
Q Consensus 543 e~~iL~~l~~~~iv~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~-----~~~~~~~LsE~~~r~I~~QIl~AL~yL 616 (853)
+.....+|+||||+. ++|.+++...... .......+++..++.++.||+.||+||
T Consensus 76 -------------------~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~l 136 (288)
T cd05093 76 -------------------CVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYL 136 (288)
T ss_pred -------------------EecCCccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHH
Confidence 345567899999975 5888888643210 011224599999999999999999999
Q ss_pred ccCceeeCCCCCccEEe-ecCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhh
Q 003052 617 HEERIVHSDLKPANFLL-VKGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWS 695 (853)
Q Consensus 617 Hs~gIIHRDLKPeNILL-~~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWS 695 (853)
|++||+||||||+|||+ .++.+||+|||+++...............+++.|+|||.+.+. .++.++||||
T Consensus 137 H~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~---------~~~~~sDiws 207 (288)
T cd05093 137 ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYR---------KFTTESDVWS 207 (288)
T ss_pred HhCCeeecccCcceEEEccCCcEEeccCCccccccCCceeecCCCCCccccccCHHHhccC---------CCCchhhHHH
Confidence 99999999999999999 5679999999999865433222222334567899999998654 3567999999
Q ss_pred hHHHHHHHHh-CCCCCCcchhHHHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCCChhHHhc
Q 003052 696 LGCILYQMVY-GRTPFSEYKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQ 763 (853)
Q Consensus 696 LGVILyELLt-G~~PF~~~~~~~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~ 763 (853)
|||++|+|++ |.+||...........+... . ....+...+..+.+||.+||..||.+|||+.+++.
T Consensus 208 lG~il~~l~t~g~~p~~~~~~~~~~~~i~~~-~-~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~ 274 (288)
T cd05093 208 LGVVLWEIFTYGKQPWYQLSNNEVIECITQG-R-VLQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHS 274 (288)
T ss_pred HHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC-C-cCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 9999999998 99999765443322233221 1 12233456788999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=334.51 Aligned_cols=264 Identities=20% Similarity=0.339 Sum_probs=200.1
Q ss_pred EcCceeeEEEeEeccCceEEEEEEe------cCCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhh
Q 003052 469 VNGKLYQRLGKIGSGGSSEVHKVIS------SDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVT 542 (853)
Q Consensus 469 v~g~~Y~ilk~LG~G~FG~Vyka~~------~~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~ 542 (853)
+..++|++.+.||+|+||.||+|.+ .+++.||||+++..... .....+.+|+.+|.++.+|+||+++++++.
T Consensus 4 ~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~~h~niv~~~~~~~- 81 (343)
T cd05103 4 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATH-SEHRALMSELKILIHIGHHLNVVNLLGACT- 81 (343)
T ss_pred cchhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCCh-HHHHHHHHHHHHHHhccCCccHhhhcceee-
Confidence 3456799999999999999999974 34678999999754332 334568899999999988999999987632
Q ss_pred HHHHHHHHhhCCCCCCCCccccCCeEEEEEecch-hhHHHHHHHhhhhcc------------------------------
Q 003052 543 EKALLREVLNGSMNNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEMD------------------------------ 591 (853)
Q Consensus 543 e~~iL~~l~~~~iv~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~~~------------------------------ 591 (853)
..+..+|+||||++ ++|.+++........
T Consensus 82 --------------------~~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 141 (343)
T cd05103 82 --------------------KPGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSI 141 (343)
T ss_pred --------------------cCCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhcccc
Confidence 23456899999976 588888865321000
Q ss_pred -----------------------------CCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCCCccEEe-ecCcEEEE
Q 003052 592 -----------------------------GSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLL-VKGSLKLI 641 (853)
Q Consensus 592 -----------------------------~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLKPeNILL-~~g~VKL~ 641 (853)
.....+++..+..++.||+.||.|||++||+||||||+|||+ .++.+||+
T Consensus 142 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~~~kl~ 221 (343)
T cd05103 142 TSSQSSASSGFVEEKSLSDVEEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKIC 221 (343)
T ss_pred ccccccccccccCCCccccchhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcCCCcEEEE
Confidence 001347888999999999999999999999999999999999 46799999
Q ss_pred ecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHh-CCCCCCcchhHHHHH
Q 003052 642 DFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVY-GRTPFSEYKTFWAKF 720 (853)
Q Consensus 642 DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLt-G~~PF~~~~~~~~~~ 720 (853)
|||+++.+.............+++.|+|||++.+. .++.++|||||||++|+|++ |..||..........
T Consensus 222 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~---------~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~ 292 (343)
T cd05103 222 DFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDR---------VYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFC 292 (343)
T ss_pred ecccccccccCcchhhcCCCCCCcceECcHHhcCC---------CCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHH
Confidence 99999875433222222234567789999998654 35679999999999999996 999997643322222
Q ss_pred HhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCCChhHHhcC
Q 003052 721 KVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQH 764 (853)
Q Consensus 721 kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~H 764 (853)
..+... .....+...++.+.+++.+||..||.+||++.+|++|
T Consensus 293 ~~~~~~-~~~~~~~~~~~~~~~~~~~cl~~~p~~Rps~~eil~~ 335 (343)
T cd05103 293 RRLKEG-TRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 335 (343)
T ss_pred HHHhcc-CCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 222221 1222334467789999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=316.06 Aligned_cols=248 Identities=25% Similarity=0.429 Sum_probs=193.2
Q ss_pred EeEeccCceEEEEEEe-cCCcEEEEEEEecCCCC-hhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHHHHhhCCC
Q 003052 478 GKIGSGGSSEVHKVIS-SDCTIYALKKIKLKGRD-YATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLREVLNGSM 555 (853)
Q Consensus 478 k~LG~G~FG~Vyka~~-~~g~~vAVKkik~~~~~-~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~~l~~~~i 555 (853)
+.||+|+||.||+|.+ .+++.||+|.+...... ......+..|..++....+|+||++++++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~---------------- 65 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYS---------------- 65 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeee----------------
Confidence 4699999999999988 46789999998754321 22333456677777666679999999876
Q ss_pred CCCCCccccCCeEEEEEecch-hhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCCCccEEe-
Q 003052 556 NNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLL- 633 (853)
Q Consensus 556 v~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLKPeNILL- 633 (853)
+..++.+|+||||+. ++|..++... ..+++.++..++.||+.||.|||++||+||||+|+||++
T Consensus 66 ------~~~~~~~~lv~e~~~~~~L~~~l~~~--------~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~ 131 (260)
T cd05611 66 ------FQSKDYLYLVMEYLNGGDCASLIKTL--------GGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLID 131 (260)
T ss_pred ------EEcCCeEEEEEeccCCCCHHHHHHHc--------CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEC
Confidence 455678999999975 5888877543 468999999999999999999999999999999999999
Q ss_pred ecCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHhCCCCCCcc
Q 003052 634 VKGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGRTPFSEY 713 (853)
Q Consensus 634 ~~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLtG~~PF~~~ 713 (853)
.++.+||+|||+++.... .....|++.|+|||.+.+.. ++.++|||||||++|+|++|..||...
T Consensus 132 ~~~~~~l~dfg~~~~~~~------~~~~~~~~~y~~pe~~~~~~---------~~~~~Dv~slG~il~~l~~g~~p~~~~ 196 (260)
T cd05611 132 QTGHLKLTDFGLSRNGLE------NKKFVGTPDYLAPETILGVG---------DDKMSDWWSLGCVIFEFLFGYPPFHAE 196 (260)
T ss_pred CCCcEEEeecccceeccc------cccCCCCcCccChhhhcCCC---------CcchhhhHHHHHHHHHHHHCCCCCCCC
Confidence 567999999999875432 22457899999999987643 467999999999999999999999765
Q ss_pred hhHHHHHHhhcC-CCCcccCCCCCChhHHHHHHHhcccCCCCCCC---hhHHhcCCCCCCC
Q 003052 714 KTFWAKFKVITD-PNHEITYEPVPNPWLLDLMKKCLAWDRNERWR---IPQLLQHPFLVPP 770 (853)
Q Consensus 714 ~~~~~~~kii~~-~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpT---a~EIL~HPwf~~~ 770 (853)
............ ...........+.++.+||.+||..||.+||+ +.|+|.||||...
T Consensus 197 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~~~~~~~~ 257 (260)
T cd05611 197 TPDAVFDNILSRRINWPEEVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKSHPFFKSI 257 (260)
T ss_pred CHHHHHHHHHhcccCCCCcccccCCHHHHHHHHHHccCCHHHccCCCcHHHHHcChHhhcC
Confidence 443222222111 11111223356788999999999999999995 4799999999753
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-37 Score=356.22 Aligned_cols=266 Identities=23% Similarity=0.441 Sum_probs=232.4
Q ss_pred ceeeEEEeEeccCceEEEEEEe-cCCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHHHH
Q 003052 472 KLYQRLGKIGSGGSSEVHKVIS-SDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLREV 550 (853)
Q Consensus 472 ~~Y~ilk~LG~G~FG~Vyka~~-~~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~~l 550 (853)
+.|+++..||.|.+|.||+++. ++++..|||++.......+ .+..|.+||+.+.+|||++.+++++.-.+
T Consensus 19 d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~de---EiE~eynil~~~~~hpnv~~fyg~~~k~~------ 89 (953)
T KOG0587|consen 19 DIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDEEE---EIELEYNMLKKYSHHPNVATFYGAFIKKD------ 89 (953)
T ss_pred CccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCccccH---HHHHHHHHHHhccCCCCcceEEEEEEEec------
Confidence 5589999999999999999998 5778899999876654433 46689999999999999999999864321
Q ss_pred hhCCCCCCCCccccCCeEEEEEecch-hhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCCCc
Q 003052 551 LNGSMNNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPA 629 (853)
Q Consensus 551 ~~~~iv~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLKPe 629 (853)
--.++.+|||||||+ |+..++++... +..+.|.++.+|++.++.||.|||.+.+||||||-.
T Consensus 90 -----------~~~~DqLWLVMEfC~gGSVTDLVKn~~------g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~ 152 (953)
T KOG0587|consen 90 -----------PGNGDQLWLVMEFCGGGSVTDLVKNTK------GNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQ 152 (953)
T ss_pred -----------CCCCCeEEEEeeccCCccHHHHHhhhc------ccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCc
Confidence 134568999999987 48888877642 578999999999999999999999999999999999
Q ss_pred cEEe-ecCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHhCCC
Q 003052 630 NFLL-VKGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGRT 708 (853)
Q Consensus 630 NILL-~~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLtG~~ 708 (853)
|||+ .+|.|||+|||.+..+... -..+.+.+|||+|||||++.+.+..+ ..|+..+|+||||++..||.-|.+
T Consensus 153 NiLLT~e~~VKLvDFGvSaQldsT--~grRnT~iGtP~WMAPEViac~e~~d----~tyd~R~D~WsLGITaIEladG~P 226 (953)
T KOG0587|consen 153 NVLLTENAEVKLVDFGVSAQLDST--VGRRNTFIGTPYWMAPEVIACDESPD----ATYDYRSDLWSLGITAIEMAEGAP 226 (953)
T ss_pred eEEEeccCcEEEeeeeeeeeeecc--cccccCcCCCcccccceeeecccCCC----CCcccccchhhccceeehhcCCCC
Confidence 9999 6789999999999887542 33567899999999999998876432 358889999999999999999999
Q ss_pred CCCcchhHHHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCCChhHHhcCCCCCC
Q 003052 709 PFSEYKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQHPFLVP 769 (853)
Q Consensus 709 PF~~~~~~~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~HPwf~~ 769 (853)
|+-+..+....|.+...+...+.-+..++.++.+||..||.+|..+||+..++|+|||+..
T Consensus 227 Pl~DmHPmraLF~IpRNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~hpFi~e 287 (953)
T KOG0587|consen 227 PLCDMHPMRALFLIPRNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKHPFITE 287 (953)
T ss_pred CccCcchhhhhccCCCCCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhccCCcccc
Confidence 9999999999999999999888888899999999999999999999999999999999983
|
|
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-36 Score=325.85 Aligned_cols=257 Identities=23% Similarity=0.370 Sum_probs=206.0
Q ss_pred ceeeEEEeEeccCceEEEEEEe-cCCcEEEEEEEecCCC-ChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHHH
Q 003052 472 KLYQRLGKIGSGGSSEVHKVIS-SDCTIYALKKIKLKGR-DYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLRE 549 (853)
Q Consensus 472 ~~Y~ilk~LG~G~FG~Vyka~~-~~g~~vAVKkik~~~~-~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~~ 549 (853)
..|...+.||+|+||.||++.+ .++..||+|++..... .......+.+|++++++++ |+||++++++
T Consensus 25 ~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~---------- 93 (317)
T cd06635 25 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIK-HPNSIEYKGC---------- 93 (317)
T ss_pred hhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCC-CCCEEEEEEE----------
Confidence 3478889999999999999997 4678999999975433 2334456889999999997 8999999986
Q ss_pred HhhCCCCCCCCccccCCeEEEEEecchhhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCCCc
Q 003052 550 VLNGSMNNKDGRVKDDGYIYMVLEYGEIDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPA 629 (853)
Q Consensus 550 l~~~~iv~~~g~~~d~~~lyLVmEy~~gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLKPe 629 (853)
+.++...|+||||+.++|.+.+... ...+++..+..++.||+.||.|||++||+||||+|+
T Consensus 94 ------------~~~~~~~~lv~e~~~g~l~~~~~~~-------~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~ 154 (317)
T cd06635 94 ------------YLREHTAWLVMEYCLGSASDLLEVH-------KKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAG 154 (317)
T ss_pred ------------EeeCCeEEEEEeCCCCCHHHHHHHh-------cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcc
Confidence 3455678999999988887776542 346899999999999999999999999999999999
Q ss_pred cEEe-ecCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHhCCC
Q 003052 630 NFLL-VKGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGRT 708 (853)
Q Consensus 630 NILL-~~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLtG~~ 708 (853)
||++ .++.+||+|||++..... .....|++.|+|||.+..... ..++.++|||||||++|+|++|+.
T Consensus 155 Nil~~~~~~~kl~dfg~~~~~~~------~~~~~~~~~y~aPE~~~~~~~------~~~~~~~Dv~slGvil~el~~g~~ 222 (317)
T cd06635 155 NILLTEPGQVKLADFGSASIASP------ANSFVGTPYWMAPEVILAMDE------GQYDGKVDVWSLGITCIELAERKP 222 (317)
T ss_pred cEEECCCCCEEEecCCCccccCC------cccccCCccccChhhhhcCCC------CCCCccccHHHHHHHHHHHHhCCC
Confidence 9999 567999999999875432 124578999999999853211 135679999999999999999999
Q ss_pred CCCcchhHHHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCCChhHHhcCCCCCCCC
Q 003052 709 PFSEYKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQHPFLVPPV 771 (853)
Q Consensus 709 PF~~~~~~~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~HPwf~~~~ 771 (853)
||...........+...... .......+..+++||.+||..+|.+||++.++++|+|+....
T Consensus 223 p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~ 284 (317)
T cd06635 223 PLFNMNAMSALYHIAQNESP-TLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLRER 284 (317)
T ss_pred CCCCccHHHHHHHHHhccCC-CCCCccccHHHHHHHHHHccCCcccCcCHHHHHhChhhhccC
Confidence 99776555444444433221 222335677899999999999999999999999999996544
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-37 Score=323.63 Aligned_cols=259 Identities=22% Similarity=0.310 Sum_probs=199.0
Q ss_pred CceeeEEEeEeccCceEEEEEEec------CCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHH
Q 003052 471 GKLYQRLGKIGSGGSSEVHKVISS------DCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEK 544 (853)
Q Consensus 471 g~~Y~ilk~LG~G~FG~Vyka~~~------~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~ 544 (853)
...|++.++||+|+||.||+|... .+..||+|+++.... ......+.+|+.++.+++ |+||++++++
T Consensus 4 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~~~~l~-h~~iv~~~~~----- 76 (283)
T cd05091 4 LSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAE-GPLREEFKHEAMMRSRLQ-HPNIVCLLGV----- 76 (283)
T ss_pred HHHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCC-HHHHHHHHHHHHHHhcCC-CCCcCeEEEE-----
Confidence 345888999999999999999863 246899999975433 234456889999999997 8999999987
Q ss_pred HHHHHHhhCCCCCCCCccccCCeEEEEEecch-hhHHHHHHHhhhh--------ccCCCCCCCHHHHHHHHHHhhhhhhh
Q 003052 545 ALLREVLNGSMNNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKE--------MDGSNQTLDENWLRFYWQQILEAVNT 615 (853)
Q Consensus 545 ~iL~~l~~~~iv~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~--------~~~~~~~LsE~~~r~I~~QIl~AL~y 615 (853)
+.+...+++++||+. ++|..++...... .......+++..+..++.||+.||.|
T Consensus 77 -----------------~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~ 139 (283)
T cd05091 77 -----------------VTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEF 139 (283)
T ss_pred -----------------EcCCCceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHH
Confidence 345567899999965 5788877532110 01123468899999999999999999
Q ss_pred cccCceeeCCCCCccEEee-cCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchh
Q 003052 616 IHEERIVHSDLKPANFLLV-KGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIW 694 (853)
Q Consensus 616 LHs~gIIHRDLKPeNILL~-~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIW 694 (853)
||++||+||||||+|||+. ++.+||+|||+++...............+++.|+|||.+.+.. ++.++|||
T Consensus 140 lH~~gi~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~---------~~~~~Dv~ 210 (283)
T cd05091 140 LSSHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGK---------FSIDSDIW 210 (283)
T ss_pred HHHcCccccccchhheEecCCCceEecccccccccccchheeeccCccCCccccCHHHHhcCC---------CCcchhHH
Confidence 9999999999999999994 5689999999998764332222223445678999999986543 56789999
Q ss_pred hhHHHHHHHHh-CCCCCCcchhHHHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCCChhHHhcC
Q 003052 695 SLGCILYQMVY-GRTPFSEYKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQH 764 (853)
Q Consensus 695 SLGVILyELLt-G~~PF~~~~~~~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~H 764 (853)
||||++|||++ |..||.+.... .....+.... ....+...+.++.+|+.+||+.||.+||++.+|+..
T Consensus 211 slG~~l~el~~~g~~p~~~~~~~-~~~~~i~~~~-~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~ 279 (283)
T cd05091 211 SYGVVLWEVFSYGLQPYCGYSNQ-DVIEMIRNRQ-VLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSR 279 (283)
T ss_pred HHHHHHHHHHcCCCCCCCCCCHH-HHHHHHHcCC-cCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHH
Confidence 99999999998 89999775543 2333333322 223455678899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=318.37 Aligned_cols=254 Identities=29% Similarity=0.492 Sum_probs=197.9
Q ss_pred eeEEEeEeccCceEEEEEEec-CCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHHHHhh
Q 003052 474 YQRLGKIGSGGSSEVHKVISS-DCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLREVLN 552 (853)
Q Consensus 474 Y~ilk~LG~G~FG~Vyka~~~-~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~~l~~ 552 (853)
|++.+.||+|+||.||+|... +++.||||++........ .....+|+..++++.+|+||++++++
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~-~~~~~~e~~~l~~~~~h~~i~~~~~~------------- 66 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWE-ECMNLREVKSLRKLNEHPNIVKLKEV------------- 66 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchh-HHHHHHHHHHHHhccCCCCchhHHHH-------------
Confidence 678899999999999999985 568899999876543222 22356799999999889999998876
Q ss_pred CCCCCCCCccccCCeEEEEEecchhhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCCCccEE
Q 003052 553 GSMNNKDGRVKDDGYIYMVLEYGEIDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANFL 632 (853)
Q Consensus 553 ~~iv~~~g~~~d~~~lyLVmEy~~gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLKPeNIL 632 (853)
+.++..+|+||||++++|.+.+... ....+++..+..++.||+.||.|||++||+|+||||+||+
T Consensus 67 ---------~~~~~~~~lv~e~~~~~l~~~~~~~------~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~ 131 (283)
T cd07830 67 ---------FRENDELYFVFEYMEGNLYQLMKDR------KGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLL 131 (283)
T ss_pred ---------hhcCCcEEEEEecCCCCHHHHHHhc------ccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEE
Confidence 3446788999999988998887654 1247899999999999999999999999999999999999
Q ss_pred ee-cCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHhCCCCCC
Q 003052 633 LV-KGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGRTPFS 711 (853)
Q Consensus 633 L~-~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLtG~~PF~ 711 (853)
++ ++.++|+|||+++....... .....|+..|+|||++.... .++.++|+|||||++|+|++|++||.
T Consensus 132 i~~~~~~~l~d~~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~--------~~~~~~Di~s~G~~l~el~~g~~~~~ 200 (283)
T cd07830 132 VSGPEVVKIADFGLAREIRSRPP---YTDYVSTRWYRAPEILLRST--------SYSSPVDIWALGCIMAELYTLRPLFP 200 (283)
T ss_pred EcCCCCEEEeecccceeccCCCC---cCCCCCcccccCceeeecCc--------CcCCccchhhHHHHHHHHHhCCCccC
Confidence 95 57999999999986643222 23457899999999886432 35679999999999999999999996
Q ss_pred cchhHHHHHHhh---cCCCC-------------c-----------ccCCCCCChhHHHHHHHhcccCCCCCCChhHHhcC
Q 003052 712 EYKTFWAKFKVI---TDPNH-------------E-----------ITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQH 764 (853)
Q Consensus 712 ~~~~~~~~~kii---~~~~~-------------~-----------~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~H 764 (853)
.........+.. ..+.. . .......+..+.+||.+||..||.+|||+.|++.|
T Consensus 201 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~ 280 (283)
T cd07830 201 GSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQH 280 (283)
T ss_pred CCChHHHHHHHHHhcCCCChhhhhhHhhhhccccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhC
Confidence 543322211111 10000 0 00111235779999999999999999999999999
Q ss_pred CCC
Q 003052 765 PFL 767 (853)
Q Consensus 765 Pwf 767 (853)
|||
T Consensus 281 ~~~ 283 (283)
T cd07830 281 PYF 283 (283)
T ss_pred CCC
Confidence 997
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-36 Score=324.85 Aligned_cols=257 Identities=23% Similarity=0.348 Sum_probs=205.4
Q ss_pred ceeeEEEeEeccCceEEEEEEe-cCCcEEEEEEEecCCC-ChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHHH
Q 003052 472 KLYQRLGKIGSGGSSEVHKVIS-SDCTIYALKKIKLKGR-DYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLRE 549 (853)
Q Consensus 472 ~~Y~ilk~LG~G~FG~Vyka~~-~~g~~vAVKkik~~~~-~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~~ 549 (853)
+.|...++||+|+||.||+|++ .++..||+|++..... .......+.+|+.++++++ |+||++++++
T Consensus 21 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~---------- 89 (313)
T cd06633 21 EIFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLK-HPNTIEYKGC---------- 89 (313)
T ss_pred HHhhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCC-CCCCccEEEE----------
Confidence 3477788899999999999998 4678999999975433 2334456789999999997 8999999886
Q ss_pred HhhCCCCCCCCccccCCeEEEEEecchhhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCCCc
Q 003052 550 VLNGSMNNKDGRVKDDGYIYMVLEYGEIDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPA 629 (853)
Q Consensus 550 l~~~~iv~~~g~~~d~~~lyLVmEy~~gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLKPe 629 (853)
+.+...+|+||||+.++|.+.+... ...+++..++.++.||+.||.|||++||+||||||+
T Consensus 90 ------------~~~~~~~~lv~e~~~~~l~~~l~~~-------~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~ 150 (313)
T cd06633 90 ------------YLKEHTAWLVMEYCLGSASDLLEVH-------KKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAG 150 (313)
T ss_pred ------------EEeCCEEEEEEecCCCCHHHHHHhc-------CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChh
Confidence 4556789999999988888777542 346899999999999999999999999999999999
Q ss_pred cEEe-ecCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHhCCC
Q 003052 630 NFLL-VKGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGRT 708 (853)
Q Consensus 630 NILL-~~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLtG~~ 708 (853)
||++ .++.+||+|||++..... .....|+..|+|||++..... ..++.++|||||||++|+|++|..
T Consensus 151 nili~~~~~~kL~dfg~~~~~~~------~~~~~~~~~y~aPE~~~~~~~------~~~~~~sDv~slGvil~el~~g~~ 218 (313)
T cd06633 151 NILLTEPGQVKLADFGSASKSSP------ANSFVGTPYWMAPEVILAMDE------GQYDGKVDVWSLGITCIELAERKP 218 (313)
T ss_pred hEEECCCCCEEEeecCCCcccCC------CCCccccccccChhhccccCC------CCCCchhhHHHHHHHHHHHHhCCC
Confidence 9999 467999999999864321 235679999999999853211 135679999999999999999999
Q ss_pred CCCcchhHHHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCCChhHHhcCCCCCCCC
Q 003052 709 PFSEYKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQHPFLVPPV 771 (853)
Q Consensus 709 PF~~~~~~~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~HPwf~~~~ 771 (853)
||...+.............. .......+..+++||.+||+++|.+||++.+++.||||....
T Consensus 219 p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~~~~~~~~ 280 (313)
T cd06633 219 PLFNMNAMSALYHIAQNDSP-TLQSNEWTDSFRGFVDYCLQKIPQERPASAELLRHDFVRRDR 280 (313)
T ss_pred CCCCCChHHHHHHHHhcCCC-CCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCcccCCCc
Confidence 99776555444444332221 122334567799999999999999999999999999998643
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=321.66 Aligned_cols=253 Identities=27% Similarity=0.417 Sum_probs=203.5
Q ss_pred ceeeEEEeEeccCceEEEEEEec-CCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHHHH
Q 003052 472 KLYQRLGKIGSGGSSEVHKVISS-DCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLREV 550 (853)
Q Consensus 472 ~~Y~ilk~LG~G~FG~Vyka~~~-~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~~l 550 (853)
..|+.+++||.|+||.||+|.+. ++..||+|.+..... ......+.+|+.+++++. |+||++++++
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~-h~~i~~~~~~----------- 70 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEA-EDEIEDIQQEITVLSQCD-SPYVTKYYGS----------- 70 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEecccc-HHHHHHHHHHHHHHHhCC-CCCEeeEEEE-----------
Confidence 35888899999999999999984 578899999875432 234567889999999996 8999999986
Q ss_pred hhCCCCCCCCccccCCeEEEEEecch-hhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCCCc
Q 003052 551 LNGSMNNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPA 629 (853)
Q Consensus 551 ~~~~iv~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLKPe 629 (853)
+.++.++|+||||++ ++|.+++.. ..+++..+..++.|++.||.|||+++|+|+||+|+
T Consensus 71 -----------~~~~~~~~lv~e~~~~~~L~~~i~~---------~~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~ 130 (277)
T cd06640 71 -----------YLKGTKLWIIMEYLGGGSALDLLRA---------GPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAA 130 (277)
T ss_pred -----------EEECCEEEEEEecCCCCcHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChh
Confidence 456778999999976 478777643 35899999999999999999999999999999999
Q ss_pred cEEee-cCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHhCCC
Q 003052 630 NFLLV-KGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGRT 708 (853)
Q Consensus 630 NILL~-~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLtG~~ 708 (853)
||+++ ++.++|+|||++........ ......++..|+|||++.+.. ++.++|+|||||++|+|++|.+
T Consensus 131 Nil~~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~y~apE~~~~~~---------~~~~~Dv~slG~il~el~tg~~ 199 (277)
T cd06640 131 NVLLSEQGDVKLADFGVAGQLTDTQI--KRNTFVGTPFWMAPEVIQQSA---------YDSKADIWSLGITAIELAKGEP 199 (277)
T ss_pred hEEEcCCCCEEEcccccceeccCCcc--ccccccCcccccCHhHhccCC---------CccHHHHHHHHHHHHHHHHCCC
Confidence 99994 57899999999976643221 223457899999999986543 4679999999999999999999
Q ss_pred CCCcchhHHHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCCChhHHhcCCCCCCC
Q 003052 709 PFSEYKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQHPFLVPP 770 (853)
Q Consensus 709 PF~~~~~~~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~HPwf~~~ 770 (853)
||.+.........+.. ..........+..+.+||.+||..+|.+||++.++++|+||...
T Consensus 200 p~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~ 259 (277)
T cd06640 200 PNSDMHPMRVLFLIPK--NNPPTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKHKFIVKN 259 (277)
T ss_pred CCCCcChHhHhhhhhc--CCCCCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhChHhhhc
Confidence 9976554433322211 11222334456789999999999999999999999999999654
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-36 Score=314.45 Aligned_cols=251 Identities=24% Similarity=0.314 Sum_probs=198.2
Q ss_pred EEcCceeeEEEeEeccCceEEEEEEecCCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHH
Q 003052 468 KVNGKLYQRLGKIGSGGSSEVHKVISSDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALL 547 (853)
Q Consensus 468 ~v~g~~Y~ilk~LG~G~FG~Vyka~~~~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL 547 (853)
.+..+.|+++++||+|+||.||+|...+++.||+|.+...... ...+.+|+.++++++ |+||+++++++
T Consensus 2 ~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~~---~~~~~~E~~~l~~l~-h~~i~~~~~~~------- 70 (260)
T cd05067 2 EVPRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSMS---PEAFLAEANLMKQLQ-HPRLVRLYAVV------- 70 (260)
T ss_pred ccchHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCCc---HHHHHHHHHHHHhcC-CcCeeeEEEEE-------
Confidence 3556789999999999999999999888899999999754433 346889999999997 89999998762
Q ss_pred HHHhhCCCCCCCCccccCCeEEEEEecch-hhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCC
Q 003052 548 REVLNGSMNNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDL 626 (853)
Q Consensus 548 ~~l~~~~iv~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDL 626 (853)
....+|+||||+. ++|.+.+... .+..+++.++..++.||+.||+|||++||+||||
T Consensus 71 ----------------~~~~~~~v~e~~~~~~L~~~~~~~------~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl 128 (260)
T cd05067 71 ----------------TQEPIYIITEYMENGSLVDFLKTP------EGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDL 128 (260)
T ss_pred ----------------ccCCcEEEEEcCCCCCHHHHHHhc------CCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccc
Confidence 2345799999975 5888887543 2356899999999999999999999999999999
Q ss_pred CCccEEe-ecCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHh
Q 003052 627 KPANFLL-VKGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVY 705 (853)
Q Consensus 627 KPeNILL-~~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLt 705 (853)
||+||++ .++.++|+|||++......... ......++..|+|||++.+. .++.++|||||||++|+|++
T Consensus 129 ~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~-~~~~~~~~~~y~~pe~~~~~---------~~~~~~Di~slG~~l~el~~ 198 (260)
T cd05067 129 RAANILVSETLCCKIADFGLARLIEDNEYT-AREGAKFPIKWTAPEAINYG---------TFTIKSDVWSFGILLTEIVT 198 (260)
T ss_pred cHHhEEEcCCCCEEEccCcceeecCCCCcc-cccCCcccccccCHHHhccC---------CcCcccchHHHHHHHHHHHh
Confidence 9999999 4668999999999766422211 11234567889999998654 35679999999999999998
Q ss_pred -CCCCCCcchhHHHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCCChhHHhc
Q 003052 706 -GRTPFSEYKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQ 763 (853)
Q Consensus 706 -G~~PF~~~~~~~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~ 763 (853)
|++||.+........ .+.. ......+...+.++.+||.+||..||.+||++++++.
T Consensus 199 ~g~~p~~~~~~~~~~~-~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 255 (260)
T cd05067 199 YGRIPYPGMTNPEVIQ-NLER-GYRMPRPDNCPEELYELMRLCWKEKPEERPTFEYLRS 255 (260)
T ss_pred CCCCCCCCCChHHHHH-HHHc-CCCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 999997654432222 2221 1222334456778999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-36 Score=315.89 Aligned_cols=251 Identities=20% Similarity=0.374 Sum_probs=197.5
Q ss_pred EcCceeeEEEeEeccCceEEEEEEec-CCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHH
Q 003052 469 VNGKLYQRLGKIGSGGSSEVHKVISS-DCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALL 547 (853)
Q Consensus 469 v~g~~Y~ilk~LG~G~FG~Vyka~~~-~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL 547 (853)
+....|.+.++||+|+||.||+|.+. .++.||+|++.... .....+.+|++++++++ |+||++++++
T Consensus 3 ~~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~---~~~~~~~~e~~~l~~l~-h~~i~~~~~~-------- 70 (263)
T cd05052 3 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT---MEVEEFLKEAAVMKEIK-HPNLVQLLGV-------- 70 (263)
T ss_pred CchHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCc---hHHHHHHHHHHHHHhCC-CCChhheEEE--------
Confidence 34456999999999999999999874 57889999987542 23456889999999997 8999999876
Q ss_pred HHHhhCCCCCCCCccccCCeEEEEEecch-hhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCC
Q 003052 548 REVLNGSMNNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDL 626 (853)
Q Consensus 548 ~~l~~~~iv~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDL 626 (853)
+..+..+|+||||++ ++|.+++... ....+++..++.++.||+.||.|||++||+||||
T Consensus 71 --------------~~~~~~~~lv~e~~~~~~L~~~~~~~------~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dl 130 (263)
T cd05052 71 --------------CTREPPFYIITEFMTYGNLLDYLREC------NRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDL 130 (263)
T ss_pred --------------EcCCCCcEEEEEeCCCCcHHHHHHhC------CCCCCCHHHHHHHHHHHHHHHHHHHhCCEeeccc
Confidence 344567899999965 6888887653 2346899999999999999999999999999999
Q ss_pred CCccEEe-ecCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHh
Q 003052 627 KPANFLL-VKGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVY 705 (853)
Q Consensus 627 KPeNILL-~~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLt 705 (853)
||+|||+ .++.+||+|||++......... ......++..|+|||.+.+.. ++.++|||||||++|||++
T Consensus 131 kp~nil~~~~~~~kl~df~~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~---------~~~~~Dv~slG~il~el~t 200 (263)
T cd05052 131 AARNCLVGENHLVKVADFGLSRLMTGDTYT-AHAGAKFPIKWTAPESLAYNK---------FSIKSDVWAFGVLLWEIAT 200 (263)
T ss_pred CcceEEEcCCCcEEeCCCccccccccceee-ccCCCCCccccCCHHHhccCC---------CCchhHHHHHHHHHHHHHc
Confidence 9999999 5678999999999876442211 111233467899999986553 5678999999999999998
Q ss_pred -CCCCCCcchhHHHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCCChhHHhc
Q 003052 706 -GRTPFSEYKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQ 763 (853)
Q Consensus 706 -G~~PF~~~~~~~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~ 763 (853)
|..||.+.... .....+.. ......+...+..+.+||.+||..||.+||++.++++
T Consensus 201 ~g~~p~~~~~~~-~~~~~~~~-~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~ 257 (263)
T cd05052 201 YGMSPYPGIDLS-QVYELLEK-GYRMERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQ 257 (263)
T ss_pred CCCCCCCCCCHH-HHHHHHHC-CCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence 99999764332 22233222 2233445567889999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-36 Score=315.79 Aligned_cols=249 Identities=21% Similarity=0.316 Sum_probs=196.0
Q ss_pred CceeeEEEeEeccCceEEEEEEecCCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHHHH
Q 003052 471 GKLYQRLGKIGSGGSSEVHKVISSDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLREV 550 (853)
Q Consensus 471 g~~Y~ilk~LG~G~FG~Vyka~~~~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~~l 550 (853)
.+.|++++.||+|+||.||++...++..+|+|.++..... ...+.+|+.+++++. |+||+++++++
T Consensus 3 ~~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~~~---~~~~~~e~~~l~~l~-h~~i~~~~~~~---------- 68 (256)
T cd05113 3 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS---EDEFIEEAKVMMKLS-HEKLVQLYGVC---------- 68 (256)
T ss_pred hHHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCccc---HHHHHHHHHHHhcCC-CCCeeeEEEEE----------
Confidence 3569999999999999999998877777999998754332 245889999999997 89999999873
Q ss_pred hhCCCCCCCCccccCCeEEEEEecch-hhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCCCc
Q 003052 551 LNGSMNNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPA 629 (853)
Q Consensus 551 ~~~~iv~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLKPe 629 (853)
.+...+|+||||+. ++|.+++... ...+++..++.++.||+.||.|||++||+|+||||.
T Consensus 69 ------------~~~~~~~lv~e~~~~~~l~~~i~~~-------~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ 129 (256)
T cd05113 69 ------------TKQRPIYIVTEYMSNGCLLNYLREH-------GKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAAR 129 (256)
T ss_pred ------------ccCCCcEEEEEcCCCCcHHHHHHhc-------CCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcc
Confidence 34456899999975 5788877542 236899999999999999999999999999999999
Q ss_pred cEEe-ecCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHh-CC
Q 003052 630 NFLL-VKGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVY-GR 707 (853)
Q Consensus 630 NILL-~~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLt-G~ 707 (853)
|||+ .++.+||+|||+++........ ......++..|+|||.+.+.. ++.++|||||||++|+|++ |.
T Consensus 130 nili~~~~~~kl~d~g~~~~~~~~~~~-~~~~~~~~~~y~~pe~~~~~~---------~~~~~Di~slG~~l~~l~~~g~ 199 (256)
T cd05113 130 NCLVDDQGCVKVSDFGLSRYVLDDEYT-SSVGSKFPVRWSPPEVLLYSK---------FSSKSDVWAFGVLMWEVYSLGK 199 (256)
T ss_pred eEEEcCCCCEEECCCccceecCCCcee-ecCCCccChhhCCHHHHhcCc---------ccchhHHHHHHHHHHHHhcCCC
Confidence 9999 4678999999999865432211 111234567899999996543 5679999999999999998 99
Q ss_pred CCCCcchhHHHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCCChhHHhcC
Q 003052 708 TPFSEYKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQH 764 (853)
Q Consensus 708 ~PF~~~~~~~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~H 764 (853)
.||...........+... .....+...+..+.+++.+||..||.+||++.+|+.+
T Consensus 200 ~p~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~ 254 (256)
T cd05113 200 MPYERFNNSETVEKVSQG--LRLYRPHLASEKVYAIMYSCWHEKAEERPTFQQLLSS 254 (256)
T ss_pred CCcCcCCHHHHHHHHhcC--CCCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHh
Confidence 999765443222222221 1222334567889999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=314.07 Aligned_cols=243 Identities=22% Similarity=0.319 Sum_probs=188.1
Q ss_pred eEeccCceEEEEEEe-cCCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHHHHhhCCCCC
Q 003052 479 KIGSGGSSEVHKVIS-SDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLREVLNGSMNN 557 (853)
Q Consensus 479 ~LG~G~FG~Vyka~~-~~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~~l~~~~iv~ 557 (853)
.||+|+||.||+|++ .+++.||+|.+.... .......+.+|+++++++. |+||++++++
T Consensus 2 ~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~------------------ 61 (252)
T cd05084 2 RIGRGNFGEVFSGRLRADNTPVAVKSCRETL-PPDLKAKFLQEARILKQYS-HPNIVRLIGV------------------ 61 (252)
T ss_pred ccCcccCccEEEEEEecCCceEEEEecCccC-CHHHHHHHHHHHHHHHhCC-CCCcceEEEE------------------
Confidence 599999999999998 477899999986443 2334456889999999996 8999999987
Q ss_pred CCCccccCCeEEEEEecch-hhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCCCccEEe-ec
Q 003052 558 KDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLL-VK 635 (853)
Q Consensus 558 ~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLKPeNILL-~~ 635 (853)
+.+...+|+||||+. ++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||+ .+
T Consensus 62 ----~~~~~~~~lv~e~~~~~~L~~~~~~~-------~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~ 130 (252)
T cd05084 62 ----CTQKQPIYIVMELVQGGDFLTFLRTE-------GPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEK 130 (252)
T ss_pred ----EcCCCCeEEEEeeccCCcHHHHHHhC-------CCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEcCC
Confidence 345567899999965 5888877542 2468999999999999999999999999999999999999 46
Q ss_pred CcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHh-CCCCCCcch
Q 003052 636 GSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVY-GRTPFSEYK 714 (853)
Q Consensus 636 g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLt-G~~PF~~~~ 714 (853)
+.+||+|||++................++..|+|||.+.+.. ++.++|||||||++|+|++ |..||....
T Consensus 131 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~---------~~~~~Dv~slG~il~e~~~~~~~p~~~~~ 201 (252)
T cd05084 131 NVLKISDFGMSREEEDGVYASTGGMKQIPVKWTAPEALNYGR---------YSSESDVWSFGILLWEAFSLGAVPYANLS 201 (252)
T ss_pred CcEEECccccCcccccccccccCCCCCCceeecCchhhcCCC---------CChHHHHHHHHHHHHHHHhCCCCCccccC
Confidence 689999999997653221111111122346799999986543 5678999999999999997 999997544
Q ss_pred hHHHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCCChhHHhc
Q 003052 715 TFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQ 763 (853)
Q Consensus 715 ~~~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~ 763 (853)
.......... ......+...+..+.+||.+||..||.+||++.++++
T Consensus 202 ~~~~~~~~~~--~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~ 248 (252)
T cd05084 202 NQQTREAIEQ--GVRLPCPELCPDAVYRLMERCWEYDPGQRPSFSTVHQ 248 (252)
T ss_pred HHHHHHHHHc--CCCCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 3322222211 2233445566788999999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-36 Score=318.30 Aligned_cols=259 Identities=20% Similarity=0.299 Sum_probs=198.0
Q ss_pred cCceeeEEEeEeccCceEEEEEEecC------CcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhH
Q 003052 470 NGKLYQRLGKIGSGGSSEVHKVISSD------CTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTE 543 (853)
Q Consensus 470 ~g~~Y~ilk~LG~G~FG~Vyka~~~~------g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e 543 (853)
.++.|.+.+.||+|+||.||+|.+.. ...||+|.+..... ......+.+|+.++++++ |+||+++++++
T Consensus 4 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~-~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~--- 78 (277)
T cd05036 4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCS-EQDESDFLMEALIMSKFN-HQNIVRLIGVS--- 78 (277)
T ss_pred CHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCC-HHHHHHHHHHHHHHHhCC-CCCEeeEEEEE---
Confidence 34669999999999999999998843 46788888865433 233456889999999997 89999999863
Q ss_pred HHHHHHHhhCCCCCCCCccccCCeEEEEEecch-hhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCcee
Q 003052 544 KALLREVLNGSMNNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIV 622 (853)
Q Consensus 544 ~~iL~~l~~~~iv~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gII 622 (853)
.+....|+||||+. ++|.+++...... ......+++..+..++.||+.||.|||++||+
T Consensus 79 -------------------~~~~~~~lv~e~~~g~~L~~~i~~~~~~-~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~iv 138 (277)
T cd05036 79 -------------------FERLPRFILLELMAGGDLKSFLRENRPR-PERPSSLTMKDLLFCARDVAKGCKYLEENHFI 138 (277)
T ss_pred -------------------ccCCCcEEEEecCCCCCHHHHHHHhCCC-CCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEe
Confidence 34456799999974 6898888664211 11224689999999999999999999999999
Q ss_pred eCCCCCccEEeec-C---cEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHH
Q 003052 623 HSDLKPANFLLVK-G---SLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGC 698 (853)
Q Consensus 623 HRDLKPeNILL~~-g---~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGV 698 (853)
||||||+|||+++ + .+||+|||+++.+.............++..|+|||++.+. .++.++|||||||
T Consensus 139 H~dlkp~nil~~~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~---------~~~~~~DiwslG~ 209 (277)
T cd05036 139 HRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDG---------IFTSKTDVWSFGV 209 (277)
T ss_pred ecccchheEEEeccCCCcceEeccCccccccCCccceecCCCCCccHhhCCHHHHhcC---------CcCchhHHHHHHH
Confidence 9999999999953 2 5999999999876332221111223445689999999654 3568999999999
Q ss_pred HHHHHHh-CCCCCCcchhHHHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCCChhHHhcC
Q 003052 699 ILYQMVY-GRTPFSEYKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQH 764 (853)
Q Consensus 699 ILyELLt-G~~PF~~~~~~~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~H 764 (853)
++|+|++ |..||.+..... ....+.. ......+...+..+.+||.+||..||.+||++.++++|
T Consensus 210 il~el~~~g~~pf~~~~~~~-~~~~~~~-~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~ 274 (277)
T cd05036 210 LLWEIFSLGYMPYPGRTNQE-VMEFVTG-GGRLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILER 274 (277)
T ss_pred HHHHHHcCCCCCCCCCCHHH-HHHHHHc-CCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 9999996 999997644332 2222221 22233455677889999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-36 Score=313.78 Aligned_cols=255 Identities=27% Similarity=0.398 Sum_probs=203.7
Q ss_pred eeeEEEeEeccCceEEEEEEe-cCCcEEEEEEEecCC---CChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHH
Q 003052 473 LYQRLGKIGSGGSSEVHKVIS-SDCTIYALKKIKLKG---RDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLR 548 (853)
Q Consensus 473 ~Y~ilk~LG~G~FG~Vyka~~-~~g~~vAVKkik~~~---~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~ 548 (853)
.|++.+.||+|+||.||+|.+ .++..||+|.+.... ........+.+|+.++++++ |+||+++++++..
T Consensus 3 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~-h~~i~~~~~~~~~------ 75 (264)
T cd06653 3 NWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLR-HDRIVQYYGCLRD------ 75 (264)
T ss_pred ceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcC-CCCcceEEEEEEc------
Confidence 489999999999999999998 467899999986432 12344557889999999997 8999999986321
Q ss_pred HHhhCCCCCCCCccccCCeEEEEEecch-hhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCC
Q 003052 549 EVLNGSMNNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLK 627 (853)
Q Consensus 549 ~l~~~~iv~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLK 627 (853)
.+...+++||||+. ++|.+++... ..+++..++.++.||+.||.|||++||+|||||
T Consensus 76 --------------~~~~~~~~v~e~~~~~~L~~~~~~~--------~~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~ 133 (264)
T cd06653 76 --------------PEEKKLSIFVEYMPGGSIKDQLKAY--------GALTENVTRRYTRQILQGVSYLHSNMIVHRDIK 133 (264)
T ss_pred --------------CCCCEEEEEEEeCCCCcHHHHHHHc--------CCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCC
Confidence 12457899999975 5788777543 458999999999999999999999999999999
Q ss_pred CccEEe-ecCcEEEEecccchhcccCCc-cccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHh
Q 003052 628 PANFLL-VKGSLKLIDFGIAKAIMSDTT-NIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVY 705 (853)
Q Consensus 628 PeNILL-~~g~VKL~DFGlAk~~~~~~~-~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLt 705 (853)
|+||++ .++.++|+|||+++....... ........|+..|+|||++.+.. ++.++|||||||++|+|++
T Consensus 134 p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~---------~~~~~Di~slG~il~~l~~ 204 (264)
T cd06653 134 GANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVISGEG---------YGRKADVWSVACTVVEMLT 204 (264)
T ss_pred HHHEEEcCCCCEEECccccccccccccccCccccccCCcccccCHhhhcCCC---------CCccccHHHHHHHHHHHHh
Confidence 999999 467899999999986532111 11122457899999999987643 4578999999999999999
Q ss_pred CCCCCCcchhHHHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCCChhHHhcCCCC
Q 003052 706 GRTPFSEYKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQHPFL 767 (853)
Q Consensus 706 G~~PF~~~~~~~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~HPwf 767 (853)
|+.||.+............. ......+...+..+.++|.+||. +|..||++.+++.|||+
T Consensus 205 g~~p~~~~~~~~~~~~~~~~-~~~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~~~~~ 264 (264)
T cd06653 205 EKPPWAEYEAMAAIFKIATQ-PTKPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLRHPFV 264 (264)
T ss_pred CCCCCCccCHHHHHHHHHcC-CCCCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhcCCCC
Confidence 99999876665555544432 22334566778889999999999 57999999999999995
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-36 Score=324.42 Aligned_cols=263 Identities=21% Similarity=0.319 Sum_probs=201.1
Q ss_pred EEcCceeeEEEeEeccCceEEEEEEec--------CCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeeh
Q 003052 468 KVNGKLYQRLGKIGSGGSSEVHKVISS--------DCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDY 539 (853)
Q Consensus 468 ~v~g~~Y~ilk~LG~G~FG~Vyka~~~--------~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~ 539 (853)
.+..++|.+.+.||+|+||.||+|.+. +...+|+|.++.... ......+.+|+.+++++..|+||++++++
T Consensus 14 ~~~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~e~~~l~~l~~h~~i~~~~~~ 92 (307)
T cd05098 14 EVPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDAT-EKDLSDLISEMEMMKMIGKHKNIINLLGA 92 (307)
T ss_pred eeehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCC-hHHHHHHHHHHHHHHHhcCCCCEeeEEEE
Confidence 445578999999999999999999752 224699999975432 33445688999999999779999999986
Q ss_pred hhhHHHHHHHHhhCCCCCCCCccccCCeEEEEEecch-hhHHHHHHHhhhh--------ccCCCCCCCHHHHHHHHHHhh
Q 003052 540 EVTEKALLREVLNGSMNNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKE--------MDGSNQTLDENWLRFYWQQIL 610 (853)
Q Consensus 540 ~~~e~~iL~~l~~~~iv~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~--------~~~~~~~LsE~~~r~I~~QIl 610 (853)
+.+.+.+|+||||++ ++|.+++..+... .......+++..++.++.||+
T Consensus 93 ----------------------~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~ 150 (307)
T cd05098 93 ----------------------CTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVA 150 (307)
T ss_pred ----------------------EecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHH
Confidence 345567899999976 5999988654210 001224689999999999999
Q ss_pred hhhhhcccCceeeCCCCCccEEee-cCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCC
Q 003052 611 EAVNTIHEERIVHSDLKPANFLLV-KGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGR 689 (853)
Q Consensus 611 ~AL~yLHs~gIIHRDLKPeNILL~-~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ 689 (853)
.||+|||++||+||||||+|||++ ++.+||+|||+++.+.............+++.|+|||++.+.. ++.
T Consensus 151 ~aL~~lH~~gi~H~dlkp~Nill~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~---------~~~ 221 (307)
T cd05098 151 RGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRI---------YTH 221 (307)
T ss_pred HHHHHHHHCCcccccccHHheEEcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCC---------CCc
Confidence 999999999999999999999994 6789999999998664322111111233457899999986543 567
Q ss_pred ccchhhhHHHHHHHHh-CCCCCCcchhHHHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCCChhHHhcC
Q 003052 690 PSDIWSLGCILYQMVY-GRTPFSEYKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQH 764 (853)
Q Consensus 690 ksDIWSLGVILyELLt-G~~PF~~~~~~~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~H 764 (853)
++|||||||++|+|++ |..||.+... ...+..+... .....+...+..+.+||.+||..+|.+||++.+++++
T Consensus 222 ~~DvwslG~~l~el~~~g~~p~~~~~~-~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~ 295 (307)
T cd05098 222 QSDVWSFGVLLWEIFTLGGSPYPGVPV-EELFKLLKEG-HRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 295 (307)
T ss_pred HHHHHHHHHHHHHHHcCCCCCCCcCCH-HHHHHHHHcC-CCCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence 9999999999999998 8999976433 3333333322 2233445667889999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=320.31 Aligned_cols=254 Identities=31% Similarity=0.507 Sum_probs=207.5
Q ss_pred ceeeEEEeEeccCceEEEEEEec-CCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHHHH
Q 003052 472 KLYQRLGKIGSGGSSEVHKVISS-DCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLREV 550 (853)
Q Consensus 472 ~~Y~ilk~LG~G~FG~Vyka~~~-~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~~l 550 (853)
+.|.+.+.||+|+||.||+|.+. ++..||+|++..... ....+.+|++++++++ |+||++++++
T Consensus 19 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~---~~~~~~~e~~~l~~l~-~~~i~~~~~~----------- 83 (286)
T cd06614 19 ELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ---NKELIINEILIMKDCK-HPNIVDYYDS----------- 83 (286)
T ss_pred ccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch---hHHHHHHHHHHHHHCC-CCCeeEEEEE-----------
Confidence 44888889999999999999985 678899999986543 3456889999999997 8999999886
Q ss_pred hhCCCCCCCCccccCCeEEEEEecch-hhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCCCc
Q 003052 551 LNGSMNNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPA 629 (853)
Q Consensus 551 ~~~~iv~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLKPe 629 (853)
+.....+|+||||++ ++|.+++... ...+++..+..++.||+.||.|||++||+|+||||+
T Consensus 84 -----------~~~~~~~~lv~e~~~~~~L~~~l~~~-------~~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ 145 (286)
T cd06614 84 -----------YLVGDELWVVMEYMDGGSLTDIITQN-------FVRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSD 145 (286)
T ss_pred -----------EEECCEEEEEEeccCCCcHHHHHHHh-------ccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChh
Confidence 445578999999987 6999888764 137999999999999999999999999999999999
Q ss_pred cEEee-cCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHhCCC
Q 003052 630 NFLLV-KGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGRT 708 (853)
Q Consensus 630 NILL~-~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLtG~~ 708 (853)
||+++ ++.++|+|||++........ ......|++.|+|||++.+.. ++.++|+|||||++|+|++|+.
T Consensus 146 ni~i~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~---------~~~~~Dv~slGvil~~l~~g~~ 214 (286)
T cd06614 146 NILLSKDGSVKLADFGFAAQLTKEKS--KRNSVVGTPYWMAPEVIKRKD---------YGPKVDIWSLGIMCIEMAEGEP 214 (286)
T ss_pred hEEEcCCCCEEECccchhhhhccchh--hhccccCCcccCCHhHhcCCC---------CCCccccHHHHHHHHHHHhCCC
Confidence 99994 67999999999876543221 223456889999999986542 5679999999999999999999
Q ss_pred CCCcchhHHHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCCChhHHhcCCCCCC
Q 003052 709 PFSEYKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQHPFLVP 769 (853)
Q Consensus 709 PF~~~~~~~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~HPwf~~ 769 (853)
||...........+..............+..+.+||.+||+.+|.+||++.++|+|+||..
T Consensus 215 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~ 275 (286)
T cd06614 215 PYLREPPLRALFLITTKGIPPLKNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQHPFLKK 275 (286)
T ss_pred CCCCCCHHHHHHHHHhcCCCCCcchhhCCHHHHHHHHHHhccChhhCcCHHHHhhChHhhc
Confidence 9987665544443333222222333346788999999999999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-36 Score=318.71 Aligned_cols=253 Identities=29% Similarity=0.435 Sum_probs=203.6
Q ss_pred ceeeEEEeEeccCceEEEEEEe-cCCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHHHH
Q 003052 472 KLYQRLGKIGSGGSSEVHKVIS-SDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLREV 550 (853)
Q Consensus 472 ~~Y~ilk~LG~G~FG~Vyka~~-~~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~~l 550 (853)
..|+++++||+|+||.||+|.+ .++..||||.+..... ......+.+|+.+++++. |+||++++++
T Consensus 4 ~~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~e~~~l~~l~-h~~iv~~~~~----------- 70 (277)
T cd06641 4 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA-EDEIEDIQQEITVLSQCD-SPYVTKYYGS----------- 70 (277)
T ss_pred HhhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccc-hHHHHHHHHHHHHHHhcC-CCCEeEEEEE-----------
Confidence 3488889999999999999987 4678999999865432 234456889999999997 8999999886
Q ss_pred hhCCCCCCCCccccCCeEEEEEecchh-hHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCCCc
Q 003052 551 LNGSMNNKDGRVKDDGYIYMVLEYGEI-DLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPA 629 (853)
Q Consensus 551 ~~~~iv~~~g~~~d~~~lyLVmEy~~g-dL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLKPe 629 (853)
+.++.++|+||||+++ +|..++.. ..+++..+..++.||+.||.|||++||+|+||||.
T Consensus 71 -----------~~~~~~~~lv~e~~~~~~l~~~i~~---------~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ 130 (277)
T cd06641 71 -----------YLKDTKLWIIMEYLGGGSALDLLEP---------GPLDETQIATILREILKGLDYLHSEKKIHRDIKAA 130 (277)
T ss_pred -----------EEeCCeEEEEEEeCCCCcHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHH
Confidence 4566789999999764 77776642 36899999999999999999999999999999999
Q ss_pred cEEe-ecCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHhCCC
Q 003052 630 NFLL-VKGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGRT 708 (853)
Q Consensus 630 NILL-~~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLtG~~ 708 (853)
||++ .++.++|+|||++..+.... .......|+..|+|||.+.+. .++.++|+|||||++|+|++|..
T Consensus 131 Ni~i~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~~y~~PE~~~~~---------~~~~~~Dv~slG~~l~~l~~g~~ 199 (277)
T cd06641 131 NVLLSEHGEVKLADFGVAGQLTDTQ--IKRNTFVGTPFWMAPEVIKQS---------AYDSKADIWSLGITAIELAKGEP 199 (277)
T ss_pred hEEECCCCCEEEeecccceecccch--hhhccccCCccccChhhhccC---------CCCchhhHHHHHHHHHHHHcCCC
Confidence 9999 56789999999997654322 122346789999999998654 24578999999999999999999
Q ss_pred CCCcchhHHHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCCChhHHhcCCCCCCC
Q 003052 709 PFSEYKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQHPFLVPP 770 (853)
Q Consensus 709 PF~~~~~~~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~HPwf~~~ 770 (853)
||...........+.. ..........+.++.++|.+||..+|.+||++.++++||||...
T Consensus 200 p~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~~~~ 259 (277)
T cd06641 200 PHSELHPMKVLFLIPK--NNPPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFIVRF 259 (277)
T ss_pred CCCccchHHHHHHHhc--CCCCCCCcccCHHHHHHHHHHccCChhhCcCHHHHHhCHHHhhh
Confidence 9976554433332222 12223445567889999999999999999999999999999864
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=315.49 Aligned_cols=250 Identities=24% Similarity=0.317 Sum_probs=196.7
Q ss_pred EcCceeeEEEeEeccCceEEEEEEecCCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHH
Q 003052 469 VNGKLYQRLGKIGSGGSSEVHKVISSDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLR 548 (853)
Q Consensus 469 v~g~~Y~ilk~LG~G~FG~Vyka~~~~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~ 548 (853)
+..++|+++++||+|+||.||+|...++..+|+|.+...... ...+.+|+.++++++ |+||+++++++
T Consensus 3 ~~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~~---~~~~~~E~~~l~~l~-~~~i~~~~~~~-------- 70 (260)
T cd05070 3 IPRESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMS---PESFLEEAQIMKKLR-HDKLVQLYAVV-------- 70 (260)
T ss_pred CchHHhhhhheeccccCceEEEEEecCCceeEEEEecCCCCC---HHHHHHHHHHHHhcC-CCceEEEEeEE--------
Confidence 345679999999999999999999888888999999764433 245889999999997 89999998752
Q ss_pred HHhhCCCCCCCCccccCCeEEEEEecch-hhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCC
Q 003052 549 EVLNGSMNNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLK 627 (853)
Q Consensus 549 ~l~~~~iv~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLK 627 (853)
....+|+||||+. ++|.+++... ....+++..++.++.||+.||.|||++||+|||||
T Consensus 71 ---------------~~~~~~lv~e~~~~~~L~~~~~~~------~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~ 129 (260)
T cd05070 71 ---------------SEEPIYIVTEYMSKGSLLDFLKDG------EGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLR 129 (260)
T ss_pred ---------------CCCCcEEEEEecCCCcHHHHHHhc------CCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCc
Confidence 1234789999975 5888887653 23468999999999999999999999999999999
Q ss_pred CccEEee-cCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHh-
Q 003052 628 PANFLLV-KGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVY- 705 (853)
Q Consensus 628 PeNILL~-~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLt- 705 (853)
|+||+++ ++.+||+|||++..+...... ......++..|+|||.+.+. .++.++|||||||++|+|++
T Consensus 130 p~Nili~~~~~~~l~dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~---------~~~~~~Di~slG~~l~~l~~~ 199 (260)
T cd05070 130 SANILVGDGLVCKIADFGLARLIEDNEYT-ARQGAKFPIKWTAPEAALYG---------RFTIKSDVWSFGILLTELVTK 199 (260)
T ss_pred cceEEEeCCceEEeCCceeeeeccCcccc-cccCCCCCccccChHHHhcC---------CCcchhhhHHHHHHHHHHHhc
Confidence 9999995 568999999999865432211 11233456789999998654 35679999999999999999
Q ss_pred CCCCCCcchhHHHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCCChhHHhc
Q 003052 706 GRTPFSEYKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQ 763 (853)
Q Consensus 706 G~~PF~~~~~~~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~ 763 (853)
|.+||.+......... +.. ......+...+..+.+||.+||..||.+|||+.+++.
T Consensus 200 g~~p~~~~~~~~~~~~-~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~ 255 (260)
T cd05070 200 GRVPYPGMNNREVLEQ-VER-GYRMPCPQDCPISLHELMLQCWKKDPEERPTFEYLQS 255 (260)
T ss_pred CCCCCCCCCHHHHHHH-HHc-CCCCCCCCcCCHHHHHHHHHHcccCcccCcCHHHHHH
Confidence 9999976544332222 221 2223344566788999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-36 Score=324.36 Aligned_cols=258 Identities=22% Similarity=0.337 Sum_probs=201.5
Q ss_pred eEEcCceeeEEEeEeccCceEEEEEEec------CCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehh
Q 003052 467 FKVNGKLYQRLGKIGSGGSSEVHKVISS------DCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYE 540 (853)
Q Consensus 467 ~~v~g~~Y~ilk~LG~G~FG~Vyka~~~------~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~ 540 (853)
+.+..++|.+.+.||+|+||.||++... .+..+|+|+++.... ......+.+|+.+++++.+|+||++++++
T Consensus 30 ~~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~~h~~iv~~~~~- 107 (302)
T cd05055 30 WEFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAH-SSEREALMSELKIMSHLGNHENIVNLLGA- 107 (302)
T ss_pred ccccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCC-hHHHHHHHHHHHHHHhccCCCCcceEEEE-
Confidence 4556678999999999999999999741 335799999875433 33445688999999999779999999986
Q ss_pred hhHHHHHHHHhhCCCCCCCCccccCCeEEEEEecch-hhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccC
Q 003052 541 VTEKALLREVLNGSMNNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEE 619 (853)
Q Consensus 541 ~~e~~iL~~l~~~~iv~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~ 619 (853)
+...+.+|+||||+. ++|.+++... ....+++..+..++.||+.||.|||++
T Consensus 108 ---------------------~~~~~~~~lv~e~~~~~~L~~~i~~~------~~~~l~~~~~~~i~~~i~~~l~~lH~~ 160 (302)
T cd05055 108 ---------------------CTIGGPILVITEYCCYGDLLNFLRRK------RESFLTLEDLLSFSYQVAKGMAFLASK 160 (302)
T ss_pred ---------------------EecCCceEEEEEcCCCCcHHHHHHhC------CCCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 344567899999965 6898888653 123489999999999999999999999
Q ss_pred ceeeCCCCCccEEee-cCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHH
Q 003052 620 RIVHSDLKPANFLLV-KGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGC 698 (853)
Q Consensus 620 gIIHRDLKPeNILL~-~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGV 698 (853)
||+|+||||+|||++ ++.+||+|||+++.+.............+++.|+|||.+.+.. ++.++|||||||
T Consensus 161 ~ivH~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~---------~~~~~DiwslGv 231 (302)
T cd05055 161 NCIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFNCV---------YTFESDVWSYGI 231 (302)
T ss_pred CeehhhhccceEEEcCCCeEEECCCcccccccCCCceeecCCCCcccccCCHhhhccCC---------CCcHhHHHHHHH
Confidence 999999999999995 5689999999998765433222222345678999999986543 567999999999
Q ss_pred HHHHHHh-CCCCCCcchhHHHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCCChhHHhc
Q 003052 699 ILYQMVY-GRTPFSEYKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQ 763 (853)
Q Consensus 699 ILyELLt-G~~PF~~~~~~~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~ 763 (853)
++|+|++ |..||..........+.+... .....+...++.+.+||.+||..+|++||++.++++
T Consensus 232 il~el~t~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~ 296 (302)
T cd05055 232 LLWEIFSLGSNPYPGMPVDSKFYKLIKEG-YRMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQ 296 (302)
T ss_pred HHHHHHhCCCCCcCCCCchHHHHHHHHcC-CcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 9999998 999997654333333333222 222234456788999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=315.61 Aligned_cols=248 Identities=22% Similarity=0.345 Sum_probs=195.5
Q ss_pred ceeeEEEeEeccCceEEEEEEecCCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHHHHh
Q 003052 472 KLYQRLGKIGSGGSSEVHKVISSDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLREVL 551 (853)
Q Consensus 472 ~~Y~ilk~LG~G~FG~Vyka~~~~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~~l~ 551 (853)
.+|++.+.||+|+||.||+|.+.++..+|+|++...... ...+.+|++++++++ |+||++++++
T Consensus 4 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~~---~~~~~~e~~~l~~l~-~~~i~~~~~~------------ 67 (256)
T cd05059 4 SELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAMS---EDDFIEEAKVMMKLS-HPNLVQLYGV------------ 67 (256)
T ss_pred HHcchhhhhccCCCceEEEeEecCCccEEEEEeccCCCC---HHHHHHHHHHHHhCC-CCCEEEEEEE------------
Confidence 458899999999999999999877778999998654332 235778999999997 8999999876
Q ss_pred hCCCCCCCCccccCCeEEEEEecch-hhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCCCcc
Q 003052 552 NGSMNNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPAN 630 (853)
Q Consensus 552 ~~~iv~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLKPeN 630 (853)
+.+.+.+|+||||++ ++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|
T Consensus 68 ----------~~~~~~~~lv~e~~~~~~L~~~l~~~-------~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~n 130 (256)
T cd05059 68 ----------CTKQRPIFIVTEYMANGCLLNYLRER-------KGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARN 130 (256)
T ss_pred ----------EcCCCceEEEEecCCCCCHHHHHHhc-------ccCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhh
Confidence 345567899999975 5888887643 2368999999999999999999999999999999999
Q ss_pred EEe-ecCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHh-CCC
Q 003052 631 FLL-VKGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVY-GRT 708 (853)
Q Consensus 631 ILL-~~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLt-G~~ 708 (853)
|++ .++.+||+|||+++........ ......++..|+|||.+.+. .++.++|||||||++|+|++ |++
T Consensus 131 i~i~~~~~~kl~dfg~~~~~~~~~~~-~~~~~~~~~~y~~Pe~~~~~---------~~~~~~Di~slG~il~~l~~~g~~ 200 (256)
T cd05059 131 CLVGEDNVVKVSDFGLARYVLDDQYT-SSQGTKFPVKWAPPEVFDYS---------RFSSKSDVWSFGVLMWEVFSEGKM 200 (256)
T ss_pred EEECCCCcEEECCcccceeccccccc-ccCCCCCCccccCHHHhccC---------CCCchhhHHHHHHHHHHHhccCCC
Confidence 999 5679999999999865432211 11122344579999998764 35679999999999999998 899
Q ss_pred CCCcchhHHHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCCChhHHhcC
Q 003052 709 PFSEYKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQH 764 (853)
Q Consensus 709 PF~~~~~~~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~H 764 (853)
||...........+.. ......+...+.++.+|+.+||..+|.+||++.++++.
T Consensus 201 p~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~ 254 (256)
T cd05059 201 PYERFSNSEVVESVSA--GYRLYRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQ 254 (256)
T ss_pred CCCCCCHHHHHHHHHc--CCcCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHH
Confidence 9976544332222222 22233445578899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-36 Score=309.40 Aligned_cols=253 Identities=30% Similarity=0.454 Sum_probs=204.2
Q ss_pred eeeEEEeEeccCceEEEEEEe-cCCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHHHHh
Q 003052 473 LYQRLGKIGSGGSSEVHKVIS-SDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLREVL 551 (853)
Q Consensus 473 ~Y~ilk~LG~G~FG~Vyka~~-~~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~~l~ 551 (853)
+|++.++||+|+||.||++.+ .++..||+|++............+.+|++++++++ |+||++++++
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~------------ 67 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVN-HPNIISYKEA------------ 67 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCC-CCCchhhhhh------------
Confidence 388999999999999999987 46789999999876554555667889999999998 8999998765
Q ss_pred hCCCCCCCCccccCCeEEEEEecch-hhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCCCcc
Q 003052 552 NGSMNNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPAN 630 (853)
Q Consensus 552 ~~~iv~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLKPeN 630 (853)
+.+...+|+||||+. ++|..++.... .....+++..+..++.||+.||.|||+.||+||||+|+|
T Consensus 68 ----------~~~~~~~~~v~e~~~~~~L~~~~~~~~----~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~n 133 (256)
T cd08530 68 ----------FLDGNKLCIVMEYAPFGDLSKAISKRK----KKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSAN 133 (256)
T ss_pred ----------hccCCEEEEEehhcCCCCHHHHHHHHH----hhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcce
Confidence 344578999999975 58888876532 123578999999999999999999999999999999999
Q ss_pred EEee-cCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHhCCCC
Q 003052 631 FLLV-KGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGRTP 709 (853)
Q Consensus 631 ILL~-~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLtG~~P 709 (853)
|+++ ++.+||+|||+++..... ......|++.|+|||.+.+. .++.++|+||||+++|+|++|+.|
T Consensus 134 i~~~~~~~~kl~d~g~~~~~~~~----~~~~~~~~~~~~~Pe~~~~~---------~~~~~~D~~slG~~~~~l~~g~~p 200 (256)
T cd08530 134 ILLVANDLVKIGDLGISKVLKKN----MAKTQIGTPHYMAPEVWKGR---------PYSYKSDIWSLGCLLYEMATFAPP 200 (256)
T ss_pred EEEecCCcEEEeeccchhhhccC----CcccccCCccccCHHHHCCC---------CCCchhhHHHHHHHHHHHHhCCCC
Confidence 9994 568999999999876543 12245789999999998654 356789999999999999999999
Q ss_pred CCcchhHHHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCCChhHHhcCCCC
Q 003052 710 FSEYKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQHPFL 767 (853)
Q Consensus 710 F~~~~~~~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~HPwf 767 (853)
|...........+... . ....+...+.+++++|.+||..+|++||++.++++||++
T Consensus 201 ~~~~~~~~~~~~~~~~-~-~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~p~~ 256 (256)
T cd08530 201 FEARSMQDLRYKVQRG-K-YPPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILASPAV 256 (256)
T ss_pred CCCCCHHHHHHHHhcC-C-CCCCchhhCHHHHHHHHHHcCCCcccCCCHHHHhcCCCC
Confidence 9775543322222221 1 112333567889999999999999999999999999985
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=315.57 Aligned_cols=261 Identities=25% Similarity=0.420 Sum_probs=211.4
Q ss_pred eeeEEEeEeccCceEEEEEEe-cCCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHHHHh
Q 003052 473 LYQRLGKIGSGGSSEVHKVIS-SDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLREVL 551 (853)
Q Consensus 473 ~Y~ilk~LG~G~FG~Vyka~~-~~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~~l~ 551 (853)
..+.+..||.|+.|.||+++. .+|.+.|||.+...+.. +...+++..+.++.+...+|+||+.++||.
T Consensus 93 dl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nk-ee~kRILmDldvv~~s~dcpyIV~c~GyFi---------- 161 (391)
T KOG0983|consen 93 DLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNK-EENKRILMDLDVVLKSHDCPYIVQCFGYFI---------- 161 (391)
T ss_pred HhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCH-HHHHHHHHhhhHHhhccCCCeeeeeeeEEe----------
Confidence 456778899999999999988 56899999999876554 456678899999988888999999999854
Q ss_pred hCCCCCCCCccccCCeEEEEEecchhhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccC-ceeeCCCCCcc
Q 003052 552 NGSMNNKDGRVKDDGYIYMVLEYGEIDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEE-RIVHSDLKPAN 630 (853)
Q Consensus 552 ~~~iv~~~g~~~d~~~lyLVmEy~~gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~-gIIHRDLKPeN 630 (853)
.+..++|.||.+..-+..+++. ..++++|..+-.+..-++.||.||.++ ||||||+||.|
T Consensus 162 ------------~n~dV~IcMelMs~C~ekLlkr-------ik~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSN 222 (391)
T KOG0983|consen 162 ------------TNTDVFICMELMSTCAEKLLKR-------IKGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSN 222 (391)
T ss_pred ------------eCchHHHHHHHHHHHHHHHHHH-------hcCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccc
Confidence 3445678899876544444433 236799999999999999999999864 89999999999
Q ss_pred EEe-ecCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHhCCCC
Q 003052 631 FLL-VKGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGRTP 709 (853)
Q Consensus 631 ILL-~~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLtG~~P 709 (853)
||| ..|+|||||||++..+.+...+ +...|-+.|||||.+.-... -+|..++||||||++++||.||+.|
T Consensus 223 ILlDe~GniKlCDFGIsGrlvdSkAh---trsAGC~~YMaPERidp~~~------~kYDiRaDVWSlGITlveLaTg~yP 293 (391)
T KOG0983|consen 223 ILLDERGNIKLCDFGISGRLVDSKAH---TRSAGCAAYMAPERIDPPDK------PKYDIRADVWSLGITLVELATGQYP 293 (391)
T ss_pred eEEccCCCEEeecccccceeeccccc---ccccCCccccCccccCCCCC------CccchhhhhhhhccchhhhhcccCC
Confidence 999 5689999999999887654433 35579999999999965432 2688999999999999999999999
Q ss_pred CCcchhHHHHH-HhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCCChhHHhcCCCCCCCCC
Q 003052 710 FSEYKTFWAKF-KVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQHPFLVPPVS 772 (853)
Q Consensus 710 F~~~~~~~~~~-kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~HPwf~~~~~ 772 (853)
|.+.+..++.. +++.+....+......++.+.+|+..||.+|+.+||...++|+|||+.....
T Consensus 294 y~~c~tdFe~ltkvln~ePP~L~~~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h~Fi~~ye~ 357 (391)
T KOG0983|consen 294 YKGCKTDFEVLTKVLNEEPPLLPGHMGFSPDFQSFVKDCLTKDHRKRPKYNKLLEHPFIKRYET 357 (391)
T ss_pred CCCCCccHHHHHHHHhcCCCCCCcccCcCHHHHHHHHHHhhcCcccCcchHHHhcCcceeecch
Confidence 98765544444 3443333344445568999999999999999999999999999999987643
|
|
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-36 Score=317.80 Aligned_cols=261 Identities=20% Similarity=0.266 Sum_probs=201.9
Q ss_pred EcCceeeEEEeEeccCceEEEEEEecC-----CcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhH
Q 003052 469 VNGKLYQRLGKIGSGGSSEVHKVISSD-----CTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTE 543 (853)
Q Consensus 469 v~g~~Y~ilk~LG~G~FG~Vyka~~~~-----g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e 543 (853)
+.+++|++.+.||+|+||.||+|.+.. +..|++|+++.. ........+.+|+.+++++. |+||+++++++.
T Consensus 3 ~~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~-~~~~~~~~~~~e~~~l~~l~-h~ni~~~~~~~~-- 78 (280)
T cd05043 3 ISRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDH-ASEIQVTLLLQESCLLYGLS-HQNILPILHVCI-- 78 (280)
T ss_pred cchhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCC-CCHHHHHHHHHHHHHHHhCC-CCCCCeEEEEEe--
Confidence 556789999999999999999999855 678899988643 33445567889999999995 999999998632
Q ss_pred HHHHHHHhhCCCCCCCCccccCCeEEEEEecch-hhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCcee
Q 003052 544 KALLREVLNGSMNNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIV 622 (853)
Q Consensus 544 ~~iL~~l~~~~iv~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gII 622 (853)
.++...++++||+. ++|..++.............+++..+..++.||+.||+|||++||+
T Consensus 79 -------------------~~~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~ 139 (280)
T cd05043 79 -------------------EDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVI 139 (280)
T ss_pred -------------------cCCCCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEe
Confidence 23456799999965 6888887654221111225699999999999999999999999999
Q ss_pred eCCCCCccEEe-ecCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHH
Q 003052 623 HSDLKPANFLL-VKGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILY 701 (853)
Q Consensus 623 HRDLKPeNILL-~~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILy 701 (853)
||||||+|||+ .++.+||+|||+++.+.............++..|+|||++.+.. ++.++|||||||++|
T Consensus 140 H~di~p~nil~~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~---------~~~~~Di~slG~~l~ 210 (280)
T cd05043 140 HKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKE---------YSSASDVWSFGVLLW 210 (280)
T ss_pred ecccCHhhEEEcCCCcEEECCCCCcccccCCceEEeCCCCCcchhccCHHHHhcCC---------CCchhhHHHhHHHHH
Confidence 99999999999 56799999999998664332221122345677899999986543 567999999999999
Q ss_pred HHHh-CCCCCCcchhHHHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCCChhHHhc
Q 003052 702 QMVY-GRTPFSEYKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQ 763 (853)
Q Consensus 702 ELLt-G~~PF~~~~~~~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~ 763 (853)
+|++ |+.||....... ....+... .........++.+.++|.+||..||.+||++.++++
T Consensus 211 el~~~g~~p~~~~~~~~-~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~ 271 (280)
T cd05043 211 ELMTLGQTPYVEIDPFE-MAAYLKDG-YRLAQPINCPDELFAVMACCWALDPEERPSFSQLVQ 271 (280)
T ss_pred HHhcCCCCCcCcCCHHH-HHHHHHcC-CCCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 9998 999997755433 22222221 222334456788999999999999999999999984
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-36 Score=311.39 Aligned_cols=254 Identities=32% Similarity=0.461 Sum_probs=198.7
Q ss_pred ceeeEEEeEeccCceEEEEEEec-CCcEEEEEEEecCC-CChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHHH
Q 003052 472 KLYQRLGKIGSGGSSEVHKVISS-DCTIYALKKIKLKG-RDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLRE 549 (853)
Q Consensus 472 ~~Y~ilk~LG~G~FG~Vyka~~~-~g~~vAVKkik~~~-~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~~ 549 (853)
+.|++.+.||+|+||.||+|... +++.||+|.++... .+......+.+|++++++++ |+||++++++
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~-~~~i~~~~~~---------- 70 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD-HPNVIKYLAS---------- 70 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCC-CCCeeeeeee----------
Confidence 35999999999999999999985 78999999997533 23334567889999999996 8999999886
Q ss_pred HhhCCCCCCCCccccCCeEEEEEecch-hhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCCC
Q 003052 550 VLNGSMNNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKP 628 (853)
Q Consensus 550 l~~~~iv~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLKP 628 (853)
+.+++.+|+||||+. ++|..++... ......+++..++.++.||+.||.|||+.||+||||||
T Consensus 71 ------------~~~~~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p 134 (267)
T cd08224 71 ------------FIENNELNIVLELADAGDLSRMIKHF----KKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKP 134 (267)
T ss_pred ------------eecCCeEEEEEecCCCCCHHHHHHHh----cccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcCh
Confidence 345567899999976 5888877542 12345689999999999999999999999999999999
Q ss_pred ccEEe-ecCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHhCC
Q 003052 629 ANFLL-VKGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGR 707 (853)
Q Consensus 629 eNILL-~~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLtG~ 707 (853)
+||++ .++.++|+|||++..+..... ......|++.|+|||.+.+.. ++.++|||||||++|+|++|+
T Consensus 135 ~nil~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~y~apE~~~~~~---------~~~~~Di~slG~il~~l~~g~ 203 (267)
T cd08224 135 ANVFITATGVVKLGDLGLGRFFSSKTT--AAHSLVGTPYYMSPERIHENG---------YNFKSDIWSLGCLLYEMAALQ 203 (267)
T ss_pred hhEEECCCCcEEEeccceeeeccCCCc--ccceecCCccccCHHHhccCC---------CCchhcHHHHHHHHHHHHHCC
Confidence 99999 567999999999986543221 123467899999999986543 567999999999999999999
Q ss_pred CCCCcch-hHHHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCCChhHHhc
Q 003052 708 TPFSEYK-TFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQ 763 (853)
Q Consensus 708 ~PF~~~~-~~~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~ 763 (853)
.||.... ........+.............+..+.++|.+||..+|.+||++.+|++
T Consensus 204 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~ 260 (267)
T cd08224 204 SPFYGDKMNLYSLCKKIEKCDYPPLPADHYSEELRDLVSRCINPDPEKRPDISYVLQ 260 (267)
T ss_pred CCcccCCccHHHHHhhhhcCCCCCCChhhcCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 9995432 2222222222211111112256678999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=315.06 Aligned_cols=255 Identities=28% Similarity=0.385 Sum_probs=198.9
Q ss_pred eeeEEEeEeccCceEEEEEEecC-CcEEEEEEEec---CCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHH
Q 003052 473 LYQRLGKIGSGGSSEVHKVISSD-CTIYALKKIKL---KGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLR 548 (853)
Q Consensus 473 ~Y~ilk~LG~G~FG~Vyka~~~~-g~~vAVKkik~---~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~ 548 (853)
+|.+.++||+|+||.||++.+.. +..+++|.++. ..........+.+|+.++++++ |+||+++++++
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~-------- 71 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLD-HPAIVKFHASF-------- 71 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCC-CCcHHHHHHHH--------
Confidence 48899999999999999998843 34455555543 2222233345678999999997 89999988763
Q ss_pred HHhhCCCCCCCCccccCCeEEEEEecch-hhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCC
Q 003052 549 EVLNGSMNNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLK 627 (853)
Q Consensus 549 ~l~~~~iv~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLK 627 (853)
.+...+|+||||+. ++|...+.... .....+++..++.++.||+.||.|||++||+|+|||
T Consensus 72 --------------~~~~~~~lv~e~~~~~~l~~~~~~~~----~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~ 133 (260)
T cd08222 72 --------------LERDAFCIITEYCEGRDLDCKLEELK----HTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLK 133 (260)
T ss_pred --------------hcCCceEEEEEeCCCCCHHHHHHHHh----hcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCC
Confidence 34556899999976 47777775431 134579999999999999999999999999999999
Q ss_pred CccEEeecCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHhCC
Q 003052 628 PANFLLVKGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGR 707 (853)
Q Consensus 628 PeNILL~~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLtG~ 707 (853)
|+||++.++.+||+|||+++....... ......|++.|+|||.+.+.. ++.++|+||||+++|+|++|.
T Consensus 134 ~~nili~~~~~~l~d~g~~~~~~~~~~--~~~~~~~~~~~~~pe~~~~~~---------~~~~~Dv~slG~~~~~l~~~~ 202 (260)
T cd08222 134 AKNIFLKNNLLKIGDFGVSRLLMGSCD--LATTFTGTPYYMSPEALKHQG---------YDSKSDIWSLGCILYEMCCLA 202 (260)
T ss_pred hhheEeecCCEeecccCceeecCCCcc--cccCCCCCcCccCHHHHccCC---------CCchhhHHHHHHHHHHHHhCC
Confidence 999999888999999999987643222 223567899999999986543 456899999999999999999
Q ss_pred CCCCcchhHHHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCCChhHHhcCCCC
Q 003052 708 TPFSEYKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQHPFL 767 (853)
Q Consensus 708 ~PF~~~~~~~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~HPwf 767 (853)
.||............... .....+...+..+.+||.+||..||.+||++.++++||||
T Consensus 203 ~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~ 260 (260)
T cd08222 203 HAFEGQNFLSVVLRIVEG--PTPSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILRNPFI 260 (260)
T ss_pred CCCCCccHHHHHHHHHcC--CCCCCcchhcHHHHHHHHHHhcCChhhCcCHHHHhhCCCC
Confidence 999765554444443332 1222345667889999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-36 Score=314.49 Aligned_cols=251 Identities=22% Similarity=0.290 Sum_probs=196.6
Q ss_pred ceeeEEEeEeccCceEEEEEEec----CCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHH
Q 003052 472 KLYQRLGKIGSGGSSEVHKVISS----DCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALL 547 (853)
Q Consensus 472 ~~Y~ilk~LG~G~FG~Vyka~~~----~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL 547 (853)
..|++.+.||+|+||.||+|.+. +...||||.++... .......+.+|+.++++++ |+||++++++
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~-~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~-------- 73 (266)
T cd05033 4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGS-SDKQRLDFLTEASIMGQFD-HPNIIRLEGV-------- 73 (266)
T ss_pred HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCC-ChHHHHHHHHHHHHHHhCC-CCCcceEeEE--------
Confidence 46899999999999999999874 23579999987543 3334556889999999997 8999999886
Q ss_pred HHHhhCCCCCCCCccccCCeEEEEEecch-hhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCC
Q 003052 548 REVLNGSMNNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDL 626 (853)
Q Consensus 548 ~~l~~~~iv~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDL 626 (853)
+.+...+|+||||+. ++|.+++... ...+++..++.++.|++.||.|||++||+||||
T Consensus 74 --------------~~~~~~~~iv~e~~~~~~L~~~~~~~-------~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di 132 (266)
T cd05033 74 --------------VTKSRPVMIITEYMENGSLDKFLREN-------DGKFTVGQLVGMLRGIASGMKYLSEMNYVHRDL 132 (266)
T ss_pred --------------EecCCceEEEEEcCCCCCHHHHHHhc-------cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCC
Confidence 345567899999975 5888887653 247899999999999999999999999999999
Q ss_pred CCccEEee-cCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHh
Q 003052 627 KPANFLLV-KGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVY 705 (853)
Q Consensus 627 KPeNILL~-~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLt 705 (853)
||+|||++ ++.+||+|||+++.+.............+++.|+|||.+.+.. ++.++|||||||++|+|++
T Consensus 133 ~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~---------~~~~~Dv~slG~~l~~l~~ 203 (266)
T cd05033 133 AARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAIAYRK---------FTSASDVWSFGIVMWEVMS 203 (266)
T ss_pred CcceEEEcCCCCEEECccchhhcccccccceeccCCCCCccccChhhhccCC---------CccccchHHHHHHHHHHHc
Confidence 99999995 5689999999998775222221112234567899999986543 5679999999999999997
Q ss_pred -CCCCCCcchhHHHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCCChhHHhcC
Q 003052 706 -GRTPFSEYKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQH 764 (853)
Q Consensus 706 -G~~PF~~~~~~~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~H 764 (853)
|..||.+.........+ ... .....+...+..+.+|+.+||..||.+||++.+++++
T Consensus 204 ~g~~p~~~~~~~~~~~~~-~~~-~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~ 261 (266)
T cd05033 204 YGERPYWDMSNQDVIKAV-EDG-YRLPPPMDCPSALYQLMLDCWQKDRNERPTFSQIVST 261 (266)
T ss_pred cCCCCCCCCCHHHHHHHH-HcC-CCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 99999765443322222 221 1222344567889999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=350.29 Aligned_cols=253 Identities=24% Similarity=0.373 Sum_probs=213.9
Q ss_pred eeEEEeEeccCceEEEEEEec-CCcEEEEEEEec--CCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHHHH
Q 003052 474 YQRLGKIGSGGSSEVHKVISS-DCTIYALKKIKL--KGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLREV 550 (853)
Q Consensus 474 Y~ilk~LG~G~FG~Vyka~~~-~g~~vAVKkik~--~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~~l 550 (853)
.+...+||+|+|-+||+|.+. +|..||--.++. -.......++|..|+.+|+.|+ |+||+++++++...
T Consensus 42 ~k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~-H~NIirfy~SW~d~------- 113 (632)
T KOG0584|consen 42 LKFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLK-HPNIIRFYDSWVDT------- 113 (632)
T ss_pred eehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCC-CCceeeeeeheecC-------
Confidence 344557999999999999984 565565443332 2345566788999999999998 99999999986432
Q ss_pred hhCCCCCCCCccccCCeEEEEEecch-hhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccC--ceeeCCCC
Q 003052 551 LNGSMNNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEE--RIVHSDLK 627 (853)
Q Consensus 551 ~~~~iv~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~--gIIHRDLK 627 (853)
+..++.+|.|++. |+|..+++++ +.++.+.++.|++||+.||.|||++ .|||||||
T Consensus 114 -------------~n~~in~iTEL~TSGtLr~Y~kk~--------~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLK 172 (632)
T KOG0584|consen 114 -------------DNKTINFITELFTSGTLREYRKKH--------RRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLK 172 (632)
T ss_pred -------------CCceeeeeeecccCCcHHHHHHHh--------ccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccc
Confidence 2356889999954 7999998876 5689999999999999999999998 59999999
Q ss_pred CccEEee--cCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHh
Q 003052 628 PANFLLV--KGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVY 705 (853)
Q Consensus 628 PeNILL~--~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLt 705 (853)
.+||+|+ .|.|||+|+|+|+....... ...+|||.|||||++.. .|...+||||||++++||+|
T Consensus 173 CDNIFinG~~G~VKIGDLGLAtl~r~s~a----ksvIGTPEFMAPEmYEE----------~YnE~VDVYaFGMCmLEMvT 238 (632)
T KOG0584|consen 173 CDNIFVNGNLGEVKIGDLGLATLLRKSHA----KSVIGTPEFMAPEMYEE----------NYNELVDVYAFGMCMLEMVT 238 (632)
T ss_pred cceEEEcCCcCceeecchhHHHHhhcccc----ceeccCccccChHHHhh----------hcchhhhhhhhhHHHHHHHh
Confidence 9999994 58999999999998754322 25799999999999863 36779999999999999999
Q ss_pred CCCCCCcchhHHHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCCChhHHhcCCCCCCC
Q 003052 706 GRTPFSEYKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQHPFLVPP 770 (853)
Q Consensus 706 G~~PF~~~~~~~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~HPwf~~~ 770 (853)
+.+||.+..+..++++.+..+..+-.+.....+++++||.+||.. ..+|+++.|||+||||...
T Consensus 239 ~eYPYsEC~n~AQIYKKV~SGiKP~sl~kV~dPevr~fIekCl~~-~~~R~sa~eLL~d~Ff~~d 302 (632)
T KOG0584|consen 239 SEYPYSECTNPAQIYKKVTSGIKPAALSKVKDPEVREFIEKCLAT-KSERLSAKELLKDPFFDED 302 (632)
T ss_pred ccCChhhhCCHHHHHHHHHcCCCHHHhhccCCHHHHHHHHHHhcC-chhccCHHHHhhChhhccc
Confidence 999999988888999988887777777777789999999999999 9999999999999999864
|
|
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=329.43 Aligned_cols=255 Identities=17% Similarity=0.280 Sum_probs=193.3
Q ss_pred eEecc--CceEEEEEEe-cCCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHHHHhhCCC
Q 003052 479 KIGSG--GSSEVHKVIS-SDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLREVLNGSM 555 (853)
Q Consensus 479 ~LG~G--~FG~Vyka~~-~~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~~l~~~~i 555 (853)
+||+| +||+||++.+ .+++.||+|++............+.+|+.+++.++ |+||++++++
T Consensus 5 ~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~-h~niv~~~~~---------------- 67 (328)
T cd08226 5 EIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFR-HPNIMTSWTV---------------- 67 (328)
T ss_pred HhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCC-CCCcceEeee----------------
Confidence 46666 9999999998 47899999999876555555677889999998887 8999999887
Q ss_pred CCCCCccccCCeEEEEEecch-hhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCCCccEEe-
Q 003052 556 NNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLL- 633 (853)
Q Consensus 556 v~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLKPeNILL- 633 (853)
|..+.++|+||||+. ++|.+++.+.. ...+++..++.++.||+.||+|||++||+||||||+|||+
T Consensus 68 ------~~~~~~~~~v~e~~~~~~l~~~l~~~~------~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~ 135 (328)
T cd08226 68 ------FTTGSWLWVISPFMAYGSANSLLKTYF------PEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILIS 135 (328)
T ss_pred ------EecCCceEEEEecccCCCHHHHHHhhc------ccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEe
Confidence 456678999999976 48887776541 2458999999999999999999999999999999999999
Q ss_pred ecCcEEEEecccchhcccCCcccc-----ccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHhCCC
Q 003052 634 VKGSLKLIDFGIAKAIMSDTTNIQ-----RDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGRT 708 (853)
Q Consensus 634 ~~g~VKL~DFGlAk~~~~~~~~~~-----~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLtG~~ 708 (853)
.++.+|++|||.+........... .....++..|+|||++.+... .++.++|||||||++|+|++|++
T Consensus 136 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-------~~~~~~DiwslG~~l~el~~g~~ 208 (328)
T cd08226 136 GDGLVSLSGLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWLSPELLRQDLY-------GYNVKSDIYSVGITACELATGRV 208 (328)
T ss_pred CCCcEEEechHHHhhhhccCccccccccccccccCccCccChhhhcCCCC-------CCCchhhHHHHHHHHHHHHhCCC
Confidence 467999999987644322111100 011235667999999975422 36789999999999999999999
Q ss_pred CCCcchhHHHHHHhhcCCCC--------------------------------------------cccCCCCCChhHHHHH
Q 003052 709 PFSEYKTFWAKFKVITDPNH--------------------------------------------EITYEPVPNPWLLDLM 744 (853)
Q Consensus 709 PF~~~~~~~~~~kii~~~~~--------------------------------------------~~~~~~~~s~~l~dLI 744 (853)
||.+..........+..... ........++.+.+||
T Consensus 209 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 288 (328)
T cd08226 209 PFQDMLRTQMLLQKLKGPPYSPLDITTFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLV 288 (328)
T ss_pred CCCCcChHHHHHHHhcCCCCCCccccccchhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHH
Confidence 99765433222222111000 0001122456789999
Q ss_pred HHhcccCCCCCCChhHHhcCCCCCC
Q 003052 745 KKCLAWDRNERWRIPQLLQHPFLVP 769 (853)
Q Consensus 745 ~kcL~~DP~kRpTa~EIL~HPwf~~ 769 (853)
++||.+||++|||+.++|+||||..
T Consensus 289 ~~~l~~dP~~Rpta~e~l~~~~~~~ 313 (328)
T cd08226 289 ELCLQQDPEKRPSASSLLSHAFFKQ 313 (328)
T ss_pred HHHccCCcccCCCHHHHhhCHHHHH
Confidence 9999999999999999999999964
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-36 Score=320.28 Aligned_cols=259 Identities=21% Similarity=0.303 Sum_probs=196.4
Q ss_pred ceeeEEEeEeccCceEEEEEEecC-----------------CcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCcee
Q 003052 472 KLYQRLGKIGSGGSSEVHKVISSD-----------------CTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNII 534 (853)
Q Consensus 472 ~~Y~ilk~LG~G~FG~Vyka~~~~-----------------g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV 534 (853)
.+|+++++||+|+||.||+|.+.. ...||+|++..... ......+.+|++++++++ |+||+
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~-~~~~~~~~~e~~~l~~l~-~~~i~ 82 (296)
T cd05051 5 QPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDAS-DNAREDFLKEVKILSRLS-DPNIA 82 (296)
T ss_pred hhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccC-HHHHHHHHHHHHHHHhcC-CCCEe
Confidence 569999999999999999987632 24589999875533 244567889999999997 89999
Q ss_pred EeeehhhhHHHHHHHHhhCCCCCCCCccccCCeEEEEEecch-hhHHHHHHHhhhhc---cCCCCCCCHHHHHHHHHHhh
Q 003052 535 QLIDYEVTEKALLREVLNGSMNNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEM---DGSNQTLDENWLRFYWQQIL 610 (853)
Q Consensus 535 ~Lid~~~~e~~iL~~l~~~~iv~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~~---~~~~~~LsE~~~r~I~~QIl 610 (853)
++++++ .++..+|+||||+. ++|..++....... ......+++..++.++.||+
T Consensus 83 ~~~~~~----------------------~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~ 140 (296)
T cd05051 83 RLLGVC----------------------TVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIA 140 (296)
T ss_pred EEEEEE----------------------ecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHH
Confidence 998873 44567899999965 58888886542100 01123689999999999999
Q ss_pred hhhhhcccCceeeCCCCCccEEee-cCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCC
Q 003052 611 EAVNTIHEERIVHSDLKPANFLLV-KGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGR 689 (853)
Q Consensus 611 ~AL~yLHs~gIIHRDLKPeNILL~-~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ 689 (853)
.||.|||++||+||||||+||+++ ++.++|+|||+++...............+++.|+|||.+.+. .++.
T Consensus 141 ~al~~LH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~---------~~~~ 211 (296)
T cd05051 141 SGMRYLESLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLG---------KFTT 211 (296)
T ss_pred HHHHHHHHcCccccccchhceeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcC---------CCCc
Confidence 999999999999999999999994 579999999999865443322223355678899999998654 3568
Q ss_pred ccchhhhHHHHHHHHh--CCCCCCcchhHHHHHHhhc-----CCCCcccCCCCCChhHHHHHHHhcccCCCCCCChhHHh
Q 003052 690 PSDIWSLGCILYQMVY--GRTPFSEYKTFWAKFKVIT-----DPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLL 762 (853)
Q Consensus 690 ksDIWSLGVILyELLt--G~~PF~~~~~~~~~~kii~-----~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL 762 (853)
++|||||||++|+|++ |..||.............. ........+...+.++.+||.+||..||.+||++.+|+
T Consensus 212 ~~Dv~slG~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~ 291 (296)
T cd05051 212 KSDVWAFGVTLWEILTLCREQPYEHLTDQQVIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIH 291 (296)
T ss_pred cchhhhhHHHHHHHHhcCCCCCCCCcChHHHHHHHHhccccccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHH
Confidence 9999999999999998 7889876433222111111 01111222344567899999999999999999999997
Q ss_pred c
Q 003052 763 Q 763 (853)
Q Consensus 763 ~ 763 (853)
+
T Consensus 292 ~ 292 (296)
T cd05051 292 L 292 (296)
T ss_pred H
Confidence 5
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=317.28 Aligned_cols=254 Identities=32% Similarity=0.540 Sum_probs=200.1
Q ss_pred eeEEEeEeccCceEEEEEEec-CCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHHHHhh
Q 003052 474 YQRLGKIGSGGSSEVHKVISS-DCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLREVLN 552 (853)
Q Consensus 474 Y~ilk~LG~G~FG~Vyka~~~-~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~~l~~ 552 (853)
|++.+.||+|+||.||+|... +++.||+|++............+.+|+.+++++. |+||+++++++
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~-~~~i~~~~~~~------------ 67 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELK-HPNIVKLLDVI------------ 67 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcC-CCCHHHHHhhh------------
Confidence 567788999999999999985 5789999999876544444456788999999997 89999988763
Q ss_pred CCCCCCCCccccCCeEEEEEecchhhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCCCccEE
Q 003052 553 GSMNNKDGRVKDDGYIYMVLEYGEIDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANFL 632 (853)
Q Consensus 553 ~~iv~~~g~~~d~~~lyLVmEy~~gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLKPeNIL 632 (853)
.+...+|+||||++++|.+++... ...+++..++.++.||+.||.|||++||+||||+|+||+
T Consensus 68 ----------~~~~~~~~v~e~~~~~l~~~i~~~-------~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~ 130 (282)
T cd07829 68 ----------HTERKLYLVFEYCDMDLKKYLDKR-------PGPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNIL 130 (282)
T ss_pred ----------hcCCceEEEecCcCcCHHHHHHhh-------ccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEE
Confidence 345689999999988999988754 146999999999999999999999999999999999999
Q ss_pred ee-cCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHhCCCCCC
Q 003052 633 LV-KGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGRTPFS 711 (853)
Q Consensus 633 L~-~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLtG~~PF~ 711 (853)
++ ++.+||+|||+++....... ......++..|+|||.+.+.. .++.++|||||||++|+|++|++||.
T Consensus 131 ~~~~~~~~l~d~g~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~--------~~~~~~Dv~slG~~l~~l~~~~~~~~ 200 (282)
T cd07829 131 INRDGVLKLADFGLARAFGIPLR--TYTHEVVTLWYRAPEILLGSK--------HYSTAVDIWSVGCIFAEMITGKPLFP 200 (282)
T ss_pred EcCCCCEEEecCCcccccCCCcc--ccCccccCcCcCChHHhcCCc--------CCCccccHHHHHHHHHHHHhCCCCCC
Confidence 94 57999999999987643322 223456788999999986541 35689999999999999999999997
Q ss_pred cchhHHHHHHhhc---CCCC------------cc-----------cCCCCCChhHHHHHHHhcccCCCCCCChhHHhcCC
Q 003052 712 EYKTFWAKFKVIT---DPNH------------EI-----------TYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQHP 765 (853)
Q Consensus 712 ~~~~~~~~~kii~---~~~~------------~~-----------~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~HP 765 (853)
.........++.. .+.. .. ...+..+..+.+||.+||..||.+||++.+++.||
T Consensus 201 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~p 280 (282)
T cd07829 201 GDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHP 280 (282)
T ss_pred CccHHHHHHHHHHHhCCCcHHHHHhhcccccccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhCc
Confidence 6443322211110 0000 00 00122366799999999999999999999999999
Q ss_pred CC
Q 003052 766 FL 767 (853)
Q Consensus 766 wf 767 (853)
||
T Consensus 281 ~~ 282 (282)
T cd07829 281 YF 282 (282)
T ss_pred CC
Confidence 98
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-38 Score=347.57 Aligned_cols=254 Identities=29% Similarity=0.456 Sum_probs=216.2
Q ss_pred ceeeEEEeEeccCceEEEEEEecCC-cEEEEEEEecCCC-ChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHHH
Q 003052 472 KLYQRLGKIGSGGSSEVHKVISSDC-TIYALKKIKLKGR-DYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLRE 549 (853)
Q Consensus 472 ~~Y~ilk~LG~G~FG~Vyka~~~~g-~~vAVKkik~~~~-~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~~ 549 (853)
..++++..||-||||.|-++..... ..+|+|++++... +......+..|-+||..++ .+.||+||.-
T Consensus 420 ~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~-s~fIvrLYrT---------- 488 (732)
T KOG0614|consen 420 SDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECR-SDFIVRLYRT---------- 488 (732)
T ss_pred hhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcC-chHHHHHHHH----------
Confidence 4577888999999999998876443 3589999987653 3344556778888888887 7788887643
Q ss_pred HhhCCCCCCCCccccCCeEEEEEec-chhhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCCC
Q 003052 550 VLNGSMNNKDGRVKDDGYIYMVLEY-GEIDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKP 628 (853)
Q Consensus 550 l~~~~iv~~~g~~~d~~~lyLVmEy-~~gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLKP 628 (853)
|.+..++||+||- ++|.|..++..+ +.|.+..+++|+..+++|++|||++|||+|||||
T Consensus 489 ------------frd~kyvYmLmEaClGGElWTiLrdR--------g~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKP 548 (732)
T KOG0614|consen 489 ------------FRDSKYVYMLMEACLGGELWTILRDR--------GSFDDYTARFYVACVLEAFEYLHRKGIIYRDLKP 548 (732)
T ss_pred ------------hccchhhhhhHHhhcCchhhhhhhhc--------CCcccchhhhhHHHHHHHHHHHHhcCceeccCCh
Confidence 7888999999998 567999988765 7899999999999999999999999999999999
Q ss_pred ccEEe-ecCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHhCC
Q 003052 629 ANFLL-VKGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGR 707 (853)
Q Consensus 629 eNILL-~~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLtG~ 707 (853)
+|+|| .+|.+||.|||+|+.+..... ..++||||.|.|||++..... ..++|+||||+++||||+|.
T Consensus 549 ENllLd~~Gy~KLVDFGFAKki~~g~K---TwTFcGTpEYVAPEIILnKGH---------D~avDyWaLGIli~ELL~G~ 616 (732)
T KOG0614|consen 549 ENLLLDNRGYLKLVDFGFAKKIGSGRK---TWTFCGTPEYVAPEIILNKGH---------DRAVDYWALGILIYELLTGS 616 (732)
T ss_pred hheeeccCCceEEeehhhHHHhccCCc---eeeecCCcccccchhhhccCc---------chhhHHHHHHHHHHHHHcCC
Confidence 99999 578999999999999866443 348999999999999987754 47999999999999999999
Q ss_pred CCCCcchhHHHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCCC-----hhHHhcCCCCCC
Q 003052 708 TPFSEYKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWR-----IPQLLQHPFLVP 769 (853)
Q Consensus 708 ~PF~~~~~~~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpT-----a~EIL~HPwf~~ 769 (853)
+||.+.+++.. +..|..+...+.++.....++.+||+++...+|.+|.. +.+|-+|.||..
T Consensus 617 pPFs~~dpmkt-Yn~ILkGid~i~~Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH~Wf~g 682 (732)
T KOG0614|consen 617 PPFSGVDPMKT-YNLILKGIDKIEFPRRITKTATDLIKKLCRDNPTERLGYQKGGINDIKKHRWFEG 682 (732)
T ss_pred CCCCCCchHHH-HHHHHhhhhhhhcccccchhHHHHHHHHHhcCcHhhhccccCChHHHHhhhhhhc
Confidence 99999887654 44445556677788889999999999999999999996 899999999964
|
|
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-36 Score=324.99 Aligned_cols=251 Identities=18% Similarity=0.323 Sum_probs=195.0
Q ss_pred CceeeEEEeEeccCceEEEEEEec-CCc----EEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHH
Q 003052 471 GKLYQRLGKIGSGGSSEVHKVISS-DCT----IYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKA 545 (853)
Q Consensus 471 g~~Y~ilk~LG~G~FG~Vyka~~~-~g~----~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~ 545 (853)
...|++++.||+|+||.||+|.+. ++. .||+|+++... .......+.+|+.+++.+. |+||+++++++.
T Consensus 6 ~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~-h~niv~~~g~~~---- 79 (316)
T cd05108 6 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASVD-NPHVCRLLGICL---- 79 (316)
T ss_pred hhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccC-CHHHHHHHHHHHHHHHhCC-CCCCCeEEEEEc----
Confidence 456999999999999999999863 333 38999987432 2334456889999999997 899999998742
Q ss_pred HHHHHhhCCCCCCCCccccCCeEEEEEecch-hhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeC
Q 003052 546 LLREVLNGSMNNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHS 624 (853)
Q Consensus 546 iL~~l~~~~iv~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHR 624 (853)
. ...++|+||+. ++|.+++... ...+++..+..++.||+.||+|||++||+||
T Consensus 80 ------------------~-~~~~~v~e~~~~g~l~~~l~~~-------~~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~ 133 (316)
T cd05108 80 ------------------T-STVQLITQLMPFGCLLDYVREH-------KDNIGSQYLLNWCVQIAKGMNYLEERRLVHR 133 (316)
T ss_pred ------------------C-CCceeeeecCCCCCHHHHHHhc-------cccCCHHHHHHHHHHHHHHHHHHHhcCeecc
Confidence 1 23578888854 6888887653 2458899999999999999999999999999
Q ss_pred CCCCccEEe-ecCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHH
Q 003052 625 DLKPANFLL-VKGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQM 703 (853)
Q Consensus 625 DLKPeNILL-~~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyEL 703 (853)
||||+|||+ .++.+||+|||+++.+.............++..|+|||++.+. .++.++|||||||++|||
T Consensus 134 dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~apE~~~~~---------~~~~~~Di~slGv~l~el 204 (316)
T cd05108 134 DLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMALESILHR---------IYTHQSDVWSYGVTVWEL 204 (316)
T ss_pred ccchhheEecCCCcEEEccccccccccCCCcceeccCCccceeecChHHhccC---------CCCchhhhHHHHHHHHHH
Confidence 999999999 4578999999999876543332222234457789999998654 356799999999999999
Q ss_pred Hh-CCCCCCcchhHHHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCCChhHHhcC
Q 003052 704 VY-GRTPFSEYKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQH 764 (853)
Q Consensus 704 Lt-G~~PF~~~~~~~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~H 764 (853)
++ |..||.+.... ....++.. ......+...+..+.++|.+||..||.+||++.+++.+
T Consensus 205 ~t~g~~p~~~~~~~-~~~~~~~~-~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~ 264 (316)
T cd05108 205 MTFGSKPYDGIPAS-EISSILEK-GERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIE 264 (316)
T ss_pred HcCCCCCCCCCCHH-HHHHHHhC-CCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 97 99999764332 22222222 22333445667889999999999999999999999987
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=321.77 Aligned_cols=262 Identities=20% Similarity=0.323 Sum_probs=200.1
Q ss_pred EEcCceeeEEEeEeccCceEEEEEEec--------CCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeeh
Q 003052 468 KVNGKLYQRLGKIGSGGSSEVHKVISS--------DCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDY 539 (853)
Q Consensus 468 ~v~g~~Y~ilk~LG~G~FG~Vyka~~~--------~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~ 539 (853)
.+...+|.+.++||+|+||.||+|.+. ....+|+|.++.... ......+.+|+.+++++.+|+||++++++
T Consensus 8 ~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~E~~~l~~l~~h~~iv~~~~~ 86 (314)
T cd05099 8 EFPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNAT-DKDLADLISEMELMKLIGKHKNIINLLGV 86 (314)
T ss_pred cccHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCC-hHHHHHHHHHHHHHHhccCCCCeeeEEEE
Confidence 444578999999999999999999752 235789999875433 34455688999999999889999999986
Q ss_pred hhhHHHHHHHHhhCCCCCCCCccccCCeEEEEEecch-hhHHHHHHHhhhh--------ccCCCCCCCHHHHHHHHHHhh
Q 003052 540 EVTEKALLREVLNGSMNNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKE--------MDGSNQTLDENWLRFYWQQIL 610 (853)
Q Consensus 540 ~~~e~~iL~~l~~~~iv~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~--------~~~~~~~LsE~~~r~I~~QIl 610 (853)
+.+.+.+|+||||+. ++|.+++...... .......+++..+..++.||+
T Consensus 87 ----------------------~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~ 144 (314)
T cd05099 87 ----------------------CTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVA 144 (314)
T ss_pred ----------------------EccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHH
Confidence 344567899999965 5898888764210 011235689999999999999
Q ss_pred hhhhhcccCceeeCCCCCccEEee-cCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCC
Q 003052 611 EAVNTIHEERIVHSDLKPANFLLV-KGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGR 689 (853)
Q Consensus 611 ~AL~yLHs~gIIHRDLKPeNILL~-~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ 689 (853)
.||.|||++||+||||||+|||++ ++.+||+|||+++...............++..|||||++.+. .++.
T Consensus 145 ~aL~~lH~~gi~H~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~---------~~~~ 215 (314)
T cd05099 145 RGMEYLESRRCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDR---------VYTH 215 (314)
T ss_pred HHHHHHHHCCeeeccccceeEEEcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccC---------CcCc
Confidence 999999999999999999999994 678999999999866432221111223345689999998654 3567
Q ss_pred ccchhhhHHHHHHHHh-CCCCCCcchhHHHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCCChhHHhc
Q 003052 690 PSDIWSLGCILYQMVY-GRTPFSEYKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQ 763 (853)
Q Consensus 690 ksDIWSLGVILyELLt-G~~PF~~~~~~~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~ 763 (853)
++|||||||++|+|++ |..||...... ..+..+... .....+...+..+.+||.+||..||.+||++.++++
T Consensus 216 ~~DiwslG~~l~el~~~g~~p~~~~~~~-~~~~~~~~~-~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~ 288 (314)
T cd05099 216 QSDVWSFGILMWEIFTLGGSPYPGIPVE-ELFKLLREG-HRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVE 288 (314)
T ss_pred cchhhHHHHHHHHHHhCCCCCCCCCCHH-HHHHHHHcC-CCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 9999999999999998 89999765432 333333322 222334556778999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=325.34 Aligned_cols=258 Identities=21% Similarity=0.268 Sum_probs=192.5
Q ss_pred EEEeEeccCceEEEEEEecCCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHHHHhhCCC
Q 003052 476 RLGKIGSGGSSEVHKVISSDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLREVLNGSM 555 (853)
Q Consensus 476 ilk~LG~G~FG~Vyka~~~~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~~l~~~~i 555 (853)
+.+.+|.|+++.||++.. +++.||||++............+.+|+.++++++ |+||++++++
T Consensus 6 i~~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~-h~~i~~~~~~---------------- 67 (314)
T cd08216 6 IGKCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQ-HPNILPYVTS---------------- 67 (314)
T ss_pred hhHhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcC-Ccchhhhhhe----------------
Confidence 334445555555555444 6889999999876555566677999999999998 8999998765
Q ss_pred CCCCCccccCCeEEEEEecch-hhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCCCccEEee
Q 003052 556 NNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLLV 634 (853)
Q Consensus 556 v~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLKPeNILL~ 634 (853)
+.+...+|++|||++ ++|.+++... ....+++..++.++.||+.||+|||++||+||||||+|||++
T Consensus 68 ------~~~~~~~~~~~e~~~~~~l~~~l~~~------~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~ 135 (314)
T cd08216 68 ------FIVDSELYVVSPLMAYGSCEDLLKTH------FPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLS 135 (314)
T ss_pred ------eecCCeEEEEEeccCCCCHHHHHHHh------cccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEe
Confidence 455677899999977 5787777654 224689999999999999999999999999999999999994
Q ss_pred -cCcEEEEecccchhcccCCc-----cccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHhCCC
Q 003052 635 -KGSLKLIDFGIAKAIMSDTT-----NIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGRT 708 (853)
Q Consensus 635 -~g~VKL~DFGlAk~~~~~~~-----~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLtG~~ 708 (853)
++.+||+|||.+..+..... ........++..|+|||++.+... .|+.++|||||||++|+|++|+.
T Consensus 136 ~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-------~~~~~~Diws~G~il~el~~g~~ 208 (314)
T cd08216 136 GDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEVLQQNLQ-------GYNEKSDIYSVGITACELANGHV 208 (314)
T ss_pred cCCceEEecCccceeeccccccccccccccccccccccccCHHHhcCCCC-------CCCcchhHHHHHHHHHHHHhCCC
Confidence 68999999999876543211 111234567889999999965321 36789999999999999999999
Q ss_pred CCCcchhHHHHHHhhcCCCC-------------------------------cccCCCCCChhHHHHHHHhcccCCCCCCC
Q 003052 709 PFSEYKTFWAKFKVITDPNH-------------------------------EITYEPVPNPWLLDLMKKCLAWDRNERWR 757 (853)
Q Consensus 709 PF~~~~~~~~~~kii~~~~~-------------------------------~~~~~~~~s~~l~dLI~kcL~~DP~kRpT 757 (853)
||............+..... ........+.++.+||.+||.+||.+|||
T Consensus 209 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt 288 (314)
T cd08216 209 PFKDMPATQMLLEKVRGTVPCLLDKSTYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPS 288 (314)
T ss_pred CCCCCCHHHHHHHHHhccCccccccCchhhhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcC
Confidence 99765433322221110000 00011122356889999999999999999
Q ss_pred hhHHhcCCCCCCC
Q 003052 758 IPQLLQHPFLVPP 770 (853)
Q Consensus 758 a~EIL~HPwf~~~ 770 (853)
+.++|+||||+.-
T Consensus 289 ~~~ll~~p~~~~~ 301 (314)
T cd08216 289 ASQLLNHSFFKQC 301 (314)
T ss_pred HHHHhcCchHhhh
Confidence 9999999999743
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-36 Score=324.03 Aligned_cols=256 Identities=23% Similarity=0.377 Sum_probs=204.0
Q ss_pred ceeeEEEeEeccCceEEEEEEec-CCcEEEEEEEecCCC-ChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHHH
Q 003052 472 KLYQRLGKIGSGGSSEVHKVISS-DCTIYALKKIKLKGR-DYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLRE 549 (853)
Q Consensus 472 ~~Y~ilk~LG~G~FG~Vyka~~~-~g~~vAVKkik~~~~-~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~~ 549 (853)
..|...+.||+|+||.||+|++. ++..+|+|.+..... .......+.+|+++++.++ |+||+++++++
T Consensus 15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~--------- 84 (308)
T cd06634 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR-HPNTIQYRGCY--------- 84 (308)
T ss_pred HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCC-CCCcccEEEEE---------
Confidence 45888889999999999999984 668899999875322 2334456789999999997 89999998863
Q ss_pred HhhCCCCCCCCccccCCeEEEEEecchhhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCCCc
Q 003052 550 VLNGSMNNKDGRVKDDGYIYMVLEYGEIDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPA 629 (853)
Q Consensus 550 l~~~~iv~~~g~~~d~~~lyLVmEy~~gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLKPe 629 (853)
.....+|+||||+.++|.+.+... ...+++..++.++.||+.||.|||++||+||||||+
T Consensus 85 -------------~~~~~~~lv~e~~~~~l~~~~~~~-------~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~ 144 (308)
T cd06634 85 -------------LREHTAWLVMEYCLGSASDLLEVH-------KKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAG 144 (308)
T ss_pred -------------EcCCeeEEEEEccCCCHHHHHHHc-------CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHH
Confidence 345678999999888887776532 246899999999999999999999999999999999
Q ss_pred cEEe-ecCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHhCCC
Q 003052 630 NFLL-VKGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGRT 708 (853)
Q Consensus 630 NILL-~~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLtG~~ 708 (853)
|||+ .++.+||+|||++...... ....|++.|+|||.+.+.... .++.++|||||||++|+|++|..
T Consensus 145 nil~~~~~~~kl~dfg~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~------~~~~~~Di~slG~il~el~~g~~ 212 (308)
T cd06634 145 NILLSEPGLVKLGDFGSASIMAPA------NXFVGTPYWMAPEVILAMDEG------QYDGKVDVWSLGITCIELAERKP 212 (308)
T ss_pred hEEECCCCcEEECCcccceeecCc------ccccCCccccCHHHHhhcccC------CCCcccchHHHHHHHHHHHcCCC
Confidence 9999 5679999999998765321 245789999999998542111 35679999999999999999999
Q ss_pred CCCcchhHHHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCCChhHHhcCCCCCCC
Q 003052 709 PFSEYKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQHPFLVPP 770 (853)
Q Consensus 709 PF~~~~~~~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~HPwf~~~ 770 (853)
||.+............... ........+..+.+||.+||..+|.+||++.++++|||+...
T Consensus 213 p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~~~~~ 273 (308)
T cd06634 213 PLFNMNAMSALYHIAQNES-PALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRE 273 (308)
T ss_pred CCccccHHHHHHHHhhcCC-CCcCcccccHHHHHHHHHHhhCCcccCCCHHHHhhCcccccc
Confidence 9977655444443333221 112233567889999999999999999999999999999864
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-36 Score=320.71 Aligned_cols=264 Identities=19% Similarity=0.318 Sum_probs=202.7
Q ss_pred eEEcCceeeEEEeEeccCceEEEEEEec--------CCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeee
Q 003052 467 FKVNGKLYQRLGKIGSGGSSEVHKVISS--------DCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLID 538 (853)
Q Consensus 467 ~~v~g~~Y~ilk~LG~G~FG~Vyka~~~--------~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid 538 (853)
+.+..+.|.+.+.||+|+||.||+|... ++..||+|.++... .......+.+|+.+++.+.+|+||+++++
T Consensus 10 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~i~~~~~ 88 (304)
T cd05101 10 WEFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDA-TEKDLSDLVSEMEMMKMIGKHKNIINLLG 88 (304)
T ss_pred ccccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeeccccc-chHHHHHHHHHHHHHHhhccCCCchheeE
Confidence 4566788999999999999999999741 23579999987543 23445568899999999977999999988
Q ss_pred hhhhHHHHHHHHhhCCCCCCCCccccCCeEEEEEecch-hhHHHHHHHhhhh--------ccCCCCCCCHHHHHHHHHHh
Q 003052 539 YEVTEKALLREVLNGSMNNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKE--------MDGSNQTLDENWLRFYWQQI 609 (853)
Q Consensus 539 ~~~~e~~iL~~l~~~~iv~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~--------~~~~~~~LsE~~~r~I~~QI 609 (853)
+ +.....+|+||||+. ++|.+++...... .......+++..+..++.||
T Consensus 89 ~----------------------~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi 146 (304)
T cd05101 89 A----------------------CTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQV 146 (304)
T ss_pred E----------------------EecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHH
Confidence 6 345567899999975 5898888754210 00123468889999999999
Q ss_pred hhhhhhcccCceeeCCCCCccEEe-ecCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCC
Q 003052 610 LEAVNTIHEERIVHSDLKPANFLL-VKGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCG 688 (853)
Q Consensus 610 l~AL~yLHs~gIIHRDLKPeNILL-~~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys 688 (853)
+.||.|||++||+||||||+|||+ .++.+||+|||+++.+.............+++.|+|||++.+. .|+
T Consensus 147 ~~al~~LH~~givH~dlkp~Nili~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~---------~~~ 217 (304)
T cd05101 147 ARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDR---------VYT 217 (304)
T ss_pred HHHHHHHHHCCeeecccccceEEEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccC---------CCC
Confidence 999999999999999999999999 4679999999999876433222222234567889999998654 356
Q ss_pred CccchhhhHHHHHHHHh-CCCCCCcchhHHHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCCChhHHhcC
Q 003052 689 RPSDIWSLGCILYQMVY-GRTPFSEYKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQH 764 (853)
Q Consensus 689 ~ksDIWSLGVILyELLt-G~~PF~~~~~~~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~H 764 (853)
.++|||||||++|+|++ |..||.+... ......+... .....+...+..+.+||.+||..+|.+||++.++++.
T Consensus 218 ~~~Di~slG~~l~el~~~g~~p~~~~~~-~~~~~~~~~~-~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~ 292 (304)
T cd05101 218 HQSDVWSFGVLMWEIFTLGGSPYPGIPV-EELFKLLKEG-HRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVED 292 (304)
T ss_pred chhhHHHHHHHHHHHHcCCCCCcccCCH-HHHHHHHHcC-CcCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHH
Confidence 79999999999999998 8899976433 2333333322 2223345567889999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=310.69 Aligned_cols=251 Identities=26% Similarity=0.324 Sum_probs=198.6
Q ss_pred EcCceeeEEEeEeccCceEEEEEEecCCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHH
Q 003052 469 VNGKLYQRLGKIGSGGSSEVHKVISSDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLR 548 (853)
Q Consensus 469 v~g~~Y~ilk~LG~G~FG~Vyka~~~~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~ 548 (853)
+..+.|.+.++||+|+||.||+|...++..+|||.+...... ...+.+|+.+++++. |+||++++++
T Consensus 3 ~~~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~~~---~~~~~~e~~~l~~l~-h~~i~~~~~~--------- 69 (261)
T cd05034 3 IPRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTMS---PEAFLQEAQIMKKLR-HDKLVQLYAV--------- 69 (261)
T ss_pred cchhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCccC---HHHHHHHHHHHhhCC-CCCEeeeeee---------
Confidence 456789999999999999999999877788999998754433 345889999999998 8999999876
Q ss_pred HHhhCCCCCCCCccccCCeEEEEEecch-hhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCC
Q 003052 549 EVLNGSMNNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLK 627 (853)
Q Consensus 549 ~l~~~~iv~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLK 627 (853)
+.+...+|+||||+. ++|.+++... ....+++..++.++.||+.||.|||++||+|+|||
T Consensus 70 -------------~~~~~~~~~v~e~~~~~~L~~~i~~~------~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~ 130 (261)
T cd05034 70 -------------CSEEEPIYIVTEYMSKGSLLDFLKSG------EGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLA 130 (261)
T ss_pred -------------eecCCceEEEEeccCCCCHHHHHhcc------ccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcc
Confidence 344567899999975 5888888653 23468999999999999999999999999999999
Q ss_pred CccEEe-ecCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHh-
Q 003052 628 PANFLL-VKGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVY- 705 (853)
Q Consensus 628 PeNILL-~~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLt- 705 (853)
|+||++ .++.+||+|||+++.+..... .......++..|+|||.+.+.. ++.++|||||||++|+|++
T Consensus 131 p~nili~~~~~~~l~d~g~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~---------~~~~~Di~slG~il~~l~t~ 200 (261)
T cd05034 131 ARNILVGENLVCKIADFGLARLIEDDEY-TAREGAKFPIKWTAPEAANYGR---------FTIKSDVWSFGILLTEIVTY 200 (261)
T ss_pred hheEEEcCCCCEEECccccceeccchhh-hhhhccCCCccccCHHHhccCC---------cCchhHHHHHHHHHHHHHhC
Confidence 999999 567999999999986643211 1112233567899999987543 4678999999999999998
Q ss_pred CCCCCCcchhHHHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCCChhHHhc
Q 003052 706 GRTPFSEYKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQ 763 (853)
Q Consensus 706 G~~PF~~~~~~~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~ 763 (853)
|+.||.+.........+... .....+...+.++.+++.+||..||.+||++.++++
T Consensus 201 g~~p~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~ 256 (261)
T cd05034 201 GRVPYPGMTNREVLEQVERG--YRMPRPPNCPEELYDLMLQCWDKDPEERPTFEYLQS 256 (261)
T ss_pred CCCCCCCCCHHHHHHHHHcC--CCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 99999765443322222221 122233445788999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=325.67 Aligned_cols=257 Identities=28% Similarity=0.425 Sum_probs=200.7
Q ss_pred CceeeEEEeEeccCceEEEEEEec-CCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHHH
Q 003052 471 GKLYQRLGKIGSGGSSEVHKVISS-DCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLRE 549 (853)
Q Consensus 471 g~~Y~ilk~LG~G~FG~Vyka~~~-~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~~ 549 (853)
+++|++++.||.|+||.||+|.+. +++.||||++............+.+|+.++++++ ||||+++++++.
T Consensus 9 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~-------- 79 (328)
T cd07856 9 TNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLR-HENIISLSDIFI-------- 79 (328)
T ss_pred ccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcC-CCCeeeEeeeEe--------
Confidence 356999999999999999999974 7789999998765444344556789999999997 899999988632
Q ss_pred HhhCCCCCCCCccccCCeEEEEEecchhhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCCCc
Q 003052 550 VLNGSMNNKDGRVKDDGYIYMVLEYGEIDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPA 629 (853)
Q Consensus 550 l~~~~iv~~~g~~~d~~~lyLVmEy~~gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLKPe 629 (853)
.....+|+||||++++|..++.. ..+++..+..++.||+.||.|||++||+||||||.
T Consensus 80 -------------~~~~~~~lv~e~~~~~L~~~~~~---------~~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~ 137 (328)
T cd07856 80 -------------SPLEDIYFVTELLGTDLHRLLTS---------RPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPS 137 (328)
T ss_pred -------------cCCCcEEEEeehhccCHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHH
Confidence 23456899999998888777643 36889999999999999999999999999999999
Q ss_pred cEEe-ecCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHhCCC
Q 003052 630 NFLL-VKGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGRT 708 (853)
Q Consensus 630 NILL-~~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLtG~~ 708 (853)
|||+ .++.+||+|||++...... .....+++.|+|||++.+.. .++.++|||||||++|+|++|++
T Consensus 138 Nili~~~~~~~l~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~--------~~~~~~Dv~slG~il~el~tg~~ 204 (328)
T cd07856 138 NILINENCDLKICDFGLARIQDPQ-----MTGYVSTRYYRAPEIMLTWQ--------KYDVEVDIWSAGCIFAEMLEGKP 204 (328)
T ss_pred HEeECCCCCEEeCccccccccCCC-----cCCCcccccccCceeeeccC--------CcCcHHHHHHHHHHHHHHHhCCC
Confidence 9999 5679999999999754321 12457899999999875422 35789999999999999999999
Q ss_pred CCCcchhHHH---HHHhhcC--------------------CCC--cc---cCCCCCChhHHHHHHHhcccCCCCCCChhH
Q 003052 709 PFSEYKTFWA---KFKVITD--------------------PNH--EI---TYEPVPNPWLLDLMKKCLAWDRNERWRIPQ 760 (853)
Q Consensus 709 PF~~~~~~~~---~~kii~~--------------------~~~--~~---~~~~~~s~~l~dLI~kcL~~DP~kRpTa~E 760 (853)
||........ ..+.+.. ... .. ......+..+.++|.+||+.+|.+||++.+
T Consensus 205 ~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~e 284 (328)
T cd07856 205 LFPGKDHVNQFSIITDLLGTPPDDVINTICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAE 284 (328)
T ss_pred CCCCCCHHHHHHHHHHHhCCCCHHHHHhccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHH
Confidence 9965432111 0000000 000 00 011345678999999999999999999999
Q ss_pred HhcCCCCCCCC
Q 003052 761 LLQHPFLVPPV 771 (853)
Q Consensus 761 IL~HPwf~~~~ 771 (853)
++.||||....
T Consensus 285 ll~~~~~~~~~ 295 (328)
T cd07856 285 ALAHPYLAPYH 295 (328)
T ss_pred HhcCCcccccc
Confidence 99999997543
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-36 Score=309.66 Aligned_cols=249 Identities=30% Similarity=0.460 Sum_probs=196.9
Q ss_pred EeccCceEEEEEEec-CCcEEEEEEEecCCC-ChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHHHHhhCCCCC
Q 003052 480 IGSGGSSEVHKVISS-DCTIYALKKIKLKGR-DYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLREVLNGSMNN 557 (853)
Q Consensus 480 LG~G~FG~Vyka~~~-~g~~vAVKkik~~~~-~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~~l~~~~iv~ 557 (853)
||.|+||.||++.+. +++.||+|++..... .......+.+|+++++++. |+||+++++.
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~-h~~i~~~~~~------------------ 61 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQ-SPYVVKLYYS------------------ 61 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCC-CcchhHHHHh------------------
Confidence 689999999999985 588999999975433 2234556889999999998 8999988754
Q ss_pred CCCccccCCeEEEEEecch-hhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCCCccEEe-ec
Q 003052 558 KDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLL-VK 635 (853)
Q Consensus 558 ~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLKPeNILL-~~ 635 (853)
+..+..+|+||||+. ++|.+++... ..+++..+..++.||+.||.|||++||+||||+|+||++ .+
T Consensus 62 ----~~~~~~~~lv~e~~~~~~L~~~l~~~--------~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~~~ 129 (265)
T cd05579 62 ----FQGKKNLYLVMEYLPGGDLASLLENV--------GSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSN 129 (265)
T ss_pred ----eecCcEEEEEEecCCCCcHHHHHHHc--------CCCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEcCC
Confidence 456678999999975 5888887653 368999999999999999999999999999999999999 56
Q ss_pred CcEEEEecccchhcccCCc------cccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHhCCCC
Q 003052 636 GSLKLIDFGIAKAIMSDTT------NIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGRTP 709 (853)
Q Consensus 636 g~VKL~DFGlAk~~~~~~~------~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLtG~~P 709 (853)
+.+||+|||++........ ........++..|+|||.+.... ++.++|||||||++|+|++|..|
T Consensus 130 ~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~---------~~~~~Dv~slG~~~~~l~~g~~p 200 (265)
T cd05579 130 GHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQG---------HSKTVDWWSLGCILYEFLVGIPP 200 (265)
T ss_pred CCEEEEecccchhcccCcccccccccccccCcccCccccCHHHhcCCC---------CCcchhhHHHHHHHHHHHhCCCC
Confidence 7999999999986543211 11223457899999999986543 46799999999999999999999
Q ss_pred CCcchhHHHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCh---hHHhcCCCCCC
Q 003052 710 FSEYKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRI---PQLLQHPFLVP 769 (853)
Q Consensus 710 F~~~~~~~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa---~EIL~HPwf~~ 769 (853)
|........ +..+.............+..+.+||.+||+.+|.+|||+ .++|+||||+.
T Consensus 201 ~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~~~~~~~ 262 (265)
T cd05579 201 FHGETPEEI-FQNILNGKIEWPEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNHPFFKG 262 (265)
T ss_pred CCCCCHHHH-HHHHhcCCcCCCccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhcCccccC
Confidence 976544332 222222122221122237889999999999999999999 99999999974
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-36 Score=314.11 Aligned_cols=250 Identities=25% Similarity=0.305 Sum_probs=195.5
Q ss_pred EcCceeeEEEeEeccCceEEEEEEecCCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHH
Q 003052 469 VNGKLYQRLGKIGSGGSSEVHKVISSDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLR 548 (853)
Q Consensus 469 v~g~~Y~ilk~LG~G~FG~Vyka~~~~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~ 548 (853)
+...+|++.++||+|+||.||+|.+.++..||+|+++..... ...+.+|+.+++++. |+||+++++++
T Consensus 3 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~~---~~~~~~E~~~l~~l~-~~~i~~~~~~~-------- 70 (262)
T cd05071 3 IPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS---PEAFLQEAQVMKKLR-HEKLVQLYAVV-------- 70 (262)
T ss_pred CChHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCccC---HHHHHHHHHHHHhCC-CCCcceEEEEE--------
Confidence 345679999999999999999999876677999999754332 245789999999997 89999998752
Q ss_pred HHhhCCCCCCCCccccCCeEEEEEecch-hhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCC
Q 003052 549 EVLNGSMNNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLK 627 (853)
Q Consensus 549 ~l~~~~iv~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLK 627 (853)
....+|+||||+. ++|.+++... ....+++..++.++.||+.||.|||+.||+|||||
T Consensus 71 ---------------~~~~~~lv~e~~~~~~L~~~~~~~------~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~ 129 (262)
T cd05071 71 ---------------SEEPIYIVTEYMSKGSLLDFLKGE------MGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLR 129 (262)
T ss_pred ---------------CCCCcEEEEEcCCCCcHHHHHhhc------cccCCCHHHHHHHHHHHHHHHHHHHHCCccccccC
Confidence 1235699999976 5888888653 22468999999999999999999999999999999
Q ss_pred CccEEe-ecCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHh-
Q 003052 628 PANFLL-VKGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVY- 705 (853)
Q Consensus 628 PeNILL-~~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLt- 705 (853)
|+||++ .++.+||+|||+++.+...... ......++..|+|||++.+. .++.++|||||||++|+|++
T Consensus 130 p~Nill~~~~~~~L~dfg~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~---------~~~~~~DvwslG~~l~ellt~ 199 (262)
T cd05071 130 AANILVGENLVCKVADFGLARLIEDNEYT-ARQGAKFPIKWTAPEAALYG---------RFTIKSDVWSFGILLTELTTK 199 (262)
T ss_pred cccEEEcCCCcEEeccCCceeeccccccc-cccCCcccceecCHhHhccC---------CCCchhhHHHHHHHHHHHHcC
Confidence 999999 4568999999999866432221 11234567789999988654 35679999999999999999
Q ss_pred CCCCCCcchhHHHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCCChhHHhc
Q 003052 706 GRTPFSEYKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQ 763 (853)
Q Consensus 706 G~~PF~~~~~~~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~ 763 (853)
|..||.+.........+.. ..........+..+.+||.+||+.||.+||++.++++
T Consensus 200 g~~p~~~~~~~~~~~~~~~--~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~ 255 (262)
T cd05071 200 GRVPYPGMVNREVLDQVER--GYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQA 255 (262)
T ss_pred CCCCCCCCChHHHHHHHhc--CCCCCCccccCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence 8999976544332222222 1122334556788999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-36 Score=320.18 Aligned_cols=256 Identities=23% Similarity=0.319 Sum_probs=193.9
Q ss_pred ceeeEEEeEeccCceEEEEEEec-CC--cEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHH
Q 003052 472 KLYQRLGKIGSGGSSEVHKVISS-DC--TIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLR 548 (853)
Q Consensus 472 ~~Y~ilk~LG~G~FG~Vyka~~~-~g--~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~ 548 (853)
+.|++.+.||+|+||.||+|... ++ ..+++|.++.. ........+.+|+.++.++.+|+||++++++
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~-~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~--------- 71 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEF-ASENDHRDFAGELEVLCKLGHHPNIINLLGA--------- 71 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEcccc-CCHHHHHHHHHHHHHHHhhcCCCchhheEEE---------
Confidence 45899999999999999999874 33 24688887632 2333455688999999999879999999886
Q ss_pred HHhhCCCCCCCCccccCCeEEEEEecch-hhHHHHHHHhhhh--------ccCCCCCCCHHHHHHHHHHhhhhhhhcccC
Q 003052 549 EVLNGSMNNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKE--------MDGSNQTLDENWLRFYWQQILEAVNTIHEE 619 (853)
Q Consensus 549 ~l~~~~iv~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~--------~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~ 619 (853)
+.+.+.+|+||||+. ++|.+++...... .......+++..++.++.||+.||+|||++
T Consensus 72 -------------~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~ 138 (297)
T cd05089 72 -------------CENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEK 138 (297)
T ss_pred -------------EccCCcceEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 344567899999965 5898888653210 011224689999999999999999999999
Q ss_pred ceeeCCCCCccEEe-ecCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHH
Q 003052 620 RIVHSDLKPANFLL-VKGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGC 698 (853)
Q Consensus 620 gIIHRDLKPeNILL-~~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGV 698 (853)
||+||||||+|||+ .++.+||+|||++....... .......+..|+|||++.+.. ++.++|||||||
T Consensus 139 ~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~---------~~~~~DvwSlG~ 206 (297)
T cd05089 139 QFIHRDLAARNVLVGENLASKIADFGLSRGEEVYV---KKTMGRLPVRWMAIESLNYSV---------YTTKSDVWSFGV 206 (297)
T ss_pred CcccCcCCcceEEECCCCeEEECCcCCCcccccee---ccCCCCcCccccCchhhccCC---------CCchhhHHHHHH
Confidence 99999999999999 46689999999986432111 111223356799999986543 567999999999
Q ss_pred HHHHHHh-CCCCCCcchhHHHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCCChhHHhcC
Q 003052 699 ILYQMVY-GRTPFSEYKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQH 764 (853)
Q Consensus 699 ILyELLt-G~~PF~~~~~~~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~H 764 (853)
++|||++ |..||.+............ ......+...+..+.+||.+||..||.+||++.++++.
T Consensus 207 il~el~t~g~~pf~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~ 271 (297)
T cd05089 207 LLWEIVSLGGTPYCGMTCAELYEKLPQ--GYRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQ 271 (297)
T ss_pred HHHHHHcCCCCCCCCCCHHHHHHHHhc--CCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 9999997 9999976543322222222 12223345577889999999999999999999999754
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-38 Score=321.80 Aligned_cols=272 Identities=29% Similarity=0.415 Sum_probs=212.9
Q ss_pred EcCceeeEEEeEeccCceEEEEEEe-cCCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHH
Q 003052 469 VNGKLYQRLGKIGSGGSSEVHKVIS-SDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALL 547 (853)
Q Consensus 469 v~g~~Y~ilk~LG~G~FG~Vyka~~-~~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL 547 (853)
..+..|..+.+||+|.||.||+|+. ++++.||+|++-..+.........++|+++|..|+ |+|++.+++.+.+..
T Consensus 14 ~~~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lk-Henv~nliEic~tk~--- 89 (376)
T KOG0669|consen 14 DEVSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLK-HENVVNLIEICRTKA--- 89 (376)
T ss_pred ecchHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhc-chhHHHHHHHHhhcc---
Confidence 3445688899999999999999998 46678999998766655555566789999999998 899999988754321
Q ss_pred HHHhhCCCCCCCCccccCCeEEEEEecchhhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCC
Q 003052 548 REVLNGSMNNKDGRVKDDGYIYMVLEYGEIDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLK 627 (853)
Q Consensus 548 ~~l~~~~iv~~~g~~~d~~~lyLVmEy~~gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLK 627 (853)
.....+...+|+||++|+.||..++... ...|+..++..++++++.||.|+|.+.|+|||+|
T Consensus 90 -----------Tp~~r~r~t~ylVf~~cehDLaGlLsn~-------~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmK 151 (376)
T KOG0669|consen 90 -----------TPTNRDRATFYLVFDFCEHDLAGLLSNR-------KVRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMK 151 (376)
T ss_pred -----------CCcccccceeeeeHHHhhhhHHHHhcCc-------cccccHHHHHHHHHHHHHHHHHHHHhhHHhhccc
Confidence 1123456779999999999999988653 3579999999999999999999999999999999
Q ss_pred CccEEee-cCcEEEEecccchhcccCCcc--ccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHH
Q 003052 628 PANFLLV-KGSLKLIDFGIAKAIMSDTTN--IQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMV 704 (853)
Q Consensus 628 PeNILL~-~g~VKL~DFGlAk~~~~~~~~--~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELL 704 (853)
++|+||+ +|.+||+|||+++.+...... ...+..+-|.+|++||.+.|.. .|+++.|||+.|||+.||+
T Consensus 152 aaNvLIt~dgilklADFGlar~fs~~~n~~kprytnrvvTLwYrppEllLG~r--------~yg~~iDiWgAgCimaeMw 223 (376)
T KOG0669|consen 152 AANVLITKDGILKLADFGLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDR--------EYGPPIDIWGAGCIMAEMW 223 (376)
T ss_pred HhhEEEcCCceEEeeccccccceecccccCCCCcccceeeeecCCHHHhhccc--------ccCCcchhHhHHHHHHHHH
Confidence 9999995 589999999999877543221 1234556799999999998764 5889999999999999999
Q ss_pred hCCCCCCcchhHHHHHHh--hcC----------------------CCCccc--------CCCCCChhHHHHHHHhcccCC
Q 003052 705 YGRTPFSEYKTFWAKFKV--ITD----------------------PNHEIT--------YEPVPNPWLLDLMKKCLAWDR 752 (853)
Q Consensus 705 tG~~PF~~~~~~~~~~ki--i~~----------------------~~~~~~--------~~~~~s~~l~dLI~kcL~~DP 752 (853)
+|.+.|.+..+...+..+ +.. +..... .+..-++++.+||.++|..||
T Consensus 224 trspimqgnteqqql~~Is~LcGs~tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP 303 (376)
T KOG0669|consen 224 TRSPIMQGNTEQQQLHLISQLCGSITKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDP 303 (376)
T ss_pred ccCccccCChHHHHHHHHHHHhccCCcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCc
Confidence 999999775443222111 100 000000 011224568899999999999
Q ss_pred CCCCChhHHhcCCCCCCC
Q 003052 753 NERWRIPQLLQHPFLVPP 770 (853)
Q Consensus 753 ~kRpTa~EIL~HPwf~~~ 770 (853)
.+|+++.++|+|.||...
T Consensus 304 ~kR~~ad~alnh~~F~kd 321 (376)
T KOG0669|consen 304 TKRIDADQALNHDFFWKD 321 (376)
T ss_pred ccCcchHhhhchhhhhcC
Confidence 999999999999999754
|
|
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-36 Score=313.54 Aligned_cols=253 Identities=31% Similarity=0.431 Sum_probs=198.0
Q ss_pred eeeEEEeEeccCceEEEEEEe-cCCcEEEEEEEecCC-CChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHHHH
Q 003052 473 LYQRLGKIGSGGSSEVHKVIS-SDCTIYALKKIKLKG-RDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLREV 550 (853)
Q Consensus 473 ~Y~ilk~LG~G~FG~Vyka~~-~~g~~vAVKkik~~~-~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~~l 550 (853)
.|++.+.||+|+||.||+|.+ .++..||||.+.... .+......+.+|+.+++.+. |+||++++++
T Consensus 3 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~-h~~i~~~~~~----------- 70 (267)
T cd08229 3 NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLN-HPNVIKYYAS----------- 70 (267)
T ss_pred hhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHcc-CCchhhhhhe-----------
Confidence 488889999999999999997 578899999887543 23344567889999999996 8999998865
Q ss_pred hhCCCCCCCCccccCCeEEEEEecch-hhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCCCc
Q 003052 551 LNGSMNNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPA 629 (853)
Q Consensus 551 ~~~~iv~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLKPe 629 (853)
+.+++.+|++|||+. ++|.+++.... .....+++..++.++.||+.||.|||++||+|+||||+
T Consensus 71 -----------~~~~~~~~~v~e~~~~~~L~~~~~~~~----~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~ 135 (267)
T cd08229 71 -----------FIEDNELNIVLELADAGDLSRMIKHFK----KQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPA 135 (267)
T ss_pred -----------eEeCCeEEEEEEecCCCCHHHHHHHhh----ccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHH
Confidence 455678999999976 48888775421 13457899999999999999999999999999999999
Q ss_pred cEEe-ecCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHhCCC
Q 003052 630 NFLL-VKGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGRT 708 (853)
Q Consensus 630 NILL-~~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLtG~~ 708 (853)
||++ .++.++|+|||++..+..... .....+|+..|+|||.+.+.. ++.++|||||||++|+|++|..
T Consensus 136 nili~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~~~ape~~~~~~---------~~~~~Dv~slG~il~~l~~g~~ 204 (267)
T cd08229 136 NVFITATGVVKLGDLGLGRFFSSKTT--AAHSLVGTPYYMSPERIHENG---------YNFKSDIWSLGCLLYEMAALQS 204 (267)
T ss_pred HEEEcCCCCEEECcchhhhccccCCc--ccccccCCcCccCHHHhcCCC---------ccchhhHHHHHHHHHHHHhCCC
Confidence 9999 567999999999987643222 123467999999999986543 4678999999999999999999
Q ss_pred CCCcchh-HHHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCCChhHHhc
Q 003052 709 PFSEYKT-FWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQ 763 (853)
Q Consensus 709 PF~~~~~-~~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~ 763 (853)
||.+... .....+.+.............+..+++||.+||..||.+|||+.+|++
T Consensus 205 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~ 260 (267)
T cd08229 205 PFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEELRQLVNMCINPDPEKRPDITYVYD 260 (267)
T ss_pred CcccccchHHHHhhhhhcCCCCCCCcccccHHHHHHHHHhcCCCcccCCCHHHHHH
Confidence 9964322 223323322222221222346778999999999999999999998874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-36 Score=311.95 Aligned_cols=242 Identities=24% Similarity=0.357 Sum_probs=190.5
Q ss_pred eEeccCceEEEEEEe---cCCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHHHHhhCCC
Q 003052 479 KIGSGGSSEVHKVIS---SDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLREVLNGSM 555 (853)
Q Consensus 479 ~LG~G~FG~Vyka~~---~~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~~l~~~~i 555 (853)
+||+|+||.||+|.+ .++..+|+|+++....+......+.+|+.+++++. |+||+++++++.
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~-------------- 66 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLD-NPYIVRMIGICE-------------- 66 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCC-CCCcceEEEEEc--------------
Confidence 589999999999965 35688999999866655556677899999999997 899999988631
Q ss_pred CCCCCccccCCeEEEEEecch-hhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCCCccEEee
Q 003052 556 NNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLLV 634 (853)
Q Consensus 556 v~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLKPeNILL~ 634 (853)
...+++||||++ ++|.+++... ..+++..+..++.||+.||.|||++||+||||||.|||+.
T Consensus 67 ---------~~~~~lv~e~~~~~~L~~~l~~~--------~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~ 129 (257)
T cd05116 67 ---------AESWMLVMELAELGPLNKFLQKN--------KHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLV 129 (257)
T ss_pred ---------CCCcEEEEecCCCCcHHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEc
Confidence 234689999976 5788877543 4689999999999999999999999999999999999994
Q ss_pred -cCcEEEEecccchhcccCCcccc-ccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHh-CCCCCC
Q 003052 635 -KGSLKLIDFGIAKAIMSDTTNIQ-RDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVY-GRTPFS 711 (853)
Q Consensus 635 -~g~VKL~DFGlAk~~~~~~~~~~-~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLt-G~~PF~ 711 (853)
++.+||+|||+++.......... .....+++.|+|||.+... .++.++|||||||++|||++ |..||.
T Consensus 130 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~---------~~~~~~Di~slG~~l~el~t~g~~p~~ 200 (257)
T cd05116 130 TQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYY---------KFSSKSDVWSFGVLMWEAFSYGQKPYK 200 (257)
T ss_pred CCCeEEECCCccccccCCCCCeeeecCCCCCCccccCHhHhccC---------CcCchhHHHHHHHHHHHHHhCCCCCCC
Confidence 56899999999987644322111 1223456799999998643 35679999999999999997 999997
Q ss_pred cchhHHHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCCChhHHhc
Q 003052 712 EYKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQ 763 (853)
Q Consensus 712 ~~~~~~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~ 763 (853)
..... .....+.. ......+...++++.+||.+||+.||.+||++.+|..
T Consensus 201 ~~~~~-~~~~~i~~-~~~~~~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~ 250 (257)
T cd05116 201 GMKGN-EVTQMIES-GERMECPQRCPPEMYDLMKLCWTYGVDERPGFAVVEL 250 (257)
T ss_pred CCCHH-HHHHHHHC-CCCCCCCCCCCHHHHHHHHHHhccCchhCcCHHHHHH
Confidence 65433 22222322 1223455567889999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-37 Score=332.30 Aligned_cols=254 Identities=27% Similarity=0.430 Sum_probs=201.0
Q ss_pred CceeeEEEeEeccCceEEEEEEec-CCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCC-----CceeEeeehhhhHH
Q 003052 471 GKLYQRLGKIGSGGSSEVHKVISS-DCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGK-----NNIIQLIDYEVTEK 544 (853)
Q Consensus 471 g~~Y~ilk~LG~G~FG~Vyka~~~-~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~h-----pNIV~Lid~~~~e~ 544 (853)
..+|.++.+||+|.||.|-++.+. .+..||||+++.-.. .....+-||++|.++..+ .-++++.+|
T Consensus 88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~k---YreAa~iEi~vLqki~~~DP~g~~rcv~m~~w----- 159 (415)
T KOG0671|consen 88 TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDK---YREAALIEIEVLQKINESDPNGKFRCVQMRDW----- 159 (415)
T ss_pred ccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHH---HhhHHHHHHHHHHHHHhcCCCCceEEEeeehh-----
Confidence 467999999999999999999984 458899999975432 233456899999999533 246777666
Q ss_pred HHHHHHhhCCCCCCCCccccCCeEEEEEecchhhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeC
Q 003052 545 ALLREVLNGSMNNKDGRVKDDGYIYMVLEYGEIDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHS 624 (853)
Q Consensus 545 ~iL~~l~~~~iv~~~g~~~d~~~lyLVmEy~~gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHR 624 (853)
|...+++|||+|.+|.++.+++... ...+++..+++.+++||+.+++|||+.+|+|-
T Consensus 160 -----------------FdyrghiCivfellG~S~~dFlk~N------~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HT 216 (415)
T KOG0671|consen 160 -----------------FDYRGHICIVFELLGLSTFDFLKEN------NYIPFPIDHIRHMGYQLLESVAFLHDLKLTHT 216 (415)
T ss_pred -----------------hhccCceEEEEeccChhHHHHhccC------CccccchHHHHHHHHHHHHHHHHHHhcceeec
Confidence 5677899999999999999999765 55789999999999999999999999999999
Q ss_pred CCCCccEEeec---------------------CcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCc
Q 003052 625 DLKPANFLLVK---------------------GSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGN 683 (853)
Q Consensus 625 DLKPeNILL~~---------------------g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~ 683 (853)
||||||||+.+ -.|||+|||.|+...... .+.+.|..|+|||++.+-
T Consensus 217 DLKPENILfvss~~~~~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~h-----s~iVsTRHYRAPEViLgL------- 284 (415)
T KOG0671|consen 217 DLKPENILFVSSEYFKTYNPKKKVCFIRPLKSTAIKVIDFGSATFDHEHH-----STIVSTRHYRAPEVILGL------- 284 (415)
T ss_pred CCChheEEEeccceEEEeccCCccceeccCCCcceEEEecCCcceeccCc-----ceeeeccccCCchheecc-------
Confidence 99999999932 138999999998654332 467899999999999886
Q ss_pred cccCCCccchhhhHHHHHHHHhCCCCCCcchhHH---HHHHhhcCCCC----------------cccCC-----------
Q 003052 684 IIKCGRPSDIWSLGCILYQMVYGRTPFSEYKTFW---AKFKVITDPNH----------------EITYE----------- 733 (853)
Q Consensus 684 ~~~ys~ksDIWSLGVILyELLtG~~PF~~~~~~~---~~~kii~~~~~----------------~~~~~----------- 733 (853)
.|+.++||||+||||+||++|...|...++.+ .+.+++. +.+ .+.++
T Consensus 285 --GwS~pCDvWSiGCIL~ElytG~~LFqtHen~EHLaMMerIlG-p~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v 361 (415)
T KOG0671|consen 285 --GWSQPCDVWSIGCILVELYTGETLFQTHENLEHLAMMERILG-PIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYV 361 (415)
T ss_pred --CcCCccCceeeeeEEEEeeccceecccCCcHHHHHHHHHhhC-CCcHHHhhhhhhHhhhhcccccCccccccccchhh
Confidence 47889999999999999999999997544322 2222221 111 01100
Q ss_pred --------------CCCChhHHHHHHHhcccCCCCCCChhHHhcCCCCCCC
Q 003052 734 --------------PVPNPWLLDLMKKCLAWDRNERWRIPQLLQHPFLVPP 770 (853)
Q Consensus 734 --------------~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~HPwf~~~ 770 (853)
......+.|||++||.+||.+|+|+.|+|.||||...
T Consensus 362 ~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~~RiTl~EAL~HpFF~~~ 412 (415)
T KOG0671|consen 362 FEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPARRITLREALSHPFFARL 412 (415)
T ss_pred hcCCccHHHHhccCcHHHhHHHHHHHHHHccCccccccHHHHhcCHHhhcC
Confidence 0011237899999999999999999999999999864
|
|
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=317.07 Aligned_cols=257 Identities=23% Similarity=0.328 Sum_probs=197.3
Q ss_pred CceeeEEEeEeccCceEEEEEEec------CCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHH
Q 003052 471 GKLYQRLGKIGSGGSSEVHKVISS------DCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEK 544 (853)
Q Consensus 471 g~~Y~ilk~LG~G~FG~Vyka~~~------~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~ 544 (853)
...|.+.+.||+|+||.||+|... ++..+++|.++... ......+.+|+.+++++. |+||++++++
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~e~~~l~~l~-h~~i~~~~~~----- 75 (291)
T cd05094 4 RRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPT--LAARKDFQREAELLTNLQ-HEHIVKFYGV----- 75 (291)
T ss_pred hHHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCcc--HHHHHHHHHHHHHHhcCC-CCCcceEEEE-----
Confidence 456999999999999999999752 34568888886432 233456889999999997 8999999987
Q ss_pred HHHHHHhhCCCCCCCCccccCCeEEEEEecch-hhHHHHHHHhhhh--------ccCCCCCCCHHHHHHHHHHhhhhhhh
Q 003052 545 ALLREVLNGSMNNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKE--------MDGSNQTLDENWLRFYWQQILEAVNT 615 (853)
Q Consensus 545 ~iL~~l~~~~iv~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~--------~~~~~~~LsE~~~r~I~~QIl~AL~y 615 (853)
+.+...+++||||+. ++|.+++...... .......+++..++.++.||+.||.|
T Consensus 76 -----------------~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~ 138 (291)
T cd05094 76 -----------------CGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVY 138 (291)
T ss_pred -----------------EccCCceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence 345567899999975 6899888754211 01123458999999999999999999
Q ss_pred cccCceeeCCCCCccEEe-ecCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchh
Q 003052 616 IHEERIVHSDLKPANFLL-VKGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIW 694 (853)
Q Consensus 616 LHs~gIIHRDLKPeNILL-~~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIW 694 (853)
||++||+||||||+|||+ .++.+||+|||+++...............|+..|+|||.+.+. .++.++|||
T Consensus 139 lH~~~i~H~dlkp~Nil~~~~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~---------~~~~~~Di~ 209 (291)
T cd05094 139 LASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYR---------KFTTESDVW 209 (291)
T ss_pred HHhCCeeecccCcceEEEccCCcEEECCCCcccccCCCceeecCCCCCcceeecChHHhccC---------CCCchhhHH
Confidence 999999999999999999 4679999999999765433222222345678899999998764 356799999
Q ss_pred hhHHHHHHHHh-CCCCCCcchhHHHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCCChhHHhc
Q 003052 695 SLGCILYQMVY-GRTPFSEYKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQ 763 (853)
Q Consensus 695 SLGVILyELLt-G~~PF~~~~~~~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~ 763 (853)
||||++|+|++ |..||....... ....+.... ....+...+..+.+||.+||..||++||++.++++
T Consensus 210 slG~il~el~t~g~~p~~~~~~~~-~~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~ 277 (291)
T cd05094 210 SFGVILWEIFTYGKQPWFQLSNTE-VIECITQGR-VLERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYK 277 (291)
T ss_pred HHHHHHHHHHhCCCCCCCCCCHHH-HHHHHhCCC-CCCCCccCCHHHHHHHHHHcccChhhCcCHHHHHH
Confidence 99999999998 999996644432 222222211 12233456778999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-36 Score=314.24 Aligned_cols=248 Identities=23% Similarity=0.324 Sum_probs=198.7
Q ss_pred ceeeEEEeEeccCceEEEEEEecCCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHHHHh
Q 003052 472 KLYQRLGKIGSGGSSEVHKVISSDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLREVL 551 (853)
Q Consensus 472 ~~Y~ilk~LG~G~FG~Vyka~~~~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~~l~ 551 (853)
..|++.++||.|+||.||+|.+.++..+|+|++..... .....+.+|+.+++.++ |+||++++++
T Consensus 6 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~--~~~~~~~~e~~~l~~l~-~~~i~~~~~~------------ 70 (261)
T cd05148 6 EEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDL--LKQQDFQKEVQALKRLR-HKHLISLFAV------------ 70 (261)
T ss_pred HHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccch--hhHHHHHHHHHHHhcCC-Ccchhheeee------------
Confidence 45899999999999999999998888999999876533 23446889999999997 8999999876
Q ss_pred hCCCCCCCCccccCCeEEEEEecch-hhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCCCcc
Q 003052 552 NGSMNNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPAN 630 (853)
Q Consensus 552 ~~~iv~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLKPeN 630 (853)
+.+...+|+||||++ ++|.+++... ....+++..++.++.||+.||.|||++||+||||||+|
T Consensus 71 ----------~~~~~~~~lv~e~~~~~~L~~~~~~~------~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~n 134 (261)
T cd05148 71 ----------CSVGEPVYIITELMEKGSLLAFLRSP------EGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARN 134 (261)
T ss_pred ----------EecCCCeEEEEeecccCCHHHHHhcC------CCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcce
Confidence 345567899999976 4998888653 23568999999999999999999999999999999999
Q ss_pred EEe-ecCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHh-CCC
Q 003052 631 FLL-VKGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVY-GRT 708 (853)
Q Consensus 631 ILL-~~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLt-G~~ 708 (853)
||+ .++.+||+|||++........ ......++..|+|||.+... .++.++|||||||++|+|++ |+.
T Consensus 135 ilv~~~~~~kl~d~g~~~~~~~~~~--~~~~~~~~~~~~~PE~~~~~---------~~~~~~DiwslG~~l~~l~~~g~~ 203 (261)
T cd05148 135 ILVGEDLVCKVADFGLARLIKEDVY--LSSDKKIPYKWTAPEAASHG---------TFSTKSDVWSFGILLYEMFTYGQV 203 (261)
T ss_pred EEEcCCceEEEccccchhhcCCccc--cccCCCCceEecCHHHHccC---------CCCchhhHHHHHHHHHHHHcCCCC
Confidence 999 466999999999987643221 11234567789999998654 35678999999999999998 899
Q ss_pred CCCcchhHHHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCCChhHHhc
Q 003052 709 PFSEYKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQ 763 (853)
Q Consensus 709 PF~~~~~~~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~ 763 (853)
||........ +..+.. ......+...+..+.++|.+||..||.+|||+.++++
T Consensus 204 p~~~~~~~~~-~~~~~~-~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~ 256 (261)
T cd05148 204 PYPGMNNHEV-YDQITA-GYRMPCPAKCPQEIYKIMLECWAAEPEDRPSFKALRE 256 (261)
T ss_pred CCCcCCHHHH-HHHHHh-CCcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 9976543322 222222 2223344567788999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-36 Score=328.74 Aligned_cols=154 Identities=25% Similarity=0.306 Sum_probs=129.7
Q ss_pred CCCCCCcCCCCCceeEEcC-ceeeEEEeEeccCceEEEEEEec-CCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCC
Q 003052 453 ASAPRKRNYDPDLFFKVNG-KLYQRLGKIGSGGSSEVHKVISS-DCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGK 530 (853)
Q Consensus 453 ~~~~rk~~~dp~~~~~v~g-~~Y~ilk~LG~G~FG~Vyka~~~-~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~h 530 (853)
....++++|+|..+.++.. .+|.+.++||.|.|++||+|.+. +.+.||+|+++.... ..+..+.||++|++++.+
T Consensus 58 ~~dY~kGGYHpV~IGD~F~~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAqh---YtEaAlDEIklL~~v~~~ 134 (590)
T KOG1290|consen 58 PEDYRKGGYHPVRIGDVFNGGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQH---YTEAALDEIKLLQQVREG 134 (590)
T ss_pred hhhhhcCCCceeeccccccCceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhhH---HHHHHHHHHHHHHHHHhc
Confidence 4456789999987776655 89999999999999999999994 558999999986433 233567999999999743
Q ss_pred -------CceeEeeehhhhHHHHHHHHhhCCCCCCCCccccCCeEEEEEecchhhHHHHHHHhhhhccCCCCCCCHHHHH
Q 003052 531 -------NNIIQLIDYEVTEKALLREVLNGSMNNKDGRVKDDGYIYMVLEYGEIDLAHMLSQKWKEMDGSNQTLDENWLR 603 (853)
Q Consensus 531 -------pNIV~Lid~~~~e~~iL~~l~~~~iv~~~g~~~d~~~lyLVmEy~~gdL~~~L~~~~k~~~~~~~~LsE~~~r 603 (853)
..||+|+|+|... -..+.++|||+|++|.+|..+|+.. ..+.++...++
T Consensus 135 Dp~~~~~~~VV~LlD~Fkhs------------------GpNG~HVCMVfEvLGdnLLklI~~s------~YrGlpl~~VK 190 (590)
T KOG1290|consen 135 DPNDPGKKCVVQLLDHFKHS------------------GPNGQHVCMVFEVLGDNLLKLIKYS------NYRGLPLSCVK 190 (590)
T ss_pred CCCCCCCceeeeeeccceec------------------CCCCcEEEEEehhhhhHHHHHHHHh------CCCCCcHHHHH
Confidence 4799999986421 3456789999999999999999875 45789999999
Q ss_pred HHHHHhhhhhhhcccC-ceeeCCCCCccEEe
Q 003052 604 FYWQQILEAVNTIHEE-RIVHSDLKPANFLL 633 (853)
Q Consensus 604 ~I~~QIl~AL~yLHs~-gIIHRDLKPeNILL 633 (853)
.|++||+.||.|||.. ||||-||||+||||
T Consensus 191 ~I~~qvL~GLdYLH~ecgIIHTDlKPENvLl 221 (590)
T KOG1290|consen 191 EICRQVLTGLDYLHRECGIIHTDLKPENVLL 221 (590)
T ss_pred HHHHHHHHHHHHHHHhcCccccCCCcceeee
Confidence 9999999999999976 99999999999999
|
|
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=310.52 Aligned_cols=250 Identities=24% Similarity=0.296 Sum_probs=195.3
Q ss_pred EcCceeeEEEeEeccCceEEEEEEecCCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHH
Q 003052 469 VNGKLYQRLGKIGSGGSSEVHKVISSDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLR 548 (853)
Q Consensus 469 v~g~~Y~ilk~LG~G~FG~Vyka~~~~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~ 548 (853)
+....|.+.++||+|+||.||+|.+..+..+|+|++..... ....+.+|+.+++++. |+||+++++++
T Consensus 3 ~~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~~---~~~~~~~E~~~l~~l~-h~~i~~~~~~~-------- 70 (260)
T cd05069 3 IPRESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTM---MPEAFLQEAQIMKKLR-HDKLVPLYAVV-------- 70 (260)
T ss_pred CChHHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCCc---cHHHHHHHHHHHHhCC-CCCeeeEEEEE--------
Confidence 34567999999999999999999987777799998865432 2345789999999997 89999998752
Q ss_pred HHhhCCCCCCCCccccCCeEEEEEecch-hhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCC
Q 003052 549 EVLNGSMNNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLK 627 (853)
Q Consensus 549 ~l~~~~iv~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLK 627 (853)
..+..|+||||+. ++|.+++... ....+++..+..++.||+.||.|||+.||+|||||
T Consensus 71 ---------------~~~~~~~v~e~~~~~~L~~~~~~~------~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~ 129 (260)
T cd05069 71 ---------------SEEPIYIVTEFMGKGSLLDFLKEG------DGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLR 129 (260)
T ss_pred ---------------cCCCcEEEEEcCCCCCHHHHHhhC------CCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccC
Confidence 2235789999976 5898888653 23458899999999999999999999999999999
Q ss_pred CccEEe-ecCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHh-
Q 003052 628 PANFLL-VKGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVY- 705 (853)
Q Consensus 628 PeNILL-~~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLt- 705 (853)
|+||++ .++.+||+|||+++....... .......++..|+|||.+.+.. ++.++|||||||++|+|++
T Consensus 130 ~~Nill~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~~y~~Pe~~~~~~---------~~~~~Di~slG~~l~el~t~ 199 (260)
T cd05069 130 AANILVGDNLVCKIADFGLARLIEDNEY-TARQGAKFPIKWTAPEAALYGR---------FTIKSDVWSFGILLTELVTK 199 (260)
T ss_pred cceEEEcCCCeEEECCCccceEccCCcc-cccCCCccchhhCCHHHhccCC---------cChHHHHHHHHHHHHHHHhC
Confidence 999999 467899999999976543221 1112345677899999886543 5679999999999999999
Q ss_pred CCCCCCcchhHHHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCCChhHHhc
Q 003052 706 GRTPFSEYKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQ 763 (853)
Q Consensus 706 G~~PF~~~~~~~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~ 763 (853)
|..||.+.........+... .....+...+..+.+||.+||.+||.+||++.++++
T Consensus 200 g~~p~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 255 (260)
T cd05069 200 GRVPYPGMVNREVLEQVERG--YRMPCPQGCPESLHELMKLCWKKDPDERPTFEYIQS 255 (260)
T ss_pred CCCCCCCCCHHHHHHHHHcC--CCCCCCcccCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 99999775443322222221 222334456788999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=309.61 Aligned_cols=246 Identities=26% Similarity=0.380 Sum_probs=194.1
Q ss_pred EcCceeeEEEeEeccCceEEEEEEecCCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHH
Q 003052 469 VNGKLYQRLGKIGSGGSSEVHKVISSDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLR 548 (853)
Q Consensus 469 v~g~~Y~ilk~LG~G~FG~Vyka~~~~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~ 548 (853)
++.+.|++.+.||+|+||.||++... +..+|+|.++... ....+.+|+.+++++. |+||+++++++
T Consensus 3 ~~~~~~~~~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~~----~~~~~~~e~~~l~~l~-~~~i~~~~~~~-------- 68 (256)
T cd05082 3 LNMKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA----TAQAFLAEASVMTQLR-HSNLVQLLGVI-------- 68 (256)
T ss_pred ccHHhCeeeeeecccCCCeEEEEEEc-CCcEEEEEeCCCc----hHHHHHHHHHHHHhCC-CCCeeeEEEEE--------
Confidence 34567999999999999999999764 6678999986432 2346889999999997 89999998753
Q ss_pred HHhhCCCCCCCCccccCCeEEEEEecch-hhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCC
Q 003052 549 EVLNGSMNNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLK 627 (853)
Q Consensus 549 ~l~~~~iv~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLK 627 (853)
+.++..+|+||||++ ++|.+++... ....+++..+..++.||+.||+|||++||+|||||
T Consensus 69 -------------~~~~~~~~lv~e~~~~~~L~~~~~~~------~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk 129 (256)
T cd05082 69 -------------VEEKGGLYIVTEYMAKGSLVDYLRSR------GRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLA 129 (256)
T ss_pred -------------EcCCCceEEEEECCCCCcHHHHHHhc------CCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccc
Confidence 234567899999976 5888887653 22458999999999999999999999999999999
Q ss_pred CccEEe-ecCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHh-
Q 003052 628 PANFLL-VKGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVY- 705 (853)
Q Consensus 628 PeNILL-~~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLt- 705 (853)
|+||++ .++.+||+|||+++...... ....++..|+|||++.+.. ++.++|||||||++|+|++
T Consensus 130 p~nil~~~~~~~kl~dfg~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~---------~~~~~Dv~slG~i~~~l~~~ 195 (256)
T cd05082 130 ARNVLVSEDNVAKVSDFGLTKEASSTQ-----DTGKLPVKWTAPEALREKK---------FSTKSDVWSFGILLWEIYSF 195 (256)
T ss_pred hheEEEcCCCcEEecCCccceeccccC-----CCCccceeecCHHHHccCC---------CCchhhhHHHHHHHHHHHhC
Confidence 999999 56799999999998653322 2345567899999986543 5678999999999999997
Q ss_pred CCCCCCcchhHHHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCCChhHHhc
Q 003052 706 GRTPFSEYKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQ 763 (853)
Q Consensus 706 G~~PF~~~~~~~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~ 763 (853)
|+.||..... ......+.. ..........++.+.+||.+||..||.+|||+.++++
T Consensus 196 g~~p~~~~~~-~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~ 251 (256)
T cd05082 196 GRVPYPRIPL-KDVVPRVEK-GYKMDAPDGCPPVVYDVMKQCWHLDAATRPSFLQLRE 251 (256)
T ss_pred CCCCCCCCCH-HHHHHHHhc-CCCCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 9999975432 222222221 1222334567888999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=323.52 Aligned_cols=265 Identities=20% Similarity=0.311 Sum_probs=201.8
Q ss_pred eEEcCceeeEEEeEeccCceEEEEEEecC--------CcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeee
Q 003052 467 FKVNGKLYQRLGKIGSGGSSEVHKVISSD--------CTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLID 538 (853)
Q Consensus 467 ~~v~g~~Y~ilk~LG~G~FG~Vyka~~~~--------g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid 538 (853)
+.+...+|++.+.||+|+||.||+|.+.. ...||+|.++... .......+.+|+.+++++.+|+||+++++
T Consensus 7 ~~~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~~ 85 (334)
T cd05100 7 WELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDA-TDKDLSDLVSEMEMMKMIGKHKNIINLLG 85 (334)
T ss_pred cccCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEccccc-CHHHHHHHHHHHHHHHhhcCCCCeeeeeE
Confidence 45666789999999999999999997521 2368999887543 33445678899999999977999999998
Q ss_pred hhhhHHHHHHHHhhCCCCCCCCccccCCeEEEEEecch-hhHHHHHHHhhhh--------ccCCCCCCCHHHHHHHHHHh
Q 003052 539 YEVTEKALLREVLNGSMNNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKE--------MDGSNQTLDENWLRFYWQQI 609 (853)
Q Consensus 539 ~~~~e~~iL~~l~~~~iv~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~--------~~~~~~~LsE~~~r~I~~QI 609 (853)
+ +..++.+|++|||++ ++|.+++...... .......+++..+..++.||
T Consensus 86 ~----------------------~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi 143 (334)
T cd05100 86 A----------------------CTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQV 143 (334)
T ss_pred E----------------------EccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHH
Confidence 6 344567899999975 5898888653210 01123458889999999999
Q ss_pred hhhhhhcccCceeeCCCCCccEEe-ecCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCC
Q 003052 610 LEAVNTIHEERIVHSDLKPANFLL-VKGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCG 688 (853)
Q Consensus 610 l~AL~yLHs~gIIHRDLKPeNILL-~~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys 688 (853)
+.||.|||++||+||||||+|||+ .++.+||+|||+++...............++..|+|||++.+.. ++
T Consensus 144 ~~al~~LH~~givH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~---------~~ 214 (334)
T cd05100 144 ARGMEYLASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRV---------YT 214 (334)
T ss_pred HHHHHHHHHCCeeccccccceEEEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCC---------cC
Confidence 999999999999999999999999 46799999999998654322211112234567899999997653 56
Q ss_pred CccchhhhHHHHHHHHh-CCCCCCcchhHHHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCCChhHHhcCC
Q 003052 689 RPSDIWSLGCILYQMVY-GRTPFSEYKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQHP 765 (853)
Q Consensus 689 ~ksDIWSLGVILyELLt-G~~PF~~~~~~~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~HP 765 (853)
.++|||||||++|||++ |..||.+.... ..+..+... .....+...+..+.+||.+||..+|.+||++.+++++-
T Consensus 215 ~~~Di~slG~il~el~~~g~~p~~~~~~~-~~~~~~~~~-~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l 290 (334)
T cd05100 215 HQSDVWSFGVLLWEIFTLGGSPYPGIPVE-ELFKLLKEG-HRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDL 290 (334)
T ss_pred chhhhHHHHHHHHHHHhcCCCCCCCCCHH-HHHHHHHcC-CCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHH
Confidence 78999999999999998 89999765432 333333221 22233445677899999999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=308.25 Aligned_cols=246 Identities=23% Similarity=0.307 Sum_probs=197.1
Q ss_pred EcCceeeEEEeEeccCceEEEEEEecCCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHH
Q 003052 469 VNGKLYQRLGKIGSGGSSEVHKVISSDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLR 548 (853)
Q Consensus 469 v~g~~Y~ilk~LG~G~FG~Vyka~~~~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~ 548 (853)
+..+.|++.+.||.|+||.||+|... ++.||+|.++.... ....+.+|+.++++++ |+||+++++++
T Consensus 3 ~~~~~~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~---~~~~~~~e~~~l~~l~-~~~i~~~~~~~-------- 69 (256)
T cd05039 3 INSKELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDST---AAQAFLAEASVMTTLR-HPNLVQLLGVV-------- 69 (256)
T ss_pred cChhhccceeeeecCCCceEEEEEec-CcEEEEEEeccchh---HHHHHHHHHHHHHhcC-CcceeeeEEEE--------
Confidence 45677999999999999999999875 67899999976533 4556889999999997 89999999873
Q ss_pred HHhhCCCCCCCCccccCCeEEEEEecch-hhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCC
Q 003052 549 EVLNGSMNNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLK 627 (853)
Q Consensus 549 ~l~~~~iv~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLK 627 (853)
.+...+|+||||++ ++|.+++... ....+++..++.++.|++.||.|||++||+|||||
T Consensus 70 --------------~~~~~~~~v~e~~~~~~L~~~~~~~------~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~ 129 (256)
T cd05039 70 --------------LQGNPLYIVTEYMAKGSLVDYLRSR------GRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLA 129 (256)
T ss_pred --------------cCCCCeEEEEEecCCCcHHHHHHhc------CCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcc
Confidence 34567899999977 5998888654 22368999999999999999999999999999999
Q ss_pred CccEEe-ecCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHh-
Q 003052 628 PANFLL-VKGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVY- 705 (853)
Q Consensus 628 PeNILL-~~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLt- 705 (853)
|+||++ .++.+||+|||+++....... ...++..|+|||.+.... ++.++|||||||++|+|++
T Consensus 130 p~Nili~~~~~~~l~d~g~~~~~~~~~~-----~~~~~~~~~ape~~~~~~---------~~~~~Di~slG~il~~l~~~ 195 (256)
T cd05039 130 ARNVLVSEDLVAKVSDFGLAKEASQGQD-----SGKLPVKWTAPEALREKK---------FSTKSDVWSFGILLWEIYSF 195 (256)
T ss_pred cceEEEeCCCCEEEcccccccccccccc-----cCCCcccccCchhhcCCc---------CCcHHHHHHHHHHHHHHHhc
Confidence 999999 467999999999987632211 334567899999986543 5678999999999999997
Q ss_pred CCCCCCcchhHHHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCCChhHHhc
Q 003052 706 GRTPFSEYKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQ 763 (853)
Q Consensus 706 G~~PF~~~~~~~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~ 763 (853)
|..||....... ....+.. ......+...++.+.+||.+||..+|.+||++.++++
T Consensus 196 g~~p~~~~~~~~-~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 251 (256)
T cd05039 196 GRVPYPRIPLKD-VVPHVEK-GYRMEAPEGCPPEVYKVMKDCWELDPAKRPTFKQLRE 251 (256)
T ss_pred CCCCCCCCCHHH-HHHHHhc-CCCCCCccCCCHHHHHHHHHHhccChhhCcCHHHHHH
Confidence 999997654322 2222221 1222334556788999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=313.10 Aligned_cols=251 Identities=20% Similarity=0.294 Sum_probs=193.5
Q ss_pred cCceeeEEEeEeccCceEEEEEEe-cCCc----EEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHH
Q 003052 470 NGKLYQRLGKIGSGGSSEVHKVIS-SDCT----IYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEK 544 (853)
Q Consensus 470 ~g~~Y~ilk~LG~G~FG~Vyka~~-~~g~----~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~ 544 (853)
...+|+++++||+|+||.||+|.+ .++. .||+|+++.... ......+.+|+.++..+. |+||+++++++.
T Consensus 5 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~-~~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~--- 79 (279)
T cd05109 5 KETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTS-PKANKEILDEAYVMAGVG-SPYVCRLLGICL--- 79 (279)
T ss_pred chhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCC-HHHHHHHHHHHHHHHhcC-CCCCceEEEEEc---
Confidence 346799999999999999999986 3443 489999875433 334456889999999987 899999988632
Q ss_pred HHHHHHhhCCCCCCCCccccCCeEEEEEecch-hhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceee
Q 003052 545 ALLREVLNGSMNNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVH 623 (853)
Q Consensus 545 ~iL~~l~~~~iv~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIH 623 (853)
....+++|||+. ++|.+++... ...+++..+..++.||+.||.|||++||+|
T Consensus 80 --------------------~~~~~l~~~~~~~g~l~~~l~~~-------~~~~~~~~~~~~~~qi~~~L~~lH~~~iiH 132 (279)
T cd05109 80 --------------------TSTVQLVTQLMPYGCLLDYVREN-------KDRIGSQDLLNWCVQIAKGMSYLEEVRLVH 132 (279)
T ss_pred --------------------CCCcEEEEEcCCCCCHHHHHhhc-------cCCCCHHHHHHHHHHHHHHHHHHHHCCeec
Confidence 124678999965 6888877542 246899999999999999999999999999
Q ss_pred CCCCCccEEe-ecCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHH
Q 003052 624 SDLKPANFLL-VKGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQ 702 (853)
Q Consensus 624 RDLKPeNILL-~~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyE 702 (853)
|||||+|||+ .++.+||+|||+++.+.............+++.|+|||.+.+.. ++.++|||||||++||
T Consensus 133 ~dlkp~Nil~~~~~~~kL~dfG~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~---------~~~~~Di~slG~~l~e 203 (279)
T cd05109 133 RDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILHRR---------FTHQSDVWSYGVTVWE 203 (279)
T ss_pred cccccceEEEcCCCcEEECCCCceeecccccceeecCCCccchhhCCHHHhccCC---------CCchhHHHHHHHHHHH
Confidence 9999999999 55789999999998765332222222234567899999986543 5679999999999999
Q ss_pred HHh-CCCCCCcchhHHHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCCChhHHhc
Q 003052 703 MVY-GRTPFSEYKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQ 763 (853)
Q Consensus 703 LLt-G~~PF~~~~~~~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~ 763 (853)
|++ |..||...... .....+.. ......+...+..+.++|.+||..||++||++.+++.
T Consensus 204 l~t~g~~p~~~~~~~-~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~ 263 (279)
T cd05109 204 LMTFGAKPYDGIPAR-EIPDLLEK-GERLPQPPICTIDVYMIMVKCWMIDSECRPRFRELVD 263 (279)
T ss_pred HHcCCCCCCCCCCHH-HHHHHHHC-CCcCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 998 99999764332 22222222 2222334556788999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=354.00 Aligned_cols=145 Identities=26% Similarity=0.372 Sum_probs=124.1
Q ss_pred ceeeEEEeEeccCceEEEEEEec-CCcEEEEEEEecCCC-ChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHHH
Q 003052 472 KLYQRLGKIGSGGSSEVHKVISS-DCTIYALKKIKLKGR-DYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLRE 549 (853)
Q Consensus 472 ~~Y~ilk~LG~G~FG~Vyka~~~-~g~~vAVKkik~~~~-~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~~ 549 (853)
+.|.++++||+|+||.||+|.+. +++.||||+++.... .......+.+|+.+++.++ |+||++++++
T Consensus 4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~-hp~Iv~~~~~---------- 72 (669)
T cd05610 4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSK-SPFIVHLYYS---------- 72 (669)
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcC-CCCcCeEEEE----------
Confidence 45999999999999999999985 678999999975432 3334456789999999887 8999999865
Q ss_pred HhhCCCCCCCCccccCCeEEEEEecch-hhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCCC
Q 003052 550 VLNGSMNNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKP 628 (853)
Q Consensus 550 l~~~~iv~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLKP 628 (853)
+....++||||||+. ++|..++... ..+++..++.|+.||+.||.|||.+|||||||||
T Consensus 73 ------------~~~~~~~~lVmEy~~g~~L~~li~~~--------~~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP 132 (669)
T cd05610 73 ------------LQSANNVYLVMEYLIGGDVKSLLHIY--------GYFDEEMAVKYISEVALALDYLHRHGIIHRDLKP 132 (669)
T ss_pred ------------EEECCEEEEEEeCCCCCCHHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccH
Confidence 456678999999974 6888887543 4689999999999999999999999999999999
Q ss_pred ccEEe-ecCcEEEEecccch
Q 003052 629 ANFLL-VKGSLKLIDFGIAK 647 (853)
Q Consensus 629 eNILL-~~g~VKL~DFGlAk 647 (853)
+|||| .++.+||+|||+++
T Consensus 133 ~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 133 DNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred HHEEEcCCCCEEEEeCCCCc
Confidence 99999 56799999999986
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=306.19 Aligned_cols=244 Identities=23% Similarity=0.331 Sum_probs=191.9
Q ss_pred EeEeccCceEEEEEEecCCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHHHHhhCCCCC
Q 003052 478 GKIGSGGSSEVHKVISSDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLREVLNGSMNN 557 (853)
Q Consensus 478 k~LG~G~FG~Vyka~~~~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~~l~~~~iv~ 557 (853)
++||+|+||.||+|.+.+++.||+|++...... .....+.+|+++++++. |+||++++++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~-~~~~~~~~e~~~l~~l~-~~~i~~~~~~------------------ 60 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPP-DLKRKFLQEAEILKQYD-HPNIVKLIGV------------------ 60 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCH-HHHHHHHHHHHHHHhCC-CCCeEEEEEE------------------
Confidence 369999999999999866899999998765433 34557889999999997 8999999886
Q ss_pred CCCccccCCeEEEEEecch-hhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCCCccEEe-ec
Q 003052 558 KDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLL-VK 635 (853)
Q Consensus 558 ~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLKPeNILL-~~ 635 (853)
+.+..+.|+||||+. ++|.+++... ...+++..+..++.+++.||.|||++||+||||||+|||+ .+
T Consensus 61 ----~~~~~~~~~v~e~~~~~~l~~~l~~~-------~~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~~~ 129 (251)
T cd05041 61 ----CVQKQPIYIVMELVPGGSLLTFLRKK-------KNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGEN 129 (251)
T ss_pred ----EecCCCeEEEEEcCCCCcHHHHHHhc-------CCCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEcCC
Confidence 345567899999975 5888877542 2468899999999999999999999999999999999999 56
Q ss_pred CcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHh-CCCCCCcch
Q 003052 636 GSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVY-GRTPFSEYK 714 (853)
Q Consensus 636 g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLt-G~~PF~~~~ 714 (853)
+.+||+|||+++...............++..|+|||.+.+. .++.++|||||||++|+|++ |..||....
T Consensus 130 ~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~---------~~~~~~Di~slG~i~~~l~t~~~~p~~~~~ 200 (251)
T cd05041 130 NVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEALNYG---------RYTSESDVWSYGILLWETFSLGDTPYPGMS 200 (251)
T ss_pred CcEEEeeccccccccCCcceeccccCcceeccCChHhhccC---------CCCcchhHHHHHHHHHHHHhccCCCCccCC
Confidence 79999999999865422211111223446679999998654 35679999999999999998 899997654
Q ss_pred hHHHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCCChhHHhc
Q 003052 715 TFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQ 763 (853)
Q Consensus 715 ~~~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~ 763 (853)
.......+ .. ......+...+.++.+||.+||..+|.+||++.|+|+
T Consensus 201 ~~~~~~~~-~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~ 247 (251)
T cd05041 201 NQQTRERI-ES-GYRMPAPQLCPEEIYRLMLQCWAYDPENRPSFSEIYN 247 (251)
T ss_pred HHHHHHHH-hc-CCCCCCCccCCHHHHHHHHHHhccChhhCcCHHHHHH
Confidence 33222222 21 2233345566789999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=315.83 Aligned_cols=258 Identities=21% Similarity=0.297 Sum_probs=196.6
Q ss_pred cCceeeEEEeEeccCceEEEEEEec------CCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhH
Q 003052 470 NGKLYQRLGKIGSGGSSEVHKVISS------DCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTE 543 (853)
Q Consensus 470 ~g~~Y~ilk~LG~G~FG~Vyka~~~------~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e 543 (853)
+.++|.+.++||+|+||.||+|... ++..+|+|.+.... ......+.+|+++++++. |+||++++++
T Consensus 3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~e~~~l~~l~-h~~i~~~~~~---- 75 (280)
T cd05092 3 KRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEAS--ESARQDFQREAELLTVLQ-HQHIVRFYGV---- 75 (280)
T ss_pred ChHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCC--HHHHHHHHHHHHHHhcCC-CCCCceEEEE----
Confidence 4567899999999999999999642 34678999887543 334557899999999996 8999999876
Q ss_pred HHHHHHHhhCCCCCCCCccccCCeEEEEEecch-hhHHHHHHHhhhh-------ccCCCCCCCHHHHHHHHHHhhhhhhh
Q 003052 544 KALLREVLNGSMNNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKE-------MDGSNQTLDENWLRFYWQQILEAVNT 615 (853)
Q Consensus 544 ~~iL~~l~~~~iv~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~-------~~~~~~~LsE~~~r~I~~QIl~AL~y 615 (853)
+.+...+|+||||+. ++|.+++...... .......+++..++.++.||+.||.|
T Consensus 76 ------------------~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~ 137 (280)
T cd05092 76 ------------------CTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVY 137 (280)
T ss_pred ------------------EecCCceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHH
Confidence 345567899999965 5888888653210 01112458999999999999999999
Q ss_pred cccCceeeCCCCCccEEe-ecCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchh
Q 003052 616 IHEERIVHSDLKPANFLL-VKGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIW 694 (853)
Q Consensus 616 LHs~gIIHRDLKPeNILL-~~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIW 694 (853)
||++||+||||||+|||+ .++.+||+|||+++...............+++.|+|||.+.+.. ++.++|||
T Consensus 138 LH~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~---------~~~~~Di~ 208 (280)
T cd05092 138 LASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRK---------FTTESDIW 208 (280)
T ss_pred HHHCCeecccccHhhEEEcCCCCEEECCCCceeEcCCCceeecCCCccccccccCHHHhccCC---------cCchhhHH
Confidence 999999999999999999 46689999999997654322211122344678899999987653 56799999
Q ss_pred hhHHHHHHHHh-CCCCCCcchhHHHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCCChhHHhc
Q 003052 695 SLGCILYQMVY-GRTPFSEYKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQ 763 (853)
Q Consensus 695 SLGVILyELLt-G~~PF~~~~~~~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~ 763 (853)
||||++|+|++ |.+||............... .....+...++.+.+||.+||..||.+||++.+|+.
T Consensus 209 slG~il~el~~~g~~p~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~ 276 (280)
T cd05092 209 SFGVVLWEIFTYGKQPWYQLSNTEAIECITQG--RELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHS 276 (280)
T ss_pred HHHHHHHHHHcCCCCCCccCCHHHHHHHHHcC--ccCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 99999999998 99999765443332222221 122334456788999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=310.28 Aligned_cols=255 Identities=19% Similarity=0.258 Sum_probs=188.4
Q ss_pred eEeccCceEEEEEEecC---CcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHHHHhhCCC
Q 003052 479 KIGSGGSSEVHKVISSD---CTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLREVLNGSM 555 (853)
Q Consensus 479 ~LG~G~FG~Vyka~~~~---g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~~l~~~~i 555 (853)
+||+|+||.||+|...+ ...+|+|.+.... .......+.+|+.+++.++ |+||++++++
T Consensus 2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~e~~~~~~l~-h~nii~~~~~---------------- 63 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASA-TPDEQLLFLQEVQPYRELN-HPNVLQCLGQ---------------- 63 (269)
T ss_pred cCCccCCceEEEEEEecCCCCeEEEEeecCccC-ChHHHHHHHHHHHHHHhCC-CCCcceEEEE----------------
Confidence 59999999999997533 3467888776433 2333456789999999986 8999999986
Q ss_pred CCCCCccccCCeEEEEEecch-hhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCCCccEEe-
Q 003052 556 NNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLL- 633 (853)
Q Consensus 556 v~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLKPeNILL- 633 (853)
+.+...+|+||||+. ++|.+++...... ....+++..++.++.||+.||+|||++||+||||||+|||+
T Consensus 64 ------~~~~~~~~lv~e~~~~g~L~~~l~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~ 134 (269)
T cd05042 64 ------CIESIPYLLVLEFCPLGDLKNYLRSNRGM---VAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLT 134 (269)
T ss_pred ------ECCCCceEEEEEeCCCCcHHHHHHhcccc---ccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEec
Confidence 345567899999976 5898888654211 12345788899999999999999999999999999999999
Q ss_pred ecCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHh-CCCCCCc
Q 003052 634 VKGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVY-GRTPFSE 712 (853)
Q Consensus 634 ~~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLt-G~~PF~~ 712 (853)
.++.+||+|||++................+++.|+|||++....... ....++.++|||||||++|||++ |..||..
T Consensus 135 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~--~~~~~~~~~DiwslG~~l~el~~~~~~p~~~ 212 (269)
T cd05042 135 ADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEIRGQDL--LPKDQTKKSNIWSLGVTMWELFTAADQPYPD 212 (269)
T ss_pred CCCcEEEeccccccccccchheeccCCCCCcccccCHHHHhhccccc--cccccchhhHHHHHHHHHHHHHhCCCCCCCc
Confidence 56799999999997643322211223345678899999986532210 11246789999999999999998 8899976
Q ss_pred chhHHHHHHhhcCCCCc---ccCCCCCChhHHHHHHHhcccCCCCCCChhHHhc
Q 003052 713 YKTFWAKFKVITDPNHE---ITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQ 763 (853)
Q Consensus 713 ~~~~~~~~kii~~~~~~---~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~ 763 (853)
..+.......+...... .......+..+.+++..|+ .||.+||++.+|++
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~ 265 (269)
T cd05042 213 LSDEQVLKQVVREQDIKLPKPQLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHE 265 (269)
T ss_pred CCHHHHHHHHhhccCccCCCCcccccCCHHHHHHHHHHh-cCcccccCHHHHHH
Confidence 65443333333322221 2233456778899999998 59999999999985
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=317.25 Aligned_cols=260 Identities=23% Similarity=0.322 Sum_probs=193.1
Q ss_pred CceeeEEEeEeccCceEEEEEEecC---------------CcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeE
Q 003052 471 GKLYQRLGKIGSGGSSEVHKVISSD---------------CTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQ 535 (853)
Q Consensus 471 g~~Y~ilk~LG~G~FG~Vyka~~~~---------------g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~ 535 (853)
..+|++.++||+|+||.||+|.+.. ...||+|++..... ......+.+|+++|++++ |+||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~ei~~l~~l~-h~~i~~ 81 (295)
T cd05097 4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVT-KTARNDFLKEIKIMSRLK-NPNIIR 81 (295)
T ss_pred hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCC-HHHHHHHHHHHHHHHhCC-CCCcCe
Confidence 3579999999999999999997632 13589999875432 334456889999999998 899999
Q ss_pred eeehhhhHHHHHHHHhhCCCCCCCCccccCCeEEEEEecch-hhHHHHHHHhhh----hccCCCCCCCHHHHHHHHHHhh
Q 003052 536 LIDYEVTEKALLREVLNGSMNNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWK----EMDGSNQTLDENWLRFYWQQIL 610 (853)
Q Consensus 536 Lid~~~~e~~iL~~l~~~~iv~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k----~~~~~~~~LsE~~~r~I~~QIl 610 (853)
+++++ .....+|+||||+. ++|.+++..... ........+++..+..++.||+
T Consensus 82 ~~~~~----------------------~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~ 139 (295)
T cd05097 82 LLGVC----------------------VSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIA 139 (295)
T ss_pred EEEEE----------------------cCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHH
Confidence 99873 44567899999976 588888754311 0111123478899999999999
Q ss_pred hhhhhcccCceeeCCCCCccEEee-cCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCC
Q 003052 611 EAVNTIHEERIVHSDLKPANFLLV-KGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGR 689 (853)
Q Consensus 611 ~AL~yLHs~gIIHRDLKPeNILL~-~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ 689 (853)
.||.|||++||+||||||+|||++ ++.+||+|||+++.+.............+++.|+|||++.+. .++.
T Consensus 140 ~al~~lH~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~---------~~~~ 210 (295)
T cd05097 140 SGMKYLASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLG---------KFTT 210 (295)
T ss_pred HHHHHHHhcCeeccccChhhEEEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccC---------CcCc
Confidence 999999999999999999999994 568999999999865432222122234567899999998654 3568
Q ss_pred ccchhhhHHHHHHHHh--CCCCCCcchhHHHHHHh---hcC--CCCcccCCCCCChhHHHHHHHhcccCCCCCCChhHHh
Q 003052 690 PSDIWSLGCILYQMVY--GRTPFSEYKTFWAKFKV---ITD--PNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLL 762 (853)
Q Consensus 690 ksDIWSLGVILyELLt--G~~PF~~~~~~~~~~ki---i~~--~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL 762 (853)
++|||||||++|+|++ |..||............ ... .......+...++.+.+||.+||..||.+||++.+|+
T Consensus 211 ~~DvwSlG~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~ 290 (295)
T cd05097 211 ASDVWAFGVTLWEMFTLCKEQPYSLLSDEQVIENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIH 290 (295)
T ss_pred hhhHHHHHHHHHHHHHcCCCCCCcccChHHHHHHHHHhhhhccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHH
Confidence 9999999999999987 77888654322211111 110 0111222344567899999999999999999999997
Q ss_pred c
Q 003052 763 Q 763 (853)
Q Consensus 763 ~ 763 (853)
+
T Consensus 291 ~ 291 (295)
T cd05097 291 H 291 (295)
T ss_pred H
Confidence 5
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=313.59 Aligned_cols=251 Identities=22% Similarity=0.290 Sum_probs=189.9
Q ss_pred eeeEEEeEeccCceEEEEEEe-----cCCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHH
Q 003052 473 LYQRLGKIGSGGSSEVHKVIS-----SDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALL 547 (853)
Q Consensus 473 ~Y~ilk~LG~G~FG~Vyka~~-----~~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL 547 (853)
.|++++.||+|+||+||++.. .++..||+|.++.... ......+.+|+++|++++ |+||+++++++..
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~----- 77 (283)
T cd05080 5 YLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECG-QQNTSGWKKEINILKTLY-HENIVKYKGCCSE----- 77 (283)
T ss_pred hceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccC-hHHHHHHHHHHHHHHhCC-CCCEeeEEEEEec-----
Confidence 359999999999999988652 3567899999976532 233456889999999997 9999999986421
Q ss_pred HHHhhCCCCCCCCccccCCeEEEEEecch-hhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCC
Q 003052 548 REVLNGSMNNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDL 626 (853)
Q Consensus 548 ~~l~~~~iv~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDL 626 (853)
.....+|+||||+. ++|.+++.. ..+++.+++.++.||+.||.|||++||+||||
T Consensus 78 ---------------~~~~~~~lv~e~~~~~~l~~~~~~---------~~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dl 133 (283)
T cd05080 78 ---------------QGGKGLQLIMEYVPLGSLRDYLPK---------HKLNLAQLLLFAQQICEGMAYLHSQHYIHRDL 133 (283)
T ss_pred ---------------CCCceEEEEecCCCCCCHHHHHHH---------cCCCHHHHHHHHHHHHHHHHHHHHCCeecccc
Confidence 23456899999976 478777753 35899999999999999999999999999999
Q ss_pred CCccEEe-ecCcEEEEecccchhcccCCcccc-ccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHH
Q 003052 627 KPANFLL-VKGSLKLIDFGIAKAIMSDTTNIQ-RDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMV 704 (853)
Q Consensus 627 KPeNILL-~~g~VKL~DFGlAk~~~~~~~~~~-~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELL 704 (853)
||+|||+ .++.+||+|||+++.+........ .....++..|+|||++.+. .++.++|||||||++|+|+
T Consensus 134 kp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~---------~~~~~~Di~slG~~l~el~ 204 (283)
T cd05080 134 AARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLKEN---------KFSYASDVWSFGVTLYELL 204 (283)
T ss_pred ChheEEEcCCCcEEEeecccccccCCcchhhccCCCCCCCceeeCHhHhccc---------CCCcccccHHHHHHHHHHH
Confidence 9999999 457899999999987643222111 1223466789999998654 3567999999999999999
Q ss_pred hCCCCCCcchhH-HHHHHh------------hcCCCCcccCCCCCChhHHHHHHHhcccCCCCCCChhHHhc
Q 003052 705 YGRTPFSEYKTF-WAKFKV------------ITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQ 763 (853)
Q Consensus 705 tG~~PF~~~~~~-~~~~ki------------i~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~ 763 (853)
+|..||...... ...... ..........+...+..+.+|+.+||..||.+||++.+++.
T Consensus 205 tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~ 276 (283)
T cd05080 205 THCDSKQSPPKKFEEMIGPKQGQMTVVRLIELLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIP 276 (283)
T ss_pred hCCCCCCCCcchhhhhhcccccccchhhhhhhhhcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 999998543211 111000 00011112234456788999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=317.98 Aligned_cols=256 Identities=23% Similarity=0.349 Sum_probs=193.6
Q ss_pred ceeeEEEeEeccCceEEEEEEec-CCc--EEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHH
Q 003052 472 KLYQRLGKIGSGGSSEVHKVISS-DCT--IYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLR 548 (853)
Q Consensus 472 ~~Y~ilk~LG~G~FG~Vyka~~~-~g~--~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~ 548 (853)
..|++.+.||+|+||.||+|.+. ++. .+|+|.++.. ........+.+|+.++.++.+|+||++++++
T Consensus 7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~-~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~--------- 76 (303)
T cd05088 7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY-ASKDDHRDFAGELEVLCKLGHHPNIINLLGA--------- 76 (303)
T ss_pred hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEeccc-CCHHHHHHHHHHHHHHHHhcCCCCcceEEEE---------
Confidence 46899999999999999999874 443 4577776532 2233445688999999999779999999987
Q ss_pred HHhhCCCCCCCCccccCCeEEEEEecch-hhHHHHHHHhhhhc--------cCCCCCCCHHHHHHHHHHhhhhhhhcccC
Q 003052 549 EVLNGSMNNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEM--------DGSNQTLDENWLRFYWQQILEAVNTIHEE 619 (853)
Q Consensus 549 ~l~~~~iv~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~~--------~~~~~~LsE~~~r~I~~QIl~AL~yLHs~ 619 (853)
+.+++.+|+||||+. ++|.+++....... ......+++..++.++.||+.||+|||++
T Consensus 77 -------------~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~ 143 (303)
T cd05088 77 -------------CEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK 143 (303)
T ss_pred -------------ECCCCCceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhC
Confidence 345667899999975 68888886542100 01224689999999999999999999999
Q ss_pred ceeeCCCCCccEEe-ecCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHH
Q 003052 620 RIVHSDLKPANFLL-VKGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGC 698 (853)
Q Consensus 620 gIIHRDLKPeNILL-~~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGV 698 (853)
||+||||||+|||+ .++.+||+|||+++..... .......++..|+|||.+.+. .++.++|||||||
T Consensus 144 gi~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~---------~~~~~~Di~slG~ 211 (303)
T cd05088 144 QFIHRDLAARNILVGENYVAKIADFGLSRGQEVY---VKKTMGRLPVRWMAIESLNYS---------VYTTNSDVWSYGV 211 (303)
T ss_pred CccccccchheEEecCCCcEEeCccccCcccchh---hhcccCCCcccccCHHHHhcc---------CCcccccchhhhh
Confidence 99999999999999 5679999999998643211 111122346789999988654 3567999999999
Q ss_pred HHHHHHh-CCCCCCcchhHHHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCCChhHHhcC
Q 003052 699 ILYQMVY-GRTPFSEYKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQH 764 (853)
Q Consensus 699 ILyELLt-G~~PF~~~~~~~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~H 764 (853)
++|+|++ |.+||...... ..+..+.. ......+...++.+.+||.+||..+|.+||++.++|.+
T Consensus 212 il~ellt~g~~p~~~~~~~-~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 276 (303)
T cd05088 212 LLWEIVSLGGTPYCGMTCA-ELYEKLPQ-GYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 276 (303)
T ss_pred HHHHHHhcCCCCcccCChH-HHHHHHhc-CCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 9999998 99999754332 22222221 11222334467789999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=313.09 Aligned_cols=257 Identities=24% Similarity=0.379 Sum_probs=199.7
Q ss_pred eeEEEeEeccCceEEEEEEe----cCCcEEEEEEEecCCC--ChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHH
Q 003052 474 YQRLGKIGSGGSSEVHKVIS----SDCTIYALKKIKLKGR--DYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALL 547 (853)
Q Consensus 474 Y~ilk~LG~G~FG~Vyka~~----~~g~~vAVKkik~~~~--~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL 547 (853)
|++.+.||+|+||.||++.+ .++..||||.++.... .......+.+|+.++.++.+|+||+++++.
T Consensus 2 ~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~-------- 73 (288)
T cd05583 2 FELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYA-------- 73 (288)
T ss_pred ceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhhee--------
Confidence 88999999999999999975 2567899999975322 123344578999999999889999988765
Q ss_pred HHHhhCCCCCCCCccccCCeEEEEEecch-hhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCC
Q 003052 548 REVLNGSMNNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDL 626 (853)
Q Consensus 548 ~~l~~~~iv~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDL 626 (853)
+..+..+|+||||+. ++|...+... ..+++..++.++.|++.||.|||+.||+||||
T Consensus 74 --------------~~~~~~~~lv~e~~~~~~L~~~~~~~--------~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl 131 (288)
T cd05583 74 --------------FQTDTKLHLILDYVNGGELFTHLYQR--------EHFTESEVRVYIAEIVLALDHLHQLGIIYRDI 131 (288)
T ss_pred --------------eecCCEEEEEEecCCCCcHHHHHhhc--------CCcCHHHHHHHHHHHHHHHHHHHHCCeeccCC
Confidence 455678999999976 5887776542 46899999999999999999999999999999
Q ss_pred CCccEEe-ecCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHh
Q 003052 627 KPANFLL-VKGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVY 705 (853)
Q Consensus 627 KPeNILL-~~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLt 705 (853)
||.||++ .++.++|+|||+++.+...... .....+|+..|+|||.+.+... .++.++||||||+++|+|++
T Consensus 132 ~p~nil~~~~~~~~l~dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~-------~~~~~~Dv~slG~il~el~t 203 (288)
T cd05583 132 KLENILLDSEGHVVLTDFGLSKEFLAEEEE-RAYSFCGTIEYMAPEVIRGGSG-------GHDKAVDWWSLGVLTFELLT 203 (288)
T ss_pred CHHHeEECCCCCEEEEECcccccccccccc-ccccccCCccccCHHHhcCCCC-------CCcchhhhHHHHHHHHHHHh
Confidence 9999999 5678999999999876433221 1234578999999999865421 24678999999999999999
Q ss_pred CCCCCCcch---hHHHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCCC---hhHHhcCCCCCCC
Q 003052 706 GRTPFSEYK---TFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWR---IPQLLQHPFLVPP 770 (853)
Q Consensus 706 G~~PF~~~~---~~~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpT---a~EIL~HPwf~~~ 770 (853)
|..||.... ......+.+.. .....+...+..+.+||.+||+.||.+||| +.++|+||||+..
T Consensus 204 g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~~~~~~ 272 (288)
T cd05583 204 GASPFTVDGEQNSQSEISRRILK--SKPPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHPFFQGI 272 (288)
T ss_pred CCCCcccCcccchHHHHHHHHHc--cCCCCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCcccccC
Confidence 999995321 11122222221 112344556788999999999999999998 5778999999754
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=314.02 Aligned_cols=255 Identities=20% Similarity=0.336 Sum_probs=195.2
Q ss_pred eeEEEeEeccCceEEEEEEec------CCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHH
Q 003052 474 YQRLGKIGSGGSSEVHKVISS------DCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALL 547 (853)
Q Consensus 474 Y~ilk~LG~G~FG~Vyka~~~------~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL 547 (853)
|++.+.||+|+||.||+|... ....+|+|.+..... ......+.+|+.+++.+. |+||+++++.
T Consensus 2 ~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~E~~~l~~l~-h~~iv~~~~~-------- 71 (290)
T cd05045 2 LVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENAS-SSELRDLLSEFNLLKQVN-HPHVIKLYGA-------- 71 (290)
T ss_pred ccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCC-HHHHHHHHHHHHHHhhCC-CCCEeeEEEE--------
Confidence 788899999999999999863 225688888865433 334456889999999997 8999999876
Q ss_pred HHHhhCCCCCCCCccccCCeEEEEEecch-hhHHHHHHHhhhh----------------ccCCCCCCCHHHHHHHHHHhh
Q 003052 548 REVLNGSMNNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKE----------------MDGSNQTLDENWLRFYWQQIL 610 (853)
Q Consensus 548 ~~l~~~~iv~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~----------------~~~~~~~LsE~~~r~I~~QIl 610 (853)
+..++..|+||||+. ++|.+++...... .......+++..++.++.||+
T Consensus 72 --------------~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~ 137 (290)
T cd05045 72 --------------CSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQIS 137 (290)
T ss_pred --------------EecCCCcEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHH
Confidence 345567899999976 5888887653211 011224688999999999999
Q ss_pred hhhhhcccCceeeCCCCCccEEe-ecCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCC
Q 003052 611 EAVNTIHEERIVHSDLKPANFLL-VKGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGR 689 (853)
Q Consensus 611 ~AL~yLHs~gIIHRDLKPeNILL-~~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ 689 (853)
.||.|||++||+||||||+|||+ +++.+||+|||+++...............++..|+|||.+.+. .++.
T Consensus 138 ~~l~~LH~~~ivH~dikp~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~---------~~~~ 208 (290)
T cd05045 138 RGMQYLAEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDH---------IYTT 208 (290)
T ss_pred HHHHHHHHCCeehhhhhhheEEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccC---------Ccch
Confidence 99999999999999999999999 4668999999999866443322222344567899999998654 3567
Q ss_pred ccchhhhHHHHHHHHh-CCCCCCcchhHHHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCCChhHHhc
Q 003052 690 PSDIWSLGCILYQMVY-GRTPFSEYKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQ 763 (853)
Q Consensus 690 ksDIWSLGVILyELLt-G~~PF~~~~~~~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~ 763 (853)
++|||||||++|+|++ |..||.+.... .....+.. ......+...+..+.+||.+||..||.+||++.++++
T Consensus 209 ~~Di~slG~~l~el~t~g~~p~~~~~~~-~~~~~~~~-~~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~ 281 (290)
T cd05045 209 QSDVWSFGVLLWEIVTLGGNPYPGIAPE-RLFNLLKT-GYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISK 281 (290)
T ss_pred HhHHHHHHHHHHHHHhcCCCCCCCCCHH-HHHHHHhC-CCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence 9999999999999998 99999765432 22222222 1223334556788999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=317.56 Aligned_cols=254 Identities=24% Similarity=0.406 Sum_probs=199.3
Q ss_pred eeEEEeEeccCceEEEEEEe-cCCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHHHHhh
Q 003052 474 YQRLGKIGSGGSSEVHKVIS-SDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLREVLN 552 (853)
Q Consensus 474 Y~ilk~LG~G~FG~Vyka~~-~~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~~l~~ 552 (853)
|....+||+|+||.||++.. .++..||||++.... ......+.+|+.+++++. |+||++++++
T Consensus 22 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~e~~~l~~l~-h~~iv~~~~~------------- 85 (292)
T cd06657 22 LDNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRK--QQRRELLFNEVVIMRDYQ-HENVVEMYNS------------- 85 (292)
T ss_pred hhhHHHcCCCCCeEEEEEEEcCCCeEEEEEEecccc--hhHHHHHHHHHHHHHhcC-CcchhheeeE-------------
Confidence 33446799999999999988 577899999986433 233456889999999997 8999999876
Q ss_pred CCCCCCCCccccCCeEEEEEecchh-hHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCCCccE
Q 003052 553 GSMNNKDGRVKDDGYIYMVLEYGEI-DLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANF 631 (853)
Q Consensus 553 ~~iv~~~g~~~d~~~lyLVmEy~~g-dL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLKPeNI 631 (853)
+..+.++|+||||+.+ +|.+++.. ..+++..++.++.||+.||+|||++||+||||||+||
T Consensus 86 ---------~~~~~~~~lv~e~~~~~~L~~~~~~---------~~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Ni 147 (292)
T cd06657 86 ---------YLVGDELWVVMEFLEGGALTDIVTH---------TRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSI 147 (292)
T ss_pred ---------EEeCCEEEEEEecCCCCcHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHE
Confidence 4556789999999765 67665532 3589999999999999999999999999999999999
Q ss_pred Eee-cCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHhCCCCC
Q 003052 632 LLV-KGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGRTPF 710 (853)
Q Consensus 632 LL~-~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLtG~~PF 710 (853)
+++ ++.++|+|||++........ ......|++.|+|||.+.+. .++.++|+||+||++|+|++|..||
T Consensus 148 lv~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~y~~pE~~~~~---------~~~~~~Dv~slGvil~el~tg~~p~ 216 (292)
T cd06657 148 LLTHDGRVKLSDFGFCAQVSKEVP--RRKSLVGTPYWMAPELISRL---------PYGPEVDIWSLGIMVIEMVDGEPPY 216 (292)
T ss_pred EECCCCCEEEcccccceecccccc--cccccccCccccCHHHhcCC---------CCCchhhHHHHHHHHHHHHhCCCCC
Confidence 994 67899999999876543221 12346789999999988643 3567999999999999999999999
Q ss_pred CcchhHHHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCCChhHHhcCCCCCCCCC
Q 003052 711 SEYKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQHPFLVPPVS 772 (853)
Q Consensus 711 ~~~~~~~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~HPwf~~~~~ 772 (853)
...................+......++.+.++|.+||..||.+||++.++|.||||.....
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~R~~~~~ll~~~~~~~~~~ 278 (292)
T cd06657 217 FNEPPLKAMKMIRDNLPPKLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAGP 278 (292)
T ss_pred CCCCHHHHHHHHHhhCCcccCCcccCCHHHHHHHHHHHhCCcccCcCHHHHhcChHHhccCC
Confidence 76544332222211112222233456788999999999999999999999999999987654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-35 Score=308.46 Aligned_cols=255 Identities=18% Similarity=0.249 Sum_probs=187.9
Q ss_pred eEeccCceEEEEEEec---CCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHHHHhhCCC
Q 003052 479 KIGSGGSSEVHKVISS---DCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLREVLNGSM 555 (853)
Q Consensus 479 ~LG~G~FG~Vyka~~~---~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~~l~~~~i 555 (853)
.||+|+||.||+|... ++..+|+|.++..... .....+.+|+.++++++ |+||++++++
T Consensus 2 ~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~-~~~~~~~~E~~~l~~l~-h~~iv~~~~~---------------- 63 (269)
T cd05087 2 EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASV-QEQMKFLEEAQPYRSLQ-HSNLLQCLGQ---------------- 63 (269)
T ss_pred cccccCCceEEEEEEcCCCCceEEEEEecCCCCCh-HHHHHHHHHHHHHHhCC-CCCEeeEEEE----------------
Confidence 5999999999999764 3357999998765432 23346889999999997 8999999876
Q ss_pred CCCCCccccCCeEEEEEecch-hhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCCCccEEee
Q 003052 556 NNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLLV 634 (853)
Q Consensus 556 v~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLKPeNILL~ 634 (853)
+.+...+|+||||+. ++|.+++..... .....+++..++.++.||+.||.|||+.||+||||||+||+++
T Consensus 64 ------~~~~~~~~lv~e~~~~g~L~~~l~~~~~---~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~ 134 (269)
T cd05087 64 ------CTEVTPYLLVMEFCPLGDLKGYLRSCRK---AELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLT 134 (269)
T ss_pred ------EcCCCCcEEEEECCCCCcHHHHHHHhhh---cccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEc
Confidence 344566899999976 688888865421 1123567788889999999999999999999999999999994
Q ss_pred -cCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHh-CCCCCCc
Q 003052 635 -KGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVY-GRTPFSE 712 (853)
Q Consensus 635 -~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLt-G~~PF~~ 712 (853)
++.+||+|||+++...............|+..|+|||++.+.... .....++.++|||||||++|||++ |+.||..
T Consensus 135 ~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~--~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~ 212 (269)
T cd05087 135 ADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEVHGN--LLVVDQTKESNVWSLGVTIWELFELGSQPYRH 212 (269)
T ss_pred CCCcEEECCccccccccCcceeecCCCcCCcccccCHhHhcccccc--ccccCCCccchhHHHHHHHHHHHhCCCCCCCC
Confidence 568999999999764432222222345688899999998643211 001235789999999999999996 9999976
Q ss_pred chhHHHHHHhhcCCCCcc---cCCCCCChhHHHHHHHhcccCCCCCCChhHHhc
Q 003052 713 YKTFWAKFKVITDPNHEI---TYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQ 763 (853)
Q Consensus 713 ~~~~~~~~kii~~~~~~~---~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~ 763 (853)
..........+....... ......+..+.++|.+|+ .+|.+|||+.+|+.
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~ 265 (269)
T cd05087 213 LSDEQVLTYTVREQQLKLPKPRLKLPLSDRWYEVMQFCW-LQPEQRPSAEEVHL 265 (269)
T ss_pred CChHHHHHHHhhcccCCCCCCccCCCCChHHHHHHHHHh-cCcccCCCHHHHHH
Confidence 544333222222111111 122245677899999998 68999999999984
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-35 Score=331.77 Aligned_cols=265 Identities=23% Similarity=0.349 Sum_probs=204.5
Q ss_pred eEEcCceeeEEEeEeccCceEEEEEEec------CCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehh
Q 003052 467 FKVNGKLYQRLGKIGSGGSSEVHKVISS------DCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYE 540 (853)
Q Consensus 467 ~~v~g~~Y~ilk~LG~G~FG~Vyka~~~------~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~ 540 (853)
+.+..+.|.+.++||+|+||.||+|++. .+..||||+++..... .....+.+|+++|.++..|+||+++++++
T Consensus 32 ~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~-~~~~~~~~E~~~l~~l~~H~niv~~~~~~ 110 (401)
T cd05107 32 WEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARS-SEKQALMSELKIMSHLGPHLNIVNLLGAC 110 (401)
T ss_pred ceecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCCh-hHHHHHHHHHHHHHhcCCCCCeEEEEEEE
Confidence 5556677999999999999999999853 3367999999865333 23346889999999998899999999863
Q ss_pred hhHHHHHHHHhhCCCCCCCCccccCCeEEEEEecch-hhHHHHHHHhhhhc-----------------------------
Q 003052 541 VTEKALLREVLNGSMNNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEM----------------------------- 590 (853)
Q Consensus 541 ~~e~~iL~~l~~~~iv~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~~----------------------------- 590 (853)
...+.+|+||||+. ++|.+++.......
T Consensus 111 ----------------------~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 168 (401)
T cd05107 111 ----------------------TKGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHV 168 (401)
T ss_pred ----------------------ccCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccch
Confidence 44567899999976 59999886532100
Q ss_pred -------------------------------------------------------------cCCCCCCCHHHHHHHHHHh
Q 003052 591 -------------------------------------------------------------DGSNQTLDENWLRFYWQQI 609 (853)
Q Consensus 591 -------------------------------------------------------------~~~~~~LsE~~~r~I~~QI 609 (853)
......+++..++.|+.||
T Consensus 169 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi 248 (401)
T cd05107 169 SLGSESDGGYMDMSKDESADYVPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQV 248 (401)
T ss_pred hhhhccCccccccCCccccCccchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHH
Confidence 0112357888899999999
Q ss_pred hhhhhhcccCceeeCCCCCccEEee-cCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCC
Q 003052 610 LEAVNTIHEERIVHSDLKPANFLLV-KGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCG 688 (853)
Q Consensus 610 l~AL~yLHs~gIIHRDLKPeNILL~-~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys 688 (853)
+.||.|||+.||+||||||+|||++ ++.+||+|||+++.+.............|++.|||||.+.+. .++
T Consensus 249 ~~aL~~LH~~~ivHrdlkp~NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~---------~~~ 319 (401)
T cd05107 249 ANGMEFLASKNCVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNN---------LYT 319 (401)
T ss_pred HHHHHHHhcCCcCcccCCcceEEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCC---------CCC
Confidence 9999999999999999999999995 568999999999865433222222345678899999999654 356
Q ss_pred CccchhhhHHHHHHHHh-CCCCCCcchhHHHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCCChhHHhcC
Q 003052 689 RPSDIWSLGCILYQMVY-GRTPFSEYKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQH 764 (853)
Q Consensus 689 ~ksDIWSLGVILyELLt-G~~PF~~~~~~~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~H 764 (853)
.++|||||||++|||++ |..||............+.. ......+...+.++.+||.+||..+|.+||++.+|++.
T Consensus 320 ~~~DvwslGvil~e~l~~g~~P~~~~~~~~~~~~~~~~-~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~ 395 (401)
T cd05107 320 TLSDVWSFGILLWEIFTLGGTPYPELPMNEQFYNAIKR-GYRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHL 395 (401)
T ss_pred cHhHHHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHHc-CCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 79999999999999998 89999765443333333322 22233455678899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-35 Score=303.74 Aligned_cols=243 Identities=30% Similarity=0.490 Sum_probs=198.3
Q ss_pred EeccCceEEEEEEec-CCcEEEEEEEecCCC-ChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHHHHhhCCCCC
Q 003052 480 IGSGGSSEVHKVISS-DCTIYALKKIKLKGR-DYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLREVLNGSMNN 557 (853)
Q Consensus 480 LG~G~FG~Vyka~~~-~g~~vAVKkik~~~~-~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~~l~~~~iv~ 557 (853)
||.|+||.||++.+. +++.||+|.+..... .......+.+|+.+++++. |+||+++++.
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~------------------ 61 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRIN-HPFIVKLHYA------------------ 61 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcC-CCcHHHHHHH------------------
Confidence 699999999999984 578999999876533 2234556889999999998 8999988765
Q ss_pred CCCccccCCeEEEEEecc-hhhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCCCccEEe-ec
Q 003052 558 KDGRVKDDGYIYMVLEYG-EIDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLL-VK 635 (853)
Q Consensus 558 ~~g~~~d~~~lyLVmEy~-~gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLKPeNILL-~~ 635 (853)
+.++..+|+||||+ +++|.+++... ..+++..+..++.||+.||.|||+.+++|+||||+||++ .+
T Consensus 62 ----~~~~~~~~~v~e~~~~~~L~~~l~~~--------~~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~~~ 129 (250)
T cd05123 62 ----FQTEEKLYLVLEYAPGGELFSHLSKE--------GRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDAD 129 (250)
T ss_pred ----eecCCeeEEEEecCCCCcHHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEcCC
Confidence 45677899999998 67898888653 468999999999999999999999999999999999999 56
Q ss_pred CcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHhCCCCCCcchh
Q 003052 636 GSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGRTPFSEYKT 715 (853)
Q Consensus 636 g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLtG~~PF~~~~~ 715 (853)
+.++|+|||++....... .......|+..|+|||.+.+.. ++.++|+||||+++|+|++|..||.....
T Consensus 130 ~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~~~~Pe~~~~~~---------~~~~~D~~slG~~~~~l~~g~~p~~~~~~ 198 (250)
T cd05123 130 GHIKLTDFGLAKELSSEG--SRTNTFCGTPEYLAPEVLLGKG---------YGKAVDWWSLGVLLYEMLTGKPPFYAEDR 198 (250)
T ss_pred CcEEEeecCcceecccCC--CcccCCcCCccccChHHhCCCC---------CCchhhHHHHHHHHHHHHHCCCCCCCCCH
Confidence 799999999998764322 1223567899999999986543 45789999999999999999999976544
Q ss_pred HHHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCh---hHHhcCCCC
Q 003052 716 FWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRI---PQLLQHPFL 767 (853)
Q Consensus 716 ~~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa---~EIL~HPwf 767 (853)
. .....+.. ....++...+..+.+||.+||..||.+||++ .++++||||
T Consensus 199 ~-~~~~~~~~--~~~~~~~~~~~~l~~~i~~~l~~~p~~R~~~~~~~~l~~~~~f 250 (250)
T cd05123 199 K-EIYEKILK--DPLRFPEFLSPEARDLISGLLQKDPTKRLGSGGAEEIKAHPFF 250 (250)
T ss_pred H-HHHHHHhc--CCCCCCCCCCHHHHHHHHHHhcCCHhhCCCcccHHHHHhCCCC
Confidence 2 22333322 3344555668889999999999999999999 999999998
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-35 Score=314.43 Aligned_cols=259 Identities=24% Similarity=0.328 Sum_probs=193.3
Q ss_pred ceeeEEEeEeccCceEEEEEEec-----------------CCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCcee
Q 003052 472 KLYQRLGKIGSGGSSEVHKVISS-----------------DCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNII 534 (853)
Q Consensus 472 ~~Y~ilk~LG~G~FG~Vyka~~~-----------------~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV 534 (853)
++|++.++||+|+||.||+|... +...+|+|++.... .......+.+|+.+|++++ |+||+
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~~~E~~~l~~l~-~~~i~ 82 (296)
T cd05095 5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDA-NKNARNDFLKEIKIMSRLK-DPNII 82 (296)
T ss_pred hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccC-CHHHHHHHHHHHHHHHhCC-CCCcc
Confidence 56999999999999999998542 23468999987543 2334557889999999996 89999
Q ss_pred EeeehhhhHHHHHHHHhhCCCCCCCCccccCCeEEEEEecch-hhHHHHHHHhhhhc---cCCCCCCCHHHHHHHHHHhh
Q 003052 535 QLIDYEVTEKALLREVLNGSMNNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEM---DGSNQTLDENWLRFYWQQIL 610 (853)
Q Consensus 535 ~Lid~~~~e~~iL~~l~~~~iv~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~~---~~~~~~LsE~~~r~I~~QIl 610 (853)
+++++ +.++..+|+||||+. ++|.+++....... ......+++..+..++.||+
T Consensus 83 ~~~~~----------------------~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~ 140 (296)
T cd05095 83 RLLAV----------------------CITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIA 140 (296)
T ss_pred eEEEE----------------------EecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHH
Confidence 99987 344567899999975 58988886542110 11224588899999999999
Q ss_pred hhhhhcccCceeeCCCCCccEEe-ecCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCC
Q 003052 611 EAVNTIHEERIVHSDLKPANFLL-VKGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGR 689 (853)
Q Consensus 611 ~AL~yLHs~gIIHRDLKPeNILL-~~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ 689 (853)
.||.|||++||+||||||+|||+ .++.+||+|||+++.+.............+++.|+|||+..+. .++.
T Consensus 141 ~al~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~---------~~~~ 211 (296)
T cd05095 141 SGMKYLSSLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLG---------KFTT 211 (296)
T ss_pred HHHHHHHHCCeecccCChheEEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcC---------Cccc
Confidence 99999999999999999999999 5679999999999865433221112234557789999987654 3578
Q ss_pred ccchhhhHHHHHHHHh--CCCCCCcchhHHHHHH---hhcC--CCCcccCCCCCChhHHHHHHHhcccCCCCCCChhHHh
Q 003052 690 PSDIWSLGCILYQMVY--GRTPFSEYKTFWAKFK---VITD--PNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLL 762 (853)
Q Consensus 690 ksDIWSLGVILyELLt--G~~PF~~~~~~~~~~k---ii~~--~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL 762 (853)
++|||||||++|||++ |..||........... .... .......+...++.+.+||.+||..||.+||++.+|+
T Consensus 212 ~~DiwSlG~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~ 291 (296)
T cd05095 212 ASDVWAFGVTLWEILTLCKEQPYSQLSDEQVIENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIH 291 (296)
T ss_pred hhhhhHHHHHHHHHHHhCCCCCccccChHHHHHHHHHHHhhccccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHH
Confidence 9999999999999998 7899965433221111 1100 1111222344567899999999999999999999987
Q ss_pred c
Q 003052 763 Q 763 (853)
Q Consensus 763 ~ 763 (853)
+
T Consensus 292 ~ 292 (296)
T cd05095 292 A 292 (296)
T ss_pred H
Confidence 5
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-35 Score=306.20 Aligned_cols=251 Identities=22% Similarity=0.296 Sum_probs=196.3
Q ss_pred EEcCceeeEEEeEeccCceEEEEEEecCCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHH
Q 003052 468 KVNGKLYQRLGKIGSGGSSEVHKVISSDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALL 547 (853)
Q Consensus 468 ~v~g~~Y~ilk~LG~G~FG~Vyka~~~~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL 547 (853)
.+..+.|++.++||+|+||.||++...++..+|+|.+.... .....+.+|+.+++++. |+||+++++++
T Consensus 2 ~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~---~~~~~~~~e~~~l~~l~-~~~i~~~~~~~------- 70 (260)
T cd05073 2 EIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS---MSVEAFLAEANVMKTLQ-HDKLVKLHAVV------- 70 (260)
T ss_pred cccccceeEEeEecCccceEEEEEEecCCccEEEEecCCCh---hHHHHHHHHHHHHHhcC-CCCcceEEEEE-------
Confidence 34567899999999999999999988777789999887532 23456889999999997 89999998763
Q ss_pred HHHhhCCCCCCCCccccCCeEEEEEecch-hhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCC
Q 003052 548 REVLNGSMNNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDL 626 (853)
Q Consensus 548 ~~l~~~~iv~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDL 626 (853)
.+ ...|++|||++ ++|.+++... ....+++..++.++.||+.||.|||++||+||||
T Consensus 71 ---------------~~-~~~~~v~e~~~~~~L~~~~~~~------~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl 128 (260)
T cd05073 71 ---------------TK-EPIYIITEFMAKGSLLDFLKSD------EGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDL 128 (260)
T ss_pred ---------------cC-CCeEEEEEeCCCCcHHHHHHhC------CccccCHHHHHHHHHHHHHHHHHHHhCCcccccc
Confidence 22 45799999975 5898888653 2346888999999999999999999999999999
Q ss_pred CCccEEe-ecCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHh
Q 003052 627 KPANFLL-VKGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVY 705 (853)
Q Consensus 627 KPeNILL-~~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLt 705 (853)
||+||++ .++.+||+|||++..+..... .......++..|+|||.+... .++.++|||||||++|+|++
T Consensus 129 ~p~ni~i~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~---------~~~~~~Di~slG~~l~~l~t 198 (260)
T cd05073 129 RAANILVSASLVCKIADFGLARVIEDNEY-TAREGAKFPIKWTAPEAINFG---------SFTIKSDVWSFGILLMEIVT 198 (260)
T ss_pred CcceEEEcCCCcEEECCCcceeeccCCCc-ccccCCcccccccCHhHhccC---------CcCccccchHHHHHHHHHHh
Confidence 9999999 456999999999986643221 112233466789999998654 35678999999999999998
Q ss_pred -CCCCCCcchhHHHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCCChhHHhc
Q 003052 706 -GRTPFSEYKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQ 763 (853)
Q Consensus 706 -G~~PF~~~~~~~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~ 763 (853)
|..||.+.........+.. ..........+.++.+++.+||..||.+||++.+++.
T Consensus 199 ~g~~p~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~ 255 (260)
T cd05073 199 YGRIPYPGMSNPEVIRALER--GYRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQS 255 (260)
T ss_pred cCCCCCCCCCHHHHHHHHhC--CCCCCCcccCCHHHHHHHHHHcccCcccCcCHHHHHH
Confidence 9999976544322222222 1222334456788999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-35 Score=303.65 Aligned_cols=243 Identities=22% Similarity=0.316 Sum_probs=190.2
Q ss_pred eEeccCceEEEEEEecCCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHHHHhhCCCCCC
Q 003052 479 KIGSGGSSEVHKVISSDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLREVLNGSMNNK 558 (853)
Q Consensus 479 ~LG~G~FG~Vyka~~~~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~~l~~~~iv~~ 558 (853)
+||+|+||.||+|...++..+|+|++..... ......+.+|+.++++++ |+||+++++++
T Consensus 2 ~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~-~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~------------------ 61 (250)
T cd05085 2 LLGKGNFGEVFKGTLKDKTPVAVKTCKEDLP-QELKIKFLSEARILKQYD-HPNIVKLIGVC------------------ 61 (250)
T ss_pred ccCCCCCceEEEEEecCCcEEEEEecCCcCC-HHHHHHHHHHHHHHHhCC-CCCcCeEEEEE------------------
Confidence 6899999999999988888999999875433 233346889999999996 99999999873
Q ss_pred CCccccCCeEEEEEecch-hhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCCCccEEe-ecC
Q 003052 559 DGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLL-VKG 636 (853)
Q Consensus 559 ~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLKPeNILL-~~g 636 (853)
.....+|+||||+. ++|.+++... ...+++..+..++.||+.||.|||++|++||||||+||++ .++
T Consensus 62 ----~~~~~~~lv~e~~~~~~L~~~~~~~-------~~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~~~~ 130 (250)
T cd05085 62 ----TQRQPIYIVMELVPGGDFLSFLRKK-------KDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGENN 130 (250)
T ss_pred ----ecCCccEEEEECCCCCcHHHHHHhc-------CCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEcCCC
Confidence 44567899999965 5888777542 2458899999999999999999999999999999999999 567
Q ss_pred cEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHh-CCCCCCcchh
Q 003052 637 SLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVY-GRTPFSEYKT 715 (853)
Q Consensus 637 ~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLt-G~~PF~~~~~ 715 (853)
.+||+|||++......... ......++..|+|||++.+. .++.++|||||||++|+|++ |..||.....
T Consensus 131 ~~~l~d~g~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~---------~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~ 200 (250)
T cd05085 131 VLKISDFGMSRQEDDGIYS-SSGLKQIPIKWTAPEALNYG---------RYSSESDVWSYGILLWETFSLGVCPYPGMTN 200 (250)
T ss_pred eEEECCCccceeccccccc-cCCCCCCcccccCHHHhccC---------CCCchhHHHHHHHHHHHHhcCCCCCCCCCCH
Confidence 8999999999754322111 11123446789999998654 35678999999999999998 9999976544
Q ss_pred HHHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCCChhHHhcC
Q 003052 716 FWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQH 764 (853)
Q Consensus 716 ~~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~H 764 (853)
......+.. ......+...+..+.+|+.+||..+|++||++.++++.
T Consensus 201 ~~~~~~~~~--~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~ 247 (250)
T cd05085 201 QQAREQVEK--GYRMSCPQKCPDDVYKVMQRCWDYKPENRPKFSELQKE 247 (250)
T ss_pred HHHHHHHHc--CCCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHH
Confidence 333332222 22233445577889999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=310.35 Aligned_cols=248 Identities=27% Similarity=0.431 Sum_probs=191.8
Q ss_pred eEEEeEeccCceEEEEEEec-----CCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHHH
Q 003052 475 QRLGKIGSGGSSEVHKVISS-----DCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLRE 549 (853)
Q Consensus 475 ~ilk~LG~G~FG~Vyka~~~-----~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~~ 549 (853)
.+.+.||.|.||.||+|... .+..|+||.++.. ........+.+|+++++++ +|+||+++++++
T Consensus 2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~-~~~~~~~~~~~e~~~l~~l-~h~ni~~~~g~~--------- 70 (259)
T PF07714_consen 2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPS-SSEEEEEEFLNEIQILRKL-RHPNIVKLYGFC--------- 70 (259)
T ss_dssp EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTT-SSHHHHHHHHHHHHHHHTH-SBTTBE-EEEEE---------
T ss_pred EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccc-cccccceeeeecccccccc-cccccccccccc---------
Confidence 46788999999999999876 2367999999653 3334467799999999999 599999999874
Q ss_pred HhhCCCCCCCCccccCCeEEEEEecch-hhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCCC
Q 003052 550 VLNGSMNNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKP 628 (853)
Q Consensus 550 l~~~~iv~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLKP 628 (853)
...+.+++||||+. ++|.+++... ....+++..+..|+.||+.||.|||+++|+|+||++
T Consensus 71 -------------~~~~~~~lv~e~~~~g~L~~~L~~~------~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~ 131 (259)
T PF07714_consen 71 -------------IENEPLFLVMEYCPGGSLDDYLKSK------NKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSP 131 (259)
T ss_dssp -------------ESSSSEEEEEE--TTEBHHHHHHHT------CTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SG
T ss_pred -------------ccccccccccccccccccccccccc------cccccccccccccccccccccccccccccccccccc
Confidence 34455899999986 6899998875 346799999999999999999999999999999999
Q ss_pred ccEEee-cCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHh-C
Q 003052 629 ANFLLV-KGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVY-G 706 (853)
Q Consensus 629 eNILL~-~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLt-G 706 (853)
.|||++ ++.+||+|||+++...............+...|+|||++.... ++.++||||||+++|||++ |
T Consensus 132 ~nill~~~~~~Kl~~f~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~---------~~~ksDVysfG~~l~ei~~~~ 202 (259)
T PF07714_consen 132 SNILLDSNGQVKLSDFGLSRPISEKSKYKNDSSQQLPLRYLAPEVLKDGE---------YTKKSDVYSFGMLLYEILTLG 202 (259)
T ss_dssp GGEEEETTTEEEEESTTTGEETTTSSSEEESTTSESGGGGS-HHHHHHSE---------ESHHHHHHHHHHHHHHHHTTS
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccc---------ccccccccccccccccccccc
Confidence 999995 6799999999998763322222233456778999999997653 5689999999999999999 7
Q ss_pred CCCCCcchhHHHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCCChhHHhc
Q 003052 707 RTPFSEYKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQ 763 (853)
Q Consensus 707 ~~PF~~~~~~~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~ 763 (853)
+.||.+......... +.. ......+...+.++.++|.+||..||.+||++.+|++
T Consensus 203 ~~p~~~~~~~~~~~~-~~~-~~~~~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~ 257 (259)
T PF07714_consen 203 KFPFSDYDNEEIIEK-LKQ-GQRLPIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQ 257 (259)
T ss_dssp SGTTTTSCHHHHHHH-HHT-TEETTSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHH
T ss_pred ccccccccccccccc-ccc-cccceeccchhHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence 899987644332222 222 2333445567888999999999999999999999985
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-35 Score=312.50 Aligned_cols=258 Identities=20% Similarity=0.300 Sum_probs=196.6
Q ss_pred CceeeEEEeEeccCceEEEEEEec------CCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHH
Q 003052 471 GKLYQRLGKIGSGGSSEVHKVISS------DCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEK 544 (853)
Q Consensus 471 g~~Y~ilk~LG~G~FG~Vyka~~~------~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~ 544 (853)
.++|++.+.||+|+||.||+|.+. ++..||+|++..... ......+.+|+.+++++. |+||++++++
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~ei~~l~~l~-h~~iv~~~~~----- 76 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEAS-ADMQADFQREAALMAEFD-HPNIVKLLGV----- 76 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcC-HHHHHHHHHHHHHHHhcC-CCchheEEEE-----
Confidence 356999999999999999999863 457899999875432 334456889999999997 8999999886
Q ss_pred HHHHHHhhCCCCCCCCccccCCeEEEEEecch-hhHHHHHHHhhhh--------------ccCCCCCCCHHHHHHHHHHh
Q 003052 545 ALLREVLNGSMNNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKE--------------MDGSNQTLDENWLRFYWQQI 609 (853)
Q Consensus 545 ~iL~~l~~~~iv~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~--------------~~~~~~~LsE~~~r~I~~QI 609 (853)
+.++..+|+||||+. ++|.+++...... .......+++..+..++.||
T Consensus 77 -----------------~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i 139 (288)
T cd05050 77 -----------------CAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQV 139 (288)
T ss_pred -----------------EcCCCccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHH
Confidence 344567899999966 5898888653211 11122458899999999999
Q ss_pred hhhhhhcccCceeeCCCCCccEEe-ecCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCC
Q 003052 610 LEAVNTIHEERIVHSDLKPANFLL-VKGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCG 688 (853)
Q Consensus 610 l~AL~yLHs~gIIHRDLKPeNILL-~~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys 688 (853)
+.||.|||++||+||||||+|||+ .++.+||+|||++..+.............++..|+|||.+.+. .++
T Consensus 140 ~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~---------~~~ 210 (288)
T cd05050 140 AAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYN---------RYT 210 (288)
T ss_pred HHHHHHHHhCCeecccccHhheEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcC---------CCC
Confidence 999999999999999999999999 5679999999999765432221112233456789999998654 356
Q ss_pred CccchhhhHHHHHHHHh-CCCCCCcchhHHHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCCChhHHhc
Q 003052 689 RPSDIWSLGCILYQMVY-GRTPFSEYKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQ 763 (853)
Q Consensus 689 ~ksDIWSLGVILyELLt-G~~PF~~~~~~~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~ 763 (853)
.++|||||||++|+|++ |..||.+.... .....+.... ....+...+..+.+||.+||..||.+||++.|+++
T Consensus 211 ~~~Dv~slG~il~el~~~~~~p~~~~~~~-~~~~~~~~~~-~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~ 284 (288)
T cd05050 211 TESDVWAYGVVLWEIFSYGMQPYYGMAHE-EVIYYVRDGN-VLSCPDNCPLELYNLMRLCWSKLPSDRPSFASINR 284 (288)
T ss_pred chhHHHHHHHHHHHHHhCCCCCCCCCCHH-HHHHHHhcCC-CCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 79999999999999997 88899764433 2222222221 12233456788999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-35 Score=315.59 Aligned_cols=259 Identities=18% Similarity=0.225 Sum_probs=180.3
Q ss_pred eeEEcCceeeEEEeEeccCceEEEEEEecC----CcEEEEEEEecCCCChhhHh---------hHHHHHHHHHHhcCCCc
Q 003052 466 FFKVNGKLYQRLGKIGSGGSSEVHKVISSD----CTIYALKKIKLKGRDYATAY---------GFCQEIEYLNKLKGKNN 532 (853)
Q Consensus 466 ~~~v~g~~Y~ilk~LG~G~FG~Vyka~~~~----g~~vAVKkik~~~~~~~~~~---------~~l~EI~iLkkL~~hpN 532 (853)
+.++.++.|++.++||+|+||.||+|...+ +..+|+|+............ ....+...+..+. |+|
T Consensus 6 ~~~i~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~-h~~ 84 (294)
T PHA02882 6 LIDITGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNID-HLG 84 (294)
T ss_pred eeccCCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCC-CCC
Confidence 345677889999999999999999998743 34566665543332211100 0111122222233 677
Q ss_pred eeEeeehhhhHHHHHHHHhhCCCCCCCCccccCCeEEEEEecchhhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhh
Q 003052 533 IIQLIDYEVTEKALLREVLNGSMNNKDGRVKDDGYIYMVLEYGEIDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEA 612 (853)
Q Consensus 533 IV~Lid~~~~e~~iL~~l~~~~iv~~~g~~~d~~~lyLVmEy~~gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~A 612 (853)
|++++++.... .....+.|++||++..++.+.+... ..+++..++.++.||+.|
T Consensus 85 i~~~~~~~~~~------------------~~~~~~~~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~i~~qi~~~ 138 (294)
T PHA02882 85 IPKYYGCGSFK------------------RCRMYYRFILLEKLVENTKEIFKRI--------KCKNKKLIKNIMKDMLTT 138 (294)
T ss_pred CCcEEEeeeEe------------------cCCceEEEEEEehhccCHHHHHHhh--------ccCCHHHHHHHHHHHHHH
Confidence 77777642211 0111256888998766666655432 346788899999999999
Q ss_pred hhhcccCceeeCCCCCccEEee-cCcEEEEecccchhcccCCcc-----ccccccccCccccCchhhccCCCCCCCcccc
Q 003052 613 VNTIHEERIVHSDLKPANFLLV-KGSLKLIDFGIAKAIMSDTTN-----IQRDSQVGTLSYMSPEAFMCNESDENGNIIK 686 (853)
Q Consensus 613 L~yLHs~gIIHRDLKPeNILL~-~g~VKL~DFGlAk~~~~~~~~-----~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ 686 (853)
|.|||+++|+||||||+|||++ ++.+||+|||+|+.+...... .......||+.|+|||++.+..
T Consensus 139 l~~lH~~~iiHrDiKp~Nill~~~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~--------- 209 (294)
T PHA02882 139 LEYIHEHGISHGDIKPENIMVDGNNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGAC--------- 209 (294)
T ss_pred HHHHHhCCeecCCCCHHHEEEcCCCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCC---------
Confidence 9999999999999999999994 579999999999876432211 1123457999999999987653
Q ss_pred CCCccchhhhHHHHHHHHhCCCCCCcchhHH--------HHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCh
Q 003052 687 CGRPSDIWSLGCILYQMVYGRTPFSEYKTFW--------AKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRI 758 (853)
Q Consensus 687 ys~ksDIWSLGVILyELLtG~~PF~~~~~~~--------~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa 758 (853)
|+.++|||||||++|||++|.+||.+..... ...+.+.... . .....+..+.+++..|+..+|.+||++
T Consensus 210 ~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~--~-~~~~~~~~~~~~~~~~~~~~~~~rp~~ 286 (294)
T PHA02882 210 VTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIHAAKCDFIKRLHEGK--I-KIKNANKFIYDFIECVTKLSYEEKPDY 286 (294)
T ss_pred CCcHHHHHHHHHHHHHHHhCCCCCCccccchHHHHHhHHHHHHHhhhhh--h-ccCCCCHHHHHHHHHHHhCCCCCCCCH
Confidence 5689999999999999999999997652211 1112222111 1 223456889999999999999999999
Q ss_pred hHHhc
Q 003052 759 PQLLQ 763 (853)
Q Consensus 759 ~EIL~ 763 (853)
.+|++
T Consensus 287 ~~l~~ 291 (294)
T PHA02882 287 DALIK 291 (294)
T ss_pred HHHHH
Confidence 99975
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=330.68 Aligned_cols=267 Identities=31% Similarity=0.519 Sum_probs=213.1
Q ss_pred cCceeeEEEeEeccCceEEEEEEe-cCCcEEEEEEEecCCC--C---hhhHhhHHHHHHHHHHhcCCCceeEeeehhhhH
Q 003052 470 NGKLYQRLGKIGSGGSSEVHKVIS-SDCTIYALKKIKLKGR--D---YATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTE 543 (853)
Q Consensus 470 ~g~~Y~ilk~LG~G~FG~Vyka~~-~~g~~vAVKkik~~~~--~---~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e 543 (853)
.+++|-++..||+|||+.||+|.+ ...+.||||+-..+.. + ....+..++|..|.+.|. ||.||++|||+.
T Consensus 461 Ln~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLD-HpRIVKlYDyfs-- 537 (775)
T KOG1151|consen 461 LNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELD-HPRIVKLYDYFS-- 537 (775)
T ss_pred hHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccC-cceeeeeeeeee--
Confidence 357899999999999999999998 4568899998755432 1 123345789999999998 899999999863
Q ss_pred HHHHHHHhhCCCCCCCCccccCCeEEEEEecchh-hHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccC--c
Q 003052 544 KALLREVLNGSMNNKDGRVKDDGYIYMVLEYGEI-DLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEE--R 620 (853)
Q Consensus 544 ~~iL~~l~~~~iv~~~g~~~d~~~lyLVmEy~~g-dL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~--g 620 (853)
-|...+|-|+|||+| ||..+++++ ..++|++++.|+.||+.||.||.+. .
T Consensus 538 -------------------lDtdsFCTVLEYceGNDLDFYLKQh--------klmSEKEARSIiMQiVnAL~YLNEikpP 590 (775)
T KOG1151|consen 538 -------------------LDTDSFCTVLEYCEGNDLDFYLKQH--------KLMSEKEARSIIMQIVNALKYLNEIKPP 590 (775)
T ss_pred -------------------eccccceeeeeecCCCchhHHHHhh--------hhhhHHHHHHHHHHHHHHHHHHhccCCC
Confidence 345678999999998 788888775 5799999999999999999999986 6
Q ss_pred eeeCCCCCccEEeec----CcEEEEecccchhcccCCccc-----cccccccCccccCchhhccCCCCCCCccccCCCcc
Q 003052 621 IVHSDLKPANFLLVK----GSLKLIDFGIAKAIMSDTTNI-----QRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPS 691 (853)
Q Consensus 621 IIHRDLKPeNILL~~----g~VKL~DFGlAk~~~~~~~~~-----~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ks 691 (853)
|||-||||.||||.+ |.|||.|||+++.+..+..+. ......||.||++||+|.-.... .+.+.++
T Consensus 591 IIHYDLKPgNILLv~GtacGeIKITDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkeP-----PKIsnKV 665 (775)
T KOG1151|consen 591 IIHYDLKPGNILLVNGTACGEIKITDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEP-----PKISNKV 665 (775)
T ss_pred eeeeccCCccEEEecCcccceeEeeecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCC-----Cccccce
Confidence 999999999999954 479999999999876543331 12346799999999998654222 2578899
Q ss_pred chhhhHHHHHHHHhCCCCCCcchhHHHHH---HhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCCChhHHhcCCCCC
Q 003052 692 DIWSLGCILYQMVYGRTPFSEYKTFWAKF---KVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQHPFLV 768 (853)
Q Consensus 692 DIWSLGVILyELLtG~~PF~~~~~~~~~~---kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~HPwf~ 768 (853)
||||+|||+|.+|+|+-||........++ -++......+...+.++.++++||++||++.-+.|+.+.++-.||||.
T Consensus 666 DVWSvGVIFyQClYGrKPFGhnqsQQdILqeNTIlkAtEVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~dpyll 745 (775)
T KOG1151|consen 666 DVWSVGVIFYQCLYGRKPFGHNQSQQDILQENTILKATEVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLACDPYLL 745 (775)
T ss_pred eeEeeehhhhhhhccCCCCCCchhHHHHHhhhchhcceeccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHccCcccc
Confidence 99999999999999999997643332222 223222333444567889999999999999999999999999999998
Q ss_pred CCC
Q 003052 769 PPV 771 (853)
Q Consensus 769 ~~~ 771 (853)
+..
T Consensus 746 Ph~ 748 (775)
T KOG1151|consen 746 PHI 748 (775)
T ss_pred chh
Confidence 754
|
|
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-35 Score=303.59 Aligned_cols=248 Identities=21% Similarity=0.328 Sum_probs=193.4
Q ss_pred ceeeEEEeEeccCceEEEEEEecCCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHHHHh
Q 003052 472 KLYQRLGKIGSGGSSEVHKVISSDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLREVL 551 (853)
Q Consensus 472 ~~Y~ilk~LG~G~FG~Vyka~~~~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~~l~ 551 (853)
..|++.+.||+|+||.||++.+.++..+|+|+++..... ...+.+|+++++++. |+||++++++
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~~---~~~~~~e~~~l~~l~-~~~i~~~~~~------------ 67 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAMS---EEDFIEEAQVMMKLS-HPKLVQLYGV------------ 67 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCCC---HHHHHHHHHHHHhCC-CCCeeeEEEE------------
Confidence 458999999999999999998877788999998754332 235789999999997 8999999886
Q ss_pred hCCCCCCCCccccCCeEEEEEecch-hhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCCCcc
Q 003052 552 NGSMNNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPAN 630 (853)
Q Consensus 552 ~~~iv~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLKPeN 630 (853)
+.....+|+||||+. ++|.+++... ...+++..++.++.|++.||+|||++||+||||||+|
T Consensus 68 ----------~~~~~~~~~v~e~~~~~~L~~~~~~~-------~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~n 130 (256)
T cd05112 68 ----------CTERSPICLVFEFMEHGCLSDYLRAQ-------RGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARN 130 (256)
T ss_pred ----------EccCCceEEEEEcCCCCcHHHHHHhC-------ccCCCHHHHHHHHHHHHHHHHHHHHCCccccccccce
Confidence 344567899999976 4777776542 2468899999999999999999999999999999999
Q ss_pred EEee-cCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHh-CCC
Q 003052 631 FLLV-KGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVY-GRT 708 (853)
Q Consensus 631 ILL~-~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLt-G~~ 708 (853)
|+++ ++.+||+|||+++........ ......++..|+|||.+.+.. ++.++|||||||++|||++ |+.
T Consensus 131 i~i~~~~~~~l~d~g~~~~~~~~~~~-~~~~~~~~~~~~aPe~~~~~~---------~~~~~Dv~slG~~l~el~~~g~~ 200 (256)
T cd05112 131 CLVGENQVVKVSDFGMTRFVLDDQYT-SSTGTKFPVKWSSPEVFSFSK---------YSSKSDVWSFGVLMWEVFSEGKT 200 (256)
T ss_pred EEEcCCCeEEECCCcceeecccCccc-ccCCCccchhhcCHhHhccCC---------cChHHHHHHHHHHHHHHHcCCCC
Confidence 9994 568999999999765432211 112234567899999987543 5679999999999999998 999
Q ss_pred CCCcchhHHHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCCChhHHhcC
Q 003052 709 PFSEYKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQH 764 (853)
Q Consensus 709 PF~~~~~~~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~H 764 (853)
||...... .....+... .....+...+..+.+|+.+||..+|.+||++.+++++
T Consensus 201 p~~~~~~~-~~~~~~~~~-~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~ 254 (256)
T cd05112 201 PYENRSNS-EVVETINAG-FRLYKPRLASQSVYELMQHCWKERPEDRPSFSLLLHQ 254 (256)
T ss_pred CCCcCCHH-HHHHHHhCC-CCCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHh
Confidence 99754332 222222221 1222234467889999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-35 Score=310.51 Aligned_cols=249 Identities=21% Similarity=0.328 Sum_probs=191.0
Q ss_pred ceeeEEEeEeccCceEEEEEEec-CCc----EEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHH
Q 003052 472 KLYQRLGKIGSGGSSEVHKVISS-DCT----IYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKAL 546 (853)
Q Consensus 472 ~~Y~ilk~LG~G~FG~Vyka~~~-~g~----~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~i 546 (853)
+.|++++.||+|+||.||+|.+. ++. .+++|.+.... .......+..|+.++.++. |+||+++++++
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~~~~~l~~l~-h~~iv~~~~~~------ 78 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRS-GRQTFQEITDHMLAMGSLD-HAYIVRLLGIC------ 78 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeeccccc-chHHHHHHHHHHHHHhcCC-CCCcceEEEEE------
Confidence 56899999999999999999873 443 47777775332 2233456778888888887 89999999863
Q ss_pred HHHHhhCCCCCCCCccccCCeEEEEEecch-hhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCC
Q 003052 547 LREVLNGSMNNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSD 625 (853)
Q Consensus 547 L~~l~~~~iv~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRD 625 (853)
....++++|||+. ++|.+++... ...+++..+..++.||+.||.|||++||+|||
T Consensus 79 -----------------~~~~~~~i~e~~~~gsL~~~l~~~-------~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~d 134 (279)
T cd05111 79 -----------------PGASLQLVTQLSPLGSLLDHVRQH-------RDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRN 134 (279)
T ss_pred -----------------CCCccEEEEEeCCCCcHHHHHHhc-------ccCCCHHHHHHHHHHHHHHHHHHHHCCEeccc
Confidence 1234678899955 6998888653 24689999999999999999999999999999
Q ss_pred CCCccEEee-cCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHH
Q 003052 626 LKPANFLLV-KGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMV 704 (853)
Q Consensus 626 LKPeNILL~-~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELL 704 (853)
|||+|||++ ++.+||+|||+++...............|+..|+|||.+.+. .++.++|||||||++|||+
T Consensus 135 lkp~nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~---------~~~~~~Dv~slG~il~el~ 205 (279)
T cd05111 135 LAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILFG---------RYTHQSDVWSYGVTVWEMM 205 (279)
T ss_pred cCcceEEEcCCCcEEEcCCccceeccCCCcccccCCCCCcccccCHHHhccC---------CcCchhhHHHHHHHHHHHH
Confidence 999999995 568999999999876433322223345678899999998654 3567999999999999999
Q ss_pred h-CCCCCCcchhHHHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCCChhHHhc
Q 003052 705 Y-GRTPFSEYKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQ 763 (853)
Q Consensus 705 t-G~~PF~~~~~~~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~ 763 (853)
+ |..||.+..... ....+.. ......+...+..+.+++.+||..||.+||++.|+++
T Consensus 206 t~g~~p~~~~~~~~-~~~~~~~-~~~~~~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~ 263 (279)
T cd05111 206 SYGAEPYAGMRPHE-VPDLLEK-GERLAQPQICTIDVYMVMVKCWMIDENVRPTFKELAN 263 (279)
T ss_pred cCCCCCCCCCCHHH-HHHHHHC-CCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 8 999997654322 2222222 2222333445677899999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-35 Score=307.12 Aligned_cols=251 Identities=23% Similarity=0.285 Sum_probs=194.9
Q ss_pred CceeeEEEeEeccCceEEEEEEec-C---CcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHH
Q 003052 471 GKLYQRLGKIGSGGSSEVHKVISS-D---CTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKAL 546 (853)
Q Consensus 471 g~~Y~ilk~LG~G~FG~Vyka~~~-~---g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~i 546 (853)
..+|++.+.||+|+||.||+|.+. + +..+|+|.++.... ......+.+|+.++++++ |+||++++++
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~e~~~l~~l~-h~~i~~~~~~------- 73 (267)
T cd05066 3 ASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYT-EKQRRDFLSEASIMGQFD-HPNIIHLEGV------- 73 (267)
T ss_pred HHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCC-HHHHHHHHHHHHHHHhCC-CCCcceEEEE-------
Confidence 356999999999999999999873 2 23799999875433 334557889999999997 8999999886
Q ss_pred HHHHhhCCCCCCCCccccCCeEEEEEecch-hhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCC
Q 003052 547 LREVLNGSMNNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSD 625 (853)
Q Consensus 547 L~~l~~~~iv~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRD 625 (853)
+.+++.+|+||||+. ++|.+++... ...+++..+..++.||+.||.|||++||+|||
T Consensus 74 ---------------~~~~~~~~lv~e~~~~~~L~~~~~~~-------~~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~d 131 (267)
T cd05066 74 ---------------VTKSKPVMIVTEYMENGSLDAFLRKH-------DGQFTVIQLVGMLRGIASGMKYLSDMGYVHRD 131 (267)
T ss_pred ---------------EecCCccEEEEEcCCCCCHHHHHHhc-------CCCCCHHHHHHHHHHHHHHHHHHHHCCEeehh
Confidence 345567899999986 5888877543 24689999999999999999999999999999
Q ss_pred CCCccEEe-ecCcEEEEecccchhcccCCcccc-ccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHH
Q 003052 626 LKPANFLL-VKGSLKLIDFGIAKAIMSDTTNIQ-RDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQM 703 (853)
Q Consensus 626 LKPeNILL-~~g~VKL~DFGlAk~~~~~~~~~~-~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyEL 703 (853)
|||+|||+ .++.+||+|||+++.+........ .....++..|+|||.+.+. .++.++|+|||||++|+|
T Consensus 132 lkp~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~---------~~~~~~Dv~slG~~l~el 202 (267)
T cd05066 132 LAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYR---------KFTSASDVWSYGIVMWEV 202 (267)
T ss_pred hchhcEEECCCCeEEeCCCCcccccccccceeeecCCCccceeecCHhHhccC---------ccCchhhhHHHHHHHHHH
Confidence 99999999 567899999999987644322111 1122345689999999754 356799999999999998
Q ss_pred Hh-CCCCCCcchhHHHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCCChhHHhc
Q 003052 704 VY-GRTPFSEYKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQ 763 (853)
Q Consensus 704 Lt-G~~PF~~~~~~~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~ 763 (853)
++ |..||.+..... ....+... .........++.+.+|+.+||+.+|.+||++.++++
T Consensus 203 l~~g~~p~~~~~~~~-~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 261 (267)
T cd05066 203 MSYGERPYWEMSNQD-VIKAIEEG-YRLPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVS 261 (267)
T ss_pred hcCCCCCcccCCHHH-HHHHHhCC-CcCCCCCCCCHHHHHHHHHHcccCchhCCCHHHHHH
Confidence 86 999997654432 22222222 222334456788999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=305.68 Aligned_cols=253 Identities=23% Similarity=0.340 Sum_probs=196.1
Q ss_pred EEcCceeeEEEeEeccCceEEEEEEecCC----cEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhH
Q 003052 468 KVNGKLYQRLGKIGSGGSSEVHKVISSDC----TIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTE 543 (853)
Q Consensus 468 ~v~g~~Y~ilk~LG~G~FG~Vyka~~~~g----~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e 543 (853)
++..+.|.+.++||+|+||.||+|.+.+. ..+|||.+..... ......+.+|+.+++++. |+||+++++++.
T Consensus 2 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~-~~~~~~~~~e~~~l~~~~-h~~i~~~~~~~~-- 77 (270)
T cd05056 2 EIQREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTS-PSVREKFLQEAYIMRQFD-HPHIVKLIGVIT-- 77 (270)
T ss_pred eechhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCC-HHHHHHHHHHHHHHHhCC-CCchhceeEEEc--
Confidence 34567799999999999999999987432 4689998865432 344557889999999997 899999988632
Q ss_pred HHHHHHHhhCCCCCCCCccccCCeEEEEEecch-hhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCcee
Q 003052 544 KALLREVLNGSMNNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIV 622 (853)
Q Consensus 544 ~~iL~~l~~~~iv~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gII 622 (853)
+...|+||||+. ++|.+++... ...+++..++.++.||+.||.|||++|++
T Consensus 78 ---------------------~~~~~lv~e~~~~~~L~~~l~~~-------~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ 129 (270)
T cd05056 78 ---------------------ENPVWIVMELAPLGELRSYLQVN-------KYSLDLASLILYSYQLSTALAYLESKRFV 129 (270)
T ss_pred ---------------------CCCcEEEEEcCCCCcHHHHHHhC-------CCCCCHHHHHHHHHHHHHHHHHHHhCCee
Confidence 234689999975 5898888653 23589999999999999999999999999
Q ss_pred eCCCCCccEEee-cCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHH
Q 003052 623 HSDLKPANFLLV-KGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILY 701 (853)
Q Consensus 623 HRDLKPeNILL~-~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILy 701 (853)
||||||+|||++ ++.+||+|||+++........ ......++..|+|||.+... .++.++|||||||++|
T Consensus 130 H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~---------~~~~~~Di~slG~il~ 199 (270)
T cd05056 130 HRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYY-KASKGKLPIKWMAPESINFR---------RFTSASDVWMFGVCMW 199 (270)
T ss_pred ccccChheEEEecCCCeEEccCceeeecccccce-ecCCCCccccccChhhhccC---------CCCchhhhHHHHHHHH
Confidence 999999999994 579999999999866443211 11223455689999988654 3567999999999999
Q ss_pred HHHh-CCCCCCcchhHHHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCCChhHHhcC
Q 003052 702 QMVY-GRTPFSEYKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQH 764 (853)
Q Consensus 702 ELLt-G~~PF~~~~~~~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~H 764 (853)
+|++ |..||...........+... .....+...+..+.+||.+||..+|.+|||+.+++..
T Consensus 200 el~~~g~~pf~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~ 261 (270)
T cd05056 200 EILMLGVKPFQGVKNNDVIGRIENG--ERLPMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQ 261 (270)
T ss_pred HHHHcCCCCCCCCCHHHHHHHHHcC--CcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 9986 99999765543333222221 2223445677889999999999999999999998853
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-35 Score=306.19 Aligned_cols=250 Identities=22% Similarity=0.279 Sum_probs=193.6
Q ss_pred ceeeEEEeEeccCceEEEEEEec-CC---cEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHH
Q 003052 472 KLYQRLGKIGSGGSSEVHKVISS-DC---TIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALL 547 (853)
Q Consensus 472 ~~Y~ilk~LG~G~FG~Vyka~~~-~g---~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL 547 (853)
..|++.+.||+|+||.||+|... ++ ..||||.++... .......|..|+.+++++. |+||++++++
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~-h~ni~~~~~~-------- 73 (269)
T cd05065 4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGY-TEKQRRDFLSEASIMGQFD-HPNIIHLEGV-------- 73 (269)
T ss_pred HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCC-CHHHHHHHHHHHHHHHhCC-CcCcceEEEE--------
Confidence 45899999999999999999874 33 369999987543 3344567899999999997 8999999886
Q ss_pred HHHhhCCCCCCCCccccCCeEEEEEecch-hhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCC
Q 003052 548 REVLNGSMNNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDL 626 (853)
Q Consensus 548 ~~l~~~~iv~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDL 626 (853)
+.++..+|+||||++ ++|.+++... ...+++..++.++.|++.||.|||++||+||||
T Consensus 74 --------------~~~~~~~~lv~e~~~~~~L~~~l~~~-------~~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl 132 (269)
T cd05065 74 --------------VTKSRPVMIITEFMENGALDSFLRQN-------DGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDL 132 (269)
T ss_pred --------------ECCCCceEEEEecCCCCcHHHHHhhC-------CCCCCHHHHHHHHHHHHHHHHHHHHCCEeeccc
Confidence 345667899999976 4787777543 246899999999999999999999999999999
Q ss_pred CCccEEee-cCcEEEEecccchhcccCCccccccccc---cCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHH
Q 003052 627 KPANFLLV-KGSLKLIDFGIAKAIMSDTTNIQRDSQV---GTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQ 702 (853)
Q Consensus 627 KPeNILL~-~g~VKL~DFGlAk~~~~~~~~~~~~t~~---GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyE 702 (853)
||+||+++ ++.+||+|||+++............... ++..|+|||.+.+.. ++.++|||||||++||
T Consensus 133 ~p~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~---------~~~~~DvwslG~~l~e 203 (269)
T cd05065 133 AARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYRK---------FTSASDVWSYGIVMWE 203 (269)
T ss_pred ChheEEEcCCCcEEECCCccccccccCccccccccccCCCcceeecCHhHhccCc---------ccchhhhhhhHHHHHH
Confidence 99999994 5699999999997654322211111112 245799999987543 5679999999999999
Q ss_pred HHh-CCCCCCcchhHHHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCCChhHHhc
Q 003052 703 MVY-GRTPFSEYKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQ 763 (853)
Q Consensus 703 LLt-G~~PF~~~~~~~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~ 763 (853)
|++ |..||...........+.. ......+...+..+.+++.+||..+|.+||++.+|+.
T Consensus 204 ~l~~g~~p~~~~~~~~~~~~i~~--~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 263 (269)
T cd05065 204 VMSYGERPYWDMSNQDVINAIEQ--DYRLPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVS 263 (269)
T ss_pred HhcCCCCCCCCCCHHHHHHHHHc--CCcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 886 9999976544322222221 2233334456788999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-35 Score=353.58 Aligned_cols=261 Identities=25% Similarity=0.359 Sum_probs=196.9
Q ss_pred ceeeEEEeEeccCceEEEEEEec-CCcEEEEEEEecCCC-ChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHHH
Q 003052 472 KLYQRLGKIGSGGSSEVHKVISS-DCTIYALKKIKLKGR-DYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLRE 549 (853)
Q Consensus 472 ~~Y~ilk~LG~G~FG~Vyka~~~-~g~~vAVKkik~~~~-~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~~ 549 (853)
.+|++.++||+|+||.||+|.+. +++.||||++..... .......+.+|+++++++. ||||++++++
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~-HPNIVkl~~v---------- 70 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLI-HPGIVPVYSI---------- 70 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCC-CcCcCeEEEE----------
Confidence 46999999999999999999984 678999999975433 2334557899999999998 8999999876
Q ss_pred HhhCCCCCCCCccccCCeEEEEEecch-hhHHHHHHHhhhhcc---CCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCC
Q 003052 550 VLNGSMNNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEMD---GSNQTLDENWLRFYWQQILEAVNTIHEERIVHSD 625 (853)
Q Consensus 550 l~~~~iv~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~~~---~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRD 625 (853)
+.+++.+|+||||++ ++|.+++...+.... .....++...+..++.||+.||+|||++||+|||
T Consensus 71 ------------~~d~~~lyLVMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRD 138 (932)
T PRK13184 71 ------------CSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRD 138 (932)
T ss_pred ------------EeeCCEEEEEEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccC
Confidence 456678999999976 588888875432110 1123466778899999999999999999999999
Q ss_pred CCCccEEe-ecCcEEEEecccchhcccCCc----------------cccccccccCccccCchhhccCCCCCCCccccCC
Q 003052 626 LKPANFLL-VKGSLKLIDFGIAKAIMSDTT----------------NIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCG 688 (853)
Q Consensus 626 LKPeNILL-~~g~VKL~DFGlAk~~~~~~~----------------~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys 688 (853)
|||+|||+ .+|.+||+|||+|+....... .......+||+.|||||++.+.. ++
T Consensus 139 LKPeNILLd~dg~vKLiDFGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~---------~S 209 (932)
T PRK13184 139 LKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVP---------AS 209 (932)
T ss_pred CchheEEEcCCCCEEEEecCcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCC---------CC
Confidence 99999999 467999999999986521100 00112357999999999987653 56
Q ss_pred CccchhhhHHHHHHHHhCCCCCCcchhHHHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCCChhHHhcC
Q 003052 689 RPSDIWSLGCILYQMVYGRTPFSEYKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQH 764 (853)
Q Consensus 689 ~ksDIWSLGVILyELLtG~~PF~~~~~~~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~H 764 (853)
.++|||||||++|||++|+.||..........................++.+.+++.+||..||.+|++..+.|.+
T Consensus 210 ~kSDIWSLGVILyELLTG~~PF~~~~~~ki~~~~~i~~P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~ 285 (932)
T PRK13184 210 ESTDIYALGVILYQMLTLSFPYRRKKGRKISYRDVILSPIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQ 285 (932)
T ss_pred cHhHHHHHHHHHHHHHHCCCCCCCcchhhhhhhhhccChhhccccccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 7999999999999999999999764332222211111111111123567789999999999999999876665543
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-36 Score=337.00 Aligned_cols=260 Identities=27% Similarity=0.449 Sum_probs=199.4
Q ss_pred EcCceeeEEEeEeccCceEEEEEEecC-CcEEEEEEEecCCC-ChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHH
Q 003052 469 VNGKLYQRLGKIGSGGSSEVHKVISSD-CTIYALKKIKLKGR-DYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKAL 546 (853)
Q Consensus 469 v~g~~Y~ilk~LG~G~FG~Vyka~~~~-g~~vAVKkik~~~~-~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~i 546 (853)
.+...|..++.||-|+||+|.++...| ...||+|.+.+..- .......+..|-.||.... .+-||+|
T Consensus 626 MdKSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEAD-n~WVVrL---------- 694 (1034)
T KOG0608|consen 626 MDKSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEAD-NEWVVRL---------- 694 (1034)
T ss_pred ccccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcC-CcceEEE----------
Confidence 445679999999999999999998744 47899999865421 1112223344555555444 3445554
Q ss_pred HHHHhhCCCCCCCCccccCCeEEEEEecc-hhhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCC
Q 003052 547 LREVLNGSMNNKDGRVKDDGYIYMVLEYG-EIDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSD 625 (853)
Q Consensus 547 L~~l~~~~iv~~~g~~~d~~~lyLVmEy~-~gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRD 625 (853)
+..|+|.+.+|+||||. |||+..+|.+. +.|.|..+++|+.++..|+++.|..|+||||
T Consensus 695 ------------yySFQDkdnLYFVMdYIPGGDmMSLLIrm--------gIFeE~LARFYIAEltcAiesVHkmGFIHRD 754 (1034)
T KOG0608|consen 695 ------------YYSFQDKDNLYFVMDYIPGGDMMSLLIRM--------GIFEEDLARFYIAELTCAIESVHKMGFIHRD 754 (1034)
T ss_pred ------------EEEeccCCceEEEEeccCCccHHHHHHHh--------ccCHHHHHHHHHHHHHHHHHHHHhccceecc
Confidence 45699999999999995 46999988876 7899999999999999999999999999999
Q ss_pred CCCccEEee-cCcEEEEecccchhccc--C------Ccc--------------------------------ccccccccC
Q 003052 626 LKPANFLLV-KGSLKLIDFGIAKAIMS--D------TTN--------------------------------IQRDSQVGT 664 (853)
Q Consensus 626 LKPeNILL~-~g~VKL~DFGlAk~~~~--~------~~~--------------------------------~~~~t~~GT 664 (853)
|||+||||+ +|+|||.|||||.-+.- + ... ......+||
T Consensus 755 iKPDNILIDrdGHIKLTDFGLCTGfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt 834 (1034)
T KOG0608|consen 755 IKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGT 834 (1034)
T ss_pred cCccceEEccCCceeeeeccccccceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCC
Confidence 999999994 78999999999964321 0 000 001246899
Q ss_pred ccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHhCCCCCCcchhHHHHHHhh-cCCCCcccCCCCCChhHHHH
Q 003052 665 LSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGRTPFSEYKTFWAKFKVI-TDPNHEITYEPVPNPWLLDL 743 (853)
Q Consensus 665 p~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLtG~~PF~~~~~~~~~~kii-~~~~~~~~~~~~~s~~l~dL 743 (853)
+.|+|||++.... |+..+||||.|||||||+.|++||-...+....++++ ......+.+...+++++.+|
T Consensus 835 ~nyiapevl~r~g---------~~q~cdwws~gvil~em~~g~~pf~~~tp~~tq~kv~nw~~~l~~~~~~~ls~e~~~l 905 (1034)
T KOG0608|consen 835 PNYIAPEVLARTG---------YTQLCDWWSVGVILYEMLVGQPPFLADTPGETQYKVINWRNFLHIPYQGNLSKEALDL 905 (1034)
T ss_pred CcccChHHhcccC---------ccccchhhHhhHHHHHHhhCCCCccCCCCCcceeeeeehhhccccccccccCHHHHHH
Confidence 9999999998764 5578999999999999999999997665554444443 22345566777889999999
Q ss_pred HHHhcccCCCCCC---ChhHHhcCCCCCC
Q 003052 744 MKKCLAWDRNERW---RIPQLLQHPFLVP 769 (853)
Q Consensus 744 I~kcL~~DP~kRp---Ta~EIL~HPwf~~ 769 (853)
|.++. .+++.|. .++||-.||||+.
T Consensus 906 i~kLc-~sad~RLGkng~d~vKaHpfFkg 933 (1034)
T KOG0608|consen 906 IQKLC-CSADSRLGKNGADQVKAHPFFKG 933 (1034)
T ss_pred HHHHh-cChhhhhcccchhhhhcCccccc
Confidence 99865 4788887 4788999999974
|
|
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-35 Score=303.93 Aligned_cols=245 Identities=21% Similarity=0.278 Sum_probs=192.1
Q ss_pred EeEeccCceEEEEEEecC--C--cEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHHHHhhC
Q 003052 478 GKIGSGGSSEVHKVISSD--C--TIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLREVLNG 553 (853)
Q Consensus 478 k~LG~G~FG~Vyka~~~~--g--~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~~l~~~ 553 (853)
+.||+|+||.||+|.+.+ + ..||||.+...... .....+.+|+.++++++ |+||+++++++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~l~~l~-h~~iv~~~~~~------------- 65 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS-DIMDDFLKEAAIMHSLD-HENLIRLYGVV------------- 65 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccH-HHHHHHHHHHHHHhhcC-CCCccceeEEE-------------
Confidence 358999999999998743 3 36899999876544 55667899999999997 89999998763
Q ss_pred CCCCCCCccccCCeEEEEEecch-hhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCCCccEE
Q 003052 554 SMNNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANFL 632 (853)
Q Consensus 554 ~iv~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLKPeNIL 632 (853)
.+ ..+|+||||+. ++|.+.+.... ...+++..++.++.||+.||.|||++||+||||||+||+
T Consensus 66 ---------~~-~~~~~v~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil 129 (257)
T cd05040 66 ---------LT-HPLMMVTELAPLGSLLDRLRKDA------LGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNIL 129 (257)
T ss_pred ---------cC-CeEEEEEEecCCCcHHHHHHhcc------cccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEE
Confidence 23 67899999975 68988886541 146899999999999999999999999999999999999
Q ss_pred e-ecCcEEEEecccchhcccCCccc-cccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHh-CCCC
Q 003052 633 L-VKGSLKLIDFGIAKAIMSDTTNI-QRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVY-GRTP 709 (853)
Q Consensus 633 L-~~g~VKL~DFGlAk~~~~~~~~~-~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLt-G~~P 709 (853)
+ .++.+||+|||+++.+....... ......++..|+|||.+.+. .++.++|||||||++|+|++ |+.|
T Consensus 130 ~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~---------~~~~~~Di~slG~~l~el~t~g~~p 200 (257)
T cd05040 130 LASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLRTR---------TFSHASDVWMFGVTLWEMFTYGEEP 200 (257)
T ss_pred EecCCEEEeccccccccccccccceecccCCCCCceecCHHHhccc---------CcCchhhhHHHHHHHHHHHhCCCCC
Confidence 9 46799999999998765422211 11234678899999998654 35678999999999999998 9999
Q ss_pred CCcchhHHHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCCChhHHhc
Q 003052 710 FSEYKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQ 763 (853)
Q Consensus 710 F~~~~~~~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~ 763 (853)
|...........+.. .......+...+..+.+++.+||..+|.+||++.++++
T Consensus 201 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~ 253 (257)
T cd05040 201 WAGLSGSQILKKIDK-EGERLERPEACPQDIYNVMLQCWAHNPADRPTFAALRE 253 (257)
T ss_pred CCCCCHHHHHHHHHh-cCCcCCCCccCCHHHHHHHHHHCCCCcccCCCHHHHHH
Confidence 976544332222221 22223334456788999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-35 Score=311.65 Aligned_cols=255 Identities=22% Similarity=0.322 Sum_probs=194.1
Q ss_pred CceeeEEEeEeccCceEEEEEEe-----cCCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHH
Q 003052 471 GKLYQRLGKIGSGGSSEVHKVIS-----SDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKA 545 (853)
Q Consensus 471 g~~Y~ilk~LG~G~FG~Vyka~~-----~~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~ 545 (853)
++.|+++++||+|+||.||+|.. .++..||+|.++.... ......+.+|+.+|+++. |+||+++++++..
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~-~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~--- 77 (284)
T cd05079 3 KRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESG-GNHIADLKKEIEILRNLY-HENIVKYKGICTE--- 77 (284)
T ss_pred hhhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCcccc-HHHHHHHHHHHHHHHhCC-CCCeeeeeeEEec---
Confidence 45689999999999999999974 3567899999875432 334457889999999997 8999999876321
Q ss_pred HHHHHhhCCCCCCCCccccCCeEEEEEecch-hhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeC
Q 003052 546 LLREVLNGSMNNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHS 624 (853)
Q Consensus 546 iL~~l~~~~iv~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHR 624 (853)
.+...+|+||||+. ++|.+++.+. ...+++..+..++.||+.||+|||++||+||
T Consensus 78 -----------------~~~~~~~lv~e~~~g~~L~~~l~~~-------~~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~ 133 (284)
T cd05079 78 -----------------DGGNGIKLIMEFLPSGSLKEYLPRN-------KNKINLKQQLKYAVQICKGMDYLGSRQYVHR 133 (284)
T ss_pred -----------------CCCCceEEEEEccCCCCHHHHHHhc-------cCCCCHHHHHHHHHHHHHHHHHHHHCCeeec
Confidence 12356899999975 5888887543 2358999999999999999999999999999
Q ss_pred CCCCccEEe-ecCcEEEEecccchhcccCCcc-ccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHH
Q 003052 625 DLKPANFLL-VKGSLKLIDFGIAKAIMSDTTN-IQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQ 702 (853)
Q Consensus 625 DLKPeNILL-~~g~VKL~DFGlAk~~~~~~~~-~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyE 702 (853)
||||+|||+ .++.+||+|||+++.+...... .......|+..|+|||++.+. .++.++|||||||++|+
T Consensus 134 dlkp~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~---------~~~~~~Di~slG~il~e 204 (284)
T cd05079 134 DLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQS---------KFYIASDVWSFGVTLYE 204 (284)
T ss_pred ccchheEEEcCCCCEEECCCccccccccCccceeecCCCCCCccccCHHHhccC---------CCCccccchhhhhhhhh
Confidence 999999999 5678999999999876433221 112245678889999998654 25679999999999999
Q ss_pred HHhCCCCCCcchh--------------HHHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCCChhHHhcC
Q 003052 703 MVYGRTPFSEYKT--------------FWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQH 764 (853)
Q Consensus 703 LLtG~~PF~~~~~--------------~~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~H 764 (853)
|++++.|+..... .......+.. ......+...+..+.+||.+||..||.+||++.+++++
T Consensus 205 llt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 279 (284)
T cd05079 205 LLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRVLEE-GKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEG 279 (284)
T ss_pred hhcCCCCCccccchhhhhcccccccccHHHHHHHHHc-CccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence 9998776532110 0111111111 11222344567889999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-35 Score=306.60 Aligned_cols=258 Identities=21% Similarity=0.338 Sum_probs=197.7
Q ss_pred ceeeEEEeEeccCceEEEEEEec------CCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHH
Q 003052 472 KLYQRLGKIGSGGSSEVHKVISS------DCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKA 545 (853)
Q Consensus 472 ~~Y~ilk~LG~G~FG~Vyka~~~------~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~ 545 (853)
+.|++++.||+|+||.||+|+.+ +.+.+|+|.+.... .......+.+|+++|+++. |+||++++++
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~------ 76 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTK-DENLQSEFRRELDMFRKLS-HKNVVRLLGL------ 76 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCcc-chHHHHHHHHHHHHHHhcC-CcceeeeEEE------
Confidence 56899999999999999999863 23678999886532 2234556889999999996 8999999986
Q ss_pred HHHHHhhCCCCCCCCccccCCeEEEEEecch-hhHHHHHHHhhhhcc-CCCCCCCHHHHHHHHHHhhhhhhhcccCceee
Q 003052 546 LLREVLNGSMNNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEMD-GSNQTLDENWLRFYWQQILEAVNTIHEERIVH 623 (853)
Q Consensus 546 iL~~l~~~~iv~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~~~-~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIH 623 (853)
+.+....|+||||++ ++|.+++........ .....+++..+..++.||+.||.|||++||+|
T Consensus 77 ----------------~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H 140 (275)
T cd05046 77 ----------------CREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVH 140 (275)
T ss_pred ----------------ECCCCcceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCccc
Confidence 345567899999986 589888865421100 01126899999999999999999999999999
Q ss_pred CCCCCccEEe-ecCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHH
Q 003052 624 SDLKPANFLL-VKGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQ 702 (853)
Q Consensus 624 RDLKPeNILL-~~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyE 702 (853)
|||||+|||+ .++.++|+|||+++...... ........++..|+|||.+.+.. ++.++|||||||++|+
T Consensus 141 ~dlkp~Nili~~~~~~~l~~~~~~~~~~~~~-~~~~~~~~~~~~y~~PE~~~~~~---------~~~~~Di~slG~~l~~ 210 (275)
T cd05046 141 RDLAARNCLVSSQREVKVSLLSLSKDVYNSE-YYKLRNALIPLRWLAPEAVQEDD---------FSTKSDVWSFGVLMWE 210 (275)
T ss_pred CcCccceEEEeCCCcEEEcccccccccCccc-ccccCCceeEEeecChhhhccCC---------CCchhhHHHHHHHHHH
Confidence 9999999999 56799999999987543221 11223446778899999986543 4578999999999999
Q ss_pred HHh-CCCCCCcchhHHHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCCChhHHhcC
Q 003052 703 MVY-GRTPFSEYKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQH 764 (853)
Q Consensus 703 LLt-G~~PF~~~~~~~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~H 764 (853)
|++ |..||.+..... ..................+..+.++|.+||..||.+||++.+++.+
T Consensus 211 l~~~~~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~ 272 (275)
T cd05046 211 VFTQGELPFYGLSDEE-VLNRLQAGKLELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSA 272 (275)
T ss_pred HHhCCCCCccccchHH-HHHHHHcCCcCCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHH
Confidence 998 899997644332 2222222222333445677889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=302.82 Aligned_cols=242 Identities=21% Similarity=0.314 Sum_probs=188.3
Q ss_pred EeEeccCceEEEEEEec--C--CcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHHHHhhC
Q 003052 478 GKIGSGGSSEVHKVISS--D--CTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLREVLNG 553 (853)
Q Consensus 478 k~LG~G~FG~Vyka~~~--~--g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~~l~~~ 553 (853)
++||+|+||.||+|... + +..+|+|.+...... .....+.+|+.+++++. |+||+++++++.
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~------------ 66 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIA-AGKKEFLREASVMAQLD-HPCIVRLIGVCK------------ 66 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccch-HHHHHHHHHHHHHHhcC-CCCeeeEEEEEc------------
Confidence 36999999999999762 2 268999999865443 34456889999999997 899999988631
Q ss_pred CCCCCCCccccCCeEEEEEecch-hhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCCCccEE
Q 003052 554 SMNNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANFL 632 (853)
Q Consensus 554 ~iv~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLKPeNIL 632 (853)
...+++||||+. ++|.+++... ..+++..+..++.||+.||.|||.+||+||||||+|||
T Consensus 67 -----------~~~~~~v~e~~~~~~L~~~l~~~--------~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nil 127 (257)
T cd05060 67 -----------GEPLMLVMELAPLGPLLKYLKKR--------REIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVL 127 (257)
T ss_pred -----------CCceEEEEEeCCCCcHHHHHHhC--------CCCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEE
Confidence 235799999965 5888888653 36899999999999999999999999999999999999
Q ss_pred e-ecCcEEEEecccchhcccCCcccc-ccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHh-CCCC
Q 003052 633 L-VKGSLKLIDFGIAKAIMSDTTNIQ-RDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVY-GRTP 709 (853)
Q Consensus 633 L-~~g~VKL~DFGlAk~~~~~~~~~~-~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLt-G~~P 709 (853)
+ .++.+||+|||+++.......... .....++..|+|||.+.+. .++.++|||||||++|+|++ |.+|
T Consensus 128 i~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~---------~~~~~~Di~slG~~l~~~~~~g~~p 198 (257)
T cd05060 128 LVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINYG---------KFSSKSDVWSYGVTLWEAFSYGAKP 198 (257)
T ss_pred EcCCCcEEeccccccceeecCCcccccccCccccccccCHHHhcCC---------CCCccchHHHHHHHHHHHHcCCCCC
Confidence 9 567999999999987643322111 1112235689999998654 35679999999999999997 9999
Q ss_pred CCcchhHHHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCCChhHHhc
Q 003052 710 FSEYKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQ 763 (853)
Q Consensus 710 F~~~~~~~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~ 763 (853)
|...... .....+.. ......+...+..+.+||.+||..||.+||++.++++
T Consensus 199 ~~~~~~~-~~~~~~~~-~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~ 250 (257)
T cd05060 199 YGEMKGA-EVIAMLES-GERLPRPEECPQEIYSIMLSCWKYRPEDRPTFSELES 250 (257)
T ss_pred cccCCHH-HHHHHHHc-CCcCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 9765443 22222322 2223345567788999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=306.22 Aligned_cols=248 Identities=23% Similarity=0.368 Sum_probs=186.7
Q ss_pred eEeccCceEEEEEEec-CCc--EEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHHHHhhCCC
Q 003052 479 KIGSGGSSEVHKVISS-DCT--IYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLREVLNGSM 555 (853)
Q Consensus 479 ~LG~G~FG~Vyka~~~-~g~--~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~~l~~~~i 555 (853)
.||+|+||.||+|... ++. .+|+|.++.. ........+.+|++++.++.+|+||+++++++
T Consensus 2 ~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~--------------- 65 (270)
T cd05047 2 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY-ASKDDHRDFAGELEVLCKLGHHPNIINLLGAC--------------- 65 (270)
T ss_pred cCCCCCCceEEEEEEcCCCCeeEEEEEEcccc-CCHHHHHHHHHHHHHHHhhccCCCeeeEEEEE---------------
Confidence 5899999999999984 343 4678877633 22344456889999999998899999999873
Q ss_pred CCCCCccccCCeEEEEEecch-hhHHHHHHHhhhh--------ccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCC
Q 003052 556 NNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKE--------MDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDL 626 (853)
Q Consensus 556 v~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~--------~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDL 626 (853)
...+.+|+||||+. ++|.+++...... .......+++..++.++.||+.||+|||++||+||||
T Consensus 66 -------~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~di 138 (270)
T cd05047 66 -------EHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDL 138 (270)
T ss_pred -------ecCCCceEEEEeCCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeeccc
Confidence 44567899999975 6899888653210 0112245899999999999999999999999999999
Q ss_pred CCccEEe-ecCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHh
Q 003052 627 KPANFLL-VKGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVY 705 (853)
Q Consensus 627 KPeNILL-~~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLt 705 (853)
||+|||+ .++.+||+|||++...... ........+..|+|||++... .++.++|||||||++|||++
T Consensus 139 kp~nili~~~~~~kl~dfgl~~~~~~~---~~~~~~~~~~~y~apE~~~~~---------~~~~~~Di~slG~il~el~~ 206 (270)
T cd05047 139 AARNILVGENYVAKIADFGLSRGQEVY---VKKTMGRLPVRWMAIESLNYS---------VYTTNSDVWSYGVLLWEIVS 206 (270)
T ss_pred ccceEEEcCCCeEEECCCCCccccchh---hhccCCCCccccCChHHHccC---------CCCchhhHHHHHHHHHHHHc
Confidence 9999999 5679999999998643211 111123346679999998654 35679999999999999996
Q ss_pred -CCCCCCcchhHHHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCCChhHHhc
Q 003052 706 -GRTPFSEYKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQ 763 (853)
Q Consensus 706 -G~~PF~~~~~~~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~ 763 (853)
|..||.+.... ..+..+.. ......+...+..+.+|+.+||..||.+||++.+++.
T Consensus 207 ~g~~pf~~~~~~-~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 263 (270)
T cd05047 207 LGGTPYCGMTCA-ELYEKLPQ-GYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILV 263 (270)
T ss_pred CCCCCccccCHH-HHHHHHhC-CCCCCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHH
Confidence 99999654332 22222221 1222234456778999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=306.76 Aligned_cols=252 Identities=23% Similarity=0.355 Sum_probs=191.7
Q ss_pred ceeeEEEeEeccCceEEEEEEe-----cCCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHH
Q 003052 472 KLYQRLGKIGSGGSSEVHKVIS-----SDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKAL 546 (853)
Q Consensus 472 ~~Y~ilk~LG~G~FG~Vyka~~-----~~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~i 546 (853)
..|++++.||+|+||.||+|.. .++..||+|++.... ......+.+|+++|++++ |+||+++++++.
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~----- 75 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHST--AEHLRDFEREIEILKSLQ-HDNIVKYKGVCY----- 75 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCC--HHHHHHHHHHHHHHHhCC-CCCeeEEEEEEc-----
Confidence 5699999999999999999974 356889999987543 334456889999999997 899999988632
Q ss_pred HHHHhhCCCCCCCCccccCCeEEEEEecch-hhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCC
Q 003052 547 LREVLNGSMNNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSD 625 (853)
Q Consensus 547 L~~l~~~~iv~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRD 625 (853)
..+...+|+||||+. ++|.+++... ...+++..++.++.||+.||.|||++||+|||
T Consensus 76 ---------------~~~~~~~~lv~e~~~~~~L~~~l~~~-------~~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~d 133 (284)
T cd05081 76 ---------------SAGRRNLRLVMEYLPYGSLRDYLQKH-------RERLDHRKLLLYASQICKGMEYLGSKRYVHRD 133 (284)
T ss_pred ---------------cCCCCceEEEEEecCCCCHHHHHHhc-------CcCCCHHHHHHHHHHHHHHHHHHHHCCceecc
Confidence 123456899999975 6898888643 24689999999999999999999999999999
Q ss_pred CCCccEEe-ecCcEEEEecccchhcccCCcccc-ccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHH
Q 003052 626 LKPANFLL-VKGSLKLIDFGIAKAIMSDTTNIQ-RDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQM 703 (853)
Q Consensus 626 LKPeNILL-~~g~VKL~DFGlAk~~~~~~~~~~-~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyEL 703 (853)
|||+|||+ .++.+||+|||+++.......... .....++..|+|||++.+. .++.++|||||||++|||
T Consensus 134 lkp~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~---------~~~~~~Di~slG~~l~el 204 (284)
T cd05081 134 LATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPESLTES---------KFSVASDVWSFGVVLYEL 204 (284)
T ss_pred CCHhhEEECCCCeEEECCCcccccccCCCcceeecCCCCCceEeeCHHHhccC---------CcChHHHHHHHHHHHHHH
Confidence 99999999 467899999999987643322111 1122345569999998654 356799999999999999
Q ss_pred HhCCCCCCcchhHHH---------------HHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCCChhHHhc
Q 003052 704 VYGRTPFSEYKTFWA---------------KFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQ 763 (853)
Q Consensus 704 LtG~~PF~~~~~~~~---------------~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~ 763 (853)
++|..++......+. ....+.. ..........+..+.+||.+||..+|++|||+.+|++
T Consensus 205 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 278 (284)
T cd05081 205 FTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIELLKN-NGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELAL 278 (284)
T ss_pred hhcCCcCCCcchhhhhhcccccccccchHHHHHHHhc-CCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 998877643221110 0111111 1222334456788999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=305.72 Aligned_cols=251 Identities=17% Similarity=0.309 Sum_probs=195.2
Q ss_pred cCceeeEEEeEeccCceEEEEEEec-CC----cEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHH
Q 003052 470 NGKLYQRLGKIGSGGSSEVHKVISS-DC----TIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEK 544 (853)
Q Consensus 470 ~g~~Y~ilk~LG~G~FG~Vyka~~~-~g----~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~ 544 (853)
....|++.+.||+|+||.||+|... ++ ..+|+|.+..... ......+.+|+.+++++. |+||+++++++.
T Consensus 5 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~-~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~--- 79 (279)
T cd05057 5 KETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETS-PKANKEILDEAYVMASVD-HPHVVRLLGICL--- 79 (279)
T ss_pred CHHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCC-HHHHHHHHHHHHHHHhCC-CCCcceEEEEEe---
Confidence 3467999999999999999999863 33 2589998875533 344556889999999996 899999998732
Q ss_pred HHHHHHhhCCCCCCCCccccCCeEEEEEecch-hhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceee
Q 003052 545 ALLREVLNGSMNNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVH 623 (853)
Q Consensus 545 ~iL~~l~~~~iv~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIH 623 (853)
. ..+++||||+. ++|.+++... ...+++..+..++.||+.||+|||++||+|
T Consensus 80 -------------------~-~~~~~v~e~~~~g~L~~~l~~~-------~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H 132 (279)
T cd05057 80 -------------------S-SQVQLITQLMPLGCLLDYVRNH-------KDNIGSQYLLNWCVQIAKGMSYLEEKRLVH 132 (279)
T ss_pred -------------------c-CceEEEEecCCCCcHHHHHHhc-------cCCCCHHHHHHHHHHHHHHHHHHHhCCEEe
Confidence 2 46799999965 5888887653 245899999999999999999999999999
Q ss_pred CCCCCccEEe-ecCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHH
Q 003052 624 SDLKPANFLL-VKGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQ 702 (853)
Q Consensus 624 RDLKPeNILL-~~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyE 702 (853)
|||||+|||+ .++.+||+|||+++.+.............++..|+|||.+... .++.++|||||||++||
T Consensus 133 ~di~p~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~---------~~~~~~Di~slG~~l~e 203 (279)
T cd05057 133 RDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESILHR---------IYTHKSDVWSYGVTVWE 203 (279)
T ss_pred cccCcceEEEcCCCeEEECCCcccccccCcccceecCCCcccccccCHHHhhcC---------CcCchhhHHHHHHHHHH
Confidence 9999999999 5679999999999876543322222223346789999988644 35679999999999999
Q ss_pred HHh-CCCCCCcchhHHHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCCChhHHhc
Q 003052 703 MVY-GRTPFSEYKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQ 763 (853)
Q Consensus 703 LLt-G~~PF~~~~~~~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~ 763 (853)
|++ |+.||.+.... .....+.. ......+...+..+.++|.+||..||.+||++.++++
T Consensus 204 l~~~g~~p~~~~~~~-~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~ 263 (279)
T cd05057 204 LMTFGAKPYEGIPAV-EIPDLLEK-GERLPQPPICTIDVYMVLVKCWMIDAESRPTFKELIN 263 (279)
T ss_pred HhcCCCCCCCCCCHH-HHHHHHhC-CCCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 998 99999775432 22222222 2233444556788999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=303.57 Aligned_cols=243 Identities=22% Similarity=0.348 Sum_probs=187.0
Q ss_pred eEeccCceEEEEEEec---CCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHHHHhhCCC
Q 003052 479 KIGSGGSSEVHKVISS---DCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLREVLNGSM 555 (853)
Q Consensus 479 ~LG~G~FG~Vyka~~~---~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~~l~~~~i 555 (853)
.||+|+||.||+|... ++..||+|++.... .......+.+|+.++++++ |+||+++++++.
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~-~~~~~~~~~~E~~~l~~l~-h~~ii~~~~~~~-------------- 65 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNEN-EKSVRDEMMREAEIMHQLD-NPYIVRMIGVCE-------------- 65 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEccccc-ChHHHHHHHHHHHHHHhcC-CCCeEEEEEEEc--------------
Confidence 3899999999999763 34569999987543 2334456889999999996 899999998631
Q ss_pred CCCCCccccCCeEEEEEecch-hhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCCCccEEee
Q 003052 556 NNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLLV 634 (853)
Q Consensus 556 v~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLKPeNILL~ 634 (853)
...+|+||||++ ++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++
T Consensus 66 ---------~~~~~lv~e~~~~~~L~~~l~~~-------~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~ 129 (257)
T cd05115 66 ---------AEALMLVMEMASGGPLNKFLSGK-------KDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLV 129 (257)
T ss_pred ---------CCCeEEEEEeCCCCCHHHHHHhC-------CCCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEc
Confidence 235799999975 5888877542 24689999999999999999999999999999999999994
Q ss_pred -cCcEEEEecccchhcccCCccc-cccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHh-CCCCCC
Q 003052 635 -KGSLKLIDFGIAKAIMSDTTNI-QRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVY-GRTPFS 711 (853)
Q Consensus 635 -~g~VKL~DFGlAk~~~~~~~~~-~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLt-G~~PF~ 711 (853)
++.+||+|||+++.+....... ......+++.|+|||++.+.. ++.++|||||||++|+|++ |..||.
T Consensus 130 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~---------~~~~~Di~slG~~l~el~~~g~~p~~ 200 (257)
T cd05115 130 NQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRK---------FSSRSDVWSYGITMWEAFSYGQKPYK 200 (257)
T ss_pred CCCcEEeccCCccccccCCccceeccCCCCCCcccCCHHHHccCC---------CCchhhHHHHHHHHHHHhcCCCCCcC
Confidence 5689999999998654332211 111223467899999986542 5679999999999999996 999997
Q ss_pred cchhHHHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCCChhHHhcC
Q 003052 712 EYKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQH 764 (853)
Q Consensus 712 ~~~~~~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~H 764 (853)
+...... ...+.. ......+...++++.++|.+||..||++||++.+|++.
T Consensus 201 ~~~~~~~-~~~~~~-~~~~~~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~ 251 (257)
T cd05115 201 KMKGPEV-MSFIEQ-GKRLDCPAECPPEMYALMKDCWIYKWEDRPNFAKVEER 251 (257)
T ss_pred cCCHHHH-HHHHHC-CCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 6544322 222222 22334455678899999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=303.32 Aligned_cols=250 Identities=22% Similarity=0.317 Sum_probs=192.8
Q ss_pred ceeeEEEeEeccCceEEEEEEec-CC---cEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHH
Q 003052 472 KLYQRLGKIGSGGSSEVHKVISS-DC---TIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALL 547 (853)
Q Consensus 472 ~~Y~ilk~LG~G~FG~Vyka~~~-~g---~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL 547 (853)
..|+..+.||+|+||.||+|... ++ ..+|+|+++.... ......+.+|+++++++. |+||++++++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~e~~~l~~l~-h~~i~~~~~~-------- 74 (268)
T cd05063 5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYT-EKQRQDFLSEASIMGQFS-HHNIIRLEGV-------- 74 (268)
T ss_pred HHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCC-HHHHHHHHHHHHHHhcCC-CCCeeEEEEE--------
Confidence 46888999999999999999874 33 3799999875432 334556889999999997 8899999886
Q ss_pred HHHhhCCCCCCCCccccCCeEEEEEecch-hhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCC
Q 003052 548 REVLNGSMNNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDL 626 (853)
Q Consensus 548 ~~l~~~~iv~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDL 626 (853)
+.+.+.+|+||||++ ++|.+++... ...+++..+..++.|++.||+|||+.||+||||
T Consensus 75 --------------~~~~~~~~lv~e~~~~~~L~~~~~~~-------~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl 133 (268)
T cd05063 75 --------------VTKFKPAMIITEYMENGALDKYLRDH-------DGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDL 133 (268)
T ss_pred --------------EccCCCcEEEEEcCCCCCHHHHHHhc-------CCCCCHHHHHHHHHHHHHHHHHHHHCCeecccc
Confidence 345567899999976 4787777542 356899999999999999999999999999999
Q ss_pred CCccEEe-ecCcEEEEecccchhcccCCcccc-ccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHH
Q 003052 627 KPANFLL-VKGSLKLIDFGIAKAIMSDTTNIQ-RDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMV 704 (853)
Q Consensus 627 KPeNILL-~~g~VKL~DFGlAk~~~~~~~~~~-~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELL 704 (853)
||+||++ .++.+||+|||++........... ......++.|+|||++.+. .++.++|||||||++|||+
T Consensus 134 kp~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~---------~~~~~~Dv~slG~il~ell 204 (268)
T cd05063 134 AARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYR---------KFTSASDVWSFGIVMWEVM 204 (268)
T ss_pred chhhEEEcCCCcEEECCCccceecccccccceeccCCCcCceecCHHHhhcC---------CcChHhHHHHHHHHHHHHH
Confidence 9999999 566899999999986643222111 1112234579999998654 3567999999999999999
Q ss_pred h-CCCCCCcchhHHHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCCChhHHhc
Q 003052 705 Y-GRTPFSEYKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQ 763 (853)
Q Consensus 705 t-G~~PF~~~~~~~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~ 763 (853)
+ |+.||...... .....+... .........+..+.+|+.+||..||.+||++.++++
T Consensus 205 ~~g~~p~~~~~~~-~~~~~i~~~-~~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~ 262 (268)
T cd05063 205 SFGERPYWDMSNH-EVMKAINDG-FRLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVN 262 (268)
T ss_pred hCCCCCCCcCCHH-HHHHHHhcC-CCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 7 99999764432 222333221 222333456778999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=298.89 Aligned_cols=247 Identities=23% Similarity=0.343 Sum_probs=192.1
Q ss_pred eEEEeEeccCceEEEEEEecC-----CcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHHH
Q 003052 475 QRLGKIGSGGSSEVHKVISSD-----CTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLRE 549 (853)
Q Consensus 475 ~ilk~LG~G~FG~Vyka~~~~-----g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~~ 549 (853)
.+.+.||.|+||.||++.+.. +..+|+|++...... .....+.+|+.+++.+ +|+||++++++
T Consensus 2 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~l~~l-~~~~i~~~~~~---------- 69 (258)
T smart00219 2 TLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADE-QQIEEFLREARIMRKL-DHPNIVKLLGV---------- 69 (258)
T ss_pred cccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCCh-HHHHHHHHHHHHHHhc-CCCchheEEEE----------
Confidence 467789999999999998843 378999999654332 2456788999999999 59999999987
Q ss_pred HhhCCCCCCCCccccCCeEEEEEecch-hhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCCC
Q 003052 550 VLNGSMNNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKP 628 (853)
Q Consensus 550 l~~~~iv~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLKP 628 (853)
+.+.+.+|++|||+. ++|.+++.... ...+++..+..++.||+.||.|||++||+||||||
T Consensus 70 ------------~~~~~~~~~i~e~~~~~~l~~~~~~~~------~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~ 131 (258)
T smart00219 70 ------------CTEEEPLMIVMEYMEGGDLLDYLRKNR------PKELSLSDLLSFALQIARGMEYLESKNFIHRDLAA 131 (258)
T ss_pred ------------EcCCCeeEEEEeccCCCCHHHHHHhhh------hccCCHHHHHHHHHHHHHHHHHHhcCCeeeccccc
Confidence 344567999999975 58888876541 12289999999999999999999999999999999
Q ss_pred ccEEee-cCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHh-C
Q 003052 629 ANFLLV-KGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVY-G 706 (853)
Q Consensus 629 eNILL~-~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLt-G 706 (853)
+||+++ ++.++|+|||+++......... .....+++.|+|||.+.+. .++.++|||||||++|+|++ |
T Consensus 132 ~nil~~~~~~~~l~dfg~~~~~~~~~~~~-~~~~~~~~~y~~Pe~~~~~---------~~~~~~Di~slG~i~~~l~~~g 201 (258)
T smart00219 132 RNCLVGENLVVKISDFGLSRDLYDDDYYK-KKGGKLPIRWMAPESLKDG---------KFTSKSDVWSFGVLLWEIFTLG 201 (258)
T ss_pred ceEEEccCCeEEEcccCCceecccccccc-cccCCCcccccChHHhccC---------CCCcchhHHHHHHHHHHHHhCC
Confidence 999995 5689999999998765432211 1123377899999998543 35689999999999999998 8
Q ss_pred CCCCCcchhHHHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCCChhHHhc
Q 003052 707 RTPFSEYKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQ 763 (853)
Q Consensus 707 ~~PF~~~~~~~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~ 763 (853)
.+||........... +.... ....+...+.++.+++.+||..||.+|||+.++++
T Consensus 202 ~~p~~~~~~~~~~~~-~~~~~-~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~ 256 (258)
T smart00219 202 ESPYPGMSNEEVLEY-LKKGY-RLPKPENCPPEIYKLMLQCWAEDPEDRPTFSELVE 256 (258)
T ss_pred CCCCCCCCHHHHHHH-HhcCC-CCCCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHh
Confidence 999976443322222 22211 22334457888999999999999999999999986
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=336.80 Aligned_cols=241 Identities=28% Similarity=0.380 Sum_probs=197.1
Q ss_pred ceeeEEEeEeccCceEEEEEEe-cCCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHHHH
Q 003052 472 KLYQRLGKIGSGGSSEVHKVIS-SDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLREV 550 (853)
Q Consensus 472 ~~Y~ilk~LG~G~FG~Vyka~~-~~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~~l 550 (853)
..|.+...||.|+|+.|..+.+ .+++.+++|++.....+ -.+|+.++.+..+|+||+.+.+.
T Consensus 322 ~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~~------~~~e~~~~~~~~~h~niv~~~~v----------- 384 (612)
T KOG0603|consen 322 ESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRADD------NQDEIPISLLVRDHPNIVKSHDV----------- 384 (612)
T ss_pred hhhccccccCCCCccceeeeeccccccchhheeccccccc------cccccchhhhhcCCCcceeecce-----------
Confidence 4588888899999999999988 46688999999876332 23688899999999999999876
Q ss_pred hhCCCCCCCCccccCCeEEEEEecchh-hHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCCCc
Q 003052 551 LNGSMNNKDGRVKDDGYIYMVLEYGEI-DLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPA 629 (853)
Q Consensus 551 ~~~~iv~~~g~~~d~~~lyLVmEy~~g-dL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLKPe 629 (853)
+.++.++|+|||++.+ .+.+.+... ......+..|+.+|+.|+.|||++|||||||||+
T Consensus 385 -----------~~~~~~~~~v~e~l~g~ell~ri~~~---------~~~~~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~ 444 (612)
T KOG0603|consen 385 -----------YEDGKEIYLVMELLDGGELLRRIRSK---------PEFCSEASQWAAELVSAVDYLHEQGVVHRDLKPG 444 (612)
T ss_pred -----------ecCCceeeeeehhccccHHHHHHHhc---------chhHHHHHHHHHHHHHHHHHHHhcCeeecCCChh
Confidence 5677889999999665 344433321 2333788889999999999999999999999999
Q ss_pred cEEe--ecCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHhCC
Q 003052 630 NFLL--VKGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGR 707 (853)
Q Consensus 630 NILL--~~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLtG~ 707 (853)
|||+ +.|+++|+|||.++..... ..+.|-|..|.|||++...+ |+.++||||||++||+||+|+
T Consensus 445 NIL~~~~~g~lrltyFG~a~~~~~~-----~~tp~~t~~y~APEvl~~~~---------yt~acD~WSLGvlLy~ML~G~ 510 (612)
T KOG0603|consen 445 NILLDGSAGHLRLTYFGFWSELERS-----CDTPALTLQYVAPEVLAIQE---------YTEACDWWSLGVLLYEMLTGR 510 (612)
T ss_pred heeecCCCCcEEEEEechhhhCchh-----hcccchhhcccChhhhccCC---------CCcchhhHHHHHHHHHHHhCC
Confidence 9999 4679999999999877543 33668899999999998554 567999999999999999999
Q ss_pred CCCCcchhHHHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCCChhHHhcCCCC
Q 003052 708 TPFSEYKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQHPFL 767 (853)
Q Consensus 708 ~PF~~~~~~~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~HPwf 767 (853)
.||.....-..+...+..+ .+...+|..+++||.+||++||.+|+++.+++.||||
T Consensus 511 tp~~~~P~~~ei~~~i~~~----~~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h~w~ 566 (612)
T KOG0603|consen 511 TLFAAHPAGIEIHTRIQMP----KFSECVSDEAKDLLQQLLQVDPALRLGADEIGAHPWF 566 (612)
T ss_pred CccccCCchHHHHHhhcCC----ccccccCHHHHHHHHHhccCChhhCcChhhhccCcch
Confidence 9996544333444443322 3347789999999999999999999999999999999
|
|
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-34 Score=301.24 Aligned_cols=252 Identities=27% Similarity=0.412 Sum_probs=196.7
Q ss_pred eeEEEeEeccCceEEEEEEecC--CcEEEEEEEecCC--------CChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhH
Q 003052 474 YQRLGKIGSGGSSEVHKVISSD--CTIYALKKIKLKG--------RDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTE 543 (853)
Q Consensus 474 Y~ilk~LG~G~FG~Vyka~~~~--g~~vAVKkik~~~--------~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e 543 (853)
|++.+.||+|+||.||+|.+.. ++.+|+|.+.... ........+.+|+.++.+...|+||++++++
T Consensus 2 y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~---- 77 (269)
T cd08528 2 YAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKT---- 77 (269)
T ss_pred chhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEee----
Confidence 7888999999999999999854 5889999986432 2223445577899999876669999999886
Q ss_pred HHHHHHHhhCCCCCCCCccccCCeEEEEEecch-hhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhccc-Cce
Q 003052 544 KALLREVLNGSMNNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHE-ERI 621 (853)
Q Consensus 544 ~~iL~~l~~~~iv~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs-~gI 621 (853)
+.+++++|+||||+. ++|.+++.... .....+++..++.++.||+.||.|||+ .||
T Consensus 78 ------------------~~~~~~~~lv~e~~~~~~l~~~l~~~~----~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i 135 (269)
T cd08528 78 ------------------FLENDRLYIVMDLIEGAPLGEHFNSLK----EKKQRFTEERIWNIFVQMVLALRYLHKEKRI 135 (269)
T ss_pred ------------------EccCCeEEEEEecCCCCcHHHHHHHHH----hccCCCCHHHHHHHHHHHHHHHHHhccCCce
Confidence 445678999999976 47777765421 123569999999999999999999996 789
Q ss_pred eeCCCCCccEEe-ecCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHH
Q 003052 622 VHSDLKPANFLL-VKGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCIL 700 (853)
Q Consensus 622 IHRDLKPeNILL-~~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVIL 700 (853)
+||||||+|||+ .++.+||+|||++....... ......|+..|+|||.+.+. .++.++|||||||++
T Consensus 136 ~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~---~~~~~~~~~~~~~Pe~~~~~---------~~~~~~Dv~slG~ll 203 (269)
T cd08528 136 VHRDLTPNNIMLGEDDKVTITDFGLAKQKQPES---KLTSVVGTILYSCPEIVKNE---------PYGEKADVWAFGCIL 203 (269)
T ss_pred eecCCCHHHEEECCCCcEEEecccceeeccccc---ccccccCcccCcChhhhcCC---------CCchHHHHHHHHHHH
Confidence 999999999999 56789999999998654332 22356799999999999754 256799999999999
Q ss_pred HHHHhCCCCCCcchhHHHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCCChhHHhcC
Q 003052 701 YQMVYGRTPFSEYKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQH 764 (853)
Q Consensus 701 yELLtG~~PF~~~~~~~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~H 764 (853)
|+|++|++||.............. ...........++.+.+||.+||..||.+||++.|+..+
T Consensus 204 ~~l~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~ 266 (269)
T cd08528 204 YQMCTLQPPFYSTNMLSLATKIVE-AVYEPLPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAM 266 (269)
T ss_pred HHHHhCCCcccccCHHHHHHHHhh-ccCCcCCcccCCHHHHHHHHHHCCCCCccCCCHHHHHHH
Confidence 999999999976544333323222 222222223567889999999999999999999998754
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=303.10 Aligned_cols=249 Identities=21% Similarity=0.323 Sum_probs=190.8
Q ss_pred eEeccCceEEEEEEecC-------CcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHHHHh
Q 003052 479 KIGSGGSSEVHKVISSD-------CTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLREVL 551 (853)
Q Consensus 479 ~LG~G~FG~Vyka~~~~-------g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~~l~ 551 (853)
.||+|+||.||+|...+ +..+|+|.+..... ......+.+|+.+++.++ |+||++++++
T Consensus 2 ~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~e~~~l~~l~-h~~i~~~~~~------------ 67 (269)
T cd05044 2 FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGAT-DQEKKEFLKEAHLMSNFN-HPNIVKLLGV------------ 67 (269)
T ss_pred ccccccceeEEeeeecccccCcccceeehhhhhhcccc-hhhHHHHHHHHHHHHhcC-CCCeeeEeee------------
Confidence 59999999999998642 25789998865432 233456889999999997 8999999886
Q ss_pred hCCCCCCCCccccCCeEEEEEecch-hhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCCCcc
Q 003052 552 NGSMNNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPAN 630 (853)
Q Consensus 552 ~~~iv~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLKPeN 630 (853)
+.+....|+||||+. ++|.+++........ ....+++..+..++.||+.||.|||+.+|+|+||||+|
T Consensus 68 ----------~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~n 136 (269)
T cd05044 68 ----------CLLNEPQYIIMELMEGGDLLSYLRDARVERF-GPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARN 136 (269)
T ss_pred ----------ecCCCCeEEEEeccCCCcHHHHHHHhhhccc-CCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChhe
Confidence 344567899999965 699988875432211 23458899999999999999999999999999999999
Q ss_pred EEeec-C-----cEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHH
Q 003052 631 FLLVK-G-----SLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMV 704 (853)
Q Consensus 631 ILL~~-g-----~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELL 704 (853)
||++. + .+||+|||+++...............++..|+|||++.+. .++.++|||||||++|+|+
T Consensus 137 il~~~~~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~---------~~~~~~Dv~slG~il~ell 207 (269)
T cd05044 137 CLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVRWMAPESLLDG---------KFTTQSDVWSFGVLMWEIL 207 (269)
T ss_pred EEEecCCCCCCcceEECCcccccccccccccccCcccCCCccccCHHHHccC---------CcccchhHHHHHHHHHHHH
Confidence 99954 3 6999999999866433222222234567899999999654 3568999999999999999
Q ss_pred h-CCCCCCcchhHHHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCCChhHHhc
Q 003052 705 Y-GRTPFSEYKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQ 763 (853)
Q Consensus 705 t-G~~PF~~~~~~~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~ 763 (853)
+ |..||........ ...+.. ...+..+...+..+.+||.+||..+|.+||++.++++
T Consensus 208 t~g~~p~~~~~~~~~-~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 265 (269)
T cd05044 208 TLGQQPYPALNNQEV-LQHVTA-GGRLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQE 265 (269)
T ss_pred HcCCCCCcccCHHHH-HHHHhc-CCccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 8 9999976544332 222221 2233344566788999999999999999999999875
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=304.14 Aligned_cols=254 Identities=21% Similarity=0.245 Sum_probs=185.8
Q ss_pred eEeccCceEEEEEEecCC---cEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHHHHhhCCC
Q 003052 479 KIGSGGSSEVHKVISSDC---TIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLREVLNGSM 555 (853)
Q Consensus 479 ~LG~G~FG~Vyka~~~~g---~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~~l~~~~i 555 (853)
+||+|+||.||++...++ ..+++|.++.... ......+.+|+.+++.++ |+||++++++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~e~~~~~~l~-h~~iv~~~~~---------------- 63 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANAS-SKEQNEFLQQGDPYRILQ-HPNILQCLGQ---------------- 63 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCC-hHHHHHHHHHHHHHhccC-CcchhheEEE----------------
Confidence 599999999999975433 3456666654332 234557899999999986 8999999986
Q ss_pred CCCCCccccCCeEEEEEecch-hhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCCCccEEe-
Q 003052 556 NNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLL- 633 (853)
Q Consensus 556 v~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLKPeNILL- 633 (853)
+.+...+|+||||+. ++|.+++.+... ....+++..++.++.||+.||.|||+++|+||||||+|||+
T Consensus 64 ------~~~~~~~~lv~e~~~~~~L~~~l~~~~~----~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~ 133 (268)
T cd05086 64 ------CVEAIPYLLVFEYCELGDLKSYLSQEQW----HRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLT 133 (268)
T ss_pred ------ecCCCccEEEEecCCCCcHHHHHHhhhc----ccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEc
Confidence 344567899999977 589888865311 12457788889999999999999999999999999999999
Q ss_pred ecCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHh-CCCCCCc
Q 003052 634 VKGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVY-GRTPFSE 712 (853)
Q Consensus 634 ~~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLt-G~~PF~~ 712 (853)
.++.+||+|||++...............+|+..|+|||++....... ....++.++|||||||++|||++ |..||..
T Consensus 134 ~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~--~~~~~~~~~DiwslG~~l~el~~~~~~p~~~ 211 (268)
T cd05086 134 SDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPELVGEFHGGL--ITAEQTKPSNVWALGVTLWELFENAAQPYSH 211 (268)
T ss_pred CCccEEecccccccccCcchhhhcccCCcCcccccCchhcccccCcc--ccCCCCCcchhHHHHHHHHHHHhCCCCCCCC
Confidence 56799999999986432211111223567899999999986432110 11245789999999999999996 6788876
Q ss_pred chhHHHHHHhhcCCCC---cccCCCCCChhHHHHHHHhcccCCCCCCChhHHhc
Q 003052 713 YKTFWAKFKVITDPNH---EITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQ 763 (853)
Q Consensus 713 ~~~~~~~~kii~~~~~---~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~ 763 (853)
..........+..... ........++.+.++|..|| .+|.+||++.+|++
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~ 264 (268)
T cd05086 212 LSDREVLNHVIKDQQVKLFKPQLELPYSERWYEVLQFCW-LSPEKRATAEEVHR 264 (268)
T ss_pred CCHHHHHHHHHhhcccccCCCccCCCCcHHHHHHHHHHh-hCcccCCCHHHHHH
Confidence 5544333333322211 12223346778899999999 68999999999975
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=303.11 Aligned_cols=261 Identities=18% Similarity=0.248 Sum_probs=195.5
Q ss_pred eeEEEeEeccCceEEEEEEec----CCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHHH
Q 003052 474 YQRLGKIGSGGSSEVHKVISS----DCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLRE 549 (853)
Q Consensus 474 Y~ilk~LG~G~FG~Vyka~~~----~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~~ 549 (853)
|++.+.||+|+||.||+|... ++..||||++............+.+|+++++++. |+||+++++++.....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~---- 75 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFD-HPNVIKLIGVSLRSRA---- 75 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCC-CCCcceEEEEEccCCC----
Confidence 567788999999999999853 4578999999876655556667889999999997 8999999997532110
Q ss_pred HhhCCCCCCCCccccCCeEEEEEecch-hhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCCC
Q 003052 550 VLNGSMNNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKP 628 (853)
Q Consensus 550 l~~~~iv~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLKP 628 (853)
.......++++||+. ++|..++..... ......+++..++.++.||+.||+|||++||+||||||
T Consensus 76 ------------~~~~~~~~~~~~~~~~~~l~~~~~~~~~--~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp 141 (273)
T cd05074 76 ------------KGRLPIPMVILPFMKHGDLHTFLLMSRI--GEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAA 141 (273)
T ss_pred ------------CCcccceEEEEecCCCCcHHHHHHHhcc--cCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccch
Confidence 001124578899865 577777643211 11223589999999999999999999999999999999
Q ss_pred ccEEee-cCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHh-C
Q 003052 629 ANFLLV-KGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVY-G 706 (853)
Q Consensus 629 eNILL~-~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLt-G 706 (853)
+||+++ ++.+||+|||+++...............+++.|++||.+.... ++.++|||||||++|+|++ |
T Consensus 142 ~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~---------~~~~sDi~slG~il~el~~~g 212 (273)
T cd05074 142 RNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPVKWLALESLADNV---------YTTHSDVWAFGVTMWEIMTRG 212 (273)
T ss_pred hhEEEcCCCCEEECcccccccccCCcceecCCCccCchhhcCHhHHhcCc---------cchhhhhHHHHHHHHHHhhCC
Confidence 999994 6699999999998664332222222345677899999986543 4578999999999999998 9
Q ss_pred CCCCCcchhHHHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCCChhHHhcC
Q 003052 707 RTPFSEYKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQH 764 (853)
Q Consensus 707 ~~PF~~~~~~~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~H 764 (853)
++||.+..... ....+... .........+..+.+++.+||..+|.+||++.+++++
T Consensus 213 ~~p~~~~~~~~-~~~~~~~~-~~~~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~ 268 (273)
T cd05074 213 QTPYAGVENSE-IYNYLIKG-NRLKQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQ 268 (273)
T ss_pred CCCCCCCCHHH-HHHHHHcC-CcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 99997654432 22222211 1222334566789999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=304.29 Aligned_cols=236 Identities=22% Similarity=0.347 Sum_probs=178.5
Q ss_pred eEeccCceEEEEEEecC-------------CcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHH
Q 003052 479 KIGSGGSSEVHKVISSD-------------CTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKA 545 (853)
Q Consensus 479 ~LG~G~FG~Vyka~~~~-------------g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~ 545 (853)
.||+|+||.||+|+..+ ...+|+|.+..... .....+.+|+.++..+. ||||+++++++
T Consensus 2 ~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~--~~~~~~~~~~~~l~~l~-hp~iv~~~~~~----- 73 (262)
T cd05077 2 HLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHR--DISLAFFETASMMRQVS-HKHIVLLYGVC----- 73 (262)
T ss_pred ccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhh--hHHHHHHHHHHHHHhCC-CCCEeeEEEEE-----
Confidence 58999999999998521 12578888765432 33456788999999997 89999999873
Q ss_pred HHHHHhhCCCCCCCCccccCCeEEEEEecchh-hHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeC
Q 003052 546 LLREVLNGSMNNKDGRVKDDGYIYMVLEYGEI-DLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHS 624 (853)
Q Consensus 546 iL~~l~~~~iv~~~g~~~d~~~lyLVmEy~~g-dL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHR 624 (853)
.++...|+||||+++ .|..++... ...+++.+++.++.||+.||.|||++||+||
T Consensus 74 -----------------~~~~~~~lv~e~~~~~~l~~~~~~~-------~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~ 129 (262)
T cd05077 74 -----------------VRDVENIMVEEFVEFGPLDLFMHRK-------SDVLTTPWKFKVAKQLASALSYLEDKDLVHG 129 (262)
T ss_pred -----------------ecCCCCEEEEecccCCCHHHHHHhc-------CCCCCHHHHHHHHHHHHHHHHHhhhCCeECC
Confidence 345567999999775 555554332 3568999999999999999999999999999
Q ss_pred CCCCccEEeec-C-------cEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhh
Q 003052 625 DLKPANFLLVK-G-------SLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSL 696 (853)
Q Consensus 625 DLKPeNILL~~-g-------~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSL 696 (853)
||||+|||+.. + .+||+|||++...... ....|+..|+|||++.... .++.++|||||
T Consensus 130 dlkp~Nill~~~~~~~~~~~~~~l~d~g~~~~~~~~------~~~~~~~~y~aPE~~~~~~--------~~~~~~Diwsl 195 (262)
T cd05077 130 NVCTKNILLAREGIDGECGPFIKLSDPGIPITVLSR------QECVERIPWIAPECVEDSK--------NLSIAADKWSF 195 (262)
T ss_pred CCCcccEEEecCCccCCCCceeEeCCCCCCccccCc------ccccccccccChhhhcCCC--------CCCchhHHHHH
Confidence 99999999953 3 2899999998755321 2456889999999885321 36789999999
Q ss_pred HHHHHHHH-hCCCCCCcchhHHHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCCChhHHhcC
Q 003052 697 GCILYQMV-YGRTPFSEYKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQH 764 (853)
Q Consensus 697 GVILyELL-tG~~PF~~~~~~~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~H 764 (853)
||++|+|+ .|..||...... ....... .. .......+.++.+||.+||..||.+||++.+|+++
T Consensus 196 G~~l~el~~~~~~p~~~~~~~-~~~~~~~-~~--~~~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~ 260 (262)
T cd05077 196 GTTLWEICYNGEIPLKDKTLA-EKERFYE-GQ--CMLVTPSCKELADLMTHCMNYDPNQRPFFRAIMRD 260 (262)
T ss_pred HHHHHHHHhCCCCCCCCcchh-HHHHHHh-cC--ccCCCCChHHHHHHHHHHcCCChhhCcCHHHHHHh
Confidence 99999998 589998754322 1111111 11 11222345679999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-34 Score=336.59 Aligned_cols=273 Identities=20% Similarity=0.252 Sum_probs=177.6
Q ss_pred ceeeEEEeEeccCceEEEEEEec-C----CcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcC--CCceeEeeehhhhHH
Q 003052 472 KLYQRLGKIGSGGSSEVHKVISS-D----CTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKG--KNNIIQLIDYEVTEK 544 (853)
Q Consensus 472 ~~Y~ilk~LG~G~FG~Vyka~~~-~----g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~--hpNIV~Lid~~~~e~ 544 (853)
+.|.+.++||+|+||.||+|++. + +..||||++..... .|+.+..++.+ +.++..++..+
T Consensus 132 ~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~---------~e~~~~e~l~~~~~~~~~~~~~~~---- 198 (566)
T PLN03225 132 DDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA---------VEIWMNERVRRACPNSCADFVYGF---- 198 (566)
T ss_pred CCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch---------hHHHHHHHHHhhchhhHHHHHHhh----
Confidence 56999999999999999999984 4 68899999864322 12222222221 11221111110
Q ss_pred HHHHHHhhCCCCCCCCccccCCeEEEEEecch-hhHHHHHHHhhhh------cc------CCCCCCCHHHHHHHHHHhhh
Q 003052 545 ALLREVLNGSMNNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKE------MD------GSNQTLDENWLRFYWQQILE 611 (853)
Q Consensus 545 ~iL~~l~~~~iv~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~------~~------~~~~~LsE~~~r~I~~QIl~ 611 (853)
.+ .. . ...+..+|+||||++ ++|.+++...... +. .......+..++.|+.||+.
T Consensus 199 ------~~----~~-~-~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~ 266 (566)
T PLN03225 199 ------LE----PV-S-SKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILF 266 (566)
T ss_pred ------hc----cc-c-cccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHH
Confidence 00 00 0 345678999999966 5788877643100 00 01112234567789999999
Q ss_pred hhhhcccCceeeCCCCCccEEee--cCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCc------
Q 003052 612 AVNTIHEERIVHSDLKPANFLLV--KGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGN------ 683 (853)
Q Consensus 612 AL~yLHs~gIIHRDLKPeNILL~--~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~------ 683 (853)
||.|||++||+||||||+|||++ .+.+||+|||+|+.+..... .....++||+.|||||.+..........
T Consensus 267 aL~yLH~~gIiHRDLKP~NILl~~~~~~~KL~DFGlA~~l~~~~~-~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~ 345 (566)
T PLN03225 267 ALDGLHSTGIVHRDVKPQNIIFSEGSGSFKIIDLGAAADLRVGIN-YIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVAT 345 (566)
T ss_pred HHHHHHHCCEEeCcCCHHHEEEeCCCCcEEEEeCCCccccccccc-cCCcccccCCCccChHHhhccCCCCCCccccccc
Confidence 99999999999999999999996 36899999999986543222 2234678999999999775433221110
Q ss_pred -------cccCCCccchhhhHHHHHHHHhCCCCCCcchhHHHHHHhhcCCCCc-------------------ccCCCCCC
Q 003052 684 -------IIKCGRPSDIWSLGCILYQMVYGRTPFSEYKTFWAKFKVITDPNHE-------------------ITYEPVPN 737 (853)
Q Consensus 684 -------~~~ys~ksDIWSLGVILyELLtG~~PF~~~~~~~~~~kii~~~~~~-------------------~~~~~~~s 737 (853)
...+..++|||||||+||||+++..++... .......+...... +.......
T Consensus 346 ~~sp~l~~~~~~~k~DVwSlGviL~el~~~~~~~~~~--~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 423 (566)
T PLN03225 346 ALSPVLWQLNLPDRFDIYSAGLIFLQMAFPNLRSDSN--LIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDG 423 (566)
T ss_pred cccchhccccCCCCcccHHHHHHHHHHHhCcCCCchH--HHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccc
Confidence 123556789999999999999988776542 11111111110000 00011122
Q ss_pred hhHHHHHHHhcccCCCCCCChhHHhcCCCCCCCCC
Q 003052 738 PWLLDLMKKCLAWDRNERWRIPQLLQHPFLVPPVS 772 (853)
Q Consensus 738 ~~l~dLI~kcL~~DP~kRpTa~EIL~HPwf~~~~~ 772 (853)
..+.+||.+||++||.+|||+.++|+||||.....
T Consensus 424 ~~~~dLi~~mL~~dP~kR~ta~e~L~Hpff~~~~~ 458 (566)
T PLN03225 424 GAGWELLKSMMRFKGRQRISAKAALAHPYFDREGL 458 (566)
T ss_pred hHHHHHHHHHccCCcccCCCHHHHhCCcCcCCCCc
Confidence 33568999999999999999999999999986543
|
|
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-34 Score=299.89 Aligned_cols=245 Identities=20% Similarity=0.282 Sum_probs=184.0
Q ss_pred eEeccCceEEEEEEec----CCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHHHHhhCC
Q 003052 479 KIGSGGSSEVHKVISS----DCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLREVLNGS 554 (853)
Q Consensus 479 ~LG~G~FG~Vyka~~~----~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~~l~~~~ 554 (853)
.||+|+||.||+|... +...+|+|.+... ........+.+|+.+++.++ |+||+++++++.
T Consensus 2 ~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~-~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~------------- 66 (262)
T cd05058 2 VIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRI-TDLEEVEQFLKEGIIMKDFS-HPNVLSLLGICL------------- 66 (262)
T ss_pred cccccCCceEEEEEEecCCCceEEEEEEecCcc-CCHHHHHHHHHHHHHHccCC-CCCcceEEEEee-------------
Confidence 5899999999999863 2357999988543 23344567889999999986 999999988532
Q ss_pred CCCCCCccccCCeEEEEEecch-hhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCCCccEEe
Q 003052 555 MNNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLL 633 (853)
Q Consensus 555 iv~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLKPeNILL 633 (853)
..++..|+||||+. ++|.+++... ...+++..+..++.||+.||.|||+.||+||||||+|||+
T Consensus 67 --------~~~~~~~lv~e~~~~~~L~~~~~~~-------~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili 131 (262)
T cd05058 67 --------PSEGSPLVVLPYMKHGDLRNFIRSE-------THNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCML 131 (262)
T ss_pred --------cCCCCcEEEEecCCCCCHHHHHHhc-------CCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEE
Confidence 23456789999965 6888887643 2346778888999999999999999999999999999999
Q ss_pred -ecCcEEEEecccchhcccCCcc--ccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHh-CCCC
Q 003052 634 -VKGSLKLIDFGIAKAIMSDTTN--IQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVY-GRTP 709 (853)
Q Consensus 634 -~~g~VKL~DFGlAk~~~~~~~~--~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLt-G~~P 709 (853)
.++.+||+|||+++........ .......++..|+|||.+.+. .++.++|||||||++|||++ |.+|
T Consensus 132 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~---------~~~~~~Di~slG~~l~el~~~~~~~ 202 (262)
T cd05058 132 DESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESLQTQ---------KFTTKSDVWSFGVLLWELMTRGAPP 202 (262)
T ss_pred cCCCcEEECCccccccccCCcceeecccccCcCCccccChhHhccC---------ccchHHHHHHHHHHHHHHHcCCCCC
Confidence 4569999999999865432111 011234567889999998654 35679999999999999999 5677
Q ss_pred CCcchhHHHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCCChhHHhcC
Q 003052 710 FSEYKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQH 764 (853)
Q Consensus 710 F~~~~~~~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~H 764 (853)
|...+... ....+... .....+...+..+.+++.+||..+|.+||++.++++.
T Consensus 203 ~~~~~~~~-~~~~~~~~-~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~ 255 (262)
T cd05058 203 YPDVDSFD-ITVYLLQG-RRLLQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSR 255 (262)
T ss_pred CCCCCHHH-HHHHHhcC-CCCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence 76544432 22222221 1222334457789999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=304.40 Aligned_cols=254 Identities=21% Similarity=0.349 Sum_probs=195.0
Q ss_pred CceeeEEEeEeccCceEEEEEEec-----CCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHH
Q 003052 471 GKLYQRLGKIGSGGSSEVHKVISS-----DCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKA 545 (853)
Q Consensus 471 g~~Y~ilk~LG~G~FG~Vyka~~~-----~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~ 545 (853)
.+.|++++.||+|+||.||+|... ++..||||++...... .....+.+|+++++++. |+||+++++++.
T Consensus 3 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~ei~~l~~l~-~~~i~~~~~~~~---- 76 (284)
T cd05038 3 KRHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEE-QHRSDFEREIEILRTLD-HENIVKYKGVCE---- 76 (284)
T ss_pred hhhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccch-HHHHHHHHHHHHHHhCC-CCChheEEeeee----
Confidence 356888999999999999999853 3578999999866543 44567899999999996 899999988632
Q ss_pred HHHHHhhCCCCCCCCccccCCeEEEEEecch-hhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeC
Q 003052 546 LLREVLNGSMNNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHS 624 (853)
Q Consensus 546 iL~~l~~~~iv~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHR 624 (853)
.....++|+||||+. ++|.+++... ...+++..+..++.||+.||.|||++||+||
T Consensus 77 ----------------~~~~~~~~lv~e~~~~~~l~~~l~~~-------~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~ 133 (284)
T cd05038 77 ----------------KPGGRSLRLIMEYLPSGSLRDYLQRH-------RDQINLKRLLLFSSQICKGMDYLGSQRYIHR 133 (284)
T ss_pred ----------------cCCCCceEEEEecCCCCCHHHHHHhC-------ccccCHHHHHHHHHHHHHHHHHHHhCCeecC
Confidence 122557899999975 5888888653 2358999999999999999999999999999
Q ss_pred CCCCccEEe-ecCcEEEEecccchhcccCCcccc-ccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHH
Q 003052 625 DLKPANFLL-VKGSLKLIDFGIAKAIMSDTTNIQ-RDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQ 702 (853)
Q Consensus 625 DLKPeNILL-~~g~VKL~DFGlAk~~~~~~~~~~-~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyE 702 (853)
||||+|||+ .++.+||+|||++........... .....++..|+|||.+.+. .++.++|||||||++||
T Consensus 134 dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~---------~~~~~~Di~slG~~l~e 204 (284)
T cd05038 134 DLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPECLRTS---------KFSSASDVWSFGVTLYE 204 (284)
T ss_pred CCCHHhEEEcCCCCEEEcccccccccccCCcceeccCCCCCcccccCcHHHccC---------CCCcccchHHHhhhhhe
Confidence 999999999 457899999999987653222111 1123456679999998654 35678999999999999
Q ss_pred HHhCCCCCCcchhHH--------------HHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCCChhHHhc
Q 003052 703 MVYGRTPFSEYKTFW--------------AKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQ 763 (853)
Q Consensus 703 LLtG~~PF~~~~~~~--------------~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~ 763 (853)
|++|..||....... .....+. .......+...+..+.+|+.+||..||.+||++.+|++
T Consensus 205 l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 278 (284)
T cd05038 205 LFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELLK-EGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLIL 278 (284)
T ss_pred eeccCCCcccccchhccccccccccccHHHHHHHHH-cCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 999999986432111 1111111 12222333455678999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-34 Score=298.52 Aligned_cols=242 Identities=22% Similarity=0.322 Sum_probs=190.5
Q ss_pred CceeeEEEeEeccCceEEEEEEecCCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHHHH
Q 003052 471 GKLYQRLGKIGSGGSSEVHKVISSDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLREV 550 (853)
Q Consensus 471 g~~Y~ilk~LG~G~FG~Vyka~~~~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~~l 550 (853)
.+.|++.+.||+|+||.||++.. +++.||+|+++... ....+.+|+.++++++ |+||+++++++.
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~----~~~~~~~e~~~l~~~~-~~~i~~~~~~~~--------- 69 (254)
T cd05083 5 LQKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDV----TAQAFLEETAVMTKLH-HKNLVRLLGVIL--------- 69 (254)
T ss_pred HHHceeeeeeccCCCCceEeccc-CCCceEEEeecCcc----hHHHHHHHHHHHHhCC-CCCcCeEEEEEc---------
Confidence 35699999999999999999875 56779999986532 2346889999999997 899999988632
Q ss_pred hhCCCCCCCCccccCCeEEEEEecch-hhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCCCc
Q 003052 551 LNGSMNNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPA 629 (853)
Q Consensus 551 ~~~~iv~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLKPe 629 (853)
. ..+|+||||+. ++|.+++... ....+++..+..++.||+.||.|||++|++||||||+
T Consensus 70 -------------~-~~~~~v~e~~~~~~L~~~l~~~------~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~ 129 (254)
T cd05083 70 -------------H-NGLYIVMELMSKGNLVNFLRTR------GRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAAR 129 (254)
T ss_pred -------------C-CCcEEEEECCCCCCHHHHHHhc------CcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcc
Confidence 1 23689999976 5998888653 2346899999999999999999999999999999999
Q ss_pred cEEee-cCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHh-CC
Q 003052 630 NFLLV-KGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVY-GR 707 (853)
Q Consensus 630 NILL~-~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLt-G~ 707 (853)
|||++ ++.+||+|||+++...... .....+..|+|||.+.+.. ++.++|+|||||++|+|++ |+
T Consensus 130 nili~~~~~~kl~Dfg~~~~~~~~~-----~~~~~~~~y~~pe~~~~~~---------~~~~~Dv~slG~~l~el~~~g~ 195 (254)
T cd05083 130 NILVSEDGVAKVSDFGLARVGSMGV-----DNSKLPVKWTAPEALKHKK---------FSSKSDVWSYGVLLWEVFSYGR 195 (254)
T ss_pred eEEEcCCCcEEECCCccceeccccC-----CCCCCCceecCHHHhccCC---------cCchhhHHHHHHHHHHHHhCCC
Confidence 99994 6799999999997643211 1234567899999986543 5679999999999999997 99
Q ss_pred CCCCcchhHHHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCCChhHHhc
Q 003052 708 TPFSEYKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQ 763 (853)
Q Consensus 708 ~PF~~~~~~~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~ 763 (853)
+||......... ..+.. ..........+..+.+||.+||..+|.+||++.+++.
T Consensus 196 ~p~~~~~~~~~~-~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 249 (254)
T cd05083 196 APYPKMSLKEVK-ECVEK-GYRMEPPEGCPADVYVLMTSCWETEPKKRPSFHKLRE 249 (254)
T ss_pred CCCccCCHHHHH-HHHhC-CCCCCCCCcCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 999765443222 22221 1222334456788999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=298.60 Aligned_cols=226 Identities=22% Similarity=0.336 Sum_probs=178.2
Q ss_pred cCceEEEEEEe-cCCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHHHHhhCCCCCCCCc
Q 003052 483 GGSSEVHKVIS-SDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLREVLNGSMNNKDGR 561 (853)
Q Consensus 483 G~FG~Vyka~~-~~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~~l~~~~iv~~~g~ 561 (853)
|.||.||+|.+ .+++.||+|++..... +.+|...+.... |+||++++++
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~~-------~~~~~~~~~~~~-~~~i~~~~~~---------------------- 53 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSSE-------YSRERLTIIPHC-VPNMVCLHKY---------------------- 53 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchhh-------hhhHHHHHHhcC-CCceeehhhh----------------------
Confidence 89999999998 5778999999976432 223444443333 7899988775
Q ss_pred cccCCeEEEEEecch-hhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCCCccEEe-ecCcEE
Q 003052 562 VKDDGYIYMVLEYGE-IDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLL-VKGSLK 639 (853)
Q Consensus 562 ~~d~~~lyLVmEy~~-gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLKPeNILL-~~g~VK 639 (853)
+.+...+|+||||+. ++|.+.+... ..+++..+..++.||+.||.|||++||+||||||+||++ .++.++
T Consensus 54 ~~~~~~~~lv~e~~~~~~L~~~l~~~--------~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~ 125 (237)
T cd05576 54 IVSEDSVFLVLQHAEGGKLWSHISKF--------LNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGHIQ 125 (237)
T ss_pred eecCCeEEEEEecCCCCCHHHHHHHh--------cCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEE
Confidence 455678999999976 5888887653 358999999999999999999999999999999999999 567999
Q ss_pred EEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHhCCCCCCcchhHHHH
Q 003052 640 LIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGRTPFSEYKTFWAK 719 (853)
Q Consensus 640 L~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLtG~~PF~~~~~~~~~ 719 (853)
|+|||++...... .....++..|+|||.+.+.. ++.++||||+||++|+|++|+.||........
T Consensus 126 l~df~~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~---------~~~~~DvwslG~il~el~~g~~~~~~~~~~~~- 190 (237)
T cd05576 126 LTYFSRWSEVEDS-----CDGEAVENMYCAPEVGGISE---------ETEACDWWSLGAILFELLTGKTLVECHPSGIN- 190 (237)
T ss_pred Eecccchhccccc-----cccCCcCccccCCcccCCCC---------CCchhhHHHHHHHHHHHHHCcchhhcCchhcc-
Confidence 9999988765432 12446778899999886542 46789999999999999999999864322110
Q ss_pred HHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCh-----hHHhcCCCC
Q 003052 720 FKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRI-----PQLLQHPFL 767 (853)
Q Consensus 720 ~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa-----~EIL~HPwf 767 (853)
.......+...++.+++||.+||+.||.+||++ +++++||||
T Consensus 191 ------~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h~~~ 237 (237)
T cd05576 191 ------THTTLNIPEWVSEEARSLLQQLLQFNPTERLGAGVAGVEDIKSHPFF 237 (237)
T ss_pred ------cccccCCcccCCHHHHHHHHHHccCCHHHhcCCCccchHHHHcCCCC
Confidence 111223445677889999999999999999996 999999997
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-35 Score=340.42 Aligned_cols=258 Identities=22% Similarity=0.344 Sum_probs=209.7
Q ss_pred cCceeeEEEeEeccCceEEEEEEe------cCCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhH
Q 003052 470 NGKLYQRLGKIGSGGSSEVHKVIS------SDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTE 543 (853)
Q Consensus 470 ~g~~Y~ilk~LG~G~FG~Vyka~~------~~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e 543 (853)
.-..-+..++||+|+||+||+|+- .+...||||.++.+.. ......|.+|+++|..|+ |+|||+|+++
T Consensus 484 ~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~-~~~~~dF~REaeLla~l~-H~nIVrLlGV---- 557 (774)
T KOG1026|consen 484 PRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAE-NQARQDFRREAELLAELQ-HPNIVRLLGV---- 557 (774)
T ss_pred chhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhccccc-HHHHHHHHHHHHHHHhcc-CCCeEEEEEE----
Confidence 334467788999999999999974 2346899999986544 345678999999999998 9999999987
Q ss_pred HHHHHHHhhCCCCCCCCccccCCeEEEEEecch-hhHHHHHHHhhhhccC--C----CCCCCHHHHHHHHHHhhhhhhhc
Q 003052 544 KALLREVLNGSMNNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEMDG--S----NQTLDENWLRFYWQQILEAVNTI 616 (853)
Q Consensus 544 ~~iL~~l~~~~iv~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~~~~--~----~~~LsE~~~r~I~~QIl~AL~yL 616 (853)
+..++-+|||+||+. |||.++|..+--.... . ..+|+..+...|+.||+.|+.||
T Consensus 558 ------------------C~~~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YL 619 (774)
T KOG1026|consen 558 ------------------CREGDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYL 619 (774)
T ss_pred ------------------EccCCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHH
Confidence 456677899999976 7999999865322211 1 23489999999999999999999
Q ss_pred ccCceeeCCCCCccEEeecC-cEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhh
Q 003052 617 HEERIVHSDLKPANFLLVKG-SLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWS 695 (853)
Q Consensus 617 Hs~gIIHRDLKPeNILL~~g-~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWS 695 (853)
-++.+|||||-..|+|++++ .|||+||||++.+...+.......-.-...||+||.|+.+ +|+.++||||
T Consensus 620 s~~~FVHRDLATRNCLVge~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~---------kFTteSDVWs 690 (774)
T KOG1026|consen 620 SSHHFVHRDLATRNCLVGENLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYG---------KFTTESDVWS 690 (774)
T ss_pred HhCcccccchhhhhceeccceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcC---------cccchhhhhh
Confidence 99999999999999999776 8999999999977654444332233445799999999865 5788999999
Q ss_pred hHHHHHHHHh-CCCCCCcchhHHHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCCChhHHh
Q 003052 696 LGCILYQMVY-GRTPFSEYKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLL 762 (853)
Q Consensus 696 LGVILyELLt-G~~PF~~~~~~~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL 762 (853)
+||+|||+++ |+-||.+..+.+ .+..+..... +.-+...+.++.+||..||+.+|.+||++.||-
T Consensus 691 ~GVvLWEIFsyG~QPy~glSn~E-VIe~i~~g~l-L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~ 756 (774)
T KOG1026|consen 691 FGVVLWEIFSYGKQPYYGLSNQE-VIECIRAGQL-LSCPENCPTEVYSLMLECWNENPKRRPSFKEIH 756 (774)
T ss_pred hhhhhhhhhccccCcccccchHH-HHHHHHcCCc-ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHH
Confidence 9999999994 999999876653 4444454444 677788999999999999999999999999874
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=308.59 Aligned_cols=276 Identities=24% Similarity=0.432 Sum_probs=220.6
Q ss_pred CCCceeEEcCceeeEEEeEeccCceEEEEEEe-cCCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehh
Q 003052 462 DPDLFFKVNGKLYQRLGKIGSGGSSEVHKVIS-SDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYE 540 (853)
Q Consensus 462 dp~~~~~v~g~~Y~ilk~LG~G~FG~Vyka~~-~~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~ 540 (853)
+++....+..+..+-++.||.|+||+|+|..+ ..|+..|||+|.....+ ....+++.|.....+-...||||++++..
T Consensus 54 ~~~~~~~F~~~~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~-keq~rll~e~d~~mks~~cp~IVkfyGa~ 132 (361)
T KOG1006|consen 54 DDAHLHTFTSDNLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIE-KEQKRLLMEHDTVMKSSNCPNIVKFYGAL 132 (361)
T ss_pred CcccccccccchHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccch-HHHHHHHHHHHHHHhhcCCcHHHHHhhhh
Confidence 33445555666677788999999999999988 57899999999877653 44567899999999999999999998864
Q ss_pred hhHHHHHHHHhhCCCCCCCCccccCCeEEEEEecchhhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccC-
Q 003052 541 VTEKALLREVLNGSMNNKDGRVKDDGYIYMVLEYGEIDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEE- 619 (853)
Q Consensus 541 ~~e~~iL~~l~~~~iv~~~g~~~d~~~lyLVmEy~~gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~- 619 (853)
. .++..||.||++..+|..+.+..+.. ....++|..+..|....+.||.||-..
T Consensus 133 F----------------------~EGdcWiCMELMd~SlDklYk~vy~v---q~~~ipE~Ilg~ItvatV~AL~yLK~~l 187 (361)
T KOG1006|consen 133 F----------------------SEGDCWICMELMDISLDKLYKRVYSV---QKSRIPENILGHITVATVDALDYLKEEL 187 (361)
T ss_pred h----------------------cCCceeeeHHHHhhhHHHHHHHHHHH---HhccCcHhhhhheeeeehhHHHHHHHHh
Confidence 3 33457999999998877666544322 235799999999999999999999865
Q ss_pred ceeeCCCCCccEEe-ecCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHH
Q 003052 620 RIVHSDLKPANFLL-VKGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGC 698 (853)
Q Consensus 620 gIIHRDLKPeNILL-~~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGV 698 (853)
+|||||+||.|||| ..|.|||||||+|..+... ...+.-.|-..|||||.+..... .|..++|+||||+
T Consensus 188 kiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~S---iAkT~daGCrpYmAPERi~p~~~-------gyDiRSDvWSLGI 257 (361)
T KOG1006|consen 188 KIIHRDVKPSNILLDRHGDVKLCDFGICGQLVDS---IAKTVDAGCRPYMAPERIDPSDK-------GYDIRSDVWSLGI 257 (361)
T ss_pred hhhhccCChhheEEecCCCEeeecccchHhHHHH---HHhhhccCCccccChhccCCccC-------Ccchhhhhhhhcc
Confidence 89999999999999 5789999999999877542 22334578899999999965432 4788999999999
Q ss_pred HHHHHHhCCCCCCcchhHHHHHHhhcCCCCccc-CCC---CCChhHHHHHHHhcccCCCCCCChhHHhcCCCCCCCCCC
Q 003052 699 ILYQMVYGRTPFSEYKTFWAKFKVITDPNHEIT-YEP---VPNPWLLDLMKKCLAWDRNERWRIPQLLQHPFLVPPVST 773 (853)
Q Consensus 699 ILyELLtG~~PF~~~~~~~~~~kii~~~~~~~~-~~~---~~s~~l~dLI~kcL~~DP~kRpTa~EIL~HPwf~~~~~~ 773 (853)
+|||+.||..||.+.+...+....+..+..++. .+. ..+..+..||.-||.+|-..||...+++++||+.-....
T Consensus 258 TL~EvAtG~fPyr~w~svfeql~~Vv~gdpp~l~~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~~fyr~y~~~ 336 (361)
T KOG1006|consen 258 TLYEVATGNFPYRKWDSVFEQLCQVVIGDPPILLFDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKFPFYRMYAVE 336 (361)
T ss_pred eEeeeecCCCCcchHHHHHHHHHHHHcCCCCeecCcccccccCHHHHHHHHHHhhcccccCcchhhhhcCchhhhhhhc
Confidence 999999999999988777666665544443332 222 257789999999999999999999999999999765443
|
|
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=303.39 Aligned_cols=236 Identities=18% Similarity=0.308 Sum_probs=181.2
Q ss_pred eEeccCceEEEEEEecC-C-------cEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHHHH
Q 003052 479 KIGSGGSSEVHKVISSD-C-------TIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLREV 550 (853)
Q Consensus 479 ~LG~G~FG~Vyka~~~~-g-------~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~~l 550 (853)
.||+|+||.||+|.+.. + ..+|+|.+.... ......+.+|+.+++.+. |+||++++++
T Consensus 2 ~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~e~~~l~~~~-h~~iv~~~~~----------- 67 (258)
T cd05078 2 SLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSH--RNYSESFFEAASMMSQLS-HKHLVLNYGV----------- 67 (258)
T ss_pred CCCcccchhheeeeecccccccccccchhhHHhhcchh--HHHHHHHHHHHHHHHhCC-CCChhheeeE-----------
Confidence 59999999999998732 2 347888875432 233456788999999987 8999999876
Q ss_pred hhCCCCCCCCccccCCeEEEEEecch-hhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCCCc
Q 003052 551 LNGSMNNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPA 629 (853)
Q Consensus 551 ~~~~iv~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLKPe 629 (853)
+..+...|+||||+. ++|..++... ...+++.+++.++.||+.||.|||++||+||||||+
T Consensus 68 -----------~~~~~~~~lv~e~~~~g~L~~~l~~~-------~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~ 129 (258)
T cd05078 68 -----------CVCGDESIMVQEYVKFGSLDTYLKKN-------KNLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAK 129 (258)
T ss_pred -----------EEeCCCcEEEEecCCCCcHHHHHhcC-------CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccc
Confidence 344567899999976 4788777643 236899999999999999999999999999999999
Q ss_pred cEEeec-C--------cEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHH
Q 003052 630 NFLLVK-G--------SLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCIL 700 (853)
Q Consensus 630 NILL~~-g--------~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVIL 700 (853)
|||+++ + .++|+|||++..... .....+++.|+|||++.+.. .++.++|||||||++
T Consensus 130 nili~~~~~~~~~~~~~~~l~d~g~~~~~~~------~~~~~~~~~y~aPE~~~~~~--------~~~~~~DiwslG~~l 195 (258)
T cd05078 130 NVLLIREEDRKTGNPPFIKLSDPGISITVLP------KEILLERIPWVPPECIENPQ--------NLSLAADKWSFGTTL 195 (258)
T ss_pred eEEEecccccccCCCceEEecccccccccCC------chhccccCCccCchhccCCC--------CCCchhhHHHHHHHH
Confidence 999943 2 279999999875432 12457899999999986532 356789999999999
Q ss_pred HHHHhC-CCCCCcchhHHHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCCChhHHhcC
Q 003052 701 YQMVYG-RTPFSEYKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQH 764 (853)
Q Consensus 701 yELLtG-~~PF~~~~~~~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~H 764 (853)
|+|++| .+||......... ..... ...++...+.++.+||.+||+.||.+|||+.+|++.
T Consensus 196 ~~l~~g~~~~~~~~~~~~~~-~~~~~---~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 256 (258)
T cd05078 196 WEIFSGGDKPLSALDSQKKL-QFYED---RHQLPAPKWTELANLINQCMDYEPDFRPSFRAIIRD 256 (258)
T ss_pred HHHHcCCCCChhhccHHHHH-HHHHc---cccCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHh
Confidence 999998 5777654443222 12111 123444456789999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-34 Score=296.55 Aligned_cols=235 Identities=22% Similarity=0.362 Sum_probs=179.5
Q ss_pred EeEeccCceEEEEEEecCCc-----------EEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHH
Q 003052 478 GKIGSGGSSEVHKVISSDCT-----------IYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKAL 546 (853)
Q Consensus 478 k~LG~G~FG~Vyka~~~~g~-----------~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~i 546 (853)
+.||+|+||.||+|.+.+.. .+++|.+...... ...+.+|+.+|+++. |+||+++++++
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~---~~~~~~e~~~l~~l~-h~~i~~~~~~~------ 70 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD---SLAFFETASLMSQLS-HKHLVKLYGVC------ 70 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh---HHHHHHHHHHHHcCC-CcchhheeeEE------
Confidence 36999999999999985432 4777776644322 456889999999997 89999998863
Q ss_pred HHHHhhCCCCCCCCccccCCeEEEEEecch-hhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCC
Q 003052 547 LREVLNGSMNNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSD 625 (853)
Q Consensus 547 L~~l~~~~iv~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRD 625 (853)
.. ...|+||||+. ++|.+++... ...+++..+..++.||+.||.|||++||+|||
T Consensus 71 ----------------~~-~~~~lv~e~~~~~~L~~~l~~~-------~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~d 126 (259)
T cd05037 71 ----------------VR-DENIMVEEYVKFGPLDVFLHRE-------KNNVSLHWKLDVAKQLASALHYLEDKKLVHGN 126 (259)
T ss_pred ----------------ec-CCcEEEEEcCCCCcHHHHHHhh-------ccCCCHHHHHHHHHHHHHHHHHHhhCCeeccc
Confidence 22 34689999976 5888877653 12689999999999999999999999999999
Q ss_pred CCCccEEee-cC-------cEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhH
Q 003052 626 LKPANFLLV-KG-------SLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLG 697 (853)
Q Consensus 626 LKPeNILL~-~g-------~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLG 697 (853)
|||+|||++ ++ .+||+|||++..... .....++..|+|||++.+.. ..++.++||||||
T Consensus 127 lkp~Nill~~~~~~~~~~~~~kl~Dfg~a~~~~~------~~~~~~~~~y~aPE~~~~~~-------~~~~~~~Di~slG 193 (259)
T cd05037 127 VCGKNILVARYGLNEGYVPFIKLSDPGIPITVLS------REERVERIPWIAPECIRNGQ-------ASLTIAADKWSFG 193 (259)
T ss_pred CccceEEEecCccccCCceeEEeCCCCccccccc------ccccccCCCccChhhhcCCC-------CCcchhhHHHHHH
Confidence 999999995 33 599999999986543 12346778899999987542 1367899999999
Q ss_pred HHHHHHHh-CCCCCCcchhHHHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCCChhHHhc
Q 003052 698 CILYQMVY-GRTPFSEYKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQ 763 (853)
Q Consensus 698 VILyELLt-G~~PF~~~~~~~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~ 763 (853)
|++|+|++ |..||....... ....... ... .+......+.+||.+||..||.+||++.++++
T Consensus 194 ~~~~~l~~~~~~p~~~~~~~~-~~~~~~~-~~~--~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 256 (259)
T cd05037 194 TTLLEICSNGEEPLSTLSSSE-KERFYQD-QHR--LPMPDCAELANLINQCWTYDPTKRPSFRAILR 256 (259)
T ss_pred HHHHHHHhCCCCCcccCCchh-HHHHHhc-CCC--CCCCCchHHHHHHHHHhccChhhCCCHHHHHH
Confidence 99999999 688886653221 1111111 111 12222367999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-34 Score=305.70 Aligned_cols=251 Identities=20% Similarity=0.311 Sum_probs=191.8
Q ss_pred CceeeEEEeEeccCceEEEEEEec-CCc----EEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHH
Q 003052 471 GKLYQRLGKIGSGGSSEVHKVISS-DCT----IYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKA 545 (853)
Q Consensus 471 g~~Y~ilk~LG~G~FG~Vyka~~~-~g~----~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~ 545 (853)
...|+..+.||+|+||.||+|.+. ++. .+|+|.+..... ......+.+|+.+++++. |+||+++++++.
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~~~~l~-h~niv~~~~~~~---- 79 (303)
T cd05110 6 ETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTG-PKANVEFMDEALIMASMD-HPHLVRLLGVCL---- 79 (303)
T ss_pred hhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCC-HHHHHHHHHHHHHHHhCC-CCCcccEEEEEc----
Confidence 356889999999999999999873 443 478888765432 233345789999999996 999999998632
Q ss_pred HHHHHhhCCCCCCCCccccCCeEEEEEecch-hhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeC
Q 003052 546 LLREVLNGSMNNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHS 624 (853)
Q Consensus 546 iL~~l~~~~iv~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHR 624 (853)
. ...++++||+. ++|.+++... ...+++..+..++.||+.||.|||++||+||
T Consensus 80 ------------------~-~~~~~v~e~~~~g~l~~~~~~~-------~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~ 133 (303)
T cd05110 80 ------------------S-PTIQLVTQLMPHGCLLDYVHEH-------KDNIGSQLLLNWCVQIAKGMMYLEERRLVHR 133 (303)
T ss_pred ------------------C-CCceeeehhcCCCCHHHHHHhc-------ccCCCHHHHHHHHHHHHHHHHHHhhcCeecc
Confidence 1 23578999965 6888887643 2468999999999999999999999999999
Q ss_pred CCCCccEEe-ecCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHH
Q 003052 625 DLKPANFLL-VKGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQM 703 (853)
Q Consensus 625 DLKPeNILL-~~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyEL 703 (853)
||||+|||+ .++.+||+|||+++.+.............++..|+|||.+.+.. ++.++|||||||++|||
T Consensus 134 dikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~---------~~~~~DiwslG~~l~el 204 (303)
T cd05110 134 DLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRK---------FTHQSDVWSYGVTIWEL 204 (303)
T ss_pred ccccceeeecCCCceEEccccccccccCcccccccCCCccccccCCHHHhccCC---------CChHHHHHHHHHHHHHH
Confidence 999999999 46789999999998764332222222345678999999986543 56799999999999999
Q ss_pred Hh-CCCCCCcchhHHHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCCChhHHhcC
Q 003052 704 VY-GRTPFSEYKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQH 764 (853)
Q Consensus 704 Lt-G~~PF~~~~~~~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~H 764 (853)
++ |..||.+.... .....+.. ......+...+..+.++|.+||..||++||++.++++.
T Consensus 205 ~t~g~~p~~~~~~~-~~~~~~~~-~~~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~ 264 (303)
T cd05110 205 MTFGGKPYDGIPTR-EIPDLLEK-GERLPQPPICTIDVYMVMVKCWMIDADSRPKFKELAAE 264 (303)
T ss_pred HhCCCCCCCCCCHH-HHHHHHHC-CCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 97 99999764322 22222222 22233344567789999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-34 Score=319.11 Aligned_cols=247 Identities=30% Similarity=0.427 Sum_probs=188.0
Q ss_pred eeEEEeEeccCceEEEEEEecCCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHHHHhhC
Q 003052 474 YQRLGKIGSGGSSEVHKVISSDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLREVLNG 553 (853)
Q Consensus 474 Y~ilk~LG~G~FG~Vyka~~~~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~~l~~~ 553 (853)
|.--..||+|+||.||+|...++..||||++....... ...|.+|+.+|.+++ |+|+|+|++|+
T Consensus 77 Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~--~~eF~~Ei~~ls~l~-H~Nlv~LlGyC------------- 140 (361)
T KOG1187|consen 77 FSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQG--EREFLNEVEILSRLR-HPNLVKLLGYC------------- 140 (361)
T ss_pred CchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcc--hhHHHHHHHHHhcCC-CcCcccEEEEE-------------
Confidence 55566799999999999999988999999887654432 334999999999999 99999999984
Q ss_pred CCCCCCCccccCC-eEEEEEecch-hhHHHHHHHhhhhccCCCC-CCCHHHHHHHHHHhhhhhhhcccCc---eeeCCCC
Q 003052 554 SMNNKDGRVKDDG-YIYMVLEYGE-IDLAHMLSQKWKEMDGSNQ-TLDENWLRFYWQQILEAVNTIHEER---IVHSDLK 627 (853)
Q Consensus 554 ~iv~~~g~~~d~~-~lyLVmEy~~-gdL~~~L~~~~k~~~~~~~-~LsE~~~r~I~~QIl~AL~yLHs~g---IIHRDLK 627 (853)
.+.+ ..+||+||+. |+|.+.+... .. .++|....+|+.+++.||+|||... |||||||
T Consensus 141 ---------~e~~~~~~LVYEym~nGsL~d~L~~~-------~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiK 204 (361)
T KOG1187|consen 141 ---------LEGGEHRLLVYEYMPNGSLEDHLHGK-------KGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIK 204 (361)
T ss_pred ---------ecCCceEEEEEEccCCCCHHHHhCCC-------CCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCC
Confidence 3444 5899999966 7999988653 12 8899999999999999999999864 9999999
Q ss_pred CccEEee-cCcEEEEecccchhcccCCcccccccc-ccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHh
Q 003052 628 PANFLLV-KGSLKLIDFGIAKAIMSDTTNIQRDSQ-VGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVY 705 (853)
Q Consensus 628 PeNILL~-~g~VKL~DFGlAk~~~~~~~~~~~~t~-~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLt 705 (853)
+.||||+ +...||+|||+|+........ ..+. .||.+|+|||.+... ..+.++|||||||+|.||++
T Consensus 205 ssNILLD~~~~aKlsDFGLa~~~~~~~~~--~~~~~~gt~gY~~PEy~~~g---------~lt~KsDVySFGVvllElit 273 (361)
T KOG1187|consen 205 SSNILLDEDFNAKLSDFGLAKLGPEGDTS--VSTTVMGTFGYLAPEYASTG---------KLTEKSDVYSFGVVLLELIT 273 (361)
T ss_pred HHHeeECCCCCEEccCccCcccCCccccc--eeeecCCCCccCChhhhccC---------CcCcccccccchHHHHHHHh
Confidence 9999997 559999999999765431111 1122 899999999999764 35679999999999999999
Q ss_pred CCCCCCcch-------hHHHH-------HHhhcCCCCc-ccCCC-CCChhHHHHHHHhcccCCCCCCChhHHhc
Q 003052 706 GRTPFSEYK-------TFWAK-------FKVITDPNHE-ITYEP-VPNPWLLDLMKKCLAWDRNERWRIPQLLQ 763 (853)
Q Consensus 706 G~~PF~~~~-------~~~~~-------~kii~~~~~~-~~~~~-~~s~~l~dLI~kcL~~DP~kRpTa~EIL~ 763 (853)
|+.+.+... ..|.. ...+.++... ..+.. ..-..+..+..+|+..+|.+||++.|+++
T Consensus 274 gr~~~d~~~~~~~~~l~~w~~~~~~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~ 347 (361)
T KOG1187|consen 274 GRKAVDQSRPRGELSLVEWAKPLLEEGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVK 347 (361)
T ss_pred CCcccCCCCCcccccHHHHHHHHHHCcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHH
Confidence 998886421 11211 1111222211 11111 11122567888999999999999999754
|
|
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=300.00 Aligned_cols=236 Identities=19% Similarity=0.291 Sum_probs=178.9
Q ss_pred eEeccCceEEEEEEecC-------------------------CcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCce
Q 003052 479 KIGSGGSSEVHKVISSD-------------------------CTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNI 533 (853)
Q Consensus 479 ~LG~G~FG~Vyka~~~~-------------------------g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNI 533 (853)
+||+|+||.||+|.... ...+|+|++..... .....+.+|+.+++++. |+||
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~--~~~~~~~~~~~~~~~l~-h~ni 78 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHR--DIALAFFETASLMSQVS-HIHL 78 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHH--HHHHHHHHHHHHHhcCC-CCCe
Confidence 59999999999987411 13478888865432 33456788999998887 8999
Q ss_pred eEeeehhhhHHHHHHHHhhCCCCCCCCccccCCeEEEEEecchh-hHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhh
Q 003052 534 IQLIDYEVTEKALLREVLNGSMNNKDGRVKDDGYIYMVLEYGEI-DLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEA 612 (853)
Q Consensus 534 V~Lid~~~~e~~iL~~l~~~~iv~~~g~~~d~~~lyLVmEy~~g-dL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~A 612 (853)
+++++++ .++...|+||||+++ +|..++.. ....+++.++..++.||+.|
T Consensus 79 v~~~~~~----------------------~~~~~~~lv~ey~~~g~L~~~l~~-------~~~~~~~~~~~~i~~qi~~~ 129 (274)
T cd05076 79 AFVHGVC----------------------VRGSENIMVEEFVEHGPLDVCLRK-------EKGRVPVAWKITVAQQLASA 129 (274)
T ss_pred eeEEEEE----------------------EeCCceEEEEecCCCCcHHHHHHh-------cCCCCCHHHHHHHHHHHHHH
Confidence 9999873 455678999999775 66666543 23568999999999999999
Q ss_pred hhhcccCceeeCCCCCccEEeec-C-------cEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCcc
Q 003052 613 VNTIHEERIVHSDLKPANFLLVK-G-------SLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNI 684 (853)
Q Consensus 613 L~yLHs~gIIHRDLKPeNILL~~-g-------~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~ 684 (853)
|+|||++||+||||||+|||++. + .+||+|||++...... ....++..|+|||.+.+..
T Consensus 130 l~~lH~~~iiH~dlkp~Nill~~~~~~~~~~~~~kl~d~g~~~~~~~~------~~~~~~~~~~aPe~~~~~~------- 196 (274)
T cd05076 130 LSYLEDKNLVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVSFTALSR------EERVERIPWIAPECVPGGN------- 196 (274)
T ss_pred HHHHHcCCccCCCCCcccEEEeccCcccCccceeeecCCccccccccc------cccccCCcccCchhhcCCC-------
Confidence 99999999999999999999953 1 4899999998654321 1346788999999886531
Q ss_pred ccCCCccchhhhHHHHHHHH-hCCCCCCcchhHHHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCCChhHHhc
Q 003052 685 IKCGRPSDIWSLGCILYQMV-YGRTPFSEYKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQ 763 (853)
Q Consensus 685 ~~ys~ksDIWSLGVILyELL-tG~~PF~~~~~~~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~ 763 (853)
.++.++|||||||++|||+ +|..||........ ...... ....+....+.+.+||.+||..+|.+||++.+||+
T Consensus 197 -~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~-~~~~~~---~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~ 271 (274)
T cd05076 197 -SLSTAADKWSFGTTLLEICFDGEVPLKERTPSEK-ERFYEK---KHRLPEPSCKELATLISQCLTYEPTQRPSFRTILR 271 (274)
T ss_pred -CCCcHHHHHHHHHHHHHHHhCCCCCccccChHHH-HHHHHh---ccCCCCCCChHHHHHHHHHcccChhhCcCHHHHHH
Confidence 3678999999999999985 79999976433221 111111 11222334567999999999999999999999997
Q ss_pred C
Q 003052 764 H 764 (853)
Q Consensus 764 H 764 (853)
+
T Consensus 272 ~ 272 (274)
T cd05076 272 D 272 (274)
T ss_pred h
Confidence 5
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-35 Score=323.03 Aligned_cols=260 Identities=26% Similarity=0.362 Sum_probs=200.6
Q ss_pred eEEcCceeeEEEeEeccCceEEEEEEe-cCCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCC-----CceeEeeehh
Q 003052 467 FKVNGKLYQRLGKIGSGGSSEVHKVIS-SDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGK-----NNIIQLIDYE 540 (853)
Q Consensus 467 ~~v~g~~Y~ilk~LG~G~FG~Vyka~~-~~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~h-----pNIV~Lid~~ 540 (853)
.++...+|.+....|+|-|+.|..|.+ .-+..||||+|..+. ...+.=+.|++||++|... -|+++|+.
T Consensus 427 gE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE---~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r-- 501 (752)
T KOG0670|consen 427 GELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNE---VMHKTGLKELEILKKLNDADPEDKFHCLRLFR-- 501 (752)
T ss_pred hhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecch---HHhhhhhHHHHHHHHhhccCchhhhHHHHHHH--
Confidence 345567899999999999999999998 456799999998543 3344557999999999742 23333322
Q ss_pred hhHHHHHHHHhhCCCCCCCCccccCCeEEEEEecchhhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCc
Q 003052 541 VTEKALLREVLNGSMNNKDGRVKDDGYIYMVLEYGEIDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEER 620 (853)
Q Consensus 541 ~~e~~iL~~l~~~~iv~~~g~~~d~~~lyLVmEy~~gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~g 620 (853)
.|...+++|||+|-+..+|.++|++. +.+..|....++.|+.||+.||.+|-..|
T Consensus 502 --------------------~F~hknHLClVFE~LslNLRevLKKy-----G~nvGL~ikaVRsYaqQLflALklLK~c~ 556 (752)
T KOG0670|consen 502 --------------------HFKHKNHLCLVFEPLSLNLREVLKKY-----GRNVGLHIKAVRSYAQQLFLALKLLKKCG 556 (752)
T ss_pred --------------------HhhhcceeEEEehhhhchHHHHHHHh-----CcccceeehHHHHHHHHHHHHHHHHHhcC
Confidence 26677899999999999999999876 34567999999999999999999999999
Q ss_pred eeeCCCCCccEEeecC--cEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHH
Q 003052 621 IVHSDLKPANFLLVKG--SLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGC 698 (853)
Q Consensus 621 IIHRDLKPeNILL~~g--~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGV 698 (853)
|+|.||||+|||++++ .+||||||.|...... ..+.+.-+..|+|||++.|.. |.+..|+||+||
T Consensus 557 vlHaDIKPDNiLVNE~k~iLKLCDfGSA~~~~en----eitPYLVSRFYRaPEIiLG~~---------yd~~iD~WSvgc 623 (752)
T KOG0670|consen 557 VLHADIKPDNILVNESKNILKLCDFGSASFASEN----EITPYLVSRFYRAPEIILGLP---------YDYPIDTWSVGC 623 (752)
T ss_pred eeecccCccceEeccCcceeeeccCccccccccc----cccHHHHHHhccCcceeecCc---------ccCCccceeece
Confidence 9999999999999654 7999999999766443 233567788999999999875 457899999999
Q ss_pred HHHHHHhCCCCCCcchhHHH--HHHhhcCCC------------------CcccC-------------------C------
Q 003052 699 ILYQMVYGRTPFSEYKTFWA--KFKVITDPN------------------HEITY-------------------E------ 733 (853)
Q Consensus 699 ILyELLtG~~PF~~~~~~~~--~~kii~~~~------------------~~~~~-------------------~------ 733 (853)
+||||+||+..|.+..+-.. .+.-+..+. ..+.+ +
T Consensus 624 tLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s 703 (752)
T KOG0670|consen 624 TLYELYTGKILFPGRTNNQMLRLFMELKGKFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGS 703 (752)
T ss_pred eeEEeeccceecCCCCcHHHHHHHHHhcCCCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHH
Confidence 99999999999976433211 110000000 00000 0
Q ss_pred -----CCCC-------hhHHHHHHHhcccCCCCCCChhHHhcCCCCCC
Q 003052 734 -----PVPN-------PWLLDLMKKCLAWDRNERWRIPQLLQHPFLVP 769 (853)
Q Consensus 734 -----~~~s-------~~l~dLI~kcL~~DP~kRpTa~EIL~HPwf~~ 769 (853)
..++ ..+++||.+||..||.+|.|+.|+|+||||..
T Consensus 704 ~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~KRit~nqAL~HpFi~~ 751 (752)
T KOG0670|consen 704 ELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEKRITVNQALKHPFITE 751 (752)
T ss_pred HHhccCCCCchhHHHHHHHHHHHHHHhccChhhcCCHHHHhcCCcccC
Confidence 0011 23789999999999999999999999999964
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-33 Score=333.74 Aligned_cols=259 Identities=24% Similarity=0.335 Sum_probs=210.4
Q ss_pred EcCceeeEEEeEeccCceEEEEEEec--CCc----EEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhh
Q 003052 469 VNGKLYQRLGKIGSGGSSEVHKVISS--DCT----IYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVT 542 (853)
Q Consensus 469 v~g~~Y~ilk~LG~G~FG~Vyka~~~--~g~----~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~ 542 (853)
+..+..++.+.||+|+||.||.|... .+. .||||.++.. .+.+....|++|..+|+++. |||||++++++
T Consensus 689 v~~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~-~~~~~~~~Fl~Ea~~m~~f~-HpNiv~liGv~-- 764 (1025)
T KOG1095|consen 689 VPRKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRL-SSEQEVSDFLKEALLMSKFD-HPNIVSLIGVC-- 764 (1025)
T ss_pred CChhheEeeeeeccccccceEEEEEecCCCCccceEEEEEecccc-CCHHHHHHHHHHHHHHhcCC-CcceeeEEEee--
Confidence 55667888999999999999999863 332 4899998754 44566778999999999998 99999999974
Q ss_pred HHHHHHHHhhCCCCCCCCccccCCeEEEEEecch-hhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCce
Q 003052 543 EKALLREVLNGSMNNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERI 621 (853)
Q Consensus 543 e~~iL~~l~~~~iv~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gI 621 (853)
-+....+|++||++ |||..+|++.+..... ...|+......++.+|++|++||+++++
T Consensus 765 --------------------l~~~~~~i~leyM~gGDL~sflr~~r~~~~~-~~~L~~~dLl~~a~dvA~G~~YLe~~~f 823 (1025)
T KOG1095|consen 765 --------------------LDSGPPLILLEYMEGGDLLSFLRESRPAPFQ-PSNLSMRDLLAFALDVAKGMNYLESKHF 823 (1025)
T ss_pred --------------------cCCCCcEEEehhcccCcHHHHHHhcccccCC-CCCCCHHHHHHHHHHHhhhhHHHHhCCC
Confidence 23566899999966 6999999875332222 4568899999999999999999999999
Q ss_pred eeCCCCCccEEee-cCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHH
Q 003052 622 VHSDLKPANFLLV-KGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCIL 700 (853)
Q Consensus 622 IHRDLKPeNILL~-~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVIL 700 (853)
|||||...|+||+ ...+||+|||||+-+.....+.......-...|||||.++.. .|+.|+|||||||+|
T Consensus 824 vHRDLAaRNCLL~~~r~VKIaDFGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~---------iFtskSDvWsFGVll 894 (1025)
T KOG1095|consen 824 VHRDLAARNCLLDERRVVKIADFGLARDIYDKDYYRKHGEAMLPVKWMPPESLKDG---------IFTSKSDVWSFGVLL 894 (1025)
T ss_pred cCcchhhhheeecccCcEEEcccchhHhhhhchheeccCccccceecCCHHHHhhc---------ccccccchhhhHHHH
Confidence 9999999999995 568999999999955443332221221234589999999864 477899999999999
Q ss_pred HHHHh-CCCCCCcchhHHHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCCChhHHhc
Q 003052 701 YQMVY-GRTPFSEYKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQ 763 (853)
Q Consensus 701 yELLt-G~~PF~~~~~~~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~ 763 (853)
||+++ |..||.+..+........... .+..+..++..+.++|..||..+|++||++..|++
T Consensus 895 WEifslG~~PY~~~~n~~v~~~~~~gg--RL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~ 956 (1025)
T KOG1095|consen 895 WEIFSLGATPYPSRSNFEVLLDVLEGG--RLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVE 956 (1025)
T ss_pred HHHHhCCCCCCCCcchHHHHHHHHhCC--ccCCCCCCChHHHHHHHHHccCChhhCccHHHHHh
Confidence 99996 999999888766555455544 66777788888999999999999999999999997
|
|
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-34 Score=325.46 Aligned_cols=250 Identities=27% Similarity=0.404 Sum_probs=189.9
Q ss_pred eeeEEEeEeccCceEEEEEEe-cCCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHHHHh
Q 003052 473 LYQRLGKIGSGGSSEVHKVIS-SDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLREVL 551 (853)
Q Consensus 473 ~Y~ilk~LG~G~FG~Vyka~~-~~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~~l~ 551 (853)
.|..-+.||+||||.||++++ .+|+.||||.+.... .......+++|+++|++|+ |+|||++++...+...
T Consensus 14 ~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~-~~r~~e~~~~EieilkKLn-h~NIVk~f~iee~~~~------ 85 (732)
T KOG4250|consen 14 LWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKES-SLRPRERWCREIEILKKLN-HPNIVKLFDIEETKFL------ 85 (732)
T ss_pred ceeehhhhcCCccceeeeecccccccchhHHhhhhhc-ccchHHHHHHHHHHHHHcC-chhhhhhcccCCcccc------
Confidence 466777899999999999996 688999999998754 3455667999999999999 9999999987543210
Q ss_pred hCCCCCCCCccccCCeEEEEEecch-hhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCCCcc
Q 003052 552 NGSMNNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPAN 630 (853)
Q Consensus 552 ~~~iv~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLKPeN 630 (853)
.--...-.+|||||. |+|...+.+- .+...|+|.+++.++..+..||.|||++||+||||||.|
T Consensus 86 ----------~~~~~~~vlvmEyC~gGsL~~~L~~P-----EN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~N 150 (732)
T KOG4250|consen 86 ----------GLVTRLPVLVMEYCSGGSLRKVLNSP-----ENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGN 150 (732)
T ss_pred ----------CcccccceEEEeecCCCcHHHHhcCc-----ccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCc
Confidence 011234589999976 5888887642 244679999999999999999999999999999999999
Q ss_pred EEee---cC--cEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHh
Q 003052 631 FLLV---KG--SLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVY 705 (853)
Q Consensus 631 ILL~---~g--~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLt 705 (853)
|++- +| .-||+|||+|+.+.++. ...+++||+.|.+||++.... +|+..+|.|||||++|++.|
T Consensus 151 Ivl~~Gedgq~IyKLtDfG~Arel~d~s---~~~S~vGT~~YLhPel~E~q~--------~y~~tVDLWS~GvtlY~caT 219 (732)
T KOG4250|consen 151 IVLQIGEDGQSIYKLTDFGAARELDDNS---LFTSLVGTEEYLHPELYERQK--------KYTATVDLWSFGVTLYECAT 219 (732)
T ss_pred EEEeecCCCceEEeeecccccccCCCCC---eeeeecCchhhcChHHHhhcc--------CcCceeehhhhhhHHHHHhc
Confidence 9993 24 46999999999886544 456899999999999997521 57789999999999999999
Q ss_pred CCCCCCcchh----HHHHHHhhcCCC------------Cc------ccCCCCCChh----HHHHHHHhcccCCCCCC
Q 003052 706 GRTPFSEYKT----FWAKFKVITDPN------------HE------ITYEPVPNPW----LLDLMKKCLAWDRNERW 756 (853)
Q Consensus 706 G~~PF~~~~~----~~~~~kii~~~~------------~~------~~~~~~~s~~----l~dLI~kcL~~DP~kRp 756 (853)
|..||..... ......++.... .+ ++++...++- +-..|..+|.++|.+|+
T Consensus 220 G~lPF~p~~~pk~~~~~~~~~~tkkp~~v~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~ 296 (732)
T KOG4250|consen 220 GELPFIPFGGPKNNKEIMWHIITKKPSGVAIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRG 296 (732)
T ss_pred cCCCCCcCCCccccchhhhhhhccCCCceeEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhC
Confidence 9999943221 112222222111 11 1122222222 45677889999999999
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-33 Score=317.22 Aligned_cols=254 Identities=19% Similarity=0.317 Sum_probs=203.2
Q ss_pred eEEcCceeeEEEeEeccCceEEEEEEec--CC--cE-EEEEEEecCC-CChhhHhhHHHHHHHHHHhcCCCceeEeeehh
Q 003052 467 FKVNGKLYQRLGKIGSGGSSEVHKVISS--DC--TI-YALKKIKLKG-RDYATAYGFCQEIEYLNKLKGKNNIIQLIDYE 540 (853)
Q Consensus 467 ~~v~g~~Y~ilk~LG~G~FG~Vyka~~~--~g--~~-vAVKkik~~~-~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~ 540 (853)
|.+...+-.+.++||+|+||.||+|... ++ .. ||||..+... ........|++|.++|++++ |+|||++|++.
T Consensus 152 Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~-H~NVVr~yGVa 230 (474)
T KOG0194|consen 152 WELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLN-HPNVVRFYGVA 230 (474)
T ss_pred cEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCC-CCCEEEEEEEE
Confidence 4444555666789999999999999863 22 23 8999988633 45677788999999999988 99999999974
Q ss_pred hhHHHHHHHHhhCCCCCCCCccccCCeEEEEEecch-hhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccC
Q 003052 541 VTEKALLREVLNGSMNNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEE 619 (853)
Q Consensus 541 ~~e~~iL~~l~~~~iv~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~ 619 (853)
.+..-+|||||+|. |+|.++|++. ...++..+...++.+.+.||+|||++
T Consensus 231 ----------------------~~~~Pl~ivmEl~~gGsL~~~L~k~-------~~~v~~~ek~~~~~~AA~Gl~YLh~k 281 (474)
T KOG0194|consen 231 ----------------------VLEEPLMLVMELCNGGSLDDYLKKN-------KKSLPTLEKLRFCYDAARGLEYLHSK 281 (474)
T ss_pred ----------------------cCCCccEEEEEecCCCcHHHHHHhC-------CCCCCHHHHHHHHHHHHhHHHHHHHC
Confidence 34456899999976 5999999874 23699999999999999999999999
Q ss_pred ceeeCCCCCccEEeec-CcEEEEecccchhcccCCcccccccc-ccCccccCchhhccCCCCCCCccccCCCccchhhhH
Q 003052 620 RIVHSDLKPANFLLVK-GSLKLIDFGIAKAIMSDTTNIQRDSQ-VGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLG 697 (853)
Q Consensus 620 gIIHRDLKPeNILL~~-g~VKL~DFGlAk~~~~~~~~~~~~t~-~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLG 697 (853)
++|||||-..|+|++. +.+||+|||+++.... ....... .-...|+|||.+... .|+.++||||||
T Consensus 282 ~~IHRDIAARNcL~~~~~~vKISDFGLs~~~~~---~~~~~~~~klPirWLAPEtl~~~---------~~s~kTDV~sfG 349 (474)
T KOG0194|consen 282 NCIHRDIAARNCLYSKKGVVKISDFGLSRAGSQ---YVMKKFLKKLPIRWLAPETLNTG---------IFSFKTDVWSFG 349 (474)
T ss_pred CCcchhHhHHHheecCCCeEEeCccccccCCcc---eeeccccccCcceecChhhhccC---------ccccccchhhee
Confidence 9999999999999976 5669999999976431 1111112 245789999999654 478899999999
Q ss_pred HHHHHHHh-CCCCCCcchhHHHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCCChhHHhc
Q 003052 698 CILYQMVY-GRTPFSEYKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQ 763 (853)
Q Consensus 698 VILyELLt-G~~PF~~~~~~~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~ 763 (853)
|++||+++ |..||.+........++... ......+...+..+..++.+|+..||++||++.++.+
T Consensus 350 V~~~Eif~~g~~Py~g~~~~~v~~kI~~~-~~r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~ 415 (474)
T KOG0194|consen 350 VLLWEIFENGAEPYPGMKNYEVKAKIVKN-GYRMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKK 415 (474)
T ss_pred eeEEeeeccCCCCCCCCCHHHHHHHHHhc-CccCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHH
Confidence 99999998 88999987776555555343 3444555677888999999999999999999998875
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-32 Score=315.20 Aligned_cols=284 Identities=21% Similarity=0.297 Sum_probs=187.2
Q ss_pred cCceeeEEEeEeccCceEEEEEEe-----------------cCCcEEEEEEEecCCCChhhHhh--------------HH
Q 003052 470 NGKLYQRLGKIGSGGSSEVHKVIS-----------------SDCTIYALKKIKLKGRDYATAYG--------------FC 518 (853)
Q Consensus 470 ~g~~Y~ilk~LG~G~FG~Vyka~~-----------------~~g~~vAVKkik~~~~~~~~~~~--------------~l 518 (853)
..+.|.+.++||+|+||.||+|.. ..++.||||++...... .... ..
T Consensus 143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~--~~~~fl~e~~~~~~~~e~~~ 220 (507)
T PLN03224 143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQG--VRQDFLKTGTLAKGSAETGM 220 (507)
T ss_pred cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchh--hHHHHHhhhhhhhcccchhH
Confidence 346799999999999999999964 23467999999754321 1122 33
Q ss_pred HHHHHHHHhcCCCc----eeEeeehhhhHHHHHHHHhhCCCCCCCCccccCCeEEEEEecch-hhHHHHHHHhhhhc---
Q 003052 519 QEIEYLNKLKGKNN----IIQLIDYEVTEKALLREVLNGSMNNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEM--- 590 (853)
Q Consensus 519 ~EI~iLkkL~~hpN----IV~Lid~~~~e~~iL~~l~~~~iv~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~~--- 590 (853)
.|+.++.+++++++ ++++++|+... ...+ ....+..|+||||++ ++|.+++.......
T Consensus 221 vE~~~l~~l~~~~l~~~~~~~~lg~~~~~-------------~~~g-~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~ 286 (507)
T PLN03224 221 VEAYMCAKIKRNPIAAASCAEYLGYFTSN-------------TADG-AFTKGSQWLVWKFESDATLGDALDGKLGPFPGC 286 (507)
T ss_pred HHHHHHHHhhcccchhhhhhhhhhhcccc-------------cccc-cccCCceEEEEEcCCCCcHHHHHhhccCCCcch
Confidence 46666666664332 23333332110 0111 123456899999966 58888776421100
Q ss_pred -------------cCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCCCccEEe-ecCcEEEEecccchhcccCCccc
Q 003052 591 -------------DGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLL-VKGSLKLIDFGIAKAIMSDTTNI 656 (853)
Q Consensus 591 -------------~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLKPeNILL-~~g~VKL~DFGlAk~~~~~~~~~ 656 (853)
......+++..++.++.||+.||.|||+++|+||||||+|||+ .++.+||+|||+++....... .
T Consensus 287 L~e~l~~g~~l~~~~~~~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~-~ 365 (507)
T PLN03224 287 LEEFMMAGKKIPDNMPQDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGIN-F 365 (507)
T ss_pred HHHHHhcCCchhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEECCCCcEEEEeCcCccccccCCc-c
Confidence 0012345778899999999999999999999999999999999 457999999999976533211 1
Q ss_pred cccccccCccccCchhhccCCCCCCCc-----------cccCC--CccchhhhHHHHHHHHhCCC-CCCcchhHHHHH--
Q 003052 657 QRDSQVGTLSYMSPEAFMCNESDENGN-----------IIKCG--RPSDIWSLGCILYQMVYGRT-PFSEYKTFWAKF-- 720 (853)
Q Consensus 657 ~~~t~~GTp~YmAPEvl~~~~~~~~~~-----------~~~ys--~ksDIWSLGVILyELLtG~~-PF~~~~~~~~~~-- 720 (853)
......+|+.|+|||.+.......... ...|+ .+.||||+|||+|+|++|.. ||.+...+...+
T Consensus 366 ~~~~g~~tp~Y~aPE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~ 445 (507)
T PLN03224 366 NPLYGMLDPRYSPPEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQ 445 (507)
T ss_pred CccccCCCcceeChhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhh
Confidence 111234589999999986532211000 00122 35799999999999999986 775432221111
Q ss_pred --------HhhcCCCCcccCCCCCChhHHHHHHHhcccCC---CCCCChhHHhcCCCCCCC
Q 003052 721 --------KVITDPNHEITYEPVPNPWLLDLMKKCLAWDR---NERWRIPQLLQHPFLVPP 770 (853)
Q Consensus 721 --------kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP---~kRpTa~EIL~HPwf~~~ 770 (853)
+........+......++.++|||.+||.++| .+|+|+.|+|+||||.+.
T Consensus 446 ~~~~~~~~r~~~~~~~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp~f~~~ 506 (507)
T PLN03224 446 YDNDLNRWRMYKGQKYDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHRFFLPE 506 (507)
T ss_pred ccchHHHHHhhcccCCCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCCCcCCC
Confidence 11122223333445567889999999999876 689999999999999753
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=286.37 Aligned_cols=254 Identities=28% Similarity=0.509 Sum_probs=196.3
Q ss_pred cCceeeEEEeEeccCceEEEEEEe-cCCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHH
Q 003052 470 NGKLYQRLGKIGSGGSSEVHKVIS-SDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLR 548 (853)
Q Consensus 470 ~g~~Y~ilk~LG~G~FG~Vyka~~-~~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~ 548 (853)
+.+.|++++++|+|-|+.||.|+. .+...++||+++.- ..+.+.+||+||+.|.+++||+.|+|.....
T Consensus 36 ~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPV-----kkkKIkREikIL~nL~gg~NIi~L~DiV~Dp----- 105 (338)
T KOG0668|consen 36 NQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPV-----KKKKIKREIKILQNLRGGPNIIKLLDIVKDP----- 105 (338)
T ss_pred ccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechH-----HHHHHHHHHHHHHhccCCCCeeehhhhhcCc-----
Confidence 346799999999999999999987 56678899998743 3346889999999999999999999975321
Q ss_pred HHhhCCCCCCCCccccCCeEEEEEecchh-hHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCC
Q 003052 549 EVLNGSMNNKDGRVKDDGYIYMVLEYGEI-DLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLK 627 (853)
Q Consensus 549 ~l~~~~iv~~~g~~~d~~~lyLVmEy~~g-dL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLK 627 (853)
......+|+||... |...+. ..|+...+++++.+|+.||.|||+.||+|||+|
T Consensus 106 ---------------~SktpaLiFE~v~n~Dfk~ly-----------~tl~d~dIryY~~elLkALdyCHS~GImHRDVK 159 (338)
T KOG0668|consen 106 ---------------ESKTPSLIFEYVNNTDFKQLY-----------PTLTDYDIRYYIYELLKALDYCHSMGIMHRDVK 159 (338)
T ss_pred ---------------cccCchhHhhhhccccHHHHh-----------hhhchhhHHHHHHHHHHHHhHHHhcCcccccCC
Confidence 22346789999664 433322 468899999999999999999999999999999
Q ss_pred CccEEeec--CcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHh
Q 003052 628 PANFLLVK--GSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVY 705 (853)
Q Consensus 628 PeNILL~~--g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLt 705 (853)
|.|++|+. ..++|+|+|+|..+.... ..+..+.+.+|--||++..-. .|...-|+|||||+|..|++
T Consensus 160 PhNvmIdh~~rkLrlIDWGLAEFYHp~~---eYnVRVASRyfKGPELLVdy~--------~YDYSLD~WS~GcmlA~miF 228 (338)
T KOG0668|consen 160 PHNVMIDHELRKLRLIDWGLAEFYHPGK---EYNVRVASRYFKGPELLVDYQ--------MYDYSLDMWSLGCMLASMIF 228 (338)
T ss_pred cceeeechhhceeeeeecchHhhcCCCc---eeeeeeehhhcCCchheeech--------hccccHHHHHHHHHHHHHHh
Confidence 99999954 489999999998875433 233567889999999997543 47789999999999999999
Q ss_pred CCCCCC----cchhHHHHHHhhc---------------CCC-------------CcccC---CCCCChhHHHHHHHhccc
Q 003052 706 GRTPFS----EYKTFWAKFKVIT---------------DPN-------------HEITY---EPVPNPWLLDLMKKCLAW 750 (853)
Q Consensus 706 G~~PF~----~~~~~~~~~kii~---------------~~~-------------~~~~~---~~~~s~~l~dLI~kcL~~ 750 (853)
.+-||. +.+++..+.+++. ++. ..+.. ....++++.|||.++|.+
T Consensus 229 rkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrY 308 (338)
T KOG0668|consen 229 RKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRY 308 (338)
T ss_pred ccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhh
Confidence 999983 2222211111111 100 00111 123468899999999999
Q ss_pred CCCCCCChhHHhcCCCCCCC
Q 003052 751 DRNERWRIPQLLQHPFLVPP 770 (853)
Q Consensus 751 DP~kRpTa~EIL~HPwf~~~ 770 (853)
|-.+|+|+.|++.||||.+-
T Consensus 309 DHqeRlTakEam~HpyF~~~ 328 (338)
T KOG0668|consen 309 DHQERLTAKEAMAHPYFAPV 328 (338)
T ss_pred ccccccchHHHhcCchHHHH
Confidence 99999999999999999754
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-32 Score=274.33 Aligned_cols=240 Identities=35% Similarity=0.559 Sum_probs=192.1
Q ss_pred CceEEEEEEec-CCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHHHHhhCCCCCCCCcc
Q 003052 484 GSSEVHKVISS-DCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLREVLNGSMNNKDGRV 562 (853)
Q Consensus 484 ~FG~Vyka~~~-~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~~l~~~~iv~~~g~~ 562 (853)
+||.||+|... ++..+|+|++........ ...+.+|++.+++++ |+||++++++ +
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-~~~~~~e~~~~~~l~-~~~i~~~~~~----------------------~ 56 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKK-RERILREISILKKLK-HPNIVRLYDV----------------------F 56 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccH-HHHHHHHHHHHHhCC-CCcHHHHHhh----------------------e
Confidence 68999999985 578999999976544322 567889999999994 8999988775 3
Q ss_pred ccCCeEEEEEecchh-hHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCCCccEEee-cCcEEE
Q 003052 563 KDDGYIYMVLEYGEI-DLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLLV-KGSLKL 640 (853)
Q Consensus 563 ~d~~~lyLVmEy~~g-dL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLKPeNILL~-~g~VKL 640 (853)
......+++|||.++ +|.+++... ..+++..+..++.+++.+|.|||+.||+|+||+|.||+++ ++.++|
T Consensus 57 ~~~~~~~l~~e~~~~~~L~~~~~~~--------~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~~~~~~~l 128 (244)
T smart00220 57 EDEDKLYLVMEYCDGGDLFDLLKKR--------GRLSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLDEDGHVKL 128 (244)
T ss_pred eeCCEEEEEEeCCCCCCHHHHHHhc--------cCCCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEECCCCcEEE
Confidence 344688999999776 888887653 2389999999999999999999999999999999999994 579999
Q ss_pred EecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHhCCCCCCcchhHHHHH
Q 003052 641 IDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGRTPFSEYKTFWAKF 720 (853)
Q Consensus 641 ~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLtG~~PF~~~~~~~~~~ 720 (853)
+|||++....... ......|+..|++||.+.+. .++.++|||+||+++|+|++|..||..........
T Consensus 129 ~d~~~~~~~~~~~---~~~~~~~~~~~~~pE~~~~~---------~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~ 196 (244)
T smart00220 129 ADFGLARQLDPGG---LLTTFVGTPEYMAPEVLLGK---------GYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELF 196 (244)
T ss_pred ccccceeeecccc---ccccccCCcCCCCHHHHccC---------CCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHH
Confidence 9999998765432 22356789999999998744 34679999999999999999999997633333444
Q ss_pred HhhcCCCCcccCCCC-CChhHHHHHHHhcccCCCCCCChhHHhcCCCC
Q 003052 721 KVITDPNHEITYEPV-PNPWLLDLMKKCLAWDRNERWRIPQLLQHPFL 767 (853)
Q Consensus 721 kii~~~~~~~~~~~~-~s~~l~dLI~kcL~~DP~kRpTa~EIL~HPwf 767 (853)
..+............ .+..+.+++.+||..||.+||++.++++||||
T Consensus 197 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~~~~~~~ 244 (244)
T smart00220 197 KKIGKPKPPFPPPEWKISPEAKDLIRKLLVKDPEKRLTAEEALQHPFF 244 (244)
T ss_pred HHHhccCCCCccccccCCHHHHHHHHHHccCCchhccCHHHHhhCCCC
Confidence 444333332222221 67789999999999999999999999999997
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-33 Score=323.68 Aligned_cols=253 Identities=24% Similarity=0.385 Sum_probs=194.9
Q ss_pred eeEEEeEeccCceE-EEEEEecCCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHHHHhh
Q 003052 474 YQRLGKIGSGGSSE-VHKVISSDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLREVLN 552 (853)
Q Consensus 474 Y~ilk~LG~G~FG~-Vyka~~~~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~~l~~ 552 (853)
|.-.+.+|.|+-|+ ||+|.. +++.||||.+-....+ -..+||..|+.-+.|+|||++++.
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~y-e~R~VAVKrll~e~~~-----~A~rEi~lL~eSD~H~NviRyyc~------------- 571 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGVY-EGREVAVKRLLEEFFD-----FAQREIQLLQESDEHPNVIRYYCS------------- 571 (903)
T ss_pred eccHHHcccCCCCcEEEEEee-CCceehHHHHhhHhHH-----HHHHHHHHHHhccCCCceEEEEee-------------
Confidence 44455689999986 689877 5678999998754333 345999999999999999999875
Q ss_pred CCCCCCCCccccCCeEEEEEecchhhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCCCccEE
Q 003052 553 GSMNNKDGRVKDDGYIYMVLEYGEIDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANFL 632 (853)
Q Consensus 553 ~~iv~~~g~~~d~~~lyLVmEy~~gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLKPeNIL 632 (853)
-+++.++||.+|.|..+|.+++.....+.. .......+.++.|++.||+|||+.+||||||||.|||
T Consensus 572 ---------E~d~qF~YIalELC~~sL~dlie~~~~d~~----~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNIL 638 (903)
T KOG1027|consen 572 ---------EQDRQFLYIALELCACSLQDLIESSGLDVE----MQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNIL 638 (903)
T ss_pred ---------ccCCceEEEEehHhhhhHHHHHhccccchh----hcccccHHHHHHHHHHHHHHHHhcccccccCCCceEE
Confidence 357789999999999999999987411111 1111446778899999999999999999999999999
Q ss_pred eec----C--cEEEEecccchhcccCCcccc-ccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHh
Q 003052 633 LVK----G--SLKLIDFGIAKAIMSDTTNIQ-RDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVY 705 (853)
Q Consensus 633 L~~----g--~VKL~DFGlAk~~~~~~~~~~-~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLt 705 (853)
|.- + .++|+|||+|+.+..+..... ..+..||-+|+|||++..... ..++|||||||++|+.++
T Consensus 639 I~~~~~~~~~ra~iSDfglsKkl~~~~sS~~r~s~~sGt~GW~APE~L~~~~~---------~~avDiFslGCvfyYvlt 709 (903)
T KOG1027|consen 639 ISVPSADGTLRAKISDFGLSKKLAGGKSSFSRLSGGSGTSGWQAPEQLREDRK---------TQAVDIFSLGCVFYYVLT 709 (903)
T ss_pred EEccCCCcceeEEecccccccccCCCcchhhcccCCCCcccccCHHHHhcccc---------CcccchhhcCceEEEEec
Confidence 942 3 689999999998875544333 356789999999999987643 358999999999999887
Q ss_pred C-CCCCCcchhHHHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCCChhHHhcCCCCCC
Q 003052 706 G-RTPFSEYKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQHPFLVP 769 (853)
Q Consensus 706 G-~~PF~~~~~~~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~HPwf~~ 769 (853)
| ..||.+... ....++.....-....+....++.|||.+||..||..||+|.++|.||||-.
T Consensus 710 gG~HpFGd~~~--R~~NIl~~~~~L~~L~~~~d~eA~dLI~~ml~~dP~~RPsa~~VL~HPlFW~ 772 (903)
T KOG1027|consen 710 GGSHPFGDSLE--RQANILTGNYTLVHLEPLPDCEAKDLISRMLNPDPQLRPSATDVLNHPLFWD 772 (903)
T ss_pred CCccCCCchHH--hhhhhhcCccceeeeccCchHHHHHHHHHhcCCCcccCCCHHHHhCCCccCC
Confidence 5 999976432 2223333222222223322237999999999999999999999999999964
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=298.83 Aligned_cols=257 Identities=26% Similarity=0.408 Sum_probs=200.0
Q ss_pred EeEeccCceEEEEEEe-cCCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHHHHhhCCCC
Q 003052 478 GKIGSGGSSEVHKVIS-SDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLREVLNGSMN 556 (853)
Q Consensus 478 k~LG~G~FG~Vyka~~-~~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~~l~~~~iv 556 (853)
+-||-|+||+||.+++ ++|+.+|+|++..-.......+++.+|+++|.-++ |.||+..+|...... +
T Consensus 59 RPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFk-HdNVLSaLDILQPph----------~- 126 (449)
T KOG0664|consen 59 RPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFR-HDNVLSLLDILQPAN----------P- 126 (449)
T ss_pred CcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhc-cccHHHHHHhcCCCC----------c-
Confidence 4699999999999998 78999999999876666677788999999999998 889988887643211 0
Q ss_pred CCCCccccCCeEEEEEecchhhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCCCccEEee-c
Q 003052 557 NKDGRVKDDGYIYMVLEYGEIDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLLV-K 635 (853)
Q Consensus 557 ~~~g~~~d~~~lyLVmEy~~gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLKPeNILL~-~ 635 (853)
..|+ .+|+|.|++..||..+|- +.+.|+.+.++-+++||++||+|||+.||+||||||.|+|++ +
T Consensus 127 ---dfFq---EiYV~TELmQSDLHKIIV--------SPQ~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVNSN 192 (449)
T KOG0664|consen 127 ---SFFQ---ELYVLTELMQSDLHKIIV--------SPQALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVNSN 192 (449)
T ss_pred ---hHHH---HHHHHHHHHHhhhhheec--------cCCCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEeccC
Confidence 1111 267888888777776664 447899999999999999999999999999999999999995 5
Q ss_pred CcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHhCCCCCCcchh
Q 003052 636 GSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGRTPFSEYKT 715 (853)
Q Consensus 636 g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLtG~~PF~~~~~ 715 (853)
..+||||||+|+....+. ....+..+-|-+|+|||+++|.. .|+.++||||.|||+.|||..+..|....+
T Consensus 193 CvLKICDFGLARvee~d~-~~hMTqEVVTQYYRAPEiLMGaR--------hYs~AvDiWSVGCIFaELLgRrILFQAq~P 263 (449)
T KOG0664|consen 193 CILKICDFGLARTWDQRD-RLNMTHEVVTQYYRAPELLMGAR--------RYTGAVDIWSVGCIFAELLQRKILFQAAGP 263 (449)
T ss_pred ceEEecccccccccchhh-hhhhHHHHHHHHhccHHHhhcch--------hhcCccceehhhHHHHHHHhhhhhhhccCh
Confidence 689999999999765432 22344567899999999999864 588999999999999999999999965444
Q ss_pred HHHH---HHhhcCCC--------------------CcccC--------CCCCChhHHHHHHHhcccCCCCCCChhHHhcC
Q 003052 716 FWAK---FKVITDPN--------------------HEITY--------EPVPNPWLLDLMKKCLAWDRNERWRIPQLLQH 764 (853)
Q Consensus 716 ~~~~---~kii~~~~--------------------~~~~~--------~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~H 764 (853)
.... ...+..+. ....+ +.....+..+++.++|..||.+|++..+.+.|
T Consensus 264 iqQL~lItdLLGTPs~EaMr~ACEGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~ 343 (449)
T KOG0664|consen 264 IEQLQMIIDLLGTPSQEAMKYACEGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQH 343 (449)
T ss_pred HHHHHHHHHHhCCCcHHHHHHHhhhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhccc
Confidence 3221 11111111 11111 12233457899999999999999999999999
Q ss_pred CCCCC
Q 003052 765 PFLVP 769 (853)
Q Consensus 765 Pwf~~ 769 (853)
+|+..
T Consensus 344 ~~~~e 348 (449)
T KOG0664|consen 344 RYLEE 348 (449)
T ss_pred ccccc
Confidence 99754
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.4e-32 Score=291.89 Aligned_cols=257 Identities=26% Similarity=0.430 Sum_probs=201.5
Q ss_pred ceeeEEEeEeccCceEEEEEEe-cCCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHHHH
Q 003052 472 KLYQRLGKIGSGGSSEVHKVIS-SDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLREV 550 (853)
Q Consensus 472 ~~Y~ilk~LG~G~FG~Vyka~~-~~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~~l 550 (853)
.+|.-++.+|.|.- .|-.+.+ -.++.||+|++...........+..+|..++..+. |+||++++.++...+.+
T Consensus 17 ~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~-~~nii~l~n~ftP~~~l---- 90 (369)
T KOG0665|consen 17 KRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVN-HKNIISLLNVFTPQKTL---- 90 (369)
T ss_pred eeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhc-ccceeeeeeccCccccH----
Confidence 46888888999998 5656655 46788999999877555555566789999999998 89999999987543322
Q ss_pred hhCCCCCCCCccccCCeEEEEEecchhhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCCCcc
Q 003052 551 LNGSMNNKDGRVKDDGYIYMVLEYGEIDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPAN 630 (853)
Q Consensus 551 ~~~~iv~~~g~~~d~~~lyLVmEy~~gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLKPeN 630 (853)
.....+|+||||+..+|.+.+.. .++-..+++|+.|++.|++|||+.||+||||||+|
T Consensus 91 ------------~~~~e~y~v~e~m~~nl~~vi~~----------elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsn 148 (369)
T KOG0665|consen 91 ------------EEFQEVYLVMELMDANLCQVILM----------ELDHETISYILYQMLCGIKHLHSAGIIHRDLKPSN 148 (369)
T ss_pred ------------HHHHhHHHHHHhhhhHHHHHHHH----------hcchHHHHHHHHHHHHHHHHHHhcceeecccCccc
Confidence 12234799999999999998874 37888999999999999999999999999999999
Q ss_pred EEe-ecCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHhCCCC
Q 003052 631 FLL-VKGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGRTP 709 (853)
Q Consensus 631 ILL-~~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLtG~~P 709 (853)
|++ .++.+||.|||+|+..... ...+.++.|.+|+|||++.+.. |...+||||+||++.||++|+..
T Consensus 149 ivv~~~~~lKi~dfg~ar~e~~~---~~mtpyVvtRyyrapevil~~~---------~ke~vdiwSvGci~gEli~~~Vl 216 (369)
T KOG0665|consen 149 IVVNSDCTLKILDFGLARTEDTD---FMMTPYVVTRYYRAPEVILGMG---------YKENVDIWSVGCIMGELILGTVL 216 (369)
T ss_pred ceecchhheeeccchhhcccCcc---cccCchhheeeccCchheeccC---------CcccchhhhhhhHHHHHhhceEE
Confidence 999 6789999999999864332 3456789999999999998764 45789999999999999999999
Q ss_pred CCcchhHHHHHHhh---cCCCCc------------------------------ccCC------CCCChhHHHHHHHhccc
Q 003052 710 FSEYKTFWAKFKVI---TDPNHE------------------------------ITYE------PVPNPWLLDLMKKCLAW 750 (853)
Q Consensus 710 F~~~~~~~~~~kii---~~~~~~------------------------------~~~~------~~~s~~l~dLI~kcL~~ 750 (853)
|.+...+....+++ ..+... ..++ ..-...+++|+.+||..
T Consensus 217 f~g~d~idQ~~ki~~~lgtpd~~F~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi 296 (369)
T KOG0665|consen 217 FPGKDHIDQWNKIIEQLGTPDPSFMKQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVI 296 (369)
T ss_pred ecCchHHHHHHHHHHHhcCCCHHHHHHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhcc
Confidence 97644332222221 111100 0011 11223489999999999
Q ss_pred CCCCCCChhHHhcCCCCC
Q 003052 751 DRNERWRIPQLLQHPFLV 768 (853)
Q Consensus 751 DP~kRpTa~EIL~HPwf~ 768 (853)
||++|.+++++|+||||+
T Consensus 297 ~pe~Risv~daL~HPY~~ 314 (369)
T KOG0665|consen 297 DPEKRISVDDALRHPYIK 314 (369)
T ss_pred ChhhcccHHHHhcCCeee
Confidence 999999999999999996
|
|
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.4e-32 Score=307.55 Aligned_cols=261 Identities=21% Similarity=0.298 Sum_probs=210.8
Q ss_pred ceeEEcCceeeEEEeEeccCceEEEEEEec--CC--cEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehh
Q 003052 465 LFFKVNGKLYQRLGKIGSGGSSEVHKVISS--DC--TIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYE 540 (853)
Q Consensus 465 ~~~~v~g~~Y~ilk~LG~G~FG~Vyka~~~--~g--~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~ 540 (853)
+-.-+..+..++.++||+|.||+|++|.+. .| -.||||.++..... .....|++|+.+|.+|+ |+|+|+||++.
T Consensus 103 lkclIpee~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~-~~mddflrEas~M~~L~-H~hliRLyGvV 180 (1039)
T KOG0199|consen 103 LKCLIPEEQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLN-AIMDDFLREASHMLKLQ-HPHLIRLYGVV 180 (1039)
T ss_pred cceeccHHHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccc-hhHHHHHHHHHHHHhcc-CcceeEEeeee
Confidence 334455566777889999999999999883 34 46899999876554 36778999999999999 99999999975
Q ss_pred hhHHHHHHHHhhCCCCCCCCccccCCeEEEEEecch-hhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccC
Q 003052 541 VTEKALLREVLNGSMNNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEE 619 (853)
Q Consensus 541 ~~e~~iL~~l~~~~iv~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~ 619 (853)
.+ .-+.||||++. |+|.+.|.+. ....|.......|+.||+.||.||..+
T Consensus 181 l~-----------------------qp~mMV~ELaplGSLldrLrka------~~~~llv~~Lcdya~QiA~aM~YLesk 231 (1039)
T KOG0199|consen 181 LD-----------------------QPAMMVFELAPLGSLLDRLRKA------KKAILLVSRLCDYAMQIAKAMQYLESK 231 (1039)
T ss_pred cc-----------------------chhhHHhhhcccchHHHHHhhc------cccceeHHHHHHHHHHHHHHHHHHhhh
Confidence 43 23579999976 5899888763 346788999999999999999999999
Q ss_pred ceeeCCCCCccEEe-ecCcEEEEecccchhcccCCccccccc-cccCccccCchhhccCCCCCCCccccCCCccchhhhH
Q 003052 620 RIVHSDLKPANFLL-VKGSLKLIDFGIAKAIMSDTTNIQRDS-QVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLG 697 (853)
Q Consensus 620 gIIHRDLKPeNILL-~~g~VKL~DFGlAk~~~~~~~~~~~~t-~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLG 697 (853)
++|||||-..|||| ....|||||||+.+.+........+.. ..-...|+|||.|... .|+.++|+|++|
T Consensus 232 rlvHRDLAARNlllasprtVKI~DFGLmRaLg~ned~Yvm~p~rkvPfAWCaPEsLrh~---------kFShaSDvWmyG 302 (1039)
T KOG0199|consen 232 RLVHRDLAARNLLLASPRTVKICDFGLMRALGENEDMYVMAPQRKVPFAWCAPESLRHR---------KFSHASDVWMYG 302 (1039)
T ss_pred hhhhhhhhhhhheecccceeeeecccceeccCCCCcceEecCCCcCcccccCHhHhccc---------cccccchhhhhh
Confidence 99999999999999 667999999999998876554433222 2234589999999765 578899999999
Q ss_pred HHHHHHHh-CCCCCCcchhHHHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCCChhHHhcCCCC
Q 003052 698 CILYQMVY-GRTPFSEYKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQHPFL 767 (853)
Q Consensus 698 VILyELLt-G~~PF~~~~~~~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~HPwf 767 (853)
|+||||++ |+.||.+..... +++.+. ....+.-+..+++++.++++.||..+|.+|||+..|...-++
T Consensus 303 VTiWEMFtyGEePW~G~~g~q-IL~~iD-~~erLpRPk~csedIY~imk~cWah~paDRptFsair~~~~l 371 (1039)
T KOG0199|consen 303 VTIWEMFTYGEEPWVGCRGIQ-ILKNID-AGERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDLVL 371 (1039)
T ss_pred hhHHhhhccCCCCCCCCCHHH-HHHhcc-ccccCCCCCCChHHHHHHHHHhccCCccccccHHHHHHhHHH
Confidence 99999995 899999876653 333333 455666677889999999999999999999999998755443
|
|
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.7e-32 Score=303.15 Aligned_cols=246 Identities=25% Similarity=0.388 Sum_probs=197.5
Q ss_pred ceeeEEEeEeccCceEEEEEEec---CC--cEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHH
Q 003052 472 KLYQRLGKIGSGGSSEVHKVISS---DC--TIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKAL 546 (853)
Q Consensus 472 ~~Y~ilk~LG~G~FG~Vyka~~~---~g--~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~i 546 (853)
.+..+.++||.|.||.||+|+.. .| -.||||..+.+- +.+..+.|+.|..+|++++ |||||+|++++..
T Consensus 389 e~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~-t~d~tekflqEa~iMrnfd-HphIikLIGv~~e---- 462 (974)
T KOG4257|consen 389 ELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDC-TPDDTEKFLQEASIMRNFD-HPHIIKLIGVCVE---- 462 (974)
T ss_pred hhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCC-ChhhHHHHHHHHHHHHhCC-Ccchhheeeeeec----
Confidence 33445567999999999999863 23 258899887643 3445678999999999998 9999999998543
Q ss_pred HHHHhhCCCCCCCCccccCCeEEEEEecch-hhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCC
Q 003052 547 LREVLNGSMNNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSD 625 (853)
Q Consensus 547 L~~l~~~~iv~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRD 625 (853)
.-+|||||++. |.|.++++.. ...|+......|..||+.||.|||+.++||||
T Consensus 463 -------------------~P~WivmEL~~~GELr~yLq~n-------k~sL~l~tL~ly~~Qi~talaYLeSkrfVHRD 516 (974)
T KOG4257|consen 463 -------------------QPMWIVMELAPLGELREYLQQN-------KDSLPLRTLTLYCYQICTALAYLESKRFVHRD 516 (974)
T ss_pred -------------------cceeEEEecccchhHHHHHHhc-------cccchHHHHHHHHHHHHHHHHHHHhhchhhhh
Confidence 34799999977 6899998764 45789999999999999999999999999999
Q ss_pred CCCccEEee-cCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHH
Q 003052 626 LKPANFLLV-KGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMV 704 (853)
Q Consensus 626 LKPeNILL~-~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELL 704 (853)
|...|||+. ...|||+|||+++.+...... ..+...-...|||||.+.. ..++.++|||.|||++||+|
T Consensus 517 IAaRNiLVsSp~CVKLaDFGLSR~~ed~~yY-kaS~~kLPIKWmaPESINf---------RrFTtASDVWMFgVCmWEIl 586 (974)
T KOG4257|consen 517 IAARNILVSSPQCVKLADFGLSRYLEDDAYY-KASRGKLPIKWMAPESINF---------RRFTTASDVWMFGVCMWEIL 586 (974)
T ss_pred hhhhheeecCcceeeecccchhhhccccchh-hccccccceeecCccccch---------hcccchhhHHHHHHHHHHHH
Confidence 999999994 568999999999988654433 2233344568999998843 35788999999999999977
Q ss_pred -hCCCCCCcchhHHHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCCChhHH
Q 003052 705 -YGRTPFSEYKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQL 761 (853)
Q Consensus 705 -tG~~PF~~~~~~~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EI 761 (853)
.|.-||.+.++..-+..+ ....++..++.+++.+..|+.+||.+||.+||++.+|
T Consensus 587 ~lGvkPfqgvkNsDVI~~i--EnGeRlP~P~nCPp~LYslmskcWayeP~kRPrftei 642 (974)
T KOG4257|consen 587 SLGVKPFQGVKNSDVIGHI--ENGERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEI 642 (974)
T ss_pred HhcCCccccccccceEEEe--cCCCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHH
Confidence 699999886554322221 2355667788899999999999999999999986654
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-30 Score=290.71 Aligned_cols=254 Identities=24% Similarity=0.315 Sum_probs=199.5
Q ss_pred ceeeEEEeEeccCceEEEEEEecCCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHHHHh
Q 003052 472 KLYQRLGKIGSGGSSEVHKVISSDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLREVL 551 (853)
Q Consensus 472 ~~Y~ilk~LG~G~FG~Vyka~~~~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~~l~ 551 (853)
+...+.++||+|-||.|.+|.-..+..||||+++...... ....|..||++|.+|+ ||||++|++++
T Consensus 538 s~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~-~r~~F~kEIkiLsqLk-hPNIveLvGVC----------- 604 (807)
T KOG1094|consen 538 SRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKN-ARNDFLKEIKILSRLK-HPNIVELLGVC----------- 604 (807)
T ss_pred hheehhhhhcCcccceeEEEEecCceEEEEeecCcccchh-HHHHHHHHHHHHhccC-CCCeeEEEeee-----------
Confidence 4577889999999999999998778899999998765443 3567999999999996 99999999874
Q ss_pred hCCCCCCCCccccCCeEEEEEecch-hhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCCCcc
Q 003052 552 NGSMNNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPAN 630 (853)
Q Consensus 552 ~~~iv~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLKPeN 630 (853)
..++-+++||||++ |+|.+++.++-. ..+.-.....|+.||+.||+||.+.++|||||.+.|
T Consensus 605 -----------~~DePicmI~EYmEnGDLnqFl~ahea------pt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rN 667 (807)
T KOG1094|consen 605 -----------VQDDPLCMITEYMENGDLNQFLSAHEL------PTAETAPGVSICTQIASGMAYLESLNFVHRDLATRN 667 (807)
T ss_pred -----------ecCCchHHHHHHHhcCcHHHHHHhccC------cccccchhHHHHHHHHHHHHHHHhhchhhccccccc
Confidence 34556799999976 799999987521 223444556699999999999999999999999999
Q ss_pred EEee-cCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHH--hCC
Q 003052 631 FLLV-KGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMV--YGR 707 (853)
Q Consensus 631 ILL~-~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELL--tG~ 707 (853)
+|++ +.++||+|||+++.+............+-...|||||.+..+ +++.++|+|++|+++||++ +..
T Consensus 668 cLv~~e~~iKiadfgmsR~lysg~yy~vqgr~vlpiRwmawEsillg---------kFttaSDvWafgvTlwE~~~~C~e 738 (807)
T KOG1094|consen 668 CLVDGEFTIKIADFGMSRNLYSGDYYRVQGRAVLPIRWMAWESILLG---------KFTTASDVWAFGVTLWEVFMLCRE 738 (807)
T ss_pred eeecCcccEEecCcccccccccCCceeeecceeeeeeehhHHHHHhc---------cccchhhhhhhHHHHHHHHHHHhh
Confidence 9995 679999999999977655544444455677899999998765 4678999999999999976 688
Q ss_pred CCCCcchhHH---HHHHhhcCCCC--cccCCCCCChhHHHHHHHhcccCCCCCCChhHHhcC
Q 003052 708 TPFSEYKTFW---AKFKVITDPNH--EITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQH 764 (853)
Q Consensus 708 ~PF~~~~~~~---~~~kii~~~~~--~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~H 764 (853)
-||.+..... .......++.. -+..+..++..+.+||.+||.+|-.+||+++++-.|
T Consensus 739 ~Py~~lt~e~vven~~~~~~~~~~~~~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~ 800 (807)
T KOG1094|consen 739 QPYSQLTDEQVVENAGEFFRDQGRQVVLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLF 800 (807)
T ss_pred CchhhhhHHHHHHhhhhhcCCCCcceeccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHH
Confidence 9997643321 11122222211 123355678889999999999999999999998643
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.3e-31 Score=264.06 Aligned_cols=225 Identities=22% Similarity=0.409 Sum_probs=181.0
Q ss_pred eEEcCceeeEEEeEeccCceEEEEEEe-cCCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHH
Q 003052 467 FKVNGKLYQRLGKIGSGGSSEVHKVIS-SDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKA 545 (853)
Q Consensus 467 ~~v~g~~Y~ilk~LG~G~FG~Vyka~~-~~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~ 545 (853)
+++..+....+..||+|+||.|-+.++ .+|...|+|.+...-.. ......++|+.+..+...+|.+|.+++.
T Consensus 41 ~eV~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~-q~q~r~L~dldi~~r~~~CPf~V~FyGa------ 113 (282)
T KOG0984|consen 41 FEVPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNS-QEQKRLLMDLDIIMRTVDCPFTVHFYGA------ 113 (282)
T ss_pred cccchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcCh-HHHHHHHHhhhhhccCCCCCeEEEeehh------
Confidence 344445566677899999999998888 68899999999876554 3445688999999998889999998874
Q ss_pred HHHHHhhCCCCCCCCccccCCeEEEEEecchhhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccC-ceeeC
Q 003052 546 LLREVLNGSMNNKDGRVKDDGYIYMVLEYGEIDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEE-RIVHS 624 (853)
Q Consensus 546 iL~~l~~~~iv~~~g~~~d~~~lyLVmEy~~gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~-gIIHR 624 (853)
+.+...++|.||.+..+|..+..+.++ .++.++|..+-+|+.-++.||.|||++ .||||
T Consensus 114 ----------------~~regdvwIcME~M~tSldkfy~~v~~----~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHR 173 (282)
T KOG0984|consen 114 ----------------LFREGDVWICMELMDTSLDKFYRKVLK----KGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHR 173 (282)
T ss_pred ----------------hhccccEEEeHHHhhhhHHHHHHHHHh----cCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhc
Confidence 345567999999999888877766544 578999999999999999999999987 89999
Q ss_pred CCCCccEEe-ecCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHH
Q 003052 625 DLKPANFLL-VKGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQM 703 (853)
Q Consensus 625 DLKPeNILL-~~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyEL 703 (853)
|+||.|||| .+|++|+||||++..+.+.- ..+...|--.|||||.+..+... ..|+.++||||||++++||
T Consensus 174 DvKPsNiLIn~~GqVKiCDFGIsG~L~dSi---Akt~daGCkpYmaPEri~~e~n~-----~gY~vksDvWSLGItmiEl 245 (282)
T KOG0984|consen 174 DVKPSNILINYDGQVKICDFGISGYLVDSI---AKTMDAGCKPYMAPERINPELNQ-----KGYSVKSDVWSLGITMIEM 245 (282)
T ss_pred cCCcceEEEccCCcEEEcccccceeehhhh---HHHHhcCCCccCChhhcCcccCc-----ccceeehhhhhhhhhhhhh
Confidence 999999999 57899999999998765422 22235688899999999765432 2689999999999999999
Q ss_pred HhCCCCCCcchhHHHHHH-hhcCC
Q 003052 704 VYGRTPFSEYKTFWAKFK-VITDP 726 (853)
Q Consensus 704 LtG~~PF~~~~~~~~~~k-ii~~~ 726 (853)
.+++.||......++..+ +..++
T Consensus 246 A~lr~PY~~w~tpF~qLkqvVeep 269 (282)
T KOG0984|consen 246 AILRFPYESWGTPFQQLKQVVEEP 269 (282)
T ss_pred hhccccccccCCHHHHHHHHhcCC
Confidence 999999976554444444 44433
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-30 Score=285.67 Aligned_cols=253 Identities=30% Similarity=0.457 Sum_probs=190.7
Q ss_pred ceeeEEEeEeccCceEEEEEEec----CCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHH
Q 003052 472 KLYQRLGKIGSGGSSEVHKVISS----DCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALL 547 (853)
Q Consensus 472 ~~Y~ilk~LG~G~FG~Vyka~~~----~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL 547 (853)
..|.++++||+|.|++||++++. ..+.||+|.|...... ..+.+|+++|..+.++.||+.+.++
T Consensus 36 ~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~p----~ri~~El~~L~~~gG~~ni~~~~~~-------- 103 (418)
T KOG1167|consen 36 NAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSSP----SRILNELEMLYRLGGSDNIIKLNGC-------- 103 (418)
T ss_pred hhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccCc----hHHHHHHHHHHHhccchhhhcchhh--------
Confidence 45889999999999999999873 3578999999765442 3578999999999999999988754
Q ss_pred HHHhhCCCCCCCCccccCCeEEEEEecchh-hHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCC
Q 003052 548 REVLNGSMNNKDGRVKDDGYIYMVLEYGEI-DLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDL 626 (853)
Q Consensus 548 ~~l~~~~iv~~~g~~~d~~~lyLVmEy~~g-dL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDL 626 (853)
+..++.+.+||||.+. ...+++ ..++...++.|++.++.||.|+|.+|||||||
T Consensus 104 --------------~rnnd~v~ivlp~~~H~~f~~l~-----------~~l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDi 158 (418)
T KOG1167|consen 104 --------------FRNNDQVAIVLPYFEHDRFRDLY-----------RSLSLAEIRWYLRNLLKALAHLHKNGIVHRDI 158 (418)
T ss_pred --------------hccCCeeEEEecccCccCHHHHH-----------hcCCHHHHHHHHHHHHHHhhhhhccCccccCC
Confidence 6778889999999875 333332 24788999999999999999999999999999
Q ss_pred CCccEEee--cCcEEEEecccchhcccCC-------------c-----------------------------cccccccc
Q 003052 627 KPANFLLV--KGSLKLIDFGIAKAIMSDT-------------T-----------------------------NIQRDSQV 662 (853)
Q Consensus 627 KPeNILL~--~g~VKL~DFGlAk~~~~~~-------------~-----------------------------~~~~~t~~ 662 (853)
||.|+|.+ .+.-.|+|||+|....... . ........
T Consensus 159 KpsNFL~n~~t~rg~LvDFgLA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrA 238 (418)
T KOG1167|consen 159 KPSNFLYNRRTQRGVLVDFGLAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRA 238 (418)
T ss_pred CccccccccccCCceEEechhHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccC
Confidence 99999995 4688999999997211000 0 00012346
Q ss_pred cCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHhCCCCCCcc----hhHHHHH---------H------h-
Q 003052 663 GTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGRTPFSEY----KTFWAKF---------K------V- 722 (853)
Q Consensus 663 GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLtG~~PF~~~----~~~~~~~---------k------i- 722 (853)
||++|+|||++...+ ..+.++||||.|||+.-+++++.||... ..+.++. + .
T Consensus 239 GT~GfRaPEvL~k~~--------~QttaiDiws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~ 310 (418)
T KOG1167|consen 239 GTPGFRAPEVLFRCP--------RQTTAIDIWSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRI 310 (418)
T ss_pred CCCCCCchHHHhhcc--------CcCCccceeeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCce
Confidence 999999999997654 3467999999999999999999999321 1110000 0 0
Q ss_pred -hcC-CC---------------------------CcccCCCCCChhHHHHHHHhcccCCCCCCChhHHhcCCCCCC
Q 003052 723 -ITD-PN---------------------------HEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQHPFLVP 769 (853)
Q Consensus 723 -i~~-~~---------------------------~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~HPwf~~ 769 (853)
+.. .+ .........+.++.+|+.+||..||.+|+|++++|+||||..
T Consensus 311 ~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkHpFF~~ 386 (418)
T KOG1167|consen 311 LLWQKSNIPTIPELRVNFETLHIESIYKSRQPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKHPFFDE 386 (418)
T ss_pred eeeccccccccHHHHhchhccChhhcccccccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcCcCCcc
Confidence 000 00 000011233457899999999999999999999999999973
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.6e-30 Score=289.95 Aligned_cols=247 Identities=20% Similarity=0.351 Sum_probs=198.2
Q ss_pred ceeeEEEeEeccCceEEEEEEecC-CcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHHHH
Q 003052 472 KLYQRLGKIGSGGSSEVHKVISSD-CTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLREV 550 (853)
Q Consensus 472 ~~Y~ilk~LG~G~FG~Vyka~~~~-g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~~l 550 (853)
.+..+.++||-|.||.||.|.++. .-.||||.++.+.. ....|+.|..+|+.++ |||+|+|++++..
T Consensus 267 tdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtM---eveEFLkEAAvMKeik-HpNLVqLLGVCT~-------- 334 (1157)
T KOG4278|consen 267 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM---EVEEFLKEAAVMKEIK-HPNLVQLLGVCTH-------- 334 (1157)
T ss_pred hheeeeeccCCCcccceeeeeeeccceeeehhhhhhcch---hHHHHHHHHHHHHhhc-CccHHHHhhhhcc--------
Confidence 446677899999999999999853 35699999986543 3567999999999998 9999999988543
Q ss_pred hhCCCCCCCCccccCCeEEEEEec-chhhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCCCc
Q 003052 551 LNGSMNNKDGRVKDDGYIYMVLEY-GEIDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPA 629 (853)
Q Consensus 551 ~~~~iv~~~g~~~d~~~lyLVmEy-~~gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLKPe 629 (853)
+.-+|||.|| |-|+|.++|.+..+ ..++.-...+++.||..|+.||..+++|||||-..
T Consensus 335 --------------EpPFYIiTEfM~yGNLLdYLRecnr------~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAAR 394 (1157)
T KOG4278|consen 335 --------------EPPFYIITEFMCYGNLLDYLRECNR------SEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAAR 394 (1157)
T ss_pred --------------CCCeEEEEecccCccHHHHHHHhch------hhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhh
Confidence 3457999999 55899999988733 45777788899999999999999999999999999
Q ss_pred cEEeecC-cEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHh-CC
Q 003052 630 NFLLVKG-SLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVY-GR 707 (853)
Q Consensus 630 NILL~~g-~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLt-G~ 707 (853)
|+|+.++ .||++|||+++.+..+... ......-...|.|||-+..+ .++.|+|||+|||+|||+.| |.
T Consensus 395 NCLVgEnhiVKvADFGLsRlMtgDTYT-AHAGAKFPIKWTAPEsLAyN---------tFSiKSDVWAFGVLLWEIATYGM 464 (1157)
T KOG4278|consen 395 NCLVGENHIVKVADFGLSRLMTGDTYT-AHAGAKFPIKWTAPESLAYN---------TFSIKSDVWAFGVLLWEIATYGM 464 (1157)
T ss_pred hccccccceEEeeccchhhhhcCCcee-cccCccCcccccCccccccc---------ccccchhhHHHHHHHHHHHhcCC
Confidence 9999665 7899999999987654322 11222335689999998654 47889999999999999985 89
Q ss_pred CCCCcchhHHHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCCChhHHh
Q 003052 708 TPFSEYKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLL 762 (853)
Q Consensus 708 ~PF~~~~~~~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL 762 (853)
.||.+.+- ...+..+. ......-+..+++...+||+.||+|+|.+||++.||-
T Consensus 465 sPYPGidl-SqVY~LLE-kgyRM~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiH 517 (1157)
T KOG4278|consen 465 SPYPGIDL-SQVYGLLE-KGYRMDGPEGCPPKVYELMRACWNWSPSDRPSFAEIH 517 (1157)
T ss_pred CCCCCccH-HHHHHHHh-ccccccCCCCCCHHHHHHHHHHhcCCcccCccHHHHH
Confidence 99987543 23333333 3445556778899999999999999999999998874
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.6e-31 Score=294.54 Aligned_cols=198 Identities=33% Similarity=0.556 Sum_probs=169.8
Q ss_pred eeeEEEeEeccCceEEEEEEec-CCcEEEEEEEecCCCC------hhhHhhHHHHHHHHHHhc--CCCceeEeeehhhhH
Q 003052 473 LYQRLGKIGSGGSSEVHKVISS-DCTIYALKKIKLKGRD------YATAYGFCQEIEYLNKLK--GKNNIIQLIDYEVTE 543 (853)
Q Consensus 473 ~Y~ilk~LG~G~FG~Vyka~~~-~g~~vAVKkik~~~~~------~~~~~~~l~EI~iLkkL~--~hpNIV~Lid~~~~e 543 (853)
.|..++.||+|+||.|++|+++ +...|+||.|.+..-- ....-.+--||.||..|+ .|+||++++++
T Consensus 562 ~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdf---- 637 (772)
T KOG1152|consen 562 DYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDF---- 637 (772)
T ss_pred cceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhhe----
Confidence 4999999999999999999985 4578999999765321 122223557999999997 47899999987
Q ss_pred HHHHHHHhhCCCCCCCCccccCCeEEEEEec-ch-hhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCce
Q 003052 544 KALLREVLNGSMNNKDGRVKDDGYIYMVLEY-GE-IDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERI 621 (853)
Q Consensus 544 ~~iL~~l~~~~iv~~~g~~~d~~~lyLVmEy-~~-gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gI 621 (853)
|++++++||+||- ++ .||+++|..+ ..++|.++..|++||+.|+++||+.||
T Consensus 638 ------------------FEddd~yyl~te~hg~gIDLFd~IE~k--------p~m~E~eAk~IFkQV~agi~hlh~~~i 691 (772)
T KOG1152|consen 638 ------------------FEDDDYYYLETEVHGEGIDLFDFIEFK--------PRMDEPEAKLIFKQVVAGIKHLHDQGI 691 (772)
T ss_pred ------------------eecCCeeEEEecCCCCCcchhhhhhcc--------CccchHHHHHHHHHHHhccccccccCc
Confidence 7899999999998 33 5999999865 679999999999999999999999999
Q ss_pred eeCCCCCccEEe-ecCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHH
Q 003052 622 VHSDLKPANFLL-VKGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCIL 700 (853)
Q Consensus 622 IHRDLKPeNILL-~~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVIL 700 (853)
||||||-+|+.+ .+|.+||+|||.|...... ....++||..|.|||++.|..| .+..-|||+||++|
T Consensus 692 vhrdikdenvivd~~g~~klidfgsaa~~ksg----pfd~f~gtv~~aapevl~g~~y--------~gk~qdiwalgill 759 (772)
T KOG1152|consen 692 VHRDIKDENVIVDSNGFVKLIDFGSAAYTKSG----PFDVFVGTVDYAAPEVLGGEKY--------LGKPQDIWALGILL 759 (772)
T ss_pred eecccccccEEEecCCeEEEeeccchhhhcCC----CcceeeeeccccchhhhCCCcc--------CCCcchhhhhhhee
Confidence 999999999999 6789999999999876543 3357899999999999998865 46789999999999
Q ss_pred HHHHhCCCCCCc
Q 003052 701 YQMVYGRTPFSE 712 (853)
Q Consensus 701 yELLtG~~PF~~ 712 (853)
|-+++...||.+
T Consensus 760 ytivykenpyyn 771 (772)
T KOG1152|consen 760 YTIVYKENPYYN 771 (772)
T ss_pred eEEEeccCCCcC
Confidence 999999999864
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-29 Score=299.74 Aligned_cols=264 Identities=24% Similarity=0.394 Sum_probs=208.1
Q ss_pred eeEEcCceeeEEEeEeccCceEEEEEEec----C----CcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEee
Q 003052 466 FFKVNGKLYQRLGKIGSGGSSEVHKVISS----D----CTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLI 537 (853)
Q Consensus 466 ~~~v~g~~Y~ilk~LG~G~FG~Vyka~~~----~----g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Li 537 (853)
.+.+..+...+.+.||+|.||.|++|... . ...||||.++..... .....+..|+++|+.+.+|+||+.++
T Consensus 290 ~~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~-~~~~~~~~El~~m~~~g~H~niv~ll 368 (609)
T KOG0200|consen 290 KWEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASS-SEKKDLMSELNVLKELGKHPNIVNLL 368 (609)
T ss_pred ceeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCc-HHHHHHHHHHHHHHHhcCCcchhhhe
Confidence 46666666677889999999999999742 1 357999999876665 66778999999999999999999998
Q ss_pred ehhhhHHHHHHHHhhCCCCCCCCccccCCeEEEEEecch-hhHHHHHHHhh--hhccCCC------CCCCHHHHHHHHHH
Q 003052 538 DYEVTEKALLREVLNGSMNNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKW--KEMDGSN------QTLDENWLRFYWQQ 608 (853)
Q Consensus 538 d~~~~e~~iL~~l~~~~iv~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~--k~~~~~~------~~LsE~~~r~I~~Q 608 (853)
++ +...+.+++|+||+. |+|..++..++ ..+...+ ..|+......++.|
T Consensus 369 G~----------------------~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~Q 426 (609)
T KOG0200|consen 369 GA----------------------CTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQ 426 (609)
T ss_pred ee----------------------eccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHH
Confidence 86 334678999999976 79999998875 1111221 34899999999999
Q ss_pred hhhhhhhcccCceeeCCCCCccEEeecC-cEEEEecccchhcccCCcccccccccc--CccccCchhhccCCCCCCCccc
Q 003052 609 ILEAVNTIHEERIVHSDLKPANFLLVKG-SLKLIDFGIAKAIMSDTTNIQRDSQVG--TLSYMSPEAFMCNESDENGNII 685 (853)
Q Consensus 609 Il~AL~yLHs~gIIHRDLKPeNILL~~g-~VKL~DFGlAk~~~~~~~~~~~~t~~G--Tp~YmAPEvl~~~~~~~~~~~~ 685 (853)
|+.|++||++.++|||||-..|||+.++ .+||+|||+|+.......... ..-.| ...|||||.+...
T Consensus 427 Ia~GMe~L~~~~~vHRDLAaRNVLi~~~~~~kIaDFGlar~~~~~~~y~~-~~~~~~LP~kWmApEsl~~~--------- 496 (609)
T KOG0200|consen 427 IANGMEYLASVPCVHRDLAARNVLITKNKVIKIADFGLARDHYNKDYYRT-KSSAGTLPVKWMAPESLFDR--------- 496 (609)
T ss_pred HHHHHHHHhhCCccchhhhhhhEEecCCCEEEEccccceeccCCCCceEe-cCCCCccceeecCHHHhccC---------
Confidence 9999999999999999999999999665 899999999996554333221 11222 2359999999764
Q ss_pred cCCCccchhhhHHHHHHHHh-CCCCCCcchhHHHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCCChhHHhc
Q 003052 686 KCGRPSDIWSLGCILYQMVY-GRTPFSEYKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQ 763 (853)
Q Consensus 686 ~ys~ksDIWSLGVILyELLt-G~~PF~~~~~~~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~ 763 (853)
.|+.++||||+||+||||++ |..||.+.......+..+.. ......+..++.++.++|+.||+.+|++||++.++.+
T Consensus 497 ~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~~~l~~~l~~-G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~ 574 (609)
T KOG0200|consen 497 VFTSKSDVWSFGILLWEIFTLGGTPYPGIPPTEELLEFLKE-GNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVE 574 (609)
T ss_pred cccccchhhHHHHHHHHHhhCCCCCCCCCCcHHHHHHHHhc-CCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHH
Confidence 47789999999999999996 89999875433334444433 3445566677899999999999999999999999874
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.6e-31 Score=298.55 Aligned_cols=258 Identities=25% Similarity=0.381 Sum_probs=209.4
Q ss_pred ceeeEEEeEeccCceEEEEEEe-cCCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHHHH
Q 003052 472 KLYQRLGKIGSGGSSEVHKVIS-SDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLREV 550 (853)
Q Consensus 472 ~~Y~ilk~LG~G~FG~Vyka~~-~~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~~l 550 (853)
++|.++..+|.|.||.|||+++ ..++..|+|+++....+ ....+.+||-+++..+ |+||+-+++-+
T Consensus 15 ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~d--d~~~iqqei~~~~dc~-h~nivay~gsy---------- 81 (829)
T KOG0576|consen 15 DDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGD--DFSGIQQEIGMLRDCR-HPNIVAYFGSY---------- 81 (829)
T ss_pred cchhheeeecCCcccchhhhcccccCchhhheeeeccCCc--cccccccceeeeecCC-CcChHHHHhhh----------
Confidence 5699999999999999999998 57789999999986543 2334668888888887 88988877643
Q ss_pred hhCCCCCCCCccccCCeEEEEEecchh-hHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCCCc
Q 003052 551 LNGSMNNKDGRVKDDGYIYMVLEYGEI-DLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPA 629 (853)
Q Consensus 551 ~~~~iv~~~g~~~d~~~lyLVmEy~~g-dL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLKPe 629 (853)
-....++|+||||++ +|.+... ..++++|.++.+..++.+.||+|||+.|-+|||||-.
T Consensus 82 ------------lr~dklwicMEycgggslQdiy~--------~TgplselqiayvcRetl~gl~ylhs~gk~hRdiKGa 141 (829)
T KOG0576|consen 82 ------------LRRDKLWICMEYCGGGSLQDIYH--------VTGPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGA 141 (829)
T ss_pred ------------hhhcCcEEEEEecCCCcccceee--------ecccchhHHHHHHHhhhhccchhhhcCCccccccccc
Confidence 334568999999885 6665543 3478999999999999999999999999999999999
Q ss_pred cEEe-ecCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHhCCC
Q 003052 630 NFLL-VKGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGRT 708 (853)
Q Consensus 630 NILL-~~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLtG~~ 708 (853)
|||+ +.|.+||+|||.+..+.. +-..+..+.|||+|||||+..-.. ...|...+|||++|+...|+-.-++
T Consensus 142 nilltd~gDvklaDfgvsaqita--ti~KrksfiGtpywmapEvaaver------kggynqlcdiwa~gitAiel~eLqp 213 (829)
T KOG0576|consen 142 NILLTDEGDVKLADFGVSAQITA--TIAKRKSFIGTPYWMAPEVAAVER------KGGYNQLCDIWALGITAIELGELQP 213 (829)
T ss_pred ceeecccCceeecccCchhhhhh--hhhhhhcccCCccccchhHHHHHh------cccccccccccccccchhhhhhcCC
Confidence 9999 678999999999987653 233456899999999999875432 2257889999999999999999999
Q ss_pred CCCcchhHHHHHHhhcCCCCc--ccCCCCCChhHHHHHHHhcccCCCCCCChhHHhcCCCCCCC
Q 003052 709 PFSEYKTFWAKFKVITDPNHE--ITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQHPFLVPP 770 (853)
Q Consensus 709 PF~~~~~~~~~~kii~~~~~~--~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~HPwf~~~ 770 (853)
|..+..++...+..-...... ..-...+++.+.+|++.+|.++|++||+++-+|.|||+...
T Consensus 214 plfdlhpmr~l~LmTkS~~qpp~lkDk~kws~~fh~fvK~altknpKkRptaeklL~h~fvs~~ 277 (829)
T KOG0576|consen 214 PLFDLHPMRALFLMTKSGFQPPTLKDKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT 277 (829)
T ss_pred cccccchHHHHHHhhccCCCCCcccCCccchHHHHHHHHHHhcCCCccCCChhhheeceeeccc
Confidence 987777766555443332222 23345677889999999999999999999999999999754
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3e-30 Score=296.98 Aligned_cols=253 Identities=23% Similarity=0.315 Sum_probs=206.5
Q ss_pred EcCceeeEEEeEeccCceEEEEEEec----CCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHH
Q 003052 469 VNGKLYQRLGKIGSGGSSEVHKVISS----DCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEK 544 (853)
Q Consensus 469 v~g~~Y~ilk~LG~G~FG~Vyka~~~----~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~ 544 (853)
++-...+|.++||.|.||.|++|+.+ ....||||.+|.... ......|+.|..||-++. ||||++|.++.
T Consensus 626 Id~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~Gyt-ekqrrdFL~EAsIMGQFd-HPNIIrLEGVV---- 699 (996)
T KOG0196|consen 626 IDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYT-EKQRRDFLSEASIMGQFD-HPNIIRLEGVV---- 699 (996)
T ss_pred cChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCcc-HHHHhhhhhhhhhcccCC-CCcEEEEEEEE----
Confidence 33345678889999999999999873 335799999986544 456678999999999998 99999999873
Q ss_pred HHHHHHhhCCCCCCCCccccCCeEEEEEecch-hhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceee
Q 003052 545 ALLREVLNGSMNNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVH 623 (853)
Q Consensus 545 ~iL~~l~~~~iv~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIH 623 (853)
....-+.||.||++ |.|..+|+++ .+.|+..++..+++.|+.|++||-+.|+||
T Consensus 700 ------------------Tks~PvMIiTEyMENGsLDsFLR~~-------DGqftviQLVgMLrGIAsGMkYLsdm~YVH 754 (996)
T KOG0196|consen 700 ------------------TKSKPVMIITEYMENGSLDSFLRQN-------DGQFTVIQLVGMLRGIASGMKYLSDMNYVH 754 (996)
T ss_pred ------------------ecCceeEEEhhhhhCCcHHHHHhhc-------CCceEeehHHHHHHHHHHHhHHHhhcCchh
Confidence 33456899999987 6888888764 467999999999999999999999999999
Q ss_pred CCCCCccEEeecC-cEEEEecccchhcccCCcccccccccc--CccccCchhhccCCCCCCCccccCCCccchhhhHHHH
Q 003052 624 SDLKPANFLLVKG-SLKLIDFGIAKAIMSDTTNIQRDSQVG--TLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCIL 700 (853)
Q Consensus 624 RDLKPeNILL~~g-~VKL~DFGlAk~~~~~~~~~~~~t~~G--Tp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVIL 700 (853)
|||...|||++.+ .+|++|||+++.+.++. ....++.-| ...|.|||.+... +++.++||||+||+|
T Consensus 755 RDLAARNILVNsnLvCKVsDFGLSRvledd~-~~~ytt~GGKIPiRWTAPEAIa~R---------KFTsASDVWSyGIVm 824 (996)
T KOG0196|consen 755 RDLAARNILVNSNLVCKVSDFGLSRVLEDDP-EAAYTTLGGKIPIRWTAPEAIAYR---------KFTSASDVWSYGIVM 824 (996)
T ss_pred hhhhhhheeeccceEEEeccccceeecccCC-CccccccCCccceeecChhHhhhc---------ccCchhhccccceEE
Confidence 9999999999766 78999999999775544 222333334 3589999999755 577899999999999
Q ss_pred HHHH-hCCCCCCcchhHHHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCCChhHHhcC
Q 003052 701 YQMV-YGRTPFSEYKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQH 764 (853)
Q Consensus 701 yELL-tG~~PF~~~~~~~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~H 764 (853)
||.+ +|..||.+..+.. .++.+.+ ...+..+.+++..+..|+..||++|.++||++.||+.+
T Consensus 825 WEVmSyGERPYWdmSNQd-VIkaIe~-gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~ 887 (996)
T KOG0196|consen 825 WEVMSYGERPYWDMSNQD-VIKAIEQ-GYRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVST 887 (996)
T ss_pred EEecccCCCcccccchHH-HHHHHHh-ccCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHH
Confidence 9966 7999998866643 3333332 45667788899999999999999999999999998865
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.8e-29 Score=313.52 Aligned_cols=236 Identities=21% Similarity=0.256 Sum_probs=174.6
Q ss_pred eeeEEEeEeccCceEEEEEEe-cCCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHHHHh
Q 003052 473 LYQRLGKIGSGGSSEVHKVIS-SDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLREVL 551 (853)
Q Consensus 473 ~Y~ilk~LG~G~FG~Vyka~~-~~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~~l~ 551 (853)
.|...+.||+|+||.||+|.+ .++..||||+++..... ...|++++++++ ||||+++++++
T Consensus 691 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~------~~~~~~~l~~l~-HpnIv~~~~~~----------- 752 (968)
T PLN00113 691 SLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI------PSSEIADMGKLQ-HPNIVKLIGLC----------- 752 (968)
T ss_pred hCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc------cHHHHHHHhhCC-CCCcceEEEEE-----------
Confidence 356677899999999999998 57789999998643221 235688999996 99999999873
Q ss_pred hCCCCCCCCccccCCeEEEEEecch-hhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcc---cCceeeCCCC
Q 003052 552 NGSMNNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIH---EERIVHSDLK 627 (853)
Q Consensus 552 ~~~iv~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLH---s~gIIHRDLK 627 (853)
.+...+|+||||+. ++|.+++. .+++..+..|+.||+.||+||| +.+|+|||||
T Consensus 753 -----------~~~~~~~lv~Ey~~~g~L~~~l~-----------~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk 810 (968)
T PLN00113 753 -----------RSEKGAYLIHEYIEGKNLSEVLR-----------NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLS 810 (968)
T ss_pred -----------EcCCCCEEEEeCCCCCcHHHHHh-----------cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCC
Confidence 44566899999976 68888873 3788999999999999999999 6699999999
Q ss_pred CccEEeec-CcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHhC
Q 003052 628 PANFLLVK-GSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYG 706 (853)
Q Consensus 628 PeNILL~~-g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLtG 706 (853)
|+||+++. +..++. ||.+...... ....||+.|||||++.+. .|+.++|||||||++|||++|
T Consensus 811 p~Nil~~~~~~~~~~-~~~~~~~~~~------~~~~~t~~y~aPE~~~~~---------~~~~~sDv~S~Gvvl~el~tg 874 (968)
T PLN00113 811 PEKIIIDGKDEPHLR-LSLPGLLCTD------TKCFISSAYVAPETRETK---------DITEKSDIYGFGLILIELLTG 874 (968)
T ss_pred HHhEEECCCCceEEE-eccccccccC------CCccccccccCcccccCC---------CCCcccchhhHHHHHHHHHhC
Confidence 99999964 455554 6665433211 234789999999998654 366899999999999999999
Q ss_pred CCCCCcch----hHHHHHHhh---------cCCCCccc--CCCCCChhHHHHHHHhcccCCCCCCChhHHhcC
Q 003052 707 RTPFSEYK----TFWAKFKVI---------TDPNHEIT--YEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQH 764 (853)
Q Consensus 707 ~~PF~~~~----~~~~~~kii---------~~~~~~~~--~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~H 764 (853)
+.||.... ......+.. .++..... .......++.+++.+||..||.+||++.|+++.
T Consensus 875 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~ 947 (968)
T PLN00113 875 KSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKT 947 (968)
T ss_pred CCCCCcccCCCCcHHHHHHHhcCccchhheeCccccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHH
Confidence 99985321 111111110 01110000 001112246789999999999999999999865
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.7e-29 Score=302.49 Aligned_cols=185 Identities=19% Similarity=0.229 Sum_probs=136.9
Q ss_pred CeEEEEEecchhhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCCCccEEee-cC--------
Q 003052 566 GYIYMVLEYGEIDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLLV-KG-------- 636 (853)
Q Consensus 566 ~~lyLVmEy~~gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLKPeNILL~-~g-------- 636 (853)
..++++|||++++|.+++... ...+++..++.|++||+.||.|||++||+||||||+||||. .|
T Consensus 53 ~~~~~~~e~~~~~L~~~l~~~-------~~~~~~~~~~~i~~qi~~al~~lH~~gIvHrDlKP~NiLl~~~~~~k~~d~~ 125 (793)
T PLN00181 53 DSIVRALECEDVSLRQWLDNP-------DRSVDAFECFHVFRQIVEIVNAAHSQGIVVHNVRPSCFVMSSFNHVSFIESA 125 (793)
T ss_pred chhhhhhccCCccHHHHHhcc-------cccccHHHHHHHHHHHHHHHHHHHhCCeeeccCCchhEEEcccCcEEEeecc
Confidence 457889999999999988642 35699999999999999999999999999999999999993 23
Q ss_pred -----------cEEEEecccchhcccCC--------------ccccccccccCccccCchhhccCCCCCCCccccCCCcc
Q 003052 637 -----------SLKLIDFGIAKAIMSDT--------------TNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPS 691 (853)
Q Consensus 637 -----------~VKL~DFGlAk~~~~~~--------------~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ks 691 (853)
.+||+|||+++...... ........+||++|||||++.+.. |+.++
T Consensus 126 ~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~---------~~~~s 196 (793)
T PLN00181 126 SCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPEEDNGSS---------SNCAS 196 (793)
T ss_pred ccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChhhhccCC---------CCchh
Confidence 45666666665421100 000112357899999999987653 56899
Q ss_pred chhhhHHHHHHHHhCCCCCCcchhHHHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCCChhHHhcCCCCCCC
Q 003052 692 DIWSLGCILYQMVYGRTPFSEYKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQHPFLVPP 770 (853)
Q Consensus 692 DIWSLGVILyELLtG~~PF~~~~~~~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~HPwf~~~ 770 (853)
|||||||+||||++|.+||.............. ..... ....+.+.+++.+||..||.+||++.|+|+||||...
T Consensus 197 DVwSlGviL~ELl~~~~~~~~~~~~~~~~~~~~---~~~~~-~~~~~~~~~~~~~~L~~~P~~Rps~~eil~h~~~~~~ 271 (793)
T PLN00181 197 DVYRLGVLLFELFCPVSSREEKSRTMSSLRHRV---LPPQI-LLNWPKEASFCLWLLHPEPSCRPSMSELLQSEFINEP 271 (793)
T ss_pred hhhhHHHHHHHHhhCCCchhhHHHHHHHHHHhh---cChhh-hhcCHHHHHHHHHhCCCChhhCcChHHHhhchhhhhh
Confidence 999999999999999999865332221111111 00111 1123457899999999999999999999999999764
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.2e-27 Score=230.40 Aligned_cols=211 Identities=36% Similarity=0.553 Sum_probs=175.8
Q ss_pred EeccCceEEEEEEec-CCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHHHHhhCCCCCC
Q 003052 480 IGSGGSSEVHKVISS-DCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLREVLNGSMNNK 558 (853)
Q Consensus 480 LG~G~FG~Vyka~~~-~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~~l~~~~iv~~ 558 (853)
||+|++|.||++... +++.+++|++....... ....+.+|+++++.+. |++|+++++++
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~-~~~~~~~e~~~~~~l~-~~~i~~~~~~~------------------ 60 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSS-LLEELLREIEILKKLN-HPNIVKLYGVF------------------ 60 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchh-HHHHHHHHHHHHHhcC-CCCeeeEeeee------------------
Confidence 689999999999985 47899999998654432 3456889999999998 69999998873
Q ss_pred CCccccCCeEEEEEecch-hhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCCCccEEeec--
Q 003052 559 DGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLLVK-- 635 (853)
Q Consensus 559 ~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLKPeNILL~~-- 635 (853)
......+++|||++ ++|.+++... ...+++..++.++.+++.+|.|||+.|++|+||+|.||++..
T Consensus 61 ----~~~~~~~~~~e~~~~~~l~~~~~~~-------~~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~~~ 129 (215)
T cd00180 61 ----EDENHLYLVMEYCEGGSLKDLLKEN-------EGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDN 129 (215)
T ss_pred ----ecCCeEEEEEecCCCCcHHHHHHhc-------cCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeCCC
Confidence 33468899999987 6888887643 146899999999999999999999999999999999999965
Q ss_pred CcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHhCCCCCCcchh
Q 003052 636 GSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGRTPFSEYKT 715 (853)
Q Consensus 636 g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLtG~~PF~~~~~ 715 (853)
+.++|+|||++........ ......+...|++||.+.... .++.+.|+|+||+++|+|
T Consensus 130 ~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~~~~pe~~~~~~--------~~~~~~D~~~lg~~~~~l------------ 187 (215)
T cd00180 130 GKVKLADFGLSKLLTSDKS--LLKTIVGTPAYMAPEVLLGKG--------YYSEKSDIWSLGVILYEL------------ 187 (215)
T ss_pred CcEEEecCCceEEccCCcc--hhhcccCCCCccChhHhcccC--------CCCchhhhHHHHHHHHHH------------
Confidence 7999999999986643321 123456889999999986541 246789999999999999
Q ss_pred HHHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCCChhHHhcCC
Q 003052 716 FWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQHP 765 (853)
Q Consensus 716 ~~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~HP 765 (853)
..+.+++.+||..||.+||++.++++|+
T Consensus 188 ----------------------~~~~~~l~~~l~~~p~~R~~~~~l~~~~ 215 (215)
T cd00180 188 ----------------------PELKDLIRKMLQKDPEKRPSAKEILEHL 215 (215)
T ss_pred ----------------------HHHHHHHHHHhhCCcccCcCHHHHhhCC
Confidence 5689999999999999999999999885
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.6e-28 Score=268.66 Aligned_cols=250 Identities=23% Similarity=0.296 Sum_probs=181.4
Q ss_pred eeEEEeEeccCceEEEEEEecCCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhc-CCCceeEeeehhhhHHHHHHHHhh
Q 003052 474 YQRLGKIGSGGSSEVHKVISSDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLK-GKNNIIQLIDYEVTEKALLREVLN 552 (853)
Q Consensus 474 Y~ilk~LG~G~FG~Vyka~~~~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~-~hpNIV~Lid~~~~e~~iL~~l~~ 552 (853)
..+++.||+|.||.||||...+ +.||||++.. ...+.|.+|-+|+.... .|+||++++.+...
T Consensus 212 l~l~eli~~Grfg~V~KaqL~~-~~VAVKifp~-----~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr---------- 275 (534)
T KOG3653|consen 212 LQLLELIGRGRFGCVWKAQLDN-RLVAVKIFPE-----QEKQSFQNEKNIYSLPGMKHENILQFIGAEKR---------- 275 (534)
T ss_pred hhhHHHhhcCccceeehhhccC-ceeEEEecCH-----HHHHHHHhHHHHHhccCccchhHHHhhchhcc----------
Confidence 5567789999999999998744 7899999974 44557888988888653 59999999886321
Q ss_pred CCCCCCCCccccCCeEEEEEecch-hhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccC---------cee
Q 003052 553 GSMNNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEE---------RIV 622 (853)
Q Consensus 553 ~~iv~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~---------gII 622 (853)
+ -.+...++||+||.+ |+|.++|+.+ .+++....+++.-|++||+|||+- .|+
T Consensus 276 -------~-t~~~~eywLVt~fh~kGsL~dyL~~n---------tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~Ia 338 (534)
T KOG3653|consen 276 -------G-TADRMEYWLVTEFHPKGSLCDYLKAN---------TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIA 338 (534)
T ss_pred -------C-CccccceeEEeeeccCCcHHHHHHhc---------cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccc
Confidence 0 112446899999955 7999999874 899999999999999999999973 599
Q ss_pred eCCCCCccEEe-ecCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHH
Q 003052 623 HSDLKPANFLL-VKGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILY 701 (853)
Q Consensus 623 HRDLKPeNILL-~~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILy 701 (853)
|||||..|||+ ++++..|+|||+|..+............+||..|||||++.+.-.-.++. -=.++||||+|.+||
T Consensus 339 HRDlkSkNVLvK~DlTccIaDFGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~---Afkr~DvYamgLVLW 415 (534)
T KOG3653|consen 339 HRDLKSKNVLVKNDLTCCIADFGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRD---AFKRIDVYAMGLVLW 415 (534)
T ss_pred cccccccceEEccCCcEEeeccceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHH---HHHHHHHHHHHHHHH
Confidence 99999999999 67899999999998876432222223479999999999997653211110 114799999999999
Q ss_pred HHHhCCC------------CCCc----chhHHHHHHhhcCCCCcccCCCC-----CChhHHHHHHHhcccCCCCCCChh
Q 003052 702 QMVYGRT------------PFSE----YKTFWAKFKVITDPNHEITYEPV-----PNPWLLDLMKKCLAWDRNERWRIP 759 (853)
Q Consensus 702 ELLtG~~------------PF~~----~~~~~~~~kii~~~~~~~~~~~~-----~s~~l~dLI~kcL~~DP~kRpTa~ 759 (853)
||++... ||.. ...+.+..........+..++.. .-.-+++.|..||..|++.|.|+.
T Consensus 416 Ei~SRC~~~~~~~vp~Yqlpfe~evG~hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~ 494 (534)
T KOG3653|consen 416 EIASRCTDADPGPVPEYQLPFEAEVGNHPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAG 494 (534)
T ss_pred HHHhhcccccCCCCCcccCchhHHhcCCCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhH
Confidence 9996533 3321 01112222222222222222211 123378999999999999999975
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.9e-27 Score=274.51 Aligned_cols=249 Identities=20% Similarity=0.288 Sum_probs=201.1
Q ss_pred ceeeEEEeEeccCceEEEEEEe-cCC----cEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHH
Q 003052 472 KLYQRLGKIGSGGSSEVHKVIS-SDC----TIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKAL 546 (853)
Q Consensus 472 ~~Y~ilk~LG~G~FG~Vyka~~-~~g----~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~i 546 (853)
...+..++||+|+||+||+|.+ ..+ -+||+|++..... ...-..++.|.-+|.+|. |+|+++|++++...
T Consensus 696 telkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~-~~~s~e~LdeAl~masld-Hpnl~RLLgvc~~s--- 770 (1177)
T KOG1025|consen 696 TELKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTS-PKASIELLDEALRMASLD-HPNLLRLLGVCMLS--- 770 (1177)
T ss_pred hhhhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCC-chhhHHHHHHHHHHhcCC-CchHHHHhhhcccc---
Confidence 3456677899999999999987 334 3689999865433 233456899999999998 99999999985432
Q ss_pred HHHHhhCCCCCCCCccccCCeEEEEEecch-hhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCC
Q 003052 547 LREVLNGSMNNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSD 625 (853)
Q Consensus 547 L~~l~~~~iv~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRD 625 (853)
.+.||++|+. |.|.++++.+ +..+-......|..||++||.|||.++++|||
T Consensus 771 --------------------~~qlvtq~mP~G~LlDyvr~h-------r~~igsq~lLnw~~QIAkgM~YLe~qrlVHrd 823 (1177)
T KOG1025|consen 771 --------------------TLQLVTQLMPLGCLLDYVREH-------RDNIGSQDLLNWCYQIAKGMKYLEEQRLVHRD 823 (1177)
T ss_pred --------------------hHHHHHHhcccchHHHHHHHh-------hccccHHHHHHHHHHHHHHHHHHHhcchhhhh
Confidence 2568888866 6999999875 35688888999999999999999999999999
Q ss_pred CCCccEEe-ecCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHH
Q 003052 626 LKPANFLL-VKGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMV 704 (853)
Q Consensus 626 LKPeNILL-~~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELL 704 (853)
|-..|||+ .-+++||.|||+|+.+..+..........-.+.|||-|.+... .|+.++|||||||++||++
T Consensus 824 LaaRNVLVksP~hvkitdfgla~ll~~d~~ey~~~~gK~pikwmale~i~~~---------~~thqSDVWsfGVtiWElm 894 (1177)
T KOG1025|consen 824 LAARNVLVKSPNHVKITDFGLAKLLAPDEKEYSAPGGKVPIKWMALESIRIR---------KYTHQSDVWSFGVTIWELM 894 (1177)
T ss_pred hhhhheeecCCCeEEEEecchhhccCcccccccccccccCcHHHHHHHhhcc---------CCCchhhhhhhhhhHHHHH
Confidence 99999999 5579999999999988766554443344456789999998765 4678999999999999998
Q ss_pred h-CCCCCCcchhHHHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCCChhHHhc
Q 003052 705 Y-GRTPFSEYKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQ 763 (853)
Q Consensus 705 t-G~~PF~~~~~~~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~ 763 (853)
| |.-||.+... .++-+.+..+ .++..++..+-++.-+|.+||..|+..||++.++..
T Consensus 895 TFGa~Py~gi~~-~eI~dlle~g-eRLsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~ 952 (1177)
T KOG1025|consen 895 TFGAKPYDGIPA-EEIPDLLEKG-ERLSQPPICTIDVYMVMVKCWMIDADSRPTFKELAE 952 (1177)
T ss_pred hcCCCccCCCCH-HHhhHHHhcc-ccCCCCCCccHHHHHHHHHHhccCcccCccHHHHHH
Confidence 6 9999987543 4555555544 347778888999999999999999999999888753
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.4e-28 Score=252.70 Aligned_cols=257 Identities=21% Similarity=0.311 Sum_probs=197.8
Q ss_pred ceeeEEEeEeccCceEEEEEEec-CCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHHHH
Q 003052 472 KLYQRLGKIGSGGSSEVHKVISS-DCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLREV 550 (853)
Q Consensus 472 ~~Y~ilk~LG~G~FG~Vyka~~~-~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~~l 550 (853)
+.|.+.+.||+|.||.+.+|.++ +.+.+|+|.+... ......|.+|..+--.|.+|.||+.-|++
T Consensus 24 d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p---~tt~~dF~rEfhY~~~Ls~H~hIi~tY~v----------- 89 (378)
T KOG1345|consen 24 DVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRP---QTTQADFVREFHYSFFLSPHQHIIDTYEV----------- 89 (378)
T ss_pred hhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcc---hhhHHHHHHHhccceeeccchhhhHHHHH-----------
Confidence 56999999999999999999985 4577899998754 34556799999998889989999877654
Q ss_pred hhCCCCCCCCccccCCeEEEEEecch-hhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCCCc
Q 003052 551 LNGSMNNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPA 629 (853)
Q Consensus 551 ~~~~iv~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLKPe 629 (853)
.|+..++++++|||++ |||...+.. ..+-|...+.++.|+++||.|||+++|||||||.+
T Consensus 90 ----------aFqt~d~YvF~qE~aP~gdL~snv~~---------~GigE~~~K~v~~ql~SAi~fMHsknlVHRdlK~e 150 (378)
T KOG1345|consen 90 ----------AFQTSDAYVFVQEFAPRGDLRSNVEA---------AGIGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAE 150 (378)
T ss_pred ----------HhhcCceEEEeeccCccchhhhhcCc---------ccccHHHHHHHHHHHHHHHHHhhccchhhcccccc
Confidence 3778889999999977 688877654 46889999999999999999999999999999999
Q ss_pred cEEe-ec--CcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHhC
Q 003052 630 NFLL-VK--GSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYG 706 (853)
Q Consensus 630 NILL-~~--g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLtG 706 (853)
|||| +. -.|||||||+.+.... .+ .-.--+..|.+||++..... ..+.+.+..|||.||+|+|.+|||
T Consensus 151 NiLif~~df~rvKlcDFG~t~k~g~---tV--~~~~~~~~y~~pe~~~~~~n----e~~~~~ps~D~WqfGIi~f~cltG 221 (378)
T KOG1345|consen 151 NILIFDADFYRVKLCDFGLTRKVGT---TV--KYLEYVNNYHAPELCDTVVN----EKLVVNPSTDIWQFGIIFFYCLTG 221 (378)
T ss_pred eEEEecCCccEEEeeecccccccCc---ee--hhhhhhcccCCcHHHhhccc----cceEecccccchheeeeeeeeecC
Confidence 9999 32 3899999999875422 11 12234567999998865422 234677899999999999999999
Q ss_pred CCCCCc----chhHHHHHHhhcCCCCcc-cCCCCCChhHHHHHHHhcccCCCCC---CChhHHhcCCCCCCC
Q 003052 707 RTPFSE----YKTFWAKFKVITDPNHEI-TYEPVPNPWLLDLMKKCLAWDRNER---WRIPQLLQHPFLVPP 770 (853)
Q Consensus 707 ~~PF~~----~~~~~~~~kii~~~~~~~-~~~~~~s~~l~dLI~kcL~~DP~kR---pTa~EIL~HPwf~~~ 770 (853)
.+||.. ....+............. ..-...++.+..+.++-|..++++| +++.......|....
T Consensus 222 ~~PWQka~~~d~~Y~~~~~w~~rk~~~~P~~F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk~~w~E~~ 293 (378)
T KOG1345|consen 222 KFPWQKASIMDKPYWEWEQWLKRKNPALPKKFNPFSEKALRLFKKSLTPRFKDRCKIWTAKKMRKCLWKEKL 293 (378)
T ss_pred CCcchhhhccCchHHHHHHHhcccCccCchhhcccCHHHHHHHHHhcCCcccccchhHHHHHHHHHHHHHhh
Confidence 999963 233444443333222211 1112457778999999999999999 777777777886543
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=6.4e-27 Score=257.27 Aligned_cols=256 Identities=22% Similarity=0.289 Sum_probs=189.2
Q ss_pred CceeeEEEeEeccCceEEEEEEecCCcEEEEEEEecCCCChhhHhhHHHHHHHHHHh-cCCCceeEeeehhhhHHHHHHH
Q 003052 471 GKLYQRLGKIGSGGSSEVHKVISSDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKL-KGKNNIIQLIDYEVTEKALLRE 549 (853)
Q Consensus 471 g~~Y~ilk~LG~G~FG~Vyka~~~~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL-~~hpNIV~Lid~~~~e~~iL~~ 549 (853)
.+...+++.||+|-||.||+|.++ |..||||++....+ ..|.+|.+|++.+ -.|+||+.+++.-....
T Consensus 210 arqI~L~e~IGkGRyGEVwrG~wr-Ge~VAVKiF~srdE-----~SWfrEtEIYqTvmLRHENILgFIaaD~~~~----- 278 (513)
T KOG2052|consen 210 ARQIVLQEIIGKGRFGEVWRGRWR-GEDVAVKIFSSRDE-----RSWFRETEIYQTVMLRHENILGFIAADNKDN----- 278 (513)
T ss_pred hheeEEEEEecCccccceeecccc-CCceEEEEecccch-----hhhhhHHHHHHHHHhccchhhhhhhccccCC-----
Confidence 456888999999999999999884 45699999975432 2578898888863 34999998886521110
Q ss_pred HhhCCCCCCCCccccCCeEEEEEecch-hhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccC--------c
Q 003052 550 VLNGSMNNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEE--------R 620 (853)
Q Consensus 550 l~~~~iv~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~--------g 620 (853)
..-..+|||.+|-+ |+|+++|.. ..++......++.-++.||+|||.. .
T Consensus 279 -------------gs~TQLwLvTdYHe~GSL~DyL~r---------~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPa 336 (513)
T KOG2052|consen 279 -------------GSWTQLWLVTDYHEHGSLYDYLNR---------NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPA 336 (513)
T ss_pred -------------CceEEEEEeeecccCCcHHHHHhh---------ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCch
Confidence 11236899999966 799999976 4799999999999999999999953 5
Q ss_pred eeeCCCCCccEEe-ecCcEEEEecccchhcccCCc--cccccccccCccccCchhhccCCCCCCCccccCCCccchhhhH
Q 003052 621 IVHSDLKPANFLL-VKGSLKLIDFGIAKAIMSDTT--NIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLG 697 (853)
Q Consensus 621 IIHRDLKPeNILL-~~g~VKL~DFGlAk~~~~~~~--~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLG 697 (853)
|.|||||..|||+ .+|...|+|+|+|-....... ....+..+||-.|||||++...-... ...-=..+||||||
T Consensus 337 IAHRDlKSKNILVKkn~~C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~---~Fesyk~ADIYafg 413 (513)
T KOG2052|consen 337 IAHRDLKSKNILVKKNGTCCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMK---HFESYKRADIYAFG 413 (513)
T ss_pred hhccccccccEEEccCCcEEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChh---hhhhhhHHHHHHHH
Confidence 9999999999999 678999999999976544321 22335679999999999996532211 00111469999999
Q ss_pred HHHHHHHh----------CCCCCCc----chhHHHHHHhhcCCCCcccCCCCC--Chh---HHHHHHHhcccCCCCCCCh
Q 003052 698 CILYQMVY----------GRTPFSE----YKTFWAKFKVITDPNHEITYEPVP--NPW---LLDLMKKCLAWDRNERWRI 758 (853)
Q Consensus 698 VILyELLt----------G~~PF~~----~~~~~~~~kii~~~~~~~~~~~~~--s~~---l~dLI~kcL~~DP~kRpTa 758 (853)
.++||++- -++||.+ ...+.++.+++-........+..+ .+. +..+|+.||..||.-|.|+
T Consensus 414 LVlWEiarRc~~ggi~eey~~Pyyd~Vp~DPs~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltA 493 (513)
T KOG2052|consen 414 LVLWEIARRCESGGIVEEYQLPYYDVVPSDPSFEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTA 493 (513)
T ss_pred HHHHHHHHHhhcCCEehhhcCCcccCCCCCCCHHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHH
Confidence 99999973 2678864 344556666654444444444333 222 5678999999999999987
Q ss_pred hHHh
Q 003052 759 PQLL 762 (853)
Q Consensus 759 ~EIL 762 (853)
--|-
T Consensus 494 LriK 497 (513)
T KOG2052|consen 494 LRIK 497 (513)
T ss_pred HHHH
Confidence 5543
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.94 E-value=6.2e-26 Score=229.67 Aligned_cols=211 Identities=37% Similarity=0.529 Sum_probs=169.8
Q ss_pred eeEEEeEeccCceEEEEEEecC-CcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHHHHhh
Q 003052 474 YQRLGKIGSGGSSEVHKVISSD-CTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLREVLN 552 (853)
Q Consensus 474 Y~ilk~LG~G~FG~Vyka~~~~-g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~~l~~ 552 (853)
|.+.+.||.|+||.||++.... +..+|+|.+...... .....+.+|++.+++++ |+||+++++++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~e~~~~~~~~-~~~i~~~~~~~------------ 66 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTE-KQREEFLREIRILKKLK-HPNIVKLYGVF------------ 66 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccch-HHHHHHHHHHHHHHhCC-CCChhhheeee------------
Confidence 5678899999999999999864 788999999865433 24567889999999996 78999988763
Q ss_pred CCCCCCCCccccCCeEEEEEecchh-hHHHHHHHhhhhccCCCCC-CCHHHHHHHHHHhhhhhhhcccCceeeCCCCCcc
Q 003052 553 GSMNNKDGRVKDDGYIYMVLEYGEI-DLAHMLSQKWKEMDGSNQT-LDENWLRFYWQQILEAVNTIHEERIVHSDLKPAN 630 (853)
Q Consensus 553 ~~iv~~~g~~~d~~~lyLVmEy~~g-dL~~~L~~~~k~~~~~~~~-LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLKPeN 630 (853)
.....+|+++||+++ +|.+++... .. +++..++.++.+++.+|.|||++|++|+||+|.|
T Consensus 67 ----------~~~~~~~~v~e~~~~~~L~~~~~~~--------~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~n 128 (225)
T smart00221 67 ----------EDPEPLYLVMEYCEGGDLFDYLRKK--------GGKLSEEEARFYLRQILEALEYLHSLGIVHRDLKPEN 128 (225)
T ss_pred ----------ecCCceEEEEeccCCCCHHHHHHhc--------ccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHH
Confidence 344678999999776 888887653 23 8899999999999999999999999999999999
Q ss_pred EEee-cCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHhCCCC
Q 003052 631 FLLV-KGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGRTP 709 (853)
Q Consensus 631 ILL~-~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLtG~~P 709 (853)
|+++ ++.++|+|||++......... ......++..|++||.+. .. ..++.++|+|+||+++|+|++|+.|
T Consensus 129 i~v~~~~~~~l~d~g~~~~~~~~~~~-~~~~~~~~~~~~~pe~~~-~~-------~~~~~~~Dv~~lG~~~~~l~~g~~p 199 (225)
T smart00221 129 ILLGMDGLVKLADFGLARFIHRDLAA-LLKTVKGTPFYLAPEVLL-GG-------KGYGEAVDIWSLGVILYELLWGPEP 199 (225)
T ss_pred EEEcCCCCEEEeeCceeeEecCcccc-cccceeccCCcCCHhHhc-CC-------CCCCchhhHHHHHHHHHHHHHCCCC
Confidence 9995 579999999999877543211 223567889999999984 11 1356799999999999999999999
Q ss_pred CCc-chhHHHHHHhhcC
Q 003052 710 FSE-YKTFWAKFKVITD 725 (853)
Q Consensus 710 F~~-~~~~~~~~kii~~ 725 (853)
|.. .++.....+.+..
T Consensus 200 f~~~~~~~~~~~~~~~~ 216 (225)
T smart00221 200 FSGEGEFTSLLSDVWSF 216 (225)
T ss_pred ccccchhHHHHHHHHhc
Confidence 977 5555555555543
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1e-24 Score=224.67 Aligned_cols=262 Identities=33% Similarity=0.496 Sum_probs=199.9
Q ss_pred eeEEEeEeccCceEEEEEEecCCcEEEEEEEecCCCChh-hHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHHHHhh
Q 003052 474 YQRLGKIGSGGSSEVHKVISSDCTIYALKKIKLKGRDYA-TAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLREVLN 552 (853)
Q Consensus 474 Y~ilk~LG~G~FG~Vyka~~~~g~~vAVKkik~~~~~~~-~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~~l~~ 552 (853)
|.+.+.||.|+||.||++.+. ..+++|.+........ ....+.+|+.++..+.++++|+++++++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~------------ 67 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFF------------ 67 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEE------------
Confidence 778899999999999999887 7789999987665543 5667899999999999777899998874
Q ss_pred CCCCCCCCccccCCeEEEEEecchh-hHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCCCccE
Q 003052 553 GSMNNKDGRVKDDGYIYMVLEYGEI-DLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANF 631 (853)
Q Consensus 553 ~~iv~~~g~~~d~~~lyLVmEy~~g-dL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLKPeNI 631 (853)
......+++++|+.+ ++.+++...... ..+.+..+..++.|++.++.|+|..|++||||||+||
T Consensus 68 ----------~~~~~~~~~~~~~~~~~l~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~ni 132 (384)
T COG0515 68 ----------QDEGSLYLVMEYVDGGSLEDLLKKIGRK-----GPLSESEALFILAQILSALEYLHSKGIIHRDIKPENI 132 (384)
T ss_pred ----------ecCCEEEEEEecCCCCcHHHHHHhcccc-----cCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHe
Confidence 334448999999764 666444432100 3699999999999999999999999999999999999
Q ss_pred Eeec-C-cEEEEecccchhcccCCccc----cccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHh
Q 003052 632 LLVK-G-SLKLIDFGIAKAIMSDTTNI----QRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVY 705 (853)
Q Consensus 632 LL~~-g-~VKL~DFGlAk~~~~~~~~~----~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLt 705 (853)
++.. + .++++|||+++.+....... .....+||..|+|||.+.+.. ...++...|+|++|++++++++
T Consensus 133 l~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~------~~~~~~~~D~~s~g~~~~~~~~ 206 (384)
T COG0515 133 LLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLS------LAYASSSSDIWSLGITLYELLT 206 (384)
T ss_pred eecCCCCeEEEeccCcceecCCCCccccccccccccccccccCCHHHhcCCC------CCCCCchHhHHHHHHHHHHHHh
Confidence 9954 4 69999999998654433221 235779999999999997631 0135679999999999999999
Q ss_pred CCCCCCcchh---HHHHHHhhcCCCCc-ccCCCCC------ChhHHHHHHHhcccCCCCCCChhHHhcCCCCCCC
Q 003052 706 GRTPFSEYKT---FWAKFKVITDPNHE-ITYEPVP------NPWLLDLMKKCLAWDRNERWRIPQLLQHPFLVPP 770 (853)
Q Consensus 706 G~~PF~~~~~---~~~~~kii~~~~~~-~~~~~~~------s~~l~dLI~kcL~~DP~kRpTa~EIL~HPwf~~~ 770 (853)
|..||..... .......+...... ....... ...+.+++.+|+..+|..|.+..+...++|....
T Consensus 207 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~~~~~~~ 281 (384)
T COG0515 207 GLPPFEGEKNSSATSQTLKIILELPTPSLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHL 281 (384)
T ss_pred CCCCCCCCCccccHHHHHHHHHhcCCcccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhchHhhCc
Confidence 9999876542 23333333322222 1111111 2468999999999999999999999999776543
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.93 E-value=2e-26 Score=228.30 Aligned_cols=161 Identities=23% Similarity=0.300 Sum_probs=122.7
Q ss_pred hhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCCCccEEe-ecCcEEEEecccchhcccCCcc
Q 003052 577 IDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLL-VKGSLKLIDFGIAKAIMSDTTN 655 (853)
Q Consensus 577 gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLKPeNILL-~~g~VKL~DFGlAk~~~~~~~~ 655 (853)
|+|.+++..+ +..+++..++.|+.||+.||.|||+++ ||+|||+ .++.+|+ ||+++.....
T Consensus 1 GsL~~~l~~~-------~~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~~~~~~~--fG~~~~~~~~--- 62 (176)
T smart00750 1 VSLADILEVR-------GRPLNEEEIWAVCLQCLRALRELHRQA------KSGNILLTWDGLLKL--DGSVAFKTPE--- 62 (176)
T ss_pred CcHHHHHHHh-------CCCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcCccceee--ccceEeeccc---
Confidence 4677777643 356999999999999999999999999 9999999 4568888 9999765331
Q ss_pred ccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHhCCCCCCcchhHHHHHHhhcCCCCcc-----
Q 003052 656 IQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGRTPFSEYKTFWAKFKVITDPNHEI----- 730 (853)
Q Consensus 656 ~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLtG~~PF~~~~~~~~~~kii~~~~~~~----- 730 (853)
...||+.|||||++.+.. |+.++|||||||++|||++|+.||............+.......
T Consensus 63 ----~~~g~~~y~aPE~~~~~~---------~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 129 (176)
T smart00750 63 ----QSRVDPYFMAPEVIQGQS---------YTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPRDR 129 (176)
T ss_pred ----cCCCcccccChHHhcCCC---------CcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCcccc
Confidence 237899999999997653 56799999999999999999999976443322222221111111
Q ss_pred cCCCCCCh--hHHHHHHHhcccCCCCCCChhHHhcCCCCC
Q 003052 731 TYEPVPNP--WLLDLMKKCLAWDRNERWRIPQLLQHPFLV 768 (853)
Q Consensus 731 ~~~~~~s~--~l~dLI~kcL~~DP~kRpTa~EIL~HPwf~ 768 (853)
......+. ++.+||.+||..||.+||++.++++|+|+.
T Consensus 130 ~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~ 169 (176)
T smart00750 130 SNLESVSAARSFADFMRVCASRLPQRREAANHYLAHCRAL 169 (176)
T ss_pred ccHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHH
Confidence 01111222 689999999999999999999999999975
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.2e-25 Score=240.12 Aligned_cols=259 Identities=19% Similarity=0.264 Sum_probs=201.4
Q ss_pred CceeeEEEeEeccCceEEEEEEec------CCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHH
Q 003052 471 GKLYQRLGKIGSGGSSEVHKVISS------DCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEK 544 (853)
Q Consensus 471 g~~Y~ilk~LG~G~FG~Vyka~~~------~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~ 544 (853)
..+++....+-+|.||.||.|++. +.+.+-+|.++... ..-+...++.|--.|..+. |+|+..+.++.
T Consensus 283 r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~A-S~iQv~~~L~es~lly~~s-H~nll~V~~V~---- 356 (563)
T KOG1024|consen 283 RCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHA-SQIQVNLLLQESMLLYGAS-HPNLLSVLGVS---- 356 (563)
T ss_pred hhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcc-cHHHHHHHHHHHHHHhcCc-CCCccceeEEE----
Confidence 345777778999999999999764 23456667665432 3344556778888887777 88988887763
Q ss_pred HHHHHHhhCCCCCCCCccccCCeEEEEEecch-hhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceee
Q 003052 545 ALLREVLNGSMNNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVH 623 (853)
Q Consensus 545 ~iL~~l~~~~iv~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIH 623 (853)
.++....++++.+.+ ++|..++...+.......+.++-.+...++.||+.|+.|||++||||
T Consensus 357 -----------------ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViH 419 (563)
T KOG1024|consen 357 -----------------IEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIH 419 (563)
T ss_pred -----------------eeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCccc
Confidence 234556677788855 69999998765444444567888888999999999999999999999
Q ss_pred CCCCCccEEeecC-cEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHH
Q 003052 624 SDLKPANFLLVKG-SLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQ 702 (853)
Q Consensus 624 RDLKPeNILL~~g-~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyE 702 (853)
.||...|.+|++- .+||+|=.+++-+-..+.+......--...||+||.+..+. |+.++|+|||||+|||
T Consensus 420 kDiAaRNCvIdd~LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~---------yssasDvWsfGVllWE 490 (563)
T KOG1024|consen 420 KDIAARNCVIDDQLQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSH---------YSSASDVWSFGVLLWE 490 (563)
T ss_pred chhhhhcceehhheeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhh---------hcchhhhHHHHHHHHH
Confidence 9999999999765 89999999998765544443333333456899999998764 6779999999999999
Q ss_pred HHh-CCCCCCcchhHHHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCCChhHHhc
Q 003052 703 MVY-GRTPFSEYKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQ 763 (853)
Q Consensus 703 LLt-G~~PF~~~~~~~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~ 763 (853)
|+| |+.||.+.++++... .+.+ ..++..+..++.++..++..||..+|++||+.+|+..
T Consensus 491 Lmtlg~~PyaeIDPfEm~~-ylkd-GyRlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~ 550 (563)
T KOG1024|consen 491 LMTLGKLPYAEIDPFEMEH-YLKD-GYRLAQPFNCPDELFTVMACCWALLPEERPSFSQLVI 550 (563)
T ss_pred HHhcCCCCccccCHHHHHH-HHhc-cceecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHH
Confidence 996 999999988875433 3332 4566777788999999999999999999999998863
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=9.6e-24 Score=231.99 Aligned_cols=254 Identities=22% Similarity=0.282 Sum_probs=187.3
Q ss_pred eeeEEEeEeccCceEEEEEEecCC--cEEEEEEEecCCCChhhHhhHHHHHHHHHHhc---CCCceeEeeehhhhHHHHH
Q 003052 473 LYQRLGKIGSGGSSEVHKVISSDC--TIYALKKIKLKGRDYATAYGFCQEIEYLNKLK---GKNNIIQLIDYEVTEKALL 547 (853)
Q Consensus 473 ~Y~ilk~LG~G~FG~Vyka~~~~g--~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~---~hpNIV~Lid~~~~e~~iL 547 (853)
.|++.++||+|+||.||+|.+... ..+|+|........... .+..|+.+|..+. +..++..+++...
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~--~l~~E~~vl~~l~~~~~~~~~~~~~~~G~------ 90 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPS--VLKIEIQVLKKLEKKNGPSHFPKLLDHGR------ 90 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCc--cchhHHHHHHHHhhhcCCCCCCEEEEecc------
Confidence 699999999999999999998553 47888888754332111 4668999999987 3457777776521
Q ss_pred HHHhhCCCCCCCCccccCCeEEEEEecchhhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCC
Q 003052 548 REVLNGSMNNKDGRVKDDGYIYMVLEYGEIDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLK 627 (853)
Q Consensus 548 ~~l~~~~iv~~~g~~~d~~~lyLVmEy~~gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLK 627 (853)
..+.+-||||+.++.+|.++.... ..+.|+...+..++.|++.+|++||+.|++|||||
T Consensus 91 ---------------~~~~~~~iVM~l~G~sL~dl~~~~------~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiK 149 (322)
T KOG1164|consen 91 ---------------STEDFNFIVMSLLGPSLEDLRKRN------PPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIK 149 (322)
T ss_pred ---------------CCCceeEEEEeccCccHHHHHHhC------CCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcC
Confidence 356678999999999999876543 24789999999999999999999999999999999
Q ss_pred CccEEeec------CcEEEEecccch--hcccCCcc---cc---ccccccCccccCchhhccCCCCCCCccccCCCccch
Q 003052 628 PANFLLVK------GSLKLIDFGIAK--AIMSDTTN---IQ---RDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDI 693 (853)
Q Consensus 628 PeNILL~~------g~VKL~DFGlAk--~~~~~~~~---~~---~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDI 693 (853)
|+|+++.. ..+.|.|||+|+ .+...... .. ...+.||..|+++.+..+.+ .+++.|+
T Consensus 150 p~N~~~g~~~~~~~~~~~llDfGlar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e---------~~r~DDl 220 (322)
T KOG1164|consen 150 PENFVVGQSSRSEVRTLYLLDFGLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIE---------QGRRDDL 220 (322)
T ss_pred HHHeeecCCCCcccceEEEEecCCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCc---------cCCchhh
Confidence 99999943 359999999999 43322211 11 12456999999999988764 4689999
Q ss_pred hhhHHHHHHHHhCCCCCCcchhHHH--HHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCCChhHHhcC
Q 003052 694 WSLGCILYQMVYGRTPFSEYKTFWA--KFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQH 764 (853)
Q Consensus 694 WSLGVILyELLtG~~PF~~~~~~~~--~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~H 764 (853)
||++.++.+|+.|..||........ .+................+.++..++..+-..+...+|....+...
T Consensus 221 es~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~ 293 (322)
T KOG1164|consen 221 ESLFYMLLELLKGSLPWEALEMTDLKSKFEKDPRKLLTDRFGDLKPEEFAKILEYIDSLDYEDKPDYEKLAEL 293 (322)
T ss_pred hhHHHHHHHHhcCCCCCccccccchHHHHHHHhhhhccccccCCChHHHHHHHHHhhccCCcCCCCHHHHHHH
Confidence 9999999999999999966443211 1111111111000233445677788887777888888877766543
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.92 E-value=8.9e-26 Score=266.51 Aligned_cols=256 Identities=25% Similarity=0.336 Sum_probs=184.0
Q ss_pred EEEeEeccCceEEEEEEe-cCCcEEEEEEEecC---CCCh-hhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHHHH
Q 003052 476 RLGKIGSGGSSEVHKVIS-SDCTIYALKKIKLK---GRDY-ATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLREV 550 (853)
Q Consensus 476 ilk~LG~G~FG~Vyka~~-~~g~~vAVKkik~~---~~~~-~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~~l 550 (853)
....+|.|+||.|+.+.. .....++.|.+... .... .....+..|+-+-..|. |+||+..++...
T Consensus 322 ~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~-h~~~~e~l~~~~--------- 391 (601)
T KOG0590|consen 322 PGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLS-HPNIIETLDIVQ--------- 391 (601)
T ss_pred ccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeeccccc-CCchhhhHHHHh---------
Confidence 456799999998887765 34444555554421 1111 11112445555555565 788866554422
Q ss_pred hhCCCCCCCCccccCCeEEEEEecchhhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCCCcc
Q 003052 551 LNGSMNNKDGRVKDDGYIYMVLEYGEIDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPAN 630 (853)
Q Consensus 551 ~~~~iv~~~g~~~d~~~lyLVmEy~~gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLKPeN 630 (853)
+...++-+||||.+||+.++... ..+....+..+++||+.||+|||+.||.||||||+|
T Consensus 392 -------------~~~~~~~~mE~~~~Dlf~~~~~~--------~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~en 450 (601)
T KOG0590|consen 392 -------------EIDGILQSMEYCPYDLFSLVMSN--------GKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLEN 450 (601)
T ss_pred -------------hcccchhhhhcccHHHHHHHhcc--------cccchhhhhHHHHHHHHHHHHHHhcCceeccCcccc
Confidence 12223334999998998888653 468889999999999999999999999999999999
Q ss_pred EEee-cCcEEEEecccchhcccCCcc--ccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHhCC
Q 003052 631 FLLV-KGSLKLIDFGIAKAIMSDTTN--IQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGR 707 (853)
Q Consensus 631 ILL~-~g~VKL~DFGlAk~~~~~~~~--~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLtG~ 707 (853)
+++. .|.+||+|||.+..+..+... ......+|+..|+|||++.+..++. +.+||||+|++++.|++|+
T Consensus 451 ll~~~~g~lki~Dfg~~~vf~~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydp--------r~vDiwS~~ii~~~m~~~~ 522 (601)
T KOG0590|consen 451 LLVTENGILKIIDFGAASVFRYPWEKNIHESSGIVGSDPYLAPEVLTGKEYDP--------RAVDVWSCGIIYICMILGR 522 (601)
T ss_pred EEEecCCceEEeecCcceeeccCcchhhhhhcCcccCCcCcCcccccccccCc--------chhhhhhccceEEEEecCC
Confidence 9995 569999999999887654443 4456789999999999999988764 7899999999999999999
Q ss_pred CCCCcchhHHHHHHhhcCC------CCcccCCCCCChhHHHHHHHhcccCCCCCCChhHHhcCCCCCCC
Q 003052 708 TPFSEYKTFWAKFKVITDP------NHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQHPFLVPP 770 (853)
Q Consensus 708 ~PF~~~~~~~~~~kii~~~------~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~HPwf~~~ 770 (853)
.||.-.......+...... .........++...+.+|.+||++||.+|.|+++|++.+||+..
T Consensus 523 ~~Wk~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d~W~~~i 591 (601)
T KOG0590|consen 523 FPWKVAKKSDNSFKTNNYSDQRNIFEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILNDEWIRSI 591 (601)
T ss_pred CccccccccccchhhhccccccccccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhhChHhhhc
Confidence 9995432221111111000 01111223445668999999999999999999999999999753
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=2e-24 Score=246.84 Aligned_cols=235 Identities=25% Similarity=0.401 Sum_probs=186.9
Q ss_pred EeccCceEEEEEEe----cCCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHHHHhhCCC
Q 003052 480 IGSGGSSEVHKVIS----SDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLREVLNGSM 555 (853)
Q Consensus 480 LG~G~FG~Vyka~~----~~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~~l~~~~i 555 (853)
+|+|+||.|+++.. ..+..||+|+.++.............|..++..++.|+.++++.
T Consensus 2 lg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lh------------------ 63 (612)
T KOG0603|consen 2 LGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLH------------------ 63 (612)
T ss_pred CCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeee------------------
Confidence 79999999998764 34578999999776443322224456777777777677666664
Q ss_pred CCCCCccccCCeEEEEEecch-hhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCCCccEEe-
Q 003052 556 NNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLL- 633 (853)
Q Consensus 556 v~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLKPeNILL- 633 (853)
.+|+.++.+|++++|.. ++|...+.. ...+.+...+.+...++.|++++|..||+|||+|++||++
T Consensus 64 ----yafqt~~kl~l~ld~~rgg~lft~l~~--------~~~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld 131 (612)
T KOG0603|consen 64 ----YAFQTDGKLYLILDFLRGGDLFTRLSK--------EVMFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLL 131 (612)
T ss_pred ----eeeccccchhHhhhhcccchhhhcccc--------CCchHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeec
Confidence 44778888999999955 477665543 3678899999999999999999999999999999999999
Q ss_pred ecCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHhCCCCCCcc
Q 003052 634 VKGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGRTPFSEY 713 (853)
Q Consensus 634 ~~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLtG~~PF~~~ 713 (853)
.+|++|+.|||+++....... .|||..|||||++.+. ...+|+||+|+++|||++|..||..
T Consensus 132 ~~Ghi~~tdfglske~v~~~~------~cgt~eymApEI~~gh-----------~~a~D~ws~gvl~felltg~~pf~~- 193 (612)
T KOG0603|consen 132 LEGHIKLTDFGLSKEAVKEKI------ACGTYEYRAPEIINGH-----------LSAADWWSFGVLAFELLTGTLPFGG- 193 (612)
T ss_pred ccCccccCCchhhhHhHhhhh------cccchhhhhhHhhhcc-----------CCcccchhhhhhHHHHhhCCCCCch-
Confidence 689999999999998765332 2999999999999732 4689999999999999999999987
Q ss_pred hhHHHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCCC-----hhHHhcCCCCC
Q 003052 714 KTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWR-----IPQLLQHPFLV 768 (853)
Q Consensus 714 ~~~~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpT-----a~EIL~HPwf~ 768 (853)
+ ..+.|. ...+..+...+..+++++..++..+|.+|.- +.|+++|+||.
T Consensus 194 ~----~~~~Il--~~~~~~p~~l~~~a~~~~~~l~~r~p~nrLg~~~~~~~eik~h~f~~ 247 (612)
T KOG0603|consen 194 D----TMKRIL--KAELEMPRELSAEARSLFRQLFKRNPENRLGAGPDGVDEIKQHEFFQ 247 (612)
T ss_pred H----HHHHHh--hhccCCchhhhHHHHHHHHHHHhhCHHHHhccCcchhHHHhccchhe
Confidence 2 222222 2244566677888999999999999999985 58999999985
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.9e-22 Score=215.65 Aligned_cols=202 Identities=23% Similarity=0.340 Sum_probs=168.8
Q ss_pred cCceeeEEEeEeccCceEEEEEEe-cCCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHH
Q 003052 470 NGKLYQRLGKIGSGGSSEVHKVIS-SDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLR 548 (853)
Q Consensus 470 ~g~~Y~ilk~LG~G~FG~Vyka~~-~~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~ 548 (853)
-|-.|++.++||+|+||+.+.|.. -++..||||.-..+.+- -.+..|.+..+.|.+.++|...+-|
T Consensus 26 VG~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~A----PQLrdEYr~YKlL~g~~GIP~vYYF--------- 92 (449)
T KOG1165|consen 26 VGPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSEA----PQLRDEYRTYKLLGGTEGIPQVYYF--------- 92 (449)
T ss_pred ecccceeccccccCcceeeecccccccCceEEEEeccccCCc----chHHHHHHHHHHHcCCCCCCceeee---------
Confidence 356799999999999999999987 57899999987765443 2466899999999999999988755
Q ss_pred HHhhCCCCCCCCccccCCeEEEEEecchhhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCCC
Q 003052 549 EVLNGSMNNKDGRVKDDGYIYMVLEYGEIDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKP 628 (853)
Q Consensus 549 ~l~~~~iv~~~g~~~d~~~lyLVmEy~~gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLKP 628 (853)
-+.+.+-.||||+++.+|.+++.-+ +..|+.+.+..++.|++.-++|+|++.+|+|||||
T Consensus 93 -------------GqeG~~NiLVidLLGPSLEDLFD~C-------gR~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKP 152 (449)
T KOG1165|consen 93 -------------GQEGKYNILVIDLLGPSLEDLFDLC-------GRRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKP 152 (449)
T ss_pred -------------ccccchhhhhhhhhCcCHHHHHHHh-------cCcccHHhHHHHHHHHHHHHHHHHhcceeecccCc
Confidence 2344566899999887777766543 56899999999999999999999999999999999
Q ss_pred ccEEeec------CcEEEEecccchhcccCCccc-----cccccccCccccCchhhccCCCCCCCccccCCCccchhhhH
Q 003052 629 ANFLLVK------GSLKLIDFGIAKAIMSDTTNI-----QRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLG 697 (853)
Q Consensus 629 eNILL~~------g~VKL~DFGlAk~~~~~~~~~-----~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLG 697 (853)
+|+||.. +.|.|+|||+|+.+.++.+.. ......||..||+--...|.+. +++.|+-|||
T Consensus 153 dNFLIGrp~~k~~n~IhiiDFGmAK~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQ---------SRRDDLEaLG 223 (449)
T KOG1165|consen 153 DNFLIGRPGTKDANVIHIIDFGMAKEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQ---------SRRDDLEALG 223 (449)
T ss_pred cceeecCCCCCCCceEEEEeccchhhhcCccccccCccccccccccceeeeEeeccccchh---------hhhhhHHHhh
Confidence 9999942 368999999999987765432 2346789999999988877753 5789999999
Q ss_pred HHHHHHHhCCCCCCcc
Q 003052 698 CILYQMVYGRTPFSEY 713 (853)
Q Consensus 698 VILyELLtG~~PF~~~ 713 (853)
-++++.|-|.+||.+.
T Consensus 224 HvFmYFLRGsLPWQGL 239 (449)
T KOG1165|consen 224 HVFMYFLRGSLPWQGL 239 (449)
T ss_pred hhhhhhccCCCccccc
Confidence 9999999999999764
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=4e-22 Score=205.57 Aligned_cols=245 Identities=23% Similarity=0.296 Sum_probs=185.1
Q ss_pred CceeeEEEeEeccCceEEEEEEe-cCCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHHH
Q 003052 471 GKLYQRLGKIGSGGSSEVHKVIS-SDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLRE 549 (853)
Q Consensus 471 g~~Y~ilk~LG~G~FG~Vyka~~-~~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~~ 549 (853)
+..|+++++||.|+||.+|.+.. .+|..||||+-..+.... .+..|.++.+.|++-..|..+..|
T Consensus 14 ~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~hp----qL~yEskvY~iL~~g~GiP~i~~y---------- 79 (341)
T KOG1163|consen 14 GGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKHP----QLLYESKVYRILQGGVGIPHIRHY---------- 79 (341)
T ss_pred ccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCCCc----chhHHHHHHHHhccCCCCchhhhh----------
Confidence 45699999999999999999998 688999999987654432 366899999999977777766554
Q ss_pred HhhCCCCCCCCccccCCeEEEEEecchhhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCCCc
Q 003052 550 VLNGSMNNKDGRVKDDGYIYMVLEYGEIDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPA 629 (853)
Q Consensus 550 l~~~~iv~~~g~~~d~~~lyLVmEy~~gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLKPe 629 (853)
..+..+-.+|||+.+.+|.+++.-+ ...|+...+..++-|++.-++|+|.+++|||||||+
T Consensus 80 ------------~~e~~ynvlVMdLLGPsLEdLfnfC-------~R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPd 140 (341)
T KOG1163|consen 80 ------------GTEKDYNVLVMDLLGPSLEDLFNFC-------SRRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPD 140 (341)
T ss_pred ------------ccccccceeeeeccCccHHHHHHHH-------hhhhhHHhHHHHHHHHHHHHHHHHhhccccccCCcc
Confidence 3455677999999888777776543 346999999999999999999999999999999999
Q ss_pred cEEeec----CcEEEEecccchhcccCCccc-----cccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHH
Q 003052 630 NFLLVK----GSLKLIDFGIAKAIMSDTTNI-----QRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCIL 700 (853)
Q Consensus 630 NILL~~----g~VKL~DFGlAk~~~~~~~~~-----~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVIL 700 (853)
|+|..- ..+.|+|||+|+.+.+..+.. ......||..|.+--...+.+. ++..|+-|+|.+|
T Consensus 141 NFLMGlgrh~~kl~LIDFGLaKky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eq---------SRRDDmeSvgYvL 211 (341)
T KOG1163|consen 141 NFLMGLGRHCNKLYLIDFGLAKKYRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQ---------SRRDDMESVGYVL 211 (341)
T ss_pred ceeeccccccceEEEEeccchhhhccccccccCccccCCccceeeeehhhhhhhhhhh---------hhhhhhhhhccee
Confidence 999943 479999999999876533321 1235689999999887766542 5789999999999
Q ss_pred HHHHhCCCCCCcchhH--HHHHHhhcCCCCcc---cCCCCCChhHHHHHHHhcccCCCCCCC
Q 003052 701 YQMVYGRTPFSEYKTF--WAKFKVITDPNHEI---TYEPVPNPWLLDLMKKCLAWDRNERWR 757 (853)
Q Consensus 701 yELLtG~~PF~~~~~~--~~~~kii~~~~~~~---~~~~~~s~~l~dLI~kcL~~DP~kRpT 757 (853)
.++.-|..||.+.... .+.+..|....... .+....+.++.-.|.-|-..--++-|.
T Consensus 212 mYfnrG~LPWQglka~tk~QKyEkI~EkK~s~~ie~LC~G~P~EF~myl~Y~R~L~F~E~Pd 273 (341)
T KOG1163|consen 212 MYFNRGSLPWQGLKAATKKQKYEKISEKKMSTPIEVLCKGFPAEFAMYLNYCRGLGFEEKPD 273 (341)
T ss_pred eeeecCCCcccccchhhHHHHHHHHHHhhcCCCHHHHhCCCcHHHHHHHHHHhhcCCCCCCc
Confidence 9999999999875432 22222222211111 223456677777777776665555554
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.2e-22 Score=224.78 Aligned_cols=166 Identities=19% Similarity=0.199 Sum_probs=124.1
Q ss_pred cCceeeEEEeEeccCceEEEEEEec--CCcEEEEEEEecCC---CChhhHhhHHHHHHHHHHhcCCCcee-EeeehhhhH
Q 003052 470 NGKLYQRLGKIGSGGSSEVHKVISS--DCTIYALKKIKLKG---RDYATAYGFCQEIEYLNKLKGKNNII-QLIDYEVTE 543 (853)
Q Consensus 470 ~g~~Y~ilk~LG~G~FG~Vyka~~~--~g~~vAVKkik~~~---~~~~~~~~~l~EI~iLkkL~~hpNIV-~Lid~~~~e 543 (853)
....|.+.+.||+|+||+||+|.+. ++..+|||++.... ........+.+|+++|++|. |+||+ .++++
T Consensus 16 ~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~-h~~iv~~l~~~---- 90 (365)
T PRK09188 16 LSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVR-GIGVVPQLLAT---- 90 (365)
T ss_pred ccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhcc-CCCCCcEEEEc----
Confidence 3466999999999999999999874 56778999876331 12334456889999999998 55666 55432
Q ss_pred HHHHHHHhhCCCCCCCCccccCCeEEEEEecchh-hHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCcee
Q 003052 544 KALLREVLNGSMNNKDGRVKDDGYIYMVLEYGEI-DLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIV 622 (853)
Q Consensus 544 ~~iL~~l~~~~iv~~~g~~~d~~~lyLVmEy~~g-dL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gII 622 (853)
+..|+||||+++ +|. .+. ... ...++.|++.||.|||++||+
T Consensus 91 ----------------------~~~~LVmE~~~G~~L~-~~~-----------~~~---~~~~~~~i~~aL~~lH~~gIi 133 (365)
T PRK09188 91 ----------------------GKDGLVRGWTEGVPLH-LAR-----------PHG---DPAWFRSAHRALRDLHRAGIT 133 (365)
T ss_pred ----------------------CCcEEEEEccCCCCHH-HhC-----------ccc---hHHHHHHHHHHHHHHHHCCCe
Confidence 236999999875 554 211 011 146788999999999999999
Q ss_pred eCCC-CCccEEe-ecCcEEEEecccchhcccCCcccc------ccccccCccccCchhhccCC
Q 003052 623 HSDL-KPANFLL-VKGSLKLIDFGIAKAIMSDTTNIQ------RDSQVGTLSYMSPEAFMCNE 677 (853)
Q Consensus 623 HRDL-KPeNILL-~~g~VKL~DFGlAk~~~~~~~~~~------~~t~~GTp~YmAPEvl~~~~ 677 (853)
|||| ||+|||+ .++.+||+|||+|+.+........ ....++++.|+|||.+....
T Consensus 134 HrDL~KP~NILv~~~~~ikLiDFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~~ 196 (365)
T PRK09188 134 HNDLAKPQNWLMGPDGEAAVIDFQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPRE 196 (365)
T ss_pred eCCCCCcceEEEcCCCCEEEEECccceecccCcchhhhhhhhhhhhhhccCccCCcccCChhh
Confidence 9999 9999999 457899999999997654332211 13567899999999986543
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.85 E-value=8.1e-22 Score=234.46 Aligned_cols=220 Identities=28% Similarity=0.397 Sum_probs=154.9
Q ss_pred ceeeEEEeEeccCceEEEEEEecC-CcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHHHH
Q 003052 472 KLYQRLGKIGSGGSSEVHKVISSD-CTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLREV 550 (853)
Q Consensus 472 ~~Y~ilk~LG~G~FG~Vyka~~~~-g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~~l 550 (853)
..|..++.|-.|+||.||.++++. .+.+|+ ++.+... || .||..+.+.
T Consensus 83 ~df~~IklisngAygavylvrh~~trqrfa~-kiNkq~l-------------il------Rnilt~a~n----------- 131 (1205)
T KOG0606|consen 83 SDFNTIKLISNGAYGAVYLVRHKETRQRFAM-KINKQNL-------------IL------RNILTFAGN----------- 131 (1205)
T ss_pred cccceeEeeccCCCCceeeeeccccccchhh-cccccch-------------hh------hccccccCC-----------
Confidence 348889999999999999999864 467888 4443211 11 123333221
Q ss_pred hhCCCCCCCCccccCCeEEEEEecchhhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCCCcc
Q 003052 551 LNGSMNNKDGRVKDDGYIYMVLEYGEIDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPAN 630 (853)
Q Consensus 551 ~~~~iv~~~g~~~d~~~lyLVmEy~~gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLKPeN 630 (853)
.+.| ||=...++ .-+.++. +++.+++|||+.||+|||+||+|
T Consensus 132 -----------------pfvv-----gDc~tllk--------~~g~lPv--------dmvla~Eylh~ygivhrdlkpdn 173 (1205)
T KOG0606|consen 132 -----------------PFVV-----GDCATLLK--------NIGPLPV--------DMVLAVEYLHSYGIVHRDLKPDN 173 (1205)
T ss_pred -----------------ccee-----chhhhhcc--------cCCCCcc--------hhhHHhHhhccCCeecCCCCCCc
Confidence 1222 22122221 1234443 34889999999999999999999
Q ss_pred EEe-ecCcEEEEecccchhcccCCcc-------------ccccccccCccccCchhhccCCCCCCCccccCCCccchhhh
Q 003052 631 FLL-VKGSLKLIDFGIAKAIMSDTTN-------------IQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSL 696 (853)
Q Consensus 631 ILL-~~g~VKL~DFGlAk~~~~~~~~-------------~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSL 696 (853)
+|| .-|++|+.|||+.+........ ......||||.|+|||++... .|++.+|||++
T Consensus 174 llIT~mGhiKlTDfgLsk~GLms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrq---------gygkpvdwwam 244 (1205)
T KOG0606|consen 174 LLITSMGHIKLTDFGLSKKGLMSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQ---------GYGKPVDWWAM 244 (1205)
T ss_pred ceeeecccccccchhhhhhhhhhccchhhhcchHHHHHHhhhccccCCccccChhhhhhh---------ccCCCccHHHH
Confidence 999 5799999999999864321110 111346999999999999765 47899999999
Q ss_pred HHHHHHHHhCCCCCCcchhHHHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCC---ChhHHhcCCCCCC
Q 003052 697 GCILYQMVYGRTPFSEYKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERW---RIPQLLQHPFLVP 769 (853)
Q Consensus 697 GVILyELLtG~~PF~~~~~~~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRp---Ta~EIL~HPwf~~ 769 (853)
|+|+||.+-|+.||.+..+....-..+.+...-..-.....++++++|.++|..+|..|. .+-++.+|+||..
T Consensus 245 GiIlyeFLVgcvpffGdtpeelfg~visd~i~wpE~dea~p~Ea~dli~~LL~qnp~~Rlgt~ga~evk~h~ff~~ 320 (1205)
T KOG0606|consen 245 GIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPEEDEALPPEAQDLIEQLLRQNPLCRLGTGGALEVKQHGFFQL 320 (1205)
T ss_pred HHHHHHHheeeeeccCCCHHHHHhhhhhhhccccccCcCCCHHHHHHHHHHHHhChHhhcccchhhhhhhccceee
Confidence 999999999999998865543333333322211122345678899999999999999997 5788999999974
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.83 E-value=1.6e-20 Score=202.88 Aligned_cols=262 Identities=20% Similarity=0.209 Sum_probs=151.1
Q ss_pred eeeEEEeEeccCceEEEEEEe-cCCcEEEEEEEecCCCCh-hhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHHHH
Q 003052 473 LYQRLGKIGSGGSSEVHKVIS-SDCTIYALKKIKLKGRDY-ATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLREV 550 (853)
Q Consensus 473 ~Y~ilk~LG~G~FG~Vyka~~-~~g~~vAVKkik~~~~~~-~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~~l 550 (853)
.+...+.||.|+|+.||.+++ .+++.+|||++....... .....+.+|.-....+.+-.|-... ...++.+
T Consensus 13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a-------~~~~r~l 85 (288)
T PF14531_consen 13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEA-------YRHLRFL 85 (288)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHH-------HHHH-B-
T ss_pred EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHH-------HHhceEE
Confidence 466778899999999999999 567899999997665322 2344455555444333220000000 0001111
Q ss_pred hhCC---CCCCCCccccC---C-----eEEEEEecchhhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccC
Q 003052 551 LNGS---MNNKDGRVKDD---G-----YIYMVLEYGEIDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEE 619 (853)
Q Consensus 551 ~~~~---iv~~~g~~~d~---~-----~lyLVmEy~~gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~ 619 (853)
..-. +.+....+... . ..+++|+-..+||..++..-...-. ....+.......+..|+++.+++||..
T Consensus 86 ~P~d~~~i~~~~~~~~~~~~~~~~~v~n~~~l~P~~~~dL~~~~~~l~~~~~-~~~~l~~~arl~lT~Q~I~lvA~Lh~~ 164 (288)
T PF14531_consen 86 VPLDLLRIPGKPPFFERGPGQSIYWVLNRFLLMPRAQGDLQDLVEALFSRAQ-THSPLAFAARLSLTVQMIRLVANLHSY 164 (288)
T ss_dssp --SEEEEETTS-SEEEECETTEEEEEESEEEEEE--SEEHHHHHHHHHHHTT-TSHHHHHHHHHHHHHHHHHHHHHHHHT
T ss_pred eeeEEEEEcCCCcceecCCCCccceeehhhhccchhhhcHHHHHHHHhhccc-ccchhHHHHHHHHHHHHHHHHHHHhhc
Confidence 1111 11111111111 1 2477888888888777654322111 111122233345568999999999999
Q ss_pred ceeeCCCCCccEEe-ecCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHH
Q 003052 620 RIVHSDLKPANFLL-VKGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGC 698 (853)
Q Consensus 620 gIIHRDLKPeNILL-~~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGV 698 (853)
||+|+||||+|+|+ .+|.++|+||+......... .....+..|.+||.......- ......++.+.|.|+||+
T Consensus 165 GlVHgdi~~~nfll~~~G~v~Lg~F~~~~r~g~~~-----~~~~~~~~~~PPe~~~~~~~~-~~~~~~~t~~~DaW~LG~ 238 (288)
T PF14531_consen 165 GLVHGDIKPENFLLDQDGGVFLGDFSSLVRAGTRY-----RCSEFPVAFTPPELESCAGQF-GQNNAPYTFATDAWQLGI 238 (288)
T ss_dssp TEEEST-SGGGEEE-TTS-EEE--GGGEEETTEEE-----EGGGS-TTTS-HHHHHHHTSC-HHSEEEE-HHHHHHHHHH
T ss_pred ceEecccceeeEEEcCCCCEEEcChHHHeecCcee-----eccCCCcccCChhhhhhhccc-CcccceeeeccCHHHHHH
Confidence 99999999999999 57899999998876543211 113455789999987543110 002346789999999999
Q ss_pred HHHHHHhCCCCCCcchhHHHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCC
Q 003052 699 ILYQMVYGRTPFSEYKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNER 755 (853)
Q Consensus 699 ILyELLtG~~PF~~~~~~~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kR 755 (853)
++|.|++|+.||.......... ..+......+..++.||.++|++||.+|
T Consensus 239 ~ly~lWC~~lPf~~~~~~~~~~-------~~f~~C~~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 239 TLYSLWCGRLPFGLSSPEADPE-------WDFSRCRDMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp HHHHHHHSS-STCCCGGGSTSG-------GGGTTSS---HHHHHHHHHHT-SSGGGS
T ss_pred HHHHHHHccCCCCCCCcccccc-------ccchhcCCcCHHHHHHHHHHccCCcccC
Confidence 9999999999997533221110 0222223567889999999999999988
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.82 E-value=2.8e-20 Score=190.36 Aligned_cols=140 Identities=21% Similarity=0.231 Sum_probs=101.4
Q ss_pred EEeEeccCceEEEEEEecCCcEEEEEEEecCCCChhh-------Hh-----------------hHHHHHHHHHHhcCCCc
Q 003052 477 LGKIGSGGSSEVHKVISSDCTIYALKKIKLKGRDYAT-------AY-----------------GFCQEIEYLNKLKGKNN 532 (853)
Q Consensus 477 lk~LG~G~FG~Vyka~~~~g~~vAVKkik~~~~~~~~-------~~-----------------~~l~EI~iLkkL~~hpN 532 (853)
.+.||+|+||.||+|.+.+|+.||||+++........ .. ...+|+++|.++. +++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-~~~ 80 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLV-TAG 80 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHH-HCC
Confidence 3579999999999999888999999999765321111 01 1124777777775 233
Q ss_pred eeEeeehhhhHHHHHHHHhhCCCCCCCCccccCCeEEEEEecchhh-HHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhh
Q 003052 533 IIQLIDYEVTEKALLREVLNGSMNNKDGRVKDDGYIYMVLEYGEID-LAHMLSQKWKEMDGSNQTLDENWLRFYWQQILE 611 (853)
Q Consensus 533 IV~Lid~~~~e~~iL~~l~~~~iv~~~g~~~d~~~lyLVmEy~~gd-L~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~ 611 (853)
|..... +... ..||||||++++ +...+.. ...+++..+..++.||+.
T Consensus 81 v~~p~~-----------------------~~~~-~~~iVmE~i~g~~l~~~~~~--------~~~~~~~~~~~i~~qi~~ 128 (190)
T cd05147 81 IPCPEP-----------------------ILLK-SHVLVMEFIGDDGWAAPRLK--------DAPLSESKARELYLQVIQ 128 (190)
T ss_pred CCCCcE-----------------------EEec-CCEEEEEEeCCCCCcchhhh--------cCCCCHHHHHHHHHHHHH
Confidence 211111 1111 138999998763 3222211 246899999999999999
Q ss_pred hhhhc-ccCceeeCCCCCccEEeecCcEEEEecccchhc
Q 003052 612 AVNTI-HEERIVHSDLKPANFLLVKGSLKLIDFGIAKAI 649 (853)
Q Consensus 612 AL~yL-Hs~gIIHRDLKPeNILL~~g~VKL~DFGlAk~~ 649 (853)
+|.|| |+.||+||||||+|||++++.++|+|||+|...
T Consensus 129 ~L~~l~H~~giiHrDlkP~NIli~~~~v~LiDFG~a~~~ 167 (190)
T cd05147 129 IMRILYQDCRLVHADLSEYNLLYHDGKLYIIDVSQSVEH 167 (190)
T ss_pred HHHHHHHhCCcccCCCCHHHEEEECCcEEEEEccccccC
Confidence 99999 799999999999999998899999999999754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.4e-20 Score=223.85 Aligned_cols=257 Identities=22% Similarity=0.241 Sum_probs=182.1
Q ss_pred eeeEEEeEeccCceEEEEEEecCCcEEEEEEEecCCCC--hhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHHHH
Q 003052 473 LYQRLGKIGSGGSSEVHKVISSDCTIYALKKIKLKGRD--YATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLREV 550 (853)
Q Consensus 473 ~Y~ilk~LG~G~FG~Vyka~~~~g~~vAVKkik~~~~~--~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~~l 550 (853)
.|...+.||++.|=+|.+|.+..|. |+||++-+.... .......+.|++ ..+..+||++.+..+.++++.
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik--~~l~~~pn~lPfqk~~~t~kA----- 95 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIK--FALMKAPNCLPFQKVLVTDKA----- 95 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHH--HHhhcCCcccchHHHHHhhHH-----
Confidence 4777888999999999999998876 899998765432 223333345555 345568999998877665553
Q ss_pred hhCCCCCCCCccccCCeEEEEEecchhhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCCCcc
Q 003052 551 LNGSMNNKDGRVKDDGYIYMVLEYGEIDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPAN 630 (853)
Q Consensus 551 ~~~~iv~~~g~~~d~~~lyLVmEy~~gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLKPeN 630 (853)
-|||-+|.-.+|++.+.-+ ..|.+.+.+.|+.||+.||..+|..||+|+|||.||
T Consensus 96 -----------------AylvRqyvkhnLyDRlSTR--------PFL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsEN 150 (1431)
T KOG1240|consen 96 -----------------AYLVRQYVKHNLYDRLSTR--------PFLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSEN 150 (1431)
T ss_pred -----------------HHHHHHHHhhhhhhhhccc--------hHHHHHHHHHHHHHHHHHHHHHHHcCccccccccce
Confidence 3677778777787777543 667888889999999999999999999999999999
Q ss_pred EEee-cCcEEEEecccchhcccCC-----ccccccccccCccccCchhhccCC-CCCCCccc-cCCCccchhhhHHHHHH
Q 003052 631 FLLV-KGSLKLIDFGIAKAIMSDT-----TNIQRDSQVGTLSYMSPEAFMCNE-SDENGNII-KCGRPSDIWSLGCILYQ 702 (853)
Q Consensus 631 ILL~-~g~VKL~DFGlAk~~~~~~-----~~~~~~t~~GTp~YmAPEvl~~~~-~~~~~~~~-~ys~ksDIWSLGVILyE 702 (853)
|||. -+.+.|+||..-|...-+. ....+.+..--..|+|||.|.... +...+... ..+++.||||+||+++|
T Consensus 151 ILiTSWNW~~LtDFAsFKPtYLPeDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaE 230 (1431)
T KOG1240|consen 151 ILITSWNWLYLTDFASFKPTYLPEDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAE 230 (1431)
T ss_pred EEEeeechhhhhcccccCCccCCCCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHH
Confidence 9995 5689999998766432111 112223444456899999986532 11111111 26789999999999999
Q ss_pred HHh-CCCCCCcchhHHHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCCChhHHhcC
Q 003052 703 MVY-GRTPFSEYKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQH 764 (853)
Q Consensus 703 LLt-G~~PF~~~~~~~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~H 764 (853)
|++ |++||.- .++.... .......+..++...+..+++||..|++.||.+|.++++.|+-
T Consensus 231 Lf~Eg~PlF~L-SQL~aYr-~~~~~~~e~~Le~Ied~~~Rnlil~Mi~rdPs~RlSAedyL~~ 291 (1431)
T KOG1240|consen 231 LFLEGRPLFTL-SQLLAYR-SGNADDPEQLLEKIEDVSLRNLILSMIQRDPSKRLSAEDYLQK 291 (1431)
T ss_pred HHhcCCCcccH-HHHHhHh-ccCccCHHHHHHhCcCccHHHHHHHHHccCchhccCHHHHHHh
Confidence 986 7888842 2222111 1111112222233345568999999999999999999999986
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.80 E-value=1.9e-19 Score=183.39 Aligned_cols=141 Identities=20% Similarity=0.191 Sum_probs=101.7
Q ss_pred EEeEeccCceEEEEEEecCCcEEEEEEEecCCCChhh------------------------HhhHHHHHHHHHHhcCCCc
Q 003052 477 LGKIGSGGSSEVHKVISSDCTIYALKKIKLKGRDYAT------------------------AYGFCQEIEYLNKLKGKNN 532 (853)
Q Consensus 477 lk~LG~G~FG~Vyka~~~~g~~vAVKkik~~~~~~~~------------------------~~~~l~EI~iLkkL~~hpN 532 (853)
.+.||+|+||.||+|.+.+|+.||||++......... ...+.+|...+.++. +++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-~~~ 80 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLY-EAG 80 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHH-hCC
Confidence 4679999999999999888999999999865322111 011235666666665 333
Q ss_pred eeEeeehhhhHHHHHHHHhhCCCCCCCCccccCCeEEEEEecchhh-HHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhh
Q 003052 533 IIQLIDYEVTEKALLREVLNGSMNNKDGRVKDDGYIYMVLEYGEID-LAHMLSQKWKEMDGSNQTLDENWLRFYWQQILE 611 (853)
Q Consensus 533 IV~Lid~~~~e~~iL~~l~~~~iv~~~g~~~d~~~lyLVmEy~~gd-L~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~ 611 (853)
|.....+ ... ..||||||+++. +...+.. ...+++..+..++.|++.
T Consensus 81 i~~p~~~----------------------~~~--~~~lVmE~~~g~~~~~~~l~--------~~~~~~~~~~~i~~~l~~ 128 (190)
T cd05145 81 VPVPEPI----------------------LLK--KNVLVMEFIGDDGSPAPRLK--------DVPLEEEEAEELYEQVVE 128 (190)
T ss_pred CCCceEE----------------------Eec--CCEEEEEEecCCCchhhhhh--------hccCCHHHHHHHHHHHHH
Confidence 3211111 011 238999998764 3222111 135788899999999999
Q ss_pred hhhhccc-CceeeCCCCCccEEeecCcEEEEecccchhcc
Q 003052 612 AVNTIHE-ERIVHSDLKPANFLLVKGSLKLIDFGIAKAIM 650 (853)
Q Consensus 612 AL~yLHs-~gIIHRDLKPeNILL~~g~VKL~DFGlAk~~~ 650 (853)
+|.+||. +||+||||||+|||++++.++|+|||+|+...
T Consensus 129 ~l~~lH~~~givHrDlkP~NIll~~~~~~liDFG~a~~~~ 168 (190)
T cd05145 129 QMRRLYQEAGLVHGDLSEYNILYHDGKPYIIDVSQAVELD 168 (190)
T ss_pred HHHHHHHhCCEecCCCChhhEEEECCCEEEEEcccceecC
Confidence 9999999 99999999999999998899999999998653
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.80 E-value=2.3e-19 Score=195.41 Aligned_cols=219 Identities=19% Similarity=0.260 Sum_probs=154.0
Q ss_pred hcCCCceeEeeehhhhHHHHHHHHhhCCCCCCC-----CccccCCeEEEEEecchhhHHHHHHHhhhhccCCCCCCCHHH
Q 003052 527 LKGKNNIIQLIDYEVTEKALLREVLNGSMNNKD-----GRVKDDGYIYMVLEYGEIDLAHMLSQKWKEMDGSNQTLDENW 601 (853)
Q Consensus 527 L~~hpNIV~Lid~~~~e~~iL~~l~~~~iv~~~-----g~~~d~~~lyLVmEy~~gdL~~~L~~~~k~~~~~~~~LsE~~ 601 (853)
|-.|||||++..+|..+...|..-....-..+. ...-....+|+||..+..+|.+++.. ...+...
T Consensus 272 La~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~tLr~yl~~---------~~~s~r~ 342 (598)
T KOG4158|consen 272 LAKHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQTLREYLWT---------RHRSYRT 342 (598)
T ss_pred cCCCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchhhHHHHHhc---------CCCchHH
Confidence 345999999999987776544321111111111 12345568999999999899998854 4678888
Q ss_pred HHHHHHHhhhhhhhcccCceeeCCCCCccEEe--ec-C--cEEEEecccchhcccCCccc----cccccccCccccCchh
Q 003052 602 LRFYWQQILEAVNTIHEERIVHSDLKPANFLL--VK-G--SLKLIDFGIAKAIMSDTTNI----QRDSQVGTLSYMSPEA 672 (853)
Q Consensus 602 ~r~I~~QIl~AL~yLHs~gIIHRDLKPeNILL--~~-g--~VKL~DFGlAk~~~~~~~~~----~~~t~~GTp~YmAPEv 672 (853)
.+-++.|+++|+.|||.+||.|||||.+|||| ++ + .+.|+|||+|-......-.. ..-...|.-..||||+
T Consensus 343 ~~~~laQlLEav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi 422 (598)
T KOG4158|consen 343 GRVILAQLLEAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEI 422 (598)
T ss_pred HHHHHHHHHHHHHHHHHccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhh
Confidence 99999999999999999999999999999999 33 3 68999999985432211110 1123468889999999
Q ss_pred hccCCCCCCCccccCCCccchhhhHHHHHHHHhCCCCCCcchhHHHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCC
Q 003052 673 FMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGRTPFSEYKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDR 752 (853)
Q Consensus 673 l~~~~~~~~~~~~~ys~ksDIWSLGVILyELLtG~~PF~~~~~~~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP 752 (853)
...-+..- -.++| .++|.|+.|.+.||+++...||..........+...+ ..-...+..+++.+++|+..+|+.||
T Consensus 423 ~ta~PGp~--avvny-~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~Yqe-~qLPalp~~vpp~~rqlV~~lL~r~p 498 (598)
T KOG4158|consen 423 ATAVPGPN--AVVNY-EKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRTYQE-SQLPALPSRVPPVARQLVFDLLKRDP 498 (598)
T ss_pred hhcCCCCc--eeecc-chhhhhhhhhhHHHHhccCCcccccchheechhhhhh-hhCCCCcccCChHHHHHHHHHhcCCc
Confidence 86543221 12334 4899999999999999999999763322211111111 12234566778899999999999999
Q ss_pred CCCCCh
Q 003052 753 NERWRI 758 (853)
Q Consensus 753 ~kRpTa 758 (853)
.+|+++
T Consensus 499 skRvsp 504 (598)
T KOG4158|consen 499 SKRVSP 504 (598)
T ss_pred cccCCc
Confidence 999984
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.79 E-value=4e-19 Score=215.33 Aligned_cols=210 Identities=24% Similarity=0.313 Sum_probs=161.5
Q ss_pred CCcCCCCCceeEEcCceeeEEEeEeccCceEEEEEEecCCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEe
Q 003052 457 RKRNYDPDLFFKVNGKLYQRLGKIGSGGSSEVHKVISSDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQL 536 (853)
Q Consensus 457 rk~~~dp~~~~~v~g~~Y~ilk~LG~G~FG~Vyka~~~~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~L 536 (853)
+.....+...+.+.|..|.|.+.||+|+||.||+|...+++.||||+-+....- .|.--.+++.+|+ +-+.
T Consensus 683 ~~~~l~~~~~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~W-----EfYI~~q~~~RLk--~~~~-- 753 (974)
T KOG1166|consen 683 RVPKLNPNTEFEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPW-----EFYICLQVMERLK--PQML-- 753 (974)
T ss_pred cccccCccceeeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCce-----eeeehHHHHHhhc--hhhh--
Confidence 444556777899999999999999999999999999988999999998755431 1222234455554 1111
Q ss_pred eehhhhHHHHHHHHhhCCCCCCCCccccCCeEEEEEecch-hhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhh
Q 003052 537 IDYEVTEKALLREVLNGSMNNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNT 615 (853)
Q Consensus 537 id~~~~e~~iL~~l~~~~iv~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~y 615 (853)
+++..+..++...+.-++|+||.+ |+|.++++ ....++|..+.+|+.|++..|++
T Consensus 754 ----------------~~~~~~~~a~~~~~~S~lv~ey~~~Gtlld~~N--------~~~~m~e~lv~~~~~qml~ive~ 809 (974)
T KOG1166|consen 754 ----------------PSIMHISSAHVFQNASVLVSEYSPYGTLLDLIN--------TNKVMDEYLVMFFSCQMLRIVEH 809 (974)
T ss_pred ----------------cchHHHHHHHccCCcceeeeeccccccHHHhhc--------cCCCCCchhhhHHHHHHHHHHHH
Confidence 122222233344455689999965 68999887 34789999999999999999999
Q ss_pred cccCceeeCCCCCccEEeecC--------cEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccC
Q 003052 616 IHEERIVHSDLKPANFLLVKG--------SLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKC 687 (853)
Q Consensus 616 LHs~gIIHRDLKPeNILL~~g--------~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~y 687 (853)
||..+|||+||||+|+||... -++|+|||.+.-+.--.........++|-.+-.+|...|.. |
T Consensus 810 lH~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grp---------W 880 (974)
T KOG1166|consen 810 LHAMGIIHGDIKPDNFLLRREICADSDSKGLYLIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRP---------W 880 (974)
T ss_pred HHhcceecccCCcceeEeecccCCCCcccceEEEecccceeeeEcCCCcEEeeeeccccchhHHHhcCCC---------C
Confidence 999999999999999999432 58999999986544322234556788999999999998874 6
Q ss_pred CCccchhhhHHHHHHHHhCCC
Q 003052 688 GRPSDIWSLGCILYQMVYGRT 708 (853)
Q Consensus 688 s~ksDIWSLGVILyELLtG~~ 708 (853)
++.+|.|.|+.++|-||+|++
T Consensus 881 tYq~DyfGlAa~~h~mLFG~y 901 (974)
T KOG1166|consen 881 TYQIDYFGLAATVHVMLFGKY 901 (974)
T ss_pred chhhhhHHHHHHHHHHHHHHH
Confidence 789999999999999999864
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.78 E-value=4.4e-19 Score=183.88 Aligned_cols=187 Identities=16% Similarity=0.117 Sum_probs=135.0
Q ss_pred EEEeEeccCceEEEEEEecCCcEEEEEEEecCCCChh--hHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHHHHhhC
Q 003052 476 RLGKIGSGGSSEVHKVISSDCTIYALKKIKLKGRDYA--TAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLREVLNG 553 (853)
Q Consensus 476 ilk~LG~G~FG~Vyka~~~~g~~vAVKkik~~~~~~~--~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~~l~~~ 553 (853)
+...|++|+||+||.+.. .+..++.+.+.....-.. ....+.+|+++|++|.++++|.+++++
T Consensus 6 ~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~-------------- 70 (218)
T PRK12274 6 VNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW-------------- 70 (218)
T ss_pred cceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE--------------
Confidence 456799999999997766 566677777765433111 122478999999999988999999875
Q ss_pred CCCCCCCccccCCeEEEEEecchh-hHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCC-CCccE
Q 003052 554 SMNNKDGRVKDDGYIYMVLEYGEI-DLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDL-KPANF 631 (853)
Q Consensus 554 ~iv~~~g~~~d~~~lyLVmEy~~g-dL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDL-KPeNI 631 (853)
+..|++|||+.| +|...+. .. ...++.|++.+|.+||++||+|||| ||+||
T Consensus 71 ------------~~~~lvmeyI~G~~L~~~~~--------------~~-~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NI 123 (218)
T PRK12274 71 ------------DGRHLDRSYLAGAAMYQRPP--------------RG-DLAYFRAARRLLQQLHRCGVAHNDLAKEANW 123 (218)
T ss_pred ------------cCEEEEEeeecCccHHhhhh--------------hh-hHHHHHHHHHHHHHHHHCcCccCCCCCcceE
Confidence 135999999766 4533211 11 1347789999999999999999999 79999
Q ss_pred Ee-ecCcEEEEecccchhcccCCcc-----------ccccccccCccccCchhhccCCCCCCCccccCC-CccchhhhHH
Q 003052 632 LL-VKGSLKLIDFGIAKAIMSDTTN-----------IQRDSQVGTLSYMSPEAFMCNESDENGNIIKCG-RPSDIWSLGC 698 (853)
Q Consensus 632 LL-~~g~VKL~DFGlAk~~~~~~~~-----------~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys-~ksDIWSLGV 698 (853)
|+ .+|.++|+|||+|......... ....-...++.|+.|+....... .+ ...++++.|+
T Consensus 124 Lv~~~g~i~LIDFG~A~~~~~~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~--------~~~~~~~w~~~g~ 195 (218)
T PRK12274 124 LVQEDGSPAVIDFQLAVRGNPRARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKR--------TSWIRELWFATGK 195 (218)
T ss_pred EEcCCCCEEEEECCCceecCCcchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhcc--------chhHHHHHHHhcc
Confidence 99 4678999999999854332210 00111236888999986543211 12 4678899999
Q ss_pred HHHHHHhCCCCCCc
Q 003052 699 ILYQMVYGRTPFSE 712 (853)
Q Consensus 699 ILyELLtG~~PF~~ 712 (853)
.+|.++|+..++.+
T Consensus 196 ~~~~~~~~~~~~~~ 209 (218)
T PRK12274 196 PVYRFVTRRVLHWE 209 (218)
T ss_pred hHHHHHhccCCccc
Confidence 99999999999754
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.78 E-value=6.3e-19 Score=185.38 Aligned_cols=180 Identities=17% Similarity=0.234 Sum_probs=128.5
Q ss_pred cCceeeEEEeEeccCceEEEEEEecCCcEEEEEEEecCCCChh-hHhh------HHHHHHHHHHhcCCCceeEeeehhhh
Q 003052 470 NGKLYQRLGKIGSGGSSEVHKVISSDCTIYALKKIKLKGRDYA-TAYG------FCQEIEYLNKLKGKNNIIQLIDYEVT 542 (853)
Q Consensus 470 ~g~~Y~ilk~LG~G~FG~Vyka~~~~g~~vAVKkik~~~~~~~-~~~~------~l~EI~iLkkL~~hpNIV~Lid~~~~ 542 (853)
-..+|++++.||.|+||.||++.. ++..+|||.+........ .... +.+|++.+.+|. |++|..+.+++..
T Consensus 29 l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~-~~GI~~~~d~~~~ 106 (232)
T PRK10359 29 LSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVR-SEGLASLNDFYLL 106 (232)
T ss_pred hhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHH-HCCCCcceEeeee
Confidence 456799999999999999999755 566899999975543222 2222 578999999996 8899988887432
Q ss_pred HHHHHHHHhhCCCCCCCCccccCCeEEEEEecchh-hHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCce
Q 003052 543 EKALLREVLNGSMNNKDGRVKDDGYIYMVLEYGEI-DLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERI 621 (853)
Q Consensus 543 e~~iL~~l~~~~iv~~~g~~~d~~~lyLVmEy~~g-dL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gI 621 (853)
. ....+...+..||||||++| +|.++. .+++. ...+|+.+|..||.+||
T Consensus 107 ~--------------~~~~~~~~~~~~lvmEyi~G~tL~~~~------------~~~~~----~~~~i~~~l~~lH~~gi 156 (232)
T PRK10359 107 A--------------ERKTLRYAHTYIMLIEYIEGVELNDMP------------EISED----VKAKIKASIESLHQHGM 156 (232)
T ss_pred c--------------ccccccccCCeEEEEEEECCccHHHhh------------hccHH----HHHHHHHHHHHHHHcCC
Confidence 1 11113345678999999886 665542 13332 45699999999999999
Q ss_pred eeCCCCCccEEeecCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHH
Q 003052 622 VHSDLKPANFLLVKGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILY 701 (853)
Q Consensus 622 IHRDLKPeNILL~~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILy 701 (853)
+||||||.||+++.+.++|+|||..+........ -.++... .|+.++|+|+|||++.
T Consensus 157 ~H~Dikp~Nili~~~gi~liDfg~~~~~~e~~a~--------------d~~vler---------~y~~~~di~~lg~~~~ 213 (232)
T PRK10359 157 VSGDPHKGNFIVSKNGLRIIDLSGKRCTAQRKAK--------------DRIDLER---------HYGIKNEIKDLGYYLL 213 (232)
T ss_pred ccCCCChHHEEEeCCCEEEEECCCcccccchhhH--------------HHHHHHh---------HhcccccccceeEeeh
Confidence 9999999999995444999999988755321111 0022222 2456899999999887
Q ss_pred HHH
Q 003052 702 QMV 704 (853)
Q Consensus 702 ELL 704 (853)
.+.
T Consensus 214 ~~~ 216 (232)
T PRK10359 214 IYK 216 (232)
T ss_pred HHH
Confidence 654
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.74 E-value=1.4e-17 Score=173.42 Aligned_cols=137 Identities=20% Similarity=0.291 Sum_probs=101.8
Q ss_pred EEeEeccCceEEEEEEecCCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhc----CCCceeEeeehhhhHHHHHHHHhh
Q 003052 477 LGKIGSGGSSEVHKVISSDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLK----GKNNIIQLIDYEVTEKALLREVLN 552 (853)
Q Consensus 477 lk~LG~G~FG~Vyka~~~~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~----~hpNIV~Lid~~~~e~~iL~~l~~ 552 (853)
.+.||+|+||.||. +......+||++...... ....+.+|+.+++.|. .|+||+++++++.+.
T Consensus 7 ~~~LG~G~~~~Vy~--hp~~~~k~IKv~~~~~~~--~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~--------- 73 (210)
T PRK10345 7 QSPLGTGRHRKCYA--HPEDAQRCIKIVYHRGDG--GDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETD--------- 73 (210)
T ss_pred cceecCCCceEEEE--CCCCcCeEEEEEeccccc--hHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeC---------
Confidence 45799999999996 543334579988764322 3346889999999995 389999999985432
Q ss_pred CCCCCCCCccccCCeEE-EEEecch---hhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhh-hhcccCceeeCCCC
Q 003052 553 GSMNNKDGRVKDDGYIY-MVLEYGE---IDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAV-NTIHEERIVHSDLK 627 (853)
Q Consensus 553 ~~iv~~~g~~~d~~~ly-LVmEy~~---gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL-~yLHs~gIIHRDLK 627 (853)
...+++| +||||++ ++|.+++.+. .+++. ..++.|++.++ +|||+++|+|||||
T Consensus 74 ----------~g~g~v~~~I~e~~G~~~~tL~~~l~~~---------~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlK 132 (210)
T PRK10345 74 ----------CGTGYVYDVIADFDGKPSITLTEFAEQC---------RYEED--VAQLRQLLKKLKRYLLDNRIVTMELK 132 (210)
T ss_pred ----------CCCeEEEEEEecCCCCcchhHHHHHHcc---------cccHh--HHHHHHHHHHHHHHHHHCCEeecCCC
Confidence 1123544 7899955 6999998542 35655 35678888888 99999999999999
Q ss_pred CccEEeec-----CcEEEEecccch
Q 003052 628 PANFLLVK-----GSLKLIDFGIAK 647 (853)
Q Consensus 628 PeNILL~~-----g~VKL~DFGlAk 647 (853)
|+|||+.. +.++|+||+.++
T Consensus 133 p~NILl~~~~~~~~~~~LiDg~G~~ 157 (210)
T PRK10345 133 PQNILCQRISESEVIPVVCDNIGES 157 (210)
T ss_pred HHHEEEeccCCCCCcEEEEECCCCc
Confidence 99999942 279999955443
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.72 E-value=1.5e-17 Score=175.99 Aligned_cols=145 Identities=20% Similarity=0.220 Sum_probs=106.9
Q ss_pred CceeeEEEeEeccCceEEEEEE--ecCCcEEEEEEEecCCCChh----------------------hHhhHHHHHHHHHH
Q 003052 471 GKLYQRLGKIGSGGSSEVHKVI--SSDCTIYALKKIKLKGRDYA----------------------TAYGFCQEIEYLNK 526 (853)
Q Consensus 471 g~~Y~ilk~LG~G~FG~Vyka~--~~~g~~vAVKkik~~~~~~~----------------------~~~~~l~EI~iLkk 526 (853)
|..|.+.+.||+|+||.||+|. ..+++.||||+++....... ....+.+|+.++++
T Consensus 27 ~~~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~ 106 (237)
T smart00090 27 GILSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQR 106 (237)
T ss_pred CchHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHH
Confidence 4468899999999999999998 46889999999976432110 11224578888888
Q ss_pred hcCC-CceeEeeehhhhHHHHHHHHhhCCCCCCCCccccCCeEEEEEecchh-hHHHHHHHhhhhccCCCCCCCHHHHHH
Q 003052 527 LKGK-NNIIQLIDYEVTEKALLREVLNGSMNNKDGRVKDDGYIYMVLEYGEI-DLAHMLSQKWKEMDGSNQTLDENWLRF 604 (853)
Q Consensus 527 L~~h-pNIV~Lid~~~~e~~iL~~l~~~~iv~~~g~~~d~~~lyLVmEy~~g-dL~~~L~~~~k~~~~~~~~LsE~~~r~ 604 (853)
+.++ ..+.+++++ ...|+||||+++ +|...+.. ...+.+..++.
T Consensus 107 L~~~~i~~p~~~~~--------------------------~~~~lV~E~~~g~~L~~~~~~--------~~~~~~~~~~~ 152 (237)
T smart00090 107 LYEAGVPVPKPIAW--------------------------RRNVLVMEFIGGDGLPAPRLK--------DVEPEEEEEFE 152 (237)
T ss_pred HHhcCCCCCeeeEe--------------------------cCceEEEEEecCCcccccccc--------cCCcchHHHHH
Confidence 8631 112222221 124899999887 44333211 23466677889
Q ss_pred HHHHhhhhhhhcccCc-eeeCCCCCccEEeecCcEEEEecccchhc
Q 003052 605 YWQQILEAVNTIHEER-IVHSDLKPANFLLVKGSLKLIDFGIAKAI 649 (853)
Q Consensus 605 I~~QIl~AL~yLHs~g-IIHRDLKPeNILL~~g~VKL~DFGlAk~~ 649 (853)
++.||+.+|.+||.+| |+||||||+||+++++.++|+|||+|...
T Consensus 153 i~~qi~~~l~~LH~~g~iiH~Dikp~NIli~~~~i~LiDFg~a~~~ 198 (237)
T smart00090 153 LYDDILEEMRKLYKEGELVHGDLSEYNILVHDGKVVIIDVSQSVEL 198 (237)
T ss_pred HHHHHHHHHHHHHhcCCEEeCCCChhhEEEECCCEEEEEChhhhcc
Confidence 9999999999999999 99999999999999889999999998754
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.72 E-value=2.7e-18 Score=193.85 Aligned_cols=182 Identities=27% Similarity=0.386 Sum_probs=136.1
Q ss_pred cCCeEEEEEecchh-hHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCCCccEEe-ecCcEEEE
Q 003052 564 DDGYIYMVLEYGEI-DLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLL-VKGSLKLI 641 (853)
Q Consensus 564 d~~~lyLVmEy~~g-dL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLKPeNILL-~~g~VKL~ 641 (853)
...++||.|++|.. .|.++|..+ ......+......++.|+..|++| +|.+|||+||.||++ .++.+||+
T Consensus 327 ~~~~lyI~Mn~c~~~tledWl~rr-----~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~~d~q~kIg 398 (516)
T KOG1033|consen 327 KKVYLYIQMNLCEKETLEDWLRRR-----RTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFSDDDQLKIG 398 (516)
T ss_pred cccchhhhhhhhhhhhHHHHhhCC-----CcccccchhHHHHHHHhhccchhh---ccchhhhccccccccccchhhhhh
Confidence 35679999999885 777777533 133456777888999999999999 999999999999999 56689999
Q ss_pred ecccchhcccCC----ccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHh-CCCCCCcchhH
Q 003052 642 DFGIAKAIMSDT----TNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVY-GRTPFSEYKTF 716 (853)
Q Consensus 642 DFGlAk~~~~~~----~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLt-G~~PF~~~~~~ 716 (853)
|||+........ .....+..+||.+||+||.+.+.. |+.++||||||+|||||+. =...|..
T Consensus 399 DFgl~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~---------y~~kvdIyaLGlil~EL~~~f~T~~er---- 465 (516)
T KOG1033|consen 399 DFGLVTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQ---------YSEKVDIYALGLILAELLIQFSTQFER---- 465 (516)
T ss_pred hhhheeecccCCcccchhhhhhhcccccccCCHHHHhhhh---------hhhhcchhhHHHHHHHHHHHhccHHHH----
Confidence 999997765433 122345678999999999998874 6689999999999999996 3333322
Q ss_pred HHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCCChhHHhcCCCC
Q 003052 717 WAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQHPFL 767 (853)
Q Consensus 717 ~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~HPwf 767 (853)
...+..+.+...+..+... .+.-..|+.+||...|.+||++.+.--|+|.
T Consensus 466 ~~t~~d~r~g~ip~~~~~d-~p~e~~ll~~lls~~p~~RP~~~~~~~~~~~ 515 (516)
T KOG1033|consen 466 IATLTDIRDGIIPPEFLQD-YPEEYTLLQQLLSPSPEERPSAIEVALHEFL 515 (516)
T ss_pred HHhhhhhhcCCCChHHhhc-CcHHHHHHHHhcCCCcccCchHHHHhhhhhc
Confidence 2223333333332222222 2335799999999999999988888888875
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.72 E-value=6.5e-19 Score=208.51 Aligned_cols=261 Identities=23% Similarity=0.290 Sum_probs=197.0
Q ss_pred eeeEEEeEeccCceEEEEEEec--CCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHHHH
Q 003052 473 LYQRLGKIGSGGSSEVHKVISS--DCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLREV 550 (853)
Q Consensus 473 ~Y~ilk~LG~G~FG~Vyka~~~--~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~~l 550 (853)
.|.+.+.||+|+|+.|-.+... ....+|+|.+...............|+.+-+.+..|.|++.+++.
T Consensus 21 ~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~----------- 89 (601)
T KOG0590|consen 21 QYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEP----------- 89 (601)
T ss_pred cccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCc-----------
Confidence 4778888999999999888763 335677777776654444444455677777777778888887764
Q ss_pred hhCCCCCCCCccccCCeEEEEEecch-hhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcc-cCceeeCCCCC
Q 003052 551 LNGSMNNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIH-EERIVHSDLKP 628 (853)
Q Consensus 551 ~~~~iv~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLH-s~gIIHRDLKP 628 (853)
..+....+++++|.. +++...+.. ......+...+..++.|+..+|.|+| ..++.||||||
T Consensus 90 -----------~~~~~~~~~~~~~s~g~~~f~~i~~------~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP 152 (601)
T KOG0590|consen 90 -----------SSSPRSYLLSLSYSDGGSLFSKISH------PDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKP 152 (601)
T ss_pred -----------cCCCcccccccCccccccccccccc------CCccCCCCcchhhhhhhhccCccccCcccccccCCCCC
Confidence 456677899999954 466655521 11125777888899999999999999 99999999999
Q ss_pred ccEEe-ecC-cEEEEecccchhccc-CCcccccccccc-CccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHH
Q 003052 629 ANFLL-VKG-SLKLIDFGIAKAIMS-DTTNIQRDSQVG-TLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMV 704 (853)
Q Consensus 629 eNILL-~~g-~VKL~DFGlAk~~~~-~~~~~~~~t~~G-Tp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELL 704 (853)
+|.++ ..+ .+|++|||+|..+.. ..........+| ++.|+|||.+.+.. +.+...|+||+|+++.-|+
T Consensus 153 ~n~~l~~s~~~l~~~df~~At~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~--------~~~~~~d~~S~g~~l~~~~ 224 (601)
T KOG0590|consen 153 SNSLLDESGSALKIADFGLATAYRNKNGAERSLKDRCGSSPPYGAPEHLSGKA--------YRGPSVDVWSLGIVLSAML 224 (601)
T ss_pred ccchhccCCCcccCCCchhhccccccCCcceeeecccCCCCCCCCcccccchh--------hcCCCcccccccccccccc
Confidence 99999 456 899999999998876 444445566789 99999999998753 2467899999999999999
Q ss_pred hCCCCCCcchhHHHH-HHhhcCC-CCcccCCCCCChhHHHHHHHhcccCCCCCCChhHHhcCCCCCC
Q 003052 705 YGRTPFSEYKTFWAK-FKVITDP-NHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQHPFLVP 769 (853)
Q Consensus 705 tG~~PF~~~~~~~~~-~kii~~~-~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~HPwf~~ 769 (853)
+|..||......... ...+... ..........+....+++.++|..+|..|.+.+++-.+||+..
T Consensus 225 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~d~~~~~ 291 (601)
T KOG0590|consen 225 TGELPWDFPSRKDGRYSSWKSNKGRFTQLPWNSISDQAHDLLHKILKENPSNRLSIEELKLDNWLSS 291 (601)
T ss_pred cCCCCccccccccccceeecccccccccCccccCChhhhhcccccccCCchhccccccccccccccc
Confidence 999999653322211 1111111 1123334456677899999999999999999999999999977
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.71 E-value=6.1e-18 Score=176.99 Aligned_cols=244 Identities=16% Similarity=0.248 Sum_probs=188.3
Q ss_pred eeeEEEeEeccCceEEEEEEecCCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHHHHhh
Q 003052 473 LYQRLGKIGSGGSSEVHKVISSDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLREVLN 552 (853)
Q Consensus 473 ~Y~ilk~LG~G~FG~Vyka~~~~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~~l~~ 552 (853)
...++-+|.+...|..|+|++..+. +++|+++...-.......|..|.-.|+-+. ||||+.+++.
T Consensus 191 ~lnl~tkl~e~hsgelwrgrwqgnd-ivakil~vr~~t~risrdfneefp~lrifs-hpnilpvlga------------- 255 (448)
T KOG0195|consen 191 SLNLITKLAESHSGELWRGRWQGND-IVAKILNVREVTARISRDFNEEFPALRIFS-HPNILPVLGA------------- 255 (448)
T ss_pred hhhhhhhhccCCCcccccccccCcc-hhhhhhhhhhcchhhcchhhhhCcceeeec-CCchhhhhhh-------------
Confidence 3556678999999999999986554 566777766555555556777777777666 8888877654
Q ss_pred CCCCCCCCccccCCeEEEEEecch-hhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCc--eeeCCCCCc
Q 003052 553 GSMNNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEER--IVHSDLKPA 629 (853)
Q Consensus 553 ~~iv~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~g--IIHRDLKPe 629 (853)
+....++.++..|++ ++|+..+.+. .+-.++..++.+++.+|++|+.|||+.. |.---|...
T Consensus 256 ---------cnsppnlv~isq~mp~gslynvlhe~------t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~ 320 (448)
T KOG0195|consen 256 ---------CNSPPNLVIISQYMPFGSLYNVLHEQ------TSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSK 320 (448)
T ss_pred ---------ccCCCCceEeeeeccchHHHHHHhcC------ccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccc
Confidence 566677889999976 6899888765 4566788899999999999999999873 444467888
Q ss_pred cEEeecC---cEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHhC
Q 003052 630 NFLLVKG---SLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYG 706 (853)
Q Consensus 630 NILL~~g---~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLtG 706 (853)
.++|+++ .+-.+|-.++-.. ....-.|.||+||.+...+.+.+ -.++|+|||++++|||.|.
T Consensus 321 hvmidedltarismad~kfsfqe---------~gr~y~pawmspealqrkped~n------~raadmwsfaillwel~tr 385 (448)
T KOG0195|consen 321 HVMIDEDLTARISMADTKFSFQE---------VGRAYSPAWMSPEALQRKPEDLN------IRAADMWSFAILLWELNTR 385 (448)
T ss_pred eEEecchhhhheecccceeeeec---------cccccCcccCCHHHHhcCchhcc------hhhhhHHHHHHHHHHhhcc
Confidence 8999765 4555564444221 12344789999999988776532 3689999999999999999
Q ss_pred CCCCCcchhHHHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCCChhHHh
Q 003052 707 RTPFSEYKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLL 762 (853)
Q Consensus 707 ~~PF~~~~~~~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL 762 (853)
..||.+..+++--.++... ......++..+..+..|+.-|+..||.+||.+..|+
T Consensus 386 evpfadlspmecgmkiale-glrv~ippgis~hm~klm~icmnedpgkrpkfdmiv 440 (448)
T KOG0195|consen 386 EVPFADLSPMECGMKIALE-GLRVHIPPGISRHMNKLMNICMNEDPGKRPKFDMIV 440 (448)
T ss_pred ccccccCCchhhhhhhhhc-cccccCCCCccHHHHHHHHHHhcCCCCcCCCcceeh
Confidence 9999998888776666554 456677889999999999999999999999987765
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.65 E-value=6.8e-16 Score=158.02 Aligned_cols=135 Identities=22% Similarity=0.208 Sum_probs=102.4
Q ss_pred EeEeccCceEEEEEEecCCcEEEEEEEecCCCChh------hHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHHHHh
Q 003052 478 GKIGSGGSSEVHKVISSDCTIYALKKIKLKGRDYA------TAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLREVL 551 (853)
Q Consensus 478 k~LG~G~FG~Vyka~~~~g~~vAVKkik~~~~~~~------~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~~l~ 551 (853)
+.||+|++|.||+|.. .+..+++|+......... ....+.+|+.++..+. +++|.....+
T Consensus 2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-~~~i~~p~~~------------ 67 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRAR-KAGVNVPAVY------------ 67 (211)
T ss_pred cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHH-HCCCCCCeEE------------
Confidence 5699999999999987 566789998764332111 1234678999999887 4454433322
Q ss_pred hCCCCCCCCccccCCeEEEEEecchh-hHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCCCcc
Q 003052 552 NGSMNNKDGRVKDDGYIYMVLEYGEI-DLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPAN 630 (853)
Q Consensus 552 ~~~iv~~~g~~~d~~~lyLVmEy~~g-dL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLKPeN 630 (853)
+.+....++||||++| +|.+.+... .. ....++.+|+.+|.+||+.||+||||+|.|
T Consensus 68 ----------~~~~~~~~lv~e~~~G~~L~~~~~~~-----------~~-~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~N 125 (211)
T PRK14879 68 ----------FVDPENFIIVMEYIEGEPLKDLINSN-----------GM-EELELSREIGRLVGKLHSAGIIHGDLTTSN 125 (211)
T ss_pred ----------EEeCCCCEEEEEEeCCcCHHHHHHhc-----------cH-HHHHHHHHHHHHHHHHHhCCcccCCCCccc
Confidence 2234457899999765 787776432 11 778899999999999999999999999999
Q ss_pred EEeecCcEEEEecccchh
Q 003052 631 FLLVKGSLKLIDFGIAKA 648 (853)
Q Consensus 631 ILL~~g~VKL~DFGlAk~ 648 (853)
||++++.++|+|||+++.
T Consensus 126 il~~~~~~~liDf~~a~~ 143 (211)
T PRK14879 126 MILSGGKIYLIDFGLAEF 143 (211)
T ss_pred EEEECCCEEEEECCcccC
Confidence 999988999999999864
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.64 E-value=7e-16 Score=157.69 Aligned_cols=139 Identities=22% Similarity=0.197 Sum_probs=97.1
Q ss_pred ceeeEEEeEeccCceEEEEEEecCCcEEEEEEEecCCCChhhH--------------------hhHHHHHHHHHHhcCCC
Q 003052 472 KLYQRLGKIGSGGSSEVHKVISSDCTIYALKKIKLKGRDYATA--------------------YGFCQEIEYLNKLKGKN 531 (853)
Q Consensus 472 ~~Y~ilk~LG~G~FG~Vyka~~~~g~~vAVKkik~~~~~~~~~--------------------~~~l~EI~iLkkL~~hp 531 (853)
..|.+.+.||+|+||.||++...+++.||||++.......... ..+.+|+.++.++.+..
T Consensus 15 ~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 94 (198)
T cd05144 15 VVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEG 94 (198)
T ss_pred chhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcC
Confidence 3478888999999999999998889999999987643211111 11334444444443210
Q ss_pred -ceeEeeehhhhHHHHHHHHhhCCCCCCCCccccCCeEEEEEecchh-hHHHHHHHhhhhccCCCCCCCHHHHHHHHHHh
Q 003052 532 -NIIQLIDYEVTEKALLREVLNGSMNNKDGRVKDDGYIYMVLEYGEI-DLAHMLSQKWKEMDGSNQTLDENWLRFYWQQI 609 (853)
Q Consensus 532 -NIV~Lid~~~~e~~iL~~l~~~~iv~~~g~~~d~~~lyLVmEy~~g-dL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QI 609 (853)
.+...+ +....++||||+++ +|..... ......++.+|
T Consensus 95 i~v~~~~--------------------------~~~~~~lv~e~~~g~~L~~~~~--------------~~~~~~~~~~i 134 (198)
T cd05144 95 FPVPKPI--------------------------DWNRHAVVMEYIDGVELYRVRV--------------LEDPEEVLDEI 134 (198)
T ss_pred CCCCcee--------------------------ecCCceEEEEEeCCcchhhccc--------------cccHHHHHHHH
Confidence 111111 12345899999776 4433211 13456788999
Q ss_pred hhhhhhcccCceeeCCCCCccEEee-cCcEEEEecccchhcc
Q 003052 610 LEAVNTIHEERIVHSDLKPANFLLV-KGSLKLIDFGIAKAIM 650 (853)
Q Consensus 610 l~AL~yLHs~gIIHRDLKPeNILL~-~g~VKL~DFGlAk~~~ 650 (853)
+.++.++|..||+||||||+||+++ ++.++|+|||+|....
T Consensus 135 ~~~l~~lh~~gi~H~Dl~p~Nill~~~~~~~liDfg~~~~~~ 176 (198)
T cd05144 135 LEEIVKAYKHGIIHGDLSEFNILVDDDEKIYIIDWPQMVSTD 176 (198)
T ss_pred HHHHHHHHHCCCCcCCCCcccEEEcCCCcEEEEECCccccCC
Confidence 9999999999999999999999995 6799999999997554
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.62 E-value=1.6e-15 Score=152.34 Aligned_cols=160 Identities=21% Similarity=0.209 Sum_probs=100.5
Q ss_pred EEeEeccCceEEEEEEecCCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehh-hhHHHHHHHHhhCCC
Q 003052 477 LGKIGSGGSSEVHKVISSDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYE-VTEKALLREVLNGSM 555 (853)
Q Consensus 477 lk~LG~G~FG~Vyka~~~~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~-~~e~~iL~~l~~~~i 555 (853)
.+.||+|+||.||+|.+.+++.||||++............+ .+...+.... +.+...+..+. ..+...+..+....+
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~-~~~~~~~~~~-~~~~~~~~~~~~~~e~~~l~~l~~~~~ 79 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRY-RTGDYRFGRK-KSNWRYLSRLWAEKEFRNLKRLYEAGV 79 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhh-hHHHHHhccC-CcchhhhhhHHHHHHHHHHHHHHHcCC
Confidence 45799999999999998888999999987654332211111 1113333333 44444443332 233333333333211
Q ss_pred CCCCCccccCCeEEEEEecchh-hHH-HHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhccc-CceeeCCCCCccEE
Q 003052 556 NNKDGRVKDDGYIYMVLEYGEI-DLA-HMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHE-ERIVHSDLKPANFL 632 (853)
Q Consensus 556 v~~~g~~~d~~~lyLVmEy~~g-dL~-~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs-~gIIHRDLKPeNIL 632 (853)
. ....+. ....++||||+++ .+. ..+... .. ...++.++.+++.++.+||. +||+||||||+||+
T Consensus 80 ~-~~~~~~-~~~~~lv~e~~~g~~~~~~~l~~~---------~~-~~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nil 147 (187)
T cd05119 80 P-VPKPID-LNRHVLVMEFIGGDGIPAPRLKDV---------RL-LEDPEELYDQILELMRKLYREAGLVHGDLSEYNIL 147 (187)
T ss_pred C-CCceEe-cCCCEEEEEEeCCCCccChhhhhh---------hh-cccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEE
Confidence 1 111111 1235899999775 111 111111 01 15678899999999999999 99999999999999
Q ss_pred eecCcEEEEecccchhcc
Q 003052 633 LVKGSLKLIDFGIAKAIM 650 (853)
Q Consensus 633 L~~g~VKL~DFGlAk~~~ 650 (853)
++++.++|+|||.+....
T Consensus 148 i~~~~~~liDfg~a~~~~ 165 (187)
T cd05119 148 VDDGKVYIIDVPQAVEID 165 (187)
T ss_pred EECCcEEEEECccccccc
Confidence 998899999999997654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.61 E-value=2.2e-15 Score=176.97 Aligned_cols=136 Identities=24% Similarity=0.259 Sum_probs=100.4
Q ss_pred eeEEEeEeccCceEEEEEEecCCcEEEEEEE-ecCCCC-----hhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHH
Q 003052 474 YQRLGKIGSGGSSEVHKVISSDCTIYALKKI-KLKGRD-----YATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALL 547 (853)
Q Consensus 474 Y~ilk~LG~G~FG~Vyka~~~~g~~vAVKki-k~~~~~-----~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL 547 (853)
|...+.||+|+||.||++...... +++|+. .+.... ......+.+|++++++++ +++|+....+.
T Consensus 335 ~~~~~~iG~G~~g~Vy~~~~~~~~-~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-~~~i~~p~~~~------- 405 (535)
T PRK09605 335 KIPDHLIGKGAEADIKKGEYLGRD-AVIKERVPKGYRHPELDERLRTERTRAEARLLSEAR-RAGVPTPVIYD------- 405 (535)
T ss_pred cCccceeccCCcEEEEEEeecCcc-ceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhc-ccCCCeeEEEE-------
Confidence 455678999999999999875443 344433 221111 112345789999999998 56666554331
Q ss_pred HHHhhCCCCCCCCccccCCeEEEEEecchh-hHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCC
Q 003052 548 REVLNGSMNNKDGRVKDDGYIYMVLEYGEI-DLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDL 626 (853)
Q Consensus 548 ~~l~~~~iv~~~g~~~d~~~lyLVmEy~~g-dL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDL 626 (853)
.+....++||||+++ +|.+++. ....++.+|+.+|.|||++||+||||
T Consensus 406 ---------------~~~~~~~lv~E~~~g~~L~~~l~----------------~~~~~~~~i~~~L~~lH~~giiHrDl 454 (535)
T PRK09605 406 ---------------VDPEEKTIVMEYIGGKDLKDVLE----------------GNPELVRKVGEIVAKLHKAGIVHGDL 454 (535)
T ss_pred ---------------EeCCCCEEEEEecCCCcHHHHHH----------------HHHHHHHHHHHHHHHHHhCCCccCCC
Confidence 223346899999764 7776653 24568899999999999999999999
Q ss_pred CCccEEeecCcEEEEecccchhc
Q 003052 627 KPANFLLVKGSLKLIDFGIAKAI 649 (853)
Q Consensus 627 KPeNILL~~g~VKL~DFGlAk~~ 649 (853)
||+|||+.++.++|+|||+|+..
T Consensus 455 kp~NILl~~~~~~liDFGla~~~ 477 (535)
T PRK09605 455 TTSNFIVRDDRLYLIDFGLGKYS 477 (535)
T ss_pred ChHHEEEECCcEEEEeCcccccC
Confidence 99999998889999999999753
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.61 E-value=3e-15 Score=152.13 Aligned_cols=131 Identities=23% Similarity=0.214 Sum_probs=97.5
Q ss_pred eEeccCceEEEEEEecCCcEEEEEEEecCCCCh------hhHhhHHHHHHHHHHhcCCC-ceeEeeehhhhHHHHHHHHh
Q 003052 479 KIGSGGSSEVHKVISSDCTIYALKKIKLKGRDY------ATAYGFCQEIEYLNKLKGKN-NIIQLIDYEVTEKALLREVL 551 (853)
Q Consensus 479 ~LG~G~FG~Vyka~~~~g~~vAVKkik~~~~~~------~~~~~~l~EI~iLkkL~~hp-NIV~Lid~~~~e~~iL~~l~ 551 (853)
.||+|+||.||++.. ++..+++|+........ .....+.+|++++..+.++. ++..++.+
T Consensus 1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~------------ 67 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDV------------ 67 (199)
T ss_pred CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEE------------
Confidence 389999999999985 56779999865432211 12345678999999998432 33333322
Q ss_pred hCCCCCCCCccccCCeEEEEEecchh-hHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCCCcc
Q 003052 552 NGSMNNKDGRVKDDGYIYMVLEYGEI-DLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPAN 630 (853)
Q Consensus 552 ~~~iv~~~g~~~d~~~lyLVmEy~~g-dL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLKPeN 630 (853)
+....++||||++| +|.+.+... . . .++.+|+.+|.+||+.||+||||+|.|
T Consensus 68 ------------~~~~~~lv~e~~~g~~l~~~~~~~--------~-~------~~~~~i~~~l~~lH~~gi~H~Dl~~~N 120 (199)
T TIGR03724 68 ------------DPDNKTIVMEYIEGKPLKDVIEEG--------N-D------ELLREIGRLVGKLHKAGIVHGDLTTSN 120 (199)
T ss_pred ------------ECCCCEEEEEEECCccHHHHHhhc--------H-H------HHHHHHHHHHHHHHHCCeecCCCCcce
Confidence 23446899999764 776665331 0 0 778999999999999999999999999
Q ss_pred EEeecCcEEEEecccchhc
Q 003052 631 FLLVKGSLKLIDFGIAKAI 649 (853)
Q Consensus 631 ILL~~g~VKL~DFGlAk~~ 649 (853)
||++++.++|+|||+++..
T Consensus 121 il~~~~~~~liDfg~a~~~ 139 (199)
T TIGR03724 121 IIVRDDKLYLIDFGLGKYS 139 (199)
T ss_pred EEEECCcEEEEECCCCcCC
Confidence 9999889999999998753
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.60 E-value=2e-15 Score=173.30 Aligned_cols=270 Identities=21% Similarity=0.221 Sum_probs=206.5
Q ss_pred CcCCCCCceeEEcCceeeEEEeEec--cCceEEEEEEe---cCCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCc
Q 003052 458 KRNYDPDLFFKVNGKLYQRLGKIGS--GGSSEVHKVIS---SDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNN 532 (853)
Q Consensus 458 k~~~dp~~~~~v~g~~Y~ilk~LG~--G~FG~Vyka~~---~~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpN 532 (853)
+..|+...+..+....+.+.+.+|. |.+|.||.+.. .++..+|+|+-+...........-.+|+...+++..|+|
T Consensus 100 s~~~~~S~~~s~~~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~ 179 (524)
T KOG0601|consen 100 SPIYGASPFDSFFDQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHEN 179 (524)
T ss_pred ccccCCCCccchhhhhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCcccc
Confidence 3444555555566677888999999 99999999875 466889999976655544444455688888888888888
Q ss_pred eeEeeehhhhHHHHHHHHhhCCCCCCCCccccCCeEEEEEecchhhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhh-
Q 003052 533 IIQLIDYEVTEKALLREVLNGSMNNKDGRVKDDGYIYMVLEYGEIDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILE- 611 (853)
Q Consensus 533 IV~Lid~~~~e~~iL~~l~~~~iv~~~g~~~d~~~lyLVmEy~~gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~- 611 (853)
+++.+.. +...+.+|+-+|+|+.+|..+.... ...+++..++.++.+...
T Consensus 180 ~v~~~~~----------------------~e~~~~lfiqtE~~~~sl~~~~~~~-------~~~~p~~~l~~~~~~~~~~ 230 (524)
T KOG0601|consen 180 PVRDSPA----------------------WEGSGILFIQTELCGESLQSYCHTP-------CNFLPDNLLWNSLRDWLSR 230 (524)
T ss_pred ccccCcc----------------------cccCCcceeeeccccchhHHhhhcc-------cccCCchhhhhHHhhhhhc
Confidence 8875443 6778889999999998888877653 346889999999999999
Q ss_pred ---hhhhcccCceeeCCCCCccEEe-ec-CcEEEEecccchhcccCCccccc---cccccCccccCchhhccCCCCCCCc
Q 003052 612 ---AVNTIHEERIVHSDLKPANFLL-VK-GSLKLIDFGIAKAIMSDTTNIQR---DSQVGTLSYMSPEAFMCNESDENGN 683 (853)
Q Consensus 612 ---AL~yLHs~gIIHRDLKPeNILL-~~-g~VKL~DFGlAk~~~~~~~~~~~---~t~~GTp~YmAPEvl~~~~~~~~~~ 683 (853)
||.++|+.+|+|-|+||+||++ .+ ...+++|||+...+......... ....|...|++||++.+.
T Consensus 231 ~~~al~~~hs~~~~~~~~kp~~i~~~~~~~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l------- 303 (524)
T KOG0601|consen 231 DVTALSHLHSNNIVHDDLKPANIFTTSDWTSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGL------- 303 (524)
T ss_pred ccccccccCCCcccccccchhheecccccceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccc-------
Confidence 9999999999999999999999 45 58999999999877554321110 122578899999999764
Q ss_pred cccCCCccchhhhHHHHHHHHhCCCCCC-cchhHHHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCCChhHHh
Q 003052 684 IIKCGRPSDIWSLGCILYQMVYGRTPFS-EYKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLL 762 (853)
Q Consensus 684 ~~~ys~ksDIWSLGVILyELLtG~~PF~-~~~~~~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL 762 (853)
++...|||+||.++.+..+|..++. ++..-|..++... ....+....+..+...+..||..+|..|++++.++
T Consensus 304 ---~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~---ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~ 377 (524)
T KOG0601|consen 304 ---ATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGY---IPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILT 377 (524)
T ss_pred ---cchHhhhcchhhhhHhhHhhcccccCCCCCCcccccccc---CchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHh
Confidence 5689999999999999988876663 3334444333222 22334445566677799999999999999999999
Q ss_pred cCCCCCC
Q 003052 763 QHPFLVP 769 (853)
Q Consensus 763 ~HPwf~~ 769 (853)
.|+++..
T Consensus 378 ~l~~i~s 384 (524)
T KOG0601|consen 378 ALNVIHS 384 (524)
T ss_pred ccccccc
Confidence 9999864
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.53 E-value=1.6e-14 Score=165.61 Aligned_cols=203 Identities=22% Similarity=0.291 Sum_probs=142.7
Q ss_pred hCCCCCCCCccccCCeEEEEEecch-hhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCce-eeCCCCCc
Q 003052 552 NGSMNNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERI-VHSDLKPA 629 (853)
Q Consensus 552 ~~~iv~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gI-IHRDLKPe 629 (853)
|.++..+.|.+.++..+++|.+||+ |+|.+.+... ...+++.....++++|+.||.|||.-.| .|+.|+..
T Consensus 6 h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~-------~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~ 78 (484)
T KOG1023|consen 6 HDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNE-------DIKLDYFFILSFIRDISKGLAYLHNSPIGYHGALKSS 78 (484)
T ss_pred hhhhhhheeeEecCCceEEEEeeecCccHHhHHhcc-------ccCccHHHHHHHHHHHHHHHHHHhcCcceeeeeeccc
Confidence 3344444455666688999999987 7899988752 4678888899999999999999998865 99999999
Q ss_pred cEEeec-CcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHhCCC
Q 003052 630 NFLLVK-GSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGRT 708 (853)
Q Consensus 630 NILL~~-g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLtG~~ 708 (853)
|.+++. -.+||.|||+.................-...|.|||.+......... ...+.+.||||+|+++||+++...
T Consensus 79 nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~--~~~~~~gdiYs~~ii~~ei~~r~~ 156 (484)
T KOG1023|consen 79 NCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLE--SALTQKGDIYSFGIIMYEILFRSG 156 (484)
T ss_pred cceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhccccccccc--ccccccCCeehHHHHHHHHHhccC
Confidence 999965 48999999998765321000111122245579999999875333210 113678999999999999999999
Q ss_pred CCCcc----hhHHHHHHhhcC-CC---Cc-ccCCCCCChhHHHHHHHhcccCCCCCCChhHHhcC
Q 003052 709 PFSEY----KTFWAKFKVITD-PN---HE-ITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQH 764 (853)
Q Consensus 709 PF~~~----~~~~~~~kii~~-~~---~~-~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~H 764 (853)
||... .. .++...+.. .. .+ +.......+.+..++..||..+|.+||++.++-..
T Consensus 157 ~~~~~~~~~~~-~eii~~~~~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~ 220 (484)
T KOG1023|consen 157 PFDLRNLVEDP-DEIILRVKKGGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIEQIRSK 220 (484)
T ss_pred ccccccccCCh-HHHHHHHHhcCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccHHHHHhh
Confidence 99642 22 122222222 11 11 11111345578999999999999999999988653
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.52 E-value=7.5e-14 Score=131.95 Aligned_cols=132 Identities=22% Similarity=0.289 Sum_probs=102.8
Q ss_pred EEEeEeccCceEEEEEEecCCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCC-CceeEeeehhhhHHHHHHHHhhCC
Q 003052 476 RLGKIGSGGSSEVHKVISSDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGK-NNIIQLIDYEVTEKALLREVLNGS 554 (853)
Q Consensus 476 ilk~LG~G~FG~Vyka~~~~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~h-pNIV~Lid~~~~e~~iL~~l~~~~ 554 (853)
+++.||+|.++.||++...+ ..+++|.+..... ...+.+|+.+++.+.++ .++.+++.+.
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~----~~~~~~e~~~~~~l~~~~~~~p~~~~~~-------------- 62 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK----GADREREVAILQLLARKGLPVPKVLASG-------------- 62 (155)
T ss_pred cceecccccccceEEEEecC-CeEEEEecCCCCc----hhHHHHHHHHHHHHHHcCCCCCeEEEEc--------------
Confidence 35779999999999999855 6799999865433 34578999999999865 6777776652
Q ss_pred CCCCCCccccCCeEEEEEecchhhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccC---ceeeCCCCCccE
Q 003052 555 MNNKDGRVKDDGYIYMVLEYGEIDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEE---RIVHSDLKPANF 631 (853)
Q Consensus 555 iv~~~g~~~d~~~lyLVmEy~~gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~---gIIHRDLKPeNI 631 (853)
...+..|++|||+.+.... .++......++.+++.+|.+||.. +|+|+||+|+||
T Consensus 63 --------~~~~~~~~v~e~~~g~~~~--------------~~~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Ni 120 (155)
T cd05120 63 --------ESDGWSYLLMEWIEGETLD--------------EVSEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNI 120 (155)
T ss_pred --------CCCCccEEEEEecCCeecc--------------cCCHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceE
Confidence 2335789999997642111 114456677889999999999985 799999999999
Q ss_pred Eeec-CcEEEEecccchh
Q 003052 632 LLVK-GSLKLIDFGIAKA 648 (853)
Q Consensus 632 LL~~-g~VKL~DFGlAk~ 648 (853)
|+++ +.++|+|||.++.
T Consensus 121 l~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 121 LVDDGKILGIIDWEYAGY 138 (155)
T ss_pred EEECCcEEEEEecccccC
Confidence 9965 7999999999864
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.46 E-value=3.2e-13 Score=143.24 Aligned_cols=138 Identities=23% Similarity=0.285 Sum_probs=97.3
Q ss_pred EeEe-ccCceEEEEEEecCCcEEEEEEEecCCC-----------ChhhHhhHHHHHHHHHHhcCCCc--eeEeeehhhhH
Q 003052 478 GKIG-SGGSSEVHKVISSDCTIYALKKIKLKGR-----------DYATAYGFCQEIEYLNKLKGKNN--IIQLIDYEVTE 543 (853)
Q Consensus 478 k~LG-~G~FG~Vyka~~~~g~~vAVKkik~~~~-----------~~~~~~~~l~EI~iLkkL~~hpN--IV~Lid~~~~e 543 (853)
..|| .||.|+||++... +..++||.+...+. .......+.+|+.++.+|. +++ +++.+++...+
T Consensus 37 ~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~-~~gi~vP~pl~~~~~~ 114 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLY-EAGLPVPRPIAARVVR 114 (239)
T ss_pred ceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHH-hCCCCCceeEeeeeee
Confidence 3577 8889999998774 56789998864321 1122345788999999997 434 45555542111
Q ss_pred HHHHHHHhhCCCCCCCCccccCCeEEEEEecchh--hHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCce
Q 003052 544 KALLREVLNGSMNNKDGRVKDDGYIYMVLEYGEI--DLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERI 621 (853)
Q Consensus 544 ~~iL~~l~~~~iv~~~g~~~d~~~lyLVmEy~~g--dL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gI 621 (853)
. ......++||||+++ +|.+++.. ..+++.. +.+|+.+|.+||++||
T Consensus 115 ~------------------~~~~~~~lV~e~l~G~~~L~~~l~~---------~~l~~~~----~~~i~~~l~~lH~~GI 163 (239)
T PRK01723 115 H------------------GLFYRADILIERIEGARDLVALLQE---------APLSEEQ----WQAIGQLIARFHDAGV 163 (239)
T ss_pred c------------------CcceeeeEEEEecCCCCCHHHHHhc---------CCCCHHH----HHHHHHHHHHHHHCCC
Confidence 0 001123699999774 77777643 2455543 5689999999999999
Q ss_pred eeCCCCCccEEee-cCcEEEEecccchh
Q 003052 622 VHSDLKPANFLLV-KGSLKLIDFGIAKA 648 (853)
Q Consensus 622 IHRDLKPeNILL~-~g~VKL~DFGlAk~ 648 (853)
+||||||+|||++ ++.++|+|||.+..
T Consensus 164 ~HrDlkp~NILv~~~~~v~LIDfg~~~~ 191 (239)
T PRK01723 164 YHADLNAHNILLDPDGKFWLIDFDRGEL 191 (239)
T ss_pred CCCCCCchhEEEcCCCCEEEEECCCccc
Confidence 9999999999995 56899999998864
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.30 E-value=1e-12 Score=157.81 Aligned_cols=258 Identities=20% Similarity=0.226 Sum_probs=175.1
Q ss_pred ceeeEEEeEeccCceEEEEEEe-cCCcEEEEEEEecCCCChh-hHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHHH
Q 003052 472 KLYQRLGKIGSGGSSEVHKVIS-SDCTIYALKKIKLKGRDYA-TAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLRE 549 (853)
Q Consensus 472 ~~Y~ilk~LG~G~FG~Vyka~~-~~g~~vAVKkik~~~~~~~-~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~~ 549 (853)
+.+.+++-+-+|+|+.++.+.- ..+..+++|+......-.. .....+. ..||.-.
T Consensus 804 d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~----------~s~~~i~------------- 860 (1205)
T KOG0606|consen 804 DGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRS----------KSNILIT------------- 860 (1205)
T ss_pred ccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCC----------ccCcccc-------------
Confidence 4577788899999999998765 3444555555543211000 0111111 1111110
Q ss_pred HhhCCCCCCCCccccCCeEEEEEecch-hhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCCC
Q 003052 550 VLNGSMNNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKP 628 (853)
Q Consensus 550 l~~~~iv~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLKP 628 (853)
..++..+.....+......++||+|.+ ++|...+... +..++.-++.++..+..+++|||...++|||++|
T Consensus 861 p~~P~v~~~~~s~~~rsP~~L~~~~~~~~~~~Skl~~~--------~~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p 932 (1205)
T KOG0606|consen 861 PRSPAVVRSFPSFPCRSPLPLVGHYLNGGDLPSKLHNS--------GCLSAEPARSPILERVQSLESLHSSLRKHRDLKP 932 (1205)
T ss_pred CCCCceecccCCCCCCCCcchhhHHhccCCchhhhhcC--------CCcccccccchhHHHHhhhhccccchhhcccccc
Confidence 001122222222455667899999964 5777666543 5688888999999999999999999999999999
Q ss_pred ccEEe-ecCcEEEEecccchhccc------C-----------------------CccccccccccCccccCchhhccCCC
Q 003052 629 ANFLL-VKGSLKLIDFGIAKAIMS------D-----------------------TTNIQRDSQVGTLSYMSPEAFMCNES 678 (853)
Q Consensus 629 eNILL-~~g~VKL~DFGlAk~~~~------~-----------------------~~~~~~~t~~GTp~YmAPEvl~~~~~ 678 (853)
.|+|+ ..|+.++.|||....... . ..........||+.|.+||.+.+..
T Consensus 933 ~~~l~~~~gh~~l~~~~t~~~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~- 1011 (1205)
T KOG0606|consen 933 DSLLIAYDGHRPLTDFGTLSKVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRR- 1011 (1205)
T ss_pred cchhhcccCCcccCccccccccccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCccccccc-
Confidence 99999 578999999984432110 0 0001123457999999999998764
Q ss_pred CCCCccccCCCccchhhhHHHHHHHHhCCCCCCcchhHHHHHHhhcCCCCcc-cCCCCCChhHHHHHHHhcccCCCCCCC
Q 003052 679 DENGNIIKCGRPSDIWSLGCILYQMVYGRTPFSEYKTFWAKFKVITDPNHEI-TYEPVPNPWLLDLMKKCLAWDRNERWR 757 (853)
Q Consensus 679 ~~~~~~~~ys~ksDIWSLGVILyELLtG~~PF~~~~~~~~~~kii~~~~~~~-~~~~~~s~~l~dLI~kcL~~DP~kRpT 757 (853)
.+..+|||++|++++|.++|.+||...... ..+..+....... .-+...++.+++++.+.|..+|.+|..
T Consensus 1012 --------hgs~ad~~~~g~~l~e~l~g~pp~na~tpq-~~f~ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~ 1082 (1205)
T KOG0606|consen 1012 --------HGSAADWWSSGVCLFEVLTGIPPFNAETPQ-QIFENILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLG 1082 (1205)
T ss_pred --------CCCcchhhhhhhhhhhhhcCCCCCCCcchh-hhhhccccCCCCCCCCccccChhhhhhhhhhhccCchhccC
Confidence 357899999999999999999999775443 4444443322221 223345788999999999999999999
Q ss_pred hh---HHhcCCCCCCC
Q 003052 758 IP---QLLQHPFLVPP 770 (853)
Q Consensus 758 a~---EIL~HPwf~~~ 770 (853)
+. ++-.|+||...
T Consensus 1083 a~~~~e~k~~~~~~~~ 1098 (1205)
T KOG0606|consen 1083 AKGAAEVKGHPFFQDV 1098 (1205)
T ss_pred cccccccccCCccCCC
Confidence 88 99999999753
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.27 E-value=1.7e-11 Score=126.60 Aligned_cols=160 Identities=19% Similarity=0.231 Sum_probs=94.2
Q ss_pred EeEeccCceEEEEEEecC-------CcEEEEEEEecCCCChhhHhhHH-HHHHHHHHhcCCCceeEeee-hhhhHHHHHH
Q 003052 478 GKIGSGGSSEVHKVISSD-------CTIYALKKIKLKGRDYATAYGFC-QEIEYLNKLKGKNNIIQLID-YEVTEKALLR 548 (853)
Q Consensus 478 k~LG~G~FG~Vyka~~~~-------g~~vAVKkik~~~~~~~~~~~~l-~EI~iLkkL~~hpNIV~Lid-~~~~e~~iL~ 548 (853)
..||.|--+.||.|...+ +..+|||+.+...........++ .+-+. +....+.|-.+++. |...|-..|.
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf-~~~~~k~~~~~~~~~wa~kE~r~L~ 81 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRF-KDRFSKLNPRKIIRMWAEKEMHNLK 81 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCccc-ccCcCCCCHHHHHHHHHHHHHHHHH
Confidence 468999999999998753 47899999975433222221111 00000 00000111111111 2223334444
Q ss_pred HHhhCCCCCCCCccccCCeEEEEEecchhh-HHH-HHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhc-ccCceeeCC
Q 003052 549 EVLNGSMNNKDGRVKDDGYIYMVLEYGEID-LAH-MLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTI-HEERIVHSD 625 (853)
Q Consensus 549 ~l~~~~iv~~~g~~~d~~~lyLVmEy~~gd-L~~-~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yL-Hs~gIIHRD 625 (853)
.+....+. ....+ .-..-+|||||.+++ +.. .+. ...+++..+..++.+++.+|..| |..||||+|
T Consensus 82 rl~~~Gv~-vP~pi-~~~~~~lvME~Ig~~~~~~~~Lk---------d~~~~~~~~~~i~~~i~~~l~~l~H~~glVHGD 150 (197)
T cd05146 82 RMQKAGIP-CPEVV-VLKKHVLVMSFIGDDQVPAPKLK---------DAKLNDEEMKNAYYQVLSMMKQLYKECNLVHAD 150 (197)
T ss_pred HHHHcCCC-CCeEE-EecCCEEEEEEcCCCCccchhhh---------ccccCHHHHHHHHHHHHHHHHHHHHhCCeecCC
Confidence 43322110 00001 113458999998753 211 111 12355667778889999999999 899999999
Q ss_pred CCCccEEeecCcEEEEecccchhc
Q 003052 626 LKPANFLLVKGSLKLIDFGIAKAI 649 (853)
Q Consensus 626 LKPeNILL~~g~VKL~DFGlAk~~ 649 (853)
|++.|||+.+|.+.|+|||.|-..
T Consensus 151 Ls~~NIL~~~~~v~iIDF~qav~~ 174 (197)
T cd05146 151 LSEYNMLWHDGKVWFIDVSQSVEP 174 (197)
T ss_pred CCHHHEEEECCcEEEEECCCceeC
Confidence 999999999899999999988644
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.23 E-value=3.1e-11 Score=118.95 Aligned_cols=127 Identities=20% Similarity=0.185 Sum_probs=91.7
Q ss_pred EEeEeccCceEEEEEEecCCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHHHHhhCCCC
Q 003052 477 LGKIGSGGSSEVHKVISSDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLREVLNGSMN 556 (853)
Q Consensus 477 lk~LG~G~FG~Vyka~~~~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~~l~~~~iv 556 (853)
++.|+.|.++.||++... +..|++|....... ....+.+|+.+++.+.+...+.+++.+
T Consensus 3 ~~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~---~~~~~~~E~~~l~~l~~~~~~P~~~~~----------------- 61 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTE---LLINRENEAENSKLAAEAGIGPKLYYF----------------- 61 (170)
T ss_pred eeecCCcccCceEEEEEC-CeEEEEEeCCCCcc---cccCHHHHHHHHHHHHHhCCCCceEEE-----------------
Confidence 456899999999999875 66799998764422 122457899999998754334444432
Q ss_pred CCCCccccCCeEEEEEecchh-hHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCce-----eeCCCCCcc
Q 003052 557 NKDGRVKDDGYIYMVLEYGEI-DLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERI-----VHSDLKPAN 630 (853)
Q Consensus 557 ~~~g~~~d~~~lyLVmEy~~g-dL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gI-----IHRDLKPeN 630 (853)
+...-++||||+++ .+... ......++.+++.+|..||..++ +|+|++|.|
T Consensus 62 -------~~~~~~lv~e~i~G~~l~~~----------------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~N 118 (170)
T cd05151 62 -------DPETGVLITEFIEGSELLTE----------------DFSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGN 118 (170)
T ss_pred -------eCCCCeEEEEecCCCccccc----------------cccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCc
Confidence 11123799999776 22110 01123456799999999999885 999999999
Q ss_pred EEeecCcEEEEecccch
Q 003052 631 FLLVKGSLKLIDFGIAK 647 (853)
Q Consensus 631 ILL~~g~VKL~DFGlAk 647 (853)
|+++++.++|+|||.|.
T Consensus 119 il~~~~~~~liDf~~a~ 135 (170)
T cd05151 119 FLLDDGRLWLIDWEYAG 135 (170)
T ss_pred EEEECCeEEEEeccccc
Confidence 99998899999999885
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.19 E-value=5.6e-11 Score=136.78 Aligned_cols=157 Identities=17% Similarity=0.221 Sum_probs=93.2
Q ss_pred EeEeccCceEEEEEEecCCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcC-------------CCceeEeeeh-----
Q 003052 478 GKIGSGGSSEVHKVISSDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKG-------------KNNIIQLIDY----- 539 (853)
Q Consensus 478 k~LG~G~FG~Vyka~~~~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~-------------hpNIV~Lid~----- 539 (853)
+.||.|++|.||+|+..+|+.||||+.+... ...+..++.+|+.+.. +..++.-+..
T Consensus 123 ~plasaSigQVh~A~l~~G~~VaVKv~rp~i-----~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~E 197 (437)
T TIGR01982 123 KPLAAASIAQVHRARLVDGKEVAVKVLRPGI-----EKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRE 197 (437)
T ss_pred cceeeeehhheEEEEecCCCEEEEEeeCCCc-----HHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHH
Confidence 4599999999999999999999999986432 2234455555554310 0011110000
Q ss_pred --hhhHHHHHHHHh----hCCCCCCCCcc-ccCCeEEEEEecchh-hHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhh
Q 003052 540 --EVTEKALLREVL----NGSMNNKDGRV-KDDGYIYMVLEYGEI-DLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILE 611 (853)
Q Consensus 540 --~~~e~~iL~~l~----~~~iv~~~g~~-~d~~~lyLVmEy~~g-dL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~ 611 (853)
+..|...+..+. +...+.....+ ...+..+|||||++| +|.+...... ..+. ...++..++.
T Consensus 198 ldf~~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~-------~~~~---~~~ia~~~~~ 267 (437)
T TIGR01982 198 LDLRREAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDE-------AGLD---RKALAENLAR 267 (437)
T ss_pred HCHHHHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHh-------cCCC---HHHHHHHHHH
Confidence 111222222222 11112211111 123345899999865 6655543210 1111 2345555555
Q ss_pred -hhhhcccCceeeCCCCCccEEe-ecCcEEEEecccchhc
Q 003052 612 -AVNTIHEERIVHSDLKPANFLL-VKGSLKLIDFGIAKAI 649 (853)
Q Consensus 612 -AL~yLHs~gIIHRDLKPeNILL-~~g~VKL~DFGlAk~~ 649 (853)
.+..+|..|++|+|+||.||++ .+|.++|+|||++..+
T Consensus 268 ~~l~ql~~~g~~H~D~hPgNilv~~~g~i~liDfG~~~~l 307 (437)
T TIGR01982 268 SFLNQVLRDGFFHADLHPGNIFVLKDGKIIALDFGIVGRL 307 (437)
T ss_pred HHHHHHHhCCceeCCCCcccEEECCCCcEEEEeCCCeeEC
Confidence 4678899999999999999999 5679999999998765
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.18 E-value=2.4e-11 Score=139.99 Aligned_cols=248 Identities=23% Similarity=0.146 Sum_probs=172.6
Q ss_pred ceeeEEEeEeccCceEEEEEEe--cCCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHHH
Q 003052 472 KLYQRLGKIGSGGSSEVHKVIS--SDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLRE 549 (853)
Q Consensus 472 ~~Y~ilk~LG~G~FG~Vyka~~--~~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~~ 549 (853)
.+|..+..||.|.|+.|+++.. .++..|++|.+............-+.|+.+...+.-|.++++.+..
T Consensus 265 ~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~---------- 334 (524)
T KOG0601|consen 265 TDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSS---------- 334 (524)
T ss_pred CCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCC----------
Confidence 4588899999999999998764 4668899999876655444433345777777777767776665432
Q ss_pred HhhCCCCCCCCccccCCeEEEEEecchh-hHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCCC
Q 003052 550 VLNGSMNNKDGRVKDDGYIYMVLEYGEI-DLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKP 628 (853)
Q Consensus 550 l~~~~iv~~~g~~~d~~~lyLVmEy~~g-dL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLKP 628 (853)
+......|+-.|||.+ ++...+. ....+.+...+.+..|++.++.++|+..++|+|+||
T Consensus 335 ------------W~~~r~~~ip~e~~~~~s~~l~~~--------~~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~p 394 (524)
T KOG0601|consen 335 ------------WSQLRQGYIPLEFCEGGSSSLRSV--------TSQMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKP 394 (524)
T ss_pred ------------ccccccccCchhhhcCcchhhhhH--------HHHhcCcchhhhhHHHHHhccccccchhhhcccccc
Confidence 3344456788999854 3322221 114578888999999999999999999999999999
Q ss_pred ccEEeec--CcEEEEecccchhcccCCccccccccccCcccc-CchhhccCCCCCCCccccCCCccchhhhHHHHHHHHh
Q 003052 629 ANFLLVK--GSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYM-SPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVY 705 (853)
Q Consensus 629 eNILL~~--g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~Ym-APEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLt 705 (853)
.||++.+ +..++.|||++..+.- ......+.-+|+ ..|++.... .+..+.|++|||..+++.++
T Consensus 395 sni~i~~~~~~~~~~~~~~~t~~~~-----~~~~~~~~~r~~p~~~~~~e~~--------~~~~~~~~~sl~~~~~e~~~ 461 (524)
T KOG0601|consen 395 SNILISNDGFFSKLGDFGCWTRLAF-----SSGVFHHIDRLYPIAEILLEDY--------PHLSKADIFSLGLSVDEAIT 461 (524)
T ss_pred cceeeccchhhhhccccccccccce-----ecccccccccccccchhhcccc--------cccccccccccccccccccc
Confidence 9999955 6889999999875321 111233444455 355554332 35679999999999999998
Q ss_pred CCCCCCcchhHHHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCCChhHHhcCCCCC
Q 003052 706 GRTPFSEYKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQHPFLV 768 (853)
Q Consensus 706 G~~PF~~~~~~~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~HPwf~ 768 (853)
|...-...... .. +.. ...........++..+.+.++..|+..|+.+.++..|.=|.
T Consensus 462 ~~~ls~~~~~~-~~---i~~--~~~p~~~~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~~ 518 (524)
T KOG0601|consen 462 GSPLSESGVQS-LT---IRS--GDTPNLPGLKLQLQVLLKVMINPDRKRRPSAVELSLHSEFY 518 (524)
T ss_pred CcccCcccccc-ee---eec--ccccCCCchHHhhhhhhhhhcCCccccchhhhhhcccchhh
Confidence 86543322221 11 111 11112223336789999999999999999999999887553
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.16 E-value=3.5e-11 Score=141.00 Aligned_cols=162 Identities=15% Similarity=0.189 Sum_probs=90.5
Q ss_pred eeEEEeEeccCceEEEEEEecC-CcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcC-----CCc--eeEe---------
Q 003052 474 YQRLGKIGSGGSSEVHKVISSD-CTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKG-----KNN--IIQL--------- 536 (853)
Q Consensus 474 Y~ilk~LG~G~FG~Vyka~~~~-g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~-----hpN--IV~L--------- 536 (853)
|.. +.||.|++|.||+|+.++ |+.||||++...... .+...+.+|+.+-. -+. .+++
T Consensus 122 fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~-----~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~ 195 (537)
T PRK04750 122 FDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILP-----VIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEK 195 (537)
T ss_pred cCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHH-----HHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHH
Confidence 444 579999999999999976 999999999854221 12233333332210 000 0000
Q ss_pred -----eehhhhHHHHHHHHh----hCCCCCCCCccc-cCCeEEEEEecchh-hHHHHHHHhhhhccCCCCCCCHHHHHHH
Q 003052 537 -----IDYEVTEKALLREVL----NGSMNNKDGRVK-DDGYIYMVLEYGEI-DLAHMLSQKWKEMDGSNQTLDENWLRFY 605 (853)
Q Consensus 537 -----id~~~~e~~iL~~l~----~~~iv~~~g~~~-d~~~lyLVmEy~~g-dL~~~L~~~~k~~~~~~~~LsE~~~r~I 605 (853)
+|+ ..|...+.++. +...+.....+. -.+..+|||||+.| .+.+.-.-. ........+.+..+..+
T Consensus 196 ~l~~ElD~-~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~--~~g~d~~~la~~~v~~~ 272 (537)
T PRK04750 196 TLHDELDL-MREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALR--AAGTDMKLLAERGVEVF 272 (537)
T ss_pred HHHHhhCH-HHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHH--hcCCCHHHHHHHHHHHH
Confidence 011 01111111111 111222222222 13345799999775 565432111 00000113566667777
Q ss_pred HHHhhhhhhhcccCceeeCCCCCccEEee-cC----cEEEEecccchhccc
Q 003052 606 WQQILEAVNTIHEERIVHSDLKPANFLLV-KG----SLKLIDFGIAKAIMS 651 (853)
Q Consensus 606 ~~QIl~AL~yLHs~gIIHRDLKPeNILL~-~g----~VKL~DFGlAk~~~~ 651 (853)
+.||+ ..|++|+|+||.||++. +| .++++|||++..+..
T Consensus 273 ~~Qif-------~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 273 FTQVF-------RDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred HHHHH-------hCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 77776 48999999999999994 45 899999999976643
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.97 E-value=4.9e-10 Score=121.18 Aligned_cols=185 Identities=21% Similarity=0.274 Sum_probs=124.0
Q ss_pred ccCCeEEEEEecch-hhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccC--ceeeCCCCCccEEee-cCcE
Q 003052 563 KDDGYIYMVLEYGE-IDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEE--RIVHSDLKPANFLLV-KGSL 638 (853)
Q Consensus 563 ~d~~~lyLVmEy~~-gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~--gIIHRDLKPeNILL~-~g~V 638 (853)
.+...+.++.||+. |+|..+|++..+ ....+.....++|.-||+.||.|||+. -|+|+++..+-|++. +|-|
T Consensus 142 ~e~~rviFiteymssgs~~~fLkrt~~----~~~a~~~~~wkkw~tqIlsal~yLhs~~PpiihgnlTc~tifiq~ngLI 217 (458)
T KOG1266|consen 142 EEKPRVIFITEYMSSGSLKQFLKRTKK----NQKALFQKAWKKWCTQILSALSYLHSCDPPIIHGNLTCDTIFIQHNGLI 217 (458)
T ss_pred ccccceEEEEecccchhHHHHHHHHHH----hhhhhhHHHHHHHHHHHHhhhhhhhccCCccccCCcchhheeecCCceE
Confidence 45567899999976 688888876433 456788888899999999999999987 599999999999994 5666
Q ss_pred EEEecccc--hhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHhCCCCCCcch--
Q 003052 639 KLIDFGIA--KAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGRTPFSEYK-- 714 (853)
Q Consensus 639 KL~DFGlA--k~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLtG~~PF~~~~-- 714 (853)
|++--... ................|-++|.|||.=... +.+.++|||++|....+|..|..--.+..
T Consensus 218 kig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~t---------n~~~a~dIy~fgmcAlemailEiq~tnseS~ 288 (458)
T KOG1266|consen 218 KIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTT---------NTTGASDIYKFGMCALEMAILEIQSTNSESK 288 (458)
T ss_pred EecccCccccchhhhhhhHhhhhccccCCccccCCcCccc---------ccccchhhhhhhHHHHHHHHheeccCCCcce
Confidence 66421111 000000000111233577899999953222 34568999999999999987765422211
Q ss_pred --hHHHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCCChhHHhcCCCCCC
Q 003052 715 --TFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQHPFLVP 769 (853)
Q Consensus 715 --~~~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~HPwf~~ 769 (853)
....+...+ +... +..-+++|.+||+-.|+.||++.++|.||.+-.
T Consensus 289 ~~~ee~ia~~i------~~le---n~lqr~~i~kcl~~eP~~rp~ar~llfHpllfe 336 (458)
T KOG1266|consen 289 VEVEENIANVI------IGLE---NGLQRGSITKCLEGEPNGRPDARLLLFHPLLFE 336 (458)
T ss_pred eehhhhhhhhe------eecc---CccccCcCcccccCCCCCCcchhhhhcCceeee
Confidence 111111111 1111 122368999999999999999999999998643
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.91 E-value=3.5e-09 Score=108.81 Aligned_cols=128 Identities=25% Similarity=0.276 Sum_probs=78.9
Q ss_pred EEEEEEecCCcEEEEEEEecCCCChh------------------------hHhhHHHHHHHHHHhcCCC-ceeEeeehhh
Q 003052 487 EVHKVISSDCTIYALKKIKLKGRDYA------------------------TAYGFCQEIEYLNKLKGKN-NIIQLIDYEV 541 (853)
Q Consensus 487 ~Vyka~~~~g~~vAVKkik~~~~~~~------------------------~~~~~l~EI~iLkkL~~hp-NIV~Lid~~~ 541 (853)
.||.|...++..+|||+.+....... ......+|.+.|.++.... ++.+++++.
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~- 79 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN- 79 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence 48999998899999999875422111 1112456777777776432 455555431
Q ss_pred hHHHHHHHHhhCCCCCCCCccccCCeEEEEEecch--hhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhh-ccc
Q 003052 542 TEKALLREVLNGSMNNKDGRVKDDGYIYMVLEYGE--IDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNT-IHE 618 (853)
Q Consensus 542 ~e~~iL~~l~~~~iv~~~g~~~d~~~lyLVmEy~~--gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~y-LHs 618 (853)
.-+|||||.+ |.....+... .++......++.+++..+.. +|.
T Consensus 80 -------------------------~~~ivME~I~~~G~~~~~l~~~---------~~~~~~~~~~~~~il~~~~~~~~~ 125 (188)
T PF01163_consen 80 -------------------------RNVIVMEYIGEDGVPLPRLKDV---------DLSPEEPKELLEEILEEIIKMLHK 125 (188)
T ss_dssp -------------------------TTEEEEE--EETTEEGGCHHHC---------GGGGSTHHHHHHHHHHHHHHHHHC
T ss_pred -------------------------CCEEEEEecCCCccchhhHHhc---------cccchhHHHHHHHHHHHHHHHHHh
Confidence 1379999977 5222222221 12234556777888885555 579
Q ss_pred CceeeCCCCCccEEeecCcEEEEecccchhc
Q 003052 619 ERIVHSDLKPANFLLVKGSLKLIDFGIAKAI 649 (853)
Q Consensus 619 ~gIIHRDLKPeNILL~~g~VKL~DFGlAk~~ 649 (853)
.||+|+||.+.|||+.++.+.|+|||.|...
T Consensus 126 ~givHGDLs~~NIlv~~~~~~iIDf~qav~~ 156 (188)
T PF01163_consen 126 AGIVHGDLSEYNILVDDGKVYIIDFGQAVDS 156 (188)
T ss_dssp TTEEESS-STTSEEEETTCEEE--GTTEEET
T ss_pred cCceecCCChhhEEeecceEEEEecCcceec
Confidence 9999999999999999999999999988643
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.89 E-value=1e-08 Score=119.93 Aligned_cols=164 Identities=20% Similarity=0.290 Sum_probs=118.2
Q ss_pred ecCCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHHHHhhCCCCCCCCccccCCeEEEEE
Q 003052 493 SSDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLREVLNGSMNNKDGRVKDDGYIYMVL 572 (853)
Q Consensus 493 ~~~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~~l~~~~iv~~~g~~~d~~~lyLVm 572 (853)
..++..+.|++.+.... .......+-++-|+.++ ||||+++++. ++.++.+|||+
T Consensus 34 k~~~~~vsVF~~~~~~~--~~~~~~~~A~k~lKtlR-HP~Il~yL~t----------------------~e~~~~~ylvT 88 (690)
T KOG1243|consen 34 KADGGPVSVFVYKRSNG--EVTELAKRAVKRLKTLR-HPNILSYLDT----------------------TEEEGTLYLVT 88 (690)
T ss_pred eccCCceEEEEEeCCCc--hhhHHHHHHHHHhhhcc-Cchhhhhhhh----------------------hcccCceEEEe
Confidence 35778888888876655 33334567788888888 8999998875 45566899999
Q ss_pred ecchhhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcc-cCceeeCCCCCccEEe-ecCcEEEEecccchhcc
Q 003052 573 EYGEIDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIH-EERIVHSDLKPANFLL-VKGSLKLIDFGIAKAIM 650 (853)
Q Consensus 573 Ey~~gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLH-s~gIIHRDLKPeNILL-~~g~VKL~DFGlAk~~~ 650 (853)
|.+. -|..++++ +....+...+.||+.||.||| +.+++|++|.-+.|++ ..|..||++|-++....
T Consensus 89 ErV~-Pl~~~lk~-----------l~~~~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~ 156 (690)
T KOG1243|consen 89 ERVR-PLETVLKE-----------LGKEEVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFVNESGEWKLGGLELVSKAS 156 (690)
T ss_pred eccc-cHHHHHHH-----------hHHHHHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccc
Confidence 9954 23344433 346778888999999999997 5689999999999999 57899999999886443
Q ss_pred cCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHhC
Q 003052 651 SDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYG 706 (853)
Q Consensus 651 ~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLtG 706 (853)
.-.. ......---.|..|+.+... ....|.|-|||++++++.|
T Consensus 157 ~~~~--~~~~~~~~~s~~~P~~~~~s-----------~~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 157 GFNA--PAKSLYLIESFDDPEEIDPS-----------EWSIDSWGLGCLIEELFNG 199 (690)
T ss_pred cCCc--ccccchhhhcccChhhcCcc-----------ccchhhhhHHHHHHHHhCc
Confidence 2111 01112222346677765322 1357999999999999999
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.83 E-value=5.6e-08 Score=110.84 Aligned_cols=221 Identities=19% Similarity=0.186 Sum_probs=153.8
Q ss_pred ceEEEEEEe-cCCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHHHHhhCCCCCCCCccc
Q 003052 485 SSEVHKVIS-SDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLREVLNGSMNNKDGRVK 563 (853)
Q Consensus 485 FG~Vyka~~-~~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~~l~~~~iv~~~g~~~ 563 (853)
-.+.|++.. .||..|++|++....... ......-+++++++. |.|||.+.+++.+.. -
T Consensus 289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~~--~nk~t~lve~wkkl~-h~NvV~frevf~t~t------------------F 347 (655)
T KOG3741|consen 289 SITTYKATSNVDGNAYVLKRLHGDRDQS--TNKDTSLVEAWKKLC-HTNVVPFREVFLTYT------------------F 347 (655)
T ss_pred cceeEeeeeccCCceeeeeeeccccccC--cccchHHHHHHHHhc-cCceeehhhhhhhhc------------------c
Confidence 356799987 689999999994332111 111224577889998 899999988765321 2
Q ss_pred cCCeEEEEEecch--hhHHHHHHHhhhhc-------cCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCCCccEEee
Q 003052 564 DDGYIYMVLEYGE--IDLAHMLSQKWKEM-------DGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLLV 634 (853)
Q Consensus 564 d~~~lyLVmEy~~--gdL~~~L~~~~k~~-------~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLKPeNILL~ 634 (853)
.+..+++|++|.+ .+|.+..-...... ...+..++|..+|.|+.||..||.++|+.|+.-+-|.|.+||+.
T Consensus 348 ~D~SlvlvYDYyP~s~TL~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv~ 427 (655)
T KOG3741|consen 348 GDLSLVLVYDYYPSSPTLYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILVT 427 (655)
T ss_pred CcceEEEEEecCCCCchHHHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEee
Confidence 4567899999954 57777654332222 34556789999999999999999999999999999999999996
Q ss_pred cC-cEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHhCCCCC-Cc
Q 003052 635 KG-SLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGRTPF-SE 712 (853)
Q Consensus 635 ~g-~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLtG~~PF-~~ 712 (853)
.. .|+|...|+...+..+. + |-+... .+-|.=.||.+++.|.||..-- ..
T Consensus 428 G~~RIriS~C~i~Dvl~~d~---------~-------~~le~~------------Qq~D~~~lG~ll~aLAt~~~ns~~~ 479 (655)
T KOG3741|consen 428 GKMRIRISGCGIMDVLQEDP---------T-------EPLESQ------------QQNDLRDLGLLLLALATGTENSNRT 479 (655)
T ss_pred CcceEEEecccceeeecCCC---------C-------cchhHH------------hhhhHHHHHHHHHHHhhcccccccc
Confidence 65 88887777655443222 0 122222 2568999999999999996542 11
Q ss_pred chhHHHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCCChhHHhcC
Q 003052 713 YKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQH 764 (853)
Q Consensus 713 ~~~~~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~H 764 (853)
........+.+ ....+.+++++|.-+...++++ -++.+++.|
T Consensus 480 d~~~~s~~~~I---------~~~yS~D~rn~v~yl~s~~~~~-ksI~~llp~ 521 (655)
T KOG3741|consen 480 DSTQSSHLTRI---------TTTYSTDLRNVVEYLESLNFRE-KSIQDLLPM 521 (655)
T ss_pred cchHHHHHHHh---------hhhhhHHHHHHHHHHHhcCccc-ccHHHHHHH
Confidence 11111112221 2346678999999999998887 778888876
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=98.82 E-value=1.7e-08 Score=103.14 Aligned_cols=142 Identities=16% Similarity=0.185 Sum_probs=88.8
Q ss_pred EeEeccCceEEEEEEecCCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCC-CceeEeeehhhhHHHHHHHHhhCCCC
Q 003052 478 GKIGSGGSSEVHKVISSDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGK-NNIIQLIDYEVTEKALLREVLNGSMN 556 (853)
Q Consensus 478 k~LG~G~FG~Vyka~~~~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~h-pNIV~Lid~~~~e~~iL~~l~~~~iv 556 (853)
+.||.|.++.||++...+|..|++|+....... .....+.+|+++++.+..+ ..+.+++.+....
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~-~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~------------- 69 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALL-PSAHDVAREYRVLRALAGTGVPVPKVLALCEDP------------- 69 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccC-cccccHHHHHHHHHHhhCCCCCCCCEEEECCCC-------------
Confidence 568999999999998876678999997654321 1234578999999999753 2345555442110
Q ss_pred CCCCccccCCeEEEEEecchh-hHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcc------------------
Q 003052 557 NKDGRVKDDGYIYMVLEYGEI-DLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIH------------------ 617 (853)
Q Consensus 557 ~~~g~~~d~~~lyLVmEy~~g-dL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLH------------------ 617 (853)
...+..|+||||++| .+.+.+. ...+++.....++.+++.+|.+||
T Consensus 70 ------~~~~~~~~v~e~i~G~~l~~~~~---------~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~ 134 (223)
T cd05154 70 ------SVLGTPFYVMERVDGRVLRDRLL---------RPELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGY 134 (223)
T ss_pred ------CccCCceEEEEEeCCEecCCCCC---------CCCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCch
Confidence 012356899999765 2222110 012233333333333333333333
Q ss_pred --------------------------------------cCceeeCCCCCccEEeec---CcEEEEecccchh
Q 003052 618 --------------------------------------EERIVHSDLKPANFLLVK---GSLKLIDFGIAKA 648 (853)
Q Consensus 618 --------------------------------------s~gIIHRDLKPeNILL~~---g~VKL~DFGlAk~ 648 (853)
...++|+|+.|.|||++. +.+.|+||+.+..
T Consensus 135 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 135 LERQVARWRRQYDASRTDEPPAMERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHHHHHHHHHhhcccccHHHHHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 246899999999999955 4589999998863
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.77 E-value=7.6e-08 Score=98.09 Aligned_cols=130 Identities=23% Similarity=0.225 Sum_probs=87.5
Q ss_pred eEeccCceEEEEEEecCCcEEEEEEEecC-CCChhh-----HhhHHHHHHHHHHhcCC-CceeEeeehhhhHHHHHHHHh
Q 003052 479 KIGSGGSSEVHKVISSDCTIYALKKIKLK-GRDYAT-----AYGFCQEIEYLNKLKGK-NNIIQLIDYEVTEKALLREVL 551 (853)
Q Consensus 479 ~LG~G~FG~Vyka~~~~g~~vAVKkik~~-~~~~~~-----~~~~l~EI~iLkkL~~h-pNIV~Lid~~~~e~~iL~~l~ 551 (853)
.+++|+-+.+|.+.+.+.. +++|.-..+ .+.... ...-.+|.++|.+++.- -++..+++
T Consensus 3 ~i~~GAEa~i~~~~~~g~~-av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~d------------- 68 (204)
T COG3642 3 LIKQGAEAIIYLTDFLGLP-AVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYD------------- 68 (204)
T ss_pred hhhCCcceeEEeeeccCcc-eEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEE-------------
Confidence 4789999999999664433 444443222 222221 12345788888887632 12333333
Q ss_pred hCCCCCCCCccccCCeEEEEEecchh-hHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCCCcc
Q 003052 552 NGSMNNKDGRVKDDGYIYMVLEYGEI-DLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPAN 630 (853)
Q Consensus 552 ~~~iv~~~g~~~d~~~lyLVmEy~~g-dL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLKPeN 630 (853)
.+.....|+|||.+| .|.+.+... . ..+++.+=.-+.-||.+||+|+||.+.|
T Consensus 69 -----------vD~~~~~I~me~I~G~~lkd~l~~~-----------~----~~~~r~vG~~vg~lH~~givHGDLTtsN 122 (204)
T COG3642 69 -----------VDPDNGLIVMEYIEGELLKDALEEA-----------R----PDLLREVGRLVGKLHKAGIVHGDLTTSN 122 (204)
T ss_pred -----------EcCCCCEEEEEEeCChhHHHHHHhc-----------c----hHHHHHHHHHHHHHHhcCeecCCCccce
Confidence 244556899999887 444455432 1 3455666667788999999999999999
Q ss_pred EEeecCcEEEEecccchh
Q 003052 631 FLLVKGSLKLIDFGIAKA 648 (853)
Q Consensus 631 ILL~~g~VKL~DFGlAk~ 648 (853)
|++.++.+.++||||+..
T Consensus 123 iIl~~~~i~~IDfGLg~~ 140 (204)
T COG3642 123 IILSGGRIYFIDFGLGEF 140 (204)
T ss_pred EEEeCCcEEEEECCcccc
Confidence 999998999999999863
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.73 E-value=1.1e-07 Score=96.80 Aligned_cols=142 Identities=23% Similarity=0.239 Sum_probs=96.3
Q ss_pred EEEeEeccCceEEEEEEecCCcEEEEEEEe-cCCCCh-----hhHhhHHHHHHHHHHhcCCC-ceeEeeehhhhHHHHHH
Q 003052 476 RLGKIGSGGSSEVHKVISSDCTIYALKKIK-LKGRDY-----ATAYGFCQEIEYLNKLKGKN-NIIQLIDYEVTEKALLR 548 (853)
Q Consensus 476 ilk~LG~G~FG~Vyka~~~~g~~vAVKkik-~~~~~~-----~~~~~~l~EI~iLkkL~~hp-NIV~Lid~~~~e~~iL~ 548 (853)
.+..|-+|+-+.|+++.+ .|+.+.||.-. +..+.. -...+..+|+++|.++..-- .+.+++
T Consensus 11 ~l~likQGAEArv~~~~~-~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~----------- 78 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSF-SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLI----------- 78 (229)
T ss_pred cceeeeccceeeEeeecc-CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEE-----------
Confidence 456788999999999987 44555566543 222222 12235668999998886210 011111
Q ss_pred HHhhCCCCCCCCccccCCeEEEEEecchh--hHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCC
Q 003052 549 EVLNGSMNNKDGRVKDDGYIYMVLEYGEI--DLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDL 626 (853)
Q Consensus 549 ~l~~~~iv~~~g~~~d~~~lyLVmEy~~g--dL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDL 626 (853)
|.|...-+|+|||.+| .+.+++.... ...........+++.|=..|.-||.++|||+||
T Consensus 79 -------------~~D~~~~~i~ME~~~g~~~vk~~i~~~~------~~~~~d~~~~~~~~~iG~~igklH~ndiiHGDL 139 (229)
T KOG3087|consen 79 -------------FIDTYGGQIYMEFIDGASTVKDFILSTM------EDESEDEGLAELARRIGELIGKLHDNDIIHGDL 139 (229)
T ss_pred -------------EEecCCCeEEEEeccchhHHHHHHHHHc------cCcccchhHHHHHHHHHHHHHHhhhCCeecccc
Confidence 3344455899999887 7888876641 122333333778889999999999999999999
Q ss_pred CCccEEee-cC---cEEEEecccchh
Q 003052 627 KPANFLLV-KG---SLKLIDFGIAKA 648 (853)
Q Consensus 627 KPeNILL~-~g---~VKL~DFGlAk~ 648 (853)
..+||+|. +| .+.|+|||++..
T Consensus 140 TTSNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 140 TTSNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred cccceEEecCCCcCceEEEeecchhc
Confidence 99999993 33 469999999853
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.72 E-value=1.3e-08 Score=119.51 Aligned_cols=154 Identities=21% Similarity=0.316 Sum_probs=114.7
Q ss_pred HhhhhhhhcccC-ceeeCCCCCccEEe-ecCcEEEEecccchhcccCCcccc-------ccccccCccccCchhhccCCC
Q 003052 608 QILEAVNTIHEE-RIVHSDLKPANFLL-VKGSLKLIDFGIAKAIMSDTTNIQ-------RDSQVGTLSYMSPEAFMCNES 678 (853)
Q Consensus 608 QIl~AL~yLHs~-gIIHRDLKPeNILL-~~g~VKL~DFGlAk~~~~~~~~~~-------~~t~~GTp~YmAPEvl~~~~~ 678 (853)
+++.||.|+|.. ++||+.|.|++|.+ ..|.+||+.|+++-.......... .....-...|.|||++.+..
T Consensus 107 ~v~dgl~flh~sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~~~- 185 (700)
T KOG2137|consen 107 NVADGLAFLHRSAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLGTT- 185 (700)
T ss_pred cccchhhhhccCcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcccc-
Confidence 455999999976 89999999999999 567999999999865443211100 01122456899999997642
Q ss_pred CCCCccccCCCccchhhhHHHHHHHH-hCCCCCCcchh-HHHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCC
Q 003052 679 DENGNIIKCGRPSDIWSLGCILYQMV-YGRTPFSEYKT-FWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERW 756 (853)
Q Consensus 679 ~~~~~~~~ys~ksDIWSLGVILyELL-tG~~PF~~~~~-~~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRp 756 (853)
.+.++|+||+||++|-+. .|+..|..... ....+......-....+....+.++++-|.++|..++..||
T Consensus 186 --------~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~~~~~~~~~~s~~~p~el~~~l~k~l~~~~~~rp 257 (700)
T KOG2137|consen 186 --------NTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRNLLNAGAFGYSNNLPSELRESLKKLLNGDSAVRP 257 (700)
T ss_pred --------ccccccceeeeeEEEEEecCCcchhhccCCcchhhhhhcccccccccccccCcHHHHHHHHHHhcCCcccCc
Confidence 457999999999999999 67776654322 22223333333444556677889999999999999999999
Q ss_pred ChhHHhcCCCCCCC
Q 003052 757 RIPQLLQHPFLVPP 770 (853)
Q Consensus 757 Ta~EIL~HPwf~~~ 770 (853)
++.+++..|||...
T Consensus 258 ~~~~l~~~~ff~D~ 271 (700)
T KOG2137|consen 258 TLDLLLSIPFFSDP 271 (700)
T ss_pred chhhhhcccccCCc
Confidence 99999999999754
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.55 E-value=9.6e-07 Score=95.71 Aligned_cols=75 Identities=21% Similarity=0.241 Sum_probs=62.0
Q ss_pred eEEEEEecchh--hHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCCCccEEeec--------C
Q 003052 567 YIYMVLEYGEI--DLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLLVK--------G 636 (853)
Q Consensus 567 ~lyLVmEy~~g--dL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLKPeNILL~~--------g 636 (853)
.-|||||++++ +|.+++... .....++.....++.+|+..+.-||.+||+|+||++.|||+.. .
T Consensus 109 ~s~LVte~l~~~~sL~~~~~~~------~~~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~ 182 (268)
T PRK15123 109 TSFIITEDLAPTISLEDYCADW------ATNPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFPGREEDL 182 (268)
T ss_pred eeEEEEeeCCCCccHHHHHHhh------cccCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEeccccCCCCCc
Confidence 46899999776 688877532 1134567788899999999999999999999999999999953 4
Q ss_pred cEEEEecccch
Q 003052 637 SLKLIDFGIAK 647 (853)
Q Consensus 637 ~VKL~DFGlAk 647 (853)
.+.|+||+.+.
T Consensus 183 ~~~LIDl~r~~ 193 (268)
T PRK15123 183 KLSVIDLHRAQ 193 (268)
T ss_pred eEEEEECCccc
Confidence 79999999885
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.54 E-value=4.3e-07 Score=101.61 Aligned_cols=255 Identities=14% Similarity=0.154 Sum_probs=152.4
Q ss_pred eeEEEeEeccCceEEEEEEecCCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHHHHhhC
Q 003052 474 YQRLGKIGSGGSSEVHKVISSDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLREVLNG 553 (853)
Q Consensus 474 Y~ilk~LG~G~FG~Vyka~~~~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~~l~~~ 553 (853)
-...+.||+|+-+.+|-.-.-.+ .+.|+......-.. .+-+..|.+.-.||-+..-+.|-
T Consensus 13 i~~gr~LgqGgea~ly~l~e~~d--~VAKIYh~Pppa~~-----aqk~a~la~~p~~p~~~~rvaWP------------- 72 (637)
T COG4248 13 IPPGRPLGQGGEADLYTLGEVRD--QVAKIYHAPPPAAQ-----AQKVAELAATPDAPLLNYRVAWP------------- 72 (637)
T ss_pred cCCCccccCCccceeeecchhhc--hhheeecCCCchHH-----HHHHHHhccCCCCcchhhhhccc-------------
Confidence 34456799999999997644221 35577665432211 12334455554454332212221
Q ss_pred CCCCCCCccccCCeEEEEEecchh--hHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCCCccE
Q 003052 554 SMNNKDGRVKDDGYIYMVLEYGEI--DLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANF 631 (853)
Q Consensus 554 ~iv~~~g~~~d~~~lyLVmEy~~g--dL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLKPeNI 631 (853)
...++|. .....+-+.|....+ .+..++.-. .++.+...+.+..+.+.++.|+.+...||.+|.+-+|+.++||
T Consensus 73 -qa~L~G~-~~~~~iGflmP~v~g~~pI~~~y~p~--tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~ 148 (637)
T COG4248 73 -QATLHGG-RRGKVIGFLMPKVSGKEPIHMIYSPA--TRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSF 148 (637)
T ss_pred -HHHhhCC-CccceeEEecccCCCccchhhhcCch--hhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccce
Confidence 1111221 122237788888554 344444322 2334567788999999999999999999999999999999999
Q ss_pred Ee-ecCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHhC-CCC
Q 003052 632 LL-VKGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYG-RTP 709 (853)
Q Consensus 632 LL-~~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLtG-~~P 709 (853)
|+ +++.|.|+|=..-... .........+|.+.|.+||.-.-..... ..-+...|.|.|||++|+||.| +.|
T Consensus 149 lVsd~~~V~LVdsDsfqi~---~ng~~~~cpVg~~eftPPElQ~~~sf~g----~~r~~~hD~FGLavLiF~lL~ggrHP 221 (637)
T COG4248 149 LVSDDSKVVLVDSDSFQIN---ANGTLHLCPVGVSEFTPPELQTLPSFVG----FERTANHDNFGLAVLIFHLLFGGRHP 221 (637)
T ss_pred eeecCceEEEEcccceeec---cCCceEecccCccccCCHHHhccccccc----cCCCccccchhHHHHHHHHHhcCCCC
Confidence 99 5568888874322111 1122334678999999999865221111 1124578999999999999876 999
Q ss_pred CCcch-------hHHHH-----HHhhcCCCCcccC------CCCCChhHHHHHHHhcccC--CCCCCChh
Q 003052 710 FSEYK-------TFWAK-----FKVITDPNHEITY------EPVPNPWLLDLMKKCLAWD--RNERWRIP 759 (853)
Q Consensus 710 F~~~~-------~~~~~-----~kii~~~~~~~~~------~~~~s~~l~dLI~kcL~~D--P~kRpTa~ 759 (853)
|.+.. +.+.. |....+....... ..-.++.+..|..+|+..- +.-||+++
T Consensus 222 ysGI~~~~~ap~p~E~~Ia~g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~ 291 (637)
T COG4248 222 YSGIPLISDAPNPLETDIAHGRFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAK 291 (637)
T ss_pred CCcccccCCCCCcchhhhhcceeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHH
Confidence 96532 11111 1111110111111 1234567888999998753 56799854
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.46 E-value=4.6e-07 Score=97.23 Aligned_cols=138 Identities=28% Similarity=0.259 Sum_probs=96.7
Q ss_pred CceeeEEEeEeccCceEEEEEEecCCcEEEEEEEecCCCCh--------------------hhHhhHHHHHHHHHHhcCC
Q 003052 471 GKLYQRLGKIGSGGSSEVHKVISSDCTIYALKKIKLKGRDY--------------------ATAYGFCQEIEYLNKLKGK 530 (853)
Q Consensus 471 g~~Y~ilk~LG~G~FG~Vyka~~~~g~~vAVKkik~~~~~~--------------------~~~~~~l~EI~iLkkL~~h 530 (853)
+..+.+..+||-|--+.||.|.+..|..+|||.-+...... .......+|.++|.+|...
T Consensus 90 ~~ve~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~ 169 (304)
T COG0478 90 GIVEAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPE 169 (304)
T ss_pred ChHHhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhc
Confidence 34567788999999999999999999999999875432211 1122345677777777533
Q ss_pred -CceeEeeehhhhHHHHHHHHhhCCCCCCCCccccCCeEEEEEecchhh-HHHHHHHhhhhccCCCCCCCHHHHHHHHHH
Q 003052 531 -NNIIQLIDYEVTEKALLREVLNGSMNNKDGRVKDDGYIYMVLEYGEID-LAHMLSQKWKEMDGSNQTLDENWLRFYWQQ 608 (853)
Q Consensus 531 -pNIV~Lid~~~~e~~iL~~l~~~~iv~~~g~~~d~~~lyLVmEy~~gd-L~~~L~~~~k~~~~~~~~LsE~~~r~I~~Q 608 (853)
-.|.+-++ .++..+||||.+|- |.. -+++......++..
T Consensus 170 G~~VP~P~~--------------------------~nRHaVvMe~ieG~eL~~-------------~r~~~en~~~il~~ 210 (304)
T COG0478 170 GVKVPKPIA--------------------------WNRHAVVMEYIEGVELYR-------------LRLDVENPDEILDK 210 (304)
T ss_pred CCCCCCccc--------------------------cccceeeeehcccceeec-------------ccCcccCHHHHHHH
Confidence 23333333 34568999998762 211 12345556666777
Q ss_pred hhhhhhhcccCceeeCCCCCccEEee-cCcEEEEecccch
Q 003052 609 ILEAVNTIHEERIVHSDLKPANFLLV-KGSLKLIDFGIAK 647 (853)
Q Consensus 609 Il~AL~yLHs~gIIHRDLKPeNILL~-~g~VKL~DFGlAk 647 (853)
|+.-+.-+-..||||+|+.+-|||++ +|.+.++||-.+.
T Consensus 211 il~~~~~~~~~GiVHGDlSefNIlV~~dg~~~vIDwPQ~v 250 (304)
T COG0478 211 ILEEVRKAYRRGIVHGDLSEFNILVTEDGDIVVIDWPQAV 250 (304)
T ss_pred HHHHHHHHHHcCccccCCchheEEEecCCCEEEEeCcccc
Confidence 77777777789999999999999995 5699999997654
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.34 E-value=2.8e-06 Score=88.23 Aligned_cols=74 Identities=27% Similarity=0.377 Sum_probs=62.1
Q ss_pred eEEEEEecchh--hHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCCCccEEeecC----cEEE
Q 003052 567 YIYMVLEYGEI--DLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLLVKG----SLKL 640 (853)
Q Consensus 567 ~lyLVmEy~~g--dL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLKPeNILL~~g----~VKL 640 (853)
..|+|+|++++ +|.+++... ..++......++.+++..+.-||.+||+|+||++.|||+..+ .+.|
T Consensus 91 ~s~lite~l~~~~~L~~~~~~~--------~~~~~~~~~~ll~~l~~~i~~lH~~gi~H~Dl~~~NILv~~~~~~~~~~l 162 (206)
T PF06293_consen 91 RSYLITEALPGAQDLRDLLQQW--------EQLDPSQRRELLRALARLIAKLHDAGIYHGDLNPSNILVDPDDGQYRFYL 162 (206)
T ss_pred eEEEEEEeCCCcccHHHHHHhh--------cccchhhHHHHHHHHHHHHHHHHHCcCCCCCCCcccEEEeCCCCceeEEE
Confidence 46899999765 788887653 226777788999999999999999999999999999999544 5999
Q ss_pred Eecccchh
Q 003052 641 IDFGIAKA 648 (853)
Q Consensus 641 ~DFGlAk~ 648 (853)
+||+-++.
T Consensus 163 IDld~~~~ 170 (206)
T PF06293_consen 163 IDLDRMRF 170 (206)
T ss_pred Ecchhcee
Confidence 99998764
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.29 E-value=1e-07 Score=110.91 Aligned_cols=242 Identities=17% Similarity=0.167 Sum_probs=165.8
Q ss_pred ceeeEEEeEeccCceEEEEEEecCCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCc-eeEeeehhhhHHHHHHHH
Q 003052 472 KLYQRLGKIGSGGSSEVHKVISSDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNN-IIQLIDYEVTEKALLREV 550 (853)
Q Consensus 472 ~~Y~ilk~LG~G~FG~Vyka~~~~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpN-IV~Lid~~~~e~~iL~~l 550 (853)
+.|...+.+++|+++++||.+..-.+....+.+... ....-++++|.+++ ||| .+..+
T Consensus 242 kws~~fh~fvK~altknpKkRptaeklL~h~fvs~~-------l~~rl~~eLLdK~n-~P~~~v~~~------------- 300 (829)
T KOG0576|consen 242 KWSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT-------LSRRLAIELLDKVN-NPNPVVRYL------------- 300 (829)
T ss_pred cchHHHHHHHHHHhcCCCccCCChhhheeceeeccc-------hhhHHHHHHHHHcc-CCCCccccc-------------
Confidence 446677789999999999998755555556666543 22446888999998 666 33322
Q ss_pred hhCCCCCCCCccccCCeEEEEEecchhh--HHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCCC
Q 003052 551 LNGSMNNKDGRVKDDGYIYMVLEYGEID--LAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKP 628 (853)
Q Consensus 551 ~~~~iv~~~g~~~d~~~lyLVmEy~~gd--L~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLKP 628 (853)
+.++.+.+.+++|+++++. ... ++......|.+-+...+.+.-+++|+|||+.-=+|||
T Consensus 301 ---------~d~~~E~~~~i~~~i~s~~rs~~~-------~~~~se~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d--- 361 (829)
T KOG0576|consen 301 ---------EDYDGEDYLWIPMRICSTGRSSAL-------EMTVSEIALEQYQFAYPLRKETRPLAELHSSYKVHRD--- 361 (829)
T ss_pred ---------ccCCcccccchhhhhhcCCccccc-------cCChhhHhhhhhhhhhhhhhhcccccccccccccCcc---
Confidence 2356677899999997642 111 1111223344555666777888999999998779999
Q ss_pred ccEEeecCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHhCCC
Q 003052 629 ANFLLVKGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGRT 708 (853)
Q Consensus 629 eNILL~~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLtG~~ 708 (853)
||+..++..|+.||+....+.... ...+..+|+.++|||+...+.+ ....|.|++|+-..+|--|-+
T Consensus 362 -~~l~s~~~~~~~~~~v~~~L~~~~---~~~t~~~~~~~~~pev~~~~~~---------~~~p~~~~~~~~~~~~ap~~p 428 (829)
T KOG0576|consen 362 -NILGSEEEVKLLDFAVPPQLTRTM---KPRTAIGTPEPLAPEVIQENTI---------DGCPDSGSLAVSAIQMAPGLP 428 (829)
T ss_pred -cccccccccccccccCCcccCccc---ccccCCCCCCCCCchhhccccc---------ccCCCccCCCcchhhcCCCCC
Confidence 999999999999999988775432 3557899999999999877654 458899999998888888877
Q ss_pred CCCcchhHHHHHHhhcCCCCcccCC--CCCChhH-HHHHHHhcccCCCCCCChhHHhcCCCCCC
Q 003052 709 PFSEYKTFWAKFKVITDPNHEITYE--PVPNPWL-LDLMKKCLAWDRNERWRIPQLLQHPFLVP 769 (853)
Q Consensus 709 PF~~~~~~~~~~kii~~~~~~~~~~--~~~s~~l-~dLI~kcL~~DP~kRpTa~EIL~HPwf~~ 769 (853)
|-.. +...... +.......... ..+++-. +++...||..-|..|++...++.|.+|..
T Consensus 429 Pr~~--P~~~~~~-~g~~p~s~~L~~~~aw~~~~~~~~~~~~~~g~P~~pkv~mgacfsKvfng 489 (829)
T KOG0576|consen 429 PRSS--PPAVLPM-IGNGPNSPMLTDKSAWSPVFHRDFPAPCLNGLPPTPKVHMGACFSKVFNG 489 (829)
T ss_pred CCCC--CccccCC-CCCCCCccccchhhhcCcccccCCcccccCCCCCCCcchhhHHHHHHhcc
Confidence 7543 1111111 11111001111 1112222 35888999999999999999999999864
|
|
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.29 E-value=2.6e-06 Score=90.65 Aligned_cols=162 Identities=17% Similarity=0.216 Sum_probs=99.5
Q ss_pred EEEeEeccCceEEEEEEecCCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEee-ehhhhHHHHHHHHhhCC
Q 003052 476 RLGKIGSGGSSEVHKVISSDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLI-DYEVTEKALLREVLNGS 554 (853)
Q Consensus 476 ilk~LG~G~FG~Vyka~~~~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Li-d~~~~e~~iL~~l~~~~ 554 (853)
+...|..|--+.||+|...++..+|||+++...............-...+..+. |.-+++ .|...|-.-|.++....
T Consensus 52 ~~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~--~rr~lv~~W~~kEf~NL~R~~eAG 129 (268)
T COG1718 52 LVGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRS--NRRKLVFAWARKEFRNLKRAYEAG 129 (268)
T ss_pred eEeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCC--CHHHHHHHHHHHHHHHHHHHHHcC
Confidence 344678888889999998889999999998765444333322222222222221 222222 23344444454444221
Q ss_pred -CCCCCCccccCCeEEEEEecchhhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhccc-CceeeCCCCCccEE
Q 003052 555 -MNNKDGRVKDDGYIYMVLEYGEIDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHE-ERIVHSDLKPANFL 632 (853)
Q Consensus 555 -iv~~~g~~~d~~~lyLVmEy~~gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs-~gIIHRDLKPeNIL 632 (853)
-+.-.-.+. .-.|||||.+... .-.-. + ....+....+..+..+++..+.-|-. .|+||+||..-|||
T Consensus 130 VrvP~Pi~~~---~nVLvMEfIg~~g--~pAP~---L--kDv~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL 199 (268)
T COG1718 130 VRVPEPIAFR---NNVLVMEFIGDDG--LPAPR---L--KDVPLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNIL 199 (268)
T ss_pred CCCCCceeec---CCeEEEEeccCCC--CCCCC---c--ccCCcCchhHHHHHHHHHHHHHHHHHhcCcccccchhhheE
Confidence 111111111 2379999976431 00000 0 11233444688889999999998887 89999999999999
Q ss_pred eecCcEEEEecccchhc
Q 003052 633 LVKGSLKLIDFGIAKAI 649 (853)
Q Consensus 633 L~~g~VKL~DFGlAk~~ 649 (853)
+.+|.+.|+|||-|-..
T Consensus 200 ~~~~~p~iID~~QaV~~ 216 (268)
T COG1718 200 VHDGEPYIIDVSQAVTI 216 (268)
T ss_pred EECCeEEEEECcccccc
Confidence 99999999999988644
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.11 E-value=1.2e-05 Score=84.66 Aligned_cols=144 Identities=21% Similarity=0.300 Sum_probs=85.9
Q ss_pred CceeeEEEeEeccCceEEEEEEecCCcEEEEEEEecCCCChhhH-hh------HHHHHHHHHHhcCCCceeEeeeh-hhh
Q 003052 471 GKLYQRLGKIGSGGSSEVHKVISSDCTIYALKKIKLKGRDYATA-YG------FCQEIEYLNKLKGKNNIIQLIDY-EVT 542 (853)
Q Consensus 471 g~~Y~ilk~LG~G~FG~Vyka~~~~g~~vAVKkik~~~~~~~~~-~~------~l~EI~iLkkL~~hpNIV~Lid~-~~~ 542 (853)
...|.+++.+-......|.+..- +++.|++|............ .. ..+++..+.++.. ..+..+.++ ...
T Consensus 30 ~~~~~~~kv~k~~~r~~ValIei-~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~-~g~~~~~~~yl~~ 107 (229)
T PF06176_consen 30 DNNYKIIKVFKNTKRNYVALIEI-DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRN-EGFTEPADPYLAA 107 (229)
T ss_pred hCCceEEEeecCCCccEEEEEEE-CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHH-cCccccccceeee
Confidence 45688888887777777766644 56779999887544322111 11 1233333333321 111111110 000
Q ss_pred HHHHHHHHhhCCCCCCCCccccCCeEEEEEecchh-hHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCce
Q 003052 543 EKALLREVLNGSMNNKDGRVKDDGYIYMVLEYGEI-DLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERI 621 (853)
Q Consensus 543 e~~iL~~l~~~~iv~~~g~~~d~~~lyLVmEy~~g-dL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gI 621 (853)
++ -.+.-....+|||||++| .|.++. .+++ .+...|..+|.-||..|+
T Consensus 108 ek---------------k~~~~~~~~~ll~EYIeG~~l~d~~------------~i~e----~~~~ki~~~ikqlH~~G~ 156 (229)
T PF06176_consen 108 EK---------------KIFRYTSSYVLLMEYIEGVELNDIE------------DIDE----DLAEKIVEAIKQLHKHGF 156 (229)
T ss_pred ee---------------eeccceeEEEEEEEEecCeecccch------------hcCH----HHHHHHHHHHHHHHHcCC
Confidence 11 012223456799999887 333221 1233 234567788999999999
Q ss_pred eeCCCCCccEEeecCcEEEEecccch
Q 003052 622 VHSDLKPANFLLVKGSLKLIDFGIAK 647 (853)
Q Consensus 622 IHRDLKPeNILL~~g~VKL~DFGlAk 647 (853)
.|+|+.|.|+++.++.++++||+..+
T Consensus 157 ~HGD~hpgNFlv~~~~i~iID~~~k~ 182 (229)
T PF06176_consen 157 YHGDPHPGNFLVSNNGIRIIDTQGKR 182 (229)
T ss_pred ccCCCCcCcEEEECCcEEEEECcccc
Confidence 99999999999998899999998765
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.10 E-value=1.9e-05 Score=82.69 Aligned_cols=144 Identities=12% Similarity=0.141 Sum_probs=98.8
Q ss_pred EeccCceEEEEEEecCCcEEEEEEEecCC-CC---hhhHhhHHHHHHHHHHhcCCC-ceeEeeehhhhHHHHHHHHhhCC
Q 003052 480 IGSGGSSEVHKVISSDCTIYALKKIKLKG-RD---YATAYGFCQEIEYLNKLKGKN-NIIQLIDYEVTEKALLREVLNGS 554 (853)
Q Consensus 480 LG~G~FG~Vyka~~~~g~~vAVKkik~~~-~~---~~~~~~~l~EI~iLkkL~~hp-NIV~Lid~~~~e~~iL~~l~~~~ 554 (853)
-|+||.+-|+.....+ +.|-+|.-.... .. .-....|.+|+..|.+|.... .+.+.+ +...
T Consensus 26 ~~rgG~SgV~r~~~~g-~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~------------ 91 (216)
T PRK09902 26 YRRNGMSGVQCVERNG-KKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEA------------ 91 (216)
T ss_pred cCCCCcceEEEEEeCC-cEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeee------------
Confidence 4678888898876533 357777764111 11 223456889999999997421 133333 1100
Q ss_pred CCCCCCccccCCeEEEEEecch--hhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCCCccEE
Q 003052 555 MNNKDGRVKDDGYIYMVLEYGE--IDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANFL 632 (853)
Q Consensus 555 iv~~~g~~~d~~~lyLVmEy~~--gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLKPeNIL 632 (853)
........-+||+|-++ .+|.+++.+. .-...++.....++.+|+..|.-||+.|+.|+|+.+.|||
T Consensus 92 -----~k~~~~~rA~LVTe~L~g~~~L~~~l~~~------~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIl 160 (216)
T PRK09902 92 -----VKIEGEWRALLVTEDMAGFISIADWYAQH------AVSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIY 160 (216)
T ss_pred -----eccCCceEEEEEEEeCCCCccHHHHHhcC------CcCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhhee
Confidence 00111234689999766 4888887543 1235678888899999999999999999999999999999
Q ss_pred ee-cCc--EEEEecccchh
Q 003052 633 LV-KGS--LKLIDFGIAKA 648 (853)
Q Consensus 633 L~-~g~--VKL~DFGlAk~ 648 (853)
+. +|. ++++||--++.
T Consensus 161 l~~~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 161 VKTEGKAEAGFLDLEKSRR 179 (216)
T ss_pred ecCCCCeeEEEEEhhccch
Confidence 94 665 99999987654
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.08 E-value=3.6e-05 Score=78.75 Aligned_cols=77 Identities=21% Similarity=0.343 Sum_probs=52.2
Q ss_pred EEeEeccCceEEEEEEecCCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCC-ceeEeeehhhhHHHHHHHHhhCCC
Q 003052 477 LGKIGSGGSSEVHKVISSDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKN-NIIQLIDYEVTEKALLREVLNGSM 555 (853)
Q Consensus 477 lk~LG~G~FG~Vyka~~~~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hp-NIV~Lid~~~~e~~iL~~l~~~~i 555 (853)
++.|+.|..+.||++...+ ..+++|..... .....+.+|..+++.|..+. .+.+++.+...
T Consensus 2 i~~l~~G~~n~~~~v~~~~-~~~vlK~~~~~----~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~------------- 63 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDD-GRYVLKFYRPP----DAAERLRREAAVLRQLAEHGIPVPRVLAFDTS------------- 63 (239)
T ss_dssp EEEEEESSSSEEEEEEETT-SEEEEEEESSH----HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEE-------------
T ss_pred CccCCCCCeeeEEEEEECC-cEEEEEEeCCC----CCHHHHHHHHHHHHHHHhcCCCCceEEeeccc-------------
Confidence 4679999999999999877 58999997643 33445778999999887542 24455542110
Q ss_pred CCCCCccccCCeEEEEEecchh
Q 003052 556 NNKDGRVKDDGYIYMVLEYGEI 577 (853)
Q Consensus 556 v~~~g~~~d~~~lyLVmEy~~g 577 (853)
.......|++|++++|
T Consensus 64 ------~~~~~~~~~~~~~i~g 79 (239)
T PF01636_consen 64 ------DEFNGFPYLLMEYIPG 79 (239)
T ss_dssp ------TEETSEEEEEEEEESS
T ss_pred ------ccccccceEEEEEecc
Confidence 1233458999999665
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=97.89 E-value=9.3e-05 Score=78.24 Aligned_cols=139 Identities=17% Similarity=0.164 Sum_probs=78.3
Q ss_pred EeEeccCceEEEEEEecCCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCc-eeEeeehhhhHHHHHHHHhhCCCC
Q 003052 478 GKIGSGGSSEVHKVISSDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNN-IIQLIDYEVTEKALLREVLNGSMN 556 (853)
Q Consensus 478 k~LG~G~FG~Vyka~~~~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpN-IV~Lid~~~~e~~iL~~l~~~~iv 556 (853)
..||+|..+.||+.. +..+++|...... ....+.+|.++++.+....- +.+.+++
T Consensus 7 ~~i~~G~t~~~y~~~---~~~~VlR~~~~~~----~~~~i~~E~~~l~~l~~~glpvP~~~~~----------------- 62 (226)
T TIGR02172 7 TQTGEGGNGESYTHK---TGKWMLKLYNPGF----DKETIKREFDASRKVFSLGIPTPHPFDL----------------- 62 (226)
T ss_pred eeecCCCCcceeEec---CCCEEEEeCCCCC----CHHHHHHHHHHHHHHHHcCCCCCceEEE-----------------
Confidence 468999999999842 4457788876432 22346789999999874321 3444433
Q ss_pred CCCCccccCCeEEEEEecchhh----------------HHHHHHHhhhhccC---CCCCCCHHH----------------
Q 003052 557 NKDGRVKDDGYIYMVLEYGEID----------------LAHMLSQKWKEMDG---SNQTLDENW---------------- 601 (853)
Q Consensus 557 ~~~g~~~d~~~lyLVmEy~~gd----------------L~~~L~~~~k~~~~---~~~~LsE~~---------------- 601 (853)
..+.+.+++|||+++|. +...+.+..+.+.. ....+....
T Consensus 63 -----~~~~~~~glv~e~i~G~~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~ 137 (226)
T TIGR02172 63 -----VEDGGRLGLIYELIVGKRSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKD 137 (226)
T ss_pred -----EecCCeeeeeeeecCCccchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHH
Confidence 23445567899997662 11222221121221 111111111
Q ss_pred HHHHHHHhhhhhhhcccCceeeCCCCCccEEeecCcEEEEecccch
Q 003052 602 LRFYWQQILEAVNTIHEERIVHSDLKPANFLLVKGSLKLIDFGIAK 647 (853)
Q Consensus 602 ~r~I~~QIl~AL~yLHs~gIIHRDLKPeNILL~~g~VKL~DFGlAk 647 (853)
.+..+...+..+. -...++|+|+.|.||+++++.+.|+||+.+.
T Consensus 138 ~~~~l~~~l~~~~--~~~~~~HgD~~~~Nii~~~~~~~iIDwe~a~ 181 (226)
T TIGR02172 138 YKEKARAFIKEVP--DTSTCLHGDFQIGNLITSGKGTYWIDLGDFG 181 (226)
T ss_pred HHHHHHHHHHhCC--CCCceEecCCCCCcEEEcCCCcEEEechhcC
Confidence 1111111111110 0125799999999999976559999999875
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=97.81 E-value=0.00024 Score=74.07 Aligned_cols=146 Identities=25% Similarity=0.314 Sum_probs=97.2
Q ss_pred CceeeEEEeEeccCc-eEEEEEEecCCcEEEEEEEec---CCC----------Ch------hhHhhHHHHHHHHHHhcCC
Q 003052 471 GKLYQRLGKIGSGGS-SEVHKVISSDCTIYALKKIKL---KGR----------DY------ATAYGFCQEIEYLNKLKGK 530 (853)
Q Consensus 471 g~~Y~ilk~LG~G~F-G~Vyka~~~~g~~vAVKkik~---~~~----------~~------~~~~~~l~EI~iLkkL~~h 530 (853)
+..++.++.||.|.- |.||++.. +|+.||+|+++. ... .. .....|..|-+...+|+..
T Consensus 36 ~~~I~flefLg~g~~~~~V~kv~I-~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~ 114 (207)
T PF13095_consen 36 GDDIEFLEFLGHGSHDGYVFKVEI-DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEA 114 (207)
T ss_pred CCcEeeeeecCCCCceeEEEEEEE-CCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhc
Confidence 367899999999999 99999987 556899999422 111 00 2223577899998888743
Q ss_pred --Cce--eEeeehh-hhHHHHHHHHhhCCCCCCCCccccCCeEEEEEecchhhHHHHHHHhhhhccCCCCCCCHHHHHHH
Q 003052 531 --NNI--IQLIDYE-VTEKALLREVLNGSMNNKDGRVKDDGYIYMVLEYGEIDLAHMLSQKWKEMDGSNQTLDENWLRFY 605 (853)
Q Consensus 531 --pNI--V~Lid~~-~~e~~iL~~l~~~~iv~~~g~~~d~~~lyLVmEy~~gdL~~~L~~~~k~~~~~~~~LsE~~~r~I 605 (853)
.++ ++.++|. .++..-+..+... ...........||.||.... ..+... -
T Consensus 115 ~~e~~~Avkc~Gyl~L~~~~q~~~~~~~-----~~~~~~~~~~aIVKD~v~~~----------------~~~~~~----~ 169 (207)
T PF13095_consen 115 GREGLWAVKCHGYLLLTEDQQFEQLRQR-----GSDHRPLPIRAIVKDFVPDD----------------PPLQIR----D 169 (207)
T ss_pred cccCceEEEeeEEEEEchHHHHHHhhcc-----cccCCCCccEEEEEeecCCc----------------cccchh----H
Confidence 344 8999985 2312222222110 22233444568999996532 112222 2
Q ss_pred HHHhhhhhhhcccCceeeCCCCCccEEeecCcEEEEecccc
Q 003052 606 WQQILEAVNTIHEERIVHSDLKPANFLLVKGSLKLIDFGIA 646 (853)
Q Consensus 606 ~~QIl~AL~yLHs~gIIHRDLKPeNILL~~g~VKL~DFGlA 646 (853)
+.+|++-|..+|..||+=+|+|+.|.. .-||+|||.+
T Consensus 170 ~~~~~~dl~~~~k~gI~~~Dv~~~ny~----~G~lvDfs~~ 206 (207)
T PF13095_consen 170 IPQMLRDLKILHKLGIVPRDVKPRNYR----GGKLVDFSSS 206 (207)
T ss_pred HHHHHHHHHHHHHCCeeeccCcccccc----CCEEEecccC
Confidence 457888889999999999999999976 3489999864
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.76 E-value=5.3e-05 Score=89.07 Aligned_cols=158 Identities=20% Similarity=0.289 Sum_probs=88.0
Q ss_pred eEeccCceEEEEEEecCCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhc----C-CCc-----eeEeeehh--------
Q 003052 479 KIGSGGSSEVHKVISSDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLK----G-KNN-----IIQLIDYE-------- 540 (853)
Q Consensus 479 ~LG~G~FG~Vyka~~~~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~----~-hpN-----IV~Lid~~-------- 540 (853)
-|+.++-|.||+|+.++|+.||||+....-.. .+...+.+|+.+- . .+. +..+++-+
T Consensus 132 PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~-----~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~El 206 (517)
T COG0661 132 PIASASIAQVHRAVLKSGEEVAVKVQRPGIRE-----RIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREEL 206 (517)
T ss_pred chhhhhHhhheeEEecCCCEEEEEecCCChHH-----HHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHh
Confidence 48999999999999999999999999765332 2333344444331 0 111 11111110
Q ss_pred --hhHHHHHHH----HhhCCCCCCCCcc-ccCCeEEEEEecchh-hHHHHHHHhhhhccCC-CCCCCHHHHHHHHHHhhh
Q 003052 541 --VTEKALLRE----VLNGSMNNKDGRV-KDDGYIYMVLEYGEI-DLAHMLSQKWKEMDGS-NQTLDENWLRFYWQQILE 611 (853)
Q Consensus 541 --~~e~~iL~~----l~~~~iv~~~g~~-~d~~~lyLVmEy~~g-dL~~~L~~~~k~~~~~-~~~LsE~~~r~I~~QIl~ 611 (853)
..|.....+ +.+...+.....+ +-.+.-.|+|||.+| -+.+...-+ . .+. ...+.+..++.++.|++
T Consensus 207 Dy~~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~--~-~g~d~k~ia~~~~~~f~~q~~- 282 (517)
T COG0661 207 DYRREAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALK--S-AGIDRKELAELLVRAFLRQLL- 282 (517)
T ss_pred CHHHHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHH--h-cCCCHHHHHHHHHHHHHHHHH-
Confidence 011111111 1112222222222 223455799999776 444432111 0 000 01233344444444443
Q ss_pred hhhhcccCceeeCCCCCccEEe-ecCcEEEEecccchhccc
Q 003052 612 AVNTIHEERIVHSDLKPANFLL-VKGSLKLIDFGIAKAIMS 651 (853)
Q Consensus 612 AL~yLHs~gIIHRDLKPeNILL-~~g~VKL~DFGlAk~~~~ 651 (853)
..|++|.|..|.||++ .+|.+.+.|||+...+..
T Consensus 283 ------~dgffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~ 317 (517)
T COG0661 283 ------RDGFFHADPHPGNILVRSDGRIVLLDFGIVGRLDP 317 (517)
T ss_pred ------hcCccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence 3899999999999999 578999999999876643
|
|
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.75 E-value=6.2e-05 Score=76.69 Aligned_cols=128 Identities=22% Similarity=0.196 Sum_probs=87.6
Q ss_pred eEEEeEeccCceEEEEEEecCCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHHHHhhCC
Q 003052 475 QRLGKIGSGGSSEVHKVISSDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLREVLNGS 554 (853)
Q Consensus 475 ~ilk~LG~G~FG~Vyka~~~~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~~l~~~~ 554 (853)
+..+.||+|.+|.||++.+..+ .+|+|+-..+. ....+..|.++|..+.+-.--.+++.|-
T Consensus 25 ~v~~~L~KG~~s~Vyl~~~~~~-~~a~Kvrr~ds----~r~~l~kEakiLeil~g~~~~p~vy~yg-------------- 85 (201)
T COG2112 25 RVEKELAKGTTSVVYLGEWRGG-EVALKVRRRDS----PRRNLEKEAKILEILAGEGVTPEVYFYG-------------- 85 (201)
T ss_pred hhhhhhhcccccEEEEeeccCc-eEEEEEecCCc----chhhHHHHHHHHHHhhhcCCCceEEEec--------------
Confidence 4556799999999999988554 67888876443 3446789999999998765556666552
Q ss_pred CCCCCCccccCCeEEEEEecchh-hHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCC-Cc-cE
Q 003052 555 MNNKDGRVKDDGYIYMVLEYGEI-DLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLK-PA-NF 631 (853)
Q Consensus 555 iv~~~g~~~d~~~lyLVmEy~~g-dL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLK-Pe-NI 631 (853)
..++.|||..| .|...-.. .. +.-+..+++.---|-..||-|..|. |. ||
T Consensus 86 ------------~~~i~me~i~G~~L~~~~~~-----------~~----rk~l~~vlE~a~~LD~~GI~H~El~~~~k~v 138 (201)
T COG2112 86 ------------EDFIRMEYIDGRPLGKLEIG-----------GD----RKHLLRVLEKAYKLDRLGIEHGELSRPWKNV 138 (201)
T ss_pred ------------hhhhhhhhhcCcchhhhhhc-----------cc----HHHHHHHHHHHHHHHHhccchhhhcCCceeE
Confidence 23566999776 44433211 11 2233455566455666799999887 44 56
Q ss_pred EeecCcEEEEecccchh
Q 003052 632 LLVKGSLKLIDFGIAKA 648 (853)
Q Consensus 632 LL~~g~VKL~DFGlAk~ 648 (853)
++.++.+.|+||.-|+.
T Consensus 139 lv~~~~~~iIDFd~At~ 155 (201)
T COG2112 139 LVNDRDVYIIDFDSATF 155 (201)
T ss_pred EecCCcEEEEEccchhh
Confidence 66777999999998873
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=97.53 E-value=0.00012 Score=90.83 Aligned_cols=208 Identities=24% Similarity=0.316 Sum_probs=130.5
Q ss_pred hHHHHHHHHHHhcCCCceeEeeehhhhHHHHHHHHhhCCCCCCCCccccCCeEEEEEecchh-hHHHHHHHhhhhccCCC
Q 003052 516 GFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLREVLNGSMNNKDGRVKDDGYIYMVLEYGEI-DLAHMLSQKWKEMDGSN 594 (853)
Q Consensus 516 ~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~~l~~~~iv~~~g~~~d~~~lyLVmEy~~g-dL~~~L~~~~k~~~~~~ 594 (853)
...-|+..+.++. |+|++.++.|...+.. .. -.+.+..|+|.. ++...+.. -
T Consensus 228 ~~E~e~~~l~k~~-~~n~~~~~~~~le~~~-----------------~g-~~~~v~~~~~s~~~~~~~~q~--------v 280 (1351)
T KOG1035|consen 228 TTEIELESLSKIA-HDNLGGYFVYGLERLF-----------------RG-IVLDVLQEICSKVELRSLLQS--------V 280 (1351)
T ss_pred HHHHHHHHHHhhc-cccccceeEEeehhhc-----------------ch-HHHHHHHhhcCccchHHHHhh--------c
Confidence 3445677777777 8899998887432210 00 011233344443 44444443 2
Q ss_pred CCCCHHHHHHHHHHhhhhhhhcccCceeeCCCCCc---cEEe-ecCcEEEE--ecccchhcccCCccccccccccCcccc
Q 003052 595 QTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPA---NFLL-VKGSLKLI--DFGIAKAIMSDTTNIQRDSQVGTLSYM 668 (853)
Q Consensus 595 ~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLKPe---NILL-~~g~VKL~--DFGlAk~~~~~~~~~~~~t~~GTp~Ym 668 (853)
+.++...++.+..+++.||.|+|++...|.-|... +... .++.+.+. ||+..+.+...... ....-...|.
T Consensus 281 ~~i~~~~~r~~~~~~~~GL~~~h~~~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~---~~~~~~~~~~ 357 (1351)
T KOG1035|consen 281 GSIPLETLRILHQKLLEGLAYLHSLSLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKS---FSDLLAEIRN 357 (1351)
T ss_pred cccCHHHHHHHHHHHhhhHHHHHHhccceeEEecccccccccCccceeecchhhhcccccCCCcccc---hhhcCccccc
Confidence 67899999999999999999999984433332222 1111 12345555 88888766443221 2345566788
Q ss_pred CchhhccCCCCCCCccccCCCccchhhhHHHHHHHHhCCCCCCcchhHHHHHHhhcCCCCcccCCCCCChhHHHHHHHhc
Q 003052 669 SPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGRTPFSEYKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCL 748 (853)
Q Consensus 669 APEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLtG~~PF~~~~~~~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL 748 (853)
++|....+.. ..+...|+|.+|..+..+..|..+-....... ..+ +........+++.+|+
T Consensus 358 ~~e~~~~~~~-------~~~r~~dL~~lgll~~~~~~~~~i~~~~~~~~---~~l---------~~~~~~~~~d~~~~~~ 418 (1351)
T KOG1035|consen 358 ADEDLKENTA-------KKSRLTDLWCLGLLLLQLSQGEDISEKSAVPV---SLL---------DVLSTSELLDALPKCL 418 (1351)
T ss_pred cccccccccc-------hhhhhhHHHHHHHHHhhhhhcCcccccccchh---hhh---------ccccchhhhhhhhhhc
Confidence 8887765543 23456799999999999998866532211111 010 1111115789999999
Q ss_pred ccCCCCCCChhHHhcCCCCCCCCC
Q 003052 749 AWDRNERWRIPQLLQHPFLVPPVS 772 (853)
Q Consensus 749 ~~DP~kRpTa~EIL~HPwf~~~~~ 772 (853)
.-+.++|+.+.+++.|+|...+..
T Consensus 419 ~~~~~~Rl~~~~ll~~~f~~~~~~ 442 (1351)
T KOG1035|consen 419 DEDSEERLSALELLTHPFLRFPTD 442 (1351)
T ss_pred chhhhhccchhhhhhchhcccccc
Confidence 999999999999999999976543
|
|
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.49 E-value=0.0017 Score=68.03 Aligned_cols=58 Identities=12% Similarity=0.049 Sum_probs=38.4
Q ss_pred EEeEeccCceEEEEEEecC--CcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEee
Q 003052 477 LGKIGSGGSSEVHKVISSD--CTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLI 537 (853)
Q Consensus 477 lk~LG~G~FG~Vyka~~~~--g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Li 537 (853)
++.|..|-...||++...+ ++.|++|+....... .....+|+.+++.+..+..+.+++
T Consensus 3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~---~~d~~~E~~~~~~l~~~gl~P~v~ 62 (235)
T cd05157 3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTEL---IIDRERELRIHKLLSKHGLAPKLY 62 (235)
T ss_pred EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCccc---eecHHHHHHHHHHHHhCCCCCeEE
Confidence 4568888899999998764 567888876533211 122347999999986544444444
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=97.47 E-value=0.00068 Score=71.54 Aligned_cols=70 Identities=26% Similarity=0.293 Sum_probs=45.4
Q ss_pred EeccCc-eEEEEEEecCCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHHHHhhCCCCCC
Q 003052 480 IGSGGS-SEVHKVISSDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLREVLNGSMNNK 558 (853)
Q Consensus 480 LG~G~F-G~Vyka~~~~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~~l~~~~iv~~ 558 (853)
|-.|.+ ..||++...+ ..+.||+..... ...+.+|+++++.+..+--+.+++++.
T Consensus 6 ~~~g~~~~~v~~~~~~~-~~~~vk~~~~~~-----~~~~~~E~~~l~~l~~~~~vP~v~~~~------------------ 61 (244)
T cd05150 6 VTEGQSGATVYRLDGKN-PGLYLKIAPSGP-----TYELEREAERLRWLAGKLPVPEVIDYG------------------ 61 (244)
T ss_pred cCCCCCcCeEEEEcCCC-CcEEEEecCCCc-----ccchHHHHHHHHHHHhcCCCCeEEEEE------------------
Confidence 445555 7899997643 567777765432 224668999999997654455555542
Q ss_pred CCccccCCeEEEEEecchh
Q 003052 559 DGRVKDDGYIYMVLEYGEI 577 (853)
Q Consensus 559 ~g~~~d~~~lyLVmEy~~g 577 (853)
...+..++|||+.+|
T Consensus 62 ----~~~~~~~lv~e~i~G 76 (244)
T cd05150 62 ----SDDGRAWLLTSAVPG 76 (244)
T ss_pred ----ecCCccEEEEEeeCC
Confidence 223456899999665
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=97.45 E-value=0.0006 Score=85.00 Aligned_cols=82 Identities=17% Similarity=0.189 Sum_probs=52.1
Q ss_pred EEeEeccCceEEEEEEecCC---cEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCc--eeEeeehhhhHHHHHHHHh
Q 003052 477 LGKIGSGGSSEVHKVISSDC---TIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNN--IIQLIDYEVTEKALLREVL 551 (853)
Q Consensus 477 lk~LG~G~FG~Vyka~~~~g---~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpN--IV~Lid~~~~e~~iL~~l~ 551 (853)
++.|+.|.++.+|+....++ ..+++|+...... ......+.+|+++|+.|..+.+ |.+++.++...
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~-~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~-------- 113 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKL-LQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDA-------- 113 (822)
T ss_pred EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCcc-CccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCC--------
Confidence 46689999999999876543 3677777643321 1223457799999999974444 35555542110
Q ss_pred hCCCCCCCCccccCCeEEEEEecchhh
Q 003052 552 NGSMNNKDGRVKDDGYIYMVLEYGEID 578 (853)
Q Consensus 552 ~~~iv~~~g~~~d~~~lyLVmEy~~gd 578 (853)
...+..|+||||++|.
T Consensus 114 -----------~v~G~~flVME~v~G~ 129 (822)
T PLN02876 114 -----------SVIGTAFYIMEYLEGR 129 (822)
T ss_pred -----------CcCCCceEEEEecCCc
Confidence 0113568999997663
|
|
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.35 E-value=0.0015 Score=77.07 Aligned_cols=162 Identities=15% Similarity=0.154 Sum_probs=90.3
Q ss_pred EeEeccCceEEEEEEecCCcEEEEEEEecCCCCh--hhHhhHHHHHHHHHHhcCCCceeEeee-----------hhh---
Q 003052 478 GKIGSGGSSEVHKVISSDCTIYALKKIKLKGRDY--ATAYGFCQEIEYLNKLKGKNNIIQLID-----------YEV--- 541 (853)
Q Consensus 478 k~LG~G~FG~Vyka~~~~g~~vAVKkik~~~~~~--~~~~~~l~EI~iLkkL~~hpNIV~Lid-----------~~~--- 541 (853)
+.||.-+.|.||+|+.++|..||||+-+..-... .....+.-=.+++.++-.+-++.-++| |..
T Consensus 167 ~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA~ 246 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEAK 246 (538)
T ss_pred chhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHHH
Confidence 3599999999999999999999999987654332 111122223344444443333222222 110
Q ss_pred hHHHHHHHHhhCC---CCCCCCcccc-CCeEEEEEecchh----hHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhh
Q 003052 542 TEKALLREVLNGS---MNNKDGRVKD-DGYIYMVLEYGEI----DLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAV 613 (853)
Q Consensus 542 ~e~~iL~~l~~~~---iv~~~g~~~d-~~~lyLVmEy~~g----dL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL 613 (853)
+-.++.+.+.+-+ .+.....+.+ ...-.|+|||++| |+ +.|.+. .++...+...+.++..
T Consensus 247 Nae~~~~~f~~~~~~~~V~VP~Vy~~~st~RVLtME~~~G~~i~Dl-~~i~~~---------gi~~~~i~~~l~~~~~-- 314 (538)
T KOG1235|consen 247 NAERFRENFKDFSLLTYVLVPKVYWDLSTKRVLTMEYVDGIKINDL-DAIDKR---------GISPHDILNKLVEAYL-- 314 (538)
T ss_pred hHHHHHHHHHhcccccceeCCeehhhcCcceEEEEEecCCccCCCH-HHHHHc---------CCCHHHHHHHHHHHHH--
Confidence 0011112222333 1222233322 2356899999776 44 344332 3444433322222221
Q ss_pred hhcccCceeeCCCCCccEEee-----cCcEEEEecccchhccc
Q 003052 614 NTIHEERIVHSDLKPANFLLV-----KGSLKLIDFGIAKAIMS 651 (853)
Q Consensus 614 ~yLHs~gIIHRDLKPeNILL~-----~g~VKL~DFGlAk~~~~ 651 (853)
.-|-..|++|+|-.|.||++. ++.+.|.|||+...+..
T Consensus 315 ~qIf~~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~ 357 (538)
T KOG1235|consen 315 EQIFKTGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISH 357 (538)
T ss_pred HHHHhcCCccCCCCCCcEEEecCCCCCccEEEEcccccccccH
Confidence 222346899999999999996 34899999999986643
|
|
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.29 E-value=0.0032 Score=72.19 Aligned_cols=63 Identities=19% Similarity=0.137 Sum_probs=42.8
Q ss_pred EEeEeccCceEEEEEEecCC-cEEEEEEEecC----CCC-hhhHhhHHHHHHHHHHhcCC--CceeEeeeh
Q 003052 477 LGKIGSGGSSEVHKVISSDC-TIYALKKIKLK----GRD-YATAYGFCQEIEYLNKLKGK--NNIIQLIDY 539 (853)
Q Consensus 477 lk~LG~G~FG~Vyka~~~~g-~~vAVKkik~~----~~~-~~~~~~~l~EI~iLkkL~~h--pNIV~Lid~ 539 (853)
.+.||.|.+..||++...+| +.++||.-... ... .....+...|.+.|+.+... .++.+++.+
T Consensus 31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~ 101 (401)
T PRK09550 31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY 101 (401)
T ss_pred eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE
Confidence 35799999999999999776 47899985321 111 12344567888888887532 356666654
|
|
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.25 E-value=0.00048 Score=77.10 Aligned_cols=165 Identities=20% Similarity=0.224 Sum_probs=97.8
Q ss_pred eeEEEeEeccCceEEEEEEecCCcEEEEEEEecCCCChhhHhhH-HHHHHHHHHhcCCCceeEeee-hhhhHHHHHHHHh
Q 003052 474 YQRLGKIGSGGSSEVHKVISSDCTIYALKKIKLKGRDYATAYGF-CQEIEYLNKLKGKNNIIQLID-YEVTEKALLREVL 551 (853)
Q Consensus 474 Y~ilk~LG~G~FG~Vyka~~~~g~~vAVKkik~~~~~~~~~~~~-l~EI~iLkkL~~hpNIV~Lid-~~~~e~~iL~~l~ 551 (853)
-.+-+.|..|--+-||.|...+|..+|||+++...........+ .-|.++-.-.. ..|--+++. |-..|.+-|.++.
T Consensus 146 ~~inGCiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyc-k~NPRKMVk~WAEKE~RNLkRl~ 224 (520)
T KOG2270|consen 146 VEINGCISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYC-KHNPRKMVKTWAEKEMRNLKRLN 224 (520)
T ss_pred eecccccccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccc-cCCcHHHHHHHHHHHHHHHHHHH
Confidence 34445688899999999999999999999987542211111111 01111111000 012122222 2233444444444
Q ss_pred hCCCCCCCCccccCCeEEEEEecchhhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhccc-CceeeCCCCCcc
Q 003052 552 NGSMNNKDGRVKDDGYIYMVLEYGEIDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHE-ERIVHSDLKPAN 630 (853)
Q Consensus 552 ~~~iv~~~g~~~d~~~lyLVmEy~~gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs-~gIIHRDLKPeN 630 (853)
...+... ....- ....|||+|++.+-.-. -+ -....++...++.+..|++.-+.-|.. .++||.||.--|
T Consensus 225 ~aGIP~P-ePIlL-k~hVLVM~FlGrdgw~a--Pk-----LKd~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADLSEfN 295 (520)
T KOG2270|consen 225 NAGIPCP-EPILL-KNHVLVMEFLGRDGWAA--PK-----LKDASLSTSKARELYQQCVRIMRRLYQKCRLVHADLSEFN 295 (520)
T ss_pred hcCCCCC-Cceee-ecceEeeeeccCCCCcC--cc-----cccccCChHHHHHHHHHHHHHHHHHHHHhceeccchhhhh
Confidence 3332111 11111 12479999987421111 01 123467778889999999988888865 589999999999
Q ss_pred EEeecCcEEEEecccchh
Q 003052 631 FLLVKGSLKLIDFGIAKA 648 (853)
Q Consensus 631 ILL~~g~VKL~DFGlAk~ 648 (853)
+|+.+|.+.|+|.+.+-.
T Consensus 296 ~LyhdG~lyiIDVSQSVE 313 (520)
T KOG2270|consen 296 LLYHDGKLYIIDVSQSVE 313 (520)
T ss_pred heEECCEEEEEEcccccc
Confidence 999999999999987754
|
|
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=97.21 E-value=0.00012 Score=92.40 Aligned_cols=187 Identities=19% Similarity=0.054 Sum_probs=126.7
Q ss_pred CeEEEEEecch-hhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccC-----ceeeCCCCCccEEee-cCcE
Q 003052 566 GYIYMVLEYGE-IDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEE-----RIVHSDLKPANFLLV-KGSL 638 (853)
Q Consensus 566 ~~lyLVmEy~~-gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~-----gIIHRDLKPeNILL~-~g~V 638 (853)
...|.+++|+. |++++.|.+...+ ...+.+..+-...++.+.+..-+|.. -.+|++||+-|.+|. +-.+
T Consensus 1304 ~ee~~r~~~~~~g~~f~iIikg~ee----~~~ld~~~v~~~~kvsvl~~~~~ls~tnlg~T~v~~~Lkf~lpmIVtny~v 1379 (2724)
T KOG1826|consen 1304 TEEYIRSLYVEFGKLFSIIIKGLEE----SPDLDRSPVHLRHKVSVLNRNVILSLTNLGNTNVSKSLKFTLPMIVTNYNV 1379 (2724)
T ss_pred hHHHHHHHHHHHhHHHHHHHhcccc----CCcchhchHHHHHHHHHhccchhhhcccCCccchhhhhhhhccceecCCcc
Confidence 34578899965 6888888765332 24455555555566668888887764 279999999999995 5589
Q ss_pred EEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHhCCCCCCcchhHHH
Q 003052 639 KLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGRTPFSEYKTFWA 718 (853)
Q Consensus 639 KL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLtG~~PF~~~~~~~~ 718 (853)
|++++|+.+..... .......++++.|++|++... +.++.++|+|..|+.+|++.-|..+|...-..
T Consensus 1380 ~~gk~gLdKIknp~--~sf~Gl~l~sp~~v~qli~N~---------ik~t~rsdilr~s~~ly~rs~~n~~fi~flq~-- 1446 (2724)
T KOG1826|consen 1380 KLGKGGLDKIKNPV--LSFFGLELCSPIYVLQLIKNE---------IKFTKRSDILRRSLSLYLRSDGNAYFIFFLQP-- 1446 (2724)
T ss_pred cccccccccccCch--HhhhhhhhCCHHHHHHHHHHH---------HhhhhHHHHHHHHHHHHHHhcccHHHHHHHHH--
Confidence 99999999832221 223456789999999998843 45677899999999999999998888543222
Q ss_pred HHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCCChhHHhcCCCCCC
Q 003052 719 KFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQHPFLVP 769 (853)
Q Consensus 719 ~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~HPwf~~ 769 (853)
..+.+.+.......+...+.++-.....+|-+.-..||.-..++.-+.|..
T Consensus 1447 ~Lkgiidn~tf~sIe~l~pgdaNve~~~~Ll~K~~~rp~q~isls~d~~a~ 1497 (2724)
T KOG1826|consen 1447 ALKGIIDNHTFFSIEKLKPGDANVEALHRLLWKYMERPGQYISLSRDHFAV 1497 (2724)
T ss_pred HHcCcccccccccccccCCCcccHHHHHHHHHHhhhcchhhhhcccccccc
Confidence 222222222222223333344455566666677788898888888777643
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.15 E-value=0.0049 Score=65.00 Aligned_cols=31 Identities=39% Similarity=0.640 Sum_probs=26.0
Q ss_pred cCceeeCCCCCccEEeecCcE-EEEecccchh
Q 003052 618 EERIVHSDLKPANFLLVKGSL-KLIDFGIAKA 648 (853)
Q Consensus 618 s~gIIHRDLKPeNILL~~g~V-KL~DFGlAk~ 648 (853)
..+++|+|+.+.|||++++.+ .|+||+.|..
T Consensus 163 ~~~l~HGD~~~~Nvlv~~~~i~giIDw~~a~~ 194 (235)
T cd05155 163 PPVWFHGDLAPGNLLVQDGRLSAVIDFGCLGV 194 (235)
T ss_pred CceEEeCCCCCCcEEEECCCEEEEEeCcccCc
Confidence 346999999999999987765 6999998753
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=97.04 E-value=0.0061 Score=63.57 Aligned_cols=132 Identities=23% Similarity=0.267 Sum_probs=83.6
Q ss_pred EeEeccCceEEEEEEecCCcEEEEEEEecCC--------------CChhhHhhHHHHHHHHHHhc-CCCceeEeeehhhh
Q 003052 478 GKIGSGGSSEVHKVISSDCTIYALKKIKLKG--------------RDYATAYGFCQEIEYLNKLK-GKNNIIQLIDYEVT 542 (853)
Q Consensus 478 k~LG~G~FG~Vyka~~~~g~~vAVKkik~~~--------------~~~~~~~~~l~EI~iLkkL~-~hpNIV~Lid~~~~ 542 (853)
..||+|+.-.||.- .+....+||++.... ..........+|+.....+. ... .
T Consensus 7 ~~i~~G~~R~cy~H--P~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~-----~----- 74 (199)
T PF10707_consen 7 DLIAQGGERDCYQH--PDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRG-----V----- 74 (199)
T ss_pred cccccCCCceEEEC--CCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccC-----C-----
Confidence 35899999999975 334447889887665 11122345677888877776 210 0
Q ss_pred HHHHHHHHhhCCCCCCCCccccCCeEEEEEecc---hh----hHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhh
Q 003052 543 EKALLREVLNGSMNNKDGRVKDDGYIYMVLEYG---EI----DLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNT 615 (853)
Q Consensus 543 e~~iL~~l~~~~iv~~~g~~~d~~~lyLVmEy~---~g----dL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~y 615 (853)
....+..++|..+++--+-+|+|.. .| +|.+++.. ..+++ ..+. .+-.-..|
T Consensus 75 --------~~~~i~r~~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~---------~~~~~-~~~~---~L~~f~~~ 133 (199)
T PF10707_consen 75 --------DWSHIPRFYGFVETNLGLGLVVELIRDADGNISPTLEDYLKE---------GGLTE-ELRQ---ALDEFKRY 133 (199)
T ss_pred --------cccccccEeEEEecCCceEEEEEEEECCCCCcCccHHHHHHc---------CCccH-HHHH---HHHHHHHH
Confidence 0123444445566666778888872 22 56666633 34665 3333 33344567
Q ss_pred cccCceeeCCCCCccEEee---cC--cEEEEe
Q 003052 616 IHEERIVHSDLKPANFLLV---KG--SLKLID 642 (853)
Q Consensus 616 LHs~gIIHRDLKPeNILL~---~g--~VKL~D 642 (853)
|-+++|+.+||+|.||++. ++ .+.|+|
T Consensus 134 l~~~~Iv~~dl~~~NIv~~~~~~~~~~lvlID 165 (199)
T PF10707_consen 134 LLDHHIVIRDLNPHNIVVQRRDSGEFRLVLID 165 (199)
T ss_pred HHHcCCeecCCCcccEEEEecCCCceEEEEEe
Confidence 8889999999999999993 23 578888
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=96.99 E-value=0.0021 Score=68.54 Aligned_cols=29 Identities=31% Similarity=0.470 Sum_probs=25.5
Q ss_pred ceeeCCCCCccEEeecCcEEEEecccchh
Q 003052 620 RIVHSDLKPANFLLVKGSLKLIDFGIAKA 648 (853)
Q Consensus 620 gIIHRDLKPeNILL~~g~VKL~DFGlAk~ 648 (853)
.++|+|+.|.||+++++.+.|+||..|..
T Consensus 147 ~l~H~Dl~~~Nil~~~~~~~lIDwE~a~~ 175 (256)
T TIGR02721 147 APLHMDVHAYNLVVTPQGLKLIDWEYASD 175 (256)
T ss_pred eeecCCCCcCcEEEeCCCCEEEeccccCc
Confidence 58999999999999766689999998853
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=96.76 E-value=0.00085 Score=74.13 Aligned_cols=137 Identities=15% Similarity=0.224 Sum_probs=88.7
Q ss_pred eeeEEEeEeccCceEEEEEEecCCcEEEEEEEecCCCChhhH--------------------hhHHHHHHHHHHhcCCCc
Q 003052 473 LYQRLGKIGSGGSSEVHKVISSDCTIYALKKIKLKGRDYATA--------------------YGFCQEIEYLNKLKGKNN 532 (853)
Q Consensus 473 ~Y~ilk~LG~G~FG~Vyka~~~~g~~vAVKkik~~~~~~~~~--------------------~~~l~EI~iLkkL~~hpN 532 (853)
.|.+.+.||-|--+.||.+.+..|+.+++|.-.......... -...+|..+|+.|..|
T Consensus 93 v~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~-- 170 (465)
T KOG2268|consen 93 VESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYER-- 170 (465)
T ss_pred hhhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHc--
Confidence 477888999999999999999999999999865432221111 1122344444444322
Q ss_pred eeEeeehhhhHHHHHHHHhhCCCCCCCCccccCCeEEEEEecchh-hHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhh
Q 003052 533 IIQLIDYEVTEKALLREVLNGSMNNKDGRVKDDGYIYMVLEYGEI-DLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILE 611 (853)
Q Consensus 533 IV~Lid~~~~e~~iL~~l~~~~iv~~~g~~~d~~~lyLVmEy~~g-dL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~ 611 (853)
+.-+. ...+.+..++|||+..+ .|...- ... .+..+...++.
T Consensus 171 --------------------gfpVP---kpiD~~RH~Vvmelv~g~Pl~~v~-----------~v~---d~~~ly~~lm~ 213 (465)
T KOG2268|consen 171 --------------------GFPVP---KPIDHNRHCVVMELVDGYPLRQVR-----------HVE---DPPTLYDDLMG 213 (465)
T ss_pred --------------------CCCCC---CcccccceeeHHHhhcccceeeee-----------ecC---ChHHHHHHHHH
Confidence 11111 12345667999999654 322210 111 23344556666
Q ss_pred hhhhcccCceeeCCCCCccEEee-cCcEEEEecccchh
Q 003052 612 AVNTIHEERIVHSDLKPANFLLV-KGSLKLIDFGIAKA 648 (853)
Q Consensus 612 AL~yLHs~gIIHRDLKPeNILL~-~g~VKL~DFGlAk~ 648 (853)
-+.-|..+|+||+|..-=||++. ++.++++||--+-.
T Consensus 214 ~Iv~la~~GlIHgDFNEFNimv~dd~~i~vIDFPQmvS 251 (465)
T KOG2268|consen 214 LIVRLANHGLIHGDFNEFNIMVKDDDKIVVIDFPQMVS 251 (465)
T ss_pred HHHHHHHcCceecccchheeEEecCCCEEEeechHhhc
Confidence 67778899999999999999995 77899999976543
|
|
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=96.75 E-value=0.0092 Score=65.54 Aligned_cols=29 Identities=38% Similarity=0.512 Sum_probs=25.1
Q ss_pred CceeeCCCCCccEEeecCc-EEEEecccch
Q 003052 619 ERIVHSDLKPANFLLVKGS-LKLIDFGIAK 647 (853)
Q Consensus 619 ~gIIHRDLKPeNILL~~g~-VKL~DFGlAk 647 (853)
.+++|+|+.+.||+++++. +.|+||+.|.
T Consensus 187 ~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 187 RGVIHADLFPDNVLFDGDSVKGVIDFYFAC 216 (307)
T ss_pred CccCCCCCCcCcEEEECCceEEEeeccccc
Confidence 5899999999999996654 5899999874
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.74 E-value=0.025 Score=62.22 Aligned_cols=29 Identities=34% Similarity=0.471 Sum_probs=25.5
Q ss_pred CceeeCCCCCccEEeecCcE-EEEecccch
Q 003052 619 ERIVHSDLKPANFLLVKGSL-KLIDFGIAK 647 (853)
Q Consensus 619 ~gIIHRDLKPeNILL~~g~V-KL~DFGlAk 647 (853)
.++||+|+.|.|||+.++.+ -|+||+.|.
T Consensus 187 ~~liHgD~~~~Nil~~~~~~~~iIDf~~~~ 216 (319)
T PRK05231 187 RGVIHADLFRDNVLFEGDRLSGFIDFYFAC 216 (319)
T ss_pred cccCCCCCCCCcEEEECCceEEEEeccccc
Confidence 48999999999999987765 799999875
|
|
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=96.64 E-value=0.0056 Score=66.45 Aligned_cols=147 Identities=16% Similarity=0.171 Sum_probs=78.8
Q ss_pred EEeEeccCceEEEEEEecCCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCC-ceeEeeehhhhHHHHHHHHhhCCC
Q 003052 477 LGKIGSGGSSEVHKVISSDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKN-NIIQLIDYEVTEKALLREVLNGSM 555 (853)
Q Consensus 477 lk~LG~G~FG~Vyka~~~~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hp-NIV~Lid~~~~e~~iL~~l~~~~i 555 (853)
++.|..|....+|++...+ ..+++|+... .. ...+..|+.++..|..+. .+.+++..
T Consensus 19 i~~i~~G~~n~~y~v~~~~-~~~vLr~~~~--~~---~~~~~~e~~~l~~L~~~g~~vp~~i~~---------------- 76 (296)
T cd05153 19 FEGISAGIENTNYFVTTDS-GRYVLTLFEK--VS---AEELPFFLALLDHLAERGLPVPRPIAD---------------- 76 (296)
T ss_pred eecccCccccceEEEEeCC-CcEEEEEcCC--CC---hHhccHHHHHHHHHHHCCCCCCccccC----------------
Confidence 4568888888999987644 4588888764 11 234667888888886432 23333221
Q ss_pred CCCCC--ccccCCeEEEEEecchhhH--------HHHHHHhhhhcc----CCCC----CCCHHHHHH------------H
Q 003052 556 NNKDG--RVKDDGYIYMVLEYGEIDL--------AHMLSQKWKEMD----GSNQ----TLDENWLRF------------Y 605 (853)
Q Consensus 556 v~~~g--~~~d~~~lyLVmEy~~gdL--------~~~L~~~~k~~~----~~~~----~LsE~~~r~------------I 605 (853)
..| ....++..++|++|.+|.. ...+.+....+. .-.. .....+... .
T Consensus 77 --~~g~~~~~~~~~~~~l~~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 154 (296)
T cd05153 77 --RDGEYLSELAGKPAALVEFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAED 154 (296)
T ss_pred --CCCcEeeeeCCceEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHH
Confidence 111 1133456789999965411 111111111111 0000 000011111 0
Q ss_pred HHHhhhhhhhccc-------CceeeCCCCCccEEeecCc-EEEEecccch
Q 003052 606 WQQILEAVNTIHE-------ERIVHSDLKPANFLLVKGS-LKLIDFGIAK 647 (853)
Q Consensus 606 ~~QIl~AL~yLHs-------~gIIHRDLKPeNILL~~g~-VKL~DFGlAk 647 (853)
...+..++.++.. .+++|+|+.|.|||++++. +.|+||+.|.
T Consensus 155 ~~~~~~~~~~l~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~ 204 (296)
T cd05153 155 RALLADELARQDAFDPSDLPRGVIHADLFRDNVLFDGDELSGVIDFYFAC 204 (296)
T ss_pred HHHHHHHHHHHHhhhhhcCCCcCCccCcCcccEEEeCCceEEEeehhhhc
Confidence 1112223333332 4799999999999997665 5799999875
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=96.62 E-value=0.017 Score=63.07 Aligned_cols=59 Identities=20% Similarity=0.112 Sum_probs=38.2
Q ss_pred EEeEeccCceEEEEEEecC-------CcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeee
Q 003052 477 LGKIGSGGSSEVHKVISSD-------CTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLID 538 (853)
Q Consensus 477 lk~LG~G~FG~Vyka~~~~-------g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid 538 (853)
++.|..|-...||++...+ ++.|++|+...... ......+|.++++.+....-..+++.
T Consensus 3 i~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~~---~~~~r~~E~~~~~~l~~~g~~P~~~~ 68 (302)
T cd05156 3 VSKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSVE---LLIDRERELVVFARLSERNLGPKLYG 68 (302)
T ss_pred EEEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCCc---ceechHHHHHHHHHHHhCCCCCceEE
Confidence 3457777788999987654 47788898654322 22345689999999875433334443
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=96.53 E-value=0.0049 Score=63.61 Aligned_cols=100 Identities=22% Similarity=0.206 Sum_probs=74.3
Q ss_pred HHHHHHHHhcCCCceeEeeehhhhHHHHHHHHhhCCCCCCCCccccCCeEEEEEecchh-hHHHHHHHhhhhccCCCCCC
Q 003052 519 QEIEYLNKLKGKNNIIQLIDYEVTEKALLREVLNGSMNNKDGRVKDDGYIYMVLEYGEI-DLAHMLSQKWKEMDGSNQTL 597 (853)
Q Consensus 519 ~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~~l~~~~iv~~~g~~~d~~~lyLVmEy~~g-dL~~~L~~~~k~~~~~~~~L 597 (853)
.|.-+|+.+.+.+++.++++++- -++|.||.+. .+.... ..+ ......
T Consensus 8 ~E~lll~~l~~~~~~pk~lG~CG--------------------------~~~v~E~~~~~~~~~~~----~~l-~~~~~~ 56 (188)
T PF12260_consen 8 NEPLLLQLLQGSEPFPKLLGSCG--------------------------RFYVVEYVGAGSLYGIY----RPL-SQFLQS 56 (188)
T ss_pred cHHHHHHHcCCCCCCCCeeeECC--------------------------CEEEEEeecCccccccc----ccc-cccccc
Confidence 68888999988789999988741 1568888663 332110 000 011246
Q ss_pred CHHHHHHHHHHhhhhhhhccc---CceeeCCCCCccEEee-cCcEEEEecccchhc
Q 003052 598 DENWLRFYWQQILEAVNTIHE---ERIVHSDLKPANFLLV-KGSLKLIDFGIAKAI 649 (853)
Q Consensus 598 sE~~~r~I~~QIl~AL~yLHs---~gIIHRDLKPeNILL~-~g~VKL~DFGlAk~~ 649 (853)
++..+..|+.+++..+.+|+. ..+.-.|++++||-+. +|.+|++|...+...
T Consensus 57 ~w~~R~~iA~~lL~~l~~l~~~~~~~~~lcDv~~~nfgv~~~~~lk~iDld~v~~~ 112 (188)
T PF12260_consen 57 PWEQRAKIALQLLELLEELDHGPLGFFYLCDVSPDNFGVNDDGRLKLIDLDDVFVE 112 (188)
T ss_pred CHHHHHHHHHHHHHHHHHHhcCCCCcEEEeecchHHeEEeCCCcEEEEechhcchh
Confidence 889999999999999999998 4689999999999995 569999999877544
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=96.39 E-value=0.019 Score=65.02 Aligned_cols=61 Identities=15% Similarity=0.089 Sum_probs=39.7
Q ss_pred eEeccCceEEEEEEecCC-cEEEEEEEecC----C-CChhhHhhHHHHHHHHHHhcCC--CceeEeeeh
Q 003052 479 KIGSGGSSEVHKVISSDC-TIYALKKIKLK----G-RDYATAYGFCQEIEYLNKLKGK--NNIIQLIDY 539 (853)
Q Consensus 479 ~LG~G~FG~Vyka~~~~g-~~vAVKkik~~----~-~~~~~~~~~l~EI~iLkkL~~h--pNIV~Lid~ 539 (853)
.||.|....||++...++ +-++||.-... + .-.-...+...|..+|+..... ..+.+++.|
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~ 70 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHF 70 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEE
Confidence 589999999999998654 57888875321 1 1123344556788888776542 246666654
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=96.17 E-value=0.1 Score=57.58 Aligned_cols=77 Identities=13% Similarity=-0.085 Sum_probs=50.5
Q ss_pred EEeEeccCceEEEEEEecCCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCC--CceeEeeehhhhHHHHHHHHhhCC
Q 003052 477 LGKIGSGGSSEVHKVISSDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGK--NNIIQLIDYEVTEKALLREVLNGS 554 (853)
Q Consensus 477 lk~LG~G~FG~Vyka~~~~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~h--pNIV~Lid~~~~e~~iL~~l~~~~ 554 (853)
.+.||.|..+.||.....+++ +.+|..+. .. ....+.+|...|+.|... -.|.++++++..
T Consensus 19 ~~~i~~G~~~~vy~~~~~~~~-~~~k~~~~-~~---~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~------------ 81 (297)
T PRK10593 19 VECISEQPYAALWALYDSQGN-PMPLMARS-FS---TPGVAQQEAWKLSMLARSGTVRMPTVYGVMTH------------ 81 (297)
T ss_pred eeecCCccceeEEEEEcCCCC-EEEEEecc-cc---cchHHHHHHHHHHHHccCCCCCcCcEEEEecc------------
Confidence 456999999999999776664 56666442 11 123577999999999754 246666654211
Q ss_pred CCCCCCccccCCeEEEEEecchh
Q 003052 555 MNNKDGRVKDDGYIYMVLEYGEI 577 (853)
Q Consensus 555 iv~~~g~~~d~~~lyLVmEy~~g 577 (853)
....+.-|||||+.++
T Consensus 82 -------~~~~g~~~LVmE~i~G 97 (297)
T PRK10593 82 -------EQSPGPDVLLLERLRG 97 (297)
T ss_pred -------CCcCCCeEEEEeccCC
Confidence 0123557999999554
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=95.15 E-value=0.35 Score=52.81 Aligned_cols=30 Identities=37% Similarity=0.571 Sum_probs=25.2
Q ss_pred CceeeCCCCCccEEeec-Cc-EEEEecccchh
Q 003052 619 ERIVHSDLKPANFLLVK-GS-LKLIDFGIAKA 648 (853)
Q Consensus 619 ~gIIHRDLKPeNILL~~-g~-VKL~DFGlAk~ 648 (853)
..++|+|+.|.|||+++ +. .-|+||+.+..
T Consensus 185 ~~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i 216 (276)
T cd05152 185 TVLVHGDLHPGHILIDEDARVTGLIDWTEAKV 216 (276)
T ss_pred CeeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence 46999999999999976 65 56999998864
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=95.13 E-value=0.024 Score=63.92 Aligned_cols=74 Identities=15% Similarity=0.331 Sum_probs=58.6
Q ss_pred ccCCeEEEEEecchhhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccC-ceeeCCCCCccEEeecCcEEEE
Q 003052 563 KDDGYIYMVLEYGEIDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEE-RIVHSDLKPANFLLVKGSLKLI 641 (853)
Q Consensus 563 ~d~~~lyLVmEy~~gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~-gIIHRDLKPeNILL~~g~VKL~ 641 (853)
.+.-|.|++|++.++.|.-. ..-...++..|+++.+..+.-+..+ ..-||||...||||++|+|-|+
T Consensus 296 de~~y~yl~~kdhgt~is~i------------k~~~~~e~lsff~s~~sil~~lekkf~fehrnlt~~niLId~GnvtLI 363 (488)
T COG5072 296 DETLYLYLHFKDHGTPISII------------KADRSEEELSFFWSCISILDILEKKFPFEHRNLTLDNILIDEGNVTLI 363 (488)
T ss_pred CCceEEEEEEecCCceeeee------------ecccHHHHHHHHHHHHHHHhhhhhcCCcccccccccceeeecCceEEE
Confidence 34567899999977654321 2245677888888888877777655 6899999999999999999999
Q ss_pred ecccchh
Q 003052 642 DFGIAKA 648 (853)
Q Consensus 642 DFGlAk~ 648 (853)
||-+|+.
T Consensus 364 DfklsRl 370 (488)
T COG5072 364 DFKLSRL 370 (488)
T ss_pred Eeeeeec
Confidence 9999984
|
|
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=95.06 E-value=0.2 Score=57.81 Aligned_cols=62 Identities=18% Similarity=0.169 Sum_probs=38.9
Q ss_pred EEeEeccCceEEEEEEecCCcEEEEEEEecCCC----C-hhhHhhHHHHHHHHHHhcC--CCceeEeeeh
Q 003052 477 LGKIGSGGSSEVHKVISSDCTIYALKKIKLKGR----D-YATAYGFCQEIEYLNKLKG--KNNIIQLIDY 539 (853)
Q Consensus 477 lk~LG~G~FG~Vyka~~~~g~~vAVKkik~~~~----~-~~~~~~~l~EI~iLkkL~~--hpNIV~Lid~ 539 (853)
.+.||.|....||++.+. +..|+||.-....+ . .....+...|...|+.+.. ...+.+++.+
T Consensus 37 ~~eiggGn~N~VyrV~~~-~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~ 105 (418)
T PLN02756 37 IKEVGDGNLNFVYIVVSS-SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHF 105 (418)
T ss_pred EEEcCCCceeeEEEEEcC-CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEE
Confidence 567999999999999874 34588887652211 0 1123344567777776652 2356666654
|
|
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=95.05 E-value=0.13 Score=59.22 Aligned_cols=63 Identities=13% Similarity=0.094 Sum_probs=42.3
Q ss_pred EEeEeccCceEEEEEEecC-CcEEEEEEEecC---CCC-hhhHhhHHHHHHHHHHhcC--CCceeEeeeh
Q 003052 477 LGKIGSGGSSEVHKVISSD-CTIYALKKIKLK---GRD-YATAYGFCQEIEYLNKLKG--KNNIIQLIDY 539 (853)
Q Consensus 477 lk~LG~G~FG~Vyka~~~~-g~~vAVKkik~~---~~~-~~~~~~~l~EI~iLkkL~~--hpNIV~Lid~ 539 (853)
++.||.|.-.-||++.+.+ ++-++||.-... +.+ .-...+...|.++|+.+.. ...+.+++.|
T Consensus 34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~ 103 (409)
T PRK12396 34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLF 103 (409)
T ss_pred eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEE
Confidence 5679999999999999843 466888875321 111 3344556778888887754 2357777765
|
|
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=94.94 E-value=0.04 Score=64.41 Aligned_cols=81 Identities=25% Similarity=0.256 Sum_probs=55.2
Q ss_pred CccchhhhHHHHHHHHhCCCCCCcchhHHHH---HHhhcCCCCcc------cCCCCCChhHHHHHHHhcccCCCCCCChh
Q 003052 689 RPSDIWSLGCILYQMVYGRTPFSEYKTFWAK---FKVITDPNHEI------TYEPVPNPWLLDLMKKCLAWDRNERWRIP 759 (853)
Q Consensus 689 ~ksDIWSLGVILyELLtG~~PF~~~~~~~~~---~kii~~~~~~~------~~~~~~s~~l~dLI~kcL~~DP~kRpTa~ 759 (853)
+|+|||++|.++.++..|...|......... .+....+.... .+....+..+..++.+|+-..|..||...
T Consensus 110 pKsdVwsl~~i~~el~L~~~l~~~~~~s~~l~~i~k~~~~d~~~~~~a~e~~~~~~~d~~~~~~~~~c~~~~~~ir~l~~ 189 (725)
T KOG1093|consen 110 PKSDVWSLGFIILELYLGISLEAELTESEYLEILLKYYTDDQELLSTAMEHLIQLLADKKRLPLLKKCLWLEPIIRPLPM 189 (725)
T ss_pred cchhhhhHHHHHHHHHHhhHHHHHHHHHHHHHHHHHhccCchhHHHHHHHHHHHHhhhHhHHHHhccCCccccccccchh
Confidence 4799999999999999998888654332221 11111111000 01122345578899999999999999999
Q ss_pred HHhcCCCCCC
Q 003052 760 QLLQHPFLVP 769 (853)
Q Consensus 760 EIL~HPwf~~ 769 (853)
++.+|+-|..
T Consensus 190 ~~~k~~i~~e 199 (725)
T KOG1093|consen 190 ELSKRCSFTE 199 (725)
T ss_pred HHhcCccHHH
Confidence 9999998854
|
|
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=94.93 E-value=0.19 Score=56.16 Aligned_cols=30 Identities=23% Similarity=0.475 Sum_probs=25.6
Q ss_pred ceeeCCCCCccEEeec-CcEEEEecccchhc
Q 003052 620 RIVHSDLKPANFLLVK-GSLKLIDFGIAKAI 649 (853)
Q Consensus 620 gIIHRDLKPeNILL~~-g~VKL~DFGlAk~~ 649 (853)
.++|+|+.+.||+|.+ +-+-|+||+++...
T Consensus 199 ~lvHGD~~~gNlii~~~~~~gVlDwe~~~lG 229 (321)
T COG3173 199 VLVHGDYRPGNLIIDPGRPTGVLDWELATLG 229 (321)
T ss_pred eeeeCCcccCCEEEeCCCeeEEEeccccccC
Confidence 5899999999999954 46889999998753
|
|
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=94.90 E-value=0.41 Score=53.98 Aligned_cols=31 Identities=26% Similarity=0.494 Sum_probs=26.0
Q ss_pred ccCceeeCCCCCccEEeec--CcEEEEecccch
Q 003052 617 HEERIVHSDLKPANFLLVK--GSLKLIDFGIAK 647 (853)
Q Consensus 617 Hs~gIIHRDLKPeNILL~~--g~VKL~DFGlAk 647 (853)
+...++|+||++.|||+++ +.+.|+||.+|.
T Consensus 198 ~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~ 230 (344)
T PLN02236 198 QEIGFCHNDLQYGNIMIDEETRAITIIDYEYAS 230 (344)
T ss_pred CCceEEeCCCCcCcEEEeCCCCcEEEEeehhcc
Confidence 3447999999999999964 479999998874
|
|
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=94.88 E-value=0.14 Score=58.66 Aligned_cols=29 Identities=31% Similarity=0.368 Sum_probs=25.6
Q ss_pred CceeeCCCCCccEEeecCcEEEEecccch
Q 003052 619 ERIVHSDLKPANFLLVKGSLKLIDFGIAK 647 (853)
Q Consensus 619 ~gIIHRDLKPeNILL~~g~VKL~DFGlAk 647 (853)
...+|.||-+.|||..++.+.++||-.|.
T Consensus 227 ~VfCHNDL~~gNIL~~~~~l~lID~EYA~ 255 (383)
T PTZ00384 227 VLFCHNDLFFTNILDFNQGIYFIDFDFAG 255 (383)
T ss_pred eeeeeccCCcccEEecCCCEEEEEecccc
Confidence 46899999999999988889999997663
|
|
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=94.80 E-value=0.52 Score=52.58 Aligned_cols=44 Identities=11% Similarity=-0.016 Sum_probs=30.7
Q ss_pred cCceEEEEEEecCCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcC
Q 003052 483 GGSSEVHKVISSDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKG 529 (853)
Q Consensus 483 G~FG~Vyka~~~~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~ 529 (853)
+.-..||++...++..|++|+....... ...+..|+.++..|..
T Consensus 36 s~eN~vy~v~~~~~~~~vlKv~r~~~~~---~~~i~~E~~~l~~L~~ 79 (325)
T PRK11768 36 SYENRVYQFGDEDGRRVVAKFYRPERWS---DAQILEEHAFALELAE 79 (325)
T ss_pred cccceEEEEecCCCCEEEEEEcCcccCC---HHHHHHHHHHHHHHHH
Confidence 4456799998877878999987543222 3346678888888864
|
|
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=93.94 E-value=0.94 Score=50.72 Aligned_cols=28 Identities=36% Similarity=0.602 Sum_probs=24.3
Q ss_pred ceeeCCCCCccEEee--cCcEEEEecccch
Q 003052 620 RIVHSDLKPANFLLV--KGSLKLIDFGIAK 647 (853)
Q Consensus 620 gIIHRDLKPeNILL~--~g~VKL~DFGlAk 647 (853)
-++|.||.+.|||+. ++.++|+||..|.
T Consensus 183 v~CHnDl~~~NiL~~~~~~~l~lID~EYag 212 (330)
T PLN02421 183 VFAHNDLLSGNLMLNEDEGKLYFIDFEYGS 212 (330)
T ss_pred EEEECCCCcccEEEeCCCCcEEEEcccccC
Confidence 389999999999995 3579999999874
|
|
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=92.72 E-value=0.63 Score=59.79 Aligned_cols=47 Identities=15% Similarity=0.133 Sum_probs=30.8
Q ss_pred EeEeccCceEEEEEEecCCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcC
Q 003052 478 GKIGSGGSSEVHKVISSDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKG 529 (853)
Q Consensus 478 k~LG~G~FG~Vyka~~~~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~ 529 (853)
+.|+ |..-.+|++...++..|++|+...... ...+..|..+|..|..
T Consensus 31 ~~L~-s~~d~nf~v~~~~g~~yVLKi~~~~~~----~~~~~~q~~~L~hL~~ 77 (1013)
T PRK06148 31 TPLD-GERDLNFRLTTDDGADYILKIVNPSEP----RVESDFQTAALDHLAA 77 (1013)
T ss_pred eecC-CcCCceEEEEeCCCCeEEEEEcCCccc----hhHHHHHHHHHHHHHh
Confidence 4564 456788998877787899999875421 1223456667776653
|
|
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=92.30 E-value=0.19 Score=54.68 Aligned_cols=29 Identities=28% Similarity=0.419 Sum_probs=26.1
Q ss_pred CceeeCCCCCccEEeecCcEEEEecccch
Q 003052 619 ERIVHSDLKPANFLLVKGSLKLIDFGIAK 647 (853)
Q Consensus 619 ~gIIHRDLKPeNILL~~g~VKL~DFGlAk 647 (853)
.+++|+|+.+.||+++++.+.|+||+.+.
T Consensus 187 ~~liHgD~~~~Nil~~~~~i~lIDfd~~~ 215 (313)
T TIGR02906 187 RGFCHQDYAYHNILLKDNEVYVIDFDYCT 215 (313)
T ss_pred CceEcCCCCcccEEEeCCcEEEEECcccc
Confidence 58999999999999987889999999764
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=91.41 E-value=2.3 Score=47.02 Aligned_cols=58 Identities=21% Similarity=0.230 Sum_probs=36.7
Q ss_pred EEEeEeccCceEEEEEEecCCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhc--CCCceeEeeeh
Q 003052 476 RLGKIGSGGSSEVHKVISSDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLK--GKNNIIQLIDY 539 (853)
Q Consensus 476 ilk~LG~G~FG~Vyka~~~~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~--~hpNIV~Lid~ 539 (853)
-.+.||.|....+|+.. .+++.|.||+-.... ...|..|..-|+.|. ..-.+.+.+.+
T Consensus 21 ~~~~v~GG~i~~a~~~~-~~~~~~FvK~~~~~~-----~~~f~~Ea~gL~~L~~~~~~~vP~vi~~ 80 (288)
T PF03881_consen 21 SIEPVSGGDINEAYRLD-TDGGSYFVKVNSESG-----RDMFEGEAEGLKALAEANPIRVPKVIAW 80 (288)
T ss_dssp EEEEE--SSSSEEEEEE-TTS-EEEEEEEEGGG-----CCHHHHHHHHHHHHCHTTTSBS--EEEE
T ss_pred eeEecCCCChhheEEEE-CCCccEEEEecChhh-----HHHHHHHHHHHHHHHhcCCCCCCeEEEE
Confidence 34568999999999987 566778999877322 235778999999884 23345555554
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >PHA03111 Ser/Thr kinase; Provisional | Back alignment and domain information |
|---|
Probab=91.26 E-value=0.19 Score=56.23 Aligned_cols=51 Identities=27% Similarity=0.421 Sum_probs=36.5
Q ss_pred HHHHHHHHHHhhhhhhhcc----cCceeeCCCCCccEEe-ecC------------------cEEEEecccchhc
Q 003052 599 ENWLRFYWQQILEAVNTIH----EERIVHSDLKPANFLL-VKG------------------SLKLIDFGIAKAI 649 (853)
Q Consensus 599 E~~~r~I~~QIl~AL~yLH----s~gIIHRDLKPeNILL-~~g------------------~VKL~DFGlAk~~ 649 (853)
.+.++.++.||+.-.-.+- ..+.+|-||||+|||+ +.. ..+|.||.+++.-
T Consensus 278 ~~YikfifLQiaLLyikIYelp~c~nF~H~DLKPdNILiFds~~~i~I~~~~~~~vF~Epi~~~LnDFDfSqv~ 351 (444)
T PHA03111 278 VEYIKFIFLQIALLYIKIYELPCCDNFLHVDLKPDNILIFDSDEPISITLKDATYVFNEPIKACLNDFDFSQVA 351 (444)
T ss_pred HHHHHHHHHHHHHHHHhhhcCCCcceeeeccCCCCcEEEecCCCcEEEEECCeEEEeccchhhhhcccCHHHHc
Confidence 4567888999987654443 3479999999999999 322 1467788887643
|
|
| >PF05445 Pox_ser-thr_kin: Poxvirus serine/threonine protein kinase; InterPro: IPR008790 This family of proteins contain poxvirus serine/threonine protein kinases, which are essential for phosphorylation of virion proteins during virion assembly | Back alignment and domain information |
|---|
Probab=91.04 E-value=0.24 Score=55.67 Aligned_cols=52 Identities=27% Similarity=0.392 Sum_probs=36.6
Q ss_pred CHHHHHHHHHHhhhhhhhcc----cCceeeCCCCCccEEe-ecC------------------cEEEEecccchhc
Q 003052 598 DENWLRFYWQQILEAVNTIH----EERIVHSDLKPANFLL-VKG------------------SLKLIDFGIAKAI 649 (853)
Q Consensus 598 sE~~~r~I~~QIl~AL~yLH----s~gIIHRDLKPeNILL-~~g------------------~VKL~DFGlAk~~ 649 (853)
-..-++.++.||+.-.--+- ..+.+|-||||+|||+ +.. .++|-||.+++.-
T Consensus 273 ~~~YvkfifLQiaLLyikIYelp~c~nF~H~DLKPdNILiFds~~~i~I~~~~~~~vF~Epi~~~LnDFDfSqv~ 347 (434)
T PF05445_consen 273 NVEYVKFIFLQIALLYIKIYELPCCTNFLHVDLKPDNILIFDSKEPIRIKFGNRNYVFKEPIRCCLNDFDFSQVA 347 (434)
T ss_pred HHHHHHHHHHHHHHHHeeeecCCCcceeeecccCcCcEEEecCCCceEEEECCeEEEecccceeeecccCHHHhc
Confidence 34567888888876442232 3479999999999999 321 2578899988754
|
; GO: 0004672 protein kinase activity, 0005524 ATP binding |
| >PTZ00296 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=89.98 E-value=2.7 Score=49.17 Aligned_cols=29 Identities=31% Similarity=0.482 Sum_probs=25.3
Q ss_pred CceeeCCCCCccEEeecCcEEEEecccch
Q 003052 619 ERIVHSDLKPANFLLVKGSLKLIDFGIAK 647 (853)
Q Consensus 619 ~gIIHRDLKPeNILL~~g~VKL~DFGlAk 647 (853)
..++|.|+-+.|||..++.++|+||-.|.
T Consensus 284 ~VfCHNDl~~~NiL~~~~~l~LIDfEYAg 312 (442)
T PTZ00296 284 IVFCHNDLQENNIINTNKCLRLIDFEYSG 312 (442)
T ss_pred eeEEeCCCCccceeecCCCEEEEeecccc
Confidence 36899999999999977789999998763
|
|
| >PRK10271 thiK thiamine kinase; Provisional | Back alignment and domain information |
|---|
Probab=89.61 E-value=0.54 Score=48.81 Aligned_cols=29 Identities=28% Similarity=0.446 Sum_probs=25.7
Q ss_pred ceeeCCCCCccEEeecCcEEEEecccchh
Q 003052 620 RIVHSDLKPANFLLVKGSLKLIDFGIAKA 648 (853)
Q Consensus 620 gIIHRDLKPeNILL~~g~VKL~DFGlAk~ 648 (853)
-.+|+|+.|.||++.++.++|+||+.|..
T Consensus 78 ~p~H~D~~~~N~~~~~~~~~lIDwe~a~~ 106 (188)
T PRK10271 78 APLHMDVHAGNLVHSASGLRLIDWEYAGD 106 (188)
T ss_pred eeecCCCCCccEEEECCCEEEEeCCcccC
Confidence 57999999999999777799999998853
|
|
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=85.95 E-value=2.8 Score=44.99 Aligned_cols=37 Identities=27% Similarity=0.421 Sum_probs=30.7
Q ss_pred hhhhhhccc--CceeeCCCCCccEEe-ecCcEEEEecccc
Q 003052 610 LEAVNTIHE--ERIVHSDLKPANFLL-VKGSLKLIDFGIA 646 (853)
Q Consensus 610 l~AL~yLHs--~gIIHRDLKPeNILL-~~g~VKL~DFGlA 646 (853)
+.+|.-.|+ .+.+|+|-.|+|||- ..|.+||.|=+.-
T Consensus 151 i~~L~~fH~~~~~~lHGD~np~NiM~D~~G~lKlVDP~~L 190 (308)
T PF07387_consen 151 IKDLMDFHSENQHCLHGDCNPDNIMCDKFGYLKLVDPVCL 190 (308)
T ss_pred HHHHHHhhccCCCeecCCCChhheeecCCCCEEecChhhh
Confidence 466777884 379999999999999 5789999997754
|
The function of this family is unknown. |
| >COG0510 ycfN Thiamine kinase and related kinases [Coenzyme transport and metabolism] | Back alignment and domain information |
|---|
Probab=85.16 E-value=1.3 Score=48.35 Aligned_cols=50 Identities=34% Similarity=0.546 Sum_probs=40.0
Q ss_pred CHHHHHHHHHHhhhhhhhcccC--ceeeCCCCCccEEeec-CcEEEEecccch
Q 003052 598 DENWLRFYWQQILEAVNTIHEE--RIVHSDLKPANFLLVK-GSLKLIDFGIAK 647 (853)
Q Consensus 598 sE~~~r~I~~QIl~AL~yLHs~--gIIHRDLKPeNILL~~-g~VKL~DFGlAk 647 (853)
.....+..+..+-.++.-++.. -++|.|+.|+|+|+++ |.++|+||..|.
T Consensus 130 ~~~~~~~~~~~l~~~l~~~~~~~~v~cH~Dl~~~N~l~t~~~~l~LIDWEyAg 182 (269)
T COG0510 130 DNHLLRKKLKELRRALEEVPKDDLVPCHNDLNPGNLLLTDKGGLFLIDWEYAG 182 (269)
T ss_pred hhHHHHHHHHHHHHHhhhcCCCceeeecCCCCccceEEcCCCcEEEEecccCC
Confidence 3444555666777777777765 6999999999999977 999999998775
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 853 | ||||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 2e-63 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 3e-63 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 8e-63 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 3e-62 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 3e-62 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 8e-62 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 1e-61 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 1e-60 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 1e-21 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 1e-21 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 1e-20 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 2e-20 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 2e-20 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 2e-20 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 3e-20 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 6e-20 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 1e-19 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 3e-19 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 3e-19 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 3e-19 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 1e-18 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-18 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 3e-18 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 3e-18 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 6e-18 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 6e-18 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 8e-18 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 1e-17 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 1e-17 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 1e-17 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 1e-17 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 1e-17 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 1e-17 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 1e-17 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 1e-17 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 2e-17 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 2e-17 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 2e-17 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 2e-17 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 2e-17 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 2e-17 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 2e-17 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 2e-17 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 2e-17 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 2e-17 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 2e-17 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 2e-17 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 2e-17 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 2e-17 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 2e-17 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 2e-17 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 2e-17 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 2e-17 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 2e-17 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 2e-17 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 2e-17 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 2e-17 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 2e-17 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 2e-17 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 3e-17 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 3e-17 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 3e-17 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 3e-17 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 4e-17 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 4e-17 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 4e-17 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 4e-17 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 4e-17 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 4e-17 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 4e-17 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 4e-17 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 4e-17 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 5e-17 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 5e-17 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 5e-17 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 5e-17 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 5e-17 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 6e-17 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 6e-17 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 6e-17 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 6e-17 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 7e-17 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 7e-17 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 7e-17 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 7e-17 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 7e-17 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 8e-17 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 9e-17 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 1e-16 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 1e-16 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 1e-16 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 2e-16 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 2e-16 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 2e-16 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 2e-16 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 2e-16 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 3e-16 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 3e-16 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 4e-16 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 4e-16 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 5e-16 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 5e-16 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 5e-16 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 6e-16 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 6e-16 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 6e-16 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 7e-16 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 7e-16 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 8e-16 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 8e-16 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 9e-16 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 1e-15 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 1e-15 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 1e-15 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 1e-15 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-15 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 2e-15 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 2e-15 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 3e-15 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 3e-15 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 3e-15 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 3e-15 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 3e-15 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 3e-15 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 4e-15 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 4e-15 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 4e-15 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 4e-15 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 5e-15 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 5e-15 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 6e-15 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 6e-15 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 6e-15 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 7e-15 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 8e-15 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 8e-15 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 8e-15 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 9e-15 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 9e-15 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 1e-14 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 1e-14 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 1e-14 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 1e-14 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 1e-14 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 1e-14 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 1e-14 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 1e-14 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 1e-14 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 1e-14 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 1e-14 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 2e-14 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 2e-14 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-14 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 2e-14 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 2e-14 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 2e-14 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 2e-14 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 2e-14 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 2e-14 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 3e-14 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 3e-14 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 3e-14 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 3e-14 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 4e-14 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 4e-14 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 4e-14 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 4e-14 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 4e-14 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 4e-14 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 5e-14 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 5e-14 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 6e-14 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 7e-14 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 7e-14 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 9e-14 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 9e-14 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 1e-13 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 1e-13 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 1e-13 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 1e-13 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 1e-13 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 1e-13 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 1e-13 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 1e-13 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 2e-13 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 2e-13 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 2e-13 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 2e-13 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 2e-13 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-13 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 2e-13 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 3e-13 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 3e-13 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 3e-13 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 3e-13 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 3e-13 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 3e-13 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 3e-13 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 4e-13 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 4e-13 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 4e-13 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 4e-13 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 4e-13 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 4e-13 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 4e-13 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 5e-13 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 5e-13 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 5e-13 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 5e-13 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 5e-13 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 5e-13 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 5e-13 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 5e-13 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 5e-13 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 6e-13 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 6e-13 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 6e-13 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 6e-13 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 6e-13 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 6e-13 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 6e-13 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 6e-13 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 6e-13 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 6e-13 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 6e-13 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 6e-13 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 6e-13 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 6e-13 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 6e-13 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 6e-13 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 7e-13 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 7e-13 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 7e-13 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 7e-13 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 7e-13 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 7e-13 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 7e-13 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 7e-13 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 7e-13 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 7e-13 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 8e-13 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 8e-13 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 8e-13 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 8e-13 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 8e-13 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 8e-13 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 8e-13 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 8e-13 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 8e-13 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 8e-13 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 8e-13 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 8e-13 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 8e-13 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 9e-13 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 9e-13 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 9e-13 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 9e-13 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 1e-12 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 1e-12 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 1e-12 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 1e-12 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 1e-12 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 1e-12 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 1e-12 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 1e-12 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 1e-12 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 1e-12 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 1e-12 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 1e-12 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 1e-12 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 1e-12 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 1e-12 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 1e-12 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 1e-12 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 1e-12 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 1e-12 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 1e-12 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-12 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 1e-12 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 1e-12 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 2e-12 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-12 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 2e-12 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 2e-12 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 2e-12 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 2e-12 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 2e-12 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 2e-12 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 2e-12 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 2e-12 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 2e-12 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 2e-12 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 2e-12 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-12 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 2e-12 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 2e-12 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 2e-12 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 2e-12 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 2e-12 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 2e-12 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 2e-12 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 2e-12 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-12 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 3e-12 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 3e-12 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 3e-12 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 3e-12 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 3e-12 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 3e-12 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 3e-12 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 3e-12 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 3e-12 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 3e-12 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 3e-12 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 3e-12 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 4e-12 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 4e-12 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 4e-12 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 4e-12 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 4e-12 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 5e-12 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 5e-12 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 5e-12 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 5e-12 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 5e-12 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 5e-12 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 5e-12 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 6e-12 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 6e-12 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 6e-12 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 6e-12 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 6e-12 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 6e-12 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 6e-12 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 6e-12 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 6e-12 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 6e-12 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 6e-12 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 6e-12 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 6e-12 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 7e-12 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 7e-12 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 7e-12 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 7e-12 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 7e-12 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 7e-12 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 7e-12 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 7e-12 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 7e-12 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 7e-12 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 8e-12 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 8e-12 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 8e-12 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 8e-12 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 8e-12 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 8e-12 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 8e-12 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 8e-12 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 8e-12 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 8e-12 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 8e-12 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 8e-12 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 8e-12 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 8e-12 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 9e-12 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 9e-12 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 9e-12 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 9e-12 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 9e-12 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 9e-12 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 9e-12 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 9e-12 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 9e-12 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 9e-12 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 9e-12 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 1e-11 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 1e-11 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 1e-11 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 1e-11 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 1e-11 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-11 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 1e-11 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 1e-11 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 1e-11 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-11 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 1e-11 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 1e-11 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 1e-11 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 1e-11 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 1e-11 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 1e-11 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-11 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 1e-11 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 1e-11 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 1e-11 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 1e-11 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 1e-11 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 1e-11 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 1e-11 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 1e-11 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 1e-11 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 2e-11 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 2e-11 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 2e-11 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 2e-11 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 2e-11 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 2e-11 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 2e-11 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 2e-11 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 2e-11 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 2e-11 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 2e-11 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 2e-11 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 2e-11 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 2e-11 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-11 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 2e-11 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 2e-11 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 2e-11 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 2e-11 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 2e-11 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 2e-11 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 2e-11 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 2e-11 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 2e-11 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-11 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-11 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 2e-11 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 2e-11 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 2e-11 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-11 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 2e-11 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-11 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 2e-11 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 2e-11 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-11 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 2e-11 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 2e-11 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 2e-11 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 2e-11 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-11 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 2e-11 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 2e-11 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 2e-11 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 3e-11 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 3e-11 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 3e-11 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 3e-11 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 3e-11 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 3e-11 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 3e-11 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-11 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 3e-11 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 3e-11 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 3e-11 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-11 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 3e-11 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 3e-11 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 3e-11 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 3e-11 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 3e-11 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 3e-11 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 3e-11 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 4e-11 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 4e-11 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 4e-11 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 4e-11 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 4e-11 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 4e-11 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 4e-11 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 4e-11 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 4e-11 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 4e-11 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 4e-11 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 4e-11 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 4e-11 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-11 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 5e-11 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 5e-11 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 5e-11 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 5e-11 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 5e-11 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 5e-11 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 6e-11 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 6e-11 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 6e-11 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 6e-11 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 7e-11 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 7e-11 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 7e-11 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 7e-11 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 8e-11 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 8e-11 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 8e-11 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 8e-11 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 8e-11 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 9e-11 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 9e-11 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 9e-11 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 9e-11 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 9e-11 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 9e-11 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 9e-11 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 9e-11 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 9e-11 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 9e-11 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 1e-10 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 1e-10 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 1e-10 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 1e-10 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 1e-10 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 1e-10 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 1e-10 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 1e-10 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 1e-10 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-10 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 1e-10 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 1e-10 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 1e-10 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 1e-10 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 1e-10 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 1e-10 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 1e-10 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 1e-10 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-10 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 2e-10 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 2e-10 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 2e-10 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 2e-10 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 2e-10 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 2e-10 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 3e-10 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 3e-10 | ||
| 3eb0_A | 383 | Crystal Structure Of Cgd4_240 From Cryptosporidium | 3e-10 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 4e-10 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 5e-10 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 5e-10 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 5e-10 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 6e-10 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 6e-10 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 6e-10 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 8e-10 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 8e-10 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 8e-10 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 9e-10 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 9e-10 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 9e-10 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 1e-09 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 1e-09 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 1e-09 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-09 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 1e-09 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 1e-09 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 1e-09 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 1e-09 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 1e-09 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 1e-09 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 1e-09 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-09 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 1e-09 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 2e-09 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-09 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-09 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 2e-09 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-09 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-09 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 2e-09 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 2e-09 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-09 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 2e-09 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 2e-09 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 2e-09 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 2e-09 | ||
| 3ofm_A | 350 | Structure Of A Human Ck2alpha Prime, The Paralog Is | 2e-09 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 2e-09 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 2e-09 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 2e-09 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 2e-09 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 2e-09 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 2e-09 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 2e-09 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 3e-09 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 3e-09 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 3e-09 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 3e-09 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 3e-09 | ||
| 3e3b_X | 339 | Crystal Structure Of Catalytic Subunit Of Human Pro | 3e-09 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 3e-09 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-09 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 4e-09 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 4e-09 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 4e-09 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 4e-09 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 4e-09 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 4e-09 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 4e-09 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 4e-09 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 4e-09 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 5e-09 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 5e-09 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 6e-09 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 6e-09 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 6e-09 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 6e-09 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 6e-09 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 7e-09 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 7e-09 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 7e-09 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 7e-09 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 8e-09 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 9e-09 | ||
| 3k2l_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 9e-09 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 9e-09 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 1e-08 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 1e-08 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 1e-08 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-08 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 1e-08 | ||
| 3juh_A | 335 | Crystal Structure Of A Mutant Of Human Protein Kina | 2e-08 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 2e-08 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 2e-08 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 2e-08 | ||
| 3u87_A | 349 | Structure Of A Chimeric Construct Of Human Ck2alpha | 2e-08 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 3e-08 | ||
| 4dgl_C | 335 | Crystal Structure Of The Ck2 Tetrameric Holoenzyme | 3e-08 | ||
| 2zjw_A | 340 | Crystal Structure Of Human Ck2 Alpha Complexed With | 3e-08 | ||
| 1jwh_A | 337 | Crystal Structure Of Human Protein Kinase Ck2 Holoe | 3e-08 | ||
| 1pjk_A | 334 | Crystal Structure Of A C-terminal Deletion Mutant O | 3e-08 | ||
| 3nsz_A | 330 | Human Ck2 Catalytic Domain In Complex With Amppn Le | 3e-08 | ||
| 3q9w_A | 336 | Crystal Structure Of Human Ck2 Alpha In Complex Wit | 3e-08 | ||
| 3nga_A | 333 | Human Ck2 Catalytic Domain In Complex With Cx-4945 | 3e-08 | ||
| 3bqc_A | 335 | High Ph-Value Crystal Structure Of Emodin In Comple | 3e-08 | ||
| 3q04_A | 328 | Crystal Structure Of The Apo-Form Of Human Ck2 Alph | 3e-08 | ||
| 2r7i_A | 335 | Crystal Structure Of Catalytic Subunit Of Protein K | 3e-08 | ||
| 3mb6_A | 331 | Human Ck2 Catalytic Domain In Complex With A Difura | 3e-08 | ||
| 3h30_A | 334 | Crystal Structure Of The Catalytic Subunit Of Human | 3e-08 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 4e-08 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 4e-08 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 4e-08 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 6e-08 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 6e-08 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 7e-08 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 7e-08 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 7e-08 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 8e-08 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 1e-07 | ||
| 2pvh_A | 352 | Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri | 1e-07 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 1e-07 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 1e-07 | ||
| 3pvg_A | 331 | Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C | 1e-07 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 1e-07 | ||
| 2qc6_A | 332 | Protein Kinase Ck2 In Complex With Dbc Length = 332 | 2e-07 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 2e-07 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 2e-07 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 2e-07 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 2e-07 | ||
| 2wu6_A | 381 | Crystal Structure Of The Human Clk3 In Complex With | 2e-07 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 2e-07 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 2e-07 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 2e-07 | ||
| 3kxg_A | 327 | Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun | 2e-07 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 2e-07 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 2e-07 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 2e-07 | ||
| 2exe_A | 357 | Crystal Structure Of The Phosphorylated Clk3 Length | 2e-07 | ||
| 4dgn_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 2e-07 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 2e-07 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 3e-07 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 3e-07 | ||
| 4dgm_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 3e-07 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 3e-07 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 3e-07 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 3e-07 | ||
| 4anm_A | 335 | Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | 3e-07 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 3e-07 | ||
| 1z57_A | 339 | Crystal Structure Of Human Clk1 In Complex With 10z | 3e-07 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 3e-07 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 3e-07 | ||
| 2eu9_A | 355 | Crystal Structure Of Clk3 Length = 355 | 3e-07 | ||
| 1ds5_A | 332 | Dimeric Crystal Structure Of The Alpha Subunit In C | 3e-07 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 3e-07 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 3e-07 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 3e-07 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 4e-07 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 4e-07 | ||
| 1daw_A | 327 | Crystal Structure Of A Binary Complex Of Protein Ki | 4e-07 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 4e-07 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 4e-07 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 4e-07 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 4e-07 | ||
| 3nr9_A | 368 | Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length | 4e-07 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 4e-07 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 4e-07 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 4e-07 | ||
| 1m2p_A | 325 | Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra | 4e-07 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 4e-07 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 5e-07 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 5e-07 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 5e-07 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 5e-07 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 5e-07 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 5e-07 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 5e-07 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 5e-07 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 6e-07 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 6e-07 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 7e-07 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 7e-07 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 9e-07 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 9e-07 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 1e-06 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-06 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 1e-06 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 1e-06 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 1e-06 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 1e-06 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 2e-06 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-06 | ||
| 2vag_A | 339 | Crystal Structure Of Di-Phosphorylated Human Clk1 I | 2e-06 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 2e-06 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 2e-06 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 2e-06 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-06 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 2e-06 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 2e-06 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 2e-06 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 2e-06 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 2e-06 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 2e-06 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 3e-06 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 3e-06 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 3e-06 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 3e-06 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 3e-06 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 3e-06 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 3e-06 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 3e-06 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 3e-06 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 4e-06 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 4e-06 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 4e-06 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 4e-06 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 4e-06 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 4e-06 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 4e-06 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 4e-06 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 4e-06 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 5e-06 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 6e-06 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 6e-06 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 7e-06 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 7e-06 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 8e-06 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 8e-06 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 1e-05 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 1e-05 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 1e-05 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 1e-05 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 1e-05 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 2e-05 | ||
| 3anq_A | 368 | Human Dyrk1aINHIBITOR COMPLEX Length = 368 | 2e-05 | ||
| 2vx3_A | 382 | Crystal Structure Of The Human Dual Specificity Tyr | 2e-05 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 2e-05 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 2e-05 | ||
| 4f99_A | 361 | Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti | 2e-05 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 2e-05 | ||
| 4aze_A | 382 | Human Dyrk1a In Complex With Leucettine L41 Length | 2e-05 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 2e-05 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 3e-05 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-05 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 3e-05 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 3e-05 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-05 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-05 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 3e-05 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 3e-05 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 3e-05 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 3e-05 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 3e-05 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 3e-05 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-05 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 3e-05 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-05 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 3e-05 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-05 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 4e-05 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 5e-05 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 5e-05 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 6e-05 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 6e-05 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 7e-05 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 7e-05 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 7e-05 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 8e-05 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 8e-05 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 9e-05 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 9e-05 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 9e-05 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 1e-04 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 1e-04 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 1e-04 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 1e-04 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 1e-04 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 1e-04 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 1e-04 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 1e-04 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 1e-04 | ||
| 3llt_A | 360 | Crystal Structure Of Pf14_0431, Kinase Domain Lengt | 2e-04 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 2e-04 | ||
| 3sv0_A | 483 | Crystal Structure Of Casein Kinase-1 Like Protein I | 2e-04 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 2e-04 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 2e-04 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 3e-04 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 3e-04 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 3e-04 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 3e-04 | ||
| 3kga_A | 299 | Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe | 3e-04 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 3e-04 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 3e-04 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 3e-04 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 3e-04 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 3e-04 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 3e-04 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 3e-04 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 3e-04 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 3e-04 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 3e-04 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 3e-04 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 3e-04 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 3e-04 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 4e-04 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 4e-04 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 4e-04 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 4e-04 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 4e-04 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 4e-04 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 4e-04 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 4e-04 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 4e-04 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 4e-04 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 4e-04 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 4e-04 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 5e-04 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 5e-04 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 5e-04 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 5e-04 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 5e-04 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 5e-04 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 5e-04 | ||
| 2csn_A | 297 | Binary Complex Of Casein Kinase-1 With Cki7 Length | 6e-04 | ||
| 1eh4_A | 298 | Binary Complex Of Casein Kinase-1 From S. Pombe Wit | 6e-04 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 6e-04 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 6e-04 | ||
| 1q8y_A | 373 | The Structure Of The Yeast Sr Protein Kinase, Sky1p | 6e-04 | ||
| 1how_A | 373 | The X-Ray Crystal Structure Of Sky1p, An Sr Protein | 6e-04 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 6e-04 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 6e-04 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 6e-04 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 7e-04 |
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335 | Back alignment and structure |
|
| >pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340 | Back alignment and structure |
|
| >pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337 | Back alignment and structure |
|
| >pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334 | Back alignment and structure |
|
| >pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330 | Back alignment and structure |
|
| >pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336 | Back alignment and structure |
|
| >pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333 | Back alignment and structure |
|
| >pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328 | Back alignment and structure |
|
| >pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331 | Back alignment and structure |
|
| >pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|2WU6|A Chain A, Crystal Structure Of The Human Clk3 In Complex With Dki Length = 381 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|2EXE|A Chain A, Crystal Structure Of The Phosphorylated Clk3 Length = 357 | Back alignment and structure |
|
| >pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|2EU9|A Chain A, Crystal Structure Of Clk3 Length = 355 | Back alignment and structure |
|
| >pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|3NR9|A Chain A, Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length = 368 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2VAG|A Chain A, Crystal Structure Of Di-Phosphorylated Human Clk1 In Complex With A Novel Substituted Indole Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368 | Back alignment and structure |
|
| >pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|3LLT|A Chain A, Crystal Structure Of Pf14_0431, Kinase Domain Length = 360 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|3SV0|A Chain A, Crystal Structure Of Casein Kinase-1 Like Protein In Plant Length = 483 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|2CSN|A Chain A, Binary Complex Of Casein Kinase-1 With Cki7 Length = 297 | Back alignment and structure |
|
| >pdb|1EH4|A Chain A, Binary Complex Of Casein Kinase-1 From S. Pombe With An Atp Competitive Inhibitor, Ic261 Length = 298 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373 | Back alignment and structure |
|
| >pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 380 bits (977), Expect = e-125
Identities = 144/410 (35%), Positives = 214/410 (52%), Gaps = 34/410 (8%)
Query: 422 SQAPLSKNSSSDMKLEASKSEKQEKAVSSKGASAPRKRNYDPDLFFKVNGKLYQRLGKIG 481
+ L S + A+K E+Q G K + + V G++Y L +IG
Sbjct: 6 HSSGLVPRGSGMKETAAAKFERQHMDSPDLGTDDDDKASSSANECISVKGRIYSILKQIG 65
Query: 482 SGGSSEVHKVISSDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKN-NIIQLIDYE 540
SGGSS+V +V++ IYA+K + L+ D T + EI YLNKL+ + II+L DYE
Sbjct: 66 SGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYE 125
Query: 541 VTEKALLREVLNGSMNNKDGRVKDDGYIYMVLEYGEIDLAHMLSQKWKEMDGSNQTLDEN 600
+T++ YIYMV+E G IDL L +K +++D
Sbjct: 126 ITDQ----------------------YIYMVMECGNIDLNSWLKKK--------KSIDPW 155
Query: 601 WLRFYWQQILEAVNTIHEERIVHSDLKPANFLLVKGSLKLIDFGIAKAIMSDTTNIQRDS 660
+ YW+ +LEAV+TIH+ IVHSDLKPANFL+V G LKLIDFGIA + DTT++ +DS
Sbjct: 156 ERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVDGMLKLIDFGIANQMQPDTTSVVKDS 215
Query: 661 QVGTLSYMSPEAFM--CNESDENGNIIKCGRPSDIWSLGCILYQMVYGRTPFSEYKTFWA 718
QVG ++YM PEA + + + K SD+WSLGCILY M YG+TPF + +
Sbjct: 216 QVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQIS 275
Query: 719 KFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQHPFLVPPVSTQPSSS 778
K I DPNHEI + +P L D++K CL D +R IP+LL HP++ +
Sbjct: 276 KLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPVNQMA 335
Query: 779 QDQSYQLLQLLAEASASDHEASTICSQLSQLIRNPVMLAATQLSTSQDQQ 828
+ + ++ +L + + ++I L + + S+S+ +
Sbjct: 336 KGTTEEMKYVLGQLVGLN-SPNSILKAAKTLYEHYSGGESHNSSSSKTFE 384
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 372 bits (956), Expect = e-122
Identities = 137/366 (37%), Positives = 201/366 (54%), Gaps = 34/366 (9%)
Query: 466 FFKVNGKLYQRLGKIGSGGSSEVHKVISSDCTIYALKKIKLKGRDYATAYGFCQEIEYLN 525
V G++Y L +IGSGGSS+V +V++ IYA+K + L+ D T + EI YLN
Sbjct: 3 CISVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLN 62
Query: 526 KLKGKN-NIIQLIDYEVTEKALLREVLNGSMNNKDGRVKDDGYIYMVLEYGEIDLAHMLS 584
KL+ + II+L DYE+T++ YIYMV+E G IDL L
Sbjct: 63 KLQQHSDKIIRLYDYEITDQ----------------------YIYMVMECGNIDLNSWLK 100
Query: 585 QKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLLVKGSLKLIDFG 644
+K +++D + YW+ +LEAV+TIH+ IVHSDLKPANFL+V G LKLIDFG
Sbjct: 101 KK--------KSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVDGMLKLIDFG 152
Query: 645 IAKAIMSDTTNIQRDSQVGTLSYMSPEAFM--CNESDENGNIIKCGRPSDIWSLGCILYQ 702
IA + DTT++ +DSQVGT++YM PEA + + + K SD+WSLGCILY
Sbjct: 153 IANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYY 212
Query: 703 MVYGRTPFSEYKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLL 762
M YG+TPF + +K I DPNHEI + +P L D++K CL D +R IP+LL
Sbjct: 213 MTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELL 272
Query: 763 QHPFLVPPVSTQPSSSQDQSYQLLQLLAEASASDHEASTICSQLSQLIRNPVMLAATQLS 822
HP++ ++ + ++ +L + + ++I L + + S
Sbjct: 273 AHPYVQIQTHPVNQMAKGTTEEMKYVLGQLVGLN-SPNSILKAAKTLYEHYSGGESHNSS 331
Query: 823 TSQDQQ 828
+S+ +
Sbjct: 332 SSKTFE 337
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 366 bits (941), Expect = e-120
Identities = 134/320 (41%), Positives = 187/320 (58%), Gaps = 36/320 (11%)
Query: 468 KVNGKLYQRLGKIGSGGSSEVHKVISSDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKL 527
V G++Y L +IGSGGSS+V +V++ IYA+K + L+ D T + EI YLNKL
Sbjct: 24 SVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKL 83
Query: 528 KGKN-NIIQLIDYEVTEKALLREVLNGSMNNKDGRVKDDGYIYMVLEYGEIDLAHMLSQK 586
+ + II+L DYE+T++ YIYMV+E G IDL L +K
Sbjct: 84 QQHSDKIIRLYDYEITDQ----------------------YIYMVMECGNIDLNSWLKKK 121
Query: 587 WKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLLVKGSLKLIDFGIA 646
+++D + YW+ +LEAV+TIH+ IVHSDLKPANFL+V G LKLIDFGIA
Sbjct: 122 --------KSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVDGMLKLIDFGIA 173
Query: 647 KAIMSDTTNIQRDSQVGTLSYMSPEAFM--CNESDENGNIIKCGRPSDIWSLGCILYQMV 704
+ DTT++ +DSQVGT++YM PEA + + + K SD+WSLGCILY M
Sbjct: 174 NQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMT 233
Query: 705 YGRTPFSEYKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQH 764
YG+TPF + +K I DPNHEI + +P L D++K CL D +R IP+LL H
Sbjct: 234 YGKTPFQQIINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 293
Query: 765 PFLVP---PVSTQPSSSQDQ 781
P++ PV+ + ++
Sbjct: 294 PYVQIQTHPVNQMAKGTTEE 313
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 192 bits (489), Expect = 2e-55
Identities = 63/302 (20%), Positives = 126/302 (41%), Gaps = 47/302 (15%)
Query: 474 YQRLGKIGSGGSSEVHKVIS-SDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNN 532
++ + IGSGG +V K D Y +K++K + A +E++ L KL N
Sbjct: 13 FKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYN-NEKAE-----REVKALAKLDHVN- 65
Query: 533 IIQLIDYEVTEKALLREVLNGSMNNKDGRVKDDGYIYMVLEYGEI-DLAHMLSQKWKEMD 591
I+ S +K +++ +E+ + L + ++
Sbjct: 66 IVHYNGCWDGFDYDPETSSKNSSRSKTK------CLFIQMEFCDKGTLEQWIEKR----- 114
Query: 592 GSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLLVK-GSLKLIDFGIAKAIM 650
+ LD+ ++QI + V+ IH +++++ DLKP+N LV +K+ DFG+ ++
Sbjct: 115 -RGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLK 173
Query: 651 SDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGRTPF 710
+D +R GTL YMSPE + G+ D+++LG IL ++++
Sbjct: 174 NDG---KRTRSKGTLRYMSPE--QISS-------QDYGKEVDLYALGLILAELLHVCDTA 221
Query: 711 SEYKTFWAKFKVITDPNHEITYEPVPNPW---LLDLMKKCLAWDRNERWRIPQLLQHPFL 767
E F+ + + + + L++K L+ +R ++L+ +
Sbjct: 222 FETSKFFTD----------LRDGIISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTV 271
Query: 768 VP 769
Sbjct: 272 WK 273
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 192 bits (491), Expect = 6e-55
Identities = 77/347 (22%), Positives = 139/347 (40%), Gaps = 51/347 (14%)
Query: 474 YQRLGKIGSGGSSEVHKVIS-SDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNN 532
Y RL KIG G + V S D Y +K+I + +E+ L +K N
Sbjct: 26 YVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPN- 84
Query: 533 IIQLIDYEVTEKALLREVLNGSMNNKDGRVKDDGYIYMVLEYGEI-DLAHMLSQKWKEMD 591
I+Q + +++G +Y+V++Y E DL ++ +
Sbjct: 85 IVQYRE----------------------SFEENGSLYIVMDYCEGGDLFKRINAQ----- 117
Query: 592 GSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPAN-FLLVKGSLKLIDFGIAKAIM 650
E+ + ++ QI A+ +H+ +I+H D+K N FL G+++L DFGIA+ +
Sbjct: 118 -KGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLN 176
Query: 651 SDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGRTPF 710
S + + +GT Y+SPE +C SDIW+LGC+LY++ + F
Sbjct: 177 STVELAR--ACIGTPYYLSPE--ICEN-------KPYNNKSDIWALGCVLYELCTLKHAF 225
Query: 711 SEYKTFWAKFKVITDPNHEITYEPVPN---PWLLDLMKKCLAWDRNERWRIPQLLQHPFL 767
K+I+ + PV L L+ + + +R + +L+ F+
Sbjct: 226 EAGSMKNLVLKIISGS-----FPPVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILEKGFI 280
Query: 768 VPPVSTQPSSSQDQSYQLLQLLAEASASDHEASTICSQLSQLIRNPV 814
+ S L+ ++ + A S + + P
Sbjct: 281 AKRIEKFLSPQLIAEEFCLKTFSKFGSQPIPAKRPASGQNSISVMPA 327
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 190 bits (484), Expect = 2e-54
Identities = 79/340 (23%), Positives = 131/340 (38%), Gaps = 48/340 (14%)
Query: 453 ASAPRKRNYDPDLFFKVNGKLYQRLGKIGSGGSSEVHKVIS-SDCTIYALKKIKLKGR-D 510
S+ R+ Y ++ K Y + K+G GG S V V D YALK+I + D
Sbjct: 10 HSSGRENLYFQGHMVIIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQD 69
Query: 511 YATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLREVLNGSMNNKDGRVKDDGYIYM 570
A +E + N I++L+ Y + E+ E ++
Sbjct: 70 REEAQ---READMHRLFNHPN-ILRLVAYCLRERGAKHEA------------------WL 107
Query: 571 VLEY---GEIDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLK 627
+L + G L + + + L E+ + + I + IH + H DLK
Sbjct: 108 LLPFFKRGT------LWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLK 161
Query: 628 PANFLLVK-GSLKLIDFGIAKAIMSDTTNIQR-------DSQVGTLSYMSPEAFMCNESD 679
P N LL G L+D G ++ +Q T+SY +PE + +
Sbjct: 162 PTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPE--LFS--V 217
Query: 680 ENGNIIKCGRPSDIWSLGCILYQMVYGRTPFSEYKTFWAKFKVITDPNHEITYEPVPNPW 739
++ +I +D+WSLGC+LY M++G P+ + I P +
Sbjct: 218 QSHCVI--DERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQNQLSIPQSPRHSSA 275
Query: 740 LLDLMKKCLAWDRNERWRIPQLLQHP-FLVPPVSTQPSSS 778
L L+ + D ++R IP LL L PP Q ++
Sbjct: 276 LWQLLNSMMTVDPHQRPHIPLLLSQLEALQPPAPGQHTTQ 315
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 182 bits (464), Expect = 5e-52
Identities = 80/307 (26%), Positives = 129/307 (42%), Gaps = 52/307 (16%)
Query: 474 YQRLGKIGSGGSSEVHKVIS-SDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNN 532
Y+ L IG+G K+ SD I K++ A E+ L +LK N
Sbjct: 8 YEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPN- 66
Query: 533 IIQLIDYEVTEKALLREVLNGSMNNKDGRVKDDGYIYMVLEYGEI-DLAHMLSQKWKEMD 591
I++ D + + +Y+V+EY E DLA ++ +
Sbjct: 67 IVRYYDRIIDR--------------------TNTTLYIVMEYCEGGDLASVI----TKGT 102
Query: 592 GSNQTLDENWLRFYWQQILEAVNTIHEER-----IVHSDLKPAN-FLLVKGSLKLIDFGI 645
Q LDE ++ Q+ A+ H ++H DLKPAN FL K ++KL DFG+
Sbjct: 103 KERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGL 162
Query: 646 AKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVY 705
A+ + DT+ + VGT YMSPE N + SDIWSLGC+LY++
Sbjct: 163 ARILNHDTS--FAKTFVGTPYYMSPE--QMNR-------MSYNEKSDIWSLGCLLYELCA 211
Query: 706 GRTPFSEYKTFWAKFKVITDPNHEITYEPVPNPW---LLDLMKKCLAWDRNERWRIPQLL 762
PF + I E + +P + L +++ + L R + ++L
Sbjct: 212 LMPPF-TAFSQKELAGKIR----EGKFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEIL 266
Query: 763 QHPFLVP 769
++P ++
Sbjct: 267 ENPLILE 273
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 180 bits (458), Expect = 6e-51
Identities = 72/354 (20%), Positives = 118/354 (33%), Gaps = 56/354 (15%)
Query: 421 KSQAPLSKNSSSDMKLEASKSEKQEKAVSSKGA--SAPRKRNYDPDLFFKVNGKLYQRLG 478
+ ++ S + Q + VS +G + YDP + +QRL
Sbjct: 4 HHHHSSGVDLGTENLYFQSMHQLQPRRVSFRGEASETLQSPGYDPSRPESFFQQSFQRLS 63
Query: 479 KIGSGGSSEVHKVIS-SDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLI 537
++G G EV KV S D +YA+K+ R E+ K+ ++L
Sbjct: 64 RLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLE 123
Query: 538 DYEVTEKALLREVLNGSMNNKDGRVKDDGYIYMVLEYGEIDLAHMLSQKWKEMDGSNQTL 597
++ G +Y+ E L +L
Sbjct: 124 Q----------------------AWEEGGILYLQTELCGPSLQQHCEAW-------GASL 154
Query: 598 DENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLLVK-GSLKLIDFGIAKAIMSDTTNI 656
E + Y + L A+ +H + +VH D+KPAN L G KL DFG+ + T
Sbjct: 155 PEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVEL---GTAG 211
Query: 657 QRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGRTPFSEYKTF 716
+ Q G YM+PE + G +D++SLG + ++ +
Sbjct: 212 AGEVQEGDPRYMAPE--LLQG--------SYGTAADVFSLGLTILEVACNMELPHGGEG- 260
Query: 717 WAKFKVITDPNHEITYEPVPNPW---LLDLMKKCLAWDRNERWRIPQLLQHPFL 767
W + + P L ++ L D R LL P L
Sbjct: 261 WQQLRQGYLP------PEFTAGLSSELRSVLVMMLEPDPKLRATAEALLALPVL 308
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 177 bits (452), Expect = 3e-50
Identities = 65/324 (20%), Positives = 123/324 (37%), Gaps = 60/324 (18%)
Query: 474 YQRLGKIGSGGSSEVHKVIS-SDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNN 532
++ + +G G +V K + D YA+KKI+ +T E+ L L
Sbjct: 8 FEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTIL---SEVMLLASLN-HQY 63
Query: 533 IIQLIDYEVTEKALLREVLNGSMNNKDGRVKDDGYIYMVLEY---GEIDLAHMLSQKWKE 589
+++ Y + + VK +++ +EY G L
Sbjct: 64 VVRY--YAAWLE-------RRNFVKPMTAVKKKSTLFIQMEYCENGT------LYDLIHS 108
Query: 590 MDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLLVK-GSLKLIDFGIAKA 648
N + ++QILEA++ IH + I+H DLKP N + + ++K+ DFG+AK
Sbjct: 109 E---NLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKN 165
Query: 649 IMSDT------------TNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSL 696
+ ++ S +GT Y++ E + + + K D++SL
Sbjct: 166 VHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATE--VLDGTGHYNE--KI----DMYSL 217
Query: 697 GCILYQMVYGRTPFSEYKTFWAKFKVITDPNHEITYEPVPNPW------LLDLMKKCLAW 750
G I ++M+Y + E K + ++ E P+ +++ +
Sbjct: 218 GIIFFEMIYPFSTGMERVNILKKLR-------SVSIEFPPDFDDNKMKVEKKIIRLLIDH 270
Query: 751 DRNERWRIPQLLQHPFLVPPVSTQ 774
D N+R LL +L +
Sbjct: 271 DPNKRPGARTLLNSGWLPVKHQDE 294
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 176 bits (449), Expect = 1e-49
Identities = 81/320 (25%), Positives = 130/320 (40%), Gaps = 53/320 (16%)
Query: 474 YQRLGKIGSGGSSEVHKVIS-SDCTIYALKKIKLKGRDYATAYGFC-QEIEYLNKLKGKN 531
++ KIG G SEV++ D ALKK+++ A A C +EI+ L +L
Sbjct: 34 FRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLN-HP 92
Query: 532 NIIQLIDYEVTEKALLREVLNGSMNNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEM 590
N+I+ +D + +VLE + DL+ M+ K
Sbjct: 93 NVIKYYA----------------------SFIEDNELNIVLELADAGDLSRMI----KHF 126
Query: 591 DGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPAN-FLLVKGSLKLIDFGIAKAI 649
+ + E + Y+ Q+ A+ +H R++H D+KPAN F+ G +KL D G+ +
Sbjct: 127 KKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFF 186
Query: 650 MSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGRTP 709
S S VGT YMSPE +E+ SDIWSLGC+LY+M ++P
Sbjct: 187 SS--KTTAAHSLVGTPYYMSPE--RIHEN-------GYNFKSDIWSLGCLLYEMAALQSP 235
Query: 710 FSEYKTFWAK--FKVITDPNHEITYEPVPN----PWLLDLMKKCLAWDRNERWRIPQLLQ 763
F K K+ Y P+P+ L L+ C+ D +R + +
Sbjct: 236 FYGDKMNLYSLCKKIEQCD-----YPPLPSDHYSEELRQLVNMCINPDPEKRPDVTYVYD 290
Query: 764 HPFLVPPVSTQPSSSQDQSY 783
+ + +
Sbjct: 291 VAKRMHACTASSLEHHHHHH 310
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 175 bits (445), Expect = 3e-49
Identities = 65/310 (20%), Positives = 129/310 (41%), Gaps = 49/310 (15%)
Query: 474 YQRLGKIGSGGSSEVHKVIS-SDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNN 532
++ + +G GG V + + D YA+K+I+L R+ A +E++ L KL+
Sbjct: 7 FEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELARE-KVMREVKALAKLEHPG- 64
Query: 533 IIQLIDYEVTEKALLREVLNGSMNNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEMD 591
I++ + + + + K Y+Y+ ++ +L ++ +
Sbjct: 65 IVRYFNAWLEK----------NTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGR----- 109
Query: 592 GSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPAN-FLLVKGSLKLIDFGIAKAIM 650
+ + + + + QI EAV +H + ++H DLKP+N F + +K+ DFG+ A+
Sbjct: 110 CTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMD 169
Query: 651 SDT----------TNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCIL 700
D + QVGT YMSPE + + + DI+SLG IL
Sbjct: 170 QDEEEQTVLTPMPAYARHTGQVGTKLYMSPE--QIHGNSYS-------HKVDIFSLGLIL 220
Query: 701 YQMVYGRTPFSEYKTFWAKFKVITDPNHEITYEPVPN---PWLLDLMKKCLAWDRNERWR 757
++++Y PFS + + + P+ P +++ L+ ER
Sbjct: 221 FELLY---PFSTQMERVRTLTDV----RNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPE 273
Query: 758 IPQLLQHPFL 767
++++
Sbjct: 274 AINIIENAVF 283
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 166 bits (422), Expect = 7e-46
Identities = 65/333 (19%), Positives = 112/333 (33%), Gaps = 68/333 (20%)
Query: 468 KVNGKLYQRLGKIGSGGSSEVHKVISSDC-TIYALKKIKLKGRDYATAYGFCQEIEYLNK 526
+ L+ +G G ++ V + ++A+K +E E L K
Sbjct: 5 STSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFN-NISFLRPVDVQMREFEVLKK 63
Query: 527 LKGKNNIIQLIDYEVTEKALLREVLNGSMNNKDGRVKDDGYIYMVLEY---GEIDLAHML 583
L KN I++L + + E+ + +++E+ G L +L
Sbjct: 64 LNHKN-IVKL--FAIEEE------------------TTTRHKVLIMEFCPCGS--LYTVL 100
Query: 584 SQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLLVKGS-----L 638
+ + L E+ + ++ +N + E IVH ++KP N + V G
Sbjct: 101 EEP-----SNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVY 155
Query: 639 KLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGC 698
KL DFG A+ + D Q S GT Y+ P+ + ++ K G D+WS+G
Sbjct: 156 KLTDFGAARELEDDE---QFVSLYGTEEYLHPDMYERAVLRKDHQ-KKYGATVDLWSIGV 211
Query: 699 ILYQMVYGRTPFSEY----------------KTFWAKFKVITDPNHEITYEPVPNPW--- 739
Y G PF + K A V N I +
Sbjct: 212 TFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSL 271
Query: 740 -------LLDLMKKCLAWDRNERWRIPQLLQHP 765
L ++ L D+ + W Q
Sbjct: 272 SRGLQVLLTPVLANILEADQEKCWGFDQFFAET 304
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 166 bits (422), Expect = 1e-45
Identities = 70/347 (20%), Positives = 125/347 (36%), Gaps = 52/347 (14%)
Query: 449 SSKGASAPRKRNYDPDLFFKVNGKLYQRLGKIGSGGSSEVHKVIS-SDCTIYALKKIKLK 507
S G ++ R ++ ++ + + GG + V++ YALK++
Sbjct: 5 GSLGGASGRDQSDFVGQTVELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSN 64
Query: 508 GRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLREVLNGSMNNKDGRVKDDGY 567
+ A QE+ ++ KL G NI+Q K
Sbjct: 65 EEEKNRA--IIQEVCFMKKLSGHPNIVQFCSAASIGKE---------------ESDTGQA 107
Query: 568 IYMVLEY---GEIDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEER--IV 622
+++L G+ + + + S L + + + Q AV +H ++ I+
Sbjct: 108 EFLLLTELCKGQ-LVEFLKKME------SRGPLSCDTVLKIFYQTCRAVQHMHRQKPPII 160
Query: 623 HSDLKPANFLLVK-GSLKLIDFGIAKAIMSDTTNIQRDSQ----------VGTLSYMSPE 671
H DLK N LL G++KL DFG A I + T Y +PE
Sbjct: 161 HRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPE 220
Query: 672 AFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGRTPFSEYKTFWAKFKVITDPNHEIT 731
+ + + I G DIW+LGCILY + + + PF + AK +++ + I
Sbjct: 221 --IIDL--YSNFPI--GEKQDIWALGCILYLLCFRQHPFEDG----AKLRIVNG-KYSIP 269
Query: 732 YEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQHPFLVPPVSTQPSSS 778
L++ L + ER I +++ + S
Sbjct: 270 PHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAARNVNPKS 316
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 161 bits (410), Expect = 1e-44
Identities = 56/326 (17%), Positives = 97/326 (29%), Gaps = 79/326 (24%)
Query: 472 KLYQRLGKIGSGGSSEVHKVIS-SDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGK 530
+ L KIGSG V K + D IYA+K+ K +E+ L
Sbjct: 11 TEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQH 70
Query: 531 NNIIQLIDYEVTEKALLREVLNGSMNNKDGRVKDDGYIYMVLEY-GEIDLAHMLSQKWKE 589
+++++ +D ++ + EY LA + E
Sbjct: 71 SHVVRYFSAWA----------------------EDDHMLIQNEYCNGGSLADAI----SE 104
Query: 590 MDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLL---------------- 633
E L+ Q+ + IH +VH D+KP+N +
Sbjct: 105 NYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDED 164
Query: 634 ----VKGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGR 689
K K+ D G I S + G +++ E N +
Sbjct: 165 DWASNKVMFKIGDLGHVTRISS------PQVEEGDSRFLANEVLQENYT--------HLP 210
Query: 690 PSDIWSLGCILYQMVYGRTPFSEYKTFWAKFKVITDPNHEI---TYEPVPNPW---LLDL 743
+DI++L + + HEI +P +L
Sbjct: 211 KADIFALALTVVCAAGAEPLPRNGDQW-----------HEIRQGRLPRIPQVLSQEFTEL 259
Query: 744 MKKCLAWDRNERWRIPQLLQHPFLVP 769
+K + D R L++H L+
Sbjct: 260 LKVMIHPDPERRPSAMALVKHSVLLS 285
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 164 bits (415), Expect = 2e-44
Identities = 50/376 (13%), Positives = 113/376 (30%), Gaps = 33/376 (8%)
Query: 421 KSQAPLSKNSSSDMKLEASKSEKQEKAVSSKGASAPRKRNYDPDLFFKVNGKLYQRLGKI 480
+ + + +K A+ E V + A + + + +
Sbjct: 17 REEELIGYCREEALKEPAAMVEAVTATVWPQNAETTVDSLLSQG------ERKLKLVEPL 70
Query: 481 GSGGSSEVHKVISSD-CTIYALKKIKLKGR-DYATAYGFCQEIEYLNKLKGKNNIIQLID 538
G S V V + +ALK + + + +L G++
Sbjct: 71 RVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDR 130
Query: 539 YEVTEKALLREVLNGSMNNKDGRVKDDGYI---YMVLEYGEIDLAHMLSQKWKEMDGSNQ 595
+ + V + + +DD + +++ +DL + S +
Sbjct: 131 RRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFST-LDFVYVFRG 189
Query: 596 TLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLLVK-GSLKLIDFGIAKAIMSDTT 654
L Q++ + + +VH P N ++ G L L D + +
Sbjct: 190 DEGILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTRGP 249
Query: 655 NIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGRTPFSE-- 712
++Y E + + + W LG +Y++ PF
Sbjct: 250 AS-----SVPVTYAPREFLNASTAT-------FTHALNAWQLGLSIYRVWCLFLPFGLVT 297
Query: 713 --YKTFWAKFKVITDPNHEITYEPVPN--PWLLDLMKKCLAWDRNERWRIPQLLQHPFLV 768
K W + + + + ++ L+ + L +DR R + ++ P +
Sbjct: 298 PGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEFL 357
Query: 769 PPVSTQPSSSQDQSYQ 784
+ + SSS + Q
Sbjct: 358 -QLQNEISSSL-STGQ 371
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 163 bits (414), Expect = 1e-43
Identities = 68/336 (20%), Positives = 129/336 (38%), Gaps = 51/336 (15%)
Query: 467 FKVNGKLYQRLGK-IGSGGSSEVHKVISSDCTIYALKKIKLKGRDYATAYGFCQEIEYLN 525
F+ + K K +G G S V S A+K++ + D A EI+ L
Sbjct: 9 FEQSLKNLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDFCDIAL-----MEIKLLT 63
Query: 526 KLKGKNNIIQLIDYEVTEKALLREVLNGSMNNKDGRVKDDGYIYMVLEYGEIDLAHMLSQ 585
+ N+I+ E D ++Y+ LE ++L ++
Sbjct: 64 ESDDHPNVIRYYCSE----------------------TTDRFLYIALELCNLNLQDLVES 101
Query: 586 KWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLLVKGS-------- 637
K D + + E +QI V +H +I+H DLKP N L+ S
Sbjct: 102 K-NVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQT 160
Query: 638 ------LKLIDFGIAKAIMSDTTNIQRDSQ--VGTLSYMSPEAFMCNESDENGNIIKCGR 689
+ + DFG+ K + S ++ + + GT + +PE + + + + R
Sbjct: 161 GAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKR--RLTR 218
Query: 690 PSDIWSLGCILYQMV-YGRTPFSEYKTFWAKFK--VITDPNHEITYEPVPNPWLLDLMKK 746
DI+S+GC+ Y ++ G+ PF + + + + + + ++ DL+ +
Sbjct: 219 SIDIFSMGCVFYYILSKGKHPFGDKYSRESNIIRGIFSLDEMKCLHDRSLIAEATDLISQ 278
Query: 747 CLAWDRNERWRIPQLLQHPFLVPPVSTQPSSSQDQS 782
+ D +R ++L+HP P S + S
Sbjct: 279 MIDHDPLKRPTAMKVLRHPLFWPK-SKKLEFLLKVS 313
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 159 bits (403), Expect = 1e-43
Identities = 84/343 (24%), Positives = 134/343 (39%), Gaps = 61/343 (17%)
Query: 447 AVSSKGASAPRKRNYDPDLFFKVNGKLYQRLGKIGSGGSSEVHKVISSDC-TIYALKKIK 505
+ +G YD + + + +G G V+ A+K+I
Sbjct: 3 RSTEEGDCESDLLEYDYEYDENGDRVV------LGKGTYGIVYAGRDLSNQVRIAIKEIP 56
Query: 506 LKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLREVLNGSMNNKDGRVKDD 565
+ Y+ +EI LK KN I+Q Y G ++
Sbjct: 57 ERDSRYSQP--LHEEIALHKHLKHKN-IVQ---YL-------------------GSFSEN 91
Query: 566 GYIYMVLEY---GEIDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIV 622
G+I + +E G + + +L KW + +E + FY +QILE + +H+ +IV
Sbjct: 92 GFIKIFMEQVPGGSL--SALLRSKWGPL-----KDNEQTIGFYTKQILEGLKYLHDNQIV 144
Query: 623 HSDLKPANFLL--VKGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDE 680
H D+K N L+ G LK+ DFG +K + N ++ GTL YM+PE
Sbjct: 145 HRDIKGDNVLINTYSGVLKISDFGTSKRL--AGINPCTETFTGTLQYMAPEII------- 195
Query: 681 NGNIIKCGRPSDIWSLGCILYQMVYGRTPFSEYKTFW-AKFKVITDPNHEITYEPVPNPW 739
+ G+ +DIWSLGC + +M G+ PF E A FKV H +P
Sbjct: 196 DKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVH----PEIPESM 251
Query: 740 ---LLDLMKKCLAWDRNERWRIPQLLQHPFLVPPVSTQPSSSQ 779
+ KC D ++R LL FL + + +
Sbjct: 252 SAEAKAFILKCFEPDPDKRACANDLLVDEFLKVSSKKKKTQPK 294
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 157 bits (399), Expect = 3e-42
Identities = 44/375 (11%), Positives = 111/375 (29%), Gaps = 28/375 (7%)
Query: 405 HKSMEGRQHTGNS-PELKSQAPLSKNSSSDMKLEASKSEKQEKAVSSKGASAPRKRNYDP 463
H GR++ P L S+ + + + +
Sbjct: 5 HHHSSGRENLYFQGPGDVVIEELFNRIPQANVRTTSEYMQSAADSLVSTSLWNTGQPFRV 64
Query: 464 DLFFKVNGKLYQRLGKIGSGGSSEVHKVI-SSDCTIYALKKI-KLKGRDYATAYGFCQEI 521
+ + R +G + + + + +E+
Sbjct: 65 ESELGERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEV 124
Query: 522 EYLNKLKGKNNIIQLIDYEVTEKALLREVLNGSMNNKDGRVKDDGY------IYMVLEYG 575
L L+G N Q + +++ K RV+ D + +
Sbjct: 125 LRLRLLRGIKNQKQAKVHL--RFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM 182
Query: 576 EIDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLL-V 634
+ +L + ++++L + Q++ + ++H +VH+ L+P + +L
Sbjct: 183 QSNLQTFG-EVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQ 241
Query: 635 KGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKC--GRPSD 692
+G + L F + + + + PE + + D
Sbjct: 242 RGGVFLTGFEHLVRDGARVVS------SVSRGFEPPELEARRATISYHRDRRTLMTFSFD 295
Query: 693 IWSLGCILYQMVYGRTPFSEYKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDR 752
W+LG ++Y + P ++ + + +P + L++ L + +
Sbjct: 296 AWALGLVIYWIWCADLPITKDAALGGSEWIFRSCKN------IP-QPVRALLEGFLRYPK 348
Query: 753 NERWRIPQLLQHPFL 767
+R Q ++ P
Sbjct: 349 EDRLLPLQAMETPEY 363
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 158 bits (400), Expect = 3e-42
Identities = 74/407 (18%), Positives = 135/407 (33%), Gaps = 81/407 (19%)
Query: 468 KVNGKLYQRLGKIGSGGSSEVHKVISSDC-TIYALKKIKLKGRDYATAYGFCQEIEYLNK 526
+ L+ +G G ++ V + ++A+K +E E L K
Sbjct: 5 STSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFN-NISFLRPVDVQMREFEVLKK 63
Query: 527 LKGKNNIIQLIDYEVTEKALLREVLNGSMNNKDGRVKDDGYIYMVLEY---GEIDLAHML 583
L KN I++L + + E+ + +++E+ G L +L
Sbjct: 64 LNHKN-IVKL--FAIEEE------------------TTTRHKVLIMEFCPCGS--LYTVL 100
Query: 584 SQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLLVKGS-----L 638
+ + L E+ + ++ +N + E IVH ++KP N + V G
Sbjct: 101 EEP-----SNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVY 155
Query: 639 KLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGC 698
KL DFG A+ + D Q S GT Y+ P+ + ++ K G D+WS+G
Sbjct: 156 KLTDFGAARELEDDE---QFVSLYGTEEYLHPDMYERAVLRKDHQ-KKYGATVDLWSIGV 211
Query: 699 ILYQMVYGRTPFSEY----------------KTFWAKFKVITDPNHEITYEPVPNPW--- 739
Y G PF + K A V N I +
Sbjct: 212 TFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSL 271
Query: 740 -------LLDLMKKCLAWDRNERWRIPQLLQ-----------HPFLVP--PVSTQPSSSQ 779
L ++ L D+ + W Q H F + S
Sbjct: 272 SRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHRMVIHVFSLQQMTAHKIYIHSY 331
Query: 780 DQSYQLLQLLAEASASDHEASTICSQLSQLIRNPVMLAATQLSTSQD 826
+ + +L+ + + + + +L+ P LA T+++
Sbjct: 332 NTATIFHELVYKQTKIISSNQELIYEGRRLVLEPGRLAQHFPKTTEE 378
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 154 bits (390), Expect = 7e-42
Identities = 66/300 (22%), Positives = 125/300 (41%), Gaps = 46/300 (15%)
Query: 474 YQRLGK-IGSGGSSEVHKVISSDCTI-YALKKIKLKGRDYATAYGFCQEIEYLNKLKGKN 531
+ + IG G V+K + ++ T+ A +++ + + F +E E L L+ N
Sbjct: 27 FLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPN 86
Query: 532 NIIQLIDYEVTEKALLREVLNGSMNNKDGRVKDDGYIYMVLEYGEIDLAHMLSQKWKEMD 591
I++ D + VK I +V E M S K
Sbjct: 87 -IVRFYDSWEST------------------VKGKKCIVLVTEL-------MTSGTLKTYL 120
Query: 592 GSNQTLDENWLRFYWQQILEAVNTIHEER--IVHSDLKPANFLL--VKGSLKLIDFGIAK 647
+ + LR + +QIL+ + +H I+H DLK N + GS+K+ D G+A
Sbjct: 121 KRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT 180
Query: 648 AIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGR 707
+ + + +GT +M+PE M E K D+++ G + +M
Sbjct: 181 -LKRASF---AKAVIGTPEFMAPE--MYEE--------KYDESVDVYAFGMCMLEMATSE 226
Query: 708 TPFSEYKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQHPFL 767
P+SE + ++ +T +++ V P + ++++ C+ +++ER+ I LL H F
Sbjct: 227 YPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFF 286
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 154 bits (390), Expect = 1e-41
Identities = 62/344 (18%), Positives = 124/344 (36%), Gaps = 72/344 (20%)
Query: 474 YQRLGKIGSGGSSEVHKVIS-SDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNN 532
++ + +G GG V + + D YA+K+I+L R+ A +E++ L KL+
Sbjct: 8 FEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREK-VMREVKALAKLEHPGI 66
Query: 533 IIQLIDYEVT----------------------------------EKALLREVLNGSMNNK 558
+ + T + + + +
Sbjct: 67 VRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQ 126
Query: 559 DGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIH 617
Y+Y+ ++ +L ++++ S + + + QI EAV +H
Sbjct: 127 LQPSSPKVYLYIQMQLCRKENLKDWMNRR-----CSLEDREHGVCLHIFIQIAEAVEFLH 181
Query: 618 EERIVHSDLKPAN-FLLVKGSLKLIDFGIAKAIMSDT----------TNIQRDSQVGTLS 666
+ ++H DLKP+N F + +K+ DFG+ A+ D QVGT
Sbjct: 182 SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKL 241
Query: 667 YMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGRTPFSEYKTFWAKFKVITDP 726
YMSPE + + DI+SLG IL++++Y + E +
Sbjct: 242 YMSPE--QIHGN-------NYSHKVDIFSLGLILFELLYSFSTQMERVRIITDVR----- 287
Query: 727 NHEITYEPVPN---PWLLDLMKKCLAWDRNERWRIPQLLQHPFL 767
+ + + P +++ L+ ER ++++
Sbjct: 288 --NLKFPLLFTQKYPQEHMMVQDMLSPSPTERPEATDIIENAIF 329
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 155 bits (394), Expect = 2e-41
Identities = 42/415 (10%), Positives = 111/415 (26%), Gaps = 28/415 (6%)
Query: 400 NDPSTHKSMEGRQHTGNSPELKSQAPLSKNSSSDMKLEASKSEKQEKAVSSKGASAPRKR 459
+ + +G G P L S+ + + +
Sbjct: 8 SSGRENLYFQG--FRGTDPGDVVIEELFNRIPQANVRTTSEYMQSAADSLVSTSLWNTGQ 65
Query: 460 NYDPDLFFKVNGKLYQRLGKIGSGGSSEVHKVI-SSDCTIYALKKIKLKGRDYATAY-GF 517
+ + + R +G + + + R + A
Sbjct: 66 PFRVESELGERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQM 125
Query: 518 CQEIEYLNKLKGKNNIIQLIDYEVTEKALLREVLNGSMNNKDGRVKDDGY----IYMVLE 573
+E+ L L+G N Q + R+ + + +
Sbjct: 126 KEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYP 185
Query: 574 YGEIDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLL 633
+ +L + ++++L + Q++ + ++H +VH+ L+P + +L
Sbjct: 186 RMQSNLQ-TFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVL 244
Query: 634 VK-GSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSD 692
+ G + L F + + + D
Sbjct: 245 DQRGGVFLTGFEHLVR-DGASAVSPIGRGFAPPETTAERMLPFGQHHPT----LMTFAFD 299
Query: 693 IWSLGCILYQMVYGRTPFSEYKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDR 752
W+LG +Y + P ++ + + +P + L++ L + +
Sbjct: 300 TWTLGLAIYWIWCADLPNTDDAALGGSEWIFRSC------KNIP-QPVRALLEGFLRYPK 352
Query: 753 NERWRIPQLLQHPFL------VPPVSTQPSSSQDQSYQLLQLLAEASASDHEAST 801
+R Q ++ P + + + + + + S D +
Sbjct: 353 EDRLLPLQAMETPEYEQLRTELSAALPLYQTDGEPTREGGAPPSGTSQPDEAGAA 407
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 154 bits (392), Expect = 8e-41
Identities = 63/319 (19%), Positives = 114/319 (35%), Gaps = 49/319 (15%)
Query: 458 KRNYDPDLFFKVNGKL-YQRLGKIGSGGSSEVHKVISSDCTIYALKKIKLKGRDYATAYG 516
+ + D + + GK+ + +G G + D A+K+I + +A
Sbjct: 9 QDDGDEETSVVIVGKISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFSFAD--- 65
Query: 517 FCQEIEYLNKLKGKNNIIQLIDYEVTEKALLREVLNGSMNNKDGRVKDDGYIYMVLEYGE 576
+E++ L + N+I+ E KD + Y+ +E
Sbjct: 66 --REVQLLRESDEHPNVIRYFCTE----------------------KDRQFQYIAIELCA 101
Query: 577 IDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLLVKG 636
L + QK + QQ + +H IVH DLKP N L+
Sbjct: 102 ATLQEYVEQK-------DFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMP 154
Query: 637 S------LKLIDFGIAKAIMSDTTNI-QRDSQVGTLSYMSPEAFMCNESDENGNIIKCGR 689
+ + DFG+ K + + +R GT +++PE + +
Sbjct: 155 NAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKE------NPTY 208
Query: 690 PSDIWSLGCILYQM-VYGRTPFSEYKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCL 748
DI+S GC+ Y + G PF + A + + E + +L++K +
Sbjct: 209 TVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSLDCLHPEKHEDVIARELIEKMI 268
Query: 749 AWDRNERWRIPQLLQHPFL 767
A D +R +L+HPF
Sbjct: 269 AMDPQKRPSAKHVLKHPFF 287
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 148 bits (377), Expect = 5e-40
Identities = 82/316 (25%), Positives = 130/316 (41%), Gaps = 65/316 (20%)
Query: 472 KLYQRLGKIGSGGSSEVHKVIS-SDCTIYALKKIKLKGRDYATA-------YGFCQEIEY 523
+ Y+ +G G SS V + I C YA+K I + G +A +E++
Sbjct: 17 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 76
Query: 524 LNKLKGKNNIIQLID-YEVTEKALLREVLNGSMNNKDGRVKDDGYIYMVLEY---GEIDL 579
L K+ G NIIQL D YE + + ++V + GE L
Sbjct: 77 LRKVSGHPNIIQLKDTYE-----------------------TNTFFFLVFDLMKKGE--L 111
Query: 580 AHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLLVKGS-L 638
L++K TL E R + +LE + +H+ IVH DLKP N LL +
Sbjct: 112 FDYLTEK--------VTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNI 163
Query: 639 KLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGC 698
KL DFG + + D R+ GT SY++PE C+ +D + G+ D+WS G
Sbjct: 164 KLTDFGFSCQL--DPGEKLREV-CGTPSYLAPEIIECSMNDNHPG---YGKEVDMWSTGV 217
Query: 699 ILYQMVYGRTPF---SEYKTF----WAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWD 751
I+Y ++ G PF + ++ + + + DL+ + L
Sbjct: 218 IMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWDDYSDTV------KDLVSRFLVVQ 271
Query: 752 RNERWRIPQLLQHPFL 767
+R+ + L HPF
Sbjct: 272 PQKRYTAEEALAHPFF 287
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 149 bits (378), Expect = 8e-40
Identities = 70/367 (19%), Positives = 130/367 (35%), Gaps = 65/367 (17%)
Query: 410 GRQHTGNSPELKSQAPLSKNSSSDMKLEASKSEKQEKAVSSKGASAPRKRNYDPDLFFKV 469
G +G + L S A + S+ ++ ++E E + ++ +
Sbjct: 3 GSVSSGQAHSLASLAKTWSSGSAKLQRLGPETEDNEGVLLTEKLKPVDYEYREE------ 56
Query: 470 NGKLYQRLGKIGSGGSSEVHKVISSDC-TIYALKKIKLKGRDYATAYGFCQEIEYLNKLK 528
++G G EVH++ A+KK++L+ +E+ L
Sbjct: 57 -VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRV-------EELVACAGLS 108
Query: 529 GKNNIIQLIDYEVTEKALLREVLNGSMNNKDGRVKDDGYIYMVLEYGEIDLAHMLSQKWK 588
I+ L G V++ ++ + +E E L ++
Sbjct: 109 SPR-IVPLY----------------------GAVREGPWVNIFMELLEGGSLGQLIKQMG 145
Query: 589 EMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLLVK--GSLKLIDFGIA 646
L E+ +Y Q LE + +H RI+H D+K N LL L DFG A
Sbjct: 146 -------CLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHA 198
Query: 647 KAIMSD---TTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIK---CGRPSDIWSLGCIL 700
+ D + + D GT ++M+PE ++ C DIWS C++
Sbjct: 199 LCLQPDGLGKSLLTGDYIPGTETHMAPE------------VVMGKPCDAKVDIWSSCCMM 246
Query: 701 YQMVYGRTPFSEYKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQ 760
M+ G P+++Y K+ ++P P P +++ L + R +
Sbjct: 247 LHMLNGCHPWTQYFRGPLCLKIASEPPPIREIPPSCAPLTAQAIQEGLRKEPVHRASAME 306
Query: 761 LLQHPFL 767
L +
Sbjct: 307 LRRKVGK 313
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 2e-38
Identities = 71/323 (21%), Positives = 117/323 (36%), Gaps = 41/323 (12%)
Query: 472 KLYQRLGKIGSGGSSEVHKVIS-SDCTIYALKKI---KLKGRDYATAYGFCQEIEYLNKL 527
K Y G IG G V I I A+K + K++ + E+ + KL
Sbjct: 26 KKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKL 85
Query: 528 KGKNNIIQLID-YE-------VTEKAL---LREVLNGSMNNKDGRVKDDGYIYMVLEYGE 576
N I +L + YE V E L + LN +++ G+ D + E
Sbjct: 86 HHPN-IARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPE 144
Query: 577 IDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLLVK- 635
+ + + + E + +QI A++ +H + I H D+KP NFL
Sbjct: 145 CNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFLFSTN 204
Query: 636 --GSLKLIDFGIAKAIMSDTTNIQRDSQ--VGTLSYMSPEAFMCNESDENGNIIKCGRPS 691
+KL+DFG++K GT +++PE N G
Sbjct: 205 KSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVL-------NTTNESYGPKC 257
Query: 692 DIWSLGCILYQMVYGRTPFSEYKTFWAK-----FKVITDPNHEITYEPVPN--PWLLDLM 744
D WS G +L+ ++ G P F + + P DL+
Sbjct: 258 DAWSAGVLLHLLLMGAVP------FPGVNDADTISQVLNKKLCFENPNYNVLSPLARDLL 311
Query: 745 KKCLAWDRNERWRIPQLLQHPFL 767
L + +ER+ + LQHP++
Sbjct: 312 SNLLNRNVDERFDAMRALQHPWI 334
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 3e-38
Identities = 85/397 (21%), Positives = 141/397 (35%), Gaps = 73/397 (18%)
Query: 394 KEGGIPNDPSTHKSMEGRQHTGNSPELKSQAPLSKNSSSDMKLEASKSEKQEKAVSSKGA 453
KE H R+ P + + + ++ + +
Sbjct: 17 KERRRARREIRHLPNLNREQRRAFIRSLRDDPSQSANLLAEAKKLNDAQPKGTENLYFQS 76
Query: 454 SAPRKRNYDPDLFFKVNGKLYQRLGKIGSGGSSEVHKVIS-SDCTIYALKKI---KLKGR 509
P D + + Y IG G SS V + + + +A+K + +
Sbjct: 77 MGPEDELPDWAAAKEFY-QKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLS 135
Query: 510 D---YATAYGFCQEIEYLNKLKGKNNIIQLID-YEVTEKALLREVLNGSMNNKDGRVKDD 565
+E L ++ G +II LID YE
Sbjct: 136 PEQLEEVREATRRETHILRQVAGHPHIITLIDSYE-----------------------SS 172
Query: 566 GYIYMVLEY---GEIDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIV 622
++++V + GE L L++K L E R + +LEAV+ +H IV
Sbjct: 173 SFMFLVFDLMRKGE--LFDYLTEK--------VALSEKETRSIMRSLLEAVSFLHANNIV 222
Query: 623 HSDLKPANFLLVKGS-LKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDEN 681
H DLKP N LL ++L DFG + + + R+ GT Y++PE C+ + +
Sbjct: 223 HRDLKPENILLDDNMQIRLSDFGFSCHL--EPGEKLREL-CGTPGYLAPEILKCSMDETH 279
Query: 682 GNIIKCGRPSDIWSLGCILYQMVYGRTPFSEYKTFWAK-----FKVITDPNHEITYEPVP 736
G+ D+W+ G IL+ ++ G P FW + ++I + Y+
Sbjct: 280 PGY---GKEVDLWACGVILFTLLAGSPP------FWHRRQILMLRMIMEGQ----YQFSS 326
Query: 737 NPWL------LDLMKKCLAWDRNERWRIPQLLQHPFL 767
W DL+ + L D R Q LQHPF
Sbjct: 327 PEWDDRSSTVKDLISRLLQVDPEARLTAEQALQHPFF 363
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 4e-38
Identities = 97/348 (27%), Positives = 143/348 (41%), Gaps = 71/348 (20%)
Query: 472 KLYQRLGKIGSGGSSEVHKVIS-SDCTIYALKKIKLK------GRDYATAYGFCQEIEYL 524
Y +GSG EV C A+K I + R+ A EIE L
Sbjct: 10 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEIL 69
Query: 525 NKLKGKNNIIQLIDYEVTEKALLREVLNGSMNNKDGRVKDDGYIYMVLEY---GEIDLAH 581
KL II++ + D Y+VLE GE L
Sbjct: 70 KKLNHPC-IIKIKN-----------------------FFDAEDYYIVLELMEGGE--LFD 103
Query: 582 MLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLLVKGS---- 637
+ + L E + Y+ Q+L AV +HE I+H DLKP N LL
Sbjct: 104 KVVGN--------KRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCL 155
Query: 638 LKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLG 697
+K+ DFG +K I+ +T+ ++ + GT +Y++PE + + R D WSLG
Sbjct: 156 IKITDFGHSK-ILGETSLMR--TLCGTPTYLAPEVLVSVGTA------GYNRAVDCWSLG 206
Query: 698 CILYQMVYGRTPFSEYKTFWAKFKVITDPNHEITYEPVPNPWL------LDLMKKCLAWD 751
IL+ + G PFSE++T + IT Y +P W LDL+KK L D
Sbjct: 207 VILFICLSGYPPFSEHRTQVSLKDQITSGK----YNFIPEVWAEVSEKALDLVKKLLVVD 262
Query: 752 RNERWRIPQLLQHPFL----VPPVSTQPSSSQDQSYQLLQLLAEASAS 795
R+ + L+HP+L + S +++S L Q+LA+ S S
Sbjct: 263 PKARFTTEEALRHPWLQDEDMKRKFQDLLSEENESTALPQVLAQPSTS 310
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 144 bits (364), Expect = 8e-38
Identities = 65/330 (19%), Positives = 110/330 (33%), Gaps = 75/330 (22%)
Query: 476 RLGK-IGSGGSSEVHKVISSDCTIYALKKIK---------------LKGRDYATAYGFCQ 519
R+ + + G +++ + YALKK + K + F
Sbjct: 34 RIIRTLNQGKFNKIILCEKDN-KFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKN 92
Query: 520 EIEYLNKLKGKNNIIQLIDYEVTEKALLREVLNGSMNNKDGRVKDDGYIYMVLEY---GE 576
E++ + +K + + + + +Y++ EY
Sbjct: 93 ELQIITDIKNEY-CLTC--EGIIT--------------------NYDEVYIIYEYMENDS 129
Query: 577 IDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEER-IVHSDLKPANFLL-V 634
+ + + ++ + +L + + IH E+ I H D+KP+N L+
Sbjct: 130 --ILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDK 187
Query: 635 KGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIW 694
G +KL DFG ++ M D GT +M PE F + G DIW
Sbjct: 188 NGRVKLSDFGESE-YMVDKK---IKGSRGTYEFMPPEFF-------SNESSYNGAKVDIW 236
Query: 695 SLGCILYQMVYGRTPFSEYKTFWAKFKVI-------------TDPNHEITYEPVPNPWL- 740
SLG LY M Y PFS + F I N +L
Sbjct: 237 SLGICLYVMFYNVVPFSLKISLVELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLS 296
Query: 741 ---LDLMKKCLAWDRNERWRIPQLLQHPFL 767
+D +K L + ER L+H +L
Sbjct: 297 NEDIDFLKLFLRKNPAERITSEDALKHEWL 326
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 8e-38
Identities = 72/359 (20%), Positives = 128/359 (35%), Gaps = 78/359 (21%)
Query: 439 SKSEKQEKAVSSKGASAPRKRNYDPDLFFKVNGKLYQRLGKIGSGGSSEVHKVISSDC-T 497
K+ A A+AP + L + + Y R +G GG ++ ++ +D
Sbjct: 8 GKAGVPGVAAPGAPAAAPPAKEIPEVLVDPRSRRRYVRGRFLGKGGFAKCFEISDADTKE 67
Query: 498 IYALKKI-KLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLREVLNGSMN 556
++A K + K EI L ++ ++ + E
Sbjct: 68 VFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQH-VVGF--HGFFE------------- 111
Query: 557 NKDGRVKDDGYIYMVLEY---GEIDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAV 613
D+ ++++VLE L + ++ + L E R+Y +QI+
Sbjct: 112 -------DNDFVFVVLELCRRRS--LLELHKRR--------KALTEPEARYYLRQIVLGC 154
Query: 614 NTIHEERIVHSDLKPANFLL-VKGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEA 672
+H R++H DLK N L +K+ DFG+A + D ++ GT +Y++PE
Sbjct: 155 QYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD--GERKKVLCGTPNYIAPEV 212
Query: 673 FMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGRTPFSEYKTFWAKFKVITDPNHEITY 732
D+WS+GCI+Y ++ G+ PF + TY
Sbjct: 213 LSKKGHSFE---------VDVWSIGCIMYTLLVGKPPFE-------------TSCLKETY 250
Query: 733 E-------PVPNPWL----LDLMKKCLAWDRNERWRIPQLLQHPFLV---PPVSTQPSS 777
+P + L++K L D R I +LL F P +
Sbjct: 251 LRIKKNEYSIP-KHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSGYIPARLPITC 308
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 8e-38
Identities = 88/321 (27%), Positives = 126/321 (39%), Gaps = 77/321 (23%)
Query: 472 KLYQRLGKIGSGGSSEVHKVIS-SDCTIYALKKI---KLKGRDYATA---YGFCQEIEYL 524
Y +GSG EV C A++ I K A EIE L
Sbjct: 135 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEIL 194
Query: 525 NKLKGKNNIIQLIDYEVTEKALLREVLNGSMNNKDGRVKDDGYIYMVLEYGEIDLAHMLS 584
KL II++ + D Y+VLE
Sbjct: 195 KKLNHPC-IIKIKN-----------------------FFDAEDYYIVLEL---------- 220
Query: 585 QKWKEMDG--------SNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLLVKG 636
M+G N+ L E + Y+ Q+L AV +HE I+H DLKP N LL
Sbjct: 221 -----MEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQ 275
Query: 637 S----LKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSD 692
+K+ DFG +K I+ +T+ ++ + GT +Y++PE + R D
Sbjct: 276 EEDCLIKITDFGHSK-ILGETSLMR--TLCGTPTYLAPEVL------VSVGTAGYNRAVD 326
Query: 693 IWSLGCILYQMVYGRTPFSEYKTFWAKFKVITDPNHEITYEPVPNPWL------LDLMKK 746
WSLG IL+ + G PFSE++T + IT Y +P W LDL+KK
Sbjct: 327 CWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGK----YNFIPEVWAEVSEKALDLVKK 382
Query: 747 CLAWDRNERWRIPQLLQHPFL 767
L D R+ + L+HP+L
Sbjct: 383 LLVVDPKARFTTEEALRHPWL 403
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 141 bits (359), Expect = 1e-37
Identities = 66/328 (20%), Positives = 119/328 (36%), Gaps = 78/328 (23%)
Query: 470 NGKLYQRLGKIGSGGSSEVHKVISSDC-TIYALKKI-KLKGRDYATAYGFCQEIEYLNKL 527
+ + Y R +G GG ++ ++ +D ++A K + K EI L
Sbjct: 13 SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSL 72
Query: 528 KGKNNIIQLIDYEVTEKALLREVLNGSMNNKDGRVKDDGYIYMVLEY---GEIDLAHMLS 584
++ ++ + E D+ ++++VLE L +
Sbjct: 73 AHQH-VVGF--HGFFE--------------------DNDFVFVVLELCRRRS--LLELHK 107
Query: 585 QKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLL-VKGSLKLIDF 643
++ + L E R+Y +QI+ +H R++H DLK N L +K+ DF
Sbjct: 108 RR--------KALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDF 159
Query: 644 GIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQM 703
G+A + D ++ GT +Y++PE D+WS+GCI+Y +
Sbjct: 160 GLATKVEYD--GERKKVLCGTPNYIAPEVLSKKGHSFE---------VDVWSIGCIMYTL 208
Query: 704 VYGRTPFSEYKTFWAKFKVITDPNHEITYE-------PVPNPWL----LDLMKKCLAWDR 752
+ G+ PF + TY +P + L++K L D
Sbjct: 209 LVGKPPFE-------------TSCLKETYLRIKKNEYSIP-KHINPVAASLIQKMLQTDP 254
Query: 753 NERWRIPQLLQHPFLV---PPVSTQPSS 777
R I +LL F P +
Sbjct: 255 TARPTINELLNDEFFTSGYIPARLPITC 282
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 2e-37
Identities = 76/340 (22%), Positives = 128/340 (37%), Gaps = 80/340 (23%)
Query: 472 KLYQRLGK--IGSGGSSEVHKVIS-SDCTIYALKKI---KLKGRDYATAYGFCQEIEYLN 525
+YQ L + +G G + V I+ YA+K I R +E+E L
Sbjct: 12 DVYQ-LQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVF-----REVEMLY 65
Query: 526 KLKGKNNIIQLID-YEVTEKALLREVLNGSMNNKDGRVKDDGYIYMVLEY---GEIDLAH 581
+ +G N+++LI+ +E ++ Y+V E G I L+H
Sbjct: 66 QCQGHRNVLELIEFFE-----------------------EEDRFYLVFEKMRGGSI-LSH 101
Query: 582 MLSQKW-KEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLLVK----G 636
+ ++ E++ S Q + A++ +H + I H DLKP N L
Sbjct: 102 IHKRRHFNELEASV----------VVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVS 151
Query: 637 SLKLIDFGIAKAI-----MSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPS 691
+K+ DF + I S + + + G+ YM+PE + + +
Sbjct: 152 PVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASI----YDKRC 207
Query: 692 DIWSLGCILYQMVYGRTPF---SEYKTFWAKFKVITDPNHEI-------TYEPVPNPWLL 741
D+WSLG ILY ++ G PF W + + + + YE W
Sbjct: 208 DLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAH 267
Query: 742 ------DLMKKCLAWDRNERWRIPQLLQHPFLVPPVSTQP 775
DL+ K L D +R Q+LQHP++
Sbjct: 268 ISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENT 307
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 2e-37
Identities = 76/361 (21%), Positives = 131/361 (36%), Gaps = 77/361 (21%)
Query: 441 SEKQEKAVSSKGASAPRKRNYDPDLFFKVNGKLYQRLGKIGSGGSSEVHKVIS-SDCTIY 499
V + + + + F+ + K ++G G + V + IS S Y
Sbjct: 4 HHHHSSGVDLGTENLYFQSMENFNNFYILTSK------ELGRGKFAVVRQCISKSTGQEY 57
Query: 500 ALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLID-YEVTEKALLREVLNGSMNNK 558
A K +K + R EI L K +I L + YE
Sbjct: 58 AAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYE------------------ 99
Query: 559 DGRVKDDGYIYMVLEY---GEIDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNT 615
+ I ++LEY GE + + + EM + EN + +QILE V
Sbjct: 100 -----NTSEIILILEYAAGGE--IFSLCLPELAEM------VSENDVIRLIKQILEGVYY 146
Query: 616 IHEERIVHSDLKPANFLLV----KGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPE 671
+H+ IVH DLKP N LL G +K++DFG+++ I R+ +GT Y++PE
Sbjct: 147 LHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKI--GHACELREI-MGTPEYLAPE 203
Query: 672 AFMCNESDENGNIIKC---GRPSDIWSLGCILYQMVYGRTPF---SEYKTFW----AKFK 721
I+ +D+W++G I Y ++ +PF +T+
Sbjct: 204 ------------ILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVD 251
Query: 722 VITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQHPFLVPPVSTQPSSSQDQ 781
+ ++ D ++ L + +R L H +L ++
Sbjct: 252 YSEETFSSVSQLAT------DFIQSLLVKNPEKRPTAEICLSHSWLQQWDFENLFHPEET 305
Query: 782 S 782
S
Sbjct: 306 S 306
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 3e-37
Identities = 75/317 (23%), Positives = 138/317 (43%), Gaps = 40/317 (12%)
Query: 458 KRNYDPDLFFKVNGKLYQRLGKIGSGGSSEVHKVI-SSDCTIYALKKIKLKGRDYATAYG 516
K P+ + + + LG+IG G V+K++ I A+K+I+ D
Sbjct: 8 KLKISPEQHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTV-DEKEQKQ 66
Query: 517 FCQEIEYLNKLKGKNNIIQLIDYEVTEKALLREVLNGSMNNKDGRVKDDGYIYMVLEYGE 576
+++ + + I+Q Y AL RE G ++ +E
Sbjct: 67 LLMDLDVVMRSSDCPYIVQF--YG----ALFRE----------------GDCWICMELMS 104
Query: 577 IDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEER-IVHSDLKPANFLL-V 634
+ +D + E L ++A+N + E I+H D+KP+N LL
Sbjct: 105 TSFDKFYKYVYSVLDD---VIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDR 161
Query: 635 KGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIW 694
G++KL DFGI+ + D+ I + G YM+PE + S + ++ SD+W
Sbjct: 162 SGNIKLCDFGIS-GQLVDS--IAKTRDAGCRPYMAPERIDPSASRQGYDV-----RSDVW 213
Query: 695 SLGCILYQMVYGRTPFSEYKT-FWAKFKVITDPNHEITYEPVPN--PWLLDLMKKCLAWD 751
SLG LY++ GR P+ ++ + F +V+ +++ P ++ + CL D
Sbjct: 214 SLGITLYELATGRFPYPKWNSVFDQLTQVVKGDPPQLSNSEEREFSPSFINFVNLCLTKD 273
Query: 752 RNERWRIPQLLQHPFLV 768
++R + +LL+HPF++
Sbjct: 274 ESKRPKYKELLKHPFIL 290
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 3e-37
Identities = 73/324 (22%), Positives = 122/324 (37%), Gaps = 85/324 (26%)
Query: 472 KLYQRLGKIGSGGSSEVHKVIS-SDCTIYALKKI---KLKGRDYATAYGFCQEIEYLNKL 527
+Y+ IG G S V + I+ +A+K + K + +E + L
Sbjct: 24 DVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHML 83
Query: 528 KGKNNIIQLID-YEVTEKALLREVLNGSMNNKDGRVKDDGYIYMVLEY---GEIDLAHML 583
K + I++L++ Y DG +YMV E+ + L +
Sbjct: 84 KHPH-IVELLETYS-----------------------SDGMLYMVFEFMDGAD--LCFEI 117
Query: 584 SQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLLV----KGSLK 639
++ + E Y +QILEA+ H+ I+H D+KP LL +K
Sbjct: 118 VKRAD----AGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVK 173
Query: 640 LIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKC---GRPSDIWSL 696
L FG+A + +VGT +M+PE ++K G+P D+W
Sbjct: 174 LGGFGVAIQLGESGLVAG--GRVGTPHFMAPE------------VVKREPYGKPVDVWGC 219
Query: 697 GCILYQMVYGRTPFSEYKTFWAKFKVITDPNHEI-------TYEPVPNPWLL------DL 743
G IL+ ++ G P F+ + Y+ P W DL
Sbjct: 220 GVILFILLSGCLP------FY-------GTKERLFEGIIKGKYKMNPRQWSHISESAKDL 266
Query: 744 MKKCLAWDRNERWRIPQLLQHPFL 767
+++ L D ER + + L HP+L
Sbjct: 267 VRRMLMLDPAERITVYEALNHPWL 290
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 5e-37
Identities = 76/368 (20%), Positives = 132/368 (35%), Gaps = 78/368 (21%)
Query: 427 SKNSSSDMKLEASKSEKQEKAVSSKGASAPRKRNYDPDLFFKVNGKLYQRLGKIGSGGSS 486
+ SS + S ++K A K + YQ +GSGG
Sbjct: 7 HHHHSSGLVPRGSHMAPCNDLHATKLAPGKEKEPLE---------SQYQVGPLLGSGGFG 57
Query: 487 EV----HKVISSDCTIYALKKIKLKGRDYATAYGFCQ-EIEYLNKLK-GKNNIIQLIDYE 540
V + I ++K ++ E+ L K+ G + +I+L +
Sbjct: 58 SVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRL--LD 115
Query: 541 VTEKALLREVLNGSMNNKDGRVKDDGYIYMVLEY--GEIDLAHMLSQKWKEMDGSNQTLD 598
E ++LE DL ++++ L
Sbjct: 116 WFE--------------------RPDSFVLILERPEPVQDLFDFITER--------GALQ 147
Query: 599 ENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLL--VKGSLKLIDFGIAKAIMSDTTNI 656
E R ++ Q+LEAV H ++H D+K N L+ +G LKLIDFG +
Sbjct: 148 EELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSG--------AL 199
Query: 657 QRDSQ----VGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGRTPFSE 712
+D+ GT Y PE + GR + +WSLG +LY MV G PF
Sbjct: 200 LKDTVYTDFDGTRVYSPPEWIRYHRYH--------GRSAAVWSLGILLYDMVCGDIPFEH 251
Query: 713 YKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQHPFLVPPVS 772
+ ++I ++ + + L++ CLA ++R ++ HP++ +
Sbjct: 252 DE------EII---RGQVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLL 302
Query: 773 TQPSSSQD 780
Q ++
Sbjct: 303 PQETAEIH 310
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 9e-37
Identities = 81/420 (19%), Positives = 150/420 (35%), Gaps = 99/420 (23%)
Query: 442 EKQEKAVSSKGASAPRKRNYDPDLFFKVN----GKLYQRLGKIGSGGSSEVHKVIS-SDC 496
S + + +P ++ + G+ Y ++ K+GSG EV +
Sbjct: 2 HHHHHHSSGRENLYFQGIAINPGMYVRKKEGKIGESYFKVRKLGSGAYGEVLLCKEKNGH 61
Query: 497 TIYALKKI---KLKGRDYATAYGFCQ--------EIEYLNKLKGKNNIIQLID-YEVTEK 544
+ A+K I + Y+ + EI L L N II+L D +E
Sbjct: 62 SEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPN-IIKLFDVFE---- 116
Query: 545 ALLREVLNGSMNNKDGRVKDDGYIYMVLEY---GEIDLAHMLSQKWKEMDGSNQTLDENW 601
D Y Y+V E+ GE L ++ DE
Sbjct: 117 -------------------DKKYFYLVTEFYEGGE------LFEQIINR----HKFDECD 147
Query: 602 LRFYWQQILEAVNTIHEERIVHSDLKPANFLLVK----GSLKLIDFGIAKAIMSDTTNIQ 657
+QIL + +H+ IVH D+KP N LL ++K++DFG++ D +
Sbjct: 148 AANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDY---K 204
Query: 658 RDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGRTPFSEYKTFW 717
++GT Y++PE D+WS G I+Y ++ G P F
Sbjct: 205 LRDRLGTAYYIAPEVL-------KKKY---NEKCDVWSCGVIMYILLCGYPP------FG 248
Query: 718 AK-----FKVITDPNHEITYEPVPNPWL----LDLMKKCLAWDRNERWRIPQLLQHPFLV 768
+ K + + ++ + +L+K L +D N+R + L ++
Sbjct: 249 GQNDQDIIKKVE--KGKYYFDFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIK 306
Query: 769 PPVSTQPSSSQDQSYQLLQLLAEASASDHEASTICSQLSQLIRNPVMLAATQLSTSQDQQ 828
+ S Q L + + +L+Q ++ ++L+T ++++
Sbjct: 307 KYANNINKSDQKTLCGALSNMRKFEG--------SQKLAQAA---ILFIGSKLTTLEERK 355
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 9e-37
Identities = 72/361 (19%), Positives = 126/361 (34%), Gaps = 75/361 (20%)
Query: 438 ASKSEKQEKAVSSKGASAPRKRNYDPDLFFKVNGKLYQRLGKIGSGGSSEV----HKVIS 493
+ ++ + + G P D + F Y+ +G GG V
Sbjct: 1 SMLTKPLQGPPAPPGTPTPPPGGKDREAFEAE----YRLGPLLGKGGFGTVFAGHRLTDR 56
Query: 494 SDCTIYALKKIKLKGRDYATAYGFCQ-EIEYLNKLKGKN---NIIQLIDYEVTEKALLRE 549
I + + ++ G + C E+ L K+ +I+L + E
Sbjct: 57 LQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRL--LDWFE------ 108
Query: 550 VLNGSMNNKDGRVKDDGYIYMVLEYGE--IDLAHMLSQKWKEMDGSNQTLDENWLRFYWQ 607
+VLE DL +++K L E R ++
Sbjct: 109 --------------TQEGFMLVLERPLPAQDLFDYITEK--------GPLGEGPSRCFFG 146
Query: 608 QILEAVNTIHEERIVHSDLKPANFLL--VKGSLKLIDFGIAKAIMSDTTNIQRDSQ---- 661
Q++ A+ H +VH D+K N L+ +G KLIDFG + D
Sbjct: 147 QVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSG--------ALLHDEPYTDF 198
Query: 662 VGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGRTPFSEYKTFWAKFK 721
GT Y PE ++ P+ +WSLG +LY MV G PF + +
Sbjct: 199 DGTRVYSPPEWISRHQYH--------ALPATVWSLGILLYDMVCGDIPFERDQ------E 244
Query: 722 VITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQHPFLVPPVSTQPSSSQDQ 781
++ E+ + +P L+++CLA + R + ++L P++ P P +
Sbjct: 245 IL---EAELHFPAHVSPDCCALIRRCLAPKPSSRPSLEEILLDPWMQTPAEDVPLNPSKG 301
Query: 782 S 782
Sbjct: 302 G 302
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 2e-36
Identities = 77/354 (21%), Positives = 130/354 (36%), Gaps = 87/354 (24%)
Query: 472 KLYQRLGKIGSGGSSEVHKVIS-SDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGK 530
L + +G G S K + +A+K I + +EI L +G
Sbjct: 11 DLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQ-----KEITALKLCEGH 65
Query: 531 NNIIQLID-YEVTEKALLREVLNGSMNNKDGRVKDDGYIYMVLEY---GEIDLAHMLSQK 586
NI++L + + D + ++V+E GE+ + +K
Sbjct: 66 PNIVKLHEVFH-----------------------DQLHTFLVMELLNGGEL-FERIKKKK 101
Query: 587 -WKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLLVKGS----LKLI 641
+ E + S ++++ AV+ +H+ +VH DLKP N L + +K+I
Sbjct: 102 HFSETEASY----------IMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKII 151
Query: 642 DFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILY 701
DFG A+ D ++ + TL Y +PE N DE C D+WSLG ILY
Sbjct: 152 DFGFARLKPPDNQPLK--TPCFTLHYAAPELLNQNGYDE-----SC----DLWSLGVILY 200
Query: 702 QMVYGRTPFSEYKTFWAK-FKVITDPNHEI-------TYEPVPNPWLL------DLMKKC 747
M+ G+ P F + + EI + W DL++
Sbjct: 201 TMLSGQVP------FQSHDRSLTCTSAVEIMKKIKKGDFSFEGEAWKNVSQEAKDLIQGL 254
Query: 748 LAWDRNERWRIPQLLQHPFLV-------PPVSTQPSSSQDQSYQLLQLLAEASA 794
L D N+R ++ L + +L P+ T + + A A
Sbjct: 255 LTVDPNKRLKMSGLRYNEWLQDGSQLSSNPLMTPDILGSSGAAVHTCVKATFHA 308
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 4e-36
Identities = 87/378 (23%), Positives = 147/378 (38%), Gaps = 93/378 (24%)
Query: 472 KLYQRLGKIGSGGSSEVHKVIS-SDCTIYALKKI---KLKGRDYATAYGFCQEIEYLNKL 527
+ Y + +G G EV K YA+K I K +D +T +E+E L KL
Sbjct: 22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTST---ILREVELLKKL 78
Query: 528 KGKNNIIQLIDYEVTEKALLREVLNGSMNNKDGRVKDDGYIYMVLEY---GEIDLAHMLS 584
N I++L +E+ E D Y+V E GE L +
Sbjct: 79 DHPN-IMKL--FEILE--------------------DSSSFYIVGELYTGGE--LFDEII 113
Query: 585 QKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLLV----KGSLKL 640
++ + E+ +Q+ + +H+ IVH DLKP N LL +K+
Sbjct: 114 KR--------KRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKI 165
Query: 641 IDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCIL 700
IDFG++ +T ++GT Y++PE G D+WS G IL
Sbjct: 166 IDFGLSTCFQQNTK---MKDRIGTAYYIAPEVL-------RGTY---DEKCDVWSAGVIL 212
Query: 701 YQMVYGRTPFSEYKTFWAK-----FKVITDPNHEITYEPVPNPWLL------DLMKKCLA 749
Y ++ G P F+ K K + + ++ W DL++K L
Sbjct: 213 YILLSGTPP------FYGKNEYDILKRVE--TGKYAFD--LPQWRTISDDAKDLIRKMLT 262
Query: 750 WDRNERWRIPQLLQHPFLVPPVSTQPSSSQDQSYQ-LLQLLAEASASDHEASTICSQLSQ 808
+ + R Q L+HP++ S P+ S S + + + + A +L+Q
Sbjct: 263 FHPSLRITATQCLEHPWIQKYSSETPTISDLPSLESAMTNIRQFQA--------EKKLAQ 314
Query: 809 LIRNPVMLAATQLSTSQD 826
++ A++L+T +
Sbjct: 315 AA---LLYMASKLTTLDE 329
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 4e-36
Identities = 72/409 (17%), Positives = 131/409 (32%), Gaps = 68/409 (16%)
Query: 474 YQRLGKIGSGGSSEVHKVI-SSDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNN 532
++ ++G+GG V + I A+K+ + + +C EI+ + KL N
Sbjct: 16 WEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCR-QELSPKNRERWCLEIQIMKKLNHPN- 73
Query: 533 IIQLIDYEVTEKALLREVLNGSMNNKDGRVKDDGYIYMVLEY---GEIDLAHMLSQKWKE 589
++ + + L + + +EY G+ L L+Q
Sbjct: 74 VVSAREVPDGLQKL----------------APNDLPLLAMEYCEGGD--LRKYLNQF--- 112
Query: 590 MDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLLVKGS----LKLIDFGI 645
+ L E +R I A+ +HE RI+H DLKP N +L G K+ID G
Sbjct: 113 --ENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGY 170
Query: 646 AKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVY 705
AK + VGTL Y++PE + D WS G + ++ +
Sbjct: 171 AKELDQGE---LCTEFVGTLQYLAPELLEQKKYTV-----TV----DYWSFGTLAFECIT 218
Query: 706 GRTPF--------------SEYKTFWAKFKVITDPNHEITYEPVPNPW-------LLDLM 744
G PF + + +T + P PN L +
Sbjct: 219 GFRPFLPNWQPVQWHGKVREKSNEHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWL 278
Query: 745 KKCLAWDRNERWRIPQLLQHPFLVPPVSTQPSSSQDQSYQLLQLLAEASASDHEASTICS 804
+ L W + +R PQ S + + +++E + +
Sbjct: 279 QCMLMWHQRQRGTDPQNPNVGCFQALDSILSLKLLSVMNMVSGRVHTYPVTENE--NLQN 336
Query: 805 QLSQLIRNPVMLAATQLSTSQDQQCKLLLKLSKLCLELQKRLANLRENK 853
S L ++ + Q + + + +
Sbjct: 337 LKSWLQQDTGIPEEEQELLQASGLALNSAQPLTQYVIDCTVIDGRQGEG 385
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 5e-36
Identities = 84/352 (23%), Positives = 139/352 (39%), Gaps = 96/352 (27%)
Query: 474 YQRLGKIGSGGSSEVHKVISSDCT--IYALKKIKLKGRDY---ATAYGFCQEIEYLNKLK 528
Y+++GKIG G V K + D T I A+KK D A +EI L +LK
Sbjct: 5 YEKIGKIGEGSYGVVFKCRNRD-TGQIVAIKKFLESEDDPVIKKIAL---REIRMLKQLK 60
Query: 529 GKNNIIQLIDYEVTEKALLREVLNGSMNNKDGRVKDDGYIYMVLEYGEIDLAHMLSQKWK 588
N ++ L++ V + +++V EY + +
Sbjct: 61 HPN-LVNLLE-----------V-----------FRRKRRLHLVFEYCDHTVL-------H 90
Query: 589 EMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLLV--KGSLKLIDFGIA 646
E+D + + E+ ++ Q L+AVN H+ +H D+KP N +L+ +KL DFG A
Sbjct: 91 ELDRYQRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPEN-ILITKHSVIKLCDFGFA 149
Query: 647 KAIMSDT---TNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQM 703
+ + + + +V T Y SPE + + + G P D+W++GC+ ++
Sbjct: 150 RLLTGPSDYYDD-----EVATRWYRSPELLVGDT--------QYGPPVDVWAIGCVFAEL 196
Query: 704 VYGRTPF---SE----YKTF----------W------AKFKVITDPNHEITYEP----VP 736
+ G + S+ Y F + P+ E EP P
Sbjct: 197 LSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSGVKIPDPE-DMEPLELKFP 255
Query: 737 N--PWLLDLMKKCLAWDRNERWRIPQLLQHPFL--------VPPVSTQPSSS 778
N L L+K CL D ER QLL HP+ + +P+ +
Sbjct: 256 NISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENIREIEDLAKEHDKPAEN 307
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 5e-36
Identities = 76/373 (20%), Positives = 140/373 (37%), Gaps = 83/373 (22%)
Query: 472 KLYQRLGKIGSGGSSEVHKVIS-SDCTIYALKKI---KLKGRDYATAYGFCQEIEYLNKL 527
Y+ +G G EV A+K I ++K + + +E++ L +L
Sbjct: 26 DRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKES--LLREVQLLKQL 83
Query: 528 KGKNNIIQLID-YEVTEKALLREVLNGSMNNKDGRVKDDGYIYMVLEY---GEIDLAHML 583
N I++L + +E D GY Y+V E GE+ ++
Sbjct: 84 DHPN-IMKLYEFFE-----------------------DKGYFYLVGEVYTGGEL-FDEII 118
Query: 584 SQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLLV----KGSLK 639
S+K E +Q+L + +H+ +IVH DLKP N LL +++
Sbjct: 119 SRK---------RFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIR 169
Query: 640 LIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCI 699
+IDFG++ + ++GT Y++PE +G D+WS G I
Sbjct: 170 IIDFGLSTHFEASKK---MKDKIGTAYYIAPEVL-------HGTY---DEKCDVWSTGVI 216
Query: 700 LYQMVYGRTPFSEYKTFWAKFKVITDPNHEITYEPVPNPWLL------DLMKKCLAWDRN 753
LY ++ G PF+ + K + + T+E W DL++K L + +
Sbjct: 217 LYILLSGCPPFNG-ANEYDILKKVE--KGKYTFE--LPQWKKVSESAKDLIRKMLTYVPS 271
Query: 754 ERWRIPQLLQHPFLVPPVSTQPSSSQDQSYQLLQLLAEASASDHEASTICSQLSQLIRNP 813
R L H ++ Q S + + + +L+Q
Sbjct: 272 MRISARDALDHEWIQTYTKEQISVDVPSLDNAILNIRQFQG--------TQKLAQAA--- 320
Query: 814 VMLAATQLSTSQD 826
++ ++L++ +
Sbjct: 321 LLYMGSKLTSQDE 333
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 7e-36
Identities = 70/323 (21%), Positives = 126/323 (39%), Gaps = 74/323 (22%)
Query: 467 FKVNGKLYQRLGKIGSGGSSEVHKVI-SSDCTIYALKKIKLKGRDYATAYGFCQEIEYLN 525
+V + + ++G G V K+ I A+K+I+ + +++
Sbjct: 2 MEVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATV-NSQEQKRLLMDLDISM 60
Query: 526 KLKGKNNIIQLIDYEVTEKALLREVLNGSMNNKDGRVKDDGYIYMVLEYGEIDLAHMLSQ 585
+ + Y AL RE G +++ +E
Sbjct: 61 RTVDCPFTVTF--YG----ALFRE----------------GDVWICMEL----------- 87
Query: 586 KWKEMDGS-----------NQTLDENWLRFYWQQILEAVNTIHEE-RIVHSDLKPANFLL 633
MD S QT+ E+ L I++A+ +H + ++H D+KP+N L+
Sbjct: 88 ----MDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLI 143
Query: 634 -VKGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSD 692
G +K+ DFGI+ + D + +D G YM+PE + + ++ SD
Sbjct: 144 NALGQVKMCDFGIS-GYLVDD--VAKDIDAGCKPYMAPERINPELNQKGYSV-----KSD 195
Query: 693 IWSLGCILYQMVYGRTPFSEYKTFWAKFKVITDPNHEITYEPVPN-------PWLLDLMK 745
IWSLG + ++ R P+ + T F+ + ++ EP P +D
Sbjct: 196 IWSLGITMIELAILRFPYDSWGTP---FQQLK----QVVEEPSPQLPADKFSAEFVDFTS 248
Query: 746 KCLAWDRNERWRIPQLLQHPFLV 768
+CL + ER P+L+QHPF
Sbjct: 249 QCLKKNSKERPTYPELMQHPFFT 271
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 7e-36
Identities = 77/324 (23%), Positives = 122/324 (37%), Gaps = 92/324 (28%)
Query: 472 KLYQRLGKIGSGGSSEVHKVIS-SDCTIYALKKI---KLKGRDYATAYGFCQEIEYLNKL 527
Y ++G G S V + + + +A K I KL RD+ +E KL
Sbjct: 6 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQ---KLEREARICRKL 62
Query: 528 KGKNNIIQLID-YEVTEKALLREVLNGSMNNKDGRVKDDGYIYMVLEY---GEIDLAHML 583
+ N I++L D + ++ + Y+V + GE L +
Sbjct: 63 QHPN-IVRLHDSIQ-----------------------EESFHYLVFDLVTGGE--LFEDI 96
Query: 584 SQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLLV---KGS-LK 639
+ + E QQILE++ H IVH +LKP N LL KG+ +K
Sbjct: 97 VAR--------EFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVK 148
Query: 640 LIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKC---GRPSDIWSL 696
L DFG+A ++D+ GT Y+SPE ++K +P DIW+
Sbjct: 149 LADFGLAI-EVNDSEAWH--GFAGTPGYLSPE------------VLKKDPYSKPVDIWAC 193
Query: 697 GCILYQMVYGRTPFSEYKTFWAKFKVITDPNHEI-------TYEPVPNPWL------LDL 743
G ILY ++ G P FW + H + Y+ W L
Sbjct: 194 GVILYILLVGYPP------FWD------EDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSL 241
Query: 744 MKKCLAWDRNERWRIPQLLQHPFL 767
+ L + +R Q L+ P++
Sbjct: 242 IDSMLTVNPKKRITADQALKVPWI 265
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 7e-36
Identities = 66/321 (20%), Positives = 126/321 (39%), Gaps = 71/321 (22%)
Query: 467 FKVNGKLYQRLGKIGSGGSSEVHKVI-SSDCTIYALKKIKLKGRDYATAYGFCQEIEYLN 525
++ + LG++GSG +V K+ + A+K+++ G + +++ +
Sbjct: 20 YQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSG-NKEENKRILMDLDVVL 78
Query: 526 KLKGKNNIIQLIDYEVTEKALLREVLNGSMNNKDGRVKDDGYIYMVLEYGEIDLAHMLSQ 585
K I+Q + + +++ +E
Sbjct: 79 KSHDCPYIVQC--FG----TFITN----------------TDVFIAMEL----------- 105
Query: 586 KWKEMDGS--------NQTLDENWLRFYWQQILEAVNTIHEER-IVHSDLKPANFLL-VK 635
M + E L I++A+ + E+ ++H D+KP+N LL +
Sbjct: 106 ----MGTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDER 161
Query: 636 GSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWS 695
G +KL DFGI+ + D +D G +YM+PE + + I+ +D+WS
Sbjct: 162 GQIKLCDFGIS-GRLVDD--KAKDRSAGCAAYMAPERIDPPDPTKPDYDIR----ADVWS 214
Query: 696 LGCILYQMVYGRTPFSEYKTFWAKFKVITDPNHEITYEPVPN--------PWLLDLMKKC 747
LG L ++ G+ P+ KT F+V+T ++ E P +K C
Sbjct: 215 LGISLVELATGQFPYKNCKTD---FEVLT----KVLQEEPPLLPGHMGFSGDFQSFVKDC 267
Query: 748 LAWDRNERWRIPQLLQHPFLV 768
L D +R + +LL+H F+
Sbjct: 268 LTKDHRKRPKYNKLLEHSFIK 288
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 1e-35
Identities = 77/325 (23%), Positives = 120/325 (36%), Gaps = 72/325 (22%)
Query: 462 DPDLFFKVNGKLYQRLGK-IGSGGSSEVHKVIS-SDCTIYALKKIKLKGRDYATAYGFCQ 519
+L+F+ + +GSG +VH V S +K I K R
Sbjct: 11 RENLYFQGTIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTIN-KDRSQVPMEQIEA 69
Query: 520 EIEYLNKLKGKNNIIQLIDYEVTEKALLREVLNGSMNNKDGRVKDDGYIYMVLEY---GE 576
EIE L L N II++ +EV E D +Y+V+E GE
Sbjct: 70 EIEVLKSLDHPN-IIKI--FEVFE--------------------DYHNMYIVMETCEGGE 106
Query: 577 IDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLLV-- 634
L ++ + L E ++ +Q++ A+ H + +VH DLKP N L
Sbjct: 107 ------LLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDT 160
Query: 635 --KGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSD 692
+K+IDFG+A+ + + + GT YM+PE F ++ D
Sbjct: 161 SPHSPIKIIDFGLAE-LFKSDEHST--NAAGTALYMAPEVF-------KRDV---TFKCD 207
Query: 693 IWSLGCILYQMVYGRTPFSEYKTFWAK-----FKVITDPNHEITYEPVPNPWLL-----D 742
IWS G ++Y ++ G P F + T L D
Sbjct: 208 IWSAGVVMYFLLTGCLP------FTGTSLEEVQQKATYKE----PNYAVECRPLTPQAVD 257
Query: 743 LMKKCLAWDRNERWRIPQLLQHPFL 767
L+K+ L D R Q+L H +
Sbjct: 258 LLKQMLTKDPERRPSAAQVLHHEWF 282
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 136 bits (346), Expect = 2e-35
Identities = 82/350 (23%), Positives = 134/350 (38%), Gaps = 87/350 (24%)
Query: 474 YQRLGKIGSGGSSEVHKVISSDCT--IYALKKIKLKGRDY---ATAYGFCQEIEYLNKLK 528
Y+ LG +G G V K + D T I A+KK D A +EI+ L +L+
Sbjct: 27 YENLGLVGEGSYGMVMKCRNKD-TGRIVAIKKFLESDDDKMVKKIAM---REIKLLKQLR 82
Query: 529 GKNNIIQLIDYEVTEKALLREVLNGSMNNKDGRVKDDGYIYMVLEYGEIDLAHMLSQKWK 588
+N ++ L EV K Y+V E+ + +
Sbjct: 83 HEN-LVNL--LEV--------------------CKKKKRWYLVFEFVDHTIL-------D 112
Query: 589 EMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLL-VKGSLKLIDFGIAK 647
+++ LD ++ Y QI+ + H I+H D+KP N L+ G +KL DFG A+
Sbjct: 113 DLELFPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFAR 172
Query: 648 AIMSDT---TNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMV 704
+ + + +V T Y +PE + + K G+ D+W++GC++ +M
Sbjct: 173 TLAAPGEVYDD-----EVATRWYRAPELLVGDV--------KYGKAVDVWAIGCLVTEMF 219
Query: 705 YGRTPF---SE----YKTF----------W------AKFKVITDPNHEITYEP----VPN 737
G F S+ Y F + P + EP P
Sbjct: 220 MGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFAGVRLPEIK-EREPLERRYPK 278
Query: 738 --PWLLDLMKKCLAWDRNERWRIPQLLQHP-FLVPPVSTQPSSSQDQSYQ 784
++DL KKCL D ++R +LL H F + + + S Q
Sbjct: 279 LSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQMDGFAERFSQELQLKVQ 328
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 134 bits (341), Expect = 2e-35
Identities = 72/311 (23%), Positives = 119/311 (38%), Gaps = 72/311 (23%)
Query: 474 YQRLGKIGSGGSSEVHKVISSDC-TIYALKKI-KLKGRDYATAYGFCQEIEYLNKLKGKN 531
++ +G G + V++ S A+K I K E++ +LK +
Sbjct: 13 FKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPS 72
Query: 532 NIIQLIDYEVTEKALLREVLNGSMNNKDGRVKDDGYIYMVLEY---GEIDLAHMLSQKWK 588
I++L Y E D Y+Y+VLE GE + L + K
Sbjct: 73 -ILEL--YNYFE--------------------DSNYVYLVLEMCHNGE--MNRYLKNRVK 107
Query: 589 EMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLL-VKGSLKLIDFGIAK 647
EN R + QI+ + +H I+H DL +N LL ++K+ DFG+A
Sbjct: 108 -------PFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLAT 160
Query: 648 AIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGR 707
+ + + + GT +Y+SPE + SD+WSLGC+ Y ++ GR
Sbjct: 161 QLKMP--HEKHYTLCGTPNYISPEIATRSAHGL---------ESDVWSLGCMFYTLLIGR 209
Query: 708 TPFSEYKTFWAKFKVITDPNHEITYEPVPN------PWL----LDLMKKCLAWDRNERWR 757
PF + T V +L DL+ + L + +R
Sbjct: 210 PPFD-------------TDTVKNTLNKVVLADYEMPSFLSIEAKDLIHQLLRRNPADRLS 256
Query: 758 IPQLLQHPFLV 768
+ +L HPF+
Sbjct: 257 LSSVLDHPFMS 267
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 2e-35
Identities = 70/328 (21%), Positives = 127/328 (38%), Gaps = 79/328 (24%)
Query: 474 YQRLGKIGSGGSSEVHKVISSDC-TIYALKKI-KLKGRDYATAYGFCQEIEYLNKLKGKN 531
++ +G G V+ I ALK + K + + +E+E + L+ N
Sbjct: 11 FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 70
Query: 532 NIIQLIDYEVTEKALLREVLNGSMNNKDGRVKDDGYIYMVLEY---GEIDLAHMLSQKWK 588
I++L Y D +Y++LEY G + L +
Sbjct: 71 -ILRL--YGYFH--------------------DATRVYLILEYAPLGT--VYRELQKL-- 103
Query: 589 EMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLL-VKGSLKLIDFGIAK 647
DE Y ++ A++ H +R++H D+KP N LL G LK+ DFG +
Sbjct: 104 ------SKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSV 157
Query: 648 AIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGR 707
+ +R GTL Y+ PE M + + D+WSLG + Y+ + G+
Sbjct: 158 ----HAPSSRRTDLCGTLDYLPPE--MIEGRMHDEKV-------DLWSLGVLCYEFLVGK 204
Query: 708 TPFSEYKTFWAKFKVITDPNHEITYEPVPN------PWL----LDLMKKCLAWDRNERWR 757
PF ++ TY+ + ++ DL+ + L + ++R
Sbjct: 205 PPF-------------EANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKHNPSQRPM 251
Query: 758 IPQLLQHPFLV----PPVSTQPSSSQDQ 781
+ ++L+HP++ P + Q S +
Sbjct: 252 LREVLEHPWITANSSKPSNCQNKESASK 279
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 2e-35
Identities = 73/342 (21%), Positives = 128/342 (37%), Gaps = 67/342 (19%)
Query: 443 KQEKAVSSKGASAPRKRNYDPDLFFKVN----GKLYQRLGKIGSGGSSEVHKVIS-SDCT 497
+ + P +F ++YQR+ K+GSG EV
Sbjct: 4 HHHHSSGRENLYFQGDLQATPGMFITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKVTHV 63
Query: 498 IYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLID-YEVTEKALLREVLNGSMN 556
A+K I+ ++ +E+ L L N I++L D +E
Sbjct: 64 ERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPN-IMKLYDFFE---------------- 106
Query: 557 NKDGRVKDDGYIYMVLEY---GEIDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAV 613
D Y+V+E GE+ ++ + +E +Q+L V
Sbjct: 107 -------DKRNYYLVMECYKGGEL-FDEIIHRM---------KFNEVDAAVIIKQVLSGV 149
Query: 614 NTIHEERIVHSDLKPANFLLV----KGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMS 669
+H+ IVH DLKP N LL +K++DFG++ + ++GT Y++
Sbjct: 150 TYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKK---MKERLGTAYYIA 206
Query: 670 PEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGRTPFSEYKTFWAKFKVITDPNHE 729
PE D+WS+G IL+ ++ G PF +T + + +
Sbjct: 207 PEVL-------RKKY---DEKCDVWSIGVILFILLAGYPPFGG-QTDQEILRKVE--KGK 253
Query: 730 ITYEPVPNPWL----LDLMKKCLAWDRNERWRIPQLLQHPFL 767
T++ + DL+K+ L +D R Q L+HP++
Sbjct: 254 YTFDSPEWKNVSEGAKDLIKQMLQFDSQRRISAQQALEHPWI 295
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 3e-35
Identities = 74/321 (23%), Positives = 123/321 (38%), Gaps = 87/321 (27%)
Query: 472 KLYQRLGKIGSGGSSEVHKVIS-SDCTIYALKKI---KLKGRDYATAYGFCQEIEYLNKL 527
+ Y + +G G EV K YA+K I K +D + +E+E L KL
Sbjct: 22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTS---TILREVELLKKL 78
Query: 528 KGKNNIIQLID-YEVTEKALLREVLNGSMNNKDGRVKDDGYIYMVLEY---GEIDLAHML 583
N I++L + E D Y+V E GE L +
Sbjct: 79 DHPN-IMKLFEILE-----------------------DSSSFYIVGELYTGGE--LFDEI 112
Query: 584 SQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLLV----KGSLK 639
++ + E+ +Q+ + +H+ IVH DLKP N LL +K
Sbjct: 113 IKR--------KRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIK 164
Query: 640 LIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKC--GRPSDIWSLG 697
+IDFG++ +T ++GT Y++PE +++ D+WS G
Sbjct: 165 IIDFGLSTCFQQNTK---MKDRIGTAYYIAPE------------VLRGTYDEKCDVWSAG 209
Query: 698 CILYQMVYGRTPFSEYKTFWAK-----FKVITDPNHEITYEPVPNPWL------LDLMKK 746
ILY ++ G P F+ K K + + ++ W DL++K
Sbjct: 210 VILYILLSGTPP------FYGKNEYDILKRVE--TGKYAFD--LPQWRTISDDAKDLIRK 259
Query: 747 CLAWDRNERWRIPQLLQHPFL 767
L + + R Q L+HP++
Sbjct: 260 MLTFHPSLRITATQCLEHPWI 280
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 3e-35
Identities = 81/322 (25%), Positives = 120/322 (37%), Gaps = 88/322 (27%)
Query: 472 KLYQRLGKIGSGGSSEVHKVIS-SDCTIYALKKI---KLKGRDYATAYGFCQEIEYLNKL 527
Y+ IG G S + I + +A+K I K +EIE L +
Sbjct: 22 DGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPT---------EEIEILLRY 72
Query: 528 KGKNNIIQLID-YEVTEKALLREVLNGSMNNKDGRVKDDGYIYMVLEY---GEIDLAHML 583
NII L D Y+ D Y+Y+V E GE+ L +L
Sbjct: 73 GQHPNIITLKDVYD-----------------------DGKYVYVVTELMKGGEL-LDKIL 108
Query: 584 SQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLLV-----KGSL 638
QK E I + V +H + +VH DLKP+N L V S+
Sbjct: 109 RQK---------FFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESI 159
Query: 639 KLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGC 698
++ DFG AK + ++ + + T ++++PE D C DIWSLG
Sbjct: 160 RICDFGFAKQLRAENGLLM--TPCYTANFVAPEVLERQGYDA-----AC----DIWSLGV 208
Query: 699 ILYQMVYGRTPFSEYKTFWAKFKVITDPNHEI-------TYEPVPNPWLL------DLMK 745
+LY M+ G TP F D EI + W DL+
Sbjct: 209 LLYTMLTGYTP------FANGPD---DTPEEILARIGSGKFSLSGGYWNSVSDTAKDLVS 259
Query: 746 KCLAWDRNERWRIPQLLQHPFL 767
K L D ++R +L+HP++
Sbjct: 260 KMLHVDPHQRLTAALVLRHPWI 281
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 5e-35
Identities = 76/346 (21%), Positives = 129/346 (37%), Gaps = 87/346 (25%)
Query: 449 SSKGASAPRKRNYDPDLFFKVNGKLYQR--LGK-IGSGGSSEVHKVIS-SDCTIYALKKI 504
+ ++ + + K + + +G G S V + + + +A K I
Sbjct: 3 HMASMTGGQQMGRGSEFMMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKII 62
Query: 505 ---KLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLID-YEVTEKALLREVLNGSMNNKDG 560
KL RD+ +E KL+ N I++L D +
Sbjct: 63 NTKKLSARDFQ---KLEREARICRKLQHPN-IVRLHDSIQ-------------------- 98
Query: 561 RVKDDGYIYMVLEY---GEIDLAHMLSQKWK--EMDGSNQTLDENWLRFYWQQILEAVNT 615
++ + Y+V + GE L + + E D S+ QQILE++
Sbjct: 99 ---EESFHYLVFDLVTGGE--LFEDIVAREFYSEADASH----------CIQQILESIAY 143
Query: 616 IHEERIVHSDLKPANFLLV---KGS-LKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPE 671
H IVH +LKP N LL KG+ +KL DFG+A + GT Y+SPE
Sbjct: 144 CHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGF---AGTPGYLSPE 200
Query: 672 AFMCNESDENGNIIKC---GRPSDIWSLGCILYQMVYGRTPF---SEYKTFWA----KFK 721
++K +P DIW+ G ILY ++ G PF +++ + +
Sbjct: 201 ------------VLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYD 248
Query: 722 VITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQHPFL 767
+ +T E L+ L + +R Q L+ P++
Sbjct: 249 YPSPEWDTVTPEA------KSLIDSMLTVNPKKRITADQALKVPWI 288
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 5e-35
Identities = 75/327 (22%), Positives = 140/327 (42%), Gaps = 52/327 (15%)
Query: 453 ASAPRKRNYDPDLFFKVN-GKLYQRLGKIGSGGSSEVHKVI-SSDCTIYALKKIKLKGRD 510
+ +P + + DL + +++ + +G+G +V+K + A+K + + G +
Sbjct: 4 SDSPARSLDEIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDE 63
Query: 511 YATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLREVLNGSMNNKDGRVKDDGYIYM 570
QEI L K NI G+ K+ DD +++
Sbjct: 64 EEE---IKQEINMLKKYSHHRNIATYY---------------GAFIKKNPPGMDD-QLWL 104
Query: 571 VLEYGE----IDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDL 626
V+E+ DL TL E W+ + ++IL ++ +H+ +++H D+
Sbjct: 105 VMEFCGAGSVTDLIKNTK---------GNTLKEEWIAYICREILRGLSHLHQHKVIHRDI 155
Query: 627 KPANFLLVK-GSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNII 685
K N LL + +KL+DFG++ + D T +R++ +GT +M+PE C+E+ +
Sbjct: 156 KGQNVLLTENAEVKLVDFGVSAQL--DRTVGRRNTFIGTPYWMAPEVIACDENPDATYDF 213
Query: 686 KCGRPSDIWSLGCILYQMVYGRTPFSEYKTFWAKFKVITDPNHEITYEPV--PNPW---L 740
K D+WSLG +M G P + A F + +P P W
Sbjct: 214 KS----DLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNP------APRLKSKKWSKKF 263
Query: 741 LDLMKKCLAWDRNERWRIPQLLQHPFL 767
++ CL + ++R QL++HPF+
Sbjct: 264 QSFIESCLVKNHSQRPATEQLMKHPFI 290
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 6e-35
Identities = 63/254 (24%), Positives = 120/254 (47%), Gaps = 47/254 (18%)
Query: 519 QEIEYLNKLKGKNNIIQLIDYEVTEKALLREVLNGSMNNKDGRVKDDGYIYMVLEY---G 575
QEI L KL N+++L EV + ++ ++YMV E G
Sbjct: 85 QEIAILKKLD-HPNVVKL--VEVLDDP------------------NEDHLYMVFELVNQG 123
Query: 576 EIDLAHMLSQKWKEMD-GSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLL- 633
+ M+ + + L E+ RFY+Q +++ + +H ++I+H D+KP+N L+
Sbjct: 124 PV------------MEVPTLKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVG 171
Query: 634 VKGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDI 693
G +K+ DFG++ + + ++ VGT ++M+PE +E+ + + G+ D+
Sbjct: 172 EDGHIKIADFGVS-NEFKGSDALLSNT-VGTPAFMAPE--SLSETRKIFS----GKALDV 223
Query: 694 WSLGCILYQMVYGRTPFSEYKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRN 753
W++G LY V+G+ PF + + I E +P L DL+ + L +
Sbjct: 224 WAMGVTLYCFVFGQCPFMD-ERIMCLHSKIKSQALEFPDQPDIAEDLKDLITRMLDKNPE 282
Query: 754 ERWRIPQLLQHPFL 767
R +P++ HP++
Sbjct: 283 SRIVVPEIKLHPWV 296
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 8e-35
Identities = 79/343 (23%), Positives = 139/343 (40%), Gaps = 83/343 (24%)
Query: 472 KLYQRLGKIGSGGSSEVHKVIS-SDCTIYALK---KIKLKGRDYATAY-GFCQEIEYLNK 526
Y ++GSG + V K S YA K K + + + +E+ L +
Sbjct: 12 DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQ 71
Query: 527 LKGKNNIIQLID-YEVTEKALLREVLNGSMNNKDGRVKDDGYIYMVLEY---GEIDLAHM 582
+ N +I L D YE + + ++LE GE L
Sbjct: 72 VLHHN-VITLHDVYE-----------------------NRTDVVLILELVSGGE--LFDF 105
Query: 583 LSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLLV-----KGS 637
L+QK ++L E + +QIL+ VN +H ++I H DLKP N +L+
Sbjct: 106 LAQK--------ESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPH 157
Query: 638 LKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKC---GRPSDIW 694
+KLIDFG+A I + ++ GT +++PE I+ G +D+W
Sbjct: 158 IKLIDFGLAHEI--EDGVEFKNI-FGTPEFVAPE------------IVNYEPLGLEADMW 202
Query: 695 SLGCILYQMVYGRTPF---SEYKTFWAKFKVITDPNHEITYEPVPNPWL------LDLMK 745
S+G I Y ++ G +PF ++ +T + ++Y+ + D ++
Sbjct: 203 SIGVITYILLSGASPFLGDTKQETL---ANIT-----SVSYDFDEEFFSHTSELAKDFIR 254
Query: 746 KCLAWDRNERWRIPQLLQHPFLVPPVSTQPSSSQDQSYQLLQL 788
K L + +R I + L+HP++ P + Q ++ L
Sbjct: 255 KLLVKETRKRLTIQEALRHPWITPVDNQQAMVRRESVVNLENF 297
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 133 bits (338), Expect = 1e-34
Identities = 85/355 (23%), Positives = 135/355 (38%), Gaps = 93/355 (26%)
Query: 438 ASKSEKQEKAVSSKGASAPRKRNYDPDLFFKVNGKLYQRLGKIGSGGSSEVHKVIS-SDC 496
+ + P+ R P+ F + +G G S V +
Sbjct: 4 TAAEPRPGAGSLQHAQPPPQPRKKRPEDF--------KFGKILGEGSFSTVVLARELATS 55
Query: 497 TIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQL--IDYEVTEKALLREV---- 550
YA+K ++ K +II+ + Y E+ ++ +
Sbjct: 56 REYAIKILE------------------------KRHIIKENKVPYVTRERDVMSRLDHPF 91
Query: 551 ---LNGSMNNKDGRVKDDGYIYMVLEY---GEIDLAHMLSQKWKEMDGSNQTLDENWLRF 604
L + +DD +Y L Y GE +L K + DE RF
Sbjct: 92 FVKLYFTF-------QDDEKLYFGLSYAKNGE-----LLKYIRKI-----GSFDETCTRF 134
Query: 605 YWQQILEAVNTIHEERIVHSDLKPANFLL-VKGSLKLIDFGIAKAIMSDTTNIQRDSQVG 663
Y +I+ A+ +H + I+H DLKP N LL +++ DFG AK + ++ + +S VG
Sbjct: 135 YTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVG 194
Query: 664 TLSYMSPEAFMCNESDENGNIIK---CGRPSDIWSLGCILYQMVYGRTPF---SEYKTFW 717
T Y+SPE ++ + SD+W+LGCI+YQ+V G PF +EY F
Sbjct: 195 TAQYVSPE------------LLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQ 242
Query: 718 AKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERW------RIPQLLQHPF 766
K+I + P DL++K L D +R L HPF
Sbjct: 243 ---KIIKLE---YDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPF 291
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 2e-34
Identities = 79/416 (18%), Positives = 147/416 (35%), Gaps = 101/416 (24%)
Query: 434 MKLEASKSEKQEKAVSSKGASAPRKRNYDP---DLFFKVNGK-----------LYQRLGK 479
M+ K P+ +YD D++ K + Y L +
Sbjct: 1 MRGSHHHHHHGSKVRGKY--DGPKINDYDKFYEDIWKKYVPQPVEVKQGSVYDYYDILEE 58
Query: 480 IGSGGSSEVHKVIS-SDCTIYALKKI-KLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLI 537
+GSG VH+ + + ++ K I D T EI +N+L +I L
Sbjct: 59 LGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVK---NEISIMNQLHHPK-LINLH 114
Query: 538 D-YEVTEKALLREVLNGSMNNKDGRVKDDGYIYMVLEY---GE-----IDLAHMLSQKWK 588
D +E D + ++LE+ GE + +S
Sbjct: 115 DAFE-----------------------DKYEMVLILEFLSGGELFDRIAAEDYKMS---- 147
Query: 589 EMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLLVK---GSLKLIDFGI 645
E + N Y +Q E + +HE IVH D+KP N + S+K+IDFG+
Sbjct: 148 EAEVIN----------YMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGL 197
Query: 646 AKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVY 705
A + + I + T + +PE + + G +D+W++G + Y ++
Sbjct: 198 ATKL--NPDEIVKV-TTATAEFAAPEIV-------DREPV--GFYTDMWAIGVLGYVLLS 245
Query: 706 GRTPF---SEYKTFWAKFKVITDPNHEITYEPVPNPWLL------DLMKKCLAWDRNERW 756
G +PF + +T + + ++ + + D +K L + +R
Sbjct: 246 GLSPFAGEDDLETLQNVKRC------DWEFD--EDAFSSVSPEAKDFIKNLLQKEPRKRL 297
Query: 757 RIPQLLQHPFLVPPVSTQPSS-SQDQSYQLLQLLAEASASDHEASTICSQLSQLIR 811
+ L+HP+L S S + ++ Q + E A +++
Sbjct: 298 TVHDALEHPWLKGDHSNLTSRIPSSRYNKIRQKIKEKYADWPAPQPAIGRIANFSS 353
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 3e-34
Identities = 85/341 (24%), Positives = 131/341 (38%), Gaps = 96/341 (28%)
Query: 472 KLYQRLGKIGSGGSSEVHKVIS-SDCTIYALKKI---KLKGRDYATAYGFCQEIEYLNKL 527
+ YQ ++G G S V + + YA I KL RD+ +E L
Sbjct: 11 EEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLE---REARICRLL 67
Query: 528 KGKNNIIQLID-YEVTEKALLREVLNGSMNNKDGRVKDDGYIYMVLEY---GEIDLAHML 583
K N I++L D ++G+ Y++ + GE L +
Sbjct: 68 KHPN-IVRLHDSIS-----------------------EEGHHYLIFDLVTGGE--LFEDI 101
Query: 584 SQKWK--EMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLLV---KGS- 637
+ E D S+ QQILEAV H+ +VH +LKP N LL KG+
Sbjct: 102 VAREYYSEADASH----------CIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAA 151
Query: 638 LKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKC---GRPSDIW 694
+KL DFG+A + + GT Y+SPE +++ G+P D+W
Sbjct: 152 VKLADFGLAIEVEGEQQAWF--GFAGTPGYLSPE------------VLRKDPYGKPVDLW 197
Query: 695 SLGCILYQMVYGRTPFSEYKTFWAKFKVITDPNHEI-------TYEPVPNPWLL------ 741
+ G ILY ++ G P FW + H + Y+ W
Sbjct: 198 ACGVILYILLVGYPP------FWD------EDQHRLYQQIKAGAYDFPSPEWDTVTPEAK 245
Query: 742 DLMKKCLAWDRNERWRIPQLLQHPFLVPPVSTQPSSSQDQS 782
DL+ K L + ++R + L+HP++ ST S Q
Sbjct: 246 DLINKMLTINPSKRITAAEALKHPWISHR-STVASCMHRQE 285
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 131 bits (333), Expect = 4e-34
Identities = 85/348 (24%), Positives = 129/348 (37%), Gaps = 97/348 (27%)
Query: 472 KLYQRLGKIGSGGSSEVHKVIS-SDCTIYALKKI-KLKGRDYATAYGFCQEIEYLNKLKG 529
K + + +GSG SEV V ++ALK I K ++ EI L K+K
Sbjct: 9 KTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLE---NEIAVLKKIKH 65
Query: 530 KNNIIQLID-YEVTEKALLREVLNGSMNNKDGRVKDDGYIYMVLEY---GE----IDLAH 581
+N I+ L D YE + Y+V++ GE I
Sbjct: 66 EN-IVTLEDIYE-----------------------STTHYYLVMQLVSGGELFDRI---- 97
Query: 582 MLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLLV----KGS 637
+ + E D S QQ+L AV +HE IVH DLKP N L +
Sbjct: 98 LERGVYTEKDASL----------VIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSK 147
Query: 638 LKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKC---GRPSDIW 694
+ + DFG++K + + + GT Y++PE ++ + D W
Sbjct: 148 IMITDFGLSKMEQNGIMS----TACGTPGYVAPE------------VLAQKPYSKAVDCW 191
Query: 695 SLGCILYQMVYGRTPF---SEYKTFWAKFKVITDPNHEIT---YEPVPNPW------LLD 742
S+G I Y ++ G PF +E K F +I YE W D
Sbjct: 192 SIGVITYILLCGYPPFYEETESKLF-----------EKIKEGYYEFESPFWDDISESAKD 240
Query: 743 LMKKCLAWDRNERWRIPQLLQHPFLVPPVSTQPSSSQDQSYQLLQLLA 790
+ L D NER+ + L HP++ + S Q+ + A
Sbjct: 241 FICHLLEKDPNERYTCEKALSHPWIDGNTALHRDIYPSVSLQIQKNFA 288
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 7e-34
Identities = 84/335 (25%), Positives = 131/335 (39%), Gaps = 84/335 (25%)
Query: 474 YQRLGKIGSGGSSEVHKVISSDC-TIYALKKIKLKGRDY---ATAYGFCQEIEYLNKLKG 529
Y++L KIG G V K + + I ALK+++L D ++A +EI L +LK
Sbjct: 4 YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSAL---REICLLKELKH 60
Query: 530 KNNIIQLIDYEVTEKALLREVLNGSMNNKDGRVKDDGYIYMVLEYGEIDLAHMLSQKWKE 589
KN I++L D ++K L +V E+ + DL K
Sbjct: 61 KN-IVRLHDVLHSDKKL----------------------TLVFEFCDQDLK-------KY 90
Query: 590 MDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLL-VKGSLKLIDFGIAKA 648
D N LD ++ + Q+L+ + H ++H DLKP N L+ G LKL +FG+A+A
Sbjct: 91 FDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARA 150
Query: 649 IMSDT---TNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVY 705
+ +V TL Y P+ + D+WS GCI ++
Sbjct: 151 FGIPVRCYSA-----EVVTLWYRPPDVLFGAK--------LYSTSIDMWSAGCIFAELAN 197
Query: 706 GRTPF----SEYKTFWAKFKVITDPNHEI--------TYEPVPN-----------PWL-- 740
P F+++ P E Y+P P P L
Sbjct: 198 AGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNA 257
Query: 741 --LDLMKKCLAWDRNERWRIPQLLQHPF---LVPP 770
DL++ L + +R + LQHP+ PP
Sbjct: 258 TGRDLLQNLLKCNPVQRISAEEALQHPYFSDFCPP 292
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 7e-34
Identities = 80/414 (19%), Positives = 149/414 (35%), Gaps = 97/414 (23%)
Query: 397 GIPNDPSTHKSMEGRQHTGNSPELKSQAPLSKNSSSDMKLEASKSEKQEKAVSSKGASAP 456
G+ + S++D+ K+ A++ + P
Sbjct: 11 GVDLGTENLYFQSMKNSGDQDSRSGHNEAKEVWSNADLTERMPVKSKRTSALAVDIPAPP 70
Query: 457 RKRNYDPDLFFKVN-GKLYQ--RLGKIGSGGSSEVHKVIS-SDCTIYALKKI---KLKGR 509
++ + Y + +G G +VHK + A K I +K +
Sbjct: 71 APFDHRIVTAKQGAVNSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDK 130
Query: 510 DYATAYGFCQEIEYLNKLKGKNNIIQLID-YEVTEKALLREVLNGSMNNKDGRVKDDGYI 568
+ EI +N+L N +IQL D +E I
Sbjct: 131 EE-----VKNEISVMNQLDHAN-LIQLYDAFE-----------------------SKNDI 161
Query: 569 YMVLEY---GE-----IDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEER 620
+V+EY GE ID ++ L+ E+D + +QI E + +H+
Sbjct: 162 VLVMEYVDGGELFDRIIDESYNLT----ELDTIL----------FMKQICEGIRHMHQMY 207
Query: 621 IVHSDLKPANFLLV---KGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNE 677
I+H DLKP N L V +K+IDFG+A+ + + GT +++PE
Sbjct: 208 ILHLDLKPENILCVNRDAKQIKIIDFGLARRY--KPREKLKVN-FGTPEFLAPE------ 258
Query: 678 SDENGNIIKC---GRPSDIWSLGCILYQMVYGRTPF---SEYKTFWAKFKVITDPNHEIT 731
++ P+D+WS+G I Y ++ G +PF ++ +T ++
Sbjct: 259 ------VVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETL---NNIL-----ACR 304
Query: 732 YEPVPNPWLL------DLMKKCLAWDRNERWRIPQLLQHPFLVPPVSTQPSSSQ 779
++ + + + K L +++ R + L+HP+L S+Q
Sbjct: 305 WDLEDEEFQDISEEAKEFISKLLIKEKSWRISASEALKHPWLSDHKLHSRLSAQ 358
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 8e-34
Identities = 63/309 (20%), Positives = 117/309 (37%), Gaps = 65/309 (21%)
Query: 472 KLYQRLGKIGSGGSSEVHKVIS-SDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGK 530
+ Y +G G VH+ + S Y K +K+KG D +EI LN + +
Sbjct: 5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVK---KEISILNIARHR 61
Query: 531 NNIIQLID-YEVTEKALLREVLNGSMNNKDGRVKDDGYIYMVLEY---GEIDLAHMLSQK 586
N I+ L + +E + M+ E+ + + ++
Sbjct: 62 N-ILHLHESFE-----------------------SMEELVMIFEFISGLD--IFERINTS 95
Query: 587 WKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLLVK---GSLKLIDF 643
L+E + Y Q+ EA+ +H I H D++P N + ++K+I+F
Sbjct: 96 -------AFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEF 148
Query: 644 GIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQM 703
G A+ + + R Y +PE +++ +D+WSLG ++Y +
Sbjct: 149 GQARQL--KPGDNFRL-LFTAPEYYAPEVH-------QHDVV--STATDMWSLGTLVYVL 196
Query: 704 VYGRTPF---SEYKTFWAKFKVITDPNHEITYEPVPN--PWLLDLMKKCLAWDRNERWRI 758
+ G PF + + I + + E +D + + L +R R
Sbjct: 197 LSGINPFLAETNQQIIEN----IMNAEYTFDEEAFKEISIEAMDFVDRLLVKERKSRMTA 252
Query: 759 PQLLQHPFL 767
+ LQHP+L
Sbjct: 253 SEALQHPWL 261
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 8e-34
Identities = 77/345 (22%), Positives = 136/345 (39%), Gaps = 87/345 (25%)
Query: 472 KLYQRLGKIGSGGSSEVHKVIS-SDCTIYALKKI---KLKGRDYATAY-GFCQEIEYLNK 526
Y ++GSG + V K S YA K I + K + +E+ L +
Sbjct: 11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 70
Query: 527 LKGKNNIIQLID-YEVTEKALLREVLNGSMNNKDGRVKDDGYIYMVLEY---GE-----I 577
++ N +I L + YE + + ++LE GE
Sbjct: 71 IQHPN-VITLHEVYE-----------------------NKTDVILILELVAGGELFDFLA 106
Query: 578 DLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLLV--- 634
+ + E + + + +QIL V +H +I H DLKP N +L+
Sbjct: 107 EKESL-----TEEEATE----------FLKQILNGVYYLHSLQIAHFDLKPENIMLLDRN 151
Query: 635 --KGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSD 692
K +K+IDFG+A I D N ++ GT +++PE N + G +D
Sbjct: 152 VPKPRIKIIDFGLAHKI--DFGNEFKNI-FGTPEFVAPEIV-------NYEPL--GLEAD 199
Query: 693 IWSLGCILYQMVYGRTPF---SEYKTFWAKFKVITDPNHEITYEPVPNPWLL------DL 743
+WS+G I Y ++ G +PF ++ +T ++ + YE + D
Sbjct: 200 MWSIGVITYILLSGASPFLGDTKQETLAN----VS----AVNYEFEDEYFSNTSALAKDF 251
Query: 744 MKKCLAWDRNERWRIPQLLQHPFLVPPVSTQPSSSQDQSYQLLQL 788
+++ L D +R I LQHP++ P + Q S + + + +
Sbjct: 252 IRRLLVKDPKKRMTIQDSLQHPWIKPKDTQQALSRKASAVNMEKF 296
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 9e-34
Identities = 78/326 (23%), Positives = 128/326 (39%), Gaps = 74/326 (22%)
Query: 474 YQRLGKIGSGGSSEVHKVISSDCTIYALKKIKL----KGRDYATAYGFCQEIEYLNKLKG 529
Y IG+G V + + A+KK+ K R E++ + +K
Sbjct: 42 YTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRFKNR----------ELQIMRIVKH 91
Query: 530 KNNIIQLIDYEVTEKALLREVLNGSMNNKDGRVKDDGYIYMVLEYGEIDLAHMLSQKWKE 589
N ++ L + + +G KD+ ++ +VLEY + K
Sbjct: 92 PN-VVDLKAFFYS----------------NGDKKDEVFLNLVLEYVPETVYRASRHYAK- 133
Query: 590 MDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLL--VKGSLKLIDFGIAK 647
QT+ ++ Y Q+L ++ IH I H D+KP N LL G LKLIDFG AK
Sbjct: 134 ---LKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAK 190
Query: 648 AIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGR 707
+++ N+ S + + Y +PE + ++ NI DIWS GC++ +++ G+
Sbjct: 191 ILIAGEPNV---SYICSRYYRAPEL-IFGATNYTTNI-------DIWSTGCVMAELMQGQ 239
Query: 708 TPF---SEYKTFWAKFKVITDPNHEI--------------TYEPVP---------NPWLL 741
F S KV+ P+ E P P P +
Sbjct: 240 PLFPGESGIDQLVEIIKVLGTPSREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAI 299
Query: 742 DLMKKCLAWDRNERWRIPQLLQHPFL 767
DL+ + L + + R + L HPF
Sbjct: 300 DLISRLLEYTPSARLTAIEALCHPFF 325
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 1e-33
Identities = 77/318 (24%), Positives = 117/318 (36%), Gaps = 90/318 (28%)
Query: 476 RLGK-IGSGGSSEVHKVIS-SDCTIYALKKI---KLKGRDYATAYGFCQEIEYLNKLKGK 530
L IG G EV + A KKI ++ D F QEIE + L
Sbjct: 12 TLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVD-----RFKQEIEIMKSLDHP 66
Query: 531 NNIIQLID-YEVTEKALLREVLNGSMNNKDGRVKDDGYIYMVLEY---GEIDLAHMLSQK 586
N II+L + +E D+ IY+V+E GE L + K
Sbjct: 67 N-IIRLYETFE-----------------------DNTDIYLVMELCTGGE--LFERVVHK 100
Query: 587 WKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLLV----KGSLKLID 642
+ E+ + +L AV H+ + H DLKP NFL + LKLID
Sbjct: 101 --------RVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLID 152
Query: 643 FGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIK--CGRPSDIWSLGCIL 700
FG+A ++ ++VGT Y+SP+ +++ G D WS G ++
Sbjct: 153 FGLAA-RFKPGKMMR--TKVGTPYYVSPQ------------VLEGLYGPECDEWSAGVMM 197
Query: 701 YQMVYGRTPFSEYKTFWAK-----FKVITDPNHEITYEPVPNPWLL------DLMKKCLA 749
Y ++ G P F A I + + WL L+++ L
Sbjct: 198 YVLLCGYPP------FSAPTDSEVMLKIREGT----FTFPEKDWLNVSPQAESLIRRLLT 247
Query: 750 WDRNERWRIPQLLQHPFL 767
+R Q L+H +
Sbjct: 248 KSPKQRITSLQALEHEWF 265
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 1e-33
Identities = 77/344 (22%), Positives = 134/344 (38%), Gaps = 85/344 (24%)
Query: 472 KLYQRLGKIGSGGSSEVHKVIS-SDCTIYALKKI---KLKGRDYATAY-GFCQEIEYLNK 526
Y ++GSG + V K S YA K I + + +E+ L +
Sbjct: 12 DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQ 71
Query: 527 LKGKNNIIQLID-YEVTEKALLREVLNGSMNNKDGRVKDDGYIYMVLEY---GE-----I 577
+ N II L D YE + + ++LE GE
Sbjct: 72 VLHPN-IITLHDVYE-----------------------NRTDVVLILELVSGGELFDFLA 107
Query: 578 DLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLLV--- 634
+ E + ++ + +QIL+ VN +H ++I H DLKP N +L+
Sbjct: 108 QKESL-----SEEEATS----------FIKQILDGVNYLHTKKIAHFDLKPENIMLLDKN 152
Query: 635 --KGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKC---GR 689
+KLIDFG+A I + ++ GT +++PE I+ G
Sbjct: 153 IPIPHIKLIDFGLAHEI--EDGVEFKNI-FGTPEFVAPE------------IVNYEPLGL 197
Query: 690 PSDIWSLGCILYQMVYGRTPF---SEYKTFWAKFKVITDPNHEITYEPVPN--PWLLDLM 744
+D+WS+G I Y ++ G +PF ++ +T IT +++ E D +
Sbjct: 198 EADMWSIGVITYILLSGASPFLGDTKQET----LANITAVSYDFDEEFFSQTSELAKDFI 253
Query: 745 KKCLAWDRNERWRIPQLLQHPFLVPPVSTQPSSSQDQSYQLLQL 788
+K L + +R I + L+HP++ P + Q ++ L
Sbjct: 254 RKLLVKETRKRLTIQEALRHPWITPVDTQQAMVRRESVVNLENF 297
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 2e-33
Identities = 73/335 (21%), Positives = 126/335 (37%), Gaps = 78/335 (23%)
Query: 474 YQRLGKIGSGGSSEVHKVISSDC-TIYALKKIKLKGRDYA------TAYGFCQEIEYLNK 526
Y+ + +IG G V+K ALK +++ + +E+ L +
Sbjct: 11 YEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTV---REVALLRR 67
Query: 527 LKGKN--NIIQLIDYEVTEKALLREVLNGSMNNKDGRVKDDGYIYMVLEYGEIDLAHMLS 584
L+ N+++L+D V S +++ + + +V E+ + DL L
Sbjct: 68 LEAFEHPNVVRLMD-----------VCATSRTDREIK------VTLVFEHVDQDLRTYLD 110
Query: 585 QKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLL-VKGSLKLIDF 643
L ++ +Q L ++ +H IVH DLKP N L+ G++KL DF
Sbjct: 111 ------KAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADF 164
Query: 644 GIAKAIMSDT--TNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILY 701
G+A+ T V TL Y +PE + + P D+WS+GCI
Sbjct: 165 GLARIYSYQMALTP-----VVVTLWYRAPEVLLQS---------TYATPVDMWSVGCIFA 210
Query: 702 QMVYGRTPF---SEYKTFWAKFKVITDPNHEI-------------TYEPVPN----PWL- 740
+M + F SE F +I P + P P P +
Sbjct: 211 EMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEME 270
Query: 741 ---LDLMKKCLAWDRNERWRIPQLLQHPFL--VPP 770
L+ + L ++ ++R + LQH +L
Sbjct: 271 ESGAQLLLEMLTFNPHKRISAFRALQHSYLHKDEG 305
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 3e-33
Identities = 76/350 (21%), Positives = 139/350 (39%), Gaps = 73/350 (20%)
Query: 442 EKQEKAVSSKGASAPRKRNYDPDLFFKVNGKLYQRLGKIGSGGSSEV----HKVISSDCT 497
E+ KAV +G +A + + K Y + +GSG V K + +
Sbjct: 4 EEPPKAVELEGLAACEG---------EYSQK-YSTMSPLGSGAFGFVWTAVDKEKNKEVV 53
Query: 498 IYALKKIKLKGRDYATAYGFCQ---EIEYLNKLKGKNNIIQLIDYEVTEKALLREVLNGS 554
+ +KK K+ + + EI L++++ N II++ ++ E
Sbjct: 54 VKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHAN-IIKV--LDIFE----------- 99
Query: 555 MNNKDGRVKDDGYIYMVLEYGE--IDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEA 612
+ G+ +V+E +DL + + LDE + ++Q++ A
Sbjct: 100 ---------NQGFFQLVMEKHGSGLDLFAFIDRH--------PRLDEPLASYIFRQLVSA 142
Query: 613 VNTIHEERIVHSDLKPANFLL-VKGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPE 671
V + + I+H D+K N ++ ++KLIDFG A A + + GT+ Y +PE
Sbjct: 143 VGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSA-AYLERGKLF--YTFCGTIEYCAPE 199
Query: 672 AFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGRTPFSEY-KTFWAKFKVITDPNHEI 730
M N G ++WSLG LY +V+ PF E +T A P
Sbjct: 200 VLMGNPYR--------GPELEMWSLGVTLYTLVFEENPFCELEETVEAAIHP---PYL-- 246
Query: 731 TYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQHPFLVPPVSTQPSSSQD 780
+ L+ L+ L R + +L+ P++ PV+ + ++
Sbjct: 247 -----VSKELMSLVSGLLQPVPERRTTLEKLVTDPWVTQPVNLADYTWEE 291
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 3e-33
Identities = 92/333 (27%), Positives = 141/333 (42%), Gaps = 82/333 (24%)
Query: 474 YQRLGKIGSGGSSEVHKVISSDCTIYALKKIKLKGRDY---ATAYGFCQEIEYLNKLKGK 530
YQ+L K+G G V+K S I ALK+I+L D +TA +EI L +L
Sbjct: 23 YQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAI---REISLLKELHHP 79
Query: 531 NNIIQLIDYEVTEKALLREVLNGSMNNKDGRVKDDGYIYMVLEYGEIDLAHMLSQKWKEM 590
N I+ LID +E+ L +V E+ E DL K +
Sbjct: 80 N-IVSLIDVIHSERCL----------------------TLVFEFMEKDLK-------KVL 109
Query: 591 DGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLL-VKGSLKLIDFGIAKAI 649
D + L ++ ++ Y Q+L V H+ RI+H DLKP N L+ G+LKL DFG+A+A
Sbjct: 110 DENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARAF 169
Query: 650 MSDT---TNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYG 706
T+ +V TL Y +P+ M ++ K DIWS+GCI +M+ G
Sbjct: 170 GIPVRSYTH-----EVVTLWYRAPDVLMGSK--------KYSTSVDIWSIGCIFAEMITG 216
Query: 707 RTPF---SEYKTFWAKFKVITDPNHEI--------TYEPV------PNPW---------- 739
+ F ++ F ++ PN ++ PW
Sbjct: 217 KPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPLWKQRTFQVFEKKPWSSIIPGFCQE 276
Query: 740 LLDLMKKCLAWDRNERWRIPQLLQHPFL--VPP 770
+DL+ L +D N+R + HP+ + P
Sbjct: 277 GIDLLSNMLCFDPNKRISARDAMNHPYFKDLDP 309
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 4e-33
Identities = 87/359 (24%), Positives = 145/359 (40%), Gaps = 87/359 (24%)
Query: 474 YQRLGKIGSGGSSEVHKVISSDC-TIYALKKIKLKGRDYATAYGF----CQEIEYLNKLK 528
Y +L K+G G + V+K S + ALK+I+L+ + G +E+ L LK
Sbjct: 4 YIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEE-----GAPCTAIREVSLLKDLK 58
Query: 529 GKNNIIQLIDYEVTEKALLREVLNGSMNNKDGRVKDDGYIYMVLEYGEIDLAHMLSQKWK 588
N I+ L D TEK+L +V EY + DL +
Sbjct: 59 HAN-IVTLHDIIHTEKSL----------------------TLVFEYLDKDLK-------Q 88
Query: 589 EMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLL-VKGSLKLIDFGIAK 647
+D ++ + ++ + Q+L + H ++++H DLKP N L+ +G LKL DFG+A+
Sbjct: 89 YLDDCGNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLAR 148
Query: 648 AIMSDT---TNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMV 704
A T N +V TL Y P+ + + D+W +GCI Y+M
Sbjct: 149 AKSIPTKTYDN-----EVVTLWYRPPDILLGST--------DYSTQIDMWGVGCIFYEMA 195
Query: 705 YGRTPF---SEYKTFWAKFKVITDPNHEI--------TYEPV------PNPWL------- 740
GR F + + F+++ P E ++ L
Sbjct: 196 TGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKTYNYPKYRAEALLSHAPRLD 255
Query: 741 ---LDLMKKCLAWDRNERWRIPQLLQHPF---LVPPVSTQPSSSQDQSYQLLQLLAEAS 793
DL+ K L ++ R ++HPF L + P ++ + + +QL EAS
Sbjct: 256 SDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLGERIHKLPDTTSIFALKEIQLQKEAS 314
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 4e-33
Identities = 71/375 (18%), Positives = 130/375 (34%), Gaps = 83/375 (22%)
Query: 421 KSQAPLSKNSSSDMKLEASKSEKQEKAVS--SKGASAPRKRNYDPDLFFKVNG--KLYQR 476
+ Q+P + + + + L K N Y+
Sbjct: 6 QGQSPPVPFPAPAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKV 65
Query: 477 LGK-IGSGGSSEVHKVIS-SDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNII 534
+ +G G + +V ++ + +ALK ++ +E+E + +I+
Sbjct: 66 TSQVLGLGINGKVLQIFNKRTQEKFALKMLQ-DCPK------ARREVELHWRASQCPHIV 118
Query: 535 QLID-YEVTEKALLREVLNGSMNNKDGRVKDDGYIYMVLEY---GEIDLAHMLSQKWK-- 588
+++D YE + + +V+E GE+ + + + +
Sbjct: 119 RIVDVYE------------------NLYAGRK-CLLIVMECLDGGEL-FSRIQDRGDQAF 158
Query: 589 -EMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLLVKGS----LKLIDF 643
E + S + I EA+ +H I H D+KP N L LKL DF
Sbjct: 159 TEREASE----------IMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDF 208
Query: 644 GIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQM 703
G AK S + T Y++PE + D+ C D+WSLG I+Y +
Sbjct: 209 GFAKETTSHNSLTTP---CYTPYYVAPEVLGPEKYDK-----SC----DMWSLGVIMYIL 256
Query: 704 VYGRTPFSEYKTFWAKFKVITDPN--HEI---TYEPVPNPWLL------DLMKKCLAWDR 752
+ G P F++ + P I YE W L++ L +
Sbjct: 257 LCGYPP------FYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEP 310
Query: 753 NERWRIPQLLQHPFL 767
+R I + + HP++
Sbjct: 311 TQRMTITEFMNHPWI 325
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 5e-33
Identities = 91/326 (27%), Positives = 140/326 (42%), Gaps = 79/326 (24%)
Query: 474 YQRLGKIGSGGSSEVHKVISSDCTIYALKKIKLKGRDY---ATAYGFCQEIEYLNKLKGK 530
Y L KIG G V+K ++ +ALKKI+L+ D +T +EI L +LK
Sbjct: 4 YHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTI---REISILKELKHS 60
Query: 531 NNIIQLIDYEVTEKALLREVLNGSMNNKDGRVKDDGYIYMVLEYGEIDLAHMLSQKWKEM 590
N I++L D T+K L +V E+ + DL K +
Sbjct: 61 N-IVKLYDVIHTKKRL----------------------VLVFEHLDQDLK-------KLL 90
Query: 591 DGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLL-VKGSLKLIDFGIAKAI 649
D L+ + + Q+L + H+ R++H DLKP N L+ +G LK+ DFG+A+A
Sbjct: 91 DVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAF 150
Query: 650 MSDT---TNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYG 706
T+ ++ TL Y +P+ M ++ K DIWS+GCI +MV G
Sbjct: 151 GIPVRKYTH-----EIVTLWYRAPDVLMGSK--------KYSTTIDIWSVGCIFAEMVNG 197
Query: 707 RTPF---SEYKTFWAKFKVITDPNHEI---------------TYEPVP--------NPWL 740
F SE F+++ PN + YEP+P +
Sbjct: 198 TPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESG 257
Query: 741 LDLMKKCLAWDRNERWRIPQLLQHPF 766
+DL+ K L D N+R Q L+H +
Sbjct: 258 IDLLSKMLKLDPNQRITAKQALEHAY 283
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 134 bits (338), Expect = 6e-33
Identities = 77/398 (19%), Positives = 141/398 (35%), Gaps = 82/398 (20%)
Query: 410 GRQHTGNSPELKSQAPLSKNSSSDMKLEASKSEKQEKAVSSKGASAPRKRNYDPDLFFKV 469
G+ + ++ + K S + V
Sbjct: 89 GQSKPCEPTAPVLIPGDERKRRRGYDVDEQGKIVRGKGTVSSNYDNYVFDIWKQYYPQPV 148
Query: 470 NGK------LYQRLGKIGSGGSSEVHKVIS-SDCTIYALKKI-KLKGRDYATAYGFCQEI 521
K Y ++G+G VH+V + +A K + D T +EI
Sbjct: 149 EIKHDHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVR---KEI 205
Query: 522 EYLNKLKGKNNIIQLID-YEVTEKALLREVLNGSMNNKDGRVKDDGYIYMVLEY---GEI 577
+ ++ L+ ++ L D +E DD + M+ E+ GE
Sbjct: 206 QTMSVLRHPT-LVNLHDAFE-----------------------DDNEMVMIYEFMSGGE- 240
Query: 578 DLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLLV--- 634
L ++ + + + E+ Y +Q+ + + +HE VH DLKP N +
Sbjct: 241 -LFEKVADE-------HNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKR 292
Query: 635 KGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKC---GRPS 691
LKLIDFG+ + D + + GT + +PE + + G +
Sbjct: 293 SNELKLIDFGLTAHL--DPKQSVKVT-TGTAEFAAPE------------VAEGKPVGYYT 337
Query: 692 DIWSLGCILYQMVYGRTPF---SEYKTFWAKFKVITDPNHEITYEPVPNPWL----LDLM 744
D+WS+G + Y ++ G +PF ++ +T + + + + + D +
Sbjct: 338 DMWSVGVLSYILLSGLSPFGGENDDETLRN----VK--SCDWNMDDSAFSGISEDGKDFI 391
Query: 745 KKCLAWDRNERWRIPQLLQHPFLVPPVSTQPSSSQDQS 782
+K L D N R I Q L+HP+L P + S S
Sbjct: 392 RKLLLADPNTRMTIHQALEHPWLTPGNAPGRDSQIPSS 429
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 7e-33
Identities = 89/375 (23%), Positives = 144/375 (38%), Gaps = 88/375 (23%)
Query: 428 KNSSSDMKLEASKSEKQEKAVSSKGASAPRKRNYDPDLFFKVNG-----KLYQRLGKIGS 482
+ S +++ + S ++AP + PD + + ++ ++G
Sbjct: 4 HHHHSSGVDLGTENLYFQSMSSVTASAAPGTASLVPDYWIDGSNRDALSDFFEVESELGR 63
Query: 483 GGSSEVHKVIS-SDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLID-YE 540
G +S V++ YALK +K K D EI L +L N II+L + +E
Sbjct: 64 GATSIVYRCKQKGTQKPYALKVLK-KTVDKKIVR---TEIGVLLRLSHPN-IIKLKEIFE 118
Query: 541 VTEKALLREVLNGSMNNKDGRVKDDGYIYMVLEY---GE----IDLAHMLSQKWKEMDGS 593
I +VLE GE I + + E D +
Sbjct: 119 -----------------------TPTEISLVLELVTGGELFDRI----VEKGYYSERDAA 151
Query: 594 NQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLLV----KGSLKLIDFGIAKAI 649
+ +QILEAV +HE IVH DLKP N L LK+ DFG++K I
Sbjct: 152 D----------AVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSK-I 200
Query: 650 MSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKC---GRPSDIWSLGCILYQMVYG 706
+ ++ + GT Y +PE I++ G D+WS+G I Y ++ G
Sbjct: 201 VEHQVLMK--TVCGTPGYCAPE------------ILRGCAYGPEVDMWSVGIITYILLCG 246
Query: 707 RTPFSEYKTFWAKFKVITDPNHEITYEPVPNPWLL------DLMKKCLAWDRNERWRIPQ 760
PF + + F+ I + Y + W DL++K + D +R Q
Sbjct: 247 FEPFYDERGDQFMFRRILNCE----YYFISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQ 302
Query: 761 LLQHPFLVPPVSTQP 775
LQHP++ +
Sbjct: 303 ALQHPWVTGKAANFV 317
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 9e-33
Identities = 78/322 (24%), Positives = 134/322 (41%), Gaps = 83/322 (25%)
Query: 472 KLYQRLGKIGSGGSSEVHKVIS-SDCTIYALKKI---KLKGRDYATAY-GFCQEIEYLNK 526
Y+ ++GSG + V K YA K I +L + +E+ L +
Sbjct: 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILRE 64
Query: 527 LKGKNNIIQLID-YEVTEKALLREVLNGSMNNKDGRVKDDGYIYMVLEY---GEIDLAHM 582
++ N II L D +E + + ++LE GE L
Sbjct: 65 IRHPN-IITLHDIFE-----------------------NKTDVVLILELVSGGE--LFDF 98
Query: 583 LSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLLV-----KGS 637
L++K ++L E+ + +QIL+ V+ +H +RI H DLKP N +L+
Sbjct: 99 LAEK--------ESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPR 150
Query: 638 LKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKC---GRPSDIW 694
+KLIDFGIA I + N ++ GT +++PE I+ G +D+W
Sbjct: 151 IKLIDFGIAHKI--EAGNEFKNI-FGTPEFVAPE------------IVNYEPLGLEADMW 195
Query: 695 SLGCILYQMVYGRTPF---SEYKTFWAKFKVITDPNHEITYEPVPNPWLL------DLMK 745
S+G I Y ++ G +PF ++ +T I+ + Y+ + D ++
Sbjct: 196 SIGVITYILLSGASPFLGETKQETLTN----IS----AVNYDFDEEYFSNTSELAKDFIR 247
Query: 746 KCLAWDRNERWRIPQLLQHPFL 767
+ L D R I Q L+H ++
Sbjct: 248 RLLVKDPKRRMTIAQSLEHSWI 269
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 1e-32
Identities = 68/319 (21%), Positives = 112/319 (35%), Gaps = 78/319 (24%)
Query: 472 KLYQRLGK--IGSGGSSEVHKVIS-SDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLK 528
YQ L K +G G + +V + ALK + QE+++ +
Sbjct: 28 DDYQ-LSKQVLGLGVNGKVLECFHRRTGQKCALKLLY-DSPK------ARQEVDHHWQAS 79
Query: 529 GKNNIIQLID-YEVTEKALLREVLNGSMNNKDGRVKDDGYIYMVLEY---GEIDLAHMLS 584
G +I+ ++D YE + +++E GE+ + +
Sbjct: 80 GGPHIVCILDVYENMHHG-------------------KRCLLIIMECMEGGEL-FSRIQE 119
Query: 585 QKWK---EMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLLVK----GS 637
+ + E + + + I A+ +H I H D+KP N L
Sbjct: 120 RGDQAFTEREAAE----------IMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAV 169
Query: 638 LKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLG 697
LKL DFG AK T + T Y++PE + D+ C D+WSLG
Sbjct: 170 LKLTDFGFAKET----TQNALQTPCYTPYYVAPEVLGPEKYDK-----SC----DMWSLG 216
Query: 698 CILYQMVYGRTPF---SEYKTFWAKFKVITDPNHEITYEPVPNPWLL------DLMKKCL 748
I+Y ++ G PF + + I Y W L++ L
Sbjct: 217 VIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQ----YGFPNPEWSEVSEDAKQLIRLLL 272
Query: 749 AWDRNERWRIPQLLQHPFL 767
D ER I Q + HP++
Sbjct: 273 KTDPTERLTITQFMNHPWI 291
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 126 bits (320), Expect = 1e-32
Identities = 76/325 (23%), Positives = 131/325 (40%), Gaps = 83/325 (25%)
Query: 477 LGK-IGSGGSSEVHKVISSDC-TIYALKKI-KLKGRDYATAYGFCQEIEYLNKLKGKNNI 533
+G+ +G G V+ I ALK + K + + +EIE + L+ N I
Sbjct: 18 IGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPN-I 76
Query: 534 IQLIDYEVTEKALLREVLNGSMNNKDGRVKDDGYIYMVLEY---GEIDLAHMLSQKWKEM 590
+++ Y D IY++LE+ GE L L +
Sbjct: 77 LRM--YNY--------------------FHDRKRIYLMLEFAPRGE--LYKELQK----- 107
Query: 591 DGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLL-VKGSLKLIDFGIAKAI 649
+ DE + +++ +A++ HE +++H D+KP N L+ KG LK+ DFG +
Sbjct: 108 ---HGRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVH- 163
Query: 650 MSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGRTP 709
+++R + GTL Y+ PE DE D+W G + Y+ + G P
Sbjct: 164 ---APSLRRRTMCGTLDYLPPEMIEGKTHDEK---------VDLWCAGVLCYEFLVGMPP 211
Query: 710 FSEYKTFWAKFKVITDPNHEITYEPVPN------PWL----LDLMKKCLAWDRNERWRIP 759
F P+H T+ + N P+L DL+ K L + +R +
Sbjct: 212 FD-------------SPSHTETHRRIVNVDLKFPPFLSDGSKDLISKLLRYHPPQRLPLK 258
Query: 760 QLLQHPF-------LVPPVSTQPSS 777
+++HP+ ++PPV S
Sbjct: 259 GVMEHPWVKANSRRVLPPVYQSTQS 283
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 2e-32
Identities = 72/327 (22%), Positives = 125/327 (38%), Gaps = 74/327 (22%)
Query: 474 YQRLGKIGSGGSSEVHKVISSDCT--IYALKKIKLKGRDY---ATAYGFCQEIEYLNKLK 528
Y+ + +IG G +V K ALK+++++ + + +E+ L L+
Sbjct: 13 YECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTI---REVAVLRHLE 69
Query: 529 GKN--NIIQLIDYEVTEKALLREVLNGSMNNKDGRVKDDGYIYMVLEYGEIDLAHMLSQK 586
N+++L D V S +++ + + +V E+ + DL L
Sbjct: 70 TFEHPNVVRLFD-----------VCTVSRTDRETK------LTLVFEHVDQDLTTYLD-- 110
Query: 587 WKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLL-VKGSLKLIDFGI 645
+ ++ Q+L ++ +H R+VH DLKP N L+ G +KL DFG+
Sbjct: 111 ----KVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGL 166
Query: 646 AKAIMSDT--TNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQM 703
A+ T+ V TL Y +PE + + P D+WS+GCI +M
Sbjct: 167 ARIYSFQMALTS-----VVVTLWYRAPEVLLQS---------SYATPVDLWSVGCIFAEM 212
Query: 704 VYGRTPF---SEYKTFWAKFKVITDPNHEI-------------TYEPVPN----PWL--- 740
+ F S+ VI P E + P +
Sbjct: 213 FRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDEL 272
Query: 741 -LDLMKKCLAWDRNERWRIPQLLQHPF 766
DL+ KCL ++ +R L HP+
Sbjct: 273 GKDLLLKCLTFNPAKRISAYSALSHPY 299
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 5e-32
Identities = 74/328 (22%), Positives = 124/328 (37%), Gaps = 77/328 (23%)
Query: 474 YQRLGKIGSGGSSEVHKVISSDC-TIYALKKIKL----KGRDYATAYGFCQEIEYLNKLK 528
Y IG+G V++ D + A+KK+ K R E++ + KL
Sbjct: 56 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR----------ELQIMRKLD 105
Query: 529 GKNNIIQLIDYEVTEKALLREVLNGSMNNKDGRVKDDGYIYMVLEYGEIDLAHMLSQKWK 588
N I++L + + G KD+ Y+ +VL+Y + + +
Sbjct: 106 HCN-IVRLRYFFYS----------------SGEKKDEVYLNLVLDYVPETVYRVARHYSR 148
Query: 589 EMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLLV---KGSLKLIDFGI 645
+ QTL +++ Y Q+ ++ IH I H D+KP N LL+ LKL DFG
Sbjct: 149 ----AKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQN-LLLDPDTAVLKLCDFGS 203
Query: 646 AKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVY 705
AK ++ N+ S + + Y +PE + +D +I D+WS GC+L +++
Sbjct: 204 AKQLVRGEPNV---SYICSRYYRAPEL-IFGATDYTSSI-------DVWSAGCVLAELLL 252
Query: 706 GRTPF---SEYKTFWAKFKVITDPNHEI--------------TYEPVP---------NPW 739
G+ F S KV+ P E + P P
Sbjct: 253 GQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPE 312
Query: 740 LLDLMKKCLAWDRNERWRIPQLLQHPFL 767
+ L + L + R + H F
Sbjct: 313 AIALCSRLLEYTPTARLTPLEACAHSFF 340
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 6e-32
Identities = 83/346 (23%), Positives = 131/346 (37%), Gaps = 93/346 (26%)
Query: 474 YQRLGKIGSGGSSEVHKVISSDC-TIYALKKIKLKGRDYA------TAYGFCQEIEYLNK 526
Y++L +G G + V+K + I A+KKIKL R A TA +EI+ L +
Sbjct: 12 YEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTAL---REIKLLQE 68
Query: 527 LKGKNNIIQLIDYEVTEKALLREVLNGSMNNKDGRVKDDGYIYMVLEYGEIDLAHMLSQK 586
L N II L+D + + +V ++ E DL +
Sbjct: 69 LSHPN-IIGLLDAFGHKSNI----------------------SLVFDFMETDLEVI---- 101
Query: 587 WKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLL-VKGSLKLIDFGI 645
+ ++ L + ++ Y L+ + +H+ I+H DLKP N LL G LKL DFG+
Sbjct: 102 ---IKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGL 158
Query: 646 AKAIMSDT---TNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQ 702
AK+ S T+ QV T Y +PE G D+W++GCIL +
Sbjct: 159 AKSFGSPNRAYTH-----QVVTRWYRAPELLFGAR--------MYGVGVDMWAVGCILAE 205
Query: 703 MVYGRTPF----SE----YKTFWAKFKVITDPNHEI--------TYEPVPN--------- 737
++ PF S+ + F+ + P E Y +
Sbjct: 206 LLLRV-PFLPGDSDLDQLTRI----FETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHI 260
Query: 738 -PWL----LDLMKKCLAWDRNERWRIPQLLQHP-FLVPPVSTQPSS 777
LDL++ ++ R Q L+ F P T
Sbjct: 261 FSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPGPTPGCQ 306
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 8e-32
Identities = 76/361 (21%), Positives = 137/361 (37%), Gaps = 80/361 (22%)
Query: 476 RLGK-IGSGGSSEV----HKVISSDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGK 530
RL K IG G ++V H + + I + K +L + +E+ + L
Sbjct: 18 RLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLF---REVRIMKILNHP 74
Query: 531 NNIIQLIDYEVTEKALLREVLNGSMNNKDGRVKDDGYIYMVLEY---GEIDLAHMLSQKW 587
N I++L +EV + + +Y+++EY GE + L
Sbjct: 75 N-IVKL--FEV-------------IETEK-------TLYLIMEYASGGE--VFDYLVAHG 109
Query: 588 KEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLL-VKGSLKLIDFGIA 646
+ + E R ++QI+ AV H++RIVH DLK N LL ++K+ DFG +
Sbjct: 110 R--------MKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFS 161
Query: 647 KAIMSDTTNIQRDSQ-----VGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILY 701
N G Y +PE F + D G D+WSLG ILY
Sbjct: 162 --------NEFTVGGKLDAFCGAPPYAAPELFQGKKYD--------GPEVDVWSLGVILY 205
Query: 702 QMVYGRTPFSEYKTFWAKFKVITDPNHEITYEPVPNPWL----LDLMKKCLAWDRNERWR 757
+V G PF + + + + I P ++ +L+K+ L + +R
Sbjct: 206 TLVSGSLPFDG-QNLKELRERVLRGKYRI---P---FYMSTDCENLLKRFLVLNPIKRGT 258
Query: 758 IPQLLQHPFL---VPPVSTQPSSSQDQSYQLLQLLAEASASDHEASTICSQLSQLIRNPV 814
+ Q+++ ++ +P + + + + I LS++ + +
Sbjct: 259 LEQIMKDRWINAGHEEDELKPFVEPELDISDQKRIDIMVGMGYSQEEIQESLSKMKYDEI 318
Query: 815 M 815
Sbjct: 319 T 319
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 2e-31
Identities = 81/341 (23%), Positives = 127/341 (37%), Gaps = 70/341 (20%)
Query: 474 YQRLGKIGSGGSSEVHKVISSDC-TIYALKKIKLKGRDY---ATAYGFCQEIEYLNKLKG 529
Y++L KIG G EV K ALKK+ ++ TA +EI+ L LK
Sbjct: 19 YEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITAL---REIKILQLLKH 75
Query: 530 KNNIIQLIDYEVTEKALLREVLNGSMNNKDGRVKDDGYIYMVLEYGEIDLAHMLSQKWKE 589
+N ++ LI+ T+ + G IY+V ++ E DLA
Sbjct: 76 EN-VVNLIEICRTKA--------------SPYNRCKGSIYLVFDFCEHDLA-------GL 113
Query: 590 MDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLLV-KGSLKLIDFGIAKA 648
+ + ++ Q +L + IH +I+H D+K AN L+ G LKL DFG+A+A
Sbjct: 114 LSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARA 173
Query: 649 IMSDTTNIQRD--SQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYG 706
+ ++V TL Y PE + G P D+W GCI+ +M
Sbjct: 174 FSLAKNSQPNRYTNRVVTLWYRPPELLLGER--------DYGPPIDLWGAGCIMAEMWTR 225
Query: 707 RTPF---SE----YKTF----------WAK------FKVITDPNH------EITYEPVPN 737
+E W ++ + + V +
Sbjct: 226 SPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRD 285
Query: 738 PWLLDLMKKCLAWDRNERWRIPQLLQHP-FLVPPVSTQPSS 777
P+ LDL+ K L D +R L H F P+ +
Sbjct: 286 PYALDLIDKLLVLDPAQRIDSDDALNHDFFWSDPMPSDLKG 326
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 2e-31
Identities = 61/309 (19%), Positives = 107/309 (34%), Gaps = 72/309 (23%)
Query: 476 RLGK-IGSGGSSEVH-------------KVISSDCTIYALKKIKLKGRDYATAYGFCQEI 521
L + +G G EV K++ + + IK +EI
Sbjct: 10 DLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIK-------------KEI 56
Query: 522 EYLNKLKGKNNIIQLIDYEVTEKALLREVLNGSMNNKDGRVKDDGYIYMVLEY---GEID 578
L +N +++ Y + Y+ LEY GE
Sbjct: 57 CINKMLNHEN-VVKF--YGHRR--------------------EGNIQYLFLEYCSGGE-- 91
Query: 579 LAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLL-VKGS 637
L + + E + ++ Q++ V +H I H D+KP N LL + +
Sbjct: 92 LFDRIEPDIG--------MPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDN 143
Query: 638 LKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLG 697
LK+ DFG+A + + GTL Y++PE E P D+WS G
Sbjct: 144 LKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFH--------AEPVDVWSCG 195
Query: 698 CILYQMVYGRTPFSEYKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWR 757
+L M+ G P+ + ++ + + + L L+ K L + + R
Sbjct: 196 IVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARIT 255
Query: 758 IPQLLQHPF 766
IP + + +
Sbjct: 256 IPDIKKDRW 264
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 125 bits (314), Expect = 3e-31
Identities = 50/356 (14%), Positives = 103/356 (28%), Gaps = 79/356 (22%)
Query: 467 FKVNGKLYQRLGKIGSGGSSEVHKVISSDCT------IYALKKIKLKGRDYATAYGFCQE 520
F++ KL +G G ++V++ D + LK K Y Q
Sbjct: 60 FQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPW--EFYIGTQL 117
Query: 521 IEYLNKLKGKNNIIQLIDYEVTEKALLREVLNGSMNNKDGRVKDDGYIYMVLEYGE-IDL 579
+E L ++ ++ + + +V E L
Sbjct: 118 MERLKPSM-QHMFMKFYSAHLFQN----------------------GSVLVGELYSYGTL 154
Query: 580 AHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLL------ 633
+ ++ + + + + + ++L + +H+ I+H D+KP NF+L
Sbjct: 155 LNAINLYKNT---PEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLE 211
Query: 634 ------VKGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKC 687
+ L LID G + + ++ T + E +
Sbjct: 212 QDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVE-------------MLS 258
Query: 688 GRP----SDIWSLGCILYQMVYGRTPFSEYKTFWAKFKVITDPNHEITYEPVPNPWLLDL 743
+P D + + +Y M++G V + LD+
Sbjct: 259 NKPWNYQIDYFGVAATVYCMLFGTYMK-----------VKNEGGECKPEGLFRRLPHLDM 307
Query: 744 MKK----CLAWDRNERWRIPQLLQHPFLVPPVSTQPSSSQDQSYQLLQLLAEASAS 795
+ L LL+ + + +L+ LL E S
Sbjct: 308 WNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRS 363
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 4e-31
Identities = 81/360 (22%), Positives = 137/360 (38%), Gaps = 89/360 (24%)
Query: 473 LYQRLG-KIGSGGSSEVHKVISSDCT---IYALKKIKLKGRDYATAYGFCQEIEYLNKLK 528
L++ G K+G G V+K D YALK+I+ G +A C+EI L +LK
Sbjct: 21 LFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGIS-MSA---CREIALLRELK 76
Query: 529 GKNNIIQLIDYEVTEKALLREVLNGSMNNKDGRVKDDGYIYMVLEYGEIDLAHML-SQKW 587
N +I L ++V + K ++++ +Y E DL H++ +
Sbjct: 77 HPN-VISL-----------QKVFLSHADRK---------VWLLFDYAEHDLWHIIKFHRA 115
Query: 588 KEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLLV-----KGSLKLID 642
+ + L ++ QIL+ ++ +H ++H DLKPAN L++ +G +K+ D
Sbjct: 116 SKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIAD 175
Query: 643 FGIAKAIMSDT-TNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILY 701
G A+ S D V T Y +PE + + DIW++GCI
Sbjct: 176 MGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGAR--------HYTKAIDIWAIGCIFA 227
Query: 702 QMVYGR-----------------------------TP----------FSEYKTFWAKFKV 722
+++ P E+ T F+
Sbjct: 228 ELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRR 287
Query: 723 ITDPNHEI-----TYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQHP-FLVPPVSTQPS 776
T N + ++ P+ L++K L D +R Q +Q P FL P+ T
Sbjct: 288 NTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYFLEDPLPTSDV 347
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 4e-31
Identities = 77/333 (23%), Positives = 136/333 (40%), Gaps = 83/333 (24%)
Query: 474 YQRLGKIGSGGSSEVHKVISSDC-TIYALKKIKLKGRDYATAYGF----CQEIEYLNKLK 528
+++L K+G+G + V+K ++ ALK++KL + G +EI + +LK
Sbjct: 7 FKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEE-----GTPSTAIREISLMKELK 61
Query: 529 GKNNIIQLIDYEVTEKALLREVLNGSMNNKDGRVKDDGYIYMVLEYGEIDLAHMLSQKWK 588
+N I++L D TE L +V E+ + DL + +
Sbjct: 62 HEN-IVRLYDVIHTENKL----------------------TLVFEFMDNDLKKYMDSR-- 96
Query: 589 EMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLL-VKGSLKLIDFGIAK 647
+ + + L+ N ++++ Q+L+ + HE +I+H DLKP N L+ +G LKL DFG+A+
Sbjct: 97 TVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLAR 156
Query: 648 AIMSDT---TNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMV 704
A ++ +V TL Y +P+ M + DIWS GCIL +M+
Sbjct: 157 AFGIPVNTFSS-----EVVTLWYRAPDVLMGSR--------TYSTSIDIWSCGCILAEMI 203
Query: 705 YGR--------------------TP----------FSEYKTFWAKFKVITDPNH-EITYE 733
G+ TP +Y + + +
Sbjct: 204 TGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTKLPKYNPNIQQRPPRDLRQVLQPHTK 263
Query: 734 PVPNPWLLDLMKKCLAWDRNERWRIPQLLQHPF 766
+ L+D + L + + R Q L HP+
Sbjct: 264 EPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPW 296
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 4e-31
Identities = 87/352 (24%), Positives = 147/352 (41%), Gaps = 63/352 (17%)
Query: 457 RKRNYDPDLFFKVN-GKLYQRLGKIGSGGSSEVHKVIS-SDCTIYALKKIKLKGRDYATA 514
RK + ++ ++++ +G++G G +V+K + + A K I+ K +
Sbjct: 3 RKSREYEHVRRDLDPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELED 62
Query: 515 YGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLREVLNGSMNNKDGRVKDDGYIYMVLEY 574
+ EIE L I++L+ A DG +++++E+
Sbjct: 63 --YIVEIEILATCDHPY-IVKLLG------AYYH----------------DGKLWIMIEF 97
Query: 575 GE----IDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPAN 630
+ M ++ L E ++ +Q+LEA+N +H +RI+H DLK N
Sbjct: 98 CPGGAVDAI----------MLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGN 147
Query: 631 FLL-VKGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGR 689
L+ ++G ++L DFG++ A T +RDS +GT +M+PE MC + K
Sbjct: 148 VLMTLEGDIRLADFGVS-AKNLKTLQ-KRDSFIGTPYWMAPEVVMCETMKDTPYDYKA-- 203
Query: 690 PSDIWSLGCILYQMVYGRTPFSEYKTFWAKFKVITDPNHEITYEPVPNPW---LLDLMKK 746
DIWSLG L +M P E K+ + P+ W D +K
Sbjct: 204 --DIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPTLLT---PSKWSVEFRDFLKI 258
Query: 747 CLAWDRNERWRIPQLLQHPFLVPPVSTQPSSSQDQSYQLLQLLAEASASDHE 798
L + R QLL+HPF+ S + L +L+AEA A E
Sbjct: 259 ALDKNPETRPSAAQLLEHPFVSSITSNKA---------LRELVAEAKAEVME 301
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 9e-31
Identities = 64/348 (18%), Positives = 120/348 (34%), Gaps = 75/348 (21%)
Query: 476 RLGK-IGSGGSSEVH-------------KVISSDCTIYALKKIKLKGRDYATAYGFCQEI 521
L + +G G EV K++ + + IK +EI
Sbjct: 10 DLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIK-------------KEI 56
Query: 522 EYLNKLKGKNNIIQLIDYEVTEKALLREVLNGSMNNKDGRVKDDGYIYMVLEY---GEID 578
L +N +++ Y + Y+ LEY GE
Sbjct: 57 CINKMLNHEN-VVKF--YGH-------------RREGN-------IQYLFLEYCSGGE-- 91
Query: 579 LAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLL-VKGS 637
L + + E + ++ Q++ V +H I H D+KP N LL + +
Sbjct: 92 LFDRIEPDIG--------MPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDN 143
Query: 638 LKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLG 697
LK+ DFG+A + + GTL Y++PE E P D+WS G
Sbjct: 144 LKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFH--------AEPVDVWSCG 195
Query: 698 CILYQMVYGRTPFSEYKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWR 757
+L M+ G P+ + ++ + + + L L+ K L + + R
Sbjct: 196 IVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARIT 255
Query: 758 IPQLLQHPFL---VPPVSTQPSSSQDQSYQLLQLLAEASASDHEASTI 802
IP + + + + + +P + + ++ S+ + S +
Sbjct: 256 IPDIKKDRWYNKPLKKGAKRPRVTSGGVSESPSGFSKHIQSNLDFSPV 303
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 1e-29
Identities = 70/345 (20%), Positives = 129/345 (37%), Gaps = 79/345 (22%)
Query: 474 YQRLGKIGSG--GSSEVHKVISSDCT----IYALKKIKLKGRDYATAYGFCQ-EIEYLNK 526
Y +G+G G V +ALKK+ R + E++ +
Sbjct: 9 YSLGKTLGTGSFG-----IVCEVFDIESGKRFALKKVLQDPR-------YKNRELDIMKV 56
Query: 527 LKGKNNIIQLIDYEVTEK----------------ALLREVLNGSMNNKDGRVKDDGYIYM 570
L N II+L+DY T +N + + Y+ +
Sbjct: 57 LDHVN-IIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNV 115
Query: 571 VLEYGEIDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPAN 630
++EY L +L + S +++ N + Y Q+ AV IH I H D+KP N
Sbjct: 116 IMEYVPDTLHKVLKSFIR----SGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQN 171
Query: 631 FLL--VKGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCG 688
L+ +LKL DFG AK ++ ++ + + + Y +PE M ++ +I
Sbjct: 172 LLVNSKDNTLKLCDFGSAKKLIPSEPSV---AYICSRFYRAPE-LMLGATEYTPSI---- 223
Query: 689 RPSDIWSLGCILYQMVYGRTPF---SEYKTFWAKFKVITDPNHEI--------------T 731
D+WS+GC+ +++ G+ F + +++ P E T
Sbjct: 224 ---DLWSIGCVFGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPT 280
Query: 732 YEPVP---------NPWLLDLMKKCLAWDRNERWRIPQLLQHPFL 767
+ +DL+++ L ++ + R + + HPF
Sbjct: 281 LKAKDWRKILPEGTPSLAIDLLEQILRYEPDLRINPYEAMAHPFF 325
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 1e-29
Identities = 50/287 (17%), Positives = 106/287 (36%), Gaps = 49/287 (17%)
Query: 479 KIGSGGSSEVHK------VISSDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNN 532
IG G +V+ V A++ I ++ + F +E+ + + +N
Sbjct: 40 LIGKGRFGQVYHGRWHGEV--------AIRLIDIERDNEDQLKAFKREVMAYRQTRHEN- 90
Query: 533 IIQLIDYEVTEKALLREVLNGSMNNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEMD 591
++ + G ++ ++ + L ++
Sbjct: 91 VVLFM----------------------GACMSPPHLAIITSLCKGRTLYSVVRDA----- 123
Query: 592 GSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLLVKGSLKLIDFGIAKAIMS 651
LD N R Q+I++ + +H + I+H DLK N G + + DFG+
Sbjct: 124 --KIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYDNGKVVITDFGLFSISGV 181
Query: 652 DTTNIQRD---SQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGRT 708
+ D Q G L +++PE D + + + SD+++LG I Y++
Sbjct: 182 LQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREW 241
Query: 709 PFSEYKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNER 755
PF +++ T ++ + + D++ C A+++ ER
Sbjct: 242 PFKTQPAEAIIWQMGTGMKPNLSQIGMG-KEISDILLFCWAFEQEER 287
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 1e-29
Identities = 78/342 (22%), Positives = 126/342 (36%), Gaps = 95/342 (27%)
Query: 474 YQRLGKIGSGGSSEVHKVISSDC-TIYALKKIKLKGRDY---ATAYGFCQEIEYLNKLKG 529
Y+R+ K+G G EV+K I + A+K+I+L+ + TA +E+ L +L+
Sbjct: 36 YRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTA---IREVSLLKELQH 92
Query: 530 KNNIIQLIDYEVTEKALLREVLNGSMNNKDGRVKDDGYIYMVLEYGEIDLAHMLSQKWKE 589
+N II+L L +++ EY E DL K
Sbjct: 93 RN-IIELKSVIHHNHRL----------------------HLIFEYAENDLK-------KY 122
Query: 590 MDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLL------VKGSLKLIDF 643
MD N + ++ + Q++ VN H R +H DLKP N LL LK+ DF
Sbjct: 123 MD-KNPDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDF 181
Query: 644 GIAKAIMSDT---TNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCIL 700
G+A+A T+ ++ TL Y PE + + DIWS+ CI
Sbjct: 182 GLARAFGIPIRQFTH-----EIITLWYRPPEILLGSR--------HYSTSVDIWSIACIW 228
Query: 701 YQMVYGR--------------------TP----------FSEYKTFWAKFKVITDPNHEI 730
+M+ P ++K + KF+ +
Sbjct: 229 AEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGVTALPDWKQSFPKFR--GKTLKRV 286
Query: 731 TYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQHPFL--VPP 770
+ + LDL+ L D +R L+HP+
Sbjct: 287 -LGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYFSHNDF 327
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 2e-29
Identities = 90/399 (22%), Positives = 151/399 (37%), Gaps = 108/399 (27%)
Query: 422 SQAPLSKNSSSDMKLEASKSEKQEKAVSSKGASAPRKRNYDPDLFFKVNGKLYQRLGKIG 481
+ +PL + + LE +K + ++ + F + L IG
Sbjct: 42 NNSPLRREKNILEYLEWAKPFTSKV----------KQMRLHREDF--------EILKVIG 83
Query: 482 SGGSSEVHKVISSDC-TIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYE 540
G EV V + ++A+K + K +++ +
Sbjct: 84 RGAFGEVAVVKLKNADKVFAMKILN------------------------KWEMLKRAETA 119
Query: 541 VT--EKALLREV-------LNGSMNNKDGRVKDDGYIYMVLEY---GEIDLAHMLSQKWK 588
E+ +L L+ + +DD +Y+V++Y G DL +LS+
Sbjct: 120 CFREERDVLVNGDSKWITTLHYAF-------QDDNNLYLVMDYYVGG--DLLTLLSK--- 167
Query: 589 EMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLL-VKGSLKLIDFGIAK 647
L E RFY +++ A++++H+ VH D+KP N L+ + G ++L DFG
Sbjct: 168 ----FEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCL 223
Query: 648 AIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGR 707
+M D T +Q VGT Y+SPE E + G D WSLG +Y+M+YG
Sbjct: 224 KLMEDGT-VQSSVAVGTPDYISPEILQAMEGGKGR----YGPECDWWSLGVCMYEMLYGE 278
Query: 708 TPF---SEYKTFWAKFKVITDPNHEITYEPVPNPWL----LDLMKKCLAWDRNERWR--- 757
TPF S +T + I + + P + DL+++ + E R
Sbjct: 279 TPFYAESLVET----YGKIMNHKERFQF-PTQVTDVSENAKDLIRRLI--CSREH-RLGQ 330
Query: 758 --IPQLLQHPF-----------LVPPVSTQPSSSQDQSY 783
I +HPF P + SS D S
Sbjct: 331 NGIEDFKKHPFFSGIDWDNIRNCEAPYIPEVSSPTDTSN 369
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 2e-29
Identities = 71/334 (21%), Positives = 125/334 (37%), Gaps = 84/334 (25%)
Query: 474 YQRLGKIGSGGSSEVHKVISSDC-TIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNN 532
YQ + K+G G SEV + I+ +K +K + +EI+ L L+G N
Sbjct: 38 YQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKI-----KREIKILENLRGGPN 92
Query: 533 IIQLIDYEVTEKALLREVLNGSMNNKDGRVKDDGYIYMVLEYGEIDLAHMLSQKWKEMDG 592
II L D ++ ++ + D +
Sbjct: 93 IITLAD-----------IVKDPVSRTP--------ALVFEHVNNTDFKQLY--------- 124
Query: 593 SNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLL--VKGSLKLIDFGIAKAIM 650
QTL + +RFY +IL+A++ H I+H D+KP N ++ L+LID+G+A+
Sbjct: 125 --QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH 182
Query: 651 SDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGRTPF 710
R V + + PE + + + ++ D+WSLGC+L M++ + PF
Sbjct: 183 PGQEYNVR---VASRYFKGPE-LLVDYQMYDYSL-------DMWSLGCMLASMIFRKEPF 231
Query: 711 ----SEYKTFWAKFKVI-TDPNHEI-----------------TYEPVP------------ 736
Y KV+ T+ ++ +
Sbjct: 232 FHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHL 291
Query: 737 -NPWLLDLMKKCLAWDRNERWRIPQLLQHPFLVP 769
+P LD + K L +D R + ++HP+
Sbjct: 292 VSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYT 325
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 2e-29
Identities = 77/334 (23%), Positives = 136/334 (40%), Gaps = 64/334 (19%)
Query: 467 FKVNGKLYQRLGKIGSGGSSEVHKVISSDC-TIYALKKIKLKGRDYAT-AYGFCQEIEYL 524
F + + Y L +G GG+ V + +DC A+KKI L A +EI+ +
Sbjct: 7 FDLGSR-YMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHAL---REIKII 62
Query: 525 NKLKGKNNIIQLIDYEVTEKALLREVLNGSMNNKDGRVKDDGYIYMVLEYGEIDLAHMLS 584
+L N I+++ + + L + + +Y+V EY E DLA++L
Sbjct: 63 RRLDHDN-IVKVFEILGPSGSQLTDDVGSLTELNS--------VYIVQEYMETDLANVLE 113
Query: 585 QKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLLVKGS---LKLI 641
Q L E R + Q+L + IH ++H DLKPAN L + LK+
Sbjct: 114 Q---------GPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPAN-LFINTEDLVLKIG 163
Query: 642 DFGIAKAIMSDTTNIQRDSQ-VGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCIL 700
DFG+A+ + ++ S+ + T Y SP + + ++ I D+W+ GCI
Sbjct: 164 DFGLARIMDPHYSHKGHLSEGLVTKWYRSPR-LLLSPNNYTKAI-------DMWAAGCIF 215
Query: 701 YQMVYGRTPF--SEYKTFWAK-FKVITDPNHE----------------ITYEPVP----- 736
+M+ G+T F + + I + E +T P
Sbjct: 216 AEMLTGKTLFAGAHELEQMQLILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLL 275
Query: 737 ---NPWLLDLMKKCLAWDRNERWRIPQLLQHPFL 767
+ +D +++ L + +R + L HP++
Sbjct: 276 PGISREAVDFLEQILTFSPMDRLTAEEALSHPYM 309
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 3e-29
Identities = 65/245 (26%), Positives = 102/245 (41%), Gaps = 43/245 (17%)
Query: 564 DDGYIYMVLEY---GEIDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEER 620
D+ Y+Y+V+EY G DL +LS+ + + RFY +I+ A++++H
Sbjct: 132 DENYLYLVMEYYVGG--DLLTLLSKF-------GERIPAEMARFYLAEIVMAIDSVHRLG 182
Query: 621 IVHSDLKPANFLL-VKGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESD 679
VH D+KP N LL G ++L DFG + +D T ++ VGT Y+SPE
Sbjct: 183 YVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGT-VRSLVAVGTPDYLSPEILQAVGGG 241
Query: 680 ENGNIIKCGRPSDIWSLGCILYQMVYGRTPF---SEYKTFWAKFKVITDPNHEITYEPVP 736
G D W+LG Y+M YG+TPF S +T + I ++ P+
Sbjct: 242 PGTG--SYGPECDWWALGVFAYEMFYGQTPFYADSTAET----YGKIVHYKEHLSL-PLV 294
Query: 737 NPWL----LDLMKKCLAWDRNER---WRIPQLLQHPF-----------LVPPVSTQPSSS 778
+ + D +++ L R HPF VPP + +
Sbjct: 295 DEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTHPFFFGLDWDGLRDSVPPFTPDFEGA 353
Query: 779 QDQSY 783
D
Sbjct: 354 TDTCN 358
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 5e-29
Identities = 81/361 (22%), Positives = 132/361 (36%), Gaps = 101/361 (27%)
Query: 415 GNSPELKSQAPLSKNSSSDMKLEASKSEKQEKAVSSKGASAPRKRNYDPDLFFKVNGKLY 474
GN+ K S+ S L +K + +K + P + D F
Sbjct: 1 GNAAAAKKG---SEQESVKEFLAKAKEDFLKKWET------PSQNTAQLDQF-------- 43
Query: 475 QRLGKIGSGGSSEVHKVISSDC-TIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNI 533
R+ +G+G V V + YA+K + K +
Sbjct: 44 DRIKTLGTGSFGRVMLVKHKESGNHYAMKILD------------------------KQKV 79
Query: 534 IQL--IDYEVTEKALLREVLNGSMNNKDGRVKDDGYIYMVLEY---GEIDLAHMLSQKWK 588
++L I++ + EK +L+ V + + KD+ +YMV+EY GE + L +
Sbjct: 80 VKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGE--MFSHLRRI-- 135
Query: 589 EMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLL-VKGSLKLIDFGIAK 647
E RFY QI+ +H +++ DLKP N L+ +G +++ DFG AK
Sbjct: 136 ------GRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK 189
Query: 648 AIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIK---CGRPSDIWSLGCILYQMV 704
+ T + GT ++PE II + D W+LG ++Y+M
Sbjct: 190 RV-KGRTW----TLCGTPEALAPE------------IILSKGYNKAVDWWALGVLIYEMA 232
Query: 705 YGRTPFSEYKTFWAKFKVITDPNHEITYE-----PV--P---NPWLLDLMKKCLAWDRNE 754
G PF YE V P + L DL++ L D +
Sbjct: 233 AGYPPF-------------FADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQVDLTK 279
Query: 755 R 755
R
Sbjct: 280 R 280
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 7e-29
Identities = 74/313 (23%), Positives = 120/313 (38%), Gaps = 82/313 (26%)
Query: 476 RLGK-IGSGGSSEV----HKVISSDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGK 530
LG +G G +V H++ + L + K++ D +EI+ L +
Sbjct: 14 VLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLD--VVGKIKREIQNLKLFRHP 71
Query: 531 NNIIQLIDYEVTEKALLREVLNGSMNNKDGRVKDDGYIYMVLEY---GEIDLAHMLSQKW 587
+ II+L Y+V ++ +MV+EY GE L + +
Sbjct: 72 H-IIKL--YQV-------------ISTPT-------DFFMVMEYVSGGE--LFDYICKHG 106
Query: 588 KEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLL-VKGSLKLIDFGIA 646
+ ++E R +QQIL AV+ H +VH DLKP N LL + K+ DFG++
Sbjct: 107 R--------VEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLS 158
Query: 647 KAIMSDTTNIQRDSQV-----GTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILY 701
N+ D + G+ +Y +PE G DIWS G ILY
Sbjct: 159 --------NMMSDGEFLRTSCGSPNYAAPEVISGRLYA--------GPEVDIWSCGVILY 202
Query: 702 QMVYGRTPFSEY-------KTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNE 754
++ G PF + K F + P + N + L+ L D +
Sbjct: 203 ALLCGTLPFDDEHVPTLFKKIRGGVFYI---PEY-------LNRSVATLLMHMLQVDPLK 252
Query: 755 RWRIPQLLQHPFL 767
R I + +H +
Sbjct: 253 RATIKDIREHEWF 265
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 119 bits (299), Expect = 9e-29
Identities = 82/317 (25%), Positives = 131/317 (41%), Gaps = 79/317 (24%)
Query: 474 YQRLGKIGSGGSSEVHKVISSDC-TIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNN 532
Y+ + IG G EV V +YA+K + K
Sbjct: 71 YEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLS------------------------KFE 106
Query: 533 IIQL--IDYEVTEKALLREV-------LNGSMNNKDGRVKDDGYIYMVLEY---GEIDLA 580
+I+ + E+ ++ L + +DD Y+YMV+EY G+ L
Sbjct: 107 MIKRSDSAFFWEERDIMAFANSPWVVQLFYAF-------QDDRYLYMVMEYMPGGD--LV 157
Query: 581 HMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLL-VKGSLK 639
+++S N + E W RFY +++ A++ IH +H D+KP N LL G LK
Sbjct: 158 NLMS---------NYDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLK 208
Query: 640 LIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCI 699
L DFG + + ++ D+ VGT Y+SPE G GR D WS+G
Sbjct: 209 LADFGTCMKMNKEGM-VRCDTAVGTPDYISPEVLK-----SQGGDGYYGRECDWWSVGVF 262
Query: 700 LYQMVYGRTPF---SEYKTFWAKFKVITDPNHEITYEPVPNPWL----LDLMKKCLAWDR 752
LY+M+ G TPF S T+ K++ NH+ + + + +L+ L DR
Sbjct: 263 LYEMLVGDTPFYADSLVGTY---SKIM---NHKNSLTFPDDNDISKEAKNLICAFLT-DR 315
Query: 753 NERWR---IPQLLQHPF 766
R + ++ +H F
Sbjct: 316 EVRLGRNGVEEIKRHLF 332
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 1e-28
Identities = 76/340 (22%), Positives = 127/340 (37%), Gaps = 77/340 (22%)
Query: 476 RLGK-IGSGGSSEV----HKVISSDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGK 530
+G +G G +V + LKK KL+ R +EI+ L +L+ K
Sbjct: 8 LMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLR-RIPNGEANVKKEIQLLRRLRHK 66
Query: 531 NNIIQLIDYEVTEKALLREVLNGSMNNKDGRVKDDGYIYMVLEY---GEIDLAHMLSQKW 587
N +IQL +V + +YMV+EY G ++ + +K
Sbjct: 67 N-VIQL--VDVLYNE------------------EKQKMYMVMEYCVCGMQEMLDSVPEK- 104
Query: 588 KEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLL-VKGSLKLIDFGIA 646
Y+ Q+++ + +H + IVH D+KP N LL G+LK+ G+A
Sbjct: 105 --------RFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVA 156
Query: 647 KAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYG 706
+A+ + + G+ ++ PE NG G DIWS G LY + G
Sbjct: 157 EALHPFAADDTCRTSQGSPAFQPPEIA-------NGLDTFSGFKVDIWSAGVTLYNITTG 209
Query: 707 RTPFSEYKTFWAKFKVITDPNHEITYEPVPN------PWL----LDLMKKCLAWDRNERW 756
PF N +E + DL+K L ++ +R+
Sbjct: 210 LYPFE-------------GDNIYKLFENIGKGSYAIPGDCGPPLSDLLKGMLEYEPAKRF 256
Query: 757 RIPQLLQHPFL-------VPPVSTQPSSSQDQSYQLLQLL 789
I Q+ QH + PV PS ++ + ++
Sbjct: 257 SIRQIRQHSWFRKKHPPAEAPVPIPPSPDTKDRWRSMTVV 296
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 1e-28
Identities = 61/317 (19%), Positives = 108/317 (34%), Gaps = 94/317 (29%)
Query: 472 KLYQRLGK-IGSGGSSEVHKVIS-SDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKG 529
Y+ + +G G + +V ++ + +ALK ++ +E+E +
Sbjct: 17 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQ-DCPK------ARREVELHWRASQ 69
Query: 530 KNNIIQLID-YEVTEKALLREVLNGSMNNKDGRVKDDGYIYMVLEY---GEIDLAHMLSQ 585
+I++++D YE + + +V+E GE L +
Sbjct: 70 CPHIVRIVDVYE------------------NLYAGRK-CLLIVMECLDGGE--LFSRIQD 108
Query: 586 KWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLLVK----GSLKLI 641
+ +Q E + I EA+ +H I H D+KP N L LKL
Sbjct: 109 R------GDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLT 162
Query: 642 DFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILY 701
DFG AK + Y + D+WSLG I+Y
Sbjct: 163 DFGFAK-------------ETTGEKY--------------------DKSCDMWSLGVIMY 189
Query: 702 QMVYGRTPFSEYKTFWAKFKVITDPN--HEI---TYEPVPNPWLL------DLMKKCLAW 750
++ G P F++ + P I YE W L++ L
Sbjct: 190 ILLCGYPP------FYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKT 243
Query: 751 DRNERWRIPQLLQHPFL 767
+ +R I + + HP++
Sbjct: 244 EPTQRMTITEFMNHPWI 260
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 1e-28
Identities = 66/331 (19%), Positives = 115/331 (34%), Gaps = 74/331 (22%)
Query: 474 YQRLGKIGSGGSSEVHKVISSDC-TIYALKKIKLKGRDYATAYGFCQ-EIEYLNKLKGKN 531
+Q G G V A+KK+ R F E++ + L +
Sbjct: 25 FQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPR-------FRNRELQIMQDLAVLH 77
Query: 532 --NIIQLIDYEVTEKALLREVLNGSMNNKDGRVKDDGYIYMVLEYGEIDLAHMLSQKWKE 589
NI+QL Y R + D Y+ +V+EY L ++
Sbjct: 78 HPNIVQLQSY---------------FYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYR- 121
Query: 590 MDGSNQTLDENWLRFYWQQILEAVNTIHEE--RIVHSDLKPANFLL--VKGSLKLIDFGI 645
++ + Q++ ++ +H + H D+KP N L+ G+LKL DFG
Sbjct: 122 ---RQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGS 178
Query: 646 AKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVY 705
AK + N+ + + + Y +PE + + DIWS+GCI +M+
Sbjct: 179 AKKLSPSEPNV---AYICSRYYRAPE-LIFGNQHYTTAV-------DIWSVGCIFAEMML 227
Query: 706 GRTPF---SEYKTFWAKFKVITDPNHEI--------------TYEPVP------------ 736
G F + +V+ P+ E+ + +P
Sbjct: 228 GEPIFRGDNSAGQLHEIVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKD 287
Query: 737 NPWLLDLMKKCLAWDRNERWRIPQLLQHPFL 767
DL+ L + ER + + L HP+
Sbjct: 288 AKEAYDLLSALLQYLPEERMKPYEALCHPYF 318
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 116 bits (294), Expect = 1e-28
Identities = 91/386 (23%), Positives = 145/386 (37%), Gaps = 98/386 (25%)
Query: 476 RLGK-IGSGGSSEV----HKVISSDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGK 530
+ + +G G +V H + + + LK D +EI YL KL
Sbjct: 12 IIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSD--MHMRVEREISYL-KLLRH 68
Query: 531 NNIIQLIDYEVTEKALLREVLNGSMNNKDGRVKDDGYIYMVLEY--GEIDLAHMLSQKWK 588
+II+L Y+V + I MV+EY GE L + +K +
Sbjct: 69 PHIIKL--YDV-------------ITTPT-------DIVMVIEYAGGE--LFDYIVEKKR 104
Query: 589 EMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLL-VKGSLKLIDFGIAK 647
+ E+ R ++QQI+ A+ H +IVH DLKP N LL ++K+ DFG++
Sbjct: 105 --------MTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLS- 155
Query: 648 AIMSDTTNIQRDSQV-----GTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQ 702
NI D G+ +Y +PE G D+WS G +LY
Sbjct: 156 -------NIMTDGNFLKTSCGSPNYAAPEVINGKLYA--------GPEVDVWSCGIVLYV 200
Query: 703 MVYGRTPFSEYKTFWAKFKVITDPNHEITYEPVPN------PWL----LDLMKKCLAWDR 752
M+ GR PF D ++ V + +L L+++ + D
Sbjct: 201 MLVGRLPFD-------------DEFIPNLFKKVNSCVYVMPDFLSPGAQSLIRRMIVADP 247
Query: 753 NERWRIPQLLQHPFL-------VPPVSTQPSSSQDQSYQLLQLLAEASASDHEASTICSQ 805
+R I ++ + P+ + P+ S D +++ L EA + I
Sbjct: 248 MQRITIQEIRRDPWFNVNLPDYLRPMEEVQGSYADS--RIVSKLGEAMGFSED--YIVEA 303
Query: 806 LSQLIRNPVMLAATQLSTSQDQQCKL 831
L N V A L +Q Q KL
Sbjct: 304 LRSDENNEVKEAYNLLHENQVIQEKL 329
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 5e-28
Identities = 45/150 (30%), Positives = 68/150 (45%), Gaps = 20/150 (13%)
Query: 564 DDGYIYMVLEYGE-IDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIV 622
DG +Y+ + +DLA ML + L +QI A++ H
Sbjct: 105 IDGQLYVDMRLINGVDLAAMLRR--------QGPLAPPRAVAIVRQIGSALDAAHAAGAT 156
Query: 623 HSDLKPANFLLVK-GSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDEN 681
H D+KP N L+ L+DFGIA A +D Q + VGTL YM+PE F + +
Sbjct: 157 HRDVKPENILVSADDFAYLVDFGIASA-TTDEKLTQLGNTVGTLYYMAPERFSESHATY- 214
Query: 682 GNIIKCGRPSDIWSLGCILYQMVYGRTPFS 711
+DI++L C+LY+ + G P+
Sbjct: 215 --------RADIYALTCVLYECLTGSPPYQ 236
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 7e-28
Identities = 73/351 (20%), Positives = 130/351 (37%), Gaps = 70/351 (19%)
Query: 429 NSSSDMKLEASKSEKQEKAVSSKGASAPRK---RNYDPDLFFKVNGKLYQRLGKIGSGGS 485
+ SS + L Q V+ + A + DP L KIG G +
Sbjct: 6 HHSSGVDLGTENLYFQSGVVTHEQFKAALRMVVDQGDPR-------LLLDSYVKIGEGST 58
Query: 486 SEVHKVISSDC-TIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEK 544
V A+K + L+ + E+ + + N ++++
Sbjct: 59 GIVCLAREKHSGRQVAVKMMDLRKQQRRELL--FNEVVIMRDYQHFN-VVEMYK------ 109
Query: 545 ALLREVLNGSMNNKDGRVKDDGYIYMVLEYGEIDLAHMLSQKWKEMDG-------SNQTL 597
+ L +++++E+ + G S L
Sbjct: 110 SYLV----------------GEELWVLMEF---------------LQGGALTDIVSQVRL 138
Query: 598 DENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLL-VKGSLKLIDFGIAKAIMSDTTNI 656
+E + + +L+A+ +H + ++H D+K + LL + G +KL DFG I
Sbjct: 139 NEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQI--SKDVP 196
Query: 657 QRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGRTPFSEYKTF 716
+R S VGT +M+PE + + DIWSLG ++ +MV G P+
Sbjct: 197 KRKSLVGTPYWMAPEVISRSLYAT-----EV----DIWSLGIMVIEMVDGEPPYFSDSPV 247
Query: 717 WAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQHPFL 767
A ++ P ++ +P L D +++ L D ER +LL HPFL
Sbjct: 248 QAMKRLRDSPPPKLKNSHKVSPVLRDFLERMLVRDPQERATAQELLDHPFL 298
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 8e-28
Identities = 72/305 (23%), Positives = 124/305 (40%), Gaps = 60/305 (19%)
Query: 472 KLYQRLGKIGSGGSSEVHKVISSDC-TIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGK 530
K Y R KIG G S V+ + A++++ L+ + EI + + K
Sbjct: 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELI--INEILVMRENKNP 77
Query: 531 NNIIQLIDYEVTEKALLREVLNGSMNNKDGRVKDDGYIYMVLEYGEIDLAHMLSQKWKEM 590
N I+ +D + L +++V+EY +
Sbjct: 78 N-IVNYLD------SYLV----------------GDELWVVMEY---------------L 99
Query: 591 DG-------SNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLL-VKGSLKLID 642
G + +DE + ++ L+A+ +H +++H D+K N LL + GS+KL D
Sbjct: 100 AGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTD 159
Query: 643 FGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQ 702
FG A ++ + +R + VGT +M+PE K DIWSLG + +
Sbjct: 160 FGFC-AQITPEQS-KRSTMVGTPYWMAPEVVTRKAYGP-----KV----DIWSLGIMAIE 208
Query: 703 MVYGRTPFSEYKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLL 762
M+ G P+ A + + T+ E+ + D + +CL D +R +LL
Sbjct: 209 MIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELL 268
Query: 763 QHPFL 767
QH FL
Sbjct: 269 QHQFL 273
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 1e-27
Identities = 68/335 (20%), Positives = 129/335 (38%), Gaps = 77/335 (22%)
Query: 450 SKGASAPRKRNYDPDLFFKVNGKLYQRLGKIGSGGSSEVHKVISSD-CTIYALKKIKLKG 508
S + + D F + L IG G +V V +D +YA+K +
Sbjct: 1 SMPPVFDENEDVNFDHF--------EILRAIGKGSFGKVCIVQKNDTKKMYAMKYMN--- 49
Query: 509 RDYATAYGFCQEIEYLNKLKGKNNIIQL--IDYEVTEKALLREV-------LNGSMNNKD 559
K ++ + E +++ + L S
Sbjct: 50 ---------------------KQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSF---- 84
Query: 560 GRVKDDGYIYMVLEY---GEIDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTI 616
+D+ ++MV++ G DL + L Q N E ++ + +++ A++ +
Sbjct: 85 ---QDEEDMFMVVDLLLGG--DLRYHLQQ--------NVHFKEETVKLFICELVMALDYL 131
Query: 617 HEERIVHSDLKPANFLL-VKGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMC 675
+RI+H D+KP N LL G + + DF IA + +T + GT YM+PE F
Sbjct: 132 QNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQI---TTMAGTKPYMAPEMFSS 188
Query: 676 NESDENGNIIKCGRPSDIWSLGCILYQMVYGRTPFSEYKTFWAK--FKVITDPNHEITYE 733
+ D WSLG Y+++ GR P+ + +K +TY
Sbjct: 189 RKGAG------YSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFE--TTVVTYP 240
Query: 734 PVPNPWLLDLMKKCLAWDRNERW-RIPQLLQHPFL 767
+ ++ L+KK L + ++R+ ++ + P++
Sbjct: 241 SAWSQEMVSLLKKLLEPNPDQRFSQLSDVQNFPYM 275
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 2e-27
Identities = 62/319 (19%), Positives = 130/319 (40%), Gaps = 55/319 (17%)
Query: 467 FKVNGKLYQRLGKIGSGGSSEVHKVISSDC-TIYALKKIKLKGRDYATAYGFCQEIEYLN 525
+ +N Y+ IGSG ++ V + A+K+I L+ + + +EI+ ++
Sbjct: 10 WSINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLE-KCQTSMDELLKEIQAMS 68
Query: 526 KLKGKNNIIQLIDYEVTEKALLREVLNGSMNNKDGRVKDDGYIYMVLEY-GEIDLAHMLS 584
+ N I+ S V D +++V++ + ++
Sbjct: 69 QCHHPN-IVSYY---------------TSF------VVKD-ELWLVMKLLSGGSVLDIIK 105
Query: 585 QKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLL-VKGSLKLIDF 643
+ + + LDE+ + +++LE + +H+ +H D+K N LL GS+++ DF
Sbjct: 106 HIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADF 165
Query: 644 GIAKAIMSDTTNIQRDSQ----VGTLSYMSPEAFMCNESDENGNIIKCGRP----SDIWS 695
G++ A ++ +I R+ VGT +M+PE +++ R +DIWS
Sbjct: 166 GVS-AFLATGGDITRNKVRKTFVGTPCWMAPE------------VMEQVRGYDFKADIWS 212
Query: 696 LGCILYQMVYGRTPFSEYKTFWAKFKVITDP----NHEITYEPVPNPW---LLDLMKKCL 748
G ++ G P+ +Y + + + + + + ++ CL
Sbjct: 213 FGITAIELATGAAPYHKYPPMKVLMLTLQNDPPSLETGVQDKEMLKKYGKSFRKMISLCL 272
Query: 749 AWDRNERWRIPQLLQHPFL 767
D +R +LL+H F
Sbjct: 273 QKDPEKRPTAAELLRHKFF 291
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 114 bits (286), Expect = 2e-27
Identities = 74/359 (20%), Positives = 124/359 (34%), Gaps = 104/359 (28%)
Query: 462 DPDLFFKVNGKLYQRLGKIGSGGSSEVHKVI-SSDCTIYALKKIKLKGRDYATAYGFCQE 520
++ ++++ ++G+G V KV + A K I L+ + +E
Sbjct: 23 QKQKVGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQ-IIRE 81
Query: 521 IEYLNKLKGKNNIIQLIDYEVTEKALLREVLNGSMNNKDGRVKDDGYIYMVLEYGEIDLA 580
++ L++ I+ Y A + G I + +E+
Sbjct: 82 LQVLHECNSPY-IVGF--YG----AFYSD----------------GEISICMEH------ 112
Query: 581 HMLSQKWKEMDG--------SNQTLDENWLRFYWQQILEAVNTIHEER-IVHSDLKPANF 631
MDG + E L +++ + + E+ I+H D+KP+N
Sbjct: 113 ---------MDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNI 163
Query: 632 LL-VKGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRP 690
L+ +G +KL DFG++ + D+ +S VGT SYMSPE
Sbjct: 164 LVNSRGEIKLCDFGVS-GQLIDS---MANSFVGTRSYMSPERLQGTHYSVQ--------- 210
Query: 691 SDIWSLGCILYQMVYGRTPF--SEYKTFWAKFKVITDPNHE------------------- 729
SDIWS+G L +M GR P + K F + +
Sbjct: 211 SDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKFGMD 270
Query: 730 -------------ITYEPVPN-------PWLLDLMKKCLAWDRNERWRIPQLLQHPFLV 768
I EP P D + KCL + ER + QL+ H F+
Sbjct: 271 SRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIK 329
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 2e-27
Identities = 70/298 (23%), Positives = 116/298 (38%), Gaps = 61/298 (20%)
Query: 520 EIEYLNKLKGKNNIIQLIDYEVTEKALLREVLNGSMNNKDGRVKDDGYIYMVLEY---GE 576
EI L+ N I++ EV + ++ +++EY GE
Sbjct: 66 EIINHRSLRHPN-IVRF--KEV-------------ILTPT-------HLAIIMEYASGGE 102
Query: 577 IDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLL--- 633
L + + E+ RF++QQ+L V+ H +I H DLK N LL
Sbjct: 103 --LYERICNAGR--------FSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGS 152
Query: 634 VKGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDI 693
LK+ DFG +K+ + + Q S VGT +Y++PE + E D G+ +D+
Sbjct: 153 PAPRLKICDFGYSKSSVLHS---QPKSTVGTPAYIAPEVLLRQEYD--------GKIADV 201
Query: 694 WSLGCILYQMVYGRTPFSEYKTFWAKFKVITDPNHEITYEPVPNPWL----LDLMKKCLA 749
WS G LY M+ G PF + ++ + Y + + L+ +
Sbjct: 202 WSCGVTLYVMLVGAYPFED-PEEPRDYRKTIQRILSVKYSIPDDIRISPECCHLISRIFV 260
Query: 750 WDRNERWRIPQLLQHPFL---VPPVSTQPSSSQDQSY---QLLQLLAEASASDHEAST 801
D R IP++ H + +P S++ Q Q +Q L EA+
Sbjct: 261 ADPATRISIPEIKTHSWFLKNLPADLMNESNTGSQFQEPEQPMQSLDTIMQIISEATI 318
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 3e-27
Identities = 58/196 (29%), Positives = 94/196 (47%), Gaps = 22/196 (11%)
Query: 564 DDGYIYMVLEYGE-IDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIV 622
+D Y+V+EY E L+ + L + + QIL+ + H+ RIV
Sbjct: 82 EDDCYYLVMEYIEGPTLSEYIESHGP--------LSVDTAINFTNQILDGIKHAHDMRIV 133
Query: 623 HSDLKPANFLLVK-GSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDEN 681
H D+KP N L+ +LK+ DFGIAKA +S+T+ Q + +GT+ Y SPE +DE
Sbjct: 134 HRDIKPQNILIDSNKTLKIFDFGIAKA-LSETSLTQTNHVLGTVQYFSPEQAKGEATDE- 191
Query: 682 GNIIKCGRPSDIWSLGCILYQMVYGRTPFSEYKTFWAKFKVITDPNHEITYEPVPN--PW 739
+DI+S+G +LY+M+ G PF+ K I D +T + +
Sbjct: 192 --------CTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVTTDVRKDIPQS 243
Query: 740 LLDLMKKCLAWDRNER 755
L +++ + D+ R
Sbjct: 244 LSNVILRATEKDKANR 259
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 3e-27
Identities = 72/369 (19%), Positives = 132/369 (35%), Gaps = 74/369 (20%)
Query: 412 QHTGNSPELKSQAPLSKNSSSDMKLEASKSEKQEKAVSSKGASAPRKRNYDPDLFFKVNG 471
+ + P ++N ++ + + ++ + ++ DP+
Sbjct: 2 SYYHHHHHHDYDIPTTENLYFQGAMDPMPAGGRAGSLKDPDVAELFFKD-DPE------- 53
Query: 472 KLYQRLGKIGSGGSSEVHKVISSDC-TIYALKKIKLKGRDYATAYG-FCQEIEYLNKLKG 529
KL+ L +IG G V+ + A+KK+ G+ + +E+ +L KL+
Sbjct: 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRH 113
Query: 530 KNNIIQLIDYEVTEKALLREVLNGSMNNKDGRVKDDGYIYMVLEY---GEIDLAHMLSQK 586
N IQ LR + ++V+EY DL
Sbjct: 114 PN-TIQYRG------CYLR----------------EHTAWLVMEYCLGSASDL------- 143
Query: 587 WKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLL-VKGSLKLIDFGI 645
++ + L E + L+ + +H ++H D+K N LL G +KL DFG
Sbjct: 144 ---LEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGS 200
Query: 646 AKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVY 705
A +IM+ +S VGT +M+PE + + + K D+WSLG ++
Sbjct: 201 A-SIMA-----PANSFVGTPYWMAPEVILAMDEGQYDG--KV----DVWSLGITCIELAE 248
Query: 706 GRTPFSEYKTFWAKFKVITDPNHEITYEPVPN-------PWLLDLMKKCLAWDRNERWRI 758
+ P A + I P + + + CL +R
Sbjct: 249 RKPPLFNMNAMSALYH--------IAQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTS 300
Query: 759 PQLLQHPFL 767
LL+H F+
Sbjct: 301 EVLLKHRFV 309
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 4e-27
Identities = 68/317 (21%), Positives = 122/317 (38%), Gaps = 68/317 (21%)
Query: 479 KIGSGGSSEVHKVISSDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLID 538
KIG+G VH+ + A+K + + F +E+ + +L+ N I+ +
Sbjct: 44 KIGAGSFGTVHRAEWHGSDV-AVKILMEQDFHAERVNEFLREVAIMKRLRHPN-IVLFM- 100
Query: 539 YEVTEKALLREVLNGSMNNKDGRVKDDGYIYMVLEY---GEIDLAHMLSQKWKEMDGSNQ 595
G V + +V EY G L +L + G+ +
Sbjct: 101 ---------------------GAVTQPPNLSIVTEYLSRG--SLYRLLHKS-----GARE 132
Query: 596 TLDENWLRFYW-QQILEAVNTIHEER--IVHSDLKPANFLLVK-GSLKLIDFGIAKAIMS 651
LDE R + + +N +H IVH +LK N L+ K ++K+ DFG+++ +
Sbjct: 133 QLDER-RRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSR--LK 189
Query: 652 DTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGRTPFS 711
+T + S GT +M+PE S+E K D++S G IL+++ + P+
Sbjct: 190 ASTFLSSKSAAGTPEWMAPEVLRDEPSNE-----KS----DVYSFGVILWELATLQQPWG 240
Query: 712 EYKTFWAKFKVITD---PNHEITYEPVP---NPWLLDLMKKCLAWDRNER---WRIPQLL 762
V +P NP + +++ C + +R I LL
Sbjct: 241 NLNPAQVVAAVGFKCKRL-------EIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLL 293
Query: 763 QHPFLVPPVSTQPSSSQ 779
+ L+ P+ S
Sbjct: 294 RP--LIKSAVPPPNRSD 308
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 1e-26
Identities = 77/341 (22%), Positives = 127/341 (37%), Gaps = 81/341 (23%)
Query: 474 YQRLGKIGSGGSSEVHKVISSDC-TIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNN 532
Y +GSG V I A+KK+ + A +E+ L ++ +N
Sbjct: 26 YVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHEN- 84
Query: 533 IIQLIDYEVTEKALLREVLNGSMNNKDGRVKDDGYIYMVLEYGEIDLAHMLSQKWKEMDG 592
+I L+D + +++ Y+V+ + + DL ++ K
Sbjct: 85 VIGLLD----------------VFTPASSLRNFYDFYLVMPFMQTDLQKIMGLK------ 122
Query: 593 SNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLLVKGS--LKLIDFGIAKAIM 650
E +++ Q+L+ + IH +VH DLKP N L V LK++DFG+A+
Sbjct: 123 ----FSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGN-LAVNEDCELKILDFGLARHAD 177
Query: 651 SDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGRTPF 710
++ T V T Y +PE + + DIWS+GCI+ +M+ G+T F
Sbjct: 178 AEMTG-----YVVTRWYRAPEVILSWM--------HYNQTVDIWSVGCIMAEMLTGKTLF 224
Query: 711 SEYKTFWAKFKVITD----PNHEI-----------------TYEPVP--------NPWLL 741
K + + I P E +P
Sbjct: 225 KG-KDYLDQLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAA 283
Query: 742 DLMKKCLAWDRNERWRIPQLLQHPFLVP-------PVSTQP 775
DL++K L D ++R Q L HPF P + QP
Sbjct: 284 DLLEKMLELDVDKRLTAAQALTHPFFEPFRDPEEETEAQQP 324
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 2e-26
Identities = 69/345 (20%), Positives = 119/345 (34%), Gaps = 86/345 (24%)
Query: 467 FKVNGKLYQRLGKIGSGGSSEVHKVISSDCTIYALKKIKLKGRDYATAYGF-----CQ-- 519
+ Y I SG V + S+ A+K++ D T C+
Sbjct: 18 HAMQSP-YTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRV 76
Query: 520 --EIEYLNKLKGKNNIIQLIDYEVTEKALLREVLNGSMNNKDGRVKDDGYIYMVLEYGEI 577
EI LN N I+ L D + +M+ +Y+V E
Sbjct: 77 LREIRLLNHFHHPN-ILGLRD-------IFVHFEEPAMHK----------LYLVTELMRT 118
Query: 578 DLAHMLSQKWKEMDGSNQ-TLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLLVKG 636
DLA ++ + + ++++ IL ++ +HE +VH DL P N +L+
Sbjct: 119 DLAQVIH--------DQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGN-ILLAD 169
Query: 637 --SLKLIDFGIAKAIMSDT--TNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSD 692
+ + DF +A+ +D T+ V Y +PE + + D
Sbjct: 170 NNDITICDFNLAREDTADANKTH-----YVTHRWYRAPE-LVMQFKGFTKLV-------D 216
Query: 693 IWSLGCILYQMVYGRTPFSEYKTFWAKFKVITD----PNHEI------------------ 730
+WS GC++ +M + F TF+ + I + P E
Sbjct: 217 MWSAGCVMAEMFNRKALFRG-STFYNQLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLS 275
Query: 731 TYEPVP--------NPWLLDLMKKCLAWDRNERWRIPQLLQHPFL 767
+P LDL+ K L ++ R Q L+HP+
Sbjct: 276 NVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPYF 320
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 2e-26
Identities = 78/325 (24%), Positives = 131/325 (40%), Gaps = 71/325 (21%)
Query: 474 YQRLGKIGSGGSSEVHKVI-SSDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNN 532
YQ L +GSG V + A+KK+ + A +E+ L +K +N
Sbjct: 31 YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHEN- 89
Query: 533 IIQLIDYEVTEKALLREVLNGSMNNKDGRVKDDGYIYMVLEYGEIDLAHMLSQKWKEMDG 592
+I L+D + +++ +Y+V DL +++
Sbjct: 90 VIGLLD----------------VFTPARSLEEFNDVYLVTHLMGADLNNIVKC------- 126
Query: 593 SNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLLVKGS--LKLIDFGIAKAIM 650
Q L ++ ++F QIL + IH I+H DLKP+N L V LK++DFG+A+
Sbjct: 127 --QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSN-LAVNEDCELKILDFGLARHTA 183
Query: 651 SDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGRTPF 710
+ T V T Y +PE M N N + DIWS+GCI+ +++ GRT F
Sbjct: 184 DEMTG-----YVATRWYRAPE-IMLNWMHYNQTV-------DIWSVGCIMAELLTGRTLF 230
Query: 711 --SEYKTFWAK-FKVITDPNHEI-----------------TYEPVP--------NPWLLD 742
+++ +++ P E+ + NP +D
Sbjct: 231 PGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVD 290
Query: 743 LMKKCLAWDRNERWRIPQLLQHPFL 767
L++K L D ++R Q L H +
Sbjct: 291 LLEKMLVLDSDKRITAAQALAHAYF 315
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 2e-26
Identities = 77/334 (23%), Positives = 126/334 (37%), Gaps = 91/334 (27%)
Query: 476 RLGK-IGSGGSSEV----HKVISSDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGK 530
LG +G G +V H++ + L + K++ D +EI+ L +
Sbjct: 19 ILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLD--VVGKIRREIQNLKLFRHP 76
Query: 531 NNIIQLIDYEVTEKALLREVLNGSMNNKDGRVKDDGYIYMVLEY---GEIDLAHMLSQKW 587
+ II+L Y+V ++ I+MV+EY GE L + +
Sbjct: 77 H-IIKL--YQV-------------ISTPS-------DIFMVMEYVSGGE--LFDYICKNG 111
Query: 588 KEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLL-VKGSLKLIDFGIA 646
+ LDE R +QQIL V+ H +VH DLKP N LL + K+ DFG++
Sbjct: 112 R--------LDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLS 163
Query: 647 KAIMSDTTNIQRDSQV-----GTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILY 701
N+ D + G+ +Y +PE G DIWS G ILY
Sbjct: 164 --------NMMSDGEFLRTSCGSPNYAAPEVISGRLYA--------GPEVDIWSSGVILY 207
Query: 702 QMVYGRTPFSEYKTFWAKFKVITDPNHEITYEPVPN------PWL----LDLMKKCLAWD 751
++ G PF D + ++ + + +L + L+K L D
Sbjct: 208 ALLCGTLPFD-------------DDHVPTLFKKICDGIFYTPQYLNPSVISLLKHMLQVD 254
Query: 752 RNERWRIPQLLQHPFL---VPPVSTQPSSSQDQS 782
+R I + +H + +P S +
Sbjct: 255 PMKRATIKDIREHEWFKQDLPKYLFPEDPSYSST 288
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 3e-26
Identities = 71/305 (23%), Positives = 127/305 (41%), Gaps = 60/305 (19%)
Query: 472 KLYQRLGKIGSGGSSEVHKVISSDC-TIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGK 530
+++ L K+G G V+K I + I A+K++ ++ +EI + +
Sbjct: 29 EVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQE----IIKEISIMQQCDSP 84
Query: 531 NNIIQLIDYEVTEKALLREVLNGSMNNKDGRVKDDGYIYMVLEYGE----IDLAHMLSQK 586
+ +++ + + + +++V+EY D+
Sbjct: 85 H-VVKYYG------SYFK----------------NTDLWIVMEYCGAGSVSDI------- 114
Query: 587 WKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLL-VKGSLKLIDFGI 645
+ N+TL E+ + Q L+ + +H R +H D+K N LL +G KL DFG+
Sbjct: 115 ---IRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGV 171
Query: 646 AKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVY 705
A + T +R++ +GT +M+PE + DIWSLG +M
Sbjct: 172 AGQL--TDTMAKRNTVIGTPFWMAPEVIQEIGYNC-----VA----DIWSLGITAIEMAE 220
Query: 706 GRTPFSEYKTFWAKFKVITDPNHEITYEPVPNPW---LLDLMKKCLAWDRNERWRIPQLL 762
G+ P+++ A F + T+P P W D +K+CL +R QLL
Sbjct: 221 GKPPYADIHPMRAIFMIPTNPPPTFRK---PELWSDNFTDFVKQCLVKSPEQRATATQLL 277
Query: 763 QHPFL 767
QHPF+
Sbjct: 278 QHPFV 282
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 5e-26
Identities = 71/399 (17%), Positives = 137/399 (34%), Gaps = 78/399 (19%)
Query: 374 DPKPEIKKQEWPKEQQDCVVKEGGIPNDPSTHKSMEGRQHTGNSPELKSQAPLSKNSSSD 433
+ + ++ + ++ + + P+L +
Sbjct: 99 EERLVCSREIFDTYIMKELLACSHPFSKSAIEHVQGHLVKKQVPPDLFQPYIEEICQNLR 158
Query: 434 MKLEASKSEKQEKAVSSKGASAPRKRNYDPDLFFKVNGKLYQRLGKIGSGGSSEVHKVIS 493
+ E + + + + + F +++ +G+ G G EV+
Sbjct: 159 GDVFQKFIESDKFTRFCQWKNVELNIHLTMNDF-----SVHRIIGR-GGFG--EVYGCRK 210
Query: 494 SDC-TIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYE--VTEKALLREV 550
+D +YA+K + K I + E+ +L V
Sbjct: 211 ADTGKMYAMKCLD------------------------KKRIKMKQGETLALNERIMLSLV 246
Query: 551 LNGSMNNKDGR--VK------DDGYIYMVLEY---GEIDLAHMLSQKWKEMDGSNQTLDE 599
+ D V + +L+ G DL + LSQ E
Sbjct: 247 -----STGDCPFIVCMSYAFHTPDKLSFILDLMNGG--DLHYHLSQH--------GVFSE 291
Query: 600 NWLRFYWQQILEAVNTIHEERIVHSDLKPANFLL-VKGSLKLIDFGIAKAIMSDTTNIQR 658
+RFY +I+ + +H +V+ DLKPAN LL G +++ D G+A +
Sbjct: 292 ADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPH--- 348
Query: 659 DSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGRTPFSEYKTFWA 718
+ VGT YM+PE + +D +SLGC+L++++ G +PF ++KT
Sbjct: 349 -ASVGTHGYMAPEVLQKGVA--------YDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK 399
Query: 719 K--FKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNER 755
++ + +P L L++ L D N R
Sbjct: 400 HEIDRMTL--TMAVELPDSFSPELRSLLEGLLQRDVNRR 436
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 5e-26
Identities = 58/297 (19%), Positives = 106/297 (35%), Gaps = 77/297 (25%)
Query: 474 YQRLGKIGSGGSSEVHKVISSDCTIY----ALKKIKLKGRDYATAYGFCQEIEYLNKLKG 529
Y+ G I GG ++ + D + LK + G A A E ++L ++
Sbjct: 82 YEVKGCIAHGGLGWIYL--ALDRNVNGRPVVLKGLVHSGDAEAQAM-AMAERQFLAEV-- 136
Query: 530 KN--NIIQLIDYEVTEKALLREVLNGSMNNKDGRVKDDGYIYMVLEY--GEIDLAHMLSQ 585
+I+Q+ ++ ++ G D Y+V+EY G+ L
Sbjct: 137 -VHPSIVQIFNF-------------VEHTDRHG----DPVGYIVMEYVGGQ-SLKRSK-- 175
Query: 586 KWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLLVKGSLKLIDFGI 645
Q L Y +IL A++ +H +V++DLKP N +L + LKLID G
Sbjct: 176 --------GQKLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEEQLKLIDLGA 227
Query: 646 AKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRP---SDIWSLGCILYQ 702
++ + GT + +PE I P +DI+++G L
Sbjct: 228 VSR-INSFGYL-----YGTPGFQAPE-------------IVRTGPTVATDIYTVGRTLAA 268
Query: 703 MVYGRTPFSEYKTFWAKFKVITDPNHEITYEPVP--NPWLLDLMKKCLAWDRNERWR 757
+ + + +PV L+++ + D +R+
Sbjct: 269 LTLDLPTRNG-----------RYVDGLPEDDPVLKTYDSYGRLLRRAIDPDPRQRFT 314
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 7e-26
Identities = 79/305 (25%), Positives = 129/305 (42%), Gaps = 61/305 (20%)
Query: 472 KLYQRLGKIGSGGSSEVHKVISSDC-TIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGK 530
+L+ +L KIG G EV K I + + A+K I L+ + QEI L++
Sbjct: 22 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIE-DIQQEITVLSQCDSP 80
Query: 531 NNIIQLIDYEVTEKALLREVLNGSMNNKDGRVKDDGYIYMVLEY-GEIDLAHMLSQKWKE 589
+ + GS +KD +++++EY G +L
Sbjct: 81 Y-VTKYY---------------GSY------LKDT-KLWIIMEYLGGGSALDLLEPG--- 114
Query: 590 MDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLL-VKGSLKLIDFGIAKA 648
LDE + ++IL+ ++ +H E+ +H D+K AN LL G +KL DFG+A
Sbjct: 115 ------PLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVA-G 167
Query: 649 IMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGRT 708
++DT +R++ VGT +M+PE + D K DIWSLG ++ G
Sbjct: 168 QLTDTQI-KRNTFVGTPFWMAPEVIKQSAYDS-----KA----DIWSLGITAIELARGEP 217
Query: 709 PFSEYKTFWAKFKVITDPNHEITYEPVP---NPW---LLDLMKKCLAWDRNERWRIPQLL 762
P SE F I P + L + ++ CL + + R +LL
Sbjct: 218 PHSELHPMKVLFL--------IPKNNPPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELL 269
Query: 763 QHPFL 767
+H F+
Sbjct: 270 KHKFI 274
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 8e-26
Identities = 64/395 (16%), Positives = 128/395 (32%), Gaps = 115/395 (29%)
Query: 460 NYDPDLFFKV-------NGKLYQRLGKIGSGGSSEVHKVI-SSDCTIYALKKIKLKGRDY 511
+Y P + + + Y + K+G G S V + T A+K ++
Sbjct: 1 DYRPGGYHPAFKGEPYKDAR-YILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYT 59
Query: 512 ATAYGFCQEIEYLNKLK----------GKNNIIQLIDY-EVTEKALLREVLNGSMNNKDG 560
A EI+ L ++ G N+I++L+D+
Sbjct: 60 EAAE---DEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH------------------- 97
Query: 561 RVKDDGYIYMVLEYGEIDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIH-EE 619
+ + ++ MV E +L ++ + ++ + +++ +Q+L ++ +H
Sbjct: 98 KGPNGVHVVMVFEVLGENLLALIKKY------EHRGIPLIYVKQISKQLLLGLDYMHRRC 151
Query: 620 RIVHSDLKPANFLL-------VKGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEA 672
I+H+D+KP N L+ +K+ D G A + Q T Y SPE
Sbjct: 152 GIIHTDIKPENVLMEIVDSPENLIQIKIADLGNA---CWYDEHYTNSIQ--TREYRSPEV 206
Query: 673 FMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGRT------------------------ 708
+ G G +DIWS C++++++ G
Sbjct: 207 LL-------G--APWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELL 257
Query: 709 -PFSEYKTFWAKF-KVITDPNHEITYEPVPNPW-------------------LLDLMKKC 747
Y K+ + + + W + D +
Sbjct: 258 GELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPM 317
Query: 748 LAWDRNERWRIPQLLQHPFLVPPVSTQPSSSQDQS 782
L D +R L+ HP+L + + D+
Sbjct: 318 LQLDPRKRADAGGLVNHPWLKDTLGMEEIRVPDRE 352
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 1e-25
Identities = 68/298 (22%), Positives = 110/298 (36%), Gaps = 70/298 (23%)
Query: 479 KIGSGGSSEVHKVI-SSDCTIYALKKIKLKGRDYATAYG-----FCQEIEYLNKLKGKNN 532
+IG GG VHK D ++ A+K + L + T F +E+ ++ L N
Sbjct: 26 QIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPN- 84
Query: 533 IIQLIDYEVTEKALLREVLNGSMNNKDGRVKDDGYIYMVLEY---GEIDLAHMLSQKWKE 589
I++L G M+N MV+E+ G DL H L K
Sbjct: 85 IVKLY---------------GLMHNP---------PRMVMEFVPCG--DLYHRLLDKAHP 118
Query: 590 MDGSNQTLDENWLRFYW-QQILEAVNTIHEER--IVHSDLKPANFLLVKG------SLKL 640
+ S ++ I + + + IVH DL+ N L K+
Sbjct: 119 IKWS--------VKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKV 170
Query: 641 IDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCIL 700
DFG+++ + + +G +M+PE E +D +S IL
Sbjct: 171 ADFGLSQQSVHSVS-----GLLGNFQWMAPETIGAEEE-------SYTEKADTYSFAMIL 218
Query: 701 YQMVYGRTPFSEYKTFWAKFKVITDPNHEITYEPVP---NPWLLDLMKKCLAWDRNER 755
Y ++ G PF EY K K I E +P P L ++++ C + D +R
Sbjct: 219 YTILTGEGPFDEYSYG--KIKFINMIREEGLRPTIPEDCPPRLRNVIELCWSGDPKKR 274
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 1e-25
Identities = 76/329 (23%), Positives = 128/329 (38%), Gaps = 73/329 (22%)
Query: 471 GKLYQRLGKIGSGGSSEVHKVISSDC-TIYALKKIKLKGRDYATAYGFCQEIEYLNKLKG 529
+Y+ L +GSG V + A+KK+ + A +E+ L ++
Sbjct: 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRH 83
Query: 530 KNNIIQLIDYEVTEKALLREVLNGSMNNKDGRVKDDGYIYMVLEYGEIDLAHMLSQKWKE 589
+N +I L+D + + D Y+V+ + DL ++
Sbjct: 84 EN-VIGLLD--------VFTPDETLDDFTD--------FYLVMPFMGTDLGKLMK----- 121
Query: 590 MDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLLVKG--SLKLIDFGIAK 647
++ L E+ ++F Q+L+ + IH I+H DLKP N L V LK++DFG+A+
Sbjct: 122 ----HEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGN-LAVNEDCELKILDFGLAR 176
Query: 648 AIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGR 707
S+ T V T Y +PE + N + DIWS+GCI+ +M+ G+
Sbjct: 177 QADSEMTG-----YVVTRWYRAPE-VILNWMRYTQTV-------DIWSVGCIMAEMITGK 223
Query: 708 TPFSEYKTFWAKFKVITD----PNHEI-----------------TYEPVP--------NP 738
T F + K I P E E +P
Sbjct: 224 TLFKG-SDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASP 282
Query: 739 WLLDLMKKCLAWDRNERWRIPQLLQHPFL 767
++L++K L D +R + L HP+
Sbjct: 283 LAVNLLEKMLVLDAEQRVTAGEALAHPYF 311
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 2e-25
Identities = 68/293 (23%), Positives = 114/293 (38%), Gaps = 75/293 (25%)
Query: 479 KIGSGGSSEVHKVISSDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLID 538
+G G V K + A+K+I+ + A F E+ L+++ N I++L
Sbjct: 15 VVGRGAFGVVCKAKWRAKDV-AIKQIESESERKA----FIVELRQLSRVNHPN-IVKLY- 67
Query: 539 YEVTEKALLREVLNGSMNNKDGRVKDDGYIYMVLEY---GEIDLAHMLSQKWKEMDGSNQ 595
G+ N + +V+EY G L ++L
Sbjct: 68 --------------GACLNP---------VCLVMEYAEGG--SLYNVLHGA-----EPLP 97
Query: 596 TLDENWLRFYW-QQILEAVNTIHEER---IVHSDLKPANFLLVKG--SLKLIDFGIAKAI 649
W Q + V +H + ++H DLKP N LLV G LK+ DFG A I
Sbjct: 98 YYTAA-HAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDI 156
Query: 650 MSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGRTP 709
+ T + G+ ++M+PE F + E KC D++S G IL++++ R P
Sbjct: 157 QTHMT-----NNKGSAAWMAPEVFEGSNYSE-----KC----DVFSWGIILWEVITRRKP 202
Query: 710 FSEYKTF-WAKFKVITD---PNHEITYEPVPN---PWLLDLMKKCLAWDRNER 755
F E + + + P P+ + LM +C + D ++R
Sbjct: 203 FDEIGGPAFRIMWAVHNGTRP-------PLIKNLPKPIESLMTRCWSKDPSQR 248
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 4e-25
Identities = 74/429 (17%), Positives = 138/429 (32%), Gaps = 115/429 (26%)
Query: 421 KSQAPLSKNSSSDMKLEASKSEKQEKAVSSKGASAPRKRNYDPDLFFKVNGKLYQRLGKI 480
++ A NS + + S+ E Q++ D +++ + Y+ I
Sbjct: 5 EAAAAQQHNSGTQHTVSGSQQEGQQRKQHHSSKPTASMPRPHSD--WQIPDR-YEIRHLI 61
Query: 481 GSGGSSEVHKVISSDC-TIYALKKIKLKGRDYATAYGFCQ----EIEYLNKLKGKNNIIQ 535
G+G V + + A+KKI D C+ EI LN+L + +++
Sbjct: 62 GTGSYGHVCEAYDKLEKRVVAIKKILRVFEDL----IDCKRILREIAILNRLNHDH-VVK 116
Query: 536 LIDYEVTEKALLREVLNGSMNNKDGRVKDDGYIYMVLEYGEIDLAHMLSQKWKEMDGSNQ 595
++D + + + +Y+VLE + D + +
Sbjct: 117 VLDIVIPKDV-----------------EKFDELYVVLEIADSDFKKLFR--------TPV 151
Query: 596 TLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLL-VKGSLKLIDFGIAKAIMSDTT 654
L E ++ +L V +H I+H DLKPAN L+ S+K+ DFG+A+ +
Sbjct: 152 YLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPEN 211
Query: 655 NIQRDSQVGTLSYMSPEAFMCNESDENG-----------------NIIKCGRPSDIWSLG 697
+ M+ F ++ + D+WS+G
Sbjct: 212 GNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIG 271
Query: 698 CILYQMV----------YGRTPF---SEYKTFWAK---------------------FKVI 723
CI +++ R P S F ++
Sbjct: 272 CIFAELLNMIKENVAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNIL 331
Query: 724 TDPNHEI-----------------TYEPVP--------NPWLLDLMKKCLAWDRNERWRI 758
P+ E E + + L+K+ L ++ N+R I
Sbjct: 332 GTPSEEDIEALEKEDAKRYIRIFPKREGTDLAERFPASSADAIHLLKRMLVFNPNKRITI 391
Query: 759 PQLLQHPFL 767
+ L HPF
Sbjct: 392 NECLAHPFF 400
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 8e-25
Identities = 78/388 (20%), Positives = 138/388 (35%), Gaps = 92/388 (23%)
Query: 431 SSDMKLEASKSEKQEKAVSSKGASAPRKRNYDPDLFFKVN--------GKLYQRLGKIGS 482
+ D+K+ + ++ VS ++ + F+ V K YQ L IGS
Sbjct: 13 TLDVKIAFCQGFDKQVDVSYIAKHYNMSKSKVDNQFYSVEVGDSTFTVLKRYQNLKPIGS 72
Query: 483 GGSSEVHKVISSDC-TIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEV 541
G V + A+KK+ ++ A +E+ + + KN II L++
Sbjct: 73 GAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKN-IISLLN--- 128
Query: 542 TEKALLREVLNGSMNNKDGRVKDDGYIYMVLEYGEIDLAHMLSQKWKEMDGSNQTLDENW 601
+ +++ +Y+V+E + +L ++ + LD
Sbjct: 129 -------------VFTPQKTLEEFQDVYLVMELMDANLCQVIQME----------LDHER 165
Query: 602 LRFYWQQILEAVNTIHEERIVHSDLKPANFLLVKG--SLKLIDFGIAKAIMSDTTNIQRD 659
+ + Q+L + +H I+H DLKP+N ++VK +LK++DFG+A+ +
Sbjct: 166 MSYLLYQMLCGIKHLHSAGIIHRDLKPSN-IVVKSDCTLKILDFGLARTAGTSFMMTP-- 222
Query: 660 SQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGRT----------- 708
V T Y +PE + DIWS+GCI+ +MV +
Sbjct: 223 -YVVTRYYRAPEVILGM---------GYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQW 272
Query: 709 -----------------------------PFSEYKTFWAKFKVITDPNHEITYEPVPNPW 739
P TF F P +
Sbjct: 273 NKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLK-ASQ 331
Query: 740 LLDLMKKCLAWDRNERWRIPQLLQHPFL 767
DL+ K L D +R + LQHP++
Sbjct: 332 ARDLLSKMLVIDPAKRISVDDALQHPYI 359
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 2e-24
Identities = 72/309 (23%), Positives = 123/309 (39%), Gaps = 98/309 (31%)
Query: 474 YQRLGKIGSGGSSEVHKVIS-SDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNN 532
+Q L +G+G VH + S + YA+K +K K
Sbjct: 8 FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLK------------------------KEI 43
Query: 533 IIQL--IDYEVTEKALLREV-------LNGSMNNKDGRVKDDGYIYMVLEY---GEIDLA 580
+++L +++ E+ +L V + G+ +D I+M+++Y GE L
Sbjct: 44 VVRLKQVEHTNDERLMLSIVTHPFIIRMWGTF-------QDAQQIFMIMDYIEGGE--LF 94
Query: 581 HMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLL-VKGSLK 639
+L + Q +FY ++ A+ +H + I++ DLKP N LL G +K
Sbjct: 95 SLLRKS--------QRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIK 146
Query: 640 LIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIK---CGRPSDIWSL 696
+ DFG AK + D T + GT Y++PE ++ + D WS
Sbjct: 147 ITDFGFAKYV-PDVTY----TLCGTPDYIAPE------------VVSTKPYNKSIDWWSF 189
Query: 697 GCILYQMVYGRTPFSEYKTFWAKFKVITDPNHEITYE-----PVPNPWLL-----DLMKK 746
G ++Y+M+ G TPF D N TYE + P DL+ +
Sbjct: 190 GILIYEMLAGYTPF-------------YDSNTMKTYEKILNAELRFPPFFNEDVKDLLSR 236
Query: 747 CLAWDRNER 755
+ D ++R
Sbjct: 237 LITRDLSQR 245
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 2e-24
Identities = 88/348 (25%), Positives = 136/348 (39%), Gaps = 90/348 (25%)
Query: 474 YQRLGKIGSGGSSEVHKVISSDC-TIYALKKIKLKGRDYATAYG---FCQ----EIEYLN 525
Y L IG G V + A+KKI + + +CQ EI+ L
Sbjct: 29 YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKI--------SPFEHQTYCQRTLREIKILL 80
Query: 526 KLKGKNNIIQLIDYEVTEKALLREVLNGSMNNKDGRVKDDGYIYMVLEYGEIDLAHMLSQ 585
+ + +N II + D +A E KD +Y+V + E DL +L
Sbjct: 81 RFRHEN-IIGIND---IIRAPTIE------QMKD--------VYIVQDLMETDLYKLLKT 122
Query: 586 KWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLLVKG--SLKLIDF 643
Q L + + ++ QIL + IH ++H DLKP+N LL+ LK+ DF
Sbjct: 123 ---------QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSN-LLLNTTCDLKICDF 172
Query: 644 GIAKAIMSDTTNIQRDSQ-VGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQ 702
G+A+ D + ++ V T Y +PE M N +I DIWS+GCIL +
Sbjct: 173 GLARVADPDHDHTGFLTEYVATRWYRAPE-IMLNSKGYTKSI-------DIWSVGCILAE 224
Query: 703 MVYGRTPF--SEYKTFWAK-FKVITDPNHEI-----------------TYEPVP------ 736
M+ R F Y ++ P+ E VP
Sbjct: 225 MLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFP 284
Query: 737 --NPWLLDLMKKCLAWDRNERWRIPQLLQHPFLVP-------PVSTQP 775
+ LDL+ K L ++ ++R + Q L HP+L P++ P
Sbjct: 285 NADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDEPIAEAP 332
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 3e-24
Identities = 75/351 (21%), Positives = 134/351 (38%), Gaps = 98/351 (27%)
Query: 467 FKVNGKLYQRLGKIGSGGSSEVHKVISSDC-TIYALKKIKLKGRDYATAYG---FCQ--- 519
+ ++ +Q +G G V I A+KKI+ + F
Sbjct: 7 YNISSD-FQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIE--------PFDKPLFALRTL 57
Query: 520 -EIEYLNKLKGKNNIIQLIDYEVTEKALLREVL--NGSMNNKDGRVKDDGYIYMVLEYGE 576
EI+ L K +N II + + + + N + +Y++ E +
Sbjct: 58 REIKILKHFKHEN-IITIFN-----------IQRPDSFENFNE--------VYIIQELMQ 97
Query: 577 IDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLLVKG 636
DL ++S Q L ++ ++++ Q L AV +H ++H DLKP+N LL+
Sbjct: 98 TDLHRVIS---------TQMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSN-LLINS 147
Query: 637 --SLKLIDFGIAKAIMSDTTNIQRDSQ--------VGTLSYMSPEAFMCNESDENGNIIK 686
LK+ DFG+A+ I + + V T Y +PE M + + +
Sbjct: 148 NCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPE-VMLTSAKYSRAM-- 204
Query: 687 CGRPSDIWSLGCILYQMVYGRTPFSEYKTFWAKFKVITD----PNHEIT----------- 731
D+WS GCIL ++ R F + + + +I P+ +
Sbjct: 205 -----DVWSCGCILAELFLRRPIFPG-RDYRHQLLLIFGIIGTPHSDNDLRCIESPRARE 258
Query: 732 -------YEPVP--------NPWLLDLMKKCLAWDRNERWRIPQLLQHPFL 767
Y P NP +DL+++ L +D +R + L+HP+L
Sbjct: 259 YIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYL 309
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 3e-24
Identities = 43/146 (29%), Positives = 78/146 (53%), Gaps = 20/146 (13%)
Query: 569 YMVLEYGE-IDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLK 627
Y+V+EY + + L ++ + M + ++ +A+N H+ I+H D+K
Sbjct: 92 YIVMEYVDGVTLRDIVHTEGP-MT-PKRAIE------VIADACQALNFSHQNGIIHRDVK 143
Query: 628 PANFLLVK-GSLKLIDFGIAKAIMSDTTNIQRDSQV-GTLSYMSPEAFMCNESDENGNII 685
PAN ++ ++K++DFGIA+AI ++ + + V GT Y+SPE + D
Sbjct: 144 PANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDA----- 198
Query: 686 KCGRPSDIWSLGCILYQMVYGRTPFS 711
SD++SLGC+LY+++ G PF+
Sbjct: 199 ----RSDVYSLGCVLYEVLTGEPPFT 220
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 3e-24
Identities = 71/337 (21%), Positives = 123/337 (36%), Gaps = 84/337 (24%)
Query: 474 YQRLGKIGSGGSSEVHKVISSDC-TIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNN 532
YQ L IGSG V + A+KK+ ++ A +E+ + + KN
Sbjct: 27 YQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKN- 85
Query: 533 IIQLIDYEVTEKALLREVLNGSMNNKDGRVKDDGYIYMVLEYGEIDLAHMLSQKWKEMDG 592
II L++ + +D +Y+V+E + +L ++ +
Sbjct: 86 IIGLLN--------VFTPQKSLEEFQD--------VYIVMELMDANLCQVIQME------ 123
Query: 593 SNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLLVKG--SLKLIDFGIAKAIM 650
LD + + Q+L + +H I+H DLKP+N ++VK +LK++DFG+A+
Sbjct: 124 ----LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSN-IVVKSDCTLKILDFGLARTAG 178
Query: 651 SDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGRT-- 708
+ V T Y +PE + DIWS+GCI+ +M+ G
Sbjct: 179 TSFMMTP---YVVTRYYRAPEVILGM---------GYKENVDIWSVGCIMGEMIKGGVLF 226
Query: 709 --------------------------------------PFSEYKTFWAKFKVITDPNHEI 730
P +F F + P
Sbjct: 227 PGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSE 286
Query: 731 TYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQHPFL 767
+ DL+ K L D ++R + + LQHP++
Sbjct: 287 H-NKLKASQARDLLSKMLVIDASKRISVDEALQHPYI 322
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 3e-24
Identities = 81/403 (20%), Positives = 132/403 (32%), Gaps = 123/403 (30%)
Query: 454 SAPRKRNYDP---DLFFKVNGKL---YQRLGKIGSGGSSEVHKVISSDC-TIYALKKIKL 506
P YD + + Y+ L IG G +V K ALK ++
Sbjct: 73 GGPNNGGYDDDQGSYVQVPHDHVAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRN 132
Query: 507 KGRDYATAYGFCQEIEYLNKLK-----GKNNIIQLIDYEVTEKALLREVLNGSMNNKDGR 561
+ R + A +EI L L+ N+I +++
Sbjct: 133 EKRFHRQAA---EEIRILEHLRKQDKDNTMNVIHMLEN---------------------- 167
Query: 562 VKDDGYIYMVLEYGEIDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERI 621
+I M E ++L ++ + Q +R + IL+ ++ +H+ RI
Sbjct: 168 FTFRNHICMTFELLSMNLYELIKK------NKFQGFSLPLVRKFAHSILQCLDALHKNRI 221
Query: 622 VHSDLKPANFLLV---KGSLKLIDFGIAKAIMSD-TTNIQRDSQVGTLSYMSPEAFMCNE 677
+H DLKP N LL + +K+IDFG + T IQ + Y +PE +
Sbjct: 222 IHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRVYTYIQ------SRFYRAPEVIL--- 272
Query: 678 SDENGNIIKCGRPSDIWSLGCILYQMVYGRTPF--------------------------- 710
G + G P D+WSLGCIL +++ G
Sbjct: 273 ----G--ARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLDAS 326
Query: 711 --------SEYKTFWAKFKVITDPN----------HEITYEPVPNPWLLDLMKK------ 746
S+ + ++D + ++ P W L
Sbjct: 327 KRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFL 386
Query: 747 -----CLAWDRNERWRIPQLLQHPFL-----VPPVSTQPSSSQ 779
CL WD R Q L+HP+L PP + S +
Sbjct: 387 DFLKQCLEWDPAVRMTPGQALRHPWLRRRLPKPPTGEKTSVKR 429
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 7e-24
Identities = 64/301 (21%), Positives = 112/301 (37%), Gaps = 80/301 (26%)
Query: 479 KIGSGGSSEVHKVISSDCTIYALKKIKLKGRDYATAYG--FCQEIEYLNKLKGKNNIIQL 536
IG GG +V++ + A+K + + + QE + LK N II L
Sbjct: 14 IIGIGGFGKVYRAFWIGDEV-AVKAARHDPDEDISQTIENVRQEAKLFAMLKHPN-IIAL 71
Query: 537 IDYEVTEKALLREVLNGSMNNKDGRVKDDGYIYMVLEY---GEIDLAHMLSQKWKEMDGS 593
G + + +V+E+ G L +LS
Sbjct: 72 R----------------------GVCLKEPNLCLVMEFARGG--PLNRVLS--------- 98
Query: 594 NQTLDENWLRFYW-QQILEAVNTIHEER---IVHSDLKPANFLLVKGS---------LKL 640
+ + + + W QI +N +H+E I+H DLK +N L+++ LK+
Sbjct: 99 GKRIPPD-ILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKI 157
Query: 641 IDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCIL 700
DFG+A+ TT + S G ++M+PE + + D+WS G +L
Sbjct: 158 TDFGLAR-EWHRTT---KMSAAGAYAWMAPEVIRASMFSK-----GS----DVWSYGVLL 204
Query: 701 YQMVYGRTPFSEYKTFWAKFKVITD---PNHEITYEPVPN---PWLLDLMKKCLAWDRNE 754
++++ G PF + V + P+P+ LM+ C D +
Sbjct: 205 WELLTGEVPFRGIDGLAVAYGVAMNKLAL-------PIPSTCPEPFAKLMEDCWNPDPHS 257
Query: 755 R 755
R
Sbjct: 258 R 258
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 8e-24
Identities = 75/372 (20%), Positives = 133/372 (35%), Gaps = 111/372 (29%)
Query: 467 FKVNGKLYQRLGKIGSGGSSEVHKVISSDC-TIYALKKIKLKGRDYATAYGFCQ----EI 521
V K Y+ + K+G G V K I + A+KKI ++ Q EI
Sbjct: 5 RHVLRK-YELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNST----DAQRTFREI 59
Query: 522 EYLNKLKGKNNIIQLIDYEVTEKALLREVLNGSMNNKDGRVKDDGYIYMVLEYGEIDLAH 581
L +L G NI+ L++ + N++D +Y+V +Y E DL
Sbjct: 60 MILTELSGHENIVNLLNVLRAD------------NDRD--------VYLVFDYMETDLHA 99
Query: 582 MLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLL-VKGSLKL 640
++ L+ ++ Q+++ + +H ++H D+KP+N LL + +K+
Sbjct: 100 VIR---------ANILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAECHVKV 150
Query: 641 IDFGIAKAIMSDTTNIQRDSQ-------------------VGTLSYMSPEAFMCNESDEN 681
DFG++++ ++ V T Y +PE + +
Sbjct: 151 ADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPE-ILLGSTKYT 209
Query: 682 GNIIKCGRPSDIWSLGCILYQMVYGR--------------------TPFSE--------- 712
I D+WSLGCIL +++ G+ P +E
Sbjct: 210 KGI-------DMWSLGCILGEILCGKPIFPGSSTMNQLERIIGVIDFPSNEDVESIQSPF 262
Query: 713 ---------------YKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWR 757
F + +I + N LDL+ K L ++ N+R
Sbjct: 263 AKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKRIS 322
Query: 758 IPQLLQHPFLVP 769
L+HPF+
Sbjct: 323 ANDALKHPFVSI 334
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 1e-23
Identities = 61/296 (20%), Positives = 106/296 (35%), Gaps = 73/296 (24%)
Query: 480 IGSGGSSEVHKVISSDC-TIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLID 538
+G GG EV +YA KK+ K + +
Sbjct: 193 LGRGGFGEVFACQMKATGKLYACKKLN------------------------KKRLKKRKG 228
Query: 539 YEVT--EKALLREV-------LNGSMNNKDGRVKDDGYIYMVLEY---GEIDLAHMLSQK 586
Y+ EK +L +V L + K + +V+ G D+ + +
Sbjct: 229 YQGAMVEKKILAKVHSRFIVSLAYAFETKT-------DLCLVMTIMNGG--DIRYHIYNV 279
Query: 587 WKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLL-VKGSLKLIDFGI 645
++ N E FY QI+ + +H+ I++ DLKP N LL G++++ D G+
Sbjct: 280 DED----NPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGL 335
Query: 646 AKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIK---CGRPSDIWSLGCILYQ 702
A + + T + GT +M+PE ++ D ++LG LY+
Sbjct: 336 AVELKAGQTKTK--GYAGTPGFMAPE------------LLLGEEYDFSVDYFALGVTLYE 381
Query: 703 MVYGRTPFSEYKTFWAK---FKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNER 755
M+ R PF + + +TY +P D + L D +R
Sbjct: 382 MIAARGPFRARGEKVENKELKQRVL--EQAVTYPDKFSPASKDFCEALLQKDPEKR 435
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 2e-23
Identities = 78/396 (19%), Positives = 128/396 (32%), Gaps = 149/396 (37%)
Query: 474 YQRLGKIGSGGSSEVHKVI--SSDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLK--- 528
Y+ +G +G G +V + + + + ALK I+ G+ A EI L K+K
Sbjct: 21 YEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAAR---LEINVLKKIKEKD 77
Query: 529 --GKNNIIQLIDY--------EVTEKAL---LREVLNGSMNNKDGRVKDDGYIYMVLEYG 575
K + + D+ E L E L K++ + L +
Sbjct: 78 KENKFLCVLMSDWFNFHGHMCIAFEL-LGKNTFEFL-----------KENNFQPYPLPH- 124
Query: 576 EIDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLLV- 634
+R Q+ A+ +HE ++ H+DLKP N L V
Sbjct: 125 --------------------------VRHMAYQLCHALRFLHENQLTHTDLKPENILFVN 158
Query: 635 -------------------KGSLKLIDFGIAKAIMSD---TTNIQRDSQVGTLSYMSPEA 672
S+++ DFG A TT + T Y PE
Sbjct: 159 SEFETLYNEHKSCEEKSVKNTSIRVADFG--SATFDHEHHTTIVA------TRHYRPPE- 209
Query: 673 FMCNESDENGNII---KCGRPSDIWSLGCILYQMVYGRTPF---SEY------------- 713
+I +P D+WS+GCIL++ G T F
Sbjct: 210 -----------VILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENREHLVMMEKILGPI 258
Query: 714 -----------KTFW-------------AKFKVITDPNHE-ITYEPVPNPWLLDLMKKCL 748
K F+ K P + + + + L DLM++ L
Sbjct: 259 PSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRML 318
Query: 749 AWDRNERWRIPQLLQHPFL--VPPVSTQPSSSQDQS 782
+D +R + + L HPF + P +S++ S
Sbjct: 319 EFDPAQRITLAEALLHPFFAGLTPEERSFHTSRNPS 354
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 99.6 bits (249), Expect = 2e-23
Identities = 45/290 (15%), Positives = 103/290 (35%), Gaps = 64/290 (22%)
Query: 479 KIGSGGSSEVHKVISSDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLID 538
K+ S E+ K I +K +K++ + F +E L N ++ ++
Sbjct: 17 KLNENHSGELWKGRWQGNDI-VVKVLKVRDWSTRKSRDFNEECPRLRIFSHPN-VLPVL- 73
Query: 539 YEVTEKALLREVLNGSMNNKDGRVKDDGYIYMVLEY---GEIDLAHMLSQKWKEMDGSNQ 595
G+ + + ++ + G L ++L +G+N
Sbjct: 74 --------------GACQSPPA-----PHPTLITHWMPYG--SLYNVLH------EGTNF 106
Query: 596 TLDENWLRFYW-QQILEAVNTIHEER--IVHSDLKPANFLLVK-GSLKLIDFGIAKAIMS 651
+D++ + + + +H I L + ++ + + ++ + + S
Sbjct: 107 VVDQS-QAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQS 165
Query: 652 DTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGRTPFS 711
+ ++++PEA + E+ N D+WS +L+++V PF+
Sbjct: 166 PGR-------MYAPAWVAPEAL--QKKPEDTNRRSA----DMWSFAVLLWELVTREVPFA 212
Query: 712 EYKTFWAKFKVITD---PNHEITYEPVP---NPWLLDLMKKCLAWDRNER 755
+ KV + P +P +P + LMK C+ D +R
Sbjct: 213 DLSNMEIGMKVALEGLRP-------TIPPGISPHVSKLMKICMNEDPAKR 255
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 104 bits (260), Expect = 3e-23
Identities = 71/297 (23%), Positives = 111/297 (37%), Gaps = 78/297 (26%)
Query: 480 IGSGGSSEVHKVISSDC-TIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLID 538
+G GG EV +YA KK++ K I +
Sbjct: 192 LGKGGFGEVCACQVRATGKMYACKKLE------------------------KKRIKKRKG 227
Query: 539 YEVT--EKALLREV-------LNGSMNNKDGRVKDDGYIYMVLEY---GEIDLAHMLSQK 586
+ EK +L +V L + KD + +VL G DL +
Sbjct: 228 EAMALNEKQILEKVNSRFVVSLAYAYETKD-------ALCLVLTLMNGG--DLKFHIYHM 278
Query: 587 WKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLL-VKGSLKLIDFGI 645
+ E FY +I + +H ERIV+ DLKP N LL G +++ D G+
Sbjct: 279 GQAG------FPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGL 332
Query: 646 AKAIMS-DTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIK---CGRPSDIWSLGCILY 701
A + T +VGT+ YM+PE ++K D W+LGC+LY
Sbjct: 333 AVHVPEGQTIK----GRVGTVGYMAPE------------VVKNERYTFSPDWWALGCLLY 376
Query: 702 QMVYGRTPFSEYKTFWAK---FKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNER 755
+M+ G++PF + K + +++ Y +P L + L D ER
Sbjct: 377 EMIAGQSPFQQRKKKIKREEVERLVK--EVPEEYSERFSPQARSLCSQLLCKDPAER 431
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 99.7 bits (249), Expect = 4e-23
Identities = 55/296 (18%), Positives = 107/296 (36%), Gaps = 72/296 (24%)
Query: 479 KIGSGGSSEVHK------VISSDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNN 532
+IGSG V+K V A+K + + F E+ L K + N
Sbjct: 31 RIGSGSFGTVYKGKWHGDV--------AVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVN- 81
Query: 533 IIQLIDYEVTEKALLREVLNGSMNNKDGRVKDDGYIYMVLEYGEIDLAHMLSQKWKEMDG 592
I+ + G + +V ++ +G
Sbjct: 82 ILLFM----------------------GYSTAPQ-LAIVTQW---------------CEG 103
Query: 593 SN---------QTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLLVK-GSLKLID 642
S+ + L +Q ++ +H + I+H DLK N L + ++K+ D
Sbjct: 104 SSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGD 163
Query: 643 FGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQ 702
FG+A + + Q + G++ +M+PE + SD+++ G +LY+
Sbjct: 164 FGLATEKSRWSGSHQFEQLSGSILWMAPEVIR------MQDSNPYSFQSDVYAFGIVLYE 217
Query: 703 MVYGRTPFSEYKTFWAKFKVITDPNHEITYEPVPN---PWLLDLMKKCLAWDRNER 755
++ G+ P+S +++ + V + + LM +CL R+ER
Sbjct: 218 LMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVRSNCPKRMKRLMAECLKKKRDER 273
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 98.9 bits (247), Expect = 8e-23
Identities = 53/333 (15%), Positives = 106/333 (31%), Gaps = 81/333 (24%)
Query: 479 KIGSGGSSEVHKVISSDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLID 538
+G G + KV + + +L D T F +E++ + L+ N +++ I
Sbjct: 17 VLGKGCFGQAIKVTHRETGE-VMVMKELIRFDEETQRTFLKEVKVMRCLEHPN-VLKFI- 73
Query: 539 YEVTEKALLREVLNGSMNNKDGRVKDDGYIYMVLEYGEIDLAHMLSQKWKEMDGSN--QT 596
G + D + + EY + G
Sbjct: 74 ---------------------GVLYKDKRLNFITEY---------------IKGGTLRGI 97
Query: 597 LDENWLRFYWQQIL-------EAVNTIHEERIVHSDLKPANFLLVKGSL--KLIDFGIAK 647
+ ++ W Q + + +H I+H DL N LV+ + + DFG+A+
Sbjct: 98 IKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHN-CLVRENKNVVVADFGLAR 156
Query: 648 AIMSDTTN------------IQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWS 695
++ + T +R + VG +M+PE DE D++S
Sbjct: 157 LMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDE---------KVDVFS 207
Query: 696 LGCILYQMVYGRTPFSEYKTFWAKFKVITDPNHEITYEPVPN---PWLLDLMKKCLAWDR 752
G +L +++ +Y F + + P P + +C D
Sbjct: 208 FGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLDR---YCPPNCPPSFFPITVRCCDLDP 264
Query: 753 NER---WRIPQLLQHPFLVPPVSTQPSSSQDQS 782
+R ++ L+ + +Q
Sbjct: 265 EKRPSFVKLEHWLETLRMHLAGHLPLGPQLEQL 297
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 1e-22
Identities = 72/377 (19%), Positives = 126/377 (33%), Gaps = 143/377 (37%)
Query: 474 YQRLGKIGSGGSSEVHKVI--SSDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLK--- 528
Y+ + +G G +V + I + A+K +K R A EI+ L L
Sbjct: 16 YEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAAR---SEIQVLEHLNTTD 72
Query: 529 --GKNNIIQLIDY--------EVTEKAL---LREVLNGSMNNKDGRVKDDGYIYMVLEYG 575
+Q++++ V E L + + K++G++ L++
Sbjct: 73 PNSTFRCVQMLEWFEHHGHICIVFEL-LGLSTYDFI-----------KENGFLPFRLDH- 119
Query: 576 EIDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLLV- 634
+R QI ++VN +H ++ H+DLKP N L V
Sbjct: 120 --------------------------IRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQ 153
Query: 635 -------------------KGSLKLIDFGIAKAIMSDTTNIQRDSQ-VGTLSYMSPEAFM 674
+K++DFG S T + + S V T Y +PE
Sbjct: 154 SDYTEAYNPKIKRDERTLINPDIKVVDFG------SATYDDEHHSTLVSTRHYRAPE--- 204
Query: 675 CNESDENGNII---KCGRPSDIWSLGCILYQMV--------------------------- 704
+I +P D+WS+GCIL +
Sbjct: 205 ---------VILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHLAMMERILGPLPK 255
Query: 705 -------------YGRTPFSEYKTFWAKFKVITDPNHE-ITYEPVPNPWLLDLMKKCLAW 750
+ R + E+ + P E + + V + L DL++K L +
Sbjct: 256 HMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEY 315
Query: 751 DRNERWRIPQLLQHPFL 767
D +R + + L+HPF
Sbjct: 316 DPAKRITLREALKHPFF 332
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 97.7 bits (244), Expect = 4e-22
Identities = 57/205 (27%), Positives = 94/205 (45%), Gaps = 45/205 (21%)
Query: 568 IYMVLEY---GEIDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHS 624
++ V+EY G DL + ++ + L E RFY +I A+N +HE I++
Sbjct: 85 LFFVIEYVNGG--DLMFHMQRQ--------RKLPEEHARFYSAEISLALNYLHERGIIYR 134
Query: 625 DLKPANFLL-VKGSLKLIDFGIAKAIMS--DTTNIQRDSQVGTLSYMSPEAFMCNESDEN 681
DLK N LL +G +KL D+G+ K + DTT+ + GT +Y++PE
Sbjct: 135 DLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTS----TFCGTPNYIAPE---------- 180
Query: 682 GNIIK---CGRPSDIWSLGCILYQMVYGRTPFSEYKTFWAK--------FKVITDPNHEI 730
I++ G D W+LG ++++M+ GR+PF + F+VI +I
Sbjct: 181 --ILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVIL--EKQI 236
Query: 731 TYEPVPNPWLLDLMKKCLAWDRNER 755
+ ++K L D ER
Sbjct: 237 RIPRSLSVKAASVLKSFLNKDPKER 261
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 97.7 bits (244), Expect = 4e-22
Identities = 56/214 (26%), Positives = 85/214 (39%), Gaps = 49/214 (22%)
Query: 568 IYMVLEY---GEIDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHS 624
++ V+EY G DL + + D + FY +I+ + +H + IV+
Sbjct: 93 LFFVMEYLNGG--DLMYHIQSC--------HKFDLSRATFYAAEIILGLQFLHSKGIVYR 142
Query: 625 DLKPANFLL-VKGSLKLIDFGIAKAIMS--DTTNIQRDSQVGTLSYMSPEAFMCNESDEN 681
DLK N LL G +K+ DFG+ K M TN + GT Y++PE
Sbjct: 143 DLKLDNILLDKDGHIKIADFGMCKENMLGDAKTN----TFCGTPDYIAPE---------- 188
Query: 682 GNIIK---CGRPSDIWSLGCILYQMVYGRTPF---SEYKTFWAKFKVITDPNHEITYEPV 735
I+ D WS G +LY+M+ G++PF E + F + I Y
Sbjct: 189 --ILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHS----IR--MDNPFYPRW 240
Query: 736 PNPWLLDLMKKCLAWDRNERWRI---PQLLQHPF 766
DL+ K R R+ + QHP
Sbjct: 241 LEKEAKDLLVKLF--VREPEKRLGVRGDIRQHPL 272
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 97.7 bits (244), Expect = 5e-22
Identities = 73/375 (19%), Positives = 138/375 (36%), Gaps = 101/375 (26%)
Query: 413 HTGNSPELKSQAPLSKNSSSDMKLEASKSEKQEKAVSSKGASAPRKRNYDPDLF--FKVN 470
H + E + + +S + + K + F KV
Sbjct: 3 HHHHHHEEEGGSSGGAAGTSADGGDGGEQLLTVKHELRTANLTGHAEKVGIENFELLKV- 61
Query: 471 GKLYQRLGKIGSGGSSEVHKVI-------SSDCTIYALKKIKLKGRDYATAYGFCQEIEY 523
LG G+ G KV +YA+K +K
Sbjct: 62 ------LGT-GAYG-----KVFLVRKISGHDTGKLYAMKVLK------------------ 91
Query: 524 LNKLKGKNNIIQ---LIDYEVTEKALLREV--------LNGSMNNKDGRVKDDGYIYMVL 572
K I+Q ++ TE+ +L + L+ + + + ++++L
Sbjct: 92 ------KATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAF-------QTETKLHLIL 138
Query: 573 EY---GEIDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPA 629
+Y GE L LSQ+ + E+ ++ Y +I+ A+ +H+ I++ D+K
Sbjct: 139 DYINGGE--LFTHLSQR--------ERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLE 188
Query: 630 NFLL-VKGSLKLIDFGIAKAIMSD---TTNIQRDSQVGTLSYMSPEAFMCNESDENGNII 685
N LL G + L DFG++K ++D GT+ YM+P+ +S
Sbjct: 189 NILLDSNGHVVLTDFGLSKEFVADETERAY----DFCGTIEYMAPDIVRGGDS------- 237
Query: 686 KCGRPSDIWSLGCILYQMVYGRTPFSEYKTFWAKFKVITDPNHEITYEPVPNPWLL---- 741
+ D WSLG ++Y+++ G +PF+ ++ ++ I P P +
Sbjct: 238 GHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEIS----RRILKSEPPYPQEMSALA 293
Query: 742 -DLMKKCLAWDRNER 755
DL+++ L D +R
Sbjct: 294 KDLIQRLLMKDPKKR 308
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 97.4 bits (243), Expect = 1e-21
Identities = 78/370 (21%), Positives = 134/370 (36%), Gaps = 105/370 (28%)
Query: 419 ELKSQAPLSKNSSSDMKLEASKSEKQEKAVSSKGASAPRKRNYDPDLF--FKVNGKLYQR 476
+ + + ++EK + S + F +V G+
Sbjct: 7 HHHHDYDIPTTENLYFQGAMGSGIEEEKEAMNTRESGKASSSLGLQDFDLLRVIGR---- 62
Query: 477 LGKIGSGGSSEVHKVI----SSDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNN 532
GS KV+ IYA++ +K K
Sbjct: 63 ----GSYA-----KVLLVRLKKTDRIYAMRVVK------------------------KEL 89
Query: 533 IIQL--IDYEVTEKALLREV--------LNGSMNNKDGRVKDDGYIYMVLEY---GEIDL 579
+ ID+ TEK + + L+ + ++ V+EY G DL
Sbjct: 90 VNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTES-------RLFFVIEYVNGG--DL 140
Query: 580 AHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLL-VKGSL 638
+ ++ + L E RFY +I A+N +HE I++ DLK N LL +G +
Sbjct: 141 MFHMQRQ--------RKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHI 192
Query: 639 KLIDFGIAKAIMS--DTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKC---GRPSDI 693
KL D+G+ K + DTT+ + GT +Y++PE I++ G D
Sbjct: 193 KLTDYGMCKEGLRPGDTTS----TFCGTPNYIAPE------------ILRGEDYGFSVDW 236
Query: 694 WSLGCILYQMVYGRTPFSEYKTFWAK--------FKVITDPNHEITYEPVPNPWLLDLMK 745
W+LG ++++M+ GR+PF + F+VI +I + ++K
Sbjct: 237 WALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVIL--EKQIRIPRSLSVKAASVLK 294
Query: 746 KCLAWDRNER 755
L D ER
Sbjct: 295 SFLNKDPKER 304
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 97.9 bits (244), Expect = 1e-21
Identities = 95/428 (22%), Positives = 157/428 (36%), Gaps = 100/428 (23%)
Query: 353 KDTKTPVDQAVRAPQASTSVIDPKPEIKKQEWPKEQQDCVVKEGGIPNDPSTHKSMEGRQ 412
K+ VDQ AP + SV + ++ P ++ + ++ E R+
Sbjct: 39 KERPQDVDQR-EAPLNNFSVAQCQLMKTERPRPNTFIIRCLQWTTVIERTFHVETPEERE 97
Query: 413 HTGNSPELKSQAPLSKNSSSDMKLEASKSEKQEKAVSSKGASAPRKRNYDPDLF--FKVN 470
+ + + L K ++++M + A + + A K + F K+
Sbjct: 98 EWTTAIQTVADG-LKKQAAAEMDFRSGSPSDNSGAEEMEVSLAKPKHRVTMNEFEYLKLL 156
Query: 471 GKLYQRLGKIGSGGSSEVHKVI----SSDCTIYALKKIKLKGRDYATAYGFCQEIEYLNK 526
GK G+ G KVI + YA+K +K
Sbjct: 157 GK--------GTFG-----KVILVKEKATGRYYAMKILK--------------------- 182
Query: 527 LKGKNNIIQ--LIDYEVTEKALLREV-------LNGSMNNKDGRVKDDGYIYMVLEY--- 574
K I+ + + +TE +L+ L S D + V+EY
Sbjct: 183 ---KEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHD-------RLCFVMEYANG 232
Query: 575 GEIDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEER-IVHSDLKPANFLL 633
GE L LS++ + E+ RFY +I+ A++ +H E+ +V+ DLK N +L
Sbjct: 233 GE--LFFHLSRE--------RVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLML 282
Query: 634 -VKGSLKLIDFGIAKAIMS--DTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRP 690
G +K+ DFG+ K + T + GT Y++PE N GR
Sbjct: 283 DKDGHIKITDFGLCKEGIKDGATMK----TFCGTPEYLAPEVLEDN---------DYGRA 329
Query: 691 SDIWSLGCILYQMVYGRTPF---SEYKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKC 747
D W LG ++Y+M+ GR PF K F I EI + P L+
Sbjct: 330 VDWWGLGVVMYEMMCGRLPFYNQDHEKLFEL----IL--MEEIRFPRTLGPEAKSLLSGL 383
Query: 748 LAWDRNER 755
L D +R
Sbjct: 384 LKKDPKQR 391
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 95.4 bits (238), Expect = 3e-21
Identities = 85/362 (23%), Positives = 134/362 (37%), Gaps = 120/362 (33%)
Query: 444 QEKAVSSKGASAPRKRNYDPDLF--FKVNGKLYQRLGKIGSGGSSEVHKVI----SSDCT 497
+E + G D F +V LGK GS G KV+
Sbjct: 3 KESSKEGNGIGVNSSNRLGIDNFEFIRV-------LGK-GSFG-----KVMLARVKETGD 49
Query: 498 IYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQL--IDYEVTEKALLREV----- 550
+YA+K +K K+ I+Q ++ +TEK +L
Sbjct: 50 LYAVKVLK------------------------KDVILQDDDVECTMTEKRILSLARNHPF 85
Query: 551 ---LNGSMNNKDGRVKDDGYIYMVLEY---GEIDLAHMLSQKWKEMDGSNQTLDENWLRF 604
L D ++ V+E+ G DL + + + DE RF
Sbjct: 86 LTQLFCCFQTPD-------RLFFVMEFVNGG--DLMFHIQKS--------RRFDEARARF 128
Query: 605 YWQQILEAVNTIHEERIVHSDLKPANFLL-VKGSLKLIDFGIAKAIMS--DTTNIQRDSQ 661
Y +I+ A+ +H++ I++ DLK N LL +G KL DFG+ K + TT +
Sbjct: 129 YAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTA----TF 184
Query: 662 VGTLSYMSPEAFMCNESDENGNIIKC---GRPSDIWSLGCILYQMVYGRTPF---SEYKT 715
GT Y++PE I++ G D W++G +LY+M+ G PF +E
Sbjct: 185 CGTPDYIAPE------------ILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDL 232
Query: 716 FWAKFKVITDPNHEITYEPVPNP-WL----LDLMKKCLAWDRNER------WRIPQLLQH 764
F A I + V P WL ++K + + R +L+H
Sbjct: 233 FEA-----------ILNDEVVYPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRH 281
Query: 765 PF 766
PF
Sbjct: 282 PF 283
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 94.2 bits (235), Expect = 4e-21
Identities = 48/208 (23%), Positives = 87/208 (41%), Gaps = 54/208 (25%)
Query: 565 DGYIYMVLEY---GEIDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERI 621
+G +Y++L++ G+ L LS++ E ++FY ++ A++ +H I
Sbjct: 98 EGKLYLILDFLRGGD--LFTRLSKE--------VMFTEEDVKFYLAELALALDHLHSLGI 147
Query: 622 VHSDLKPANFLL-VKGSLKLIDFGIAKAIMS--DTTNIQRDSQVGTLSYMSPEAFMCNES 678
++ DLKP N LL +G +KL DFG++K + S GT+ YM+PE
Sbjct: 148 IYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAY----SFCGTVEYMAPE------- 196
Query: 679 DENGNIIKC---GRPSDIWSLGCILYQMVYGRTPF---SEYKTFWAKFKVITDPNHEITY 732
++ + +D WS G ++++M+ G PF +T I
Sbjct: 197 -----VVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTM-----------ILK 240
Query: 733 EPVPNPWLL-----DLMKKCLAWDRNER 755
+ P L L++ + R
Sbjct: 241 AKLGMPQFLSPEAQSLLRMLFKRNPANR 268
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 94.2 bits (235), Expect = 5e-21
Identities = 54/202 (26%), Positives = 83/202 (41%), Gaps = 48/202 (23%)
Query: 568 IYMVLEY---GEIDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHS 624
+ V+EY G +L LS++ + E RFY +I+ A+ +H +V+
Sbjct: 80 LCFVMEYANGG--ELFFHLSRE--------RVFTEERARFYGAEIVSALEYLHSRDVVYR 129
Query: 625 DLKPANFLL-VKGSLKLIDFGIAKAIMS--DTTNIQRDSQVGTLSYMSPEAFMCNESDEN 681
D+K N +L G +K+ DFG+ K +S T + GT Y++PE N
Sbjct: 130 DIKLENLMLDKDGHIKITDFGLCKEGISDGATMK----TFCGTPEYLAPEVLEDN----- 180
Query: 682 GNIIKCGRPSDIWSLGCILYQMVYGRTPF---SEYKTFWAKFKVITDPNHEITYEPVPNP 738
GR D W LG ++Y+M+ GR PF + F I E + P
Sbjct: 181 ----DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFEL-----------ILMEEIRFP 225
Query: 739 WLL-----DLMKKCLAWDRNER 755
L L+ L D +R
Sbjct: 226 RTLSPEAKSLLAGLLKKDPKQR 247
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 95.2 bits (237), Expect = 8e-21
Identities = 79/383 (20%), Positives = 127/383 (33%), Gaps = 121/383 (31%)
Query: 467 FKVNGKLYQRLGKIGSGGSSEVHKVISSDC-TIYALKKIKLKGRDYATAYGFCQ----EI 521
V Y IG G V+ + A+KK+ D C+ EI
Sbjct: 22 VHVPDN-YIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLI----DCKRILREI 76
Query: 522 EYLNKLKGKNNIIQLIDYEVTEKALLREVLNGSMNNKDGRVKDDGYIYMVLEYGEIDLAH 581
LN+LK II+L D + + + +Y+VLE + DL
Sbjct: 77 TILNRLKSDY-IIRLYDLIIPD-----------------DLLKFDELYIVLEIADSDLKK 118
Query: 582 MLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLL-VKGSLKL 640
+ + L E ++ +L N IHE I+H DLKPAN LL S+K+
Sbjct: 119 LFK--------TPIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKV 170
Query: 641 IDFGIAKAIMSDTTNIQRDSQ--------------------VGTLSYMSPEAFMCNESDE 680
DFG+A+ I S+ + V T Y +PE + + +
Sbjct: 171 CDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPE-LILLQENY 229
Query: 681 NGNIIKCGRPSDIWSLGCILYQMVY-----------------GRTPFSEYKTFWAKFKVI 723
+I DIWS GCI +++ G + F +K
Sbjct: 230 TKSI-------DIWSTGCIFAELLNMLQSHINDPTNRFPLFPGSSCFPLSPDRNSKKVHE 282
Query: 724 TDPNHEIT-------------------------------YEPVP--------NPWLLDLM 744
++ +P+ + ++L+
Sbjct: 283 KSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSISDDGINLL 342
Query: 745 KKCLAWDRNERWRIPQLLQHPFL 767
+ L ++ N+R I Q L HP+L
Sbjct: 343 ESMLKFNPNKRITIDQALDHPYL 365
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 94.6 bits (235), Expect = 9e-21
Identities = 52/354 (14%), Positives = 103/354 (29%), Gaps = 89/354 (25%)
Query: 467 FKVNGKLYQRLGKIGSGGSS--EVHKVI-SSDCTIYALKKIKLKGRDYATAYGFCQEIEY 523
F G Y+ L IG G V+ +++I L+ E+
Sbjct: 20 FLPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHV 79
Query: 524 LNKLKGKNNIIQLIDYEVTEKALLREVLNGSMNNKDGRVKDDGYIYMVLEY-GEIDLAHM 582
N I+ + + D+ +++V + +
Sbjct: 80 SKLFNHPN-IVPYR---------------ATF------IADN-ELWVVTSFMAYGSAKDL 116
Query: 583 LSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLL-VKGSLKLI 641
+ ++E + + Q +L+A++ IH VH +K ++ L+ V G + L
Sbjct: 117 ICT------HFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLS 170
Query: 642 DFGIAKAIMSD-----TTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSL 696
+++S + V L ++SPE N + K DI+S+
Sbjct: 171 GLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDA---KS----DIYSV 223
Query: 697 GCILYQMVYGRTPFSEYKTFWAKFKVITDP------------------------------ 726
G ++ G PF + + +
Sbjct: 224 GITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTSTIPAEELTMSPSRSVANSGLSD 283
Query: 727 ----------NHEITYEPVPNPW---LLDLMKKCLAWDRNERWRIPQLLQHPFL 767
N + P + +++CL + + R LL H F
Sbjct: 284 SLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFF 337
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 1e-20
Identities = 58/220 (26%), Positives = 92/220 (41%), Gaps = 58/220 (26%)
Query: 568 IYMVLEY---GEIDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHS 624
+Y VL+Y GE L + L ++ + E RFY +I A+ +H IV+
Sbjct: 114 LYFVLDYINGGE--LFYHLQRE--------RCFLEPRARFYAAEIASALGYLHSLNIVYR 163
Query: 625 DLKPANFLL-VKGSLKLIDFGIAKAIMS--DTTNIQRDSQVGTLSYMSPEAFMCNESDEN 681
DLKP N LL +G + L DFG+ K + TT+ + GT Y++PE
Sbjct: 164 DLKPENILLDSQGHIVLTDFGLCKENIEHNSTTS----TFCGTPEYLAPE---------- 209
Query: 682 GNIIKC---GRPSDIWSLGCILYQMVYGRTPF---SEYKTFWAKFKVITDPNHEITYEPV 735
++ R D W LG +LY+M+YG PF + + + I +P+
Sbjct: 210 --VLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDN-----------ILNKPL 256
Query: 736 PNPWLL-----DLMKKCLAWDRNERWRIP----QLLQHPF 766
+ L++ L DR +R ++ H F
Sbjct: 257 QLKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKSHVF 296
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 92.6 bits (231), Expect = 1e-20
Identities = 58/205 (28%), Positives = 88/205 (42%), Gaps = 54/205 (26%)
Query: 568 IYMVLEY---GEIDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHS 624
+Y++LEY GE L L ++ E+ FY +I A+ +H++ I++
Sbjct: 96 LYLILEYLSGGE--LFMQLERE--------GIFMEDTACFYLAEISMALGHLHQKGIIYR 145
Query: 625 DLKPANFLL-VKGSLKLIDFGIAKAIMS--DTTNIQRDSQVGTLSYMSPEAFMCNESDEN 681
DLKP N +L +G +KL DFG+ K + T+ + GT+ YM+PE
Sbjct: 146 DLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTH----TFCGTIEYMAPE---------- 191
Query: 682 GNIIKC---GRPSDIWSLGCILYQMVYGRTPF---SEYKTFWAKFKVITDPNHEITYEPV 735
I+ R D WSLG ++Y M+ G PF + KT I +
Sbjct: 192 --ILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDK-----------ILKCKL 238
Query: 736 PNPWLL-----DLMKKCLAWDRNER 755
P L DL+KK L + R
Sbjct: 239 NLPPYLTQEARDLLKKLLKRNAASR 263
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 91.5 bits (228), Expect = 6e-20
Identities = 50/205 (24%), Positives = 82/205 (40%), Gaps = 54/205 (26%)
Query: 568 IYMVLEY---GEIDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHS 624
+Y V+EY G DL + + Q E FY +I + + + I++
Sbjct: 96 LYFVMEYVNGG--DLMYHIQQV--------GRFKEPHAVFYAAEIAIGLFFLQSKGIIYR 145
Query: 625 DLKPANFLL-VKGSLKLIDFGIAKAIMS--DTTNIQRDSQVGTLSYMSPEAFMCNESDEN 681
DLK N +L +G +K+ DFG+ K + TT + GT Y++PE
Sbjct: 146 DLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTK----TFCGTPDYIAPE---------- 191
Query: 682 GNIIKC---GRPSDIWSLGCILYQMVYGRTPF---SEYKTFWAKFKVITDPNHEITYEPV 735
II G+ D W+ G +LY+M+ G+ PF E + F + I V
Sbjct: 192 --IIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQS-----------IMEHNV 238
Query: 736 PNP-WL----LDLMKKCLAWDRNER 755
P + + + K + +R
Sbjct: 239 AYPKSMSKEAVAICKGLMTKHPGKR 263
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 93.5 bits (232), Expect = 9e-20
Identities = 83/476 (17%), Positives = 157/476 (32%), Gaps = 116/476 (24%)
Query: 316 SHQEGSTLGAVEPVEDFSRNPEPANRGDMVHLSCSSLKDTKTPVDQAVRAPQASTSVIDP 375
+ ++ + D + + L+ + + + ++ + + S + D
Sbjct: 189 PNGLSDPYVKLKLIPDPKSESKQKTKTIKSSLNPEWNETFRFQLKESDKDRRLSVEIWD- 247
Query: 376 KPEIKKQEWPKEQQDCV--VKEGGIPNDPSTHKSMEGRQHTGNSP---ELKSQAPLSKNS 430
+ ++ + +++ G+ EG P ++ K
Sbjct: 248 WDLTSRNDFMGSLSFGISELQKAGVDGWFKLLSQEEGEYFNVPVPPEGSEGNEELRQKFE 307
Query: 431 SSDMKLEASKSEKQEKAVSSKGASAPRKRNYDPDLFFKVNGKLYQRLGKIGSGGSSEVHK 490
+ + E++ SK + + F LGK GS G K
Sbjct: 308 RAKIGQGTKAPEEKTANTISKFDNNGNRDRMKLTDF-----NFLMVLGK-GSFG-----K 356
Query: 491 VI----SSDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQL--IDYEVTEK 544
V+ +YA+K +K K+ +IQ ++ + EK
Sbjct: 357 VMLSERKGTDELYAVKILK------------------------KDVVIQDDDVECTMVEK 392
Query: 545 ALLREV--------LNGSMNNKDGRVKDDGYIYMVLEY---GEIDLAHMLSQKWKEMDGS 593
+L L+ D +Y V+EY G DL + + Q +
Sbjct: 393 RVLALPGKPPFLTQLHSCFQTMD-------RLYFVMEYVNGG--DLMYHIQQVGR----- 438
Query: 594 NQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLL-VKGSLKLIDFGIAKAIMS- 651
E FY +I + + + I++ DLK N +L +G +K+ DFG+ K +
Sbjct: 439 ---FKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWD 495
Query: 652 -DTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKC---GRPSDIWSLGCILYQMVYGR 707
TT + GT Y++PE II G+ D W+ G +LY+M+ G+
Sbjct: 496 GVTTK----TFCGTPDYIAPE------------IIAYQPYGKSVDWWAFGVLLYEMLAGQ 539
Query: 708 TPF---SEYKTFWAKFKVITDPNHEITYEPVPNPWLL-----DLMKKCLAWDRNER 755
PF E + F + I V P + + K + +R
Sbjct: 540 APFEGEDEDELFQS-----------IMEHNVAYPKSMSKEAVAICKGLMTKHPGKR 584
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 90.8 bits (226), Expect = 1e-19
Identities = 66/385 (17%), Positives = 113/385 (29%), Gaps = 153/385 (39%)
Query: 474 YQRLGKIGSGGSSEVHKVISSDC-TIYALKKIKLKGRDYATAYGFCQEIEYLNKLK---- 528
+ + K+G G V D YA+K ++ + +A E + L K++
Sbjct: 37 FLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAK---IEADILKKIQNDDI 93
Query: 529 GKNNIIQLIDY--------EVTEKAL---LREVLNGSMNNKDGRVKDDGYIYMVLEYGEI 577
NNI++ + E L L E++ + Y +E
Sbjct: 94 NNNNIVKYHGKFMYYDHMCLIFEP-LGPSLYEII-----------TRNNYNGFHIED--- 138
Query: 578 DLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLLV--- 634
++ Y +IL+A+N + + + H+DLKP N LL
Sbjct: 139 ------------------------IKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPY 174
Query: 635 -----------------------KGSLKLIDFGIAKAIMSD---TTNIQRDSQVGTLSYM 668
+KLIDFG A + I T Y
Sbjct: 175 FEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFG--CATFKSDYHGSIIN------TRQYR 226
Query: 669 SPEAFMCNESDENGNII---KCGRPSDIWSLGCILYQM---------------------V 704
+PE +I SD+WS GC+L ++ +
Sbjct: 227 APE------------VILNLGWDVSSDMWSFGCVLAELYTGSLLFRTHEHMEHLAMMESI 274
Query: 705 YGRTP---------------FSEYKTFWAKFKVITDPNHEITY-------EPVPNPWLLD 742
P ++ + A + + N + + + D
Sbjct: 275 IQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCD 334
Query: 743 LMKKCLAWDRNERWRIPQLLQHPFL 767
+ L D R +LL+H FL
Sbjct: 335 FLYSILQIDPTLRPSPAELLKHKFL 359
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 86.7 bits (215), Expect = 2e-18
Identities = 57/313 (18%), Positives = 113/313 (36%), Gaps = 74/313 (23%)
Query: 475 QRLGKIGSGGSSEVHKVISSDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNII 534
Q L G V K + + A+K +D ++ E+ L +K +N I+
Sbjct: 27 QLLEVKARGRFGCVWKAQLLNEYV-AVKI--FPIQDKQ-SWQNEYEVYSLPGMKHEN-IL 81
Query: 535 QLIDYEVTEKALLREVLNGSMNNKDGRVKDDGYIYMVLEYGEI-DLAHMLSQKWKEMDGS 593
Q I E ++ ++ ++ + E L+ L
Sbjct: 82 QFIGAEKRGTSVDVDLW------------------LITAFHEKGSLSDFLK--------- 114
Query: 594 NQTLDENWLRFYWQQILEAVNTIHEE----------RIVHSDLKPANFLLVK--GSLKLI 641
+ N L + + + +HE+ I H D+K N +L+K + +
Sbjct: 115 ANVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKN-VLLKNNLTACIA 173
Query: 642 DFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILY 701
DFG+A + + QVGT YM+PE + + ++ D++++G +L+
Sbjct: 174 DFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRI----DMYAMGLVLW 229
Query: 702 QMVYGRTPFS----EYKTFWAKFKVITDPNHEITYEPV---------PNPW--------L 740
++ T EY + + ++ P+ E E V + W L
Sbjct: 230 ELASRCTAADGPVDEYMLPFEE-EIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAML 288
Query: 741 LDLMKKCLAWDRN 753
+ +++C WD +
Sbjct: 289 CETIEEC--WDHD 299
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 9e-18
Identities = 66/308 (21%), Positives = 110/308 (35%), Gaps = 72/308 (23%)
Query: 479 KIGSGGSSEVHKVISSDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLID 538
+G G EV + + A+K RD ++ E+ L+ +N I+ I
Sbjct: 15 CVGKGRYGEVWRGSWQGENV-AVKI--FSSRDEK-SWFRETELYNTVMLRHEN-ILGFIA 69
Query: 539 YEVTEKALLREVLNGSMNNKDGRVKDDGYIYMVLEYGEI-DLAHMLSQKWKEMDGSNQTL 597
++T + ++ +++ Y E+ L L TL
Sbjct: 70 SDMTSRHSSTQL------------------WLITHYHEMGSLYDYLQ---------LTTL 102
Query: 598 DENWLRFYWQQILEAVNTIHEER--------IVHSDLKPANFLLVK--GSLKLIDFGIAK 647
D I + +H E I H DLK N +LVK G + D G+A
Sbjct: 103 DTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKN-ILVKKNGQCCIADLGLAV 161
Query: 648 AIMSDTT--NIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVY 705
T ++ + +VGT YM+PE + + + DIW+ G +L+++
Sbjct: 162 MHSQSTNQLDVGNNPRVGTKRYMAPEVL---DETIQVDCFDSYKRVDIWAFGLVLWEVAR 218
Query: 706 GRTPFS---EYKTFWAKFKVITDPNHEITYE---------PVPNPW--------LLDLMK 745
+YK + V DP+ E + +PN W L LMK
Sbjct: 219 RMVSNGIVEDYKPPFYD-VVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMK 277
Query: 746 KCLAWDRN 753
+C W +N
Sbjct: 278 EC--WYQN 283
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 84.6 bits (209), Expect = 2e-17
Identities = 73/421 (17%), Positives = 128/421 (30%), Gaps = 156/421 (37%)
Query: 459 RNYDPDLFFKV------NGKLYQRLGKIGSGGSSEVHKVISSDCTIY-ALKKIKLKGRDY 511
+Y + V NG+ Y + K+G G S V + A+K +K
Sbjct: 19 NDYCKGGYHLVKIGDLFNGR-YHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYT 77
Query: 512 ATAYGFCQEIEYLNKLK-------GKNNIIQLIDY-EVTEKALLREVLNGSMNNKDGRVK 563
TA EI L ++ + ++QL+D +++ NG+
Sbjct: 78 ETAL---DEIRLLKSVRNSDPNDPNREMVVQLLDDFKISGV-------NGT--------- 118
Query: 564 DDGYIYMVLEYGEIDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEE-RIV 622
+I MV E L + + + Q L ++ QQ+L+ ++ +H + RI+
Sbjct: 119 ---HICMVFEVLGHHLLKWIIK------SNYQGLPLPCVKKIIQQVLQGLDYLHTKCRII 169
Query: 623 HSDLKPANFLLV------------------------------------------------ 634
H+D+KP N LL
Sbjct: 170 HTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKN 229
Query: 635 --KGSLKLIDFGIAKAI-MSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPS 691
K +K+ D G A + T +IQ T Y S E + + + P+
Sbjct: 230 AEKLKVKIADLGNACWVHKHFTEDIQ------TRQYRSLEVLIGSGYNT---------PA 274
Query: 692 DIWSLGCILYQMVYGRTPFSEY-----------------------KTFWAKFKVIT---D 725
DIWS C+ +++ G F + + K
Sbjct: 275 DIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFT 334
Query: 726 PNHEITYEPVPNPW-------------------LLDLMKKCLAWDRNERWRIPQLLQHPF 766
++ + PW D + L +R + L+HP+
Sbjct: 335 KKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHPW 394
Query: 767 L 767
L
Sbjct: 395 L 395
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 82.9 bits (205), Expect = 3e-17
Identities = 61/308 (19%), Positives = 114/308 (37%), Gaps = 72/308 (23%)
Query: 479 KIGSGGSSEVHKVISSDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLID 538
IG G EV + + A+K R+ ++ EI L+ NI+ I
Sbjct: 49 SIGKGRFGEVWRGKWRGEEV-AVKI--FSSREER-SWFREAEIYQTVMLR-HENILGFIA 103
Query: 539 YEVTEKALLREVLNGSMNNKDGRVKDDGYIYMVLEYGEI-DLAHMLSQKWKEMDGSNQTL 597
+ + + +++V +Y E L L++ T+
Sbjct: 104 ADNKDNGTWTQ------------------LWLVSDYHEHGSLFDYLNRY---------TV 136
Query: 598 DENWLRFYWQQILEAVNTIHEER--------IVHSDLKPANFLLVK--GSLKLIDFGIA- 646
+ + +H E I H DLK N +LVK G+ + D G+A
Sbjct: 137 TVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKN-ILVKKNGTCCIADLGLAV 195
Query: 647 -KAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVY 705
+DT +I + +VGT YM+PE + N + + +DI+++G + +++
Sbjct: 196 RHDSATDTIDIAPNHRVGTKRYMAPEVL---DDSINMKHFESFKRADIYAMGLVFWEIAR 252
Query: 706 GRTPFS---EYKTFWAKFKVITDPNHEITYE---------PVPNPW--------LLDLMK 745
+ +Y+ + V +DP+ E + +PN W + +M+
Sbjct: 253 RCSIGGIHEDYQLPY-YDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMR 311
Query: 746 KCLAWDRN 753
+C W N
Sbjct: 312 EC--WYAN 317
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 83.2 bits (206), Expect = 4e-17
Identities = 67/370 (18%), Positives = 105/370 (28%), Gaps = 125/370 (33%)
Query: 474 YQRLGKIGSGGSSEVHKVISSDC-TIYALKKIKLKGRDYATAYGFCQEIEYLNKLK---- 528
Y+ IG G +V K A+K IK K A E+ L +
Sbjct: 56 YEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQ---IEVRLLELMNKHDT 112
Query: 529 -GKNNIIQLIDYEVTEKALLREVLNGSMNNKDGRVKDDGYIYMVLEYGEIDLAHMLSQKW 587
K I+ L + ++ +V E +L +L
Sbjct: 113 EMKYYIVHLKRH----------------------FMFRNHLCLVFEMLSYNLYDLLRNT- 149
Query: 588 KEMDGSNQTLDENWLRFYWQQILEAVNTIHEER--IVHSDLKPANFLLV---KGSLKLID 642
+ + + N R + QQ+ A+ + I+H DLKP N LL + ++K++D
Sbjct: 150 -----NFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVD 204
Query: 643 FGIAKAIMSD-TTNIQRDSQVGTLSYMSPEAFMCNESDENGNII---KCGRPSDIWSL-- 696
FG + + IQ + Y SPE ++ D+WSL
Sbjct: 205 FGSSCQLGQRIYQYIQ------SRFYRSPE------------VLLGMPYDLAIDMWSLGC 246
Query: 697 -------GCILYQ------------MVYGRTP-------------FSEYKTFWAKFKVIT 724
G L+ V G P F + K
Sbjct: 247 ILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHILDQAPKARKFFEKLPDGTWNLKKTK 306
Query: 725 D---------------------------PNHEITYEPVPNPWLLDLMKKCLAWDRNERWR 757
D E + DL+ + L +D R +
Sbjct: 307 DGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDYDPKTRIQ 366
Query: 758 IPQLLQHPFL 767
LQH F
Sbjct: 367 PYYALQHSFF 376
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 82.5 bits (204), Expect = 5e-17
Identities = 66/307 (21%), Positives = 112/307 (36%), Gaps = 70/307 (22%)
Query: 479 KIGSGGSSEVHKVISSDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLID 538
+IG G EV + A+K + A ++ EI ++ +N I+ I
Sbjct: 44 QIGKGRYGEVWMGKWRGEKV-AVKV--FFTTEEA-SWFRETEIYQTVLMRHEN-ILGFIA 98
Query: 539 YEVTEKALLREVLNGSMNNKDGRVKDDGYIYMVLEYGEI-DLAHMLSQKWKEMDGSNQTL 597
++ + +Y++ +Y E L L TL
Sbjct: 99 ADIKGTGSWTQ------------------LYLITDYHENGSLYDYLKST---------TL 131
Query: 598 DENWLRFYWQQILEAVNTIHEER--------IVHSDLKPANFLLVK--GSLKLIDFGIAK 647
D + + + +H E I H DLK N +LVK G+ + D G+A
Sbjct: 132 DAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKN-ILVKKNGTCCIADLGLAV 190
Query: 648 AIMSDT--TNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVY 705
+SDT +I +++VGT YM PE + N N + +D++S G IL+++
Sbjct: 191 KFISDTNEVDIPPNTRVGTKRYMPPEVL---DESLNRNHFQSYIMADMYSFGLILWEVAR 247
Query: 706 GRTPFSEYKTFWAKFKVIT--DPNHEITYE---------PVPNPW--------LLDLMKK 746
+ + + + DP++E E PN W + LM +
Sbjct: 248 RCVSGGIVEEYQLPYHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTE 307
Query: 747 CLAWDRN 753
C W N
Sbjct: 308 C--WAHN 312
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 77.1 bits (190), Expect = 3e-15
Identities = 53/245 (21%), Positives = 99/245 (40%), Gaps = 36/245 (14%)
Query: 476 RLG-KIGSGGSSEVHKVIS-SDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNI 533
LG KIGSGG ++ + A +K++ ++ + E+++ ++ K+ I
Sbjct: 40 VLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLF---SELKFYQRVAKKDCI 96
Query: 534 IQLIDYEVTEKALLREVL-NGSMNNKDGRVKDDGYIYMVLEYGEIDLAHMLSQKWKEMDG 592
+ I+ + + + +G K Y +MV+E IDL + Q
Sbjct: 97 KKWIERKQLDYLGIPLFYGSGLTEFKGRS-----YRFMVMERLGIDLQKISGQ------- 144
Query: 593 SNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLLVKGSLK---LIDFGIAKAI 649
N T ++ + ++L+ + IHE VH D+K AN LL + L D+G++
Sbjct: 145 -NGTFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVYLADYGLSYRY 203
Query: 650 MSDTTNI-----QRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMV 704
+ + R GT+ + S +A R SD+ LG + + +
Sbjct: 204 CPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVA---------LSRRSDVEILGYCMLRWL 254
Query: 705 YGRTP 709
G+ P
Sbjct: 255 CGKLP 259
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 76.6 bits (189), Expect = 3e-15
Identities = 55/275 (20%), Positives = 95/275 (34%), Gaps = 61/275 (22%)
Query: 467 FKVNGKLYQRLGKIGSGGSSEVHKVIS-SDCTIYALK--KIKLKGRDYATAYGFCQEIEY 523
V ++ KIG G E+ + A+K +K + E +
Sbjct: 5 LMVGPN-FRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQL------HLEYRF 57
Query: 524 LNKLKGKNNIIQLIDYEVTEKALLREVLNGSMNNKDGRVKDDGYIYMVLEYGEIDLAHML 583
+L + I Q+ + G Y MVLE L +
Sbjct: 58 YKQLGSGDGIPQVYYF--------------------GP--CGKYNAMVLELLGPSLEDLF 95
Query: 584 SQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLLVKGSLK---- 639
+ S +T+ L Q++ + +H + +++ D+KP NFL+ + K
Sbjct: 96 DLCDRTF--SLKTV----LMIA-IQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQV 148
Query: 640 --LIDFGIAKAIMSDTTNI-----QRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSD 692
+IDF +AK + T + S GT YMS + E R D
Sbjct: 149 IHIIDFALAKEYIDPETKKHIPYREHKSLTGTARYMSINTHLGKE---------QSRRDD 199
Query: 693 IWSLGCILYQMVYGRTPFSEYK--TFWAKFKVITD 725
+ +LG + + G P+ K T +++ I D
Sbjct: 200 LEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGD 234
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 74.3 bits (183), Expect = 1e-14
Identities = 52/270 (19%), Positives = 95/270 (35%), Gaps = 62/270 (22%)
Query: 469 VNGKLYQRLGKIGSGGSSEVHKVIS-SDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKL 527
V Y+ +IG G + + + + A+K + A E L
Sbjct: 8 VGVH-YKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD----APQLRDEYRTYKLL 62
Query: 528 KGKNNIIQLIDYEVTEKALLREVLNGSMNNKDGRVKDDGYIYMVLEYGEIDLAHMLSQKW 587
G I + + G+ + + +V++ L +L
Sbjct: 63 AGCTGIPNVYYF--------------------GQ--EGLHNVLVIDLLGPSLEDLLDLCG 100
Query: 588 KEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLLVKGSLK------LI 641
++ S +T+ +Q+L V +IHE+ +V+ D+KP NFL+ + + K ++
Sbjct: 101 RKF--SVKTV----AMAA-KQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVV 153
Query: 642 DFGIAKAIMSDTTNI-----QRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSL 696
DFG+ K T ++ + GT YMS + E R D+ +L
Sbjct: 154 DFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGRE---------QSRRDDLEAL 204
Query: 697 GCILYQMVYGRTPFSEYKTFWAKFKVITDP 726
G + + G P W K T+
Sbjct: 205 GHVFMYFLRGSLP-------WQGLKAATNK 227
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 73.6 bits (181), Expect = 2e-14
Identities = 57/271 (21%), Positives = 100/271 (36%), Gaps = 55/271 (20%)
Query: 467 FKVNGKLYQRLGKIGSGGSSEVHKVIS-SDCTIYALKKIKLKGRDYATAYGFCQEIEYLN 525
+V + Y+ KIGSG +++ + A+K +K + E +
Sbjct: 5 LRVGNR-YRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHI----ESKIYK 59
Query: 526 KLKGKNNIIQLIDYEVTEKALLREVLNGSMNNKDGRVKDDGYIYMVLEYGEIDLAHMLSQ 585
++G I + G + Y MV+E L + +
Sbjct: 60 MMQGGVGIPTIRWC--------------------GA--EGDYNVMVMELLGPSLEDLFNF 97
Query: 586 KWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLLVKGS----LKLI 641
++ S +T+ L Q++ + IH + +H D+KP NFL+ G + +I
Sbjct: 98 CSRKF--SLKTV----LLLA-DQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYII 150
Query: 642 DFGIAKAIMSDTTNI-----QRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSL 696
DFG+AK T+ + + GT Y S + E R D+ SL
Sbjct: 151 DFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIE---------QSRRDDLESL 201
Query: 697 GCILYQMVYGRTPFSEYK--TFWAKFKVITD 725
G +L G P+ K T K++ I++
Sbjct: 202 GYVLMYFNLGSLPWQGLKAATKRQKYERISE 232
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 74.1 bits (182), Expect = 3e-14
Identities = 60/358 (16%), Positives = 111/358 (31%), Gaps = 94/358 (26%)
Query: 479 KIGSGGSSEVHKVISSDCTIYALKKIKLKGRDYATAYGFCQEIE--YLNKLKGKNNIIQL 536
IG G V+K + + A+K R F E + ++ N I +
Sbjct: 20 LIGRGRYGAVYKGSLDERPV-AVKVFSFANRQ-----NFINEKNIYRVPLMEHDN-IARF 72
Query: 537 IDYEVTEKALLREVLNGSMNNKDGRVKDDGYIYMVLEYGE----IDLAHMLSQKWKEMDG 592
I + A R +V+EY + + W
Sbjct: 73 IVGDERVTADGRMEY-----------------LLVMEYYPNGSLXKYLSLHTSDWVSS-- 113
Query: 593 SNQTLDENWLRFYWQQILEAVNTIHEE---------RIVHSDLKPANFLLVK--GSLKLI 641
+ + +H E I H DL N +LVK G+ +
Sbjct: 114 CRLAHS----------VTRGLAYLHTELPRGDHYKPAISHRDLNSRN-VLVKNDGTCVIS 162
Query: 642 DFGIAKAIMSDTTNIQRD------SQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWS 695
DFG++ + + + S+VGT+ YM+PE + + + D+++
Sbjct: 163 DFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLE--GAVNLRDXESALKQVDMYA 220
Query: 696 LGCILYQMVYGRTPFS------EYKTFWAKFKVITDPNHEITYEPV---------PNPW- 739
LG I +++ T EY+ + +V P E V P W
Sbjct: 221 LGLIYWEIFMRCTDLFPGESVPEYQMAFQT-EVGNHPTFEDMQVLVSREKQRPKFPEAWK 279
Query: 740 --------LLDLMKKCLAWDRNERWR-----IPQLLQHPFLVPPVSTQPSSSQDQSYQ 784
L + ++ C WD++ R + + ++ + S + +
Sbjct: 280 ENSLAVRSLKETIEDC--WDQDAEARLTAQXAEERMAELMMIWERNKSVSPTAHHHHH 335
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 71.7 bits (176), Expect = 2e-13
Identities = 47/296 (15%), Positives = 103/296 (34%), Gaps = 45/296 (15%)
Query: 434 MKLEASKSEKQEKAVSSKGASAPRKRNYDPDLFFKVNGKLYQRLG-KIGSGGSSEVHKVI 492
M+++A+++ +Q A ++ + + ++G IG GG ++
Sbjct: 2 MRVKAAQAGRQSSAKRHLAEQFA-----VGEIITDMAAAAW-KVGLPIGQGGFGCIYLAD 55
Query: 493 SSDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLREVL- 551
+ + + + E+++ + I + I + + +
Sbjct: 56 MNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKYWG 115
Query: 552 NGSMNNKDGRVKDDGYIYMVLEYGEIDLAHMLSQKWKEMDGSNQTL----DENWLRFYWQ 607
+G + Y +M+++ DL + K S +T+
Sbjct: 116 SGLHDKNGKS-----YRFMIMDRFGSDLQKIYEANAKRF--SRKTVLQLSL--------- 159
Query: 608 QILEAVNTIHEERIVHSDLKPANFLLVKGSLK---LIDFGIAKAIMSDTTNI-----QRD 659
+IL+ + IHE VH D+K +N LL + L+D+G+A + + +
Sbjct: 160 RILDILEYIHEHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKR 219
Query: 660 SQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGRTPFSEYKT 715
GT+ + S +A R D+ LG + Q + G P+ +
Sbjct: 220 CHDGTIEFTSIDAHNGVA---------PSRRGDLEILGYCMIQWLTGHLPWEDNLK 266
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 70.2 bits (172), Expect = 3e-13
Identities = 28/237 (11%), Positives = 54/237 (22%), Gaps = 67/237 (28%)
Query: 562 VKDDGYIYMVLEYGE-IDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEER 620
V +V E+ L + + Q + A + H
Sbjct: 100 VHTRAGGLVVAEWIRGGSLQEVADT----------SPSPVGAIRAMQSLAAAADAAHRAG 149
Query: 621 IVHSDLKPANFLLVK-GSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESD 679
+ S P+ + G + L M
Sbjct: 150 VALSIDHPSRVRVSIDGDVVLAYPA----------------------TMPDA-------- 179
Query: 680 ENGNIIKCGRPSDIWSLGCILYQMVYGRTPFSEYKTFWAKFKVITDPNHEITYEP----- 734
DI +G LY ++ R P E + EP
Sbjct: 180 --------NPQDDIRGIGASLYALLVNRWPLPE-AGVRSGLAPAERDTAGQPIEPADIDR 230
Query: 735 -VPNPWLLDLMKKCLAWDRNERW---------RIPQLLQHPFLVPPVSTQPSSSQDQ 781
+P + + + + D R + + ++ P+ P S+ +
Sbjct: 231 DIP-FQISAVAARSVQGDGGIRSASTLLNLMQQATAVADRTEVLGPIDEAPVSAAPR 286
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 70.0 bits (171), Expect = 1e-12
Identities = 57/270 (21%), Positives = 99/270 (36%), Gaps = 60/270 (22%)
Query: 467 FKVNGKLYQRLGKIGSGGSSEVHKVIS-SDCTIYALKKIKLKGRDYATAYGFCQEIEYLN 525
+V K ++ KIGSG E++ + A+K +K + Y E +
Sbjct: 3 PRVGNK-FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLY----ESKIYR 57
Query: 526 KLKGKNNIIQLIDYEVTEKALLREVLNGSMNNKDGRVKDDGYIYMVLEYGEIDLAHMLSQ 585
L+G I + + G + Y +V++ L + +
Sbjct: 58 ILQGGTGIPNVRWF--------------------GV--EGDYNVLVMDLLGPSLEDLFNF 95
Query: 586 KWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLLVKGS----LKLI 641
+++ S +T+ L Q++ V +H + +H D+KP NFL+ G + +I
Sbjct: 96 CSRKL--SLKTV----LMLA-DQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYII 148
Query: 642 DFGIAKAIMSDTTNI-----QRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSL 696
DFG+AK +T+ + + GT Y S + E R D+ SL
Sbjct: 149 DFGLAKKYRDTSTHQHIPYRENKNLTGTARYASVNTHLGIE---------QSRRDDLESL 199
Query: 697 GCILYQMVYGRTPFSEYKTFWAKFKVITDP 726
G +L + G P W K T
Sbjct: 200 GYVLMYFLRGSLP-------WQGLKAGTKK 222
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 69.0 bits (169), Expect = 2e-12
Identities = 25/126 (19%), Positives = 44/126 (34%), Gaps = 24/126 (19%)
Query: 608 QILEAVNTIHEERIVHSDLKPANFLLVKGSLK---LIDFGIAKAIMSDTTNIQ-----RD 659
++L+A+ +HE VH ++ N + L +G A ++ R
Sbjct: 167 RLLDALEFLHENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRS 226
Query: 660 SQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGRTPFSEYKTFWAK 719
G L ++S + R SD+ SLG + + +YG P W
Sbjct: 227 PHEGDLEFISMDLHKGCG---------PSRRSDLQSLGYCMLKWLYGFLP-------WTN 270
Query: 720 FKVITD 725
T+
Sbjct: 271 CLPNTE 276
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 65.6 bits (159), Expect = 5e-11
Identities = 105/712 (14%), Positives = 203/712 (28%), Gaps = 223/712 (31%)
Query: 42 DLFRHVQAAFKRHRPLGSMQSNSIMPKRSLVPKREASRCLGTSVDIN-----VDT--DKS 94
D+ + AF + +Q MP +S++ K E + + ++ T K
Sbjct: 20 DILSVFEDAFVDNFDCKDVQD---MP-KSILSKEEIDHIIMSKDAVSGTLRLFWTLLSKQ 75
Query: 95 KDMVSLSHGHAVKDPISQIKNEAATAVAETQEDASITPPSILGTRTNTFDEN--FNPFDA 152
++MV V++ + + + Q S+ + R +++N F ++
Sbjct: 76 EEMVQ----KFVEEVLRINYKFLMSPIKTEQRQPSMMTRMYIEQRDRLYNDNQVFAKYNV 131
Query: 153 QRDHSKLTIGCKENNSLTLAHLEPP-----H-DQGQRKVRFSVGNSTSCQGADDRMATGM 206
R L + ++ L L P G K + C ++ M
Sbjct: 132 SRLQPYLKL--RQA----LLELRPAKNVLIDGVLGSGK---TWVALDVCL--SYKVQCKM 180
Query: 207 ENLSSHMGSLALTEMEW-DASNQVEVSTVVNNNSKLQQVRNTEPDISLRPDGASSLAKRT 265
+ ++ W + N TV+ KL +P+ + R D +S++ R
Sbjct: 181 DF-----------KIFWLNLKNCNSPETVLEMLQKLL--YQIDPNWTSRSDHSSNIKLRI 227
Query: 266 TVVQDQLHQFRNFLGQP--------------ATQFSMVGSSCP---TSTYIHSTSAPMLN 308
+Q +L R L A ++ SC T+ + T
Sbjct: 228 HSIQAEL---RRLLKSKPYENCLLVLLNVQNAKAWNAFNLSCKILLTTRFKQVTDFLSAA 284
Query: 309 STTKCSRSHQEGSTLGAVEPVEDFSRN--------PEPANRGDMVHLSC--SSLKDT--- 355
+TT S H TL E + P + LS S++D
Sbjct: 285 TTTHISLDHHS-MTLTPDEVKSLLLKYLDCRPQDLPREVLTTNPRRLSIIAESIRDGLAT 343
Query: 356 -----KTPVDQAVRAPQASTSVIDPKPEIKKQEWPKEQQDCVVKEGGIPND---PSTHKS 407
D+ ++S +V++P E +K V P P+ S
Sbjct: 344 WDNWKHVNCDKLTTIIESSLNVLEP-AEYRKM-----FDRLSV----FPPSAHIPTILLS 393
Query: 408 MEGRQHTGNSPELKSQAPLSKNSSSDMKLEASKS--EKQEKAVSSKGASAPRKRNYDPDL 465
+ + + + S EKQ K P +
Sbjct: 394 LIWFDVIKSDVMV------------VVNKLHKYSLVEKQPK----------ESTISIPSI 431
Query: 466 FFKVNGKLYQRLGKIGSGGSSEVHKVISSDCTIYALKKIKLKGRDYATAYGFCQEIEYLN 525
+ ++ KL +H+ I +++ N
Sbjct: 432 YLELKVKLENEY---------ALHRSI----------------------------VDHYN 454
Query: 526 KLKGKNNIIQLIDYEVTEKALLREVLNGSMNNKDGRVKDDGYIYMVLEYGEIDLAHM--- 582
K ++ ++ D Y Y + + H+
Sbjct: 455 IPKT---------FD---------------SDDLIPPYLDQYFYSHIGH------HLKNI 484
Query: 583 -LSQKWKEMDGSNQTLDENWLR-------FYWQQILEAVNTIH-----EERIVHSDLKPA 629
++ LD +L W +NT+ + I +D P
Sbjct: 485 EHPERMTLF--RMVFLDFRFLEQKIRHDSTAWNASGSILNTLQQLKFYKPYICDND--PK 540
Query: 630 NFLLVKGSLKLIDFGI---AKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNES 678
LV ++DF I S T++ R ++ M+ + + E+
Sbjct: 541 YERLVN---AILDFLPKIEENLICSKYTDLLR------IALMAEDEAIFEEA 583
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 51.4 bits (122), Expect = 1e-06
Identities = 58/334 (17%), Positives = 100/334 (29%), Gaps = 107/334 (32%)
Query: 537 IDYEVTEKAL-LREVLNGSMNN--KDGRVKD--DGYIYMVLEYGEIDLAHMLSQKWKEMD 591
+D+E E +++L+ + + KD D +L EID H++ K D
Sbjct: 7 MDFETGEHQYQYKDILSVFEDAFVDNFDCKDVQD-MPKSILSKEEID--HIIMSK----D 59
Query: 592 GSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLLVKGSLKLIDFGIAKAIMS 651
+ TL R +W L + ++ V L+ N+ F +MS
Sbjct: 60 AVSGTL-----RLFW--TLLSKQEEMVQKFVEEVLRI-NY----------KF-----LMS 96
Query: 652 DTTNIQRDSQVGTLSYMSPEAFMCNESDE--NGNIIKCGRPSDIWSLGCILYQM------ 703
QR + T Y+ + N++ N+ R L L ++
Sbjct: 97 PIKTEQRQPSMMTRMYIEQRDRLYNDNQVFAKYNV---SRLQPYLKLRQALLELRPAKNV 153
Query: 704 -VYG------------------RTPFSEYKTFWAKFKVITDPNHEITYEPVPNPWLLDLM 744
+ G ++K FW K P +L+++
Sbjct: 154 LIDGVLGSGKTWVALDVCLSYKVQCKMDFKIFWLNLKNCNSPET-----------VLEML 202
Query: 745 KK-CLAWDRNERWRIPQLLQHPFLVPPVSTQPSSSQDQSYQLLQLLAEASASDHEASTIC 803
+K D N H S +L +LL +E
Sbjct: 203 QKLLYQIDPN----WTSRSDHS------SNIKLRIHSIQAELRRLLKSK---PYENC--- 246
Query: 804 SQLSQLI----RNPVMLAATQLSTSQDQQCKLLL 833
L L+ +N A + CK+LL
Sbjct: 247 --L--LVLLNVQNAKAWNAF------NLSCKILL 270
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 62.1 bits (151), Expect = 4e-10
Identities = 58/303 (19%), Positives = 117/303 (38%), Gaps = 74/303 (24%)
Query: 479 KIGSGGSSEVHK-VISSDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLI 537
K+G G EV++ V A+K +K D F +E + ++K N ++QL+
Sbjct: 227 KLGGGQYGEVYEGVWKKYSLTVAVKTLK---EDTMEVEEFLKEAAVMKEIKHPN-LVQLL 282
Query: 538 DYEVTEKALLREVLNGSMNNKDGRVKDDGYIYMVLEY---GEIDLAHMLSQKWKEMDGSN 594
G + Y++ E+ G +L L +E +
Sbjct: 283 ----------------------GVCTREPPFYIITEFMTYG--NLLDYL----RECNRQE 314
Query: 595 QTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLLV-KGSLKLIDFGIAKAIMSDT 653
+ L + QI A+ + ++ +H +L N L+ +K+ DFG+++ + DT
Sbjct: 315 VSAVV--LLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDT 372
Query: 654 TNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMV-YGRTPFSE 712
++ + + +PE+ N+ IK SD+W+ G +L+++ YG +P+
Sbjct: 373 YTAHAGAKF-PIKWTAPESLAYNKFS-----IK----SDVWAFGVLLWEIATYGMSPYPG 422
Query: 713 YKTFWAKFKVITDPNHEITYEPVPN-----------PWLLDLMKKCLAWDRNERWRIPQL 761
+ YE + + +LM+ C W+ ++R ++
Sbjct: 423 I------------DLSQ-VYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEI 469
Query: 762 LQH 764
Q
Sbjct: 470 HQA 472
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 62.1 bits (151), Expect = 4e-10
Identities = 72/316 (22%), Positives = 115/316 (36%), Gaps = 71/316 (22%)
Query: 479 KIGSGGSSEVHKVISSDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLID 538
K+G G EV + T A+K +K + F QE + + KL+ + ++QL
Sbjct: 191 KLGQGCFGEVWMGTWNGTTRVAIKTLK---PGTMSPEAFLQEAQVMKKLRHEK-LVQLY- 245
Query: 539 YEVTEKALLREVLNGSMNNKDGRVKDDGYIYMVLEYGEI-DLAHMLSQKWKEMDGSNQTL 597
V ++ IY+V EY L L K G L
Sbjct: 246 ---------------------AVVSEEP-IYIVTEYMSKGSLLDFL----KGETGKYLRL 279
Query: 598 DENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLLV-KGSLKLIDFGIAKAIMSDTTNI 656
+ L QI + + VH DL+ AN L+ K+ DFG+A+ I +
Sbjct: 280 PQ--LVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTA 337
Query: 657 QRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMV-YGRTPFSEYKT 715
++ ++ + + +PEA + IK SD+WS G +L ++ GR P+
Sbjct: 338 RQGAKF-PIKWTAPEAALYGRFT-----IK----SDVWSFGILLTELTTKGRVPYPGM-- 385
Query: 716 FWAKFKVITDPNHEITYE-------PVPN---PWLLDLMKKCLAWDRNERWR---IPQLL 762
N E+ + P P L DLM +C + ER + L
Sbjct: 386 ----------VNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFL 435
Query: 763 QHPFLVPPVSTQPSSS 778
+ F QP +
Sbjct: 436 EDYFTSTEPQYQPGEN 451
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 61.1 bits (147), Expect = 5e-10
Identities = 67/357 (18%), Positives = 104/357 (29%), Gaps = 85/357 (23%)
Query: 474 YQRLGKIGSGGSSEVHKVISSDCTIYALKKIKLKGRDYA------TAYGFCQEIEYLNKL 527
QR KIG G EV + I+ T A+K I ++G D T EI +L
Sbjct: 22 LQRCEKIGEGVFGEVFQTIADH-TPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKEL 80
Query: 528 KGKN--------NIIQLIDYEVTEKALLREVL---------NGSMNNKDGRVKDDG-YIY 569
+ I L + + +L GS N++ KDD +I
Sbjct: 81 SLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIV 140
Query: 570 MVLEYGEIDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEE-RIVHSDLKP 628
+ E+G IDL M + + Q+ ++ R H DL
Sbjct: 141 LEFEFGGIDLEQM----------RTKLSSLATAKSILHQLTASLAVAEASLRFEHRDLHW 190
Query: 629 ANFLLVK-GSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKC 687
N LL K KL K+ + +Q +II
Sbjct: 191 GNVLLKKTSLKKLHYTLNGKSSTIPSCGLQV------------------------SIIDY 226
Query: 688 GRPSDIWSLGCILYQMVYGRTPFS-----EYKTFWAKFKVITDPNHEITYEPVPNP-WLL 741
+ + F+ ++ + K N Y P N WL
Sbjct: 227 TLSRLERDGIVVFCDVSMDEDLFTGDGDYQFDIYRLMKKEN--NNRWGEYHPYSNVLWLH 284
Query: 742 DLMKKCLAWDRNERWRIPQLLQHPFLVPPVSTQPSSSQDQSYQLLQ--LLAEASASD 796
L K +L+ +T + Q +L +SA+D
Sbjct: 285 YLTDK--------------MLKQMTFKTKCNTPAMKQIKRKIQEFHRTMLNFSSATD 327
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 61.3 bits (149), Expect = 7e-10
Identities = 66/292 (22%), Positives = 104/292 (35%), Gaps = 72/292 (24%)
Query: 479 KIGSGGSSEVHKVISSDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLID 538
K+G+G EV + T A+K +K + F E + L+ +++L
Sbjct: 195 KLGAGQFGEVWMATYNKHTKVAVKTMK---PGSMSVEAFLAEANVMKTLQHDK-LVKLH- 249
Query: 539 YEVTEKALLREVLNGSMNNKDGRVKDDGYIYMVLEYGEI-DLAHMLSQKWKEMDGSNQTL 597
V + IY++ E+ L L K +GS Q L
Sbjct: 250 ---------------------AVVTKEP-IYIITEFMAKGSLLDFL----KSDEGSKQPL 283
Query: 598 DENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLLV-KGSLKLIDFGIAKAIMSDTTNI 656
+ L + QI E + I + +H DL+ AN L+ K+ DFG+A+ I +
Sbjct: 284 PK--LIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTA 341
Query: 657 QRDSQVGTLSY--MSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMV-YGRTPFSEY 713
+ +PEA IK SD+WS G +L ++V YGR P+
Sbjct: 342 ---REGAKFPIKWTAPEAINFGSFT-----IK----SDVWSFGILLMEIVTYGRIPYPGM 389
Query: 714 KTFWAKFKVITDPNHEITYE-------PVPN---PWLLDLMKKCLAWDRNER 755
N E+ P P L ++M +C ER
Sbjct: 390 ------------SNPEVIRALERGYRMPRPENCPEELYNIMMRCWKNRPEER 429
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 60.1 bits (146), Expect = 1e-09
Identities = 64/301 (21%), Positives = 103/301 (34%), Gaps = 66/301 (21%)
Query: 479 KIGSGGSSEVHK-----VISSDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNI 533
++G G V + + + A+K+++ G D F +EI+ L L I
Sbjct: 30 QLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRD--FQREIQILKALHSDF-I 86
Query: 534 IQLIDYEVTEKALLREVLNGSMNNKDGRVKDDGY--IYMVLEYGEI-DLAHMLSQKWKEM 590
++ G G + +V+EY L L +
Sbjct: 87 VKYR----------------------GVSYGPGRQSLRLVMEYLPSGCLRDFLQRH---- 120
Query: 591 DGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLLVKGSL-KLIDFGIAKAI 649
LD + L Y QI + + + R VH DL N L+ + K+ DFG+AK +
Sbjct: 121 ---RARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLL 177
Query: 650 MSDTTNIQRDSQVGTL--SYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMV-YG 706
D + + G + +PE+ N R SD+WS G +LY++ Y
Sbjct: 178 PLDK-DYYVVREPGQSPIFWYAPESLSDN---------IFSRQSDVWSFGVVLYELFTYC 227
Query: 707 RTPFSEYKTFWAKFKVITD--PNHEITYE-------PVPN---PWLLDLMKKCLAWDRNE 754
S F D + P P + +LMK C A +
Sbjct: 228 DKSCSPSAEFLRMMGCERDVPALSRLLELLEEGQRLPAPPACPAEVHELMKLCWAPSPQD 287
Query: 755 R 755
R
Sbjct: 288 R 288
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 56.8 bits (138), Expect = 6e-09
Identities = 59/312 (18%), Positives = 105/312 (33%), Gaps = 83/312 (26%)
Query: 479 KIGSGGSSEVHKVISSDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLID 538
+IGSG VH + A+K I+ + F +E E + KL ++QL
Sbjct: 15 EIGSGQFGLVHLGYWLNKDKVAIKTIR---EGAMSEEDFIEEAEVMMKLSHPK-LVQLY- 69
Query: 539 YEVTEKALLREVLNGSMNNKDGRVKDDGYIYMVLEYGEI-DLAHMLSQKWKEMDGSNQTL 597
G + I +V E+ E L+ L + G
Sbjct: 70 ---------------------GVCLEQAPICLVTEFMEHGCLSDYL----RTQRG---LF 101
Query: 598 DENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLLV-KGSLKLIDFGIAKAIMSDTTNI 656
L + E + + E ++H DL N L+ +K+ DFG+ + ++ D
Sbjct: 102 AAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT- 160
Query: 657 QRDSQVGTL---SYMSPEAFMCNE-SDENGNIIKCGRPSDIWSLGCILYQMV-YGRTPFS 711
S GT + SPE F + S K SD+WS G +++++ G+ P+
Sbjct: 161 ---SSTGTKFPVKWASPEVFSFSRYS------SK----SDVWSFGVLMWEVFSEGKIPYE 207
Query: 712 EYKTFWAKFKVITDPNHEITYE-------PVPN---PWLLDLMKKCLAWDRNER------ 755
N E+ + P + +M C +R
Sbjct: 208 NR------------SNSEVVEDISTGFRLYKPRLASTHVYQIMNHCWRERPEDRPAFSRL 255
Query: 756 -WRIPQLLQHPF 766
++ ++ +
Sbjct: 256 LRQLAEIAESGL 267
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 58.4 bits (141), Expect = 6e-09
Identities = 69/298 (23%), Positives = 109/298 (36%), Gaps = 68/298 (22%)
Query: 479 KIGSGGSSEVHKVISSDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLID 538
K+G G EV + T A+K +K + F QE + + KL+ + ++QL
Sbjct: 274 KLGQGCFGEVWMGTWNGTTRVAIKTLK---PGTMSPEAFLQEAQVMKKLRHEK-LVQLY- 328
Query: 539 YEVTEKALLREVLNGSMNNKDGRVKDDGYIYMVLEYGEI-DLAHMLSQKWKEMDGSNQTL 597
V ++ IY+V EY L L K G L
Sbjct: 329 ---------------------AVVSEEP-IYIVTEYMSKGSLLDFL----KGETGKYLRL 362
Query: 598 DENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLLV-KGSLKLIDFGIAKAIMSDTTNI 656
+ L QI + + VH DL+ AN L+ K+ DFG+A+ I +
Sbjct: 363 PQ--LVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTA 420
Query: 657 QRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMV-YGRTPFSEYKT 715
++ ++ + + +PEA + IK SD+WS G +L ++ GR P+
Sbjct: 421 RQGAKF-PIKWTAPEAALYGRFT-----IK----SDVWSFGILLTELTTKGRVPYPGM-- 468
Query: 716 FWAKFKVITDPNHEITYE-------PVPN---PWLLDLMKKCLAWDRNERWRIPQLLQ 763
N E+ + P P L DLM +C + ER L
Sbjct: 469 ----------VNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQA 516
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 56.9 bits (138), Expect = 8e-09
Identities = 61/299 (20%), Positives = 105/299 (35%), Gaps = 80/299 (26%)
Query: 479 KIGSGGSSEVHK---VISSDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQ 535
++GSG V K + A+K +K + D A E + +L I++
Sbjct: 24 ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPY-IVR 82
Query: 536 LIDYEVTEKALLREVLNGSMNNKDGRVKDDGYIYMVLEYGEI-DLAHMLSQKWKEMDGSN 594
+I G + + +V+E E+ L L Q N
Sbjct: 83 MI----------------------GICEAES-WMLVMEMAELGPLNKYLQQ--------N 111
Query: 595 QTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLLVKGSL-KLIDFGIAKAIMSDT 653
+ + + + Q+ + + E VH DL N LLV K+ DFG++KA+ +D
Sbjct: 112 RHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADE 171
Query: 654 TNIQRDSQVGT---LSYMSPEAFMCNESDENGNIIKCGR---PSDIWSLGCILYQMV-YG 706
+ +Q + + +PE I + SD+WS G ++++ YG
Sbjct: 172 NYYK--AQTHGKWPVKWYAPEC------------INYYKFSSKSDVWSFGVLMWEAFSYG 217
Query: 707 RTPFSEYKTFWAKFKVITDPNHEITYE-------PVPN---PWLLDLMKKCLAWDRNER 755
+ P+ K E+T P + DLM C +D R
Sbjct: 218 QKPYRGMK------------GSEVTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENR 264
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 56.0 bits (136), Expect = 1e-08
Identities = 57/295 (19%), Positives = 101/295 (34%), Gaps = 78/295 (26%)
Query: 479 KIGSGGSSEVHKVISSDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLID 538
++GSG V A+K IK + F QE + + KL +++
Sbjct: 15 ELGSGQFGVVKLGKWKGQYDVAVKMIK---EGSMSEDEFFQEAQTMMKLSHPK-LVKFY- 69
Query: 539 YEVTEKALLREVLNGSMNNKDGRVKDDGYIYMVLEYGEI-DLAHMLSQKWKEMDGSNQTL 597
G + IY+V EY L + L + L
Sbjct: 70 ---------------------GVCSKEYPIYIVTEYISNGCLLNYLRSH-------GKGL 101
Query: 598 DENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLLV--KGSLKLIDFGIAKAIMSDTTN 655
+ + L + E + + + +H DL N LV +K+ DFG+ + ++ D
Sbjct: 102 EPSQLLEMCYDVCEGMAFLESHQFIHRDLAARN-CLVDRDLCVKVSDFGMTRYVLDDQYV 160
Query: 656 IQRDSQVGTL---SYMSPEAFMCNE-SDENGNIIKCGRPSDIWSLGCILYQMV-YGRTPF 710
S VGT + +PE F + S K SD+W+ G +++++ G+ P+
Sbjct: 161 ----SSVGTKFPVKWSAPEVFHYFKYS------SK----SDVWAFGILMWEVFSLGKMPY 206
Query: 711 SEYKTFWAKFKVITDPNHEITYE-------PVPN---PWLLDLMKKCLAWDRNER 755
Y N E+ + P+ + +M C +R
Sbjct: 207 DLY------------TNSEVVLKVSQGHRLYRPHLASDTIYQIMYSCWHELPEKR 249
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 55.8 bits (135), Expect = 2e-08
Identities = 64/326 (19%), Positives = 102/326 (31%), Gaps = 89/326 (27%)
Query: 479 KIGSGGSSEVHK----VISSDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNII 534
IGSG S EV V A+K +K G F E + + N II
Sbjct: 56 IIGSGDSGEVCYGRLRVPGQRDVPVAIKALK-AGYTERQRRDFLSEASIMGQFDHPN-II 113
Query: 535 QLIDYEVTEKALLREVLNGSMNNKDGRVKDDGYIYMVLEY---GEIDLAHMLSQKWKEMD 591
+L G V +V EY G L L
Sbjct: 114 RLE----------------------GVVTRGRLAMIVTEYMENG--SLDTFLRT------ 143
Query: 592 GSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLLVKGSL-KLIDFGIAKAIM 650
+ L + + + + + VH DL N L+ + K+ DFG+++ +
Sbjct: 144 -HDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLE 202
Query: 651 SDTTNIQRDSQVGTLSY--MSPEAFMCNESDENGNIIKCGR---PSDIWSLGCILYQMV- 704
D + G + +PEA I SD+WS G ++++++
Sbjct: 203 DDPDAA-YTTTGGKIPIRWTAPEA------------IAFRTFSSASDVWSFGVVMWEVLA 249
Query: 705 YGRTPFSEYKTFWAKFKVITDPNHEITYE-------PVPN---PWLLDLMKKCLAWDRNE 754
YG P+ N ++ P P L LM C DR +
Sbjct: 250 YGERPYWNMT------------NRDVISSVEEGYRLPAPMGCPHALHQLMLDCWHKDRAQ 297
Query: 755 R-------WRIPQLLQHPFLVPPVST 773
R + L++ P + +T
Sbjct: 298 RPRFSQIVSVLDALIRSPESLRATAT 323
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 55.8 bits (135), Expect = 3e-08
Identities = 75/382 (19%), Positives = 131/382 (34%), Gaps = 99/382 (25%)
Query: 441 SEKQEKAVSSKGASAPRKRNY-DPDLFFKVNGKLYQ----------RLGK-IGSGGSSEV 488
S+++ + P R + DP F +++ + K +G+G EV
Sbjct: 2 SDEKRLHFGNGHLKLPGLRTFVDPHTFEDPTQTVHEFAKELDATNISIDKVVGAGEFGEV 61
Query: 489 H----KVISSDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEK 544
K+ S A+K +K G F E + + N II+L
Sbjct: 62 CSGRLKLPSKKEISVAIKTLK-VGYTEKQRRDFLGEASIMGQFDHPN-IIRLE------- 112
Query: 545 ALLREVLNGSMNNKDGRVKDDGYIYMVLEYGEI-DLAHMLSQKWKEMDGSNQTLDENWLR 603
G V + +V EY E L L ++ D L
Sbjct: 113 ---------------GVVTKSKPVMIVTEYMENGSLDSFL----RKHDAQ---FTVIQLV 150
Query: 604 FYWQQILEAVNTIHEERIVHSDLKPANFLLVKGSL--KLIDFGIAKAIMSDTTNIQRDSQ 661
+ I + + + VH DL N +L+ +L K+ DFG+ + + D ++
Sbjct: 151 GMLRGIASGMKYLSDMGYVHRDLAARN-ILINSNLVCKVSDFGLGRVLEDDPEAA-YTTR 208
Query: 662 VGTLSY--MSPEAFMCNESDENGNIIKCGR---PSDIWSLGCILYQMV-YGRTPFSEYKT 715
G + SPEA I + SD+WS G +L++++ YG P+ E
Sbjct: 209 GGKIPIRWTSPEA------------IAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMS- 255
Query: 716 FWAKFKVITDPNHEITYE-------PVPN---PWLLDLMKKCLAWDRNER-------WRI 758
N ++ P P L LM C DRN R +
Sbjct: 256 -----------NQDVIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSIL 304
Query: 759 PQLLQHPFLVPPVSTQPSSSQD 780
+L+++P + +++ + +
Sbjct: 305 DKLIRNPGSLKIITSAAARPSN 326
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 54.9 bits (133), Expect = 3e-08
Identities = 58/297 (19%), Positives = 106/297 (35%), Gaps = 82/297 (27%)
Query: 479 KIGSGGSSEVHKVISSDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLID 538
++G+G V A+K IK + F +E + + L + ++QL
Sbjct: 31 ELGTGQFGVVKYGKWRGQYDVAIKMIK---EGSMSEDEFIEEAKVMMNLSHEK-LVQLY- 85
Query: 539 YEVTEKALLREVLNGSMNNKDGRVKDDGYIYMVLEY---GEIDLAHMLSQKWKEMDGSNQ 595
G I+++ EY G L + L +EM
Sbjct: 86 ---------------------GVCTKQRPIFIITEYMANG--CLLNYL----REMRH--- 115
Query: 596 TLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLLV--KGSLKLIDFGIAKAIMSDT 653
L + + EA+ + ++ +H DL N LV +G +K+ DFG+++ ++ D
Sbjct: 116 RFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARN-CLVNDQGVVKVSDFGLSRYVLDDE 174
Query: 654 TNIQRDSQVGTL---SYMSPEAFMCNE-SDENGNIIKCGRPSDIWSLGCILYQMV-YGRT 708
S VG+ + PE M ++ S K SDIW+ G +++++ G+
Sbjct: 175 YT----SSVGSKFPVRWSPPEVLMYSKFS------SK----SDIWAFGVLMWEIYSLGKM 220
Query: 709 PFSEYKTFWAKFKVITDPNHEITYE-------PVPN---PWLLDLMKKCLAWDRNER 755
P+ + N E P+ + +M C +ER
Sbjct: 221 PYERF------------TNSETAEHIAQGLRLYRPHLASEKVYTIMYSCWHEKADER 265
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 54.5 bits (132), Expect = 4e-08
Identities = 65/295 (22%), Positives = 103/295 (34%), Gaps = 82/295 (27%)
Query: 479 KIGSGGSSEVHKVISSDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLID 538
IG G +V + A+K IK + ATA F E + +L+ N ++QL+
Sbjct: 28 TIGKGEFGDVMLGDYRGNKV-AVKCIK----NDATAQAFLAEASVMTQLRHSN-LVQLL- 80
Query: 539 YEVTEKALLREVLNGSMNNKDGRV-KDDGYIYMVLEY---GEIDLAHMLSQKWKEMDGSN 594
G + ++ G +Y+V EY G L L + S
Sbjct: 81 ---------------------GVIVEEKGGLYIVTEYMAKG--SLVDYL----RSRGRSV 113
Query: 595 QTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLLV-KGSLKLIDFGIAKAIMSDT 653
D L + + EA+ + VH DL N L+ K+ DFG+ K
Sbjct: 114 LGGDC--LLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTK------ 165
Query: 654 TNIQRDSQVGTLSY--MSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMV-YGRTPF 710
G L +PEA + K SD+WS G +L+++ +GR P+
Sbjct: 166 -EASSTQDTGKLPVKWTAPEALREKKFS-----TK----SDVWSFGILLWEIYSFGRVPY 215
Query: 711 SEYKTFWAKFKVITDPNHEITYE-------PVPN---PWLLDLMKKCLAWDRNER 755
P ++ P+ P + ++MK C D R
Sbjct: 216 PRI------------PLKDVVPRVEKGYKMDAPDGCPPAVYEVMKNCWHLDAAMR 258
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 54.5 bits (132), Expect = 5e-08
Identities = 37/131 (28%), Positives = 55/131 (41%), Gaps = 36/131 (27%)
Query: 617 HEERIVHSDLKPANFLLVKG-SLKLIDFGIAKAIMSD-----TTNIQRDSQVGTLSYMSP 670
HE +H D+K AN LL + + K+ DFG+A+A T+ I VGT +YM+P
Sbjct: 150 HENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRI-----VGTTAYMAP 204
Query: 671 EAFMCNESDENGNI-IKCGRPSDIWSLGCILYQMVYGRTPFSEYKTF-----WA------ 718
EA G I K SDI+S G +L +++ G E++
Sbjct: 205 EAL-------RGEITPK----SDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDE 253
Query: 719 --KFKVITDPN 727
+ D
Sbjct: 254 EKTIEDYIDKK 264
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 55.0 bits (133), Expect = 5e-08
Identities = 59/302 (19%), Positives = 100/302 (33%), Gaps = 72/302 (23%)
Query: 479 KIGSGGSSEVHK-VISSDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLI 537
+IG G EV + +D T+ A+K + + F QE L + N I++LI
Sbjct: 121 QIGRGNFGEVFSGRLRADNTLVAVKSCR-ETLPPDLKAKFLQEARILKQYSHPN-IVRLI 178
Query: 538 DYEVTEKALLREVLNGSMNNKDGRVKDDGYIYMVLEY---GEIDLAHMLSQKWKEMDGSN 594
G IY+V+E G D L +
Sbjct: 179 ----------------------GVCTQKQPIYIVMELVQGG--DFLTFLRTE-------G 207
Query: 595 QTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLL-VKGSLKLIDFGIAKAIMSDT 653
L L + + + +H DL N L+ K LK+ DFG+++
Sbjct: 208 ARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGV 267
Query: 654 TNIQRDSQVGTLSYMSPEAFMCNE-SDENGNIIKCGRPSDIWSLGCILYQMV-YGRTPFS 711
+ + + +PEA S + SD+WS G +L++ G +P+
Sbjct: 268 YAASGGLRQVPVKWTAPEALNYGRYS------SE----SDVWSFGILLWETFSLGASPYP 317
Query: 712 EYKTFWAKFKVITDPNHEITYE-------PVPN---PWLLDLMKKCLAWDRNERWRIPQL 761
N + P P + LM++C A++ +R +
Sbjct: 318 NLS------------NQQTREFVEKGGRLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTI 365
Query: 762 LQ 763
Q
Sbjct: 366 YQ 367
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 54.6 bits (132), Expect = 5e-08
Identities = 56/306 (18%), Positives = 105/306 (34%), Gaps = 75/306 (24%)
Query: 479 KIGSGGSSEVHK-----VISSDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNI 533
++G G V + + + A+KK++ ++ F +EIE L L+ N I
Sbjct: 17 QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRD--FEREIEILKSLQHDN-I 73
Query: 534 IQLIDYEVTEKALLREVLNGSMNNKDGRVKDDGY--IYMVLEYGEI-DLAHMLSQKWKEM 590
++ G G + +++EY L L +
Sbjct: 74 VKYK----------------------GVCYSAGRRNLKLIMEYLPYGSLRDYLQKH---- 107
Query: 591 DGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLLVKGSL-KLIDFGIAKAI 649
+ +D L Y QI + + + +R +H DL N L+ + K+ DFG+ K +
Sbjct: 108 ---KERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVL 164
Query: 650 MSDTTNIQRDSQVGTLS---YMSPEAFMCNESDENGNIIKCGR---PSDIWSLGCILYQM 703
D + + S + +PE+ + + SD+WS G +LY++
Sbjct: 165 PQDKEFFK--VKEPGESPIFWYAPES------------LTESKFSVASDVWSFGVVLYEL 210
Query: 704 V-YGRTPFSEYKTFWAKFKVITDP---NHEITYE-------PVPN---PWLLDLMKKCLA 749
Y S F + P P+ + +M +C
Sbjct: 211 FTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWN 270
Query: 750 WDRNER 755
+ N+R
Sbjct: 271 NNVNQR 276
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 54.6 bits (132), Expect = 5e-08
Identities = 59/329 (17%), Positives = 111/329 (33%), Gaps = 82/329 (24%)
Query: 479 KIGSGGSSEVHK---VISSDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQ 535
++G G V + + A+K +K +G + A +E + +++L I++
Sbjct: 17 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLK-QGTEKADTEEMMREAQIMHQLDNPY-IVR 74
Query: 536 LIDYEVTEKALLREVLNGSMNNKDGRVKDDGYIYMVLEYGEI-DLAHMLSQKWKEMDGSN 594
LI G + + + +V+E L L K
Sbjct: 75 LI----------------------GVCQAEA-LMLVMEMAGGGPLHKFLVGK-------R 104
Query: 595 QTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLLVKGSL-KLIDFGIAKAIMSDT 653
+ + + + Q+ + + E+ VH DL N LLV K+ DFG++KA+ +D
Sbjct: 105 EEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADD 164
Query: 654 TNIQRDSQVGT---LSYMSPEAFMCNESDENGNIIKCGR---PSDIWSLGCILYQMV-YG 706
+ ++ L + +PE I + SD+WS G +++ + YG
Sbjct: 165 SYYT--ARSAGKWPLKWYAPEC------------INFRKFSSRSDVWSYGVTMWEALSYG 210
Query: 707 RTPFSEYKTFWAKFKVITDPNHEITYE-------PVPN---PWLLDLMKKCLAWDRNERW 756
+ P+ + K E+ P P L LM C + +R
Sbjct: 211 QKPYKKMK------------GPEVMAFIEQGKRMECPPECPPELYALMSDCWIYKWEDRP 258
Query: 757 RIPQLLQH--PFLVPPVSTQPSSSQDQSY 783
+ Q S +
Sbjct: 259 DFLTVEQRMRACYYSLASKVEGHHHHHHH 287
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 54.5 bits (132), Expect = 6e-08
Identities = 75/309 (24%), Positives = 113/309 (36%), Gaps = 86/309 (27%)
Query: 479 KIGSGGSSEVHKVISSDCTIYALKKIKLKGRDYATAYG---FCQEIEYLNKLKGKNNIIQ 535
IG G +V+K + D ALK+ + G F EIE L+ + + ++
Sbjct: 46 LIGHGVFGKVYKGVLRDGAKVALKRRTPESSQ-----GIEEFETEIETLSFCRHPH-LVS 99
Query: 536 LIDY--EVTEKALLREVLNGSMNNKDGRVKDDGYIYMVLEYGEIDLAHMLSQKWKEMDGS 593
LI + E E L+ Y YM E G +L L D
Sbjct: 100 LIGFCDERNEMILI-------------------YKYM--ENG--NLKRHLYGS----DLP 132
Query: 594 NQTLDENWLRFYWQQILE-AVNT------IHEERIVHSDLKPANFLLVKG-SLKLIDFGI 645
++ W+Q LE + +H I+H D+K N LL + K+ DFGI
Sbjct: 133 TMSMS-------WEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGI 185
Query: 646 AKAIMSD-----TTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCIL 700
+K +T + GTL Y+ PE F+ E K SD++S G +L
Sbjct: 186 SKKGTELDQTHLSTVV-----KGTLGYIDPEYFIKGRLTE-----K----SDVYSFGVVL 231
Query: 701 YQMVYGRTPFSEYKTF-------WAK-------FKVITDPNHEITYEPVPNPWLLDLMKK 746
++++ R+ + WA + I DPN P D K
Sbjct: 232 FEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVK 291
Query: 747 CLAWDRNER 755
CLA +R
Sbjct: 292 CLALSSEDR 300
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 53.8 bits (130), Expect = 8e-08
Identities = 47/314 (14%), Positives = 94/314 (29%), Gaps = 105/314 (33%)
Query: 479 KIGSGGSSEVHK--------VISSDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGK 530
+G G +++ K T LK + R+Y+ + F + ++KL K
Sbjct: 15 SLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSES--FFEAASMMSKLSHK 72
Query: 531 NNIIQLIDYEVTEKALLREVLNGSMNNKDGRVKDDGYIYMVLEYGEI-DLAHMLSQKWKE 589
+ ++ G +V E+ + L L K+
Sbjct: 73 H-LVLNY----------------------GVCVCGDENILVQEFVKFGSLDTYL----KK 105
Query: 590 MDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLLVKGSL---------KL 640
++ W +Q+ A++ + E ++H ++ N LL++ KL
Sbjct: 106 NKNC---INILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKL 162
Query: 641 IDFGIAKAIMSDTTNIQRDSQVGTLSY-------MSPEAFMCNESDENGNI--IKCGRPS 691
D GI+ ++ + PE N + +
Sbjct: 163 SDPGISITVLPK-------------DILQERIPWVPPECIE------NPKNLNLA----T 199
Query: 692 DIWSLGCILYQMV-YGRTPFSEYKTFWAKFKVITDPNHEIT---------YEPVPNPWLL 741
D WS G L+++ G P S + P L
Sbjct: 200 DKWSFGTTLWEICSGGDKPLSALD------------SQRKLQFYEDRHQLPAPKAAE-LA 246
Query: 742 DLMKKCLAWDRNER 755
+L+ C+ ++ + R
Sbjct: 247 NLINNCMDYEPDHR 260
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 53.0 bits (128), Expect = 1e-07
Identities = 57/295 (19%), Positives = 109/295 (36%), Gaps = 76/295 (25%)
Query: 479 KIGSGGSSEVHK-VISSDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLI 537
K+G G EV++ V A+K +K D F +E + ++K N ++QL+
Sbjct: 20 KLGGGQYGEVYEGVWKKYSLTVAVKTLK---EDTMEVEEFLKEAAVMKEIKHPN-LVQLL 75
Query: 538 DYEVTEKALLREVLNGSMNNKDGRVKDDGYIYMVLEY---GEIDLAHMLSQKWKEMDGSN 594
G + Y++ E+ G +L L +E +
Sbjct: 76 ----------------------GVCTREPPFYIITEFMTYG--NLLDYL----RECNRQE 107
Query: 595 QTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLLV-KGSLKLIDFGIAKAIMSDT 653
+ L + QI A+ + ++ +H DL N L+ +K+ DFG+++ + DT
Sbjct: 108 VSAVV--LLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT 165
Query: 654 TNIQRDSQVGTLSY--MSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMV-YGRTPF 710
+PE+ N+ IK SD+W+ G +L+++ YG +P+
Sbjct: 166 ---YTAHAGAKFPIKWTAPESLAYNKFS-----IK----SDVWAFGVLLWEIATYGMSPY 213
Query: 711 SEYKTFWAKFKVITDPNHEITYE-------PVPN---PWLLDLMKKCLAWDRNER 755
++ P + +LM+ C W+ ++R
Sbjct: 214 PGI------------DLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDR 256
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 53.9 bits (130), Expect = 1e-07
Identities = 68/304 (22%), Positives = 104/304 (34%), Gaps = 84/304 (27%)
Query: 479 KIGSGGSSEVHKVISSDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLID 538
IG G +V + A+K IK + ATA F E + +L+ N ++QL+
Sbjct: 200 TIGKGEFGDVMLGDYRGNKV-AVKCIK----NDATAQAFLAEASVMTQLRHSN-LVQLL- 252
Query: 539 YEVTEKALLREVLNGSMNNKDGRV-KDDGYIYMVLEY---GEIDLAHMLSQKWKEMDGSN 594
G + ++ G +Y+V EY G L L + S
Sbjct: 253 ---------------------GVIVEEKGGLYIVTEYMAKG--SLVDYL----RSRGRSV 285
Query: 595 QTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLLV-KGSLKLIDFGIAKAIMSDT 653
D L + + EA+ + VH DL N L+ K+ DFG+ K
Sbjct: 286 LGGDC--LLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTK------ 337
Query: 654 TNIQRDSQVGTLSY--MSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMV-YGRTPF 710
G L +PEA + K SD+WS G +L+++ +GR P+
Sbjct: 338 -EASSTQDTGKLPVKWTAPEALREKKFS-----TK----SDVWSFGILLWEIYSFGRVPY 387
Query: 711 SEYKTFWAKFKVITDPNHEITYEPVPN-----------PWLLDLMKKCLAWDRNERWRIP 759
P + V P + D+MK C D R
Sbjct: 388 PRI------------PLKD-VVPRVEKGYKMDAPDGCPPAVYDVMKNCWHLDAATRPTFL 434
Query: 760 QLLQ 763
QL +
Sbjct: 435 QLRE 438
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 52.6 bits (127), Expect = 2e-07
Identities = 66/296 (22%), Positives = 108/296 (36%), Gaps = 80/296 (27%)
Query: 479 KIGSGGSSEVHKVISSDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLID 538
++G+G EV + T A+K +K + + F E + +L+ + +++L
Sbjct: 20 RLGAGQFGEVWMGYYNGHTKVAVKSLK---QGSMSPDAFLAEANLMKQLQHQR-LVRLY- 74
Query: 539 YEVTEKALLREVLNGSMNNKDGRVKDDGYIYMVLEY---GEIDLAHMLSQKWKEMDGSNQ 595
V + IY++ EY G L L K G
Sbjct: 75 ---------------------AVVTQEP-IYIITEYMENG--SLVDFL----KTPSGIKL 106
Query: 596 TLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLLV--KGSLKLIDFGIAKAIMSDT 653
T+++ L QI E + I E +H DL+ AN +LV S K+ DFG+A+ I +
Sbjct: 107 TINK--LLDMAAQIAEGMAFIEERNYIHRDLRAAN-ILVSDTLSCKIADFGLARLIEDNE 163
Query: 654 TNIQRDSQVGTLSY--MSPEAFMCNE-SDENGNIIKCGRPSDIWSLGCILYQMV-YGRTP 709
+ +PEA + IK SD+WS G +L ++V +GR P
Sbjct: 164 YTA---REGAKFPIKWTAPEAINYGTFT------IK----SDVWSFGILLTEIVTHGRIP 210
Query: 710 FSEYKTFWAKFKVITDPNHEITYE-------PVPN---PWLLDLMKKCLAWDRNER 755
+ N E+ P+ L LM+ C +R
Sbjct: 211 YPGM------------TNPEVIQNLERGYRMVRPDNCPEELYQLMRLCWKERPEDR 254
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 53.1 bits (128), Expect = 2e-07
Identities = 57/306 (18%), Positives = 103/306 (33%), Gaps = 75/306 (24%)
Query: 479 KIGSGGSSEVHK-----VISSDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNI 533
++G G V + + + A+KK L+ F +EIE L L+ N I
Sbjct: 48 QLGKGNFGSVEMCRYDPLQDNTGEVVAVKK--LQHSTEEHLRDFEREIEILKSLQHDN-I 104
Query: 534 IQLIDYEVTEKALLREVLNGSMNNKDGRVKDDGY--IYMVLEYGEI-DLAHMLSQKWKEM 590
++ G G + +++EY L L +
Sbjct: 105 VKYK----------------------GVCYSAGRRNLKLIMEYLPYGSLRDYLQKH---- 138
Query: 591 DGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLLVKGSL-KLIDFGIAKAI 649
+ +D L Y QI + + + +R +H DL N L+ + K+ DFG+ K +
Sbjct: 139 ---KERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVL 195
Query: 650 MSDTTNIQRDSQVGTLS---YMSPEAFMCNESDENGNIIKCGR---PSDIWSLGCILYQM 703
D + + S + +PE+ + + SD+WS G +LY++
Sbjct: 196 PQDKEYYK--VKEPGESPIFWYAPES------------LTESKFSVASDVWSFGVVLYEL 241
Query: 704 V-YGRTPFSEYKTFWAKFKVITDP---NHEITYE-------PVPN---PWLLDLMKKCLA 749
Y S F + P P+ + +M +C
Sbjct: 242 FTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWN 301
Query: 750 WDRNER 755
+ N+R
Sbjct: 302 NNVNQR 307
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 53.0 bits (128), Expect = 2e-07
Identities = 57/247 (23%), Positives = 107/247 (43%), Gaps = 63/247 (25%)
Query: 479 KIGSGGSSEVHKVISSDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLID 538
+G GG +V+K +D T+ A+K++K + F E+E ++ +N +++L
Sbjct: 37 ILGRGGFGKVYKGRLADGTLVAVKRLKEERTQ-GGELQFQTEVEMISMAVHRN-LLRLRG 94
Query: 539 Y--EVTEKALLRE-VLNGSMNNKDGRVKDDGYIYMVLEYGEIDLAHMLSQKWKEMDGSNQ 595
+ TE+ L+ + NGS +A L +E S
Sbjct: 95 FCMTPTERLLVYPYMANGS------------------------VASCL----RERPESQP 126
Query: 596 TLDENWLRFYWQQILE-AVNT------IHEE---RIVHSDLKPANFLLVKG-SLKLIDFG 644
LD W + A+ + +H+ +I+H D+K AN LL + + DFG
Sbjct: 127 PLD-------WPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFG 179
Query: 645 IAKAIMSDTTNIQRDSQV-GTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQM 703
+AK + T++ + V GT+ +++PE +S E K +D++ G +L ++
Sbjct: 180 LAKLMDYKDTHV--TTAVRGTIGHIAPEYLSTGKSSE-----K----TDVFGYGVMLLEL 228
Query: 704 VYGRTPF 710
+ G+ F
Sbjct: 229 ITGQRAF 235
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 52.7 bits (127), Expect = 2e-07
Identities = 57/307 (18%), Positives = 102/307 (33%), Gaps = 77/307 (25%)
Query: 479 KIGSGGSSEVHK-----VISSDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNI 533
+G G +V + A+K +K +EIE L L +N I
Sbjct: 28 DLGEGHFGKVELCRYDPEGDNTGEQVAVKSLK-PESGGNHIADLKKEIEILRNLYHEN-I 85
Query: 534 IQLIDYEVTEKALLREVLNGSMNNKDGRVKDDGY--IYMVLEYGEI-DLAHMLSQKWKEM 590
++ G +DG I +++E+ L L +
Sbjct: 86 VKYK----------------------GICTEDGGNGIKLIMEFLPSGSLKEYLPKN---- 119
Query: 591 DGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLLVKGSL-KLIDFGIAKAI 649
++ Y QI + ++ + + VH DL N L+ K+ DFG+ KAI
Sbjct: 120 ---KNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAI 176
Query: 650 MSDTTNIQRDSQVGTL--SYMSPEAFMCNESDENGNIIKCGR---PSDIWSLGCILYQMV 704
+D + +PE + + SD+WS G L++++
Sbjct: 177 ETDK-EYYTVKDDRDSPVFWYAPEC------------LMQSKFYIASDVWSFGVTLHELL 223
Query: 705 -YGRTPFSEYKTFWAKFKVITDPNHEITYEPVPN---------------PWLLDLMKKCL 748
Y + S F K+I + ++T + N + LM+KC
Sbjct: 224 TYCDSDSSPMALF---LKMIGPTHGQMTVTRLVNTLKEGKRLPCPPNCPDEVYQLMRKCW 280
Query: 749 AWDRNER 755
+ + R
Sbjct: 281 EFQPSNR 287
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 52.2 bits (126), Expect = 3e-07
Identities = 50/300 (16%), Positives = 104/300 (34%), Gaps = 81/300 (27%)
Query: 479 KIGSGGSSEVHK----VISSDCTIY-ALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNI 533
+GSG V+K I A+K+++ + E + + + +
Sbjct: 22 VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELR-EATSPKANKEILDEAYVMASVDNPH-V 79
Query: 534 IQLIDYEVTEKALLREVLNGSMNNKDGRVKDDGYIYMVLEYGEI-DLAHMLSQKWKEMDG 592
+L+ G + ++ + L + +
Sbjct: 80 CRLL----------------------GICLTST-VQLITQLMPFGCLLDYVREH------ 110
Query: 593 SNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLLV-KGSLKLIDFGIAKAIMS 651
+ +L + QI + +N + + R+VH DL N L+ +K+ DFG+AK + +
Sbjct: 111 -KDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 169
Query: 652 DTTNIQRDSQVGTL--SYMSPEAFMCNESDENGNIIKCGR---PSDIWSLGCILYQMV-Y 705
+ + ++ G + +M+ E+ I SD+WS G +++++ +
Sbjct: 170 E--EKEYHAEGGKVPIKWMALES------------ILHRIYTHQSDVWSYGVTVWELMTF 215
Query: 706 GRTPFSEYKTFWAKFKVITDPNHEITYE-------PVPN---PWLLDLMKKCLAWDRNER 755
G P+ P EI+ P P + +M+KC D + R
Sbjct: 216 GSKPYDGI------------PASEISSILEKGERLPQPPICTIDVYMIMRKCWMIDADSR 263
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 52.6 bits (126), Expect = 4e-07
Identities = 61/299 (20%), Positives = 109/299 (36%), Gaps = 80/299 (26%)
Query: 479 KIGSGGSSEVHK--VISSDCTIY-ALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQ 535
++G G V + I A+K +K +G + A +E + +++L I++
Sbjct: 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLK-QGTEKADTEEMMREAQIMHQLDNPY-IVR 400
Query: 536 LIDYEVTEKALLREVLNGSMNNKDGRVKDDGYIYMVLEYGEI-DLAHMLSQKWKEMDGSN 594
LI G + + + +V+E L L K +E+ SN
Sbjct: 401 LI----------------------GVCQAEA-LMLVMEMAGGGPLHKFLVGKREEIPVSN 437
Query: 595 QTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLLVKGSL-KLIDFGIAKAIMSDT 653
L Q+ + + E+ VH +L N LLV K+ DFG++KA+ +D
Sbjct: 438 VA---ELLH----QVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADD 490
Query: 654 TNIQRDSQVGT---LSYMSPEAFMCNESDENGNIIKCGR---PSDIWSLGCILYQMV-YG 706
+ ++ L + +PE I + SD+WS G +++ + YG
Sbjct: 491 SYYT--ARSAGKWPLKWYAPEC------------INFRKFSSRSDVWSYGVTMWEALSYG 536
Query: 707 RTPFSEYKTFWAKFKVITDPNHEITYE-------PVPN---PWLLDLMKKCLAWDRNER 755
+ P+ + K E+ P P L LM C + +R
Sbjct: 537 QKPYKKMK------------GPEVMAFIEQGKRMECPPECPPELYALMSDCWIYKWEDR 583
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 51.5 bits (124), Expect = 4e-07
Identities = 58/303 (19%), Positives = 102/303 (33%), Gaps = 84/303 (27%)
Query: 479 KIGSGGSSEVHK----VISSDCTIYALKKIKLKGRDYATAYG-FCQEIEYLNKLKGKNNI 533
K+G G V + S A+K +K A F +E+ ++ L +N +
Sbjct: 25 KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRN-L 83
Query: 534 IQLIDYEVTEKALLREVLNGSMNNKDGRVKDDGYIYMVLEY---GEIDLAHMLSQKWKEM 590
I+L G V + MV E G + L + +
Sbjct: 84 IRLY----------------------GVVLTPP-MKMVTELAPLGSL-LDRLRKHQ---- 115
Query: 591 DGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLLVKGSL-KLIDFGIAKAI 649
L Y Q+ E + + +R +H DL N LL L K+ DFG+ +A+
Sbjct: 116 ----GHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRAL 171
Query: 650 MSDTTNIQRDSQVGTLSY--MSPEAFMCNESDENGNIIKCGR---PSDIWSLGCILYQMV 704
+ + + + + +PE+ +K SD W G L++M
Sbjct: 172 PQND-DHYVMQEHRKVPFAWCAPES------------LKTRTFSHASDTWMFGVTLWEMF 218
Query: 705 -YGRTPFSEYKTFWAKFKVITDPNHEITYE--------PVPN---PWLLDLMKKCLAWDR 752
YG+ P+ +I ++ P P + ++M +C A
Sbjct: 219 TYGQEPWIGL------------NGSQILHKIDKEGERLPRPEDCPQDIYNVMVQCWAHKP 266
Query: 753 NER 755
+R
Sbjct: 267 EDR 269
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 51.6 bits (124), Expect = 5e-07
Identities = 63/307 (20%), Positives = 108/307 (35%), Gaps = 79/307 (25%)
Query: 479 KIGSGGSSEVHK-----VISSDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNI 533
+G G +V + A+K +K G+ QEI+ L L ++ I
Sbjct: 38 DLGEGHFGKVSLYCYDPTNDGTGEMVAVKALK-ADAGPQHRSGWKQEIDILRTLYHEH-I 95
Query: 534 IQLIDYEVTEKALLREVLNGSMNNKDGRVKDDGY--IYMVLEYGEI-DLAHMLSQKWKEM 590
I+ G +D G + +V+EY + L L +
Sbjct: 96 IKYK----------------------GCCEDAGAASLQLVMEYVPLGSLRDYLPR----- 128
Query: 591 DGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLLVKGSL-KLIDFGIAKAI 649
++ L + QQI E + +H + +H DL N LL L K+ DFG+AKA+
Sbjct: 129 ----HSIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAV 184
Query: 650 MSDTTNIQRDSQVGTL--SYMSPEAFMCNESDENGNIIKCGR---PSDIWSLGCILYQMV 704
R + G + +PE +K + SD+WS G LY+++
Sbjct: 185 PEGH-EYYRVREDGDSPVFWYAPEC------------LKEYKFYYASDVWSFGVTLYELL 231
Query: 705 -YGRTPFSEYKTFWAKFKVITDPNHEITYEPVPN---------------PWLLDLMKKCL 748
+ + S F ++I ++T + + LMK C
Sbjct: 232 THCDSSQSPPTKF---LELIGIAQGQMTVLRLTELLERGERLPRPDKCPAEVYHLMKNCW 288
Query: 749 AWDRNER 755
+ + R
Sbjct: 289 ETEASFR 295
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 50.8 bits (122), Expect = 9e-07
Identities = 62/303 (20%), Positives = 101/303 (33%), Gaps = 85/303 (28%)
Query: 479 KIGSGGSSEVHK-----VISSDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNI 533
IG+G EV+K A+K +K G F E + + N I
Sbjct: 51 VIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLK-AGYTEKQRVDFLGEAGIMGQFSHHN-I 108
Query: 534 IQLIDYEVTEKALLREVLNGSMNNKDGRVKDDGYIYMVLEY---GEIDLAHMLSQKWKEM 590
I+L G + + ++ EY G L L +K
Sbjct: 109 IRLE----------------------GVISKYKPMMIITEYMENG--ALDKFLREK---- 140
Query: 591 DGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLLVKGSL--KLIDFGIAKA 648
+ L + I + + VH DL N +LV +L K+ DFG+++
Sbjct: 141 ---DGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARN-ILVNSNLVCKVSDFGLSRV 196
Query: 649 IMSDTTNIQRDSQVGTLSY--MSPEAFMCNESDENGNIIKCGR---PSDIWSLGCILYQM 703
+ D + G + +PEA I + SD+WS G +++++
Sbjct: 197 LEDDPEAT-YTTSGGKIPIRWTAPEA------------ISYRKFTSASDVWSFGIVMWEV 243
Query: 704 V-YGRTPFSEYKTFWAKFKVITDPNHEITYE-------PVPN---PWLLDLMKKCLAWDR 752
+ YG P+ E NHE+ P P + LM +C +R
Sbjct: 244 MTYGERPYWELS------------NHEVMKAINDGFRLPTPMDCPSAIYQLMMQCWQQER 291
Query: 753 NER 755
R
Sbjct: 292 ARR 294
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 49.5 bits (119), Expect = 2e-06
Identities = 45/207 (21%), Positives = 78/207 (37%), Gaps = 54/207 (26%)
Query: 568 IYMVLEYGEI-DLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDL 626
++++E +L H L + S L L Y QI +A+ + VH D+
Sbjct: 87 TWIIMELYPYGELGHYL----ERNKNS---LKVLTLVLYSLQICKAMAYLESINCVHRDI 139
Query: 627 KPANFLLVKGSL-KLIDFGIAKAIMSDTTNIQRDSQVGTL---SYMSPEAFMCNESDENG 682
N L+ KL DFG+++ I + T +MSPE+
Sbjct: 140 AVRNILVASPECVKLGDFGLSRYIEDEDYY----KASVTRLPIKWMSPES---------- 185
Query: 683 NIIKCGR---PSDIWSLGCILYQMV-YGRTPFSEYKTFWAKFKVITDPNHEITYE----- 733
I R SD+W +++++ +G+ PF + N ++
Sbjct: 186 --INFRRFTTASDVWMFAVCMWEILSFGKQPFFWLE------------NKDVIGVLEKGD 231
Query: 734 --PVPN---PWLLDLMKKCLAWDRNER 755
P P+ P L LM +C +D ++R
Sbjct: 232 RLPKPDLCPPVLYTLMTRCWDYDPSDR 258
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 50.3 bits (120), Expect = 2e-06
Identities = 56/338 (16%), Positives = 109/338 (32%), Gaps = 80/338 (23%)
Query: 476 RLGK-IGSGGSSEVHK------VISSDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLK 528
+LGK +G G +V + ++ C A+K +K +G ++ E++ L +
Sbjct: 25 KLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLK-EGATHSEHRALMSELKILIHIG 83
Query: 529 GKNNIIQLI---------DYEVTEKA---LLREVLNGSMNNKDGRVKDDGYIYMVLEYGE 576
N++ L+ + E L L N +Y
Sbjct: 84 HHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVG 143
Query: 577 IDLAHM----LSQKWKEMDGSNQTLDENWLRFYWQ----------------------QIL 610
+ S + S+ ++E L + Q+
Sbjct: 144 AIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVA 203
Query: 611 EAVNTIHEERIVHSDLKPANFLLVKG-SLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMS 669
+ + + + +H DL N LL + +K+ DFG+A+ I D +++ L +M+
Sbjct: 204 KGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMA 263
Query: 670 PEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMV-YGRTPFSEYKTFWAKFKVITDPNH 728
PE SD+WS G +L+++ G +P Y +
Sbjct: 264 PETIFDRVYTIQ---------SDVWSFGVLLWEIFSLGASP---YPGV--------KIDE 303
Query: 729 EITYEPVPN-----------PWLLDLMKKCLAWDRNER 755
E + P + M C + ++R
Sbjct: 304 EF-CRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQR 340
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 50.0 bits (120), Expect = 2e-06
Identities = 52/276 (18%), Positives = 98/276 (35%), Gaps = 68/276 (24%)
Query: 517 FCQEIEYLNKLKGKNNIIQLIDYEVTEKALLREVLNGSMNNKDGRVKDDGYIYMVLEY-- 574
E++ ++ L NI+ L+ G G + ++ EY
Sbjct: 96 LMSELKIMSHLGQHENIVNLL----------------------GACTHGGPVLVITEYCC 133
Query: 575 -GEIDLAHML------SQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLK 627
G DL + L + +N T L + Q+ + + + + +H D+
Sbjct: 134 YG--DLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVA 191
Query: 628 PANFLLVKGSL-KLIDFGIAKAIMSDTTNIQRDSQVGTL--SYMSPEAFMCNESDENGNI 684
N LL G + K+ DFG+A+ IM+D + L +M+PE+
Sbjct: 192 ARNVLLTNGHVAKIGDFGLARDIMND--SNYIVKGNARLPVKWMAPESIFDCVYT----- 244
Query: 685 IKCGRPSDIWSLGCILYQMV-YGRTPFSEYKTFWAKFKVITD------PNHEITYEPVPN 737
++ SD+WS G +L+++ G P+ +K++ D P P
Sbjct: 245 VQ----SDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLVKDGYQMAQPAF------APK 294
Query: 738 PWLLDLMKKCLAWDRNER-------WRIPQLLQHPF 766
+ +M+ C A + R + + Q
Sbjct: 295 N-IYSIMQACWALEPTHRPTFQQICSFLQEQAQEDR 329
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 49.6 bits (119), Expect = 2e-06
Identities = 39/203 (19%), Positives = 72/203 (35%), Gaps = 45/203 (22%)
Query: 568 IYMVLEYGEI-DLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDL 626
+ +V +Y + L + Q L L + QI + + + E +VH +L
Sbjct: 89 LQLVTQYLPLGSLLDHVRQ-------HRGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNL 141
Query: 627 KPANFLLVKGSL-KLIDFGIAKAIMSDTTNIQRDSQVGTL--SYMSPEAFMCNESDENGN 683
N LL S ++ DFG+A + D + Q +M+ E+ +
Sbjct: 142 AARNVLLKSPSQVQVADFGVADLLPPD--DKQLLYSEAKTPIKWMALESIHFGKYT---- 195
Query: 684 IIKCGRPSDIWSLGCILYQMV-YGRTPFSEYKTFWAKFKVITDPNHEITYE-------PV 735
+ SD+WS G +++++ +G P++ E+
Sbjct: 196 -HQ----SDVWSYGVTVWELMTFGAEPYAGL------------RLAEVPDLLEKGERLAQ 238
Query: 736 PN---PWLLDLMKKCLAWDRNER 755
P + +M KC D N R
Sbjct: 239 PQICTIDVYMVMVKCWMIDENIR 261
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 49.2 bits (118), Expect = 3e-06
Identities = 48/206 (23%), Positives = 84/206 (40%), Gaps = 52/206 (25%)
Query: 568 IYMVLEY---GEIDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHS 624
+++++E G +L L + S LD L Y Q+ A+ + +R VH
Sbjct: 90 VWIIMELCTLG--ELRSFL----QVRKYS---LDLASLILYAYQLSTALAYLESKRFVHR 140
Query: 625 DLKPANFLLVKGSL-KLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGN 683
D+ N L+ KL DFG+++ + T ++ + +M+PE+
Sbjct: 141 DIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKL-PIKWMAPES----------- 188
Query: 684 IIKCGR---PSDIWSLGCILYQMV-YGRTPFSEYKTFWAKFKVITDPNHEITYE------ 733
I R SD+W G +++++ +G PF K N+++
Sbjct: 189 -INFRRFTSASDVWMFGVCMWEILMHGVKPFQGVK------------NNDVIGRIENGER 235
Query: 734 -PVPN---PWLLDLMKKCLAWDRNER 755
P+P P L LM KC A+D + R
Sbjct: 236 LPMPPNCPPTLYSLMTKCWAYDPSRR 261
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 48.4 bits (116), Expect = 4e-06
Identities = 65/311 (20%), Positives = 110/311 (35%), Gaps = 75/311 (24%)
Query: 476 RLGK-IGSGGSSEVHK------VISSDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLK 528
GK +G+G +V + + S A+K +K E++ L+ L
Sbjct: 26 SFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLK-PSAHLTEREALMSELKVLSYLG 84
Query: 529 GKNNIIQLIDYEVTEKALLREVLNGSMNNKDGRVKDDGYIYMVLEY---GEIDLAHMLSQ 585
NI+ L+ G G ++ EY G DL + L +
Sbjct: 85 NHMNIVNLL----------------------GACTIGGPTLVITEYCCYG--DLLNFLRR 120
Query: 586 KWKEMDGSNQTLDENW-----------LRFYWQQILEAVNTIHEERIVHSDLKPANFLLV 634
K S + L F +Q + + + + + +H DL N LL
Sbjct: 121 KRDSFICSKTSPAIMEDDELALDLEDLLSFSYQ-VAKGMAFLASKNCIHRDLAARNILLT 179
Query: 635 KGSL-KLIDFGIAKAIMSDTTNIQRDSQVGTLSY--MSPEAFMCNESDENGNIIKCGRPS 691
G + K+ DFG+A+ I +D + L M+PE+ + S
Sbjct: 180 HGRITKICDFGLARDIKND--SNYVVKGNARLPVKWMAPESIFNCVYT-----FE----S 228
Query: 692 DIWSLGCILYQMV-YGRTPFSEYKTFWAKFKVITD------PNHEITYEPVPNPWLLDLM 744
D+WS G L+++ G +P+ +K+I + P H P + D+M
Sbjct: 229 DVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGFRMLSPEH------APAE-MYDIM 281
Query: 745 KKCLAWDRNER 755
K C D +R
Sbjct: 282 KTCWDADPLKR 292
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 48.5 bits (116), Expect = 5e-06
Identities = 57/326 (17%), Positives = 109/326 (33%), Gaps = 65/326 (19%)
Query: 479 KIGSGGSSEVH----KVISSDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNII 534
+G G V K A+K +K + F +E + + + +
Sbjct: 30 MLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPH-VA 88
Query: 535 QLIDYEVTEKALLREVLNGSMNNKDGRVKDDGYIYMVLEY---GEIDLAHMLSQKWKEMD 591
+L+ G + ++L + G DL L +
Sbjct: 89 KLV---------------GVSL-RSRAKGRLPIPMVILPFMKHG--DLHAFLLASRIGEN 130
Query: 592 GSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLLVKG-SLKLIDFGIAKAIM 650
N L L + I + + +H DL N +L + ++ + DFG+++ I
Sbjct: 131 PFNLPLQT--LVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIY 188
Query: 651 SDTTNIQRDSQVGTL--SYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMV-YGR 707
S + R L +++ E+ N + SD+W+ G +++++ G+
Sbjct: 189 S--GDYYRQGCASKLPVKWLALESLADNLYTVH---------SDVWAFGVTMWEIMTRGQ 237
Query: 708 TPFSEYKTFWAKFKVITDPNHEITY--------EPVPN--PWLLDLMKKCLAWDRNERWR 757
TP++ N EI + P + DLM +C + D +R
Sbjct: 238 TPYAGI------------ENAEIYNYLIGGNRLKQPPECMEEVYDLMYQCWSADPKQRPS 285
Query: 758 IPQLLQHPFLVPPVSTQPSSSQDQSY 783
L + + S+SQD Y
Sbjct: 286 FTCLRMELENILGHLSVLSTSQDPLY 311
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 49.1 bits (117), Expect = 5e-06
Identities = 45/204 (22%), Positives = 84/204 (41%), Gaps = 48/204 (23%)
Query: 568 IYMVLEYGEI-DLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDL 626
+++++E + +L L + +LD L Y Q+ A+ + +R VH D+
Sbjct: 465 VWIIMELCTLGELRSFLQVR-------KFSLDLASLILYAYQLSTALAYLESKRFVHRDI 517
Query: 627 KPANFLLV-KGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNII 685
N L+ +KL DFG+++ + T ++ + +M+PE+ I
Sbjct: 518 AARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKL-PIKWMAPES------------I 564
Query: 686 KCGR---PSDIWSLGCILYQMV-YGRTPFSEYKTFWAKFKVITDPNHEITYE-------P 734
R SD+W G +++++ +G PF N+++ P
Sbjct: 565 NFRRFTSASDVWMFGVCMWEILMHGVKPFQGV------------KNNDVIGRIENGERLP 612
Query: 735 VPN---PWLLDLMKKCLAWDRNER 755
+P P L LM KC A+D + R
Sbjct: 613 MPPNCPPTLYSLMTKCWAYDPSRR 636
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 48.5 bits (116), Expect = 5e-06
Identities = 55/300 (18%), Positives = 96/300 (32%), Gaps = 89/300 (29%)
Query: 517 FCQEIEYLNKLKGKNNIIQLIDYEVTEKALLREVLNGSMNNKDGRVKDDGYIYMVLEY-- 574
F E ++K +N I++ I G ++++E
Sbjct: 80 FLMEALIISKFNHQN-IVRCI----------------------GVSLQSLPRFILMELMA 116
Query: 575 -GEIDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQI------LEAVNTIHEERIVHSDLK 627
G DL L ++ + +L L + I LE E +H D+
Sbjct: 117 GG--DLKSFL-RETRPRPSQPSSLAMLDLLHVARDIACGCQYLE------ENHFIHRDIA 167
Query: 628 PANFLLVKGS----LKLIDFGIAKAIMS-DTTNIQRDSQVGTLSYMSPEAFMCNESDENG 682
N LL K+ DFG+A+ I + + + +M PEAFM
Sbjct: 168 ARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLP-VKWMPPEAFMEG------ 220
Query: 683 NIIKCGRPSDIWSLGCILYQMV-YGRTPFSEYKTFWAKFKVITDPNHEITY--------E 733
+D WS G +L+++ G P+ N E+ +
Sbjct: 221 ---IFTSKTDTWSFGVLLWEIFSLGYMPYPSK------------SNQEVLEFVTSGGRMD 265
Query: 734 PVPN--PWLLDLMKKCLAWDRNER-------WRIPQLLQHPFLV---PPVSTQPSSSQDQ 781
P N + +M +C +R RI Q P ++ P+ P +++
Sbjct: 266 PPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPDVINTALPIEYGPLVEEEE 325
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 48.6 bits (116), Expect = 5e-06
Identities = 64/392 (16%), Positives = 119/392 (30%), Gaps = 89/392 (22%)
Query: 399 PNDPSTH-KSMEGRQHTGNS-----PELKSQAPLSKNSSSDMKLEASKSEKQEKAVSSKG 452
P DP H GR+ + P + K+ +
Sbjct: 3 PIDPMGHHHHHHGRRRASVAAGILVPRGSPGLDGICSIEELSTSLYKKAGSENLYFQGAN 62
Query: 453 ASAPRKRNYDPDLFFKVNGKLYQR------LGK-IGSGGSSEVH----KVISSDCTIYAL 501
+P+L V + + IG G V+ A+
Sbjct: 63 TVHIDLSALNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAV 122
Query: 502 KKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLREVLNGSMNNKDGR 561
K + + D F E + N ++ L+ G
Sbjct: 123 KSLN-RITDIGEVSQFLTEGIIMKDFSHPN-VLSLL----------------------GI 158
Query: 562 V-KDDGYIYMVLEY---GEIDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIH 617
+ +G +VL Y G DL + + + N T+ + L + Q+ + + +
Sbjct: 159 CLRSEGSPLVVLPYMKHG--DLRNFIRNE-----THNPTVKD--LIGFGLQVAKGMKFLA 209
Query: 618 EERIVHSDLKPANFLLVKGSL-KLIDFGIAKAIMSDTTNIQRDSQVGTL--SYMSPEAFM 674
++ VH DL N +L + K+ DFG+A+ + + + L +M+ E+
Sbjct: 210 SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQ 269
Query: 675 CNESDENGNIIKCGRPSDIWSLGCILYQMV-YGRTPFSEYKTFWAKFKVITDPNHEITYE 733
+ SD+WS G +L++++ G P+ + +IT
Sbjct: 270 TQKFTTK---------SDVWSFGVLLWELMTRGAPPYPDV------------NTFDITVY 308
Query: 734 -------PVPN---PWLLDLMKKCLAWDRNER 755
P L ++M KC R
Sbjct: 309 LLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMR 340
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 47.7 bits (114), Expect = 8e-06
Identities = 39/206 (18%), Positives = 78/206 (37%), Gaps = 51/206 (24%)
Query: 568 IYMVLEYGEI-DLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDL 626
+ ++ + L + + + +L + QI + +N + + R+VH DL
Sbjct: 91 VQLITQLMPFGCLLDYVREH-------KDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDL 143
Query: 627 KPANFLLVKGSL-KLIDFGIAKAIMSDTTNIQRDSQVGTL--SYMSPEAFMCNESDENGN 683
N L+ K+ DFG+AK + ++ + ++ G + +M+ E+
Sbjct: 144 AARNVLVKTPQHVKITDFGLAKLLGAE--EKEYHAEGGKVPIKWMALES----------- 190
Query: 684 IIKCGR---PSDIWSLGCILYQMV-YGRTPFSEYKTFWAKFKVITDPNHEITYE------ 733
I SD+WS G +++++ +G P+ P EI+
Sbjct: 191 -ILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI------------PASEISSILEKGER 237
Query: 734 -PVPN---PWLLDLMKKCLAWDRNER 755
P P + +M KC D + R
Sbjct: 238 LPQPPICTIDVYMIMVKCWMIDADSR 263
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 46.9 bits (112), Expect = 1e-05
Identities = 42/210 (20%), Positives = 81/210 (38%), Gaps = 47/210 (22%)
Query: 563 KDDGYIYMVLEY---GEIDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEE 619
+G +++L Y G DL + N T+ + L + Q+ + + E+
Sbjct: 93 PPEGLPHVLLPYMCHG--DLLQFIRS-----PQRNPTVKD--LISFGLQVARGMEYLAEQ 143
Query: 620 RIVHSDLKPANFLLVKG-SLKLIDFGIAKAIMSDTTNIQRDSQVGTL--SYMSPEAFMCN 676
+ VH DL N +L + ++K+ DFG+A+ I+ + + L + + E+
Sbjct: 144 KFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALESLQTY 203
Query: 677 ESDENGNIIKCGRPSDIWSLGCILYQMV-YGRTPFSEYKTFWAKFKVITDPNHEITYE-- 733
K SD+WS G +L++++ G P+ ++T+
Sbjct: 204 RFT-----TK----SDVWSFGVLLWELLTRGAPPYRHI------------DPFDLTHFLA 242
Query: 734 -----PVPN---PWLLDLMKKCLAWDRNER 755
P P L +M++C D R
Sbjct: 243 QGRRLPQPEYCPDSLYQVMQQCWEADPAVR 272
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 45.3 bits (108), Expect = 4e-05
Identities = 56/325 (17%), Positives = 107/325 (32%), Gaps = 83/325 (25%)
Query: 460 NYDPDLFFKVNGKLYQR------LGK-IGSGGSSEVH----KVISSDCTIYALKKIKLKG 508
+P+L V + + IG G V+ A+K + +
Sbjct: 6 ALNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLN-RI 64
Query: 509 RDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLREVLNGSMNNKDGRV-KDDGY 567
D F E + N ++ L+ G + +G
Sbjct: 65 TDIGEVSQFLTEGIIMKDFSHPN-VLSLL----------------------GICLRSEGS 101
Query: 568 IYMVLEY---GEIDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHS 624
+VL Y G DL + + + N T+ + L + Q+ + + + ++ VH
Sbjct: 102 PLVVLPYMKHG--DLRNFIRN-----ETHNPTVKD--LIGFGLQVAKGMKYLASKKFVHR 152
Query: 625 DLKPANFLLVKG-SLKLIDFGIAKAIMSDTTNIQRDSQVGTL--SYMSPEAFMCNESDEN 681
DL N +L + ++K+ DFG+A+ + + L +M+ E+ +
Sbjct: 153 DLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTK 212
Query: 682 GNIIKCGRPSDIWSLGCILYQMV-YGRTPFSEYKTFWAKFKVITDPNHEITYE------- 733
SD+WS G +L++++ G P+ + +IT
Sbjct: 213 ---------SDVWSFGVLLWELMTRGAPPYPDV------------NTFDITVYLLQGRRL 251
Query: 734 PVPN---PWLLDLMKKCLAWDRNER 755
P L ++M KC R
Sbjct: 252 LQPEYCPDPLYEVMLKCWHPKAEMR 276
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 45.8 bits (109), Expect = 4e-05
Identities = 56/300 (18%), Positives = 96/300 (32%), Gaps = 89/300 (29%)
Query: 517 FCQEIEYLNKLKGKNNIIQLIDYEVTEKALLREVLNGSMNNKDGRVKDDGYIYMVLEY-- 574
F E ++K +N I++ I G +++LE
Sbjct: 121 FLMEALIISKFNHQN-IVRCI----------------------GVSLQSLPRFILLELMA 157
Query: 575 -GEIDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQI------LEAVNTIHEERIVHSDLK 627
G DL L ++ + +L L + I LE E +H D+
Sbjct: 158 GG--DLKSFL-RETRPRPSQPSSLAMLDLLHVARDIACGCQYLE------ENHFIHRDIA 208
Query: 628 PANFLLVKGS----LKLIDFGIAKAIMS-DTTNIQRDSQVGTLSYMSPEAFMCNESDENG 682
N LL K+ DFG+A+ I + + + +M PEAFM
Sbjct: 209 ARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLP-VKWMPPEAFMEG------ 261
Query: 683 NIIKCGRPSDIWSLGCILYQMV-YGRTPFSEYKTFWAKFKVITDPNHEITY--------E 733
+D WS G +L+++ G P+ N E+ +
Sbjct: 262 ---IFTSKTDTWSFGVLLWEIFSLGYMPYPSK------------SNQEVLEFVTSGGRMD 306
Query: 734 PVPN--PWLLDLMKKCLAWDRNER-------WRIPQLLQHPFLV---PPVSTQPSSSQDQ 781
P N + +M +C +R RI Q P ++ P+ P +++
Sbjct: 307 PPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPDVINTALPIEYGPLVEEEE 366
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 44.6 bits (106), Expect = 8e-05
Identities = 53/338 (15%), Positives = 112/338 (33%), Gaps = 82/338 (24%)
Query: 479 KIGSGGSSEVHK------VISSDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNN 532
++G G V++ V T A+K + + F E + + ++
Sbjct: 32 ELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVN-EAASMRERIEFLNEASVMKEF-NCHH 89
Query: 533 IIQLIDYEVTEKALLREVLNGSMNNKDGRVKDDGYIYMVLEY---GEIDLAHML--SQKW 587
+++L+ G V +++E G DL L +
Sbjct: 90 VVRLL----------------------GVVSQGQPTLVIMELMTRG--DLKSYLRSLRPA 125
Query: 588 KEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLLVKG-SLKLIDFGIA 646
+ + + +I + + ++ + VH DL N ++ + ++K+ DFG+
Sbjct: 126 MANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMT 185
Query: 647 KAIMSDTTNIQRDSQVGTL--SYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMV 704
+ I T+ R G L +MSPE+ SD+WS G +L+++
Sbjct: 186 RDIYE--TDYYRKGGKGLLPVRWMSPESLKDGVFTTY---------SDVWSFGVVLWEIA 234
Query: 705 -YGRTPFSEYKTFWAKFKVITDPNHEITY--------EPVPN--PWLLDLMKKCLAWDRN 753
P+ N ++ + N L +LM+ C ++
Sbjct: 235 TLAEQPYQGL------------SNEQVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPK 282
Query: 754 ER-------WRIPQLLQHPF-LVPPVSTQPSSSQDQSY 783
R I + ++ F V ++ + +
Sbjct: 283 MRPSFLEIISSIKEEMEPGFREVSFYYSEENKLPEPEE 320
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 44.6 bits (106), Expect = 9e-05
Identities = 50/298 (16%), Positives = 94/298 (31%), Gaps = 66/298 (22%)
Query: 479 KIGSGGSSEVH----KVISSDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNII 534
+G G V K A+K +KL F E + N +I
Sbjct: 41 ILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPN-VI 99
Query: 535 QLIDYEVTEKALLREVLNGSMNNKDGRVKDDGYIYMVLEY---GEIDLAHMLSQKWKEMD 591
+L+ + + ++L + G DL L E
Sbjct: 100 RLLGV-CI----------------EMSSQGIPKPMVILPFMKYG--DLHTYLLYSRLETG 140
Query: 592 GSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLLVKG-SLKLIDFGIAKAIM 650
+ L L + I + + +H DL N +L ++ + DFG++K I
Sbjct: 141 PKHIPLQT--LLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIY 198
Query: 651 SDTTNIQRDSQVGTL--SYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMV-YGR 707
S + R ++ + +++ E+ SD+W+ G ++++ G
Sbjct: 199 S--GDYYRQGRIAKMPVKWIAIESLADRVYTSK---------SDVWAFGVTMWEIATRGM 247
Query: 708 TPFSEYKTFWAKFKVITDPNHEITY--------EPVPN--PWLLDLMKKCLAWDRNER 755
TP+ NHE+ + + L ++M C D +R
Sbjct: 248 TPYPGV------------QNHEMYDYLLHGHRLKQPEDCLDELYEIMYSCWRTDPLDR 293
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 43.4 bits (103), Expect = 2e-04
Identities = 64/326 (19%), Positives = 114/326 (34%), Gaps = 84/326 (25%)
Query: 479 KIGSGGSSEVHK------VISSDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNN 532
++G G +V + D + A+K LK A F +E E L L+ ++
Sbjct: 22 ELGEGAFGKVFLAECYNLSPTKDKMLVAVKA--LKDPTLAARKDFQREAELLTNLQHEH- 78
Query: 533 IIQLIDYEVTEKALLREVLNGSMNNKDGRVKDDGYIYMVLEY---GEIDL--------AH 581
I++ G D + MV EY G DL
Sbjct: 79 IVKFY----------------------GVCGDGDPLIMVFEYMKHG--DLNKFLRAHGPD 114
Query: 582 MLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLLVKG-SLKL 640
+ + + L + + QI + + + VH DL N L+ +K+
Sbjct: 115 AMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKI 174
Query: 641 IDFGIAKAIMS-DTTNIQRDSQVGTLSYMSPEAFMCNE-SDENGNIIKCGRPSDIWSLGC 698
DFG+++ + S D + + + + +M PE+ M + + E SD+WS G
Sbjct: 175 GDFGMSRDVYSTDYYRVGGHTML-PIRWMPPESIMYRKFTTE----------SDVWSFGV 223
Query: 699 ILYQMV-YGRTPFSEYKTFWAKFKVITDPNHEITYE-------PVPN---PWLLDLMKKC 747
IL+++ YG+ P+ + N E+ P + D+M C
Sbjct: 224 ILWEIFTYGKQPWFQL------------SNTEVIECITQGRVLERPRVCPKEVYDVMLGC 271
Query: 748 LAWDRNERWRIPQL---LQHPFLVPP 770
+ +R I ++ L P
Sbjct: 272 WQREPQQRLNIKEIYKILHALGKATP 297
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* Length = 258 | Back alignment and structure |
|---|
Score = 43.1 bits (101), Expect = 2e-04
Identities = 27/181 (14%), Positives = 51/181 (28%), Gaps = 17/181 (9%)
Query: 470 NGKLYQRLGKIGSGGSSEVHKVISSDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKG 529
G + G I +G + V +K+ F + EYL +
Sbjct: 45 KGYITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIY---RIETSEFDKMDEYLYGDER 101
Query: 530 KNNIIQLIDYEVTEKALLREVLN-GSMNNKDGRV-----KDDGYIYMVLEYGEIDLAHML 583
+ +V +E N V + M + A L
Sbjct: 102 FDMRRISPKEKVFIWTE-KEFRNLERAKEAGVSVPQPYTYMKNVLLMEFIGEDELPAPTL 160
Query: 584 SQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLLVKGSLKLIDF 643
+ +E+ + + + + E +VH+DL N ++ + ID
Sbjct: 161 VELGRELK------ELDVEGIFNDVVENVKRLYQEAELVHADLSEYN-IMYIDKVYFIDM 213
Query: 644 G 644
G
Sbjct: 214 G 214
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 43.4 bits (103), Expect = 2e-04
Identities = 73/357 (20%), Positives = 119/357 (33%), Gaps = 102/357 (28%)
Query: 479 KIGSGGSSEVHK---VISSDCTIYALKKIKLKGRDYATAYG---FCQEIEYLNKLKGKNN 532
IG G +V K A+K++K +YA+ F E+E L KL N
Sbjct: 32 VIGEGNFGQVLKARIKKDGLRMDAAIKRMK----EYASKDDHRDFAGELEVLCKLGHHPN 87
Query: 533 IIQLIDYEVTEKALLREVLNGSMNNKDGRVKDDGYIYMVLEY---GEIDLAHML------ 583
II L+ G + GY+Y+ +EY G +L L
Sbjct: 88 IINLL----------------------GACEHRGYLYLAIEYAPHG--NLLDFLRKSRVL 123
Query: 584 --SQKWKEMDGSNQTLDENWLRFYWQQI------LEAVNTIHEERIVHSDLKPANFLLVK 635
+ + + TL L + + L +H DL N L+ +
Sbjct: 124 ETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ------FIHRDLAARNILVGE 177
Query: 636 G-SLKLIDFGIAKAIMSDTTNIQRDSQVGTL--SYMSPEAFMCNESDENGNIIKCGRPSD 692
K+ DFG +S + +G L +M+ E+ + SD
Sbjct: 178 NYVAKIADFG-----LSRGQEVYVKKTMGRLPVRWMAIESLNYSVYT-----TN----SD 223
Query: 693 IWSLGCILYQMV-YGRTPFSEYKTFWAKFKVITDPNHEITYEPVPN-----------PWL 740
+WS G +L+++V G TP+ E+ YE +P +
Sbjct: 224 VWSYGVLLWEIVSLGGTPYCGM------------TCAEL-YEKLPQGYRLEKPLNCDDEV 270
Query: 741 LDLMKKCLAWDRNERWRIPQL---LQHPFLVPPVSTQPSSSQDQSYQLLQLLAEASA 794
DLM++C ER Q+ L + + +Y + AE +A
Sbjct: 271 YDLMRQCWREKPYERPSFAQILVSLNRMLEERKTYVNTTLYEKFTYAGIDCSAEEAA 327
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 42.7 bits (101), Expect = 3e-04
Identities = 66/313 (21%), Positives = 113/313 (36%), Gaps = 74/313 (23%)
Query: 476 RLGK-IGSGGSSEVHK------VISSDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLK 528
GK +GSG +V + A+K +K + D + E++ + +L
Sbjct: 48 EFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLK-EKADSSEREALMSELKMMTQLG 106
Query: 529 GKNNIIQLIDYEVTEKALLREVLNGSMNNKDGRVKDDGYIYMVLEY-------------- 574
NI+ L+ G G IY++ EY
Sbjct: 107 SHENIVNLL----------------------GACTLSGPIYLIFEYCCYGDLLNYLRSKR 144
Query: 575 --GEIDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANFL 632
D +QK E + L L + Q+ + + + + VH DL N L
Sbjct: 145 EKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVL 204
Query: 633 LVKGSL-KLIDFGIAKAIMSDTTNIQRDSQVGTL--SYMSPEAFMCNESDENGNIIKCGR 689
+ G + K+ DFG+A+ IMSD + L +M+PE+ IK
Sbjct: 205 VTHGKVVKICDFGLARDIMSD--SNYVVRGNARLPVKWMAPESLFEGIYT-----IK--- 254
Query: 690 PSDIWSLGCILYQMV-YGRTPFSEYKTFWAKFKVITD------PNHEITYEPVPNPWLLD 742
SD+WS G +L+++ G P+ +K+I + P + +
Sbjct: 255 -SDVWSYGILLWEIFSLGVNPYPGIPVDANFYKLIQNGFKMDQPFY------ATEE-IYI 306
Query: 743 LMKKCLAWDRNER 755
+M+ C A+D +R
Sbjct: 307 IMQSCWAFDSRKR 319
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 42.7 bits (101), Expect = 3e-04
Identities = 60/306 (19%), Positives = 107/306 (34%), Gaps = 78/306 (25%)
Query: 479 KIGSGGSSEVHK------VISSDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNN 532
++G G +V + D + A+K LK + F +E E L L+ ++
Sbjct: 48 ELGEGAFGKVFLAECHNLLPEQDKMLVAVKA--LKEASESARQDFQREAELLTMLQHQH- 104
Query: 533 IIQLIDYEVTEKALLREVLNGSMNNKDGRVKDDGYIYMVLEY---GEIDLAHMLSQKWKE 589
I++ G + + MV EY G DL L +
Sbjct: 105 IVRFF----------------------GVCTEGRPLLMVFEYMRHG--DLNRFLRSHGPD 140
Query: 590 MDGSNQTLDENWLRFYWQQILEAVNTI-------HEERIVHSDLKPANFLLVKG-SLKLI 641
D Q+L + + VH DL N L+ +G +K+
Sbjct: 141 AKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIG 200
Query: 642 DFGIAKAIMS-DTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCIL 700
DFG+++ I S D + + + + +M PE+ + + SD+WS G +L
Sbjct: 201 DFGMSRDIYSTDYYRVGGRTML-PIRWMPPESILYRKFTTE---------SDVWSFGVVL 250
Query: 701 YQMV-YGRTPFSEYKTFWAKFKVITDPNHE-ITY-------EPVPN--PWLLDLMKKCLA 749
+++ YG+ P+ + N E I E P + +M+ C
Sbjct: 251 WEIFTYGKQPWYQL------------SNTEAIDCITQGRELERPRACPPEVYAIMRGCWQ 298
Query: 750 WDRNER 755
+ +R
Sbjct: 299 REPQQR 304
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 42.7 bits (101), Expect = 3e-04
Identities = 50/297 (16%), Positives = 103/297 (34%), Gaps = 78/297 (26%)
Query: 517 FCQEIEYLNKLKGKNNIIQLIDYEVTEKALLREVLNGSMNNKDGRVKDDGYIYMVLEY-- 574
E+E + + NII L+ G DG +Y+++EY
Sbjct: 121 LISEMEMMKMIGKHKNIINLL----------------------GACTQDGPLYVIVEYAS 158
Query: 575 -GEIDLAHML--SQKWKEMDGSNQTLDENW-------LRFYWQQILEAVNTIHEERIVHS 624
G +L L + N + + + +Q + + + ++ +H
Sbjct: 159 KG--NLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQ-VARGMEYLASKKCIHR 215
Query: 625 DLKPANFLLVKG-SLKLIDFGIAKAIMSDTTNIQRDSQVGTL--SYMSPEAFMCNESDEN 681
DL N L+ + +K+ DFG+A+ I + + + G L +M+PEA
Sbjct: 216 DLAARNVLVTEDNVMKIADFGLARDIHHI--DYYKKTTNGRLPVKWMAPEALFDRIYT-- 271
Query: 682 GNIIKCGRPSDIWSLGCILYQMV-YGRTPFSEYKTFWAKFKVITDPNHEITYEPVPN--- 737
+ SD+WS G +L+++ G +P+ P E+ ++ +
Sbjct: 272 ---HQ----SDVWSFGVLLWEIFTLGGSPYPGV------------PVEEL-FKLLKEGHR 311
Query: 738 --------PWLLDLMKKCLAWDRNERWRIPQLLQH--PFLVPPVSTQPSSSQDQSYQ 784
L +M+ C ++R QL++ + + + +
Sbjct: 312 MDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTSNQEMGYYHHHHHH 368
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* Length = 282 | Back alignment and structure |
|---|
Score = 42.2 bits (99), Expect = 4e-04
Identities = 27/168 (16%), Positives = 49/168 (29%), Gaps = 25/168 (14%)
Query: 477 LGKIGSGGSSEVHKVISSDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQL 536
+G G S V S +K K+ F + E +
Sbjct: 95 GKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTS------FKKVKEKRDYGDLHF----- 143
Query: 537 IDYEVTEKALLREVLNGSMNNKDGRVKDDGYIYMVLEYGEIDLAHMLSQKWKEMDGSNQT 596
+ ++ E +++ + G + + + + +
Sbjct: 144 --SVLAIRSARNEFRALQ------KLQGLAVPKVYAWEG-----NAVLMELIDAKELYRV 190
Query: 597 LDENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLLVKGSLKLIDFG 644
EN ILE V + IVH DL N L+ + + +IDF
Sbjct: 191 RVENPDEVLDM-ILEEVAKFYHRGIVHGDLSQYNVLVSEEGIWIIDFP 237
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 42.3 bits (100), Expect = 5e-04
Identities = 49/271 (18%), Positives = 94/271 (34%), Gaps = 86/271 (31%)
Query: 517 FCQEIEYLNKLKGKNNIIQLIDYEVTEKALLREVLNGSMNNKDGRVKDDGYIYMVLEY-- 574
E+E + + NII L+ G DG +Y+++EY
Sbjct: 133 LVSEMEMMKMIGKHKNIINLL----------------------GACTQDGPLYVIVEYAS 170
Query: 575 -GEIDLAHML---SQKWKEMDGSNQTLDENWL------RFYWQ-----QILEAVNTIHEE 619
G +L L E + E + +Q + L +
Sbjct: 171 KG--NLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLA------SQ 222
Query: 620 RIVHSDLKPANFLLVKG-SLKLIDFGIAKAIMSDTTNIQRDSQVGTL--SYMSPEAFMCN 676
+ +H DL N L+ + +K+ DFG+A+ I + + + + G L +M+PEA
Sbjct: 223 KCIHRDLAARNVLVTENNVMKIADFGLARDINNI--DYYKKTTNGRLPVKWMAPEALFDR 280
Query: 677 ESDENGNIIKCGRPSDIWSLGCILYQMV-YGRTPFSEYKTFWAKFKVITDPNHEITYEPV 735
+ SD+WS G +++++ G +P+ P E+ ++ +
Sbjct: 281 VYT-----HQ----SDVWSFGVLMWEIFTLGGSPYPGI------------PVEEL-FKLL 318
Query: 736 PN-----------PWLLDLMKKCLAWDRNER 755
L +M+ C ++R
Sbjct: 319 KEGHRMDKPANCTNELYMMMRDCWHAVPSQR 349
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 41.5 bits (98), Expect = 7e-04
Identities = 54/259 (20%), Positives = 98/259 (37%), Gaps = 61/259 (23%)
Query: 476 RLGK-IGSGGSSEVHK------VISSDCTIYALKKIKLKGRDYATAYG---FCQEIEYLN 525
+LGK +G G +V + ++ C A+K +K + AT E++ L
Sbjct: 30 KLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLK----EGATHSEHRALMSELKILI 85
Query: 526 KLKGKNNIIQLIDYEVTEKALLREVLNGSMNNKDGRV-KDDGYIYMVLEYGEI-DLAHML 583
+ N++ L+ G K G + +++E+ + +L+ L
Sbjct: 86 HIGHHLNVVNLL----------------------GACTKPGGPLMVIVEFCKFGNLSTYL 123
Query: 584 --------SQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLLVK 635
K D L L Y Q+ + + + + +H DL N LL +
Sbjct: 124 RSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSE 183
Query: 636 G-SLKLIDFGIAKAIMSDTTNIQRDSQVGTL--SYMSPEAFMCNESDENGNIIKCGRPSD 692
+K+ DFG+A+ I D L +M+PE I+ SD
Sbjct: 184 KNVVKICDFGLARDIYKD--PDYVRKGDARLPLKWMAPETIFDRVYT-----IQ----SD 232
Query: 693 IWSLGCILYQMV-YGRTPF 710
+WS G +L+++ G +P+
Sbjct: 233 VWSFGVLLWEIFSLGASPY 251
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 41.4 bits (98), Expect = 7e-04
Identities = 59/326 (18%), Positives = 102/326 (31%), Gaps = 98/326 (30%)
Query: 479 KIGSGGSSEVHK------VISSDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNN 532
++G +V+K A+K +K K F E +L+ N
Sbjct: 16 ELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLRE-EFRHEAMLRARLQHPN- 73
Query: 533 IIQLIDYEVTEKALLREVLNGSMNNKDGRVKDDGYIYMVLEY---GEIDL--------AH 581
++ L+ G V D + M+ Y G DL H
Sbjct: 74 VVCLL----------------------GVVTKDQPLSMIFSYCSHG--DLHEFLVMRSPH 109
Query: 582 MLSQKWKEMDGSNQTLDENWLRFYWQQI------LEAVNTIHEERIVHSDLKPANFLLVK 635
+ L+ QI L + + +VH DL N L+
Sbjct: 110 SDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHH------VVHKDLATRNVLVYD 163
Query: 636 G-SLKLIDFGIAKAIMSDTTNIQRDSQVGTL--SYMSPEAFMCNESDENGNIIKCGR--- 689
++K+ D G+ + + + + + L +M+PEA I G+
Sbjct: 164 KLNVKISDLGLFREVYA--ADYYKLLGNSLLPIRWMAPEA------------IMYGKFSI 209
Query: 690 PSDIWSLGCILYQMV-YGRTPFSEYKTFWAKFKVITDPNHE-ITY-------EPVPN--P 738
SDIWS G +L+++ YG P+ Y N + + +
Sbjct: 210 DSDIWSYGVVLWEVFSYGLQPYCGY------------SNQDVVEMIRNRQVLPCPDDCPA 257
Query: 739 WLLDLMKKCLAWDRNERWRIPQLLQH 764
W+ LM +C + R R +
Sbjct: 258 WVYALMIECWNEFPSRRPRFKDIHSR 283
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 853 | |||
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.96 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.91 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.87 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.8 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.61 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.17 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.04 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 98.8 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.71 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.28 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.12 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.1 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.02 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 97.87 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 97.78 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 97.74 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 97.72 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.36 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.35 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.12 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.08 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.06 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 96.92 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 96.79 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.74 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 96.61 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 96.56 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 96.5 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 95.95 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 95.68 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 94.64 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 94.64 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 91.54 |
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-56 Score=487.21 Aligned_cols=255 Identities=29% Similarity=0.446 Sum_probs=217.7
Q ss_pred ceeeEEEeEeccCceEEEEEEe-cCCcEEEEEEEecCCC-ChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHHH
Q 003052 472 KLYQRLGKIGSGGSSEVHKVIS-SDCTIYALKKIKLKGR-DYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLRE 549 (853)
Q Consensus 472 ~~Y~ilk~LG~G~FG~Vyka~~-~~g~~vAVKkik~~~~-~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~~ 549 (853)
++|++++.||+|+||+||+|++ .+++.||||++.+... .......+.+|+++|++|+ |||||+++++
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~-HpnIv~l~~~---------- 100 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLD-HPFFVKLYFT---------- 100 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCC-CTTBCCEEEE----------
T ss_pred cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCC-CCCCCeEEEE----------
Confidence 4599999999999999999998 5789999999976432 2233456889999999997 9999999987
Q ss_pred HhhCCCCCCCCccccCCeEEEEEecch-hhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCCC
Q 003052 550 VLNGSMNNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKP 628 (853)
Q Consensus 550 l~~~~iv~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLKP 628 (853)
|++++++|||||||. |+|.+++.+. +.++|..++.|+.||+.||+|||++|||||||||
T Consensus 101 ------------~~~~~~~yivmEy~~gG~L~~~i~~~--------~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKP 160 (311)
T 4aw0_A 101 ------------FQDDEKLYFGLSYAKNGELLKYIRKI--------GSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKP 160 (311)
T ss_dssp ------------EECSSEEEEEECCCTTEEHHHHHHHH--------SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSG
T ss_pred ------------EEeCCEEEEEEecCCCCCHHHHHHHc--------CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCH
Confidence 677889999999986 5999999765 5799999999999999999999999999999999
Q ss_pred ccEEe-ecCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHhCC
Q 003052 629 ANFLL-VKGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGR 707 (853)
Q Consensus 629 eNILL-~~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLtG~ 707 (853)
+|||| .+|.+||+|||+|+.+..........+.|||+.|||||++.+.. |+.++|||||||+||+|++|+
T Consensus 161 eNILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~---------y~~~~DiWSlGvilyeml~G~ 231 (311)
T 4aw0_A 161 ENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKS---------ACKSSDLWALGCIIYQLVAGL 231 (311)
T ss_dssp GGEEECTTSCEEECCCTTCEECCTTTTCCCBCCCCSCGGGCCHHHHHHSC---------BCHHHHHHHHHHHHHHHHHSS
T ss_pred HHeEEcCCCCEEEEEcCCceecCCCCCcccccCcccCcccCCHHHHcCCC---------CCcHHHHHHHHHHHHHHHhCC
Confidence 99999 56899999999999875544444456789999999999998763 678999999999999999999
Q ss_pred CCCCcchhHHHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCCChhH------HhcCCCCCC
Q 003052 708 TPFSEYKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQ------LLQHPFLVP 769 (853)
Q Consensus 708 ~PF~~~~~~~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~E------IL~HPwf~~ 769 (853)
+||.+.+......++... .+.++...++++++||.+||++||.+|||+.| |++||||+.
T Consensus 232 ~PF~~~~~~~~~~~i~~~---~~~~p~~~s~~~~dli~~lL~~dp~~R~t~~e~~~~~~i~~Hp~F~~ 296 (311)
T 4aw0_A 232 PPFRAGNEGLIFAKIIKL---EYDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFES 296 (311)
T ss_dssp CSSCCSSHHHHHHHHHHT---CCCCCTTCCHHHHHHHHHHSCSSGGGSTTSGGGTCHHHHHTSGGGTT
T ss_pred CCCCCCCHHHHHHHHHcC---CCCCCcccCHHHHHHHHHHccCCHhHCcChHHHcCCHHHHCCCCcCC
Confidence 999876554444444332 24566778999999999999999999999988 589999975
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-56 Score=491.06 Aligned_cols=255 Identities=24% Similarity=0.407 Sum_probs=216.4
Q ss_pred ceeeEEEeEeccCceEEEEEEe-cCCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHHHH
Q 003052 472 KLYQRLGKIGSGGSSEVHKVIS-SDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLREV 550 (853)
Q Consensus 472 ~~Y~ilk~LG~G~FG~Vyka~~-~~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~~l 550 (853)
..|+++++||+|+||+||+|++ .+++.||||++...... ....+.+|+.+|++|+ |||||+++++
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~--~~~~~~~Ei~il~~l~-HpnIV~l~~~----------- 139 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQ--RRELLFNEVVIMRDYQ-HENVVEMYNS----------- 139 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCS--SGGGGHHHHHHHHHCC-CTTBCCEEEE-----------
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchh--HHHHHHHHHHHHHhCC-CCCCCcEEEE-----------
Confidence 4599999999999999999998 47899999999865433 3346889999999997 9999999987
Q ss_pred hhCCCCCCCCccccCCeEEEEEecchh-hHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCCCc
Q 003052 551 LNGSMNNKDGRVKDDGYIYMVLEYGEI-DLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPA 629 (853)
Q Consensus 551 ~~~~iv~~~g~~~d~~~lyLVmEy~~g-dL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLKPe 629 (853)
|.+++.+|||||||++ +|.+++.. ..++|..++.|+.||+.||+|||++|||||||||+
T Consensus 140 -----------~~~~~~~~ivmEy~~gg~L~~~l~~---------~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~ 199 (346)
T 4fih_A 140 -----------YLVGDELWVVMEFLEGGALTDIVTH---------TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSD 199 (346)
T ss_dssp -----------EEETTEEEEEECCCTTEEHHHHHHH---------SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGG
T ss_pred -----------EEECCEEEEEEeCCCCCcHHHHHHc---------CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHH
Confidence 5677889999999874 89888754 36999999999999999999999999999999999
Q ss_pred cEEe-ecCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHhCCC
Q 003052 630 NFLL-VKGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGRT 708 (853)
Q Consensus 630 NILL-~~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLtG~~ 708 (853)
|||| .+|.+||+|||+|+.+..... ...+.|||+.|||||++.+. .|+.++||||||||||||++|++
T Consensus 200 NILl~~~g~vKl~DFGla~~~~~~~~--~~~~~~GTp~YmAPEvl~~~---------~y~~~~DiWSlGvilyeml~G~~ 268 (346)
T 4fih_A 200 SILLTHDGRVKLSDFGFCAQVSKEVP--RRKSLVGTPYWMAPELISRL---------PYGPEVDIWSLGIMVIEMVDGEP 268 (346)
T ss_dssp GEEECTTCCEEECCCTTCEECCSSSC--CBCCCCSCGGGCCHHHHTTC---------CBCTHHHHHHHHHHHHHHHHSSC
T ss_pred HEEECCCCCEEEecCcCceecCCCCC--cccccccCcCcCCHHHHCCC---------CCCcHHHHHHHHHHHHHHHHCCC
Confidence 9999 568999999999987754322 34578999999999999765 36789999999999999999999
Q ss_pred CCCcchhHHHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCCChhHHhcCCCCCCCC
Q 003052 709 PFSEYKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQHPFLVPPV 771 (853)
Q Consensus 709 PF~~~~~~~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~HPwf~~~~ 771 (853)
||.+.........+.......+......++++++||.+||.+||.+|||+.|+|+||||+...
T Consensus 269 PF~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~Hp~~~~~~ 331 (346)
T 4fih_A 269 PYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAG 331 (346)
T ss_dssp TTTTSCHHHHHHHHHHSSCCCCSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGCC
T ss_pred CCCCcCHHHHHHHHHcCCCCCCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhcCCC
Confidence 998866655444444433334444556789999999999999999999999999999998643
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-56 Score=478.70 Aligned_cols=258 Identities=24% Similarity=0.393 Sum_probs=219.2
Q ss_pred CceeeEEEeEeccCceEEEEEEe-cCCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHHH
Q 003052 471 GKLYQRLGKIGSGGSSEVHKVIS-SDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLRE 549 (853)
Q Consensus 471 g~~Y~ilk~LG~G~FG~Vyka~~-~~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~~ 549 (853)
++.|++.++||+|+||+||+|.+ .++..||+|++............|.+|+++|++|+ |||||++++++...
T Consensus 25 gr~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~-HpnIV~~~~~~~~~------ 97 (290)
T 3fpq_A 25 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQ-HPNIVRFYDSWEST------ 97 (290)
T ss_dssp SSEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCC-CTTBCCEEEEEEEE------
T ss_pred CceEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCC-CCCCCcEEEEEeec------
Confidence 44568888999999999999998 46789999999877666666778999999999997 99999999975321
Q ss_pred HhhCCCCCCCCccccCCeEEEEEecch-hhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCc--eeeCCC
Q 003052 550 VLNGSMNNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEER--IVHSDL 626 (853)
Q Consensus 550 l~~~~iv~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~g--IIHRDL 626 (853)
...+.++||||||++ |+|.+++.+. ..+++..++.|+.||+.||.|||++| ||||||
T Consensus 98 ------------~~~~~~~~lvmEy~~gg~L~~~l~~~--------~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDl 157 (290)
T 3fpq_A 98 ------------VKGKKCIVLVTELMTSGTLKTYLKRF--------KVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDL 157 (290)
T ss_dssp ------------ETTEEEEEEEEECCCSCBHHHHHHHH--------SSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCC
T ss_pred ------------cCCCcEEEEEEeCCCCCCHHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHHCCCCEEeccc
Confidence 233567999999986 5999999765 57999999999999999999999998 999999
Q ss_pred CCccEEee--cCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHH
Q 003052 627 KPANFLLV--KGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMV 704 (853)
Q Consensus 627 KPeNILL~--~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELL 704 (853)
||+||||+ +|.+||+|||+|+..... ...+.+||+.|||||++.+ .|+.++|||||||+||||+
T Consensus 158 Kp~NILl~~~~g~vKl~DFGla~~~~~~----~~~~~~GTp~YmAPE~~~~----------~y~~~~DiwSlGvilyell 223 (290)
T 3fpq_A 158 KCDNIFITGPTGSVKIGDLGLATLKRAS----FAKAVIGTPEFMAPEMYEE----------KYDESVDVYAFGMCMLEMA 223 (290)
T ss_dssp CGGGEEESSTTSCEEECCTTGGGGCCTT----SBEESCSSCCCCCGGGGGT----------CCCTHHHHHHHHHHHHHHH
T ss_pred ChhheeEECCCCCEEEEeCcCCEeCCCC----ccCCcccCccccCHHHcCC----------CCCcHHHHHHHHHHHHHHH
Confidence 99999995 579999999999864322 2346899999999999854 3678999999999999999
Q ss_pred hCCCCCCcchhHHHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCCChhHHhcCCCCCC
Q 003052 705 YGRTPFSEYKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQHPFLVP 769 (853)
Q Consensus 705 tG~~PF~~~~~~~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~HPwf~~ 769 (853)
||++||.+.......+..+........++...++++++||.+||.+||.+|||+.|+|+||||+.
T Consensus 224 tg~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~Hp~~~~ 288 (290)
T 3fpq_A 224 TSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQE 288 (290)
T ss_dssp HSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC-
T ss_pred HCCCCCCCCCcHHHHHHHHHcCCCCCCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCccccC
Confidence 99999987666666666666555555566678889999999999999999999999999999974
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-56 Score=476.54 Aligned_cols=255 Identities=30% Similarity=0.440 Sum_probs=202.3
Q ss_pred ceeeEEEeEeccCceEEEEEEe-cCCcEEEEEEEecCCC-ChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHHH
Q 003052 472 KLYQRLGKIGSGGSSEVHKVIS-SDCTIYALKKIKLKGR-DYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLRE 549 (853)
Q Consensus 472 ~~Y~ilk~LG~G~FG~Vyka~~-~~g~~vAVKkik~~~~-~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~~ 549 (853)
++|++++.||+|+||+||+|.+ .+++.||||++.+... .......+.+|+++|++|+ |||||+++++
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~~~~~---------- 81 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLR-HPHIIKLYDV---------- 81 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCC-CTTBCCEEEE----------
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCC-CCCCCeEEEE----------
Confidence 3599999999999999999998 5789999999976543 2334456889999999997 9999999987
Q ss_pred HhhCCCCCCCCccccCCeEEEEEecchhhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCCCc
Q 003052 550 VLNGSMNNKDGRVKDDGYIYMVLEYGEIDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPA 629 (853)
Q Consensus 550 l~~~~iv~~~g~~~d~~~lyLVmEy~~gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLKPe 629 (853)
|.+++.+||||||++|+|.+++.++ +.+++..++.|+.||+.||+|||++||+||||||+
T Consensus 82 ------------~~~~~~~~ivmEy~~g~L~~~l~~~--------~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~ 141 (275)
T 3hyh_A 82 ------------IKSKDEIIMVIEYAGNELFDYIVQR--------DKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPE 141 (275)
T ss_dssp ------------EECSSEEEEEEECCCEEHHHHHHHS--------CSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTT
T ss_pred ------------EEECCEEEEEEeCCCCCHHHHHHHc--------CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCChH
Confidence 5677899999999999999998764 57999999999999999999999999999999999
Q ss_pred cEEe-ecCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHhCCC
Q 003052 630 NFLL-VKGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGRT 708 (853)
Q Consensus 630 NILL-~~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLtG~~ 708 (853)
|||| .+|.+||+|||+|+...... ...+.+||+.|||||++.+..+ ++.++|||||||++|+|++|++
T Consensus 142 NILl~~~~~vkl~DFGla~~~~~~~---~~~~~~GT~~Y~APE~~~~~~y--------~~~~~DiwSlGvily~lltg~~ 210 (275)
T 3hyh_A 142 NLLLDEHLNVKIADFGLSNIMTDGN---FLKTSCGSPNYAAPEVISGKLY--------AGPEVDVWSCGVILYVMLCRRL 210 (275)
T ss_dssp TEEECTTCCEEECCSSCC------------------CTTSCHHHHSSSSC--------CCTHHHHHHHHHHHHHHHHSSC
T ss_pred HeEECCCCCEEEeecCCCeecCCCC---ccCCeeECcccCChhhhcCCCC--------CCChhhhHHHHHHHHHHHHCCC
Confidence 9999 46799999999998764322 2346899999999999987642 4679999999999999999999
Q ss_pred CCCcchhHHHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCCChhHHhcCCCCCCCC
Q 003052 709 PFSEYKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQHPFLVPPV 771 (853)
Q Consensus 709 PF~~~~~~~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~HPwf~~~~ 771 (853)
||.+.... ..+..+... ...++...++++++||.+||++||.+|||+.|+|+||||+...
T Consensus 211 PF~~~~~~-~~~~~i~~~--~~~~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~hpw~k~~~ 270 (275)
T 3hyh_A 211 PFDDESIP-VLFKNISNG--VYTLPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQDDWFKVDL 270 (275)
T ss_dssp SSCCSSHH-HHHHHHHHT--CCCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHCHHHHTTC
T ss_pred CCCCCCHH-HHHHHHHcC--CCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHcCcccccCC
Confidence 99875443 333333322 2345667899999999999999999999999999999997544
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-56 Score=491.97 Aligned_cols=257 Identities=26% Similarity=0.417 Sum_probs=214.8
Q ss_pred ceeeEEEeEeccCceEEEEEEe-cCCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHHHH
Q 003052 472 KLYQRLGKIGSGGSSEVHKVIS-SDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLREV 550 (853)
Q Consensus 472 ~~Y~ilk~LG~G~FG~Vyka~~-~~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~~l 550 (853)
++|+++++||+|+||+||+|++ .+++.||||++.+..........+.+|+++|++|+ |||||+++++
T Consensus 24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~-HpnIV~~~~~----------- 91 (350)
T 4b9d_A 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMK-HPNIVQYRES----------- 91 (350)
T ss_dssp CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCC-CTTBCCEEEE-----------
T ss_pred cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCC-CCCCCcEEEE-----------
Confidence 5699999999999999999998 57899999999887766667778999999999997 9999999987
Q ss_pred hhCCCCCCCCccccCCeEEEEEecch-hhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCCCc
Q 003052 551 LNGSMNNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPA 629 (853)
Q Consensus 551 ~~~~iv~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLKPe 629 (853)
|++++.+|||||||+ |+|.++|... ....++|..++.|+.||+.||.|||++|||||||||+
T Consensus 92 -----------~~~~~~~yiVmEy~~gg~L~~~i~~~------~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~ 154 (350)
T 4b9d_A 92 -----------FEENGSLYIVMDYCEGGDLFKRINAQ------KGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQ 154 (350)
T ss_dssp -----------EEETTEEEEEEECCTTCBHHHHHHHT------TTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGG
T ss_pred -----------EEECCEEEEEEeCCCCCcHHHHHHHc------CCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHH
Confidence 567789999999987 5999999754 3356899999999999999999999999999999999
Q ss_pred cEEe-ecCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHhCCC
Q 003052 630 NFLL-VKGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGRT 708 (853)
Q Consensus 630 NILL-~~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLtG~~ 708 (853)
|||| .+|.+||+|||+|+.+.... ....+.+||+.|||||++.+.. |+.++||||||||||||++|++
T Consensus 155 NILl~~~g~vKl~DFGla~~~~~~~--~~~~~~~GT~~YmAPE~l~~~~---------y~~~~DiwSlGvilyemltG~~ 223 (350)
T 4b9d_A 155 NIFLTKDGTVQLGDFGIARVLNSTV--ELARACIGTPYYLSPEICENKP---------YNNKSDIWALGCVLYELCTLKH 223 (350)
T ss_dssp GEEECTTCCEEECSTTEESCCCHHH--HHHHHHHSCCTTCCHHHHTTCC---------CCHHHHHHHHHHHHHHHHHSSC
T ss_pred HEEECCCCCEEEcccccceeecCCc--ccccccCCCccccCHHHHCCCC---------CCcHHHHHHHHHHHHHHHHCCC
Confidence 9999 56899999999998764321 1234679999999999998753 6689999999999999999999
Q ss_pred CCCcchhHHHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCCChhHHhcCCCCCCC
Q 003052 709 PFSEYKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQHPFLVPP 770 (853)
Q Consensus 709 PF~~~~~~~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~HPwf~~~ 770 (853)
||.+........++..... ...+..+++++++||.+||++||.+|||+.|+|+||||+..
T Consensus 224 PF~~~~~~~~~~~i~~~~~--~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~~ 283 (350)
T 4b9d_A 224 AFEAGSMKNLVLKIISGSF--PPVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILEKGFIAKR 283 (350)
T ss_dssp SCCCSSHHHHHHHHHHTCC--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHHTT
T ss_pred CCCCcCHHHHHHHHHcCCC--CCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCHHhhcC
Confidence 9988666555555544322 23455678999999999999999999999999999999754
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-55 Score=494.31 Aligned_cols=254 Identities=24% Similarity=0.413 Sum_probs=217.9
Q ss_pred ceeeEEEeEeccCceEEEEEEe-cCCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHHHH
Q 003052 472 KLYQRLGKIGSGGSSEVHKVIS-SDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLREV 550 (853)
Q Consensus 472 ~~Y~ilk~LG~G~FG~Vyka~~-~~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~~l 550 (853)
+.|+++++||+|+||.||+|++ .+++.||||++...... ....+.+|+.+|++|+ |||||+++++
T Consensus 151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~--~~~~~~~Ei~il~~l~-HpnIV~l~~~----------- 216 (423)
T 4fie_A 151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQ--RRELLFNEVVIMRDYQ-HENVVEMYNS----------- 216 (423)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCS--SGGGHHHHHHHHHHCC-CTTBCCEEEE-----------
T ss_pred HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchh--HHHHHHHHHHHHHhCC-CCCCCceEEE-----------
Confidence 4599999999999999999998 57899999999865433 3456889999999997 9999999987
Q ss_pred hhCCCCCCCCccccCCeEEEEEecch-hhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCCCc
Q 003052 551 LNGSMNNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPA 629 (853)
Q Consensus 551 ~~~~iv~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLKPe 629 (853)
|.+++.+|||||||+ |+|.+++.. ..++|..++.|+.||+.||+|||++|||||||||+
T Consensus 217 -----------~~~~~~~~iVmEy~~gG~L~~~i~~---------~~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~ 276 (423)
T 4fie_A 217 -----------YLVGDELWVVMEFLEGGALTDIVTH---------TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSD 276 (423)
T ss_dssp -----------EEETTEEEEEEECCTTEEHHHHHHH---------SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTT
T ss_pred -----------EEECCEEEEEEeCCCCCcHHHHHhc---------cCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHH
Confidence 566788999999987 489888754 36999999999999999999999999999999999
Q ss_pred cEEe-ecCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHhCCC
Q 003052 630 NFLL-VKGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGRT 708 (853)
Q Consensus 630 NILL-~~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLtG~~ 708 (853)
|||| .+|.+||+|||+|+.+..... ...+.|||++|||||++.+. .|+.++||||||||+|||++|++
T Consensus 277 NILl~~~g~vKl~DFGla~~~~~~~~--~~~~~~GTp~YmAPEvl~~~---------~y~~~~DiWSlGvilyeml~G~~ 345 (423)
T 4fie_A 277 SILLTHDGRVKLSDFGFCAQVSKEVP--RRKSLVGTPYWMAPELISRL---------PYGPEVDIWSLGIMVIEMVDGEP 345 (423)
T ss_dssp TEEECTTCCEEECCCTTCEECCSSCC--CBCCCEECTTTCCHHHHTTC---------CBCTHHHHHHHHHHHHHHHHSSC
T ss_pred HEEEcCCCCEEEecCccceECCCCCc--cccccccCcCcCCHHHHCCC---------CCCcHHHHHHHHHHHHHHHHCCC
Confidence 9999 578999999999987754322 34578999999999999765 36789999999999999999999
Q ss_pred CCCcchhHHHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCCChhHHhcCCCCCCC
Q 003052 709 PFSEYKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQHPFLVPP 770 (853)
Q Consensus 709 PF~~~~~~~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~HPwf~~~ 770 (853)
||.+.........+.......+.....+++++++||.+||.+||.+|||+.|+|+||||+..
T Consensus 346 PF~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~Hp~~~~~ 407 (423)
T 4fie_A 346 PYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKA 407 (423)
T ss_dssp TTTTSCHHHHHHHHHHSCCCCCSCTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGC
T ss_pred CCCCcCHHHHHHHHHcCCCCCCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHHhcCC
Confidence 99887665555555444444455566789999999999999999999999999999999764
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-54 Score=484.54 Aligned_cols=267 Identities=26% Similarity=0.404 Sum_probs=218.5
Q ss_pred CceeeEEEeEeccCceEEEEEEe-cCCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHHH
Q 003052 471 GKLYQRLGKIGSGGSSEVHKVIS-SDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLRE 549 (853)
Q Consensus 471 g~~Y~ilk~LG~G~FG~Vyka~~-~~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~~ 549 (853)
+++|+++++||+|+||+||+|++ .+++.||||+++...........+++|+++|++|+ |||||++++++..
T Consensus 53 ~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~------- 124 (398)
T 4b99_A 53 GDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFK-HDNIIAIKDILRP------- 124 (398)
T ss_dssp CSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCC-CTTBCCEEEECCC-------
T ss_pred CCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcC-CCCcceEeeeeec-------
Confidence 35799999999999999999998 57899999999877666666778899999999997 9999999997532
Q ss_pred HhhCCCCCCCCccccCCeEEEEEecchhhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCCCc
Q 003052 550 VLNGSMNNKDGRVKDDGYIYMVLEYGEIDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPA 629 (853)
Q Consensus 550 l~~~~iv~~~g~~~d~~~lyLVmEy~~gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLKPe 629 (853)
...|.+.+.+||||||++|+|.+++... +.+++..++.|++||+.||.|||++|||||||||+
T Consensus 125 ---------~~~~~~~~~~~ivmE~~~g~L~~~i~~~--------~~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~ 187 (398)
T 4b99_A 125 ---------TVPYGEFKSVYVVLDLMESDLHQIIHSS--------QPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPS 187 (398)
T ss_dssp ---------SSCTTTCCCEEEEEECCSEEHHHHHTSS--------SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGG
T ss_pred ---------ccccccCCEEEEEEeCCCCCHHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCcc
Confidence 1235677889999999999999988643 67999999999999999999999999999999999
Q ss_pred cEEe-ecCcEEEEecccchhcccCC--ccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHhC
Q 003052 630 NFLL-VKGSLKLIDFGIAKAIMSDT--TNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYG 706 (853)
Q Consensus 630 NILL-~~g~VKL~DFGlAk~~~~~~--~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLtG 706 (853)
|||+ .+|.+||+|||+|+.+.... ......+.+||++|||||++.+.. +|+.++||||||||+|||++|
T Consensus 188 NIl~~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~--------~~~~~~DiWSlG~il~ell~G 259 (398)
T 4b99_A 188 NLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLH--------EYTQAIDLWSVGCIFGEMLAR 259 (398)
T ss_dssp GEEECTTCCEEECCCTTCBCC-------CCCCCSSCCCCTTCCHHHHTTCS--------CCCTHHHHHHHHHHHHHHHHT
T ss_pred ccccCCCCCEEEeecceeeecccCccccccccccceeChHhcCHHHhcCCC--------CCCChhheehhHHHHHHHHHC
Confidence 9999 56799999999998764321 122345789999999999987653 467899999999999999999
Q ss_pred CCCCCcchhHHHHHHh---hcCCCCcc-------------------------cCCCCCChhHHHHHHHhcccCCCCCCCh
Q 003052 707 RTPFSEYKTFWAKFKV---ITDPNHEI-------------------------TYEPVPNPWLLDLMKKCLAWDRNERWRI 758 (853)
Q Consensus 707 ~~PF~~~~~~~~~~ki---i~~~~~~~-------------------------~~~~~~s~~l~dLI~kcL~~DP~kRpTa 758 (853)
++||.+.+.......+ ...+.... ...+..++++++||.+||.+||.+|||+
T Consensus 260 ~~pF~g~~~~~~l~~I~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta 339 (398)
T 4b99_A 260 RQLFPGKNYVHQLQLIMMVLGTPSPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISA 339 (398)
T ss_dssp SCSSCCSSHHHHHHHHHHHHCCCCGGGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCH
T ss_pred CCCCCCCCHHHHHHHHHHhcCCCChHHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCH
Confidence 9999875544333222 22211110 0113467889999999999999999999
Q ss_pred hHHhcCCCCCCC
Q 003052 759 PQLLQHPFLVPP 770 (853)
Q Consensus 759 ~EIL~HPwf~~~ 770 (853)
.|+|+||||+..
T Consensus 340 ~e~L~Hp~f~~~ 351 (398)
T 4b99_A 340 AAALRHPFLAKY 351 (398)
T ss_dssp HHHTTSGGGTTT
T ss_pred HHHhcCHhhCcC
Confidence 999999999864
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-55 Score=473.48 Aligned_cols=253 Identities=24% Similarity=0.404 Sum_probs=207.2
Q ss_pred ceeeEEEeEeccCceEEEEEEec----CCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHH
Q 003052 472 KLYQRLGKIGSGGSSEVHKVISS----DCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALL 547 (853)
Q Consensus 472 ~~Y~ilk~LG~G~FG~Vyka~~~----~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL 547 (853)
.+|++++.||+|+||+||+|++. +++.||||++++..........+.+|+++|++|+ |||||+++++
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~-HpnIv~l~~~-------- 94 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVN-HPFIVKLHYA-------- 94 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCC-CTTEECEEEE--------
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCC-CCCCCeEEEE--------
Confidence 46999999999999999999873 4678999999765443333446889999999997 9999999987
Q ss_pred HHHhhCCCCCCCCccccCCeEEEEEecch-hhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCC
Q 003052 548 REVLNGSMNNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDL 626 (853)
Q Consensus 548 ~~l~~~~iv~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDL 626 (853)
|++++.+||||||+. |+|.+++.+. +.+++..++.|+.||+.||+|||++|||||||
T Consensus 95 --------------~~~~~~~~ivmEy~~gg~L~~~l~~~--------~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDl 152 (304)
T 3ubd_A 95 --------------FQTEGKLYLILDFLRGGDLFTRLSKE--------VMFTEEDVKFYLAELALALDHLHSLGIIYRDL 152 (304)
T ss_dssp --------------EEETTEEEEEECCCTTCEEHHHHHHH--------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSC
T ss_pred --------------EEECCEEEEEEEcCCCCCHHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCC
Confidence 567789999999987 5999999765 57999999999999999999999999999999
Q ss_pred CCccEEe-ecCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHh
Q 003052 627 KPANFLL-VKGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVY 705 (853)
Q Consensus 627 KPeNILL-~~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLt 705 (853)
||+|||+ .+|.+||+|||+|+....... ...+.+||+.|||||++.+.. |+.++|||||||+||||++
T Consensus 153 Kp~NILl~~~g~vKl~DFGla~~~~~~~~--~~~~~~GT~~YmAPE~~~~~~---------y~~~~DiwSlGvilyemlt 221 (304)
T 3ubd_A 153 KPENILLDEEGHIKLTDFGLSKESIDHEK--KAYSFCGTVEYMAPEVVNRRG---------HTQSADWWSFGVLMFEMLT 221 (304)
T ss_dssp CGGGEEECTTSCEEEESSEEEEC-----C--CCCSCCCCGGGCCHHHHHTSC---------CCTHHHHHHHHHHHHHHHH
T ss_pred CHHHeEEcCCCCEEecccccceeccCCCc--cccccccCcccCCHHHhccCC---------CCCCCcccchHHHHHHHHh
Confidence 9999999 568999999999986543322 234789999999999998764 5689999999999999999
Q ss_pred CCCCCCcchhHHHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCCC-----hhHHhcCCCCCC
Q 003052 706 GRTPFSEYKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWR-----IPQLLQHPFLVP 769 (853)
Q Consensus 706 G~~PF~~~~~~~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpT-----a~EIL~HPwf~~ 769 (853)
|++||.+.+.......+... ...++...++++++||.+||++||.+||| ++|+++||||+.
T Consensus 222 G~~PF~~~~~~~~~~~i~~~---~~~~p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~Hp~f~~ 287 (304)
T 3ubd_A 222 GTLPFQGKDRKETMTMILKA---KLGMPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRHSFFST 287 (304)
T ss_dssp SSCSSCCSSHHHHHHHHHHC---CCCCCTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHTSGGGTT
T ss_pred CCCCCCCcCHHHHHHHHHcC---CCCCCCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHcCccccC
Confidence 99999876655444444432 23456778999999999999999999998 479999999975
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-53 Score=470.88 Aligned_cols=253 Identities=26% Similarity=0.393 Sum_probs=209.2
Q ss_pred ceeeEEEeEeccCceEEEEEEe-cCCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHHHH
Q 003052 472 KLYQRLGKIGSGGSSEVHKVIS-SDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLREV 550 (853)
Q Consensus 472 ~~Y~ilk~LG~G~FG~Vyka~~-~~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~~l 550 (853)
..|++.++||+|+||+||+|++ .+++.||||+++.... ..+|+.+|++|+ |||||+++++
T Consensus 58 ~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-------~~~E~~il~~l~-HpnIV~l~~~----------- 118 (336)
T 4g3f_A 58 HWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-------RVEELVACAGLS-SPRIVPLYGA----------- 118 (336)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-------CTHHHHTTTTCC-CTTBCCEEEE-----------
T ss_pred hheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-------HHHHHHHHHhCC-CCCCCcEEEE-----------
Confidence 5699999999999999999998 5789999999986432 247999999997 9999999987
Q ss_pred hhCCCCCCCCccccCCeEEEEEecch-hhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCCCc
Q 003052 551 LNGSMNNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPA 629 (853)
Q Consensus 551 ~~~~iv~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLKPe 629 (853)
|.+++++||||||++ ++|.++|.+. +.|++..++.|+.||+.||.|||++|||||||||+
T Consensus 119 -----------~~~~~~~~ivmEy~~gg~L~~~l~~~--------~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~ 179 (336)
T 4g3f_A 119 -----------VREGPWVNIFMELLEGGSLGQLIKQM--------GCLPEDRALYYLGQALEGLEYLHTRRILHGDVKAD 179 (336)
T ss_dssp -----------EEETTEEEEEECCCTTCBHHHHHHHH--------SSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGG
T ss_pred -----------EEECCEEEEEEeccCCCcHHHHHHHc--------CCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHH
Confidence 567789999999987 5999999765 57999999999999999999999999999999999
Q ss_pred cEEee-cC-cEEEEecccchhcccCCcc---ccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHH
Q 003052 630 NFLLV-KG-SLKLIDFGIAKAIMSDTTN---IQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMV 704 (853)
Q Consensus 630 NILL~-~g-~VKL~DFGlAk~~~~~~~~---~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELL 704 (853)
||||+ +| .+||+|||+|+.+...... ......+||+.|||||++.+.. |+.++|||||||+||||+
T Consensus 180 NILl~~~g~~vKl~DFGla~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~---------y~~~~DiwSlGvilyeml 250 (336)
T 4g3f_A 180 NVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKP---------CDAKVDIWSSCCMMLHML 250 (336)
T ss_dssp GEEECTTSCCEEECCCTTCEEC------------CCCCCCGGGCCHHHHTTCC---------CCTHHHHHHHHHHHHHHH
T ss_pred HEEEeCCCCEEEEeeCCCCeEccCCCcccceecCCccccCccccCHHHHCCCC---------CCcHHHHHHHHHHHHHHH
Confidence 99995 55 6999999999876543211 1224578999999999998764 568999999999999999
Q ss_pred hCCCCCCcchhHHHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCCChhHH-------------hcCCCCCCCC
Q 003052 705 YGRTPFSEYKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQL-------------LQHPFLVPPV 771 (853)
Q Consensus 705 tG~~PF~~~~~~~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EI-------------L~HPwf~~~~ 771 (853)
+|++||.+........++.........+++.+++.+++||.+||.+||.+|||+.|| |+|||+....
T Consensus 251 tG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~~l~hPw~~~~~ 330 (336)
T 4g3f_A 251 NGCHPWTQYFRGPLCLKIASEPPPIREIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVGGLKSPWKGEYK 330 (336)
T ss_dssp HSSCSSTTTCCSCCHHHHHHSCCGGGGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTTSSCSCSSSSCC
T ss_pred HCcCCCCCCCHHHHHHHHHcCCCCchhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhhhccCCCcCCCC
Confidence 999999765443333344444333345667889999999999999999999999997 6899997653
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-51 Score=455.95 Aligned_cols=253 Identities=24% Similarity=0.359 Sum_probs=198.9
Q ss_pred ceeeEEEeEeccCceEEEEEEec----CCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHH
Q 003052 472 KLYQRLGKIGSGGSSEVHKVISS----DCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALL 547 (853)
Q Consensus 472 ~~Y~ilk~LG~G~FG~Vyka~~~----~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL 547 (853)
++|+++++||+|+||+||+|+++ +++.||||++..... ...+.+|+++|+.+.+||||++++++
T Consensus 21 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~----~~~~~~E~~~l~~~~~h~nIv~l~~~-------- 88 (361)
T 4f9c_A 21 NVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSH----PIRIAAELQCLTVAGGQDNVMGVKYC-------- 88 (361)
T ss_dssp GTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTSC----HHHHHHHHHHHHHTCSBTTBCCCSEE--------
T ss_pred CcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccccC----HHHHHHHHHHHHHhcCCCCCceEEEE--------
Confidence 56999999999999999999873 457899999975432 23577999999999889999999876
Q ss_pred HHHhhCCCCCCCCccccCCeEEEEEecch-hhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCC
Q 003052 548 REVLNGSMNNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDL 626 (853)
Q Consensus 548 ~~l~~~~iv~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDL 626 (853)
|++.+++||||||++ ++|.+++. .+++.+++.|++||+.||+|||++|||||||
T Consensus 89 --------------~~~~~~~~lvmE~~~g~~L~~~~~-----------~l~~~~~~~~~~qll~al~ylH~~gIiHRDi 143 (361)
T 4f9c_A 89 --------------FRKNDHVVIAMPYLEHESFLDILN-----------SLSFQEVREYMLNLFKALKRIHQFGIVHRDV 143 (361)
T ss_dssp --------------EEETTEEEEEEECCCCCCHHHHHT-----------TCCHHHHHHHHHHHHHHHHHHHHTTEECSCC
T ss_pred --------------EEECCEEEEEEeCCCcccHHHHHc-----------CCCHHHHHHHHHHHHHHHHHHHHCCeEeCcC
Confidence 567789999999986 58888772 4899999999999999999999999999999
Q ss_pred CCccEEeec--CcEEEEecccchhcccCCc--------------------------cccccccccCccccCchhhccCCC
Q 003052 627 KPANFLLVK--GSLKLIDFGIAKAIMSDTT--------------------------NIQRDSQVGTLSYMSPEAFMCNES 678 (853)
Q Consensus 627 KPeNILL~~--g~VKL~DFGlAk~~~~~~~--------------------------~~~~~t~~GTp~YmAPEvl~~~~~ 678 (853)
||+||||+. +.+||+|||+|+....... .....+.+||++|||||++.+..
T Consensus 144 KPeNiLl~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~- 222 (361)
T 4f9c_A 144 KPSNFLYNRRLKKYALVDFGLAQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCP- 222 (361)
T ss_dssp SGGGEEEETTTTEEEECCCTTCEECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCS-
T ss_pred CHHHeEEeCCCCeEEECcCCCCcccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCC-
Confidence 999999953 6999999999976432211 01124568999999999997643
Q ss_pred CCCCccccCCCccchhhhHHHHHHHHhCCCCCCcchh-HHH---HHHhhc------------------------------
Q 003052 679 DENGNIIKCGRPSDIWSLGCILYQMVYGRTPFSEYKT-FWA---KFKVIT------------------------------ 724 (853)
Q Consensus 679 ~~~~~~~~ys~ksDIWSLGVILyELLtG~~PF~~~~~-~~~---~~kii~------------------------------ 724 (853)
.|+.++||||+|||+|||++|++||..... ... +.....
T Consensus 223 -------~y~~~~DiWSlG~il~ell~G~~Pf~~~~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~ 295 (361)
T 4f9c_A 223 -------NQTTAIDMWSAGVIFLSLLSGRYPFYKASDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLC 295 (361)
T ss_dssp -------CCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHH
T ss_pred -------CCCCccchhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHH
Confidence 367899999999999999999999953221 111 111100
Q ss_pred ----CC--------------CCcccCCCCCChhHHHHHHHhcccCCCCCCChhHHhcCCCCCC
Q 003052 725 ----DP--------------NHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQHPFLVP 769 (853)
Q Consensus 725 ----~~--------------~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~HPwf~~ 769 (853)
.. ..........+++++|||.+||++||.+|+|++|+|+||||+.
T Consensus 296 ~~~~~~~~~~p~~~~~~~~~~~~~~~~~~is~~a~DLl~~lL~~dP~~R~ta~eaL~Hp~f~~ 358 (361)
T 4f9c_A 296 ERLRGMDSSTPKLTSDIQGHATNLEGWNEVPDEAYDLLDKLLDLNPASRITAEEALLHPFFKD 358 (361)
T ss_dssp HHHC----------------------CTTCCHHHHHHHHHHTCSCTTTSCCHHHHHTSGGGTT
T ss_pred HhhccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCcccCC
Confidence 00 0001122456788999999999999999999999999999975
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-51 Score=447.40 Aligned_cols=258 Identities=21% Similarity=0.293 Sum_probs=206.2
Q ss_pred eeEEcCceeeEEEeEeccCceEEEEEEecCCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHH
Q 003052 466 FFKVNGKLYQRLGKIGSGGSSEVHKVISSDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKA 545 (853)
Q Consensus 466 ~~~v~g~~Y~ilk~LG~G~FG~Vyka~~~~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~ 545 (853)
.|++.-+.|++.++||+|+||+||+|++.+ .||||+++...........|.+|+.+|++|+ |||||++++++
T Consensus 30 ~Wei~~~~l~l~~~iG~G~fG~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~-HpNIV~l~g~~----- 101 (307)
T 3omv_A 30 YWEIEASEVMLSTRIGSGSFGTVYKGKWHG--DVAVKILKVVDPTPEQFQAFRNEVAVLRKTR-HVNILLFMGYM----- 101 (307)
T ss_dssp CCBCCTTSCCEEEECCCCSSSEEEEEESSS--EEEEEECCCSSCCHHHHHHHHHHHHHHTTCC-CTTBCCEEEEE-----
T ss_pred CcEEcHHHeEEeeEEeeCCCcEEEEEEECC--cEEEEEEEecCCCHHHHHHHHHHHHHHHhCC-CCCEeeEEEEE-----
Confidence 456677789999999999999999998754 5899999877666677788999999999997 99999999873
Q ss_pred HHHHHhhCCCCCCCCccccCCeEEEEEecch-hhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeC
Q 003052 546 LLREVLNGSMNNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHS 624 (853)
Q Consensus 546 iL~~l~~~~iv~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHR 624 (853)
.++.+||||||++ |+|.++|... ...+++..+..|+.||+.||.|||++|||||
T Consensus 102 ------------------~~~~~~iVmEy~~gGsL~~~l~~~-------~~~l~~~~~~~i~~qia~gL~yLH~~~IiHR 156 (307)
T 3omv_A 102 ------------------TKDNLAIVTQWCEGSSLYKHLHVQ-------ETKFQMFQLIDIARQTAQGMDYLHAKNIIHR 156 (307)
T ss_dssp ------------------CSSSCEEEEECCSSCBHHHHHHTS-------CCCCCHHHHHHHHHHHHHHHHHHHHTTCBCS
T ss_pred ------------------ECCeEEEEEEcCCCCCHHHHHhhc-------CCCCCHHHHHHHHHHHHHHHHHHHHCCccCC
Confidence 1235799999987 5999988642 3579999999999999999999999999999
Q ss_pred CCCCccEEee-cCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHH
Q 003052 625 DLKPANFLLV-KGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQM 703 (853)
Q Consensus 625 DLKPeNILL~-~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyEL 703 (853)
||||+||||+ ++.+||+|||+|+............+.+||+.|||||++.+.... .|+.++|||||||+||||
T Consensus 157 DlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~------~y~~ksDVwS~Gvvl~El 230 (307)
T 3omv_A 157 DMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNN------PFSFQSDVYSYGIVLYEL 230 (307)
T ss_dssp CCCSSSEEEETTEEEEECCCSSCBC------------CCCCTTSCCHHHHHCCSSC------CCCHHHHHHHHHHHHHHH
T ss_pred ccCHHHEEECCCCcEEEeeccCceecccCCcceeecccccCCCccCHHHhhccCCC------CCCcHHHhHhHHHHHHHH
Confidence 9999999995 569999999999876543333344567999999999999765322 478899999999999999
Q ss_pred HhCCCCCCcchhHHHHHHhhcCCCCc---ccCCCCCChhHHHHHHHhcccCCCCCCChhHHh
Q 003052 704 VYGRTPFSEYKTFWAKFKVITDPNHE---ITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLL 762 (853)
Q Consensus 704 LtG~~PF~~~~~~~~~~kii~~~~~~---~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL 762 (853)
+||+.||.+..........+...... ...+..+++.+.+||.+||+.||.+|||+.||+
T Consensus 231 ltg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~ 292 (307)
T 3omv_A 231 MTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQIL 292 (307)
T ss_dssp HHSSCTTTTCCCHHHHHHHHHTTCCCCCSTTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHH
T ss_pred HHCCCCCCCCChHHHHHHHHhcCCCCCCcccccccchHHHHHHHHHHcCCCHhHCcCHHHHH
Confidence 99999998765544444443332211 233456788999999999999999999999874
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-51 Score=446.67 Aligned_cols=268 Identities=24% Similarity=0.361 Sum_probs=194.4
Q ss_pred eeeEEEeEeccCceEEEEEEe-cCCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHHHHh
Q 003052 473 LYQRLGKIGSGGSSEVHKVIS-SDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLREVL 551 (853)
Q Consensus 473 ~Y~ilk~LG~G~FG~Vyka~~-~~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~~l~ 551 (853)
+|++++.||+|+||+||+|++ .+++.||||+++.... ......+.+|+++|++|+ |||||++++++.....
T Consensus 6 dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~-~~~~~~~~~E~~il~~l~-HpnIV~~~~~~~~~~~------ 77 (299)
T 4g31_A 6 DFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNR-ELAREKVMREVKALAKLE-HPGIVRYFNAWLEKNT------ 77 (299)
T ss_dssp HEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSS-HHHHHHHHHHHHHHTTCC-CTTBCCEEEEEEEEC-------
T ss_pred hCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCC-HHHHHHHHHHHHHHHhCC-CCCCCeEEEEEEecCc------
Confidence 599999999999999999998 4789999999986543 344567899999999997 9999999998643211
Q ss_pred hCCCCCCCCccccCCeEEEEEecch-hhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCCCcc
Q 003052 552 NGSMNNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPAN 630 (853)
Q Consensus 552 ~~~iv~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLKPeN 630 (853)
........+..++|||||||. ++|.+++..+. ......+..++.|+.||+.||+|||++|||||||||+|
T Consensus 78 ----~~~~~~~~~~~~l~ivmE~~~gg~L~~~l~~~~-----~~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~N 148 (299)
T 4g31_A 78 ----TEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRC-----TIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSN 148 (299)
T ss_dssp -------------CEEEEEEEECCCSCCHHHHHHTCC-----SGGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGG
T ss_pred ----cccccccCCCcEEEEEEecCCCCcHHHHHHhcC-----CCChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHH
Confidence 000111345567999999986 59999887541 11235567789999999999999999999999999999
Q ss_pred EEe-ecCcEEEEecccchhcccCCcc----------ccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHH
Q 003052 631 FLL-VKGSLKLIDFGIAKAIMSDTTN----------IQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCI 699 (853)
Q Consensus 631 ILL-~~g~VKL~DFGlAk~~~~~~~~----------~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVI 699 (853)
||| .+|.+||+|||+|+.+...... ....+.|||+.|||||++.+. .|+.++|||||||+
T Consensus 149 ILl~~~~~vKl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~---------~y~~~~DiwSlGvi 219 (299)
T 4g31_A 149 IFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGN---------SYSHKVDIFSLGLI 219 (299)
T ss_dssp EEECTTCCEEECCCCCC--------------------------CCCTTSCHHHHTTC---------CCCTHHHHHHHHHH
T ss_pred eEECCCCcEEEccCccceecCCCccccccccccccccccCCcccCccccCHHHHcCC---------CCCCHHHHHHHHHH
Confidence 999 5689999999999876542211 122457899999999999865 36789999999999
Q ss_pred HHHHHhCCCCCCcchhHHHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCCChhHHhcCCCCCCC
Q 003052 700 LYQMVYGRTPFSEYKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQHPFLVPP 770 (853)
Q Consensus 700 LyELLtG~~PF~~~~~~~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~HPwf~~~ 770 (853)
||||++ ||............+.....+. .....++.+.+||.+||++||.+|||+.|+|+||||+..
T Consensus 220 lyell~---Pf~~~~~~~~~~~~~~~~~~p~-~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h~~~~~~ 286 (299)
T 4g31_A 220 LFELLY---PFSTQMERVRTLTDVRNLKFPP-LFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDL 286 (299)
T ss_dssp HHHHHS---CCSSHHHHHHHHHHHHTTCCCH-HHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGCCC
T ss_pred HHHHcc---CCCCccHHHHHHHHHhcCCCCC-CCcccCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCCC
Confidence 999996 8876443333333222221111 112335668899999999999999999999999999753
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-50 Score=439.84 Aligned_cols=261 Identities=21% Similarity=0.301 Sum_probs=203.0
Q ss_pred EEcCceeeEEEeEeccCceEEEEEEec------CCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhh
Q 003052 468 KVNGKLYQRLGKIGSGGSSEVHKVISS------DCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEV 541 (853)
Q Consensus 468 ~v~g~~Y~ilk~LG~G~FG~Vyka~~~------~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~ 541 (853)
.+..++|.+.++||+|+||+||+|++. ++..||||+++.. .......|.+|+++|++|+ |||||+++++
T Consensus 37 ~i~~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~--~~~~~~~f~~E~~il~~l~-HpnIV~l~g~-- 111 (329)
T 4aoj_A 37 HIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA--SESARQDFQREAELLTMLQ-HQHIVRFFGV-- 111 (329)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCC--SHHHHHHHHHHHHHHTTCC-CTTBCCEEEE--
T ss_pred ccCHHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcC--CHHHHHHHHHHHHHHHhCC-CCCCCcEEEE--
Confidence 344467999999999999999999863 4678999999754 3445567999999999997 9999999987
Q ss_pred hHHHHHHHHhhCCCCCCCCccccCCeEEEEEecch-hhHHHHHHHhhhh-------ccCCCCCCCHHHHHHHHHHhhhhh
Q 003052 542 TEKALLREVLNGSMNNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKE-------MDGSNQTLDENWLRFYWQQILEAV 613 (853)
Q Consensus 542 ~e~~iL~~l~~~~iv~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~-------~~~~~~~LsE~~~r~I~~QIl~AL 613 (853)
+.+...+||||||++ |+|.+++...... ......++++.++..|+.||+.||
T Consensus 112 --------------------~~~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl 171 (329)
T 4aoj_A 112 --------------------CTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGM 171 (329)
T ss_dssp --------------------ECSSSSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHH
T ss_pred --------------------EEECCEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHH
Confidence 456678999999987 5999998764211 111235799999999999999999
Q ss_pred hhcccCceeeCCCCCccEEee-cCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccc
Q 003052 614 NTIHEERIVHSDLKPANFLLV-KGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSD 692 (853)
Q Consensus 614 ~yLHs~gIIHRDLKPeNILL~-~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksD 692 (853)
.|||+++||||||||+||||+ ++.+||+|||+|+.+............+||+.|||||++.+. .|+.++|
T Consensus 172 ~yLH~~~iiHRDLKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~---------~~~~~sD 242 (329)
T 4aoj_A 172 VYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYR---------KFTTESD 242 (329)
T ss_dssp HHHHHTTCCCSCCCGGGEEEETTTEEEECCCC----------------CCCCGGGCCHHHHTTC---------CCCHHHH
T ss_pred HHHhcCCeecccccHhhEEECCCCcEEEcccccceeccCCCcceecCcccccccccChhhhcCC---------CCCcccc
Confidence 999999999999999999995 569999999999976544333334467899999999999765 3678999
Q ss_pred hhhhHHHHHHHHh-CCCCCCcchhHHHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCCChhHHhcC
Q 003052 693 IWSLGCILYQMVY-GRTPFSEYKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQH 764 (853)
Q Consensus 693 IWSLGVILyELLt-G~~PF~~~~~~~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~H 764 (853)
||||||+||||+| |+.||.+.........+... .....+..+++++.+||.+||..||++|||+.||+++
T Consensus 243 vwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~~g--~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~ 313 (329)
T 4aoj_A 243 VWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQG--RELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHAR 313 (329)
T ss_dssp HHHHHHHHHHHHTTSCCTTCSSCHHHHHHHHHHT--CCCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHH
T ss_pred ccchHHHHHHHHcCCCCCCCCCCHHHHHHHHHcC--CCCCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence 9999999999998 99999886655444443332 2345566789999999999999999999999999864
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-50 Score=433.55 Aligned_cols=258 Identities=21% Similarity=0.293 Sum_probs=207.9
Q ss_pred EcCceeeEEEeEeccCceEEEEEEec------CCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhh
Q 003052 469 VNGKLYQRLGKIGSGGSSEVHKVISS------DCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVT 542 (853)
Q Consensus 469 v~g~~Y~ilk~LG~G~FG~Vyka~~~------~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~ 542 (853)
+..++|.+.++||+|+||+||+|.+. ++..||||+++.. .......|.+|+++|++|+ |||||+++++
T Consensus 10 I~r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~--~~~~~~~f~~E~~il~~l~-HpnIV~l~g~--- 83 (299)
T 4asz_A 10 IKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA--SDNARKDFHREAELLTNLQ-HEHIVKFYGV--- 83 (299)
T ss_dssp CCGGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSC--CHHHHHHHHHHHHHHTTCC-CTTBCCEEEE---
T ss_pred cCHHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCC--ChHHHHHHHHHHHHHHhCC-CCCCccEEEE---
Confidence 44467999999999999999999863 4678999999754 3345567999999999997 9999999987
Q ss_pred HHHHHHHHhhCCCCCCCCccccCCeEEEEEecch-hhHHHHHHHhhhh-----ccCCCCCCCHHHHHHHHHHhhhhhhhc
Q 003052 543 EKALLREVLNGSMNNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKE-----MDGSNQTLDENWLRFYWQQILEAVNTI 616 (853)
Q Consensus 543 e~~iL~~l~~~~iv~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~-----~~~~~~~LsE~~~r~I~~QIl~AL~yL 616 (853)
+.+++.+||||||++ |+|.++|...... .......|++..+..|+.||+.||.||
T Consensus 84 -------------------~~~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yL 144 (299)
T 4asz_A 84 -------------------CVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYL 144 (299)
T ss_dssp -------------------ECSSSSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHH
T ss_pred -------------------EeeCCEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHH
Confidence 456678999999986 6999999764211 112345799999999999999999999
Q ss_pred ccCceeeCCCCCccEEee-cCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhh
Q 003052 617 HEERIVHSDLKPANFLLV-KGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWS 695 (853)
Q Consensus 617 Hs~gIIHRDLKPeNILL~-~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWS 695 (853)
|+++||||||||+||||+ ++.+||+|||+|+..............+||+.|||||++.+.. |+.++||||
T Consensus 145 H~~~iiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~---------~~~k~DVwS 215 (299)
T 4asz_A 145 ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRK---------FTTESDVWS 215 (299)
T ss_dssp HHTTCCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCC---------CCHHHHHHH
T ss_pred HhCCcccCccCHhhEEECCCCcEEECCcccceecCCCCceeecCceecChhhcCHHHHcCCC---------CCchhhHHH
Confidence 999999999999999994 5699999999999765443333334567999999999998763 678999999
Q ss_pred hHHHHHHHHh-CCCCCCcchhHHHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCCChhHHh
Q 003052 696 LGCILYQMVY-GRTPFSEYKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLL 762 (853)
Q Consensus 696 LGVILyELLt-G~~PF~~~~~~~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL 762 (853)
|||+||||+| |+.||.+.........+... .....+..+++++.+||.+||+.||++|||+.+|+
T Consensus 216 ~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~~~--~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~ 281 (299)
T 4asz_A 216 LGVVLWEIFTYGKQPWYQLSNNEVIECITQG--RVLQRPRTCPQEVYELMLGCWQREPHMRKNIKGIH 281 (299)
T ss_dssp HHHHHHHHHTTTCCTTTTSCHHHHHHHHHHT--CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred HHHHHHHHHcCCCCCCCCCCHHHHHHHHHcC--CCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHH
Confidence 9999999998 99999886654444333332 22345667889999999999999999999999985
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-50 Score=474.34 Aligned_cols=254 Identities=25% Similarity=0.353 Sum_probs=206.3
Q ss_pred ceeeEEEeEeccCceEEEEEEe-cCCcEEEEEEEecCCCC-hhhHhhHHHHHHHHHHhc--CCCceeEeeehhhhHHHHH
Q 003052 472 KLYQRLGKIGSGGSSEVHKVIS-SDCTIYALKKIKLKGRD-YATAYGFCQEIEYLNKLK--GKNNIIQLIDYEVTEKALL 547 (853)
Q Consensus 472 ~~Y~ilk~LG~G~FG~Vyka~~-~~g~~vAVKkik~~~~~-~~~~~~~l~EI~iLkkL~--~hpNIV~Lid~~~~e~~iL 547 (853)
++|++++.||+|+||+||+|++ .+++.||||++.+.... ......+.+|..++..+. +|||||+++++
T Consensus 189 ddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~-------- 260 (689)
T 3v5w_A 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYA-------- 260 (689)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEE--------
T ss_pred HHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEE--------
Confidence 5699999999999999999998 47899999999754211 111223445554444433 48999999876
Q ss_pred HHHhhCCCCCCCCccccCCeEEEEEecch-hhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCC
Q 003052 548 REVLNGSMNNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDL 626 (853)
Q Consensus 548 ~~l~~~~iv~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDL 626 (853)
|++.+++||||||+. |+|..+|.+. +.|+|..+++|+.||+.||.|||++|||||||
T Consensus 261 --------------f~~~~~lylVmEy~~GGdL~~~l~~~--------~~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDL 318 (689)
T 3v5w_A 261 --------------FHTPDKLSFILDLMNGGDLHYHLSQH--------GVFSEADMRFYAAEIILGLEHMHNRFVVYRDL 318 (689)
T ss_dssp --------------EECSSEEEEEECCCCSCBHHHHHHHH--------CCCCHHHHHHHHHHHHHHHHHHHTTTEECCCC
T ss_pred --------------EEECCEEEEEEecCCCCcHHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCC
Confidence 678889999999976 5999999765 67999999999999999999999999999999
Q ss_pred CCccEEe-ecCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHh
Q 003052 627 KPANFLL-VKGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVY 705 (853)
Q Consensus 627 KPeNILL-~~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLt 705 (853)
||+|||| .+|++||+|||+|+.+.... ..+.|||+.|||||++..+. .|+.++||||||||||||++
T Consensus 319 KPeNILld~~G~vKL~DFGlA~~~~~~~----~~t~~GTp~YmAPEvl~~~~--------~y~~~vDiWSLGvilYEmLt 386 (689)
T 3v5w_A 319 KPANILLDEHGHVRISDLGLACDFSKKK----PHASVGTHGYMAPEVLQKGV--------AYDSSADWFSLGCMLFKLLR 386 (689)
T ss_dssp SGGGEEECTTSCEEECCCTTCEECSSCC----CCSCCSCGGGCCHHHHSTTC--------CCCTHHHHHHHHHHHHHHHH
T ss_pred chHHeEEeCCCCEEecccceeeecCCCC----CCCccCCcCccCHHHHhCCC--------CCCcHHHHHHHHHHHHHHHh
Confidence 9999999 56899999999998765432 24789999999999996432 36789999999999999999
Q ss_pred CCCCCCcch--hHHHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCCC-----hhHHhcCCCCCC
Q 003052 706 GRTPFSEYK--TFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWR-----IPQLLQHPFLVP 769 (853)
Q Consensus 706 G~~PF~~~~--~~~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpT-----a~EIL~HPwf~~ 769 (853)
|++||.+.. .....+..+.. ....++...++++++||.+||.+||.+|++ +.||++||||+.
T Consensus 387 G~~PF~~~~~~~~~~i~~~i~~--~~~~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~HpfF~~ 455 (689)
T 3v5w_A 387 GHSPFRQHKTKDKHEIDRMTLT--MAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRS 455 (689)
T ss_dssp SSCTTCGGGCCCHHHHHHHHHH--CCCCCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTSGGGTT
T ss_pred CCCCCCCCChHHHHHHHHhhcC--CCCCCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcCccccC
Confidence 999997532 22333333332 234566778999999999999999999998 799999999964
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-49 Score=464.78 Aligned_cols=257 Identities=25% Similarity=0.372 Sum_probs=215.4
Q ss_pred ceeeEEEeEeccCceEEEEEEe-cCCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHHHH
Q 003052 472 KLYQRLGKIGSGGSSEVHKVIS-SDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLREV 550 (853)
Q Consensus 472 ~~Y~ilk~LG~G~FG~Vyka~~-~~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~~l 550 (853)
++|++++.||+|+||+||+|.+ .+++.||||++.... ......+.+|+.+|+.|+ |||||+++++
T Consensus 157 ~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~--~~~~~~~~~Ei~il~~l~-hpnIv~l~~~----------- 222 (573)
T 3uto_A 157 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH--ESDKETVRKEIQTMSVLR-HPTLVNLHDA----------- 222 (573)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS--HHHHHHHHHHHHHHHHTC-CTTBCCEEEE-----------
T ss_pred cccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccc--hhhHHHHHHHHHHHHhCC-CCCCCeEEEE-----------
Confidence 4699999999999999999998 578999999997653 334456889999999997 9999999987
Q ss_pred hhCCCCCCCCccccCCeEEEEEecch-hhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCCCc
Q 003052 551 LNGSMNNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPA 629 (853)
Q Consensus 551 ~~~~iv~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLKPe 629 (853)
|+++..+||||||+. |+|.++|... ...|+|..++.|++||+.||.|||++||+||||||+
T Consensus 223 -----------~~~~~~~~iv~E~~~gg~L~~~i~~~-------~~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~ 284 (573)
T 3uto_A 223 -----------FEDDNEMVMIYEFMSGGELFEKVADE-------HNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPE 284 (573)
T ss_dssp -----------EECSSEEEEEEECCCCCBHHHHHTCT-------TSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGG
T ss_pred -----------EEECCEEEEEEeecCCCcHHHHHHHh-------CCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChh
Confidence 677889999999986 5999888542 357999999999999999999999999999999999
Q ss_pred cEEee---cCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHhC
Q 003052 630 NFLLV---KGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYG 706 (853)
Q Consensus 630 NILL~---~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLtG 706 (853)
||||+ .|.+||+|||+|+.+.... ...+.|||+.|||||++.+. .|+.++||||||||||||++|
T Consensus 285 Nill~~~~~~~vKl~DFG~a~~~~~~~---~~~~~~GT~~y~APEv~~~~---------~y~~~~DiWSlGvilyeml~G 352 (573)
T 3uto_A 285 NIMFTTKRSNELKLIDFGLTAHLDPKQ---SVKVTTGTAEFAAPEVAEGK---------PVGYYTDMWSVGVLSYILLSG 352 (573)
T ss_dssp GEEESSSSCCCEEECCCSSCEECCTTS---EEEEECSSGGGCCHHHHTTC---------CBCHHHHHHHHHHHHHHHHHS
T ss_pred hccccCCCCCCEEEeeccceeEccCCC---ceeeeEECccccCHHHhCCC---------CCCcHHHHHHHHHHHHHHHHC
Confidence 99994 3699999999999775432 23467999999999999875 367899999999999999999
Q ss_pred CCCCCcchhHHHHHHhhcCC-CCcccCCCCCChhHHHHHHHhcccCCCCCCChhHHhcCCCCCCCCC
Q 003052 707 RTPFSEYKTFWAKFKVITDP-NHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQHPFLVPPVS 772 (853)
Q Consensus 707 ~~PF~~~~~~~~~~kii~~~-~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~HPwf~~~~~ 772 (853)
++||.+.........+.... ..........++++++||.+||.+||.+|||+.|+|+||||+....
T Consensus 353 ~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~Hpw~~~~~~ 419 (573)
T 3uto_A 353 LSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNA 419 (573)
T ss_dssp CCSSCCSSHHHHHHHHHTTCCCCCSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTSCCCC
T ss_pred CCCCCCcCHHHHHHHHHhCCCCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCcCcCCCCC
Confidence 99998766554444443321 1122233567899999999999999999999999999999987543
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-49 Score=440.99 Aligned_cols=266 Identities=21% Similarity=0.342 Sum_probs=215.8
Q ss_pred eEEcCceeeEEEeEeccCceEEEEEEecC------CcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehh
Q 003052 467 FKVNGKLYQRLGKIGSGGSSEVHKVISSD------CTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYE 540 (853)
Q Consensus 467 ~~v~g~~Y~ilk~LG~G~FG~Vyka~~~~------g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~ 540 (853)
|++.-++|++.++||+|+||+||+|.+.. ++.||||+++.... ......|.+|+++|.++.||||||++++++
T Consensus 59 wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~-~~~~~~~~~E~~il~~l~hhpnIV~l~g~~ 137 (353)
T 4ase_A 59 WEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT-HSEHRALMSELKILIHIGHHLNVVNLLGAC 137 (353)
T ss_dssp HBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCC-HHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccC-hHHHHHHHHHHHHHHHcCCCCcEEEEEEEE
Confidence 34555789999999999999999998632 36799999976443 344567999999999999899999999873
Q ss_pred hhHHHHHHHHhhCCCCCCCCccccCCeEEEEEecch-hhHHHHHHHhhhhcc--------CCCCCCCHHHHHHHHHHhhh
Q 003052 541 VTEKALLREVLNGSMNNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEMD--------GSNQTLDENWLRFYWQQILE 611 (853)
Q Consensus 541 ~~e~~iL~~l~~~~iv~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~~~--------~~~~~LsE~~~r~I~~QIl~ 611 (853)
. .+++.+|||||||+ |+|.++|........ .....+++..+..|+.||+.
T Consensus 138 ~---------------------~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~ 196 (353)
T 4ase_A 138 T---------------------KPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAK 196 (353)
T ss_dssp C---------------------CTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHH
T ss_pred E---------------------ecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHH
Confidence 2 34457899999987 599999976533211 12356899999999999999
Q ss_pred hhhhcccCceeeCCCCCccEEe-ecCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCc
Q 003052 612 AVNTIHEERIVHSDLKPANFLL-VKGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRP 690 (853)
Q Consensus 612 AL~yLHs~gIIHRDLKPeNILL-~~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~k 690 (853)
||.|||+++||||||||+|||| .++.+||+|||+|+.+..........+.+||+.|||||++.+. .|+.+
T Consensus 197 gl~yLH~~~iiHRDLK~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~---------~y~~k 267 (353)
T 4ase_A 197 GMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDR---------VYTIQ 267 (353)
T ss_dssp HHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHC---------CCCHH
T ss_pred HHHhHhhCCeecCccCccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcC---------CCCCc
Confidence 9999999999999999999999 4679999999999977654444445577899999999999876 36789
Q ss_pred cchhhhHHHHHHHHh-CCCCCCcchhHHHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCCChhHHhcC
Q 003052 691 SDIWSLGCILYQMVY-GRTPFSEYKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQH 764 (853)
Q Consensus 691 sDIWSLGVILyELLt-G~~PF~~~~~~~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~H 764 (853)
+|||||||+||||+| |+.||.+..........+.. ......+...++++.+||.+||..||.+|||+.||++|
T Consensus 268 sDVwS~Gv~l~El~t~G~~Pf~~~~~~~~~~~~i~~-g~~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~ 341 (353)
T 4ase_A 268 SDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKE-GTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 341 (353)
T ss_dssp HHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHH-TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ccEeehHHHHHHHHhCCCCCCCCCCHHHHHHHHHHc-CCCCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence 999999999999998 99999875443333333332 23345566788999999999999999999999999986
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-49 Score=431.86 Aligned_cols=259 Identities=21% Similarity=0.293 Sum_probs=208.8
Q ss_pred CceeeEEEeEeccCceEEEEEEe------cCCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHH
Q 003052 471 GKLYQRLGKIGSGGSSEVHKVIS------SDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEK 544 (853)
Q Consensus 471 g~~Y~ilk~LG~G~FG~Vyka~~------~~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~ 544 (853)
-..++++++||+|+||+||+|.. .+++.||||+++.... ......|.+|+.+|++|+ |||||+++++
T Consensus 25 ~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~-~~~~~~f~~E~~il~~l~-HpNIV~l~g~----- 97 (308)
T 4gt4_A 25 LSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAE-GPLREEFRHEAMLRARLQ-HPNVVCLLGV----- 97 (308)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CC-C-CHHHHHHHHHHHHHCC-CTTBCCEEEE-----
T ss_pred HHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccC-hHHHHHHHHHHHHHHhCC-CCCCCCcceE-----
Confidence 35688999999999999999985 2457899999975433 334467999999999997 9999999987
Q ss_pred HHHHHHhhCCCCCCCCccccCCeEEEEEecch-hhHHHHHHHhhhhc--------cCCCCCCCHHHHHHHHHHhhhhhhh
Q 003052 545 ALLREVLNGSMNNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEM--------DGSNQTLDENWLRFYWQQILEAVNT 615 (853)
Q Consensus 545 ~iL~~l~~~~iv~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~~--------~~~~~~LsE~~~r~I~~QIl~AL~y 615 (853)
+.++..+||||||++ |+|.++|..+.... ......+++..+..|+.||+.||.|
T Consensus 98 -----------------~~~~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~y 160 (308)
T 4gt4_A 98 -----------------VTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEY 160 (308)
T ss_dssp -----------------ECSSSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHH
T ss_pred -----------------EEECCEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHH
Confidence 455667899999986 69999996542110 1123569999999999999999999
Q ss_pred cccCceeeCCCCCccEEee-cCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchh
Q 003052 616 IHEERIVHSDLKPANFLLV-KGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIW 694 (853)
Q Consensus 616 LHs~gIIHRDLKPeNILL~-~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIW 694 (853)
||+++||||||||+||||+ ++.+||+|||+|+.+............+||+.|||||++.+. .|+.++|||
T Consensus 161 LH~~~iiHRDLK~~NILl~~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~---------~~s~ksDVw 231 (308)
T 4gt4_A 161 LSSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYG---------KFSIDSDIW 231 (308)
T ss_dssp HHHTTCCCSCCSGGGEEECGGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHC---------CCCHHHHHH
T ss_pred HHhCCCCCCCccccceEECCCCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCC---------CCCccchhh
Confidence 9999999999999999994 579999999999977554433344567899999999999875 367899999
Q ss_pred hhHHHHHHHHh-CCCCCCcchhHHHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCCChhHHhcC
Q 003052 695 SLGCILYQMVY-GRTPFSEYKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQH 764 (853)
Q Consensus 695 SLGVILyELLt-G~~PF~~~~~~~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~H 764 (853)
||||+||||+| |..||.+......... +.. ......+..+++++.+||.+||..||.+|||+.||+++
T Consensus 232 SfGvvl~El~t~g~~Pf~~~~~~~~~~~-i~~-~~~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~ 300 (308)
T 4gt4_A 232 SYGVVLWEVFSYGLQPYCGYSNQDVVEM-IRN-RQVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSR 300 (308)
T ss_dssp HHHHHHHHHHTTTCCTTTTCCHHHHHHH-HHT-TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred hHHHHHHHHHhCCCCCCCCCCHHHHHHH-HHc-CCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 99999999998 8999988665433333 332 22334566788999999999999999999999999875
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-48 Score=420.51 Aligned_cols=275 Identities=48% Similarity=0.800 Sum_probs=223.6
Q ss_pred eeEEcCceeeEEEeEeccCceEEEEEEecCCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCC-CceeEeeehhhhHH
Q 003052 466 FFKVNGKLYQRLGKIGSGGSSEVHKVISSDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGK-NNIIQLIDYEVTEK 544 (853)
Q Consensus 466 ~~~v~g~~Y~ilk~LG~G~FG~Vyka~~~~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~h-pNIV~Lid~~~~e~ 544 (853)
.+.+.++.|++++.||+|+||.||+|.+.+++.||||++............+.+|+.+|+++.+| +||++++++
T Consensus 3 ~i~~~~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~----- 77 (343)
T 3dbq_A 3 CISVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDY----- 77 (343)
T ss_dssp CEESSSCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEE-----
T ss_pred eeeeecCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeee-----
Confidence 35678899999999999999999999998899999999988776666777899999999999854 899999987
Q ss_pred HHHHHHhhCCCCCCCCccccCCeEEEEEecchhhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeC
Q 003052 545 ALLREVLNGSMNNKDGRVKDDGYIYMVLEYGEIDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHS 624 (853)
Q Consensus 545 ~iL~~l~~~~iv~~~g~~~d~~~lyLVmEy~~gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHR 624 (853)
+.++.++|+||||++++|.+++... ..+++..++.|+.||+.||.|||++||+||
T Consensus 78 -----------------~~~~~~~~lv~e~~~~~L~~~l~~~--------~~~~~~~~~~i~~qi~~al~~lH~~~iiHr 132 (343)
T 3dbq_A 78 -----------------EITDQYIYMVMECGNIDLNSWLKKK--------KSIDPWERKSYWKNMLEAVHTIHQHGIVHS 132 (343)
T ss_dssp -----------------EECSSEEEEEECCCSEEHHHHHHHS--------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCC
T ss_pred -----------------EeeCCEEEEEEeCCCCCHHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHhCCeecC
Confidence 4566789999999889999998764 579999999999999999999999999999
Q ss_pred CCCCccEEeecCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCC--CccccCCCccchhhhHHHHHH
Q 003052 625 DLKPANFLLVKGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDEN--GNIIKCGRPSDIWSLGCILYQ 702 (853)
Q Consensus 625 DLKPeNILL~~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~--~~~~~ys~ksDIWSLGVILyE 702 (853)
||||+|||++++.+||+|||+|+.+............+||+.|+|||++.+...... .....|+.++|||||||++|+
T Consensus 133 Dikp~NIll~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~e 212 (343)
T 3dbq_A 133 DLKPANFLIVDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYY 212 (343)
T ss_dssp CCCGGGEEEETTEEEECCCSSSCCC------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHH
T ss_pred CCCcceEEEECCcEEEeecccccccCcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHH
Confidence 999999999999999999999987654433333446789999999999975221100 001257889999999999999
Q ss_pred HHhCCCCCCcchhHHHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCCChhHHhcCCCCCCC
Q 003052 703 MVYGRTPFSEYKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQHPFLVPP 770 (853)
Q Consensus 703 LLtG~~PF~~~~~~~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~HPwf~~~ 770 (853)
|++|+.||.+..........+........++...+.++.+||.+||..||.+|||+.|+|+||||...
T Consensus 213 ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~ 280 (343)
T 3dbq_A 213 MTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQ 280 (343)
T ss_dssp HHHSSCTTTTCCSHHHHHHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSC
T ss_pred HHhCCCcchhhhhHHHHHHHHhcCCcccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCcccccc
Confidence 99999999875444444444445556666777778899999999999999999999999999999754
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-47 Score=435.09 Aligned_cols=333 Identities=23% Similarity=0.331 Sum_probs=259.0
Q ss_pred ceeeEEEeEeccCceEEEEEEec-CCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHHHH
Q 003052 472 KLYQRLGKIGSGGSSEVHKVISS-DCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLREV 550 (853)
Q Consensus 472 ~~Y~ilk~LG~G~FG~Vyka~~~-~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~~l 550 (853)
++|+++++||+|+||.||+|.+. +++.||||++............+.+|+++|++++ ||||++++++
T Consensus 22 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~----------- 89 (486)
T 3mwu_A 22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLD-HPNIMKLFEI----------- 89 (486)
T ss_dssp HHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCC-CTTBCCEEEE-----------
T ss_pred cceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCC-CCCcCeEEEE-----------
Confidence 56999999999999999999984 7889999999764433334556889999999997 9999999987
Q ss_pred hhCCCCCCCCccccCCeEEEEEecch-hhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCCCc
Q 003052 551 LNGSMNNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPA 629 (853)
Q Consensus 551 ~~~~iv~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLKPe 629 (853)
+.+...+|+||||+. ++|.+.+... ..+++..++.++.||+.||.|||++||+||||||+
T Consensus 90 -----------~~~~~~~~lv~e~~~~~~L~~~~~~~--------~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~ 150 (486)
T 3mwu_A 90 -----------LEDSSSFYIVGELYTGGELFDEIIKR--------KRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPE 150 (486)
T ss_dssp -----------EECSSEEEEEECCCCSCBHHHHHHHH--------SSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGG
T ss_pred -----------EEcCCEEEEEEEcCCCCcHHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchH
Confidence 566788999999976 5888888664 56999999999999999999999999999999999
Q ss_pred cEEee----cCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHh
Q 003052 630 NFLLV----KGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVY 705 (853)
Q Consensus 630 NILL~----~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLt 705 (853)
|||+. ++.+||+|||+|+.+.... .....+||+.|+|||++.+. |+.++|||||||++|+|++
T Consensus 151 Nil~~~~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~----------~~~~~DiwslG~il~~ll~ 217 (486)
T 3mwu_A 151 NILLESKEKDCDIKIIDFGLSTCFQQNT---KMKDRIGTAYYIAPEVLRGT----------YDEKCDVWSAGVILYILLS 217 (486)
T ss_dssp GEEESSSSTTCCEEECSCSCTTTBCCC-------CCTTGGGGCCGGGGGSC----------CCHHHHHHHHHHHHHHHHH
T ss_pred HEEEecCCCCCCEEEEECCcCeECCCCC---ccCCCcCCCCCCCHHHhCCC----------CCchhhHHHHHHHHHHHHh
Confidence 99993 3479999999998764332 23467899999999999652 5789999999999999999
Q ss_pred CCCCCCcchhHHHHHHhhcCC-CCcccCCCCCChhHHHHHHHhcccCCCCCCChhHHhcCCCCCCCCCCCCCCChH----
Q 003052 706 GRTPFSEYKTFWAKFKVITDP-NHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQHPFLVPPVSTQPSSSQD---- 780 (853)
Q Consensus 706 G~~PF~~~~~~~~~~kii~~~-~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~HPwf~~~~~~~~~~~~~---- 780 (853)
|++||.+.........+.... ..........++.+++||.+||.+||.+|||+.|+|+||||+......+.....
T Consensus 218 g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~hp~~~~~~~~~~~~~~~~~~~ 297 (486)
T 3mwu_A 218 GTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKYSSETPTISDLPSLE 297 (486)
T ss_dssp SSCSSCCSSHHHHHHHHHHTCCCSCSGGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHCHHHHHTCCCCCCGGGHHHHH
T ss_pred CCCCCCCCCHHHHHHHHHhCCCCCCCcccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcCHhhccCcccCccccccccHH
Confidence 999998765543333332211 111222345688899999999999999999999999999997654433221110
Q ss_pred --------------HHHHHHHHHHHhhcChHHHHHHHHHHHhhhhCCccceeecccCcHHHHHHHHHHHH----------
Q 003052 781 --------------QSYQLLQLLAEASASDHEASTICSQLSQLIRNPVMLAATQLSTSQDQQCKLLLKLS---------- 836 (853)
Q Consensus 781 --------------~~~~llq~l~~~~~s~~e~s~l~~q~~~l~~n~~~~~s~~~~~sq~~q~~~~~~~~---------- 836 (853)
.....+..++....+..+...+...|..+|.|.+|.++.+ |+...+...+.
T Consensus 298 ~~~~~~~~~~~~~~~~~~~l~~ia~~l~~~~~~~~l~~~F~~~D~d~dG~I~~~-----El~~~l~~~~~~~g~~~~~~~ 372 (486)
T 3mwu_A 298 SAMTNIRQFQAEKKLAQAALLYMASKLTTLDETKQLTEIFRKLDTNNDGMLDRD-----ELVRGYHEFMRLKGVDSNSLI 372 (486)
T ss_dssp HHHHHHHHHHHSCHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHCTTCSSSBCHH-----HHHHHHHHHHHHHTCCGGGHH
T ss_pred HHHHHHHHHHHHHHHHHHHHHHHHHHhccHHHHHHHHHHHHHhCCCCCceeeHH-----HHHHHHHHhhhhhcccchhcc
Confidence 1112233444445577788899999999999999999987 77655443332
Q ss_pred -----HHHHHHHHHHHhhhcCC
Q 003052 837 -----KLCLELQKRLANLRENK 853 (853)
Q Consensus 837 -----~~~~~~~~i~~~~d~d~ 853 (853)
....+++++|..+|.|+
T Consensus 373 ~~~~~~~~~~~~~~~~~~D~d~ 394 (486)
T 3mwu_A 373 QNEGSTIEDQIDSLMPLLDMDG 394 (486)
T ss_dssp HHTSSCHHHHHHHHHHHHCTTC
T ss_pred cccchhhHHHHHHHHHHhcCCC
Confidence 22778999999999874
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-47 Score=426.07 Aligned_cols=275 Identities=48% Similarity=0.797 Sum_probs=224.4
Q ss_pred eeEEcCceeeEEEeEeccCceEEEEEEecCCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcC-CCceeEeeehhhhHH
Q 003052 466 FFKVNGKLYQRLGKIGSGGSSEVHKVISSDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKG-KNNIIQLIDYEVTEK 544 (853)
Q Consensus 466 ~~~v~g~~Y~ilk~LG~G~FG~Vyka~~~~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~-hpNIV~Lid~~~~e~ 544 (853)
.+.+.++.|++++.||+|+||.||+|.+.+++.||||++............+.+|+.+|++|.+ |+||++++++
T Consensus 50 ~~~~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~----- 124 (390)
T 2zmd_A 50 CISVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDY----- 124 (390)
T ss_dssp CEEETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEE-----
T ss_pred cccccCCceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEE-----
Confidence 4677788999999999999999999999889999999998776666677789999999999985 7999999987
Q ss_pred HHHHHHhhCCCCCCCCccccCCeEEEEEecchhhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeC
Q 003052 545 ALLREVLNGSMNNKDGRVKDDGYIYMVLEYGEIDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHS 624 (853)
Q Consensus 545 ~iL~~l~~~~iv~~~g~~~d~~~lyLVmEy~~gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHR 624 (853)
+..+..+|||||+++++|.+++... ..+++..++.|+.||+.||.|||++||+||
T Consensus 125 -----------------~~~~~~~~lv~E~~~~~L~~~l~~~--------~~~~~~~~~~i~~qi~~aL~~lH~~~ivHr 179 (390)
T 2zmd_A 125 -----------------EITDQYIYMVMECGNIDLNSWLKKK--------KSIDPWERKSYWKNMLEAVHTIHQHGIVHS 179 (390)
T ss_dssp -----------------EECSSEEEEEEECCSEEHHHHHHHC--------SSCCHHHHHHHHHHHHHHHHHHHTTTCCCC
T ss_pred -----------------EecCCEEEEEEecCCCCHHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHHCCeeec
Confidence 3456679999999888999998754 478999999999999999999999999999
Q ss_pred CCCCccEEeecCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCC--CccccCCCccchhhhHHHHHH
Q 003052 625 DLKPANFLLVKGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDEN--GNIIKCGRPSDIWSLGCILYQ 702 (853)
Q Consensus 625 DLKPeNILL~~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~--~~~~~ys~ksDIWSLGVILyE 702 (853)
||||+||||.++.+||+|||+|+.+............+||+.|+|||++.+...... .....|+.++||||||||||+
T Consensus 180 Dlkp~NIll~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~e 259 (390)
T 2zmd_A 180 DLKPANFLIVDGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYY 259 (390)
T ss_dssp CCCGGGEEESSSCEEECCCSSSCCC---------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHH
T ss_pred CCCHHHEEEECCeEEEEecCccccccCCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHH
Confidence 999999999889999999999987654433333456789999999999975321100 001247889999999999999
Q ss_pred HHhCCCCCCcchhHHHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCCChhHHhcCCCCCCC
Q 003052 703 MVYGRTPFSEYKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQHPFLVPP 770 (853)
Q Consensus 703 LLtG~~PF~~~~~~~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~HPwf~~~ 770 (853)
|++|+.||.+.......+..+..+.....++...+.++.+||.+||..||.+||++.|+|+||||...
T Consensus 260 ll~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~~ 327 (390)
T 2zmd_A 260 MTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQ 327 (390)
T ss_dssp HHHSSCTTTTCCCHHHHHHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSC
T ss_pred HHHCCCcchhhhHHHHHHHHHhCccccCCCCccchHHHHHHHHHHcccChhhCCCHHHHhhCcCcccc
Confidence 99999999765443344444445555566677778899999999999999999999999999999754
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-46 Score=430.28 Aligned_cols=332 Identities=24% Similarity=0.313 Sum_probs=256.0
Q ss_pred ceeeEEEeEeccCceEEEEEEec-CCcEEEEEEEecCCCCh-----------hhHhhHHHHHHHHHHhcCCCceeEeeeh
Q 003052 472 KLYQRLGKIGSGGSSEVHKVISS-DCTIYALKKIKLKGRDY-----------ATAYGFCQEIEYLNKLKGKNNIIQLIDY 539 (853)
Q Consensus 472 ~~Y~ilk~LG~G~FG~Vyka~~~-~g~~vAVKkik~~~~~~-----------~~~~~~l~EI~iLkkL~~hpNIV~Lid~ 539 (853)
+.|+++++||+|+||.||+|.+. ++..||||++....... .....+.+|+.+|++++ ||||++++++
T Consensus 36 ~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~ 114 (504)
T 3q5i_A 36 ESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLD-HPNIIKLFDV 114 (504)
T ss_dssp GTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCC-CTTBCCEEEE
T ss_pred cceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCC-CCCCCeEEEE
Confidence 56999999999999999999984 67899999997654221 23456889999999997 8999999987
Q ss_pred hhhHHHHHHHHhhCCCCCCCCccccCCeEEEEEecch-hhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhccc
Q 003052 540 EVTEKALLREVLNGSMNNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHE 618 (853)
Q Consensus 540 ~~~e~~iL~~l~~~~iv~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs 618 (853)
+.+...+|+||||+. ++|.+.+... ..+++..++.++.||+.||.|||+
T Consensus 115 ----------------------~~~~~~~~lv~e~~~gg~L~~~l~~~--------~~~~~~~~~~i~~qi~~~l~~lH~ 164 (504)
T 3q5i_A 115 ----------------------FEDKKYFYLVTEFYEGGELFEQIINR--------HKFDECDAANIMKQILSGICYLHK 164 (504)
T ss_dssp ----------------------EECSSEEEEEEECCTTCBHHHHHHHH--------SCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred ----------------------EEcCCEEEEEEecCCCCcHHHHHHHc--------CCCCHHHHHHHHHHHHHHHHHHHH
Confidence 566788999999986 4898888664 569999999999999999999999
Q ss_pred CceeeCCCCCccEEeec-C---cEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchh
Q 003052 619 ERIVHSDLKPANFLLVK-G---SLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIW 694 (853)
Q Consensus 619 ~gIIHRDLKPeNILL~~-g---~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIW 694 (853)
+||+||||||+|||+.. + .+||+|||+|+.+.... .....+||+.|+|||++.+ .|+.++|||
T Consensus 165 ~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~----------~~~~~~Diw 231 (504)
T 3q5i_A 165 HNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDY---KLRDRLGTAYYIAPEVLKK----------KYNEKCDVW 231 (504)
T ss_dssp TTEECSCCSGGGEEESSTTCCSSEEECCCTTCEECCTTS---CBCCCCSCTTTCCHHHHTT----------CBCTHHHHH
T ss_pred CCeEeCCCcHHHEEEecCCCCccEEEEECCCCEEcCCCC---ccccccCCcCCCCHHHhcc----------CCCchHHHH
Confidence 99999999999999953 3 69999999998764432 2346789999999999863 367899999
Q ss_pred hhHHHHHHHHhCCCCCCcchhHHHHHHhhcCCCCcc--cCCCCCChhHHHHHHHhcccCCCCCCChhHHhcCCCCCCCCC
Q 003052 695 SLGCILYQMVYGRTPFSEYKTFWAKFKVITDPNHEI--TYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQHPFLVPPVS 772 (853)
Q Consensus 695 SLGVILyELLtG~~PF~~~~~~~~~~kii~~~~~~~--~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~HPwf~~~~~ 772 (853)
||||++|+|++|.+||.+.........+.. ....+ ......++++++||.+||.+||.+|||+.|+|+||||+....
T Consensus 232 slG~il~~ll~g~~pf~~~~~~~~~~~i~~-~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~~ 310 (504)
T 3q5i_A 232 SCGVIMYILLCGYPPFGGQNDQDIIKKVEK-GKYYFDFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKKYAN 310 (504)
T ss_dssp HHHHHHHHHHHSSCSSCCSSHHHHHHHHHH-CCCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHTCC
T ss_pred HHHHHHHHHHhCCCCCCCCCHHHHHHHHHc-CCCCCCccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcCHhhhhchh
Confidence 999999999999999987655433333322 22211 122467889999999999999999999999999999976543
Q ss_pred CCCCCCh-----------------HHHHHHHHHHHHhhcChHHHHHHHHHHHhhhhCCccceeecccCcHHHHHHHHHHH
Q 003052 773 TQPSSSQ-----------------DQSYQLLQLLAEASASDHEASTICSQLSQLIRNPVMLAATQLSTSQDQQCKLLLKL 835 (853)
Q Consensus 773 ~~~~~~~-----------------~~~~~llq~l~~~~~s~~e~s~l~~q~~~l~~n~~~~~s~~~~~sq~~q~~~~~~~ 835 (853)
....... ......+..++.......+...+...|..+|.|.+|.++.+ |+...+....
T Consensus 311 ~~~~~~~~~~~~~~~~~~~~~~~~kl~~a~l~~i~~~~~~~~~~~~l~~~F~~~D~d~dG~I~~~-----El~~~l~~~~ 385 (504)
T 3q5i_A 311 NINKSDQKTLCGALSNMRKFEGSQKLAQAAILFIGSKLTTLEERKELTDIFKKLDKNGDGQLDKK-----ELIEGYNVLR 385 (504)
T ss_dssp CCCGGGHHHHHHHHHHHHHCCCCSHHHHHHHHHHHHHTSCHHHHHHHHHHHHHHCTTCSSEECHH-----HHHHHHHHHH
T ss_pred cccccchhhHHHHHHHHHHHHHHHHHHHHHHHHhhccCCcHHHHHHHHHHHHeeCCCCCCeEcHH-----HHHHHHHHhh
Confidence 3221111 11122334445555577888899999999999999999977 6665543321
Q ss_pred ---------HHHHHHHHHHHHhhhcCC
Q 003052 836 ---------SKLCLELQKRLANLRENK 853 (853)
Q Consensus 836 ---------~~~~~~~~~i~~~~d~d~ 853 (853)
.....+++++|+.+|.|.
T Consensus 386 ~~~~~~~~~~~~~~~~~~~~~~~D~d~ 412 (504)
T 3q5i_A 386 NFKNELGELKNVEEEVDNILKEVDFDK 412 (504)
T ss_dssp HHC--CCSCCCHHHHHHHHHHHHCTTC
T ss_pred hcccccccccccHHHHHHHHHHhCCCC
Confidence 234788999999998874
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-47 Score=431.88 Aligned_cols=333 Identities=22% Similarity=0.322 Sum_probs=256.7
Q ss_pred ceeeEEEeEeccCceEEEEEEec-CCcEEEEEEEecCCCC-hhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHHH
Q 003052 472 KLYQRLGKIGSGGSSEVHKVISS-DCTIYALKKIKLKGRD-YATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLRE 549 (853)
Q Consensus 472 ~~Y~ilk~LG~G~FG~Vyka~~~-~g~~vAVKkik~~~~~-~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~~ 549 (853)
++|++.+.||+|+||.||+|.+. +++.||||++...... ......+.+|+.+|++++ ||||++++++
T Consensus 26 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~---------- 94 (484)
T 3nyv_A 26 DRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLD-HPNIMKLYEF---------- 94 (484)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCC-CTTBCCEEEE----------
T ss_pred CceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCC-CCCCCcEEEE----------
Confidence 57999999999999999999985 7899999999765432 334556889999999996 9999999987
Q ss_pred HhhCCCCCCCCccccCCeEEEEEecch-hhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCCC
Q 003052 550 VLNGSMNNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKP 628 (853)
Q Consensus 550 l~~~~iv~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLKP 628 (853)
+.+.+.+|+||||+. ++|.+.+... ..+++..++.++.||+.||.|||++||+||||||
T Consensus 95 ------------~~~~~~~~lv~e~~~~~~L~~~~~~~--------~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp 154 (484)
T 3nyv_A 95 ------------FEDKGYFYLVGEVYTGGELFDEIISR--------KRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKP 154 (484)
T ss_dssp ------------EECSSEEEEEECCCCSCBHHHHHHTC--------SCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCG
T ss_pred ------------EEeCCEEEEEEecCCCCCHHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCH
Confidence 566788999999975 5888887643 5799999999999999999999999999999999
Q ss_pred ccEEee----cCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHH
Q 003052 629 ANFLLV----KGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMV 704 (853)
Q Consensus 629 eNILL~----~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELL 704 (853)
+|||+. ++.+||+|||+|+.+.... .....+||+.|+|||++.+. |+.++|||||||++|+|+
T Consensus 155 ~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~----------~~~~~DiwslG~il~~ll 221 (484)
T 3nyv_A 155 ENLLLESKSKDANIRIIDFGLSTHFEASK---KMKDKIGTAYYIAPEVLHGT----------YDEKCDVWSTGVILYILL 221 (484)
T ss_dssp GGEEESSSSTTCCEEECCTTHHHHBCCCC---SHHHHTTGGGTCCHHHHHTC----------CCTHHHHHHHHHHHHHHH
T ss_pred HHEEEecCCCCCcEEEEeeeeeEEccccc---ccccCCCCccccCceeecCC----------CCCcceeHHHHHHHHHHH
Confidence 999993 4689999999998765432 23356899999999999652 568999999999999999
Q ss_pred hCCCCCCcchhHHHHHHhhcCC-CCcccCCCCCChhHHHHHHHhcccCCCCCCChhHHhcCCCCCCCCCC----CCCCCh
Q 003052 705 YGRTPFSEYKTFWAKFKVITDP-NHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQHPFLVPPVST----QPSSSQ 779 (853)
Q Consensus 705 tG~~PF~~~~~~~~~~kii~~~-~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~HPwf~~~~~~----~~~~~~ 779 (853)
+|++||.+.........+.... ..........++.+++||.+||.+||.+|||+.|+|+||||+..... ......
T Consensus 222 ~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h~~~~~~~~~~~~~~~~~~~ 301 (484)
T 3nyv_A 222 SGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSESAKDLIRKMLTYVPSMRISARDALDHEWIQTYTKEQISVDVPSLD 301 (484)
T ss_dssp HSSCSSCCSSHHHHHHHHHHCCCCCCSGGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHHHHTC-----CCCBCH
T ss_pred HCCCCCCCCCHHHHHHHHHcCCCCCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhhChhhcccccccccccccchH
Confidence 9999998765544333333221 11122224578889999999999999999999999999999643221 111111
Q ss_pred HH-------------HHHHHHHHHHhhcChHHHHHHHHHHHhhhhCCccceeecccCcHHHHHHHHHHHH----------
Q 003052 780 DQ-------------SYQLLQLLAEASASDHEASTICSQLSQLIRNPVMLAATQLSTSQDQQCKLLLKLS---------- 836 (853)
Q Consensus 780 ~~-------------~~~llq~l~~~~~s~~e~s~l~~q~~~l~~n~~~~~s~~~~~sq~~q~~~~~~~~---------- 836 (853)
.. ....+..++.......+...+...|..+|.|.+|.++.+ |+...+...+.
T Consensus 302 ~~~~~~~~~~~~~kl~qa~l~~i~~~~~~~~~~~~l~~~F~~~D~d~dG~I~~~-----El~~~l~~~~~~~g~~~~~~~ 376 (484)
T 3nyv_A 302 NAILNIRQFQGTQKLAQAALLYMGSKLTSQDETKELTAIFHKMDKNGDGQLDRA-----ELIEGYKELMRMKGQDASMLD 376 (484)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHCTTCSSEEEHH-----HHHHHHHHHHC----CGGGCS
T ss_pred HHHHHHHHHhhhhHHHHHHHHHHHhccCcHHHHHHHHHHHHHhCcCCCceEeHH-----HHHHHHHHHhhhccccccccc
Confidence 11 111223333333455677788899999999999999987 76554433321
Q ss_pred --HHHHHHHHHHHhhhcCC
Q 003052 837 --KLCLELQKRLANLRENK 853 (853)
Q Consensus 837 --~~~~~~~~i~~~~d~d~ 853 (853)
....+++++|..+|.|+
T Consensus 377 ~~~~~~~~~~~~~~~D~d~ 395 (484)
T 3nyv_A 377 ASAVEHEVDQVLDAVDFDK 395 (484)
T ss_dssp HHHHHHHHHHHHHHHTCCT
T ss_pred ccccHHHHHHHHHHhCCCC
Confidence 22788899999999874
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-46 Score=432.01 Aligned_cols=332 Identities=25% Similarity=0.344 Sum_probs=254.6
Q ss_pred ceeeEEEeEeccCceEEEEEEec-CCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHHHH
Q 003052 472 KLYQRLGKIGSGGSSEVHKVISS-DCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLREV 550 (853)
Q Consensus 472 ~~Y~ilk~LG~G~FG~Vyka~~~-~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~~l 550 (853)
+.|+++++||+|+||.||+|.+. ++..||||++............+.+|+.+|++++ ||||++++++
T Consensus 37 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~----------- 104 (494)
T 3lij_A 37 EMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLD-HPNIMKLYDF----------- 104 (494)
T ss_dssp HHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCC-CTTBCCEEEE-----------
T ss_pred cCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCC-CCCCCeEEEE-----------
Confidence 46999999999999999999985 6789999999876544444567889999999997 8999999987
Q ss_pred hhCCCCCCCCccccCCeEEEEEecch-hhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCCCc
Q 003052 551 LNGSMNNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPA 629 (853)
Q Consensus 551 ~~~~iv~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLKPe 629 (853)
+.+...+|+||||+. ++|.+.+... ..+++..++.|+.||+.||.|||++||+||||||+
T Consensus 105 -----------~~~~~~~~lv~e~~~~g~L~~~~~~~--------~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~ 165 (494)
T 3lij_A 105 -----------FEDKRNYYLVMECYKGGELFDEIIHR--------MKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPE 165 (494)
T ss_dssp -----------EECSSEEEEEEECCCSCBHHHHHHHH--------SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGG
T ss_pred -----------EEeCCEEEEEEecCCCCcHHHHHHHc--------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChh
Confidence 466778999999976 4888888664 56999999999999999999999999999999999
Q ss_pred cEEeec----CcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHh
Q 003052 630 NFLLVK----GSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVY 705 (853)
Q Consensus 630 NILL~~----g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLt 705 (853)
|||+.. +.+||+|||+|+.+.... .....+||+.|+|||++.+ .|+.++|||||||++|+|++
T Consensus 166 Nil~~~~~~~~~~kl~DfG~a~~~~~~~---~~~~~~gt~~y~aPE~l~~----------~~~~~~DiwslG~il~~ll~ 232 (494)
T 3lij_A 166 NLLLESKEKDALIKIVDFGLSAVFENQK---KMKERLGTAYYIAPEVLRK----------KYDEKCDVWSIGVILFILLA 232 (494)
T ss_dssp GEEESCSSTTCCEEECCCTTCEECBTTB---CBCCCCSCTTTCCHHHHTT----------CBCTHHHHHHHHHHHHHHHH
T ss_pred hEEEeCCCCCCcEEEEECCCCeECCCCc---cccccCCCcCeeCHHHHcc----------cCCCchhHHHHHHHHHHHHh
Confidence 999942 359999999998765332 2346789999999999853 36789999999999999999
Q ss_pred CCCCCCcchhHHHHHHhhcCCCCcc--cCCCCCChhHHHHHHHhcccCCCCCCChhHHhcCCCCCCCC------CCCCC-
Q 003052 706 GRTPFSEYKTFWAKFKVITDPNHEI--TYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQHPFLVPPV------STQPS- 776 (853)
Q Consensus 706 G~~PF~~~~~~~~~~kii~~~~~~~--~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~HPwf~~~~------~~~~~- 776 (853)
|.+||.+.........+.. ....+ ......++.+++||.+||.+||.+|||+.|+|+||||+... ...+.
T Consensus 233 g~~pf~~~~~~~~~~~i~~-~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~~~~~~~~~~~~~ 311 (494)
T 3lij_A 233 GYPPFGGQTDQEILRKVEK-GKYTFDSPEWKNVSEGAKDLIKQMLQFDSQRRISAQQALEHPWIKEMCSKKESGIELPSL 311 (494)
T ss_dssp SSCSSCCSSHHHHHHHHHH-TCCCCCSGGGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHHHHHHHHC---CCCC
T ss_pred CCCCCCCCCHHHHHHHHHh-CCCCCCchhcccCCHHHHHHHHHHCCCChhhCccHHHHhcCcccccCccccccccccccc
Confidence 9999987555433333222 12221 22245788999999999999999999999999999996310 01111
Q ss_pred -----------CChHHHHHHHHHHHHhhcChHHHHHHHHHHHhhhhCCccceeecccCcHHHHHHHHHHH---------H
Q 003052 777 -----------SSQDQSYQLLQLLAEASASDHEASTICSQLSQLIRNPVMLAATQLSTSQDQQCKLLLKL---------S 836 (853)
Q Consensus 777 -----------~~~~~~~~llq~l~~~~~s~~e~s~l~~q~~~l~~n~~~~~s~~~~~sq~~q~~~~~~~---------~ 836 (853)
..+......+..++.......+...+...|..+|.|.+|.++.+ |+...+.... .
T Consensus 312 ~~~~~~~~~~~~~~~l~qa~l~~ia~~~~~~~~~~~l~~~F~~~D~d~dG~I~~~-----El~~~l~~~~~~~~~~~~~~ 386 (494)
T 3lij_A 312 ANAIENMRKFQNSQKLAQAALLYMASKLTSQEETKELTDIFRHIDKNGDGQLDRQ-----ELIDGYSKLSGEEVAVFDLP 386 (494)
T ss_dssp SSHHHHHHTTTTCCHHHHHHHHHHHHHSCCHHHHHHHHHHHHHHCTTCSSEECHH-----HHHHTTHHHHSSCCCCC--C
T ss_pred HHHHHHHHHHHHhHHHHHHHHHHHHHhcccHHHHHHHHHHHHHhCcCCCCeEcHH-----HHHHHHHHhccccccccccc
Confidence 11222334455566666678888999999999999999999977 6665543321 2
Q ss_pred HHHHHHHHHHHhhhcCC
Q 003052 837 KLCLELQKRLANLRENK 853 (853)
Q Consensus 837 ~~~~~~~~i~~~~d~d~ 853 (853)
....+++++|+.+|.|+
T Consensus 387 ~~~~~~~~~~~~~D~d~ 403 (494)
T 3lij_A 387 QIESEVDAILGAADFDR 403 (494)
T ss_dssp HHHHHHHHHHHHHCTTC
T ss_pred ccHHHHHHHHHHhCCCC
Confidence 34778888999888774
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-46 Score=406.94 Aligned_cols=254 Identities=25% Similarity=0.398 Sum_probs=216.2
Q ss_pred ceeeEEEeEeccCceEEEEEEe-cCCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHHHH
Q 003052 472 KLYQRLGKIGSGGSSEVHKVIS-SDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLREV 550 (853)
Q Consensus 472 ~~Y~ilk~LG~G~FG~Vyka~~-~~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~~l 550 (853)
..|++++.||+|+||.||+|.+ .+++.||||++............+.+|+++|++++ ||||++++++
T Consensus 15 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~l~~~----------- 82 (328)
T 3fe3_A 15 GNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILN-HPNIVKLFEV----------- 82 (328)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCC-CTTBCCEEEE-----------
T ss_pred CCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCC-CCCEeeEEEE-----------
Confidence 4599999999999999999998 67899999999877666666778899999999997 8999999987
Q ss_pred hhCCCCCCCCccccCCeEEEEEecch-hhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCCCc
Q 003052 551 LNGSMNNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPA 629 (853)
Q Consensus 551 ~~~~iv~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLKPe 629 (853)
+.+.+.+|+||||+. ++|.+++... +.+++..++.++.||+.||.|||++||+||||||+
T Consensus 83 -----------~~~~~~~~lv~e~~~~~~L~~~l~~~--------~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~ 143 (328)
T 3fe3_A 83 -----------IETEKTLYLIMEYASGGEVFDYLVAH--------GRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAE 143 (328)
T ss_dssp -----------EECSSEEEEEECCCTTCBHHHHHHHH--------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGG
T ss_pred -----------EEECCEEEEEEECCCCCcHHHHHHHc--------CCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHH
Confidence 456778999999985 5999988765 56999999999999999999999999999999999
Q ss_pred cEEe-ecCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHhCCC
Q 003052 630 NFLL-VKGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGRT 708 (853)
Q Consensus 630 NILL-~~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLtG~~ 708 (853)
|||+ .++.+||+|||+++...... .....+||+.|+|||++.+..+ ++.++|||||||++|+|++|+.
T Consensus 144 NIll~~~~~~kl~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~--------~~~~~DiwslG~il~ell~g~~ 212 (328)
T 3fe3_A 144 NLLLDADMNIKIADFGFSNEFTVGG---KLDAFCGAPPYAAPELFQGKKY--------DGPEVDVWSLGVILYTLVSGSL 212 (328)
T ss_dssp GEEECTTSCEEECSTTCCGGGSSSC---GGGTTSSSGGGCCHHHHHTCCC--------CSHHHHHHHHHHHHHHHHHSSC
T ss_pred HEEEcCCCCEEEeeccCceecCCCC---ccccccCCcceeCcccccCCCc--------CCchhhhhhhHHHHHHHHhCCC
Confidence 9999 46799999999998764332 2346799999999999987643 3578999999999999999999
Q ss_pred CCCcchhHHHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCCChhHHhcCCCCCCC
Q 003052 709 PFSEYKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQHPFLVPP 770 (853)
Q Consensus 709 PF~~~~~~~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~HPwf~~~ 770 (853)
||.+.........+... ....+...++++.+||.+||..||.+|||+.|+|+||||...
T Consensus 213 pf~~~~~~~~~~~i~~~---~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~~~~~ 271 (328)
T 3fe3_A 213 PFDGQNLKELRERVLRG---KYRIPFYMSTDCENLLKRFLVLNPIKRGTLEQIMKDRWINAG 271 (328)
T ss_dssp SSCCSSHHHHHHHHHHC---CCCCCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTTCTTTTTT
T ss_pred CCCCCCHHHHHHHHHhC---CCCCCCCCCHHHHHHHHHHCCCChhHCcCHHHHhcCHhhcCC
Confidence 99876544333333322 223455678999999999999999999999999999999754
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-46 Score=403.85 Aligned_cols=261 Identities=32% Similarity=0.527 Sum_probs=208.7
Q ss_pred cCceeeEEEeEeccCceEEEEEEecCCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHHH
Q 003052 470 NGKLYQRLGKIGSGGSSEVHKVISSDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLRE 549 (853)
Q Consensus 470 ~g~~Y~ilk~LG~G~FG~Vyka~~~~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~~ 549 (853)
..++|+++++||+|+||.||+|.+.+++.||||++............+.+|+++|++++ |+||++++++
T Consensus 19 l~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~---------- 87 (311)
T 3niz_A 19 LMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELH-HPNIVSLIDV---------- 87 (311)
T ss_dssp SSCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCC-CTTBCCEEEE----------
T ss_pred hHhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcC-CCCEeeeeeE----------
Confidence 34679999999999999999999988999999999876555555567889999999997 9999999987
Q ss_pred HhhCCCCCCCCccccCCeEEEEEecchhhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCCCc
Q 003052 550 VLNGSMNNKDGRVKDDGYIYMVLEYGEIDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPA 629 (853)
Q Consensus 550 l~~~~iv~~~g~~~d~~~lyLVmEy~~gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLKPe 629 (853)
+.++..+|+||||++++|.+.+... ...+++..++.++.||+.||.|||++||+||||||+
T Consensus 88 ------------~~~~~~~~lv~e~~~~~l~~~~~~~-------~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~ 148 (311)
T 3niz_A 88 ------------IHSERCLTLVFEFMEKDLKKVLDEN-------KTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQ 148 (311)
T ss_dssp ------------ECCSSCEEEEEECCSEEHHHHHHTC-------TTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGG
T ss_pred ------------EccCCEEEEEEcCCCCCHHHHHHhc-------cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchH
Confidence 4566789999999999998887653 356999999999999999999999999999999999
Q ss_pred cEEe-ecCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHhCCC
Q 003052 630 NFLL-VKGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGRT 708 (853)
Q Consensus 630 NILL-~~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLtG~~ 708 (853)
|||+ .++.+||+|||+|+....... .....+||+.|+|||++.+.. .|+.++|||||||++|+|++|+.
T Consensus 149 NIl~~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~--------~~~~~~DiwslG~il~~ll~g~~ 218 (311)
T 3niz_A 149 NLLINSDGALKLADFGLARAFGIPVR--SYTHEVVTLWYRAPDVLMGSK--------KYSTSVDIWSIGCIFAEMITGKP 218 (311)
T ss_dssp GEEECTTCCEEECCCTTCEETTSCCC-----CCCCCCTTCCHHHHTTCC--------SCCTHHHHHHHHHHHHHHHHSSC
T ss_pred hEEECCCCCEEEccCcCceecCCCcc--cccCCcccCCcCCHHHhcCCC--------CCCchHHhHHHHHHHHHHHhCCC
Confidence 9999 567999999999987643222 233568999999999996532 36789999999999999999999
Q ss_pred CCCcchh---HHHHHHhhcCCCCcc------------------------cCCCCCChhHHHHHHHhcccCCCCCCChhHH
Q 003052 709 PFSEYKT---FWAKFKVITDPNHEI------------------------TYEPVPNPWLLDLMKKCLAWDRNERWRIPQL 761 (853)
Q Consensus 709 PF~~~~~---~~~~~kii~~~~~~~------------------------~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EI 761 (853)
||.+... ...+...+..+.... ...+..++++.+||.+||.+||.+|||+.|+
T Consensus 219 pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~el 298 (311)
T 3niz_A 219 LFPGVTDDDQLPKIFSILGTPNPREWPQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDA 298 (311)
T ss_dssp SCCCSSTTTHHHHHHHHHCCCCTTTSGGGTTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHH
T ss_pred CCCCCChHHHHHHHHHHHCCCChHHhhhhhccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHH
Confidence 9965332 222333222211110 0123456789999999999999999999999
Q ss_pred hcCCCCCCC
Q 003052 762 LQHPFLVPP 770 (853)
Q Consensus 762 L~HPwf~~~ 770 (853)
|+||||+..
T Consensus 299 l~hp~f~~~ 307 (311)
T 3niz_A 299 MNHPYFKDL 307 (311)
T ss_dssp HTSGGGTTS
T ss_pred hcCcccccC
Confidence 999999864
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-46 Score=416.48 Aligned_cols=262 Identities=28% Similarity=0.452 Sum_probs=202.5
Q ss_pred ceeeEEEeEeccCceEEEEEEe-cCCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHHHH
Q 003052 472 KLYQRLGKIGSGGSSEVHKVIS-SDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLREV 550 (853)
Q Consensus 472 ~~Y~ilk~LG~G~FG~Vyka~~-~~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~~l 550 (853)
++|++++.||+|+||.||+|.+ .+++.||||++............+.+|+.+|+++.+|+||+++++++..
T Consensus 9 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~-------- 80 (388)
T 3oz6_A 9 RKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRA-------- 80 (388)
T ss_dssp TTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEEC--------
T ss_pred CceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEec--------
Confidence 4699999999999999999998 5779999999987666666777889999999999999999999987431
Q ss_pred hhCCCCCCCCccccCCeEEEEEecchhhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCCCcc
Q 003052 551 LNGSMNNKDGRVKDDGYIYMVLEYGEIDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPAN 630 (853)
Q Consensus 551 ~~~~iv~~~g~~~d~~~lyLVmEy~~gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLKPeN 630 (853)
.+...+|+||||++++|..++.. ..+++..++.++.||+.||.|||++||+||||||+|
T Consensus 81 ------------~~~~~~~lv~e~~~~~L~~~~~~---------~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~N 139 (388)
T 3oz6_A 81 ------------DNDRDVYLVFDYMETDLHAVIRA---------NILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSN 139 (388)
T ss_dssp ------------TTSSCEEEEEECCSEEHHHHHHH---------TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGG
T ss_pred ------------CCCCEEEEEecccCcCHHHHHHc---------CCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHH
Confidence 23457999999999999988864 369999999999999999999999999999999999
Q ss_pred EEe-ecCcEEEEecccchhcccCC-------------------ccccccccccCccccCchhhccCCCCCCCccccCCCc
Q 003052 631 FLL-VKGSLKLIDFGIAKAIMSDT-------------------TNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRP 690 (853)
Q Consensus 631 ILL-~~g~VKL~DFGlAk~~~~~~-------------------~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~k 690 (853)
||+ .++.+||+|||+|+.+.... ........+||++|+|||++.+.. .|+.+
T Consensus 140 Ill~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--------~~~~~ 211 (388)
T 3oz6_A 140 ILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGST--------KYTKG 211 (388)
T ss_dssp EEECTTCCEEECCCTTCEESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCC--------CCCTH
T ss_pred eEEcCCCCEEecCCcccccccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCC--------CCCCh
Confidence 999 56799999999998653210 111234578999999999997532 46789
Q ss_pred cchhhhHHHHHHHHhCCCCCCcchhHHHHHHhh---cCCCCc--------------------------------------
Q 003052 691 SDIWSLGCILYQMVYGRTPFSEYKTFWAKFKVI---TDPNHE-------------------------------------- 729 (853)
Q Consensus 691 sDIWSLGVILyELLtG~~PF~~~~~~~~~~kii---~~~~~~-------------------------------------- 729 (853)
+||||||||+|||++|++||.+.........++ ..+...
T Consensus 212 ~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 291 (388)
T 3oz6_A 212 IDMWSLGCILGEILCGKPIFPGSSTMNQLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNL 291 (388)
T ss_dssp HHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHH
T ss_pred hhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhh
Confidence 999999999999999999997755443332221 111100
Q ss_pred ---ccCCCCCChhHHHHHHHhcccCCCCCCChhHHhcCCCCCCC
Q 003052 730 ---ITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQHPFLVPP 770 (853)
Q Consensus 730 ---~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~HPwf~~~ 770 (853)
.......++++.+||.+||.+||.+|||+.|+|+||||...
T Consensus 292 ~~~~~~~~~~~~~~~dll~~~L~~dP~~R~t~~e~l~Hp~~~~~ 335 (388)
T 3oz6_A 292 LLKINPKADCNEEALDLLDKLLQFNPNKRISANDALKHPFVSIF 335 (388)
T ss_dssp HHHHCTTCCCCHHHHHHHHHHCCSSGGGSCCHHHHTTSTTTTTT
T ss_pred cccccccccCCHHHHHHHHHhhccCcccCCCHHHHhCCHHHHHh
Confidence 00112567889999999999999999999999999999753
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-46 Score=394.32 Aligned_cols=259 Identities=29% Similarity=0.465 Sum_probs=209.8
Q ss_pred ceeeEEEeEeccCceEEEEEEec-CCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHHHH
Q 003052 472 KLYQRLGKIGSGGSSEVHKVISS-DCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLREV 550 (853)
Q Consensus 472 ~~Y~ilk~LG~G~FG~Vyka~~~-~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~~l 550 (853)
++|+++++||+|+||.||+|.+. +++.||||++............+.+|+.+|++++ |+||++++++
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~----------- 69 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELK-HKNIVRLHDV----------- 69 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCC-CTTBCCEEEE-----------
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCC-CCCEeeEEeE-----------
Confidence 46999999999999999999984 6789999999877666666677889999999997 8999999987
Q ss_pred hhCCCCCCCCccccCCeEEEEEecchhhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCCCcc
Q 003052 551 LNGSMNNKDGRVKDDGYIYMVLEYGEIDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPAN 630 (853)
Q Consensus 551 ~~~~iv~~~g~~~d~~~lyLVmEy~~gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLKPeN 630 (853)
+.++..+|+||||++++|.+.+... ...+++..++.++.||+.||.|||++||+||||||+|
T Consensus 70 -----------~~~~~~~~lv~e~~~~~l~~~~~~~-------~~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~N 131 (292)
T 3o0g_A 70 -----------LHSDKKLTLVFEFCDQDLKKYFDSC-------NGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQN 131 (292)
T ss_dssp -----------EEETTEEEEEEECCSEEHHHHHHHT-------TTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGG
T ss_pred -----------EEeCCEEEEEEecCCCCHHHHHHhC-------CCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHH
Confidence 4567789999999999888877653 3579999999999999999999999999999999999
Q ss_pred EEe-ecCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHhCCCC
Q 003052 631 FLL-VKGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGRTP 709 (853)
Q Consensus 631 ILL-~~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLtG~~P 709 (853)
||+ .++.+||+|||+++....... .....+||+.|+|||++.+.. .|+.++|||||||++|+|++|..|
T Consensus 132 il~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~--------~~~~~~DiwslG~il~~l~~~~~p 201 (292)
T 3o0g_A 132 LLINRNGELKLANFGLARAFGIPVR--CYSAEVVTLWYRPPDVLFGAK--------LYSTSIDMWSAGCIFAELANAGRP 201 (292)
T ss_dssp EEECTTSCEEECCCTTCEECCSCCS--CCCSCCSCGGGCCHHHHTTCS--------CCCTHHHHHHHHHHHHHHTTTSCC
T ss_pred EEEcCCCCEEEeecccceecCCccc--cccCCccccCCcChHHHcCCC--------CcCchHHHHHHHHHHHHHHHcCCC
Confidence 999 467999999999987643222 234568999999999997643 367899999999999999988888
Q ss_pred CCcchhHHH----HHHhhcCCCCc-----------------------ccCCCCCChhHHHHHHHhcccCCCCCCChhHHh
Q 003052 710 FSEYKTFWA----KFKVITDPNHE-----------------------ITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLL 762 (853)
Q Consensus 710 F~~~~~~~~----~~kii~~~~~~-----------------------~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL 762 (853)
|........ .......+... .......++.+++||.+||.+||.+|||+.|+|
T Consensus 202 ~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l 281 (292)
T 3o0g_A 202 LFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEAL 281 (292)
T ss_dssp SCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHH
T ss_pred CcCCCCHHHHHHHHHHHhCCCChhhhhhhcccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHh
Confidence 533222221 22221111100 111234678899999999999999999999999
Q ss_pred cCCCCCCC
Q 003052 763 QHPFLVPP 770 (853)
Q Consensus 763 ~HPwf~~~ 770 (853)
+||||...
T Consensus 282 ~hp~f~~~ 289 (292)
T 3o0g_A 282 QHPYFSDF 289 (292)
T ss_dssp TSGGGTTC
T ss_pred cCcccccC
Confidence 99999864
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-46 Score=394.83 Aligned_cols=258 Identities=30% Similarity=0.474 Sum_probs=207.1
Q ss_pred ceeeEEEeEeccCceEEEEEEecCCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHHHHh
Q 003052 472 KLYQRLGKIGSGGSSEVHKVISSDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLREVL 551 (853)
Q Consensus 472 ~~Y~ilk~LG~G~FG~Vyka~~~~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~~l~ 551 (853)
++|++++.||+|+||.||+|.+.+++.||||++............+.+|+.+|++++ ||||++++++
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~------------ 68 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELK-HSNIVKLYDV------------ 68 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCC-CTTBCCEEEE------------
T ss_pred ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcC-CCCEeeeeeE------------
Confidence 469999999999999999999988899999999876554444566889999999997 8999999987
Q ss_pred hCCCCCCCCccccCCeEEEEEecchhhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCCCccE
Q 003052 552 NGSMNNKDGRVKDDGYIYMVLEYGEIDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANF 631 (853)
Q Consensus 552 ~~~iv~~~g~~~d~~~lyLVmEy~~gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLKPeNI 631 (853)
+.+.+.+|+||||++++|.+++... ...+++..++.++.||+.||.|||++||+||||||+||
T Consensus 69 ----------~~~~~~~~lv~e~~~~~l~~~~~~~-------~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Ni 131 (288)
T 1ob3_A 69 ----------IHTKKRLVLVFEHLDQDLKKLLDVC-------EGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNL 131 (288)
T ss_dssp ----------EECSSCEEEEEECCSEEHHHHHHTS-------TTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGE
T ss_pred ----------EccCCeEEEEEEecCCCHHHHHHhc-------ccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHE
Confidence 4556789999999999998887642 35799999999999999999999999999999999999
Q ss_pred Ee-ecCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHhCCCCC
Q 003052 632 LL-VKGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGRTPF 710 (853)
Q Consensus 632 LL-~~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLtG~~PF 710 (853)
|+ .++.+||+|||+++....... .....+||+.|+|||++.+.. .|+.++|||||||++|+|++|+.||
T Consensus 132 l~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~--------~~~~~~DiwslG~il~~l~~g~~pf 201 (288)
T 1ob3_A 132 LINREGELKIADFGLARAFGIPVR--KYTHEIVTLWYRAPDVLMGSK--------KYSTTIDIWSVGCIFAEMVNGTPLF 201 (288)
T ss_dssp EECTTSCEEECCTTHHHHHCC-----------CCCTTCCHHHHTTCC--------SCCTHHHHHHHHHHHHHHHHSSCSC
T ss_pred EEcCCCCEEEeECccccccCcccc--ccccccccccccCchheeCCC--------CCCcHHHHHHHHHHHHHHHhCCCCC
Confidence 99 567999999999987643221 223568999999999996532 3678999999999999999999999
Q ss_pred CcchhHHHHHHh---hcCCCCc-----------------------ccCCCCCChhHHHHHHHhcccCCCCCCChhHHhcC
Q 003052 711 SEYKTFWAKFKV---ITDPNHE-----------------------ITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQH 764 (853)
Q Consensus 711 ~~~~~~~~~~ki---i~~~~~~-----------------------~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~H 764 (853)
.+.........+ ...+... ..+....++.+.+||.+||..||.+|||+.|+|+|
T Consensus 202 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 281 (288)
T 1ob3_A 202 PGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH 281 (288)
T ss_dssp CCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred CCCCHHHHHHHHHHHHCCCChhhchhhhcccccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 775443322222 1111100 01123467889999999999999999999999999
Q ss_pred CCCCC
Q 003052 765 PFLVP 769 (853)
Q Consensus 765 Pwf~~ 769 (853)
|||+.
T Consensus 282 p~f~~ 286 (288)
T 1ob3_A 282 AYFKE 286 (288)
T ss_dssp GGGGC
T ss_pred cchhh
Confidence 99974
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-45 Score=397.98 Aligned_cols=266 Identities=24% Similarity=0.297 Sum_probs=216.8
Q ss_pred cCCCCCceeEEcCceeeEEEeEeccCceEEEEEEec-CCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEee
Q 003052 459 RNYDPDLFFKVNGKLYQRLGKIGSGGSSEVHKVISS-DCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLI 537 (853)
Q Consensus 459 ~~~dp~~~~~v~g~~Y~ilk~LG~G~FG~Vyka~~~-~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Li 537 (853)
..|++.....+..+.|+++++||+|+||+||+|.+. +++.||||++............+..|+..+.++..|+||++++
T Consensus 44 ~~~~p~~~~~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~ 123 (311)
T 3p1a_A 44 PGYDPSRPESFFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLE 123 (311)
T ss_dssp TTCCTTSSSCHHHHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred CCCCCCCccchhhhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEE
Confidence 344554444445578999999999999999999985 7899999999876666666667788898888887899999999
Q ss_pred ehhhhHHHHHHHHhhCCCCCCCCccccCCeEEEEEecchhhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcc
Q 003052 538 DYEVTEKALLREVLNGSMNNKDGRVKDDGYIYMVLEYGEIDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIH 617 (853)
Q Consensus 538 d~~~~e~~iL~~l~~~~iv~~~g~~~d~~~lyLVmEy~~gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLH 617 (853)
++ +.+++.+|+||||++++|.+++... ...+++..++.|+.||+.||.|||
T Consensus 124 ~~----------------------~~~~~~~~lv~e~~~~~L~~~~~~~-------~~~l~~~~~~~i~~qi~~aL~~LH 174 (311)
T 3p1a_A 124 QA----------------------WEEGGILYLQTELCGPSLQQHCEAW-------GASLPEAQVWGYLRDTLLALAHLH 174 (311)
T ss_dssp EE----------------------EEETTEEEEEEECCCCBHHHHHHHH-------CSCCCHHHHHHHHHHHHHHHHHHH
T ss_pred EE----------------------EEeCCEEEEEEeccCCCHHHHHHhc-------CCCCCHHHHHHHHHHHHHHHHHHH
Confidence 87 4567789999999999999988764 346999999999999999999999
Q ss_pred cCceeeCCCCCccEEe-ecCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhh
Q 003052 618 EERIVHSDLKPANFLL-VKGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSL 696 (853)
Q Consensus 618 s~gIIHRDLKPeNILL-~~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSL 696 (853)
++||+||||||+|||+ .++.+||+|||+++...... .....+||+.|+|||++.+ .|+.++|||||
T Consensus 175 ~~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~----------~~~~~~Diwsl 241 (311)
T 3p1a_A 175 SQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAG---AGEVQEGDPRYMAPELLQG----------SYGTAADVFSL 241 (311)
T ss_dssp HTTEECCCCSGGGEEECGGGCEEECCCTTCEECC---------CCCCCGGGCCGGGGGT----------CCSTHHHHHHH
T ss_pred HCCEecCCCCHHHEEECCCCCEEEccceeeeecccCC---CCcccCCCccccCHhHhcC----------CCCchhhHHHH
Confidence 9999999999999999 56799999999998664322 2235679999999999865 25689999999
Q ss_pred HHHHHHHHhCCCCCCcchhHHHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCCChhHHhcCCCCCCC
Q 003052 697 GCILYQMVYGRTPFSEYKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQHPFLVPP 770 (853)
Q Consensus 697 GVILyELLtG~~PF~~~~~~~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~HPwf~~~ 770 (853)
||++|||++|..||.+....... ........+....++++.+||.+||..||.+|||+.|+|+||||+.+
T Consensus 242 G~il~el~~g~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~p 311 (311)
T 3p1a_A 242 GLTILEVACNMELPHGGEGWQQL----RQGYLPPEFTAGLSSELRSVLVMMLEPDPKLRATAEALLALPVLRQP 311 (311)
T ss_dssp HHHHHHHHHTCCCCSSHHHHHHH----TTTCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGSCC
T ss_pred HHHHHHHHhCCCCCCCccHHHHH----hccCCCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHHhCccccCC
Confidence 99999999997777654433222 22222333455678999999999999999999999999999999753
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-46 Score=411.22 Aligned_cols=254 Identities=24% Similarity=0.373 Sum_probs=209.1
Q ss_pred ceeeEEEeEeccCceEEEEEEec-CCcEEEEEEEecCCC-ChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHHH
Q 003052 472 KLYQRLGKIGSGGSSEVHKVISS-DCTIYALKKIKLKGR-DYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLRE 549 (853)
Q Consensus 472 ~~Y~ilk~LG~G~FG~Vyka~~~-~g~~vAVKkik~~~~-~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~~ 549 (853)
++|++++.||+|+||.||+|++. +++.||||++++... .......+.+|+.+|..+.+||||++++++
T Consensus 23 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~---------- 92 (353)
T 3txo_A 23 DNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCC---------- 92 (353)
T ss_dssp CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEE----------
T ss_pred hheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEE----------
Confidence 56999999999999999999984 678999999986421 223345578999999999889999999987
Q ss_pred HhhCCCCCCCCccccCCeEEEEEecch-hhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCCC
Q 003052 550 VLNGSMNNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKP 628 (853)
Q Consensus 550 l~~~~iv~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLKP 628 (853)
+.+...+|+||||+. ++|..++... ..+++..++.|+.||+.||.|||++||+||||||
T Consensus 93 ------------~~~~~~~~lv~E~~~gg~L~~~l~~~--------~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp 152 (353)
T 3txo_A 93 ------------FQTPDRLFFVMEFVNGGDLMFHIQKS--------RRFDEARARFYAAEIISALMFLHDKGIIYRDLKL 152 (353)
T ss_dssp ------------EECSSEEEEEEECCCSCBHHHHHHHH--------SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCG
T ss_pred ------------EEeCCEEEEEEeCCCCCcHHHHHHHc--------CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCH
Confidence 567788999999986 5999888764 5699999999999999999999999999999999
Q ss_pred ccEEe-ecCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHhCC
Q 003052 629 ANFLL-VKGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGR 707 (853)
Q Consensus 629 eNILL-~~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLtG~ 707 (853)
+|||| .+|.+||+|||+|+...... ....+.+||+.|+|||++.+. .|+.++|||||||++|||++|+
T Consensus 153 ~NILl~~~g~ikL~DFG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~---------~~~~~~DiwslG~il~ell~G~ 221 (353)
T 3txo_A 153 DNVLLDHEGHCKLADFGMCKEGICNG--VTTATFCGTPDYIAPEILQEM---------LYGPAVDWWAMGVLLYEMLCGH 221 (353)
T ss_dssp GGEEECTTSCEEECCCTTCBCSCC-----------CCGGGCCHHHHHHH---------HCTTHHHHHHHHHHHHHHHHSS
T ss_pred HHEEECCCCCEEEccccceeecccCC--ccccccCCCcCeEChhhcCCC---------CcCCccCCCcchHHHHHHHhCC
Confidence 99999 56899999999998643322 223467999999999999765 3678999999999999999999
Q ss_pred CCCCcchhHHHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCh------hHHhcCCCCCC
Q 003052 708 TPFSEYKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRI------PQLLQHPFLVP 769 (853)
Q Consensus 708 ~PF~~~~~~~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa------~EIL~HPwf~~ 769 (853)
+||.+.........+.. ....++...++.+.+||.+||.+||.+||++ .+|++||||..
T Consensus 222 ~Pf~~~~~~~~~~~i~~---~~~~~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~hp~f~~ 286 (353)
T 3txo_A 222 APFEAENEDDLFEAILN---DEVVYPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRHPFFKE 286 (353)
T ss_dssp CSSCCSSHHHHHHHHHH---CCCCCCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHTSGGGTT
T ss_pred CCCCCCCHHHHHHHHHc---CCCCCCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhhCCcccC
Confidence 99987655443333333 2334566788999999999999999999999 89999999974
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-46 Score=396.87 Aligned_cols=254 Identities=28% Similarity=0.478 Sum_probs=214.5
Q ss_pred ceeeEEEeEeccCceEEEEEEe-cCCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHHHH
Q 003052 472 KLYQRLGKIGSGGSSEVHKVIS-SDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLREV 550 (853)
Q Consensus 472 ~~Y~ilk~LG~G~FG~Vyka~~-~~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~~l 550 (853)
++|+++++||+|+||.||+|.+ .+++.||||++....... ...+.+|+.++++++ ||||++++++
T Consensus 20 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~E~~~l~~l~-hp~iv~~~~~----------- 85 (297)
T 3fxz_A 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK--KELIINEILVMRENK-NPNIVNYLDS----------- 85 (297)
T ss_dssp GTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSC--HHHHHHHHHHHHHCC-CTTBCCEEEE-----------
T ss_pred hceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccH--HHHHHHHHHHHhcCC-CCCCCeEeEE-----------
Confidence 5699999999999999999997 577899999997654332 345789999999997 8999999987
Q ss_pred hhCCCCCCCCccccCCeEEEEEecch-hhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCCCc
Q 003052 551 LNGSMNNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPA 629 (853)
Q Consensus 551 ~~~~iv~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLKPe 629 (853)
+.+.+.+|+||||+. ++|.+++.. ..+++..++.++.||+.||.|||++||+||||||+
T Consensus 86 -----------~~~~~~~~lv~e~~~~~~L~~~~~~---------~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~ 145 (297)
T 3fxz_A 86 -----------YLVGDELWVVMEYLAGGSLTDVVTE---------TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSD 145 (297)
T ss_dssp -----------EEETTEEEEEEECCTTCBHHHHHHH---------SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGG
T ss_pred -----------EEECCEEEEEEECCCCCCHHHHHhh---------cCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHH
Confidence 455678999999984 699888865 35999999999999999999999999999999999
Q ss_pred cEEe-ecCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHhCCC
Q 003052 630 NFLL-VKGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGRT 708 (853)
Q Consensus 630 NILL-~~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLtG~~ 708 (853)
|||+ .++.+||+|||+|+....... .....+||+.|+|||++.+. .|+.++|||||||++|+|++|+.
T Consensus 146 Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~---------~~~~~~DiwslG~il~ell~g~~ 214 (297)
T 3fxz_A 146 NILLGMDGSVKLTDFGFCAQITPEQS--KRSTMVGTPYWMAPEVVTRK---------AYGPKVDIWSLGIMAIEMIEGEP 214 (297)
T ss_dssp GEEECTTCCEEECCCTTCEECCSTTC--CBCCCCSCGGGCCHHHHHCS---------CBCTHHHHHHHHHHHHHHHHSSC
T ss_pred HEEECCCCCEEEeeCCCceecCCccc--ccCCccCCcCccChhhhcCC---------CCCcHHHHHHHHHHHHHHHhCCC
Confidence 9999 477999999999987654322 23467899999999999765 36789999999999999999999
Q ss_pred CCCcchhHHHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCCChhHHhcCCCCCCC
Q 003052 709 PFSEYKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQHPFLVPP 770 (853)
Q Consensus 709 PF~~~~~~~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~HPwf~~~ 770 (853)
||.+.........+..........+...+..+.+||.+||..||.+|||+.|+|+||||+..
T Consensus 215 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~ 276 (297)
T 3fxz_A 215 PYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHQFLKIA 276 (297)
T ss_dssp TTTTSCHHHHHHHHHHHCSCCCSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGC
T ss_pred CCCCCCHHHHHHHHHhCCCCCCCCccccCHHHHHHHHHHccCChhHCcCHHHHhhChhhccc
Confidence 99876665555555444444445566778899999999999999999999999999999754
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-46 Score=422.40 Aligned_cols=265 Identities=26% Similarity=0.425 Sum_probs=198.3
Q ss_pred ceeeEEEeEeccCceEEEEEEec-CCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHHHH
Q 003052 472 KLYQRLGKIGSGGSSEVHKVISS-DCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLREV 550 (853)
Q Consensus 472 ~~Y~ilk~LG~G~FG~Vyka~~~-~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~~l 550 (853)
++|++++.||+|+||.||+|.+. +++.||||++............+.+|+++|++++ |+||+++++++..
T Consensus 53 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~-------- 123 (458)
T 3rp9_A 53 DRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLN-HDHVVKVLDIVIP-------- 123 (458)
T ss_dssp TTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCC-CTTBCCEEEECCC--------
T ss_pred CCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCC-CCCCCceEEEEec--------
Confidence 56999999999999999999984 7789999999876666677778999999999996 9999999997532
Q ss_pred hhCCCCCCCCccccCCeEEEEEecchhhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCCCcc
Q 003052 551 LNGSMNNKDGRVKDDGYIYMVLEYGEIDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPAN 630 (853)
Q Consensus 551 ~~~~iv~~~g~~~d~~~lyLVmEy~~gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLKPeN 630 (853)
..+.....+|+||||++++|..++... ..+++..++.|+.||+.||.|||++|||||||||+|
T Consensus 124 ---------~~~~~~~~~~lv~e~~~~~L~~~~~~~--------~~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~N 186 (458)
T 3rp9_A 124 ---------KDVEKFDELYVVLEIADSDFKKLFRTP--------VYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPAN 186 (458)
T ss_dssp ---------SCTTTCCCEEEEECCCSEEHHHHHHSS--------CCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGG
T ss_pred ---------CCcccCceEEEEEeccccchhhhcccC--------CCCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhh
Confidence 123455789999999999999888643 579999999999999999999999999999999999
Q ss_pred EEe-ecCcEEEEecccchhcccCCcc-------------------------ccccccccCccccCchhhccCCCCCCCcc
Q 003052 631 FLL-VKGSLKLIDFGIAKAIMSDTTN-------------------------IQRDSQVGTLSYMSPEAFMCNESDENGNI 684 (853)
Q Consensus 631 ILL-~~g~VKL~DFGlAk~~~~~~~~-------------------------~~~~t~~GTp~YmAPEvl~~~~~~~~~~~ 684 (853)
||| .++.+||+|||+|+........ ......+||++|+|||++....
T Consensus 187 ILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~------- 259 (458)
T 3rp9_A 187 CLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQE------- 259 (458)
T ss_dssp EEECTTCCEEECCCTTCBCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCC-------
T ss_pred EEECCCCCEeecccccchhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCC-------
Confidence 999 4679999999999876422110 1234678999999999875332
Q ss_pred ccCCCccchhhhHHHHHHHHh-----------CCCCCCcch-----------------------hHHHHHHhhcCCCC--
Q 003052 685 IKCGRPSDIWSLGCILYQMVY-----------GRTPFSEYK-----------------------TFWAKFKVITDPNH-- 728 (853)
Q Consensus 685 ~~ys~ksDIWSLGVILyELLt-----------G~~PF~~~~-----------------------~~~~~~kii~~~~~-- 728 (853)
.|+.++||||||||||||++ |+++|.+.. .+..++..+..+..
T Consensus 260 -~~~~~~DiwSlG~il~elltg~~~~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~ 338 (458)
T 3rp9_A 260 -NYTEAIDVWSIGCIFAELLNMIKENVAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEED 338 (458)
T ss_dssp -CCCTHHHHHHHHHHHHHHHTTSTTTCSSGGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHH
T ss_pred -CCCcHhHHHHHHHHHHHHHHhccccccccccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHH
Confidence 47789999999999999998 777775432 11112222211110
Q ss_pred -----------------------cccCCCCCChhHHHHHHHhcccCCCCCCChhHHhcCCCCCCC
Q 003052 729 -----------------------EITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQHPFLVPP 770 (853)
Q Consensus 729 -----------------------~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~HPwf~~~ 770 (853)
.....+..++++.+||.+||.+||.+|||+.|+|+||||...
T Consensus 339 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~t~~e~L~Hp~f~~~ 403 (458)
T 3rp9_A 339 IEALEKEDAKRYIRIFPKREGTDLAERFPASSADAIHLLKRMLVFNPNKRITINECLAHPFFKEV 403 (458)
T ss_dssp HHTSSCHHHHHHHTTSCCCCCCCGGGGSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTT
T ss_pred HhhcCCHHHHHHHHhcCCCCCCCHHHHCCCCCHHHHHHHHHHhccCccccCCHHHHhcCHhhhhc
Confidence 011123458889999999999999999999999999999864
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-45 Score=394.89 Aligned_cols=275 Identities=48% Similarity=0.797 Sum_probs=220.9
Q ss_pred eeEEcCceeeEEEeEeccCceEEEEEEecCCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcC-CCceeEeeehhhhHH
Q 003052 466 FFKVNGKLYQRLGKIGSGGSSEVHKVISSDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKG-KNNIIQLIDYEVTEK 544 (853)
Q Consensus 466 ~~~v~g~~Y~ilk~LG~G~FG~Vyka~~~~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~-hpNIV~Lid~~~~e~ 544 (853)
.+.+.++.|++++.||+|+||.||+|.+.+++.||||++............+.+|+.+|+++.+ |+||++++++
T Consensus 22 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~----- 96 (313)
T 3cek_A 22 SMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDY----- 96 (313)
T ss_dssp EEEETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEE-----
T ss_pred eeeeccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEE-----
Confidence 3677889999999999999999999999889999999998776666677789999999999986 7999999987
Q ss_pred HHHHHHhhCCCCCCCCccccCCeEEEEEecchhhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeC
Q 003052 545 ALLREVLNGSMNNKDGRVKDDGYIYMVLEYGEIDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHS 624 (853)
Q Consensus 545 ~iL~~l~~~~iv~~~g~~~d~~~lyLVmEy~~gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHR 624 (853)
+.++..+|+|||+++++|.+++... ..+++..++.++.||+.||.|||++||+||
T Consensus 97 -----------------~~~~~~~~lv~e~~~~~L~~~l~~~--------~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~ 151 (313)
T 3cek_A 97 -----------------EITDQYIYMVMECGNIDLNSWLKKK--------KSIDPWERKSYWKNMLEAVHTIHQHGIVHS 151 (313)
T ss_dssp -----------------EECSSEEEEEECCCSEEHHHHHHHC--------SSCCHHHHHHHHHHHHHHHHHHHHTTCCCC
T ss_pred -----------------eecCCEEEEEEecCCCcHHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHHCCceec
Confidence 4556789999999888999998754 578999999999999999999999999999
Q ss_pred CCCCccEEeecCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCC--CccccCCCccchhhhHHHHHH
Q 003052 625 DLKPANFLLVKGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDEN--GNIIKCGRPSDIWSLGCILYQ 702 (853)
Q Consensus 625 DLKPeNILL~~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~--~~~~~ys~ksDIWSLGVILyE 702 (853)
||||+|||++++.+||+|||+++..............+||+.|+|||++.+...... .....++.++|||||||++|+
T Consensus 152 dlkp~NIl~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~e 231 (313)
T 3cek_A 152 DLKPANFLIVDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYY 231 (313)
T ss_dssp CCCGGGEEEETTEEEECCCSSSCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHH
T ss_pred CCCcccEEEECCeEEEeeccccccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHH
Confidence 999999999999999999999987654333323345689999999999975321100 001246789999999999999
Q ss_pred HHhCCCCCCcchhHHHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCCChhHHhcCCCCCCC
Q 003052 703 MVYGRTPFSEYKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQHPFLVPP 770 (853)
Q Consensus 703 LLtG~~PF~~~~~~~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~HPwf~~~ 770 (853)
|++|+.||............+........++...+.++.+||.+||..||.+||++.|+|+||||...
T Consensus 232 l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~~~~~ 299 (313)
T 3cek_A 232 MTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQ 299 (313)
T ss_dssp HHHSSCTTTTCCSHHHHHHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHCC
T ss_pred HHhCCCchhhHHHHHHHHHHHHhcccccCCcccchHHHHHHHHHHccCCcccCcCHHHHhcCccccCC
Confidence 99999999765433333344444455555666778899999999999999999999999999999754
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-46 Score=402.45 Aligned_cols=257 Identities=19% Similarity=0.212 Sum_probs=187.7
Q ss_pred ceeeEEEeEeccCceEEEEEEecCCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHHHHh
Q 003052 472 KLYQRLGKIGSGGSSEVHKVISSDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLREVL 551 (853)
Q Consensus 472 ~~Y~ilk~LG~G~FG~Vyka~~~~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~~l~ 551 (853)
++|.+.++||+|+||+||+|++ +|+.||||+++.... ....+..|+..+.+++ |||||++++++..+
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~~~---~~~~~e~Ei~~~~~l~-HpNIv~l~g~~~~~-------- 69 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREE---RSWFREAEIYQTVMLR-HENILGFIAADNKD-------- 69 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEE-TTEEEEEEEECGGGH---HHHHHHHHHHTSTTCC-CTTBCCEEEEEEEE--------
T ss_pred cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccch---hhHHHHHHHHHHhcCC-CCCCCcEEEEEEec--------
Confidence 4689999999999999999987 578899999975421 1112334555556676 99999999985321
Q ss_pred hCCCCCCCCccccCCeEEEEEecch-hhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccC--------cee
Q 003052 552 NGSMNNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEE--------RIV 622 (853)
Q Consensus 552 ~~~iv~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~--------gII 622 (853)
......+||||||++ |+|.+++.. ..+++..+..|+.|++.||.|||++ +||
T Consensus 70 ----------~~~~~~~~lV~Ey~~~gsL~~~l~~---------~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~Ii 130 (303)
T 3hmm_A 70 ----------NGTWTQLWLVSDYHEHGSLFDYLNR---------YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIA 130 (303)
T ss_dssp ----------CSSSEEEEEEEECCTTCBHHHHHHH---------CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEE
T ss_pred ----------CCCceEEEEEecCCCCCcHHHHHHh---------CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEe
Confidence 011236899999987 699999865 3689999999999999999999987 999
Q ss_pred eCCCCCccEEee-cCcEEEEecccchhcccCCcc--ccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHH
Q 003052 623 HSDLKPANFLLV-KGSLKLIDFGIAKAIMSDTTN--IQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCI 699 (853)
Q Consensus 623 HRDLKPeNILL~-~g~VKL~DFGlAk~~~~~~~~--~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVI 699 (853)
||||||+||||+ ++.+||+|||+|+........ ......+||+.|||||++.+.... ....|+.++|||||||+
T Consensus 131 HRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~---~~~~~~~k~DVwS~Gvv 207 (303)
T 3hmm_A 131 HRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINM---KHFESFKRADIYAMGLV 207 (303)
T ss_dssp CSCCCGGGEEECTTSCEEECCCTTCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCT---TCHHHHHHHHHHHHHHH
T ss_pred eccCCcccEEECCCCCEEEEeCCCCccccCCCCceeeecccccccccccCHHHhcccccc---cCCccChhHhhhhHHHH
Confidence 999999999994 679999999999876543221 122356899999999999764321 11246789999999999
Q ss_pred HHHHHhCCCCCCcch--------------hHHHHHHhhcCCCCcccCCCC-----CChhHHHHHHHhcccCCCCCCChhH
Q 003052 700 LYQMVYGRTPFSEYK--------------TFWAKFKVITDPNHEITYEPV-----PNPWLLDLMKKCLAWDRNERWRIPQ 760 (853)
Q Consensus 700 LyELLtG~~PF~~~~--------------~~~~~~kii~~~~~~~~~~~~-----~s~~l~dLI~kcL~~DP~kRpTa~E 760 (853)
||||+||.+||.... ......+.+.........+.. ....+.+||.+||..||.+|||+.|
T Consensus 208 l~El~tg~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 287 (303)
T 3hmm_A 208 FWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALR 287 (303)
T ss_dssp HHHHHHTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHH
T ss_pred HHHHHHCCCCCCccccccccchhcccccchHHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHH
Confidence 999999988763211 122233333322222222221 1235789999999999999999999
Q ss_pred Hhc
Q 003052 761 LLQ 763 (853)
Q Consensus 761 IL~ 763 (853)
|++
T Consensus 288 i~~ 290 (303)
T 3hmm_A 288 IKK 290 (303)
T ss_dssp HHH
T ss_pred HHH
Confidence 985
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-45 Score=402.29 Aligned_cols=254 Identities=25% Similarity=0.399 Sum_probs=211.1
Q ss_pred CceeeEEEeEeccCceEEEEEEec-CCcEEEEEEEecCCC-ChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHH
Q 003052 471 GKLYQRLGKIGSGGSSEVHKVISS-DCTIYALKKIKLKGR-DYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLR 548 (853)
Q Consensus 471 g~~Y~ilk~LG~G~FG~Vyka~~~-~g~~vAVKkik~~~~-~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~ 548 (853)
-++|++++.||+|+||.||+|.+. +++.||||++++... .......+.+|+.+|++++ ||||++++++
T Consensus 4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~l~~~--------- 73 (337)
T 1o6l_A 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTR-HPFLTALKYA--------- 73 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCC-CTTBCCEEEE---------
T ss_pred hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCC-CCcCcceEEE---------
Confidence 357999999999999999999984 689999999975421 1223446789999999997 9999999876
Q ss_pred HHhhCCCCCCCCccccCCeEEEEEecch-hhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCC
Q 003052 549 EVLNGSMNNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLK 627 (853)
Q Consensus 549 ~l~~~~iv~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLK 627 (853)
+.+...+|+||||+. ++|..++... ..+++..++.++.||+.||.|||++||+|||||
T Consensus 74 -------------~~~~~~~~lv~E~~~gg~L~~~l~~~--------~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlk 132 (337)
T 1o6l_A 74 -------------FQTHDRLCFVMEYANGGELFFHLSRE--------RVFTEERARFYGAEIVSALEYLHSRDVVYRDIK 132 (337)
T ss_dssp -------------EECSSEEEEEEECCTTCBHHHHHHHH--------SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCC
T ss_pred -------------EEeCCEEEEEEeCCCCCcHHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCC
Confidence 566788999999986 4898888754 579999999999999999999999999999999
Q ss_pred CccEEe-ecCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHhC
Q 003052 628 PANFLL-VKGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYG 706 (853)
Q Consensus 628 PeNILL-~~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLtG 706 (853)
|+|||+ .+|.+||+|||+|+....... ...+.+||+.|+|||++.+. .|+.++|||||||++|||++|
T Consensus 133 p~NIll~~~g~vkL~DFG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~---------~~~~~~DiwslG~il~ell~g 201 (337)
T 1o6l_A 133 LENLMLDKDGHIKITDFGLCKEGISDGA--TMKTFCGTPEYLAPEVLEDN---------DYGRAVDWWGLGVVMYEMMCG 201 (337)
T ss_dssp GGGEEECTTSCEEECCCTTCBCSCCTTC--CBCCCEECGGGCCGGGGSSS---------CBCTTHHHHHHHHHHHHHHHS
T ss_pred HHHEEECCCCCEEEeeccchhhcccCCC--cccccccChhhCChhhhcCC---------CCCchhhcccchhHHHHHhcC
Confidence 999999 568999999999986433222 23467999999999999765 367899999999999999999
Q ss_pred CCCCCcchhHHHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCC-----ChhHHhcCCCCCC
Q 003052 707 RTPFSEYKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERW-----RIPQLLQHPFLVP 769 (853)
Q Consensus 707 ~~PF~~~~~~~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRp-----Ta~EIL~HPwf~~ 769 (853)
+.||.+.........+.. ....++...++++++||.+||..||.+|| ++.||++||||..
T Consensus 202 ~~Pf~~~~~~~~~~~i~~---~~~~~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h~~f~~ 266 (337)
T 1o6l_A 202 RLPFYNQDHERLFELILM---EEIRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLS 266 (337)
T ss_dssp SCSSCCSSHHHHHHHHHH---CCCCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTT
T ss_pred CCCCCCCCHHHHHHHHHc---CCCCCCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcCCCcCC
Confidence 999977554333333332 22345667899999999999999999999 9999999999964
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-45 Score=405.27 Aligned_cols=254 Identities=29% Similarity=0.445 Sum_probs=209.9
Q ss_pred ceeeEEEeEeccCceEEEEEEec-CCcEEEEEEEecCCCCh----hhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHH
Q 003052 472 KLYQRLGKIGSGGSSEVHKVISS-DCTIYALKKIKLKGRDY----ATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKAL 546 (853)
Q Consensus 472 ~~Y~ilk~LG~G~FG~Vyka~~~-~g~~vAVKkik~~~~~~----~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~i 546 (853)
+.|++.+.||+|+||.||+|.+. +++.||||+++...... .....+.+|+.+|+++. ||||++++++
T Consensus 12 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~-hpnIv~l~~~------- 83 (361)
T 2yab_A 12 DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVL-HPNIITLHDV------- 83 (361)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCC-CTTBCCEEEE-------
T ss_pred hceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCC-CcCCCcEEEE-------
Confidence 56999999999999999999984 67899999998754322 12456889999999997 9999999987
Q ss_pred HHHHhhCCCCCCCCccccCCeEEEEEecch-hhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCC
Q 003052 547 LREVLNGSMNNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSD 625 (853)
Q Consensus 547 L~~l~~~~iv~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRD 625 (853)
|.+...+|+||||+. ++|.+++... ..+++..++.++.||+.||.|||++||+|||
T Consensus 84 ---------------~~~~~~~~lv~e~~~gg~L~~~l~~~--------~~l~~~~~~~i~~qi~~aL~~LH~~givHrD 140 (361)
T 2yab_A 84 ---------------YENRTDVVLILELVSGGELFDFLAQK--------ESLSEEEATSFIKQILDGVNYLHTKKIAHFD 140 (361)
T ss_dssp ---------------EECSSEEEEEEECCCSCBHHHHHTTC--------SCCBHHHHHHHHHHHHHHHHHHHHTTEECCC
T ss_pred ---------------EEeCCEEEEEEEcCCCCcHHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHHCCcccCC
Confidence 566788999999984 6999988543 5799999999999999999999999999999
Q ss_pred CCCccEEee-cC----cEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHH
Q 003052 626 LKPANFLLV-KG----SLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCIL 700 (853)
Q Consensus 626 LKPeNILL~-~g----~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVIL 700 (853)
|||+|||+. ++ .+||+|||+++.+.... .....+||+.|+|||++.+. .|+.++|||||||++
T Consensus 141 lkp~NIll~~~~~~~~~vkl~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~---------~~~~~~DiwslGvil 208 (361)
T 2yab_A 141 LKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGV---EFKNIFGTPEFVAPEIVNYE---------PLGLEADMWSIGVIT 208 (361)
T ss_dssp CSGGGEEESCTTSSSCCEEECCCSSCEECCTTC---CCCCCCSCGGGCCHHHHTTC---------CCCTHHHHHHHHHHH
T ss_pred CCHHHEEEeCCCCCccCEEEEecCCceEcCCCC---ccccCCCCccEECchHHcCC---------CCCccccHHHHHHHH
Confidence 999999994 44 79999999998764422 23467899999999999764 367899999999999
Q ss_pred HHHHhCCCCCCcchhHHHHHHhhcCCCCcc--cCCCCCChhHHHHHHHhcccCCCCCCChhHHhcCCCCCC
Q 003052 701 YQMVYGRTPFSEYKTFWAKFKVITDPNHEI--TYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQHPFLVP 769 (853)
Q Consensus 701 yELLtG~~PF~~~~~~~~~~kii~~~~~~~--~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~HPwf~~ 769 (853)
|+|++|.+||.+.........+ ......+ .+....++.+++||.+||.+||.+|||+.|+|+||||..
T Consensus 209 ~~ll~g~~Pf~~~~~~~~~~~i-~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~ 278 (361)
T 2yab_A 209 YILLSGASPFLGDTKQETLANI-TAVSYDFDEEFFSQTSELAKDFIRKLLVKETRKRLTIQEALRHPWITP 278 (361)
T ss_dssp HHHHHSCCSSCCSSHHHHHHHH-HTTCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTSC
T ss_pred HHHHhCCCCCCCCCHHHHHHHH-HhcCCCCCchhccCCCHHHHHHHHHHCCCChhHCcCHHHHhcCcCcCC
Confidence 9999999999875544333333 2222211 223567888999999999999999999999999999975
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-45 Score=410.01 Aligned_cols=256 Identities=27% Similarity=0.397 Sum_probs=209.6
Q ss_pred CceeeEEEeEeccCceEEEEEEec-CCcEEEEEEEecCCC-ChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHH
Q 003052 471 GKLYQRLGKIGSGGSSEVHKVISS-DCTIYALKKIKLKGR-DYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLR 548 (853)
Q Consensus 471 g~~Y~ilk~LG~G~FG~Vyka~~~-~g~~vAVKkik~~~~-~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~ 548 (853)
-++|+++++||+|+||.||+|++. +++.||||++++... .......+.+|+.+|.++..||||++++++
T Consensus 51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~--------- 121 (396)
T 4dc2_A 51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSC--------- 121 (396)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEE---------
T ss_pred hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEE---------
Confidence 367999999999999999999985 678999999986533 223345578999999999789999999986
Q ss_pred HHhhCCCCCCCCccccCCeEEEEEecch-hhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCC
Q 003052 549 EVLNGSMNNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLK 627 (853)
Q Consensus 549 ~l~~~~iv~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLK 627 (853)
|++...+|+||||+. ++|..++... ..+++..++.|+.||+.||.|||++||+|||||
T Consensus 122 -------------~~~~~~~~lV~E~~~gg~L~~~l~~~--------~~l~~~~~~~~~~qi~~aL~~LH~~givHrDLK 180 (396)
T 4dc2_A 122 -------------FQTESRLFFVIEYVNGGDLMFHMQRQ--------RKLPEEHARFYSAEISLALNYLHERGIIYRDLK 180 (396)
T ss_dssp -------------EECSSEEEEEEECCTTCBHHHHHHHH--------SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCC
T ss_pred -------------EEECCEEEEEEEcCCCCcHHHHHHHc--------CCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCC
Confidence 567789999999986 4898888764 569999999999999999999999999999999
Q ss_pred CccEEe-ecCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHhC
Q 003052 628 PANFLL-VKGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYG 706 (853)
Q Consensus 628 PeNILL-~~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLtG 706 (853)
|+|||| .+|.+||+|||+|+....... ...+.+||+.|+|||++.+. .|+.++|||||||++|||++|
T Consensus 181 p~NILl~~~g~ikL~DFGla~~~~~~~~--~~~~~~gt~~Y~aPE~l~~~---------~~~~~~DiwslGvllyell~G 249 (396)
T 4dc2_A 181 LDNVLLDSEGHIKLTDYGMCKEGLRPGD--TTSTFCGTPNYIAPEILRGE---------DYGFSVDWWALGVLMFEMMAG 249 (396)
T ss_dssp GGGEEECTTSCEEECCCTTCBCCCCTTC--CBCCCCBCGGGCCHHHHTTC---------CBCTHHHHHHHHHHHHHHHHS
T ss_pred HHHEEECCCCCEEEeecceeeecccCCC--ccccccCCcccCCchhhcCC---------CCChHHHHHHHHHHHHHHHhC
Confidence 999999 567999999999986433222 23478999999999999765 367899999999999999999
Q ss_pred CCCCCcch--------hHHHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCh------hHHhcCCCCCC
Q 003052 707 RTPFSEYK--------TFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRI------PQLLQHPFLVP 769 (853)
Q Consensus 707 ~~PF~~~~--------~~~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa------~EIL~HPwf~~ 769 (853)
++||.... .....+..+.. ....++...++++++||.+||.+||.+||++ .||++||||..
T Consensus 250 ~~Pf~~~~~~~~~~~~~~~~~~~~i~~--~~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~Hpff~~ 324 (396)
T 4dc2_A 250 RSPFDIVGSSDNPDQNTEDYLFQVILE--KQIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRN 324 (396)
T ss_dssp SCSSTTTTC------CCHHHHHHHHHH--CCCCCCTTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHSTTTTT
T ss_pred CCCCcccccccccchhhHHHHHHHHhc--cccCCCCcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcCccccC
Confidence 99995321 11122233322 2334566789999999999999999999995 79999999964
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-45 Score=398.72 Aligned_cols=261 Identities=22% Similarity=0.361 Sum_probs=208.5
Q ss_pred ceeeEEEeEeccCceEEEEEEec-CCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHHHH
Q 003052 472 KLYQRLGKIGSGGSSEVHKVISS-DCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLREV 550 (853)
Q Consensus 472 ~~Y~ilk~LG~G~FG~Vyka~~~-~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~~l 550 (853)
++|++++.||+|+||.||+|.+. +++.||||++...... .....+.+|+.+++.++ |+||++++++
T Consensus 7 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~-hpnIv~~~~~----------- 73 (323)
T 3tki_A 7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV-DCPENIKKEICINKMLN-HENVVKFYGH----------- 73 (323)
T ss_dssp TCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--------CHHHHHHHHHHCC-CTTBCCEEEE-----------
T ss_pred hhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEccccc-chHHHHHHHHHHHHhCC-CCCCCeEEEE-----------
Confidence 56999999999999999999985 7789999999765332 23356889999999997 8999999987
Q ss_pred hhCCCCCCCCccccCCeEEEEEecchh-hHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCCCc
Q 003052 551 LNGSMNNKDGRVKDDGYIYMVLEYGEI-DLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPA 629 (853)
Q Consensus 551 ~~~~iv~~~g~~~d~~~lyLVmEy~~g-dL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLKPe 629 (853)
+.+++.+|+||||+.+ +|.+++.. ...+++..++.++.||+.||.|||++||+||||||+
T Consensus 74 -----------~~~~~~~~lv~e~~~~~~L~~~l~~--------~~~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~ 134 (323)
T 3tki_A 74 -----------RREGNIQYLFLEYCSGGELFDRIEP--------DIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPE 134 (323)
T ss_dssp -----------EECSSEEEEEEECCTTEEGGGGSBT--------TTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGG
T ss_pred -----------EecCCeEEEEEEcCCCCcHHHHHhh--------cCCCCHHHHHHHHHHHHHHHHHHHHCCccccccchH
Confidence 5667889999999864 77776643 356999999999999999999999999999999999
Q ss_pred cEEee-cCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHhCCC
Q 003052 630 NFLLV-KGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGRT 708 (853)
Q Consensus 630 NILL~-~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLtG~~ 708 (853)
|||++ ++.+||+|||+++.+............+||+.|+|||++.+.. .++.++|||||||++|+|++|+.
T Consensus 135 NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--------~~~~~~DiwslG~il~~ll~g~~ 206 (323)
T 3tki_A 135 NLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE--------FHAEPVDVWSCGIVLTAMLAGEL 206 (323)
T ss_dssp GEEECTTCCEEECCCTTCEECEETTEECCBCSCCSCGGGSCHHHHHCSS--------BCHHHHHHHHHHHHHHHHHHSSC
T ss_pred HEEEeCCCCEEEEEeeccceeccCCcccccCCCccCcCccCcHHhccCC--------CCCCcccHHHHHHHHHHHHhCCC
Confidence 99995 5799999999998765433333344678999999999997653 23578999999999999999999
Q ss_pred CCCcchhHHHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCCChhHHhcCCCCCCCCC
Q 003052 709 PFSEYKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQHPFLVPPVS 772 (853)
Q Consensus 709 PF~~~~~~~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~HPwf~~~~~ 772 (853)
||.........+................++.+.+||.+||..||.+|||+.|+|+||||.....
T Consensus 207 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h~~~~~~~~ 270 (323)
T 3tki_A 207 PWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPLK 270 (323)
T ss_dssp SCSSSCTTSHHHHHHHTTCTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCCCC
T ss_pred CCCCCchHHHHHHHHhcccccCCccccCCHHHHHHHHHHccCChhhCcCHHHHhhChhhccccc
Confidence 9976443222222222222222233457888999999999999999999999999999986543
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-45 Score=389.77 Aligned_cols=266 Identities=25% Similarity=0.380 Sum_probs=205.6
Q ss_pred cCceeeEEEeEeccCceEEEEEEe-cCCcEEEEEEEecCCCC---hhhHhhHHHHHHHHHHhc--CCCceeEeeehhhhH
Q 003052 470 NGKLYQRLGKIGSGGSSEVHKVIS-SDCTIYALKKIKLKGRD---YATAYGFCQEIEYLNKLK--GKNNIIQLIDYEVTE 543 (853)
Q Consensus 470 ~g~~Y~ilk~LG~G~FG~Vyka~~-~~g~~vAVKkik~~~~~---~~~~~~~l~EI~iLkkL~--~hpNIV~Lid~~~~e 543 (853)
...+|+++++||+|+||.||+|.+ .+++.||||++...... ......+.+|+.+++++. .|+||+++++++...
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~ 86 (308)
T 3g33_A 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS 86 (308)
T ss_dssp ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence 346799999999999999999998 57789999999754321 122335678999988887 499999999975321
Q ss_pred HHHHHHHhhCCCCCCCCccccCCeEEEEEecchhhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceee
Q 003052 544 KALLREVLNGSMNNKDGRVKDDGYIYMVLEYGEIDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVH 623 (853)
Q Consensus 544 ~~iL~~l~~~~iv~~~g~~~d~~~lyLVmEy~~gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIH 623 (853)
. ......+|+||||++++|.+++... ....+++..++.++.||+.||.|||++||+|
T Consensus 87 ~-----------------~~~~~~~~lv~e~~~~~L~~~~~~~------~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH 143 (308)
T 3g33_A 87 R-----------------TDREIKVTLVFEHVDQDLRTYLDKA------PPPGLPAETIKDLMRQFLRGLDFLHANCIVH 143 (308)
T ss_dssp C-----------------SSSEEEEEEEEECCCCBHHHHHHTC------CTTCSCHHHHHHHHHHHHHHHHHHHHTTCCC
T ss_pred C-----------------CCCceeEEEEehhhhcCHHHHHhhc------cCCCCCHHHHHHHHHHHHHHHHHHHHCCccc
Confidence 0 1122368999999999999988754 2345999999999999999999999999999
Q ss_pred CCCCCccEEe-ecCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHH
Q 003052 624 SDLKPANFLL-VKGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQ 702 (853)
Q Consensus 624 RDLKPeNILL-~~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyE 702 (853)
|||||+|||+ .++.+||+|||+|+...... .....+||+.|+|||++.+.. |+.++|||||||++|+
T Consensus 144 ~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~---------~~~~~DiwslG~il~~ 211 (308)
T 3g33_A 144 RDLKPENILVTSGGTVKLADFGLARIYSYQM---ALTPVVVTLWYRAPEVLLQST---------YATPVDMWSVGCIFAE 211 (308)
T ss_dssp SCCCTTTEEECTTSCEEECSCSCTTTSTTCC---CSGGGGCCCSSCCHHHHHTSC---------CCSTHHHHHHHHHHHH
T ss_pred CCCCHHHEEEcCCCCEEEeeCccccccCCCc---ccCCccccccccCchHHcCCC---------CCchHHHHHHHHHHHH
Confidence 9999999999 56799999999998664322 234678999999999997653 5689999999999999
Q ss_pred HHhCCCCCCcchhHHHHHHh---hcCCCCc---------------------ccCCCCCChhHHHHHHHhcccCCCCCCCh
Q 003052 703 MVYGRTPFSEYKTFWAKFKV---ITDPNHE---------------------ITYEPVPNPWLLDLMKKCLAWDRNERWRI 758 (853)
Q Consensus 703 LLtG~~PF~~~~~~~~~~ki---i~~~~~~---------------------~~~~~~~s~~l~dLI~kcL~~DP~kRpTa 758 (853)
|++|++||.+.........+ +..+... ....+..++.+.+||.+||.+||.+|||+
T Consensus 212 l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~ 291 (308)
T 3g33_A 212 MFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISA 291 (308)
T ss_dssp TTTSSCSCCCSSHHHHHHHHHHHHCCCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCH
T ss_pred HHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCH
Confidence 99999999775544333222 2111100 00123567889999999999999999999
Q ss_pred hHHhcCCCCCCC
Q 003052 759 PQLLQHPFLVPP 770 (853)
Q Consensus 759 ~EIL~HPwf~~~ 770 (853)
.|+|+||||...
T Consensus 292 ~e~l~h~~~~~~ 303 (308)
T 3g33_A 292 FRALQHSYLHKD 303 (308)
T ss_dssp HHHHTSTTC---
T ss_pred HHHhcCccccCC
Confidence 999999999753
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-45 Score=402.30 Aligned_cols=257 Identities=23% Similarity=0.322 Sum_probs=211.9
Q ss_pred EcCceeeEEEeEeccCceEEEEEEec-CCcEEEEEEEecCCC-ChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHH
Q 003052 469 VNGKLYQRLGKIGSGGSSEVHKVISS-DCTIYALKKIKLKGR-DYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKAL 546 (853)
Q Consensus 469 v~g~~Y~ilk~LG~G~FG~Vyka~~~-~g~~vAVKkik~~~~-~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~i 546 (853)
+.-++|++++.||+|+||.||+|++. +++.||||+++.... .......+.+|+.+|.++.+||||++++++
T Consensus 14 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~------- 86 (345)
T 1xjd_A 14 LKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCT------- 86 (345)
T ss_dssp --CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEE-------
T ss_pred CChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEE-------
Confidence 34467999999999999999999984 678999999976421 112334577899999998779999999886
Q ss_pred HHHHhhCCCCCCCCccccCCeEEEEEecch-hhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCC
Q 003052 547 LREVLNGSMNNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSD 625 (853)
Q Consensus 547 L~~l~~~~iv~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRD 625 (853)
+++...+|+||||+. ++|.+++... ..+++..++.|+.||+.||.|||++||+|||
T Consensus 87 ---------------~~~~~~~~lv~E~~~gg~L~~~l~~~--------~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrD 143 (345)
T 1xjd_A 87 ---------------FQTKENLFFVMEYLNGGDLMYHIQSC--------HKFDLSRATFYAAEIILGLQFLHSKGIVYRD 143 (345)
T ss_dssp ---------------EECSSEEEEEEECCTTCBHHHHHHHH--------SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCC
T ss_pred ---------------EEeCCEEEEEEeCCCCCcHHHHHHHc--------CCCCHHHHHHHHHHHHHHHHHHHHCCeEeCC
Confidence 567788999999985 5999988764 5699999999999999999999999999999
Q ss_pred CCCccEEe-ecCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHH
Q 003052 626 LKPANFLL-VKGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMV 704 (853)
Q Consensus 626 LKPeNILL-~~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELL 704 (853)
|||+|||+ .+|.+||+|||+|+....... .....+||+.|+|||++.+. .|+.++|||||||++|||+
T Consensus 144 lkp~NIll~~~g~vkL~DFG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~---------~~~~~~DiwslG~il~ell 212 (345)
T 1xjd_A 144 LKLDNILLDKDGHIKIADFGMCKENMLGDA--KTNTFCGTPDYIAPEILLGQ---------KYNHSVDWWSFGVLLYEML 212 (345)
T ss_dssp CCGGGEEECTTSCEEECCCTTCBCCCCTTC--CBCCCCSCGGGCCHHHHTTC---------CBCTHHHHHHHHHHHHHHH
T ss_pred CChhhEEECCCCCEEEeEChhhhhcccCCC--cccCCCCCcccCChhhhcCC---------CCCChhhhHHHHHHHHHHh
Confidence 99999999 568999999999986533221 23467999999999999765 3678999999999999999
Q ss_pred hCCCCCCcchhHHHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCCChh-HHhcCCCCCC
Q 003052 705 YGRTPFSEYKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIP-QLLQHPFLVP 769 (853)
Q Consensus 705 tG~~PF~~~~~~~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~-EIL~HPwf~~ 769 (853)
+|+.||.+.........+... ...++...++++++||.+||..||.+||++. +|++||||..
T Consensus 213 ~g~~Pf~~~~~~~~~~~i~~~---~~~~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~~hp~f~~ 275 (345)
T 1xjd_A 213 IGQSPFHGQDEEELFHSIRMD---NPFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFRE 275 (345)
T ss_dssp HSSCSSCCSSHHHHHHHHHHC---CCCCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGSGGGTT
T ss_pred cCCCCCCCCCHHHHHHHHHhC---CCCCCcccCHHHHHHHHHHhcCCHhHcCCChHHHHcCccccC
Confidence 999999875544333333222 2345667889999999999999999999998 9999999975
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-44 Score=397.58 Aligned_cols=255 Identities=27% Similarity=0.408 Sum_probs=210.6
Q ss_pred ceeeEEEeEeccCceEEEEEEec-CCcEEEEEEEecCCC-ChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHHH
Q 003052 472 KLYQRLGKIGSGGSSEVHKVISS-DCTIYALKKIKLKGR-DYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLRE 549 (853)
Q Consensus 472 ~~Y~ilk~LG~G~FG~Vyka~~~-~g~~vAVKkik~~~~-~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~~ 549 (853)
.+|++++.||+|+||.||+|++. +++.||||++++... .......+.+|+.+|+++.+||||++++++
T Consensus 9 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~---------- 78 (345)
T 3a8x_A 9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSC---------- 78 (345)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEE----------
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEE----------
Confidence 56999999999999999999984 678999999986543 344556688999999999779999999986
Q ss_pred HhhCCCCCCCCccccCCeEEEEEecch-hhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCCC
Q 003052 550 VLNGSMNNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKP 628 (853)
Q Consensus 550 l~~~~iv~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLKP 628 (853)
+.+...+|+||||+. ++|.+++... ..+++..++.|+.||+.||.|||++||+||||||
T Consensus 79 ------------~~~~~~~~lv~e~~~gg~L~~~l~~~--------~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp 138 (345)
T 3a8x_A 79 ------------FQTESRLFFVIEYVNGGDLMFHMQRQ--------RKLPEEHARFYSAEISLALNYLHERGIIYRDLKL 138 (345)
T ss_dssp ------------EECSSEEEEEECCCCSCBHHHHHHHH--------SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCG
T ss_pred ------------EEeCCEEEEEEeCCCCCcHHHHHHHc--------CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCH
Confidence 566788999999985 5998888754 4699999999999999999999999999999999
Q ss_pred ccEEe-ecCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHhCC
Q 003052 629 ANFLL-VKGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGR 707 (853)
Q Consensus 629 eNILL-~~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLtG~ 707 (853)
+|||+ .+|.+||+|||+|+....... .....+||+.|+|||++.+. .|+.++|||||||++|||++|+
T Consensus 139 ~NIll~~~g~~kL~DFG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~---------~~~~~~DiwslG~il~ell~g~ 207 (345)
T 3a8x_A 139 DNVLLDSEGHIKLTDYGMCKEGLRPGD--TTSTFCGTPNYIAPEILRGE---------DYGFSVDWWALGVLMFEMMAGR 207 (345)
T ss_dssp GGEEECTTSCEEECCGGGCBCSCCTTC--CBCCCCSCGGGCCHHHHTTC---------CBCTHHHHHHHHHHHHHHHHSS
T ss_pred HHEEECCCCCEEEEeccccccccCCCC--cccccCCCccccCccccCCC---------CCChHHhHHHHHHHHHHHHhCC
Confidence 99999 567999999999986433221 23467999999999999764 3678999999999999999999
Q ss_pred CCCCcc--------hhHHHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCh------hHHhcCCCCCC
Q 003052 708 TPFSEY--------KTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRI------PQLLQHPFLVP 769 (853)
Q Consensus 708 ~PF~~~--------~~~~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa------~EIL~HPwf~~ 769 (853)
.||... ......+..+.. ....++...+..+++||.+||.+||.+||++ .++++||||..
T Consensus 208 ~pf~~~~~~~~~~~~~~~~~~~~i~~--~~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~hp~f~~ 281 (345)
T 3a8x_A 208 SPFDIVGSSDNPDQNTEDYLFQVILE--KQIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRN 281 (345)
T ss_dssp CTTTTTTC-------CHHHHHHHHHH--CCCCCCTTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTSGGGTT
T ss_pred CCcCCcccccccccccHHHHHHHHHc--CCCCCCCCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcCCccCC
Confidence 999641 111122222222 2234566788999999999999999999996 89999999974
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-45 Score=419.07 Aligned_cols=259 Identities=27% Similarity=0.407 Sum_probs=202.9
Q ss_pred ceeeEEEeEeccCceEEEEEEe-cCCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHHHH
Q 003052 472 KLYQRLGKIGSGGSSEVHKVIS-SDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLREV 550 (853)
Q Consensus 472 ~~Y~ilk~LG~G~FG~Vyka~~-~~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~~l 550 (853)
++|+++++||+|+||.||+|.+ .+++.||||++............+.+|+.+|+.++ |+||+++++++...
T Consensus 62 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~~------- 133 (464)
T 3ttj_A 62 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVN-HKNIISLLNVFTPQ------- 133 (464)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCC-CTTBCCCSEEECSC-------
T ss_pred CCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCC-CCCCCcEEEEEccC-------
Confidence 5699999999999999999998 46789999999876556666778899999999996 99999999975321
Q ss_pred hhCCCCCCCCccccCCeEEEEEecchhhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCCCcc
Q 003052 551 LNGSMNNKDGRVKDDGYIYMVLEYGEIDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPAN 630 (853)
Q Consensus 551 ~~~~iv~~~g~~~d~~~lyLVmEy~~gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLKPeN 630 (853)
..+.+...+||||||++++|.+.+. ..+++..++.++.||+.||+|||++||+||||||+|
T Consensus 134 ---------~~~~~~~~~~lv~E~~~~~l~~~~~----------~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~N 194 (464)
T 3ttj_A 134 ---------KTLEEFQDVYLVMELMDANLCQVIQ----------MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSN 194 (464)
T ss_dssp ---------CSTTTCCEEEEEEECCSEEHHHHHT----------SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGG
T ss_pred ---------CccccCCeEEEEEeCCCCCHHHHHh----------hcCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHh
Confidence 1234556899999999988887763 248999999999999999999999999999999999
Q ss_pred EEee-cCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHhCCCC
Q 003052 631 FLLV-KGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGRTP 709 (853)
Q Consensus 631 ILL~-~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLtG~~P 709 (853)
|||+ ++.+||+|||+|+...... .....+||++|+|||++.+. .|+.++|||||||++|||++|++|
T Consensus 195 Ill~~~~~~kl~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~---------~~~~~~DiwSlG~il~ell~g~~p 262 (464)
T 3ttj_A 195 IVVKSDCTLKILDFGLARTAGTSF---MMTPYVVTRYYRAPEVILGM---------GYKENVDIWSVGCIMGEMVRHKIL 262 (464)
T ss_dssp EEECTTSCEEECCCCCC-----CC---CC----CCCTTCCHHHHTTC---------CCCTTHHHHHHHHHHHHHHHSSCS
T ss_pred EEEeCCCCEEEEEEEeeeecCCCc---ccCCCcccccccCHHHHcCC---------CCCHHHHHHHHHHHHHHHHhCCCC
Confidence 9995 6799999999998764321 23467999999999999765 367899999999999999999999
Q ss_pred CCcchhHHHHHHhh---cCCCCc---------------------cc----CCCC-----------CChhHHHHHHHhccc
Q 003052 710 FSEYKTFWAKFKVI---TDPNHE---------------------IT----YEPV-----------PNPWLLDLMKKCLAW 750 (853)
Q Consensus 710 F~~~~~~~~~~kii---~~~~~~---------------------~~----~~~~-----------~s~~l~dLI~kcL~~ 750 (853)
|.+.+......+++ ..+... .. ++.. .++++++||.+||.+
T Consensus 263 F~g~~~~~~~~~i~~~lg~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~ 342 (464)
T 3ttj_A 263 FPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVI 342 (464)
T ss_dssp SCCSSHHHHHHHHHHHHCSCCHHHHTTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCS
T ss_pred CCCCCHHHHHHHHHHhcCCCCHHHHHHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCC
Confidence 98755433322221 111000 00 0000 045689999999999
Q ss_pred CCCCCCChhHHhcCCCCCC
Q 003052 751 DRNERWRIPQLLQHPFLVP 769 (853)
Q Consensus 751 DP~kRpTa~EIL~HPwf~~ 769 (853)
||.+|||+.|+|+||||..
T Consensus 343 dP~~R~ta~e~L~Hp~~~~ 361 (464)
T 3ttj_A 343 DPAKRISVDDALQHPYINV 361 (464)
T ss_dssp STTTSCCHHHHHTSTTTGG
T ss_pred ChhhCCCHHHHhcChhhhh
Confidence 9999999999999999974
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-45 Score=396.80 Aligned_cols=258 Identities=28% Similarity=0.443 Sum_probs=200.5
Q ss_pred ceeeEEEeEeccCceEEEEEEe-cCCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHHHH
Q 003052 472 KLYQRLGKIGSGGSSEVHKVIS-SDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLREV 550 (853)
Q Consensus 472 ~~Y~ilk~LG~G~FG~Vyka~~-~~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~~l 550 (853)
++|+++++||+|+||.||+|.+ .+++.||||+++...........+.+|+.+|++++ |+||++++++
T Consensus 34 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~----------- 101 (329)
T 3gbz_A 34 DRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQ-HRNIIELKSV----------- 101 (329)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCC-CTTBCCEEEE-----------
T ss_pred hhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcC-CCCcceEEEE-----------
Confidence 5699999999999999999998 47789999999876555555566789999999996 9999999987
Q ss_pred hhCCCCCCCCccccCCeEEEEEecchhhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCCCcc
Q 003052 551 LNGSMNNKDGRVKDDGYIYMVLEYGEIDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPAN 630 (853)
Q Consensus 551 ~~~~iv~~~g~~~d~~~lyLVmEy~~gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLKPeN 630 (853)
+.++..+|+||||++++|.+++... ..+++..++.|+.||+.||.|||++||+||||||+|
T Consensus 102 -----------~~~~~~~~lv~e~~~~~L~~~~~~~--------~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~N 162 (329)
T 3gbz_A 102 -----------IHHNHRLHLIFEYAENDLKKYMDKN--------PDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQN 162 (329)
T ss_dssp -----------EEETTEEEEEEECCSEEHHHHHHHC--------TTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGG
T ss_pred -----------EecCCEEEEEEecCCCCHHHHHhhc--------CCCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHH
Confidence 4567789999999999999988754 469999999999999999999999999999999999
Q ss_pred EEee-c-----CcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHH
Q 003052 631 FLLV-K-----GSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMV 704 (853)
Q Consensus 631 ILL~-~-----g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELL 704 (853)
||+. + +.+||+|||+|+.+..... .....+||+.|+|||++.+.. .|+.++|||||||++|+|+
T Consensus 163 Ill~~~~~~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~--------~~~~~~DiwslG~il~ell 232 (329)
T 3gbz_A 163 LLLSVSDASETPVLKIGDFGLARAFGIPIR--QFTHEIITLWYRPPEILLGSR--------HYSTSVDIWSIACIWAEML 232 (329)
T ss_dssp EEEEC-----CCEEEECCTTHHHHHC-------------CCTTCCHHHHTTCC--------CCCTHHHHHHHHHHHHHHH
T ss_pred EEEecCCCCccceEEECcCCCccccCCccc--ccCCCcCCccccCHHHhcCCC--------CCCcHHHHHHHHHHHHHHH
Confidence 9993 2 2599999999987643322 234568999999999997642 3678999999999999999
Q ss_pred hCCCCCCcchhHHHHHHhh---cCCCCcc------------c------------CCCCCChhHHHHHHHhcccCCCCCCC
Q 003052 705 YGRTPFSEYKTFWAKFKVI---TDPNHEI------------T------------YEPVPNPWLLDLMKKCLAWDRNERWR 757 (853)
Q Consensus 705 tG~~PF~~~~~~~~~~kii---~~~~~~~------------~------------~~~~~s~~l~dLI~kcL~~DP~kRpT 757 (853)
+|++||.+.........+. ..+.... . .....++++.+||.+||.+||.+|||
T Consensus 233 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t 312 (329)
T 3gbz_A 233 MKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRIS 312 (329)
T ss_dssp HSSCSSCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCC
T ss_pred HCCCCcCCCCHHHHHHHHHHHhCCCchhhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCC
Confidence 9999998765544333322 1111000 0 01115678999999999999999999
Q ss_pred hhHHhcCCCCCCC
Q 003052 758 IPQLLQHPFLVPP 770 (853)
Q Consensus 758 a~EIL~HPwf~~~ 770 (853)
+.|+|+||||...
T Consensus 313 ~~e~l~hp~f~~~ 325 (329)
T 3gbz_A 313 AKNALEHPYFSHN 325 (329)
T ss_dssp HHHHHTSGGGSSS
T ss_pred HHHHhCCcccCCC
Confidence 9999999999854
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=408.61 Aligned_cols=265 Identities=30% Similarity=0.413 Sum_probs=205.4
Q ss_pred ceeeEEEeEeccCceEEEEEEe-cCCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHHHH
Q 003052 472 KLYQRLGKIGSGGSSEVHKVIS-SDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLREV 550 (853)
Q Consensus 472 ~~Y~ilk~LG~G~FG~Vyka~~-~~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~~l 550 (853)
++|++++.||+|+||.||+|.+ .+++.||||++............+.+|+++|++++ |+||+++++++...
T Consensus 26 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~------- 97 (432)
T 3n9x_A 26 DNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLK-SDYIIRLYDLIIPD------- 97 (432)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCC-CTTBCCEEEECCCS-------
T ss_pred CCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcC-CCCcceEEEEEecC-------
Confidence 5699999999999999999998 46788999999876666667778999999999997 89999999975321
Q ss_pred hhCCCCCCCCccccCCeEEEEEecchhhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCCCcc
Q 003052 551 LNGSMNNKDGRVKDDGYIYMVLEYGEIDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPAN 630 (853)
Q Consensus 551 ~~~~iv~~~g~~~d~~~lyLVmEy~~gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLKPeN 630 (853)
.+.....+|+||||++++|.+++... ..+++..++.|+.||+.||.|||++||+||||||+|
T Consensus 98 ----------~~~~~~~~~lv~e~~~~~L~~~~~~~--------~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~N 159 (432)
T 3n9x_A 98 ----------DLLKFDELYIVLEIADSDLKKLFKTP--------IFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPAN 159 (432)
T ss_dssp ----------CTTTCCCEEEEEECCSEEHHHHHHSS--------CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGG
T ss_pred ----------CCCcCCeEEEEEecCCcCHHHHHhcc--------CCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHH
Confidence 12333679999999999999988643 579999999999999999999999999999999999
Q ss_pred EEe-ecCcEEEEecccchhcccCCcc--------------------ccccccccCccccCchhhccCCCCCCCccccCCC
Q 003052 631 FLL-VKGSLKLIDFGIAKAIMSDTTN--------------------IQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGR 689 (853)
Q Consensus 631 ILL-~~g~VKL~DFGlAk~~~~~~~~--------------------~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ 689 (853)
||| .++.+||+|||+|+........ ......+||++|+|||++.... .|+.
T Consensus 160 ILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~--------~~~~ 231 (432)
T 3n9x_A 160 CLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQE--------NYTK 231 (432)
T ss_dssp EEECTTCCEEECCCTTCEEC-------------------------------CCCCCTTCCHHHHTTCS--------CCCT
T ss_pred eEECCCCCEEEccCCCcccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCC--------CCCc
Confidence 999 4679999999999876432211 1235789999999999975432 4778
Q ss_pred ccchhhhHHHHHHHHhCC-----------CCCCcch--------------------hHHHHHHhhcCCCC----------
Q 003052 690 PSDIWSLGCILYQMVYGR-----------TPFSEYK--------------------TFWAKFKVITDPNH---------- 728 (853)
Q Consensus 690 ksDIWSLGVILyELLtG~-----------~PF~~~~--------------------~~~~~~kii~~~~~---------- 728 (853)
++||||||||+|||++|. ++|.+.. .+..++..+..+..
T Consensus 232 ~~DiwSlG~il~ell~g~~p~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~ 311 (432)
T 3n9x_A 232 SIDIWSTGCIFAELLNMLQSHINDPTNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPE 311 (432)
T ss_dssp HHHHHHHHHHHHHHHTTCTTTCSSGGGCCCSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHH
T ss_pred ccccchHHHHHHHHHhcccccccccccccccCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHH
Confidence 999999999999999854 4443311 11122222221110
Q ss_pred ----------cc-----cCCCCCChhHHHHHHHhcccCCCCCCChhHHhcCCCCCCC
Q 003052 729 ----------EI-----TYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQHPFLVPP 770 (853)
Q Consensus 729 ----------~~-----~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~HPwf~~~ 770 (853)
.. ...+..++.+.+||.+||.+||.+|||+.|+|+||||...
T Consensus 312 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~ 368 (432)
T 3n9x_A 312 VIKYIKLFPHRKPINLKQKYPSISDDGINLLESMLKFNPNKRITIDQALDHPYLKDV 368 (432)
T ss_dssp HHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTCGGGTTT
T ss_pred HHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHhcCCcccCCCHHHHhcChhhhhc
Confidence 00 0113578899999999999999999999999999999764
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-45 Score=392.92 Aligned_cols=264 Identities=29% Similarity=0.479 Sum_probs=197.8
Q ss_pred ceeeEEEeEeccCceEEEEEEe-cCCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHHHH
Q 003052 472 KLYQRLGKIGSGGSSEVHKVIS-SDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLREV 550 (853)
Q Consensus 472 ~~Y~ilk~LG~G~FG~Vyka~~-~~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~~l 550 (853)
.+|++++.||+|+||.||+|.+ .+++.||||+++.... ......+.+|+.+|++++ ||||++++++
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~-hp~iv~~~~~----------- 71 (317)
T 2pmi_A 5 SQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSE-EGTPSTAIREISLMKELK-HENIVRLYDV----------- 71 (317)
T ss_dssp --------------CEEEEEECSSSCCEEEEEEEECCST-TCSCHHHHHHHHHHTTCC-BTTBCCEEEE-----------
T ss_pred cceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccc-cccHHHHHHHHHHHHhcC-CCCcceEEEE-----------
Confidence 4699999999999999999998 4678999999986542 223346789999999997 8999999987
Q ss_pred hhCCCCCCCCccccCCeEEEEEecchhhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCCCcc
Q 003052 551 LNGSMNNKDGRVKDDGYIYMVLEYGEIDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPAN 630 (853)
Q Consensus 551 ~~~~iv~~~g~~~d~~~lyLVmEy~~gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLKPeN 630 (853)
+.+++.+|+||||++++|.+++..... ......+++..++.++.||+.||.|||++||+||||||+|
T Consensus 72 -----------~~~~~~~~lv~e~~~~~L~~~l~~~~~--~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~N 138 (317)
T 2pmi_A 72 -----------IHTENKLTLVFEFMDNDLKKYMDSRTV--GNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQN 138 (317)
T ss_dssp -----------ECCTTEEEEEEECCCCBHHHHHHHHHS--SSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGG
T ss_pred -----------EEECCeEEEEEEecCCCHHHHHHhccc--cccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHH
Confidence 456678999999999999998876421 1223469999999999999999999999999999999999
Q ss_pred EEe-ecCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHhCCCC
Q 003052 631 FLL-VKGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGRTP 709 (853)
Q Consensus 631 ILL-~~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLtG~~P 709 (853)
||+ .+|.+||+|||+++....... .....+||+.|+|||++.+.. .|+.++|||||||++|+|++|+.|
T Consensus 139 Il~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~--------~~~~~~DiwslG~il~el~~g~~p 208 (317)
T 2pmi_A 139 LLINKRGQLKLGDFGLARAFGIPVN--TFSSEVVTLWYRAPDVLMGSR--------TYSTSIDIWSCGCILAEMITGKPL 208 (317)
T ss_dssp EEECTTCCEEECCCSSCEETTSCCC--CCCCCCSCCTTCCHHHHTTCC--------CCCTHHHHHHHHHHHHHHHHSSCS
T ss_pred eEEcCCCCEEECcCccceecCCCcc--cCCCCcccccccCchHhhCCC--------CCCcHHHHHHHHHHHHHHHhCCCC
Confidence 999 567999999999987643222 223568999999999997532 367899999999999999999999
Q ss_pred CCcchhHHHH---HHhhcCCCCc----------------------------ccCCCCCChhHHHHHHHhcccCCCCCCCh
Q 003052 710 FSEYKTFWAK---FKVITDPNHE----------------------------ITYEPVPNPWLLDLMKKCLAWDRNERWRI 758 (853)
Q Consensus 710 F~~~~~~~~~---~kii~~~~~~----------------------------~~~~~~~s~~l~dLI~kcL~~DP~kRpTa 758 (853)
|.+....... ......+... .......+..+.+||.+||..||.+|||+
T Consensus 209 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~ 288 (317)
T 2pmi_A 209 FPGTNDEEQLKLIFDIMGTPNESLWPSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSA 288 (317)
T ss_dssp CCCSSHHHHHHHHHHHHCSCCTTTCGGGGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCH
T ss_pred CCCCChHHHHHHHHHHhCCCChhHhhhhhhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCH
Confidence 9765443222 2221111100 01122467789999999999999999999
Q ss_pred hHHhcCCCCCCCC
Q 003052 759 PQLLQHPFLVPPV 771 (853)
Q Consensus 759 ~EIL~HPwf~~~~ 771 (853)
.|+|+||||....
T Consensus 289 ~e~l~hp~f~~~~ 301 (317)
T 2pmi_A 289 KQALHHPWFAEYY 301 (317)
T ss_dssp HHHTTSGGGGGGC
T ss_pred HHHhCChhhhccc
Confidence 9999999998654
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=393.47 Aligned_cols=250 Identities=27% Similarity=0.447 Sum_probs=210.6
Q ss_pred ceeeEEEeEeccCceEEEEEEec-CCcEEEEEEEecCCC-ChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHHH
Q 003052 472 KLYQRLGKIGSGGSSEVHKVISS-DCTIYALKKIKLKGR-DYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLRE 549 (853)
Q Consensus 472 ~~Y~ilk~LG~G~FG~Vyka~~~-~g~~vAVKkik~~~~-~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~~ 549 (853)
++|++++.||+|+||.||+|.+. +++.||+|+++.... .......+.+|+.+|+.+. ||||++++++
T Consensus 6 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~Iv~~~~~---------- 74 (318)
T 1fot_A 6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVT-HPFIIRMWGT---------- 74 (318)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCC-BTTBCCEEEE----------
T ss_pred HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCC-CCCCceEeEE----------
Confidence 56999999999999999999984 789999999976422 1123445778999999986 8999999886
Q ss_pred HhhCCCCCCCCccccCCeEEEEEecch-hhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCCC
Q 003052 550 VLNGSMNNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKP 628 (853)
Q Consensus 550 l~~~~iv~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLKP 628 (853)
+.+...+|+||||+. ++|.+++... ..+++..++.++.||+.||.|||++||+||||||
T Consensus 75 ------------~~~~~~~~lv~e~~~gg~L~~~l~~~--------~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp 134 (318)
T 1fot_A 75 ------------FQDAQQIFMIMDYIEGGELFSLLRKS--------QRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKP 134 (318)
T ss_dssp ------------EECSSEEEEEECCCCSCBHHHHHHHT--------SSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCG
T ss_pred ------------EEeCCEEEEEEeCCCCCCHHHHHHHc--------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCh
Confidence 567788999999986 5999988754 5699999999999999999999999999999999
Q ss_pred ccEEe-ecCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHhCC
Q 003052 629 ANFLL-VKGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGR 707 (853)
Q Consensus 629 eNILL-~~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLtG~ 707 (853)
+|||+ .+|.+||+|||+++..... ..+.+||+.|+|||++.+. .|+.++|||||||++|||++|+
T Consensus 135 ~NIll~~~g~~kL~Dfg~a~~~~~~-----~~~~~gt~~y~aPE~~~~~---------~~~~~~DiwslG~il~ell~g~ 200 (318)
T 1fot_A 135 ENILLDKNGHIKITDFGFAKYVPDV-----TYTLCGTPDYIAPEVVSTK---------PYNKSIDWWSFGILIYEMLAGY 200 (318)
T ss_dssp GGEEECTTSCEEECCCSSCEECSSC-----BCCCCSCTTTCCHHHHTTC---------CBCTTHHHHHHHHHHHHHHHSS
T ss_pred heEEEcCCCCEEEeecCcceecCCc-----cccccCCccccCHhHhcCC---------CCCcccchhhhHHHHHHHHhCC
Confidence 99999 5689999999999865332 2367999999999999765 3678999999999999999999
Q ss_pred CCCCcchhHHHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCC-----ChhHHhcCCCCCC
Q 003052 708 TPFSEYKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERW-----RIPQLLQHPFLVP 769 (853)
Q Consensus 708 ~PF~~~~~~~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRp-----Ta~EIL~HPwf~~ 769 (853)
.||.+.........++.. ...++...++++.+||.+||..||.+|| +++++++||||..
T Consensus 201 ~pf~~~~~~~~~~~i~~~---~~~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~hp~f~~ 264 (318)
T 1fot_A 201 TPFYDSNTMKTYEKILNA---ELRFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKE 264 (318)
T ss_dssp CTTCCSSHHHHHHHHHHC---CCCCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSS
T ss_pred CCCCCCCHHHHHHHHHhC---CCCCCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhcCccccC
Confidence 999876554444444332 2345667889999999999999999999 9999999999974
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-44 Score=381.23 Aligned_cols=262 Identities=24% Similarity=0.389 Sum_probs=219.7
Q ss_pred eEEcCceeeEEEeEeccCceEEEEEEe-cCCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHH
Q 003052 467 FKVNGKLYQRLGKIGSGGSSEVHKVIS-SDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKA 545 (853)
Q Consensus 467 ~~v~g~~Y~ilk~LG~G~FG~Vyka~~-~~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~ 545 (853)
+..+++.|++.+.||+|+||.||+|.+ .++..||+|++............+.+|+.+|++++ |+||+++++++..
T Consensus 21 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~--- 96 (290)
T 1t4h_A 21 MSNDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQ-HPNIVRFYDSWES--- 96 (290)
T ss_dssp ECTTSCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCC-CTTBCCEEEEEEE---
T ss_pred cccCceeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCC-CCCeeeeeeeecc---
Confidence 344567799999999999999999998 46688999999877666667778999999999997 9999999987432
Q ss_pred HHHHHhhCCCCCCCCccccCCeEEEEEecch-hhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCc--ee
Q 003052 546 LLREVLNGSMNNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEER--IV 622 (853)
Q Consensus 546 iL~~l~~~~iv~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~g--II 622 (853)
...+..++|+||||++ ++|.+++... ..+++..++.++.||+.||.|||++| |+
T Consensus 97 ---------------~~~~~~~~~lv~e~~~~~~L~~~l~~~--------~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~ 153 (290)
T 1t4h_A 97 ---------------TVKGKKCIVLVTELMTSGTLKTYLKRF--------KVMKIKVLRSWCRQILKGLQFLHTRTPPII 153 (290)
T ss_dssp ---------------ESSSCEEEEEEEECCCSCBHHHHHHHH--------SSCCHHHHHHHHHHHHHHHHHHHTSSSCCC
T ss_pred ---------------ccCCCceEEEEEEecCCCCHHHHHHHc--------cCCCHHHHHHHHHHHHHHHHHHHcCCCCEE
Confidence 1234678999999985 5999988764 56999999999999999999999999 99
Q ss_pred eCCCCCccEEee--cCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHH
Q 003052 623 HSDLKPANFLLV--KGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCIL 700 (853)
Q Consensus 623 HRDLKPeNILL~--~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVIL 700 (853)
||||||+|||++ ++.+||+|||++....... ....+||+.|+|||++.+ .++.++|||||||++
T Consensus 154 H~dikp~Nil~~~~~~~~kl~Dfg~~~~~~~~~----~~~~~~t~~y~aPE~~~~----------~~~~~~Di~slG~~l 219 (290)
T 1t4h_A 154 HRDLKCDNIFITGPTGSVKIGDLGLATLKRASF----AKAVIGTPEFMAPEMYEE----------KYDESVDVYAFGMCM 219 (290)
T ss_dssp CSCCCGGGEEESSTTSCEEECCTTGGGGCCTTS----BEESCSSCCCCCGGGGGT----------CCCTHHHHHHHHHHH
T ss_pred ECCCCHHHEEEECCCCCEEEeeCCCcccccccc----cccccCCcCcCCHHHHhc----------cCCCcchHHHHHHHH
Confidence 999999999995 5799999999997543322 235689999999998864 257899999999999
Q ss_pred HHHHhCCCCCCcchhHHHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCCChhHHhcCCCCCC
Q 003052 701 YQMVYGRTPFSEYKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQHPFLVP 769 (853)
Q Consensus 701 yELLtG~~PF~~~~~~~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~HPwf~~ 769 (853)
|+|++|+.||.+..........+........++...++.+.+||.+||..||.+|||+.++|+||||+.
T Consensus 220 ~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~f~~ 288 (290)
T 1t4h_A 220 LEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQE 288 (290)
T ss_dssp HHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC-
T ss_pred HHHHhCCCCCCCcCcHHHHHHHHhccCCccccCCCCCHHHHHHHHHHccCChhhCCCHHHHhhCccccc
Confidence 999999999987666556655555544455556667789999999999999999999999999999975
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-44 Score=410.10 Aligned_cols=255 Identities=27% Similarity=0.403 Sum_probs=211.3
Q ss_pred ceeeEEEeEeccCceEEEEEEe-cCCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHHHH
Q 003052 472 KLYQRLGKIGSGGSSEVHKVIS-SDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLREV 550 (853)
Q Consensus 472 ~~Y~ilk~LG~G~FG~Vyka~~-~~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~~l 550 (853)
+.|++++.||+|+||.||+|.+ .+++.||+|++............+.+|+.+|++++ ||||++++++
T Consensus 11 ~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~-hpnIv~l~~~----------- 78 (444)
T 3soa_A 11 EEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLK-HPNIVRLHDS----------- 78 (444)
T ss_dssp HHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCC-BTTBCCEEEE-----------
T ss_pred CCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCC-CcCCCeEEEE-----------
Confidence 5699999999999999999998 57789999999877665566677899999999996 9999999987
Q ss_pred hhCCCCCCCCccccCCeEEEEEecch-hhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCCCc
Q 003052 551 LNGSMNNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPA 629 (853)
Q Consensus 551 ~~~~iv~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLKPe 629 (853)
+.+++.+|+||||+. ++|.+.+... ..+++..++.++.||+.||.|||++||+||||||+
T Consensus 79 -----------~~~~~~~~lv~E~~~gg~L~~~i~~~--------~~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~ 139 (444)
T 3soa_A 79 -----------ISEEGHHYLIFDLVTGGELFEDIVAR--------EYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPE 139 (444)
T ss_dssp -----------EECSSEEEEEECCCBCCBHHHHHHHC--------SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSST
T ss_pred -----------EEECCEEEEEEEeCCCCCHHHHHHHc--------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHH
Confidence 567788999999986 5898888754 56999999999999999999999999999999999
Q ss_pred cEEee----cCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHh
Q 003052 630 NFLLV----KGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVY 705 (853)
Q Consensus 630 NILL~----~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLt 705 (853)
|||++ ++.+||+|||+|+....... .....+||+.|+|||++.+. .|+.++|||||||++|+|++
T Consensus 140 NIll~~~~~~~~vkL~DFG~a~~~~~~~~--~~~~~~gt~~Y~APE~l~~~---------~~~~~~DIwSlGvilyell~ 208 (444)
T 3soa_A 140 NLLLASKLKGAAVKLADFGLAIEVEGEQQ--AWFGFAGTPGYLSPEVLRKD---------PYGKPVDLWACGVILYILLV 208 (444)
T ss_dssp TEEESBSSTTCCEEECCCSSCBCCCTTCC--BCCCSCSCGGGCCHHHHTTC---------CBCTHHHHHHHHHHHHHHHH
T ss_pred HEEEeccCCCCcEEEccCceeEEecCCCc--eeecccCCcccCCHHHhcCC---------CCCCccccHHHHHHHHHHHh
Confidence 99995 35899999999987654322 23467899999999999764 36789999999999999999
Q ss_pred CCCCCCcchhHHHHHHhhcCCCCcc--cCCCCCChhHHHHHHHhcccCCCCCCChhHHhcCCCCCC
Q 003052 706 GRTPFSEYKTFWAKFKVITDPNHEI--TYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQHPFLVP 769 (853)
Q Consensus 706 G~~PF~~~~~~~~~~kii~~~~~~~--~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~HPwf~~ 769 (853)
|.+||.+.........+.. ....+ ......++.+++||.+||..||.+|||+.|+|+||||..
T Consensus 209 G~~Pf~~~~~~~~~~~i~~-~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~hp~~~~ 273 (444)
T 3soa_A 209 GYPPFWDEDQHRLYQQIKA-GAYDFPSPEWDTVTPEAKDLINKMLTINPSKRITAAEALKHPWISH 273 (444)
T ss_dssp SSCSCCCSSHHHHHHHHHH-TCCCCCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSCTTHH
T ss_pred CCCCCCCccHHHHHHHHHh-CCCCCCccccccCCHHHHHHHHHHcCCChhHCCCHHHHhcCccccC
Confidence 9999977554433332222 22222 222467889999999999999999999999999999964
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-44 Score=399.92 Aligned_cols=267 Identities=19% Similarity=0.277 Sum_probs=211.5
Q ss_pred EEcCceeeEEEeEecc--CceEEEEEEec-CCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHH
Q 003052 468 KVNGKLYQRLGKIGSG--GSSEVHKVISS-DCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEK 544 (853)
Q Consensus 468 ~v~g~~Y~ilk~LG~G--~FG~Vyka~~~-~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~ 544 (853)
-..+++|+++++||+| +||.||+|.+. +++.||||++............+.+|+.+|++++ |+||++++++
T Consensus 21 ~~~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~----- 94 (389)
T 3gni_B 21 LPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFN-HPNIVPYRAT----- 94 (389)
T ss_dssp CCCGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCC-CTTBCCEEEE-----
T ss_pred cCCCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCC-CCCCCcEeEE-----
Confidence 3456789999999999 99999999985 7899999999887666666777889999999998 8999999987
Q ss_pred HHHHHHhhCCCCCCCCccccCCeEEEEEecch-hhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceee
Q 003052 545 ALLREVLNGSMNNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVH 623 (853)
Q Consensus 545 ~iL~~l~~~~iv~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIH 623 (853)
+.+++.+|+||||+. ++|.+++... ....+++..++.|+.||+.||.|||++||+|
T Consensus 95 -----------------~~~~~~~~lv~e~~~~~~L~~~l~~~------~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH 151 (389)
T 3gni_B 95 -----------------FIADNELWVVTSFMAYGSAKDLICTH------FMDGMNELAIAYILQGVLKALDYIHHMGYVH 151 (389)
T ss_dssp -----------------EEETTEEEEEEECCTTCBHHHHHHHT------CTTCCCHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred -----------------EEECCEEEEEEEccCCCCHHHHHhhh------cccCCCHHHHHHHHHHHHHHHHHHHhCCeec
Confidence 456778999999986 5898888754 2356999999999999999999999999999
Q ss_pred CCCCCccEEee-cCcEEEEecccchhcccCCc-----cccccccccCccccCchhhccCCCCCCCccccCCCccchhhhH
Q 003052 624 SDLKPANFLLV-KGSLKLIDFGIAKAIMSDTT-----NIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLG 697 (853)
Q Consensus 624 RDLKPeNILL~-~g~VKL~DFGlAk~~~~~~~-----~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLG 697 (853)
|||||+||||+ ++.+||+|||++........ .......+||+.|+|||++.+.. ..|+.++||||||
T Consensus 152 rDlkp~NIll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-------~~~~~~~DiwslG 224 (389)
T 3gni_B 152 RSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNL-------QGYDAKSDIYSVG 224 (389)
T ss_dssp CCCSGGGEEECTTCCEEECCGGGCEECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTS-------SCBCTHHHHHHHH
T ss_pred CCCCHHHEEEcCCCCEEEcccccceeeccccccccccccccccccccccccCHHHHhccC-------CCCCcHhHHHHHH
Confidence 99999999995 77999999999875432211 11122458999999999997632 1467899999999
Q ss_pred HHHHHHHhCCCCCCcchhHHHHHHhhcCCC-------------------------------------------CcccCCC
Q 003052 698 CILYQMVYGRTPFSEYKTFWAKFKVITDPN-------------------------------------------HEITYEP 734 (853)
Q Consensus 698 VILyELLtG~~PF~~~~~~~~~~kii~~~~-------------------------------------------~~~~~~~ 734 (853)
|++|+|++|+.||.+..........+.... ....+..
T Consensus 225 ~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 304 (389)
T 3gni_B 225 ITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHR 304 (389)
T ss_dssp HHHHHHHHSSCTTTTCCSTTHHHHC-------------------------------------------------------
T ss_pred HHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCccccccccccccccccccccccccccccccccCccccccCCCCCCcccc
Confidence 999999999999976433222222111000 0011334
Q ss_pred CCChhHHHHHHHhcccCCCCCCChhHHhcCCCCCCC
Q 003052 735 VPNPWLLDLMKKCLAWDRNERWRIPQLLQHPFLVPP 770 (853)
Q Consensus 735 ~~s~~l~dLI~kcL~~DP~kRpTa~EIL~HPwf~~~ 770 (853)
..++.+.+||.+||.+||.+|||+.|+|+||||...
T Consensus 305 ~~s~~~~~li~~~L~~dP~~Rpta~ell~hp~f~~~ 340 (389)
T 3gni_B 305 TFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQI 340 (389)
T ss_dssp -CCHHHHHHHHHHTCSCTTTSCCHHHHTTSGGGGGC
T ss_pred ccCHHHHHHHHHHhhcCcccCCCHHHHhcCHHHHHH
Confidence 567889999999999999999999999999999754
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-45 Score=400.92 Aligned_cols=255 Identities=22% Similarity=0.304 Sum_probs=211.5
Q ss_pred CceeeEEEeEeccCceEEEEEEec-CCcEEEEEEEecCCC-ChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHH
Q 003052 471 GKLYQRLGKIGSGGSSEVHKVISS-DCTIYALKKIKLKGR-DYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLR 548 (853)
Q Consensus 471 g~~Y~ilk~LG~G~FG~Vyka~~~-~g~~vAVKkik~~~~-~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~ 548 (853)
-.+|++++.||+|+||.||+|.+. +++.||||+++.... .......+.+|+.+|..+.+|++|++++++
T Consensus 19 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~--------- 89 (353)
T 2i0e_A 19 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSC--------- 89 (353)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEE---------
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEE---------
Confidence 356999999999999999999985 568999999976421 112344578999999998889999999876
Q ss_pred HHhhCCCCCCCCccccCCeEEEEEecch-hhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCC
Q 003052 549 EVLNGSMNNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLK 627 (853)
Q Consensus 549 ~l~~~~iv~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLK 627 (853)
+++...+|+||||+. ++|.+++... ..+++..++.|+.||+.||.|||++||+|||||
T Consensus 90 -------------~~~~~~~~lv~E~~~gg~L~~~l~~~--------~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlk 148 (353)
T 2i0e_A 90 -------------FQTMDRLYFVMEYVNGGDLMYHIQQV--------GRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLK 148 (353)
T ss_dssp -------------EECSSEEEEEEECCCSCBHHHHHHHH--------SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCC
T ss_pred -------------EEcCCEEEEEEeCCCCCcHHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCC
Confidence 567789999999985 5999988764 469999999999999999999999999999999
Q ss_pred CccEEe-ecCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHhC
Q 003052 628 PANFLL-VKGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYG 706 (853)
Q Consensus 628 PeNILL-~~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLtG 706 (853)
|+|||+ .+|.+||+|||+|+....... .....+||+.|+|||++.+. .|+.++|||||||++|||++|
T Consensus 149 p~NIll~~~g~vkL~DFG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~---------~~~~~~DiwslG~il~ell~G 217 (353)
T 2i0e_A 149 LDNVMLDSEGHIKIADFGMCKENIWDGV--TTKTFCGTPDYIAPEIIAYQ---------PYGKSVDWWAFGVLLYEMLAG 217 (353)
T ss_dssp GGGEEECTTSCEEECCCTTCBCCCCTTC--CBCCCCSCGGGCCHHHHTTC---------CBSTHHHHHHHHHHHHHHHHS
T ss_pred HHHEEEcCCCcEEEEeCCcccccccCCc--ccccccCCccccChhhhcCC---------CcCCcccccchHHHHHHHHcC
Confidence 999999 567999999999986433221 23467999999999999765 367899999999999999999
Q ss_pred CCCCCcchhHHHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCCC-----hhHHhcCCCCCC
Q 003052 707 RTPFSEYKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWR-----IPQLLQHPFLVP 769 (853)
Q Consensus 707 ~~PF~~~~~~~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpT-----a~EIL~HPwf~~ 769 (853)
++||.+.........+.. ....++...++++.+||.+||..||.+||+ +.+|++||||..
T Consensus 218 ~~Pf~~~~~~~~~~~i~~---~~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h~~f~~ 282 (353)
T 2i0e_A 218 QAPFEGEDEDELFQSIME---HNVAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRY 282 (353)
T ss_dssp SCSSCCSSHHHHHHHHHH---CCCCCCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTSGGGTT
T ss_pred CCCCCCCCHHHHHHHHHh---CCCCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCccccC
Confidence 999987554433333332 223456678999999999999999999995 699999999964
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-44 Score=398.79 Aligned_cols=254 Identities=26% Similarity=0.387 Sum_probs=210.7
Q ss_pred ceeeEEEeEeccCceEEEEEEec-CCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHHHH
Q 003052 472 KLYQRLGKIGSGGSSEVHKVISS-DCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLREV 550 (853)
Q Consensus 472 ~~Y~ilk~LG~G~FG~Vyka~~~-~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~~l 550 (853)
+.|++.+.||+|+||.||+|.+. +++.||||++............+.+|+.+|++|+ ||||++++++
T Consensus 29 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~-hpnIv~~~~~----------- 96 (362)
T 2bdw_A 29 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQ-HPNIVRLHDS----------- 96 (362)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCC-CTTBCCEEEE-----------
T ss_pred cCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCC-CCCCCeEEEE-----------
Confidence 56999999999999999999984 6789999999877666666677899999999997 9999999987
Q ss_pred hhCCCCCCCCccccCCeEEEEEecch-hhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCCCc
Q 003052 551 LNGSMNNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPA 629 (853)
Q Consensus 551 ~~~~iv~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLKPe 629 (853)
+.+.+.+|+||||+. ++|.+.+... ..+++..++.++.||+.||.|||++||+||||||+
T Consensus 97 -----------~~~~~~~~lv~e~~~gg~L~~~l~~~--------~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~ 157 (362)
T 2bdw_A 97 -----------IQEESFHYLVFDLVTGGELFEDIVAR--------EFYSEADASHCIQQILESIAYCHSNGIVHRNLKPE 157 (362)
T ss_dssp -----------EECSSEEEEEECCCCSCBHHHHHTTC--------SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGG
T ss_pred -----------EEeCCEEEEEEecCCCCCHHHHHHHc--------CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchH
Confidence 566788999999976 4888887543 57999999999999999999999999999999999
Q ss_pred cEEeec----CcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHh
Q 003052 630 NFLLVK----GSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVY 705 (853)
Q Consensus 630 NILL~~----g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLt 705 (853)
|||++. +.+||+|||+++...... .....+||+.|+|||++.+. .|+.++|||||||++|+|++
T Consensus 158 NIll~~~~~~~~~kl~DfG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~---------~~~~~~DiwslG~il~~ll~ 225 (362)
T 2bdw_A 158 NLLLASKAKGAAVKLADFGLAIEVNDSE---AWHGFAGTPGYLSPEVLKKD---------PYSKPVDIWACGVILYILLV 225 (362)
T ss_dssp GEEESCSSTTCCEEECCCTTCBCCTTCC---SCCCSCSCTTTCCHHHHTTC---------CCCTHHHHHHHHHHHHHHHH
T ss_pred HEEEecCCCCCCEEEeecCcceEecCCc---ccccCCCCccccCHHHHccC---------CCCchhhHHHHHHHHHHHHH
Confidence 999942 369999999998765322 22357899999999999765 35689999999999999999
Q ss_pred CCCCCCcchhHHHHHHhhcCCCCcc--cCCCCCChhHHHHHHHhcccCCCCCCChhHHhcCCCCCC
Q 003052 706 GRTPFSEYKTFWAKFKVITDPNHEI--TYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQHPFLVP 769 (853)
Q Consensus 706 G~~PF~~~~~~~~~~kii~~~~~~~--~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~HPwf~~ 769 (853)
|++||.+.........+... ...+ ......++++++||.+||..||.+||++.++|+||||..
T Consensus 226 g~~Pf~~~~~~~~~~~i~~~-~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~ 290 (362)
T 2bdw_A 226 GYPPFWDEDQHRLYAQIKAG-AYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICN 290 (362)
T ss_dssp SSCSSCCSSHHHHHHHHHHT-CCCCCTTGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTSHHHHT
T ss_pred CCCCCCCCCHHHHHHHHHhC-CCCCCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcccCC
Confidence 99999775543333222221 1111 112346888999999999999999999999999999964
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=397.23 Aligned_cols=258 Identities=28% Similarity=0.428 Sum_probs=207.2
Q ss_pred ceeeEEEeEeccCceEEEEEEe-cCCcEEEEEEEecCC---CChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHH
Q 003052 472 KLYQRLGKIGSGGSSEVHKVIS-SDCTIYALKKIKLKG---RDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALL 547 (853)
Q Consensus 472 ~~Y~ilk~LG~G~FG~Vyka~~-~~g~~vAVKkik~~~---~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL 547 (853)
+.|++.+.||+|+||.||+|.+ .+++.||||++.... ........+.+|+.+|++++ ||||++++++
T Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~~~~~-------- 94 (351)
T 3c0i_A 24 DVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLK-HPHIVELLET-------- 94 (351)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCC-CTTBCCEEEE--------
T ss_pred cceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCC-CCCCCcEEEE--------
Confidence 5799999999999999999998 477999999997532 11123456889999999997 9999999987
Q ss_pred HHHhhCCCCCCCCccccCCeEEEEEecch-hhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCC
Q 003052 548 REVLNGSMNNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDL 626 (853)
Q Consensus 548 ~~l~~~~iv~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDL 626 (853)
+.+++.+|+||||+. ++|.+.+..... ....+++..++.++.||+.||.|||++||+||||
T Consensus 95 --------------~~~~~~~~lv~e~~~g~~L~~~l~~~~~----~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDl 156 (351)
T 3c0i_A 95 --------------YSSDGMLYMVFEFMDGADLCFEIVKRAD----AGFVYSEAVASHYMRQILEALRYCHDNNIIHRDV 156 (351)
T ss_dssp --------------EEETTEEEEEEECCSSCBHHHHHHHHHH----TTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCC
T ss_pred --------------EEeCCEEEEEEeCCCCCCHHHHHHHhcc----cCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccC
Confidence 456778999999987 588887765422 2346899999999999999999999999999999
Q ss_pred CCccEEeec-C---cEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHH
Q 003052 627 KPANFLLVK-G---SLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQ 702 (853)
Q Consensus 627 KPeNILL~~-g---~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyE 702 (853)
||+|||++. + .+||+|||+++....... .....+||+.|+|||++.+. .|+.++|||||||++|+
T Consensus 157 kp~NIl~~~~~~~~~vkl~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~---------~~~~~~DiwslG~il~~ 225 (351)
T 3c0i_A 157 KPHCVLLASKENSAPVKLGGFGVAIQLGESGL--VAGGRVGTPHFMAPEVVKRE---------PYGKPVDVWGCGVILFI 225 (351)
T ss_dssp SGGGEEECSSSTTCCEEECCCTTCEECCTTSC--BCCCCCSCGGGCCHHHHTTC---------CBCTHHHHHHHHHHHHH
T ss_pred ChHHeEEecCCCCCcEEEecCcceeEecCCCe--eecCCcCCcCccCHHHHcCC---------CCCchHhhHHHHHHHHH
Confidence 999999943 3 499999999987654321 23467899999999999765 36789999999999999
Q ss_pred HHhCCCCCCcchhHHHHHHhhcCCCCc--ccCCCCCChhHHHHHHHhcccCCCCCCChhHHhcCCCCCC
Q 003052 703 MVYGRTPFSEYKTFWAKFKVITDPNHE--ITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQHPFLVP 769 (853)
Q Consensus 703 LLtG~~PF~~~~~~~~~~kii~~~~~~--~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~HPwf~~ 769 (853)
|++|+.||.+.... .+..+...... .......+..+++||.+||..||.+|||+.|+|+||||..
T Consensus 226 ll~g~~pf~~~~~~--~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~ 292 (351)
T 3c0i_A 226 LLSGCLPFYGTKER--LFEGIIKGKYKMNPRQWSHISESAKDLVRRMLMLDPAERITVYEALNHPWLKE 292 (351)
T ss_dssp HHHSSCSSCSSHHH--HHHHHHHTCCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHT
T ss_pred HHHCCCCCCCcHHH--HHHHHHcCCCCCCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcChhhcC
Confidence 99999999875432 22222111111 1122457889999999999999999999999999999975
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-45 Score=382.32 Aligned_cols=266 Identities=24% Similarity=0.395 Sum_probs=197.2
Q ss_pred EEcCceeeEEEeEeccCceEEEEEEe-cCCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHH
Q 003052 468 KVNGKLYQRLGKIGSGGSSEVHKVIS-SDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKAL 546 (853)
Q Consensus 468 ~v~g~~Y~ilk~LG~G~FG~Vyka~~-~~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~i 546 (853)
.+..++|++++.||+|+||.||+|.+ .+++.||||+++........ ..+..|...+.+...|+||++++++
T Consensus 3 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~-~~~~~~~~~~~~~~~h~~iv~~~~~------- 74 (290)
T 3fme_A 3 EVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQ-KRLLMDLDISMRTVDCPFTVTFYGA------- 74 (290)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHH-HHHHHHHHHHHTTCCCTTBCCEEEE-------
T ss_pred cccHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHH-HHHHHHHHHHHHhCCCCeEEEEeee-------
Confidence 34557899999999999999999998 57889999999865443333 3344455554444459999999987
Q ss_pred HHHHhhCCCCCCCCccccCCeEEEEEecchhhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccC-ceeeCC
Q 003052 547 LREVLNGSMNNKDGRVKDDGYIYMVLEYGEIDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEE-RIVHSD 625 (853)
Q Consensus 547 L~~l~~~~iv~~~g~~~d~~~lyLVmEy~~gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~-gIIHRD 625 (853)
+.+++.+|+||||++++|.+++..... ....+++..++.++.||+.||.|||++ ||+|||
T Consensus 75 ---------------~~~~~~~~lv~e~~~~~l~~~l~~~~~----~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~d 135 (290)
T 3fme_A 75 ---------------LFREGDVWICMELMDTSLDKFYKQVID----KGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRD 135 (290)
T ss_dssp ---------------EECSSSEEEEEECCSEEHHHHHHHHHH----TTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCC
T ss_pred ---------------eeccCCEEEEEehhccchHHHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCC
Confidence 455678999999999998888765432 346799999999999999999999998 999999
Q ss_pred CCCccEEee-cCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHH
Q 003052 626 LKPANFLLV-KGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMV 704 (853)
Q Consensus 626 LKPeNILL~-~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELL 704 (853)
|||+|||++ ++.+||+|||+++....... ....+||+.|+|||++..... ...++.++|||||||++|+|+
T Consensus 136 lkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~-----~~~~~~~~Di~slG~il~~l~ 207 (290)
T 3fme_A 136 VKPSNVLINALGQVKMCDFGISGYLVDDVA---KDIDAGCKPYMAPERINPELN-----QKGYSVKSDIWSLGITMIELA 207 (290)
T ss_dssp CSGGGCEECTTCCEEBCCC------------------CCCCCCSCHHHHSCCTT-----C--CCHHHHHHHHHHHHHHHH
T ss_pred CCHHHEEECCCCCEEEeecCCccccccccc---ccccCCCccccChhhcChhhc-----CcCCCcHHHHHHHHHHHHHHH
Confidence 999999995 57999999999987644322 234589999999999843211 124678999999999999999
Q ss_pred hCCCCCCcchh-HHHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCCChhHHhcCCCCCC
Q 003052 705 YGRTPFSEYKT-FWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQHPFLVP 769 (853)
Q Consensus 705 tG~~PF~~~~~-~~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~HPwf~~ 769 (853)
+|+.||..... .......+... .........++++.+||.+||..||.+|||+.|+|+||||..
T Consensus 208 ~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~hp~f~~ 272 (290)
T 3fme_A 208 ILRFPYDSWGTPFQQLKQVVEEP-SPQLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQHPFFTL 272 (290)
T ss_dssp HTSCSSCCCSCHHHHHHHHHHSC-CCCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHH
T ss_pred HCCCCccccCchHHHHHHHhccC-CCCcccccCCHHHHHHHHHHhhcChhhCcCHHHHHhCccccc
Confidence 99999975332 22233333322 222233467889999999999999999999999999999964
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-45 Score=402.30 Aligned_cols=254 Identities=27% Similarity=0.405 Sum_probs=209.3
Q ss_pred ceeeEEEeEeccCceEEEEEEe-cCCcEEEEEEEecCCCC-hhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHHH
Q 003052 472 KLYQRLGKIGSGGSSEVHKVIS-SDCTIYALKKIKLKGRD-YATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLRE 549 (853)
Q Consensus 472 ~~Y~ilk~LG~G~FG~Vyka~~-~~g~~vAVKkik~~~~~-~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~~ 549 (853)
..|++.+.||+|+||.||+|.+ .+++.||||++...... ......+.+|+.+|+.++ ||||++++++
T Consensus 9 ~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~l~~~---------- 77 (336)
T 3h4j_B 9 GPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLR-HPHIIKLYDV---------- 77 (336)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCC-CTTBCCEEEE----------
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCC-CCCCCeEEEE----------
Confidence 4599999999999999999998 57789999999754221 122345789999999997 8999999987
Q ss_pred HhhCCCCCCCCccccCCeEEEEEecchhhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCCCc
Q 003052 550 VLNGSMNNKDGRVKDDGYIYMVLEYGEIDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPA 629 (853)
Q Consensus 550 l~~~~iv~~~g~~~d~~~lyLVmEy~~gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLKPe 629 (853)
+.+...+|+||||++++|.+++... ..+++..++.++.||+.||.|||++||+||||||+
T Consensus 78 ------------~~~~~~~~lv~E~~~g~l~~~l~~~--------~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~ 137 (336)
T 3h4j_B 78 ------------ITTPTDIVMVIEYAGGELFDYIVEK--------KRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPE 137 (336)
T ss_dssp ------------EECSSEEEEEECCCCEEHHHHHHHH--------CSCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTT
T ss_pred ------------EEeCCEEEEEEECCCCcHHHHHHHc--------CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchh
Confidence 4566789999999999999988765 56999999999999999999999999999999999
Q ss_pred cEEee-cCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHhCCC
Q 003052 630 NFLLV-KGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGRT 708 (853)
Q Consensus 630 NILL~-~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLtG~~ 708 (853)
|||++ ++.+||+|||+++...... .....+||+.|+|||++.+.. .++.++|||||||++|+|++|+.
T Consensus 138 NIll~~~~~~kl~DFG~s~~~~~~~---~~~~~~gt~~y~aPE~~~~~~--------~~~~~~DiwslG~il~~ll~g~~ 206 (336)
T 3h4j_B 138 NLLLDDNLNVKIADFGLSNIMTDGN---FLKTSCGSPNYAAPEVINGKL--------YAGPEVDVWSCGIVLYVMLVGRL 206 (336)
T ss_dssp TEEECTTCCEEECCSSCTBTTTTSB---TTCCCTTSTTTSCGGGSCCSG--------GGCHHHHHHHHHHHHHHHHHSSC
T ss_pred hEEEcCCCCEEEEEeccceeccCCc---ccccccCCcCcCCHHHHcCCC--------CCCCccchhHHHHHHHHHHhCCC
Confidence 99995 5699999999998764332 234678999999999997653 23679999999999999999999
Q ss_pred CCCcchhHHHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCCChhHHhcCCCCCCC
Q 003052 709 PFSEYKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQHPFLVPP 770 (853)
Q Consensus 709 PF~~~~~~~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~HPwf~~~ 770 (853)
||.+.... ..+..+. ......+...++.+.+||.+||..||.+|||+.|+++||||...
T Consensus 207 Pf~~~~~~-~~~~~i~--~~~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~ 265 (336)
T 3h4j_B 207 PFDDEFIP-NLFKKVN--SCVYVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRRDPWFNVN 265 (336)
T ss_dssp SSBCSSST-TCBCCCC--SSCCCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTCHHHHTT
T ss_pred CCCCccHH-HHHHHHH--cCCCCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHhChhhccC
Confidence 99763221 1111111 12233456678999999999999999999999999999999754
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-44 Score=389.43 Aligned_cols=256 Identities=27% Similarity=0.418 Sum_probs=208.4
Q ss_pred ceeeEEEeEeccCceEEEEEEec-CCcEEEEEEEecCCCCh----hhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHH
Q 003052 472 KLYQRLGKIGSGGSSEVHKVISS-DCTIYALKKIKLKGRDY----ATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKAL 546 (853)
Q Consensus 472 ~~Y~ilk~LG~G~FG~Vyka~~~-~g~~vAVKkik~~~~~~----~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~i 546 (853)
+.|++.+.||+|+||.||+|.+. +++.||||+++...... .....+.+|+.+|++++ ||||++++++
T Consensus 11 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~------- 82 (326)
T 2y0a_A 11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ-HPNVITLHEV------- 82 (326)
T ss_dssp HHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCC-CTTBCCEEEE-------
T ss_pred cceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCC-CCCCCcEEEE-------
Confidence 56999999999999999999984 67899999998654321 13456889999999997 9999999987
Q ss_pred HHHHhhCCCCCCCCccccCCeEEEEEecch-hhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCC
Q 003052 547 LREVLNGSMNNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSD 625 (853)
Q Consensus 547 L~~l~~~~iv~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRD 625 (853)
+.+...+|+||||+. ++|.+++... ..+++..++.++.||+.||.|||++||+|||
T Consensus 83 ---------------~~~~~~~~lv~e~~~~~~L~~~l~~~--------~~~~~~~~~~i~~qi~~al~~lH~~~ivH~D 139 (326)
T 2y0a_A 83 ---------------YENKTDVILILELVAGGELFDFLAEK--------ESLTEEEATEFLKQILNGVYYLHSLQIAHFD 139 (326)
T ss_dssp ---------------EECSSEEEEEEECCCSCBHHHHHTTS--------SCCBHHHHHHHHHHHHHHHHHHHHTTEECCC
T ss_pred ---------------EEeCCEEEEEEEcCCCCCHHHHHHhc--------CCcCHHHHHHHHHHHHHHHHHHHHCCeEcCC
Confidence 456778999999985 6999888543 5799999999999999999999999999999
Q ss_pred CCCccEEee-cC----cEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHH
Q 003052 626 LKPANFLLV-KG----SLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCIL 700 (853)
Q Consensus 626 LKPeNILL~-~g----~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVIL 700 (853)
|||+|||+. ++ .+||+|||+++.+.... .....+||+.|+|||++.+. .|+.++|||||||++
T Consensus 140 lkp~NIll~~~~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~---------~~~~~~DiwslG~il 207 (326)
T 2y0a_A 140 LKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGN---EFKNIFGTPEFVAPEIVNYE---------PLGLEADMWSIGVIT 207 (326)
T ss_dssp CCGGGEEESCSSSSSCCEEECCCTTCEECCTTS---CCCCCCSCTTTCCHHHHTTC---------CCCTHHHHHHHHHHH
T ss_pred CCHHHEEEecCCCCCCCEEEEECCCCeECCCCC---ccccccCCcCcCCceeecCC---------CCCcHHHHHHHHHHH
Confidence 999999994 34 79999999998764322 22356899999999999654 357899999999999
Q ss_pred HHHHhCCCCCCcchhHHHHHHhhcC-CCCcccCCCCCChhHHHHHHHhcccCCCCCCChhHHhcCCCCCCC
Q 003052 701 YQMVYGRTPFSEYKTFWAKFKVITD-PNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQHPFLVPP 770 (853)
Q Consensus 701 yELLtG~~PF~~~~~~~~~~kii~~-~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~HPwf~~~ 770 (853)
|+|++|..||.+.........+... ...........+..+.+||.+||..||.+|||+.|+|+||||...
T Consensus 208 ~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~ 278 (326)
T 2y0a_A 208 YILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPK 278 (326)
T ss_dssp HHHHHSCCSSCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTSCC
T ss_pred HHHHHCcCCCCCCCHHHHHHHHHhcCCCcCccccccCCHHHHHHHHHHccCChhhCCCHHHHhcCCCccCC
Confidence 9999999999765443332222211 111112234678889999999999999999999999999999753
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-44 Score=396.81 Aligned_cols=250 Identities=24% Similarity=0.402 Sum_probs=210.9
Q ss_pred ceeeEEEeEeccCceEEEEEEec-CCcEEEEEEEecCCC-ChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHHH
Q 003052 472 KLYQRLGKIGSGGSSEVHKVISS-DCTIYALKKIKLKGR-DYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLRE 549 (853)
Q Consensus 472 ~~Y~ilk~LG~G~FG~Vyka~~~-~g~~vAVKkik~~~~-~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~~ 549 (853)
++|++++.||+|+||.||+|.+. +++.||||++..... .......+.+|+.+|+++. ||||++++++
T Consensus 41 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~---------- 109 (350)
T 1rdq_E 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN-FPFLVKLEFS---------- 109 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCC-CTTBCCEEEE----------
T ss_pred HHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCC-CCCCCeEEEE----------
Confidence 56999999999999999999984 789999999975432 1233456789999999996 9999999876
Q ss_pred HhhCCCCCCCCccccCCeEEEEEecch-hhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCCC
Q 003052 550 VLNGSMNNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKP 628 (853)
Q Consensus 550 l~~~~iv~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLKP 628 (853)
+.+...+|+||||+. ++|.+++... ..+++..++.|+.||+.||.|||++||+||||||
T Consensus 110 ------------~~~~~~~~lv~e~~~gg~L~~~l~~~--------~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp 169 (350)
T 1rdq_E 110 ------------FKDNSNLYMVMEYVAGGEMFSHLRRI--------GRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKP 169 (350)
T ss_dssp ------------EECSSEEEEEEECCTTCBHHHHHHHH--------CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSG
T ss_pred ------------EEcCCEEEEEEcCCCCCcHHHHHHHc--------CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCcc
Confidence 567788999999985 6999988764 4699999999999999999999999999999999
Q ss_pred ccEEe-ecCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHhCC
Q 003052 629 ANFLL-VKGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGR 707 (853)
Q Consensus 629 eNILL-~~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLtG~ 707 (853)
+|||+ .+|.+||+|||+|+..... ..+.+||+.|+|||++.+. .|+.++|||||||++|+|++|+
T Consensus 170 ~NIll~~~g~~kL~DFg~a~~~~~~-----~~~~~gt~~y~aPE~~~~~---------~~~~~~DiwslG~il~ell~g~ 235 (350)
T 1rdq_E 170 ENLLIDQQGYIQVTDFGFAKRVKGR-----TWTLCGTPEALAPEIILSK---------GYNKAVDWWALGVLIYEMAAGY 235 (350)
T ss_dssp GGEEECTTSCEEECCCTTCEECSSC-----BCCCEECGGGCCHHHHTTC---------CBCTHHHHHHHHHHHHHHHHSS
T ss_pred ceEEECCCCCEEEcccccceeccCC-----cccccCCccccCHHHhcCC---------CCCCcCCEecccHhHhHHhhCC
Confidence 99999 5679999999999876432 2367899999999999765 3678999999999999999999
Q ss_pred CCCCcchhHHHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCCC-----hhHHhcCCCCCC
Q 003052 708 TPFSEYKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWR-----IPQLLQHPFLVP 769 (853)
Q Consensus 708 ~PF~~~~~~~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpT-----a~EIL~HPwf~~ 769 (853)
+||.+.........+... ...++...++.+.+||.+||..||.+||+ +.+|++||||..
T Consensus 236 ~Pf~~~~~~~~~~~i~~~---~~~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h~~f~~ 299 (350)
T 1rdq_E 236 PPFFADQPIQIYEKIVSG---KVRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFAT 299 (350)
T ss_dssp CSSCCSSHHHHHHHHHHC---CCCCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTT
T ss_pred CCCCCCCHHHHHHHHHcC---CCCCCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHhCcCcCC
Confidence 999876554333333332 23456678899999999999999999998 999999999964
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-44 Score=390.04 Aligned_cols=254 Identities=29% Similarity=0.458 Sum_probs=201.0
Q ss_pred CceeeEEEeEeccCceEEEEEEe----cCCcEEEEEEEecCCC--ChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHH
Q 003052 471 GKLYQRLGKIGSGGSSEVHKVIS----SDCTIYALKKIKLKGR--DYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEK 544 (853)
Q Consensus 471 g~~Y~ilk~LG~G~FG~Vyka~~----~~g~~vAVKkik~~~~--~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~ 544 (853)
.+.|++++.||+|+||.||+|.+ .+++.||+|+++.... .......+.+|+.+|++++ |+||++++++
T Consensus 16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~----- 89 (327)
T 3a62_A 16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVK-HPFIVDLIYA----- 89 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCC-CTTBCCEEEE-----
T ss_pred HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCC-CCCccceeEE-----
Confidence 46799999999999999999987 4778999999986532 2233445779999999997 8999999986
Q ss_pred HHHHHHhhCCCCCCCCccccCCeEEEEEecch-hhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceee
Q 003052 545 ALLREVLNGSMNNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVH 623 (853)
Q Consensus 545 ~iL~~l~~~~iv~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIH 623 (853)
+.+.+.+|+||||+. ++|.+++... ..+++..++.++.||+.||.|||++||+|
T Consensus 90 -----------------~~~~~~~~lv~e~~~~~~L~~~l~~~--------~~~~~~~~~~~~~qi~~al~~lH~~~ivH 144 (327)
T 3a62_A 90 -----------------FQTGGKLYLILEYLSGGELFMQLERE--------GIFMEDTACFYLAEISMALGHLHQKGIIY 144 (327)
T ss_dssp -----------------EECSSCEEEEEECCTTEEHHHHHHHH--------SSCCHHHHHHHHHHHHHHHHHHHHTTCCC
T ss_pred -----------------EEcCCEEEEEEeCCCCCcHHHHHHhC--------CCCCHHHHHHHHHHHHHHHHHHHhCCEEc
Confidence 456778999999986 5898888754 56899999999999999999999999999
Q ss_pred CCCCCccEEe-ecCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHH
Q 003052 624 SDLKPANFLL-VKGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQ 702 (853)
Q Consensus 624 RDLKPeNILL-~~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyE 702 (853)
|||||+|||+ .+|.+||+|||+++....... .....+||+.|+|||++.+.. ++.++|||||||++|+
T Consensus 145 ~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~---------~~~~~DiwslG~il~e 213 (327)
T 3a62_A 145 RDLKPENIMLNHQGHVKLTDFGLCKESIHDGT--VTHTFCGTIEYMAPEILMRSG---------HNRAVDWWSLGALMYD 213 (327)
T ss_dssp CCCCTTTEEECTTSCEEECCCSCC------------CTTSSCCTTSCHHHHTTSC---------CCTHHHHHHHHHHHHH
T ss_pred ccCCHHHeEECCCCcEEEEeCCcccccccCCc--cccccCCCcCccCHhhCcCCC---------CCCcccchhHHHHHHH
Confidence 9999999999 567999999999986543222 234678999999999997653 5689999999999999
Q ss_pred HHhCCCCCCcchhHHHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCC-----ChhHHhcCCCCCC
Q 003052 703 MVYGRTPFSEYKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERW-----RIPQLLQHPFLVP 769 (853)
Q Consensus 703 LLtG~~PF~~~~~~~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRp-----Ta~EIL~HPwf~~ 769 (853)
|++|+.||.+.........+... ...++...+..+++||.+||..||.+|| ++.|+++||||..
T Consensus 214 l~~g~~pf~~~~~~~~~~~i~~~---~~~~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~hp~f~~ 282 (327)
T 3a62_A 214 MLTGAPPFTGENRKKTIDKILKC---KLNLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFFRH 282 (327)
T ss_dssp HHHSSCSCCCSSHHHHHHHHHHT---CCCCCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHSGGGSS
T ss_pred HHHCCCCCCCCCHHHHHHHHHhC---CCCCCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcCCcccC
Confidence 99999999875544333333322 2345567789999999999999999999 8899999999974
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-44 Score=392.34 Aligned_cols=253 Identities=24% Similarity=0.352 Sum_probs=203.1
Q ss_pred CceeeEEEeEeccCceEEEEEEe-cCCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhc----CCCceeEeeehhhhHHH
Q 003052 471 GKLYQRLGKIGSGGSSEVHKVIS-SDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLK----GKNNIIQLIDYEVTEKA 545 (853)
Q Consensus 471 g~~Y~ilk~LG~G~FG~Vyka~~-~~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~----~hpNIV~Lid~~~~e~~ 545 (853)
.++|+++++||+|+||.||+|.+ .+++.||||+++.. ......+..|+.+++++. .|+||++++++
T Consensus 34 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~------ 104 (360)
T 3llt_A 34 NNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI---KKYTRSAKIEADILKKIQNDDINNNNIVKYHGK------ 104 (360)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC---HHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEE------
T ss_pred cCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc---hhhhhhhHHHHHHHHHhcccCCCCCCeecccce------
Confidence 46799999999999999999998 57789999999742 234455778999999997 58999999886
Q ss_pred HHHHHhhCCCCCCCCccccCCeEEEEEecchhhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCC
Q 003052 546 LLREVLNGSMNNKDGRVKDDGYIYMVLEYGEIDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSD 625 (853)
Q Consensus 546 iL~~l~~~~iv~~~g~~~d~~~lyLVmEy~~gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRD 625 (853)
+...+.+|+||||++++|.+++... ....+++..++.++.||+.||.|||++||+|||
T Consensus 105 ----------------~~~~~~~~lv~e~~~~~L~~~~~~~------~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrD 162 (360)
T 3llt_A 105 ----------------FMYYDHMCLIFEPLGPSLYEIITRN------NYNGFHIEDIKLYCIEILKALNYLRKMSLTHTD 162 (360)
T ss_dssp ----------------EEETTEEEEEECCCCCBHHHHHHHT------TTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSC
T ss_pred ----------------eeECCeeEEEEcCCCCCHHHHHHhc------CCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCC
Confidence 4556789999999988999998764 234699999999999999999999999999999
Q ss_pred CCCccEEee--------------------------cCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCC
Q 003052 626 LKPANFLLV--------------------------KGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESD 679 (853)
Q Consensus 626 LKPeNILL~--------------------------~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~ 679 (853)
|||+|||++ ++.+||+|||+|+..... ....+||+.|+|||++.+.
T Consensus 163 lkp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~-----~~~~~gt~~y~aPE~~~~~--- 234 (360)
T 3llt_A 163 LKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY-----HGSIINTRQYRAPEVILNL--- 234 (360)
T ss_dssp CSGGGEEESCTTCCEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSC-----CCSCCSCGGGCCHHHHTTC---
T ss_pred CCcccEEEccccccccccchhcccccccccccccCCCCEEEEeccCceecCCC-----CcCccCcccccCcHHHcCC---
Confidence 999999995 568999999999864332 2356899999999999765
Q ss_pred CCCccccCCCccchhhhHHHHHHHHhCCCCCCcchhHHHHHHh--hcCCCC---------------------cccCC---
Q 003052 680 ENGNIIKCGRPSDIWSLGCILYQMVYGRTPFSEYKTFWAKFKV--ITDPNH---------------------EITYE--- 733 (853)
Q Consensus 680 ~~~~~~~ys~ksDIWSLGVILyELLtG~~PF~~~~~~~~~~ki--i~~~~~---------------------~~~~~--- 733 (853)
.|+.++|||||||++|+|++|+.||...........+ ...+.. ...++
T Consensus 235 ------~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~ 308 (360)
T 3llt_A 235 ------GWDVSSDMWSFGCVLAELYTGSLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENA 308 (360)
T ss_dssp ------CCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTC
T ss_pred ------CCCCccchHHHHHHHHHHHHCCCCCCCCcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccc
Confidence 3678999999999999999999999764433221111 111000 00011
Q ss_pred -----------------CCCChhHHHHHHHhcccCCCCCCChhHHhcCCCCC
Q 003052 734 -----------------PVPNPWLLDLMKKCLAWDRNERWRIPQLLQHPFLV 768 (853)
Q Consensus 734 -----------------~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~HPwf~ 768 (853)
...++.+.+||.+||++||.+|||+.|+|+||||+
T Consensus 309 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f~ 360 (360)
T 3llt_A 309 SSINSIKHVKKCLPLYKIIKHELFCDFLYSILQIDPTLRPSPAELLKHKFLE 360 (360)
T ss_dssp SCHHHHHHHHTCCCHHHHCCCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGC
T ss_pred cchhhhhhhhhcccccccchHHHHHHHHHHHhcCChhhCCCHHHHhcCcccC
Confidence 11236678999999999999999999999999995
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-45 Score=408.99 Aligned_cols=261 Identities=29% Similarity=0.448 Sum_probs=210.3
Q ss_pred CceeeEEEeEeccCceEEEEEEec-CCcEEEEEEEecCCC-ChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHH
Q 003052 471 GKLYQRLGKIGSGGSSEVHKVISS-DCTIYALKKIKLKGR-DYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLR 548 (853)
Q Consensus 471 g~~Y~ilk~LG~G~FG~Vyka~~~-~g~~vAVKkik~~~~-~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~ 548 (853)
.++|+++++||+|+||.||+|.+. +++.||+|++++... .......+.+|+.+|+.++ ||||++++++
T Consensus 68 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~-hp~Iv~l~~~--------- 137 (410)
T 3v8s_A 68 AEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFAN-SPWVVQLFYA--------- 137 (410)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCC-CTTBCCEEEE---------
T ss_pred ccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCC-CCCCCeEEEE---------
Confidence 367999999999999999999985 678999999975321 1112234779999999986 8999999876
Q ss_pred HHhhCCCCCCCCccccCCeEEEEEecc-hhhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCC
Q 003052 549 EVLNGSMNNKDGRVKDDGYIYMVLEYG-EIDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLK 627 (853)
Q Consensus 549 ~l~~~~iv~~~g~~~d~~~lyLVmEy~-~gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLK 627 (853)
|.++.++||||||+ +++|.+++.. ..+++.+++.|+.||+.||.|||++||+|||||
T Consensus 138 -------------~~~~~~~~lV~E~~~gg~L~~~l~~---------~~~~e~~~~~~~~qi~~aL~~LH~~givHrDLK 195 (410)
T 3v8s_A 138 -------------FQDDRYLYMVMEYMPGGDLVNLMSN---------YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVK 195 (410)
T ss_dssp -------------EECSSEEEEEECCCTTEEHHHHHHH---------CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCS
T ss_pred -------------EEECCEEEEEEeCCCCCcHHHHHHc---------CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCC
Confidence 56788999999998 4699988754 358999999999999999999999999999999
Q ss_pred CccEEe-ecCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHhC
Q 003052 628 PANFLL-VKGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYG 706 (853)
Q Consensus 628 PeNILL-~~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLtG 706 (853)
|+|||| .+|.+||+|||+|+...... .....+.+||+.|+|||++.+...+ ..|+.++|||||||++|||++|
T Consensus 196 p~NILl~~~g~ikL~DFG~a~~~~~~~-~~~~~~~~gt~~Y~APE~l~~~~~~-----~~~~~~~DiwSlGvilyell~G 269 (410)
T 3v8s_A 196 PDNMLLDKSGHLKLADFGTCMKMNKEG-MVRCDTAVGTPDYISPEVLKSQGGD-----GYYGRECDWWSVGVFLYEMLVG 269 (410)
T ss_dssp GGGEEECTTSCEEECCCTTCEECCTTS-EEECCSCCSCGGGCCHHHHHTTTTT-----CEEETHHHHHHHHHHHHHHHHS
T ss_pred HHHeeECCCCCEEEeccceeEeeccCC-cccccCCcCCccccCHHHhhccCCC-----cCCCCcceEecchHHHHHHHhC
Confidence 999999 56899999999998764332 1223477999999999999865322 1377899999999999999999
Q ss_pred CCCCCcchhHHHHHHhhcCC-CCcccCCCCCChhHHHHHHHhcccCCCC--CCChhHHhcCCCCCC
Q 003052 707 RTPFSEYKTFWAKFKVITDP-NHEITYEPVPNPWLLDLMKKCLAWDRNE--RWRIPQLLQHPFLVP 769 (853)
Q Consensus 707 ~~PF~~~~~~~~~~kii~~~-~~~~~~~~~~s~~l~dLI~kcL~~DP~k--RpTa~EIL~HPwf~~ 769 (853)
++||.+........+++... ...+......++++++||.+||..+|.+ |+++.||++||||+.
T Consensus 270 ~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~Hp~f~~ 335 (410)
T 3v8s_A 270 DTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKN 335 (410)
T ss_dssp SCTTCCSSHHHHHHHHHTHHHHCCCCTTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTSGGGCC
T ss_pred CCCCCCCChhhHHHHHHhccccccCCCcccccHHHHHHHHHHccChhhhCCCCCHHHHhcCccccC
Confidence 99998755443333332210 1122233467899999999999999988 999999999999975
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=405.07 Aligned_cols=259 Identities=24% Similarity=0.418 Sum_probs=211.1
Q ss_pred EcCceeeEEEeEeccCceEEEEEEec-CCcEEEEEEEecCCC-ChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHH
Q 003052 469 VNGKLYQRLGKIGSGGSSEVHKVISS-DCTIYALKKIKLKGR-DYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKAL 546 (853)
Q Consensus 469 v~g~~Y~ilk~LG~G~FG~Vyka~~~-~g~~vAVKkik~~~~-~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~i 546 (853)
+..++|++++.||+|+||.||+|.+. +++.||+|++..... .......+.+|+.+|++++ ||||++++++
T Consensus 12 v~~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~-hp~Iv~l~~~------- 83 (384)
T 4fr4_A 12 VNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLE-HPFLVNLWYS------- 83 (384)
T ss_dssp CCGGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCC-CTTBCCEEEE-------
T ss_pred CChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCC-CCCCCcEEEE-------
Confidence 33467999999999999999999984 678999999975431 2223456889999999996 9999999876
Q ss_pred HHHHhhCCCCCCCCccccCCeEEEEEecch-hhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCC
Q 003052 547 LREVLNGSMNNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSD 625 (853)
Q Consensus 547 L~~l~~~~iv~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRD 625 (853)
|.+...+|+||||+. ++|..++... ..+++..++.|+.||+.||.|||++||+|||
T Consensus 84 ---------------~~~~~~~~lv~e~~~gg~L~~~l~~~--------~~l~~~~~~~~~~qi~~aL~~LH~~givHrD 140 (384)
T 4fr4_A 84 ---------------FQDEEDMFMVVDLLLGGDLRYHLQQN--------VHFKEETVKLFICELVMALDYLQNQRIIHRD 140 (384)
T ss_dssp ---------------EECSSEEEEEECCCTTEEHHHHHHTT--------CCCCHHHHHHHHHHHHHHHHHHHHTTEECCC
T ss_pred ---------------EEeCCEEEEEEecCCCCcHHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHHCCceecc
Confidence 567788999999975 5898888643 5799999999999999999999999999999
Q ss_pred CCCccEEe-ecCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHH
Q 003052 626 LKPANFLL-VKGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMV 704 (853)
Q Consensus 626 LKPeNILL-~~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELL 704 (853)
|||+|||| .+|.+||+|||+|+.+.... ...+.+||+.|+|||++.+... ..|+.++|||||||++|+|+
T Consensus 141 lkp~NIll~~~g~vkL~DFG~a~~~~~~~---~~~~~~gt~~Y~aPE~~~~~~~------~~~~~~~DiwSlG~il~ell 211 (384)
T 4fr4_A 141 MKPDNILLDEHGHVHITDFNIAAMLPRET---QITTMAGTKPYMAPEMFSSRKG------AGYSFAVDWWSLGVTAYELL 211 (384)
T ss_dssp CSGGGEEECTTSCEEECCCTTCEECCTTC---CBCCCCSCGGGCCGGGTCCCSS------CCBCTTHHHHHHHHHHHHHH
T ss_pred CcHHHeEECCCCCEEEeccceeeeccCCC---ceeccCCCccccCCeeeccCCC------CCCCccceeechHHHHHHHH
Confidence 99999999 56799999999998764322 2347899999999999975321 14788999999999999999
Q ss_pred hCCCCCCcc--hhHHHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCCC-hhHHhcCCCCCC
Q 003052 705 YGRTPFSEY--KTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWR-IPQLLQHPFLVP 769 (853)
Q Consensus 705 tG~~PF~~~--~~~~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpT-a~EIL~HPwf~~ 769 (853)
+|+.||... .........+.. ....++...++.+.+||.+||..||.+||+ +.++++||||..
T Consensus 212 tG~~Pf~~~~~~~~~~~~~~~~~--~~~~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~hp~f~~ 277 (384)
T 4fr4_A 212 RGRRPYHIRSSTSSKEIVHTFET--TVVTYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQNFPYMND 277 (384)
T ss_dssp HSSCSSCCCTTSCHHHHHHHHHH--CCCCCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHTSGGGTT
T ss_pred hCCCCCCCCCCccHHHHHHHHhh--cccCCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHcChhhhc
Confidence 999999642 222222222221 223456678899999999999999999998 999999999964
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-44 Score=396.77 Aligned_cols=279 Identities=24% Similarity=0.387 Sum_probs=207.8
Q ss_pred EcCceeeEEEeEeccCceEEEEEEe-cCCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHH
Q 003052 469 VNGKLYQRLGKIGSGGSSEVHKVIS-SDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALL 547 (853)
Q Consensus 469 v~g~~Y~ilk~LG~G~FG~Vyka~~-~~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL 547 (853)
...++|++++.||+|+||.||+|.+ .+++.||||++...... ..+|+.+|+.++ |+||+++++++.......
T Consensus 4 ~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~------~~~E~~il~~l~-hpnIv~l~~~~~~~~~~~ 76 (383)
T 3eb0_A 4 TSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRY------KNRELDIMKVLD-HVNIIKLVDYFYTTGDEE 76 (383)
T ss_dssp --CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTS------CCHHHHHHTTCC-CTTBCCEEEEEEEC----
T ss_pred cccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcch------HHHHHHHHHHcC-CCCccchhheeeecCccc
Confidence 3456799999999999999999998 57899999999755332 237999999997 999999999864321100
Q ss_pred HHH-----hhC-------C----CCCCCCccccCCeEEEEEecchhhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhh
Q 003052 548 REV-----LNG-------S----MNNKDGRVKDDGYIYMVLEYGEIDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILE 611 (853)
Q Consensus 548 ~~l-----~~~-------~----iv~~~g~~~d~~~lyLVmEy~~gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~ 611 (853)
... .+. . .........+..++|+||||++++|.+.+..... .+..+++..++.|+.||+.
T Consensus 77 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~----~~~~l~~~~~~~i~~qi~~ 152 (383)
T 3eb0_A 77 PKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTLHKVLKSFIR----SGRSIPMNLISIYIYQLFR 152 (383)
T ss_dssp ---------------------------------CCEEEEEECCCSEEHHHHHHHHHH----TTCCCCHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccccccccccccccCCCceEEEEEEecCCccHHHHHHHHHh----cCCCCCHHHHHHHHHHHHH
Confidence 000 000 0 0000001155678999999999998888876433 3467999999999999999
Q ss_pred hhhhcccCceeeCCCCCccEEee--cCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCC
Q 003052 612 AVNTIHEERIVHSDLKPANFLLV--KGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGR 689 (853)
Q Consensus 612 AL~yLHs~gIIHRDLKPeNILL~--~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ 689 (853)
||.|||++||+||||||+|||++ ++.+||+|||+|+.+..... ....+||+.|+|||++.+.. .|+.
T Consensus 153 aL~~LH~~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~--------~~~~ 221 (383)
T 3eb0_A 153 AVGFIHSLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEP---SVAYICSRFYRAPELMLGAT--------EYTP 221 (383)
T ss_dssp HHHHHHTTTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSC---CCCCCCCSSCCCHHHHTTCS--------SCCT
T ss_pred HHHHHHHCcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCC---CcCcccCCCccCHHHhcCCC--------CCCc
Confidence 99999999999999999999995 57899999999987644332 23668999999999987542 3678
Q ss_pred ccchhhhHHHHHHHHhCCCCCCcchhHHHHHHhh---cCCC-----------------------CcccCCCCCChhHHHH
Q 003052 690 PSDIWSLGCILYQMVYGRTPFSEYKTFWAKFKVI---TDPN-----------------------HEITYEPVPNPWLLDL 743 (853)
Q Consensus 690 ksDIWSLGVILyELLtG~~PF~~~~~~~~~~kii---~~~~-----------------------~~~~~~~~~s~~l~dL 743 (853)
++|||||||++|+|++|++||.+.........++ ..+. ....++...++++.+|
T Consensus 222 ~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 301 (383)
T 3eb0_A 222 SIDLWSIGCVFGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDL 301 (383)
T ss_dssp HHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHH
T ss_pred chhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHH
Confidence 9999999999999999999998755443332222 1110 0011344577889999
Q ss_pred HHHhcccCCCCCCChhHHhcCCCCCC
Q 003052 744 MKKCLAWDRNERWRIPQLLQHPFLVP 769 (853)
Q Consensus 744 I~kcL~~DP~kRpTa~EIL~HPwf~~ 769 (853)
|.+||.+||.+|||+.|+|+||||..
T Consensus 302 i~~~L~~dP~~R~t~~e~l~hp~f~~ 327 (383)
T 3eb0_A 302 LEQILRYEPDLRINPYEAMAHPFFDH 327 (383)
T ss_dssp HHHHCCSSGGGSCCHHHHHTSGGGHH
T ss_pred HHHHccCChhhCCCHHHHhcCHHHHH
Confidence 99999999999999999999999963
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-45 Score=385.93 Aligned_cols=258 Identities=27% Similarity=0.500 Sum_probs=201.3
Q ss_pred ceeeEEEeEeccCceEEEEEEe-cCCcEEEEEEEecCCCC------------------------hhhHhhHHHHHHHHHH
Q 003052 472 KLYQRLGKIGSGGSSEVHKVIS-SDCTIYALKKIKLKGRD------------------------YATAYGFCQEIEYLNK 526 (853)
Q Consensus 472 ~~Y~ilk~LG~G~FG~Vyka~~-~~g~~vAVKkik~~~~~------------------------~~~~~~~l~EI~iLkk 526 (853)
++|++.+.||+|+||.||+|.+ .+++.||||++...... ......+.+|+++|++
T Consensus 13 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~ 92 (298)
T 2zv2_A 13 NQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILKK 92 (298)
T ss_dssp TTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHHT
T ss_pred cceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHHh
Confidence 4699999999999999999998 46789999999765321 1123568899999999
Q ss_pred hcCCCceeEeeehhhhHHHHHHHHhhCCCCCCCCccccCCeEEEEEecchh-hHHHHHHHhhhhccCCCCCCCHHHHHHH
Q 003052 527 LKGKNNIIQLIDYEVTEKALLREVLNGSMNNKDGRVKDDGYIYMVLEYGEI-DLAHMLSQKWKEMDGSNQTLDENWLRFY 605 (853)
Q Consensus 527 L~~hpNIV~Lid~~~~e~~iL~~l~~~~iv~~~g~~~d~~~lyLVmEy~~g-dL~~~L~~~~k~~~~~~~~LsE~~~r~I 605 (853)
++ |+||+++++++.. .....+|+||||+++ +|.+++ ....+++..++.+
T Consensus 93 l~-h~~iv~~~~~~~~--------------------~~~~~~~lv~e~~~~~~l~~~~---------~~~~~~~~~~~~~ 142 (298)
T 2zv2_A 93 LD-HPNVVKLVEVLDD--------------------PNEDHLYMVFELVNQGPVMEVP---------TLKPLSEDQARFY 142 (298)
T ss_dssp CC-CTTBCCEEEEEEC--------------------SSSSEEEEEEECCTTCBSCCSS---------CSSCCCHHHHHHH
T ss_pred CC-CCCCCeEEEEEEc--------------------CCCCEEEEEEecCCCCcHHHHh---------hcCCCCHHHHHHH
Confidence 97 9999999987421 135689999999864 554432 2357999999999
Q ss_pred HHHhhhhhhhcccCceeeCCCCCccEEe-ecCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCcc
Q 003052 606 WQQILEAVNTIHEERIVHSDLKPANFLL-VKGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNI 684 (853)
Q Consensus 606 ~~QIl~AL~yLHs~gIIHRDLKPeNILL-~~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~ 684 (853)
+.||+.||.|||++||+||||||+|||+ .++.+||+|||+++.+..... .....+||+.|+|||++.+...
T Consensus 143 ~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~------ 214 (298)
T 2zv2_A 143 FQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDA--LLSNTVGTPAFMAPESLSETRK------ 214 (298)
T ss_dssp HHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECSSSSC--EECCCCSCGGGCCGGGCCTTCC------
T ss_pred HHHHHHHHHHHHHCCeeccCCCHHHEEECCCCCEEEecCCCccccccccc--cccCCcCCccccChhhhccCCC------
Confidence 9999999999999999999999999999 467999999999987654322 2345689999999999976432
Q ss_pred ccCCCccchhhhHHHHHHHHhCCCCCCcchhHHHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCCChhHHhcC
Q 003052 685 IKCGRPSDIWSLGCILYQMVYGRTPFSEYKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQH 764 (853)
Q Consensus 685 ~~ys~ksDIWSLGVILyELLtG~~PF~~~~~~~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~H 764 (853)
..++.++|||||||++|+|++|+.||.+.........+.. ...........++++.+||.+||..||.+||++.|+|+|
T Consensus 215 ~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~h 293 (298)
T 2zv2_A 215 IFSGKALDVWAMGVTLYCFVFGQCPFMDERIMCLHSKIKS-QALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLH 293 (298)
T ss_dssp CEESHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH-CCCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTC
T ss_pred CCCCchhhhHhHHHHHHHHHHCCCCCCCccHHHHHHHHhc-ccCCCCCccccCHHHHHHHHHHhhcChhhCCCHHHHhcC
Confidence 1246789999999999999999999987544332222222 222333345678899999999999999999999999999
Q ss_pred CCCC
Q 003052 765 PFLV 768 (853)
Q Consensus 765 Pwf~ 768 (853)
|||.
T Consensus 294 p~~~ 297 (298)
T 2zv2_A 294 PWVT 297 (298)
T ss_dssp HHHH
T ss_pred cccc
Confidence 9985
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-44 Score=396.18 Aligned_cols=260 Identities=27% Similarity=0.436 Sum_probs=205.3
Q ss_pred ceeeEEEeEeccCceEEEEEEe-cCCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHHHH
Q 003052 472 KLYQRLGKIGSGGSSEVHKVIS-SDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLREV 550 (853)
Q Consensus 472 ~~Y~ilk~LG~G~FG~Vyka~~-~~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~~l 550 (853)
+.|++++.||+|+||.||+|.+ .+++.||||++............+.+|+++|++++ |+||+++++++...
T Consensus 25 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~~------- 96 (367)
T 1cm8_A 25 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMR-HENVIGLLDVFTPD------- 96 (367)
T ss_dssp SSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCC-BTTBCCCSEEECSC-------
T ss_pred ceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCC-CcCCCCceeeEecC-------
Confidence 5699999999999999999998 57899999999776656566677899999999998 99999999875321
Q ss_pred hhCCCCCCCCccccCCeEEEEEecchhhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCCCcc
Q 003052 551 LNGSMNNKDGRVKDDGYIYMVLEYGEIDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPAN 630 (853)
Q Consensus 551 ~~~~iv~~~g~~~d~~~lyLVmEy~~gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLKPeN 630 (853)
+...+...+|+||||++++|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|
T Consensus 97 ---------~~~~~~~~~~lv~e~~~~~L~~~~~~---------~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~N 158 (367)
T 1cm8_A 97 ---------ETLDDFTDFYLVMPFMGTDLGKLMKH---------EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGN 158 (367)
T ss_dssp ---------SSTTTCCCCEEEEECCSEEHHHHHHH---------CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGG
T ss_pred ---------CccccCceEEEEEecCCCCHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHH
Confidence 11233456799999998899988864 369999999999999999999999999999999999
Q ss_pred EEee-cCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHhCCCC
Q 003052 631 FLLV-KGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGRTP 709 (853)
Q Consensus 631 ILL~-~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLtG~~P 709 (853)
||++ ++.+||+|||+|+..... ....+||++|+|||++.+.. .|+.++|||||||++|+|++|++|
T Consensus 159 Ill~~~~~~kl~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~--------~~~~~~DiwslG~il~ell~g~~p 225 (367)
T 1cm8_A 159 LAVNEDCELKILDFGLARQADSE-----MTGYVVTRWYRAPEVILNWM--------RYTQTVDIWSVGCIMAEMITGKTL 225 (367)
T ss_dssp EEECTTCCEEECCCTTCEECCSS-----CCSSCSCGGGCCTHHHHTTT--------CCCTTHHHHHHHHHHHHHHHSSCS
T ss_pred EEEcCCCCEEEEeeecccccccc-----cCcCcCCCCcCCHHHHhCCC--------CCChhhhHHHHHHHHHHHHhCCCC
Confidence 9994 679999999999865432 23578999999999997632 367899999999999999999999
Q ss_pred CCcchhHHHHH---HhhcCCCC-------------------------cccCCCCCChhHHHHHHHhcccCCCCCCChhHH
Q 003052 710 FSEYKTFWAKF---KVITDPNH-------------------------EITYEPVPNPWLLDLMKKCLAWDRNERWRIPQL 761 (853)
Q Consensus 710 F~~~~~~~~~~---kii~~~~~-------------------------~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EI 761 (853)
|.+........ .....+.. -.......++.+.+||.+||..||.+|||+.|+
T Consensus 226 f~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~ 305 (367)
T 1cm8_A 226 FKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEA 305 (367)
T ss_dssp SCCSSHHHHHHHHHHHHCCCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHH
T ss_pred CCCCCHHHHHHHHHHhcCCCCHHHHHHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHH
Confidence 97654432222 11111100 011224568889999999999999999999999
Q ss_pred hcCCCCCCC
Q 003052 762 LQHPFLVPP 770 (853)
Q Consensus 762 L~HPwf~~~ 770 (853)
|+||||...
T Consensus 306 l~hp~f~~~ 314 (367)
T 1cm8_A 306 LAHPYFESL 314 (367)
T ss_dssp HHSGGGTTT
T ss_pred hcChHHHhh
Confidence 999999764
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-44 Score=396.21 Aligned_cols=258 Identities=26% Similarity=0.407 Sum_probs=200.1
Q ss_pred cCceeeEEEeEeccCceEEEEEEec-CCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHH
Q 003052 470 NGKLYQRLGKIGSGGSSEVHKVISS-DCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLR 548 (853)
Q Consensus 470 ~g~~Y~ilk~LG~G~FG~Vyka~~~-~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~ 548 (853)
..++|++++.||+|+||.||+|.+. +++.||||++...... ...+.+|+.++++++ |+||++++++
T Consensus 18 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~-hpniv~~~~~--------- 84 (361)
T 3uc3_A 18 DSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAI---DENVQREIINHRSLR-HPNIVRFKEV--------- 84 (361)
T ss_dssp CTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTS---CHHHHHHHHHHHHCC-CTTBCCEEEE---------
T ss_pred CCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCccc---cHHHHHHHHHHHhCC-CCCCCcEEEE---------
Confidence 4567999999999999999999985 7789999999765432 235779999999997 8999999987
Q ss_pred HHhhCCCCCCCCccccCCeEEEEEecch-hhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCC
Q 003052 549 EVLNGSMNNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLK 627 (853)
Q Consensus 549 ~l~~~~iv~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLK 627 (853)
+.+...+|+||||+. ++|.+++... +.+++..++.++.||+.||.|||++||+|||||
T Consensus 85 -------------~~~~~~~~lv~e~~~~~~L~~~l~~~--------~~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlk 143 (361)
T 3uc3_A 85 -------------ILTPTHLAIIMEYASGGELYERICNA--------GRFSEDEARFFFQQLLSGVSYCHSMQICHRDLK 143 (361)
T ss_dssp -------------EECSSEEEEEEECCCSCBHHHHHHHH--------SSCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCC
T ss_pred -------------EeeCCEEEEEEEeCCCCCHHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCC
Confidence 456778999999985 5999888654 569999999999999999999999999999999
Q ss_pred CccEEeec-C--cEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHH
Q 003052 628 PANFLLVK-G--SLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMV 704 (853)
Q Consensus 628 PeNILL~~-g--~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELL 704 (853)
|+|||++. + .+||+|||+|+...... .....+||+.|+|||++.+..+ ++.++|||||||++|+|+
T Consensus 144 p~Nill~~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~--------~~~~~DiwslG~il~ell 212 (361)
T 3uc3_A 144 LENTLLDGSPAPRLKICDFGYSKSSVLHS---QPKSTVGTPAYIAPEVLLRQEY--------DGKIADVWSCGVTLYVML 212 (361)
T ss_dssp GGGEEECSSSSCCEEECCCCCC------------------CTTSCHHHHHCSSC--------CHHHHHHHHHHHHHHHHH
T ss_pred HHHEEEcCCCCceEEEeecCccccccccC---CCCCCcCCCCcCChhhhcCCCC--------CCCeeeeehhHHHHHHHH
Confidence 99999953 3 49999999998543222 2235689999999999977543 234589999999999999
Q ss_pred hCCCCCCcchh---HHHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCCChhHHhcCCCCCCCCC
Q 003052 705 YGRTPFSEYKT---FWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQHPFLVPPVS 772 (853)
Q Consensus 705 tG~~PF~~~~~---~~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~HPwf~~~~~ 772 (853)
+|+.||.+... .......+......+......++.+.+||.+||.+||.+|||+.|+|+||||.....
T Consensus 213 ~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~~~ 283 (361)
T 3uc3_A 213 VGAYPFEDPEEPRDYRKTIQRILSVKYSIPDDIRISPECCHLISRIFVADPATRISIPEIKTHSWFLKNLP 283 (361)
T ss_dssp HSSCSCC----CCCHHHHHHHHHTTCCCCCTTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTSHHHHTTCC
T ss_pred hCCCCCCCCccHHHHHHHHHHHhcCCCCCCCcCCCCHHHHHHHHHHccCChhHCcCHHHHHhCcchhcCCc
Confidence 99999975322 223333333333333444467899999999999999999999999999999976543
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-44 Score=396.20 Aligned_cols=251 Identities=30% Similarity=0.428 Sum_probs=206.0
Q ss_pred ceeeEEEeEeccCceEEEEEEec-CCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHHHH
Q 003052 472 KLYQRLGKIGSGGSSEVHKVISS-DCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLREV 550 (853)
Q Consensus 472 ~~Y~ilk~LG~G~FG~Vyka~~~-~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~~l 550 (853)
+.|++.+.||+|+||.||+|.+. +++.||||++...... ..+|+++|.++.+||||++++++
T Consensus 22 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~------~~~E~~~l~~~~~hp~iv~~~~~----------- 84 (342)
T 2qr7_A 22 DGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRD------PTEEIEILLRYGQHPNIITLKDV----------- 84 (342)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCC------CHHHHHHHHHHTTSTTBCCEEEE-----------
T ss_pred ccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCC------hHHHHHHHHHhcCCCCcCeEEEE-----------
Confidence 56999999999999999999984 6789999999865432 45799999999889999999987
Q ss_pred hhCCCCCCCCccccCCeEEEEEecch-hhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCCCc
Q 003052 551 LNGSMNNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPA 629 (853)
Q Consensus 551 ~~~~iv~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLKPe 629 (853)
+.+...+|+||||+. ++|.+.+... ..+++..++.++.||+.||.|||++||+||||||+
T Consensus 85 -----------~~~~~~~~lv~E~~~gg~L~~~i~~~--------~~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~ 145 (342)
T 2qr7_A 85 -----------YDDGKYVYVVTELMKGGELLDKILRQ--------KFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPS 145 (342)
T ss_dssp -----------EECSSEEEEEECCCCSCBHHHHHHTC--------TTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGG
T ss_pred -----------EEcCCEEEEEEeCCCCCcHHHHHHHc--------CCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHH
Confidence 567789999999985 5898888643 56999999999999999999999999999999999
Q ss_pred cEEeec--C---cEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHH
Q 003052 630 NFLLVK--G---SLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMV 704 (853)
Q Consensus 630 NILL~~--g---~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELL 704 (853)
|||+.+ + .+||+|||+|+.+..... ...+.+||+.|+|||++.+. .|+.++|||||||++|+|+
T Consensus 146 NIl~~~~~~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~---------~~~~~~DiwslG~il~ell 214 (342)
T 2qr7_A 146 NILYVDESGNPESIRICDFGFAKQLRAENG--LLMTPCYTANFVAPEVLERQ---------GYDAACDIWSLGVLLYTML 214 (342)
T ss_dssp GEEESSSSCSGGGEEECCCTTCEECBCTTC--CBCCSSCCSSCCCHHHHHHH---------HHHHHHHHHHHHHHHHHHH
T ss_pred HEEEecCCCCcCeEEEEECCCcccCcCCCC--ceeccCCCccccCHHHhcCC---------CCCCccCeeeHhHHHHHHh
Confidence 999832 2 599999999987654322 23467999999999999754 3567999999999999999
Q ss_pred hCCCCCCcc--hhHHHHHHhhcCCCCcc--cCCCCCChhHHHHHHHhcccCCCCCCChhHHhcCCCCCC
Q 003052 705 YGRTPFSEY--KTFWAKFKVITDPNHEI--TYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQHPFLVP 769 (853)
Q Consensus 705 tG~~PF~~~--~~~~~~~kii~~~~~~~--~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~HPwf~~ 769 (853)
+|..||.+. ......+..+......+ .+....++++++||.+||..||.+||++.++|+||||..
T Consensus 215 ~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~ 283 (342)
T 2qr7_A 215 TGYTPFANGPDDTPEEILARIGSGKFSLSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRHPWIVH 283 (342)
T ss_dssp HSSCSSCSSTTSCHHHHHHHHHHCCCCCCSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHT
T ss_pred cCCCCCCCCCcCCHHHHHHHHccCCcccCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCCeecC
Confidence 999999752 22233333333222222 233567899999999999999999999999999999964
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-44 Score=396.95 Aligned_cols=267 Identities=22% Similarity=0.300 Sum_probs=205.6
Q ss_pred CCCCceeEEcCceeeEEEeEeccCceEEEEEEe-cCCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcC-------CCc
Q 003052 461 YDPDLFFKVNGKLYQRLGKIGSGGSSEVHKVIS-SDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKG-------KNN 532 (853)
Q Consensus 461 ~dp~~~~~v~g~~Y~ilk~LG~G~FG~Vyka~~-~~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~-------hpN 532 (853)
|.+.....+..++|+++++||+|+||.||+|++ .+++.||||+++.. ......+.+|+.+|+++.+ |+|
T Consensus 26 ~~~~~~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~~~~ 102 (397)
T 1wak_A 26 YHLVKIGDLFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA---EHYTETALDEIRLLKSVRNSDPNDPNREM 102 (397)
T ss_dssp CCSSCTTCEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHHSCTTCGGGGG
T ss_pred ceEEehhhhcCCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC---CcchHHHHHHHHHHHHHhhcCCCCCCcce
Confidence 443333344457899999999999999999998 56789999999743 3345568899999999974 778
Q ss_pred eeEeeehhhhHHHHHHHHhhCCCCCCCCccccCCeEEEEEecchhhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhh
Q 003052 533 IIQLIDYEVTEKALLREVLNGSMNNKDGRVKDDGYIYMVLEYGEIDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEA 612 (853)
Q Consensus 533 IV~Lid~~~~e~~iL~~l~~~~iv~~~g~~~d~~~lyLVmEy~~gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~A 612 (853)
|+++++++... ..+..++|+||||++++|.+.+... ....+++..++.|+.||+.|
T Consensus 103 iv~~~~~~~~~------------------~~~~~~~~lv~e~~~~~l~~~~~~~------~~~~~~~~~~~~i~~qi~~a 158 (397)
T 1wak_A 103 VVQLLDDFKIS------------------GVNGTHICMVFEVLGHHLLKWIIKS------NYQGLPLPCVKKIIQQVLQG 158 (397)
T ss_dssp BCCEEEEEEEE------------------ETTEEEEEEEECCCCCBHHHHHHHT------TTSCCCHHHHHHHHHHHHHH
T ss_pred eeeeecceeec------------------CCCCceEEEEEeccCccHHHHHHhc------ccCCCCHHHHHHHHHHHHHH
Confidence 99998874210 1145689999999999888887654 23569999999999999999
Q ss_pred hhhcccC-ceeeCCCCCccEEeecC--------------------------------------------------cEEEE
Q 003052 613 VNTIHEE-RIVHSDLKPANFLLVKG--------------------------------------------------SLKLI 641 (853)
Q Consensus 613 L~yLHs~-gIIHRDLKPeNILL~~g--------------------------------------------------~VKL~ 641 (853)
|.|||++ ||+||||||+||||+.+ .+||+
T Consensus 159 L~~lH~~~givHrDikp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~ 238 (397)
T 1wak_A 159 LDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIA 238 (397)
T ss_dssp HHHHHHTTCEECCCCSGGGEEECCCHHHHHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEEC
T ss_pred HHHHHHhCCEecCCCCHHHeeEeccchhhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEec
Confidence 9999998 99999999999999532 69999
Q ss_pred ecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHhCCCCCCcch-------
Q 003052 642 DFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGRTPFSEYK------- 714 (853)
Q Consensus 642 DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLtG~~PF~~~~------- 714 (853)
|||+|+..... ....+||+.|+|||++.+.. |+.++|||||||+||+|++|+.||....
T Consensus 239 DfG~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~---------~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~ 304 (397)
T 1wak_A 239 DLGNACWVHKH-----FTEDIQTRQYRSLEVLIGSG---------YNTPADIWSTACMAFELATGDYLFEPHSGEEYTRD 304 (397)
T ss_dssp CGGGCEETTBC-----SCSCCSCGGGCCHHHHHTSC---------CCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHH
T ss_pred ccccccccccc-----CccCCCCCcccCChhhcCCC---------CCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCch
Confidence 99999866432 23568999999999998653 5689999999999999999999996422
Q ss_pred --hHHHHHHhhcCCCCc------------------------------------ccCCCCCChhHHHHHHHhcccCCCCCC
Q 003052 715 --TFWAKFKVITDPNHE------------------------------------ITYEPVPNPWLLDLMKKCLAWDRNERW 756 (853)
Q Consensus 715 --~~~~~~kii~~~~~~------------------------------------~~~~~~~s~~l~dLI~kcL~~DP~kRp 756 (853)
............... ..++...+..+.+||.+||.+||.+||
T Consensus 305 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp 384 (397)
T 1wak_A 305 EDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRA 384 (397)
T ss_dssp HHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSC
T ss_pred HHHHHHHHHhcCCCChHHhhcccccccccCCccccccccccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcC
Confidence 111122211111000 001111234588999999999999999
Q ss_pred ChhHHhcCCCCC
Q 003052 757 RIPQLLQHPFLV 768 (853)
Q Consensus 757 Ta~EIL~HPwf~ 768 (853)
|+.|+|+||||.
T Consensus 385 t~~e~l~hp~~~ 396 (397)
T 1wak_A 385 TAAECLRHPWLN 396 (397)
T ss_dssp CHHHHHTSGGGG
T ss_pred CHHHHhhCcccc
Confidence 999999999995
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-44 Score=389.92 Aligned_cols=268 Identities=29% Similarity=0.430 Sum_probs=209.1
Q ss_pred ceeeEEEeEeccCceEEEEEEe-cCCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHHHH
Q 003052 472 KLYQRLGKIGSGGSSEVHKVIS-SDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLREV 550 (853)
Q Consensus 472 ~~Y~ilk~LG~G~FG~Vyka~~-~~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~~l 550 (853)
.+|+++++||+|+||.||+|.+ .+++.||||++............+.+|+.+|++++ |+||+++++++......
T Consensus 17 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~---- 91 (351)
T 3mi9_A 17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLK-HENVVNLIEICRTKASP---- 91 (351)
T ss_dssp GGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCC-CTTBCCEEEEEEEC-------
T ss_pred cceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhcc-CCCcccHhheeeccccc----
Confidence 5699999999999999999998 57899999999776655555556889999999998 99999999986432110
Q ss_pred hhCCCCCCCCccccCCeEEEEEecchhhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCCCcc
Q 003052 551 LNGSMNNKDGRVKDDGYIYMVLEYGEIDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPAN 630 (853)
Q Consensus 551 ~~~~iv~~~g~~~d~~~lyLVmEy~~gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLKPeN 630 (853)
.....+.+|+||||++++|...+... ...+++..++.++.||+.||.|||++||+||||||+|
T Consensus 92 ----------~~~~~~~~~lv~e~~~~~l~~~l~~~-------~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~N 154 (351)
T 3mi9_A 92 ----------YNRCKGSIYLVFDFCEHDLAGLLSNV-------LVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAAN 154 (351)
T ss_dssp ---------------CEEEEEEECCSEEHHHHHHCT-------TSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGG
T ss_pred ----------cccCCceEEEEEeccCCCHHHHHhhc-------cCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHH
Confidence 12235689999999999888887643 3469999999999999999999999999999999999
Q ss_pred EEee-cCcEEEEecccchhcccCC--ccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHhCC
Q 003052 631 FLLV-KGSLKLIDFGIAKAIMSDT--TNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGR 707 (853)
Q Consensus 631 ILL~-~g~VKL~DFGlAk~~~~~~--~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLtG~ 707 (853)
||++ ++.+||+|||+|+.+.... ........+||+.|+|||++.+.. .|+.++|||||||++|+|++|+
T Consensus 155 Il~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--------~~~~~~DiwslG~il~ell~g~ 226 (351)
T 3mi9_A 155 VLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGER--------DYGPPIDLWGAGCIMAEMWTRS 226 (351)
T ss_dssp EEECTTSCEEECCCTTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCC--------SCCTHHHHHHHHHHHHHHHHSS
T ss_pred EEEcCCCCEEEccchhcccccccccccccccCCcccccCccCchhhcCCC--------CCCcHhHHHHHHHHHHHHHhCC
Confidence 9994 6799999999998764221 112234568999999999996542 3678999999999999999999
Q ss_pred CCCCcchhHHHHHH---hhcCCCCcccCCC---------------------------CCChhHHHHHHHhcccCCCCCCC
Q 003052 708 TPFSEYKTFWAKFK---VITDPNHEITYEP---------------------------VPNPWLLDLMKKCLAWDRNERWR 757 (853)
Q Consensus 708 ~PF~~~~~~~~~~k---ii~~~~~~~~~~~---------------------------~~s~~l~dLI~kcL~~DP~kRpT 757 (853)
+||.+......... ........ .++. ..++.+.+||.+||.+||.+|||
T Consensus 227 ~pf~~~~~~~~~~~i~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t 305 (351)
T 3mi9_A 227 PIMQGNTEQHQLALISQLCGSITPE-VWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRID 305 (351)
T ss_dssp CSCCCSSHHHHHHHHHHHHCCCCTT-TSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCC
T ss_pred CCCCCCChHHHHHHHHHHhCCCChh-hccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCC
Confidence 99987544322221 11111111 0000 02567899999999999999999
Q ss_pred hhHHhcCCCCCCC
Q 003052 758 IPQLLQHPFLVPP 770 (853)
Q Consensus 758 a~EIL~HPwf~~~ 770 (853)
+.|+|+||||...
T Consensus 306 ~~e~l~hp~f~~~ 318 (351)
T 3mi9_A 306 SDDALNHDFFWSD 318 (351)
T ss_dssp HHHHHTSGGGGSS
T ss_pred HHHHhCCCCcCCC
Confidence 9999999999754
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-44 Score=380.93 Aligned_cols=258 Identities=28% Similarity=0.450 Sum_probs=201.0
Q ss_pred ceeeEEEeEeccCceEEEEEEec-CCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHHHH
Q 003052 472 KLYQRLGKIGSGGSSEVHKVISS-DCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLREV 550 (853)
Q Consensus 472 ~~Y~ilk~LG~G~FG~Vyka~~~-~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~~l 550 (853)
++|+++++||+|+||.||+|.+. +++.||||++............+.+|+.++++++ |+||++++++
T Consensus 3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~----------- 70 (311)
T 4agu_A 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLK-HPNLVNLLEV----------- 70 (311)
T ss_dssp CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCC-CTTBCCEEEE-----------
T ss_pred ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCC-CCCccchhhe-----------
Confidence 46999999999999999999984 6889999999877666666677889999999998 8999999987
Q ss_pred hhCCCCCCCCccccCCeEEEEEecchh-hHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCCCc
Q 003052 551 LNGSMNNKDGRVKDDGYIYMVLEYGEI-DLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPA 629 (853)
Q Consensus 551 ~~~~iv~~~g~~~d~~~lyLVmEy~~g-dL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLKPe 629 (853)
+.+.+.+|+||||+++ +|..++.. ...+++..++.++.||+.||.|||++||+||||||+
T Consensus 71 -----------~~~~~~~~lv~e~~~~~~l~~~~~~--------~~~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~ 131 (311)
T 4agu_A 71 -----------FRRKRRLHLVFEYCDHTVLHELDRY--------QRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPE 131 (311)
T ss_dssp -----------EEETTEEEEEEECCSEEHHHHHHHT--------SSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGG
T ss_pred -----------eecCCeEEEEEEeCCCchHHHHHhh--------hcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChh
Confidence 4566789999999886 45544432 256999999999999999999999999999999999
Q ss_pred cEEee-cCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHhCCC
Q 003052 630 NFLLV-KGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGRT 708 (853)
Q Consensus 630 NILL~-~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLtG~~ 708 (853)
|||++ ++.+||+|||+++....... .....+||+.|+|||++.+.. .|+.++|||||||++|+|++|++
T Consensus 132 Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~--------~~~~~~Di~slG~il~~l~~g~~ 201 (311)
T 4agu_A 132 NILITKHSVIKLCDFGFARLLTGPSD--YYDDEVATRWYRSPELLVGDT--------QYGPPVDVWAIGCVFAELLSGVP 201 (311)
T ss_dssp GEEECTTSCEEECCCTTCEECC--------------GGGCCHHHHHTCS--------CCCTHHHHHHHHHHHHHHHHSSC
T ss_pred hEEEcCCCCEEEeeCCCchhccCccc--ccCCCcCCccccChHHHhcCC--------CCCcchhhHHHHHHHHHHHhCCC
Confidence 99994 67999999999987643222 223568999999999997532 36789999999999999999999
Q ss_pred CCCcchhHHHHHHh---hcCC---------------CCccc----------CCCCCChhHHHHHHHhcccCCCCCCChhH
Q 003052 709 PFSEYKTFWAKFKV---ITDP---------------NHEIT----------YEPVPNPWLLDLMKKCLAWDRNERWRIPQ 760 (853)
Q Consensus 709 PF~~~~~~~~~~ki---i~~~---------------~~~~~----------~~~~~s~~l~dLI~kcL~~DP~kRpTa~E 760 (853)
||.+.........+ .... ..... .....+..+.+||.+||..||.+|||+.|
T Consensus 202 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e 281 (311)
T 4agu_A 202 LWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQ 281 (311)
T ss_dssp SCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHH
T ss_pred CCCCCCHHHHHHHHHHHhcccccccccccccccccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHH
Confidence 99765443222111 1100 00000 01346778999999999999999999999
Q ss_pred HhcCCCCCCC
Q 003052 761 LLQHPFLVPP 770 (853)
Q Consensus 761 IL~HPwf~~~ 770 (853)
+|+||||+..
T Consensus 282 ll~hp~f~~~ 291 (311)
T 4agu_A 282 LLHHPYFENI 291 (311)
T ss_dssp HHTSGGGTTC
T ss_pred HhcChHHHhc
Confidence 9999999864
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-44 Score=390.93 Aligned_cols=258 Identities=29% Similarity=0.519 Sum_probs=199.8
Q ss_pred ceeeEEEeEeccCceEEEEEEec-CCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHHHH
Q 003052 472 KLYQRLGKIGSGGSSEVHKVISS-DCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLREV 550 (853)
Q Consensus 472 ~~Y~ilk~LG~G~FG~Vyka~~~-~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~~l 550 (853)
++|+++++||+|+||.||+|.+. +++.||||++...... .....+.+|+.+|++++ |+||++++++
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~-h~~iv~~~~~----------- 68 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEE-GAPCTAIREVSLLKDLK-HANIVTLHDI----------- 68 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC-------CCCCCCCHHHHSCCC-CTTBCCEEEE-----------
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEeccccc-ccchhHHHHHHHHHhcC-CCCCCeeeeE-----------
Confidence 35999999999999999999985 7789999999755432 22224568999999997 8999999987
Q ss_pred hhCCCCCCCCccccCCeEEEEEecchhhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCCCcc
Q 003052 551 LNGSMNNKDGRVKDDGYIYMVLEYGEIDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPAN 630 (853)
Q Consensus 551 ~~~~iv~~~g~~~d~~~lyLVmEy~~gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLKPeN 630 (853)
+.+...+|+||||++++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|
T Consensus 69 -----------~~~~~~~~lv~e~~~~~l~~~~~~~-------~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~N 130 (324)
T 3mtl_A 69 -----------IHTEKSLTLVFEYLDKDLKQYLDDC-------GNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQN 130 (324)
T ss_dssp -----------EECSSCEEEEEECCSEEHHHHHHHT-------TTCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGG
T ss_pred -----------EeeCCEEEEEecccccCHHHHHHhc-------CCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHH
Confidence 4566789999999999999988763 3569999999999999999999999999999999999
Q ss_pred EEe-ecCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHhCCCC
Q 003052 631 FLL-VKGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGRTP 709 (853)
Q Consensus 631 ILL-~~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLtG~~P 709 (853)
||+ .++.+||+|||+++....... .....+||+.|+|||++.+.. .|+.++|||||||++|+|++|+.|
T Consensus 131 Il~~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~--------~~~~~~DiwslG~il~~l~~g~~p 200 (324)
T 3mtl_A 131 LLINERGELKLADFGLARAKSIPTK--TYDNEVVTLWYRPPDILLGST--------DYSTQIDMWGVGCIFYEMATGRPL 200 (324)
T ss_dssp EEECTTCCEEECSSSEEECC--------------CGGGCCHHHHTTCC--------CCCTHHHHHHHHHHHHHHHHSSCS
T ss_pred EEECCCCCEEEccCcccccccCCcc--ccccccCcccccChhhhcCCC--------CCCcHHHHHHHHHHHHHHHhCCCC
Confidence 999 567999999999986543222 233568999999999996532 367899999999999999999999
Q ss_pred CCcchhHHH---HHHhhcCCCCc------------------------ccCCCCCChhHHHHHHHhcccCCCCCCChhHHh
Q 003052 710 FSEYKTFWA---KFKVITDPNHE------------------------ITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLL 762 (853)
Q Consensus 710 F~~~~~~~~---~~kii~~~~~~------------------------~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL 762 (853)
|.+...... +......+... .......++++.+||.+||.+||.+|||+.|+|
T Consensus 201 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l 280 (324)
T 3mtl_A 201 FPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAM 280 (324)
T ss_dssp CCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCHHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHT
T ss_pred CCCCCHHHHHHHHHHHhCCCChHhchhhhcchhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHh
Confidence 977543322 22222211110 011234678899999999999999999999999
Q ss_pred cCCCCCCC
Q 003052 763 QHPFLVPP 770 (853)
Q Consensus 763 ~HPwf~~~ 770 (853)
+||||...
T Consensus 281 ~hp~f~~~ 288 (324)
T 3mtl_A 281 KHPFFLSL 288 (324)
T ss_dssp TSGGGGGG
T ss_pred cChhhhhc
Confidence 99999753
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-44 Score=390.33 Aligned_cols=254 Identities=23% Similarity=0.374 Sum_probs=208.5
Q ss_pred ceeeEEEeEeccCceEEEEEEec-CCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHHHH
Q 003052 472 KLYQRLGKIGSGGSSEVHKVISS-DCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLREV 550 (853)
Q Consensus 472 ~~Y~ilk~LG~G~FG~Vyka~~~-~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~~l 550 (853)
++|++.+.||+|+||.||+|.+. +++.||+|++.... .....+.+|+.+|++++ ||||++++++
T Consensus 5 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~---~~~~~~~~E~~~l~~l~-hpnIv~~~~~----------- 69 (321)
T 1tki_A 5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG---TDQVLVKKEISILNIAR-HRNILHLHES----------- 69 (321)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT---HHHHHHHHHHHHHHHSC-CTTBCCEEEE-----------
T ss_pred hceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCc---ccHHHHHHHHHHHHhCC-CCCCCeEeEE-----------
Confidence 56999999999999999999984 67899999997543 23445789999999997 9999999987
Q ss_pred hhCCCCCCCCccccCCeEEEEEecch-hhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCCCc
Q 003052 551 LNGSMNNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPA 629 (853)
Q Consensus 551 ~~~~iv~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLKPe 629 (853)
+.+...+|+||||++ ++|.+.+... ...+++..++.++.||+.||.|||++||+||||||+
T Consensus 70 -----------~~~~~~~~lv~e~~~g~~L~~~l~~~-------~~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~ 131 (321)
T 1tki_A 70 -----------FESMEELVMIFEFISGLDIFERINTS-------AFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPE 131 (321)
T ss_dssp -----------EEETTEEEEEECCCCCCBHHHHHTSS-------SCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGG
T ss_pred -----------EecCCEEEEEEEeCCCCCHHHHHHhc-------CCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHH
Confidence 456778999999986 4898887542 346999999999999999999999999999999999
Q ss_pred cEEee---cCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHhC
Q 003052 630 NFLLV---KGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYG 706 (853)
Q Consensus 630 NILL~---~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLtG 706 (853)
|||++ ++.+||+|||+++.+.... .....+||+.|+|||++.+. .++.++|||||||++|+|++|
T Consensus 132 NIl~~~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~---------~~~~~~DiwslG~il~~ll~g 199 (321)
T 1tki_A 132 NIIYQTRRSSTIKIIEFGQARQLKPGD---NFRLLFTAPEYYAPEVHQHD---------VVSTATDMWSLGTLVYVLLSG 199 (321)
T ss_dssp GEEESSSSCCCEEECCCTTCEECCTTC---EEEEEESCGGGSCHHHHTTC---------EECHHHHHHHHHHHHHHHHHS
T ss_pred HEEEccCCCCCEEEEECCCCeECCCCC---ccccccCChhhcCcHHhcCC---------CCCchhhHHHHHHHHHHHHhC
Confidence 99995 5799999999998764332 22356899999999999764 357899999999999999999
Q ss_pred CCCCCcchhHHHHHHhhcCCC-CcccCCCCCChhHHHHHHHhcccCCCCCCChhHHhcCCCCCCC
Q 003052 707 RTPFSEYKTFWAKFKVITDPN-HEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQHPFLVPP 770 (853)
Q Consensus 707 ~~PF~~~~~~~~~~kii~~~~-~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~HPwf~~~ 770 (853)
..||.+.........+..... .........+.++.+||.+||..||.+|||+.|+|+||||...
T Consensus 200 ~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~ 264 (321)
T 1tki_A 200 INPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQK 264 (321)
T ss_dssp SCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHSC
T ss_pred CCCCcCCCHHHHHHHHHcCCCCCChhhhccCCHHHHHHHHHHcCCChhHCcCHHHHhcChhhccC
Confidence 999987554433333322211 1111224578899999999999999999999999999999764
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-44 Score=403.73 Aligned_cols=260 Identities=25% Similarity=0.404 Sum_probs=205.0
Q ss_pred ceeeEEEeEeccCceEEEEEEec-CCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHHHH
Q 003052 472 KLYQRLGKIGSGGSSEVHKVISS-DCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLREV 550 (853)
Q Consensus 472 ~~Y~ilk~LG~G~FG~Vyka~~~-~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~~l 550 (853)
..|++++.||+|+||.||+|.+. +++.||||++...... +.+|+++|++|+ |+||+++++++...
T Consensus 54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~------~~~E~~il~~l~-hpniv~l~~~~~~~------- 119 (420)
T 1j1b_A 54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF------KNRELQIMRKLD-HCNIVRLRYFFYSS------- 119 (420)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTTS------CCHHHHHHHTCC-CTTBCCEEEEEEEE-------
T ss_pred ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccchh------HHHHHHHHHHcC-CCCccceeeEEecc-------
Confidence 46999999999999999999984 6899999999754321 347999999997 99999999875321
Q ss_pred hhCCCCCCCCccccCCeEEEEEecchhhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCCCcc
Q 003052 551 LNGSMNNKDGRVKDDGYIYMVLEYGEIDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPAN 630 (853)
Q Consensus 551 ~~~~iv~~~g~~~d~~~lyLVmEy~~gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLKPeN 630 (853)
+...+..++++||||++++|.+.+..... ....+++..++.|+.||+.||.|||++||+||||||+|
T Consensus 120 ---------~~~~~~~~~~lv~e~~~~~l~~~~~~~~~----~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~N 186 (420)
T 1j1b_A 120 ---------GEKKDEVYLNLVLDYVPETVYRVARHYSR----AKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQN 186 (420)
T ss_dssp ---------ETTTTEEEEEEEEECCCEEHHHHHHHHHH----TTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGG
T ss_pred ---------CCCCcceeEEeehhcccccHHHHHHHHhh----ccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhh
Confidence 11234456889999999888777654322 34679999999999999999999999999999999999
Q ss_pred EEee-c-CcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHhCCC
Q 003052 631 FLLV-K-GSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGRT 708 (853)
Q Consensus 631 ILL~-~-g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLtG~~ 708 (853)
|||+ + +.+||+|||+|+.+..... ....+||+.|+|||++.+.. .|+.++||||||||||||++|++
T Consensus 187 ILl~~~~~~~kl~DFG~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~--------~~~~~~DiwSlG~il~ell~G~~ 255 (420)
T 1j1b_A 187 LLLDPDTAVLKLCDFGSAKQLVRGEP---NVSYICSRYYRAPELIFGAT--------DYTSSIDVWSAGCVLAELLLGQP 255 (420)
T ss_dssp EEEETTTTEEEECCCTTCEECCTTCC---CCSCCSCTTSCCHHHHTTCS--------SCCTHHHHHHHHHHHHHHHHSSC
T ss_pred EEEeCCCCeEEeccchhhhhcccCCC---ceeeeeCCCcCCHHHHcCCC--------CCCchhhhHHHHHHHHHHHhCCC
Confidence 9996 3 4689999999987644322 23578999999999996542 36789999999999999999999
Q ss_pred CCCcchhHHHHHHh---hcCCC-----------Cccc------------CCCCCChhHHHHHHHhcccCCCCCCChhHHh
Q 003052 709 PFSEYKTFWAKFKV---ITDPN-----------HEIT------------YEPVPNPWLLDLMKKCLAWDRNERWRIPQLL 762 (853)
Q Consensus 709 PF~~~~~~~~~~ki---i~~~~-----------~~~~------------~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL 762 (853)
||.+........++ +..+. ..+. +....++++.+||.+||.+||.+|||+.|+|
T Consensus 256 pf~~~~~~~~l~~i~~~lg~p~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l 335 (420)
T 1j1b_A 256 IFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEAC 335 (420)
T ss_dssp SSCCSSHHHHHHHHHHHHCSCCHHHHHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHH
T ss_pred CCCCCCHHHHHHHHHHHhCCCCHHHHHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHh
Confidence 99775443322222 11110 0111 2345678899999999999999999999999
Q ss_pred cCCCCCC
Q 003052 763 QHPFLVP 769 (853)
Q Consensus 763 ~HPwf~~ 769 (853)
+||||..
T Consensus 336 ~hp~f~~ 342 (420)
T 1j1b_A 336 AHSFFDE 342 (420)
T ss_dssp TSGGGGG
T ss_pred CCHhhcc
Confidence 9999964
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-43 Score=369.01 Aligned_cols=254 Identities=20% Similarity=0.238 Sum_probs=208.9
Q ss_pred ceeeEEEeEeccCceEEEEEEec-CCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHHHH
Q 003052 472 KLYQRLGKIGSGGSSEVHKVISS-DCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLREV 550 (853)
Q Consensus 472 ~~Y~ilk~LG~G~FG~Vyka~~~-~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~~l 550 (853)
.+|++++.||+|+||.||+|.+. +++.||||++............+.+|+.++.++..||||++++++
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~----------- 79 (289)
T 1x8b_A 11 TEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSA----------- 79 (289)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEE-----------
T ss_pred chhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeee-----------
Confidence 56999999999999999999985 789999999987665555667789999999999779999999987
Q ss_pred hhCCCCCCCCccccCCeEEEEEecchh-hHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCCCc
Q 003052 551 LNGSMNNKDGRVKDDGYIYMVLEYGEI-DLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPA 629 (853)
Q Consensus 551 ~~~~iv~~~g~~~d~~~lyLVmEy~~g-dL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLKPe 629 (853)
+.+++.+|+||||+++ +|.+++..... ....+++..++.++.||+.||.|||++||+||||||+
T Consensus 80 -----------~~~~~~~~lv~e~~~~~~L~~~l~~~~~----~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~ 144 (289)
T 1x8b_A 80 -----------WAEDDHMLIQNEYCNGGSLADAISENYR----IMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPS 144 (289)
T ss_dssp -----------EEETTEEEEEEECCTTCBHHHHHHHHHH----HTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGG
T ss_pred -----------eecCCeEEEEEEecCCCcHHHHHHhhcc----cccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHH
Confidence 4566789999999865 99999876533 1256999999999999999999999999999999999
Q ss_pred cEEeec--------------------CcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCC
Q 003052 630 NFLLVK--------------------GSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGR 689 (853)
Q Consensus 630 NILL~~--------------------g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ 689 (853)
|||++. ..+||+|||++...... ....||+.|+|||++.+.. .++.
T Consensus 145 NIl~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~------~~~~gt~~y~aPE~~~~~~--------~~~~ 210 (289)
T 1x8b_A 145 NIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSP------QVEEGDSRFLANEVLQENY--------THLP 210 (289)
T ss_dssp GEEEC--------------------CCCEEECCCTTCEETTCS------CCCCCCGGGCCHHHHTTCC--------TTHH
T ss_pred HEEEcCCCCCcccccccccccccCCceEEEEcccccccccCCc------cccCCCccccChhHhcCCC--------CCCc
Confidence 999942 26999999999866432 2346999999999997542 3457
Q ss_pred ccchhhhHHHHHHHHhCCCCCCcchhHHHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCCChhHHhcCCCCCC
Q 003052 690 PSDIWSLGCILYQMVYGRTPFSEYKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQHPFLVP 769 (853)
Q Consensus 690 ksDIWSLGVILyELLtG~~PF~~~~~~~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~HPwf~~ 769 (853)
++|||||||++|+|++|.+||........... ......+...++.+.+||.+||..||.+|||+.++|+||||..
T Consensus 211 ~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~ 285 (289)
T 1x8b_A 211 KADIFALALTVVCAAGAEPLPRNGDQWHEIRQ-----GRLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLS 285 (289)
T ss_dssp HHHHHHHHHHHHHHTTCCCCCSSSHHHHHHHT-----TCCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTCTTC--
T ss_pred hhhHHHHHHHHHHHhcCCCCCcchhHHHHHHc-----CCCCCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhChHhhh
Confidence 99999999999999999988866544332221 1112345567899999999999999999999999999999975
Q ss_pred C
Q 003052 770 P 770 (853)
Q Consensus 770 ~ 770 (853)
.
T Consensus 286 ~ 286 (289)
T 1x8b_A 286 A 286 (289)
T ss_dssp -
T ss_pred h
Confidence 3
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-43 Score=371.00 Aligned_cols=257 Identities=26% Similarity=0.386 Sum_probs=211.7
Q ss_pred CceeeEEEeEeccCceEEEEEEe-cCCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHHH
Q 003052 471 GKLYQRLGKIGSGGSSEVHKVIS-SDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLRE 549 (853)
Q Consensus 471 g~~Y~ilk~LG~G~FG~Vyka~~-~~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~~ 549 (853)
.++|++.+.||+|+||.||+|.+ .+++.||+|++............+.+|+.++++++ |+||++++++
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~---------- 73 (284)
T 3kk8_A 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQ-HPNIVRLHDS---------- 73 (284)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCC-CTTBCCEEEE----------
T ss_pred hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcC-CCCcCeEEEE----------
Confidence 35699999999999999999998 46789999999877666666677889999999997 8999999987
Q ss_pred HhhCCCCCCCCccccCCeEEEEEecch-hhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCCC
Q 003052 550 VLNGSMNNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKP 628 (853)
Q Consensus 550 l~~~~iv~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLKP 628 (853)
+.+....|+||||+. ++|.+.+... ..+++..++.++.||+.||.|||++||+||||||
T Consensus 74 ------------~~~~~~~~~v~e~~~~~~l~~~~~~~--------~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp 133 (284)
T 3kk8_A 74 ------------IQEESFHYLVFDLVTGGELFEDIVAR--------EFYSEADASHCIQQILESIAYCHSNGIVHRNLKP 133 (284)
T ss_dssp ------------EECSSEEEEEECCCCSCBHHHHHHHH--------SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCG
T ss_pred ------------EEcCCEEEEEEecCCCCCHHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCH
Confidence 456778999999976 4888887654 5699999999999999999999999999999999
Q ss_pred ccEEee-cC---cEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHH
Q 003052 629 ANFLLV-KG---SLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMV 704 (853)
Q Consensus 629 eNILL~-~g---~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELL 704 (853)
+|||++ ++ .+||+|||++....... ......||+.|+|||++.+. .++.++|||||||++|+|+
T Consensus 134 ~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~---------~~~~~~Di~slG~~l~~l~ 201 (284)
T 3kk8_A 134 ENLLLASKAKGAAVKLADFGLAIEVNDSE---AWHGFAGTPGYLSPEVLKKD---------PYSKPVDIWACGVILYILL 201 (284)
T ss_dssp GGEEESSSSTTCCEEECCCTTCEECCSSC---BCCCSCSCGGGCCHHHHTTC---------CBCTHHHHHHHHHHHHHHH
T ss_pred HHEEEecCCCCCcEEEeeceeeEEcccCc---cccCCCCCcCCcCchhhcCC---------CCCcccchHHHHHHHHHHH
Confidence 999994 33 49999999997664322 22357899999999999765 3578999999999999999
Q ss_pred hCCCCCCcchhHHHHHHhhcCC-CCcccCCCCCChhHHHHHHHhcccCCCCCCChhHHhcCCCCCCC
Q 003052 705 YGRTPFSEYKTFWAKFKVITDP-NHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQHPFLVPP 770 (853)
Q Consensus 705 tG~~PF~~~~~~~~~~kii~~~-~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~HPwf~~~ 770 (853)
+|+.||.+.........+.... ..........++++.+||.+||..||.+|||+.|+|+||||...
T Consensus 202 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~ 268 (284)
T 3kk8_A 202 VGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICNR 268 (284)
T ss_dssp HSSCSSCCSSHHHHHHHHHHTCCCCCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTTSHHHHSC
T ss_pred HCCCCCCCCchhHHHHHHHhccccCCchhhcccCHHHHHHHHHHcccChhhCCCHHHHhcCccccCC
Confidence 9999997755443332222211 11122224678899999999999999999999999999999754
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=395.52 Aligned_cols=262 Identities=27% Similarity=0.416 Sum_probs=207.3
Q ss_pred CceeeEEEeEeccCceEEEEEEecCCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHHHH
Q 003052 471 GKLYQRLGKIGSGGSSEVHKVISSDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLREV 550 (853)
Q Consensus 471 g~~Y~ilk~LG~G~FG~Vyka~~~~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~~l 550 (853)
..+|++++.||+|+||.||+|.+..+..+|+|++...... ..+|+++|+.++ |+||+++++++...
T Consensus 39 ~~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~~------~~~E~~il~~l~-h~niv~l~~~~~~~------- 104 (394)
T 4e7w_A 39 EIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRF------KNRELQIMRIVK-HPNVVDLKAFFYSN------- 104 (394)
T ss_dssp EEEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTTS------CCHHHHHHHTCC-CTTBCCEEEEEEEE-------
T ss_pred cceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcch------HHHHHHHHHhCC-CCCcceEEEEEEec-------
Confidence 3569999999999999999999977777999998754322 237999999997 99999999985321
Q ss_pred hhCCCCCCCCccccCCeEEEEEecchhhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCCCcc
Q 003052 551 LNGSMNNKDGRVKDDGYIYMVLEYGEIDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPAN 630 (853)
Q Consensus 551 ~~~~iv~~~g~~~d~~~lyLVmEy~~gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLKPeN 630 (853)
+...+..++|+||||+++++...+..... ....+++..++.|+.||+.||.|||++||+||||||+|
T Consensus 105 ---------~~~~~~~~~~lv~e~~~~~l~~~~~~~~~----~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~N 171 (394)
T 4e7w_A 105 ---------GDKKDEVFLNLVLEYVPETVYRASRHYAK----LKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQN 171 (394)
T ss_dssp ---------SSSSSCEEEEEEEECCSEEHHHHHHHHHH----TTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGG
T ss_pred ---------CCCCCceEEEEEeeccCccHHHHHHHHHh----hcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHH
Confidence 11244556899999999877776654322 24679999999999999999999999999999999999
Q ss_pred EEee--cCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHhCCC
Q 003052 631 FLLV--KGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGRT 708 (853)
Q Consensus 631 ILL~--~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLtG~~ 708 (853)
|||+ ++.+||+|||+|+.+..... ....+||+.|+|||++.+.. .|+.++|||||||++|||++|++
T Consensus 172 ill~~~~~~~kL~DFG~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~--------~~~~~~DiwSlG~il~ell~g~~ 240 (394)
T 4e7w_A 172 LLLDPPSGVLKLIDFGSAKILIAGEP---NVSYICSRYYRAPELIFGAT--------NYTTNIDIWSTGCVMAELMQGQP 240 (394)
T ss_dssp EEEETTTTEEEECCCTTCEECCTTCC---CCSSCSCGGGCCHHHHTTCS--------SCCTHHHHHHHHHHHHHHHHSSC
T ss_pred EEEcCCCCcEEEeeCCCcccccCCCC---CcccccCcCccCHHHHcCCC--------CCCcHHHHHHHHHHHHHHHhCCC
Confidence 9996 67999999999987644332 23678999999999996542 36789999999999999999999
Q ss_pred CCCcchhHHHHHHhh---cCCCC-----------------------cccCCCCCChhHHHHHHHhcccCCCCCCChhHHh
Q 003052 709 PFSEYKTFWAKFKVI---TDPNH-----------------------EITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLL 762 (853)
Q Consensus 709 PF~~~~~~~~~~kii---~~~~~-----------------------~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL 762 (853)
||.+.........++ ..+.. ...+....++++.+||.+||.+||.+|||+.|+|
T Consensus 241 pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l 320 (394)
T 4e7w_A 241 LFPGESGIDQLVEIIKVLGTPSREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEAL 320 (394)
T ss_dssp SSCCSSHHHHHHHHHHHHCCCCHHHHHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHH
T ss_pred CCCCCCHHHHHHHHHHHhCCCCHHHHHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHh
Confidence 998755433322221 11100 0112345778999999999999999999999999
Q ss_pred cCCCCCCC
Q 003052 763 QHPFLVPP 770 (853)
Q Consensus 763 ~HPwf~~~ 770 (853)
+||||...
T Consensus 321 ~hp~f~~~ 328 (394)
T 4e7w_A 321 CHPFFDEL 328 (394)
T ss_dssp TSGGGSTT
T ss_pred cChhhhhh
Confidence 99999753
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-43 Score=399.80 Aligned_cols=258 Identities=27% Similarity=0.447 Sum_probs=202.9
Q ss_pred CceeeEEEeEeccCceEEEEEEec-CCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhc-----CCCceeEeeehhhhHH
Q 003052 471 GKLYQRLGKIGSGGSSEVHKVISS-DCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLK-----GKNNIIQLIDYEVTEK 544 (853)
Q Consensus 471 g~~Y~ilk~LG~G~FG~Vyka~~~-~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~-----~hpNIV~Lid~~~~e~ 544 (853)
..+|+++++||+|+||.||+|.+. +++.||||++... ......+.+|+.+++.++ .|+||++++++
T Consensus 96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~----- 167 (429)
T 3kvw_A 96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE---KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLEN----- 167 (429)
T ss_dssp TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEE-----
T ss_pred cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc---cchHHHHHHHHHHHHHHhhccccCCcCEEEEEee-----
Confidence 456999999999999999999984 6789999999753 233456778999999986 35688888876
Q ss_pred HHHHHHhhCCCCCCCCccccCCeEEEEEecchhhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeC
Q 003052 545 ALLREVLNGSMNNKDGRVKDDGYIYMVLEYGEIDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHS 624 (853)
Q Consensus 545 ~iL~~l~~~~iv~~~g~~~d~~~lyLVmEy~~gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHR 624 (853)
+.....+|+||||++++|.+++... ....+++..++.|+.||+.||.|||++||+||
T Consensus 168 -----------------~~~~~~~~lv~e~~~~~L~~~l~~~------~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHr 224 (429)
T 3kvw_A 168 -----------------FTFRNHICMTFELLSMNLYELIKKN------KFQGFSLPLVRKFAHSILQCLDALHKNRIIHC 224 (429)
T ss_dssp -----------------EEETTEEEEEECCCCCBHHHHHHHT------TTCCCCHHHHHHHHHHHHHHHHHHHHHTEECS
T ss_pred -----------------cccCCeEEEEEeccCCCHHHHHHhc------cCCCCCHHHHHHHHHHHHHHHHHHHHCCeecC
Confidence 4566789999999999999988764 23469999999999999999999999999999
Q ss_pred CCCCccEEee-cCc--EEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHH
Q 003052 625 DLKPANFLLV-KGS--LKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILY 701 (853)
Q Consensus 625 DLKPeNILL~-~g~--VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILy 701 (853)
||||+||||+ ++. +||+|||+|+..... ..+.+||+.|+|||++.+.. |+.++|||||||++|
T Consensus 225 DlKp~NILl~~~~~~~vkL~DFG~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~---------~~~~~DiwSlG~il~ 290 (429)
T 3kvw_A 225 DLKPENILLKQQGRSGIKVIDFGSSCYEHQR-----VYTYIQSRFYRAPEVILGAR---------YGMPIDMWSLGCILA 290 (429)
T ss_dssp CCSGGGEEESSTTSCCEEECCCTTCEETTCC-----CCSSCSCGGGCCHHHHHTBC---------CCTHHHHHHHHHHHH
T ss_pred CCCHHHeEEccCCCcceEEeecccceecCCc-----ccccCCCCCccChHHHhCCC---------CCchHHHHhHHHHHH
Confidence 9999999995 444 999999999754322 23678999999999997653 678999999999999
Q ss_pred HHHhCCCCCCcchhHHHHH---HhhcCCCCc-------------------------------------------------
Q 003052 702 QMVYGRTPFSEYKTFWAKF---KVITDPNHE------------------------------------------------- 729 (853)
Q Consensus 702 ELLtG~~PF~~~~~~~~~~---kii~~~~~~------------------------------------------------- 729 (853)
||++|++||.+........ ..+..+...
T Consensus 291 elltG~~pf~~~~~~~~l~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 370 (429)
T 3kvw_A 291 ELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPES 370 (429)
T ss_dssp HHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTBTTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTC
T ss_pred HHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHhhhhhhhccCCCCCcccccccccccccccccccccchhhccCCccc
Confidence 9999999997654432221 111110000
Q ss_pred ----ccCCCCCChhHHHHHHHhcccCCCCCCChhHHhcCCCCCCCCCC
Q 003052 730 ----ITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQHPFLVPPVST 773 (853)
Q Consensus 730 ----~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~HPwf~~~~~~ 773 (853)
.......++.+.+||.+||.+||.+|||+.|+|+||||+...+.
T Consensus 371 ~~~~~~l~~~~~~~~~dli~~~L~~dP~~Rpta~e~L~Hpw~~~~~~~ 418 (429)
T 3kvw_A 371 REWGNALKGCDDPLFLDFLKQCLEWDPAVRMTPGQALRHPWLRRRLPK 418 (429)
T ss_dssp SCHHHHTTTCCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTTTC-----
T ss_pred hhhHhhccccchHHHHHHHHHHCCCChhhCCCHHHHhCChhhccCCCC
Confidence 00112336779999999999999999999999999999876543
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-43 Score=375.75 Aligned_cols=257 Identities=28% Similarity=0.417 Sum_probs=203.5
Q ss_pred ceeeEEEeEeccCceEEEEEEe-cCCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHHHH
Q 003052 472 KLYQRLGKIGSGGSSEVHKVIS-SDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLREV 550 (853)
Q Consensus 472 ~~Y~ilk~LG~G~FG~Vyka~~-~~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~~l 550 (853)
+.|.+.++||+|+||.||+|.+ .++..+|+|++...... .....+.+|+++|++++ |+||++++++
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~E~~~l~~l~-hp~iv~~~~~----------- 88 (285)
T 3is5_A 22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQ-VPMEQIEAEIEVLKSLD-HPNIIKIFEV----------- 88 (285)
T ss_dssp HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCC-SCHHHHHHHHHHHHTCC-CTTBCCEEEE-----------
T ss_pred hheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccc-hhHHHHHHHHHHHHhCC-CchHHhHHHh-----------
Confidence 5699999999999999999998 46789999999865432 23456889999999997 8999999987
Q ss_pred hhCCCCCCCCccccCCeEEEEEecchh-hHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCCCc
Q 003052 551 LNGSMNNKDGRVKDDGYIYMVLEYGEI-DLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPA 629 (853)
Q Consensus 551 ~~~~iv~~~g~~~d~~~lyLVmEy~~g-dL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLKPe 629 (853)
+.+...+|+||||+.+ +|.+.+..... ....+++..++.++.||+.||.|||++||+||||||+
T Consensus 89 -----------~~~~~~~~lv~e~~~~~~L~~~l~~~~~----~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~ 153 (285)
T 3is5_A 89 -----------FEDYHNMYIVMETCEGGELLERIVSAQA----RGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPE 153 (285)
T ss_dssp -----------EECSSEEEEEECCCSCCBHHHHHHHHHH----HTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGG
T ss_pred -----------eecCCeEEEEEEeCCCCcHHHHHHhhhh----cccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHH
Confidence 4567789999999864 88888865432 2357999999999999999999999999999999999
Q ss_pred cEEee----cCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHh
Q 003052 630 NFLLV----KGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVY 705 (853)
Q Consensus 630 NILL~----~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLt 705 (853)
|||+. ++.+||+|||+++.+.... .....+||+.|+|||++.+ .++.++|||||||++|+|++
T Consensus 154 NIl~~~~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~~t~~y~aPE~~~~----------~~~~~~Di~slG~il~~ll~ 220 (285)
T 3is5_A 154 NILFQDTSPHSPIKIIDFGLAELFKSDE---HSTNAAGTALYMAPEVFKR----------DVTFKCDIWSAGVVMYFLLT 220 (285)
T ss_dssp GEEESSSSTTCCEEECCCCCCCC-------------CTTGGGCCHHHHTT----------CCCHHHHHHHHHHHHHHHHH
T ss_pred HEEEecCCCCCCEEEEeeecceecCCcc---cCcCcccccCcCChHHhcc----------CCCcccCeehHHHHHHHHHh
Confidence 99993 2579999999998654322 2235689999999999853 25689999999999999999
Q ss_pred CCCCCCcchhHHHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCCChhHHhcCCCCCC
Q 003052 706 GRTPFSEYKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQHPFLVP 769 (853)
Q Consensus 706 G~~PF~~~~~~~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~HPwf~~ 769 (853)
|+.||.+........................++.+.+||.+||..||.+|||+.|+|+||||+.
T Consensus 221 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~f~~ 284 (285)
T 3is5_A 221 GCLPFTGTSLEEVQQKATYKEPNYAVECRPLTPQAVDLLKQMLTKDPERRPSAAQVLHHEWFKQ 284 (285)
T ss_dssp SSCSSCCSSHHHHHHHHHHCCCCCCC--CCCCHHHHHHHHHHTCSCTTTSCCHHHHHTSGGGGC
T ss_pred CCCCCCCCCHHHHHhhhccCCcccccccCcCCHHHHHHHHHHccCChhhCcCHHHHhcCHHhhc
Confidence 9999987544333333222212112222346788999999999999999999999999999974
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=390.36 Aligned_cols=265 Identities=28% Similarity=0.439 Sum_probs=209.3
Q ss_pred CceeeEEEeEeccCceEEEEEEec-CCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHHH
Q 003052 471 GKLYQRLGKIGSGGSSEVHKVISS-DCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLRE 549 (853)
Q Consensus 471 g~~Y~ilk~LG~G~FG~Vyka~~~-~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~~ 549 (853)
+.+|++++.||+|+||.||+|.+. ++..||||++.... .......+.+|+++|++++ |+||+++++++...
T Consensus 26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~------ 97 (364)
T 3qyz_A 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFE-HQTYCQRTLREIKILLRFR-HENIIGINDIIRAP------ 97 (364)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTT-CHHHHHHHHHHHHHHHHCC-CTTBCCCCEEECCS------
T ss_pred cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEecccc-CcHHHHHHHHHHHHHHhcC-CCCCccceeEEecC------
Confidence 357999999999999999999984 67889999997533 3444567889999999997 99999999875321
Q ss_pred HhhCCCCCCCCccccCCeEEEEEecchhhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCCCc
Q 003052 550 VLNGSMNNKDGRVKDDGYIYMVLEYGEIDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPA 629 (853)
Q Consensus 550 l~~~~iv~~~g~~~d~~~lyLVmEy~~gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLKPe 629 (853)
.+.....+|+||||++++|.+++.. ..+++..++.|+.||+.||.|||++||+||||||+
T Consensus 98 -----------~~~~~~~~~iv~e~~~~~L~~~l~~---------~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~ 157 (364)
T 3qyz_A 98 -----------TIEQMKDVYIVQDLMETDLYKLLKT---------QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPS 157 (364)
T ss_dssp -----------STTTCCCEEEEEECCSEEHHHHHHH---------CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGG
T ss_pred -----------CccccceEEEEEcccCcCHHHHHHh---------CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChH
Confidence 1234467899999999999988864 36999999999999999999999999999999999
Q ss_pred cEEe-ecCcEEEEecccchhcccCCcc-ccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHhCC
Q 003052 630 NFLL-VKGSLKLIDFGIAKAIMSDTTN-IQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGR 707 (853)
Q Consensus 630 NILL-~~g~VKL~DFGlAk~~~~~~~~-~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLtG~ 707 (853)
|||+ .++.+||+|||+++........ ......+||+.|+|||++.+.. .|+.++|||||||++|+|++|+
T Consensus 158 NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--------~~~~~~DiwslG~il~ell~g~ 229 (364)
T 3qyz_A 158 NLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSK--------GYTKSIDIWSVGCILAEMLSNR 229 (364)
T ss_dssp GEEECTTCCEEECCCTTCEECCGGGCBCCTTCCCCSCGGGCCHHHHHTBC--------SCSTHHHHHHHHHHHHHHHHSS
T ss_pred hEEECCCCCEEEEeCcceEecCCCCCccccccccccccCCCCCHHhcCCC--------CCCcchhHHHHHHHHHHHHHCC
Confidence 9999 4669999999999866432221 1124568999999999876442 3678999999999999999999
Q ss_pred CCCCcchhHH---HHHHhhcCCCC----------------------c---ccCCCCCChhHHHHHHHhcccCCCCCCChh
Q 003052 708 TPFSEYKTFW---AKFKVITDPNH----------------------E---ITYEPVPNPWLLDLMKKCLAWDRNERWRIP 759 (853)
Q Consensus 708 ~PF~~~~~~~---~~~kii~~~~~----------------------~---~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~ 759 (853)
+||.+..... .+...+..+.. . .......++++.+||.+||.+||.+|||+.
T Consensus 230 ~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ 309 (364)
T 3qyz_A 230 PIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVE 309 (364)
T ss_dssp CSSCCSSGGGHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHH
T ss_pred CCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHH
Confidence 9997643221 12211111110 0 011245678899999999999999999999
Q ss_pred HHhcCCCCCCCC
Q 003052 760 QLLQHPFLVPPV 771 (853)
Q Consensus 760 EIL~HPwf~~~~ 771 (853)
|+|+||||....
T Consensus 310 e~l~hp~~~~~~ 321 (364)
T 3qyz_A 310 QALAHPYLEQYY 321 (364)
T ss_dssp HHHTSGGGTTTC
T ss_pred HHhcCcchhhcc
Confidence 999999998653
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-43 Score=386.02 Aligned_cols=254 Identities=29% Similarity=0.374 Sum_probs=194.1
Q ss_pred ceeeEEEeEeccCceEEEEEEec-CCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHHHH
Q 003052 472 KLYQRLGKIGSGGSSEVHKVISS-DCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLREV 550 (853)
Q Consensus 472 ~~Y~ilk~LG~G~FG~Vyka~~~-~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~~l 550 (853)
+.|++.+.||+|+||.||+|.+. +++.||||+++... ....+.+|+.+|++++ |+||++++++
T Consensus 53 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~----~~~~~~~E~~~l~~l~-h~niv~~~~~----------- 116 (349)
T 2w4o_A 53 DFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV----DKKIVRTEIGVLLRLS-HPNIIKLKEI----------- 116 (349)
T ss_dssp GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC--------------CHHHHHCC-CTTBCCEEEE-----------
T ss_pred CcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch----hHHHHHHHHHHHHhCC-CCCCcceeee-----------
Confidence 56999999999999999999985 57899999998543 2345779999999997 8999999987
Q ss_pred hhCCCCCCCCccccCCeEEEEEecch-hhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCCCc
Q 003052 551 LNGSMNNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPA 629 (853)
Q Consensus 551 ~~~~iv~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLKPe 629 (853)
+.+...+|+||||+. ++|.+++... ..+++..++.++.||+.||.|||++||+||||||+
T Consensus 117 -----------~~~~~~~~lv~e~~~~~~L~~~l~~~--------~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~ 177 (349)
T 2w4o_A 117 -----------FETPTEISLVLELVTGGELFDRIVEK--------GYYSERDAADAVKQILEAVAYLHENGIVHRDLKPE 177 (349)
T ss_dssp -----------EECSSEEEEEECCCCSCBHHHHHTTC--------SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGG
T ss_pred -----------EecCCeEEEEEEeCCCCCHHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcc
Confidence 456678999999976 5898887543 56999999999999999999999999999999999
Q ss_pred cEEee----cCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHh
Q 003052 630 NFLLV----KGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVY 705 (853)
Q Consensus 630 NILL~----~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLt 705 (853)
|||++ ++.+||+|||+++...... .....+||+.|+|||++.+. .|+.++|||||||++|+|++
T Consensus 178 NIll~~~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~---------~~~~~~DiwslG~il~ell~ 245 (349)
T 2w4o_A 178 NLLYATPAPDAPLKIADFGLSKIVEHQV---LMKTVCGTPGYCAPEILRGC---------AYGPEVDMWSVGIITYILLC 245 (349)
T ss_dssp GEEESSSSTTCCEEECCCC-------------------CGGGSCHHHHTTC---------CCCTHHHHHHHHHHHHHHHH
T ss_pred cEEEecCCCCCCEEEccCccccccCccc---ccccccCCCCccCHHHhcCC---------CCCcccchHHHHHHHHHHHh
Confidence 99995 5789999999998764322 22357899999999999765 35789999999999999999
Q ss_pred CCCCCCcchhHHHHHHhhcCCCCcc--cCCCCCChhHHHHHHHhcccCCCCCCChhHHhcCCCCCCCCC
Q 003052 706 GRTPFSEYKTFWAKFKVITDPNHEI--TYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQHPFLVPPVS 772 (853)
Q Consensus 706 G~~PF~~~~~~~~~~kii~~~~~~~--~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~HPwf~~~~~ 772 (853)
|..||.+.......+..+....... ......+..+.+||.+||..||.+|||+.|+|+||||.....
T Consensus 246 g~~pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~~ 314 (349)
T 2w4o_A 246 GFEPFYDERGDQFMFRRILNCEYYFISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQHPWVTGKAA 314 (349)
T ss_dssp SSCTTCCTTCHHHHHHHHHTTCCCCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTTSTTC
T ss_pred CCCCCCCCcccHHHHHHHHhCCCccCCchhhhCCHHHHHHHHHHccCChhhCcCHHHHhcCcccCCCcc
Confidence 9999976554433333333222221 223457888999999999999999999999999999986543
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-44 Score=405.61 Aligned_cols=263 Identities=29% Similarity=0.453 Sum_probs=209.5
Q ss_pred CceeeEEEeEeccCceEEEEEEec-CCcEEEEEEEecCCC-ChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHH
Q 003052 471 GKLYQRLGKIGSGGSSEVHKVISS-DCTIYALKKIKLKGR-DYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLR 548 (853)
Q Consensus 471 g~~Y~ilk~LG~G~FG~Vyka~~~-~g~~vAVKkik~~~~-~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~ 548 (853)
.++|+++++||+|+||+||+|++. +++.||||++++... .......+.+|+.+|..++ |+||++++++
T Consensus 73 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~-hp~Iv~l~~~--------- 142 (437)
T 4aw2_A 73 REDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGD-SKWITTLHYA--------- 142 (437)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSC-TTTBCCEEEE---------
T ss_pred hhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCC-CCCEEEEEEE---------
Confidence 367999999999999999999985 568999999975321 1122334789999999986 8999999876
Q ss_pred HHhhCCCCCCCCccccCCeEEEEEecc-hhhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCC
Q 003052 549 EVLNGSMNNKDGRVKDDGYIYMVLEYG-EIDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLK 627 (853)
Q Consensus 549 ~l~~~~iv~~~g~~~d~~~lyLVmEy~-~gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLK 627 (853)
|.+...+||||||+ +++|.+++... ...+++..++.|+.||+.||.|||++||||||||
T Consensus 143 -------------~~~~~~~~lV~Ey~~gg~L~~~l~~~-------~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLK 202 (437)
T 4aw2_A 143 -------------FQDDNNLYLVMDYYVGGDLLTLLSKF-------EDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIK 202 (437)
T ss_dssp -------------EECSSEEEEEECCCTTCBHHHHHHTT-------TTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCS
T ss_pred -------------EeeCCEEEEEEecCCCCcHHHHHHHc-------cCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccC
Confidence 56778999999997 46999988652 3579999999999999999999999999999999
Q ss_pred CccEEe-ecCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHhC
Q 003052 628 PANFLL-VKGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYG 706 (853)
Q Consensus 628 PeNILL-~~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLtG 706 (853)
|+|||| .+|.+||+|||+|+....... ......+||+.|||||++...... ...|+.++|||||||++|||++|
T Consensus 203 p~NILl~~~g~vkL~DFGla~~~~~~~~-~~~~~~~GT~~Y~APE~l~~~~~~----~~~~~~~~DvwSlGvil~elltG 277 (437)
T 4aw2_A 203 PDNILMDMNGHIRLADFGSCLKLMEDGT-VQSSVAVGTPDYISPEILQAMEGG----KGRYGPECDWWSLGVCMYEMLYG 277 (437)
T ss_dssp GGGEEECTTSCEEECCCTTCEECCTTSC-EECCSCCSCGGGCCHHHHHHHHTS----CCEECTHHHHHHHHHHHHHHHHS
T ss_pred HHHeeEcCCCCEEEcchhhhhhcccCCC-cccccccCCcCeeChHHHhhcccC----CCCCCCcCeeHHHHHHHHHHHhC
Confidence 999999 468999999999987654322 223457999999999999732100 11478899999999999999999
Q ss_pred CCCCCcchhHHHHHHhhcCCCCcccCC---CCCChhHHHHHHHhcccCCCC--CCChhHHhcCCCCCC
Q 003052 707 RTPFSEYKTFWAKFKVITDPNHEITYE---PVPNPWLLDLMKKCLAWDRNE--RWRIPQLLQHPFLVP 769 (853)
Q Consensus 707 ~~PF~~~~~~~~~~kii~~~~~~~~~~---~~~s~~l~dLI~kcL~~DP~k--RpTa~EIL~HPwf~~ 769 (853)
++||.+........+++.. ...+.++ ...++++++||++||..+|++ |+++.|+++||||..
T Consensus 278 ~~Pf~~~~~~~~~~~i~~~-~~~~~~p~~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~Hpff~~ 344 (437)
T 4aw2_A 278 ETPFYAESLVETYGKIMNH-KERFQFPTQVTDVSENAKDLIRRLICSREHRLGQNGIEDFKKHPFFSG 344 (437)
T ss_dssp SCTTCCSSHHHHHHHHHTH-HHHCCCCSSCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTSGGGTT
T ss_pred CCCCCCCChhHHHHhhhhc-cccccCCcccccCCHHHHHHHHHHhcccccccCCCCHHHHhCCCccCC
Confidence 9999876554333333221 1112222 347899999999999999988 999999999999964
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-43 Score=383.91 Aligned_cols=260 Identities=24% Similarity=0.347 Sum_probs=208.7
Q ss_pred CceeeEE-EeEeccCceEEEEEEec-CCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHH
Q 003052 471 GKLYQRL-GKIGSGGSSEVHKVISS-DCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLR 548 (853)
Q Consensus 471 g~~Y~il-k~LG~G~FG~Vyka~~~-~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~ 548 (853)
+.+|.+. +.||+|+||.||+|.+. +++.||||+++...........+.+|+.+++++.+|+||++++++
T Consensus 27 ~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~--------- 97 (327)
T 3lm5_A 27 NNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEV--------- 97 (327)
T ss_dssp HHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEE---------
T ss_pred hhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEE---------
Confidence 3568887 88999999999999984 689999999987655555556789999999999989999999987
Q ss_pred HHhhCCCCCCCCccccCCeEEEEEecchh-hHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCC
Q 003052 549 EVLNGSMNNKDGRVKDDGYIYMVLEYGEI-DLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLK 627 (853)
Q Consensus 549 ~l~~~~iv~~~g~~~d~~~lyLVmEy~~g-dL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLK 627 (853)
+.+...+|+||||+.+ +|.+++... ....+++..++.++.||+.||.|||++||+|||||
T Consensus 98 -------------~~~~~~~~lv~e~~~~~~L~~~~~~~------~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dik 158 (327)
T 3lm5_A 98 -------------YENTSEIILILEYAAGGEIFSLCLPE------LAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLK 158 (327)
T ss_dssp -------------EECSSEEEEEEECCTTEEGGGGGSSC------C-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCC
T ss_pred -------------EEeCCeEEEEEEecCCCcHHHHHHHh------cccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCC
Confidence 4667789999999765 777665432 23679999999999999999999999999999999
Q ss_pred CccEEee----cCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHH
Q 003052 628 PANFLLV----KGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQM 703 (853)
Q Consensus 628 PeNILL~----~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyEL 703 (853)
|+|||++ ++.+||+|||+++...... .....+||+.|+|||++.+. .|+.++|||||||++|+|
T Consensus 159 p~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~---------~~~~~~DiwslG~il~~l 226 (327)
T 3lm5_A 159 PQNILLSSIYPLGDIKIVDFGMSRKIGHAC---ELREIMGTPEYLAPEILNYD---------PITTATDMWNIGIIAYML 226 (327)
T ss_dssp GGGEEESCBTTBCCEEECCGGGCEEC------------CCCGGGCCHHHHTTC---------CCCTHHHHHHHHHHHHHH
T ss_pred hHHEEEecCCCCCcEEEeeCccccccCCcc---ccccccCCcCccCCeeecCC---------CCCchhhHHHHHHHHHHH
Confidence 9999995 4799999999998764322 22356899999999999755 356899999999999999
Q ss_pred HhCCCCCCcchhHHHHHHhhcC-CCCcccCCCCCChhHHHHHHHhcccCCCCCCChhHHhcCCCCCCC
Q 003052 704 VYGRTPFSEYKTFWAKFKVITD-PNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQHPFLVPP 770 (853)
Q Consensus 704 LtG~~PF~~~~~~~~~~kii~~-~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~HPwf~~~ 770 (853)
++|+.||...........+... ...........++.+.+||.+||..||.+|||+.++|+||||+..
T Consensus 227 l~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h~~~~~~ 294 (327)
T 3lm5_A 227 LTHTSPFVGEDNQETYLNISQVNVDYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSHSWLQQW 294 (327)
T ss_dssp HHSSCSSCCSSHHHHHHHHHHTCCCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTCGGGCCC
T ss_pred HhCCCCCCCCCchHHHHHHHhcccccCchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCCHhhccc
Confidence 9999999775554333332221 122222334578889999999999999999999999999999864
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-43 Score=395.45 Aligned_cols=254 Identities=26% Similarity=0.372 Sum_probs=201.4
Q ss_pred ceeeEEEeEeccCceEEEEEEec-CCcEEEEEEEecCCCC-hhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHHH
Q 003052 472 KLYQRLGKIGSGGSSEVHKVISS-DCTIYALKKIKLKGRD-YATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLRE 549 (853)
Q Consensus 472 ~~Y~ilk~LG~G~FG~Vyka~~~-~g~~vAVKkik~~~~~-~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~~ 549 (853)
.+|++++.||+|+||.||+|++. +++.||||++++.... ......+.+|..++.+..+||||++++++
T Consensus 38 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~---------- 107 (373)
T 2r5t_A 38 SDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFS---------- 107 (373)
T ss_dssp GGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEE----------
T ss_pred hheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEE----------
Confidence 56999999999999999999985 6789999999765432 22334566777775443458999999876
Q ss_pred HhhCCCCCCCCccccCCeEEEEEecch-hhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCCC
Q 003052 550 VLNGSMNNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKP 628 (853)
Q Consensus 550 l~~~~iv~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLKP 628 (853)
|++...+|+||||+. ++|.+++... ..+++..++.|+.||+.||.|||++||+||||||
T Consensus 108 ------------~~~~~~~~lv~E~~~gg~L~~~l~~~--------~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp 167 (373)
T 2r5t_A 108 ------------FQTADKLYFVLDYINGGELFYHLQRE--------RCFLEPRARFYAAEIASALGYLHSLNIVYRDLKP 167 (373)
T ss_dssp ------------EECSSEEEEEEECCCSCBHHHHHHHH--------SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCG
T ss_pred ------------EEeCCEEEEEEeCCCCCcHHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCH
Confidence 567789999999976 5998888764 5699999999999999999999999999999999
Q ss_pred ccEEe-ecCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHhCC
Q 003052 629 ANFLL-VKGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGR 707 (853)
Q Consensus 629 eNILL-~~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLtG~ 707 (853)
+|||| .+|++||+|||+|+....... ...+.+||+.|+|||++.+. .|+.++|||||||++|||++|.
T Consensus 168 ~NIll~~~g~ikL~DFG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~---------~~~~~~DiwslG~il~ell~G~ 236 (373)
T 2r5t_A 168 ENILLDSQGHIVLTDFGLCKENIEHNS--TTSTFCGTPEYLAPEVLHKQ---------PYDRTVDWWCLGAVLYEMLYGL 236 (373)
T ss_dssp GGEEECTTSCEEECCCCBCGGGBCCCC--CCCSBSCCCCCCCHHHHTTC---------CCCTHHHHHHHHHHHHHHHHSS
T ss_pred HHEEECCCCCEEEeeCccccccccCCC--ccccccCCccccCHHHhCCC---------CCCchhhhHHHHHHHHHHHcCC
Confidence 99999 578999999999986543222 23478999999999999765 3678999999999999999999
Q ss_pred CCCCcchhHHHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCh----hHHhcCCCCCC
Q 003052 708 TPFSEYKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRI----PQLLQHPFLVP 769 (853)
Q Consensus 708 ~PF~~~~~~~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa----~EIL~HPwf~~ 769 (853)
.||.+.........++.. ...++...+..+++||.+||.+||.+||++ .++++||||..
T Consensus 237 ~Pf~~~~~~~~~~~i~~~---~~~~~~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~i~~h~~f~~ 299 (373)
T 2r5t_A 237 PPFYSRNTAEMYDNILNK---PLQLKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKSHVFFSL 299 (373)
T ss_dssp CTTCCSBHHHHHHHHHHS---CCCCCSSSCHHHHHHHHHHTCSSGGGSTTTTTTHHHHHTSGGGTT
T ss_pred CCCCCCCHHHHHHHHHhc---ccCCCCCCCHHHHHHHHHHcccCHHhCCCCCCCHHHHhCCccccC
Confidence 999876554433333332 234566788999999999999999999997 69999999964
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-43 Score=387.77 Aligned_cols=256 Identities=23% Similarity=0.377 Sum_probs=212.9
Q ss_pred ceeeEEEeEeccCceEEEEEEe-cCCcEEEEEEEecCCC-ChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHHH
Q 003052 472 KLYQRLGKIGSGGSSEVHKVIS-SDCTIYALKKIKLKGR-DYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLRE 549 (853)
Q Consensus 472 ~~Y~ilk~LG~G~FG~Vyka~~-~~g~~vAVKkik~~~~-~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~~ 549 (853)
+.|++++.||+|+||.||+|.+ .+++.||||++..... .......+.+|+++|++++ |+||++++++
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~---------- 122 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR-HPNTIQYRGC---------- 122 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCC-CTTBCCEEEE----------
T ss_pred hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCC-CCCEeeEEEE----------
Confidence 5699999999999999999998 5788999999986543 3344567889999999997 8999999987
Q ss_pred HhhCCCCCCCCccccCCeEEEEEecchhhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCCCc
Q 003052 550 VLNGSMNNKDGRVKDDGYIYMVLEYGEIDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPA 629 (853)
Q Consensus 550 l~~~~iv~~~g~~~d~~~lyLVmEy~~gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLKPe 629 (853)
+.++..+|+||||+.++|.+.+... ...+++..++.++.||+.||.|||++||+||||||+
T Consensus 123 ------------~~~~~~~~lv~e~~~g~l~~~l~~~-------~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~ 183 (348)
T 1u5q_A 123 ------------YLREHTAWLVMEYCLGSASDLLEVH-------KKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAG 183 (348)
T ss_dssp ------------EEETTEEEEEEECCSEEHHHHHHHH-------TSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGG
T ss_pred ------------EEECCeEEEEEecCCCCHHHHHHHh-------cCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHH
Confidence 4556789999999999988887653 257999999999999999999999999999999999
Q ss_pred cEEee-cCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHhCCC
Q 003052 630 NFLLV-KGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGRT 708 (853)
Q Consensus 630 NILL~-~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLtG~~ 708 (853)
|||++ ++.+||+|||+++.... ....+||+.|+|||++.+... ..|+.++|||||||++|||++|+.
T Consensus 184 NIll~~~~~~kL~DfG~a~~~~~------~~~~~gt~~y~aPE~~~~~~~------~~~~~~~DiwslG~il~ell~g~~ 251 (348)
T 1u5q_A 184 NILLSEPGLVKLGDFGSASIMAP------ANSFVGTPYWMAPEVILAMDE------GQYDGKVDVWSLGITCIELAERKP 251 (348)
T ss_dssp GEEEETTTEEEECCCTTCBSSSS------BCCCCSCGGGCCHHHHHTTSS------CCBCTHHHHHHHHHHHHHHHHSSC
T ss_pred HEEECCCCCEEEeeccCceecCC------CCcccCCcceeCHhhhccccC------CCCCcHHHHHHHHHHHHHHHhCCC
Confidence 99995 57999999999976532 125689999999999964221 146789999999999999999999
Q ss_pred CCCcchhHHHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCCChhHHhcCCCCCCC
Q 003052 709 PFSEYKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQHPFLVPP 770 (853)
Q Consensus 709 PF~~~~~~~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~HPwf~~~ 770 (853)
||.+.........+..... ........+..+.+||.+||..||.+|||+.++|+||||...
T Consensus 252 p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h~~~~~~ 312 (348)
T 1u5q_A 252 PLFNMNAMSALYHIAQNES-PALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRE 312 (348)
T ss_dssp TTTTSCHHHHHHHHHHSCC-CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHHSC
T ss_pred CCCCCChHHHHHHHHhcCC-CCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHhhChhhhcc
Confidence 9987665554444443322 222345678889999999999999999999999999999754
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=371.31 Aligned_cols=261 Identities=22% Similarity=0.361 Sum_probs=209.0
Q ss_pred ceeeEEEeEeccCceEEEEEEec-CCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHHHH
Q 003052 472 KLYQRLGKIGSGGSSEVHKVISS-DCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLREV 550 (853)
Q Consensus 472 ~~Y~ilk~LG~G~FG~Vyka~~~-~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~~l 550 (853)
++|++++.||+|+||.||+|.+. +++.||||++...... .....+.+|+.++++++ |+||++++++
T Consensus 7 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~-h~~i~~~~~~----------- 73 (276)
T 2yex_A 7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV-DCPENIKKEICINKMLN-HENVVKFYGH----------- 73 (276)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCT-THHHHHHHHHHHHHTCC-CTTBCCEEEE-----------
T ss_pred cceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccch-hhhHHHHHHHHHHHhcC-CCCceeeeeE-----------
Confidence 46999999999999999999985 7789999999765432 34456889999999997 8999999987
Q ss_pred hhCCCCCCCCccccCCeEEEEEecchh-hHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCCCc
Q 003052 551 LNGSMNNKDGRVKDDGYIYMVLEYGEI-DLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPA 629 (853)
Q Consensus 551 ~~~~iv~~~g~~~d~~~lyLVmEy~~g-dL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLKPe 629 (853)
+.+.+.+|+||||+++ +|.+++.. ...+++..++.++.||+.||.|||++||+||||||+
T Consensus 74 -----------~~~~~~~~lv~e~~~~~~L~~~l~~--------~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ 134 (276)
T 2yex_A 74 -----------RREGNIQYLFLEYCSGGELFDRIEP--------DIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPE 134 (276)
T ss_dssp -----------EEETTEEEEEEECCTTEEGGGGSBT--------TTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGG
T ss_pred -----------EEcCCEEEEEEEecCCCcHHHHHhh--------ccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChH
Confidence 4566789999999864 77766543 356999999999999999999999999999999999
Q ss_pred cEEee-cCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHhCCC
Q 003052 630 NFLLV-KGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGRT 708 (853)
Q Consensus 630 NILL~-~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLtG~~ 708 (853)
|||++ ++.+||+|||++..+............+||+.|+|||++.+.. .++.++|||||||++|+|++|+.
T Consensus 135 Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--------~~~~~~Di~slG~il~~l~~g~~ 206 (276)
T 2yex_A 135 NLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE--------FHAEPVDVWSCGIVLTAMLAGEL 206 (276)
T ss_dssp GEEECTTCCEEECCCTTCEECEETTEECCBCCCCSCGGGCCGGGGTCSS--------BCHHHHHHHHHHHHHHHHHHSSC
T ss_pred HEEEccCCCEEEeeCCCccccCCCcchhcccCCccccCccChHHHhcCC--------CCCCcchHHHHHHHHHHHHhCCC
Confidence 99995 5799999999998664333222334678999999999997643 23568999999999999999999
Q ss_pred CCCcchhHHHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCCChhHHhcCCCCCCCCC
Q 003052 709 PFSEYKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQHPFLVPPVS 772 (853)
Q Consensus 709 PF~~~~~~~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~HPwf~~~~~ 772 (853)
||.........+..+.............++.+.+||.+||..||.+|||+.|+++||||.....
T Consensus 207 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~ 270 (276)
T 2yex_A 207 PWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPLK 270 (276)
T ss_dssp CCSCSCTTSHHHHHHHTTCTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCCCC
T ss_pred CCCCCchHHHHHHHhhhcccccCchhhcCHHHHHHHHHHCCCCchhCCCHHHHhcCccccChhh
Confidence 9976433222222222222222223456888999999999999999999999999999987643
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=379.61 Aligned_cols=264 Identities=25% Similarity=0.390 Sum_probs=200.6
Q ss_pred CceeeEE-EeEeccCceEEEEEEe-cCCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHH
Q 003052 471 GKLYQRL-GKIGSGGSSEVHKVIS-SDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLR 548 (853)
Q Consensus 471 g~~Y~il-k~LG~G~FG~Vyka~~-~~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~ 548 (853)
.+.|++. +.||+|+||.||+|.+ .+++.||||++..... .....+.+|+.+|.++.+|+||++++++
T Consensus 11 ~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~~~~h~~i~~~~~~--------- 79 (316)
T 2ac3_A 11 EDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPG--HIRSRVFREVEMLYQCQGHRNVLELIEF--------- 79 (316)
T ss_dssp TTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSS--CCHHHHHHHHHHHHHTCCCTTBCCEEEE---------
T ss_pred ceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcc--hhHHHHHHHHHHHHHhcCCCCeeeEEEE---------
Confidence 3568886 6799999999999997 4788999999976533 2345688999999998789999999987
Q ss_pred HHhhCCCCCCCCccccCCeEEEEEecch-hhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCC
Q 003052 549 EVLNGSMNNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLK 627 (853)
Q Consensus 549 ~l~~~~iv~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLK 627 (853)
+.+.+.+|+||||+. ++|.+++... ..+++..++.++.||+.||.|||++||+|||||
T Consensus 80 -------------~~~~~~~~lv~e~~~~~~L~~~l~~~--------~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlk 138 (316)
T 2ac3_A 80 -------------FEEEDRFYLVFEKMRGGSILSHIHKR--------RHFNELEASVVVQDVASALDFLHNKGIAHRDLK 138 (316)
T ss_dssp -------------EEETTEEEEEEECCTTCBHHHHHHHH--------SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCC
T ss_pred -------------EeeCCEEEEEEEcCCCCcHHHHHhcc--------CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCC
Confidence 456678999999986 6999988764 469999999999999999999999999999999
Q ss_pred CccEEeec-C---cEEEEecccchhcccCCc-----cccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHH
Q 003052 628 PANFLLVK-G---SLKLIDFGIAKAIMSDTT-----NIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGC 698 (853)
Q Consensus 628 PeNILL~~-g---~VKL~DFGlAk~~~~~~~-----~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGV 698 (853)
|+|||++. + .+||+|||+++....... .......+||+.|+|||++.+... ....|+.++|||||||
T Consensus 139 p~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~----~~~~~~~~~DiwslG~ 214 (316)
T 2ac3_A 139 PENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSE----EASIYDKRCDLWSLGV 214 (316)
T ss_dssp GGGEEESCSSSSCSEEECCTTCCC-------------------CCSGGGCCHHHHHHTSH----HHHHHTTTHHHHHHHH
T ss_pred HHHEEEccCCCcCceEEEEccCccccccCCccccccccccccccCCcCccChHHhhcccc----cccCCCcccccHhHHH
Confidence 99999953 3 399999999986542211 111235679999999999965210 0114678999999999
Q ss_pred HHHHHHhCCCCCCcchh--------------HHHHHHhhcCCCCccc--CCCCCChhHHHHHHHhcccCCCCCCChhHHh
Q 003052 699 ILYQMVYGRTPFSEYKT--------------FWAKFKVITDPNHEIT--YEPVPNPWLLDLMKKCLAWDRNERWRIPQLL 762 (853)
Q Consensus 699 ILyELLtG~~PF~~~~~--------------~~~~~kii~~~~~~~~--~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL 762 (853)
++|+|++|+.||.+... ....+..+......+. .....++.+++||.+||..||.+|||+.|+|
T Consensus 215 il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l 294 (316)
T 2ac3_A 215 ILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVL 294 (316)
T ss_dssp HHHHHHHSSCSCCCCCCSCSCC----CCHHHHHHHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHH
T ss_pred HHHHHHHCCCCCcccccccccccccccchhHHHHHHHHHhccCcccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHh
Confidence 99999999999965321 1112222222221111 1135678899999999999999999999999
Q ss_pred cCCCCCCC
Q 003052 763 QHPFLVPP 770 (853)
Q Consensus 763 ~HPwf~~~ 770 (853)
+||||...
T Consensus 295 ~hp~~~~~ 302 (316)
T 2ac3_A 295 QHPWVQGC 302 (316)
T ss_dssp HSTTCC--
T ss_pred cChhhcCC
Confidence 99999864
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=387.27 Aligned_cols=260 Identities=28% Similarity=0.419 Sum_probs=202.6
Q ss_pred CceeeEEEeEeccCceEEEEEEec-CCcEEEEEEEecCCCCh---hhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHH
Q 003052 471 GKLYQRLGKIGSGGSSEVHKVISS-DCTIYALKKIKLKGRDY---ATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKAL 546 (853)
Q Consensus 471 g~~Y~ilk~LG~G~FG~Vyka~~~-~g~~vAVKkik~~~~~~---~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~i 546 (853)
.++|++++.||+|+||.||+|.+. +++.||||++....... .....+.+|+++|++++ |+||++++++
T Consensus 9 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~------- 80 (346)
T 1ua2_A 9 AKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELS-HPNIIGLLDA------- 80 (346)
T ss_dssp ----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCC-CTTBCCEEEE-------
T ss_pred hcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCC-CCCCCeEEEE-------
Confidence 357999999999999999999984 67899999997543221 22346789999999997 9999999987
Q ss_pred HHHHhhCCCCCCCCccccCCeEEEEEecchhhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCC
Q 003052 547 LREVLNGSMNNKDGRVKDDGYIYMVLEYGEIDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDL 626 (853)
Q Consensus 547 L~~l~~~~iv~~~g~~~d~~~lyLVmEy~~gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDL 626 (853)
+.+...+|+||||++++|..++... ...+++..++.++.||+.||.|||++||+||||
T Consensus 81 ---------------~~~~~~~~lv~e~~~~~l~~~~~~~-------~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dl 138 (346)
T 1ua2_A 81 ---------------FGHKSNISLVFDFMETDLEVIIKDN-------SLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDL 138 (346)
T ss_dssp ---------------ECCTTCCEEEEECCSEEHHHHHTTC-------CSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCC
T ss_pred ---------------EeeCCceEEEEEcCCCCHHHHHHhc-------CcCCCHHHHHHHHHHHHHHHHHHHHCCEECCCC
Confidence 4456678999999999988877542 356899999999999999999999999999999
Q ss_pred CCccEEe-ecCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHh
Q 003052 627 KPANFLL-VKGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVY 705 (853)
Q Consensus 627 KPeNILL-~~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLt 705 (853)
||+|||+ .++.+||+|||+++.+..... .....+||+.|+|||++.+.. .|+.++|||||||++|+|++
T Consensus 139 kp~Nil~~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~--------~~~~~~DiwslG~il~ell~ 208 (346)
T 1ua2_A 139 KPNNLLLDENGVLKLADFGLAKSFGSPNR--AYTHQVVTRWYRAPELLFGAR--------MYGVGVDMWAVGCILAELLL 208 (346)
T ss_dssp CGGGEEECTTCCEEECCCGGGSTTTSCCC--CCCCSCCCCTTCCHHHHTTCS--------CCCHHHHHHHHHHHHHHHHH
T ss_pred CHHHEEEcCCCCEEEEecccceeccCCcc--cCCcccccccccCchHhhCCC--------CCCchhhhHhHHHHHHHHHH
Confidence 9999999 567999999999987643322 234678999999999996542 36789999999999999999
Q ss_pred CCCCCCcchhHHHHHHhh---cCCCCcc----------------------cCCCCCChhHHHHHHHhcccCCCCCCChhH
Q 003052 706 GRTPFSEYKTFWAKFKVI---TDPNHEI----------------------TYEPVPNPWLLDLMKKCLAWDRNERWRIPQ 760 (853)
Q Consensus 706 G~~PF~~~~~~~~~~kii---~~~~~~~----------------------~~~~~~s~~l~dLI~kcL~~DP~kRpTa~E 760 (853)
|.+||.+.........+. ..+.... ......+..+++||.+||..||.+|||+.|
T Consensus 209 g~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e 288 (346)
T 1ua2_A 209 RVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQ 288 (346)
T ss_dssp SSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHH
T ss_pred CCCCCCCCCHHHHHHHHHHHcCCCChhhhhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHH
Confidence 999998765443332222 1111100 001345678999999999999999999999
Q ss_pred HhcCCCCCCC
Q 003052 761 LLQHPFLVPP 770 (853)
Q Consensus 761 IL~HPwf~~~ 770 (853)
+|+||||...
T Consensus 289 ll~h~~f~~~ 298 (346)
T 1ua2_A 289 ALKMKYFSNR 298 (346)
T ss_dssp HHTSGGGTSS
T ss_pred HhcChhhhcC
Confidence 9999999764
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-44 Score=403.24 Aligned_cols=254 Identities=26% Similarity=0.403 Sum_probs=201.2
Q ss_pred CceeeEEEeEeccCceEEEEEEe-cCCcEEEEEEEecCCC-ChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHH
Q 003052 471 GKLYQRLGKIGSGGSSEVHKVIS-SDCTIYALKKIKLKGR-DYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLR 548 (853)
Q Consensus 471 g~~Y~ilk~LG~G~FG~Vyka~~-~~g~~vAVKkik~~~~-~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~ 548 (853)
.+.|++++.||+|+||.||+|.+ .+++.||||+++.... .......+.+|+.+|++++ |+||++++++
T Consensus 147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~l~~~--------- 216 (446)
T 4ejn_A 147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSR-HPFLTALKYS--------- 216 (446)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCS-CTTSCCEEEE---------
T ss_pred hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCC-CCeEeeEEEE---------
Confidence 35699999999999999999998 5778999999975421 2233445778999999987 8999999886
Q ss_pred HHhhCCCCCCCCccccCCeEEEEEecch-hhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhccc-CceeeCCC
Q 003052 549 EVLNGSMNNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHE-ERIVHSDL 626 (853)
Q Consensus 549 ~l~~~~iv~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs-~gIIHRDL 626 (853)
+.+.+.+|+||||++ ++|.+++... ..+++..++.|+.||+.||.|||+ +||+||||
T Consensus 217 -------------~~~~~~~~lv~e~~~~~~L~~~l~~~--------~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDl 275 (446)
T 4ejn_A 217 -------------FQTHDRLCFVMEYANGGELFFHLSRE--------RVFSEDRARFYGAEIVSALDYLHSEKNVVYRDL 275 (446)
T ss_dssp -------------EEETTEEEEEECCCSSCBHHHHHHHH--------SCCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCC
T ss_pred -------------EeeCCEEEEEEeeCCCCcHHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHhhcCCEEECCC
Confidence 556778999999986 4888888654 579999999999999999999998 99999999
Q ss_pred CCccEEe-ecCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHh
Q 003052 627 KPANFLL-VKGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVY 705 (853)
Q Consensus 627 KPeNILL-~~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLt 705 (853)
||+|||| .++.+||+|||+|+....... .....+||+.|+|||++.+. .|+.++|||||||++|||++
T Consensus 276 kp~NIll~~~~~~kl~DFG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~---------~~~~~~DiwslG~il~ell~ 344 (446)
T 4ejn_A 276 KLENLMLDKDGHIKITDFGLCKEGIKDGA--TMKTFCGTPEYLAPEVLEDN---------DYGRAVDWWGLGVVMYEMMC 344 (446)
T ss_dssp CGGGEEECSSSCEEECCCCCCCTTCC-------CCSSSCGGGCCHHHHHTS---------CCCTHHHHHHHHHHHHHHHH
T ss_pred CHHHEEECCCCCEEEccCCCceeccCCCc--ccccccCCccccCHhhcCCC---------CCCCccchhhhHHHHHHHhh
Confidence 9999999 567999999999986443222 23467999999999999765 36789999999999999999
Q ss_pred CCCCCCcchhHHHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCC-----ChhHHhcCCCCCC
Q 003052 706 GRTPFSEYKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERW-----RIPQLLQHPFLVP 769 (853)
Q Consensus 706 G~~PF~~~~~~~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRp-----Ta~EIL~HPwf~~ 769 (853)
|+.||.+.........+... ...++...++.+.+||.+||.+||.+|| ++.|+|+||||..
T Consensus 345 g~~Pf~~~~~~~~~~~i~~~---~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~hp~f~~ 410 (446)
T 4ejn_A 345 GRLPFYNQDHEKLFELILME---EIRFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAG 410 (446)
T ss_dssp SSCSSCCSSHHHHHHHHHHC---CCCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTT
T ss_pred CCCCCCCCCHHHHHHHHHhC---CCCCCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhCccccC
Confidence 99999775544333333322 2345667889999999999999999999 9999999999975
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-43 Score=400.82 Aligned_cols=265 Identities=28% Similarity=0.396 Sum_probs=208.3
Q ss_pred CceeeEEEeEeccCceEEEEEEe-cCCcEEEEEEEecCCC-ChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHH
Q 003052 471 GKLYQRLGKIGSGGSSEVHKVIS-SDCTIYALKKIKLKGR-DYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLR 548 (853)
Q Consensus 471 g~~Y~ilk~LG~G~FG~Vyka~~-~~g~~vAVKkik~~~~-~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~ 548 (853)
.++|++++.||+|+||.||+|++ .+++.||||++++... .......+.+|+.+|.++. |+||++++++
T Consensus 60 ~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~-hp~Iv~l~~~--------- 129 (412)
T 2vd5_A 60 RDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGD-RRWITQLHFA--------- 129 (412)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSC-TTTBCCEEEE---------
T ss_pred hhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcC-CCCeeeEEEE---------
Confidence 36799999999999999999998 4789999999975321 1223445789999999986 8999999876
Q ss_pred HHhhCCCCCCCCccccCCeEEEEEecc-hhhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCC
Q 003052 549 EVLNGSMNNKDGRVKDDGYIYMVLEYG-EIDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLK 627 (853)
Q Consensus 549 ~l~~~~iv~~~g~~~d~~~lyLVmEy~-~gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLK 627 (853)
|++.+++|+||||+ +++|.+++... +..+++..++.|+.||+.||.|||++||+|||||
T Consensus 130 -------------~~~~~~~~lVmE~~~gg~L~~~l~~~-------~~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLK 189 (412)
T 2vd5_A 130 -------------FQDENYLYLVMEYYVGGDLLTLLSKF-------GERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIK 189 (412)
T ss_dssp -------------EECSSEEEEEECCCCSCBHHHHHHHH-------SSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCS
T ss_pred -------------EeeCCEEEEEEcCCCCCcHHHHHHhc-------CCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccC
Confidence 56778999999997 56999998754 2469999999999999999999999999999999
Q ss_pred CccEEee-cCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHhC
Q 003052 628 PANFLLV-KGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYG 706 (853)
Q Consensus 628 PeNILL~-~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLtG 706 (853)
|+||||+ +|++||+|||+|+.+..... ......+||+.|+|||++....... ....|+.++|||||||++|||++|
T Consensus 190 p~NILld~~g~vkL~DFGla~~~~~~~~-~~~~~~~Gt~~Y~APE~l~~~~~~~--~~~~~~~~~DiwSlGvilyelltG 266 (412)
T 2vd5_A 190 PDNILLDRCGHIRLADFGSCLKLRADGT-VRSLVAVGTPDYLSPEILQAVGGGP--GTGSYGPECDWWALGVFAYEMFYG 266 (412)
T ss_dssp GGGEEECTTSCEEECCCTTCEECCTTSC-EECSSCCSCGGGCCHHHHHHHHTCT--TCSEECTHHHHHHHHHHHHHHHHS
T ss_pred HHHeeecCCCCEEEeechhheeccCCCc-cccceeccccCcCCHHHHhhcccCc--CCCCCChHHhhhHHhHHHHHHHhC
Confidence 9999994 68999999999987644322 1233579999999999997421100 012478899999999999999999
Q ss_pred CCCCCcchhHHHHHHhhcCC--CCcccCCCCCChhHHHHHHHhcccCCCCC---CChhHHhcCCCCCC
Q 003052 707 RTPFSEYKTFWAKFKVITDP--NHEITYEPVPNPWLLDLMKKCLAWDRNER---WRIPQLLQHPFLVP 769 (853)
Q Consensus 707 ~~PF~~~~~~~~~~kii~~~--~~~~~~~~~~s~~l~dLI~kcL~~DP~kR---pTa~EIL~HPwf~~ 769 (853)
++||.+........+++... ..........++++++||.+||. +|.+| +++.||++||||..
T Consensus 267 ~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~Hpff~~ 333 (412)
T 2vd5_A 267 QTPFYADSTAETYGKIVHYKEHLSLPLVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTHPFFFG 333 (412)
T ss_dssp SCTTCCSSHHHHHHHHHTHHHHCCCC----CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTSGGGTT
T ss_pred CCCCCCCCHHHHHHHHHhcccCcCCCccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcCCCcCC
Confidence 99998755443333332110 01111235678999999999999 99998 59999999999974
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-43 Score=380.76 Aligned_cols=253 Identities=26% Similarity=0.427 Sum_probs=208.8
Q ss_pred eeeEEEeEeccCceEEEEEEec-CCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHHHHh
Q 003052 473 LYQRLGKIGSGGSSEVHKVISS-DCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLREVL 551 (853)
Q Consensus 473 ~Y~ilk~LG~G~FG~Vyka~~~-~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~~l~ 551 (853)
.|...++||+|+||.||+|.+. +++.||||++...... ....+.+|+.++++++ |+||++++++
T Consensus 46 ~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~-h~niv~~~~~------------ 110 (321)
T 2c30_A 46 LLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQ--RRELLFNEVVIMRDYQ-HFNVVEMYKS------------ 110 (321)
T ss_dssp HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCC--SHHHHHHHHHHHTTCC-CTTBCCEEEE------------
T ss_pred hhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchh--HHHHHHHHHHHHHhCC-CCCcceEEEE------------
Confidence 4778889999999999999985 7899999999865432 3446889999999997 8999999987
Q ss_pred hCCCCCCCCccccCCeEEEEEecch-hhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCCCcc
Q 003052 552 NGSMNNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPAN 630 (853)
Q Consensus 552 ~~~iv~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLKPeN 630 (853)
+.....+|+||||+. ++|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|
T Consensus 111 ----------~~~~~~~~lv~e~~~~~~L~~~l~~---------~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~N 171 (321)
T 2c30_A 111 ----------YLVGEELWVLMEFLQGGALTDIVSQ---------VRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDS 171 (321)
T ss_dssp ----------EEETTEEEEEECCCCSCBHHHHHTT---------CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGG
T ss_pred ----------EEECCEEEEEEecCCCCCHHHHHHh---------cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHH
Confidence 445678999999975 588887643 469999999999999999999999999999999999
Q ss_pred EEee-cCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHhCCCC
Q 003052 631 FLLV-KGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGRTP 709 (853)
Q Consensus 631 ILL~-~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLtG~~P 709 (853)
||++ ++.+||+|||+++....... .....+||+.|+|||++.+. .|+.++|||||||++|+|++|+.|
T Consensus 172 Ill~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~---------~~~~~~Dv~slG~il~el~~g~~p 240 (321)
T 2c30_A 172 ILLTLDGRVKLSDFGFCAQISKDVP--KRKSLVGTPYWMAPEVISRS---------LYATEVDIWSLGIMVIEMVDGEPP 240 (321)
T ss_dssp EEECTTCCEEECCCTTCEECCSSSC--CBCCCCSCGGGCCHHHHTTC---------CBCTHHHHHHHHHHHHHHHHSSCT
T ss_pred EEECCCCcEEEeeeeeeeecccCcc--ccccccCCccccCHhhhcCC---------CCCchhhHHHHHHHHHHHHhCCCC
Confidence 9995 67999999999987654322 23467899999999999654 367899999999999999999999
Q ss_pred CCcchhHHHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCCChhHHhcCCCCCCC
Q 003052 710 FSEYKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQHPFLVPP 770 (853)
Q Consensus 710 F~~~~~~~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~HPwf~~~ 770 (853)
|...........+..............++.+.+||.+||..||.+|||+.++|+||||...
T Consensus 241 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~~ 301 (321)
T 2c30_A 241 YFSDSPVQAMKRLRDSPPPKLKNSHKVSPVLRDFLERMLVRDPQERATAQELLDHPFLLQT 301 (321)
T ss_dssp TTTSCHHHHHHHHHHSSCCCCTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGGGC
T ss_pred CCCCCHHHHHHHHhcCCCCCcCccccCCHHHHHHHHHHccCChhhCcCHHHHhcChhhccC
Confidence 9876554444444333333333344568889999999999999999999999999999753
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-43 Score=376.91 Aligned_cols=266 Identities=25% Similarity=0.413 Sum_probs=211.7
Q ss_pred CceeeEEEeEeccCceEEEEEEe--cCCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhc--CCCceeEeeehhhhHHHH
Q 003052 471 GKLYQRLGKIGSGGSSEVHKVIS--SDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLK--GKNNIIQLIDYEVTEKAL 546 (853)
Q Consensus 471 g~~Y~ilk~LG~G~FG~Vyka~~--~~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~--~hpNIV~Lid~~~~e~~i 546 (853)
+++|++++.||+|+||.||+|.+ .+++.||||++............+.+|+.+++++. .|+||+++++++...
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~--- 86 (326)
T 1blx_A 10 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVS--- 86 (326)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEE---
T ss_pred hhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeec---
Confidence 35699999999999999999998 36788999999865544444446778999999885 699999999874210
Q ss_pred HHHHhhCCCCCCCCccccCCeEEEEEecchhhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCC
Q 003052 547 LREVLNGSMNNKDGRVKDDGYIYMVLEYGEIDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDL 626 (853)
Q Consensus 547 L~~l~~~~iv~~~g~~~d~~~lyLVmEy~~gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDL 626 (853)
.......+|+||||++++|.+++... ....+++..++.++.||+.||.|||++||+||||
T Consensus 87 --------------~~~~~~~~~lv~e~~~~~L~~~l~~~------~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dl 146 (326)
T 1blx_A 87 --------------RTDRETKLTLVFEHVDQDLTTYLDKV------PEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDL 146 (326)
T ss_dssp --------------ECSSEEEEEEEEECCSCBHHHHHHHS------CTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCC
T ss_pred --------------ccCCCceEEEEEecCCCCHHHHHHhc------ccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccC
Confidence 01245689999999999999988764 2345999999999999999999999999999999
Q ss_pred CCccEEe-ecCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHh
Q 003052 627 KPANFLL-VKGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVY 705 (853)
Q Consensus 627 KPeNILL-~~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLt 705 (853)
||+|||+ .++.+||+|||+++...... .....+||+.|+|||++.+. .++.++|||||||++|+|++
T Consensus 147 kp~Nili~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~---------~~~~~~Di~slG~il~~l~~ 214 (326)
T 1blx_A 147 KPQNILVTSSGQIKLADFGLARIYSFQM---ALTSVVVTLWYRAPEVLLQS---------SYATPVDLWSVGCIFAEMFR 214 (326)
T ss_dssp CGGGEEECTTCCEEECSCCSCCCCCGGG---GGCCCCCCCTTCCHHHHTTC---------CCCTHHHHHHHHHHHHHHHH
T ss_pred CHHHeEEcCCCCEEEecCcccccccCCC---CccccccccceeCHHHHhcC---------CCCcchhHHHHHHHHHHHHc
Confidence 9999999 56799999999998654322 23457899999999999765 35689999999999999999
Q ss_pred CCCCCCcchhHHHHHHhh---cCCC---------------------CcccCCCCCChhHHHHHHHhcccCCCCCCChhHH
Q 003052 706 GRTPFSEYKTFWAKFKVI---TDPN---------------------HEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQL 761 (853)
Q Consensus 706 G~~PF~~~~~~~~~~kii---~~~~---------------------~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EI 761 (853)
|+.||.+.........++ ..+. ....+....+..+++||.+||..||.+||++.++
T Consensus 215 g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~ 294 (326)
T 1blx_A 215 RKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSA 294 (326)
T ss_dssp SSCSCCCSSHHHHHHHHHHHHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHH
T ss_pred CCCCCCCCCHHHHHHHHHHHcCCCCcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHH
Confidence 999998755433322221 1110 0011234567889999999999999999999999
Q ss_pred hcCCCCCCCC
Q 003052 762 LQHPFLVPPV 771 (853)
Q Consensus 762 L~HPwf~~~~ 771 (853)
|+||||....
T Consensus 295 l~hp~~~~~~ 304 (326)
T 1blx_A 295 LSHPYFQDLE 304 (326)
T ss_dssp HTSGGGTTCC
T ss_pred hcCccccccc
Confidence 9999997643
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-43 Score=384.05 Aligned_cols=253 Identities=26% Similarity=0.391 Sum_probs=187.5
Q ss_pred eeeEE---EeEeccCceEEEEEEec-CCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHH
Q 003052 473 LYQRL---GKIGSGGSSEVHKVISS-DCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLR 548 (853)
Q Consensus 473 ~Y~il---k~LG~G~FG~Vyka~~~-~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~ 548 (853)
+|.+. +.||+|+||.||+|.+. +++.||||++... ....+.+|+.+|+++.+||||++++++
T Consensus 9 ~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~e~~~l~~l~~h~niv~~~~~--------- 74 (325)
T 3kn6_A 9 HYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKR-----MEANTQKEITALKLCEGHPNIVKLHEV--------- 74 (325)
T ss_dssp HEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEGG-----GHHHHHHHHHHHHHTTTCTTBCCEEEE---------
T ss_pred ccccccCCCccccCCCeEEEEEEECCCCCEEEEEEEChh-----hhhhHHHHHHHHHHhcCCCCeeEEEEE---------
Confidence 46664 67999999999999984 6789999999753 234577999999999999999999987
Q ss_pred HHhhCCCCCCCCccccCCeEEEEEecch-hhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCC
Q 003052 549 EVLNGSMNNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLK 627 (853)
Q Consensus 549 ~l~~~~iv~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLK 627 (853)
+.++..+|+||||++ ++|.+++... ..+++..++.|+.||+.||.|||++||+|||||
T Consensus 75 -------------~~~~~~~~lv~e~~~~~~L~~~l~~~--------~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlk 133 (325)
T 3kn6_A 75 -------------FHDQLHTFLVMELLNGGELFERIKKK--------KHFSETEASYIMRKLVSAVSHMHDVGVVHRDLK 133 (325)
T ss_dssp -------------EECSSEEEEEECCCCSCBHHHHHHHC--------SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCC
T ss_pred -------------EEcCCEEEEEEEccCCCcHHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCC
Confidence 466788999999986 4999888653 579999999999999999999999999999999
Q ss_pred CccEEeec-C---cEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHH
Q 003052 628 PANFLLVK-G---SLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQM 703 (853)
Q Consensus 628 PeNILL~~-g---~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyEL 703 (853)
|+|||+.. + .+||+|||+++....... .....+||+.|+|||++.+. .|+.++|||||||++|+|
T Consensus 134 p~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~~t~~y~aPE~~~~~---------~~~~~~DiwslG~il~~l 202 (325)
T 3kn6_A 134 PENLLFTDENDNLEIKIIDFGFARLKPPDNQ--PLKTPCFTLHYAAPELLNQN---------GYDESCDLWSLGVILYTM 202 (325)
T ss_dssp GGGEEEEC----CEEEECCCTTCEECCC------------------------C---------CCCHHHHHHHHHHHHHHH
T ss_pred HHHEEEecCCCcccEEEeccccceecCCCCC--cccccCCCcCccCHHHhcCC---------CCCCccchHHHHHHHHHH
Confidence 99999953 3 799999999986543222 23467899999999999765 356899999999999999
Q ss_pred HhCCCCCCcchh------HHHHHHhhcCCCCcccC--CCCCChhHHHHHHHhcccCCCCCCChhHHhcCCCCCCCC
Q 003052 704 VYGRTPFSEYKT------FWAKFKVITDPNHEITY--EPVPNPWLLDLMKKCLAWDRNERWRIPQLLQHPFLVPPV 771 (853)
Q Consensus 704 LtG~~PF~~~~~------~~~~~kii~~~~~~~~~--~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~HPwf~~~~ 771 (853)
++|+.||..... .......+......+.. ....++++++||.+||..||.+|||+.|+++||||....
T Consensus 203 l~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h~w~~~~~ 278 (325)
T 3kn6_A 203 LSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDGS 278 (325)
T ss_dssp HHSSCTTC-------CCCHHHHHHHHTTTCCCCCSHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTCGGGCTTC
T ss_pred HhCCCCCCCCccccccccHHHHHHHHHcCCCCCCcccccCCCHHHHHHHHHHCCCChhHCCCHHHHhcChhhccCc
Confidence 999999975332 12333333332222211 134688899999999999999999999999999998653
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-44 Score=395.81 Aligned_cols=260 Identities=27% Similarity=0.446 Sum_probs=193.8
Q ss_pred ceeeEEEeEeccCceEEEEEEe-cCCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHHHH
Q 003052 472 KLYQRLGKIGSGGSSEVHKVIS-SDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLREV 550 (853)
Q Consensus 472 ~~Y~ilk~LG~G~FG~Vyka~~-~~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~~l 550 (853)
++|++++.||+|+||.||+|.+ .+++.||||++............+.+|+.+|++++ |+||+++++++...
T Consensus 29 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~------- 100 (367)
T 2fst_X 29 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMK-HENVIGLLDVFTPA------- 100 (367)
T ss_dssp TTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCC-CTTBCCCSEEECSC-------
T ss_pred CceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCC-CCCCCcEEEEEecC-------
Confidence 5699999999999999999998 57789999999876666666678899999999998 99999999875321
Q ss_pred hhCCCCCCCCccccCCeEEEEEecchhhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCCCcc
Q 003052 551 LNGSMNNKDGRVKDDGYIYMVLEYGEIDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPAN 630 (853)
Q Consensus 551 ~~~~iv~~~g~~~d~~~lyLVmEy~~gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLKPeN 630 (853)
..+.+...+|+||||++++|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|
T Consensus 101 ---------~~~~~~~~~~lv~e~~~~~L~~~~~~---------~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~N 162 (367)
T 2fst_X 101 ---------RSLEEFNDVYLVTHLMGADLNNIVKC---------QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSN 162 (367)
T ss_dssp ---------SSGGGCCCCEEEEECCCEECC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGG
T ss_pred ---------CccccCCeEEEEecccCCCHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhh
Confidence 12344567899999998888877743 469999999999999999999999999999999999
Q ss_pred EEee-cCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHhCCCC
Q 003052 631 FLLV-KGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGRTP 709 (853)
Q Consensus 631 ILL~-~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLtG~~P 709 (853)
||++ ++.+||+|||+|+..... ....+||++|+|||++.+.. .|+.++|||||||++|+|++|++|
T Consensus 163 Ill~~~~~~kL~DFG~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~--------~~~~~~DiwslG~il~ell~g~~p 229 (367)
T 2fst_X 163 LAVNEDCELKILDFGLARHTADE-----MTGYVATRWYRAPEIMLNWM--------HYNQTVDIWSVGCIMAELLTGRTL 229 (367)
T ss_dssp EEECTTCCEEECC--------------------CCCTTCCHHHHTTCC--------SCCTTHHHHHHHHHHHHHHHSSCS
T ss_pred EEECCCCCEEEeecccccccccc-----CCCcCcCcCccChHHHcCCc--------CCCchhhHHHHHHHHHHHHhCCCC
Confidence 9994 679999999999865432 23568999999999997532 467899999999999999999999
Q ss_pred CCcchhHHHH---HHhhcCCCC----------------------cc---cCCCCCChhHHHHHHHhcccCCCCCCChhHH
Q 003052 710 FSEYKTFWAK---FKVITDPNH----------------------EI---TYEPVPNPWLLDLMKKCLAWDRNERWRIPQL 761 (853)
Q Consensus 710 F~~~~~~~~~---~kii~~~~~----------------------~~---~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EI 761 (853)
|.+....... .+.+..+.. .. ......++.+.+||.+||.+||.+|||+.|+
T Consensus 230 f~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~ 309 (367)
T 2fst_X 230 FPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQA 309 (367)
T ss_dssp CCCSSHHHHHHHHHHHHCSCCHHHHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHH
T ss_pred CCCCCHHHHHHHHHHHhCCCCHHHHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHH
Confidence 9775443222 222111100 00 0113457889999999999999999999999
Q ss_pred hcCCCCCCC
Q 003052 762 LQHPFLVPP 770 (853)
Q Consensus 762 L~HPwf~~~ 770 (853)
|+||||...
T Consensus 310 L~hp~~~~~ 318 (367)
T 2fst_X 310 LAHAYFAQY 318 (367)
T ss_dssp HTSGGGTTT
T ss_pred hcChhhhhc
Confidence 999999864
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-43 Score=391.35 Aligned_cols=259 Identities=26% Similarity=0.398 Sum_probs=199.2
Q ss_pred ceeeEEEeEeccCceEEEEEEe-cCCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHHHH
Q 003052 472 KLYQRLGKIGSGGSSEVHKVIS-SDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLREV 550 (853)
Q Consensus 472 ~~Y~ilk~LG~G~FG~Vyka~~-~~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~~l 550 (853)
++|++++.||+|+||.||+|.+ .+++.||||++............+.+|+.+++.++ |+||+++++++...
T Consensus 25 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~------- 96 (371)
T 2xrw_A 25 KRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVN-HKNIIGLLNVFTPQ------- 96 (371)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCC-CTTBCCEEEEECSC-------
T ss_pred hheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcC-CCCccceEEeeccc-------
Confidence 5699999999999999999998 46789999999876666666677899999999997 99999999975321
Q ss_pred hhCCCCCCCCccccCCeEEEEEecchhhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCCCcc
Q 003052 551 LNGSMNNKDGRVKDDGYIYMVLEYGEIDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPAN 630 (853)
Q Consensus 551 ~~~~iv~~~g~~~d~~~lyLVmEy~~gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLKPeN 630 (853)
+.+.+...+|+||||++++|.+.+. ..+++..++.++.||+.||.|||++||+||||||+|
T Consensus 97 ---------~~~~~~~~~~lv~e~~~~~l~~~~~----------~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~N 157 (371)
T 2xrw_A 97 ---------KSLEEFQDVYIVMELMDANLCQVIQ----------MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSN 157 (371)
T ss_dssp ---------CSTTTCCEEEEEEECCSEEHHHHHH----------SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGG
T ss_pred ---------cccccccceEEEEEcCCCCHHHHHh----------hccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHH
Confidence 1234456899999999999888774 248999999999999999999999999999999999
Q ss_pred EEee-cCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHhCCCC
Q 003052 631 FLLV-KGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGRTP 709 (853)
Q Consensus 631 ILL~-~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLtG~~P 709 (853)
||++ ++.+||+|||+|+...... .....+||+.|+|||++.+. .|+.++|||||||++|+|++|+.|
T Consensus 158 Il~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~---------~~~~~~DiwslG~il~el~~g~~p 225 (371)
T 2xrw_A 158 IVVKSDCTLKILDFGLARTAGTSF---MMTPYVVTRYYRAPEVILGM---------GYKENVDIWSVGCIMGEMIKGGVL 225 (371)
T ss_dssp EEECTTSCEEECCCCC-------------------CTTCCHHHHTTC---------CCCTTHHHHHHHHHHHHHHHSSCS
T ss_pred EEEcCCCCEEEEEeeccccccccc---ccCCceecCCccCHHHhcCC---------CCCchHhHHHHHHHHHHHHhCCCC
Confidence 9995 6799999999998654321 23357899999999999765 356899999999999999999999
Q ss_pred CCcchhHHHHHHhhcCCCCc---------------------------------ccCCCC------CChhHHHHHHHhccc
Q 003052 710 FSEYKTFWAKFKVITDPNHE---------------------------------ITYEPV------PNPWLLDLMKKCLAW 750 (853)
Q Consensus 710 F~~~~~~~~~~kii~~~~~~---------------------------------~~~~~~------~s~~l~dLI~kcL~~ 750 (853)
|.+.........++...... ..++.. .+..+++||.+||.+
T Consensus 226 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~ 305 (371)
T 2xrw_A 226 FPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVI 305 (371)
T ss_dssp SCCSSHHHHHHHHHC-CCCCCHHHHTTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCS
T ss_pred CCCCCHHHHHHHHHHHhCCCCHHHHHHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcC
Confidence 98765543333332211000 000000 145689999999999
Q ss_pred CCCCCCChhHHhcCCCCCC
Q 003052 751 DRNERWRIPQLLQHPFLVP 769 (853)
Q Consensus 751 DP~kRpTa~EIL~HPwf~~ 769 (853)
||.+|||+.|+|+||||..
T Consensus 306 dP~~R~t~~e~l~hp~~~~ 324 (371)
T 2xrw_A 306 DASKRISVDEALQHPYINV 324 (371)
T ss_dssp SGGGSCCHHHHHHSHHHHT
T ss_pred ChhhCCCHHHHhCCcchhh
Confidence 9999999999999999964
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-43 Score=390.22 Aligned_cols=256 Identities=25% Similarity=0.387 Sum_probs=209.3
Q ss_pred ceeeEEEeEeccCceEEEEEEec-CCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHHHH
Q 003052 472 KLYQRLGKIGSGGSSEVHKVISS-DCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLREV 550 (853)
Q Consensus 472 ~~Y~ilk~LG~G~FG~Vyka~~~-~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~~l 550 (853)
+.|++++.||+|+||.||+|.+. +++.||+|++..... .....+.+|+.+|++++ |+||++++++
T Consensus 51 ~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~--~~~~~~~~E~~il~~l~-hpnIv~~~~~----------- 116 (387)
T 1kob_A 51 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYP--LDKYTVKNEISIMNQLH-HPKLINLHDA----------- 116 (387)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSH--HHHHHHHHHHHHHTTCC-STTBCCEEEE-----------
T ss_pred cceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccch--hhHHHHHHHHHHHHhCC-CcCCCeEEEE-----------
Confidence 46999999999999999999984 678999999976532 33446889999999997 8999999987
Q ss_pred hhCCCCCCCCccccCCeEEEEEecch-hhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCCCc
Q 003052 551 LNGSMNNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPA 629 (853)
Q Consensus 551 ~~~~iv~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLKPe 629 (853)
+.+...+|+||||+. ++|.+++... ...+++..++.++.||+.||.|||++||+||||||+
T Consensus 117 -----------~~~~~~~~lv~E~~~gg~L~~~l~~~-------~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~ 178 (387)
T 1kob_A 117 -----------FEDKYEMVLILEFLSGGELFDRIAAE-------DYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPE 178 (387)
T ss_dssp -----------EECSSEEEEEEECCCCCBHHHHTTCT-------TCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGG
T ss_pred -----------EEeCCEEEEEEEcCCCCcHHHHHHhh-------cCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchH
Confidence 456778999999975 5888877532 346999999999999999999999999999999999
Q ss_pred cEEee---cCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHhC
Q 003052 630 NFLLV---KGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYG 706 (853)
Q Consensus 630 NILL~---~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLtG 706 (853)
|||++ .+.+||+|||+|+...... .....+||+.|+|||++.+. .++.++|||||||++|+|++|
T Consensus 179 NIll~~~~~~~vkL~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~---------~~~~~~DiwSlG~il~elltg 246 (387)
T 1kob_A 179 NIMCETKKASSVKIIDFGLATKLNPDE---IVKVTTATAEFAAPEIVDRE---------PVGFYTDMWAIGVLGYVLLSG 246 (387)
T ss_dssp GEEESSTTCCCEEECCCTTCEECCTTS---CEEEECSSGGGCCHHHHTTC---------CBCHHHHHHHHHHHHHHHHHS
T ss_pred HeEEecCCCCceEEEecccceecCCCc---ceeeeccCCCccCchhccCC---------CCCCcccEeeHhHHHHHHHhC
Confidence 99994 3579999999998764322 22356899999999999764 357899999999999999999
Q ss_pred CCCCCcchhHHHHHHhhcCC-CCcccCCCCCChhHHHHHHHhcccCCCCCCChhHHhcCCCCCCCC
Q 003052 707 RTPFSEYKTFWAKFKVITDP-NHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQHPFLVPPV 771 (853)
Q Consensus 707 ~~PF~~~~~~~~~~kii~~~-~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~HPwf~~~~ 771 (853)
..||.+.........+.... ..........++++++||.+||..||.+|||+.|+|+||||....
T Consensus 247 ~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~ 312 (387)
T 1kob_A 247 LSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDH 312 (387)
T ss_dssp CCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSCC
T ss_pred CCCCCCCCHHHHHHHHHhCCCCCCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCccccCCc
Confidence 99998765543333332221 111222345788999999999999999999999999999998654
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-43 Score=378.00 Aligned_cols=256 Identities=28% Similarity=0.440 Sum_probs=208.4
Q ss_pred ceeeEEEeEeccCceEEEEEEec-CCcEEEEEEEecCCCCh----hhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHH
Q 003052 472 KLYQRLGKIGSGGSSEVHKVISS-DCTIYALKKIKLKGRDY----ATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKAL 546 (853)
Q Consensus 472 ~~Y~ilk~LG~G~FG~Vyka~~~-~g~~vAVKkik~~~~~~----~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~i 546 (853)
+.|++.+.||+|+||.||+|.+. +++.||||++....... .....+.+|+.+|+++. |+||++++++
T Consensus 12 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~------- 83 (321)
T 2a2a_A 12 DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVL-HHNVITLHDV------- 83 (321)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCC-CTTBCCEEEE-------
T ss_pred ccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCC-CCCcceEEEE-------
Confidence 56999999999999999999984 67899999998654322 13456889999999997 8999999987
Q ss_pred HHHHhhCCCCCCCCccccCCeEEEEEecch-hhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCC
Q 003052 547 LREVLNGSMNNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSD 625 (853)
Q Consensus 547 L~~l~~~~iv~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRD 625 (853)
+.+...+|+||||+. ++|.+++... ..+++..++.++.||+.||.|||++||+|||
T Consensus 84 ---------------~~~~~~~~lv~e~~~~~~L~~~l~~~--------~~~~~~~~~~i~~qi~~aL~~lH~~~ivH~d 140 (321)
T 2a2a_A 84 ---------------YENRTDVVLILELVSGGELFDFLAQK--------ESLSEEEATSFIKQILDGVNYLHTKKIAHFD 140 (321)
T ss_dssp ---------------EECSSEEEEEECCCCSCBHHHHHHTC--------SCEEHHHHHHHHHHHHHHHHHHHHTTEECCC
T ss_pred ---------------EecCCEEEEEEEcCCCCcHHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHhCCeecCC
Confidence 456778999999985 6999888643 5689999999999999999999999999999
Q ss_pred CCCccEEee-cC----cEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHH
Q 003052 626 LKPANFLLV-KG----SLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCIL 700 (853)
Q Consensus 626 LKPeNILL~-~g----~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVIL 700 (853)
|||+|||+. ++ .+||+|||+++...... .....+||+.|+|||++.+. .++.++|||||||++
T Consensus 141 ikp~NIl~~~~~~~~~~~kl~Dfg~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~---------~~~~~~Di~slG~il 208 (321)
T 2a2a_A 141 LKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGV---EFKNIFGTPEFVAPEIVNYE---------PLGLEADMWSIGVIT 208 (321)
T ss_dssp CSGGGEEESCTTSSSCCEEECCCTTCEECCTTC---CCCCCCSCGGGCCHHHHTTC---------CCCTHHHHHHHHHHH
T ss_pred CChHHEEEecCCCCcCCEEEccCccceecCccc---cccccCCCCCccCcccccCC---------CCCCccccHHHHHHH
Confidence 999999994 44 69999999998764422 22356899999999999765 356899999999999
Q ss_pred HHHHhCCCCCCcchhHHHHHHhhcCC-CCcccCCCCCChhHHHHHHHhcccCCCCCCChhHHhcCCCCCCC
Q 003052 701 YQMVYGRTPFSEYKTFWAKFKVITDP-NHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQHPFLVPP 770 (853)
Q Consensus 701 yELLtG~~PF~~~~~~~~~~kii~~~-~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~HPwf~~~ 770 (853)
|+|++|..||.+.........+.... ..........+..+.+||.+||..||.+|||+.|+|+||||...
T Consensus 209 ~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~hp~~~~~ 279 (321)
T 2a2a_A 209 YILLSGASPFLGDTKQETLANITSVSYDFDEEFFSHTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPV 279 (321)
T ss_dssp HHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHHHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHHSTTTSCS
T ss_pred HHHHHCCCCCCCCCHHHHHHHHHhcccccChhhhcccCHHHHHHHHHHcCCChhhCcCHHHHhcCccccCC
Confidence 99999999997754433332222211 11111224578889999999999999999999999999999753
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-43 Score=395.92 Aligned_cols=255 Identities=22% Similarity=0.334 Sum_probs=196.0
Q ss_pred eeeEE-EeEeccCceEEEEEEec-CCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHHHH
Q 003052 473 LYQRL-GKIGSGGSSEVHKVISS-DCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLREV 550 (853)
Q Consensus 473 ~Y~il-k~LG~G~FG~Vyka~~~-~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~~l 550 (853)
.|.+. +.||+|+||+||+|.+. +++.||||++... ..+.+|+.++.++.+|+||+++++++..
T Consensus 62 ~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-------~~~~~E~~~~~~~~~hp~iv~l~~~~~~-------- 126 (400)
T 1nxk_A 62 DYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-------PKARREVELHWRASQCPHIVRIVDVYEN-------- 126 (400)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-------HHHHHHHHHHHHHTTSTTBCCEEEEEEE--------
T ss_pred cceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc-------hhHHHHHHHHHHhcCCCCcceEeEEEee--------
Confidence 47776 68999999999999984 6789999999632 2467899999888889999999987431
Q ss_pred hhCCCCCCCCccccCCeEEEEEecch-hhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCCCc
Q 003052 551 LNGSMNNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPA 629 (853)
Q Consensus 551 ~~~~iv~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLKPe 629 (853)
.+.+..++||||||+. ++|.+++... ....+++..++.|+.||+.||.|||++||+||||||+
T Consensus 127 ----------~~~~~~~~~lv~E~~~gg~L~~~l~~~------~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~ 190 (400)
T 1nxk_A 127 ----------LYAGRKCLLIVMECLDGGELFSRIQDR------GDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPE 190 (400)
T ss_dssp ----------EETTEEEEEEEEECCCSEEHHHHHHCC---------CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGG
T ss_pred ----------cccCCcEEEEEEEeCCCCcHHHHHHHh------CCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcc
Confidence 1334678999999986 5999988653 2346999999999999999999999999999999999
Q ss_pred cEEee----cCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHh
Q 003052 630 NFLLV----KGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVY 705 (853)
Q Consensus 630 NILL~----~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLt 705 (853)
||||+ ++.+||+|||+++...... ...+.+||+.|+|||++.+. .|+.++||||||||+|+|++
T Consensus 191 Nill~~~~~~~~~kl~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~---------~~~~~~DiwslG~il~ell~ 258 (400)
T 1nxk_A 191 NLLYTSKRPNAILKLTDFGFAKETTSHN---SLTTPCYTPYYVAPEVLGPE---------KYDKSCDMWSLGVIMYILLC 258 (400)
T ss_dssp GEEESSSSTTCCEEECCCTTCEECC--------------CTTCCGGGSCCC---------CSSSHHHHHHHHHHHHHHHH
T ss_pred eEEEecCCCCccEEEEecccccccCCCC---ccccCCCCCCccCHhhcCCC---------CCCCcccHHHHHHHHHHHHh
Confidence 99995 5689999999998654322 23467999999999999654 36789999999999999999
Q ss_pred CCCCCCcchh------HHHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCCChhHHhcCCCCCCCC
Q 003052 706 GRTPFSEYKT------FWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQHPFLVPPV 771 (853)
Q Consensus 706 G~~PF~~~~~------~~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~HPwf~~~~ 771 (853)
|+.||.+... ....... .............+.++++||.+||..||.+|||+.|+|+||||....
T Consensus 259 g~~pf~~~~~~~~~~~~~~~i~~-~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~ 329 (400)
T 1nxk_A 259 GYPPFYSNHGLAISPGMKTRIRM-GQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQST 329 (400)
T ss_dssp SSCSCCCCTTCSSCCSHHHHHHH-TCCCCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHTTT
T ss_pred CCCCCCCCccccccHHHHHHHHc-CcccCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccCCC
Confidence 9999965432 1111111 111111112245788999999999999999999999999999997543
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-43 Score=421.14 Aligned_cols=256 Identities=22% Similarity=0.306 Sum_probs=214.5
Q ss_pred cCceeeEEEeEeccCceEEEEEEec-CCcEEEEEEEecCCC-ChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHH
Q 003052 470 NGKLYQRLGKIGSGGSSEVHKVISS-DCTIYALKKIKLKGR-DYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALL 547 (853)
Q Consensus 470 ~g~~Y~ilk~LG~G~FG~Vyka~~~-~g~~vAVKkik~~~~-~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL 547 (853)
.-.+|++++.||+|+||.||+|.+. +++.||||++++... .......+.+|+.+|..+.+|++|++++++
T Consensus 339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~-------- 410 (674)
T 3pfq_A 339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSC-------- 410 (674)
T ss_dssp -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEE--------
T ss_pred cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEE--------
Confidence 3456999999999999999999984 678999999985421 122344578999999999889999999876
Q ss_pred HHHhhCCCCCCCCccccCCeEEEEEecch-hhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCC
Q 003052 548 REVLNGSMNNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDL 626 (853)
Q Consensus 548 ~~l~~~~iv~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDL 626 (853)
|++...+||||||+. ++|..++... ..+++..++.|+.||+.||.|||++|||||||
T Consensus 411 --------------~~~~~~~~lV~E~~~gg~L~~~l~~~--------~~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDL 468 (674)
T 3pfq_A 411 --------------FQTMDRLYFVMEYVNGGDLMYHIQQV--------GRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDL 468 (674)
T ss_dssp --------------CBCSSEEEEEEECCCSCBHHHHHHHH--------SSCCHHHHHHHHHHHHHHHHHHHHTSEECCCC
T ss_pred --------------EEeCCEEEEEEeCcCCCcHHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHhCCeEeccC
Confidence 567788999999976 5999988765 56999999999999999999999999999999
Q ss_pred CCccEEe-ecCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHh
Q 003052 627 KPANFLL-VKGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVY 705 (853)
Q Consensus 627 KPeNILL-~~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLt 705 (853)
||+|||| .+|++||+|||+|+....... ...+.+||+.|||||++.+. .|+.++|||||||+||||++
T Consensus 469 Kp~NILl~~~g~ikL~DFGla~~~~~~~~--~~~~~~GT~~Y~APE~l~~~---------~~~~~~DvwSlGvilyellt 537 (674)
T 3pfq_A 469 KLDNVMLDSEGHIKIADFGMCKENIWDGV--TTKTFCGTPDYIAPEIIAYQ---------PYGKSVDWWAFGVLLYEMLA 537 (674)
T ss_dssp CSTTEEECSSSCEEECCCTTCEECCCTTC--CBCCCCSCSSSCCHHHHTCC---------CBSTHHHHHHHHHHHHHHHH
T ss_pred ChhhEEEcCCCcEEEeecceeeccccCCc--ccccccCCCcccCHhhhcCC---------CCCccceEechHHHHHHHHc
Confidence 9999999 567999999999986433222 23478999999999999765 36789999999999999999
Q ss_pred CCCCCCcchhHHHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCh-----hHHhcCCCCCC
Q 003052 706 GRTPFSEYKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRI-----PQLLQHPFLVP 769 (853)
Q Consensus 706 G~~PF~~~~~~~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa-----~EIL~HPwf~~ 769 (853)
|++||.+.+.......++. ....++...++++++||.+||.+||.+|+++ .||++||||..
T Consensus 538 G~~Pf~~~~~~~~~~~i~~---~~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~h~ff~~ 603 (674)
T 3pfq_A 538 GQAPFEGEDEDELFQSIME---HNVAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRY 603 (674)
T ss_dssp SSCSSCCSSHHHHHHHHHS---SCCCCCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHSSGGGSS
T ss_pred CCCCCCCCCHHHHHHHHHh---CCCCCCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhcCccccC
Confidence 9999987655444334433 2345667889999999999999999999998 99999999974
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-43 Score=385.87 Aligned_cols=249 Identities=26% Similarity=0.422 Sum_probs=206.9
Q ss_pred ceeeEEEeEeccCceEEEEEEe-cCCcEEEEEEEecCCCCh------hhHhhHHHHHHHHHHhcCCCceeEeeehhhhHH
Q 003052 472 KLYQRLGKIGSGGSSEVHKVIS-SDCTIYALKKIKLKGRDY------ATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEK 544 (853)
Q Consensus 472 ~~Y~ilk~LG~G~FG~Vyka~~-~~g~~vAVKkik~~~~~~------~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~ 544 (853)
++|++++.||+|+||.||+|.+ .+++.||||+++...... .....+.+|+.+|++++ |+||++++++
T Consensus 24 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~Iv~~~~~----- 97 (335)
T 3dls_A 24 QKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVE-HANIIKVLDI----- 97 (335)
T ss_dssp HHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCC-CTTBCCEEEE-----
T ss_pred cceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCC-CCCEeeEEEE-----
Confidence 5699999999999999999998 577899999998654221 13345778999999996 8999999987
Q ss_pred HHHHHHhhCCCCCCCCccccCCeEEEEEecch-h-hHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCcee
Q 003052 545 ALLREVLNGSMNNKDGRVKDDGYIYMVLEYGE-I-DLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIV 622 (853)
Q Consensus 545 ~iL~~l~~~~iv~~~g~~~d~~~lyLVmEy~~-g-dL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gII 622 (853)
+.+.+.+|+||||++ + +|.+++... ..+++..++.|+.||+.||.|||++||+
T Consensus 98 -----------------~~~~~~~~lv~e~~~~g~~l~~~~~~~--------~~l~~~~~~~i~~qi~~~L~~LH~~~iv 152 (335)
T 3dls_A 98 -----------------FENQGFFQLVMEKHGSGLDLFAFIDRH--------PRLDEPLASYIFRQLVSAVGYLRLKDII 152 (335)
T ss_dssp -----------------EECSSEEEEEEECCTTSCBHHHHHHTC--------CCCCHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred -----------------EeeCCEEEEEEEeCCCCccHHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHhCCeE
Confidence 566788999999864 4 888887643 5799999999999999999999999999
Q ss_pred eCCCCCccEEe-ecCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHH
Q 003052 623 HSDLKPANFLL-VKGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILY 701 (853)
Q Consensus 623 HRDLKPeNILL-~~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILy 701 (853)
||||||+|||+ .++.+||+|||+++...... .....+||+.|+|||++.+.. .++.++|||||||++|
T Consensus 153 H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~--------~~~~~~DiwslG~il~ 221 (335)
T 3dls_A 153 HRDIKDENIVIAEDFTIKLIDFGSAAYLERGK---LFYTFCGTIEYCAPEVLMGNP--------YRGPELEMWSLGVTLY 221 (335)
T ss_dssp CSCCSGGGEEECTTSCEEECCCTTCEECCTTC---CBCEECSCGGGCCHHHHTTCC--------BCSHHHHHHHHHHHHH
T ss_pred EeccCHHHEEEcCCCcEEEeecccceECCCCC---ceeccCCCccccChhhhcCCC--------CCCCcccchhHHHHHH
Confidence 99999999999 46799999999998764432 223578999999999997653 2367899999999999
Q ss_pred HHHhCCCCCCcchhHHHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCCChhHHhcCCCCCCCC
Q 003052 702 QMVYGRTPFSEYKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQHPFLVPPV 771 (853)
Q Consensus 702 ELLtG~~PF~~~~~~~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~HPwf~~~~ 771 (853)
+|++|+.||...... . ......+...++.+.+||.+||..||.+|||+.++|+||||....
T Consensus 222 el~~g~~pf~~~~~~------~---~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~hp~~~~~~ 282 (335)
T 3dls_A 222 TLVFEENPFCELEET------V---EAAIHPPYLVSKELMSLVSGLLQPVPERRTTLEKLVTDPWVTQPV 282 (335)
T ss_dssp HHHHSSCSCSSGGGG------T---TTCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHCTTTTCCC
T ss_pred HHHhCCCchhhHHHH------H---hhccCCCcccCHHHHHHHHHHccCChhhCcCHHHHhcCccccCCc
Confidence 999999999764331 1 112233445788999999999999999999999999999998754
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-43 Score=381.15 Aligned_cols=258 Identities=28% Similarity=0.457 Sum_probs=202.6
Q ss_pred ceeeEEEeEeccCceEEEEEEec-CCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHHHH
Q 003052 472 KLYQRLGKIGSGGSSEVHKVISS-DCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLREV 550 (853)
Q Consensus 472 ~~Y~ilk~LG~G~FG~Vyka~~~-~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~~l 550 (853)
++|++++.||+|+||.||+|.+. +++.||||++............+.+|+.++++++ |+||++++++
T Consensus 25 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~----------- 92 (331)
T 4aaa_A 25 EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLR-HENLVNLLEV----------- 92 (331)
T ss_dssp GGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCC-CTTBCCEEEE-----------
T ss_pred hhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCC-CCCEeeEEEE-----------
Confidence 56999999999999999999985 5789999999877666666667889999999998 8999999987
Q ss_pred hhCCCCCCCCccccCCeEEEEEecchhhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCCCcc
Q 003052 551 LNGSMNNKDGRVKDDGYIYMVLEYGEIDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPAN 630 (853)
Q Consensus 551 ~~~~iv~~~g~~~d~~~lyLVmEy~~gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLKPeN 630 (853)
+.+...+|+||||+++++...+.. ....+++..++.++.||+.||.|||++||+||||||+|
T Consensus 93 -----------~~~~~~~~lv~e~~~~~~l~~~~~-------~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~N 154 (331)
T 4aaa_A 93 -----------CKKKKRWYLVFEFVDHTILDDLEL-------FPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPEN 154 (331)
T ss_dssp -----------EEETTEEEEEEECCSEEHHHHHHH-------STTCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGG
T ss_pred -----------eecCCEEEEEEecCCcchHHHHHh-------hccCCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChhe
Confidence 456778999999988754444432 12569999999999999999999999999999999999
Q ss_pred EEe-ecCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHhCCCC
Q 003052 631 FLL-VKGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGRTP 709 (853)
Q Consensus 631 ILL-~~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLtG~~P 709 (853)
||+ .++.+||+|||+++.+..... .....+||+.|+|||++.+.. .++.++|||||||++|+|++|++|
T Consensus 155 il~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~--------~~~~~~Di~slG~il~~l~~g~~p 224 (331)
T 4aaa_A 155 ILVSQSGVVKLCDFGFARTLAAPGE--VYDDEVATRWYRAPELLVGDV--------KYGKAVDVWAIGCLVTEMFMGEPL 224 (331)
T ss_dssp EEECTTSCEEECCCTTC--------------CCCCCTTCCHHHHTTCT--------TCCTHHHHHHHHHHHHHHHHSSCS
T ss_pred EEEcCCCcEEEEeCCCceeecCCcc--ccCCCcCCccccCcccccCCC--------CcchHHHHHHHHHHHHHHHhCCCC
Confidence 999 567999999999986643222 223568999999999997542 367899999999999999999999
Q ss_pred CCcchhHHHHHHhhc---CC---------------CCc----------ccCCCCCChhHHHHHHHhcccCCCCCCChhHH
Q 003052 710 FSEYKTFWAKFKVIT---DP---------------NHE----------ITYEPVPNPWLLDLMKKCLAWDRNERWRIPQL 761 (853)
Q Consensus 710 F~~~~~~~~~~kii~---~~---------------~~~----------~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EI 761 (853)
|.+.........+.. .. ... ....+..++.+.+||.+||..||.+|||+.|+
T Consensus 225 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~el 304 (331)
T 4aaa_A 225 FPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAEL 304 (331)
T ss_dssp CCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGG
T ss_pred CCCCCcHHHHHHHHHHhCCCChhhhhHhhhccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHH
Confidence 976554333222211 00 000 00113467889999999999999999999999
Q ss_pred hcCCCCCC
Q 003052 762 LQHPFLVP 769 (853)
Q Consensus 762 L~HPwf~~ 769 (853)
|+||||+.
T Consensus 305 l~hp~f~~ 312 (331)
T 4aaa_A 305 LHHDFFQM 312 (331)
T ss_dssp GGSHHHHG
T ss_pred hcCchhcc
Confidence 99999964
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=379.51 Aligned_cols=278 Identities=22% Similarity=0.334 Sum_probs=201.8
Q ss_pred ceeeEEEeEeccCceEEEEEEec-CCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHH--HHHH
Q 003052 472 KLYQRLGKIGSGGSSEVHKVISS-DCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEK--ALLR 548 (853)
Q Consensus 472 ~~Y~ilk~LG~G~FG~Vyka~~~-~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~--~iL~ 548 (853)
++|++++.||+|+||.||+|.+. +++.||||+++.... ......+.+|+++|++++ ||||+++++++.... .+..
T Consensus 6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~~~~~~ 83 (332)
T 3qd2_B 6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNR-ELAREKVMREVKALAKLE-HPGIVRYFNAWLETPPEKWQE 83 (332)
T ss_dssp HHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCST-TTHHHHHHHHHHHHTSCC-CTTBCCEEEEEEECCSCHHHH
T ss_pred hcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCc-hhHHHHHHHHHHHHHhCC-CCCEeeEEEEEEEeccchhhh
Confidence 46999999999999999999985 789999999986543 334567899999999997 999999998753210 0000
Q ss_pred HH---------------------------------hhCCCCCCCCccccCCeEEEEEecchh-hHHHHHHHhhhhccCCC
Q 003052 549 EV---------------------------------LNGSMNNKDGRVKDDGYIYMVLEYGEI-DLAHMLSQKWKEMDGSN 594 (853)
Q Consensus 549 ~l---------------------------------~~~~iv~~~g~~~d~~~lyLVmEy~~g-dL~~~L~~~~k~~~~~~ 594 (853)
++ .....+..........++|+||||+.+ +|.+++.... ..
T Consensus 84 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-----~~ 158 (332)
T 3qd2_B 84 EMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRC-----SL 158 (332)
T ss_dssp HHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCC-----SG
T ss_pred hhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhccc-----Cc
Confidence 00 000111111122445579999999865 8988886531 22
Q ss_pred CCCCHHHHHHHHHHhhhhhhhcccCceeeCCCCCccEEee-cCcEEEEecccchhcccCCcc----------cccccccc
Q 003052 595 QTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLLV-KGSLKLIDFGIAKAIMSDTTN----------IQRDSQVG 663 (853)
Q Consensus 595 ~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLKPeNILL~-~g~VKL~DFGlAk~~~~~~~~----------~~~~t~~G 663 (853)
....+..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||+++........ ......+|
T Consensus 159 ~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~g 238 (332)
T 3qd2_B 159 EDREHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVG 238 (332)
T ss_dssp GGSCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-
T ss_pred cchhhHHHHHHHHHHHHHHHHHHhCCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCC
Confidence 3456778999999999999999999999999999999995 679999999999876543211 12235689
Q ss_pred CccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHhCCCCCCcchhHHHHHHhhcCCCCcccCCCCCChhHHHH
Q 003052 664 TLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGRTPFSEYKTFWAKFKVITDPNHEITYEPVPNPWLLDL 743 (853)
Q Consensus 664 Tp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLtG~~PF~~~~~~~~~~kii~~~~~~~~~~~~~s~~l~dL 743 (853)
|+.|+|||++.+. .|+.++|||||||++|+|++|..|+....... .......... .....++.+.+|
T Consensus 239 t~~y~aPE~~~~~---------~~~~~~Di~slG~il~el~~~~~~~~~~~~~~---~~~~~~~~~~-~~~~~~~~~~~l 305 (332)
T 3qd2_B 239 TKLYMSPEQIHGN---------NYSHKVDIFSLGLILFELLYSFSTQMERVRII---TDVRNLKFPL-LFTQKYPQEHMM 305 (332)
T ss_dssp CGGGSCHHHHHCC---------CCCTHHHHHHHHHHHHHHHSCCCCHHHHHHHH---HHHHTTCCCH-HHHHHCHHHHHH
T ss_pred CcCccChHHhcCC---------CCcchhhHHHHHHHHHHHHHcCCChhHHHHHH---HHhhccCCCc-ccccCChhHHHH
Confidence 9999999999765 35789999999999999999988874432222 2222111111 112345678999
Q ss_pred HHHhcccCCCCCCChhHHhcCCCCCC
Q 003052 744 MKKCLAWDRNERWRIPQLLQHPFLVP 769 (853)
Q Consensus 744 I~kcL~~DP~kRpTa~EIL~HPwf~~ 769 (853)
|.+||..||.+|||+.|+|+||||+.
T Consensus 306 i~~~l~~~p~~Rps~~~~l~~~~f~~ 331 (332)
T 3qd2_B 306 VQDMLSPSPTERPEATDIIENAIFEN 331 (332)
T ss_dssp HHHHHCSSGGGSCCHHHHHHSTTCCC
T ss_pred HHHHccCCCCcCCCHHHHhhchhhhc
Confidence 99999999999999999999999974
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-43 Score=369.60 Aligned_cols=253 Identities=26% Similarity=0.424 Sum_probs=205.1
Q ss_pred ceeeEEEeEeccCceEEEEEEec-CCcEEEEEEEecCCCC-hhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHHH
Q 003052 472 KLYQRLGKIGSGGSSEVHKVISS-DCTIYALKKIKLKGRD-YATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLRE 549 (853)
Q Consensus 472 ~~Y~ilk~LG~G~FG~Vyka~~~-~g~~vAVKkik~~~~~-~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~~ 549 (853)
++|++.+.||+|+||.||+|.+. ++..||||++...... ......+.+|+.++++++ |+||++++++
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~---------- 77 (279)
T 3fdn_A 9 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR-HPNILRLYGY---------- 77 (279)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCC-CTTBCCEEEE----------
T ss_pred ccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCC-CCCCcchhhe----------
Confidence 56999999999999999999984 5678999999754321 222345789999999998 8999999987
Q ss_pred HhhCCCCCCCCccccCCeEEEEEecch-hhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCCC
Q 003052 550 VLNGSMNNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKP 628 (853)
Q Consensus 550 l~~~~iv~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLKP 628 (853)
+.+...+|+||||++ ++|.+.+... ..+++..++.++.||+.||.|||++||+||||||
T Consensus 78 ------------~~~~~~~~lv~e~~~~~~l~~~l~~~--------~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp 137 (279)
T 3fdn_A 78 ------------FHDATRVYLILEYAPLGTVYRELQKL--------SKFDEQRTATYITELANALSYCHSKRVIHRDIKP 137 (279)
T ss_dssp ------------EECSSEEEEEECCCTTEEHHHHHHHH--------SSCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCG
T ss_pred ------------EecCCEEEEEEecCCCCcHHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHhCCEecccCCh
Confidence 456778999999987 5888888664 4699999999999999999999999999999999
Q ss_pred ccEEe-ecCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHhCC
Q 003052 629 ANFLL-VKGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGR 707 (853)
Q Consensus 629 eNILL-~~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLtG~ 707 (853)
+|||+ .++.+||+|||++...... .....+||+.|+|||++.+.. ++.++|||||||++|+|++|.
T Consensus 138 ~Nili~~~~~~~l~Dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~---------~~~~~Di~slG~il~~l~~g~ 204 (279)
T 3fdn_A 138 ENLLLGSAGELKIADFGWSVHAPSS----RRTDLCGTLDYLPPEMIEGRM---------HDEKVDLWSLGVLCYEFLVGK 204 (279)
T ss_dssp GGEEECTTSCEEECSCCEESCC------------CCCCTTCCHHHHTTCC---------CCTTHHHHHHHHHHHHHHHSS
T ss_pred HhEEEcCCCCEEEEeccccccCCcc----cccccCCCCCccCHhHhccCC---------CCccchhHhHHHHHHHHHHCC
Confidence 99999 5679999999998654332 223568999999999997653 567999999999999999999
Q ss_pred CCCCcchhHHHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCCChhHHhcCCCCCCCC
Q 003052 708 TPFSEYKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQHPFLVPPV 771 (853)
Q Consensus 708 ~PF~~~~~~~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~HPwf~~~~ 771 (853)
.||...........+.. ....++...+..+.+||.+||..||.+||++.|+|+||||....
T Consensus 205 ~p~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h~~~~~~~ 265 (279)
T 3fdn_A 205 PPFEANTYQETYKRISR---VEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITANS 265 (279)
T ss_dssp CTTCCSSHHHHHHHHHH---TCCCCCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHCHHHHHHC
T ss_pred CCCCCCcHHHHHHHHHh---CCCCCCCcCCHHHHHHHHHHhccChhhCCCHHHHhhCccccCCc
Confidence 99986544332222221 22345566788999999999999999999999999999997543
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-43 Score=386.96 Aligned_cols=259 Identities=27% Similarity=0.426 Sum_probs=204.4
Q ss_pred ceeeEEEeEeccCceEEEEEEe-cCCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHHHH
Q 003052 472 KLYQRLGKIGSGGSSEVHKVIS-SDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLREV 550 (853)
Q Consensus 472 ~~Y~ilk~LG~G~FG~Vyka~~-~~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~~l 550 (853)
++|.+.+.||+|+||.||+|.+ .+++.||||++............+.+|+.++++++ |+||+++++++....
T Consensus 42 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~------ 114 (371)
T 4exu_A 42 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQ-HENVIGLLDVFTPAS------ 114 (371)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCC-CTTBCCCSEEECSCS------
T ss_pred ccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcC-CCCchhhhhheeccC------
Confidence 5699999999999999999998 46789999999876666666678899999999998 999999999753211
Q ss_pred hhCCCCCCCCccccCCeEEEEEecchhhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCCCcc
Q 003052 551 LNGSMNNKDGRVKDDGYIYMVLEYGEIDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPAN 630 (853)
Q Consensus 551 ~~~~iv~~~g~~~d~~~lyLVmEy~~gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLKPeN 630 (853)
.......+|+||||++++|.+.+. ..+++..++.++.||+.||.|||++||+||||||+|
T Consensus 115 ----------~~~~~~~~~lv~e~~~~~l~~~~~----------~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~N 174 (371)
T 4exu_A 115 ----------SLRNFYDFYLVMPFMQTDLQKIMG----------MEFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGN 174 (371)
T ss_dssp ----------SSTTCCCCEEEEECCCEEHHHHTT----------SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGG
T ss_pred ----------CcccceeEEEEEccccccHHHHhh----------cCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHH
Confidence 112222459999999998877653 359999999999999999999999999999999999
Q ss_pred EEee-cCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHhCCCC
Q 003052 631 FLLV-KGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGRTP 709 (853)
Q Consensus 631 ILL~-~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLtG~~P 709 (853)
||++ ++.+||+|||+++..... ....+||+.|+|||++.+.. .++.++|||||||++|+|++|+.|
T Consensus 175 Ill~~~~~~kL~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~--------~~~~~~DiwslG~il~el~~g~~p 241 (371)
T 4exu_A 175 LAVNEDCELKILDFGLARHADAE-----MTGYVVTRWYRAPEVILSWM--------HYNQTVDIWSVGCIMAEMLTGKTL 241 (371)
T ss_dssp EEECTTCCEEECSTTCC-------------CTTCCCTTSCHHHHSCCS--------CCCTTHHHHHHHHHHHHHHHSSCS
T ss_pred eEECCCCCEEEEecCcccccccC-----cCCcccCccccCHHHhcCCC--------CCCcHHhHHHHHHHHHHHHhCCCC
Confidence 9995 679999999999865432 23568999999999997532 367899999999999999999999
Q ss_pred CCcchhHHHHHHhh---cCCCC-------------------------cccCCCCCChhHHHHHHHhcccCCCCCCChhHH
Q 003052 710 FSEYKTFWAKFKVI---TDPNH-------------------------EITYEPVPNPWLLDLMKKCLAWDRNERWRIPQL 761 (853)
Q Consensus 710 F~~~~~~~~~~kii---~~~~~-------------------------~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EI 761 (853)
|.+.........++ ..+.. ........++.+.+||.+||.+||.+|||+.|+
T Consensus 242 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~el 321 (371)
T 4exu_A 242 FKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQA 321 (371)
T ss_dssp CCCSSHHHHHHHHHHHHCCCCHHHHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHH
T ss_pred CCCCChHHHHHHHHHHhCCCcHHHHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHH
Confidence 97654332222211 11100 001124568889999999999999999999999
Q ss_pred hcCCCCCCC
Q 003052 762 LQHPFLVPP 770 (853)
Q Consensus 762 L~HPwf~~~ 770 (853)
|+||||...
T Consensus 322 l~hp~f~~~ 330 (371)
T 4exu_A 322 LTHPFFEPF 330 (371)
T ss_dssp HTSGGGTTT
T ss_pred hcCcccccC
Confidence 999999854
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-43 Score=379.36 Aligned_cols=265 Identities=28% Similarity=0.448 Sum_probs=208.2
Q ss_pred CceeeEEEeEeccCceEEEEEEec-CCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHHH
Q 003052 471 GKLYQRLGKIGSGGSSEVHKVISS-DCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLRE 549 (853)
Q Consensus 471 g~~Y~ilk~LG~G~FG~Vyka~~~-~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~~ 549 (853)
.+.|++.+.||+|+||.||+|.+. +++.||||++.... .......+.+|+.+|++++ |+||+++++++..
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~------- 80 (353)
T 2b9h_A 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFD-KPLFALRTLREIKILKHFK-HENIITIFNIQRP------- 80 (353)
T ss_dssp CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCS-SHHHHHHHHHHHHHHHHCC-CTTBCCEEEECCC-------
T ss_pred ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccc-cchHHHHHHHHHHHHHhCc-CCCcCCeeeeecc-------
Confidence 467999999999999999999984 67899999996432 3344556889999999997 9999999987432
Q ss_pred HhhCCCCCCCCccccCCeEEEEEecchhhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCCCc
Q 003052 550 VLNGSMNNKDGRVKDDGYIYMVLEYGEIDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPA 629 (853)
Q Consensus 550 l~~~~iv~~~g~~~d~~~lyLVmEy~~gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLKPe 629 (853)
..+.....+|+||||++++|.+++.. ..+++..++.++.||+.||.|||++||+||||||+
T Consensus 81 ----------~~~~~~~~~~lv~e~~~~~L~~~~~~---------~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~ 141 (353)
T 2b9h_A 81 ----------DSFENFNEVYIIQELMQTDLHRVIST---------QMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPS 141 (353)
T ss_dssp ----------SCSTTCCCEEEEECCCSEEHHHHHHH---------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGG
T ss_pred ----------cccCccceEEEEEeccCccHHHHHhh---------cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHH
Confidence 22455678999999999999888764 36999999999999999999999999999999999
Q ss_pred cEEe-ecCcEEEEecccchhcccCCccc--------cccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHH
Q 003052 630 NFLL-VKGSLKLIDFGIAKAIMSDTTNI--------QRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCIL 700 (853)
Q Consensus 630 NILL-~~g~VKL~DFGlAk~~~~~~~~~--------~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVIL 700 (853)
|||+ .++.+||+|||+++.+....... .....+||+.|+|||++.+.. .++.++|||||||++
T Consensus 142 Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--------~~~~~~Di~slG~il 213 (353)
T 2b9h_A 142 NLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSA--------KYSRAMDVWSCGCIL 213 (353)
T ss_dssp GEEECTTCCEEECCCTTCEECC----------------CCCCCCGGGCCHHHHHSCC--------CCCHHHHHHHHHHHH
T ss_pred HeEEcCCCcEEEEecccccccccccccccCccccccchhhccccccccCCeeeccCC--------CccchhhHHHHHHHH
Confidence 9999 46799999999998654321110 122468999999999986532 367899999999999
Q ss_pred HHHHhCCCCCCcchhHHHH---HHhhcCCCCc--------------------------ccCCCCCChhHHHHHHHhcccC
Q 003052 701 YQMVYGRTPFSEYKTFWAK---FKVITDPNHE--------------------------ITYEPVPNPWLLDLMKKCLAWD 751 (853)
Q Consensus 701 yELLtG~~PF~~~~~~~~~---~kii~~~~~~--------------------------~~~~~~~s~~l~dLI~kcL~~D 751 (853)
|+|++|++||.+....... ......+... .......++++.+||.+||..|
T Consensus 214 ~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~d 293 (353)
T 2b9h_A 214 AELFLRRPIFPGRDYRHQLLLIFGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFD 293 (353)
T ss_dssp HHHHHSSCSCCCSSHHHHHHHHHHHHCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSS
T ss_pred HHHHhCCCCCCCCCcHHHHHHHHHHhCCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcC
Confidence 9999999999765432221 2211111100 0112356788999999999999
Q ss_pred CCCCCChhHHhcCCCCCCCC
Q 003052 752 RNERWRIPQLLQHPFLVPPV 771 (853)
Q Consensus 752 P~kRpTa~EIL~HPwf~~~~ 771 (853)
|.+|||+.|+|+||||....
T Consensus 294 P~~Rpt~~ell~hp~~~~~~ 313 (353)
T 2b9h_A 294 PAKRITAKEALEHPYLQTYH 313 (353)
T ss_dssp GGGSCCHHHHHTSGGGTTTC
T ss_pred cccCCCHHHHhcCccccccC
Confidence 99999999999999997643
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-43 Score=382.77 Aligned_cols=270 Identities=26% Similarity=0.386 Sum_probs=206.7
Q ss_pred ceeeEEEeEeccCceEEEEEEe-cCCcEEEEEEEecCC---CChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHH
Q 003052 472 KLYQRLGKIGSGGSSEVHKVIS-SDCTIYALKKIKLKG---RDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALL 547 (853)
Q Consensus 472 ~~Y~ilk~LG~G~FG~Vyka~~-~~g~~vAVKkik~~~---~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL 547 (853)
++|++.+.||+|+||.||+|.+ .++..||+|++.... ........+.+|+++|++++ ||||++++++
T Consensus 26 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~-------- 96 (345)
T 3hko_A 26 KKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLH-HPNIARLYEV-------- 96 (345)
T ss_dssp HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCC-CTTBCCEEEE--------
T ss_pred hheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCC-CCCcceeehh--------
Confidence 5699999999999999999998 567899999997542 12344567889999999997 9999999987
Q ss_pred HHHhhCCCCCCCCccccCCeEEEEEecch-hhHHHHHHHhhhh--------------------------------ccCCC
Q 003052 548 REVLNGSMNNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKE--------------------------------MDGSN 594 (853)
Q Consensus 548 ~~l~~~~iv~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~--------------------------------~~~~~ 594 (853)
+.+...+|+||||+. ++|.+++...... .....
T Consensus 97 --------------~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (345)
T 3hko_A 97 --------------YEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLD 162 (345)
T ss_dssp --------------EECSSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECC
T ss_pred --------------hccCCeEEEEEeCCCCCcHHHHHHHhhccccccccccccccccccccccccccccccccccccccc
Confidence 456778999999975 6898887522110 00012
Q ss_pred CCCCHHHHHHHHHHhhhhhhhcccCceeeCCCCCccEEee-cC--cEEEEecccchhcccCCc--cccccccccCccccC
Q 003052 595 QTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLLV-KG--SLKLIDFGIAKAIMSDTT--NIQRDSQVGTLSYMS 669 (853)
Q Consensus 595 ~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLKPeNILL~-~g--~VKL~DFGlAk~~~~~~~--~~~~~t~~GTp~YmA 669 (853)
..+++..++.++.||+.||.|||++||+||||||+|||++ ++ .+||+|||+++.+..... .......+||+.|+|
T Consensus 163 ~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~a 242 (345)
T 3hko_A 163 FVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVA 242 (345)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCC
T ss_pred ccccHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccC
Confidence 2357888999999999999999999999999999999995 34 799999999986543221 112346789999999
Q ss_pred chhhccCCCCCCCccccCCCccchhhhHHHHHHHHhCCCCCCcchhHHHHHHhhcCCC-CcccCCCCCChhHHHHHHHhc
Q 003052 670 PEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGRTPFSEYKTFWAKFKVITDPN-HEITYEPVPNPWLLDLMKKCL 748 (853)
Q Consensus 670 PEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLtG~~PF~~~~~~~~~~kii~~~~-~~~~~~~~~s~~l~dLI~kcL 748 (853)
||++.+.. ..|+.++|||||||++|+|++|+.||.+.........+..... .........++.+.+||.+||
T Consensus 243 PE~~~~~~-------~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l 315 (345)
T 3hko_A 243 PEVLNTTN-------ESYGPKCDAWSAGVLLHLLLMGAVPFPGVNDADTISQVLNKKLCFENPNYNVLSPLARDLLSNLL 315 (345)
T ss_dssp HHHHTCSS-------SCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCTTSGGGGGSCHHHHHHHHHHS
T ss_pred chhhccCC-------CCCCcHHHHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHhcccccCCcccccCCHHHHHHHHHHc
Confidence 99996532 1467899999999999999999999987655544444433211 111122246788999999999
Q ss_pred ccCCCCCCChhHHhcCCCCCCCC
Q 003052 749 AWDRNERWRIPQLLQHPFLVPPV 771 (853)
Q Consensus 749 ~~DP~kRpTa~EIL~HPwf~~~~ 771 (853)
..||.+||++.++|+||||....
T Consensus 316 ~~~p~~Rps~~~~l~hp~~~~~~ 338 (345)
T 3hko_A 316 NRNVDERFDAMRALQHPWISQFS 338 (345)
T ss_dssp CSCTTTSCCHHHHHHSHHHHTTS
T ss_pred CCChhHCCCHHHHhcChhhccCh
Confidence 99999999999999999997653
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-43 Score=382.48 Aligned_cols=263 Identities=25% Similarity=0.395 Sum_probs=200.8
Q ss_pred ceeeEEEeEeccCceEEEEEEecCCcEEEEEEEecCCCC---------hhhHhhHHHHHHHHHHhcCCCceeEeeehhhh
Q 003052 472 KLYQRLGKIGSGGSSEVHKVISSDCTIYALKKIKLKGRD---------YATAYGFCQEIEYLNKLKGKNNIIQLIDYEVT 542 (853)
Q Consensus 472 ~~Y~ilk~LG~G~FG~Vyka~~~~g~~vAVKkik~~~~~---------~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~ 542 (853)
..|++.+.||+|+||.||+|.+.++..||||++...... ......+.+|+++|++++ |+||+++++++..
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~ 100 (362)
T 3pg1_A 22 SPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFH-HPNILGLRDIFVH 100 (362)
T ss_dssp CSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCC-CTTBCCCSEEEEE
T ss_pred cceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCC-CcCccceeeeEEe
Confidence 459999999999999999999988999999999654332 222367889999999997 9999999987532
Q ss_pred HHHHHHHHhhCCCCCCCCccccCCeEEEEEecchhhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCcee
Q 003052 543 EKALLREVLNGSMNNKDGRVKDDGYIYMVLEYGEIDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIV 622 (853)
Q Consensus 543 e~~iL~~l~~~~iv~~~g~~~d~~~lyLVmEy~~gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gII 622 (853)
. .......+|+||||++++|.+.+... ...+++..++.++.||+.||.|||++||+
T Consensus 101 ~-----------------~~~~~~~~~lv~e~~~~~l~~~~~~~-------~~~~~~~~~~~~~~qi~~~l~~lH~~~iv 156 (362)
T 3pg1_A 101 F-----------------EEPAMHKLYLVTELMRTDLAQVIHDQ-------RIVISPQHIQYFMYHILLGLHVLHEAGVV 156 (362)
T ss_dssp C-----------------CTTTCCEEEEEEECCSEEHHHHHHCT-------TSCCCHHHHHHHHHHHHHHHHHHHHTTCC
T ss_pred c-----------------cCCCcceEEEEEccCCCCHHHHHHhc-------ccCCCHHHHHHHHHHHHHHHHHHHHCcCE
Confidence 1 01344579999999999999888642 35799999999999999999999999999
Q ss_pred eCCCCCccEEee-cCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHH
Q 003052 623 HSDLKPANFLLV-KGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILY 701 (853)
Q Consensus 623 HRDLKPeNILL~-~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILy 701 (853)
||||||+|||++ ++.+||+|||+++...... .....+||+.|+|||++.+.. .++.++|||||||++|
T Consensus 157 H~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~--------~~~~~~DiwslG~il~ 225 (362)
T 3pg1_A 157 HRDLHPGNILLADNNDITICDFNLAREDTADA---NKTHYVTHRWYRAPELVMQFK--------GFTKLVDMWSAGCVMA 225 (362)
T ss_dssp CCCCCGGGEEECTTCCEEECCTTC------------------CGGGCCHHHHTTCT--------TCCTHHHHHHHHHHHH
T ss_pred ecCCChHHEEEcCCCCEEEEecCccccccccc---ccceecccceecCcHHhcCCC--------CCCcHhHHHhHHHHHH
Confidence 999999999994 6799999999998554322 223568999999999987532 3678999999999999
Q ss_pred HHHhCCCCCCcchhHHHHHHh---hcCCC--------------------Cc------ccCCCCCChhHHHHHHHhcccCC
Q 003052 702 QMVYGRTPFSEYKTFWAKFKV---ITDPN--------------------HE------ITYEPVPNPWLLDLMKKCLAWDR 752 (853)
Q Consensus 702 ELLtG~~PF~~~~~~~~~~ki---i~~~~--------------------~~------~~~~~~~s~~l~dLI~kcL~~DP 752 (853)
+|++|+.||.+.........+ ...+. .. .......++.+.+||.+||.+||
T Consensus 226 ~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP 305 (362)
T 3pg1_A 226 EMFNRKALFRGSTFYNQLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNP 305 (362)
T ss_dssp HHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSG
T ss_pred HHHhCCCCCCCCCHHHHHHHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCCh
Confidence 999999999765433222111 11100 00 01123457789999999999999
Q ss_pred CCCCChhHHhcCCCCCCC
Q 003052 753 NERWRIPQLLQHPFLVPP 770 (853)
Q Consensus 753 ~kRpTa~EIL~HPwf~~~ 770 (853)
.+|||+.|+|+||||...
T Consensus 306 ~~Rpt~~ell~hp~f~~~ 323 (362)
T 3pg1_A 306 QRRISTEQALRHPYFESL 323 (362)
T ss_dssp GGSCCHHHHHTSGGGTTT
T ss_pred hhCCCHHHHHcCchhhhc
Confidence 999999999999999864
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-42 Score=366.08 Aligned_cols=263 Identities=30% Similarity=0.471 Sum_probs=211.9
Q ss_pred ceeeEEEeEeccCceEEEEEEec-CCcEEEEEEEecCCCC-------hhhHhhHHHHHHHHHHhcCCCceeEeeehhhhH
Q 003052 472 KLYQRLGKIGSGGSSEVHKVISS-DCTIYALKKIKLKGRD-------YATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTE 543 (853)
Q Consensus 472 ~~Y~ilk~LG~G~FG~Vyka~~~-~g~~vAVKkik~~~~~-------~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e 543 (853)
++|++.+.||+|+||.||+|.+. +++.||||++...... ......+.+|+.+|+++.+|+||++++++
T Consensus 17 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~---- 92 (298)
T 1phk_A 17 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDT---- 92 (298)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEE----
T ss_pred hccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeee----
Confidence 56999999999999999999984 6789999999765421 12345678999999999889999999987
Q ss_pred HHHHHHHhhCCCCCCCCccccCCeEEEEEecch-hhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCcee
Q 003052 544 KALLREVLNGSMNNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIV 622 (853)
Q Consensus 544 ~~iL~~l~~~~iv~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gII 622 (853)
+.+...+|+||||++ ++|.+++... ..+++..++.++.||+.||.|||++||+
T Consensus 93 ------------------~~~~~~~~lv~e~~~~~~L~~~l~~~--------~~~~~~~~~~~~~qi~~~l~~lH~~~i~ 146 (298)
T 1phk_A 93 ------------------YETNTFFFLVFDLMKKGELFDYLTEK--------VTLSEKETRKIMRALLEVICALHKLNIV 146 (298)
T ss_dssp ------------------EECSSEEEEEEECCTTCBHHHHHHHH--------SSCCHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred ------------------eccCCeEEEEEeccCCCcHHHHHhcc--------CCCCHHHHHHHHHHHHHHHHHHHHCCcc
Confidence 456778999999986 5999988764 5699999999999999999999999999
Q ss_pred eCCCCCccEEe-ecCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHH
Q 003052 623 HSDLKPANFLL-VKGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILY 701 (853)
Q Consensus 623 HRDLKPeNILL-~~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILy 701 (853)
||||||+|||+ .++.+||+|||++....... .....+||+.|+|||++.+.... ....++.++|||||||++|
T Consensus 147 H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~---~~~~~~~~~Di~slG~~l~ 220 (298)
T 1phk_A 147 HRDLKPENILLDDDMNIKLTDFGFSCQLDPGE---KLREVCGTPSYLAPEIIECSMND---NHPGYGKEVDMWSTGVIMY 220 (298)
T ss_dssp CSCCSGGGEEECTTCCEEECCCTTCEECCTTC---CBCCCCSCGGGCCHHHHHHHHCT---TSCCBCTHHHHHHHHHHHH
T ss_pred cCCCCcceEEEcCCCcEEEecccchhhcCCCc---ccccccCCccccCHHHhcccccc---ccccCCcccccHhHHHHHH
Confidence 99999999999 46799999999998764322 22356899999999998643111 0124678999999999999
Q ss_pred HHHhCCCCCCcchhHHHHHHhhcCCCCccc--CCCCCChhHHHHHHHhcccCCCCCCChhHHhcCCCCCCCC
Q 003052 702 QMVYGRTPFSEYKTFWAKFKVITDPNHEIT--YEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQHPFLVPPV 771 (853)
Q Consensus 702 ELLtG~~PF~~~~~~~~~~kii~~~~~~~~--~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~HPwf~~~~ 771 (853)
+|++|+.||...........+... ..... .....+..+.+||.+||..||.+||++.++|+||||....
T Consensus 221 ~l~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~ 291 (298)
T 1phk_A 221 TLLAGSPPFWHRKQMLMLRMIMSG-NYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQYV 291 (298)
T ss_dssp HHHHSSCSSCCSSHHHHHHHHHHT-CCCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCTTC
T ss_pred HHHHCCCCCcCccHHHHHHHHhcC-CcccCcccccccCHHHHHHHHHHccCCcccCCCHHHHHhChHhhhcc
Confidence 999999999775544333222221 11211 1234678899999999999999999999999999998654
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-43 Score=375.52 Aligned_cols=255 Identities=29% Similarity=0.434 Sum_probs=200.3
Q ss_pred cCceeeEEEeEeccCceEEEEEEe-cCCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHH
Q 003052 470 NGKLYQRLGKIGSGGSSEVHKVIS-SDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLR 548 (853)
Q Consensus 470 ~g~~Y~ilk~LG~G~FG~Vyka~~-~~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~ 548 (853)
+.++|+++++||+|+||.||+|.+ .+++.||||+++... ...+.+|+.+|+++.+|+||+++++++..
T Consensus 34 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~E~~~l~~l~~~~~i~~~~~~~~~------ 102 (330)
T 3nsz_A 34 NQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK-----KKKIKREIKILENLRGGPNIITLADIVKD------ 102 (330)
T ss_dssp EGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCC-----HHHHHHHHHHHHHHTTSTTBCCEEEEEEC------
T ss_pred CCCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccc-----hHHHHHHHHHHHHcCCCCCEEEeeeeecc------
Confidence 346799999999999999999998 577899999997432 34578999999999999999999987421
Q ss_pred HHhhCCCCCCCCccccCCeEEEEEecch-hhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCC
Q 003052 549 EVLNGSMNNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLK 627 (853)
Q Consensus 549 ~l~~~~iv~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLK 627 (853)
.....+|+||||++ ++|.+++. .+++..++.++.||+.||.|||++||+|||||
T Consensus 103 --------------~~~~~~~lv~e~~~~~~l~~~~~-----------~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dik 157 (330)
T 3nsz_A 103 --------------PVSRTPALVFEHVNNTDFKQLYQ-----------TLTDYDIRFYMYEILKALDYCHSMGIMHRDVK 157 (330)
T ss_dssp --------------TTTCCEEEEEECCCCCCHHHHGG-----------GCCHHHHHHHHHHHHHHHHHHHHTTEECCCCS
T ss_pred --------------CCCCceEEEEeccCchhHHHHHH-----------hCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCC
Confidence 12567899999976 46666552 38999999999999999999999999999999
Q ss_pred CccEEee-cC-cEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHh
Q 003052 628 PANFLLV-KG-SLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVY 705 (853)
Q Consensus 628 PeNILL~-~g-~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLt 705 (853)
|+|||++ ++ .+||+|||+|+.+..... ....+||+.|+|||++.+.. .|+.++|||||||++|+|++
T Consensus 158 p~Nil~~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~~~~~y~aPE~~~~~~--------~~~~~~DiwslG~il~~ll~ 226 (330)
T 3nsz_A 158 PHNVMIDHEHRKLRLIDWGLAEFYHPGQE---YNVRVASRYFKGPELLVDYQ--------MYDYSLDMWSLGCMLASMIF 226 (330)
T ss_dssp GGGEEEETTTTEEEECCCTTCEECCTTCC---CCSCCSCGGGCCHHHHTTCC--------CCCTHHHHHHHHHHHHHHHH
T ss_pred HHHEEEcCCCCEEEEEeCCCceEcCCCCc---cccccccccccChhhhcCCC--------cCCchhhHHHHHHHHHHHHh
Confidence 9999996 55 899999999986643322 23568999999999996532 36789999999999999999
Q ss_pred CCCCCCcchhH-HHH---HHh---------hcCCCC----------------------cccCCCCCChhHHHHHHHhccc
Q 003052 706 GRTPFSEYKTF-WAK---FKV---------ITDPNH----------------------EITYEPVPNPWLLDLMKKCLAW 750 (853)
Q Consensus 706 G~~PF~~~~~~-~~~---~ki---------i~~~~~----------------------~~~~~~~~s~~l~dLI~kcL~~ 750 (853)
|+.||...... ... ... +..... ........++.+.+||.+||.+
T Consensus 227 g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~ 306 (330)
T 3nsz_A 227 RKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRY 306 (330)
T ss_dssp TCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCS
T ss_pred CCCCcccCCchHHHHHHHHHhcCCchhhhHHHHhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcC
Confidence 99999432111 110 000 000000 0001122678899999999999
Q ss_pred CCCCCCChhHHhcCCCCCCCC
Q 003052 751 DRNERWRIPQLLQHPFLVPPV 771 (853)
Q Consensus 751 DP~kRpTa~EIL~HPwf~~~~ 771 (853)
||.+|||+.|+|+||||+...
T Consensus 307 dP~~Rpta~e~l~hp~f~~~~ 327 (330)
T 3nsz_A 307 DHQSRLTAREAMEHPYFYTVV 327 (330)
T ss_dssp SGGGSCCHHHHHTSGGGTTCC
T ss_pred CcccCCCHHHHhcCccHhhhc
Confidence 999999999999999998643
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=364.86 Aligned_cols=253 Identities=28% Similarity=0.376 Sum_probs=207.0
Q ss_pred ceeeEEEeEeccCceEEEEEEec-CCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHHHH
Q 003052 472 KLYQRLGKIGSGGSSEVHKVISS-DCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLREV 550 (853)
Q Consensus 472 ~~Y~ilk~LG~G~FG~Vyka~~~-~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~~l 550 (853)
++|++.+.||+|+||.||+|.+. ++..||+|++...... ....+.+|+++|++++ |+||++++++
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~--~~~~~~~E~~~l~~l~-h~~i~~~~~~----------- 74 (277)
T 3f3z_A 9 QYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVE--DVDRFKQEIEIMKSLD-HPNIIRLYET----------- 74 (277)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCS--CHHHHHHHHHHHHTCC-CTTBCCEEEE-----------
T ss_pred hhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccc--hHHHHHHHHHHHHhCC-CCCEeeEEEE-----------
Confidence 56999999999999999999985 5678999999765432 2456889999999996 8999999987
Q ss_pred hhCCCCCCCCccccCCeEEEEEecch-hhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCCCc
Q 003052 551 LNGSMNNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPA 629 (853)
Q Consensus 551 ~~~~iv~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLKPe 629 (853)
+.+...+|+||||+. ++|.+++... ..+++..++.++.||+.||.|||++||+||||||+
T Consensus 75 -----------~~~~~~~~lv~e~~~~~~L~~~~~~~--------~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~ 135 (277)
T 3f3z_A 75 -----------FEDNTDIYLVMELCTGGELFERVVHK--------RVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPE 135 (277)
T ss_dssp -----------EECSSEEEEEEECCCSCBHHHHHHHH--------CSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGG
T ss_pred -----------EecCCeEEEEEeccCCCcHHHHHHHc--------CCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHH
Confidence 456778999999985 5888888654 56999999999999999999999999999999999
Q ss_pred cEEe---e-cCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHh
Q 003052 630 NFLL---V-KGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVY 705 (853)
Q Consensus 630 NILL---~-~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLt 705 (853)
|||+ + ++.+||+|||++..+.... .....+||+.|+|||++.+. ++.++|||||||++|+|++
T Consensus 136 Nil~~~~~~~~~~~l~Dfg~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~----------~~~~~Di~slG~~l~~l~~ 202 (277)
T 3f3z_A 136 NFLFLTDSPDSPLKLIDFGLAARFKPGK---MMRTKVGTPYYVSPQVLEGL----------YGPECDEWSAGVMMYVLLC 202 (277)
T ss_dssp GEEESSSSTTCCEEECCCTTCEECCTTS---CBCCCCSCTTTCCHHHHTTC----------BCTTHHHHHHHHHHHHHHH
T ss_pred HEEEecCCCCCcEEEEecccceeccCcc---chhccCCCCCccChHHhccc----------CCchhhehhHHHHHHHHHH
Confidence 9999 3 4589999999998764332 22466899999999998642 5789999999999999999
Q ss_pred CCCCCCcchhHHHHHHhhcCCCC-cccCCCCCChhHHHHHHHhcccCCCCCCChhHHhcCCCCCCC
Q 003052 706 GRTPFSEYKTFWAKFKVITDPNH-EITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQHPFLVPP 770 (853)
Q Consensus 706 G~~PF~~~~~~~~~~kii~~~~~-~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~HPwf~~~ 770 (853)
|+.||...........+...... ........++.+.+||.+||..||.+||++.++|+||||...
T Consensus 203 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~~ 268 (277)
T 3f3z_A 203 GYPPFSAPTDSEVMLKIREGTFTFPEKDWLNVSPQAESLIRRLLTKSPKQRITSLQALEHEWFEKQ 268 (277)
T ss_dssp SSCSSCCSSHHHHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHHH
T ss_pred CCCCCCCCCHHHHHHHHHhCCCCCCchhhhcCCHHHHHHHHHHccCChhhCcCHHHHhcCHHHhcc
Confidence 99999876554433333322111 111112568889999999999999999999999999999753
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-43 Score=385.93 Aligned_cols=260 Identities=24% Similarity=0.380 Sum_probs=208.2
Q ss_pred cCceeeEEEeEeccCceEEEEEEe----cCCcEEEEEEEecCCC--ChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhH
Q 003052 470 NGKLYQRLGKIGSGGSSEVHKVIS----SDCTIYALKKIKLKGR--DYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTE 543 (853)
Q Consensus 470 ~g~~Y~ilk~LG~G~FG~Vyka~~----~~g~~vAVKkik~~~~--~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e 543 (853)
..+.|++++.||+|+||.||+|.+ .+++.||||+++.... .......+.+|+++|+++.+|+||++++++
T Consensus 52 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~---- 127 (355)
T 1vzo_A 52 GIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYA---- 127 (355)
T ss_dssp CGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEE----
T ss_pred cccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEE----
Confidence 346799999999999999999998 3678999999975421 112334567899999999889999999876
Q ss_pred HHHHHHHhhCCCCCCCCccccCCeEEEEEecch-hhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCcee
Q 003052 544 KALLREVLNGSMNNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIV 622 (853)
Q Consensus 544 ~~iL~~l~~~~iv~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gII 622 (853)
+.+...+|+||||+. ++|.+++... ..+++..++.++.||+.||.|||++||+
T Consensus 128 ------------------~~~~~~~~lv~e~~~~~~L~~~l~~~--------~~~~~~~~~~~~~qi~~aL~~LH~~~iv 181 (355)
T 1vzo_A 128 ------------------FQTETKLHLILDYINGGELFTHLSQR--------ERFTEHEVQIYVGEIVLALEHLHKLGII 181 (355)
T ss_dssp ------------------EEETTEEEEEECCCCSCBHHHHHHHH--------SCCCHHHHHHHHHHHHHHHHHHHHTTCC
T ss_pred ------------------EeeCceEEEEeecCCCCCHHHHHHHc--------CCCCHHHHHHHHHHHHHHHHHHHHCCcc
Confidence 456678999999986 5999988764 4699999999999999999999999999
Q ss_pred eCCCCCccEEe-ecCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHH
Q 003052 623 HSDLKPANFLL-VKGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILY 701 (853)
Q Consensus 623 HRDLKPeNILL-~~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILy 701 (853)
||||||+|||| .++.+||+|||+++.+..... ......+||+.|+|||++.+... .++.++|||||||++|
T Consensus 182 H~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~-------~~~~~~DvwslG~il~ 253 (355)
T 1vzo_A 182 YRDIKLENILLDSNGHVVLTDFGLSKEFVADET-ERAYDFCGTIEYMAPDIVRGGDS-------GHDKAVDWWSLGVLMY 253 (355)
T ss_dssp CCCCCGGGEEECTTSCEEESCSSEEEECCGGGG-GGGCGGGSCCTTCCHHHHTTCC----------CTHHHHHHHHHHHH
T ss_pred cCCCCHHHEEECCCCcEEEeeCCCCeecccCCC-CcccCcccCcCccChhhhcCCCC-------CCCchhhHHHHHHHHH
Confidence 99999999999 567999999999986643222 12345789999999999975321 3678999999999999
Q ss_pred HHHhCCCCCCcc---hhHHHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCC-----ChhHHhcCCCCCC
Q 003052 702 QMVYGRTPFSEY---KTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERW-----RIPQLLQHPFLVP 769 (853)
Q Consensus 702 ELLtG~~PF~~~---~~~~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRp-----Ta~EIL~HPwf~~ 769 (853)
+|++|+.||... .........+.. ....++...+..+.+||.+||..||.+|| ++.|+++||||..
T Consensus 254 ell~g~~pf~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~f~~ 327 (355)
T 1vzo_A 254 ELLTGASPFTVDGEKNSQAEISRRILK--SEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQK 327 (355)
T ss_dssp HHHHSSCTTSCTTSCCCHHHHHHHHHH--CCCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTT
T ss_pred HHHHCCCCCccCCccchHHHHHHHHhc--cCCCCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcchhc
Confidence 999999999632 122222222221 12234566788999999999999999999 9999999999975
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-43 Score=391.44 Aligned_cols=266 Identities=27% Similarity=0.448 Sum_probs=190.8
Q ss_pred ceeeEE-EeEeccCceEEEEEEec---CCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHH
Q 003052 472 KLYQRL-GKIGSGGSSEVHKVISS---DCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALL 547 (853)
Q Consensus 472 ~~Y~il-k~LG~G~FG~Vyka~~~---~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL 547 (853)
+.|.+. ++||+|+||.||+|.+. +++.||||++...... ..+.+|+.+|++|+ |+||+++++++..
T Consensus 20 ~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~----~~~~~E~~~l~~l~-hpniv~~~~~~~~----- 89 (405)
T 3rgf_A 20 DLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGIS----MSACREIALLRELK-HPNVISLQKVFLS----- 89 (405)
T ss_dssp HHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSCC----HHHHHHHHHHHHCC-CTTBCCCCEEEEE-----
T ss_pred hhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCCC----HHHHHHHHHHHhcC-CCCeeeEeeEEec-----
Confidence 346664 47999999999999964 5688999999754332 35779999999998 9999999987421
Q ss_pred HHHhhCCCCCCCCccccCCeEEEEEecchhhHHHHHHHhhhhc-cCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCC
Q 003052 548 REVLNGSMNNKDGRVKDDGYIYMVLEYGEIDLAHMLSQKWKEM-DGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDL 626 (853)
Q Consensus 548 ~~l~~~~iv~~~g~~~d~~~lyLVmEy~~gdL~~~L~~~~k~~-~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDL 626 (853)
..+..+|+||||++++|.+++....... ......+++..++.|+.||+.||.|||++||+||||
T Consensus 90 ---------------~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dl 154 (405)
T 3rgf_A 90 ---------------HADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDL 154 (405)
T ss_dssp ---------------TTTTEEEEEEECCSEEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCC
T ss_pred ---------------CCCCeEEEEEeCCCCCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCc
Confidence 3466899999999999999887543221 112235999999999999999999999999999999
Q ss_pred CCccEEee-----cCcEEEEecccchhcccCCc-cccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHH
Q 003052 627 KPANFLLV-----KGSLKLIDFGIAKAIMSDTT-NIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCIL 700 (853)
Q Consensus 627 KPeNILL~-----~g~VKL~DFGlAk~~~~~~~-~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVIL 700 (853)
||+||||. ++.+||+|||+|+.+..... .......+||+.|+|||++.+.. .|+.++||||||||+
T Consensus 155 kp~NIll~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--------~~~~~~DiwSlG~il 226 (405)
T 3rgf_A 155 KPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGAR--------HYTKAIDIWAIGCIF 226 (405)
T ss_dssp CGGGEEECCSSTTTTCEEECCTTCCC----------------CCCTTCCHHHHTTCC--------SCCHHHHHHHHHHHH
T ss_pred CHHHeEEecCCCCCCcEEEEECCCceecCCCCcccccCCCceecCcccCchhhcCCC--------cccchhhhHHHHHHH
Confidence 99999992 35899999999987643211 12234678999999999997642 367899999999999
Q ss_pred HHHHhCCCCCCcch------------hHHHHHHhhcCCCCcc--------------------------------cCCCCC
Q 003052 701 YQMVYGRTPFSEYK------------TFWAKFKVITDPNHEI--------------------------------TYEPVP 736 (853)
Q Consensus 701 yELLtG~~PF~~~~------------~~~~~~kii~~~~~~~--------------------------------~~~~~~ 736 (853)
|+|++|++||.+.. .+..++..+..+.... ......
T Consensus 227 ~ell~g~~pf~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (405)
T 3rgf_A 227 AELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKP 306 (405)
T ss_dssp HHHHHSSCTTCCCC------CCCCHHHHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCT
T ss_pred HHHHhCCCCCCCccccccccccchHHHHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCC
Confidence 99999999996432 2222333322211100 001123
Q ss_pred ChhHHHHHHHhcccCCCCCCChhHHhcCCCCCCC
Q 003052 737 NPWLLDLMKKCLAWDRNERWRIPQLLQHPFLVPP 770 (853)
Q Consensus 737 s~~l~dLI~kcL~~DP~kRpTa~EIL~HPwf~~~ 770 (853)
++.+.+||.+||.+||.+|||+.|+|+||||...
T Consensus 307 ~~~~~~Ll~~~L~~dP~~R~ta~e~L~hp~f~~~ 340 (405)
T 3rgf_A 307 DSKAFHLLQKLLTMDPIKRITSEQAMQDPYFLED 340 (405)
T ss_dssp TSHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTSS
T ss_pred CHHHHHHHHHHccCCcccCCCHHHHhcChhhccC
Confidence 6778999999999999999999999999999764
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-43 Score=373.50 Aligned_cols=272 Identities=25% Similarity=0.415 Sum_probs=205.6
Q ss_pred CceeeEEEeEeccCceEEEEEEec-CCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHHH
Q 003052 471 GKLYQRLGKIGSGGSSEVHKVISS-DCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLRE 549 (853)
Q Consensus 471 g~~Y~ilk~LG~G~FG~Vyka~~~-~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~~ 549 (853)
+.+|++++.||+|+||.||+|.+. +++.||||++... +......+.+|++++++++ |+||+++++++....
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~----- 81 (320)
T 2i6l_A 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLT--DPQSVKHALREIKIIRRLD-HDNIVKVFEILGPSG----- 81 (320)
T ss_dssp TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECC--SHHHHHHHHHHHHHHHTCC-CTTBCCEEEEECTTS-----
T ss_pred CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecC--ChHHHHHHHHHHHHHHhcC-CCCeeEEEEeccccc-----
Confidence 467999999999999999999985 5789999999754 3445567889999999997 999999999753221
Q ss_pred HhhCCCCCCCCccccCCeEEEEEecchhhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCCCc
Q 003052 550 VLNGSMNNKDGRVKDDGYIYMVLEYGEIDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPA 629 (853)
Q Consensus 550 l~~~~iv~~~g~~~d~~~lyLVmEy~~gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLKPe 629 (853)
..+....+.+.+...+|+||||++++|.+++.. ..+++..++.++.||+.||.|||++||+||||||+
T Consensus 82 ---~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~---------~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~ 149 (320)
T 2i6l_A 82 ---SQLTDDVGSLTELNSVYIVQEYMETDLANVLEQ---------GPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPA 149 (320)
T ss_dssp ---CBCCC----CCSCSEEEEEEECCSEEHHHHHTT---------CCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGG
T ss_pred ---cccccccccccccCceeEEeeccCCCHHHHhhc---------CCccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHH
Confidence 122233445677889999999999999888743 46999999999999999999999999999999999
Q ss_pred cEEee--cCcEEEEecccchhcccCCc-cccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHhC
Q 003052 630 NFLLV--KGSLKLIDFGIAKAIMSDTT-NIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYG 706 (853)
Q Consensus 630 NILL~--~g~VKL~DFGlAk~~~~~~~-~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLtG 706 (853)
|||++ ++.+||+|||+++....... ........||+.|+|||++.+.. .++.++|||||||++|+|++|
T Consensus 150 Nil~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--------~~~~~~Di~slG~il~el~~g 221 (320)
T 2i6l_A 150 NLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPN--------NYTKAIDMWAAGCIFAEMLTG 221 (320)
T ss_dssp GEEEETTTTEEEECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTT--------CCCHHHHHHHHHHHHHHHHHS
T ss_pred HEEEcCCCCeEEEccCccccccCCCcccccccccccccccccCcHHhcCcc--------cCCchhhhHhHHHHHHHHHhC
Confidence 99995 45899999999986543211 11223557899999999986532 367899999999999999999
Q ss_pred CCCCCcchhHHHHHHhhcCC---------------------------CCcccCCCCCChhHHHHHHHhcccCCCCCCChh
Q 003052 707 RTPFSEYKTFWAKFKVITDP---------------------------NHEITYEPVPNPWLLDLMKKCLAWDRNERWRIP 759 (853)
Q Consensus 707 ~~PF~~~~~~~~~~kii~~~---------------------------~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~ 759 (853)
+.||.+.........+.... ..........+.++.+||.+||..||.+|||+.
T Consensus 222 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ 301 (320)
T 2i6l_A 222 KTLFAGAHELEQMQLILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAE 301 (320)
T ss_dssp SCSSCCSSHHHHHHHHHHHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHH
T ss_pred CCCCCCCCHHHHHHHHHHhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHH
Confidence 99997755433222221100 000112245788999999999999999999999
Q ss_pred HHhcCCCCCCC
Q 003052 760 QLLQHPFLVPP 770 (853)
Q Consensus 760 EIL~HPwf~~~ 770 (853)
|+|+||||...
T Consensus 302 ell~hp~~~~~ 312 (320)
T 2i6l_A 302 EALSHPYMSIY 312 (320)
T ss_dssp HHHTSHHHHTT
T ss_pred HHhCCcccccc
Confidence 99999999753
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-42 Score=380.74 Aligned_cols=260 Identities=27% Similarity=0.436 Sum_probs=210.6
Q ss_pred ceeeEEEeEeccCceEEEEEEec-CCcEEEEEEEecCCCC------hhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHH
Q 003052 472 KLYQRLGKIGSGGSSEVHKVISS-DCTIYALKKIKLKGRD------YATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEK 544 (853)
Q Consensus 472 ~~Y~ilk~LG~G~FG~Vyka~~~-~g~~vAVKkik~~~~~------~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~ 544 (853)
..|++.+.||+|+||.||+|.+. +|+.||||++...... ......+.+|+.+++++.+|+||++++++
T Consensus 94 ~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~----- 168 (365)
T 2y7j_A 94 QKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDS----- 168 (365)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEE-----
T ss_pred hhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEE-----
Confidence 56999999999999999999985 7899999999765422 12245678999999999779999999987
Q ss_pred HHHHHHhhCCCCCCCCccccCCeEEEEEecchh-hHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceee
Q 003052 545 ALLREVLNGSMNNKDGRVKDDGYIYMVLEYGEI-DLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVH 623 (853)
Q Consensus 545 ~iL~~l~~~~iv~~~g~~~d~~~lyLVmEy~~g-dL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIH 623 (853)
+.....+|+||||+.+ +|.+++... ..+++..++.++.||+.||.|||++||+|
T Consensus 169 -----------------~~~~~~~~lv~e~~~g~~L~~~l~~~--------~~l~~~~~~~i~~qi~~~L~~LH~~gi~H 223 (365)
T 2y7j_A 169 -----------------YESSSFMFLVFDLMRKGELFDYLTEK--------VALSEKETRSIMRSLLEAVSFLHANNIVH 223 (365)
T ss_dssp -----------------EEBSSEEEEEECCCTTCBHHHHHHHH--------SSCCHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred -----------------EeeCCEEEEEEEeCCCCcHHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHhCCeec
Confidence 4567789999999865 899888754 46999999999999999999999999999
Q ss_pred CCCCCccEEe-ecCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHH
Q 003052 624 SDLKPANFLL-VKGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQ 702 (853)
Q Consensus 624 RDLKPeNILL-~~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyE 702 (853)
|||||+|||+ .+|.+||+|||++..+.... .....+||+.|+|||++.+..... ...|+.++|||||||++|+
T Consensus 224 ~Dlkp~NIl~~~~~~ikl~DfG~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~---~~~~~~~~Di~slG~il~e 297 (365)
T 2y7j_A 224 RDLKPENILLDDNMQIRLSDFGFSCHLEPGE---KLRELCGTPGYLAPEILKCSMDET---HPGYGKEVDLWACGVILFT 297 (365)
T ss_dssp SCCSGGGEEECTTCCEEECCCTTCEECCTTC---CBCCCCSCGGGCCHHHHHHTTCTT---SCCBCTTHHHHHHHHHHHH
T ss_pred CCCCHHHEEECCCCCEEEEecCcccccCCCc---ccccCCCCCCccChhhcccccccc---CcCCCchhhHHhHHHHHHH
Confidence 9999999999 46799999999998765332 224678999999999997543211 1247889999999999999
Q ss_pred HHhCCCCCCcchhHHHHHHhhcCCCCcc--cCCCCCChhHHHHHHHhcccCCCCCCChhHHhcCCCCC
Q 003052 703 MVYGRTPFSEYKTFWAKFKVITDPNHEI--TYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQHPFLV 768 (853)
Q Consensus 703 LLtG~~PF~~~~~~~~~~kii~~~~~~~--~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~HPwf~ 768 (853)
|++|+.||.+.........+... .... ......+..+.+||.+||..||.+||++.++|+||||+
T Consensus 298 ll~g~~pf~~~~~~~~~~~i~~~-~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~f~ 364 (365)
T 2y7j_A 298 LLAGSPPFWHRRQILMLRMIMEG-QYQFSSPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQHPFFE 364 (365)
T ss_dssp HHHSSCSSCCSSHHHHHHHHHHT-CCCCCHHHHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGC
T ss_pred HHHCCCCCCCCCHHHHHHHHHhC-CCCCCCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCcccC
Confidence 99999999775544333222221 1111 11235678899999999999999999999999999996
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-43 Score=403.18 Aligned_cols=254 Identities=27% Similarity=0.364 Sum_probs=209.9
Q ss_pred ceeeEEEeEeccCceEEEEEEec-CCcEEEEEEEecCCC-ChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHHH
Q 003052 472 KLYQRLGKIGSGGSSEVHKVISS-DCTIYALKKIKLKGR-DYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLRE 549 (853)
Q Consensus 472 ~~Y~ilk~LG~G~FG~Vyka~~~-~g~~vAVKkik~~~~-~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~~ 549 (853)
..|.+.+.||+|+||.||+|.+. +++.||||++..... .......+.+|+.+|+.++ ||||++++++
T Consensus 16 ~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~-HpnIv~l~~~---------- 84 (476)
T 2y94_A 16 GHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFR-HPHIIKLYQV---------- 84 (476)
T ss_dssp TTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCC-CTTBCCEEEE----------
T ss_pred cCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCC-CCCCCcEEEE----------
Confidence 45999999999999999999984 789999999975422 1123456889999999997 8999999987
Q ss_pred HhhCCCCCCCCccccCCeEEEEEecc-hhhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCCC
Q 003052 550 VLNGSMNNKDGRVKDDGYIYMVLEYG-EIDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKP 628 (853)
Q Consensus 550 l~~~~iv~~~g~~~d~~~lyLVmEy~-~gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLKP 628 (853)
+.+...+|+||||+ +++|.+++.. .+.+++..++.++.||+.||.|||++||+||||||
T Consensus 85 ------------~~~~~~~~lv~E~~~gg~L~~~l~~--------~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp 144 (476)
T 2y94_A 85 ------------ISTPSDIFMVMEYVSGGELFDYICK--------NGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKP 144 (476)
T ss_dssp ------------EECSSEEEEEEECCSSEEHHHHTTS--------SSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSG
T ss_pred ------------EEECCEEEEEEeCCCCCcHHHHHHh--------cCCCCHHHHHHHHHHHHHHHHHHHHCCCCcccccH
Confidence 45667899999998 4699888754 25799999999999999999999999999999999
Q ss_pred ccEEee-cCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHhCC
Q 003052 629 ANFLLV-KGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGR 707 (853)
Q Consensus 629 eNILL~-~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLtG~ 707 (853)
+|||++ ++.+||+|||+++...... ...+.+||+.|+|||++.+.. .++.++|||||||++|+|++|+
T Consensus 145 ~NIll~~~~~vkL~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~--------~~~~~~DiwSlGvil~elltG~ 213 (476)
T 2y94_A 145 ENVLLDAHMNAKIADFGLSNMMSDGE---FLRTSCGSPNYAAPEVISGRL--------YAGPEVDIWSSGVILYALLCGT 213 (476)
T ss_dssp GGEEECTTCCEEECCCSSCEECCTTC---CBCCCCSCSTTCCHHHHTTCC--------BCSHHHHHHHHHHHHHHHHHSS
T ss_pred HHEEEecCCCeEEEeccchhhccccc---cccccCCCcCeEChhhccCCC--------CCCCcceehhhHHHHHHHhhCC
Confidence 999994 6799999999998764322 234679999999999997653 2367999999999999999999
Q ss_pred CCCCcchhHHHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCCChhHHhcCCCCCCC
Q 003052 708 TPFSEYKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQHPFLVPP 770 (853)
Q Consensus 708 ~PF~~~~~~~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~HPwf~~~ 770 (853)
.||.+........++.. . ....+...++.+.+||.+||..||.+|||+.|+++||||...
T Consensus 214 ~Pf~~~~~~~~~~~i~~-~--~~~~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~hp~~~~~ 273 (476)
T 2y94_A 214 LPFDDDHVPTLFKKICD-G--IFYTPQYLNPSVISLLKHMLQVDPMKRATIKDIREHEWFKQD 273 (476)
T ss_dssp CSSCCSSSHHHHHHHHT-T--CCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHTT
T ss_pred CCCCCCCHHHHHHHHhc-C--CcCCCccCCHHHHHHHHHHcCCCchhCcCHHHHHhCHHhhhc
Confidence 99987544333333322 2 233455678899999999999999999999999999999754
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-44 Score=394.01 Aligned_cols=269 Identities=13% Similarity=0.105 Sum_probs=199.3
Q ss_pred CceeeEEEeEeccCceEEEEEEe-cCCcEEEEEEEecCC-CChhhHhhHHHHHHHHHHhc--CCCceeEeeehhhhHHHH
Q 003052 471 GKLYQRLGKIGSGGSSEVHKVIS-SDCTIYALKKIKLKG-RDYATAYGFCQEIEYLNKLK--GKNNIIQLIDYEVTEKAL 546 (853)
Q Consensus 471 g~~Y~ilk~LG~G~FG~Vyka~~-~~g~~vAVKkik~~~-~~~~~~~~~l~EI~iLkkL~--~hpNIV~Lid~~~~e~~i 546 (853)
.+.|++.+.||+|+||.||+|.+ .+++.||||++.... ........+.+|+.+|+.+. .||||+++++.+..
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~---- 147 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIF---- 147 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCC----
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhh----
Confidence 46799999999999999999997 568999999998653 23345567889997776665 59999998743210
Q ss_pred HHHHhhCCCCCCCCccccC------------C-----eEEEEEecchhhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHh
Q 003052 547 LREVLNGSMNNKDGRVKDD------------G-----YIYMVLEYGEIDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQI 609 (853)
Q Consensus 547 L~~l~~~~iv~~~g~~~d~------------~-----~lyLVmEy~~gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QI 609 (853)
..+.+.+. . ..||||||++++|.+++..... .......+++..++.|+.||
T Consensus 148 -----------~~~~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~~g~L~~~l~~~~~-~~~~~~~l~~~~~~~i~~qi 215 (377)
T 3byv_A 148 -----------PFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLS-HSSTHKSLVHHARLQLTLQV 215 (377)
T ss_dssp -----------CSEEEECTTSCSEEEC------CEEESEEEEEECCSEEHHHHHHHHHH-TTTTTHHHHHHHHHHHHHHH
T ss_pred -----------hhhhhhccCCccccccccCCCceEEEEEEEEEeccCCCHHHHHHhccc-cccccccccHHHHHHHHHHH
Confidence 01112222 1 3799999999999999986521 11112334558888999999
Q ss_pred hhhhhhcccCceeeCCCCCccEEee-cCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCC--CCCcccc
Q 003052 610 LEAVNTIHEERIVHSDLKPANFLLV-KGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESD--ENGNIIK 686 (853)
Q Consensus 610 l~AL~yLHs~gIIHRDLKPeNILL~-~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~--~~~~~~~ 686 (853)
+.||.|||++||+||||||+||||+ ++.+||+|||+|+.... .....+| +.|+|||++.+.... .......
T Consensus 216 ~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~-----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~ 289 (377)
T 3byv_A 216 IRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA-----RVVSSVS-RGFEPPELEARRATISYHRDRRTL 289 (377)
T ss_dssp HHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCGGGCEETTC-----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEE
T ss_pred HHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEechhheecCC-----cccCCCC-cCccChhhhccccccccccccccc
Confidence 9999999999999999999999994 67999999999985422 2336688 999999999764000 0000114
Q ss_pred CCCccchhhhHHHHHHHHhCCCCCCcchhHHHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCCChhHHhcCCC
Q 003052 687 CGRPSDIWSLGCILYQMVYGRTPFSEYKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQHPF 766 (853)
Q Consensus 687 ys~ksDIWSLGVILyELLtG~~PF~~~~~~~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~HPw 766 (853)
|+.++|||||||++|||++|+.||.+.........+ .......++++.+||.+||..||.+||++.|+|+|||
T Consensus 290 ~~~~~DvwSlG~il~elltg~~Pf~~~~~~~~~~~~-------~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~ 362 (377)
T 3byv_A 290 MTFSFDAWALGLVIYWIWCADLPITKDAALGGSEWI-------FRSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPE 362 (377)
T ss_dssp CCHHHHHHHHHHHHHHHHHSSCCC------CCSGGG-------GSSCCCCCHHHHHHHHHHTCSSGGGCCCHHHHHTSHH
T ss_pred CChhhhHHHHHHHHHHHHHCCCCCcccccccchhhh-------hhhccCCCHHHHHHHHHHcCCCchhCCCHHHHhhChH
Confidence 678999999999999999999999764332111111 1122567889999999999999999999999999999
Q ss_pred CC
Q 003052 767 LV 768 (853)
Q Consensus 767 f~ 768 (853)
|.
T Consensus 363 f~ 364 (377)
T 3byv_A 363 YE 364 (377)
T ss_dssp HH
T ss_pred HH
Confidence 95
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-42 Score=370.16 Aligned_cols=260 Identities=26% Similarity=0.451 Sum_probs=207.8
Q ss_pred eeEEcCceeeEEEeEeccCceEEEEEEec-CCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHH
Q 003052 466 FFKVNGKLYQRLGKIGSGGSSEVHKVISS-DCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEK 544 (853)
Q Consensus 466 ~~~v~g~~Y~ilk~LG~G~FG~Vyka~~~-~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~ 544 (853)
+.+...+.|++++.||+|+||.||+|.+. +++.||||++..... ...+.+|+.+++++. |+||++++++
T Consensus 23 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~----~~~~~~e~~~l~~l~-h~~i~~~~~~----- 92 (314)
T 3com_A 23 LTKQPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESD----LQEIIKEISIMQQCD-SPHVVKYYGS----- 92 (314)
T ss_dssp -------CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTSC----CHHHHHHHHHHHTCC-CTTBCCEEEE-----
T ss_pred hhhcchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchHH----HHHHHHHHHHHHhCC-CCCCccEEEE-----
Confidence 33445577999999999999999999985 688999999986432 345789999999996 8999999987
Q ss_pred HHHHHHhhCCCCCCCCccccCCeEEEEEecchh-hHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceee
Q 003052 545 ALLREVLNGSMNNKDGRVKDDGYIYMVLEYGEI-DLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVH 623 (853)
Q Consensus 545 ~iL~~l~~~~iv~~~g~~~d~~~lyLVmEy~~g-dL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIH 623 (853)
+.+.+.+|+||||+++ +|.+++... ...+++..++.++.||+.||.|||++||+|
T Consensus 93 -----------------~~~~~~~~lv~e~~~~~~L~~~~~~~-------~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H 148 (314)
T 3com_A 93 -----------------YFKNTDLWIVMEYCGAGSVSDIIRLR-------NKTLTEDEIATILQSTLKGLEYLHFMRKIH 148 (314)
T ss_dssp -----------------EEETTEEEEEEECCTTEEHHHHHHHH-------TCCCCHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred -----------------EEeCCEEEEEeecCCCCCHHHHHHhc-------CCCCCHHHHHHHHHHHHHHHHHHHhCCCcC
Confidence 3456789999999875 898888643 357999999999999999999999999999
Q ss_pred CCCCCccEEe-ecCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHH
Q 003052 624 SDLKPANFLL-VKGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQ 702 (853)
Q Consensus 624 RDLKPeNILL-~~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyE 702 (853)
|||||+|||+ .++.+||+|||++........ ......||+.|+|||++.+. .++.++|||||||++|+
T Consensus 149 ~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~---------~~~~~~Di~slG~il~~ 217 (314)
T 3com_A 149 RDIKAGNILLNTEGHAKLADFGVAGQLTDTMA--KRNTVIGTPFWMAPEVIQEI---------GYNCVADIWSLGITAIE 217 (314)
T ss_dssp CCCSGGGEEECTTCCEEECCCTTCEECBTTBS--CBCCCCSCGGGCCHHHHSSS---------CBCTTHHHHHHHHHHHH
T ss_pred CCcCHHHEEECCCCCEEEeecccchhhhhhcc--ccCccCCCCCccChhhcCCC---------CCCccccHHHHHHHHHH
Confidence 9999999999 567999999999986643222 23456899999999999764 35689999999999999
Q ss_pred HHhCCCCCCcchhHHHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCCChhHHhcCCCCCCC
Q 003052 703 MVYGRTPFSEYKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQHPFLVPP 770 (853)
Q Consensus 703 LLtG~~PF~~~~~~~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~HPwf~~~ 770 (853)
|++|+.||.+....................+...+..+.+||.+||..||.+|||+.++|+||||...
T Consensus 218 l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~~~~~~~ 285 (314)
T 3com_A 218 MAEGKPPYADIHPMRAIFMIPTNPPPTFRKPELWSDNFTDFVKQCLVKSPEQRATATQLLQHPFVRSA 285 (314)
T ss_dssp HHHSSCTTTTSCHHHHHHHHHHSCCCCCSSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHTC
T ss_pred HHhCCCCCCCCChHHHHHHHhcCCCcccCCcccCCHHHHHHHHHHccCChhhCcCHHHHHhCHHHhcC
Confidence 99999999876665554444444333444455578889999999999999999999999999999754
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=384.75 Aligned_cols=254 Identities=27% Similarity=0.341 Sum_probs=200.2
Q ss_pred ceeeEEEeEeccCceEEEEEEec-CCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCc-----eeEeeehhhhHHH
Q 003052 472 KLYQRLGKIGSGGSSEVHKVISS-DCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNN-----IIQLIDYEVTEKA 545 (853)
Q Consensus 472 ~~Y~ilk~LG~G~FG~Vyka~~~-~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpN-----IV~Lid~~~~e~~ 545 (853)
++|++.+.||+|+||.||+|.+. +++.||||+++.. ......+.+|+.+++.+.+|++ |++++++
T Consensus 54 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~------ 124 (382)
T 2vx3_A 54 DRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK---KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRH------ 124 (382)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS---HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEE------
T ss_pred eeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc---HHHHHHHHHHHHHHHHHHhcccccceeEEEeeee------
Confidence 57999999999999999999984 6788999999743 2344567789999999987775 6666554
Q ss_pred HHHHHhhCCCCCCCCccccCCeEEEEEecchhhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcc--cCceee
Q 003052 546 LLREVLNGSMNNKDGRVKDDGYIYMVLEYGEIDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIH--EERIVH 623 (853)
Q Consensus 546 iL~~l~~~~iv~~~g~~~d~~~lyLVmEy~~gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLH--s~gIIH 623 (853)
+...+.+|+||||++++|.+++... ....+++..++.++.||+.||.||| ..||+|
T Consensus 125 ----------------~~~~~~~~lv~e~~~~~L~~~l~~~------~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH 182 (382)
T 2vx3_A 125 ----------------FMFRNHLCLVFEMLSYNLYDLLRNT------NFRGVSLNLTRKFAQQMCTALLFLATPELSIIH 182 (382)
T ss_dssp ----------------EEETTEEEEEEECCCCBHHHHHHHT------TTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEEC
T ss_pred ----------------eccCCceEEEEecCCCCHHHHHhhc------CcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEc
Confidence 5667889999999999999998764 2246999999999999999999999 469999
Q ss_pred CCCCCccEEee---cCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHH
Q 003052 624 SDLKPANFLLV---KGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCIL 700 (853)
Q Consensus 624 RDLKPeNILL~---~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVIL 700 (853)
|||||+||||. ++.+||+|||+|+..... ....+||+.|+|||++.+.. |+.++|||||||++
T Consensus 183 rDlkp~NIll~~~~~~~~kL~DFG~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~---------~~~~~DiwSlG~il 248 (382)
T 2vx3_A 183 CDLKPENILLCNPKRSAIKIVDFGSSCQLGQR-----IYQYIQSRFYRSPEVLLGMP---------YDLAIDMWSLGCIL 248 (382)
T ss_dssp CCCSGGGEEESSTTSCCEEECCCTTCEETTCC-----CCSSCSCGGGCCHHHHTTCC---------CCTHHHHHHHHHHH
T ss_pred CCCCcccEEEecCCCCcEEEEeccCceecccc-----cccccCCccccChHHHcCCC---------CCcHHHHHHHHHHH
Confidence 99999999994 458999999999876432 23578999999999997653 56899999999999
Q ss_pred HHHHhCCCCCCcchhHHHHHHhh---cCCCCc-----------------------------ccCCC-C------------
Q 003052 701 YQMVYGRTPFSEYKTFWAKFKVI---TDPNHE-----------------------------ITYEP-V------------ 735 (853)
Q Consensus 701 yELLtG~~PF~~~~~~~~~~kii---~~~~~~-----------------------------~~~~~-~------------ 735 (853)
|||++|++||.+.........+. ..+... ..+.. .
T Consensus 249 ~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~ 328 (382)
T 2vx3_A 249 VEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVET 328 (382)
T ss_dssp HHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTCTTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTT
T ss_pred HHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhHHHHHHHHhccccccccccccccccccCCcchhhHHHHhhccc
Confidence 99999999998654433222211 100000 00000 0
Q ss_pred ----------------CChhHHHHHHHhcccCCCCCCChhHHhcCCCCCCC
Q 003052 736 ----------------PNPWLLDLMKKCLAWDRNERWRIPQLLQHPFLVPP 770 (853)
Q Consensus 736 ----------------~s~~l~dLI~kcL~~DP~kRpTa~EIL~HPwf~~~ 770 (853)
..+.+++||.+||.+||.+|||+.|+|+||||+..
T Consensus 329 ~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~Rpta~e~L~hp~f~~~ 379 (382)
T 2vx3_A 329 GGPGGRRAGESGHTVADYLKFKDLILRMLDYDPKTRIQPYYALQHSFFKKT 379 (382)
T ss_dssp TSGGGTTTTCTTCCHHHHHHHHHHHHHHTCSCTTTSCCHHHHTTSGGGCC-
T ss_pred cCCCccccccccccchhhHHHHHHHHHhcCCChhhCCCHHHHhcCcccccC
Confidence 00368999999999999999999999999999754
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-42 Score=374.35 Aligned_cols=255 Identities=24% Similarity=0.423 Sum_probs=211.3
Q ss_pred CceeeEEEeEeccCceEEEEEEec-CCcEEEEEEEecCCC-ChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHH
Q 003052 471 GKLYQRLGKIGSGGSSEVHKVISS-DCTIYALKKIKLKGR-DYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLR 548 (853)
Q Consensus 471 g~~Y~ilk~LG~G~FG~Vyka~~~-~g~~vAVKkik~~~~-~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~ 548 (853)
.++|.+.+.||+|+||.||+|.+. +++.||+|++..... .......+.+|+.+++++. |+||++++++
T Consensus 40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~--------- 109 (335)
T 2owb_A 40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLA-HQHVVGFHGF--------- 109 (335)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCC-CTTBCCEEEE---------
T ss_pred CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCC-CCCCCeEEEE---------
Confidence 467999999999999999999985 568999999976532 3445567889999999996 9999999987
Q ss_pred HHhhCCCCCCCCccccCCeEEEEEecch-hhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCC
Q 003052 549 EVLNGSMNNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLK 627 (853)
Q Consensus 549 ~l~~~~iv~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLK 627 (853)
+.+.+.+|+||||++ ++|.+++... ..+++..++.++.||+.||.|||++||+|||||
T Consensus 110 -------------~~~~~~~~lv~e~~~~~~L~~~~~~~--------~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlk 168 (335)
T 2owb_A 110 -------------FEDNDFVFVVLELCRRRSLLELHKRR--------KALTEPEARYYLRQIVLGCQYLHRNRVIHRDLK 168 (335)
T ss_dssp -------------EECSSEEEEEECCCTTCBHHHHHHHH--------CSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCC
T ss_pred -------------EecCCeEEEEEecCCCCCHHHHHhcc--------CCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCC
Confidence 456778999999987 5888877654 569999999999999999999999999999999
Q ss_pred CccEEee-cCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHhC
Q 003052 628 PANFLLV-KGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYG 706 (853)
Q Consensus 628 PeNILL~-~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLtG 706 (853)
|+|||++ ++.+||+|||+++....... .....+||+.|+|||++.+. .++.++|||||||++|+|++|
T Consensus 169 p~NIl~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~---------~~~~~~Di~slG~il~~l~~g 237 (335)
T 2owb_A 169 LGNLFLNEDLEVKIGDFGLATKVEYDGE--RKKVLCGTPNYIAPEVLSKK---------GHSFEVDVWSIGCIMYTLLVG 237 (335)
T ss_dssp GGGEEECTTCCEEECCCTTCEECCSTTC--CBCCCCSCCSSCCHHHHHTS---------CBCTHHHHHHHHHHHHHHHHS
T ss_pred chhEEEcCCCCEEEeeccCceecccCcc--cccccCCCccccCHHHhccC---------CCCchhhHHHHHHHHHHHHHC
Confidence 9999994 67999999999987643222 23356899999999999765 356899999999999999999
Q ss_pred CCCCCcchhHHHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCCChhHHhcCCCCCCC
Q 003052 707 RTPFSEYKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQHPFLVPP 770 (853)
Q Consensus 707 ~~PF~~~~~~~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~HPwf~~~ 770 (853)
+.||...........+.. ....++...++.+.+||.+||..||.+||++.|+|+||||...
T Consensus 238 ~~pf~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~~~~~~~ 298 (335)
T 2owb_A 238 KPPFETSCLKETYLRIKK---NEYSIPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSG 298 (335)
T ss_dssp SCTTCCSSHHHHHHHHHH---TCCCCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHTS
T ss_pred cCCCCCCCHHHHHHHHhc---CCCCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCccccCC
Confidence 999976544333222222 1233456678899999999999999999999999999999754
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-42 Score=364.33 Aligned_cols=256 Identities=24% Similarity=0.423 Sum_probs=211.9
Q ss_pred cCceeeEEEeEeccCceEEEEEEec-CCcEEEEEEEecCCC-ChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHH
Q 003052 470 NGKLYQRLGKIGSGGSSEVHKVISS-DCTIYALKKIKLKGR-DYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALL 547 (853)
Q Consensus 470 ~g~~Y~ilk~LG~G~FG~Vyka~~~-~g~~vAVKkik~~~~-~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL 547 (853)
..++|.+.+.||+|+||.||+|.+. +++.||+|++..... .......+.+|+.+++++. |+||++++++
T Consensus 13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~-------- 83 (294)
T 2rku_A 13 SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLA-HQHVVGFHGF-------- 83 (294)
T ss_dssp TTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCC-CTTBCCEEEE--------
T ss_pred cccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCC-CCCEeeeeee--------
Confidence 3467999999999999999999985 578999999976532 3445567889999999996 9999999987
Q ss_pred HHHhhCCCCCCCCccccCCeEEEEEecch-hhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCC
Q 003052 548 REVLNGSMNNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDL 626 (853)
Q Consensus 548 ~~l~~~~iv~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDL 626 (853)
+.+.+.+|+||||++ ++|.+++... ..+++..++.++.||+.||.|||++||+||||
T Consensus 84 --------------~~~~~~~~lv~e~~~~~~L~~~~~~~--------~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl 141 (294)
T 2rku_A 84 --------------FEDNDFVFVVLELCRRRSLLELHKRR--------KALTEPEARYYLRQIVLGCQYLHRNRVIHRDL 141 (294)
T ss_dssp --------------EECSSEEEEEEECCTTCBHHHHHHHH--------CSCCHHHHHHHHHHHHHHHHHHHHTTEECCCC
T ss_pred --------------eccCCEEEEEEecCCCCCHHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCC
Confidence 456778999999987 5888877654 56999999999999999999999999999999
Q ss_pred CCccEEee-cCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHh
Q 003052 627 KPANFLLV-KGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVY 705 (853)
Q Consensus 627 KPeNILL~-~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLt 705 (853)
||+|||++ ++.+||+|||+++....... .....+||+.|+|||++.+. .++.++|||||||++|+|++
T Consensus 142 ~p~Nil~~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~---------~~~~~~Di~slG~~l~~l~~ 210 (294)
T 2rku_A 142 KLGNLFLNEDLEVKIGDFGLATKVEYDGE--RKKVLCGTPNYIAPEVLSKK---------GHSFEVDVWSIGCIMYTLLV 210 (294)
T ss_dssp CGGGEEECTTCCEEECCCTTCEECCSTTC--CBCCCCSCCSSCCHHHHTTS---------CBCTHHHHHHHHHHHHHHHH
T ss_pred ChHhEEEcCCCCEEEEeccCceecccCcc--ccccccCCCCcCCcchhccC---------CCCchhhHHHHHHHHHHHHh
Confidence 99999994 67999999999987643222 22356899999999999754 35689999999999999999
Q ss_pred CCCCCCcchhHHHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCCChhHHhcCCCCCCC
Q 003052 706 GRTPFSEYKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQHPFLVPP 770 (853)
Q Consensus 706 G~~PF~~~~~~~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~HPwf~~~ 770 (853)
|+.||...........+.. .....+...++.+.+||.+||..||.+||++.++|+||||...
T Consensus 211 g~~p~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~~~~~~~ 272 (294)
T 2rku_A 211 GKPPFETSCLKETYLRIKK---NEYSIPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSG 272 (294)
T ss_dssp SSCTTCCSSHHHHHHHHHT---TCCCCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHTS
T ss_pred CCCCCCCCCHHHHHHHHhh---ccCCCccccCHHHHHHHHHHcccChhhCcCHHHHhhChheecC
Confidence 9999987544333333222 2234456778899999999999999999999999999999754
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-43 Score=371.58 Aligned_cols=262 Identities=27% Similarity=0.410 Sum_probs=209.7
Q ss_pred ceeeEEEeEeccCceEEEEEEe-cCCcEEEEEEEecCCC--ChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHH
Q 003052 472 KLYQRLGKIGSGGSSEVHKVIS-SDCTIYALKKIKLKGR--DYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLR 548 (853)
Q Consensus 472 ~~Y~ilk~LG~G~FG~Vyka~~-~~g~~vAVKkik~~~~--~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~ 548 (853)
++|++.+.||+|+||.||+|.+ .+++.||+|+++.... .......+.+|+.++++++ |+||+++++++..
T Consensus 5 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~------ 77 (305)
T 2wtk_C 5 GKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLR-HKNVIQLVDVLYN------ 77 (305)
T ss_dssp CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCC-CTTBCCEEEEEEC------
T ss_pred cceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcC-CCCeeEEEEEEEc------
Confidence 4699999999999999999998 4678999999976431 1234456889999999997 9999999987421
Q ss_pred HHhhCCCCCCCCccccCCeEEEEEecchhhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCCC
Q 003052 549 EVLNGSMNNKDGRVKDDGYIYMVLEYGEIDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKP 628 (853)
Q Consensus 549 ~l~~~~iv~~~g~~~d~~~lyLVmEy~~gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLKP 628 (853)
.+...+|+||||++++|.+++... ....+++..++.++.||+.||.|||++||+||||||
T Consensus 78 --------------~~~~~~~lv~e~~~~~l~~~~~~~------~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp 137 (305)
T 2wtk_C 78 --------------EEKQKMYMVMEYCVCGMQEMLDSV------PEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKP 137 (305)
T ss_dssp --------------C---CEEEEEECCSEEHHHHHHHS------TTCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSG
T ss_pred --------------CCCCeEEEEehhccCCHHHHHHhC------cccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCc
Confidence 344578999999988887777653 235799999999999999999999999999999999
Q ss_pred ccEEe-ecCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHhCC
Q 003052 629 ANFLL-VKGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGR 707 (853)
Q Consensus 629 eNILL-~~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLtG~ 707 (853)
+|||+ .++.+||+|||++................||+.|+|||++.+... .++.++|||||||++|+|++|+
T Consensus 138 ~NIl~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-------~~~~~~Di~slG~il~~l~~g~ 210 (305)
T 2wtk_C 138 GNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPEIANGLDT-------FSGFKVDIWSAGVTLYNITTGL 210 (305)
T ss_dssp GGEEECTTCCEEECCCTTCEECCTTCSSCEECCCCSCGGGCCHHHHTCCSC-------EESHHHHHHHHHHHHHHHHHSS
T ss_pred ccEEEcCCCcEEeeccccccccCccccccccccCCCCCCCcChhhccCccc-------CCcchhhHHHHHHHHHHHHhCC
Confidence 99999 567999999999987643322333346679999999999975421 3467999999999999999999
Q ss_pred CCCCcchhHHHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCCChhHHhcCCCCCCC
Q 003052 708 TPFSEYKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQHPFLVPP 770 (853)
Q Consensus 708 ~PF~~~~~~~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~HPwf~~~ 770 (853)
.||.+...... ...+... ...++...++.+.+||.+||..||.+||++.|+++||||...
T Consensus 211 ~p~~~~~~~~~-~~~i~~~--~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~ 270 (305)
T 2wtk_C 211 YPFEGDNIYKL-FENIGKG--SYAIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKK 270 (305)
T ss_dssp CSCCCSSHHHH-HHHHHHC--CCCCCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHSHHHHSC
T ss_pred CCCCCchHHHH-HHHHhcC--CCCCCCccCHHHHHHHHHHccCChhhCCCHHHHhcCcccccC
Confidence 99987544332 2222221 223455678899999999999999999999999999999654
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-43 Score=388.93 Aligned_cols=271 Identities=13% Similarity=0.126 Sum_probs=190.3
Q ss_pred ceeeEEEeEeccCceEEEEEEec-CCcEEEEEEEecCCC-ChhhHhhHHHHHHHHHHhc-CCCceeEeeehh-------h
Q 003052 472 KLYQRLGKIGSGGSSEVHKVISS-DCTIYALKKIKLKGR-DYATAYGFCQEIEYLNKLK-GKNNIIQLIDYE-------V 541 (853)
Q Consensus 472 ~~Y~ilk~LG~G~FG~Vyka~~~-~g~~vAVKkik~~~~-~~~~~~~~l~EI~iLkkL~-~hpNIV~Lid~~-------~ 541 (853)
..|++.+.||+|+||.||+|.+. +++.||||++..... .......+.+|+.+++.|+ .||||++++..+ .
T Consensus 62 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~ 141 (371)
T 3q60_A 62 RKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVA 141 (371)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEE
T ss_pred eeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhee
Confidence 45999999999999999999984 778999999987654 3345556778877777776 499988855321 1
Q ss_pred hHHHHHHHHhhCCCCCCCCc--cccCCeEEEEEecchhhHHHHHHHhhhhccCCCCCCCHHHH------HHHHHHhhhhh
Q 003052 542 TEKALLREVLNGSMNNKDGR--VKDDGYIYMVLEYGEIDLAHMLSQKWKEMDGSNQTLDENWL------RFYWQQILEAV 613 (853)
Q Consensus 542 ~e~~iL~~l~~~~iv~~~g~--~~d~~~lyLVmEy~~gdL~~~L~~~~k~~~~~~~~LsE~~~------r~I~~QIl~AL 613 (853)
.+. .+.+...... ......+||||||++++|.+++..... .+.+... ..++.||+.||
T Consensus 142 ~~~-------~~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~-------~~~~~~~~~~~vk~~i~~qi~~aL 207 (371)
T 3q60_A 142 VQS-------QPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDF-------VYVFRGDEGILALHILTAQLIRLA 207 (371)
T ss_dssp ETT-------SCSSSBCSCC---CCEEEEEEEECCCSEEHHHHHHHHHH-------SCCCCHHHHHHHHHHHHHHHHHHH
T ss_pred cCC-------CCCeeeccCCcccceeeeEEEEecCCCCCHHHHHHHhcc-------ccchhhhhhhhhHHHHHHHHHHHH
Confidence 000 0000000000 001145899999999999999987522 3444444 56779999999
Q ss_pred hhcccCceeeCCCCCccEEe-ecCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccc
Q 003052 614 NTIHEERIVHSDLKPANFLL-VKGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSD 692 (853)
Q Consensus 614 ~yLHs~gIIHRDLKPeNILL-~~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksD 692 (853)
.|||++||+||||||+|||| .+|.+||+|||+|+...... ....||+.|+|||++.+.. ..|+.++|
T Consensus 208 ~~LH~~~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~~-----~~~~~t~~y~aPE~~~~~~-------~~~~~~~D 275 (371)
T 3q60_A 208 ANLQSKGLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTRG-----PASSVPVTYAPREFLNAST-------ATFTHALN 275 (371)
T ss_dssp HHHHHTTEEETTCSGGGEEECTTSCEEECCGGGEEETTCEE-----EGGGSCGGGCCHHHHTCSE-------EECCHHHH
T ss_pred HHHHHCCCccCcCCHHHEEECCCCCEEEEecceeeecCCCc-----cCccCCcCCcChhhccCCC-------CCcCcccc
Confidence 99999999999999999999 46799999999998653211 1456779999999996521 24788999
Q ss_pred hhhhHHHHHHHHhCCCCCCcchhHHH-HHH---hhc--CCCCcccCCCCCChhHHHHHHHhcccCCCCCCChhHHhcCCC
Q 003052 693 IWSLGCILYQMVYGRTPFSEYKTFWA-KFK---VIT--DPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQHPF 766 (853)
Q Consensus 693 IWSLGVILyELLtG~~PF~~~~~~~~-~~k---ii~--~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~HPw 766 (853)
||||||++|+|++|+.||.+...... .+. ... ............++++.+||.+||..||.+|||+.++|+|||
T Consensus 276 iwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~ 355 (371)
T 3q60_A 276 AWQLGLSIYRVWCLFLPFGLVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPE 355 (371)
T ss_dssp HHHHHHHHHHHHHSSCSTTBCCTTCTTCCCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTSHH
T ss_pred HHHHHHHHHHHHhCCCCCCCcCcccccchhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCHH
Confidence 99999999999999999976422100 000 011 111122223467899999999999999999999999999999
Q ss_pred CC
Q 003052 767 LV 768 (853)
Q Consensus 767 f~ 768 (853)
|.
T Consensus 356 f~ 357 (371)
T 3q60_A 356 FL 357 (371)
T ss_dssp HH
T ss_pred HH
Confidence 95
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-42 Score=365.08 Aligned_cols=251 Identities=25% Similarity=0.445 Sum_probs=208.2
Q ss_pred ceeeEEEeEeccCceEEEEEEec-CCcEEEEEEEecCCCC-hhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHHH
Q 003052 472 KLYQRLGKIGSGGSSEVHKVISS-DCTIYALKKIKLKGRD-YATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLRE 549 (853)
Q Consensus 472 ~~Y~ilk~LG~G~FG~Vyka~~~-~g~~vAVKkik~~~~~-~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~~ 549 (853)
+.|++.+.||+|+||.||+|.+. ++..||||++...... ......+.+|+.++++++ |+||++++++
T Consensus 14 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~---------- 82 (284)
T 2vgo_A 14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLR-HPNILRMYNY---------- 82 (284)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCC-CTTBCCEEEE----------
T ss_pred hhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCC-CCCEeeEEEE----------
Confidence 56999999999999999999985 6688999999754221 122346789999999997 8999999987
Q ss_pred HhhCCCCCCCCccccCCeEEEEEecch-hhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCCC
Q 003052 550 VLNGSMNNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKP 628 (853)
Q Consensus 550 l~~~~iv~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLKP 628 (853)
+.+.+.+|+||||+. ++|.+++... ..+++..++.++.||+.||.|||++||+||||||
T Consensus 83 ------------~~~~~~~~lv~e~~~~~~L~~~l~~~--------~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p 142 (284)
T 2vgo_A 83 ------------FHDRKRIYLMLEFAPRGELYKELQKH--------GRFDEQRSATFMEELADALHYCHERKVIHRDIKP 142 (284)
T ss_dssp ------------EECSSEEEEEECCCTTEEHHHHHHHH--------SSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSG
T ss_pred ------------EEcCCEEEEEEEeCCCCcHHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCH
Confidence 456678999999986 5999888764 4699999999999999999999999999999999
Q ss_pred ccEEe-ecCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHhCC
Q 003052 629 ANFLL-VKGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGR 707 (853)
Q Consensus 629 eNILL-~~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLtG~ 707 (853)
+|||+ .++.+||+|||++...... .....+||+.|+|||++.+. .++.++|||||||++|+|++|.
T Consensus 143 ~Nil~~~~~~~kl~Dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~---------~~~~~~Di~slG~il~~l~~g~ 209 (284)
T 2vgo_A 143 ENLLMGYKGELKIADFGWSVHAPSL----RRRTMCGTLDYLPPEMIEGK---------THDEKVDLWCAGVLCYEFLVGM 209 (284)
T ss_dssp GGEEECTTCCEEECCCTTCEECSSS----CBCCCCSCGGGCCHHHHTTC---------CBCTTHHHHHHHHHHHHHHHSS
T ss_pred HHEEEcCCCCEEEecccccccCccc----ccccccCCCCcCCHHHhccC---------CCCcccchhhHHHHHHHHHHCC
Confidence 99999 4679999999999755332 22356899999999999764 3567999999999999999999
Q ss_pred CCCCcchhHHHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCCChhHHhcCCCCCC
Q 003052 708 TPFSEYKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQHPFLVP 769 (853)
Q Consensus 708 ~PF~~~~~~~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~HPwf~~ 769 (853)
.||...........+.. ....++...+..+++||.+||..||.+||++.++++||||+.
T Consensus 210 ~pf~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h~~~~~ 268 (284)
T 2vgo_A 210 PPFDSPSHTETHRRIVN---VDLKFPPFLSDGSKDLISKLLRYHPPQRLPLKGVMEHPWVKA 268 (284)
T ss_dssp CTTCCSSHHHHHHHHHT---TCCCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTCHHHHH
T ss_pred CCCCCCCHhHHHHHHhc---cccCCCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhhCHHHHh
Confidence 99987554433333322 223455677899999999999999999999999999999964
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-42 Score=367.78 Aligned_cols=263 Identities=27% Similarity=0.437 Sum_probs=206.4
Q ss_pred CceeeEEEeEeccCceEEEEEEec-CCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHHH
Q 003052 471 GKLYQRLGKIGSGGSSEVHKVISS-DCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLRE 549 (853)
Q Consensus 471 g~~Y~ilk~LG~G~FG~Vyka~~~-~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~~ 549 (853)
.+.|++++.||+|+||.||+|.+. +++.||+|++..... .....+.+|+.++++++ ||||++++++
T Consensus 18 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~e~~~l~~l~-h~~i~~~~~~---------- 84 (302)
T 2j7t_A 18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSE--EELEDYIVEIEILATCD-HPYIVKLLGA---------- 84 (302)
T ss_dssp GGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC------CCHHHHHHHHHHHHHCC-CTTBCCEEEE----------
T ss_pred ccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCH--HHHHHHHHHHHHHhcCC-CCCEeeeeee----------
Confidence 367999999999999999999985 678999999975532 33456889999999996 9999999987
Q ss_pred HhhCCCCCCCCccccCCeEEEEEecchh-hHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCCC
Q 003052 550 VLNGSMNNKDGRVKDDGYIYMVLEYGEI-DLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKP 628 (853)
Q Consensus 550 l~~~~iv~~~g~~~d~~~lyLVmEy~~g-dL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLKP 628 (853)
+.+++.+|+||||+++ +|.+++... ...+++..++.++.||+.||.|||++||+||||||
T Consensus 85 ------------~~~~~~~~lv~e~~~~~~l~~~~~~~-------~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp 145 (302)
T 2j7t_A 85 ------------YYHDGKLWIMIEFCPGGAVDAIMLEL-------DRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKA 145 (302)
T ss_dssp ------------EECC-CEEEEEECCTTEEHHHHHHHH-------TSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSG
T ss_pred ------------eeeCCeEEEEEEeCCCCcHHHHHHhh-------ccCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCH
Confidence 3456689999999864 787777653 24699999999999999999999999999999999
Q ss_pred ccEEee-cCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHhCC
Q 003052 629 ANFLLV-KGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGR 707 (853)
Q Consensus 629 eNILL~-~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLtG~ 707 (853)
+|||++ ++.+||+|||++........ .....+||+.|+|||++...... ...++.++|||||||++|+|++|.
T Consensus 146 ~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~----~~~~~~~~Di~slG~il~~l~~g~ 219 (302)
T 2j7t_A 146 GNVLMTLEGDIRLADFGVSAKNLKTLQ--KRDSFIGTPYWMAPEVVMCETMK----DTPYDYKADIWSLGITLIEMAQIE 219 (302)
T ss_dssp GGEEECTTSCEEECCCHHHHHHHHHHH--C-----CCGGGCCHHHHHHHHTT----STTTTTHHHHHHHHHHHHHHHHSS
T ss_pred HHEEECCCCCEEEEECCCCcccccccc--ccccccCChhhcCCeeeccccCC----CCCCchhhhHHHHHHHHHHHhcCC
Confidence 999995 67999999999865432111 12356899999999998532110 114678999999999999999999
Q ss_pred CCCCcchhHHHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCCChhHHhcCCCCCCCC
Q 003052 708 TPFSEYKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQHPFLVPPV 771 (853)
Q Consensus 708 ~PF~~~~~~~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~HPwf~~~~ 771 (853)
.||......................+...+..+.+||.+||..||.+|||+.++++||||....
T Consensus 220 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~ 283 (302)
T 2j7t_A 220 PPHHELNPMRVLLKIAKSDPPTLLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLEHPFVSSIT 283 (302)
T ss_dssp CTTTTSCHHHHHHHHHHSCCCCCSSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTTSTTTTTCC
T ss_pred CCCccCCHHHHHHHHhccCCcccCCccccCHHHHHHHHHHcccChhhCCCHHHHhcChHHhhhc
Confidence 9998766554444444433333334456788899999999999999999999999999998643
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-43 Score=366.07 Aligned_cols=255 Identities=27% Similarity=0.436 Sum_probs=186.5
Q ss_pred ceeeEEEeEeccCceEEEEEEe-cCCcEEEEEEEecCCC-ChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHHH
Q 003052 472 KLYQRLGKIGSGGSSEVHKVIS-SDCTIYALKKIKLKGR-DYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLRE 549 (853)
Q Consensus 472 ~~Y~ilk~LG~G~FG~Vyka~~-~~g~~vAVKkik~~~~-~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~~ 549 (853)
+.|++.+.||+|+||.||+|.+ .+++.||||++..... .......+.+|+.++++++ |+||++++++
T Consensus 11 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~---------- 79 (278)
T 3cok_A 11 EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLK-HPSILELYNY---------- 79 (278)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBC-CTTBCCEEEE----------
T ss_pred ccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCC-CCCeEeEEEE----------
Confidence 4699999999999999999998 5788999999975422 1122356889999999997 8999999987
Q ss_pred HhhCCCCCCCCccccCCeEEEEEecch-hhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCCC
Q 003052 550 VLNGSMNNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKP 628 (853)
Q Consensus 550 l~~~~iv~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLKP 628 (853)
+.+.+.+|+||||++ ++|.+++... ...+++..++.++.||+.||.|||++||+||||||
T Consensus 80 ------------~~~~~~~~lv~e~~~~~~L~~~l~~~-------~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p 140 (278)
T 3cok_A 80 ------------FEDSNYVYLVLEMCHNGEMNRYLKNR-------VKPFSENEARHFMHQIITGMLYLHSHGILHRDLTL 140 (278)
T ss_dssp ------------EECSSEEEEEEECCTTEEHHHHHHTC-------SSCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCG
T ss_pred ------------EccCCeEEEEEecCCCCcHHHHHhhc-------cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCH
Confidence 456778999999985 5888887642 35799999999999999999999999999999999
Q ss_pred ccEEe-ecCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHhCC
Q 003052 629 ANFLL-VKGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGR 707 (853)
Q Consensus 629 eNILL-~~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLtG~ 707 (853)
+|||+ .++.+||+|||++........ .....+||+.|+|||++.+. .++.++|||||||++|+|++|+
T Consensus 141 ~Nili~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~---------~~~~~~Di~slG~il~~l~~g~ 209 (278)
T 3cok_A 141 SNLLLTRNMNIKIADFGLATQLKMPHE--KHYTLCGTPNYISPEIATRS---------AHGLESDVWSLGCMFYTLLIGR 209 (278)
T ss_dssp GGEEECTTCCEEECCCTTCEECC---------------------------------------CTHHHHHHHHHHHHHHSS
T ss_pred HHEEEcCCCCEEEEeecceeeccCCCC--cceeccCCCCcCCcchhcCC---------CCCchhhHHHHHHHHHHHHhCC
Confidence 99999 467999999999986543222 12356899999999998754 3567999999999999999999
Q ss_pred CCCCcchhHHHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCCChhHHhcCCCCCCC
Q 003052 708 TPFSEYKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQHPFLVPP 770 (853)
Q Consensus 708 ~PF~~~~~~~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~HPwf~~~ 770 (853)
.||............. ......+...+..+.+||.+||..||.+||++.++|+||||...
T Consensus 210 ~p~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~ 269 (278)
T 3cok_A 210 PPFDTDTVKNTLNKVV---LADYEMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLDHPFMSRN 269 (278)
T ss_dssp CSSCCCSCC-----CC---SSCCCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSTTTC--
T ss_pred CCCCChhHHHHHHHHh---hcccCCccccCHHHHHHHHHHcccCHhhCCCHHHHhcCccccCC
Confidence 9997643222111111 12233455678899999999999999999999999999999754
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-43 Score=380.93 Aligned_cols=256 Identities=27% Similarity=0.405 Sum_probs=205.7
Q ss_pred EcCceeeEEEeEeccCceEEEEEEec-CCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHH
Q 003052 469 VNGKLYQRLGKIGSGGSSEVHKVISS-DCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALL 547 (853)
Q Consensus 469 v~g~~Y~ilk~LG~G~FG~Vyka~~~-~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL 547 (853)
+..++|++++.||+|+||.||+|.+. ++..||+|++.... .......+.+|+.+|++++ |+||++++++
T Consensus 30 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~-------- 99 (360)
T 3eqc_A 30 LKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI-KPAIRNQIIRELQVLHECN-SPYIVGFYGA-------- 99 (360)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCC-CHHHHHHHHHHHGGGGGCC-CTTBCCEEEE--------
T ss_pred cccccceeeeeecCCCCeEEEEEEECCCCcEEEEEEecccc-CHHHHHHHHHHHHHHHHCC-CCCEEEEeEE--------
Confidence 34567999999999999999999985 77899999998653 3445567899999999996 9999999987
Q ss_pred HHHhhCCCCCCCCccccCCeEEEEEecchh-hHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccC-ceeeCC
Q 003052 548 REVLNGSMNNKDGRVKDDGYIYMVLEYGEI-DLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEE-RIVHSD 625 (853)
Q Consensus 548 ~~l~~~~iv~~~g~~~d~~~lyLVmEy~~g-dL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~-gIIHRD 625 (853)
+.+++.+|+||||+.+ +|.+++... ..+++..++.++.||+.||.|||+. ||+|||
T Consensus 100 --------------~~~~~~~~lv~e~~~~~~L~~~l~~~--------~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~d 157 (360)
T 3eqc_A 100 --------------FYSDGEISICMEHMDGGSLDQVLKKA--------GRIPEQILGKVSIAVIKGLTYLREKHKIMHRD 157 (360)
T ss_dssp --------------EEETTEEEEEECCCTTCBHHHHHHHH--------SSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSC
T ss_pred --------------EEECCEEEEEEECCCCCCHHHHHHHc--------CCCCHHHHHHHHHHHHHHHHHHHHhCCEEcCC
Confidence 4556789999999865 999988764 4699999999999999999999996 999999
Q ss_pred CCCccEEe-ecCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHH
Q 003052 626 LKPANFLL-VKGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMV 704 (853)
Q Consensus 626 LKPeNILL-~~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELL 704 (853)
|||+|||+ .++.+||+|||+++...... ....+||+.|+|||++.+. .|+.++|||||||++|+|+
T Consensus 158 lkp~Nil~~~~~~~kl~Dfg~~~~~~~~~----~~~~~gt~~y~aPE~~~~~---------~~~~~~Di~slG~il~~l~ 224 (360)
T 3eqc_A 158 VKPSNILVNSRGEIKLCDFGVSGQLIDSM----ANSFVGTRSYMSPERLQGT---------HYSVQSDIWSMGLSLVEMA 224 (360)
T ss_dssp CSGGGEEECTTCCEEECCCCCCHHHHHHC--------CCCCTTCCHHHHTTC---------CCSHHHHHHHHHHHHHHHH
T ss_pred ccHHHEEECCCCCEEEEECCCCccccccc----ccCCCCCCCeECHHHHcCC---------CCCchhhHHHHHHHHHHHH
Confidence 99999999 46799999999998664322 2356899999999999765 3568999999999999999
Q ss_pred hCCCCCCcchhHHHH-----------------------------------------HHhhcCCCCcccCCCCCChhHHHH
Q 003052 705 YGRTPFSEYKTFWAK-----------------------------------------FKVITDPNHEITYEPVPNPWLLDL 743 (853)
Q Consensus 705 tG~~PF~~~~~~~~~-----------------------------------------~kii~~~~~~~~~~~~~s~~l~dL 743 (853)
+|+.||......... ...+.............+.++.+|
T Consensus 225 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 304 (360)
T 3eqc_A 225 VGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDF 304 (360)
T ss_dssp HTSCCSSCCCHHHHHHHHC------------------------------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHH
T ss_pred hCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCCCcccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHH
Confidence 999999653321110 001111111111223467889999
Q ss_pred HHHhcccCCCCCCChhHHhcCCCCCC
Q 003052 744 MKKCLAWDRNERWRIPQLLQHPFLVP 769 (853)
Q Consensus 744 I~kcL~~DP~kRpTa~EIL~HPwf~~ 769 (853)
|.+||.+||.+|||+.|+|+||||+.
T Consensus 305 i~~~L~~dP~~Rpt~~ell~hp~~~~ 330 (360)
T 3eqc_A 305 VNKCLIKNPAERADLKQLMVHAFIKR 330 (360)
T ss_dssp HHHHHCSSTTTSCCHHHHHTSHHHHH
T ss_pred HHHHhhcChhhCCCHHHHhhChHhhc
Confidence 99999999999999999999999964
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-43 Score=409.01 Aligned_cols=257 Identities=26% Similarity=0.403 Sum_probs=210.0
Q ss_pred cCceeeEEEeEeccCceEEEEEEec-CCcEEEEEEEecCCC-ChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHH
Q 003052 470 NGKLYQRLGKIGSGGSSEVHKVISS-DCTIYALKKIKLKGR-DYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALL 547 (853)
Q Consensus 470 ~g~~Y~ilk~LG~G~FG~Vyka~~~-~g~~vAVKkik~~~~-~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL 547 (853)
..+.|++++.||+|+||.||+|.+. +++.||||++.+... .......+.+|+.+|++++ |+||++++++
T Consensus 182 ~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~-hp~Iv~l~~~-------- 252 (576)
T 2acx_A 182 TKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVN-SRFVVSLAYA-------- 252 (576)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCC-CTTBCCEEEE--------
T ss_pred cccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcC-CCCEeeEEEE--------
Confidence 3467999999999999999999984 789999999975421 1123345789999999997 8999999876
Q ss_pred HHHhhCCCCCCCCccccCCeEEEEEecch-hhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCC
Q 003052 548 REVLNGSMNNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDL 626 (853)
Q Consensus 548 ~~l~~~~iv~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDL 626 (853)
+.+...+|+||||+. ++|.+++... ....+++..++.|+.||+.||.|||++||+||||
T Consensus 253 --------------~~~~~~l~lVmEy~~gg~L~~~l~~~------~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDL 312 (576)
T 2acx_A 253 --------------YETKDALCLVLTLMNGGDLKFHIYHM------GQAGFPEARAVFYAAEICCGLEDLHRERIVYRDL 312 (576)
T ss_dssp --------------EECSSEEEEEECCCCSCBHHHHHHSS------SSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCC
T ss_pred --------------EeeCCEEEEEEEcCCCCcHHHHHHhc------CCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCC
Confidence 567788999999985 6998888653 2245999999999999999999999999999999
Q ss_pred CCccEEe-ecCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHh
Q 003052 627 KPANFLL-VKGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVY 705 (853)
Q Consensus 627 KPeNILL-~~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLt 705 (853)
||+|||| .+|.+||+|||+|+.+.... .....+||+.|+|||++.+. .|+.++|||||||++|||++
T Consensus 313 KPeNILld~~g~vKL~DFGla~~~~~~~---~~~~~~GT~~Y~APEvl~~~---------~~~~~~DiwSLGvilyeLlt 380 (576)
T 2acx_A 313 KPENILLDDHGHIRISDLGLAVHVPEGQ---TIKGRVGTVGYMAPEVVKNE---------RYTFSPDWWALGCLLYEMIA 380 (576)
T ss_dssp CGGGEEECTTSCEEECCCTTCEECCTTC---CEECCCSCGGGCCHHHHTTC---------EESSHHHHHHHHHHHHHHHH
T ss_pred chheEEEeCCCCeEEEecccceecccCc---cccccCCCccccCHHHHcCC---------CCCccchHHHHHHHHHHHHh
Confidence 9999999 46899999999998764332 22356999999999999764 36789999999999999999
Q ss_pred CCCCCCcch---hHHHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCC-----ChhHHhcCCCCCC
Q 003052 706 GRTPFSEYK---TFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERW-----RIPQLLQHPFLVP 769 (853)
Q Consensus 706 G~~PF~~~~---~~~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRp-----Ta~EIL~HPwf~~ 769 (853)
|++||.... ........+.. ....++...++++++||.+||.+||.+|| ++.||++||||..
T Consensus 381 G~~PF~~~~~~~~~~~i~~~i~~--~~~~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~HpfF~~ 450 (576)
T 2acx_A 381 GQSPFQQRKKKIKREEVERLVKE--VPEEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFKK 450 (576)
T ss_dssp SSCSSSCSSSCCCHHHHHHHHHH--CCCCCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTSGGGTT
T ss_pred CCCCCcccccchhHHHHHHHhhc--ccccCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhChhhcc
Confidence 999997642 12223333322 22345567889999999999999999999 7999999999974
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-42 Score=360.87 Aligned_cols=262 Identities=29% Similarity=0.428 Sum_probs=212.9
Q ss_pred ceeeEEEeEeccCceEEEEEEec-CCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHHHH
Q 003052 472 KLYQRLGKIGSGGSSEVHKVISS-DCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLREV 550 (853)
Q Consensus 472 ~~Y~ilk~LG~G~FG~Vyka~~~-~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~~l 550 (853)
++|++++.||+|+||.||+|.+. +++.||+|++............+.+|+.++++++ |+||+++++++..
T Consensus 6 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~-------- 76 (279)
T 2w5a_A 6 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELK-HPNIVRYYDRIID-------- 76 (279)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCC-CTTBCCEEEEEEE--------
T ss_pred hheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcC-CCCCCeEEEEEec--------
Confidence 56999999999999999999984 7799999999877666666778999999999997 9999999986421
Q ss_pred hhCCCCCCCCccccCCeEEEEEecch-hhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCc-----eeeC
Q 003052 551 LNGSMNNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEER-----IVHS 624 (853)
Q Consensus 551 ~~~~iv~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~g-----IIHR 624 (853)
.....+|+||||++ ++|.+++..... ....+++..++.++.||+.||.|||++| |+||
T Consensus 77 ------------~~~~~~~lv~e~~~~~~L~~~l~~~~~----~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~ 140 (279)
T 2w5a_A 77 ------------RTNTTLYIVMEYCEGGDLASVITKGTK----ERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHR 140 (279)
T ss_dssp ------------GGGTEEEEEEECCTTEEHHHHHHHHHH----TTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCC
T ss_pred ------------CCCceEEEEEeCCCCCCHHHHHHhhcc----cCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEe
Confidence 23567999999986 499999876532 2356999999999999999999999999 9999
Q ss_pred CCCCccEEee-cCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHH
Q 003052 625 DLKPANFLLV-KGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQM 703 (853)
Q Consensus 625 DLKPeNILL~-~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyEL 703 (853)
||||+|||++ ++.+||+|||+++....... ......||+.|+|||++.+. .++.++|||||||++|+|
T Consensus 141 dl~p~NIl~~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~---------~~~~~~Di~slG~il~~l 209 (279)
T 2w5a_A 141 DLKPANVFLDGKQNVKLGDFGLARILNHDTS--FAKTFVGTPYYMSPEQMNRM---------SYNEKSDIWSLGCLLYEL 209 (279)
T ss_dssp CCSGGGEEECSSSCEEECCCCHHHHC---CH--HHHHHHSCCTTCCHHHHHCC----------CCHHHHHHHHHHHHHHH
T ss_pred ccchhhEEEcCCCCEEEecCchheeeccccc--cccccCCCccccChHHhccC---------CCCchhhHHHHHHHHHHH
Confidence 9999999995 67999999999987643221 12356899999999999765 356799999999999999
Q ss_pred HhCCCCCCcchhHHHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCCChhHHhcCCCCCCCC
Q 003052 704 VYGRTPFSEYKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQHPFLVPPV 771 (853)
Q Consensus 704 LtG~~PF~~~~~~~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~HPwf~~~~ 771 (853)
++|+.||...........+.... ....+...+..+.+||.+||..||.+||++.|||+|+|+..+.
T Consensus 210 ~~g~~p~~~~~~~~~~~~i~~~~--~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~~~~ 275 (279)
T 2w5a_A 210 CALMPPFTAFSQKELAGKIREGK--FRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLILEHH 275 (279)
T ss_dssp HHSSCSSCCSSHHHHHHHHHHTC--CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCCGGG
T ss_pred HHCCCCCcccCHHHHHHHHhhcc--cccCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhChhhhhhc
Confidence 99999998755433222222211 1234456788999999999999999999999999999998654
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-42 Score=368.55 Aligned_cols=268 Identities=24% Similarity=0.455 Sum_probs=206.5
Q ss_pred CceeeEEEeEeccCceEEEEEEe-cCCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHHH
Q 003052 471 GKLYQRLGKIGSGGSSEVHKVIS-SDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLRE 549 (853)
Q Consensus 471 g~~Y~ilk~LG~G~FG~Vyka~~-~~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~~ 549 (853)
...|++++.||+|+||.||+|.+ .+++.||||++...... ...+.+|+.+++++.+|+||+++++++....
T Consensus 23 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~---~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~----- 94 (326)
T 2x7f_A 23 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDE---EEEIKQEINMLKKYSHHRNIATYYGAFIKKN----- 94 (326)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSST---THHHHHHHHHHHHHCCSTTBCCEEEEEEECC-----
T ss_pred CCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCccc---HHHHHHHHHHHHhccCCCCeeeeeeEEeecc-----
Confidence 45699999999999999999998 57889999999765433 3457899999999978999999999753210
Q ss_pred HhhCCCCCCCCccccCCeEEEEEecchh-hHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCCC
Q 003052 550 VLNGSMNNKDGRVKDDGYIYMVLEYGEI-DLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKP 628 (853)
Q Consensus 550 l~~~~iv~~~g~~~d~~~lyLVmEy~~g-dL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLKP 628 (853)
.......+|+||||+++ +|.+++... ....+++..++.++.||+.||.|||++||+||||||
T Consensus 95 -----------~~~~~~~~~lv~e~~~~~~L~~~l~~~------~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp 157 (326)
T 2x7f_A 95 -----------PPGMDDQLWLVMEFCGAGSVTDLIKNT------KGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKG 157 (326)
T ss_dssp -------------CCCCEEEEEEECCTTEEHHHHHHHS------GGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSG
T ss_pred -----------CccccceEEEEEEcCCCCcHHHHHHhc------ccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcH
Confidence 01125689999999865 999988764 124699999999999999999999999999999999
Q ss_pred ccEEee-cCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHhCC
Q 003052 629 ANFLLV-KGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGR 707 (853)
Q Consensus 629 eNILL~-~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLtG~ 707 (853)
+|||++ ++.+||+|||++........ .....+||+.|+|||++.+.... ...++.++|||||||++|+|++|.
T Consensus 158 ~NIl~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~----~~~~~~~~Di~slG~il~~l~~g~ 231 (326)
T 2x7f_A 158 QNVLLTENAEVKLVDFGVSAQLDRTVG--RRNTFIGTPYWMAPEVIACDENP----DATYDFKSDLWSLGITAIEMAEGA 231 (326)
T ss_dssp GGEEECTTCCEEECCCTTTC---------------CCGGGCCHHHHC------------CCTTHHHHHHHHHHHHHHHSS
T ss_pred HHEEEcCCCCEEEeeCcCceecCcCcc--ccccccCCccccChhhhcccccc----CcCCCccchHHHHHHHHHHHHhCC
Confidence 999994 67999999999986643221 22356899999999999743211 124678999999999999999999
Q ss_pred CCCCcchhHHHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCCChhHHhcCCCCCCC
Q 003052 708 TPFSEYKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQHPFLVPP 770 (853)
Q Consensus 708 ~PF~~~~~~~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~HPwf~~~ 770 (853)
.||.+.........+...... .......+..+.+||.+||..||.+||++.++|+||||...
T Consensus 232 ~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~hp~~~~~ 293 (326)
T 2x7f_A 232 PPLCDMHPMRALFLIPRNPAP-RLKSKKWSKKFQSFIESCLVKNHSQRPATEQLMKHPFIRDQ 293 (326)
T ss_dssp CTTTTSCHHHHHHHHHHSCCC-CCSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTSHHHHCC
T ss_pred CCCCCCcHHHHHHHhhcCccc-cCCccccCHHHHHHHHHHhccChhhCCCHHHHhhChHHhhC
Confidence 999876655444444333222 22345678899999999999999999999999999999753
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-42 Score=376.58 Aligned_cols=265 Identities=25% Similarity=0.343 Sum_probs=194.8
Q ss_pred ceeeEEEeEeccCceEEEEEEe-cCCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHHHH
Q 003052 472 KLYQRLGKIGSGGSSEVHKVIS-SDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLREV 550 (853)
Q Consensus 472 ~~Y~ilk~LG~G~FG~Vyka~~-~~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~~l 550 (853)
++|++.+.||+|+||.||+|.+ .+++.||||++...... ...+.+|++.+..++ |+||+++++++...
T Consensus 23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~~~~l~~l~-h~niv~~~~~~~~~------- 91 (360)
T 3e3p_A 23 DRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRF---RNRELQIMQDLAVLH-HPNIVQLQSYFYTL------- 91 (360)
T ss_dssp TTEEEC----------CEEEEETTTCCEEEEEEEECCTTC---CCHHHHHHHHHHHHC-CTTBCCEEEEEEEE-------
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCccc---cHHHHHHHHHHHhcC-CCCcccHHHhhhcc-------
Confidence 4599999999999999999998 46789999999654322 234667888888886 99999999985321
Q ss_pred hhCCCCCCCCccccCCeEEEEEecchhhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcc--cCceeeCCCCC
Q 003052 551 LNGSMNNKDGRVKDDGYIYMVLEYGEIDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIH--EERIVHSDLKP 628 (853)
Q Consensus 551 ~~~~iv~~~g~~~d~~~lyLVmEy~~gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLH--s~gIIHRDLKP 628 (853)
........++|+||||++++|...+..... ....+++..++.++.||+.||.||| ++||+||||||
T Consensus 92 --------~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~----~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp 159 (360)
T 3e3p_A 92 --------GERDRRDIYLNVVMEYVPDTLHRCCRNYYR----RQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKP 159 (360)
T ss_dssp --------CSSCTTCEEEEEEEECCSCBHHHHHHHHHT----TTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCG
T ss_pred --------ccccccceeEEEEeecccccHHHHHHHHhh----cccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCH
Confidence 011233446899999999888777665432 3467999999999999999999999 99999999999
Q ss_pred ccEEee--cCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHhC
Q 003052 629 ANFLLV--KGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYG 706 (853)
Q Consensus 629 eNILL~--~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLtG 706 (853)
+|||++ ++.+||+|||+++.+..... ....+||+.|+|||++.+.. .|+.++|||||||++|+|++|
T Consensus 160 ~NIll~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~--------~~~~~~Di~slG~il~ell~g 228 (360)
T 3e3p_A 160 HNVLVNEADGTLKLCDFGSAKKLSPSEP---NVAYICSRYYRAPELIFGNQ--------HYTTAVDIWSVGCIFAEMMLG 228 (360)
T ss_dssp GGEEEETTTTEEEECCCTTCBCCCTTSC---CCSTTSCGGGCCHHHHTTCS--------SCCTHHHHHHHHHHHHHHHHS
T ss_pred HHEEEeCCCCcEEEeeCCCceecCCCCC---cccccCCcceeCHHHHcCCC--------CCCcHHHHHHHHHHHHHHHhC
Confidence 999995 57999999999987654322 23568999999999996542 367899999999999999999
Q ss_pred CCCCCcchhHHHHHHhh---cCCC-----------Ccc---------------cCCCCCChhHHHHHHHhcccCCCCCCC
Q 003052 707 RTPFSEYKTFWAKFKVI---TDPN-----------HEI---------------TYEPVPNPWLLDLMKKCLAWDRNERWR 757 (853)
Q Consensus 707 ~~PF~~~~~~~~~~kii---~~~~-----------~~~---------------~~~~~~s~~l~dLI~kcL~~DP~kRpT 757 (853)
+.||.+.........+. ..+. ... ......++.+.+||.+||++||.+|||
T Consensus 229 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt 308 (360)
T 3e3p_A 229 EPIFRGDNSAGQLHEIVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMK 308 (360)
T ss_dssp SCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCC
T ss_pred CCCcCCCChHHHHHHHHHHcCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCC
Confidence 99997654433222221 1110 000 011224567999999999999999999
Q ss_pred hhHHhcCCCCCCC
Q 003052 758 IPQLLQHPFLVPP 770 (853)
Q Consensus 758 a~EIL~HPwf~~~ 770 (853)
+.|+|+||||...
T Consensus 309 ~~e~l~hp~f~~~ 321 (360)
T 3e3p_A 309 PYEALCHPYFDEL 321 (360)
T ss_dssp HHHHTTSGGGGGG
T ss_pred HHHHhcCcccccc
Confidence 9999999999754
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-43 Score=395.13 Aligned_cols=257 Identities=32% Similarity=0.453 Sum_probs=193.4
Q ss_pred ceeeEEEeEeccCceEEEEEEe-cCCcEEEEEEEecCCC------ChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHH
Q 003052 472 KLYQRLGKIGSGGSSEVHKVIS-SDCTIYALKKIKLKGR------DYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEK 544 (853)
Q Consensus 472 ~~Y~ilk~LG~G~FG~Vyka~~-~~g~~vAVKkik~~~~------~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~ 544 (853)
+.|.+.+.||+|+||.||+|.+ .+++.||||++..... .......+.+|+.+|++++ ||||+++++++
T Consensus 135 ~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~l~~~~---- 209 (419)
T 3i6u_A 135 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLN-HPCIIKIKNFF---- 209 (419)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCC-CTTBCCCCEEE----
T ss_pred ccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCC-CCCEeeEEEEE----
Confidence 4699999999999999999998 4678999999976431 1223345889999999996 99999998863
Q ss_pred HHHHHHhhCCCCCCCCccccCCeEEEEEecch-hhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceee
Q 003052 545 ALLREVLNGSMNNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVH 623 (853)
Q Consensus 545 ~iL~~l~~~~iv~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIH 623 (853)
+...+|+||||+. ++|.+++.. ...+++..++.++.||+.||.|||++||+|
T Consensus 210 -------------------~~~~~~lv~e~~~~g~L~~~l~~--------~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH 262 (419)
T 3i6u_A 210 -------------------DAEDYYIVLELMEGGELFDKVVG--------NKRLKEATCKLYFYQMLLAVQYLHENGIIH 262 (419)
T ss_dssp -------------------ESSEEEEEEECCTTCBGGGGTSS--------SCCCCHHHHHHHHHHHHHHHHHHHHTTCCC
T ss_pred -------------------ecCceEEEEEcCCCCcHHHHHhc--------cCCCCHHHHHHHHHHHHHHHHHHHHCCccc
Confidence 2345799999986 477665542 367999999999999999999999999999
Q ss_pred CCCCCccEEeec----CcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHH
Q 003052 624 SDLKPANFLLVK----GSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCI 699 (853)
Q Consensus 624 RDLKPeNILL~~----g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVI 699 (853)
|||||+|||++. ..+||+|||+|+...... .....+||+.|+|||++.+... ..|+.++|||||||+
T Consensus 263 rDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~------~~~~~~~DiwslG~i 333 (419)
T 3i6u_A 263 RDLKPENVLLSSQEEDCLIKITDFGHSKILGETS---LMRTLCGTPTYLAPEVLVSVGT------AGYNRAVDCWSLGVI 333 (419)
T ss_dssp SCCCGGGEEESSSSSSCCEEECCSSTTTSCC--------------CTTCCTTTTC----------CTTHHHHHHHHHHHH
T ss_pred cCCChHhEEEecCCCcceEEEeecccceecCCCc---cccccCCCCCccCceeeecCCC------CCCCchhhhHhHHHH
Confidence 999999999942 259999999998764322 2346789999999999864221 146789999999999
Q ss_pred HHHHHhCCCCCCcchhHHHHHHhhcCCCCcc--cCCCCCChhHHHHHHHhcccCCCCCCChhHHhcCCCCCC
Q 003052 700 LYQMVYGRTPFSEYKTFWAKFKVITDPNHEI--TYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQHPFLVP 769 (853)
Q Consensus 700 LyELLtG~~PF~~~~~~~~~~kii~~~~~~~--~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~HPwf~~ 769 (853)
+|+|++|++||.+..........+....... ......++.+.+||.+||.+||.+||++.|+|+||||..
T Consensus 334 l~~lltg~~pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~ 405 (419)
T 3i6u_A 334 LFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQD 405 (419)
T ss_dssp HHHHHHSSCSSCCCSSSCCHHHHHHTTCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCC
T ss_pred HHHHHHCCCCCCCCcchHHHHHHHhcCCCCCCchhhcccCHHHHHHHHHHccCChhHCcCHHHHhCCcccCC
Confidence 9999999999975432222222222211111 122457888999999999999999999999999999964
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=385.49 Aligned_cols=252 Identities=27% Similarity=0.372 Sum_probs=199.9
Q ss_pred eeEEEeEeccCceEEEEEEe-cCCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHHHHhh
Q 003052 474 YQRLGKIGSGGSSEVHKVIS-SDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLREVLN 552 (853)
Q Consensus 474 Y~ilk~LG~G~FG~Vyka~~-~~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~~l~~ 552 (853)
|...+.||+|+||.||+|.+ .+++.||+|+++.... .....+.+|+.+|++++ |+||++++++
T Consensus 91 ~~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~-hpnIv~~~~~------------- 154 (373)
T 2x4f_A 91 VSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGM--KDKEEVKNEISVMNQLD-HANLIQLYDA------------- 154 (373)
T ss_dssp EEEEEECC-----CEEEEEETTTCCEEEEEEEECCSH--HHHHHHHHHHHHHTTCC-CTTBCCEEEE-------------
T ss_pred eecceEEecCcCEEEEEEEEcCCCcEEEEEEEccccc--ccHHHHHHHHHHHHhCC-CCCCCeEEEE-------------
Confidence 34467899999999999998 5688999999986532 34557889999999997 8999999987
Q ss_pred CCCCCCCCccccCCeEEEEEecch-hhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCCCccE
Q 003052 553 GSMNNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANF 631 (853)
Q Consensus 553 ~~iv~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLKPeNI 631 (853)
+.+.+.+|+||||++ ++|.+.+... ...+++..++.++.||+.||.|||++||+||||||+||
T Consensus 155 ---------~~~~~~~~lv~E~~~~~~L~~~l~~~-------~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NI 218 (373)
T 2x4f_A 155 ---------FESKNDIVLVMEYVDGGELFDRIIDE-------SYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENI 218 (373)
T ss_dssp ---------EECSSEEEEEEECCTTCEEHHHHHHT-------GGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGE
T ss_pred ---------EEECCEEEEEEeCCCCCcHHHHHHhc-------CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHE
Confidence 456678999999986 5888877643 24589999999999999999999999999999999999
Q ss_pred Eee---cCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHhCCC
Q 003052 632 LLV---KGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGRT 708 (853)
Q Consensus 632 LL~---~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLtG~~ 708 (853)
|+. ++.+||+|||+++.+..... ....+||+.|+|||++.+. .++.++|||||||++|+|++|+.
T Consensus 219 ll~~~~~~~~kl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~---------~~~~~~DiwslG~il~elltg~~ 286 (373)
T 2x4f_A 219 LCVNRDAKQIKIIDFGLARRYKPREK---LKVNFGTPEFLAPEVVNYD---------FVSFPTDMWSVGVIAYMLLSGLS 286 (373)
T ss_dssp EEEETTTTEEEECCCSSCEECCTTCB---CCCCCSSCTTCCHHHHTTC---------BCCHHHHHHHHHHHHHHHHHSSC
T ss_pred EEecCCCCcEEEEeCCCceecCCccc---cccccCCCcEeChhhccCC---------CCCcHHhHHHHHHHHHHHHhCCC
Confidence 993 35899999999987643322 2356899999999999654 35689999999999999999999
Q ss_pred CCCcchhHHHHHHhhcCCC-CcccCCCCCChhHHHHHHHhcccCCCCCCChhHHhcCCCCCC
Q 003052 709 PFSEYKTFWAKFKVITDPN-HEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQHPFLVP 769 (853)
Q Consensus 709 PF~~~~~~~~~~kii~~~~-~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~HPwf~~ 769 (853)
||.+.........++.... .........++++++||.+||.+||.+||++.|+|+||||..
T Consensus 287 pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~hp~~~~ 348 (373)
T 2x4f_A 287 PFLGDNDAETLNNILACRWDLEDEEFQDISEEAKEFISKLLIKEKSWRISASEALKHPWLSD 348 (373)
T ss_dssp TTCCSSHHHHHHHHHHTCCCSCSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHC
T ss_pred CCCCCCHHHHHHHHHhccCCCChhhhccCCHHHHHHHHHHcCCChhhCCCHHHHhcCcCcCC
Confidence 9987655443333332211 111222457889999999999999999999999999999964
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-42 Score=366.25 Aligned_cols=254 Identities=28% Similarity=0.387 Sum_probs=205.4
Q ss_pred ceeeEEEeEeccCceEEEEEEec-CCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHHHH
Q 003052 472 KLYQRLGKIGSGGSSEVHKVISS-DCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLREV 550 (853)
Q Consensus 472 ~~Y~ilk~LG~G~FG~Vyka~~~-~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~~l 550 (853)
+.|++.+.||+|+||.||+|.+. +++.||+|+++.... .....+.+|+.+|++++ |+||++++++
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~-h~~i~~~~~~----------- 74 (304)
T 2jam_A 9 KTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPA--FRDSSLENEIAVLKKIK-HENIVTLEDI----------- 74 (304)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC--------HHHHHHHHHHHCC-CTTBCCEEEE-----------
T ss_pred ccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccc--cchHHHHHHHHHHHhCC-CCCeeehhhh-----------
Confidence 56999999999999999999984 789999999986432 22345789999999997 8999999987
Q ss_pred hhCCCCCCCCccccCCeEEEEEecch-hhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCCCc
Q 003052 551 LNGSMNNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPA 629 (853)
Q Consensus 551 ~~~~iv~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLKPe 629 (853)
+.+...+|+||||+. ++|.+++... ..+++..++.++.||+.||.|||++||+||||||+
T Consensus 75 -----------~~~~~~~~lv~e~~~~~~L~~~l~~~--------~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~ 135 (304)
T 2jam_A 75 -----------YESTTHYYLVMQLVSGGELFDRILER--------GVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPE 135 (304)
T ss_dssp -----------EECSSEEEEEECCCCSCBHHHHHHHH--------SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGG
T ss_pred -----------cccCCEEEEEEEcCCCccHHHHHHHc--------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHH
Confidence 456778999999985 5998888654 46999999999999999999999999999999999
Q ss_pred cEEe---e-cCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHh
Q 003052 630 NFLL---V-KGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVY 705 (853)
Q Consensus 630 NILL---~-~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLt 705 (853)
|||+ + ++.+||+|||+++..... .....+||+.|+|||++.+. .|+.++|||||||++|+|++
T Consensus 136 NIl~~~~~~~~~~kl~Dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~---------~~~~~~Di~slG~il~~l~~ 202 (304)
T 2jam_A 136 NLLYLTPEENSKIMITDFGLSKMEQNG----IMSTACGTPGYVAPEVLAQK---------PYSKAVDCWSIGVITYILLC 202 (304)
T ss_dssp GCEESSSSTTCCEEBCSCSTTCCCCCB----TTHHHHSCCCBCCTTTBSSC---------SCCHHHHHHHHHHHHHHHHH
T ss_pred HEEEecCCCCCCEEEccCCcceecCCC----ccccccCCCCccChHHhccC---------CCCchhhHHHHHHHHHHHHH
Confidence 9999 2 468999999999754322 22356799999999999754 35689999999999999999
Q ss_pred CCCCCCcchhHHHHHHhhcCC-CCcccCCCCCChhHHHHHHHhcccCCCCCCChhHHhcCCCCCCCC
Q 003052 706 GRTPFSEYKTFWAKFKVITDP-NHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQHPFLVPPV 771 (853)
Q Consensus 706 G~~PF~~~~~~~~~~kii~~~-~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~HPwf~~~~ 771 (853)
|+.||.+.........+.... ..........++.+.+||.+||..||.+||++.|+|+||||....
T Consensus 203 g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~ 269 (304)
T 2jam_A 203 GYPPFYEETESKLFEKIKEGYYEFESPFWDDISESAKDFICHLLEKDPNERYTCEKALSHPWIDGNT 269 (304)
T ss_dssp SSCTTTTSCHHHHHHHHHHCCCCCCTTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHSSC
T ss_pred CCCCCCCCCHHHHHHHHHcCCCCCCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCccccCCC
Confidence 999997654432222222211 112223356788999999999999999999999999999997654
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=378.09 Aligned_cols=266 Identities=21% Similarity=0.347 Sum_probs=208.9
Q ss_pred eEEcCceeeEEEeEeccCceEEEEEEe------cCCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehh
Q 003052 467 FKVNGKLYQRLGKIGSGGSSEVHKVIS------SDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYE 540 (853)
Q Consensus 467 ~~v~g~~Y~ilk~LG~G~FG~Vyka~~------~~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~ 540 (853)
+.+..++|++.+.||+|+||.||+|.+ .+++.||||+++... .......+.+|+++|.++.+||||+++++++
T Consensus 17 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~ 95 (359)
T 3vhe_A 17 WEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNLLGAC 95 (359)
T ss_dssp HBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred ccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcC-CHHHHHHHHHHHHHHHhhcCCcceeeeeeee
Confidence 345567899999999999999999984 345789999997543 3344567899999999998899999999874
Q ss_pred hhHHHHHHHHhhCCCCCCCCccccCCeEEEEEecch-hhHHHHHHHhhhhcc----------------------------
Q 003052 541 VTEKALLREVLNGSMNNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEMD---------------------------- 591 (853)
Q Consensus 541 ~~e~~iL~~l~~~~iv~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~~~---------------------------- 591 (853)
. ..+..+|+||||+. ++|.+++........
T Consensus 96 ~---------------------~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 154 (359)
T 3vhe_A 96 T---------------------KPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLD 154 (359)
T ss_dssp C---------------------STTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-------------------------
T ss_pred e---------------------cCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhcccc
Confidence 2 23445899999986 499999876422100
Q ss_pred ------------------------------CCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCCCccEEe-ecCcEEE
Q 003052 592 ------------------------------GSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLL-VKGSLKL 640 (853)
Q Consensus 592 ------------------------------~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLKPeNILL-~~g~VKL 640 (853)
.....+++..++.|+.||+.||.|||++||+||||||+|||+ .++.+||
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl 234 (359)
T 3vhe_A 155 SITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKI 234 (359)
T ss_dssp -----------------------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEE
T ss_pred ccCccccccccccccccccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCcEEE
Confidence 002238999999999999999999999999999999999999 4679999
Q ss_pred EecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHh-CCCCCCcchhHHHH
Q 003052 641 IDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVY-GRTPFSEYKTFWAK 719 (853)
Q Consensus 641 ~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLt-G~~PF~~~~~~~~~ 719 (853)
+|||+++.+.............||+.|+|||++.+. .|+.++|||||||++|+|++ |..||.+.......
T Consensus 235 ~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~---------~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~ 305 (359)
T 3vhe_A 235 CDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDR---------VYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF 305 (359)
T ss_dssp CCCGGGSCTTSCTTCEEC--CEECGGGCCHHHHHHC---------CCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHH
T ss_pred EeccceeeecccccchhccccCCCceeEChhhhcCC---------CCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHH
Confidence 999999876544433344567899999999999765 35689999999999999998 99999764432222
Q ss_pred HHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCCChhHHhcC
Q 003052 720 FKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQH 764 (853)
Q Consensus 720 ~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~H 764 (853)
...+.. ......+...++++.+||.+||..||.+|||+.|+++|
T Consensus 306 ~~~~~~-~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 349 (359)
T 3vhe_A 306 CRRLKE-GTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 349 (359)
T ss_dssp HHHHHH-TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHc-CCCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHH
Confidence 222221 22334456678899999999999999999999999976
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-43 Score=370.26 Aligned_cols=272 Identities=21% Similarity=0.346 Sum_probs=191.7
Q ss_pred eEEcCceeeEEEeEeccCceEEEEEEe-cCCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHH
Q 003052 467 FKVNGKLYQRLGKIGSGGSSEVHKVIS-SDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKA 545 (853)
Q Consensus 467 ~~v~g~~Y~ilk~LG~G~FG~Vyka~~-~~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~ 545 (853)
+.+..+.|++.+.||+|+||.||+|.+ .+++.||||++..... ......+.+|+.++++++ |+||++++++
T Consensus 10 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~-h~~i~~~~~~------ 81 (303)
T 2vwi_A 10 WSINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKC-QTSMDELLKEIQAMSQCH-HPNIVSYYTS------ 81 (303)
T ss_dssp ---CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC-----------------CCCCCC-CTTBCCEEEE------
T ss_pred cccchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhc-chhHHHHHHHHHHHhhcC-CCCEeeEEEE------
Confidence 456678899999999999999999997 4678999999875432 233456789999999996 9999999987
Q ss_pred HHHHHhhCCCCCCCCccccCCeEEEEEecch-hhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeC
Q 003052 546 LLREVLNGSMNNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHS 624 (853)
Q Consensus 546 iL~~l~~~~iv~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHR 624 (853)
+...+.+|+||||+. ++|.+++.............+++..++.++.||+.||.|||++||+||
T Consensus 82 ----------------~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~ 145 (303)
T 2vwi_A 82 ----------------FVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHR 145 (303)
T ss_dssp ----------------EESSSCEEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCC
T ss_pred ----------------EeecCCcEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCC
Confidence 445567999999985 589998876443333345679999999999999999999999999999
Q ss_pred CCCCccEEe-ecCcEEEEecccchhcccCCc---cccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHH
Q 003052 625 DLKPANFLL-VKGSLKLIDFGIAKAIMSDTT---NIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCIL 700 (853)
Q Consensus 625 DLKPeNILL-~~g~VKL~DFGlAk~~~~~~~---~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVIL 700 (853)
||||+|||+ .++.+||+|||++........ .......+||+.|+|||++.+.. .++.++|||||||++
T Consensus 146 dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--------~~~~~~Di~slG~il 217 (303)
T 2vwi_A 146 DVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVR--------GYDFKADIWSFGITA 217 (303)
T ss_dssp CCSGGGEEECTTCCEEECCCHHHHHCC---------------CCCTTCCHHHHHHHH--------CCCTHHHHHHHHHHH
T ss_pred CCChhhEEEcCCCCEEEEeccchheeccCCCccchhhhcccCCCccccCHHHhcccc--------CCCchhhHHHHHHHH
Confidence 999999999 567999999999987643211 11223568999999999986421 356899999999999
Q ss_pred HHHHhCCCCCCcchhHHHHHHhhcCCCCc-------ccCCCCCChhHHHHHHHhcccCCCCCCChhHHhcCCCCCCC
Q 003052 701 YQMVYGRTPFSEYKTFWAKFKVITDPNHE-------ITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQHPFLVPP 770 (853)
Q Consensus 701 yELLtG~~PF~~~~~~~~~~kii~~~~~~-------~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~HPwf~~~ 770 (853)
|+|++|+.||................... .......+..+.+||.+||..||.+||++.++++||||...
T Consensus 218 ~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~ 294 (303)
T 2vwi_A 218 IELATGAAPYHKYPPMKVLMLTLQNDPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQKA 294 (303)
T ss_dssp HHHHHSSCTTTTSCGGGHHHHHHTSSCCCTTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTSTTC---
T ss_pred HHHHhCCCCCccCchhhHHHHHhccCCCccccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhChhhhcC
Confidence 99999999997654433222222211111 12234567889999999999999999999999999999754
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-42 Score=370.78 Aligned_cols=254 Identities=26% Similarity=0.414 Sum_probs=200.3
Q ss_pred CceeeEEEeEeccCceEEEEEEe-c-CCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCC-----CceeEeeehhhhH
Q 003052 471 GKLYQRLGKIGSGGSSEVHKVIS-S-DCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGK-----NNIIQLIDYEVTE 543 (853)
Q Consensus 471 g~~Y~ilk~LG~G~FG~Vyka~~-~-~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~h-----pNIV~Lid~~~~e 543 (853)
.++|++++.||+|+||.||+|.+ . +++.||||+++.. ......+.+|+.+++.+.+. ++|++++++
T Consensus 13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~---- 85 (339)
T 1z57_A 13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV---DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEW---- 85 (339)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS---HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEE----
T ss_pred cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC---CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecc----
Confidence 46799999999999999999987 3 6789999999743 23445688999999999732 257777765
Q ss_pred HHHHHHHhhCCCCCCCCccccCCeEEEEEecchhhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceee
Q 003052 544 KALLREVLNGSMNNKDGRVKDDGYIYMVLEYGEIDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVH 623 (853)
Q Consensus 544 ~~iL~~l~~~~iv~~~g~~~d~~~lyLVmEy~~gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIH 623 (853)
+.+.+++|+||||++++|.+++... ....+++..++.++.||+.||.|||++||+|
T Consensus 86 ------------------~~~~~~~~lv~e~~~~~l~~~l~~~------~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH 141 (339)
T 1z57_A 86 ------------------FEHHGHICIVFELLGLSTYDFIKEN------GFLPFRLDHIRKMAYQICKSVNFLHSNKLTH 141 (339)
T ss_dssp ------------------EEETTEEEEEEECCCCBHHHHHHHT------TTCCCCHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred ------------------cccCCcEEEEEcCCCCCHHHHHHhc------CCCCCcHHHHHHHHHHHHHHHHHHHHCCCcC
Confidence 5667789999999999999988764 2346899999999999999999999999999
Q ss_pred CCCCCccEEee--------------------cCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCc
Q 003052 624 SDLKPANFLLV--------------------KGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGN 683 (853)
Q Consensus 624 RDLKPeNILL~--------------------~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~ 683 (853)
|||||+|||+. ++.+||+|||+++..... ....+||+.|+|||++.+.
T Consensus 142 ~Dlkp~Nil~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~------- 209 (339)
T 1z57_A 142 TDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATYDDEH-----HSTLVSTRHYRAPEVILAL------- 209 (339)
T ss_dssp CCCCGGGEEESCCCEEEEEC----CEEEEESCCCEEECCCSSCEETTSC-----CCSSCSCGGGCCHHHHTTS-------
T ss_pred CCCCHHHEEEeccccccccCCccccccccccCCCceEeeCcccccCccc-----cccccCCccccChHHhhCC-------
Confidence 99999999994 457999999999764322 2356899999999999765
Q ss_pred cccCCCccchhhhHHHHHHHHhCCCCCCcchhHHH---HHHhhcCCCC--------------------------------
Q 003052 684 IIKCGRPSDIWSLGCILYQMVYGRTPFSEYKTFWA---KFKVITDPNH-------------------------------- 728 (853)
Q Consensus 684 ~~~ys~ksDIWSLGVILyELLtG~~PF~~~~~~~~---~~kii~~~~~-------------------------------- 728 (853)
.|+.++|||||||++|||++|..||........ ..........
T Consensus 210 --~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 287 (339)
T 1z57_A 210 --GWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRA 287 (339)
T ss_dssp --CCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHHHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHH
T ss_pred --CCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhc
Confidence 356899999999999999999999976433221 1111110000
Q ss_pred -----c-ccCCCCCChhHHHHHHHhcccCCCCCCChhHHhcCCCCCC
Q 003052 729 -----E-ITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQHPFLVP 769 (853)
Q Consensus 729 -----~-~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~HPwf~~ 769 (853)
. .......++.+.+||.+||..||.+|||+.|+|+||||..
T Consensus 288 ~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~f~~ 334 (339)
T 1z57_A 288 CKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRITLREALKHPFFDL 334 (339)
T ss_dssp CCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHHHHTTSGGGGG
T ss_pred CcchhhhcccchhhHHHHHHHHHHHhCcCcccccCHHHHhcCHHHHH
Confidence 0 0001112456889999999999999999999999999974
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-42 Score=370.69 Aligned_cols=262 Identities=21% Similarity=0.310 Sum_probs=204.0
Q ss_pred eEEcCceeeEEEeEeccCceEEEEEEecCCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHH
Q 003052 467 FKVNGKLYQRLGKIGSGGSSEVHKVISSDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKAL 546 (853)
Q Consensus 467 ~~v~g~~Y~ilk~LG~G~FG~Vyka~~~~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~i 546 (853)
+.+...+|++.+.||+|+||.||+|.+ +++.||||++............+.+|+++|++++ |+||++++++
T Consensus 32 ~~i~~~~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~------- 102 (309)
T 3p86_A 32 MDIPWCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLR-HPNIVLFMGA------- 102 (309)
T ss_dssp CBCCGGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCC-CTTBCCEEEE-------
T ss_pred ccCChhHceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCC-CCCEeeEEEE-------
Confidence 345567899999999999999999987 5778999999877766677778999999999997 8999999987
Q ss_pred HHHHhhCCCCCCCCccccCCeEEEEEecchh-hHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCc--eee
Q 003052 547 LREVLNGSMNNKDGRVKDDGYIYMVLEYGEI-DLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEER--IVH 623 (853)
Q Consensus 547 L~~l~~~~iv~~~g~~~d~~~lyLVmEy~~g-dL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~g--IIH 623 (853)
+.+...+|+||||+.+ +|.+++..... ...+++..++.++.||+.||.|||++| |+|
T Consensus 103 ---------------~~~~~~~~lv~e~~~~~~L~~~l~~~~~-----~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH 162 (309)
T 3p86_A 103 ---------------VTQPPNLSIVTEYLSRGSLYRLLHKSGA-----REQLDERRRLSMAYDVAKGMNYLHNRNPPIVH 162 (309)
T ss_dssp ---------------ECSTTCCEEEEECCTTCBHHHHHHSTTH-----HHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCC
T ss_pred ---------------EEECCceEEEEecCCCCcHHHHHhhcCC-----CCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEC
Confidence 4556678999999864 99988865311 124899999999999999999999999 999
Q ss_pred CCCCCccEEee-cCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHH
Q 003052 624 SDLKPANFLLV-KGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQ 702 (853)
Q Consensus 624 RDLKPeNILL~-~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyE 702 (853)
|||||+|||++ ++.+||+|||+++...... ......+||+.|+|||++.+.. ++.++|||||||++|+
T Consensus 163 ~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~---------~~~~~DiwslG~il~e 231 (309)
T 3p86_A 163 RNLKSPNLLVDKKYTVKVCDFGLSRLKASTF--LSSKSAAGTPEWMAPEVLRDEP---------SNEKSDVYSFGVILWE 231 (309)
T ss_dssp TTCCGGGEEECTTCCEEECCCC-------------------CCTTSCHHHHTTCC---------CCTTHHHHHHHHHHHH
T ss_pred CCCChhhEEEeCCCcEEECCCCCCccccccc--cccccCCCCccccChhhhcCCC---------CCchhhHHHHHHHHHH
Confidence 99999999995 5699999999998654322 1234578999999999997653 5679999999999999
Q ss_pred HHhCCCCCCcchhHHHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCCChhHHhc--CCCCCC
Q 003052 703 MVYGRTPFSEYKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQ--HPFLVP 769 (853)
Q Consensus 703 LLtG~~PF~~~~~~~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~--HPwf~~ 769 (853)
|++|+.||.+........... ........+...++.+.+||.+||..||.+|||+.++++ ++|+..
T Consensus 232 lltg~~Pf~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~ 299 (309)
T 3p86_A 232 LATLQQPWGNLNPAQVVAAVG-FKCKRLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKS 299 (309)
T ss_dssp HHHCCCTTTTSCHHHHHHHHH-HSCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC-
T ss_pred HHhCCCCCCCCCHHHHHHHHH-hcCCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 999999998765543333222 123344556678899999999999999999999999997 455543
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-42 Score=361.87 Aligned_cols=255 Identities=28% Similarity=0.431 Sum_probs=204.6
Q ss_pred ceeeEEEeEeccCceEEEEEEec-CCcEEEEEEEecCCCCh----hhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHH
Q 003052 472 KLYQRLGKIGSGGSSEVHKVISS-DCTIYALKKIKLKGRDY----ATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKAL 546 (853)
Q Consensus 472 ~~Y~ilk~LG~G~FG~Vyka~~~-~g~~vAVKkik~~~~~~----~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~i 546 (853)
+.|++.+.||+|+||.||+|.+. +++.||+|+++...... .....+.+|+.+|++++ |+||++++++
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~------- 76 (283)
T 3bhy_A 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIR-HPNIITLHDI------- 76 (283)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCC-CTTBCCEEEE-------
T ss_pred hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCC-CCCeeehhhe-------
Confidence 56999999999999999999985 68899999998654321 13456889999999997 8999999987
Q ss_pred HHHHhhCCCCCCCCccccCCeEEEEEecch-hhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCC
Q 003052 547 LREVLNGSMNNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSD 625 (853)
Q Consensus 547 L~~l~~~~iv~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRD 625 (853)
+.+...+|+||||+. ++|.+++... ..+++..++.++.||+.||.|||++||+|||
T Consensus 77 ---------------~~~~~~~~lv~e~~~~~~L~~~l~~~--------~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~d 133 (283)
T 3bhy_A 77 ---------------FENKTDVVLILELVSGGELFDFLAEK--------ESLTEDEATQFLKQILDGVHYLHSKRIAHFD 133 (283)
T ss_dssp ---------------EECSSEEEEEEECCCSCBHHHHHHHH--------SSCCHHHHHHHHHHHHHHHHHHHHTTEECSC
T ss_pred ---------------ecCCCeEEEEEeecCCCcHHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHhCCccCCC
Confidence 456678999999985 6999988654 5699999999999999999999999999999
Q ss_pred CCCccEEee-cC----cEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHH
Q 003052 626 LKPANFLLV-KG----SLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCIL 700 (853)
Q Consensus 626 LKPeNILL~-~g----~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVIL 700 (853)
|||+|||+. ++ .+||+|||++....... ......||+.|+|||++.+. .++.++|||||||++
T Consensus 134 l~p~Nil~~~~~~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~---------~~~~~~Di~slG~il 201 (283)
T 3bhy_A 134 LKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGN---EFKNIFGTPEFVAPEIVNYE---------PLGLEADMWSIGVIT 201 (283)
T ss_dssp CSGGGEEESCSSSSSCCEEECCCTTCEECC-----------CCCGGGCCHHHHTTC---------CCCTHHHHHHHHHHH
T ss_pred CChHHEEEecCCCCCCceEEEecccceeccCCC---cccccCCCcCccCcceecCC---------CCCcchhhhhHHHHH
Confidence 999999994 33 79999999998664322 22356799999999999754 356799999999999
Q ss_pred HHHHhCCCCCCcchhHHHHHHhhcC-CCCcccCCCCCChhHHHHHHHhcccCCCCCCChhHHhcCCCCCC
Q 003052 701 YQMVYGRTPFSEYKTFWAKFKVITD-PNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQHPFLVP 769 (853)
Q Consensus 701 yELLtG~~PF~~~~~~~~~~kii~~-~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~HPwf~~ 769 (853)
|+|++|..||.+.........+... ...........+..+.+||.+||..||.+||++.++|+||||+.
T Consensus 202 ~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~ 271 (283)
T 3bhy_A 202 YILLSGASPFLGETKQETLTNISAVNYDFDEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKA 271 (283)
T ss_dssp HHHHHSSCTTCCSSHHHHHHHHHTTCCCCCHHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHH
T ss_pred HHHHHCCCCCCCcchHHHHHHhHhcccCCcchhcccCCHHHHHHHHHHccCCHhHCcCHHHHHhCHHHHH
Confidence 9999999999775443322222211 11111223456788999999999999999999999999999964
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-42 Score=403.06 Aligned_cols=259 Identities=24% Similarity=0.345 Sum_probs=210.2
Q ss_pred CceeeEEEeEeccCceEEEEEEec-CCcEEEEEEEecCCCC-hhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHH
Q 003052 471 GKLYQRLGKIGSGGSSEVHKVISS-DCTIYALKKIKLKGRD-YATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLR 548 (853)
Q Consensus 471 g~~Y~ilk~LG~G~FG~Vyka~~~-~g~~vAVKkik~~~~~-~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~ 548 (853)
.+.|.+++.||+|+||.||+|++. +++.||||++.+.... ......+.+|+.+|++++ ||||++++++
T Consensus 184 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~-hp~Iv~l~~~--------- 253 (543)
T 3c4z_A 184 EDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVH-SRFIVSLAYA--------- 253 (543)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCC-CTTBCCEEEE---------
T ss_pred hhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcC-CCCEeeEEEE---------
Confidence 356999999999999999999984 6899999999754321 123346789999999996 8999999876
Q ss_pred HHhhCCCCCCCCccccCCeEEEEEecch-hhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCC
Q 003052 549 EVLNGSMNNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLK 627 (853)
Q Consensus 549 ~l~~~~iv~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLK 627 (853)
|.+...+|+||||+. ++|..++.... .....+++..++.|+.||+.||.|||++||+|||||
T Consensus 254 -------------~~~~~~l~lVmE~~~gg~L~~~l~~~~----~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLK 316 (543)
T 3c4z_A 254 -------------FETKTDLCLVMTIMNGGDIRYHIYNVD----EDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLK 316 (543)
T ss_dssp -------------EECSSEEEEEECCCTTCBHHHHHHTSS----TTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCC
T ss_pred -------------EeeCCEEEEEEEeccCCCHHHHHHHhh----cccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCC
Confidence 566788999999976 58988876531 123579999999999999999999999999999999
Q ss_pred CccEEe-ecCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHhC
Q 003052 628 PANFLL-VKGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYG 706 (853)
Q Consensus 628 PeNILL-~~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLtG 706 (853)
|+|||| .+|.+||+|||+|+.+..... .....+||+.|+|||++.+. .|+.++|||||||++|||++|
T Consensus 317 P~NILl~~~g~vkL~DFGla~~~~~~~~--~~~~~~GT~~Y~APE~l~~~---------~~~~~~DiwSlGvilyelltG 385 (543)
T 3c4z_A 317 PENVLLDDDGNVRISDLGLAVELKAGQT--KTKGYAGTPGFMAPELLLGE---------EYDFSVDYFALGVTLYEMIAA 385 (543)
T ss_dssp GGGEEECTTSCEEECCCTTCEECCTTCC--CBCCCCSCTTTSCHHHHTTC---------CBCTHHHHHHHHHHHHHHHHS
T ss_pred hHHEEEeCCCCEEEeecceeeeccCCCc--ccccccCCccccChhhhcCC---------CCChHHhcCcchHHHHHHHhC
Confidence 999999 567999999999987644322 22356999999999999765 367899999999999999999
Q ss_pred CCCCCcch---hHHHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCCC-----hhHHhcCCCCCC
Q 003052 707 RTPFSEYK---TFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWR-----IPQLLQHPFLVP 769 (853)
Q Consensus 707 ~~PF~~~~---~~~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpT-----a~EIL~HPwf~~ 769 (853)
++||.+.. ........+.. ....++...++++++||.+||.+||.+||+ +.+|++||||..
T Consensus 386 ~~PF~~~~~~~~~~~~~~~i~~--~~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~Hpff~~ 454 (543)
T 3c4z_A 386 RGPFRARGEKVENKELKQRVLE--QAVTYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRD 454 (543)
T ss_dssp SCSSCCTTCCCCHHHHHHHHHH--CCCCCCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTSGGGTT
T ss_pred CCCCCCCccchhHHHHHHHHhh--cccCCCcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHcCccccC
Confidence 99997642 12223332222 223456678999999999999999999996 589999999975
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-42 Score=377.28 Aligned_cols=259 Identities=27% Similarity=0.427 Sum_probs=202.8
Q ss_pred ceeeEEEeEeccCceEEEEEEe-cCCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHHHH
Q 003052 472 KLYQRLGKIGSGGSSEVHKVIS-SDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLREV 550 (853)
Q Consensus 472 ~~Y~ilk~LG~G~FG~Vyka~~-~~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~~l 550 (853)
++|.+.+.||+|+||.||+|.+ .+++.||||++............+.+|+.+|++++ |+||+++++++...
T Consensus 24 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~------- 95 (353)
T 3coi_A 24 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQ-HENVIGLLDVFTPA------- 95 (353)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCC-CTTBCCCSEEECSC-------
T ss_pred ceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcC-CCCcccHhheEecc-------
Confidence 4699999999999999999998 46889999999876655566677899999999997 99999999875321
Q ss_pred hhCCCCCCCCccccCCeEEEEEecchhhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCCCcc
Q 003052 551 LNGSMNNKDGRVKDDGYIYMVLEYGEIDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPAN 630 (853)
Q Consensus 551 ~~~~iv~~~g~~~d~~~lyLVmEy~~gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLKPeN 630 (853)
+.......+|+||||++++|.+++. ..+++..++.++.||+.||.|||++||+||||||+|
T Consensus 96 ---------~~~~~~~~~~lv~e~~~~~l~~~~~----------~~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~N 156 (353)
T 3coi_A 96 ---------SSLRNFYDFYLVMPFMQTDLQKIMG----------LKFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGN 156 (353)
T ss_dssp ---------SSGGGCCCCEEEEECCSEEGGGTTT----------SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGG
T ss_pred ---------cccccceeEEEEeccccCCHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHH
Confidence 1112233569999999887765542 359999999999999999999999999999999999
Q ss_pred EEee-cCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHhCCCC
Q 003052 631 FLLV-KGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGRTP 709 (853)
Q Consensus 631 ILL~-~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLtG~~P 709 (853)
||++ ++.+||+|||+++..... ....+||+.|+|||++.+.. .++.++|||||||++|+|++|+.|
T Consensus 157 Il~~~~~~~kl~Dfg~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~--------~~~~~~Di~slG~il~el~~g~~p 223 (353)
T 3coi_A 157 LAVNEDCELKILDFGLARHADAE-----MTGYVVTRWYRAPEVILSWM--------HYNQTVDIWSVGCIMAEMLTGKTL 223 (353)
T ss_dssp EEECTTCCEEECSTTCTTC-------------CCSBCCSCHHHHSCCS--------CCCTTHHHHHHHHHHHHHHHSSCS
T ss_pred EeECCCCcEEEeecccccCCCCC-----ccccccCcCcCCHHHHhCcC--------CCCchhhHHHHHHHHHHHHhCCCC
Confidence 9995 679999999999865322 23568999999999987532 367899999999999999999999
Q ss_pred CCcchhHHHHHHhh---cCC------------------------CC-cccCCCCCChhHHHHHHHhcccCCCCCCChhHH
Q 003052 710 FSEYKTFWAKFKVI---TDP------------------------NH-EITYEPVPNPWLLDLMKKCLAWDRNERWRIPQL 761 (853)
Q Consensus 710 F~~~~~~~~~~kii---~~~------------------------~~-~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EI 761 (853)
|.+.........+. ..+ .. ........++.+.+||.+||..||.+|||+.++
T Consensus 224 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~ 303 (353)
T 3coi_A 224 FKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQA 303 (353)
T ss_dssp SBSSCHHHHHHHHHHHHCBCCHHHHTTCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHH
T ss_pred CCCCCHHHHHHHHHHHhCCCCHHHHHHHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHH
Confidence 97644322211111 000 00 011224568889999999999999999999999
Q ss_pred hcCCCCCCC
Q 003052 762 LQHPFLVPP 770 (853)
Q Consensus 762 L~HPwf~~~ 770 (853)
|+||||...
T Consensus 304 l~hp~f~~~ 312 (353)
T 3coi_A 304 LTHPFFEPF 312 (353)
T ss_dssp HTSGGGTTT
T ss_pred hcCcchhhc
Confidence 999999764
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-43 Score=374.71 Aligned_cols=262 Identities=24% Similarity=0.379 Sum_probs=204.2
Q ss_pred CceeeEEEeEeccCceEEEEEEe-cCCcEEEEEEEecCCC-ChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHH
Q 003052 471 GKLYQRLGKIGSGGSSEVHKVIS-SDCTIYALKKIKLKGR-DYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLR 548 (853)
Q Consensus 471 g~~Y~ilk~LG~G~FG~Vyka~~-~~g~~vAVKkik~~~~-~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~ 548 (853)
.++|++.+.||+|+||.||+|.+ .+++.||||+++.... +......+.+|+.++++++ ||||+++++++..+
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~----- 84 (311)
T 3ork_A 11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN-HPAIVAVYDTGEAE----- 84 (311)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCC-CTTBCCEEEEEEEE-----
T ss_pred cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCC-CCCcceEEEeeecc-----
Confidence 36799999999999999999998 5778999999986543 3345567889999999997 99999999875321
Q ss_pred HHhhCCCCCCCCccccCCeEEEEEecch-hhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCC
Q 003052 549 EVLNGSMNNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLK 627 (853)
Q Consensus 549 ~l~~~~iv~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLK 627 (853)
......+|+||||++ ++|.+++... ..+++..++.++.||+.||.|||++||+|||||
T Consensus 85 -------------~~~~~~~~lv~e~~~g~~L~~~l~~~--------~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlk 143 (311)
T 3ork_A 85 -------------TPAGPLPYIVMEYVDGVTLRDIVHTE--------GPMTPKRAIEVIADACQALNFSHQNGIIHRDVK 143 (311)
T ss_dssp -------------ETTEEEEEEEEECCCEEEHHHHHHHH--------CSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCC
T ss_pred -------------CCCCcccEEEEecCCCCCHHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCC
Confidence 111235699999985 6999988754 569999999999999999999999999999999
Q ss_pred CccEEe-ecCcEEEEecccchhcccCCcc-ccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHh
Q 003052 628 PANFLL-VKGSLKLIDFGIAKAIMSDTTN-IQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVY 705 (853)
Q Consensus 628 PeNILL-~~g~VKL~DFGlAk~~~~~~~~-~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLt 705 (853)
|+|||+ .++.+||+|||+++.+...... ......+||+.|+|||++.+.. ++.++|||||||++|+|++
T Consensus 144 p~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---------~~~~~Di~slG~~l~~ll~ 214 (311)
T 3ork_A 144 PANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDS---------VDARSDVYSLGCVLYEVLT 214 (311)
T ss_dssp GGGEEEETTSCEEECCCSCC------------------CCTTCCHHHHHTCC---------CCHHHHHHHHHHHHHHHHH
T ss_pred HHHEEEcCCCCEEEeeccCcccccccccccccccccCcCcccCCHHHhcCCC---------CCchHhHHHHHHHHHHHHh
Confidence 999999 4679999999999876443221 1223567999999999997653 5679999999999999999
Q ss_pred CCCCCCcchhHHHHHHhhcCC-CCcccCCCCCChhHHHHHHHhcccCCCCCCChhHHhcCCCCC
Q 003052 706 GRTPFSEYKTFWAKFKVITDP-NHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQHPFLV 768 (853)
Q Consensus 706 G~~PF~~~~~~~~~~kii~~~-~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~HPwf~ 768 (853)
|+.||.+.............. ..........+.++.+||.+||..||.+||++.++|.|+|+.
T Consensus 215 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~ 278 (311)
T 3ork_A 215 GEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVR 278 (311)
T ss_dssp SSCSCCCSSHHHHHHHHHHCCCCCHHHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred CCCCCCCCChHHHHHHHhcCCCCCcccccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHH
Confidence 999998766554444443322 222223456788999999999999999999999999999985
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-42 Score=372.83 Aligned_cols=252 Identities=28% Similarity=0.433 Sum_probs=208.8
Q ss_pred EcCceeeEEEeEeccCceEEEEEEe-cCCcEEEEEEEecCCCCh----hhHhhHHHHHHHHHHhcC-CCceeEeeehhhh
Q 003052 469 VNGKLYQRLGKIGSGGSSEVHKVIS-SDCTIYALKKIKLKGRDY----ATAYGFCQEIEYLNKLKG-KNNIIQLIDYEVT 542 (853)
Q Consensus 469 v~g~~Y~ilk~LG~G~FG~Vyka~~-~~g~~vAVKkik~~~~~~----~~~~~~l~EI~iLkkL~~-hpNIV~Lid~~~~ 542 (853)
....+|++.+.||+|+||.||+|.+ .+++.||||++....... .....+.+|+.+++++.+ |+||++++++
T Consensus 40 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~--- 116 (320)
T 3a99_A 40 PLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDW--- 116 (320)
T ss_dssp CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEE---
T ss_pred CccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEE---
Confidence 3446799999999999999999998 577899999997654321 122456789999999984 8999999987
Q ss_pred HHHHHHHHhhCCCCCCCCccccCCeEEEEEecch--hhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCc
Q 003052 543 EKALLREVLNGSMNNKDGRVKDDGYIYMVLEYGE--IDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEER 620 (853)
Q Consensus 543 e~~iL~~l~~~~iv~~~g~~~d~~~lyLVmEy~~--gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~g 620 (853)
+.+.+.+|+||||+. ++|.+++... ..+++..++.++.||+.||.|||++|
T Consensus 117 -------------------~~~~~~~~lv~e~~~~~~~L~~~l~~~--------~~l~~~~~~~i~~qi~~~L~~LH~~~ 169 (320)
T 3a99_A 117 -------------------FERPDSFVLILERPEPVQDLFDFITER--------GALQEELARSFFWQVLEAVRHCHNCG 169 (320)
T ss_dssp -------------------EECSSEEEEEEECCSSEEEHHHHHHHH--------CSCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred -------------------EecCCcEEEEEEcCCCCccHHHHHhcc--------CCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 456678999999975 6899988764 57999999999999999999999999
Q ss_pred eeeCCCCCccEEee--cCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHH
Q 003052 621 IVHSDLKPANFLLV--KGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGC 698 (853)
Q Consensus 621 IIHRDLKPeNILL~--~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGV 698 (853)
|+||||||+|||++ ++.+||+|||+++...... .....||+.|+|||++.+.. .++.++|||||||
T Consensus 170 ivH~Dlkp~NIll~~~~~~~kL~Dfg~~~~~~~~~----~~~~~gt~~y~aPE~~~~~~--------~~~~~~Di~slG~ 237 (320)
T 3a99_A 170 VLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV----YTDFDGTRVYSPPEWIRYHR--------YHGRSAAVWSLGI 237 (320)
T ss_dssp EECCCCSGGGEEEETTTTEEEECCCTTCEECCSSC----BCCCCSCGGGSCHHHHHHSC--------BCHHHHHHHHHHH
T ss_pred cEeCCCCHHHEEEeCCCCCEEEeeCcccccccccc----ccCCCCCccCCChHHhccCC--------CCCccchHHhHHH
Confidence 99999999999996 4699999999998764322 23568999999999997653 2357899999999
Q ss_pred HHHHHHhCCCCCCcchhHHHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCCChhHHhcCCCCCCCC
Q 003052 699 ILYQMVYGRTPFSEYKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQHPFLVPPV 771 (853)
Q Consensus 699 ILyELLtG~~PF~~~~~~~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~HPwf~~~~ 771 (853)
++|+|++|+.||........ ....++...++.+.+||.+||..||.+||++.++++||||....
T Consensus 238 il~el~~g~~pf~~~~~~~~---------~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~hp~~~~~~ 301 (320)
T 3a99_A 238 LLYDMVCGDIPFEHDEEIIR---------GQVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVL 301 (320)
T ss_dssp HHHHHHHSSCSCCSHHHHHH---------CCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSCC
T ss_pred HHHHHHHCCCCCCChhhhhc---------ccccccccCCHHHHHHHHHHccCChhhCcCHHHHhcCHhhcCcc
Confidence 99999999999977543211 11234566788999999999999999999999999999998643
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-42 Score=365.94 Aligned_cols=257 Identities=28% Similarity=0.430 Sum_probs=206.3
Q ss_pred CceeeEEEeEeccCceEEEEEEe-cCCcEEEEEEEecCCC-ChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHH
Q 003052 471 GKLYQRLGKIGSGGSSEVHKVIS-SDCTIYALKKIKLKGR-DYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLR 548 (853)
Q Consensus 471 g~~Y~ilk~LG~G~FG~Vyka~~-~~g~~vAVKkik~~~~-~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~ 548 (853)
+++|++++.||+|+||.||+|.+ .++..||+|++..... .......+.+|+.++++++ ||||++++++
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-hp~iv~~~~~--------- 79 (294)
T 4eqm_A 10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLS-HQNIVSMIDV--------- 79 (294)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCC-BTTBCCEEEE---------
T ss_pred hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCC-CCCCceEEEe---------
Confidence 46799999999999999999998 4678999999976543 3455567899999999997 8999999987
Q ss_pred HHhhCCCCCCCCccccCCeEEEEEecch-hhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCC
Q 003052 549 EVLNGSMNNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLK 627 (853)
Q Consensus 549 ~l~~~~iv~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLK 627 (853)
+.+++.+|+||||+. ++|.+++... ..+++..++.++.||+.||.|||++||+|||||
T Consensus 80 -------------~~~~~~~~lv~e~~~g~~L~~~l~~~--------~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlk 138 (294)
T 4eqm_A 80 -------------DEEDDCYYLVMEYIEGPTLSEYIESH--------GPLSVDTAINFTNQILDGIKHAHDMRIVHRDIK 138 (294)
T ss_dssp -------------EECSSEEEEEEECCCSCBHHHHHHHH--------CSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCC
T ss_pred -------------eeeCCeEEEEEeCCCCCCHHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCC
Confidence 466788999999986 4999988764 579999999999999999999999999999999
Q ss_pred CccEEe-ecCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHhC
Q 003052 628 PANFLL-VKGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYG 706 (853)
Q Consensus 628 PeNILL-~~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLtG 706 (853)
|+|||+ .++.+||+|||+++.+..... ......+||+.|+|||++.+.. ++.++|||||||++|+|++|
T Consensus 139 p~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~---------~~~~~Di~slG~~l~~ll~g 208 (294)
T 4eqm_A 139 PQNILIDSNKTLKIFDFGIAKALSETSL-TQTNHVLGTVQYFSPEQAKGEA---------TDECTDIYSIGIVLYEMLVG 208 (294)
T ss_dssp GGGEEECTTSCEEECCCSSSTTC--------------CCSSCCHHHHHTCC---------CCTTHHHHHHHHHHHHHHHS
T ss_pred HHHEEECCCCCEEEEeCCCccccccccc-cccCccccCccccCHhHhcCCC---------CCchHhHHHHHHHHHHHHhC
Confidence 999999 567999999999987643221 1233568999999999997653 56799999999999999999
Q ss_pred CCCCCcchhHHHHHHhhcCCCCc--ccCCCCCChhHHHHHHHhcccCCCCCCChhHHhcCCCCC
Q 003052 707 RTPFSEYKTFWAKFKVITDPNHE--ITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQHPFLV 768 (853)
Q Consensus 707 ~~PF~~~~~~~~~~kii~~~~~~--~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~HPwf~ 768 (853)
+.||.+........+.+...... .......++.+.++|.+||..||.+||+..+.+.+.|..
T Consensus 209 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~ 272 (294)
T 4eqm_A 209 EPPFNGETAVSIAIKHIQDSVPNVTTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSS 272 (294)
T ss_dssp SCSSCSSCHHHHHHHHHSSCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHT
T ss_pred CCCCCCCChHHHHHHHhhccCCCcchhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHH
Confidence 99998876655555555443222 234566788999999999999999999766666666643
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-42 Score=379.95 Aligned_cols=262 Identities=20% Similarity=0.314 Sum_probs=207.4
Q ss_pred EcCceeeEEEeEeccCceEEEEEEec--------CCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehh
Q 003052 469 VNGKLYQRLGKIGSGGSSEVHKVISS--------DCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYE 540 (853)
Q Consensus 469 v~g~~Y~ilk~LG~G~FG~Vyka~~~--------~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~ 540 (853)
+..+.|++.+.||+|+||.||+|.+. ++..||||+++... .......+.+|+.+|+++.+||||++++++
T Consensus 78 ~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~- 155 (370)
T 2psq_A 78 FPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA-TEKDLSDLVSEMEMMKMIGKHKNIINLLGA- 155 (370)
T ss_dssp CCGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTC-BHHHHHHHHHHHHHHHHSCCCTTBCCEEEE-
T ss_pred ccHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCc-CHHHHHHHHHHHHHHHHhcCCCCEeeEEEE-
Confidence 34577999999999999999999862 34579999997653 344566789999999999779999999987
Q ss_pred hhHHHHHHHHhhCCCCCCCCccccCCeEEEEEecchh-hHHHHHHHhhhh--------ccCCCCCCCHHHHHHHHHHhhh
Q 003052 541 VTEKALLREVLNGSMNNKDGRVKDDGYIYMVLEYGEI-DLAHMLSQKWKE--------MDGSNQTLDENWLRFYWQQILE 611 (853)
Q Consensus 541 ~~e~~iL~~l~~~~iv~~~g~~~d~~~lyLVmEy~~g-dL~~~L~~~~k~--------~~~~~~~LsE~~~r~I~~QIl~ 611 (853)
+.+.+.+|+||||+.+ +|.+++...... .......+++..++.++.||+.
T Consensus 156 ---------------------~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~ 214 (370)
T 2psq_A 156 ---------------------CTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLAR 214 (370)
T ss_dssp ---------------------ECSSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHH
T ss_pred ---------------------EccCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHH
Confidence 4556778999999864 999998764210 0112346899999999999999
Q ss_pred hhhhcccCceeeCCCCCccEEe-ecCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCc
Q 003052 612 AVNTIHEERIVHSDLKPANFLL-VKGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRP 690 (853)
Q Consensus 612 AL~yLHs~gIIHRDLKPeNILL-~~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~k 690 (853)
||.|||++||+||||||+|||+ .++.+||+|||+|+.+.............||+.|+|||++.+. .|+.+
T Consensus 215 aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~---------~~~~~ 285 (370)
T 2psq_A 215 GMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDR---------VYTHQ 285 (370)
T ss_dssp HHHHHHHTTEECSCCCGGGEEECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTC---------CCCHH
T ss_pred HHHHHHhCCeeccccchhhEEECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCC---------CCCcH
Confidence 9999999999999999999999 5679999999999876543332233455788999999999765 36789
Q ss_pred cchhhhHHHHHHHHh-CCCCCCcchhHHHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCCChhHHhcC
Q 003052 691 SDIWSLGCILYQMVY-GRTPFSEYKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQH 764 (853)
Q Consensus 691 sDIWSLGVILyELLt-G~~PF~~~~~~~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~H 764 (853)
+|||||||++|||++ |..||.+..... .+..+.. ......+...+.++.+||.+||..||.+||++.|++++
T Consensus 286 ~DvwslG~il~ellt~g~~p~~~~~~~~-~~~~~~~-~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~ 358 (370)
T 2psq_A 286 SDVWSFGVLMWEIFTLGGSPYPGIPVEE-LFKLLKE-GHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED 358 (370)
T ss_dssp HHHHHHHHHHHHHHTTSCCSSTTCCGGG-HHHHHHT-TCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHHHHHHcCCCCCCCCCCHHH-HHHHHhc-CCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 999999999999999 999997644322 2222222 12234456678899999999999999999999999963
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-42 Score=376.28 Aligned_cols=263 Identities=21% Similarity=0.313 Sum_probs=201.2
Q ss_pred EEcCceeeEEEeEeccCceEEEEEEe-cCCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcC----------CCceeEe
Q 003052 468 KVNGKLYQRLGKIGSGGSSEVHKVIS-SDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKG----------KNNIIQL 536 (853)
Q Consensus 468 ~v~g~~Y~ilk~LG~G~FG~Vyka~~-~~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~----------hpNIV~L 536 (853)
.+...+|++++.||+|+||.||+|.+ .+++.||||++... ......+.+|+.+++++.+ |+||+++
T Consensus 15 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~ 91 (373)
T 1q8y_A 15 PYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD---KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKL 91 (373)
T ss_dssp EETTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCC
T ss_pred cccCCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC---ccchhhhhHHHHHHHHhhcccccchhccccchHHHH
Confidence 34567899999999999999999998 57789999999743 2344567899999999874 5677777
Q ss_pred eehhhhHHHHHHHHhhCCCCCCCCccccCCeEEEEEecchhhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhc
Q 003052 537 IDYEVTEKALLREVLNGSMNNKDGRVKDDGYIYMVLEYGEIDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTI 616 (853)
Q Consensus 537 id~~~~e~~iL~~l~~~~iv~~~g~~~d~~~lyLVmEy~~gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yL 616 (853)
++++... -.+..++|+||||++++|.+++... ....+++..++.++.||+.||.||
T Consensus 92 ~~~~~~~------------------~~~~~~~~lv~e~~~~~L~~~~~~~------~~~~~~~~~~~~i~~qi~~aL~~l 147 (373)
T 1q8y_A 92 LDHFNHK------------------GPNGVHVVMVFEVLGENLLALIKKY------EHRGIPLIYVKQISKQLLLGLDYM 147 (373)
T ss_dssp CEEEEEE------------------ETTEEEEEEEECCCCEEHHHHHHHT------TTSCCCHHHHHHHHHHHHHHHHHH
T ss_pred HHHhhcc------------------CCCCceEEEEEecCCCCHHHHHHHh------hccCCcHHHHHHHHHHHHHHHHHH
Confidence 7653211 0122378999999988999998764 235699999999999999999999
Q ss_pred ccC-ceeeCCCCCccEEee-c------CcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCC
Q 003052 617 HEE-RIVHSDLKPANFLLV-K------GSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCG 688 (853)
Q Consensus 617 Hs~-gIIHRDLKPeNILL~-~------g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys 688 (853)
|++ ||+||||||+|||++ + +.+||+|||+++..... ....+||+.|+|||++.+.. |+
T Consensus 148 H~~~~ivH~Dikp~NIll~~~~~~~~~~~~kl~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~---------~~ 213 (373)
T 1q8y_A 148 HRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEH-----YTNSIQTREYRSPEVLLGAP---------WG 213 (373)
T ss_dssp HHTTCEECSCCSGGGEEEEEEETTTTEEEEEECCCTTCEETTBC-----CCSCCSCGGGCCHHHHHTCC---------CC
T ss_pred HhcCCEEecCCChHHeEEeccCCCcCcceEEEcccccccccCCC-----CCCCCCCccccCcHHHhCCC---------CC
Confidence 998 999999999999993 1 27999999999866432 23568999999999997653 56
Q ss_pred CccchhhhHHHHHHHHhCCCCCCcch---------hHHHHHHhhcCCCC-------------------------------
Q 003052 689 RPSDIWSLGCILYQMVYGRTPFSEYK---------TFWAKFKVITDPNH------------------------------- 728 (853)
Q Consensus 689 ~ksDIWSLGVILyELLtG~~PF~~~~---------~~~~~~kii~~~~~------------------------------- 728 (853)
.++|||||||++|+|++|+.||.... ........+.....
T Consensus 214 ~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 293 (373)
T 1q8y_A 214 CGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLE 293 (373)
T ss_dssp THHHHHHHHHHHHHHHHSSCCC---------CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHH
T ss_pred chHhHHHHHHHHHHHHhCCCCCCCCcccccCChHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchh
Confidence 89999999999999999999997432 11112221111000
Q ss_pred -----cccCCCCCChhHHHHHHHhcccCCCCCCChhHHhcCCCCCCCC
Q 003052 729 -----EITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQHPFLVPPV 771 (853)
Q Consensus 729 -----~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~HPwf~~~~ 771 (853)
...++...+..+.+||.+||..||.+|||+.|+|+||||+...
T Consensus 294 ~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~ 341 (373)
T 1q8y_A 294 DVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNHPWLKDTL 341 (373)
T ss_dssp HHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHHTCGGGTTCT
T ss_pred hhhhhcccCCcchHHHHHHHHHHHhccCccccCCHHHHhhChhhhccc
Confidence 0011223346789999999999999999999999999998654
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-42 Score=369.65 Aligned_cols=272 Identities=17% Similarity=0.241 Sum_probs=191.7
Q ss_pred EcCceeeEEEeEeccCceEEEEEEecCC----cEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHH
Q 003052 469 VNGKLYQRLGKIGSGGSSEVHKVISSDC----TIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEK 544 (853)
Q Consensus 469 v~g~~Y~ilk~LG~G~FG~Vyka~~~~g----~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~ 544 (853)
+..++|++.+.||+|+||.||+|.+... ..||||+++...........+.+|+.++++++ |+||+++++++....
T Consensus 20 i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~ 98 (323)
T 3qup_A 20 IPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFD-HPHVAKLVGVSLRSR 98 (323)
T ss_dssp CC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCC-CTTBCCCCEEEECC-
T ss_pred cChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCC-CCceehhhceeeccc
Confidence 3446799999999999999999987533 27999999876555566678999999999996 999999999753321
Q ss_pred HHHHHHhhCCCCCCCCccccCCeEEEEEecchh-hHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceee
Q 003052 545 ALLREVLNGSMNNKDGRVKDDGYIYMVLEYGEI-DLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVH 623 (853)
Q Consensus 545 ~iL~~l~~~~iv~~~g~~~d~~~lyLVmEy~~g-dL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIH 623 (853)
. ......+|+||||+.+ +|.+++..... ......+++..++.++.||+.||.|||++||+|
T Consensus 99 ~----------------~~~~~~~~~v~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH 160 (323)
T 3qup_A 99 A----------------KGRLPIPMVILPFMKHGDLHAFLLASRI--GENPFNLPLQTLVRFMVDIACGMEYLSSRNFIH 160 (323)
T ss_dssp ----------------------CEEEEEECCTTCBHHHHHHHHHC-----CCCCCHHHHHHHHHHHHHHHHHHHHTTCCC
T ss_pred c----------------ccCCCccEEEEEeccCCcHHHHHHhhhc--cccccccCHHHHHHHHHHHHHHHHHHHcCCccc
Confidence 1 1112245999999765 99998876422 122246999999999999999999999999999
Q ss_pred CCCCCccEEee-cCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHH
Q 003052 624 SDLKPANFLLV-KGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQ 702 (853)
Q Consensus 624 RDLKPeNILL~-~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyE 702 (853)
|||||+|||++ ++.+||+|||+|+...............|++.|+|||++.+.. |+.++|||||||++|+
T Consensus 161 ~Dikp~NIli~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~---------~~~~~Di~slG~il~e 231 (323)
T 3qup_A 161 RDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNL---------YTVHSDVWAFGVTMWE 231 (323)
T ss_dssp SCCSGGGEEECTTSCEEECCCCC-----------------CCGGGCCHHHHHHCC---------CCHHHHHHHHHHHHHH
T ss_pred CCCCcceEEEcCCCCEEEeeccccccccccccccccccccCcccccCchhhcCCC---------CCCccchhhHHHHHHH
Confidence 99999999995 6799999999998765433332333456788999999997653 5689999999999999
Q ss_pred HHh-CCCCCCcchhHHHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCCC-------hhHHhcCCCCCCC
Q 003052 703 MVY-GRTPFSEYKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWR-------IPQLLQHPFLVPP 770 (853)
Q Consensus 703 LLt-G~~PF~~~~~~~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpT-------a~EIL~HPwf~~~ 770 (853)
|++ |..||.+.........+... .....+...++.+.+||.+||..||.+||| +++++.|||+...
T Consensus 232 ll~~g~~p~~~~~~~~~~~~~~~~--~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~~~~~ 305 (323)
T 3qup_A 232 IMTRGQTPYAGIENAEIYNYLIGG--NRLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVLST 305 (323)
T ss_dssp HHTTSCCTTTTCCGGGHHHHHHTT--CCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC------
T ss_pred HHhCCCCCccccChHHHHHHHhcC--CCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhhhcCC
Confidence 999 99999765443333333222 233445677889999999999999999999 8899999999764
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-42 Score=373.22 Aligned_cols=257 Identities=32% Similarity=0.446 Sum_probs=197.7
Q ss_pred ceeeEEEeEeccCceEEEEEEec-CCcEEEEEEEecCCC------ChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHH
Q 003052 472 KLYQRLGKIGSGGSSEVHKVISS-DCTIYALKKIKLKGR------DYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEK 544 (853)
Q Consensus 472 ~~Y~ilk~LG~G~FG~Vyka~~~-~g~~vAVKkik~~~~------~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~ 544 (853)
+.|++.+.||+|+||.||+|.+. +++.||||++..... .......+.+|+.+|++++ |+||+++++++
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~---- 84 (322)
T 2ycf_A 10 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLN-HPCIIKIKNFF---- 84 (322)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCC-CTTBCCEEEEE----
T ss_pred hceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCC-CCCCceEeeEE----
Confidence 56999999999999999999984 678999999975432 1223345889999999996 99999999873
Q ss_pred HHHHHHhhCCCCCCCCccccCCeEEEEEecch-hhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceee
Q 003052 545 ALLREVLNGSMNNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVH 623 (853)
Q Consensus 545 ~iL~~l~~~~iv~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIH 623 (853)
..+ .+|+||||+. ++|.+++... ..+++..++.++.||+.||.|||++||+|
T Consensus 85 ------------------~~~-~~~lv~e~~~~~~L~~~~~~~--------~~~~~~~~~~~~~qi~~~l~~lH~~~ivH 137 (322)
T 2ycf_A 85 ------------------DAE-DYYIVLELMEGGELFDKVVGN--------KRLKEATCKLYFYQMLLAVQYLHENGIIH 137 (322)
T ss_dssp ------------------ESS-SEEEEEECCTTEETHHHHSTT--------CCCCHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred ------------------cCC-ceEEEEecCCCCcHHHHHhcc--------CCCCHHHHHHHHHHHHHHHHHHHHCCeec
Confidence 222 3799999986 4888877542 57999999999999999999999999999
Q ss_pred CCCCCccEEeec-C---cEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHH
Q 003052 624 SDLKPANFLLVK-G---SLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCI 699 (853)
Q Consensus 624 RDLKPeNILL~~-g---~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVI 699 (853)
|||||+|||++. + .+||+|||+++...... .....+||+.|+|||++.+... ..|+.++|||||||+
T Consensus 138 ~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~------~~~~~~~Di~slG~i 208 (322)
T 2ycf_A 138 RDLKPENVLLSSQEEDCLIKITDFGHSKILGETS---LMRTLCGTPTYLAPEVLVSVGT------AGYNRAVDCWSLGVI 208 (322)
T ss_dssp CCCSGGGEEESSSSSSCCEEECCCTTCEECCCCH---HHHHHHSCCTTCCHHHHHHTTT------TTCTTHHHHHHHHHH
T ss_pred cCCCHHHEEEecCCCCCeEEEccCccceeccccc---ccccccCCcCccCchhhccCCC------CCCCchhhHHHHHHH
Confidence 999999999943 3 49999999998664321 2235689999999999853211 146789999999999
Q ss_pred HHHHHhCCCCCCcchhHHHHHHhhcCCCCc--ccCCCCCChhHHHHHHHhcccCCCCCCChhHHhcCCCCCC
Q 003052 700 LYQMVYGRTPFSEYKTFWAKFKVITDPNHE--ITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQHPFLVP 769 (853)
Q Consensus 700 LyELLtG~~PF~~~~~~~~~~kii~~~~~~--~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~HPwf~~ 769 (853)
+|+|++|..||............+...... .......+..+.+||.+||..||.+||++.++|+||||..
T Consensus 209 l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h~~~~~ 280 (322)
T 2ycf_A 209 LFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQD 280 (322)
T ss_dssp HHHHHHSSCSSCSTTCSSCHHHHHHHTCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGCC
T ss_pred HHHHHhCCCCCcccchHHHHHHHHHhCccccCchhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhhCcCcCC
Confidence 999999999997543211111111111111 1122456888999999999999999999999999999964
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-42 Score=369.87 Aligned_cols=255 Identities=25% Similarity=0.387 Sum_probs=198.5
Q ss_pred CceeeEEEeEeccCceEEEEEEec-CC-cEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCC-----ceeEeeehhhhH
Q 003052 471 GKLYQRLGKIGSGGSSEVHKVISS-DC-TIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKN-----NIIQLIDYEVTE 543 (853)
Q Consensus 471 g~~Y~ilk~LG~G~FG~Vyka~~~-~g-~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hp-----NIV~Lid~~~~e 543 (853)
.++|++++.||+|+||.||+|.+. ++ ..||||+++.. ......+.+|+.+++++.++. +|+.++++
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~---- 90 (355)
T 2eu9_A 18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV---GKYREAARLEINVLKKIKEKDKENKFLCVLMSDW---- 90 (355)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEE----
T ss_pred cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc---ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeee----
Confidence 467999999999999999999984 44 68999999743 234456789999999997432 25666554
Q ss_pred HHHHHHHhhCCCCCCCCccccCCeEEEEEecchhhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceee
Q 003052 544 KALLREVLNGSMNNKDGRVKDDGYIYMVLEYGEIDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVH 623 (853)
Q Consensus 544 ~~iL~~l~~~~iv~~~g~~~d~~~lyLVmEy~~gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIH 623 (853)
+...+.+|+||||++++|.+.+... ....+++..++.++.||+.||.|||++||+|
T Consensus 91 ------------------~~~~~~~~lv~e~~~~~l~~~l~~~------~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH 146 (355)
T 2eu9_A 91 ------------------FNFHGHMCIAFELLGKNTFEFLKEN------NFQPYPLPHVRHMAYQLCHALRFLHENQLTH 146 (355)
T ss_dssp ------------------EEETTEEEEEEECCCCBHHHHHHHT------TTCCCCHHHHHHHHHHHHHHHHHHHTTTEEC
T ss_pred ------------------eeeCCeEEEEEeccCCChHHHHHhc------cCCCCCHHHHHHHHHHHHHHHHHHHHCCccc
Confidence 5667789999999998988888664 2357999999999999999999999999999
Q ss_pred CCCCCccEEe--------------------ecCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCc
Q 003052 624 SDLKPANFLL--------------------VKGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGN 683 (853)
Q Consensus 624 RDLKPeNILL--------------------~~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~ 683 (853)
|||||+|||+ .++.+||+|||+++..... ....+||+.|+|||++.+.
T Consensus 147 ~Dlkp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~------- 214 (355)
T 2eu9_A 147 TDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATFDHEH-----HTTIVATRHYRPPEVILEL------- 214 (355)
T ss_dssp CCCCGGGEEESCCCEEEEECCC-CCCEEEESCCCEEECCCTTCEETTSC-----CCSSCSCGGGCCHHHHTTC-------
T ss_pred CCCCHHHEEEecccccccccccccccccccCCCcEEEeecCcccccccc-----ccCCcCCCcccCCeeeecC-------
Confidence 9999999999 2458999999999864322 2356899999999999765
Q ss_pred cccCCCccchhhhHHHHHHHHhCCCCCCcchhHHH---HHHhhcCCCCc-------------------------------
Q 003052 684 IIKCGRPSDIWSLGCILYQMVYGRTPFSEYKTFWA---KFKVITDPNHE------------------------------- 729 (853)
Q Consensus 684 ~~~ys~ksDIWSLGVILyELLtG~~PF~~~~~~~~---~~kii~~~~~~------------------------------- 729 (853)
.|+.++|||||||++|+|++|+.||........ ..+........
T Consensus 215 --~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 292 (355)
T 2eu9_A 215 --GWAQPCDVWSIGCILFEYYRGFTLFQTHENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKEN 292 (355)
T ss_dssp --CCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHH
T ss_pred --CCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhcccccc
Confidence 356899999999999999999999976443221 11111100000
Q ss_pred -------ccCCCCCChhHHHHHHHhcccCCCCCCChhHHhcCCCCCCC
Q 003052 730 -------ITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQHPFLVPP 770 (853)
Q Consensus 730 -------~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~HPwf~~~ 770 (853)
.......+..+.+||.+||..||.+|||+.|+|+||||...
T Consensus 293 ~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~ 340 (355)
T 2eu9_A 293 CKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRITLAEALLHPFFAGL 340 (355)
T ss_dssp CCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHHHHTTSGGGGGC
T ss_pred CCcccccccccchhHHHHHHHHHHHhcCChhhCcCHHHHhcChhhcCC
Confidence 00001113468899999999999999999999999999753
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=362.14 Aligned_cols=254 Identities=28% Similarity=0.440 Sum_probs=209.9
Q ss_pred CceeeEEEeEeccCceEEEEEEe-cCCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHHH
Q 003052 471 GKLYQRLGKIGSGGSSEVHKVIS-SDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLRE 549 (853)
Q Consensus 471 g~~Y~ilk~LG~G~FG~Vyka~~-~~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~~ 549 (853)
.+.|++++.||+|+||.||+|.+ .+++.||||++...... .....+.+|+.+++++. |+||++++++
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~l~~l~-h~~i~~~~~~---------- 88 (303)
T 3a7i_A 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAE-DEIEDIQQEITVLSQCD-SPYVTKYYGS---------- 88 (303)
T ss_dssp GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCS-TTHHHHHHHHHHHHHCC-CTTBCCEEEE----------
T ss_pred HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccH-HHHHHHHHHHHHHHhCC-CCCEeEEEEE----------
Confidence 35699999999999999999998 56789999999865433 33556889999999996 8999999986
Q ss_pred HhhCCCCCCCCccccCCeEEEEEecchh-hHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCCC
Q 003052 550 VLNGSMNNKDGRVKDDGYIYMVLEYGEI-DLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKP 628 (853)
Q Consensus 550 l~~~~iv~~~g~~~d~~~lyLVmEy~~g-dL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLKP 628 (853)
+.+...+|+||||+++ +|.+++.. ..+++..++.++.||+.||.|||++||+||||||
T Consensus 89 ------------~~~~~~~~lv~e~~~~~~L~~~~~~---------~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p 147 (303)
T 3a7i_A 89 ------------YLKDTKLWIIMEYLGGGSALDLLEP---------GPLDETQIATILREILKGLDYLHSEKKIHRDIKA 147 (303)
T ss_dssp ------------EEETTEEEEEEECCTTEEHHHHHTT---------SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSG
T ss_pred ------------EecCCeEEEEEEeCCCCcHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCh
Confidence 4456789999999864 88887743 4699999999999999999999999999999999
Q ss_pred ccEEe-ecCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHhCC
Q 003052 629 ANFLL-VKGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGR 707 (853)
Q Consensus 629 eNILL-~~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLtG~ 707 (853)
+|||+ .++.+||+|||++....... ......+||+.|+|||++.+. .++.++|||||||++|+|++|+
T Consensus 148 ~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~---------~~~~~~Di~slG~il~~l~~g~ 216 (303)
T 3a7i_A 148 ANVLLSEHGEVKLADFGVAGQLTDTQ--IKRNTFVGTPFWMAPEVIKQS---------AYDSKADIWSLGITAIELARGE 216 (303)
T ss_dssp GGEEECTTSCEEECCCTTCEECBTTB--CCBCCCCSCGGGCCHHHHTTC---------CBCTHHHHHHHHHHHHHHHHSS
T ss_pred heEEECCCCCEEEeecccceecCccc--cccCccCCCcCccCHHHHhcC---------CCCchhhhHHHHHHHHHHccCC
Confidence 99999 46799999999998764332 123467899999999999764 3567999999999999999999
Q ss_pred CCCCcchhHHHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCCChhHHhcCCCCCCC
Q 003052 708 TPFSEYKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQHPFLVPP 770 (853)
Q Consensus 708 ~PF~~~~~~~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~HPwf~~~ 770 (853)
.||...........+... .........+..+.+||.+||..||.+|||+.++|+||||...
T Consensus 217 ~p~~~~~~~~~~~~~~~~--~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~ 277 (303)
T 3a7i_A 217 PPHSELHPMKVLFLIPKN--NPPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFILRN 277 (303)
T ss_dssp CTTTTSCHHHHHHHHHHS--CCCCCCSSCCHHHHHHHHHHCCSSGGGSCCHHHHTTCHHHHHH
T ss_pred CCCCCcCHHHHHHHhhcC--CCCCCccccCHHHHHHHHHHcCCChhhCcCHHHHhhChhhhcC
Confidence 999876554433333222 1223455678889999999999999999999999999999653
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-42 Score=359.94 Aligned_cols=255 Identities=25% Similarity=0.333 Sum_probs=200.5
Q ss_pred ceeeEEEeEeccCceEEEEEEec-CCcEEEEEEEecCCC-ChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHHH
Q 003052 472 KLYQRLGKIGSGGSSEVHKVISS-DCTIYALKKIKLKGR-DYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLRE 549 (853)
Q Consensus 472 ~~Y~ilk~LG~G~FG~Vyka~~~-~g~~vAVKkik~~~~-~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~~ 549 (853)
++|++.+.||+|+||.||+|.+. +++.||||++..... .......+.+|+.++++++ |+||++++++
T Consensus 11 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~---------- 79 (276)
T 2h6d_A 11 GHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFR-HPHIIKLYQV---------- 79 (276)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCC-CTTBCCEEEE----------
T ss_pred ccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCC-CCCEeEEEEE----------
Confidence 56999999999999999999985 788999999975422 1223446889999999997 8999999987
Q ss_pred HhhCCCCCCCCccccCCeEEEEEecch-hhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCCC
Q 003052 550 VLNGSMNNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKP 628 (853)
Q Consensus 550 l~~~~iv~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLKP 628 (853)
+.+...+|+||||+. ++|.+++... ..+++..++.++.||+.||.|||++||+||||||
T Consensus 80 ------------~~~~~~~~lv~e~~~~~~L~~~l~~~--------~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p 139 (276)
T 2h6d_A 80 ------------ISTPTDFFMVMEYVSGGELFDYICKH--------GRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKP 139 (276)
T ss_dssp ------------EECSSEEEEEEECCCSCBHHHHHHHH--------CSCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCG
T ss_pred ------------EecCCeEEEEEeccCCCcHHHHHhcc--------CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCh
Confidence 455678999999985 5999988764 4689999999999999999999999999999999
Q ss_pred ccEEee-cCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHhCC
Q 003052 629 ANFLLV-KGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGR 707 (853)
Q Consensus 629 eNILL~-~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLtG~ 707 (853)
+|||++ ++.+||+|||++....... .....+||+.|+|||++.+..+ ++.++|||||||++|+|++|+
T Consensus 140 ~Nil~~~~~~~~l~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~--------~~~~~Di~slG~~l~~l~~g~ 208 (276)
T 2h6d_A 140 ENVLLDAHMNAKIADFGLSNMMSDGE---FLRTSCGSPNYAAPEVISGRLY--------AGPEVDIWSCGVILYALLCGT 208 (276)
T ss_dssp GGEEECTTSCEEECCCCGGGCCCC----------------CCTGGGTTSCC--------CHHHHHHHHHHHHHHHHHHSS
T ss_pred hhEEECCCCCEEEeecccccccCCCc---ceecccCCccccCHHHHcCCCC--------CCccchHHHHHHHHHHHHhCC
Confidence 999994 6799999999998764322 1235689999999999976532 357899999999999999999
Q ss_pred CCCCcchhHHHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCCChhHHhcCCCCCCCC
Q 003052 708 TPFSEYKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQHPFLVPPV 771 (853)
Q Consensus 708 ~PF~~~~~~~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~HPwf~~~~ 771 (853)
.||......... ..+... ....+...+..+.+||.+||..||.+||++.++++||||+...
T Consensus 209 ~p~~~~~~~~~~-~~~~~~--~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h~~~~~~~ 269 (276)
T 2h6d_A 209 LPFDDEHVPTLF-KKIRGG--VFYIPEYLNRSVATLLMHMLQVDPLKRATIKDIREHEWFKQDL 269 (276)
T ss_dssp CSSCCSSHHHHH-HHHHHC--CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHTTC
T ss_pred CCCCCCcHHHHH-HHhhcC--cccCchhcCHHHHHHHHHHccCChhhCCCHHHHHhChhhccCc
Confidence 999765433222 222211 1234556788999999999999999999999999999997654
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=356.75 Aligned_cols=252 Identities=21% Similarity=0.319 Sum_probs=206.5
Q ss_pred EEcCceeeEEEeEeccCceEEEEEEecCCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHH
Q 003052 468 KVNGKLYQRLGKIGSGGSSEVHKVISSDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALL 547 (853)
Q Consensus 468 ~v~g~~Y~ilk~LG~G~FG~Vyka~~~~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL 547 (853)
.+..+.|++++.||+|+||.||+|.+.+++.||+|++....... ..+.+|++++++++ |+||++++++
T Consensus 6 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~---~~~~~E~~~l~~l~-h~~i~~~~~~-------- 73 (269)
T 4hcu_A 6 VIDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSE---EDFIEEAEVMMKLS-HPKLVQLYGV-------- 73 (269)
T ss_dssp BCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSBCH---HHHHHHHHHHHTCC-CTTBCCEEEE--------
T ss_pred EeChhhceeeheecCCCccEEEEEEecCCCeEEEEEecccccCH---HHHHHHHHHHHhCC-CCCEeeEEEE--------
Confidence 44557899999999999999999999888889999998654432 45889999999998 8999999987
Q ss_pred HHHhhCCCCCCCCccccCCeEEEEEecchh-hHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCC
Q 003052 548 REVLNGSMNNKDGRVKDDGYIYMVLEYGEI-DLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDL 626 (853)
Q Consensus 548 ~~l~~~~iv~~~g~~~d~~~lyLVmEy~~g-dL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDL 626 (853)
+.++..+|+||||+++ +|.+++... ...+++..++.++.||+.||.|||++||+||||
T Consensus 74 --------------~~~~~~~~lv~e~~~~~~L~~~l~~~-------~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~di 132 (269)
T 4hcu_A 74 --------------CLEQAPICLVFEFMEHGCLSDYLRTQ-------RGLFAAETLLGMCLDVCEGMAYLEEACVIHRDL 132 (269)
T ss_dssp --------------ECSSSSEEEEEECCTTCBHHHHHHTT-------TTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCC
T ss_pred --------------EecCCceEEEEEeCCCCcHHHHHHhc-------CcccCHHHHHHHHHHHHHHHHHHHhCCeecCCc
Confidence 4556779999999864 888888643 356999999999999999999999999999999
Q ss_pred CCccEEe-ecCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHh
Q 003052 627 KPANFLL-VKGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVY 705 (853)
Q Consensus 627 KPeNILL-~~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLt 705 (853)
||+|||+ .++.+||+|||+++....... .......||+.|+|||++.+.. ++.++|||||||++|+|++
T Consensus 133 kp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~---------~~~~~Di~slG~~l~~ll~ 202 (269)
T 4hcu_A 133 AARNCLVGENQVIKVSDFGMTRFVLDDQY-TSSTGTKFPVKWASPEVFSFSR---------YSSKSDVWSFGVLMWEVFS 202 (269)
T ss_dssp CGGGEEECGGGCEEECCTTGGGGBCCHHH-HSTTSTTCCGGGCCHHHHHHCC---------CCHHHHHHHHHHHHHHHHT
T ss_pred chheEEEcCCCCEEecccccccccccccc-ccccCcccccccCCHHHhcCCC---------CCchhhhHHHHHHHHHHhc
Confidence 9999999 567999999999986643221 1223456788999999997653 5689999999999999999
Q ss_pred -CCCCCCcchhHHHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCCChhHHhcC
Q 003052 706 -GRTPFSEYKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQH 764 (853)
Q Consensus 706 -G~~PF~~~~~~~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~H 764 (853)
|+.||...........+... .....+...++.+.+||.+||..||.+||++.++++|
T Consensus 203 ~g~~p~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~ 260 (269)
T 4hcu_A 203 EGKIPYENRSNSEVVEDISTG--FRLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQ 260 (269)
T ss_dssp TSCCTTTTCCHHHHHHHHHTT--CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCCCCCCCHHHHHHHHhcC--ccCCCCCcCCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence 99999875554333333221 2333455678899999999999999999999999975
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=358.90 Aligned_cols=267 Identities=23% Similarity=0.349 Sum_probs=200.3
Q ss_pred ceeeEEEeEeccCceEEEEEEe-cCCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHHHH
Q 003052 472 KLYQRLGKIGSGGSSEVHKVIS-SDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLREV 550 (853)
Q Consensus 472 ~~Y~ilk~LG~G~FG~Vyka~~-~~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~~l 550 (853)
..|++++.||+|+||.||+|.+ .+++.||||++... ......+.+|+.++++++ |+||+++++++...
T Consensus 6 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~------- 74 (303)
T 1zy4_A 6 SDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT---EEKLSTILSEVMLLASLN-HQYVVRYYAAWLER------- 74 (303)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE---HHHHHHHHHHHHHHTTCC-CTTBCCEEEEEEEC-------
T ss_pred ccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc---HHHHHHHHHHHHHHHhcC-chHHHHHHHHHHhh-------
Confidence 4699999999999999999998 47889999999643 344567889999999997 99999999875432
Q ss_pred hhCCCCCCCCccccCCeEEEEEecch-hhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCCCc
Q 003052 551 LNGSMNNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPA 629 (853)
Q Consensus 551 ~~~~iv~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLKPe 629 (853)
..++.....+.+...+|+||||++ ++|.+++... ...+++..++.++.||+.||.|||++||+||||||+
T Consensus 75 --~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-------~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~ 145 (303)
T 1zy4_A 75 --RNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSE-------NLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPM 145 (303)
T ss_dssp --CCCCC------CEEEEEEEEECCCSCBHHHHHHHS-------CGGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGG
T ss_pred --cchhhhhcccccCCceEEEEecCCCCCHHHhhhcc-------ccccchHHHHHHHHHHHHHHHHHHhCCeecccCCHH
Confidence 223333344566788999999986 5999998753 245788999999999999999999999999999999
Q ss_pred cEEe-ecCcEEEEecccchhcccCCc------------cccccccccCccccCchhhccCCCCCCCccccCCCccchhhh
Q 003052 630 NFLL-VKGSLKLIDFGIAKAIMSDTT------------NIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSL 696 (853)
Q Consensus 630 NILL-~~g~VKL~DFGlAk~~~~~~~------------~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSL 696 (853)
|||+ .++.+||+|||+++....... .......+||+.|+|||++.+.. .++.++|||||
T Consensus 146 Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--------~~~~~~Di~sl 217 (303)
T 1zy4_A 146 NIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTG--------HYNEKIDMYSL 217 (303)
T ss_dssp GEEECTTSCEEECCCCCCSCTTC-------------------------CTTSCHHHHTSCS--------CCCTHHHHHHH
T ss_pred hEEEcCCCCEEEeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCC--------CCcchhhHHHH
Confidence 9999 567999999999986542210 11223567999999999997532 36789999999
Q ss_pred HHHHHHHHhCCCCCCcchhHHHHHHhhcCCC--CcccCCCCCChhHHHHHHHhcccCCCCCCChhHHhcCCCCCC
Q 003052 697 GCILYQMVYGRTPFSEYKTFWAKFKVITDPN--HEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQHPFLVP 769 (853)
Q Consensus 697 GVILyELLtG~~PF~~~~~~~~~~kii~~~~--~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~HPwf~~ 769 (853)
||++|+|++ ||............+.... ....+....+..+.+||.+||..||.+|||+.++|+||||..
T Consensus 218 G~il~~l~~---p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~ 289 (303)
T 1zy4_A 218 GIIFFEMIY---PFSTGMERVNILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPV 289 (303)
T ss_dssp HHHHHHHHS---CCSSHHHHHHHHHHHHSTTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHSSCSCC
T ss_pred HHHHHHHHh---ccCCchhHHHHHHhccccccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCCCCcCC
Confidence 999999998 6654333333333332221 222334456677999999999999999999999999999974
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-42 Score=360.84 Aligned_cols=258 Identities=29% Similarity=0.415 Sum_probs=201.7
Q ss_pred eeEEEeEeccCceEEEEEEe-cCCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHHHHhh
Q 003052 474 YQRLGKIGSGGSSEVHKVIS-SDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLREVLN 552 (853)
Q Consensus 474 Y~ilk~LG~G~FG~Vyka~~-~~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~~l~~ 552 (853)
|.....||+|+||.||+|.+ .++..||||++..... .....+.+|+.++++++ |+||++++++
T Consensus 24 ~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~-h~~iv~~~~~------------- 87 (295)
T 2clq_A 24 NGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDS--RYSQPLHEEIALHKHLK-HKNIVQYLGS------------- 87 (295)
T ss_dssp TSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC-----HHHHHHHHHHHTCC-CTTBCCEEEE-------------
T ss_pred CCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCch--HHHHHHHHHHHHHHhCC-CCCEeeEeeE-------------
Confidence 44455899999999999998 5678999999976533 33456889999999997 8999999987
Q ss_pred CCCCCCCCccccCCeEEEEEecch-hhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCCCccE
Q 003052 553 GSMNNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANF 631 (853)
Q Consensus 553 ~~iv~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLKPeNI 631 (853)
+.+.+.+|+||||+. ++|.+++.... ....+++..++.++.||+.||.|||++||+||||||+||
T Consensus 88 ---------~~~~~~~~lv~e~~~~~~L~~~l~~~~-----~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Ni 153 (295)
T 2clq_A 88 ---------FSENGFIKIFMEQVPGGSLSALLRSKW-----GPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNV 153 (295)
T ss_dssp ---------EEETTEEEEEEECCSEEEHHHHHHHTT-----CCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGE
T ss_pred ---------EEeCCcEEEEEEeCCCCCHHHHHHhhc-----cCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhE
Confidence 455678999999985 68988886541 224578999999999999999999999999999999999
Q ss_pred Eee--cCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHhCCCC
Q 003052 632 LLV--KGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGRTP 709 (853)
Q Consensus 632 LL~--~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLtG~~P 709 (853)
|++ ++.+||+|||+++....... ......||+.|+|||++.+.. ..++.++|||||||++|+|++|+.|
T Consensus 154 l~~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~-------~~~~~~~Di~slG~il~~l~~g~~p 224 (295)
T 2clq_A 154 LINTYSGVLKISDFGTSKRLAGINP--CTETFTGTLQYMAPEIIDKGP-------RGYGKAADIWSLGCTIIEMATGKPP 224 (295)
T ss_dssp EEETTTCCEEECCTTTCEESCC-------CCCCCCGGGCCHHHHHHGG-------GGCSHHHHHHHHHHHHHHHHHTSCT
T ss_pred EEECCCCCEEEeecccccccCCCCC--cccccCCCccccChhhhcCCC-------CCCCcHHHHHHHHHHHHHHHHCCCC
Confidence 995 67999999999986543221 223568999999999997542 1367899999999999999999999
Q ss_pred CCcchhHHH-HHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCCChhHHhcCCCCCCCC
Q 003052 710 FSEYKTFWA-KFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQHPFLVPPV 771 (853)
Q Consensus 710 F~~~~~~~~-~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~HPwf~~~~ 771 (853)
|........ ...... .......+...++.+.+||.+||..||.+||++.++|+||||....
T Consensus 225 f~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~ 286 (295)
T 2clq_A 225 FYELGEPQAAMFKVGM-FKVHPEIPESMSAEAKAFILKCFEPDPDKRACANDLLVDEFLKVSS 286 (295)
T ss_dssp TGGGSSHHHHHHHHHH-HCCCCCCCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHTSGGGCC--
T ss_pred ccCCCchhHHHHhhcc-ccccccccccCCHHHHHHHHHHccCChhhCCCHHHHhcChhhhhcc
Confidence 965432221 111111 1122234566788999999999999999999999999999997543
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-42 Score=367.40 Aligned_cols=266 Identities=22% Similarity=0.360 Sum_probs=201.3
Q ss_pred EcCceeeEEEeEeccCceEEEEEEec-CCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHH
Q 003052 469 VNGKLYQRLGKIGSGGSSEVHKVISS-DCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALL 547 (853)
Q Consensus 469 v~g~~Y~ilk~LG~G~FG~Vyka~~~-~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL 547 (853)
+.+++|++.++||+|+||.||+|.+. +++.||||++..... ......+.+|+++|++++ |+||+++++++..
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~----- 78 (319)
T 4euu_A 6 TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISF-LRPVDVQMREFEVLKKLN-HKNIVKLFAIEEE----- 78 (319)
T ss_dssp CSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGG-GSCHHHHHHHHHHHHHCC-CTTBCCEEEEEEC-----
T ss_pred CCCCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccc-cchHHHHHHHHHHHHhcC-CCCcceEEEEeec-----
Confidence 45678999999999999999999985 578999999975432 223456789999999998 9999999987421
Q ss_pred HHHhhCCCCCCCCccccCCeEEEEEecch-hhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCC
Q 003052 548 REVLNGSMNNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDL 626 (853)
Q Consensus 548 ~~l~~~~iv~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDL 626 (853)
.+...+|+||||+. ++|.+++..... ...+++..++.++.||+.||.|||++||+||||
T Consensus 79 ---------------~~~~~~~lv~e~~~~~~L~~~l~~~~~-----~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dl 138 (319)
T 4euu_A 79 ---------------TTTRHKVLIMEFCPCGSLYTVLEEPSN-----AYGLPESEFLIVLRDVVGGMNHLRENGIVHRNI 138 (319)
T ss_dssp ---------------TTTCCEEEEEECCTTCBHHHHHHSGGG-----TTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCC
T ss_pred ---------------CCCceEEEEEeCCCCCCHHHHHHHhcc-----ccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCC
Confidence 23447899999986 699998876421 234999999999999999999999999999999
Q ss_pred CCccEEe----e-cCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHH
Q 003052 627 KPANFLL----V-KGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILY 701 (853)
Q Consensus 627 KPeNILL----~-~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILy 701 (853)
||+|||+ + ++.+||+|||+|+....... ....+||+.|+|||++....... .....|+.++|||||||++|
T Consensus 139 kp~NIll~~~~~~~~~~kL~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~-~~~~~~~~~~DiwslG~il~ 214 (319)
T 4euu_A 139 KPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQ---FVSLYGTEEYLHPDMYERAVLRK-DHQKKYGATVDLWSIGVTFY 214 (319)
T ss_dssp SGGGEEEEECTTSCEEEEECCCTTCEECCTTCC---BCCCCSCGGGCCHHHHHHHTSCC-CCCCCBCTTHHHHHHHHHHH
T ss_pred CHHHEEEeccCCCCceEEEccCCCceecCCCCc---eeecccCCCccCHHHhhhccccc-cccCCCCcHHHHHHHHHHHH
Confidence 9999998 2 23699999999987644322 23568999999999986321110 01125788999999999999
Q ss_pred HHHhCCCCCCcc----hhHHHHHHhhcCCCC------------------cc----cCCCCCChhHHHHHHHhcccCCCCC
Q 003052 702 QMVYGRTPFSEY----KTFWAKFKVITDPNH------------------EI----TYEPVPNPWLLDLMKKCLAWDRNER 755 (853)
Q Consensus 702 ELLtG~~PF~~~----~~~~~~~kii~~~~~------------------~~----~~~~~~s~~l~dLI~kcL~~DP~kR 755 (853)
||++|+.||... .......+++..... .. .+....+..+.+||.+||.+||.+|
T Consensus 215 el~~g~~pf~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R 294 (319)
T 4euu_A 215 HAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKC 294 (319)
T ss_dssp HHHHSSCSEECTTCGGGCHHHHHHHHHHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTS
T ss_pred HHHhCCCCCCCCCccchhHHHHHHHhcCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhh
Confidence 999999999532 112222222221110 00 1111224568999999999999999
Q ss_pred CChhHHhcCC
Q 003052 756 WRIPQLLQHP 765 (853)
Q Consensus 756 pTa~EIL~HP 765 (853)
||+.|+|+||
T Consensus 295 ~s~~ell~h~ 304 (319)
T 4euu_A 295 WGFDQFFAET 304 (319)
T ss_dssp CCHHHHHHHH
T ss_pred ccHHHhhhcc
Confidence 9999999997
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-42 Score=369.37 Aligned_cols=274 Identities=23% Similarity=0.451 Sum_probs=192.2
Q ss_pred CCCceeEEcCceeeEEEeEeccCceEEEEEEe-cCCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehh
Q 003052 462 DPDLFFKVNGKLYQRLGKIGSGGSSEVHKVIS-SDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYE 540 (853)
Q Consensus 462 dp~~~~~v~g~~Y~ilk~LG~G~FG~Vyka~~-~~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~ 540 (853)
.+...+.+..++|++++.||+|+||.||+|.+ .+++.||||++..... ......+.+|+..+.+..+|+||++++++
T Consensus 12 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~~~~~~~h~niv~~~~~- 89 (327)
T 3aln_A 12 SPEQHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVD-EKEQKQLLMDLDVVMRSSDCPYIVQFYGA- 89 (327)
T ss_dssp CCCEEECCCSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCC-HHHHHHHHHHHHHHHSSCCCTTBCCEEEE-
T ss_pred ChHHhcccCHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccC-chHHHHHHHHHHHHHHcCCCCcEeeeeeE-
Confidence 34445666678899999999999999999998 4788999999986543 33444567777755555569999999987
Q ss_pred hhHHHHHHHHhhCCCCCCCCccccCCeEEEEEecchhhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccC-
Q 003052 541 VTEKALLREVLNGSMNNKDGRVKDDGYIYMVLEYGEIDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEE- 619 (853)
Q Consensus 541 ~~e~~iL~~l~~~~iv~~~g~~~d~~~lyLVmEy~~gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~- 619 (853)
+.+.+.+|+||||++++|.+++...... ....+++..++.++.||+.||.|||++
T Consensus 90 ---------------------~~~~~~~~lv~e~~~~~l~~~~~~~~~~---~~~~~~~~~~~~i~~~i~~~l~~lH~~~ 145 (327)
T 3aln_A 90 ---------------------LFREGDCWICMELMSTSFDKFYKYVYSV---LDDVIPEEILGKITLATVKALNHLKENL 145 (327)
T ss_dssp ---------------------EECSSEEEEEECCCSEEHHHHHHHHHHT---TCCCCCHHHHHHHHHHHHHHHHHHHHHH
T ss_pred ---------------------EEeCCceEEEEeecCCChHHHHHHHHhh---hcccCcHHHHHHHHHHHHHHHHHHhccC
Confidence 4556789999999999888887653221 246799999999999999999999999
Q ss_pred ceeeCCCCCccEEe-ecCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHH
Q 003052 620 RIVHSDLKPANFLL-VKGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGC 698 (853)
Q Consensus 620 gIIHRDLKPeNILL-~~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGV 698 (853)
||+||||||+|||+ .++.+||+|||+++....... .....||+.|+|||++...... ..++.++|||||||
T Consensus 146 ~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~-----~~~~~~~Di~slG~ 217 (327)
T 3aln_A 146 KIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIA---KTRDAGCRPYMAPERIDPSASR-----QGYDVRSDVWSLGI 217 (327)
T ss_dssp SCCCSCCCGGGEEEETTTEEEECCCSSSCC--------------------------------------CCSHHHHHHHHH
T ss_pred CEeECCCCHHHEEEcCCCCEEEccCCCceecccccc---cccCCCCccccCceeeccccCc-----CCCCchhhHHHHHH
Confidence 99999999999999 467999999999987643221 2345799999999998432111 14678999999999
Q ss_pred HHHHHHhCCCCCCcchhHHHHHHhhcCCC-Cc--ccCCCCCChhHHHHHHHhcccCCCCCCChhHHhcCCCCCC
Q 003052 699 ILYQMVYGRTPFSEYKTFWAKFKVITDPN-HE--ITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQHPFLVP 769 (853)
Q Consensus 699 ILyELLtG~~PF~~~~~~~~~~kii~~~~-~~--~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~HPwf~~ 769 (853)
++|+|++|+.||.+..........+.... .. .......++.+.+||.+||..||.+||++.++++||||..
T Consensus 218 il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~ 291 (327)
T 3aln_A 218 TLYELATGRFPYPKWNSVFDQLTQVVKGDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFILM 291 (327)
T ss_dssp HHHHHHHSCCCSSCC-------CCCCCSCCCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHH
T ss_pred HHHHHHHCCCCCCCcchHHHHHHHHhcCCCCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhChHHHH
Confidence 99999999999977544333222222111 11 1122357888999999999999999999999999999963
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-41 Score=354.09 Aligned_cols=251 Identities=22% Similarity=0.303 Sum_probs=206.6
Q ss_pred EcCceeeEEEeEeccCceEEEEEEecCCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHH
Q 003052 469 VNGKLYQRLGKIGSGGSSEVHKVISSDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLR 548 (853)
Q Consensus 469 v~g~~Y~ilk~LG~G~FG~Vyka~~~~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~ 548 (853)
+..++|++++.||+|+||.||+|.+.++..||+|+++...... ..+.+|++++++++ |+||++++++
T Consensus 5 l~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~---~~~~~E~~~l~~l~-h~~i~~~~~~--------- 71 (268)
T 3sxs_A 5 LKREEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSE---DEFFQEAQTMMKLS-HPKLVKFYGV--------- 71 (268)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTBCH---HHHHHHHHHHHHCC-CTTBCCEEEE---------
T ss_pred echhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCCcH---HHHHHHHHHHHhCC-CCCEeeEEEE---------
Confidence 4557899999999999999999999888889999998654432 45889999999998 8999999987
Q ss_pred HHhhCCCCCCCCccccCCeEEEEEecch-hhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCC
Q 003052 549 EVLNGSMNNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLK 627 (853)
Q Consensus 549 ~l~~~~iv~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLK 627 (853)
+.+...+|+||||++ ++|.+++... ...+++..++.++.||+.||.|||++||+|||||
T Consensus 72 -------------~~~~~~~~lv~e~~~~~~L~~~l~~~-------~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dik 131 (268)
T 3sxs_A 72 -------------CSKEYPIYIVTEYISNGCLLNYLRSH-------GKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLA 131 (268)
T ss_dssp -------------ECSSSSEEEEEECCTTCBHHHHHHHH-------GGGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCS
T ss_pred -------------EccCCceEEEEEccCCCcHHHHHHHc-------CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcC
Confidence 456677999999985 5899888764 2359999999999999999999999999999999
Q ss_pred CccEEe-ecCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHh-
Q 003052 628 PANFLL-VKGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVY- 705 (853)
Q Consensus 628 PeNILL-~~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLt- 705 (853)
|+|||+ .++.+||+|||+++....... .......||+.|+|||++.+. .++.++|||||||++|+|++
T Consensus 132 p~Nil~~~~~~~~l~Dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~---------~~~~~~Di~slG~il~~l~~~ 201 (268)
T 3sxs_A 132 ARNCLVDRDLCVKVSDFGMTRYVLDDQY-VSSVGTKFPVKWSAPEVFHYF---------KYSSKSDVWAFGILMWEVFSL 201 (268)
T ss_dssp GGGEEECTTCCEEECCTTCEEECCTTCE-EECCSCCCCGGGCCHHHHHHS---------EEETTHHHHHHHHHHHHHHTT
T ss_pred cceEEECCCCCEEEccCccceecchhhh-hcccCCCcCcccCCHHHHhcc---------CCchhhhhHHHHHHHHHHHcC
Confidence 999999 567999999999986644322 222345678889999999765 35679999999999999998
Q ss_pred CCCCCCcchhHHHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCCChhHHhcC
Q 003052 706 GRTPFSEYKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQH 764 (853)
Q Consensus 706 G~~PF~~~~~~~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~H 764 (853)
|..||............... .....+...++.+.+||.+||..||.+|||+.++++|
T Consensus 202 g~~p~~~~~~~~~~~~~~~~--~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~ 258 (268)
T 3sxs_A 202 GKMPYDLYTNSEVVLKVSQG--HRLYRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSS 258 (268)
T ss_dssp TCCTTTTSCHHHHHHHHHTT--CCCCCCTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred CCCCccccChHHHHHHHHcC--CCCCCCCcChHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 99999876554444333322 2233445568889999999999999999999999986
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-42 Score=378.58 Aligned_cols=263 Identities=20% Similarity=0.236 Sum_probs=209.7
Q ss_pred EcCceeeEEEeEeccCceEEEEEEe------cCCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhh
Q 003052 469 VNGKLYQRLGKIGSGGSSEVHKVIS------SDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVT 542 (853)
Q Consensus 469 v~g~~Y~ilk~LG~G~FG~Vyka~~------~~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~ 542 (853)
+..+.|+++++||+|+||.||+|.. .++..||||+++... .......+.+|+.+|++++ |+||++++++
T Consensus 68 ~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~-hpnIv~~~~~--- 142 (367)
T 3l9p_A 68 VPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC-SEQDELDFLMEALIISKFN-HQNIVRCIGV--- 142 (367)
T ss_dssp CCGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSC-CHHHHHHHHHHHHHHHHCC-CTTBCCEEEE---
T ss_pred cCHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEeccccc-ChhhHHHHHHHHHHHHhCC-CCCCCeEEEE---
Confidence 4457799999999999999999984 245789999997433 3344556889999999996 9999999987
Q ss_pred HHHHHHHHhhCCCCCCCCccccCCeEEEEEecch-hhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCce
Q 003052 543 EKALLREVLNGSMNNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERI 621 (853)
Q Consensus 543 e~~iL~~l~~~~iv~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gI 621 (853)
+.+...+|+||||+. ++|.+++..... .......+++..++.++.||+.||.|||++||
T Consensus 143 -------------------~~~~~~~~lv~e~~~~g~L~~~l~~~~~-~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~i 202 (367)
T 3l9p_A 143 -------------------SLQSLPRFILLELMAGGDLKSFLRETRP-RPSQPSSLAMLDLLHVARDIACGCQYLEENHF 202 (367)
T ss_dssp -------------------ECSSSSCEEEEECCTTEEHHHHHHHHSC-CSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred -------------------EecCCCCEEEEEeCCCCCHHHHHHhhcc-ccCccccccHHHHHHHHHHHHHHHHHHHhCCe
Confidence 445667799999985 599999876521 11223569999999999999999999999999
Q ss_pred eeCCCCCccEEee-cC---cEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhH
Q 003052 622 VHSDLKPANFLLV-KG---SLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLG 697 (853)
Q Consensus 622 IHRDLKPeNILL~-~g---~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLG 697 (853)
+||||||+||||+ +| .+||+|||+|+.+............+||+.|+|||++.+.. |+.++||||||
T Consensus 203 vHrDlkp~NIll~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~---------~~~~~DvwslG 273 (367)
T 3l9p_A 203 IHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGI---------FTSKTDTWSFG 273 (367)
T ss_dssp CCSCCCGGGEEESCSSTTCCEEECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCC---------CCHHHHHHHHH
T ss_pred eCCCCChhhEEEecCCCCceEEECCCccccccccccccccCCCcCCcccEECHHHhcCCC---------CCcHHHHHHHH
Confidence 9999999999995 33 59999999998764433333334567899999999997653 56899999999
Q ss_pred HHHHHHHh-CCCCCCcchhHHHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCCChhHHhcCCCC
Q 003052 698 CILYQMVY-GRTPFSEYKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQHPFL 767 (853)
Q Consensus 698 VILyELLt-G~~PF~~~~~~~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~HPwf 767 (853)
|++|||++ |..||...........+... .....+...+..+.+||.+||..||.+||++.+|++|.|+
T Consensus 274 ~il~ellt~g~~pf~~~~~~~~~~~i~~~--~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~ 342 (367)
T 3l9p_A 274 VLLWEIFSLGYMPYPSKSNQEVLEFVTSG--GRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEY 342 (367)
T ss_dssp HHHHHHHTTSCCSSTTCCHHHHHHHHHTT--CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred HHHHHHHhCCCCCCCCCCHHHHHHHHHcC--CCCCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence 99999998 99999875544333333222 2233455678889999999999999999999999998775
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-41 Score=361.86 Aligned_cols=266 Identities=23% Similarity=0.355 Sum_probs=189.2
Q ss_pred eEEcCceeeEEEeEeccCceEEEEEEec-CCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHH
Q 003052 467 FKVNGKLYQRLGKIGSGGSSEVHKVISS-DCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKA 545 (853)
Q Consensus 467 ~~v~g~~Y~ilk~LG~G~FG~Vyka~~~-~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~ 545 (853)
+...-+.|++++.||+|+||.||+|.+. +++.||||++............+.++..+++.+ .|+||++++++
T Consensus 20 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~-~h~~i~~~~~~------ 92 (318)
T 2dyl_A 20 YQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSH-DCPYIVQCFGT------ 92 (318)
T ss_dssp EECCGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTT-TCTTBCCEEEE------
T ss_pred hhhhhccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhc-CCCceeeEEEE------
Confidence 3444467999999999999999999984 788999999987654433333333344445555 59999999987
Q ss_pred HHHHHhhCCCCCCCCccccCCeEEEEEecchhhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccC-ceeeC
Q 003052 546 LLREVLNGSMNNKDGRVKDDGYIYMVLEYGEIDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEE-RIVHS 624 (853)
Q Consensus 546 iL~~l~~~~iv~~~g~~~d~~~lyLVmEy~~gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~-gIIHR 624 (853)
+.+...+|+||||++..+..++... ...+++..++.++.||+.||.|||++ ||+||
T Consensus 93 ----------------~~~~~~~~lv~e~~~~~~~~l~~~~-------~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~ 149 (318)
T 2dyl_A 93 ----------------FITNTDVFIAMELMGTCAEKLKKRM-------QGPIPERILGKMTVAIVKALYYLKEKHGVIHR 149 (318)
T ss_dssp ----------------EECSSEEEEEECCCSEEHHHHHHHH-------TSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCC
T ss_pred ----------------EecCCcEEEEEeccCCcHHHHHHHh-------ccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeC
Confidence 4556789999999976655554432 35799999999999999999999995 99999
Q ss_pred CCCCccEEe-ecCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHH
Q 003052 625 DLKPANFLL-VKGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQM 703 (853)
Q Consensus 625 DLKPeNILL-~~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyEL 703 (853)
||||+|||+ .++.+||+|||+++.+.... .....+||+.|+|||++...... ...++.++|||||||++|+|
T Consensus 150 dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~----~~~~~~~~Di~slG~il~~l 222 (318)
T 2dyl_A 150 DVKPSNILLDERGQIKLCDFGISGRLVDDK---AKDRSAGCAAYMAPERIDPPDPT----KPDYDIRADVWSLGISLVEL 222 (318)
T ss_dssp CCCGGGEEECTTSCEEECCCTTC-----------------CCTTCCHHHHC------------CCTHHHHHHHHHHHHHH
T ss_pred CCCHHHEEECCCCCEEEEECCCchhccCCc---cccccCCCccccChhhccccccc----ccCCccccchhhHHHHHHHH
Confidence 999999999 46799999999997664322 22356899999999999642211 12467899999999999999
Q ss_pred HhCCCCCCcchhHH-HHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCCChhHHhcCCCCCC
Q 003052 704 VYGRTPFSEYKTFW-AKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQHPFLVP 769 (853)
Q Consensus 704 LtG~~PF~~~~~~~-~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~HPwf~~ 769 (853)
++|+.||....... ...................++++.+||.+||..||.+||++.++|+||||..
T Consensus 223 ~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~ 289 (318)
T 2dyl_A 223 ATGQFPYKNCKTDFEVLTKVLQEEPPLLPGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKR 289 (318)
T ss_dssp HHSSCTTTTCCSHHHHHHHHHHSCCCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHH
T ss_pred HhCCCCCCCCCccHHHHHHHhccCCCCCCccCCCCHHHHHHHHHHccCChhHCcCHHHHhhCHHHHh
Confidence 99999997643322 2223333323333333457889999999999999999999999999999964
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-42 Score=387.00 Aligned_cols=263 Identities=23% Similarity=0.293 Sum_probs=199.5
Q ss_pred eeEEcCceeeEEEeEeccCceEEEEEEecCCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHH
Q 003052 466 FFKVNGKLYQRLGKIGSGGSSEVHKVISSDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKA 545 (853)
Q Consensus 466 ~~~v~g~~Y~ilk~LG~G~FG~Vyka~~~~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~ 545 (853)
.+.+.+..|.+.+.||+|+||+||.....+++.||||++..... ..+.+|+++|+++..||||++++++
T Consensus 18 ~~~i~~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~-----~~~~~E~~~l~~l~~HpnIv~l~~~------ 86 (432)
T 3p23_A 18 VVIVGKISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECF-----SFADREVQLLRESDEHPNVIRYFCT------ 86 (432)
T ss_dssp CEEETTEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTE-----EECHHHHHHHHHSCCCTTBCCEEEE------
T ss_pred cEEEccEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHH-----HHHHHHHHHHHhccCCCCcCeEEEE------
Confidence 35667778999999999999997765567889999999975432 2356899999999779999999876
Q ss_pred HHHHHhhCCCCCCCCccccCCeEEEEEecchhhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCC
Q 003052 546 LLREVLNGSMNNKDGRVKDDGYIYMVLEYGEIDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSD 625 (853)
Q Consensus 546 iL~~l~~~~iv~~~g~~~d~~~lyLVmEy~~gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRD 625 (853)
+.+...+||||||++++|.+++... ...+.+..++.++.||+.||.|||++||+|||
T Consensus 87 ----------------~~~~~~~~lv~E~~~g~L~~~l~~~-------~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrD 143 (432)
T 3p23_A 87 ----------------EKDRQFQYIAIELCAATLQEYVEQK-------DFAHLGLEPITLLQQTTSGLAHLHSLNIVHRD 143 (432)
T ss_dssp ----------------EEETTEEEEEEECCSEEHHHHHHSS-------SCCCCSSCHHHHHHHHHHHHHHHHHTTCCCCC
T ss_pred ----------------EecCCEEEEEEECCCCCHHHHHHhc-------CCCccchhHHHHHHHHHHHHHHHHHCcCEeCC
Confidence 4667789999999999999988653 23455666789999999999999999999999
Q ss_pred CCCccEEee----cC--cEEEEecccchhcccCCc-cccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHH
Q 003052 626 LKPANFLLV----KG--SLKLIDFGIAKAIMSDTT-NIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGC 698 (853)
Q Consensus 626 LKPeNILL~----~g--~VKL~DFGlAk~~~~~~~-~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGV 698 (853)
|||+||||. ++ .+||+|||+|+.+..... .......+||+.|+|||++.+... ..++.++|||||||
T Consensus 144 lKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~------~~~t~~~DiwSlG~ 217 (432)
T 3p23_A 144 LKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCK------ENPTYTVDIFSAGC 217 (432)
T ss_dssp CSTTSEEECCCBTTTBCCEEECCTTEEECC------------CCSCTTSCCGGGTSCC---------CCCTHHHHHHHHH
T ss_pred CCHHHEEEecCCCCCceeEEEecccceeeccCCCcceeeccccCCCcCccChhhhhcccc------cCCCcHHHHHHHHH
Confidence 999999994 23 588999999987653221 122345789999999999975321 14677999999999
Q ss_pred HHHHHHh-CCCCCCcchhHHHHHHhhcCCCCc-ccCCCCCChhHHHHHHHhcccCCCCCCChhHHhcCCCCCC
Q 003052 699 ILYQMVY-GRTPFSEYKTFWAKFKVITDPNHE-ITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQHPFLVP 769 (853)
Q Consensus 699 ILyELLt-G~~PF~~~~~~~~~~kii~~~~~~-~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~HPwf~~ 769 (853)
++|||++ |..||.......... ........ .......+..+.+||.+||..||.+|||+.++|+||||..
T Consensus 218 il~ellt~g~~pf~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~hp~f~~ 289 (432)
T 3p23_A 218 VFYYVISEGSHPFGKSLQRQANI-LLGACSLDCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKHPFFWS 289 (432)
T ss_dssp HHHHHHTTSCBTTBSTTTHHHHH-HTTCCCCTTSCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTSTTTCC
T ss_pred HHHHHHcCCCCCcchhhHHHHHH-HhccCCccccCccccccHHHHHHHHHHHhCCHhhCCCHHHHHhCccccC
Confidence 9999999 999996543322222 12111111 1112223455899999999999999999999999999964
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=359.09 Aligned_cols=254 Identities=27% Similarity=0.425 Sum_probs=207.6
Q ss_pred ceeeEEEeEeccCceEEEEEEec-CCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHHHH
Q 003052 472 KLYQRLGKIGSGGSSEVHKVISS-DCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLREV 550 (853)
Q Consensus 472 ~~Y~ilk~LG~G~FG~Vyka~~~-~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~~l 550 (853)
++|++++.||+|+||.||+|.+. +++.||||++............+.+|++++++++ |+||++++++
T Consensus 22 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~----------- 89 (287)
T 2wei_A 22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLD-HPNIMKLFEI----------- 89 (287)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCC-CTTBCCEEEE-----------
T ss_pred hcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcc-CCCccEEEEE-----------
Confidence 56999999999999999999985 7789999999876554455667889999999996 8999999987
Q ss_pred hhCCCCCCCCccccCCeEEEEEecch-hhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCCCc
Q 003052 551 LNGSMNNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPA 629 (853)
Q Consensus 551 ~~~~iv~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLKPe 629 (853)
+.+...+|+||||+. ++|.+.+... ..+++..++.++.||+.||.|||++||+||||||+
T Consensus 90 -----------~~~~~~~~lv~e~~~~~~L~~~l~~~--------~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~ 150 (287)
T 2wei_A 90 -----------LEDSSSFYIVGELYTGGELFDEIIKR--------KRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPE 150 (287)
T ss_dssp -----------EECSSEEEEEECCCCSCBHHHHHHHH--------SSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGG
T ss_pred -----------EeCCCeEEEEEEccCCCCHHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChh
Confidence 456678999999975 5888887654 46999999999999999999999999999999999
Q ss_pred cEEeec----CcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHh
Q 003052 630 NFLLVK----GSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVY 705 (853)
Q Consensus 630 NILL~~----g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLt 705 (853)
|||++. +.+||+|||++........ .....||+.|+|||++.+. ++.++|||||||++|+|++
T Consensus 151 NIlv~~~~~~~~~kL~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~----------~~~~~Di~slG~~l~~l~~ 217 (287)
T 2wei_A 151 NILLESKEKDCDIKIIDFGLSTCFQQNTK---MKDRIGTAYYIAPEVLRGT----------YDEKCDVWSAGVILYILLS 217 (287)
T ss_dssp GEEESCSSTTCCEEECSTTGGGTBCCCSS---CSCHHHHHTTCCHHHHTTC----------CCTHHHHHHHHHHHHHHHH
T ss_pred hEEEecCCCcccEEEeccCcceeecCCCc---cccccCcccccChHHhcCC----------CCCchhhHhHHHHHHHHHh
Confidence 999942 3699999999987643322 2345799999999998642 5679999999999999999
Q ss_pred CCCCCCcchhHHHHHHhhcCC-CCcccCCCCCChhHHHHHHHhcccCCCCCCChhHHhcCCCCCC
Q 003052 706 GRTPFSEYKTFWAKFKVITDP-NHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQHPFLVP 769 (853)
Q Consensus 706 G~~PF~~~~~~~~~~kii~~~-~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~HPwf~~ 769 (853)
|..||.+.........+.... ..........++.+.+||.+||..||.+|||+.++|+||||..
T Consensus 218 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~~~~ 282 (287)
T 2wei_A 218 GTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQK 282 (287)
T ss_dssp SSCSSCCSSHHHHHHHHHHCCCCCCSGGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHH
T ss_pred CCCCCCCCCHHHHHHHHHcCCCCCCchhhhhcCHHHHHHHHHHcccChhhCcCHHHHhcCHHHhc
Confidence 999998755433222222211 1112222456888999999999999999999999999999964
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=368.05 Aligned_cols=266 Identities=23% Similarity=0.356 Sum_probs=207.4
Q ss_pred eEEcCceeeEEEeEeccCceEEEEEEec------CCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehh
Q 003052 467 FKVNGKLYQRLGKIGSGGSSEVHKVISS------DCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYE 540 (853)
Q Consensus 467 ~~v~g~~Y~ilk~LG~G~FG~Vyka~~~------~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~ 540 (853)
+.+..+.|++.+.||+|+||.||+|.+. ++..||||++.... .......+.+|+.+|+++..||||++++++
T Consensus 40 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~- 117 (344)
T 1rjb_A 40 WEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA-DSSEREALMSELKMMTQLGSHENIVNLLGA- 117 (344)
T ss_dssp GBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC-------CHHHHHHHHHHHHHCCCTTBCCEEEE-
T ss_pred cccCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEeccccc-CHHHHHHHHHHHHHHHhhcCCCCeeeEEEE-
Confidence 4556678999999999999999999862 34689999997543 233446788999999999779999999987
Q ss_pred hhHHHHHHHHhhCCCCCCCCccccCCeEEEEEecch-hhHHHHHHHhhhhcc---------------CCCCCCCHHHHHH
Q 003052 541 VTEKALLREVLNGSMNNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEMD---------------GSNQTLDENWLRF 604 (853)
Q Consensus 541 ~~e~~iL~~l~~~~iv~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~~~---------------~~~~~LsE~~~r~ 604 (853)
+.+.+.+|+||||++ ++|.+++........ .....+++..++.
T Consensus 118 ---------------------~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 176 (344)
T 1rjb_A 118 ---------------------CTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLC 176 (344)
T ss_dssp ---------------------ECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHH
T ss_pred ---------------------EeeCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHH
Confidence 345667899999986 599999876422100 0123589999999
Q ss_pred HHHHhhhhhhhcccCceeeCCCCCccEEee-cCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCc
Q 003052 605 YWQQILEAVNTIHEERIVHSDLKPANFLLV-KGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGN 683 (853)
Q Consensus 605 I~~QIl~AL~yLHs~gIIHRDLKPeNILL~-~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~ 683 (853)
++.||+.||.|||++||+||||||+|||++ ++.+||+|||+++.+.............||+.|+|||++.+..
T Consensus 177 i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~------ 250 (344)
T 1rjb_A 177 FAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGI------ 250 (344)
T ss_dssp HHHHHHHHHHHHHHTTEEETTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCC------
T ss_pred HHHHHHHHHHHHHhCCcccCCCChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCC------
Confidence 999999999999999999999999999995 6799999999998765544333344567899999999997653
Q ss_pred cccCCCccchhhhHHHHHHHHh-CCCCCCcchhHHHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCCChhHHh
Q 003052 684 IIKCGRPSDIWSLGCILYQMVY-GRTPFSEYKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLL 762 (853)
Q Consensus 684 ~~~ys~ksDIWSLGVILyELLt-G~~PF~~~~~~~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL 762 (853)
|+.++|||||||++|+|++ |..||.+..........+.. ......+...++.+.+||.+||..||.+||++.+++
T Consensus 251 ---~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~ 326 (344)
T 1rjb_A 251 ---YTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYKLIQN-GFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLT 326 (344)
T ss_dssp ---CCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHT-TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred ---CChhHhHHHHHHHHHHHHcCCCCCcccCCcHHHHHHHHhc-CCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHH
Confidence 5689999999999999998 99999765433333333332 223344556788999999999999999999999999
Q ss_pred cCC
Q 003052 763 QHP 765 (853)
Q Consensus 763 ~HP 765 (853)
+|.
T Consensus 327 ~~l 329 (344)
T 1rjb_A 327 SFL 329 (344)
T ss_dssp HHH
T ss_pred HHH
Confidence 864
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-41 Score=373.23 Aligned_cols=264 Identities=21% Similarity=0.339 Sum_probs=211.0
Q ss_pred eEEcCceeeEEEeEeccCceEEEEEEec--------CCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeee
Q 003052 467 FKVNGKLYQRLGKIGSGGSSEVHKVISS--------DCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLID 538 (853)
Q Consensus 467 ~~v~g~~Y~ilk~LG~G~FG~Vyka~~~--------~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid 538 (853)
+.+..++|.+.++||+|+||.||+|.+. .+..||||+++... .......+.+|+++++++..|+||+++++
T Consensus 64 ~~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hpnIv~~~~ 142 (382)
T 3tt0_A 64 WELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA-TEKDLSDLISEMEMMKMIGKHKNIINLLG 142 (382)
T ss_dssp TBCCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred cccchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeecccc-CHHHHHHHHHHHHHHHHhcCCchhhhhee
Confidence 4556678999999999999999999862 23579999997653 34455678999999999977999999998
Q ss_pred hhhhHHHHHHHHhhCCCCCCCCccccCCeEEEEEecchh-hHHHHHHHhhhh--------ccCCCCCCCHHHHHHHHHHh
Q 003052 539 YEVTEKALLREVLNGSMNNKDGRVKDDGYIYMVLEYGEI-DLAHMLSQKWKE--------MDGSNQTLDENWLRFYWQQI 609 (853)
Q Consensus 539 ~~~~e~~iL~~l~~~~iv~~~g~~~d~~~lyLVmEy~~g-dL~~~L~~~~k~--------~~~~~~~LsE~~~r~I~~QI 609 (853)
+ +.+++.+|+||||+.+ +|.+++...... .......+++..++.|+.||
T Consensus 143 ~----------------------~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi 200 (382)
T 3tt0_A 143 A----------------------CTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQV 200 (382)
T ss_dssp E----------------------ECSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHH
T ss_pred e----------------------eccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHH
Confidence 7 4556678999999864 999998765210 01123469999999999999
Q ss_pred hhhhhhcccCceeeCCCCCccEEee-cCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCC
Q 003052 610 LEAVNTIHEERIVHSDLKPANFLLV-KGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCG 688 (853)
Q Consensus 610 l~AL~yLHs~gIIHRDLKPeNILL~-~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys 688 (853)
+.||.|||++||+||||||+||||+ ++.+||+|||+|+...............||+.|+|||++.+. .++
T Consensus 201 ~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~---------~~~ 271 (382)
T 3tt0_A 201 ARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDR---------IYT 271 (382)
T ss_dssp HHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSC---------CCC
T ss_pred HHHHHHHHhCCEecCCCCcceEEEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCC---------CCC
Confidence 9999999999999999999999995 679999999999876543332333456789999999999765 356
Q ss_pred CccchhhhHHHHHHHHh-CCCCCCcchhHHHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCCChhHHhcC
Q 003052 689 RPSDIWSLGCILYQMVY-GRTPFSEYKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQH 764 (853)
Q Consensus 689 ~ksDIWSLGVILyELLt-G~~PF~~~~~~~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~H 764 (853)
.++|||||||++|+|++ |..||.+.... .....+.. ......+...++++.+||.+||..||.+||++.|++++
T Consensus 272 ~~~DiwslG~il~ellt~g~~p~~~~~~~-~~~~~~~~-~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 346 (382)
T 3tt0_A 272 HQSDVWSFGVLLWEIFTLGGSPYPGVPVE-ELFKLLKE-GHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 346 (382)
T ss_dssp HHHHHHHHHHHHHHHHTTSCCSSTTCCHH-HHHHHHHT-TCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred chhHHHHHHHHHHHHHhCCCCCCCCCCHH-HHHHHHHc-CCCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 89999999999999999 99999775443 23333322 22334456778999999999999999999999999975
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-41 Score=356.84 Aligned_cols=253 Identities=21% Similarity=0.233 Sum_probs=202.3
Q ss_pred EcCceeeEEEeEeccCceEEEEEEe-cCCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHH
Q 003052 469 VNGKLYQRLGKIGSGGSSEVHKVIS-SDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALL 547 (853)
Q Consensus 469 v~g~~Y~ilk~LG~G~FG~Vyka~~-~~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL 547 (853)
+.+++|++.+.||+|+||.||+|.+ .+++.||||++..... ...+.+|+.+++++.+|+||++++++
T Consensus 7 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~~~~e~~~~~~l~~~~~i~~~~~~-------- 74 (298)
T 1csn_A 7 VVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD----APQLRDEYRTYKLLAGCTGIPNVYYF-------- 74 (298)
T ss_dssp EETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT----SCCHHHHHHHHHHTTTCTTCCCEEEE--------
T ss_pred ccccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCc----cHHHHHHHHHHHHHhcCCCCCeEEee--------
Confidence 3457799999999999999999998 5788999999975432 23578999999999889999999876
Q ss_pred HHHhhCCCCCCCCccccCCeEEEEEecchhhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCC
Q 003052 548 REVLNGSMNNKDGRVKDDGYIYMVLEYGEIDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLK 627 (853)
Q Consensus 548 ~~l~~~~iv~~~g~~~d~~~lyLVmEy~~gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLK 627 (853)
+.+...+|+||||++++|.+++... ...+++..++.++.||+.||.|||++||+|||||
T Consensus 75 --------------~~~~~~~~lv~e~~~~~L~~~l~~~-------~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlk 133 (298)
T 1csn_A 75 --------------GQEGLHNVLVIDLLGPSLEDLLDLC-------GRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIK 133 (298)
T ss_dssp --------------EEETTEEEEEEECCCCBHHHHHHHT-------TTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCC
T ss_pred --------------cCCCceeEEEEEecCCCHHHHHHHh-------ccCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCC
Confidence 4567789999999988999998753 3469999999999999999999999999999999
Q ss_pred CccEEee-cCc-----EEEEecccchhcccCCcc-----ccccccccCccccCchhhccCCCCCCCccccCCCccchhhh
Q 003052 628 PANFLLV-KGS-----LKLIDFGIAKAIMSDTTN-----IQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSL 696 (853)
Q Consensus 628 PeNILL~-~g~-----VKL~DFGlAk~~~~~~~~-----~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSL 696 (853)
|+|||++ ++. +||+|||+++........ ......+||+.|+|||++.+.. ++.++|||||
T Consensus 134 p~NIl~~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---------~~~~~Di~sl 204 (298)
T 1csn_A 134 PDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGRE---------QSRRDDLEAL 204 (298)
T ss_dssp GGGEEECCSSSTTTTCEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCC---------CCHHHHHHHH
T ss_pred HHHEEeccCCCCCCCeEEEEECccccccccccccccccccCccCCCCCcccCCchhhcCCC---------CChHHHHHHH
Confidence 9999994 343 999999999876543221 1234668999999999997653 5689999999
Q ss_pred HHHHHHHHhCCCCCCcch--hHHHHHHhhc---CCCCcccCCCCCChhHHHHHHHhcccCCCCCCChhHHhc
Q 003052 697 GCILYQMVYGRTPFSEYK--TFWAKFKVIT---DPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQ 763 (853)
Q Consensus 697 GVILyELLtG~~PF~~~~--~~~~~~kii~---~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~ 763 (853)
||++|+|++|+.||.+.. .....+..+. ............++++.+||.+||..||.+||++.+|++
T Consensus 205 G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~ 276 (298)
T 1csn_A 205 GHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQG 276 (298)
T ss_dssp HHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred HHHHHHHHcCCCCcchhhccccHHHHHHHHhhccCccHHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHH
Confidence 999999999999997632 1111111110 001111223467889999999999999999999999885
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-41 Score=356.94 Aligned_cols=252 Identities=19% Similarity=0.312 Sum_probs=203.5
Q ss_pred EEcCceeeEEEeEeccCceEEEEEEecCCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHH
Q 003052 468 KVNGKLYQRLGKIGSGGSSEVHKVISSDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALL 547 (853)
Q Consensus 468 ~v~g~~Y~ilk~LG~G~FG~Vyka~~~~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL 547 (853)
.+..++|++++.||+|+||.||+|.+.++..||||+++...... ..+.+|++++++++ |+||++++++
T Consensus 20 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~---~~~~~E~~~l~~l~-h~~i~~~~~~-------- 87 (283)
T 3gen_A 20 EIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE---DEFIEEAKVMMNLS-HEKLVQLYGV-------- 87 (283)
T ss_dssp BCCGGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSBCH---HHHHHHHHHHHTCC-CTTBCCEEEE--------
T ss_pred cCCHHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCCCH---HHHHHHHHHHhcCC-CCCEeeEEEE--------
Confidence 34557899999999999999999999888899999998654432 45889999999998 8999999987
Q ss_pred HHHhhCCCCCCCCccccCCeEEEEEecch-hhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCC
Q 003052 548 REVLNGSMNNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDL 626 (853)
Q Consensus 548 ~~l~~~~iv~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDL 626 (853)
+.+...+|+||||+. ++|.+++... ...+++..++.++.||+.||.|||++||+||||
T Consensus 88 --------------~~~~~~~~lv~e~~~~~~L~~~l~~~-------~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di 146 (283)
T 3gen_A 88 --------------CTKQRPIFIITEYMANGCLLNYLREM-------RHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDL 146 (283)
T ss_dssp --------------ECSSSSEEEEECCCTTCBHHHHHHCG-------GGCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSC
T ss_pred --------------EecCCCeEEEEeccCCCcHHHHHHHh-------ccCCCHHHHHHHHHHHHHHHHHHHHCCccCCCC
Confidence 456678999999985 6899888653 246999999999999999999999999999999
Q ss_pred CCccEEee-cCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHh
Q 003052 627 KPANFLLV-KGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVY 705 (853)
Q Consensus 627 KPeNILL~-~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLt 705 (853)
||+|||++ ++.+||+|||+++....... .......||+.|+|||++.+.. ++.++|||||||++|+|++
T Consensus 147 kp~Nili~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~---------~~~~~Dv~slG~~l~~l~t 216 (283)
T 3gen_A 147 AARNCLVNDQGVVKVSDFGLSRYVLDDEY-TSSVGSKFPVRWSPPEVLMYSK---------FSSKSDIWAFGVLMWEIYS 216 (283)
T ss_dssp SGGGEEECTTSCEEECSTTGGGGBCCHHH-HSTTSTTSCGGGCCHHHHHHCC---------CSHHHHHHHHHHHHHHHHT
T ss_pred ccceEEEcCCCCEEEcccccccccccccc-ccccCCccCcccCCHHHhccCC---------CCchhhHHHHHHHHHHHHh
Confidence 99999994 67999999999986643221 1223456788999999997653 5679999999999999998
Q ss_pred -CCCCCCcchhHHHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCCChhHHhcC
Q 003052 706 -GRTPFSEYKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQH 764 (853)
Q Consensus 706 -G~~PF~~~~~~~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~H 764 (853)
|+.||...........+.. ......+...++.+.+||.+||..||.+|||+.++++|
T Consensus 217 ~g~~p~~~~~~~~~~~~~~~--~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~ 274 (283)
T 3gen_A 217 LGKMPYERFTNSETAEHIAQ--GLRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSN 274 (283)
T ss_dssp TTCCTTTTSCHHHHHHHHHT--TCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred CCCCCccccChhHHHHHHhc--ccCCCCCCcCCHHHHHHHHHHccCChhHCcCHHHHHHH
Confidence 9999987655433333322 12233455678899999999999999999999999975
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=360.19 Aligned_cols=258 Identities=22% Similarity=0.328 Sum_probs=195.3
Q ss_pred eEEcCceeeEEEeEeccCceEEEEEEecCCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHH
Q 003052 467 FKVNGKLYQRLGKIGSGGSSEVHKVISSDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKAL 546 (853)
Q Consensus 467 ~~v~g~~Y~ilk~LG~G~FG~Vyka~~~~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~i 546 (853)
.++.+.+|++.++||+|+||.||+|.+.. .||||+++...........+.+|+.+|++++ |+||++++++.
T Consensus 19 ~ei~~~~y~~~~~lG~G~~g~Vy~~~~~~--~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~------ 89 (289)
T 3og7_A 19 WEIPDGQITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTR-HVNILLFMGYS------ 89 (289)
T ss_dssp CBCCTTSCEEEEEEEECSSEEEEEEESSS--EEEEEEESCSSCCHHHHHHHHHHHHHHTTCC-CTTBCCEEEEE------
T ss_pred CccCccceeeeeEecCCCCeEEEEEEEcC--ceEEEEEeccCCCHHHHHHHHHHHHHHHhCC-CCcEEEEEeec------
Confidence 35667889999999999999999998643 5999999887777777788999999999998 89999998862
Q ss_pred HHHHhhCCCCCCCCccccCCeEEEEEecch-hhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCC
Q 003052 547 LREVLNGSMNNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSD 625 (853)
Q Consensus 547 L~~l~~~~iv~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRD 625 (853)
....+|+||||+. ++|.+++... ...+++..++.++.||+.||.|||++||+|||
T Consensus 90 -----------------~~~~~~lv~e~~~~~~L~~~l~~~-------~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~D 145 (289)
T 3og7_A 90 -----------------TAPQLAIVTQWCEGSSLYHHLHAS-------ETKFEMKKLIDIARQTARGMDYLHAKSIIHRD 145 (289)
T ss_dssp -----------------CSSSCEEEEECCCEEEHHHHHTTC----------CCHHHHHHHHHHHHHHHHHHHHTTCCCSC
T ss_pred -----------------cCCccEEEEEecCCCcHHHHHhhc-------cCCCCHHHHHHHHHHHHHHHHHHHhCCccccc
Confidence 3445799999986 5888887542 35699999999999999999999999999999
Q ss_pred CCCccEEe-ecCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHH
Q 003052 626 LKPANFLL-VKGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMV 704 (853)
Q Consensus 626 LKPeNILL-~~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELL 704 (853)
|||+|||+ .++.+||+|||+++...............||+.|+|||++..... ..++.++|||||||++|+|+
T Consensus 146 lkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~------~~~~~~~Di~slG~il~el~ 219 (289)
T 3og7_A 146 LKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDS------NPYSFQSDVYAFGIVLYELM 219 (289)
T ss_dssp CCGGGEEEETTTEEEECCCC------------------CCCTTCCHHHHC----------CCSCHHHHHHHHHHHHHHHH
T ss_pred CccceEEECCCCCEEEccceeccccccccccccccccCCCccccCchhhcccCC------CCCCcccchHHHHHHHHHHH
Confidence 99999999 467999999999986543333333346689999999999963321 14678999999999999999
Q ss_pred hCCCCCCcchhHHHHHHhhcCCCCc---ccCCCCCChhHHHHHHHhcccCCCCCCChhHHhc
Q 003052 705 YGRTPFSEYKTFWAKFKVITDPNHE---ITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQ 763 (853)
Q Consensus 705 tG~~PF~~~~~~~~~~kii~~~~~~---~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~ 763 (853)
+|+.||.+..........+...... .......++.+.+||.+||..||.+||++.++++
T Consensus 220 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 281 (289)
T 3og7_A 220 TGQLPYSNINNRDQIIEMVGRGSLSPDLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILA 281 (289)
T ss_dssp HSSCTTSSCCCHHHHHHHHHHTSCCCCTTSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HCCCCccccchHHHHHHHhcccccCcchhhccccCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 9999997755444333333221111 1233467788999999999999999999999985
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-42 Score=372.67 Aligned_cols=263 Identities=24% Similarity=0.354 Sum_probs=206.7
Q ss_pred ceeeEEEeEeccCceEEEEEEecCCcEEEEEEEecCCCChh---------------hHhhHHHHHHHHHHhcCCCceeEe
Q 003052 472 KLYQRLGKIGSGGSSEVHKVISSDCTIYALKKIKLKGRDYA---------------TAYGFCQEIEYLNKLKGKNNIIQL 536 (853)
Q Consensus 472 ~~Y~ilk~LG~G~FG~Vyka~~~~g~~vAVKkik~~~~~~~---------------~~~~~l~EI~iLkkL~~hpNIV~L 536 (853)
++|++++.||+|+||.||+|.+ +++.||||++........ ....+.+|+.++++++ |+||+++
T Consensus 31 ~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~ 108 (348)
T 2pml_X 31 NDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIK-NEYCLTC 108 (348)
T ss_dssp TTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCC-CTTBCCC
T ss_pred CceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCC-CCCcceE
Confidence 5699999999999999999999 889999999975432211 1156889999999997 9999999
Q ss_pred eehhhhHHHHHHHHhhCCCCCCCCccccCCeEEEEEecchh-hHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhh
Q 003052 537 IDYEVTEKALLREVLNGSMNNKDGRVKDDGYIYMVLEYGEI-DLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNT 615 (853)
Q Consensus 537 id~~~~e~~iL~~l~~~~iv~~~g~~~d~~~lyLVmEy~~g-dL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~y 615 (853)
+++ +.+.+.+|+||||+++ +|.+++.....-.......+++..++.++.||+.||.|
T Consensus 109 ~~~----------------------~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~ 166 (348)
T 2pml_X 109 EGI----------------------ITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSY 166 (348)
T ss_dssp SEE----------------------EESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHH
T ss_pred EEE----------------------EeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHH
Confidence 887 4556789999999875 77766221100011124689999999999999999999
Q ss_pred ccc-CceeeCCCCCccEEe-ecCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCC-ccc
Q 003052 616 IHE-ERIVHSDLKPANFLL-VKGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGR-PSD 692 (853)
Q Consensus 616 LHs-~gIIHRDLKPeNILL-~~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~-ksD 692 (853)
||+ +||+||||||+|||+ .++.+||+|||++...... ......||+.|+|||++.+.. .++. ++|
T Consensus 167 lH~~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~--------~~~~~~~D 234 (348)
T 2pml_X 167 IHNEKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDK----KIKGSRGTYEFMPPEFFSNES--------SYNGAKVD 234 (348)
T ss_dssp HHHTSCEECCCCCGGGEEECTTSCEEECCCTTCEECBTT----EECSSCSCGGGCCGGGGSSCC--------CEEHHHHH
T ss_pred HhccCCEeecCCChHhEEEcCCCcEEEeccccccccccc----cccCCCCCcCccCchhhcCCC--------CCCcchhh
Confidence 999 999999999999999 5679999999999875432 234678999999999997652 1334 899
Q ss_pred hhhhHHHHHHHHhCCCCCCcchhHHHHHHhhcCCCCcccC-----------------CCCCChhHHHHHHHhcccCCCCC
Q 003052 693 IWSLGCILYQMVYGRTPFSEYKTFWAKFKVITDPNHEITY-----------------EPVPNPWLLDLMKKCLAWDRNER 755 (853)
Q Consensus 693 IWSLGVILyELLtG~~PF~~~~~~~~~~kii~~~~~~~~~-----------------~~~~s~~l~dLI~kcL~~DP~kR 755 (853)
||||||++|+|++|+.||............+......... ....+..+.+||.+||..||.+|
T Consensus 235 i~slG~il~~l~~g~~pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R 314 (348)
T 2pml_X 235 IWSLGICLYVMFYNVVPFSLKISLVELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAER 314 (348)
T ss_dssp HHHHHHHHHHHHHSSCSSCCSSCSHHHHHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGS
T ss_pred HHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhC
Confidence 9999999999999999997654423333333332222211 14578899999999999999999
Q ss_pred CChhHHhcCCCCCCC
Q 003052 756 WRIPQLLQHPFLVPP 770 (853)
Q Consensus 756 pTa~EIL~HPwf~~~ 770 (853)
|++.|+|+||||...
T Consensus 315 ps~~e~l~hp~f~~~ 329 (348)
T 2pml_X 315 ITSEDALKHEWLADT 329 (348)
T ss_dssp CCHHHHHTSGGGTTC
T ss_pred CCHHHHhcCccccCC
Confidence 999999999999753
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=361.59 Aligned_cols=262 Identities=20% Similarity=0.337 Sum_probs=207.3
Q ss_pred EEcCceeeEEEeEeccCceEEEEEEe------cCCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhh
Q 003052 468 KVNGKLYQRLGKIGSGGSSEVHKVIS------SDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEV 541 (853)
Q Consensus 468 ~v~g~~Y~ilk~LG~G~FG~Vyka~~------~~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~ 541 (853)
.+..++|.+.+.||+|+||.||+|.+ .++..||||+++... .......+.+|+++|++++ ||||++++++
T Consensus 19 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~-- 94 (314)
T 2ivs_A 19 EFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENA-SPSELRDLLSEFNVLKQVN-HPHVIKLYGA-- 94 (314)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTC-CHHHHHHHHHHHHHHTTCC-CTTBCCEEEE--
T ss_pred ccchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCC-CHHHHHHHHHHHHHHhhCC-CCceeeEEEE--
Confidence 44567899999999999999999986 234789999997543 3455567899999999996 9999999987
Q ss_pred hHHHHHHHHhhCCCCCCCCccccCCeEEEEEecch-hhHHHHHHHhhhhc----------------cCCCCCCCHHHHHH
Q 003052 542 TEKALLREVLNGSMNNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEM----------------DGSNQTLDENWLRF 604 (853)
Q Consensus 542 ~e~~iL~~l~~~~iv~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~~----------------~~~~~~LsE~~~r~ 604 (853)
+.+.+.+|+||||+. ++|.+++....... ......+++..++.
T Consensus 95 --------------------~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 154 (314)
T 2ivs_A 95 --------------------CSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLIS 154 (314)
T ss_dssp --------------------ECSSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHH
T ss_pred --------------------EecCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHH
Confidence 445667899999986 69999987642100 00123589999999
Q ss_pred HHHHhhhhhhhcccCceeeCCCCCccEEee-cCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCc
Q 003052 605 YWQQILEAVNTIHEERIVHSDLKPANFLLV-KGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGN 683 (853)
Q Consensus 605 I~~QIl~AL~yLHs~gIIHRDLKPeNILL~-~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~ 683 (853)
++.||+.||.|||++||+||||||+|||++ ++.+||+|||+++...............||+.|+|||++.+.
T Consensus 155 i~~qi~~~l~~lH~~~ivH~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~------- 227 (314)
T 2ivs_A 155 FAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDH------- 227 (314)
T ss_dssp HHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHC-------
T ss_pred HHHHHHHHHHHHHHCCCcccccchheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCC-------
Confidence 999999999999999999999999999995 569999999999876544333333456788999999999764
Q ss_pred cccCCCccchhhhHHHHHHHHh-CCCCCCcchhHHHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCCChhHHh
Q 003052 684 IIKCGRPSDIWSLGCILYQMVY-GRTPFSEYKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLL 762 (853)
Q Consensus 684 ~~~ys~ksDIWSLGVILyELLt-G~~PF~~~~~~~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL 762 (853)
.++.++|||||||++|+|++ |..||.+...... ...+.. ......+...++++.+||.+||..||.+||++.+++
T Consensus 228 --~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~-~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~ 303 (314)
T 2ivs_A 228 --IYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPERL-FNLLKT-GHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADIS 303 (314)
T ss_dssp --EECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGH-HHHHHT-TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred --CcCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHH-HHHhhc-CCcCCCCccCCHHHHHHHHHHccCChhhCcCHHHHH
Confidence 36789999999999999999 9999976443222 222222 123344567789999999999999999999999998
Q ss_pred cC
Q 003052 763 QH 764 (853)
Q Consensus 763 ~H 764 (853)
++
T Consensus 304 ~~ 305 (314)
T 2ivs_A 304 KD 305 (314)
T ss_dssp HH
T ss_pred HH
Confidence 74
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-41 Score=361.34 Aligned_cols=250 Identities=27% Similarity=0.418 Sum_probs=199.5
Q ss_pred CceeeEEEeEeccCceEEEEEEe-cCCcEEEEEEEecCCCCh----hhHhhHHHHHHHHHHhc---CCCceeEeeehhhh
Q 003052 471 GKLYQRLGKIGSGGSSEVHKVIS-SDCTIYALKKIKLKGRDY----ATAYGFCQEIEYLNKLK---GKNNIIQLIDYEVT 542 (853)
Q Consensus 471 g~~Y~ilk~LG~G~FG~Vyka~~-~~g~~vAVKkik~~~~~~----~~~~~~l~EI~iLkkL~---~hpNIV~Lid~~~~ 542 (853)
.++|++.+.||+|+||.||+|.+ .+++.||||++....... .....+.+|+.+++++. .|+||+++++++
T Consensus 30 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~-- 107 (312)
T 2iwi_A 30 EAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWF-- 107 (312)
T ss_dssp ---CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC--
T ss_pred hhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEE--
Confidence 35699999999999999999988 567899999997653221 23345668999999995 599999999874
Q ss_pred HHHHHHHHhhCCCCCCCCccccCCeEEEEEec-c-hhhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCc
Q 003052 543 EKALLREVLNGSMNNKDGRVKDDGYIYMVLEY-G-EIDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEER 620 (853)
Q Consensus 543 e~~iL~~l~~~~iv~~~g~~~d~~~lyLVmEy-~-~gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~g 620 (853)
.+.+.+|+|||| + +++|.+++... ..+++..++.++.||+.||.|||++|
T Consensus 108 --------------------~~~~~~~~v~e~~~~~~~L~~~l~~~--------~~~~~~~~~~~~~qi~~~l~~lH~~~ 159 (312)
T 2iwi_A 108 --------------------ETQEGFMLVLERPLPAQDLFDYITEK--------GPLGEGPSRCFFGQVVAAIQHCHSRG 159 (312)
T ss_dssp -------------------------CEEEEECCSSEEEHHHHHHHH--------CSCCHHHHHHHHHHHHHHHHHHHHHT
T ss_pred --------------------ecCCeEEEEEEecCCCCCHHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 344567999998 4 46999988764 46999999999999999999999999
Q ss_pred eeeCCCCCccEEee--cCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHH
Q 003052 621 IVHSDLKPANFLLV--KGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGC 698 (853)
Q Consensus 621 IIHRDLKPeNILL~--~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGV 698 (853)
|+||||||+|||++ ++.+||+|||+++...... .....||+.|+|||++.+..+ ++.++|||||||
T Consensus 160 i~H~dlkp~Nil~~~~~~~~kl~dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~--------~~~~~Di~slG~ 227 (312)
T 2iwi_A 160 VVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEP----YTDFDGTRVYSPPEWISRHQY--------HALPATVWSLGI 227 (312)
T ss_dssp EECCCCSGGGEEEETTTTEEEECCCSSCEECCSSC----BCCCCSCTTTSCHHHHHHSCB--------CHHHHHHHHHHH
T ss_pred eeecCCChhhEEEeCCCCeEEEEEcchhhhcccCc----ccccCCcccccCceeeecCCC--------CCccchHHHHHH
Confidence 99999999999996 5789999999998764322 235689999999999976532 345899999999
Q ss_pred HHHHHHhCCCCCCcchhHHHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCCChhHHhcCCCCCCCC
Q 003052 699 ILYQMVYGRTPFSEYKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQHPFLVPPV 771 (853)
Q Consensus 699 ILyELLtG~~PF~~~~~~~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~HPwf~~~~ 771 (853)
++|+|++|+.||........ ....++...+..+.+||.+||..||.+||++.|+|+||||....
T Consensus 228 il~~l~~g~~pf~~~~~~~~---------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~~~~~~~~ 291 (312)
T 2iwi_A 228 LLYDMVCGDIPFERDQEILE---------AELHFPAHVSPDCCALIRRCLAPKPSSRPSLEEILLDPWMQTPA 291 (312)
T ss_dssp HHHHHHHSSCSCCSHHHHHH---------TCCCCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHSTTTCC--
T ss_pred HHHHHHHCCCCCCChHHHhh---------hccCCcccCCHHHHHHHHHHccCChhhCcCHHHHhcChhhcCch
Confidence 99999999999977543211 12234566788999999999999999999999999999998654
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=363.90 Aligned_cols=254 Identities=19% Similarity=0.269 Sum_probs=199.7
Q ss_pred EcCceeeEEEeEeccCceEEEEEEe-cCCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHH
Q 003052 469 VNGKLYQRLGKIGSGGSSEVHKVIS-SDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALL 547 (853)
Q Consensus 469 v~g~~Y~ilk~LG~G~FG~Vyka~~-~~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL 547 (853)
+..++|++.+.||+|+||.||+|.+ .+++.||+|++... +......+.+|+++|++++ |+||++++++
T Consensus 7 ~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~--~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~-------- 75 (310)
T 3s95_A 7 FRPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRF--DEETQRTFLKEVKVMRCLE-HPNVLKFIGV-------- 75 (310)
T ss_dssp ECGGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCC--CHHHHHHHHHHHHHHTTCC-CTTBCCEEEE--------
T ss_pred eChhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccC--CHHHHHHHHHHHHHHHhCC-CcCcccEEEE--------
Confidence 3446799999999999999999998 46789999998543 4455667899999999997 9999999987
Q ss_pred HHHhhCCCCCCCCccccCCeEEEEEecchh-hHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCC
Q 003052 548 REVLNGSMNNKDGRVKDDGYIYMVLEYGEI-DLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDL 626 (853)
Q Consensus 548 ~~l~~~~iv~~~g~~~d~~~lyLVmEy~~g-dL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDL 626 (853)
+.++..+|+||||+.+ +|.+++... ...+++..+..++.||+.||.|||++||+||||
T Consensus 76 --------------~~~~~~~~lv~e~~~~~~L~~~l~~~-------~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dl 134 (310)
T 3s95_A 76 --------------LYKDKRLNFITEYIKGGTLRGIIKSM-------DSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDL 134 (310)
T ss_dssp --------------EEETTEEEEEEECCTTCBHHHHHHHC-------CTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCC
T ss_pred --------------EecCCeeEEEEEecCCCcHHHHHHhc-------cCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCC
Confidence 4566789999999865 999988753 356999999999999999999999999999999
Q ss_pred CCccEEee-cCcEEEEecccchhcccCCccc------------cccccccCccccCchhhccCCCCCCCccccCCCccch
Q 003052 627 KPANFLLV-KGSLKLIDFGIAKAIMSDTTNI------------QRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDI 693 (853)
Q Consensus 627 KPeNILL~-~g~VKL~DFGlAk~~~~~~~~~------------~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDI 693 (853)
||+|||++ ++.+||+|||+++......... .....+||+.|+|||++.+. .|+.++||
T Consensus 135 kp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---------~~~~~~Di 205 (310)
T 3s95_A 135 NSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGR---------SYDEKVDV 205 (310)
T ss_dssp STTSEEECTTSCEEECCCTTCEECC--------------------CCCCSCGGGCCHHHHTTC---------CCCTHHHH
T ss_pred CcCeEEECCCCCEEEeecccceecccccccccccccccccccccccccCCCcceeCHHHhcCC---------CCCcHHHH
Confidence 99999994 6699999999998654322111 11256899999999999765 35689999
Q ss_pred hhhHHHHHHHHhCCCCCCcchhHHHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCCChhHHhc
Q 003052 694 WSLGCILYQMVYGRTPFSEYKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQ 763 (853)
Q Consensus 694 WSLGVILyELLtG~~PF~~~~~~~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~ 763 (853)
|||||++|+|++|..||......................+...++.+.+||.+||..||.+||++.++++
T Consensus 206 ~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~ 275 (310)
T 3s95_A 206 FSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLDRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEH 275 (310)
T ss_dssp HHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHHHHHTCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhccccccCCCCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 9999999999999999964321100000000000011234567788999999999999999999999985
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-41 Score=358.61 Aligned_cols=265 Identities=22% Similarity=0.326 Sum_probs=208.7
Q ss_pred eEEcCceeeEEEeEeccCceEEEEEEe------cCCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehh
Q 003052 467 FKVNGKLYQRLGKIGSGGSSEVHKVIS------SDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYE 540 (853)
Q Consensus 467 ~~v~g~~Y~ilk~LG~G~FG~Vyka~~------~~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~ 540 (853)
+.+...+|++.+.||+|+||.||+|.+ .+++.||||+++... .......+.+|+.+|+++..||||++++++
T Consensus 18 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~- 95 (313)
T 1t46_A 18 WEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA-HLTEREALMSELKVLSYLGNHMNIVNLLGA- 95 (313)
T ss_dssp GBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEE-
T ss_pred cccChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcch-hHHHHHHHHHHHHHHhhcccCCCeeeEEEE-
Confidence 455667899999999999999999985 245789999997553 334456789999999999779999999987
Q ss_pred hhHHHHHHHHhhCCCCCCCCccccCCeEEEEEecch-hhHHHHHHHhhhhc----------cCCCCCCCHHHHHHHHHHh
Q 003052 541 VTEKALLREVLNGSMNNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEM----------DGSNQTLDENWLRFYWQQI 609 (853)
Q Consensus 541 ~~e~~iL~~l~~~~iv~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~~----------~~~~~~LsE~~~r~I~~QI 609 (853)
+.+.+.+|+||||+. ++|.+++....... ......+++..++.++.||
T Consensus 96 ---------------------~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi 154 (313)
T 1t46_A 96 ---------------------CTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQV 154 (313)
T ss_dssp ---------------------ECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHH
T ss_pred ---------------------EecCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHH
Confidence 345667899999986 49999987652210 1122359999999999999
Q ss_pred hhhhhhcccCceeeCCCCCccEEee-cCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCC
Q 003052 610 LEAVNTIHEERIVHSDLKPANFLLV-KGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCG 688 (853)
Q Consensus 610 l~AL~yLHs~gIIHRDLKPeNILL~-~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys 688 (853)
+.||.|||++||+||||||+|||++ ++.+||+|||+++...............||+.|+|||++.+. .++
T Consensus 155 ~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~---------~~~ 225 (313)
T 1t46_A 155 AKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNC---------VYT 225 (313)
T ss_dssp HHHHHHHHHTTCCCSCCSGGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHC---------CCC
T ss_pred HHHHHHHHHCCeecCCCccceEEEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCC---------CCC
Confidence 9999999999999999999999994 679999999999877554433333456788999999999765 356
Q ss_pred CccchhhhHHHHHHHHh-CCCCCCcchhHHHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCCChhHHhcC
Q 003052 689 RPSDIWSLGCILYQMVY-GRTPFSEYKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQH 764 (853)
Q Consensus 689 ~ksDIWSLGVILyELLt-G~~PF~~~~~~~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~H 764 (853)
.++|||||||++|+|++ |..||.+..........+.. ......+...+..+.+||.+||..||.+||++.+++++
T Consensus 226 ~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 301 (313)
T 1t46_A 226 FESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKE-GFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQL 301 (313)
T ss_dssp HHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHHHHHHHH-TCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred hHHHHHHHHHHHHHHHhCCCCCCCcccchhHHHHHhcc-CCCCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHH
Confidence 89999999999999998 99999764332222222221 12223345678899999999999999999999999964
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-41 Score=365.88 Aligned_cols=251 Identities=22% Similarity=0.281 Sum_probs=198.8
Q ss_pred cCceeeEEEeEeccCceEEEEEEe-cCCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHH
Q 003052 470 NGKLYQRLGKIGSGGSSEVHKVIS-SDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLR 548 (853)
Q Consensus 470 ~g~~Y~ilk~LG~G~FG~Vyka~~-~~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~ 548 (853)
.+..|++.+.||+|+||.||+|.+ .+++.||||++..... ...+.+|+.++++|.+|+||++++++
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~~~~E~~~l~~l~~h~~i~~~~~~--------- 73 (330)
T 2izr_A 7 VGPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR----APQLHLEYRFYKQLGSGDGIPQVYYF--------- 73 (330)
T ss_dssp ETTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS----SCCHHHHHHHHHHHCSCTTSCCEEEE---------
T ss_pred EcCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc----hHHHHHHHHHHHHhhCCCCCCEEEEE---------
Confidence 356799999999999999999998 5778999999976533 23578999999999779999999987
Q ss_pred HHhhCCCCCCCCccccCCeEEEEEecchhhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCCC
Q 003052 549 EVLNGSMNNKDGRVKDDGYIYMVLEYGEIDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKP 628 (853)
Q Consensus 549 ~l~~~~iv~~~g~~~d~~~lyLVmEy~~gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLKP 628 (853)
+.+...+|+||||++++|.+++... ...+++..++.|+.||+.||.|||++||+||||||
T Consensus 74 -------------~~~~~~~~lv~e~~~~~L~~~~~~~-------~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp 133 (330)
T 2izr_A 74 -------------GPCGKYNAMVLELLGPSLEDLFDLC-------DRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKP 133 (330)
T ss_dssp -------------EEETTEEEEEEECCCCBHHHHHHHT-------TTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCG
T ss_pred -------------EecCCccEEEEEeCCCCHHHHHHHc-------CCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCH
Confidence 4556789999999988999988753 35799999999999999999999999999999999
Q ss_pred ccEEee-cCc-----EEEEecccchhcccCCccc-----cccccccCccccCchhhccCCCCCCCccccCCCccchhhhH
Q 003052 629 ANFLLV-KGS-----LKLIDFGIAKAIMSDTTNI-----QRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLG 697 (853)
Q Consensus 629 eNILL~-~g~-----VKL~DFGlAk~~~~~~~~~-----~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLG 697 (853)
+|||++ ++. +||+|||+|+.+....... .....+||+.|+|||++.+.. |+.++||||||
T Consensus 134 ~Nill~~~~~~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---------~~~~~Di~slG 204 (330)
T 2izr_A 134 ENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLTGTARYMSINTHLGKE---------QSRRDDLEALG 204 (330)
T ss_dssp GGEEECCGGGTCTTSEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCC---------CCHHHHHHHHH
T ss_pred HHeeeccCCCCCCceEEEEEcccceeeecCCCCccccccccCCcCCCccccChHHHcCCC---------CCchhHHHHHH
Confidence 999994 444 9999999998765432211 124678999999999997653 56899999999
Q ss_pred HHHHHHHhCCCCCCcc--hhHHHHHHhhcCC---CCcccCCCCCChhHHHHHHHhcccCCCCCCChhHHhc
Q 003052 698 CILYQMVYGRTPFSEY--KTFWAKFKVITDP---NHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQ 763 (853)
Q Consensus 698 VILyELLtG~~PF~~~--~~~~~~~kii~~~---~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~ 763 (853)
|++|||++|+.||.+. ......+..+... ..........+ ++.+||.+||..||.+||++.+|++
T Consensus 205 ~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~ 274 (330)
T 2izr_A 205 HMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRATPIEVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRK 274 (330)
T ss_dssp HHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHHSCHHHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred HHHHHHhcCCCCccccccccHHHHHHHHHhhhccCCHHHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHH
Confidence 9999999999999753 2222222221110 00001112233 8999999999999999999998876
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-41 Score=359.51 Aligned_cols=269 Identities=23% Similarity=0.336 Sum_probs=194.1
Q ss_pred eeEEcCceeeEEEeEeccCceEEEEEEe-cCCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHH
Q 003052 466 FFKVNGKLYQRLGKIGSGGSSEVHKVIS-SDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEK 544 (853)
Q Consensus 466 ~~~v~g~~Y~ilk~LG~G~FG~Vyka~~-~~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~ 544 (853)
.+.+.+.+|++.++||+|+||.||+|.+ .+++.||||++... .......+.+|+.+++++.+|+||+++++++...
T Consensus 22 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~- 98 (337)
T 3ll6_A 22 TVELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSN--EEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIG- 98 (337)
T ss_dssp EEEETTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEES--SHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEEC-
T ss_pred eeeccCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCC--chHHHHHHHHHHHHHHHhccCCChhhcccccccc-
Confidence 4677888999999999999999999998 47789999998654 3344557889999999998899999999875211
Q ss_pred HHHHHHhhCCCCCCCCccccCCeEEEEEecchhhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCc--ee
Q 003052 545 ALLREVLNGSMNNKDGRVKDDGYIYMVLEYGEIDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEER--IV 622 (853)
Q Consensus 545 ~iL~~l~~~~iv~~~g~~~d~~~lyLVmEy~~gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~g--II 622 (853)
..........+|+||||++++|.+++.... ....+++..++.|+.||+.||.|||++| |+
T Consensus 99 -------------~~~~~~~~~~~~lv~e~~~g~L~~~l~~~~-----~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~iv 160 (337)
T 3ll6_A 99 -------------KEESDTGQAEFLLLTELCKGQLVEFLKKME-----SRGPLSCDTVLKIFYQTCRAVQHMHRQKPPII 160 (337)
T ss_dssp -------------TTTSTTSSEEEEEEEECCSEEHHHHHHHHH-----TTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCB
T ss_pred -------------ccccccCCceEEEEEEecCCCHHHHHHHhh-----ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEE
Confidence 111235566799999999999999887532 2356999999999999999999999999 99
Q ss_pred eCCCCCccEEee-cCcEEEEecccchhcccCCccc----------cccccccCccccCchhhccCCCCCCCccccCCCcc
Q 003052 623 HSDLKPANFLLV-KGSLKLIDFGIAKAIMSDTTNI----------QRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPS 691 (853)
Q Consensus 623 HRDLKPeNILL~-~g~VKL~DFGlAk~~~~~~~~~----------~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ks 691 (853)
||||||+|||++ ++.+||+|||+++......... .....+||+.|+|||++..... ..++.++
T Consensus 161 H~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~------~~~~~~~ 234 (337)
T 3ll6_A 161 HRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSN------FPIGEKQ 234 (337)
T ss_dssp CCCCCGGGCEECTTSCEEBCCCTTCBCCSSCC-------------------------------CCTT------SCSSHHH
T ss_pred EccCCcccEEECCCCCEEEecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhcccc------CCCChHH
Confidence 999999999995 5799999999998764322110 1124579999999999843211 1467899
Q ss_pred chhhhHHHHHHHHhCCCCCCcchhHHHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCCChhHHhcCCC
Q 003052 692 DIWSLGCILYQMVYGRTPFSEYKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQHPF 766 (853)
Q Consensus 692 DIWSLGVILyELLtG~~PF~~~~~~~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~HPw 766 (853)
|||||||++|+|++|+.||.+........ ...........+..+.+||.+||..||.+||++.|+++|-+
T Consensus 235 Dv~slG~il~el~~g~~p~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~ 304 (337)
T 3ll6_A 235 DIWALGCILYLLCFRQHPFEDGAKLRIVN-----GKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQ 304 (337)
T ss_dssp HHHHHHHHHHHHHHSSCCC-----------------CCCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHH
T ss_pred hHHHHHHHHHHHHhCCCCCcchhHHHhhc-----CcccCCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence 99999999999999999997643322111 12222334456678999999999999999999999998744
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-41 Score=352.03 Aligned_cols=250 Identities=25% Similarity=0.374 Sum_probs=193.7
Q ss_pred EEcCceeeEEEeEeccCceEEEEEEecCCcEEEEEEEecCCCC--hhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHH
Q 003052 468 KVNGKLYQRLGKIGSGGSSEVHKVISSDCTIYALKKIKLKGRD--YATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKA 545 (853)
Q Consensus 468 ~v~g~~Y~ilk~LG~G~FG~Vyka~~~~g~~vAVKkik~~~~~--~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~ 545 (853)
++....|++.+.||+|+||.||+|.+. ++.||||+++..... ......+.+|+++++.++ |+||++++++
T Consensus 3 ~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~------ 74 (271)
T 3dtc_A 3 EIDFAELTLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLK-HPNIIALRGV------ 74 (271)
T ss_dssp BCCTTSEEEEEEEEEETTEEEEEEEET-TEEEEEEEC----------CHHHHHHHHHHHHHCC-CTTBCCEEEE------
T ss_pred ccchhheeeeeeeccCCCeEEEEEEEc-CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcC-CCCEeeEEEE------
Confidence 345577999999999999999999975 778999998765332 233456889999999997 8999999987
Q ss_pred HHHHHhhCCCCCCCCccccCCeEEEEEecch-hhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCc---e
Q 003052 546 LLREVLNGSMNNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEER---I 621 (853)
Q Consensus 546 iL~~l~~~~iv~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~g---I 621 (853)
+.+++.+|+||||+. ++|.+++.. ..+++..++.++.||+.||.|||++| |
T Consensus 75 ----------------~~~~~~~~lv~e~~~~~~L~~~~~~---------~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i 129 (271)
T 3dtc_A 75 ----------------CLKEPNLCLVMEFARGGPLNRVLSG---------KRIPPDILVNWAVQIARGMNYLHDEAIVPI 129 (271)
T ss_dssp ----------------ECCC--CEEEEECCTTEEHHHHHTS---------SCCCHHHHHHHHHHHHHHHHHHHHSSSSCC
T ss_pred ----------------EecCCceEEEEEcCCCCCHHHHhhc---------CCCCHHHHHHHHHHHHHHHHHHHhCCCCce
Confidence 345667899999985 588777632 47999999999999999999999999 9
Q ss_pred eeCCCCCccEEee---------cCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccc
Q 003052 622 VHSDLKPANFLLV---------KGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSD 692 (853)
Q Consensus 622 IHRDLKPeNILL~---------~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksD 692 (853)
+||||||+|||++ ++.+||+|||+++....... ....||+.|+|||++.+.. ++.++|
T Consensus 130 ~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~~----~~~~~~~~y~aPE~~~~~~---------~~~~~D 196 (271)
T 3dtc_A 130 IHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTK----MSAAGAYAWMAPEVIRASM---------FSKGSD 196 (271)
T ss_dssp CCSCCSGGGEEESSCCSSSCCSSCCEEECCCCC-----------------CCGGGSCHHHHHHCC---------CSHHHH
T ss_pred eecCCchHHEEEecccccccccCcceEEccCCcccccccccc----cCCCCccceeCHHHhccCC---------CCchhh
Confidence 9999999999995 46799999999986643222 2568999999999997653 567999
Q ss_pred hhhhHHHHHHHHhCCCCCCcchhHHHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCCChhHHhcC
Q 003052 693 IWSLGCILYQMVYGRTPFSEYKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQH 764 (853)
Q Consensus 693 IWSLGVILyELLtG~~PF~~~~~~~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~H 764 (853)
||||||++|+|++|+.||.+............ .......+...++.+.+||.+||..||.+||++.|+++|
T Consensus 197 i~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 267 (271)
T 3dtc_A 197 VWSYGVLLWELLTGEVPFRGIDGLAVAYGVAM-NKLALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQ 267 (271)
T ss_dssp HHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHT-SCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHHHHhCCCCCCCCCHHHHHHhhhc-CCCCCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHH
Confidence 99999999999999999987665544443333 233444566778999999999999999999999999975
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-41 Score=361.21 Aligned_cols=265 Identities=21% Similarity=0.347 Sum_probs=208.3
Q ss_pred EEcCceeeEEEeEeccCceEEEEEEe------cCCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhh
Q 003052 468 KVNGKLYQRLGKIGSGGSSEVHKVIS------SDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEV 541 (853)
Q Consensus 468 ~v~g~~Y~ilk~LG~G~FG~Vyka~~------~~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~ 541 (853)
.+..++|++.+.||+|+||.||+|.+ .+++.||||+++... .......+.+|+.+|+++.+|+||+++++++.
T Consensus 23 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~ 101 (316)
T 2xir_A 23 EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNLLGACT 101 (316)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred ecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCC-CcHHHHHHHHHHHHHHhcccCCCeeeEEEEEe
Confidence 34557899999999999999999985 345789999997653 33445678899999999988999999998742
Q ss_pred hHHHHHHHHhhCCCCCCCCccccCCeEEEEEecch-hhHHHHHHHhhhhccC--------CCCCCCHHHHHHHHHHhhhh
Q 003052 542 TEKALLREVLNGSMNNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEMDG--------SNQTLDENWLRFYWQQILEA 612 (853)
Q Consensus 542 ~e~~iL~~l~~~~iv~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~~~~--------~~~~LsE~~~r~I~~QIl~A 612 (853)
..+..+|+||||+. ++|.+++......... ....+++..++.++.||+.|
T Consensus 102 ---------------------~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~a 160 (316)
T 2xir_A 102 ---------------------KPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKG 160 (316)
T ss_dssp ---------------------CTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHH
T ss_pred ---------------------cCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHH
Confidence 23456899999987 5999998764221100 12338999999999999999
Q ss_pred hhhcccCceeeCCCCCccEEe-ecCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCcc
Q 003052 613 VNTIHEERIVHSDLKPANFLL-VKGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPS 691 (853)
Q Consensus 613 L~yLHs~gIIHRDLKPeNILL-~~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ks 691 (853)
|.|||++||+||||||+|||+ .++.+||+|||+++...............||+.|+|||++.+.. ++.++
T Consensus 161 l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~---------~~~~~ 231 (316)
T 2xir_A 161 MEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRV---------YTIQS 231 (316)
T ss_dssp HHHHHHTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCC---------CCHHH
T ss_pred HHHHHhCCcccccCccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhcccc---------ccchh
Confidence 999999999999999999999 46799999999998765443333344567899999999997653 56899
Q ss_pred chhhhHHHHHHHHh-CCCCCCcchhHHHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCCChhHHhcC
Q 003052 692 DIWSLGCILYQMVY-GRTPFSEYKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQH 764 (853)
Q Consensus 692 DIWSLGVILyELLt-G~~PF~~~~~~~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~H 764 (853)
|||||||++|+|++ |..||.+..........+.. ......+...++.+.+||.+||..||.+||++.++++|
T Consensus 232 Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 304 (316)
T 2xir_A 232 DVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKE-GTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 304 (316)
T ss_dssp HHHHHHHHHHHHHTTSCCSSTTCCCSHHHHHHHHH-TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHHHHHhCCCCCCcccchhHHHHHHhcc-CccCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 99999999999998 99999764322222222221 12233455678899999999999999999999999976
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-41 Score=364.17 Aligned_cols=254 Identities=21% Similarity=0.252 Sum_probs=202.6
Q ss_pred EEcCceeeEEEeEeccCceEEEEEEec----CCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhH
Q 003052 468 KVNGKLYQRLGKIGSGGSSEVHKVISS----DCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTE 543 (853)
Q Consensus 468 ~v~g~~Y~ilk~LG~G~FG~Vyka~~~----~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e 543 (853)
.+...+|++.+.||+|+||.||+|.+. .+..||||+++... .......+.+|+.+|++++ |+||+++++++
T Consensus 45 ~~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~--- 119 (325)
T 3kul_A 45 EIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGY-TERQRRDFLSEASIMGQFD-HPNIIRLEGVV--- 119 (325)
T ss_dssp BCCGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTC-CHHHHHHHHHHHHHHTTCC-CTTBCCEEEEE---
T ss_pred ccChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCC-CHHHHHHHHHHHHHHHhCC-CCCCCcEEEEE---
Confidence 345578999999999999999999984 33469999997543 3445567899999999997 99999999873
Q ss_pred HHHHHHHhhCCCCCCCCccccCCeEEEEEecch-hhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCcee
Q 003052 544 KALLREVLNGSMNNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIV 622 (853)
Q Consensus 544 ~~iL~~l~~~~iv~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gII 622 (853)
.+...+|+||||++ ++|.+++... ...+++..++.++.||+.||.|||++||+
T Consensus 120 -------------------~~~~~~~lv~e~~~~~~L~~~l~~~-------~~~~~~~~~~~i~~qi~~~L~~LH~~~iv 173 (325)
T 3kul_A 120 -------------------TRGRLAMIVTEYMENGSLDTFLRTH-------DGQFTIMQLVGMLRGVGAGMRYLSDLGYV 173 (325)
T ss_dssp -------------------CGGGCCEEEEECCTTCBHHHHHHTT-------TTCSCHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred -------------------EeCCccEEEeeCCCCCcHHHHHHhc-------ccCCCHHHHHHHHHHHHHHHHHHHHCCee
Confidence 45567899999985 4999888542 35799999999999999999999999999
Q ss_pred eCCCCCccEEe-ecCcEEEEecccchhcccCCcc-ccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHH
Q 003052 623 HSDLKPANFLL-VKGSLKLIDFGIAKAIMSDTTN-IQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCIL 700 (853)
Q Consensus 623 HRDLKPeNILL-~~g~VKL~DFGlAk~~~~~~~~-~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVIL 700 (853)
||||||+|||+ .++.+||+|||+++.+...... .......||+.|+|||++.+. .|+.++|||||||++
T Consensus 174 H~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~---------~~~~~~Di~slG~il 244 (325)
T 3kul_A 174 HRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFR---------TFSSASDVWSFGVVM 244 (325)
T ss_dssp CSCCSGGGEEECTTCCEEECCCSSCEECC----CCEECC---CCGGGSCHHHHHHC---------EECHHHHHHHHHHHH
T ss_pred CCCCCcceEEECCCCCEEECCCCcccccccCccceeeccCCCCcccccCHhHhcCC---------CCCcHHHHHHHHHHH
Confidence 99999999999 4679999999999876443221 122234578899999999765 367899999999999
Q ss_pred HHHHh-CCCCCCcchhHHHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCCChhHHhc
Q 003052 701 YQMVY-GRTPFSEYKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQ 763 (853)
Q Consensus 701 yELLt-G~~PF~~~~~~~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~ 763 (853)
|+|++ |..||.+.........+.. ......+...++.+.+||.+||..||.+||++.+|++
T Consensus 245 ~ell~~g~~p~~~~~~~~~~~~~~~--~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~ 306 (325)
T 3kul_A 245 WEVLAYGERPYWNMTNRDVISSVEE--GYRLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVS 306 (325)
T ss_dssp HHHHTTSCCTTTTSCHHHHHHHHHT--TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHcCCCCCcccCCHHHHHHHHHc--CCCCCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 99998 9999977655433333322 2333455678899999999999999999999999985
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-41 Score=363.46 Aligned_cols=261 Identities=19% Similarity=0.272 Sum_probs=205.6
Q ss_pred EcCceeeEEEeEeccCceEEEEEEecC------CcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhh
Q 003052 469 VNGKLYQRLGKIGSGGSSEVHKVISSD------CTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVT 542 (853)
Q Consensus 469 v~g~~Y~ilk~LG~G~FG~Vyka~~~~------g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~ 542 (853)
+..+.|++++.||+|+||.||+|.+.. ++.||||+++... .......+.+|+.+|++++ |+||++++++
T Consensus 44 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~--- 118 (343)
T 1luf_A 44 YPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA-SADMQADFQREAALMAEFD-NPNIVKLLGV--- 118 (343)
T ss_dssp CCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC-CHHHHHHHHHHHHHHHTCC-CTTBCCEEEE---
T ss_pred ecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEecccc-CHHHHHHHHHHHHHHHhCC-CCCEEEEEEE---
Confidence 344679999999999999999999842 3789999997543 3345567899999999996 9999999987
Q ss_pred HHHHHHHHhhCCCCCCCCccccCCeEEEEEecchh-hHHHHHHHhhhhc----------------cCCCCCCCHHHHHHH
Q 003052 543 EKALLREVLNGSMNNKDGRVKDDGYIYMVLEYGEI-DLAHMLSQKWKEM----------------DGSNQTLDENWLRFY 605 (853)
Q Consensus 543 e~~iL~~l~~~~iv~~~g~~~d~~~lyLVmEy~~g-dL~~~L~~~~k~~----------------~~~~~~LsE~~~r~I 605 (853)
+.+...+|+||||+.+ +|.+++....... ......+++..++.+
T Consensus 119 -------------------~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i 179 (343)
T 1luf_A 119 -------------------CAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCI 179 (343)
T ss_dssp -------------------ECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHH
T ss_pred -------------------EccCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHH
Confidence 3456678999999865 9999987631100 011257999999999
Q ss_pred HHHhhhhhhhcccCceeeCCCCCccEEe-ecCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCcc
Q 003052 606 WQQILEAVNTIHEERIVHSDLKPANFLL-VKGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNI 684 (853)
Q Consensus 606 ~~QIl~AL~yLHs~gIIHRDLKPeNILL-~~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~ 684 (853)
+.||+.||.|||++||+||||||+|||+ .++.+||+|||+++...............||+.|+|||++.+..
T Consensus 180 ~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~------- 252 (343)
T 1luf_A 180 ARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNR------- 252 (343)
T ss_dssp HHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCC-------
T ss_pred HHHHHHHHHHHHhCCeecCCCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCC-------
Confidence 9999999999999999999999999999 46799999999998765433222334567899999999997653
Q ss_pred ccCCCccchhhhHHHHHHHHh-CCCCCCcchhHHHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCCChhHHhc
Q 003052 685 IKCGRPSDIWSLGCILYQMVY-GRTPFSEYKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQ 763 (853)
Q Consensus 685 ~~ys~ksDIWSLGVILyELLt-G~~PF~~~~~~~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~ 763 (853)
|+.++|||||||++|+|++ |..||.+.........+.. . .....+...+..+.+||.+||..||.+||++.++++
T Consensus 253 --~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~-~-~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~ 328 (343)
T 1luf_A 253 --YTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEVIYYVRD-G-NILACPENCPLELYNLMRLCWSKLPADRPSFCSIHR 328 (343)
T ss_dssp --CCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHT-T-CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred --cCcccccHHHHHHHHHHHhcCCCcCCCCChHHHHHHHhC-C-CcCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 5689999999999999998 9999987554433333322 2 222345667889999999999999999999999986
Q ss_pred C
Q 003052 764 H 764 (853)
Q Consensus 764 H 764 (853)
+
T Consensus 329 ~ 329 (343)
T 1luf_A 329 I 329 (343)
T ss_dssp H
T ss_pred H
Confidence 4
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-41 Score=350.24 Aligned_cols=252 Identities=17% Similarity=0.238 Sum_probs=207.1
Q ss_pred cCceeeEEEeEeccCceEEEEEEecCCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHHH
Q 003052 470 NGKLYQRLGKIGSGGSSEVHKVISSDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLRE 549 (853)
Q Consensus 470 ~g~~Y~ilk~LG~G~FG~Vyka~~~~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~~ 549 (853)
..++|++.+.||+|+||.||+|.+. ++.||||+++...........+.+|+.+|++++ |+||+++++++..
T Consensus 8 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~------- 78 (271)
T 3kmu_A 8 DFKQLNFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFS-HPNVLPVLGACQS------- 78 (271)
T ss_dssp CGGGCEEEEEEEEETTEEEEEEEET-TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCS-CTTEECEEEEECT-------
T ss_pred CHHHhHHHHHhcCCCcceEEEEEEC-CeeEEEEEecccccCHHHHHHHHHHHHHHHhcC-CCchhheEEEEcc-------
Confidence 3467999999999999999999985 778999999987666666778999999999996 9999999997432
Q ss_pred HhhCCCCCCCCccccCCeEEEEEecch-hhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCc--eeeCCC
Q 003052 550 VLNGSMNNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEER--IVHSDL 626 (853)
Q Consensus 550 l~~~~iv~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~g--IIHRDL 626 (853)
.+...+|+||||+. ++|.+++... ....+++..++.++.||+.||.|||++| |+||||
T Consensus 79 -------------~~~~~~~lv~e~~~~~~L~~~l~~~------~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~di 139 (271)
T 3kmu_A 79 -------------PPAPHPTLITHWMPYGSLYNVLHEG------TNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHAL 139 (271)
T ss_dssp -------------TTSSSCEEEEECCTTCBHHHHHHSC------SSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCC
T ss_pred -------------CCCCCeEeeecccCCCcHHHHHhhc------ccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCC
Confidence 12367899999987 5999998653 2346999999999999999999999999 999999
Q ss_pred CCccEEee-cCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHh
Q 003052 627 KPANFLLV-KGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVY 705 (853)
Q Consensus 627 KPeNILL~-~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLt 705 (853)
||+|||++ ++.++|+|||++..... ....||+.|+|||++.+.... .++.++|||||||++|+|++
T Consensus 140 kp~Nil~~~~~~~~l~~~~~~~~~~~-------~~~~~t~~y~aPE~~~~~~~~------~~~~~~Di~slG~il~el~~ 206 (271)
T 3kmu_A 140 NSRSVMIDEDMTARISMADVKFSFQS-------PGRMYAPAWVAPEALQKKPED------TNRRSADMWSFAVLLWELVT 206 (271)
T ss_dssp SGGGEEECTTSCEEEEGGGSCCTTSC-------TTCBSCGGGSCHHHHHSCGGG------SCHHHHHHHHHHHHHHHHHH
T ss_pred ccceEEEcCCcceeEEeccceeeecc-------cCccCCccccChhhhccCCCC------CCCchhhHHHHHHHHHHHHh
Confidence 99999995 56899999998764321 245799999999999865432 23458999999999999999
Q ss_pred CCCCCCcchhHHHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCCChhHHhc
Q 003052 706 GRTPFSEYKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQ 763 (853)
Q Consensus 706 G~~PF~~~~~~~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~ 763 (853)
|+.||.+............. ......+...++.+.+||.+||..||.+|||+.++++
T Consensus 207 g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 263 (271)
T 3kmu_A 207 REVPFADLSNMEIGMKVALE-GLRPTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVP 263 (271)
T ss_dssp CSCTTTTSCHHHHHHHHHHS-CCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCCccccChHHHHHHHHhc-CCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 99999876655444444332 2333456678899999999999999999999999985
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-41 Score=381.40 Aligned_cols=269 Identities=23% Similarity=0.307 Sum_probs=193.6
Q ss_pred CceeeEEEeEeccCceEEEEEEecCCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHHHH
Q 003052 471 GKLYQRLGKIGSGGSSEVHKVISSDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLREV 550 (853)
Q Consensus 471 g~~Y~ilk~LG~G~FG~Vyka~~~~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~~l 550 (853)
++.|.+.+.||+|+||+||.+...+++.||||++.... ...+.+|+.+|+++.+||||++++++
T Consensus 14 ~~~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~~-----~~~~~~E~~~l~~l~~HpnIv~~~~~----------- 77 (434)
T 2rio_A 14 KNLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDF-----CDIALMEIKLLTESDDHPNVIRYYCS----------- 77 (434)
T ss_dssp SSCEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGGG-----HHHHHHHHHHHHHHTTSTTBCCEEEE-----------
T ss_pred hheeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHHH-----HHHHHHHHHHHHhccCCCCcCeEEEE-----------
Confidence 45688889999999999988777789999999997532 23567999999998779999999876
Q ss_pred hhCCCCCCCCccccCCeEEEEEecchhhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCCCcc
Q 003052 551 LNGSMNNKDGRVKDDGYIYMVLEYGEIDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPAN 630 (853)
Q Consensus 551 ~~~~iv~~~g~~~d~~~lyLVmEy~~gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLKPeN 630 (853)
+.++..+||||||++++|.+++...... ........+..++.++.||+.||.|||++||+||||||+|
T Consensus 78 -----------~~~~~~~~lv~E~~~gsL~~~l~~~~~~-~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~N 145 (434)
T 2rio_A 78 -----------ETTDRFLYIALELCNLNLQDLVESKNVS-DENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQN 145 (434)
T ss_dssp -----------EECSSEEEEEECCCSEEHHHHHHTC-------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGG
T ss_pred -----------EecCCeEEEEEecCCCCHHHHHhccCCC-chhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHh
Confidence 4567789999999999999998754210 0000112344567899999999999999999999999999
Q ss_pred EEeec--------------CcEEEEecccchhcccCCccc--cccccccCccccCchhhccCCCCCCCccccCCCccchh
Q 003052 631 FLLVK--------------GSLKLIDFGIAKAIMSDTTNI--QRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIW 694 (853)
Q Consensus 631 ILL~~--------------g~VKL~DFGlAk~~~~~~~~~--~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIW 694 (853)
||++. +.+||+|||+|+......... .....+||+.|+|||++.+..... ....++.++|||
T Consensus 146 ILl~~~~~~~~~~~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~--~~~~~~~~~Diw 223 (434)
T 2rio_A 146 ILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQ--TKRRLTRSIDIF 223 (434)
T ss_dssp EEEECCHHHHSCCTTCCCSCEEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTS--CCCCCCTHHHHH
T ss_pred EEEecCcccccccccCCCceEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccc--cccCcchhhhhH
Confidence 99953 279999999998765432211 123568999999999997632110 112578999999
Q ss_pred hhHHHHHHHHh-CCCCCCcchhHHH-HHHhhcC-CCCcccCCCCCChhHHHHHHHhcccCCCCCCChhHHhcCCCCCC
Q 003052 695 SLGCILYQMVY-GRTPFSEYKTFWA-KFKVITD-PNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQHPFLVP 769 (853)
Q Consensus 695 SLGVILyELLt-G~~PF~~~~~~~~-~~kii~~-~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~HPwf~~ 769 (853)
||||++|||++ |..||.+...... ....... ...........++++.+||.+||..||.+|||+.++|+||||..
T Consensus 224 SlG~il~ellt~g~~Pf~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~hp~f~~ 301 (434)
T 2rio_A 224 SMGCVFYYILSKGKHPFGDKYSRESNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLFWP 301 (434)
T ss_dssp HHHHHHHHHHTTSCCTTCSTTTHHHHHHHTCCCCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSC
T ss_pred hHHHHHHHHHhCCCCCCCCchhhHHHHhcCCCCcccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHhCCccCC
Confidence 99999999998 9999976433221 1111111 00000011123467999999999999999999999999999964
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-41 Score=361.10 Aligned_cols=262 Identities=19% Similarity=0.217 Sum_probs=199.9
Q ss_pred eeEEcCceeeEEEeEeccCceEEEEEEecCCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHH
Q 003052 466 FFKVNGKLYQRLGKIGSGGSSEVHKVISSDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKA 545 (853)
Q Consensus 466 ~~~v~g~~Y~ilk~LG~G~FG~Vyka~~~~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~ 545 (853)
.+.+..++|+++++||+|+||.||+|.+. ++.||||++.... .....+.+|+.+|++++ ||||+++++++...
T Consensus 18 n~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~-- 90 (322)
T 3soc_A 18 NLYFQSMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQD---KQSWQNEYEVYSLPGMK-HENILQFIGAEKRG-- 90 (322)
T ss_dssp CEEETTEEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGGG---HHHHHHHHHHHTSTTCC-CTTBCCEEEEEEEE--
T ss_pred ccccchhhchhhheecccCceEEEEEEEC-CCEEEEEEeecCc---hHHHHHHHHHHHHhcCC-CCCchhhcceeccC--
Confidence 35577789999999999999999999875 6889999997542 23334567999999997 99999999975321
Q ss_pred HHHHHhhCCCCCCCCccccCCeEEEEEecchh-hHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccC-----
Q 003052 546 LLREVLNGSMNNKDGRVKDDGYIYMVLEYGEI-DLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEE----- 619 (853)
Q Consensus 546 iL~~l~~~~iv~~~g~~~d~~~lyLVmEy~~g-dL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~----- 619 (853)
......+|+||||+.+ +|.+++.. ..+++..++.++.||+.||.|||++
T Consensus 91 ----------------~~~~~~~~lv~e~~~~g~L~~~l~~---------~~~~~~~~~~i~~qi~~al~~LH~~~~~l~ 145 (322)
T 3soc_A 91 ----------------TSVDVDLWLITAFHEKGSLSDFLKA---------NVVSWNELCHIAETMARGLAYLHEDIPGLK 145 (322)
T ss_dssp ----------------CSSSEEEEEEEECCTTCBHHHHHHH---------CCBCHHHHHHHHHHHHHHHHHHTCCEEEET
T ss_pred ----------------CCCCceEEEEEecCCCCCHHHHHHh---------cCCCHHHHHHHHHHHHHHHHHHHhhccccc
Confidence 0113458999999865 99999865 3599999999999999999999999
Q ss_pred -----ceeeCCCCCccEEee-cCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccch
Q 003052 620 -----RIVHSDLKPANFLLV-KGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDI 693 (853)
Q Consensus 620 -----gIIHRDLKPeNILL~-~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDI 693 (853)
||+||||||+|||++ ++.+||+|||+|+.+............+||+.|+|||++.+.... ...++.++||
T Consensus 146 ~~~~~~ivH~Dlkp~Nill~~~~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~----~~~~~~~~Di 221 (322)
T 3soc_A 146 DGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINF----QRDAFLRIDM 221 (322)
T ss_dssp TEEECEEECSCCSGGGEEECTTCCEEECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCC----CHHHHHHHHH
T ss_pred cccCCCEEeCCCChHhEEECCCCeEEEccCCcccccccccCccccccCccCccccCHhhccccccc----CcCCCccchh
Confidence 999999999999994 569999999999876544333333457899999999999764221 1245678999
Q ss_pred hhhHHHHHHHHhCCCCCCcch---------------hHHHHHHhhcCCCCcccCCC-----CCChhHHHHHHHhcccCCC
Q 003052 694 WSLGCILYQMVYGRTPFSEYK---------------TFWAKFKVITDPNHEITYEP-----VPNPWLLDLMKKCLAWDRN 753 (853)
Q Consensus 694 WSLGVILyELLtG~~PF~~~~---------------~~~~~~kii~~~~~~~~~~~-----~~s~~l~dLI~kcL~~DP~ 753 (853)
|||||++|||++|+.||.+.. .................... ..+..+.+||.+||..||.
T Consensus 222 wslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~ 301 (322)
T 3soc_A 222 YAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAE 301 (322)
T ss_dssp HHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGG
T ss_pred HHHHHHHHHHHhCCCCCCCCcchhccchhhhhccCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChh
Confidence 999999999999999996421 11112222222111111111 1123489999999999999
Q ss_pred CCCChhHHhc
Q 003052 754 ERWRIPQLLQ 763 (853)
Q Consensus 754 kRpTa~EIL~ 763 (853)
+|||+.|+++
T Consensus 302 ~Rps~~ell~ 311 (322)
T 3soc_A 302 ARLSAGCVGE 311 (322)
T ss_dssp GSCCHHHHHH
T ss_pred hCcCHHHHHH
Confidence 9999999985
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-41 Score=371.92 Aligned_cols=254 Identities=22% Similarity=0.304 Sum_probs=204.5
Q ss_pred EEcCceeeEEEeEeccCceEEEEEEec-CCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHH
Q 003052 468 KVNGKLYQRLGKIGSGGSSEVHKVISS-DCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKAL 546 (853)
Q Consensus 468 ~v~g~~Y~ilk~LG~G~FG~Vyka~~~-~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~i 546 (853)
.++.+.|.+.+.||+|+||.||+|.+. +++.||||+++... .......+.+|+++|++++ ||||++++++
T Consensus 110 ~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~-hpniv~~~~~------- 180 (377)
T 3cbl_A 110 VLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETL-PPDLKAKFLQEARILKQYS-HPNIVRLIGV------- 180 (377)
T ss_dssp BCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTS-CHHHHTTTTHHHHHHTTCC-CTTBCCEEEE-------
T ss_pred EEchHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccC-CHHHHHHHHHHHHHHHhCC-CCCEEEEEEE-------
Confidence 445578999999999999999999985 77899999997542 3344557889999999997 8999999987
Q ss_pred HHHHhhCCCCCCCCccccCCeEEEEEecch-hhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCC
Q 003052 547 LREVLNGSMNNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSD 625 (853)
Q Consensus 547 L~~l~~~~iv~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRD 625 (853)
+.+...+|+||||+. ++|.+++... ...+++..+..++.||+.||.|||++||+|||
T Consensus 181 ---------------~~~~~~~~lv~e~~~~g~L~~~l~~~-------~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrD 238 (377)
T 3cbl_A 181 ---------------CTQKQPIYIVMELVQGGDFLTFLRTE-------GARLRVKTLLQMVGDAAAGMEYLESKCCIHRD 238 (377)
T ss_dssp ---------------ECSSSSCEEEEECCTTCBHHHHHHHH-------GGGCCHHHHHHHHHHHHHHHHHHHHTTEECSC
T ss_pred ---------------EecCCCcEEEEEcCCCCCHHHHHHhc-------CCCCCHHHHHHHHHHHHHHHHHHHHCCcCCcc
Confidence 345567899999986 6999988754 23589999999999999999999999999999
Q ss_pred CCCccEEee-cCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHH
Q 003052 626 LKPANFLLV-KGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMV 704 (853)
Q Consensus 626 LKPeNILL~-~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELL 704 (853)
|||+|||++ ++.+||+|||+++...............+++.|+|||++.+. .|+.++|||||||++|||+
T Consensus 239 lkp~Nil~~~~~~~kl~DfG~s~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~---------~~~~~~DvwslG~il~el~ 309 (377)
T 3cbl_A 239 LAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALNYG---------RYSSESDVWSFGILLWETF 309 (377)
T ss_dssp CSGGGEEECTTCCEEECCGGGCEECTTSEEECCSSCCEEEGGGSCHHHHHHC---------EEEHHHHHHHHHHHHHHHH
T ss_pred cCHHHEEEcCCCcEEECcCCCceecCCCceeecCCCCCCCcCcCCHhHhccC---------CCCchhhHHHHHHHHHHHH
Confidence 999999995 679999999999865432211111223467889999999754 3678999999999999999
Q ss_pred h-CCCCCCcchhHHHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCCChhHHhc
Q 003052 705 Y-GRTPFSEYKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQ 763 (853)
Q Consensus 705 t-G~~PF~~~~~~~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~ 763 (853)
+ |..||.+.........+.. ......+...++.+.+||.+||..||.+|||+.+|++
T Consensus 310 t~g~~p~~~~~~~~~~~~~~~--~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~ 367 (377)
T 3cbl_A 310 SLGASPYPNLSNQQTREFVEK--GGRLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQ 367 (377)
T ss_dssp TTSCCSSTTSCHHHHHHHHHT--TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred hCCCCCCCCCCHHHHHHHHHc--CCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 8 9999987654433222222 2233455667889999999999999999999999985
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-41 Score=359.38 Aligned_cols=270 Identities=25% Similarity=0.382 Sum_probs=207.2
Q ss_pred CceeEEcCceeeEEEeEeccCceEEEEEEe-cCCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhh
Q 003052 464 DLFFKVNGKLYQRLGKIGSGGSSEVHKVIS-SDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVT 542 (853)
Q Consensus 464 ~~~~~v~g~~Y~ilk~LG~G~FG~Vyka~~-~~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~ 542 (853)
...+.+.+++|++++.||+|+||.||+|.+ .+++.||||++... .......+.+|+.++++++ |+||+++++++..
T Consensus 21 g~~~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~ 97 (317)
T 2buj_A 21 GHMVIIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCH--EQQDREEAQREADMHRLFN-HPNILRLVAYCLR 97 (317)
T ss_dssp EEEEEETTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEES--SHHHHHHHHHHHHHHHTCC-CTTBCCCCEEEEE
T ss_pred ccEEEECCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecC--CHHHHHHHHHHHHHHhhcC-CCCeeeEEEEEEe
Confidence 456778889999999999999999999998 67899999999764 3345567889999999996 9999999987532
Q ss_pred HHHHHHHHhhCCCCCCCCccccCCeEEEEEecchh-hHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCce
Q 003052 543 EKALLREVLNGSMNNKDGRVKDDGYIYMVLEYGEI-DLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERI 621 (853)
Q Consensus 543 e~~iL~~l~~~~iv~~~g~~~d~~~lyLVmEy~~g-dL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gI 621 (853)
+ ......+|+||||+.+ +|.+++..... ....+++..++.++.||+.||.|||++||
T Consensus 98 ~------------------~~~~~~~~lv~e~~~~~~L~~~l~~~~~----~~~~~~~~~~~~i~~qi~~~L~~LH~~~i 155 (317)
T 2buj_A 98 E------------------RGAKHEAWLLLPFFKRGTLWNEIERLKD----KGNFLTEDQILWLLLGICRGLEAIHAKGY 155 (317)
T ss_dssp E------------------ETTEEEEEEEEECCTTCBHHHHHHHHHT----TTCCCCHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred c------------------cCCCceeEEEEEeCCCCcHHHHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHhCCc
Confidence 1 1234578999999875 99988876422 34679999999999999999999999999
Q ss_pred eeCCCCCccEEe-ecCcEEEEecccchhcccCCcc-------ccccccccCccccCchhhccCCCCCCCccccCCCccch
Q 003052 622 VHSDLKPANFLL-VKGSLKLIDFGIAKAIMSDTTN-------IQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDI 693 (853)
Q Consensus 622 IHRDLKPeNILL-~~g~VKL~DFGlAk~~~~~~~~-------~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDI 693 (853)
+||||||+|||+ .++.+||+|||+++........ .......||+.|+|||++.+... ..++.++||
T Consensus 156 vH~dlkp~NIl~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~------~~~~~~~Di 229 (317)
T 2buj_A 156 AHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSH------CVIDERTDV 229 (317)
T ss_dssp ECCCCCGGGEEECTTSCEEECCCSSCEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSE------EEECTHHHH
T ss_pred ccCCCCHHHEEEcCCCCEEEEecCcchhcccccccccccccccccccccCCcccCCHhHhccCCC------cCCCchhhH
Confidence 999999999999 5679999999998764321110 01124568999999999865421 136789999
Q ss_pred hhhHHHHHHHHhCCCCCCcchhHH-HHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCCChhHHhcCC
Q 003052 694 WSLGCILYQMVYGRTPFSEYKTFW-AKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQHP 765 (853)
Q Consensus 694 WSLGVILyELLtG~~PF~~~~~~~-~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~HP 765 (853)
|||||++|+|++|+.||....... .....+.. ..........+..+.+||.+||..||.+||++.+++++-
T Consensus 230 ~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L 301 (317)
T 2buj_A 230 WSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQN-QLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQL 301 (317)
T ss_dssp HHHHHHHHHHHHSSCTTHHHHHTTSCHHHHHHC-C--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HHHHHHHHHHHhCCCChhhhhcccchhhHHhhc-cCCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHh
Confidence 999999999999999995421100 00111111 222333456788999999999999999999999999874
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=345.61 Aligned_cols=252 Identities=21% Similarity=0.312 Sum_probs=204.8
Q ss_pred EEcCceeeEEEeEeccCceEEEEEEecCCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHH
Q 003052 468 KVNGKLYQRLGKIGSGGSSEVHKVISSDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALL 547 (853)
Q Consensus 468 ~v~g~~Y~ilk~LG~G~FG~Vyka~~~~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL 547 (853)
.++.+.|++.+.||+|+||.||+|.+.+++.||+|++....... ..+.+|+.++++++ |+||++++++
T Consensus 4 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~---~~~~~e~~~l~~l~-h~~i~~~~~~-------- 71 (267)
T 3t9t_A 4 VIDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSE---EDFIEEAEVMMKLS-HPKLVQLYGV-------- 71 (267)
T ss_dssp BCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTBCH---HHHHHHHHHHHTCC-CTTBCCEEEE--------
T ss_pred EEchhheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCCCH---HHHHHHHHHHHhCC-CCCEeeEEEE--------
Confidence 34557899999999999999999999888899999998654432 45889999999997 9999999987
Q ss_pred HHHhhCCCCCCCCccccCCeEEEEEecch-hhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCC
Q 003052 548 REVLNGSMNNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDL 626 (853)
Q Consensus 548 ~~l~~~~iv~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDL 626 (853)
+.+.+.+|+||||++ ++|.+++... ...+++..++.++.||+.||.|||++||+||||
T Consensus 72 --------------~~~~~~~~lv~e~~~~~~L~~~~~~~-------~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl 130 (267)
T 3t9t_A 72 --------------CLEQAPICLVTEFMEHGCLSDYLRTQ-------RGLFAAETLLGMCLDVCEGMAYLEEACVIHRDL 130 (267)
T ss_dssp --------------ECSSSSCEEEECCCTTCBHHHHHHHT-------TTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSC
T ss_pred --------------EccCCCeEEEEeCCCCCcHHHHHhhC-------cccCCHHHHHHHHHHHHHHHHHHHhCCcccCCC
Confidence 345567899999986 5899888653 246899999999999999999999999999999
Q ss_pred CCccEEe-ecCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHh
Q 003052 627 KPANFLL-VKGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVY 705 (853)
Q Consensus 627 KPeNILL-~~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLt 705 (853)
||+|||+ .++.+||+|||+++...... ........||+.|+|||++.+.. ++.++|||||||++|+|++
T Consensus 131 ~p~Nili~~~~~~kl~dfg~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~---------~~~~~Di~slG~il~~l~~ 200 (267)
T 3t9t_A 131 AARNCLVGENQVIKVSDFGMTRFVLDDQ-YTSSTGTKFPVKWASPEVFSFSR---------YSSKSDVWSFGVLMWEVFS 200 (267)
T ss_dssp CGGGEEECGGGCEEECCTTGGGGBCCHH-HHSTTSTTCCGGGCCHHHHHHCC---------CCHHHHHHHHHHHHHHHHT
T ss_pred chheEEECCCCCEEEccccccccccccc-ccccccccccccccChhhhcCCC---------ccchhchhhhHHHHHHHhc
Confidence 9999999 56799999999998664321 11223456788999999997653 5679999999999999999
Q ss_pred -CCCCCCcchhHHHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCCChhHHhcC
Q 003052 706 -GRTPFSEYKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQH 764 (853)
Q Consensus 706 -G~~PF~~~~~~~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~H 764 (853)
|+.||...........+... .....+...+..+.+||.+||..||.+||++.+++++
T Consensus 201 ~g~~p~~~~~~~~~~~~i~~~--~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~ 258 (267)
T 3t9t_A 201 EGKIPYENRSNSEVVEDISTG--FRLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQ 258 (267)
T ss_dssp TSCCTTTTCCHHHHHHHHHTT--CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred cCCCCCCCCCHHHHHHHHhcC--CcCCCCccCcHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 99999875443333222221 2223445678889999999999999999999999864
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-40 Score=359.27 Aligned_cols=264 Identities=20% Similarity=0.321 Sum_probs=206.3
Q ss_pred eEEcCceeeEEEeEeccCceEEEEEEec--------CCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeee
Q 003052 467 FKVNGKLYQRLGKIGSGGSSEVHKVISS--------DCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLID 538 (853)
Q Consensus 467 ~~v~g~~Y~ilk~LG~G~FG~Vyka~~~--------~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid 538 (853)
+.+..++|++.+.||+|+||.||+|.+. ++..||||+++... .......+.+|+.+|+++..||||+++++
T Consensus 30 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~~~ 108 (334)
T 2pvf_A 30 WEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA-TEKDLSDLVSEMEMMKMIGKHKNIINLLG 108 (334)
T ss_dssp TBCCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred ccCCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCC-cHHHHHHHHHHHHHHHHhhcCCCEeeEEE
Confidence 3455678999999999999999999863 45789999997543 33455678899999999977999999998
Q ss_pred hhhhHHHHHHHHhhCCCCCCCCccccCCeEEEEEecchh-hHHHHHHHhhhh--------ccCCCCCCCHHHHHHHHHHh
Q 003052 539 YEVTEKALLREVLNGSMNNKDGRVKDDGYIYMVLEYGEI-DLAHMLSQKWKE--------MDGSNQTLDENWLRFYWQQI 609 (853)
Q Consensus 539 ~~~~e~~iL~~l~~~~iv~~~g~~~d~~~lyLVmEy~~g-dL~~~L~~~~k~--------~~~~~~~LsE~~~r~I~~QI 609 (853)
+ +.+.+.+|+||||+.+ +|.+++...... .......+++..++.++.||
T Consensus 109 ~----------------------~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi 166 (334)
T 2pvf_A 109 A----------------------CTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQL 166 (334)
T ss_dssp E----------------------ECSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHH
T ss_pred E----------------------EccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHH
Confidence 7 4456678999999864 999998754210 00012358999999999999
Q ss_pred hhhhhhcccCceeeCCCCCccEEe-ecCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCC
Q 003052 610 LEAVNTIHEERIVHSDLKPANFLL-VKGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCG 688 (853)
Q Consensus 610 l~AL~yLHs~gIIHRDLKPeNILL-~~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys 688 (853)
+.||.|||++||+||||||+|||+ .++.+||+|||+++...............||+.|+|||++.+. .++
T Consensus 167 ~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~---------~~~ 237 (334)
T 2pvf_A 167 ARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDR---------VYT 237 (334)
T ss_dssp HHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHC---------EEC
T ss_pred HHHHHHHHhCCeeCCCCccceEEEcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCC---------CcC
Confidence 999999999999999999999999 4679999999999876543322223345688999999999764 367
Q ss_pred CccchhhhHHHHHHHHh-CCCCCCcchhHHHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCCChhHHhcC
Q 003052 689 RPSDIWSLGCILYQMVY-GRTPFSEYKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQH 764 (853)
Q Consensus 689 ~ksDIWSLGVILyELLt-G~~PF~~~~~~~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~H 764 (853)
.++|||||||++|+|++ |..||.+..... ....+.. ......+...+..+.+||.+||..||.+||++.+++++
T Consensus 238 ~~~Di~slG~il~ellt~g~~p~~~~~~~~-~~~~~~~-~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 312 (334)
T 2pvf_A 238 HQSDVWSFGVLMWEIFTLGGSPYPGIPVEE-LFKLLKE-GHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED 312 (334)
T ss_dssp HHHHHHHHHHHHHHHHTTSCCSSTTCCHHH-HHHHHHH-TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred hHHHHHHHHHHHHHHHhCCCCCcCcCCHHH-HHHHHhc-CCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 89999999999999999 999997654332 2222221 12233455678899999999999999999999999964
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=358.46 Aligned_cols=264 Identities=21% Similarity=0.330 Sum_probs=207.5
Q ss_pred eEEcCceeeEEEeEeccCceEEEEEEec-CC-----cEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehh
Q 003052 467 FKVNGKLYQRLGKIGSGGSSEVHKVISS-DC-----TIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYE 540 (853)
Q Consensus 467 ~~v~g~~Y~ilk~LG~G~FG~Vyka~~~-~g-----~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~ 540 (853)
+.+..+.|++.+.||+|+||.||+|.+. ++ ..||+|++.... .......+.+|+.+|+++..||||++++++
T Consensus 41 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~- 118 (333)
T 2i1m_A 41 WEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTA-HADEKEALMSELKIMSHLGQHENIVNLLGA- 118 (333)
T ss_dssp GBCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEE-
T ss_pred ccCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhccccc-ChHHHHHHHHHHHHHHhhcCCCCeeeEEEE-
Confidence 3455577999999999999999999974 22 479999997653 334456788999999999679999999987
Q ss_pred hhHHHHHHHHhhCCCCCCCCccccCCeEEEEEecch-hhHHHHHHHhhhhccC------CCCCCCHHHHHHHHHHhhhhh
Q 003052 541 VTEKALLREVLNGSMNNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEMDG------SNQTLDENWLRFYWQQILEAV 613 (853)
Q Consensus 541 ~~e~~iL~~l~~~~iv~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~~~~------~~~~LsE~~~r~I~~QIl~AL 613 (853)
+.+.+.+|+||||+. ++|.+++......... ....+++..++.++.||+.||
T Consensus 119 ---------------------~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l 177 (333)
T 2i1m_A 119 ---------------------CTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGM 177 (333)
T ss_dssp ---------------------ECSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHH
T ss_pred ---------------------EecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHH
Confidence 445667899999986 4999998765322111 135689999999999999999
Q ss_pred hhcccCceeeCCCCCccEEee-cCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccc
Q 003052 614 NTIHEERIVHSDLKPANFLLV-KGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSD 692 (853)
Q Consensus 614 ~yLHs~gIIHRDLKPeNILL~-~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksD 692 (853)
.|||++||+||||||+|||++ ++.+||+|||+++...............||+.|+|||++.+.. ++.++|
T Consensus 178 ~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~---------~~~~~D 248 (333)
T 2i1m_A 178 AFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCV---------YTVQSD 248 (333)
T ss_dssp HHHHHTTEECSCCSGGGCEEEGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCC---------CCHHHH
T ss_pred HHHhcCCcccCCcccceEEECCCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCC---------CChHHH
Confidence 999999999999999999995 6799999999998765443333334567889999999997653 568999
Q ss_pred hhhhHHHHHHHHh-CCCCCCcchhHHHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCCChhHHhc
Q 003052 693 IWSLGCILYQMVY-GRTPFSEYKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQ 763 (853)
Q Consensus 693 IWSLGVILyELLt-G~~PF~~~~~~~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~ 763 (853)
||||||++|+|++ |..||.+..........+.. ......+...+..+.+||.+||..||.+||++.++++
T Consensus 249 i~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 319 (333)
T 2i1m_A 249 VWSYGILLWEIFSLGLNPYPGILVNSKFYKLVKD-GYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICS 319 (333)
T ss_dssp HHHHHHHHHHHTTTSCCSSTTCCSSHHHHHHHHH-TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHHHHHcCCCCCCcccchhHHHHHHHhc-CCCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHH
Confidence 9999999999998 99999764332222222221 1223345566888999999999999999999999986
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-41 Score=365.70 Aligned_cols=256 Identities=24% Similarity=0.306 Sum_probs=178.6
Q ss_pred ceeeEEE-eEeccCceEEEEEEec-CCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHHH
Q 003052 472 KLYQRLG-KIGSGGSSEVHKVISS-DCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLRE 549 (853)
Q Consensus 472 ~~Y~ilk-~LG~G~FG~Vyka~~~-~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~~ 549 (853)
++|.+++ .||+|+||.||+|.+. +++.||||++.... ...+|+..+.++.+|+||+++++++...
T Consensus 28 ~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~e~~~~~~~~~h~~i~~~~~~~~~~------ 94 (336)
T 3fhr_A 28 DDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP-------KARQEVDHHWQASGGPHIVCILDVYENM------ 94 (336)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSH-------HHHHHHHHHHHHTTSTTBCCEEEEEEEE------
T ss_pred ceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcH-------HHHHHHHHHHHhcCCCChHHHHHHHhhc------
Confidence 5688866 5999999999999985 78999999997431 2345666666666799999999975321
Q ss_pred HhhCCCCCCCCccccCCeEEEEEecchh-hHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCCC
Q 003052 550 VLNGSMNNKDGRVKDDGYIYMVLEYGEI-DLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKP 628 (853)
Q Consensus 550 l~~~~iv~~~g~~~d~~~lyLVmEy~~g-dL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLKP 628 (853)
.....++|+||||+.+ +|.+++... ....+++..++.++.||+.||.|||++||+||||||
T Consensus 95 ------------~~~~~~~~lv~e~~~gg~L~~~l~~~------~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp 156 (336)
T 3fhr_A 95 ------------HHGKRCLLIIMECMEGGELFSRIQER------GDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKP 156 (336)
T ss_dssp ------------ETTEEEEEEEEECCTTEEHHHHHHTC-------CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSG
T ss_pred ------------cCCCceEEEEEeccCCCCHHHHHHhc------CCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCH
Confidence 1235568999999865 999988754 235799999999999999999999999999999999
Q ss_pred ccEEee----cCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHH
Q 003052 629 ANFLLV----KGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMV 704 (853)
Q Consensus 629 eNILL~----~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELL 704 (853)
+|||++ ++.+||+|||+++..... .....+||+.|+|||++.+. .|+.++|||||||++|+|+
T Consensus 157 ~NIll~~~~~~~~~kl~Dfg~~~~~~~~----~~~~~~~t~~y~aPE~~~~~---------~~~~~~Di~slG~il~~l~ 223 (336)
T 3fhr_A 157 ENLLYTSKEKDAVLKLTDFGFAKETTQN----ALQTPCYTPYYVAPEVLGPE---------KYDKSCDMWSLGVIMYILL 223 (336)
T ss_dssp GGEEESCSSTTCCEEECCCTTCEEC--------------------------C---------HHHHHHHHHHHHHHHHHHH
T ss_pred HHEEEEecCCCceEEEeccccceecccc----ccccCCCCcCccChhhhCCC---------CCCchhhHHHHHHHHHHHH
Confidence 999994 346999999999865432 22356899999999998654 3668999999999999999
Q ss_pred hCCCCCCcchhHHH---HHHhhcCCC--CcccCCCCCChhHHHHHHHhcccCCCCCCChhHHhcCCCCCCCC
Q 003052 705 YGRTPFSEYKTFWA---KFKVITDPN--HEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQHPFLVPPV 771 (853)
Q Consensus 705 tG~~PF~~~~~~~~---~~kii~~~~--~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~HPwf~~~~ 771 (853)
+|+.||........ ....+.... .........++++.+||.+||..||.+|||+.|+|+||||....
T Consensus 224 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~ 295 (336)
T 3fhr_A 224 CGFPPFYSNTGQAISPGMKRRIRLGQYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQSM 295 (336)
T ss_dssp HSSCCC---------------------CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTGG
T ss_pred HCCCCCCCccchhhhhhHHHhhhccccccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccccc
Confidence 99999965432211 111111111 11122245788999999999999999999999999999997643
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-41 Score=368.96 Aligned_cols=256 Identities=16% Similarity=0.192 Sum_probs=192.7
Q ss_pred EEcCceeeEEEeEeccCceEEEEEEecC------CcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcC------------
Q 003052 468 KVNGKLYQRLGKIGSGGSSEVHKVISSD------CTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKG------------ 529 (853)
Q Consensus 468 ~v~g~~Y~ilk~LG~G~FG~Vyka~~~~------g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~------------ 529 (853)
.+..+.|++.+.||+|+||.||+|.+.. ++.||||++..... .+.+|+++++++.+
T Consensus 31 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~------~~~~e~~~~~~~~~~~~~~e~~~~~~ 104 (364)
T 3op5_A 31 DMAAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNG------PLFTELKFYQRAAKPEQIQKWIRTRK 104 (364)
T ss_dssp CTTCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCH------HHHHHHHHHHHHCCHHHHHHHHHHTT
T ss_pred ccCCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccch------hHHHHHHHHHhhhhhHHHHHHHHHhh
Confidence 3566789999999999999999998854 47899999976432 24566666666554
Q ss_pred --CCceeEeeehhhhHHHHHHHHhhCCCCCCCCccccCCeEEEEEecchhhHHHHHHHhhhhccCCCCCCCHHHHHHHHH
Q 003052 530 --KNNIIQLIDYEVTEKALLREVLNGSMNNKDGRVKDDGYIYMVLEYGEIDLAHMLSQKWKEMDGSNQTLDENWLRFYWQ 607 (853)
Q Consensus 530 --hpNIV~Lid~~~~e~~iL~~l~~~~iv~~~g~~~d~~~lyLVmEy~~gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~ 607 (853)
|+||+++++++..+ ..+..++||||||++++|.+++... ...+++..++.|+.
T Consensus 105 l~h~~iv~~~~~~~~~------------------~~~~~~~~lv~e~~g~~L~~~~~~~-------~~~l~~~~~~~i~~ 159 (364)
T 3op5_A 105 LKYLGVPKYWGSGLHD------------------KNGKSYRFMIMDRFGSDLQKIYEAN-------AKRFSRKTVLQLSL 159 (364)
T ss_dssp CSCCCSCCEEEEEEEE------------------ETTEEEEEEEEECEEEEHHHHHHHT-------TSCCCHHHHHHHHH
T ss_pred ccCCCCCeEEeeeeec------------------cCCcceEEEEEeCCCCCHHHHHHhc-------cCCCCHHHHHHHHH
Confidence 78888887764321 1223678999999988999988653 35799999999999
Q ss_pred HhhhhhhhcccCceeeCCCCCccEEee---cCcEEEEecccchhcccCCccc-----cccccccCccccCchhhccCCCC
Q 003052 608 QILEAVNTIHEERIVHSDLKPANFLLV---KGSLKLIDFGIAKAIMSDTTNI-----QRDSQVGTLSYMSPEAFMCNESD 679 (853)
Q Consensus 608 QIl~AL~yLHs~gIIHRDLKPeNILL~---~g~VKL~DFGlAk~~~~~~~~~-----~~~t~~GTp~YmAPEvl~~~~~~ 679 (853)
||+.||.|||++||+||||||+||||+ ++.+||+|||+|+.+....... .....+||+.|+|||++.+..
T Consensus 160 qi~~~l~~lH~~~iiHrDlkp~Nill~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-- 237 (364)
T 3op5_A 160 RILDILEYIHEHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVA-- 237 (364)
T ss_dssp HHHHHHHHHHHTTEECCCCCGGGEEEESSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCC--
T ss_pred HHHHHHHHHHHCCeEEecCCHHHEEEecCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCC--
Confidence 999999999999999999999999995 4699999999998764322111 113456999999999997653
Q ss_pred CCCccccCCCccchhhhHHHHHHHHhCCCCCCcchhHHHH---HHh-hcCCCC----cccCCCCCChhHHHHHHHhcccC
Q 003052 680 ENGNIIKCGRPSDIWSLGCILYQMVYGRTPFSEYKTFWAK---FKV-ITDPNH----EITYEPVPNPWLLDLMKKCLAWD 751 (853)
Q Consensus 680 ~~~~~~~ys~ksDIWSLGVILyELLtG~~PF~~~~~~~~~---~ki-i~~~~~----~~~~~~~~s~~l~dLI~kcL~~D 751 (853)
|+.++|||||||++|||++|+.||.+....... ... ...... ........+.++.+||..||..|
T Consensus 238 -------~~~~~Di~slG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~ 310 (364)
T 3op5_A 238 -------PSRRGDLEILGYCMIQWLTGHLPWEDNLKDPKYVRDSKIRYRENIASLMDKCFPAANAPGEIAKYMETVKLLD 310 (364)
T ss_dssp -------CCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHHHHHHHHHHHHHCHHHHHHHHSCTTCCCHHHHHHHHHHHTCC
T ss_pred -------CCchhhHHHHHHHHHHHHhCCCCccccccCHHHHHHHHHHhhhhHHHHHHHhcccccCHHHHHHHHHHHhcCC
Confidence 578999999999999999999999753111110 000 000000 00012456788999999999999
Q ss_pred CCCCCChhHHhc
Q 003052 752 RNERWRIPQLLQ 763 (853)
Q Consensus 752 P~kRpTa~EIL~ 763 (853)
|.+||++.+|++
T Consensus 311 p~~RP~~~~l~~ 322 (364)
T 3op5_A 311 YTEKPLYENLRD 322 (364)
T ss_dssp TTCCCCHHHHHH
T ss_pred CCCCCCHHHHHH
Confidence 999999999885
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-40 Score=351.80 Aligned_cols=256 Identities=20% Similarity=0.302 Sum_probs=199.1
Q ss_pred EEcCceeeEEEeEeccCceEEEEEEe-----cCCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhh
Q 003052 468 KVNGKLYQRLGKIGSGGSSEVHKVIS-----SDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVT 542 (853)
Q Consensus 468 ~v~g~~Y~ilk~LG~G~FG~Vyka~~-----~~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~ 542 (853)
.+..++|+++++||+|+||.||+|.. .+++.||||++... .......+.+|+.+|++++ |+||+++++++..
T Consensus 6 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~ 82 (295)
T 3ugc_A 6 QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS--TEEHLRDFEREIEILKSLQ-HDNIVKYKGVCYS 82 (295)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCC--CHHHHHHHHHHHHHHHTCC-CTTBCCEEEEECH
T ss_pred cCCHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccC--CHHHHHHHHHHHHHHHhCC-CCCEeeEEEEEec
Confidence 34567899999999999999999983 36789999999754 3345567889999999997 8999999997543
Q ss_pred HHHHHHHHhhCCCCCCCCccccCCeEEEEEecch-hhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCce
Q 003052 543 EKALLREVLNGSMNNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERI 621 (853)
Q Consensus 543 e~~iL~~l~~~~iv~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gI 621 (853)
. +...+|+||||++ ++|.+++... ...+++..++.++.||+.||.|||++||
T Consensus 83 ~--------------------~~~~~~lv~e~~~~~~L~~~l~~~-------~~~~~~~~~~~~~~qi~~~l~~lH~~~i 135 (295)
T 3ugc_A 83 A--------------------GRRNLKLIMEYLPYGSLRDYLQKH-------KERIDHIKLLQYTSQICKGMEYLGTKRY 135 (295)
T ss_dssp H--------------------HHTSCEEEEECCTTCBHHHHHHHC-------GGGCCHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred C--------------------CCCceEEEEEeCCCCCHHHHHHhc-------ccccCHHHHHHHHHHHHHHHHHHhcCCc
Confidence 2 2245799999985 5999998764 2358999999999999999999999999
Q ss_pred eeCCCCCccEEe-ecCcEEEEecccchhcccCCcc-ccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHH
Q 003052 622 VHSDLKPANFLL-VKGSLKLIDFGIAKAIMSDTTN-IQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCI 699 (853)
Q Consensus 622 IHRDLKPeNILL-~~g~VKL~DFGlAk~~~~~~~~-~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVI 699 (853)
+||||||+|||+ .++.+||+|||+++........ .......|++.|+|||++.+.. |+.++|||||||+
T Consensus 136 vH~Dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~---------~~~~~Di~slG~~ 206 (295)
T 3ugc_A 136 IHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTESK---------FSVASDVWSFGVV 206 (295)
T ss_dssp CCSCCSGGGEEEEETTEEEECCCCSCC-------------CTTCGGGGCCHHHHHHCC---------CCHHHHHHHHHHH
T ss_pred ccCCCCHhhEEEcCCCeEEEccCcccccccCCcceeeeccCCCCccceeCcHHhcCCC---------CChHHHHHHHHHH
Confidence 999999999999 5679999999999876433221 1223456888999999997653 5689999999999
Q ss_pred HHHHHhCCCCCCcchhHH---------------HHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCCChhHHhc
Q 003052 700 LYQMVYGRTPFSEYKTFW---------------AKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQ 763 (853)
Q Consensus 700 LyELLtG~~PF~~~~~~~---------------~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~ 763 (853)
+|+|++|..||....... .....+. .......+...++++.+||.+||..||.+|||+.|+++
T Consensus 207 l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~ 284 (295)
T 3ugc_A 207 LYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLK-NNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL 284 (295)
T ss_dssp HHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHHHHHHH-TTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred HHHHHhcccccCCChHHHHhhhcCccccchhHHHHHHHHh-ccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 999999999996532211 1111111 12233456677899999999999999999999999985
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-40 Score=349.74 Aligned_cols=252 Identities=24% Similarity=0.340 Sum_probs=200.2
Q ss_pred EEcCceeeEEEeEeccCceEEEEEEe-cCCcEEEEEEEecCCCChhh-----HhhHHHHHHHHHHhcCCCceeEeeehhh
Q 003052 468 KVNGKLYQRLGKIGSGGSSEVHKVIS-SDCTIYALKKIKLKGRDYAT-----AYGFCQEIEYLNKLKGKNNIIQLIDYEV 541 (853)
Q Consensus 468 ~v~g~~Y~ilk~LG~G~FG~Vyka~~-~~g~~vAVKkik~~~~~~~~-----~~~~l~EI~iLkkL~~hpNIV~Lid~~~ 541 (853)
.+.+++|++.+.||+|+||.||+|.+ .+++.||||++......... ...+.+|+.++++++ |+||+++++++.
T Consensus 15 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~ 93 (287)
T 4f0f_A 15 TLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLN-HPNIVKLYGLMH 93 (287)
T ss_dssp BCCSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCC-CTTBCCEEEEET
T ss_pred hhhhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCC-CCCchhhheeec
Confidence 34567899999999999999999998 57789999999765432221 156889999999997 999999998742
Q ss_pred hHHHHHHHHhhCCCCCCCCccccCCeEEEEEecch-hhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCc
Q 003052 542 TEKALLREVLNGSMNNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEER 620 (853)
Q Consensus 542 ~e~~iL~~l~~~~iv~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~g 620 (853)
+.. ++||||+. ++|.+.+... ...+++..++.++.||+.||.|||++|
T Consensus 94 ----------------------~~~--~lv~e~~~~~~L~~~l~~~-------~~~~~~~~~~~~~~~l~~~l~~lH~~~ 142 (287)
T 4f0f_A 94 ----------------------NPP--RMVMEFVPCGDLYHRLLDK-------AHPIKWSVKLRLMLDIALGIEYMQNQN 142 (287)
T ss_dssp ----------------------TTT--EEEEECCTTCBHHHHHHCT-------TSCCCHHHHHHHHHHHHHHHHHHHTSS
T ss_pred ----------------------CCC--eEEEEecCCCCHHHHHhcc-------cCCccHHHHHHHHHHHHHHHHHHHhCC
Confidence 222 69999986 6888877543 357999999999999999999999999
Q ss_pred --eeeCCCCCccEEee-cCc-----EEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccc
Q 003052 621 --IVHSDLKPANFLLV-KGS-----LKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSD 692 (853)
Q Consensus 621 --IIHRDLKPeNILL~-~g~-----VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksD 692 (853)
|+||||||+|||++ ++. +||+|||+++.... .....+||+.|+|||++.+.. ..|+.++|
T Consensus 143 ~~ivH~dikp~Nil~~~~~~~~~~~~kl~Dfg~~~~~~~-----~~~~~~g~~~y~aPE~~~~~~-------~~~~~~~D 210 (287)
T 4f0f_A 143 PPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVH-----SVSGLLGNFQWMAPETIGAEE-------ESYTEKAD 210 (287)
T ss_dssp SCCBCSCCSGGGEEESCCCTTCSCCEEECCCTTCBCCSS-----CEECCCCCCTTSCGGGSSCSS-------CEECHHHH
T ss_pred CCeecCCCCcceEEEeccCCCCceeEEeCCCCccccccc-----cccccCCCccccCchhhccCC-------CCcCchhh
Confidence 99999999999994 344 99999999975432 223578999999999985432 14678999
Q ss_pred hhhhHHHHHHHHhCCCCCCcchhHH-HHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCCChhHHhc
Q 003052 693 IWSLGCILYQMVYGRTPFSEYKTFW-AKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQ 763 (853)
Q Consensus 693 IWSLGVILyELLtG~~PF~~~~~~~-~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~ 763 (853)
||||||++|+|++|+.||....... .....+.........+...++++.+||.+||..||.+||++.++++
T Consensus 211 i~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 282 (287)
T 4f0f_A 211 TYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVK 282 (287)
T ss_dssp HHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHHHHSCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHHHHHcCCCCCccccccHHHHHHHHhccCCCCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 9999999999999999997543211 1122222223344556678899999999999999999999999986
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=350.37 Aligned_cols=253 Identities=23% Similarity=0.369 Sum_probs=191.5
Q ss_pred EEcCceeeEEEeEeccCceEEEEEEecC----CcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhH
Q 003052 468 KVNGKLYQRLGKIGSGGSSEVHKVISSD----CTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTE 543 (853)
Q Consensus 468 ~v~g~~Y~ilk~LG~G~FG~Vyka~~~~----g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e 543 (853)
.+..++|++.+.||+|+||.||+|.+.. +..||+|+++... .......+.+|+.++++++ ||||+++++++
T Consensus 11 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~--- 85 (281)
T 1mp8_A 11 EIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCT-SDSVREKFLQEALTMRQFD-HPHIVKLIGVI--- 85 (281)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTT-SHHHHHHHHHHHHHHHTCC-CTTBCCEEEEE---
T ss_pred EEehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccC-CHHHHHHHHHHHHHHHhCC-CCccceEEEEE---
Confidence 4556789999999999999999998742 3579999987543 3445567889999999997 99999999863
Q ss_pred HHHHHHHhhCCCCCCCCccccCCeEEEEEecchh-hHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCcee
Q 003052 544 KALLREVLNGSMNNKDGRVKDDGYIYMVLEYGEI-DLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIV 622 (853)
Q Consensus 544 ~~iL~~l~~~~iv~~~g~~~d~~~lyLVmEy~~g-dL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gII 622 (853)
.++.+|+||||+.+ +|.+++... ...+++..++.++.||+.||.|||++||+
T Consensus 86 --------------------~~~~~~lv~e~~~~~~L~~~l~~~-------~~~~~~~~~~~~~~qi~~~l~~lH~~~i~ 138 (281)
T 1mp8_A 86 --------------------TENPVWIIMELCTLGELRSFLQVR-------KYSLDLASLILYAYQLSTALAYLESKRFV 138 (281)
T ss_dssp --------------------CSSSCEEEEECCTTEEHHHHHHHT-------TTTSCHHHHHHHHHHHHHHHHHHHHTTCC
T ss_pred --------------------ccCccEEEEecCCCCCHHHHHHhc-------CCCCCHHHHHHHHHHHHHHHHHHHhCCee
Confidence 23457999999874 999888653 24699999999999999999999999999
Q ss_pred eCCCCCccEEee-cCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHH
Q 003052 623 HSDLKPANFLLV-KGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILY 701 (853)
Q Consensus 623 HRDLKPeNILL~-~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILy 701 (853)
||||||+|||++ ++.+||+|||+++....... .......+|+.|+|||++.+.. |+.++|||||||++|
T Consensus 139 H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~---------~~~~~Di~slG~~l~ 208 (281)
T 1mp8_A 139 HRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTY-YKASKGKLPIKWMAPESINFRR---------FTSASDVWMFGVCMW 208 (281)
T ss_dssp CSCCSGGGEEEEETTEEEECC--------------------CCGGGCCHHHHHHCC---------CSHHHHHHHHHHHHH
T ss_pred cccccHHHEEECCCCCEEECccccccccCcccc-cccccCCCcccccChhhcccCC---------CCCccCchHHHHHHH
Confidence 999999999994 78999999999987643221 1223456788999999997653 567999999999999
Q ss_pred HHHh-CCCCCCcchhHHHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCCChhHHhcC
Q 003052 702 QMVY-GRTPFSEYKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQH 764 (853)
Q Consensus 702 ELLt-G~~PF~~~~~~~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~H 764 (853)
+|++ |..||.+.........+.. ......+...++.+.+||.+||..||.+||++.+++++
T Consensus 209 ell~~g~~pf~~~~~~~~~~~i~~--~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~ 270 (281)
T 1mp8_A 209 EILMHGVKPFQGVKNNDVIGRIEN--GERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQ 270 (281)
T ss_dssp HHHTTSCCTTTTCCGGGHHHHHHT--TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHhcCCCCCCcCCHHHHHHHHHc--CCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 9996 9999976543322222222 12234556788999999999999999999999999853
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=357.00 Aligned_cols=262 Identities=17% Similarity=0.251 Sum_probs=208.5
Q ss_pred EEcCceeeEEEeEeccCceEEEEEEec------CCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhh
Q 003052 468 KVNGKLYQRLGKIGSGGSSEVHKVISS------DCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEV 541 (853)
Q Consensus 468 ~v~g~~Y~ilk~LG~G~FG~Vyka~~~------~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~ 541 (853)
.+..++|++.+.||+|+||.||+|.+. +++.||||++.... .......+.+|+.+|+++. |+||++++++
T Consensus 21 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~-- 96 (322)
T 1p4o_A 21 EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA-SMRERIEFLNEASVMKEFN-CHHVVRLLGV-- 96 (322)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS-CHHHHHHHHHHHHHGGGCC-CTTBCCEEEE--
T ss_pred cchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEeccccc-CHHHHHHHHHHHHHHHhcC-CCCEeeeEEE--
Confidence 455678999999999999999999864 35789999997543 3344556889999999997 8999999987
Q ss_pred hHHHHHHHHhhCCCCCCCCccccCCeEEEEEecch-hhHHHHHHHhhhhc--cCCCCCCCHHHHHHHHHHhhhhhhhccc
Q 003052 542 TEKALLREVLNGSMNNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEM--DGSNQTLDENWLRFYWQQILEAVNTIHE 618 (853)
Q Consensus 542 ~e~~iL~~l~~~~iv~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~~--~~~~~~LsE~~~r~I~~QIl~AL~yLHs 618 (853)
+.+...+|+||||+. ++|.+++....... ......+++..++.++.||+.||.|||+
T Consensus 97 --------------------~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~ 156 (322)
T 1p4o_A 97 --------------------VSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNA 156 (322)
T ss_dssp --------------------ECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred --------------------EccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHH
Confidence 345667899999986 59999887643221 1122467999999999999999999999
Q ss_pred CceeeCCCCCccEEee-cCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhH
Q 003052 619 ERIVHSDLKPANFLLV-KGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLG 697 (853)
Q Consensus 619 ~gIIHRDLKPeNILL~-~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLG 697 (853)
+||+||||||+|||++ ++.+||+|||+++...............||+.|+|||++.+.. ++.++||||||
T Consensus 157 ~~i~H~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~---------~~~~~Di~slG 227 (322)
T 1p4o_A 157 NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGV---------FTTYSDVWSFG 227 (322)
T ss_dssp TTCBCSCCSGGGEEECTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCC---------CCHHHHHHHHH
T ss_pred CCCccCCCccceEEEcCCCeEEECcCccccccccccccccccCCCCCCCccChhhhccCC---------CCchhhHHHHH
Confidence 9999999999999994 6799999999998765433322334557899999999997653 56899999999
Q ss_pred HHHHHHHh-CCCCCCcchhHHHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCCChhHHhcC
Q 003052 698 CILYQMVY-GRTPFSEYKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQH 764 (853)
Q Consensus 698 VILyELLt-G~~PF~~~~~~~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~H 764 (853)
|++|+|++ |..||.+.........+... .....+...+..+.+||.+||..||.+||++.++++|
T Consensus 228 ~il~el~~~g~~p~~~~~~~~~~~~~~~~--~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~ 293 (322)
T 1p4o_A 228 VVLWEIATLAEQPYQGLSNEQVLRFVMEG--GLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS 293 (322)
T ss_dssp HHHHHHHHTSCCTTTTSCHHHHHHHHHTT--CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHhcCCCccccCCHHHHHHHHHcC--CcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 99999999 89999875543333322222 1223455678899999999999999999999999987
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=359.97 Aligned_cols=265 Identities=19% Similarity=0.237 Sum_probs=204.7
Q ss_pred EEcCceeeEEEeEeccCceEEEEEEe------cCCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhh
Q 003052 468 KVNGKLYQRLGKIGSGGSSEVHKVIS------SDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEV 541 (853)
Q Consensus 468 ~v~g~~Y~ilk~LG~G~FG~Vyka~~------~~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~ 541 (853)
.+..++|++++.||+|+||.||+|.+ .++..||||++.... .......+.+|+.++++++ |+||++++++
T Consensus 26 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~-- 101 (327)
T 2yfx_A 26 EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC-SEQDELDFLMEALIISKFN-HQNIVRCIGV-- 101 (327)
T ss_dssp BCCGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSC-CHHHHHHHHHHHHHHHHCC-CTTBCCEEEE--
T ss_pred cCChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEecccc-chhhHHHHHHHHHHHhhCC-CCCCCeEEEE--
Confidence 34557899999999999999999983 356789999997443 3344557889999999995 9999999987
Q ss_pred hHHHHHHHHhhCCCCCCCCccccCCeEEEEEecc-hhhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCc
Q 003052 542 TEKALLREVLNGSMNNKDGRVKDDGYIYMVLEYG-EIDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEER 620 (853)
Q Consensus 542 ~e~~iL~~l~~~~iv~~~g~~~d~~~lyLVmEy~-~gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~g 620 (853)
+.+...+|+||||+ +++|.+++..... .......+++..++.++.||+.||.|||++|
T Consensus 102 --------------------~~~~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ 160 (327)
T 2yfx_A 102 --------------------SLQSLPRFILMELMAGGDLKSFLRETRP-RPSQPSSLAMLDLLHVARDIACGCQYLEENH 160 (327)
T ss_dssp --------------------ECSSSSCEEEEECCTTEEHHHHHHHTSC-CSSSTTSCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred --------------------EcCCCCcEEEEecCCCCcHHHHHHhhcc-cccccccccHHHHHHHHHHHHHHHHHHhhCC
Confidence 34556779999998 5699999876421 1112246999999999999999999999999
Q ss_pred eeeCCCCCccEEee----cCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhh
Q 003052 621 IVHSDLKPANFLLV----KGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSL 696 (853)
Q Consensus 621 IIHRDLKPeNILL~----~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSL 696 (853)
|+||||||+|||++ ...+||+|||+++...............||+.|+|||++.+.. ++.++|||||
T Consensus 161 i~H~dlkp~NIli~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~---------~~~~~Di~sl 231 (327)
T 2yfx_A 161 FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGI---------FTSKTDTWSF 231 (327)
T ss_dssp CCCSCCCGGGEEESCSSTTCCEEECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCC---------CCHHHHHHHH
T ss_pred eecCcCCHhHEEEecCCCcceEEECccccccccccccccccCCCcCCCcceeCHhHhcCCC---------CCchhhHHHH
Confidence 99999999999995 2369999999998765433333334567899999999997653 5689999999
Q ss_pred HHHHHHHHh-CCCCCCcchhHHHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCCChhHHhcCCCCC
Q 003052 697 GCILYQMVY-GRTPFSEYKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQHPFLV 768 (853)
Q Consensus 697 GVILyELLt-G~~PF~~~~~~~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~HPwf~ 768 (853)
||++|+|++ |..||......... ..+... .....+...+..+.+||.+||..||.+||++.++++|.|+.
T Consensus 232 G~il~ellt~g~~p~~~~~~~~~~-~~~~~~-~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~ 302 (327)
T 2yfx_A 232 GVLLWEIFSLGYMPYPSKSNQEVL-EFVTSG-GRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYC 302 (327)
T ss_dssp HHHHHHHHTTSCCSSTTCCHHHHH-HHHHTT-CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHHHHHcCCCCCCCCcCHHHHH-HHHhcC-CCCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence 999999998 99999765443222 222221 22334556788999999999999999999999999998863
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=359.32 Aligned_cols=255 Identities=17% Similarity=0.301 Sum_probs=194.3
Q ss_pred eEEcCceeeEEEeEeccCceEEEEEEec-CCcE----EEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhh
Q 003052 467 FKVNGKLYQRLGKIGSGGSSEVHKVISS-DCTI----YALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEV 541 (853)
Q Consensus 467 ~~v~g~~Y~ilk~LG~G~FG~Vyka~~~-~g~~----vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~ 541 (853)
..+...+|+++++||+|+||.||+|.+. +++. ||+|.+.... .......+.+|+.+|++++ |+||+++++++
T Consensus 10 ~~l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~- 86 (327)
T 3poz_A 10 RILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASVD-NPHVCRLLGIC- 86 (327)
T ss_dssp EECCGGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC--------CHHHHHHHHHHHHHCC-BTTBCCEEEEE-
T ss_pred hhcCHHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeeccccc-CHHHHHHHHHHHHHHHhCC-CCCEeEEEEEE-
Confidence 3445678999999999999999999974 4443 5777775432 2234457889999999997 89999999874
Q ss_pred hHHHHHHHHhhCCCCCCCCccccCCeEEEEEecch-hhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCc
Q 003052 542 TEKALLREVLNGSMNNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEER 620 (853)
Q Consensus 542 ~e~~iL~~l~~~~iv~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~g 620 (853)
.+. ..++||||+. ++|.+++... ...+++..++.|+.||+.||.|||++|
T Consensus 87 ---------------------~~~-~~~~v~e~~~~g~L~~~l~~~-------~~~~~~~~~~~~~~qi~~~l~~LH~~~ 137 (327)
T 3poz_A 87 ---------------------LTS-TVQLITQLMPFGCLLDYVREH-------KDNIGSQYLLNWCVQIAKGMNYLEDRR 137 (327)
T ss_dssp ---------------------ESS-SEEEEEECCTTCBHHHHHHHS-------TTSCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred ---------------------ecC-CeEEEEEecCCCcHHHHHHhc-------CCCCCHHHHHHHHHHHHHHHHHHhhCC
Confidence 222 3678888855 6898888653 356999999999999999999999999
Q ss_pred eeeCCCCCccEEe-ecCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHH
Q 003052 621 IVHSDLKPANFLL-VKGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCI 699 (853)
Q Consensus 621 IIHRDLKPeNILL-~~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVI 699 (853)
|+||||||+|||+ .++.+||+|||+|+.+.............||+.|+|||++.+. .|+.++|||||||+
T Consensus 138 ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~---------~~~~~~Di~slG~i 208 (327)
T 3poz_A 138 LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHR---------IYTHQSDVWSYGVT 208 (327)
T ss_dssp CCCSCCCGGGEEEEETTEEEECCTTHHHHHTTTCC-------CCCGGGSCHHHHHHC---------CCCHHHHHHHHHHH
T ss_pred eeCCCCChheEEECCCCCEEEccCcceeEccCCcccccccCCCccccccChHHhccC---------CCCchhhhhhhHHH
Confidence 9999999999999 5689999999999987554433333455678999999999865 35689999999999
Q ss_pred HHHHHh-CCCCCCcchhHHHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCCChhHHhcC
Q 003052 700 LYQMVY-GRTPFSEYKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQH 764 (853)
Q Consensus 700 LyELLt-G~~PF~~~~~~~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~H 764 (853)
+|||++ |+.||.+..... ....+.. ......+...+..+.+||.+||..||.+||++.+++++
T Consensus 209 l~ellt~g~~p~~~~~~~~-~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~ 272 (327)
T 3poz_A 209 VWELMTFGSKPYDGIPASE-ISSILEK-GERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIE 272 (327)
T ss_dssp HHHHHTTSCCTTTTCCGGG-HHHHHHT-TCCCCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHH
T ss_pred HHHHHhcCCCCccCCCHHH-HHHHHHc-CCCCCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence 999999 999997644322 1222221 22334556678899999999999999999999999976
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-40 Score=347.97 Aligned_cols=250 Identities=21% Similarity=0.242 Sum_probs=197.4
Q ss_pred CceeeEEEeEeccCceEEEEEEe-cCCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHHH
Q 003052 471 GKLYQRLGKIGSGGSSEVHKVIS-SDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLRE 549 (853)
Q Consensus 471 g~~Y~ilk~LG~G~FG~Vyka~~-~~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~~ 549 (853)
+++|++.+.||+|+||.||+|.+ .+++.||||++...... ..+.+|+.+++++.++++|..+..+
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~e~~~l~~l~~~~~i~~~~~~---------- 73 (296)
T 3uzp_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH----PQLHIESKIYKMMQGGVGIPTIRWC---------- 73 (296)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSC----CHHHHHHHHHHHHTTSTTCCCEEEE----------
T ss_pred ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcch----hHHHHHHHHHHHhhcCCCCCccccc----------
Confidence 46799999999999999999998 67889999998765432 2478999999999976666655433
Q ss_pred HhhCCCCCCCCccccCCeEEEEEecchhhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCCCc
Q 003052 550 VLNGSMNNKDGRVKDDGYIYMVLEYGEIDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPA 629 (853)
Q Consensus 550 l~~~~iv~~~g~~~d~~~lyLVmEy~~gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLKPe 629 (853)
+.+...+|+||||++++|.+++... ...+++..++.++.||+.||.|||++||+||||||+
T Consensus 74 ------------~~~~~~~~lv~e~~~~~L~~~~~~~-------~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~ 134 (296)
T 3uzp_A 74 ------------GAEGDYNVMVMELLGPSLEDLFNFC-------SRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPD 134 (296)
T ss_dssp ------------EEETTEEEEEEECCCCBHHHHHHHT-------TTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGG
T ss_pred ------------cCCCCceEEEEEecCCCHHHHHHhh-------ccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHH
Confidence 3456788999999988999988643 346999999999999999999999999999999999
Q ss_pred cEEe----ecCcEEEEecccchhcccCCcc-----ccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHH
Q 003052 630 NFLL----VKGSLKLIDFGIAKAIMSDTTN-----IQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCIL 700 (853)
Q Consensus 630 NILL----~~g~VKL~DFGlAk~~~~~~~~-----~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVIL 700 (853)
|||+ .++.+||+|||+++........ ......+||+.|+|||++.+.. ++.++|||||||++
T Consensus 135 NIl~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---------~~~~~Di~slG~il 205 (296)
T 3uzp_A 135 NFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIE---------QSRRDDLESLGYVL 205 (296)
T ss_dssp GEEECCGGGTTCEEECCCTTCEECBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCC---------CCHHHHHHHHHHHH
T ss_pred HeEEecCCCCCeEEEeeCCCcccccccccccccccccccccccccccCChhhhcCCC---------CCcchhhHHHHHHH
Confidence 9999 3568999999999876543221 1124568999999999997653 56899999999999
Q ss_pred HHHHhCCCCCCcchh------HHHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCCChhHHhc
Q 003052 701 YQMVYGRTPFSEYKT------FWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQ 763 (853)
Q Consensus 701 yELLtG~~PF~~~~~------~~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~ 763 (853)
|+|++|+.||.+... .......... ..........++.+.+||.+||..||.+||++.++++
T Consensus 206 ~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 273 (296)
T 3uzp_A 206 MYFNLGSLPWQGLKAATKRQKYERISEKKMS-TPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ 273 (296)
T ss_dssp HHHHHSSCTTSSCCCSSSSSHHHHHHHHHHH-SCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred HHHHhCCCCCCCcCchhhhhhhhhhcccccC-CchHHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHH
Confidence 999999999975321 1111111100 1111123557889999999999999999999999885
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=355.24 Aligned_cols=265 Identities=17% Similarity=0.213 Sum_probs=196.9
Q ss_pred EcCceeeEEEeEeccCceEEEEEEec----CCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHH
Q 003052 469 VNGKLYQRLGKIGSGGSSEVHKVISS----DCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEK 544 (853)
Q Consensus 469 v~g~~Y~ilk~LG~G~FG~Vyka~~~----~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~ 544 (853)
+..+.|.+.+.||+|+||.||+|... ++..||||+++...........+.+|+.++++++ |+||+++++++....
T Consensus 31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~ 109 (313)
T 3brb_A 31 IDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFS-HPNVIRLLGVCIEMS 109 (313)
T ss_dssp CCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCC-CTTBCCCCEEEEC--
T ss_pred cCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCC-CCCeeeeeEEEeecc
Confidence 44577999999999999999999863 3358999999877666666778999999999997 999999999854321
Q ss_pred HHHHHHhhCCCCCCCCccccCCeEEEEEecch-hhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceee
Q 003052 545 ALLREVLNGSMNNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVH 623 (853)
Q Consensus 545 ~iL~~l~~~~iv~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIH 623 (853)
......+|+||||+. ++|.+++..... ......+++..++.++.||+.||.|||++||+|
T Consensus 110 -----------------~~~~~~~~~v~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH 170 (313)
T 3brb_A 110 -----------------SQGIPKPMVILPFMKYGDLHTYLLYSRL--ETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLH 170 (313)
T ss_dssp ----------------------CEEEEEECCTTCBHHHHHHHTTB--TTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCC
T ss_pred -----------------ccCCcccEEEEecccCCCHHHHHHHhhh--hcCCccCCHHHHHHHHHHHHHHHHHHHhCCccc
Confidence 112235799999977 499988864321 223467999999999999999999999999999
Q ss_pred CCCCCccEEee-cCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHH
Q 003052 624 SDLKPANFLLV-KGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQ 702 (853)
Q Consensus 624 RDLKPeNILL~-~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyE 702 (853)
|||||+|||++ ++.+||+|||+++.+.............|++.|+|||++.+. .|+.++|||||||++|+
T Consensus 171 ~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~---------~~~~~~Di~slG~il~e 241 (313)
T 3brb_A 171 RDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADR---------VYTSKSDVWAFGVTMWE 241 (313)
T ss_dssp CCCSGGGEEECTTSCEEECSCSCC----------------CCGGGSCHHHHHSS---------CCCHHHHHHHHHHHHHH
T ss_pred CCCCcceEEEcCCCcEEEeecCcceecccccccCcccccCCCccccCchhhcCC---------CccchhhhHHHHHHHHH
Confidence 99999999994 569999999999876543322233355688999999999765 35689999999999999
Q ss_pred HHh-CCCCCCcchhHHHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCCChhHHhcC
Q 003052 703 MVY-GRTPFSEYKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQH 764 (853)
Q Consensus 703 LLt-G~~PF~~~~~~~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~H 764 (853)
|++ |..||.+............. .....+...++.+.+||.+||..||.+||++.+++++
T Consensus 242 l~~~g~~p~~~~~~~~~~~~~~~~--~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~ 302 (313)
T 3brb_A 242 IATRGMTPYPGVQNHEMYDYLLHG--HRLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQ 302 (313)
T ss_dssp HHTTSCCSSTTCCGGGHHHHHHTT--CCCCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred HHhcCCCCCccCCHHHHHHHHHcC--CCCCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 999 99999765433222222221 2234456678899999999999999999999999864
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-40 Score=347.97 Aligned_cols=250 Identities=21% Similarity=0.241 Sum_probs=194.1
Q ss_pred CceeeEEEeEeccCceEEEEEEe-cCCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHHH
Q 003052 471 GKLYQRLGKIGSGGSSEVHKVIS-SDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLRE 549 (853)
Q Consensus 471 g~~Y~ilk~LG~G~FG~Vyka~~-~~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~~ 549 (853)
+++|++.+.||+|+||.||+|.+ .+++.||||++...... ..+.+|+.+++++.++++|..+..+
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~e~~~l~~l~~~~~i~~~~~~---------- 73 (296)
T 4hgt_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH----PQLHIESKIYKMMQGGVGIPTIRWC---------- 73 (296)
T ss_dssp ---CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---C----CCHHHHHHHHHHHTTSTTCCCEEEE----------
T ss_pred CCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccccc----hHHHHHHHHHHHhcCCCCCCeeeee----------
Confidence 46799999999999999999998 57789999997654332 3478999999999977666655443
Q ss_pred HhhCCCCCCCCccccCCeEEEEEecchhhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCCCc
Q 003052 550 VLNGSMNNKDGRVKDDGYIYMVLEYGEIDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPA 629 (853)
Q Consensus 550 l~~~~iv~~~g~~~d~~~lyLVmEy~~gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLKPe 629 (853)
+.+...+|+||||++++|.+++... ...+++..++.++.||+.||.|||++||+||||||+
T Consensus 74 ------------~~~~~~~~lv~e~~~~~L~~~~~~~-------~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~ 134 (296)
T 4hgt_A 74 ------------GAEGDYNVMVMELLGPSLEDLFNFC-------SRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPD 134 (296)
T ss_dssp ------------EEETTEEEEEEECCCCBHHHHHHHT-------TSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGG
T ss_pred ------------cCCCCceEEEEEccCCCHHHHHHHh-------cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHH
Confidence 3566788999999988999988753 356999999999999999999999999999999999
Q ss_pred cEEe----ecCcEEEEecccchhcccCCcc-----ccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHH
Q 003052 630 NFLL----VKGSLKLIDFGIAKAIMSDTTN-----IQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCIL 700 (853)
Q Consensus 630 NILL----~~g~VKL~DFGlAk~~~~~~~~-----~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVIL 700 (853)
|||+ .++.+||+|||+++........ ......+||+.|+|||++.+.. ++.++|||||||++
T Consensus 135 NIl~~~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---------~~~~~Di~slG~il 205 (296)
T 4hgt_A 135 NFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIE---------QSRRDDLESLGYVL 205 (296)
T ss_dssp GEEECCGGGTTCEEECCCTTCEECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCC---------CCHHHHHHHHHHHH
T ss_pred HeeeeccCCCCeEEEecCccceeccCcccCccCCCCcccccCCCccccchHHhcCCC---------CCchhHHHHHHHHH
Confidence 9999 3468999999999876543221 1223568999999999997653 56899999999999
Q ss_pred HHHHhCCCCCCcchh------HHHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCCChhHHhc
Q 003052 701 YQMVYGRTPFSEYKT------FWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQ 763 (853)
Q Consensus 701 yELLtG~~PF~~~~~------~~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~ 763 (853)
|+|++|+.||.+... ......... ...........++++.+||.+||..||.+||++.++++
T Consensus 206 ~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~ 273 (296)
T 4hgt_A 206 MYFNLGSLPWQGLKAATKRQKYERISEKKM-STPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ 273 (296)
T ss_dssp HHHHHSSCTTSSCCCSSSSSHHHHHHHHHH-HSCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred HHHhcCCCCCcccchhhhhhhhhhhhcccc-cchhhhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHH
Confidence 999999999965321 111111100 01111122456789999999999999999999999985
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-40 Score=349.12 Aligned_cols=252 Identities=20% Similarity=0.352 Sum_probs=205.5
Q ss_pred EEcCceeeEEEeEeccCceEEEEEEec-CCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHH
Q 003052 468 KVNGKLYQRLGKIGSGGSSEVHKVISS-DCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKAL 546 (853)
Q Consensus 468 ~v~g~~Y~ilk~LG~G~FG~Vyka~~~-~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~i 546 (853)
.+....|++.+.||+|+||.||+|.+. ++..||+|++.... .....+.+|+.++++++ |+||++++++
T Consensus 9 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~E~~~l~~l~-h~~i~~~~~~------- 77 (288)
T 3kfa_A 9 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT---MEVEEFLKEAAVMKEIK-HPNLVQLLGV------- 77 (288)
T ss_dssp BCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCS---THHHHHHHHHHHHHHCC-CTTBCCEEEE-------
T ss_pred cccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCH---HHHHHHHHHHHHHHhCC-CCCEeeEEEE-------
Confidence 455678999999999999999999985 57889999997543 23456889999999998 8999999987
Q ss_pred HHHHhhCCCCCCCCccccCCeEEEEEecch-hhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCC
Q 003052 547 LREVLNGSMNNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSD 625 (853)
Q Consensus 547 L~~l~~~~iv~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRD 625 (853)
+.++..+|+||||+. ++|.+++... ....+++..++.++.||+.||.|||++||+|||
T Consensus 78 ---------------~~~~~~~~~v~e~~~~~~L~~~~~~~------~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~d 136 (288)
T 3kfa_A 78 ---------------CTREPPFYIITEFMTYGNLLDYLREC------NRQEVSAVVLLYMATQISSAMEYLEKKNFIHRD 136 (288)
T ss_dssp ---------------ECSSSSEEEEEECCTTEEHHHHHHHC------CTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSC
T ss_pred ---------------EccCCCEEEEEEcCCCCcHHHHHHhc------ccCCccHhHHHHHHHHHHHHHHHHHHCCccCCC
Confidence 455677999999987 6999988764 335699999999999999999999999999999
Q ss_pred CCCccEEe-ecCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHH
Q 003052 626 LKPANFLL-VKGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMV 704 (853)
Q Consensus 626 LKPeNILL-~~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELL 704 (853)
|||+|||+ .++.+||+|||+++....... .......||+.|+|||++.+.. ++.++|||||||++|+|+
T Consensus 137 ikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~---------~~~~~Di~slG~il~~ll 206 (288)
T 3kfa_A 137 LAARNCLVGENHLVKVADFGLSRLMTGDTY-TAHAGAKFPIKWTAPESLAYNK---------FSIKSDVWAFGVLLWEIA 206 (288)
T ss_dssp CSGGGEEECGGGCEEECCCCGGGTSCSSSS-EEETTEEECGGGCCHHHHHHCC---------CCHHHHHHHHHHHHHHHH
T ss_pred CCcceEEEcCCCCEEEccCccceeccCCcc-ccccCCccccCcCChhhhccCC---------CCchhhHHHHHHHHHHHH
Confidence 99999999 567899999999987654322 2233556789999999997653 568999999999999999
Q ss_pred h-CCCCCCcchhHHHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCCChhHHhc
Q 003052 705 Y-GRTPFSEYKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQ 763 (853)
Q Consensus 705 t-G~~PF~~~~~~~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~ 763 (853)
+ |..||.+....... ..+.. ......+...++.+.+||.+||..||.+||++.++++
T Consensus 207 ~~g~~p~~~~~~~~~~-~~~~~-~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~ 264 (288)
T 3kfa_A 207 TYGMSPYPGIDLSQVY-ELLEK-DYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ 264 (288)
T ss_dssp TTSCCSSTTCCGGGHH-HHHHT-TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred hCCCCCCCCCCHHHHH-HHHhc-cCCCCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHH
Confidence 9 99999764332211 12211 2233445677889999999999999999999999985
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=363.43 Aligned_cols=268 Identities=16% Similarity=0.167 Sum_probs=204.4
Q ss_pred eeEEcCceeeEEEeEeccCceEEEEEEecC---------CcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEe
Q 003052 466 FFKVNGKLYQRLGKIGSGGSSEVHKVISSD---------CTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQL 536 (853)
Q Consensus 466 ~~~v~g~~Y~ilk~LG~G~FG~Vyka~~~~---------g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~L 536 (853)
+....++.|++.+.||+|+||.||+|.+.. ++.||||++... ..+.+|++++++++ |+||+++
T Consensus 36 i~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-------~~~~~E~~~l~~l~-h~niv~~ 107 (352)
T 2jii_A 36 LTDKSGRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-------GRLFNEQNFFQRAA-KPLQVNK 107 (352)
T ss_dssp EECTTSCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-------STHHHHHHHHHHHC-CHHHHHH
T ss_pred eecccCCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-------chHHHHHHHHHHhc-ccchhhh
Confidence 334557889999999999999999999853 788999999854 25789999999997 8999987
Q ss_pred eehhhhHHHHHHHHhhCCCCCCCCcccc-CCeEEEEEecchhhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhh
Q 003052 537 IDYEVTEKALLREVLNGSMNNKDGRVKD-DGYIYMVLEYGEIDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNT 615 (853)
Q Consensus 537 id~~~~e~~iL~~l~~~~iv~~~g~~~d-~~~lyLVmEy~~gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~y 615 (853)
++.... .....+..+.+.+.. +..+|+||||++++|.+++... ....+++..++.|+.||+.||.|
T Consensus 108 ~~~~~~-------~~~~~i~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~------~~~~l~~~~~~~i~~qi~~~L~~ 174 (352)
T 2jii_A 108 WKKLYS-------TPLLAIPTCMGFGVHQDKYRFLVLPSLGRSLQSALDVS------PKHVLSERSVLQVACRLLDALEF 174 (352)
T ss_dssp HHHHTT-------CTTCSCCCCCEEEEETTTEEEEEEECCCEEHHHHHHHS------GGGCCCHHHHHHHHHHHHHHHHH
T ss_pred hhhhcc-------CCccCccchhhccccCCcEEEEEecCCCcCHHHHHHhC------CcCCCCHHHHHHHHHHHHHHHHH
Confidence 654211 112234445555544 7899999999988999999753 12579999999999999999999
Q ss_pred cccCceeeCCCCCccEEeecC---cEEEEecccchhcccCCcc-----ccccccccCccccCchhhccCCCCCCCccccC
Q 003052 616 IHEERIVHSDLKPANFLLVKG---SLKLIDFGIAKAIMSDTTN-----IQRDSQVGTLSYMSPEAFMCNESDENGNIIKC 687 (853)
Q Consensus 616 LHs~gIIHRDLKPeNILL~~g---~VKL~DFGlAk~~~~~~~~-----~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~y 687 (853)
||++||+||||||+|||++.+ .+||+|||+++.+...... .......||+.|+|||++.+. .+
T Consensus 175 LH~~~ivH~Dikp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---------~~ 245 (352)
T 2jii_A 175 LHENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGC---------GP 245 (352)
T ss_dssp HHHTTCBCSCCCGGGEEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTC---------CC
T ss_pred HHhCCccCCCCCHHHEEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccC---------CC
Confidence 999999999999999999644 7999999999876432211 112345899999999999765 35
Q ss_pred CCccchhhhHHHHHHHHhCCCCCCcch-hH---HHHHHhhcCCCCcccC----CCCCChhHHHHHHHhcccCCCCCCChh
Q 003052 688 GRPSDIWSLGCILYQMVYGRTPFSEYK-TF---WAKFKVITDPNHEITY----EPVPNPWLLDLMKKCLAWDRNERWRIP 759 (853)
Q Consensus 688 s~ksDIWSLGVILyELLtG~~PF~~~~-~~---~~~~kii~~~~~~~~~----~~~~s~~l~dLI~kcL~~DP~kRpTa~ 759 (853)
+.++|||||||++|+|++|+.||.... .. ......+......+.. ....++.+.+||.+||..||.+||++.
T Consensus 246 ~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ 325 (352)
T 2jii_A 246 SRRSDLQSLGYCMLKWLYGFLPWTNCLPNTEDIMKQKQKFVDKPGPFVGPCGHWIRPSETLQKYLKVVMALTYEEKPPYA 325 (352)
T ss_dssp CHHHHHHHHHHHHHHHHHSCCTTGGGTTCHHHHHHHHHHHHHSCCCEECTTSCEECCCHHHHHHHHHHHTCCTTCCCCHH
T ss_pred CchhhHHHHHHHHHHHHhCCCCcccCCcCHHHHHHHHHhccCChhhhhhhccccCCCcHHHHHHHHHHHhCChhhCCCHH
Confidence 689999999999999999999997643 11 1111111111111111 124578999999999999999999999
Q ss_pred HHhc
Q 003052 760 QLLQ 763 (853)
Q Consensus 760 EIL~ 763 (853)
+|++
T Consensus 326 ~l~~ 329 (352)
T 2jii_A 326 MLRN 329 (352)
T ss_dssp HHHH
T ss_pred HHHH
Confidence 9985
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-41 Score=361.29 Aligned_cols=252 Identities=19% Similarity=0.298 Sum_probs=197.2
Q ss_pred cCceeeEEEeEeccCceEEEEEEec-CCcE----EEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHH
Q 003052 470 NGKLYQRLGKIGSGGSSEVHKVISS-DCTI----YALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEK 544 (853)
Q Consensus 470 ~g~~Y~ilk~LG~G~FG~Vyka~~~-~g~~----vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~ 544 (853)
...+|++++.||+|+||.||+|.+. ++.. ||+|.+..... ......+.+|+.++++++ |+||+++++++
T Consensus 11 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~-~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~---- 84 (325)
T 3kex_A 11 KETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSG-RQSFQAVTDHMLAIGSLD-HAHIVRLLGLC---- 84 (325)
T ss_dssp CTTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTS-CSCBCSCCHHHHHHHTCC-CTTBCCEEEEE----
T ss_pred CHhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEecccccc-HHHHHHHHHHHHHHhcCC-CCCcCeEEEEE----
Confidence 3467999999999999999999974 4443 77777754322 233345778999999997 99999999863
Q ss_pred HHHHHHhhCCCCCCCCccccCCeEEEEEecch-hhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceee
Q 003052 545 ALLREVLNGSMNNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVH 623 (853)
Q Consensus 545 ~iL~~l~~~~iv~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIH 623 (853)
. +..+|+||||+. ++|.+++... ...+++..++.|+.||+.||.|||++||+|
T Consensus 85 ------------------~-~~~~~~v~e~~~~~~L~~~l~~~-------~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH 138 (325)
T 3kex_A 85 ------------------P-GSSLQLVTQYLPLGSLLDHVRQH-------RGALGPQLLLNWGVQIAKGMYYLEEHGMVH 138 (325)
T ss_dssp ------------------C-BSSEEEEEECCTTCBSHHHHHSS-------GGGSCTTHHHHHHHHHHHHHHHHHHTTCCC
T ss_pred ------------------c-CCccEEEEEeCCCCCHHHHHHHc-------cccCCHHHHHHHHHHHHHHHHHHHhCCCCC
Confidence 2 345899999976 6888887643 246899999999999999999999999999
Q ss_pred CCCCCccEEe-ecCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHH
Q 003052 624 SDLKPANFLL-VKGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQ 702 (853)
Q Consensus 624 RDLKPeNILL-~~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyE 702 (853)
|||||+|||+ .++.+||+|||+|+.+.............||+.|+|||++.+.. |+.++|||||||++|+
T Consensus 139 ~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~---------~~~~~Di~slG~~l~e 209 (325)
T 3kex_A 139 RNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFGK---------YTHQSDVWSYGVTVWE 209 (325)
T ss_dssp SCCSSTTEEESSSSCEEECSCSGGGGSCCCTTCCC-----CCTTTSCHHHHHHCC---------CCHHHHHHHHHHHHHH
T ss_pred CccchheEEECCCCeEEECCCCcccccCcccccccccCCCCcccccChHHhccCC---------CChhhHhHHhHHHHHH
Confidence 9999999999 56799999999999875544433345667889999999997653 5689999999999999
Q ss_pred HHh-CCCCCCcchhHHHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCCChhHHhcC
Q 003052 703 MVY-GRTPFSEYKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQH 764 (853)
Q Consensus 703 LLt-G~~PF~~~~~~~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~H 764 (853)
|++ |+.||.+....... ..+.. ......+...+..+.+||.+||..||.+||++.++++|
T Consensus 210 l~~~g~~p~~~~~~~~~~-~~~~~-~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~ 270 (325)
T 3kex_A 210 LMTFGAEPYAGLRLAEVP-DLLEK-GERLAQPQICTIDVYMVMVKCWMIDENIRPTFKELANE 270 (325)
T ss_dssp HHTTSCCTTTTSCTTHHH-HHHHT-TCBCCCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHH
T ss_pred HHhCCCCCccccCHHHHH-HHHHc-CCCCCCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 999 99999765432222 22221 22334455677889999999999999999999999987
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=349.96 Aligned_cols=247 Identities=18% Similarity=0.312 Sum_probs=196.9
Q ss_pred EEcCceeeEEEeEeccCceEEEEEEec-CC-------cEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeeh
Q 003052 468 KVNGKLYQRLGKIGSGGSSEVHKVISS-DC-------TIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDY 539 (853)
Q Consensus 468 ~v~g~~Y~ilk~LG~G~FG~Vyka~~~-~g-------~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~ 539 (853)
++..++|++.+.||+|+||.||+|.+. ++ ..||+|++..... .....+.+|+.++++++ |+||++++++
T Consensus 4 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~--~~~~~~~~E~~~l~~l~-h~~iv~~~~~ 80 (289)
T 4fvq_A 4 KIRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHR--NYSESFFEAASMMSKLS-HKHLVLNYGV 80 (289)
T ss_dssp BCCGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGG--GGHHHHHHHHHHHHTSC-CTTBCCEEEE
T ss_pred EechhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccH--HHHHHHHHHHHHHHhCC-CCCEeEEEEE
Confidence 456678999999999999999999874 33 4699999975432 34456889999999998 9999999987
Q ss_pred hhhHHHHHHHHhhCCCCCCCCccccCCeEEEEEecch-hhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhccc
Q 003052 540 EVTEKALLREVLNGSMNNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHE 618 (853)
Q Consensus 540 ~~~e~~iL~~l~~~~iv~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs 618 (853)
+.+++.+|+||||+. ++|.+++... ...+++.+++.++.||+.||.|||+
T Consensus 81 ----------------------~~~~~~~~lv~e~~~~~~L~~~l~~~-------~~~~~~~~~~~i~~qi~~~L~~LH~ 131 (289)
T 4fvq_A 81 ----------------------CVCGDENILVQEFVKFGSLDTYLKKN-------KNCINILWKLEVAKQLAAAMHFLEE 131 (289)
T ss_dssp ----------------------ECCTTCCEEEEECCTTCBHHHHHHHT-------GGGCCHHHHHHHHHHHHHHHHHHHH
T ss_pred ----------------------EEeCCCCEEEEECCCCCCHHHHHHhC-------CCCCCHHHHHHHHHHHHHHHHHHhh
Confidence 345567799999987 5999998764 2348999999999999999999999
Q ss_pred CceeeCCCCCccEEee-cCc--------EEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCC
Q 003052 619 ERIVHSDLKPANFLLV-KGS--------LKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGR 689 (853)
Q Consensus 619 ~gIIHRDLKPeNILL~-~g~--------VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ 689 (853)
+||+||||||+|||++ ++. +||+|||++...... ....||+.|+|||++.+.. .++.
T Consensus 132 ~~ivH~Dlkp~NIll~~~~~~~~~~~~~~kl~Dfg~~~~~~~~------~~~~~~~~y~aPE~~~~~~--------~~~~ 197 (289)
T 4fvq_A 132 NTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPK------DILQERIPWVPPECIENPK--------NLNL 197 (289)
T ss_dssp TTCCCCCCCGGGEEEEECCBGGGTBCCEEEECCCCSCTTTSCH------HHHHHTTTTSCHHHHHCGG--------GCCH
T ss_pred CCeECCCcCcceEEEecCCcccccccceeeeccCcccccccCc------cccCCcCcccCHHHhCCCC--------CCCc
Confidence 9999999999999994 444 999999999765321 2457899999999997521 4678
Q ss_pred ccchhhhHHHHHHHHhC-CCCCCcchhHHHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCCChhHHhcC
Q 003052 690 PSDIWSLGCILYQMVYG-RTPFSEYKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQH 764 (853)
Q Consensus 690 ksDIWSLGVILyELLtG-~~PF~~~~~~~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~H 764 (853)
++|||||||++|+|++| .+||...... ........ ....+...++++.+||.+||..||.+|||+.++++|
T Consensus 198 ~~DiwslG~il~el~~g~~~~~~~~~~~-~~~~~~~~---~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 269 (289)
T 4fvq_A 198 ATDKWSFGTTLWEICSGGDKPLSALDSQ-RKLQFYED---RHQLPAPKAAELANLINNCMDYEPDHRPSFRAIIRD 269 (289)
T ss_dssp HHHHHHHHHHHHHHHTTTCCTTTTSCHH-HHHHHHHT---TCCCCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred hhHHHHHHHHHHHHHcCCCCCccccchH-HHHHHhhc---cCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 99999999999999995 5555443332 22222221 223344557789999999999999999999999987
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-40 Score=347.21 Aligned_cols=261 Identities=24% Similarity=0.386 Sum_probs=204.6
Q ss_pred CceeeEEEeEeccCceEEEEEEec-CCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHHH
Q 003052 471 GKLYQRLGKIGSGGSSEVHKVISS-DCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLRE 549 (853)
Q Consensus 471 g~~Y~ilk~LG~G~FG~Vyka~~~-~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~~ 549 (853)
+..|++++.||+|+||.||+|.+. +++.||+|++.... ..+.+|++++++++ |+||+++++++.....
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~---- 78 (284)
T 2a19_B 10 GMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN------EKAEREVKALAKLD-HVNIVHYNGCWDGFDY---- 78 (284)
T ss_dssp HHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS------GGGHHHHHHHHHCC-CTTBCCEEEEEEEEEE----
T ss_pred ccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc------HHHHHHHHHHHhCC-CCCEEEEeeeEecccc----
Confidence 356999999999999999999985 78999999998653 24678999999997 9999999987432000
Q ss_pred HhhCCCCCCCCccccCCeEEEEEecchh-hHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCCC
Q 003052 550 VLNGSMNNKDGRVKDDGYIYMVLEYGEI-DLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKP 628 (853)
Q Consensus 550 l~~~~iv~~~g~~~d~~~lyLVmEy~~g-dL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLKP 628 (853)
.+..............+|+||||+++ +|.+++... ....+++..++.++.||+.||.|||++||+||||||
T Consensus 79 --~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~------~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp 150 (284)
T 2a19_B 79 --DPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKR------RGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKP 150 (284)
T ss_dssp --C---------CCEEEEEEEEECCCCSCBHHHHHHHG------GGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSG
T ss_pred --CcccccccccccCcceEEEEEeccCCCCHHHHHhhc------cCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCH
Confidence 00000111122345679999999875 999998764 235799999999999999999999999999999999
Q ss_pred ccEEe-ecCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHhCC
Q 003052 629 ANFLL-VKGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGR 707 (853)
Q Consensus 629 eNILL-~~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLtG~ 707 (853)
+|||+ .++.+||+|||+++....... .....||+.|+|||++.+.. ++.++|||||||++|+|++|.
T Consensus 151 ~Nil~~~~~~~kl~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~---------~~~~~Di~slG~il~~l~~~~ 218 (284)
T 2a19_B 151 SNIFLVDTKQVKIGDFGLVTSLKNDGK---RTRSKGTLRYMSPEQISSQD---------YGKEVDLYALGLILAELLHVC 218 (284)
T ss_dssp GGEEEEETTEEEECCCTTCEESSCCSC---CCCCCSCCTTSCHHHHHCSC---------CCTHHHHHHHHHHHHHHHSCC
T ss_pred HHEEEcCCCCEEECcchhheecccccc---ccccCCcccccChhhhccCC---------CcchhhhHHHHHHHHHHHhcC
Confidence 99999 567999999999987654322 23568999999999997653 568999999999999999999
Q ss_pred CCCCcchhHHHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCCChhHHhcCCCCCC
Q 003052 708 TPFSEYKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQHPFLVP 769 (853)
Q Consensus 708 ~PF~~~~~~~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~HPwf~~ 769 (853)
.||......... +... ..+...+..+.+||.+||..||.+||++.|+++|.|...
T Consensus 219 ~~~~~~~~~~~~---~~~~----~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~ 273 (284)
T 2a19_B 219 DTAFETSKFFTD---LRDG----IISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWK 273 (284)
T ss_dssp SSHHHHHHHHHH---HHTT----CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHT
T ss_pred CcchhHHHHHHH---hhcc----cccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHh
Confidence 998654333222 2211 234557788999999999999999999999999987643
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-40 Score=350.84 Aligned_cols=251 Identities=25% Similarity=0.343 Sum_probs=194.7
Q ss_pred ceeeEEEeEeccCceEEEEEEec-CCcEEEEEEEecCCC-ChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHHH
Q 003052 472 KLYQRLGKIGSGGSSEVHKVISS-DCTIYALKKIKLKGR-DYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLRE 549 (853)
Q Consensus 472 ~~Y~ilk~LG~G~FG~Vyka~~~-~g~~vAVKkik~~~~-~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~~ 549 (853)
+.|++.+.||+|+||.||+|.+. +++.||||++..... +......+.+|+.++++++ |+||++++++
T Consensus 34 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-hp~iv~~~~~---------- 102 (309)
T 2h34_A 34 GPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQ-EPHVVPIHDF---------- 102 (309)
T ss_dssp CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCC-CTTBCCEEEE----------
T ss_pred ccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcC-CCCeeEEEEE----------
Confidence 46999999999999999999984 678999999976533 3334567889999999997 8999999987
Q ss_pred HhhCCCCCCCCccccCCeEEEEEecch-hhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCCC
Q 003052 550 VLNGSMNNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKP 628 (853)
Q Consensus 550 l~~~~iv~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLKP 628 (853)
+.+++.+|+||||+. ++|.+++... ..+++..++.++.||+.||.|||++||+||||||
T Consensus 103 ------------~~~~~~~~lv~e~~~~~~L~~~l~~~--------~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp 162 (309)
T 2h34_A 103 ------------GEIDGQLYVDMRLINGVDLAAMLRRQ--------GPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKP 162 (309)
T ss_dssp ------------EEETTEEEEEEECCCCEEHHHHHHHH--------CSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCG
T ss_pred ------------EeeCCeEEEEEEecCCCCHHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCCh
Confidence 455678999999986 4999988764 4699999999999999999999999999999999
Q ss_pred ccEEe-ecCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHhCC
Q 003052 629 ANFLL-VKGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGR 707 (853)
Q Consensus 629 eNILL-~~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLtG~ 707 (853)
+|||+ .++.+||+|||++........ ......+||+.|+|||++.+. .++.++|||||||++|+|++|+
T Consensus 163 ~NIl~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~---------~~~~~~Di~slG~il~~l~~g~ 232 (309)
T 2h34_A 163 ENILVSADDFAYLVDFGIASATTDEKL-TQLGNTVGTLYYMAPERFSES---------HATYRADIYALTCVLYECLTGS 232 (309)
T ss_dssp GGEEECTTSCEEECSCCC-----------------CCGGGCCGGGTCC-------------CCCHHHHHHHHHHHHHHSS
T ss_pred HHEEEcCCCCEEEecCccCcccccccc-ccccccCCCcCccCHHHHcCC---------CCCchHhHHHHHHHHHHHHHCC
Confidence 99999 467999999999986643221 122356899999999999754 3567999999999999999999
Q ss_pred CCCCcchhHHHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCC-ChhHHhc
Q 003052 708 TPFSEYKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERW-RIPQLLQ 763 (853)
Q Consensus 708 ~PF~~~~~~~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRp-Ta~EIL~ 763 (853)
.||.+.........+..............++++.+||.+||..||.+|| ++.++++
T Consensus 233 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~ 289 (309)
T 2h34_A 233 PPYQGDQLSVMGAHINQAIPRPSTVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSA 289 (309)
T ss_dssp CSSCSCHHHHHHHHHHSCCCCGGGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHH
T ss_pred CCCCCchHHHHHHHhccCCCCccccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHH
Confidence 9998755442222222222223344567788999999999999999999 7887774
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-40 Score=346.87 Aligned_cols=254 Identities=21% Similarity=0.303 Sum_probs=203.5
Q ss_pred cCceeeEEE-eEeccCceEEEEEEec---CCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHH
Q 003052 470 NGKLYQRLG-KIGSGGSSEVHKVISS---DCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKA 545 (853)
Q Consensus 470 ~g~~Y~ilk-~LG~G~FG~Vyka~~~---~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~ 545 (853)
..+.|.+++ .||+|+||.||+|.+. ++..||||+++... .......+.+|+++|++++ |+||+++++++
T Consensus 7 ~~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~----- 79 (287)
T 1u59_A 7 KRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT-EKADTEEMMREAQIMHQLD-NPYIVRLIGVC----- 79 (287)
T ss_dssp CGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSC-CHHHHHHHHHHHHHHHHCC-CTTBCCEEEEE-----
T ss_pred cHHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCcc-chhHHHHHHHHHHHHHhCC-CCCEeEEEEEe-----
Confidence 345677877 9999999999999863 56789999998653 3455667899999999996 99999999873
Q ss_pred HHHHHhhCCCCCCCCccccCCeEEEEEecchh-hHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeC
Q 003052 546 LLREVLNGSMNNKDGRVKDDGYIYMVLEYGEI-DLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHS 624 (853)
Q Consensus 546 iL~~l~~~~iv~~~g~~~d~~~lyLVmEy~~g-dL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHR 624 (853)
....+|+||||+++ +|.+++... ...+++..++.++.||+.||.|||++||+||
T Consensus 80 ------------------~~~~~~lv~e~~~~~~L~~~l~~~-------~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~ 134 (287)
T 1u59_A 80 ------------------QAEALMLVMEMAGGGPLHKFLVGK-------REEIPVSNVAELLHQVSMGMKYLEEKNFVHR 134 (287)
T ss_dssp ------------------ESSSEEEEEECCTTEEHHHHHTTC-------TTTSCHHHHHHHHHHHHHHHHHHHHTTEECC
T ss_pred ------------------cCCCcEEEEEeCCCCCHHHHHHhC-------CccCCHHHHHHHHHHHHHHHHHHHHCCEeeC
Confidence 23458999999865 888887542 3569999999999999999999999999999
Q ss_pred CCCCccEEe-ecCcEEEEecccchhcccCCcc-ccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHH
Q 003052 625 DLKPANFLL-VKGSLKLIDFGIAKAIMSDTTN-IQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQ 702 (853)
Q Consensus 625 DLKPeNILL-~~g~VKL~DFGlAk~~~~~~~~-~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyE 702 (853)
||||+|||+ .++.+||+|||+++........ .......||+.|+|||++.+. .++.++|||||||++|+
T Consensus 135 dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~---------~~~~~~Di~slG~il~e 205 (287)
T 1u59_A 135 DLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFR---------KFSSRSDVWSYGVTMWE 205 (287)
T ss_dssp CCSGGGEEEEETTEEEECCCTTCEECTTCSCEECCCCSSCCCGGGCCHHHHHHC---------EECHHHHHHHHHHHHHH
T ss_pred CCchheEEEcCCCCEEECcccceeeeccCcceeeccccccccccccCHHHhccC---------CCCchhhHHHHHHHHHH
Confidence 999999999 5679999999999876433221 112345678999999999754 36789999999999999
Q ss_pred HHh-CCCCCCcchhHHHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCCChhHHhcCCC
Q 003052 703 MVY-GRTPFSEYKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQHPF 766 (853)
Q Consensus 703 LLt-G~~PF~~~~~~~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~HPw 766 (853)
|++ |+.||.+.........+.. ......+...++.+.+||.+||..||.+||++.++++|.|
T Consensus 206 llt~g~~p~~~~~~~~~~~~i~~--~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~ 268 (287)
T 1u59_A 206 ALSYGQKPYKKMKGPEVMAFIEQ--GKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMR 268 (287)
T ss_dssp HHTTSCCTTTTCCTHHHHHHHHT--TCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHH
T ss_pred HHcCCCCCcccCCHHHHHHHHhc--CCcCCCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence 998 9999976544332222222 2223455678899999999999999999999999998744
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=344.92 Aligned_cols=255 Identities=22% Similarity=0.315 Sum_probs=199.6
Q ss_pred cCceeeEEEeEeccCceEEEEEEe-----cCCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHH
Q 003052 470 NGKLYQRLGKIGSGGSSEVHKVIS-----SDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEK 544 (853)
Q Consensus 470 ~g~~Y~ilk~LG~G~FG~Vyka~~-----~~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~ 544 (853)
..+.|+++++||+|+||.||+|.. .+++.||||++..... ......+.+|+.+|++++ |+||+++++++..
T Consensus 19 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~-- 94 (302)
T 4e5w_A 19 EKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESG-GNHIADLKKEIEILRNLY-HENIVKYKGICTE-- 94 (302)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC------CCHHHHHHHHHHHHTCC-CTTBCCEEEEEEC--
T ss_pred hhhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEeccccc-chhHHHHHHHHHHHHhCC-CCCeeeeeeEEec--
Confidence 346799999999999999999983 4678999999976542 233456889999999997 8999999987432
Q ss_pred HHHHHHhhCCCCCCCCccccCCeEEEEEecchh-hHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceee
Q 003052 545 ALLREVLNGSMNNKDGRVKDDGYIYMVLEYGEI-DLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVH 623 (853)
Q Consensus 545 ~iL~~l~~~~iv~~~g~~~d~~~lyLVmEy~~g-dL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIH 623 (853)
.+...+|+||||+++ +|.+++... ...+++..++.++.||+.||.|||++||+|
T Consensus 95 ------------------~~~~~~~lv~e~~~~~~L~~~l~~~-------~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H 149 (302)
T 4e5w_A 95 ------------------DGGNGIKLIMEFLPSGSLKEYLPKN-------KNKINLKQQLKYAVQICKGMDYLGSRQYVH 149 (302)
T ss_dssp ---------------------CCEEEEEECCTTCBHHHHHHHH-------TTTCCHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred ------------------CCCceEEEEEEeCCCCcHHHHHHhc-------cccCCHHHHHHHHHHHHHHHHHhhcCCccc
Confidence 123568999999864 999988654 246999999999999999999999999999
Q ss_pred CCCCCccEEe-ecCcEEEEecccchhcccCCcc-ccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHH
Q 003052 624 SDLKPANFLL-VKGSLKLIDFGIAKAIMSDTTN-IQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILY 701 (853)
Q Consensus 624 RDLKPeNILL-~~g~VKL~DFGlAk~~~~~~~~-~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILy 701 (853)
|||||+|||+ .++.+||+|||+++........ .......||+.|+|||++.+. .++.++|||||||++|
T Consensus 150 ~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~---------~~~~~~Di~slG~il~ 220 (302)
T 4e5w_A 150 RDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQS---------KFYIASDVWSFGVTLH 220 (302)
T ss_dssp SCCSGGGEEEEETTEEEECCCTTCEECCTTCCEEECCCCTTCCGGGCCHHHHHHC---------EEEHHHHHHHHHHHHH
T ss_pred CCCchheEEEcCCCCEEECcccccccccCCCcceeccCCCCCCccccCCeeecCC---------CCCcchhHHHHHHHHH
Confidence 9999999999 5779999999999876543221 223356789999999999765 3567999999999999
Q ss_pred HHHhCCCCCCcch--------------hHHHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCCChhHHhc
Q 003052 702 QMVYGRTPFSEYK--------------TFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQ 763 (853)
Q Consensus 702 ELLtG~~PF~~~~--------------~~~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~ 763 (853)
+|++|..||.... ........+.. ......+...++.+.+||.+||..||.+|||+.++++
T Consensus 221 ~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 295 (302)
T 4e5w_A 221 ELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTLKE-GKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIE 295 (302)
T ss_dssp HHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHHHHHHT-TCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHH
T ss_pred HHHHccCCCcchhhHHhhccCCcccccCHHHHHHHHhc-cCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHH
Confidence 9999999874321 11122222221 2233455678899999999999999999999999985
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-40 Score=344.94 Aligned_cols=252 Identities=24% Similarity=0.314 Sum_probs=203.1
Q ss_pred eEEcCceeeEEEeEeccCceEEEEEEecCCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHH
Q 003052 467 FKVNGKLYQRLGKIGSGGSSEVHKVISSDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKAL 546 (853)
Q Consensus 467 ~~v~g~~Y~ilk~LG~G~FG~Vyka~~~~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~i 546 (853)
+.+..+.|++++.||+|+||.||+|.+.++..||||++...... ...+.+|+++|++++ |+||+++++++
T Consensus 8 ~~v~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~-h~~i~~~~~~~------ 77 (279)
T 1qpc_A 8 WEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS---PDAFLAEANLMKQLQ-HQRLVRLYAVV------ 77 (279)
T ss_dssp TBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSSC---HHHHHHHHHHHHHCC-CTTBCCEEEEE------
T ss_pred cccCHHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCccc---HHHHHHHHHHHHhCC-CcCcceEEEEE------
Confidence 45566889999999999999999999988888999999765433 346889999999996 89999999863
Q ss_pred HHHHhhCCCCCCCCccccCCeEEEEEecch-hhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCC
Q 003052 547 LREVLNGSMNNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSD 625 (853)
Q Consensus 547 L~~l~~~~iv~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRD 625 (853)
. .+.+|+||||+. ++|.+++.... ...+++..++.++.||+.||.|||++||+|||
T Consensus 78 ----------------~-~~~~~~v~e~~~~~~L~~~l~~~~------~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~d 134 (279)
T 1qpc_A 78 ----------------T-QEPIYIITEYMENGSLVDFLKTPS------GIKLTINKLLDMAAQIAEGMAFIEERNYIHRD 134 (279)
T ss_dssp ----------------C-SSSCEEEEECCTTCBHHHHTTSHH------HHTCCHHHHHHHHHHHHHHHHHHHHTTEECSC
T ss_pred ----------------c-CCCcEEEEecCCCCCHHHHHhcCC------CCCCCHHHHHHHHHHHHHHHHHHHHCCeeccC
Confidence 1 234799999985 69998886431 13689999999999999999999999999999
Q ss_pred CCCccEEee-cCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHH
Q 003052 626 LKPANFLLV-KGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMV 704 (853)
Q Consensus 626 LKPeNILL~-~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELL 704 (853)
|||+|||++ ++.+||+|||+++....... .......|++.|+|||++.+. .++.++|||||||++|+|+
T Consensus 135 ikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~---------~~~~~~Di~slG~il~el~ 204 (279)
T 1qpc_A 135 LRAANILVSDTLSCKIADFGLARLIEDNEY-TAREGAKFPIKWTAPEAINYG---------TFTIKSDVWSFGILLTEIV 204 (279)
T ss_dssp CSGGGEEECTTSCEEECCCTTCEECSSSCE-ECCTTCCCCTTTSCHHHHHHC---------EECHHHHHHHHHHHHHHHH
T ss_pred CCHhhEEEcCCCCEEECCCcccccccCccc-ccccCCCCccCccChhhhccC---------CCCchhhhHHHHHHHHHHH
Confidence 999999994 56999999999987643221 122345678899999999754 3568999999999999999
Q ss_pred h-CCCCCCcchhHHHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCCChhHHhc
Q 003052 705 Y-GRTPFSEYKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQ 763 (853)
Q Consensus 705 t-G~~PF~~~~~~~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~ 763 (853)
+ |+.||.+.........+.. ......+...+.++.+||.+||..||.+||++.++++
T Consensus 205 ~~g~~p~~~~~~~~~~~~~~~--~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 262 (279)
T 1qpc_A 205 THGRIPYPGMTNPEVIQNLER--GYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRS 262 (279)
T ss_dssp TTTCCSSTTCCHHHHHHHHHT--TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred hCCCCCCcccCHHHHHHHHhc--ccCCCCcccccHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 9 9999977554332222222 1223345567889999999999999999999999885
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-40 Score=354.92 Aligned_cols=259 Identities=23% Similarity=0.330 Sum_probs=200.1
Q ss_pred EcCceeeEEEeEeccCceEEEEEEec-CCcE--EEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHH
Q 003052 469 VNGKLYQRLGKIGSGGSSEVHKVISS-DCTI--YALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKA 545 (853)
Q Consensus 469 v~g~~Y~ilk~LG~G~FG~Vyka~~~-~g~~--vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~ 545 (853)
+..+.|++.+.||+|+||.||+|.+. ++.. +|+|.++... .......+.+|+.+|+++.+||||++++++
T Consensus 22 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~------ 94 (327)
T 1fvr_A 22 LDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA-SKDDHRDFAGELEVLCKLGHHPNIINLLGA------ 94 (327)
T ss_dssp CCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC-------CHHHHHHHHHTTCCCCTTBCCEEEE------
T ss_pred ccHHHccceeeeecCCCceEEEEEEccCCcccceeeeeecccc-chHHHHHHHHHHHHHHhccCCCchhhhcee------
Confidence 44467999999999999999999984 5554 4999987532 233445688999999999779999999987
Q ss_pred HHHHHhhCCCCCCCCccccCCeEEEEEecch-hhHHHHHHHhhhh--------ccCCCCCCCHHHHHHHHHHhhhhhhhc
Q 003052 546 LLREVLNGSMNNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKE--------MDGSNQTLDENWLRFYWQQILEAVNTI 616 (853)
Q Consensus 546 iL~~l~~~~iv~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~--------~~~~~~~LsE~~~r~I~~QIl~AL~yL 616 (853)
+.+.+.+|+||||++ ++|.+++...... .......+++..++.++.||+.||.||
T Consensus 95 ----------------~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~L 158 (327)
T 1fvr_A 95 ----------------CEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYL 158 (327)
T ss_dssp ----------------EEETTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHH
T ss_pred ----------------eeeCCceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHH
Confidence 456678999999985 5999988754100 011235799999999999999999999
Q ss_pred ccCceeeCCCCCccEEe-ecCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhh
Q 003052 617 HEERIVHSDLKPANFLL-VKGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWS 695 (853)
Q Consensus 617 Hs~gIIHRDLKPeNILL-~~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWS 695 (853)
|++||+||||||+|||+ .++.+||+|||+++..... .......+++.|+|||++.+. .++.++||||
T Consensus 159 H~~~ivH~dlkp~NIl~~~~~~~kL~Dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~---------~~~~~~Di~s 226 (327)
T 1fvr_A 159 SQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVY---VKKTMGRLPVRWMAIESLNYS---------VYTTNSDVWS 226 (327)
T ss_dssp HHTTEECSCCSGGGEEECGGGCEEECCTTCEESSCEE---CCC----CCTTTCCHHHHHHC---------EECHHHHHHH
T ss_pred HhCCccCCCCccceEEEcCCCeEEEcccCcCcccccc---ccccCCCCCccccChhhhccc---------cCCchhcchH
Confidence 99999999999999999 4569999999999743221 122345678999999999764 3578999999
Q ss_pred hHHHHHHHHh-CCCCCCcchhHHHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCCChhHHhcC
Q 003052 696 LGCILYQMVY-GRTPFSEYKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQH 764 (853)
Q Consensus 696 LGVILyELLt-G~~PF~~~~~~~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~H 764 (853)
|||++|+|++ |+.||.+.........+.. ......+...++.+.+||.+||..||.+||++.+++++
T Consensus 227 lG~il~ellt~g~~pf~~~~~~~~~~~~~~--~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 294 (327)
T 1fvr_A 227 YGVLLWEIVSLGGTPYCGMTCAELYEKLPQ--GYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 294 (327)
T ss_dssp HHHHHHHHHTTSCCTTTTCCHHHHHHHGGG--TCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHcCCCCCCCCCcHHHHHHHhhc--CCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 9999999998 9999977554333222222 12233455678899999999999999999999999976
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=347.43 Aligned_cols=255 Identities=31% Similarity=0.434 Sum_probs=191.9
Q ss_pred ceeeEEEeEeccCceEEEEEEe-cCCcEEEEEEEecCC-CChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHHH
Q 003052 472 KLYQRLGKIGSGGSSEVHKVIS-SDCTIYALKKIKLKG-RDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLRE 549 (853)
Q Consensus 472 ~~Y~ilk~LG~G~FG~Vyka~~-~~g~~vAVKkik~~~-~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~~ 549 (853)
..|++.+.||+|+||.||+|.+ .+++.||||++.... .+......+.+|+.++++++ |+||++++++
T Consensus 32 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~---------- 100 (310)
T 2wqm_A 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLN-HPNVIKYYAS---------- 100 (310)
T ss_dssp GGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCC-CTTBCCEEEE----------
T ss_pred cceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCC-CCCEeeEEEE----------
Confidence 4699999999999999999998 578899999998643 34455667889999999997 9999999987
Q ss_pred HhhCCCCCCCCccccCCeEEEEEecchh-hHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCCC
Q 003052 550 VLNGSMNNKDGRVKDDGYIYMVLEYGEI-DLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKP 628 (853)
Q Consensus 550 l~~~~iv~~~g~~~d~~~lyLVmEy~~g-dL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLKP 628 (853)
+.+++.+|+||||+.+ +|.+++..... ....+++..++.++.||+.||.|||++||+||||||
T Consensus 101 ------------~~~~~~~~lv~e~~~~~~L~~~l~~~~~----~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p 164 (310)
T 2wqm_A 101 ------------FIEDNELNIVLELADAGDLSRMIKHFKK----QKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKP 164 (310)
T ss_dssp ------------EEETTEEEEEEECCCSCBHHHHHHHHHH----TTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCG
T ss_pred ------------EEcCCcEEEEEecCCCCCHHHHHHHhcc----cccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcH
Confidence 4456789999999875 89888865422 245799999999999999999999999999999999
Q ss_pred ccEEee-cCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHhCC
Q 003052 629 ANFLLV-KGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGR 707 (853)
Q Consensus 629 eNILL~-~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLtG~ 707 (853)
+|||++ ++.+||+|||+++....... ......||+.|+|||++.+. .++.++|||||||++|+|++|.
T Consensus 165 ~NIl~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~---------~~~~~~Dv~slG~il~~l~~g~ 233 (310)
T 2wqm_A 165 ANVFITATGVVKLGDLGLGRFFSSKTT--AAHSLVGTPYYMSPERIHEN---------GYNFKSDIWSLGCLLYEMAALQ 233 (310)
T ss_dssp GGEEECTTSCEEECCC--------------------CCSSCCHHHHTTC---------CCCHHHHHHHHHHHHHHHHHSS
T ss_pred HHEEEcCCCCEEEEeccceeeecCCCc--cccccCCCeeEeChHHhCCC---------CCCchhhHHHHHHHHHHHHhCC
Confidence 999995 67999999999986643222 22356799999999999764 3568999999999999999999
Q ss_pred CCCCcch-hHHHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCCChhHHhcC
Q 003052 708 TPFSEYK-TFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQH 764 (853)
Q Consensus 708 ~PF~~~~-~~~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~H 764 (853)
.||.+.. ........+.............+.++.+||.+||..||.+||++.+++++
T Consensus 234 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~ 291 (310)
T 2wqm_A 234 SPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDV 291 (310)
T ss_dssp CTTC---CCHHHHHHHHHTTCSCCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCcccchhHHHHHHHhhcccCCCCcccccCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence 9996532 22222233332222222335678899999999999999999999999863
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=345.63 Aligned_cols=252 Identities=22% Similarity=0.320 Sum_probs=199.2
Q ss_pred EcCceeeEEE-eEeccCceEEEEEEe---cCCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHH
Q 003052 469 VNGKLYQRLG-KIGSGGSSEVHKVIS---SDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEK 544 (853)
Q Consensus 469 v~g~~Y~ilk-~LG~G~FG~Vyka~~---~~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~ 544 (853)
++.++|++.+ .||+|+||.||+|.+ .+++.||||+++...........+.+|+.++++++ |+||+++++++
T Consensus 13 ~~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~---- 87 (291)
T 1xbb_A 13 LDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLD-NPYIVRMIGIC---- 87 (291)
T ss_dssp CCGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCC-CTTBCCEEEEE----
T ss_pred ecchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCC-CCCEEEEEEEE----
Confidence 3456799998 999999999999965 34578999999876555555677999999999996 99999999873
Q ss_pred HHHHHHhhCCCCCCCCccccCCeEEEEEecch-hhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceee
Q 003052 545 ALLREVLNGSMNNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVH 623 (853)
Q Consensus 545 ~iL~~l~~~~iv~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIH 623 (853)
....+|+||||+. ++|.+++... ..+++..++.++.||+.||.|||++||+|
T Consensus 88 -------------------~~~~~~lv~e~~~~~~L~~~l~~~--------~~~~~~~~~~i~~qi~~~l~~LH~~~i~H 140 (291)
T 1xbb_A 88 -------------------EAESWMLVMEMAELGPLNKYLQQN--------RHVKDKNIIELVHQVSMGMKYLEESNFVH 140 (291)
T ss_dssp -------------------ESSSEEEEEECCTTEEHHHHHHHC--------TTCCHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred -------------------CCCCcEEEEEeCCCCCHHHHHHhC--------cCCCHHHHHHHHHHHHHHHHHHHhCCeEc
Confidence 3456899999986 5899888653 46999999999999999999999999999
Q ss_pred CCCCCccEEe-ecCcEEEEecccchhcccCCccc-cccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHH
Q 003052 624 SDLKPANFLL-VKGSLKLIDFGIAKAIMSDTTNI-QRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILY 701 (853)
Q Consensus 624 RDLKPeNILL-~~g~VKL~DFGlAk~~~~~~~~~-~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILy 701 (853)
|||||+|||+ .++.+||+|||+++......... ......||+.|+|||++.+. .++.++|||||||++|
T Consensus 141 ~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~---------~~~~~~Di~slG~il~ 211 (291)
T 1xbb_A 141 RDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYY---------KFSSKSDVWSFGVLMW 211 (291)
T ss_dssp SCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC----CCCGGGCCHHHHHHC---------EEEHHHHHHHHHHHHH
T ss_pred CCCCcceEEEeCCCcEEEccCCcceeeccCCCcccccccCCCCceeeChHHhccC---------CCChhhhHHHHHHHHH
Confidence 9999999999 56799999999998764432211 12234578999999999764 3567999999999999
Q ss_pred HHHh-CCCCCCcchhHHHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCCChhHHhc
Q 003052 702 QMVY-GRTPFSEYKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQ 763 (853)
Q Consensus 702 ELLt-G~~PF~~~~~~~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~ 763 (853)
+|++ |+.||.+....... ..+.. ......+...++.+.+||.+||..||.+||++.++++
T Consensus 212 ~l~~~g~~p~~~~~~~~~~-~~~~~-~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 272 (291)
T 1xbb_A 212 EAFSYGQKPYRGMKGSEVT-AMLEK-GERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVEL 272 (291)
T ss_dssp HHHTTTCCSSTTCCHHHHH-HHHHT-TCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred HHHhcCCCCCCCCCHHHHH-HHHHc-CCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 9999 99999875543322 22222 2233455677899999999999999999999999984
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-40 Score=354.25 Aligned_cols=256 Identities=22% Similarity=0.325 Sum_probs=204.3
Q ss_pred EcCceeeEEEeEeccCceEEEEEEe-----cCCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhH
Q 003052 469 VNGKLYQRLGKIGSGGSSEVHKVIS-----SDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTE 543 (853)
Q Consensus 469 v~g~~Y~ilk~LG~G~FG~Vyka~~-----~~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e 543 (853)
++.++|++++.||+|+||.||+|.. .+++.||||++... .......+.+|+++|++++ |+||+++++++.
T Consensus 20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~-- 94 (327)
T 3lxl_A 20 FEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHS--GPDQQRDFQREIQILKALH-SDFIVKYRGVSY-- 94 (327)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSC--CHHHHHHHHHHHHHHHTCC-CTTBCCEEEEEE--
T ss_pred hchhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccC--CHHHHHHHHHHHHHHHhcC-CCceeEEEEEEe--
Confidence 3457799999999999999999983 46789999999764 3344566889999999996 899999998742
Q ss_pred HHHHHHHhhCCCCCCCCccccCCeEEEEEecc-hhhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCcee
Q 003052 544 KALLREVLNGSMNNKDGRVKDDGYIYMVLEYG-EIDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIV 622 (853)
Q Consensus 544 ~~iL~~l~~~~iv~~~g~~~d~~~lyLVmEy~-~gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gII 622 (853)
..+...+|+||||+ +++|.+++.... ..+++..++.++.||+.||.|||++||+
T Consensus 95 ------------------~~~~~~~~lv~e~~~~~~L~~~l~~~~-------~~~~~~~~~~i~~qi~~al~~lH~~~iv 149 (327)
T 3lxl_A 95 ------------------GPGRQSLRLVMEYLPSGCLRDFLQRHR-------ARLDASRLLLYSSQICKGMEYLGSRRCV 149 (327)
T ss_dssp ------------------CSSSCEEEEEEECCTTCBHHHHHHHHG-------GGCCHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred ------------------cCCCceEEEEEeecCCCCHHHHHHhcc-------cCCCHHHHHHHHHHHHHHHHHHHhCCcc
Confidence 13567799999998 469999887641 3589999999999999999999999999
Q ss_pred eCCCCCccEEe-ecCcEEEEecccchhcccCCcc-ccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHH
Q 003052 623 HSDLKPANFLL-VKGSLKLIDFGIAKAIMSDTTN-IQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCIL 700 (853)
Q Consensus 623 HRDLKPeNILL-~~g~VKL~DFGlAk~~~~~~~~-~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVIL 700 (853)
||||||+|||+ .++.+||+|||+++........ .......||+.|+|||++.+. .++.++|||||||++
T Consensus 150 H~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~---------~~~~~~Di~slG~il 220 (327)
T 3lxl_A 150 HRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDN---------IFSRQSDVWSFGVVL 220 (327)
T ss_dssp CSCCSGGGEEEEETTEEEECCGGGCEECCTTCSEEECSSCCCSCGGGSCHHHHHHC---------EEEHHHHHHHHHHHH
T ss_pred CCCCChhhEEECCCCCEEEcccccceecccCCccceeeccCCccccccCHHHhccC---------CCChHHhHHHHHHHH
Confidence 99999999999 6789999999999876432221 122345789999999999765 356899999999999
Q ss_pred HHHHhCCCCCCcchhH--------------HHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCCChhHHhcC
Q 003052 701 YQMVYGRTPFSEYKTF--------------WAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQH 764 (853)
Q Consensus 701 yELLtG~~PF~~~~~~--------------~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~H 764 (853)
|+|++|..||...... ......+. .......+...++.+.+||.+||..||.+|||+.+++++
T Consensus 221 ~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 297 (327)
T 3lxl_A 221 YELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLELLE-EGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQ 297 (327)
T ss_dssp HHHHTTTCGGGSHHHHHHHHCC----CCHHHHHHHHHH-TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHhCCCCCccccchhhhhcccccccccHHHHHHHhh-cccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 9999999999653321 11112222 123344566788999999999999999999999999654
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-40 Score=348.66 Aligned_cols=258 Identities=22% Similarity=0.319 Sum_probs=194.9
Q ss_pred cCceeeEEEeEeccCceEEEEEEecCCcEEEEEEEecCCCChhhHhhHHHHHHHHHHh-cCCCceeEeeehhhhHHHHHH
Q 003052 470 NGKLYQRLGKIGSGGSSEVHKVISSDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKL-KGKNNIIQLIDYEVTEKALLR 548 (853)
Q Consensus 470 ~g~~Y~ilk~LG~G~FG~Vyka~~~~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL-~~hpNIV~Lid~~~~e~~iL~ 548 (853)
..++|++++.||+|+||.||+|.+ +++.||||++... ....+.+|.+++..+ -.|+||+++++++..
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~-----~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~------ 73 (301)
T 3q4u_A 6 VARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSR-----DEKSWFRETELYNTVMLRHENILGFIASDMT------ 73 (301)
T ss_dssp CGGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGG-----GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEE------
T ss_pred ccCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEeccc-----cchhhHHHHHHHHHhhccCcCeeeEEEeecc------
Confidence 346799999999999999999987 6788999999753 233466788888874 259999999987432
Q ss_pred HHhhCCCCCCCCccccCCeEEEEEecchh-hHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcc--------cC
Q 003052 549 EVLNGSMNNKDGRVKDDGYIYMVLEYGEI-DLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIH--------EE 619 (853)
Q Consensus 549 ~l~~~~iv~~~g~~~d~~~lyLVmEy~~g-dL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLH--------s~ 619 (853)
.+.....+|+||||+++ +|.+++.. ..+++..++.++.||+.||.||| ++
T Consensus 74 ------------~~~~~~~~~lv~e~~~~g~L~~~l~~---------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~ 132 (301)
T 3q4u_A 74 ------------SRHSSTQLWLITHYHEMGSLYDYLQL---------TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKP 132 (301)
T ss_dssp ------------EETTEEEEEEEECCCTTCBHHHHHTT---------CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBC
T ss_pred ------------ccCCCceeEEehhhccCCCHHHHHhh---------cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCC
Confidence 12345678999999864 99998843 46999999999999999999999 99
Q ss_pred ceeeCCCCCccEEee-cCcEEEEecccchhcccCCccc--cccccccCccccCchhhccCCCCCCCccccCCCccchhhh
Q 003052 620 RIVHSDLKPANFLLV-KGSLKLIDFGIAKAIMSDTTNI--QRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSL 696 (853)
Q Consensus 620 gIIHRDLKPeNILL~-~g~VKL~DFGlAk~~~~~~~~~--~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSL 696 (853)
||+||||||+|||++ ++.+||+|||+|+......... .....+||+.|+|||++.+.... ....++.++|||||
T Consensus 133 ~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~---~~~~~~~~~Dvwsl 209 (301)
T 3q4u_A 133 AIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQV---DCFDSYKRVDIWAF 209 (301)
T ss_dssp EEECSCCCGGGEEECTTSCEEECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCT---TCHHHHHHHHHHHH
T ss_pred CeecCCCChHhEEEcCCCCEEEeeCCCeeecccccccccccccccccccceeChhhhcCcCCC---CcccCCchhhHHHH
Confidence 999999999999994 6799999999997654432211 12345899999999999765321 11134579999999
Q ss_pred HHHHHHHHhC----------CCCCCcc----hhHHHHHHhhcCCCCcccCC-----CCCChhHHHHHHHhcccCCCCCCC
Q 003052 697 GCILYQMVYG----------RTPFSEY----KTFWAKFKVITDPNHEITYE-----PVPNPWLLDLMKKCLAWDRNERWR 757 (853)
Q Consensus 697 GVILyELLtG----------~~PF~~~----~~~~~~~kii~~~~~~~~~~-----~~~s~~l~dLI~kcL~~DP~kRpT 757 (853)
||++|||++| ..||.+. ...................+ ...+..+.+||.+||..||.+|||
T Consensus 210 G~il~el~tg~~~~~~~~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps 289 (301)
T 3q4u_A 210 GLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLT 289 (301)
T ss_dssp HHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCC
T ss_pred HHHHHHHHhhhcCccccccccccccccCCCCcchhhhhHHHhccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCC
Confidence 9999999999 8898542 11222222222111111111 123456999999999999999999
Q ss_pred hhHHhc
Q 003052 758 IPQLLQ 763 (853)
Q Consensus 758 a~EIL~ 763 (853)
+.++++
T Consensus 290 ~~~i~~ 295 (301)
T 3q4u_A 290 ALRIKK 295 (301)
T ss_dssp HHHHHH
T ss_pred HHHHHH
Confidence 999986
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=346.26 Aligned_cols=252 Identities=20% Similarity=0.293 Sum_probs=197.2
Q ss_pred CceeeEEEeEeccCceEEEEEEecC----CcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHH
Q 003052 471 GKLYQRLGKIGSGGSSEVHKVISSD----CTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKAL 546 (853)
Q Consensus 471 g~~Y~ilk~LG~G~FG~Vyka~~~~----g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~i 546 (853)
...|++.+.||+|+||.||+|.+.+ ...+|+|.+... ........+.+|+.++++++ |+||+++++++
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~-~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~------ 95 (298)
T 3f66_A 24 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI-TDIGEVSQFLTEGIIMKDFS-HPNVLSLLGIC------ 95 (298)
T ss_dssp GEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTC-CSHHHHHHHHHHHHHHHTCC-CTTBCCCCEEE------
T ss_pred ceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccC-CCHHHHHHHHHHHHHHHhCC-CCCEeeeeeEE------
Confidence 3569999999999999999998632 235899988753 34455667899999999997 99999999863
Q ss_pred HHHHhhCCCCCCCCccccCCeEEEEEecchh-hHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCC
Q 003052 547 LREVLNGSMNNKDGRVKDDGYIYMVLEYGEI-DLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSD 625 (853)
Q Consensus 547 L~~l~~~~iv~~~g~~~d~~~lyLVmEy~~g-dL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRD 625 (853)
+..++.+|+||||+++ +|.+++... ...+++..++.++.||+.||.|||++||+|||
T Consensus 96 ---------------~~~~~~~~~v~e~~~~~~L~~~l~~~-------~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~d 153 (298)
T 3f66_A 96 ---------------LRSEGSPLVVLPYMKHGDLRNFIRNE-------THNPTVKDLIGFGLQVAKGMKYLASKKFVHRD 153 (298)
T ss_dssp ---------------CCSSSCCEEEEECCTTCBHHHHHHCT-------TCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSC
T ss_pred ---------------EcCCCceEEEEeCCCCCCHHHHHHhc-------ccCCCHHHHHHHHHHHHHHHHHHHhCCccCCC
Confidence 2445678999999875 999988642 35689999999999999999999999999999
Q ss_pred CCCccEEee-cCcEEEEecccchhcccCCc--cccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHH
Q 003052 626 LKPANFLLV-KGSLKLIDFGIAKAIMSDTT--NIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQ 702 (853)
Q Consensus 626 LKPeNILL~-~g~VKL~DFGlAk~~~~~~~--~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyE 702 (853)
|||+|||++ ++.+||+|||+++....... ........||+.|+|||++.+.. ++.++|||||||++|+
T Consensus 154 ikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~---------~~~~~Di~slG~il~~ 224 (298)
T 3f66_A 154 LAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQK---------FTTKSDVWSFGVLLWE 224 (298)
T ss_dssp CSGGGEEECTTCCEEECSCGGGCCCSCGGGCBC-----CCBCGGGSCHHHHHHCC---------CCHHHHHHHHHHHHHH
T ss_pred CchheEEECCCCCEEECcccccccccccchhccccccCCCCCccccChHHhcCCC---------CChHHHHHHHHHHHHH
Confidence 999999994 56999999999986643221 11223557889999999997653 5689999999999999
Q ss_pred HHh-CCCCCCcchhHHHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCCChhHHhc
Q 003052 703 MVY-GRTPFSEYKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQ 763 (853)
Q Consensus 703 LLt-G~~PF~~~~~~~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~ 763 (853)
|++ |.+||.+............. .....+...+..+.+||.+||..||.+||++.++++
T Consensus 225 l~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 284 (298)
T 3f66_A 225 LMTRGAPPYPDVNTFDITVYLLQG--RRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVS 284 (298)
T ss_dssp HHTTSCCSSTTSCTTTHHHHHHTT--CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHhCCCCCCccCCHHHHHHHHhcC--CCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 999 67777654433222222221 222334567888999999999999999999999985
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-41 Score=363.61 Aligned_cols=256 Identities=23% Similarity=0.281 Sum_probs=198.2
Q ss_pred ceeeEEEeEeccCceEEEEEEecCCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHHHHh
Q 003052 472 KLYQRLGKIGSGGSSEVHKVISSDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLREVL 551 (853)
Q Consensus 472 ~~Y~ilk~LG~G~FG~Vyka~~~~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~~l~ 551 (853)
+.|++.+.||+|+||.||+|.+.+++.||||++..... .....+.+|+.+|++++ |+||++++++
T Consensus 39 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~-h~~iv~~~~~------------ 103 (321)
T 2qkw_B 39 NNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESS--QGIEEFETEIETLSFCR-HPHLVSLIGF------------ 103 (321)
T ss_dssp CCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCS--SHHHHHHHHHHGGGSCC-CTTBCCEEEE------------
T ss_pred hccCccceeecCCCeeEEEEEECCCCEEEEEEecccCh--HHHHHHHHHHHHHHhCC-CCCEeeEEEE------------
Confidence 56999999999999999999988889999999876533 34556889999999997 8999999987
Q ss_pred hCCCCCCCCccccCCeEEEEEecch-hhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCCCcc
Q 003052 552 NGSMNNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPAN 630 (853)
Q Consensus 552 ~~~iv~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLKPeN 630 (853)
+.+.+.+|+||||+. ++|.+++... ......+++..++.++.||+.||.|||++||+||||||+|
T Consensus 104 ----------~~~~~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~N 169 (321)
T 2qkw_B 104 ----------CDERNEMILIYKYMENGNLKRHLYGS----DLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSIN 169 (321)
T ss_dssp ----------CCCTTCCEEEEECCTTCBTGGGSSSS----CCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTT
T ss_pred ----------EcCCCeEEEEEEcCCCCcHHHHHhcc----CCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHH
Confidence 345667899999986 4887766432 1123469999999999999999999999999999999999
Q ss_pred EEee-cCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHhCCCC
Q 003052 631 FLLV-KGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGRTP 709 (853)
Q Consensus 631 ILL~-~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLtG~~P 709 (853)
||++ ++.+||+|||+++..............+||+.|+|||++.+. .++.++|||||||++|+|++|+.|
T Consensus 170 il~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---------~~~~~~Di~slG~il~ell~g~~p 240 (321)
T 2qkw_B 170 ILLDENFVPKITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKG---------RLTEKSDVYSFGVVLFEVLCARSA 240 (321)
T ss_dssp EEECTTCCEEECCCTTCEECSSSSCCCCBCCCEEETTTCCHHHHHHC---------BCCTHHHHHHHHHHHHHHHHCCTT
T ss_pred EEECCCCCEEEeecccccccccccccccccccCCCccccCHHHhcCC---------CCCcccchHhHHHHHHHHHhCCCc
Confidence 9994 679999999999865433322233456799999999999765 356899999999999999999999
Q ss_pred CCcchh-----HHHH-HHhhcC--------CCCcccCCCCCChhHHHHHHHhcccCCCCCCChhHHhcCC
Q 003052 710 FSEYKT-----FWAK-FKVITD--------PNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQHP 765 (853)
Q Consensus 710 F~~~~~-----~~~~-~kii~~--------~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~HP 765 (853)
|.+... .... ...... +..........+..+.+||.+||..||.+|||+.|+++|.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L 310 (321)
T 2qkw_B 241 IVQSLPREMVNLAEWAVESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKL 310 (321)
T ss_dssp CSCSSSSSCCCHHHHTHHHHTTTCCCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred ccccCcHHHHHHHHHhhhccccccHHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHH
Confidence 964321 1100 001111 0011111222345689999999999999999999999763
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-40 Score=355.61 Aligned_cols=254 Identities=17% Similarity=0.313 Sum_probs=191.8
Q ss_pred EEcCceeeEEEeEeccCceEEEEEEec-CCcE----EEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhh
Q 003052 468 KVNGKLYQRLGKIGSGGSSEVHKVISS-DCTI----YALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVT 542 (853)
Q Consensus 468 ~v~g~~Y~ilk~LG~G~FG~Vyka~~~-~g~~----vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~ 542 (853)
.+...+|++++.||+|+||.||+|.+. +++. ||+|.+.... .......+.+|+.+|++++ ||||+++++++
T Consensus 11 ~l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~-~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~-- 86 (327)
T 3lzb_A 11 ILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASVD-NPHVCRLLGIC-- 86 (327)
T ss_dssp ECCTTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCS-SCCCHHHHHHHHHHHTTCC-BTTBCCCCEEE--
T ss_pred ccCHhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeecccc-CHHHHHHHHHHHHHHHhCC-CCCeeEEEEEE--
Confidence 445678999999999999999999974 4443 5677665432 2234456889999999997 89999999873
Q ss_pred HHHHHHHHhhCCCCCCCCccccCCeEEEEEecch-hhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCce
Q 003052 543 EKALLREVLNGSMNNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERI 621 (853)
Q Consensus 543 e~~iL~~l~~~~iv~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gI 621 (853)
.+. ..++||||+. ++|.+++... ...+++..++.|+.||+.||.|||++||
T Consensus 87 --------------------~~~-~~~~v~~~~~~g~L~~~l~~~-------~~~~~~~~~~~i~~qi~~aL~~LH~~~i 138 (327)
T 3lzb_A 87 --------------------LTS-TVQLITQLMPFGCLLDYVREH-------KDNIGSQYLLNWCVQIAKGMNYLEDRRL 138 (327)
T ss_dssp --------------------ESS-SEEEEECCCSSCBHHHHHHHT-------TTCCCHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred --------------------ecC-CceEEEEecCCCcHHHHHHhc-------CCCCCHHHHHHHHHHHHHHHHHHhhCCC
Confidence 222 3678888854 6898888763 3569999999999999999999999999
Q ss_pred eeCCCCCccEEe-ecCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHH
Q 003052 622 VHSDLKPANFLL-VKGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCIL 700 (853)
Q Consensus 622 IHRDLKPeNILL-~~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVIL 700 (853)
+||||||+|||+ .++.+||+|||+++.+.............||+.|+|||++.+.. |+.++|||||||++
T Consensus 139 vH~Dikp~NIl~~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~---------~~~~~Di~slG~il 209 (327)
T 3lzb_A 139 VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI---------YTHQSDVWSYGVTV 209 (327)
T ss_dssp CCSCCCGGGEEEEETTEEEECCTTC----------------CCCGGGSCHHHHHHCC---------CCHHHHHHHHHHHH
T ss_pred cCCCCCHHHEEEcCCCCEEEccCcceeEccCccccccccCCCccccccCHHHHcCCC---------CChHHHHHHHHHHH
Confidence 999999999999 56899999999998765443333334556788999999998653 56899999999999
Q ss_pred HHHHh-CCCCCCcchhHHHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCCChhHHhcC
Q 003052 701 YQMVY-GRTPFSEYKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQH 764 (853)
Q Consensus 701 yELLt-G~~PF~~~~~~~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~H 764 (853)
|+|++ |..||.+...... ...+.. ......+...+.++.+||.+||..||.+||++.|+++.
T Consensus 210 ~ell~~g~~p~~~~~~~~~-~~~~~~-~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 272 (327)
T 3lzb_A 210 WELMTFGSKPYDGIPASEI-SSILEK-GERLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIE 272 (327)
T ss_dssp HHHHTTSCCTTTTCCGGGH-HHHHHT-TCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHCCCCCCCCCCHHHH-HHHHHc-CCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 99999 9999976443222 222221 22334456678899999999999999999999999973
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-40 Score=362.39 Aligned_cols=255 Identities=16% Similarity=0.180 Sum_probs=198.4
Q ss_pred CCceeEEcCceeeEEEeEeccCceEEEEEE------ecCCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcC--CCcee
Q 003052 463 PDLFFKVNGKLYQRLGKIGSGGSSEVHKVI------SSDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKG--KNNII 534 (853)
Q Consensus 463 p~~~~~v~g~~Y~ilk~LG~G~FG~Vyka~------~~~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~--hpNIV 534 (853)
+...+.+.++.|.+.++||+|+||.||+|+ ..+++.||||+++... ...+.+|+++++++++ |+||+
T Consensus 56 ~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-----~~~~~~e~~~~~~l~~~~~~~iv 130 (365)
T 3e7e_A 56 PKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN-----PWEFYIGTQLMERLKPSMQHMFM 130 (365)
T ss_dssp SSCEEECSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC-----HHHHHHHHHHHHHSCGGGGGGBC
T ss_pred cceeEEECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC-----hhHHHHHHHHHHHhhhhhhhhhh
Confidence 445677888999999999999999999994 3567899999997542 3357788999888864 67888
Q ss_pred EeeehhhhHHHHHHHHhhCCCCCCCCccccCCeEEEEEecch-hhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhh
Q 003052 535 QLIDYEVTEKALLREVLNGSMNNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAV 613 (853)
Q Consensus 535 ~Lid~~~~e~~iL~~l~~~~iv~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL 613 (853)
+++++ +...+.+||||||++ ++|.+++..... .....+++..++.|+.||+.||
T Consensus 131 ~~~~~----------------------~~~~~~~~lv~e~~~~g~L~~~l~~~~~---~~~~~l~~~~~~~i~~qi~~~L 185 (365)
T 3e7e_A 131 KFYSA----------------------HLFQNGSVLVGELYSYGTLLNAINLYKN---TPEKVMPQGLVISFAMRMLYMI 185 (365)
T ss_dssp CEEEE----------------------EECSSCEEEEECCCCSCBHHHHHHHHHT---STTCSCCHHHHHHHHHHHHHHH
T ss_pred hhhee----------------------eecCCCcEEEEeccCCCcHHHHHHHhhc---ccccCCCHHHHHHHHHHHHHHH
Confidence 88876 456678899999986 699999876422 1246799999999999999999
Q ss_pred hhcccCceeeCCCCCccEEee------------cCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCC
Q 003052 614 NTIHEERIVHSDLKPANFLLV------------KGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDEN 681 (853)
Q Consensus 614 ~yLHs~gIIHRDLKPeNILL~------------~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~ 681 (853)
.|||++|||||||||+||||+ ++.+||+|||+|+.+............+||+.|||||++.+.
T Consensus 186 ~~lH~~~ivHrDiKp~NIll~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----- 260 (365)
T 3e7e_A 186 EQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNK----- 260 (365)
T ss_dssp HHHHTTTEECCCCSGGGEEECGGGTCC------CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTC-----
T ss_pred HHHhhCCeecCCCCHHHEEecccccCccccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCC-----
Confidence 999999999999999999995 479999999999765433333344577899999999999765
Q ss_pred CccccCCCccchhhhHHHHHHHHhCCCCCCcchhHHHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCCChhHH
Q 003052 682 GNIIKCGRPSDIWSLGCILYQMVYGRTPFSEYKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQL 761 (853)
Q Consensus 682 ~~~~~ys~ksDIWSLGVILyELLtG~~PF~~~~~~~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EI 761 (853)
.|+.++|||||||++|||++|+.||....... .. +.. .+ .....+..+.+++.+||..+|.+|++..+.
T Consensus 261 ----~~~~~~DiwslG~il~elltg~~pf~~~~~~~--~~-~~~---~~-~~~~~~~~~~~~~~~~l~~~p~~r~~~~~~ 329 (365)
T 3e7e_A 261 ----PWNYQIDYFGVAATVYCMLFGTYMKVKNEGGE--CK-PEG---LF-RRLPHLDMWNEFFHVMLNIPDCHHLPSLDL 329 (365)
T ss_dssp ----CBSTHHHHHHHHHHHHHHHHSSCCCEEEETTE--EE-ECS---CC-TTCSSHHHHHHHHHHHHCCCCTTCCCCHHH
T ss_pred ----CCCccccHHHHHHHHHHHHhCCCccccCCCCc--ee-ech---hc-cccCcHHHHHHHHHHHcCCCCCCcchHHHH
Confidence 36789999999999999999999995432210 00 000 00 111235668999999999999999765555
Q ss_pred hc
Q 003052 762 LQ 763 (853)
Q Consensus 762 L~ 763 (853)
|.
T Consensus 330 l~ 331 (365)
T 3e7e_A 330 LR 331 (365)
T ss_dssp HH
T ss_pred HH
Confidence 44
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=342.48 Aligned_cols=253 Identities=21% Similarity=0.298 Sum_probs=197.2
Q ss_pred EEcCceeeEEEeEeccCceEEEEEEecC----CcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhH
Q 003052 468 KVNGKLYQRLGKIGSGGSSEVHKVISSD----CTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTE 543 (853)
Q Consensus 468 ~v~g~~Y~ilk~LG~G~FG~Vyka~~~~----g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e 543 (853)
.+..++|++.+.||+|+||.||+|.+.. +..||+|++.... .......+.+|+.++++++ ||||+++++++
T Consensus 8 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~--- 82 (281)
T 3cc6_A 8 GIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDC-TLDNKEKFMSEAVIMKNLD-HPHIVKLIGII--- 82 (281)
T ss_dssp SCCGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTS-CHHHHHHHHHHHHHHHHHC-CTTBCCEEEEE---
T ss_pred eecccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEeccccc-CchHHHHHHHHHHHHHhCC-CCCcceEEEEE---
Confidence 3445779999999999999999998642 2469999987653 3345567899999999997 99999999873
Q ss_pred HHHHHHHhhCCCCCCCCccccCCeEEEEEecch-hhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCcee
Q 003052 544 KALLREVLNGSMNNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIV 622 (853)
Q Consensus 544 ~~iL~~l~~~~iv~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gII 622 (853)
. +...|+||||+. ++|.+++... ...+++..++.++.||+.||.|||++||+
T Consensus 83 -------------------~-~~~~~~v~e~~~~~~L~~~l~~~-------~~~~~~~~~~~~~~~i~~~l~~lH~~~i~ 135 (281)
T 3cc6_A 83 -------------------E-EEPTWIIMELYPYGELGHYLERN-------KNSLKVLTLVLYSLQICKAMAYLESINCV 135 (281)
T ss_dssp -------------------C-SSSCEEEEECCTTCBHHHHHHHH-------TTTCCHHHHHHHHHHHHHHHHHHHHTTCC
T ss_pred -------------------c-CCCCEEEEecCCCCCHHHHHHhc-------cccCCHHHHHHHHHHHHHHHHHHHHCCcc
Confidence 2 234589999976 5899888654 24689999999999999999999999999
Q ss_pred eCCCCCccEEe-ecCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHH
Q 003052 623 HSDLKPANFLL-VKGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILY 701 (853)
Q Consensus 623 HRDLKPeNILL-~~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILy 701 (853)
||||||+|||+ .++.+||+|||+++....... .......||+.|+|||++.+. .++.++|||||||++|
T Consensus 136 H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~---------~~~~~~Di~slG~il~ 205 (281)
T 3cc6_A 136 HRDIAVRNILVASPECVKLGDFGLSRYIEDEDY-YKASVTRLPIKWMSPESINFR---------RFTTASDVWMFAVCMW 205 (281)
T ss_dssp CCCCSGGGEEEEETTEEEECCCCGGGCC----------CCCCCGGGCCHHHHHHC---------CCCHHHHHHHHHHHHH
T ss_pred cCCCccceEEECCCCcEEeCccCCCcccccccc-cccccCCCCcceeCchhhccC---------CCCchhccHHHHHHHH
Confidence 99999999999 567999999999987643221 122345678999999999765 3567999999999999
Q ss_pred HHHh-CCCCCCcchhHHHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCCChhHHhcC
Q 003052 702 QMVY-GRTPFSEYKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQH 764 (853)
Q Consensus 702 ELLt-G~~PF~~~~~~~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~H 764 (853)
+|++ |+.||...........+.. ......+...++.+.+||.+||..||.+||++.+++++
T Consensus 206 ~llt~g~~p~~~~~~~~~~~~~~~--~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~ 267 (281)
T 3cc6_A 206 EILSFGKQPFFWLENKDVIGVLEK--GDRLPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCS 267 (281)
T ss_dssp HHHTTTCCTTTTSCGGGHHHHHHH--TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHhCCCCCcccCChHHHHHHHhc--CCCCCCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHH
Confidence 9998 9999964332221111111 12233455678899999999999999999999999964
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-41 Score=361.94 Aligned_cols=261 Identities=21% Similarity=0.273 Sum_probs=199.6
Q ss_pred EcCceeeEEEeEeccCceEEEEEEecCCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHH
Q 003052 469 VNGKLYQRLGKIGSGGSSEVHKVISSDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLR 548 (853)
Q Consensus 469 v~g~~Y~ilk~LG~G~FG~Vyka~~~~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~ 548 (853)
+..+.|++.+.||+|+||.||+|...+++.||||++...... .....+.+|+++++++. |+||++++++
T Consensus 27 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~-h~~iv~~~~~--------- 95 (326)
T 3uim_A 27 VASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQ-GGELQFQTEVEMISMAV-HRNLLRLRGF--------- 95 (326)
T ss_dssp TTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC------CCCHHHHHHHGGGTCC-CTTBCCCCEE---------
T ss_pred HHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCc-hHHHHHHHHHHHHHhcc-CCCccceEEE---------
Confidence 345679999999999999999999888899999999765432 22235889999999997 8999999987
Q ss_pred HHhhCCCCCCCCccccCCeEEEEEecchh-hHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccC---ceeeC
Q 003052 549 EVLNGSMNNKDGRVKDDGYIYMVLEYGEI-DLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEE---RIVHS 624 (853)
Q Consensus 549 ~l~~~~iv~~~g~~~d~~~lyLVmEy~~g-dL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~---gIIHR 624 (853)
+.+...+|+||||+.+ +|.+++.... .....+++..++.++.||+.||.|||++ ||+||
T Consensus 96 -------------~~~~~~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~ 158 (326)
T 3uim_A 96 -------------CMTPTERLLVYPYMANGSVASCLRERP----ESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHR 158 (326)
T ss_dssp -------------ECCSSCCEEEEECCTTCBHHHHHHCCS----TTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECC
T ss_pred -------------EecCCceEEEEEeccCCCHHHHHHhcc----ccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeC
Confidence 4456678999999865 9998886541 2345699999999999999999999999 99999
Q ss_pred CCCCccEEee-cCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHH
Q 003052 625 DLKPANFLLV-KGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQM 703 (853)
Q Consensus 625 DLKPeNILL~-~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyEL 703 (853)
||||+|||++ ++.+||+|||+++....... ......+||+.|+|||++.+. .++.++|||||||++|+|
T Consensus 159 Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~---------~~~~~~Di~slG~il~~l 228 (326)
T 3uim_A 159 DVKAANILLDEEFEAVVGDFGLAKLMDYKDT-HVTTAVRGTIGHIAPEYLSTG---------KSSEKTDVFGYGVMLLEL 228 (326)
T ss_dssp CCSGGGEEECTTCCEEECCCSSCEECCSSSS-CEECCCCSCGGGCCHHHHHHS---------EECHHHHHHHHHHHHHHH
T ss_pred CCchhhEEECCCCCEEeccCccccccCcccc-cccccccCCcCccCHHHhccC---------CCCccccchhHHHHHHHH
Confidence 9999999995 56999999999987643322 223456799999999999765 357899999999999999
Q ss_pred HhCCCCCCcch-------hHHHHHHhh-cCCCC--------cccCCCCCChhHHHHHHHhcccCCCCCCChhHHhcCCCC
Q 003052 704 VYGRTPFSEYK-------TFWAKFKVI-TDPNH--------EITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQHPFL 767 (853)
Q Consensus 704 LtG~~PF~~~~-------~~~~~~kii-~~~~~--------~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~HPwf 767 (853)
++|+.||.... ......... ..... ...+....+..+.+||.+||..||.+|||+.++++|-+-
T Consensus 229 ~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~ 308 (326)
T 3uim_A 229 ITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEG 308 (326)
T ss_dssp HHCCCSBCHHHHTTTSCSBHHHHHTTTTSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHT
T ss_pred HhCCCcccccccccccchhHHHHHHHHhhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcC
Confidence 99999995311 111111111 11000 011111223568999999999999999999999998654
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-40 Score=371.92 Aligned_cols=251 Identities=22% Similarity=0.286 Sum_probs=203.4
Q ss_pred EEcCceeeEEEeEeccCceEEEEEEecCCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHH
Q 003052 468 KVNGKLYQRLGKIGSGGSSEVHKVISSDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALL 547 (853)
Q Consensus 468 ~v~g~~Y~ilk~LG~G~FG~Vyka~~~~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL 547 (853)
.+..+.|++.++||+|+||.||+|.+.++..||||+++.... ....+.+|+.+|++++ |+||+++++++
T Consensus 184 ~i~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~-h~~iv~l~~~~------- 252 (454)
T 1qcf_A 184 EIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSM---SVEAFLAEANVMKTLQ-HDKLVKLHAVV------- 252 (454)
T ss_dssp BCCGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTSB---CHHHHHHHHHHHTTCC-CTTBCCEEEEE-------
T ss_pred eechHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCCc---cHHHHHHHHHHHhhCC-CCCEeeEEEEE-------
Confidence 455577999999999999999999998888899999986543 3456899999999997 99999999863
Q ss_pred HHHhhCCCCCCCCccccCCeEEEEEecch-hhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCC
Q 003052 548 REVLNGSMNNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDL 626 (853)
Q Consensus 548 ~~l~~~~iv~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDL 626 (853)
. ...+|+||||+. ++|.+++..... ..+++..+..++.||+.||.|||++||+||||
T Consensus 253 ---------------~-~~~~~lv~e~~~~g~L~~~l~~~~~------~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDl 310 (454)
T 1qcf_A 253 ---------------T-KEPIYIITEFMAKGSLLDFLKSDEG------SKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDL 310 (454)
T ss_dssp ---------------C-SSSCEEEECCCTTCBHHHHHHSHHH------HTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSC
T ss_pred ---------------e-CCccEEEEeecCCCcHHHHHHhccC------CCCCHHHHHHHHHHHHHHHHHHHhCCccCCCC
Confidence 2 345799999975 599999875421 35889999999999999999999999999999
Q ss_pred CCccEEee-cCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHh
Q 003052 627 KPANFLLV-KGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVY 705 (853)
Q Consensus 627 KPeNILL~-~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLt 705 (853)
||+|||++ ++.+||+|||+|+...... ........+|+.|+|||++... .|+.++|||||||+||||++
T Consensus 311 kp~Nill~~~~~~kl~DFG~a~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~---------~~~~~~DvwslG~~l~el~t 380 (454)
T 1qcf_A 311 RAANILVSASLVCKIADFGLARVIEDNE-YTAREGAKFPIKWTAPEAINFG---------SFTIKSDVWSFGILLMEIVT 380 (454)
T ss_dssp SGGGEEECTTCCEEECSTTGGGGBCCHH-HHTTCSSSSCGGGSCHHHHHHC---------CCCHHHHHHHHHHHHHHHHT
T ss_pred CHHHEEECCCCcEEEeeCCCceEcCCCc-eeccCCCcccccccCHHHhccC---------CCCcHHHHHhHHHHHHHHHh
Confidence 99999995 6799999999998764321 1122344678899999999765 36789999999999999999
Q ss_pred -CCCCCCcchhHHHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCCChhHHhc
Q 003052 706 -GRTPFSEYKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQ 763 (853)
Q Consensus 706 -G~~PF~~~~~~~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~ 763 (853)
|+.||.+.........+... .....+...++.+.+||.+||..||.+|||+.+|+.
T Consensus 381 ~g~~P~~~~~~~~~~~~i~~~--~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~ 437 (454)
T 1qcf_A 381 YGRIPYPGMSNPEVIRALERG--YRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQS 437 (454)
T ss_dssp TSCCSSTTCCHHHHHHHHHHT--CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCCCCCCCCHHHHHHHHHcC--CCCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHH
Confidence 99999876544333333221 223345567889999999999999999999999875
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-39 Score=368.08 Aligned_cols=247 Identities=27% Similarity=0.377 Sum_probs=199.0
Q ss_pred EEcCceeeEEEeEeccCceEEEEEEecCCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHH
Q 003052 468 KVNGKLYQRLGKIGSGGSSEVHKVISSDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALL 547 (853)
Q Consensus 468 ~v~g~~Y~ilk~LG~G~FG~Vyka~~~~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL 547 (853)
.+..+.|+++++||+|+||.||+|.+. ++.||||+++... ....+.+|+.+|++++ |+||+++++++.
T Consensus 189 ~i~~~~~~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~----~~~~~~~E~~~l~~l~-h~niv~~~~~~~------ 256 (450)
T 1k9a_A 189 ALNMKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA----TAQAFLAEASVMTQLR-HSNLVQLLGVIV------ 256 (450)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEESSCT----TSHHHHHHHHHHHTCC-CTTBCCEEEEEE------
T ss_pred ccChHHeEEEeeecCcCCeeEEEEEec-CCeEEEEEeCCch----HHHHHHHHHHHHHhcc-CCCEEEEEEEEE------
Confidence 344567999999999999999999875 6789999997543 3456889999999997 999999998732
Q ss_pred HHHhhCCCCCCCCccccCCeEEEEEecch-hhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCC
Q 003052 548 REVLNGSMNNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDL 626 (853)
Q Consensus 548 ~~l~~~~iv~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDL 626 (853)
.....+|+||||+. ++|.+++... ....+++..++.++.||+.||.|||++||+||||
T Consensus 257 ---------------~~~~~~~iv~e~~~~g~L~~~l~~~------~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDl 315 (450)
T 1k9a_A 257 ---------------EEKGGLYIVTEYMAKGSLVDYLRSR------GRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDL 315 (450)
T ss_dssp ---------------CTTSCEEEEEECCTTCBHHHHHHHH------CTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCC
T ss_pred ---------------cCCCceEEEEEecCCCcHHHHHHhc------CCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCC
Confidence 33447899999986 5999998765 2235899999999999999999999999999999
Q ss_pred CCccEEee-cCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHh
Q 003052 627 KPANFLLV-KGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVY 705 (853)
Q Consensus 627 KPeNILL~-~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLt 705 (853)
||+|||++ ++.+||+|||+++..... .....+++.|+|||++.+. .|+.++|||||||++|||++
T Consensus 316 kp~Nill~~~~~~kl~DfG~a~~~~~~-----~~~~~~~~~y~aPE~~~~~---------~~~~~sDvwslG~~l~el~t 381 (450)
T 1k9a_A 316 AARNVLVSEDNVAKVSDFGLTKEASST-----QDTGKLPVKWTAPEALREK---------KFSTKSDVWSFGILLWEIYS 381 (450)
T ss_dssp CGGGEEECTTSCEEECCCTTCEECC-----------CCCTTTSCHHHHHSS---------CCCHHHHHHHHHHHHHHHHT
T ss_pred CHhhEEECCCCCEEEeeCCCccccccc-----ccCCCCCcceeCHHHhcCC---------CCCcHHHHHHHHHHHHHHHh
Confidence 99999995 679999999999854321 1234788999999999765 36789999999999999998
Q ss_pred -CCCCCCcchhHHHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCCChhHHhc
Q 003052 706 -GRTPFSEYKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQ 763 (853)
Q Consensus 706 -G~~PF~~~~~~~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~ 763 (853)
|+.||.+.........+ .. ......+...++.+.+||.+||..||.+|||+.++++
T Consensus 382 ~g~~P~~~~~~~~~~~~i-~~-~~~~~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~ 438 (450)
T 1k9a_A 382 FGRVPYPRIPLKDVVPRV-EK-GYKMDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLRE 438 (450)
T ss_dssp TTCCSSTTSCTTTHHHHH-HT-TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCCCCCCCCHHHHHHHH-Hc-CCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 99999764432222222 22 2234456678899999999999999999999999874
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-40 Score=363.80 Aligned_cols=253 Identities=22% Similarity=0.290 Sum_probs=190.6
Q ss_pred EcCceeeEEEeEeccCceEEEEEEec----CCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHH
Q 003052 469 VNGKLYQRLGKIGSGGSSEVHKVISS----DCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEK 544 (853)
Q Consensus 469 v~g~~Y~ilk~LG~G~FG~Vyka~~~----~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~ 544 (853)
+....|.+.+.||+|+||.||+|++. ++..||||+++... .......+.+|+.+|++++ |+||++++++
T Consensus 42 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~-h~niv~~~~~----- 114 (373)
T 2qol_A 42 LDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGY-TEKQRRDFLGEASIMGQFD-HPNIIRLEGV----- 114 (373)
T ss_dssp CCGGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTC-CHHHHHHHHHHHHHHTTCC-CTTBCCEEEE-----
T ss_pred cCHhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCcc-CHHHHHHHHHHHHHHHhCC-CCCCCeEEEE-----
Confidence 34467999999999999999999874 45789999997653 3445567899999999997 9999999987
Q ss_pred HHHHHHhhCCCCCCCCccccCCeEEEEEecch-hhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceee
Q 003052 545 ALLREVLNGSMNNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVH 623 (853)
Q Consensus 545 ~iL~~l~~~~iv~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIH 623 (853)
+.+...+|+||||++ ++|.+++... ...+++..++.++.||+.||.|||++||+|
T Consensus 115 -----------------~~~~~~~~lv~e~~~~~sL~~~l~~~-------~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH 170 (373)
T 2qol_A 115 -----------------VTKSKPVMIVTEYMENGSLDSFLRKH-------DAQFTVIQLVGMLRGIASGMKYLSDMGYVH 170 (373)
T ss_dssp -----------------ECSSSSCEEEEECCTTCBHHHHHHTT-------TTCSCHHHHHHHHHHHHHHHHHHHHTTCCC
T ss_pred -----------------EeeCCceEEEEeCCCCCcHHHHHHhC-------CCCCCHHHHHHHHHHHHHHHHHHHHCCeeC
Confidence 445667899999985 6999988643 356999999999999999999999999999
Q ss_pred CCCCCccEEe-ecCcEEEEecccchhcccCCcc-ccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHH
Q 003052 624 SDLKPANFLL-VKGSLKLIDFGIAKAIMSDTTN-IQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILY 701 (853)
Q Consensus 624 RDLKPeNILL-~~g~VKL~DFGlAk~~~~~~~~-~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILy 701 (853)
|||||+|||+ .++.+||+|||+++........ .......+|+.|+|||++.+.. |+.++|||||||++|
T Consensus 171 ~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~---------~~~~~Dv~SlG~il~ 241 (373)
T 2qol_A 171 RDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRK---------FTSASDVWSYGIVLW 241 (373)
T ss_dssp SCCCGGGEEECTTCCEEECCC----------------------CTTSCHHHHHHCC---------CCHHHHHHHHHHHHH
T ss_pred CCCCcceEEEcCCCCEEECcCccccccccCCccceeccCCCcCCCccChhhhccCC---------cCchhcHHHHHHHHH
Confidence 9999999999 4679999999999876543211 1112234678999999997653 567999999999999
Q ss_pred HHHh-CCCCCCcchhHHHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCCChhHHhc
Q 003052 702 QMVY-GRTPFSEYKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQ 763 (853)
Q Consensus 702 ELLt-G~~PF~~~~~~~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~ 763 (853)
||++ |+.||.+....... ..+.. ......+...+..+.+||.+||..||.+||++.++++
T Consensus 242 ellt~g~~P~~~~~~~~~~-~~i~~-~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~ 302 (373)
T 2qol_A 242 EVMSYGERPYWEMSNQDVI-KAVDE-GYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVS 302 (373)
T ss_dssp HHHTTC-CTTTTCCHHHHH-HHHHT-TEECCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHhCCCCCCCCCCHHHHH-HHHHc-CCCCCCCccccHHHHHHHHHHhCcChhhCcCHHHHHH
Confidence 9997 99999765543322 22222 2223344567788999999999999999999999875
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-39 Score=348.83 Aligned_cols=254 Identities=22% Similarity=0.317 Sum_probs=200.1
Q ss_pred EcCceeeEEEeEeccCceEEEEEEe-----cCCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhH
Q 003052 469 VNGKLYQRLGKIGSGGSSEVHKVIS-----SDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTE 543 (853)
Q Consensus 469 v~g~~Y~ilk~LG~G~FG~Vyka~~-----~~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e 543 (853)
+.++.|+++++||+|+||.||++.. .+++.||||+++... .......+.+|+++|++++ |+||+++++++..
T Consensus 28 ~~~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~- 104 (318)
T 3lxp_A 28 FHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADA-GPQHRSGWKQEIDILRTLY-HEHIIKYKGCCED- 104 (318)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTC-CHHHHHHHHHHHHHHHHCC-CTTBCCEEEEEEE-
T ss_pred ecHHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEecccc-ChHHHHHHHHHHHHHHhCC-CcchhhEEEEEec-
Confidence 3445569999999999999998864 267889999998653 3445567899999999998 8999999987432
Q ss_pred HHHHHHHhhCCCCCCCCccccCCeEEEEEecchh-hHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCcee
Q 003052 544 KALLREVLNGSMNNKDGRVKDDGYIYMVLEYGEI-DLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIV 622 (853)
Q Consensus 544 ~~iL~~l~~~~iv~~~g~~~d~~~lyLVmEy~~g-dL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gII 622 (853)
.+...+|+||||+.+ +|.+++.. ..+++..++.++.||+.||.|||++||+
T Consensus 105 -------------------~~~~~~~lv~e~~~~~~L~~~l~~---------~~~~~~~~~~i~~~l~~~l~~LH~~~iv 156 (318)
T 3lxp_A 105 -------------------AGAASLQLVMEYVPLGSLRDYLPR---------HSIGLAQLLLFAQQICEGMAYLHAQHYI 156 (318)
T ss_dssp -------------------TTTTEEEEEECCCTTCBHHHHGGG---------SCCCHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred -------------------CCCceEEEEEecccCCcHHHHHhh---------CCCCHHHHHHHHHHHHHHHHHHHhCCcc
Confidence 224679999999864 99888754 2599999999999999999999999999
Q ss_pred eCCCCCccEEee-cCcEEEEecccchhcccCCcc-ccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHH
Q 003052 623 HSDLKPANFLLV-KGSLKLIDFGIAKAIMSDTTN-IQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCIL 700 (853)
Q Consensus 623 HRDLKPeNILL~-~g~VKL~DFGlAk~~~~~~~~-~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVIL 700 (853)
||||||+|||++ ++.+||+|||+++........ .......||+.|+|||++.+. .++.++|||||||++
T Consensus 157 H~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~---------~~~~~~Di~slG~il 227 (318)
T 3lxp_A 157 HRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEY---------KFYYASDVWSFGVTL 227 (318)
T ss_dssp CSCCSGGGEEECTTCCEEECCGGGCEECCTTCSEEEC---CCCCGGGCCHHHHHHC---------EEEHHHHHHHHHHHH
T ss_pred CCCCchheEEEcCCCCEEECCccccccccccccccccccCCCCCceeeChHHhcCC---------CCCcHHHHHHHHHHH
Confidence 999999999994 568999999999876543221 122356789999999999765 356799999999999
Q ss_pred HHHHhCCCCCCcchhHH--------------HHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCCChhHHhc
Q 003052 701 YQMVYGRTPFSEYKTFW--------------AKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQ 763 (853)
Q Consensus 701 yELLtG~~PF~~~~~~~--------------~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~ 763 (853)
|+|++|..||....... .....+. .......+...++.+.+||.+||..||.+|||+.++++
T Consensus 228 ~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 303 (318)
T 3lxp_A 228 YELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLE-RGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIP 303 (318)
T ss_dssp HHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHHHHH-TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHhCCCcccccchhhhhhhcccccchhHHHHHHHHh-cccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 99999999996532211 1111121 22334455677899999999999999999999999984
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-40 Score=359.55 Aligned_cols=262 Identities=20% Similarity=0.215 Sum_probs=191.7
Q ss_pred eEEcCceeeEEEeEeccCceEEEEEEec----CCcEEEEEEEecCCCChh---------hHhhHHHHHHHHHHhcCCCce
Q 003052 467 FKVNGKLYQRLGKIGSGGSSEVHKVISS----DCTIYALKKIKLKGRDYA---------TAYGFCQEIEYLNKLKGKNNI 533 (853)
Q Consensus 467 ~~v~g~~Y~ilk~LG~G~FG~Vyka~~~----~g~~vAVKkik~~~~~~~---------~~~~~l~EI~iLkkL~~hpNI 533 (853)
..+.+++|++.+.||+|+||.||+|.+. ++..||||++........ ....+.+|+.+++.+. |+||
T Consensus 32 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~-h~ni 110 (345)
T 2v62_A 32 DDMEGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLD-YLGI 110 (345)
T ss_dssp ECTTSCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCS-CCCC
T ss_pred ccccCceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhcccc-ccCc
Confidence 3455688999999999999999999985 567899999986543211 1123556777777775 8889
Q ss_pred eEeeehhhhHHHHHHHHhhCCCCCCCCccccCCeEEEEEecchhhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhh
Q 003052 534 IQLIDYEVTEKALLREVLNGSMNNKDGRVKDDGYIYMVLEYGEIDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAV 613 (853)
Q Consensus 534 V~Lid~~~~e~~iL~~l~~~~iv~~~g~~~d~~~lyLVmEy~~gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL 613 (853)
+++++++..+ +.+..++|+||||++++|.+++... ..+++..++.|+.||+.||
T Consensus 111 ~~~~~~~~~~------------------~~~~~~~~lv~e~~~~~L~~~l~~~--------~~~~~~~~~~i~~qi~~aL 164 (345)
T 2v62_A 111 PLFYGSGLTE------------------FKGRSYRFMVMERLGIDLQKISGQN--------GTFKKSTVLQLGIRMLDVL 164 (345)
T ss_dssp CCEEEEEEEE------------------SSSCEEEEEEEECEEEEHHHHCBGG--------GBCCHHHHHHHHHHHHHHH
T ss_pred ceeecccccc------------------cCCCcEEEEEEeccCCCHHHHHHhc--------CCCCHHHHHHHHHHHHHHH
Confidence 8888874321 2347789999999988999988654 3799999999999999999
Q ss_pred hhcccCceeeCCCCCccEEee-cC--cEEEEecccchhcccCCcc-----ccccccccCccccCchhhccCCCCCCCccc
Q 003052 614 NTIHEERIVHSDLKPANFLLV-KG--SLKLIDFGIAKAIMSDTTN-----IQRDSQVGTLSYMSPEAFMCNESDENGNII 685 (853)
Q Consensus 614 ~yLHs~gIIHRDLKPeNILL~-~g--~VKL~DFGlAk~~~~~~~~-----~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~ 685 (853)
.|||++||+||||||+|||++ ++ .+||+|||+|+.+...... ......+||+.|+|||++.+..
T Consensus 165 ~~LH~~~ivH~Dlkp~NIll~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-------- 236 (345)
T 2v62_A 165 EYIHENEYVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVA-------- 236 (345)
T ss_dssp HHHHHTTEECSCCSGGGEEEESSSTTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCC--------
T ss_pred HHHHhCCeeCCCcCHHHEEEccCCCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCC--------
Confidence 999999999999999999995 44 8999999999876432211 1124568999999999998653
Q ss_pred cCCCccchhhhHHHHHHHHhCCCCCCcch-h---HHHHHHhhcCCCCc----ccCCCCCChhHHHHHHHhcccCCCCCCC
Q 003052 686 KCGRPSDIWSLGCILYQMVYGRTPFSEYK-T---FWAKFKVITDPNHE----ITYEPVPNPWLLDLMKKCLAWDRNERWR 757 (853)
Q Consensus 686 ~ys~ksDIWSLGVILyELLtG~~PF~~~~-~---~~~~~kii~~~~~~----~~~~~~~s~~l~dLI~kcL~~DP~kRpT 757 (853)
++.++|||||||++|||++|+.||.+.. . .............. .......+.++.+||.+||..||.+||+
T Consensus 237 -~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps 315 (345)
T 2v62_A 237 -LSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVAVQTAKTNLLDELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPN 315 (345)
T ss_dssp -CCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHHHHHHHHHHHHTTTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCC
T ss_pred -CCchhhHHHHHHHHHHHHhCCCCccccccccHHHHHHHHhhcccccHHHHhhccccccHHHHHHHHHHHhhcCcccCCC
Confidence 5789999999999999999999995421 1 11111111100000 0011257789999999999999999999
Q ss_pred hhHHhcC
Q 003052 758 IPQLLQH 764 (853)
Q Consensus 758 a~EIL~H 764 (853)
+.+|++.
T Consensus 316 ~~~l~~~ 322 (345)
T 2v62_A 316 YQALKKI 322 (345)
T ss_dssp HHHHHHH
T ss_pred HHHHHHH
Confidence 9998864
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=373.83 Aligned_cols=252 Identities=20% Similarity=0.361 Sum_probs=204.7
Q ss_pred EEcCceeeEEEeEeccCceEEEEEEec-CCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHH
Q 003052 468 KVNGKLYQRLGKIGSGGSSEVHKVISS-DCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKAL 546 (853)
Q Consensus 468 ~v~g~~Y~ilk~LG~G~FG~Vyka~~~-~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~i 546 (853)
.+....|++.++||+|+||.||+|.+. ++..||||+++..... ...|.+|+.+|++++ |+||++++++
T Consensus 216 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~-hpniv~l~~~------- 284 (495)
T 1opk_A 216 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME---VEEFLKEAAVMKEIK-HPNLVQLLGV------- 284 (495)
T ss_dssp BCCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSSC---HHHHHHHHHHHHHCC-CTTBCCEEEE-------
T ss_pred ccCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcccc---hHHHHHHHHHHHhcC-CCCEeeEEEE-------
Confidence 344567999999999999999999985 4788999999765433 456899999999997 9999999987
Q ss_pred HHHHhhCCCCCCCCccccCCeEEEEEecch-hhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCC
Q 003052 547 LREVLNGSMNNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSD 625 (853)
Q Consensus 547 L~~l~~~~iv~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRD 625 (853)
+.+...+||||||+. ++|.+++... ....+++..++.|+.||+.||.|||++||+|||
T Consensus 285 ---------------~~~~~~~~lv~E~~~~g~L~~~l~~~------~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrD 343 (495)
T 1opk_A 285 ---------------CTREPPFYIITEFMTYGNLLDYLREC------NRQEVSAVVLLYMATQISSAMEYLEKKNFIHRN 343 (495)
T ss_dssp ---------------ECSSSSCEEEEECCTTCBHHHHHHHS------CTTTSCHHHHHHHHHHHHHHHHHHHHTTEECSC
T ss_pred ---------------EecCCcEEEEEEccCCCCHHHHHHhc------CcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCC
Confidence 345567899999986 6999998754 235689999999999999999999999999999
Q ss_pred CCCccEEe-ecCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHH
Q 003052 626 LKPANFLL-VKGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMV 704 (853)
Q Consensus 626 LKPeNILL-~~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELL 704 (853)
|||+|||| .++.+||+|||+++....... .......+++.|+|||++.+. .|+.++|||||||+||||+
T Consensus 344 lkp~NIll~~~~~~kl~DFG~a~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~---------~~~~~sDvwSlG~~l~el~ 413 (495)
T 1opk_A 344 LAARNCLVGENHLVKVADFGLSRLMTGDTY-TAHAGAKFPIKWTAPESLAYN---------KFSIKSDVWAFGVLLWEIA 413 (495)
T ss_dssp CSGGGEEECGGGCEEECCTTCEECCTTCCE-ECCTTCCCCGGGCCHHHHHHC---------EECHHHHHHHHHHHHHHHH
T ss_pred CChhhEEECCCCcEEEeecccceeccCCce-eecCCCcCCcceeCHhHHhcC---------CCCcHHhHHhHHHHHHHHH
Confidence 99999999 567999999999987643221 122345678899999999764 3678999999999999999
Q ss_pred h-CCCCCCcchhHHHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCCChhHHhc
Q 003052 705 Y-GRTPFSEYKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQ 763 (853)
Q Consensus 705 t-G~~PF~~~~~~~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~ 763 (853)
+ |..||.+..... ....+.. ......+...++.+.+||.+||..||.+|||+.+|++
T Consensus 414 t~g~~p~~~~~~~~-~~~~~~~-~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~ 471 (495)
T 1opk_A 414 TYGMSPYPGIDLSQ-VYELLEK-DYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ 471 (495)
T ss_dssp TTSCCSSTTCCGGG-HHHHHHT-TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred hCCCCCCCCCCHHH-HHHHHHc-CCCCCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHH
Confidence 8 999997654322 2222221 2333455677899999999999999999999999986
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-40 Score=353.87 Aligned_cols=264 Identities=18% Similarity=0.218 Sum_probs=202.2
Q ss_pred EEcCceeeEEEeEeccCceEEEEEEecCCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHH
Q 003052 468 KVNGKLYQRLGKIGSGGSSEVHKVISSDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALL 547 (853)
Q Consensus 468 ~v~g~~Y~ilk~LG~G~FG~Vyka~~~~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL 547 (853)
.+..+.|++.+.||+|+||.||+|.+.. .+|+|+++...........+.+|+.++++++ |+||++++++
T Consensus 29 ~i~~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~-------- 97 (319)
T 2y4i_B 29 DIPFEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTR-HENVVLFMGA-------- 97 (319)
T ss_dssp SSCCSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCC-CTTBCCCCEE--------
T ss_pred cCCHHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCC-CCCEeEEEEE--------
Confidence 3445679999999999999999998854 4999999876554445556788999999997 8999999887
Q ss_pred HHHhhCCCCCCCCccccCCeEEEEEecch-hhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCC
Q 003052 548 REVLNGSMNNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDL 626 (853)
Q Consensus 548 ~~l~~~~iv~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDL 626 (853)
+.+...+|+||||+. ++|.+++... ...+++..++.++.||+.||.|||++||+||||
T Consensus 98 --------------~~~~~~~~iv~e~~~~~~L~~~l~~~-------~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl 156 (319)
T 2y4i_B 98 --------------CMSPPHLAIITSLCKGRTLYSVVRDA-------KIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDL 156 (319)
T ss_dssp --------------EECSSCEEEECBCCCSEEHHHHTTSS-------CCCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCC
T ss_pred --------------EecCCceEEEeecccCCcHHHHHHhc-------CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCC
Confidence 445667999999986 6888887542 346999999999999999999999999999999
Q ss_pred CCccEEeecCcEEEEecccchhcccCC---ccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHH
Q 003052 627 KPANFLLVKGSLKLIDFGIAKAIMSDT---TNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQM 703 (853)
Q Consensus 627 KPeNILL~~g~VKL~DFGlAk~~~~~~---~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyEL 703 (853)
||+|||++++.+||+|||+++...... .........||+.|+|||++.+...........|+.++|||||||++|+|
T Consensus 157 kp~NIl~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el 236 (319)
T 2y4i_B 157 KSKNVFYDNGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYEL 236 (319)
T ss_dssp CSTTEEEC--CCEECCCSCCC----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHH
T ss_pred ChhhEEEeCCCEEEeecCCccccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHH
Confidence 999999998999999999987543211 11122345799999999999764322211223578899999999999999
Q ss_pred HhCCCCCCcchhHHHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCCChhHHhcC
Q 003052 704 VYGRTPFSEYKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQH 764 (853)
Q Consensus 704 LtG~~PF~~~~~~~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~H 764 (853)
++|+.||.............. ...........+.++.+||.+||..||.+|||+.++++.
T Consensus 237 ~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~ 296 (319)
T 2y4i_B 237 HAREWPFKTQPAEAIIWQMGT-GMKPNLSQIGMGKEISDILLFCWAFEQEERPTFTKLMDM 296 (319)
T ss_dssp HHSSCSSSSCCHHHHHHHHHT-TCCCCCCCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHH
T ss_pred HhCCCCCCCCCHHHHHHHhcc-CCCCCCCcCCCCHHHHHHHHHHhcCChhhCcCHHHHHHH
Confidence 999999987554433333222 222222233567889999999999999999999999974
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-39 Score=349.05 Aligned_cols=255 Identities=21% Similarity=0.297 Sum_probs=197.0
Q ss_pred EEcCceeeEEEeEeccCceEEEEEEecC-----CcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhh
Q 003052 468 KVNGKLYQRLGKIGSGGSSEVHKVISSD-----CTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVT 542 (853)
Q Consensus 468 ~v~g~~Y~ilk~LG~G~FG~Vyka~~~~-----g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~ 542 (853)
.+....|.+.+.||+|+||.||+|.+.. +..||||+++... .......+.+|+.++++++ |+||++++++
T Consensus 40 ~i~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~--- 114 (333)
T 1mqb_A 40 EIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY-TEKQRVDFLGEAGIMGQFS-HHNIIRLEGV--- 114 (333)
T ss_dssp BCCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHTCC-CTTBCCEEEE---
T ss_pred cCChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCC-CHHHHHHHHHHHHHHHhCC-CCCCCcEEEE---
Confidence 3456779999999999999999998742 2359999997543 3344557889999999997 8999999987
Q ss_pred HHHHHHHHhhCCCCCCCCccccCCeEEEEEecchh-hHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCce
Q 003052 543 EKALLREVLNGSMNNKDGRVKDDGYIYMVLEYGEI-DLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERI 621 (853)
Q Consensus 543 e~~iL~~l~~~~iv~~~g~~~d~~~lyLVmEy~~g-dL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gI 621 (853)
+.+...+|+||||+++ +|.+++... ...+++..++.++.||+.||.|||++||
T Consensus 115 -------------------~~~~~~~~lv~e~~~~~~L~~~l~~~-------~~~~~~~~~~~i~~qi~~aL~~LH~~~i 168 (333)
T 1mqb_A 115 -------------------ISKYKPMMIITEYMENGALDKFLREK-------DGEFSVLQLVGMLRGIAAGMKYLANMNY 168 (333)
T ss_dssp -------------------ECSSSSEEEEEECCTTEEHHHHHHHT-------TTCSCHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred -------------------EecCCCcEEEEeCCCCCcHHHHHHhC-------CCCCCHHHHHHHHHHHHHHHHHHHhCCe
Confidence 4556789999999865 999888653 3579999999999999999999999999
Q ss_pred eeCCCCCccEEee-cCcEEEEecccchhcccCCcc-ccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHH
Q 003052 622 VHSDLKPANFLLV-KGSLKLIDFGIAKAIMSDTTN-IQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCI 699 (853)
Q Consensus 622 IHRDLKPeNILL~-~g~VKL~DFGlAk~~~~~~~~-~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVI 699 (853)
+||||||+|||++ ++.+||+|||+++........ .......||+.|+|||++.+. .++.++|||||||+
T Consensus 169 vH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~---------~~~~~~Di~slG~i 239 (333)
T 1mqb_A 169 VHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYR---------KFTSASDVWSFGIV 239 (333)
T ss_dssp CCSCCCGGGEEECTTCCEEECCCCC-----------------CCCGGGSCHHHHHSC---------CCCHHHHHHHHHHH
T ss_pred eCCCCChheEEECCCCcEEECCCCcchhhccccccccccCCCCccccccCchhcccC---------CCCchhhhHHHHHH
Confidence 9999999999994 679999999999876543211 112234568899999999765 35679999999999
Q ss_pred HHHHHh-CCCCCCcchhHHHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCCChhHHhcC
Q 003052 700 LYQMVY-GRTPFSEYKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQH 764 (853)
Q Consensus 700 LyELLt-G~~PF~~~~~~~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~H 764 (853)
+|+|++ |+.||.+......... +... .....+...+..+.+||.+||..||.+||++.+++++
T Consensus 240 l~ellt~g~~pf~~~~~~~~~~~-~~~~-~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~ 303 (333)
T 1mqb_A 240 MWEVMTYGERPYWELSNHEVMKA-INDG-FRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSI 303 (333)
T ss_dssp HHHHHTTSCCTTTTCCHHHHHHH-HHTT-CCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred HHHHHcCCCCCcccCCHHHHHHH-HHCC-CcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 999998 9999976554332222 2221 2233455678899999999999999999999999864
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-39 Score=340.18 Aligned_cols=251 Identities=19% Similarity=0.272 Sum_probs=194.9
Q ss_pred ceeeEEEeEeccCceEEEEEEec-CC---cEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHH
Q 003052 472 KLYQRLGKIGSGGSSEVHKVISS-DC---TIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALL 547 (853)
Q Consensus 472 ~~Y~ilk~LG~G~FG~Vyka~~~-~g---~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL 547 (853)
..|.+.++||+|+||.||+|.+. ++ ..||+|++... ........+.+|+.++++++ |+||+++++++.
T Consensus 21 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~-~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~------ 92 (298)
T 3pls_A 21 VVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRI-TEMQQVEAFLREGLLMRGLN-HPNVLALIGIML------ 92 (298)
T ss_dssp EEEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTC-CSHHHHHHHHHHHHHHHTCC-CTTBCCCCEEEC------
T ss_pred eEEccCceeccCCCceEEEEEEecCCCceeeeeeeecccc-ccHHHHHHHHHHHHHHHhCC-CCCeeeEEEEEe------
Confidence 45888899999999999999863 22 37999998753 33455667899999999997 999999998742
Q ss_pred HHHhhCCCCCCCCccccCCeEEEEEecc-hhhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCC
Q 003052 548 REVLNGSMNNKDGRVKDDGYIYMVLEYG-EIDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDL 626 (853)
Q Consensus 548 ~~l~~~~iv~~~g~~~d~~~lyLVmEy~-~gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDL 626 (853)
..+...|+||||+ +++|.+++... ...+++..++.++.||+.||.|||++||+||||
T Consensus 93 ---------------~~~~~~~~v~e~~~~~~L~~~~~~~-------~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~di 150 (298)
T 3pls_A 93 ---------------PPEGLPHVLLPYMCHGDLLQFIRSP-------QRNPTVKDLISFGLQVARGMEYLAEQKFVHRDL 150 (298)
T ss_dssp ---------------CSSSCCEEEECCCTTCBHHHHHHCT-------TCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCC
T ss_pred ---------------cCCCCcEEEEecccCCCHHHHHhcc-------ccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCC
Confidence 2234458999996 56999888642 357899999999999999999999999999999
Q ss_pred CCccEEee-cCcEEEEecccchhcccCC--ccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHH
Q 003052 627 KPANFLLV-KGSLKLIDFGIAKAIMSDT--TNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQM 703 (853)
Q Consensus 627 KPeNILL~-~g~VKL~DFGlAk~~~~~~--~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyEL 703 (853)
||+|||++ ++.+||+|||+++.+.... .........||+.|+|||++.+. .++.++|||||||++|+|
T Consensus 151 kp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~---------~~~~~~Di~slG~il~~l 221 (298)
T 3pls_A 151 AARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALESLQTY---------RFTTKSDVWSFGVLLWEL 221 (298)
T ss_dssp SGGGEEECTTCCEEECCTTSSCTTTTGGGGCSCCSSCTTCGGGGSCHHHHTTC---------CCCHHHHHHHHHHHHHHH
T ss_pred CcceEEEcCCCcEEeCcCCCcccccCCcccccccCcCCCCCccccChhhhccC---------CCChhhchhhHHHHHHHH
Confidence 99999995 5699999999998654322 11122356789999999999765 356899999999999999
Q ss_pred HhC-CCCCCcchhHHHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCCChhHHhc
Q 003052 704 VYG-RTPFSEYKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQ 763 (853)
Q Consensus 704 LtG-~~PF~~~~~~~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~ 763 (853)
++| .+||....... ....+.. ......+...+..+.+||.+||..||.+|||+.++++
T Consensus 222 ~~g~~~~~~~~~~~~-~~~~~~~-~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~ 280 (298)
T 3pls_A 222 LTRGAPPYRHIDPFD-LTHFLAQ-GRRLPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVG 280 (298)
T ss_dssp HHTSCCTTTTSCGGG-HHHHHHT-TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred hhCCCCCCccCCHHH-HHHHhhc-CCCCCCCccchHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 995 55554433322 2222221 1223345567889999999999999999999999885
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=343.21 Aligned_cols=247 Identities=26% Similarity=0.368 Sum_probs=192.1
Q ss_pred EEcCceeeEEEeEeccCceEEEEEEecCCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHH
Q 003052 468 KVNGKLYQRLGKIGSGGSSEVHKVISSDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALL 547 (853)
Q Consensus 468 ~v~g~~Y~ilk~LG~G~FG~Vyka~~~~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL 547 (853)
.+..+.|++.+.||+|+||.||+|.+. ++.||||+++... ....+.+|+.++++++ |+||+++++++.
T Consensus 17 ~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~----~~~~~~~E~~~l~~l~-h~~iv~~~~~~~------ 84 (278)
T 1byg_A 17 ALNMKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA----TAQAFLAEASVMTQLR-HSNLVQLLGVIV------ 84 (278)
T ss_dssp BCCGGGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCCC------HHHHHTHHHHTTCC-CTTBCCEEEEEC------
T ss_pred cCChhhceEEeEEecCCCceEEEEEEc-CCEEEEEEecchh----HHHHHHHHHHHHHhCC-CCCEeeEEEEEE------
Confidence 345578999999999999999999874 7789999997542 3456889999999997 899999998732
Q ss_pred HHHhhCCCCCCCCccccCCeEEEEEecchh-hHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCC
Q 003052 548 REVLNGSMNNKDGRVKDDGYIYMVLEYGEI-DLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDL 626 (853)
Q Consensus 548 ~~l~~~~iv~~~g~~~d~~~lyLVmEy~~g-dL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDL 626 (853)
...+.+|+||||+++ +|.+++..... ..+++..++.++.||+.||.|||++||+||||
T Consensus 85 ---------------~~~~~~~lv~e~~~~~~L~~~l~~~~~------~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl 143 (278)
T 1byg_A 85 ---------------EEKGGLYIVTEYMAKGSLVDYLRSRGR------SVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDL 143 (278)
T ss_dssp ---------------CC--CCEEEECCCTTEEHHHHHHHHHH------HHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCC
T ss_pred ---------------cCCCceEEEEecCCCCCHHHHHHhccc------ccCCHHHHHHHHHHHHHHHHHHHhCCccccCC
Confidence 234468999999865 99999876421 24889999999999999999999999999999
Q ss_pred CCccEEee-cCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHh
Q 003052 627 KPANFLLV-KGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVY 705 (853)
Q Consensus 627 KPeNILL~-~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLt 705 (853)
||+|||++ ++.+||+|||+++...... ....+++.|+|||++.+.. ++.++|||||||++|+|++
T Consensus 144 kp~Nil~~~~~~~~l~Dfg~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~---------~~~~~Di~slG~il~~l~t 209 (278)
T 1byg_A 144 AARNVLVSEDNVAKVSDFGLTKEASSTQ-----DTGKLPVKWTAPEALREKK---------FSTKSDVWSFGILLWEIYS 209 (278)
T ss_dssp SGGGEEECTTSCEEECCCCC-----------------CCTTTSCHHHHHHCC---------CCHHHHHHHHHHHHHHHHT
T ss_pred CcceEEEeCCCcEEEeeccccccccccc-----cCCCccccccCHHHhCCCC---------CCchhcHHHHHHHHHHHHh
Confidence 99999994 6799999999998654321 2447899999999997653 5679999999999999998
Q ss_pred -CCCCCCcchhHHHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCCChhHHhc
Q 003052 706 -GRTPFSEYKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQ 763 (853)
Q Consensus 706 -G~~PF~~~~~~~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~ 763 (853)
|+.||........ ...+.. ......+...++.+.+||.+||..||.+||++.++++
T Consensus 210 ~g~~p~~~~~~~~~-~~~~~~-~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 266 (278)
T 1byg_A 210 FGRVPYPRIPLKDV-VPRVEK-GYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLRE 266 (278)
T ss_dssp TSCCSCTTSCGGGH-HHHHTT-TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCCCCCCCCHHHH-HHHHhc-CCCCCCcccCCHHHHHHHHHHhcCChhhCCCHHHHHH
Confidence 9999976433222 222221 2233455677899999999999999999999999985
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-39 Score=340.81 Aligned_cols=257 Identities=20% Similarity=0.296 Sum_probs=194.7
Q ss_pred eEEcCceeeEEEeEeccCceEEEEEEec--CCc--EEEEEEEecCCC-ChhhHhhHHHHHHHHHHhcCCCceeEeeehhh
Q 003052 467 FKVNGKLYQRLGKIGSGGSSEVHKVISS--DCT--IYALKKIKLKGR-DYATAYGFCQEIEYLNKLKGKNNIIQLIDYEV 541 (853)
Q Consensus 467 ~~v~g~~Y~ilk~LG~G~FG~Vyka~~~--~g~--~vAVKkik~~~~-~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~ 541 (853)
..+..++|++++.||+|+||.||+|.+. +++ .||||+++.... .......+.+|++++++++ |+||+++++++.
T Consensus 13 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~ 91 (291)
T 1u46_A 13 CLIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLD-HRNLIRLYGVVL 91 (291)
T ss_dssp EECCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCC-CTTBCCEEEEEC
T ss_pred cccchhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCC-CCCcccEEEEEc
Confidence 4566788999999999999999999863 333 689999976532 3345567899999999997 999999998742
Q ss_pred hHHHHHHHHhhCCCCCCCCccccCCeEEEEEecch-hhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCc
Q 003052 542 TEKALLREVLNGSMNNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEER 620 (853)
Q Consensus 542 ~e~~iL~~l~~~~iv~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~g 620 (853)
+. .+++||||+. ++|.+++... ...+++..++.++.||+.||.|||++|
T Consensus 92 ----------------------~~-~~~~v~e~~~~~~L~~~l~~~-------~~~~~~~~~~~~~~~i~~~l~~lH~~~ 141 (291)
T 1u46_A 92 ----------------------TP-PMKMVTELAPLGSLLDRLRKH-------QGHFLLGTLSRYAVQVAEGMGYLESKR 141 (291)
T ss_dssp ----------------------SS-SCEEEEECCTTCBHHHHHHHH-------GGGSCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred ----------------------cC-CceeeEecccCCCHHHHHHhc-------cCCcCHHHHHHHHHHHHHHHHHHHhCC
Confidence 22 3789999976 5899888764 145899999999999999999999999
Q ss_pred eeeCCCCCccEEe-ecCcEEEEecccchhcccCCcc-ccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHH
Q 003052 621 IVHSDLKPANFLL-VKGSLKLIDFGIAKAIMSDTTN-IQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGC 698 (853)
Q Consensus 621 IIHRDLKPeNILL-~~g~VKL~DFGlAk~~~~~~~~-~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGV 698 (853)
|+||||||+|||+ .++.+||+|||+++........ .......||+.|+|||++.+. .++.++|||||||
T Consensus 142 i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~---------~~~~~~Di~slG~ 212 (291)
T 1u46_A 142 FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTR---------TFSHASDTWMFGV 212 (291)
T ss_dssp EECSCCCGGGEEEEETTEEEECCCTTCEECCC-CCEEEC-----CCGGGCCHHHHHHC---------EEEHHHHHHHHHH
T ss_pred cccCCCchheEEEcCCCCEEEccccccccccccccchhhhccCCCCceeeCchhhcCC---------CCCchhhHHHHHH
Confidence 9999999999999 5779999999999876443221 122345688899999999764 3567999999999
Q ss_pred HHHHHHh-CCCCCCcchhHHHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCCChhHHhcC
Q 003052 699 ILYQMVY-GRTPFSEYKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQH 764 (853)
Q Consensus 699 ILyELLt-G~~PF~~~~~~~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~H 764 (853)
++|+|++ |+.||.+.........+ .........+...+.++.+||.+||..||.+||++.+++++
T Consensus 213 il~~l~~~g~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~ 278 (291)
T 1u46_A 213 TLWEMFTYGQEPWIGLNGSQILHKI-DKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDF 278 (291)
T ss_dssp HHHHHHTTSCCTTTTCCHHHHHHHH-HTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHhCCCCCcccCCHHHHHHHH-HccCCCCCCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence 9999999 99999876544333333 22233344556778999999999999999999999999963
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-39 Score=367.42 Aligned_cols=257 Identities=25% Similarity=0.300 Sum_probs=201.4
Q ss_pred EEcCceeeEEEeEeccCceEEEEEEecCCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHH
Q 003052 468 KVNGKLYQRLGKIGSGGSSEVHKVISSDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALL 547 (853)
Q Consensus 468 ~v~g~~Y~ilk~LG~G~FG~Vyka~~~~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL 547 (853)
.+..+.|++.++||+|+||.||+|.+.++..||||+++..... ...+.+|+.+|++++ |+||+++++++
T Consensus 180 ~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~-hp~iv~~~~~~------- 248 (452)
T 1fmk_A 180 EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS---PEAFLQEAQVMKKLR-HEKLVQLYAVV------- 248 (452)
T ss_dssp BCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSSC---HHHHHHHHHHHHHCC-CTTBCCEEEEE-------
T ss_pred ccChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCCCC---HHHHHHHHHHHHhCC-CCCEeeEEEEE-------
Confidence 3455779999999999999999999988788999999865433 346889999999997 89999999863
Q ss_pred HHHhhCCCCCCCCccccCCeEEEEEecch-hhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCC
Q 003052 548 REVLNGSMNNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDL 626 (853)
Q Consensus 548 ~~l~~~~iv~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDL 626 (853)
.+ ..+|+||||+. ++|.+++.... ...+++..+..++.||+.||.|||++||+||||
T Consensus 249 ---------------~~-~~~~iv~e~~~~gsL~~~l~~~~------~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDl 306 (452)
T 1fmk_A 249 ---------------SE-EPIYIVTEYMSKGSLLDFLKGET------GKYLRLPQLVDMAAQIASGMAYVERMNYVHRDL 306 (452)
T ss_dssp ---------------CS-SSCEEEECCCTTCBHHHHHSHHH------HTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCC
T ss_pred ---------------cC-CceEEEehhhcCCCHHHHHHhcC------CCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCC
Confidence 22 45799999986 59999987541 246899999999999999999999999999999
Q ss_pred CCccEEee-cCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHh
Q 003052 627 KPANFLLV-KGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVY 705 (853)
Q Consensus 627 KPeNILL~-~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLt 705 (853)
||+|||++ ++.+||+|||+++....... .......+++.|+|||++.+. .|+.++|||||||++|||++
T Consensus 307 kp~Nill~~~~~~kl~DfG~a~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~---------~~~~~sDvwslG~~l~el~t 376 (452)
T 1fmk_A 307 RAANILVGENLVCKVADFGLARLIEDNEY-TARQGAKFPIKWTAPEAALYG---------RFTIKSDVWSFGILLTELTT 376 (452)
T ss_dssp SGGGEEECGGGCEEECCCCTTC---------------CCGGGSCHHHHHHC---------CCCHHHHHHHHHHHHHHHHT
T ss_pred ChhhEEECCCCCEEECCCccceecCCCce-ecccCCcccccccCHhHHhcC---------CCCccccHHhHHHHHHHHHh
Confidence 99999994 57999999999987643221 122345678899999999765 35789999999999999999
Q ss_pred -CCCCCCcchhHHHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCCChhHHhcC--CCCCC
Q 003052 706 -GRTPFSEYKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQH--PFLVP 769 (853)
Q Consensus 706 -G~~PF~~~~~~~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~H--Pwf~~ 769 (853)
|+.||.+.........+.. ......+...++.+.+||.+||..||.+|||+.+|++. .++..
T Consensus 377 ~g~~P~~~~~~~~~~~~i~~--~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~ 441 (452)
T 1fmk_A 377 KGRVPYPGMVNREVLDQVER--GYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 441 (452)
T ss_dssp TTCCSSTTCCHHHHHHHHHT--TCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSC
T ss_pred CCCCCCCCCCHHHHHHHHHc--CCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhcc
Confidence 9999987554433322222 22334456778899999999999999999999999873 55543
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-39 Score=346.75 Aligned_cols=246 Identities=24% Similarity=0.361 Sum_probs=188.6
Q ss_pred EcCceeeEEEeEeccCceEEEEEEecCCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHH
Q 003052 469 VNGKLYQRLGKIGSGGSSEVHKVISSDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLR 548 (853)
Q Consensus 469 v~g~~Y~ilk~LG~G~FG~Vyka~~~~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~ 548 (853)
++.+.|++.+.||+|+||.||+|.+. ++.||||++... .....+.+|+++|++++ ||||+++++++.
T Consensus 5 i~~~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~----~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~------- 71 (307)
T 2eva_A 5 IDYKEIEVEEVVGRGAFGVVCKAKWR-AKDVAIKQIESE----SERKAFIVELRQLSRVN-HPNIVKLYGACL------- 71 (307)
T ss_dssp CCGGGEEEEEEEECCSSSEEEEEEET-TEEEEEEECSST----THHHHHHHHHHHHHHCC-CTTBCCEEEBCT-------
T ss_pred CCHhHeeeeeEeecCCCceEEEEEEC-CeeEEEEEecCh----hHHHHHHHHHHHHhcCC-CCCcCeEEEEEc-------
Confidence 34577999999999999999999874 678999998643 23456889999999997 999999998742
Q ss_pred HHhhCCCCCCCCccccCCeEEEEEecch-hhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhccc---CceeeC
Q 003052 549 EVLNGSMNNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHE---ERIVHS 624 (853)
Q Consensus 549 ~l~~~~iv~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs---~gIIHR 624 (853)
+.+|+||||+. ++|.+++.... ....+++..+..++.||+.||.|||+ +||+||
T Consensus 72 -----------------~~~~lv~e~~~~~~L~~~l~~~~-----~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~ 129 (307)
T 2eva_A 72 -----------------NPVCLVMEYAEGGSLYNVLHGAE-----PLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHR 129 (307)
T ss_dssp -----------------TTTEEEEECCTTCBHHHHHHCSS-----SEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCC
T ss_pred -----------------CCcEEEEEcCCCCCHHHHHhccC-----CCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecC
Confidence 12589999986 59998886431 12357899999999999999999999 899999
Q ss_pred CCCCccEEee-cCc-EEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHH
Q 003052 625 DLKPANFLLV-KGS-LKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQ 702 (853)
Q Consensus 625 DLKPeNILL~-~g~-VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyE 702 (853)
||||+|||++ ++. +||+|||+++..... .....||+.|+|||++.+. .++.++|||||||++|+
T Consensus 130 dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~---------~~~~~~Di~slG~il~e 195 (307)
T 2eva_A 130 DLKPPNLLLVAGGTVLKICDFGTACDIQTH-----MTNNKGSAAWMAPEVFEGS---------NYSEKCDVFSWGIILWE 195 (307)
T ss_dssp CCSGGGEEEETTTTEEEECCCCC-----------------CCTTSSCHHHHTCC---------CCCTHHHHHHHHHHHHH
T ss_pred CCChhHEEEeCCCCEEEEcccccccccccc-----cccCCCCCceEChhhhCCC---------CCCcHHHHHHHHHHHHH
Confidence 9999999995 454 899999999765332 1245799999999999764 35689999999999999
Q ss_pred HHhCCCCCCcchh-HHHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCCChhHHhcC
Q 003052 703 MVYGRTPFSEYKT-FWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQH 764 (853)
Q Consensus 703 LLtG~~PF~~~~~-~~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~H 764 (853)
|++|+.||..... .......... ..........+..+.+||.+||..||.+|||+.+++++
T Consensus 196 l~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 257 (307)
T 2eva_A 196 VITRRKPFDEIGGPAFRIMWAVHN-GTRPPLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKI 257 (307)
T ss_dssp HHHTCCTTTTTCSSHHHHHHHHHT-TCCCCCBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHCCCCchhhCccHHHHHHHHhc-CCCCCcccccCHHHHHHHHHHhcCChhhCcCHHHHHHH
Confidence 9999999975321 1111111111 12223445678899999999999999999999999873
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=363.14 Aligned_cols=266 Identities=22% Similarity=0.358 Sum_probs=198.8
Q ss_pred EEcCceeeEEEeEeccCceEEEEEEec-CCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHH
Q 003052 468 KVNGKLYQRLGKIGSGGSSEVHKVISS-DCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKAL 546 (853)
Q Consensus 468 ~v~g~~Y~ilk~LG~G~FG~Vyka~~~-~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~i 546 (853)
.+.+++|++.++||+|+||.||+|.+. +++.||||++..... ......+.+|+++|++++ |+||+++++++..
T Consensus 5 ~~~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~---- 78 (396)
T 4eut_A 5 STSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISF-LRPVDVQMREFEVLKKLN-HKNIVKLFAIEEE---- 78 (396)
T ss_dssp ECSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGG-GSCHHHHHHHHHHHHHCC-CTTBCCEEEEEEC----
T ss_pred CCCCCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccc-cchHHHHHHHHHHHHhcC-CCCCCeEEEeecc----
Confidence 345678999999999999999999985 578999999975432 223456789999999997 8999999987421
Q ss_pred HHHHhhCCCCCCCCccccCCeEEEEEecch-hhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCC
Q 003052 547 LREVLNGSMNNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSD 625 (853)
Q Consensus 547 L~~l~~~~iv~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRD 625 (853)
.+...+|+||||+. ++|.+++.... ....+++..++.++.||+.||.|||++||+|||
T Consensus 79 ----------------~~~~~~~lv~e~~~~g~L~~~l~~~~-----~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~D 137 (396)
T 4eut_A 79 ----------------TTTRHKVLIMEFCPCGSLYTVLEEPS-----NAYGLPESEFLIVLRDVVGGMNHLRENGIVHRN 137 (396)
T ss_dssp ----------------TTTCCEEEEECCCTTEEHHHHTTSGG-----GTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCC
T ss_pred ----------------CCCCeeEEEEecCCCCCHHHHHHhhh-----cccCCCHHHHHHHHHHHHHHHHHHHHCCEEECC
Confidence 23347899999985 59998886541 123499999999999999999999999999999
Q ss_pred CCCccEEe----e-cCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHH
Q 003052 626 LKPANFLL----V-KGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCIL 700 (853)
Q Consensus 626 LKPeNILL----~-~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVIL 700 (853)
|||+|||+ + ++.+||+|||+|+...... .....+||+.|+|||++.+..... .....|+.++|||||||++
T Consensus 138 lkp~NIll~~~~~~~~~~kL~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~-~~~~~~~~~~DiwSlG~il 213 (396)
T 4eut_A 138 IKPGNIMRVIGEDGQSVYKLTDFGAARELEDDE---QFVSLYGTEEYLHPDMYERAVLRK-DHQKKYGATVDLWSIGVTF 213 (396)
T ss_dssp CCGGGEEEEECTTSCEEEEECCGGGCEECCCGG---GSSCSSSCCTTCCHHHHHHHCC---CHHHHHHHHHHHHHHHHHH
T ss_pred cCHHHEEEeecCCCceeEEEecCCCceEccCCC---ccccccCCccccCHHHhhcccccc-ccccCCCcHHHHHHHHHHH
Confidence 99999998 2 2369999999998764432 223578999999999986521110 0012467899999999999
Q ss_pred HHHHhCCCCCCcc----hhHHHHHHhhcCCCCc------------------cc----CCCCCChhHHHHHHHhcccCCCC
Q 003052 701 YQMVYGRTPFSEY----KTFWAKFKVITDPNHE------------------IT----YEPVPNPWLLDLMKKCLAWDRNE 754 (853)
Q Consensus 701 yELLtG~~PF~~~----~~~~~~~kii~~~~~~------------------~~----~~~~~s~~l~dLI~kcL~~DP~k 754 (853)
|||++|+.||... .......+++...... .. +....+..+.+||.+||.+||.+
T Consensus 214 ~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~ 293 (396)
T 4eut_A 214 YHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEK 293 (396)
T ss_dssp HHHHHSSCSEECTTCTTTCHHHHHHHHHSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTT
T ss_pred HHHHHCCCCCCCCCcccchHHHHHHHhcCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhh
Confidence 9999999999532 1222233333221110 00 11122346889999999999999
Q ss_pred CCChhHHhcC
Q 003052 755 RWRIPQLLQH 764 (853)
Q Consensus 755 RpTa~EIL~H 764 (853)
||++.+++++
T Consensus 294 R~s~~e~l~~ 303 (396)
T 4eut_A 294 CWGFDQFFAE 303 (396)
T ss_dssp SCCHHHHHHH
T ss_pred hccHHHHHHH
Confidence 9999998543
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=350.07 Aligned_cols=268 Identities=21% Similarity=0.212 Sum_probs=191.5
Q ss_pred cCceeeEEEeEeccCceEEEEEEecCCcEEEEEEEecCCCChhhHhhHHHHHHHHHH-hcCCCceeEeeehhhhHHHHHH
Q 003052 470 NGKLYQRLGKIGSGGSSEVHKVISSDCTIYALKKIKLKGRDYATAYGFCQEIEYLNK-LKGKNNIIQLIDYEVTEKALLR 548 (853)
Q Consensus 470 ~g~~Y~ilk~LG~G~FG~Vyka~~~~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkk-L~~hpNIV~Lid~~~~e~~iL~ 548 (853)
+-+.|++++.||+|+||.||+|.. +++.||||++.... ...+..|.+++.. ...|+||+++++++..
T Consensus 11 ~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~-----~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~------ 78 (336)
T 3g2f_A 11 DLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFAN-----RQNFINEKNIYRVPLMEHDNIARFIVGDER------ 78 (336)
T ss_dssp CTTSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGGG-----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEE------
T ss_pred ChHHhheeeecccCCCeEEEEEEE-CCeEEEEEEeeccc-----hhhHHHHHHHHHHHhccCcchhhheecccc------
Confidence 346799999999999999999976 67899999997542 2234455555443 2349999999875321
Q ss_pred HHhhCCCCCCCCccccCCeEEEEEecch-hhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccC--------
Q 003052 549 EVLNGSMNNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEE-------- 619 (853)
Q Consensus 549 ~l~~~~iv~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~-------- 619 (853)
..+.+...+|+||||++ ++|.+++... .+++..++.++.||+.||.|||++
T Consensus 79 -----------~~~~~~~~~~lv~e~~~~g~L~~~l~~~---------~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~ 138 (336)
T 3g2f_A 79 -----------VTADGRMEYLLVMEYYPNGSLXKYLSLH---------TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYK 138 (336)
T ss_dssp -----------ECTTSCEEEEEEECCCTTCBHHHHHHHC---------CBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCB
T ss_pred -----------cccCCCceEEEEEecCCCCcHHHHHhhc---------ccchhHHHHHHHHHHHHHHHHHhhhccccccc
Confidence 01344567899999985 5999998653 468999999999999999999999
Q ss_pred -ceeeCCCCCccEEee-cCcEEEEecccchhcccCCc------cccccccccCccccCchhhccCCCCCCCccccCCCcc
Q 003052 620 -RIVHSDLKPANFLLV-KGSLKLIDFGIAKAIMSDTT------NIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPS 691 (853)
Q Consensus 620 -gIIHRDLKPeNILL~-~g~VKL~DFGlAk~~~~~~~------~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ks 691 (853)
||+||||||+|||++ ++.+||+|||+|+.+..... .......+||+.|+|||++.+..... ....++.++
T Consensus 139 ~~ivH~Dikp~Nill~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~--~~~~~~~~~ 216 (336)
T 3g2f_A 139 PAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLR--DXESALKQV 216 (336)
T ss_dssp CCEECSSCSGGGEEECTTSCEEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGG--GHHHHHHHH
T ss_pred cceeecccccceEEEcCCCcEEEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccc--ccccccccc
Confidence 999999999999995 57999999999987643211 11223568999999999997632210 112466799
Q ss_pred chhhhHHHHHHHHhCCCCCCcch-----------------hHHHHHHhhcCCCCcccCCCCC------ChhHHHHHHHhc
Q 003052 692 DIWSLGCILYQMVYGRTPFSEYK-----------------TFWAKFKVITDPNHEITYEPVP------NPWLLDLMKKCL 748 (853)
Q Consensus 692 DIWSLGVILyELLtG~~PF~~~~-----------------~~~~~~kii~~~~~~~~~~~~~------s~~l~dLI~kcL 748 (853)
|||||||++|||++|..||.... .................++... ++.+.+||.+||
T Consensus 217 DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl 296 (336)
T 3g2f_A 217 DMYALGLIYWEIFMRCTDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCW 296 (336)
T ss_dssp HHHHHHHHHHHHHTTBGGGSTTSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHS
T ss_pred chHHHHHHHHHHHhcCCcCCCccchhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHh
Confidence 99999999999999977763211 0111111122222222223222 236999999999
Q ss_pred ccCCCCCCChhHH------hcCCCCCCCC
Q 003052 749 AWDRNERWRIPQL------LQHPFLVPPV 771 (853)
Q Consensus 749 ~~DP~kRpTa~EI------L~HPwf~~~~ 771 (853)
..||.+|||+.|+ +.++|-+...
T Consensus 297 ~~dP~~Rps~~e~l~~L~~ll~~~~~~~~ 325 (336)
T 3g2f_A 297 DQDAEARLTAQXAEERMAELMMIWERNKS 325 (336)
T ss_dssp CSSGGGSCCHHHHHHHHHHHHHCCCC---
T ss_pred cCChhhCcchHHHHHHHHHHHHHHHhccc
Confidence 9999999999999 5578876543
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-39 Score=370.28 Aligned_cols=251 Identities=21% Similarity=0.282 Sum_probs=199.1
Q ss_pred CceeeEEEeEeccCceEEEEEEe-cCCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHHH
Q 003052 471 GKLYQRLGKIGSGGSSEVHKVIS-SDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLRE 549 (853)
Q Consensus 471 g~~Y~ilk~LG~G~FG~Vyka~~-~~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~~ 549 (853)
++.|+++++||+|+||.||+|.+ .+++.||||++...... ..+.+|+++++.|.++++|..+..+
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~----~~~~~E~~il~~L~~~~~i~~i~~~---------- 71 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH----PQLLYESKIYRILQGGTGIPNVRWF---------- 71 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSS----CCHHHHHHHHHHTTTSTTCCCEEEE----------
T ss_pred CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccccc----HHHHHHHHHHHHhcCCCCCCeEEEE----------
Confidence 46799999999999999999998 57889999998765432 2478999999999988888777654
Q ss_pred HhhCCCCCCCCccccCCeEEEEEecchhhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCCCc
Q 003052 550 VLNGSMNNKDGRVKDDGYIYMVLEYGEIDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPA 629 (853)
Q Consensus 550 l~~~~iv~~~g~~~d~~~lyLVmEy~~gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLKPe 629 (853)
+.+..+.||||||++++|.+++... ...+++..++.|+.||+.||.|||++|||||||||+
T Consensus 72 ------------~~~~~~~~lvme~~g~sL~~ll~~~-------~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~ 132 (483)
T 3sv0_A 72 ------------GVEGDYNVLVMDLLGPSLEDLFNFC-------SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPD 132 (483)
T ss_dssp ------------EEETTEEEEEEECCCCBHHHHHHHT-------TTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGG
T ss_pred ------------EeeCCEEEEEEECCCCCHHHHHHhh-------cCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcc
Confidence 3456788999999988999998753 357999999999999999999999999999999999
Q ss_pred cEEe----ecCcEEEEecccchhcccCCcc-----ccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHH
Q 003052 630 NFLL----VKGSLKLIDFGIAKAIMSDTTN-----IQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCIL 700 (853)
Q Consensus 630 NILL----~~g~VKL~DFGlAk~~~~~~~~-----~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVIL 700 (853)
|||| .++.+||+|||+|+.+...... ......+||+.|+|||++.+.. |+.++|||||||||
T Consensus 133 NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~---------~s~~sDvwSlGvil 203 (483)
T 3sv0_A 133 NFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASVNTHLGIE---------QSRRDDLESLGYVL 203 (483)
T ss_dssp GEEECCGGGTTCEEECCCTTCEECBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCC---------CCHHHHHHHHHHHH
T ss_pred eEEEecCCCCCeEEEEeCCcceeccCCccccccccccccccCCCccccCHHHhcCCC---------CChHHHHHHHHHHH
Confidence 9999 3568999999999876543321 1123678999999999997653 56899999999999
Q ss_pred HHHHhCCCCCCcchh--HHHHHHhhcC---CCCcccCCCCCChhHHHHHHHhcccCCCCCCChhHHhc
Q 003052 701 YQMVYGRTPFSEYKT--FWAKFKVITD---PNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQ 763 (853)
Q Consensus 701 yELLtG~~PF~~~~~--~~~~~kii~~---~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~ 763 (853)
|||++|+.||.+... ....+..+.. ..........++.++.+||.+||..||.+||++.+|++
T Consensus 204 ~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~ 271 (483)
T 3sv0_A 204 MYFLRGSLPWQGLKAGTKKQKYEKISEKKVATSIEALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKR 271 (483)
T ss_dssp HHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHSCHHHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred HHHHhCCCCCccccchhHHHHHHHHhhccccccHHHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 999999999975321 1111111100 00111122456789999999999999999999988764
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-39 Score=373.46 Aligned_cols=258 Identities=24% Similarity=0.304 Sum_probs=207.0
Q ss_pred eEEcCceeeEEEeEeccCceEEEEEEecCCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHH
Q 003052 467 FKVNGKLYQRLGKIGSGGSSEVHKVISSDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKAL 546 (853)
Q Consensus 467 ~~v~g~~Y~ilk~LG~G~FG~Vyka~~~~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~i 546 (853)
+.+..+.|++.++||+|+||.||+|.+.++..||||+++..... ...|.+|+++|++|+ |+||+++++++
T Consensus 262 ~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~-hpniv~~~~~~------ 331 (535)
T 2h8h_A 262 WEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS---PEAFLQEAQVMKKLR-HEKLVQLYAVV------ 331 (535)
T ss_dssp SBCCGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTSSC---HHHHHHHHHHHHHCC-CTTBCCEEEEE------
T ss_pred eecchhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCCCC---HHHHHHHHHHHHhCC-CCCEeeEEEEE------
Confidence 34556779999999999999999999988788999999865433 346889999999997 89999999863
Q ss_pred HHHHhhCCCCCCCCccccCCeEEEEEecch-hhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCC
Q 003052 547 LREVLNGSMNNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSD 625 (853)
Q Consensus 547 L~~l~~~~iv~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRD 625 (853)
.+ ..+||||||+. ++|.+++.... ...+++..+..|+.||+.||.|||++||+|||
T Consensus 332 ----------------~~-~~~~lv~e~~~~gsL~~~l~~~~------~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrD 388 (535)
T 2h8h_A 332 ----------------SE-EPIYIVTEYMSKGSLLDFLKGET------GKYLRLPQLVDMAAQIASGMAYVERMNYVHRD 388 (535)
T ss_dssp ----------------CS-SSCEEEECCCTTEEHHHHHSHHH------HTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSC
T ss_pred ----------------ee-ccceEeeehhcCCcHHHHHhhcC------CCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCC
Confidence 22 45799999986 59999987542 24589999999999999999999999999999
Q ss_pred CCCccEEee-cCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHH
Q 003052 626 LKPANFLLV-KGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMV 704 (853)
Q Consensus 626 LKPeNILL~-~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELL 704 (853)
|||+||||+ ++.+||+|||+++.+.... ........+++.|+|||++.+. .|+.++|||||||+||||+
T Consensus 389 lkp~NIll~~~~~~kl~DFG~a~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~---------~~~~~sDvwSlGv~l~el~ 458 (535)
T 2h8h_A 389 LRAANILVGENLVCKVADFGLARLIEDNE-YTARQGAKFPIKWTAPEAALYG---------RFTIKSDVWSFGILLTELT 458 (535)
T ss_dssp CSGGGEEECGGGCEEECCTTSTTTCCCHH-HHTTCSTTSCGGGSCHHHHHHC---------CCCHHHHHHHHHHHHHHHT
T ss_pred CCHhhEEEcCCCcEEEcccccceecCCCc-eecccCCcCcccccCHHHhccC---------CCCchhhHHHHHHHHHHHH
Confidence 999999994 5699999999998764321 1122345678899999999765 3678999999999999999
Q ss_pred h-CCCCCCcchhHHHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCCChhHHhcC--CCCCC
Q 003052 705 Y-GRTPFSEYKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQH--PFLVP 769 (853)
Q Consensus 705 t-G~~PF~~~~~~~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~H--Pwf~~ 769 (853)
+ |+.||.+.........+.. ......+..++..+.+||.+||..||++|||+.+|++. .|+..
T Consensus 459 t~g~~P~~~~~~~~~~~~i~~--~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~ 524 (535)
T 2h8h_A 459 TKGRVPYPGMVNREVLDQVER--GYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 524 (535)
T ss_dssp TTTCCSSTTCCHHHHHHHHHT--TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCC
T ss_pred hCCCCCCCCCCHHHHHHHHHc--CCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhc
Confidence 9 9999987554333222222 22334456778899999999999999999999999874 55543
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-39 Score=344.20 Aligned_cols=257 Identities=22% Similarity=0.306 Sum_probs=189.1
Q ss_pred ceeeEEEeEeccCceEEEEEEecCCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhc-CCCceeEeeehhhhHHHHHHHH
Q 003052 472 KLYQRLGKIGSGGSSEVHKVISSDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLK-GKNNIIQLIDYEVTEKALLREV 550 (853)
Q Consensus 472 ~~Y~ilk~LG~G~FG~Vyka~~~~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~-~hpNIV~Lid~~~~e~~iL~~l 550 (853)
++|+++++||+|+||.||+|.+. ++.||||++.... ...+.+|.+++..+. .|+||+++++++...
T Consensus 37 ~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~-----~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~------- 103 (337)
T 3mdy_A 37 KQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTTE-----EASWFRETEIYQTVLMRHENILGFIAADIKG------- 103 (337)
T ss_dssp HHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGGG-----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEES-------
T ss_pred cceEEEeEeecCCCeEEEEEEEC-CceEEEEEEeccc-----cchhhhHHHHHHHHhhcCCCeeeEEEEEccC-------
Confidence 57999999999999999999885 7889999996432 234556777776652 599999999874321
Q ss_pred hhCCCCCCCCccccCCeEEEEEecchh-hHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccC--------ce
Q 003052 551 LNGSMNNKDGRVKDDGYIYMVLEYGEI-DLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEE--------RI 621 (853)
Q Consensus 551 ~~~~iv~~~g~~~d~~~lyLVmEy~~g-dL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~--------gI 621 (853)
......+|+||||+.+ +|.+++.. ..+++..++.++.||+.||.|||++ ||
T Consensus 104 -----------~~~~~~~~lv~e~~~~g~L~~~l~~---------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~i 163 (337)
T 3mdy_A 104 -----------TGSWTQLYLITDYHENGSLYDYLKS---------TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAI 163 (337)
T ss_dssp -----------CGGGCEEEEEECCCTTCBHHHHHHH---------CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCE
T ss_pred -----------CCCCCceEEEEeccCCCcHHHHhhc---------cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCE
Confidence 1122679999999865 99998854 3699999999999999999999999 99
Q ss_pred eeCCCCCccEEe-ecCcEEEEecccchhcccCCccc--cccccccCccccCchhhccCCCCCCCccccCCCccchhhhHH
Q 003052 622 VHSDLKPANFLL-VKGSLKLIDFGIAKAIMSDTTNI--QRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGC 698 (853)
Q Consensus 622 IHRDLKPeNILL-~~g~VKL~DFGlAk~~~~~~~~~--~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGV 698 (853)
+||||||+|||+ .++.+||+|||+|+.+....... .....+||+.|+|||++.+..... ...++.++|||||||
T Consensus 164 vH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~---~~~~~~~~DiwslG~ 240 (337)
T 3mdy_A 164 AHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRN---HFQSYIMADMYSFGL 240 (337)
T ss_dssp ECSCCCGGGEEECTTSCEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTT---CTHHHHHHHHHHHHH
T ss_pred EecccchHHEEECCCCCEEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCc---cccCccccchHHHHH
Confidence 999999999999 56799999999997664332211 123568999999999997654321 011123599999999
Q ss_pred HHHHHHhC----------CCCCCcch----hHHHHHHhhcCCCCcccCCC-----CCChhHHHHHHHhcccCCCCCCChh
Q 003052 699 ILYQMVYG----------RTPFSEYK----TFWAKFKVITDPNHEITYEP-----VPNPWLLDLMKKCLAWDRNERWRIP 759 (853)
Q Consensus 699 ILyELLtG----------~~PF~~~~----~~~~~~kii~~~~~~~~~~~-----~~s~~l~dLI~kcL~~DP~kRpTa~ 759 (853)
++|||++| ..||.... .................++. ..++++.+||.+||..||.+|||+.
T Consensus 241 il~el~tg~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ 320 (337)
T 3mdy_A 241 ILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTAL 320 (337)
T ss_dssp HHHHHHTTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHH
T ss_pred HHHHHHhccCcccccccccccHhhhcCCCCchhhhHHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHH
Confidence 99999999 77775321 11122222221122222221 3345689999999999999999999
Q ss_pred HHhcC
Q 003052 760 QLLQH 764 (853)
Q Consensus 760 EIL~H 764 (853)
++++|
T Consensus 321 ell~~ 325 (337)
T 3mdy_A 321 RVKKT 325 (337)
T ss_dssp HHHHH
T ss_pred HHHHH
Confidence 99975
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=366.09 Aligned_cols=279 Identities=14% Similarity=0.102 Sum_probs=195.9
Q ss_pred ceeeEEEeEeccCceEEEEEEe-cCCcEEEEEEEecCCC-ChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHHH
Q 003052 472 KLYQRLGKIGSGGSSEVHKVIS-SDCTIYALKKIKLKGR-DYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLRE 549 (853)
Q Consensus 472 ~~Y~ilk~LG~G~FG~Vyka~~-~~g~~vAVKkik~~~~-~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~~ 549 (853)
..|++.+.||+|+||.||+|.+ .+++.||||++..... .......+.+|+.+++.+.+..|+..+..+.. ++..
T Consensus 78 ~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~----~~~~ 153 (413)
T 3dzo_A 78 RTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLR----FIFP 153 (413)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTC----BCCC
T ss_pred eeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcc----cccc
Confidence 4588999999999999999997 5788999999984332 22335668899999999986444332221100 0000
Q ss_pred ---HhhCCCCCC-----CCccccCCeEEEEEecchhhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCce
Q 003052 550 ---VLNGSMNNK-----DGRVKDDGYIYMVLEYGEIDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERI 621 (853)
Q Consensus 550 ---l~~~~iv~~-----~g~~~d~~~lyLVmEy~~gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gI 621 (853)
+.......+ .+.......+|++|++++++|.+++..... .......+++..+..++.||+.||.|||++||
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~ll~~l~~-~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i 232 (413)
T 3dzo_A 154 FDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLS-HSSTHKSLVHHARLQLTLQVIRLLASLHHYGL 232 (413)
T ss_dssp CEEEECCC---------------CCSEEEEEECCSEEHHHHHHHHHH-HTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred hhhcccCCCCccccccCCCccccccceEEEeehhcCCHHHHHHHhhc-ccccCCCCCHHHHHHHHHHHHHHHHHHHhCCc
Confidence 000000000 000111235789999988899888854321 12234568888999999999999999999999
Q ss_pred eeCCCCCccEEe-ecCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCC-ccccCCCccchhhhHHH
Q 003052 622 VHSDLKPANFLL-VKGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENG-NIIKCGRPSDIWSLGCI 699 (853)
Q Consensus 622 IHRDLKPeNILL-~~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~-~~~~ys~ksDIWSLGVI 699 (853)
|||||||+|||| .++.+||+|||+++..... ....+| +.|+|||++.+....... ....|+.++|||||||+
T Consensus 233 iHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~-----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvi 306 (413)
T 3dzo_A 233 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS-----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLA 306 (413)
T ss_dssp ECSCCCGGGEEECTTCCEEECCGGGCEETTEE-----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHH
T ss_pred ccCCcccceEEEecCCeEEEEeccceeecCCc-----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHH
Confidence 999999999999 4679999999999865332 346788 999999999532100000 11247789999999999
Q ss_pred HHHHHhCCCCCCcchhHHHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCCChhHHhcCCCCC
Q 003052 700 LYQMVYGRTPFSEYKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQHPFLV 768 (853)
Q Consensus 700 LyELLtG~~PF~~~~~~~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~HPwf~ 768 (853)
+|||++|+.||...........+ +......++.+.+||.+||..||.+||++.++|+||||.
T Consensus 307 l~elltg~~Pf~~~~~~~~~~~~-------~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~~l~~~~~~ 368 (413)
T 3dzo_A 307 IYWIWCADLPNTDDAALGGSEWI-------FRSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYE 368 (413)
T ss_dssp HHHHHHSSCCCCTTGGGSCSGGG-------GSSCCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHH
T ss_pred HHHHHHCCCCCCCcchhhhHHHH-------HhhcccCCHHHHHHHHHHccCChhhCcCHHHHHhCHHHH
Confidence 99999999999765432111111 112235678999999999999999999999999999995
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-39 Score=358.47 Aligned_cols=253 Identities=20% Similarity=0.302 Sum_probs=189.6
Q ss_pred CceeeEEEeEeccCceEEEEEEec--CC--cEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHH
Q 003052 471 GKLYQRLGKIGSGGSSEVHKVISS--DC--TIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKAL 546 (853)
Q Consensus 471 g~~Y~ilk~LG~G~FG~Vyka~~~--~g--~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~i 546 (853)
...|++.+.||+|+||.||+|... ++ ..||+|.++.. ........+.+|+.+|++++ ||||+++++++
T Consensus 88 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~il~~l~-hpnIv~~~~~~------ 159 (373)
T 3c1x_A 88 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI-TDIGEVSQFLTEGIIMKDFS-HPNVLSLLGIC------ 159 (373)
T ss_dssp TEEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSC-SCSHHHHHHHHHHTTSTTCC-CTTBCCCCEEE------
T ss_pred hceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCC-CCHHHHHHHHHHHHHHHhCC-CCCcceEEEEE------
Confidence 356899999999999999999863 32 36899988653 33345667899999999997 99999999863
Q ss_pred HHHHhhCCCCCCCCccccCCeEEEEEecchh-hHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCC
Q 003052 547 LREVLNGSMNNKDGRVKDDGYIYMVLEYGEI-DLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSD 625 (853)
Q Consensus 547 L~~l~~~~iv~~~g~~~d~~~lyLVmEy~~g-dL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRD 625 (853)
+..++.+|+||||+.+ +|.+++... ...+++..++.++.||+.||.|||++||+|||
T Consensus 160 ---------------~~~~~~~~lv~e~~~~g~L~~~l~~~-------~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrD 217 (373)
T 3c1x_A 160 ---------------LRSEGSPLVVLPYMKHGDLRNFIRNE-------THNPTVKDLIGFGLQVAKGMKFLASKKFVHRD 217 (373)
T ss_dssp ---------------CCCSSCCEEEEECCTTCBHHHHHHCT-------TCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSC
T ss_pred ---------------EcCCCCeEEEEECCCCCCHHHHHhhc-------ccCCCHHHHHHHHHHHHHHHHHHHHCCEecCc
Confidence 2345678999999864 999988643 35689999999999999999999999999999
Q ss_pred CCCccEEee-cCcEEEEecccchhcccCCcc--ccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHH
Q 003052 626 LKPANFLLV-KGSLKLIDFGIAKAIMSDTTN--IQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQ 702 (853)
Q Consensus 626 LKPeNILL~-~g~VKL~DFGlAk~~~~~~~~--~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyE 702 (853)
|||+|||++ ++.+||+|||+++.+...... .......||+.|+|||++.+. .|+.++|||||||++||
T Consensus 218 lkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~---------~~~~~~DvwSlG~il~e 288 (373)
T 3c1x_A 218 LAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQ---------KFTTKSDVWSFGVLLWE 288 (373)
T ss_dssp CCGGGEEECTTCCEEECCC---------------------CCGGGSCHHHHHHC---------CCCHHHHHHHHHHHHHH
T ss_pred cchheEEECCCCCEEEeeccccccccccccccccccCCCCCcccccChHHhcCC---------CCCcHHHHHHHHHHHHH
Confidence 999999995 679999999999866432211 112345688899999999765 35689999999999999
Q ss_pred HHh-CCCCCCcchhHHHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCCChhHHhcC
Q 003052 703 MVY-GRTPFSEYKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQH 764 (853)
Q Consensus 703 LLt-G~~PF~~~~~~~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~H 764 (853)
|++ |.+||.+.........+.. ......+...+..+.+||.+||..||.+||++.+++++
T Consensus 289 llt~~~~p~~~~~~~~~~~~~~~--~~~~~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~ 349 (373)
T 3c1x_A 289 LMTRGAPPYPDVNTFDITVYLLQ--GRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSR 349 (373)
T ss_dssp HHTTSCCSCTTSCSSCHHHHHHT--TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHhCcCCCCCCCCHHHHHHHHHc--CCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 999 7888865433222222222 12233455678899999999999999999999999864
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-41 Score=364.29 Aligned_cols=261 Identities=19% Similarity=0.158 Sum_probs=191.6
Q ss_pred CceeeEEEeEeccCceEEEEEEecCCcEEEEEEEecCCC------ChhhHhhHHHHHHHHHHhc--------CCCceeEe
Q 003052 471 GKLYQRLGKIGSGGSSEVHKVISSDCTIYALKKIKLKGR------DYATAYGFCQEIEYLNKLK--------GKNNIIQL 536 (853)
Q Consensus 471 g~~Y~ilk~LG~G~FG~Vyka~~~~g~~vAVKkik~~~~------~~~~~~~~l~EI~iLkkL~--------~hpNIV~L 536 (853)
.++|+++++||+|+||.||+|++ +++.||||++..... .......+.+|+.+|+.++ .|+||+++
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l 97 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL 97 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCE
T ss_pred cccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhh
Confidence 35699999999999999999998 678999999987642 2223356889999999997 58888888
Q ss_pred eehhhhHHHHHHHHhhCCCCCCCCccc-------------cCCeEEEEEecch-hhHHHHHHHhhhhccCCCCCCCHHHH
Q 003052 537 IDYEVTEKALLREVLNGSMNNKDGRVK-------------DDGYIYMVLEYGE-IDLAHMLSQKWKEMDGSNQTLDENWL 602 (853)
Q Consensus 537 id~~~~e~~iL~~l~~~~iv~~~g~~~-------------d~~~lyLVmEy~~-gdL~~~L~~~~k~~~~~~~~LsE~~~ 602 (853)
.+.+.... ..|++++.+++.|. +...+||||||+. +++.+.+.+ ..+++..+
T Consensus 98 ~~~~~~~~-----~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~---------~~~~~~~~ 163 (336)
T 2vuw_A 98 NSVHCVQG-----SYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT---------KLSSLATA 163 (336)
T ss_dssp EEEEEEES-----SCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT---------TCCCHHHH
T ss_pred cceeEecC-----CCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh---------cCCCHHHH
Confidence 77532100 00111222222233 3788999999975 444444321 46899999
Q ss_pred HHHHHHhhhhhhhcc-cCceeeCCCCCccEEee-cC--------------------cEEEEecccchhcccCCccccccc
Q 003052 603 RFYWQQILEAVNTIH-EERIVHSDLKPANFLLV-KG--------------------SLKLIDFGIAKAIMSDTTNIQRDS 660 (853)
Q Consensus 603 r~I~~QIl~AL~yLH-s~gIIHRDLKPeNILL~-~g--------------------~VKL~DFGlAk~~~~~~~~~~~~t 660 (853)
+.|+.||+.||.||| ++||+||||||+||||+ ++ .+||+|||+|+.... ..
T Consensus 164 ~~i~~qi~~aL~~lH~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~-------~~ 236 (336)
T 2vuw_A 164 KSILHQLTASLAVAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERD-------GI 236 (336)
T ss_dssp HHHHHHHHHHHHHHHHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEET-------TE
T ss_pred HHHHHHHHHHHHHHHHhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCC-------Cc
Confidence 999999999999999 99999999999999995 44 899999999986643 14
Q ss_pred cccCccccCchhhccCCCCCCCccccCCCccchhhhHHH-HHHHHhCCCCCCcchhHHHHH-Hhh---cC-CCCcccCCC
Q 003052 661 QVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCI-LYQMVYGRTPFSEYKTFWAKF-KVI---TD-PNHEITYEP 734 (853)
Q Consensus 661 ~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVI-LyELLtG~~PF~~~~~~~~~~-kii---~~-~~~~~~~~~ 734 (853)
.+||+.|||||++.+.. +.++||||||++ .++++.|..||.+........ ... .. .........
T Consensus 237 ~~gt~~y~aPE~~~g~~----------~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (336)
T 2vuw_A 237 VVFCDVSMDEDLFTGDG----------DYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKTKCNTPAMK 306 (336)
T ss_dssp EECCCCTTCSGGGCCCS----------SHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHHHHHTCCCSSCCCSHHHH
T ss_pred EEEeecccChhhhcCCC----------ccceehhhhhCCCCcccccccCCCcchhhhhHHHHhhhhhhccCcccchhhhh
Confidence 58999999999997653 468999998777 788999999996532111111 111 11 111111122
Q ss_pred CCChhHHHHHHHhcccCCCCCCChhHHh-cCCCCC
Q 003052 735 VPNPWLLDLMKKCLAWDRNERWRIPQLL-QHPFLV 768 (853)
Q Consensus 735 ~~s~~l~dLI~kcL~~DP~kRpTa~EIL-~HPwf~ 768 (853)
..++++++||.+||++| |+.|+| +||||+
T Consensus 307 ~~s~~~~dli~~~L~~d-----sa~e~l~~Hp~f~ 336 (336)
T 2vuw_A 307 QIKRKIQEFHRTMLNFS-----SATDLLCQHSLFK 336 (336)
T ss_dssp HHHHHHHHHHHHGGGSS-----SHHHHHHHCGGGC
T ss_pred hcCHHHHHHHHHHhccC-----CHHHHHhcCCCcC
Confidence 35678999999999987 999999 999985
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-39 Score=344.13 Aligned_cols=252 Identities=26% Similarity=0.299 Sum_probs=193.8
Q ss_pred eeEEEeEeccCceEEEEEEecCCcEEEEEEEecCC--CChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHHHHh
Q 003052 474 YQRLGKIGSGGSSEVHKVISSDCTIYALKKIKLKG--RDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLREVL 551 (853)
Q Consensus 474 Y~ilk~LG~G~FG~Vyka~~~~g~~vAVKkik~~~--~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~~l~ 551 (853)
|...+.||+|+||.||+|.. +++.||||++.... ........+.+|+.++++++ ||||++++++
T Consensus 33 ~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~------------ 98 (307)
T 2nru_A 33 SVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQ-HENLVELLGF------------ 98 (307)
T ss_dssp TTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCC-CTTBCCEEEE------------
T ss_pred cccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcC-CCCeEEEEEE------------
Confidence 44457899999999999987 57789999997543 23344567889999999997 8999999987
Q ss_pred hCCCCCCCCccccCCeEEEEEecch-hhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCCCcc
Q 003052 552 NGSMNNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPAN 630 (853)
Q Consensus 552 ~~~iv~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLKPeN 630 (853)
+.+.+.+|+||||+. ++|.+++.... ....+++..++.++.||+.||.|||++||+||||||+|
T Consensus 99 ----------~~~~~~~~lv~e~~~~~~L~~~l~~~~-----~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~N 163 (307)
T 2nru_A 99 ----------SSDGDDLCLVYVYMPNGSLLDRLSCLD-----GTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSAN 163 (307)
T ss_dssp ----------ECSSSSCEEEEECCTTCBHHHHHHTGG-----GCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGG
T ss_pred ----------EecCCceEEEEEecCCCcHHHHHHhcc-----CCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHH
Confidence 345667899999985 68988886431 23569999999999999999999999999999999999
Q ss_pred EEee-cCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHhCCCC
Q 003052 631 FLLV-KGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGRTP 709 (853)
Q Consensus 631 ILL~-~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLtG~~P 709 (853)
||++ ++.+||+|||+++..............+||+.|+|||++.+. ++.++|||||||++|+|++|..|
T Consensus 164 ili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~----------~~~~~Dv~slG~il~~l~~g~~p 233 (307)
T 2nru_A 164 ILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRGE----------ITPKSDIYSFGVVLLEIITGLPA 233 (307)
T ss_dssp EEECTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTTE----------ECTHHHHHHHHHHHHHHHHCCCS
T ss_pred EEEcCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcCC----------CCccchhHHHHHHHHHHHHCCCC
Confidence 9995 569999999999866543333233456899999999998642 56799999999999999999999
Q ss_pred CCcchhH---HHHHHhhcCCCC---------cccCCCCCChhHHHHHHHhcccCCCCCCChhHHhcC
Q 003052 710 FSEYKTF---WAKFKVITDPNH---------EITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQH 764 (853)
Q Consensus 710 F~~~~~~---~~~~kii~~~~~---------~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~H 764 (853)
|...... ......+..... ........+..+.+||.+||..||.+||++.+++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~ 300 (307)
T 2nru_A 234 VDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQL 300 (307)
T ss_dssp BCTTBSSSBTTHHHHHHHTTSCCHHHHSCSSCSCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred cccCcchHHHHHHHHHhhhhhhhhhhhccccccccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 9753221 111111111000 001112234568999999999999999999999864
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-38 Score=342.71 Aligned_cols=255 Identities=20% Similarity=0.310 Sum_probs=200.0
Q ss_pred EcCceeeEEEeEeccCceEEEEEEe-----cCCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhH
Q 003052 469 VNGKLYQRLGKIGSGGSSEVHKVIS-----SDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTE 543 (853)
Q Consensus 469 v~g~~Y~ilk~LG~G~FG~Vyka~~-----~~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e 543 (853)
+..+.|++++.||+|+||.||+|.. .+++.||||++.... ......+.+|+.+|++++ |+||+++++++..
T Consensus 38 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~- 113 (326)
T 2w1i_A 38 FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST--EEHLRDFEREIEILKSLQ-HDNIVKYKGVCYS- 113 (326)
T ss_dssp CCGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCC--SHHHHHHHHHHHHHHTCC-CTTBCCEEEEECC-
T ss_pred cCHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCC--HHHHHHHHHHHHHHHhCC-CCCeeeEEEEEEe-
Confidence 3457799999999999999999983 467899999997642 344567899999999997 9999999987432
Q ss_pred HHHHHHHhhCCCCCCCCccccCCeEEEEEecch-hhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCcee
Q 003052 544 KALLREVLNGSMNNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIV 622 (853)
Q Consensus 544 ~~iL~~l~~~~iv~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gII 622 (853)
.+...+|+||||++ ++|.+++... ...+++..++.++.||+.||.|||++||+
T Consensus 114 -------------------~~~~~~~lv~e~~~~~~L~~~l~~~-------~~~~~~~~~~~i~~qi~~aL~~LH~~~iv 167 (326)
T 2w1i_A 114 -------------------AGRRNLKLIMEYLPYGSLRDYLQKH-------KERIDHIKLLQYTSQICKGMEYLGTKRYI 167 (326)
T ss_dssp -----------------------CCEEEECCCTTCBHHHHHHHS-------TTSSCHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred -------------------cCCCceEEEEECCCCCCHHHHHHhc-------ccCCCHHHHHHHHHHHHHHHHHHHhCCEe
Confidence 12346899999986 4999988753 24699999999999999999999999999
Q ss_pred eCCCCCccEEe-ecCcEEEEecccchhcccCCccc-cccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHH
Q 003052 623 HSDLKPANFLL-VKGSLKLIDFGIAKAIMSDTTNI-QRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCIL 700 (853)
Q Consensus 623 HRDLKPeNILL-~~g~VKL~DFGlAk~~~~~~~~~-~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVIL 700 (853)
||||||+|||+ .++.+||+|||+++......... ......|++.|+|||++.+. .++.++|||||||++
T Consensus 168 H~dikp~NIli~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~---------~~~~~~Di~slG~il 238 (326)
T 2w1i_A 168 HRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTES---------KFSVASDVWSFGVVL 238 (326)
T ss_dssp CSCCCGGGEEEEETTEEEECCCTTCEECCSSCSEEECSSCCSCCGGGCCHHHHHHC---------EEEHHHHHHHHHHHH
T ss_pred ccCCCcceEEEcCCCcEEEecCcchhhccccccccccccCCCCceeEECchhhcCC---------CCCchhhHHHHHHHH
Confidence 99999999999 46799999999998765432211 12345678899999999765 356799999999999
Q ss_pred HHHHhCCCCCCcchhHH---------------HHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCCChhHHhc
Q 003052 701 YQMVYGRTPFSEYKTFW---------------AKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQ 763 (853)
Q Consensus 701 yELLtG~~PF~~~~~~~---------------~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~ 763 (853)
|+|++|..||....... .....+.. ......+...+.++.+||.+||..||.+||++.++++
T Consensus 239 ~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~ 315 (326)
T 2w1i_A 239 YELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKN-NGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL 315 (326)
T ss_dssp HHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHHHHHHHT-TCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred HHHHhcCCCCCCCHHHHHHhhccccchhhhHHHHHHHhhc-CCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 99999999986431110 11111111 2223345667889999999999999999999999985
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-38 Score=374.81 Aligned_cols=248 Identities=22% Similarity=0.300 Sum_probs=195.8
Q ss_pred eeeEE-EeEeccCceEEEEEEec---CCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHH
Q 003052 473 LYQRL-GKIGSGGSSEVHKVISS---DCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLR 548 (853)
Q Consensus 473 ~Y~il-k~LG~G~FG~Vyka~~~---~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~ 548 (853)
.+.+. ++||+|+||.||+|.+. .++.||||+++....+......+.+|+++|++|+ |+||+++++++
T Consensus 369 ~~~l~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~-hpnIv~l~~~~-------- 439 (635)
T 4fl3_A 369 LLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLD-NPYIVRMIGIC-------- 439 (635)
T ss_dssp GEEEEEEEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCC-CTTBCCEEEEE--------
T ss_pred hccccCCEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCC-CCCEeeEEEEE--------
Confidence 34443 47999999999999652 4578999999876655556678999999999997 99999999873
Q ss_pred HHhhCCCCCCCCccccCCeEEEEEecch-hhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCC
Q 003052 549 EVLNGSMNNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLK 627 (853)
Q Consensus 549 ~l~~~~iv~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLK 627 (853)
. ...+|+||||+. ++|.+++... ..+++..++.|+.||+.||.|||++||||||||
T Consensus 440 --------------~-~~~~~lv~E~~~~g~L~~~l~~~--------~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLk 496 (635)
T 4fl3_A 440 --------------E-AESWMLVMEMAELGPLNKYLQQN--------RHVKDKNIIELVHQVSMGMKYLEESNFVHRDLA 496 (635)
T ss_dssp --------------E-SSSEEEEEECCTTEEHHHHHHHC--------TTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCS
T ss_pred --------------e-cCCEEEEEEccCCCCHHHHHhhC--------CCCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCC
Confidence 2 234789999976 5899988643 569999999999999999999999999999999
Q ss_pred CccEEe-ecCcEEEEecccchhcccCCcc-ccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHh
Q 003052 628 PANFLL-VKGSLKLIDFGIAKAIMSDTTN-IQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVY 705 (853)
Q Consensus 628 PeNILL-~~g~VKL~DFGlAk~~~~~~~~-~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLt 705 (853)
|+|||| .++.+||+|||+|+.+...... .......||+.|+|||++.+. .|+.++|||||||++|||++
T Consensus 497 p~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~t~~y~APE~~~~~---------~~~~~sDvwSlGv~l~ellt 567 (635)
T 4fl3_A 497 ARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYY---------KFSSKSDVWSFGVLMWEAFS 567 (635)
T ss_dssp GGGEEEEETTEEEECCTTHHHHTTC-------------CGGGSCHHHHHHC---------CCCHHHHHHHHHHHHHHHHT
T ss_pred hHhEEEeCCCCEEEEEcCCccccccCccccccccCCCCceeeeChhhhcCC---------CCCcHHHHHHHHHHHHHHHh
Confidence 999999 5679999999999876543221 122344678999999999765 36789999999999999998
Q ss_pred -CCCCCCcchhHHHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCCChhHHhc
Q 003052 706 -GRTPFSEYKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQ 763 (853)
Q Consensus 706 -G~~PF~~~~~~~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~ 763 (853)
|+.||.+.........+.. ......+...++++.+||.+||..||.+||++.+|++
T Consensus 568 ~G~~Pf~~~~~~~~~~~i~~--~~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~ 624 (635)
T 4fl3_A 568 YGQKPYRGMKGSEVTAMLEK--GERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVEL 624 (635)
T ss_dssp TTCCSSTTCCHHHHHHHHHT--TCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred CCCCCCCCCCHHHHHHHHHc--CCCCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence 9999987655433222222 2233456678899999999999999999999999974
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-38 Score=337.26 Aligned_cols=236 Identities=22% Similarity=0.344 Sum_probs=183.9
Q ss_pred ceeeEE-EeEeccCceEEEEEEe-cCCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHHH
Q 003052 472 KLYQRL-GKIGSGGSSEVHKVIS-SDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLRE 549 (853)
Q Consensus 472 ~~Y~il-k~LG~G~FG~Vyka~~-~~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~~ 549 (853)
..|.++ +.||+|+||.||+|.+ .+++.||||++... ..+.+|+.++.++..|+||+++++++..
T Consensus 17 ~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~e~~~~~~~~~h~~i~~~~~~~~~------- 82 (299)
T 3m2w_A 17 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-------PKARREVELHWRASQCPHIVRIVDVYEN------- 82 (299)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-------HHHHHHHHHHHHHTTSTTBCCEEEEEEE-------
T ss_pred cchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc-------HHHHHHHHHHHHhccCCCchhHHhhhhh-------
Confidence 347777 7799999999999998 57789999999742 2467899999888789999999987431
Q ss_pred HhhCCCCCCCCccccCCeEEEEEecch-hhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCCC
Q 003052 550 VLNGSMNNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKP 628 (853)
Q Consensus 550 l~~~~iv~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLKP 628 (853)
.+.+..++|+||||+. ++|.+++... ....+++..++.++.||+.||.|||++||+||||||
T Consensus 83 -----------~~~~~~~~~lv~e~~~~~~L~~~l~~~------~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp 145 (299)
T 3m2w_A 83 -----------LYAGRKCLLIVMECLDGGELFSRIQDR------GDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKP 145 (299)
T ss_dssp -----------EETTEEEEEEEECCCCSCBHHHHHHHC------TTCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSG
T ss_pred -----------hcCCCceEEEEEeecCCCcHHHHHHhc------cCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCH
Confidence 1234678999999986 4999998764 235799999999999999999999999999999999
Q ss_pred ccEEee----cCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHH
Q 003052 629 ANFLLV----KGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMV 704 (853)
Q Consensus 629 eNILL~----~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELL 704 (853)
+|||++ ++.+||+|||++..... . .|+.++|||||||++|+|+
T Consensus 146 ~Nil~~~~~~~~~~kl~Dfg~a~~~~~------------------------~---------~~~~~~DiwslG~il~el~ 192 (299)
T 3m2w_A 146 ENLLYTSKRPNAILKLTDFGFAKETTG------------------------E---------KYDKSCDMWSLGVIMYILL 192 (299)
T ss_dssp GGEEESSSSTTCCEEECCCTTCEECTT------------------------C---------GGGGHHHHHHHHHHHHHHH
T ss_pred HHEEEecCCCCCcEEEecccccccccc------------------------c---------cCCchhhHHHHHHHHHHHH
Confidence 999995 56899999999864321 0 2567899999999999999
Q ss_pred hCCCCCCcchhHHHHHHhhcC-CCCcccCC----CCCChhHHHHHHHhcccCCCCCCChhHHhcCCCCCCCC
Q 003052 705 YGRTPFSEYKTFWAKFKVITD-PNHEITYE----PVPNPWLLDLMKKCLAWDRNERWRIPQLLQHPFLVPPV 771 (853)
Q Consensus 705 tG~~PF~~~~~~~~~~kii~~-~~~~~~~~----~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~HPwf~~~~ 771 (853)
+|+.||.+............. ......++ ...++++.+||.+||..||.+|||+.|+|+||||....
T Consensus 193 tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~~~~~~ 264 (299)
T 3m2w_A 193 CGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQST 264 (299)
T ss_dssp HSSCSCCC-------CCSCCSSCTTCCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTGG
T ss_pred HCCCCCCCCcchhhhHHHHHHHhhccccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcChhhcccc
Confidence 999999764432211111000 00111111 45688899999999999999999999999999997643
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-38 Score=340.00 Aligned_cols=258 Identities=19% Similarity=0.257 Sum_probs=195.4
Q ss_pred CceeeEEEeEeccCceEEEEEEecCCcEEEEEEEecCCCChhhHhhHHHHHHHHHHh-cCCCceeEeeehhhhHHHHHHH
Q 003052 471 GKLYQRLGKIGSGGSSEVHKVISSDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKL-KGKNNIIQLIDYEVTEKALLRE 549 (853)
Q Consensus 471 g~~Y~ilk~LG~G~FG~Vyka~~~~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL-~~hpNIV~Lid~~~~e~~iL~~ 549 (853)
.+.|++.+.||+|+||.||+|.+ +++.||||++... ....+.+|++++..+ ..|+||+++++++..+
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~-----~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~------ 108 (342)
T 1b6c_B 41 ARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSR-----EERSWFREAEIYQTVMLRHENILGFIAADNKD------ 108 (342)
T ss_dssp HHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECGG-----GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECC------
T ss_pred cccEEEEeeecCCCCcEEEEEEE-cCccEEEEEeCch-----hHHHHHHHHHHHHHhhcCCCcEEEEEeeeccc------
Confidence 46799999999999999999988 5789999999643 234577899999885 3599999999874321
Q ss_pred HhhCCCCCCCCccccCCeEEEEEecchh-hHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcc--------cCc
Q 003052 550 VLNGSMNNKDGRVKDDGYIYMVLEYGEI-DLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIH--------EER 620 (853)
Q Consensus 550 l~~~~iv~~~g~~~d~~~lyLVmEy~~g-dL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLH--------s~g 620 (853)
......+|+||||+.+ +|.+++.. ..+++..++.++.||+.||.||| ++|
T Consensus 109 ------------~~~~~~~~lv~e~~~~g~L~~~l~~---------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ 167 (342)
T 1b6c_B 109 ------------NGTWTQLWLVSDYHEHGSLFDYLNR---------YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPA 167 (342)
T ss_dssp ------------CSSCCCEEEEECCCTTCBHHHHHHH---------CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCE
T ss_pred ------------CCccceeEEEEeecCCCcHHHHHhc---------cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCC
Confidence 0111378999999875 99998864 35899999999999999999999 899
Q ss_pred eeeCCCCCccEEe-ecCcEEEEecccchhcccCCccc--cccccccCccccCchhhccCCCCCCCccccCCCccchhhhH
Q 003052 621 IVHSDLKPANFLL-VKGSLKLIDFGIAKAIMSDTTNI--QRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLG 697 (853)
Q Consensus 621 IIHRDLKPeNILL-~~g~VKL~DFGlAk~~~~~~~~~--~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLG 697 (853)
|+||||||+|||+ .++.+||+|||+++......... .....+||+.|+|||++.+.... ....++.++||||||
T Consensus 168 ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~---~~~~~~~~~Di~slG 244 (342)
T 1b6c_B 168 IAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINM---KHFESFKRADIYAMG 244 (342)
T ss_dssp EECSCCSGGGEEECTTSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCT---TCHHHHHHHHHHHHH
T ss_pred eeeCCCCHHHEEECCCCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccc---cccccCCcccHHHHH
Confidence 9999999999999 46799999999998765432211 22456899999999999765321 011234689999999
Q ss_pred HHHHHHHhC----------CCCCCcch----hHHHHHHhhcCCCCcccCCC-----CCChhHHHHHHHhcccCCCCCCCh
Q 003052 698 CILYQMVYG----------RTPFSEYK----TFWAKFKVITDPNHEITYEP-----VPNPWLLDLMKKCLAWDRNERWRI 758 (853)
Q Consensus 698 VILyELLtG----------~~PF~~~~----~~~~~~kii~~~~~~~~~~~-----~~s~~l~dLI~kcL~~DP~kRpTa 758 (853)
|++|+|++| ..||.... ........+.........+. ..+..+.+||.+||..||.+|||+
T Consensus 245 ~il~el~tg~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~ 324 (342)
T 1b6c_B 245 LVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTA 324 (342)
T ss_dssp HHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCH
T ss_pred HHHHHHHhccCcCCcccccccCccccCcCcccHHHHHHHHHHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCH
Confidence 999999999 78986531 12222233222222222221 223468999999999999999999
Q ss_pred hHHhcC
Q 003052 759 PQLLQH 764 (853)
Q Consensus 759 ~EIL~H 764 (853)
.++++|
T Consensus 325 ~~i~~~ 330 (342)
T 1b6c_B 325 LRIKKT 330 (342)
T ss_dssp HHHHHH
T ss_pred HHHHHH
Confidence 999975
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-38 Score=370.66 Aligned_cols=249 Identities=21% Similarity=0.311 Sum_probs=193.6
Q ss_pred ceeeEEE-eEeccCceEEEEEEec---CCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHH
Q 003052 472 KLYQRLG-KIGSGGSSEVHKVISS---DCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALL 547 (853)
Q Consensus 472 ~~Y~ilk-~LG~G~FG~Vyka~~~---~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL 547 (853)
+.|.+.+ +||+|+||.||+|.+. ++..||||+++.... ......+.+|+++|++++ |+||+++++++
T Consensus 335 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~-~~~~~~~~~E~~il~~l~-hpniv~l~~~~------- 405 (613)
T 2ozo_A 335 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTE-KADTEEMMREAQIMHQLD-NPYIVRLIGVC------- 405 (613)
T ss_dssp TSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCS-STTHHHHHHHHHHHTTCC-CTTBCCEEEEE-------
T ss_pred cceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCC-hHHHHHHHHHHHHHHhCC-CCCEeeEEEEe-------
Confidence 4455555 8999999999999874 446799999986532 334567899999999996 99999999873
Q ss_pred HHHhhCCCCCCCCccccCCeEEEEEecch-hhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCC
Q 003052 548 REVLNGSMNNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDL 626 (853)
Q Consensus 548 ~~l~~~~iv~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDL 626 (853)
.+ ..+||||||+. ++|.+++... ...+++..++.|+.||+.||.|||++||+||||
T Consensus 406 ---------------~~-~~~~lv~E~~~~g~L~~~l~~~-------~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDl 462 (613)
T 2ozo_A 406 ---------------QA-EALMLVMEMAGGGPLHKFLVGK-------REEIPVSNVAELLHQVSMGMKYLEEKNFVHRNL 462 (613)
T ss_dssp ---------------ES-SSEEEEEECCTTCBHHHHHTTC-------TTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCC
T ss_pred ---------------cc-CCeEEEEEeCCCCcHHHHHhhc-------cCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcC
Confidence 22 35899999976 4898887542 356999999999999999999999999999999
Q ss_pred CCccEEe-ecCcEEEEecccchhcccCCcc-ccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHH
Q 003052 627 KPANFLL-VKGSLKLIDFGIAKAIMSDTTN-IQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMV 704 (853)
Q Consensus 627 KPeNILL-~~g~VKL~DFGlAk~~~~~~~~-~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELL 704 (853)
||+|||| .++.+||+|||+|+.+...... .......+|+.|+|||++.+. .|+.++|||||||+||||+
T Consensus 463 kp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~y~APE~~~~~---------~~~~~sDvwSlGv~l~ell 533 (613)
T 2ozo_A 463 AARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFR---------KFSSRSDVWSYGVTMWEAL 533 (613)
T ss_dssp SGGGEEEEETTEEEECCCSTTTTCC--------------CCTTSCHHHHHHC---------CCCHHHHHHHHHHHHHHHH
T ss_pred CHHHEEEcCCCcEEEeeccCcccccCCCceeeeccCCCCccceeCHhhhcCC---------CCCcHHHHHHHHHHHHHHH
Confidence 9999999 5679999999999876432221 112234567899999999765 3678999999999999999
Q ss_pred h-CCCCCCcchhHHHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCCChhHHhc
Q 003052 705 Y-GRTPFSEYKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQ 763 (853)
Q Consensus 705 t-G~~PF~~~~~~~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~ 763 (853)
+ |+.||.+.........+.. ......+...++++.+||.+||..||.+||++.+|++
T Consensus 534 t~G~~Pf~~~~~~~~~~~i~~--~~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~ 591 (613)
T 2ozo_A 534 SYGQKPYKKMKGPEVMAFIEQ--GKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQ 591 (613)
T ss_dssp TTSCCTTTTCCSHHHHHHHHT--TCCCCCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHH
T ss_pred HCCCCCCCCCCHHHHHHHHHc--CCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 8 9999987554433322222 2234456678899999999999999999999999863
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-37 Score=363.90 Aligned_cols=252 Identities=23% Similarity=0.362 Sum_probs=199.4
Q ss_pred EEcCceeeEEEeEeccCceEEEEEEecC----CcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhH
Q 003052 468 KVNGKLYQRLGKIGSGGSSEVHKVISSD----CTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTE 543 (853)
Q Consensus 468 ~v~g~~Y~ilk~LG~G~FG~Vyka~~~~----g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e 543 (853)
.+..++|++.+.||+|+||.||+|.+.. +..||||+++... .......+.+|+.+|++++ ||||+++++++
T Consensus 386 ~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~-HpnIv~l~~~~--- 460 (656)
T 2j0j_A 386 EIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCT-SDSVREKFLQEALTMRQFD-HPHIVKLIGVI--- 460 (656)
T ss_dssp BCCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTT-CHHHHHHHHHHHHHHHHCC-CTTBCCEEEEE---
T ss_pred ccccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccC-CHHHHHHHHHHHHHHHhCC-CCCCCeEEEEE---
Confidence 4455789999999999999999998742 3579999887543 3344567899999999997 99999999863
Q ss_pred HHHHHHHhhCCCCCCCCccccCCeEEEEEecch-hhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCcee
Q 003052 544 KALLREVLNGSMNNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIV 622 (853)
Q Consensus 544 ~~iL~~l~~~~iv~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gII 622 (853)
.++.+|+||||+. ++|.+++... ...+++..++.++.||+.||.|||++||+
T Consensus 461 --------------------~~~~~~lv~E~~~~g~L~~~l~~~-------~~~l~~~~~~~i~~qi~~aL~~LH~~giv 513 (656)
T 2j0j_A 461 --------------------TENPVWIIMELCTLGELRSFLQVR-------KFSLDLASLILYAYQLSTALAYLESKRFV 513 (656)
T ss_dssp --------------------CSSSCEEEEECCTTCBHHHHHHHT-------TTTCCHHHHHHHHHHHHHHHHHHHHTTCC
T ss_pred --------------------ecCceEEEEEcCCCCcHHHHHHhc-------cCCCCHHHHHHHHHHHHHHHHHHHhCCcc
Confidence 2345799999987 5999888653 24689999999999999999999999999
Q ss_pred eCCCCCccEEe-ecCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHH
Q 003052 623 HSDLKPANFLL-VKGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILY 701 (853)
Q Consensus 623 HRDLKPeNILL-~~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILy 701 (853)
||||||+|||+ .++.+||+|||+++....... .......||+.|+|||++.+. .|+.++|||||||++|
T Consensus 514 HrDikp~NILl~~~~~vkL~DFG~a~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~---------~~~~~~DiwSlG~il~ 583 (656)
T 2j0j_A 514 HRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTY-YKASKGKLPIKWMAPESINFR---------RFTSASDVWMFGVCMW 583 (656)
T ss_dssp CSCCSGGGEEEEETTEEEECCCCCCCSCCC-----------CCGGGCCHHHHHHC---------CCCHHHHHHHHHHHHH
T ss_pred ccccchHhEEEeCCCCEEEEecCCCeecCCCcc-eeccCCCCCcceeCHHHhcCC---------CCCchhhHHHHHHHHH
Confidence 99999999999 578999999999987643321 122345678999999999765 3568999999999999
Q ss_pred HHHh-CCCCCCcchhHHHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCCChhHHhc
Q 003052 702 QMVY-GRTPFSEYKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQ 763 (853)
Q Consensus 702 ELLt-G~~PF~~~~~~~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~ 763 (853)
||++ |..||.+.........+... .....+...++.+.+||.+||..||.+||++.++++
T Consensus 584 ellt~g~~Pf~~~~~~~~~~~i~~~--~~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~ 644 (656)
T 2j0j_A 584 EILMHGVKPFQGVKNNDVIGRIENG--ERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKA 644 (656)
T ss_dssp HHHTTSCCTTTTCCHHHHHHHHHHT--CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHcCCCCCCCCCHHHHHHHHHcC--CCCCCCccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 9997 99999876544333333222 223455678899999999999999999999999985
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-38 Score=372.99 Aligned_cols=262 Identities=24% Similarity=0.325 Sum_probs=199.3
Q ss_pred ceeeEEEeEeccCceEEEEEEe-cCCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHHHH
Q 003052 472 KLYQRLGKIGSGGSSEVHKVIS-SDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLREV 550 (853)
Q Consensus 472 ~~Y~ilk~LG~G~FG~Vyka~~-~~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~~l 550 (853)
.+|++.++||+|+||.||+|.+ .+++.||||++.... .......+.+|+++|++++ ||||+++++++..
T Consensus 14 grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~-~~~~~~~~~~Ei~iL~~L~-HpnIV~l~~v~~~-------- 83 (676)
T 3qa8_A 14 GPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQEL-SPKNRERWCLEIQIMKKLN-HPNVVSAREVPDG-------- 83 (676)
T ss_dssp ---CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCC-CHHHHHHHHHHHHHHHHCC-BTTBCCEEECCTT--------
T ss_pred CCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccC-CHHHHHHHHHHHHHHHhCC-CCCCCceeeeecc--------
Confidence 5699999999999999999998 567899999987543 3455667899999999997 9999999987421
Q ss_pred hhCCCCCCCCccccCCeEEEEEecc-hhhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCCCc
Q 003052 551 LNGSMNNKDGRVKDDGYIYMVLEYG-EIDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPA 629 (853)
Q Consensus 551 ~~~~iv~~~g~~~d~~~lyLVmEy~-~gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLKPe 629 (853)
...+...+.+|+||||+ +++|.+++... .....+++..++.++.||+.||.|||++||+||||||+
T Consensus 84 --------~~~~~~~~~~~LVmEy~~ggsL~~~L~~~-----~~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~ 150 (676)
T 3qa8_A 84 --------LQKLAPNDLPLLAMEYCEGGDLRKYLNQF-----ENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPE 150 (676)
T ss_dssp --------TCCCCTTSSCCCEEECCSSCBHHHHHHSS-----SCTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCST
T ss_pred --------cccccCCCeEEEEEEeCCCCCHHHHHHhc-----ccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHH
Confidence 12244567789999998 46999888653 12346999999999999999999999999999999999
Q ss_pred cEEeec-C---cEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHh
Q 003052 630 NFLLVK-G---SLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVY 705 (853)
Q Consensus 630 NILL~~-g---~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLt 705 (853)
|||++. + .+||+|||+++...... .....+||+.|+|||++.+. .|+.++|||||||++|+|++
T Consensus 151 NILl~~~g~~~~vKL~DFG~a~~~~~~~---~~~~~~gt~~Y~APE~l~~~---------~~s~ksDIwSLGviLyeLlt 218 (676)
T 3qa8_A 151 NIVLQPGPQRLIHKIIDLGYAKELDQGE---LCTEFVGTLQYLAPELLEQK---------KYTVTVDYWSFGTLAFECIT 218 (676)
T ss_dssp TEEEECCSSSCEEEECSCCCCCBTTSCC---CCCCCCSCCTTCSSCSSCCS---------CCSTTHHHHHHHHHHHHHHS
T ss_pred HeEeecCCCceeEEEccccccccccccc---ccccccCCcccCChHHhccC---------CCCchhHHHHHHHHHHHHHH
Confidence 999953 3 48999999998764432 22357899999999999754 35689999999999999999
Q ss_pred CCCCCCcchhHHHHHHhh-----------cCCCCcc----------cCCCCCChhHHHHHHHhcccCCCCCCChhHHhcC
Q 003052 706 GRTPFSEYKTFWAKFKVI-----------TDPNHEI----------TYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQH 764 (853)
Q Consensus 706 G~~PF~~~~~~~~~~kii-----------~~~~~~~----------~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~H 764 (853)
|..||............+ ....... ......++.+.+||.+||.+||.+|||+.++|+|
T Consensus 219 G~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~h 298 (676)
T 3qa8_A 219 GFRPFLPNWQPVQWHGKVREKSNEHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNV 298 (676)
T ss_dssp SCSSCCSSCHHHHSSTTCC------CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCC
T ss_pred CCCCCCcccchhhhhhhhhcccchhhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcC
Confidence 999996543222111000 0000000 1112245679999999999999999999999999
Q ss_pred CCCC
Q 003052 765 PFLV 768 (853)
Q Consensus 765 Pwf~ 768 (853)
|||.
T Consensus 299 p~F~ 302 (676)
T 3qa8_A 299 GCFQ 302 (676)
T ss_dssp TTHH
T ss_pred HHHH
Confidence 9974
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-37 Score=370.02 Aligned_cols=243 Identities=22% Similarity=0.257 Sum_probs=191.8
Q ss_pred CceeeEEEeEeccCceEEEEEEec--CCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHH
Q 003052 471 GKLYQRLGKIGSGGSSEVHKVISS--DCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLR 548 (853)
Q Consensus 471 g~~Y~ilk~LG~G~FG~Vyka~~~--~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~ 548 (853)
..+|++.+.||+|+||.||+|.+. +++.||||++.... .......+.+|+.+|++++ ||||+++++++....
T Consensus 79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~~---- 152 (681)
T 2pzi_A 79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSG-DAEAQAMAMAERQFLAEVV-HPSIVQIFNFVEHTD---- 152 (681)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSC-CHHHHHHHHHHHGGGGGCC-CTTBCCEEEEEEEEC----
T ss_pred CCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccC-CHHHHHHHHHHHHHHHhcC-CCCcCeEeeeEeecC----
Confidence 467999999999999999999985 67899999987543 3345567889999999997 999999999853210
Q ss_pred HHhhCCCCCCCCccccCCeEEEEEecch-hhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCC
Q 003052 549 EVLNGSMNNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLK 627 (853)
Q Consensus 549 ~l~~~~iv~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLK 627 (853)
......+||||||++ ++|.+++. ..+++..++.|+.||+.||.|||++||||||||
T Consensus 153 -------------~~~~~~~~lv~E~~~g~~L~~~~~----------~~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlk 209 (681)
T 2pzi_A 153 -------------RHGDPVGYIVMEYVGGQSLKRSKG----------QKLPVAEAIAYLLEILPALSYLHSIGLVYNDLK 209 (681)
T ss_dssp -------------TTSCEEEEEEEECCCCEECC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCS
T ss_pred -------------CCCCceeEEEEEeCCCCcHHHHHh----------CCCCHHHHHHHHHHHHHHHHHHHHCCCeecccC
Confidence 011223799999986 47665442 269999999999999999999999999999999
Q ss_pred CccEEeecCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHhCC
Q 003052 628 PANFLLVKGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGR 707 (853)
Q Consensus 628 PeNILL~~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLtG~ 707 (853)
|+|||++.+.+||+|||+++..... ...+||+.|+|||++.+. ++.++|||||||++|+|++|.
T Consensus 210 p~NIll~~~~~kl~DFG~a~~~~~~------~~~~gt~~y~aPE~~~~~----------~~~~sDi~slG~~l~~l~~g~ 273 (681)
T 2pzi_A 210 PENIMLTEEQLKLIDLGAVSRINSF------GYLYGTPGFQAPEIVRTG----------PTVATDIYTVGRTLAALTLDL 273 (681)
T ss_dssp GGGEEECSSCEEECCCTTCEETTCC------SCCCCCTTTSCTTHHHHC----------SCHHHHHHHHHHHHHHHHSCC
T ss_pred hHHeEEeCCcEEEEecccchhcccC------CccCCCccccCHHHHcCC----------CCCceehhhhHHHHHHHHhCC
Confidence 9999998889999999999876432 356899999999999754 357999999999999999999
Q ss_pred CCCCcchhHHHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCCChhHHhcCCCC
Q 003052 708 TPFSEYKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQHPFL 767 (853)
Q Consensus 708 ~PF~~~~~~~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~HPwf 767 (853)
+||.+... ............++.+.+||.+||.+||.+||+..+.+.|+|+
T Consensus 274 ~~~~~~~~---------~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~ 324 (681)
T 2pzi_A 274 PTRNGRYV---------DGLPEDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLT 324 (681)
T ss_dssp CEETTEEC---------SSCCTTCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHH
T ss_pred CCCccccc---------ccccccccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHH
Confidence 99865211 0000000001124678999999999999999999998888775
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-36 Score=319.44 Aligned_cols=224 Identities=15% Similarity=0.099 Sum_probs=176.4
Q ss_pred EcCceeeEEEeEeccCceEEEEEEec-CCcEEEEEEEecCCCC-hhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHH
Q 003052 469 VNGKLYQRLGKIGSGGSSEVHKVISS-DCTIYALKKIKLKGRD-YATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKAL 546 (853)
Q Consensus 469 v~g~~Y~ilk~LG~G~FG~Vyka~~~-~g~~vAVKkik~~~~~-~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~i 546 (853)
+.+.+|++.+.||+|+||.||+|.+. +++.||||++...... ......+.+|+.++.++. |+||++++++
T Consensus 28 ~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-hp~iv~~~~~------- 99 (286)
T 3uqc_A 28 IANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRID-KPGVARVLDV------- 99 (286)
T ss_dssp ETTTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCC-CTTBCCEEEE-------
T ss_pred EecCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCC-CCCcceeeEE-------
Confidence 34467999999999999999999985 5789999999866443 445567899999999996 8999999987
Q ss_pred HHHHhhCCCCCCCCccccCCeEEEEEecch-hhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCC
Q 003052 547 LREVLNGSMNNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSD 625 (853)
Q Consensus 547 L~~l~~~~iv~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRD 625 (853)
+.+++.+|+||||++ ++|.+++.. + ..+..+..|+.||+.||.|||++||+|||
T Consensus 100 ---------------~~~~~~~~lv~e~~~g~~L~~~l~~---------~-~~~~~~~~i~~ql~~aL~~lH~~givH~D 154 (286)
T 3uqc_A 100 ---------------VHTRAGGLVVAEWIRGGSLQEVADT---------S-PSPVGAIRAMQSLAAAADAAHRAGVALSI 154 (286)
T ss_dssp ---------------EEETTEEEEEEECCCEEEHHHHHTT---------C-CCHHHHHHHHHHHHHHHHHHHHTTCCCCC
T ss_pred ---------------EEECCcEEEEEEecCCCCHHHHHhc---------C-CChHHHHHHHHHHHHHHHHHHHCCCccCC
Confidence 455678999999986 589888742 2 35667888999999999999999999999
Q ss_pred CCCccEEee-cCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHH
Q 003052 626 LKPANFLLV-KGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMV 704 (853)
Q Consensus 626 LKPeNILL~-~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELL 704 (853)
|||+|||++ +|.+||+++| |++| ++.++|||||||++|+|+
T Consensus 155 ikp~NIll~~~g~~kl~~~~----------------------~~~~----------------~~~~~Di~slG~il~ell 196 (286)
T 3uqc_A 155 DHPSRVRVSIDGDVVLAYPA----------------------TMPD----------------ANPQDDIRGIGASLYALL 196 (286)
T ss_dssp CSGGGEEEETTSCEEECSCC----------------------CCTT----------------CCHHHHHHHHHHHHHHHH
T ss_pred CCcccEEEcCCCCEEEEecc----------------------ccCC----------------CCchhHHHHHHHHHHHHH
Confidence 999999995 6789987543 3332 357899999999999999
Q ss_pred hCCCCCCcchhHHHHH---HhhcC-CCCcccCCCCCChhHHHHHHHhcccCCCCCCChhHHhcC
Q 003052 705 YGRTPFSEYKTFWAKF---KVITD-PNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQH 764 (853)
Q Consensus 705 tG~~PF~~~~~~~~~~---kii~~-~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~H 764 (853)
+|+.||.+........ +.+.. ...........++++.+||.+||..||.+| |+.|+++.
T Consensus 197 tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~ 259 (286)
T 3uqc_A 197 VNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNL 259 (286)
T ss_dssp HSEECSCCCSBCCCSEECCBCTTSCBCCHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHH
T ss_pred HCCCCCCcCCcchhhHHHHHHhccCCCChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHH
Confidence 9999997644321110 11111 011112345678899999999999999999 99999863
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=5.6e-32 Score=317.02 Aligned_cols=228 Identities=14% Similarity=0.116 Sum_probs=150.9
Q ss_pred eEeccCceEEEEEEe-cCCcEEEEEEEecCCC--------ChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHHH
Q 003052 479 KIGSGGSSEVHKVIS-SDCTIYALKKIKLKGR--------DYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLRE 549 (853)
Q Consensus 479 ~LG~G~FG~Vyka~~-~~g~~vAVKkik~~~~--------~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~~ 549 (853)
.++.|++|.+..++. -.|+.||||++.+... .......|.+|+++|+++.+|+||++++++
T Consensus 241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~---------- 310 (569)
T 4azs_A 241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAH---------- 310 (569)
T ss_dssp C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEE----------
T ss_pred ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEE----------
Confidence 477888888777654 4678899999976532 123445689999999999999999999998
Q ss_pred HhhCCCCCCCCccccCCeEEEEEecchh-hHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCCC
Q 003052 550 VLNGSMNNKDGRVKDDGYIYMVLEYGEI-DLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKP 628 (853)
Q Consensus 550 l~~~~iv~~~g~~~d~~~lyLVmEy~~g-dL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLKP 628 (853)
+++++.+||||||++| +|.+.|.+. +.+++. .|+.||+.||+|||++|||||||||
T Consensus 311 ------------~ed~~~~yLVMEyv~G~~L~d~i~~~--------~~l~~~---~I~~QIl~AL~ylH~~GIIHRDIKP 367 (569)
T 4azs_A 311 ------------GENAQSGWLVMEKLPGRLLSDMLAAG--------EEIDRE---KILGSLLRSLAALEKQGFWHDDVRP 367 (569)
T ss_dssp ------------EECSSEEEEEEECCCSEEHHHHHHTT--------CCCCHH---HHHHHHHHHHHHHHHTTCEESCCCG
T ss_pred ------------EEECCEEEEEEecCCCCcHHHHHHhC--------CCCCHH---HHHHHHHHHHHHHHHCCceeccCch
Confidence 6788899999999875 999998753 567764 5889999999999999999999999
Q ss_pred ccEEe-ecCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHhCC
Q 003052 629 ANFLL-VKGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGR 707 (853)
Q Consensus 629 eNILL-~~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLtG~ 707 (853)
+|||| .+|.+||+|||+|+....... ...+.+||+.|||||++.+. +..++|+|++|+++|+|++|.
T Consensus 368 eNILL~~dg~vKL~DFGlAr~~~~~~~--~~~t~vGTp~YmAPE~l~g~----------~~~~~d~~s~g~~~~~l~~~~ 435 (569)
T 4azs_A 368 WNVMVDARQHARLIDFGSIVTTPQDCS--WPTNLVQSFFVFVNELFAEN----------KSWNGFWRSAPVHPFNLPQPW 435 (569)
T ss_dssp GGEEECTTSCEEECCCTTEESCC---C--CSHHHHHHHHHHHHHHC---------------------------CCCCTTH
T ss_pred HhEEECCCCCEEEeecccCeeCCCCCc--cccCceechhhccHHHhCCC----------CCCcccccccccchhhhcccc
Confidence 99999 578999999999987654332 33478999999999999764 346799999999999887765
Q ss_pred CCCCcchhHHHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCCChhHHhcCCCC
Q 003052 708 TPFSEYKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQHPFL 767 (853)
Q Consensus 708 ~PF~~~~~~~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~HPwf 767 (853)
.+|.. ..+ ..+ . ....+..++..++..+|..|+.......|+|.
T Consensus 436 ~~~~~-----~l~---~~~--~------~~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~ 479 (569)
T 4azs_A 436 SNWLY-----AVW---QEP--V------ERWNFVLLLALFEKKAKLPSAEQQRGATEQWI 479 (569)
T ss_dssp HHHHH-----HHH---TSC--G------GGCSHHHHHHHHHTGGGSCCGGGSSCCHHHHH
T ss_pred chhHH-----Hhh---cCC--C------CCCcHHHHHHHHhCCCCCCCCChhhhccchhH
Confidence 54411 010 000 0 00124566666777777777766666666553
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=1.2e-25 Score=261.89 Aligned_cols=188 Identities=20% Similarity=0.177 Sum_probs=138.5
Q ss_pred EEEeEeccCceEEEEEEecCCcEEEEEEEecCCCCh------hhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHHH
Q 003052 476 RLGKIGSGGSSEVHKVISSDCTIYALKKIKLKGRDY------ATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLRE 549 (853)
Q Consensus 476 ilk~LG~G~FG~Vyka~~~~g~~vAVKkik~~~~~~------~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~~ 549 (853)
..+.||+|+||.||+|. ..+..+|+|++..+.... .....+.+|+++|++++ |+||+++..+.
T Consensus 340 ~~~~LG~G~fg~Vy~~~-~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~-h~nIv~~~~~~--------- 408 (540)
T 3en9_A 340 PEHLIGKGAEADIKRDS-YLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVK-DFGIPAPYIFD--------- 408 (540)
T ss_dssp --------CCEEEEEEE-CSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGG-GGTCCCCCEEE---------
T ss_pred CCCEEeeCCCEEEEEEE-ECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcC-CCCcCceEEEE---------
Confidence 35579999999999994 456778999876543221 12345789999999997 89999443331
Q ss_pred HhhCCCCCCCCccccCCeEEEEEecch-hhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCCC
Q 003052 550 VLNGSMNNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKP 628 (853)
Q Consensus 550 l~~~~iv~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLKP 628 (853)
.+....||||||++ ++|.+++.. +..|+.||+.||.|||++||+||||||
T Consensus 409 -------------~~~~~~~lVmE~~~ggsL~~~l~~----------------~~~i~~qi~~aL~~LH~~gIiHrDiKp 459 (540)
T 3en9_A 409 -------------VDLDNKRIMMSYINGKLAKDVIED----------------NLDIAYKIGEIVGKLHKNDVIHNDLTT 459 (540)
T ss_dssp -------------EETTTTEEEEECCCSEEHHHHSTT----------------CTHHHHHHHHHHHHHHHTTEECTTCCT
T ss_pred -------------EeCCccEEEEECCCCCCHHHHHHH----------------HHHHHHHHHHHHHHHHHCcCccCCCCH
Confidence 12334599999986 699887643 458899999999999999999999999
Q ss_pred ccEEeecCcEEEEecccchhcccCCccc-----cccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHH
Q 003052 629 ANFLLVKGSLKLIDFGIAKAIMSDTTNI-----QRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQM 703 (853)
Q Consensus 629 eNILL~~g~VKL~DFGlAk~~~~~~~~~-----~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyEL 703 (853)
+|||+++ .+||+|||+|+......... .....+||+.|||||++.... ..|+..+|+|+..+-..+.
T Consensus 460 ~NILl~~-~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~-------~~Y~~~~d~ws~vl~~l~~ 531 (540)
T 3en9_A 460 SNFIFDK-DLYIIDFGLGKISNLDEDKAVDLIVFKKAVLSTHHEKFDEIWERFL-------EGYKSVYDRWEIILELMKD 531 (540)
T ss_dssp TSEEESS-SEEECCCTTCEECCCHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHH-------HHHHHHCTTHHHHHHHHHH
T ss_pred HHEEECC-eEEEEECccCEECCCccccccchhhhhhhhcCCCCcCCHHHHHHHH-------HHHHHHHhHHHHHHHHHHH
Confidence 9999988 99999999998765422111 124678999999999997521 1366788999999999888
Q ss_pred HhCCCCCC
Q 003052 704 VYGRTPFS 711 (853)
Q Consensus 704 LtG~~PF~ 711 (853)
+.++.+|.
T Consensus 532 v~~r~rY~ 539 (540)
T 3en9_A 532 VERRARYV 539 (540)
T ss_dssp HHTCSCCC
T ss_pred HHhccccC
Confidence 88877764
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.87 E-value=1.4e-22 Score=217.10 Aligned_cols=148 Identities=20% Similarity=0.140 Sum_probs=113.9
Q ss_pred CceeeEEEeEeccCceEEEEEEecCCcEEEEEEEecCCCCh----------------hhHhhHHHHHHHHHHhcCCCcee
Q 003052 471 GKLYQRLGKIGSGGSSEVHKVISSDCTIYALKKIKLKGRDY----------------ATAYGFCQEIEYLNKLKGKNNII 534 (853)
Q Consensus 471 g~~Y~ilk~LG~G~FG~Vyka~~~~g~~vAVKkik~~~~~~----------------~~~~~~l~EI~iLkkL~~hpNIV 534 (853)
+..|.+.+.||+|+||.||+|.+.+++.||||+++...... .....+.+|+.+|+++. |.++.
T Consensus 89 ~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~-~~~v~ 167 (282)
T 1zar_A 89 GKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ-GLAVP 167 (282)
T ss_dssp TSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT-TSSSC
T ss_pred CeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc-CCCcC
Confidence 45577779999999999999999778999999997543211 13456889999999998 34444
Q ss_pred EeeehhhhHHHHHHHHhhCCCCCCCCccccCCeEEEEEecchh-hHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhh
Q 003052 535 QLIDYEVTEKALLREVLNGSMNNKDGRVKDDGYIYMVLEYGEI-DLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAV 613 (853)
Q Consensus 535 ~Lid~~~~e~~iL~~l~~~~iv~~~g~~~d~~~lyLVmEy~~g-dL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL 613 (853)
.+++ .+.+|+||||+++ +|.+ + .......++.||+.||
T Consensus 168 ~~~~--------------------------~~~~~lvmE~~~g~~L~~-l--------------~~~~~~~i~~qi~~~l 206 (282)
T 1zar_A 168 KVYA--------------------------WEGNAVLMELIDAKELYR-V--------------RVENPDEVLDMILEEV 206 (282)
T ss_dssp CEEE--------------------------EETTEEEEECCCCEEGGG-C--------------CCSCHHHHHHHHHHHH
T ss_pred eEEe--------------------------ccceEEEEEecCCCcHHH-c--------------chhhHHHHHHHHHHHH
Confidence 3322 1345999999864 7655 2 1123457999999999
Q ss_pred hhcccCceeeCCCCCccEEeecCcEEEEecccchhcccCCccccccccccCccccCchhhcc
Q 003052 614 NTIHEERIVHSDLKPANFLLVKGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMC 675 (853)
Q Consensus 614 ~yLHs~gIIHRDLKPeNILL~~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~ 675 (853)
.|||++||+||||||+|||+++|.+||+|||+|+. +..|+|||++.+
T Consensus 207 ~~lH~~giiHrDlkp~NILl~~~~vkl~DFG~a~~---------------~~~~~a~e~l~r 253 (282)
T 1zar_A 207 AKFYHRGIVHGDLSQYNVLVSEEGIWIIDFPQSVE---------------VGEEGWREILER 253 (282)
T ss_dssp HHHHHTTEECSCCSTTSEEEETTEEEECCCTTCEE---------------TTSTTHHHHHHH
T ss_pred HHHHHCCCEeCCCCHHHEEEECCcEEEEECCCCeE---------------CCCCCHHHHHHH
Confidence 99999999999999999999988999999999852 346799998853
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.80 E-value=1e-19 Score=191.73 Aligned_cols=141 Identities=21% Similarity=0.264 Sum_probs=105.3
Q ss_pred CceeeEEEeEeccCceEEEEEEe-cCCcE--EEEEEEecCCCChh----------------------hHhhHHHHHHHHH
Q 003052 471 GKLYQRLGKIGSGGSSEVHKVIS-SDCTI--YALKKIKLKGRDYA----------------------TAYGFCQEIEYLN 525 (853)
Q Consensus 471 g~~Y~ilk~LG~G~FG~Vyka~~-~~g~~--vAVKkik~~~~~~~----------------------~~~~~l~EI~iLk 525 (853)
+..|.+.+.||+|+||.||+|.+ .+|+. ||||+++....... ....+.+|+.+|.
T Consensus 46 ~~~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 125 (258)
T 1zth_A 46 GYITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLE 125 (258)
T ss_dssp TSEEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHH
T ss_pred CCchhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHH
Confidence 45688999999999999999998 78888 99999865421111 1124678999999
Q ss_pred HhcCC-CceeEeeehhhhHHHHHHHHhhCCCCCCCCccccCCeEEEEEecchh------hHHHHHHHhhhhccCCCCCCC
Q 003052 526 KLKGK-NNIIQLIDYEVTEKALLREVLNGSMNNKDGRVKDDGYIYMVLEYGEI------DLAHMLSQKWKEMDGSNQTLD 598 (853)
Q Consensus 526 kL~~h-pNIV~Lid~~~~e~~iL~~l~~~~iv~~~g~~~d~~~lyLVmEy~~g------dL~~~L~~~~k~~~~~~~~Ls 598 (853)
+|.++ -++..++++ ...||||||+++ .|.+.... ++
T Consensus 126 ~l~~~~i~~p~~~~~--------------------------~~~~lVmE~~g~~g~~~~~L~~~~~~-----------~~ 168 (258)
T 1zth_A 126 RAKEAGVSVPQPYTY--------------------------MKNVLLMEFIGEDELPAPTLVELGRE-----------LK 168 (258)
T ss_dssp HHHHTTCCCCCEEEE--------------------------ETTEEEEECCEETTEECCBHHHHGGG-----------GG
T ss_pred HHHhCCCCCCeEEEc--------------------------CCCEEEEEecCCCCCccccHHHHhhc-----------cC
Confidence 98733 123333321 134899999853 55544321 23
Q ss_pred HHHHHHHHHHhhhhhhhcc-cCceeeCCCCCccEEeecCcEEEEecccchhc
Q 003052 599 ENWLRFYWQQILEAVNTIH-EERIVHSDLKPANFLLVKGSLKLIDFGIAKAI 649 (853)
Q Consensus 599 E~~~r~I~~QIl~AL~yLH-s~gIIHRDLKPeNILL~~g~VKL~DFGlAk~~ 649 (853)
+..+..++.||+.||.||| ++||+||||||+|||+++ .++|+|||+|...
T Consensus 169 ~~~~~~i~~qi~~~l~~lH~~~givHrDlkp~NILl~~-~~~liDFG~a~~~ 219 (258)
T 1zth_A 169 ELDVEGIFNDVVENVKRLYQEAELVHADLSEYNIMYID-KVYFIDMGQAVTL 219 (258)
T ss_dssp GSCHHHHHHHHHHHHHHHHHTSCEECSSCSTTSEEESS-SEEECCCTTCEET
T ss_pred hHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEEcC-cEEEEECcccccC
Confidence 5567889999999999999 999999999999999988 9999999999654
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.61 E-value=3.3e-16 Score=175.48 Aligned_cols=146 Identities=12% Similarity=0.135 Sum_probs=91.4
Q ss_pred CceeeEEEeEeccCceEEEEEEecCCcEEEEEEEecCCCCh------------hhHhhHHHHHHHHHHhcCCCceeEeee
Q 003052 471 GKLYQRLGKIGSGGSSEVHKVISSDCTIYALKKIKLKGRDY------------ATAYGFCQEIEYLNKLKGKNNIIQLID 538 (853)
Q Consensus 471 g~~Y~ilk~LG~G~FG~Vyka~~~~g~~vAVKkik~~~~~~------------~~~~~~l~EI~iLkkL~~hpNIV~Lid 538 (853)
+..|.+.+.||.|+||.||+|.+.+|+.||||+++...... .....++.++++..... |+|+.++
T Consensus 94 g~iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE-~~nL~rL-- 170 (397)
T 4gyi_A 94 KDVYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKE-FAFMKAL-- 170 (397)
T ss_dssp TSCSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHH-HHHHHHH--
T ss_pred CCEEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHH-HHHHHHH--
Confidence 45699999999999999999999999999999986432110 00011122222211111 1222222
Q ss_pred hhhhHHHHHHHHhhCCCCCCCCccccCCeEEEEEecchh-hHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcc
Q 003052 539 YEVTEKALLREVLNGSMNNKDGRVKDDGYIYMVLEYGEI-DLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIH 617 (853)
Q Consensus 539 ~~~~e~~iL~~l~~~~iv~~~g~~~d~~~lyLVmEy~~g-dL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLH 617 (853)
.+..+ .....+.. ...+|||||++| .|..+ .....+..++.||+.+|.|||
T Consensus 171 ------------~~~gv-~vp~p~~~-~~~~LVME~i~G~~L~~l--------------~~~~~~~~l~~qll~~l~~lH 222 (397)
T 4gyi_A 171 ------------YEEGF-PVPEPIAQ-SRHTIVMSLVDALPMRQV--------------SSVPDPASLYADLIALILRLA 222 (397)
T ss_dssp ------------HHTTC-SCCCEEEE-ETTEEEEECCSCEEGGGC--------------CCCSCHHHHHHHHHHHHHHHH
T ss_pred ------------HhcCC-CCCeeeec-cCceEEEEecCCccHhhh--------------cccHHHHHHHHHHHHHHHHHH
Confidence 11111 11111111 123799999875 33211 122345678899999999999
Q ss_pred cCceeeCCCCCccEEeecC-----------cEEEEecccch
Q 003052 618 EERIVHSDLKPANFLLVKG-----------SLKLIDFGIAK 647 (853)
Q Consensus 618 s~gIIHRDLKPeNILL~~g-----------~VKL~DFGlAk 647 (853)
.+|||||||||.|||+.++ .+.|+||+-+-
T Consensus 223 ~~gIVHrDLKp~NILl~~dgd~~d~~~~~~~~~iID~~Q~V 263 (397)
T 4gyi_A 223 KHGLIHGDFNEFNILIREEKDAEDPSSITLTPIIIXFPQMV 263 (397)
T ss_dssp HTTEECSCCSTTSEEEEEEECSSCTTSEEEEEEECCCTTCE
T ss_pred HCCCcCCCCCHHHEEEeCCCCcccccccccceEEEEeCCcc
Confidence 9999999999999999532 28999999764
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.17 E-value=6.6e-11 Score=123.12 Aligned_cols=136 Identities=18% Similarity=0.256 Sum_probs=102.3
Q ss_pred eeEEEeEeccCceEEEEEEecCCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHHHHhhC
Q 003052 474 YQRLGKIGSGGSSEVHKVISSDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLREVLNG 553 (853)
Q Consensus 474 Y~ilk~LG~G~FG~Vyka~~~~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~~l~~~ 553 (853)
|++...+|.|+++.||++... ++.+++|+...... .....+.+|+.+|+.|..+..+.+++++
T Consensus 16 ~~~~~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~--~~~~~~~~E~~~l~~l~~~~~vP~v~~~-------------- 78 (263)
T 3tm0_A 16 YRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYK--GTTYDVEREKDMMLWLEGKLPVPKVLHF-------------- 78 (263)
T ss_dssp SEEEECCSCCSSSEEEEEECS-SCEEEEEEECGGGT--TSTTCHHHHHHHHHHHTTTSCCCCEEEE--------------
T ss_pred ceeEeeccCCCCCeEEEEECC-CCcEEEEeCCcccC--CCHHHHHHHHHHHHHHhcCCCCCeEEEE--------------
Confidence 788888999999999999764 57899999875321 1123588999999999766677777765
Q ss_pred CCCCCCCccccCCeEEEEEecchh-hHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhccc--------------
Q 003052 554 SMNNKDGRVKDDGYIYMVLEYGEI-DLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHE-------------- 618 (853)
Q Consensus 554 ~iv~~~g~~~d~~~lyLVmEy~~g-dL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs-------------- 618 (853)
+.+.+..|+||||++| +|.+.+ .+......++.++..+|..||+
T Consensus 79 --------~~~~~~~~lv~e~i~G~~l~~~~-------------~~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~ 137 (263)
T 3tm0_A 79 --------ERHDGWSNLLMSEADGVLCSEEY-------------EDEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDS 137 (263)
T ss_dssp --------EEETTEEEEEEECCSSEEHHHHC-------------CTTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHH
T ss_pred --------EecCCceEEEEEecCCeehhhcc-------------CCcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHH
Confidence 3445678999999876 554431 0112234677788888888887
Q ss_pred ---------------------------------------------CceeeCCCCCccEEeecCc-EEEEecccch
Q 003052 619 ---------------------------------------------ERIVHSDLKPANFLLVKGS-LKLIDFGIAK 647 (853)
Q Consensus 619 ---------------------------------------------~gIIHRDLKPeNILL~~g~-VKL~DFGlAk 647 (853)
..++|+|++|.|||++++. +.|+||+.|.
T Consensus 138 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 138 RLAELDYLLNNDLADVDCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp HHHHHHHHHHTTCSCCSGGGGSTTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred HHHHHHHHHhccccccccccccccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence 5699999999999997775 4699999874
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.04 E-value=5.7e-10 Score=114.51 Aligned_cols=131 Identities=18% Similarity=0.165 Sum_probs=85.8
Q ss_pred eeEEEeEeccCceEEEEEEecCCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCc-eeEeeehhhhHHHHHHHHhh
Q 003052 474 YQRLGKIGSGGSSEVHKVISSDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNN-IIQLIDYEVTEKALLREVLN 552 (853)
Q Consensus 474 Y~ilk~LG~G~FG~Vyka~~~~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpN-IV~Lid~~~~e~~iL~~l~~ 552 (853)
|.+....+.|.++.||++...++..+++|+.... ....+.+|+.+|+.|.++.- +.+++.+
T Consensus 22 ~~~~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~-----~~~~~~~E~~~l~~l~~~~~~vP~~~~~------------- 83 (264)
T 1nd4_A 22 YDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSG-----ALNELQDEAARLSWLATTGVPCAAVLDV------------- 83 (264)
T ss_dssp CEEEECSCTTSSCEEEEEECTTSCCEEEEEECSC-----TTSCHHHHHHHHHHHHTTTCCBCCEEEE-------------
T ss_pred CceEecccCCCCceEEEEecCCCCeEEEEeCCcc-----cchhhhHHHHHHHHHHhCCCCCCeEEEe-------------
Confidence 4443333466679999998777778999997643 12357799999999986532 4556654
Q ss_pred CCCCCCCCccccCCeEEEEEecchh-hHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhccc-------------
Q 003052 553 GSMNNKDGRVKDDGYIYMVLEYGEI-DLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHE------------- 618 (853)
Q Consensus 553 ~~iv~~~g~~~d~~~lyLVmEy~~g-dL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs------------- 618 (853)
..+++..|+||||++| .|. .. ... ...++.+++..|..||.
T Consensus 84 ---------~~~~~~~~~v~e~i~G~~l~--~~-----------~~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~ 138 (264)
T 1nd4_A 84 ---------VTEAGRDWLLLGEVPGQDLL--SS-----------HLA---PAEKVSIMADAMRRLHTLDPATCPFDHQAK 138 (264)
T ss_dssp ---------EECSSCEEEEEECCSSEETT--TS-----------CCC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHH
T ss_pred ---------ccCCCCCEEEEEecCCcccC--cC-----------cCC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHH
Confidence 2344568999999765 331 00 001 11233344444444443
Q ss_pred ---------------------------------------------CceeeCCCCCccEEeecCcE-EEEecccch
Q 003052 619 ---------------------------------------------ERIVHSDLKPANFLLVKGSL-KLIDFGIAK 647 (853)
Q Consensus 619 ---------------------------------------------~gIIHRDLKPeNILL~~g~V-KL~DFGlAk 647 (853)
.+++|+|++|.|||++++.+ +|+|||.|.
T Consensus 139 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~ 213 (264)
T 1nd4_A 139 HRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 213 (264)
T ss_dssp HHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred HHHHHHHHHHhcCCccchhhhhhccCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence 34999999999999977754 699999875
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=98.80 E-value=5.2e-09 Score=114.35 Aligned_cols=141 Identities=15% Similarity=0.250 Sum_probs=95.7
Q ss_pred EEeEeccCceEEEEEEecCCcEEEEEEEe--cCCCChhhHhhHHHHHHHHHHhcCC-CceeEeeehhhhHHHHHHHHhhC
Q 003052 477 LGKIGSGGSSEVHKVISSDCTIYALKKIK--LKGRDYATAYGFCQEIEYLNKLKGK-NNIIQLIDYEVTEKALLREVLNG 553 (853)
Q Consensus 477 lk~LG~G~FG~Vyka~~~~g~~vAVKkik--~~~~~~~~~~~~l~EI~iLkkL~~h-pNIV~Lid~~~~e~~iL~~l~~~ 553 (853)
++.|+.|.++.||++...+ ..+++|+.. ... .......+.+|+.+|+.|... ..+.+++.++...
T Consensus 43 ~~~l~~G~sn~~y~v~~~~-~~~vlr~~~~p~~~-~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~---------- 110 (359)
T 3dxp_A 43 VEQFKGGQSNPTFKLVTPG-QTYVMRAKPGPKSK-LLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDE---------- 110 (359)
T ss_dssp EEECCC-CCSCEEEEECSS-CEEEEECCCC-----------CHHHHHHHHHHHTTSSSCCCCEEEEECCT----------
T ss_pred EEEcCCcccceEEEEEECC-ceEEEEeCCCCCCC-CCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCC----------
Confidence 5678999999999998754 568888765 321 112234678999999999852 3466666552210
Q ss_pred CCCCCCCccccCCeEEEEEecchhh-HHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhccc--------------
Q 003052 554 SMNNKDGRVKDDGYIYMVLEYGEID-LAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHE-------------- 618 (853)
Q Consensus 554 ~iv~~~g~~~d~~~lyLVmEy~~gd-L~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs-------------- 618 (853)
...+..|+||||++|. +.+ .....+++.....++.+++.+|..||.
T Consensus 111 ---------~~~g~~~~vme~v~G~~l~~----------~~~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~ 171 (359)
T 3dxp_A 111 ---------SVIGRAFYIMEFVSGRVLWD----------QSLPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKP 171 (359)
T ss_dssp ---------TTTSSCEEEEECCCCBCCCC----------TTCTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCC
T ss_pred ---------CccCCeEEEEEecCCeecCC----------CccccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCC
Confidence 0114578999998762 211 011346778888888999999999986
Q ss_pred --------------------------------------------CceeeCCCCCccEEeec-C--cEEEEecccchh
Q 003052 619 --------------------------------------------ERIVHSDLKPANFLLVK-G--SLKLIDFGIAKA 648 (853)
Q Consensus 619 --------------------------------------------~gIIHRDLKPeNILL~~-g--~VKL~DFGlAk~ 648 (853)
.+++|+|+++.|||++. + .+.|+||++|..
T Consensus 172 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 172 GNYFQRQIERWTKQYKLSETESIPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp SCHHHHHHHHHHHHHHHHCCSCCHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred CCchHHHHHHHHHHHHhcCCcCChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 47999999999999954 3 369999999864
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.71 E-value=6.6e-09 Score=111.05 Aligned_cols=191 Identities=16% Similarity=0.187 Sum_probs=105.5
Q ss_pred EeEeccCceEEEEEEecCCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCc--eeEeeehhhhHHHHHHHHhhCCC
Q 003052 478 GKIGSGGSSEVHKVISSDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNN--IIQLIDYEVTEKALLREVLNGSM 555 (853)
Q Consensus 478 k~LG~G~FG~Vyka~~~~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpN--IV~Lid~~~~e~~iL~~l~~~~i 555 (853)
+.|+.|.+..||++. ..+++|+.... .....+.+|..+|+.+..+.. +.+++.+...
T Consensus 26 ~~~~~G~~n~v~~v~----~~~vlR~~~~~----~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~------------- 84 (304)
T 3sg8_A 26 EISGEGNDCIAYEIN----RDFIFKFPKHS----RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMP------------- 84 (304)
T ss_dssp CEEEECSSEEEEEST----TSEEEEEESSH----HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCC-------------
T ss_pred EecCCCCcceEEEEC----CEEEEEecCCc----chHHHHHHHHHHHHHHHhcCCCCCCceEeecCC-------------
Confidence 348999999999874 45888886432 334568899999999854322 2333322100
Q ss_pred CCCCCccccCCeEEEEEecchh-hHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhccc----------------
Q 003052 556 NNKDGRVKDDGYIYMVLEYGEI-DLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHE---------------- 618 (853)
Q Consensus 556 v~~~g~~~d~~~lyLVmEy~~g-dL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs---------------- 618 (853)
-......|+|||+.+| .|..... ..++......++.+++..|..||+
T Consensus 85 ------~~~~~~~~~vm~~i~G~~l~~~~~----------~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~ 148 (304)
T 3sg8_A 85 ------SETYQMSFAGFTKIKGVPLTPLLL----------NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFRE 148 (304)
T ss_dssp ------CSSCSCSCEEEECCCCEECCHHHH----------HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHH
T ss_pred ------CCCCCcceEEEcccCCeECCcccc----------ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHH
Confidence 0011234889999765 3322111 123344444444444444444442
Q ss_pred ------------------------------------------CceeeCCCCCccEEeec--C-cEEEEecccchhcccCC
Q 003052 619 ------------------------------------------ERIVHSDLKPANFLLVK--G-SLKLIDFGIAKAIMSDT 653 (853)
Q Consensus 619 ------------------------------------------~gIIHRDLKPeNILL~~--g-~VKL~DFGlAk~~~~~~ 653 (853)
..++|+|++|.|||+++ + .+.|+||+.+......
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~- 227 (304)
T 3sg8_A 149 KINEDNKKIKKLLSRELKGPQMKKVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPD- 227 (304)
T ss_dssp HHHHHHHHHHHHHTTTSCHHHHHHHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTT-
T ss_pred HHHHHHHHHHHHhcccCCcccHHHHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChH-
Confidence 35899999999999976 4 5789999998643210
Q ss_pred ccccccccccCccc---cCchhhcc--CCCCCC---CccccCCCccchhhhHHHHHHHHhCCCCCC
Q 003052 654 TNIQRDSQVGTLSY---MSPEAFMC--NESDEN---GNIIKCGRPSDIWSLGCILYQMVYGRTPFS 711 (853)
Q Consensus 654 ~~~~~~t~~GTp~Y---mAPEvl~~--~~~~~~---~~~~~ys~ksDIWSLGVILyELLtG~~PF~ 711 (853)
.. ......+ ..|+.+.. ..|... .-........+.|++|.++|.+.+|..+|.
T Consensus 228 ~D-----l~~~~~~~~~~~~~~~~~~l~~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~~ 288 (304)
T 3sg8_A 228 ND-----FISLMEDDEEYGMEFVSKILNHYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDWY 288 (304)
T ss_dssp HH-----HHTTCCTTTSCCHHHHHHHHHHHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHHH
T ss_pred HH-----HHHHHhhccccCHHHHHHHHHHcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHHH
Confidence 00 0011111 22222110 000000 000001123589999999999999998873
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.12 E-value=1.7e-05 Score=85.20 Aligned_cols=72 Identities=21% Similarity=0.151 Sum_probs=47.8
Q ss_pred EEeEeccCceEEEEEEecCCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCC--ceeEeeehhhhHHHHHHHHhhCC
Q 003052 477 LGKIGSGGSSEVHKVISSDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKN--NIIQLIDYEVTEKALLREVLNGS 554 (853)
Q Consensus 477 lk~LG~G~FG~Vyka~~~~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hp--NIV~Lid~~~~e~~iL~~l~~~~ 554 (853)
++.++.|....||++ +..+++|+-. .......+.+|..+|+.|.++- .|.+.+.+..
T Consensus 24 v~~l~~G~~n~v~~v----g~~~VlR~~~----~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~------------- 82 (306)
T 3tdw_A 24 VESLGEGFRNYAILV----NGDWVFRFPK----SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGK------------- 82 (306)
T ss_dssp EEEEEECSSEEEEEE----TTTEEEEEES----SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEE-------------
T ss_pred eeecCCCcceeEEEE----CCEEEEEecC----CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecc-------------
Confidence 345889999999998 4568888842 2233456889999999998642 2334433310
Q ss_pred CCCCCCccccCCeEEEEEecchh
Q 003052 555 MNNKDGRVKDDGYIYMVLEYGEI 577 (853)
Q Consensus 555 iv~~~g~~~d~~~lyLVmEy~~g 577 (853)
...+..|+||||.+|
T Consensus 83 --------~~~g~~~~v~e~i~G 97 (306)
T 3tdw_A 83 --------RSDGNPFVGYRKVQG 97 (306)
T ss_dssp --------CTTSCEEEEEECCCS
T ss_pred --------cCCCceEEEEeccCC
Confidence 124557899999765
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.02 E-value=3.7e-05 Score=79.84 Aligned_cols=71 Identities=14% Similarity=0.091 Sum_probs=49.3
Q ss_pred EeccCce-EEEEEEec-CCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHHHHhhCCCCC
Q 003052 480 IGSGGSS-EVHKVISS-DCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLREVLNGSMNN 557 (853)
Q Consensus 480 LG~G~FG-~Vyka~~~-~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~~l~~~~iv~ 557 (853)
+..|..| .||+.... ++..+++|+-... ....+.+|..+|+.|..+--|.+++.+
T Consensus 32 ~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~-----~~~~~~~E~~~l~~l~~~vPVP~v~~~------------------ 88 (272)
T 4gkh_A 32 DNVGQSGATIYRLYGKPNAPELFLKHGKGS-----VANDVTDEMVRLNWLTAFMPLPTIKHF------------------ 88 (272)
T ss_dssp EECSSSSCEEEEEECCTTCCCEEEEEEETH-----HHHHHHHHHHHHHHHTTTSCCCCEEEE------------------
T ss_pred ccCCCcCCeEEEEEecCCCeEEEEEECCCC-----CHhHHHHHHHHHHHhccCCCcCeEEEE------------------
Confidence 4556555 69998774 4567888886532 344577899999999765445555554
Q ss_pred CCCccccCCeEEEEEecchh
Q 003052 558 KDGRVKDDGYIYMVLEYGEI 577 (853)
Q Consensus 558 ~~g~~~d~~~lyLVmEy~~g 577 (853)
+.+++..|+|||+++|
T Consensus 89 ----~~~~~~~~lvme~l~G 104 (272)
T 4gkh_A 89 ----IRTPDDAWLLTTAIPG 104 (272)
T ss_dssp ----EEETTEEEEEEECCCS
T ss_pred ----EEECCeEEEEEEeeCC
Confidence 3456778999999765
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=97.87 E-value=4.7e-05 Score=84.13 Aligned_cols=53 Identities=15% Similarity=0.046 Sum_probs=35.3
Q ss_pred EEeEeccCceEEEEEEec-CCcEEEEEEEecCCC----C-hhhHhhHHHHHHHHHHhcC
Q 003052 477 LGKIGSGGSSEVHKVISS-DCTIYALKKIKLKGR----D-YATAYGFCQEIEYLNKLKG 529 (853)
Q Consensus 477 lk~LG~G~FG~Vyka~~~-~g~~vAVKkik~~~~----~-~~~~~~~l~EI~iLkkL~~ 529 (853)
++.||.|.++.||++... +++.|+||......+ . ......+..|.++|+.+..
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~ 93 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGE 93 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHT
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhh
Confidence 457999999999999764 457899998753221 0 0123346789999998864
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=97.74 E-value=8e-05 Score=80.75 Aligned_cols=65 Identities=9% Similarity=-0.019 Sum_probs=41.0
Q ss_pred eEEEeE-eccCceEEEEEEec-------CCcEEEEEEEecCCC-ChhhHhhHHHHHHHHHHhcCC--CceeEeeeh
Q 003052 475 QRLGKI-GSGGSSEVHKVISS-------DCTIYALKKIKLKGR-DYATAYGFCQEIEYLNKLKGK--NNIIQLIDY 539 (853)
Q Consensus 475 ~ilk~L-G~G~FG~Vyka~~~-------~g~~vAVKkik~~~~-~~~~~~~~l~EI~iLkkL~~h--pNIV~Lid~ 539 (853)
..++.| +.|....+|++... ++..+++|+...... .......+.+|+.+|+.|..+ -.+.+++.+
T Consensus 23 ~~~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~ 98 (357)
T 3ats_A 23 TVESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWI 98 (357)
T ss_dssp EEEEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEE
T ss_pred EEEEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEE
Confidence 345678 88999999998754 256788887643210 000123577899999998754 235555544
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=97.72 E-value=5e-05 Score=80.98 Aligned_cols=29 Identities=24% Similarity=0.374 Sum_probs=25.7
Q ss_pred CceeeCCCCCccEEe-ecCcEEEEecccch
Q 003052 619 ERIVHSDLKPANFLL-VKGSLKLIDFGIAK 647 (853)
Q Consensus 619 ~gIIHRDLKPeNILL-~~g~VKL~DFGlAk 647 (853)
.+++|+|+++.|||+ .++.+.|+||+.|.
T Consensus 222 ~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 222 PNLCHQDYGTGNTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp CCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred CceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence 579999999999999 46789999999774
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.36 E-value=0.00043 Score=73.55 Aligned_cols=30 Identities=20% Similarity=0.214 Sum_probs=26.2
Q ss_pred CceeeCCCCCccEEeecCcEEEEecccchh
Q 003052 619 ERIVHSDLKPANFLLVKGSLKLIDFGIAKA 648 (853)
Q Consensus 619 ~gIIHRDLKPeNILL~~g~VKL~DFGlAk~ 648 (853)
..++|+|+.+.|||..++.+.|+||..|..
T Consensus 173 ~~l~HgDl~~~Nil~~~~~~~lID~e~a~~ 202 (301)
T 3dxq_A 173 LAACHCDPLCENFLDTGERMWIVDWEYSGM 202 (301)
T ss_dssp CEEECSCCCGGGEEECSSCEEECCCTTCEE
T ss_pred ceeeccCCCcCCEEECCCCEEEEecccccC
Confidence 369999999999998778899999998753
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.35 E-value=0.00091 Score=74.71 Aligned_cols=32 Identities=19% Similarity=0.376 Sum_probs=28.3
Q ss_pred ccCceeeCCCCCccEEeecCcEEEEecccchh
Q 003052 617 HEERIVHSDLKPANFLLVKGSLKLIDFGIAKA 648 (853)
Q Consensus 617 Hs~gIIHRDLKPeNILL~~g~VKL~DFGlAk~ 648 (853)
+...++|+|+++.|||++.+.++|+||+.|..
T Consensus 230 ~~~~liHGDl~~~Nil~~~~~~~lID~e~a~~ 261 (420)
T 2pyw_A 230 RAQALIHGDLHTGSVMVTQDSTQVIDPEFSFY 261 (420)
T ss_dssp BCCEEECSCCSGGGEEECSSCEEECCCTTCEE
T ss_pred CCCeEEecCCCCCcEEEeCCCCEEEeCccccc
Confidence 56789999999999999766699999998864
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.12 E-value=0.0066 Score=63.90 Aligned_cols=57 Identities=19% Similarity=0.065 Sum_probs=43.3
Q ss_pred CceeeEEEeEeccCceEEEEEEecCCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcC
Q 003052 471 GKLYQRLGKIGSGGSSEVHKVISSDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKG 529 (853)
Q Consensus 471 g~~Y~ilk~LG~G~FG~Vyka~~~~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~ 529 (853)
|....-++.+|.|..+.||++...+|+.|++|+-..... .....|..|...|+.|..
T Consensus 14 G~~v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~--~~~~~~~~Ea~~L~~L~~ 70 (288)
T 3f7w_A 14 GREVAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAP--ALDGLFRAEALGLDWLGR 70 (288)
T ss_dssp CCCEEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCC--CCTTHHHHHHHHHHHHTC
T ss_pred CCCeEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCc--chhhHHHHHHHHHHHHHh
Confidence 344566788999999999999999999999998653322 222347789999999864
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.08 E-value=0.0031 Score=67.20 Aligned_cols=147 Identities=14% Similarity=0.162 Sum_probs=79.9
Q ss_pred eEeccCceEEEEEEecCCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCC-ceeEeeehhhhHHHHHHHHhhCCCCC
Q 003052 479 KIGSGGSSEVHKVISSDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKN-NIIQLIDYEVTEKALLREVLNGSMNN 557 (853)
Q Consensus 479 ~LG~G~FG~Vyka~~~~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hp-NIV~Lid~~~~e~~iL~~l~~~~iv~ 557 (853)
.|+ |....||++...+|+.+++|+....... ...+..|..+++.|..+. .+.+++.. . +.
T Consensus 33 ~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~~~---~~~~~~E~~~~~~L~~~g~~vp~~~~~-~-----------g~--- 93 (328)
T 1zyl_A 33 PLN-SYENRVYQFQDEDRRRFVVKFYRPERWT---ADQILEEHQFALQLVNDEVPVAAPVAF-N-----------GQ--- 93 (328)
T ss_dssp EEC-CSSSEEEEECCTTCCCEEEEEECTTTSC---HHHHHHHHHHHHHHHHTTCSBCCCCCB-T-----------TB---
T ss_pred eec-CcccceEEEEcCCCCEEEEEEcCCCCCC---HHHHHHHHHHHHHHHHcCCeecceeec-C-----------Cc---
Confidence 466 8888999987767767999998643222 234667888888886432 13333321 0 00
Q ss_pred CCCccccCCeEEEEEecchh-h-----------HHHHHHHhhhhccC----CCCCCCHHH--------------------
Q 003052 558 KDGRVKDDGYIYMVLEYGEI-D-----------LAHMLSQKWKEMDG----SNQTLDENW-------------------- 601 (853)
Q Consensus 558 ~~g~~~d~~~lyLVmEy~~g-d-----------L~~~L~~~~k~~~~----~~~~LsE~~-------------------- 601 (853)
.....++..|+||+|.+| . +...+.+-...... ....++...
T Consensus 94 --~~~~~~g~~~~l~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~ 171 (328)
T 1zyl_A 94 --TLLNHQGFYFAVFPSVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLK 171 (328)
T ss_dssp --SCEEETTEEEEEEECCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTH
T ss_pred --EEEEECCEEEEEEEecCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHH
Confidence 012235677899999654 1 11111111000000 001111111
Q ss_pred --HHHHHHHhhhhhhhc----ccCceeeCCCCCccEEeecCcEEEEecccch
Q 003052 602 --LRFYWQQILEAVNTI----HEERIVHSDLKPANFLLVKGSLKLIDFGIAK 647 (853)
Q Consensus 602 --~r~I~~QIl~AL~yL----Hs~gIIHRDLKPeNILL~~g~VKL~DFGlAk 647 (853)
....+..++..+.-+ ....++|+|+++.|||+++ .+.|+||+.|.
T Consensus 172 ~~~~~~~~~~~~~l~~~~~~~~~~~l~HgD~~~~Nil~~~-~~~lIDfe~a~ 222 (328)
T 1zyl_A 172 AAFLKATDELIAAVTAHWREDFTVLRLHGDCHAGNILWRD-GPMFVDLDDAR 222 (328)
T ss_dssp HHHHHHHHHHHHHHHHHCCSCSCCEECCSSCSGGGEEESS-SEEECCCTTCC
T ss_pred HHHHHHHHHHHHHHHHHhhhcCCeeeeeCCCCcccEeEcC-CCEEEECCCCC
Confidence 011122222222221 3457999999999999985 89999998775
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.06 E-value=0.0083 Score=63.71 Aligned_cols=50 Identities=10% Similarity=0.021 Sum_probs=32.2
Q ss_pred EEEeEeccCceEEEEEEecCCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCC
Q 003052 476 RLGKIGSGGSSEVHKVISSDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGK 530 (853)
Q Consensus 476 ilk~LG~G~FG~Vyka~~~~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~h 530 (853)
-++.|+.|....||++...++ .|++|+..... ....+..|+.+++.|..+
T Consensus 26 ~~~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~~----~~~~l~~e~~~l~~L~~~ 75 (322)
T 2ppq_A 26 SYKGIAEGVENSNFLLHTTKD-PLILTLYEKRV----EKNDLPFFLGLMQHLAAK 75 (322)
T ss_dssp EEEEECC---EEEEEEEESSC-CEEEEEECC-------CCHHHHHHHHHHHHHHT
T ss_pred EeeccCCCcccceEEEEeCCc-cEEEEEeCCCC----CHHHHHHHHHHHHHHHHC
Confidence 356688899999999987655 58889886521 122456788888888743
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=96.92 E-value=0.0054 Score=66.43 Aligned_cols=73 Identities=18% Similarity=0.117 Sum_probs=52.1
Q ss_pred EEeEeccCceEEEEEEecCCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCC--CceeEeeehhhhHHHHHHHHhhCC
Q 003052 477 LGKIGSGGSSEVHKVISSDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGK--NNIIQLIDYEVTEKALLREVLNGS 554 (853)
Q Consensus 477 lk~LG~G~FG~Vyka~~~~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~h--pNIV~Lid~~~~e~~iL~~l~~~~ 554 (853)
++.|+.|.+..+|++.. ++..|++|+.... ....+..|...|+.|... ..|.+++.+
T Consensus 41 ~~~l~gG~~n~~y~v~~-~~~~~vlK~~~~~-----~~~~~~~E~~~L~~L~~~~~v~VP~vl~~--------------- 99 (312)
T 3jr1_A 41 KEKLYSGEMNEIWLIND-EVQTVFVKINERS-----YRSMFRAEADQLALLAKTNSINVPLVYGI--------------- 99 (312)
T ss_dssp EEEECCSSSSEEEEEES-SSCEEEEEEEEGG-----GHHHHHHHHHHHHHHHHTTSSBCCCEEEE---------------
T ss_pred eEEeCCccceeeeEEEE-CCCeEEEEeCCcc-----cHHHHHHHHHHHHHHHhhCCCCcceEEEE---------------
Confidence 46689999999999976 4567888887642 244578999999998643 445566554
Q ss_pred CCCCCCccccCCeEEEEEecchh
Q 003052 555 MNNKDGRVKDDGYIYMVLEYGEI 577 (853)
Q Consensus 555 iv~~~g~~~d~~~lyLVmEy~~g 577 (853)
....+..|+||||.++
T Consensus 100 -------~~~~g~~~lvme~l~G 115 (312)
T 3jr1_A 100 -------GNSQGHSFLLLEALNK 115 (312)
T ss_dssp -------EECSSEEEEEEECCCC
T ss_pred -------eecCCceEEEEEeccC
Confidence 2234678999999653
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=96.79 E-value=0.0077 Score=67.86 Aligned_cols=58 Identities=14% Similarity=0.020 Sum_probs=38.5
Q ss_pred EEeEeccCceEEEEEEecC--------CcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeee
Q 003052 477 LGKIGSGGSSEVHKVISSD--------CTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLID 538 (853)
Q Consensus 477 lk~LG~G~FG~Vyka~~~~--------g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid 538 (853)
++.|+.|....||++...+ ++.|++|+..... . ...+.+|..+++.|..+.-..++++
T Consensus 78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~-~---~~~li~E~~~l~~L~~~g~~P~l~~ 143 (429)
T 1nw1_A 78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE-T---ESHLVAESVIFTLLSERHLGPKLYG 143 (429)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC-C---HHHHHHHHHHHHHHHHTTSSSCEEE
T ss_pred EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCC-c---HHHHHHHHHHHHHHHhCCCCCcEEE
Confidence 4568889999999998643 4678888874321 1 1245589999998875433344443
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.74 E-value=0.0019 Score=70.51 Aligned_cols=29 Identities=31% Similarity=0.482 Sum_probs=25.1
Q ss_pred CceeeCCCCCccEEeecCcEEEEecccch
Q 003052 619 ERIVHSDLKPANFLLVKGSLKLIDFGIAK 647 (853)
Q Consensus 619 ~gIIHRDLKPeNILL~~g~VKL~DFGlAk 647 (853)
.+++|+|+.+.|||+.++.+.|+||..|.
T Consensus 212 ~~l~HgDl~~~Nil~~~~~~~lID~e~a~ 240 (369)
T 3c5i_A 212 IVFCHNDLQENNIINTNKCLRLIDFEYSG 240 (369)
T ss_dssp EEEECSCCCGGGEEECC-CEEECCCTTCE
T ss_pred eEEEeCCCCcccEEecCCcEEEEEecCCC
Confidence 36999999999999987779999998774
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=96.61 E-value=0.0077 Score=67.04 Aligned_cols=141 Identities=17% Similarity=0.176 Sum_probs=77.9
Q ss_pred EeEeccCceEEEEEEec--------CCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHHH
Q 003052 478 GKIGSGGSSEVHKVISS--------DCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLRE 549 (853)
Q Consensus 478 k~LG~G~FG~Vyka~~~--------~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~~ 549 (853)
+.|..|-...+|++... +++.|++|+.-.. ......+.+|..+++.|..+.-..+++.+
T Consensus 56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~---~~~~~~~~rE~~vl~~L~~~gv~P~ll~~---------- 122 (379)
T 3feg_A 56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI---LQGVDSLVLESVMFAILAERSLGPQLYGV---------- 122 (379)
T ss_dssp EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC------CCHHHHHHHHHHHHHHHHTTSSCCEEEE----------
T ss_pred EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc---cchHHHHHHHHHHHHHHHhcCCCCeEEEE----------
Confidence 45777888899999864 2467888885321 12234566899999998755444455443
Q ss_pred HhhCCCCCCCCccccCCeEEEEEecchh------h-----HHHHHHHhhhhccCCC----CCC--CHHHHHHHHHHhhhh
Q 003052 550 VLNGSMNNKDGRVKDDGYIYMVLEYGEI------D-----LAHMLSQKWKEMDGSN----QTL--DENWLRFYWQQILEA 612 (853)
Q Consensus 550 l~~~~iv~~~g~~~d~~~lyLVmEy~~g------d-----L~~~L~~~~k~~~~~~----~~L--sE~~~r~I~~QIl~A 612 (853)
+.+ .+||||.+| + +...+.+.++++.... ... -+.++..++.++-..
T Consensus 123 ------------~~~----g~v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~ 186 (379)
T 3feg_A 123 ------------FPE----GRLEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDL 186 (379)
T ss_dssp ------------ETT----EEEEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHC
T ss_pred ------------cCC----ccEEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhc
Confidence 222 278888543 1 1122222223222221 111 235556565544221
Q ss_pred -------------------hhhcc--------cCceeeCCCCCccEEeec-----CcEEEEecccch
Q 003052 613 -------------------VNTIH--------EERIVHSDLKPANFLLVK-----GSLKLIDFGIAK 647 (853)
Q Consensus 613 -------------------L~yLH--------s~gIIHRDLKPeNILL~~-----g~VKL~DFGlAk 647 (853)
+..|. ...++|+|+.+.|||+.. +.+.|+||..|.
T Consensus 187 ~~~~~~~~~~~~~~~l~~~~~~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~ 253 (379)
T 3feg_A 187 PPTGLPEMNLLEMYSLKDEMGNLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSS 253 (379)
T ss_dssp CCCSCCSCCHHHHTTHHHHHHHHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred cCcccchhhhhhhHHHHHHHHHHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence 22221 236999999999999954 489999998874
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=96.56 E-value=0.027 Score=64.20 Aligned_cols=59 Identities=17% Similarity=0.060 Sum_probs=37.2
Q ss_pred EEeEeccCceEEEEEEecC-CcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeee
Q 003052 477 LGKIGSGGSSEVHKVISSD-CTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLID 538 (853)
Q Consensus 477 lk~LG~G~FG~Vyka~~~~-g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid 538 (853)
++.|+.|-...+|++...+ +..|++|+....... .....+|..+|+.|..+.-..+++.
T Consensus 113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~---~idR~~E~~vl~~L~~~gl~P~ll~ 172 (458)
T 2qg7_A 113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDE---IINREREKKISCILYNKNIAKKIYV 172 (458)
T ss_dssp EEEECC--CEEEEEEEETTTTEEEEEEEECC-CCS---CSCHHHHHHHHHHHTTSSSBCCEEE
T ss_pred EEEcCCCeEeEEEEEEECCCCceEEEEECCCChhh---hcCHHHHHHHHHHHHhcCCCCCEEE
Confidence 4568889999999998755 467888877432211 1122589999999986543345544
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=96.50 E-value=0.013 Score=62.86 Aligned_cols=31 Identities=32% Similarity=0.482 Sum_probs=26.7
Q ss_pred cCceeeCCCCCccEEeec-----CcEEEEecccchh
Q 003052 618 EERIVHSDLKPANFLLVK-----GSLKLIDFGIAKA 648 (853)
Q Consensus 618 s~gIIHRDLKPeNILL~~-----g~VKL~DFGlAk~ 648 (853)
...++|+|+.+.|||+.. +.+.|+||+.|..
T Consensus 182 ~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~ 217 (333)
T 3csv_A 182 DMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL 217 (333)
T ss_dssp CCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred CCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence 458999999999999964 5799999998864
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=95.95 E-value=0.033 Score=57.68 Aligned_cols=122 Identities=18% Similarity=0.146 Sum_probs=76.8
Q ss_pred hhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcc-cCceeeCCCCCccEEe-ecCcEEEEecccchhcccCCc
Q 003052 577 IDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIH-EERIVHSDLKPANFLL-VKGSLKLIDFGIAKAIMSDTT 654 (853)
Q Consensus 577 gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLH-s~gIIHRDLKPeNILL-~~g~VKL~DFGlAk~~~~~~~ 654 (853)
.+|.++|..+ +.+|+|.++|.++.|.+.+|.-+- ...-..+=+-|..|+| .+|.|.+.+ +.+.
T Consensus 33 vSL~eIL~~~-------~~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~~dG~V~f~~-~~s~------- 97 (229)
T 2yle_A 33 LSLEEILRLY-------NQPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVWRDGAVTLAP-AADD------- 97 (229)
T ss_dssp EEHHHHHHHH-------TSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEETTSCEEECC-C----------
T ss_pred ccHHHHHHHc-------CCCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEecCCceeccc-cccc-------
Confidence 4788888765 579999999999999999988761 1111133345788888 578877653 2110
Q ss_pred cccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHhCCCCCCcchhHHHHHHhhcCCCCcccCCC
Q 003052 655 NIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGRTPFSEYKTFWAKFKVITDPNHEITYEP 734 (853)
Q Consensus 655 ~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLtG~~PF~~~~~~~~~~kii~~~~~~~~~~~ 734 (853)
.....+.|||.+.. ..+.+.=|||||+++|..+--..|= ..+.
T Consensus 98 -------~~~~~~~~pe~~~~----------~~te~~~IysLG~tLY~ALDygL~e--------------------~eE~ 140 (229)
T 2yle_A 98 -------AGEPPPVAGKLGYS----------QCMETEVIESLGIIIYKALDYGLKE--------------------NEER 140 (229)
T ss_dssp ----------------CCSSS----------SSCHHHHHHHHHHHHHHHHTTTCCT--------------------TEEE
T ss_pred -------ccccCCCChhhccc----------cchHHHHHHHHHHHHHHHhhcCCCc--------------------ccch
Confidence 12234668887631 1245778999999999988432221 2334
Q ss_pred CCChhHHHHHHHhccc
Q 003052 735 VPNPWLLDLMKKCLAW 750 (853)
Q Consensus 735 ~~s~~l~dLI~kcL~~ 750 (853)
.+++.|..||..|..-
T Consensus 141 eLS~~LE~LL~~Mt~~ 156 (229)
T 2yle_A 141 ELSPPLEQLIDHMANT 156 (229)
T ss_dssp CCCHHHHHHHHHHTTC
T ss_pred hhCHHHHHHHHHHHhc
Confidence 5778888888888765
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=95.68 E-value=0.064 Score=58.13 Aligned_cols=30 Identities=27% Similarity=0.391 Sum_probs=26.0
Q ss_pred CceeeCCCCCccEEee-cCcEEEEecccchh
Q 003052 619 ERIVHSDLKPANFLLV-KGSLKLIDFGIAKA 648 (853)
Q Consensus 619 ~gIIHRDLKPeNILL~-~g~VKL~DFGlAk~ 648 (853)
..++|+|+.+.|||++ ++.+.|+||+.+..
T Consensus 206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~ 236 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPML 236 (339)
T ss_dssp CEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred ceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence 4799999999999996 46899999987754
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=94.64 E-value=0.24 Score=55.85 Aligned_cols=59 Identities=15% Similarity=0.090 Sum_probs=37.8
Q ss_pred EEeEeccCceEEEEEEecC--------CcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeee
Q 003052 477 LGKIGSGGSSEVHKVISSD--------CTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLID 538 (853)
Q Consensus 477 lk~LG~G~FG~Vyka~~~~--------g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid 538 (853)
++.|..|-...+|++...+ ++.|++++..... +......+|..+++.|....-..++++
T Consensus 75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t---~~~idR~~E~~~l~~L~~~gi~P~l~~ 141 (424)
T 3mes_A 75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHV---GKFYDSKVELDVFRYLSNINIAPNIIA 141 (424)
T ss_dssp EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC----CCCCHHHHHHHHHHHHHTTSSCCEEE
T ss_pred EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCc---chhcCHHHHHHHHHHHHhcCCCCCEEE
Confidence 4567778889999998752 5678888854321 112234589999998875443444443
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=91.54 E-value=0.61 Score=51.64 Aligned_cols=28 Identities=39% Similarity=0.590 Sum_probs=23.4
Q ss_pred ceeeCCCCCccEEee-------cCcEEEEecccch
Q 003052 620 RIVHSDLKPANFLLV-------KGSLKLIDFGIAK 647 (853)
Q Consensus 620 gIIHRDLKPeNILL~-------~g~VKL~DFGlAk 647 (853)
.++|+|+.+.|||+. ++.++|+||-+|.
T Consensus 245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~ 279 (401)
T 3g15_A 245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSS 279 (401)
T ss_dssp EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCE
T ss_pred eeEEecCCCCeEEEecCcccCcCCeEEEechHhcc
Confidence 478999999999993 2469999998875
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 853 | ||||
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 9e-60 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 1e-55 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 5e-55 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 6e-55 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 1e-54 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 5e-54 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 1e-53 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 6e-53 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 8e-51 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 2e-49 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 9e-49 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 3e-48 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 4e-48 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 8e-48 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 1e-47 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 2e-46 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 2e-46 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 3e-46 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 3e-45 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 3e-45 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 8e-45 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 1e-44 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 6e-44 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 9e-44 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 2e-43 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 5e-43 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 9e-43 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 4e-42 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 2e-41 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 2e-41 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 4e-41 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 6e-41 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 1e-40 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 1e-40 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 2e-40 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 7e-40 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 7e-40 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 9e-40 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 1e-39 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 1e-39 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 2e-39 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 2e-38 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 2e-38 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 3e-38 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 4e-38 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 1e-37 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 2e-37 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 3e-37 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 1e-36 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 5e-36 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 2e-35 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 4e-35 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 2e-34 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 3e-34 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 4e-34 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 4e-34 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 6e-34 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 8e-34 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 8e-34 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 5e-33 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 2e-32 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 1e-28 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 5e-17 |
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 202 bits (516), Expect = 9e-60
Identities = 79/337 (23%), Positives = 140/337 (41%), Gaps = 56/337 (16%)
Query: 458 KRNYDPDLFFKVNGKLYQRLGKIGSGGSSEVHKVIS-SDCTIYALKKIKLKGRDYATAYG 516
R+ +P+ ++ +G++G G +V+K + + A K I K +
Sbjct: 5 TRDLNPE-------DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELED-- 55
Query: 517 FCQEIEYLNKLKGKNNIIQLIDYEVTEKALLREVLNGSMNNKDGRVKDDGYIYMVLEYGE 576
+ EI+ L N I++L+D + +++++E+
Sbjct: 56 YMVEIDILASCDHPN-IVKLLDA----------------------FYYENNLWILIEFCA 92
Query: 577 IDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLLVK- 635
+ + + L E+ ++ +Q L+A+N +H+ +I+H DLK N L
Sbjct: 93 GGAVDAVMLE------LERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLD 146
Query: 636 GSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWS 695
G +KL DFG++ +RDS +GT +M+PE MC S + +D+WS
Sbjct: 147 GDIKLADFGVSAKNTRTIQ--RRDSFIGTPYWMAPEVVMCETSKDR----PYDYKADVWS 200
Query: 696 LGCILYQMVYGRTPFSEYKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNER 755
LG L +M P E K+ + + D +KKCL + + R
Sbjct: 201 LGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSNFKDFLKKCLEKNVDAR 260
Query: 756 WRIPQLLQHPFLVPPVSTQPSSSQDQSYQLLQLLAEA 792
W QLLQHPF+ + D + + +L+AEA
Sbjct: 261 WTTSQLLQHPFV----------TVDSNKPIRELIAEA 287
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 190 bits (485), Expect = 1e-55
Identities = 62/303 (20%), Positives = 124/303 (40%), Gaps = 45/303 (14%)
Query: 470 NGKLYQRLGKIGSGGSSEVHKVISSDCT-IYALKKIKLKGRDYATAYGFCQEIEYLNKLK 528
+G+ + +IG G V+K + ++ T A +++ + + F +E E L L+
Sbjct: 7 DGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQ 66
Query: 529 GKNNIIQLIDYEVTEKALLREVLNGSMNNKDGRVKDDGYIYMVLEYGEIDLAHMLSQKWK 588
N I++ D + VK I +V E ++
Sbjct: 67 HPN-IVRFYDSWEST------------------VKGKKCIVLVTELMTSGTLKTYLKR-- 105
Query: 589 EMDGSNQTLDENWLRFYWQQILEAVNTIHEE--RIVHSDLKPANFLLVK--GSLKLIDFG 644
+ + LR + +QIL+ + +H I+H DLK N + GS+K+ D G
Sbjct: 106 -----FKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLG 160
Query: 645 IAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMV 704
+A + + +GT +M+PE + K D+++ G + +M
Sbjct: 161 LATLKRASFAK----AVIGTPEFMAPEMYEE----------KYDESVDVYAFGMCMLEMA 206
Query: 705 YGRTPFSEYKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQH 764
P+SE + ++ +T +++ V P + ++++ C+ +++ER+ I LL H
Sbjct: 207 TSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH 266
Query: 765 PFL 767
F
Sbjct: 267 AFF 269
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 190 bits (484), Expect = 5e-55
Identities = 68/331 (20%), Positives = 123/331 (37%), Gaps = 53/331 (16%)
Query: 462 DPD---LFFKVN-GKLYQRLGKIGSGGSSEVHKVIS-SDCTIYALKKIKLKGRDYATAYG 516
DPD LFFK + KL+ L +IG G V+ + + A+KK+ G+ +
Sbjct: 1 DPDVAELFFKDDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQ 60
Query: 517 -FCQEIEYLNKLKGKNNIIQLIDYEVTEKALLREVLNGSMNNKDGRVKDDGYIYMVLEYG 575
+E+ +L KL+ N IQ + ++V+EY
Sbjct: 61 DIIKEVRFLQKLRHPN-TIQYRGC----------------------YLREHTAWLVMEY- 96
Query: 576 EIDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLLVK 635
L ++ + L E + L+ + +H ++H D+K N LL +
Sbjct: 97 ------CLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSE 150
Query: 636 -GSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIW 694
G +KL DFG A + + VGT +M+PE + + + D+W
Sbjct: 151 PGLVKLGDFGSASIMAPANS------FVGTPYWMAPEVILAMDEG------QYDGKVDVW 198
Query: 695 SLGCILYQMVYGRTPFSEYKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNE 754
SLG ++ + P A + + + + + + + + CL +
Sbjct: 199 SLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWS-EYFRNFVDSCLQKIPQD 257
Query: 755 RWRIPQLLQHPFLV---PPVSTQPSSSQDQS 782
R LL+H F++ PP + +
Sbjct: 258 RPTSEVLLKHRFVLRERPPTVIMDLIQRTKD 288
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 189 bits (480), Expect = 6e-55
Identities = 58/300 (19%), Positives = 110/300 (36%), Gaps = 41/300 (13%)
Query: 474 YQRLGKIGSGGSSEVHKVIS-SDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNN 532
+ + +G G EV ++ A+K + +K R +EI L +N
Sbjct: 7 WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMK-RAVDCPENIKKEICINKMLNHEN- 64
Query: 533 IIQLIDYEVTEKALLREVLNGSMNNKDGRVKDDGYIYMVLEYGEIDLAHMLSQKWKEMDG 592
+++ + ++ Y+ LEY +
Sbjct: 65 VVKFYGH----------------------RREGNIQYLFLEYCSGGELFDRIEP------ 96
Query: 593 SNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLLV-KGSLKLIDFGIAKAIMS 651
+ + E + ++ Q++ V +H I H D+KP N LL + +LK+ DFG+A
Sbjct: 97 -DIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRY 155
Query: 652 DTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGRTPFS 711
+ + GTL Y++PE E P D+WS G +L M+ G P+
Sbjct: 156 NNRERLLNKMCGTLPYVAPELLKRREFH--------AEPVDVWSCGIVLTAMLAGELPWD 207
Query: 712 EYKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQHPFLVPPV 771
+ ++ + + + L L+ K L + + R IP + + + P+
Sbjct: 208 QPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPL 267
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 188 bits (478), Expect = 1e-54
Identities = 78/306 (25%), Positives = 130/306 (42%), Gaps = 49/306 (16%)
Query: 474 YQRLGKIGSGGSSEVHKVIS-SDCTIYALKKIKLKGRDYATAY-------GFCQEIEYLN 525
Y+ +G G SS V + I C YA+K I + G +A +E++ L
Sbjct: 5 YEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILR 64
Query: 526 KLKGKNNIIQLIDYEVTEKALLREVLNGSMNNKDGRVKDDGYIYMVLEYGE-IDLAHMLS 584
K+ G NIIQL D + + + ++V + + +L L+
Sbjct: 65 KVSGHPNIIQLKDT----------------------YETNTFFFLVFDLMKKGELFDYLT 102
Query: 585 QKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLLVK-GSLKLIDF 643
+K TL E R + +LE + +H+ IVH DLKP N LL ++KL DF
Sbjct: 103 EK--------VTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDF 154
Query: 644 GIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQM 703
G + + + GT SY++PE C+ +D + G+ D+WS G I+Y +
Sbjct: 155 GFSCQLDPGE---KLREVCGTPSYLAPEIIECSMNDNHP---GYGKEVDMWSTGVIMYTL 208
Query: 704 VYGRTPFSEYKTFWAKFKVITDPNHEITYEPVPN--PWLLDLMKKCLAWDRNERWRIPQL 761
+ G PF + ++I N++ + + DL+ + L +R+ +
Sbjct: 209 LAGSPPFWH-RKQMLMLRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEA 267
Query: 762 LQHPFL 767
L HPF
Sbjct: 268 LAHPFF 273
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 187 bits (475), Expect = 5e-54
Identities = 69/298 (23%), Positives = 119/298 (39%), Gaps = 46/298 (15%)
Query: 472 KLYQRLGKIGSGGSSEVHKVIS-SDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGK 530
K Y R KIG G S V+ + + A++++ L+ + EI + + K
Sbjct: 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKEL--IINEILVMRENKNP 77
Query: 531 NNIIQLIDYEVTEKALLREVLNGSMNNKDGRVKDDGYIYMVLEYGEIDLAHMLSQKWKEM 590
N I+ +D +++V+EY + +
Sbjct: 78 N-IVNYLDS----------------------YLVGDELWVVMEYLAGGSLTDVVTETCM- 113
Query: 591 DGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLL-VKGSLKLIDFGIAKAI 649
DE + ++ L+A+ +H +++H D+K N LL + GS+KL DFG I
Sbjct: 114 -------DEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQI 166
Query: 650 MSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGRTP 709
+ + +R + VGT +M+PE DIWSLG + +M+ G P
Sbjct: 167 TPEQS--KRSTMVGTPYWMAPEVVTRKAYGP---------KVDIWSLGIMAIEMIEGEPP 215
Query: 710 FSEYKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQHPFL 767
+ A + + T+ E+ + D + +CL D +R +LLQH FL
Sbjct: 216 YLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFL 273
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 185 bits (470), Expect = 1e-53
Identities = 81/302 (26%), Positives = 130/302 (43%), Gaps = 46/302 (15%)
Query: 474 YQRLGKIGSGGSSEVHKVIS-SDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNN 532
Y+ L IG+G K+ SD I K++ A E+ L +LK N
Sbjct: 6 YEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPN- 64
Query: 533 IIQLIDYEVTEKALLREVLNGSMNNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEMD 591
I++ D + + +Y+V+EY E DLA ++++ KE
Sbjct: 65 IVRYYDRIIDR--------------------TNTTLYIVMEYCEGGDLASVITKGTKE-- 102
Query: 592 GSNQTLDENWLRFYWQQILEAVNTIHEE-----RIVHSDLKPANFLLV-KGSLKLIDFGI 645
Q LDE ++ Q+ A+ H ++H DLKPAN L K ++KL DFG+
Sbjct: 103 --RQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGL 160
Query: 646 AKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVY 705
A+ + DT+ + VGT YMSPE +E SDIWSLGC+LY++
Sbjct: 161 ARILNHDTS--FAKAFVGTPYYMSPEQMNRMSYNE---------KSDIWSLGCLLYELCA 209
Query: 706 GRTPFSEYKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQHP 765
PF+ + K+ I Y + L +++ + L R + ++L++P
Sbjct: 210 LMPPFTAFSQKELAGKIREGKFRRIPYR--YSDELNEIITRMLNLKDYHRPSVEEILENP 267
Query: 766 FL 767
+
Sbjct: 268 LI 269
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 183 bits (465), Expect = 6e-53
Identities = 72/297 (24%), Positives = 123/297 (41%), Gaps = 49/297 (16%)
Query: 474 YQRLGKIGSGGSSEVHKVIS-SDCTIYALKKI-KLKGRDYATAYGFCQEIEYLNKLKGKN 531
++ +G G V+ I ALK + K + + +E+E + L+
Sbjct: 8 FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR-HP 66
Query: 532 NIIQLIDYEVTEKALLREVLNGSMNNKDGRVKDDGYIYMVLEYGEIDLAHMLSQKWKEMD 591
NI++L Y D +Y++LEY + + QK
Sbjct: 67 NILRLYGY----------------------FHDATRVYLILEYAPLGTVYRELQKLS--- 101
Query: 592 GSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLLV-KGSLKLIDFGIAKAIM 650
DE Y ++ A++ H +R++H D+KP N LL G LK+ DFG +
Sbjct: 102 ----KFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP 157
Query: 651 SDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGRTPF 710
S +R + GTL Y+ PE DE D+WSLG + Y+ + G+ PF
Sbjct: 158 SS----RRTTLCGTLDYLPPEMIEGRMHDE---------KVDLWSLGVLCYEFLVGKPPF 204
Query: 711 SEYKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQHPFL 767
T+ +K I+ E T+ DL+ + L + ++R + ++L+HP++
Sbjct: 205 EA-NTYQETYKRIS--RVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWI 258
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 177 bits (450), Expect = 8e-51
Identities = 59/296 (19%), Positives = 110/296 (37%), Gaps = 44/296 (14%)
Query: 474 YQRLGKIGSGGSSEVHKVISSDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNI 533
+IGSG V+K A+K + + F E+ L K + N I
Sbjct: 10 ITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVN-I 66
Query: 534 IQLIDYEVTEKALLREVLNGSMNNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEMDG 592
+ + Y + +V ++ E L H L
Sbjct: 67 LLFMGYS-----------------------TAPQLAIVTQWCEGSSLYHHLHII------ 97
Query: 593 SNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLLVK-GSLKLIDFGIAKAIMS 651
+ L +Q + ++ +H + I+H DLK N L + ++K+ DFG+A
Sbjct: 98 -ETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSR 156
Query: 652 DTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGRTPFS 711
+ + Q + G++ +M+PE + + SD+++ G +LY+++ G+ P+S
Sbjct: 157 WSGSHQFEQLSGSILWMAPEVIRMQDKN------PYSFQSDVYAFGIVLYELMTGQLPYS 210
Query: 712 EYKTFWAKFKVITDPNHEITYEPVPN---PWLLDLMKKCLAWDRNERWRIPQLLQH 764
++ V + + LM +CL R+ER PQ+L
Sbjct: 211 NINNRDQIIFMVGRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILAS 266
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 175 bits (444), Expect = 2e-49
Identities = 72/338 (21%), Positives = 120/338 (35%), Gaps = 88/338 (26%)
Query: 474 YQRLGKIGSGGSSEVHKVIS-SDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNN 532
++++ ++G+G V KV + A K I L+ + +E++ L++
Sbjct: 8 FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQ-IIRELQVLHECNSPY- 65
Query: 533 IIQLIDYEVTEKALLREVLNGSMNNKDGRVKDDGYIYMVLEYGEIDLAHMLSQKWKEMDG 592
I+ DG I + +E+ + + +K
Sbjct: 66 IVGFYGA----------------------FYSDGEISICMEHMDGGSLDQVLKK------ 97
Query: 593 SNQTLDENWLRFYWQQILEAVNTIHEE-RIVHSDLKPANFLLV-KGSLKLIDFGIAKAIM 650
+ E L +++ + + E+ +I+H D+KP+N L+ +G +KL DFG++ ++
Sbjct: 98 -AGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI 156
Query: 651 SDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGRTPF 710
N S VGT SYMSPE SDIWS+G L +M GR P
Sbjct: 157 DSMAN----SFVGTRSYMSPERLQGTHYSV---------QSDIWSMGLSLVEMAVGRYPI 203
Query: 711 ----------------------------------SEYKTFWAKFKVITDPNHEITYEPVP 736
S Y I + I EP P
Sbjct: 204 PPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPP 263
Query: 737 N-------PWLLDLMKKCLAWDRNERWRIPQLLQHPFL 767
D + KCL + ER + QL+ H F+
Sbjct: 264 KLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFI 301
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 172 bits (437), Expect = 9e-49
Identities = 76/321 (23%), Positives = 127/321 (39%), Gaps = 61/321 (19%)
Query: 456 PRKRNYDPDLFFKVNGKLYQRLGKIGSGGSSEVHKVIS-SDCTIYALKKIKLKG-RDYAT 513
PRK+ + ++ +G G S V + YA+K ++ +
Sbjct: 2 PRKKRPED----------FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENK 51
Query: 514 AYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLREVLNGSMNNKDGRVKDDGYIYMVLE 573
+E + +++L ++L +DD +Y L
Sbjct: 52 VPYVTRERDVMSRLDHPF-FVKLYFT----------------------FQDDEKLYFGLS 88
Query: 574 YGEIDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLL 633
Y + +K + DE RFY +I+ A+ +H + I+H DLKP N LL
Sbjct: 89 YAKNGELLKYIRKIG-------SFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILL 141
Query: 634 VK-GSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSD 692
+ +++ DFG AK + ++ + +S VGT Y+SPE + + SD
Sbjct: 142 NEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACK---------SSD 192
Query: 693 IWSLGCILYQMVYGRTPFSEYKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDR 752
+W+LGCI+YQ+V G PF + K+I E + P DL++K L D
Sbjct: 193 LWALGCIIYQLVAGLPPFRAGNEYLIFQKII---KLEYDFPEKFFPKARDLVEKLLVLDA 249
Query: 753 NERWRIPQ------LLQHPFL 767
+R + L HPF
Sbjct: 250 TKRLGCEEMEGYGPLKAHPFF 270
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 172 bits (438), Expect = 3e-48
Identities = 62/301 (20%), Positives = 114/301 (37%), Gaps = 52/301 (17%)
Query: 474 YQRLGKIGSGGSSEVHKVIS-SDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNN 532
Y ++G+G VH+V + +A K + +EI+ ++ L+
Sbjct: 28 YDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKET--VRKEIQTMSVLRHPT- 84
Query: 533 IIQLIDYEVTEKALLREVLNGSMNNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEMD 591
++ L D +DD + M+ E+ +L ++ +
Sbjct: 85 LVNLHDA----------------------FEDDNEMVMIYEFMSGGELFEKVADE----- 117
Query: 592 GSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLLVK---GSLKLIDFGIAKA 648
+ + E+ Y +Q+ + + +HE VH DLKP N + LKLIDFG+
Sbjct: 118 --HNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAH 175
Query: 649 IMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGRT 708
+ + GT + +PE G +D+WS+G + Y ++ G +
Sbjct: 176 LDPKQS---VKVTTGTAEFAAPEVAEGK---------PVGYYTDMWSVGVLSYILLSGLS 223
Query: 709 PFSEYKTFWAKFKVITDPNHEITYEPVPN--PWLLDLMKKCLAWDRNERWRIPQLLQHPF 766
PF + + + + + D ++K L D N R I Q L+HP+
Sbjct: 224 PFGG-ENDDETLRNVKSCDWNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPW 282
Query: 767 L 767
L
Sbjct: 283 L 283
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 172 bits (437), Expect = 4e-48
Identities = 70/347 (20%), Positives = 130/347 (37%), Gaps = 56/347 (16%)
Query: 474 YQRLGKIGSGGSSEVHKVIS-SDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNN 532
Y L ++GSG VH+ + + ++ K I EI +N+L
Sbjct: 31 YDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYT--VKNEISIMNQLHHPK- 87
Query: 533 IIQLIDYEVTEKALLREVLNGSMNNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEMD 591
+I L D +D + ++LE+ +L ++ +
Sbjct: 88 LINLHDA----------------------FEDKYEMVLILEFLSGGELFDRIAAE----- 120
Query: 592 GSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLLVK---GSLKLIDFGIAKA 648
+ + E + Y +Q E + +HE IVH D+KP N + S+K+IDFG+A
Sbjct: 121 --DYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATK 178
Query: 649 IMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGRT 708
+ D T + +PE G +D+W++G + Y ++ G +
Sbjct: 179 LNPDEIVKV---TTATAEFAAPEIVDRE---------PVGFYTDMWAIGVLGYVLLSGLS 226
Query: 709 PFSEYKTFWAKFKVITDPNHEITYEPVPN--PWLLDLMKKCLAWDRNERWRIPQLLQHPF 766
PF+ + + + + E + + P D +K L + +R + L+HP+
Sbjct: 227 PFAG-EDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPW 285
Query: 767 L----VPPVSTQPSSSQDQSYQLLQLLAEASASDHEASTICSQLSQL 809
L S PSS ++ Q ++ + A + S L
Sbjct: 286 LKGDHSNLTSRIPSSRYNKIRQKIKEKYADWPAPQPAIGRIANFSSL 332
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 170 bits (432), Expect = 8e-48
Identities = 67/330 (20%), Positives = 123/330 (37%), Gaps = 56/330 (16%)
Query: 474 YQRLGKIGSGGSSEVHKVI-SSDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNN 532
Y +G G VH+ + +S Y K +K+KG D +EI LN + +N
Sbjct: 7 YMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVL---VKKEISILNIARHRN- 62
Query: 533 IIQLIDYEVTEKALLREVLNGSMNNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEMD 591
I+ L + + + M+ E+ +D+ ++
Sbjct: 63 ILHLHES----------------------FESMEELVMIFEFISGLDIFERINTS----- 95
Query: 592 GSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLLVK---GSLKLIDFGIAKA 648
L+E + Y Q+ EA+ +H I H D++P N + ++K+I+FG A+
Sbjct: 96 --AFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQ 153
Query: 649 IMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGRT 708
+ Y +PE + +D+WSLG ++Y ++ G
Sbjct: 154 LKPGDN---FRLLFTAPEYYAPEVHQHD---------VVSTATDMWSLGTLVYVLLSGIN 201
Query: 709 PFSEYKTFWAKFKVITDPNHEITYEPVPN--PWLLDLMKKCLAWDRNERWRIPQLLQHPF 766
PF +T + I + + E +D + + L +R R + LQHP+
Sbjct: 202 PFLA-ETNQQIIENIMNAEYTFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQHPW 260
Query: 767 L---VPPVSTQPSSSQDQSYQLLQLLAEAS 793
L + VST+ + L+ +
Sbjct: 261 LKQKIERVSTKVIRTLKHRRYYHTLIKKDL 290
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 170 bits (430), Expect = 1e-47
Identities = 81/327 (24%), Positives = 126/327 (38%), Gaps = 63/327 (19%)
Query: 474 YQRLGKIGSGGSSEVHKVIS-SDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNN 532
Y++L KIG G EV K ALKK+ ++ +EI+ L LK N
Sbjct: 12 YEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKH-EN 70
Query: 533 IIQLIDYEVTEKALLREVLNGSMNNKDGRVKDDGYIYMVLEYGEIDLAHMLSQKWKEMDG 592
++ LI+ T+ + G IY+V ++ E DLA +LS +
Sbjct: 71 VVNLIEICRTKASPYNR--------------CKGSIYLVFDFCEHDLAGLLSNVLVKFTL 116
Query: 593 SNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLLVK-GSLKLIDFGIAKAI-- 649
S ++ Q +L + IH +I+H D+K AN L+ + G LKL DFG+A+A
Sbjct: 117 S-------EIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSL 169
Query: 650 MSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGRTP 709
++ + ++V TL Y PE + G P D+W GCI+ +M
Sbjct: 170 AKNSQPNRYTNRVVTLWYRPPELLLGERDY--------GPPIDLWGAGCIMAEMWTRSPI 221
Query: 710 F---SEYKTFWAKFKVITDPNHEI--------------------------TYEPVPNPWL 740
+E ++ E+ V +P+
Sbjct: 222 MQGNTEQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYA 281
Query: 741 LDLMKKCLAWDRNERWRIPQLLQHPFL 767
LDL+ K L D +R L H F
Sbjct: 282 LDLIDKLLVLDPAQRIDSDDALNHDFF 308
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 165 bits (419), Expect = 2e-46
Identities = 77/328 (23%), Positives = 131/328 (39%), Gaps = 56/328 (17%)
Query: 465 LFFKVN-GKLYQRLGKIGSGGSSEVHKVIS-SDCTIYALKKIKLK----GRDYATAYGFC 518
+F + N Y ++GSG + V K S YA K IK + R +
Sbjct: 2 VFRQENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIE 61
Query: 519 QEIEYLNKLKGKNNIIQLIDYEVTEKALLREVLNGSMNNKDGRVKDDGYIYMVLEYGEID 578
+E+ L +++ N +I L + ++ + ++LE
Sbjct: 62 REVSILKEIQHPN-VITLHEV----------------------YENKTDVILILEL---- 94
Query: 579 LAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLLV---- 634
+ + + ++L E + +QIL V +H +I H DLKP N +L+
Sbjct: 95 ---VAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNV 151
Query: 635 -KGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDI 693
K +K+IDFG+A I + + GT +++PE G +D+
Sbjct: 152 PKPRIKIIDFGLAHKIDFGN---EFKNIFGTPEFVAPEIVNYE---------PLGLEADM 199
Query: 694 WSLGCILYQMVYGRTPFSEYKTFWAKFKVITDPNHEITYEPVPN--PWLLDLMKKCLAWD 751
WS+G I Y ++ G +PF T ++ N+E E N D +++ L D
Sbjct: 200 WSIGVITYILLSGASPF-LGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKD 258
Query: 752 RNERWRIPQLLQHPFLVPPVSTQPSSSQ 779
+R I LQHP++ P + Q SS
Sbjct: 259 PKKRMTIQDSLQHPWIKPKDTQQALSSA 286
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 165 bits (420), Expect = 2e-46
Identities = 71/326 (21%), Positives = 122/326 (37%), Gaps = 53/326 (16%)
Query: 474 YQRLGKIGSGGSSEVHKVIS-SDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNN 532
Y +G+G SEV + A+K I K + EI L+K+K N
Sbjct: 11 YDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGS-MENEIAVLHKIKHPN- 68
Query: 533 IIQLIDYEVTEKALLREVLNGSMNNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEMD 591
I+ L D + G++Y++++ +L + +K
Sbjct: 69 IVALDDI----------------------YESGGHLYLIMQLVSGGELFDRIVEK----- 101
Query: 592 GSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLLV----KGSLKLIDFGIAK 647
E Q+L+AV +H+ IVH DLKP N L + + DFG++K
Sbjct: 102 ---GFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSK 158
Query: 648 AIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGR 707
+ + GT Y++PE + D WS+G I Y ++ G
Sbjct: 159 MEDPGSV---LSTACGTPGYVAPEVLAQKPYSK---------AVDCWSIGVIAYILLCGY 206
Query: 708 TPFSEYKTFWAKFKVITDPNHEITYEPVPN--PWLLDLMKKCLAWDRNERWRIPQLLQHP 765
PF + + F+ I +E + D ++ + D +R+ Q LQHP
Sbjct: 207 PPFYD-ENDAKLFEQILKAEYEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQHP 265
Query: 766 FLVPPVSTQPSSSQDQSYQLLQLLAE 791
++ + + Q S Q+ + A+
Sbjct: 266 WIAGDTALDKNIHQSVSEQIKKNFAK 291
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 165 bits (418), Expect = 3e-46
Identities = 85/321 (26%), Positives = 135/321 (42%), Gaps = 67/321 (20%)
Query: 474 YQRLGKIGSGGSSEVHKVISSDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNI 533
Y L KIG G V+K ++ +ALKKI+L+ D +EI L +LK +NI
Sbjct: 4 YHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELK-HSNI 62
Query: 534 IQLIDYEVTEKALLREVLNGSMNNKDGRVKDDGYIYMVLEYGEIDLAHMLSQKWKEMDGS 593
++L D + + +V E+ + DL +L
Sbjct: 63 VKLYDV----------------------IHTKKRLVLVFEHLDQDLKKLLDVC------- 93
Query: 594 NQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLLVK-GSLKLIDFGIAKAIMSD 652
L+ + + Q+L + H+ R++H DLKP N L+ + G LK+ DFG+A+A
Sbjct: 94 EGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIP 153
Query: 653 TTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGRTPF-- 710
+ ++ TL Y +P+ M ++ K DIWS+GCI +MV G F
Sbjct: 154 VR--KYTHEIVTLWYRAPDVLMGSK--------KYSTTIDIWSVGCIFAEMVNGTPLFPG 203
Query: 711 -SEYKTFWAKFKVITDPNHEI---------------TYEPVP--------NPWLLDLMKK 746
SE F+++ PN + YEP+P + +DL+ K
Sbjct: 204 VSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSK 263
Query: 747 CLAWDRNERWRIPQLLQHPFL 767
L D N+R Q L+H +
Sbjct: 264 MLKLDPNQRITAKQALEHAYF 284
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 163 bits (414), Expect = 3e-45
Identities = 69/374 (18%), Positives = 132/374 (35%), Gaps = 64/374 (17%)
Query: 474 YQRLGK-IGSGGSSEVHKVIS-SDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKN 531
Y+ + +G G + +V ++ + +ALK ++ + +E+E +
Sbjct: 13 YKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPK-------ARREVELHWRASQCP 65
Query: 532 NIIQLIDYEVTEKALLREVLNGSMNNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEM 590
+I++++D + + +V+E + +L + +
Sbjct: 66 HIVRIVDVY------------------ENLYAGRKCLLIVMECLDGGELFSRIQDR---- 103
Query: 591 DGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLLVK----GSLKLIDFGIA 646
+Q E + I EA+ +H I H D+KP N L LKL DFG A
Sbjct: 104 --GDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFA 161
Query: 647 KAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYG 706
K S + T Y++PE K + D+WSLG I+Y ++ G
Sbjct: 162 KETTSHNSLTTPCY---TPYYVAPEVLGPE---------KYDKSCDMWSLGVIMYILLCG 209
Query: 707 RTPF---SEYKTFWAKFKVITDPNHEITYEPVPN--PWLLDLMKKCLAWDRNERWRIPQL 761
PF I +E + L++ L + +R I +
Sbjct: 210 YPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEF 269
Query: 762 LQHPFLVPPVSTQPSSSQDQSYQLLQLLAEASASDHE-ASTICSQLSQLIRNPVMLAATQ 820
+ HP++ Q + ++L E + + S L+ + + + +
Sbjct: 270 MNHPWI-----MQSTKVPQTPLHTSRVLKEDKERWEDVKEEMTSALATMRVDYEQI---K 321
Query: 821 LSTSQDQQCKLLLK 834
+ +D LLLK
Sbjct: 322 IKKIEDASNPLLLK 335
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 161 bits (409), Expect = 3e-45
Identities = 69/304 (22%), Positives = 114/304 (37%), Gaps = 61/304 (20%)
Query: 474 YQRLGKIGSGGSSEVHKVIS-SDCTIYALKKIKL----KGRDYATAYGFCQEIEYLNKLK 528
YQ +GSGG V+ I SD A+K ++ + E+ L K+
Sbjct: 6 YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 65
Query: 529 GKN-NIIQLIDYEVTEKALLREVLNGSMNNKDGRVKDDGYIYMVLEY--GEIDLAHMLSQ 585
+I+L+D+ + ++LE DL +++
Sbjct: 66 SGFSGVIRLLDW----------------------FERPDSFVLILERPEPVQDLFDFITE 103
Query: 586 KWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLLV--KGSLKLIDF 643
+ L E R ++ Q+LEAV H ++H D+K N L+ +G LKLIDF
Sbjct: 104 R--------GALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDF 155
Query: 644 GIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQM 703
G + GT Y PE + GR + +WSLG +LY M
Sbjct: 156 GSGALLKDTVYT----DFDGTRVYSPPEWIRYHR--------YHGRSAAVWSLGILLYDM 203
Query: 704 VYGRTPFSEYKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQ 763
V G PF + ++ + + L++ CLA ++R ++
Sbjct: 204 VCGDIPFEHDEEII---------RGQVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQN 254
Query: 764 HPFL 767
HP++
Sbjct: 255 HPWM 258
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 163 bits (412), Expect = 8e-45
Identities = 76/332 (22%), Positives = 122/332 (36%), Gaps = 68/332 (20%)
Query: 467 FKVNGKLYQRLGKIGSGGSSEVHKVIS-SDCTIYALKKIKLKGRDYATAYGFCQEIEYLN 525
F V + Y L IG G V + A+KKI +EI+ L
Sbjct: 4 FDVGPR-YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKIS-PFEHQTYCQRTLREIKILL 61
Query: 526 KLKGKNNIIQLIDYEVTEKALLREVLNGSMNNKDGRVKDDGYIYMVLEYGEIDLAHMLSQ 585
+ + +N II + D + ++ +Y+V DL +L
Sbjct: 62 RFRHEN-IIGINDII-----------------RAPTIEQMKDVYLVTHLMGADLYKLLK- 102
Query: 586 KWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLLVK-GSLKLIDFG 644
Q L + + ++ QIL + IH ++H DLKP+N LL LK+ DFG
Sbjct: 103 --------TQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFG 154
Query: 645 IAKAIMSDTTNIQR-DSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQM 703
+A+ D + V T Y +PE + ++ + DIWS+GCIL +M
Sbjct: 155 LARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGY--------TKSIDIWSVGCILAEM 206
Query: 704 VYGRTPF---SEYKTFWAKFKVITDPNHEITYE-------------------------PV 735
+ R F ++ P+ E P
Sbjct: 207 LSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPN 266
Query: 736 PNPWLLDLMKKCLAWDRNERWRIPQLLQHPFL 767
+ LDL+ K L ++ ++R + Q L HP+L
Sbjct: 267 ADSKALDLLDKMLTFNPHKRIEVEQALAHPYL 298
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 161 bits (408), Expect = 1e-44
Identities = 72/323 (22%), Positives = 121/323 (37%), Gaps = 64/323 (19%)
Query: 474 YQRLGKIGSGGSSEVHKV--ISSDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKN 531
Y+ + +IG G +V K + + ALK+++++ + +E+ L L+
Sbjct: 9 YECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFE 68
Query: 532 --NIIQLIDYEVTEKALLREVLNGSMNNKDGRVKDDGYIYMVLEYGEIDLAHMLSQKWKE 589
N+++L D R + + +V E+ + DL L +
Sbjct: 69 HPNVVRLFDVCT-----------------VSRTDRETKLTLVFEHVDQDLTTYLDKV--- 108
Query: 590 MDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLLV-KGSLKLIDFGIAKA 648
+ ++ Q+L ++ +H R+VH DLKP N L+ G +KL DFG+A+
Sbjct: 109 ---PEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARI 165
Query: 649 IMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGRT 708
S V TL Y +PE + + P D+WS+GCI +M +
Sbjct: 166 YSFQMAL---TSVVVTLWYRAPEVLLQS---------SYATPVDLWSVGCIFAEMFRRKP 213
Query: 709 PF---SEYKTFWAKFKVITDPNHEITYEPVPNPW---------------------LLDLM 744
F S+ VI P E V P DL+
Sbjct: 214 LFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLL 273
Query: 745 KKCLAWDRNERWRIPQLLQHPFL 767
KCL ++ +R L HP+
Sbjct: 274 LKCLTFNPAKRISAYSALSHPYF 296
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (405), Expect = 6e-44
Identities = 74/338 (21%), Positives = 124/338 (36%), Gaps = 69/338 (20%)
Query: 474 YQRLGKIGSGGSSEVHKVISSDC-TIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNN 532
Y IG+G V++ D + A+KK+ R +E++ + KL N
Sbjct: 22 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF------KNRELQIMRKLDHCN- 74
Query: 533 IIQLIDYEVTEKALLREVLNGSMNNKDGRVKDDGYIYMVLEYGEIDLAHMLSQKWKEMDG 592
I++L + + G KD+ Y+ +VL+Y + + +
Sbjct: 75 IVRLRYFFYSS----------------GEKKDEVYLNLVLDYVPETVYRVA----RHYSR 114
Query: 593 SNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLLVK--GSLKLIDFGIAKAIM 650
+ QTL +++ Y Q+ ++ IH I H D+KP N LL LKL DFG AK ++
Sbjct: 115 AKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV 174
Query: 651 SDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGRTPF 710
N S + + Y +PE D+WS GC+L +++ G+ F
Sbjct: 175 RGEPN---VSYICSRYYRAPELIFGA--------TDYTSSIDVWSAGCVLAELLLGQPIF 223
Query: 711 ---SEYKTFWAKFKVITDPNHEITYEPVPN-----------------------PWLLDLM 744
S KV+ P E E PN P + L
Sbjct: 224 PGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALC 283
Query: 745 KKCLAWDRNERWRIPQLLQHPFL--VPPVSTQPSSSQD 780
+ L + R + H F + + + + +D
Sbjct: 284 SRLLEYTPTARLTPLEACAHSFFDELRDPNVKLPNGRD 321
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 158 bits (400), Expect = 9e-44
Identities = 78/322 (24%), Positives = 123/322 (38%), Gaps = 67/322 (20%)
Query: 474 YQRLGKIGSGGSSEVHKVIS-SDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNN 532
+Q++ KIG G V+K + + ALKKI+L +EI L +L N
Sbjct: 4 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN-HPN 62
Query: 533 IIQLIDYEVTEKALLREVLNGSMNNKDGRVKDDGYIYMVLEYGEIDLAHMLSQKWKEMDG 592
I++L+D + +Y+V E+ DL +
Sbjct: 63 IVKLLDVI----------------------HTENKLYLVFEFLHQDLKKFMDASAL---- 96
Query: 593 SNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLL-VKGSLKLIDFGIAKAIMS 651
+ ++ Y Q+L+ + H R++H DLKP N L+ +G++KL DFG+A+A
Sbjct: 97 --TGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGV 154
Query: 652 DTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGRTPF- 710
+V TL Y +PE + + DIWSLGCI +MV R F
Sbjct: 155 PVR--TYTHEVVTLWYRAPEILLGCK--------YYSTAVDIWSLGCIFAEMVTRRALFP 204
Query: 711 --SEYKTFWAKFKVITDPNHEITYEPVPNPW-----------------------LLDLMK 745
SE + F+ + P+ + P L+
Sbjct: 205 GDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLS 264
Query: 746 KCLAWDRNERWRIPQLLQHPFL 767
+ L +D N+R L HPF
Sbjct: 265 QMLHYDPNKRISAKAALAHPFF 286
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 157 bits (397), Expect = 2e-43
Identities = 75/333 (22%), Positives = 120/333 (36%), Gaps = 70/333 (21%)
Query: 476 RLGKIGSGGSSEVHKVIS-SDCTIYALKKIKLKGRDYATAYG---FCQEIEYLNKLKGKN 531
+L +G G + V+K + I A+KKIKL R A +EI+ L +L
Sbjct: 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELS-HP 60
Query: 532 NIIQLIDYEVTEKALLREVLNGSMNNKDGRVKDDGYIYMVLEYGEIDLAHMLSQKWKEMD 591
NII L+D I +V ++ M + +
Sbjct: 61 NIIGLLDAF----------------------GHKSNISLVFDF-------METDLEVIIK 91
Query: 592 GSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLLVK-GSLKLIDFGIAKAIM 650
++ L + ++ Y L+ + +H+ I+H DLKP N LL + G LKL DFG+AK+
Sbjct: 92 DNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFG 151
Query: 651 SDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGRTPF 710
S QV T Y +PE G D+W++GCIL +++
Sbjct: 152 SPNRAYTH--QVVTRWYRAPELLFGARMY--------GVGVDMWAVGCILAELLLRVPFL 201
Query: 711 ---SEYKTFWAKFKVITDPNHEITYEPVPNPW----------------------LLDLMK 745
S+ F+ + P E + P LLDL++
Sbjct: 202 PGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQ 261
Query: 746 KCLAWDRNERWRIPQLLQHPFLVPPVSTQPSSS 778
++ R Q L+ + P
Sbjct: 262 GLFLFNPCARITATQALKMKYFSNRPGPTPGCQ 294
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (392), Expect = 5e-43
Identities = 64/294 (21%), Positives = 107/294 (36%), Gaps = 52/294 (17%)
Query: 474 YQRLGKIGSGGSSEVHKVISSDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNI 533
+ L IG G +V A+K IK ATA F E + +L+ N +
Sbjct: 9 LKLLQTIGKGEFGDVMLGDYRG-NKVAVKCIKND----ATAQAFLAEASVMTQLRHSN-L 62
Query: 534 IQLIDYEVTEKALLREVLNGSMNNKDGRVKDDGYIYMVLEYGEI-DLAHMLSQKWKEMDG 592
+QL+ V ++ G +Y+V EY L L + +
Sbjct: 63 VQLLGVIV---------------------EEKGGLYIVTEYMAKGSLVDYLRSRGR---- 97
Query: 593 SNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLLVK-GSLKLIDFGIAKAIMS 651
L + L + + EA+ + VH DL N L+ + K+ DFG+ K S
Sbjct: 98 --SVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS 155
Query: 652 DTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMV-YGRTPF 710
+ + + +PEA + SD+WS G +L+++ +GR P+
Sbjct: 156 TQD-----TGKLPVKWTAPEALREKKFST---------KSDVWSFGILLWEIYSFGRVPY 201
Query: 711 SEYKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQH 764
+V + + P P + ++MK C D R QL +
Sbjct: 202 PRIPLKDVVPRVEKGYKMDAP-DGCP-PAVYEVMKNCWHLDAAMRPSFLQLREQ 253
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (391), Expect = 9e-43
Identities = 58/297 (19%), Positives = 101/297 (34%), Gaps = 46/297 (15%)
Query: 474 YQRLGKIGSGGSSEVHKVISSDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNI 533
+ + ++G+G EV + T A+K +K + + F E + +L+ + +
Sbjct: 15 LKLVERLGAGQFGEVWMGYYNGHTKVAVKSLK---QGSMSPDAFLAEANLMKQLQHQR-L 70
Query: 534 IQLIDYEVTEKALLREVLNGSMNNKDGRVKDDGYIYMVLEYGEIDLAHMLSQKWKEMDGS 593
++L IY++ EY E +
Sbjct: 71 VRLYAVV-----------------------TQEPIYIITEYMENGSLVDFLKTPS----- 102
Query: 594 NQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLLVK-GSLKLIDFGIAKAIMSD 652
L N L QI E + I E +H DL+ AN L+ S K+ DFG+A+ ++ D
Sbjct: 103 GIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLAR-LIED 161
Query: 653 TTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGRTPFSE 712
R+ + + +PEA SD+WS G +L ++V
Sbjct: 162 NEYTAREGAKFPIKWTAPEAINYG---------TFTIKSDVWSFGILLTEIVTHGRIPYP 212
Query: 713 YKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQ--HPFL 767
T + + + + P L LM+ C +R L F
Sbjct: 213 GMTNPEVIQNLERGYRMVRPDNCP-EELYQLMRLCWKERPEDRPTFDYLRSVLEDFF 268
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 154 bits (389), Expect = 4e-42
Identities = 68/302 (22%), Positives = 121/302 (40%), Gaps = 55/302 (18%)
Query: 474 YQRLGKIGSGGSSEVHKVIS-SDCTIYALKKIKLKG-RDYATAYGFCQEIEYLNKLKGKN 531
+Q L +G+G VH + S + YA+K +K + E L+ +
Sbjct: 6 FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPF 65
Query: 532 NIIQLIDYEVTEKALLREVLNGSMNNKDGRVKDDGYIYMVLEYGEIDLAHMLSQKWKEMD 591
II++ +D I+M+++Y + + +
Sbjct: 66 -IIRMWGT----------------------FQDAQQIFMIMDY-------IEGGELFSLL 95
Query: 592 GSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLLVK-GSLKLIDFGIAKAIM 650
+Q +FY ++ A+ +H + I++ DLKP N LL K G +K+ DFG AK +
Sbjct: 96 RKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVP 155
Query: 651 SDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGRTPF 710
T + GT Y++PE + D WS G ++Y+M+ G TPF
Sbjct: 156 DVTY-----TLCGTPDYIAPEVVSTK---------PYNKSIDWWSFGILIYEMLAGYTPF 201
Query: 711 SEYKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWR-----IPQLLQHP 765
+ T K++ N E+ + P N + DL+ + + D ++R + HP
Sbjct: 202 YDSNTMKTYEKIL---NAELRFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHP 258
Query: 766 FL 767
+
Sbjct: 259 WF 260
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 151 bits (383), Expect = 2e-41
Identities = 50/310 (16%), Positives = 95/310 (30%), Gaps = 59/310 (19%)
Query: 471 GKLYQRLGKIGSGGSSEVHKVIS-SDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKG 529
G Y+ +IG G + + + + A+K + E L G
Sbjct: 4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQ----LRDEYRTYKLLAG 59
Query: 530 KNNIIQLIDYEVTEKALLREVLNGSMNNKDGRVKDDGYIYMVLEYGEIDLAHMLSQKWKE 589
I + + ++ + +V++ L +L
Sbjct: 60 CTGIPNVYYF----------------------GQEGLHNVLVIDLLGPSLEDLLDLC--- 94
Query: 590 MDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLL------VKGSLKLIDF 643
+ + +Q+L V +IHE+ +V+ D+KP NFL+ + ++DF
Sbjct: 95 ----GRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDF 150
Query: 644 GIAKAIMSDTTN-----IQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGC 698
G+ K T ++ + GT YMS + E R D+ +LG
Sbjct: 151 GMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQS---------RRDDLEALGH 201
Query: 699 ILYQMVYGRTPFSEYK--TFWAKFKVITDPNHEITYEPVPN---PWLLDLMKKCLAWDRN 753
+ + G P+ K T K++ I + + M +
Sbjct: 202 VFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRELCAGFPEEFYKYMHYARNLAFD 261
Query: 754 ERWRIPQLLQ 763
L
Sbjct: 262 ATPDYDYLQG 271
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (385), Expect = 2e-41
Identities = 63/320 (19%), Positives = 119/320 (37%), Gaps = 33/320 (10%)
Query: 456 PRKRNYDPDLFFKVNGKLYQRLGKIGSGGSSEVHKVI------SSDCTIYALKKIKLKGR 509
R+ YD ++ + + +GSG +V + A+K +K +
Sbjct: 23 FREYEYDLK--WEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLK-EKA 79
Query: 510 DYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKAL---LREVLNGSMNNKDGRVKDDG 566
D + E++ + +L NI+ L+ + G + N
Sbjct: 80 DSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLN--------- 130
Query: 567 YIYMVLEYGEIDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDL 626
Y+ E D +QK E + L L + Q+ + + + + VH DL
Sbjct: 131 YLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDL 190
Query: 627 KPANFLLVK-GSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNII 685
N L+ +K+ DFG+A+ IMSD+ + R + + +M+PE+
Sbjct: 191 AARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEG--------- 241
Query: 686 KCGRPSDIWSLGCILYQMV-YGRTPFSEYKTFWAKFKVITDPNHEITYEPVPNPWLLDLM 744
SD+WS G +L+++ G P+ +K+I ++ + +M
Sbjct: 242 IYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYKLI-QNGFKMDQPFYATEEIYIIM 300
Query: 745 KKCLAWDRNERWRIPQLLQH 764
+ C A+D +R P L
Sbjct: 301 QSCWAFDSRKRPSFPNLTSF 320
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (383), Expect = 4e-41
Identities = 65/328 (19%), Positives = 109/328 (33%), Gaps = 62/328 (18%)
Query: 474 YQRLGKIGSGGSSEVHKVIS-SDCTIYALKKIKLKG-RDYATAYGFCQEIEYLNKLKGKN 531
+ +G G +V +A+K +K E L+
Sbjct: 4 FILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHP 63
Query: 532 NIIQLIDYEVTEKALLREVLNGSMNNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEM 590
+ + + ++ V+EY DL + +
Sbjct: 64 FLTHMFCT----------------------FQTKENLFFVMEYLNGGDLMYHIQSC---- 97
Query: 591 DGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLLVK-GSLKLIDFGIAKAI 649
D + FY +I+ + +H + IV+ DLK N LL K G +K+ DFG+ K
Sbjct: 98 ----HKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKEN 153
Query: 650 MSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGRTP 709
M + ++ GT Y++PE + K D WS G +LY+M+ G++P
Sbjct: 154 MLGDA--KTNTFCGTPDYIAPEILLGQ---------KYNHSVDWWSFGVLLYEMLIGQSP 202
Query: 710 FSEYKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIP-QLLQHPF-- 766
F + F I Y DL+ K + +R + + QHP
Sbjct: 203 F-HGQDEEELFHSIR--MDNPFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFR 259
Query: 767 -----------LVPPVSTQPSSSQDQSY 783
+ PP + S D S
Sbjct: 260 EINWEELERKEIDPPFRPKVKSPFDCSN 287
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 152 bits (384), Expect = 6e-41
Identities = 65/305 (21%), Positives = 112/305 (36%), Gaps = 53/305 (17%)
Query: 474 YQRLGKIGSGGSSEVHKVISSDC-TIYALKKIKLKG-RDYATAYGFCQEIEYLNKLKGKN 531
+ IG GG EV+ +D +YA+K + K + E L+ + +
Sbjct: 6 FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGD 65
Query: 532 --NIIQLIDYEVTEKALLREVLNGSMNNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWK 588
I+ + + +L+ DL + LSQ
Sbjct: 66 CPFIVCMSYA----------------------FHTPDKLSFILDLMNGGDLHYHLSQHGV 103
Query: 589 EMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLLVK-GSLKLIDFGIAK 647
E +RFY +I+ + +H +V+ DLKPAN LL + G +++ D G+A
Sbjct: 104 FS--------EADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLAC 155
Query: 648 AIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGR 707
+ GT YM+PE +D +SLGC+L++++ G
Sbjct: 156 DFSKKKPHASV----GTHGYMAPEVLQKGV--------AYDSSADWFSLGCMLFKLLRGH 203
Query: 708 TPFSEYKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIP-----QLL 762
+PF ++KT + +P L L++ L D N R ++
Sbjct: 204 SPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVK 263
Query: 763 QHPFL 767
+ PF
Sbjct: 264 ESPFF 268
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (374), Expect = 1e-40
Identities = 47/293 (16%), Positives = 97/293 (33%), Gaps = 46/293 (15%)
Query: 474 YQRLGKIGSGGSSEVHKVISSDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNI 533
L ++G+G V A+K IK F +E + + L + +
Sbjct: 6 LTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDE---FIEEAKVMMNLSHEK-L 61
Query: 534 IQLIDYEVTEKALLREVLNGSMNNKDGRVKDDGYIYMVLEYGEIDLAHMLSQKWKEMDGS 593
+QL I+++ EY +
Sbjct: 62 VQLYGV----------------------CTKQRPIFIITEYMANGCLLNY------LREM 93
Query: 594 NQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLLV-KGSLKLIDFGIAKAIMSD 652
L + + EA+ + ++ +H DL N L+ +G +K+ DFG+++ ++ D
Sbjct: 94 RHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDD 153
Query: 653 TTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMV-YGRTPFS 711
+ + PE M + K SDIW+ G +++++ G+ P+
Sbjct: 154 EYT-SSVGSKFPVRWSPPEVLMYS---------KFSSKSDIWAFGVLMWEIYSLGKMPYE 203
Query: 712 EYKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQH 764
+ + + + + + +M C +ER LL +
Sbjct: 204 RFTNSETAEHIAQ--GLRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSN 254
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 148 bits (375), Expect = 1e-40
Identities = 66/299 (22%), Positives = 117/299 (39%), Gaps = 40/299 (13%)
Query: 474 YQRLGKIGSGGSSEVHKVIS-SDCTIYALKKIKL-KGRDYATAYGFCQEIEYLNKLKGKN 531
Y+ +G GG SEVH A+K ++ RD + F +E + L
Sbjct: 9 YELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPA 68
Query: 532 NIIQLIDYEVTEKALLREVLNGSMNNKDGRVKDDGYIYMVLEYGEIDLAHMLSQKWKEMD 591
I+ + D E Y+V+EY + +
Sbjct: 69 -IVAVYDTGEAET------------------PAGPLPYIVMEYVDGVTLRDIVHTEG--- 106
Query: 592 GSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLLVKGS-LKLIDFGIAKAIM 650
+ +A+N H+ I+H D+KPAN ++ + +K++DFGIA+AI
Sbjct: 107 ----PMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIA 162
Query: 651 -SDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGRTP 709
S + Q + +GT Y+SPE + SD++SLGC+LY+++ G P
Sbjct: 163 DSGNSVTQTAAVIGTAQYLSPEQARGD---------SVDARSDVYSLGCVLYEVLTGEPP 213
Query: 710 FSEYKTFWAKFKVIT-DPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQHPFL 767
F+ ++ + DP + L ++ K LA + R++ ++ +
Sbjct: 214 FTGDSPVSVAYQHVREDPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLV 272
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (373), Expect = 2e-40
Identities = 49/292 (16%), Positives = 98/292 (33%), Gaps = 44/292 (15%)
Query: 474 YQRLGKIGSGGSSEVHKVISSDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNI 533
+ +IGSG VH + A+K I+ F +E E + KL +
Sbjct: 7 LTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEED---FIEEAEVMMKLSHPK-L 62
Query: 534 IQLIDYEVTEKALLREVLNGSMNNKDGRVKDDGYIYMVLEYGEIDLAHMLSQKWKEMDGS 593
+QL + I +V E+ E + + +
Sbjct: 63 VQLYGV----------------------CLEQAPICLVFEFMEHGCLSDYLRTQRGLF-- 98
Query: 594 NQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLL-VKGSLKLIDFGIAKAIMSD 652
L + E + + E ++H DL N L+ +K+ DFG+ + ++ D
Sbjct: 99 ----AAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD 154
Query: 653 TTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGRTPFSE 712
+ + SPE F + + SD+WS G +++++ E
Sbjct: 155 QYT-SSTGTKFPVKWASPEVFSFS---------RYSSKSDVWSFGVLMWEVFSEGKIPYE 204
Query: 713 YKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQH 764
++ + I+ + + + + +M C +R +LL+
Sbjct: 205 NRSNSEVVEDIST-GFRLYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQ 255
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (370), Expect = 7e-40
Identities = 77/329 (23%), Positives = 119/329 (36%), Gaps = 72/329 (21%)
Query: 474 YQRLGKIGSGGSSEVHKVIS-SDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNN 532
Y++L KIG G V K + I ALK+++L D +EI L +LK KN
Sbjct: 4 YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKN- 62
Query: 533 IIQLIDYEVTEKALLREVLNGSMNNKDGRVKDDGYIYMVLEYGEIDLAHMLSQKWKEMDG 592
I++L D + D + +V E K D
Sbjct: 63 IVRLHDV----------------------LHSDKKLTLVFE-------FCDQDLKKYFDS 93
Query: 593 SNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLL-VKGSLKLIDFGIAKAIMS 651
N LD ++ + Q+L+ + H ++H DLKP N L+ G LKL +FG+A+A
Sbjct: 94 CNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGI 153
Query: 652 DTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGRTPF- 710
++V TL Y P+ + D+WS GCI ++ P
Sbjct: 154 PVR--CYSAEVVTLWYRPPDVLFGAK--------LYSTSIDMWSAGCIFAELANAGRPLF 203
Query: 711 ---SEYKTFWAKFKVITDPNHE-----------------------ITYEPVPNPWLLDLM 744
F+++ P E + P N DL+
Sbjct: 204 PGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLL 263
Query: 745 KKCLAWDRNERWRIPQLLQHPFL---VPP 770
+ L + +R + LQHP+ PP
Sbjct: 264 QNLLKCNPVQRISAEEALQHPYFSDFCPP 292
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (369), Expect = 7e-40
Identities = 59/304 (19%), Positives = 107/304 (35%), Gaps = 48/304 (15%)
Query: 469 VNGKLYQRLGKIGSGGSSEVHKVI----SSDCTIYALKKIKLKGRDYATAYG-FCQEIEY 523
+ K + L K+G G V + S A+K +K A F +E+
Sbjct: 5 IGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNA 64
Query: 524 LNKLKGKNNIIQLIDYEVTEKALLREVLNGSMNNKDGRVKDDGYIYMVLEYGEIDLAHML 583
++ L +N +I+L + + MV E L +L
Sbjct: 65 MHSLDHRN-LIRLYGVVL-----------------------TPPMKMVTEL--APLGSLL 98
Query: 584 SQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLL-VKGSLKLID 642
+ K L Y Q+ E + + +R +H DL N LL + +K+ D
Sbjct: 99 DRLRKH----QGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGD 154
Query: 643 FGIAKAI-MSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILY 701
FG+ +A+ +D + ++ + ++ +PE+ SD W G L+
Sbjct: 155 FGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTR---------TFSHASDTWMFGVTLW 205
Query: 702 QMV-YGRTPFSEYKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQ 760
+M YG+ P+ K+ + E P + ++M +C A +R
Sbjct: 206 EMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCP-QDIYNVMVQCWAHKPEDRPTFVA 264
Query: 761 LLQH 764
L
Sbjct: 265 LRDF 268
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (369), Expect = 9e-40
Identities = 62/309 (20%), Positives = 102/309 (33%), Gaps = 47/309 (15%)
Query: 474 YQRLGKIGSGGSSEVHKVISSDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNI 533
+ K+G G EV + T A+K +K + F QE + + KL+ +
Sbjct: 19 LRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLK---PGTMSPEAFLQEAQVMKKLR-HEKL 74
Query: 534 IQLIDYEVTEKALLREVLNGSMNNKDGRVKDDGYIYMVLEYGEIDLAHMLSQKWKEMDGS 593
+QL E IY+V EY +
Sbjct: 75 VQLYAVVSEEP-----------------------IYIVTEYMSKGSLLDFLKGET----- 106
Query: 594 NQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLLVK-GSLKLIDFGIAKAIMSD 652
+ L L QI + + VH DL+ AN L+ + K+ DFG+A+ ++ D
Sbjct: 107 GKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLAR-LIED 165
Query: 653 TTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGRTPFSE 712
R + + +PEA + SD+WS G +L ++
Sbjct: 166 NEYTARQGAKFPIKWTAPEAALYGRFTI---------KSDVWSFGILLTELTTKGRVPYP 216
Query: 713 YKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQL---LQHPFLVP 769
+ + + + P L DLM +C + ER L L+ F
Sbjct: 217 GMVNREVLDQV-ERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST 275
Query: 770 PVSTQPSSS 778
QP +
Sbjct: 276 EPQYQPGEN 284
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (368), Expect = 1e-39
Identities = 57/297 (19%), Positives = 102/297 (34%), Gaps = 51/297 (17%)
Query: 479 KIGSGGSSEVHKVI---SSDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQ 535
++GSG V K A+K +K + D A E + +L I++
Sbjct: 14 ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPY-IVR 72
Query: 536 LIDYEVTEKALLREVLNGSMNNKDGRVKDDGYIYMVLEYGEIDLAHMLSQKWKEMDGSNQ 595
+I E +V+E E+ + Q+ N+
Sbjct: 73 MIGICEAES-----------------------WMLVMEMAELGPLNKYLQQ-------NR 102
Query: 596 TLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLLVK-GSLKLIDFGIAKAIMSD-T 653
+ + + Q+ + + E VH DL N LLV K+ DFG++KA+ +D
Sbjct: 103 HVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADEN 162
Query: 654 TNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMV-YGRTPFSE 712
+ + + +PE K SD+WS G ++++ YG+ P+
Sbjct: 163 YYKAQTHGKWPVKWYAPECINYY---------KFSSKSDVWSFGVLMWEAFSYGQKPYRG 213
Query: 713 YKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQL---LQHPF 766
K + P + DLM C +D R + L++ +
Sbjct: 214 MKGSEVTAMLEKGERMGCP-AGCP-REMYDLMNLCWTYDVENRPGFAAVELRLRNYY 268
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 146 bits (369), Expect = 1e-39
Identities = 54/318 (16%), Positives = 104/318 (32%), Gaps = 61/318 (19%)
Query: 467 FKVNGKLYQRLGKIGSGGSSEVHKVIS-SDCTIYALKKIKLKGRDYATAYGFCQEIEYLN 525
+V + Y+ KIGSG +++ + A+K +K + E +
Sbjct: 3 LRVGNR-YRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQ----LHIESKIYK 57
Query: 526 KLKGKNNIIQLIDYEVTEKALLREVLNGSMNNKDGRVKDDGYIYMVLEYGEIDLAHMLSQ 585
++G I + + Y MV+E L + +
Sbjct: 58 MMQGGVGIPTIRWCGA----------------------EGDYNVMVMELLGPSLEDLFNF 95
Query: 586 KWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLL----VKGSLKLI 641
++ + Q++ + IH + +H D+KP NFL+ + +I
Sbjct: 96 C-------SRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYII 148
Query: 642 DFGIAKAIMSDTTN-----IQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSL 696
DFG+AK T+ + + GT Y S + E R D+ SL
Sbjct: 149 DFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIE---------QSRRDDLESL 199
Query: 697 GCILYQMVYGRTPFSEYKTFWAKFKVITDPNHEITYEPVPN-----PWLLDLMKKCLAWD 751
G +L G P+ K + K +++ + C +
Sbjct: 200 GYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLR 259
Query: 752 RNERWR---IPQLLQHPF 766
+++ + QL ++ F
Sbjct: 260 FDDKPDYSYLRQLFRNLF 277
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (372), Expect = 2e-39
Identities = 73/326 (22%), Positives = 127/326 (38%), Gaps = 69/326 (21%)
Query: 472 KLYQRLGKIGSGGSSEVHKVIS-SDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGK 530
+Y+ L +GSG V + A+KK+ + A +E+ L ++ +
Sbjct: 18 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHE 77
Query: 531 NNIIQLIDYEVTEKALLREVLNGSMNNKDGRVKDDGYIYMVLEYGEIDLAHMLSQKWKEM 590
N +I L+D D + D Y+V+ + DL ++
Sbjct: 78 N-VIGLLDVFTP----------------DETLDDFTDFYLVMPFMGTDLGKLMK------ 114
Query: 591 DGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLLVK-GSLKLIDFGIAKAI 649
++ L E+ ++F Q+L+ + IH I+H DLKP N + + LK++DFG+A+
Sbjct: 115 ---HEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQA 171
Query: 650 MSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGRTP 709
S+ T V T Y +PE + + + DIWS+GCI+ +M+ G+T
Sbjct: 172 DSEMT-----GYVVTRWYRAPEVILNWM--------RYTQTVDIWSVGCIMAEMITGKTL 218
Query: 710 F---SEYKTFWAKFKVITDPNHEI-------------------------TYEPVPNPWLL 741
F KV P E + +P +
Sbjct: 219 FKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAV 278
Query: 742 DLMKKCLAWDRNERWRIPQLLQHPFL 767
+L++K L D +R + L HP+
Sbjct: 279 NLLEKMLVLDAEQRVTAGEALAHPYF 304
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (363), Expect = 2e-38
Identities = 81/351 (23%), Positives = 137/351 (39%), Gaps = 72/351 (20%)
Query: 474 YQRLGKIGSGGSSEVHKVIS-SDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNN 532
YQ L +GSG V A+KK+ + A +E+ L +K +N
Sbjct: 20 YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHEN- 78
Query: 533 IIQLIDYEVTEKALLREVLNGSMNNKDGRVKDDGYIYMVLEYGEIDLAHMLSQKWKEMDG 592
+I L+D ++L ++ +Y+V DL ++
Sbjct: 79 VIGLLDVFTPARSL----------------EEFNDVYLVTHLMGADLNNI---------V 113
Query: 593 SNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLLVK-GSLKLIDFGIAKAIMS 651
Q L ++ ++F QIL + IH I+H DLKP+N + + LK++DFG+A
Sbjct: 114 KCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA----- 168
Query: 652 DTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGRTPF- 710
T+ + V T Y +PE + N + + DIWS+GCI+ +++ GRT F
Sbjct: 169 RHTDDEMTGYVATRWYRAPEIML--------NWMHYNQTVDIWSVGCIMAELLTGRTLFP 220
Query: 711 --SEYKTFWAKFKVITDPNHEI-------------------------TYEPVPNPWLLDL 743
+++ P E+ NP +DL
Sbjct: 221 GTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDL 280
Query: 744 MKKCLAWDRNERWRIPQLLQHPFL--VPPVSTQPSSSQ-DQSYQLLQLLAE 791
++K L D ++R Q L H + +P + DQS++ LL +
Sbjct: 281 LEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVADPYDQSFESRDLLID 331
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (360), Expect = 2e-38
Identities = 60/326 (18%), Positives = 111/326 (34%), Gaps = 52/326 (15%)
Query: 456 PRKRNYDPDLFFKVNGKLYQRLGKIGSGGSSEVHKVI------SSDCTIYALKKIKLKGR 509
P + YD ++ +G+G +V + S A+K +K
Sbjct: 9 PTQLPYDHK--WEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLK-PSA 65
Query: 510 DYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLREVLNGSMNNKDGRVKDDGYIY 569
E++ L+ L NI+ L+ G
Sbjct: 66 HLTEREALMSELKVLSYLGNHMNIVNLLGA----------------------CTIGGPTL 103
Query: 570 MVLEYGEI-DLAHMLSQK----------WKEMDGSNQTLDENWLRFYWQQILEAVNTIHE 618
++ EY DL + L +K M+ LD L + Q+ + + +
Sbjct: 104 VITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLAS 163
Query: 619 ERIVHSDLKPANFLLVK-GSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNE 677
+ +H DL N LL K+ DFG+A+ I +D+ + + + + +M+PE+
Sbjct: 164 KNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNC- 222
Query: 678 SDENGNIIKCGRPSDIWSLGCILYQMVYGRTPFSEYKTFWAKFKVITDPNHEITYEPVPN 737
SD+WS G L+++ + +KF + +
Sbjct: 223 --------VYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGFRMLSPEHAP 274
Query: 738 PWLLDLMKKCLAWDRNERWRIPQLLQ 763
+ D+MK C D +R Q++Q
Sbjct: 275 AEMYDIMKTCWDADPLKRPTFKQIVQ 300
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (362), Expect = 3e-38
Identities = 76/338 (22%), Positives = 122/338 (36%), Gaps = 67/338 (19%)
Query: 468 KVNGKLYQRLGKIGSGGSSEVHKVIS-SDCTIYALKKIKLKGRDYATAYG-FCQEIEYLN 525
KV + L +G G +V V + YA+K ++ + E L
Sbjct: 1 KVTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQ 60
Query: 526 KLKGKNNIIQLIDYEVTEKALLREVLNGSMNNKDGRVKDDGYIYMVLEYGEID-LAHMLS 584
+ + L + V+EY L LS
Sbjct: 61 NTRHPF-LTALKYAFQ----------------------THDRLCFVMEYANGGELFFHLS 97
Query: 585 QKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLLVK-GSLKLIDF 643
++ E RFY +I+ A+ +H +V+ D+K N +L K G +K+ DF
Sbjct: 98 RERV--------FTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDF 149
Query: 644 GIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQM 703
G+ K +SD + GT Y++PE N GR D W LG ++Y+M
Sbjct: 150 GLCKEGISDGA--TMKTFCGTPEYLAPEVLEDN---------DYGRAVDWWGLGVVMYEM 198
Query: 704 VYGRTPFSEYKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWR-----I 758
+ GR PF + F++I EI + +P L+ L D +R
Sbjct: 199 MCGRLPFYN-QDHERLFELIL--MEEIRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDA 255
Query: 759 PQLLQHPF-------------LVPPVSTQPSSSQDQSY 783
++++H F L+PP Q +S D Y
Sbjct: 256 KEVMEHRFFLSINWQDVVQKKLLPPFKPQVTSEVDTRY 293
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 143 bits (360), Expect = 4e-38
Identities = 73/332 (21%), Positives = 121/332 (36%), Gaps = 86/332 (25%)
Query: 474 YQRLGKIGSGGSSEVHKVIS-SDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNN 532
YQ + K+G G SEV + I+ ++ +K +K + +EI+ L L+G N
Sbjct: 37 YQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKK-----IKREIKILENLRGGPN 91
Query: 533 IIQLIDYEVTEKALLREVLNGSMNNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEMD 591
II L D + +V E+ D +
Sbjct: 92 IITLADI--------------------VKDPVSRTPALVFEHVNNTDFKQLY-------- 123
Query: 592 GSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLLVK--GSLKLIDFGIAKAI 649
QTL + +RFY +IL+A++ H I+H D+KP N ++ L+LID+G+A+
Sbjct: 124 ---QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFY 180
Query: 650 MSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGRTP 709
R V + + PE + + D+WSLGC+L M++ + P
Sbjct: 181 HPGQEYNVR---VASRYFKGPELLVDYQ--------MYDYSLDMWSLGCMLASMIFRKEP 229
Query: 710 F----SEYKTFWAKFKVITDPNH----------------EITYEPVPNPW---------- 739
F Y KV+ + +I W
Sbjct: 230 FFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQH 289
Query: 740 -----LLDLMKKCLAWDRNERWRIPQLLQHPF 766
LD + K L +D R + ++HP+
Sbjct: 290 LVSPEALDFLDKLLRYDHQSRLTAREAMEHPY 321
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (356), Expect = 1e-37
Identities = 64/314 (20%), Positives = 130/314 (41%), Gaps = 52/314 (16%)
Query: 468 KVNGKLYQRLGKIGSGGSSEVHKVI----SSDCTIYALKKIKLK--GRDYATAYGFCQEI 521
KV + ++ L +G+G +V V +YA+K +K + T E
Sbjct: 20 KVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTER 79
Query: 522 EYLNKLKGKNNIIQLIDYEVTEKALLREVLNGSMNNKDGRVKDDGYIYMVLEYGEI-DLA 580
+ L ++ ++ L + + ++++L+Y +L
Sbjct: 80 QVLEHIRQSPFLVTLHYA----------------------FQTETKLHLILDYINGGELF 117
Query: 581 HMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLLVK-GSLK 639
LSQ+ + E+ ++ Y +I+ A+ +H+ I++ D+K N LL G +
Sbjct: 118 THLSQRER--------FTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVV 169
Query: 640 LIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCI 699
L DFG++K ++D T + GT+ YM+P+ +S + D WSLG +
Sbjct: 170 LTDFGLSKEFVADETE-RAYDFCGTIEYMAPDIVRGGDS-------GHDKAVDWWSLGVL 221
Query: 700 LYQMVYGRTPFSEYKTFWAKFKVIT-DPNHEITYEPVPNPWLLDLMKKCLAWDRNERWR- 757
+Y+++ G +PF+ ++ ++ E Y + DL+++ L D +R
Sbjct: 222 MYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSALAKDLIQRLLMKDPKKRLGC 281
Query: 758 ----IPQLLQHPFL 767
++ +H F
Sbjct: 282 GPRDADEIKEHLFF 295
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 140 bits (353), Expect = 2e-37
Identities = 54/300 (18%), Positives = 106/300 (35%), Gaps = 30/300 (10%)
Query: 474 YQRLGKIGSGGSSEVHKVIS------SDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKL 527
+ + IG G V + + T+ A+K +K + A F +E + +
Sbjct: 15 IEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQAD-FQREAALMAEF 73
Query: 528 KGKNNIIQLIDYEVTEKALL--REVLNGSMNNKDGRVKDDGYIYMVLEYGEIDLAH-MLS 584
N + L V + L + G +N ++ + + L+H LS
Sbjct: 74 DNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNE---------FLRSMSPHTVCSLSHSDLS 124
Query: 585 QKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLLVK-GSLKLIDF 643
+ + L +Q+ + + E + VH DL N L+ + +K+ DF
Sbjct: 125 TRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADF 184
Query: 644 GIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQM 703
G+++ I S + + +M PE+ N + SD+W+ G +L+++
Sbjct: 185 GLSRNIYSADYYKADGNDAIPIRWMPPESIFYN---------RYTTESDVWAYGVVLWEI 235
Query: 704 VYGRTPFSEYKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQ 763
+ D N E P L +LM+ C + +R + +
Sbjct: 236 FSYGLQPYYGMAHEEVIYYVRDGNILACPENCP-LELYNLMRLCWSKLPADRPSFCSIHR 294
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (350), Expect = 3e-37
Identities = 60/316 (18%), Positives = 112/316 (35%), Gaps = 58/316 (18%)
Query: 479 KIGSGGSSEVHKVI---SSDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQ 535
++G G V + + A+K +K +G + A +E + +++L I++
Sbjct: 16 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLK-QGTEKADTEEMMREAQIMHQLDNPY-IVR 73
Query: 536 LIDYEVTEKALLREVLNGSMNNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEMDGSN 594
LI + +V+E L L K +E
Sbjct: 74 LIGVC-----------------------QAEALMLVMEMAGGGPLHKFLVGKREE----- 105
Query: 595 QTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLLVK-GSLKLIDFGIAKAI-MSD 652
+ + + Q+ + + E+ VH DL N LLV K+ DFG++KA+ D
Sbjct: 106 --IPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADD 163
Query: 653 TTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMV-YGRTPFS 711
+ R + L + +PE K SD+WS G +++ + YG+ P+
Sbjct: 164 SYYTARSAGKWPLKWYAPECINFR---------KFSSRSDVWSYGVTMWEALSYGQKPYK 214
Query: 712 EYKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWR---IPQLLQHPFLV 768
+ K + E P P L LM C + +R + Q ++ +
Sbjct: 215 KMKGPEVMAFIEQGKRMECP-PECP-PELYALMSDCWIYKWEDRPDFLTVEQRMRACYY- 271
Query: 769 PPVSTQPSSSQDQSYQ 784
+ S + +
Sbjct: 272 ----SLASKVEGHHHH 283
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 138 bits (348), Expect = 1e-36
Identities = 56/315 (17%), Positives = 111/315 (35%), Gaps = 49/315 (15%)
Query: 463 PDLFFKVNGKLYQRLGKIGSGGSSEVHKVI---SSDCTIYALKKIKLKGRDYATAYGFCQ 519
P ++ ++ + IG G +V K A+K++K F
Sbjct: 1 PTIYPVLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRD-FAG 59
Query: 520 EIEYLNKLKGKNNIIQLIDYEVTEKALLREVLNGSMNNKDGRVKDDGYIYMVLEYGEI-D 578
E+E L KL NII L+ + GY+Y+ +EY +
Sbjct: 60 ELEVLCKLGHHPNIINLLGA----------------------CEHRGYLYLAIEYAPHGN 97
Query: 579 LAHMLSQKW--------KEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPAN 630
L L + + + TL L + + ++ + +++ +H DL N
Sbjct: 98 LLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARN 157
Query: 631 FLLVKGS-LKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGR 689
L+ + K+ DFG+++ + + +M+ E+ +
Sbjct: 158 ILVGENYVAKIADFGLSRGQEVYVK---KTMGRLPVRWMAIESLNYS---------VYTT 205
Query: 690 PSDIWSLGCILYQMVYGRTPFSEYKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLA 749
SD+WS G +L+++V T ++ + + + + + DLM++C
Sbjct: 206 NSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQ-GYRLEKPLNCDDEVYDLMRQCWR 264
Query: 750 WDRNERWRIPQLLQH 764
ER Q+L
Sbjct: 265 EKPYERPSFAQILVS 279
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 135 bits (340), Expect = 5e-36
Identities = 61/297 (20%), Positives = 109/297 (36%), Gaps = 49/297 (16%)
Query: 474 YQRLGKIGSGGSSEVHKVI----SSDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKG 529
+ IG G +VH+ I + A+K K D F QE + +
Sbjct: 9 IELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREK-FLQEALTMRQFDH 67
Query: 530 KNNIIQLIDYEVTEKALLREVLNGSMNNKDGRVKDDGYIYMVLEYGEIDLAHMLSQKWKE 589
+ I++LI + +++++E + Q
Sbjct: 68 PH-IVKLIGVI-----------------------TENPVWIIMELCTLGELRSFLQVR-- 101
Query: 590 MDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLL-VKGSLKLIDFGIAKA 648
+LD L Y Q+ A+ + +R VH D+ N L+ +KL DFG+++
Sbjct: 102 ----KYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSR- 156
Query: 649 IMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQM-VYGR 707
M D+T + + +M+PE+ + SD+W G ++++ ++G
Sbjct: 157 YMEDSTYYKASKGKLPIKWMAPESINFR---------RFTSASDVWMFGVCMWEILMHGV 207
Query: 708 TPFSEYKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQH 764
PF K ++ + P P L LM KC A+D + R R +L
Sbjct: 208 KPFQGVKNNDVIGRIEN--GERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQ 262
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 135 bits (341), Expect = 2e-35
Identities = 71/345 (20%), Positives = 123/345 (35%), Gaps = 81/345 (23%)
Query: 464 DLFFKVNGKLYQRLGKIGSGGSSEVHKVIS-SDCTIYALKKIKLKGRDYATAYGFCQEIE 522
D F V + YQ L IGSG V A+KK+ ++ A +E+
Sbjct: 10 DSTFTVLKR-YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELV 68
Query: 523 YLNKLKGKNNIIQLIDYEVTEKALLREVLNGSMNNKDGRVKDDGYIYMVLEYGEIDLAHM 582
+ + NII L++ +K L ++ +Y+V+E + +L +
Sbjct: 69 LMKCVN-HKNIISLLNVFTPQKTL----------------EEFQDVYLVMELMDANLCQV 111
Query: 583 LSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLLV-KGSLKLI 641
+ + D + + Q+L + +H I+H DLKP+N ++ +LK++
Sbjct: 112 IQMEL----------DHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKIL 161
Query: 642 DFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILY 701
DFG+A+ + V T Y +PE + DIWS+GCI+
Sbjct: 162 DFGLARTAGTSFM---MTPYVVTRYYRAPEVILGM---------GYKENVDIWSVGCIMG 209
Query: 702 QMVYGRTPF---SEYKTFWAKFKVITDPNHEITYEPVPNPW------------------- 739
+MV + F + + + P E + P
Sbjct: 210 EMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFP 269
Query: 740 -----------------LLDLMKKCLAWDRNERWRIPQLLQHPFL 767
DL+ K L D +R + LQHP++
Sbjct: 270 DSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYI 314
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 132 bits (334), Expect = 4e-35
Identities = 54/313 (17%), Positives = 116/313 (37%), Gaps = 47/313 (15%)
Query: 453 ASAPRKRNYDPDLFFKVNGKLYQRLGKIGSGGSSEVHKVISSDC-TIYALKKIKLKGRDY 511
A P NYD +++ K+G G EV++ + A+K +K +
Sbjct: 1 AMDPSSPNYDK---WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV 57
Query: 512 ATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLREVLNGSMNNKDGRVKDDGYIYMV 571
F +E + ++K N ++QL+ E YI
Sbjct: 58 EE---FLKEAAVMKEIKHPN-LVQLLGVCTREPPF--------------------YIITE 93
Query: 572 LEYGEIDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANF 631
L ++ + + Q + L + QI A+ + ++ +H DL N
Sbjct: 94 FMTYGNLLDYL-------RECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNC 146
Query: 632 LLVK-GSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRP 690
L+ + +K+ DFG+++ + DT + + +PE+ N K
Sbjct: 147 LVGENHLVKVADFGLSRLMTGDTYT-AHAGAKFPIKWTAPESLAYN---------KFSIK 196
Query: 691 SDIWSLGCILYQMVYGRTPFSEYKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAW 750
SD+W+ G +L+++ ++++ + ++ + + +LM+ C W
Sbjct: 197 SDVWAFGVLLWEIATYGMSPYPGIDLSQVYELL-EKDYRMERPEGCPEKVYELMRACWQW 255
Query: 751 DRNERWRIPQLLQ 763
+ ++R ++ Q
Sbjct: 256 NPSDRPSFAEIHQ 268
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (331), Expect = 2e-34
Identities = 45/293 (15%), Positives = 92/293 (31%), Gaps = 46/293 (15%)
Query: 479 KIGSGGSSEVHKVISSD----CTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNII 534
IG G V+ D A+K + + D F E + N ++
Sbjct: 34 VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLN-RITDIGEVSQFLTEGIIMKDFSHPN-VL 91
Query: 535 QLIDYEVTEKALLREVLNGSMNNKDGRVKDDGYIYMVLEYGEIDLAHMLSQKWKEMDGSN 594
L+ + + +G +VL Y + +
Sbjct: 92 SLLGICL---------------------RSEGSPLVVLPYMKHGDLRNF------IRNET 124
Query: 595 QTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLLVKGS-LKLIDFGIAKAIMSD- 652
L + Q+ + + + ++ VH DL N +L + +K+ DFG+A+ +
Sbjct: 125 HNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE 184
Query: 653 -TTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGRTPFS 711
+ + + +M+ E+ K SD+WS G +L++++ P
Sbjct: 185 FDSVHNKTGAKLPVKWMALESLQTQ---------KFTTKSDVWSFGVLLWELMTRGAPPY 235
Query: 712 EYKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQH 764
+ + + L ++M KC R +L+
Sbjct: 236 PDVNTFDITVYLLQ-GRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSR 287
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 130 bits (328), Expect = 3e-34
Identities = 53/297 (17%), Positives = 93/297 (31%), Gaps = 47/297 (15%)
Query: 474 YQRLGKIGSGGSSEVHKVISSD-----CTIYALKKIKLKGRDYATAYGFCQEIEYLNKLK 528
R IG+G EV+K + A+K +K G F E + +
Sbjct: 9 VTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLK-AGYTEKQRVDFLGEAGIMGQFS 67
Query: 529 GKNNIIQLIDYEVTEKALLREVLNGSMNNKDGRVKDDGYIYMVLEYGEIDLAHMLSQKWK 588
N II+L + + ++ EY E ++
Sbjct: 68 HHN-IIRLEGV----------------------ISKYKPMMIITEYMENGALDKFLREKD 104
Query: 589 EMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLLVK-GSLKLIDFGIAK 647
L + I + + VH DL N L+ K+ DFG+++
Sbjct: 105 GE------FSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSR 158
Query: 648 AIMSDTTNIQRDSQ-VGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYG 706
+ D S + + +PEA K SD+WS G ++++++
Sbjct: 159 VLEDDPEATYTTSGGKIPIRWTAPEAISYR---------KFTSASDVWSFGIVMWEVMTY 209
Query: 707 RTPFSEYKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQ 763
+ K I D T P + LM +C +R R + ++
Sbjct: 210 GERPYWELSNHEVMKAINDGFRLPTPMDCP-SAIYQLMMQCWQQERARRPKFADIVS 265
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (329), Expect = 4e-34
Identities = 42/297 (14%), Positives = 102/297 (34%), Gaps = 47/297 (15%)
Query: 474 YQRLGKIGSGGSSEVHKVISSD-----CTIYALKKIKLKGRDYATAYGFCQEIEYLNKLK 528
++++ +GSG V+K + A+K+++ A E + +
Sbjct: 11 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKE-ILDEAYVMASVD 69
Query: 529 GKNNIIQLIDYEVTEKALLREVLNGSMNNKDGRVKDDGYIYMVLEYGEIDLAHMLSQKWK 588
+ + +L+ + L + +
Sbjct: 70 NPH-VCRLLGI----------------------CLTSTVQLITQLMPFGCLLDYVREHKD 106
Query: 589 EMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLLVK-GSLKLIDFGIAK 647
+ +L + QI + +N + + R+VH DL N L+ +K+ DFG+AK
Sbjct: 107 NIG-------SQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAK 159
Query: 648 AIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGR 707
+ ++ + + +M+ E+ + SD+WS G +++++
Sbjct: 160 LLGAEEKEYHAEGGKVPIKWMALESILHRIYTH---------QSDVWSYGVTVWELMTFG 210
Query: 708 TPFSEYKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQH 764
+ + ++ + + P+ + +M KC D + R + +L+
Sbjct: 211 SKPYDGIPASEISSIL-EKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIE 266
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 130 bits (328), Expect = 4e-34
Identities = 52/309 (16%), Positives = 101/309 (32%), Gaps = 51/309 (16%)
Query: 474 YQRLGKIGSGGSSEVHKVI--------SSDCTIYALKKIKLKGRDYATAYGFCQEIEYLN 525
+G G +V + T A+K +K + + E+E +
Sbjct: 15 LVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSD-LISEMEMMK 73
Query: 526 KLKGKNNIIQLIDYEVTEKALLREVLNGSMNNKDGRVKDDGYIYMVLEYGE-IDLAHMLS 584
+ NII L+ DG +Y+++EY +L L
Sbjct: 74 MIGKHKNIINLLGACT----------------------QDGPLYVIVEYASKGNLREYLQ 111
Query: 585 QKWK--------EMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLLV-K 635
+ + L L Q+ + + ++ +H DL N L+
Sbjct: 112 ARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTED 171
Query: 636 GSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWS 695
+K+ DFG+A+ I + + + +M+PEA SD+WS
Sbjct: 172 NVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDR---------IYTHQSDVWS 222
Query: 696 LGCILYQMVYGRTPFSEYKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNER 755
G +L+++ FK++ + + L +M+ C ++R
Sbjct: 223 FGVLLWEIFTLGGSPYPGVPVEELFKLLKEGHRMDKPSNCT-NELYMMMRDCWHAVPSQR 281
Query: 756 WRIPQLLQH 764
QL++
Sbjct: 282 PTFKQLVED 290
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 130 bits (327), Expect = 6e-34
Identities = 58/309 (18%), Positives = 117/309 (37%), Gaps = 52/309 (16%)
Query: 479 KIGSGGSSEVHKVISSDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKN-NIIQLI 537
IG G EV + A+K + + +E E + ++ NI+ I
Sbjct: 10 SIGKGRFGEVWRGKWRG-EEVAVKIFSSREER-----SWFREAEIYQTVMLRHENILGFI 63
Query: 538 DYEVTEKALLREVLNGSMNNKDGRVKDDGYIYMVLEYGEI-DLAHMLSQKWKEMDGSNQT 596
+ + + +++V +Y E L L++ ++G +
Sbjct: 64 AADNKDNGTWTQ------------------LWLVSDYHEHGSLFDYLNRYTVTVEGMIK- 104
Query: 597 LDENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLL-VKGSLKLIDFGIAKAIMS--DT 653
L + +E V T + I H DLK N L+ G+ + D G+A S DT
Sbjct: 105 LALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDT 164
Query: 654 TNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGRTPFSEY 713
+I + +VGT YM+PE + N + + +DI+++G + +++ + +
Sbjct: 165 IDIAPNHRVGTKRYMAPEVL---DDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIH 221
Query: 714 KTF--WAKFKVITDPNHEITYE---------PVPNPW--------LLDLMKKCLAWDRNE 754
+ + V +DP+ E + +PN W + +M++C +
Sbjct: 222 EDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAA 281
Query: 755 RWRIPQLLQ 763
R ++ +
Sbjct: 282 RLTALRIKK 290
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 129 bits (326), Expect = 8e-34
Identities = 58/307 (18%), Positives = 103/307 (33%), Gaps = 52/307 (16%)
Query: 468 KVNGKLYQRLGKIGSGGSSEVHKVI----SSDCTIYALKKIKLKGRDYATAYGFCQEIEY 523
+++ + IG+G EV A+K +K G F E
Sbjct: 22 EIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLK-SGYTEKQRRDFLSEASI 80
Query: 524 LNKLKGKNNIIQLIDYEVTEKALLREVLNGSMNNKDGRVKDDGYIYMVLEYGEI-DLAHM 582
+ + N +I L V + ++ E+ E L
Sbjct: 81 MGQFDHPN-VIHLEGV----------------------VTKSTPVMIITEFMENGSLDSF 117
Query: 583 LSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLLVK-GSLKLI 641
L Q + L + I + + + VH DL N L+ K+
Sbjct: 118 LRQNDGQFT-------VIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVS 170
Query: 642 DFGIAKAIMSDTTNIQRDSQVG---TLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGC 698
DFG+++ + DT++ S +G + + +PEA K SD+WS G
Sbjct: 171 DFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYR---------KFTSASDVWSYGI 221
Query: 699 ILYQMV-YGRTPFSEYKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWR 757
++++++ YG P+ + + D + L LM C DRN R +
Sbjct: 222 VMWEVMSYGERPYWDMTNQDVINAIEQDYRLPPPMDCPSA--LHQLMLDCWQKDRNHRPK 279
Query: 758 IPQLLQH 764
Q++
Sbjct: 280 FGQIVNT 286
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 129 bits (325), Expect = 8e-34
Identities = 51/298 (17%), Positives = 101/298 (33%), Gaps = 29/298 (9%)
Query: 474 YQRLGKIGSGGSSEVHKVI------SSDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKL 527
+ +G G +V + ++ C A+K +K +G ++ E++ L +
Sbjct: 15 LKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLK-EGATHSEHRALMSELKILIHI 73
Query: 528 KGKNNIIQLIDYEVTEKALLREVLNGSMNNKDGRVKDDGYIYMVLEYGEIDLAHMLSQKW 587
N++ L+ L ++ + Y + K
Sbjct: 74 GHHLNVVNLLGACTKPGGPLMVIVEFCKF------------GNLSTYLRSKRNEFVPYKV 121
Query: 588 KEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLL-VKGSLKLIDFGIA 646
D L L Y Q+ + + + + +H DL N LL K +K+ DFG+A
Sbjct: 122 APEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLA 181
Query: 647 KAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYG 706
+ I D +++ L +M+PE SD+WS G +L+++
Sbjct: 182 RDIYKDPDYVRKGDARLPLKWMAPETIFDR---------VYTIQSDVWSFGVLLWEIFSL 232
Query: 707 RTPFSEYKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQH 764
+F + P + M C + ++R +L++H
Sbjct: 233 GASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 290
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 127 bits (320), Expect = 5e-33
Identities = 44/314 (14%), Positives = 105/314 (33%), Gaps = 45/314 (14%)
Query: 461 YDPDLFFKVNGKLYQRLGKIGSGGSSEVHKVI------SSDCTIYALKKIKLKGRDYATA 514
Y PD + +V + ++G G V++ + T A+K + +
Sbjct: 10 YVPDEW-EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVN-EAASMRER 67
Query: 515 YGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLREVLNGSMNNKDGRVKDDGYIYMVLEY 574
F E + + + + L G V +++E
Sbjct: 68 IEFLNEASVMKEFNCHHVVRLL-----------------------GVVSQGQPTLVIMEL 104
Query: 575 ---GEIDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANF 631
G++ + + + + +I + + ++ + VH DL N
Sbjct: 105 MTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNC 164
Query: 632 LLVK-GSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRP 690
++ + ++K+ DFG+ + I + + + +MSPE+
Sbjct: 165 MVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDG---------VFTTY 215
Query: 691 SDIWSLGCILYQMVYGRTPFSEYKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAW 750
SD+WS G +L+++ + + + + + + P L +LM+ C +
Sbjct: 216 SDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLDKPDNCP-DMLFELMRMCWQY 274
Query: 751 DRNERWRIPQLLQH 764
+ R +++
Sbjct: 275 NPKMRPSFLEIISS 288
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 127 bits (319), Expect = 2e-32
Identities = 63/371 (16%), Positives = 121/371 (32%), Gaps = 72/371 (19%)
Query: 438 ASKSEKQEKAVSSKGASAPRKRNYDPDLFFKVNGKL----YQRLGKIGSGGSSEVHKVIS 493
A+ ++K + S K A K ++ + R+ +G+G V V
Sbjct: 3 AAAAKKGSEQESVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKH 62
Query: 494 -SDCTIYALKKIKL-KGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLREVL 551
YA+K + K E L + +++L
Sbjct: 63 KESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN-FPFLVKLEFSFKD--------- 112
Query: 552 NGSMNNKDGRVKDDGYIYMVLEYGEIDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILE 611
+ ++ ++ L + E RFY QI+
Sbjct: 113 ------------NSNLYMVMEYVAGGEMFSHLRRI--------GRFSEPHARFYAAQIVL 152
Query: 612 AVNTIHEERIVHSDLKPANFLL-VKGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSP 670
+H +++ DLKP N L+ +G +++ DFG AK + T + GT ++P
Sbjct: 153 TFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTLC-----GTPEALAP 207
Query: 671 EAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGRTPFSEYKTFWAKFKVITDPNHEI 730
E + + D W+LG ++Y+M G PF + K+ + ++
Sbjct: 208 EIILSK---------GYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKI---VSGKV 255
Query: 731 TYEPVPNPWLLDLMKKCLAWDRNERWR-----IPQLLQHPF-------------LVPPVS 772
+ + L DL++ L D +R+ + + H + + P
Sbjct: 256 RFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAIYQRKVEAPFI 315
Query: 773 TQPSSSQDQSY 783
+ D S
Sbjct: 316 PKFKGPGDTSN 326
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 116 bits (290), Expect = 1e-28
Identities = 59/360 (16%), Positives = 125/360 (34%), Gaps = 76/360 (21%)
Query: 470 NGKLYQRLGKIGSGGSSEVHKVIS-SDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLK 528
+ + Y + K+G G S V + T A+K ++ D EI+ L ++
Sbjct: 12 DAR-YILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVR---GDKVYTEAAEDEIKLLQRVN 67
Query: 529 GKNNIIQLIDYEVTEKALLREVLNGSMNNKDGRVKDDGYIYMVLEYGEIDLAHMLSQKWK 588
+N + + +L+ + + + +G + + GE LA + + +
Sbjct: 68 DADNTKE---DSMGANHILKLLDHFNHKGPNGVH----VVMVFEVLGENLLALIKKYEHR 120
Query: 589 EMDGSNQTLDENWLRFYWQQILEAVNTIHEER-IVHSDLKPANFLL--VKGSLKLIDFGI 645
+ +++ +Q+L ++ +H I+H+D+KP N L+ V LI I
Sbjct: 121 GIP-------LIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKI 173
Query: 646 AKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVY 705
A + + + + T Y SPE + G +DIWS C++++++
Sbjct: 174 ADLGNACWYDEHYTNSIQTREYRSPEVLLGA---------PWGCGADIWSTACLIFELIT 224
Query: 706 GRTPF--------------------------------SEYKTFWAKFKVITDPNHEITYE 733
G F +Y + + + ++ +
Sbjct: 225 GDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFW 284
Query: 734 PVPN-------------PWLLDLMKKCLAWDRNERWRIPQLLQHPFLVPPVSTQPSSSQD 780
P+ + + D + L D +R L+ HP+L + + D
Sbjct: 285 PLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNHPWLKDTLGMEEIRVPD 344
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 77.9 bits (191), Expect = 5e-17
Identities = 34/221 (15%), Positives = 60/221 (27%), Gaps = 43/221 (19%)
Query: 479 KIGSGGSSEVHKVISSDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLID 538
+G G S V S +K K+ F + E + +++ +
Sbjct: 7 LMGEGKESAVFNCYSEKFGECVVKFHKVGHTS------FKKVKEKRDYGDLHFSVLAIRS 60
Query: 539 YEVTEKALLREVLNGSMNNKDGRVKDDGYIYMVLEYGEIDLAHMLSQKWKEMDGSNQTLD 598
+AL + L G + V + + L +
Sbjct: 61 ARNEFRALQK--LQGL------------AVPKVYAWEGNAVLMEL-----IDAKELYRVR 101
Query: 599 ENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLLVKGSLKLIDFGIAKAI--MSDTTNI 656
ILE V + IVH DL N L+ + + +IDF + + +
Sbjct: 102 VENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSEEGIWIIDFPQSVEVGEEGWREIL 161
Query: 657 QRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLG 697
+RD + + DI S
Sbjct: 162 ERDVRNIITYFSR----------------TYRTEKDINSAI 186
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 853 | |||
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.89 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.09 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.66 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.61 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 96.88 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 96.04 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 95.63 |
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-55 Score=467.34 Aligned_cols=261 Identities=22% Similarity=0.360 Sum_probs=212.8
Q ss_pred ceeeEEEeEeccCceEEEEEEe-cCCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHHHH
Q 003052 472 KLYQRLGKIGSGGSSEVHKVIS-SDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLREV 550 (853)
Q Consensus 472 ~~Y~ilk~LG~G~FG~Vyka~~-~~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~~l 550 (853)
++|+++++||+|+||+||+|++ .+++.||||++...... .....+.+|+++|++++ ||||++++++
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~-~~~~~~~~Ei~~l~~l~-HpnIv~~~~~----------- 71 (271)
T d1nvra_ 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV-DCPENIKKEICINKMLN-HENVVKFYGH----------- 71 (271)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--------CHHHHHHHHHTCC-CTTBCCEEEE-----------
T ss_pred cceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcc-hHHHHHHHHHHHHHhCC-CCCEeeEeee-----------
Confidence 4699999999999999999998 47899999999765432 23456889999999997 9999999987
Q ss_pred hhCCCCCCCCccccCCeEEEEEecch-hhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCCCc
Q 003052 551 LNGSMNNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPA 629 (853)
Q Consensus 551 ~~~~iv~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLKPe 629 (853)
+.+++.+||||||+. ++|.+++.. ...+++..++.|+.||+.||+|||++||+||||||+
T Consensus 72 -----------~~~~~~~~ivmEy~~gg~L~~~l~~--------~~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~ 132 (271)
T d1nvra_ 72 -----------RREGNIQYLFLEYCSGGELFDRIEP--------DIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPE 132 (271)
T ss_dssp -----------EEETTEEEEEEECCTTEEGGGGSBT--------TTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGG
T ss_pred -----------eccCceeEEEEeccCCCcHHHHHhc--------CCCCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHH
Confidence 566788999999987 488877753 357999999999999999999999999999999999
Q ss_pred cEEee-cCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHhCCC
Q 003052 630 NFLLV-KGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGRT 708 (853)
Q Consensus 630 NILL~-~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLtG~~ 708 (853)
||||+ ++.+||+|||+|+.+..........+.+||+.|||||++.+.. +++.++|||||||++|||++|++
T Consensus 133 NILl~~~~~~KL~DFG~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~--------~~~~~~DiwSlGvilyeml~G~~ 204 (271)
T d1nvra_ 133 NLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE--------FHAEPVDVWSCGIVLTAMLAGEL 204 (271)
T ss_dssp GEEECTTCCEEECCCTTCEECEETTEECCBCCCCSCGGGSCTHHHHCSS--------BCHHHHHHHHHHHHHHHHHHSSC
T ss_pred HEEECCCCCEEEccchhheeeccCCccccccceeeCcCccCHhHhcCCC--------CCCCceeeeHhHHHHHHHHhCCC
Confidence 99994 6799999999999765443333445789999999999998654 24578999999999999999999
Q ss_pred CCCcchhHHHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCCChhHHhcCCCCCCCCC
Q 003052 709 PFSEYKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQHPFLVPPVS 772 (853)
Q Consensus 709 PF~~~~~~~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~HPwf~~~~~ 772 (853)
||.........+..+.............++++++||.+||..||.+|||+.|+|+||||+.+..
T Consensus 205 pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hpwf~~~l~ 268 (271)
T d1nvra_ 205 PWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPLK 268 (271)
T ss_dssp SCSSSSTTSHHHHHHHTTCTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCCCC
T ss_pred CCCCCChHHHHHHHHhcCCCCCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCcCCC
Confidence 9976443333333333333333333457889999999999999999999999999999987654
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6e-54 Score=455.88 Aligned_cols=258 Identities=24% Similarity=0.398 Sum_probs=218.8
Q ss_pred cCceeeEEEeEeccCceEEEEEEec-CCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHH
Q 003052 470 NGKLYQRLGKIGSGGSSEVHKVISS-DCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLR 548 (853)
Q Consensus 470 ~g~~Y~ilk~LG~G~FG~Vyka~~~-~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~ 548 (853)
+|+.|++.++||+|+||+||+|++. ++..||+|++............+.+|+++|++++ |||||++++++...
T Consensus 7 ~gry~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~-HpnIv~~~~~~~~~----- 80 (270)
T d1t4ha_ 7 DGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQ-HPNIVRFYDSWEST----- 80 (270)
T ss_dssp TSCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCC-CTTBCCEEEEEEEE-----
T ss_pred CCCEEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCC-CCCeeeEEEEEeec-----
Confidence 3455688889999999999999984 6789999999877666666778999999999998 99999999975321
Q ss_pred HHhhCCCCCCCCccccCCeEEEEEecch-hhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCc--eeeCC
Q 003052 549 EVLNGSMNNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEER--IVHSD 625 (853)
Q Consensus 549 ~l~~~~iv~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~g--IIHRD 625 (853)
...+..+||||||++ ++|.+++.+. ..+++..++.|+.||+.||+|||++| |+|||
T Consensus 81 -------------~~~~~~~~ivmE~~~~g~L~~~l~~~--------~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrD 139 (270)
T d1t4ha_ 81 -------------VKGKKCIVLVTELMTSGTLKTYLKRF--------KVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRD 139 (270)
T ss_dssp -------------SSSCEEEEEEEECCCSCBHHHHHHHH--------SSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSC
T ss_pred -------------cccCCEEEEEEeCCCCCcHHHHHhcc--------ccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCC
Confidence 234567999999976 5999988765 57999999999999999999999998 99999
Q ss_pred CCCccEEee--cCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHH
Q 003052 626 LKPANFLLV--KGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQM 703 (853)
Q Consensus 626 LKPeNILL~--~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyEL 703 (853)
|||+||||+ ++.+||+|||+|+..... ...+.+||+.|||||++.+ .|+.++|||||||++|||
T Consensus 140 iKp~NILl~~~~~~~Kl~DFGla~~~~~~----~~~~~~GT~~Y~aPE~~~~----------~~~~~~DIwSlGvilyel 205 (270)
T d1t4ha_ 140 LKCDNIFITGPTGSVKIGDLGLATLKRAS----FAKAVIGTPEFMAPEMYEE----------KYDESVDVYAFGMCMLEM 205 (270)
T ss_dssp CCGGGEEESSTTSCEEECCTTGGGGCCTT----SBEESCSSCCCCCGGGGGT----------CCCTHHHHHHHHHHHHHH
T ss_pred cChhhceeeCCCCCEEEeecCcceeccCC----ccCCcccCccccCHHHhCC----------CCCCcCchhhHHHHHHHH
Confidence 999999994 469999999999864332 2236799999999999864 367899999999999999
Q ss_pred HhCCCCCCcchhHHHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCCChhHHhcCCCCC
Q 003052 704 VYGRTPFSEYKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQHPFLV 768 (853)
Q Consensus 704 LtG~~PF~~~~~~~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~HPwf~ 768 (853)
++|+.||.+........+.+........++...++++++||.+||.+||++|||+.|+|+||||+
T Consensus 206 ~~g~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~Hp~fk 270 (270)
T d1t4ha_ 206 ATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQ 270 (270)
T ss_dssp HHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC
T ss_pred HHCCCCCCCcccHHHHHHHHHcCCCCcccCccCCHHHHHHHHHHccCCHhHCcCHHHHhCCcccC
Confidence 99999998766666666666655555556667889999999999999999999999999999995
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.7e-54 Score=462.23 Aligned_cols=253 Identities=28% Similarity=0.482 Sum_probs=216.4
Q ss_pred ceeeEEEeEeccCceEEEEEEe-cCCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHHHH
Q 003052 472 KLYQRLGKIGSGGSSEVHKVIS-SDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLREV 550 (853)
Q Consensus 472 ~~Y~ilk~LG~G~FG~Vyka~~-~~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~~l 550 (853)
++|+++++||+|+||+||+|.+ .+++.||||+++..... ..+.+.+|+.+|++++ |||||+++++
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~--~~~~~~~E~~il~~l~-HpnIv~~~~~----------- 85 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP--KKELIINEILVMRENK-NPNIVNYLDS----------- 85 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCS--CHHHHHHHHHHHHHCC-CTTBCCEEEE-----------
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccCh--HHHHHHHHHHHHHhCC-CCCEeeEeEE-----------
Confidence 4599999999999999999998 57899999999865433 2456889999999997 8999999987
Q ss_pred hhCCCCCCCCccccCCeEEEEEecchh-hHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCCCc
Q 003052 551 LNGSMNNKDGRVKDDGYIYMVLEYGEI-DLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPA 629 (853)
Q Consensus 551 ~~~~iv~~~g~~~d~~~lyLVmEy~~g-dL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLKPe 629 (853)
|.+++++||||||+.+ +|.+++.. ..+++..++.|+.||+.||.|||++|||||||||+
T Consensus 86 -----------~~~~~~~~ivmEy~~gg~L~~~~~~---------~~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~ 145 (293)
T d1yhwa1 86 -----------YLVGDELWVVMEYLAGGSLTDVVTE---------TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSD 145 (293)
T ss_dssp -----------EEETTEEEEEEECCTTCBHHHHHHH---------SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGG
T ss_pred -----------EEECCEEEEEEEecCCCcHHHHhhc---------cCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHH
Confidence 5667789999999864 88876643 36999999999999999999999999999999999
Q ss_pred cEEe-ecCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHhCCC
Q 003052 630 NFLL-VKGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGRT 708 (853)
Q Consensus 630 NILL-~~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLtG~~ 708 (853)
|||+ .+|.+||+|||+|+.+..... .....+||+.|||||++.+. .|+.++|||||||++|+|++|++
T Consensus 146 NILl~~~~~vkl~DFG~a~~~~~~~~--~~~~~~gt~~Y~aPE~~~~~---------~~~~~~DiwSlGvilyemltG~~ 214 (293)
T d1yhwa1 146 NILLGMDGSVKLTDFGFCAQITPEQS--KRSTMVGTPYWMAPEVVTRK---------AYGPKVDIWSLGIMAIEMIEGEP 214 (293)
T ss_dssp GEEECTTCCEEECCCTTCEECCSTTC--CBCCCCSCGGGCCHHHHSSS---------CBCTHHHHHHHHHHHHHHHHSSC
T ss_pred HeEECCCCcEeeccchhheeeccccc--cccccccCCCccChhhhcCC---------CCCchhceehHhHHHHHHhhCCC
Confidence 9999 567999999999987654322 33467899999999999765 36789999999999999999999
Q ss_pred CCCcchhHHHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCCChhHHhcCCCCCC
Q 003052 709 PFSEYKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQHPFLVP 769 (853)
Q Consensus 709 PF~~~~~~~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~HPwf~~ 769 (853)
||.+.........+.......+..+...++.+++||.+||..||.+|||+.|+|+||||+.
T Consensus 215 Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~Hp~~~~ 275 (293)
T d1yhwa1 215 PYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKI 275 (293)
T ss_dssp TTTTSCHHHHHHHHHHHCSCCCSSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTTCGGGGG
T ss_pred CCCCCCHHHHHHHHHhCCCCCCCCcccCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhCC
Confidence 9988766666666555545555566678899999999999999999999999999999964
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-53 Score=456.04 Aligned_cols=260 Identities=28% Similarity=0.490 Sum_probs=217.9
Q ss_pred ceeeEEEeEeccCceEEEEEEe-cCCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHHHH
Q 003052 472 KLYQRLGKIGSGGSSEVHKVIS-SDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLREV 550 (853)
Q Consensus 472 ~~Y~ilk~LG~G~FG~Vyka~~-~~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~~l 550 (853)
+.|++++.||+|+||+||+|++ .+++.||||+++.... .....+.+|+++|++|+ |||||+++++
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~--~~~~~~~~E~~il~~l~-HpnIv~l~~~----------- 77 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSE--EELEDYMVEIDILASCD-HPNIVKLLDA----------- 77 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSS--GGGGGTHHHHHHHHHCC-CTTBCCEEEE-----------
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCH--HHHHHHHHHHHHHHhCC-CCCCCeEEEE-----------
Confidence 5699999999999999999998 4778999999986533 34567899999999997 8999999987
Q ss_pred hhCCCCCCCCccccCCeEEEEEecch-hhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCCCc
Q 003052 551 LNGSMNNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPA 629 (853)
Q Consensus 551 ~~~~iv~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLKPe 629 (853)
+.+++.+||||||+. ++|.+++.+. ...+++..++.|+.||+.||.|||++||+||||||+
T Consensus 78 -----------~~~~~~~~lvmEy~~~g~L~~~~~~~-------~~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~ 139 (288)
T d2jfla1 78 -----------FYYENNLWILIEFCAGGAVDAVMLEL-------ERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAG 139 (288)
T ss_dssp -----------EEETTEEEEEEECCTTEEHHHHHHHH-------TSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGG
T ss_pred -----------EeeCCeEEEEEecCCCCcHHHHHHhc-------CCCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChh
Confidence 556788999999986 5888877653 257999999999999999999999999999999999
Q ss_pred cEEee-cCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHhCCC
Q 003052 630 NFLLV-KGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGRT 708 (853)
Q Consensus 630 NILL~-~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLtG~~ 708 (853)
||||+ +|.+||+|||+|+...... ....+.+||+.|||||++.+.... ...|+.++|||||||++|||++|++
T Consensus 140 NIll~~~~~~Kl~DFG~a~~~~~~~--~~~~~~~Gt~~y~APE~l~~~~~~----~~~y~~k~DiwSlGvilyemltg~~ 213 (288)
T d2jfla1 140 NILFTLDGDIKLADFGVSAKNTRTI--QRRDSFIGTPYWMAPEVVMCETSK----DRPYDYKADVWSLGITLIEMAEIEP 213 (288)
T ss_dssp GEEECTTSCEEECCCTTCEECHHHH--HHHTCCCSCCTTCCHHHHTTCSTT----TSSTTTHHHHHHHHHHHHHHHHSSC
T ss_pred heeECCCCCEEEEechhhhccCCCc--ccccccccccccCCHHHHhhcccC----CCCCChhhhHHHHHHHHHHHhhCCC
Confidence 99994 6799999999997654321 123467999999999999754322 1257899999999999999999999
Q ss_pred CCCcchhHHHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCCChhHHhcCCCCCC
Q 003052 709 PFSEYKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQHPFLVP 769 (853)
Q Consensus 709 PF~~~~~~~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~HPwf~~ 769 (853)
||.+.........+.......+..+...++++++||.+||+.||.+|||+.|+|+||||+.
T Consensus 214 Pf~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~hp~~~~ 274 (288)
T d2jfla1 214 PHHELNPMRVLLKIAKSEPPTLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQHPFVTV 274 (288)
T ss_dssp TTTTSCGGGHHHHHHHSCCCCCSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGCC
T ss_pred CCCCCCHHHHHHHHHcCCCCCCCccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCC
Confidence 9987666555555555444445556678899999999999999999999999999999974
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-53 Score=451.25 Aligned_cols=251 Identities=27% Similarity=0.440 Sum_probs=212.0
Q ss_pred ceeeEEEeEeccCceEEEEEEec-CCcEEEEEEEecCCC-ChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHHH
Q 003052 472 KLYQRLGKIGSGGSSEVHKVISS-DCTIYALKKIKLKGR-DYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLRE 549 (853)
Q Consensus 472 ~~Y~ilk~LG~G~FG~Vyka~~~-~g~~vAVKkik~~~~-~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~~ 549 (853)
++|++++.||+|+||+||+|+++ +++.||||++.+... +......+.+|+++|++++ ||||++++++
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~-hpnIv~~~~~---------- 74 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR-HPNILRLYGY---------- 74 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCC-CTTBCCEEEE----------
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcC-CCCCCeEEEE----------
Confidence 46999999999999999999984 678999999975432 2233456889999999997 9999999987
Q ss_pred HhhCCCCCCCCccccCCeEEEEEecch-hhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCCC
Q 003052 550 VLNGSMNNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKP 628 (853)
Q Consensus 550 l~~~~iv~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLKP 628 (853)
+.+++.+||||||++ ++|.+++... ..+++..++.|+.||+.||+|||++||+||||||
T Consensus 75 ------------~~~~~~~~ivmEy~~~g~L~~~l~~~--------~~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp 134 (263)
T d2j4za1 75 ------------FHDATRVYLILEYAPLGTVYRELQKL--------SKFDEQRTATYITELANALSYCHSKRVIHRDIKP 134 (263)
T ss_dssp ------------EECSSEEEEEEECCTTCBHHHHHHHH--------SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCG
T ss_pred ------------EEECCEEEEEEeecCCCcHHHHHhhc--------CCCCHHHHHHHHHHHHHHHHHHHHCCeeeeeecc
Confidence 567789999999987 5999988764 5799999999999999999999999999999999
Q ss_pred ccEEee-cCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHhCC
Q 003052 629 ANFLLV-KGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGR 707 (853)
Q Consensus 629 eNILL~-~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLtG~ 707 (853)
+||||+ +|.+||+|||+|+...... ....+||+.|||||++.+.. |+.++|||||||+||+|++|+
T Consensus 135 ~Nill~~~~~~kl~DFG~a~~~~~~~----~~~~~Gt~~Y~APE~~~~~~---------~~~~~DiwSlGvilyell~G~ 201 (263)
T d2j4za1 135 ENLLLGSAGELKIADFGWSVHAPSSR----RTTLCGTLDYLPPEMIEGRM---------HDEKVDLWSLGVLCYEFLVGK 201 (263)
T ss_dssp GGEEECTTSCEEECCCCSCSCCCCCC----CEETTEEGGGCCHHHHTTCC---------CCTTHHHHHHHHHHHHHHHSS
T ss_pred ccceecCCCCEeecccceeeecCCCc----ccccCCCCcccCHHHHcCCC---------CCchhhhhhHhHHHHHHhcCC
Confidence 999994 6799999999998664322 23678999999999998753 568999999999999999999
Q ss_pred CCCCcchhHHHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCCChhHHhcCCCCCC
Q 003052 708 TPFSEYKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQHPFLVP 769 (853)
Q Consensus 708 ~PF~~~~~~~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~HPwf~~ 769 (853)
+||.+...... +..+.. ....++...++++++||.+||+.||.+|||+.|+|+||||..
T Consensus 202 ~Pf~~~~~~~~-~~~i~~--~~~~~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~hp~~~~ 260 (263)
T d2j4za1 202 PPFEANTYQET-YKRISR--VEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITA 260 (263)
T ss_dssp CTTCCSSHHHH-HHHHHT--TCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTCHHHHH
T ss_pred CCCCCCCHHHH-HHHHHc--CCCCCCccCCHHHHHHHHHHccCCHhHCcCHHHHHcCcCcCC
Confidence 99987554433 333332 234456678999999999999999999999999999999963
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-53 Score=449.01 Aligned_cols=258 Identities=30% Similarity=0.439 Sum_probs=203.8
Q ss_pred ceeeEEEeEeccCceEEEEEEe-cCCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHHHH
Q 003052 472 KLYQRLGKIGSGGSSEVHKVIS-SDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLREV 550 (853)
Q Consensus 472 ~~Y~ilk~LG~G~FG~Vyka~~-~~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~~l 550 (853)
++|++++.||+|+||+||+|++ .+++.||||++............+.+|+++|++++ ||||+++++++..
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~-HpnIv~~~~~~~~-------- 74 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELK-HPNIVRYYDRIID-------- 74 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCC-CTTBCCEEEEEEC--------
T ss_pred hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCC-CCCEeeEEEEEEe--------
Confidence 4699999999999999999998 57899999999887766667778999999999997 9999999997432
Q ss_pred hhCCCCCCCCccccCCeEEEEEecch-hhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCc-----eeeC
Q 003052 551 LNGSMNNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEER-----IVHS 624 (853)
Q Consensus 551 ~~~~iv~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~g-----IIHR 624 (853)
..++.+||||||+. ++|.+++.+..+ .+..+++..++.|+.||+.||.|||++| ||||
T Consensus 75 ------------~~~~~~~ivmEy~~~g~L~~~i~~~~~----~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHr 138 (269)
T d2java1 75 ------------RTNTTLYIVMEYCEGGDLASVITKGTK----ERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHR 138 (269)
T ss_dssp ----------------CEEEEEECCTTEEHHHHHHHHHH----HTCCCCHHHHHHHHHHHHHHHHHHHHHCC--------
T ss_pred ------------CCCCEEEEEEecCCCCcHHHHHHhccc----cCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeC
Confidence 23457899999986 599998876533 2357999999999999999999999876 9999
Q ss_pred CCCCccEEe-ecCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHH
Q 003052 625 DLKPANFLL-VKGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQM 703 (853)
Q Consensus 625 DLKPeNILL-~~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyEL 703 (853)
||||+|||| .+|.+||+|||+|+.+..... .....+||+.|||||++.+. .|+.++|||||||++|||
T Consensus 139 DiKp~NIll~~~~~vkl~DFG~a~~~~~~~~--~~~~~~gt~~Y~APE~l~~~---------~~~~~~DIwSlGvilyel 207 (269)
T d2java1 139 DLKPANVFLDGKQNVKLGDFGLARILNHDTS--FAKAFVGTPYYMSPEQMNRM---------SYNEKSDIWSLGCLLYEL 207 (269)
T ss_dssp -CCGGGEEECTTSCEEECCHHHHHHC-------------CCCSCCCHHHHTTC---------CCCHHHHHHHHHHHHHHH
T ss_pred cCchhhcCcCCCCcEEEeeccceeecccCCC--ccccCCCCcccCCHHHHcCC---------CCChHHHHHhhCHHHHHH
Confidence 999999999 467999999999998754322 23467999999999999765 367899999999999999
Q ss_pred HhCCCCCCcchhHHHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCCChhHHhcCCCC
Q 003052 704 VYGRTPFSEYKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQHPFL 767 (853)
Q Consensus 704 LtG~~PF~~~~~~~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~HPwf 767 (853)
++|+.||.+.........+..... ...+...++++++||.+||..||.+|||+.|||+|||+
T Consensus 208 ~tg~~Pf~~~~~~~~~~~i~~~~~--~~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~hp~i 269 (269)
T d2java1 208 CALMPPFTAFSQKELAGKIREGKF--RRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLI 269 (269)
T ss_dssp HHSSCSCCCSSHHHHHHHHHHTCC--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred hhCCCCCCCCCHHHHHHHHHcCCC--CCCCcccCHHHHHHHHHHcCCChhHCcCHHHHHhCCcC
Confidence 999999987655433333333221 23455678999999999999999999999999999996
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.9e-53 Score=453.00 Aligned_cols=255 Identities=29% Similarity=0.461 Sum_probs=210.4
Q ss_pred ceeeEEEeEeccCceEEEEEEe-cCCcEEEEEEEecCCC-ChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHHH
Q 003052 472 KLYQRLGKIGSGGSSEVHKVIS-SDCTIYALKKIKLKGR-DYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLRE 549 (853)
Q Consensus 472 ~~Y~ilk~LG~G~FG~Vyka~~-~~g~~vAVKkik~~~~-~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~~ 549 (853)
++|++++.||+|+||+||+|.+ .+++.||||++.+... .......+.+|+++|++++ ||||++++++
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~-HpnIv~l~~~---------- 76 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLD-HPFFVKLYFT---------- 76 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCC-STTBCCEEEE----------
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcC-CCCeeEEEEE----------
Confidence 4599999999999999999998 5789999999975432 2233456889999999997 8999999987
Q ss_pred HhhCCCCCCCCccccCCeEEEEEecch-hhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCCC
Q 003052 550 VLNGSMNNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKP 628 (853)
Q Consensus 550 l~~~~iv~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLKP 628 (853)
|.+++.+||||||+. ++|.+++... +.+++..++.++.||+.||.|||++|||||||||
T Consensus 77 ------------~~~~~~~~ivmEy~~gg~L~~~~~~~--------~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp 136 (288)
T d1uu3a_ 77 ------------FQDDEKLYFGLSYAKNGELLKYIRKI--------GSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKP 136 (288)
T ss_dssp ------------EECSSEEEEEECCCTTEEHHHHHHHH--------SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSG
T ss_pred ------------EEECCEEEEEEEccCCCCHHHhhhcc--------CCCCHHHHHHHHHHHHHHHHhhccccEEcCcCCc
Confidence 567789999999987 5999888765 5799999999999999999999999999999999
Q ss_pred ccEEe-ecCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHhCC
Q 003052 629 ANFLL-VKGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGR 707 (853)
Q Consensus 629 eNILL-~~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLtG~ 707 (853)
+|||+ .+|.+||+|||+|+.+..........+.+||+.|||||++.+.. |+.++|||||||+||||++|+
T Consensus 137 ~NIll~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~---------~~~~~DiwSlGvilyell~g~ 207 (288)
T d1uu3a_ 137 ENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKS---------ACKSSDLWALGCIIYQLVAGL 207 (288)
T ss_dssp GGEEECTTSCEEECCCTTCEECC----------CCCCGGGCCHHHHHTCC---------CCHHHHHHHHHHHHHHHHHSS
T ss_pred cccccCCCceEEecccccceecccCCcccccccccCCccccCceeeccCC---------CCcccceehhhHHHHHHhhCC
Confidence 99999 46799999999998775443333445678999999999998763 568999999999999999999
Q ss_pred CCCCcchhHHHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCCChhH------HhcCCCCCC
Q 003052 708 TPFSEYKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQ------LLQHPFLVP 769 (853)
Q Consensus 708 ~PF~~~~~~~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~E------IL~HPwf~~ 769 (853)
.||.+.+......++.. ....++...++++++||.+||++||.+|||++| |++||||..
T Consensus 208 ~Pf~~~~~~~~~~~i~~---~~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~~~~i~~Hpff~~ 272 (288)
T d1uu3a_ 208 PPFRAGNEYLIFQKIIK---LEYDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFES 272 (288)
T ss_dssp CSSCCSSHHHHHHHHHT---TCCCCCTTCCHHHHHHHHTTSCSSGGGSTTSGGGTCHHHHHTSGGGTT
T ss_pred CCCCCcCHHHHHHHHHc---CCCCCCccCCHHHHHHHHHHccCCHhHCcCHHHHcCCHHHHcCCccCC
Confidence 99987655444333332 233456778999999999999999999999998 588999975
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.7e-53 Score=458.74 Aligned_cols=256 Identities=27% Similarity=0.404 Sum_probs=206.4
Q ss_pred EcCceeeEEEeEeccCceEEEEEEe-cCCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHH
Q 003052 469 VNGKLYQRLGKIGSGGSSEVHKVIS-SDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALL 547 (853)
Q Consensus 469 v~g~~Y~ilk~LG~G~FG~Vyka~~-~~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL 547 (853)
+..++|+++++||+|+||+||+|++ .+++.||+|+++.... ......+.+|+.+|++++ |||||+++++
T Consensus 3 l~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~-~~~~~~~~~Ei~il~~l~-HpnIv~l~~~-------- 72 (322)
T d1s9ja_ 3 LKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIK-PAIRNQIIRELQVLHECN-SPYIVGFYGA-------- 72 (322)
T ss_dssp CCGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCC-TTHHHHHHHHGGGGGGCC-CTTBCCEEEE--------
T ss_pred CCccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhC-HHHHHHHHHHHHHHHhCC-CCCCCcEEEE--------
Confidence 3457799999999999999999998 4778999999986543 344567889999999997 8999999987
Q ss_pred HHHhhCCCCCCCCccccCCeEEEEEecch-hhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhccc-CceeeCC
Q 003052 548 REVLNGSMNNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHE-ERIVHSD 625 (853)
Q Consensus 548 ~~l~~~~iv~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs-~gIIHRD 625 (853)
|.+++.+||||||+. ++|.+++.+. +.+++..++.++.||+.||.|||+ +||+|||
T Consensus 73 --------------~~~~~~~~iVmEy~~gg~L~~~l~~~--------~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRD 130 (322)
T d1s9ja_ 73 --------------FYSDGEISICMEHMDGGSLDQVLKKA--------GRIPEQILGKVSIAVIKGLTYLREKHKIMHRD 130 (322)
T ss_dssp --------------EECSSEEEEEEECCTTEEHHHHHHHH--------SSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSC
T ss_pred --------------EEECCEEEEEEEcCCCCcHHHHHhhc--------CCCCHHHHHHHHHHHHHHHHHHHHhCCEEccc
Confidence 567788999999977 4999988764 569999999999999999999997 5999999
Q ss_pred CCCccEEe-ecCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHH
Q 003052 626 LKPANFLL-VKGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMV 704 (853)
Q Consensus 626 LKPeNILL-~~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELL 704 (853)
|||+|||| .+|.+||+|||+|+.+.... ..+.+||+.|||||++.+. .|+.++|||||||++|||+
T Consensus 131 iKP~NILl~~~~~vkl~DFGla~~~~~~~----~~~~~GT~~Y~APEvl~~~---------~y~~~~DiWSlGvil~ell 197 (322)
T d1s9ja_ 131 VKPSNILVNSRGEIKLCDFGVSGQLIDSM----ANSFVGTRSYMSPERLQGT---------HYSVQSDIWSMGLSLVEMA 197 (322)
T ss_dssp CSGGGEEECTTCCEEECCCCCCHHHHHHT----C---CCSSCCCCHHHHHCS---------CCCTTHHHHHHHHHHHHHH
T ss_pred cCHHHeeECCCCCEEEeeCCCccccCCCc----cccccCCccccCchHHcCC---------CCCcHHHHHHHHHHHHHHH
Confidence 99999999 57899999999999765322 2367999999999999875 3678999999999999999
Q ss_pred hCCCCCCcchhHHH--H---------------------------------------HHhhcCCCCcccCCCCCChhHHHH
Q 003052 705 YGRTPFSEYKTFWA--K---------------------------------------FKVITDPNHEITYEPVPNPWLLDL 743 (853)
Q Consensus 705 tG~~PF~~~~~~~~--~---------------------------------------~kii~~~~~~~~~~~~~s~~l~dL 743 (853)
+|+.||.+.+.... . ...+.............+.++++|
T Consensus 198 ~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dl 277 (322)
T d1s9ja_ 198 VGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDF 277 (322)
T ss_dssp HSSCCSSCCCTTHHHHHC------------------------------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHH
T ss_pred HCCCCCCCCCHHHHHHHHHHHhcCCcccCCcccccccccccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHH
Confidence 99999964321110 0 000000000111112357889999
Q ss_pred HHHhcccCCCCCCChhHHhcCCCCCC
Q 003052 744 MKKCLAWDRNERWRIPQLLQHPFLVP 769 (853)
Q Consensus 744 I~kcL~~DP~kRpTa~EIL~HPwf~~ 769 (853)
|.+||.+||.+|||++|+|+||||+.
T Consensus 278 i~~~L~~dP~~R~ta~e~L~Hpf~~~ 303 (322)
T d1s9ja_ 278 VNKCLIKNPAERADLKQLMVHAFIKR 303 (322)
T ss_dssp HHHHTCSSTTTSCCHHHHHTSHHHHH
T ss_pred HHHHcCCChhHCcCHHHHhhCHhhCc
Confidence 99999999999999999999999964
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2e-52 Score=451.85 Aligned_cols=256 Identities=25% Similarity=0.378 Sum_probs=197.4
Q ss_pred ceeeEEEeEeccCceEEEEEEec-CCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHHHH
Q 003052 472 KLYQRLGKIGSGGSSEVHKVISS-DCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLREV 550 (853)
Q Consensus 472 ~~Y~ilk~LG~G~FG~Vyka~~~-~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~~l 550 (853)
+.|++++.||+|+||+||+|++. +++.||||++....... ....+.+|+.+|++++ ||||++++++
T Consensus 9 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~-~~~~~~~Ei~il~~l~-HpnIv~l~~~----------- 75 (307)
T d1a06a_ 9 DIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEG-KEGSMENEIAVLHKIK-HPNIVALDDI----------- 75 (307)
T ss_dssp GTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC-----------CHHHHHHHTCC-CTTBCCEEEE-----------
T ss_pred cceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhh-HHHHHHHHHHHHHhCC-CCCCCcEEEE-----------
Confidence 45999999999999999999984 67899999998654332 2345789999999997 8999999987
Q ss_pred hhCCCCCCCCccccCCeEEEEEecch-hhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCCCc
Q 003052 551 LNGSMNNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPA 629 (853)
Q Consensus 551 ~~~~iv~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLKPe 629 (853)
+.+++++||||||+. ++|.+++... +.+++..++.|+.||+.||+|||++||+||||||+
T Consensus 76 -----------~~~~~~~~lvmE~~~gg~L~~~l~~~--------~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~ 136 (307)
T d1a06a_ 76 -----------YESGGHLYLIMQLVSGGELFDRIVEK--------GFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPE 136 (307)
T ss_dssp -----------EECSSEEEEEECCCCSCBHHHHHHTC--------SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGG
T ss_pred -----------EEECCEEEEEEeccCCCcHHHhhhcc--------cCCCHHHHHHHHHHHHHHHHhhhhceeeeEEeccc
Confidence 567789999999987 6999988653 67999999999999999999999999999999999
Q ss_pred cEEee----cCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHh
Q 003052 630 NFLLV----KGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVY 705 (853)
Q Consensus 630 NILL~----~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLt 705 (853)
|||+. ++.+||+|||+|+...... ...+.+||+.|||||++.+.. |+.++|||||||+||||++
T Consensus 137 Nil~~~~~~~~~vkl~DFG~a~~~~~~~---~~~~~~GT~~y~APE~~~~~~---------~~~~~DiwSlGvilyell~ 204 (307)
T d1a06a_ 137 NLLYYSLDEDSKIMISDFGLSKMEDPGS---VLSTACGTPGYVAPEVLAQKP---------YSKAVDCWSIGVIAYILLC 204 (307)
T ss_dssp GEEESSSSTTCCEEECCC---------------------CTTSCHHHHTTCC---------CCTHHHHHHHHHHHHHHHH
T ss_pred ceeecccCCCceEEEeccceeEEccCCC---eeeeeeeCccccCcHHHcCCC---------CCcHHHhhhhhHHHHHHHh
Confidence 99993 4689999999998764322 234678999999999997653 5689999999999999999
Q ss_pred CCCCCCcchhHHHHHHhhcCC-CCcccCCCCCChhHHHHHHHhcccCCCCCCChhHHhcCCCCCCCC
Q 003052 706 GRTPFSEYKTFWAKFKVITDP-NHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQHPFLVPPV 771 (853)
Q Consensus 706 G~~PF~~~~~~~~~~kii~~~-~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~HPwf~~~~ 771 (853)
|++||.+.........+.... ..........++++++||.+||.+||.+|||+.|+|+||||....
T Consensus 205 g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~ 271 (307)
T d1a06a_ 205 GYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQHPWIAGDT 271 (307)
T ss_dssp SSCSCCCSSHHHHHHHHHTTCCCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTTSSC
T ss_pred CCCCCCCCCHHHHHHHHhccCCCCCCccccCCCHHHHHHHHHHccCCHhHCcCHHHHhcCHhhCCCC
Confidence 999998765544333333321 222234456789999999999999999999999999999998643
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.8e-52 Score=452.79 Aligned_cols=256 Identities=23% Similarity=0.382 Sum_probs=212.8
Q ss_pred ceeeEEEeEeccCceEEEEEEe-cCCcEEEEEEEecCCC-ChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHHH
Q 003052 472 KLYQRLGKIGSGGSSEVHKVIS-SDCTIYALKKIKLKGR-DYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLRE 549 (853)
Q Consensus 472 ~~Y~ilk~LG~G~FG~Vyka~~-~~g~~vAVKkik~~~~-~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~~ 549 (853)
+.|+++++||+|+||+||+|++ .+++.||||++..... .......+.+|+++|++|+ |||||+++++
T Consensus 15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~~~~~---------- 83 (309)
T d1u5ra_ 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR-HPNTIQYRGC---------- 83 (309)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCC-CTTBCCEEEE----------
T ss_pred HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCC-CCCEeeEEEE----------
Confidence 4699999999999999999998 5778999999987654 3345567899999999997 9999999987
Q ss_pred HhhCCCCCCCCccccCCeEEEEEecchhhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCCCc
Q 003052 550 VLNGSMNNKDGRVKDDGYIYMVLEYGEIDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPA 629 (853)
Q Consensus 550 l~~~~iv~~~g~~~d~~~lyLVmEy~~gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLKPe 629 (853)
+.+++.+|||||||.+++.+.+... ...+++..++.|+.||+.||.|||++|||||||||+
T Consensus 84 ------------~~~~~~~~iv~E~~~~g~l~~~~~~-------~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~ 144 (309)
T d1u5ra_ 84 ------------YLREHTAWLVMEYCLGSASDLLEVH-------KKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAG 144 (309)
T ss_dssp ------------EEETTEEEEEEECCSEEHHHHHHHH-------TSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGG
T ss_pred ------------EEECCEEEEEEEecCCCchHHHHHh-------CCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcc
Confidence 4567789999999876444433322 257999999999999999999999999999999999
Q ss_pred cEEee-cCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHhCCC
Q 003052 630 NFLLV-KGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGRT 708 (853)
Q Consensus 630 NILL~-~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLtG~~ 708 (853)
||||+ ++.+||+|||+|+.... ....+||+.|||||++.+.... .|+.++|||||||++|||++|+.
T Consensus 145 NILl~~~~~~Kl~DFG~a~~~~~------~~~~~GT~~Y~APE~~~~~~~~------~y~~~~DiwSlGvilyel~~g~~ 212 (309)
T d1u5ra_ 145 NILLSEPGLVKLGDFGSASIMAP------ANSFVGTPYWMAPEVILAMDEG------QYDGKVDVWSLGITCIELAERKP 212 (309)
T ss_dssp GEEEETTTEEEECCCTTCBSSSS------BCCCCSCGGGCCHHHHTTTTSC------CBCTHHHHHHHHHHHHHHHHSSC
T ss_pred eEEECCCCCEEEeecccccccCC------CCccccCccccCHHHHhccCCC------CcCchhhhhhHHHHHHHHHHCCC
Confidence 99995 67999999999986532 2356899999999999764322 47889999999999999999999
Q ss_pred CCCcchhHHHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCCChhHHhcCCCCCCC
Q 003052 709 PFSEYKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQHPFLVPP 770 (853)
Q Consensus 709 PF~~~~~~~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~HPwf~~~ 770 (853)
||.+.........+...... .......++++++||.+||.+||.+|||+.|+|+||||...
T Consensus 213 Pf~~~~~~~~~~~i~~~~~~-~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~Hp~~~~~ 273 (309)
T d1u5ra_ 213 PLFNMNAMSALYHIAQNESP-ALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRE 273 (309)
T ss_dssp TTTTSCHHHHHHHHHHSCCC-CCSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHHSC
T ss_pred CCCCCCHHHHHHHHHhCCCC-CCCCCCCCHHHHHHHHHHCcCChhHCcCHHHHHhCHHhcCC
Confidence 99887666555555543322 22345678999999999999999999999999999999754
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-51 Score=440.52 Aligned_cols=256 Identities=28% Similarity=0.421 Sum_probs=212.5
Q ss_pred ceeeEEEeEeccCceEEEEEEe-cCCcEEEEEEEecCCCC----hhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHH
Q 003052 472 KLYQRLGKIGSGGSSEVHKVIS-SDCTIYALKKIKLKGRD----YATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKAL 546 (853)
Q Consensus 472 ~~Y~ilk~LG~G~FG~Vyka~~-~~g~~vAVKkik~~~~~----~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~i 546 (853)
++|++++.||+|+||+||+|++ .+|+.||||++++.... ......+.+|+.+|++|+ |||||+++++
T Consensus 10 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~-HpnIv~~~~~------- 81 (293)
T d1jksa_ 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ-HPNVITLHEV------- 81 (293)
T ss_dssp GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCC-CTTBCCEEEE-------
T ss_pred cCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCC-CCCCCcEEEE-------
Confidence 5699999999999999999998 57899999999765332 223457889999999997 8999999987
Q ss_pred HHHHhhCCCCCCCCccccCCeEEEEEecch-hhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCC
Q 003052 547 LREVLNGSMNNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSD 625 (853)
Q Consensus 547 L~~l~~~~iv~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRD 625 (853)
|.+++.+||||||+. ++|.+++... +.+++..++.|+.||+.||+|||++||+|||
T Consensus 82 ---------------~~~~~~~~iv~E~~~gg~L~~~i~~~--------~~l~~~~~~~~~~qi~~al~yLH~~~ivHrD 138 (293)
T d1jksa_ 82 ---------------YENKTDVILILELVAGGELFDFLAEK--------ESLTEEEATEFLKQILNGVYYLHSLQIAHFD 138 (293)
T ss_dssp ---------------EECSSEEEEEEECCCSCBHHHHHHHH--------SSCCHHHHHHHHHHHHHHHHHHHHTTEECCC
T ss_pred ---------------EEECCEEEEEEEcCCCccccchhccc--------cccchhHHHHHHHHHHHHHHhhhhcceeecc
Confidence 567889999999986 5999998765 5799999999999999999999999999999
Q ss_pred CCCccEEee-cC----cEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHH
Q 003052 626 LKPANFLLV-KG----SLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCIL 700 (853)
Q Consensus 626 LKPeNILL~-~g----~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVIL 700 (853)
|||+|||++ +| .+||+|||+|+...... ...+.+||+.|||||++.+. .|+.++|||||||++
T Consensus 139 iKp~Nill~~~~~~~~~vkl~DfG~a~~~~~~~---~~~~~~~t~~y~APE~~~~~---------~~~~~~DiwSlGvil 206 (293)
T d1jksa_ 139 LKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGN---EFKNIFGTPEFVAPEIVNYE---------PLGLEADMWSIGVIT 206 (293)
T ss_dssp CSGGGEEESCSSSSSCCEEECCCTTCEECTTSC---BCSCCCCCGGGCCHHHHTTC---------CBCTHHHHHHHHHHH
T ss_pred cccceEEEecCCCcccceEecchhhhhhcCCCc---cccccCCCCcccCHHHHcCC---------CCCCcccchhhhHHH
Confidence 999999994 33 59999999998764332 23467899999999999765 367899999999999
Q ss_pred HHHHhCCCCCCcchhHHHHHHhhcCC-CCcccCCCCCChhHHHHHHHhcccCCCCCCChhHHhcCCCCCCC
Q 003052 701 YQMVYGRTPFSEYKTFWAKFKVITDP-NHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQHPFLVPP 770 (853)
Q Consensus 701 yELLtG~~PF~~~~~~~~~~kii~~~-~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~HPwf~~~ 770 (853)
|||++|+.||.+.........+.... ..........++++++||.+||..||.+|||+.|+|+||||+..
T Consensus 207 yell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~ 277 (293)
T d1jksa_ 207 YILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPK 277 (293)
T ss_dssp HHHHHSSCSSCCSSHHHHHHHHHTTCCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTCC-
T ss_pred HHHHcCCCCCCCCCHHHHHHHHHhcCCCCCchhcCCCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCC
Confidence 99999999998765544333333221 11222345678899999999999999999999999999999753
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-51 Score=452.08 Aligned_cols=253 Identities=25% Similarity=0.408 Sum_probs=214.4
Q ss_pred ceeeEEEeEeccCceEEEEEEe-cCCcEEEEEEEecCCC-ChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHHH
Q 003052 472 KLYQRLGKIGSGGSSEVHKVIS-SDCTIYALKKIKLKGR-DYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLRE 549 (853)
Q Consensus 472 ~~Y~ilk~LG~G~FG~Vyka~~-~~g~~vAVKkik~~~~-~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~~ 549 (853)
++|++++.||+|+||.||+|++ .+++.||||++++... .......+.+|+.+|++++ ||||++++++
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~-hp~Iv~l~~~---------- 73 (337)
T d1o6la_ 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTR-HPFLTALKYA---------- 73 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCC-CTTBCCEEEE----------
T ss_pred HhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCC-CCCEEEEEee----------
Confidence 5699999999999999999998 5789999999976432 2233456889999999997 9999999987
Q ss_pred HhhCCCCCCCCccccCCeEEEEEecch-hhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCCC
Q 003052 550 VLNGSMNNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKP 628 (853)
Q Consensus 550 l~~~~iv~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLKP 628 (853)
|+++.++|+||||+. ++|..++... +.++|..++.|+.||+.||+|||++|||||||||
T Consensus 74 ------------~~~~~~~~iv~ey~~gg~L~~~~~~~--------~~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP 133 (337)
T d1o6la_ 74 ------------FQTHDRLCFVMEYANGGELFFHLSRE--------RVFTEERARFYGAEIVSALEYLHSRDVVYRDIKL 133 (337)
T ss_dssp ------------EECSSEEEEEEECCTTCBHHHHHHHH--------SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCG
T ss_pred ------------eccccccccceeccCCCchhhhhhcc--------cCCcHHHHHHHHHHHhhhhhhhhhcCccccccCH
Confidence 677889999999977 5898888765 6799999999999999999999999999999999
Q ss_pred ccEEe-ecCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHhCC
Q 003052 629 ANFLL-VKGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGR 707 (853)
Q Consensus 629 eNILL-~~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLtG~ 707 (853)
+|||| .+|.+||+|||+|+....... ...+.+||+.|||||++.+.. |+.++|||||||++|||++|+
T Consensus 134 ~NILl~~~g~vkl~DFG~a~~~~~~~~--~~~~~~GT~~Y~aPE~~~~~~---------y~~~~DiwSlGvilyeml~G~ 202 (337)
T d1o6la_ 134 ENLMLDKDGHIKITDFGLCKEGISDGA--TMKTFCGTPEYLAPEVLEDND---------YGRAVDWWGLGVVMYEMMCGR 202 (337)
T ss_dssp GGEEECTTSCEEECCCTTCBCSCCTTC--CBCCCEECGGGCCGGGGSSSC---------BCTTHHHHHHHHHHHHHHHSS
T ss_pred HHeEecCCCCEEEeecccccccccCCc--ccccceeCHHHhhhhhccCCC---------CChhhcccchhhHHHHHHHCC
Confidence 99999 468999999999987644322 334789999999999997763 678999999999999999999
Q ss_pred CCCCcchhHHHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCCC-----hhHHhcCCCCCC
Q 003052 708 TPFSEYKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWR-----IPQLLQHPFLVP 769 (853)
Q Consensus 708 ~PF~~~~~~~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpT-----a~EIL~HPwf~~ 769 (853)
+||.+.+.......+.. ..+.++...++++++||.+||++||.+|++ +.|+++||||..
T Consensus 203 ~pf~~~~~~~~~~~i~~---~~~~~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~Hp~f~~ 266 (337)
T d1o6la_ 203 LPFYNQDHERLFELILM---EEIRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLS 266 (337)
T ss_dssp CSSCCSSHHHHHHHHHH---CCCCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTT
T ss_pred CCCCCcCHHHHHHHHhc---CCCCCCccCCHHHHHHHHhhccCCchhhcccccccHHHHHcCccccc
Confidence 99987655433333332 234567778999999999999999999994 899999999964
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=3.9e-51 Score=435.72 Aligned_cols=263 Identities=29% Similarity=0.456 Sum_probs=218.6
Q ss_pred ceeeEEEeEeccCceEEEEEEe-cCCcEEEEEEEecCCCCh-------hhHhhHHHHHHHHHHhcCCCceeEeeehhhhH
Q 003052 472 KLYQRLGKIGSGGSSEVHKVIS-SDCTIYALKKIKLKGRDY-------ATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTE 543 (853)
Q Consensus 472 ~~Y~ilk~LG~G~FG~Vyka~~-~~g~~vAVKkik~~~~~~-------~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e 543 (853)
++|++++.||+|+||+||+|++ .+++.||||++++..... .....+.+|+.+|++|..||||++++++
T Consensus 3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~---- 78 (277)
T d1phka_ 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDT---- 78 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEE----
T ss_pred ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEee----
Confidence 5799999999999999999998 578899999998754321 2234588999999999989999999987
Q ss_pred HHHHHHHhhCCCCCCCCccccCCeEEEEEecch-hhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCcee
Q 003052 544 KALLREVLNGSMNNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIV 622 (853)
Q Consensus 544 ~~iL~~l~~~~iv~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gII 622 (853)
|.+++++||||||++ ++|.+++... +.+++..++.|+.||+.||+|||++||+
T Consensus 79 ------------------~~~~~~~~ivmE~~~~g~L~~~l~~~--------~~l~e~~~~~~~~qi~~al~~lH~~~iv 132 (277)
T d1phka_ 79 ------------------YETNTFFFLVFDLMKKGELFDYLTEK--------VTLSEKETRKIMRALLEVICALHKLNIV 132 (277)
T ss_dssp ------------------EECSSEEEEEEECCTTCBHHHHHHHH--------SSCCHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred ------------------cccCcceEEEEEcCCCchHHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHHcCCc
Confidence 677889999999986 5999999765 5799999999999999999999999999
Q ss_pred eCCCCCccEEe-ecCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHH
Q 003052 623 HSDLKPANFLL-VKGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILY 701 (853)
Q Consensus 623 HRDLKPeNILL-~~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILy 701 (853)
||||||+|||+ .++.+||+|||+|+.+.... .....+||+.|+|||++.+...+. ...|+.++||||+||+||
T Consensus 133 HrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~---~~~~~~gt~~y~~PE~~~~~~~~~---~~~~~~~~DiwslGvily 206 (277)
T d1phka_ 133 HRDLKPENILLDDDMNIKLTDFGFSCQLDPGE---KLREVCGTPSYLAPEIIECSMNDN---HPGYGKEVDMWSTGVIMY 206 (277)
T ss_dssp CSCCSGGGEEECTTCCEEECCCTTCEECCTTC---CBCCCCSCGGGCCHHHHHHHHCTT---SCCBCTHHHHHHHHHHHH
T ss_pred ccccccceEEEcCCCCeEEccchheeEccCCC---ceeeeeccCCCCCHHHhhcccccc---CCCCCchheEcccchhhh
Confidence 99999999999 46799999999998765432 234678999999999998654321 225788999999999999
Q ss_pred HHHhCCCCCCcchhHHHHHHhhcCC-CCcccCCCCCChhHHHHHHHhcccCCCCCCChhHHhcCCCCCCC
Q 003052 702 QMVYGRTPFSEYKTFWAKFKVITDP-NHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQHPFLVPP 770 (853)
Q Consensus 702 ELLtG~~PF~~~~~~~~~~kii~~~-~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~HPwf~~~ 770 (853)
+|++|+.||.+.........+.... ..........++++++||.+||+.||.+|||+.|+|+||||+..
T Consensus 207 eml~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h~~~~~~ 276 (277)
T d1phka_ 207 TLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQY 276 (277)
T ss_dssp HHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCTT
T ss_pred hhccCCCCCCCCCHHHHHHHHHhCCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHHHHh
Confidence 9999999998866554444443322 11222334678999999999999999999999999999999864
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=4.5e-51 Score=449.58 Aligned_cols=256 Identities=25% Similarity=0.388 Sum_probs=213.8
Q ss_pred ceeeEEEeEeccCceEEEEEEe-cCCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHHHH
Q 003052 472 KLYQRLGKIGSGGSSEVHKVIS-SDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLREV 550 (853)
Q Consensus 472 ~~Y~ilk~LG~G~FG~Vyka~~-~~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~~l 550 (853)
+.|++++.||+|+||.||+|++ .+++.||||+++.... .....+.+|+.+|++|+ |||||+++++
T Consensus 29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~--~~~~~~~~Ei~il~~l~-HpnIv~~~~~----------- 94 (352)
T d1koba_ 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYP--LDKYTVKNEISIMNQLH-HPKLINLHDA----------- 94 (352)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSH--HHHHHHHHHHHHHTTCC-STTBCCEEEE-----------
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcch--hHHHHHHHHHHHHHhCC-CCCCCcEEEE-----------
Confidence 4599999999999999999998 5789999999986542 33456889999999997 8999999987
Q ss_pred hhCCCCCCCCccccCCeEEEEEecch-hhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCCCc
Q 003052 551 LNGSMNNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPA 629 (853)
Q Consensus 551 ~~~~iv~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLKPe 629 (853)
|.+++.+|||||||. ++|.+.+... ...|++..++.|+.||+.||.|||++|||||||||+
T Consensus 95 -----------~~~~~~~~ivmE~~~gg~L~~~~~~~-------~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~ 156 (352)
T d1koba_ 95 -----------FEDKYEMVLILEFLSGGELFDRIAAE-------DYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPE 156 (352)
T ss_dssp -----------EECSSEEEEEEECCCCCBHHHHTTCT-------TCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGG
T ss_pred -----------EEECCEEEEEEEcCCCChHHHHHHhc-------CCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccccc
Confidence 567789999999987 5888766432 357999999999999999999999999999999999
Q ss_pred cEEee---cCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHhC
Q 003052 630 NFLLV---KGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYG 706 (853)
Q Consensus 630 NILL~---~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLtG 706 (853)
||||+ ++.+||+|||+|+.+.... ...+.+||+.|||||++.+. .|+.++|||||||++|+|++|
T Consensus 157 NILl~~~~~~~vkL~DFGla~~~~~~~---~~~~~~gt~~y~aPE~~~~~---------~~~~~~DiwSlGvilyelltG 224 (352)
T d1koba_ 157 NIMCETKKASSVKIIDFGLATKLNPDE---IVKVTTATAEFAAPEIVDRE---------PVGFYTDMWAIGVLGYVLLSG 224 (352)
T ss_dssp GEEESSTTCCCEEECCCTTCEECCTTS---CEEEECSSGGGCCHHHHTTC---------CBCHHHHHHHHHHHHHHHHHS
T ss_pred cccccccCCCeEEEeecccceecCCCC---ceeeccCcccccCHHHHcCC---------CCCCccchHHHHHHHHHHHhC
Confidence 99994 4689999999998775432 23467899999999999765 367899999999999999999
Q ss_pred CCCCCcchhHHHHHHhhcCC-CCcccCCCCCChhHHHHHHHhcccCCCCCCChhHHhcCCCCCCCC
Q 003052 707 RTPFSEYKTFWAKFKVITDP-NHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQHPFLVPPV 771 (853)
Q Consensus 707 ~~PF~~~~~~~~~~kii~~~-~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~HPwf~~~~ 771 (853)
++||.+.........+.... ..........++++++||.+||++||.+|||+.|+|+||||+...
T Consensus 225 ~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~Hp~~~~~~ 290 (352)
T d1koba_ 225 LSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDH 290 (352)
T ss_dssp CCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSCC
T ss_pred CCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhCCCc
Confidence 99998766554444433321 222233456789999999999999999999999999999998643
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=3.9e-51 Score=449.74 Aligned_cols=256 Identities=25% Similarity=0.367 Sum_probs=212.3
Q ss_pred ceeeEEEeEeccCceEEEEEEe-cCCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHHHH
Q 003052 472 KLYQRLGKIGSGGSSEVHKVIS-SDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLREV 550 (853)
Q Consensus 472 ~~Y~ilk~LG~G~FG~Vyka~~-~~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~~l 550 (853)
++|++++.||+|+||.||+|++ .+|+.||||++.... ......+.+|+.+|++|+ |||||+++++
T Consensus 26 ~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~--~~~~~~~~~E~~il~~l~-HpnIv~~~~~----------- 91 (350)
T d1koaa2 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH--ESDKETVRKEIQTMSVLR-HPTLVNLHDA----------- 91 (350)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCS--HHHHHHHHHHHHHHHHTC-CTTBCCEEEE-----------
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccc--hhhHHHHHHHHHHHHhCC-CCCCCcEEEE-----------
Confidence 4699999999999999999998 578899999997653 334567889999999997 9999999987
Q ss_pred hhCCCCCCCCccccCCeEEEEEecch-hhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCCCc
Q 003052 551 LNGSMNNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPA 629 (853)
Q Consensus 551 ~~~~iv~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLKPe 629 (853)
|.+++.+||||||+. ++|.+++... .+.+++..++.|+.||+.||.|||++|||||||||+
T Consensus 92 -----------~~~~~~~~ivmE~~~gg~L~~~l~~~-------~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~ 153 (350)
T d1koaa2 92 -----------FEDDNEMVMIYEFMSGGELFEKVADE-------HNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPE 153 (350)
T ss_dssp -----------EEETTEEEEEECCCCSCBHHHHHTCT-------TSCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGG
T ss_pred -----------EEECCEEEEEEEcCCCCCHHHHHHhh-------cCCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechh
Confidence 567789999999986 5998888542 357999999999999999999999999999999999
Q ss_pred cEEee---cCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHhC
Q 003052 630 NFLLV---KGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYG 706 (853)
Q Consensus 630 NILL~---~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLtG 706 (853)
||||. ++.+||+|||+|+.+.... ...+.+||+.|||||++.+.. |+.++|||||||++|+|++|
T Consensus 154 NIll~~~~~~~vkL~DFG~a~~~~~~~---~~~~~~gT~~Y~aPEv~~~~~---------~~~~~DiwSlGvilyell~G 221 (350)
T d1koaa2 154 NIMFTTKRSNELKLIDFGLTAHLDPKQ---SVKVTTGTAEFAAPEVAEGKP---------VGYYTDMWSVGVLSYILLSG 221 (350)
T ss_dssp GEEESSTTSCCEEECCCTTCEECCTTS---CEEEECSCTTTCCHHHHHTCC---------BCHHHHHHHHHHHHHHHHHS
T ss_pred HeeeccCCCCeEEEeecchheeccccc---ccceecCcccccCHHHHcCCC---------CChhHhhhhhhHHHHHHHhC
Confidence 99994 4689999999998765432 234679999999999998753 56899999999999999999
Q ss_pred CCCCCcchhHHHHHHhhcC-CCCcccCCCCCChhHHHHHHHhcccCCCCCCChhHHhcCCCCCCCC
Q 003052 707 RTPFSEYKTFWAKFKVITD-PNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQHPFLVPPV 771 (853)
Q Consensus 707 ~~PF~~~~~~~~~~kii~~-~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~HPwf~~~~ 771 (853)
+.||.+.........+... ...........++++++||.+||++||.+|||+.|+|+||||....
T Consensus 222 ~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~~~~~~ 287 (350)
T d1koaa2 222 LSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGN 287 (350)
T ss_dssp SCSSCCSSHHHHHHHHHHTCCCSCCGGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHSTTTSCTT
T ss_pred CCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCC
Confidence 9999876554333333222 1112223345788999999999999999999999999999998643
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=3.5e-51 Score=443.89 Aligned_cols=250 Identities=27% Similarity=0.447 Sum_probs=212.1
Q ss_pred ceeeEEEeEeccCceEEEEEEe-cCCcEEEEEEEecCCC-ChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHHH
Q 003052 472 KLYQRLGKIGSGGSSEVHKVIS-SDCTIYALKKIKLKGR-DYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLRE 549 (853)
Q Consensus 472 ~~Y~ilk~LG~G~FG~Vyka~~-~~g~~vAVKkik~~~~-~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~~ 549 (853)
++|++++.||+|+||+||+|++ .+++.||||+++.... .......+.+|+.+|++++ ||||++++++
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~-HpnIv~~~~~---------- 72 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVT-HPFIIRMWGT---------- 72 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCC-BTTBCCEEEE----------
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhcc-CcChhheeee----------
Confidence 4699999999999999999998 5789999999975432 2234456889999999997 8999999987
Q ss_pred HhhCCCCCCCCccccCCeEEEEEecchh-hHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCCC
Q 003052 550 VLNGSMNNKDGRVKDDGYIYMVLEYGEI-DLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKP 628 (853)
Q Consensus 550 l~~~~iv~~~g~~~d~~~lyLVmEy~~g-dL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLKP 628 (853)
+.+++.+|+||||+.+ +|..++... ..+++..++.|+.||+.||.|||++|||||||||
T Consensus 73 ------------~~~~~~~~ivmE~~~gg~l~~~~~~~--------~~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp 132 (316)
T d1fota_ 73 ------------FQDAQQIFMIMDYIEGGELFSLLRKS--------QRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKP 132 (316)
T ss_dssp ------------EECSSEEEEEECCCCSCBHHHHHHHT--------SSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCG
T ss_pred ------------EeeCCeeeeEeeecCCcccccccccc--------ccccccHHHHHHHHHHHhhhhhccCcEEccccCc
Confidence 5677899999999764 777776654 5789999999999999999999999999999999
Q ss_pred ccEEe-ecCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHhCC
Q 003052 629 ANFLL-VKGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGR 707 (853)
Q Consensus 629 eNILL-~~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLtG~ 707 (853)
+|||| .+|.+||+|||+|+..... ..+.+||+.|||||++.+.. |+.++|||||||++|+|++|+
T Consensus 133 ~NILl~~~g~vkL~DFG~a~~~~~~-----~~~~~Gt~~Y~APE~l~~~~---------y~~~~DiwSlGvilyemltG~ 198 (316)
T d1fota_ 133 ENILLDKNGHIKITDFGFAKYVPDV-----TYTLCGTPDYIAPEVVSTKP---------YNKSIDWWSFGILIYEMLAGY 198 (316)
T ss_dssp GGEEECTTSCEEECCCSSCEECSSC-----BCCCCSCTTTCCHHHHTTCC---------BCTTHHHHHHHHHHHHHHHSS
T ss_pred hheeEcCCCCEEEecCccceEeccc-----cccccCcccccCHHHHcCCC---------CCchhhccccchhHHHHHhCC
Confidence 99999 4679999999999876432 23679999999999997653 668999999999999999999
Q ss_pred CCCCcchhHHHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCC-----ChhHHhcCCCCCC
Q 003052 708 TPFSEYKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERW-----RIPQLLQHPFLVP 769 (853)
Q Consensus 708 ~PF~~~~~~~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRp-----Ta~EIL~HPwf~~ 769 (853)
.||.+........++... ...++...++++++||.+||.+||.+|+ |+++||+||||+.
T Consensus 199 ~Pf~~~~~~~~~~~i~~~---~~~~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~Hp~f~~ 262 (316)
T d1fota_ 199 TPFYDSNTMKTYEKILNA---ELRFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKE 262 (316)
T ss_dssp CTTCCSSHHHHHHHHHHC---CCCCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSS
T ss_pred CCCCCcCHHHHHHHHHcC---CCCCCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHcCccccc
Confidence 999876655444444432 2345677889999999999999999996 9999999999975
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.7e-51 Score=436.23 Aligned_cols=261 Identities=29% Similarity=0.469 Sum_probs=209.5
Q ss_pred ceeeEEEeEeccCceEEEEEEe-cCCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHHHH
Q 003052 472 KLYQRLGKIGSGGSSEVHKVIS-SDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLREV 550 (853)
Q Consensus 472 ~~Y~ilk~LG~G~FG~Vyka~~-~~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~~l 550 (853)
++|+++++||+|+||+||+|.+ .+++.||||+++...........+.+|+++|++++ |||||+++++
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~-Hp~Iv~~~~~----------- 69 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN-HPNIVKLLDV----------- 69 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCC-CTTBCCEEEE-----------
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCC-CCcEEEeccc-----------
Confidence 4699999999999999999998 57899999999766544445567889999999997 9999999987
Q ss_pred hhCCCCCCCCccccCCeEEEEEecchhhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCCCcc
Q 003052 551 LNGSMNNKDGRVKDDGYIYMVLEYGEIDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPAN 630 (853)
Q Consensus 551 ~~~~iv~~~g~~~d~~~lyLVmEy~~gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLKPeN 630 (853)
|.+++.+|+||||+++++...+... ....+++..++.|+.||+.||+|||++|||||||||+|
T Consensus 70 -----------~~~~~~~~iv~e~~~~~~~~~~~~~------~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeN 132 (298)
T d1gz8a_ 70 -----------IHTENKLYLVFEFLHQDLKKFMDAS------ALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQN 132 (298)
T ss_dssp -----------EEETTEEEEEEECCSEEHHHHHHHT------TTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGG
T ss_pred -----------cccccceeEEEeecCCchhhhhhhh------cccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchh
Confidence 5677889999999988877776554 34679999999999999999999999999999999999
Q ss_pred EEe-ecCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHhCCCC
Q 003052 631 FLL-VKGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGRTP 709 (853)
Q Consensus 631 ILL-~~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLtG~~P 709 (853)
||+ .++.+||+|||+|+....... .....+||+.|+|||++.... +++.++|||||||++|+|++|+.|
T Consensus 133 Il~~~~~~~kl~DFG~a~~~~~~~~--~~~~~~gt~~y~apE~~~~~~--------~~~~~~DiwSlGvily~m~~G~~P 202 (298)
T d1gz8a_ 133 LLINTEGAIKLADFGLARAFGVPVR--TYTHEVVTLWYRAPEILLGCK--------YYSTAVDIWSLGCIFAEMVTRRAL 202 (298)
T ss_dssp EEECTTSCEEECSTTHHHHHCCCSB--CTTCCBCCCTTCCHHHHTTCS--------SCCTHHHHHHHHHHHHHHHHSSCS
T ss_pred eeecccCcceeccCCcceeccCCcc--cceeecccceeeehhhhcccc--------CCCccccccccchhhhHHhhCCCC
Confidence 999 567999999999987754322 334678999999999987654 357899999999999999999999
Q ss_pred CCcchhHHHHHHhh---cCCCCc------------cc-----------CCCCCChhHHHHHHHhcccCCCCCCChhHHhc
Q 003052 710 FSEYKTFWAKFKVI---TDPNHE------------IT-----------YEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQ 763 (853)
Q Consensus 710 F~~~~~~~~~~kii---~~~~~~------------~~-----------~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~ 763 (853)
|.+.+.......+. ..+... .. .....++++++||.+||.+||++|||+.|+|+
T Consensus 203 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~ 282 (298)
T d1gz8a_ 203 FPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA 282 (298)
T ss_dssp CCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred CCCCCHHHHHHHHHHhcCCCchhhccccccccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence 98755443332221 111100 00 11245678999999999999999999999999
Q ss_pred CCCCCCCC
Q 003052 764 HPFLVPPV 771 (853)
Q Consensus 764 HPwf~~~~ 771 (853)
||||+.-.
T Consensus 283 H~ff~~~~ 290 (298)
T d1gz8a_ 283 HPFFQDVT 290 (298)
T ss_dssp SGGGTTCC
T ss_pred CHhhccCC
Confidence 99997543
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.4e-51 Score=436.30 Aligned_cols=265 Identities=26% Similarity=0.422 Sum_probs=210.9
Q ss_pred CceeeEEEeEeccCceEEEEEEe-cC-CcEEEEEEEecCCCChhhHhhHHHHHHHHHHhc--CCCceeEeeehhhhHHHH
Q 003052 471 GKLYQRLGKIGSGGSSEVHKVIS-SD-CTIYALKKIKLKGRDYATAYGFCQEIEYLNKLK--GKNNIIQLIDYEVTEKAL 546 (853)
Q Consensus 471 g~~Y~ilk~LG~G~FG~Vyka~~-~~-g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~--~hpNIV~Lid~~~~e~~i 546 (853)
.++|+++++||+|+||+||+|++ .+ ++.||||+++...........+.+|+.+|+.|. +||||+++++++...
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~--- 82 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVS--- 82 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEE---
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeeccc---
Confidence 36799999999999999999998 44 567999999876555444556789999999885 699999999875321
Q ss_pred HHHHhhCCCCCCCCccccCCeEEEEEecchhhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCC
Q 003052 547 LREVLNGSMNNKDGRVKDDGYIYMVLEYGEIDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDL 626 (853)
Q Consensus 547 L~~l~~~~iv~~~g~~~d~~~lyLVmEy~~gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDL 626 (853)
.+....++|++|||+++++....... ....+++..++.|+.||+.||+|||++|||||||
T Consensus 83 --------------~~~~~~~~~~~~e~~~~~~~~~~~~~------~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDi 142 (305)
T d1blxa_ 83 --------------RTDRETKLTLVFEHVDQDLTTYLDKV------PEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDL 142 (305)
T ss_dssp --------------ECSSEEEEEEEEECCSCBHHHHHHHS------CTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCC
T ss_pred --------------ccccCceEEEEEEeccCCchhhhhhc------cCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCC
Confidence 12445689999999887665544433 3467999999999999999999999999999999
Q ss_pred CCccEEee-cCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHh
Q 003052 627 KPANFLLV-KGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVY 705 (853)
Q Consensus 627 KPeNILL~-~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLt 705 (853)
||+|||++ .+.+||+|||+++...... .....+||+.|||||++.+.. |+.++|||||||++|||++
T Consensus 143 Kp~NILi~~~~~~kl~dfg~~~~~~~~~---~~~~~~gT~~Y~APE~~~~~~---------y~~~~DiwSlG~il~ell~ 210 (305)
T d1blxa_ 143 KPQNILVTSSGQIKLADFGLARIYSFQM---ALTSVVVTLWYRAPEVLLQSS---------YATPVDLWSVGCIFAEMFR 210 (305)
T ss_dssp CGGGEEECTTCCEEECSCCSCCCCCGGG---GGCCCCCCCTTCCHHHHTTCC---------CCTHHHHHHHHHHHHHHHH
T ss_pred CccEEEEcCCCCeeecchhhhhhhcccc---cCCCcccChhhcCcchhcCCC---------CChhehhhchHHHHHHHHH
Confidence 99999994 6899999999998654322 334789999999999997653 6789999999999999999
Q ss_pred CCCCCCcchhHHHHHHh---hcCCC---------------------CcccCCCCCChhHHHHHHHhcccCCCCCCChhHH
Q 003052 706 GRTPFSEYKTFWAKFKV---ITDPN---------------------HEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQL 761 (853)
Q Consensus 706 G~~PF~~~~~~~~~~ki---i~~~~---------------------~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EI 761 (853)
|++||.+.........+ ...+. ....+....++.+++||.+||.+||.+|||+.|+
T Consensus 211 g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~ 290 (305)
T d1blxa_ 211 RKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSA 290 (305)
T ss_dssp SSCSCCCSSHHHHHHHHHHHHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHH
T ss_pred CCCCCCCCCHHHHHHHHHHhhCCCchhcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHH
Confidence 99999876544332222 11110 0112234567889999999999999999999999
Q ss_pred hcCCCCCCC
Q 003052 762 LQHPFLVPP 770 (853)
Q Consensus 762 L~HPwf~~~ 770 (853)
|+||||+.-
T Consensus 291 L~Hpff~~i 299 (305)
T d1blxa_ 291 LSHPYFQDL 299 (305)
T ss_dssp HTSGGGTTC
T ss_pred hcChhhcCc
Confidence 999999753
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=6.2e-51 Score=447.97 Aligned_cols=250 Identities=24% Similarity=0.402 Sum_probs=212.5
Q ss_pred ceeeEEEeEeccCceEEEEEEe-cCCcEEEEEEEecCC-CChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHHH
Q 003052 472 KLYQRLGKIGSGGSSEVHKVIS-SDCTIYALKKIKLKG-RDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLRE 549 (853)
Q Consensus 472 ~~Y~ilk~LG~G~FG~Vyka~~-~~g~~vAVKkik~~~-~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~~ 549 (853)
++|+++++||+|+||.||+|++ .+++.||||++.+.. ........+++|+++|+.++ ||||++++++
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~-hpnIv~~~~~---------- 109 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN-FPFLVKLEFS---------- 109 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCC-CTTBCCEEEE----------
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcC-CCcEeecccc----------
Confidence 5699999999999999999998 578999999997543 12234456889999999997 9999999987
Q ss_pred HhhCCCCCCCCccccCCeEEEEEecch-hhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCCC
Q 003052 550 VLNGSMNNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKP 628 (853)
Q Consensus 550 l~~~~iv~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLKP 628 (853)
+.+...+|+||||+. ++|...+... +.+++..++.|+.||+.||.|||++|||||||||
T Consensus 110 ------------~~~~~~~~~v~e~~~~g~l~~~l~~~--------~~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP 169 (350)
T d1rdqe_ 110 ------------FKDNSNLYMVMEYVAGGEMFSHLRRI--------GRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKP 169 (350)
T ss_dssp ------------EECSSEEEEEEECCTTCBHHHHHHHH--------CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSG
T ss_pred ------------cccccccccccccccccchhhhHhhc--------CCCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCH
Confidence 567788999999965 5888888765 5799999999999999999999999999999999
Q ss_pred ccEEe-ecCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHhCC
Q 003052 629 ANFLL-VKGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGR 707 (853)
Q Consensus 629 eNILL-~~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLtG~ 707 (853)
+|||| .+|.+||+|||+|+.+... ..+.+||+.|||||++.+.. |+.++|||||||+||||++|+
T Consensus 170 ~NILl~~~g~ikL~DFG~a~~~~~~-----~~~~~Gt~~Y~APE~~~~~~---------~~~~~DiwSlGvilyemltG~ 235 (350)
T d1rdqe_ 170 ENLLIDQQGYIQVTDFGFAKRVKGR-----TWTLCGTPEALAPEIILSKG---------YNKAVDWWALGVLIYEMAAGY 235 (350)
T ss_dssp GGEEECTTSCEEECCCTTCEECSSC-----BCCCEECGGGCCHHHHTTCC---------BCTHHHHHHHHHHHHHHHHSS
T ss_pred HHcccCCCCCEEeeeceeeeecccc-----cccccCccccCCHHHHcCCC---------CCccccccchhHHHHHHHhCC
Confidence 99999 5779999999999876432 23678999999999998753 678999999999999999999
Q ss_pred CCCCcchhHHHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCC-----ChhHHhcCCCCCC
Q 003052 708 TPFSEYKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERW-----RIPQLLQHPFLVP 769 (853)
Q Consensus 708 ~PF~~~~~~~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRp-----Ta~EIL~HPwf~~ 769 (853)
+||.+.+.......+... ...++...++++.+||.+||.+||.+|+ |+++||+||||..
T Consensus 236 ~Pf~~~~~~~~~~~i~~~---~~~~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~Hp~f~~ 299 (350)
T d1rdqe_ 236 PPFFADQPIQIYEKIVSG---KVRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFAT 299 (350)
T ss_dssp CSSCCSSHHHHHHHHHHC---CCCCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTT
T ss_pred CCCCCcCHHHHHHHHhcC---CCCCCccCCHHHHHHHHHHhhhCHHhccccccccHHHHHcCccccC
Confidence 999886655444444432 2345667899999999999999999995 9999999999974
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-51 Score=437.63 Aligned_cols=255 Identities=28% Similarity=0.412 Sum_probs=200.9
Q ss_pred EEEeEeccCceEEEEEEe-cCCcEEEEEEEecCCCCh---hhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHHHHh
Q 003052 476 RLGKIGSGGSSEVHKVIS-SDCTIYALKKIKLKGRDY---ATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLREVL 551 (853)
Q Consensus 476 ilk~LG~G~FG~Vyka~~-~~g~~vAVKkik~~~~~~---~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~~l~ 551 (853)
.+++||+|+||+||+|++ .+++.||||+++...... .....+.+|+.+|++++ |||||+++++
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~~~~~------------ 68 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELS-HPNIIGLLDA------------ 68 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCC-CTTBCCEEEE------------
T ss_pred cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCC-CCCEeEEEee------------
Confidence 578899999999999998 568999999997654321 22346889999999997 8999999987
Q ss_pred hCCCCCCCCccccCCeEEEEEecchhhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCCCccE
Q 003052 552 NGSMNNKDGRVKDDGYIYMVLEYGEIDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANF 631 (853)
Q Consensus 552 ~~~iv~~~g~~~d~~~lyLVmEy~~gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLKPeNI 631 (853)
+.+++++||||||+.+++...+.. .+..+++..++.|++||+.||+|||++||+||||||+||
T Consensus 69 ----------~~~~~~~~ivmE~~~~~~~~~~~~-------~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NI 131 (299)
T d1ua2a_ 69 ----------FGHKSNISLVFDFMETDLEVIIKD-------NSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNL 131 (299)
T ss_dssp ----------ECCTTCCEEEEECCSEEHHHHHTT-------CCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGE
T ss_pred ----------eccCCceeehhhhhcchHHhhhhh-------cccCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceE
Confidence 556778999999988766555433 346799999999999999999999999999999999999
Q ss_pred Ee-ecCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHhCCCCC
Q 003052 632 LL-VKGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGRTPF 710 (853)
Q Consensus 632 LL-~~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLtG~~PF 710 (853)
|+ .++.+||+|||+|+....... .....+||+.|||||++.+.. .|+.++|||||||++|||++|.+||
T Consensus 132 li~~~~~~KL~DFG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~--------~~~~~~DiwSlGvil~el~~g~~pf 201 (299)
T d1ua2a_ 132 LLDENGVLKLADFGLAKSFGSPNR--AYTHQVVTRWYRAPELLFGAR--------MYGVGVDMWAVGCILAELLLRVPFL 201 (299)
T ss_dssp EECTTCCEEECCCGGGSTTTSCCC--CCCCSCCCCTTCCHHHHTTCS--------CCCHHHHHHHHHHHHHHHHHSSCSS
T ss_pred EecCCCccccccCccccccCCCcc--cccceecChhhccHHHHccCC--------CCChhhhhhhcchHHHHHHhCcCCC
Confidence 99 467999999999987654322 234678999999999986543 3678999999999999999999999
Q ss_pred CcchhHHHHHH---hhcCCCCcc----------------------cCCCCCChhHHHHHHHhcccCCCCCCChhHHhcCC
Q 003052 711 SEYKTFWAKFK---VITDPNHEI----------------------TYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQHP 765 (853)
Q Consensus 711 ~~~~~~~~~~k---ii~~~~~~~----------------------~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~HP 765 (853)
.+........+ .+..+.... ......++++++||.+||++||++|||+.|+|+||
T Consensus 202 ~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp 281 (299)
T d1ua2a_ 202 PGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMK 281 (299)
T ss_dssp CCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSG
T ss_pred CCCCHHHHHHHHHHhcCCCChhhccchhccchhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCCH
Confidence 77555433322 222111100 00124578899999999999999999999999999
Q ss_pred CCCCC
Q 003052 766 FLVPP 770 (853)
Q Consensus 766 wf~~~ 770 (853)
||+..
T Consensus 282 ~f~~~ 286 (299)
T d1ua2a_ 282 YFSNR 286 (299)
T ss_dssp GGTSS
T ss_pred hhCCC
Confidence 99854
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.1e-51 Score=432.59 Aligned_cols=248 Identities=28% Similarity=0.441 Sum_probs=207.3
Q ss_pred ceeeEEEeEeccCceEEEEEEe-cCCcEEEEEEEecCCCCh----hhHhhHHHHHHHHHHhcC-CCceeEeeehhhhHHH
Q 003052 472 KLYQRLGKIGSGGSSEVHKVIS-SDCTIYALKKIKLKGRDY----ATAYGFCQEIEYLNKLKG-KNNIIQLIDYEVTEKA 545 (853)
Q Consensus 472 ~~Y~ilk~LG~G~FG~Vyka~~-~~g~~vAVKkik~~~~~~----~~~~~~l~EI~iLkkL~~-hpNIV~Lid~~~~e~~ 545 (853)
.+|++.+.||+|+||+||+|++ .+++.||||++....... .....+.+|+.+|+++++ ||||++++++
T Consensus 4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~------ 77 (273)
T d1xwsa_ 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDW------ 77 (273)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEE------
T ss_pred CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEE------
Confidence 4699999999999999999998 578999999997643211 122346799999999974 8999999987
Q ss_pred HHHHHhhCCCCCCCCccccCCeEEEEEecch--hhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceee
Q 003052 546 LLREVLNGSMNNKDGRVKDDGYIYMVLEYGE--IDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVH 623 (853)
Q Consensus 546 iL~~l~~~~iv~~~g~~~d~~~lyLVmEy~~--gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIH 623 (853)
|.+++.+|+||||+. +++.+++... ..+++..++.|+.||+.||.|||++||+|
T Consensus 78 ----------------~~~~~~~~lv~e~~~~~~~l~~~~~~~--------~~l~e~~~~~~~~qi~~al~~lH~~~iiH 133 (273)
T d1xwsa_ 78 ----------------FERPDSFVLILERPEPVQDLFDFITER--------GALQEELARSFFWQVLEAVRHCHNCGVLH 133 (273)
T ss_dssp ----------------EECSSEEEEEEECCSSEEEHHHHHHHH--------CSCCHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred ----------------EeeCCeEEEEEEeccCcchHHHHHhcc--------CCCCHHHHHHHHHHHHHHHHHHHHCCCcc
Confidence 567788999999964 4777777654 57999999999999999999999999999
Q ss_pred CCCCCccEEee-c-CcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHH
Q 003052 624 SDLKPANFLLV-K-GSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILY 701 (853)
Q Consensus 624 RDLKPeNILL~-~-g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILy 701 (853)
|||||+|||++ + +.+||+|||+|+..... ...+.+||+.|||||++.+.. .++.++|||||||++|
T Consensus 134 rDiKp~NIll~~~~~~vkl~DFG~a~~~~~~----~~~~~~GT~~y~aPE~~~~~~--------~~~~~~DiwSlGvily 201 (273)
T d1xwsa_ 134 RDIKDENILIDLNRGELKLIDFGSGALLKDT----VYTDFDGTRVYSPPEWIRYHR--------YHGRSAAVWSLGILLY 201 (273)
T ss_dssp SCCSGGGEEEETTTTEEEECCCTTCEECCSS----CBCCCCSCGGGSCHHHHHHSC--------BCHHHHHHHHHHHHHH
T ss_pred ccCcccceEEecCCCeEEECccccceecccc----cccccccCCCcCCHHHHcCCC--------CCCcccccccceeeeh
Confidence 99999999995 3 58999999999865432 234679999999999998654 2467899999999999
Q ss_pred HHHhCCCCCCcchhHHHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCCChhHHhcCCCCCCC
Q 003052 702 QMVYGRTPFSEYKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQHPFLVPP 770 (853)
Q Consensus 702 ELLtG~~PF~~~~~~~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~HPwf~~~ 770 (853)
||++|+.||.+.+... . ....++...++++++||.+||.+||.+|||++|+|+||||+..
T Consensus 202 ell~g~~Pf~~~~~i~------~---~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~~ 261 (273)
T d1xwsa_ 202 DMVCGDIPFEHDEEII------R---GQVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDV 261 (273)
T ss_dssp HHHHSSCSCCSHHHHH------H---CCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSC
T ss_pred hHhhCCCCCCCchHHh------h---cccCCCCCCCHHHHHHHHHHccCCHhHCcCHHHHhcCHhhCCC
Confidence 9999999998754321 1 1234556789999999999999999999999999999999754
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=1.5e-50 Score=447.03 Aligned_cols=254 Identities=25% Similarity=0.354 Sum_probs=205.3
Q ss_pred ceeeEEEeEeccCceEEEEEEec-CCcEEEEEEEecCCCC-hhhHhhHHHHHHHHHHhc--CCCceeEeeehhhhHHHHH
Q 003052 472 KLYQRLGKIGSGGSSEVHKVISS-DCTIYALKKIKLKGRD-YATAYGFCQEIEYLNKLK--GKNNIIQLIDYEVTEKALL 547 (853)
Q Consensus 472 ~~Y~ilk~LG~G~FG~Vyka~~~-~g~~vAVKkik~~~~~-~~~~~~~l~EI~iLkkL~--~hpNIV~Lid~~~~e~~iL 547 (853)
++|++++.||+|+||.||+|++. +++.||||++.+.... ......+.+|..+++.++ +|||||+++++
T Consensus 4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~-------- 75 (364)
T d1omwa3 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYA-------- 75 (364)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEE--------
T ss_pred HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEE--------
Confidence 45999999999999999999984 7899999999754321 112223455655554443 39999999987
Q ss_pred HHHhhCCCCCCCCccccCCeEEEEEecch-hhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCC
Q 003052 548 REVLNGSMNNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDL 626 (853)
Q Consensus 548 ~~l~~~~iv~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDL 626 (853)
|.+++.+||||||+. ++|.+++... ..+++..++.|+.||+.||.|||++|||||||
T Consensus 76 --------------~~~~~~~~ivmE~~~gg~L~~~l~~~--------~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDl 133 (364)
T d1omwa3 76 --------------FHTPDKLSFILDLMNGGDLHYHLSQH--------GVFSEADMRFYAAEIILGLEHMHNRFVVYRDL 133 (364)
T ss_dssp --------------EECSSEEEEEECCCCSCBHHHHHHHH--------CSCCHHHHHHHHHHHHHHHHHHHHTTEECCCC
T ss_pred --------------EEECCEEEEEEEecCCCcHHHHHHhc--------ccccHHHHHHHHHHHHHHHHHHHHCCccceee
Confidence 567788999999986 6999998765 57899999999999999999999999999999
Q ss_pred CCccEEe-ecCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHh
Q 003052 627 KPANFLL-VKGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVY 705 (853)
Q Consensus 627 KPeNILL-~~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLt 705 (853)
||+|||| .+|.+||+|||+|+.+.... ....+||+.|||||++.... .|+.++|||||||+||||++
T Consensus 134 KP~NILl~~~g~iKl~DFGla~~~~~~~----~~~~~GT~~y~APE~~~~~~--------~~~~~~DiwSlGvilyemlt 201 (364)
T d1omwa3 134 KPANILLDEHGHVRISDLGLACDFSKKK----PHASVGTHGYMAPEVLQKGV--------AYDSSADWFSLGCMLFKLLR 201 (364)
T ss_dssp SGGGEEECSSSCEEECCCTTCEECSSSC----CCSCCSCGGGCCHHHHSTTC--------CCCTHHHHHHHHHHHHHHHH
T ss_pred ccceeEEcCCCcEEEeeeceeeecCCCc----ccccccccccchhHHhhcCC--------CCCcccchhHHHHHHHHHHh
Confidence 9999999 56899999999998765432 23678999999999996432 36789999999999999999
Q ss_pred CCCCCCcch--hHHHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCCC-----hhHHhcCCCCCC
Q 003052 706 GRTPFSEYK--TFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWR-----IPQLLQHPFLVP 769 (853)
Q Consensus 706 G~~PF~~~~--~~~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpT-----a~EIL~HPwf~~ 769 (853)
|+.||.+.. .......... .....++...++++++||.+||.+||.+||| ++||++||||+.
T Consensus 202 G~~Pf~~~~~~~~~~~~~~~~--~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~Hp~f~~ 270 (364)
T d1omwa3 202 GHSPFRQHKTKDKHEIDRMTL--TMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRS 270 (364)
T ss_dssp SSCSSCSSCSSCHHHHHHHSS--SCCCCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTSGGGTT
T ss_pred CCCCCCCCCHHHHHHHHHhcc--cCCCCCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHcCccccC
Confidence 999997532 2223333322 2334556678999999999999999999999 799999999974
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=2.6e-50 Score=428.10 Aligned_cols=257 Identities=30% Similarity=0.476 Sum_probs=208.0
Q ss_pred ceeeEEEeEeccCceEEEEEEecCCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHHHHh
Q 003052 472 KLYQRLGKIGSGGSSEVHKVISSDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLREVL 551 (853)
Q Consensus 472 ~~Y~ilk~LG~G~FG~Vyka~~~~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~~l~ 551 (853)
++|+++++||+|+||+||+|++++++.||||+++...........+.+|+.+|++++ ||||++++++
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~-hpnIv~~~~~------------ 68 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELK-HSNIVKLYDV------------ 68 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCC-CTTBCCEEEE------------
T ss_pred CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCC-CCcEEeeeee------------
Confidence 469999999999999999999999999999999876655555677899999999997 8999999987
Q ss_pred hCCCCCCCCccccCCeEEEEEecchhhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCCCccE
Q 003052 552 NGSMNNKDGRVKDDGYIYMVLEYGEIDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANF 631 (853)
Q Consensus 552 ~~~iv~~~g~~~d~~~lyLVmEy~~gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLKPeNI 631 (853)
|.+++.+|++|||+++++...+... ...+++..++.|+.||+.||+|||++|||||||||+||
T Consensus 69 ----------~~~~~~~~i~~e~~~~~~~~~~~~~-------~~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NI 131 (286)
T d1ob3a_ 69 ----------IHTKKRLVLVFEHLDQDLKKLLDVC-------EGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNL 131 (286)
T ss_dssp ----------EECSSCEEEEEECCSEEHHHHHHTS-------TTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGE
T ss_pred ----------cccCCceeEEEEeehhhhHHHHHhh-------cCCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCcee
Confidence 5677889999999888766666442 46799999999999999999999999999999999999
Q ss_pred Ee-ecCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHhCCCCC
Q 003052 632 LL-VKGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGRTPF 710 (853)
Q Consensus 632 LL-~~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLtG~~PF 710 (853)
|| .++.+||+|||+|........ .....+|++.|+|||++.+.. .++.++|||||||++|||++|++||
T Consensus 132 ll~~~~~~kl~DfG~a~~~~~~~~--~~~~~~~~~~y~~pE~~~~~~--------~~~~~~DiwslGv~l~el~~G~~pf 201 (286)
T d1ob3a_ 132 LINREGELKIADFGLARAFGIPVR--KYTHEIVTLWYRAPDVLMGSK--------KYSTTIDIWSVGCIFAEMVNGTPLF 201 (286)
T ss_dssp EECTTSCEEECCTTHHHHHCC-----------CCCTTCCHHHHTTCC--------SCCTHHHHHHHHHHHHHHHHSSCSC
T ss_pred eEcCCCCEEecccccceecccCcc--ccceecccchhhhHHHHhCCC--------CCCcceeehhcCcHHHHHHHCCCCC
Confidence 99 567999999999987654322 233567999999999997543 4678999999999999999999999
Q ss_pred CcchhHHHHHH---hhcCCCCc-----------------------ccCCCCCChhHHHHHHHhcccCCCCCCChhHHhcC
Q 003052 711 SEYKTFWAKFK---VITDPNHE-----------------------ITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQH 764 (853)
Q Consensus 711 ~~~~~~~~~~k---ii~~~~~~-----------------------~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~H 764 (853)
.+........+ ....+... .......++.+.+||++||++||++|||+.|+|+|
T Consensus 202 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~H 281 (286)
T d1ob3a_ 202 PGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH 281 (286)
T ss_dssp CCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred CCCCHHHHHHHHHHhhCCCChhhccchhhhhhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 76544332222 11111100 11234467789999999999999999999999999
Q ss_pred CCCC
Q 003052 765 PFLV 768 (853)
Q Consensus 765 Pwf~ 768 (853)
|||+
T Consensus 282 p~f~ 285 (286)
T d1ob3a_ 282 AYFK 285 (286)
T ss_dssp GGGG
T ss_pred cccC
Confidence 9996
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.9e-50 Score=434.87 Aligned_cols=254 Identities=23% Similarity=0.327 Sum_probs=211.6
Q ss_pred ceeeEEEeEeccCceEEEEEEe-cCCcEEEEEEEecCCC-ChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHHH
Q 003052 472 KLYQRLGKIGSGGSSEVHKVIS-SDCTIYALKKIKLKGR-DYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLRE 549 (853)
Q Consensus 472 ~~Y~ilk~LG~G~FG~Vyka~~-~~g~~vAVKkik~~~~-~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~~ 549 (853)
++|++++.||+|+||+||+|++ .+++.||||++++... .......+.+|+.++.+..+||||++++++
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~---------- 71 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCT---------- 71 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEE----------
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEE----------
Confidence 4599999999999999999998 4789999999975421 122344577888888765569999999987
Q ss_pred HhhCCCCCCCCccccCCeEEEEEecch-hhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCCC
Q 003052 550 VLNGSMNNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKP 628 (853)
Q Consensus 550 l~~~~iv~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLKP 628 (853)
+.+++.+||||||++ |+|.+++... ..+++.+++.|+.||+.||.|||++||+||||||
T Consensus 72 ------------~~~~~~~yivmEy~~~g~L~~~i~~~--------~~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp 131 (320)
T d1xjda_ 72 ------------FQTKENLFFVMEYLNGGDLMYHIQSC--------HKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKL 131 (320)
T ss_dssp ------------EECSSEEEEEEECCTTCBHHHHHHHH--------SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCG
T ss_pred ------------EccCCceeEEEeecCCCcHHHHhhcc--------CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcc
Confidence 567889999999976 4999998765 5699999999999999999999999999999999
Q ss_pred ccEEee-cCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHhCC
Q 003052 629 ANFLLV-KGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGR 707 (853)
Q Consensus 629 eNILL~-~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLtG~ 707 (853)
+|||++ +|.+||+|||+|+....... .....+||+.|+|||++.+. .|+.++|||||||++|+|++|+
T Consensus 132 ~NiL~~~~~~~kl~DFG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~---------~~~~~~DiwSlGvilyemltG~ 200 (320)
T d1xjda_ 132 DNILLDKDGHIKIADFGMCKENMLGDA--KTNTFCGTPDYIAPEILLGQ---------KYNHSVDWWSFGVLLYEMLIGQ 200 (320)
T ss_dssp GGEEECTTSCEEECCCTTCBCCCCTTC--CBCCCCSCGGGCCHHHHTTC---------CBCTHHHHHHHHHHHHHHHHSS
T ss_pred cceeecCCCceeccccchhhhcccccc--cccccCCCCCcCCHHHHcCC---------CCCchhhhhhhhHHHHHHHhCC
Confidence 999995 57999999999986643322 33467899999999999875 3678999999999999999999
Q ss_pred CCCCcchhHHHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCCChh-HHhcCCCCCC
Q 003052 708 TPFSEYKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIP-QLLQHPFLVP 769 (853)
Q Consensus 708 ~PF~~~~~~~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~-EIL~HPwf~~ 769 (853)
.||.+........++... .+.++...++++++||.+||.+||.+||++. ++++||||..
T Consensus 201 ~PF~~~~~~~~~~~i~~~---~~~~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~hpff~~ 260 (320)
T d1xjda_ 201 SPFHGQDEEELFHSIRMD---NPFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFRE 260 (320)
T ss_dssp CSSCCSSHHHHHHHHHHC---CCCCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGSGGGTT
T ss_pred CCCCCCCHHHHHHHHHcC---CCCCCccCCHHHHHHHHHhcccCCCCCcCHHHHHHhCchhcc
Confidence 999876554433333322 2345667899999999999999999999996 8999999975
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-50 Score=429.06 Aligned_cols=258 Identities=22% Similarity=0.299 Sum_probs=205.6
Q ss_pred EEcCceeeEEEeEeccCceEEEEEEecCCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHH
Q 003052 468 KVNGKLYQRLGKIGSGGSSEVHKVISSDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALL 547 (853)
Q Consensus 468 ~v~g~~Y~ilk~LG~G~FG~Vyka~~~~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL 547 (853)
++..+.|++.++||+|+||+||+|+... .||||+++....+......|.+|+.+|++++ |||||++++++
T Consensus 4 ei~~~~~~~~~~lG~G~fg~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~-HpnIv~~~~~~------- 73 (276)
T d1uwha_ 4 EIPDGQITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTR-HVNILLFMGYS------- 73 (276)
T ss_dssp BCCTTCCCCCSEEEECSSCEEEEEESSS--EEEEEECCCSSCCTTHHHHHHHHHHHHTTCC-CTTBCCEEEEE-------
T ss_pred ccccccEEEEEEEeeCCCcEEEEEEECC--EEEEEEEEcccCCHHHHHHHHHHHHHHHhCC-CCCEeeeeEEE-------
Confidence 4455679999999999999999998643 5999999877666667778999999999997 99999999863
Q ss_pred HHHhhCCCCCCCCccccCCeEEEEEecch-hhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCC
Q 003052 548 REVLNGSMNNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDL 626 (853)
Q Consensus 548 ~~l~~~~iv~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDL 626 (853)
.+..+||||||++ ++|.+++... ...+++..+..|+.||+.||+|||++|||||||
T Consensus 74 ----------------~~~~~~lv~Ey~~~g~L~~~l~~~-------~~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDl 130 (276)
T d1uwha_ 74 ----------------TAPQLAIVTQWCEGSSLYHHLHII-------ETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDL 130 (276)
T ss_dssp ----------------CSSSCEEEEECCCEEEHHHHHHTS-------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCC
T ss_pred ----------------eccEEEEEEecCCCCCHHHHHhhc-------cCCCCHHHHHHHHHHHHHHHHHHhcCCEecccc
Confidence 2345799999987 6999988643 356999999999999999999999999999999
Q ss_pred CCccEEee-cCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHh
Q 003052 627 KPANFLLV-KGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVY 705 (853)
Q Consensus 627 KPeNILL~-~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLt 705 (853)
||+||||+ ++.+||+|||+|+..............+||+.|||||++.+.... .|+.++|||||||+||||+|
T Consensus 131 Kp~NiLl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~------~~~~~sDiwS~Gv~l~el~t 204 (276)
T d1uwha_ 131 KSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKN------PYSFQSDVYAFGIVLYELMT 204 (276)
T ss_dssp CGGGEEEETTSSEEECCCCCSCC------------CCCCGGGCCHHHHTTCSSC------CCCHHHHHHHHHHHHHHHHH
T ss_pred CHHHEEEcCCCCEEEccccceeeccccCCcccccccccCcccCCHHHHhcccCC------CCCchhhhhhhHHHHHHHHH
Confidence 99999995 669999999999876544333344567899999999999764322 47889999999999999999
Q ss_pred CCCCCCcchhHHHHHHhhcCCC---CcccCCCCCChhHHHHHHHhcccCCCCCCChhHHhcC
Q 003052 706 GRTPFSEYKTFWAKFKVITDPN---HEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQH 764 (853)
Q Consensus 706 G~~PF~~~~~~~~~~kii~~~~---~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~H 764 (853)
|+.||.+..........+.... .....+...++++.+||.+||..||.+|||+.||+++
T Consensus 205 g~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~ 266 (276)
T d1uwha_ 205 GQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILAS 266 (276)
T ss_dssp SSCTTTTCCCHHHHHHHHHHTSCCCCGGGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCCCCCChHHHHHHHHhcCCCCCcchhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 9999987655444433332221 1123455678899999999999999999999999976
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-50 Score=437.56 Aligned_cols=254 Identities=23% Similarity=0.381 Sum_probs=210.3
Q ss_pred ceeeEEEeEeccCceEEEEEEec-CCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHHHH
Q 003052 472 KLYQRLGKIGSGGSSEVHKVISS-DCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLREV 550 (853)
Q Consensus 472 ~~Y~ilk~LG~G~FG~Vyka~~~-~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~~l 550 (853)
++|++++.||+|+||+||+|.+. +++.||||+++....+ ...+.+|+++|++++ ||||++++++
T Consensus 5 ~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~~---~~~~~~Ei~il~~l~-HpnIv~~~~~----------- 69 (321)
T d1tkia_ 5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTD---QVLVKKEISILNIAR-HRNILHLHES----------- 69 (321)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHH---HHHHHHHHHHHHHSC-CTTBCCEEEE-----------
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCccc---HHHHHHHHHHHHhCC-CCCCCeEEEE-----------
Confidence 45999999999999999999984 6789999999875432 345789999999998 8999999987
Q ss_pred hhCCCCCCCCccccCCeEEEEEecch-hhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCCCc
Q 003052 551 LNGSMNNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPA 629 (853)
Q Consensus 551 ~~~~iv~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLKPe 629 (853)
|++++++|||||||. ++|.+++... +..++|.+++.|+.||+.||.|||++||+||||||+
T Consensus 70 -----------~~~~~~~~lvmE~~~gg~L~~~i~~~-------~~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~ 131 (321)
T d1tkia_ 70 -----------FESMEELVMIFEFISGLDIFERINTS-------AFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPE 131 (321)
T ss_dssp -----------EEETTEEEEEECCCCCCBHHHHHTSS-------SCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGG
T ss_pred -----------EEECCEEEEEEecCCCCcHHHHHHhc-------CCCCCHHHHHHHHHHHHHHHHHHHHcCCCccccccc
Confidence 567789999999987 4999888643 346999999999999999999999999999999999
Q ss_pred cEEeec---CcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHhC
Q 003052 630 NFLLVK---GSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYG 706 (853)
Q Consensus 630 NILL~~---g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLtG 706 (853)
|||++. +.+||+|||+++...... ...+.+||+.|+|||++.+. .|+.++|||||||++|+|++|
T Consensus 132 NIll~~~~~~~ikl~DFG~~~~~~~~~---~~~~~~~t~~y~ape~~~~~---------~~~~~~DiWSlGvily~ll~G 199 (321)
T d1tkia_ 132 NIIYQTRRSSTIKIIEFGQARQLKPGD---NFRLLFTAPEYYAPEVHQHD---------VVSTATDMWSLGTLVYVLLSG 199 (321)
T ss_dssp GEEESSSSCCCEEECCCTTCEECCTTC---EEEEEESCGGGSCHHHHTTC---------EECHHHHHHHHHHHHHHHHHS
T ss_pred ceeecCCCceEEEEcccchhhccccCC---cccccccccccccchhccCC---------CCCchhhcccHHHHHHHHHhC
Confidence 999943 379999999998764322 23467899999999999765 467899999999999999999
Q ss_pred CCCCCcchhHHHHHHhhcCC-CCcccCCCCCChhHHHHHHHhcccCCCCCCChhHHhcCCCCCCC
Q 003052 707 RTPFSEYKTFWAKFKVITDP-NHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQHPFLVPP 770 (853)
Q Consensus 707 ~~PF~~~~~~~~~~kii~~~-~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~HPwf~~~ 770 (853)
++||.+.........+.... ..........++++++||.+||.+||.+|||+.|+|+||||+..
T Consensus 200 ~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~~ 264 (321)
T d1tkia_ 200 INPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQK 264 (321)
T ss_dssp SCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHSC
T ss_pred CCCCCCCCHHHHHHHHHhCCCCCChhhccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccC
Confidence 99998765544333333221 11112224578899999999999999999999999999999754
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-49 Score=433.12 Aligned_cols=261 Identities=26% Similarity=0.435 Sum_probs=206.6
Q ss_pred CceeeEEEeEeccCceEEEEEEe-cCCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHHH
Q 003052 471 GKLYQRLGKIGSGGSSEVHKVIS-SDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLRE 549 (853)
Q Consensus 471 g~~Y~ilk~LG~G~FG~Vyka~~-~~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~~ 549 (853)
.++|+++++||+|+||+||+|++ .+++.||||+++...........+.+|+++|++++ |||||++++++...
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~-hpniv~l~~~~~~~------ 89 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMR-HENVIGLLDVFTPD------ 89 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCC-BTTBCCCSEEECSC------
T ss_pred CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcC-CCCeeEEEEEeccC------
Confidence 35799999999999999999998 57899999999876666666778899999999997 99999999885432
Q ss_pred HhhCCCCCCCCccccCCeEEEEEecchhhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCCCc
Q 003052 550 VLNGSMNNKDGRVKDDGYIYMVLEYGEIDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPA 629 (853)
Q Consensus 550 l~~~~iv~~~g~~~d~~~lyLVmEy~~gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLKPe 629 (853)
+.+....++|+||||++.+|..++.. ..+++..++.|++||+.||+|||++||+||||||+
T Consensus 90 ----------~~~~~~~~~~lv~e~~~~~l~~~~~~---------~~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~ 150 (346)
T d1cm8a_ 90 ----------ETLDDFTDFYLVMPFMGTDLGKLMKH---------EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPG 150 (346)
T ss_dssp ----------SSTTTCCCCEEEEECCSEEHHHHHHH---------CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGG
T ss_pred ----------ccccccceEEEEEecccccHHHHHHh---------ccccHHHHHHHHHHHHHHHHHHHhCCCcccccCcc
Confidence 22344557899999998888777643 46999999999999999999999999999999999
Q ss_pred cEEe-ecCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHhCCC
Q 003052 630 NFLL-VKGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGRT 708 (853)
Q Consensus 630 NILL-~~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLtG~~ 708 (853)
|||+ .++.+||+|||+|+..... ....+||+.|+|||++.+.. .++.++|||||||++|+|++|++
T Consensus 151 NIL~~~~~~~kl~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~--------~~~~~~DiwSlGvil~ell~g~~ 217 (346)
T d1cm8a_ 151 NLAVNEDCELKILDFGLARQADSE-----MTGYVVTRWYRAPEVILNWM--------RYTQTVDIWSVGCIMAEMITGKT 217 (346)
T ss_dssp GEEECTTCCEEECCCTTCEECCSS-----CCSSCSCGGGCCTHHHHTTT--------CCCTTHHHHHHHHHHHHHHHSSC
T ss_pred hhhcccccccccccccceeccCCc-----cccccccccccCHHHHcCCC--------CCCccchhhcchHHHHHHHHCcC
Confidence 9999 5679999999999876432 23678999999999997643 35789999999999999999999
Q ss_pred CCCcchhHHHHHHh---hcCC-------------------------CCcccCCCCCChhHHHHHHHhcccCCCCCCChhH
Q 003052 709 PFSEYKTFWAKFKV---ITDP-------------------------NHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQ 760 (853)
Q Consensus 709 PF~~~~~~~~~~ki---i~~~-------------------------~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~E 760 (853)
||.+.+........ ...+ ..........++++.+||.+||.+||.+|||+.|
T Consensus 218 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e 297 (346)
T d1cm8a_ 218 LFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGE 297 (346)
T ss_dssp SSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHH
T ss_pred CCCCCChHHHHHHHHhccCCCcHHHHhhhcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHH
Confidence 99765433221111 1100 0001122456788999999999999999999999
Q ss_pred HhcCCCCCCC
Q 003052 761 LLQHPFLVPP 770 (853)
Q Consensus 761 IL~HPwf~~~ 770 (853)
+|+||||+..
T Consensus 298 iL~Hp~f~~~ 307 (346)
T d1cm8a_ 298 ALAHPYFESL 307 (346)
T ss_dssp HHHSGGGTTT
T ss_pred HhcChhhCcC
Confidence 9999999753
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-50 Score=439.15 Aligned_cols=257 Identities=23% Similarity=0.327 Sum_probs=204.6
Q ss_pred ceeeEEE-eEeccCceEEEEEEe-cCCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHHH
Q 003052 472 KLYQRLG-KIGSGGSSEVHKVIS-SDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLRE 549 (853)
Q Consensus 472 ~~Y~ilk-~LG~G~FG~Vyka~~-~~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~~ 549 (853)
+.|++++ .||+|+||+||+|++ .+++.||||+++.. ..+.+|+.++.++.+|||||++++++..
T Consensus 11 ~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-------~~~~~E~~~~~~~~~hpnIv~l~~~~~~------- 76 (335)
T d2ozaa1 11 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-------PKARREVELHWRASQCPHIVRIVDVYEN------- 76 (335)
T ss_dssp GTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS-------HHHHHHHHHHHHHTTSTTBCCEEEEEEE-------
T ss_pred cCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc-------HHHHHHHHHHHHhcCCCCCCeEEEEEee-------
Confidence 4598886 599999999999998 57899999999742 2467899999888789999999987532
Q ss_pred HhhCCCCCCCCccccCCeEEEEEecch-hhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCCC
Q 003052 550 VLNGSMNNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKP 628 (853)
Q Consensus 550 l~~~~iv~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLKP 628 (853)
.+..+.++|||||||+ |+|.+++.++ ....|+|.+++.|+.||+.||+|||++||+||||||
T Consensus 77 -----------~~~~~~~~~ivmEy~~gg~L~~~i~~~------~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp 139 (335)
T d2ozaa1 77 -----------LYAGRKCLLIVMECLDGGELFSRIQDR------GDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKP 139 (335)
T ss_dssp -----------EETTEEEEEEEEECCCSEEHHHHHHSC------SCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSG
T ss_pred -----------cccCCCEEEEEEECCCCCcHHHHHHhc------CCCCcCHHHHHHHHHHHHHHHHHHHHcCCccccccc
Confidence 1234578999999986 5999998653 235799999999999999999999999999999999
Q ss_pred ccEEee----cCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHH
Q 003052 629 ANFLLV----KGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMV 704 (853)
Q Consensus 629 eNILL~----~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELL 704 (853)
+|||++ .+.+||+|||+|+....... ....+||+.|||||++.+. .|+.++|||||||+||+|+
T Consensus 140 ~NIll~~~~~~~~~Kl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~---------~y~~~~DiwSlGvily~ll 207 (335)
T d2ozaa1 140 ENLLYTSKRPNAILKLTDFGFAKETTSHNS---LTTPCYTPYYVAPEVLGPE---------KYDKSCDMWSLGVIMYILL 207 (335)
T ss_dssp GGEEESCSSTTCCEEECCCTTCEECCCCCC---CCCCSCCCSSCCCCCCCGG---------GGSHHHHHHHHHHHHHHHT
T ss_pred cccccccccccccccccccceeeeccCCCc---cccccCCcccCCcHHHcCC---------CCCHHHHHHhhchhHHHHh
Confidence 999995 34799999999987654332 3467999999999999765 4678999999999999999
Q ss_pred hCCCCCCcchhH---HHHHHhhcCCCCcccC--CCCCChhHHHHHHHhcccCCCCCCChhHHhcCCCCCCCC
Q 003052 705 YGRTPFSEYKTF---WAKFKVITDPNHEITY--EPVPNPWLLDLMKKCLAWDRNERWRIPQLLQHPFLVPPV 771 (853)
Q Consensus 705 tG~~PF~~~~~~---~~~~kii~~~~~~~~~--~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~HPwf~~~~ 771 (853)
+|++||.+.... ......+......+.. ....++++++||.+||++||.+|||+.|+|+||||....
T Consensus 208 tg~~Pf~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~ 279 (335)
T d2ozaa1 208 CGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQST 279 (335)
T ss_dssp TSSCSCEETTCC--------CCCSCSSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHSHHHHTTT
T ss_pred hCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHhhCCC
Confidence 999999654322 1222222222221111 124688899999999999999999999999999996543
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6e-49 Score=430.46 Aligned_cols=259 Identities=25% Similarity=0.399 Sum_probs=206.3
Q ss_pred eeeEEEeEeccCceEEEEEEe-cCCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHHHHh
Q 003052 473 LYQRLGKIGSGGSSEVHKVIS-SDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLREVL 551 (853)
Q Consensus 473 ~Y~ilk~LG~G~FG~Vyka~~-~~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~~l~ 551 (853)
.|+.+++||+|+||+||+|++ .+++.||||+++..... +.+|+++|++|+ |+||+++++++...
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~------~~~Ei~il~~l~-h~niv~~~~~~~~~-------- 85 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF------KNRELQIMRKLD-HCNIVRLRYFFYSS-------- 85 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSS------CCHHHHHHHHCC-CTTBCCEEEEEEEC--------
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccchH------HHHHHHHHHhcC-CCCCCcEEEEEEec--------
Confidence 599999999999999999998 47899999999765432 347999999997 99999999985321
Q ss_pred hCCCCCCCCccccCCeEEEEEecchhhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCCCccE
Q 003052 552 NGSMNNKDGRVKDDGYIYMVLEYGEIDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANF 631 (853)
Q Consensus 552 ~~~iv~~~g~~~d~~~lyLVmEy~~gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLKPeNI 631 (853)
+...+..++||||||+++++...+..... ....+++.+++.|++||+.||+|||++||+||||||+||
T Consensus 86 --------~~~~~~~~~~lv~Ey~~~~~~~~l~~~~~----~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NI 153 (350)
T d1q5ka_ 86 --------GEKKDEVYLNLVLDYVPETVYRVARHYSR----AKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNL 153 (350)
T ss_dssp ----------CCSCCEEEEEEECCSEEHHHHHHHHHH----TTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGE
T ss_pred --------CccCCceEEEEEEeccCCccHHHHHhhhh----ccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceE
Confidence 11345678999999999877776654322 346799999999999999999999999999999999999
Q ss_pred Eee-cC-cEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHhCCCC
Q 003052 632 LLV-KG-SLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGRTP 709 (853)
Q Consensus 632 LL~-~g-~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLtG~~P 709 (853)
||+ ++ .+||+|||+|+.+.... ...+.+||+.|+|||++.+.. .|+.++|||||||++|||++|++|
T Consensus 154 Ll~~~~~~~kl~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~--------~~~~~~DIwSlG~il~el~~g~~p 222 (350)
T d1q5ka_ 154 LLDPDTAVLKLCDFGSAKQLVRGE---PNVSYICSRYYRAPELIFGAT--------DYTSSIDVWSAGCVLAELLLGQPI 222 (350)
T ss_dssp EECTTTCCEEECCCTTCEECCTTS---CCCSCCSCTTSCCHHHHTTCS--------SCCTHHHHHHHHHHHHHHHHTSCS
T ss_pred EEecCCCceeEecccchhhccCCc---ccccccccccccChHHhhccc--------CCCcceeecccceEEEehhhCCCC
Confidence 995 44 89999999998765432 234678999999999987542 467899999999999999999999
Q ss_pred CCcchhHHHHHHhh---cCCC-----------C------------cccCCCCCChhHHHHHHHhcccCCCCCCChhHHhc
Q 003052 710 FSEYKTFWAKFKVI---TDPN-----------H------------EITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQ 763 (853)
Q Consensus 710 F~~~~~~~~~~kii---~~~~-----------~------------~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~ 763 (853)
|...........++ ..+. . ........++++.+||.+||.+||.+|||+.|+|+
T Consensus 223 f~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 302 (350)
T d1q5ka_ 223 FPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 302 (350)
T ss_dssp SCCSSHHHHHHHHHHHHCCCCHHHHHHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CCCCCHHHHHHHHHHHhCCChHHhhhhhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 97654433322221 1100 0 00122356788999999999999999999999999
Q ss_pred CCCCCC
Q 003052 764 HPFLVP 769 (853)
Q Consensus 764 HPwf~~ 769 (853)
||||..
T Consensus 303 Hp~f~~ 308 (350)
T d1q5ka_ 303 HSFFDE 308 (350)
T ss_dssp SGGGGG
T ss_pred CHhhcc
Confidence 999965
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.5e-49 Score=424.17 Aligned_cols=268 Identities=29% Similarity=0.423 Sum_probs=204.0
Q ss_pred ceeeEEEeEeccCceEEEEEEe-cCCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHHHH
Q 003052 472 KLYQRLGKIGSGGSSEVHKVIS-SDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLREV 550 (853)
Q Consensus 472 ~~Y~ilk~LG~G~FG~Vyka~~-~~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~~l 550 (853)
.+|+++++||+|+||+||+|++ .+++.||||++............+.+|+++|++++ |+||+++++++......
T Consensus 10 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~-h~nii~~~~~~~~~~~~---- 84 (318)
T d3blha1 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLK-HENVVNLIEICRTKASP---- 84 (318)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCC-CTTBCCEEEEEEC--------
T ss_pred CCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhc-CCCccceEeeeeccccc----
Confidence 5799999999999999999998 57899999999776555555567889999999997 89999999886443211
Q ss_pred hhCCCCCCCCccccCCeEEEEEecchhhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCCCcc
Q 003052 551 LNGSMNNKDGRVKDDGYIYMVLEYGEIDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPAN 630 (853)
Q Consensus 551 ~~~~iv~~~g~~~d~~~lyLVmEy~~gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLKPeN 630 (853)
.....+.+|+||||+++++...+.. ....+++..++.|++||+.||.|||++||+||||||+|
T Consensus 85 ----------~~~~~~~~~iv~e~~~~~~~~~~~~-------~~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~N 147 (318)
T d3blha1 85 ----------YNRCKGSIYLVFDFCEHDLAGLLSN-------VLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAAN 147 (318)
T ss_dssp ----------------CEEEEEECCCEEHHHHHTC-------TTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGG
T ss_pred ----------ccccCceEEEEEeccCCCccchhhh-------cccccccHHHHHHHHHHHHHHHHhccCCEEecCcCchh
Confidence 1234567999999998776665543 34679999999999999999999999999999999999
Q ss_pred EEe-ecCcEEEEecccchhcccCC--ccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHhCC
Q 003052 631 FLL-VKGSLKLIDFGIAKAIMSDT--TNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGR 707 (853)
Q Consensus 631 ILL-~~g~VKL~DFGlAk~~~~~~--~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLtG~ 707 (853)
||+ .++.+||+|||+|+.+.... ......+.+||+.|+|||++.+.. .|+.++|||||||++|||++|+
T Consensus 148 ILl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~--------~~~~k~DiwSlGvil~el~~g~ 219 (318)
T d3blha1 148 VLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGER--------DYGPPIDLWGAGCIMAEMWTRS 219 (318)
T ss_dssp EEECTTSCEEECCCTTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCS--------SCCTHHHHHHHHHHHHHHHHSS
T ss_pred eeecCCCcEEeeecceeeecccccccccccccceecCHHHhhHHHHcCCC--------CCCcHHHcccCCceeeeHhhCC
Confidence 999 56799999999997654321 112234568999999999997642 4678999999999999999999
Q ss_pred CCCCcchhHHHH---HHhhcCCCCcccCC--------------------------CCCChhHHHHHHHhcccCCCCCCCh
Q 003052 708 TPFSEYKTFWAK---FKVITDPNHEITYE--------------------------PVPNPWLLDLMKKCLAWDRNERWRI 758 (853)
Q Consensus 708 ~PF~~~~~~~~~---~kii~~~~~~~~~~--------------------------~~~s~~l~dLI~kcL~~DP~kRpTa 758 (853)
+||.+....... .............. ...++++++||.+||++||++|||+
T Consensus 220 ~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa 299 (318)
T d3blha1 220 PIMQGNTEQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDS 299 (318)
T ss_dssp CSCCCSSHHHHHHHHHHHHCCCCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCH
T ss_pred CCCCCCCHHHHHHHHHHhcCCCChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCH
Confidence 999765443322 22222111110000 0125678899999999999999999
Q ss_pred hHHhcCCCCCC
Q 003052 759 PQLLQHPFLVP 769 (853)
Q Consensus 759 ~EIL~HPwf~~ 769 (853)
.|+|+||||..
T Consensus 300 ~elL~Hpff~~ 310 (318)
T d3blha1 300 DDALNHDFFWS 310 (318)
T ss_dssp HHHHHSGGGSS
T ss_pred HHHHcChhhcc
Confidence 99999999985
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.8e-49 Score=425.55 Aligned_cols=265 Identities=23% Similarity=0.361 Sum_probs=210.4
Q ss_pred eEEcCceeeEEEeEeccCceEEEEEEecC-C-----cEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehh
Q 003052 467 FKVNGKLYQRLGKIGSGGSSEVHKVISSD-C-----TIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYE 540 (853)
Q Consensus 467 ~~v~g~~Y~ilk~LG~G~FG~Vyka~~~~-g-----~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~ 540 (853)
+++.-++|++.++||+|+||+||+|++.. + ..||+|++..... ......+.+|+.+|.++.+|||||+++++
T Consensus 32 wei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~~HpnIv~l~~~- 109 (325)
T d1rjba_ 32 WEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKAD-SSEREALMSELKMMTQLGSHENIVNLLGA- 109 (325)
T ss_dssp GBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC-------CHHHHHHHHHHHHHCCCTTBCCEEEE-
T ss_pred ccCCHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccC-HHHHHHHHHHHHHHHHhcCCCcEeEEEEE-
Confidence 34555789999999999999999998742 2 3689999875433 33445688999999999779999999987
Q ss_pred hhHHHHHHHHhhCCCCCCCCccccCCeEEEEEecch-hhHHHHHHHhhhhc---------------cCCCCCCCHHHHHH
Q 003052 541 VTEKALLREVLNGSMNNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEM---------------DGSNQTLDENWLRF 604 (853)
Q Consensus 541 ~~e~~iL~~l~~~~iv~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~~---------------~~~~~~LsE~~~r~ 604 (853)
+.+.+.+||||||++ |+|.++|..+.... ......+++..++.
T Consensus 110 ---------------------~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 168 (325)
T d1rjba_ 110 ---------------------CTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLC 168 (325)
T ss_dssp ---------------------ECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHH
T ss_pred ---------------------EeeCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHH
Confidence 456678999999976 59999997643211 01234689999999
Q ss_pred HHHHhhhhhhhcccCceeeCCCCCccEEee-cCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCc
Q 003052 605 YWQQILEAVNTIHEERIVHSDLKPANFLLV-KGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGN 683 (853)
Q Consensus 605 I~~QIl~AL~yLHs~gIIHRDLKPeNILL~-~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~ 683 (853)
|+.||+.||+|||++|||||||||+|||++ ++.+||+|||+|+............+.+||+.|||||++.+.
T Consensus 169 i~~qi~~gl~yLH~~~IiHRDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~------- 241 (325)
T d1rjba_ 169 FAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEG------- 241 (325)
T ss_dssp HHHHHHHHHHHHHHTTEEETTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHC-------
T ss_pred HHHHHHHHHHHHHhCCeeeccCchhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCC-------
Confidence 999999999999999999999999999994 679999999999877655444444567899999999999765
Q ss_pred cccCCCccchhhhHHHHHHHHh-CCCCCCcchhHHHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCCChhHHh
Q 003052 684 IIKCGRPSDIWSLGCILYQMVY-GRTPFSEYKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLL 762 (853)
Q Consensus 684 ~~~ys~ksDIWSLGVILyELLt-G~~PF~~~~~~~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL 762 (853)
.|+.++|||||||+||||++ |++||.+........+++.. ...+..+...++++++||.+||+.||.+|||+.||+
T Consensus 242 --~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~~~~~~~~~~~-~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~ 318 (325)
T d1rjba_ 242 --IYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYKLIQN-GFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLT 318 (325)
T ss_dssp --CCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHT-TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred --CCCcceeccchhHHHHHHHhCCCCCCCCCCHHHHHHHHHhc-CCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHH
Confidence 36789999999999999997 89999875544444444433 234456677889999999999999999999999999
Q ss_pred cC
Q 003052 763 QH 764 (853)
Q Consensus 763 ~H 764 (853)
+|
T Consensus 319 ~~ 320 (325)
T d1rjba_ 319 SF 320 (325)
T ss_dssp HH
T ss_pred HH
Confidence 76
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.6e-48 Score=408.33 Aligned_cols=259 Identities=27% Similarity=0.430 Sum_probs=207.8
Q ss_pred ceeeEEEeEeccCceEEEEEEe-cCCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHHHH
Q 003052 472 KLYQRLGKIGSGGSSEVHKVIS-SDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLREV 550 (853)
Q Consensus 472 ~~Y~ilk~LG~G~FG~Vyka~~-~~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~~l 550 (853)
++|+++++||+|+||+||+|++ .+++.||||+++...........+.+|+.+|++++ |+||++++++
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~-h~niv~~~~~----------- 69 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELK-HKNIVRLHDV----------- 69 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCC-CTTBCCEEEE-----------
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcC-cCCEEeeccc-----------
Confidence 4699999999999999999998 57789999999887766667778999999999997 8999999887
Q ss_pred hhCCCCCCCCccccCCeEEEEEecchh-hHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCCCc
Q 003052 551 LNGSMNNKDGRVKDDGYIYMVLEYGEI-DLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPA 629 (853)
Q Consensus 551 ~~~~iv~~~g~~~d~~~lyLVmEy~~g-dL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLKPe 629 (853)
+.+...+++|||++.+ +|..++.. .+.+++..++.++.|++.||+|||++||+||||||+
T Consensus 70 -----------~~~~~~~~iv~~~~~~~~l~~~~~~--------~~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~ 130 (292)
T d1unla_ 70 -----------LHSDKKLTLVFEFCDQDLKKYFDSC--------NGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQ 130 (292)
T ss_dssp -----------EECSSEEEEEEECCSEEHHHHHHHT--------TTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGG
T ss_pred -----------cccccceeEEeeecccccccccccc--------ccccchhHHHHHHHHHHHHHHHhhcCCEeeecccCc
Confidence 5677889999999765 44444432 367899999999999999999999999999999999
Q ss_pred cEEe-ecCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHhCCC
Q 003052 630 NFLL-VKGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGRT 708 (853)
Q Consensus 630 NILL-~~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLtG~~ 708 (853)
|||| .++.+||+|||+|+....... ......+++.|+|||++.... .++.++|||||||++|||++|+.
T Consensus 131 NIli~~~~~~kl~DFG~a~~~~~~~~--~~~~~~~~~~~~~pe~~~~~~--------~~~~~~DiwSlG~il~ell~g~~ 200 (292)
T d1unla_ 131 NLLINRNGELKLANFGLARAFGIPVR--CYSAEVVTLWYRPPDVLFGAK--------LYSTSIDMWSAGCIFAELANAGR 200 (292)
T ss_dssp GEEECTTCCEEECCCTTCEECCSCCS--CCCSCCSCGGGCCHHHHTTCS--------CCCTHHHHHHHHHHHHHHTTTSC
T ss_pred ccccccCCceeeeecchhhcccCCCc--cceeeccccchhhhhHhccCC--------CCCchhhccccchHHHHHhhCCC
Confidence 9999 467999999999987654332 223557889999999987653 35789999999999999999999
Q ss_pred CCCcchhHHHHH----HhhcCCC-----------------------CcccCCCCCChhHHHHHHHhcccCCCCCCChhHH
Q 003052 709 PFSEYKTFWAKF----KVITDPN-----------------------HEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQL 761 (853)
Q Consensus 709 PF~~~~~~~~~~----kii~~~~-----------------------~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EI 761 (853)
||.........+ .....+. .........++.+.+||.+||++||.+|||++|+
T Consensus 201 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~ 280 (292)
T d1unla_ 201 PLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEA 280 (292)
T ss_dssp CSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHH
T ss_pred CCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHH
Confidence 974332222111 1111100 0111224457789999999999999999999999
Q ss_pred hcCCCCCCCC
Q 003052 762 LQHPFLVPPV 771 (853)
Q Consensus 762 L~HPwf~~~~ 771 (853)
|+||||....
T Consensus 281 L~Hp~f~~~~ 290 (292)
T d1unla_ 281 LQHPYFSDFC 290 (292)
T ss_dssp TTSGGGSSCS
T ss_pred hcChhhcCCC
Confidence 9999998654
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-48 Score=423.46 Aligned_cols=264 Identities=28% Similarity=0.420 Sum_probs=206.5
Q ss_pred ceeeEEEeEeccCceEEEEEEe-cCCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHHHH
Q 003052 472 KLYQRLGKIGSGGSSEVHKVIS-SDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLREV 550 (853)
Q Consensus 472 ~~Y~ilk~LG~G~FG~Vyka~~-~~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~~l 550 (853)
.+|+++++||+|+||+||+|++ .+++.||||++.... .......+.+|+.+|++|+ ||||+++++++..
T Consensus 8 ~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~~Ei~il~~l~-hp~iv~~~~~~~~-------- 77 (345)
T d1pmea_ 8 PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE-HQTYCQRTLREIKILLRFR-HENIIGINDIIRA-------- 77 (345)
T ss_dssp TTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTT-CHHHHHHHHHHHHHHHHCC-CTTBCCCCEEECC--------
T ss_pred CCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhc-ChHHHHHHHHHHHHHHHcC-CCCCCcEEEEEee--------
Confidence 4699999999999999999998 588999999997543 3445567889999999997 8999999987532
Q ss_pred hhCCCCCCCCccccCCeEEEEEecchhhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCCCcc
Q 003052 551 LNGSMNNKDGRVKDDGYIYMVLEYGEIDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPAN 630 (853)
Q Consensus 551 ~~~~iv~~~g~~~d~~~lyLVmEy~~gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLKPeN 630 (853)
..+....++|++|++++++|.+++.. ..+++..++.++.||+.||+|||++|||||||||+|
T Consensus 78 ---------~~~~~~~~~~l~~~~~~g~L~~~l~~---------~~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~N 139 (345)
T d1pmea_ 78 ---------PTIEQMKDVYLVTHLMGADLYKLLKT---------QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSN 139 (345)
T ss_dssp ---------SSTTTCCCEEEEEECCCEEHHHHHHH---------CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGG
T ss_pred ---------ccccccceEEEEEeecCCchhhhhhc---------CCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcce
Confidence 12345567888888898999999864 369999999999999999999999999999999999
Q ss_pred EEe-ecCcEEEEecccchhcccCCc-cccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHhCCC
Q 003052 631 FLL-VKGSLKLIDFGIAKAIMSDTT-NIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGRT 708 (853)
Q Consensus 631 ILL-~~g~VKL~DFGlAk~~~~~~~-~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLtG~~ 708 (853)
||| .++.+||+|||+|+....... .......+||+.|+|||++.... .|+.++||||+||++|+|++|+.
T Consensus 140 ILl~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~--------~~~~~~DiwSlG~il~eml~g~~ 211 (345)
T d1pmea_ 140 LLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSK--------GYTKSIDIWSVGCILAEMLSNRP 211 (345)
T ss_dssp EEECTTCCEEECCCTTCEECCGGGCBCCTTCCCCSCGGGCCGGGTTTBC--------SCSTHHHHHHHHHHHHHHHHSSC
T ss_pred EEECCCCCEEEcccCceeeccCCCccceeeccccccceechHHHhhcCC--------CCCchhhhhccCceehHHhhCCC
Confidence 999 567999999999986543222 12234678999999999986542 46789999999999999999999
Q ss_pred CCCcchhHHHH---HHhhcCCC----------------------Cc---ccCCCCCChhHHHHHHHhcccCCCCCCChhH
Q 003052 709 PFSEYKTFWAK---FKVITDPN----------------------HE---ITYEPVPNPWLLDLMKKCLAWDRNERWRIPQ 760 (853)
Q Consensus 709 PF~~~~~~~~~---~kii~~~~----------------------~~---~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~E 760 (853)
||.+....... ......+. .. .......++++++||.+||.+||.+|||+.|
T Consensus 212 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e 291 (345)
T d1pmea_ 212 IFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQ 291 (345)
T ss_dssp SCCCSSHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHH
T ss_pred CCCCCCHHHHHHHHhhhccCCChhhhhhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHH
Confidence 99764332111 11111100 00 0112456788999999999999999999999
Q ss_pred HhcCCCCCCCC
Q 003052 761 LLQHPFLVPPV 771 (853)
Q Consensus 761 IL~HPwf~~~~ 771 (853)
+|+||||....
T Consensus 292 ~L~hpf~~~~~ 302 (345)
T d1pmea_ 292 ALAHPYLEQYY 302 (345)
T ss_dssp HHTSGGGTTTC
T ss_pred HhcCHhhccCC
Confidence 99999998543
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.8e-48 Score=415.16 Aligned_cols=254 Identities=19% Similarity=0.323 Sum_probs=209.0
Q ss_pred eEEcCceeeEEEeEeccCceEEEEEEec-CCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHH
Q 003052 467 FKVNGKLYQRLGKIGSGGSSEVHKVISS-DCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKA 545 (853)
Q Consensus 467 ~~v~g~~Y~ilk~LG~G~FG~Vyka~~~-~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~ 545 (853)
+++..++|++.++||+|+||+||+|++. +++.||||+++..... ...|.+|+++|++|+ |||||+++++
T Consensus 12 wei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~---~~~~~~E~~il~~l~-HpnIv~~~~~------ 81 (287)
T d1opja_ 12 WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME---VEEFLKEAAVMKEIK-HPNLVQLLGV------ 81 (287)
T ss_dssp TBCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCSC---HHHHHHHHHHHHHCC-CTTBCCEEEE------
T ss_pred cEecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccch---HHHHHHHHHHHHhCC-CCCEecCCcc------
Confidence 3455678999999999999999999985 6788999999765443 346889999999997 9999999987
Q ss_pred HHHHHhhCCCCCCCCccccCCeEEEEEecch-hhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeC
Q 003052 546 LLREVLNGSMNNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHS 624 (853)
Q Consensus 546 iL~~l~~~~iv~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHR 624 (853)
+.+++.+||||||++ |+|.+++... ....+++..++.|+.||+.||+|||++||+||
T Consensus 82 ----------------~~~~~~~~iv~E~~~~g~l~~~l~~~------~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHr 139 (287)
T d1opja_ 82 ----------------CTREPPFYIITEFMTYGNLLDYLREC------NRQEVSAVVLLYMATQISSAMEYLEKKNFIHR 139 (287)
T ss_dssp ----------------ECSSSSCEEEEECCTTCBHHHHHHHS------CTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCS
T ss_pred ----------------EeeCCeeEEEeecccCcchHHHhhhc------cccchHHHHHHHHHHHHHHHHHHHHHCCcccC
Confidence 456678899999987 5888888654 34679999999999999999999999999999
Q ss_pred CCCCccEEe-ecCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHH
Q 003052 625 DLKPANFLL-VKGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQM 703 (853)
Q Consensus 625 DLKPeNILL-~~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyEL 703 (853)
||||+|||| .++.+||+|||+|+....... .......||+.|||||++.+.. |+.++|||||||++|||
T Consensus 140 DlKp~NILl~~~~~~Kl~DFG~a~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~---------~~~k~DiwS~Gv~l~el 209 (287)
T d1opja_ 140 DLAARNCLVGENHLVKVADFGLSRLMTGDTY-TAHAGAKFPIKWTAPESLAYNK---------FSIKSDVWAFGVLLWEI 209 (287)
T ss_dssp CCSGGGEEECGGGCEEECCCCCTTTCCSSSS-EEETTEEECGGGCCHHHHHHCC---------CSHHHHHHHHHHHHHHH
T ss_pred ccccCeEEECCCCcEEEccccceeecCCCCc-eeeccccccccccChHHHcCCC---------CCchhhhhhHHHHHHHH
Confidence 999999999 567999999999987654332 2233456899999999998753 67899999999999999
Q ss_pred HhCCCCCCcchhHHHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCCChhHHhc
Q 003052 704 VYGRTPFSEYKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQ 763 (853)
Q Consensus 704 LtG~~PF~~~~~~~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~ 763 (853)
++|..||............+.. ......+...++.+.+||.+||..||.+|||+.||++
T Consensus 210 l~~~~p~~~~~~~~~~~~~i~~-~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~ 268 (287)
T d1opja_ 210 ATYGMSPYPGIDLSQVYELLEK-DYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ 268 (287)
T ss_dssp HTTSCCSSTTCCHHHHHHHHHT-TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HhCCCCCCCcchHHHHHHHHhc-CCCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence 9977666544444444444443 2344566678899999999999999999999999976
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-48 Score=413.61 Aligned_cols=256 Identities=23% Similarity=0.305 Sum_probs=206.0
Q ss_pred EEcCceeeEEEeEeccCceEEEEEEecCCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHH
Q 003052 468 KVNGKLYQRLGKIGSGGSSEVHKVISSDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALL 547 (853)
Q Consensus 468 ~v~g~~Y~ilk~LG~G~FG~Vyka~~~~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL 547 (853)
++..+.|+++++||+|+||.||+|.+++++.||||+++..... ...|.+|+++|++++ |||||++++++
T Consensus 9 ei~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~---~~~~~~E~~~l~~l~-HpnIv~~~g~~------- 77 (272)
T d1qpca_ 9 EVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS---PDAFLAEANLMKQLQ-HQRLVRLYAVV------- 77 (272)
T ss_dssp BCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSSC---HHHHHHHHHHHHHCC-CTTBCCEEEEE-------
T ss_pred ecCHHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCcCC---HHHHHHHHHHHHhCC-CCCEeEEEeee-------
Confidence 4556789999999999999999999988889999999765433 346899999999996 99999999863
Q ss_pred HHHhhCCCCCCCCccccCCeEEEEEecch-hhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCC
Q 003052 548 REVLNGSMNNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDL 626 (853)
Q Consensus 548 ~~l~~~~iv~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDL 626 (853)
. ++.+||||||+. |+|.+++.... ...+++..+..|+.||+.||.|||++||+||||
T Consensus 78 ---------------~-~~~~~iv~Ey~~~g~L~~~~~~~~------~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDi 135 (272)
T d1qpca_ 78 ---------------T-QEPIYIITEYMENGSLVDFLKTPS------GIKLTINKLLDMAAQIAEGMAFIEERNYIHRDL 135 (272)
T ss_dssp ---------------C-SSSCEEEEECCTTCBHHHHTTSHH------HHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCC
T ss_pred ---------------c-cCCeEEEEEeCCCCcHHHHHhhcC------CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCcc
Confidence 1 234689999976 58887765432 235999999999999999999999999999999
Q ss_pred CCccEEee-cCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHh
Q 003052 627 KPANFLLV-KGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVY 705 (853)
Q Consensus 627 KPeNILL~-~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLt 705 (853)
||+||||+ ++.+||+|||+|+.+.... ........||+.|||||++.+. .|+.++|||||||++|||+|
T Consensus 136 Kp~NIll~~~~~~Kl~DFGla~~~~~~~-~~~~~~~~gt~~y~APE~~~~~---------~~~~~sDvwS~Gvvl~ellt 205 (272)
T d1qpca_ 136 RAANILVSDTLSCKIADFGLARLIEDNE-YTAREGAKFPIKWTAPEAINYG---------TFTIKSDVWSFGILLTEIVT 205 (272)
T ss_dssp SGGGEEECTTSCEEECCCTTCEECSSSC-EECCTTCCCCTTTSCHHHHHHC---------EECHHHHHHHHHHHHHHHHT
T ss_pred chhheeeecccceeeccccceEEccCCc-cccccccCCcccccChHHHhCC---------CCCchhhhhhhHHHHHHHHh
Confidence 99999995 5799999999998765432 2233456899999999999765 36789999999999999999
Q ss_pred CC-CCCCcchhHHHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCCChhHHhc--CCCCC
Q 003052 706 GR-TPFSEYKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQ--HPFLV 768 (853)
Q Consensus 706 G~-~PF~~~~~~~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~--HPwf~ 768 (853)
|. +||.... .......+.. ......+...++++.+||.+||..||++|||+.+|++ |+||.
T Consensus 206 ~~~~~~~~~~-~~~~~~~i~~-~~~~~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~ft 269 (272)
T d1qpca_ 206 HGRIPYPGMT-NPEVIQNLER-GYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFT 269 (272)
T ss_dssp TTCCSSTTCC-HHHHHHHHHT-TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCCCCCCC-HHHHHHHHHh-cCCCCCcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhh
Confidence 64 4554433 3333333333 2334456678899999999999999999999999987 67663
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.7e-48 Score=406.40 Aligned_cols=249 Identities=21% Similarity=0.329 Sum_probs=193.0
Q ss_pred CceeeEEEeEeccCceEEEEEEecCCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHHHH
Q 003052 471 GKLYQRLGKIGSGGSSEVHKVISSDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLREV 550 (853)
Q Consensus 471 g~~Y~ilk~LG~G~FG~Vyka~~~~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~~l 550 (853)
.++|+++++||+|+||.||+|.+.+++.||||+++..... ...|.+|+++|++++ ||||++++++
T Consensus 4 p~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~---~~~~~~E~~~l~~l~-HpnIv~~~g~----------- 68 (263)
T d1sm2a_ 4 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMS---EEDFIEEAEVMMKLS-HPKLVQLYGV----------- 68 (263)
T ss_dssp CSCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSSSC---HHHHHHHHHHHHHCC-CTTBCCEEEE-----------
T ss_pred hHHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCcCc---HHHHHHHHHHHHhcC-CCCcccccce-----------
Confidence 3569999999999999999999988889999999765443 346899999999997 9999999987
Q ss_pred hhCCCCCCCCccccCCeEEEEEecch-hhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCCCc
Q 003052 551 LNGSMNNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPA 629 (853)
Q Consensus 551 ~~~~iv~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLKPe 629 (853)
+.+++.+|+||||+. ++|.+++... ...+++..+..|+.||+.||.|||+++|+||||||+
T Consensus 69 -----------~~~~~~~~lv~E~~~~g~L~~~l~~~-------~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~ 130 (263)
T d1sm2a_ 69 -----------CLEQAPICLVFEFMEHGCLSDYLRTQ-------RGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAAR 130 (263)
T ss_dssp -----------ECSSSSCEEEEECCTTCBHHHHHHTT-------TTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGG
T ss_pred -----------eccCCceEEEEEecCCCcHHHHhhcc-------ccCCCHHHHHHHHHHHHHHHHhhhccceeecccchh
Confidence 345567899999976 5888887543 357899999999999999999999999999999999
Q ss_pred cEEee-cCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHh-CC
Q 003052 630 NFLLV-KGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVY-GR 707 (853)
Q Consensus 630 NILL~-~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLt-G~ 707 (853)
|||++ ++.+||+|||+|+........ ......||+.|||||++.+.. |+.++|||||||++|||+| |.
T Consensus 131 Nill~~~~~~Kl~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~---------~~~k~DVwS~Gvil~el~t~~~ 200 (263)
T d1sm2a_ 131 NCLVGENQVIKVSDFGMTRFVLDDQYT-SSTGTKFPVKWASPEVFSFSR---------YSSKSDVWSFGVLMWEVFSEGK 200 (263)
T ss_dssp GEEECGGGCEEECSCC-------------------CTTSCCHHHHTTCC---------CCHHHHHHHHHHHHHHHHTTSC
T ss_pred heeecCCCCeEecccchheeccCCCce-eecceecCcccCChHHhcCCC---------CCchhhhcchHHHHHHHHHCCC
Confidence 99995 679999999999876543322 223568999999999997653 6789999999999999999 56
Q ss_pred CCCCcchhHHHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCCChhHHhcC
Q 003052 708 TPFSEYKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQH 764 (853)
Q Consensus 708 ~PF~~~~~~~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~H 764 (853)
+||...... .....+.. ......+...++++.+||.+||..||++|||+.||++|
T Consensus 201 ~~~~~~~~~-~~~~~i~~-~~~~~~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~ 255 (263)
T d1sm2a_ 201 IPYENRSNS-EVVEDIST-GFRLYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQ 255 (263)
T ss_dssp CTTCSCCHH-HHHHHHHH-TCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCCCCHH-HHHHHHHh-cCCCCCccccCHHHHHHHHHHccCCHhHCcCHHHHHHH
Confidence 666554333 33333322 22334456678899999999999999999999999975
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=6.3e-48 Score=408.56 Aligned_cols=261 Identities=24% Similarity=0.372 Sum_probs=201.9
Q ss_pred CceeeEEEeEeccCceEEEEEEe-cCCcEEEEEEEecCCC-ChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHH
Q 003052 471 GKLYQRLGKIGSGGSSEVHKVIS-SDCTIYALKKIKLKGR-DYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLR 548 (853)
Q Consensus 471 g~~Y~ilk~LG~G~FG~Vyka~~-~~g~~vAVKkik~~~~-~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~ 548 (853)
.++|++.+.||+|+||.||+|++ .+++.||||+++.... +......+.+|+++|++++ ||||+++++++..+
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~-hpniv~~~~~~~~~----- 79 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN-HPAIVAVYDTGEAE----- 79 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCC-CTTBCCEEEEEEEE-----
T ss_pred cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcC-CCCCCcccceeeec-----
Confidence 35699999999999999999998 5789999999986543 4455667899999999987 89999999975321
Q ss_pred HHhhCCCCCCCCccccCCeEEEEEecch-hhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCC
Q 003052 549 EVLNGSMNNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLK 627 (853)
Q Consensus 549 ~l~~~~iv~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLK 627 (853)
......+||||||++ ++|.+++... +.+++..++.|+.||+.||.|||++||||||||
T Consensus 80 -------------~~~~~~~~lvmE~~~g~~L~~~~~~~--------~~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiK 138 (277)
T d1o6ya_ 80 -------------TPAGPLPYIVMEYVDGVTLRDIVHTE--------GPMTPKRAIEVIADACQALNFSHQNGIIHRDVK 138 (277)
T ss_dssp -------------CSSSEEEEEEEECCCEEEHHHHHHHH--------CSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCS
T ss_pred -------------cCCCceEEEEEECCCCCEehhhhccc--------CCCCHHHHHHHHHHHHHHHHHHHhCCccCcccc
Confidence 112346899999987 5888877654 579999999999999999999999999999999
Q ss_pred CccEEe-ecCcEEEEecccchhcccCC-ccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHh
Q 003052 628 PANFLL-VKGSLKLIDFGIAKAIMSDT-TNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVY 705 (853)
Q Consensus 628 PeNILL-~~g~VKL~DFGlAk~~~~~~-~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLt 705 (853)
|+|||| .++.++|+|||+++...... ........+||+.|||||++.+.. |+.++|||||||++|||+|
T Consensus 139 P~NIll~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~---------~~~~~DiwSlGvilyellt 209 (277)
T d1o6ya_ 139 PANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDS---------VDARSDVYSLGCVLYEVLT 209 (277)
T ss_dssp GGGEEEETTSCEEECCCTTCEECC----------------TTCCHHHHTTCC---------CCHHHHHHHHHHHHHHHHH
T ss_pred CcccccCccccceeehhhhhhhhccccccccccccccCcccccCHHHHcCCC---------CCcceecccchHHHHHHHh
Confidence 999999 56799999999987654322 222334678999999999997653 5689999999999999999
Q ss_pred CCCCCCcchhHHHHHHhhcCCC-CcccCCCCCChhHHHHHHHhcccCCCCCCChhHHhcCCCC
Q 003052 706 GRTPFSEYKTFWAKFKVITDPN-HEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQHPFL 767 (853)
Q Consensus 706 G~~PF~~~~~~~~~~kii~~~~-~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~HPwf 767 (853)
|++||.+........+.+.... .........++++.+||.+||.+||.+||+..+.|.|+|+
T Consensus 210 G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~ 272 (277)
T d1o6ya_ 210 GEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLV 272 (277)
T ss_dssp SSCSCCCSSHHHHHHHHHHCCCCCGGGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHH
T ss_pred CCCCCCCcCHHHHHHHHHhcCCCCCchhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHH
Confidence 9999988766655555554432 2234456788999999999999999999954444445554
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=4.6e-48 Score=418.43 Aligned_cols=251 Identities=28% Similarity=0.444 Sum_probs=199.1
Q ss_pred ceeeEEEeEeccCceEEEEEEe-cCCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHHHH
Q 003052 472 KLYQRLGKIGSGGSSEVHKVIS-SDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLREV 550 (853)
Q Consensus 472 ~~Y~ilk~LG~G~FG~Vyka~~-~~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~~l 550 (853)
++|+++++||+|+||+||+|++ .+++.||||+++... ...+.+|+.+|+++.+||||+++++++.
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~-----~~~~~~Ei~il~~l~~hpnIv~~~~~~~--------- 100 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK-----KKKIKREIKILENLRGGPNIITLADIVK--------- 100 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC-----HHHHHHHHHHHHHHTTSTTBCCEEEEEE---------
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH-----HHHHHHHHHHHHhccCCCCCcEEEEEEE---------
Confidence 5799999999999999999998 578999999997532 3457899999999998999999998743
Q ss_pred hhCCCCCCCCccccCCeEEEEEecchh-hHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCCCc
Q 003052 551 LNGSMNNKDGRVKDDGYIYMVLEYGEI-DLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPA 629 (853)
Q Consensus 551 ~~~~iv~~~g~~~d~~~lyLVmEy~~g-dL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLKPe 629 (853)
.....++|+||||+++ +|..+ .+.+++..++.+++||+.||+|||++||+||||||+
T Consensus 101 -----------~~~~~~~~~v~e~~~~~~L~~~-----------~~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~ 158 (328)
T d3bqca1 101 -----------DPVSRTPALVFEHVNNTDFKQL-----------YQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPH 158 (328)
T ss_dssp -----------CTTTCSEEEEEECCCSCBGGGT-----------TTSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGG
T ss_pred -----------ecCCCceeEEEeecCCCcHHHH-----------hcCCCHHHHHHHHHHHHHHHHHHhhccccccccccc
Confidence 1345679999999875 54322 246999999999999999999999999999999999
Q ss_pred cEEee-cC-cEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHhCC
Q 003052 630 NFLLV-KG-SLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGR 707 (853)
Q Consensus 630 NILL~-~g-~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLtG~ 707 (853)
|||++ ++ .+||+|||+|+...... .....+||+.|+|||++.+.. .|+.++|||||||++|+|++|+
T Consensus 159 NILi~~~~~~vkl~DFG~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~--------~~~~~~DiwslG~~l~e~~~g~ 227 (328)
T d3bqca1 159 NVMIDHEHRKLRLIDWGLAEFYHPGQ---EYNVRVASRYFKGPELLVDYQ--------MYDYSLDMWSLGCMLASMIFRK 227 (328)
T ss_dssp GEEEETTTTEEEECCGGGCEECCTTC---CCCSCCSCGGGCCHHHHTTCC--------CCCTHHHHHHHHHHHHHHHHTC
T ss_pred ceEEcCCCCeeeecccccceeccCCC---cccccccCccccCcccccCCC--------CCCcccchhhhhhhhHHhccCC
Confidence 99995 44 69999999998765432 234678999999999987653 3678999999999999999999
Q ss_pred CCCCcchhHH----HHHHhhc-------------CCCC------------------cccCCCCCChhHHHHHHHhcccCC
Q 003052 708 TPFSEYKTFW----AKFKVIT-------------DPNH------------------EITYEPVPNPWLLDLMKKCLAWDR 752 (853)
Q Consensus 708 ~PF~~~~~~~----~~~kii~-------------~~~~------------------~~~~~~~~s~~l~dLI~kcL~~DP 752 (853)
.||....... .....+. .... ........++++++||++||.+||
T Consensus 228 ~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP 307 (328)
T d3bqca1 228 EPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDH 307 (328)
T ss_dssp SSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSG
T ss_pred CCCCCCchhHHHHHHHHHHHCCchhhhhhhhcccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCCh
Confidence 9996432211 1111100 0000 000112357789999999999999
Q ss_pred CCCCChhHHhcCCCCCC
Q 003052 753 NERWRIPQLLQHPFLVP 769 (853)
Q Consensus 753 ~kRpTa~EIL~HPwf~~ 769 (853)
.+|||++|+|+||||+.
T Consensus 308 ~~R~ta~e~L~Hp~F~~ 324 (328)
T d3bqca1 308 QSRLTAREAMEHPYFYT 324 (328)
T ss_dssp GGSCCHHHHHTSGGGTT
T ss_pred hHCcCHHHHhcCcccCC
Confidence 99999999999999975
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-47 Score=408.73 Aligned_cols=247 Identities=21% Similarity=0.323 Sum_probs=196.1
Q ss_pred EeEeccCceEEEEEEec---CCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHHHHhhCC
Q 003052 478 GKIGSGGSSEVHKVISS---DCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLREVLNGS 554 (853)
Q Consensus 478 k~LG~G~FG~Vyka~~~---~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~~l~~~~ 554 (853)
++||+|+||.||+|.+. .++.||||+++....+......|.+|+++|++++ |||||++++++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~-HpnIv~~~g~~-------------- 77 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLD-NPYIVRMIGIC-------------- 77 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCC-CTTBCCEEEEE--------------
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCC-CCCCceEEEEe--------------
Confidence 46999999999999863 3468999999866555556678999999999997 99999999873
Q ss_pred CCCCCCccccCCeEEEEEecch-hhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCCCccEEe
Q 003052 555 MNNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPANFLL 633 (853)
Q Consensus 555 iv~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLKPeNILL 633 (853)
.+ +.+||||||++ |+|.+++... ..+++..+..|+.||+.||+|||++|||||||||+||||
T Consensus 78 --------~~-~~~~lvmE~~~~g~L~~~l~~~--------~~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill 140 (277)
T d1xbba_ 78 --------EA-ESWMLVMEMAELGPLNKYLQQN--------RHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLL 140 (277)
T ss_dssp --------ES-SSEEEEEECCTTEEHHHHHHHC--------TTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE
T ss_pred --------cc-CCEEEEEEcCCCCcHHHHHhhc--------cCCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhcc
Confidence 22 34689999987 5899888654 579999999999999999999999999999999999999
Q ss_pred -ecCcEEEEecccchhcccCCcc-ccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHh-CCCCC
Q 003052 634 -VKGSLKLIDFGIAKAIMSDTTN-IQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVY-GRTPF 710 (853)
Q Consensus 634 -~~g~VKL~DFGlAk~~~~~~~~-~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLt-G~~PF 710 (853)
.++.+||+|||+|+.+...... .......||+.|||||++.+. .|+.++|||||||++|||++ |++||
T Consensus 141 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~---------~~~~~sDiwS~Gv~l~ellt~g~~Pf 211 (277)
T d1xbba_ 141 VTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYY---------KFSSKSDVWSFGVLMWEAFSYGQKPY 211 (277)
T ss_dssp EETTEEEECCCTTCEECCTTCSEEEC----CCCGGGCCHHHHHHC---------EEEHHHHHHHHHHHHHHHHTTTCCSS
T ss_pred cccCcccccchhhhhhccccccccccccccCCCceecCchhhcCC---------CCCchhhhccchhhhhHHhhCCCCCC
Confidence 5689999999999876543222 122346799999999999765 36789999999999999997 89999
Q ss_pred CcchhHHHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCCChhHHh---cCCCC
Q 003052 711 SEYKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLL---QHPFL 767 (853)
Q Consensus 711 ~~~~~~~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL---~HPwf 767 (853)
.+.... .....+.. ......+...++++.+||.+||..||.+|||+.+|+ +|+|+
T Consensus 212 ~~~~~~-~~~~~i~~-~~~~~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~~ 269 (277)
T d1xbba_ 212 RGMKGS-EVTAMLEK-GERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYY 269 (277)
T ss_dssp TTCCHH-HHHHHHHT-TCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred CCCCHH-HHHHHHHc-CCCCCCCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCHHh
Confidence 876543 33333332 233455677889999999999999999999999984 55553
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.8e-48 Score=419.51 Aligned_cols=265 Identities=28% Similarity=0.435 Sum_probs=209.9
Q ss_pred eeEEcCceeeEEEeEeccCceEEEEEEe-cCCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHH
Q 003052 466 FFKVNGKLYQRLGKIGSGGSSEVHKVIS-SDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEK 544 (853)
Q Consensus 466 ~~~v~g~~Y~ilk~LG~G~FG~Vyka~~-~~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~ 544 (853)
.|++. ++|+++++||+|+||+||+|++ .+++.||||+++....+......+.+|+++|++|+ |+||+++++++..
T Consensus 13 ~~~~~-~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~-h~~iv~~~~~~~~-- 88 (348)
T d2gfsa1 13 IWEVP-ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMK-HENVIGLLDVFTP-- 88 (348)
T ss_dssp EEEEE-TTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCC-CTTBCCCSEEECS--
T ss_pred cccCC-CCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcC-CCCeeeEEEEEee--
Confidence 45553 5699999999999999999998 57899999999887777677778899999999997 9999999987532
Q ss_pred HHHHHHhhCCCCCCCCccccCCeEEEEEecchhhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeC
Q 003052 545 ALLREVLNGSMNNKDGRVKDDGYIYMVLEYGEIDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHS 624 (853)
Q Consensus 545 ~iL~~l~~~~iv~~~g~~~d~~~lyLVmEy~~gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHR 624 (853)
...+.+...+|++|++++++|.+++.. +.+++..++.|++||+.||+|||++||+||
T Consensus 89 --------------~~~~~~~~~~~i~~~~~gg~L~~~~~~---------~~l~e~~~~~i~~qil~aL~~LH~~giiHr 145 (348)
T d2gfsa1 89 --------------ARSLEEFNDVYLVTHLMGADLNNIVKC---------QKLTDDHVQFLIYQILRGLKYIHSADIIHR 145 (348)
T ss_dssp --------------CSSTTTCCCCEEEEECCSEEHHHHHTT---------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCC
T ss_pred --------------ccccccCceEEEEEeecCCchhhhccc---------ccccHHHHHHHHHHHHHHHHHHHhCCCccc
Confidence 122355666788887788899988743 469999999999999999999999999999
Q ss_pred CCCCccEEe-ecCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHH
Q 003052 625 DLKPANFLL-VKGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQM 703 (853)
Q Consensus 625 DLKPeNILL-~~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyEL 703 (853)
||||+|||+ .+|.+||+|||+|..... ...+.+||+.|+|||++.+.. .++.++|||||||++|+|
T Consensus 146 DiKp~NILi~~~~~~kl~dfg~a~~~~~-----~~~~~~g~~~y~apE~~~~~~--------~~~~~~DiwSlGv~l~~l 212 (348)
T d2gfsa1 146 DLKPSNLAVNEDCELKILDFGLARHTDD-----EMTGYVATRWYRAPEIMLNWM--------HYNQTVDIWSVGCIMAEL 212 (348)
T ss_dssp CCCGGGEEECTTCCEEECCC----CCTG-----GGSSSCHHHHTSCHHHHTTCS--------CCCTTHHHHHHHHHHHHH
T ss_pred ccCCccccccccccccccccchhcccCc-----ccccccccccccCchhhcCCc--------cCCcccchhhhhHHHHHH
Confidence 999999999 567999999999976532 234678999999999987643 357899999999999999
Q ss_pred HhCCCCCCcchhHHHHHHh---hcCCCCc----------------------c---cCCCCCChhHHHHHHHhcccCCCCC
Q 003052 704 VYGRTPFSEYKTFWAKFKV---ITDPNHE----------------------I---TYEPVPNPWLLDLMKKCLAWDRNER 755 (853)
Q Consensus 704 LtG~~PF~~~~~~~~~~ki---i~~~~~~----------------------~---~~~~~~s~~l~dLI~kcL~~DP~kR 755 (853)
++|++||.+.+.......+ ....... . ......++++++||.+||.+||.+|
T Consensus 213 l~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R 292 (348)
T d2gfsa1 213 LTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKR 292 (348)
T ss_dssp HHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGS
T ss_pred HhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhC
Confidence 9999999765443222221 1111000 0 0113467889999999999999999
Q ss_pred CChhHHhcCCCCCCC
Q 003052 756 WRIPQLLQHPFLVPP 770 (853)
Q Consensus 756 pTa~EIL~HPwf~~~ 770 (853)
||+.|+|+||||+..
T Consensus 293 ~ta~elL~Hp~f~~~ 307 (348)
T d2gfsa1 293 ITAAQALAHAYFAQY 307 (348)
T ss_dssp CCHHHHHTSGGGTTT
T ss_pred cCHHHHhcCHhhCCC
Confidence 999999999999864
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-47 Score=409.50 Aligned_cols=265 Identities=20% Similarity=0.325 Sum_probs=203.2
Q ss_pred EEcCceeeEEEeEeccCceEEEEEEec------CCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhh
Q 003052 468 KVNGKLYQRLGKIGSGGSSEVHKVISS------DCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEV 541 (853)
Q Consensus 468 ~v~g~~Y~ilk~LG~G~FG~Vyka~~~------~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~ 541 (853)
++..++|++.++||+|+||.||+|.+. +++.||||+++.... ......+.+|+.++.++.+|+||+++++++
T Consensus 9 ei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~-~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~- 86 (299)
T d1ywna1 9 EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT-HSEHRALMSELKILIHIGHHLNVVNLLGAC- 86 (299)
T ss_dssp BCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----C-HHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-
T ss_pred cccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccC-cHHHHHHHHHHHHHHhhcCCCeEEEeeeee-
Confidence 344577999999999999999999863 336899999875433 344567889999999999999999998763
Q ss_pred hHHHHHHHHhhCCCCCCCCccccCCeEEEEEecch-hhHHHHHHHhhhhcc--------CCCCCCCHHHHHHHHHHhhhh
Q 003052 542 TEKALLREVLNGSMNNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEMD--------GSNQTLDENWLRFYWQQILEA 612 (853)
Q Consensus 542 ~e~~iL~~l~~~~iv~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~~~--------~~~~~LsE~~~r~I~~QIl~A 612 (853)
+.++..+|+||||++ ++|.+++........ .....+++..++.|+.||+.|
T Consensus 87 --------------------~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~g 146 (299)
T d1ywna1 87 --------------------TKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKG 146 (299)
T ss_dssp --------------------CSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHH
T ss_pred --------------------ccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHH
Confidence 344567899999987 699999876533211 123468999999999999999
Q ss_pred hhhcccCceeeCCCCCccEEe-ecCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCcc
Q 003052 613 VNTIHEERIVHSDLKPANFLL-VKGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPS 691 (853)
Q Consensus 613 L~yLHs~gIIHRDLKPeNILL-~~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ks 691 (853)
|.|||++|||||||||+|||| .++.+||+|||+|+..............+||+.|||||++.+. .|+.++
T Consensus 147 l~ylH~~~ivHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~---------~~~~~s 217 (299)
T d1ywna1 147 MEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDR---------VYTIQS 217 (299)
T ss_dssp HHHHHHTTCCCSCCCGGGEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHC---------CCCHHH
T ss_pred HHHHHhCCCcCCcCCccceeECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcC---------CCCccc
Confidence 999999999999999999999 4679999999999876654444445567899999999999875 367899
Q ss_pred chhhhHHHHHHHHhC-CCCCCcchhHHHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCCChhHHhcC
Q 003052 692 DIWSLGCILYQMVYG-RTPFSEYKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQH 764 (853)
Q Consensus 692 DIWSLGVILyELLtG-~~PF~~~~~~~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~H 764 (853)
|||||||++|||++| .+||.+..........+.. ......+...++++.+||.+||..||.+|||+.||++|
T Consensus 218 DiwS~Gvil~ellt~~~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~ 290 (299)
T d1ywna1 218 DVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKE-GTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 290 (299)
T ss_dssp HHHHHHHHHHHHHTTSCCSSTTCCCSHHHHHHHHH-TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ceeehHHHHHHHHhCCCCCCCCCCHHHHHHHHHhc-CCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 999999999999986 5788765433333333332 22344566788999999999999999999999999986
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-47 Score=401.70 Aligned_cols=248 Identities=20% Similarity=0.313 Sum_probs=207.2
Q ss_pred ceeeEEEeEeccCceEEEEEEecCCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHHHHh
Q 003052 472 KLYQRLGKIGSGGSSEVHKVISSDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLREVL 551 (853)
Q Consensus 472 ~~Y~ilk~LG~G~FG~Vyka~~~~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~~l~ 551 (853)
++|+++++||+|+||+||+|++++++.||||+++...... ..|++|++++.+++ ||||++++++
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~~~---~~~~~Ev~~~~~l~-HpnIv~~~g~------------ 67 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE---DEFIEEAKVMMNLS-HEKLVQLYGV------------ 67 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSSCH---HHHHHHHHHHHTCC-CTTBCCEEEE------------
T ss_pred HHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcCCH---HHHHHHHHHHHhcC-CCceeeEEEE------------
Confidence 4688999999999999999999888899999998765443 46899999999997 9999999987
Q ss_pred hCCCCCCCCccccCCeEEEEEecch-hhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCCCcc
Q 003052 552 NGSMNNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPAN 630 (853)
Q Consensus 552 ~~~iv~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLKPeN 630 (853)
+.+++.+|+||||++ |+|.+++... ...+++..++.|+.||+.||.|||++||+||||||+|
T Consensus 68 ----------~~~~~~~~iv~Ey~~~g~l~~~~~~~-------~~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~N 130 (258)
T d1k2pa_ 68 ----------CTKQRPIFIITEYMANGCLLNYLREM-------RHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARN 130 (258)
T ss_dssp ----------ECCSSSEEEEEECCTTEEHHHHHHSG-------GGCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGG
T ss_pred ----------EeeCCceEEEEEccCCCcHHHhhhcc-------ccCCcHHHHHHHHHHHHHHHHHHhhcCccccccccee
Confidence 456678999999986 6777776543 2468999999999999999999999999999999999
Q ss_pred EEee-cCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHh-CCC
Q 003052 631 FLLV-KGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVY-GRT 708 (853)
Q Consensus 631 ILL~-~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLt-G~~ 708 (853)
||++ ++.+||+|||+|+.+..... ......+||+.|+|||++.+.. |+.++|||||||++|||+| |+.
T Consensus 131 ill~~~~~~kl~DfG~a~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~---------~~~ksDiwS~G~~l~el~t~g~~ 200 (258)
T d1k2pa_ 131 CLVNDQGVVKVSDFGLSRYVLDDEY-TSSVGSKFPVRWSPPEVLMYSK---------FSSKSDIWAFGVLMWEIYSLGKM 200 (258)
T ss_dssp EEECTTCCEEECCCSSCCBCSSSSC-CCCCCSCCCGGGCCHHHHHHCC---------CCHHHHHHHHHHHHHHHHTTSCC
T ss_pred EEEcCCCcEEECcchhheeccCCCc-eeecccCCCCCcCCcHHhcCCC---------CCcceeecccchhhHhHHhcCCC
Confidence 9995 57999999999986654322 2334568999999999998753 5689999999999999998 899
Q ss_pred CCCcchhHHHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCCChhHHhcC
Q 003052 709 PFSEYKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQH 764 (853)
Q Consensus 709 PF~~~~~~~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~H 764 (853)
||.+.........+ .. ......+...++.+.+||.+||+.||.+|||+.+||+|
T Consensus 201 Pf~~~~~~~~~~~i-~~-~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 254 (258)
T d1k2pa_ 201 PYERFTNSETAEHI-AQ-GLRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSN 254 (258)
T ss_dssp TTTTSCHHHHHHHH-HT-TCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred CCCCCCHHHHHHHH-Hh-CCCCCCcccccHHHHHHHHHHccCCHhHCcCHHHHHHH
Confidence 99876654433333 33 23445566778899999999999999999999999987
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-47 Score=420.25 Aligned_cols=259 Identities=27% Similarity=0.404 Sum_probs=198.3
Q ss_pred ceeeEEEeEeccCceEEEEEEec-CCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHHHH
Q 003052 472 KLYQRLGKIGSGGSSEVHKVISS-DCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLREV 550 (853)
Q Consensus 472 ~~Y~ilk~LG~G~FG~Vyka~~~-~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~~l 550 (853)
++|+++++||+|+||+||+|++. +++.||||++............+.+|+.+|++++ ||||+++++++..+
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~~~~~f~~~------- 88 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVN-HKNIISLLNVFTPQ------- 88 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCC-CTTBCCCSEEECSC-------
T ss_pred CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcC-CCCeeEEEEEEecc-------
Confidence 45999999999999999999984 7899999999877666666677899999999996 99999999875421
Q ss_pred hhCCCCCCCCccccCCeEEEEEecchhhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCCCcc
Q 003052 551 LNGSMNNKDGRVKDDGYIYMVLEYGEIDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPAN 630 (853)
Q Consensus 551 ~~~~iv~~~g~~~d~~~lyLVmEy~~gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLKPeN 630 (853)
+.+++..++|+||||+.+++...+. ..+++..++.+++||+.||.|||++||+||||||+|
T Consensus 89 ---------~~~~~~~~~~iv~Ey~~~~l~~~~~----------~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~N 149 (355)
T d2b1pa1 89 ---------KTLEEFQDVYLVMELMDANLCQVIQ----------MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSN 149 (355)
T ss_dssp ---------CSTTTCCEEEEEEECCSEEHHHHHT----------SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGG
T ss_pred ---------cccccCceeEEEEeccchHHHHhhh----------cCCCHHHHHHHHHHHHHHHHHhhhcccccccCCccc
Confidence 2345678999999999988877663 358999999999999999999999999999999999
Q ss_pred EEee-cCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHhCCCC
Q 003052 631 FLLV-KGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYGRTP 709 (853)
Q Consensus 631 ILL~-~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLtG~~P 709 (853)
||+. ++.+||+|||+++...... .....+||+.|+|||++.+. .|+.++||||+||++|+|++|++|
T Consensus 150 il~~~~~~~kl~df~~~~~~~~~~---~~~~~~~t~~y~aPE~l~~~---------~~~~~~DiwSlG~~l~ell~g~~p 217 (355)
T d2b1pa1 150 IVVKSDCTLKILDFGLARTAGTSF---MMTPYVVTRYYRAPEVILGM---------GYKENVDIWSVGCIMGEMVRHKIL 217 (355)
T ss_dssp EEECTTCCEEECCCCC------------------CCTTCCHHHHTTC---------CCCTTHHHHHHHHHHHHHHHSSCS
T ss_pred cccccccceeeechhhhhcccccc---ccccccccccccChhhhcCC---------CCCCCcccccccchHHHHhhCCCC
Confidence 9994 7799999999998764422 33467899999999999765 357899999999999999999999
Q ss_pred CCcchhHHHHHHhh---cCC------------------CCcc------------cCC------CCCChhHHHHHHHhccc
Q 003052 710 FSEYKTFWAKFKVI---TDP------------------NHEI------------TYE------PVPNPWLLDLMKKCLAW 750 (853)
Q Consensus 710 F~~~~~~~~~~kii---~~~------------------~~~~------------~~~------~~~s~~l~dLI~kcL~~ 750 (853)
|.+........+++ ..+ .... ... ...++++.+||++||.+
T Consensus 218 F~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~ 297 (355)
T d2b1pa1 218 FPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVI 297 (355)
T ss_dssp SCCSSHHHHHHHHHHHHCCCCHHHHTTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCS
T ss_pred CCCCCHHHHHHHHHHhccCCCHHHHHHhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcC
Confidence 97544332221111 100 0000 000 11245689999999999
Q ss_pred CCCCCCChhHHhcCCCCCC
Q 003052 751 DRNERWRIPQLLQHPFLVP 769 (853)
Q Consensus 751 DP~kRpTa~EIL~HPwf~~ 769 (853)
||++|||++|+|+||||+.
T Consensus 298 dP~~R~ta~elL~Hpw~~~ 316 (355)
T d2b1pa1 298 DPAKRISVDDALQHPYINV 316 (355)
T ss_dssp STTTSCCHHHHHTSTTTGG
T ss_pred ChhHCcCHHHHhcCcccCC
Confidence 9999999999999999975
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.2e-48 Score=417.71 Aligned_cols=258 Identities=24% Similarity=0.388 Sum_probs=209.3
Q ss_pred ceeeEEEeEeccCceEEEEEEec----CCcEEEEEEEecCCC--ChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHH
Q 003052 472 KLYQRLGKIGSGGSSEVHKVISS----DCTIYALKKIKLKGR--DYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKA 545 (853)
Q Consensus 472 ~~Y~ilk~LG~G~FG~Vyka~~~----~g~~vAVKkik~~~~--~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~ 545 (853)
++|+++++||+|+||+||+|.+. +|+.||||++++... +......+.+|+++|++++|||||++++++
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~------ 97 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYA------ 97 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEE------
T ss_pred hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeee------
Confidence 56999999999999999999862 578999999975432 222345678999999999988999999886
Q ss_pred HHHHHhhCCCCCCCCccccCCeEEEEEecch-hhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeC
Q 003052 546 LLREVLNGSMNNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHS 624 (853)
Q Consensus 546 iL~~l~~~~iv~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHR 624 (853)
+.+...+|+||||+. ++|.+++... ..+++..++.++.||+.||+|||++||+||
T Consensus 98 ----------------~~~~~~~~~v~e~~~~~~L~~~i~~~--------~~~~e~~~~~~~~Qi~~al~~lH~~~ivHr 153 (322)
T d1vzoa_ 98 ----------------FQTETKLHLILDYINGGELFTHLSQR--------ERFTEHEVQIYVGEIVLALEHLHKLGIIYR 153 (322)
T ss_dssp ----------------EEETTEEEEEECCCCSCBHHHHHHHH--------SCCCHHHHHHHHHHHHHHHHHHHHTTCCCC
T ss_pred ----------------eccCCceeeeeecccccHHHHHHHhc--------ccccHHHHHHHHHHHHHHHHHhhcCCEEec
Confidence 567788999999976 5999888765 578999999999999999999999999999
Q ss_pred CCCCccEEe-ecCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHH
Q 003052 625 DLKPANFLL-VKGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQM 703 (853)
Q Consensus 625 DLKPeNILL-~~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyEL 703 (853)
||||+|||| .+|.+||+|||+|+.+...... ...+..|++.|+|||.+.+... +|+.++|||||||+||+|
T Consensus 154 DiKp~Nill~~~~~vkL~DFG~a~~~~~~~~~-~~~~~~g~~~~~~pe~~~~~~~-------~~~~ksDIWSlG~iLyel 225 (322)
T d1vzoa_ 154 DIKLENILLDSNGHVVLTDFGLSKEFVADETE-RAYDFCGTIEYMAPDIVRGGDS-------GHDKAVDWWSLGVLMYEL 225 (322)
T ss_dssp CCCGGGEEECTTSCEEESCSSEEEECCGGGGG-GGCGGGSCCTTCCHHHHTTCC----------CTHHHHHHHHHHHHHH
T ss_pred cCCccceeecCCCCEEEeeccchhhhcccccc-cccccccccccchhHHhhcCCc-------CCCchhhhHHHHHHHHHH
Confidence 999999999 4679999999999876443222 2346789999999999976532 467899999999999999
Q ss_pred HhCCCCCCcch---hHHHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCC-----ChhHHhcCCCCCC
Q 003052 704 VYGRTPFSEYK---TFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERW-----RIPQLLQHPFLVP 769 (853)
Q Consensus 704 LtG~~PF~~~~---~~~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRp-----Ta~EIL~HPwf~~ 769 (853)
++|+.||.+.. ........... ....++...++++.+||.+||.+||.+|| |++|+|+||||+.
T Consensus 226 ltG~~PF~~~~~~~~~~~i~~~~~~--~~~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~Hpff~~ 297 (322)
T d1vzoa_ 226 LTGASPFTVDGEKNSQAEISRRILK--SEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQK 297 (322)
T ss_dssp HHSSCTTSCTTSCCCHHHHHHHHHH--CCCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTT
T ss_pred HhCCCCCCCCCHHHHHHHHHHhccc--CCCCCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcCHhhcC
Confidence 99999996532 22222222221 22344567889999999999999999999 5899999999975
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.7e-47 Score=404.96 Aligned_cols=253 Identities=21% Similarity=0.336 Sum_probs=203.7
Q ss_pred ceeeEEE-eEeccCceEEEEEEec---CCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHH
Q 003052 472 KLYQRLG-KIGSGGSSEVHKVISS---DCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALL 547 (853)
Q Consensus 472 ~~Y~ilk-~LG~G~FG~Vyka~~~---~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL 547 (853)
+.|.+.+ +||+|+||.||+|.++ ++..||||+++... .......|.+|+++|++++ |||||++++++
T Consensus 8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~-~~~~~~~~~~E~~il~~l~-HpnIv~l~g~~------- 78 (285)
T d1u59a_ 8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT-EKADTEEMMREAQIMHQLD-NPYIVRLIGVC------- 78 (285)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSC-CHHHHHHHHHHHHHHHHCC-CTTBCCEEEEE-------
T ss_pred cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhc-CHHHHHHHHHHHHHHHhCC-CCCEeeEeeee-------
Confidence 5578887 4999999999999863 34579999997543 3455677999999999997 99999999873
Q ss_pred HHHhhCCCCCCCCccccCCeEEEEEecch-hhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCC
Q 003052 548 REVLNGSMNNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDL 626 (853)
Q Consensus 548 ~~l~~~~iv~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDL 626 (853)
.+ +.+||||||++ |+|.+++... ...+++..++.|+.||+.||.|||++||+||||
T Consensus 79 ---------------~~-~~~~lvmE~~~~g~L~~~l~~~-------~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDl 135 (285)
T d1u59a_ 79 ---------------QA-EALMLVMEMAGGGPLHKFLVGK-------REEIPVSNVAELLHQVSMGMKYLEEKNFVHRDL 135 (285)
T ss_dssp ---------------ES-SSEEEEEECCTTEEHHHHHTTC-------TTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCC
T ss_pred ---------------cc-CeEEEEEEeCCCCcHHHHhhcc-------ccCCCHHHHHHHHHHHHHHHHHHHhCCeecCcC
Confidence 22 34799999987 5888876542 357999999999999999999999999999999
Q ss_pred CCccEEe-ecCcEEEEecccchhcccCCc-cccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHH
Q 003052 627 KPANFLL-VKGSLKLIDFGIAKAIMSDTT-NIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMV 704 (853)
Q Consensus 627 KPeNILL-~~g~VKL~DFGlAk~~~~~~~-~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELL 704 (853)
||+|||| .++.+||+|||+|+.+..... .......+||+.|||||++.+. .|+.++|||||||++|||+
T Consensus 136 Kp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---------~~~~ksDVwS~Gv~l~E~l 206 (285)
T d1u59a_ 136 AARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFR---------KFSSRSDVWSYGVTMWEAL 206 (285)
T ss_dssp SGGGEEEEETTEEEECCCTTCEECTTCSCEECCCCSSCCCGGGCCHHHHHHC---------EECHHHHHHHHHHHHHHHH
T ss_pred chhheeeccCCceeeccchhhhcccccccccccccccccCccccChHHHhCC---------CCCccchhhcchHHHHHHH
Confidence 9999999 577999999999987654322 1223456799999999999765 3678999999999999999
Q ss_pred h-CCCCCCcchhHHHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCCChhHH---hcCCCC
Q 003052 705 Y-GRTPFSEYKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQL---LQHPFL 767 (853)
Q Consensus 705 t-G~~PF~~~~~~~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EI---L~HPwf 767 (853)
| |+.||.+...... ...+.. ......+...++++.+||.+||..||++|||+.+| |+|+|+
T Consensus 207 t~G~~Pf~~~~~~~~-~~~i~~-~~~~~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~ 271 (285)
T d1u59a_ 207 SYGQKPYKKMKGPEV-MAFIEQ-GKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYY 271 (285)
T ss_dssp TTSCCTTTTCCTHHH-HHHHHT-TCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred hCCCCCCCCCCHHHH-HHHHHc-CCCCCCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 8 9999987654332 233332 23344567788999999999999999999999888 556665
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=6.5e-47 Score=406.74 Aligned_cols=252 Identities=21% Similarity=0.254 Sum_probs=191.8
Q ss_pred CceeeEEEeEeccCceEEEEEEec-CC---cEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHH
Q 003052 471 GKLYQRLGKIGSGGSSEVHKVISS-DC---TIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKAL 546 (853)
Q Consensus 471 g~~Y~ilk~LG~G~FG~Vyka~~~-~g---~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~i 546 (853)
.+.|++.++||+|+||+||+|.+. ++ ..||||++.... .......|.+|+++|++|+ |||||+++++
T Consensus 25 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~-HpnIv~l~g~------- 95 (299)
T d1jpaa_ 25 ISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY-TEKQRRDFLSEASIMGQFD-HPNVIHLEGV------- 95 (299)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSC-CHHHHHHHHHHHHHHTTCC-CTTBCCEEEE-------
T ss_pred hhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECccc-CHHHHHHHHHHHHHHHhCC-CCCCccEEEE-------
Confidence 356999999999999999999874 33 358888876543 3345567999999999997 9999999987
Q ss_pred HHHHhhCCCCCCCCccccCCeEEEEEecch-hhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCC
Q 003052 547 LREVLNGSMNNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSD 625 (853)
Q Consensus 547 L~~l~~~~iv~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRD 625 (853)
+.+++.+|+||||+. ++|.+++... .+.+++..+..|+.||+.||.|||++||+|||
T Consensus 96 ---------------~~~~~~~~iv~Ey~~~g~L~~~~~~~-------~~~l~~~~~~~i~~qia~gl~yLH~~~iiHrD 153 (299)
T d1jpaa_ 96 ---------------VTKSTPVMIITEFMENGSLDSFLRQN-------DGQFTVIQLVGMLRGIAAGMKYLADMNYVHRD 153 (299)
T ss_dssp ---------------ECSSSSCEEEEECCTTEEHHHHHHTT-------TTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSC
T ss_pred ---------------EeeCCEEEEEEEecCCCcceeeeccc-------cCCCCHHHHHHHHHHHHHHHHHHhhCCCccCc
Confidence 445667899999987 4788776542 35799999999999999999999999999999
Q ss_pred CCCccEEee-cCcEEEEecccchhcccCCcccc---ccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHH
Q 003052 626 LKPANFLLV-KGSLKLIDFGIAKAIMSDTTNIQ---RDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILY 701 (853)
Q Consensus 626 LKPeNILL~-~g~VKL~DFGlAk~~~~~~~~~~---~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILy 701 (853)
|||+||||+ ++.+||+|||+|+.+........ .....||+.|||||++.+.. |+.++|||||||+||
T Consensus 154 lKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~---------~~~~sDvwS~Gvvl~ 224 (299)
T d1jpaa_ 154 LAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRK---------FTSASDVWSYGIVMW 224 (299)
T ss_dssp CCGGGEEECTTCCEEECCC-----------------------CGGGSCHHHHHSCC---------CCHHHHHHHHHHHHH
T ss_pred cccceEEECCCCcEEECCcccceEccCCCCcceeeecccccCCccccCHHHHhcCC---------CCcccccccchHHHH
Confidence 999999994 67999999999987654322211 12346899999999997653 568999999999999
Q ss_pred HHHh-CCCCCCcchhHHHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCCChhHHhcC
Q 003052 702 QMVY-GRTPFSEYKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQH 764 (853)
Q Consensus 702 ELLt-G~~PF~~~~~~~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~H 764 (853)
||+| |++||.+.........+.. ......+...+..+.+||.+||..||.+|||+.||+++
T Consensus 225 el~t~g~~Pf~~~~~~~~~~~i~~--~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~ 286 (299)
T d1jpaa_ 225 EVMSYGERPYWDMTNQDVINAIEQ--DYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNT 286 (299)
T ss_dssp HHHTTSCCTTTTCCHHHHHHHHHT--TCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred HHHhCCCCCCCCCCHHHHHHHHHc--CCCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 9998 8999987655433333332 23344566788999999999999999999999998854
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-46 Score=402.41 Aligned_cols=260 Identities=23% Similarity=0.255 Sum_probs=203.0
Q ss_pred EcCceeeEEEeEeccCceEEEEEEecCCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHH
Q 003052 469 VNGKLYQRLGKIGSGGSSEVHKVISSDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLR 548 (853)
Q Consensus 469 v~g~~Y~ilk~LG~G~FG~Vyka~~~~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~ 548 (853)
+..++|++.++||+|+||.||+|++++++.||||+++..... ...|.+|+.+|++++ |+|||++++++
T Consensus 14 i~~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~~~---~~~~~~E~~~l~~l~-h~nIv~~~g~~-------- 81 (285)
T d1fmka3 14 IPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS---PEAFLQEAQVMKKLR-HEKLVQLYAVV-------- 81 (285)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSSC---HHHHHHHHHHHHHCC-CTTBCCEEEEE--------
T ss_pred cCHHHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcccCC---HHHHHHHHHHHHhcc-cCCEeEEEEEE--------
Confidence 344679999999999999999999988888999999765443 346899999999997 89999999873
Q ss_pred HHhhCCCCCCCCccccCCeEEEEEecch-hhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCC
Q 003052 549 EVLNGSMNNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLK 627 (853)
Q Consensus 549 ~l~~~~iv~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLK 627 (853)
.+ +.+|+||||+. |+|..++.... ...+++.+++.|+.||+.||+|||++||+|||||
T Consensus 82 --------------~~-~~~~lv~Ey~~~g~l~~~~~~~~------~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlK 140 (285)
T d1fmka3 82 --------------SE-EPIYIVTEYMSKGSLLDFLKGET------GKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLR 140 (285)
T ss_dssp --------------CS-SSCEEEECCCTTCBHHHHHSHHH------HTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCS
T ss_pred --------------ec-CCeEEEEEecCCCchhhhhhhcc------cccchHHHHHHHHHHHHHHHHHHhhhheeccccc
Confidence 22 34689999976 47777776542 2469999999999999999999999999999999
Q ss_pred CccEEee-cCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHhC
Q 003052 628 PANFLLV-KGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYG 706 (853)
Q Consensus 628 PeNILL~-~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLtG 706 (853)
|+||||+ ++.+||+|||+|+.+.... .......+||+.|+|||++.... ++.++|||||||++|||++|
T Consensus 141 p~NIll~~~~~~kl~DfGla~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~---------~~~ksDI~S~Giil~el~t~ 210 (285)
T d1fmka3 141 AANILVGENLVCKVADFGLARLIEDNE-YTARQGAKFPIKWTAPEAALYGR---------FTIKSDVWSFGILLTELTTK 210 (285)
T ss_dssp GGGEEECGGGCEEECCCCTTC---------------CCGGGSCHHHHHHCC---------CCHHHHHHHHHHHHHHHHTT
T ss_pred ceEEEECCCCcEEEcccchhhhccCCC-ceeeccccccccccChHHHhCCC---------CCcHHhhhcchHHHHHHHhC
Confidence 9999995 6799999999998764322 22334568999999999997653 56899999999999999996
Q ss_pred CCCCCcchhHHHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCCChhHHhc--CCCCCCCCC
Q 003052 707 RTPFSEYKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQ--HPFLVPPVS 772 (853)
Q Consensus 707 ~~PF~~~~~~~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~--HPwf~~~~~ 772 (853)
..||............+.. ......+...++++++||.+||+.||++||++.+|++ |+||....+
T Consensus 211 ~~p~~~~~~~~~~~~~i~~-~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~~p 277 (285)
T d1fmka3 211 GRVPYPGMVNREVLDQVER-GYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEP 277 (285)
T ss_dssp TCCSSTTCCHHHHHHHHHT-TCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSCC
T ss_pred CCCCCCCCCHHHHHHHHHh-cCCCCCCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcCCCC
Confidence 5555433333334443332 2334456778899999999999999999999999988 899976543
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-46 Score=397.34 Aligned_cols=253 Identities=23% Similarity=0.360 Sum_probs=192.9
Q ss_pred EEcCceeeEEEeEeccCceEEEEEEecC----CcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhH
Q 003052 468 KVNGKLYQRLGKIGSGGSSEVHKVISSD----CTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTE 543 (853)
Q Consensus 468 ~v~g~~Y~ilk~LG~G~FG~Vyka~~~~----g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e 543 (853)
++..++|++.+.||+|+||.||+|++.. +..||||+++... .......+.+|+++|++++ ||||+++++++
T Consensus 3 ei~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~-~~~~~~~~~~E~~~l~~l~-HpnIv~l~~~~--- 77 (273)
T d1mp8a_ 3 EIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCT-SDSVREKFLQEALTMRQFD-HPHIVKLIGVI--- 77 (273)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTT-SHHHHHHHHHHHHHHHTCC-CTTBCCEEEEE---
T ss_pred CcCHHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEecccc-CHHHHHHHHHHHHHHHhCC-CCCEeeEEEEE---
Confidence 4555789999999999999999998742 2468888876443 3445567999999999997 99999999873
Q ss_pred HHHHHHHhhCCCCCCCCccccCCeEEEEEecch-hhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCcee
Q 003052 544 KALLREVLNGSMNNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIV 622 (853)
Q Consensus 544 ~~iL~~l~~~~iv~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gII 622 (853)
. ++.+|+||||+. ++|.+++... ...+++..++.++.||+.||.|||++||+
T Consensus 78 -------------------~-~~~~~iv~E~~~~g~l~~~~~~~-------~~~l~~~~~~~~~~qi~~gl~ylH~~~ii 130 (273)
T d1mp8a_ 78 -------------------T-ENPVWIIMELCTLGELRSFLQVR-------KYSLDLASLILYAYQLSTALAYLESKRFV 130 (273)
T ss_dssp -------------------C-SSSCEEEEECCTTEEHHHHHHHT-------TTTSCHHHHHHHHHHHHHHHHHHHHTTCC
T ss_pred -------------------e-cCeEEEEEEeccCCcHHhhhhcc-------CCCCCHHHHHHHHHHHHHHhhhhcccCee
Confidence 2 346799999987 5777766543 35799999999999999999999999999
Q ss_pred eCCCCCccEEe-ecCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHH
Q 003052 623 HSDLKPANFLL-VKGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILY 701 (853)
Q Consensus 623 HRDLKPeNILL-~~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILy 701 (853)
||||||+|||+ .++.+||+|||+|+.+..... ......+||+.|+|||++.+.. |+.++|||||||++|
T Consensus 131 HrDlKp~NIll~~~~~~Kl~DfG~a~~~~~~~~-~~~~~~~gt~~y~apE~l~~~~---------~~~~~DiwSlGvil~ 200 (273)
T d1mp8a_ 131 HRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTY-YKASKGKLPIKWMAPESINFRR---------FTSASDVWMFGVCMW 200 (273)
T ss_dssp CSCCSGGGEEEEETTEEEECC--------------------CCGGGCCHHHHHHCC---------CSHHHHHHHHHHHHH
T ss_pred ccccchhheeecCCCcEEEccchhheeccCCcc-eeccceecCcccchhhHhccCC---------CCCccccccchHHHH
Confidence 99999999999 568999999999987643222 2234567899999999997653 568999999999999
Q ss_pred HHHh-CCCCCCcchhHHHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCCChhHHhcC
Q 003052 702 QMVY-GRTPFSEYKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQH 764 (853)
Q Consensus 702 ELLt-G~~PF~~~~~~~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~H 764 (853)
||++ |.+||.+.........+.. ......+...++.+.+||.+||..||.+|||+.||++|
T Consensus 201 e~lt~g~~P~~~~~~~~~~~~i~~--~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~ 262 (273)
T d1mp8a_ 201 EILMHGVKPFQGVKNNDVIGRIEN--GERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQ 262 (273)
T ss_dssp HHHTTSCCTTTTCCGGGHHHHHHT--TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHhcCCCCCCCCCHHHHHHHHHc--CCCCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 9997 8999977554333333322 23345567788999999999999999999999999865
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-46 Score=404.44 Aligned_cols=251 Identities=17% Similarity=0.306 Sum_probs=194.0
Q ss_pred CceeeEEEeEeccCceEEEEEEec-CCc----EEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHH
Q 003052 471 GKLYQRLGKIGSGGSSEVHKVISS-DCT----IYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKA 545 (853)
Q Consensus 471 g~~Y~ilk~LG~G~FG~Vyka~~~-~g~----~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~ 545 (853)
..+|+++++||+|+||+||+|.+. +++ .||+|+++... .......|.+|+++|++++ |||||++++++
T Consensus 8 ~~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~-HpnIv~l~g~~----- 80 (317)
T d1xkka_ 8 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASVD-NPHVCRLLGIC----- 80 (317)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC-----CTHHHHHHHHHHHHHCC-CTTBCCEEEEE-----
T ss_pred HHHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEecccc-CHHHHHHHHHHHHHHHhCC-CCCEeeEEEEE-----
Confidence 356999999999999999999874 443 58888886432 2334557899999999997 99999999874
Q ss_pred HHHHHhhCCCCCCCCccccCCeEEEEEec-chhhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeC
Q 003052 546 LLREVLNGSMNNKDGRVKDDGYIYMVLEY-GEIDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHS 624 (853)
Q Consensus 546 iL~~l~~~~iv~~~g~~~d~~~lyLVmEy-~~gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHR 624 (853)
.++ ..+++||| .+++|.+.+... ...+++..++.|+.||+.||.|||++|||||
T Consensus 81 -----------------~~~-~~~~v~e~~~~~~l~~~~~~~-------~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHr 135 (317)
T d1xkka_ 81 -----------------LTS-TVQLITQLMPFGCLLDYVREH-------KDNIGSQYLLNWCVQIAKGMNYLEDRRLVHR 135 (317)
T ss_dssp -----------------ESS-SEEEEEECCTTCBHHHHHHHT-------SSSCCHHHHHHHHHHHHHHHHHHHHTTCCCS
T ss_pred -----------------ecC-CeeEEEEeccCCccccccccc-------ccCCCHHHHHHHHHHHHHHHHHHHHcCcccC
Confidence 333 34566666 556888877653 4579999999999999999999999999999
Q ss_pred CCCCccEEe-ecCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHH
Q 003052 625 DLKPANFLL-VKGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQM 703 (853)
Q Consensus 625 DLKPeNILL-~~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyEL 703 (853)
||||+|||| .++.+||+|||+|+.+.............||+.|||||++.+.. |+.++|||||||++|||
T Consensus 136 DlKp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~---------~~~~sDvwS~Gvil~el 206 (317)
T d1xkka_ 136 DLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI---------YTHQSDVWSYGVTVWEL 206 (317)
T ss_dssp CCCGGGEEEEETTEEEECCCSHHHHTTTTCC--------CCTTTSCHHHHHHCC---------CCHHHHHHHHHHHHHHH
T ss_pred cchhhcceeCCCCCeEeeccccceecccccccccccccccCccccChHHHhcCC---------CChhhhhhhHHHHHHHH
Confidence 999999999 46799999999999876544433344567999999999998753 67899999999999999
Q ss_pred Hh-CCCCCCcchhHHHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCCChhHHhcC
Q 003052 704 VY-GRTPFSEYKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQH 764 (853)
Q Consensus 704 Lt-G~~PF~~~~~~~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~H 764 (853)
+| |.+||.+..... ....+.. ......+...++.+.+||.+||..||.+|||+.||++|
T Consensus 207 ~t~g~~p~~~~~~~~-~~~~i~~-~~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~ 266 (317)
T d1xkka_ 207 MTFGSKPYDGIPASE-ISSILEK-GERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIE 266 (317)
T ss_dssp HTTSCCTTTTSCGGG-HHHHHHH-TCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHCCCCCCCCCCHHH-HHHHHHc-CCCCCCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHH
Confidence 98 899997643322 2222222 23334566788999999999999999999999999987
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.1e-46 Score=394.44 Aligned_cols=251 Identities=20% Similarity=0.260 Sum_probs=192.2
Q ss_pred ceeeEEEeEeccCceEEEEEEecCC-----cEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHH
Q 003052 472 KLYQRLGKIGSGGSSEVHKVISSDC-----TIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKAL 546 (853)
Q Consensus 472 ~~Y~ilk~LG~G~FG~Vyka~~~~g-----~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~i 546 (853)
..|++.+.||+|+||.||+|.++.+ ..||||++..... ......|++|+++|++|+ |||||+++++
T Consensus 7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~-~~~~~~~~~E~~il~~l~-H~nIv~~~g~------- 77 (283)
T d1mqba_ 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYT-EKQRVDFLGEAGIMGQFS-HHNIIRLEGV------- 77 (283)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCC-HHHHHHHHHHHHHHHTCC-CTTBCCEEEE-------
T ss_pred HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccC-hHHHHHHHHHHHHHHhcC-CCCEeeeeEE-------
Confidence 4589999999999999999987432 3699999975433 344557899999999997 8999999987
Q ss_pred HHHHhhCCCCCCCCccccCCeEEEEEecchh-hHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCC
Q 003052 547 LREVLNGSMNNKDGRVKDDGYIYMVLEYGEI-DLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSD 625 (853)
Q Consensus 547 L~~l~~~~iv~~~g~~~d~~~lyLVmEy~~g-dL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRD 625 (853)
+.+...+|+||||+.+ ++.+.+... ...+++..+..++.||+.||.|||++||+|||
T Consensus 78 ---------------~~~~~~~~~v~e~~~~~~l~~~~~~~-------~~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrD 135 (283)
T d1mqba_ 78 ---------------ISKYKPMMIITEYMENGALDKFLREK-------DGEFSVLQLVGMLRGIAAGMKYLANMNYVHRD 135 (283)
T ss_dssp ---------------ECSSSSEEEEEECCTTEEHHHHHHHT-------TTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSC
T ss_pred ---------------EecCCceEEEEEecccCcchhhhhcc-------cccccHHHHHHHHHHHHHhhhhccccccccCc
Confidence 4456678999999765 566655442 35799999999999999999999999999999
Q ss_pred CCCccEEee-cCcEEEEecccchhcccCCcc-ccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHH
Q 003052 626 LKPANFLLV-KGSLKLIDFGIAKAIMSDTTN-IQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQM 703 (853)
Q Consensus 626 LKPeNILL~-~g~VKL~DFGlAk~~~~~~~~-~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyEL 703 (853)
|||+||||+ ++.+||+|||+|+.+...... .......||+.|||||++.+.. |+.++|||||||++|||
T Consensus 136 lKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~---------~~~~sDI~S~Gvil~el 206 (283)
T d1mqba_ 136 LAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRK---------FTSASDVWSFGIVMWEV 206 (283)
T ss_dssp CCGGGEEECTTCCEEECCCCC-----------------CCCGGGSCHHHHHSCC---------CCHHHHHHHHHHHHHHH
T ss_pred cccceEEECCCCeEEEcccchhhcccCCCccceEeccCCCCccccCHHHHccCC---------CCCcccccccHHHHHHH
Confidence 999999995 679999999999876543221 1223457899999999997653 56899999999999999
Q ss_pred HhCCCCCCcchhHHHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCCChhHHhc
Q 003052 704 VYGRTPFSEYKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQ 763 (853)
Q Consensus 704 LtG~~PF~~~~~~~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~ 763 (853)
++|..||.........+..+... .....+...+..+.+||.+||..||++|||+.||++
T Consensus 207 ~t~~~~~~~~~~~~~~~~~i~~~-~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~ 265 (283)
T d1mqba_ 207 MTYGERPYWELSNHEVMKAINDG-FRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVS 265 (283)
T ss_dssp HTTSCCTTTTCCHHHHHHHHHTT-CCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred HhCCCCccccCCHHHHHHHHhcc-CCCCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHH
Confidence 99655554333333444444432 334455667889999999999999999999999975
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-45 Score=393.32 Aligned_cols=263 Identities=21% Similarity=0.334 Sum_probs=208.8
Q ss_pred eEEcCceeeEEEeEeccCceEEEEEEecC--------CcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeee
Q 003052 467 FKVNGKLYQRLGKIGSGGSSEVHKVISSD--------CTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLID 538 (853)
Q Consensus 467 ~~v~g~~Y~ilk~LG~G~FG~Vyka~~~~--------g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid 538 (853)
|.+..++|++.+.||+|+||.||+|+... +..||||+++.... ......+.+|+.++.++.+|||||++++
T Consensus 8 ~~i~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~-~~~~~~~~~e~~~l~~~~~HpnIv~~~~ 86 (299)
T d1fgka_ 8 WELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDAT-EKDLSDLISEMEMMKMIGKHKNIINLLG 86 (299)
T ss_dssp TBCCGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCC-HHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred CcccHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccC-hHHHHHHHHHHHHHHHhcCCCeEEeccc
Confidence 45566789999999999999999998632 24799999986543 3445678999999999988999999998
Q ss_pred hhhhHHHHHHHHhhCCCCCCCCccccCCeEEEEEecch-hhHHHHHHHhhhh--------ccCCCCCCCHHHHHHHHHHh
Q 003052 539 YEVTEKALLREVLNGSMNNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKE--------MDGSNQTLDENWLRFYWQQI 609 (853)
Q Consensus 539 ~~~~e~~iL~~l~~~~iv~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~--------~~~~~~~LsE~~~r~I~~QI 609 (853)
+ +.+++.+|+||||+. |+|.++|..+... .......+++.+++.|+.||
T Consensus 87 ~----------------------~~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi 144 (299)
T d1fgka_ 87 A----------------------CTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQV 144 (299)
T ss_dssp E----------------------ECSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHH
T ss_pred c----------------------cccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHH
Confidence 7 455678999999976 5899988654211 11234579999999999999
Q ss_pred hhhhhhcccCceeeCCCCCccEEe-ecCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCC
Q 003052 610 LEAVNTIHEERIVHSDLKPANFLL-VKGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCG 688 (853)
Q Consensus 610 l~AL~yLHs~gIIHRDLKPeNILL-~~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys 688 (853)
+.||+|||++|||||||||+|||+ .++.+||+|||+++..............+||+.|+|||++.+. .|+
T Consensus 145 ~~al~ylH~~~ivHrDiKp~NiLl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~---------~y~ 215 (299)
T d1fgka_ 145 ARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDR---------IYT 215 (299)
T ss_dssp HHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHC---------CCC
T ss_pred HHHHHHhhhCCEEeeeecccceeecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCC---------CCC
Confidence 999999999999999999999999 4679999999999987655444444567899999999999765 367
Q ss_pred CccchhhhHHHHHHHHh-CCCCCCcchhHHHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCCChhHHhc
Q 003052 689 RPSDIWSLGCILYQMVY-GRTPFSEYKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQ 763 (853)
Q Consensus 689 ~ksDIWSLGVILyELLt-G~~PF~~~~~~~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~ 763 (853)
.++|||||||++|||++ |.+||.+.... ..+..+.. ...+..+...++++.+||.+||++||.+|||+.||++
T Consensus 216 ~k~DiwS~Gvvl~ell~~g~~p~~~~~~~-~~~~~i~~-~~~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~ 289 (299)
T d1fgka_ 216 HQSDVWSFGVLLWEIFTLGGSPYPGVPVE-ELFKLLKE-GHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE 289 (299)
T ss_dssp HHHHHHHHHHHHHHHHTTSCCSSTTCCHH-HHHHHHHT-TCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred chhhhHHhHHHHHHhccCCCCCCCCCCHH-HHHHHHHc-CCCCCCCccchHHHHHHHHHHccCCHhHCcCHHHHHH
Confidence 89999999999999997 79999765543 34444443 3445566778899999999999999999999999985
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-45 Score=394.66 Aligned_cols=264 Identities=22% Similarity=0.333 Sum_probs=210.9
Q ss_pred eEEcCceeeEEEeEeccCceEEEEEEe------cCCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehh
Q 003052 467 FKVNGKLYQRLGKIGSGGSSEVHKVIS------SDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYE 540 (853)
Q Consensus 467 ~~v~g~~Y~ilk~LG~G~FG~Vyka~~------~~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~ 540 (853)
+++..++|++.++||+|+||.||+|+. .+++.||||+++... .......+.+|+.+++++.+|||||+++++
T Consensus 18 ~~~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~- 95 (311)
T d1t46a_ 18 WEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA-HLTEREALMSELKVLSYLGNHMNIVNLLGA- 95 (311)
T ss_dssp GBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEE-
T ss_pred ccCCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECccc-CHHHHHHHHHHHHHHHhccCCCCEEEEEEE-
Confidence 455567899999999999999999985 244789999998654 344556789999999999889999999987
Q ss_pred hhHHHHHHHHhhCCCCCCCCccccCCeEEEEEecch-hhHHHHHHHhhhh----------ccCCCCCCCHHHHHHHHHHh
Q 003052 541 VTEKALLREVLNGSMNNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKE----------MDGSNQTLDENWLRFYWQQI 609 (853)
Q Consensus 541 ~~e~~iL~~l~~~~iv~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~----------~~~~~~~LsE~~~r~I~~QI 609 (853)
+.+...+||||||++ ++|.+++...... .......+++..++.|+.||
T Consensus 96 ---------------------~~~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi 154 (311)
T d1t46a_ 96 ---------------------CTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQV 154 (311)
T ss_dssp ---------------------ECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHH
T ss_pred ---------------------EeeCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHH
Confidence 455667899999976 5898888764321 11223469999999999999
Q ss_pred hhhhhhcccCceeeCCCCCccEEee-cCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCC
Q 003052 610 LEAVNTIHEERIVHSDLKPANFLLV-KGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCG 688 (853)
Q Consensus 610 l~AL~yLHs~gIIHRDLKPeNILL~-~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys 688 (853)
+.||+|||++|||||||||+|||++ ++.+||+|||+++..............+||+.|+|||++.+. .|+
T Consensus 155 ~~gl~~LH~~~ivHrDLKp~NIl~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---------~~~ 225 (311)
T d1t46a_ 155 AKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNC---------VYT 225 (311)
T ss_dssp HHHHHHHHHTTCCCSCCSGGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHC---------CCC
T ss_pred HHHHHHHHhCCeeecccccccccccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCC---------CCC
Confidence 9999999999999999999999994 679999999999987654444445567899999999999765 357
Q ss_pred CccchhhhHHHHHHHHh-CCCCCCcchhHHHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCCChhHHhc
Q 003052 689 RPSDIWSLGCILYQMVY-GRTPFSEYKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQ 763 (853)
Q Consensus 689 ~ksDIWSLGVILyELLt-G~~PF~~~~~~~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~ 763 (853)
.++|||||||++|||+| |.+||..........+++.. ......+...+..+.+||.+||..||.+|||+.|||+
T Consensus 226 ~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~~~~~i~~-~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~ 300 (311)
T d1t46a_ 226 FESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKE-GFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ 300 (311)
T ss_dssp HHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHHHHHHHH-TCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CcccccchHHHHHHHHhCCCCCCCCCCHHHHHHHHHhc-CCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 89999999999999998 66667554433333333322 2334455667899999999999999999999999985
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-45 Score=389.76 Aligned_cols=254 Identities=20% Similarity=0.291 Sum_probs=194.5
Q ss_pred EcCceeeEEEeEeccCceEEEEEEec--CC--cEEEEEEEecCCC-ChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhH
Q 003052 469 VNGKLYQRLGKIGSGGSSEVHKVISS--DC--TIYALKKIKLKGR-DYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTE 543 (853)
Q Consensus 469 v~g~~Y~ilk~LG~G~FG~Vyka~~~--~g--~~vAVKkik~~~~-~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e 543 (853)
++.++|++++.||+|+||.||+|+.. ++ ..||||+++.... +......|.+|+++|++++ ||||+++++++
T Consensus 5 i~~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~-H~nIv~~~g~~--- 80 (273)
T d1u46a_ 5 IGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLD-HRNLIRLYGVV--- 80 (273)
T ss_dssp CCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCC-CTTBCCEEEEE---
T ss_pred EchHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCC-CCCEEEEEEEE---
Confidence 44577999999999999999999863 22 3689999976543 3345567999999999996 99999999873
Q ss_pred HHHHHHHhhCCCCCCCCccccCCeEEEEEecch-hhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCcee
Q 003052 544 KALLREVLNGSMNNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIV 622 (853)
Q Consensus 544 ~~iL~~l~~~~iv~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gII 622 (853)
.+ ..+|+||||+. ++|.+.+... ...+++..++.++.||+.||.|||++||+
T Consensus 81 -------------------~~-~~~~lv~e~~~~~~l~~~~~~~-------~~~l~~~~~~~~~~qi~~gl~ylH~~~ii 133 (273)
T d1u46a_ 81 -------------------LT-PPMKMVTELAPLGSLLDRLRKH-------QGHFLLGTLSRYAVQVAEGMGYLESKRFI 133 (273)
T ss_dssp -------------------CS-SSCEEEEECCTTCBHHHHHHHH-------GGGSCHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred -------------------ee-cchheeeeeecCcchhhhhhcc-------cCCCCHHHHHHHHHHHHHHHHHhhhCCEe
Confidence 22 35689999976 5777776654 24699999999999999999999999999
Q ss_pred eCCCCCccEEe-ecCcEEEEecccchhcccCCccc-cccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHH
Q 003052 623 HSDLKPANFLL-VKGSLKLIDFGIAKAIMSDTTNI-QRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCIL 700 (853)
Q Consensus 623 HRDLKPeNILL-~~g~VKL~DFGlAk~~~~~~~~~-~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVIL 700 (853)
||||||+|||| .++.+||+|||+++.+....... .....+|++.|+|||++.+. .|+.++|||||||++
T Consensus 134 HrDikp~NIll~~~~~vkl~DfGl~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~---------~~~~~~Di~S~Gvil 204 (273)
T d1u46a_ 134 HRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTR---------TFSHASDTWMFGVTL 204 (273)
T ss_dssp CSCCCGGGEEEEETTEEEECCCTTCEECCC-CCEEEC-----CCGGGCCHHHHHHC---------EEEHHHHHHHHHHHH
T ss_pred eeeecHHHhccccccceeeccchhhhhcccCCCcceecCccccCcccCCHHHHhCC---------CCCcchhhhhhHHHH
Confidence 99999999999 56799999999999765433322 22345688899999999875 366899999999999
Q ss_pred HHHHh-CCCCCCcchhHHHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCCChhHHhc
Q 003052 701 YQMVY-GRTPFSEYKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQ 763 (853)
Q Consensus 701 yELLt-G~~PF~~~~~~~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~ 763 (853)
|||++ |+.||.+.........+... ...+..+...++.+.+||.+||..||++|||+.||++
T Consensus 205 ~emlt~G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~ 267 (273)
T d1u46a_ 205 WEMFTYGQEPWIGLNGSQILHKIDKE-GERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRD 267 (273)
T ss_dssp HHHHTTSCCTTTTCCHHHHHHHHHTS-CCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHhCCCCCCCCcCHHHHHHHHHhC-CCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 99998 89999876655444444333 3444556678899999999999999999999999874
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=7.6e-45 Score=389.87 Aligned_cols=257 Identities=20% Similarity=0.278 Sum_probs=203.5
Q ss_pred ceeeEEEeEeccCceEEEEEEec------CCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHH
Q 003052 472 KLYQRLGKIGSGGSSEVHKVISS------DCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKA 545 (853)
Q Consensus 472 ~~Y~ilk~LG~G~FG~Vyka~~~------~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~ 545 (853)
++|+++++||+|+||+||+|+.. +++.||||+++... .......|.+|+.+|++++ |+||++++++
T Consensus 13 ~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~~E~~il~~l~-h~niv~~~~~------ 84 (301)
T d1lufa_ 13 NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA-SADMQADFQREAALMAEFD-NPNIVKLLGV------ 84 (301)
T ss_dssp GGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC-CHHHHHHHHHHHHHHHTCC-CTTBCCEEEE------
T ss_pred HHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhc-ChHHHHHHHHHHHHHHhcC-CCCcccceee------
Confidence 56999999999999999999864 34689999997543 3344567899999999997 9999999987
Q ss_pred HHHHHhhCCCCCCCCccccCCeEEEEEecch-hhHHHHHHHhhhh----------------ccCCCCCCCHHHHHHHHHH
Q 003052 546 LLREVLNGSMNNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKE----------------MDGSNQTLDENWLRFYWQQ 608 (853)
Q Consensus 546 iL~~l~~~~iv~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~----------------~~~~~~~LsE~~~r~I~~Q 608 (853)
+.+.+.+++||||++ ++|.+++...... .......+++..+..|+.|
T Consensus 85 ----------------~~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~q 148 (301)
T d1lufa_ 85 ----------------CAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQ 148 (301)
T ss_dssp ----------------ECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHH
T ss_pred ----------------eccCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHH
Confidence 455677899999976 5899888653110 1112345899999999999
Q ss_pred hhhhhhhcccCceeeCCCCCccEEee-cCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccC
Q 003052 609 ILEAVNTIHEERIVHSDLKPANFLLV-KGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKC 687 (853)
Q Consensus 609 Il~AL~yLHs~gIIHRDLKPeNILL~-~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~y 687 (853)
|+.||+|||++|||||||||+||||+ ++.+||+|||+|+............+.+||+.|+|||++.+. .|
T Consensus 149 i~~gl~ylH~~~ivHrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~---------~~ 219 (301)
T d1lufa_ 149 VAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYN---------RY 219 (301)
T ss_dssp HHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHC---------CC
T ss_pred HHHHhhhcccCCeEeeEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccC---------CC
Confidence 99999999999999999999999995 579999999999877554443344567899999999999865 36
Q ss_pred CCccchhhhHHHHHHHHhCC-CCCCcchhHHHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCCChhHHhc
Q 003052 688 GRPSDIWSLGCILYQMVYGR-TPFSEYKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQ 763 (853)
Q Consensus 688 s~ksDIWSLGVILyELLtG~-~PF~~~~~~~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~ 763 (853)
+.++|||||||++|||++|. +||.+.........+ .... ....+...++++.+||.+||..||.+|||+.||++
T Consensus 220 t~ksDVwS~Gvvl~ell~~~~~p~~~~~~~e~~~~v-~~~~-~~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~ 294 (301)
T d1lufa_ 220 TTESDVWAYGVVLWEIFSYGLQPYYGMAHEEVIYYV-RDGN-ILACPENCPLELYNLMRLCWSKLPADRPSFCSIHR 294 (301)
T ss_dssp CHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHH-HTTC-CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ChhhhhccchhhHHHHHccCCCCCCCCCHHHHHHHH-HcCC-CCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 78999999999999999985 678776554443333 3322 23445677889999999999999999999999975
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.7e-45 Score=391.48 Aligned_cols=259 Identities=22% Similarity=0.323 Sum_probs=202.0
Q ss_pred EcCceeeEEEeEeccCceEEEEEEec-CCc--EEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHH
Q 003052 469 VNGKLYQRLGKIGSGGSSEVHKVISS-DCT--IYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKA 545 (853)
Q Consensus 469 v~g~~Y~ilk~LG~G~FG~Vyka~~~-~g~--~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~ 545 (853)
++-++|++.++||+|+||.||+|++. ++. .||||+++.... ......+.+|+++|.++.+||||++++++
T Consensus 7 i~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~~HpnIv~~~~~------ 79 (309)
T d1fvra_ 7 LDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYAS-KDDHRDFAGELEVLCKLGHHPNIINLLGA------ 79 (309)
T ss_dssp CCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC-------CHHHHHHHHHTTCCCCTTBCCEEEE------
T ss_pred cCHHHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccC-hHHHHHHHHHHHHHHhccCCCCEeeEEEE------
Confidence 34477999999999999999999884 444 467787764332 23455789999999999779999999987
Q ss_pred HHHHHhhCCCCCCCCccccCCeEEEEEecch-hhHHHHHHHhh--------hhccCCCCCCCHHHHHHHHHHhhhhhhhc
Q 003052 546 LLREVLNGSMNNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKW--------KEMDGSNQTLDENWLRFYWQQILEAVNTI 616 (853)
Q Consensus 546 iL~~l~~~~iv~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~--------k~~~~~~~~LsE~~~r~I~~QIl~AL~yL 616 (853)
+.+.+.+|+||||++ |+|.++|.... .........+++..+..++.||+.||.||
T Consensus 80 ----------------~~~~~~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~l 143 (309)
T d1fvra_ 80 ----------------CEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYL 143 (309)
T ss_dssp ----------------EEETTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHH
T ss_pred ----------------EecCCeeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhh
Confidence 456778999999977 69999886531 11123446799999999999999999999
Q ss_pred ccCceeeCCCCCccEEe-ecCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhh
Q 003052 617 HEERIVHSDLKPANFLL-VKGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWS 695 (853)
Q Consensus 617 Hs~gIIHRDLKPeNILL-~~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWS 695 (853)
|++||+||||||+|||+ .++.+||+|||+|+....... ....+||+.|+|||.+.+. .|+.++||||
T Consensus 144 H~~~iiHrDlkp~NIL~~~~~~~kl~DfG~a~~~~~~~~---~~~~~gt~~y~aPE~l~~~---------~~~~~sDvwS 211 (309)
T d1fvra_ 144 SQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVK---KTMGRLPVRWMAIESLNYS---------VYTTNSDVWS 211 (309)
T ss_dssp HHTTEECSCCSGGGEEECGGGCEEECCTTCEESSCEECC---C----CCTTTCCHHHHHHC---------EECHHHHHHH
T ss_pred hcCCccccccccceEEEcCCCceEEcccccccccccccc---ccceecCCcccchHHhccC---------CCCccceeeh
Confidence 99999999999999999 467999999999986543222 2356799999999999765 4678999999
Q ss_pred hHHHHHHHHhCC-CCCCcchhHHHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCCChhHHhcC
Q 003052 696 LGCILYQMVYGR-TPFSEYKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQH 764 (853)
Q Consensus 696 LGVILyELLtG~-~PF~~~~~~~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~H 764 (853)
|||++|||++|. +||.+..... ....+.. ...+..+...++++.+||.+||..||++|||+.||++|
T Consensus 212 fGvil~ell~~~~~p~~~~~~~~-~~~~i~~-~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~ 279 (309)
T d1fvra_ 212 YGVLLWEIVSLGGTPYCGMTCAE-LYEKLPQ-GYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 279 (309)
T ss_dssp HHHHHHHHHTTSCCTTTTCCHHH-HHHHGGG-TCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred hHHHHHHHHhcCCCCCCCCCHHH-HHHHHHh-cCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 999999999965 5776654443 3333332 23445566788999999999999999999999999976
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1e-44 Score=387.21 Aligned_cols=256 Identities=21% Similarity=0.250 Sum_probs=199.7
Q ss_pred CceeeEEEeEeccCceEEEEEEe-cCCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHHH
Q 003052 471 GKLYQRLGKIGSGGSSEVHKVIS-SDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLRE 549 (853)
Q Consensus 471 g~~Y~ilk~LG~G~FG~Vyka~~-~~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~~ 549 (853)
|++|++++.||+|+||.||+|++ .+++.||||++...... ..+.+|+++++++.+|++|+.+.++
T Consensus 6 g~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~----~~~~~E~~i~~~l~~~~~i~~~~~~---------- 71 (299)
T d1ckia_ 6 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH----PQLHIESKIYKMMQGGVGIPTIRWC---------- 71 (299)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTS----CCHHHHHHHHHHSTTSTTCCCEEEE----------
T ss_pred CCEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccC----HHHHHHHHHHHHccCCCcccEEEEE----------
Confidence 35699999999999999999998 56789999998765432 3477999999999988777777654
Q ss_pred HhhCCCCCCCCccccCCeEEEEEecchhhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCCCc
Q 003052 550 VLNGSMNNKDGRVKDDGYIYMVLEYGEIDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPA 629 (853)
Q Consensus 550 l~~~~iv~~~g~~~d~~~lyLVmEy~~gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLKPe 629 (853)
+.+...+|+||||++++|...+... ...+++..+..++.||+.||+|||++|||||||||+
T Consensus 72 ------------~~~~~~~~ivme~~~~~l~~~~~~~-------~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~ 132 (299)
T d1ckia_ 72 ------------GAEGDYNVMVMELLGPSLEDLFNFC-------SRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPD 132 (299)
T ss_dssp ------------EEETTEEEEEEECCCCBHHHHHHHT-------TTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGG
T ss_pred ------------EecCCEEEEEEEEcCCchhhhhhhc-------cCCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHh
Confidence 4567789999999998888776543 357999999999999999999999999999999999
Q ss_pred cEEee----cCcEEEEecccchhcccCCcc-----ccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHH
Q 003052 630 NFLLV----KGSLKLIDFGIAKAIMSDTTN-----IQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCIL 700 (853)
Q Consensus 630 NILL~----~g~VKL~DFGlAk~~~~~~~~-----~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVIL 700 (853)
|||+. +..+||+|||+|+.+...... ....+.+||+.|||||++.+.. |+.++|||||||++
T Consensus 133 NIl~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---------~~~~~DiwSlG~~l 203 (299)
T d1ckia_ 133 NFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIE---------QSRRDDLESLGYVL 203 (299)
T ss_dssp GEEECCGGGTTCEEECCCSSCEECBCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBC---------CCHHHHHHHHHHHH
T ss_pred hccccccCCCceeeeeccCcceeccccccccceeccccCCcCCCccccCHHHHhCCC---------CCChhhEEecCHHH
Confidence 99983 237999999999977543221 1234678999999999997653 56899999999999
Q ss_pred HHHHhCCCCCCcchhHHHHH---Hhh--cCCCCcccCCCCCChhHHHHHHHhcccCCCCCCChh---HHhcCCCCC
Q 003052 701 YQMVYGRTPFSEYKTFWAKF---KVI--TDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIP---QLLQHPFLV 768 (853)
Q Consensus 701 yELLtG~~PF~~~~~~~~~~---kii--~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~---EIL~HPwf~ 768 (853)
|||++|+.||.......... ... .............++++.+||.+||..||.+||++. ++|+|+|..
T Consensus 204 ~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~ 279 (299)
T d1ckia_ 204 MYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHR 279 (299)
T ss_dssp HHHHHSSCTTCCCC-------HHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHH
T ss_pred HHHHhCCCcccccchHHHHHHHHHhhcccCCCChhHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHH
Confidence 99999999996543221111 100 000111123446788999999999999999999987 456777654
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.4e-45 Score=385.82 Aligned_cols=248 Identities=26% Similarity=0.364 Sum_probs=194.2
Q ss_pred EEcCceeeEEEeEeccCceEEEEEEecCCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHH
Q 003052 468 KVNGKLYQRLGKIGSGGSSEVHKVISSDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALL 547 (853)
Q Consensus 468 ~v~g~~Y~ilk~LG~G~FG~Vyka~~~~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL 547 (853)
.+.-++|+++++||+|+||.||+|..+ +..||||+++... ..+.+.+|+++|++++ ||||+++++++.
T Consensus 3 ~i~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~vAvK~i~~~~----~~~~~~~E~~~l~~l~-HpnIv~~~g~~~------ 70 (262)
T d1byga_ 3 ALNMKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA----TAQAFLAEASVMTQLR-HSNLVQLLGVIV------ 70 (262)
T ss_dssp BCCGGGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCCC------HHHHHTHHHHTTCC-CTTBCCEEEEEC------
T ss_pred ccCHHHeEEeEEEecCCCeEEEEEEEC-CeEEEEEEECcHH----HHHHHHHHHHHHHhCC-CCCEeeEEEEEE------
Confidence 344567999999999999999999984 6789999997542 2356889999999997 999999998742
Q ss_pred HHHhhCCCCCCCCccccCCeEEEEEecch-hhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCC
Q 003052 548 REVLNGSMNNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDL 626 (853)
Q Consensus 548 ~~l~~~~iv~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDL 626 (853)
.+.+.+|+||||+. |+|.+++..+.. ..+++..++.|+.||+.||.|||+++|+||||
T Consensus 71 ---------------~~~~~~~lv~ey~~~g~L~~~l~~~~~------~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dl 129 (262)
T d1byga_ 71 ---------------EEKGGLYIVTEYMAKGSLVDYLRSRGR------SVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDL 129 (262)
T ss_dssp ---------------CC--CCEEEECCCTTEEHHHHHHHHHH------HHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCC
T ss_pred ---------------ecCCcEEEEEeccCCCCHHHHHHhcCC------CCCCHHHHHHHHHHHHhhccccccCceecccc
Confidence 33456899999976 599999876522 35899999999999999999999999999999
Q ss_pred CCccEEee-cCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHh
Q 003052 627 KPANFLLV-KGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVY 705 (853)
Q Consensus 627 KPeNILL~-~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLt 705 (853)
||+|||++ ++.+||+|||+++..... ....++|+.|+|||++.+.. |+.++|||||||++|||++
T Consensus 130 kp~Nil~~~~~~~kl~dfg~s~~~~~~-----~~~~~~~~~y~aPE~l~~~~---------~t~~sDIwSfG~il~el~t 195 (262)
T d1byga_ 130 AARNVLVSEDNVAKVSDFGLTKEASST-----QDTGKLPVKWTAPEALREKK---------FSTKSDVWSFGILLWEIYS 195 (262)
T ss_dssp SGGGEEECTTSCEEECCCCC-----------------CCTTTSCHHHHHHCC---------CCHHHHHHHHHHHHHHHHT
T ss_pred chHhheecCCCCEeecccccceecCCC-----CccccccccCCChHHHhCCC---------CChHHHHHhHHHHHHHHHH
Confidence 99999994 679999999999865432 23567899999999997653 5789999999999999998
Q ss_pred -CCCCCCcchhHHHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCCChhHHhcC
Q 003052 706 -GRTPFSEYKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQH 764 (853)
Q Consensus 706 -G~~PF~~~~~~~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~H 764 (853)
|++||....... ....+.. ......+...++.+.+||.+||..||.+|||+.+|+++
T Consensus 196 ~~~~p~~~~~~~~-~~~~i~~-~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~ 253 (262)
T d1byga_ 196 FGRVPYPRIPLKD-VVPRVEK-GYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQ 253 (262)
T ss_dssp TSCCSCTTSCGGG-HHHHHTT-TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCCCCCCCHHH-HHHHHHc-CCCCCCCccCCHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence 788887643332 2222322 23445566788999999999999999999999999864
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.4e-44 Score=385.65 Aligned_cols=262 Identities=16% Similarity=0.264 Sum_probs=210.4
Q ss_pred eEEcCceeeEEEeEeccCceEEEEEEec------CCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehh
Q 003052 467 FKVNGKLYQRLGKIGSGGSSEVHKVISS------DCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYE 540 (853)
Q Consensus 467 ~~v~g~~Y~ilk~LG~G~FG~Vyka~~~------~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~ 540 (853)
+++..++|++.++||+|+||.||+|.+. ++..||||+++... .......|.+|+++++++. ||||++++++
T Consensus 15 ~ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~-~~~~~~~~~~E~~il~~l~-h~nIv~~~~~- 91 (308)
T d1p4oa_ 15 WEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA-SMRERIEFLNEASVMKEFN-CHHVVRLLGV- 91 (308)
T ss_dssp TBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS-CHHHHHHHHHHHHHGGGCC-CTTBCCEEEE-
T ss_pred eeecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECccc-ChHHHHHHHHHHHHHHHcC-CCCEeeeeeE-
Confidence 3555678999999999999999999863 34689999997543 3345567899999999997 8999999987
Q ss_pred hhHHHHHHHHhhCCCCCCCCccccCCeEEEEEecch-hhHHHHHHHhhhhc--cCCCCCCCHHHHHHHHHHhhhhhhhcc
Q 003052 541 VTEKALLREVLNGSMNNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEM--DGSNQTLDENWLRFYWQQILEAVNTIH 617 (853)
Q Consensus 541 ~~e~~iL~~l~~~~iv~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~~--~~~~~~LsE~~~r~I~~QIl~AL~yLH 617 (853)
+..+..+++||||+. |+|.+++....... ......+++..+..|+.||+.||.|||
T Consensus 92 ---------------------~~~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH 150 (308)
T d1p4oa_ 92 ---------------------VSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLN 150 (308)
T ss_dssp ---------------------ECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHH
T ss_pred ---------------------EecCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHh
Confidence 445667899999976 68888886543221 123346899999999999999999999
Q ss_pred cCceeeCCCCCccEEee-cCcEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhh
Q 003052 618 EERIVHSDLKPANFLLV-KGSLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSL 696 (853)
Q Consensus 618 s~gIIHRDLKPeNILL~-~g~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSL 696 (853)
+++|+||||||+||||+ ++++||+|||+|+..............+||+.|+|||.+.+.. |+.++|||||
T Consensus 151 ~~~ivHrDlk~~NiLld~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~---------~~~~~Dv~S~ 221 (308)
T d1p4oa_ 151 ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGV---------FTTYSDVWSF 221 (308)
T ss_dssp HTTCBCSCCSGGGEEECTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCC---------CCHHHHHHHH
T ss_pred hCCeeeceEcCCceeecCCceEEEeecccceeccCCcceeeccceecccccCCHHHHccCC---------CCcccccccH
Confidence 99999999999999995 5699999999998776544444445668999999999998764 5679999999
Q ss_pred HHHHHHHHhC-CCCCCcchhHHHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCCChhHHhc
Q 003052 697 GCILYQMVYG-RTPFSEYKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQ 763 (853)
Q Consensus 697 GVILyELLtG-~~PF~~~~~~~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~ 763 (853)
||++|||++| .+||.+...... +..+... .....+...++.+.+||.+||+.||.+|||+.+|++
T Consensus 222 G~il~El~t~~~~p~~~~~~~~~-~~~i~~~-~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~ 287 (308)
T d1p4oa_ 222 GVVLWEIATLAEQPYQGLSNEQV-LRFVMEG-GLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIIS 287 (308)
T ss_dssp HHHHHHHHHTSCCTTTTSCHHHH-HHHHHTT-CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHhCCCCCCCCCCHHHH-HHHHHhC-CCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 9999999998 578876555433 3333332 233445677889999999999999999999999998
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=1.8e-43 Score=378.05 Aligned_cols=251 Identities=20% Similarity=0.226 Sum_probs=199.8
Q ss_pred cCceeeEEEeEeccCceEEEEEEe-cCCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHH
Q 003052 470 NGKLYQRLGKIGSGGSSEVHKVIS-SDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLR 548 (853)
Q Consensus 470 ~g~~Y~ilk~LG~G~FG~Vyka~~-~~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~ 548 (853)
-|.+|+++++||+|+||+||+|++ .+++.||||++..... ...+.+|+++++.|.+++||+.++++
T Consensus 3 ig~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~----~~~~~~e~~~~~~l~~~~~i~~~~~~--------- 69 (293)
T d1csna_ 3 VGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD----APQLRDEYRTYKLLAGCTGIPNVYYF--------- 69 (293)
T ss_dssp ETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT----SCCHHHHHHHHHHTTTCTTCCCEEEE---------
T ss_pred CCCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccC----cHHHHHHHHHHHHhcCCCCCCEEEEE---------
Confidence 367899999999999999999998 4678999999875432 23477899999999988999999876
Q ss_pred HHhhCCCCCCCCccccCCeEEEEEecchhhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCCC
Q 003052 549 EVLNGSMNNKDGRVKDDGYIYMVLEYGEIDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKP 628 (853)
Q Consensus 549 ~l~~~~iv~~~g~~~d~~~lyLVmEy~~gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLKP 628 (853)
+.++...|+||||++++|.+++... +..+++..+..++.|++.||.|||++|||||||||
T Consensus 70 -------------~~~~~~~~~vme~~~~~l~~~~~~~-------~~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp 129 (293)
T d1csna_ 70 -------------GQEGLHNVLVIDLLGPSLEDLLDLC-------GRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKP 129 (293)
T ss_dssp -------------EEETTEEEEEEECCCCBHHHHHHHT-------TTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCG
T ss_pred -------------eecCCccEEEEEecCCCHHHHHHhh-------ccchhhHHHHHHHHHHHHHHHHHHHCCceeccCCc
Confidence 4567789999999999999887653 35799999999999999999999999999999999
Q ss_pred ccEEee------cCcEEEEecccchhcccCCcc-----ccccccccCccccCchhhccCCCCCCCccccCCCccchhhhH
Q 003052 629 ANFLLV------KGSLKLIDFGIAKAIMSDTTN-----IQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLG 697 (853)
Q Consensus 629 eNILL~------~g~VKL~DFGlAk~~~~~~~~-----~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLG 697 (853)
+|||++ .+.+||+|||+|+.+...... ......+||+.|||||++.+.. |+.++||||||
T Consensus 130 ~Nili~~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~---------~~~~~DiwSlG 200 (293)
T d1csna_ 130 DNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGRE---------QSRRDDLEALG 200 (293)
T ss_dssp GGEEECCSSSTTTTCEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCC---------CCHHHHHHHHH
T ss_pred cceeecCcccccCCceEEcccceeEEcccCccccceeecccCceEEchhhcCHHHhcCCC---------CChHHHHHHhh
Confidence 999994 358999999999876542211 1234678999999999997653 67899999999
Q ss_pred HHHHHHHhCCCCCCcchh--HHHHHHhh---cCCCCcccCCCCCChhHHHHHHHhcccCCCCCCChhHHh
Q 003052 698 CILYQMVYGRTPFSEYKT--FWAKFKVI---TDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLL 762 (853)
Q Consensus 698 VILyELLtG~~PF~~~~~--~~~~~kii---~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL 762 (853)
|++|||++|+.||.+... .......+ .............++++.+||..|+..+|.+||+.+.+.
T Consensus 201 ~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~ 270 (293)
T d1csna_ 201 HVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQ 270 (293)
T ss_dssp HHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHH
T ss_pred HHHHHHHhCCCcCCCccchhHHHHHHHHHhccCCCChHHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHH
Confidence 999999999999964211 11111111 001111123345778899999999999999999876654
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-43 Score=380.74 Aligned_cols=250 Identities=19% Similarity=0.254 Sum_probs=195.8
Q ss_pred eEEEeEeccCceEEEEEEecCC----cEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHHHH
Q 003052 475 QRLGKIGSGGSSEVHKVISSDC----TIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLREV 550 (853)
Q Consensus 475 ~ilk~LG~G~FG~Vyka~~~~g----~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~~l 550 (853)
.+.++||+|+||+||+|++.++ ..||||+++.. ........|.+|+++|++|+ ||||+++++++
T Consensus 30 ~~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~-~~~~~~~~~~~E~~~l~~l~-HpnIv~~~g~~---------- 97 (311)
T d1r0pa_ 30 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI-TDIGEVSQFLTEGIIMKDFS-HPNVLSLLGIC---------- 97 (311)
T ss_dssp EEEEEEEEETTEEEEEEEECC----CEEEEEEEECCC-CCHHHHHHHHHHHHHHHTCC-CTTBCCCCEEE----------
T ss_pred ccceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcc-cCHHHHHHHHHHHHHHHhCC-CCCEeEEeEEE----------
Confidence 3457899999999999987432 35899999743 34455678999999999997 89999999873
Q ss_pred hhCCCCCCCCccccCCeEEEEEecchh-hHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcccCceeeCCCCCc
Q 003052 551 LNGSMNNKDGRVKDDGYIYMVLEYGEI-DLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHEERIVHSDLKPA 629 (853)
Q Consensus 551 ~~~~iv~~~g~~~d~~~lyLVmEy~~g-dL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs~gIIHRDLKPe 629 (853)
+..++.+|+||||+++ +|.+++... ...+++..+..++.||+.||.|||+.||+||||||+
T Consensus 98 -----------~~~~~~~~lv~E~~~~g~l~~~~~~~-------~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~ 159 (311)
T d1r0pa_ 98 -----------LRSEGSPLVVLPYMKHGDLRNFIRNE-------THNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAAR 159 (311)
T ss_dssp -----------EETTTEEEEEEECCTTCBHHHHHHCT-------TCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGG
T ss_pred -----------EecCCceEEEEEEeecCchhhhhccc-------cccchHHHHHHHHHHHHHhhhhhcccCcccCCccHH
Confidence 2345678999999874 777776542 356788999999999999999999999999999999
Q ss_pred cEEee-cCcEEEEecccchhcccCCcc--ccccccccCccccCchhhccCCCCCCCccccCCCccchhhhHHHHHHHHhC
Q 003052 630 NFLLV-KGSLKLIDFGIAKAIMSDTTN--IQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLGCILYQMVYG 706 (853)
Q Consensus 630 NILL~-~g~VKL~DFGlAk~~~~~~~~--~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLGVILyELLtG 706 (853)
||||+ ++.+||+|||+++........ .......||+.|+|||++.... |+.++|||||||++|||++|
T Consensus 160 NILl~~~~~~kL~DFG~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---------~~~ksDI~SfGivl~El~t~ 230 (311)
T d1r0pa_ 160 NCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQK---------FTTKSDVWSFGVLLWELMTR 230 (311)
T ss_dssp GEEECTTCCEEECSSGGGCCTTTTTCCCTTCTTCSSCCGGGSCHHHHHHCC---------CCHHHHHHHHHHHHHHHHTT
T ss_pred hEeECCCCCEEEecccchhhccccccccceecccccccccccChHHHhcCC---------CCChhHhhhhHHHHHHHHHC
Confidence 99995 569999999999876543221 1223467999999999997653 57899999999999999998
Q ss_pred CCCCCcchhHHHHHHhhcCCCCcccCCCCCChhHHHHHHHhcccCCCCCCChhHHhcC
Q 003052 707 RTPFSEYKTFWAKFKVITDPNHEITYEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQH 764 (853)
Q Consensus 707 ~~PF~~~~~~~~~~kii~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~H 764 (853)
..||............+... .....+...++++.+||.+||..||++||++.||++|
T Consensus 231 ~~p~~~~~~~~~~~~~i~~g-~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~ 287 (311)
T d1r0pa_ 231 GAPPYPDVNTFDITVYLLQG-RRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSR 287 (311)
T ss_dssp SCCSCC------CHHHHHTT-CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCCCCCCHHHHHHHHHcC-CCCCCcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 88876544333333333332 2334556778899999999999999999999999987
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=2.3e-42 Score=376.43 Aligned_cols=266 Identities=19% Similarity=0.284 Sum_probs=192.0
Q ss_pred cCceeeEEEeEeccCceEEEEEEe-cCCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHH
Q 003052 470 NGKLYQRLGKIGSGGSSEVHKVIS-SDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLR 548 (853)
Q Consensus 470 ~g~~Y~ilk~LG~G~FG~Vyka~~-~~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~ 548 (853)
.+.+|+++++||+|+||+||+|++ .+++.||||+++... .....+.+|+++|+.+. |++++.. .
T Consensus 11 ~~~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~---~~~~~~~~Ei~~l~~l~-~~~~~~~-----------~ 75 (362)
T d1q8ya_ 11 KDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK---VYTEAAEDEIKLLQRVN-DADNTKE-----------D 75 (362)
T ss_dssp TTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH---HHHHHHHHHHHHHHHHH-HTCCSHH-----------H
T ss_pred cCCcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc---cchHHHHHHHHHHHHhc-chhhhhh-----------h
Confidence 345699999999999999999998 578999999997542 23346789999999997 4333321 1
Q ss_pred HHhhCCCCCCCCcc--ccCCeEEEEEecc--hhhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhccc-Cceee
Q 003052 549 EVLNGSMNNKDGRV--KDDGYIYMVLEYG--EIDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHE-ERIVH 623 (853)
Q Consensus 549 ~l~~~~iv~~~g~~--~d~~~lyLVmEy~--~gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs-~gIIH 623 (853)
.+.|.+++.+.+.+ ......+++|+++ .++........ ....+++..++.++.||+.||.|||+ .||+|
T Consensus 76 ~~~~~~iv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~i~~i~~qil~al~~lh~~~~IvH 149 (362)
T d1q8ya_ 76 SMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKY------EHRGIPLIYVKQISKQLLLGLDYMHRRCGIIH 149 (362)
T ss_dssp HHHHTTBCCCCEEEEEEETTEEEEEEEECCCCEEHHHHHHHT------TTSCCCHHHHHHHHHHHHHHHHHHHHTTCEEC
T ss_pred hcCcCceEEEEEEeeeccccceeeeeeecccccccccccccc------cccCCcHHHHHHHHHHHHHHHHHHhhhcCccc
Confidence 22344555554444 3445667777763 33333333322 34679999999999999999999997 89999
Q ss_pred CCCCCccEEee-cC------cEEEEecccchhcccCCccccccccccCccccCchhhccCCCCCCCccccCCCccchhhh
Q 003052 624 SDLKPANFLLV-KG------SLKLIDFGIAKAIMSDTTNIQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSL 696 (853)
Q Consensus 624 RDLKPeNILL~-~g------~VKL~DFGlAk~~~~~~~~~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSL 696 (853)
|||||+||||+ ++ .+||+|||.|...... ....+||+.|+|||++.+.. |+.++||||+
T Consensus 150 rDlKp~NIll~~~~~~~~~~~~kl~dfg~s~~~~~~-----~~~~~gt~~y~aPE~~~~~~---------~~~~~DiwSl 215 (362)
T d1q8ya_ 150 TDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEH-----YTNSIQTREYRSPEVLLGAP---------WGCGADIWST 215 (362)
T ss_dssp SCCSGGGEEEEEEETTTTEEEEEECCCTTCEETTBC-----CCSCCSCGGGCCHHHHHTCC---------CCTHHHHHHH
T ss_pred ccCChhHeeeeccCcccccceeeEeecccccccccc-----cccccccccccChhhccccC---------CCccccccch
Confidence 99999999994 22 4999999999865432 23678999999999998653 5689999999
Q ss_pred HHHHHHHHhCCCCCCcchh---------HHHHHHhhcCCC------------------C------------------ccc
Q 003052 697 GCILYQMVYGRTPFSEYKT---------FWAKFKVITDPN------------------H------------------EIT 731 (853)
Q Consensus 697 GVILyELLtG~~PF~~~~~---------~~~~~kii~~~~------------------~------------------~~~ 731 (853)
||++++|++|+.||..... .......+.... . ...
T Consensus 216 G~il~el~~g~~pF~~~~~~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 295 (362)
T d1q8ya_ 216 ACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYK 295 (362)
T ss_dssp HHHHHHHHHSSCCC---------CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTC
T ss_pred HHHHHHHHHCCCCCCCCccccccchhHHHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccc
Confidence 9999999999999964221 111111111100 0 000
Q ss_pred CCCCCChhHHHHHHHhcccCCCCCCChhHHhcCCCCCCC
Q 003052 732 YEPVPNPWLLDLMKKCLAWDRNERWRIPQLLQHPFLVPP 770 (853)
Q Consensus 732 ~~~~~s~~l~dLI~kcL~~DP~kRpTa~EIL~HPwf~~~ 770 (853)
.....++.+.+||.+||.+||.+|||+.|+|+||||+..
T Consensus 296 ~~~~~~~~~~dll~~mL~~dP~~Rpta~e~L~Hp~f~~~ 334 (362)
T d1q8ya_ 296 FSKDEAKEISDFLSPMLQLDPRKRADAGGLVNHPWLKDT 334 (362)
T ss_dssp CCHHHHHHHHHHHGGGGCSSTTTCBCHHHHHTCGGGTTC
T ss_pred cCcccCHHHHHHHHHHCCCChhHCcCHHHHhcCcccCCC
Confidence 111234668999999999999999999999999999854
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-42 Score=370.54 Aligned_cols=256 Identities=19% Similarity=0.224 Sum_probs=187.2
Q ss_pred ceeeEEEeEeccCceEEEEEEecCCcEEEEEEEecCCCChhhHhhHHHHHHHH--HHhcCCCceeEeeehhhhHHHHHHH
Q 003052 472 KLYQRLGKIGSGGSSEVHKVISSDCTIYALKKIKLKGRDYATAYGFCQEIEYL--NKLKGKNNIIQLIDYEVTEKALLRE 549 (853)
Q Consensus 472 ~~Y~ilk~LG~G~FG~Vyka~~~~g~~vAVKkik~~~~~~~~~~~~l~EI~iL--kkL~~hpNIV~Lid~~~~e~~iL~~ 549 (853)
+.|.+.++||+|+||.||+|+. +|+.||||+++... ...+.+|.+++ .+++ ||||+++++++..+
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~~-----~~~~~~e~ei~~~~~~~-HpnIv~~~~~~~~~------ 69 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSRE-----ERSWFREAEIYQTVMLR-HENILGFIAADNKD------ 69 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGGG-----HHHHHHHHHHHTSTTCC-CTTBCCEEEEEEEE------
T ss_pred cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccc-----hhHHHHHHHHHHHhhCC-CCcCcceEEEEEeC------
Confidence 4689999999999999999986 67899999997532 22344555544 4555 99999999985321
Q ss_pred HhhCCCCCCCCccccCCeEEEEEecch-hhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhccc--------Cc
Q 003052 550 VLNGSMNNKDGRVKDDGYIYMVLEYGE-IDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIHE--------ER 620 (853)
Q Consensus 550 l~~~~iv~~~g~~~d~~~lyLVmEy~~-gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLHs--------~g 620 (853)
......+|+||||+. ++|.+++.+ ..+++..+..++.|++.||.|||. +|
T Consensus 70 ------------~~~~~~~~lv~Ey~~~g~L~~~l~~---------~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~ 128 (303)
T d1vjya_ 70 ------------NGTWTQLWLVSDYHEHGSLFDYLNR---------YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPA 128 (303)
T ss_dssp ------------CSSSEEEEEEEECCTTCBHHHHHHH---------CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCE
T ss_pred ------------CCcceEEEEEEecccCCCHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCC
Confidence 112236899999986 599999865 368999999999999999999996 59
Q ss_pred eeeCCCCCccEEe-ecCcEEEEecccchhcccCCcc--ccccccccCccccCchhhccCCCCCCCccccCCCccchhhhH
Q 003052 621 IVHSDLKPANFLL-VKGSLKLIDFGIAKAIMSDTTN--IQRDSQVGTLSYMSPEAFMCNESDENGNIIKCGRPSDIWSLG 697 (853)
Q Consensus 621 IIHRDLKPeNILL-~~g~VKL~DFGlAk~~~~~~~~--~~~~t~~GTp~YmAPEvl~~~~~~~~~~~~~ys~ksDIWSLG 697 (853)
||||||||+|||| .++.+||+|||+++.+...... ......+||+.|||||++.+.... ....++.++||||||
T Consensus 129 IvHrDlKp~NILl~~~~~~Kl~DFGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~---~~~~~~~k~Di~S~G 205 (303)
T d1vjya_ 129 IAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINM---KHFESFKRADIYAMG 205 (303)
T ss_dssp EECSCCCGGGEEECTTSCEEECCCTTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCT---TCHHHHHHHHHHHHH
T ss_pred eeccccCccceEEcCCCCeEEEecCccccccCCCcceeccccceecccCcCChhhccccccc---cCCCcCcchhhhhhH
Confidence 9999999999999 5679999999999876543221 123467899999999998764321 122467899999999
Q ss_pred HHHHHHHhCCCCCCcch--------------hHHHHHHhhcCCCCcccCCCC-----CChhHHHHHHHhcccCCCCCCCh
Q 003052 698 CILYQMVYGRTPFSEYK--------------TFWAKFKVITDPNHEITYEPV-----PNPWLLDLMKKCLAWDRNERWRI 758 (853)
Q Consensus 698 VILyELLtG~~PF~~~~--------------~~~~~~kii~~~~~~~~~~~~-----~s~~l~dLI~kcL~~DP~kRpTa 758 (853)
|+||||+||..||.... ..................+.. ....+.+||.+||..||.+|||+
T Consensus 206 vvl~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~ 285 (303)
T d1vjya_ 206 LVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTA 285 (303)
T ss_dssp HHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCH
T ss_pred HHHHHHhhCCCCCCcccccccchhhcccccchHHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCH
Confidence 99999999998873211 112222222222221111111 12348899999999999999999
Q ss_pred hHHhcC
Q 003052 759 PQLLQH 764 (853)
Q Consensus 759 ~EIL~H 764 (853)
.||+++
T Consensus 286 ~ei~~~ 291 (303)
T d1vjya_ 286 LRIKKT 291 (303)
T ss_dssp HHHHHH
T ss_pred HHHHHH
Confidence 999863
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.89 E-value=6.3e-24 Score=211.48 Aligned_cols=136 Identities=20% Similarity=0.149 Sum_probs=103.4
Q ss_pred eeEEEeEeccCceEEEEEEecCCcEEEEEEEecCCCC----------------hhhHhhHHHHHHHHHHhcCCCceeEee
Q 003052 474 YQRLGKIGSGGSSEVHKVISSDCTIYALKKIKLKGRD----------------YATAYGFCQEIEYLNKLKGKNNIIQLI 537 (853)
Q Consensus 474 Y~ilk~LG~G~FG~Vyka~~~~g~~vAVKkik~~~~~----------------~~~~~~~l~EI~iLkkL~~hpNIV~Li 537 (853)
|.+.++||+|+||.||+|.+.+|+.||||+++..... ........+|...|.++. +.+++..+
T Consensus 2 ~~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~v~~~~ 80 (191)
T d1zara2 2 DAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ-GLAVPKVY 80 (191)
T ss_dssp SEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT-TSSSCCEE
T ss_pred chhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHcc-CCCcceEE
Confidence 4578899999999999999988999999987642211 011123446777787776 56676666
Q ss_pred ehhhhHHHHHHHHhhCCCCCCCCccccCCeEEEEEecchhhHHHHHHHhhhhccCCCCCCCHHHHHHHHHHhhhhhhhcc
Q 003052 538 DYEVTEKALLREVLNGSMNNKDGRVKDDGYIYMVLEYGEIDLAHMLSQKWKEMDGSNQTLDENWLRFYWQQILEAVNTIH 617 (853)
Q Consensus 538 d~~~~e~~iL~~l~~~~iv~~~g~~~d~~~lyLVmEy~~gdL~~~L~~~~k~~~~~~~~LsE~~~r~I~~QIl~AL~yLH 617 (853)
++. ..+++|||+++... ..+++..+..++.||+.+|.|||
T Consensus 81 ~~~--------------------------~~~lvme~~~~~~~--------------~~l~~~~~~~i~~ql~~~l~~lH 120 (191)
T d1zara2 81 AWE--------------------------GNAVLMELIDAKEL--------------YRVRVENPDEVLDMILEEVAKFY 120 (191)
T ss_dssp EEE--------------------------TTEEEEECCCCEEG--------------GGCCCSCHHHHHHHHHHHHHHHH
T ss_pred Eec--------------------------CCEEEEEeeccccc--------------cchhhHHHHHHHHHHHHHHHHHh
Confidence 541 12799999875211 13556667889999999999999
Q ss_pred cCceeeCCCCCccEEeecCcEEEEecccchhcc
Q 003052 618 EERIVHSDLKPANFLLVKGSLKLIDFGIAKAIM 650 (853)
Q Consensus 618 s~gIIHRDLKPeNILL~~g~VKL~DFGlAk~~~ 650 (853)
++||+||||||+|||++++.++|+|||+|....
T Consensus 121 ~~giiHrDiKP~NILv~~~~~~liDFG~a~~~~ 153 (191)
T d1zara2 121 HRGIVHGDLSQYNVLVSEEGIWIIDFPQSVEVG 153 (191)
T ss_dssp HTTEECSCCSTTSEEEETTEEEECCCTTCEETT
T ss_pred hCCEEEccCChhheeeeCCCEEEEECCCcccCC
Confidence 999999999999999998899999999997653
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.09 E-value=5.7e-06 Score=83.06 Aligned_cols=79 Identities=16% Similarity=0.287 Sum_probs=52.2
Q ss_pred eeEEEeEeccCceEEEEEEecCCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeehhhhHHHHHHHHhhC
Q 003052 474 YQRLGKIGSGGSSEVHKVISSDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDYEVTEKALLREVLNG 553 (853)
Q Consensus 474 Y~ilk~LG~G~FG~Vyka~~~~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~~~~e~~iL~~l~~~ 553 (853)
|++.+..+.|+.+.||++.. +++.++||+....... ....+.+|..+|+.|..+--+.+++.+
T Consensus 16 ~~~~~~~~G~s~~~v~rv~~-~~~~~vlk~~~~~~~~--~~~~~~~E~~~l~~l~~~vpvP~vl~~-------------- 78 (263)
T d1j7la_ 16 YRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKG--TTYDVEREKDMMLWLEGKLPVPKVLHF-------------- 78 (263)
T ss_dssp SEEEECSCCCSSSEEEEEEC-SSCEEEEEEECGGGTT--STTCHHHHHHHHHHHTTTSCCCCEEEE--------------
T ss_pred eEEEEcCCCCCCCcEEEEEe-CCCeEEEEEcCCCccc--chhhHHHHHHHHHHHhccCCCCcEEEE--------------
Confidence 56666555555678999865 4455778887644321 233567899999988765445555544
Q ss_pred CCCCCCCccccCCeEEEEEecchh
Q 003052 554 SMNNKDGRVKDDGYIYMVLEYGEI 577 (853)
Q Consensus 554 ~iv~~~g~~~d~~~lyLVmEy~~g 577 (853)
..+++..|+||++.+|
T Consensus 79 --------~~~~~~~~lv~~~l~G 94 (263)
T d1j7la_ 79 --------ERHDGWSNLLMSEADG 94 (263)
T ss_dssp --------EEETTEEEEEEECCSS
T ss_pred --------EecCCceEEEEEeccc
Confidence 3456778999999765
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.66 E-value=9.3e-05 Score=79.86 Aligned_cols=61 Identities=15% Similarity=0.093 Sum_probs=37.1
Q ss_pred EEeEeccCceEEEEEEecC-CcEEEEEEEecC----CCC-hhhHhhHHHHHHHHHHhcCC--CceeEee
Q 003052 477 LGKIGSGGSSEVHKVISSD-CTIYALKKIKLK----GRD-YATAYGFCQEIEYLNKLKGK--NNIIQLI 537 (853)
Q Consensus 477 lk~LG~G~FG~Vyka~~~~-g~~vAVKkik~~----~~~-~~~~~~~l~EI~iLkkL~~h--pNIV~Li 537 (853)
.+.||.|....||++...+ ++.++||.-... ... .....+...|.++|+.+..+ ..+.+++
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~ 99 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVF 99 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEE
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEE
Confidence 4568999999999998754 577888865321 111 11233456789999887643 2344444
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.61 E-value=0.00011 Score=73.03 Aligned_cols=72 Identities=15% Similarity=0.101 Sum_probs=47.7
Q ss_pred eEeccCc-eEEEEEEecCCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCc-eeEeeehhhhHHHHHHHHhhCCCC
Q 003052 479 KIGSGGS-SEVHKVISSDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNN-IIQLIDYEVTEKALLREVLNGSMN 556 (853)
Q Consensus 479 ~LG~G~F-G~Vyka~~~~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpN-IV~Lid~~~~e~~iL~~l~~~~iv 556 (853)
.+..|.. +.||++...++..+++|...... ...+..|...|+.|..+.- +.+++.+
T Consensus 17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~-----~~~l~~E~~~l~~L~~~gvpvP~v~~~----------------- 74 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSGA-----LNELQDEAARLSWLATTGVPCAAVLDV----------------- 74 (255)
T ss_dssp ECSCTTSSCEEEEEECTTSCCEEEEEECSCT-----TSCHHHHHHHHHHHHTTTCCBCCEEEE-----------------
T ss_pred EcCCcccCCeEEEEEeCCCCEEEEEeCCccC-----HhHHHHHHHHHHHHHhcCCCCCceeee-----------------
Confidence 3455554 67999988778778888765432 2246789999988875422 3444433
Q ss_pred CCCCccccCCeEEEEEecchh
Q 003052 557 NKDGRVKDDGYIYMVLEYGEI 577 (853)
Q Consensus 557 ~~~g~~~d~~~lyLVmEy~~g 577 (853)
..+++..|+||+|++|
T Consensus 75 -----~~~~~~~~~v~~~i~G 90 (255)
T d1nd4a_ 75 -----VTEAGRDWLLLGEVPG 90 (255)
T ss_dssp -----EECSSCEEEEEECCSS
T ss_pred -----cccccceEEEEEeeec
Confidence 3455678999999753
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=96.88 E-value=0.0021 Score=66.79 Aligned_cols=43 Identities=14% Similarity=0.132 Sum_probs=32.5
Q ss_pred ceEEEEEEecCCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCC
Q 003052 485 SSEVHKVISSDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGK 530 (853)
Q Consensus 485 FG~Vyka~~~~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~h 530 (853)
--.||++...+|..|++|+....... ...+..|+..+..|..+
T Consensus 35 EN~vy~v~~~dg~~~VlK~~rp~~~s---~~~i~~E~~~l~~L~~~ 77 (325)
T d1zyla1 35 ENRVYQFQDEDRRRFVVKFYRPERWT---ADQILEEHQFALQLVND 77 (325)
T ss_dssp SSEEEEECCTTCCCEEEEEECTTTSC---HHHHHHHHHHHHHHHHT
T ss_pred cceeEEEEcCCCCEEEEEEeCCCCCC---HHHHHHHHHHHHHHHhc
Confidence 46899999989999999998754333 23467899999888743
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=96.04 E-value=0.01 Score=63.07 Aligned_cols=59 Identities=14% Similarity=0.056 Sum_probs=38.3
Q ss_pred EEeEeccCceEEEEEEecCC--------cEEEEEEEecCCCChhhHhhHHHHHHHHHHhcCCCceeEeeeh
Q 003052 477 LGKIGSGGSSEVHKVISSDC--------TIYALKKIKLKGRDYATAYGFCQEIEYLNKLKGKNNIIQLIDY 539 (853)
Q Consensus 477 lk~LG~G~FG~Vyka~~~~g--------~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~hpNIV~Lid~ 539 (853)
++.|+.|-.-.+|++...++ +.|.+++.- .... .....+|..+++.+..+.-..+++.+
T Consensus 47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g-~~~~---~idr~~E~~i~~~ls~~gl~Pkll~~ 113 (395)
T d1nw1a_ 47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYF-NPET---ESHLVAESVIFTLLSERHLGPKLYGI 113 (395)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEEC-SCCC---HHHHHHHHHHHHHHHHTTSSSCEEEE
T ss_pred EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecC-Ccch---hhHHHHHHHHHHHHHhCCCCCeEEEE
Confidence 45688899999999986432 456666654 2222 22456899999998765444556554
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=95.63 E-value=0.081 Score=53.53 Aligned_cols=50 Identities=8% Similarity=0.036 Sum_probs=31.0
Q ss_pred eEEEeEeccCceEEEEEEecCCcEEEEEEEecCCCChhhHhhHHHHHHHHHHhcC
Q 003052 475 QRLGKIGSGGSSEVHKVISSDCTIYALKKIKLKGRDYATAYGFCQEIEYLNKLKG 529 (853)
Q Consensus 475 ~ilk~LG~G~FG~Vyka~~~~g~~vAVKkik~~~~~~~~~~~~l~EI~iLkkL~~ 529 (853)
.-++.|..|---+.|++...+++ |++|++.... + ...+..|++++..|..
T Consensus 21 ~~~~~i~~G~~N~ny~v~t~~g~-yVLri~~~~~-~---~~~l~~~~~~l~~L~~ 70 (316)
T d2ppqa1 21 TSYKGIAEGVENSNFLLHTTKDP-LILTLYEKRV-E---KNDLPFFLGLMQHLAA 70 (316)
T ss_dssp EEEEEECC---EEEEEEEESSCC-EEEEEECC-------CCHHHHHHHHHHHHHH
T ss_pred eEeecCCCCcccCeEEEEECCCc-EEEEEcCCCC-C---HHHHHHHHHHHHhhhh
Confidence 33455778888899999876665 8999986431 1 2235567888888764
|